LOINC_NUM,LONG_COMMON_NAME,SHORTNAME,DisplayName,RELATEDNAMES2,SCALE_TYP
100021-5,gnaq gene mutations found [identifier] in blood or tissue by molecular genetics method nominal,gnaq gene mut anl bld/t,gnaq gene targeted mutation analysis molgen nom (bld/tiss),"blood; cmc1; g protein subunit alpha q; g-alpha-q; gaq; identity or presence; molecular genetics; molecular pathology; molpath; molpath.mutations; mut; mut anl; mutations; nominal; pcr; point in time; random; sws; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",Nom
10003-2,r wave duration in lead iii,r wave dur l-iii,,3; cardiac; cardio; cardiology; durat; ecg; ekg.measurements; electrocardiogram; electrocardiograph; heart disease; hrt; painter's colic; pb; plumbism; point in time; qnt; quan; quant; quantitative; r prime; r' wave dur l-iii; r wave dur l-iii; random; right,Qn
100035-5,exam finding location of chest,exam finding location chest,,finding; findings; h+p; h+p.px; nominal; p prime; point in time; random; thorax,Nom
100048-8,clarithromycin+ethambutol [susceptibility],clarithro+ethamb susc islt,clarithromycin+ethambutol [susc],antibiotic susceptibilities; ast; biaxin; claripen; clarithro+ethamb; etambol; ethamb; inagen; islt; isol; klacid; myambutol; mycobutol; olbutam; point in time; random; sus; suscept; susceptibilities; susceptibility; susceptibilty,OrdQn
100064-5,itch severity reporting period - reported,itch severity rptperiod reported,,clin; finding; findings; ordinal; ql; qual; qualitative; report period; screen,Ord
100079-3,left cornea endothelial cell area.min,l cornea endothelial cell area.min,,corneal; eye; l; l cornea; lt; minimal; minimum; point in time; qnt; quan; quant; quantitative; random,Qn
100088-4,taenia solium larva ab bands panel - serum by immunoblot,t solium ab bands pnl ser ib,taenia solium larva ab bands panel ib (s),blt; cysticercosis; cysticercus; immune blot; immunobl; immunoblot; microbiology; pan; panel.microbiology; panl; pnl; point in time; random; riba; serum; sr; t sol; t sol lar; t solium; t solium ab bands pnl; tapeworm; wb; wblot; west blot; west blt; western blot,-
100092-6,trypanosoma cruzi ab bands panel - serum by immunoblot,t cruzi ab bands pnl ser ib,trypanosoma cruzi ab bands panel ib (s),blt; chagas disease; immune blot; immunobl; immunoblot; microbiology; pan; panel.microbiology; panl; pnl; point in time; random; riba; serum; sr; t cruzi; t cruzi ab bands pnl; trypanosomiasis; trypanosomosis; wb; wblot; west blot; west blt; western blot,-
100103-1,fasciola sp 60kd igg ab [presence] in serum by immunoblot,fasciola sp 60kd igg ser ql ib,fasciola sp 60kd igg ib ql (s),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; blt; immune blot; immune globulin g; immunobl; immunoblot; immunoglobulin g; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; riba; screen; serum; species; spp; sr; wb; wblot; west blot; west blt; western blot,Ord
10011-5,r' wave amplitude in lead avl,r' wave amp l-avl,,cardiac; cardio; cardiology; ecg; ekg.measurements; electrical potential; electrocardiogram; electrocardiograph; heart disease; hrt; painter's colic; pb; plumbism; point in time; qnt; quan; quant; quantitative; r prime; r' wave amp l-avl; r wave amp l-avl; random; right; voltage,Qn
100121-3,chlamydia trachomatis iga ab [presence] in serum by immunoassay,c trach iga ser ql ia,c. trachomatis iga ia ql (s),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; c trac; c trach; c tracho; c trachomatis; chlam; chlam trac; chlamid; ct; eia; elfa; elisa; enzyme immunoassay; iaa; immune globulin a; immunoglobulin a; lgv; lymphogranuloma venereum; meia; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; sr; suds; trachoma,Ord
100130-4,schistosoma mansoni ab [presence] in serum by immunoblot,s mansoni ab ser ql ib,s. mansoni ab ib ql (s),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; bilharziasis; blt; immune blot; immunobl; immunoblot; microbiology; ordinal; p3; point in time; pr; ql; qual; qualitative; random; riba; s mansoni; schistosomiasis; screen; serum; sr; wb; wblot; west blot; west blt; western blot,Ord
100134-6,schistosoma sp 11kd ab [presence] in serum by immunoblot,schistosoma sp 11kd ab ser ql ib,schistosoma sp 11kd ab ib ql (s),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; bilharziasis; blood fluke; blt; cercarial dermatitis; immune blot; immunobl; immunoblot; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; riba; schistosomiasis; screen; serum; species; spp; sr; wb; wblot; west blot; west blt; western blot,Ord
100146-0,schistosoma sp 120kd ab [presence] in serum by immunoblot,schistosoma sp 120kd ab ser ql ib,schistosoma sp 120kd ab ib ql (s),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; bilharziasis; blood fluke; blt; cercarial dermatitis; immune blot; immunobl; immunoblot; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; riba; schistosomiasis; screen; serum; species; spp; sr; wb; wblot; west blot; west blt; western blot,Ord
10014-9,r' wave amplitude in lead ii,r' wave amp l-ii,,2; cardiac; cardio; cardiology; ecg; ekg.measurements; electrical potential; electrocardiogram; electrocardiograph; heart disease; hrt; painter's colic; pb; plumbism; point in time; qnt; quan; quant; quantitative; r prime; r' wave amp l-ii; r wave amp l-ii; random; right; voltage,Qn
100159-3,knee society score pre-op panel [knee society score],,,before; kss; kss pre-op; lower extremity joint; ortho; pan; panl; pnl; point in time; random; survey; systemic coronary risk evaluation,-
100164-3,knee ap instability w 90 degree flexion,knee ap instability w 90 deg flex,knee ap instability w 90 degree flexion,ap instability; ap instability^w 90 degree flexion; clin; finding; findings; kn; lower extremity joint; ordinal; point in time; ql; qual; qualitative; random; screen,Ord
100168-4,knee pain severity with level walking,,,finding; findings; levels; levl; lower extremity joint; lv; lvl; ordinal; point in time; ql; qual; qualitative; random; screen; survey,Ord
100171-8,satisfaction with level of knee pain while sitting,,,finding; findings; levels; levl; lower extremity joint; lv; lvl; ordinal; point in time; ql; qual; qualitative; random; screen; survey,Ord
100179-1,walk without assistive mobility devices,,,finding; findings; ordinal; ortho; point in time; ql; qual; qualitative; random; screen; survey,Ord
100180-9,assistive mobility devices used,,,finding; findings; nominal; ortho; point in time; random; survey,Nom
100204-7,accuracy of pre-surgery expectations of pain relief,,,before; finding; findings; ordinal; ortho; point in time; ql; qual; qualitative; random; screen; surg; survey,Ord
100225-2,bone density quantitative ultrasound study,bone density qus,,bmd; bone density qn us; den; document; finding; findings; imaging; point in time; radiology; random; study report,Doc
100228-6,upper gastrointestinal capsule endoscopy study document,ugi capsule endo study doc,,document; finding; findings; gi; gi.endoscopy; point in time; random; study report; ugi capsule endo study; up,Doc
100239-3,felt as if adverse event did not happen,,,ae; arterial stenosis; finding; findings; ordinal; ql; qual; qualitative; report period; screen; survey; survey.mtlhlth,Ord
100244-3,"aware of feelings about adverse event, but did not address them",,,ae; finding; findings; ordinal; ql; qual; qualitative; report period; screen; survey; survey.mtlhlth,Ord
10024-8,r' wave duration in lead avr,r' wave dur l-avr,,cardiac; cardio; cardiology; durat; ecg; ekg.measurements; electrocardiogram; electrocardiograph; heart disease; hrt; painter's colic; pb; plumbism; point in time; qnt; quan; quant; quantitative; r prime; r' wave dur l-avr; r wave dur l-avr; random; right,Qn
100250-0,trouble concentrating,,,finding; findings; ordinal; ql; qual; qualitative; report period; screen; survey; survey.mtlhlth,Ord
100265-8,aware of dietary intake impact on self,,,finding; findings; ordinal; point in time; ql; qual; qualitative; random; screen; survey; survey.mtlhlth,Ord
100274-0,observing score [ffmq],,,point in time; qnt; quan; quant; quantitative; random; scale; survey; survey.mtlhlth,Qn
100282-3,vaccine exemption certificate,vaccine exemption cert,,admin; doc.admin; document; finding; findings; point in time; random,Doc
100291-4,total score [harris hip score],,,hhs; lower extremity joint; ortho; point in time; qnt; quan; quant; quantitative; random; scale; survey; systemic coronary risk evaluation; tot; totl,Qn
100308-6,need help getting to essential places,,,finding; findings; ordinal; point in time; ql; qual; qualitative; random; screen; survey; survey.mtlhlth,Ord
100326-8,money spent or property sold without permission,,,finding; findings; ordinal; point in time; ql; qual; qualitative; random; screen; survey; survey.mtlhlth,Ord
100329-2,feared for safety due to verbal attack,,,finding; findings; ordinal; point in time; ql; qual; qualitative; random; screen; survey; survey.mtlhlth,Ord
100339-1,experienced attempted physical restraint,,,finding; findings; ordinal; point in time; ql; qual; qualitative; random; screen; survey; survey.mtlhlth,Ord
100342-5,volatile organic compounds associated with sars-cov-2 infection [presence] in exhaled gas by gas chromatography-mass spectrometry,vocs (volatiles) sars-cov-2 exg ql gc-ms,volatile organic compounds associated with sars-cov-2 infection gas chromatography-mass spectrometry ql (exhl gas),assoc; breath; exg; exhaled gas; exhaled gas (=breath); gas chromatography; gases; id; ii; infectious disease; infectiousdisease; microbiology; ordinal; ph; point in time; pr; public health; publichealth; ql; qual; qualitative; random; screen; severe acute respiratory syndrome; vocs (volatiles) sars-cov-2; volatiles,Ord
100345-8,influenza virus a and b and sars-cov-2 (covid-19) rna panel - specimen by naa with probe detection,fluabv+sars-cov-2 rna pnl spec naa+probe,influenza virus a and b and sars-cov-2 (covid-19) rna panel naa+probe (specimen),2019 novel coronavirus; 2019-ncov; 3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; avian influenza; bird flu; corona virus; covid19; covid-19; dna nucleic acid probe; dna probe; flua; fluabv + sars-cov-2; fluabv+sars-cov-2 rna pnl; fluav; flub; flubv; fluv; fowl plague; id; ii; infectious disease; infectiousdisease; influ; influenza a; influenza a virus; influenza b; influenza b virus; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; misc; miscellaneous; naa+probe; naat; nasba; nucleic acid sequence based analysis; other; pan; panel.microbiology; panl; pcr; ph; pnl; point in time; polymerase chain reaction; probe amp; probe with ampification; probe with target amplification; public health; publichealth; qbr; random; ribonucleic acid; sars coronavirus 1; sars-cov; sars-cov-1; sars-cov-2; sars-cov-2 rna pnl; sda; severe acute respiratory syndrome; spec; strand displacement amplification; tma; to be specified in another part of the message; transcription mediated amplification; unspecified; viral pneumonias; wuhan coronavirus,-
100359-9,gliadin 33 mer peptide [mass/volume] in stool by immunoassay,gliadin 33 mer stl ia-mcnc,gliadin 33 mer peptide ia (stl) [mass/vol],bowel movement; celiac disease; chemistry; eia; elfa; elisa; enzyme immunoassay; f98; faecal; faeces; fecal; feces; gliadine; iaa; level; mass concentration; meia; pept; point in time; qnt; quan; quant; quantitative; random; stl; stool = fecal; suds,Qn
100381-3,mentha balsamea wild igg ab [units/volume] in serum,mentha balsamea wild igg qn,mentha balsamea wild igg qn (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; immune globulin g; immunoglobulin g; point in time; qnt; quan; quant; quantitative; random; serum; sr,Qn
100394-6,astacoidea igg ab [units/volume] in serum,decapod crustaceans igg qn,decapod crustaceans igg qn (s),"abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; decapod crustaceans; decapod crustaceans igg; immune globulin g; immunoglobulin g; lobsters, crayfish; point in time; qnt; quan; quant; quantitative; random; serum; sr",Qn
100395-3,carob igg ab [units/volume] in serum,carob igg qn,carob igg qn (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; carob; carob bean gum; f296; immune globulin g; immunoglobulin g; locust bean gum; point in time; qnt; quan; quant; quantitative; random; rf296; serum; sr; st john's bread,Qn
100419-1,snow pea igg ab [units/volume] in serum,snow pea igg qn,snow pea igg qn (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; f012; f12; green pea; immune globulin g; immunoglobulin g; pea; peas; point in time; qnt; quan; quant; quantitative; random; serum; snow pea; snow pea ab.igg; sr,Qn
100426-6,squalene [mass/volume] in serum or plasma,squalene serpl-mcnc,squalene [mass/vol],chemistry; level; mass concentration; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
100428-2,carnitine free and total and acylcarnitine panel - urine,carnitine + acylcarnitine pnl ur,carnitine free and total and acylcarnitine panel (u),acyl carnitine; acylcarni; acylcarnitine pnl; carnitine + acylcarnitine pnl; carnitine.total; chemistry; fr; non-protein bound; pan; panel.chemistry; panl; pnl; point in time; random; tot; totl; ua; ur; urn,-
100430-8,cells.lrba+/cells.cd3+cd14-cd45+ in blood by flow cytometry (fc),cells.lrba+/t cells nfr bld fc,cells.lrba+/cells.cd3+cd14-cd45+ fc (bld),b220; blood; cd3 cells; cd45r; cd45ra; cd45rb; cd45rc; cd45ro; cell; cell markers; cellularity; dynamic; fc; lca; leu4; leu-4; leukocyte common antigen; leum3; leu-m3; lps receptor; lps-r; ly5; mo2; mo-2; monocytes; my4; my-4; number fraction; percent; point in time; qnt; quan; quant; quantitative; random; t cells; t200; t3; wb; whole blood,Qn
100433-2,cells.cd3-cd14-cd19+cd45+.lrba mean fluorescence intensity in blood by flow cytometry (fc),b-cells lrba mfi bld fc,cells.cd3-cd14-cd19+cd45+.lrba mean fluorescence intensity fc (bld) [units],arbitrary; average; avg; b220; b4; b-4; b-cells lrba mfi; blood; cd3 cells; cd45r; cd45ra; cd45rb; cd45rc; cd45ro; cell; cell markers; cellularity; dynamic; fc; hd-37; lca; leu12; leu-12; leu4; leu-4; leukocyte common antigen; leum3; leu-m3; lps receptor; lps-r; ly5; mo2; mo-2; my4; my-4; point in time; qnt; quan; quant; quantitative; random; t200; t3; wb; whole blood,Qn
100436-5,ubiquitin carboxyl-terminal hydrolase-l1 [mass/volume] in serum by immunoassay,uch-l1 ser ia-mcnc,ubiquitin carboxyl-terminal hydrolase-l1 ia (s) [mass/vol],eia; elfa; elisa; enzyme immunoassay; iaa; level; mass concentration; meia; point in time; qnt; quan; quant; quantitative; random; serology; serum; sr; suds; tbi (traumatic brain injury); uch-l1,Qn
100438-1,adolescent medicine outpatient progress note,adolescent med op prog note,,doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; notes; op; point in time; prog note; random; subsequent evaluation; subsequent visit evaluation; visit note,Doc
100442-3,audiology outpatient progress note,audiology op prog note,,doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; notes; op; point in time; prog note; random; subsequent evaluation; subsequent visit evaluation; visit note,Doc
100445-6,bone marrow transplant outpatient progress note,bm transplant op prog note,,bm transplant; doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; notes; op; point in time; prog note; random; subsequent evaluation; subsequent visit evaluation; visit note,Doc
100452-2,clinical cardiac electrophysiology outpatient progress note,electrophysiology op prog note,,doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; notes; op; point in time; prog note; random; subsequent evaluation; subsequent visit evaluation; visit note,Doc
100454-8,clinical neurophysiology outpatient progress note,clinical neurophys op prog note,,doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; notes; op; point in time; prog note; random; subsequent evaluation; subsequent visit evaluation; visit note,Doc
100459-7,outpatient covid-19 progress note,op covid-19 progress note,,2019 novel coronavirus; 2019-ncov; coronavirus disease 2019; covid19; covid-19 progress note; doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; notes; op; point in time; prog note; random; sars coronavirus; sars-cov-2; sars-related coronavirus; subsequent evaluation; subsequent visit evaluation; visit note,Doc
100492-8,nutrition and dietetics outpatient progress note,nutr+diet op prog note,,doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; notes; nutr+diet; nutrition+dietetics; op; point in time; prog note; random; subsequent evaluation; subsequent visit evaluation; visit note,Doc
100506-5,pediatric dermatology outpatient progress note,peds dermatology op prog note,,derm; doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; notes; op; peds; peds dermatology; point in time; prog note; random; subsequent evaluation; subsequent visit evaluation; visit note,Doc
100515-6,pediatric transplant hepatology outpatient progress note,peds transpl hepato op prog note,,doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; notes; op; peds; peds transpl hepato; point in time; prog note; random; subsequent evaluation; subsequent visit evaluation; visit note,Doc
100516-4,pediatric urology outpatient progress note,peds urology op prog note,,doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; notes; op; peds; peds urology; point in time; prog note; random; subsequent evaluation; subsequent visit evaluation; visit note,Doc
100518-0,physical medicine and rehab outpatient progress note,pm+r op prog note,,doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; notes; op; pm+r; point in time; prog note; random; subsequent evaluation; subsequent visit evaluation; visit note,Doc
100521-4,podiatry outpatient progress note,podiatry op prog note,,doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; notes; op; point in time; prog note; random; subsequent evaluation; subsequent visit evaluation; visit note,Doc
100528-9,reproductive endocrinology and infertility outpatient progress note,rei op prog note,,doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; notes; op; point in time; prog note; random; rei; subsequent evaluation; subsequent visit evaluation; visit note,Doc
100553-7,blood banking and transfusion medicine hospital progress note,bld bnk+trans med hosp prog note,,bld bnk+trans med; blood conservation; doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; hosp; inpatient; notes; point in time; prog note; random; subsequent evaluation; subsequent visit evaluation; tx; visit note,Doc
100555-2,breastfeeding hospital progress note,breastfeeding hosp prog note,,doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; hosp; inpatient; notes; point in time; prog note; random; subsequent evaluation; subsequent visit evaluation; visit note,Doc
100557-8,cardiac surgery hospital progress note,cardiac surgery hosp prog note,,doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; hosp; inpatient; notes; point in time; prog note; random; subsequent evaluation; subsequent visit evaluation; surg; visit note,Doc
100570-1,eating disorders hospital progress note,eating disorders hosp prog note,,doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; hosp; inpatient; notes; point in time; prog note; random; subsequent evaluation; subsequent visit evaluation; visit note,Doc
100583-4,hepatology hospital progress note,hepatology hosp prog note,,doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; hosp; inpatient; notes; point in time; prog note; random; subsequent evaluation; subsequent visit evaluation; visit note,Doc
100586-7,internal medicine hospital progress note,internal med hosp prog note,,doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; hosp; inpatient; notes; point in time; prog note; random; subsequent evaluation; subsequent visit evaluation; visit note,Doc
100590-9,medical aid in dying hospital progress note,maid hosp prog note,,assisted suicide; death with dignity; doc.ont; document; encounter; end of life option; evaluation and management; evaluation and management note; finding; findings; hosp; inpatient; maid; medical assistance in dying; medical assisted death; notes; physician-assisted death; point in time; prog note; random; subsequent evaluation; subsequent visit evaluation; visit note,Doc
100598-2,nurse practitioner hospital progress note,nurse pract hosp prog note,,doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; hosp; inpatient; notes; nursing; point in time; prog note; random; subsequent evaluation; subsequent visit evaluation; visit note,Doc
100606-3,oral and maxillofacial surgery hospital progress note,oms hosp prog note,,doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; hosp; inpatient; notes; oms; point in time; prog note; random; subsequent evaluation; subsequent visit evaluation; surg; visit note,Doc
100622-0,pediatric surgery hospital progress note,peds surgery hosp prog note,,doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; hosp; inpatient; notes; peds; peds surgery; point in time; prog note; random; subsequent evaluation; subsequent visit evaluation; surg; visit note,Doc
100627-9,physical therapy hospital progress note,pt hosp prog note,,doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; hosp; inpatient; notes; point in time; prog note; pt; random; subsequent evaluation; subsequent visit evaluation; visit note,Doc
100629-5,podiatry hospital progress note,podiatry hosp prog note,,doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; hosp; inpatient; notes; point in time; prog note; random; subsequent evaluation; subsequent visit evaluation; visit note,Doc
100632-9,radiology hospital progress note,radiology hosp prog note,,doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; hosp; inpatient; notes; point in time; prog note; random; subsequent evaluation; subsequent visit evaluation; visit note,Doc
100681-6,herpes virus 7 dna [log #/volume] (viral load) in serum or plasma by naa with probe detection,hhv7 dna serpl naa+probe-log#,hhv 7 dna naa+probe [log #/vol],3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; deoxyribonucleic acid; dna nucleic acid probe; dna probe; herpesvirus; hhv; hhv7; human herpes virus; human herpes virus type 7; lat; lcr; ligase chain reaction; ligation-activated transcription; log ncnc; log#; microbiology; naa+probe; naat; nasba; nucleic acid sequence based analysis; pcr; pl; plasma; plsm; point in time; polymerase chain reaction; probe amp; probe with ampification; probe with target amplification; qbr; qnt; quan; quant; quantitative; random; sda; serp; serpl; serplas; serum; serum or plasma; sr; strand displacement amplification; tma; transcription mediated amplification; viral load,Qn
100700-4,trichomonas vaginalis dna [presence] in urethra by naa with probe detection,t vaginalis dna urth ql naa+probe,t. vaginalis dna naa+probe ql (urethra),3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; deoxyribonucleic acid; dna nucleic acid probe; dna probe; genital tract; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; naa+probe; naat; nasba; nucleic acid sequence based analysis; ordinal; pcr; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; screen; sda; strand displacement amplification; t vaginalis; tma; transcription mediated amplification; tric; trich; trichimoniasis; trichomonad; trichomonads; trichomoniasis; urth,Ord
100706-1,mycoplasma genitalium rrna [presence] in specimen by naa with probe detection,m genitalium rrna spec ql naa+probe,m. genitalium rrna naa+probe ql (specimen),3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; dna nucleic acid probe; dna probe; gen-probe; lat; lcr; ligase chain reaction; ligation-activated transcription; m genitalium; m genitalium rrna; microbiology; misc; miscellaneous; myco; mycoplas; mycoplasm; mycoplasmoides genitalium; mycoplasmosis; mycoplsm; naa+probe; naat; nasba; nucleic acid sequence based analysis; ordinal; other; pcr; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; ribosomal rna; screen; sda; spec; strand displacement amplification; tma; to be specified in another part of the message; transcription mediated amplification; unspecified,Ord
100710-3,chlamydia trachomatis and neisseria gonorrhoeae rrna panel - throat by naa with probe detection,c trach+gc pnl throat naa+probe,c. trachomatis and n. gonorrhoeae rrna panel naa+probe (throat),3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; c trac; c trach; c trach+gc; c trach+gc pnl; c tracho; c trachomatis; chlam; chlam trac; chlamid; ct; ct/gc; dna nucleic acid probe; dna probe; gc; gen-probe; gono; gonorrhea; lat; lcr; lgv; ligase chain reaction; ligation-activated transcription; lymphogranuloma venereum; microbiology; n gonorrhoea; n gonorrhoeae; naa+probe; naat; nasba; nucleic acid sequence based analysis; pan; panel.microbiology; panl; pcr; pnl; point in time; polymerase chain reaction; probe amp; probe with ampification; probe with target amplification; qbr; random; ribosomal rna; sda; strand displacement amplification; throat; tma; trachoma; transcription mediated amplification; upper respiratory,-
100718-6,undersea and hyperbaric medicine discharge summary,undersea+hyperbar d/c sum,,d/c sum; disch; discharge summary; doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; notes; point in time; random; undersea+hyperbar; visit note,Doc
100721-0,community health care discharge summary,comm hlth care d/c sum,,comm hlth care; continuity assessment record and evaluation; d/c sum; disch; discharge summary; doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; notes; point in time; random; visit note,Doc
100723-6,sports medicine discharge summary,sports medicine d/c sum,,d/c sum; disch; discharge summary; doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; notes; point in time; random; visit note,Doc
100725-1,optometry discharge summary,optometry d/c sum,,d/c sum; disch; discharge summary; doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; notes; point in time; random; visit note,Doc
100732-7,cholesterol.in lipoprotein (little a) and cholesterol.in ldl panel - serum,lpald ser,cholesterol.in lipoprotein (little a) & cholesterol.in ldl panel (s),chemistry; chol; choles; cholest; cholesterol total; cholesterols; ldlc; ldl-c; lip; lipid; lipoprot; lipoproteins; low density lipoprotein cholesterol; low density lipoprotein cholesterols; lp; lp(a); lp(a) cholesterol; lpa; lpa cholest; lpa cholesterol; lpald; pan; panel.chemistry; panl; pnl; point in time; random; serum; sr,-
100739-2,aspartate aminotransferase.macromolecular [presence] in serum or plasma,ast macro serpl ql,ast.macromolecular ql,asp; aspartate amino transferase; aspartate transaminase; aspartic acid; ast; ast macro; chemistry; glutamic oxaloacetic transaminase; ordinal; pl; plasma; plsm; point in time; pr; ql; qual; qualitative; random; screen; serp; serpl; serplas; serum; serum or plasma; sgot; sr,Ord
1007-4,direct antiglobulin test.polyspecific reagent [presence] on red blood cells,dat poly-sp reag rbc ql,direct antiglobulin test.polyspecific reagent ql (rbc),antiglob; blood bank; dagt; dat; dat poly-sp reag; dct; dir; direct antiglobulin test.non specific reagent; direct coomb; direct coombs test; erythrocytes; hematology; heme; ordinal; point in time; poly specific; pr; ql; qual; qualitative; random; red blood cells; red blood corpusles; screen; universallaborders,Ord
100747-5,legionella serogroup panel - specimen,lp-sg panel spec,legionella serogroup panel (specimen),legion; legionela; lp-sg panel; microbiology; misc; miscellaneous; other; pan; panel.microbiology; panl; pnl; point in time; random; spec; to be specified in another part of the message; unspecified,-
10075-0,s' wave duration in lead iii,s' wave dur l-iii,,3; cardiac; cardio; cardiology; durat; ecg; ekg.measurements; electrocardiogram; electrocardiograph; heart disease; hrt; painter's colic; pb; plumbism; point in time; qnt; quan; quant; quantitative; random; s prime; s' wave dur l-iii; s wave dur l-iii,Qn
100754-1,platelet disorders multigene analysis in blood or tissue by sequencing,plt disorder gene anal bld/t seq,platelet disorders multigene analysis sequencing doc (bld/tiss),"blood; document; finding; findings; gene; gene panel; high-throughput sequencing; hts; molecular pathology; molpath; multi-gene study; multiple-gene panel test; next generation sequencing; ngs; pl; platelets; platelt; plt; plt disorder gene anal; point in time; random; thrombocyte; thrombocytes; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",Doc
100758-2,estimated lung age by based on clinical data,estimated lung age from clin data,,from clin data; point in time; pulmonary; qnt; quan; quant; quantitative; random,Qn
10076-8,s' wave duration in lead v1,s' wave dur l-v1,,cardiac; cardio; cardiology; durat; ecg; ekg.measurements; electrocardiogram; electrocardiograph; heart disease; hrt; painter's colic; pb; plumbism; point in time; qnt; quan; quant; quantitative; random; s prime; s' wave dur l-v1; s wave dur l-v1,Qn
100771-5,trouble focusing,,,finding; findings; ordinal; ql; qual; qualitative; report period; screen; survey; survey.mtlhlth,Ord
100776-4,feeling fearful,,,finding; findings; ordinal; ql; qual; qualitative; report period; screen; survey; survey.mtlhlth,Ord
100780-6,feeling lonely,,,finding; findings; ordinal; ql; qual; qualitative; report period; screen; survey; survey.mtlhlth,Ord
100789-7,rhizopus nigricans igg4 ab [mass/volume] in serum,r nigricans igg4-mcnc,rhizopus nigricans igg4 (s) [mass/vol],abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; level; m11; mass concentration; point in time; qnt; quan; quant; quantitative; r nigricans; random; rhizopus nigricans igg4; serum; sr,Qn
100792-1,forsythia ige ab [units/volume] in serum,forsythia ige qn,forsythia ige qn (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; forsythia ige; golden bell; immune globulin e; immunoglobulin e; point in time; qnt; quan; quant; quantitative; random; serum; sr,Qn
100795-4,s100 calcium binding protein b [mass/volume] in body fluid,s100 ca binding protein b fld-mcnc,s100 calcium binding protein b (body fld) [mass/vol],"b/f; bf; bind; bod; bodies; body fluid; body fluid, unsp; ca; cal; chemistry; fl; fld; flu; fluid; level; mass concentration; point in time; pr; prot; qnt; quan; quant; quantitative; random; s100 ca binding protein b; s-100b; s-100-beta",Qn
100798-8,testosterone free [mass/volume] in serum --2nd specimen post xxx challenge,testost free sp2 p chal ser-mcnc,testosterone free 2nd specimen post unsp challenge (s) [mass/vol],after; chemistry.challenge testing; convalescent; fr; level; mass concentration; non-protein bound; p chal; point in time; post immunization; pst; qnt; quan; quant; quantitative; random; second; serum; sp2; sp2 p chal; spec; sr; testo; testos; testost; testost free; testosterone.unconjugated,Qn
100806-9,vasopressin [moles/volume] in plasma --3rd specimen post xxx challenge,vasopressin sp3 p chal plas-scnc,vasopressin 3rd specimen post unsp challenge (p) [moles/vol],adh; adiuretin; after; antidiuretic hormone; arginine vasopressin hormone; avh; chemistry.challenge testing; level; p chal; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; sp3; sp3 p chal; spec; substance concentration; vp,Qn
100830-9,alpha subunit free [units/volume] in serum or plasma --1st specimen post xxx challenge,alpha subunit free sp1 p chal serpl-acnc,alpha subunit free 1st specimen post unsp challenge qn,acute specimen; after; alfa; alpha subunit free; arbitrary concentration; chemistry.challenge testing; first; fr; non-protein bound; p chal; pituitary glycoproteins; pl; plasma; plsm; point in time; pre immunization; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sp1; sp1 p chal; spec; sr,Qn
100834-1,alpha subunit free [units/volume] in serum or plasma --5th specimen post xxx challenge,alpha subunit free sp5 p chal serpl-acnc,alpha subunit free 5th specimen post unsp challenge qn,after; alfa; alpha subunit free; arbitrary concentration; chemistry.challenge testing; fr; non-protein bound; p chal; pituitary glycoproteins; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sp5; sp5 p chal; spec; sr,Qn
100839-0,vitamin a/retinol binding protein [ratio] in serum or plasma,vitamin a/retinol bind prot serpl-rto,vitamin a/retinol binding protein [ratio],alpha 2 microglobulin; alpha-2-microglobulin; axerol; axerophthol; bind; biosterol; chemistry; pl; plasma; plsm; point in time; pr; prot; qnt; quan; quant; quantitative; random; ratios; rbp; retinol bind prot; rto; serp; serpl; serplas; serum; serum or plasma; sr; vit a; vit a alcohol; vit a/rbp; vit a1; vit a1 alcohol; vitamin a; vitamin a alcohol; vitamin a binding protein; vitamin a1,Qn
100843-2,liver fibrosis score in serum or plasma by calculated.agile3+,liver fibr score serpl agile3+,liver fibrosis score calculated.agile3+ [score],calc; calculation; chemistry; liver fibr score; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; scale; serp; serpl; serplas; serum; serum or plasma; sr,Qn
100854-9,lymphocytes/cells in blood mononuclear cells by immunoassay,lymphocytes bld mc ia-nfr,lymphocytes/cells ia (bld mc),blood; cell; cellularity; eia; elfa; elisa; enzyme immunoassay; iaa; lymp; lymph; lympho; lymphocyte; lymphs; lymphs%; meia; microbiology; number fraction; pbmc; percent; peripheral blood mononuclear cells; point in time; qnt; quan; quant; quantitative; random; suds; wb; whole blood,Qn
100858-0,cells.cd4+cd154+/cd4 cells in blood --after stimulation with sars-cov-2 spike peptide,cd4+154/cd4 stim covid spike,cells.cd4+cd154+ /cd4 cells after stimulation with sars-cov-2 spike peptide (bld),blood; cd4 cells; cd4+154 cells; cd4+154/cd4 stim covid spike; cd40 ligand; cd40l; cell; cellularity; gp39; helper t cells; id; ii; inducer t cells; infectious disease; infectiousdisease; l3t4; leu3; leu-3; microbiology; number fraction; p stim covid spike; pept; percent; ph; point in time; public health; publichealth; qnt; quan; quant; quantitative; random; severe acute respiratory syndrome; stim; t4; t-4; t-bam; trap; tumor necrosis factor related activation protein; w3/25; wb; whole blood; x-linked hyper igm,Qn
100869-7,cryptosporidium gp60 gene [type] in specimen by molecular genetics method,crypto gp60 spec,cryptosporidium gp60 gene molgen nom (specimen),crypt; crypto; crypto gp60; cryptosporidiosis; microbiology; misc; miscellaneous; molecular genetics; nominal; other; pcr; point in time; random; spec; to be specified in another part of the message; typ; unspecified,Nom
100881-2,mr guidance for cryoablation of bone,mr guided bone cryoablation,,bon; document; finding; findings; guid; guide; guided; imaging; misc; miscellaneous; mitral regurgitation maximum velocity; mri; other; point in time; radiology; random; spec; to be specified in another part of the message; unspecified,Doc
100882-0,mr peritoneum w contrast percutaneous intraperitoneal,mr peritoneum w contr percu,,abd; abdo; abdomen+; abdominal; c; contr; contra; contrst; document; finding; findings; imaging; mitral regurgitation maximum velocity; mri; perc; point in time; radiology; random; w contr pc; w contr percu; wc,Doc
100886-1,orf virus dna [presence] in specimen by naa with probe detection,orf virus dna spec ql naa+probe,orf virus dna naa+probe ql (specimen),3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; deoxyribonucleic acid; dna nucleic acid probe; dna probe; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; misc; miscellaneous; naa+probe; naat; nasba; nucleic acid sequence based analysis; ordinal; other; pcr; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; screen; sda; spec; strand displacement amplification; tma; to be specified in another part of the message; transcription mediated amplification; unspecified,Ord
100901-8,enterobacteriaceae.carbapenemase resistance phenotype [identifier] in anal by organism specific culture,enterobac.carb res anal cult,enterobacteriaceae.carbapenemase resistance phenotype org specific cx (anal),anus; c&s; carbapenem-resistant klebsiella pneumoniae; cre; crkp; cult; cultures; enterobac.carb res; hodge test; identity or presence; microbiology; nominal; point in time; random; rectal specimen; resist; resistanc; resistant; resistent; spec,Nom
100902-6,enterobacteriaceae.carbapenemase resistance phenotype.oxa-48 [identifier] in anal by organism specific culture,enterobac.carb res oxa-48 anal cult,enterobacteriaceae.carbapenemase resistance phenotype.oxa-48 org specific cx (anal),anus; c&s; carbapenem-resistant klebsiella pneumoniae; cre; crkp; cult; cultures; enterobac.carb res; enterobac.carb res oxa-48; hodge test; identity or presence; microbiology; nominal; point in time; random; rectal specimen; resist; resistanc; resistant; resistent; spec,Nom
100907-5,vancomycin resistant enterococcus [identifier] in specimen by organism specific culture,vre spec cult,vancomycin resistant enterococcus org specific cx nom (specimen),c&s; c162; cult; cultures; identity or presence; microbiology; misc; miscellaneous; nominal; other; point in time; random; spec; to be specified in another part of the message; unspecified; vanc; vancocin; vancor; vre; vre screen,Nom
100919-0,access to help with product of interest,,,access to help prod of interest; finding; findings; ordinal; point in time; ql; qual; qualitative; random; screen; survey; survey.gnhlth,Ord
100938-0,feel safe outside home,,,finding; findings; ordinal; point in time; ql; qual; qualitative; random; screen; survey; survey.gnhlth,Ord
100940-6,neighbor relationships panel [r-outcomes],,,pan; panel.survey.r-outcomes; panl; pnl; point in time; r prime; random; right; survey; survey.r-outcomes,-
100947-1,frequency of having no one to talk to,,,finding; findings; freq of having no one to talk to; ordinal; point in time; ql; qual; qualitative; random; screen; survey; survey.mtlhlth,Ord
100948-9,frequency of feeling left out,,,finding; findings; freq of feeling left out; l; lt; ordinal; point in time; ql; qual; qualitative; random; screen; survey; survey.mtlhlth,Ord
100951-3,loneliness office of national statistics panel,,loneliness office of national statistics panel,loneliness ons panel; pan; panel.survey.r-outcomes; panl; pnl; point in time; r prime; random; right; survey; survey.r-outcomes,-
100953-9,product confidence score [r-outcomes],,,point in time; qnt; quan; quant; quantitative; r prime; random; right; scale; survey; survey.r-outcomes,Qn
100954-7,product of interest use,,,finding; findings; ordinal; point in time; ql; qual; qualitative; random; screen; survey; survey.gnhlth,Ord
10098-2,st slope in lead ii,st slope l-ii,,2; amperage; cardiac; cardio; cardiology; ecg; ekg.measurements; electrocardiogram; electrocardiograph; heart disease; hrt; painter's colic; pb; plumbism; point in time; qnt; quan; quant; quantitative; random; st slope l-ii; voltage rate,Qn
100997-6,"respiratory allergen panel, area 5 - serum","respiratory allergen panel, area 5 ser","respiratory allergen panel, area 5 (s)",allergen; allergens; allergy testing; alrgen; pan; panel.allergy; panl; pnl; point in time; random; resp allergen pnl; serum; sr,-
101009-9,integrative medicine history and physical note,integrative medicine h&p note,,doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; h&p note; hx; integrated medicine; notes; point in time; random; visit note,Doc
101010-7,bariatric surgery history and physical note,bariatric surg h&p note,,doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; h&p note; hx; metabolic and bariatric surgery; notes; point in time; random; surg; visit note,Doc
10101-4,st slope in lead v2,st slope l-v2,,amperage; cardiac; cardio; cardiology; ecg; ekg.measurements; electrocardiogram; electrocardiograph; heart disease; hrt; painter's colic; pb; plumbism; point in time; qnt; quan; quant; quantitative; random; st slope l-v2; voltage rate,Qn
101023-0,orthotics prosthetics history and physical note,orthotics prosthetics h&p note,,doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; h&p note; hx; notes; point in time; random; visit note,Doc
101031-3,chiropody consult note,chiropody consult note,,consult note; doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; notes; point in time; random; visit note,Doc
101040-4,integrative medicine procedure note,integrative medicine procedure note,,doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; integrated medicine; notes; point in time; random; visit note,Doc
101047-9,undersea and hyperbaric medicine consult note,undersea+hyperbar consult note,,consult note; doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; notes; point in time; random; undersea+hyperbar; visit note,Doc
101049-5,anesthesiology surgical operation note,anesthesiology operative note,,anesthesia; doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; notes; operative note; point in time; random; surg; visit note,Doc
101058-6,geriatric medicine team conference note,geri med team conf note,,conf note; doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; geri med; geri med team; gerontology; notes; point in time; random; visit note,Doc
101059-4,geriatric medicine letter,geri med letter,,doc.ont; document; finding; findings; geri med; gerontology; point in time; random,Doc
101064-4,co3 ag ag [presence] on red blood cells,c little o3 ag rbc ql,co3 ag ag ql (rbc),antigen; antigens; blood bank; co3 ag; erythrocytes; ordinal; point in time; pr; ql; qual; qualitative; random; red blood cells; red blood corpusles; screen,Ord
101077-6,dr^a ab [presence] in serum or plasma,dr^a ab serpl ql,dr^a ab ql,abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; blood bank; dextro; dr^a; dr^a ab; ordinal; pl; plasma; plsm; point in time; pr; ql; qual; qualitative; r prime; random; right; screen; serp; serpl; serplas; serum; serum or plasma; sr,Ord
1010-8,e sup(w) ab [presence] in serum or plasma from blood product unit,e sup(w) ab serpl bpu ql,e sup(w) ab ql (s/p bpu),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; blood bank; blood product unit; blood product unit (pack); e sup(w); ordinal; pl; plasma; plsm; point in time; pr; ql; qual; qualitative; random; screen; serp; serpl; serpl^bpu; serplas; serum; serum or plasma; sr,Ord
101092-5,hr^b ab [presence] in serum or plasma,hr^b ab serpl ql,hr^b ab ql,abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; blood bank; hr^b; hr^b ab; ordinal; pl; plasma; plsm; point in time; pr; ql; qual; qualitative; r prime; random; right; screen; serp; serpl; serplas; serum; serum or plasma; sr,Ord
101099-0,km ab [presence] in serum or plasma,km ab serpl ql,km ab ql,abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; blood bank; kell blood group system; km; km ab; mnss blood group system; ordinal; pl; plasma; plsm; point in time; pr; ql; qual; qualitative; random; screen; serp; serpl; serplas; serum; serum or plasma; sr,Ord
101102-2,kx ag [presence] on red blood cells,kx ag rbc ql,kx ag ql (rbc),antigen; antigens; blood bank; erythrocytes; kx; kx ag; ordinal; point in time; pr; ql; qual; qualitative; random; red blood cells; red blood corpusles; screen,Ord
101107-1,mds v3.0 - rai v1.18.11 - nursing home discharge (nd) item set during assessment period [cms assessment],,,centers for medicare and medicaid assessment; disch; pan; panel; panel.survey.cms; panl; pnl; report period; survey,-
101121-2,candida albicans and tropicalis dna [presence] in blood by naa with probe detection,c albicans+tropicalis dna bld ql naa probe,candida albicans+tropicalis dna naa+probe ql (bld),3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; blood; c albicans; c albicans + tropicalis dna; cand; candidiasis; deoxyribonucleic acid; dna nucleic acid probe; dna probe; lat; lcr; ligase chain reaction; ligation-activated transcription; m005; m5; microbiology; monilia; naa+probe; naat; nasba; nucleic acid sequence based analysis; ordinal; pcr; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; screen; sda; strand displacement amplification; thrush; tma; transcription mediated amplification; wb; whole blood,Ord
101123-8,bacterial carbapenem resistance blaimi gene [presence] by molecular method,blaimi islt/spm ql,bacterial carbapenem resistance blaimi gene molgen ql (islt/spec),antibiotic susceptibilities; bact; cpr; islt; islt/spm; isol; molecular genetics; ordinal; pcr; point in time; pr; ql; qual; qualitative; random; resist; resistanc; resistant; resistent; screen; spec,Ord
101130-3,mast cells/cells in bone marrow by flow cytometry (fc),masts nfr mar fc,mast cells/cells fc (bm),bm; bon; bone marrow; cell; cellularity; dynamic; fc; hematology/cell counts; mar; marrow (bone); masts; minimal angle of resolution; minimum angle of resolution; number fraction; percent; point in time; qnt; quan; quant; quantitative; random,Qn
101131-1,b-cell precursors in bone marrow by flow cytometry (fc),b-cell precursors nfr bm fc,b-cell precursors fc (bm),b cell; b-all; b-cell acute lymphoblastic leukemia; bcells; bm; bon; dynamic; fc; hematology/cell counts; number fraction; percent; point in time; qnt; quan; quant; quantitative; random,Qn
101151-9,right ventricular cardiac output by indicator dilution,rv output indicator dilution,,cardiac; co; dil; dilut; flow; hemodynamics; hemodynamics.molec; hrt; hrt ventr; point in time; qnt; quan; quant; quantitative; r; random; rt; rv; ventricular; volume rate; vrate,Qn
101184-0,4f-mdmb-binaca [mass/volume] in urine by confirmatory method,4f-mdmb-binaca ur cfm-mcnc,4f-mdmb-binaca confirm (u) [mass/vol],4f-adb; cfm; cnfr; cnfrm; conf; confirmation; confirmatory; drug/toxicology; drugs; gcms; lc/ms/ms; level; mass concentration; point in time; qnt; quan; quant; quantitative; random; ua; ur; urn,Qn
101186-5,4f-mdmb-binaca [presence] in urine by confirmatory method,4f-mdmb-binaca ur ql cfm,4f-mdmb-binaca confirm ql (u),4f-adb; cfm; cnfr; cnfrm; conf; confirmation; confirmatory; drug/toxicology; drugs; gcms; lc/ms/ms; ordinal; point in time; pr; ql; qual; qualitative; random; screen; ua; ur; urn,Ord
101187-3,adb-butinaca [mass/volume] in urine by confirmatory method,adb-butinaca ur cfm-mcnc,adb-butinaca confirm (u) [mass/vol],adb-binaca; cfm; cnfr; cnfrm; conf; confirmation; confirmatory; drug/toxicology; drugs; gcms; k2/spice; lc/ms/ms; level; mass concentration; point in time; qnt; quan; quant; quantitative; random; ua; ur; urn,Qn
101190-7,5f-mdmb-pica [mass/volume] in urine by confirmatory method,5f-mdmb-pica ur cfm-mcnc,5f-mdmb-pica confirm (u) [mass/vol],cfm; cnfr; cnfrm; conf; confirmation; confirmatory; drug/toxicology; drugs; gcms; lc/ms/ms; level; mass concentration; point in time; qnt; quan; quant; quantitative; random; ua; ur; urn,Qn
101194-9,mesocolic excision plane [anatomy] in colorectal cancer specimen,mesocolic excision plane crc spec,mesocolic excision plane nom (colorectal cancer specimen),anatomy; ca; ca spec; crc spec; nominal; pathology; point in time; random; spec,Nom
101199-8,protein.monoclonal band 5/protein.total in serum or plasma by electrophoresis,m protein 5 mfr serpl elph,protein.monoclonal band 5 elph [mass fraction],bands; bnd; chemistry; elec; elect; electr; electro; electrophhrs; electrophrs; elp; elph; ep; m protein; m protein 5; mass fraction; m-band; monoclonal band; monoclonal spike; m-protein; m-spike; para protein; paraprotein; percent; pl; plasma; plsm; point in time; pr; prot; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; spep; sr; tot; totl; tp,Qn
101209-5,hantavirus igg panel - serum or plasma by line blot,hantavirus igg panel serpl line blot,hantavirus igg panel line blot,hanta virus; hantavirus igg panel; hemorrhagic fever with renal syndrome; hfrs; hps; htnv; immune globulin g; immunoglobulin g; microbiology; orthohantavirus; pan; panel.microbiology; panl; pl; plasma; plsm; pnl; point in time; random; serp; serpl; serplas; serum; serum or plasma; snv; sr,-
101213-7,hantavirus dobrava [presence] in serum or plasma by line blot,h dobrava serpl ql line blot,hantavirus dobrava line blot ql,h dobrava; hanta virus; hemorrhagic fever with renal syndrome; hfrs; hps; htnv; microbiology; ordinal; orthohantavirus; pl; plasma; plsm; point in time; pr; ql; qual; qualitative; random; screen; serp; serpl; serplas; serum; serum or plasma; snv; sr,Ord
101214-5,hantavirus igm panel - serum or plasma by line blot,hantavirus igm panel serpl line blot,hantavirus igm panel line blot,hanta virus; hantavirus igm panel; hemorrhagic fever with renal syndrome; hfrs; hps; htnv; immune globulin m; immunoglobulin m; microbiology; orthohantavirus; pan; panel.microbiology; panl; pl; plasma; plsm; pnl; point in time; random; serp; serpl; serplas; serum; serum or plasma; snv; sr,-
101234-3,glial nuclear type 1 ab [presence] in cerebral spinal fluid by immunoblot,glial nuc type 1 ab csf ql ib,glial nuclear type 1 ab ib ql (csf),abs; aby; agna; agna-1; antby; anti; antibodies; antibody; autoantibodies; autoantibody; blt; cerebral spinal fluid; cerebrospinal fl; glial nuc type 1; i; immune blot; immunobl; immunoblot; lambert-eaton myasthenic syndrome; nuc; ordinal; paraneoplastic antibody; paraneoplastic syndrome; point in time; pr; ql; qual; qualitative; random; riba; screen; serology; sox1; sox1 nuclear antigen; spinal fl; spinal fld; spinal flu; spinal fluid; wb; wblot; west blot; west blt; western blot,Ord
10124-6,st wave mid displacement in lead v1,st wave md l-v1,,cardiac; cardio; cardiology; ecg; ekg.measurements; eklund; electrical potential; electrocardiogram; electrocardiograph; heart disease; hrt; painter's colic; pb; plumbism; point in time; qnt; quan; quant; quantitative; random; st wave md l-v1; voltage,Qn
101248-3,pathologic casts [presence] in urine sediment by light microscopy,path casts urns ql micro,pathologic casts lm ql (urine sed),cast; lm; micro; micros; microscopic; ordinal; path; path casts; point in time; pr; ql; qual; qualitative; random; screen; ua; ur; urinalysis; urine sediment; urn; urns,Ord
101250-9,aspergillus fumigatus [presence] in isolate,a fumigatus islt ql,a. fumigatus ql (isol),a fumigatus; asperg; aspergil; aspergilis; aspergilla; aspergillin; aspergillosis; aspergils; aspergilus; farmers lung; fum; islt; isol; m003; m3; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; screen; vet; veterinary,Ord
101251-7,dense fine speckled 70 protein ab [presence] in serum or plasma,dfs70 ab serpl ql,dense fine speckled 70 protein ab ql,abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; dfs70; ordinal; pl; plasma; plsm; point in time; pr; prot; ql; qual; qualitative; random; screen; serology; serp; serpl; serplas; serum; serum or plasma; sr,Ord
101261-6,mds v3.0 - rai v1.18.11 - mood during assessment period [cms assessment],,,centers for medicare and medicaid assessment; confusion assessment method (cam) pnl; pan; panel; panl; pnl; report period; survey,-
101272-3,mds v3.0 - rai v1.18.11 - oral/dental status during assessment period [cms assessment],,,centers for medicare and medicaid assessment; oral/dent status; oral/dental status; pan; panel; panel.survey.cms; panl; pnl; report period; survey,-
101273-1,mds v3.0 - rai v1.18.11 - skin conditions during assessment period [cms assessment],,,centers for medicare and medicaid assessment; integument; pan; panel; panl; pnl; report period; survey,-
101278-0,mds v3.0 - rai v1.18.11 - care area assessment (caa) summary during assessment period [cms assessment],,,centers for medicare and medicaid assessment; pan; panel; panl; pnl; report period; survey,-
101287-1,chlamydophila pneumoniae dna [presence] in throat by naa with non-probe detection,c pneum dna throat ql naa+non-probe,c. pneumoniae dna naa+non-probe ql (throat),3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; c pneum; c pneumo; c pneumoniae; chlamydia; chlamydia pneumoniae; cpn; deoxyribonucleic acid; dna nucleic acid probe; dna probe; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; naa+non-probe; naa+probe; naat; nasba; nucleic acid sequence based analysis; ordinal; pcr; pneu; pneum; pneumo; pneumon; pneumonia; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; screen; sda; strand displacement amplification; throat; tma; transcription mediated amplification; twar agent; upper respiratory,Ord
101297-0,parainfluenza virus 1+2+3+4 rna [presence] in throat by naa with non-probe detection,hpiv 1+2+3+4 rna throat ql naa+non-probe,parainfluenza virus 1+2+3+4 rna naa+non-probe ql (throat),3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; dna nucleic acid probe; dna probe; hpiv; hpiv 1+2+3+4; hpiv 1+2+3+4 rna; hpiv1; hpiv1+2+3; human respirovirus 1; i; ii; iii; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; naa+non-probe; naa+probe; naat; nasba; nucleic acid sequence based analysis; ordinal; para; parainflu; parainfluenza type 1; parainfluenza type i; pcr; pi1; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; ribonucleic acid; screen; sda; strand displacement amplification; throat; tma; transcription mediated amplification; upper respiratory,Ord
10130-3,t' wave amplitude in lead avf,t' wave amp l-avf,,cardiac; cardio; cardiology; ecg; ekg.measurements; electrical potential; electrocardiogram; electrocardiograph; heart disease; hrt; painter's colic; pb; plumbism; point in time; qnt; quan; quant; quantitative; random; t prime; t' wave amp l-avf; t wave amp l-avf; voltage,Qn
101304-4,dengue virus 1+2+3+4 rna [presence] in blood by naa with non-probe detection,denv1+2+3+4 rna bld ql naa+non-probe,denv 1+2+3+4 rna naa+non-probe ql (bld),3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; blood; breakbone fever; dengue fever; dengue type i; dengue type i+ii+iii+iv; denv; denv 1+2+3+4; denv 1+2+3+4 rna; denv1; denv1+2+3+4; dna nucleic acid probe; dna probe; flavivirus; i; ii; iii; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; naa+non-probe; naa+probe; naat; nasba; nucleic acid sequence based analysis; ordinal; pcr; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; ribonucleic acid; screen; sda; strand displacement amplification; tma; transcription mediated amplification; wb; whole blood,Ord
101317-6,17-hydroxypregnenolone [mass/volume] in serum or plasma --30 minutes post dose corticotropin,17oh-preg 30m p acth serpl-mcnc,17-hydroxypregnenolone 30 min post dose corticotropin [mass/vol],17 alpha-hydroxypregnanolone; 17 hydroxy pregnenolone; 17-alpha-hydroxypregnenolone; 17alpha-hydroxypregnenolone; 17oh-preg; 30m p acth; acth; adrenocorticotrophic hormone; adrenocorticotropin; after; c206; c74; chemistry.challenge testing; cortrosyn; level; mass concentration; p acth; p dose; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; rc206; serp; serpl; serplas; serum; serum or plasma; sr; tumor marker,Qn
101331-7,"mds v3.0 - rai v1.18.11 - ulcers, wounds and skin problems during assessment period [cms assessment]",,,centers for medicare and medicaid assessment; finding; findings; integument; nominal; report period; survey,Nom
101333-3,mds v3.0 - rai v1.18.11 - determination of pressure injury risk [cms assessment],,,centers for medicare and medicaid assessment; finding; findings; nominal; pressure injury; pressure ulcer; pressure ulcers; report period; survey; ulcer,Nom
101357-2,borrelia burgdorferi.vlse+ospc igg+igm ab [presence] in serum by immunoassay,b.burgdor.vlse+ospc igg+igm ser ql ia,borrelia burgdorferi.vlse+ospc igg+igm ia ql (s),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; b burg; b burgdor; b burgdorferi; b.burgdor.vlse+ospc ab.igg+igm; bb; burgdorf; eia; elfa; elisa; enzyme immunoassay; iaa; immune globulin g; immune globulin m; immunoglobulin g; immunoglobulin m; lyme; lyme disease; lymes; meia; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; sr; suds,Ord
101395-2,translocation analysis in embryo by molecular genetics method,translocation analysis embryo,translocation analysis molgen doc (embryo),document; finding; findings; molecular genetics; molecular pathology; molpath; molpath.translocation; pcr; point in time; random,Doc
101396-0,preimplantation multigene analysis in embryo by molecular genetics method,preimplant multigene analysis embryo,preimplantation multigene analysis molgen doc (embryo),document; finding; findings; gene; gene panel; molecular genetics; molecular pathology; molpath; multi-gene study; multiple-gene panel test; pcr; point in time; preimplant multigene analysis; random,Doc
10141-0,t' wave amplitude in lead v6,t' wave amp l-v6,,cardiac; cardio; cardiology; ecg; ekg.measurements; electrical potential; electrocardiogram; electrocardiograph; heart disease; hrt; painter's colic; pb; plumbism; point in time; qnt; quan; quant; quantitative; random; t prime; t' wave amp l-v6; t wave amp l-v6; voltage,Qn
101413-3,bictegravir [mass/volume] in serum or plasma by lc/ms/ms --trough,bictegravir trough serpl lc/ms/ms-mcnc,bictegravir trough lc/ms/ms [mass/vol],drug/toxicology; drugs; level; mass concentration; pl; plasma; plsm; point in time; pre; predose; pre-dose; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
101415-8,blastomyces sp and blastomyces dermatitidis ag panel,blastomyces sp + dermatitidis pnl ur,blastomyces sp & blastomyces dermatitidis ag panel (u),b dermat; b dermatitidis; blasto; blastomyces sp & dermatitidis pnl; blastomycosis; microbiology; pan; panel.microbiology; panl; pnl; point in time; random; species; spp; ua; ur; urn,-
101417-4,pediatric autoimmune central nervous system disorders evaluation panel - serum or plasma,peds autoimm cns disordrs eval pnl serp,pediatric autoimmune central nervous system disorders evaluation panel,assessment; chemistry; cns; eval; h&p; history and physical; pan; panel.chemistry; panl; peds; peds autoimmn cns disordrs eval pnl; pl; plasma; plsm; pnl; point in time; random; serp; serpl; serplas; serum; serum or plasma; sr,-
101418-2,microorganism level similarity to reference sample [score] in isolate or specimen by ms.maldi-tof,microorg lvl sim ref smpl islt/spm m,microorganism level similarity to reference sample ms.maldi-tof (islt/spec) [score],islt; islt/spm; isol; levels; levl; lv; lvl; microbiology; microorg lvl similar ref smpl; microorganisms; org; organism; organisms; point in time; qnt; quan; quant; quantitative; random; scale; spec,Qn
101419-0,human coronavirus 229e rna [presence] in respiratory system specimen by naa with probe detection,hcov 229e rna resp ql naa+probe,hcov 229e rna naa+probe ql (respiratory system specimen),3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; breathing; corona virus; dna nucleic acid probe; dna probe; hcov; hcov 229e; lat; lcr; ligase chain reaction; ligation-activated transcription; lungs; microbiology; naa+probe; naat; nasba; nucleic acid sequence based analysis; ordinal; pcr; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; ribonucleic acid; rs; screen; sda; spec; strand displacement amplification; tma; transcription mediated amplification,Ord
101424-0,influenza virus a h3 rna [presence] in respiratory system specimen by naa with probe detection,fluav h3 rna resp ql naa+probe,fluav h3 rna naa+probe ql (respiratory system specimen),3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; avian influenza; bird flu; breathing; dna nucleic acid probe; dna probe; flua; fluav; fluav h3; fluv; fowl plague; influ; influenza a; influenza a virus; lat; lcr; ligase chain reaction; ligation-activated transcription; lungs; microbiology; naa+probe; naat; nasba; nucleic acid sequence based analysis; ordinal; pcr; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; ribonucleic acid; rs; screen; sda; spec; strand displacement amplification; tma; transcription mediated amplification,Ord
101428-1,varicella zoster virus dna [presence] in respiratory system specimen by naa with probe detection,vzv dna resp ql naa+probe,vzv dna naa+probe ql (respiratory system specimen),3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; breathing; chicken pox; chicken pox virus; chickenpox; deoxyribonucleic acid; dna nucleic acid probe; dna probe; herpes zoster; hhv-3; human herpesvirus 3; lat; lcr; ligase chain reaction; ligation-activated transcription; lungs; microbiology; naa+probe; naat; nasba; nucleic acid sequence based analysis; ordinal; pcr; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; rs; screen; sda; shingles; spec; strand displacement amplification; tma; transcription mediated amplification; vz; vzv; zoster,Ord
101434-9,2-ketobutyrate [moles/volume] in serum or plasma,2-ketobutyrate serpl-scnc,2-ketobutyrate [moles/vol],2-ketobutyric acid; 2-oxobutanoate; 2-oxobutanoic acid; chemistry; ii; level; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; substance concentration,Qn
101440-6,history of falls,hx of falls,,clin; clin.risk; history; ordinal; point in time; ql; qual; qualitative; random; screen,Ord
101470-3,hba1+2 gene thai deletion [presence] in blood by molecular genetics method,hba1+2 thai del bld ql,hba1+2 gene thai del molgen ql (bld),blood; del; deletions; hba1+2 thai; ii; molecular genetics; molecular pathology; molpath; molpath.deletions; ordinal; pcr; point in time; pr; ql; qual; qualitative; random; screen; wb; whole blood,Ord
101481-0,ceftazidime [susceptibility] by mic.voc detection in positive blood culture,ceftazidime bld pos mic.voc det,ceftazidime mic.voc detection (pos bld culture) [susc],antibiotic susceptibilities; ast; bld pos; blood; ceftaz; forj; fortaz; minimum inhibitory concentration; point in time; random; sus; suscept; susceptibilities; susceptibility; susceptibilty; tazicef; tazj; wb; whole blood,OrdQn
101518-9,canine parvovirus 2 dna [presence] in specimen by naa with probe detection,cpv 2 dna spec ql naa+probe,canine parvovirus 2 dna naa+probe ql (specimen),3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; cpv; cpv 2; cpv 2 dna; deoxyribonucleic acid; dna nucleic acid probe; dna probe; dog; ii; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; misc; miscellaneous; naa+probe; naat; nasba; nucleic acid sequence based analysis; ordinal; other; parvo; parvo virus; parvov; pcr; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; screen; sda; spec; strand displacement amplification; tma; to be specified in another part of the message; transcription mediated amplification; unspecified; vet; veterinary,Ord
101545-2,fcgr3a gene.p.phe158 [identifier] in blood by molecular genetics method nominal,fcgr3a gene.p.158 bld,fcgr3a gene.p.phe158 molgen nom (bld),"blood; cd16a; fc gamma receptor iiia; fc gamma riii; fcgr3a gene.p.158; gamma riii, fc; identity or presence; molecular genetics; molecular pathology; molpath; nominal; p prime; pcr; point in time; random; receptors, gamma fc; wb; whole blood",Nom
101549-4,schmid fall risk assessment,schmid fall risk,,clin; clin.risk; pan; panel; panel.clinical; panl; pnl; point in time; random,-
101558-5,escherichia coli enteroinvasive dna [presence] in stool by naa with probe detection,e coli eiec dna stl ql naa+probe,e. coli enteroinvasive dna naa+probe ql (stl),3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; bowel movement; deoxyribonucleic acid; dna nucleic acid probe; dna probe; e coli; e coli eiec; e coli eiec dna; faecal; faeces; fecal; feces; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; naa+probe; naat; nasba; nucleic acid sequence based analysis; o002; ordinal; pcr; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; screen; sda; stl; stool = fecal; strand displacement amplification; tma; transcription mediated amplification,Ord
101566-8,human coronavirus rna in specimen document,hcov rna spec doc,hcov rna doc (specimen),corona virus; document; finding; findings; hcov; microbiology; misc; miscellaneous; other; point in time; random; ribonucleic acid; spec; to be specified in another part of the message; unspecified,Doc
10156-8,history of childhood diseases narrative,hx of childhood diseases,,h+p; h+p.hx; history; narrative; p prime; point in time; random; report,Nar
101570-0,spermatozoa normal chromatin/spermatozoa in semen,sperm norm chrom nfr smn,spermatozoa normal chromatin/spermatozoa (sem),control; ejaculate; fertility testing; number fraction; percent; point in time; qnt; quan; quant; quantitative; random; sem; seminal fluid; smn; smpls; sperm; sperm norm; sperm norm chrom,Qn
101575-9,delayed cord clamping newborn,delayed cord clamping nb,,finding; findings; nb; new born; obgyn; ordinal; point in time; ql; qual; qualitative; random; screen,Ord
101587-4,histoplasma capsulatum+blastomyces dermatitidis ag panel - serum or plasma,h capsul h+ b derma ag panel serpl,histoplasma capsulatum+blastomyces dermatitidis ag panel,b dermat; b dermatitidis; blasto; blastomycosis; h capsul; h capsul h+ b derma; h capsul h+ b derma ag; h capsul h+ b derma ag panel; h capsulatum; h farciminosum; histo; histopl; histoplasma farciminosum; histoplasmos; histoplasmosis; microbiology; pan; panel.microbiology; panl; pl; plasma; plsm; pnl; point in time; random; serp; serpl; serplas; serum; serum or plasma; sr,-
101623-7,semen [volume] in urine by light microscopy --post ejaculation,semen p ejac vol ur micro,semen post ejaculation lm (u) [vol],after; fertility testing; lm; micro; micros; microscopic; p ejac; point in time; pst; qnt; quan; quant; quantitative; random; ua; ur; urn; volume,Qn
101628-6,thyroglobulin heterophile ab interference [interpretation] in serum narrative,tg heterph ab intrf ser-imp,thyroglobulin heterophile ab interference nar (s) [interp],chemistry; epstein-barr virus; hetero; heteroph; hetr; impression; impression/interpretation of study; impressions; interp; interpretation; mono screen; mono slide; mono spot; mono test; mononucleosis screen; mononucleosis test; monospot; narrative; point in time; random; report; serum; sr; tg; tg heterph ab; tg heterph ab intrf; thyglobulin; thyroglbn; thyroglob; tumor marker,Nar
101633-6,mt-rnr1 gene targeted mutation analysis in blood or tissue by molecular genetics method,mt-rnr1 mut anl bld/t,mt-rnr1 gene targeted mutation analysis molgen doc (bld/tiss),"blood; document; finding; findings; mitochondrial 12s ribosomal rna; mitochondrially encoded 12s rna; molecular genetics; molecular pathology; molpath; molpath.mutations; mtrnr1; mut; mut anl; mutations; pcr; point in time; random; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",Doc
101643-5,cd3 cells [#/volume] in blood --after stimulation with sars-cov-2 nucleocapsid peptide,cd3 cells p covid nuclcap # bld,cd3 cells after stimulation with sars-cov-2 nucleocapsid peptide (bld) [#/vol],#; abs; absolute; absolutes; blood; cd3 cells; cell; cells.cd3 p covid nuclcap; cellularity; cnt; count; count/volume; ct; ii; leu4; leu-4; microbiology; number concentration; number concentration (count/vol); p covid nuclcap; pept; point in time; qnt; quan; quant; quantitative; random; severe acute respiratory syndrome; stim; t3; wb; whole blood,Qn
101675-7,imp carbapenemase [presence] in isolate by rapid immunoassay,imp carbapenemase islt ql ia.rapid,imp carbapenemase ia.rapid ql (isol),carbapenem-resistant klebsiella pneumoniae; cre; crkp; eia; elfa; elisa; enzyme immunoassay; hodge test; iaa; islt; isol; meia; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; screen; suds,Ord
101677-3,ndm carbapenemase [presence] in isolate by rapid immunoassay,ndm carbapenemase islt ql ia.rapid,ndm carbapenemase ia.rapid ql (isol),carbapenem-resistant klebsiella pneumoniae; cre; crkp; eia; elfa; elisa; enzyme immunoassay; hodge test; iaa; islt; isol; meia; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; screen; suds,Ord
101681-5,"leukotriene e4, random, urine panel","leukotriene e4, rnd, urine",leukotriene e4 panel (u),"7,9,11,14-eicosatetraenoic acid, 6-((2-amino-2-carboxyethyl)thio)-5-hydroxy-, (5s-(5r*,6s*(s*),7e,9e,11z,14z)); chemistry; lte4; pan; panel.chemistry; panl; pnl; point in time; random; ua; ur; urn",-
101684-9,percentage of body water,body h2o %,,bdy water; bod; bodies; body weight.molec; mass fraction; percent; point in time; qnt; quan; quant; quantitative; random,Qn
101692-2,maximum heart rate,maximum hr,,?tm; count/time; heart beat; heart rate max; heart rate.atom; nrate; number rate; number rate = count/time; pulse; qnt; quan; quant; quantitative,Qn
101693-0,duration of light heart rate zone,dur of light hr zone,,dur of light hr zone; durat; heart beat; heart rate.atom; point in time; pulse; qnt; quan; quant; quantitative; random,Qn
101721-9,deprecated sars-cov-2 (covid-19) in respiratory specimen by naa with probe detection,deprecated sars-cov-2 resp naa+probe,sars-cov-2 (covid-19) naa+probe (resp),2019 novel coronavirus; 2019-ncov; 3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; corona virus; covid19; covid-19; dna nucleic acid probe; dna probe; ii; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; naa+probe; naat; nasba; nucleic acid sequence based analysis; pcr; point in time; polymerase chain reaction; probe amp; probe with ampification; probe with target amplification; qbr; random; ribonucleic acid; sars coronavirus 1; sars-cov; sars-cov-1; sars-cov-2; sda; severe acute respiratory syndrome; strand displacement amplification; tma; transcription mediated amplification; viral pneumonias; wuhan coronavirus,-
101752-4,tau protein/tau protein.phosphorilated 181 [mass ratio] in cerebral spinal fluid,tau prot/p-tau181 mrto  csf,tau protein/tau protein.phosphorilated 181 (csf) [mass ratio],alzheimer disease; alzheimer's disease; cerebral spinal fluid; cerebrospinal fl; chemistry; mass concentration ratio; mass ratio; mcrto; point in time; pr; prot; p-tau181; qnt; quan; quant; quantitative; random; spinal fl; spinal fld; spinal flu; spinal fluid; tau prot/tau prot.phos 181,Qn
101768-0,trichophyton eriotrephon dna [presence] in specimen by naa with probe detection,t. eriotrephon dna spec ql naa+probe,trichophyton eriotrephon dna naa+probe ql (specimen),3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; deoxyribonucleic acid; dna nucleic acid probe; dna probe; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; misc; miscellaneous; naa+probe; naat; nasba; nucleic acid sequence based analysis; ordinal; other; pcr; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; screen; sda; spec; strand displacement amplification; t. eriotrephon; t. eriotrephon dna; tma; to be specified in another part of the message; transcription mediated amplification; unspecified,Ord
101777-1,nannizzia incurvata dna [presence] in specimen by naa with probe detection,n. incurvata dna spec ql naa+probe,nannizzia incurvata dna naa+probe ql (specimen),3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; deoxyribonucleic acid; dna nucleic acid probe; dna probe; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; misc; miscellaneous; n. incurvata; n. incurvata dna; naa+probe; naat; nasba; nucleic acid sequence based analysis; ordinal; other; pcr; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; screen; sda; spec; strand displacement amplification; tma; to be specified in another part of the message; transcription mediated amplification; unspecified,Ord
101788-8,chronic lymphocytic leukemia gene rearrangements in blood or marrow by fish,cll gene rearrange bld/mar fish,chronic lymphocytic leukemia gene rearrangements fish doc (bld/bm),b-cell cll; bld/mar; blood; bm; bon; bone marrow; cll; cll gene; cll gene rearrange; document; finding; findings; fluorescent in situ hybridization; lymphoma 1; mar; marrow (bone); minimal angle of resolution; minimum angle of resolution; molecular pathology; molpath; molpath.rearrangements; point in time; random; rearr; rearrangement; wb; whole blood; whole blood or bone marrow,Doc
101802-7,brucella sp iga ab [presence] in serum,brucella iga ser ql,brucella sp iga ql (s),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; bruc; brucellosis; immune globulin a; immunoglobulin a; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; species; spp; sr,Ord
101834-0,dexamethasone [moles/volume] in serum or plasma,dexamethasone serpl-scnc,dexamethasone [moles/vol],decadron; dexameth; dexone; drug/toxicology; drugs; hexadrol; level; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; substance concentration,Qn
101841-5,prednisolone [moles/volume] in serum or plasma,prednisolone serpl-scnc,prednisolone [moles/vol],c424; deltasone; depo-medrol; drug/toxicology; drugs; kenalog; level; medrol; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; solu-medrol; sr; substance concentration,Qn
101845-6,sweat analysis specialist review of results,sweat analys spec rev,sweat analysis specialist review nar (sweat) [interp] nar (sweat) [interp],chemistry; impression; impression/interpretation of study; impressions; interp; interpretation; narrative; point in time; random; report; sweat analys spec rev; swt,Nar
101851-4,flunisolide [moles/volume] in urine,flunisolide ur-scnc,flunisolide (u) [moles/vol],aerobid; bronalide; drug/toxicology; drugs; level; nasalide; point in time; qnt; quan; quant; quantitative; random; rhinalar; substance concentration; ua; ur; urn,Qn
101865-4,troponin t. cardiac 2h and 6h 5th generation panel in serum or plasma by high sensitivity method,troponin t 2h 6h 5th gen serpl hs,troponin t. cardiac 2h &6h 5th generation panel high sensitivity method,120 min; 120 minutes; 120min; 2 hours; chemistry; ctnt; hs; pan; panel.chemistry; panl; pl; plasma; plsm; pnl; serp; serpl; serplas; serum; serum or plasma; sr; t prime; tnt; troponin; troponin t 2h 6h,-
101875-3,gabaar igg ab [titer] in serum by cell binding immunofluorescent assay,gabaar igg titr ser cba ifa,gabaar igg cell binding immunofluorescent assay (s) [titer],4-aminobutanoic acid; 4-aminobutyrate; 4-aminobutyric acid; abs; aby; aminobutric; aminobutyric; amino-n-butyrate; antby; anti; antibodies; antibody; autoantibodies; autoantibody; dilution factor; dilution factor (titer); gaba; gabaar; gabaar ab; gamma aminobutyric acid; gamma amino-butyric acid; gamma amino-n-butyrate; gamma amino-n-butyric acid; immune globulin g; immunoglobulin g; indirect fluorescence antibody; piperidic acid; point in time; random; rec; recept; receptors; recp; recptr; serology; serum; smqn; sr; titer; titered; titre; ttr,SemiQn
101890-2,medical toxicology discharge summary,med tox d/c sum,,d/c sum; disch; discharge summary; doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; med tox; notes; point in time; random; visit note,Doc
101901-7,mental health action plan,mental health,,doc.ont; document; emotional stability; finding; findings; point in time; random,Doc
10190-7,mental status narrative,mental status,,finding; findings; h+p; h+p.px; narrative; p prime; point in time; random; report,Nar
101909-0,protein monoclonal panel - urine,protein mono pnl ur,protein monoclonal panel (u),chemistry; m protein; m-band; monoclonal band; monoclonal spike; m-protein; m-spike; pan; panel.chemistry; panl; para protein; paraprotein; pnl; point in time; pr; prot; protein mono pnl; random; ua; ur; urn,-
101912-4,troponin t.cardiac delta [mass concentration difference] in 2 hour serum or plasma,troponin t. d 2h serpl-mcdiff,troponin t.cardiac delta (2h) [mass conc diff],120 min; 120 minutes; 120min; 2 hours; 2hr; chemistry; ctnt; mcdiff; pl; plasma; plsm; qnt; quan; quant; quantitative; serp; serpl; serplas; serum; serum or plasma; sr; t prime; tnt; troponin; troponin t. d,Qn
101925-6,epidermal growth factor [mass/volume] in urine by immunoassay,egf ur ia-mcnc,epidermal growth factor ia (u) [mass/vol],chemistry; egf; eia; elfa; elisa; enzyme immunoassay; fac; fact; iaa; level; mass concentration; meia; point in time; qnt; quan; quant; quantitative; random; suds; ua; ur; urn,Qn
101929-8,supersaturation panel - urine,supersaturation pnl ur,supersaturation panel (u),chemistry; pan; panel.chemistry; panl; pnl; point in time; random; supersaturation pnl; ua; ur; urn,-
101964-5,hps3 gene targeted mutation analysis in blood or tissue by molecular genetics method,hps3 gene mut anl bld/t,hps3 gene targeted mutation analysis molgen doc (bld/tiss),"blood; document; finding; findings; hermansky-pudlak syndrome 3; hps3; hps3 mut anl; molecular genetics; molecular pathology; molpath; molpath.mutations; mut; mut anl; mutations; pcr; point in time; random; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",Doc
101971-0,cry,cry,,finding; findings; h+p; h+p.hx; ordinal; p prime; point in time; ql; qual; qualitative; random; screen,Ord
101976-9,voltage-gated calcium channel p/q type binding ab [mass/volume] in serum by immunoassay,vgcc-p/q bind ab ser ia-mcnc,voltage-gated calcium channel p/q type binding ab ia (s) [mass/vol],abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; bind; ca; cal; eia; elfa; elisa; enzyme immunoassay; iaa; lamblia intestinalis; lems; level; mass concentration; meia; point in time; qnt; quan; quant; quantitative; random; serology; serum; sr; suds; vdcc; vg; v-g; vgcc; vgcc-p/q bind; voltage-dependent calcium channels,Qn
101978-5,glucose and somatotropin post glucagon stimulation panel - serum or plasma,gluc+soma p gluca pnl serpl,glucose and somatotropin post glucagon stimulation panel,after; chemistry.challenge testing; gh; glu; glu tol; gluc; gluc+soma p gluca pnl; glucose tolerance; glucoseur; growth hormone; gtt; hgf; hgh; human growth hormone; hyperglycemic factor; pan; panel.challenge; panl; pl; plasma; plsm; pnl; point in time; pst; random; serp; serpl; serplas; serum; serum or plasma; somatotropic hormone; sr; sth; stim,-
101984-3,candida albicans dna [presence] in body fluid by probe.amp.tar,c albicans dna fld ql probe.amp.tar,c. albicans dna naa+probe ql (body fld),"3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; b/f; bf; bod; bodies; body fluid; body fluid, unsp; c albicans; c albicans dna; cand; candidiasis; deoxyribonucleic acid; dna nucleic acid probe; dna probe; fl; fld; flu; fluid; lat; lcr; ligase chain reaction; ligation-activated transcription; m005; m5; microbiology; monilia; naa+probe; naat; nasba; nucleic acid sequence based analysis; ordinal; pcr; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; screen; sda; strand displacement amplification; thrush; tma; transcription mediated amplification",Ord
102004-9,clot angle.kaolin induced in blood by thromboelastography^after addition of heparinase,clot angle.kaolin induced p hpase bld teg,clot angle.kaolin induced after addition of heparinase teg (bld) [angle],add heparinase; blood; clot angle kaolin phpase; coagulation; p hpase; point in time; qnt; quan; quant; quantitative; random; teg; thrombelastography; thrombelastometry; wb; whole blood,Qn
102005-6,chromium ige ab [presence] in serum by radioallergosorbent test (rast),cr ige rast,chromium ige rast (s) [presence],abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; c609; chrome; cr; immune globulin e; immunoglobulin e; point in time; pr; radioallergosorbent test; random; serum; smqn; sr,SemiQn
102026-2,cortisol [mass/volume] in serum or plasma --2 hours post dose glucagon,cortis 2h p gc serpl-mcnc,cortisol 2 hr post dose glucagon [mass/vol],120 min; 120 minutes; 120min; 17-hydroxycorticosterone; 2 hours; 2h p gc; after; chemistry.challenge testing; compound f; coritsol; cort; f; hgf; hydrocortisone; hyperglycemic factor; level; mass concentration; p dose; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
102049-4,hereditary sensory and autonomic neuropathy type 1 panel - serum by lc/ms/ms,hsan1 panel ser lc/ms/ms,hereditary sensory and autonomic neuropathy type 1 panel lc/ms/ms (s),chemistry; hsan1; hsan1 panel; hsn1; i; pan; panel.chemistry; panl; pnl; point in time; random; serum; sr,-
102065-0,perfluorohexane sulfonate [mass/volume] in serum or plasma by lc/ms/ms,pfhxs serpl lc/ms/ms-mcnc,perfluorohexane sulfonate lc/ms/ms [mass/vol],drug/toxicology; drugs; level; mass concentration; pfhxs; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
102068-4,perfluoroundecanoate [mass/volume] in serum or plasma by lc/ms/ms,pfunda serpl lc/ms/ms-mcnc,perfluoroundecanoate lc/ms/ms [mass/vol],drug/toxicology; drugs; level; mass concentration; pfunda; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
102078-3,car-t therapy panel - specimen,car-t panel spec,car-t therapy panel (specimen),ag; car-t panel; drug/toxicology; drugs; misc; miscellaneous; other; pan; panel.drug & toxicology; panl; pnl; point in time; random; rec; recept; receptors; recp; recptr; spec; t cell; t prime; to be specified in another part of the message; uchl-1; unspecified,-
102085-8,cns demyelinating disease panel - serum or plasma by flow cytometry (fc),cns demyelinating ds panel serpl fc,cns demyelinating disease panel fc,cns demyelinating ds panel; dis; diseases; dynamic; dz; fc; molecular pathology; molpath; pan; panel.molpath; panl; pl; plasma; plsm; pnl; point in time; random; serp; serpl; serplas; serum; serum or plasma; sr,-
102086-6,endometrial stromal tumor in tissue document by fish,endometrial stromal tumor tiss doc fish,endometrial stromal tumor fish doc (tiss),"document; finding; findings; fluorescent in situ hybridization; pathology; point in time; random; tissue; tissue, unspecified",Doc
10208-7,physical findings of vessels narrative,phys find vesl,,exam; examination; finding; findings; h+p; h+p.px; narrative; p prime; phys find; point in time; random; report; vesl; vessels.xxx,Nar
102104-7,streptococcus agalactiae [susceptibility] in urine by culture,gp b strep ur cult,s. agalactiae cx (u) [susc],ast; c&s; cult; cultures; gbs; gp b strep; group b; group b strep; microbiology; point in time; random; s agalactiae; steptococcus group b; strep; strep b; strep group b; strept; streptococci group b; sus; suscept; susceptibilities; susceptibility; susceptibilty; ua; ur; urn; vet; veterinary,OrdQn
102106-2,glycolate [moles/volume] in serum or plasma by gas chromatography-mass spectrometry,glycolate serpl gc-ms-scnc,glycolate gas chromatography-mass spectrometry [moles/vol],chemistry; gas chromatography; glycolic acid; level; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; substance concentration,Qn
102109-6,oxalate and glycolate and glyoxylate and citrate [interpretation] in urine,ox+glyco+glyox+cit ur-imp,oxalate and glycolate and glyoxylate and citrate (u) [interp],chemistry; citric acid; ethanedioate; ethanedioic acid; glycolic acid; glyoxylic acid; impression; impression/interpretation of study; impressions; interp; interpretation; nominal; ox+glyco+glyox+cit; oxal; oxalic acid; oxoacetate; oxoacetic acid; point in time; random; ua; ur; urn,Nom
102113-8,deprecated mixed chimerism post sct transplantation [ratio] in peripheral blood by molecular genetics method,deprecated mixed chimerism p sct transplt bldp-rto,mixed chimerism post sct transplantation molgen (bldp) [ratio],after; blood - peripheral; blood bank; mixed chimerism p sct transplt; molecular genetics; pcr; peripheral bld; point in time; pst; qnt; quan; quant; quantitative; random; ratios; rto,Qn
102124-5,sesamum indicum 1 ige ab [presence] in serum by radioallergosorbent test (rast),ses i 1 ige rast,sesamum indicum 1 ige rast (s) [presence],abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; f010; f10; i; immune globulin e; immunoglobulin e; point in time; pr; radioallergosorbent test; random; serum; ses i 1; ses i 1 ab.ige; sesame seed; sesamum orientale; smqn; sr,SemiQn
102125-2,abalone ige ab [presence] in serum by radioallergosorbent test (rast),abalone ige rast,abalone ige rast (s) [presence],abalone; abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; f346; immune globulin e; immunoglobulin e; perloemoen; point in time; pr; radioallergosorbent test; random; rf346; serum; smqn; sr,SemiQn
102134-4,almond tree ige ab [presence] in serum by radioallergosorbent test (rast),almond tree ige rast,almond tree ige rast (s) [presence],abs; aby; allergen; allergens; allergy testing; almond; almond tree; amygdalus communis; antby; anti; antibodies; antibody; autoantibodies; autoantibody; f020; f20; immune globulin e; immunoglobulin e; point in time; pr; prunus amygdalus; radioallergosorbent test; random; serum; smqn; sr,SemiQn
102141-9,anise ige ab [presence] in serum by radioallergosorbent test (rast),anise ige rast,anise ige rast (s) [presence],abs; aby; allergen; allergens; allergy testing; anise; aniseed; antby; anti; antibodies; antibody; autoantibodies; autoantibody; f271; immune globulin e; immunoglobulin e; point in time; pr; radioallergosorbent test; random; rf271; serum; smqn; sr,SemiQn
102144-3,apple tree ige ab [presence] in serum by radioallergosorbent test (rast),apple tree ige rast,apple tree ige rast (s) [presence],abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; apple; apple tree; autoantibodies; autoantibody; f049; f49; immune globulin e; immunoglobulin e; point in time; pr; pyrus malus; radioallergosorbent test; random; serum; smqn; sr,SemiQn
102145-0,apricot ige ab [presence] in serum by radioallergosorbent test (rast),apricot ige rast,apricot ige rast (s) [presence],abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; apricot; autoantibodies; autoantibody; f237; immune globulin e; immunoglobulin e; point in time; pr; prunus armeciaca; radioallergosorbent test; random; serum; smqn; sr,SemiQn
102152-6,aspen ige ab [presence] in serum by radioallergosorbent test (rast),aspen ige rast,aspen ige rast (s) [presence],abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; aspen; autoantibodies; autoantibody; immune globulin e; immunoglobulin e; p tremula; point in time; pr; radioallergosorbent test; random; serum; smqn; sr,SemiQn
102153-4,aspergillus fumigatus ige ab [presence] in serum by radioallergosorbent test (rast),a fumigatus ige rast,a. fumigatus ige rast (s) [presence],a fumigatus; abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; asperg; aspergil; aspergilis; aspergilla; aspergillin; aspergillosis; aspergils; aspergilus; autoantibodies; autoantibody; farmers lung; fum; immune globulin e; immunoglobulin e; m003; m3; point in time; pr; radioallergosorbent test; random; serum; smqn; sr,SemiQn
102171-6,pinto bean ige ab [presence] in serum by radioallergosorbent test (rast),pinto bean ige rast,pinto bean ige rast (s) [presence],abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; beans; f121; f300; immune globulin e; immunoglobulin e; phaseolus vulgaris; pinto bean; point in time; pr; radioallergosorbent test; random; serum; smqn; sr,SemiQn
102174-0,honey bee ige ab [presence] in serum by radioallergosorbent test (rast),honey bee ige rast,honey bee ige rast (s) [presence],abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; honey bee; honeybee; i001; i1; immune globulin e; immunoglobulin e; point in time; pr; radioallergosorbent test; random; serum; smqn; sr,SemiQn
10217-8,surgical operation note indications [interpretation] narrative,operative note indications imp,,encounter; evaluation and management; evaluation and management note; h+p; h+p.surgical procedures; impression; impression/interpretation of study; impressions; interp; interpretation; narrative; notes; operative note; operative note indications; p prime; point in time; random; report; surg; visit note,Nar
102182-3,silver birch ige ab [presence] in serum by radioallergosorbent test (rast),silver birch ige rast,silver birch ige rast (s) [presence],abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; common silver birch; ifr; immune globulin e; immunoglobulin e; isoflavone reductase; point in time; pr; radioallergosorbent test; random; serum; silver birch; smqn; sr; t3,SemiQn
102187-2,botrytis cinerea ige ab [presence] in serum by radioallergosorbent test (rast),b cinerea ige rast,botrytis cinerea ige rast (s) [presence],abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; b cinerea; immune globulin e; immunoglobulin e; m7; point in time; pr; radioallergosorbent test; random; serum; smqn; sr,SemiQn
102194-8,buckwheat ige ab [presence] in serum by radioallergosorbent test (rast),buckwheat ige rast,buckwheat ige rast (s) [presence],abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; buchwheat; buckwheat; f011; f11; immune globulin e; immunoglobulin e; point in time; pr; radioallergosorbent test; random; serum; smqn; sr,SemiQn
102211-0,catfish ige ab [presence] in serum by radioallergosorbent test (rast),catfish ige rast,catfish ige rast (s) [presence],abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; catfish; f369; immune globulin e; immunoglobulin e; point in time; pr; radioallergosorbent test; random; serum; smqn; sr,SemiQn
102212-8,cauliflower ige ab [presence] in serum by radioallergosorbent test (rast),cauliflower ige rast,cauliflower ige rast (s) [presence],abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; cauliflower; f291; immune globulin e; immunoglobulin e; point in time; pr; radioallergosorbent test; random; rf291; serum; smqn; sr,SemiQn
102214-4,japanese cedar ige ab [presence] in serum by radioallergosorbent test (rast),japanese cedar ige rast,japanese cedar ige rast (s) [presence],abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; immune globulin e; immunoglobulin e; japanese cedar; point in time; pr; radioallergosorbent test; random; serum; smqn; sr; sugi tree; t17,SemiQn
102216-9,red cedar ige ab [presence] in serum by radioallergosorbent test (rast),red cedar ige rast,red cedar ige rast (s) [presence],abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; immune globulin e; immunoglobulin e; juniper virginiana; point in time; pr; radioallergosorbent test; random; red cedar; serum; smqn; sr; t219; t57,SemiQn
102217-7,saltcedar ige ab [presence] in serum by radioallergosorbent test (rast),saltcedar ige rast,saltcedar ige rast (s) [presence],abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; immune globulin e; immunoglobulin e; point in time; pr; radioallergosorbent test; random; salt cedar; saltcedar; serum; smqn; sr; tamarisk,SemiQn
102222-7,american cheese ige ab [presence] in serum by radioallergosorbent test (rast),american cheese ige rast,american cheese ige rast (s) [presence],abs; aby; allergen; allergens; allergy testing; american cheese; antby; anti; antibodies; antibody; autoantibodies; autoantibody; f122; immune globulin e; immunoglobulin e; point in time; pr; radioallergosorbent test; random; serum; smqn; sr,SemiQn
102224-3,cottage cheese ige ab [presence] in serum by radioallergosorbent test (rast),cottage cheese ige rast,cottage cheese ige rast (s) [presence],abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; cottage cheese; dutch cheese; immune globulin e; immunoglobulin e; point in time; pot cheese; pr; radioallergosorbent test; random; serum; smqn; sr,SemiQn
102225-0,mozzarella cheese ige ab [presence] in serum by radioallergosorbent test (rast),mozzarella ige rast,mozzarella cheese ige rast (s) [presence],abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; immune globulin e; immunoglobulin e; point in time; pr; radioallergosorbent test; random; serum; smqn; sr,SemiQn
102253-2,cotton fibers ige ab [presence] in serum by radioallergosorbent test (rast),cotton fibers ige rast,cotton fibers ige rast (s) [presence],abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; cotton smooth fibers; fiber; immune globulin e; immunoglobulin e; o1; point in time; pr; radioallergosorbent test; random; serum; smqn; sr,SemiQn
102263-1,cryptococcus terreus ige ab [presence] in serum by radioallergosorbent test (rast),c terreus ige rast,cryptococcus terreus ige rast (s) [presence],abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; c terreus; crypt; crypto; cryptococcal; cryptococcosis; cryptococcosus; immune globulin e; immunoglobulin e; point in time; pr; radioallergosorbent test; random; serum; smqn; sr,SemiQn
102265-6,curry ige ab [presence] in serum by radioallergosorbent test (rast),curry ige rast,curry ige rast (s) [presence],abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; f281; immune globulin e; immunoglobulin e; point in time; pr; radioallergosorbent test; random; rf281; santa maria; serum; smqn; sr,SemiQn
102271-4,daisy ige ab [presence] in serum by radioallergosorbent test (rast),daisy ige rast,daisy ige rast (s) [presence],abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; daisy; immune globulin e; immunoglobulin e; point in time; pr; radioallergosorbent test; random; serum; smqn; sr,SemiQn
102281-3,yellow dock ige ab [presence] in serum by radioallergosorbent test (rast),yellow dock ige rast,yellow dock ige rast (s) [presence],abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; immune globulin e; immunoglobulin e; point in time; pr; radioallergosorbent test; random; serum; smqn; sr; w23; yellow dock; yellow dockweed,SemiQn
102282-1,dog dander ige ab [presence] in serum by radioallergosorbent test (rast),dog dander ige rast,dog dander ige rast (s) [presence],abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; canine; dog hair; e005; e5; immune globulin e; immunoglobulin e; point in time; pr; radioallergosorbent test; random; serum; smqn; sr,SemiQn
102289-6,eggplant ige ab [presence] in serum by radioallergosorbent test (rast),eggplant ige rast,eggplant ige rast (s) [presence],abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; aubergine; autoantibodies; autoantibody; eggplant; f262; immune globulin e; immunoglobulin e; point in time; pr; radioallergosorbent test; random; rf262; serum; smqn; sr,SemiQn
102293-8,white elm ige ab [presence] in serum by radioallergosorbent test (rast),white elm ige rast,white elm ige rast (s) [presence],abs; aby; allergen; allergens; allergy testing; american elm; antby; anti; antibodies; antibody; autoantibodies; autoantibody; elm; immune globulin e; immunoglobulin e; point in time; pr; radioallergosorbent test; random; serum; smqn; sr; t008; t8; white elm,SemiQn
102296-1,epicoccum purpurascens ige ab [presence] in serum by radioallergosorbent test (rast),e purpurascens ige rast,epicoccum purpurascens ige rast (s) [presence],abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; e nigrum; e purpurascens; epicoccum nigrans; epicoccum nigrum; epicoccus purpurascens; immune globulin e; immunoglobulin e; m14; m73; point in time; pr; radioallergosorbent test; random; serum; smqn; sr,SemiQn
102305-0,meadow fescue ige ab [presence] in serum by radioallergosorbent test (rast),meadow fescue ige rast,meadow fescue ige rast (s) [presence],abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; festuca elator; festuca pratensis; g004; g4; immune globulin e; immunoglobulin e; meadow fescue; point in time; pr; radioallergosorbent test; random; serum; smqn; sr,SemiQn
102307-6,douglas fir ige ab [presence] in serum by radioallergosorbent test (rast),douglas fir ige rast,douglas fir ige rast (s) [presence],abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; douglas fir; douglas spruce; immune globulin e; immunoglobulin e; point in time; pr; radioallergosorbent test; random; rt207; serum; smqn; sr; t207,SemiQn
102309-2,fiscus sp ige ab [presence] in serum by radioallergosorbent test (rast),fiscus ige rast,fiscus sp ige rast (s) [presence],abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; immune globulin e; immunoglobulin e; point in time; pr; radioallergosorbent test; random; serum; smqn; species; spp; sr,SemiQn
102310-0,flea ige ab [presence] in serum by radioallergosorbent test (rast),flea ige rast,flea ige rast (s) [presence],abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; flea; i054; i54; immune globulin e; immunoglobulin e; point in time; pr; radioallergosorbent test; random; serum; smqn; species; spp; sr,SemiQn
102311-8,flounder ige ab [presence] in serum by radioallergosorbent test (rast),flounder ige rast,flounder ige rast (s) [presence],abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; f147; immune globulin e; immunoglobulin e; point in time; pr; radioallergosorbent test; random; serum; smqn; sr,SemiQn
102340-7,kentucky blue grass ige ab [presence] in serum by radioallergosorbent test (rast),kent blue grass ige rast,kentucky blue grass ige rast (s) [presence],abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; g008; g8; immune globulin e; immunoglobulin e; june blue grass; june grass; june kentucky blue grass; junegrass; kent blue grass; kentucky blue grass; kentucky bluegrass; meadow grass; point in time; pr; radioallergosorbent test; random; serum; smqn; sr,SemiQn
102344-9,red top grass ige ab [presence] in serum by radioallergosorbent test (rast),red top grass ige rast,red top grass ige rast (s) [presence],abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; bent grass; bentgrass; g009; g9; immune globulin e; immunoglobulin e; point in time; pr; radioallergosorbent test; random; red top bent grass; red top grass; redtop; serum; smqn; sr,SemiQn
102364-7,setomelanomma rostrata ige ab [presence] in serum by radioallergosorbent test (rast),s rostrata ige rast,setomelanomma rostrata ige rast (s) [presence],abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; h halodes; helminthosporium halodes; immune globulin e; immunoglobulin e; m8; point in time; pr; radioallergosorbent test; random; s rostrata; serum; smqn; sr,SemiQn
102380-3,horse epithelium ige ab [presence] in serum by radioallergosorbent test (rast),horse epith ige rast,horse epithelium ige rast (s) [presence],abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; epithelia; equus spp; immune globulin e; immunoglobulin e; point in time; pr; radioallergosorbent test; random; serum; smqn; sr,SemiQn
102386-0,house dust hollister stier ige ab [presence] in serum by radioallergosorbent test (rast),house dust hs ige rast,house dust hollister stier ige rast (s) [presence],abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; h2; house dust hs; housedust; immune globulin e; immunoglobulin e; point in time; pr; radioallergosorbent test; random; serum; smqn; sr,SemiQn
102401-7,latex glove extract ige ab [presence] in serum by radioallergosorbent test (rast),ltx glv ext ige rast,latex glove extract ige rast (s) [presence],abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; hevea braziliensis; immune globulin e; immunoglobulin e; k082; k82; ltx; ltx glv ext; point in time; pr; radioallergosorbent test; random; serum; smqn; sr,SemiQn
102413-2,linden ige ab [presence] in serum by radioallergosorbent test (rast),linden ige rast,linden ige rast (s) [presence],abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; immune globulin e; immunoglobulin e; linden; point in time; pr; radioallergosorbent test; random; serum; smqn; sr; t208,SemiQn
102415-7,lobster ige ab [presence] in serum by radioallergosorbent test (rast),lobster ige rast,lobster ige rast (s) [presence],abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; f080; f80; immune globulin e; immunoglobulin e; lobster; point in time; pr; radioallergosorbent test; random; serum; smqn; sr,SemiQn
10243-4,oxygen content in inferior vena cava,o2 ct ivc-scnc,oxygen content (inferior vena cava) [moles/vol],chemistry; cto2; heart; inf; ivc; level; o2; o2 ct; o2ct; point in time; qnt; quan; quant; quantitative; random; substance concentration; to2; vc,Qn
102435-5,mesquite ige ab [presence] in serum by radioallergosorbent test (rast),mesquite ige rast,mesquite ige rast (s) [presence],abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; honey locust; immune globulin e; immunoglobulin e; mesquite; point in time; pr; radioallergosorbent test; random; serum; smqn; sr; t020; t20,SemiQn
102437-1,green nimitti ige ab [presence] in serum by radioallergosorbent test (rast),green nimitti ige rast,green nimitti ige rast (s) [presence],abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; green nimitti; i72; immune globulin e; immunoglobulin e; midge; point in time; pr; radioallergosorbent test; random; serum; smqn; sr; sudan fly,SemiQn
102443-9,cockspur ige ab [presence] in serum by radioallergosorbent test (rast),cockspur ige rast,cockspur ige rast (s) [presence],abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; barnyard grass; cockspur; f57; immune globulin e; immunoglobulin e; japanese millet; point in time; pr; radioallergosorbent test; random; serum; smqn; sr,SemiQn
102458-7,blue mussel ige ab [presence] in serum by radioallergosorbent test (rast),blue mussel ige rast,blue mussel ige rast (s) [presence],abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; blue mussel; f037; f37; immune globulin e; immunoglobulin e; point in time; pr; radioallergosorbent test; random; serum; smqn; sr,SemiQn
102461-1,nettle ige ab [presence] in serum by radioallergosorbent test (rast),nettle ige rast,nettle ige rast (s) [presence],abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; immune globulin e; immunoglobulin e; nettle; point in time; pr; radioallergosorbent test; random; serum; smqn; sr; w20,SemiQn
102468-6,jerusalem oak ige ab [presence] in serum by radioallergosorbent test (rast),jerusalem oak ige rast,jerusalem oak ige rast (s) [presence],abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; immune globulin e; immunoglobulin e; jerusalem oak; point in time; pr; radioallergosorbent test; random; serum; smqn; sr,SemiQn
102476-9,okra ige ab [presence] in serum by radioallergosorbent test (rast),okra ige rast,okra ige rast (s) [presence],abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; bamia; bhindi; bindi; f379; gumbo; hibiscus esculentus; immune globulin e; immunoglobulin e; lady's finger; okra; point in time; pr; radioallergosorbent test; random; serum; smqn; sr,SemiQn
102486-8,papaya (carica papaya) ige ab [presence] in serum by radioallergosorbent test (rast),papaya ige rast,papaya ige rast (s) [presence],abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; f293; immune globulin e; immunoglobulin e; papaw; papaya; paw paw; point in time; pr; radioallergosorbent test; random; rf293; serum; smqn; sr; tree melon,SemiQn
102487-6,paprika ige ab [presence] in serum by radioallergosorbent test (rast),paprika ige rast,paprika ige rast (s) [presence],abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; f218; immune globulin e; immunoglobulin e; paprika; point in time; pr; radioallergosorbent test; random; serum; smqn; sr; sweet pepper,SemiQn
102489-2,budgerigar droppings ige ab [presence] in serum by radioallergosorbent test (rast),budgie drop ige rast,budgerigar droppings ige rast (s) [presence],abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; australian parrot; autoantibodies; autoantibody; budgeriar; budgie; budgie drop; e77; feces; immune globulin e; immunoglobulin e; point in time; pr; radioallergosorbent test; random; serum; smqn; sr; stool,SemiQn
102507-1,black pepper ige ab [presence] in serum by radioallergosorbent test (rast),black pepper ige rast,black pepper ige rast (s) [presence],abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; black pepper; f280; immune globulin e; immunoglobulin e; point in time; pr; radioallergosorbent test; random; serum; smqn; sr,SemiQn
102513-9,phoma betae ige ab [presence] in serum by radioallergosorbent test (rast),p betae ige rast,phoma betae ige rast (s) [presence],abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; immune globulin e; immunoglobulin e; m13; p betae; pleospora betae; point in time; pr; radioallergosorbent test; random; serum; smqn; sr,SemiQn
102517-0,pigeon feather ige ab [presence] in serum by radioallergosorbent test (rast),pigeon feather ige rast,pigeon feather ige rast (s) [presence],abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; e215; feathers; immune globulin e; immunoglobulin e; point in time; pr; radioallergosorbent test; random; re215; serum; smqn; sr,SemiQn
102524-6,pine ige ab [presence] in serum by radioallergosorbent test (rast),pine ige rast,pine ige rast (s) [presence],abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; immune globulin e; immunoglobulin e; monterey pine; pine; point in time; pr; radioallergosorbent test; random; rt213; serum; smqn; sr; t213,SemiQn
102527-9,slash pine ige ab [presence] in serum by radioallergosorbent test (rast),slash pine ige rast,slash pine ige rast (s) [presence],abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; immune globulin e; immunoglobulin e; point in time; pr; radioallergosorbent test; random; serum; slash pine; smqn; sr,SemiQn
102528-7,virginia scrub pine ige ab [presence] in serum by radioallergosorbent test (rast),virg scrub pine ige rast,virginia scrub pine ige rast (s) [presence],abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; immune globulin e; immunoglobulin e; point in time; pr; radioallergosorbent test; random; serum; smqn; sr; virg scrub pine; virginia pine; virginia scrub pine,SemiQn
102536-0,black cottonwood ige ab [presence] in serum by radioallergosorbent test (rast),black cottonwood ige rast,black cottonwood ige rast (s) [presence],abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; black cottonwood; immune globulin e; immunoglobulin e; lombardy poplar; point in time; pr; radioallergosorbent test; random; serum; smqn; sr,SemiQn
102543-6,protamine ige ab [presence] in serum by radioallergosorbent test (rast),protamine ige rast,protamine ige rast (s) [presence],abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; c10; c207; immune globulin e; immunoglobulin e; point in time; pr; radioallergosorbent test; random; rc207; serum; smqn; sr,SemiQn
10255-8,type of subarachnoid drain,subarachnoid drain class,,drn; io; io.tube; nominal; point in time; random; typ,Nom
102566-7,rat urine proteins ige ab [presence] in serum by radioallergosorbent test (rast),rat urine prot ige rast,rat urine proteins ige rast (s) [presence],abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; e74; immune globulin e; immunoglobulin e; point in time; pr; protein; radioallergosorbent test; random; serum; smqn; sr,SemiQn
102605-3,spruce ige ab [presence] in serum by radioallergosorbent test (rast),spruce ige rast,spruce ige rast (s) [presence],abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; immune globulin e; immunoglobulin e; norway spruce; picea abies; point in time; pr; radioallergosorbent test; random; rt201; serum; smqn; spruce; sr; t201,SemiQn
102621-0,american sycamore ige ab [presence] in serum by radioallergosorbent test (rast),amer sycamore ige rast,american sycamore ige rast (s) [presence],abs; aby; allergen; allergens; allergy testing; amer sycamore; american sycamore; antby; anti; antibodies; antibody; autoantibodies; autoantibody; eastern sycamore; immune globulin e; immunoglobulin e; point in time; pr; radioallergosorbent test; random; serum; smqn; sr; sycamore; t061; t61,SemiQn
102662-4,black willow ige ab [presence] in serum by radioallergosorbent test (rast),black willow ige rast,black willow ige rast (s) [presence],abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; black willow; immune globulin e; immunoglobulin e; point in time; pr; radioallergosorbent test; random; serum; smqn; sr; t032; t32,SemiQn
102663-2,pussy willow ige ab [presence] in serum by radioallergosorbent test (rast),pussy willow ige rast,pussy willow ige rast (s) [presence],abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; immune globulin e; immunoglobulin e; point in time; pr; pussy willow; radioallergosorbent test; random; serum; smqn; sr; t232,SemiQn
102669-9,salmon igg ab [presence] in serum by radioallergosorbent test (rast),salmon igg rast,salmon igg rast (s) [presence],abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; atlantic salmon; autoantibodies; autoantibody; f041; f41; immune globulin g; immunoglobulin g; point in time; pr; radioallergosorbent test; random; salmon; serum; smqn; sr,SemiQn
102670-7,tuna igg ab [presence] in serum by radioallergosorbent test (rast),tuna igg rast,tuna igg rast (s) [presence],abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; f040; f40; immune globulin g; immunoglobulin g; point in time; pr; radioallergosorbent test; random; serum; smqn; sr; tuna; yellow fin,SemiQn
102673-1,almond igg ab [presence] in serum by radioallergosorbent test (rast),almond igg rast,almond igg rast (s) [presence],abs; aby; allergen; allergens; allergy testing; almond; amygdalus communis; antby; anti; antibodies; antibody; autoantibodies; autoantibody; f020; f20; immune globulin g; immunoglobulin g; point in time; pr; prunus amygdalus; radioallergosorbent test; random; serum; smqn; sr,SemiQn
102677-2,apple igg ab [presence] in serum by radioallergosorbent test (rast),apple igg rast,apple igg rast (s) [presence],abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; apple; autoantibodies; autoantibody; f049; f49; immune globulin g; immunoglobulin g; point in time; pr; pyrus malus; radioallergosorbent test; random; serum; smqn; sr,SemiQn
102690-5,soybean igg ab [presence] in serum by radioallergosorbent test (rast),soybean igg rast,soybean igg rast (s) [presence],abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; f014; f14; gly; immune globulin g; immunoglobulin g; largest; maximal; maximum; peak; point in time; pr; radioallergosorbent test; random; serum; smqn; soja hispida; soy bean; soya bean; soyabean; soybean; sr,SemiQn
102697-0,broccoli igg ab [presence] in serum by radioallergosorbent test (rast),broccoli igg rast,broccoli igg rast (s) [presence],abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; brassica oleracea cymosa; brassica oleracea var italics; broccoli; f260; immune globulin g; immunoglobulin g; point in time; pr; radioallergosorbent test; random; serum; smqn; sr,SemiQn
102715-0,cinnamon igg ab [presence] in serum by radioallergosorbent test (rast),cinnamon igg rast,cinnamon igg rast (s) [presence],abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; cinnamate; cinnamon; f220; immune globulin g; immunoglobulin g; point in time; pr; radioallergosorbent test; random; rf220; serum; smqn; sr,SemiQn
102716-8,clam igg ab [presence] in serum by radioallergosorbent test (rast),clam igg rast,clam igg rast (s) [presence],abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; clam; f207; immune globulin g; immunoglobulin g; mollusc; point in time; pr; radioallergosorbent test; random; serum; smqn; sr,SemiQn
102718-4,cockatiel droppings ige ab [presence] in serum by radioallergosorbent test (rast),cockatiel drop ige rast,cockatiel droppings ige rast (s) [presence],abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; feces; immune globulin e; immunoglobulin e; point in time; pr; radioallergosorbent test; random; serum; smqn; sr; stool,SemiQn
102727-5,cow milk igg ab [presence] in serum by radioallergosorbent test (rast),cow milk igg rast,cow milk igg rast (s) [presence],abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; f002; f2; f43; immune globulin g; immunoglobulin g; point in time; pr; radioallergosorbent test; random; serum; smqn; sr,SemiQn
102728-3,crab igg ab [presence] in serum by radioallergosorbent test (rast),crab igg rast,crab igg rast (s) [presence],abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; crab; f023; f23; immune globulin g; immunoglobulin g; point in time; pr; radioallergosorbent test; random; serum; smqn; sr,SemiQn
102732-5,echinococcus granulosus ige ab [presence] in serum by radioallergosorbent test (rast),e granulosus ige rast,e. granulosus ige rast (s) [presence],abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; e granulosus; echinococcosis; immune globulin e; immunoglobulin e; point in time; pr; radioallergosorbent test; random; serum; smqn; sr,SemiQn
102738-2,fig ige ab [presence] in serum by radioallergosorbent test (rast),fig ige rast,fig ige rast (s) [presence],abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; f174; f328; f402; fig; immune globulin e; immunoglobulin e; point in time; pr; radioallergosorbent test; random; rf328; serum; smqn; sr,SemiQn
102743-2,garlic igg ab [presence] in serum by radioallergosorbent test (rast),garlic igg rast,garlic igg rast (s) [presence],abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; f047; f47; garlic; immune globulin g; immunoglobulin g; point in time; pr; radioallergosorbent test; random; serum; smqn; sr,SemiQn
102746-5,ginger igg ab [presence] in serum by radioallergosorbent test (rast),ginger igg rast,ginger igg rast (s) [presence],abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; f270; ginger; immune globulin g; immunoglobulin g; point in time; pr; radioallergosorbent test; random; rf270; serum; smqn; sr,SemiQn
102747-3,gluten igg ab [presence] in serum by radioallergosorbent test (rast),gluten igg rast,gluten igg rast (s) [presence],abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; f079; f79; immune globulin g; immunoglobulin g; point in time; pr; radioallergosorbent test; random; serum; smqn; sr,SemiQn
102761-4,lemon igg ab [presence] in serum by radioallergosorbent test (rast),lemon igg rast,lemon igg rast (s) [presence],abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; f208; immune globulin g; immunoglobulin g; lemon; point in time; pr; radioallergosorbent test; random; serum; smqn; sr,SemiQn
102767-1,malt igg ab [presence] in serum by radioallergosorbent test (rast),malt igg rast,malt igg rast (s) [presence],abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; f090; f90; immune globulin g; immunoglobulin g; point in time; pr; radioallergosorbent test; random; serum; smqn; sr,SemiQn
102776-2,olive ige ab [presence] in serum by radioallergosorbent test (rast),olive ige rast,olea europaea ige rast (s) [presence],abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; black olive; f342; immune globulin e; immunoglobulin e; olive; point in time; pr; radioallergosorbent test; random; serum; smqn; sr,SemiQn
102782-0,papain ige ab [presence] in serum by radioallergosorbent test (rast),papain ige rast,papain ige rast (s) [presence],abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; immune globulin e; immunoglobulin e; k201; ncar p 1; point in time; pr; radioallergosorbent test; random; rk201; serum; smqn; sr,SemiQn
102796-0,walleye pike ige ab [presence] in serum by radioallergosorbent test (rast),walleye pike ige rast,walleye pike ige rast (s) [presence],abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; immune globulin e; immunoglobulin e; point in time; pr; radioallergosorbent test; random; sander vitreus; serum; smqn; sr; walleye pike,SemiQn
102800-0,pollock ige ab [presence] in serum by radioallergosorbent test (rast),pollock ige rast,pollock ige rast (s) [presence],abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; f413; immune globulin e; immunoglobulin e; point in time; pollack; pollock; pr; radioallergosorbent test; random; serum; smqn; sr,SemiQn
102819-0,red snapper igg ab [presence] in serum by radioallergosorbent test (rast),red snapper igg rast,red snapper igg rast (s) [presence],abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; f381; immune globulin g; immunoglobulin g; point in time; pr; radioallergosorbent test; random; red snapper; serum; smqn; sr,SemiQn
102842-2,watermelon igg ab [presence] in serum by radioallergosorbent test (rast),watermelon igg rast,watermelon igg rast (s) [presence],abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; citrullus vulgaris; f029; f29; f329; immune globulin g; immunoglobulin g; point in time; pr; radioallergosorbent test; random; rf329; serum; smqn; sr; watermelon,SemiQn
102868-7,wheat bran igg ab [presence] in serum by radioallergosorbent test (rast),wheat bran igg rast,wheat bran igg rast (s) [presence],abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; immune globulin g; immunoglobulin g; point in time; pr; radioallergosorbent test; random; serum; smqn; sr; wheat bran,SemiQn
102883-6,penicillium brevicompactum ige ab [presence] in serum by radioallergosorbent test (rast),p brevicompactum ige rast,p. brevicompactum ige rast (s) [presence],abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; immune globulin e; immunoglobulin e; m25; m305; p brevicompactum; point in time; pr; radioallergosorbent test; random; serum; smqn; sr,SemiQn
102899-2,red currant ige ab [presence] in serum by radioallergosorbent test (rast),red currant ige rast,red currant ige rast (s) [presence],abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; f322; immune globulin e; immunoglobulin e; point in time; pr; radioallergosorbent test; random; red currant; red current; rf322; serum; smqn; sr; white current,SemiQn
102918-0,pepsin ige ab [presence] in serum by radioallergosorbent test (rast),pepsin ige rast,pepsin ige rast (s) [presence],"abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; immune globulin e; immunoglobulin e; k213; nsus s pepsin, swine; point in time; pr; radioallergosorbent test; random; rk213; serum; smqn; sr",SemiQn
102919-8,staphylococcus aureus enterotoxin a ige ab [presence] in serum by radioallergosorbent test (rast),s aureus etx a ige rast,s. aureus enterotoxin a ige rast (s) [presence],abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; etx; immune globulin e; immunoglobulin e; m80; o71; point in time; pr; radioallergosorbent test; random; s aureus; s aureus etx; s aureus etx a; serum; smqn; sr; st a sea; staph; staphylococcal enterotoxin,SemiQn
102927-1,wheat bran igg4 ab [presence] in serum by radioallergosorbent test (rast),wheat bran igg4 rast,wheat bran igg4 rast (s) [presence],abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; point in time; pr; radioallergosorbent test; random; serum; smqn; sr; wheat bran,SemiQn
102937-0,wasp venom igg4 ab [presence] in serum by radioallergosorbent test (rast),wasp venom igg4 rast,wasp venom igg4 rast (s) [presence],abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; point in time; pr; radioallergosorbent test; random; serum; smqn; sr,SemiQn
102938-8,lactoglobulin igg4 ab [presence] in serum by radioallergosorbent test (rast),lactoglob igg4 rast,lactoglobulin igg4 rast (s) [presence],abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; point in time; pr; radioallergosorbent test; random; serum; smqn; sr,SemiQn
102947-9,australian pine ige ab [presence] in serum by radioallergosorbent test (rast),australian pine ige rast,australian pine ige rast (s) [presence],abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; australian pine; autoantibodies; autoantibody; casaurina equisetifolia; immune globulin e; immunoglobulin e; point in time; pr; radioallergosorbent test; random; serum; smqn; sr; t073; t73,SemiQn
102948-7,gerbil epithelium ige ab [presence] in serum by radioallergosorbent test (rast),gerbil epith ige rast,gerbil epithelium ige rast (s) [presence],abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; e209; epithelia; gerbill; immune globulin e; immunoglobulin e; point in time; pr; radioallergosorbent test; random; re209; serum; smqn; sr,SemiQn
102973-5,bean string ige ab [presence] in serum by radioallergosorbent test (rast),bean string ige rast,bean string ige rast (s) [presence],abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; beans; immune globulin e; immunoglobulin e; point in time; pr; radioallergosorbent test; random; serum; smqn; sr,SemiQn
1029-8,fy sup(b) ab [presence] in serum or plasma from donor,fy sup(b) ab serpl donr ql,fy sup(b) ab ql (s/p donor),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; blood bank; donr; duffy; duffy blood group system; f (little y) (little b); fy sup(b); fy^b; fyb; ordinal; pl; plasma; plsm; point in time; pr; ql; qual; qualitative; random; screen; serp; serpl; serplas; serum; serum or plasma; sr,Ord
102995-8,fox epithelium ige ab [presence] in serum by radioallergosorbent test (rast),fox epith ige rast,fox epithelium ige rast (s) [presence],abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; e210; epithelia; immune globulin e; immunoglobulin e; point in time; pr; radioallergosorbent test; random; re210; serum; smqn; sr,SemiQn
102997-4,hake ige ab [presence] in serum by radioallergosorbent test (rast),hake ige rast,hake ige rast (s) [presence],abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; f307; hake; immune globulin e; immunoglobulin e; point in time; pr; radioallergosorbent test; random; rf307; serum; smqn; sr,SemiQn
102998-2,timothy recombinant (rphl p) 1 ige ab [presence] in serum by radioallergosorbent test (rast),timothy (rphl p) 1 ige rast,timothy recombinant (rphl p) 1 ige rast (s) [presence],abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; g006; g205; g6; i; immune globulin e; immunoglobulin e; p prime; phleum pretense; point in time; pr; radioallergosorbent test; random; rg205; rph1; serum; smqn; sr; timothy; timothy (rphl p) 1; timothy grass,SemiQn
103001-4,timothy recombinant (rphl p) 6 ige ab [presence] in serum by radioallergosorbent test (rast),timothy (rphl p) 6 ige rast,timothy recombinant (rphl p) 6 ige rast (s) [presence],abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; g006; g209; g6; immune globulin e; immunoglobulin e; p prime; phleum pretense; point in time; pr; radioallergosorbent test; random; rg209; rph1; serum; smqn; sr; timothy; timothy (rphl p) 6; timothy grass,SemiQn
103006-3,timothy recombinant (rphl p) 7 + 12 ige ab [presence] in serum by radioallergosorbent test (rast),timothy (rphl p) 7+12 ige rast,timothy recombinant (rphl p) 7 + 12 ige rast (s) [presence],abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; g006; g210; g214; g6; immune globulin e; immunoglobulin e; p prime; phleum pretense; point in time; pr; radioallergosorbent test; random; rg210; rph1; serum; smqn; sr; timothy; timothy (rphl p) 7; timothy (rphl p) 7+12; timothy grass,SemiQn
103023-8,sugar beet ige ab [presence] in serum by radioallergosorbent test (rast),sugar beet ige rast,sugar beet ige rast (s) [presence],abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; b; immune globulin e; immunoglobulin e; point in time; pr; radioallergosorbent test; random; rw210; serum; smqn; sr; sugar beet; w210,SemiQn
103041-0,olive pollen native (nole e) 7 ige ab [presence] in serum by radioallergosorbent test (rast),olive (nole e) 7 ige rast,olive pollen native (nole e) 7 ige rast (s) [presence],abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; black olive; f342; immune globulin e; immunoglobulin e; olive; olive (nole e) 7; point in time; pr; radioallergosorbent test; random; serum; smqn; sr,SemiQn
103073-3,peanut recombinant (rara h) 3 ige ab [presence] in serum by radioallergosorbent test (rast),peanut (rara h) 3 ige rast,peanut recombinant (rara h) 3 ige rast (s) [presence],abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; f013; f13; f424; iii; immune globulin e; immunoglobulin e; nr1b1; peanut; peanut (rara h) 3; point in time; pr; radioallergosorbent test; random; rar alpha form; raralpha; retinoic acid receptor alpha; serum; smqn; sr,SemiQn
103074-1,hazelnut recombinant (rcor a) 8 ige ab [presence] in serum by radioallergosorbent test (rast),hazelnut (rcor a) 8 ige rast,hazelnut recombinant (rcor a) 8 ige rast (s) [presence],abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; barcelona nut; cob nut; f017; f17; f425; filbert; hazel nut; hazelnut; hazelnut (rcor a) 8; immune globulin e; immunoglobulin e; ltp; point in time; pr; radioallergosorbent test; random; serum; smqn; sr,SemiQn
103075-8,peanut recombinant (rara h) 9 ige ab [presence] in serum by radioallergosorbent test (rast),peanut (rara h) 9 ige rast,peanut recombinant (rara h) 9 ige rast (s) [presence],abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; f013; f13; f427; immune globulin e; immunoglobulin e; nr1b1; peanut; peanut (rara h) 9; point in time; pr; radioallergosorbent test; random; rar alpha form; raralpha; retinoic acid receptor alpha; serum; smqn; sr,SemiQn
103082-4,kiwi native (nact d) 1 ige ab [presence] in serum by radioallergosorbent test (rast),kiwi (nact d) 1 ige rast,kiwi native (nact d) 1 ige rast (s) [presence],abs; aby; actinidin; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; chinese gooseberry; dextro; f436; i; immune globulin e; immunoglobulin e; kiwi; kiwi (nact d) 1; kiwi fruit; kiwifruit; point in time; pr; radioallergosorbent test; random; serum; smqn; sr,SemiQn
103092-3,latex recombinant (rhev b) 3 ige ab [presence] in serum by radioallergosorbent test (rast),latex (rhev b) 3 ige rast,latex recombinant (rhev b) 3 ige rast (s) [presence],abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; hevea braziliensis; iii; immune globulin e; immunoglobulin e; k082; k217; k82; latex (rhev b) 3; ltx; point in time; pr; radioallergosorbent test; random; serum; smqn; sr,SemiQn
103093-1,latex recombinant (rhev b) 5 ige ab [presence] in serum by radioallergosorbent test (rast),latex (rhev b) 5 ige rast,latex recombinant (rhev b) 5 ige rast (s) [presence],abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; hevea braziliensis; immune globulin e; immunoglobulin e; k082; k218; k82; latex (rhev b) 5; ltx; point in time; pr; radioallergosorbent test; random; serum; smqn; sr,SemiQn
103107-9,bromelin muxf3 ige ab [presence] in serum by radioallergosorbent test (rast),bromelin muxf3 ige rast,bromelin muxf3 ige rast (s) [presence],"abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; bromelain; ccd; cross-reactive carbohydrate determinant; immune globulin e; immunoglobulin e; k202; nana c 2 bromelin, pineapple; o214; pineapple; point in time; pr; radioallergosorbent test; random; rk202; ro214; serum; smqn; sr",SemiQn
103110-3,olive pollen native (nole e) 1 ige ab [presence] in serum by radioallergosorbent test (rast),olive (nole e) 1 ige rast,olive pollen native (nole e) 1 ige rast (s) [presence],a482; abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; black olive; f342; i; immune globulin e; immunoglobulin e; olive; olive (nole e) 1; point in time; pr; radioallergosorbent test; random; serum; smqn; sr; t224,SemiQn
10315-0,upper gi tube vendor serial number,serial # upper gi tube,,"gastrointestinal content; g-tube; ident; identifier; io; io.tube; no; nominal; num; point in time; random; serial #; tub; tube, unspecified; up",Nom
103172-3,clostridium perfringens dna [presence] in wound by naa with probe detection,c perfringens dna wnd ql naa+probe,c. perfringens dna naa+probe ql (wound),3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; c perfringens; c perfringens dna; deoxyribonucleic acid; dna nucleic acid probe; dna probe; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; naa+probe; naat; nasba; nucleic acid sequence based analysis; ordinal; pcr; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; screen; sda; strand displacement amplification; tma; transcription mediated amplification; wnd,Ord
103185-5,human rhinovirus 2 rna [presence] in respiratory system specimen by naa with probe detection,human rhinovirus 2 rna resp ql naa+probe,human rhinovirus 2 rna naa+probe ql (respiratory system specimen),3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; breathing; dna nucleic acid probe; dna probe; hrv; ii; lat; lcr; ligase chain reaction; ligation-activated transcription; lungs; microbiology; naa+probe; naat; nasba; nucleic acid sequence based analysis; ordinal; pcr; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; rhino virus; rhv; ribonucleic acid; rs; screen; sda; spec; strand displacement amplification; tma; transcription mediated amplification,Ord
103190-5,mycobacterium fortuitum+chelonae dna [presence] in wound by naa with probe detection,m. fortuitum+chelonae dna wnd ql naa+pro,mycobacterium fortuitum+chelonae dna naa+probe ql (wound),3 self-sustaining sequence replication; 3sr sr; acid fast; acid fast bacilli; acid fast bacillus; afb; amplif; amplification; amplified; deoxyribonucleic acid; dna nucleic acid probe; dna probe; lat; lcr; ligase chain reaction; ligation-activated transcription; m. fortuitum+chelonae; m. fortuitum+chelonae dna; microbiology; myco; mycobact; naa+probe; naat; nasba; nucleic acid sequence based analysis; ordinal; pcr; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; screen; sda; strand displacement amplification; tma; transcription mediated amplification; tuberculosis; wnd,Ord
103213-5,duration in bed,dur in bed,,count/time; dur in bed; durat; h+p; h+p.hx; nrate; number rate; number rate = count/time; p prime; point in time; qnt; quan; quant; quantitative; random,Qn
103227-5,testosterone free [mass/volume] in serum or plasma by calculation,testost free serpl calc-mcnc,testosterone free calc [mass/vol],calc; calculation; chemistry; fr; level; ly-handelsman; mass concentration; nanjee-wheeler; non-protein bound; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sodergard; sr; testo; testos; testost; testost free; testosterone.unconjugated; vermeulen,Qn
103232-5,xr toe third - right ge 2 views,xr toe 3rd-r ge 2v,,3rd; 3rd toe; document; ext; extr-r; films; finding; findings; ge 2v; ii; imaging; le; leg; le-r; low; middle toe; minimum 2 views; phalange; plain films; point in time; r; radiology; random; rle; rt; toe 3rd-r; view; vws; xray; x-ray,Doc
103241-6,xr spine 2 or 3 views,xr spine 2v or 3v,,2v; 2v or 3v; 2vw; document; films; finding; findings; ii; iii; imaging; misc; miscellaneous; other; plain films; point in time; radiology; random; spec; spinal; spinal cord; to be specified in another part of the message; unspecified; view; vws; xray; x-ray,Doc
103252-3,xr pelvis and hip - bilateral view ap and view 2,xr pelvis and hip-bl ap + 2v,,1v; 2v; 2vw; anterio-posterior; anteroposterior; ap + 2v; ap + views; bil; bilat; both; document; ext; extr-bl; film; films; finding; findings; hip-bl; hips; ii; imaging; le; le-bl; leg; low; lower extremity joint; pelvic; pelvis + hip-bl; pelvis and hip-bl; pelvis+le; pelvis+le-bl; plain films; point in time; radiology; random; single view; view; vw; vws; xray; x-ray,Doc
103269-7,xr thoracic spine ge 4 views,xr t-spine ge 4v,,cxr; document; dorsal spine; films; finding; findings; ge 4v; imaging; minimum 4 views; plain films; point in time; radiology; random; spinal; spinal cord; th/sp; thorax; t-spine; view; vws; xray; x-ray,Doc
10327-5,eosinophils/leukocytes in sputum by manual count,eosinophil nfr spt manual,eosinophils/leukocytes manual cnt (sput),eos; eosin; eosino; eosinophil; eosins; hematology/cell counts; leuc; leuk; leukocyte; lkcs; lower respiratory; manl; number fraction; percent; point in time; qnt; quan; quant; quantitative; random; spt; sputum; wbc; wbcs; white blood cell; white blood cells,Qn
103283-8,xr wrist - right 3 or 4 views,xr wrist-r 3v or 4v,,3v; 3v or 4v; 3vw; arm; carpal bone; carpal bones; carpal bones and joint; document; ext; extr-r; films; finding; findings; iii; imaging; plain films; point in time; r; radiology; random; rt; rue; ue; ue-r; up; upper extremity joint; view; vws; wrist-r; xray; x-ray,Doc
103293-7,xr finger second - right ge 2 views,xr finger.2nd-r ge 2v,,2nd; arm; document; ext; extr-r; films; finding; findings; finger.2nd-r; finger-r; ge 2v; ii; imaging; minimum 2 views; plain films; point in time; r; radiology; random; rt; rue; ue; ue-r; up; view; vws; xray; x-ray,Doc
103309-1,xr finger fourth - right ge 2 views,xr finger.4th-r ge 2v,,4th; arm; document; ext; extr-r; films; finding; findings; finger.4th-r; finger-r; ge 2v; ii; imaging; minimum 2 views; plain films; point in time; r; radiology; random; rt; rue; ue; ue-r; up; view; vws; xray; x-ray,Doc
103336-4,xr humerus - bilateral ge 2 views,xr humerus-bl ge 2v,,arm; bil; bilat; both; document; ext; extr-bl; films; finding; findings; ge 2v; humerus-bl; ii; imaging; minimum 2 views; plain films; point in time; radiology; random; ue; ue-bl; up; upper extremity; view; vws; xray; x-ray,Doc
103348-9,xr pelvis and hip - bilateral 5 views,xr pelvis and hip-bl 5v,,5v; 5vw; bil; bilat; both; document; ext; extr-bl; films; finding; findings; hip-bl; hips; imaging; le; le-bl; leg; low; lower extremity joint; pelvic; pelvis + hip-bl; pelvis and hip-bl; pelvis+le; pelvis+le-bl; plain films; point in time; radiology; random; view; vws; xray; x-ray,Doc
103359-6,xr pelvis view ap and views 1 or 2,xr pelvis ap + 1v or 2v,,anterio-posterior; anteroposterior; ap + 1v or 2v; document; films; finding; findings; i; ii; imaging; pelvic; plain films; point in time; radiology; random; view; views & ap kub; views (ap; views+ap; vws; xray; x-ray,Doc
103364-6,xr upper extremity - right ge 2 views,xr ue-r ge 2v,,arm; document; ext; extr-r; films; finding; findings; ge 2v; ii; imaging; minimum 2 views; plain films; point in time; r; radiology; random; rt; rue; ue; ue-r; up; view; vws; xray; x-ray,Doc
103379-4,xr chest views pa and lateral and l-lateral-decubitus and r-lateral-decubitus,xr chest pa+lat+l lat decub+r lat decub,,cxr; document; films; finding; findings; imaging; lat; left; levo; pa+lat; pa+lat+l lat decub+r lat decub; plain films; point in time; postero-anterior; r prime; radiology; random; right; thorax; view; views+pa; vws; xray; x-ray,Doc
103382-8,portable xr radius and ulna - left single view,xr port radius+ulna-l 1v,,1v; arm; document; ext; extr-l; film; finding; findings; forearm; imaging; l; lt; lue; plain films; point in time; radiology; radius+ulna-l; random; single view; ue; ue-l; up; upper extremity; vw; xr port; xray; x-ray,Doc
103383-6,portable xr humerus - left 2 views,xr port humerus-l 2v,,2v; 2vw; arm; document; ext; extr-l; films; finding; findings; humerus-l; ii; imaging; l; lt; lue; plain films; point in time; radiology; random; ue; ue-l; up; upper extremity; view; vws; xr port; xray; x-ray,Doc
103426-3,portable xr wrist - right 2 views,xr port wrist-r 2v,,2v; 2vw; arm; carpal bone; carpal bones; carpal bones and joint; document; ext; extr-r; films; finding; findings; ii; imaging; plain films; point in time; r; radiology; random; rt; rue; ue; ue-r; up; upper extremity joint; view; vws; wrist-r; xr port; xray; x-ray,Doc
103427-1,xr shoulder - right ge 3 views,xr should-r ge 3v,,arm; document; ext; extr-r; films; finding; findings; ge 3v; iii; imaging; minimum 3 views; plain films; point in time; r; radiology; random; rt; rue; should-r; ue; ue-r; up; upper extremity joint; view; vws; xray; x-ray,Doc
103430-5,portable xr clavicle - left views,xr port clavicle-l views,,clavicle-l; cxr; document; films; finding; findings; imaging; l; lt; plain films; point in time; radiology; random; thorax; upper extremity; view; vws; xr port; xray; x-ray,Doc
10343-2,temazepam [mass/volume] in serum or plasma,temazepam serpl-mcnc,temazepam [mass/vol],drug/toxicology; drugs; level; mass concentration; normison; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; restoril; serp; serpl; serplas; serum; serum or plasma; sr,Qn
103443-8,xr sacroiliac joint - right 1 or 2 views,xr sij-r 1v or 2v,,1v or 2v; document; films; finding; findings; i; ii; imaging; jnt; pelvic; plain films; point in time; r; radiology; random; rt; sac; si joint; si joints; sij; sij-r; view; views le 2; vws; xray; x-ray,Doc
103459-4,portable xr femur - left 2 views,xr port femur-l 2v,,2v; 2vw; document; ext; extr-l; femoral; femur-l; films; finding; findings; ii; imaging; l; le; leg; le-l; lle; low; lower extremity; lt; plain films; point in time; radiology; random; upper leg; view; vws; xr port; xray; x-ray,Doc
103495-8,xr mastoid - right ge 3 views,xr mastoid-r ge 3v,,brain; cranial; cranium; document; films; finding; findings; ge 3v; iii; imaging; intracranial; mastoid-r; minimum 3 views; plain films; point in time; r; radiology; random; rt; skull; view; vws; xray; x-ray,Doc
103514-6,portable xr cervical spine 4 or 5 views,xr port c-spine 4v or 5v,,4v; 4v or 5v; 4vw; c/sp; cerv; c-spine; document; films; finding; findings; imaging; plain films; point in time; radiology; random; spinal; spinal cord; view; vws; xr port; xray; x-ray,Doc
103522-9,xr thumb - right single view,xr thumb-r 1v,,1v; arm; document; ext; extr-r; film; finding; findings; imaging; plain films; point in time; r; radiology; random; rt; rue; single view; thumb-r; ue; ue-r; up; vw; xray; x-ray,Doc
10352-3,bacteria identified in genital specimen by aerobe culture,bacteria genital aerobe cult,bacteria identified aer cx nom (genital specimen),aerobe; aerobe cult; aerobed; bact; c&s; cult; cultures; gen; genital tract; id; identity or presence; infectious disease; infectiousdisease; microbiology; nominal; point in time; random; universallaborders; urogenit; urogenital,Nom
103526-0,xr salivary gland - right single view,xr salivary gland-r 1v,,1v; brain; cranial; cranium; document; film; finding; findings; imaging; intracranial; plain films; point in time; r; radiology; random; rt; salivary gland-r; single view; skull; vw; xray; x-ray,Doc
103527-8,xr finger third - right single view,xr finger.3rd-r 1v,,1v; 3rd; arm; document; ext; extr-r; film; finding; findings; finger.3rd-r; finger-r; imaging; plain films; point in time; r; radiology; random; rt; rue; single view; ue; ue-r; up; vw; xray; x-ray,Doc
103533-6,xr clavicle - bilateral single view,xr clavicle-bl 1v,,1v; bil; bilat; both; clavicle-bl; clavicles; cxr; document; film; finding; findings; imaging; plain films; point in time; radiology; random; single view; thorax; upper extremity; vw; xray; x-ray,Doc
103537-7,xr radius and ulna single view,xr radius+ulna 1v,,1v; arm; document; ext; film; finding; findings; forearm; imaging; plain films; point in time; radiology; random; single view; ue; up; upper extremity; vw; xray; x-ray,Doc
103544-3,clinical cardiac electrophysiology surgical operation note,electrophysiology operative note,,doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; notes; operative note; point in time; random; surg; visit note,Doc
103562-5,ab-fubinaca metabolite 3 [mass/volume] in urine by confirmatory method,ab-fubinaca met 3 ur cfm-mcnc,ab-fubinaca metabolite 3 confirm (u) [mass/vol],ab-fubinaca acid metabolite; ab-fubinaca met 3; amb-fubinaca acid metabolite; cfm; cnfr; cnfrm; conf; confirmation; confirmatory; drug/toxicology; drugs; gcms; iii; lc/ms/ms; level; mass concentration; metab; metabolites; metb; point in time; qnt; quan; quant; quantitative; random; ua; ur; urn,Qn
10357-2,microscopic observation [identifier] in wound by gram stain,gram stn wnd,microscopic observation gram stain nom (wound),gram stn; id; identity or presence; infectious disease; infectiousdisease; microbiology; nominal; point in time; random; st; stains; stn; wnd,Nom
103589-8,flualprazolam [presence] in cord tissue by confirmatory method,flualprazolam tissco ql cfm,flualprazolam confirm ql (umb cord tissue),cfm; cnfr; cnfrm; conf; confirmation; confirmatory; drug/toxicology; drugs; flualprazolam; fwf5l8d2be; gcms; lc/ms/ms; ordinal; point in time; pr; ql; qual; qualitative; random; screen; unii-fwf5l8d2be,Ord
103608-6,sulbactam+durlobactam [susceptibility] by gradient strip,sulbactam+durlobactam islt grad strip,sulbactam+durlobactam strip [susc],antibiotic susceptibilities; ast; epsilometer; estrip; e-strip; grad strip; islt; isol; mic; minimum inhibitory concentration; point in time; random; sulb; sulbact; sus; suscept; susceptibilities; susceptibility; susceptibilty,OrdQn
103610-2,pazopanib [mass/volume] in serum or plasma by lc/ms/ms --24 hours post dose,pazopanib 24h p serpl lc/ms/ms-mcnc,pazopanib 24 hr post dose lc/ms/ms [mass/vol],after; drug/toxicology; drugs; level; mass concentration; p dose; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
103651-6,atomoxetine [presence] in urine by confirmatory method,atomoxetine ur ql cfm,atomoxetine confirm ql (u),cfm; cnfr; cnfrm; conf; confirmation; confirmatory; drug/toxicology; drugs; gcms; lc/ms/ms; ordinal; point in time; pr; ql; qual; qualitative; random; screen; strattera; ua; ur; urn,Ord
103675-5,phosphorylated tau 181 [mass/volume] in plasma by immunoassay,p-tau181 plas ia-mcnc,phosphorylated tau 181 ia (p) [mass/vol],181p; alzheimer disease; alzheimer's disease; chemistry; eia; elfa; elisa; enzyme immunoassay; iaa; level; mass concentration; meia; phospho t181; pl; plasma; plsm; point in time; pr; prot; p-tau181; pthr181; qnt; quan; quant; quantitative; random; suds; thr181; threonine 181,Qn
103684-7,vortioxetine [presence] in urine by lc/ms/ms,vortioxetine ur ql lc/ms/ms,vortioxetine lc/ms/ms ql (u),drug/toxicology; drugs; ordinal; point in time; pr; ql; qual; qualitative; random; screen; ua; ur; urn,Ord
10369-7,opiates [mass/mass] in hair,opiates hair-mcnt,opiates (hair) [mass/mass],addiction; drug/toxicology; drugs; drugs of abuse; har; heroin; illicit; mass content; op; opi; opiate; point in time; potentialforabuse; qnt; quan; quant; quantitative; random,Qn
103703-5,temporal orientation - current day of the week [cms assessment],,,centers for medicare and medicaid assessment; finding; findings; ordinal; ql; qual; qualitative; report period; screen; survey,Ord
103704-3,brief interview for mental status - summary score during assessment period [cms assessment],,,bims; bims summary score; centers for medicare and medicaid assessment; qnt; quan; quant; quantitative; report period; scale; survey,Qn
10370-5,phencyclidine [mass/mass] in hair,pcp hair-mcnt,phencyclidine (hair) [mass/mass],addiction; angel dust; drug/toxicology; drugs; drugs of abuse; har; illicit; mass content; pcp; point in time; potentialforabuse; qnt; quan; quant; quantitative; random; sernylan,Qn
103724-1,suvorexant [presence] in urine by lc/ms/ms,suvorexant ur ql lc/ms/ms,suvorexant lc/ms/ms ql (u),belsomra; c23h23cln6o2; drug/toxicology; drugs; ordinal; point in time; pr; ql; qual; qualitative; random; screen; ua; ur; urn,Ord
103737-3,cyb5 and cyb5 reductase multigene analysis in specimen by sequencing,cyb5 & cyb5 red multi spec seq,cyb5 and cyb5 reductase multigene analysis sequencing doc (specimen),cyb5 & cyb5 red multi; document; finding; findings; gene; gene panel; high-throughput sequencing; hts; misc; miscellaneous; molecular pathology; molpath; multi-gene study; multiple-gene panel test; ncyb reductase; next generation sequencing; ngs; other; point in time; random; spec; to be specified in another part of the message; unspecified,Doc
103765-4,when scientists form a hypothesis they are just guessing,sci form a hypothesis,,finding; findings; ordinal; patient safety; point in time; ql; qual; qualitative; random; sci form a hypothesis; screen,Ord
103768-8,we can trust science to find the answers that explain the natural world,trust sci to to explain nat world,,finding; findings; ordinal; patient safety; point in time; ql; qual; qualitative; random; screen; trust sci to to explain nat world,Ord
103772-0,scientist will protect each other even when they are wrong,sci will protect each other when wrong,,finding; findings; ordinal; othr; patient safety; point in time; ql; qual; qualitative; random; sci will protect each other when wrong; screen,Ord
103779-5,body language,body language,,bod; bodies; finding; findings; h+p; h+p.hx; ordinal; p prime; point in time; ql; qual; qualitative; random; screen,Ord
103800-9,mental health summary note,mental health summary note,,doc.ont; document; emotional stability; encounter; evaluation and management; evaluation and management note; finding; findings; notes; point in time; random; visit note,Doc
103804-1,surgical oncology outpatient progress note,surg onc op prog note,,cancer; doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; general surgical oncology; notes; op; point in time; prog note; random; subsequent evaluation; subsequent visit evaluation; surg; surg onc; visit note,Doc
103805-8,bariatric surgery referral note,bariatric surg referral note,,doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; metabolic and bariatric surgery; notes; point in time; random; surg; visit note,Doc
103808-2,allergy and immunology medication management note,allergy+immunology med mgmt note,,doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; med mgmt note; notes; point in time; random; visit note,Doc
103810-8,pulse pressure by invasive,pulse pressure by invasive,,art sys; blood pressure measurements.molec; point in time; qnt; quan; quant; quantitative; random,Qn
103819-9,dermatology medication management note,dermatology med mgmt note,,derm; doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; med mgmt note; notes; point in time; random; visit note,Doc
103834-8,norbuprenorphine [presence] in meconium,norbuprenorphine mec ql,norbuprenorphine ql (mec),buprenorphine metabolite; drug/toxicology; drugs; mec; nbu; norbup; ordinal; point in time; pr; ql; qual; qualitative; random; screen,Ord
103844-7,hba1 and hba2 gene deletion in amniotic fluid or chorionic villus sample by molecular genetics method,hba1 + hba2 del amn/cvs,hba1 and hba2 gene del molgen doc (amnio fld/cvs),"af; alpha-2 globin; amn; amn fl; amn/cvs; amnio; amniotic flu; amniotic fluid; chorionic villi; chorionic villus sample; del; deletions; document; finding; findings; hba1 + hba2; hba-t2; hbh; hemoglobin, alpha 2; molecular genetics; molecular pathology; molpath; molpath.deldup; pcr; point in time; random",Doc
103855-3,rfa carotid artery.internal - bilateral views w contrast ia,rfa carot a.int-bl views w contr ia,,art; arteriogram; bil; bilat; both; brain; c; carot a; carot a.int-bl; contr; contra; contrst; cranial; cranium; document; films; finding; findings; fluor; fluoro; fluoroscopy; imaging; intracranial; point in time; radiology; random; rfa; skull; view; vws; w contr ia; wc,Doc
10386-1,albumin given [volume],albumin gvn vol,albumin given [vol],alb; blood bank; gvn; point in time; protein.albumin; qnt; quan; quant; quantitative; random; volume,Qn
103863-7,ct kidney and ureter and urinary bladder w contrast iv,ct kid+uret+blad w contr iv,,abd; abd+pelvis; abdo; abdominal; c; cat scan; computed tomography; computerized tomography; contr; contra; contrst; ct scan; cystogram; document; finding; findings; imaging; kid+uret+blad; nephric; nephrogram; nephrography; pelvic; point in time; pyelogram; pyelography; radiology; random; renal; ureter+blad; w contr iv; wc,Doc
103866-0,ct lower leg - bilateral w contrast iv,ct lower leg-bl w contr iv,,bil; bilat; both; c; calf; cat scan; computed tomography; computerized tomography; contr; contra; contrst; ct scan; document; ext; extr-bl; fibula; finding; findings; imaging; le; le-bl; leg; low; lower extremity; lower leg-bl; point in time; radiology; random; tibia; w contr iv; wc,Doc
103875-1,ct pelvis w contrast po,ct pelvis w contr po,,c; cat scan; computed tomography; computerized tomography; contr; contra; contrst; ct scan; document; finding; findings; imaging; pelvic; point in time; radiology; random; w contr po; wc,Doc
103881-9,ct mastoid wo contrast,ct mastoid wo contr,,brain; c; cat scan; computed tomography; computerized tomography; contr; contra; contrst; cranial; cranium; ct scan; document; finding; findings; imaging; intracranial; point in time; radiology; random; skull; without contrast,Doc
103888-4,mg guidance for needle localization of breast,mg guided brst needle loc,,brst; document; finding; findings; guid; guide; guided; imaging; local; ndl; point in time; radiology; random,Doc
103894-2,mg breast diagnostic for implant,mg brst dx for implant,,brst; document; dx; dx for implant; films; finding; findings; imaging; point in time; radiology; random; symptomatic; view; vws,Doc
103899-1,us.doppler for transplanted kidney right,dop for transplanted kidney-r,,abd; abdo; abdomen+; abdominal; document; dop; duplex; echography; finding; findings; imaging; kidney-r; nephric; point in time; r; radiology; random; renal; rt; sonogram; sonograph; sonography; uls; ultrasound,Doc
10391-1,cytomegalovirus immune globulin given [volume],cmv ig gvn vol,cmv immune globulin given [vol],blood bank; cmv; cmv ig; cytomegalo virus; cytomgal; glb; glob; glob%; globul; globulins; gvn; hhv-5; human herpesvirus-5; imm; imun; imune; point in time; qnt; quan; quant; quantitative; random; volume,Qn
103917-1,us axilla - bilateral,us axilla-bl,,ax; axilla-bl; bil; bilat; both; document; echography; finding; findings; imaging; point in time; radiology; random; sonogram; sonograph; sonography; thorax; uls; ultrasound; upper extremity,Doc
103939-5,do you have underage persons in your household,,,finding; findings; ordinal; point in time; ql; qual; qualitative; random; screen; survey,Ord
103962-7,11-ketotestosterone [moles/volume] in serum or plasma by lc/ms/ms,11ketotestost serpl lc/ms/ms-scnc,11-ketotestosterone lc/ms/ms [moles/vol],11ketotestost; chemistry; level; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; substance concentration,Qn
103968-4,hospice care consult note,hospice care consult note,,consult note; continuity assessment record and evaluation; doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; notes; point in time; random; visit note,Doc
103984-1,do you have a travel insecurity,,,point in time; random; survey,-
104006-2,trust in science and scientist inventory,trust sci & scient inventory,,pan; panel; panel.patientsafety; panl; patient safety; pnl; point in time; random; trust sci & scient inventory,-
104027-8,bile acid malabsorption panel,bile acid malabsorption pnl patient,bile acid malabsorption panel,acd; acids; bile acid malabsorption pnl; bile acid.total; bile salt; chemistry; pan; panel.chemistry; panl; pnl; point in time; random,-
104029-4,"confusion, disorientation or impulsivity","confusion, disorient or impuls obs",,clin; clin.risk; finding; findings; ordinal; point in time; ql; qual; qualitative; random; screen,Ord
104052-6,lifestyle factors panel,,,pan; panl; pnl; point in time; random; survey,-
104055-9,did you work remotely at home completely or only on several days per week during last 2 weeks,,,14 days; 2 weeks; dextro; finding; findings; job; occupation; ordinal; past; ql; qual; qualitative; screen; survey,Ord
104057-5,were you obliged to wear masks in open public areas in last 2 weeks,,,finding; findings; ordinal; past; point in time; ql; qual; qualitative; random; screen; survey; wearmask_public_parks,Ord
104074-0,gas and lactate panel - arterial blood,gas & lactate pnl blda,gas and lactate panel (blda),2-hydroxypropanoic acid; 2-hydroxy-propionate; 2-hydroxy-propionic acid; abg; art; art bld; art blood; arterial; arterial blood; blood arterial; chemistry; gas & lactate pnl; gases; lact; lactic acid; l-lactate; pan; panel.chemistry; panl; pnl; point in time; random,-
104076-5,basic metabolic with hemoglobin and hematocrit panel - blood,bmp w hgb and hct pnl bld,basic metabolic with hemoglobin and hematocrit panel (bld),blood; bmp w hgb and hct pnl; haemoglobin; hb; hct; hematology/cell counts; hgb; hgb+hct pnl; pan; panel.hematology& cell counts; panl; pcv; pnl; point in time; random; wb; whole blood,-
104079-9,frequency of you or who was in charge of taking care of these underage persons in last 3 months,,,finding; findings; ordinal; past; point in time; ql; qual; qualitative; random; screen; survey; world heatlth organization,Ord
104094-8,alive and without mechanical ventilation [score] 3 weeks by - reported,alive and w/o mv 3w score reported,,21 days; 3 weeks; alive and w/o mv; pulmonary; qnt; quan; quant; quantitative; scale,Qn
104099-7,icu admission id,icu admission id,,admin; admin.patient; admin.patient.id; ident; identifier; intradermal; nominal; point in time; random,Nom
104101-1,hospital admission timestamp,hospital admis timestamp,,admin; admin.patient; admin.pt.demog; date and time; hosp; hospital admis timestamp; point in time; qnt; quan; quant; quantitative; random; time stamp; timestamp,Qn
104112-8,mucopolysaccharidosis [enzymatic activity/volume] in dbs,mucopolysaccharidosis dbs-ccnc,mucopolysaccharidosis (dbs) [catalytic activity/vol],blood; catalytic concentration; chemistry; dbs; dried blood spot; filter paper; fp; point in time; qnt; quan; quant; quantitative; random; wb; whole blood,Qn
104115-1,heparan-alpha-glucosaminide n-acetyltransferase [enzymatic activity/volume] in dbs,hgsnat enzyme dbs-ccnc,heparan-alpha-glucosaminide n-acetyltransferase (dbs) [catalytic activity/vol],acetyl-coa:alpha-glucosaminide n-acetyltransferase; acetyl-coa:heparan--d-glucosaminide n-acetyltransferase; alfa; blood; catalytic concentration; chemistry; dbs; dried blood spot; filter paper; fp; hgsnat enzyme; point in time; qnt; quan; quant; quantitative; random; wb; whole blood,Qn
104118-5,cd34 recipient derived/cd34 cells in bone marrow by molecular genetics method --post stem cell transplant,cd34 recip drvd/cd34 p sc trpt nfr mar,cd34 recipient derived/cd34 cells post stem cell transplant molgen (bm),after; blood bank; bm; bon; bone marrow; cd34 cells; cd34 recip drvd; cell; cellularity; gp105-120; hematopoietic stem cell; hsc; mar; marrow (bone); minimal angle of resolution; minimum angle of resolution; molecular genetics; my10; my-10; number fraction; p sc trpt; pcr; percent; point in time; pst; qnt; quan; quant; quantitative; random; stem cells,Qn
104120-1,prevention orchestra project panel,,,pan; panl; pnl; point in time; random; survey,-
104147-4,left ventricular ejection fraction - upper limit by us.3d.a3c+estimated,lv us.3d.a3c+estimated,,3d us; card.us; cardiac; cardiology; echography; ef; est; estimation; frac; fract; fractionation; fractions; hrt; hrt ventr; l; lt; lv; lvef; percent; point in time; qnt; quan; quant; quantitative; random; sonogram; sonograph; sonography; uls; ultrasound; up; ventricular; volfr; volume fraction,Qn
104151-6,left ventricular ejection fraction by us.2d.a4c+calculed by biplane method,lv ef us.2d.a4c+biplane,,2d us; card.us; cardiac; cardiology; echography; ef; frac; fract; fractionation; fractions; hrt; hrt ventr; l; lt; lv; lvef; percent; point in time; qnt; quan; quant; quantitative; random; sonogram; sonograph; sonography; uls; ultrasound; ultrasound - 2-dimensional; us.2d.a4c+biplane; ventricular; volfr; volume fraction,Qn
10415-8,transfuse blood exchange transfusion [volume],transf bld xchange vol patient,transfuse blood exchange transfusion [vol],blood bank; change; point in time; qnt; quan; quant; quantitative; random; replace; transf bld xchange; tx; volume,Qn
104168-0,tcl-1a gene rearrangements in bone marrow by fish,tcl-1a gene rearrange bm fish,tcl-1a gene rearrangements fish doc (bm),bm; bon; document; finding; findings; fluorescent in situ hybridization; molecular pathology; molpath; point in time; random; rearr; rearrangement; t-cell leukemia/lymphoma 1a protein; t-cell lymphoma-1 protein; tcl1a,Doc
104176-3,clostridium tetani toxin tent gene [presence] in specimen by naa with probe detection,c.tetani tox tent gene spec ql naa+probe,clostridium tetani toxin tent gene naa+probe ql (specimen),3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; c tetani; c tetani tox; c.tetani tox tent gene; c12; dna nucleic acid probe; dna probe; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; misc; miscellaneous; naa+probe; naat; nasba; nucleic acid sequence based analysis; ordinal; other; pcr; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; screen; sda; spec; strand displacement amplification; tet; tetanus; tma; to be specified in another part of the message; transcription mediated amplification; unspecified,Ord
104185-4,fetal secondary cause of death,fet secondary cause of death,,fetal; finding; findings; nominal; obgyn; point in time; random,Nom
104201-9,eszopiclone and zopiclone [mass/volume] in urine by lc/ms/ms,eszopiclone+zopiclone ur lc/ms/ms-mcnc,eszopiclone and zopiclone lc/ms/ms (u) [mass/vol],drug/toxicology; drugs; estorra; imovane; level; lunesta; lunivia; mass concentration; point in time; qnt; quan; quant; quantitative; random; ua; ur; urn; zopiclone; zopliclone,Qn
104205-0,patient generated medication list [identifier] episode pharmacy,patient gen med list episode pharm,,hl7smp; ident; identifier; nominal; patient gen med list,Nom
104218-3,spermatozoa nonprogressive/spermatozoa in urine --post ejaculation,sperm nonprog p ejac nfr ur,spermatozoa nonprogressive/spermatozoa post ejaculation (u),after; fertility testing; number fraction; p ejac; percent; point in time; pst; qnt; quan; quant; quantitative; random; sperm; sperm nonprog; sperm p ejac; ua; ur; urn,Qn
104235-7,dibutylone [mass/volume] in urine by confirmatory method,dibutylone ur cfm-mcnc,dibutylone confirm (u) [mass/vol],cfm; cnfr; cnfrm; conf; confirmation; confirmatory; drug/toxicology; drugs; gcms; lc/ms/ms; level; mass concentration; point in time; qnt; quan; quant; quantitative; random; ua; ur; urn,Qn
104237-3,zopiclone [mass/volume] in urine by confirmatory method,zopiclone ur cfm-mcnc,zopiclone confirm (u) [mass/vol],cfm; cnfr; cnfrm; conf; confirmation; confirmatory; drug/toxicology; drugs; gcms; imovane; lc/ms/ms; level; mass concentration; point in time; qnt; quan; quant; quantitative; random; ua; ur; urn; zopliclone,Qn
104247-2,left ventricular ejection fraction - lower limit by us.3d.a4c+estimated,lv us.3d.a4c+est,,3d us; card.us; cardiac; cardiology; echography; ef; est; estimation; frac; fract; fractionation; fractions; hrt; hrt ventr; l; low; lt; lv; lvef; percent; point in time; qnt; quan; quant; quantitative; random; sonogram; sonograph; sonography; uls; ultrasound; ventricular; volfr; volume fraction,Qn
104249-8,platelet aggregation adp induced atp secretion in blood --2 umol/l,pa adp atp secr 2 umol/l bld,platelet aggregation adp induced atp secretion 2 umol/l (bld) [rel units/vol],adenosine 5'-pyrophosphate; adenosine pyrophosphate; ado; adp; agg; aggr; aned; blood; clopidogrel response assay; coagulation; ii; left; levo; medication stress; p2y12 assay; p2y12 inhibition; pa; pa adp; pa adp atp secr; pl; platelets; platelt; plavix response assay; plt; point in time; qnt; quan; quant; quantitative; random; rlacnc; thrombocyte; thrombocytes; wb; whole blood,Qn
104260-5,hepatitis a virus cellular receptor 1 [ratio] in urine by calculation,havcr-1 ur calcn-rto,havcr-1 calc (u) [ratio],calc; calcn; calculated; cell markers; hav; havcr-1; hep; hep a; hepatis; hepatit; hepatitis; hepatitis type a; i; kidney injury molecule 1; kim-1; point in time; qnt; quan; quant; quantitative; random; ratios; rec; recept; receptors; recp; recptr; rto; t-cell immunoglobulin and mucin domain-containing protein 1; t-cell immunoglobulin mucin receptor 1; t-cell membrane protein 1; tim-1; timd-1; ua; ur; urn,Qn
104261-3,eosinophil derived neurotoxin [mass/volume] in serum by immunoassay,edn ser ia-mcnc,eosinophil derived neurotoxin ia (s) [mass/vol],edn; eia; elfa; elisa; enzyme immunoassay; eos; eosin; eosino; eosinophils; hematology/cell counts; iaa; level; mass concentration; meia; point in time; qnt; quan; quant; quantitative; random; serum; sr; suds,Qn
104273-8,clonal cells rearrangements/cells counted in specimen by molecular genetics method,clonal cells rearrange/cells nfr spec,clonal cells rearrangements/cells counted molgen (specimen),cell; cellularity; clonal cells rearrange; misc; miscellaneous; molecular genetics; molecular pathology; molpath; molpath.rearrangements; number fraction; other; pcr; percent; point in time; qnt; quan; quant; quantitative; random; rearr; rearrangement; spec; to be specified in another part of the message; unspecified,Qn
104277-9,met gene mutations tested for in blood or tissue by molecular genetics method nominal,met gene mut tested bld/t,met gene mutations tested for molgen nom (bld/tiss),"auts9; blood; dfnb97; gene mut tested; hgfr; identity or presence; met proto-oncogene, receptor tyrosine kinase; molecular genetics; molecular pathology; molpath; molpath.mutations; mut; mut tested; mutation; muts; nominal; pcr; point in time; random; rccp2; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",Nom
104278-7,braf gene mutations tested for in blood or tissue by molecular genetics method nominal,braf gene mut tested bld/t,braf gene mutations tested for molgen nom (bld/tiss),"blood; b-raf proto-oncogene, serine/threonine kinase; braf1; b-raf1; gene mut tested; identity or presence; molecular genetics; molecular pathology; molpath; molpath.mutations; mut; mut tested; mutation; muts; nominal; ns7; pcr; point in time; rafb1; random; tissue; tissue, unspecified; v-raf; wb; whole blood; whole blood or tissue",Nom
104287-8,slco1b1 gene.c.521t>c [presence] in blood or tissue by molecular genetics method,slco1b1 gene.c.521t>c bld/t ql,slco1b1 gene.c.521t>c molgen ql (bld/tiss),"blood; molecular genetics; molecular pathology; molpath; molpath.mutations; ordinal; pcr; point in time; pr; ql; qual; qualitative; random; screen; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",Ord
104310-8,abemaciclib [mass/volume] in serum or plasma,abemaciclib serpl-mcnc,abemaciclib [mass/vol],drug/toxicology; drugs; level; mass concentration; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
104313-2,niraparib [mass/volume] in serum or plasma,niraparib serpl-mcnc,niraparib [mass/vol],drug/toxicology; drugs; level; mass concentration; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
104337-1,borna disease virus rna [presence] in brain tissue by naa with probe detection,borna dv rna brain tissue ql naa+probe,borna disease virus rna naa+probe ql (brain tissue),3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; bdv; borna dv; borna dv rna; cerebral; cerebrum; dis; diseases; dna nucleic acid probe; dna probe; dz; head; intracranial; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; naa+probe; naat; nasba; nucleic acid sequence based analysis; ordinal; pcr; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; ribonucleic acid; screen; sda; strand displacement amplification; tma; transcription mediated amplification,Ord
104350-4,borrelia recurrentis [presence] in specimen by microscopy,b. recurrentis spec ql micro,borrelia recurrentis microscopy ql (specimen),b. recurrentis; micro; microbiology; micros; microscopic; misc; miscellaneous; ordinal; other; point in time; pr; ql; qual; qualitative; random; screen; spec; to be specified in another part of the message; unspecified,Ord
104364-5,chikungunya virus igg ab [titer] in serum by immunoassay --1st specimen,chikv igg sp1 titr ser ia,chikv igg spec 1 ia (s) [titer],abs; aby; acute specimen; antby; anti; antibodies; antibody; autoantibodies; autoantibody; chikv; dilution factor; dilution factor (titer); eia; elfa; elisa; enzyme immunoassay; first; iaa; immune globulin g; immunoglobulin g; meia; microbiology; point in time; pre immunization; random; serum; smqn; sp1; spec; sr; suds; titer; titered; titre; ttr,SemiQn
104374-4,corynebacterium ulcerans [presence] in upper respiratory specimen by organism specific culture,c. ulcerans upper resp ql cult,corynebacterium ulcerans org specific cx ql (upper resp),breathing; c&s; c. ulcerans; cult; cultures; lungs; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; rs; screen; spec; up; upper resp,Ord
104376-9,diphtheria toxin dna [presence] in specimen by naa with probe detection,diphth. toxin dna spec ql naa+probe,diphtheria toxin dna naa+probe ql (specimen),3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; deoxyribonucleic acid; diphth. toxin; diphth. toxin dna; dna nucleic acid probe; dna probe; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; misc; miscellaneous; naa+probe; naat; nasba; nucleic acid sequence based analysis; ordinal; other; pcr; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; screen; sda; spec; strand displacement amplification; tma; to be specified in another part of the message; transcription mediated amplification; unspecified,Ord
1043-9,h ab [presence] in serum or plasma from donor,h ab serpl donr ql,h ab ql (s/p donor),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; blood bank; bombay ab; donr; ordinal; pl; plasma; plsm; point in time; pr; ql; qual; qualitative; random; screen; serp; serpl; serplas; serum; serum or plasma; sr,Ord
104400-7,european tick borne encephalitis virus rna [presence] in tissue postmortem by naa with probe detection,tbev rna tissue postmortem ql naa+probe,european tick borne encephalitis virus rna naa+probe ql (tissue postmortem),3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; dna nucleic acid probe; dna probe; enc; enceph; encephalomyelitis; fsme; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; naa+probe; naat; nasba; nucleic acid sequence based analysis; ordinal; pcr; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; ribonucleic acid; screen; sda; strand displacement amplification; tbev; tbev rna; tissue postmortem; tma; transcription mediated amplification,Ord
104402-3,francisella tularensis ab [titer] in serum by immunoassay --2nd specimen,f tular ab sp2 titr ser ia,f. tularensis ab spec 2 ia (s) [titer],abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; convalescent; dilution factor; dilution factor (titer); eia; elfa; elisa; enzyme immunoassay; f tular; f tularensis; iaa; meia; microbiology; point in time; post immunization; random; second; serum; smqn; sp2; spec; sr; suds; titer; titered; titre; ttr; tularemia,SemiQn
104424-7,leptospira sp igm ab [titer] in serum by immunoassay --1st specimen,leptospira igm sp1 titr ser ia,leptospira sp igm spec 1 ia (s) [titer],abs; aby; acute specimen; antby; anti; antibodies; antibody; autoantibodies; autoantibody; dilution factor; dilution factor (titer); eia; elfa; elisa; enzyme immunoassay; first; iaa; immune globulin m; immunoglobulin m; leptospirosis; meia; microbiology; point in time; pre immunization; random; serum; smqn; sp1; spec; species; spp; sr; suds; titer; titered; titre; ttr,SemiQn
104475-9,zika virus igg ab [titer] in serum by immunoassay --1st specimen,zikv igg sp1 titr ser ia,zikv igg spec 1 ia (s) [titer],abs; aby; acute specimen; antby; anti; antibodies; antibody; autoantibodies; autoantibody; dilution factor; dilution factor (titer); eia; elfa; elisa; enzyme immunoassay; first; iaa; immune globulin g; immunoglobulin g; meia; microbiology; point in time; pre immunization; random; serum; smqn; sp1; spec; sr; suds; titer; titered; titre; ttr; zikv,SemiQn
104479-1,cells.recipient derived/cells in blood or tissue by molecular genetics method --post stem cell transplant,rcpt cells derived p sc trpt nfr bld/t,cells.recipient derived/cells post stem cell transplant molgen (bld/tiss),"after; blood; blood bank; cell; cells.rcpnt divd/cells; cellularity; molecular genetics; number fraction; p sc trpt; pcr; percent; point in time; pst; qnt; quan; quant; quantitative; random; rcpt cells derived; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",Qn
10448-9,t-cell ag [presence] in tissue by immune stain,t cell ag tiss ql imstn,t-cell ag immune stain ql (tiss),"antigen; antigens; cell markers; ihc; imm; immunohistochemical stain; immunostain; imstn; imun; imune; ordinal; point in time; pr; ql; qual; qualitative; random; screen; st; stains; stn; t cell; t prime; tissue; tissue, unspecified; uchl-1",Ord
10449-7,glucose [mass/volume] in serum or plasma --1 hour post meal,glucose 1h p meal serpl-mcnc,glucose 1 hr post meal [mass/vol],1 hour; 1.0hr; 1h p meal; 60 min; 60 minutes; 60m; 60min; after; chemistry.challenge testing; endocrine; endocrinology; glu; glu tol; gluc; glucose tolerance; glucoseur; gtt; level; mass concentration; p meal; pc; pl; plasma; plsm; point in time; post pran; post prandial; pp; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; universallaborders,Qn
104502-0,es^a ab [titer] in serum or plasma,es^a ab titr serpl,es^a ab [titer],abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; blood bank; dilution factor; dilution factor (titer); es^a; es^a ab; pl; plasma; plsm; point in time; random; s; s prime; serp; serpl; serplas; serum; serum or plasma; smqn; sr; titer; titered; titre; ttr,SemiQn
104506-1,ge2 ab [titer] in serum or plasma,ge2 ab titr serpl,ge2 ab [titer],abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; blood bank; dilution factor; dilution factor (titer); ge2; ge2 ab; pl; plasma; plsm; point in time; random; serp; serpl; serplas; serum; serum or plasma; smqn; sr; titer; titered; titre; ttr,SemiQn
104532-7,pain score interpretation painad,pain score interpre painad,,h+p; h+p.hx; impression; impression/interpretation of study; impressions; interp; interpret; interpretation; interpt; intrp; nominal; p prime; point in time; random,Nom
104534-3,consistency of urine,consistency ur,consistency nom (u),nominal; point in time; random; spec; typ; ua; ur; urn,Nom
104564-0,number of supermarkets and grocery stores in the county,supermarket/grocery num,,cnt; count; no; num; number; phenx; point in time; qnt; quan; quant; quantitative; random; supermarket/grocery num,Qn
10461-2,alpha-1-antichymotrypsin ag [presence] in tissue by immune stain,a1act ag tiss ql imstn,alpha-1-antichymotrypsin ag immune stain ql (tiss),"a1; a1act; act; alfa; antichymo; antigen; antigens; i; ihc; imm; immunohistochemical stain; immunostain; imstn; imun; imune; ordinal; pathology; point in time; pr; ql; qual; qualitative; random; screen; st; stains; stn; tissue; tissue, unspecified",Ord
10463-8,amyloid a component ag [presence] in tissue by immune stain,ala ag tiss ql imstn,amyloid a component ag immune stain ql (tiss),"ala; antigen; antigens; ihc; imm; immunohistochemical stain; immunostain; imstn; imun; imune; ordinal; pathology; point in time; pr; ql; qual; qualitative; random; screen; st; stains; stn; tissue; tissue, unspecified",Ord
104639-0,"time above range, very high in reporting period interstitial fluid by calculation",cgm v high rptprd intrsttl fld cal,"time above range, very high calc (reporting period interstitial fluid)",calc; calculation; cgm hyper; chemistry; interstitial fld; qnt; quan; quant; quantitative; report period; rnge,Qn
10464-6,amyloid p component ag [presence] in tissue by immune stain,alp ag tiss ql imstn,amyloid p component ag immune stain ql (tiss),"alp; antigen; antigens; ihc; imm; immunohistochemical stain; immunostain; imstn; imun; imune; ordinal; p prime; pathology; point in time; pr; ql; qual; qualitative; random; screen; st; stains; stn; tissue; tissue, unspecified",Ord
104646-5,leukocytes [#/area] in urine by computer assisted method,wbc #/area ur comp assist,wbc computer assisted (u) [#/area],#/area; artificial intelligence; automated detection; comp assist; hematology/cell counts; leuc; leuk; leukocyte; lkcs; number areic; point in time; qnt; quan; quant; quantitative; random; ua; ur; urn; wbc; wbcs; white blood cell; white blood cells,Qn
104651-5,herpes simplex virus 1 and 2 and varicella zoster virus and treponema pallidum dna panel by naa with probe detection,hsv 1 + 2 + vzv+t pall pnl naa+probe,herpes simplex virus 1 and 2 and varicella zoster virus and t.pallidum dna panel naa+probe,3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; chicken pox; chicken pox virus; chickenpox; deoxyribonucleic acid; dna nucleic acid probe; dna probe; herp splx; herpes simplex virus type 1; herpes simplex virus type 1+2; herpes simplex virus type i+ii; herpes zoster; hhv-3; hsv; hsv 1 + 2 + vzv+t pall pnl; hsv 1+2; hsv1; hsv1+2; human herpesvirus 3; i; ii; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; naa+probe; naat; nasba; nucleic acid sequence based analysis; pan; panel.microbiology; panl; pcr; pnl; point in time; polymerase chain reaction; probe amp; probe with ampification; probe with target amplification; qbr; random; sda; shingles; strand displacement amplification; syphilis; t pallidum; tma; transcription mediated amplification; treponemal; vz; vzv; zoster,-
104656-4,titanium/creatinine [mass ratio] in urine,titanium/creat ur,titanium/creatinine (u) [mass ratio],cr; crea; creat; drug/toxicology; drugs; mass concentration ratio; mass ratio; mcrto; point in time; qnt; quan; quant; quantitative; random; ti; ua; ucr; ur; urn,Qn
104659-8,sialate.total/creatinine [molar ratio] in urine,sialate.total/creat ur-srto,sialate.total/creatinine (u) [molar ratio],chemistry; cr; crea; creat; n-acetylneuraminic acid; point in time; qnt; quan; quant; quantitative; random; sa; scrto; sialic acid; substance concentration ratio; substance ratio; tot; totl; ua; ucr; ur; urn,Qn
104670-5,prkaca 19p13.1 gene rearrangement in tissue by fish,prkaca 19p13.1 rearrange tiss fish,prkaca 19p13.1 gene rearrangement fish doc (tiss),"document; fibrolamellar carcinoma; finding; findings; fluorescent in situ hybridization; gene fusion; gene fusions; gene rearrangements; molecular pathology; molpath; molpath.rearrangements; point in time; prkaca 19p13.1 rearrange; random; tissue; tissue, unspecified",Doc
104686-1,"1,1-dimethoxyoctadecane (dma 18:0)/octadecanoate (c18:0) [mass ratio] in dbs",dma 18:0/c18:0 dbs,"1,1-dimethoxyoctadecane (dma 18:0)/octadecanoate (c18:0) (dbs) [mass ratio]","1-heptadecanecarboxylic acid; blood; c18:0; c18h36o2; cetylacetic acid; chemistry; dbs; dma 18:0; dma c18:0; dried blood spot; elaidate; filter paper; fp; i; mass concentration ratio; mass ratio; mcrto; octadecanoic acid; point in time; qnt; quan; quant; quantitative; random; stearaldehyde, dimethyl acetal; stearate; stearic acid; wb; whole blood",Qn
104691-1,clofazimine+amikacin [susceptibility] by minimum inhibitory concentration (mic),clofazimine + amikacin islt mic,clofazimine+amikacin mic [susc],amikin; aminoglycosides; antibiotic susceptibilities; ast; clofazamine; clofazimine + amikacin; islt; isol; minimum inhibitory concentration; point in time; random; sus; suscept; susceptibilities; susceptibility; susceptibilty,OrdQn
104693-7,ethyl glucuronide [presence] in saliva (oral fluid) by screen method,ethyl glucuronide sal ql scn,ethyl glucuronide screen ql (sal),drug/toxicology; drugs; etg; ethanol metabolite; gluc; glucouronide; oral fluid; ordinal; point in time; pr; ql; qual; qualitative; random; sal; scn; scr; screen; scrn,Ord
104698-6,n-acetyl-l-glutamate/creatinine [molar ratio] in urine,n-acetyl-l-glutamate/creat ur-srto,n-acetyl-l-glutamate/creatinine (u) [molar ratio],c707; chemistry; cr; crea; creat; glu; glutamic acid; left; levo; point in time; qnt; quan; quant; quantitative; random; scrto; substance concentration ratio; substance ratio; ua; ucr; ur; urn,Qn
104704-2,acanthocytes [presence] in blood,acanthocytes bld ql,acanthocytes ql (bld),acanthocyte; blood; hematology/cell counts; ordinal; point in time; pr; ql; qual; qualitative; random; screen; spur cells; wb; whole blood,Ord
104711-7,parainfluenza virus 3 rna [presence] in specimen by molecular genetics method,hpiv3 rna spec ql,parainfluenza virus 3 rna molgen ql (specimen),hpiv; hpiv3; human respirovirus 3; iii; microbiology; misc; miscellaneous; molecular genetics; ordinal; other; para; parainflu; parainfluenza type 3; parainfluenza type iii; pcr; pi3; point in time; pr; ql; qual; qualitative; random; ribonucleic acid; screen; spec; to be specified in another part of the message; unspecified,Ord
104734-9,streptococcus.beta-hemolytic [presence] in specimen,b-hem strep spec ql,streptococcus.beta-hemolytic ql (specimen),b; b-hem strep; microbiology; misc; miscellaneous; ordinal; other; point in time; pr; ql; qual; qualitative; random; screen; spec; strep; strept; to be specified in another part of the message; unspecified,Ord
104735-6,influenza virus b rna [presence] in specimen by molecular genetics method,flubv rna spec ql,flubv rna molgen ql (specimen),flub; flubv; fluv; influ; influenza b; influenza b virus; microbiology; misc; miscellaneous; molecular genetics; ordinal; other; pcr; point in time; pr; ql; qual; qualitative; random; ribonucleic acid; screen; spec; to be specified in another part of the message; unspecified,Ord
104736-4,clinician guidance medication narrative,clinician guidance medication,,guid; guide; guided; med; meds; narrative; point in time; random; report; typ,Nar
104743-0,epstein barr virus dna [#/volume] in specimen by molecular genetics method,ebv dna # spec,ebv dna molgen (specimen) [#/vol],#; abs; absolute; absolutes; cnt; count; count/volume; ct; deoxyribonucleic acid; ebv; epstn; hhv-4; human herpesvirus 4; microbiology; misc; miscellaneous; molecular genetics; mono; mononucleosis; number concentration; number concentration (count/vol); other; pcr; point in time; qnt; quan; quant; quantitative; random; spec; to be specified in another part of the message; unspecified,Qn
104745-5,n-nortramadol [mass/volume] in urine,n-nortramadol ur-mcnc,n-nortramadol (u) [mass/vol],desmeth; drug/toxicology; drugs; level; mass concentration; n-desmethyltramadol; ndt; notramadol; o-desmethyltramadol; odt; point in time; qnt; quan; quant; quantitative; random; tramadol metabolite; ua; ur; urn,Qn
104746-3,medication stop criteria,med stop criteria,,finding; findings; med stop criteria; meds; nominal; point in time; random,Nom
104756-2,order identifier,order id,,clin; ident; identifier; nominal; point in time; random,Nom
10476-0,desmin ag [presence] in tissue by immune stain,desmin ag tiss ql imstn,desmin ag immune stain ql (tiss),"antigen; antigens; ihc; imm; immunohistochemical stain; immunostain; imstn; imun; imune; ordinal; pathology; point in time; pr; ql; qual; qualitative; random; screen; st; stains; stn; tissue; tissue, unspecified",Ord
104761-2,poikilocytosis [presence] in blood,poikilocytosis bld ql,poikilocytosis ql (bld),blood; hematology/cell counts; ordinal; poikilo; poikilocyte; poikilocytes; point in time; pr; ql; qual; qualitative; random; screen; wb; whole blood,Ord
104764-6,deprecated base excess in blood,deprecated base excess bld-scnc,base excess (bld) [moles/vol],base ex; be; blood; bse; exs; hematology/cell counts; level; point in time; qnt; quan; quant; quantitative; random; substance concentration; wb; whole blood,Qn
104794-3,human coronavirus hku1 rna [presence] in specimen by molecular genetics method,hcov hku1 rna spec ql,hcov hku1 rna molgen ql (specimen),corona virus; hcov; hcov hku1; microbiology; misc; miscellaneous; molecular genetics; ordinal; other; pcr; point in time; pr; ql; qual; qualitative; random; ribonucleic acid; screen; spec; to be specified in another part of the message; unspecified,Ord
104798-4,basophilic stippling [presence] in blood,baso stipl bld ql,basophilic stippling ql (bld),baso stipl; blood; hematology/cell counts; ordinal; point in time; pr; ql; qual; qualitative; random; screen; stip; stipl; wb; whole blood,Ord
10480-2,estrogen+progesterone receptor ag [presence] in tissue by immune stain,era+pgra ag tiss ql imstn,estrogen+progesterone receptor ag immune stain ql (tiss),"antigen; antigens; era+pgra; est; estr; estroge; estrogens; estrone+estradiol; estrone+estradiol+estriol; ihc; imm; immunohistochemical stain; immunostain; imstn; imun; imune; oncology; ordinal; p4; pathology; pgra; point in time; pr; pra; prog; proges; progest; progestin; ql; qual; qualitative; random; rec; recept; receptors; recp; recptr; screen; st; stains; stn; tissue; tissue, unspecified",Ord
104804-0,medication substitution criterion medication narrative,med substitution criterion medication,,finding; findings; med; med substitution criterion; meds; narrative; point in time; random; report,Nar
104805-7,creatinine renal clearance predicted,creat cl predicted serpl-vrate,creatinine renal clearance predicted [vol/time],chemistry; cl; cl predicted; clear; clearanc; clearances; clr; cr; crea; creat; flow; kidney; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; volume rate; vrate,Qn
104843-8,beryllium ige ab [presence] in serum by radioallergosorbent test (rast),beryllium ige rast,beryllium ige rast (s) [presence],abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; be; berylliosis; immune globulin e; immunoglobulin e; point in time; pr; radioallergosorbent test; random; serum; smqn; sr,SemiQn
104846-1,antimony ige ab [presence] in serum by radioallergosorbent test (rast),antimony ige rast,antimony ige rast (s) [presence],abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; immune globulin e; immunoglobulin e; point in time; pr; radioallergosorbent test; random; sb; serum; smqn; sr,SemiQn
104848-7,manganese ige ab [presence] in serum by radioallergosorbent test (rast),manganese ige rast,manganese ige rast (s) [presence],abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; immune globulin e; immunoglobulin e; mn; point in time; pr; radioallergosorbent test; random; serum; smqn; sr,SemiQn
104853-7,selenium ige ab [units/volume] in serum,selenium ige qn,selenium ige qn (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; immune globulin e; immunoglobulin e; point in time; qnt; quan; quant; quantitative; random; se; serum; sr,Qn
104865-1,bacteria [presence] in urine by computer assisted method,bacteria ur ql comp assist,bacteria computer assisted ql (u),artificial intelligence; automated detection; bact; comp assist; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; screen; ua; ur; urn,Ord
104884-2,tubular reabsorption of phosphorus panel - urine and serum or plasma,tubular reabsorp phos pnl ur+serpl,tubular reabsorption of phosphorus panel (u+s/p),chemistry; pan; panel.chemistry; panl; pl; plasma; plsm; pnl; point in time; random; serp; serpl; serplas; serum; serum or plasma; sr; tmp; tubular reabsorp phos pnl; ua; ur; ur+serpl; urn,-
104892-5,number of potentially affected by condition family member,# of potentially affctd by condit,,admin; cnt; count; fam mem; no; num; num of potentially aff by cndtn; number; point in time; qnt; quan; quant; quantitative; random,Qn
104898-2,event outcome narrative,event outcome,,admin; finding; findings; narrative; point in time; random; report,Nar
104903-0,indication [identifier] facility,indication facility,,admin; ident; identifier; nominal; point in time; random,Nom
104916-2,language of communication information person,lang of communication info,,^person; admin; nominal; persons; point in time; random; typ,Nom
10491-9,igg ag [presence] in tissue by immune stain,igg ag tiss ql imstn,igg ag immune stain ql (tiss),"antigen; antigens; ihc; imm; immune globulin g; immunoglobulin g; immunohistochemical stain; immunostain; imstn; imun; imune; ordinal; pathology; point in time; pr; ql; qual; qualitative; random; screen; st; stains; stn; tissue; tissue, unspecified",Ord
104926-1,device manufacture date,device manufacture date,,admin; point in time; qnt; quan; quant; quantitative; random,Qn
104930-3,language variant person narrative,language variant person,,^person; admin; finding; findings; narrative; persons; point in time; random; report,Nar
104943-6,ct femur [mass/volume] multisection for bone density,ct femur mcnc for bmd,,bmd; cat scan; computed tomography; computerized tomography; ct scan; den; femoral; for bmd; imaging; level; lower extremity; mass concentration; point in time; qnt; quan; quant; quantitative; radiology; random; upper leg,Qn
104957-6,communication capability per language person narrative,comm capability per language person,,^person; admin; comm capability per language; finding; findings; narrative; persons; point in time; random; report,Nar
104960-0,device identifier of unspecified type,device identi unspecified type,,admin; device identi unspecified type; ident; identifier; nominal; point in time; random,Nom
104966-7,latitude [identifier],latitude,,admin; doc.admin; ident; identifier; nominal; point in time; random,Nom
10496-8,kappa light chains ag [presence] in tissue by immune stain,kappa lc ag tiss ql imstn,immunoglobulin light chains.kappa ag immune stain ql (tiss),"antigen; antigens; bence jones protein; bj protein; bjp; chain; ihc; imm; immune globulin; immuno; immunoglob; immunoglobin; immunohistochemical stain; immunostain; imstn; imun; imune; imunoglbon; imunoglobn; kappa lc; ordinal; pathology; point in time; pr; ql; qual; qualitative; random; screen; st; stains; stn; tissue; tissue, unspecified",Ord
104972-5,medical device summary information narrative,medical device summary info,,admin; narrative; person name; point in time; random; report,Nar
104986-5,substance,substance,,admin; finding; findings; nominal; point in time; random; subs,Nom
10499-2,lambda light chains ag [presence] in tissue by immune stain,lambda lc ag tiss ql imstn,immunoglobulin light chains.lambda ag immune stain ql (tiss),"antigen; antigens; bence jones protein; bj protein; bjp; chain; ihc; imm; immune globulin; immuno; immunoglob; immunoglobin; immunohistochemical stain; immunostain; imstn; imun; imune; imunoglbon; imunoglobn; lambda lc; ordinal; pathology; point in time; pr; ql; qual; qualitative; random; screen; st; stains; stn; tissue; tissue, unspecified",Ord
105001-2,left main coronary artery diameter by us,lm diam us,,art; card.us; cardiology; coronary segment 5; dia; diam; echography; l; length; lm; lt; point in time; qnt; quan; quant; quantitative; random; sonogram; sonograph; sonography; uls; ultrasound,Qn
105009-5,chloride.reabsorbed by renal tubules/chloride.total filtered in urine and serum or plasma,cl.reab ren tub/cl.tot fil mfr ur+serpl,chloride.reabsorbed by renal tubules/chloride.total filtered (u+s/p) [mass fraction],chemistry; cl; cl-; cl reab/cl. tot filt; cl.reab ren tub; cl.tot fil; kidney; mass fraction; percent; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; tot; totl; ua; ur; ur+serpl; urn,Qn
105010-3,folate receptor alpha [interpretation] in tissue by immune stain narrative,folate alpha tiss imstn-imp,folate receptor alpha immune stain nar (tiss) [interp],"alfa; folat; folate alpha; folic acid; ihc; imm; immunohistochemical stain; immunostain; impression; impression/interpretation of study; impressions; imstn; imun; imune; interp; interpretation; narrative; pathology; point in time; pteroylglutamate; pteroylglutamic acid; random; rec; recept; receptors; recp; recptr; report; st; stains; stn; tissue; tissue, unspecified; vit m; vitamin m",Nar
105024-4,bacterial carbapenem resistance blandm-9 gene [presence] by molecular method,blandm-9 islt/spm ql,bacterial carbapenem resistance blandm-9 gene molgen ql (islt/spec),antibiotic susceptibilities; bact; cpr; islt; islt/spm; isol; molecular genetics; ordinal; pcr; point in time; pr; ql; qual; qualitative; random; resist; resistanc; resistant; resistent; screen; spec,Ord
105032-7,bacterial carbapenem resistance blaoxa-72 gene [presence] by molecular method,blaoxa-72 islt/spm ql,bacterial carbapenem resistance blaoxa-72 gene molgen ql (islt/spec),antibiotic susceptibilities; bact; cpr; islt; islt/spm; isol; molecular genetics; ordinal; pcr; point in time; pr; ql; qual; qualitative; random; resist; resistanc; resistant; resistent; screen; spec,Ord
105046-7,aptt.factor substitution [time ratio] in control platelet poor plasma by coagulation assay --2h post incubation with 1:1 normal plasma,aptt 2h p 1:1 np ppp cont,aptt.factor substitution 2 hr post incubation with 1:1 normal plasma coag (ppp control) [time ratio],120 min; 120 minutes; 120min; 2 hours; 2h p 1:1 np; 2h p inc; activated partial thromboplastin time; after; aptt; aptt correction study; clot; clottable; coag; coagulation assay; contrl; control; fac; fact; i; little(a)ptt; mixing studies; normal; partial thromboplastin time; plas; platelet poor plasma; point in time; pst; ptt; qnt; quan; quant; quantitative; random; surf; tilt tube; time ratio,Qn
105065-7,shigella species+eiec invasion plasmid antigen h ipah gene [presence] in specimen,shigella sp+eiec ipah spec ql,shigella species+eiec invasion plasmid antigen h ipah gene ql (specimen),ag; eiec; enteroinvasive e coli; enteroinvasive escherichia coli; microbiology; misc; miscellaneous; ordinal; other; point in time; pr; ql; qual; qualitative; random; screen; shigella; shigella sp+eiec; shigella sp+eiec ipah; shigellosis; to be specified in another part of the message; unspecified,Ord
105086-3,granular casts [#/area] in urine,gran casts #/area ur,granular casts (u) [#/area],#/area; cast; gran casts; number areic; point in time; qnt; quan; quant; quantitative; random; ua; ur; urinalysis; urn,Qn
105093-9,leukocyte clumps [#/area] in urine sediment,wbc clumps #/area urns,leukocyte clumps (urine sed) [#/area],#/area; leuc; leuk; leukocytes; lkcs; number areic; point in time; qnt; quan; quant; quantitative; random; ua; ur; urinalysis; urine sediment; urn; urns; wbc; wbc clumps; wbcs; white blood cell; white blood cells,Qn
105100-2,benzodiazepines tested for in urine,benzodiaz tested ur,benzodiazepines tested nom (u),benz; benzodiaz; benzodiaz tested; benzodiazepine; drug/toxicology; drugs; identity or presence; nominal; point in time; random; ua; ur; urn,Nom
105109-3,coarse granular casts [#/area] in urine sediment,coarse gran casts #/area urns,coarse granular casts (urine sed) [#/area],#/area; cast; coarse gran casts; gran casts; number areic; point in time; qnt; quan; quant; quantitative; random; ua; ur; urinalysis; urine sediment; urn; urns,Qn
105113-5,epithelial cells [#/area] in urine sediment,epi cells #/area urns,epithelial cells (urine sed) [#/area],#/area; cell; cellularity; epi; epi cells; epith; epithelia; number areic; point in time; qnt; quan; quant; quantitative; random; ua; ur; urinalysis; urine sediment; urn; urns,Qn
105117-6,epithelial cells.squamous [#/area] in urine sediment,squamous #/area urns,epithelial cells.squamous (urine sed) [#/area],#/area; cell; cellularity; epi; epi cells; epith; epithelia; number areic; point in time; qnt; quan; quant; quantitative; random; sec; sq; squamous cell; squamous epithelial cell; squamous epithelial cells; ua; ur; urinalysis; urine sediment; urn; urns,Qn
105149-9,mra upper extremity vessels - left wo contrast iv,mra ue ves-l,,ang; angio; angiography; arm; arm and hand vessels; c; contr; contra; contrst; document; ext; extr ves; extr-l; finding; findings; imaging; l; lt; lue; magnetic resonance angiographies; magnetic resonance imaging; mitral regurgitation maximum velocity; mr angiography; mra; mri; mri.angio; point in time; radiology; random; ue; ue ves; ue ves-l; ue-l; up; vesl; vessels.xxx; without contrast,Doc
105150-7,mra upper extremity vessels - right wo contrast iv,mra ue ves-r,,ang; angio; angiography; arm; arm and hand vessels; c; contr; contra; contrst; document; ext; extr ves; extr-r; finding; findings; imaging; magnetic resonance angiographies; magnetic resonance imaging; mitral regurgitation maximum velocity; mr angiography; mra; mri; mri.angio; point in time; r; radiology; random; rt; rue; ue; ue ves; ue ves-r; ue-r; up; vesl; vessels.xxx; without contrast,Doc
105163-0,mr brain during surgery w contrast iv,mr brain in surg w contr iv,,brain; c; cerebral; cerebrum; contr; contra; contrst; cranial; cranium; document; finding; findings; head; imaging; in surg; in surg w contr iv; intra operative; intracranial; intraop; intraoperative; mitral regurgitation maximum velocity; mri; point in time; radiology; random; skull; surg; w contr iv; wc,Doc
105193-7,treponema pallidum igg ab index [units/volume] in serum and csf,t pallidum igg index ser+csf-acnc,t. pallidum igg index qn (s+csf),abs; aby; ai; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; both serum and cerebrospinal fluid; cerebral spinal fluid; cerebrospinal fl; immune globulin g; immunoglobulin g; microbiology; point in time; qnt; quan; quant; quantitative; random; serum; spinal fl; spinal fld; spinal flu; spinal fluid; sr; syphilis; t pallidum; t pallidum ab.igg index; treponemal,Qn
105223-2,rhinovirus rna [presence] in bronchial specimen by naa with probe detection,rhinovirus rna bronch ql naa+probe,rhinovirus rna naa+probe ql (bronch spec),3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; bro; dna nucleic acid probe; dna probe; hrv; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; naa+probe; naat; nasba; nucleic acid sequence based analysis; ordinal; pcr; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; rhino virus; rhv; ribonucleic acid; screen; sda; strand displacement amplification; tma; transcription mediated amplification,Ord
105225-7,mycobacterium sp identified in pus by organism specific culture,mycobacterium pus cult,mycobacterium sp identified org specific cx nom (pus),acid fast; acid fast bacilli; acid fast bacillus; afb; c&s; cult; cultures; identity or presence; microbiology; myco; mycobact; nominal; point in time; random; spec; species; spp; tuberculosis,Nom
105256-2,longest amount of time family members spent in jail or prison,longest time prison,,longest time prison; ordinal; phenx; point in time; ql; qual; qualitative; random; screen,Ord
105258-8,phenx - family history of incarceration protocol 281001,fam his incarce 281001,,fam his incarce 281001; h/o; hx; pan; panel; panel.phenx; panl; pnl; point in time; random,-
10526-2,microscopic observation [identifier] in sputum by cyto stain,cyto spt,microscopic observation cyto stain nom (sput),cytology; cytology stain; cytostain; identity or presence; lower respiratory; nominal; pap smear; pap stain; papanicolaou smear; point in time; random; spt; sputum; st; stains; stn; universallaborders,Nom
105266-1,tyrosine disorders multigene analysis in blood or tissue by molecular genetics method,tyrosine dis multi anl bld/t,tyrosine disorders multigene analysis molgen doc (bld/tiss),"blood; document; finding; findings; gene; gene panel; molecular genetics; molecular pathology; molpath; multi-gene study; multiple-gene panel test; pcr; point in time; random; tissue; tissue, unspecified; tyr; tyrosine dis multi anl; wb; whole blood; whole blood or tissue",Doc
105268-7,clindamycin.induced [susceptibility] by minimum inhibitory concentration (mic),clindamycin.induced islt mic,clindamycin.induced mic [susc],antibiotic susceptibilities; ast; c306; cleocin; clij; dalacin; islt; isol; minimum inhibitory concentration; point in time; random; sobelin; sus; suscept; susceptibilities; susceptibility; susceptibilty; topical,OrdQn
105269-5,fractional excretion of calcium [ratio] in urine and serum or plasma collected for unspecified duration,fracti excret of ca ?tm ur+serpl-rto,fractional excretion of calcium unsp time (u+s/p) [ratio],?tm; ca; cal; chemistry; fracti excret of ca; pl; plasma; plsm; qnt; quan; quant; quantitative; ratios; rto; serp; serpl; serplas; serum; serum or plasma; sr; ua; ur; ur+serpl; urn,Qn
105327-1,glial fibrillary acidic protein [mass/volume] in blood by immunoassay,gfap bld ia-mcnc,glial fibrillary acidic protein ia (bld) [mass/vol],blood; eia; elfa; elisa; enzyme immunoassay; gfap; iaa; level; mass concentration; meia; point in time; pr; prot; qnt; quan; quant; quantitative; random; serology; stroke; suds; tbi (traumatic brain injury); traumatic brain injuries; wb; whole blood,Qn
105332-1,myh9 gene full mutation analysis in blood by molecular genetics method,myh9 gene full mut anl bld,myh9 gene full mutation analysis molgen doc (bld),blood; document; finding; findings; full gene sequencing; full mut anl; molecular genetics; molecular pathology; molpath; mut; mutations; myh9 gene full mut anl; myosin heavy chain 9; pcr; point in time; random; sequencing of entire coding region; wb; whole blood,Doc
105340-4,chlamydia trachomatis l3 dna [presence] in specimen by naa with probe detection,c trach l3 dna spec ql naa+probe,chlamydia trachomatis l3 dna naa+probe ql (specimen),3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; c trac; c trach; c trach l3; c trach l3 dna; c tracho; c trachomatis; chlam; chlam trac; chlamid; ct; deoxyribonucleic acid; dna nucleic acid probe; dna probe; lat; lcr; lgv; ligase chain reaction; ligation-activated transcription; lymphogranuloma venereum; microbiology; misc; miscellaneous; naa+probe; naat; nasba; nucleic acid sequence based analysis; ordinal; other; pcr; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; screen; sda; spec; strand displacement amplification; tma; to be specified in another part of the message; trachoma; transcription mediated amplification; unspecified,Ord
105342-0,3-methylglutaconate aciduria multigene analysis in blood or tissue by molecular genetics method,3 me-glutaconate acid multi anl bld/t,3-methylglutaconate aciduria multigene analysis molgen doc (bld/tiss),"3 me-glutaconate acid multi anl; 3me-glutaconate; 3-methylglutaconic acid; blood; document; finding; findings; gene; gene panel; iii; molecular genetics; molecular pathology; molpath; multi-gene study; multiple-gene panel test; pcr; point in time; random; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",Doc
105345-3,cholestasis multigene analysis in blood or tissue by molecular genetics method,cholestasis multi anl bld/t,cholestasis multigene analysis molgen doc (bld/tiss),"blood; cholestasis multi anl; document; finding; findings; gene; gene panel; molecular genetics; molecular pathology; molpath; multi-gene study; multiple-gene panel test; pcr; point in time; random; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",Doc
105348-7,methylmalonate aciduria-propionic aciduria multigene analysis in blood or tissue by molecular genetics method,methylmal acid-prop acid multi anl bld/t,methylmalonate aciduria-propionic aciduria multigene analysis molgen doc (bld/tiss),"blood; document; finding; findings; gene; gene panel; methylmal acid-prop acid multi anl; methylmalonic acid; methylmalonic acidemia; mma; molecular genetics; molecular pathology; molpath; multi-gene study; multiple-gene panel test; pcr; point in time; propionic acidemia; random; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",Doc
105349-5,neuronal ceroid lipofuscinosis multigene analysis in blood or tissue by molecular genetics method,ncl multi anl bld/t,neuronal ceroid lipofuscinosis multigene analysis molgen doc (bld/tiss),"blood; document; finding; findings; gene; gene panel; molecular genetics; molecular pathology; molpath; multi-gene study; multiple-gene panel test; ncl multi anl; pcr; point in time; random; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",Doc
105360-2,90 percent of daily air quality index (aqi) values,aqi 90th percentile,,aqi 90th percentile; cnt; count; number; phenx; point in time; qnt; quan; quant; quantitative; random,Qn
105415-4,clinical decision support for icu discharge,icu d/c dest spec,,disch; h+p; h+p.hx; icu d/c dest spec; nominal; p prime; point in time; random; typ,Nom
105435-2,legionella pneumophila dna [presence] in nasopharynx by naa with probe detection,l pneumo dna nph ql naa+probe,l. pneumophila dna naa+probe ql (nph),3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; deoxyribonucleic acid; dna nucleic acid probe; dna probe; l pneumo; l pneumonphila; lat; lcr; legion; legionela; ligase chain reaction; ligation-activated transcription; microbiology; naa+probe; naat; nasba; nasopharynx; nucleic acid sequence based analysis; ordinal; pcr; pneu; pneum; pneumophilia; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; screen; sda; strand displacement amplification; tma; transcription mediated amplification,Ord
105470-9,deprecated phenx - access health services last seen doctor protocol 270101,deprecated unable see doctor due to cost,,pan; panel; panel.phenx; panl; past; pnl; point in time; random; unable see doctor due to cost,-
105481-6,did you make any appointments to see a specialist 12 months,appnt see specialist 12mo,,1 year; 12mos; appnt see specialist; finding; findings; ordinal; phenx; ql; qual; qualitative; screen,Ord
105501-1,percentage of adults in the 40-49 year old age group with diabetes,percent 40-49 yrs age grp w diabetes,,cnt; count; number; percent 40-49 yrs age grp w diabetes; phenx; point in time; qnt; quan; quant; quantitative; random,Qn
10551-0,triamterene [mass/volume] in serum or plasma,triamterene serpl-mcnc,triamterene [mass/vol],drug/toxicology; drugs; dyrenium; level; mass concentration; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
105510-2,was blood requested for lipid profile,blood requested for lipid profile,,finding; findings; ordinal; phenx; point in time; prof; ql; qual; qualitative; random; screen,Ord
105511-0,was consent given,was consent gvn,,finding; findings; form; gvn; ordinal; phenx; point in time; ql; qual; qualitative; random; screen,Ord
105520-1,at what age did you begin taking medicine for this,age begin taking meds,,age begin taking meds; phenx; point in time; qnt; quan; quant; quantitative; random,Qn
105528-4,mj ab [units/volume] in serum,mj ab ser-acnc,mj ab qn (s),"abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; dermatomyositis, adult type; dermatomyositis, childhood type; jdm; morc3; nxp-2; point in time; qnt; quan; quant; quantitative; random; serology; serum; sr",Qn
105529-2,mda5 ab [units/volume] in serum,mda5 ab ser-acnc,mda5 ab qn (s),abs; aby; antby; anti; antibodies; antibody; anti-cadm-140; anti-mda5 autoantibodies; arbitrary concentration; autoantibodies; autoantibody; interferon-induced helicase c domain-containing protein 1; juvenile dermatomyositis; melanoma differentiation-associated gene 5; point in time; qnt; quan; quant; quantitative; random; serology; serum; sr,Qn
105544-1,fibrillarin ab [units/volume] in serum,fibrillarin ab ser-acnc,fibrillarin ab qn (s),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; point in time; qnt; quan; quant; quantitative; random; serology; serum; sr,Qn
105545-8,u2 small nuclear ribonucleoprotein ab [units/volume] in serum,u2 snrnp ab ser-acnc,u2 small nuclear ribonucleoprotein ab qn (s),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; nuc; point in time; qnt; quan; quant; quantitative; random; ribonuclear protein; rnp; serology; serum; snrnp; sr; u2 rnp; u2 snrnp; u2rnp,Qn
105571-4,ozone,o3 nfr,,number fraction; o3; percent; phenx; point in time; qnt; quan; quant; quantitative; random,Qn
105578-9,phenx - environmental justice protocol 290401,phenx envi ust proto 290401,,pan; panel; panel.phenx; panl; phenx envi ust proto 290401; pnl; point in time; random,-
105597-9,pole targeted gene mutation analysis in tissue by molecular genetics method,pole targ gene mut anlyss tiss,pole targeted gene mutation analysis molgen doc (tiss),"document; finding; findings; molecular genetics; molecular pathology; molpath; mut; mutations; pcr; point in time; pole targ gene mut anlyss; random; tissue; tissue, unspecified",Doc
105600-1,ulceration status [presence] in tissue,ulceration status tiss ql,ulceration status ql (tiss),"ordinal; pathology; point in time; pr; ql; qual; qualitative; random; screen; tissue; tissue, unspecified",Ord
105620-9,campylobacter and salmonella and shigella sp # 2 identified in stool by organism specific culture,camp & sal & shig sp stl cult org #2,campylobacter and salmonella and shigella sp identified # 2 org specific cx nom (stl),bowel movement; c&s; camp & sal & shig sp; campy; cult; cultures; faecal; faeces; fecal; feces; identity or presence; ii; microbiology; nominal; point in time; random; sal; salm + shig; salmonel; shigellosis; spec; species; spp; stl; stool = fecal,Nom
105623-3,mycoplasma hominis dna [presence] in urine by naa with probe detection,m hominis dna ur ql naa+probe,m. hominis dna naa+probe ql (u),3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; deoxyribonucleic acid; dna nucleic acid probe; dna probe; lat; lcr; ligase chain reaction; ligation-activated transcription; m hominis; metamycoplasma hominis; microbiology; myco; mycoplas; mycoplasm; mycoplasmosis; mycoplsm; naa+probe; naat; nasba; nucleic acid sequence based analysis; ordinal; pcr; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; screen; sda; strand displacement amplification; tma; transcription mediated amplification; ua; ur; urn,Ord
10563-5,cells other than spermatozoa [#/volume] in semen,cells other # smn,cells other than spermatozoa (sem) [#/vol],#; abs; absolute; absolutes; cell; cellularity; cnt; count; count/volume; ct; ejaculate; fertility testing; genitourinary; gu; number concentration; number concentration (count/vol); othr; point in time; qnt; quan; quant; quantitative; random; sem; seminal fluid; smn; smpls; sperm; uro; urology,Qn
105636-5,bacteroides fragilis dna [presence] in specimen by naa with probe detection,b fragilis dna spec ql naa+probe,b. fragilis dna naa+probe ql (specimen),3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; b fragilis; b fragilis dna; deoxyribonucleic acid; dna nucleic acid probe; dna probe; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; misc; miscellaneous; naa+probe; naat; nasba; nucleic acid sequence based analysis; ordinal; other; pcr; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; screen; sda; spec; strand displacement amplification; tma; to be specified in another part of the message; transcription mediated amplification; unspecified,Ord
105644-9,clostridium perfringens dna [presence] in specimen by naa with probe detection,c perfringens dna spec ql naa+probe,c. perfringens dna naa+probe ql (specimen),3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; c perfringens; c perfringens dna; deoxyribonucleic acid; dna nucleic acid probe; dna probe; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; misc; miscellaneous; naa+probe; naat; nasba; nucleic acid sequence based analysis; ordinal; other; pcr; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; screen; sda; spec; strand displacement amplification; tma; to be specified in another part of the message; transcription mediated amplification; unspecified,Ord
105650-6,enterobacter cloacae dna [presence] in specimen by naa with probe detection,e. cloacae dna spec ql naa+probe,enterobacter cloacae dna naa+probe ql (specimen),3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; deoxyribonucleic acid; dna nucleic acid probe; dna probe; e. cloacae; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; misc; miscellaneous; naa+probe; naat; nasba; nucleic acid sequence based analysis; ordinal; other; pcr; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; screen; sda; spec; strand displacement amplification; tma; to be specified in another part of the message; transcription mediated amplification; unspecified,Ord
105680-3,streptococcus gordonii dna [presence] in specimen by naa with probe detection,s. gordonii dna spec ql naa+probe,streptococcus gordonii dna naa+probe ql (specimen),3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; deoxyribonucleic acid; dna nucleic acid probe; dna probe; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; misc; miscellaneous; naa+probe; naat; nasba; nucleic acid sequence based analysis; ordinal; other; pcr; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; s. gordonii; screen; sda; spec; strand displacement amplification; strep; strept; tma; to be specified in another part of the message; transcription mediated amplification; unspecified,Ord
105690-2,candida haemulonii dna [presence] in specimen by naa with probe detection,candida haemulonii dna spec ql naa+probe,candida haemulonii dna naa+probe ql (specimen),3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; cand; candidiasis; deoxyribonucleic acid; dna nucleic acid probe; dna probe; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; misc; miscellaneous; naa+probe; naat; nasba; nucleic acid sequence based analysis; ordinal; other; pcr; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; screen; sda; spec; strand displacement amplification; tma; to be specified in another part of the message; transcription mediated amplification; unspecified,Ord
105692-8,cryptococcus gattii dna [presence] in specimen by naa with probe detection,c. gattii dna spec ql naa+probe,cryptococcus gattii dna naa+probe ql (specimen),3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; c. gattii; crypt; crypto; cryptococcal; cryptococcosis; cryptococcosus; cryptococcus neoformans var gattii; deoxyribonucleic acid; dna nucleic acid probe; dna probe; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; misc; miscellaneous; naa+probe; naat; nasba; nucleic acid sequence based analysis; ordinal; other; pcr; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; screen; sda; spec; strand displacement amplification; tma; to be specified in another part of the message; transcription mediated amplification; unspecified,Ord
105-7,ceforanide [susceptibility] by disk diffusion (kb),ceforanide islt kb,ceforanide disk diffusion (kb) [susc],antibiotic susceptibilities; ast; disk diffusion; id; infectious disease; infectiousdisease; islt; isol; kb; kirby-bauer; point in time; precef; random; sus; suscept; susceptibilities; susceptibility; susceptibilty,OrdQn
10570-0,consistency of cervical mucus,consistency cerv mucus ql,consistency ql (cervical mucus),cerv mucus; cervical mucus; genital tract; ordinal; point in time; pr; ql; qual; qualitative; random; screen; spec,Ord
105718-1,bromazolam/creatinine [mass ratio] in urine by confirmatory method,bromazolam/creat ur cfm,bromazolam/creatinine confirm (u) [mass ratio],cfm; cnfr; cnfrm; conf; confirmation; confirmatory; cr; crea; creat; drug/toxicology; drugs; gcms; lc/ms/ms; mass concentration ratio; mass ratio; mcrto; point in time; qnt; quan; quant; quantitative; random; ua; ucr; ur; urn,Qn
105726-4,parainfluenza virus rna [presence] in bronchoalveolar lavage by naa with probe detection,hpiv rna bal ql naa+probe,parainfluenza virus rna naa+probe ql (bal),3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; bronchial alveolar lavage; bronchoalveolar lavage; dna nucleic acid probe; dna probe; hpiv; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; naa+probe; naat; nasba; nucleic acid sequence based analysis; ordinal; para; parainflu; pcr; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; ribonucleic acid; screen; sda; strand displacement amplification; tma; transcription mediated amplification,Ord
105731-4,human metapneumovirus rna [presence] in bronchoalveolar lavage by naa with probe detection,hmpv rna bal ql naa+probe,hmpv rna naa+probe ql (bal),3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; bronchial alveolar lavage; bronchoalveolar lavage; dna nucleic acid probe; dna probe; hmpv; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; naa+probe; naat; nasba; nucleic acid sequence based analysis; ordinal; pcr; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; ribonucleic acid; screen; sda; strand displacement amplification; tma; transcription mediated amplification,Ord
105735-5,human coronavirus nl63 rna [presence] in bronchoalveolar lavage by naa with probe detection,hcov nl63 rna bal ql naa+probe,hcov nl63 rna naa+probe ql (bal),3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; bronchial alveolar lavage; bronchoalveolar lavage; corona virus; dna nucleic acid probe; dna probe; hcov; hcov nl63; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; naa+probe; naat; nasba; nucleic acid sequence based analysis; ordinal; pcr; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; ribonucleic acid; screen; sda; strand displacement amplification; tma; transcription mediated amplification,Ord
10574-2,fructose [moles/volume] in semen,fructose smn-scnc,fructose (sem) [moles/vol],chemistry; ejaculate; genitourinary; gu; level; levulose; point in time; qnt; quan; quant; quantitative; random; revulose; sem; seminal fluid; smn; smpls; substance concentration; uro; urology,Qn
105761-1,mycobacterium tuberculosis maba promoter region gene inh high level resistance mutation [identifier] in isolate or specimen by molecular genetics method nominal,mtb maba inh hl res mut islt/spm,mycobacterium tuberculosis maba promoter region gene inh high level resistance mutation molgen nom (islt/spec),acid fast; acid fast bacilli; acid fast bacillus; afb; identity or presence; islt; islt/spm; isol; levels; levl; lv; lvl; m tb; m tuberculosis; molecular genetics; molecular pathology; molpath; molpath.mutations; mtb; mtb maba inh hl res mut; mut; mutations; myco; mycobact; mycobacterium tuberculosum; nominal; pcr; point in time; random; resist; resistanc; resistant; resistent; spec; tb; tuberculosis,Nom
10576-7,germ cells.immature [#/volume] in semen,imm germ cells # smn,germ cells.immature (sem) [#/vol],#; abs; absolute; absolutes; cell; cellularity; cnt; count; count/volume; ct; ejaculate; fertility testing; genitourinary; gu; imm; imm germ cells; immat; number concentration; number concentration (count/vol); point in time; qnt; quan; quant; quantitative; random; sem; seminal fluid; smn; smpls; uro; urology,Qn
105770-2,pseudomonas aeruginosa dna [cycle threshold #] in positive blood culture by naa with probe detection,p aeruginosa dna ct bld pos qn naa+probe,p. aeruginosa dna naa+probe (pos bld culture) [threshnum],3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; bld pos; blood; deoxyribonucleic acid; dna nucleic acid probe; dna probe; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; naa+probe; naat; nasba; nucleic acid sequence based analysis; p aeruginosa; pcr; point in time; polymerase chain reaction; probe amp; probe with ampification; probe with target amplification; qbr; qnt; quan; quant; quantitative; random; sda; strand displacement amplification; tma; transcription mediated amplification; wb; whole blood,Qn
105773-6,acinetobacter calcoaceticus-baumannii complex dna [cycle threshold #] in positive blood culture by naa with probe detection,acb complex dna ct bld pos qn naa+probe,a. calcoaceticus-baumannii complex dna naa+probe (pos bld culture) [threshnum],3 self-sustaining sequence replication; 3sr sr; acb complex; amplif; amplification; amplified; bld pos; blood; compx; deoxyribonucleic acid; dna nucleic acid probe; dna probe; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; naa+probe; naat; nasba; nucleic acid sequence based analysis; pcr; point in time; polymerase chain reaction; probe amp; probe with ampification; probe with target amplification; qbr; qnt; quan; quant; quantitative; random; sda; strand displacement amplification; tma; transcription mediated amplification; wb; whole blood,Qn
105774-4,bacteroides fragilis dna [cycle threshold #] in positive blood culture by naa with probe detection,b fragilis dna ct bld pos qn naa+probe,b. fragilis dna naa+probe (pos bld culture) [threshnum],3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; b fragilis; b fragilis dna; bld pos; blood; deoxyribonucleic acid; dna nucleic acid probe; dna probe; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; naa+probe; naat; nasba; nucleic acid sequence based analysis; pcr; point in time; polymerase chain reaction; probe amp; probe with ampification; probe with target amplification; qbr; qnt; quan; quant; quantitative; random; sda; strand displacement amplification; tma; transcription mediated amplification; wb; whole blood,Qn
10577-5,glucosidase [enzymatic activity/volume] in seminal plasma,glucosidase semin plas-ccnc,glucosidase (seminal plasma) [catalytic activity/vol],catalytic concentration; chemistry; glucoinvertase; glucosidosucrase; maltase; maltase-glucoamylase; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; seminal plasma,Qn
105786-8,bacterial carbapenem resistance blaoxa-24+blaoxa-40 gene [cycle threshold #] in positive blood culture by naa with probe detection,blaoxa-24+blaoxa-40 ct bld +qn naa+prb,carbapenem resistance blaoxa-24+blaoxa-40 gene naa+probe (pos bld culture) [threshnum],3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; bact; bld pos; blood; cpr; dna nucleic acid probe; dna probe; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; naa+probe; naat; nasba; nucleic acid sequence based analysis; pcr; point in time; polymerase chain reaction; probe amp; probe with ampification; probe with target amplification; qbr; qnt; quan; quant; quantitative; random; resist; resistanc; resistant; resistent; sda; strand displacement amplification; tma; transcription mediated amplification; wb; whole blood,Qn
105793-4,bacterial beta-lactam resistance blaveb gene [cycle threshold #] in positive blood culture by naa with probe detection,bac b-lactam resist veb ct,bacterial beta-lactam resistance blaveb gene naa+probe (pos bld culture) [threshnum],3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; b; bact; bld pos; blood; dna nucleic acid probe; dna probe; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; naa+probe; naat; nasba; nucleic acid sequence based analysis; pcr; point in time; polymerase chain reaction; probe amp; probe with ampification; probe with target amplification; qbr; qnt; quan; quant; quantitative; random; resist; resistanc; resistant; resistent; sda; strand displacement amplification; tma; transcription mediated amplification; wb; whole blood,Qn
105795-9,micrococcus spp dna [cycle threshold #] in positive blood culture by naa with probe detection,microcccs spp dna ct bld +qn naa+prb,micrococcus spp dna naa+probe (pos bld culture) [threshnum],3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; bld pos; blood; deoxyribonucleic acid; dna nucleic acid probe; dna probe; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; naa+probe; naat; nasba; nucleic acid sequence based analysis; pcr; point in time; polymerase chain reaction; probe amp; probe with ampification; probe with target amplification; qbr; qnt; quan; quant; quantitative; random; sda; strand displacement amplification; tma; transcription mediated amplification; wb; whole blood,Qn
105802-3,streptococcus pneumoniae dna [cycle threshold #] in positive blood culture by naa with probe detection,s pneum dna ct bld pos qn naa+probe,s. pneumoniae dna naa+probe (pos bld culture) [threshnum],3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; bld pos; blood; deoxyribonucleic acid; dna nucleic acid probe; dna probe; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; naa+probe; naat; nasba; nucleic acid sequence based analysis; pcr; pneu; pneum; pneumo; pneumococ; pneumococcal; pneumococcal pneumonia; pneumococcus; pneumon; pneumonia; point in time; polymerase chain reaction; probe amp; probe with ampification; probe with target amplification; qbr; qnt; quan; quant; quantitative; random; s pneumo; s pneumoniae; s pneumoniase dna; sda; spn; strand displacement amplification; strep; strept; tma; transcription mediated amplification; wb; whole blood,Qn
105805-6,fusarium sp dna [cycle threshold #] in positive blood culture by naa with probe detection,fusarium dna ct bld pos qn naa+probe,fusarium sp dna naa+probe (pos bld culture) [threshnum],3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; bld pos; blood; deoxyribonucleic acid; dna nucleic acid probe; dna probe; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; naa+probe; naat; nasba; nucleic acid sequence based analysis; pcr; point in time; polymerase chain reaction; probe amp; probe with ampification; probe with target amplification; qbr; qnt; quan; quant; quantitative; random; sda; species; spp; strand displacement amplification; tma; transcription mediated amplification; wb; whole blood,Qn
105806-4,candida auris dna [cycle threshold #] in positive blood culture by naa with probe detection,c auris dna ct bld pos qn naa+probe,c. auris dna naa+probe (pos bld culture) [threshnum],3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; bld pos; blood; c auris; cand; candidiasis; deoxyribonucleic acid; dna nucleic acid probe; dna probe; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; naa+probe; naat; nasba; nucleic acid sequence based analysis; pcr; point in time; polymerase chain reaction; probe amp; probe with ampification; probe with target amplification; qbr; qnt; quan; quant; quantitative; random; sda; strand displacement amplification; tma; transcription mediated amplification; wb; whole blood,Qn
105809-8,bacterial antimicrobial resistance cfr gene [cycle threshold #] in positive blood culture by naa with probe detection,bac antimicro res cfr ct bld +,bacterial antimicrobial resistance cfr gene naa+probe (pos bld culture) [threshnum],3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; bact; bacterial antimicrobial res cfr; bld pos; blood; dna nucleic acid probe; dna probe; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; naa+probe; naat; nasba; nucleic acid sequence based analysis; pcr; point in time; polymerase chain reaction; probe amp; probe with ampification; probe with target amplification; qbr; qnt; quan; quant; quantitative; random; resist; resistanc; resistant; resistent; sda; strand displacement amplification; tma; transcription mediated amplification; wb; whole blood,Qn
105839-5,were the diluent and rx buffer reagents stored at room temperature,dil & rx buff reagen sto at rm temp,,dil & rx buff reagen sto at rm temp; finding; findings; ordinal; phenx; point in time; ql; qual; qualitative; random; screen; temp; treatment,Ord
10584-1,deprecated protein [mass/volume] in semen,deprecated prot-mcnc,protein (smpls) [mass/vol],fertility testing; genitourinary; gu; level; mass concentration; point in time; pr; prot; qnt; quan; quant; quantitative; random; uro; urology,Qn
105846-0,is the lowest reportable value at least 0.02 mg per dl,low rep value 0.02mg/dl,,finding; findings; low rep value 0.02mg/dl; ordinal; phenx; point in time; ql; qual; qualitative; random; screen,Ord
105873-4,other cells [#/volume] in blood,other cells # bld,other cells (bld) [#/vol],#; abs; absolute; absolutes; blood; cell; cellularity; cnt; count; count/volume; ct; hematology/cell counts; number concentration; number concentration (count/vol); othr; point in time; qnt; quan; quant; quantitative; random; wb; whole blood,Qn
10587-4,sexual abstinence duration,sex abstin duration time patient,sexual abstinence duration [time],durat; fertility testing; point in time; qnt; quan; quant; quantitative; random; sex abstin duration,Qn
105875-9,bordetella pertussis dna [presence] in specimen,b pert dna spec ql,b. pertussis dna ql (specimen),b pert; b pertussis; deoxyribonucleic acid; microbiology; misc; miscellaneous; ordinal; other; pertussis; point in time; pr; ql; qual; qualitative; random; screen; spec; to be specified in another part of the message; unspecified; whooping cough,Ord
10588-2,spermatogonia [#/volume] in semen,spermatogonia # smn,spermatogonia (sem) [#/vol],#; abs; absolute; absolutes; cnt; count; count/volume; ct; ejaculate; fertility testing; genitourinary; gu; number concentration; number concentration (count/vol); point in time; qnt; quan; quant; quantitative; random; sem; seminal fluid; smn; smpls; uro; urology,Qn
105905-4,entamoeba histolytica dna [presence] in stool,e histolyt dna stl ql,e. histolytica dna ql (stl),ameba; amebiasis; amebic; amoeba; bowel movement; deoxyribonucleic acid; e histolyt; e histolytica; faecal; faeces; fecal; feces; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; screen; stl; stool = fecal,Ord
105906-2,blood [presence] in urine,blood ur ql,blood ql (u),ordinal; point in time; pr; ql; qual; qualitative; random; screen; ua; ur; urinalysis; urn,Ord
105908-8,bacteria [#/area] in urine sediment,bacteria #/area urns,bacteria (urine sed) [#/area],#/area; bact; number areic; point in time; qnt; quan; quant; quantitative; random; ua; ur; urinalysis; urine sediment; urn; urns,Qn
105934-4,n-desmethyl regorafenib [mass/volume] in serum or plasma,n-desmethyl regorafenib serpl-mcnc,n-desmethyl regorafenib [mass/vol],drug/toxicology; drugs; level; mass concentration; metab; metabolites; metb; n-desmethyl regorafenib; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; regorafenibum; serp; serpl; serplas; serum; serum or plasma; sr,Qn
105936-9,abemaciclib m20 metabolite [mass/volume] in serum or plasma,abemaciclib m20 serpl-mcnc,abemaciclib m20 metabolite [mass/vol],drug/toxicology; drugs; level; mass concentration; metab; metabolites; metb; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
105947-6,1-hydroxymidazolam [presence] in urine by confirmatory method,1oh-midazolam ur ql cfm,1-hydroxymidazolam confirm ql (u),1-hydroxy midazolam; 1oh-midazolam; alpha hydroxymidazolam; alpha-hydroxymidazolam; cfm; chlonazepam metabolite; cnfr; cnfrm; conf; confirmation; confirmatory; drug/toxicology; drugs; gcms; i; lc/ms/ms; ordinal; point in time; pr; ql; qual; qualitative; random; screen; ua; ur; urn,Ord
1059-5,i ab [presence] in serum or plasma from donor,i ab serpl donr ql,i ab ql (s/p donor),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; blood bank; donr; ordinal; pl; plasma; plsm; point in time; pr; ql; qual; qualitative; random; screen; serp; serpl; serplas; serum; serum or plasma; sr,Ord
105951-8,norketamine [presence] in urine by confirmatory method,norketamine ur ql cfm,norketamine confirm ql (u),cfm; cnfr; cnfrm; conf; confirmation; confirmatory; drug/toxicology; drugs; gcms; ketamine metabolite; lc/ms/ms; ordinal; point in time; pr; ql; qual; qualitative; random; screen; ua; ur; urn,Ord
105954-2,pregabalin [presence] in urine,pregabalin ur ql,pregabalin ql (u),drug/toxicology; drugs; lyrica; ordinal; point in time; pr; ql; qual; qualitative; random; screen; ua; ur; urn,Ord
105955-9,7-aminonitrazepam [mass/volume] in urine,7aminonitrazepam ur-mcnc,7-aminonitrazepam (u) [mass/vol],7-amino nitrazepam; 7aminonitrazepam; drug/toxicology; drugs; level; mass concentration; nitrazepam metabolite; point in time; qnt; quan; quant; quantitative; random; ua; ur; urn,Qn
105961-7,pholcodine [mass/volume] in urine,pholcodine ur-mcnc,pholcodine (u) [mass/vol],c261; drug/toxicology; drugs; level; mass concentration; point in time; qnt; quan; quant; quantitative; random; ua; ur; urn,Qn
105962-5,quetiapine [mass/volume] in urine,quetiapine ur-mcnc,quetiapine (u) [mass/vol],drug/toxicology; drugs; ketipinor; level; mass concentration; point in time; qnt; quan; quant; quantitative; random; seroquel; ua; ur; urn; xeroquel,Qn
105977-3,zolpidem phenyl-4-carboxylate [presence] in urine,zolpidem phenyl-4-carb ur ql,zolpidem phenyl-4-carboxylate ql (u),adormix; ambien; ambien cr; damixan; drug/toxicology; drugs; edluar; hypnogen; ivedal; lioran; myslee; nasen; nytamel; ordinal; point in time; pr; ql; qual; qualitative; random; sanval; screen; somidem; stilnoct; stilnox; stilnox cr; sucedal; ua; ur; urn; zoldem; zolpihexal; zolpimist,Ord
105984-9,iga.kappa [presence] in serum by immunofixation,iga kappa ser ql ife,iga.kappa immunofixation ql (s),chemistry; heavy chain; ife; ifix; iga kappa; immune globulin a; immunofixation electrophoresis; immunoglobulin a; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; sr,Ord
105991-4,usual bedtime,bedtime clock time,,clock time; point in time; qnt; quan; quant; quantitative; random,Qn
105997-1,number of aperitif drinks per week,num aperitif per week,,aperitif drinks per week; cnt; count; number; point in time; qnt; quan; quant; quantitative; random,Qn
105999-7,drinks of water per day,water per d nrate,,count/time; dextro; nrate; number rate; number rate = count/time; point in time; qnt; quan; quant; quantitative; random,Qn
106024-3,fungus identified in vaginal fluid by culture,fungus vag cult,fungus identified cx nom (vag fld),c&s; cult; cultures; fung; fungal; fungi; genital vaginal; identity or presence; microbiology; nominal; point in time; random; vag fld; vag fluid; vagina; vaginal fluid,Nom
106027-6,ureaplasma parvum dna [presence] in vaginal fluid by naa with probe detection,u parvum dna vag ql naa+probe,u. parvum dna naa+probe ql (vag fld),3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; deoxyribonucleic acid; dna nucleic acid probe; dna probe; genital vaginal; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; naa+probe; naat; nasba; nucleic acid sequence based analysis; ordinal; pcr; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; screen; sda; strand displacement amplification; tma; transcription mediated amplification; u parvum; u parvum dna; vag fld; vag fluid; vagina; vaginal fluid,Ord
106046-6,methicillin resistant staphylococcus aureus [presence] in axilla by organism specific culture,mrsa axilla ql cult,mrsa isol org specific cx ql (axilla),ax; c&s; celbenin; cult; cultures; dimethoxypenicillin; metacillin; metin; microbiology; mrsa; mrsa screen; o71; ordinal; point in time; pr; ql; qual; qualitative; random; s aureus; screen; spec; staficyn; staph; staphicillin; upper extremity,Ord
106053-2,rheumatoid factor igm and iga antibody panel - serum or plasma,rf igm & iga pnl serpl,rheumatoid factor igm and iga antibody panel,ab; fac; fact; immune globulin a; immune globulin m; immunoglobulin a; immunoglobulin m; pan; panel.serology; panl; pl; plasma; plsm; pnl; point in time; random; rf; rf igm; rf igm & iga pnl; serology; serp; serpl; serplas; serum; serum or plasma; sr,-
106058-1,chlamydia trachomatis and neisseria gonorrhoeae and trichomonas vaginalis rrna panel - vagina by naa with probe detection,ct + ng + tv rrna pnl vagina naa+probe,chlamydia trachomatis and neisseria gonorrhoeae and trichomonas vaginalis rrna panel naa+probe (vagina),3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; c trac; c trach; c trach+gc; c tracho; c trachomatis; chlam; chlam trac; chlamid; ct; ct + ng + tv; ct + ng + tv rrna pnl; ct/gc; dna nucleic acid probe; dna probe; gc; gen-probe; gono; gonorrhea; lat; lcr; lgv; ligase chain reaction; ligation-activated transcription; lymphogranuloma venereum; microbiology; n gonorrhoea; n gonorrhoeae; naa+probe; naat; nasba; nucleic acid sequence based analysis; pan; panel.microbiology; panl; pcr; pnl; point in time; polymerase chain reaction; probe amp; probe with ampification; probe with target amplification; qbr; random; ribosomal rna; sda; strand displacement amplification; t vaginalis; tma; trachoma; transcription mediated amplification; tric; trich; trichimoniasis; trichomonad; trichomonads; trichomoniasis,-
106061-5,enteric bacteria panel - stool by naa with probe detection,enteric bacteria pnl stl naa+probe,enteric bacteria panel naa+probe (stl),3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; bact; bowel movement; dna nucleic acid probe; dna probe; enteric bacteria pnl; faecal; faeces; fecal; feces; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; naa+probe; naat; nasba; nucleic acid sequence based analysis; pan; panel.microbiology; panl; pcr; pnl; point in time; polymerase chain reaction; probe amp; probe with ampification; probe with target amplification; qbr; random; sda; stl; stool = fecal; strand displacement amplification; tma; transcription mediated amplification,-
10610-4,spermatozoa duplicate tail/spermatozoa in semen,sperm duplicate tail nfr smn,spermatozoa duplicate tail/spermatozoa (sem),ejaculate; fertility testing; genitourinary; gu; number fraction; percent; point in time; qnt; quan; quant; quantitative; random; sem; seminal fluid; smn; smpls; sperm; sperm duplicate tail; uro; urology,Qn
106116-7,sperm agglutination [presence] in semen by agglutination,sperm agglutn smn ql aggl,sperm agglutination aggl ql (sem),agg; agglut; agglutination; ejaculate; fertility testing; ordinal; point in time; pr; ql; qual; qualitative; random; screen; sem; seminal fluid; smn; smpls; sperm agglutn,Ord
106164-7,allergy manifestation,allergy manifest,,admin; finding; findings; nominal; point in time; random,Nom
10617-9,spermatozoa motile w igg/spermatozoa in semen by mixed antiglobulin reaction,sperm motile w igg nfr smn mar,spermatozoa motile w igg/spermatozoa mixed antiglobulin reaction (sem),antiglob; ejaculate; erymar; fertility testing; genitourinary; gu; immune globulin g; immunoglobulin g; latex mar; mar; mar test; mixed antiglobulin test; mot; number fraction; percent; point in time; qnt; quan; quant; quantitative; random; react; rxn; sem; seminal fluid; smar; smn; smpls; sperm; sperm motile; sperm motile w igg; uro; urology,Qn
106186-0,medication code,medication code,,admin; ident; identifier; nominal; point in time; random,Nom
106192-8,observation update status,observ update sta,,admin; finding; findings; nominal; observ update sta; point in time; random,Nom
10619-5,spermatozoa motile w igm/spermatozoa in semen by mixed antiglobulin reaction,sperm motile w igm nfr smn mar,spermatozoa motile w igm/spermatozoa mixed antiglobulin reaction (sem),antiglob; ejaculate; erymar; fertility testing; genitourinary; gu; immune globulin m; immunoglobulin m; latex mar; mar; mar test; mixed antiglobulin test; mot; number fraction; percent; point in time; qnt; quan; quant; quantitative; random; react; rxn; sem; seminal fluid; smar; smn; smpls; sperm; sperm motile; sperm motile w igm; uro; urology,Qn
10620-3,spermatozoa nonprogressive/spermatozoa in semen,sperm nonprog nfr smn,spermatozoa nonprogressive/spermatozoa (sem),ejaculate; fertility testing; genitourinary; gu; number fraction; percent; point in time; qnt; quan; quant; quantitative; random; sem; seminal fluid; smn; smpls; sperm; sperm nonprog; uro; urology,Qn
106208-2,human coronavirus 229e+hku1+nl63+oc43 rna [presence] in aspirate by naa with probe detection,hcov 229e+hku1+nl63+oc43 rna asp ql,hcov 229e+hku1+nl63+oc43 rna naa+probe ql (asp),3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; aspirate; corona virus; cov 229e+hku1+nl63+oc43; dna nucleic acid probe; dna probe; hcov; hcov 229e; hcov 229e+hku1+nl63+oc43; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; naa+probe; naat; nasba; nucleic acid sequence based analysis; ordinal; pcr; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; ribonucleic acid; screen; sda; strand displacement amplification; tma; transcription mediated amplification,Ord
10624-5,spermatozoa rapid/spermatozoa in semen,sperm rapid nfr smn,spermatozoa rapid/spermatozoa (sem),ejaculate; fertility testing; genitourinary; gu; number fraction; percent; point in time; qnt; quan; quant; quantitative; random; sem; seminal fluid; smn; smpls; sperm; sperm rapid; uro; urology,Qn
106261-1,us guidance for aspiration of knee - left,us guided knee-l asp,,asp; document; echography; ext; extr-l; finding; findings; guid; guide; guided; imaging; kn; knee-l; l; le; leg; le-l; lle; low; lower extremity joint; lt; point in time; radiology; random; sonogram; sonograph; sonography; uls; ultrasound,Doc
106265-2,us guidance for biopsy of tibia and fibula - left,us guided tib+fib-l bx,,bx; document; echography; ext; extr-l; finding; findings; guid; guide; guided; imaging; l; le; leg; le-l; lle; low; lt; point in time; radiology; random; sonogram; sonograph; sonography; tib+fib-l; tib-l; uls; ultrasound,Doc
106280-1,us seminal vesicle,us sem vesicle,,document; echography; finding; findings; imaging; pelvic; point in time; radiology; random; sem vesicle; sonogram; sonograph; sonography; uls; ultrasound,Doc
106302-3,pt prostate,pt prostate w rnc iv,,document; finding; findings; imaging; pelvic; pet scan; point in time; position emmision tomography; positron emission tomography; prost; prostatic; radiology; radnuc.pet; random; rn; rnc; scan; w rnc iv,Doc
106319-7,us guidance for aspiration of elbow - bilateral,us guided elbow-bl asp,,arm; asp; bil; bilat; both; document; echography; elbow-bl; ext; extr-bl; finding; findings; guid; guide; guided; imaging; olecranon; point in time; radiology; random; sonogram; sonograph; sonography; ue; ue-bl; uls; ultrasound; up; upper extremity joint,Doc
106324-7,us forearm - left,us forearm-l,,arm; document; echography; ext; extr-l; finding; findings; forearm-l; imaging; l; lt; lue; point in time; radiology; random; sonogram; sonograph; sonography; ue; ue-l; ulna; uls; ultrasound; up; upper extremity,Doc
106332-0,us guidance for fna of clavicle - left,us guided clavicle-l fna,,asp; clavicle-l; document; echography; finding; findings; fna; guid; guide; guided; imaging; l; lt; ndl; point in time; radiology; random; sonogram; sonograph; sonography; thorax; uls; ultrasound; upper extremity,Doc
10637-7,microscopic observation [identifier] in tissue by night blue stain,night blue stain tiss,microscopic observation night blue stain nom (tiss),"id; identity or presence; infectious disease; infectiousdisease; microbiology; nite blue stain; nominal; point in time; random; st; stains; stn; tissue; tissue, unspecified",Nom
106378-3,has stolen things that have value,,,finding; findings; ordinal; ql; qual; qualitative; screen; survey; survey.nichq,Ord
106387-4,"is fearful, anxious, or worried",,,finding; findings; ordinal; ql; qual; qualitative; screen; survey; survey.nichq,Ord
106389-0,feels worthless or inferior,,,finding; findings; inf; ordinal; ql; qual; qualitative; screen; survey; survey.nichq,Ord
106392-4,"is sad, unhappy, or depressed",,,finding; findings; ordinal; ql; qual; qualitative; screen; survey; survey.nichq,Ord
106404-7,inattention and hyperactivity or impulsivity score,,,qnt; quan; quant; quantitative; scale; survey; survey.nichq,Qn
106417-9,phenibut [mass/volume] in urine by confirmatory method,phenibut ur cfm-mcnc,phenibut confirm (u) [mass/vol],beta-phenyl-gaba; cfm; cnfr; cnfrm; conf; confirmation; confirmatory; drug/toxicology; drugs; gcms; lc/ms/ms; level; mass concentration; point in time; qnt; quan; quant; quantitative; random; ua; ur; urn,Qn
106421-1,total score [three-item loneliness scale],,,3; point in time; qnt; quan; quant; quantitative; random; scale; survey; tot; totl,Qn
106422-9,6-item transportation security index total score [tsi-6],,,qnt; quan; quant; quantitative; scale; survey; tot; totl,Qn
106506-9,opiates panel - urine by lc/ms/ms,opiates pnl ur lc/ms/ms,opiates panel lc/ms/ms (u),drug/toxicology; drugs; heroin; op; opi; opiate; opiates pnl; pan; panel.drug & toxicology; panl; pnl; point in time; random; ua; ur; urn,-
106510-1,is mother of advanced age qualitative,mother age patient ql,is mother of advanced age ql,finding; findings; misc; mother age; ordinal; point in time; ql; qual; qualitative; random; screen,Ord
106513-5,annual salt bush ige ab [units/volume] in serum or plasma by immunoassay,annual salt bush ige qn ia,annual salt bush ige ia qn,abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; eia; elfa; elisa; enzyme immunoassay; iaa; immune globulin e; immunoglobulin e; meia; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; suds,Qn
106525-9,outcome and assessment information set (oasis) form - version e1 - resumption of care during assessment period [cms assessment],,,centers for medicare and medicaid assessment; form version; oasis roc ve1; oasis ve1; outcome and assessment information set; pan; panel; panel.survey.cms; panl; pnl; report period; survey,-
106531-7,cabozantinib [mass/volume] in serum or plasma by lc/ms/ms --trough,cabozantinib trough serpl lc/ms/ms-mcnc,cabozantinib trough lc/ms/ms [mass/vol],cometriq; drug/toxicology; drugs; level; mass concentration; pl; plasma; plsm; point in time; pre; predose; pre-dose; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
106544-0,10-hydroxycarbazepine [mass] of dose,10oh-carbazepine dose,10-hydroxycarbazepine (dose) [mass],"10,11-dihydro-10-hydroxycarbamazepine; 10-hydroxy carbazepine; 10-hydroxycarbamazepine; 10-monohydroxyoxcarbazepine; 10-oh-carbazepine; 10oh-carbazepine; dose med or substance; drug doses; licarbazepine; oxcarbazepine metabolite; point in time; qnt; quan; quant; quantitative; random",Qn
106550-7,clostridioides difficile toxin b dna [presence] in stool by naa with probe detection,c diff tox b dna stl ql naa+probe,c. difficile toxin b dna naa+probe ql (stl),3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; bowel movement; c diff; c diff tox; c diff tox b; c diff tox b dna; c difficile; clostridium difficile; deoxyribonucleic acid; dna nucleic acid probe; dna probe; faecal; faeces; fecal; feces; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; naa+probe; naat; nasba; nucleic acid sequence based analysis; ordinal; pcr; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; screen; sda; stl; stool = fecal; strand displacement amplification; tma; transcription mediated amplification,Ord
106553-1,shigella species+eiec dna [presence] in stool by naa with probe detection,shigella sp+eiec dna stl ql naa+probe,shigella species+eiec dna naa+probe ql (stl),3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; bowel movement; deoxyribonucleic acid; dna nucleic acid probe; dna probe; faecal; faeces; fecal; feces; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; naa+probe; naat; nasba; nucleic acid sequence based analysis; ordinal; pcr; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; screen; sda; shigella sp+eiec; shigella sp+eiec dna; shigellosis; stl; stool = fecal; strand displacement amplification; tma; transcription mediated amplification,Ord
106566-3,mycoplasma hominis dna [presence] in throat by naa with probe detection,m hominis dna throat ql naa+probe,m. hominis dna naa+probe ql (throat),3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; deoxyribonucleic acid; dna nucleic acid probe; dna probe; lat; lcr; ligase chain reaction; ligation-activated transcription; m hominis; metamycoplasma hominis; microbiology; myco; mycoplas; mycoplasm; mycoplasmosis; mycoplsm; naa+probe; naat; nasba; nucleic acid sequence based analysis; ordinal; pcr; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; screen; sda; strand displacement amplification; throat; tma; transcription mediated amplification; upper respiratory,Ord
106586-1,candida parapsilosis dna [presence] in body fluid by naa with non-probe detection,c parap dna fld ql naa+non-probe,c. parapsilosis dna naa+non-probe ql (body fld),"3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; b/f; bf; bod; bodies; body fluid; body fluid, unsp; c parap; cand; candidiasis; deoxyribonucleic acid; dna nucleic acid probe; dna probe; fl; fld; flu; fluid; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; naa+non-probe; naa+probe; naat; nasba; nucleic acid sequence based analysis; ordinal; pcr; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; screen; sda; strand displacement amplification; tma; transcription mediated amplification",Ord
10659-1,cyclospora sp identified in stool by acid fast stain,cyclospora stl acid fast stn,cyclospora sp identified acid fast stain nom (stl),acd; acid fast stn; acids; afb stain; bowel movement; cyclo; cyclosporiasis; faecal; faeces; fecal; feces; id; identity or presence; infectious disease; infectiousdisease; microbiology; nominal; point in time; random; species; spp; st; stains; stl; stn; stool = fecal,Nom
106596-0,klebsiella oxytoca dna [presence] in body fluid by naa with non-probe detection,k oxytoca dna fld ql naa+non-probe,k. oxytoca dna naa+non-probe ql (body fld),"3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; b/f; bf; bod; bodies; body fluid; body fluid, unsp; deoxyribonucleic acid; dna nucleic acid probe; dna probe; fl; fld; flu; fluid; k oxytoca; k oxytoca dna; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; naa+non-probe; naa+probe; naat; nasba; nucleic acid sequence based analysis; ordinal; pcr; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; screen; sda; strand displacement amplification; tma; transcription mediated amplification",Ord
106599-4,neisseria meningitidis dna [presence] in body fluid by naa with non-probe detection,n men dna fld ql naa+non-probe,n. meningitidis dna naa+non-probe ql (body fld),"3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; b/f; bf; bod; bodies; body fluid; body fluid, unsp; deoxyribonucleic acid; dna nucleic acid probe; dna probe; fl; fld; flu; fluid; lat; lcr; ligase chain reaction; ligation-activated transcription; mening; meningid; meningitis; meningo; meningococcal meningitis; meningococcus; microbiology; n men; n menigitidis; n meningitidis; naa+non-probe; naa+probe; naat; nasba; nucleic acid sequence based analysis; ordinal; pcr; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; screen; sda; strand displacement amplification; tma; transcription mediated amplification",Ord
106601-8,pseudomonas aeruginosa dna [presence] in body fluid by naa with non-probe detection,p aeruginosa dna fld ql naa+non-probe,p. aeruginosa dna naa+non-probe ql (body fld),"3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; b/f; bf; bod; bodies; body fluid; body fluid, unsp; deoxyribonucleic acid; dna nucleic acid probe; dna probe; fl; fld; flu; fluid; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; naa+non-probe; naa+probe; naat; nasba; nucleic acid sequence based analysis; ordinal; p aeruginosa; pcr; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; screen; sda; strand displacement amplification; tma; transcription mediated amplification",Ord
106611-7,salmonella sp dna [presence] in body fluid by naa with non-probe detection,salmonella dna fld ql naa+non-probe,salmonella sp dna naa+non-probe ql (body fld),"3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; b/f; bf; bod; bodies; body fluid; body fluid, unsp; deoxyribonucleic acid; dna nucleic acid probe; dna probe; fl; fld; flu; fluid; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; naa+non-probe; naa+probe; naat; nasba; nucleic acid sequence based analysis; ordinal; pcr; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; sal; salmonel; screen; sda; species; spp; strand displacement amplification; tma; transcription mediated amplification",Ord
106614-1,infectious pathogens panel - body fluid by naa with non-probe detection,infectious path pnl fld naa+non-probe,infectious pathogens panel naa+non-probe (body fld),"3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; b/f; bf; bod; bodies; body fluid; body fluid, unsp; dna nucleic acid probe; dna probe; fl; fld; flu; fluid; infectious path pnl; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; naa+non-probe; naa+probe; naat; nasba; nucleic acid sequence based analysis; pan; panel.microbiology; panl; pcr; pnl; point in time; polymerase chain reaction; probe amp; probe with ampification; probe with target amplification; qbr; random; sda; strand displacement amplification; tma; transcription mediated amplification",-
106624-0,hospice outcomes and patient evaluation (hope) v1.0 during assessment period [cms assessment],,,assessment; centers for medicare and medicaid assessment; eval; h&p; history and physical; hope v1.0; pan; panel; panel.survey.cms; panl; pnl; report period; survey,-
106629-9,alcohol consumption environment,alcohol consumption envir,,alc; alcoholic; clin; clin.risk; finding; findings; nominal; point in time; random,Nom
106632-3,patient zip code during assessment period [cms assessment],,,centers for medicare and medicaid assessment; location; nominal; report period; survey,Nom
106679-4,treatment for shortness of breath during assessment period [cms assessment],,,centers for medicare and medicaid assessment; pan; panel; panel.survey.cms; panl; pnl; report period; survey; tx,-
106693-5,symptom impact - diarrhea during assessment period [cms assessment],,,centers for medicare and medicaid assessment; finding; findings; ordinal; ql; qual; qualitative; report period; screen; survey; sx,Ord
106713-1,was a bowel regimen initiated or continued during assessment period [cms assessment],,,centers for medicare and medicaid assessment; finding; findings; ordinal; ql; qual; qualitative; report period; screen; survey,Ord
106718-0,scheduled opioid during assessment period [cms assessment],,,centers for medicare and medicaid assessment; pan; panel; panel.survey.cms; panl; pnl; report period; survey,-
106720-6,date scheduled opioid initiated or continued during assessment period [cms assessment],,,centers for medicare and medicaid assessment; qnt; quan; quant; quantitative; report period; survey,Qn
106723-0,month of first prenatal care visit [time],m first prenatal care visit time,,m first prenatal care visit; obgyn; point in time; qnt; quan; quant; quantitative; random,Qn
106774-3,"24,25-dihydroxyvitamin d3+24,25-dihydroxyvitamin d2 [moles/volume] in serum or plasma","24,25(oh)2 vitd serpl-scnc","24,25-dihydroxyvitamin d3+24,25-dihydroxyvitamin d2 [moles/vol]","24(r),25-dihydroxycholecalciferol; 24,25(oh)2 vitd; 24,25-dihydroxy cholecalciferol; 24,25-dihydroxy vitamin d; 24,25-dihydroxyvitamin d; 24,25-dihydroxyvitamin d2 +24,25-dihydroxyvitamin d3; 24r-hydroxy calcidiol; 24r-oh-calcidiol; chemistry; hydroxy calcidiol; level; oh-calcidiol; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; substance concentration",Qn
10678-1,herpes simplex virus 1+2 ag [presence] in tissue by immune stain,hsv1+2 ag tiss ql imstn,hsv 1+2 ag immune stain ql (tiss),"antigen; antigens; herp splx; herpes simplex virus type 1; herpes simplex virus type 1+2; herpes simplex virus type i+ii; hsv; hsv 1+2; hsv1; hsv1+2; i; id; ihc; ii; imm; immunohistochemical stain; immunostain; imstn; imun; imune; infectious disease; infectiousdisease; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; screen; st; stains; stn; tissue; tissue, unspecified",Ord
106805-5,eye pupillary response swinging light test,eye pupillary resp slt,,eye.px; eyeball; finding; findings; nominal; occular; oculis; ophthalmologic; optic globe; point in time; random; slt; swinging-flashlight test; vision; visual,Nom
106863-4,coxsackievirus iga ab [units/volume] in serum by immunoassay,cv iga ser ia-acnc,coxsackievirus iga ia qn (s),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; cav; coxsackie; coxsackie virus; cv; cv ab.iga; eia; elfa; elisa; enzyme immunoassay; iaa; immune globulin a; immunoglobulin a; meia; microbiology; point in time; qnt; quan; quant; quantitative; random; serum; sr; suds,Qn
106916-0,basophils/cells in bronchoalveolar lavage,basophils nfr bal,basophils/cells (bal),baso; basophil; basos; bph; bronchial alveolar lavage; bronchoalveolar lavage; cell; cellularity; hematology/cell counts; number fraction; percent; point in time; qnt; quan; quant; quantitative; random,Qn
106925-1,intimate partner violence 4 [ipv-4],,,pan; panel; panel.survey.mtlhlth; panl; pnl; survey; survey.mtlhlth,-
10696-3,norovirus [identifier] in stool by electron microscopy,norovirus stl em,norovirus em nom (stl),bowel movement; em; faecal; faeces; fecal; feces; gastro; gastroenterology; gi; human calcivirus; id; identity or presence; infectious disease; infectiousdisease; micro; microbiology; micros; microscopic; nominal; norwalk virus; point in time; random; stl; stool = fecal,Nom
106978-0,dienedione [presence] in urine by gas chromatography-mass spectrometry,dienedione ur ql gc-ms,dienedione gas chromatography-mass spectrometry ql (u),drug/toxicology; drugs; gas chromatography; ordinal; point in time; pr; ql; qual; qualitative; random; screen; ua; ur; urn,Ord
106984-8,extracellular matrix protein 1) [mass/volume] in semen by immunoassay,ecm1 smn ia-mcnc,extracellular matrix protein 1) ia (sem) [mass/vol],chemistry; ecm1; eia; ejaculate; elfa; elisa; enzyme immunoassay; i; iaa; level; mass concentration; meia; point in time; pr; prot; qnt; quan; quant; quantitative; random; sem; seminal fluid; smn; smpls; suds; urbwd,Qn
106993-9,6 alpha-methylandrostenedione [presence] in urine by gas chromatography-mass spectrometry,6 a-methylandro ur ql gc-ms,6 alpha-methylandrostenedione gas chromatography-mass spectrometry ql (u),6 a-methylandro; alfa; drug/toxicology; drugs; gas chromatography; ordinal; point in time; pr; ql; qual; qualitative; random; screen; ua; ur; urn,Ord
10699-7,onchocerca sp identified in tissue by wet preparation,onchocerca tiss wet prep,onchocerca sp identified wet prep nom (tiss),"filariasis; id; identity or presence; infectious disease; infectiousdisease; microbiology; nominal; point in time; prep; random; river blindness; species; spp; tissue; tissue, unspecified; wet mount; wet prep",Nom
10700-3,orthopoxvirus [identifier] in skin by electron microscopy,orthopoxvirus skin em,orthopoxvirus em nom (skin),dermatologic; em; epidermis; id; identity or presence; infectious disease; infectiousdisease; integument; micro; microbiology; micros; microscopic; nominal; orthopox virus; point in time; random; skn,Nom
10701-1,ova and parasites identified in stool by concentration,o+p stl conc,ova and parasites identified concentration nom (stl),bowel movement; cnc; conc; faecal; faeces; fecal; feces; gastro; gastroenterology; gi; id; identity or presence; infectious disease; infectiousdisease; microbiology; nominal; o&p; o+p; ova and parasite; ovum; parasite; point in time; random; stl; stool = fecal; universallaborders,Nom
10705-2,human papilloma virus ag [presence] in tissue by immune stain,hpv ag tiss ql imstn,hpv ag immune stain ql (tiss),"antigen; antigens; genital warts; hpv; human papillomavirus; id; ihc; imm; immunohistochemical stain; immunostain; imstn; imun; imune; infectious disease; infectiousdisease; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; screen; st; stains; stn; tissue; tissue, unspecified",Ord
10708-6,toxic plant identified in vomitus by light microscopy,toxic plant vom micro,toxic plant identified lm nom (vomitus),identity or presence; lm; micro; microbiology; micros; microscopic; nominal; point in time; random; regurgitation; toxic plant; vom; vomitus,Nom
107095-2,medical device description panel,medical device description panel,,admin; pan; panel.admin; panl; pnl; point in time; random,-
107097-8,medical device description narrative,medical device description,,admin; finding; findings; narrative; point in time; random; report,Nar
1071-0,jk sup(a) ag [presence] on red blood cells from donor,jk sup(a) ag rbc donr ql,jk sup(a) ag ql (rbc donor),antigen; antigens; blood bank; donr; erythrocytes; hematology; heme; j (little k) (little a); jk sup(a); jk^a; k; kidd blood group system; ordinal; point in time; pr; ql; qual; qualitative; random; red blood cells; red blood corpusles; screen,Ord
107101-8,billing encounter information,billing encounter information,,admin; pan; panel; panel.admin; panl; pnl; point in time; random,-
107118-2,waveform digits series narrative,waveform digits series,,admin; finding; findings; narrative; point in time; random; report,Nar
107129-9,level of exertion information panel,level of exertion information panel,,admin; levels; levl; lv; lvl; pan; panel.admin; panl; pnl; point in time; random,-
10713-6,prototheca identified in specimen by culture,prototheca spec cult,prototheca identified cx nom (specimen),c&s; cult; cultures; id; identity or presence; infectious disease; infectiousdisease; microbiology; misc; miscellaneous; nominal; other; point in time; random; spec; to be specified in another part of the message; unspecified,Nom
107137-2,general identifier,general identifier,,admin; ident; identifier; nominal; point in time; random,Nom
107151-3,inspired oxygen information panel,inspired oxygen information panel,,admin; o2; pan; panel.admin; panl; pnl; point in time; random; to2,-
107177-8,mycobacterium sp identified in skin by organism specific culture,mycobacterium skin cult,mycobacterium sp identified org specific cx nom (skin),acid fast; acid fast bacilli; acid fast bacillus; afb; c&s; cult; cultures; dermatologic; epidermis; identity or presence; integument; microbiology; myco; mycobact; nominal; point in time; random; skn; spec; species; spp; tuberculosis,Nom
10718-5,strongyloides sp ab [units/volume] in serum by immunoassay,strongyloides ab ser ia-acnc,strongyloides sp ab ia qn (s),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; eia; elfa; elisa; enzyme immunoassay; iaa; id; infectious disease; infectiousdisease; meia; microbiology; point in time; qnt; quan; quant; quantitative; random; serum; species; spp; sr; strongyloidiasis; suds,Qn
107190-1,hemoglobin.gastrointestinal [mass/volume] in stool --2nd specimen,hemoccult sp2 stl-mcnc,hemoglobin.gastrointestinal spec 2 (stl) [mass/vol],bowel movement; convalescent; faecal; faeces; fecal; fecal occult blood; feces; fob; gastrocult; gastrointest blood; gi; guiac; haemoglobin; hb; hematology/cell counts; hemoccult; hemocult; hgb; level; mass concentration; occult blood; occult blood in stool; point in time; post immunization; qnt; quan; quant; quantitative; random; second; sp2; spec; stl; stool = fecal,Qn
107203-2,tcrb tube gene a length in base pairs [#] in specimen by molecular genetics method,tcrb tube gene a spec,tcrb tube gene a length in base pairs molgen (specimen) [#],cnt; count; len; misc; miscellaneous; molecular genetics; molecular pathology; molpath; molpath.rearrangements; number; other; pcr; point in time; qnt; quan; quant; quantitative; random; spec; to be specified in another part of the message; unspecified,Qn
107228-9,amlodipine [presence] in urine,amlodipine ur ql,amlodipine ql (u),am; drug/toxicology; drugs; norvasc; ordinal; point in time; pr; ql; qual; qualitative; random; screen; ua; ur; urn,Ord
107232-1,ankle - left circumference,ankle-l circumf,,ankle-l; body circumference.molec; ext; extr-l; girth; l; le; leg; le-l; length; lle; low; lower extremity joint; lt; point in time; qnt; quan; quant; quantitative; random,Qn
107251-1,asxl1 gene mutations found [identifier] in blood or tissue by sequencing nominal,asxl1 gene mut anl bld/t seq,asxl1 gene targeted mutation analysis sequencing nom (bld/tiss),"additional sex combs like 1, transcriptional regulator; blood; bops; high-throughput sequencing; hts; identity or presence; molecular pathology; molpath; molpath.mutations; mut; mut anl; mutations; next generation sequencing; ngs; nominal; point in time; random; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",Nom
107271-9,xr and rf wrist - right views,xr and flr wrist-r views,,arm; carpal bone; carpal bones; carpal bones and joint; document; ext; extr-r; films; finding; findings; fluor; fluoro; fluoroscopy; imaging; plain films; point in time; r; radiology; random; rt; rue; ue; ue-r; up; upper extremity joint; view; vws; wrist-r; xr and flr; xray; x-ray,Doc
107274-3,guidance for exchange of central venous catheter of unspecified body region,rf guided guidance for exchange of cvc,,cath; change; document; finding; findings; fluor; fluoro; fluoroscopy; guid; guidance for exchange; guidance for exchange of cvc; guide; guided; imaging; misc; miscellaneous; other; point in time; radiology; random; replace; spec; to be specified in another part of the message; unspecified,Doc
1072-8,jk sup(a) ag [presence] on red blood cells,jk sup(a) ag rbc ql,jk sup(a) ag ql (rbc),antigen; antigens; blood bank; erythrocytes; hematology; heme; j (little k) (little a); jk sup(a); jk^a; k; kidd blood group system; ordinal; point in time; pr; ql; qual; qualitative; random; red blood cells; red blood corpusles; screen,Ord
107284-2,busulfan area under the curve [auc] in plasma,busulfan auc plas-auc,busulfan area under the curve (stdy p) [auc],auc; busulfan auc; drug/toxicology; drugs; myleran; pl; plasma; plsm; qnt; quan; quant; quantitative; studies; study; sutdies,Qn
107-3,cefotaxime [susceptibility] by minimum lethal concentration (mlc),cefotaxime islt mlc,cefotaxime mlc [susc],antibiotic susceptibilities; ast; claforan; id; infectious disease; infectiousdisease; islt; isol; mbc; minimum bactericidal concentration; minimum lethal concentration; point in time; qnt; quan; quant; quantitative; random; sus; suscept; susceptibilities; susceptibility; susceptibilty,Qn
10730-0,trypanosoma sp identified in blood by organism specific culture,trypanos bld cult,trypanosoma sp identified org specific cx nom (bld),blood; c&s; chagas disease; cult; cultures; id; identity or presence; infectious disease; infectiousdisease; microbiology; nominal; point in time; random; sleeping sickness; spec; species; spp; trypanosomiasis; trypanosomosis; trypanosomosis (tse-tse borne); wb; whole blood,Nom
107303-0,rf guidance for embolization of unspecified body region,rf guided embol,,document; finding; findings; fluor; fluoro; fluoroscopy; guid; guide; guided; imaging; misc; miscellaneous; other; point in time; radiology; random; spec; to be specified in another part of the message; unspecified,Doc
10731-8,trypanosoma sp identified in blood by thick film,trypanos bld thick film,trypanosoma sp identified thick film nom (bld),blood; chagas disease; id; identity or presence; infectious disease; infectiousdisease; microbiology; nominal; point in time; random; sleeping sickness; species; spp; trypanosomiasis; trypanosomosis; trypanosomosis (tse-tse borne); wb; whole blood,Nom
107332-9,goal attainment scale - reported,goal attainment scale reported,,clin; clin.risk; pan; panel; panel.clinical; panl; pnl; point in time; random,-
10733-4,trypanosoma sp identified in blood by wet preparation,trypanos bld wet prep,trypanosoma sp identified wet prep nom (bld),blood; chagas disease; id; identity or presence; infectious disease; infectiousdisease; microbiology; nominal; point in time; prep; random; sleeping sickness; species; spp; trypanosomiasis; trypanosomosis; trypanosomosis (tse-tse borne); wb; wet mount; wet prep; whole blood,Nom
107335-2,promis emotional distress anxiety version 1.0 raw score,,,patient reported outcomes information system; point in time; promis emotion dist anxi 1.0 raw score; promise; qnt; quan; quant; quantitative; random; scale; survey; survey.promis,Qn
107337-8,amikacin [susceptibility] liposome inhaled breakpoints by minimum inhibitory concentration (mic),amikacin liposome inhaled brkpnts mic,amikacin liposome inhaled breakpoints mic [susc],amikin; aminoglycosides; antibiotic susceptibilities; ast; islt; isol; minimum inhibitory concentration; point in time; random; sus; suscept; susceptibilities; susceptibility; susceptibilty,OrdQn
107341-0,buprenorphine [presence] in hair,buprenorphine hair ql,buprenorphine ql (hair),bu; bup; bupe; buprenex; buprenorphine hci; buprex; butrans; drug/toxicology; drugs; finobrin; har; norspan; ordinal; point in time; pr; prefin; ql; qual; qualitative; random; screen; suboxone; subutex; temgesic,Ord
10734-2,varicella zoster virus identified in skin by electron microscopy,vzv skin em,vzv identified em nom (skin),chicken pox; chicken pox virus; chickenpox; dermatologic; em; epidermis; herpes zoster; hhv-3; human herpesvirus 3; id; identity or presence; infectious disease; infectiousdisease; integument; micro; microbiology; micros; microscopic; nominal; point in time; random; shingles; skn; vz; vzv; zoster,Nom
107344-4,influenza virus a+b rna [presence] in nasopharynx by naa with probe detection,fluav+flubv rna nph ql naa+probe,fluav+flubv rna naa+probe ql (nph),"3 self-sustaining sequence replication; 3sr sr; a,b; amplif; amplification; amplified; avian influenza; bird flu; dna nucleic acid probe; dna probe; flua; fluav; fluav + flubv; fluav+flubv; fluv; fowl plague; influ; influenza a; influenza a virus; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; naa+probe; naat; nasba; nasopharynx; nucleic acid sequence based analysis; ordinal; pcr; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; ribonucleic acid; screen; sda; strand displacement amplification; tma; transcription mediated amplification",Ord
107356-8,bordetella pertussis dna [presence] in bronchial specimen by naa with probe detection,b pert dna bronch ql naa+probe,b. pertussis dna naa+probe ql (bronch spec),3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; b pert; b pertussis; bro; deoxyribonucleic acid; dna nucleic acid probe; dna probe; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; naa+probe; naat; nasba; nucleic acid sequence based analysis; ordinal; pcr; pertussis; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; screen; sda; strand displacement amplification; tma; transcription mediated amplification; whooping cough,Ord
107361-8,adenovirus dna [presence] in bronchoalveolar lavage by naa with non-probe detection,hadv dna bal ql naa+non-probe,adenovirus dna naa+non-probe ql (bal),3 self-sustaining sequence replication; 3sr sr; adeno virus; amplif; amplification; amplified; bronchial alveolar lavage; bronchoalveolar lavage; deoxyribonucleic acid; dna nucleic acid probe; dna probe; hadv; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; naa+non-probe; naa+probe; naat; nasba; nucleic acid sequence based analysis; ordinal; pcr; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; screen; sda; strand displacement amplification; tma; transcription mediated amplification,Ord
107362-6,adenovirus dna [presence] in sputum by naa with non-probe detection,hadv dna spt ql naa+non-probe,adenovirus dna naa+non-probe ql (sput),3 self-sustaining sequence replication; 3sr sr; adeno virus; amplif; amplification; amplified; deoxyribonucleic acid; dna nucleic acid probe; dna probe; hadv; lat; lcr; ligase chain reaction; ligation-activated transcription; lower respiratory; microbiology; naa+non-probe; naa+probe; naat; nasba; nucleic acid sequence based analysis; ordinal; pcr; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; screen; sda; spt; sputum; strand displacement amplification; tma; transcription mediated amplification,Ord
1074-4,jk sup(b) ab [presence] in serum or plasma from donor,jk sup(b) ab serpl donr ql,jk sup(b) ab ql (s/p donor),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; blood bank; donr; j (little k) (little b); jk sup(b); jk^b; k; kell blood group system; kidd blood group system; ordinal; pl; plasma; plsm; point in time; pr; ql; qual; qualitative; random; screen; serp; serpl; serplas; serum; serum or plasma; sr,Ord
10749-0,collagen fibers.microscopic observation [identifier] in tissue by van gieson stain,collagen tiss vg stn,collagen fibers.microscopic observation van gieson stain nom (tiss),"fiber; identity or presence; nominal; pathology; point in time; random; st; stains; stn; tissue; tissue, unspecified; vg stain; vg stn",Nom
10754-0,fat.microscopic observation [identifier] in tissue by sudan iv stain,fat tiss sudan iv stn,fat.microscopic observation sudan iv stain nom (tiss),"identity or presence; nominal; pathology; point in time; random; st; stains; stn; sudan iv stn; sudn; tissue; tissue, unspecified",Nom
10760-7,iron.microscopic observation [identifier] in tissue by gomori stain,iron tiss gomori stn,iron.microscopic observation gomori stain nom (tiss),"fe; gomori stn; identity or presence; nominal; pathology; point in time; random; st; stains; stn; tissue; tissue, unspecified",Nom
10769-8,microscopic observation [identifier] in tissue by alizarin red s stain,ar-s stn tiss,microscopic observation alizarin red s stain nom (tiss),"ar-s stn; identity or presence; nominal; pathology; point in time; random; s prime; st; stains; stn; tissue; tissue, unspecified",Nom
10776-3,microscopic observation [identifier] in tissue by bodian stain,bodian stn tiss,microscopic observation bodian stain nom (tiss),"bodian stn; identity or presence; nominal; pathology; point in time; random; st; stains; stn; tissue; tissue, unspecified",Nom
10780-5,microscopic observation [identifier] in tissue by chloracetate esterase stain,cae stn tiss,microscopic observation chloracetate esterase stain nom (tiss),"cae; cae stn; identity or presence; naphtol as-d chloracetate esterase stain; nominal; pathology; point in time; random; specific esterase stain; st; stains; stn; tissue; tissue, unspecified",Nom
10784-7,microscopic observation [identifier] in tissue by esterase stain.non-specific,nse stn tiss,microscopic observation esterase stain.non-specific nom (tiss),"identity or presence; nominal; nse; nse stn; pathology; point in time; random; spec; st; stains; stn; tissue; tissue, unspecified",Nom
10789-6,microscopic observation [identifier] in tissue by hematoxylin-eosin-harris regressive stain,h+e stn harris regr tiss,microscopic observation hematoxylin-eosin-harris regressive stain nom (tiss),"h+e stn harris regr; identity or presence; nominal; pathology; point in time; random; st; stains; stn; tissue; tissue, unspecified",Nom
10796-1,microscopic observation [identifier] in tissue by mucicarmine stain,mucicarm stn tiss,microscopic observation mucicarmine stain nom (tiss),"identity or presence; mucicarm stn; nominal; pathology; point in time; random; st; stains; stn; tissue; tissue, unspecified",Nom
10802-7,microscopic observation [identifier] in tissue by prussian blue stain,prus bl st tiss,microscopic observation prussian blue stain nom (tiss),"identity or presence; nominal; pathology; point in time; prus bl st; random; st; stains; stn; tissue; tissue, unspecified",Nom
10842-3,deprecated hla-dq1 [presence],deprecated hla-dq1 ql,hla-dq1 ql (bld/tiss),"arbitrary concentration; blood; genetics; heredity; heritable; hla antigen; human leukocyte antigen; inherited; ordinal; point in time; ql; qual; qualitative; random; screen; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",Ord
10863-9,endomysium iga ab [titer] in serum,endomysium iga titr ser,endomysium iga (s) [titer],abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; dilution factor; dilution factor (titer); ema; endomysial; gastro; gastroenterology; gi; immune globulin a; immunoglobulin a; point in time; random; serology; serum; smqn; sr; titer; titered; titre; transglutaminase; ttr; universallaborders,SemiQn
10867-0,sulfatide igm ab [titer] in serum,sulfatide igm titr ser,sulfatide igm (s) [titer],abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; dilution factor; dilution factor (titer); immune globulin m; immunoglobulin m; point in time; random; serology; serum; smqn; sr; titer; titered; titre; ttr,SemiQn
1086-8,js sup(b) ab [presence] in serum or plasma from donor,js sup(b) ab serpl donr ql,js sup(b) ab ql (s/p donor),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; blood bank; donr; j (little s) (little b); js sup(b); js^b; kell blood group system; ordinal; pl; plasma; plsm; point in time; pr; ql; qual; qualitative; random; s; s prime; screen; serp; serpl; serplas; serum; serum or plasma; sr,Ord
10890-2,deprecated normethsuximide [mass/volume] in serum or plasma,deprecated normethsuximide ser-mcnc,normethsuximide (s) [mass/vol],desmeth; desmethylmethsuximide; dmms; drug/toxicology; drugs; level; mass concentration; methsuximide metabolite; point in time; qnt; quan; quant; quantitative; random; serum; sr; suximide metabolite,Qn
1093-4,k ab [presence] in serum or plasma,k ab serpl ql,k ab ql,abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; blood bank; kell blood group system; ordinal; pl; plasma; plsm; point in time; pr; ql; qual; qualitative; random; screen; serp; serpl; serplas; serum; serum or plasma; sr,Ord
10939-7,whiff ige ab [units/volume] in serum,whiff ige qn,whiff ige qn (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; f311; immune globulin e; immunoglobulin e; megrim; point in time; qnt; quan; quant; quantitative; random; rf311; serum; sr; whiff; white sole,Qn
10955-3,long leaf pine ige ab [units/volume] in serum,long leaf pine ige qn,long leaf pine ige qn (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; immune globulin e; immunoglobulin e; long leaf pine; longleaf pine; point in time; qnt; quan; quant; quantitative; random; serum; sr,Qn
10969-4,cystine+homocysteine [presence] in urine,cys+hcys ur ql,cystine+homocysteine ql (u),chemistry; cys+hcys; cys-cys; dicysteine; hcy; hcys; hcyst; homocyst(e)ine; ordinal; point in time; pr; ql; qual; qualitative; random; screen; ua; ur; urn,Ord
10981-9,clonidine [mass/volume] in urine,clonidine ur-mcnc,clonidine (u) [mass/vol],addiction; catapres; drug/toxicology; drugs; drugs of abuse; illicit; level; mass concentration; point in time; potentialforabuse; qnt; quan; quant; quantitative; random; ua; ur; urn,Qn
11024-7,benzodiazepines [mass/volume] in serum or plasma,benzodiaz serpl-mcnc,benzodiazepines [mass/vol],benz; benzodiaz; benzodiazepine; drug/toxicology; drugs; level; mass concentration; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
11025-4,methadone [mass/volume] in meconium,methadone mec-mcnc,methadone (mec) [mass/vol],addiction; dolophin; dolophine; drug/toxicology; drugs; drugs of abuse; illicit; level; mass concentration; mec; metd; methadose; mtd; point in time; potentialforabuse; qnt; quan; quant; quantitative; random,Qn
11033-8,thyrotropin [mass/volume] in serum or plasma --45 minutes post dose trh iv,tsh 45m p trh iv serpl-mcnc,tsh 45 min post dose trh iv [mass/vol],45m p trh iv; after; chemistry.challenge testing; endocrine; endocrinology; level; mass concentration; p dose; p trh; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; thyroid stimulating hormone; thyrotropic hormone; tsh,Qn
11049-4,deprecated hydroxyproline [mass/volume] in urine,deprecated oh-proline ur-mcnc,hydroxyproline (u) [mass/vol],chemistry; hydroxylproline; hydroxyprol; hydroxy-proline; hydrxprol; hydrxproln; hydrxyprln; hyp; level; mass concentration; ohpro; oh-proline; point in time; qnt; quan; quant; quantitative; random; ua; ur; urn,Qn
11053-6,lactate dehydrogenase [enzymatic activity/volume] in red blood cells,ldh rbc-ccnc,ldh (rbc) [catalytic activity/vol],2-hydroxypropanoic acid; 2-hydroxy-propionate; 2-hydroxy-propionic acid; catalytic concentration; chemistry; dehydrog; dehyrdogenase; erythrocytes; l.d.h; lact; lactic acid; lactic acid dehydrogenase; ld; ldh; l-lactate; l-lactate dehydrogenase; point in time; qnt; quan; quant; quantitative; random; red blood cells; red blood corpusles; tumor marker,Qn
11054-4,cholesterol in ldl/cholesterol in hdl [mass ratio] in serum or plasma,ldlc/hdlc serpl,cholesterol in ldl/cholesterol in hdl [mass ratio],cardio; cardiology; chemistry; chol; choles; cholest; cholesterol total; cholesterols; hdlc; hdl-c; heart disease; high density lipoprotein cholesterols; ldlc; ldl-c; lipid; low density lipoprotein cholesterol; low density lipoprotein cholesterols; mass concentration ratio; mass ratio; mcrto; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; tchhdl,Qn
11056-9,melatonin [flow] in 24 hour urine,melatonin 24h ur-vrate,melatonin (24h u) [vol/time],1 day; 24 hours; 24hr; chemistry; flow; qnt; quan; quant; quantitative; ua; ur; urn; volume rate; vrate,Qn
11058-5,phosphofructokinase [enzymatic activity/volume] in red blood cells,pfk rbc-ccnc,phosphofructokinase (rbc) [catalytic activity/vol],6-phosphofructokinase; catalytic concentration; chemistry; erythrocytes; pfk; phosphohexokinase; point in time; qnt; quan; quant; quantitative; random; red blood cells; red blood corpusles,Qn
11063-5,triosephosphate isomerase [enzymatic activity/volume] in red blood cells,tpi rbc-ccnc,triosephosphate isomerase (rbc) [catalytic activity/vol],catalytic concentration; chemistry; erythrocytes; isom; point in time; qnt; quan; quant; quantitative; random; red blood cells; red blood corpusles; tim; tpi; triose phosphate isomerase; triose phosphate mutase,Qn
1106-4,kp sup(b) ag [presence] on red blood cells from blood product unit,kp sup(b) ag rbc bpu ql,kp sup(b) ag ql (rbc bpu),antigen; antigens; blood bank; blood product unit; blood product unit (pack); erythrocytes; hematology; heme; k (little p) (little b); kell blood group system; kp sup(b); kp^b; ordinal; p; p prime; point in time; pr; ql; qual; qualitative; random; red blood cells; red blood corpusles; screen,Ord
1107-2,kp sup(b) ag [presence] on red blood cells from donor,kp sup(b) ag rbc donr ql,kp sup(b) ag ql (rbc donor),antigen; antigens; blood bank; donr; erythrocytes; hematology; heme; k (little p) (little b); kell blood group system; kp sup(b); kp^b; ordinal; p; p prime; point in time; pr; ql; qual; qualitative; random; red blood cells; red blood corpusles; screen,Ord
11074-2,norfentanyl [mass/volume] in serum or plasma,norfentanyl serpl-mcnc,norfentanyl [mass/vol],addiction; drug/toxicology; drugs; drugs of abuse; fentanyl metabolite; illicit; level; mass concentration; pl; plasma; plsm; point in time; potentialforabuse; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
11079-1,hiv 2 p26 ab [presence] in serum by immunoblot,hiv2 p26 ab ser ql ib,hiv 2 p26 ab ib ql (s),abs; aby; aids; antby; anti; antibodies; antibody; autoantibodies; autoantibody; blt; hiv type 2; hiv type ii; hiv2 p26; human immunodeficiency virus; id; ii; immune blot; immunobl; immunoblot; infectious disease; infectiousdisease; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; riba; screen; serum; sr; wb; wblot; west blot; west blt; western blot,Ord
1108-0,kp sup(b) ag [presence] on red blood cells,kp sup(b) ag rbc ql,kp sup(b) ag ql (rbc),antigen; antigens; blood bank; erythrocytes; hematology; heme; k (little p) (little b); kell blood group system; kp sup(b); kp^b; ordinal; p; p prime; point in time; pr; ql; qual; qualitative; random; red blood cells; red blood corpusles; screen,Ord
11092-4,barbiturates [mass/mass] in hair,barbiturates hair-mcnt,barbiturates (hair) [mass/mass],addiction; barb; barbiturate; barbs; drug/toxicology; drugs; drugs of abuse; har; illicit; mass content; point in time; potentialforabuse; qnt; quan; quant; quantitative; random,Qn
11098-1,malaoxon [mass/volume] in serum or plasma,malaoxon serpl-mcnc,malaoxon [mass/vol],drug/toxicology; drugs; level; malathion metabolite; mass concentration; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
11104-7,normoblasts basophilic/cells in bone marrow by manual count,baso normoblasts nfr mar manual,normoblasts basophilic/cells manual cnt (bm),baso normoblasts; basophilic erythroblast; bm; bon; bone marrow; cell; cellularity; erythroblast; erythroblasts; hematology/cell counts; immature erythrocytes; intermediate erythroblast; manl; mar; marrow (bone); mid erythroblast; minimal angle of resolution; minimum angle of resolution; normoblast; number fraction; percent; point in time; prorubricyte; qnt; quan; quant; quantitative; random,Qn
1111-4,le sup(a) ab [presence] in serum or plasma from donor,le sup(a) ab serpl donr ql,le sup(a) ab ql (s/p donor),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; blood bank; donr; e; l (little e); l (little e) (little a); le; le sup(a); le^a; left; levo; ordinal; pl; plasma; plsm; point in time; pr; ql; qual; qualitative; random; screen; serp; serpl; serplas; serum; serum or plasma; sr,Ord
11156-7,leukocyte morphology finding [identifier] in blood,wbc morph bld,leukocyte morphology finding nom (bld),blood; hematology/cell counts; identity or presence; leuc; leuk; leukocytes; lkcs; nominal; point in time; random; wb; wbc; wbc morph; wbcs; white blood cell; white blood cells; whole blood,Nom
1117-1,le sup(b) ab [presence] in serum or plasma from donor,le sup(b) ab serpl donr ql,le sup(b) ab ql (s/p donor),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; blood bank; donr; e; l (little e); l (little e) (little b); le; le sup(b); le^b; left; levo; ordinal; pl; plasma; plsm; point in time; pr; ql; qual; qualitative; random; screen; serp; serpl; serplas; serum; serum or plasma; sr,Ord
11175-7,helminthosporium sativum ige ab [units/volume] in serum,h sativum ige qn,helminthosporium sativum ige qn (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; drecshlera; h sativum; immune globulin e; immunoglobulin e; point in time; qnt; quan; quant; quantitative; random; serum; sr,Qn
11187-2,penicillium frequentans ige ab [units/volume] in serum,p frequentans ige qn,p. frequentans ige qn (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; immune globulin e; immunoglobulin e; m209; p frequentans; point in time; qnt; quan; quant; quantitative; random; rm209; serum; sr,Qn
11189-8,jalepeno pepper ige ab [units/volume] in serum,jalepeno pepper ige qn,jalepeno pepper ige qn (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; immune globulin e; immunoglobulin e; jalepeno pepper; point in time; qnt; quan; quant; quantitative; random; serum; sr,Qn
11195-5,rapeseed ige ab [units/volume] in serum,rapeseed ige qn,rapeseed ige qn (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; f316; immune globulin e; immunoglobulin e; point in time; qnt; quan; quant; quantitative; random; rape seed; rapeseed; rf316; serum; sr,Qn
11200-3,escargot ige ab [units/volume] in serum,escargot ige qn,escargot ige qn (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; escargot; f314; immune globulin e; immunoglobulin e; point in time; qnt; quan; quant; quantitative; random; rf314; serum; snail; sr,Qn
1120-5,le sup(b) ag [presence] on red blood cells from donor,le sup(b) ag rbc donr ql,le sup(b) ag ql (rbc donor),antigen; antigens; blood bank; donr; e; erythrocytes; hematology; heme; l (little e); l (little e) (little b); le; le sup(b); le^b; left; levo; ordinal; point in time; pr; ql; qual; qualitative; random; red blood cells; red blood corpusles; screen,Ord
11219-3,immunoglobulin light chains [presence] in serum,bj protein ser ql,immunoglobulin light chains ql (s),bence jones protein; bj protein; bjp; chain; chemistry; immune globulin; immuno; immunoglob; immunoglobin; imunoglbon; imunoglobn; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; sr,Ord
11223-5,deprecated phenolphthalein,deprecated phenolphthalein ur ql,phenolphthalein ql (u),drug/toxicology; drugs; level; mass concentration; ordinal; phenolthalein; point in time; ql; qual; qualitative; random; screen; ua; ur; urn,Ord
11230-0,amobarbital [mass/volume] in urine,amobarbital ur-mcnc,amobarbital (u) [mass/vol],addiction; amobarb; amylobarbitone; amytal; drug/toxicology; drugs; drugs of abuse; illicit; level; mass concentration; point in time; potentialforabuse; qnt; quan; quant; quantitative; random; ua; ur; urn,Qn
11238-3,hydroxyalprazolam [mass/volume] in urine,oh-alpraz ur-mcnc,hydroxyalprazolam (u) [mass/vol],drug/toxicology; drugs; hydroxy alprazolam; hydroxyalpraz; level; mass concentration; oh-alpraz; point in time; qnt; quan; quant; quantitative; random; ua; ur; urn,Qn
1125-4,le ab [presence] in serum or plasma from blood product unit,le ab serpl bpu ql,le ab ql (s/p bpu),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; blood bank; blood product unit; blood product unit (pack); e; l (little e); le; left; levo; ordinal; pl; plasma; plsm; point in time; pr; ql; qual; qualitative; random; rh blood group system; screen; serp; serpl; serpl^bpu; serplas; serum; serum or plasma; sr,Ord
1127-0,deprecated le nos ab [presence] in serum or plasma from blood product unit,deprecated le nos ab serpl bpu ql,le nos ab ql (s/p bpu),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; blood bank; blood product unit; blood product unit (pack); e; l (little e); le; le nos; left; levo; ordinal; other; pl; plasma; plsm; point in time; pr; ql; qual; qualitative; random; screen; serp; serpl; serpl^bpu; serplas; serum; serum or plasma; sr,Ord
11270-6,viral inclusion bodies [identifier] in specimen by cyto stain,vir incl bod spec cyto,viral inclusion bodies cyto stain nom (specimen),bod; body; cytology; cytology stain; cytostain; identity or presence; misc; miscellaneous; nominal; other; pap smear; pap stain; papanicolaou smear; point in time; random; spec; st; stains; stn; to be specified in another part of the message; unspecified; vir incl bod,Nom
11285-4,acuity assessment practitioner profession,acuity assess pract profession,,acuity assess pract profession; clin; nominal; point in time; random; typ,Nom
11317-5,ed service level practitioner identification,ed service level pract id,,deeds; ed service level pract id; emergency department; emergency department (deeds); levels; levl; lv; lvl; nominal; point in time; random; typ,Nom
11323-3,general health - reported,general health reported,,finding; findings; h+p; h+p.hx; nominal; p prime; point in time; random,Nom
11329-0,history general narrative - reported,hx general reported,,finding; findings; h+p; h+p.hx; hx; hx general; narrative; p prime; point in time; random; report,Nar
11345-6,history of other social factors,hx of other social factors,,h+p; h+p.hx; history; nominal; othr; p prime; point in time; random,Nom
11365-4,history of psychiatric disorders,hx of psychiatric disorders,,h+p; h+p.hx; history; nominal; p prime; point in time; random; sx; symp + dis,Nom
11376-1,injury location,injury location,,deeds; emergency department; emergency department (deeds); nominal; point in time; random; typ; ulcer,Nom
11382-9,medication allergy - reported,medication allergy reported,,h+p; h+p.hx; history; nominal; p prime; point in time; random,Nom
11383-7,patient problem outcome narrative,patient problem outcome,,finding; findings; h+p; h+p.hx; narrative; p prime; point in time; random; report,Nar
11402-5,physical findings of male genitalia narrative,phys find male genitalia,,exam; examination; finding; findings; h+p; h+p.px; male genitalia; narrative; p prime; phys find; point in time; random; report,Nar
1140-3,lu sup(ab) ab [presence] in serum or plasma from donor,lu sup(ab) ab serpl donr ql,lu sup(ab) ab ql (s/p donor),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; blood bank; donr; l (little u) (little a); l (little u) (little ab); left; levo; lu sup(a); lu sup(ab); lu^a; lu^a^b; ordinal; pl; plasma; plsm; point in time; pr; ql; qual; qualitative; random; screen; serp; serpl; serplas; serum; serum or plasma; sr,Ord
11420-7,physical findings of calf,phys find calf,,exam; examination; finding; findings; h+p; h+p.px; nominal; p prime; phys find; point in time; random,Nom
1145-2,lu sup(b) ag [presence] on red blood cells from blood product unit,lu sup(b) ag rbc bpu ql,lu sup(b) ag ql (rbc bpu),antigen; antigens; blood bank; blood product unit; blood product unit (pack); erythrocytes; hematology; heme; l (little u) (little b); left; levo; lu sup(b); lu^b; lutheran blood group system; ordinal; point in time; pr; ql; qual; qualitative; random; red blood cells; red blood corpusles; screen,Ord
11468-6,bacillus anthracis ab [units/volume] in specimen by immunofluorescence,b anthracis ab spec if-acnc,b. anthracis ab if qn (specimen),abs; aby; acif; antby; anthrax; anti; antibodies; antibody; anticomplement immunofluorescence; arbitrary concentration; autoantibodies; autoantibody; b anthracis; charbon; fa; fluorescent antibody; fluoresent; id; ifa; immune fluorescence; immunoflour; immunofluor; immunofluorescence; infectious disease; infectiousdisease; malignant carbuncle; malignant pustule; microbiology; milzbrand; misc; miscellaneous; other; point in time; qnt; quan; quant; quantitative; random; spec; splenic fever; time resolved fluorescence; to be specified in another part of the message; trf; unspecified; woolsorters disease,Qn
11478-5,microscopic observation [identifier] in stool by acid fast stain,acid fast stn stl,microscopic observation acid fast stain nom (stl),acd; acid fast stn; acids; afb stain; bowel movement; faecal; faeces; fecal; feces; gastro; gastroenterology; gi; id; identity or presence; infectious disease; infectiousdisease; microbiology; nominal; point in time; random; st; stains; stl; stn; stool = fecal,Nom
11497-5,deprecated psychology initial assessment note at first encounter,deprecated psych note 1st enctr,,1st; document; encounter; evaluation and management; evaluation and management note; finding; findings; h+p; h+p.hx; notes; p prime; visit note,Doc
1150-2,deprecated lu nos ab [presence] in serum or plasma,deprecated lu nos ab serpl ql,lu nos ab ql,abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; blood bank; l (little u) nos; left; levo; lu; lu nos; ordinal; other; pl; plasma; plsm; point in time; pr; ql; qual; qualitative; random; screen; serp; serpl; serplas; serum; serum or plasma; sr,Ord
11511-3,deprecated provider-unspecified progress note,deprecatedprogress note.total,,encounter; evaluation and management; evaluation and management note; finding; findings; h+p; h+p.hx; narrative; notes; p prime; point in time; prog note; random; report; subsequent evaluation; subsequent visit evaluation; tot; totl; visit note,Nar
11513-9,provider.signing [identifier] report,provider.signing report,,admin; ident; identifier; intradermal; nominal; point in time; random,Nom
11517-0,podiatry episode of care medical records,podiatry med records,,doc.misc; document; eoc; episode of care med rec; finding; findings; misc; point in time; random,Doc
11523-8,eeg study,eeg study,,document; eeg study; finding; findings; neuro; neurology; point in time; random; study report,Doc
11524-6,ekg study,ekg study,,card.proc; cardiac; cardio; cardiology; document; ecg; electrocardiogram; electrocardiograph; finding; findings; heart disease; hrt; point in time; random; study report,Doc
1152-8,deprecated lu nos ag [presence] on red blood cells from donor,deprecated lu nos ag rbc donr ql,lu nos ag ql (rbc donor),antigen; antigens; blood bank; donr; erythrocytes; l (little u) nos; left; levo; lu; lu nos; ordinal; other; point in time; pr; ql; qual; qualitative; random; red blood cells; red blood corpusles; screen,Ord
11536-0,deprecated nurse notes,deprecated,,attach; attach.clinrpt; document; encounter; finding; findings; nurse,Doc
11537-8,surgical drains narrative,surgical drains,,clin; finding; findings; narrative; point in time; random; report; surg,Nar
1154-4,little c ab [presence] in serum or plasma from blood product unit,little c ab serpl bpu ql,little c ab ql (s/p bpu),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; blood bank; blood product unit; blood product unit (pack); c; ordinal; pl; plasma; plsm; point in time; pr; ql; qual; qualitative; random; rh blood group system; screen; serp; serpl; serpl^bpu; serplas; serum; serum or plasma; sr,Ord
11545-1,microscopic observation [identifier] in specimen by acid fast stain,acid fast stn spec,microscopic observation acid fast stain nom (specimen),acd; acid fast stn; acids; afb stain; id; identity or presence; infectious disease; infectiousdisease; microbiology; misc; miscellaneous; nominal; other; point in time; random; spec; st; stains; stn; to be specified in another part of the message; universallaborders; unspecified,Nom
1155-1,little c ab [presence] in serum or plasma from donor,little c ab serpl donr ql,little c ab ql (s/p donor),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; blood bank; c; donr; ordinal; pl; plasma; plsm; point in time; pr; ql; qual; qualitative; random; rh blood group system; screen; serp; serpl; serplas; serum; serum or plasma; sr,Ord
11565-9,jo-1 extractable nuclear ab [units/volume] in serum,ena jo1 ab ser-acnc,jo-1 extractable nuclear ab qn (s),abs; aby; ana; anf; antby; anti; antibodies; antibody; antinuclear antibody; arbitrary concentration; autoantibodies; autoantibody; ena; ena jo1; histidyl-trna synthease; i; na; nuc; point in time; qnt; quan; quant; quantitative; random; serology; serum; sr; universallaborders,Qn
11566-7,liver kidney microsomal ab [units/volume] in serum,lkm ab ser-acnc,liver kidney microsomal ab qn (s),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; hepatology; liver; liver kidney microsome; lkm; microsm; microsom; point in time; qnt; quan; quant; quantitative; random; serology; serum; sr,Qn
1156-9,little c ab [presence] in serum or plasma,little c ab serpl ql,little c ab ql,abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; blood bank; c; ordinal; pl; plasma; plsm; point in time; pr; ql; qual; qualitative; random; rh blood group system; screen; serp; serpl; serplas; serum; serum or plasma; sr,Ord
11575-8,cefmetazole [susceptibility] by gradient strip,cefmetazole islt grad strip,cefmetazole strip [susc],antibiotic susceptibilities; ast; cefmetazon; cemetol; epsilometer; estrip; e-strip; grad strip; id; infectious disease; infectiousdisease; islt; isol; mic; minimum inhibitory concentration; point in time; random; sus; suscept; susceptibilities; susceptibility; susceptibilty; zefazone,OrdQn
11584-0,aureobasidium pullulans ab [presence] in serum,a pullulans ab ser ql,a. pullulans ab ql (s),a pullulans; abs; aby; antby; anti; antibodies; antibody; aureobasidm; autoantibodies; autoantibody; id; infectious disease; infectiousdisease; m12; microbiology; ordinal; p aureobasidium; p pullulans; point in time; pr; pullaria aureobasidium; pullulan; pullularia; pullularia pullulans; ql; qual; qualitative; random; screen; serum; sr,Ord
11586-5,brucella abortus ab [units/volume] in serum,b abortus ab ser-acnc,b. abortus ab qn (s),abort; abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; b abortus; bangs disease; bovine brucellosis; bruc; brucellosis; contagious abortion; id; infectious disease; infectiousdisease; microbiology; point in time; qnt; quan; quant; quantitative; random; serum; sr; undulant fever,Qn
11588-1,brucella melitensis ab [units/volume] in serum,b melitensis ab ser-acnc,b. melitensis ab qn (s),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; b melitensis; bruc; brucellosis; id; infectious disease; infectiousdisease; malta fever; mediterranean fever; microbiology; point in time; qnt; quan; quant; quantitative; random; serum; sr; undulant fever,Qn
1160-1,little e ab [presence] in serum or plasma from blood product unit,little e ab serpl bpu ql,little e ab ql (s/p bpu),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; blood bank; blood product unit; blood product unit (pack); e; ordinal; pl; plasma; plsm; point in time; pr; ql; qual; qualitative; random; rh blood group system; screen; serp; serpl; serpl^bpu; serplas; serum; serum or plasma; sr,Ord
11616-0,fetal heart narrative activity us,fet hrt activity us,,activ; actvty; cardiac; cardio; cardiology; echography; fetal; fetal gross body movements; finding; findings; gyn; gynecology; heart disease; hrt; movements; narrative; ob; obgyn; obsterical; obsterical.ultrasound; obstetrical; obstetrics; point in time; random; report; sonogram; sonograph; sonography; uls; ultrasound,Nar
11629-3,fetal head binocular distance us,fet head binoc d us.meas,,binoc d; brain; cranial; cranium; echoencephalogram; echoencephalography; echography; fetal; gyn; gynecology; intracranial; length; ob; obgyn; obsterical; obsterical.ultrasound; obstetrical; obstetrics; outer orbital diameter; outer orbital distance; outer orbital width; point in time; qnt; quan; quant; quantitative; random; skull; sonogram; sonograph; sonography; uls; ultrasound; us+meas,Qn
11635-0,fetal biophysical profile.tone us,fet bpp.tone us,,bpp.tone; echography; fetal; function; gyn; gynecology; ob; obgyn; obsterical; obsterical.ultrasound; obstetrical; obstetrics; ordinal; point in time; prof; ql; qual; qualitative; random; screen; sonogram; sonograph; sonography; uls; ultrasound,Ord
11642-6,deprecated mitral valve blood flow.diastolic.atrial wave.max by us.doppler,deprecated blood flow.diastolic.atrial w,,bld flow; bld flow.dias; dias; diast; diastoli; dop; duplex; dynamic; echography; largest; max v; maximal; maximum; mv; obsterical; obsterical.ultrasound; obstetrical; obstetrics; peak; peak a; point in time; qnt; quan; quant; quantitative; random; sonogram; sonograph; sonography; uls; ultrasound; v max; vel max; velocity; vmax,Qn
11673-1,cerebral artery anterior mean blood flow velocity us.doppler,cerebral a ant vmean dop,,art; average; avg; bld flow; bld flow vel; bld flow.velocity; cardio; cardiology; cereb; cerebral a ant; dop; duplex; dynamic; echography; gyn; gynecology; heart disease; mean v; ob; obgyn; obsterical; obsterical.ultrasound; obstetrical; obstetrics; point in time; qnt; quan; quant; quantitative; random; sonogram; sonograph; sonography; uls; ultrasound; v mean; vel; velocity; vmean,Qn
11676-4,ductus arteriosus mean blood flow velocity us.doppler,da vmean dop,,average; avg; bld flow; bld flow vel; bld flow.velocity; cardio; cardiology; da; dop; duplex; dynamic; echography; gyn; gynecology; heart disease; mean v; ob; obgyn; obsterical; obsterical.ultrasound; obstetrical; obstetrics; point in time; qnt; quan; quant; quantitative; random; sonogram; sonograph; sonography; uls; ultrasound; v mean; vel; velocity; vmean,Qn
11703-6,fetal ductus arteriosus peak systolic flow velocity us.doppler,fet da vmax sys dop,,bld flow; bld flow vel; bld flow.velocity; cardio; cardiology; da; dop; duplex; dynamic; echography; fetal; gyn; gynecology; heart disease; largest; max v; maximal; maximum; ob; obgyn; obsterical; obsterical.ultrasound; obstetrical; obstetrics; peak; point in time; qnt; quan; quant; quantitative; random; sonogram; sonograph; sonography; uls; ultrasound; v max; vel; vel max; velocity; vmax; vmax sys,Qn
11715-0,fetal right ventricular outflow tract peak systolic flow velocity us.doppler,fet rvot vmax sys dop,,bld flow; bld flow vel; bld flow.velocity; cardiac; cardio; cardiology; dop; duplex; dynamic; echography; fetal; gyn; gynecology; heart disease; hrt; hrt ventr; largest; max v; maximal; maximum; ob; obgyn; obsterical; obsterical.ultrasound; obstetrical; obstetrics; peak; point in time; qnt; quan; quant; quantitative; r; random; rt; rv; rvot; sonogram; sonograph; sonography; uls; ultrasound; v max; vel; vel max; velocity; ventricular; vmax; vmax sys,Qn
11750-7,fetal body weight estimated from abdominal circumference and femur length on us by hadlock 1984 method,efw from ac+fl.hadlock84,,84; abdominal circumference; abdominal circumference & femur length; bdy weight; bod; bodies; echography; efw; est; estimated fetal weight; estimation; femur length; fetal; from ac+fl; from ac+fl.hadlock84; gyn; gynecology; ob; obgyn; obsterical; obsterical.ultrasound; obstetrical; obstetrics; point in time; predicted; qnt; quan; quant; quantitative; random; sonogram; sonograph; sonography; uls; ultrasound; wt,Qn
11773-9,[percentile] body weight.75th estimated.pop birth wgt gestational age corr.ref,[prctl] bdy weight.75th ga corr,,bdy weight; bdy weight.75th; bod; bodies; est; estimation; ga corr; gest; gestation; gyn; gynecology; ob; obgyn; obsterical; obsterical.ultrasound; obstetrical; obstetrics; percentile; point in time; pop dist; populat; prenatal; qnt; quan; quant; quantitative; random; wt,Qn
11774-7,[percentile] body weight.90th estimated.pop birth wgt gestational age corr.ref,[prctl] bdy weight.90th ga corr,,bdy weight; bdy weight.90th; bod; bodies; est; estimation; ga corr; gest; gestation; gyn; gynecology; ob; obgyn; obsterical; obsterical.ultrasound; obstetrical; obstetrics; percentile; point in time; pop dist; populat; prenatal; qnt; quan; quant; quantitative; random; wt,Qn
11780-4,delivery date estimated from ovulation date,deliv date est from ovulation date,,date of confinement; deliv date; due date; edc; edd; est; est from ovulation date; estimation; gyn; gynecology; ob; obgyn; obsterical; obsterical.ultrasound; obstetrical; obstetrics; point in time; predicted; qnt; quan; quant; quantitative; random,Qn
11783-8,bowel diameter us,bowel diam us.meas,,dia; diam; echography; gyn; gynecology; length; ob; obgyn; obsterical; obsterical.ultrasound; obstetrical; obstetrics; point in time; qnt; quan; quant; quantitative; random; sonogram; sonograph; sonography; uls; ultrasound; us+meas,Qn
11796-0,fetal mitral valve diameter us,fet mv diam us.meas,,cardio; cardiology; dia; diam; echography; fetal; gyn; gynecology; heart disease; length; mv; ob; obgyn; obsterical; obsterical.ultrasound; obstetrical; obstetrics; point in time; qnt; quan; quant; quantitative; random; sonogram; sonograph; sonography; uls; ultrasound; us+meas,Qn
11799-4,pulmonic valve diameter by us,pv diam us.meas,,card.us; cardio; cardiology; dia; diam; echography; heart disease; length; point in time; pv; qnt; quan; quant; quantitative; random; sonogram; sonograph; sonography; uls; ultrasound; us+meas,Qn
11803-4,left ventricular outflow tract diameter us.doppler,lvot diam dop,,cardiac; cardio; cardiology; dia; diam; dop; duplex; echography; gyn; gynecology; heart disease; hrt; hrt ventr; l; length; lt; lv; lvot; ob; obgyn; obsterical; obsterical.ultrasound; obstetrical; obstetrics; point in time; qnt; quan; quant; quantitative; random; sonogram; sonograph; sonography; uls; ultrasound; ventricular,Qn
11812-5,fetal small bowel diameter us,fet sb diam us.meas,,dia; diam; echography; fetal; gyn; gynecology; length; ob; obgyn; obsterical; obsterical.ultrasound; obstetrical; obstetrics; point in time; qnt; quan; quant; quantitative; random; sb; small intestine; sonogram; sonograph; sonography; uls; ultrasound; us+meas,Qn
11814-1,fetal umbilical vein diameter us,fet umb v diam us.meas,,cardio; cardiology; dia; diam; echography; fetal; gyn; gynecology; heart disease; length; ob; obgyn; obsterical; obsterical.ultrasound; obstetrical; obstetrics; point in time; qnt; quan; quant; quantitative; random; sonogram; sonograph; sonography; uls; ultrasound; umb v; umbilical v^fetus; us+meas; ven; venous,Qn
11819-0,fetal thorax diameter.anterior-posterior us,fet thorax diam ap us.meas,,apad; dia; diam; diam ap; echography; fetal; gyn; gynecology; length; ob; obgyn; obsterical; obsterical.ultrasound; obstetrical; obstetrics; point in time; qnt; quan; quant; quantitative; random; sonogram; sonograph; sonography; thoracic; uls; ultrasound; us+meas,Qn
11828-1,kidney - right hilum-cortex diameter us,kidney-r diam.hilum-cort us.meas,,dia; diam; diam.hilum-cort; echography; gyn; gynecology; kidney; kidney width; kidney-r; length; nephric; nephrology; ob; obgyn; obsterical; obsterical.ultrasound; obstetrical; obstetrics; point in time; qnt; quan; quant; quantitative; r; random; renal; renal ap; rt; sonogram; sonograph; sonography; uls; ultrasound; us+meas,Qn
11829-9,ovary - left hilum-cortex diameter us,ovary-l diam.hilum-cort us.meas,,dia; diam; diam.hilum-cort; echography; gyn; gynecology; l; length; lt; ob; obgyn; obsterical; obsterical.ultrasound; obstetrical; obstetrics; ovarian; ovarian width; ovary-l; point in time; qnt; quan; quant; quantitative; random; sonogram; sonograph; sonography; uls; ultrasound; us+meas,Qn
11834-9,fetal kidney - left longitudinal diameter us,fet kidney-l long diameter us.meas,,dia; diam; echography; fetal; gyn; gynecology; kidney; kidney length; kidney-l; l; length; long diameter; longitudinal diameter; lt; nephric; nephrology; ob; obgyn; obsterical; obsterical.ultrasound; obstetrical; obstetrics; point in time; qnt; quan; quant; quantitative; random; renal; renal len; sonogram; sonograph; sonography; uls; ultrasound; us+meas,Qn
11836-4,fetal kidney - right longitudinal diameter us,fet kidney-r long diameter us.meas,,dia; diam; echography; fetal; gyn; gynecology; kidney; kidney length; kidney-r; length; long diameter; longitudinal diameter; nephric; nephrology; ob; obgyn; obsterical; obsterical.ultrasound; obstetrical; obstetrics; point in time; qnt; quan; quant; quantitative; r; random; renal; renal len; rt; sonogram; sonograph; sonography; uls; ultrasound; us+meas,Qn
11840-6,ovary - left longitudinal diameter us,ovary-l long diameter us.meas,,dia; diam; echography; gyn; gynecology; l; length; long diameter; longitudinal diameter; lt; ob; obgyn; obsterical; obsterical.ultrasound; obstetrical; obstetrics; ovarian; ovarian length; ovary-l; point in time; qnt; quan; quant; quantitative; random; sonogram; sonograph; sonography; uls; ultrasound; us+meas,Qn
11847-1,ovary - left largest follicle maximum diameter us,ovary-l.largest follicle diam.max us,,dia; diam; diam.max; echography; gyn; gynecology; l; largest; length; lt; maximal; maximum; ob; obgyn; obsterical; obsterical.ultrasound; obstetrical; obstetrics; ovarian; ovary-l; ovary-l.largest follicle; peak; point in time; qnt; quan; quant; quantitative; random; sonogram; sonograph; sonography; uls; ultrasound,Qn
11848-9,ovary - right largest follicle maximum diameter us,ovary-r.largest follicle diam.max us,,dia; diam; diam.max; echography; gyn; gynecology; largest; length; maximal; maximum; ob; obgyn; obsterical; obsterical.ultrasound; obstetrical; obstetrics; ovarian; ovary-r; ovary-r.largest follicle; peak; point in time; qnt; quan; quant; quantitative; r; random; rt; sonogram; sonograph; sonography; uls; ultrasound,Qn
11859-6,uterus thickeness us,uterus thickeness us.meas,,dia; diam; echography; gyn; gynecology; length; ob; obgyn; obsterical; obsterical.ultrasound; obstetrical; obstetrics; point in time; qnt; quan; quant; quantitative; random; sonogram; sonograph; sonography; thickeness; uls; ultrasound; us+meas; uterine; uterine thickness,Qn
11865-3,uterus diameter transverse us,uterus diam transverse us.meas,,dia; diam; diam transverse; echography; gyn; gynecology; length; ob; obgyn; obsterical; obsterical.ultrasound; obstetrical; obstetrics; point in time; qnt; quan; quant; quantitative; random; sonogram; sonograph; sonography; uls; ultrasound; us+meas; uterine; uterine width,Qn
1186-6,little i ab [presence] in serum or plasma,little i ab serpl ql,little i ab ql,abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; blood bank; i; ordinal; pl; plasma; plsm; point in time; pr; ql; qual; qualitative; random; screen; serp; serpl; serplas; serum; serum or plasma; sr,Ord
11877-8,fetal presentation us,fet pres us,,echography; fet pres; gyn; gynecology; nominal; ob; obgyn; obsterical; obsterical.ultrasound; obstetrical; obstetrics; pelvic; point in time; random; sonogram; sonograph; sonography; typ; uls; ultrasound,Nom
11884-4,gestational age estimated,ga clin est,,clin est; composite ga; est; estimation; fetal; ga; gest; gestation; gyn; gynecology; ob; obgyn; obsterical; obsterical.ultrasound; obstetrical; obstetrics; point in time; prenatal; qnt; quan; quant; quantitative; random,Qn
11890-1,gestational age estimated from abdominal circumference on us by campbell 1975 method,ga from ac.campbell75,,75; abdominal circumference; ac chart; echography; est; estimation; fetal; from ac.campbell75; ga; gest; gestation; gyn; gynecology; ob; obgyn; obsterical; obsterical.ultrasound; obstetrical; obstetrics; point in time; predicted; prenatal; qnt; quan; quant; quantitative; random; sonogram; sonograph; sonography; uls; ultrasound,Qn
11905-7,gestational age estimated from biparietal diameter on us by jeanty 1984 method,ga from bpd.jeanty84,,biparietal diameter; bpd chart; echography; est; estimation; fetal; from bpd.jeanty84; ga; gest; gestation; gyn; gynecology; ob; obgyn; obsterical; obsterical.ultrasound; obstetrical; obstetrics; point in time; predicted; prenatal; qnt; quan; quant; quantitative; random; sonogram; sonograph; sonography; uls; ultrasound,Qn
11907-3,gestational age estimated from biparietal diameter on us by sabbagha 1978 method,ga from bpd.sabbagha78,,78; biparietal diameter; bpd chart; echography; est; estimation; fetal; from bpd.sabbagha78; ga; gest; gestation; gyn; gynecology; ob; obgyn; obsterical; obsterical.ultrasound; obstetrical; obstetrics; point in time; predicted; prenatal; qnt; quan; quant; quantitative; random; sonogram; sonograph; sonography; uls; ultrasound,Qn
11916-4,gestational age estimated from fibula length (us),ga from fib length,,echography; est; estimation; fetal; fibula chart; from fib length; ga; gest; gestation; gyn; gynecology; ob; obgyn; obsterical; obsterical.ultrasound; obstetrical; obstetrics; point in time; predicted; prenatal; qnt; quan; quant; quantitative; random; sonogram; sonograph; sonography; uls; ultrasound; us+est,Qn
11922-2,gestational age estimated from femur length on us by hohler 1982 method,ga from fl.hohler82,,82; echography; est; estimation; femur length; fetal; fl chart; from fl.hohler82; ga; gest; gestation; gyn; gynecology; ob; obgyn; obsterical; obsterical.ultrasound; obstetrical; obstetrics; point in time; predicted; prenatal; qnt; quan; quant; quantitative; random; sonogram; sonograph; sonography; uls; ultrasound,Qn
11923-0,gestational age estimated from femur length on us by jeanty 1984 method,ga from fl.jeanty84,,84; echography; est; estimation; femur length; fetal; fl chart; from fl.jeanty84; ga; gest; gestation; gyn; gynecology; ob; obgyn; obsterical; obsterical.ultrasound; obstetrical; obstetrics; point in time; predicted; prenatal; qnt; quan; quant; quantitative; random; sonogram; sonograph; sonography; uls; ultrasound,Qn
1192-4,little k ab [presence] in serum or plasma,little k ab serpl ql,little k ab ql,abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; blood bank; k; kell blood group system; ordinal; pl; plasma; plsm; point in time; pr; ql; qual; qualitative; random; screen; serp; serpl; serplas; serum; serum or plasma; sr,Ord
11929-7,gestational age estimated from gestational sac diameter on us by rempen 1991 method,ga from gsd.rempen91,,91; echography; est; estimation; fetal; from gsd.rempen91; ga; ga_mgsd; gest; gestation; gestational sac diameter; gyn; gynecology; mgsd; ob; obgyn; obsterical; obsterical.ultrasound; obstetrical; obstetrics; point in time; predicted; prenatal; qnt; quan; quant; quantitative; random; sonogram; sonograph; sonography; uls; ultrasound,Qn
1193-2,little k ag [presence] on red blood cells from blood product unit,little k ag rbc bpu ql,little k ag ql (rbc bpu),antigen; antigens; blood bank; blood product unit; blood product unit (pack); erythrocytes; hematology; heme; k; kel1; kell blood group system; ordinal; point in time; pr; ql; qual; qualitative; random; red blood cells; red blood corpusles; screen,Ord
11938-8,gestational age estimated from radius length (us),ga from rad len,,echography; est; estimation; fetal; from rad len; ga; gest; gestation; gyn; gynecology; ob; obgyn; obsterical; obsterical.ultrasound; obstetrical; obstetrics; point in time; predicted; prenatal; qnt; quan; quant; quantitative; rad; random; sonogram; sonograph; sonography; uls; ultrasound; upper extremity; us+est,Qn
11947-9,head circumference/abdominal circumference derived by us,hc/ac der us,,abd; abdo; abdomen; ac; der us; echoencephalogram; echoencephalography; echography; fetal; girth; gyn; gynecology; hc; length ratio; ob; obgyn; obsterical; obsterical.ultrasound; obstetrical; obstetrics; point in time; qnt; quan; quant; quantitative; random; sonogram; sonograph; sonography; uls; ultrasound,Qn
11956-0,fetal head lateral ventricular body width/hemispheric width derived by us,fet head lvw/hw der us,,bod; bodies; brain; cranial; cranium; der us; echoencephalogram; echoencephalography; echography; fetal; gyn; gynecology; hw; intracranial; lat; length ratio; lvw; ob; obgyn; obsterical; obsterical.ultrasound; obstetrical; obstetrics; point in time; qnt; quan; quant; quantitative; random; skull; sonogram; sonograph; sonography; uls; ultrasound,Qn
11979-2,fetal abdomen circumference us,fet abd circum us.meas,,abd; abd^fetus; abd+fetus; abdo; abdomen+; abdominal; abdominal circumference; ac; circum; circumference; echography; fetal; gyn; gynecology; length; ob; obgyn; obsterical; obsterical.ultrasound; obstetrical; obstetrics; point in time; qnt; quan; quant; quantitative; random; sonogram; sonograph; sonography; uls; ultrasound; us+meas,Qn
11983-4,fetal head circumference derived from occipital-frontal diameter and outer-inner biparietal diameter (us),fet head circum by ofd+o-i bpd,,biparietal diameter; brain; by ofd+o-i bpd; circum; circumference; cranial; cranium; der us; echoencephalogram; echoencephalography; echography; fetal; gyn; gynecology; hc; head circumference; intracranial; length; ob; obgyn; obsterical; obsterical.ultrasound; obstetrical; obstetrics; occipital-frontal diameter; occipital-frontal diameter & biparietal diameter; outer to inner biparietal diameter; point in time; qnt; quan; quant; quantitative; random; skull; sonogram; sonograph; sonography; uls; ultrasound,Qn
11996-6,[#] pregnancies,pregnancies,,cnt; count; gestation; gestations; gravida; gyn; gynecology; number; ob; obgyn; obsterical; obsterical.ultrasound; obstetrical; obstetrics; point in time; pregnancy; qnt; quan; quant; quantitative; random,Qn
11999-0,fetal cerebral artery middle pulsatility index us.doppler,fet cerebral a middle pi dop,,art; cardio; cardiology; cereb; cerebral a middle; dop; duplex; echography; fetal; gyn; gynecology; heart disease; ob; obgyn; obsterical; obsterical.ultrasound; obstetrical; obstetrics; pi; point in time; qnt; quan; quant; quantitative; random; sonogram; sonograph; sonography; uls; ultrasound; velocity ratio,Qn
12006-3,uterine artery - left pulsatility index us.doppler,uterine a-l pi dop,,art; cardio; cardiology; dop; duplex; echography; gyn; gynecology; heart disease; l; lt; ob; obgyn; obsterical; obsterical.ultrasound; obstetrical; obstetrics; pi; point in time; qnt; quan; quant; quantitative; random; sonogram; sonograph; sonography; uls; ultrasound; uterine a-l; velocity ratio,Qn
12007-1,uterine artery - right pulsatility index us.doppler,uterine a-r pi dop,,art; cardio; cardiology; dop; duplex; echography; gyn; gynecology; heart disease; ob; obgyn; obsterical; obsterical.ultrasound; obstetrical; obstetrics; pi; point in time; qnt; quan; quant; quantitative; r; random; rt; sonogram; sonograph; sonography; uls; ultrasound; uterine a-r; velocity ratio,Qn
12033-7,fetal aorta ascending narrative study observation us,us aorta ascending fetus study,,ao; aortic; cardio; cardiology; echography; fetal; finding; findings; gyn; gynecology; heart disease; narrative; ob; obgyn; obsterical; obsterical.ultrasound; obstetrical; obstetrics; point in time; random; report; sonogram; sonograph; sonography; study report; uls; ultrasound,Nar
12038-6,fetal aortic arch study observation us,us ac arch fetus study,,ac arch; ao; cardio; cardiology; echography; fetal; finding; findings; gyn; gynecology; heart disease; nominal; ob; obgyn; obsterical; obsterical.ultrasound; obstetrical; obstetrics; point in time; random; sonogram; sonograph; sonography; study report; uls; ultrasound,Nom
12040-2,fetal cerebellum study observation us,us cereb fetus study,,cerebellar; echography; fetal; finding; findings; gyn; gynecology; neuro; neurology; nominal; ob; obgyn; obsterical; obsterical.ultrasound; obstetrical; obstetrics; point in time; random; sonogram; sonograph; sonography; study report; uls; ultrasound,Nom
12048-5,fetal colon narrative study observation us,us colon fetus study,,echography; fetal; finding; findings; gyn; gynecology; lgi; narrative; ob; obgyn; obsterical; obsterical.ultrasound; obstetrical; obstetrics; point in time; random; report; sonogram; sonograph; sonography; study report; uls; ultrasound,Nar
12053-5,fetal ductal arch study observation us,us ductal arch fetus study,,echography; fetal; finding; findings; gyn; gynecology; nominal; ob; obgyn; obsterical; obsterical.ultrasound; obstetrical; obstetrics; point in time; random; sonogram; sonograph; sonography; study report; uls; ultrasound,Nom
120-6,cefpodoxime [susceptibility] by minimum inhibitory concentration (mic),cefpodoxime islt mic,cefpodoxime mic [susc],antibiotic susceptibilities; ast; cefodox; cefpodoxime proxetil; id; infectious disease; infectiousdisease; islt; isol; minimum inhibitory concentration; orelox; podomexef; point in time; random; sus; suscept; susceptibilities; susceptibility; susceptibilty; vantin,OrdQn
12064-2,fetal lateral cerebral ventricles narrative study observation us,us lv fetus study,,brain; cereb; cerebral vents; cranial; cranium; echoencephalogram; echoencephalography; echography; fetal; finding; findings; gyn; gynecology; head.lat cerebral vents^fetus; intracranial; lat; lv; narrative; neuro; neurology; ob; obgyn; obsterical; obsterical.ultrasound; obstetrical; obstetrics; point in time; random; report; skull; sonogram; sonograph; sonography; study report; uls; ultrasound; ventricular,Nar
12067-5,fetal head third ventricle study observation us,us.meas head.3rd vent fetus study,,3rd; brain; cranial; cranium; echoencephalogram; echoencephalography; echography; fetal; finding; findings; gyn; gynecology; head.3rd vent; head.3rd ventricle^fetus; intracranial; nominal; ob; obgyn; obsterical; obsterical.ultrasound; obstetrical; obstetrics; point in time; random; skull; sonogram; sonograph; sonography; study report; uls; ultrasound; us+meas,Nom
12074-1,fetal atrium narrative study observation us,us hrt.atria fetus study,,atrial; cardiac; cardio; cardiology; echography; fetal; finding; findings; gyn; gynecology; heart disease; hrt; hrt.atria; hrt.atria^fetus; narrative; ob; obgyn; obsterical; obsterical.ultrasound; obstetrical; obstetrics; point in time; random; report; sonogram; sonograph; sonography; study report; uls; ultrasound,Nar
12076-6,fetal heart chambers narrative study observation us,us hrt.chambers fetus study,,cardiac; cardiac chambers; cardio; cardiology; echography; fetal; finding; findings; gyn; gynecology; heart disease; hrt; hrt.chambers; hrt.chambers^fetus; narrative; ob; obgyn; obsterical; obsterical.ultrasound; obstetrical; obstetrics; point in time; random; report; sonogram; sonograph; sonography; study report; uls; ultrasound,Nar
12126-9,body region narrative study observation us,us study,,echography; finding; findings; misc; miscellaneous; narrative; obsterical; obsterical.ultrasound; obstetrical; obstetrics; other; point in time; random; report; sonogram; sonograph; sonography; spec; study report; to be specified in another part of the message; uls; ultrasound; unspecified,Nar
12130-1,fetal narrative [interpretation] study observation general us,us fetus study [imp],,echography; fetal; gyn; gynecology; impression; impression/interpretation of study; impressions; interp; interpretation; narrative; ob; obgyn; obsterical; obsterical.ultrasound; obstetrical; obstetrics; point in time; random; report; sonogram; sonograph; sonography; study report; uls; ultrasound,Nar
12146-7,fetal nuchal fold thickness us,fet nuchal fold thickness us.meas,,aoeobservation; echography; fetal; gyn; gynecology; length; ob; obgyn; obsterical; obsterical.ultrasound; obstetrical; obstetrics; point in time; qnt; quan; quant; quantitative; random; sonogram; sonograph; sonography; thick; uls; ultrasound; us+meas,Qn
12150-9,fetal left ventricular posterior wall thickness diastolic us.m-mode+measured,fet lv.post wall thick dia us.m-mode+mea,,cardiac; cardio; cardiology; dias; diast; diastoli; echography; fetal; gyn; gynecology; heart disease; hrt; hrt ventr; l; length; lt; lv pw; lv.post wall; lvpw; lvpwd; mm; mmode; ob; obgyn; obsterical; obsterical.ultrasound; obstetrical; obstetrics; point in time; qnt; quan; quant; quantitative; random; sonogram; sonograph; sonography; thick; thickness dias; uls; ultrasound; ventricular,Qn
12155-8,fetal left ventricular posterior wall thickness.systolic measured by real time two dimension us,fet lv.post wall thick sys us.meas.rt 2d,,2; cardiac; cardio; cardiology; echography; fetal; gyn; gynecology; heart disease; hrt; hrt ventr; l; length; lt; lv pw; lv.post wall; lvpw; lvpws; ob; obgyn; obsterical; obsterical.ultrasound; obstetrical; obstetrics; point in time; qnt; quan; quant; quantitative; random; sonogram; sonograph; sonography; thick; uls; ultrasound; us.meas.rt 2d; us+meas; ventricular,Qn
12156-6,transducer site,transducer site,,anatomy; nominal; obsterical; obsterical.ultrasound; obstetrical; obstetrics; point in time; random,Nom
12162-4,fetal kidney - left volume derived by us,fet kidney-l volume der us,,der us; echography; fetal; gyn; gynecology; kidney; kidney-l; l; lt; nephric; nephrology; ob; obgyn; obsterical; obsterical.ultrasound; obstetrical; obstetrics; point in time; qnt; quan; quant; quantitative; random; renal; sonogram; sonograph; sonography; uls; ultrasound; vol; volume,Qn
12171-5,fetal lateral cerebral ventricles transverse width us,fet lv width.transverse us.meas,,brain; cereb; cerebral vents; cranial; cranium; echoencephalogram; echoencephalography; echography; fetal; gyn; gynecology; head.lat cerebral vents^fetus; intracranial; lat; lateral ventricular width; length; lv; lvw; neuro; neurology; ob; obgyn; obsterical; obsterical.ultrasound; obstetrical; obstetrics; point in time; qnt; quan; quant; quantitative; random; skull; sonogram; sonograph; sonography; uls; ultrasound; us+meas; ventricular,Qn
12181-4,calcium [moles/volume] in body fluid,calcium fld-scnc,calcium (body fld) [moles/vol],"b/f; bf; bod; bodies; body fluid; body fluid, unsp; ca; cal; chemistry; fl; fld; flu; fluid; level; point in time; qnt; quan; quant; quantitative; random; substance concentration",Qn
12200-2,cryoglobulin [presence] in serum by 4 hour cold incubation,cryoglob ser ql 4h cold inc,cryoglobulin 4 hour cold incubation ql (s),chemistry; cryo; cryoglobulins; cryoprecipitate; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; sr,Ord
12207-7,cryoglobulin [presence] in serum by 1 week cold incubation,cryoglob ser ql 1w cold inc,cryoglobulin 1 week cold incubation ql (s),7d cold incubation; chemistry; cryo; cryoglobulins; cryoprecipitate; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; sr,Ord
1222-9,mg ab [presence] in serum or plasma,mg ab serpl ql,mg ab ql,abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; blood bank; m (little g); mg; ordinal; pl; plasma; plsm; point in time; pr; ql; qual; qualitative; random; screen; serp; serpl; serplas; serum; serum or plasma; sr,Ord
12231-7,prolactin [mass/volume] in serum or plasma --baseline,prolactin bs serpl-mcnc,prolactin baseline [mass/vol],bs; chemistry.challenge testing; lactotropic hormone; lactotropin; level; mammatropic hormone; mammotropin; mass concentration; pl; plasma; plsm; point in time; prl; prol; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
12235-8,microscopic observation [identifier] in urine sediment by light microscopy,micro urns,microscopic observation lm nom (urine sed),identity or presence; kidney; lm; micro; micros; microscopic; nephrology; nominal; point in time; random; renal; ua; ur; urinalysis; urine sediment; urn; urns,Nom
12241-6,osmotic fragility of red blood cells by diluted rbc,of nfr rbc diluted,osmotic fragility diluted rbc (rbc),diluted rbc; erythrocytes; frag; fragil; hematology/cell counts; number fraction; of; osmo; osmo frag; percent; point in time; qnt; quan; quant; quantitative; random; red blood cells; red blood corpusles,Qn
12273-9,xanthochromia [presence] of body fluid qualitative,xanthochromia fld ql,xanthochromia ql (body fld),"b/f; bf; bod; bodies; body fluid; body fluid, unsp; fl; fld; flu; fluid; ordinal; point in time; pr; ql; qual; qualitative; random; screen; spec; xanthchromia; xanthochromic",Ord
12292-9,dimethyltryptamine [presence] in urine,dimet-tryptamine ur ql,dimethyltryptamine ql (u),dimet-tryptamine; dmt; drug/toxicology; drugs; ordinal; point in time; pr; ql; qual; qualitative; random; screen; ua; ur; urn,Ord
12299-4,ethinamate [presence] in urine,ethinamate ur ql,ethinamate ql (u),1-ethynylcyclohexanol carbamate; c9h13no2; drug/toxicology; drugs; ordinal; point in time; pr; ql; qual; qualitative; random; screen; ua; ur; urn; valmid,Ord
1230-2,m ag [presence] on red blood cells from donor,m ag rbc donr ql,m ag ql (rbc donor),antigen; antigens; blood bank; donr; erythrocytes; hematology; heme; mnss blood group system; ordinal; point in time; pr; ql; qual; qualitative; random; red blood cells; red blood corpusles; screen,Ord
12314-1,clorazepate [presence] in urine,clorazepate ur ql,clorazepate ql (u),chlorazepate; drug/toxicology; drugs; ordinal; point in time; pr; ql; qual; qualitative; random; screen; tranxene; ua; ur; urn,Ord
12317-4,phenolphthalein [presence] in urine,phenolphthalein ur ql,phenolphthalein ql (u),drug/toxicology; drugs; ordinal; phenolthalein; point in time; pr; ql; qual; qualitative; random; screen; ua; ur; urn,Ord
12324-0,hydroxyzine [presence] in urine,hydroxyzine ur ql,hydroxyzine ql (u),atarax; drug/toxicology; drugs; ordinal; point in time; pr; ql; qual; qualitative; random; screen; ua; ur; urn; vistaril,Ord
12332-3,antihistamines [identifier] in urine,antihistamines ur,antihistamines nom (u),antihistamine; anti-histamine; anti-histamines; drug/toxicology; drugs; identity or presence; nominal; point in time; random; ua; ur; urn,Nom
12350-5,amphetamines [presence] in stool,amphetamines stl ql,amphetamines ql (stl),addiction; amph; amphetam; amphetamine; bowel movement; drug/toxicology; drugs; drugs of abuse; faecal; faeces; fecal; feces; illicit; ordinal; point in time; potentialforabuse; pr; ql; qual; qualitative; random; screen; speed; stl; stool = fecal,Ord
12352-1,benzoylecgonine [presence] in stool,bze stl ql,benzoylecgonine ql (stl),bec; beg; benz; benzoylec; bowel movement; bze; cocaine degradation production; cocaine metabolite; crack metabolite; drug/toxicology; drugs; faecal; faeces; fecal; feces; ordinal; point in time; pr; ql; qual; qualitative; random; screen; stl; stool = fecal,Ord
12360-4,barbital [presence] in urine,barbital ur ql,barbital ql (u),addiction; barbitone; barbiturate; diethylmalonylurea; drug/toxicology; drugs; drugs of abuse; illicit; megal; neurinase; ordinal; pneumogeine-barbital; point in time; potentialforabuse; pr; provervon n; ql; qual; qualitative; random; screen; ua; ur; urn; veraine buriat; veronal; vitanerton n kerne,Ord
12385-1,deprecated nordoxepin [mass/volume] in serum or plasma,deprecated desmethyldoxepin serpl-mcnc,desmethyldoxepin [mass/vol],drug/toxicology; drugs; level; mass concentration; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
12390-1,sulfasalazine [mass/volume] in serum or plasma,sulfasalazine serpl-mcnc,sulfasalazine [mass/vol],accucol; asulfidine; azopyrin; azulfidine; drug/toxicology; drugs; level; mass concentration; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; rorasul; salazopyrin; salazosulfapyridine; salicylazosulfapyridine; sasp; serp; serpl; serplas; serum; serum or plasma; sr; ssz; sulcolon,Qn
12393-5,deprecated ketoconazole [mass/volume] in serum or plasma,deprecated ketoconazole serpl-mcnc,ketoconazole [mass/vol],drug/toxicology; drugs; level; mass concentration; nizoral; nz; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
12396-8,chlorpropamide [mass/volume] in urine,chlorpropamide ur-mcnc,chlorpropamide (u) [mass/vol],diabinese; drug/toxicology; drugs; level; mass concentration; point in time; qnt; quan; quant; quantitative; random; ua; ur; urn,Qn
12424-8,triprolidine [mass/volume] in serum or plasma,triprolidine serpl-mcnc,triprolidine [mass/vol],actidil; actifed; c19h22n2; drug/toxicology; drugs; level; mass concentration; myidil; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
12445-3,norfluoxetine [mass/volume] in urine,norfluoxetine ur-mcnc,norfluoxetine (u) [mass/vol],(s)-norfluoxetine; desmethylfluoxetine; drug/toxicology; drugs; fluoxetine metabolite; level; mass concentration; norfluoxetin; point in time; qnt; quan; quant; quantitative; random; seproxetine; ua; ur; urn,Qn
12455-2,histoplasma capsulatum yeast phase ab [presence] in cerebral spinal fluid,h capsul yst ab csf ql,h. capsulatum yeast phase ab ql (csf),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; cerebral spinal fluid; cerebrospinal fl; h capsul; h capsul yst; h capsulatum; h farciminosum; histo; histopl; histoplasma farciminosum; histoplasmos; histoplasmosis; id; infectious disease; infectiousdisease; microbiology; neuro; neurology; ordinal; point in time; pr; ql; qual; qualitative; random; screen; spinal fl; spinal fld; spinal flu; spinal fluid,Ord
12462-8,corticotropin [mass/volume] in plasma --6th specimen post xxx challenge,acth sp6 p chal plas-mcnc,corticotropin 6th specimen post unsp challenge (p) [mass/vol],acth; adrenocorticotrophic hormone; adrenocorticotropin; after; c206; c74; chemistry.challenge testing; cortrosyn; level; mass concentration; p chal; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; rc206; sp6; sp6 p chal; spec; tumor marker,Qn
12473-5,phosphoethanolamine [mass/time] in urine,petn ur-mrate,phosphoethanolamine (u) [mass/time],chemistry; mass rate; mrate; pea; petn; point in time; qnt; quan; quant; quantitative; random; ua; ur; urn,Qn
12477-6,dextromethamphetamine [mass/volume] in urine,d-methamphet ur-mcnc,dextromethamphetamine (u) [mass/vol],addiction; dextro-methamphetamine; d-methamphet; d-methamphetamine; drug/toxicology; drugs; drugs of abuse; illicit; level; mass concentration; point in time; potentialforabuse; qnt; quan; quant; quantitative; random; ua; ur; urn,Qn
12481-8,arsenic.inorganic [mass/volume] in urine,inorg arsenic ur-mcnc,arsenic.inorganic (u) [mass/vol],as; drug/toxicology; drugs; inorg arsenic; level; mass concentration; point in time; qnt; quan; quant; quantitative; random; ua; ur; urn,Qn
12491-7,methohexital [presence] in serum or plasma,methohexital serpl ql,methohexital ql,brevimytal; brevital; brevital sodium; c14h18n2o3; drug/toxicology; drugs; enallynymal sodium; methohexitone sodium; ordinal; pl; plasma; plsm; point in time; pr; ql; qual; qualitative; random; screen; serp; serpl; serplas; serum; serum or plasma; sodium methohexital; sr,Ord
1249-2,m1 ag [presence] on red blood cells,m1 ag rbc ql,m1 ag ql (rbc),antigen; antigens; blood bank; erythrocytes; hematology; heme; ordinal; point in time; pr; ql; qual; qualitative; random; red blood cells; red blood corpusles; screen,Ord
12496-6,butabarbital [presence] in stool,butabarbital stl ql,butabarbital ql (stl),addiction; barbiturate; bowel movement; butabarb; butabarbitl; butisol; drug/toxicology; drugs; drugs of abuse; faecal; faeces; fecal; feces; illicit; ordinal; point in time; potentialforabuse; pr; ql; qual; qualitative; random; screen; stl; stool = fecal,Ord
12515-3,carcinoembryonic ag [mass/volume] in body fluid,cea fld-mcnc,carcinoembryonic ag (body fld) [mass/vol],"antigen; antigens; b/f; bf; bod; bodies; body fluid; body fluid, unsp; cea; chemistry; fl; fld; flu; fluid; level; mass concentration; oncology; point in time; qnt; quan; quant; quantitative; random; tumor marker",Qn
12516-1,catecholamines [mass/volume] in urine --2nd specimen post xxx challenge,catechols sp2 p chal ur-mcnc,catecholamines 2nd specimen post unsp challenge (u) [mass/vol],after; cate; catec; catech; catechol; catecholamine; catecholamines.total; catechols; chemistry.challenge testing; convalescent; epinephrine+norepinephrine+dopamine; level; mass concentration; p chal; point in time; post immunization; pst; qnt; quan; quant; quantitative; random; second; sp2; sp2 p chal; spec; ua; ur; urn,Qn
12539-3,2-methylcitrate [mass/volume] in urine,2me-citrate ur-mcnc,2-methylcitrate (u) [mass/vol],2me-citrate; chemistry; ii; level; mass concentration; mca; methylcitric acid; methylmalonic acidemia; point in time; propionic acidemia; qnt; quan; quant; quantitative; random; ua; ur; urn,Qn
12554-2,narcotics and opioids [identifier] in urine,narcotics ur,narcotics and opioids nom (u),addiction; drug/toxicology; drugs; drugs of abuse; identity or presence; illicit; narcotic; nominal; point in time; potentialforabuse; random; ua; ur; urn,Nom
12560-9,cortisol [mass/volume] in serum or plasma --5th specimen post xxx challenge,cortis sp5 p chal serpl-mcnc,cortisol 5th specimen post unsp challenge [mass/vol],17-hydroxycorticosterone; after; chemistry.challenge testing; compound f; coritsol; cort; f; hydrocortisone; level; mass concentration; p chal; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sp5; sp5 p chal; spec; sr,Qn
12572-4,creatinine [mass/volume] in peritoneal dialysis fluid --2 hour dwell specimen,creat 2h dwell spec diafp-mcnc,creatinine 2 hr dwell specimen (perit dial fld) [mass/vol],120 min; 120 minutes; 120min; 2 hours; chemistry; cr; crea; creat; diaf; diafp; dialysate; dialysis fluid; kidney; level; mass concentration; nephrology; peritoneal dialysis fluid; point in time; qnt; quan; quant; quantitative; random; renal; spec,Qn
1257-5,n ab [presence] in serum or plasma from donor,n ab serpl donr ql,n ab ql (s/p donor),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; blood bank; donr; mnss blood group system; ordinal; pl; plasma; plsm; point in time; pr; ql; qual; qualitative; random; screen; serp; serpl; serplas; serum; serum or plasma; sr,Ord
12576-5,creatinine [mass/volume] in peritoneal dialysis fluid --1st specimen,creat sp1 diafp-mcnc,creatinine spec 1 (perit dial fld) [mass/vol],acute specimen; chemistry; cr; crea; creat; diaf; diafp; dialysate; dialysis fluid; first; kidney; level; mass concentration; nephrology; peritoneal dialysis fluid; point in time; pre immunization; qnt; quan; quant; quantitative; random; renal; sp1; spec,Qn
12585-6,creatinine [mass/time] in 2 hour urine,creat 2h ur-mrate,creatinine (2h u) [mass/time],120 min; 120 minutes; 120min; 2 hours; 2hr; chemistry; cr; crea; creat; kidney; mass rate; mrate; nephrology; qnt; quan; quant; quantitative; renal; ua; ucr; ur; urn,Qn
12594-8,dehydroepiandrosterone (dhea) [mass/volume] in serum or plasma --6th specimen post xxx challenge,dhea sp6 p chal serpl-mcnc,dhea 6th specimen post unsp challenge [mass/vol],after; chemistry.challenge testing; dhea; level; mass concentration; p chal; pl; plasma; plsm; point in time; prasterone; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sp6; sp6 p chal; spec; sr,Qn
12598-9,fat.neutral [presence] in stool,neutral fat stl ql,fat.neutral ql (stl),acylglycerol; bowel movement; chemistry; faecal; faeces; fecal; feces; neutral fat; ordinal; point in time; pr; ql; qual; qualitative; random; screen; stl; stool = fecal; universallaborders,Ord
12614-4,glucose [mass/volume] in serum or plasma --7 hours post meal,glucose 7h p meal serpl-mcnc,glucose 7 hr post meal [mass/vol],7h p meal; after; chemistry.challenge testing; endocrine; endocrinology; glu; glu tol; gluc; glucose tolerance; glucoseur; gtt; level; mass concentration; p meal; pc; pl; plasma; plsm; point in time; post pran; post prandial; pp; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
1261-7,n ag [presence] on red blood cells,n ag rbc ql,n ag ql (rbc),antigen; antigens; blood bank; erythrocytes; hematology; heme; mnss blood group system; ordinal; point in time; pr; ql; qual; qualitative; random; red blood cells; red blood corpusles; screen,Ord
12618-5,glucose [mass/volume] in serum or plasma --4th specimen post xxx challenge,glucose sp4 p chal serpl-mcnc,glucose 4th specimen post unsp challenge [mass/vol],after; chemistry.challenge testing; endocrine; endocrinology; glu; glu tol; gluc; glucose tolerance; glucoseur; gtt; level; mass concentration; p chal; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sp4; sp4 p chal; spec; sr,Qn
12624-3,glucose [mass/volume] in serum or plasma --12th specimen post xxx challenge,glucose sp12 p chal serpl-mcnc,glucose 12th specimen post unsp challenge [mass/vol],after; chemistry.challenge testing; endocrine; endocrinology; glu; glu tol; gluc; glucose tolerance; glucoseur; gtt; level; mass concentration; p chal; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sp12; sp12 p chal; spec; sr,Qn
1263-3,deprecated n nos ab [presence] in serum or plasma from donor,deprecated n nos ab serpl donr ql,n nos ab ql (s/p donor),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; blood bank; donr; ordinal; other; pl; plasma; plsm; point in time; pr; ql; qual; qualitative; random; screen; serp; serpl; serplas; serum; serum or plasma; sr,Ord
12640-9,glucose [mass/volume] in serum or plasma --6.5 hours post xxx challenge,glucose 6.5h p chal serpl-mcnc,glucose 6.5 hr post unsp challenge [mass/vol],6.5h p chal; after; chemistry.challenge testing; endocrine; endocrinology; glu; glu tol; gluc; glucose tolerance; glucoseur; gtt; level; mass concentration; p chal; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
1264-1,deprecated n nos ab [presence] in serum or plasma,deprecated n nos ab serpl ql,n nos ab ql,abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; blood bank; ordinal; other; pl; plasma; plsm; point in time; pr; ql; qual; qualitative; random; screen; serp; serpl; serplas; serum; serum or plasma; sr,Ord
12647-4,glucose [mass/volume] in serum or plasma --12 hours post xxx challenge,glucose 12h p chal serpl-mcnc,glucose 12 hr post unsp challenge [mass/vol],12h p chal; after; chemistry.challenge testing; endocrine; endocrinology; glu; glu tol; gluc; glucose tolerance; glucoseur; gtt; level; mass concentration; p chal; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
12663-1,follitropin [moles/volume] in serum or plasma --40 minutes post xxx challenge,fsh 40m p chal serpl-scnc,follitropin 40 min post unsp challenge [moles/vol],40m p chal; after; chemistry.challenge testing; follicle stimulating hormone; fsh; level; p chal; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; substance concentration,Qn
12665-6,follitropin [moles/volume] in serum or plasma --3rd specimen post xxx challenge,fsh sp3 p chal serpl-scnc,follitropin 3rd specimen post unsp challenge [moles/vol],after; chemistry.challenge testing; follicle stimulating hormone; fsh; level; p chal; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sp3; sp3 p chal; spec; sr; substance concentration,Qn
12681-3,lutropin [moles/volume] in serum or plasma --6th specimen post xxx challenge,lh sp6 p chal serpl-scnc,lutropin 6th specimen post unsp challenge [moles/vol],after; chemistry.challenge testing; icsh; interstitial cell-stimulating hormone; interstitual cell stimulating hormone; leutinizing hormone; level; lh; luteinizing hormone; lutenin; lutenizing hormone; ovulation test; p chal; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sp6; sp6 p chal; spec; sr; substance concentration,Qn
12696-1,somatotropin [moles/volume] in serum or plasma --pre xxx challenge,gh pre chal serpl-scnc,somatotropin pre unsp challenge [moles/vol],before; chemistry.challenge testing; endocrine; endocrinology; gh; growth hormone; hgh; human growth hormone; level; pl; plasma; plsm; point in time; pre chal; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; somatotropic hormone; sr; sth; substance concentration,Qn
12701-9,somatotropin [moles/volume] in serum or plasma --2.5 hours post xxx challenge,gh 2.5h p chal serpl-scnc,somatotropin 2.5 hr post unsp challenge [moles/vol],2.5h p chal; after; chemistry.challenge testing; endocrine; endocrinology; gh; growth hormone; hgh; human growth hormone; level; p chal; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; somatotropic hormone; sr; sth; substance concentration,Qn
1270-8,unidentified ab [presence] in serum or plasma,unident ab serpl ql,unidentified ab ql,abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; blood bank; nos ab; ordinal; pl; plasma; plsm; point in time; pr; ql; qual; qualitative; random; screen; serp; serpl; serplas; serum; serum or plasma; sr,Ord
127-1,cefsulodin [susceptibility] by minimum lethal concentration (mlc),cefsulodin islt mlc,cefsulodin mlc [susc],antibiotic susceptibilities; ast; cefsulodine; id; infectious disease; infectiousdisease; islt; isol; mbc; minimum bactericidal concentration; minimum lethal concentration; monaspor; point in time; pseudocef; pyocefal; qnt; quan; quant; quantitative; random; sulcephalosporin; sus; suscept; susceptibilities; susceptibility; susceptibilty; takesulin,Qn
12712-6,hemoglobin s+d+g region [presence] in blood by electrophoresis alkaline (ph 8.9),hgb s+d+g reg bld ql elph alk,hemoglobin s+d+g region elph ph 8.9 ql (bld),blood; dextro; elec; elect; electr; electro; electrophhrs; electrophrs; elp; elph; elph alk; ep; haemoglobin; hb; hbs; hematology/cell counts; hgb; hgb s; hgb s+d+g reg; ordinal; point in time; pr; ql; qual; qualitative; random; s prime; screen; sickle cell; sickle cell screen; sickle cells; sickledex; sicklequik; wb; whole blood,Ord
12713-4,hemoglobin c+e+o+a2 region [presence] in blood by electrophoresis alkaline (ph 8.9),hgb c+e+o+a2 bld ql elph alk,hemoglobin c+e+o+a2 region elph ph 8.9 ql (bld),blood; elec; elect; electr; electro; electrophhrs; electrophrs; elp; elph; elph alk; ep; haemoglobin; hb; hematology/cell counts; hgb; hgb c; hgb c+e+o+a2; ordinal; point in time; pr; ql; qual; qualitative; random; screen; wb; whole blood,Ord
12723-3,insulin-like growth factor binding protein 2 [mass/volume] in serum or plasma,igf bp2 serpl-mcnc,insulin-like growth factor binding protein 2 [mass/vol],bind; chemistry; fac; fact; hum; humulin; igf; igf bp; igf bp2; igfbp; ih7; ii; insul; lente; level; mass concentration; nph; pl; plasma; plsm; point in time; pr; prot; qnt; quan; quant; quantitative; random; semilente; serp; serpl; serplas; serum; serum or plasma; sliding; sr; ultralente,Qn
12747-2,insulin [mass/volume] in serum or plasma --3.5 hours post xxx challenge,insulin 3.5h p chal serpl-mcnc,insulin 3.5 hr post unsp challenge [mass/vol],3.5h p chal; after; chemistry.challenge testing; hum; humulin; ih7; insul; lente; level; mass concentration; nph; p chal; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; semilente; serp; serpl; serplas; serum; serum or plasma; sliding; sr; ultralente,Qn
12749-8,insulin [mass/volume] in serum or plasma --5.5 hours post xxx challenge,insulin 5.5h p chal serpl-mcnc,insulin 5.5 hr post unsp challenge [mass/vol],5.5h p chal; after; chemistry.challenge testing; hum; humulin; ih7; insul; lente; level; mass concentration; nph; p chal; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; semilente; serp; serpl; serplas; serum; serum or plasma; sliding; sr; ultralente,Qn
12780-3,nickel [mass/volume] in red blood cells,nickel rbc-mcnc,nickel (rbc) [mass/vol],drug/toxicology; drugs; erythrocytes; level; mass concentration; ni; point in time; qnt; quan; quant; quantitative; random; red blood cells; red blood corpusles,Qn
12782-9,oligoclonal bands [interpretation] in cerebral spinal fluid by electrophoresis,oligoclonal bands csf elph-imp,oligoclonal bands elph (csf) [interp],cerebral spinal fluid; cerebrospinal fl; chemistry; elec; elect; electr; electro; electrophhrs; electrophrs; elp; elph; ep; frac; fract; fraction; fractionated; fractionation; impression; impression/interpretation of study; impressions; interp; interpretation; m-spikes; neuro; neurology; nominal; point in time; pr; prot; random; spinal fl; spinal fld; spinal flu; spinal fluid,Nom
12784-5,codeine free [mass/volume] in serum or plasma,codeine free serpl-mcnc,codeine free [mass/vol],c260; c300; codeine free; drug/toxicology; drugs; fr; level; mass concentration; methylmorphine; morphine methyl ether; non-protein bound; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
12800-9,deprecated trimeprazine,deprecated trimeprazine serpl ql,trimeprazine ql,alimazine; amisal; apamezin; benalgen; coplexens; crasin; drug/toxicology; drugs; level; mass concentration; meparil; nedeltran; normain a; ordinal; palpex; panectyl; pl; plasma; plsm; point in time; pramin; ql; qual; qualitative; random; repeltin; screen; serp; serpl; serplas; serum; serum or plasma; spansule; sr; telmatin; temaridin; temaril; theralen; theralene; trixin; turysin; vallergan; variargil; vetalen,Ord
12801-7,methdilazine [mass/volume] in serum or plasma,methdilazine serpl-mcnc,methdilazine [mass/vol],disyncram; drug/toxicology; drugs; level; mass concentration; pl; plasma; plsm; point in time; product 5022; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; tacazyl; tacryl,Qn
12802-5,propiomazine [mass/volume] in serum or plasma,propiomazine serpl-mcnc,propiomazine [mass/vol],c20h24n2os; dorevan; dorevane; drug/toxicology; drugs; indorm; largon; level; mass concentration; pl; plasma; plsm; point in time; propavan; qnt; quan; quant; quantitative; random; serentin; serp; serpl; serplas; serum; serum or plasma; sr,Qn
12805-8,alkaline phosphatase isoenzyme [units/volume] in serum or plasma,alp iso serpl-acnc,alp iso qn,alk; alk phos; alkaline phos; alkaline phosphatase.total; alkp; alp; alp iso; ap; arbitrary concentration; chemistry; hepatology; iso; isoen; isoenzymes; liver; phos; phosphtase; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
12808-2,uroporphyrin [mass/time] in urine,uropor ur-mrate,uroporphyrin (u) [mass/time],chemistry; hematology; heme; mass rate; mrate; octacarboxyl porphyrin; octacarboxylporphyrin; octacarboxyphyrin; point in time; qnt; quan; quant; quantitative; random; ua; ur; urn; urophorph,Qn
12819-9,progesterone [mass/volume] in serum or plasma --6th specimen post xxx challenge,progest sp6 p chal serpl-mcnc,progesterone 6th specimen post unsp challenge [mass/vol],after; chemistry.challenge testing; level; mass concentration; p chal; p4; pl; plasma; plsm; point in time; prog; proges; progest; progestin; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sp6; sp6 p chal; spec; sr,Qn
12828-0,prolactin [mass/volume] in serum or plasma --7th specimen post xxx challenge,prolactin sp7 p chal serpl-mcnc,prolactin 7th specimen post unsp challenge [mass/vol],^7th spec pst xxx chal; after; chemistry.challenge testing; lactotropic hormone; lactotropin; level; mammatropic hormone; mammotropin; mass concentration; p chal; pl; plasma; plsm; point in time; prl; prol; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sp7; sp7 p chal; spec; sr,Qn
12832-2,prolactin [mass/volume] in serum or plasma --10 minutes post xxx challenge,prolactin 10m p chal serpl-mcnc,prolactin 10 min post unsp challenge [mass/vol],10m p chal; after; chemistry.challenge testing; lactotropic hormone; lactotropin; level; mammatropic hormone; mammotropin; mass concentration; p chal; pl; plasma; plsm; point in time; prl; prol; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
12838-9,prostaglandin d2 [mass/volume] in urine,prostaglandin d2 ur-mcnc,prostaglandin d2 (u) [mass/vol],chemistry; level; mass concentration; pg; pgd2; point in time; qnt; quan; quant; quantitative; random; ua; ur; urn,Qn
12860-3,borrelia burgdorferi 39kd ab [presence] in cerebral spinal fluid by immunoblot,b burgdor39kd ab csf ql ib,b. burgdorferi 39kd ab ib ql (csf),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; b burg; b burgdor; b burgdor39kd; b burgdorferi; bb; blt; burgdorf; cerebral spinal fluid; cerebrospinal fl; id; immune blot; immunobl; immunoblot; infectious disease; infectiousdisease; lyme; lyme disease; lymes; microbiology; neuro; neurology; ordinal; point in time; pr; ql; qual; qualitative; random; riba; screen; spinal fl; spinal fld; spinal flu; spinal fluid; wb; wblot; west blot; west blt; western blot,Ord
12866-0,borrelia burgdorferi 18kd ab [presence] in cerebral spinal fluid by immunoblot,b burgdor18kd ab csf ql ib,b. burgdorferi 18kd ab ib ql (csf),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; b burg; b burgdor; b burgdor18kd; b burgdorferi; bb; blt; burgdorf; cerebral spinal fluid; cerebrospinal fl; id; immune blot; immunobl; immunoblot; infectious disease; infectiousdisease; lyme; lyme disease; lymes; microbiology; neuro; neurology; ordinal; point in time; pr; ql; qual; qualitative; random; riba; screen; spinal fl; spinal fld; spinal flu; spinal fluid; wb; wblot; west blot; west blt; western blot,Ord
12867-8,borrelia burgdorferi 58kd ab [presence] in cerebral spinal fluid by immunoblot,b burgdor58kd ab csf ql ib,b. burgdorferi 58kd ab ib ql (csf),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; b burg; b burgdor; b burgdor58kd; b burgdorferi; bb; blt; burgdorf; cerebral spinal fluid; cerebrospinal fl; id; immune blot; immunobl; immunoblot; infectious disease; infectiousdisease; lyme; lyme disease; lymes; microbiology; neuro; neurology; ordinal; point in time; pr; ql; qual; qualitative; random; riba; screen; spinal fl; spinal fld; spinal flu; spinal fluid; wb; wblot; west blot; west blt; western blot,Ord
12882-7,borrelia burgdorferi 29kd ab [presence] in body fluid by immunoblot,b burgdor29kd ab fld ql ib,b. burgdorferi 29kd ab ib ql (body fld),"abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; b burg; b burgdor; b burgdor29kd; b burgdorferi; b/f; bb; bf; blt; bod; bodies; body fluid; body fluid, unsp; burgdorf; fl; fld; flu; fluid; id; immune blot; immunobl; immunoblot; infectious disease; infectiousdisease; lyme; lyme disease; lymes; microbiology; ordinal; osp d; ospd; outer surface protein d; point in time; pr; ql; qual; qualitative; random; riba; screen; wb; wblot; west blot; west blt; western blot",Ord
12884-3,borrelia burgdorferi 39kd ab [presence] in body fluid by immunoblot,b burgdor39kd ab fld ql ib,b. burgdorferi 39kd ab ib ql (body fld),"abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; b burg; b burgdor; b burgdor39kd; b burgdorferi; b/f; bb; bf; blt; bod; bodies; body fluid; body fluid, unsp; burgdorf; fl; fld; flu; fluid; id; immune blot; immunobl; immunoblot; infectious disease; infectiousdisease; lyme; lyme disease; lymes; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; riba; screen; wb; wblot; west blot; west blt; western blot",Ord
12895-9,hiv 1 p58 ab [presence] in serum by immunoblot,hiv1 p58 ab ser ql ib,hiv 1 p58 ab ib ql (s),abs; aby; aids; antby; anti; antibodies; antibody; autoantibodies; autoantibody; blt; hiv type 1; hiv type i; hiv1; hiv1 p58; human immunodeficiency virus; i; id; immune blot; immunobl; immunoblot; infectious disease; infectiousdisease; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; riba; screen; serum; sr; wb; wblot; west blot; west blt; western blot,Ord
12913-0,beta-n-acetylhexosaminidase [enzymatic activity/volume] in leukocytes,b-nah wbc-ccnc,beta-n-acetylhexosaminidase (wbc) [catalytic activity/vol],b; b-nah; catalytic concentration; chemistry; gm2-gangliosidosis; hex a; hex b; hexa; hexosaminidase; leukocytes; point in time; qnt; quan; quant; quantitative; random; sandhoff disease; tay sachs disease; wbcs; white blood cells,Qn
12918-9,monoamine oxidase [enzymatic activity/volume] in platelet rich plasma,monoamine oxidase prp-ccnc,monoamine oxidase (prp) [catalytic activity/vol],catalytic concentration; chemistry; mao; platelet rich plasma; point in time; qnt; quan; quant; quantitative; random,Qn
12919-7,monoamine oxidase [enzymatic activity/volume] in blood,monoamine oxidase bld-ccnc,monoamine oxidase (bld) [catalytic activity/vol],blood; catalytic concentration; chemistry; mao; point in time; qnt; quan; quant; quantitative; random; wb; whole blood,Qn
12926-2,thyroxine (t4) [mass/volume] in serum or plasma --5th specimen post xxx challenge,t4 sp5 p chal serpl-mcnc,t4 5th specimen post unsp challenge [mass/vol],after; chemistry.challenge testing; endocrine; endocrinology; level; levothyroxine; levo-thyroxine; l-thyroxine; mass concentration; p chal; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sp5; sp5 p chal; spec; sr; t4; t-4; thyroid hormone; thyrox; thyroxin; thyrx; total t4; tt4,Qn
12929-6,thyroxine (t4) [mass/volume] in serum or plasma --8th specimen post xxx challenge,t4 sp8 p chal serpl-mcnc,t4 8th specimen post unsp challenge [mass/vol],after; chemistry.challenge testing; endocrine; endocrinology; level; levothyroxine; levo-thyroxine; l-thyroxine; mass concentration; p chal; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sp8; sp8 p chal; spec; sr; t4; t-4; thyroid hormone; thyrox; thyroxin; thyrx; total t4; tt4,Qn
12931-2,thyroxine (t4) [mass/volume] in serum or plasma --1 hour post xxx challenge,t4 1h p chal serpl-mcnc,t4 1 hr post unsp challenge [mass/vol],1 hour; 1.0hr; 1h p chal; 60 min; 60 minutes; 60m; 60min; after; chemistry.challenge testing; endocrine; endocrinology; level; levothyroxine; levo-thyroxine; l-thyroxine; mass concentration; p chal; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; t4; t-4; thyroid hormone; thyrox; thyroxin; thyrx; total t4; tt4,Qn
12941-1,thyrotropin [units/volume] in serum or plasma --2nd specimen post xxx challenge,tsh sp2 p chal serpl-acnc,tsh 2nd specimen post unsp challenge qn,after; arbitrary concentration; chemistry.challenge testing; convalescent; endocrine; endocrinology; p chal; pl; plasma; plsm; point in time; post immunization; pst; qnt; quan; quant; quantitative; random; second; serp; serpl; serplas; serum; serum or plasma; sp2; sp2 p chal; spec; sr; thyroid stimulating hormone; thyrotropic hormone; tsh,Qn
12955-1,triiodothyronine (t3) [mass/volume] in serum or plasma --4th specimen post xxx challenge,t3 sp4 p chal serpl-mcnc,t3 4th specimen post unsp challenge [mass/vol],after; chemistry.challenge testing; endocrine; endocrinology; level; mass concentration; p chal; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sp4; sp4 p chal; spec; sr; t3; t-3; thyroid hormone; total t3; triodothyrne,Qn
12961-9,urea nitrogen [mass/volume] in arterial blood,bun blda-mcnc,urea nitrogen (blda) [mass/vol],abg; art; art bld; art blood; arterial; arterial blood; blood arterial; blood urea nitrogen; chemistry; level; mass concentration; n; n2; nit; point in time; qnt; quan; quant; quantitative; random; un,Qn
12966-8,urea nitrogen [mass/volume] in serum or plasma --2 hour specimen,bun 2h spec serpl-mcnc,urea nitrogen 2 hour specimen [mass/vol],120 min; 120 minutes; 120min; 2 hours; blood urea nitrogen; bun; chemistry; kidney; level; mass concentration; n; n2; nephrology; nit; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; renal; serp; serpl; serplas; serum; serum or plasma; spec; sr; un,Qn
12969-2,urea nitrogen [mass/volume] in peritoneal dialysis fluid --baseline,urea nit bs diafp-mcnc,urea nitrogen baseline (perit dial fld) [mass/vol],blood urea nitrogen; bs; chemistry; diaf; diafp; dialysate; dialysis fluid; level; mass concentration; n; n2; nit; peritoneal dialysis fluid; point in time; qnt; quan; quant; quantitative; random; un,Qn
12975-9,urea nitrogen [mass/volume] in peritoneal dialysis fluid --5th specimen,urea nit sp5 diafp-mcnc,urea nitrogen 5th specimen (perit dial fld) [mass/vol],blood urea nitrogen; chemistry; diaf; diafp; dialysate; dialysis fluid; level; mass concentration; n; n2; nit; peritoneal dialysis fluid; point in time; qnt; quan; quant; quantitative; random; sp5; spec; un,Qn
13006-2,"1,4-dichlorobenzene [mass/volume] in serum or plasma","1,4dcb serpl-mcnc","1,4-dichlorobenzene [mass/vol]","1,4dcb; 3,3'-dichlorobenzidine; c6h4cl2; dcb; dichloricide; dichlorocide; drug/toxicology; drugs; evola; globol; i; level; mass concentration; para; para dichlorobenzene; paracide; paradow; paramoth; paranuggets; para-zene; p-chlorophenyl chloride; pdb; pdcb; p-dcb; p-dichlorobenzene; p-dichlorobenzol; persia-perazol; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; santochlor; serp; serpl; serplas; serum; serum or plasma; sr",Qn
13008-8,methyl propyl ketone [mass/volume] in blood,mpk bld-mcnc,methyl propyl ketone (bld) [mass/vol],2-pentanone; blood; drug/toxicology; drugs; ethylacetone; level; mass concentration; methyl n-propyl ketone; methylpropyl ketone; mpk; point in time; qnt; quan; quant; quantitative; random; wb; whole blood,Qn
13018-7,pesticides [identifier] in urine,pesticides ur,pesticides nom (u),drug/toxicology; drugs; identity or presence; nominal; point in time; random; ua; ur; urn,Nom
13026-0,orthocresol [mass/volume] in urine,orthocresol ur-mcnc,orthocresol (u) [mass/vol],1-hydroxy-2-methylbenzene; 2-cresol; 2-hydroxytoluene; 2-methylphenol; drug/toxicology; drugs; level; mass concentration; o-cresol; o-cresylic acid; o-hydroxytoluene; o-methylphenol; o-methylphenylol; ortho-cresol; point in time; qnt; quan; quant; quantitative; random; ua; ur; urn,Qn
13038-5,c peptide [mass/volume] in serum or plasma --30 minutes post xxx challenge,c peptide 30m p chal serpl-mcnc,c peptide 30 min post unsp challenge [mass/vol],30m p chal; after; chemistry.challenge testing; connecting peptide of insulin; level; mass concentration; p chal; pept; pl; plasma; plsm; point in time; pro-insulin c peptide; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
13041-9,c peptide [mass/volume] in serum or plasma --2 hours post xxx challenge,c peptide 2h p chal serpl-mcnc,c peptide 2 hr post unsp challenge [mass/vol],120 min; 120 minutes; 120min; 2 hours; 2h p chal; after; chemistry.challenge testing; connecting peptide of insulin; level; mass concentration; p chal; pept; pl; plasma; plsm; point in time; pro-insulin c peptide; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
13047-6,plasma cells/leukocytes in blood,plasma cells nfr bld,plasma cells/leukocytes (bld),blood; cell; cellularity; hematology/cell counts; leuc; leuk; leukocyte; lkcs; myeloma cells; number fraction; percent; plasmacyte; plasmacytes; point in time; qnt; quan; quant; quantitative; random; wb; wbc; wbcs; white blood cell; white blood cells; whole blood,Qn
13051-8,deprecated protein s [units/volume] in platelet poor plasma,deprecated prot s ppp-acnc,protein s qn (ppp),arbitrary concentration; coagulation; hematology; heme; plas; platelet poor plasma; point in time; pr; prot; prot s; ps; qnt; quan; quant; quantitative; random; s prime,Qn
13074-0,phosphatidylcholine igm ab [units/volume] in serum,pc igm ser-acnc,phosphatidylcholine igm qn (s),abs; aby; antby; anti; antibodies; antibody; apc; arbitrary concentration; autoantibodies; autoantibody; coagulation; hematology; heme; immune globulin m; immunoglobulin m; neonatal respiratory distress syndrome; pc; phosphatidyl choline; point in time; ptdcho; qnt; quan; quant; quantitative; random; serum; sr,Qn
1308-6,deprecated d nos ab [presence] in serum or plasma from donor,deprecated d nos ab serpl donr ql,d nos ab ql (s/p donor),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; blood bank; dextro; donr; ordinal; other; pl; plasma; plsm; point in time; pr; ql; qual; qualitative; random; screen; serp; serpl; serplas; serum; serum or plasma; sr,Ord
13093-0,deprecated monosialoganglioside gm1 ab.igm,deprecated gm1 monosialo igm ser,monosialoganglioside gm1 igm (s),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; ganglioside monosialo; immune globulin m; immunoglobulin m; point in time; random; serology; serum; sr,OrdQn
13097-1,deprecated pm-scl extractable nuclear ab,deprecated ena pm-scl ab ser eia,pm-scl extractable nuclear ab eia (s),abs; aby; ana; anf; antby; anti; antibodies; antibody; antinuclear antibody; arbitrary concentration; autoantibodies; autoantibody; elfa; elisa; ena; ena pm/scl; enzyme immunoassay; evening; iaa; meia; na; nuc; point in time; random; scleroderma; scleroderma ab; serology; serum; sr; suds,OrdQn
13100-3,deprecated sulfate-3-glucuronyl paragloboside ab.igm in serum,deprecated sgpg igm ser,sulfate-3-glucuronyl paragloboside igm (s),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; iii; immune globulin m; immunoglobulin m; point in time; random; serology; serum; sgpg; so4; so4-2; sr; sulf,OrdQn
13102-9,deprecated disialylganglioside gd1b ab in serum,deprecated gd1b disialyl ab ser,disialylganglioside gd1b ab (s),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; ganglioside disialyl; point in time; random; serology; serum; sr,OrdQn
13104-5,deprecated disialylganglioside gd1b ab.igm,deprecated gd1b disialyl igm ser,disialylganglioside gd1b igm (s),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; ganglioside disialyl; immune globulin m; immunoglobulin m; point in time; random; serology; serum; sr,OrdQn
13106-0,deprecated tetrasialylganglioside gq1b ab in serum,deprecated gq1b tetra ab ser,tetrasialylganglioside gq1b ab (s),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; gq1b; point in time; random; serology; serum; sr,OrdQn
13112-8,deprecated nuclear ab immunofluorescence (rat kidney substrate),deprecated ana ser if rat kidney,nuclear ab if rat kidney (s),abs; aby; acif; ana; anf; antby; anti; antibodies; antibody; anticomplement immunofluorescence; antinuclear antibody; arbitrary concentration; autoantibodies; autoantibody; fa; fana; fluorescent antibody; fluoresent; ifa; immune fluorescence; immunoflour; immunofluor; immunofluorescence; na; nuc; point in time; random; serology; serum; sr; time resolved fluorescence; trf,OrdQn
13117-7,complement sc5b-9 ab [units/volume] in serum or plasma,sc5b9 ab serpl-acnc,complement sc5b-9 ab qn,abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; comp; complement sc5 b-9; complement soluble c5b-9; complmt; hematology/cell counts; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; sc5b9; serp; serpl; serplas; serum; serum or plasma; sr; terminal complement complex; ttc,Qn
13119-3,myelin associated glycoprotein ab [presence] in serum by immunoblot,mag ab ser ql ib,myelin associated glycoprotein ab ib ql (s),abs; aby; antby; anti; antibodies; antibody; assoc; autoantibodies; autoantibody; blt; gg; glycoprot; glycoproteins; gp; immune blot; immunobl; immunoblot; mag; neuro; neurology; ordinal; point in time; pr; ql; qual; qualitative; random; riba; screen; serology; serum; sr; wb; wblot; west blot; west blt; western blot,Ord
13127-6,cancer ag dm/70k [units/volume] in serum or plasma,cancer ag dm/70k serpl-acnc,cancer ag dm/70k qn,arbitrary concentration; ca; cancer ag dm/70k; carbohydrate antigen; chemistry; dianon marker 70/k; dm/70k; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; tumor marker,Qn
1312-8,deprecated d nos ag [presence] on red blood cells,deprecated d nos ag rbc ql,d nos ag ql (rbc),antigen; antigens; blood bank; dextro; erythrocytes; ordinal; other; point in time; pr; ql; qual; qualitative; random; red blood cells; red blood corpusles; screen,Ord
13136-7,streptococcus pneumoniae danish serotype 18c ab [units/volume] in serum,s pneum da 18c ab ser-acnc,s. pneumoniae danish type 18c ab qn (s),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; id; infectious disease; infectiousdisease; microbiology; pcv13; pcv7; pneu; pneum; pneumo; pneumococ; pneumococcal; pneumococcal pneumonia; pneumococcus; pneumon; pneumonia; point in time; ppsv23; qnt; quan; quant; quantitative; random; s pneum da 18c; s pneum da 18c ab; s pneum da type; s pneumo; s pneumoniae; serum; spn; sr; strep; strept; u.s. serotype 56,Qn
13138-3,deprecated streptococcus pneumoniae 23 ab [units/volume] in serum,deprecated s pneum23 ab ser-acnc,s. pneumoniae 23 ab qn (s),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; id; infectious disease; infectiousdisease; microbiology; pneu; pneum; pneumo; pneumococ; pneumococcal; pneumococcal pneumonia; pneumococcus; pneumon; pneumonia; point in time; qnt; quan; quant; quantitative; random; s pneum23; s pneumo; s pneumoniae; serum; spn; sr; strep; strept; streptococcus pneumoniae 23f,Qn
13148-2,streptococcus pneumoniae danish serotype 7f ab [units/volume] in serum --2nd specimen,s pneum da 7f ab sp2 ser-acnc,s. pneumoniae danish type 7f ab spec 2 qn (s),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; convalescent; id; infectious disease; infectiousdisease; microbiology; pcv13; pneu; pneum; pneumo; pneumococ; pneumococcal; pneumococcal pneumonia; pneumococcus; pneumon; pneumonia; point in time; post immunization; ppsv23; qnt; quan; quant; quantitative; random; s pneum da 7f; s pneum da 7f ab; s pneum da type; s pneumo; s pneumoniae; second; serum; sp2; spec; spn; sr; strep; strept; u.s. serotype 51,Qn
13151-6,deprecated streptococcus pneumoniae 9 ab [units/volume] in serum --1st specimen,deprecated s pneum9 ab sp1 ser-acnc,s. pneumoniae 9 ab spec 1 qn (s),abs; aby; acute specimen; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; first; id; infectious disease; infectiousdisease; microbiology; pneu; pneum; pneumo; pneumococ; pneumococcal; pneumococcal pneumonia; pneumococcus; pneumon; pneumonia; point in time; pre immunization; qnt; quan; quant; quantitative; random; s pneum9; s pneumo; s pneumoniae; serum; sp1; spec; spn; sr; strep; strept; streptococcus pneumoniae 9n,Qn
13158-1,streptococcus pneumoniae danish serotype 18c ab [units/volume] in serum --2nd specimen,s pneum da 18c ab sp2 ser-acnc,s. pneumoniae danish type 18c ab spec 2 qn (s),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; convalescent; id; infectious disease; infectiousdisease; microbiology; pcv13; pcv7; pneu; pneum; pneumo; pneumococ; pneumococcal; pneumococcal pneumonia; pneumococcus; pneumon; pneumonia; point in time; post immunization; ppsv23; qnt; quan; quant; quantitative; random; s pneum da 18c; s pneum da 18c ab; s pneum da type; s pneumo; s pneumoniae; second; serum; sp2; spec; spn; sr; strep; strept; u.s. serotype 56,Qn
13166-4,deprecated streptococcus pneumoniae 23 ab [units/volume] in serum,deprecated s pneum23 ab ser-acnc,s. pneumoniae 23 ab qn (s),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; id; infectious disease; infectiousdisease; microbiology; pneu; pneum; pneumo; pneumococ; pneumococcal; pneumococcal pneumonia; pneumococcus; pneumon; pneumonia; point in time; qnt; quan; quant; quantitative; random; s pneum23; s pneumo; s pneumoniae; serum; spn; sr; strep; strept; streptococcus pneumoniae 23f,Qn
13176-3,wasp venom ige ab [units/volume] in serum,wasp venom ige qn,wasp venom ige qn (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; immune globulin e; immunoglobulin e; point in time; qnt; quan; quant; quantitative; random; serum; sr,Qn
1318-5,s ag [presence] on red blood cells from blood product unit,s ag rbc bpu ql,s ag ql (rbc bpu),antigen; antigens; blood bank; blood product unit; blood product unit (pack); erythrocytes; hematology; heme; mnss blood group system; ordinal; point in time; pr; ql; qual; qualitative; random; red blood cells; red blood corpusles; s prime; screen,Ord
13200-1,rickettsia conorii igm ab [units/volume] in serum,r conorii igm ser-acnc,r. conorii igm qn (s),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; boutonneuse fever; id; immune globulin m; immunoglobulin m; infectious disease; infectiousdisease; mediterranean spotted fever; microbiology; point in time; qnt; quan; quant; quantitative; r conorii; random; ricket; rickettsial; serum; spotted fever; sr,Qn
13202-7,borrelia burgdorferi igg ab [presence] in cerebral spinal fluid by immunoblot,b burgdor igg csf ql ib,b. burgdorferi igg ib ql (csf),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; b burg; b burgdor; b burgdorferi; bb; blt; burgdorf; cerebral spinal fluid; cerebrospinal fl; id; immune blot; immune globulin g; immunobl; immunoblot; immunoglobulin g; infectious disease; infectiousdisease; lyme; lyme disease; lymes; microbiology; neuro; neurology; ordinal; point in time; pr; ql; qual; qualitative; random; riba; screen; spinal fl; spinal fld; spinal flu; spinal fluid; wb; wblot; west blot; west blt; western blot,Ord
13216-7,candida albicans immune complex [units/volume] in serum or plasma,c albicans immune cmplx qn,c. albicans immune complex qn,allergen; allergens; allergy testing; arbitrary concentration; c albicans; c albicans immune cmplx; cand; candidiasis; cic; circulating immune complex; compx; ic; imm; imun; imune; m005; m5; monilia; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; thrush,Qn
13231-6,saint louis encephalitis virus igm ab [units/volume] in cerebral spinal fluid,slev igm csf-acnc,slev igm qn (csf),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; cerebral spinal fluid; cerebrospinal fl; enc; enceph; encephalomyelitis; id; immune globulin m; immunoglobulin m; infectious disease; infectiousdisease; microbiology; neuro; neurology; point in time; qnt; quan; quant; quantitative; random; sle virus; slev; spinal fl; spinal fld; spinal flu; spinal fluid; st louis,Qn
13234-0,coxsackievirus a4 ab [units/volume] in cerebral spinal fluid,cv a4 ab csf-acnc,coxsackievirus a4 ab qn (csf),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; cav; cerebral spinal fluid; cerebrospinal fl; coxsackie; coxsackie virus; cv; cv a4; id; infectious disease; infectiousdisease; microbiology; neuro; neurology; point in time; qnt; quan; quant; quantitative; random; spinal fl; spinal fld; spinal flu; spinal fluid,Qn
13246-4,haemophilus influenzae b ab [units/volume] in serum,haem influ b ab ser-acnc,h. influenzae b ab qn (s),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; h flu; h influenza; h influenzae; haem influ; haem influ b; haemoph; hib; id; infectious disease; infectiousdisease; influ; microbiology; point in time; qnt; quan; quant; quantitative; random; serum; sr,Qn
13270-4,mycoplasma pneumoniae iga ab [units/volume] in serum,m pneumo iga ser-acnc,m. pneumoniae iga qn (s),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; enzootic pneumonia; id; immune globulin a; immunoglobulin a; infectious disease; infectiousdisease; m pneumo; m pneumonia; m pneumoniae; microbiology; myco; myco pneu; mycoplas; mycoplasm; mycoplasmoides pneumoniae; mycoplasmosis; mycoplsm; pneu; pneum; pneumo; pneumon; pneumonia; point in time; qnt; quan; quant; quantitative; random; serum; sr,Qn
13272-0,neisseria meningitidis serogroup c ab [units/volume] in serum,n men sg c ab ser-acnc,n. meningitidis c ab qn (s),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; id; infectious disease; infectiousdisease; mening; meningid; meningitis; meningo; meningococcal meningitis; meningococcus; microbiology; n men; n men serogroup; n men sg c; n menigitidis; n meningitidis; neisseria meningitidis group c; neisseria meningitidis type c; point in time; qnt; quan; quant; quantitative; random; rh blood group system; serum; sr,Qn
13292-8,colorado tick fever virus igg ab [units/volume] in serum,ctfv igg ser-acnc,colorado tick fever virus igg qn (s),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; ctfv; id; immune globulin g; immunoglobulin g; infectious disease; infectiousdisease; microbiology; point in time; qnt; quan; quant; quantitative; random; serum; sr,Qn
13-3,amikacin [susceptibility] by disk diffusion (kb),amikacin islt kb,amikacin disk diffusion (kb) [susc],amikin; aminoglycosides; antibiotic susceptibilities; ast; disk diffusion; id; infectious disease; infectiousdisease; islt; isol; kb; kirby-bauer; point in time; random; sus; suscept; susceptibilities; susceptibility; susceptibilty,OrdQn
1330-0,v ab [presence] in serum or plasma from donor,v ab serpl donr ql,v ab ql (s/p donor),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; blood bank; donr; ordinal; pl; plasma; plsm; point in time; pr; ql; qual; qualitative; random; rh blood group system; screen; serp; serpl; serplas; serum; serum or plasma; sr,Ord
13303-3,hla-a+b+c (class i) [type],hla-a+b+c,hla-a+b+c (class i) nom (bld/tiss),"a,b; blood; genetics; heredity; heritable; hla antigen; hla class i; human leukocyte antigen; inherited; nominal; point in time; random; tissue; tissue, unspecified; typ; wb; whole blood; whole blood or tissue",Nom
13319-9,ova and parasites identified in stool by light microscopy--2nd specimen,o+p sp2 stl micro,ova and parasites identified spec 2 lm nom (stl),bowel movement; convalescent; faecal; faeces; fecal; feces; gastro; gastroenterology; gi; id; identity or presence; infectious disease; infectiousdisease; lm; micro; microbiology; micros; microscopic; nominal; o&p; o+p; ova and parasite; ovum; parasite; point in time; post immunization; random; second; sp2; spec; stl; stool = fecal,Nom
13322-3,human papilloma virus igm ab [presence] in serum,hpv igm ser ql,hpv igm ql (s),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; genital warts; hpv; human papillomavirus; id; immune globulin m; immunoglobulin m; infectious disease; infectiousdisease; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; sr,Ord
13349-6,leukocytes [#/volume] in stool by manual count,wbc # stl manual,wbc manual cnt (stl) [#/vol],#; abs; absolute; absolutes; bowel movement; cnt; count; count/volume; ct; faecal; faeces; fecal; feces; hematology/cell counts; leuc; leuk; leukocyte; lkcs; manl; number concentration; number concentration (count/vol); point in time; qnt; quan; quant; quantitative; random; stl; stool = fecal; universallaborders; wbc; wbcs; white blood cell; white blood cells,Qn
13359-5,character of semen,character smn,character (sem),appearance; ejaculate; genitourinary; gu; nominal; point in time; random; sem; seminal fluid; smn; smpls; spec; uro; urology,Nom
13377-7,1-methylhistidine [mass/volume] in cerebral spinal fluid,1me-hist csf-mcnc,1-methylhistidine (csf) [mass/vol],1me-hist; cerebral spinal fluid; cerebrospinal fl; chemistry; i; level; mass concentration; methyl-histidine; point in time; qnt; quan; quant; quantitative; random; spinal fl; spinal fld; spinal flu; spinal fluid,Qn
13385-0,beta aminoisobutyrate [mass/volume] in amniotic fluid,b-aib amn-mcnc,beta aminoisobutyrate (amn fld) [mass/vol],3-aminoisobutyrate; 3-aminoisobutyric acid; af; amn; amn fl; amnio; amniotic flu; amniotic fluid; b; b-aib; chemistry; level; mass concentration; point in time; qnt; quan; quant; quantitative; random,Qn
13389-2,aspartate [mass/volume] in amniotic fluid,aspartate amn-mcnc,aspartate (amn fld) [mass/vol],af; amn; amn fl; amnio; amniotic flu; amniotic fluid; asp; aspartic acid; chemistry; level; mass concentration; point in time; qnt; quan; quant; quantitative; random,Qn
13392-6,citrulline [mass/volume] in amniotic fluid,citrulline amn-mcnc,citrulline (amn fld) [mass/vol],af; amn; amn fl; amnio; amniotic flu; amniotic fluid; chemistry; cit; citr; level; mass concentration; point in time; qnt; quan; quant; quantitative; random,Qn
13399-1,homocystine [mass/volume] in amniotic fluid,(hcys)2 amn-mcnc,homocystine (amn fld) [mass/vol],(hcys)2; af; amn; amn fl; amnio; amniotic flu; amniotic fluid; chemistry; homocyst(e)ine; homocystin; level; mass concentration; point in time; qnt; quan; quant; quantitative; random,Qn
13404-9,lysine [mass/volume] in amniotic fluid,lysine amn-mcnc,lysine (amn fld) [mass/vol],"2,6-diaminohexanoic acid; af; amn; amn fl; amnio; amniotic flu; amniotic fluid; chemistry; level; lys; mass concentration; point in time; qnt; quan; quant; quantitative; random",Qn
13414-8,serine [mass/volume] in amniotic fluid,serine amn-mcnc,serine (amn fld) [mass/vol],af; amn; amn fl; amnio; amniotic flu; amniotic fluid; chemistry; level; mass concentration; point in time; qnt; quan; quant; quantitative; random; ser,Qn
13437-9,dopamine [mass/volume] in serum or plasma --7th specimen post xxx challenge,dopamine sp7 p chal serpl-mcnc,dopamine 7th specimen post unsp challenge [mass/vol],^7th spec pst xxx chal; after; chemistry.challenge testing; level; mass concentration; p chal; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sp7; sp7 p chal; spec; sr,Qn
13462-7,apolipoprotein a-i/apolipoprotein b [mass ratio] in serum or plasma,apo a-i/apo b serpl,apolipoprotein a-i/apolipoprotein b [mass ratio],apo; apo a; apo a-i; apo b; apoa1; apob; apolipo; apolipoprot; apolipoprotein a1; apolipoproteins; cardio; cardiology; chemistry; heart disease; mass concentration ratio; mass ratio; mcrto; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
13467-6,selenium/creatinine [mass ratio] in urine,selenium/creat ur,selenium/creatinine (u) [mass ratio],cr; crea; creat; drug/toxicology; drugs; mass concentration ratio; mass ratio; mcrto; point in time; qnt; quan; quant; quantitative; random; se; ua; ucr; ur; urn,Qn
13470-0,aluminum/creatinine [mass ratio] in urine,aluminum/creat ur,aluminum/creatinine (u) [mass ratio],al; aluminium; cr; crea; creat; drug/toxicology; drugs; mass concentration ratio; mass ratio; mcrto; point in time; qnt; quan; quant; quantitative; random; ua; ucr; ur; urn,Qn
13472-6,nickel/creatinine [mass ratio] in urine,nickel/creat ur,nickel/creatinine (u) [mass ratio],cr; crea; creat; drug/toxicology; drugs; mass concentration ratio; mass ratio; mcrto; ni; point in time; qnt; quan; quant; quantitative; random; ua; ucr; ur; urn,Qn
13473-4,zinc/creatinine [mass ratio] in urine,zinc/creat ur,zinc/creatinine (u) [mass ratio],cr; crea; creat; drug/toxicology; drugs; mass concentration ratio; mass ratio; mcrto; point in time; qnt; quan; quant; quantitative; random; ua; ucr; ur; urn; zn,Qn
1347-4,yt sup(a) ag [presence] on red blood cells,yt sup(a) ag rbc ql,yt sup(a) ag ql (rbc),antigen; antigens; blood bank; erythrocytes; hematology; heme; ordinal; point in time; pr; ql; qual; qualitative; random; red blood cells; red blood corpusles; screen; t prime; y (little t) (little a); yt sup(a); yt^a,Ord
13474-2,magnesium/creatinine [mass ratio] in urine,magnesium/creat ur,magnesium/creatinine (u) [mass ratio],chemistry; cr; crea; creat; mag; magnes; mass concentration ratio; mass ratio; mcrto; mg; point in time; qnt; quan; quant; quantitative; random; ua; ucr; ur; urn,Qn
13489-0,follitropin/creatinine [mass ratio] in urine,fsh/creat ur,follitropin/creatinine (u) [mass ratio],chemistry; cr; crea; creat; follicle stimulating hormone; fsh; mass concentration ratio; mass ratio; mcrto; point in time; qnt; quan; quant; quantitative; random; ua; ucr; ur; urn,Qn
1349-0,yt sup(b) ab [presence] in serum or plasma from donor,yt sup(b) ab serpl donr ql,yt sup(b) ab ql (s/p donor),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; blood bank; donr; ordinal; pl; plasma; plsm; point in time; pr; ql; qual; qualitative; random; screen; serp; serpl; serplas; serum; serum or plasma; sr; t prime; y (little t) (little b); yt sup(b); yt^b,Ord
13493-2,deprecated cd8+cd25+ cells/100 cells in blood,deprecated cd8+cd25+ cells fr bld,cd8+cd25+ cells (bld),blood; cd8 cells; cd8+cd25+ cells; cell; cell markers; cellularity; il-2 receptor alpha chain; il-2r; il-2r tac antigen; ilr2; leu2; leu-2; number fraction; percent; point in time; qnt; quan; quant; quantitative; random; suppressor t cells; t8; t-8; tac antigen; tsuppressor; wb; whole blood,Qn
13497-3,dextroamphetamine/levoamphetamine [mass ratio] in urine,d-amphet/l-amphet ur,dextroamphetamine/levoamphetamine (u) [mass ratio],d-amphet; d-amphetamine; dexedrine; dextro-amphetamine; drug/toxicology; drugs; l-amphet; l-amphetamine; levo-amphetamine; mass concentration ratio; mass ratio; mcrto; point in time; qnt; quan; quant; quantitative; random; ua; ur; urn,Qn
13507-9,lupus erythematosus cells [presence] in blood,le cells bld ql,lupus erythematosus cells ql (bld),blood; cell; cellularity; hematology/cell counts; le; le cells; ordinal; point in time; pr; ql; qual; qualitative; random; rotary glass bead test; screen; wb; whole blood,Ord
13524-4,leukocytes other/leukocytes in body fluid by manual count,wbc other nfr fld manual,wbc other/leukocytes manual cnt (body fld),"b/f; bf; bod; bodies; body fluid; body fluid, unsp; fl; fld; flu; fluid; hematology/cell counts; leuc; leuk; leukocyte; lkcs; manl; number fraction; othr; percent; point in time; qnt; quan; quant; quantitative; random; wbc; wbc other; wbcs; white blood cell; white blood cells",Qn
13542-6,phosphate [mass/volume] in cerebral spinal fluid,phosphate csf-mcnc,phosphate (csf) [mass/vol],cerebral spinal fluid; cerebrospinal fl; chemistry; i phos; inorganic phosphate; level; mass concentration; phos; phosphate total; phosphorous; phosphorus; phosphrous; pi; po4; point in time; qnt; quan; quant; quantitative; random; spinal fl; spinal fld; spinal flu; spinal fluid,Qn
13558-2,disopyramide [presence] in serum or plasma,disopyramide serpl ql,disopyramide ql,diso durules; drug/toxicology; drugs; norpace; ordinal; pl; plasma; plsm; point in time; pr; pyramide; ql; qual; qualitative; random; rythmodan; screen; serp; serpl; serplas; serum; serum or plasma; sr,Ord
13584-8,tobramycin [mass/volume] in body fluid,tobramycin fld-mcnc,tobramycin (body fld) [mass/vol],"aminoglycosides; b/f; bf; bod; bodies; body fluid; body fluid, unsp; drug/toxicology; drugs; fl; fld; flu; fluid; level; mass concentration; nebcin; nebdin; point in time; qnt; quan; quant; quantitative; random; tobj; tobra",Qn
13603-6,17-hydroxypregnenolone [mass/volume] in serum or plasma --15 minutes post 250 ug corticotropin,17oh-preg 15m p 250 ug acth serpl-mcnc,17-hydroxypregnenolone 15 min post 250 ug corticotropin [mass/vol],15m p 250 ug acth; 17 alpha-hydroxypregnanolone; 17 hydroxy pregnenolone; 17-alpha-hydroxypregnenolone; 17alpha-hydroxypregnenolone; 17oh-preg; acth; adrenocorticotrophic hormone; adrenocorticotropin; after; c206; c74; chemistry.challenge testing; cortrosyn; level; mass concentration; mcg; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; rc206; serp; serpl; serplas; serum; serum or plasma; sr; tumor marker,Qn
1361-5,corticotropin [mass/volume] in plasma --1 minute post 1 ug/kg crh iv,acth 1m p 1 u/kg crh iv plas-mcnc,corticotropin 1 min post 1 ug/kg crh iv (p) [mass/vol],1m p 1 u/kg crh iv; acth; adrenocorticotrophic hormone; adrenocorticotropin; after; c206; c74; chemistry.challenge testing; cortrosyn; i; level; mass concentration; mcg; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; rc206; tumor marker,Qn
13616-8,nitrite [mass/volume] in water,nitrite wat-mcnc,nitrite (water) [mass/vol],chemistry; level; mass concentration; no2; point in time; qnt; quan; quant; quantitative; random; wat,Qn
13622-6,acetaminophen [mass/volume] in urine,apap ur-mcnc,acetaminophen (u) [mass/vol],acet; acetamidophenol; acetaminoph; acetominophen; addiction; apap; c209; c55; drug/toxicology; drugs; drugs of abuse; hepatology; hydroxyacetanilide; illicit; level; liver; mass concentration; n-(4-hydroxyphenyl)acetanilide; n-acetyl-p-aminophenol; p-acetamidophenol; paracetamol; p-hydroxyacetanilide; point in time; potentialforabuse; qnt; quan; quant; quantitative; random; tylenol; u209; ua; ur; urn,Qn
13628-3,deprecated spermatozoa motile/100 spermatozoa in semen,deprecated sperm motile fr smn,spermatozoa motile/100 spermatozoa (sem),ejaculate; fertility testing; genitourinary; gu; mot; number fraction; percent; point in time; qnt; quan; quant; quantitative; random; sem; seminal fluid; smn; smpls; sperm; sperm motile; uro; urology,Qn
13645-7,manganese [mass/volume] in water,manganese wat-mcnc,manganese (water) [mass/vol],drug/toxicology; drugs; level; mass concentration; mn; point in time; qnt; quan; quant; quantitative; random; wat,Qn
13653-1,epithelial cells.renal [#/volume] in urine sediment,renal epi cells # urns,epithelial cells.renal (urine sed) [#/vol],#; abs; absolute; absolutes; cell; cellularity; cnt; count; count/volume; ct; epi; epi cells; epith; epithelia; kidney; kidney cells; nephrology; number concentration; number concentration (count/vol); point in time; qnt; quan; quant; quantitative; random; rec; renal; renal epi cells; renal tubular cells; rtc; rte; ua; ur; urinalysis; urine sediment; urn; urns,Qn
1366-4,corticotropin [mass/volume] in plasma --5 minutes post 1 ug/kg crh iv,acth 5m p 1 ug/kg crh iv plas-mcnc,corticotropin 5 min post 1 ug/kg crh iv (p) [mass/vol],5m p 1 ug/kg crh iv; acth; adrenocorticotrophic hormone; adrenocorticotropin; after; c206; c74; chemistry.challenge testing; cortrosyn; i; level; mass concentration; mcg; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; rc206; tumor marker,Qn
13674-7,2-hydroxyisovalerate/creatinine [mass ratio] in urine,2oh-isovalerate/creat ur,2-hydroxyisovalerate/creatinine (u) [mass ratio],2-hia; 2-hydroxy-isovalerate; 2-hydroxyisovaleric acid; 2oh-isovalerate; chemistry; cr; crea; creat; ii; mass concentration ratio; mass ratio; mcrto; point in time; qnt; quan; quant; quantitative; random; ua; ucr; ur; urn,Qn
13688-7,3-hydroxypropionate (3-oh-c3)/creatinine [mass ratio] in urine,3oh-propionate/creat ur,3-hydroxypropionate (3-oh-c3)/creatinine (u) [mass ratio],3-hydroxy-propionate; 3-hydroxypropionic acid; 3oh-propionate; chemistry; cr; crea; creat; iii; mass concentration ratio; mass ratio; mcrto; point in time; qnt; quan; quant; quantitative; random; ua; ucr; ur; urn,Qn
13693-7,3-methylglutarate/creatinine [mass ratio] in urine,3me-glutarate/creat ur,3-methylglutarate/creatinine (u) [mass ratio],3me-glutarate; 3-methylglutaric acid; chemistry; cr; crea; creat; iii; mass concentration ratio; mass ratio; mcrto; point in time; qnt; quan; quant; quantitative; random; ua; ucr; ur; urn,Qn
13706-7,amylase/creatinine [mass ratio] in urine,amylase/creat ur,amylase/creatinine (u) [mass ratio],alpha amylase; ams; amyl; chemistry; cr; crea; creat; diastase; gastro; gastroenterology; gi; k87; mass concentration ratio; mass ratio; mcrto; point in time; qnt; quan; quant; quantitative; random; ua; ucr; ur; urn,Qn
13722-4,citrate/creatinine [mass ratio] in urine,citrate/creat ur,citrate/creatinine (u) [mass ratio],chemistry; citric acid; cr; crea; creat; mass concentration ratio; mass ratio; mcrto; point in time; qnt; quan; quant; quantitative; random; ua; ucr; ur; urn,Qn
13733-1,dopamine/creatinine [mass ratio] in urine,dopamine/creat ur,dopamine/creatinine (u) [mass ratio],chemistry; cr; crea; creat; mass concentration ratio; mass ratio; mcrto; point in time; qnt; quan; quant; quantitative; random; ua; ucr; ur; urn,Qn
13743-0,fumarate/creatinine [mass ratio] in urine,fumarate/creat ur,fumarate/creatinine (u) [mass ratio],chemistry; cr; crea; creat; fumaric acid; mass concentration ratio; mass ratio; mcrto; point in time; qnt; quan; quant; quantitative; random; ua; ucr; ur; urn,Qn
13755-4,histamine/creatinine [mass ratio] in urine,histamine/creat ur,histamine/creatinine (u) [mass ratio],chemistry; cr; crea; creat; mass concentration ratio; mass ratio; mcrto; point in time; qnt; quan; quant; quantitative; random; ua; ucr; ur; urn,Qn
13758-8,homocysteine/creatinine [mass ratio] in urine,hcys/creat ur,homocysteine/creatinine (u) [mass ratio],chemistry; cr; crea; creat; hcy; hcys; hcyst; homocyst(e)ine; mass concentration ratio; mass ratio; mcrto; point in time; qnt; quan; quant; quantitative; random; ua; ucr; ur; urn,Qn
13774-5,methylhippurate/creatinine [mass ratio] in urine,methylhippurate/creat ur,methylhippurate/creatinine (u) [mass ratio],cr; crea; creat; drug/toxicology; drugs; mass concentration ratio; mass ratio; mcrto; methylhippuric acid; point in time; qnt; quan; quant; quantitative; random; ua; ucr; ur; urn; xylene metabolite,Qn
13775-2,methylmalonate/creatinine [mass ratio] in 24 hour urine,methylmalonate/creat 24h ur,methylmalonate/creatinine (24h u) [mass ratio],1 day; 24 hours; 24hr; chemistry; cr; crea; creat; mass concentration ratio; mass ratio; mcrto; methylmalonic acid; methylmalonic acidemia; mma; propionic acidemia; qnt; quan; quant; quantitative; ua; ucr; ur; urn,Qn
13777-8,methylsuccinate/creatinine [mass ratio] in urine,me-succinate/creat ur,methylsuccinate/creatinine (u) [mass ratio],2-methylsuccinic acid; chemistry; cr; crea; creat; mass concentration ratio; mass ratio; mcrto; me-succinate; methylsuccinic acid; point in time; pyrotartaric acid; qnt; quan; quant; quantitative; random; ua; ucr; ur; urn,Qn
13789-3,phosphoethanolamine/creatinine [mass ratio] in urine,petn/creat ur,phosphoethanolamine/creatinine (u) [mass ratio],chemistry; cr; crea; creat; mass concentration ratio; mass ratio; mcrto; pea; petn; point in time; qnt; quan; quant; quantitative; random; ua; ucr; ur; urn,Qn
13794-3,phenylpyruvate/creatinine [mass ratio] in urine,phenylpyruvate/creat ur,phenylpyruvate/creatinine (u) [mass ratio],chemistry; cr; crea; creat; mass concentration ratio; mass ratio; mcrto; phenylpyruvic acid; point in time; qnt; quan; quant; quantitative; random; ua; ucr; ur; urn,Qn
1379-7,calcitonin [mass/volume] in serum or plasma --pre 2.4 mg/kg calcium short iv,calcit pre 2.4 mg/kgca siv serpl-mcnc,calcitonin pre 2.4 mg/kg calcium short iv [mass/vol],before; ca; cal; chemistry.challenge testing; ct; level; mass concentration; pl; plasma; plsm; point in time; pre 2.4 mg/kgca siv; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; thyrocalcitonin; tumor marker,Qn
13806-5,sarcosine/creatinine [mass ratio] in urine,sarcosine/creat ur,sarcosine/creatinine (u) [mass ratio],chemistry; cr; crea; creat; mass concentration ratio; mass ratio; mcrto; point in time; qnt; quan; quant; quantitative; random; sar; sarc; ua; ucr; ur; urn,Qn
13809-9,sodium/creatinine [mass ratio] in 24 hour urine,sodium/creat 24h ur,sodium/creatinine (24h u) [mass ratio],1 day; 24 hours; 24hr; chemistry; cr; crea; creat; kidney; mass concentration ratio; mass ratio; mcrto; na; na+; nephrology; qnt; quan; quant; quantitative; renal; ua; ucr; ur; urn,Qn
13820-6,urate/creatinine [mass ratio] in 24 hour urine,urate/creat 24h ur,urate/creatinine (24h u) [mass ratio],1 day; 24 hours; 24hr; chemistry; cr; crea; creat; kidney; mass concentration ratio; mass ratio; mcrto; nephrology; qnt; quan; quant; quantitative; renal; ua; ucr; ur; urates; uric acid; urn,Qn
13840-4,cd19 blasts/blasts in blood,cd19 blasts/blasts nfr bld,cd19 blasts/blasts (bld),b4; b-4; blast; blood; cd19 blasts; cell markers; hd-37; leu12; leu-12; number fraction; percent; point in time; qnt; quan; quant; quantitative; random; wb; whole blood,Qn
13842-0,cd20 blasts/blasts in blood,cd20 blasts/blasts nfr bld,cd20 blasts/blasts (bld),b1; b-1; blast; blood; bp35; cd20 blasts; cell markers; leu16; leu-16; number fraction; percent; point in time; qnt; quan; quant; quantitative; random; wb; whole blood,Qn
13844-6,cd34 blasts/blasts in blood,cd34 blasts/blasts nfr bld,cd34 blasts/blasts (bld),blast; blood; cd34 blasts; cell markers; gp105-120; hematopoietic stem cell; hsc; my10; my-10; number fraction; percent; point in time; qnt; quan; quant; quantitative; random; stem cells; wb; whole blood,Qn
13851-1,cd5+cd25+ cells/cells in blood,cd5+cd25+ cells nfr bld,cd5+cd25+ cells/cells (bld),blood; cd5 cells; cd5+cd25+ cells; cell; cell markers; cellularity; il-2 receptor alpha chain; il-2r; il-2r tac antigen; ilr2; leu1; leu-1; ly-1; number fraction; percent; point in time; qnt; quan; quant; quantitative; random; t1; tac antigen; tp67; wb; whole blood,Qn
13854-5,aldosterone [mass/volume] in serum or plasma --2 hours post 25 mg captopril po,aldost 2h p 25 mg cpl po serpl-mcnc,aldosterone 2 hr post 25 mg captopril po [mass/vol],120 min; 120 minutes; 120min; 2 hours; 2h p 25 mg cpl po; after; c246; chemistry.challenge testing; endocrine; endocrinology; level; mass concentration; p 25 mg cpl po; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
13860-2,c peptide [mass/volume] in serum or plasma --15 minutes post 1 mg glucagon iv,c peptide 15m p 1 mg gc po serpl-mcnc,c peptide 15 min post 1 mg glucagon iv [mass/vol],15m p 1 mg gc po; after; chemistry.challenge testing; connecting peptide of insulin; hgf; hyperglycemic factor; i; level; mass concentration; pept; pl; plasma; plsm; point in time; pro-insulin c peptide; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
13867-7,renin [enzymatic activity/volume] in plasma --1 hour post 25 mg captopril po,renin 1h p 25 mg cpl po plas-ccnc,renin 1 hr post 25 mg captopril po (p) [catalytic activity/vol],1 hour; 1.0hr; 1h p 25 mg cpl po; 60 min; 60 minutes; 60m; 60min; active renin; after; angiotensin forming enzyme; angiotensinogenase; c246; cardio; cardiology; catalytic concentration; chemistry.challenge testing; endocrine; endocrinology; heart disease; kidney; nephrology; p 25 mg cpl po; pl; plasma; plasma renin activity; plsm; point in time; pra; pst; qnt; quan; quant; quantitative; random; renal,Qn
13872-7,11-deoxycortisol [mass/time] in 24 hour urine,11dc 24h ur-mrate,11-deoxycortisol (24h u) [mass/time],1 day; 11dc; 24 hours; 24hr; chemistry; compound s; cortexolone; cortodoxone; deoxycortisol; desoxycortisol; mass rate; metopirone; mrate; qnt; quan; quant; quantitative; ua; ur; urn,Qn
13875-0,alkaline phosphatase.liver 2 [enzymatic activity/volume] in serum or plasma,alp liver 2 serpl-ccnc,alp liver 2 [catalytic activity/vol],alk; alk phos; alkaline phos; alkaline phosphatase.total; alkp; alp; alp liver; alp liver 2; alp-1; ap; catalytic concentration; chemistry; hepatology; ii; liver; phos; phosphtase; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
13878-4,collagen type 1 igg ab [units/volume] in serum,collagen1 igg ser-acnc,collagen type 1 igg qn (s),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; ciab; collagen type i; collagen1; i; immune globulin g; immunoglobulin g; point in time; qnt; quan; quant; quantitative; random; serology; serum; sr,Qn
13890-9,lactate dehydrogenase 5/lactate dehydrogenase.total in urine by electrophoresis,ldh5 cfr ur elph,ldh 5 elph (u) [catalytic fraction],2-hydroxypropanoic acid; 2-hydroxy-propionate; 2-hydroxy-propionic acid; catalytic fraction; chemistry; dehydrog; dehyrdogenase; elec; elect; electr; electro; electrophhrs; electrophrs; elp; elph; ep; l.d.h; lact; lactate dehydrogenase.fraction 5; lactic acid; lactic acid dehydrogenase; ld; ld5; ldh; ldh isoenzyme 5; ldh5; l-lactate; l-lactate dehydrogenase; percent; point in time; qnt; quan; quant; quantitative; random; tot; totl; tumor marker; ua; ur; urn,Qn
13895-8,sodium [moles/volume] in milk,sodium mlk-scnc,sodium (milk) [moles/vol],chemistry; level; mlk; na; na+; point in time; qnt; quan; quant; quantitative; random; substance concentration,Qn
13896-6,insulin-like growth factor-i [units/volume] in blood,igf-i bld-acnc,insulin-like growth factor-i qn (bld),arbitrary concentration; blood; chemistry; fac; fact; factor 1; fi; hum; humulin; igf; igf1; igf-1; igf-i; ih7; insul; lente; nph; point in time; qnt; quan; quant; quantitative; random; semilente; sliding; somatomedin c; ultralente; wb; whole blood,Qn
13907-1,norethindrone [mass/volume] in serum or plasma,norethindrone serpl-mcnc,norethindrone [mass/vol],aygestin; drug/toxicology; drugs; level; mass concentration; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
13917-0,coccidioides immitis ab [titer] in cerebral spinal fluid by complement fixation,c immitis ab titr csf cf,c. immitis ab cf (csf) [titer],abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; b immitis; blastomycoides immitis; c esteriformis; c immitis; cerebral spinal fluid; cerebrospinal fl; cf; coccidioides esteriformis; coccidiomycosis; coccio; comp fixation; compfix; complement fixation; dilution factor; dilution factor (titer); g immite; g louisianoideum; g metaeuropea; geotrichum immite; glenospora metaeuropea; glenosporum louisianoideum; id; infectious disease; infectiousdisease; microbiology; neuro; neurology; p esteriformis; p mazzai; point in time; posadasia esteriformis; pseudococcidioides mazzai; random; san joaquin valley fever; smqn; spinal fl; spinal fld; spinal flu; spinal fluid; t proteolyticum; titer; titered; titre; trichosporon proteolyticum; ttr; valley fever,SemiQn
13924-6,calcitonin ab [presence] in serum,calcit ab ser ql,calcitonin ab ql (s),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; ct; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serology; serum; sr; thyrocalcitonin; tumor marker,Ord
13951-9,hepatitis a virus ab [presence] in serum by immunoassay,hav ab ser ql ia,hav ab ia ql (s),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; eia; elfa; elisa; enzyme immunoassay; hav; hep; hep a; hepatis; hepatit; hepatitis; hepatitis type a; hepatology; iaa; id; infectious disease; infectiousdisease; liver; meia; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; sr; suds; universallaborders,Ord
13960-0,coproporphyrin [presence] in 24 hour urine,copro 24h ur ql,coproporphyrin ql (24h u),1 day; 24 hours; 24hr; chemistry; copro; coproporph; coproporphyrins; hematology; heme; ordinal; pr; ql; qual; qualitative; screen; tetracarboxyl porphyrin; tetracarboxylporphyrin; tetracarboxylporphyrins; tetracarboxyporphyrin; ua; ur; urn,Ord
13961-8,mercury [presence] in 24 hour urine,mercury 24h ur ql,mercury ql (24h u),1 day; 24 hours; 24hr; drug/toxicology; drugs; hg; ordinal; pr; ql; qual; qualitative; screen; ua; ur; urn,Ord
13975-8,alpha 2 globulin/protein.total in cerebral spinal fluid by electrophoresis,alpha2 glob mfr csf elph,alpha 2 globulin elph (csf) [mass fraction],a2; alfa; alpha2 glob; cerebral spinal fluid; cerebrospinal fl; chemistry; elec; elect; electr; electro; electrophhrs; electrophrs; elp; elph; ep; glb; glob; glob%; globul; globulins; ii; mass fraction; neuro; neurology; percent; point in time; pr; prot; protein.alpha 2 globulin; qnt; quan; quant; quantitative; random; spinal fl; spinal fld; spinal flu; spinal fluid; tot; totl; tp,Qn
13981-6,alpha 2 globulin/protein.total in serum or plasma by electrophoresis,alpha2 glob mfr serpl elph,alpha 2 globulin elph [mass fraction],a2; alfa; alpha2 glob; chemistry; elec; elect; electr; electro; electrophhrs; electrophrs; elp; elph; ep; glb; glob; glob%; globul; globulins; ii; mass fraction; percent; pl; plasma; plsm; point in time; pr; prot; protein.alpha 2 globulin; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; spep; sr; tot; totl; tp,Qn
13990-7,alpha 1 globulin/protein.total in urine by electrophoresis,alpha1 glob mfr ur elph,alpha 1 globulin elph (u) [mass fraction],a1; alfa; alpha1 glob; chemistry; elec; elect; electr; electro; electrophhrs; electrophrs; elp; elph; ep; glb; glob; glob%; globul; globulins; i; kidney; mass fraction; nephrology; percent; peur; point in time; pr; prot; protein.alpha 1 globulin; qnt; quan; quant; quantitative; random; renal; tot; totl; tp; ua; upep; ur; urn,Qn
14005-3,prostaglandin e1 [mass/time] in 24 hour urine,prostaglandin e1 24h ur-mrate,prostaglandin e1 (24h u) [mass/time],1 day; 24 hours; 24hr; alprostadil; cardio; cardiology; chemistry; genitourinary; gu; heart disease; mass rate; mrate; pg; pge1; qnt; quan; quant; quantitative; ua; ur; urn; uro; urology,Qn
14008-7,phosphatidylcholine igg ab [units/volume] in serum by immunoassay,pc igg ser ia-acnc,phosphatidylcholine igg ia qn (s),abs; aby; antby; anti; antibodies; antibody; apc; arbitrary concentration; autoantibodies; autoantibody; coagulation; eia; elfa; elisa; enzyme immunoassay; hematology; heme; iaa; immune globulin g; immunoglobulin g; meia; neonatal respiratory distress syndrome; pc; phosphatidyl choline; point in time; ptdcho; qnt; quan; quant; quantitative; random; serum; sr; suds,Qn
14014-5,thyroxine (t4).prealbumin bound [mass/volume] in serum or plasma,t4 pa bnd serpl-mcnc,t4.prealbumin bound [mass/vol],associated; bnd; chemistry; endocrine; endocrinology; level; levothyroxine; levo-thyroxine; l-thyroxine; mass concentration; palb; pl; plasma; plsm; point in time; pre albumin; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; t4; t-4; t4 pa bnd; tbpa; thyroid hormone; thyrox; thyroxin; thyrx; total t4; transthyretin; tt4,Qn
14018-6,cd23 cells/cells in blood,cd23 cells nfr bld,cd23 cells/cells (bld),b6; b-6; blast-2; blood; cd23 cells; cell; cell markers; cellularity; fcerii; leu20; leu-20; low affinity ige receptor; number fraction; percent; point in time; qnt; quan; quant; quantitative; random; wb; whole blood,Qn
14035-0,japanese cedar ige ab [units/volume] in serum,japanese cedar ige qn,japanese cedar ige qn (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; immune globulin e; immunoglobulin e; japanese cedar; point in time; qnt; quan; quant; quantitative; random; serum; sr; sugi tree; t17,Qn
14043-4,cortisol free [mass/time] in 12 hour urine,cortis f 12h ur-mrate,cortisol free (12h u) [mass/time],12 hours; 12hr; 17-hydroxycorticosterone; chemistry; compound f; coritsol; cort; cortis f; f; fr; hydrocortisone; mass rate; mrate; non-protein bound; qnt; quan; quant; quantitative; ua; ur; urn,Qn
14046-7,d-lactate [moles/volume] in urine,d-lactate ur-scnc,d-lactate (u) [moles/vol],2-hydroxypropanoic acid; 2-hydroxy-propionate; 2-hydroxy-propionic acid; chemistry; dextro; lact; lactic acid; level; l-lactate; point in time; qnt; quan; quant; quantitative; random; substance concentration; ua; ur; urn,Qn
14053-3,homocystine [presence] in urine,(hcys)2 ur ql,homocystine ql (u),(hcys)2; chemistry; homocyst(e)ine; homocystin; ordinal; point in time; pr; ql; qual; qualitative; random; screen; ua; ur; urn,Ord
14062-4,dexamethasone [mass/volume] in serum or plasma,dexamethasone serpl-mcnc,dexamethasone [mass/vol],decadron; dexameth; dexone; drug/toxicology; drugs; hexadrol; level; mass concentration; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
14070-7,fluphenazine [presence] in urine,fluphenazine ur ql,fluphenazine ql (u),drug/toxicology; drugs; fluphenazine hydrochloride; ordinal; point in time; pr; prolixin; ql; qual; qualitative; random; screen; ua; ur; urn,Ord
14081-4,coliform bacteria [presence] in water,coliform wat ql,coliform bacteria ql (water),bact; id; infectious disease; infectiousdisease; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; screen; wat,Ord
14094-7,trypanosoma cruzi igg ab [titer] in serum,t cruzi igg titr ser,t. cruzi igg (s) [titer],abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; chagas disease; dilution factor; dilution factor (titer); id; immune globulin g; immunoglobulin g; infectious disease; infectiousdisease; microbiology; point in time; random; serum; smqn; sr; t cruzi; titer; titered; titre; trypanosomiasis; trypanosomosis; ttr,SemiQn
14110-1,deprecated cd22 cells/100 cells in blood,deprecated lymphocytes.cd22 fr bld,cd22 lymphocytes/100 lymphs (bld),b3; b-3; bl-cam; blood; cell markers; leu14; leu-14; lyb8; lymp; lymph; lympho; lymphocyte; lymphs; lymphs%; number fraction; percent; point in time; qnt; quan; quant; quantitative; random; to-15; wb; whole blood,Qn
14114-3,17-hydroxyprogesterone [mass/volume] in serum or plasma --1 hour post 250 ug corticotropin im,17ohp 1h p 250 ug acth im serpl-mcnc,17-hydroxyprogesterone 1 hr post 250 ug corticotropin im [mass/vol],"1 hour; 1.0hr; 17-alpha-hydroxyprogesterone; 17-hydroxypregn-4-en-3,20-dione; 17-hydroxy-progest; 17-oh progesterone; 17ohp; 17-ohp; 17-p; 1h p 250 ug acth; 1h p 250 ug acth im; 60 min; 60 minutes; 60m; 60min; acth; adrenocorticotrophic hormone; adrenocorticotropin; after; c206; c74; chemistry.challenge testing; cortrosyn; endocrine; endocrinology; genetics; heredity; heritable; hydroxyproges; hydroxyprogstron; inherited; level; mass concentration; mcg; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; rc206; serp; serpl; serplas; serum; serum or plasma; sr; tumor marker",Qn
14120-0,deprecated prostate specific ag free/prostate specific ag.total in serum or plasma,deprecated psa free fr serpl,free psa/total psa [mass fraction],chemistry; fpsa; fr; genitourinary; gu; kallikrein 3; mass fraction; non-protein bound; oncology; p-30 antigen; percent; pl; plasma; plsm; point in time; ps; psa; psa free; qnt; quan; quant; quantitative; random; seminin; serp; serpl; serplas; serum; serum or plasma; spec; sr; tot; totl; tumor marker; uro; urology,Qn
14123-4,thyroxine (t4).albumin bound/albumin [mass ratio] in serum or plasma,t4 alb bnd/alb serpl,t4.albumin bound/albumin [mass ratio],alb; associated; bnd; chemistry; endocrine; endocrinology; levothyroxine; levo-thyroxine; l-thyroxine; mass concentration ratio; mass ratio; mcrto; pl; plasma; plsm; point in time; protein.albumin; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; t4; t-4; t4 alb bnd; thyroid hormone; thyrox; thyroxin; thyrx; total t4; tt4,Qn
14126-7,hiv 1 gp120+gp160 ab [presence] in serum by immunoblot,hiv1 gp120+gp160 ab ser ql ib,hiv 1 gp120+gp160 ab ib ql (s),abs; aby; aids; antby; anti; antibodies; antibody; autoantibodies; autoantibody; blt; hiv type 1; hiv type i; hiv1; hiv1 gp120; hiv1 gp120+gp160; human immunodeficiency virus; i; id; immune blot; immunobl; immunoblot; infectious disease; infectiousdisease; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; riba; screen; serum; sr; wb; wblot; west blot; west blt; western blot,Ord
14127-5,neisseria gonorrhoeae [presence] in anal by organism specific culture,n gonorrhoea anal ql cult,n. gonorrhoeae org specific cx ql (anal),anus; c&s; cult; cultures; gc; gono; gonorrhea; id; infectious disease; infectiousdisease; microbiology; n gonorrhoea; n gonorrhoeae; ordinal; point in time; pr; ql; qual; qualitative; random; rectal specimen; screen; spec,Ord
14139-0,ketones [presence] in urine --4 hours post xxx challenge,ketones 4h p chal ur ql,ketones 4 hr post unsp challenge ql (u),4h p chal; acetest; acetoacetate; acetoacetates; acetone bodies; after; chemistry.challenge testing; ketone; ketone bodies; ordinal; p chal; point in time; pr; pst; ql; qual; qualitative; random; screen; ua; ur; urn,Ord
14170-5,pituitary glycoprotein hormone.alpha subunit [mass/volume] in serum,a-pgh ser-mcnc,pituitary glycoprotein hormone.alpha subunit (s) [mass/vol],alfa; apgh; a-pgh; chemistry; gg; glycoprot; glycoproteins; gp; horm; level; mass concentration; pituitary glycoproteins; pitutary; point in time; qnt; quan; quant; quantitative; random; serum; sr,Qn
14174-7,prostaglandin f2 alpha [mass/volume] in serum or plasma,prostaglandin f2a serpl-mcnc,prostaglandin f2 alpha [mass/vol],alfa; chemistry; level; mass concentration; pg; pgf2; pgf2a; pgf2alpha; pl; plasma; plsm; point in time; prostaglandin f2a; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
14180-4,uroporphyrin [mass/volume] in red blood cells,uropor rbc-mcnc,uroporphyrin (rbc) [mass/vol],chemistry; erythrocytes; hematology; heme; level; mass concentration; octacarboxyl porphyrin; octacarboxylporphyrin; octacarboxyphyrin; point in time; qnt; quan; quant; quantitative; random; red blood cells; red blood corpusles; urophorph,Qn
14186-1,methylprednisolone [mass/volume] in serum or plasma,me-prednisolone serpl-mcnc,methylprednisolone [mass/vol],drug/toxicology; drugs; level; mass concentration; mep; me-prednisolone; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
14232-3,adrenal ab [presence] in serum,adrenal ab ser ql,adrenal ab ql (s),abs; aby; adrenal total antibodies; adrnl; antby; anti; antibodies; antibody; autoantibodies; autoantibody; endocrine; endocrinology; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serology; serum; sr; steroid cell antibodies,Ord
14237-2,myelin basic protein iga ab [units/volume] in serum,mbp iga ser-acnc,myelin basic protein iga qn (s),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; immune globulin a; immunoglobulin a; mbp; point in time; pr; prot; qnt; quan; quant; quantitative; random; serology; serum; sr,Qn
14259-6,1-pentanol [mass/volume] in blood,1pentanol bld-mcnc,1-pentanol (bld) [mass/vol],1pentanol; blood; drug/toxicology; drugs; i; level; mass concentration; n-amyl alcohol; n-butyl carbinol; n-pentanol; pentan-1-ol; pentyl alcohol; point in time; qnt; quan; quant; quantitative; random; wb; whole blood,Qn
1426-6,cortisol [mass/volume] in serum or plasma --48 hours post 40 ug corticotropin im bid 3 day,cortis 2d p 40 ug acth im serpl-mcnc,cortisol 48 hr post 40 ug corticotropin im bid 3 day [mass/vol],17-hydroxycorticosterone; 2d p 40 ug acth im; acth; adrenocorticotrophic hormone; adrenocorticotropin; after; c206; c74; chemistry.challenge testing; compound f; coritsol; cort; cortrosyn; f; hydrocortisone; iii; level; mass concentration; mcg; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; rc206; serp; serpl; serplas; serum; serum or plasma; sr; tumor marker; twice a day,Qn
14271-1,character of synovial fluid,character snv,character (syn fld),appearance; joint aspirate; joint fld; joint flu; joint fluid; nominal; point in time; random; sf; snv; spec; syn; syn fl; synov; synovial fluid,Nom
14291-9,follitropin [moles/volume] in serum or plasma --baseline,fsh bs serpl-scnc,follitropin baseline [moles/vol],bs; chemistry.challenge testing; follicle stimulating hormone; fsh; level; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; substance concentration,Qn
14295-0,organic acids/creatinine [molar ratio] in urine,organic acids/creat ur-srto,organic acids/creatinine (u) [molar ratio],acd; acid; chemistry; cr; crea; creat; point in time; qnt; quan; quant; quantitative; random; scrto; substance concentration ratio; substance ratio; ua; ucr; ur; urn,Qn
14299-2,cryoprecipitate units available [#],cryoppt avail bpu,cryoprecipitate units available (bpu) [#],blood bank; blood product unit; blood product unit (pack); cnt; count; cryo; cryoppt; cryoppt avail; cryoprec; hematology; heme; number; point in time; qnt; quan; quant; quantitative; random,Qn
14336-2,ethanol [mass/volume] in serum or plasma by gas chromatography,ethanol serpl gc-mcnc,ethanol gas chromatography [mass/vol],alc; alcohol; drug/toxicology; drugs; ethyl alcohol; etoh; gas chromatography; level; mass concentration; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
14345-3,specific gravity of amniotic fluid by refractometry,sp gr amn refractometry,specific gravity refractometry (amn fld),af; amn; amn fl; amnio; amniotic flu; amniotic fluid; chemistry; point in time; qnt; quan; quant; quantitative; random; refract; sp gr,Qn
14346-1,specific gravity of cerebral spinal fluid by refractometry,sp gr csf refractometry,specific gravity refractometry (csf),cerebral spinal fluid; cerebrospinal fl; chemistry; point in time; qnt; quan; quant; quantitative; random; refract; sp gr; spinal fl; spinal fld; spinal flu; spinal fluid,Qn
14348-7,specific gravity of peritoneal fluid by refractometry,sp gr prt refractometry,specific gravity refractometry (periton fld),ascites; ascitic fluid; ascitis; chemistry; peritoneal fluid; point in time; prt; qnt; quan; quant; quantitative; random; refract; sp gr,Qn
14358-6,microscopic observation [identifier] in aspirate by gram stain,gram stn aspirate,microscopic observation gram stain nom (asp),aspirate; gram stn; id; identity or presence; infectious disease; infectiousdisease; microbiology; nominal; point in time; random; st; stains; stn,Nom
14361-0,microscopic observation [identifier] in vaginal fluid by gram stain,gram stn vag,microscopic observation gram stain nom (vag fld),genital vaginal; gram stn; gyn; gynecology; id; identity or presence; infectious disease; infectiousdisease; microbiology; nominal; ob; obgyn; obstetrics; point in time; random; st; stains; stn; vag fld; vag fluid; vagina; vaginal fluid,Nom
14374-3,granulocytes/leukocytes in pleural fluid by manual count,granulocytes nfr plr manual,granulocytes/leukocytes manual cnt (pleur fld),gran; grans; granulocyte; granulocytes; hematology/cell counts; leuc; leuk; leukocyte; lkcs; manl; number fraction; percent; pleural; pleural fluid; point in time; qnt; quan; quant; quantitative; random; thoracentesis fluid; wbc; wbcs; white blood cell; white blood cells,Qn
14375-0,granulocytes/leukocytes in peritoneal fluid by manual count,granulocytes nfr prt manual,granulocytes/leukocytes manual cnt (periton fld),ascites; ascitic fluid; ascitis; gran; grans; granulocyte; granulocytes; hematology/cell counts; leuc; leuk; leukocyte; lkcs; manl; number fraction; percent; peritoneal fluid; point in time; prt; qnt; quan; quant; quantitative; random; wbc; wbcs; white blood cell; white blood cells,Qn
14377-6,granulocytes/leukocytes in semen by manual count,granulocytes nfr smn manual,granulocytes/leukocytes manual cnt (sem),ejaculate; genitourinary; gran; grans; granulocyte; granulocytes; gu; hematology/cell counts; leuc; leuk; leukocyte; lkcs; manl; number fraction; percent; point in time; qnt; quan; quant; quantitative; random; sem; seminal fluid; smn; smpls; uro; urology; wbc; wbcs; white blood cell; white blood cells,Qn
14379-2,granulocytes/leukocytes in gastric fluid by manual count,granulocytes nfr gast manual,granulocytes/leukocytes manual cnt (gast fld),gast; gastric contents; gastric fluid; gran; grans; granulocyte; granulocytes; hematology/cell counts; leuc; leuk; leukocyte; lkcs; manl; number fraction; percent; point in time; qnt; quan; quant; quantitative; random; wbc; wbcs; white blood cell; white blood cells,Qn
14385-9,mononuclear cells/leukocytes in gastric fluid by manual count,mononuc cells nfr gast manual,mononuclear cells/leukocytes manual cnt (gast fld),cell; cellularity; gast; gastric contents; gastric fluid; hematology/cell counts; leuc; leuk; leukocyte; lkcs; manl; mononuc; mononuc cells; number fraction; percent; point in time; qnt; quan; quant; quantitative; random; wbc; wbcs; white blood cell; white blood cells,Qn
14388-3,amylase [enzymatic activity/volume] in synovial fluid,amylase snv-ccnc,amylase (syn fld) [catalytic activity/vol],alpha amylase; ams; amyl; catalytic concentration; chemistry; diastase; joint aspirate; joint fld; joint flu; joint fluid; k87; point in time; qnt; quan; quant; quantitative; random; rheum; rheumatology; sf; snv; syn; syn fl; synov; synovial fluid,Qn
14393-3,urea nitrogen [mass/volume] in amniotic fluid,urea nit amn-mcnc,urea nitrogen (amn fld) [mass/vol],af; amn; amn fl; amnio; amniotic flu; amniotic fluid; blood urea nitrogen; chemistry; level; mass concentration; n; n2; nit; point in time; qnt; quan; quant; quantitative; random; un,Qn
14394-1,urea nitrogen [mass/volume] in pleural fluid,urea nit plr-mcnc,urea nitrogen (pleur fld) [mass/vol],blood urea nitrogen; chemistry; level; mass concentration; n; n2; nit; pleural; pleural fluid; point in time; qnt; quan; quant; quantitative; random; thoracentesis fluid; un,Qn
14412-1,aspartate aminotransferase [enzymatic activity/volume] in gastric fluid,ast gast-ccnc,ast (gast fld) [catalytic activity/vol],asp; aspartate amino transferase; aspartate transaminase; aspartic acid; ast; catalytic concentration; chemistry; gast; gastric contents; gastric fluid; glutamic oxaloacetic transaminase; hepatology; liver; point in time; qnt; quan; quant; quantitative; random; sgot,Qn
14425-3,globulin [mass/volume] in amniotic fluid,globulin amn-mcnc,globulin (amn fld) [mass/vol],af; amn; amn fl; amnio; amniotic flu; amniotic fluid; chemistry; glb; glob; glob%; globul; globulins; level; mass concentration; point in time; qnt; quan; quant; quantitative; random,Qn
14430-3,globulin [mass/volume] in synovial fluid,globulin snv-mcnc,globulin (syn fld) [mass/vol],chemistry; glb; glob; glob%; globul; globulins; joint aspirate; joint fld; joint flu; joint fluid; level; mass concentration; point in time; qnt; quan; quant; quantitative; random; sf; snv; syn; syn fl; synov; synovial fluid,Qn
14453-5,virus identified in vaginal fluid by culture,virus vag cult,virus identified cx nom (vag fld),c&s; cult; cultures; genital vaginal; gyn; gynecology; id; identity or presence; infectious disease; infectiousdisease; microbiology; nominal; ob; obgyn; obstetrics; point in time; random; vag fld; vag fluid; vagina; vaginal fluid,Nom
14458-4,virus identified in sputum by culture,virus spt cult,virus identified cx nom (sput),c&s; cult; cultures; id; identity or presence; infectious disease; infectiousdisease; lower respiratory; lung; microbiology; nominal; point in time; pulmonary; pulmonology; random; respiratory; spt; sputum,Nom
144-6,cefuroxime parenteral [susceptibility] by minimum lethal concentration (mlc),cefuroxime parenter islt mlc,cefuroxime parenteral mlc [susc],antibiotic susceptibilities; ast; c308; c33; ceftin; cefuroxime axetil; cefuroxime parenter; cefuroxime sodium; curoxim; id; infectious disease; infectiousdisease; islt; isol; kefurox; mbc; minimum bactericidal concentration; minimum lethal concentration; point in time; qnt; quan; quant; quantitative; random; sus; suscept; susceptibilities; susceptibility; susceptibilty; ultroxim; zinacef,Qn
14482-4,diphtheria identified in skin by organism specific culture,diphtheria skin cult,diphtheria identified org specific cx nom (skin),c&s; cult; cultures; dermatologic; epidermis; id; identity or presence; infectious disease; infectiousdisease; integument; microbiology; nominal; point in time; random; skn; spec; species; spp,Nom
14487-3,mycoplasma sp and ureaplasma sp [identifier] in urethra by organism specific culture,mycoplas+ureoplas urth cult,mycoplasma sp and ureaplasma sp org specific cx nom (urethra),c&s; cult; cultures; genital tract; id; identity or presence; infectious disease; infectiousdisease; microbiology; myco; mycoplas; mycoplas+ureoplas; mycoplasm; mycoplasmosis; mycoplsm; nominal; point in time; random; spec; species; spp; urth,Nom
14492-3,virus identified in eye by immunofluorescence,virus eye if,virus identified if nom (eye),acif; anticomplement immunofluorescence; eyeball; fa; fluorescent antibody; fluoresent; id; identity or presence; ifa; immune fluorescence; immunoflour; immunofluor; immunofluorescence; infectious disease; infectiousdisease; microbiology; nominal; occular; oculis; ophthalmologic; optic globe; point in time; random; time resolved fluorescence; trf; vision; visual,Nom
1449-8,cortisol [mass/volume] in serum or plasma --pre 8 mg dexamethasone po overnight high dose,cortis pre 8 mg dex serpl-mcnc,cortisol pre 8 mg dexamethasone po overnight high dose [mass/vol],17-hydroxycorticosterone; before; c350; chemistry.challenge testing; compound f; coritsol; cort; decadron; dexameth; dexone; f; hexadrol; hi dose; hydrocortisone; level; mass concentration; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
14509-4,chlamydia trachomatis ag [presence] in cervix by immunofluorescence,c trach ag cvx ql if,c. trachomatis ag if ql (cvx),acif; anticomplement immunofluorescence; antigen; antigens; c trac; c trach; c tracho; c trachomatis; cervix; chlam; chlam trac; chlamid; ct; dfa; fa; fluorescent antibody; fluoresent; genital tract; gyn; gynecology; id; ifa; immune fluorescence; immunoflour; immunofluor; immunofluorescence; infectious disease; infectiousdisease; lgv; lymphogranuloma venereum; microbiology; ob; obgyn; obstetrics; ordinal; point in time; pr; ql; qual; qualitative; random; screen; time resolved fluorescence; trachoma; trf,Ord
14516-9,pneumocystis jirovecii ag [presence] in semen by immunofluorescence,p jirovecii ag smn ql if,p. jirovecii ag if ql (sem),acif; anticomplement immunofluorescence; antigen; antigens; dfa; ejaculate; fa; fluorescent antibody; fluoresent; genitourinary; gu; ifa; immune fluorescence; immunoflour; immunofluor; immunofluorescence; microbiology; ordinal; p carinii; p jiroveci; p jirovecii; pcp; pneumocystis carinii; point in time; pr; ql; qual; qualitative; random; screen; sem; seminal fluid; smn; smpls; time resolved fluorescence; trf; uro; urology,Ord
14521-9,pneumocystis jirovecii ag [presence] in urine by immunofluorescence,p jirovecii ag ur ql if,p. jirovecii ag if ql (u),acif; anticomplement immunofluorescence; antigen; antigens; dfa; fa; fluorescent antibody; fluoresent; id; ifa; immune fluorescence; immunoflour; immunofluor; immunofluorescence; infectious disease; infectiousdisease; microbiology; ordinal; p carinii; p jiroveci; p jirovecii; pcp; pneumocystis carinii; point in time; pr; ql; qual; qualitative; random; screen; time resolved fluorescence; trf; ua; ur; urn,Ord
1452-2,creatinine [mass/volume] in 24 hour urine --24 hours post 40 ug corticotropin im bid 3 day,creat 1d p 40 ug acth im 24h ur-mcnc,creatinine 24 hr post 40 ug corticotropin im bid 3 day (24h u) [mass/vol],1 day; 1d p 40 ug acth im; 24 hours; 24hr; acth; adrenocorticotrophic hormone; adrenocorticotropin; after; c206; c74; chemistry.challenge testing; cortrosyn; cr; crea; creat; iii; level; mass concentration; mcg; pst; qnt; quan; quant; quantitative; rc206; tumor marker; twice a day; ua; ucr; ur; urn,Qn
14538-3,measles virus ag [presence] in nose by immunofluorescence,mev ag nose ql if,mev ag if ql (nose),acif; anticomplement immunofluorescence; antigen; antigens; dfa; fa; fluorescent antibody; fluoresent; id; ifa; immune fluorescence; immunoflour; immunofluor; immunofluorescence; infectious disease; infectiousdisease; mev; microbiology; msls; nasal; nos; nose (nasal passage); ordinal; point in time; pr; ql; qual; qualitative; random; rubeola; screen; smell; time resolved fluorescence; trf,Ord
1454-8,creatinine [mass/volume] in 24 hour urine --48 hours post 500 ug dexamethasone po 2.5 day low dose q6h,creat 48h p 500 ug dex 24h ur-mcnc,creatinine 48 hr post 500 ug dexamethasone po 2.5 day low dose q6h (24h u) [mass/vol],1 day; 24 hours; 24hr; 48h p 500 ug dex; after; c350; chemistry.challenge testing; cr; crea; creat; decadron; dexameth; dexone; hexadrol; level; lo dose; mass concentration; mcg; p 500 ug dex; pst; qnt; quan; quant; quantitative; ua; ucr; ur; urn,Qn
14554-0,mumps virus ag [presence] in penis by immunofluorescence,muv ag penis ql if,muv ag if ql (penis),acif; anticomplement immunofluorescence; antigen; antigens; dfa; fa; fluorescent antibody; fluoresent; id; ifa; immune fluorescence; immunoflour; immunofluor; immunofluorescence; infectious disease; infectiousdisease; microbiology; muv; ordinal; pen; penile; point in time; pr; ql; qual; qualitative; random; screen; time resolved fluorescence; trf,Ord
14557-3,mycobacterium tuberculosis dna [presence] in bronchial specimen by naa with probe detection,m tb dna bronch ql naa+probe,m. tuberculosis dna naa+probe ql (bronch spec),3 self-sustaining sequence replication; 3sr sr; acid fast; acid fast bacilli; acid fast bacillus; afb; amplif; amplification; amplified; bro; deoxyribonucleic acid; dna nucleic acid probe; dna probe; id; infectious disease; infectiousdisease; lat; lcr; ligase chain reaction; ligation-activated transcription; lung; m tb; m tuberculosis; microbiology; mtb; myco; mycobact; mycobacterium tuberculosum; naa+probe; naat; nasba; nucleic acid sequence based analysis; ordinal; pcr; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; pulmonary; pulmonology; qbr; ql; qual; qualitative; random; respiratory; screen; sda; strand displacement amplification; tb; tma; transcription mediated amplification; tuberculosis,Ord
14564-9,hemoglobin.gastrointestinal [presence] in stool --2nd specimen,hemoccult sp2 stl ql,hemoglobin.gastrointestinal spec 2 ql (stl),bowel movement; chemistry; convalescent; faecal; faeces; fecal; fecal occult blood; feces; fob; gastro; gastrocult; gastroenterology; gastrointest blood; gi; guiac; haemoglobin; hb; hemoccult; hemocult; hgb; occult blood; occult blood in stool; ordinal; point in time; post immunization; pr; ql; qual; qualitative; random; screen; second; sp2; spec; stl; stool = fecal,Ord
14567-2,11-deoxycortisol [moles/volume] in serum or plasma,11dc serpl-scnc,11-deoxycortisol [moles/vol],11dc; chemistry; compound s; cortexolone; cortodoxone; deoxycortisol; desoxycortisol; level; metopirone; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; substance concentration,Qn
14583-9,acidity.titratable [mass/volume] in gastric fluid,titratable acidity gast-mcnc,acidity.titratable (gast fld) [mass/vol],chemistry; gast; gastric contents; gastric fluid; level; mass concentration; point in time; qnt; quan; quant; quantitative; random; titratable acidity,Qn
14589-6,amylase isoenzymes [interpretation] in serum or plasma,amylase isos serpl-imp,amylase isoenzymes [interp],alpha amylase; ams; amyl; amylase isos; chemistry; diastase; gastro; gastroenterology; gi; impression; impression/interpretation of study; impressions; interp; interpretation; iso; isoamy; isoamylase; isoen; isoenzyme; k87; nominal; pl; plasma; plsm; point in time; random; serp; serpl; serplas; serum; serum or plasma; sr,Nom
14591-2,alprazolam [moles/volume] in serum or plasma,alpraz serpl-scnc,alprazolam [moles/vol],drug/toxicology; drugs; level; niravam; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; substance concentration; xanax,Qn
14596-1,amitriptyline+nortriptyline [presence] in urine,amitrip+nor ur ql,amitriptyline+nortriptyline ql (u),amit; amitrip; amitrip+nor; amitriptylene; amitriptyline metabolite; amitriptyln; aventyl; drug/toxicology; drugs; elatrol; elavil; endep; nortrip; nortriptylene; nortriptyln; ordinal; pamelor; point in time; pr; ql; qual; qualitative; random; screen; trepiline; tryptanol; tryptizol; ua; ur; urn,Ord
14602-7,deprecated amoxapine+8-hydroxyamoxapine [molecules/volume] in serum or plasma,deprecated amoxapine+8oh-amox serpl-scnc,amoxapine+8-hydroxyamoxapine [moles/vol],8-hydroxy amoxapine; 8oh-amoxapine; amox; amoxapine metabolite; amoxapine+8oh-amox; asendin; defanyl; demolox; drug/toxicology; drugs; level; moxadil; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; substance concentration,Qn
14611-8,nuclear ab pattern [interpretation] in serum,ana pat ser-imp,nuclear ab pattern (s) [interp],abs; aby; ana; ana pat; anf; antby; anti; antibodies; antibody; antinuclear antibody; autoantibodies; autoantibody; impression; impression/interpretation of study; impressions; interp; interpretation; na; nominal; nuc; point in time; random; serology; serum; sr,Nom
14621-7,appearance of peritoneal fluid,appearance prt,appearance (periton fld),appearance; ascites; ascitic fluid; ascitis; nominal; peritoneal fluid; point in time; prt; random; spec,Nom
14627-4,bicarbonate [moles/volume] in venous blood,hco3 bldv-scnc,hco3 (bldv) [moles/vol],bic; bicar; bicarb; bld ven; bld venous; blood - venous; blood ven; blood venus; chemistry; hco3; level; point in time; qnt; quan; quant; quantitative; random; substance concentration; venous,Qn
14628-2,bile acid [moles/volume] in serum or plasma,bile ac serpl-scnc,bile acid [moles/vol],acd; acids; bile acid.total; bile salt; chemistry; level; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; substance concentration; universallaborders,Qn
14644-9,chlorpromazine [presence] in gastric fluid,chlorpromazine gast ql,chlorpromazine ql (gast fld),chlopromazine; chlorpromaz; drug/toxicology; drugs; gast; gastric contents; gastric fluid; ordinal; point in time; pr; ql; qual; qualitative; random; screen; thorazine,Ord
14657-1,clozapine+norclozapine [moles/volume] in serum or plasma,clozapine+nor serpl-scnc,clozapine+norclozapine [moles/vol],clozapine metabolite; clozaril; desmethylclozapine; drug/toxicology; drugs; fazaclo; leponex; level; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; substance concentration,Qn
14658-9,cold agglutinin [titer] in serum or plasma,ca titr serpl,cold agglutinin [titer],agglut; agglutination; agglutinins; agglutins; agt; ca; cold agglutinin titration; dilution factor; dilution factor (titer); pl; plasma; plsm; point in time; random; serology; serp; serpl; serplas; serum; serum or plasma; smqn; sr; titer; titered; titre; ttr,SemiQn
14664-7,color of synovial fluid,color snv,color (syn fld),joint aspirate; joint fld; joint flu; joint fluid; nominal; point in time; random; sf; snv; spec; syn; syn fl; synov; synovial fluid,Nom
14665-4,copper [moles/volume] in serum or plasma,copper serpl-scnc,copper [moles/vol],cu; drug/toxicology; drugs; level; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; substance concentration,Qn
14682-9,creatinine [moles/volume] in serum or plasma,creat serpl-scnc,creatinine [moles/vol],chemistry; cr; crea; creat; kidney; level; nephrology; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; renal; serp; serpl; serplas; serum; serum or plasma; sr; substance concentration,Qn
14686-0,cystine [presence] in stone,cystine stone ql,cystine ql (stone),calc; calculi; chemistry; cys-cys; dicysteine; gastro; gastroenterology; gi; kidney; nephrology; ordinal; point in time; pr; ql; qual; qualitative; random; renal; screen; stn; stone; stones,Ord
14687-8,transfusion date,transf date,transfusion date [date/time],blood bank; date and time; date transfused; point in time; qnt; quan; quant; quantitative; random; time stamp; timestamp; transf date; tx,Qn
14693-6,norclobazam [moles/volume] in serum or plasma,norclobazam serpl-scnc,norclobazam [moles/vol],clobazam metabolite; desmeth; desmethylclobazam; drug/toxicology; drugs; level; n-desmethylclobazam; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; substance concentration,Qn
14694-4,norclomipramine [moles/volume] in serum or plasma,norclomipramine serpl-scnc,norclomipramine [moles/vol],clomipramine metabolite; desmeth; desmethylclomip; desmethylclomipramine; drug/toxicology; drugs; level; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; substance concentration,Qn
1469-6,follitropin [mass/volume] in serum or plasma --15 minutes post 100 ug luteinizing releasing hormone iv,fsh 15m p 100 ug lrh iv serpl-mcnc,follitropin 15 min post 100 ug luteinizing releasing hormone iv [mass/vol],15m p 100 ug lrh iv; after; chemistry.challenge testing; follicle stimulating hormone; fsh; horm; level; mass concentration; mcg; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
14721-5,ethylene glycol [moles/volume] in serum or plasma,ethylene glycol serpl-scnc,ethylene glycol [moles/vol],drug/toxicology; drugs; level; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; substance concentration,Qn
14727-2,fluoxetine [presence] in gastric fluid,fluoxetine gast ql,fluoxetine ql (gast fld),drug/toxicology; drugs; gast; gastric contents; gastric fluid; ordinal; point in time; pr; prozac; ql; qual; qualitative; random; screen,Ord
14760-3,glucose [moles/volume] in capillary blood --2 hours post meal,glucose 2h p meal bldc-scnc,glucose 2 hr post meal (bldc) [moles/vol],120 min; 120 minutes; 120min; 2 hours; 2h p meal; after; blood - capillary; cap bld; cap blood; capillary bld; capillary blood; chemistry.challenge testing; endocrine; endocrinology; finger stick; glu; glu tol; gluc; glucose tolerance; glucoseur; gtt; level; p meal; pc; point in time; post pran; post prandial; pp; pst; qnt; quan; quant; quantitative; random; substance concentration,Qn
1476-1,follitropin [mass/volume] in serum or plasma --75 minutes post 100 ug luteinizing releasing hormone iv,fsh 75m p 100 ug lrh iv serpl-mcnc,follitropin 75 min post 100 ug luteinizing releasing hormone iv [mass/vol],75m p 100 ug lrh iv; after; chemistry.challenge testing; follicle stimulating hormone; fsh; horm; level; mass concentration; mcg; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
14761-1,glucose [moles/volume] in serum or plasma --2 hours post meal,glucose 2h p meal serpl-scnc,glucose 2 hr post meal [moles/vol],120 min; 120 minutes; 120min; 2 hours; 2h p meal; after; chemistry.challenge testing; endocrine; endocrinology; glu; glu tol; gluc; glucose tolerance; glucoseur; gtt; level; p meal; pc; pl; plasma; plsm; point in time; post pran; post prandial; pp; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; substance concentration,Qn
14773-6,granulocytes/leukocytes in bronchial specimen by manual count,granulocytes nfr bronch manual,granulocytes/leukocytes manual cnt (bronch spec),bro; gran; grans; granulocyte; granulocytes; hematology/cell counts; leuc; leuk; leukocyte; lkcs; manl; number fraction; percent; point in time; qnt; quan; quant; quantitative; random; wbc; wbcs; white blood cell; white blood cells,Qn
14774-4,haloperidol [moles/volume] in serum or plasma,haloperidol serpl-scnc,haloperidol [moles/vol],drug/toxicology; drugs; haldol; level; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serenace; serp; serpl; serplas; serum; serum or plasma; sr; substance concentration,Qn
14780-1,hexacarboxylate [moles/volume] in stool,hexacarboxylate stl-scnc,hexacarboxylate (stl) [moles/vol],bowel movement; chemistry; faecal; faeces; fecal; feces; hexacarbox; level; point in time; qnt; quan; quant; quantitative; random; stl; stool = fecal; substance concentration,Qn
14781-9,hexacarboxylate [moles/volume] in urine,hexacarboxylate ur-scnc,hexacarboxylate (u) [moles/vol],chemistry; hexacarbox; level; point in time; qnt; quan; quant; quantitative; random; substance concentration; ua; ur; urn,Qn
14782-7,homovanillate [moles/volume] in urine,hva ur-scnc,homovanillate (u) [moles/vol],3-methoxy-4-hydroxy-phenylacetic acid; chemistry; homovanilic; homovanillic acid; hva; level; point in time; qnt; quan; quant; quantitative; random; substance concentration; tumor marker; ua; ur; urn,Qn
1478-7,follitropin [mass/volume] in serum or plasma --pre dose gonadotropin releasing hormone,fsh pre gnrh serpl-mcnc,follitropin pre dose gonadotropin releasing hormone [mass/vol],before; chemistry.challenge testing; follicle stimulating hormone; fsh; ghr; gnrh; horm; level; lhrh; luliberin; luteinizing hormone releasing hormone; lutropin release factor; mass concentration; pl; plasma; plsm; point in time; pre gnrh; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
14788-4,helminth+arthropod identified in specimen by rearing/culture,worm+insect spec rearing/cult,helminth+arthropod identified rearing/culture nom (specimen),arthropods; c&s; cult; cultures; fleas; fly; helminths; id; identity or presence; infectious disease; infectiousdisease; insect; lice; maggot; maggots; microbiology; misc; miscellaneous; nominal; other; point in time; random; spec; tick; ticks; to be specified in another part of the message; unspecified; worm; worm+insect; worms,Nom
14809-8,lead [moles/time] in 24 hour urine,lead 24h ur-srate,lead (24h u) [moles/time],1 day; 24 hours; 24hr; drug/toxicology; drugs; painter's colic; pb; plumbism; qnt; quan; quant; quantitative; srate; substance rate; ua; ur; urn,Qn
14810-6,leukocytes [#/volume] in bronchial specimen by manual count,wbc # bronch manual,wbc manual cnt (bronch spec) [#/vol],#; abs; absolute; absolutes; bro; cnt; count; count/volume; ct; hematology/cell counts; leuc; leuk; leukocyte; lkcs; manl; number concentration; number concentration (count/vol); point in time; qnt; quan; quant; quantitative; random; wbc; wbcs; white blood cell; white blood cells,Qn
14827-0,mesoporphyrin [moles/volume] in stool,mesopor stl-scnc,mesoporphyrin (stl) [moles/vol],bowel movement; chemistry; faecal; faeces; fecal; feces; hematology; heme; level; point in time; qnt; quan; quant; quantitative; random; stl; stool = fecal; substance concentration,Qn
14841-1,microscopic observation [identifier] in specimen by iron hematoxylin stain,ih stn spec,microscopic observation iron hematoxylin stain nom (specimen),id; identity or presence; ih stn; infectious disease; infectiousdisease; microbiology; misc; miscellaneous; nominal; other; point in time; random; spec; st; stains; stn; to be specified in another part of the message; unspecified,Nom
14858-5,leukocytes other/leukocytes in pleural fluid by manual count,wbc other nfr plr manual,wbc other/leukocytes manual cnt (pleur fld),hematology/cell counts; leuc; leuk; leukocyte; lkcs; manl; number fraction; othr; percent; pleural; pleural fluid; point in time; qnt; quan; quant; quantitative; random; thoracentesis fluid; wbc; wbc other; wbcs; white blood cell; white blood cells,Qn
1486-0,gastrin [mass/volume] in serum or plasma --20 minutes post 0.2 u/kg secretin,gastrin 20m p 0.2 u/kg sct serpl-mcnc,gastrin 20 min post 0.2 u/kg secretin [mass/vol],20m p 0.2 u/kg sct; after; chemistry.challenge testing; level; mass concentration; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; total gastrins; zollinger-ellison syndrome,Qn
14862-7,oxalate [moles/time] in 24 hour urine,oxalate 24h ur-srate,oxalate (24h u) [moles/time],1 day; 24 hours; 24hr; chemistry; ethanedioate; ethanedioic acid; kidney; nephrology; oxal; oxalic acid; qnt; quan; quant; quantitative; renal; srate; substance rate; ua; universallaborders; ur; urn,Qn
14867-6,paroxetine [moles/volume] in serum or plasma,paroxetine serpl-scnc,paroxetine [moles/vol],drug/toxicology; drugs; level; paxil; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; substance concentration,Qn
14879-1,phosphate [moles/volume] in serum or plasma,phosphate serpl-scnc,phosphate [moles/vol],chemistry; i phos; inorganic phosphate; level; phos; phosphate total; phosphorous; phosphorus; phosphrous; pi; pl; plasma; plsm; po4; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; substance concentration,Qn
14882-5,porphobilinogen [moles/time] in 24 hour urine,pbg 24h ur-srate,porphobilinogen (24h u) [moles/time],1 day; 24 hours; 24hr; chemistry; hematology; heme; pbg; porph; porphobili; porphoblngn; porpoblngn; qnt; quan; quant; quantitative; srate; substance rate; ua; ur; urn,Qn
14891-6,propranolol [moles/volume] in serum or plasma,propranolol serpl-scnc,propranolol [moles/vol],drug/toxicology; drugs; inderal; level; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; substance concentration,Qn
14897-3,deprecated protein [mass/volume] in plasma,deprecated prot plas-mcnc,protein (p) [mass/vol],chemistry; level; mass concentration; pl; plasma; plsm; point in time; pr; prot; qnt; quan; quant; quantitative; random,Qn
14898-1,protriptyline [moles/volume] in serum or plasma,protrip serpl-scnc,protriptyline [moles/vol],drug/toxicology; drugs; level; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; substance concentration; vivactil,Qn
14910-4,serotonin [moles/volume] in serum,serotonin ser-scnc,serotonin (s) [moles/vol],5-ht; 5-hydroxytryptamine; 5-hydroxytryptophane; c10h12n2o; chemistry; enteramine; level; point in time; qnt; quan; quant; quantitative; random; serum; sr; substance concentration,Qn
14958-3,microalbumin/creatinine [mass ratio] in 24 hour urine,microalbumin/creat 24h ur,albumin/creatinine dl <= 20 mg/l (24h u) [mass ratio],1 day; 24 hours; 24hr; alb; chemistry; cr; crea; creat; dl=20 mg/l; kidney; left; levo; ma; malb; mass concentration ratio; mass ratio; mcrto; micro albumin; microalbumin; nephrology; protein.albumin; qnt; quan; quant; quantitative; renal; ua; ucr; ur; urn,Qn
14965-8,cd2 abnormal blood cells/abnormal blood cells.total in blood,cd2 abn bld cells nfr,cd2 abnormal blood cells/abnormal blood cells.total (bld),abn; abnorm; blood; cd2 abn bld cells; cd2 cells; cd2r; cell; cell markers; cellularity; e-rosette receptor; leu5; leu-5; lfa-2; lymphocyte-function antigen-2; number fraction; percent; point in time; qnt; quan; quant; quantitative; random; t11; tot; totl; wb; whole blood,Qn
14970-8,estrone (e1).bioavailable [mass/volume] in serum or plasma,estrone bioavail serpl-mcnc,e1.bioavailable [mass/vol],chemistry; e1; estrone bioavail; gyn; gynecology; level; mass concentration; ob; obgyn; obstetrics; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
14971-6,estrone (e1).bioavailable/estrone (e1).total in serum or plasma,estrone bioavail mfr serpl,e1.bioavailable [mass fraction],chemistry; e1; estrone bioavail; gyn; gynecology; mass fraction; ob; obgyn; obstetrics; percent; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; tot; totl,Qn
14977-3,immunoglobulin light chains.free [type] in urine,bj protein free ur,immunoglobulin light chains.free nom (u),bence jones protein; bj protein; bj protein free; bjp; chain; chemistry; flc; fr; hematology; heme; immune globulin; immuno; immunoglob; immunoglobin; imunoglbon; imunoglobn; nominal; non-protein bound; point in time; random; typ; ua; ur; urn,Nom
14987-2,little i-1 subtype [presence] on red blood cells from donor,little i1 subtype rbc donr ql,little i-1 subtype ql (rbc donor),blood bank; donr; erythrocytes; hematology; heme; i; i1; little i1; little i1 subtype; ordinal; point in time; pr; ql; qual; qualitative; random; red blood cells; red blood corpusles; screen,Ord
1499-3,glucose [mass/volume] in serum or plasma --1 hour post 0.5 g/kg glucose iv,glucose 1h p .5 g/kg glc iv serpl-mcnc,glucose 1 hr post 0.5 g/kg glucose iv [mass/vol],1 hour; 1.0hr; 1h p .5 g/kg glc iv; 60 min; 60 minutes; 60m; 60min; after; chemistry.challenge testing; endocrine; endocrinology; glu; glu tol; gluc; glucose tolerance; glucoseur; gtt; level; mass concentration; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
15007-8,"2,3-diphosphoglycerate [moles/volume] in red blood cells","2,3dpg rbc-scnc","2,3-diphosphoglycerate (rbc) [moles/vol]","2,3dpg; 2,3-dpg; biphosphoglycerate; chemistry; dpg; erythrocytes; ii; iii; level; point in time; qnt; quan; quant; quantitative; random; red blood cells; red blood corpusles; substance concentration",Qn
15010-2,aldosterone [moles/volume] in urine,aldost ur-scnc,aldosterone (u) [moles/vol],chemistry; endocrine; endocrinology; level; point in time; qnt; quan; quant; quantitative; random; substance concentration; ua; ur; urn,Qn
15011-0,aldosterone [moles/volume] in serum or plasma --supine,aldost sup serpl-scnc,aldosterone supine [moles/vol],chemistry.challenge testing; endocrine; endocrinology; level; lying; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; substance concentration,Qn
15039-1,deprecated cobalamin [molecules/volume] in serum,deprecated cobalamin ser-scnc,cobalamin (s) [moles/vol],chemistry; level; point in time; qnt; quan; quant; quantitative; random; serum; sr; substance concentration,Qn
15048-2,creatine kinase.bb/creatine kinase.total in serum or plasma by electrophoresis,ck bb cfr serpl elph,ck.bb elph [catalytic fraction],catalytic fraction; chemistry; ck; ck 1; ck bb; ck-bb; cpk; creatine phosphokinase; elec; elect; electr; electro; electrophhrs; electrophrs; elp; elph; ep; neuro; neurology; percent; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; tot; totl,Qn
1505-7,glucose [mass/volume] in urine --1 hour post 50 g glucose po,glucose 1h p 50 g glc po ur-mcnc,glucose 1 hr post 50 g glucose po (u) [mass/vol],1 hour; 1.0hr; 1h p 50 g glc po; 60 min; 60 minutes; 60m; 60min; after; chemistry.challenge testing; glu; glu tol; gluc; glucose tolerance; glucoseur; gtt; level; mass concentration; p 50 g glc; p 50 g glc po; point in time; pst; qnt; quan; quant; quantitative; random; ua; ur; urn,Qn
15067-2,follitropin [units/volume] in serum or plasma,fsh serpl-acnc,follitropin qn,arbitrary concentration; chemistry; follicle stimulating hormone; fsh; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; universallaborders,Qn
15069-8,fructosamine [moles/volume] in serum or plasma,fructosamine serpl-scnc,fructosamine [moles/vol],chemistry; glucosamine; glycated serum protein; gsp; level; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; substance concentration; universallaborders,Qn
15078-9,lactate [moles/time] in 24 hour urine,lactate 24h ur-srate,lactate (24h u) [moles/time],1 day; 24 hours; 24hr; 2-hydroxypropanoic acid; 2-hydroxy-propionate; 2-hydroxy-propionic acid; chemistry; lact; lactic acid; l-lactate; qnt; quan; quant; quantitative; srate; substance rate; ua; ur; urn,Qn
15079-7,lutropin [units/volume] in urine,lh ur-acnc,lutropin qn (u),arbitrary concentration; chemistry; icsh; interstitial cell-stimulating hormone; interstitual cell stimulating hormone; leutinizing hormone; lh; luteinizing hormone; lutenin; lutenizing hormone; ovulation test; point in time; qnt; quan; quant; quantitative; random; ua; ur; urn,Qn
15102-7,codeine [moles/volume] in serum or plasma,codeine serpl-scnc,codeine [moles/vol],addiction; c260; c300; drug/toxicology; drugs; drugs of abuse; illicit; level; methylmorphine; morphine methyl ether; pl; plasma; plsm; point in time; potentialforabuse; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; substance concentration,Qn
15110-0,morphine [moles/volume] in serum or plasma,morphine serpl-scnc,morphine [moles/vol],addiction; c260; drug/toxicology; drugs; drugs of abuse; illicit; level; morphine sulfate; ms; mso4; omph; pl; plasma; plsm; point in time; potentialforabuse; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; substance concentration,Qn
15116-7,deprecated arsenic [molecules/volume] in urine,deprecated arsenic ur-scnc,arsenic (u) [moles/vol],as; drug/toxicology; drugs; level; point in time; qnt; quan; quant; quantitative; random; substance concentration; ua; ur; urn,Qn
15131-6,isoleucine+leucine [presence] in serum or plasma,ile+leu serpl ql,isoleucine+leucine ql,chemistry; ile; ile+leu; leu; ordinal; pl; plasma; plsm; point in time; pr; ql; qual; qualitative; random; screen; serp; serpl; serplas; serum; serum or plasma; sr,Ord
15135-7,aspartate+citrulline+glycine+homocystine+hydroxyproline [presence] in serum or plasma,amino acids mixd serpl ql,aspartate+citrulline+glycine+homocystine+hydroxyproline ql,(hcys)2; amino acids mixd; asp; aspartic acid; chemistry; cit; citr; gly; homocyst(e)ine; homocystin; hydroxylproline; hydroxyprol; hydroxy-proline; hydrxprol; hydrxproln; hydrxyprln; hyp; ohpro; oh-proline; ordinal; pl; plasma; plsm; point in time; pr; ql; qual; qualitative; random; screen; serp; serpl; serplas; serum; serum or plasma; sr,Ord
15141-5,beta aminoisobutyrate+proline [presence] in urine,b-aib+pro ur ql,beta aminoisobutyrate+proline ql (u),3-aminoisobutyrate; 3-aminoisobutyric acid; b; b-aib; b-aib+pro; chemistry; ordinal; point in time; pr; pro; ql; qual; qualitative; random; screen; ua; ur; urn,Ord
15143-1,aspartate+citrulline+glycine+homocystine+hydroxyproline [presence] in urine,amino acids mixd ur ql,aspartate+citrulline+glycine+homocystine+hydroxyproline ql (u),(hcys)2; amino acids mixd; asp; aspartic acid; chemistry; cit; citr; gly; homocyst(e)ine; homocystin; hydroxylproline; hydroxyprol; hydroxy-proline; hydrxprol; hydrxproln; hydrxyprln; hyp; ohpro; oh-proline; ordinal; point in time; pr; ql; qual; qualitative; random; screen; ua; ur; urn,Ord
15144-9,glutamate+glutamine+threonine [presence] in urine,glu+gln+thr ur ql,glutamate+glutamine+threonine ql (u),c707; chemistry; gln; glu; glu+gln; glu+gln+thr; glutamic acid; ordinal; point in time; pr; ql; qual; qualitative; random; screen; thr; ua; ur; urn,Ord
15149-8,ammonia [moles/volume] in body fluid,ammonia fld-scnc,ammonia (body fld) [moles/vol],"amm; ammon; amon; b/f; bf; bod; bodies; body fluid; body fluid, unsp; chemistry; fl; fld; flu; fluid; hepatology; kidney; level; liver; nephrology; nh3; point in time; qnt; quan; quant; quantitative; random; renal; substance concentration",Qn
15150-6,anisocytosis [presence] in blood by automated count,anisocytosis bld ql auto,anisocytosis auto ql (bld),aniso; auto; automated detection; blood; elec; elect; electr; hematology/cell counts; ordinal; point in time; pr; ql; qual; qualitative; random; screen; wb; whole blood,Ord
15153-0,deprecated indirect bilirubin [mass/volume] in serum or plasma,deprecated bilirub indirect serpl-mcnc,bilirubin.indirect differential light absorption [mass/vol],absorp; bili; bilirub indirect; bilirubin indirect; bilirubin non-conjugated; bilirubin primary; bilirubin unconjugated; bilirubins; billirubin; bu; chemistry; diff; differl; differn; level; mass concentration; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; tbil,Qn
15159-7,coagulation factor extrinsic pathway [interpretation] in platelet poor plasma narrative,extrins clotting path ppp-imp,coagulation factor extrinsic pathway nar (ppp) [interp],coag; extrins clotting path; fac; fact; hematology; heme; impression; impression/interpretation of study; impressions; interp; interpretation; narrative; plas; platelet poor plasma; point in time; random; report,Nar
15179-5,fibrin d-dimer [presence] in platelet poor plasma,d dimer ppp ql,fibrin d-dimer ql (ppp),coagulation; d dimer; dextro; fragment d-dimer; hematology; heme; ordinal; plas; platelet poor plasma; point in time; pr; ql; qual; qualitative; random; screen,Ord
15189-4,kappa light chains/lambda light chains [mass ratio] in serum,kappa lc/lambda ser,immunoglobulin light chains.kappa/immunoglobulin light chains.lambda (s) [mass ratio],bence jones protein; bj protein; bjp; chain; chemistry; hematology; heme; immune globulin; immuno; immunoglob; immunoglobin; imunoglbon; imunoglobn; kappa lc; lambda lc; mass concentration ratio; mass ratio; mcrto; point in time; qnt; quan; quant; quantitative; random; serum; sr,Qn
15192-8,variant lymphocytes [presence] in blood by automated count,variant lymphs bld ql auto,variant lymphocytes auto ql (bld),atypical lymphocytes; auto; automated detection; blood; elec; elect; electr; hematology/cell counts; lymp; lymph; lympho; lymphocyte; lymphs; lymphs%; ordinal; point in time; pr; ql; qual; qualitative; random; reactive lymphocytes; screen; variant lymphocytes; variant lymphs; wb; whole blood,Ord
15194-4,cd3-cd16+ cells/cells in blood,cd3-cd16+ cells nfr bld,cd3-cd16+ cells/cells (bld),blood; cd3 cells; cd3+cd16+ cells; cd3-cd16+ cells; cell; cell markers; cellularity; fcgr3a; leu11; leu-11; leu11b; leu-11b; leu4; leu-4; number fraction; percent; point in time; qnt; quan; quant; quantitative; random; t3; wb; whole blood,Qn
15204-1,rheumatoid factor [titer] in serum by nephelometry,rheumatoid fact titr ser neph,rheumatoid factor nephelometry (s) [titer],dilution factor; dilution factor (titer); fac; fact; light scattering; nephelom; point in time; random; rf; serology; serum; smqn; sr; titer; titered; titre; ttr,SemiQn
15215-7,epidermal allergen mix 71 (chicken feather+duck feather+goose feather+turkey feather) ige ab [presence] in serum by multidisk,epid allerg mix71 ige ql,chicken feather+duck feather+goose feather+turkey feather ige multidisk ql (s),abs; aby; allergen; allergens; allergy testing; allerscan; antby; anti; antibodies; antibody; autoantibodies; autoantibody; dander; e070; e085; e086; e70; e85; e86; e89; ep71; epid allerg mix a; epid allerg mix71; ex71; f083; f158; f83; feather mix; feathers; gallus spp; immune globulin e; immunoglobulin e; meleagis gallopavo; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; sr,Ord
15223-1,food allergen mix b (tarragon+lovage+marjoram) ige ab [presence] in serum by multidisk,food allerg mix b ige ql,tarragon+lovage+marjoram ige multidisk ql (s),a dracunculus; abs; aby; allergen; allergens; allergy testing; allerscan; antby; anti; antibodies; antibody; autoantibodies; autoantibody; esdragol; f272; f274; f275; food allerg mix b; immune globulin e; immunoglobulin e; lovage; marjoram; ordinal; point in time; pr; ql; qual; qualitative; random; rf272; rf274; rf275; screen; serum; sr; tarragon,Ord
15232-2,regional allergen mix a (common ragweed+mugwort+japanese cedar+orchard grass+timothy) ige ab [presence] in serum by multidisk,region allerg mix a ige ql,common ragweed+mugwort+japanese cedar+orchard grass+timothy ige multidisk ql (s),a artemisiifolia; a elatior; abs; aby; allergen; allergens; allergy testing; allerscan; ambrosia artemisiifolia; antby; anti; antibodies; antibody; autoantibodies; autoantibody; cocksfoot; common ragweed; g003; g006; g3; g6; immune globulin e; immunoglobulin e; japanese cedar; mugwort; orchard grass; ordinal; phleum pretense; point in time; pr; ql; qual; qualitative; random; region allerg mix a; screen; serum; short ragweed; sr; sugi tree; t17; timothy; timothy grass; w001; w006; w1; w6,Ord
15233-0,mold allergen mix a (alternaria alternata+aspergillus fumigatus+candida albicans+setomelanomma rostrata+penicillium notatum) ige ab [presence] in serum by multidisk,mold allerg mix a ige ql,alternaria alternata+aspergillus fumigatus+candida albicans+setomelanomma rostrata+penicillium notatum ige multidisk ql (s),a alternata; a fumigatus; a tenuis; abs; aby; allergen; allergens; allergy testing; allerscan; alternaria tenuis; antby; anti; antibodies; antibody; asperg; aspergil; aspergilis; aspergilla; aspergillin; aspergillosis; aspergils; aspergilus; autoantibodies; autoantibody; c albicans; c herbarum; cand; candidiasis; farmers lung; fum; hormodendrum; immune globulin e; immunoglobulin e; m001; m002; m003; m005; m006; m1; m2; m3; m5; m6; mold allerg mix a; monilia; ordinal; p chrysogenum; p notatum; point in time; pr; ql; qual; qualitative; random; screen; serum; sr; thrush,Ord
1524-8,glucose [mass/volume] in serum or plasma --30 minutes post 0.1 u/kg insulin,glucose 30m p 0.1 u/kg ins serpl-mcnc,glucose 30 min post 0.1 u/kg insulin [mass/vol],30m p 0.1 u/kg ins; after; chemistry.challenge testing; endocrine; endocrinology; glu; glu tol; gluc; glucose tolerance; glucoseur; gtt; hum; humulin; ih7; insul; lente; level; mass concentration; nph; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; semilente; serp; serpl; serplas; serum; serum or plasma; sliding; sr; ultralente,Qn
15255-3,food allergen mix 9 (kiwi+melon+banana+almond+grape) ige ab [presence] in serum by multidisk,food allerg mix9 ige ql,kiwi+melon+banana+almond+grape ige multidisk ql (s),abs; aby; allergen; allergens; allergy testing; allerscan; almond; amygdalus communis; antby; anti; antibodies; antibody; autoantibodies; autoantibody; banana; chinese gooseberry; f020; f084; f092; f20; f259; f84; f92; food allerg mix9; fruit mix; fx9; grape; grapes; immune globulin e; immunoglobulin e; kiwi fruit; kiwifruit; musa sp; ordinal; point in time; pr; prunus amygdalus; ql; qual; qualitative; random; screen; serum; sr,Ord
15271-0,weed allergen mix 1 (common ragweed+mugwort+goosefoot or lambs quarters+english plantain+saltwort) ige ab [presence] in serum by multidisk,weed allerg mix1 ige ql,common ragweed+mugwort+goosefoot or lambs quarters+english plantain+saltwort ige multidisk ql (s),a artemisiifolia; a elatior; abs; aby; allergen; allergens; allergy testing; allerscan; ambrosia artemisiifolia; antby; anti; antibodies; antibody; autoantibodies; autoantibody; buckhorn plantain; common ragweed; engl plantain; english plantain; goosefoot; immune globulin e; immunoglobulin e; lamb's quarter; lambs quarters; lamb's quarters; mugwort; ordinal; plantain buckhorn; point in time; pr; ql; qual; qualitative; quinoa; random; ribwort; russian thistle; salosola kali; salsola pestifer; saltwort; saltwort (prickly); screen; serum; short ragweed; sr; w001; w006; w009; w010; w011; w1; w10; w11; w6; w9; weed allerg mix1; weed mix; wx1,Ord
15278-5,lovage ige ab [units/volume] in serum,lovage ige qn,lovage ige qn (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; f275; immune globulin e; immunoglobulin e; lovage; point in time; qnt; quan; quant; quantitative; random; rf275; serum; sr,Qn
15292-6,testis - left height by us,height testis-l us.meas,,echography; genitourinary; gu; l; length; lt; point in time; qnt; quan; quant; quantitative; random; sonogram; sonograph; sonography; testis depth; testis-l; uls; ultrasound; uro; urologic.ultrasound; urology; us+meas,Qn
15293-4,testis - left width by us,width testis-l us.meas,,echography; genitourinary; gu; l; length; lt; point in time; qnt; quan; quant; quantitative; random; sonogram; sonograph; sonography; testis-l; uls; ultrasound; uro; urologic.ultrasound; urology; us+meas,Qn
15300-7,urinary bladder length by us,length bladder us.meas,,echography; genitourinary; gu; len; length; point in time; qnt; quan; quant; quantitative; random; sonogram; sonograph; sonography; uls; ultrasound; uro; urologic.ultrasound; urology; us+meas,Qn
15303-1,prostate length by us,length prostate us.meas,,echography; genitourinary; gu; len; length; point in time; prost; prostatic; qnt; quan; quant; quantitative; random; sonogram; sonograph; sonography; uls; ultrasound; uro; urologic.ultrasound; urology; us+meas,Qn
15316-3,volume planimetry stepsize by - reported,stepsize vol.planimetry reported,,length; point in time; qnt; quan; quant; quantitative; random; urologic.ultrasound; vol.planimetry,Qn
15338-7,other antibiotic [susceptibility] by serum bactericidal titer --trough,other antibiotic trough titr sbt,other antibiotic trough sbt (isol+s),antibiotic susceptibilities; dilution factor; dilution factor (titer); id; infectious disease; infectiousdisease; islt; isol; other antibiotic; point in time; pre; predose; pre-dose; random; schlichter test; sequence based typing; serum; serum bactericidal titer; serum killing test; smqn; sr; titer; titered; titre; ttr,SemiQn
15341-1,black fly ige ab [units/volume] in serum,black fly ige qn,black fly ige qn (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; black fly; immune globulin e; immunoglobulin e; point in time; qnt; quan; quant; quantitative; random; serum; sr,Qn
15344-5,little i ab [titer] in serum or plasma,little i ab titr serpl,little i ab [titer],abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; blood bank; dilution factor; dilution factor (titer); i; pl; plasma; plsm; point in time; random; serp; serpl; serplas; serum; serum or plasma; smqn; sr; titer; titered; titre; ttr,SemiQn
15346-0,aldosterone [mass/volume] in serum or plasma --30 minutes post xxx challenge,aldost 30m p chal serpl-mcnc,aldosterone 30 min post unsp challenge [mass/vol],30m p chal; after; chemistry.challenge testing; endocrine; endocrinology; level; mass concentration; p chal; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
15355-1,estrone sulfate [mass/volume] in serum or plasma,estrone sulfate serpl-mcnc,estrone sulfate [mass/vol],chemistry; e1; e1s; gyn; gynecology; level; mass concentration; ob; obgyn; obstetrics; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; so4; so4-2; sr; sulf,Qn
15365-0,deprecated codeine,deprecated codeine mec ql,codeine ql (mec),addiction; c260; c300; drug/toxicology; drugs; drugs of abuse; illicit; level; mass concentration; mec; methylmorphine; morphine methyl ether; ordinal; point in time; potentialforabuse; ql; qual; qualitative; random; screen,Ord
1537-0,glucose [mass/volume] in serum or plasma --4 hours post 100 g glucose po,glucose 4h p 100 g glc po serpl-mcnc,glucose 4 hr post 100 g glucose po [mass/vol],4h p 100 g glc po; after; chemistry.challenge testing; endocrine; endocrinology; glu; glu tol; gluc; glucose tolerance; glucoseur; gtt; level; mass concentration; p 100 g glc po; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
15374-2,sulfonylurea [presence] in serum or plasma,sulfonylurea serpl ql,sulfonylurea ql,drug/toxicology; drugs; ordinal; pl; plasma; plsm; point in time; pr; ql; qual; qualitative; random; screen; serp; serpl; serplas; serum; serum or plasma; sr; sulphonylurea,Ord
15384-1,leishmania mexicana igg ab [titer] in serum,l mexicana igg titr ser,l. mexicana igg (s) [titer],abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; dilution factor; dilution factor (titer); id; immune globulin g; immunoglobulin g; infectious disease; infectiousdisease; l mexicana; leishmaniasis; leishmaniosis; microbiology; point in time; random; serum; smqn; sr; titer; titered; titre; ttr,SemiQn
1538-8,glucose [mass/volume] in urine --4 hours post 100 g glucose po,glucose 4h p 100 g glc po ur-mcnc,glucose 4 hr post 100 g glucose po (u) [mass/vol],4h p 100 g glc po; after; chemistry.challenge testing; glu; glu tol; gluc; glucose tolerance; glucoseur; gtt; level; mass concentration; p 100 g glc po; point in time; pst; qnt; quan; quant; quantitative; random; ua; ur; urn,Qn
15392-4,parainfluenza virus 2 igg ab [presence] in serum,hpiv2 igg ser ql,parainfluenza virus 2 igg ql (s),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; hpiv; hpiv2; human rubulavirus 2; id; ii; immune globulin g; immunoglobulin g; infectious disease; infectiousdisease; microbiology; ordinal; para; parainflu; parainfluenza type 2; parainfluenza type ii; pi2; point in time; pr; ql; qual; qualitative; random; screen; serum; sr,Ord
15397-3,trypanosoma cruzi igm ab [titer] in serum,t cruzi igm titr ser,t. cruzi igm (s) [titer],abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; chagas disease; dilution factor; dilution factor (titer); id; immune globulin m; immunoglobulin m; infectious disease; infectiousdisease; microbiology; point in time; random; serum; smqn; sr; t cruzi; titer; titered; titre; trypanosomiasis; trypanosomosis; ttr,SemiQn
15404-7,levomethamphetamine/amphetamines.total in urine,l-methamphet mfr ur,levomethamphetamine/total amphetamines (u) [mass fraction],amph; amphetam; amphetamine; drug/toxicology; drugs; levo-methamphetamine; l-methamphet; l-methamphetamine; mass fraction; percent; point in time; qnt; quan; quant; quantitative; random; speed; tot; totl; ua; ur; urn,Qn
15405-4,methamphetamine [mass/volume] in meconium,methamphet mec-mcnc,methamphetamine (mec) [mass/vol],addiction; desoxyn; drug/toxicology; drugs; drugs of abuse; illicit; level; mass concentration; mec; methamphet; point in time; potentialforabuse; qnt; quan; quant; quantitative; random,Qn
15413-8,service comment 22,service cmnt 22-imp,service comment 22 [interp],cmmt; cmnt; com; comm; comment; comments; commt; impression; impression/interpretation of study; impressions; interp; interpretation; misc; miscellaneous; nominal; other; point in time; random; remarks; service cmnt; service cmnt 22; spec; to be specified in another part of the message; unspecified,Nom
15414-6,service comment 23,service cmnt 23-imp,service comment 23 [interp],cmmt; cmnt; com; comm; comment; comments; commt; impression; impression/interpretation of study; impressions; interp; interpretation; misc; miscellaneous; nominal; other; point in time; random; remarks; service cmnt; service cmnt 23; spec; to be specified in another part of the message; unspecified,Nom
15416-1,service comment 25,service cmnt 25-imp,service comment 25 [interp],cmmt; cmnt; com; comm; comment; comments; commt; impression; impression/interpretation of study; impressions; interp; interpretation; misc; miscellaneous; nominal; other; point in time; random; remarks; service cmnt; service cmnt 25; spec; to be specified in another part of the message; unspecified,Nom
15431-0,service comment 40,service cmnt 40-imp,service comment 40 [interp],cmmt; cmnt; com; comm; comment; comments; commt; impression; impression/interpretation of study; impressions; interp; interpretation; misc; miscellaneous; nominal; other; point in time; random; remarks; service cmnt; service cmnt 40; spec; to be specified in another part of the message; unspecified,Nom
15432-8,testosterone free/testosterone.total in serum or plasma,testost free mfr serpl,testosterone free/testosterone.total [mass fraction],chemistry; fr; mass fraction; non-protein bound; percent; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; testo; testos; testost; testost free; testosterone.unconjugated; tot; totl,Qn
15434-4,avian adenovirus ab [presence] in serum by immune diffusion (id),fadv ab ser ql id,avian adenovirus ab immune diff ql (s),abs; aby; adeno virus; antby; anti; antibodies; antibody; autoantibodies; autoantibody; bird; celo; fadv; fowl; hadv; id; imm; immunodiff; immunodiffusion; imun; imune; infectious disease; infectiousdisease; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; sr; vet; veterinary,Ord
15435-1,avian adenovirus 2 ab [presence] in serum by immune diffusion (id),fadv2 ab ser ql id,avian adenovirus 2 ab immune diff ql (s),abs; aby; adeno virus; antby; anti; antibodies; antibody; autoantibodies; autoantibody; bird; celo; fadv; fadv2; fowl; hadv; id; ii; imm; immunodiff; immunodiffusion; imun; imune; infectious disease; infectiousdisease; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; sr; vet; veterinary,Ord
15438-5,avian hemorrhagic enteritis virus ab [presence] in serum by immunoassay,aav2 ab ser ql ia,avian hemorrhagic enteritis virus ab ia ql (s),aav2; abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; bird; eia; elfa; elisa; enzyme immunoassay; fowl; hev; hev ab; iaa; id; infectious disease; infectiousdisease; meia; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; sr; suds; vet; veterinary,Ord
15451-8,avian pox virus ab [presence] in serum by immune diffusion (id),fwpv ab ser ql id,avian pox virus ab immune diff ql (s),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; avian pox; bird; canker; fowl; fowlpox; fwpv; id; imm; immunodiff; immunodiffusion; imun; imune; infectious disease; infectiousdisease; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; sore head diphtheria; sr; vet; veterinary,Ord
15452-6,avian reovirus ab [presence] in serum by immune diffusion (id),avreov ab ser ql id,avian reovirus ab immune diff ql (s),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; avreov; bird; fowl; id; imm; immunodiff; immunodiffusion; imun; imune; infectious disease; infectiousdisease; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; reo virus; reov; screen; serum; sr; vet; veterinary,Ord
15471-6,equine influenza virus a2 ab [titer] in serum by hemagglutination inhibition,eiv a2 ab titr ser hai,equine influenza virus a2 ab hai (s) [titer],abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; dilution factor; dilution factor (titer); eiv; eiv a2; equin; equine influenza; fluv; hemagglutination inhibition; hi; id; infectious disease; infectiousdisease; influ; kentucky disease; microbiology; point in time; random; serum; smqn; sr; titer; titered; titre; ttr; vet; veterinary,SemiQn
15472-4,equine influenza virus ag [presence] in nose by immunoassay,eiv ag nose ql ia,equine influenza virus ag ia ql (nose),antigen; antigens; eia; eiv; elfa; elisa; enzyme immunoassay; equin; equine influenza; fluv; iaa; id; infectious disease; infectiousdisease; influ; meia; microbiology; nasal; nos; nose (nasal passage); ordinal; point in time; pr; ql; qual; qualitative; random; screen; smell; suds; vet; veterinary,Ord
15482-3,mycobacterium avium ss paratuberculosis ab [presence] in serum by immune diffusion (id),m avium paratb ab ser ql id,m. avium ss paratuberculosis ab immune diff ql (s),abs; aby; acid fast; acid fast bacilli; acid fast bacillus; afb; antby; anti; antibodies; antibody; autoantibodies; autoantibody; id; imm; immunodiff; immunodiffusion; imun; imune; infectious disease; infectiousdisease; johnes disease; m avium; m avium paratb; microbiology; myco; mycobact; mycobacterium paratuberculosis; ordinal; paratuberculosis; point in time; pr; ql; qual; qualitative; random; screen; serum; sr; ssp; tuberculosis; vet; veterinary,Ord
15488-0,mycoplasma meleagridis ab [presence] in serum by agglutination,m meleagridis ab ser ql aggl,m. meleagridis ab aggl ql (s),abs; aby; agg; agglut; agglutination; antby; anti; antibodies; antibody; autoantibodies; autoantibody; id; infectious disease; infectiousdisease; m meleagridis; microbiology; myco; mycoplas; mycoplasm; mycoplasmosis; mycoplsm; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; sr; vet; veterinary,Ord
15490-6,mycoplasma synoviae ab [presence] in serum by agglutination,m synoviae ab ser ql aggl,m. synoviae ab aggl ql (s),abs; aby; agg; agglut; agglutination; antby; anti; antibodies; antibody; autoantibodies; autoantibody; id; infectious disease; infectiousdisease; m synoviae; microbiology; myco; mycoplas; mycoplasm; mycoplasmosis; mycoplsm; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; sr; vet; veterinary,Ord
15497-1,pseudorabies virus ab [presence] in serum by immunoassay,prv ab ser ql ia,pseudorabies virus ab ia ql (s),abs; aby; alpha-herpesvirus; antby; anti; antibodies; antibody; aujeszky's disease; aujeszkys disease virus; aujezskys disease; autoantibodies; autoantibody; eia; elfa; elisa; enzyme immunoassay; iaa; id; infectious disease; infectiousdisease; meia; microbiology; ordinal; phv1; point in time; porcine herpes virus 1; pr; prv; pseudorabies; ql; qual; qualitative; random; screen; serum; shv-1; sr; suds; suid herpesvirus-1; vet; veterinary,Ord
15515-0,"ambulance transport, medical reason for transport",,,attach; attach.amb; impression; impression/interpretation of study; impressions; interp; interpretation; nominal; point in time; random,Nom
15544-0,deprecated ascaris sp ige ab rast class [presence] in serum,deprecated ascaris ige rast ql,ascaris sp ige rast class (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; ige rast; immune globulin e; immunoglobulin e; ordinal; p1; point in time; pr; ql; qual; qualitative; random; screen; serum; species; spp; sr,Ord
15563-0,deprecated green coffee bean ige ab rast class [presence] in serum,deprecated green coffee bean ige rast ql,green coffee bean ige rast class (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; beans; f315; green bean; green coffee bean; ige rast; immune globulin e; immunoglobulin e; k70; ordinal; point in time; pr; ql; qual; qualitative; random; rf315; screen; serum; sr,Ord
15567-1,deprecated pinto bean ige ab rast class [presence] in serum,deprecated pinto bean ige rast ql,pinto bean ige rast class (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; beans; f121; f300; ige rast; immune globulin e; immunoglobulin e; ordinal; phaseolus vulgaris; pinto bean; point in time; pr; ql; qual; qualitative; random; screen; serum; sr,Ord
15571-3,deprecated american beech ige ab rast class [presence] in serum,deprecated amer beech ige rast ql,american beech ige rast class (s),abs; aby; allergen; allergens; allergy testing; amer beech; american beech; antby; anti; antibodies; antibody; autoantibodies; autoantibody; ige rast; immune globulin e; immunoglobulin e; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; sr; t005; t5,Ord
15573-9,deprecated beet ige ab rast class [presence] in serum,deprecated beet ige rast ql,beet ige rast class (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; ige rast; immune globulin e; immunoglobulin e; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; sr,Ord
15581-2,deprecated blomia tropicalis ige ab rast class [presence] in serum,deprecated b tropicalis ige rast ql,blomia tropicalis ige rast class (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; b tropicalis; d201; hdm; house dust mite; ige rast; immune globulin e; immunoglobulin e; mite; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; sr,Ord
15587-9,deprecated broccoli ige ab rast class [presence] in serum,deprecated broccoli ige rast ql,broccoli ige rast class (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; brassica oleracea cymosa; brassica oleracea var italics; broccoli; f260; ige rast; immune globulin e; immunoglobulin e; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; sr,Ord
15589-5,deprecated brussel sprouts ige ab rast class [presence] in serum,deprecated brussel sprouts ige rast ql,brussel sprouts ige rast class (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; brassica oleracea gemmifera; brussel sprouts; brussels sprouts; f217; ige rast; immune globulin e; immunoglobulin e; ordinal; point in time; pr; ql; qual; qualitative; random; rf217; screen; serum; sr,Ord
15619-0,deprecated acremonium sp ige ab rast class [presence] in serum,deprecated acremonium ige rast ql,acremonium sp ige rast class (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; cephalosporium; ige rast; immune globulin e; immunoglobulin e; m202; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; species; spp; sr,Ord
15622-4,deprecated american cheese ige ab rast class [presence] in serum,deprecated american cheese ige rast ql,american cheese ige rast class (s),abs; aby; allergen; allergens; allergy testing; american cheese; antby; anti; antibodies; antibody; autoantibodies; autoantibody; f122; ige rast; immune globulin e; immunoglobulin e; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; sr,Ord
15632-3,deprecated chestnut pollen ige ab rast class [presence] in serum,deprecated chestnut poln ige rast ql,chestnut pollen ige rast class (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; chestnut; chestnut poln; european chestnut; f299; ige rast; immune globulin e; immunoglobulin e; ordinal; point in time; pr; ql; qual; qualitative; random; rt206; screen; serum; sr; sweet chestnut; t206,Ord
1563-6,insulin [mass/volume] in serum or plasma --2 hours post dose tolbutamide iv,insulin 2h p tbm iv serpl-mcnc,insulin 2 hr post dose tolbutamide iv [mass/vol],120 min; 120 minutes; 120min; 2 hours; 2h p tbm iv; after; chemistry.challenge testing; hum; humulin; ih7; insul; lente; level; mass concentration; novo-butamide; nph; orinase; p dose; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; semilente; serp; serpl; serplas; serum; serum or plasma; sliding; sr; ultralente,Qn
15639-8,deprecated chymofast ige ab rast class in serum,deprecated chymofast ige rast ql,chymofast ige rast class (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; ige rast; immune globulin e; immunoglobulin e; ordinal; point in time; ql; qual; qualitative; random; screen; serum; sr,Ord
15654-7,deprecated cultivated corn ige ab rast class [presence] in serum,deprecated cultivated corn ige rast ql,cultivated corn ige rast class (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; corn; cultivated corn; f008; f141; f8; g202; ige rast; immune globulin e; immunoglobulin e; maize; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; sr,Ord
15707-3,deprecated fennel seed ige ab rast class [presence] in serum,deprecated fennel seed ige rast ql,fennel seed ige rast class (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; f219; fennel; fennel seed; finocchio; ige rast; immune globulin e; immunoglobulin e; ordinal; point in time; pr; ql; qual; qualitative; random; rf219; screen; seeds; serum; sr,Ord
15710-7,deprecated finch feather ige ab rast class [presence] in serum,deprecated finch feather ige rast ql,finch feather ige rast class (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; e214; feathers; ige rast; immune globulin e; immunoglobulin e; ordinal; point in time; pr; ql; qual; qualitative; random; re214; screen; serum; sr,Ord
15713-1,deprecated fiscus sp ige ab rast class [presence] in serum,deprecated fiscus ige rast ql,fiscus sp ige rast class (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; ige rast; immune globulin e; immunoglobulin e; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; species; spp; sr,Ord
15719-8,deprecated fox ige ab rast class [presence] in serum,deprecated fox ige rast ql,fox ige rast class (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; ige rast; immune globulin e; immunoglobulin e; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; sr,Ord
15721-4,deprecated fusarium culmorum ige ab rast class [presence] in serum,deprecated f culmorum ige rast ql,fusarium culmorum ige rast class (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; f culmorum; ige rast; immune globulin e; immunoglobulin e; m18; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; sr,Ord
15726-3,deprecated geotrichum candidum ige ab rast class [presence] in serum,deprecated g candidum ige rast ql,geotrichum candidum ige rast class (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; g candidum; ige rast; immune globulin e; immunoglobulin e; m212; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; sr,Ord
15730-5,deprecated glycyphagus domesticus ige ab rast class [presence] in serum,deprecated g domesticus ige rast ql,glycyphagus domesticus ige rast class (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; d073; d73; g domesticus; glycyphagus domesticus; ige rast; immune globulin e; immunoglobulin e; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; sr; storage mite,Ord
15750-3,deprecated grass rye italian ige ab rast class in serum,deprecated per rye grass ige rast ql,perennial rye grass ige rast class (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; g005; g5; ige rast; immune globulin e; immunoglobulin e; italian ryegrass; ordinal; per rye grass; perennial ryegrass; point in time; ql; qual; qualitative; random; rye grass; ryegrass; screen; serum; sr,Ord
15761-0,deprecated sweet gum ige ab rast class [presence] in serum,deprecated sweet gum ige rast ql,sweet gum ige rast class (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; ige rast; immune globulin e; immunoglobulin e; liquida styraciflua; ordinal; point in time; pr; ql; qual; qualitative; random; rt211; screen; serum; sr; sweet gum; sweetgum; t211,Ord
15769-3,deprecated setomelanomma rostrata ige ab rast class [presence] in serum,deprecated s rostrata ige rast ql,setomelanomma rostrata ige rast class (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; h halodes; helminthosporium halodes; ige rast; immune globulin e; immunoglobulin e; m8; ordinal; point in time; pr; ql; qual; qualitative; random; s rostrata; screen; serum; sr,Ord
15776-8,deprecated white hickory ige ab rast class [presence] in serum,deprecated white hickory ige rast ql,white hickory ige rast class (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; ige rast; immune globulin e; immunoglobulin e; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; sr; t041; t41; white hickory,Ord
15779-2,deprecated hop ige ab rast class [presence] in serum,deprecated hop ige rast ql,hop ige rast class (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; f324; fruit cone; hop; hops; hops oil; ige rast; immune globulin e; immunoglobulin e; ordinal; point in time; pr; ql; qual; qualitative; random; rf324; screen; serum; sr,Ord
15782-6,deprecated whitefaced hornet ige ab rast class [presence] in serum,deprecated whitefaced hornet ige rast ql,whitefaced hornet ige rast class (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; bald-faced hornet; i002; i2; ige rast; immune globulin e; immunoglobulin e; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; sr; wasp; white faced hornet; whitefaced hornet,Ord
1579-2,17-ketogenic steroids [mass/time] in 24 hour urine --pre 50 ug corticotropin im 3 day,17kgs pre 50 ug acth im 24h ur-mrate,17-ketogenic steroids pre 50 ug corticotropin im 3 day (24h u) [mass/time],1 day; 17kgs; 17-kgs; 24 hours; 24hr; acth; adrenocorticotrophic hormone; adrenocorticotropin; before; c206; c74; chemistry.challenge testing; cortrosyn; iii; ketogen; ketogenc; ketognc; mass rate; mcg; mrate; pre 50 ug acth im; qnt; quan; quant; quantitative; rc206; ste; steriods; steroid; tumor marker; ua; ur; urn,Qn
15802-2,deprecated kiwifruit ige ab rast class [presence] in serum,deprecated kiwifruit ige rast ql,kiwifruit ige rast class (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; chinese gooseberry; f084; f84; ige rast; immune globulin e; immunoglobulin e; kiwi fruit; kiwifruit; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; sr,Ord
15807-1,deprecated latex glove extract ige ab rast class [presence] in serum,deprecated ltx glv ext ige rast ql,latex glove extract ige rast class (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; hevea braziliensis; ige rast; immune globulin e; immunoglobulin e; k082; k82; ltx; ltx glv ext; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; sr,Ord
15817-0,deprecated easter lily ige ab rast class [presence] in serum,deprecated easter lily ige rast ql,easter lily ige rast class (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; easter lily; ige rast; immune globulin e; immunoglobulin e; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; sr,Ord
15830-3,deprecated corn ige ab rast class in serum,deprecated corn ige rast ql,corn ige rast class (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; corn; f008; f141; f74; f8; ige rast; immune globulin e; immunoglobulin e; maize; ordinal; point in time; ql; qual; qualitative; random; screen; serum; sr,Ord
15832-9,deprecated mango ige ab rast class [presence] in serum,deprecated mango ige rast ql,mango ige rast class (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; f091; f91; ige rast; immune globulin e; immunoglobulin e; mango; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; sr,Ord
15836-0,deprecated maple sugar ige ab rast class [presence] in serum,deprecated maple sugar ige rast ql,maple sugar ige rast class (s),abs; aby; acer; acer saccarum; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; ige rast; immune globulin e; immunoglobulin e; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; sr,Ord
15849-3,deprecated common millet ige ab rast class [presence] in serum,deprecated common millet ige rast ql,common millet ige rast class (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; common millet; f055; f55; ige rast; immune globulin e; immunoglobulin e; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; sr,Ord
15856-8,deprecated aedes mosquito ige ab rast class [presence] in serum,deprecated aedes mosquito ige rast ql,aedes mosquito ige rast class (s),abs; aby; aedes mosquito; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; i071; i71; ige rast; immune globulin e; immunoglobulin e; mosquito; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; sr,Ord
158-6,cephaloridine [susceptibility] by disk diffusion (kb),cephaloridine islt kb,cephaloridine disk diffusion (kb) [susc],antibiotic susceptibilities; ast; disk diffusion; id; infectious disease; infectiousdisease; islt; isol; kb; kirby-bauer; loridine; point in time; random; sus; suscept; susceptibilities; susceptibility; susceptibilty,OrdQn
15874-1,deprecated nutmeg ige ab rast class [presence] in serum,deprecated nutmeg ige rast ql,nutmeg ige rast class (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; f282; ige rast; immune globulin e; immunoglobulin e; myristica fragrans; ordinal; point in time; pr; ql; qual; qualitative; random; rf282; screen; serum; sr,Ord
15877-4,deprecated coastal oak ige ab rast class [presence] in serum,deprecated coastal oak ige rast ql,coastal oak ige rast class (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; coast oak; coastal oak; ige rast; immune globulin e; immunoglobulin e; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; sr,Ord
15879-0,deprecated jerusalem oak ige ab rast class [presence] in serum,deprecated jerusalem oak ige rast ql,jerusalem oak ige rast class (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; ige rast; immune globulin e; immunoglobulin e; jerusalem oak; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; sr,Ord
15883-2,deprecated virginia live oak ige ab rast class in serum,deprecated virg live oak ige rast ql,virginia live oak ige rast class (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; ige rast; immune globulin e; immunoglobulin e; live oak; ordinal; point in time; ql; qual; qualitative; random; rt218; screen; serum; sr; t103; t218; virg live oak; virginia live oak; virginia oak,Ord
15921-0,deprecated penicillin g ige ab rast class [presence] in serum,deprecated penicillin g ige rast ql,penicillin g ige rast class (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; benzylpenicillin; c1; ige rast; immune globulin e; immunoglobulin e; ordinal; pcn; pen; penicilloyl; point in time; pr; ql; qual; qualitative; random; screen; serum; sr; wycillin,Ord
15922-8,deprecated penicillin v ige ab rast class [presence] in serum,deprecated penicillin v ige rast ql,penicillin v ige rast class (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; c2; ige rast; immune globulin e; immunoglobulin e; ordinal; pcn; pen; penicilloyl; phenoxymethylpenicillin; point in time; pr; ql; qual; qualitative; random; rh blood group system; screen; serum; sr; wycillin,Ord
15931-9,deprecated phoma betae ige ab rast class [presence] in serum,deprecated p betae ige rast ql,phoma betae ige rast class (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; ige rast; immune globulin e; immunoglobulin e; m13; ordinal; p betae; pleospora betae; point in time; pr; ql; qual; qualitative; random; screen; serum; sr,Ord
15950-9,deprecated malassezia furfur ige ab rast class [presence] in serum,deprecated m furfur ige rast ql,malassezia furfur ige rast class (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; ige rast; immune globulin e; immunoglobulin e; m furfur; m70; ordinal; pityrosporum orbiculare; point in time; pr; ql; qual; qualitative; random; screen; serum; sr,Ord
15961-6,deprecated protamine ige ab rast class [presence] in serum,deprecated protamine ige rast ql,protamine ige rast class (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; c10; c207; ige rast; immune globulin e; immunoglobulin e; ordinal; point in time; pr; ql; qual; qualitative; random; rc207; screen; serum; sr,Ord
15973-1,deprecated rabbit urine proteins ige ab rast class [presence] in serum,deprecated rabbit urine prot ige rast ql,rabbit urine proteins ige rast class (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; e211; f213; ige rast; immune globulin e; immunoglobulin e; ordinal; oryctalagus spp; point in time; pr; protein; ql; qual; qualitative; random; re211; screen; serum; sr,Ord
15987-1,deprecated redwood ige ab rast class [presence] in serum,deprecated redwood ige rast ql,redwood ige rast class (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; ige rast; immune globulin e; immunoglobulin e; ordinal; point in time; pr; ql; qual; qualitative; random; redwood; screen; serum; sr,Ord
1599-0,lutropin [mass/volume] in serum or plasma --baseline,lh bs serpl-mcnc,lutropin baseline [mass/vol],bs; chemistry.challenge testing; icsh; interstitial cell-stimulating hormone; interstitual cell stimulating hormone; leutinizing hormone; level; lh; luteinizing hormone; lutenin; lutenizing hormone; mass concentration; ovulation test; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
15994-7,deprecated rice ige ab rast class [presence] in serum,deprecated rice ige rast ql,rice ige rast class (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; f009; f9; ige rast; immune globulin e; immunoglobulin e; ordinal; point in time; pr; ql; qual; qualitative; random; rice; screen; serum; sr,Ord
16022-6,deprecated bermuda grass smut ige ab rast class [presence] in serum,deprecated bermuda grass smut ige rast ql,bermuda grass smut ige rast class (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; bermuda grass smut; ige rast; immune globulin e; immunoglobulin e; m213; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; sr,Ord
16030-9,deprecated squash ige ab rast class [presence] in serum,deprecated squash ige rast ql,squash ige rast class (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; ige rast; immune globulin e; immunoglobulin e; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; sr,Ord
16047-3,deprecated mandarin ige ab rast class [presence] in serum,deprecated mandarin ige rast ql,mandarin ige rast class (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; c reticula; clementine; f302; ige rast; immune globulin e; immunoglobulin e; mandarin; mandarine; ordinal; point in time; pr; ql; qual; qualitative; random; rf302; satsumas; screen; serum; sr; tangerine,Ord
16059-8,deprecated trichoderma viride ige ab rast class [presence] in serum,deprecated t viride ige rast ql,t. viride ige rast class (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; ige rast; immune globulin e; immunoglobulin e; m015; m15; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; sr; t viridae; t viride; trichoderma viridae,Ord
16063-0,deprecated trimellitic anhydride (tma) ige ab rast class [presence] in serum,deprecated tma ige rast ql,trimellitic anhydride (tma) ige rast class (s),abs; aby; allergen; allergens; allergy testing; anhydrid; antby; anti; antibodies; antibody; autoantibodies; autoantibody; ige rast; immune globulin e; immunoglobulin e; k86; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; sr; tma; trimelllitic anhydride,Ord
16071-3,deprecated vanilla ige ab rast class [presence] in serum,deprecated vanilla ige rast ql,vanilla ige rast class (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; f234; ige rast; immune globulin e; immunoglobulin e; ordinal; point in time; pr; ql; qual; qualitative; random; rf234; screen; serum; sr; vanilla; vanillin,Ord
16074-7,deprecated walnut ige ab rast class [presence] in serum,deprecated walnut ige rast ql,walnut ige rast class (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; f256; ige rast; immune globulin e; immunoglobulin e; juglans sp; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; sr; walnut; walnuts,Ord
1609-7,prolactin [mass/volume] in serum or plasma --1.5 hours post dose insulin iv,prolactin 1.5h p ins iv serpl-mcnc,prolactin 1.5 hr post dose insulin iv [mass/vol],1 1/2 hours; 1 1/2 hr; 1.5h p ins iv; 1.5hr; 90 min; 90 minutes; 90m; 90min; after; chemistry.challenge testing; hum; humulin; ih7; insul; lactotropic hormone; lactotropin; lente; level; mammatropic hormone; mammotropin; mass concentration; nph; p dose; pl; plasma; plsm; point in time; prl; prol; pst; qnt; quan; quant; quantitative; random; semilente; serp; serpl; serplas; serum; serum or plasma; sliding; sr; ultralente,Qn
16101-8,cumin ige ab [units/volume] in serum,cumin ige qn,cumin ige qn (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; cumin; cummin; f265; immune globulin e; immunoglobulin e; point in time; qnt; quan; quant; quantitative; random; serum; sr,Qn
16107-5,cd8+hla-dr+ cells [#/volume] in blood,cd8+hla-dr+ cells # bld,cd8+hla-dr+ cells (bld) [#/vol],#; abs; absolute; absolutes; blood; cd8 cells; cd8+hla-dr+ cells; cell; cell markers; cellularity; cnt; count; count/volume; ct; human leukocyte antigen; i3; leu2; leu-2; number concentration; number concentration (count/vol); point in time; qnt; quan; quant; quantitative; random; suppressor t cells; t8; t-8; tsuppressor; wb; whole blood,Qn
16121-6,colorado tick fever virus igg ab [titer] in serum,ctfv igg titr ser,colorado tick fever virus igg (s) [titer],abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; ctfv; dilution factor; dilution factor (titer); id; immune globulin g; immunoglobulin g; infectious disease; infectiousdisease; microbiology; point in time; random; serum; smqn; sr; titer; titered; titre; ttr,SemiQn
1613-9,prolactin [mass/volume] in serum or plasma --2 hours post dose l-dopa po,prolactin 2h p l-d po serpl-mcnc,prolactin 2 hr post dose l-dopa po [mass/vol],120 min; 120 minutes; 120min; 2 hours; 2h p l-d po; after; chemistry.challenge testing; lactotropic hormone; lactotropin; left; level; levo; mammatropic hormone; mammotropin; mass concentration; p dose; pl; plasma; plsm; point in time; prl; prol; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
16141-4,nitrogen [mass/time] in 24 hour stool,n2 24h stl-mrate,nitrogen (24h stl) [mass/time],1 day; 24 hours; 24hr; bowel movement; chemistry; faecal; faeces; fecal; feces; mass rate; mrate; n; n2; nit; qnt; quan; quant; quantitative; stl; stool = fecal,Qn
1614-7,prolactin [mass/volume] in serum or plasma --30 minutes post dose trh iv,prolactin 30m p trh iv serpl-mcnc,prolactin 30 min post dose trh iv [mass/vol],30m p trh; 30m p trh iv; after; chemistry.challenge testing; lactotropic hormone; lactotropin; level; mammatropic hormone; mammotropin; mass concentration; p dose; p trh; pl; plasma; plsm; point in time; prl; prol; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
16149-7,aldosterone [mass/volume] in serum or plasma --5th specimen post xxx challenge,aldost sp5 p chal serpl-mcnc,aldosterone 5th specimen post unsp challenge [mass/vol],after; chemistry.challenge testing; endocrine; endocrinology; level; mass concentration; p chal; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sp5; sp5 p chal; spec; sr,Qn
16167-9,glucose [mass/volume] in serum or plasma --2 pm specimen,glucose 2 pm serpl-mcnc,glucose 2 pm specimen [mass/vol],chemistry.challenge testing; endocrine; endocrinology; evening; glu; glu tol; gluc; glucose tolerance; glucoseur; gtt; ii; level; mass concentration; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; spec; sr,Qn
1617-0,prolactin [mass/volume] in serum or plasma --3 hours post dose l-dopa po,prolactin 3h p l-d po serpl-mcnc,prolactin 3 hr post dose l-dopa po [mass/vol],3h p l-d po; after; chemistry.challenge testing; lactotropic hormone; lactotropin; left; level; levo; mammatropic hormone; mammotropin; mass concentration; p dose; pl; plasma; plsm; point in time; prl; prol; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
16230-5,n-desalkylflurazepam [mass/volume] in urine by confirmatory method,desalkylfluraz ur cfm-mcnc,n-desalkylflurazepam confirm (u) [mass/vol],cfm; cnfr; cnfrm; conf; confirmation; confirmatory; desalkyfluraz; desalkylfluraz; desalkylflurazepam; drug/toxicology; drugs; flurazepam metabolite; gcms; lc/ms/ms; level; mass concentration; norfludiazepam; point in time; qnt; quan; quant; quantitative; random; ua; ur; urn,Qn
16232-1,triazolam [mass/volume] in urine by confirmatory method,triazolam ur cfm-mcnc,triazolam confirm (u) [mass/vol],apo-triazo; cfm; cnfr; cnfrm; conf; confirmation; confirmatory; drug/toxicology; drugs; gcms; halcion; lc/ms/ms; level; mass concentration; novo-triolam; point in time; qnt; quan; quant; quantitative; random; ua; ur; urn,Qn
1624-6,retinol [mass/volume] in serum or plasma --3 hours post 5000 units,vit a 3h p 5000 u serpl-mcnc,retinol 3 hr post 5000 units [mass/vol],3h p 5000 u; after; axerol; axerophthol; biosterol; chemistry.challenge testing; level; mass concentration; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; vit a; vit a alcohol; vit a1; vit a1 alcohol; vitamin a; vitamin a alcohol; vitamin a1,Qn
16246-1,methadone [mass/volume] in urine by confirmatory method,methadone ur cfm-mcnc,methadone confirm (u) [mass/vol],addiction; cfm; cnfr; cnfrm; conf; confirmation; confirmatory; dolophin; dolophine; drug/toxicology; drugs; drugs of abuse; gcms; illicit; lc/ms/ms; level; mass concentration; metd; methadose; mtd; point in time; potentialforabuse; qnt; quan; quant; quantitative; random; ua; ur; urn,Qn
16248-7,6-monoacetylmorphine free [mass/volume] in serum or plasma by confirmatory method,6mam free serpl cfm-mcnc,6-monoacetylmorphine free confirm [mass/vol],6 mam; 6 mono acetyl morphine; 6-acetylmorphine; 6mam; 6mam free; acetylmorphine; cfm; cnfr; cnfrm; conf; confirmation; confirmatory; drug/toxicology; drugs; fr; gcms; heroin metabolite; lc/ms/ms; level; mam; mass concentration; non-protein bound; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
16270-1,calcium [mass/volume] in serum or plasma --1 hour post xxx challenge,calcium 1h p chal serpl-mcnc,calcium 1 hr post unsp challenge [mass/vol],1 hour; 1.0hr; 1h p chal; 60 min; 60 minutes; 60m; 60min; after; ca; cal; chemistry.challenge testing; level; mass concentration; p chal; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
16271-9,calcium [mass/volume] in serum or plasma --30 minutes post xxx challenge,calcium 30m p chal serpl-mcnc,calcium 30 min post unsp challenge [mass/vol],30m p chal; after; ca; cal; chemistry.challenge testing; level; mass concentration; p chal; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
16282-6,acetaminophen [units/volume] in urine,apap ur-acnc,acetaminophen qn (u),acet; acetamidophenol; acetaminoph; acetominophen; addiction; apap; arbitrary concentration; c209; c55; drug/toxicology; drugs; drugs of abuse; hepatology; hydroxyacetanilide; illicit; liver; n-(4-hydroxyphenyl)acetanilide; n-acetyl-p-aminophenol; p-acetamidophenol; paracetamol; p-hydroxyacetanilide; point in time; potentialforabuse; qnt; quan; quant; quantitative; random; tylenol; u209; ua; ur; urn,Qn
16286-7,deprecated testosterone free/testosterone.total in serum or plasma,deprecated testost free fr serpl,testosterone free/testosterone.total,chemistry; fr; non-protein bound; number fraction; percent; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; testo; testos; testost; testost free; testosterone.unconjugated; tot; totl,Qn
16296-6,11-hydroxyandrosterone [mass/volume] in serum or plasma,11oh-androst serpl-mcnc,11-hydroxyandrosterone [mass/vol],11-beta-hydroxyandrosterone; 11-hydroxy androsterone; 11oh-androst; chemistry; level; mass concentration; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
1631-1,somatotropin [mass/volume] in serum or plasma --30 minutes post dose insulin iv,gh 30m p ins iv serpl-mcnc,somatotropin 30 min post dose insulin iv [mass/vol],30m p ins iv; after; chemistry.challenge testing; endocrine; endocrinology; gh; growth hormone; hgh; hum; human growth hormone; humulin; ih7; insul; lente; level; mass concentration; nph; p dose; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; semilente; serp; serpl; serplas; serum; serum or plasma; sliding; somatotropic hormone; sr; sth; ultralente,Qn
16320-4,acyclovir [susceptibility] by serum bactericidal titer,acyclovir titr sbt,acyclovir sbt (isol+s),aciclovir; acifur; acv; acycloguanosine; antibiotic susceptibilities; avirax; dilution factor; dilution factor (titer); id; infectious disease; infectiousdisease; islt; isol; point in time; random; sequence based typing; serum; serum bactericidal titer; serum killing test; smqn; sr; titer; titered; titre; ttr; zovirax,SemiQn
16322-0,biperiden [mass/volume] in serum or plasma,biperiden serpl-mcnc,biperiden [mass/vol],akineton; biperiden hydrochloride; c21h30clno; drug/toxicology; drugs; level; mass concentration; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
16327-9,allyl alcohol [mass/volume] in blood,allyl alc bld-mcnc,allyl alcohol (bld) [mass/vol],1-propenol; alc; alcoholic; blood; drug/toxicology; drugs; level; mass concentration; point in time; qnt; quan; quant; quantitative; random; vinyl carbinol; wb; weed drench; whole blood,Qn
16337-8,alkaline phosphatase [enzymatic activity/volume] in urine,alp ur-ccnc,alp (u) [catalytic activity/vol],alk; alk phos; alkaline phos; alkaline phosphatase.total; alkp; alp; ap; catalytic concentration; chemistry; hepatology; liver; msk; musculoskeletal; ortho; orthopedics; phos; phosphtase; point in time; qnt; quan; quant; quantitative; random; ua; ur; urn,Qn
16356-8,deprecated amino beta guanidinopropionate [mass/volume] in plasma,deprecated ab-gp plas-mcnc,amino beta guanidinopropionate (p) [mass/vol],ab-gp; amino beta guanidinopropionic acid; amino betaguanidinopropionate; aminobetaguanidinopropionate; b; chemistry; level; mass concentration; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random,Qn
16369-1,amphetamines [presence] in urine by confirmatory method,amphetamines ur ql cfm,amphetamines confirm ql (u),addiction; amph; amphetam; amphetamine; cfm; cnfr; cnfrm; conf; confirmation; confirmatory; drug/toxicology; drugs; drugs of abuse; gcms; illicit; lc/ms/ms; ordinal; point in time; potentialforabuse; pr; ql; qual; qualitative; random; screen; speed; ua; ur; urn,Ord
1637-8,somatotropin [mass/volume] in serum or plasma --pre dose insulin iv,gh pre ins iv serpl-mcnc,somatotropin pre dose insulin iv [mass/vol],before; chemistry.challenge testing; endocrine; endocrinology; gh; growth hormone; hgh; hum; human growth hormone; humulin; ih7; insul; lente; level; mass concentration; nph; pl; plasma; plsm; point in time; pre ins iv; qnt; quan; quant; quantitative; random; semilente; serp; serpl; serplas; serum; serum or plasma; sliding; somatotropic hormone; sr; sth; ultralente,Qn
16379-0,androstenedione [mass/volume] in serum or plasma --3rd specimen post xxx challenge,androst sp3 p chal serpl-mcnc,androstenedione 3rd specimen post unsp challenge [mass/vol],after; chemistry.challenge testing; gamma-4-androstenedione; level; mass concentration; p chal; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sp3; sp3 p chal; spec; sr,Qn
16389-9,antidepressants [identifier] in serum or plasma,antidepressants serpl,antidepressants nom,addiction; antidepres; antidepressant; drug/toxicology; drugs; drugs of abuse; identity or presence; illicit; nominal; pl; plasma; plsm; point in time; potentialforabuse; random; serp; serpl; serplas; serum; serum or plasma; sr,Nom
16415-2,aspergillus flavus ab [presence] in cerebral spinal fluid,a flavus ab csf ql,a. flavus ab ql (csf),a flavus; abs; aby; antby; anti; antibodies; antibody; asperg; aspergil; aspergilis; aspergilla; aspergillin; aspergillosis; aspergils; aspergilus; autoantibodies; autoantibody; cerebral spinal fluid; cerebrospinal fl; farmers lung; id; infectious disease; infectiousdisease; m228; m311; m54; microbiology; neuro; neurology; ordinal; point in time; pr; ql; qual; qualitative; random; screen; spinal fl; spinal fld; spinal flu; spinal fluid,Ord
16444-2,benzophenone [mass/volume] in serum or plasma,benzophenone serpl-mcnc,benzophenone [mass/vol],alpha-oxodiphenylmethane; alpha-oxoditane; benzoylbenzene; c13h10o; diphenyl ketone; diphenylmethanone; drug/toxicology; drugs; level; mass concentration; oxodiphenylmethane; oxoditane; phenyl ketone; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
16450-9,benzylhydrazine [mass/volume] in serum or plasma,benzylhydrazine serpl-mcnc,benzylhydrazine [mass/vol],c7h10n2; drug/toxicology; drugs; level; mass concentration; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
1645-1,xylose [mass/volume] in blood --2 hours post 25 g xylose po,xylose 2h p 25 g xyl po bld-mcnc,xylose 2 hr post 25 g xylose po (bld) [mass/vol],120 min; 120 minutes; 120min; 2 hours; 2h p 25 g xyl po; after; blood; chemistry.challenge testing; d-xylose; level; mass concentration; p 25 g xyl po; point in time; pst; qnt; quan; quant; quantitative; random; wb; whole blood; xylose absorption test,Qn
16451-7,beryllium [presence] in urine,beryllium ur ql,beryllium ql (u),be; berylliosis; drug/toxicology; drugs; ordinal; point in time; pr; ql; qual; qualitative; random; screen; ua; ur; urn,Ord
16467-3,bismuth [presence] in blood,bismuth bld ql,bismuth ql (bld),bi; blood; drug/toxicology; drugs; ordinal; point in time; pr; ql; qual; qualitative; random; screen; wb; whole blood,Ord
16471-5,blastomyces dermatitidis ab [units/volume] in serum,b dermat ab ser-acnc,b. dermatitidis ab qn (s),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; b dermat; b dermatitidis; blasto; blastomycosis; id; infectious disease; infectiousdisease; microbiology; point in time; qnt; quan; quant; quantitative; random; serum; sr,Qn
16476-4,borrelia burgdorferi ab [presence] in body fluid by immunoassay,b burgdor ab fld ql ia,b. burgdorferi ab ia ql (body fld),"abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; b burg; b burgdor; b burgdorferi; b/f; bb; bf; bod; bodies; body fluid; body fluid, unsp; burgdorf; eia; elfa; elisa; enzyme immunoassay; fl; fld; flu; fluid; iaa; id; infectious disease; infectiousdisease; lyme; lyme disease; lymes; meia; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; screen; suds",Ord
16480-6,borrelia burgdorferi igg ab [presence] in serum or plasma by immunoassay,b burgdor igg serpl ql ia,b. burgdorferi igg ia ql,abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; b burg; b burgdor; b burgdorferi; bb; burgdorf; eia; elfa; elisa; enzyme immunoassay; iaa; id; immune globulin g; immunoglobulin g; infectious disease; infectiousdisease; lyme; lyme disease; lymes; meia; microbiology; ordinal; pl; plasma; plsm; point in time; pr; ql; qual; qualitative; random; screen; serp; serpl; serplas; serum; serum or plasma; sr; suds,Ord
16488-9,brucella abortus igg ab [units/volume] in serum by complement fixation,b abortus igg ser cf-acnc,b. abortus igg cf qn (s),abort; abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; b abortus; bangs disease; bovine brucellosis; bruc; brucellosis; cf; comp fixation; compfix; complement fixation; contagious abortion; id; immune globulin g; immunoglobulin g; infectious disease; infectiousdisease; microbiology; point in time; qnt; quan; quant; quantitative; random; serum; sr; undulant fever,Qn
16491-3,brush border ab [presence] in serum by immunofluorescence,brush border ab ser ql if,brush border ab if ql (s),abba; abs; aby; acif; antby; anti; antibodies; antibody; anticomplement immunofluorescence; autoantibodies; autoantibody; bba; fa; fluorescent antibody; fluoresent; gastro; gastroenterology; gi; ifa; immune fluorescence; immunoflour; immunofluor; immunofluorescence; kidney; nephrology; ordinal; point in time; pr; ql; qual; qualitative; random; renal; screen; serology; serum; sr; time resolved fluorescence; trf,Ord
16493-9,bufotenine [units/volume] in serum or plasma,bufotenine serpl-acnc,bufotenine qn,arbitrary concentration; bufotenin; cebilcin; drug/toxicology; drugs; mappine; nn-dimethylserotonin; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; toad hallucinogen,Qn
16507-6,calcitonin [mass/volume] in serum or plasma --4 hours post xxx challenge,calcit 4h p chal serpl-mcnc,calcitonin 4 hr post unsp challenge [mass/vol],4h p chal; after; chemistry.challenge testing; ct; level; mass concentration; p chal; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; thyrocalcitonin; tumor marker,Qn
16515-9,calcium.ionized [moles/volume] in serum or plasma --5th specimen post xxx challenge,ca-i sp5 p chal serpl-scnc,calcium.ionized 5th specimen post unsp challenge [moles/vol],after; ca; ca-i; cal; calcium active; calcium free; chemistry.challenge testing; coagulation factor i; ica; ion; level; p chal; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sp5; sp5 p chal; spec; sr; substance concentration,Qn
16516-7,calcium.ionized [moles/volume] in serum or plasma --6th specimen post xxx challenge,ca-i sp6 p chal serpl-scnc,calcium.ionized 6th specimen post unsp challenge [moles/vol],after; ca; ca-i; cal; calcium active; calcium free; chemistry.challenge testing; coagulation factor i; ica; ion; level; p chal; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sp6; sp6 p chal; spec; sr; substance concentration,Qn
16523-3,calcium [moles/volume] in serum or plasma --5 minutes post xxx challenge,calcium 5m p chal serpl-scnc,calcium 5 min post unsp challenge [moles/vol],5m p chal; after; ca; cal; chemistry.challenge testing; level; p chal; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; substance concentration,Qn
16544-9,canrenone [units/volume] in urine,canrenone ur-acnc,canrenone qn (u),arbitrary concentration; drug/toxicology; drugs; luvion; phanurane; point in time; qnt; quan; quant; quantitative; random; ua; ur; urn,Qn
16547-2,carbamate pesticides [type] in urine,carbamate pesticides ur,carbamate pesticides nom (u),drug/toxicology; drugs; nominal; point in time; random; typ; ua; ur; urn,Nom
16550-6,carbohydrates [identifier] in urine,carbohydrates ur,carbohydrates nom (u),carbohydrate; chemistry; identity or presence; nominal; point in time; random; ua; ur; urn,Nom
16557-1,carnosine [presence] in urine,carnosine ur ql,carnosine ql (u),car; chemistry; ordinal; point in time; pr; ql; qual; qualitative; random; screen; ua; ur; urn,Ord
16560-5,catecholamines [mass/volume] in plasma --5th specimen post xxx challenge,catechols sp5 p chal plas-mcnc,catecholamines 5th specimen post unsp challenge (p) [mass/vol],after; cate; catec; catech; catechol; catecholamine; catecholamines.total; catechols; chemistry.challenge testing; epinephrine+norepinephrine+dopamine; level; mass concentration; p chal; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; sp5; sp5 p chal; spec,Qn
16561-3,catecholamines [mass/volume] in plasma --6th specimen post xxx challenge,catechols sp6 p chal plas-mcnc,catecholamines 6th specimen post unsp challenge (p) [mass/vol],after; cate; catec; catech; catechol; catecholamine; catecholamines.total; catechols; chemistry.challenge testing; epinephrine+norepinephrine+dopamine; level; mass concentration; p chal; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; sp6; sp6 p chal; spec,Qn
16568-8,cefuroxime ige ab [units/volume] in serum,cefuroxime ige qn,cefuroxime ige qn (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; c308; c33; ceftin; cefuroxime axetil; immune globulin e; immunoglobulin e; point in time; qnt; quan; quant; quantitative; random; serum; sr; zinacef,Qn
16571-2,cephadrine [mass/volume] in serum or plasma,cephadrine serpl-mcnc,cephadrine [mass/vol],drug/toxicology; drugs; level; mass concentration; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
16575-3,deprecated cerebroside sulfatase b in urine,deprecated cerebroside sulfatase b ur,cerebroside sulfatase b (u) [catalytic activity/vol],aryl sulfatase a; arylsulfatase a; catalytic concentration; chemistry; metachromatic leucodystrophy; point in time; qnt; quan; quant; quantitative; random; ua; ur; urn,Qn
16584-5,chlamydophila pneumoniae rrna [presence] in sputum by probe,c pneum rrna spt ql probe,c. pneumoniae rrna probe ql (sput),c pneum; c pneumo; c pneumoniae; chlamydia; chlamydia pneumoniae; cpn; dna nucleic acid probe; dna probe; id; infectious disease; infectiousdisease; lower respiratory; lung; microbiology; ordinal; pneu; pneum; pneumo; pneumon; pneumonia; point in time; pr; pulmonary; pulmonology; ql; qual; qualitative; random; respiratory; ribosomal rna; screen; spt; sputum; twar agent,Ord
16592-8,chlamydia sp igm ab [units/volume] in cerebral spinal fluid by immunofluorescence,chlamydia igm csf if-acnc,chlamydia sp igm if qn (csf),abs; aby; acif; antby; anti; antibodies; antibody; anticomplement immunofluorescence; arbitrary concentration; autoantibodies; autoantibody; cerebral spinal fluid; cerebrospinal fl; chlam; chlamid; fa; fluorescent antibody; fluoresent; id; ifa; immune fluorescence; immune globulin m; immunoflour; immunofluor; immunofluorescence; immunoglobulin m; infectious disease; infectiousdisease; microbiology; neuro; neurology; point in time; qnt; quan; quant; quantitative; random; species; spinal fl; spinal fld; spinal flu; spinal fluid; spp; time resolved fluorescence; trf,Qn
16606-6,chlorine [mass/volume] in dialysis fluid,chlorine dial fld-mcnc,chlorine (dial fld) [mass/vol],cl2; diaf; dialysate; dialysis fluid; drug/toxicology; drugs; level; mass concentration; point in time; qnt; quan; quant; quantitative; random,Qn
16609-0,chlorphentermine [units/volume] in blood,chlorphentermin bld-acnc,chlorphentermine qn (bld),addiction; arbitrary concentration; blood; drug/toxicology; drugs; drugs of abuse; illicit; lucofen; point in time; potentialforabuse; qnt; quan; quant; quantitative; random; wb; whole blood,Qn
16636-3,coccidioides immitis iga ab [units/volume] in cerebral spinal fluid,c immitis iga csf-acnc,c. immitis iga qn (csf),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; b immitis; blastomycoides immitis; c esteriformis; c immitis; cerebral spinal fluid; cerebrospinal fl; coccidioides esteriformis; coccidiomycosis; coccio; g immite; g louisianoideum; g metaeuropea; geotrichum immite; glenospora metaeuropea; glenosporum louisianoideum; id; immune globulin a; immunoglobulin a; infectious disease; infectiousdisease; microbiology; neuro; neurology; p esteriformis; p mazzai; point in time; posadasia esteriformis; pseudococcidioides mazzai; qnt; quan; quant; quantitative; random; san joaquin valley fever; spinal fl; spinal fld; spinal flu; spinal fluid; t proteolyticum; trichosporon proteolyticum; valley fever,Qn
16642-1,cockatiel droppings igg ab [units/volume] in serum,cockatiel drop igg qn,cockatiel droppings igg qn (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; feces; immune globulin g; immunoglobulin g; point in time; qnt; quan; quant; quantitative; random; serum; sr; stool,Qn
16654-6,corticotropin [mass/volume] in plasma by radioimmunoassay (ria) --1.5 hours post xxx challenge,acth 1.5h p chal plas ria-mcnc,corticotropin 1.5 hr post unsp challenge ria (p) [mass/vol],1 1/2 hours; 1 1/2 hr; 1.5h p chal; 1.5hr; 90 min; 90 minutes; 90m; 90min; acth; adrenocorticotrophic hormone; adrenocorticotropin; after; c206; c74; chemistry.challenge testing; cortrosyn; level; mass concentration; p chal; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; radioimmunoassay; random; rc206; tumor marker,Qn
16666-0,corticotropin [mass/volume] in plasma --9th specimen post xxx challenge,acth sp9 p chal plas-mcnc,corticotropin 9th specimen post unsp challenge (p) [mass/vol],acth; adrenocorticotrophic hormone; adrenocorticotropin; after; c206; c74; chemistry.challenge testing; cortrosyn; level; mass concentration; p chal; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; rc206; sp9; sp9 p chal; spec; tumor marker,Qn
16686-8,coxsackievirus b igm ab [units/volume] in serum by neutralization test,cv b igm ser nt-acnc,coxsackievirus b igm neut test qn (s),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; cav; cbv; conventional virus neutralization test; coxsackie; coxsackie virus; cv; cv b; cvnt; id; immune globulin m; immunoglobulin m; infectious disease; infectiousdisease; microbiology; neutralization; neutralization test; nt; point in time; qnt; quan; quant; quantitative; random; serum; serum virus neutralization; sr; svn; virus neutralization test; vnt,Qn
16689-2,creatinine [mass/time] in 48 hour urine,creat 48h ur-mrate,creatinine (48 hour u) [mass/time],2 days; 2d; 48 hours; 48hr; chemistry; cr; crea; creat; kidney; mass rate; mrate; nephrology; qnt; quan; quant; quantitative; renal; ua; ucr; ur; urn,Qn
166-9,cephapirin [susceptibility] by disk diffusion (kb),cephapirin islt kb,cephapirin disk diffusion (kb) [susc],antibiotic susceptibilities; ast; cefadyl; disk diffusion; id; infectious disease; infectiousdisease; islt; isol; kb; kirby-bauer; point in time; random; sus; suscept; susceptibilities; susceptibility; susceptibilty,OrdQn
16703-1,cyclosporine [mass/volume] in plasma,cyclosporine plas-mcnc,cyclosporine (p) [mass/vol],ciclosporin; ciclosporine; csa; cyclosporin a; cyclosporins; drug/toxicology; drugs; gengraf; level; mass concentration; neoral; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; restasis; sandimmune; sangcya,Qn
16706-4,taenia solium larva igm ab [units/volume] in cerebral spinal fluid,t sol lar igm csf-acnc,t. solium larva igm qn (csf),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; cerebral spinal fluid; cerebrospinal fl; cysticercosis; cysticercus; id; immune globulin m; immunoglobulin m; infectious disease; infectiousdisease; microbiology; neuro; neurology; point in time; qnt; quan; quant; quantitative; random; spinal fl; spinal fld; spinal flu; spinal fluid; t sol; t sol lar; t solium; tapeworm,Qn
16707-2,taenia solium larva igm ab [units/volume] in serum,t sol lar igm ser-acnc,t. solium larva igm qn (s),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; cysticercosis; cysticercus; id; immune globulin m; immunoglobulin m; infectious disease; infectiousdisease; microbiology; point in time; qnt; quan; quant; quantitative; random; serum; sr; t sol; t sol lar; t solium; tapeworm,Qn
16734-6,dehydroepiandrosterone (dhea) [mass/volume] in serum or plasma --baseline,dhea bs serpl-mcnc,dhea baseline [mass/vol],bs; chemistry.challenge testing; dhea; level; mass concentration; pl; plasma; plsm; point in time; prasterone; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
16738-7,dengue virus 3 ab [titer] in serum,denv3 ab titr ser,denv 3 ab (s) [titer],abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; breakbone fever; dengue type iii; denv; denv3; dilution factor; dilution factor (titer); flavivirus; id; iii; infectious disease; infectiousdisease; microbiology; point in time; random; serum; smqn; sr; titer; titered; titre; ttr,SemiQn
16747-8,dextromoramide [presence] in serum or plasma,d-moramide serpl ql,dextromoramide ql,dextrodiphenopyrine; dextro-moramide; d-moramid; d-moramide; drug/toxicology; drugs; jetrium; narcolo; ordinal; palfium; pl; plasma; plsm; point in time; pr; ql; qual; qualitative; random; screen; serp; serpl; serplas; serum; serum or plasma; sr,Ord
16753-6,deprecated dialtrazene,deprecated dialtrazene serpl-mcnc,dialtrazene [mass/vol],drug/toxicology; drugs; level; mass concentration; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
16768-4,dichlorvos [mass/volume] in urine,dichlorvos ur-mcnc,dichlorvos (u) [mass/vol],"2,2-dichlorobinyldimethyl phosphate; c4h7cl2o4p; ddvp; dichlorophos; dichlorovos; drug/toxicology; drugs; equigand; level; mass concentration; organophosphate pesticide; point in time; qnt; quan; quant; quantitative; random; sd1750; tetravos; ua; ur; urn; vapona",Qn
16769-2,dicloxacillin [mass/volume] in urine,dicloxacillin ur-mcnc,dicloxacillin (u) [mass/vol],drug/toxicology; drugs; dynapen; level; mass concentration; pathocil; point in time; qnt; quan; quant; quantitative; random; ua; ur; urn; veracillin; veracilline,Qn
16779-1,dinitrophenol [mass/volume] in urine,dinitrophenol ur-mcnc,dinitrophenol (u) [mass/vol],c6h4n2o5; dinitrol; drug/toxicology; drugs; level; mass concentration; point in time; qnt; quan; quant; quantitative; random; ua; ur; urn,Qn
16819-5,entamoeba histolytica ab [units/volume] in serum by immunofluorescence,e histolyt ab ser if-acnc,e. histolytica ab if qn (s),abs; aby; acif; ameba; amebiasis; amebic; amoeba; antby; anti; antibodies; antibody; anticomplement immunofluorescence; arbitrary concentration; autoantibodies; autoantibody; e histolyt; e histolytica; fa; fluorescent antibody; fluoresent; id; ifa; immune fluorescence; immunoflour; immunofluor; immunofluorescence; infectious disease; infectiousdisease; microbiology; point in time; qnt; quan; quant; quantitative; random; serum; sr; time resolved fluorescence; trf,Qn
16827-8,epstein barr virus capsid igg ab [presence] in cerebral spinal fluid,ebv vca igg csf ql,ebv capsid igg ql (csf),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; cap; cerebral spinal fluid; cerebrospinal fl; ebv; ebv capsid ab; ebv vca; epstn; hhv-4; human herpesvirus 4; id; immune globulin g; immunoglobulin g; infectious disease; infectiousdisease; microbiology; mono; mononucleosis; neuro; neurology; ordinal; point in time; pr; ql; qual; qualitative; random; screen; spinal fl; spinal fld; spinal flu; spinal fluid; vca; viral capsid,Ord
16828-6,erythrocytes [#/volume] in seminal plasma by manual count,rbc # semin plas manual,rbc manual cnt (seminal plasma) [#/vol],#; abs; absolute; absolutes; cnt; count; count/volume; ct; discocytes; erthrocyte; erythrocyte; fertility testing; genitourinary; gu; manl; number concentration; number concentration (count/vol); pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; rbc; rbcs; red blood cell; red blood cells; red blood corpuscle; red blood corpusles; red cell; red cells; seminal plasma; uro; urology,Qn
16853-4,fat [mass] in stool,fat stl qn,fat (stl) [mass],bowel movement; chemistry; faecal; faeces; fecal; feces; point in time; qnt; quan; quant; quantitative; random; stl; stool = fecal,Qn
16858-3,fentanyl [mass/volume] in body fluid,fentanyl fld-mcnc,fentanyl (body fld) [mass/vol],"actiq; addiction; b/f; bf; bod; bodies; body fluid; body fluid, unsp; drug/toxicology; drugs; drugs of abuse; duragesic; durogesic; fenpat; fentanil; fl; fld; flu; fluid; illicit; level; mass concentration; point in time; potentialforabuse; qnt; quan; quant; quantitative; random; sublimaze",Qn
16859-1,fibrinogen [presence] in platelet poor plasma,fibrinogen ppp ql,fibrinogen ql (ppp),coagulation; coagulation factor i; fgn; hematology; heme; ordinal; plas; platelet poor plasma; point in time; pr; ql; qual; qualitative; random; screen,Ord
16870-8,fluconazole [mass/volume] in urine,fluconazole ur-mcnc,fluconazole (u) [mass/vol],diflucan; drug/toxicology; drugs; level; mass concentration; point in time; qnt; quan; quant; quantitative; random; ua; ur; urn,Qn
16874-0,formate+formaldehyde [mass/volume] in blood,formate+formaldehyde bld-mcnc,formate+formaldehyde (bld) [mass/vol],blood; c700; drug/toxicology; drugs; formalin; formic acid; k80; level; mass concentration; methanoate; methanoic acid; point in time; qnt; quan; quant; quantitative; random; wb; whole blood,Qn
16885-6,deprecated gamma aminobutyrate [mass/volume] in serum or plasma,deprecated gaba plas-mcnc,gamma aminobutyrate (p) [mass/vol],4-aminobutanoic acid; 4-aminobutyrate; 4-aminobutyric acid; aminobutric; aminobutyric; amino-n-butyrate; chemistry; gaba; gamma aminobutyric acid; gamma amino-butyric acid; gamma amino-n-butyrate; gamma amino-n-butyric acid; level; mass concentration; piperidic acid; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random,Qn
16886-4,deprecated gamma aminobutyrate [mass/volume] in cerebral spinal fluid,deprecated gaba csf-mcnc,gamma aminobutyrate (csf) [mass/vol],4-aminobutanoic acid; 4-aminobutyrate; 4-aminobutyric acid; aminobutric; aminobutyric; amino-n-butyrate; cerebral spinal fluid; cerebrospinal fl; chemistry; gaba; gamma aminobutyric acid; gamma amino-butyric acid; gamma amino-n-butyrate; gamma amino-n-butyric acid; level; mass concentration; piperidic acid; point in time; qnt; quan; quant; quantitative; random; spinal fl; spinal fld; spinal flu; spinal fluid,Qn
16891-4,gastrin [mass/volume] in serum or plasma --11th specimen post xxx challenge,gastrin sp11 p chal serpl-mcnc,gastrin 11th specimen post unsp challenge [mass/vol],after; chemistry.challenge testing; level; mass concentration; p chal; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sp11; sp11 p chal; spec; sr; total gastrins; zollinger-ellison syndrome,Qn
1691-5,"5,10-methylenetetrahydrofolate reductase [enzymatic activity/volume] in serum",mthfr ser-ccnc,"5,10-methylenetetrahydrofolate reductase (s) [catalytic activity/vol]",catalytic concentration; chemistry; fadh2; ferredoxin; mthfr; point in time; qnt; quan; quant; quantitative; random; serum; sr,Qn
16922-7,wild rye grass ige ab [units/volume] in serum,wild rye grass ige qn,wild rye grass ige qn (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; g070; g70; immune globulin e; immunoglobulin e; leymus triticoides; point in time; qnt; quan; quant; quantitative; random; serum; sr; wild rye grass,Qn
16940-9,heptachlorepoxide [mass/volume] in urine,heptachlorepoxide ur-mcnc,heptachlorepoxide (u) [mass/vol],drug/toxicology; drugs; level; mass concentration; point in time; qnt; quan; quant; quantitative; random; ua; ur; urn,Qn
16944-1,herpes simplex virus igm ab [units/volume] in serum,hsv igm ser-acnc,hsv igm qn (s),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; herp splx; hsv; id; immune globulin m; immunoglobulin m; infectious disease; infectiousdisease; microbiology; point in time; qnt; quan; quant; quantitative; random; serum; sr,Qn
16948-2,herpes simplex virus 1 igg ab [units/volume] in cerebral spinal fluid,hsv1 igg csf-acnc,hsv 1 igg qn (csf),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; cerebral spinal fluid; cerebrospinal fl; herp splx; herpes simplex virus type 1; herpes simplex virus type i; hsv; hsv1; i; id; immune globulin g; immunoglobulin g; infectious disease; infectiousdisease; microbiology; neuro; neurology; point in time; qnt; quan; quant; quantitative; random; spinal fl; spinal fld; spinal flu; spinal fluid,Qn
16954-0,herpes simplex virus 2 ab [presence] in serum,hsv2 ab ser ql,hsv 2 ab ql (s),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; herp splx; herpes simplex virus type 2; herpes simplex virus type ii; hsv; hsv2; id; ii; infectious disease; infectiousdisease; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; sr,Ord
16955-7,herpes simplex virus 2 igg ab [presence] in serum by immunoblot,hsv2 igg ser ql ib,hsv 2 igg ib ql (s),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; blt; herp splx; herpes simplex virus type 2; herpes simplex virus type ii; hsv; hsv2; id; ii; immune blot; immune globulin g; immunobl; immunoblot; immunoglobulin g; infectious disease; infectiousdisease; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; riba; screen; serum; sr; wb; wblot; west blot; west blt; western blot,Ord
16982-1,htlv i+ii ab [presence] in serum by immunoblot,htlv i+ii ab ser ql ib,htlv i+ii ab ib ql (s),2; abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; blt; htlv type 1+2; htlv type i+ii; human t-cell leukemia virus; human t-cell lymphotrophic virus; id; immune blot; immunobl; immunoblot; infectious disease; infectiousdisease; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; riba; screen; serum; sr; universallaborders; wb; wblot; west blot; west blt; western blot,Ord
16987-0,hydrogen/expired gas [volume fraction] in exhaled gas --2.5 hours post dose glucose,breath h2 2.5h p glc,hydrogen/expired gas 2.5 hr post dose glucose (exhl gas) [volume fraction],2.5h p glc; after; breath; chemistry.challenge testing; exg; exhaled gas; exhaled gas (=breath); gases; glu; glu tol; gluc; glucose tolerance; glucoseur; gtt; h2; hyd; p dose; p glc; percent; point in time; pst; qnt; quan; quant; quantitative; random; volfr; volume fraction,Qn
17008-4,igg/beta tubulin [mass ratio] in serum,igg/b-tubulin ser,igg/beta tubulin (s) [mass ratio],b; b-tubulin; chemistry; immune globulin g; immunoglobulin g; mass concentration ratio; mass ratio; mcrto; point in time; qnt; quan; quant; quantitative; random; serum; sr,Qn
170-1,cephradine [susceptibility] by disk diffusion (kb),cephradine islt kb,cephradine disk diffusion (kb) [susc],anspor; antibiotic susceptibilities; ast; cefamid; cefrabiotic; cefradine; cefral; cefrasol; cefril; celex; cesporan; citicef; disk diffusion; ecosporina; eskacef; id; infectious disease; infectiousdisease; islt; isol; kb; kelsef; kirby-bauer; lenzacef; lisacef; maxisporin; point in time; random; samedrin; sefril; septacef; sus; suscept; susceptibilities; susceptibility; susceptibilty; velocef; velosef,OrdQn
17015-9,influenza virus b igg ab [units/volume] in serum,flubv igg ser-acnc,flubv igg qn (s),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; flub; flubv; fluv; id; immune globulin g; immunoglobulin g; infectious disease; infectiousdisease; influ; influenza b; influenza b virus; microbiology; point in time; qnt; quan; quant; quantitative; random; serum; sr; universallaborders,Qn
17016-7,influenza virus b igm ab [units/volume] in serum,flubv igm ser-acnc,flubv igm qn (s),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; flub; flubv; fluv; id; immune globulin m; immunoglobulin m; infectious disease; infectiousdisease; influ; influenza b; influenza b virus; microbiology; point in time; qnt; quan; quant; quantitative; random; serum; sr,Qn
17027-4,isocyanate igg ab [units/volume] in serum,isocyanate igg qn,isocyanate igg qn (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; immune globulin g; immunoglobulin g; point in time; qnt; quan; quant; quantitative; random; serum; sr,Qn
17045-6,latex ige ab [units/volume] in blood,ltx ige bld qn,latex ige qn (bld),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; blood; hevea braziliensis; immune globulin e; immunoglobulin e; k082; k82; ltx; point in time; qnt; quan; quant; quantitative; random; wb; whole blood,Qn
17067-0,legionella pneumophila 4 igm ab [units/volume] in serum,l pneumo4 igm ser-acnc,l. pneumophila 4 igm qn (s),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; id; immune globulin m; immunoglobulin m; infectious disease; infectiousdisease; l pneumo; l pneumo4; l pneumonphila; legion; legionela; legionella pneumophila serogroup 4; los angeles 1; microbiology; pneu; pneum; pneumophilia; point in time; qnt; quan; quant; quantitative; random; serum; sr,Qn
17076-1,lidocaine [mass/volume] in body fluid,lidocain fld-mcnc,lidocaine (body fld) [mass/vol],"b/f; bf; bod; bodies; body fluid; body fluid, unsp; c232; c251; clid; drug/toxicology; drugs; fl; fld; flu; fluid; level; mass concentration; point in time; qnt; quan; quant; quantitative; random; xylocaine",Qn
17082-9,lipoprotein.alpha [mass/volume] in body fluid,hdl fld-mcnc,lipoprotein.alpha (body fld) [mass/vol],"alfa; b/f; bf; bod; bodies; body fluid; body fluid, unsp; chemistry; fl; fld; flu; fluid; hdl; high density lipoproteins; level; lip; lipoprot; lipoproteins; lp; mass concentration; point in time; qnt; quan; quant; quantitative; random",Qn
17090-2,loxapine+8-hydroxyloxapine [mass/volume] in serum or plasma,loxapine+8oh-lox serpl-mcnc,loxapine+8-hydroxyloxapine [mass/vol],8-hydroxy loxapine; 8oh-loxapine; drug/toxicology; drugs; hydroxyl; level; loxapine+8oh-lox; loxitane; loxitane metabolite; mass concentration; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
17104-1,cd107a cells/cells in blood,cd107a cells nfr bld,cd107a cells/cells (bld),blood; cd107a cells; cell; cell markers; cellularity; lamp-1; lysosome-associated membrane-protein 1; number fraction; percent; point in time; qnt; quan; quant; quantitative; random; wb; whole blood,Qn
17111-6,cd12 cells/cells in blood,cd12 cells nfr bld,cd12 cells/cells (bld),blood; cd12 cells; cell; cell markers; cellularity; number fraction; percent; point in time; qnt; quan; quant; quantitative; random; wb; whole blood,Qn
17125-6,cd22+cd19+ cells/cells in blood,cd22+cd19+ cells nfr bld,cd22+cd19+ cells/cells (bld),b3; b-3; b4; b-4; bl-cam; blood; cd22 cells; cd22+cd19+ cells; cell; cell markers; cellularity; hd-37; leu12; leu-12; leu14; leu-14; lyb8; number fraction; percent; point in time; qnt; quan; quant; quantitative; random; to-15; wb; whole blood,Qn
17142-1,cd37 cells/cells in blood,cd37 cells nfr bld,cd37 cells/cells (bld),blood; cd37 cells; cell; cell markers; cellularity; gp52-40; number fraction; percent; point in time; qnt; quan; quant; quantitative; random; wb; whole blood,Qn
17143-9,cd39 cells/cells in blood,cd39 cells nfr bld,cd39 cells/cells (bld),blood; cd39 cells; cell; cell markers; cellularity; number fraction; percent; point in time; qnt; quan; quant; quantitative; random; wb; whole blood,Qn
17148-8,cd41 cells/cells in blood,cd41 cells nfr bld,cd41 cells/cells (bld),alpha iib integrin chain; blood; cd41 cells; cell; cell markers; cellularity; glycoprotein iib; gpiib; number fraction; percent; point in time; qnt; quan; quant; quantitative; random; wb; whole blood,Qn
1716-0,acidity.titratable [mass/volume] in urine,titratable acidity ur-mcnc,acidity.titratable (u) [mass/vol],chemistry; level; mass concentration; point in time; qnt; quan; quant; quantitative; random; titratable acidity; ua; ur; urn,Qn
17161-1,cd47 cells/cells in blood,cd47 cells nfr bld,cd47 cells/cells (bld),blood; cd47 cells; cdw149; cell; cell markers; cellularity; gp42; iap; integrin-associated protein; mem-133; neurophilin; number fraction; oa3; ovarian carcinoma antigen 3; percent; point in time; qnt; quan; quant; quantitative; random; rh-associated protein*; wb; whole blood,Qn
17177-7,cd59 cells/cells in blood,cd59 cells nfr bld,cd59 cells/cells (bld),blood; cd59 cells; cell; cell markers; cellularity; number fraction; percent; point in time; qnt; quan; quant; quantitative; random; wb; whole blood,Qn
17180-1,cd62l cells/cells in blood,cd62l cells nfr bld,cd62l cells/cells (bld),blood; cd62l cells; cell; cell markers; cellularity; lam-1; lecam-1; leu8; leu-8; l-selectin; mel-14; number fraction; percent; point in time; qnt; quan; quant; quantitative; random; tq-1; wb; whole blood,Qn
17182-7,cd63 cells/cells in blood,cd63 cells nfr bld,cd63 cells/cells (bld),blood; cd63 cells; cell; cell markers; cellularity; gp55; granulophysin; lamp-3; limp; lysosomal-membrane-associated glycoprotein 3; me491; melanoma-associated antigen; mla1; neuroglandular antigen; nga; number fraction; percent; point in time; ptlgp40; qnt; quan; quant; quantitative; random; wb; whole blood,Qn
17183-5,cd64 cells/cells in blood,cd64 cells nfr bld,cd64 cells/cells (bld),blood; cd64 cells; cell; cell markers; cellularity; fc gamma receptor i; fc gamma ri; fc gammari; fcr i; number fraction; percent; point in time; qnt; quan; quant; quantitative; random; wb; whole blood,Qn
1719-4,adenine [mass/volume] in serum,adenine ser-mcnc,adenine (s) [mass/vol],b4 hemosan; chemistry; leuco-4; level; mass concentration; point in time; qnt; quan; quant; quantitative; random; serum; sr; vit b4; vitamin b4,Qn
17197-5,cd79b cells/cells in blood,cd79b cells nfr bld,cd79b cells/cells (bld),b29; blood; cd79b cells; cell; cell markers; cellularity; ig beta; number fraction; percent; point in time; qnt; quan; quant; quantitative; random; wb; whole blood,Qn
17211-4,cd96 cells/cells in blood,cd96 cells nfr bld,cd96 cells/cells (bld),blood; cd96 cells; cell; cell markers; cellularity; number fraction; percent; point in time; qnt; quan; quant; quantitative; random; t cell activation increased late expression; tactile; wb; whole blood,Qn
17213-0,cd98 cells/cells in blood,cd98 cells nfr bld,cd98 cells/cells (bld),4f2; blood; cd98 cells; cell; cell markers; cellularity; frp-1; number fraction; percent; point in time; qnt; quan; quant; quantitative; random; rl-388; wb; whole blood,Qn
17216-3,cytoplasmic cd3 cells/cells in blood,cycd3 cells nfr bld,cytoplasmic cd3 cells/cells (bld),blood; cell; cell markers; cellularity; cycd3; cycd3 cells; cytopl; cytoplas; leu4; leu-4; number fraction; percent; point in time; qnt; quan; quant; quantitative; random; t3; wb; whole blood,Qn
17227-0,lymphocytes/leukocytes in synovial fluid by automated count,lymphocytes nfr snv auto,lymphocytes/leukocytes auto (syn fld),auto; automated detection; elec; elect; electr; hematology/cell counts; joint aspirate; joint fld; joint flu; joint fluid; leuc; leuk; leukocyte; lkcs; lymp; lymph; lympho; lymphocyte; lymphs; lymphs%; number fraction; percent; point in time; qnt; quan; quant; quantitative; random; rheum; rheumatology; sf; snv; syn; syn fl; synov; synovial fluid; wbc; wbcs; white blood cell; white blood cells,Qn
1722-8,adenosine deaminase [enzymatic activity/volume] in blood,adenosine deaminase bld-ccnc,adenosine deaminase (bld) [catalytic activity/vol],ada; ado; aned; blood; catalytic concentration; chemistry; medication stress; point in time; qnt; quan; quant; quantitative; random; wb; whole blood,Qn
17235-3,magnesium [moles/volume] in leukocytes,magnesium wbc-scnc,magnesium (wbc) [moles/vol],chemistry; leukocytes; level; mag; magnes; mg; point in time; qnt; quan; quant; quantitative; random; substance concentration; wbcs; white blood cells,Qn
1723-6,adenosine deaminase binding protein [mass/volume] in urine,adenosine deaminase bp ur-mcnc,adenosine deaminase binding protein (u) [mass/vol],abp; ada; adabp; adenosine deaminase bp; ado; aned; bind; chemistry; level; mass concentration; medication stress; point in time; pr; prot; qnt; quan; quant; quantitative; random; ua; ur; urn,Qn
17244-5,manganese [mass/mass] in hair,manganese hair-mcnt,manganese (hair) [mass/mass],drug/toxicology; drugs; har; mass content; mn; point in time; qnt; quan; quant; quantitative; random,Qn
17247-8,melanin [units/volume] in urine,melanin ur-acnc,melanin qn (u),arbitrary concentration; chemistry; point in time; qnt; quan; quant; quantitative; random; ua; ur; urn,Qn
17248-6,melanin [units/volume] in serum or plasma,melanin serpl-acnc,melanin qn,arbitrary concentration; chemistry; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
17283-3,mirtazapine [mass/volume] in serum or plasma,mirtazapine serpl-mcnc,mirtazapine [mass/vol],avanza; drug/toxicology; drugs; level; mass concentration; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; reflex; remeron; serp; serpl; serplas; serum; serum or plasma; sr; zispin,Qn
17286-6,monocytes/leukocytes in synovial fluid by manual count,monocytes nfr snv manual,monocytes/leukocytes manual cnt (syn fld),hematology/cell counts; joint aspirate; joint fld; joint flu; joint fluid; leuc; leuk; leukocyte; lkcs; manl; mono; monocyte; monos; number fraction; percent; point in time; qnt; quan; quant; quantitative; random; sf; snv; syn; syn fl; synov; synovial fluid; wbc; wbcs; white blood cell; white blood cells,Qn
17291-6,deprecated mulberry tree ige ab [units/volume] in serum,deprecated white mulberry ige qn,white mulberry ige qn (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; immune globulin e; immunoglobulin e; mulberry; point in time; qnt; quan; quant; quantitative; random; serum; sr; t070; t70; white mulberry,Qn
17294-0,mushroom toxins [identifier] in urine,mushroom tox ur,mushroom toxins nom (u),identity or presence; microbiology; nominal; point in time; random; ua; ur; urn,Nom
1730-1,adenosine triphosphatase [enzymatic activity/volume] in semen,atpase smn-ccnc,adenosine triphosphatase (sem) [catalytic activity/vol],ado; aned; atpase; catalytic concentration; chemistry; ejaculate; genitourinary; gu; medication stress; point in time; qnt; quan; quant; quantitative; random; sem; seminal fluid; smn; smpls; uro; urology,Qn
17313-8,myelin associated glycoprotein igg ab [units/volume] in serum by immunofluorescence,mag igg ser if-acnc,myelin associated glycoprotein igg if qn (s),abs; aby; acif; antby; anti; antibodies; antibody; anticomplement immunofluorescence; arbitrary concentration; assoc; autoantibodies; autoantibody; fa; fluorescent antibody; fluoresent; gg; glycoprot; glycoproteins; gp; ifa; immune fluorescence; immune globulin g; immunoflour; immunofluor; immunofluorescence; immunoglobulin g; mag; point in time; qnt; quan; quant; quantitative; random; serology; serum; sr; time resolved fluorescence; trf,Qn
17330-2,neisseria meningitidis serogroup y ag [presence] in cerebral spinal fluid,n men sg y ag csf ql,n. meningitidis y ag ql (csf),antigen; antigens; cerebral spinal fluid; cerebrospinal fl; id; infectious disease; infectiousdisease; mening; meningid; meningitis; meningo; meningococcal meningitis; meningococcus; microbiology; n men; n men serogroup; n men sg y; n men sg y ag; n menigitidis; n meningitidis; neisseria meningitidis group y; neisseria meningitidis type y; neuro; neurology; ordinal; point in time; pr; ql; qual; qualitative; random; screen; spinal fl; spinal fld; spinal flu; spinal fluid,Ord
17342-7,neuronal nuclear type 2 ab [units/volume] in serum,hu2 ab ser-acnc,neuronal nuclear type 2 ab qn (s),abs; aby; anna 2; anna-2; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; hu; hu2; ii; neuro; neurology; neuronal nuclear type ii; nuc; oncology; paraneoplastic syndrome; point in time; qnt; quan; quant; quantitative; random; ri; serology; serum; sr,Qn
17348-4,neutrophil iga ab [units/volume] in serum,neutrophil iga ser-acnc,neutrophil iga qn (s),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; granulocytic ab; immune globulin a; immunoglobulin a; neut; neutr; neutrophils; pmn; pnm; point in time; qnt; quan; quant; quantitative; random; serology; serum; sr,Qn
1735-0,alanine [mass/volume] in cerebral spinal fluid,alanine csf-mcnc,alanine (csf) [mass/vol],ala; alpha alanine; cerebral spinal fluid; cerebrospinal fl; chemistry; l-alanine; level; mass concentration; point in time; qnt; quan; quant; quantitative; random; spinal fl; spinal fld; spinal flu; spinal fluid,Qn
17352-6,neutrophil cytoplasmic ab [interpretation] in serum,anca ab ser-imp,neutrophil cytoplasmic ab (s) [interp],abs; aby; acna; acpa; anca; antby; anti; antibodies; antibody; autoantibodies; autoantibody; cytopl; cytoplas; granulocyte ab; granulocyte nucleus ab; impression; impression/interpretation of study; impressions; interp; interpretation; neut; neutr; neutrophils; nominal; pmn; pnm; point in time; random; serology; serum; sr; vasculitis,Nom
17364-1,nitrophenol [presence] in urine,nitrophenol ur ql,nitrophenol ql (u),c6h5no3; drug/toxicology; drugs; mixed isomers; nitrophenols; ordinal; point in time; pr; ql; qual; qualitative; random; screen; ua; ur; urn,Ord
17377-3,norpropoxyphene [mass/volume] in urine by confirmatory method,norpropoxyph ur cfm-mcnc,norpropoxyphene confirm (u) [mass/vol],cfm; cnfr; cnfrm; conf; confirmation; confirmatory; drug/toxicology; drugs; gcms; lc/ms/ms; level; mass concentration; n-desmethylproproxyphene; norpropoxyp; point in time; propoxyphene metabolite; qnt; quan; quant; quantitative; random; ua; ur; urn,Qn
17404-5,human papilloma virus 33 ag [presence] in specimen,hpv33 ag spec ql,hpv 33 ag ql (specimen),antigen; antigens; genital warts; hpv; hpv33; human papillomavirus; id; infectious disease; infectiousdisease; microbiology; misc; miscellaneous; ordinal; other; papilloma virus intermediate risk; point in time; pr; ql; qual; qualitative; random; screen; spec; to be specified in another part of the message; unspecified,Ord
17406-0,human papilloma virus 43 ag [presence] in specimen,hpv43 ag spec ql,hpv 43 ag ql (specimen),antigen; antigens; genital warts; hpv; hpv43; human papillomavirus; id; infectious disease; infectiousdisease; microbiology; misc; miscellaneous; ordinal; other; papilloma virus low risk; point in time; pr; ql; qual; qualitative; random; screen; spec; to be specified in another part of the message; unspecified,Ord
17413-6,papova virus sv 40 ab [units/volume] in serum,sv40 ab ser-acnc,papova virus sv 40 ab qn (s),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; id; infectious disease; infectiousdisease; microbiology; point in time; qnt; quan; quant; quantitative; random; serum; simian virus 40; sr; sv-40,Qn
17414-4,parainfluenza virus 1+2+3 ag [presence] in specimen,hpiv1+2+3 ag spec ql,parainfluenza virus 1+2+3 ag ql (specimen),antigen; antigens; hpiv; hpiv1; hpiv1+2+3; human respirovirus 1; i; id; ii; iii; infectious disease; infectiousdisease; microbiology; misc; miscellaneous; ordinal; other; para; parainflu; parainfluenza type 1; parainfluenza type i; pi1; point in time; pr; ql; qual; qualitative; random; screen; spec; to be specified in another part of the message; unspecified,Ord
17416-9,parakeet droppings ab [units/volume] in serum,parakeet drop ab qn,parakeet droppings ab qn (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; e197; feces; point in time; qnt; quan; quant; quantitative; random; serum; sr; stool,Qn
17429-2,pentachlorophenol [mass/volume] in blood,pentachlorophen bld-mcnc,pentachlorophenol (bld) [mass/vol],blood; drug/toxicology; drugs; level; mass concentration; pcp; penta; point in time; qnt; quan; quant; quantitative; random; wb; whole blood,Qn
17436-7,phenobarbital [mass/volume] in gastric fluid,phenobarb gast-mcnc,phenobarbital (gast fld) [mass/vol],barbiturate; c417; drug/toxicology; drugs; gast; gastric contents; gastric fluid; level; luminal; mass concentration; nirvonal; phbr; phenobarb; point in time; qnt; quan; quant; quantitative; random,Qn
17440-9,phenothiazines [units/volume] in serum or plasma,phenothiaz serpl-acnc,phenothiazines qn,arbitrary concentration; dibenzothiazine; drug/toxicology; drugs; phenothiaz; phenothiazine; phenothiazn; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
17444-1,phenytoin [mass/volume] in urine,phenytoin ur-mcnc,phenytoin (u) [mass/vol],di-hydan; dilantin; dilj; diphenylhydantoin; dph; drug/toxicology; drugs; epanutin; fenantoin; lehydan; level; mass concentration; phenhydan; phyt; point in time; qnt; quan; quant; quantitative; random; sinergina; ua; ur; urn; zentropil,Qn
17450-8,phosphatidylethanolamine igm ab [presence] in serum,pe igm ser ql,phosphatidylethanolamine igm ql (s),abs; aby; antby; anti; antibodies; antibody; ape; autoantibodies; autoantibody; coagulation; hematology; heme; immune globulin m; immunoglobulin m; ordinal; pe; phosphatidyl ethanolamine; point in time; pr; ql; qual; qualitative; random; screen; serum; sr,Ord
17451-6,phosphatidylglycerol iga ab [presence] in serum,pg iga ser ql,phosphatidylglycerol iga ql (s),abs; aby; antby; anti; antibodies; antibody; apg; autoantibodies; autoantibody; coagulation; fetal lung maturity; hematology; heme; immune globulin a; immunoglobulin a; ordinal; pg; phosphatidyl glycerol; phosphotidylglycerol; point in time; pr; ql; qual; qualitative; random; screen; serum; sr,Ord
17457-3,phosphoethanolamine [presence] in urine,petn ur ql,phosphoethanolamine ql (u),chemistry; ordinal; pea; petn; point in time; pr; ql; qual; qualitative; random; screen; ua; ur; urn,Ord
17462-3,picloram [mass/volume] in urine,picloram ur-mcnc,picloram (u) [mass/vol],"4-amino-3,5,6-trichloropicolinate; 4-amino-3,5,6-trichloropicolinic acid; amdon; atcp; borolin; c6h3cl3n2o2; drug/toxicology; drugs; level; mass concentration; point in time; pyridinecarboxylic acid; qnt; quan; quant; quantitative; random; tordon; ua; ur; urn",Qn
17464-9,pigeon feather ige ab [presence] in serum,pigeon feather ige ql,pigeon feather ige ql (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; e215; feathers; immune globulin e; immunoglobulin e; ordinal; point in time; pr; ql; qual; qualitative; random; re215; screen; serum; sr,Ord
1747-5,albumin [mass/volume] in body fluid,albumin fld-mcnc,albumin (body fld) [mass/vol],"alb; b/f; bf; bod; bodies; body fluid; body fluid, unsp; chemistry; fl; fld; flu; fluid; hepatology; kidney; level; liver; mass concentration; nephrology; point in time; protein.albumin; qnt; quan; quant; quantitative; random; renal; universallaborders",Qn
17476-3,porphyrins [units/volume] in red blood cells,porphyrins rbc-acnc,porphyrins qn (rbc),arbitrary concentration; chemistry; ep; erythrocyte porphyrin; erythrocytes; hematology; heme; point in time; porph; porphyrin; qnt; quan; quant; quantitative; random; red blood cells; red blood corpusles,Qn
17495-3,prostaglandins [mass/volume] in urine,prostaglandins ur-mcnc,prostaglandins (u) [mass/vol],chemistry; level; mass concentration; point in time; qnt; quan; quant; quantitative; random; ua; ur; urn,Qn
17498-7,beta globulin [mass/volume] in body fluid by electrophoresis,b-globulin fld elph-mcnc,beta globulin elph (body fld) [mass/vol],"b; b/f; bf; b-globulin; bod; bodies; body fluid; body fluid, unsp; chemistry; elec; elect; electr; electro; electrophhrs; electrophrs; elp; elph; ep; fl; fld; flu; fluid; glb; glob; glob%; globul; globulins; level; mass concentration; point in time; protein beta globulin; qnt; quan; quant; quantitative; random",Qn
17499-5,gamma globulin [mass/volume] in body fluid by electrophoresis,gamma glob fld elph-mcnc,gamma globulin elph (body fld) [mass/vol],"b/f; bf; bod; bodies; body fluid; body fluid, unsp; chemistry; elec; elect; electr; electro; electrophhrs; electrophrs; elp; elph; ep; fl; fld; flu; fluid; glb; glob; glob%; globul; globulins; level; mass concentration; point in time; protein gamma globulin; qnt; quan; quant; quantitative; random",Qn
17509-1,marsh ragweed ige ab [units/volume] in serum,marsh ragweed ige qn,marsh ragweed ige qn (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; immune globulin e; immunoglobulin e; marsh ragweed; point in time; qnt; quan; quant; quantitative; random; serum; sr,Qn
17547-1,rotavirus ag [presence] in stool,rv ag stl ql,rotavirus ag ql (stl),antigen; antigens; bowel movement; faecal; faeces; fecal; feces; id; infectious disease; infectiousdisease; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; rota virus; rotav; rotaviral; rotaviurs; rv; screen; stl; stool = fecal,Ord
17548-9,rotavirus rna [presence] in specimen by probe,rv rna spec ql probe,rotavirus rna probe ql (specimen),dna nucleic acid probe; dna probe; id; infectious disease; infectiousdisease; microbiology; misc; miscellaneous; ordinal; other; point in time; pr; ql; qual; qualitative; random; ribonucleic acid; rota virus; rotav; rotaviral; rotaviurs; rv; screen; spec; to be specified in another part of the message; unspecified,Ord
17554-7,measles virus iga ab [units/volume] in serum,mev iga ser-acnc,mev iga qn (s),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; id; immune globulin a; immunoglobulin a; infectious disease; infectiousdisease; mev; microbiology; msls; point in time; qnt; quan; quant; quantitative; random; rubeola; serum; sr,Qn
17555-4,measles virus ab [units/volume] in serum --1st specimen,mev ab sp1 ser-acnc,mev ab spec 1 qn (s),abs; aby; acute specimen; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; first; id; infectious disease; infectiousdisease; mev; microbiology; msls; point in time; pre immunization; qnt; quan; quant; quantitative; random; rubeola; serum; sp1; spec; sr,Qn
17561-2,salmon roe ige ab [units/volume] in serum,salmon roe ige qn,salmon roe ige qn (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; atlantic salmon; autoantibodies; autoantibody; f041; f41; immune globulin e; immunoglobulin e; point in time; qnt; quan; quant; quantitative; random; salmon; salmon roe; serum; sr,Qn
17566-1,salmonella typhi o ab [presence] in serum,s typhi o ab ser ql,s. typhi o ab ql (s),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; id; infectious disease; infectiousdisease; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; s typhi; s typhi o; s typhosa; sal; salmonel; screen; serum; sr; typh; typhoid,Ord
17613-1,deprecated streptococcus pneumoniae 1 ab [units/volume] in serum --2nd specimen,deprecated s pneum1 ab sp2 ser-acnc,s. pneumoniae 1 ab spec 2 qn (s),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; convalescent; i; id; infectious disease; infectiousdisease; microbiology; pneu; pneum; pneumo; pneumococ; pneumococcal; pneumococcal pneumonia; pneumococcus; pneumon; pneumonia; point in time; post immunization; qnt; quan; quant; quantitative; random; s pneum 1; s pneumo; s pneumoniae; second; serum; sp2; spec; spn; sr; strep; strept,Qn
17616-4,deprecated streptococcus pneumoniae 12f ab [ratio] in serum --2nd specimen/1st specimen,deprecated s pneum12f ab ser-rto,s. pneumoniae 12f ab 1st specimen 2nd specimen/streptococcus pneumoniae 12f ab (s) [ratio],abs; aby; acute specimen; antby; anti; antibodies; antibody; autoantibodies; autoantibody; convalescent; first; id; infectious disease; infectiousdisease; microbiology; pneu; pneum; pneumo; pneumococ; pneumococcal; pneumococcal pneumonia; pneumococcus; pneumon; pneumonia; point in time; post immunization; pre immunization; qnt; quan; quant; quantitative; random; ratios; rto; s pneumo; s pneumoniae; second; serum; sp2; spec; spn; sr; strep; strept,Qn
1762-4,aldosterone [mass/volume] in blood,aldost bld-mcnc,aldosterone (bld) [mass/vol],blood; chemistry; endocrine; endocrinology; level; mass concentration; point in time; qnt; quan; quant; quantitative; random; wb; whole blood,Qn
1764-0,aldosterone [mass/volume] in urine,aldost ur-mcnc,aldosterone (u) [mass/vol],chemistry; endocrine; endocrinology; level; mass concentration; point in time; qnt; quan; quant; quantitative; random; ua; ur; urn,Qn
17640-4,streptococcus pneumoniae danish serotype 7f ab [ratio] in serum by immunoassay --2nd specimen/1st specimen,s pneum da 7f ab 2:1 ser ia-rto,s. pneumoniae danish type 7f ab 2nd specimen/1st specimen ia (s) [ratio],2:1; abs; aby; acute specimen; antby; anti; antibodies; antibody; autoantibodies; autoantibody; convalescent; eia; elfa; elisa; enzyme immunoassay; first; iaa; id; infectious disease; infectiousdisease; meia; microbiology; pcv13; pneu; pneum; pneumo; pneumococ; pneumococcal; pneumococcal pneumonia; pneumococcus; pneumon; pneumonia; point in time; post immunization; ppsv23; pre immunization; qnt; quan; quant; quantitative; random; ratios; rto; s pneum da 7f; s pneum da 7f ab; s pneum da type; s pneumo; s pneumoniae; second; serum; sp1; sp2; spec; spn; sr; strep; strept; suds; u.s. serotype 51,Qn
17651-1,streptococcus pneumoniae igg ab [units/volume] in serum by immunoassay --2nd specimen,s pneum igg sp2 ser ia-acnc,s. pneumoniae igg spec 2 ia qn (s),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; convalescent; eia; elfa; elisa; enzyme immunoassay; iaa; id; immune globulin g; immunoglobulin g; infectious disease; infectiousdisease; meia; microbiology; pneu; pneum; pneumo; pneumococ; pneumococcal; pneumococcal pneumonia; pneumococcus; pneumon; pneumonia; point in time; post immunization; qnt; quan; quant; quantitative; random; s pneumo; s pneumoniae; second; serum; sp2; spec; spn; sr; strep; strept; suds,Qn
17655-2,deprecated streptococcus pneumoniae group b ag in urine by immunofluorescence,deprecated s pneumb ag ur ql if,s. pneumoniae group b ag if ql (u),acif; anticomplement immunofluorescence; antigen; antigens; arbitrary concentration; dfa; fa; fluorescent antibody; fluoresent; id; ifa; immune fluorescence; immunoflour; immunofluor; immunofluorescence; infectious disease; infectiousdisease; microbiology; ordinal; pneu; pneum; pneumo; pneumococ; pneumococcal; pneumococcal pneumonia; pneumococcus; pneumon; pneumonia; point in time; ql; qual; qualitative; random; s pneumo; s pneumoniae; screen; spn; strep; strept; time resolved fluorescence; trf; ua; ur; urn,Ord
1765-7,aldosterone [mass/time] in 24 hour urine,aldost 24h ur-mrate,aldosterone (24h u) [mass/time],1 day; 24 hours; 24hr; chemistry; endocrine; endocrinology; mass rate; mrate; qnt; quan; quant; quantitative; ua; ur; urn,Qn
17667-7,sulfate.organic/sulfate.total in urine,sulfate organic mfr ur,sulfate.organic/total sulfate (u) [mass fraction],chemistry; mass fraction; percent; point in time; qnt; quan; quant; quantitative; random; so4; so4-2; sulf; sulfate organic; t sulfate; tot; totl; ua; ur; urn,Qn
17676-8,sulindac sulfide metabolite [mass/volume] in serum or plasma,sulindac metab serpl-mcnc,sulindac sulfide metabolite [mass/vol],aclin; c20h17fo3s; clinoril; clusinol; drug/toxicology; drugs; level; mass concentration; metab; metabolites; metb; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; saldac; serp; serpl; serplas; serum; serum or plasma; sr; sulindac metab,Qn
17693-3,testosterone [mass/volume] in serum or plasma --4 days post xxx challenge,testost 4d p chal serpl-mcnc,testosterone 4 days post unsp challenge [mass/vol],4d p chal; after; chemistry.challenge testing; level; mass concentration; p chal; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; testo; testos; testost,Qn
17695-8,tetrachlorodiphenylethane [mass/volume] in blood,ddd bld-mcnc,tetrachlorodiphenylethane (bld) [mass/vol],"1,1-dichloro-2,2-bis(p-chlorophenyl)ethane; blood; component of ddt; ddd; dichlorodiphenyldichloroethane; drug/toxicology; drugs; level; mass concentration; point in time; qnt; quan; quant; quantitative; random; tde; wb; whole blood",Qn
17696-6,tetrachlorodiphenylethane [mass/volume] in urine,ddd ur-mcnc,tetrachlorodiphenylethane (u) [mass/vol],"1,1-dichloro-2,2-bis(p-chlorophenyl)ethane; component of ddt; ddd; dichlorodiphenyldichloroethane; drug/toxicology; drugs; level; mass concentration; point in time; qnt; quan; quant; quantitative; random; tde; ua; ur; urn",Qn
17698-2,tetraethyl lead [mass/volume] in blood,tetraethyl lead bld-mcnc,tetraethyl lead (bld) [mass/vol],blood; drug/toxicology; drugs; level; mass concentration; painter's colic; pb; plumbism; point in time; qnt; quan; quant; quantitative; random; tetraethyllead; wb; whole blood,Qn
17710-5,tin/creatinine [mass ratio] in urine,tin/creat ur,tin/creatinine (u) [mass ratio],cr; crea; creat; drug/toxicology; drugs; mass concentration ratio; mass ratio; mcrto; point in time; qnt; quan; quant; quantitative; random; sn; ua; ucr; ur; urn,Qn
17752-7,tryptophan [presence] in urine,tryptophan ur ql,tryptophan ql (u),c244; chemistry; l-tryptophan; ordinal; point in time; pr; ql; qual; qualitative; random; screen; trp; ua; ur; urn,Ord
1775-6,alkaline phosphatase [mass/volume] in body fluid,alp fld-mcnc,alp (body fld) [mass/vol],"alk; alk phos; alkaline phos; alkaline phosphatase.total; alkp; alp; ap; b/f; bf; bod; bodies; body fluid; body fluid, unsp; chemistry; fl; fld; flu; fluid; hepatology; level; liver; mass concentration; msk; musculoskeletal; ortho; orthopedics; phos; phosphtase; point in time; qnt; quan; quant; quantitative; random",Qn
17763-4,varicella zoster virus igg ab [units/volume] in serum by immunofluorescence,vzv igg ser if-acnc,vzv igg if qn (s),abs; aby; acif; antby; anti; antibodies; antibody; anticomplement immunofluorescence; arbitrary concentration; autoantibodies; autoantibody; chicken pox; chicken pox virus; chickenpox; fa; fluorescent antibody; fluoresent; herpes zoster; hhv-3; human herpesvirus 3; id; ifa; immune fluorescence; immune globulin g; immunoflour; immunofluor; immunofluorescence; immunoglobulin g; infectious disease; infectiousdisease; microbiology; point in time; qnt; quan; quant; quantitative; random; serum; shingles; sr; time resolved fluorescence; trf; vz; vzv; zoster,Qn
1776-4,alkaline phosphatase [mass/volume] in urine,alp ur-mcnc,alp (u) [mass/vol],alk; alk phos; alkaline phos; alkaline phosphatase.total; alkp; alp; ap; chemistry; hepatology; level; liver; mass concentration; msk; musculoskeletal; ortho; orthopedics; phos; phosphtase; point in time; qnt; quan; quant; quantitative; random; ua; ur; urn,Qn
17772-5,dimethylbenzene [mass/volume] in urine,dmb ur-mcnc,dimethylbenzene (u) [mass/vol],dmb; drug/toxicology; drugs; level; mass concentration; point in time; qnt; quan; quant; quantitative; random; ua; ur; urn; xylene; xylol,Qn
1778-0,alkaline phosphatase.intestinal [enzymatic activity/volume] in serum or plasma,alp intest serpl-ccnc,alp intest [catalytic activity/vol],alk; alk phos; alkaline phos; alkaline phosphatase.gi; alkaline phosphatase.total; alkp; alp; alp intest; alp-3; alpi; ap; catalytic concentration; chemistry; iap; intest; intestine; phos; phosphtase; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
17780-8,helicobacter pylori ag [presence] in stool by immunoassay,h pylori ag stl ql ia,h. pylori ag ia ql (stl),antigen; antigens; bowel movement; c pylori; campylobacter pylori; eia; elfa; elisa; enzyme immunoassay; faecal; faeces; fecal; feces; gastro; gastroenterology; gi; h pyl; h pylori; iaa; meia; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; screen; stl; stool = fecal; suds; universallaborders,Ord
17785-7,radioactive iodine.thyroid/radioactive iodine dose [ratio],rai uptake thyroid-rto,radioactive iodine.thyroid/radioactive iodine dose (thyroid) [ratio],c616; chemistry; i; i-; point in time; qnt; quan; quant; quantitative; rai uptake; random; ratios; rto; thy,Qn
17799-8,promyelocytes/leukocytes in body fluid,promyelocytes nfr fld,promyelocytes/leukocytes (body fld),"b/f; bf; bod; bodies; body fluid; body fluid, unsp; fl; fld; flu; fluid; hematology/cell counts; leuc; leuk; leukocyte; lkcs; number fraction; percent; point in time; pro myelos; progranulocyte; progranulocytes; promyel; promyelocyte; qnt; quan; quant; quantitative; random; wbc; wbcs; white blood cell; white blood cells",Qn
1780-6,alkaline phosphatase.placental [enzymatic activity/volume] in serum or plasma,alp plac serpl-ccnc,alp plac [catalytic activity/vol],alk; alk phos; alkaline phos; alkaline phosphatase.total; alkp; alp; alp plac; ap; catalytic concentration; chemistry; phos; phosphtase; pl; placent; placenta; placntl; plap; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
1783-0,alkaline phosphatase [enzymatic activity/volume] in blood,alp bld-ccnc,alp (bld) [catalytic activity/vol],alk; alk phos; alkaline phos; alkaline phosphatase.total; alkp; alp; ap; blood; catalytic concentration; chemistry; hepatology; liver; msk; musculoskeletal; ortho; orthopedics; phos; phosphtase; point in time; qnt; quan; quant; quantitative; random; wb; whole blood,Qn
17833-5,basophils/leukocytes in synovial fluid,basophils nfr snv,basophils/leukocytes (syn fld),baso; basophil; basos; bph; hematology/cell counts; joint aspirate; joint fld; joint flu; joint fluid; leuc; leuk; leukocyte; lkcs; number fraction; percent; point in time; qnt; quan; quant; quantitative; random; sf; snv; syn; syn fl; synov; synovial fluid; wbc; wbcs; white blood cell; white blood cells,Qn
17835-0,monocytes/leukocytes in synovial fluid,monocytes nfr snv,monocytes/leukocytes (syn fld),hematology/cell counts; joint aspirate; joint fld; joint flu; joint fluid; leuc; leuk; leukocyte; lkcs; mono; monocyte; monos; number fraction; percent; point in time; qnt; quan; quant; quantitative; random; sf; snv; syn; syn fl; synov; synovial fluid; wbc; wbcs; white blood cell; white blood cells,Qn
17837-6,acid phosphatase tartrate resistant [enzymatic activity/volume] in serum,acp trap ser-ccnc,acid phosphatase tartrate resistant (s) [catalytic activity/vol],ac phos; acd; acid phosphatase.total; acids; acp; acp trap; catalytic concentration; chemistry; phos; phosphtase; point in time; qnt; quan; quant; quantitative; random; serum; sr; trap; tumor marker,Qn
17841-8,amylase [enzymatic activity/time] in 12 hour urine,amylase 12h ur-crate,amylase (12h u) [catalytic activity/time],12 hours; 12hr; alpha amylase; ams; amyl; catalytic rate; chemistry; crate; diastase; gastro; gastroenterology; gi; k87; qnt; quan; quant; quantitative; ua; ur; urn,Qn
17857-4,rheumatoid factor [titer] in serum,rheumatoid fact titr ser,rheumatoid factor (s) [titer],dilution factor; dilution factor (titer); fac; fact; point in time; random; rf; rheum; rheumatology; serology; serum; smqn; sr; titer; titered; titre; ttr,SemiQn
17880-6,bacteria # 4 identified in bronchial specimen by aerobe culture,bacteria bronch aerobe cult org #4,bacteria identified # 4 aer cx nom (bronch spec),aerobe; aerobe cult; aerobed; bact; bro; c&s; cult; cultures; id; identity or presence; infectious disease; infectiousdisease; lung; microbiology; nominal; point in time; pulmonary; pulmonology; random; respiratory,Nom
17881-4,bacteria # 5 identified in bronchial specimen by aerobe culture,bacteria bronch aerobe cult org #5,bacteria identified # 5 aer cx nom (bronch spec),aerobe; aerobe cult; aerobed; bact; bro; c&s; cult; cultures; id; identity or presence; infectious disease; infectiousdisease; lung; microbiology; nominal; point in time; pulmonary; pulmonology; random; respiratory,Nom
17887-1,bacteria # 6 identified in genital specimen by aerobe culture,bacteria genital aerobe cult org #6,bacteria identified # 6 aer cx nom (genital specimen),aerobe; aerobe cult; aerobed; bact; c&s; cult; cultures; gen; genital tract; id; identity or presence; infectious disease; infectiousdisease; microbiology; nominal; point in time; random; urogenit; urogenital,Nom
17903-6,bacteria # 6 identified in throat by aerobe culture,bacteria throat aerobe cult org #6,bacteria identified # 6 aer cx nom (throat),aerobe; aerobe cult; aerobed; bact; c&s; cult; cultures; id; identity or presence; infectious disease; infectiousdisease; microbiology; nominal; point in time; random; throat; upper respiratory,Nom
17907-7,bacteria # 5 identified in tissue by aerobe culture,bacteria tiss aerobe cult org #5,bacteria identified # 5 aer cx nom (tiss),"aerobe; aerobe cult; aerobed; bact; c&s; cult; cultures; id; identity or presence; infectious disease; infectiousdisease; microbiology; nominal; point in time; random; tissue; tissue, unspecified",Nom
17914-3,bacteria # 6 identified in wound deep by aerobe culture,bacteria deep wnd aerobe cult org #6,bacteria identified # 6 aer cx nom (deep wound),aerobe; aerobe cult; aerobed; bact; c&s; cult; cultures; deep wnd; id; identity or presence; infectious disease; infectiousdisease; microbiology; nominal; point in time; random; wnd; wound - deep,Nom
17923-4,bacteria # 2 identified in tissue by anaerobe culture,bacteria tiss anaerobe cult org #2,bacteria identified # 2 anaer cx nom (tiss),"anaero; anaerobe; anaerobe cult; bact; c&s; cult; cultures; id; identity or presence; ii; infectious disease; infectiousdisease; microbiology; nominal; point in time; random; tissue; tissue, unspecified",Nom
17926-7,bacteria # 2 identified in wound deep by anaerobe culture,bacteria deep wnd anaerobe cult org #2,bacteria identified # 2 anaer cx nom (deep wound),anaero; anaerobe; anaerobe cult; bact; c&s; cult; cultures; deep wnd; id; identity or presence; ii; infectious disease; infectiousdisease; microbiology; nominal; point in time; random; wnd; wound - deep,Nom
17945-7,bacteria # 5 identified in line specimen by iv line culture,bacteria line iv ln cult org #5,bacteria identified # 5 iv line culture nom (line specimen),bact; c&s; cult; cultures; id; identity or presence; infectious disease; infectiousdisease; intravenous; iv; iv ln cult; ln; microbiology; nominal; point in time; random,Nom
17946-5,bacteria # 6 identified in line specimen by iv line culture,bacteria line iv ln cult org #6,bacteria identified # 6 iv line culture nom (line specimen),bact; c&s; cult; cultures; id; identity or presence; infectious disease; infectiousdisease; intravenous; iv; iv ln cult; ln; microbiology; nominal; point in time; random,Nom
17951-5,bacteria # 2 identified in body fluid by aerobe culture,bacteria fld aerobe cult org #2,bacteria identified # 2 aer cx nom (body fld),"aerobe; aerobe cult; aerobed; b/f; bact; bf; bod; bodies; body fluid; body fluid, unsp; c&s; cult; cultures; fl; fld; flu; fluid; id; identity or presence; ii; infectious disease; infectiousdisease; microbiology; nominal; point in time; random",Nom
17965-5,bacteria # 3 identified in stool by culture,bacteria stl cult org #3,bacteria identified # 3 cx nom (stl),bact; bowel movement; c&s; cult; cultures; faecal; faeces; fecal; feces; gastro; gastroenterology; gi; id; identity or presence; iii; infectious disease; infectiousdisease; microbiology; nominal; point in time; random; stl; stool = fecal,Nom
17970-5,bacteria # 2 identified in urine by culture,bacteria ur cult org #2,bacteria identified # 2 cx nom (u),bact; c&s; cult; cultures; id; identity or presence; ii; infectious disease; infectiousdisease; microbiology; nominal; point in time; random; ua; ur; urn,Nom
17983-8,tricuspid valve acceleration by us.doppler,tv accel time dop,,acc; accel; acct1; at; card.us; cardio; cardiology; dop; duplex; echography; heart disease; point in time; qnt; quan; quant; quantitative; random; sonogram; sonograph; sonography; tv; uls; ultrasound,Qn
17986-1,left ventricular maximum apical 2 chamber.diastole [volume] by us 2d modified,lv apical 2ch dias.max vol us.2d.mod,,2d us; a2c; ap2; apical 2ch dias; apical 2ch dias.max; card.us; cardiac; cardio; cardiology; dias; dias.max; diast; diastoli; echography; heart disease; hrt; hrt ventr; ii; l; largest; lt; lv; lvedv; maximal; maximum; peak; point in time; qnt; quan; quant; quantitative; random; sonogram; sonograph; sonography; uls; ultrasound; ultrasound - 2-dimensional; ventricular; volume,Qn
18015-8,aorta root annulo-aortic junction diameter by us,ao.root.annulo-ao junc diam us,,ao; ao root; ao.root.annulo-ao junc; aortic; card.us; cardio; cardiology; dia; diam; echography; heart disease; length; point in time; qnt; quan; quant; quantitative; random; sonogram; sonograph; sonography; uls; ultrasound,Qn
1804-4,amylase.p3 [enzymatic activity/volume] in serum or plasma,amylase p3 serpl-ccnc,amylase.p3 [catalytic activity/vol],alpha amylase; ams; amyl; amylase p3; catalytic concentration; chemistry; diastase; gastro; gastroenterology; gi; k87; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
18052-1,right ventricular anterior wall fractional thickening freewall by us,rv.ant wall fract thickening.freewall us,,card.us; cardiac; cardio; cardiology; echography; fract thickening.freewall; heart disease; hrt; hrt ventr; length fraction; percent; point in time; qnt; quan; quant; quantitative; r; random; rt; rv; rv.ant wall; rvaw; rvfwt%; rvwt%; sonogram; sonograph; sonography; uls; ultrasound; ventricular,Qn
18059-6,mitral valve mean pressure gradient by us.doppler,mv mean press grad dop,,average; avg; card.us; cardio; cardiology; dop; duplex; echography; grad; heart disease; mean press grad; mv; mvg; point in time; press grad; qnt; quan; quant; quantitative; random; sonogram; sonograph; sonography; uls; ultrasound,Qn
18076-0,left ventricular major axis apical systole [length] by us 2d,lv major axis apical sys 2d us,,2d us; card.us; cardiac; cardio; cardiology; echography; heart disease; hrt; hrt ventr; l; lax; length; long axis; lt; lv; lvls; major axis apical sys; point in time; qnt; quan; quant; quantitative; random; sonogram; sonograph; sonography; sys; syst; uls; ultrasound; ultrasound - 2-dimensional; ventricular,Qn
18080-2,right ventricular outflow tract maximum blood flow velocity during systole by us.doppler,rvot vmax sys dop,,bld flow; bld flow vel; bld flow.velocity; card.us; cardiac; cardio; cardiology; dop; duplex; dynamic; echography; heart disease; hrt; hrt ventr; largest; max v; maximal; maximum; peak; point in time; qnt; quan; quant; quantitative; r; random; rt; rv; rvot; sonogram; sonograph; sonography; sys; sys.max; syst; uls; ultrasound; v max; v sys; vel; vel max; velocity; ventricular; vmax; vmax sys,Qn
18081-0,left ventricular minor axis at end diastole [length] by us.2d.a4c,lv ed minor axis a4c,,2d us; card.us; cardiac; cardio; cardiology; dias; diast; diastoli; echography; ed; ed minor axis; heart disease; hrt; hrt ventr; l; length; lt; lv; point in time; qnt; quan; quant; quantitative; random; sax; short axis; sonogram; sonograph; sonography; uls; ultrasound; ultrasound - 2-dimensional; ventricular,Qn
18099-2,left ventricular plane.diastole [area] by us.2d.a2c,lv plane.dia area a2c,,2d us; card.us; cardiac; cardio; cardiology; dias; diast; diastoli; echography; heart disease; hrt; hrt ventr; l; lt; lv; lvad; point in time; qnt; quan; quant; quantitative; random; sonogram; sonograph; sonography; uls; ultrasound; ultrasound - 2-dimensional; ventricular,Qn
18107-3,cardiac echo study procedure stress method,cardiac echo study proced stress method,,card.us; cardio; cardiology; heart disease; meth; method of; nominal; point in time; proced stress method; random; typ; ultrasound,Nom
18113-1,mitral valve regurgitation degree by us.doppler,mv reg deg dop,,arbitrary; card.us; cardio; cardiology; dop; duplex; echography; heart disease; mv; ordinal; point in time; ql; qual; qualitative; random; reg deg; reg degree; screen; sonogram; sonograph; sonography; uls; ultrasound,Ord
18125-5,left ventricular basal posterior segmental wall motion by us,lv.basal post swm us,,card.us; cardiac; cardio; cardiology; echography; finding; findings; heart disease; hrt; hrt ventr; l; lt; lv; lv.basal post; ordinal; point in time; ql; qual; qualitative; random; screen; segment; segment appearance; sonogram; sonograph; sonography; swm; uls; ultrasound; ventricular; wm,Ord
18129-7,left ventricular mid anterior segmental wall motion by us,lv.mid ant swm us,,card.us; cardiac; cardio; cardiology; echography; finding; findings; heart disease; hrt; hrt ventr; l; lt; lv; lv.mid ant; ordinal; point in time; ql; qual; qualitative; random; screen; segment; segment appearance; sonogram; sonograph; sonography; swm; uls; ultrasound; ventricular; wm,Ord
18137-0,left ventricular minor axis.papillary level.diastole [area] by us 2d,lv minor axis.papillary.dias area 2d us,,2d us; card.us; cardiac; cardio; cardiology; dias; diast; diastoli; echography; heart disease; hrt; hrt ventr; l; levels; levl; lt; lv; lvad; lvl; minor axis.papillary.dias; pap; point in time; qnt; quan; quant; quantitative; random; sax; saxpm; short axis; sonogram; sonograph; sonography; uls; ultrasound; ultrasound - 2-dimensional; ventricular,Qn
18139-6,stress study stage by us,stress study stage us,,card.us; cardio; cardiology; echography; heart disease; identity or presence; nominal; point in time; random; sonogram; sonograph; sonography; uls; ultrasound,Nom
18140-4,central cardiovascular study observation by us,us cent cv study,,card.us; cardio; cardiology; cent cv; echography; finding; findings; heart disease; nominal; point in time; random; sonogram; sonograph; sonography; study report; uls; ultrasound,Nom
18160-2,cardiac echo imaging device class,card echo device class,,card echo device; card.us; cardio; cardiology; heart disease; nominal; point in time; random; typ; ultrasound,Nom
18176-8,cardiac echo imaging device vendor model number,card echo device model #,,card echo device; card.us; cardio; cardiology; heart disease; ident; identifier; model #; no; nominal; num; point in time; random; ultrasound,Nom
18177-6,cardiac echo imaging device vendor serial number,card echo device serial #,,card echo device; card.us; cardio; cardiology; heart disease; ident; identifier; no; nominal; num; point in time; random; serial #; ultrasound,Nom
18204-8,caffeine renal clearance in 24 hour urine and serum or plasma,caffeine cl 24h ur+serpl-vrate,caffeine renal clearance (24h u+s/p) [vol/time],1 day; 24 hours; 24hr; caffn; cl; clear; clearanc; clearances; clr; drug/toxicology; drugs; flow; kidney; pl; plasma; plsm; qnt; quan; quant; quantitative; serp; serpl; serplas; serum; serum or plasma; sr; ua; ur; ur+serpl; urn; volume rate; vrate,Qn
18213-9,complement c1 esterase inhibitor free igm ab [mass/volume] in serum or plasma,c1inh free igm serpl-mcnc,complement c1 esterase inhibitor free igm [mass/vol],abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; c1 inactivator; c1 inhibiting factor; c1ina; c1inh; c1-inh; c1inh free; comp; complmt; fr; hematology/cell counts; immune globulin m; immunoglobulin m; inhib; inhibit; level; mass concentration; non-protein bound; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
18219-6,epinephrine [mass/volume] in urine --2nd specimen post xxx challenge,epineph sp2 p chal ur-mcnc,epinephrine 2nd specimen post unsp challenge (u) [mass/vol],adrenalin; adrenaline; adreneline; after; chemistry.challenge testing; convalescent; e; epi; epin; epinep; epineph; epinphrine; eppi; level; mass concentration; p chal; point in time; post immunization; pst; qnt; quan; quant; quantitative; random; second; sp2; sp2 p chal; spec; ua; ur; urn,Qn
18220-4,epinephrine [mass/volume] in urine --3rd specimen post xxx challenge,epineph sp3 p chal ur-mcnc,epinephrine 3rd specimen post unsp challenge (u) [mass/vol],adrenalin; adrenaline; adreneline; after; chemistry.challenge testing; e; epi; epin; epinep; epineph; epinphrine; eppi; level; mass concentration; p chal; point in time; pst; qnt; quan; quant; quantitative; random; sp3; sp3 p chal; spec; ua; ur; urn,Qn
18227-9,glucose [mass/time] in 6 hour urine,glucose 6h ur-mrate,glucose (6h u) [mass/time],6 hours; 6hr; chemistry; glu; gluc; glucoseur; mass rate; mrate; qnt; quan; quant; quantitative; ua; ur; urn,Qn
18235-2,ketone solvents [identifier] in blood,ketone solvents bld,ketone solvents nom (bld),blood; drug/toxicology; drugs; identity or presence; nominal; point in time; random; wb; whole blood,Nom
18263-4,cholesterol in hdl [mass/volume] in serum or plasma ultracentrifugate,hdlc serpl.ultracent-mcnc,cholesterol in hdl (s/p ultracentrifugate) [mass/vol],"cardio; cardiology; chemistry; chol; choles; cholest; cholesterol total; cholesterols; hdlc; hdl-c; heart disease; high density lipoprotein cholesterols; level; lipid; mass concentration; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serpl.ultracent; serplas; serum; serum or plasma; serum or plasma, ultracentrifugate; sr; tchhdl",Qn
18307-9,ova and parasites identified in stool by iron hematoxylin stain,o+p stl ih stn,ova and parasites identified iron hematoxylin stain nom (stl),bowel movement; faecal; faeces; fecal; feces; gastro; gastroenterology; gi; id; identity or presence; ih stn; infectious disease; infectiousdisease; microbiology; nominal; o&p; o+p; ova and parasite; ovum; parasite; point in time; random; st; stains; stl; stn; stool = fecal,Nom
18330-1,neutrophil cytoplasmic igg ab [units/volume] in serum,anca igg ser-acnc,neutrophil cytoplasmic igg qn (s),abs; aby; acna; acpa; anca; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; cytopl; cytoplas; granulocyte ab; granulocyte nucleus ab; immune globulin g; immunoglobulin g; neut; neutr; neutrophils; pmn; pnm; point in time; qnt; quan; quant; quantitative; random; serology; serum; sr; vasculitis,Qn
18335-0,antihistamines [presence] in urine by confirmatory method,antihistamines ur ql cfm,antihistamines confirm ql (u),antihistamine; anti-histamine; anti-histamines; cfm; cnfr; cnfrm; conf; confirmation; confirmatory; drug/toxicology; drugs; gcms; lc/ms/ms; ordinal; point in time; pr; ql; qual; qualitative; random; screen; ua; ur; urn,Ord
18347-5,deprecated streptococcus pneumoniae 12 ab [units/volume] in serum --2nd specimen,deprecated s pneum12 ab sp2 ser-acnc,s. pneumoniae 12 ab spec 2 qn (s),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; convalescent; id; infectious disease; infectiousdisease; microbiology; pneu; pneum; pneumo; pneumococ; pneumococcal; pneumococcal pneumonia; pneumococcus; pneumon; pneumonia; point in time; post immunization; qnt; quan; quant; quantitative; random; s pneum12; s pneumo; s pneumoniae; second; serum; sp2; spec; spn; sr; strep; strept; streptococcus pneumoniae 12f,Qn
18357-4,methylenedioxymethamphetamine [mass/volume] in blood,mdma bld-mcnc,methylenedioxymethamphetamine (bld) [mass/vol],addiction; blood; drug/toxicology; drugs; drugs of abuse; ecstasy; illicit; level; mass concentration; mdma; point in time; potentialforabuse; qnt; quan; quant; quantitative; random; wb; whole blood,Qn
18366-5,cytochrome c oxidase [enzymatic activity/mass] in tissue,cyc oxidase tiss-ccnt,cytochrome c oxidase (tiss) [catalytic activity/mass],"catalytic content; chemistry; cox; cyc oxidase; cyt; point in time; qnt; quan; quant; quantitative; random; tissue; tissue, unspecified",Qn
18369-9,magnesium [moles/time] in 4 hour urine,magnesium 4h ur-srate,magnesium (4 hour u) [moles/time],240 minutes; 4 hours; 4.0hr; 4hr; chemistry; mag; magnes; mg; qnt; quan; quant; quantitative; srate; substance rate; ua; ur; urn,Qn
18378-0,transcortin [mass/volume] in cerebral spinal fluid,transcortin csf-mcnc,transcortin (csf) [mass/vol],cbg; cerebral spinal fluid; cerebrospinal fl; chemistry; corticosteroid binding globulin; cortisol binding globulin; level; mass concentration; point in time; qnt; quan; quant; quantitative; random; spinal fl; spinal fld; spinal flu; spinal fluid,Qn
18385-5,butalbital [presence] in urine by confirmatory method,butalbital ur ql cfm,butalbital confirm ql (u),addiction; allylbarbital; allylbarbituric acid; barbiturate; cfm; cnfr; cnfrm; conf; confirmation; confirmatory; drug/toxicology; drugs; drugs of abuse; fiorinal; gcms; illicit; lc/ms/ms; ordinal; point in time; potentialforabuse; pr; ql; qual; qualitative; random; screen; ua; ur; urn,Ord
18386-3,chlorothiazide [presence] in serum or plasma,chlorothiazide serpl ql,chlorothiazide ql,diuril; drug/toxicology; drugs; ordinal; pl; plasma; plsm; point in time; pr; ql; qual; qualitative; random; screen; serp; serpl; serplas; serum; serum or plasma; sr,Ord
18394-7,hla-a24(9) [presence],hla-a24(9) ql,hla-a24(9) ql (bld/tiss),"blood; genetics; heredity; heritable; hla antigen; human leukocyte antigen; inherited; ordinal; point in time; pr; ql; qual; qualitative; random; screen; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",Ord
18401-0,spermatozoa igg ab [units/volume] in cervical mucus,sperm igg cerv mucus-acnc,spermatozoa igg qn (cervical mucus),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; cerv mucus; cervical mucus; fertility testing; genital tract; immune globulin g; immunoglobulin g; point in time; qnt; quan; quant; quantitative; random; sperm,Qn
18406-9,arsenic trioxide [mass/volume] in urine,arsenic trioxide ur-mcnc,arsenic trioxide (u) [mass/vol],as; drug/toxicology; drugs; level; mass concentration; point in time; qnt; quan; quant; quantitative; random; ua; ur; urn,Qn
1840-8,ammonia [moles/volume] in cerebral spinal fluid,ammonia csf-scnc,ammonia (csf) [moles/vol],amm; ammon; amon; cerebral spinal fluid; cerebrospinal fl; chemistry; level; neuro; neurology; nh3; point in time; qnt; quan; quant; quantitative; random; spinal fl; spinal fld; spinal flu; spinal fluid; substance concentration,Qn
18409-3,curvularia lunata igg ab [units/volume] in serum,c lunata igg qn,curvularia lunata igg qn (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; c lunata; culvularia lunata; immune globulin g; immunoglobulin g; m16; point in time; qnt; quan; quant; quantitative; random; serum; sr,Qn
18420-0,chaetomium globosum igg ab [units/volume] in serum,c globosum igg qn,chaetomium globosum igg qn (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; c globosum; immune globulin g; immunoglobulin g; m208; point in time; qnt; quan; quant; quantitative; random; rm208; serum; sr,Qn
18446-5,methylmalonylcarnitine (c4-dc) [mass/volume] in serum or plasma,me-malonylcarn serpl-mcnc,c4-dc [mass/vol],c4dc; c4-dc; c4-dcc; chemistry; dicarboxylic carnitine; level; mass concentration; me-malonylcarn; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
18452-3,decanoylcarnitine (c10) [mass/volume] in serum or plasma,decanoylcarn serpl-mcnc,c10 [mass/vol],c10; chemistry; level; mass concentration; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
18455-6,dodecanoylcarnitine (c12) [mass/volume] in serum or plasma,dodecanoylcarn serpl-mcnc,c12 [mass/vol],c12; chemistry; level; mass concentration; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
18458-0,3-hydroxytetradecadienoylcarnitine (c14:2-oh) [mass/volume] in serum or plasma,3oh-tdecadienoylcar serpl-mcnc,3-hydroxytetradecadienoylcarnitine (c14:2-oh) [mass/vol],3-hydroxy-tetradecadienoylcarnitine; 3oh-tdecadienoylcar; c14:2oh; chemistry; ii; iii; level; mass concentration; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
18462-2,linoleoylcarnitine (c18:2) [mass/volume] in serum or plasma,linoleoylcarn serpl-mcnc,c18:2 [mass/vol],c18:2; chemistry; ii; level; linoleylcarnitine; mass concentration; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
18472-1,organophosphate pesticides [identifier] in urine,op pesticides ur,organophosphate pesticides nom (u),drug/toxicology; drugs; identity or presence; nominal; op pesticides; point in time; random; ua; ur; urn,Nom
18478-8,human papilloma virus 16+18 dna [presence] in tissue by probe,hpv16+18 dna tiss ql probe,hpv 16+18 dna probe ql (tiss),"deoxyribonucleic acid; dna nucleic acid probe; dna probe; genital warts; hpv; hpv16; hpv16 and 18; hpv16 and 18 dna; hpv16+18; human papillomavirus; id; infectious disease; infectiousdisease; microbiology; ordinal; papilloma virus high risk; point in time; pr; ql; qual; qualitative; random; screen; tissue; tissue, unspecified",Ord
18479-6,human papilloma virus 31+35+51 dna [presence] in tissue by probe,hpv31+35+51 dna tiss ql probe,hpv 31+35+51 dna probe ql (tiss),"deoxyribonucleic acid; dna nucleic acid probe; dna probe; genital warts; hpv; hpv31; hpv31+35+51; human papillomavirus; id; infectious disease; infectiousdisease; microbiology; ordinal; papilloma virus high risk; point in time; pr; ql; qual; qualitative; random; screen; tissue; tissue, unspecified",Ord
18498-6,microscopic observation [identifier] in breast fine needle aspirate by cyto stain,cyto breast fna,microscopic observation cyto stain nom (breast fine needle aspirate),breast fna; brst; cytology; cytology stain; cytostain; fine needle; identity or presence; nominal; pap smear; pap stain; papanicolaou smear; point in time; random; st; stains; stn,Nom
18523-1,p-r interval lead i,p-r interval l-i,,cardio; cardiology; ecg; ekg.measurements; electrocardiogram; electrocardiograph; heart disease; l-i; point in time; p-r interval; qnt; quan; quant; quantitative; random,Qn
1854-9,androstenedione [mass/volume] in serum or plasma,androst serpl-mcnc,androstenedione [mass/vol],chemistry; gamma-4-androstenedione; level; mass concentration; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; universallaborders,Qn
18555-3,st amplitude.j point+20 ms lead v6,j pnt st amp+20ms l-v6,,cardio; cardiology; ecg; ekg.measurements; electrical potential; electrocardiogram; electrocardiograph; heart disease; j pnt st amp+20ms; l-v6; point in time; qnt; quan; quant; quantitative; random; voltage,Qn
18570-2,st amplitude.j point+80 ms lead avr,j pnt st amp+80ms l-avr,,cardio; cardiology; ecg; ekg.measurements; electrical potential; electrocardiogram; electrocardiograph; heart disease; j pnt st amp+80ms; l-avr; point in time; qnt; quan; quant; quantitative; random; voltage,Qn
18619-7,discharge medication dose,,,attach; attach.meds; disch; med; meds; point in time; qnt; quan; quant; quantitative; random,Qn
18623-9,"discharge medication, refills",,,attach; attach.meds; cnt; count; disch; med; meds; number; point in time; qnt; quan; quant; quantitative; random,Qn
18642-9,"psychiatric rehabilitation treatment plan, date range (from/through) set",,,attach; attach.rehab; attach.rehab.psych; complex; encounter; mental health; mentalhealth; psych; psychiatric rehabilitation tx; psychiatric rehabilitation tx plan; psychiatry; rehabilitation tx plan; rehabtx; rnge; tx; tx plan,Set
1865-5,anserine [presence] in serum or plasma,anserine serpl ql,anserine ql,beta -alanyl-n-methylhistidine; chemistry; ordinal; pl; plasma; plsm; point in time; pr; ql; qual; qualitative; random; screen; serp; serpl; serplas; serum; serum or plasma; sr,Ord
18668-4,"deprecated alcohol-substance abuse rehabilitation treatment plan, frequency of assessments for follow up #",deprecated,,alc; alcoholic; alcohol-substance abuse rehabilitation tx; alcohol-substance abuse rehabilitation tx plan; attach; attach.rehab; attach.rehab.psych; cnt; count; follow-up; mental health; mentalhealth; number; point in time; psych; psychiatry; qnt; quan; quant; quantitative; random; rehabilitation tx plan; rehabtx; subs; tx; tx plan,Qn
186-7,ciprofloxacin [susceptibility] by disk diffusion (kb),ciprofloxacin islt kb,ciprofloxacin disk diffusion (kb) [susc],antibiotic susceptibilities; ast; c250; c307; c81; ciloxan; cipro; ciprofloxacn; ciprofloxin; disk diffusion; id; infectious disease; infectiousdisease; islt; isol; kb; kirby-bauer; point in time; random; sus; suscept; susceptibilities; susceptibility; susceptibilty,OrdQn
18675-9,"alcohol-substance abuse rehabilitation treatment plan, abused substance",,,attach; attach.rehab; attach.rehab.abuse; narrative; point in time; random; report; subs; typ,Nar
18682-5,ambulance records,ambulance records,,doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; notes; point in time; random; visit note,Doc
18700-5,ed practitioner name,,,attach; attach.ed; deeds; ed pract name; emergency department; emergency department (deeds); nominal; person name; point in time; random,Nom
18701-3,ed practitioner profession,,,attach; attach.ed; deeds; ed pract profession; emergency department; emergency department (deeds); nominal; point in time; random; typ,Nom
18702-1,ed practitioner role,,,attach; attach.ed; deeds; ed pract role; emergency department; emergency department (deeds); nominal; point in time; random; typ,Nom
18734-4,occupational therapy initial evaluation note,ot initial eval note,,assessment; doc.ont; document; encounter; eval; eval note; evaluation and management; evaluation and management note; finding; findings; h&p; history and physical; initial eval note; notes; point in time; random; visit note,Doc
1873-9,apolipoprotein b-48 [mass/volume] in serum or plasma,apo b48 serpl-mcnc,apolipoprotein b-48 [mass/vol],apo; apo b; apo b48; apob; apolipo; apolipoprot; apolipoproteins; chemistry; level; mass concentration; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
18741-9,deprecated attending physician progress note,,,assessment; attach; attach.clinrpt; document; encounter; eval; eval note; evaluation and management; evaluation and management note; finding; findings; h&p; history and physical; m.d.; md; notes; point in time; random; visit note,Doc
18743-5,autopsy report,autopsy report,,doc.ont; document; finding; findings; point in time; random,Doc
1875-4,apolipoprotein c-i [mass/volume] in serum or plasma,apo c-i serpl-mcnc,apolipoprotein c-i [mass/vol],apo; apo c; apo c-i; apolipo; apolipoprot; apolipoprotein c1; apolipoproteins; chemistry; level; mass concentration; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
18757-5,deprecated nuclear medicine study,deprecated,,attach; attach.clinrpt; document; finding; findings; misc; miscellaneous; nuclear medicine; other; point in time; radionuclide scan; random; ri; scintigraphy; spec; study report; to be specified in another part of the message; unspecified,Doc
18758-3,deprecated pet scan unspecified system study,deprecated,,attach; attach.clinrpt; document; finding; findings; misc; miscellaneous; other; point in time; position emmision tomography; position emmission topography; random; spec; study report; to be specified in another part of the message; unspecified,Doc
18779-9,radiology comparison study - date and time,,,attach; attach.clinrpt; compare; comparison study; date and time; misc; miscellaneous; other; point in time; qnt; quan; quant; quantitative; rad; radiology; random; spec; study report; time stamp; timestamp; to be specified in another part of the message; unspecified,Qn
18794-8,send all items of the specified type within the time window,,,attach; attach.modifier; point in time; random,-
18795-5,send all items of the specified type within the time window relevant to the service,,,attach; attach.modifier; point in time; random,-
18804-5,include all data of the selected type that represents observations made 3 months or fewer before the starting date of service,,,attach; attach.modifier; point in time; random,-
18813-6,"ambulance transport, ordering practitioner name",,,attach; attach.amb; nominal; person name; point in time; random,Nom
1883-8,apolipoprotein a [mass/volume] in serum or plasma,apo a serpl-mcnc,apolipoprotein a [mass/vol],apo; apo a; apolipo; apolipoprot; apolipoproteins; cardio; cardiology; chemistry; heart disease; level; mass concentration; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
18850-8,narrative fetal presentation us,fet pres us,,echography; fet pres; gyn; gynecology; narrative; ob; obgyn; obsterical; obsterical.ultrasound; obstetrical; obstetrics; pelvic; point in time; random; report; sonogram; sonograph; sonography; typ; uls; ultrasound,Nar
18857-3,almecillin [susceptibility],almecillin susc islt,almecillin [susc],antibiotic susceptibilities; ast; id; infectious disease; infectiousdisease; islt; isol; point in time; random; sus; suscept; susceptibilities; susceptibility; susceptibilty,OrdQn
18878-9,cefazolin [susceptibility],cefazolin susc islt,cefazolin [susc],ancef; antibiotic susceptibilities; ast; c32; cefamezin; id; infectious disease; infectiousdisease; islt; isol; kefj; kefzol; point in time; random; sus; suscept; susceptibilities; susceptibility; susceptibilty; totacef; zolicef,OrdQn
18881-3,cefmetazole [susceptibility],cefmetazole susc islt,cefmetazole [susc],antibiotic susceptibilities; ast; cefmetazon; cemetol; id; infectious disease; infectiousdisease; islt; isol; point in time; random; sus; suscept; susceptibilities; susceptibility; susceptibilty; zefazone,OrdQn
1889-5,arachidonate (c20:4w6) [mass/volume] in serum or plasma,aa serpl-mcnc,arachidonate (c20:4w6) [mass/vol],"5,8,11,14 eicosatetraenoic acid; aa; arachidonic acid; arch acid; c20:4w6; chemistry; eicosatetraenoate; level; mass concentration; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr",Qn
18897-9,cephalexin [susceptibility],cephalexin susc islt,cephalexin [susc],antibiotic susceptibilities; ast; cefadine; gracef; id; infectious disease; infectiousdisease; islt; isol; keflex; losporal; palitrex; point in time; random; salitex; sus; suscept; susceptibilities; susceptibility; susceptibilty,OrdQn
18904-3,chlortetracycline [susceptibility],chlortetracycline susc islt,chlortetracycline [susc],antibiotic susceptibilities; ast; aureomycin; id; infectious disease; infectiousdisease; islt; isol; point in time; random; sus; suscept; susceptibilities; susceptibility; susceptibilty,OrdQn
18905-0,cinoxacin [susceptibility],cinoxacin susc islt,cinoxacin [susc],antibiotic susceptibilities; ast; azolinic acid; cinobac; cinobactin; id; infectious disease; infectiousdisease; islt; isol; nofrin; nossacin; point in time; random; sus; suscept; susceptibilities; susceptibility; susceptibilty; uronorm; uroxacin,OrdQn
18920-9,erythromycin+sulfisoxazole [susceptibility],erythro+sulf susc islt,erythromycin+sulfisoxazole [susc],antibiotic susceptibilities; ast; c212; co-erynsulfisox for oral suspension; ees; erygel; erythro+sulf; erythromycn; eryzole; esp; gantrisin; id; ilosone; ilotycin; iltycin; infectious disease; infectiousdisease; islt; isol; pediazole; point in time; random; sulfizole; sus; suscept; susceptibilities; susceptibility; susceptibilty,OrdQn
18938-1,lincomycin [susceptibility],lincomycin susc islt,lincomycin [susc],albiotic; antibiotic susceptibilities; ast; c115; cillimicina; cillimycin; id; infectious disease; infectiousdisease; islt; isol; lincocin; lincocine; point in time; random; sus; suscept; susceptibilities; susceptibility; susceptibilty,OrdQn
1896-0,argininosuccinate [mass/volume] in serum or plasma,argininosuccinate serpl-mcnc,argininosuccinate [mass/vol],argininosuccinic acid; arginosuccinate; arginosuccinic acid; asa; chemistry; level; mass concentration; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
18966-2,penicillin v [susceptibility],penicillin v susc islt,penicillin v [susc],antibiotic susceptibilities; ast; c2; id; infectious disease; infectiousdisease; islt; isol; pcn; pen; penicilloyl; phenoxymethylpenicillin; point in time; random; sus; suscept; susceptibilities; susceptibility; susceptibilty; wycillin,OrdQn
18973-8,pyrazinamide [susceptibility],pza susc islt,pyrazinamide [susc],antibiotic susceptibilities; ast; id; infectious disease; infectiousdisease; islt; isol; point in time; pza; random; sus; suscept; susceptibilities; susceptibility; susceptibilty,OrdQn
18974-6,rifampin [susceptibility],rifampin susc islt,rifampin [susc],antibiotic susceptibilities; ast; c301; id; infectious disease; infectiousdisease; islt; isol; point in time; random; rif; rifadin; rifampicin; rimactane; sus; suscept; susceptibilities; susceptibility; susceptibilty,OrdQn
18975-3,ristocetin [susceptibility],ristocetin susc islt,ristocetin [susc],antibiotic susceptibilities; ast; id; infectious disease; infectiousdisease; islt; isol; point in time; random; sus; suscept; susceptibilities; susceptibility; susceptibilty,OrdQn
18994-4,ticarcillin [susceptibility],ticarcillin susc islt,ticarcillin [susc],antibiotic susceptibilities; ast; id; infectious disease; infectiousdisease; islt; isol; point in time; random; sus; suscept; susceptibilities; susceptibility; susceptibilty; ticar; timentin; timj,OrdQn
19001-7,viomycin [susceptibility],viomycin susc islt,viomycin [susc],antibiotic susceptibilities; ast; id; infectious disease; infectiousdisease; islt; isol; point in time; random; sus; suscept; susceptibilities; susceptibility; susceptibilty; tuberactinomycin b,OrdQn
19004-1,deprecated skilled nursing service attachment,deprecated,,attach.rehab; document; finding; findings; point in time; random,Doc
1902-6,ascorbate [mass/volume] in blood,vit c bld-mcnc,ascorbate (bld) [mass/vol],ascorbic acid; blood; c702; chemistry; level; mass concentration; point in time; qnt; quan; quant; quantitative; random; vit c; vitamin c; wb; whole blood,Qn
19087-6,collection of urine specimen end time,collect end tme ur,collection end time (u) [date/time],coll; collect; collect end tme; collected; date and time; point in time; qnt; quan; quant; quantitative; random; spec; time stamp; timestamp; ua; ur; urn,Qn
19111-4,mother's hospital number,mother's hospital #,,admin; hosp; hospital #; ident; identifier; intradermal; mat; maternal; matnl; no; nominal; num; point in time; random,Nom
19114-8,lamellar bodies [#/volume] in amniotic fluid,lamellar bod # amn,lamellar bodies (amn fld) [#/vol],#; abs; absolute; absolutes; af; amn; amn fl; amnio; amniotic flu; amniotic fluid; bod; body; cnt; count; count/volume; ct; fetal lung maturity; hematology/cell counts; keratinosomes; lbc; number concentration; number concentration (count/vol); odland bodies; point in time; qnt; quan; quant; quantitative; random,Qn
19125-4,meconium [presence] in amniotic fluid,meconium amn ql,meconium ql (amn fld),af; amn; amn fl; amnio; amniotic flu; amniotic fluid; chemistry; ordinal; point in time; pr; ql; qual; qualitative; random; screen,Ord
19126-2,bacteria identified in bone marrow by aerobe culture,bacteria mar aerobe cult,bacteria identified aer cx nom (bm),aerobe; aerobe cult; aerobed; bact; bm; bon; bone marrow; c&s; cult; cultures; id; identity or presence; infectious disease; infectiousdisease; mar; marrow (bone); microbiology; minimal angle of resolution; minimum angle of resolution; nominal; point in time; random; universallaborders,Nom
1913-3,aspartate [mass/volume] in serum or plasma,aspartate serpl-mcnc,aspartate [mass/vol],asp; aspartic acid; chemistry; level; mass concentration; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
19157-7,tube number of cerebral spinal fluid,tube # csf,tube number nom (csf) [id],cerebral spinal fluid; cerebrospinal fl; ident; identifier; no; nominal; num; point in time; random; spec; spinal fl; spinal fld; spinal flu; spinal fluid; tube #,Nom
19177-5,alpha-1-fetoprotein [moles/volume] in serum or plasma,afp serpl-scnc,afp [moles/vol],a1; afp; alfa; alpha fetoprotein; alphafetoprotein; chemistry; feto; i; level; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; substance concentration; tumor marker,Qn
19179-1,choriogonadotropin.beta subunit free [moles/volume] in amniotic fluid,b-hcg free amn-scnc,free beta hcg (amn fld) [moles/vol],af; amn; amn fl; amnio; amniotic flu; amniotic fluid; b; b hcg; beta hcg; beta human chorionic gonadotropin; b-hcg; b-hcg free; cg; chemistry; choriogonadotropin beta chain; choriogonadotropins total; chorionic gonadotropin; fr; hcg; human chorionic gonadotropin; level; non-protein bound; point in time; qnt; quan; quant; quantitative; random; substance concentration; tumor marker,Qn
19184-1,tissue polypeptide specific ag [units/volume] in serum or plasma,tps ag serpl-acnc,tissue polypeptide specific ag qn,antigen; antigens; arbitrary concentration; chemistry; cytokeratin 18+19; pl; plasma; plsm; point in time; polypeptides; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; spec; sr; tiss polypept; tps; tumor marker,Qn
19205-4,prostate specific ag free [mass/volume] in semen,psa free smn-mcnc,free psa (sem) [mass/vol],chemistry; ejaculate; fpsa; fr; genitourinary; gu; kallikrein 3; level; mass concentration; non-protein bound; oncology; p-30 antigen; point in time; ps; psa; psa free; qnt; quan; quant; quantitative; random; sem; seminal fluid; seminin; smn; smpls; spec; tumor marker; uro; urology,Qn
19207-0,squamous cell carcinoma ag [units/volume] in serum or plasma,scc ag serpl-acnc,squamous cell carcinoma ag qn,antigen; antigens; arbitrary concentration; chemistry; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; scc; serp; serpl; serplas; serum; serum or plasma; sq; squamous cell associated; sr; tumor marker,Qn
19208-8,squamous cell carcinoma ag [moles/volume] in serum or plasma,scc ag serpl-scnc,squamous cell carcinoma ag [moles/vol],antigen; antigens; chemistry; level; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; scc; serp; serpl; serplas; serum; serum or plasma; sq; squamous cell associated; sr; substance concentration; tumor marker,Qn
19216-1,oxygen [partial pressure] saturation adjusted to 0.5 in venous blood,po2 satn adj to 0.5 bldv,oxygen saturation adjusted to 0.5 (bldv) [partial pressure],adj; bld ven; bld venous; blood - venous; blood ven; blood venus; chemistry; lung; o2; o2 partial pressure; p50; partial pressure; po2; point in time; pulmonary; pulmonology; qnt; quan; quant; quantitative; random; respiratory; sao2; sat; satn; satn adj to 0.5; so2; to2; venous,Qn
19225-2,deoxyhemoglobin/hemoglobin.total in arterial blood,do-hgb mfr blda,deoxyhemoglobin (blda) [mass fraction],abg; art; art bld; art blood; arterial; arterial blood; blood arterial; deoxygenated hemoglobin; deoxyhaemoglobin; do-hgb; ferrohaemoglobin; ferrohemoglobin; haemoglobin; hb; hematology/cell counts; hgb; hhb; mass fraction; percent; point in time; qnt; quan; quant; quantitative; random; reduced hemoglobin; rhb; tot; totl,Qn
19235-1,base excess standard in arterial blood by calculation,base excess std blda calc-scnc,base excess standard calc (blda) [moles/vol],abe; abg; art; art bld; art blood; arterial; arterial blood; base ex; be; blood arterial; bse; calc; calculation; chemistry; exs; level; lung; point in time; pulmonary; pulmonology; qnt; quan; quant; quantitative; random; respiratory; sbe; std; substance concentration,Qn
19238-5,base excess standard in mixed venous blood by calculation,base excess std bldmv calc-scnc,base excess standard calc (bldmv) [moles/vol],base ex; be; bld mixed venous; blood - mixed venous; bse; calc; calculation; chemistry; exs; level; lung; point in time; pulmonary; pulmonology; qnt; quan; quant; quantitative; random; respiratory; sbe; std; substance concentration,Qn
19265-8,amphetamines [identifier] in urine by confirmatory method,amphetamines pos ur cfm,amphetamines pos confirm nom (u),amph; amphetam; amphetamine; cfm; cnfr; cnfrm; conf; confirmation; confirmatory; drug/toxicology; drugs; gcms; identity or presence; lc/ms/ms; nominal; point in time; pos; random; speed; ua; ur; urn,Nom
19266-6,amphetamines cutoff [mass/volume] in urine for screen method,amphetamines cto ur scn-mcnc,amphetamines cutoff screen (u) [mass/vol],amph; amphetam; amphetamine; cto; drug/toxicology; drugs; level; mass concentration; point in time; qnt; quan; quant; quantitative; random; scn; scr; scrn; speed; ua; ur; urn,Qn
19269-0,amphetamines confirm method [identifier] in urine,amphetamines cfm meth ur,amphetamines confirm method nom (u),amph; amphetam; amphetamine; amphetamines cfm meth; cfm meth; drug/toxicology; drugs; identity or presence; meth; method of; nominal; point in time; random; speed; ua; ur; urn,Nom
19271-6,barbiturates tested for in urine by screen method nominal,barbiturates tested ur scn,barbiturates tested screen nom (u),barb; barbiturate; barbs; drug/toxicology; drugs; identity or presence; nominal; point in time; random; scn; scr; scrn; ua; ur; urn,Nom
19277-3,barbiturates screen method [identifier] in urine,barbiturates scn meth ur,barbiturates screen method nom (u),barb; barbiturate; barbiturates scn meth; barbs; drug/toxicology; drugs; identity or presence; meth; method of; nominal; point in time; random; scn; scn meth; scr; scrn; ua; ur; urn,Nom
19301-1,opiates screen method [identifier] in urine,opiates scn meth ur,opiates screen method nom (u),drug/toxicology; drugs; heroin; identity or presence; meth; method of; nominal; op; opi; opiate; opiates scn meth; point in time; random; scn; scn meth; scr; scrn; ua; ur; urn,Nom
19304-5,thiazides tested for in urine by screen method nominal,thiazides tested ur scn,thiazides tested screen nom (u),drug/toxicology; drugs; identity or presence; nominal; point in time; random; scn; scr; scrn; ua; ur; urn,Nom
19322-7,6-monoacetylmorphine (6-mam) [presence] in urine by confirmatory method,6mam ur ql cfm,6-monoacetylmorphine (6-mam) confirm ql (u),6 mam; 6 mono acetyl morphine; 6-acetylmorphine; 6mam; acetylmorphine; addiction; cfm; cnfr; cnfrm; conf; confirmation; confirmatory; drug/toxicology; drugs; drugs of abuse; gcms; heroin metabolite; illicit; lc/ms/ms; mam; ordinal; point in time; potentialforabuse; pr; ql; qual; qualitative; random; screen; ua; ur; urn,Ord
19330-0,alpha hydroxyalprazolam cutoff [mass/volume] in urine for confirmatory method,a-oh alpraz cto ur cfm-mcnc,alpha hydroxyalprazolam cutoff confirm (u) [mass/vol],alfa; alpha hydroxy alprazolam; alprozolam metabolite; a-oh alpraz; cfm; cnfr; cnfrm; conf; confirmation; confirmatory; cto; drug/toxicology; drugs; gcms; hydroxy alprazolam; hydroxyalpraz; lc/ms/ms; level; mass concentration; oh-alpraz; point in time; qnt; quan; quant; quantitative; random; ua; ur; urn,Qn
19353-2,barbital [presence] in urine by screen method,barbital ur ql scn,barbital screen ql (u),addiction; barbitone; barbiturate; diethylmalonylurea; drug/toxicology; drugs; drugs of abuse; illicit; megal; neurinase; ordinal; pneumogeine-barbital; point in time; potentialforabuse; pr; provervon n; ql; qual; qualitative; random; scn; scr; screen; scrn; ua; ur; urn; veraine buriat; veronal; vitanerton n kerne,Ord
19378-9,butorphanol [presence] in urine by confirmatory method,butorphanol ur ql cfm,butorphanol confirm ql (u),addiction; cfm; cnfr; cnfrm; conf; confirmation; confirmatory; drug/toxicology; drugs; drugs of abuse; gcms; illicit; lc/ms/ms; ordinal; point in time; potentialforabuse; pr; ql; qual; qualitative; random; screen; stadol; ua; ur; urn,Ord
19396-1,chlorpromazine [presence] in urine by confirmatory method,chlorpromazine ur ql cfm,chlorpromazine confirm ql (u),cfm; chlopromazine; chlorpromaz; cnfr; cnfrm; conf; confirmation; confirmatory; drug/toxicology; drugs; gcms; lc/ms/ms; ordinal; point in time; pr; ql; qual; qualitative; random; screen; thorazine; ua; ur; urn,Ord
1939-8,beta fructofuranosidase [enzymatic activity/volume] in serum,b-fructofuranosidase ser-ccnc,beta fructofuranosidase (s) [catalytic activity/vol],b; beta fructosidase; b-fructofuranosidase; catalytic concentration; chemistry; point in time; qnt; quan; quant; quantitative; random; saccharase; serum; sr,Qn
194-1,clindamycin [susceptibility] by disk diffusion (kb),clindamycin islt kb,clindamycin disk diffusion (kb) [susc],antibiotic susceptibilities; ast; c306; cleocin; clij; dalacin; disk diffusion; id; infectious disease; infectiousdisease; islt; isol; kb; kirby-bauer; point in time; random; sobelin; sus; suscept; susceptibilities; susceptibility; susceptibilty; topical,OrdQn
19410-0,cocaethylene cutoff [mass/volume] in urine for confirmatory method,cocaethylene cto ur cfm-mcnc,cocaethylene cutoff confirm (u) [mass/vol],cfm; cnfr; cnfrm; cocaine/ethanol by-product; conf; confirmation; confirmatory; cto; drug/toxicology; drugs; gcms; lc/ms/ms; level; mass concentration; point in time; qnt; quan; quant; quantitative; random; ua; ur; urn,Qn
19411-8,codeine [presence] in urine by screen method,codeine ur ql scn,codeine screen ql (u),addiction; c260; c300; drug/toxicology; drugs; drugs of abuse; illicit; methylmorphine; morphine methyl ether; ordinal; point in time; potentialforabuse; pr; ql; qual; qualitative; random; scn; scr; screen; scrn; ua; ur; urn,Ord
19417-5,tetrahydrocannabinol cutoff [mass/volume] in urine for screen method,thc cto ur scn-mcnc,tetrahydrocannabinol cutoff screen (u) [mass/vol],cto; delta(9)-thc; delta-9-tetrahydrocannabinol; dronabinol; drug/toxicology; drugs; level; marijuana; mass concentration; nabilone; point in time; qnt; quan; quant; quantitative; random; scn; scr; scrn; thc; ua; ur; urn,Qn
19418-3,tetrahydrocannabinol cutoff [mass/volume] in urine for confirmatory method,thc cto ur cfm-mcnc,tetrahydrocannabinol cutoff confirm (u) [mass/vol],cfm; cnfr; cnfrm; conf; confirmation; confirmatory; cto; delta(9)-thc; delta-9-tetrahydrocannabinol; dronabinol; drug/toxicology; drugs; gcms; lc/ms/ms; level; marijuana; mass concentration; nabilone; point in time; qnt; quan; quant; quantitative; random; thc; ua; ur; urn,Qn
19436-5,propoxyphene + norpropoxyphene [mass/volume] in urine,propoxyph+nor ur-mcnc,propoxyphene+norpropoxyphene (u) [mass/vol],algaphan; cosalgesic; cotonal-65; darvon; depronal; dextrogesic; dextropropoxyphene; distalgesic; dolasan; doloxene; d-propoxyphene; drug/toxicology; drugs; level; mass concentration; napsalgesic; n-desmethylproproxyphene; norpropoxyp; point in time; propoxyph+nor; propoxyphene metabolite; qnt; quan; quant; quantitative; random; ua; ur; urn,Qn
19441-5,diamorphine cutoff [mass/volume] in urine for screen method,dam cto ur scn-mcnc,diamorphine cutoff screen (u) [mass/vol],cto; dam; diacetyl morphine; drug/toxicology; drugs; heroin; level; mass concentration; point in time; qnt; quan; quant; quantitative; random; scn; scr; scrn; ua; ur; urn,Qn
19461-3,ethylamphetamine cutoff [mass/volume] in urine for confirmatory method,ethylamphet cto ur cfm-mcnc,ethylamphetamine cutoff confirm (u) [mass/vol],cfm; cnfr; cnfrm; conf; confirmation; confirmatory; cto; drug/toxicology; drugs; gcms; lc/ms/ms; level; mass concentration; point in time; qnt; quan; quant; quantitative; random; ua; ur; urn,Qn
19463-9,ethylmorphine [presence] in urine by confirmatory method,emp ur ql cfm,ethylmorphine confirm ql (u),addiction; cfm; cnfr; cnfrm; codethyline; collins elixir; conf; confirmation; confirmatory; dionina; drug/toxicology; drugs; drugs of abuse; emp; gcms; illicit; lc/ms/ms; ordinal; point in time; potentialforabuse; pr; ql; qual; qualitative; random; screen; ua; ur; urn,Ord
19472-0,fluoxetine cutoff [mass/volume] in urine for screen method,fluoxetine cto ur scn-mcnc,fluoxetine cutoff screen (u) [mass/vol],cto; drug/toxicology; drugs; level; mass concentration; point in time; prozac; qnt; quan; quant; quantitative; random; scn; scr; scrn; ua; ur; urn,Qn
19488-6,hydromorphone cutoff [mass/volume] in urine for confirmatory method,hydromorphone cto ur cfm-mcnc,hydromorphone cutoff confirm (u) [mass/vol],cfm; cnfr; cnfrm; conf; confirmation; confirmatory; cto; dihydromorphinone; dilaudid; drug/toxicology; drugs; gcms; hydromorphinone; lc/ms/ms; level; mass concentration; point in time; qnt; quan; quant; quantitative; random; ua; ur; urn,Qn
19502-4,methotrimeprazine [presence] in urine by screen method,methotrimeprazine ur ql scn,methotrimeprazine screen ql (u),drug/toxicology; drugs; hirnamin; lepurin; lerium; levamin; levohalte; levomazine; levomeprazine; levomeproma; levomepromazin; levomepromazina; levomepromazine; levomezine; levonormal; levopromazine; levoprome; levotomin; levozan; levozin; methotrimeprazine; milezin; minozinan; neozine; neuractil; neurocil; neurozil; novo-meprazine; nozinan; ordinal; point in time; pr; procrazine; ql; qual; qualitative; random; ronexine; scn; scr; screen; scrn; sinogan; sofmin; specia 246; tisercin; tisercine; tisercinetta; tisercinettes; ua; ur; urn; veractil,Ord
19543-8,mescaline [presence] in urine by confirmatory method,mescaline ur ql cfm,mescaline confirm ql (u),cfm; cnfr; cnfrm; conf; confirmation; confirmatory; drug/toxicology; drugs; gcms; lc/ms/ms; ordinal; peyote; peyotl; point in time; pr; ql; qual; qualitative; random; screen; ua; ur; urn,Ord
19550-3,methadone [presence] in urine by screen method,methadone ur ql scn,methadone screen ql (u),addiction; dolophin; dolophine; drug/toxicology; drugs; drugs of abuse; illicit; metd; methadose; mtd; ordinal; point in time; potentialforabuse; pr; ql; qual; qualitative; random; scn; scr; screen; scrn; ua; universallaborders; ur; urn,Ord
19578-4,methylphenidate [presence] in urine by confirmatory method,me-phenidate ur ql cfm,methylphenidate confirm ql (u),addiction; cfm; cnfr; cnfrm; conf; confirmation; confirmatory; drug/toxicology; drugs; drugs of abuse; gcms; illicit; lc/ms/ms; me-phenidate; ordinal; point in time; potentialforabuse; pr; ql; qual; qualitative; random; ritalin; screen; ua; ur; urn,Ord
19579-2,methylphenidate cutoff [mass/volume] in urine for screen method,me-phenidate cto ur scn-mcnc,methylphenidate cutoff screen (u) [mass/vol],cto; drug/toxicology; drugs; level; mass concentration; me-phenidate; point in time; qnt; quan; quant; quantitative; random; ritalin; scn; scr; scrn; ua; ur; urn,Qn
19581-8,methyprylon [presence] in urine by screen method,methyprylon ur ql scn,methyprylon screen ql (u),drug/toxicology; drugs; methprylon; noludar; ordinal; point in time; pr; ql; qual; qualitative; random; scn; scr; screen; scrn; ua; ur; urn,Ord
19594-1,deprecated monoacetylmorphine [mass/volume] in urine,deprecated 6mam ur-mcnc,6-monoacetylmorphine (6-mam) (u) [mass/vol],6 mam; 6 mono acetyl morphine; 6-acetylmorphine; 6mam; acetylmorphine; addiction; drug/toxicology; drugs; drugs of abuse; heroin metabolite; illicit; level; mam; mass concentration; point in time; potentialforabuse; qnt; quan; quant; quantitative; random; ua; ur; urn,Qn
19624-6,nordiazepam [presence] in urine by screen method,nordiazepam ur ql scn,nordiazepam screen ql (u),calmday; chlordiazepoxide metabolite; desmethyldiazepam; diazepam metabolite; dimethyldiazepam; drug/toxicology; drugs; madar; n-dimethyldiazepam; nordaz; nordazepam; nordiaze; ordinal; point in time; pr; praxadium; prazepam metabolite; ql; qual; qualitative; random; scn; scr; screen; scrn; stilny; tranxilium n; ua; ur; urn; vegesan,Ord
19629-5,norfluoxetine [presence] in urine by confirmatory method,norfluoxetine ur ql cfm,norfluoxetine confirm ql (u),(s)-norfluoxetine; cfm; cnfr; cnfrm; conf; confirmation; confirmatory; desmethylfluoxetine; drug/toxicology; drugs; fluoxetine metabolite; gcms; lc/ms/ms; norfluoxetin; ordinal; point in time; pr; ql; qual; qualitative; random; screen; seproxetine; ua; ur; urn,Ord
19642-8,oxycodone [presence] in urine by screen method,oxycodone ur ql scn,oxycodone screen ql (u),addiction; drug/toxicology; drugs; drugs of abuse; illicit; lortab; ordinal; oxycontin; percocet; percodan; point in time; potentialforabuse; pr; ql; qual; qualitative; random; scn; scr; screen; scrn; ua; ur; urn; vicodin,Ord
19645-1,oxycodone cutoff [mass/volume] in urine for confirmatory method,oxycodone cto ur cfm-mcnc,oxycodone cutoff confirm (u) [mass/vol],cfm; cnfr; cnfrm; conf; confirmation; confirmatory; cto; drug/toxicology; drugs; gcms; lc/ms/ms; level; lortab; mass concentration; oxycontin; percocet; percodan; point in time; qnt; quan; quant; quantitative; random; ua; ur; urn; vicodin,Qn
19649-3,oxymorphone cutoff [mass/volume] in urine for screen method,oxymorphone cto ur scn-mcnc,oxymorphone cutoff screen (u) [mass/vol],14-hydroxydihydromorphinone; cto; drug/toxicology; drugs; level; mass concentration; numorphan; numorphone; opana; point in time; qnt; quan; quant; quantitative; random; scn; scr; scrn; ua; ur; urn,Qn
19654-3,para hydroxyamphetamine cutoff [mass/volume] in urine for confirmatory method,p-oh-amphet cto ur cfm-mcnc,para hydroxyamphetamine cutoff confirm (u) [mass/vol],cfm; cnfr; cnfrm; conf; confirmation; confirmatory; cto; drug/toxicology; drugs; gcms; lc/ms/ms; level; mass concentration; methylthyramine; para hydroxy amphetamine; p-oh-amphet; point in time; qnt; quan; quant; quantitative; random; ua; ur; urn,Qn
19672-5,phenothiazines cutoff [mass/volume] in urine for screen method,phenothiaz cto ur scn-mcnc,phenothiazines cutoff screen (u) [mass/vol],cto; dibenzothiazine; drug/toxicology; drugs; level; mass concentration; phenothiaz; phenothiazine; phenothiazn; point in time; qnt; quan; quant; quantitative; random; scn; scr; scrn; ua; ur; urn,Qn
19677-4,phentermine cutoff [mass/volume] in urine for confirmatory method,phentermine cto ur cfm-mcnc,phentermine cutoff confirm (u) [mass/vol],cfm; cnfr; cnfrm; conf; confirmation; confirmatory; cto; drug/toxicology; drugs; gcms; ionamin; lc/ms/ms; level; mass concentration; point in time; qnt; quan; quant; quantitative; random; ua; ur; urn,Qn
19682-4,psilocin [presence] in urine by screen method,psilocin ur ql scn,psilocin screen ql (u),4-hydroxy-dimethyltryptamine; drug/toxicology; drugs; ordinal; point in time; pr; ql; qual; qualitative; random; scn; scr; screen; scrn; ua; ur; urn,Ord
19686-5,psilocybin [presence] in urine by screen method,psilocybin ur ql scn,psilocybin screen ql (u),drug/toxicology; drugs; ordinal; point in time; pr; ql; qual; qualitative; random; scn; scr; screen; scrn; ua; ur; urn,Ord
19688-1,psilocybin [mass/volume] in urine by confirmatory method,psilocybin ur cfm-mcnc,psilocybin confirm (u) [mass/vol],cfm; cnfr; cnfrm; conf; confirmation; confirmatory; drug/toxicology; drugs; gcms; lc/ms/ms; level; mass concentration; point in time; qnt; quan; quant; quantitative; random; ua; ur; urn,Qn
19689-9,deprecated psilocybin [mass/volume] in urine,deprecated psilocybin ur-mcnc,psilocybin (u) [mass/vol],drug/toxicology; drugs; level; mass concentration; point in time; qnt; quan; quant; quantitative; random; ua; ur; urn,Qn
19707-9,thioridazine [presence] in urine by confirmatory method,thioridazine ur ql cfm,thioridazine confirm ql (u),cfm; cnfr; cnfrm; conf; confirmation; confirmatory; drug/toxicology; drugs; gcms; lc/ms/ms; mellaril; novo-ridazine; ordinal; point in time; pr; ql; qual; qualitative; random; screen; sonapax; thioridazine hydrochloride; thioril; ua; ur; urn,Ord
19709-5,thioridazine cutoff [mass/volume] in urine for confirmatory method,thioridazine cto ur cfm-mcnc,thioridazine cutoff confirm (u) [mass/vol],cfm; cnfr; cnfrm; conf; confirmation; confirmatory; cto; drug/toxicology; drugs; gcms; lc/ms/ms; level; mass concentration; mellaril; novo-ridazine; point in time; qnt; quan; quant; quantitative; random; sonapax; thioridazine hydrochloride; thioril; ua; ur; urn,Qn
19730-1,deprecated budgerigar droppings ige ab [units/volume] in serum,deprecated budgie drop ige qn,budgerigar droppings ige qn (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; australian parrot; autoantibodies; autoantibody; budgeriar; budgie; budgie drop; e77; feces; immune globulin e; immunoglobulin e; point in time; qnt; quan; quant; quantitative; random; serum; sr; stool,Qn
19754-1,red currant ige ab [units/volume] in serum,red currant ige qn,red currant ige qn (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; f322; immune globulin e; immunoglobulin e; point in time; qnt; quan; quant; quantitative; random; red currant; red current; rf322; serum; sr; white current,Qn
19759-0,swine serum albumin ige ab [units/volume] in serum,swine serum alb ige qn,swine serum albumin ige qn (s),"abs; aby; alb; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; e222; immune globulin e; immunoglobulin e; nsus s pig serum albumine, swine; pig; point in time; pork; protein.albumin; qnt; quan; quant; quantitative; random; re222; ser; serum; sr; sus s psa",Qn
19761-6,thermoactinomyces vulgaris igg ab [presence] in serum,t vulgaris igg ser ql,t. vulgaris igg ql (s),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; farmers lung; gm23; id; immune globulin g; immunoglobulin g; infectious disease; infectiousdisease; lung; m23; m51; microbiology; ordinal; point in time; pr; pulmonary; pulmonology; ql; qual; qualitative; random; respiratory; rgm23; rm213; screen; serum; sr; t vulgaris; thermoactnom,Ord
19787-1,cleaning method endoscopy device,cleaning method endoscopy device,,gastro; gastroenterology; gi; gi.endoscopy; meth; method of; nominal; point in time; random; typ,Nom
19823-4,return visit post gi procedure [telephone number],return visit p gi proc tele,,after; gastro; gastroenterology; gi; gi.endoscopy; nominal; point in time; pst; random; return visit p gi proc; telecommunication number; telephone number,Nom
19831-7,breath rate minimum setting ventilator,breaths min setting vent,,count/time; lung; minimal; minimum; nrate; number rate; number rate = count/time; point in time; pulmonary; pulmonology; qnt; quan; quant; quantitative; random; respiratory; respiratory rate,Qn
19832-5,breath rate minimum setting ventilator alarm,breaths min setting vent alarm,,count/time; lung; minimal; minimum; nrate; number rate; number rate = count/time; point in time; pulmonary; pulmonology; qnt; quan; quant; quantitative; random; respiratory; respiratory rate; vent alarm,Qn
19834-1,breath rate setting ventilator,breaths setting vent,,count/time; lung; nrate; number rate; number rate = count/time; point in time; pulmonary; pulmonology; qnt; quan; quant; quantitative; random; respiratory; respiratory rate,Qn
19849-9,inspiratory capacity by helium rebreathing,ic he rebreath,,breathing; he; he rebreath; ic; lung; lungs; point in time; pulmonary; pulmonology; qnt; quan; quant; quantitative; random; respiratory; rs; volume,Qn
19871-3,fvc pre bronchodilation measured/predicted,fvc pre bd meas/pred,,before; breathing; fvc; fvc%; lung; lungs; point in time; pre bd; predicted fvc; pulmonary; pulmonology; qnt; quan; quant; quantitative; random; relative volume; respiratory; rs; vc,Qn
19880-4,carbon dioxide [partial pressure] (8 hour minimum) in capillary blood transcutaneous co2 monitor,pco2 8h min bldc tcco2,,1/3 day; 8 hours; 8hr; blood - capillary; cap bld; cap blood; capillary bld; capillary blood; carbonic anhydride; co2; finger stick; minimal; minimum; partial pressure; pco2; ptc; ptcco2; pulmonary; qnt; quan; quant; quantitative; tcco2; tcp; tcpco2,Qn
19889-5,carbon dioxide/gas.total.at end expiration in exhaled gas,co2 vfr exg,,breath; carbonic anhydride; co2; exg; exhaled gas; exhaled gas (=breath); exp; gases; lung; percent; point in time; pulmonary; pulmonology; qnt; quan; quant; quantitative; random; respiratory; tot; totl; volfr; volume fraction,Qn
1989-3,25-hydroxyvitamin d3 [mass/volume] in serum or plasma,25(oh)d3 serpl-mcnc,25-hydroxyvitamin d3 [mass/vol],25(oh)d3; 25-hydroxycholecalciferol; 25-hydroxyvitamin d 3; 25-hydroxyvitamin d3; calciderol; calcifediol; chemistry; level; mass concentration; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; universallaborders; vitamin d 25 hydroxy,Qn
19893-7,carbon dioxide [partial pressure] in capillary blood --during bronchodilation,pco2 during bd bldc,,blood - capillary; cap bld; cap blood; capillary bld; capillary blood; carbonic anhydride; co2; during bd; finger stick; lung; partial pressure; pco2; point in time; pulmonary; pulmonology; qnt; quan; quant; quantitative; random; respiratory,Qn
19902-6,carbon dioxide [partial pressure] in capillary blood by transcutaneous co2 monitor --post xxx treatment,pco2 p xxx tx bldc tcco2,,after; blood - capillary; cap bld; cap blood; capillary bld; capillary blood; carbonic anhydride; co2; finger stick; lung; p xxx tx; partial pressure; pco2; point in time; pst; ptc; ptcco2; pulmonary; pulmonology; qnt; quan; quant; quantitative; random; respiratory; tcco2; tcp; tcpco2; tx,Qn
19910-9,diffusion capacity.carbon monoxide predicted,diff cap.co predicted,,(diff cap; breathing; diff cap; diff cap.co; dl; dlco; fluid conductance; lung; lungs; point in time; pulmonary; pulmonology; qnt; quan; quant; quantitative; random; respiratory; rs,Qn
19915-8,diffusion capacity/alveolar volume predicted,diff cap/alv vol predicted,,(diff cap; alv; alv vol; breathing; diff cap; dl; lung; lungs; point in time; pulmonary; pulmonology; qnt; quan; quant; quantitative; random; respiratory; rs; va; vol,Qn
19923-2,expiratory reserve predicted,expiratory reserve predicted,,breathing; er; erv; lung; lungs; point in time; pulmonary; pulmonology; qnt; quan; quant; quantitative; random; respiratory; rs; volume,Qn
1993-5,calcium renal clearance in 24 hour urine and serum or plasma,calcium cl 24h ur+serpl-vrate,calcium renal clearance (24h u+s/p) [vol/time],1 day; 24 hours; 24hr; ca; cal; chemistry; cl; clear; clearanc; clearances; clr; flow; kidney; pl; plasma; plsm; qnt; quan; quant; quantitative; serp; serpl; serplas; serum; serum or plasma; sr; ua; ur; ur+serpl; urn; volume rate; vrate,Qn
19942-2,oxygen gas flow setting oxymiser,gas flow.o2 setting oxymiser,,dynamic; flow; gas flow.o2; gas flow.o2 setting; gases; lung; o2; o2 set; point in time; pulmonary; pulmonology; qnt; quan; quant; quantitative; random; respiratory; to2; volume rate; vrate,Qn
19970-3,deprecated fractional oxyhemoglobin by pulse oximetry --pre treatment,deprecated oxyhgb pre tx % pulseox,,abg; art; art bld; art blood; arterial; arterial blood; before; blood arterial; fo2hb; fractional hemoglobin; haemoglobin; haemoglobin oxygenated; hb; hbo2; hemoglobin oxygenated; hgb; lung; mass fraction; o2 saturation; o2hb; oxygen saturation; oxygenated haemoglobin; oxygenated hemoglobin; oxyhaemoglobin; oxyhgb; oxyhgb %; percent; point in time; pre tx; pulmonary; pulmonology; pulseox; qnt; quan; quant; quantitative; random; respiratory; sao2; so2; spo2; tot; totl; tx,Qn
19972-9,humidifier types,humidifier types,,lung; nominal; point in time; pulmonary; pulmonology; random; respiratory; typ,Nom
19981-0,oxygen [partial pressure] (8 hour maximum) in capillary blood,po2 8h max bldc,,1/3 day; 8 hours; 8hr; blood - capillary; cap bld; cap blood; capillary bld; capillary blood; finger stick; lung; maximum; o2; o2 partial pressure; partial pressure; po2; pulmonary; pulmonology; qnt; quan; quant; quantitative; respiratory; to2,Qn
19984-4,oxygen [partial pressure] respiratory system alveolus calculated,po2 aveolus calc,,aveolus; breathing; calc; calculation; lung; lungs; o2; o2 partial pressure; pao2; partial pressure; po2; point in time; pulmonary; pulmonology; qnt; quan; quant; quantitative; random; respiratory; rs; to2,Qn
19990-1,minimum oxygen setting ventilator alarm,o2 min setting vent alarm,,flow; lung; minimal; minimum; o2; o2 min setting; point in time; pulmonary; pulmonology; qnt; quan; quant; quantitative; random; respiratory; to2; vent alarm; volume rate; vrate,Qn
2000-8,calcium [moles/volume] in serum or plasma,calcium serpl-scnc,calcium [moles/vol],ca; cal; chemistry; level; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; substance concentration,Qn
2003-2,deprecated calcium,deprecated calcium ur ql,calcium ql (u),ca; cal; chemistry; level; ordinal; point in time; ql; qual; qualitative; random; screen; substance concentration; ua; ur; urn,Ord
20055-0,pressure minimum setting ventilator alarm,pressure min setting vent alarm,,lung; minimal; minimum; point in time; press.min; pressure; pulmonary; pulmonology; qnt; quan; quant; quantitative; random; respiratory; vent alarm,Qn
20056-8,airway pressure --at mean expiratory flow on ventilator,paw @ mean exp flow on vent,,@ mean exp flow on vent; average; avg; breathing; dynamic; lung; lungs; map; mep; paw; point in time; pressure; pulmonary; pulmonology; qnt; quan; quant; quantitative; random; respiratory; rs,Qn
200-6,colistimethate by minimum lethal concentration (mlc),colistimethate islt mlc,colistimethate mlc [susc],antibiotic susceptibilities; ast; colimicina; colimycine; colistin sulphomethate; colomycin m; coly-micin s; id; infectious disease; infectiousdisease; islt; isol; mbc; minimum bactericidal concentration; minimum lethal concentration; point in time; qnt; quan; quant; quantitative; random; sus; suscept; susceptibilities; susceptibility; susceptibilty,Qn
20073-3,minimum mean pressure setting ventilator alarm,mean pres min vent alarm,,average; avg; lung; mean pres; mean pres min; minimal; minimum; point in time; pressure; pressure mean; pulmonary; pulmonology; qnt; quan; quant; quantitative; random; respiratory; vent alarm,Qn
20075-8,peep respiratory system,peep respiratory,,breathing; lung; lungs; peep; point in time; pos; pressure; pulmonary; pulmonology; qnt; quan; quant; quantitative; random; respiratory; rs,Qn
20091-5,temperature inhaled gas by body hood,temp ihg body hood,,bod; bodies; gases; ihg; inhaled gas; inspired; lung; point in time; pulmonary; pulmonology; qnt; quan; quant; quantitative; random; respiratory; temp; temperature,Qn
20096-4,maximum airway temperature setting ventilator alarm,airway temp max vent alarm,,airway temp; airway temp max; largest; lung; maximal; maximum; peak; point in time; pulmonary; pulmonology; qnt; quan; quant; quantitative; random; respiratory; temp; temperature; vent alarm,Qn
20102-0,tidal volume expired/peak inspiratory pressure --on ventilator,vt.expired/pip on vent,,breathing; cdyn; compliance; dynamic compliance; end tidal volume; lung; lungs; pip; point in time; pressure peak; pulmonary; pulmonology; qnt; quan; quant; quantitative; random; respiratory; rs; tv; vet; vol; vol exp; vt; vt.expired,Qn
20104-6,deprecated tidal volume expired/plateau pressure calculated --post 1.5-2.0 seconds inspiratory hold on ventilator,deprecated ces p 1.5-2.0 s insp hold on,,after; breathing; calc; calculation; ces; compliance; effective static compliance; end tidal volume; lung; lungs; p 1.5-2.0 s insp hold on vent; point in time; pplat; press.plat; pst; pulmonary; pulmonology; qnt; quan; quant; quantitative; random; respiratory; rs; s prime; thoracic compliance; tv; vet; vol; vol exp; vt; vt.expired,Qn
20107-9,tidal volume expired spontaneous+mechanical respiratory system airway --on ventilator,spont+mech vet on vent airway,,breathing; end tidal volume; lung; lungs; point in time; pulmonary; pulmonology; qnt; quan; quant; quantitative; random; respiratory; rs; spont vt; spont+mech vet; tv; vet; vol; vol exp; volume; vt; vt.expired,Qn
20112-9,tidal volume setting ventilator,vt setting vent,,lung; point in time; pulmonary; pulmonology; qnt; quan; quant; quantitative; random; respiratory; tv; vol; vol setting; volume; vt; vt setting,Qn
20121-0,tidal volume.spontaneous+mechanical uncorrected for compressible gas volume --on ventilator,spont+mech vt on vent uncorrected,,breathing; gases; lung; lungs; point in time; pulmonary; pulmonology; qnt; quan; quant; quantitative; random; respiratory; rs; spont vt; spont+mech vt; tv; vol; volume; vt,Qn
20129-3,volume breathing bag by gas dilution.rebreath,volume breathing bag gas dil.rebreath,,dil; dilut; gas dil.rebreath; gases; lung; point in time; pulmonary; pulmonology; qnt; quan; quant; quantitative; random; respiratory; vol; volume,Qn
20133-5,maximum volume setting ventilator alarm,vol max vent alarm,,flow; largest; lung; maximal; maximum; peak; point in time; pulmonary; pulmonology; qnt; quan; quant; quantitative; random; respiratory; vent alarm; vol; vol max; volume rate; vrate,Qn
20139-2,volume expired 1 minute,vol exp 1m,,1 minute; breathing; end tidal volume; lung; lungs; minute ventilation; minute volume; pulmonary; pulmonology; qnt; quan; quant; quantitative; respiratory; rs; total ventilation; vet; vol; vol exp; volume,Qn
20153-3,fev1/fev total,fev1/fev total vfr,,breathing; end tidal volume; exp; fev; fev total; fev1; forced expiratory volume in 1 second; fvc; lung; lungs; percent; point in time; pulmonary; pulmonology; qnt; quan; quant; quantitative; random; respiratory; rs; s prime; tot; totl; vet; vol; vol exp; volfr; volume fraction,Qn
2015-6,cancer ag 72-4 [presence] in serum or plasma,cancer ag72-4 serpl ql,cancer ag 72-4 ql,ca; ca 72-4; cancer ag72-4; carbohydrate antigen; carbohydrate antigen 72-4; chemistry; ordinal; pl; plasma; plsm; point in time; pr; ql; qual; qualitative; random; screen; serp; serpl; serplas; serum; serum or plasma; sr; tag-72; tumor marker,Ord
20165-7,region of interest region [area] by us 2d,roi region area 2d us,,2d us; card.us; cardio; cardiology; echography; heart disease; misc; miscellaneous; other; point in time; qnt; quan; quant; quantitative; random; roi; sonogram; sonograph; sonography; spec; to be specified in another part of the message; uls; ultrasound; ultrasound - 2-dimensional; unspecified,Qn
2017-2,carbamoyl phosphate synthetase (ammonia) [enzymatic activity/mass] in tissue,cps (ammonia) tiss-ccnt,carbamoyl phosphate synthetase (ammonia) (tiss) [catalytic activity/mass],"amm; ammon; amon; carbamoyl-phosphate synthase; catalytic content; chemistry; cps; cps (ammonia); i phos; inorganic phosphate; nh3; phos; phosphate total; phosphorous; phosphorus; phosphrous; pi; po4; point in time; qnt; quan; quant; quantitative; random; tissue; tissue, unspecified",Qn
20197-0,left ventricular cardiac index by us.2d+calculated by single-plane ellipse method,lv cardiac index us.2d+sp-el,,2d us; bdy surface; bod; bodies; bsa; calc; calculation; card.us; cardiac; cardio; cardiology; co; echography; heart disease; hrt; hrt ventr; l; lt; lv; point in time; qnt; quan; quant; quantitative; random; sonogram; sonograph; sonography; surf; uls; ultrasound; ultrasound - 2-dimensional; us.2d+sp-el; ventricular; volume rate/area; volume rate/ratio,Qn
2020-6,carbon dioxide [partial pressure] in capillary blood,pco2 bldc,co2 (bldc) [partial pressure],blood - capillary; cap bld; cap blood; capillary bld; capillary blood; carbonic anhydride; chemistry; co2; finger stick; partial pressure; pco2; point in time; qnt; quan; quant; quantitative; random,Qn
20213-5,left ventricular cardiac output by us+calculated by teichholz method,lv output us+teichholz,,calc; calculation; card.us; cardiac; cardio; cardiology; co; echography; flow; heart disease; hrt; hrt ventr; l; lt; lv; point in time; qnt; quan; quant; quantitative; random; sonogram; sonograph; sonography; uls; ultrasound; us calc; us+teichholz; ventricular; volume rate; vrate,Qn
202-2,colistimethate by disk diffusion (kb),colistimethate islt kb,colistimethate disk diffusion (kb) [susc],antibiotic susceptibilities; ast; colimicina; colimycine; colistin sulphomethate; colomycin m; coly-micin s; disk diffusion; id; infectious disease; infectiousdisease; islt; isol; kb; kirby-bauer; point in time; random; sus; suscept; susceptibilities; susceptibility; susceptibilty,OrdQn
20220-0,deceleration/deceleration 2 by us,decel/decel 2 us,,card.us; cardio; cardiology; circ; circ sys; dec; decel 2; echography; heart disease; ii; misc; miscellaneous; other; point in time; qnt; quan; quant; quantitative; random; sonogram; sonograph; sonography; spec; time ratio; to be specified in another part of the message; uls; ultrasound; unspecified,Qn
20236-6,left ventricular end-diastolic volume by us 2d modified biplane ellipse calculated,lv ed vol us.2d.mod-bp-el,,2d us; calc; calculation; card.us; cardiac; cardio; cardiology; dias; diast; diastoli; echography; ed vol; heart disease; hrt; hrt ventr; l; lt; lv; method of discs; method of disks; mod-bp; point in time; qnt; quan; quant; quantitative; random; sonogram; sonograph; sonography; uls; ultrasound; ultrasound - 2-dimensional; us.2d.mod-bp; us.2d.mod-bp-el; ventricular; vol; volume,Qn
20249-9,aortic valve maximum regurgitant pressure gradient by us+calculated,av max regurg press gradient us+calc,,ao; aov; av; calc; calculation; card.us; cardio; cardiology; echography; grad; heart disease; largest; max regurg press gradient; maximal; maximum; peak; peak press grad; point in time; press grad; qnt; quan; quant; quantitative; random; sonogram; sonograph; sonography; uls; ultrasound; us calc,Qn
20251-5,pulmonic valve maximum regurgitant pressure gradient by us.calculated,pv max regurg press gradient us calc,,calc; calculation; card.us; cardio; cardiology; echography; grad; heart disease; largest; max regurg press gradient; maximal; maximum; peak; peak press grad; point in time; press grad; pv; pvg; qnt; quan; quant; quantitative; random; sonogram; sonograph; sonography; uls; ultrasound; us calc; us+calc,Qn
2025-5,carbon dioxide dissolved [moles/volume] in red blood cells,dis co2 rbc-scnc,carbon dioxide dissolved (rbc) [moles/vol],carbonic anhydride; cco2; chemistry; co2; co2 total; co2ct; ctco2; dis co2; erythrocytes; level; point in time; qnt; quan; quant; quantitative; random; red blood cells; red blood corpusles; substance concentration; tco2,Qn
20279-6,deprecated orifice.minor axis.min [area] of mitral valve us 2d,deprecatedarea orifice,,2d us; card.us; cardio; cardiology; echography; heart disease; mv; mva; point in time; qnt; quan; quant; quantitative; random; sonogram; sonograph; sonography; uls; ultrasound; ultrasound - 2-dimensional,Qn
20292-9,pulmonic flow/systemic flow by us.doppler vti + left ventricular outflow tract calculated,pulmonic/systemic dop.vti+lvot,,"calc; calculation; card.us; cardio; cardiology; circ; circ sys; dop; dop.vti+lvot; duplex; dynamic; echography; heart disease; i,lvot; left ventricular outflow tract; misc; miscellaneous; other; point in time; qnt; qp/qs; qs; quan; quant; quantitative; random; sonogram; sonograph; sonography; spec; to be specified in another part of the message; tvi; uls; ultrasound; unspecified; velocity time integral; volume rate ratio",Qn
20326-5,left ventricular stroke volume by us.2d+calculated by bullet method,lv sv us.2d+bullet,,2d us; calc; calculation; card.us; cardiac; cardiac output/heart beat; cardio; cardiology; echography; heart disease; hrt; hrt ventr; l; lt; lv; point in time; qnt; quan; quant; quantitative; random; sonogram; sonograph; sonography; sv; uls; ultrasound; ultrasound - 2-dimensional; us.2d+bullet; ventricular; vol; volume,Qn
20332-3,left ventricular cardiac output/heart rate 4 chamber by us 2d modified single-plane calculated,lv output/heart rate.4cham us.2d.mod-sp,,2d us; calc; calculation; card.us; cardiac; cardio; cardiology; co; echography; heart beat; heart disease; heart rate.4cham; hrt; hrt ventr; l; lt; lv; method of discs; method of disks; mod-sp; mod-sp4; point in time; pulse; qnt; quan; quant; quantitative; random; sonogram; sonograph; sonography; uls; ultrasound; ultrasound - 2-dimensional; us.2d.mod-sp; ventricular; volume,Qn
20345-5,tricuspid valve deceleration slope [velocity] by us,tv decel slope us,,card.us; cardio; cardiology; dec; decel slope; echography; heart disease; point in time; qnt; quan; quant; quantitative; random; sonogram; sonograph; sonography; tv; uls; ultrasound; velocity,Qn
20360-4,heart valve region [area] by us.doppler vti + diameter calculated,valve region area dop.vti+diam,,"calc; calculation; card.us; cardiac; cardio; cardiology; dop; dop.vti+diam; duplex; echography; heart disease; hrt; i,d; misc; miscellaneous; other; point in time; qnt; quan; quant; quantitative; random; sonogram; sonograph; sonography; spec; to be specified in another part of the message; tvi; uls; ultrasound; unspecified; velocity time integral",Qn
20363-8,velocity slope by us,vel slope us,,card.us; cardio; cardiology; circ; circ sys; echography; heart disease; misc; miscellaneous; other; point in time; qnt; quan; quant; quantitative; random; sonogram; sonograph; sonography; spec; to be specified in another part of the message; uls; ultrasound; unspecified; vel; vel slope; velocity; vslp,Qn
20371-1,velocity-time integral.xxx/velocity-time integral 2 by us.doppler,vti.xxx/vti 2 dop,,card.us; cardio; cardiology; circ; circ sys; dop; duplex; echography; heart disease; ii; length ratio; misc; miscellaneous; other; point in time; qnt; quan; quant; quantitative; random; sonogram; sonograph; sonography; spec; to be specified in another part of the message; uls; ultrasound; unspecified; vel; vti; vti 2; vti 2.xxx; vti.xxx,Qn
20381-0,ethambutol [susceptibility] by method for slow-growing mycobacteria,ethambutol islt slowmyco,ethambutol method for slow-growing mycobacteria [susc],afb; antibiotic susceptibilities; ast; etambol; ethamb; id; inagen; infectious disease; infectiousdisease; islt; isol; myambutol; myco; mycobacteria susceptibility; mycobacterial susceptibility; mycobutol; olbutam; point in time; random; slowmyco; sus; suscept; susceptibilities; susceptibility; susceptibilty; tb; tuberculosis,OrdQn
20397-6,sparfloxacin [susceptibility] by minimum inhibitory concentration (mic),sparfloxacin islt mic,sparfloxacin mic [susc],antibiotic susceptibilities; ast; id; infectious disease; infectiousdisease; islt; isol; minimum inhibitory concentration; point in time; random; sus; suscept; susceptibilities; susceptibility; susceptibilty; zagam,OrdQn
2040-4,cardiolipin [mass/volume] in serum,cardiolipin ser-mcnc,cardiolipin (s) [mass/vol],cardio; cardiolip; cardiolipn; cardiolpn; cl; coagulation; hematology; heme; level; mass concentration; point in time; qnt; quan; quant; quantitative; random; serum; sr,Qn
20411-5,barbiturates [mass/volume] in urine by confirmatory method,barbiturates ur cfm-mcnc,barbiturates confirm (u) [mass/vol],addiction; barb; barbiturate; barbs; cfm; cnfr; cnfrm; conf; confirmation; confirmatory; drug/toxicology; drugs; drugs of abuse; gcms; illicit; lc/ms/ms; level; mass concentration; point in time; potentialforabuse; qnt; quan; quant; quantitative; random; ua; ur; urn,Qn
20413-1,cannabinoids [mass/volume] in urine by confirmatory method,cannabinoids ur cfm-mcnc,cannabinoids confirm (u) [mass/vol],addiction; cannabinoid; cfm; cnfr; cnfrm; conf; confirmation; confirmatory; delta-9-tetrahydrocannabinol; drug/toxicology; drugs; drugs of abuse; gcms; illicit; lc/ms/ms; level; marijuana; mass concentration; point in time; potentialforabuse; qnt; quan; quant; quantitative; random; thc; ua; ur; urn,Qn
20415-6,choriogonadotropin.beta subunit [units/volume] in serum or plasma by immunoassay (eia) 3rd is,b-hcg serpl eia 3rd is-acnc,hcg.beta subunit ia 3rd is qn,3is; 3rd international standard; 3rdis; arbitrary concentration; b; b hcg; beta hcg; beta human chorionic gonadotropin; b-hcg; cg; chemistry; choriogonadotropin beta chain; choriogonadotropins total; chorionic gonadotropin; eia 3rd is; hcg; human chorionic gonadotropin; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; tumor marker,Qn
20421-4,barbiturates [presence] in serum or plasma by screen method,barbiturates serpl ql scn,barbiturates screen ql,addiction; barb; barbiturate; barbs; drug/toxicology; drugs; drugs of abuse; illicit; ordinal; pl; plasma; plsm; point in time; potentialforabuse; pr; ql; qual; qualitative; random; scn; scr; screen; scrn; serp; serpl; serplas; serum; serum or plasma; sr,Ord
20428-9,phospholipid igg ab [presence] in serum,phospholipid igg ser ql,phospholipid igg ql (s),abs; aby; antby; anti; antibodies; antibody; antiphospholipid; apa; apl; autoantibodies; autoantibody; coagulation; hematology; heme; immune globulin g; immunoglobulin g; lipid; ordinal; phoslpd; phospholipids; pl; point in time; pr; ql; qual; qualitative; random; screen; serum; sr,Ord
20436-2,glucose [mass/volume] in serum or plasma --2 hours post dose glucose,glucose 2h p glc serpl-mcnc,glucose 2 hr post dose glucose [mass/vol],120 min; 120 minutes; 120min; 2 hours; 2h p glc; after; chemistry.challenge testing; endocrine; endocrinology; glu; glu tol; gluc; glucose tolerance; glucoseur; gtt; level; mass concentration; p dose; p glc; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; universallaborders,Qn
20446-1,herpes simplex virus igg ab [interpretation] in serum by immunoassay,hsv igg ser ia-imp,hsv igg ia (s) [interp],abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; eia; elfa; elisa; enzyme immunoassay; herp splx; hsv; iaa; id; immune globulin g; immunoglobulin g; impression; impression/interpretation of study; impressions; infectious disease; infectiousdisease; interp; interpretation; meia; microbiology; nominal; point in time; random; serum; sr; suds,Nom
20449-5,borrelia burgdorferi ab [presence] in serum by immunoassay,b burgdor ab ser ql ia,b. burgdorferi ab ia ql (s),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; b burg; b burgdor; b burgdorferi; bb; burgdorf; eia; elfa; elisa; enzyme immunoassay; iaa; id; infectious disease; infectiousdisease; lyme; lyme disease; lymes; meia; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; sr; suds; universallaborders,Ord
20467-7,blood bank alert,blood bank alert patient-imp,blood bank alert [interp],impression; impression/interpretation of study; impressions; interp; interpretation; nominal; point in time; random,Nom
20468-5,thiamine [moles/volume] in serum or plasma,vit b1 serpl-scnc,thiamine [moles/vol],c106; c238; chemistry; level; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; substance concentration; universallaborders; vit b1; vit b-1; vitamin b1; vitamin b-1,Qn
20481-8,deprecated opiates [presence] in meconium by screen method,deprecated opiates mec ql scn,opiates screen ql (mec),addiction; arbitrary concentration; drug/toxicology; drugs; drugs of abuse; heroin; illicit; mec; op; opi; opiate; ordinal; point in time; potentialforabuse; ql; qual; qualitative; random; scn; scr; screen; scrn,Ord
20487-5,neisseria meningitidis serogroups a+y ag [presence] in cerebral spinal fluid,n men sg a+y ag csf ql,n. meningitidis a+y ag ql (csf),antigen; antigens; cerebral spinal fluid; cerebrospinal fl; id; infectious disease; infectiousdisease; mening; meningid; meningitis; meningo; meningococcal meningitis; meningococcus; microbiology; n men; n men sg a+y; n men sg a+y ag; n menigitidis; n meningitidis; neuro; neurology; ordinal; point in time; pr; ql; qual; qualitative; random; screen; spinal fl; spinal fld; spinal flu; spinal fluid,Ord
20491-7,epstein barr virus capsid igm ab [titer] in serum,ebv vca igm titr ser,ebv capsid igm (s) [titer],abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; cap; dilution factor; dilution factor (titer); ebv; ebv capsid ab; ebv vca; epstn; hhv-4; human herpesvirus 4; id; immune globulin m; immunoglobulin m; infectious disease; infectiousdisease; microbiology; mono; mononucleosis; point in time; random; serum; smqn; sr; titer; titered; titre; ttr; vca; viral capsid,SemiQn
20499-0,phosphatidylglycerol/surfactant.total in amniotic fluid,pg mfr amn,phosphatidylglycerol/total surfactant (amn fld) [mass fraction],af; amn; amn fl; amnio; amniotic flu; amniotic fluid; chemistry; fetal lung maturity; mass fraction; percent; pg; phosphatidyl glycerol; phosphotidylglycerol; point in time; qnt; quan; quant; quantitative; random; tot; totl,Qn
20513-8,turbidity [presence] of body fluid qualitative,turbidity fld ql,turbidity ql (body fld),"b/f; bf; bod; bodies; body fluid; body fluid, unsp; fl; fld; flu; fluid; ordinal; point in time; pr; ql; qual; qualitative; random; screen; spec",Ord
20520-3,bromazepam [mass/volume] in urine by confirmatory method,bromazepam ur cfm-mcnc,bromazepam confirm (u) [mass/vol],bromazanil; brozam; calmepam; cfm; cnfr; cnfrm; compendium; conf; confirmation; confirmatory; creosedin; drug/toxicology; drugs; durazanil; gcms; gityl; lc/ms/ms; lectopam; level; lexatin; lexaurin; lexonil; lexotan; lexotanil; mass concentration; neo-opt; normoc; point in time; qnt; quan; quant; quantitative; random; somalium; ua; ur; urn,Qn
20530-2,haloperidol [mass/volume] in urine by confirmatory method,haloperidol ur cfm-mcnc,haloperidol confirm (u) [mass/vol],cfm; cnfr; cnfrm; conf; confirmation; confirmatory; drug/toxicology; drugs; gcms; haldol; lc/ms/ms; level; mass concentration; point in time; qnt; quan; quant; quantitative; random; serenace; ua; ur; urn,Qn
20537-7,ketamine [mass/volume] in urine by confirmatory method,ketamine ur cfm-mcnc,ketamine confirm (u) [mass/vol],cfm; cnfr; cnfrm; conf; confirmation; confirmatory; drug/toxicology; drugs; gcms; ketalar; ketaset; ketavet; lc/ms/ms; level; mass concentration; point in time; qnt; quan; quant; quantitative; random; ua; ur; urn,Qn
20541-9,lormetazepam [mass/volume] in urine by confirmatory method,lormetazepam ur cfm-mcnc,lormetazepam confirm (u) [mass/vol],cfm; cnfr; cnfrm; conf; confirmation; confirmatory; drug/toxicology; drugs; gcms; lc/ms/ms; level; mass concentration; point in time; qnt; quan; quant; quantitative; random; ua; ur; urn,Qn
205-5,colistin [susceptibility] by minimum inhibitory concentration (mic),colistin islt mic,colistin mic [susc],antibiotic susceptibilities; ast; colmycin; colymycin; id; infectious disease; infectiousdisease; islt; isol; minimum inhibitory concentration; point in time; random; sus; suscept; susceptibilities; susceptibility; susceptibilty,OrdQn
20555-9,phenmetrazine [mass/volume] in urine by confirmatory method,phenmetrazine ur cfm-mcnc,phenmetrazine confirm (u) [mass/vol],addiction; cfm; cnfr; cnfrm; conf; confirmation; confirmatory; drug/toxicology; drugs; drugs of abuse; gcms; illicit; lc/ms/ms; level; mass concentration; oxazimedrine; point in time; potentialforabuse; preludin endurets; qnt; quan; quant; quantitative; random; ua; ur; urn,Qn
20557-5,phentermine [mass/volume] in urine by confirmatory method,phentermine ur cfm-mcnc,phentermine confirm (u) [mass/vol],addiction; cfm; cnfr; cnfrm; conf; confirmation; confirmatory; drug/toxicology; drugs; drugs of abuse; gcms; illicit; ionamin; lc/ms/ms; level; mass concentration; point in time; potentialforabuse; qnt; quan; quant; quantitative; random; ua; ur; urn,Qn
20565-8,"carbon dioxide, total [moles/volume] in blood",co2 bld-scnc,co2 (bld) [moles/vol],blood; carbonic anhydride; cco2; chemistry; co2; co2 total; co2ct; ctco2; level; point in time; qnt; quan; quant; quantitative; random; substance concentration; tco2; wb; whole blood,Qn
20569-0,creatine kinase.mb/creatine kinase.total in serum or plasma,ck mb cfr serpl,ck.mb [catalytic fraction],cardio; cardiology; catalytic fraction; chemistry; ck; ck 2; ck mb; ck-2; ckmb; ck-mb; cpk; creatine phosphokinase; heart disease; percent; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; tot; totl,Qn
20579-9,methanol [presence] in serum or plasma by screen method,methanol serpl ql scn,methanol screen ql,drug/toxicology; drugs; meoh; methyl alcohol; ordinal; pl; plasma; plsm; point in time; pr; ql; qual; qualitative; random; scn; scr; screen; scrn; serp; serpl; serplas; serum; serum or plasma; sr,Ord
20590-6,cd15 cells/cells in specimen,cd15 cells nfr spec,cd15 cells/cells (specimen),3-fal; 3-fl; cd15 cells; cell; cell markers; cellularity; lacto-n-neo-fucopentaose iii; leum1; leu-m1; lewis x; lex; lnfp iii; m-1; misc; miscellaneous; my1; my-1; number fraction; other; percent; point in time; qnt; quan; quant; quantitative; random; spec; ssea-1; to be specified in another part of the message; unspecified; x-hapten,Qn
20595-5,cd20 cells/cells in specimen,cd20 cells nfr spec,cd20 cells/cells (specimen),b1; b-1; bp35; cd20 cells; cell; cell markers; cells.cd20+; cellularity; leu16; leu-16; misc; miscellaneous; number fraction; other; percent; point in time; qnt; quan; quant; quantitative; random; spec; to be specified in another part of the message; unspecified,Qn
20604-5,cd3-cd16+cd56+ (natural killer) cells [#/volume] in specimen,cd3-cd16+cd56+ cells # spec,cd3-cd16+cd56+ (natural killer) cells (specimen) [#/vol],#; abs; absolute; absolutes; cd3 cells; cd3+cd16+ cells; cd3+cd16+cd56+ cells; cd3-cd16+ cells; cd3-cd16+cd56+ cells; cell; cell markers; cellularity; cnt; count; count/volume; ct; fcgr3a; leu11; leu-11; leu11b; leu-11b; leu19; leu-19; leu4; leu-4; misc; miscellaneous; natural killer cells; ncam; neural cell adhesion molecule; nkh1; number concentration; number concentration (count/vol); other; point in time; qnt; quan; quant; quantitative; random; spec; t3; to be specified in another part of the message; unspecified,Qn
20608-6,cd41 cells/cells in specimen,cd41 cells nfr spec,cd41 cells/cells (specimen),alpha iib integrin chain; cd41 cells; cell; cell markers; cellularity; glycoprotein iib; gpiib; misc; miscellaneous; number fraction; other; percent; point in time; qnt; quan; quant; quantitative; random; spec; to be specified in another part of the message; unspecified,Qn
20617-7,kappa lymphocytes/lymphocytes in specimen,lymphs kappa/lymph nfr spec,kappa lymphocytes/lymphocytes (specimen),cell markers; lymp; lymph; lympho; lymphocyte; lymphs; lymphs kappa; lymphs%; misc; miscellaneous; number fraction; other; percent; point in time; qnt; quan; quant; quantitative; random; spec; to be specified in another part of the message; tumor marker; unspecified,Qn
20641-7,cysteine [moles/volume] in serum or plasma,cysteine serpl-scnc,cysteine [moles/vol],chemistry; cys; level; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; substance concentration,Qn
2064-4,ceruloplasmin [mass/volume] in serum or plasma,ceruloplasmin serpl-mcnc,ceruloplasmin [mass/vol],caeruloplasmin; chemistry; copper oxidase; cp; ferroxidase; level; mass concentration; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; universallaborders,Qn
20688-8,aspergillus sp identified in litter by organism specific culture,aspergillus litter cult,aspergillus sp identified org specific cx nom (litter),asperg; aspergil; aspergilis; aspergilla; aspergillin; aspergillosis; aspergils; aspergilus; c&s; cult; cultures; farmers lung; id; identity or presence; infectious disease; infectiousdisease; microbiology; nominal; point in time; random; spec; species; spp,Nom
20710-0,bovine diarrhea virus rna [presence] in serum by naa with probe detection,bvdv rna ser ql naa+probe,bovine diarrhea virus rna naa+probe ql (s),3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; bdv; beef; bovine viral diarrhea; bvd; bvdv; dna nucleic acid probe; dna probe; id; infectious disease; infectiousdisease; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; mucosal disease; naa+probe; naat; nasba; nucleic acid sequence based analysis; ordinal; pcr; pestivirus; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; ribonucleic acid; screen; sda; serum; sr; strand displacement amplification; tma; transcription mediated amplification; vet; veterinary,Ord
20733-2,brucella ovis ab [presence] in serum by complement fixation,b ovis ab ser ql cf,b. ovis ab cf ql (s),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; b ovis; bruc; brucellosis; cf; comp fixation; compfix; complement fixation; id; infectious disease; infectiousdisease; microbiology; ordinal; ovine epididymitis; point in time; pr; ql; qual; qualitative; ram epididymitis; random; screen; serum; sr; vet; veterinary,Ord
20739-9,campylobacter sp identified in body fluid by organism specific culture,campylobacter fld cult,campylobacter sp identified org specific cx nom (body fld),"b/f; bf; bod; bodies; body fluid; body fluid, unsp; c&s; campy; cult; cultures; fl; fld; flu; fluid; id; identity or presence; infectious disease; infectiousdisease; microbiology; nominal; point in time; random; spec; species; spp",Nom
20760-5,clostridium chauvoei ag [presence] in tissue by immunofluorescence,c chauvoei ag tiss ql if,c. chauvoei ag if ql (tiss),"acif; anticomplement immunofluorescence; antigen; antigens; c chauvaei; c chauvoei; dfa; fa; fluorescent antibody; fluoresent; id; ifa; immune fluorescence; immunoflour; immunofluor; immunofluorescence; infectious disease; infectiousdisease; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; screen; time resolved fluorescence; tissue; tissue, unspecified; trf",Ord
20764-7,clostridium perfringens genotype [identifier] in isolate,c perfringens gentyp islt,c. perfringens genotype (isol),c perfringens; gentyp; id; identity or presence; infectious disease; infectiousdisease; islt; isol; microbiology; nominal; point in time; random,Nom
20781-1,cryptosporidium sp [presence] in stool by acid fast stain,cryptosp stl ql acid fast stn,cryptosporidium sp acid fast stain ql (stl),acd; acid fast stn; acids; afb stain; bowel movement; crypt; crypto; cryptosporidiosis; faecal; faeces; fecal; feces; gastro; gastroenterology; gi; id; infectious disease; infectiousdisease; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; screen; species; spp; st; stains; stl; stn; stool = fecal; universallaborders,Ord
20799-3,clostridium perfringens enterotoxin [presence] in body fluid,c perfringens etx fld ql,c. perfringens enterotoxin ql (body fld),"b/f; bf; bod; bodies; body fluid; body fluid, unsp; c perfringens; c perfringens etx; etx; fl; fld; flu; fluid; id; infectious disease; infectiousdisease; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; screen",Ord
20816-5,escherichia coli k88 [presence] in isolate by agglutination,e coli k88 islt ql aggl,e. coli k88 aggl ql (isol),agg; agglut; agglutination; e coli; e coli k88; id; infectious disease; infectiousdisease; islt; isol; microbiology; o002; ordinal; point in time; pr; ql; qual; qualitative; random; screen,Ord
20827-2,gallotannin [mass/mass] in gastric fluid,gallotannin gast-mcnt,gallotannin (gast fld) [mass/mass],drug/toxicology; drugs; gast; gastric contents; gastric fluid; mass content; point in time; qnt; quan; quant; quantitative; random,Qn
20833-0,haemophilus paragallinarum serotype [identifier] in isolate,h paragallinar sertyp islt,h. paragallinarum serotype nom (isol),h paragallinar; h paragallinarum; haemoph; id; identity or presence; infectious coryza; infectious disease; infectiousdisease; islt; isol; microbiology; nominal; point in time; random; sertyp,Nom
2083-4,cholesterol esterase [enzymatic activity/volume] in serum,cholest est ser-ccnc,cholesterol esterase (s) [catalytic activity/vol],acid lipase; catalytic concentration; ce; chemistry; chol; choles; cholest; cholest est; cholesterol total; cholesterols; lipid; lysosomal acid lipase; point in time; qnt; quan; quant; quantitative; random; serum; sr; wolman/cholesterol ester storage disease,Qn
20840-5,herbicide [presence] in ingesta by screen method,herbicide ingesta ql scn,herbicide screen ql (ingesta),drug/toxicology; drugs; herbicides; ordinal; point in time; pr; ql; qual; qualitative; random; scn; scr; screen; scrn,Ord
20846-2,bovine herpesvirus 1 ag [presence] in tissue by immunofluorescence,bohv1 ag tiss ql if,bovine herpesvirus 1 ag if ql (tiss),"acif; anticomplement immunofluorescence; antigen; antigens; beef; bhv1; bohv; bohv1; bohv-1; bovine herpes virus; dfa; fa; fluorescent antibody; fluoresent; herpes virus; i; ibr; id; ifa; immune fluorescence; immunoflour; immunofluor; immunofluorescence; infectious bovine rhinotracheitis; infectious disease; infectious pustular vulvovaginitis; infectiousdisease; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; screen; time resolved fluorescence; tissue; tissue, unspecified; trf; vet; veterinary",Ord
20865-2,iodine [mass/mass] in liver,iodine liver-mcnt,iodine (liver) [mass/mass],c616; drug/toxicology; drugs; hepar; hepatic; i; i-; mass content; point in time; qnt; quan; quant; quantitative; random,Qn
20876-9,mercury [mass/mass] in feed,mercury feed-mcnt,mercury (feed) [mass/mass],drug/toxicology; drugs; hg; mass content; point in time; qnt; quan; quant; quantitative; random,Qn
20892-6,mycobacterium avium ss paratuberculosis [presence] in tissue by organism specific culture,m avium paratb tiss ql cult,m. avium ss paratuberculosis org specific cx ql (tiss),"acid fast; acid fast bacilli; acid fast bacillus; afb; c&s; cult; cultures; id; infectious disease; infectiousdisease; johnes disease; m avium; m avium paratb; microbiology; myco; mycobact; mycobacterium paratuberculosis; ordinal; paratuberculosis; point in time; pr; ql; qual; qualitative; random; screen; spec; ssp; tissue; tissue, unspecified; tuberculosis; vet; veterinary",Ord
20895-9,mycoplasma gallisepticum ag [presence] in tissue by immune stain,m gallisep ag tiss ql imstn,m. gallisepticum ag immune stain ql (tiss),"antigen; antigens; avian mycoplasmosis; chronic respiratory disease; id; ihc; imm; immunohistochemical stain; immunostain; imstn; imun; imune; infectious disease; infectiousdisease; m gallisep; m gallisepticum; microbiology; myco; mycoplas; mycoplasm; mycoplasmosis; mycoplsm; ordinal; point in time; pr; ql; qual; qualitative; random; screen; st; stains; stn; tissue; tissue, unspecified; vet; veterinary",Ord
20910-6,organochlorine pesticides [identifier] in milk,oc pesticides mlk,organochlorine pesticides nom (milk),drug/toxicology; drugs; identity or presence; mlk; nominal; oc pesticides; point in time; random,Nom
20912-2,organochlorine pesticides [presence] in blood by screen method,oc pesticides bld ql scn,organochlorine pesticides screen ql (bld),blood; drug/toxicology; drugs; oc pesticides; ordinal; point in time; pr; ql; qual; qualitative; random; scn; scr; screen; scrn; wb; whole blood,Ord
20944-5,bovine respiratory syncytial virus ag [presence] in lung by immunoassay,brsv ag lung ql ia,bovine respiratory syncytial virus ag ia ql (lung),antigen; antigens; beef; brsv; eia; elfa; elisa; enzyme immunoassay; hrsv; iaa; id; infectious disease; infectiousdisease; lung; meia; microbiology; ordinal; point in time; pr; pulmonary; pulmonology; ql; qual; qualitative; random; respiratory; rsv; screen; suds; vet; veterinary,Ord
20952-8,salmonella sp identified in egg by organism specific culture,salmonella egg cult,salmonella sp identified org specific cx nom (egg),c&s; cult; cultures; eggs; id; identity or presence; infectious disease; infectiousdisease; microbiology; nominal; point in time; random; sal; salmonel; spec; species; spp; vet; veterinary,Nom
2096-6,cholesterol/triglyceride [mass ratio] in serum or plasma,cholest/trigl serpl,cholesterol/triglyceride [mass ratio],cardio; cardiology; chemistry; chol; choles; cholest; cholesterol total; cholesterols; heart disease; lipid; mass concentration ratio; mass ratio; mcrto; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; tag; tg; triacylglycerol; trig; trigly; triglycerides; triglycrides,Qn
20975-9,thallium [mass/mass] in tissue,thallium tiss-mcnt,thallium (tiss) [mass/mass],"drug/toxicology; drugs; mass content; point in time; qnt; quan; quant; quantitative; random; tissue; tissue, unspecified; tl",Qn
20985-8,western equine encephalitis virus ab [presence] in serum by complement fixation,weev ab ser ql cf,weev ab cf ql (s),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; cf; comp fixation; compfix; complement fixation; enc; enceph; encephalomyelitis; equin; id; infectious disease; infectiousdisease; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; sr; togavirus; wee virus; weev; west,Ord
20996-5,coxsackievirus b1+b2+b3+b4+b5+b6 ab [interpretation] in serum,cv b blend ab ser-imp,coxsackievirus b1+b2+b3+b4+b5+b6 ab (s) [interp],abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; cav; coxsackie; coxsackie virus; cv; cv b blend; cv b1; id; impression; impression/interpretation of study; impressions; infectious disease; infectiousdisease; interp; interpretation; microbiology; nominal; point in time; random; serum; sr,Nom
20997-3,deprecated cryptosporidium sp ag [presence] in unspecified specimen by immunofluorescence,deprecated cryptosporidium,cryptosporidium,crypt; crypto; cryptosporidiosis; id; infectious disease; infectiousdisease; microbiology,-
21002-1,fibrinogen [interpretation] in platelet poor plasma,fibrinogen ppp-imp,fibrinogen (ppp) [interp],coagulation; coagulation factor i; fgn; hematology; heme; impression; impression/interpretation of study; impressions; interp; interpretation; nominal; plas; platelet poor plasma; point in time; random,Nom
21013-8,cd22 cells [#/volume] in blood,cd22 cells # bld,cd22 cells (bld) [#/vol],#; abs; absolute; absolutes; b3; b-3; bl-cam; blood; cd22 cells; cell; cell markers; cellularity; cnt; count; count/volume; ct; leu14; leu-14; lyb8; number concentration; number concentration (count/vol); point in time; qnt; quan; quant; quantitative; random; to-15; wb; whole blood,Qn
21015-3,cd33 cells [#/volume] in blood,cd33 cells # bld,cd33 cells (bld) [#/vol],#; abs; absolute; absolutes; blood; cd33 cells; cell; cell markers; cellularity; cnt; count; count/volume; ct; gp67; leum9; leu-m9; my9; my-9; number concentration; number concentration (count/vol); p67; point in time; qnt; quan; quant; quantitative; random; wb; whole blood,Qn
21017-9,cd57 cells [#/volume] in blood,cd57 cells # bld,cd57 cells (bld) [#/vol],#; abs; absolute; absolutes; blood; cd57 cells; cell; cell markers; cellularity; cnt; count; count/volume; ct; hnk1; leu7; leu-7; number concentration; number concentration (count/vol); point in time; qnt; quan; quant; quantitative; random; wb; whole blood,Qn
21028-6,protein [interpretation] in 24 hour urine,prot 24h ur-imp,protein (24h u) [interp],1 day; 24 hours; 24hr; chemistry; impression; impression/interpretation of study; impressions; interp; interpretation; kidney; nephrology; nominal; pr; prot; renal; ua; ur; urn,Nom
21032-8,thrombin time [interpretation] in blood,tt bld-imp,thrombin time (bld) [interp],blood; coag; hematology; heme; impression; impression/interpretation of study; impressions; interp; interpretation; nominal; point in time; random; tct; throm; thrombin clotting time; thrombin time; tt; wb; whole blood,Nom
21036-9,17-hydroxycorticosteroids [mass/time] in 24 hour urine,17ohcs 24h ur-mrate,17-hydroxycorticosteroids (24h u) [mass/time],1 day; 17-cs; 17-hydroxy corticosteroids; 17ohcs; 17-ohcs; 24 hours; 24hr; chemistry; mass rate; mrate; qnt; quan; quant; quantitative; ua; ur; urn,Qn
21042-7,3-hydroxydodecanoate (3-oh-c12:0)/creatinine [mass ratio] in urine,3oh-dodecanoate/creat ur,3-hydroxydodecanoate (3-oh-c12:0)/creatinine (u) [mass ratio],3-hydroxy dodecanoate; 3-hydroxydodecanoic acid; 3oh-ddda; 3oh-dodecanoate; chemistry; cr; crea; creat; iii; mass concentration ratio; mass ratio; mcrto; point in time; qnt; quan; quant; quantitative; random; ua; ucr; ur; urn,Qn
21051-8,acrylaldehyde [mass/volume] in serum or plasma,acrylaldehyde serpl-mcnc,acrylaldehyde [mass/vol],acrolein; drug/toxicology; drugs; level; mass concentration; pl; plasma; plsm; point in time; propenal; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
2105-5,choriogonadotropin [moles/volume] in semen,hcg smn-scnc,hcg (sem) [moles/vol],cg; chemistry; choriogonadotropins total; chorionic gonadotropin; ejaculate; genitourinary; gu; hcg; human chorionic gonadotropin; level; point in time; qnt; quan; quant; quantitative; random; sem; seminal fluid; smn; smpls; substance concentration; uro; urology,Qn
21064-1,acid alpha glucosidase [enzymatic activity/volume] in amniotic fluid,acid a-glucosidase amn-ccnc,acid alpha glucosidase (amn fld) [catalytic activity/vol],"acd; acid a-glucosidase; acid maltase; acids; af; alfa; alpha galactosidase; alpha-1,4-glucosidase; amn; amn fl; amnio; amniotic flu; amniotic fluid; catalytic concentration; chemistry; gaa; glucoinvertase; glucosidosucrase; maltase; maltase-glucoamylase; point in time; pompe disease; qnt; quan; quant; quantitative; random",Qn
21078-1,green ash ige ab [units/volume] in serum,green ash ige qn,green ash ige qn (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; green ash; immune globulin e; immunoglobulin e; point in time; qnt; quan; quant; quantitative; random; serum; sr,Qn
2109-7,choriogonadotropin.alpha subunit [moles/volume] in serum or plasma,a-hcg serpl-scnc,hcg.alpha subunit [moles/vol],a hcg; a-hcg; alfa; alpha human chorionic gonadotropin; cg; chemistry; choriogonadotropins total; chorionic gonadotropin; hcg; human chorionic gonadotropin; level; pituitary glycoproteins; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; substance concentration; tumor marker,Qn
21115-1,deprecated blueberry igg ab rast class [presence] in serum,deprecated blueberry igg rast ql,blueberry igg rast class (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; blue berry; blueberry; f288; igg rast; immune globulin g; immunoglobulin g; ordinal; point in time; pr; ql; qual; qualitative; random; rf288; screen; serum; sr,Ord
21118-5,borrelia burgdorferi igg ab [presence] in synovial fluid by immunoassay,b burgdor igg snv ql ia,b. burgdorferi igg ia ql (syn fld),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; b burg; b burgdor; b burgdorferi; bb; burgdorf; eia; elfa; elisa; enzyme immunoassay; iaa; id; immune globulin g; immunoglobulin g; infectious disease; infectiousdisease; joint aspirate; joint fld; joint flu; joint fluid; lyme; lyme disease; lymes; meia; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; rheum; rheumatology; screen; sf; snv; suds; syn; syn fl; synov; synovial fluid,Ord
21136-7,deprecated melon igg ab rast class in serum,deprecated melon igg rast ql,melon igg rast class (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; f87; honey dew; honeydew; igg rast; immune globulin g; immunoglobulin g; melon; melons; ordinal; point in time; ql; qual; qualitative; random; screen; serum; sr,Ord
21138-3,carbaryl [mass/volume] in urine,carbaryl ur-mcnc,carbaryl (u) [mass/vol],"1-naphthalenol, methylcarbamate; 1-naphthol n-methylcarbamate; 1-naphthyl methylcarbamate; 1-naphthyl n-methylcarbamate; alpha-naphthalenyl methylcarbamate; alpha-naphthyl methylcarbamate; alpha-naphthyl n-methylcarbamate; drug/toxicology; drugs; level; mass concentration; point in time; qnt; quan; quant; quantitative; random; sevin; ua; ur; urn",Qn
21152-4,deprecated celery igg ab rast class [presence] in serum,deprecated celery igg rast ql,celery igg rast class (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; celery; f085; f85; igg rast; immune globulin g; immunoglobulin g; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; sr,Ord
2116-2,choriogonadotropin.intact [presence] in serum or plasma,hcg intact serpl ql,hcg.intact ql,cg; chemistry; choriogonadotropins total; chorionic gonadotropin; chorionic gonadotropin.intact; hcg; hcg intact; human chorionic gonadotropin; ordinal; pl; plasma; plsm; point in time; pr; ql; qual; qualitative; random; screen; serp; serpl; serplas; serum; serum or plasma; sr,Ord
21166-4,cd56 cells/cells in specimen,cd56 cells nfr spec,cd56 cells/cells (specimen),cd56 cells; cell; cell markers; cellularity; leu19; leu-19; misc; miscellaneous; ncam; neural cell adhesion molecule; nkh1; number fraction; other; percent; point in time; qnt; quan; quant; quantitative; random; spec; to be specified in another part of the message; unspecified,Qn
21181-3,deprecated cherry igg ab rast class [presence] in serum,deprecated cherry igg rast ql,cherry igg rast class (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; bing cherry; cherry; f242; igg rast; immune globulin g; immunoglobulin g; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; sr,Ord
21186-2,chlamydia sp igm ab [presence] in serum,chlamydia igm ser ql,chlamydia sp igm ql (s),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; chlam; chlamid; id; immune globulin m; immunoglobulin m; infectious disease; infectiousdisease; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; species; spp; sr,Ord
21188-8,chlamydia trachomatis rrna [presence] in conjunctival specimen by probe,c trach rrna conjunct ql probe,c. trachomatis rrna probe ql (conj),c trac; c trach; c tracho; c trachomatis; chlam; chlam trac; chlamid; conjunct; conjunctiva; conjunctival; ct; dna nucleic acid probe; dna probe; id; infectious disease; infectiousdisease; lgv; lymphogranuloma venereum; microbiology; ordinal; palpebral sac; point in time; pr; ql; qual; qualitative; random; ribosomal rna; screen; trachoma,Ord
21200-1,chromium [mass/mass] in nail,cr nail-mcnt,chromium (nail) [mass/mass],c609; chrome; cr; drug/toxicology; drugs; mass content; nails; point in time; qnt; quan; quant; quantitative; random; ungal nail,Qn
21220-9,deprecated cilantro ige ab rast class [presence] in serum,deprecated cilantro ige rast ql,cilantro ige rast class (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; cilantro; coriander; f317; ige rast; immune globulin e; immunoglobulin e; italian parsley; ordinal; point in time; pr; ql; qual; qualitative; random; rf317; screen; serum; sr,Ord
21227-4,deprecated cotton linters ige ab rast class [presence] in serum,deprecated cotton linters ige rast ql,cotton linters ige rast class (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; ige rast; immune globulin e; immunoglobulin e; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; sr,Ord
21250-6,doxycycline [mass/volume] in specimen,doxycycline spec-mcnc,doxycycline (specimen) [mass/vol],c206; c216; drug/toxicology; drugs; level; mass concentration; misc; miscellaneous; other; point in time; qnt; quan; quant; quantitative; random; spec; to be specified in another part of the message; unspecified; vibramycin,Qn
21252-2,echinococcus granulosus igg ab [presence] in serum by immunoblot,e granulosus igg ser ql ib,e. granulosus igg ib ql (s),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; blt; e granulosus; echinococcosis; id; immune blot; immune globulin g; immunobl; immunoblot; immunoglobulin g; infectious disease; infectiousdisease; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; riba; screen; serum; sr; wb; wblot; west blot; west blt; western blot,Ord
21256-3,deprecated elder marsh ige ab rast class in serum,deprecated burweed marshelder ige rast q,burweed marshelder ige rast class (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; burweed marsh elder; burweed marshelder; ige rast; immune globulin e; immunoglobulin e; ordinal; point in time; ql; qual; qualitative; random; screen; serum; sr,Ord
21260-5,epstein barr virus nuclear ab [titer] in serum by immunofluorescence,ebv na ab titr ser if,ebv nuclear ab if (s) [titer],abs; aby; acif; ana; anf; antby; anti; antibodies; antibody; anticomplement immunofluorescence; antinuclear antibody; autoantibodies; autoantibody; dilution factor; dilution factor (titer); ebna; ebv; ebv na; epstn; fa; fana; fluorescent antibody; fluoresent; hhv-4; human herpesvirus 4; id; ifa; immune fluorescence; immunoflour; immunofluor; immunofluorescence; infectious disease; infectiousdisease; microbiology; mono; mononucleosis; na; nuc; point in time; random; serum; smqn; sr; time resolved fluorescence; titer; titered; titre; trf; ttr; universallaborders,SemiQn
21265-4,estriol (e3).unconjugated [multiple of the median] unadjusted in serum or plasma,u estriol unadj mom serpl,e3.unconjugated unadjusted [mom],chemistry; e3; estriol free; gyn; gynecology; mom; multiple of the median; ob; obgyn; obstetrics; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; u estriol; ue3; uncnj; unconj; unconjug; unconjugat,Qn
21266-2,ethion [mass/volume] in urine,ethion ur-mcnc,ethion (u) [mass/vol],drug/toxicology; drugs; level; mass concentration; nialate; point in time; qnt; quan; quant; quantitative; random; ua; ur; urn,Qn
21268-8,fenchlorphos [mass/volume] in urine,fenchlorphos ur-mcnc,fenchlorphos (u) [mass/vol],dermafos; drug/toxicology; drugs; fenclofos; level; mass concentration; phenchlorfos; point in time; qnt; quan; quant; quantitative; random; ronnel; ua; ur; urn,Qn
21269-6,fenthion [mass/volume] in urine,fenthion ur-mcnc,fenthion (u) [mass/vol],baytex; drug/toxicology; drugs; entex; level; mass concentration; mercaptophos; point in time; qnt; quan; quant; quantitative; random; ua; ur; urn,Qn
21282-9,ganglioside gd1a igm ab [titer] in serum by immunoassay,gd1a gangl igm titr ser ia,ganglioside gd1a igm ia (s) [titer],abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; dilution factor; dilution factor (titer); disialolganglioside; eia; elfa; elisa; enzyme immunoassay; gd1a; gd1a gangl; iaa; immune globulin m; immunoglobulin m; meia; point in time; random; serology; serum; smqn; sr; suds; titer; titered; titre; ttr,SemiQn
21285-2,deprecated garlic igg ab rast class [presence] in serum,deprecated garlic igg rast ql,garlic igg rast class (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; f047; f47; garlic; igg rast; immune globulin g; immunoglobulin g; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; sr,Ord
21306-6,glucose [mass/time] in 8 hour urine,glucose 8h ur-mrate,glucose (8h u) [mass/time],1/3 day; 8 hours; 8hr; chemistry; glu; gluc; glucoseur; mass rate; mrate; qnt; quan; quant; quantitative; ua; ur; urn,Qn
21312-4,gold [mass/volume] in body fluid,gold fld-mcnc,gold (body fld) [mass/vol],"au; b/f; bf; bod; bodies; body fluid; body fluid, unsp; drug/toxicology; drugs; fl; fld; flu; fluid; level; mass concentration; point in time; qnt; quan; quant; quantitative; random",Qn
21313-2,deprecated grain elevator dust ige ab rast class [presence] in serum,deprecated grain elevat dust ige rast ql,grain elevator dust ige rast class (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; grain elevat dust; ige rast; immune globulin e; immunoglobulin e; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; sr,Ord
21331-4,hiv 1 p24 ab [titer] in serum by immunoblot,hiv1 p24 ab titr ser ib,hiv 1 p24 ab ib (s) [titer],abs; aby; aids; antby; anti; antibodies; antibody; autoantibodies; autoantibody; blt; dilution factor; dilution factor (titer); hiv type 1; hiv type i; hiv1; hiv1 p24; human immunodeficiency virus; i; id; immune blot; immunobl; immunoblot; infectious disease; infectiousdisease; microbiology; point in time; random; riba; serum; smqn; sr; titer; titered; titre; ttr; wb; wblot; west blot; west blt; western blot,SemiQn
21341-3,hla-dr locus [type],hla-dr locus,hla-dr locus nom (bld/tiss),"blood; genetics; heredity; heritable; hla antigen; human leukocyte antigen; i3; inherited; nominal; point in time; random; tissue; tissue, unspecified; typ; wb; whole blood; whole blood or tissue",Nom
21342-1,hla-dr locus 2 [type],hla-dr locus 2,hla-dr locus 2 nom (bld/tiss),"blood; genetics; heredity; heritable; hla antigen; human leukocyte antigen; i3; ii; inherited; nominal; point in time; random; tissue; tissue, unspecified; typ; wb; whole blood; whole blood or tissue",Nom
21352-0,intercellular substance igg ab [interpretation] in serum by immunofluorescence,ics igg ser if-imp,intercellular substance igg if (s) [interp],abs; aby; acif; antby; anti; antibodies; antibody; anticomplement immunofluorescence; autoantibodies; autoantibody; cell surface; fa; fluorescent antibody; fluoresent; ics; ifa; immune fluorescence; immune globulin g; immunoflour; immunofluor; immunofluorescence; immunoglobulin g; impression; impression/interpretation of study; impressions; intercellular structure; interp; interpretation; nominal; paraneoplastic pemphigus; pemphigus; point in time; random; serology; serum; sr; subs; time resolved fluorescence; trf,Nom
21354-6,deprecated karaya gum ige ab rast class [presence] in serum,deprecated karaya gum ige rast ql,karaya gum ige rast class (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; f374; ige rast; immune globulin e; immunoglobulin e; indian tragacanth; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; sr,Ord
21356-1,ketones [presence] in urine --3.5 hours post xxx challenge,ketones 3.5h p chal ur ql,ketones 3.5 hr post unsp challenge ql (u),3.5h p chal; acetest; acetoacetate; acetoacetates; acetone bodies; after; chemistry.challenge testing; ketone; ketone bodies; ordinal; p chal; point in time; pr; pst; ql; qual; qualitative; random; screen; ua; ur; urn,Ord
21376-9,deprecated macadamia ige ab rast class [presence] in serum,deprecated macadamia ige rast ql,macadamia ige rast class (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; australian nut; autoantibodies; autoantibody; f345; ige rast; immune globulin e; immunoglobulin e; macadamia nut; ordinal; point in time; pr; ql; qual; qualitative; queensland nut; random; rf345; screen; serum; sr,Ord
21380-1,prolactin [mass/time] in 24 hour urine,prolactin 24h ur-mrate,prolactin (24h u) [mass/time],1 day; 24 hours; 24hr; chemistry; lactotropic hormone; lactotropin; mammatropic hormone; mammotropin; mass rate; mrate; prl; prol; qnt; quan; quant; quantitative; ua; ur; urn,Qn
21382-7,manganese [mass/volume] in 24 hour urine,manganese 24h ur-mcnc,manganese (24h u) [mass/vol],1 day; 24 hours; 24hr; drug/toxicology; drugs; level; mass concentration; mn; qnt; quan; quant; quantitative; ua; ur; urn,Qn
2138-6,coproporphyrinogen oxidase [enzymatic activity/volume] in serum,coprogen-oxidase ser-ccnc,coproporphyrinogen oxidase (s) [catalytic activity/vol],catalytic concentration; chemistry; coprogen-oxidase; cpg o; hematology; heme; point in time; qnt; quan; quant; quantitative; random; serum; sr,Qn
21397-5,mononuclear cells [#/volume] in body fluid by manual count,mononuc cells # fld manual,mononuclear cells manual cnt (body fld) [#/vol],"#; abs; absolute; absolutes; b/f; bf; bod; bodies; body fluid; body fluid, unsp; cell; cellularity; cnt; count; count/volume; ct; fl; fld; flu; fluid; hematology/cell counts; manl; mononuc; mononuc cells; number concentration; number concentration (count/vol); point in time; qnt; quan; quant; quantitative; random",Qn
21409-8,myelin igm ab [titer] in serum,myelin igm titr ser,myelin igm (s) [titer],abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; dilution factor; dilution factor (titer); immune globulin m; immunoglobulin m; point in time; random; serology; serum; smqn; sr; titer; titered; titre; ttr,SemiQn
21416-3,neisseria gonorrhoeae dna [presence] in urine by naa with probe detection,n gonorrhoea dna ur ql naa+probe,n. gonorrhoeae dna naa+probe ql (u),3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; deoxyribonucleic acid; dna nucleic acid probe; dna probe; gc; gono; gonorrhea; id; infectious disease; infectiousdisease; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; n gonorrhoea; n gonorrhoeae; naa+probe; naat; nasba; nucleic acid sequence based analysis; ordinal; pcr; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; screen; sda; strand displacement amplification; tma; transcription mediated amplification; ua; universallaborders; ur; urn,Ord
2142-8,cortisol [mass/volume] in saliva (oral fluid),cortis sal-mcnc,cortisol (sal) [mass/vol],17-hydroxycorticosterone; chemistry; compound f; coritsol; cort; f; hydrocortisone; level; mass concentration; oral fluid; point in time; qnt; quan; quant; quantitative; random; sal; universallaborders,Qn
21430-4,deprecated onion igg ab rast class [presence] in serum,deprecated onion igg rast ql,onion igg rast class (s),abs; aby; allergen; allergens; allergy testing; allium salota dostl; antby; anti; antibodies; antibody; autoantibodies; autoantibody; f048; f48; igg rast; immune globulin g; immunoglobulin g; onion; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; sr,Ord
21437-9,oxychlordane [mass/volume] in serum or plasma,oxychlordane serpl-mcnc,oxychlordane [mass/vol],chlordane metabolite; drug/toxicology; drugs; level; mass concentration; octachlor epoxide; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
21448-6,deprecated pear igg ab rast class [presence] in serum,deprecated pear igg rast ql,pear igg rast class (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; f094; f94; igg rast; immune globulin g; immunoglobulin g; ordinal; pear; point in time; pr; ql; qual; qualitative; random; screen; serum; sr,Ord
21457-7,phorate [mass/volume] in urine,phorate ur-mcnc,phorate (u) [mass/vol],c7h17o2ps3; drug/toxicology; drugs; level; mass concentration; point in time; qnt; quan; quant; quantitative; rampart; random; thimet; ua; ur; urn,Qn
21458-5,phosphate [mass/volume] in 24 hour urine,phosphate 24h ur-mcnc,phosphate (24h u) [mass/vol],1 day; 24 hours; 24hr; chemistry; i phos; inorganic phosphate; kidney; level; mass concentration; nephrology; phos; phosphate total; phosphorous; phosphorus; phosphrous; pi; po4; qnt; quan; quant; quantitative; renal; ua; ur; urn,Qn
21472-6,deprecated pomegranate ige ab rast class [presence] in serum,deprecated pomegranate ige rast ql,pomegranate ige rast class (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; ige rast; immune globulin e; immunoglobulin e; ordinal; point in time; pomegranate; pr; ql; qual; qualitative; random; screen; serum; sr,Ord
21478-3,deprecated potato ige ab rast class in serum,deprecated potato ige rast ql,potato ige rast class (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; f035; f35; ige rast; immune globulin e; immunoglobulin e; ordinal; point in time; potato; ql; qual; qualitative; random; screen; serum; sr; white potato,Ord
21480-9,propoxur [mass/volume] in urine,propoxur ur-mcnc,propoxur (u) [mass/vol],bayer 39007; baygon; drug/toxicology; drugs; level; mass concentration; point in time; qnt; quan; quant; quantitative; random; ua; ur; urn,Qn
21484-1,mother's race,mother's race,,clin; ethnicity; gyn; gynecology; mat; maternal; matnl; nominal; ob; obgyn; obstetrics; point in time; random; typ,Nom
21497-3,rickettsia typhus group igm ab [titer] in cerebral spinal fluid by immunofluorescence,rick typhus igm titr csf if,r. typhus group igm if (csf) [titer],abs; aby; acif; antby; anti; antibodies; antibody; anticomplement immunofluorescence; autoantibodies; autoantibody; cerebral spinal fluid; cerebrospinal fl; dilution factor; dilution factor (titer); fa; fluorescent antibody; fluoresent; id; ifa; immune fluorescence; immune globulin m; immunoflour; immunofluor; immunofluorescence; immunoglobulin m; infectious disease; infectiousdisease; microbiology; neuro; neurology; point in time; random; rick typhus; ricket; rickettsial; smqn; spinal fl; spinal fld; spinal flu; spinal fluid; time resolved fluorescence; titer; titered; titre; trf; ttr; typh; typhus,SemiQn
21512-9,salmonella paratyphi a h ab [titer] in serum by immunofluorescence,s paraty a h ab titr ser if,s. paratyphi a h ab if (s) [titer],abs; aby; acif; antby; anti; antibodies; antibody; anticomplement immunofluorescence; autoantibodies; autoantibody; bombay ab; dilution factor; dilution factor (titer); fa; fluorescent antibody; fluoresent; id; ifa; immune fluorescence; immunoflour; immunofluor; immunofluorescence; infectious disease; infectiousdisease; microbiology; paratyph; paratyphoid; point in time; random; s paraty; s paraty a; s paraty a h; s paratyph; s paratyphi; sal; sal paratyph; sal paratyphi; salmonel; serum; smqn; sr; time resolved fluorescence; titer; titered; titre; trf; ttr,SemiQn
2151-9,creatine kinase [enzymatic activity/volume] in cerebral spinal fluid,ck csf-ccnc,ck (csf) [catalytic activity/vol],catalytic concentration; cerebral spinal fluid; cerebrospinal fl; chemistry; ck; cpk; creatine phosphokinase; neuro; neurology; point in time; qnt; quan; quant; quantitative; random; spinal fl; spinal fld; spinal flu; spinal fluid,Qn
2152-7,creatine kinase.bb [enzymatic activity/volume] in serum or plasma by electrophoresis,ck bb serpl elph-ccnc,ck.bb elph [catalytic activity/vol],catalytic concentration; chemistry; ck; ck 1; ck bb; ck-bb; cpk; creatine phosphokinase; elec; elect; electr; electro; electrophhrs; electrophrs; elp; elph; ep; neuro; neurology; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
21533-5,spermatozoa motile/spermatozoa in semen --3 hours post ejaculation,sperm motile 3h p ejac nfr smn,spermatozoa motile/spermatozoa 3 hr post ejaculation (sem),3h p ejac; after; ejaculate; fertility testing; genitourinary; gu; mot; number fraction; p ejac; percent; point in time; pst; qnt; quan; quant; quantitative; random; sem; seminal fluid; smn; smpls; sperm; sperm motile; uro; urology,Qn
2154-3,creatine kinase.mb [enzymatic activity/volume] in serum or plasma by electrophoresis,ck mb serpl elph-ccnc,ck.mb elph [catalytic activity/vol],cardio; cardiology; catalytic concentration; chemistry; ck; ck 2; ck mb; ck-2; ckmb; ck-mb; cpk; creatine phosphokinase; elec; elect; electr; electro; electrophhrs; electrophrs; elp; elph; ep; heart disease; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
21547-5,deprecated sunflower seed igg ab rast class [presence] in serum,deprecated sunflower seed igg rast ql,sunflower seed igg rast class (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; f183; igg rast; immune globulin g; immunoglobulin g; k84; ordinal; point in time; pr; ql; qual; qualitative; random; screen; seeds; serum; sr; sunflower; sunflower pip; sunflower seed,Ord
21565-7,tiagabine [mass/volume] in serum or plasma,tiagabine serpl-mcnc,tiagabine [mass/vol],drug/toxicology; drugs; gabitril; level; mass concentration; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
21568-1,deprecated tomato igg ab rast class [presence] in serum,deprecated tomato igg rast ql,tomato igg rast class (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; f25; igg rast; immune globulin g; immunoglobulin g; lycopersicon esculatum; lycopersicon lycopersicon; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; sr; tomato,Ord
21574-9,transferrin.carbohydrate deficient.monosialo/transferrin.total in serum or plasma,cdt monosialo/tf mfr serpl,transferrin.carbohydrate deficient.monosialo/total transferrin [mass fraction],cdt; cdt monosialo; chemistry; glycosylated transferrin; mass fraction; mono-oligo; percent; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; siderophilin; sr; tf; tot; totl; trf; trfrn,Qn
21582-2,tryptase [mass/volume] in serum or plasma,tryptase serpl-mcnc,tryptase [mass/vol],chemistry; level; mass concentration; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; universallaborders,Qn
2158-4,creatine kinase.total/creatine kinase.mb [enzymatic activity ratio] in serum or plasma,ck/ck mb serpl-crto,ck.total/creatine kinase.mb [catalytic ratio],cardio; cardiology; catalytic concentration ratio; catalytic ratio; ccrto; chemistry; ck; ck 2; ck mb; ck-2; ckmb; ck-mb; cpk; creatine phosphokinase; enzymatic activity ratio; heart disease; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; tot; totl,Qn
21584-8,deprecated turkey feather ige ab rast class [presence] in serum,deprecated turkey feather ige rast ql,turkey feather ige rast class (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; e89; feathers; ige rast; immune globulin e; immunoglobulin e; meleagis gallopavo; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; sr,Ord
21585-5,uranium [mass/volume] in 24 hour urine,uranium 24h ur-mcnc,uranium (24h u) [mass/vol],1 day; 24 hours; 24hr; drug/toxicology; drugs; level; mass concentration; qnt; quan; quant; quantitative; u; ua; ur; urn,Qn
21587-1,urate [mass/volume] in 24 hour urine,urate 24h ur-mcnc,urate (24h u) [mass/vol],1 day; 24 hours; 24hr; chemistry; kidney; level; mass concentration; nephrology; qnt; quan; quant; quantitative; renal; ua; ur; urates; uric acid; urn,Qn
21600-2,deprecated english walnut ige ab rast class [presence] in serum,deprecated english walnut ige rast ql,english walnut ige rast class (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; english walnut; ige rast; immune globulin e; immunoglobulin e; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; sr,Ord
21611-9,age estimated,age time patient est,age est,est; estimation; misc; point in time; qnt; quan; quant; quantitative; random,Qn
21632-5,atp7b gene p.his1070gln [presence] in blood or tissue by molecular genetics method,atp7b p.h1070q bld/t ql,atp7b gene p.his1070gln molgen ql (bld/tiss),"atp7b p.h1070q; atpase gene; atpase, cu++ transporting, beta polypeptide; blood; cu(2+)- transporting beta polypeptide; genetics; heredity; heritable; his1070gln; inherited; molecular genetics; molecular pathology; molpath; molpath.mutations; ordinal; p prime; pcr; point in time; pr; pwd; ql; qual; qualitative; random; screen; tissue; tissue, unspecified; wb; wc1; wd; whole blood; whole blood or tissue; wilson disease; wnd",Ord
21639-0,brca1 gene mutations tested for in blood or tissue by molecular genetics method nominal,brca1 gene mut tested bld/t,brca1 gene mutations tested for molgen nom (bld/tiss),"blood; brca; brcai; brcc1; breast cancer 1, early onset; brovca1; fancs; gene mut tested; genetics; heredity; heritable; identity or presence; inherited; iris; molecular genetics; molecular pathology; molpath; molpath.mutations; mut; mut tested; mutation; muts; nominal; oncology; papillary serous carcinoma of the peritoneum; pcr; pnca4; point in time; ppp1r53; pscp; random; rnf53; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",Nom
21640-8,brca2 gene c.6174delt [presence] in blood or tissue by molecular genetics method,brca2 c.6174delt bld/t ql,brca2 gene c.6174delt molgen ql (bld/tiss),"ashkenazi jewish workup; blood; brca; brca2 c.6174delt; brcc2; breast cancer 2, early onset; brovca2; facd; fad; fad1; fancb; fancd; fancd1; genetics; glm3; heredity; heritable; inherited; molecular genetics; molecular pathology; molpath; molpath.mutations; oncology; ordinal; pcr; pnca2; point in time; pr; ql; qual; qualitative; random; screen; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue; xrcc11",Ord
2164-2,creatinine renal clearance in 24 hour urine and serum or plasma,creat cl 24h ur+serpl-vrate,creatinine renal clearance (24h u+s/p) [vol/time],1 day; 24 hours; 24hr; chemistry; cl; clear; clearanc; clearances; clr; cr; crea; creat; flow; kidney; nephrology; pl; plasma; plsm; qnt; quan; quant; quantitative; renal; serp; serpl; serplas; serum; serum or plasma; sr; ua; ucr; ur; ur+serpl; urn; volume rate; vrate,Qn
21642-4,cacna1s gene p.arg1239gly [presence] in blood or tissue by molecular genetics method,cacna1s p.r1239g bld/t ql,cacna1s gene p.arg1239gly molgen ql (bld/tiss),"arg1239gly; blood; cach1; cacn1; cacna1s p.r1239g; cacnl1a3; calcium channel, voltage-dependent, l type, alpha 1s subunit; calcium channel, voltage-dependent, p/q type, alpha 1a subunit; cav1.1; cchl1a3; dhp receptor; genetics; heredity; heritable; hokpp; hokpp1; hypokalemic periodic paralysis; hypopp; inherited; malignant hyperthermia susceptibility 5; mhs5; molecular genetics; molecular pathology; molpath; molpath.mutations; ordinal; p prime; pcr; point in time; pr; ql; qual; qualitative; random; screen; tissue; tissue, unspecified; ttpp1; wb; whole blood; whole blood or tissue",Ord
21656-4,cftr gene mutations tested for in blood or tissue by molecular genetics method nominal,cftr mut tested bld/t,cftr gene mutations tested for molgen nom (bld/tiss),"abc35; abcc7; blood; cbavd; cf; cfa; cftr/mrp; cystic fibrosis transmembrane conductance regulator; cystic fibrosis transmembrane conductance regulator (atp-binding cassette sub-family c, member 7); dj760c5.1; gene mut tested; genetics; heredity; heritable; identity or presence; inherited; molecular genetics; molecular pathology; molpath; molpath.mutations; mrp7; mut; mut tested; mutation; muts; nominal; pcr; point in time; random; tissue; tissue, unspecified; tnr-cftr; wb; whole blood; whole blood or tissue",Nom
21657-2,col2a1 gene mutations found [identifier] in blood or tissue by molecular genetics method nominal,col2a1 gene mut anl bld/t,col2a1 gene targeted mutation analysis molgen nom (bld/tiss),"anfh; aom; blood; cartilage collagen gene; col11a3; collagen, type ii, alpha 1; genetics; heredity; heritable; identity or presence; inherited; molecular genetics; molecular pathology; molpath; molpath.mutations; mut; mut anl; mutations; nominal; pcr; point in time; primary osteoarthritis; random; sedc; spondyloepiphyseal dysplasia; stickler syndrome; stl1; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",Nom
2165-9,cryofibrinogen [mass/volume] in blood,cryofib bld-mcnc,cryofibrinogen (bld) [mass/vol],blood; chemistry; level; mass concentration; point in time; qnt; quan; quant; quantitative; random; wb; whole blood,Qn
21659-8,ctnnb1 gene mutations found [identifier] in blood or tissue by molecular genetics method nominal,ctnnb1 gene mut anl bld/t,ctnnb1 gene targeted mutation analysis molgen nom (bld/tiss),"armadillo; beta-catenin gene; blood; cadherin associated protein beta gene; catenin (cadherin-associated protein), beta 1, 88kda; colorectal cancer; ctnnb; genetics; hepatoblastoma; heredity; heritable; identity or presence; inherited; molecular genetics; molecular pathology; molpath; molpath.mutations; mrd19; mut; mut anl; mutations; nominal; pcr; pilomatricoma; point in time; random; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",Nom
21667-1,f5 gene mutations found [identifier] in blood or tissue by molecular genetics method nominal,f5 gene mut anl bld/t,f5 gene targeted mutation analysis molgen nom (bld/tiss),"activated protein c cofactor; apc; blood; coagulation factor v - leiden gene; coagulation factor v (proaccelerin, labile factor); fvl; genetics; heredity; heritable; identity or presence; inherited; labile factor; molecular genetics; molecular pathology; molpath; molpath.mutations; mut; mut anl; mutations; nominal; pccf; pcr; point in time; proaccelerin gene; random; rprgl1; thph2; thrombophilia; tissue; tissue, unspecified; universallaborders; wb; whole blood; whole blood or tissue",Nom
21677-0,fgfr3 gene p.gly375cys [presence] in blood or tissue by molecular genetics method,fgfr3 p.g375c bld/t ql,fgfr3 gene p.gly375cys molgen ql (bld/tiss),"ach; achondroplasia; blood; cd333; cek2; fgfr3 p.g375c; fibroblast growth factor receptor 3; genetics; gly375cys; heredity; heritable; hsfgfr3ex; inherited; jtk4; molecular genetics; molecular pathology; molpath; molpath.mutations; ordinal; p prime; pcr; point in time; pr; ql; qual; qualitative; random; screen; thanatophoric dwarfism; thanatophoric dysplasia; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",Ord
21686-1,hadhb gene mutations tested for in blood or tissue by molecular genetics method nominal,hadhb gene mut tested bld/t,hadhb gene mutations tested for molgen nom (bld/tiss),"blood; echb; gene mut tested; genetics; heredity; heritable; hydroxyacyl-coa dehydrogenase/3-ketoacyl-coa thiolase/enoyl-coa hydratase (trifunctional protein), beta subunit; hydroxyacyl-coenzyme a dehydrogenase/3-ketoacyl-coenzyme a thiolase/enoyl-coenzyme a hydratase (trifunctional protein), beta subunit; identity or presence; inherited; long chain-3 hydroxyacyl-coa dehydrogenase deficiency; molecular genetics; molecular pathology; molpath; molpath.mutations; mstp029; mtpb; mut; mut tested; mutation; muts; nominal; pcr; point in time; random; tissue; tissue, unspecified; tp-beta; wb; whole blood; whole blood or tissue",Nom
21697-8,hfe gene mutations tested for in blood or tissue by molecular genetics method nominal,hfe gene mut tested bld/t,hfe gene mutations tested for molgen nom (bld/tiss),"blood; gene mut tested; genetics; haemochromatosis; hemochromatosis; hereditary hemochromatosis; heredity; heritable; hfe1; hh; hlah; hla-h; identity or presence; inherited; molecular genetics; molecular pathology; molpath; molpath.mutations; mut; mut tested; mutation; muts; mvcd7; nominal; pcr; point in time; random; tfqtl2; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",Nom
21699-4,hras gene mutations tested for in blood or tissue by molecular genetics method nominal,hras gene mut tested bld/t,hras gene mutations tested for molgen nom (bld/tiss),"blood; c-bas/has; c-ha-ras1; c-h-ras; ctlo; gene mut tested; genetics; hamsv; harvey rat sarcoma viral oncogene homolog; harvey rat sarcoma virus oncogene; heredity; heritable; hras1; h-rasidx; identity or presence; inherited; molecular genetics; molecular pathology; molpath; molpath.mutations; mut; mut tested; mutation; muts; nominal; p21ras; pcr; point in time; random; rash1; tissue; tissue, unspecified; v-ha-ras viral oncogene homolog pseudogene; wb; whole blood; whole blood or tissue",Nom
21714-1,mt-tl1 gene m.3243a>g [presence] in blood or tissue by molecular genetics method,mt-tl1 m.3243a>g bld/t ql,mt-tl1 gene m.3243a>g molgen ql (bld/tiss),"a3243g; blood; diabetes mellitus-deafness syndrome maternally inherited; genetics; heredity; heritable; inherited; melas syndrome; molecular genetics; molecular pathology; molpath; molpath.mutations; mttl1; mt-tl1 m.3243a&gt;g; ordinal; pcr; point in time; pr; ql; qual; qualitative; random; screen; tissue; tissue, unspecified; trna leucine 1; trna leucine 1 (uua/g); trna-leu; wb; whole blood; whole blood or tissue",Ord
21719-0,nras gene mutations found [identifier] in blood or tissue by molecular genetics method nominal,nras gene mut anl bld/t,nras gene targeted mutation analysis molgen nom (bld/tiss),"alps4; blood; cmns; genetics; heredity; heritable; identity or presence; inherited; molecular genetics; molecular pathology; molpath; molpath.mutations; mut; mut anl; mutations; ncms; neuroblastoma ras viral (v-ras) oncogene homolog; nominal; n-ras; nras1; ns6; oncogene nras; pcr; point in time; random; tissue; tissue, unspecified; v-ras neuroblastoma ras viral oncogene homolog; wb; whole blood; whole blood or tissue",Nom
21755-4,cacna1a gene cag repeats [presence] in blood or tissue by molecular genetics method,cacna1a gene cag rpt bld/t ql,cacna1a gene cag repeats molgen ql (bld/tiss),"apca; ataxia-6; bi; blood; cach4; cacn3; cacna1a gene cag rpt; cacnl1a4; calcium channel, voltage-dependent, p/q type, alpha 1a subunit; cav2.1; ea2; fhm; genetics; heredity; heritable; hpca; inherited; mhp; mhp1; molecular genetics; molecular pathology; molpath; molpath.nucrepeat; ordinal; pcr; point in time; pr; ql; qual; qualitative; random; repeat; sca6; screen; spinocerebellar ataxia; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",Ord
2175-8,cystine [presence] in blood,cystine bld ql,cystine ql (bld),blood; chemistry; cys-cys; dicysteine; ordinal; point in time; pr; ql; qual; qualitative; random; screen; wb; whole blood,Ord
21761-2,deprecated fraxe gene cgg repeats [presence] in blood or tissue by molecular genetics method,deprecated fraxe gene cgg rpt bld/t ql,fraxe gene cgg repeats molgen ql (bld/tiss),"arbitrary; blood; fmr2; fmr2p; fragile x; fragile x mental retardation 2; fraxe; fraxe gene cgg rpt; fraxf; molecular genetics; molecular pathology; molpath; molpath.trinucleotide repeats; mrx2; ordinal; ox19; pcr; point in time; ql; qual; qualitative; random; repeat; screen; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",Ord
2177-4,cystine [mass/volume] in serum or plasma,cystine serpl-mcnc,cystine [mass/vol],chemistry; cys-cys; dicysteine; level; mass concentration; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
21775-2,"t(1;13)(p36.13;q14.1)(pax7,foxo1) cells/cells.total in blood or tissue by molecular genetics method","t(1;13)(pax7,foxo1) nfr bld/t","t(1;13)(p36.13;q14.1)(pax7,foxo1) cells/cells.total molgen (bld/tiss)","13q14.1; 1p36.13; blood; cell; cellularity; fkh; fkh1; fkhr; forkhead box o1a; forkhead in rhabdomyosarcoma; foxo1a; genetics; heredity; heritable; hup1; i; inherited; molecular genetics; molecular pathology; molpath; molpath.translocation; number fraction; paired box gene 7; paired box homeotic gene 7; paired domain gene hup1; pcr; percent; point in time; qnt; quan; quant; quantitative; random; t prime; t(1,13)(pax7,fkhr) gene translocation; t(1;13)(pax7,foxo1); tissue; tissue, unspecified; tot; totl; wb; whole blood; whole blood or tissue",Qn
21784-4,"t(14;18)(q32;q21.3)(igh,bcl2) cells/cells.total in blood or tissue by molecular genetics method","t(14;18)(igh,bcl2) nfr bld/t","t(14;18)(q32;q21.3)(igh,bcl2) cells/cells.total molgen (bld/tiss)","b-cell leukemia/lymphoma 2; b-cell nhl; b-cell non-hodgkin lymphoma; bcl-2; blood; cell; cellularity; follicular b cell lymphoma; genetics; heredity; heritable; inherited; molecular genetics; molecular pathology; molpath; molpath.translocation; number fraction; pcr; percent; point in time; qnt; quan; quant; quantitative; random; t prime; t(14,18)(igh,bcl2) gene translocation; t(14;18)(igh,bcl2); tissue; tissue, unspecified; tot; totl; wb; whole blood; whole blood or tissue",Qn
21789-3,"t(4;11)(q21.3;q23)(aff1,mll) cells/cells.total in blood or tissue by molecular genetics method","t(4;11)(aff1,mll) nfr bld/t","t(4;11)(q21.3;q23)(aff1,mll) cells/cells.total molgen (bld/tiss)","af4; all1; all-1; blood; cell; cellularity; fel; genetics; heredity; heritable; homolog of trithorax; hrx; htrx; htrx1; inherited; mllt2; molecular genetics; molecular pathology; molpath; molpath.translocation; myeloid/lymphoid or mixed-lineage leukemia (trithorax (drosophila) homolog); myeloid/lymphoid or mixed-lineage leukemia (trithorax (drosophila)); number fraction; pcr; percent; point in time; qnt; quan; quant; quantitative; random; t prime; t(4,11)(mllt2,mll) gene translocation; t(4;11)(aff1,mll); tissue; tissue, unspecified; tot; totl; trx1; wb; whole blood; whole blood or tissue",Qn
21791-9,"t(6;9)(p22;q34)(dek,nup214) cells/cells.total in blood or tissue by molecular genetics method","t(6;9)(dek,nup214) nfr bld/t","t(6;9)(p22;q34)(dek,nup214) cells/cells.total molgen (bld/tiss)","blood; cain; can; cell; cellularity; d6s231e; d9s46e; genetics; heredity; heritable; inherited; kiaa0023; molecular genetics; molecular pathology; molpath; molpath.translocation; n214; nucleoporin 214 kd; number fraction; p250; pcr; percent; point in time; qnt; quan; quant; quantitative; random; t prime; t(6,9)(dek,nup214) gene translocation; t(6;9)(dek,nup214); t(6;9)(p23;q34); tissue; tissue, unspecified; tot; totl; wb; whole blood; whole blood or tissue",Qn
21796-8,"t(9;22)(q22;q12.2)(nr4a3,ewsr1) cells/cells.total in blood or tissue by molecular genetics method","t(9;22)(nr4a3,ewsr1) nfr bld/t","t(9;22)(q22;q12.2)(nr4a3,ewsr1) cells/cells.total molgen (bld/tiss)","blood; cell; cellularity; chn; csmf; ewing sarcoma breakpoint region 1; ews; ewscr; genetics; heredity; heritable; inherited; minor; molecular genetics; molecular pathology; molpath; molpath.translocation; nor1; nuclear receptor subfamily 4, group a, member 3; number fraction; pcr; percent; point in time; qnt; quan; quant; quantitative; random; t prime; t(9,22)(csmf,ewsr1) gene translocation; t(9;22)(nr4a3,ewsr1); tec; tissue; tissue, unspecified; tot; totl; wb; whole blood; whole blood or tissue",Qn
21817-2,"t(6;9)(p22;q34)(dek,nup214) fusion transcript [presence] in blood or tissue by molecular genetics method","t(6;9)(dek,nup214) bld/t ql","t(6;9)(p22;q34)(dek,nup214) fusion transcript molgen ql (bld/tiss)","arbitrary; blood; cain; can; d6s231e; d9s46e; dna; gene fusion; gene translocation; genetics; heredity; heritable; inherited; kiaa0023; molecular genetics; molecular pathology; molpath; molpath.translocation; n214; nucleoporin 214 kd; ordinal; p250; pcr; point in time; ql; qual; qualitative; random; rna; screen; t prime; t(6,9)(dek,nup214) gene translocation; t(6;9)(dek,nup214); t(6;9)(p23;q34); tissue; tissue, unspecified; translocation; wb; whole blood; whole blood or tissue",Ord
21822-2,"t(9;22)(q34.1;q11)(abl1,bcr) fusion transcript major break points [presence] in blood or tissue by molecular genetics method","t(9;22)(abl1,bcr) major bld/t ql","t(9;22)(q34.1;q11)(abl1,bcr) fusion transcript major break points molgen ql (bld/tiss)","abl; all; arbitrary; b2a2; b2a2+b3a2; b2a3; b3a2; b3a3; bcr/abl; bcr1; bcr-abl1; blood; breakpoint; breakpoint cluster region; c3a2; chronic myeloid leukemia; cml; d22s11; d22s662; dna; gene fusion; gene translocation; genetics; heredity; heritable; inherited; jtk7; major breakpoints; mbr; mcr; minor breakpoints; molecular genetics; molecular pathology; molpath; molpath.translocation; ordinal; p150; p210; pcr; ph chromosome; philadelphia chromosome; phl; point in time; ql; qual; qualitative; random; rna; screen; t prime; t(9,22)(abl1,bcr) gene translocation; t(9,22)(abl1,bcr) gene translocation major break points; t(9,22)(abl1,bcr) translocation; t(9,22)(q34,q11); t(9,22)(q34.1,q11); t(9;22)(abl1,bcr); tissue; tissue, unspecified; translocation; v-abl abelson murine leukemia viral oncogene homolog 1; wb; whole blood; whole blood or tissue",Ord
21823-0,"t(9;22)(q34.1;q11)(abl1,bcr) fusion transcript minor break points [presence] in blood or tissue by molecular genetics method","t(9;22)(abl1,bcr) minor bld/t ql","t(9;22)(q34.1;q11)(abl1,bcr) fusion transcript minor break points molgen ql (bld/tiss)","abl; all; arbitrary; bcr/abl; bcr1; bcr-abl1; blood; breakpoint; breakpoint cluster region; chronic myeloid leukemia; cml; d22s11; d22s662; dna; e1a2; e1a3; e6a2; gene fusion; gene translocation; genetics; heredity; heritable; inherited; jtk7; major breakpoints; mbr; mcr; minor breakpoints; minor cluster region; molecular genetics; molecular pathology; molpath; molpath.translocation; ordinal; p150; p190; pcr; ph chromosome; philadelphia chromosome; phl; point in time; ql; qual; qualitative; random; rna; screen; t prime; t(9,22)(abl1,bcr) gene translocation; t(9,22)(abl1,bcr) gene translocation minor break points; t(9,22)(abl1,bcr) translocation; t(9,22)(q34,q11); t(9,22)(q34.1,q11); t(9;22)(abl1,bcr); tissue; tissue, unspecified; translocation; v-abl abelson murine leukemia viral oncogene homolog 1; wb; whole blood; whole blood or tissue",Ord
21825-5,"t(x;18)(q11.2;p11.23)(ss18,ssx1) fusion transcript [presence] in blood or tissue by molecular genetics method","t(x;18)(ss18,ssx1) bld/t ql","t(x;18)(q11.2;p11.23)(ss18,ssx1) fusion transcript molgen ql (bld/tiss)","arbitrary; blood; dna; gene fusion; gene translocation; genetics; heredity; heritable; inherited; mgc5162; molecular genetics; molecular pathology; molpath; molpath.translocation; ordinal; pcr; point in time; ql; qual; qualitative; random; rna; screen; ssrc; ssxt; synovial sarcoma translocation, chromosome 18; synovial sarcoma, translocated to x chromosome; synovial sarcoma, x breakpoint 1; syt; t prime; t(x,18)(ssxt,ssx1) gene translocation; t(x;18)(ss18,ssx1); tissue; tissue, unspecified; translocation; wb; whole blood; whole blood or tissue",Ord
2183-2,cytochrome b5 reductase [enzymatic activity/volume] in serum,cyb5 reduct ser-ccnc,cytochrome b5 reductase (s) [catalytic activity/vol],"b5 reductase, nadh-cytochrome; catalytic concentration; chemistry; cyb5 reduct; cyt; methemoglobin reductase; nadh cytochrome b5 reductase; nadh methemoglobin reductase; nadh-cytochrome b5 reductase; point in time; qnt; quan; quant; quantitative; random; serum; sr",Qn
21900-6,regional lymph nodes.pathology [class] cancer,reg ln.pathology cancer,,ca; misc; miscellaneous; nominal; oncology; other; path; point in time; random; reg ln.pathology; spec; to be specified in another part of the message; tumor registry(naaccr); unspecified,Nom
21904-8,stager.pathology cancer,stager.pathology cancer,,ca; misc; miscellaneous; nominal; oncology; other; path; point in time; random; spec; to be specified in another part of the message; tumor registry(naaccr); typ; unspecified,Nom
21916-2,descriptor.other cancer narrative,descript.other cancer,,ca; descript.other; finding; findings; misc; miscellaneous; narrative; oncology; other; othr; point in time; random; report; spec; to be specified in another part of the message; tumor registry(naaccr); unspecified,Nar
2192-3,dehydroepiandrosterone sulfate (dhea-s) [mass/time] in 24 hour urine,dhea-s 24h ur-mrate,dhea-s (24h u) [mass/time],1 day; 24 hours; 24hr; adrenal dysfunction; chemistry; dhea; dheas; dhea-s; dhea-so4; endocrine; endocrinology; mass rate; mrate; prasterone; qnt; quan; quant; quantitative; so4; so4-2; sulf; ua; ur; urn,Qn
21928-7,date 1st hormone treatment cancer,date 1st hormone cancer,,ca; first; horm; misc; miscellaneous; oncology; other; point in time; qnt; quan; quant; quantitative; random; spec; to be specified in another part of the message; tumor registry(naaccr); tx; unspecified,Qn
21948-5,biological response modifier treatment cancer,biological response modifier rx cancer,,brm; ca; misc; miscellaneous; nominal; oncology; other; point in time; random; spec; to be specified in another part of the message; treatment; tumor registry(naaccr); typ; unspecified,Nom
21951-9,reason for no chemotherapy treatment cancer,reason for no chemotherapy rx cancer,,ca; chemo; misc; miscellaneous; nominal; oncology; other; point in time; random; spec; to be specified in another part of the message; treatment; tumor registry(naaccr); typ; unspecified,Nom
21952-7,reason for no hormone treatment cancer,reason for no hormone rx cancer,,ca; horm; misc; miscellaneous; nominal; oncology; other; point in time; random; spec; to be specified in another part of the message; treatment; tumor registry(naaccr); typ; unspecified,Nom
21958-4,regional radiation treatment dose,reg radiation rx dose,,dose med or substance; energy content; oncology; point in time; qnt; quan; quant; quantitative; random; reg radiation rx; treatment; tumor registry(naaccr),Qn
21975-8,date last contact,date last contact,,oncology; past; point in time; qnt; quan; quant; quantitative; random; tumor registry(naaccr),Qn
21984-0,deprecated cause of death,deprecated cause of death,,identity or presence; nominal; point in time; random; tumor registry(naaccr),Nom
21993-1,site and laterality and sequence number override flag cancer case,site/lat/seq # o/r cancer case,,arbitrary; ca; misc; miscellaneous; no; num; oncology; ordinal; other; point in time; ql; qual; qualitative; random; screen; site/lat/seq # o/r; spec; to be specified in another part of the message; tumor registry(naaccr); unspecified,Ord
21995-6,siteandtype override flag cancer case,site/type o/r cancer case,,arbitrary; ca; misc; miscellaneous; oncology; ordinal; other; point in time; ql; qual; qualitative; random; screen; site/type o/r; spec; to be specified in another part of the message; tumor registry(naaccr); unspecified,Ord
2200-4,delta aminolevulinate [mass/time] in 24 hour urine,d-ala 24h ur-mrate,delta aminolevulinate (24h u) [mass/time],1 day; 24 hours; 24hr; 5-ala; 5-aminolevulinate; 5-aminolevulinic acid; ala; aminolevulinic acid; amnolev; amnolevuunc; chemistry; d-ala; delta-ala; delta-aminolevulinic acid; hematology; heme; mass rate; mrate; qnt; quan; quant; quantitative; ua; ur; urn,Qn
22007-9,date case report exported cancer case,date case report exported cancer case,,ca; case rprt; misc; miscellaneous; oncology; other; point in time; qnt; quan; quant; quantitative; random; spec; to be specified in another part of the message; tumor registry(naaccr); unspecified,Qn
22012-9,coding system.original.seer [identifier] cancer registry,coding sys.original.seer cancer registry,,ca; coding sys.original; coding sys.original.seer; ident; identifier; nominal; oncology; point in time; random; surveillance epidemiology and end result; tumor registry(naaccr),Nom
22017-8,state defined narrative narrative,state defined narrative,,finding; findings; narrative; oncology; point in time; random; report; tumor registry(naaccr),Nar
2202-0,deoxycholylglycine [mass/volume] in serum,do-cholylgly ser-mcnc,deoxycholylglycine (s) [mass/vol],chemistry; do-cholylgly; level; mass concentration; point in time; qnt; quan; quant; quantitative; random; serum; sr,Qn
22020-2,patient maiden name,patient maiden name,,nominal; person name; point in time; random; tumor registry(naaccr),Nom
22028-5,physician [identifier],physician,,admin; ident; identifier; intradermal; nominal; oncology; point in time; random,Nom
22041-8,chemotherapy treatment cancer narrative,chemotherapy rx cancer,,ca; chemo; finding; findings; misc; miscellaneous; narrative; oncology; other; point in time; random; report; spec; to be specified in another part of the message; treatment; tumor registry(naaccr); unspecified,Nar
22049-1,deprecated cancer identification battery,deprecatedcancer identification battery,,complex; oncology; point in time; random; tumor registry(naaccr),Multi
2206-1,"dicarboxylate, c6-c8-c10 [mass/volume] in serum",dicarboxy c6-c8-c10 ser-mcnc,"dicarboxylate, c6-c8-c10 (s) [mass/vol]",chemistry; dicarboxy c6-c8-c10; dicarboxylic acid c6-c8-c10; level; mass concentration; point in time; qnt; quan; quant; quantitative; random; serum; sr,Qn
22063-2,deprecated correction comments battery [complex] multi,deprecated correction comments battery,,complex; correctn; point in time; random; tumor registry(naaccr),Multi
22067-3,nb gene mutations tested for in blood or tissue by molecular genetics method nominal,nb gene mut tested bld/t,nb gene mutations tested for molgen nom (bld/tiss),"awd; blood; gaad; gene mut tested; genetics; heredity; heritable; identity or presence; inherited; molecular genetics; molecular pathology; molpath; molpath.mutations; mut; mut tested; mutation; muts; nb; nbs; nbs gene; ndka; ndpka; ndpk-a; neuroblastoma suppressor gene; nm23; nm23-h1; nme/nm23 nucleoside diphosphate kinase 1; nominal; pcr; point in time; random; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",Nom
22079-8,actinomyces sp ab [titer] in serum,actinomyces ab titr ser,actinomyces sp ab (s) [titer],abs; aby; actino; antby; anti; antibodies; antibody; autoantibodies; autoantibody; dilution factor; dilution factor (titer); id; infectious disease; infectiousdisease; microbiology; point in time; random; serum; smqn; species; spp; sr; titer; titered; titre; ttr,SemiQn
22080-6,adenovirus ab [titer] in serum,hadv ab titr ser,adenovirus ab (s) [titer],abs; aby; adeno virus; antby; anti; antibodies; antibody; autoantibodies; autoantibody; dilution factor; dilution factor (titer); hadv; id; infectious disease; infectiousdisease; microbiology; point in time; random; serum; smqn; sr; titer; titered; titre; ttr,SemiQn
22082-2,afipia felis igm ab [titer] in serum,a felis igm titr ser,a. felis igm (s) [titer],a felis; abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; cat scratch disease; cat scratch fever; dilution factor; dilution factor (titer); id; immune globulin m; immunoglobulin m; infectious disease; infectiousdisease; microbiology; point in time; random; serum; smqn; sr; titer; titered; titre; ttr,SemiQn
22086-3,aspergillus niger ab [presence] in serum,a niger ab ser ql,a. niger ab ql (s),a niger; abs; aby; antby; anti; antibodies; antibody; asperg; aspergil; aspergilis; aspergilla; aspergillin; aspergillosis; aspergils; aspergilus; autoantibodies; autoantibody; farmers lung; id; infectious disease; infectiousdisease; m207; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; sr; universallaborders,Ord
22104-4,babesia caballi ab [presence] in serum,b caballi ab ser ql,b. caballi ab ql (s),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; b caballi; babesia cabellii; babesiosis; id; infectious disease; infectiousdisease; microbiology; ordinal; piroplasmosis; point in time; pr; ql; qual; qualitative; random; screen; serum; sr; vet; veterinary,Ord
22108-5,babesia sp igm ab [units/volume] in serum,babesia igm ser-acnc,babesia sp igm qn (s),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; babesiosis; id; immune globulin m; immunoglobulin m; infectious disease; infectiousdisease; microbiology; piroplasmosis; point in time; qnt; quan; quant; quantitative; random; serum; species; spp; sr,Qn
22121-8,borrelia burgdorferi ab [units/volume] in serum,b burgdor ab ser-acnc,b. burgdorferi ab qn (s),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; b burg; b burgdor; b burgdorferi; bb; burgdorf; id; infectious disease; infectiousdisease; lyme; lyme disease; lymes; microbiology; point in time; qnt; quan; quant; quantitative; random; serum; sr,Qn
22173-9,chlamydophila pneumoniae igm ab [titer] in cerebral spinal fluid,c pneum igm titr csf,c. pneumoniae igm (csf) [titer],abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; c pneum; c pneumo; c pneumoniae; cerebral spinal fluid; cerebrospinal fl; chlamydia; chlamydia pneumoniae; cpn; dilution factor; dilution factor (titer); id; immune globulin m; immunoglobulin m; infectious disease; infectiousdisease; microbiology; neuro; neurology; pneu; pneum; pneumo; pneumon; pneumonia; point in time; random; smqn; spinal fl; spinal fld; spinal flu; spinal fluid; titer; titered; titre; ttr; twar agent,SemiQn
22177-0,chlamydophila psittaci iga ab [titer] in cerebral spinal fluid,c psittaci iga titr csf,c. psittaci iga (csf) [titer],abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; avian chlamydiosis; c psittaci; cerebral spinal fluid; cerebrospinal fl; chlamydia; chlamydia psittaci; chlamydial abortion; cps; dilution factor; dilution factor (titer); enzootic abortion of ewes; id; immune globulin a; immunoglobulin a; infectious disease; infectiousdisease; microbiology; neuro; neurology; ornithosis; ovine chlamydiosis; point in time; psittacosis; random; smqn; spinal fl; spinal fld; spinal flu; spinal fluid; titer; titered; titre; ttr,SemiQn
2217-8,dopamine [mass/volume] in urine,dopamine ur-mcnc,dopamine (u) [mass/vol],chemistry; level; mass concentration; point in time; qnt; quan; quant; quantitative; random; ua; universallaborders; ur; urn,Qn
22195-2,chlamydia trachomatis b igg ab [titer] in serum,c trach b igg titr ser,c. trachomatis b igg (s) [titer],abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; c trac; c trach; c trach b; c tracho; c trachomatis; chlam; chlam trac; chlamid; chlamydia trachomatis type b; ct; dilution factor; dilution factor (titer); id; immune globulin g; immunoglobulin g; infectious disease; infectiousdisease; lgv; lymphogranuloma venereum; microbiology; point in time; random; serum; smqn; sr; titer; titered; titre; trachoma; ttr,SemiQn
222-0,dicloxacillin [susceptibility] by disk diffusion (kb),dicloxacillin islt kb,dicloxacillin disk diffusion (kb) [susc],antibiotic susceptibilities; ast; disk diffusion; dynapen; id; infectious disease; infectiousdisease; islt; isol; kb; kirby-bauer; pathocil; point in time; random; sus; suscept; susceptibilities; susceptibility; susceptibilty; veracillin; veracilline,OrdQn
22200-0,chlamydia trachomatis g+f+k iga ab [titer] in serum,c trach g+f+k iga titr ser,c. trachomatis g+f+k iga (s) [titer],abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; c trac; c trach; c trach g+f+k; c tracho; c trachomatis; chlam; chlam trac; chlamid; chlamydia trachomatis type g+f+k; ct; dilution factor; dilution factor (titer); id; immune globulin a; immunoglobulin a; infectious disease; infectiousdisease; intermediate; kell blood group system; lgv; lymphogranuloma venereum; microbiology; point in time; random; serum; smqn; sr; titer; titered; titre; trachoma; ttr,SemiQn
22204-2,coccidioides immitis ab [presence] in cerebral spinal fluid,c immitis ab csf ql,c. immitis ab ql (csf),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; b immitis; blastomycoides immitis; c esteriformis; c immitis; cerebral spinal fluid; cerebrospinal fl; coccidioides esteriformis; coccidiomycosis; coccio; g immite; g louisianoideum; g metaeuropea; geotrichum immite; glenospora metaeuropea; glenosporum louisianoideum; id; infectious disease; infectiousdisease; microbiology; neuro; neurology; ordinal; p esteriformis; p mazzai; point in time; posadasia esteriformis; pr; pseudococcidioides mazzai; ql; qual; qualitative; random; san joaquin valley fever; screen; spinal fl; spinal fld; spinal flu; spinal fluid; t proteolyticum; trichosporon proteolyticum; valley fever,Ord
22232-3,coxsackievirus b4 ab [titer] in serum,cv b4 ab titr ser,coxsackievirus b4 ab (s) [titer],abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; cav; coxsackie; coxsackie virus; cv; cv b4; dilution factor; dilution factor (titer); id; infectious disease; infectiousdisease; microbiology; point in time; random; serum; smqn; sr; titer; titered; titre; ttr,SemiQn
22234-9,coxsackievirus b5 ab [titer] in serum,cv b5 ab titr ser,coxsackievirus b5 ab (s) [titer],abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; cav; coxsackie; coxsackie virus; cv; cv b5; dilution factor; dilution factor (titer); id; infectious disease; infectiousdisease; microbiology; point in time; random; serum; smqn; sr; titer; titered; titre; ttr,SemiQn
22235-6,coxsackievirus b6 ab [titer] in cerebral spinal fluid,cv b6 ab titr csf,coxsackievirus b6 ab (csf) [titer],abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; cav; cerebral spinal fluid; cerebrospinal fl; coxsackie; coxsackie virus; cv; cv b6; dilution factor; dilution factor (titer); id; infectious disease; infectiousdisease; microbiology; neuro; neurology; point in time; random; smqn; spinal fl; spinal fld; spinal flu; spinal fluid; titer; titered; titre; ttr,SemiQn
2223-6,elastase.leukocyte [enzymatic activity/volume] in plasma,elastase leukocyte plas-ccnc,elastase.leukocyte (p) [catalytic activity/vol],catalytic concentration; chemistry; ela; elastase leukocyte; leuc; leuk; leukocyte elastase; leukocytes; lkcs; lysosomal elastase; neutrophil elastase; pl; plasma; plsm; pmn elastase; point in time; qnt; quan; quant; quantitative; random; wbc; wbcs; white blood cell; white blood cells,Qn
22242-2,deprecated cytomegalovirus ab [titer] in serum,deprecated cmv ab titr ser,cmv ab (s) [titer],abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; cmv; cytomegalo virus; cytomgal; dilution factor; dilution factor (titer); hhv-5; human herpesvirus-5; id; infectious disease; infectiousdisease; microbiology; point in time; qnt; quan; quant; quantitative; random; serum; sr; titer; titered; titre; ttr,Qn
22246-3,cytomegalovirus igg ab [titer] in serum or plasma,cmv igg titr serpl,cmv igg [titer],abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; cmv; cytomegalo virus; cytomgal; dilution factor; dilution factor (titer); hhv-5; human herpesvirus-5; id; immune globulin g; immunoglobulin g; infectious disease; infectiousdisease; microbiology; pl; plasma; plsm; point in time; random; serp; serpl; serplas; serum; serum or plasma; smqn; sr; titer; titered; titre; ttr,SemiQn
22252-1,dengue virus 3 ab [presence] in serum,denv3 ab ser ql,denv 3 ab ql (s),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; breakbone fever; dengue type iii; denv; denv3; flavivirus; id; iii; infectious disease; infectiousdisease; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; sr,Ord
22256-2,eastern equine encephalitis virus ab [presence] in serum,eeev ab ser ql,eeev ab ql (s),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; eee virus; eeev; enc; enceph; encephalomyelitis; equin; id; infectious disease; infectiousdisease; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; sr; togavirus,Ord
22261-2,eastern equine encephalitis virus igm ab [titer] in serum,eeev igm titr ser,eeev igm (s) [titer],abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; dilution factor; dilution factor (titer); eee virus; eeev; enc; enceph; encephalomyelitis; equin; id; immune globulin m; immunoglobulin m; infectious disease; infectiousdisease; microbiology; point in time; random; serum; smqn; sr; titer; titered; titre; togavirus; ttr,SemiQn
22266-1,echovirus 1 ab [titer] in serum,ecv1 ab titr ser,echovirus 1 ab (s) [titer],abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; dilution factor; dilution factor (titer); echo; echo virus; echovirus type 1; ecv; ecv1; ev; i; id; infectious disease; infectiousdisease; microbiology; point in time; random; serum; smqn; sr; titer; titered; titre; ttr,SemiQn
22269-5,echovirus 14 ab [titer] in serum,ecv14 ab titr ser,echovirus 14 ab (s) [titer],abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; dilution factor; dilution factor (titer); echo; echo virus; echovirus type 14; ecv; ecv14; ev; id; infectious disease; infectiousdisease; microbiology; point in time; random; serum; smqn; sr; titer; titered; titre; ttr,SemiQn
22291-9,epstein barr virus capsid igg ab [titer] in cerebral spinal fluid,ebv vca igg titr csf,ebv capsid igg (csf) [titer],abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; cap; cerebral spinal fluid; cerebrospinal fl; dilution factor; dilution factor (titer); ebv; ebv capsid ab; ebv vca; epstn; hhv-4; human herpesvirus 4; id; immune globulin g; immunoglobulin g; infectious disease; infectiousdisease; microbiology; mono; mononucleosis; neuro; neurology; point in time; random; smqn; spinal fl; spinal fld; spinal flu; spinal fluid; titer; titered; titre; ttr; vca; viral capsid,SemiQn
2229-3,epiandrosterone [mass/volume] in serum or plasma,epiandrosterone serpl-mcnc,epiandrosterone [mass/vol],3-beta-epiandrosterone; 3-epiandrosterone; chemistry; level; mass concentration; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
22321-4,hepatitis b virus e ab [units/volume] in serum,hbv e ab ser-acnc,hbv e ab qn (s),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; e; hb envelope; hbe; hbeab; hbv; hbv e; hep; hep b; hep be; hepatis; hepatit; hepb; id; infectious disease; infectiousdisease; microbiology; point in time; qnt; quan; quant; quantitative; random; rh blood group system; serum; sr,Qn
22335-4,deprecated herpes simplex virus 2 ab [units/volume] in serum,deprecated hsv2 ab serpl-acnc,hsv 2 ab qn,abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; herp splx; herpes simplex virus type 2; herpes simplex virus type ii; hsv; hsv2; id; ii; infectious disease; infectiousdisease; microbiology; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
22336-2,deprecated herpes simplex virus 2 igg ab [presence] in serum,deprecated hsv2 igg ser ql,hsv 2 igg ql (s),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; herp splx; herpes simplex virus type 2; herpes simplex virus type ii; hsv; hsv2; id; ii; immune globulin g; immunoglobulin g; infectious disease; infectiousdisease; microbiology; ordinal; point in time; ql; qual; qualitative; random; screen; serum; sr,Ord
22354-5,histoplasma capsulatum mycelial phase ab [units/volume] in serum,h capsul myc ab ser-acnc,h. capsulatum mycelial phase ab qn (s),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; h capsul; h capsul myc; h capsulatum; h farciminosum; histo; histopl; histoplasma farciminosum; histoplasmin; histoplasmos; histoplasmosis; id; infectious disease; infectiousdisease; microbiology; mycel; point in time; qnt; quan; quant; quantitative; random; serum; sr,Qn
22357-8,hiv 1+2 ab [units/volume] in serum,hiv1+2 ab ser-acnc,hiv 1+2 ab qn (s),abs; aby; aids; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; hiv 1 & 2; hiv 1 and 2 ab; hiv type 1; hiv type i; hiv1; hiv1+2; human immunodeficiency virus; i; id; ii; infectious disease; infectiousdisease; microbiology; point in time; qnt; quan; quant; quantitative; random; serum; sr; universallaborders,Qn
22361-0,htlv i+ii ab [presence] in cerebral spinal fluid,htlv i+ii ab csf ql,htlv i+ii ab ql (csf),2; abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; cerebral spinal fluid; cerebrospinal fl; htlv type 1+2; htlv type i+ii; human t-cell leukemia virus; human t-cell lymphotrophic virus; id; infectious disease; infectiousdisease; microbiology; neuro; neurology; ordinal; point in time; pr; ql; qual; qualitative; random; screen; spinal fl; spinal fld; spinal flu; spinal fluid,Ord
22369-3,japanese encephalitis virus ab [presence] in cerebral spinal fluid,jev ab csf ql,jev ab ql (csf),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; cerebral spinal fluid; cerebrospinal fl; enc; enceph; encephalomyelitis; flavivirus; id; infectious disease; infectiousdisease; japanese b encephalitis; japanese encephalitis; jbe; je virus; jev; microbiology; neuro; neurology; ordinal; point in time; pr; ql; qual; qualitative; random; screen; spinal fl; spinal fld; spinal flu; spinal fluid,Ord
22370-1,japanese encephalitis virus ab [presence] in serum,jev ab ser ql,jev ab ql (s),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; enc; enceph; encephalomyelitis; flavivirus; id; infectious disease; infectiousdisease; japanese b encephalitis; japanese encephalitis; jbe; je virus; jev; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; sr,Ord
22379-2,lassa virus igm ab [presence] in serum,lasv igm ser ql,lassa virus igm ql (s),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; id; immune globulin m; immunoglobulin m; infectious disease; infectiousdisease; lasv; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; sr,Ord
22388-3,legionella pneumophila 4 igm ab [titer] in serum,l pneumo4 igm titr ser,l. pneumophila 4 igm (s) [titer],abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; dilution factor; dilution factor (titer); id; immune globulin m; immunoglobulin m; infectious disease; infectiousdisease; l pneumo; l pneumo4; l pneumonphila; legion; legionela; legionella pneumophila serogroup 4; los angeles 1; microbiology; pneu; pneum; pneumophilia; point in time; random; serum; smqn; sr; titer; titered; titre; ttr,SemiQn
22393-3,legionella pneumophila 7 ab [titer] in serum,l pneumo7 ab titr ser,l. pneumophila 7 ab (s) [titer],abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; chicago 8; dilution factor; dilution factor (titer); id; infectious disease; infectiousdisease; l pneumo; l pneumo7; l pneumonphila; legion; legionela; legionella pneumophila serogroup 7; microbiology; pneu; pneum; pneumophilia; point in time; random; serum; smqn; sr; titer; titered; titre; ttr,SemiQn
22410-5,lymphocytic choriomeningitis virus igg ab [titer] in serum,lcmv igg titr ser,lymphocytic choriomeningitis virus igg (s) [titer],abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; dilution factor; dilution factor (titer); id; immune globulin g; immunoglobulin g; infectious disease; infectiousdisease; lcmv; microbiology; point in time; random; serum; smqn; sr; titer; titered; titre; ttr,SemiQn
2241-8,estradiol (e2) free [moles/mass] in tissue,estradiol free tiss-scnt,free e2 (tiss) [moles/mass],"17-beta estradiol; chemistry; e2; estradiol free; estradiol.non-protein bound; fr; non-protein bound; oestradiol; point in time; qnt; quan; quant; quantitative; random; substance content; tissue; tissue, unspecified",Qn
22424-6,mycoplasma meleagridis ab [presence] in serum,m meleagridis ab ser ql,m. meleagridis ab ql (s),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; id; infectious disease; infectiousdisease; m meleagridis; microbiology; myco; mycoplas; mycoplasm; mycoplasmosis; mycoplsm; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; sr; vet; veterinary,Ord
22460-0,reagin ab [units/volume] in cerebral spinal fluid,reagin ab csf-acnc,reagin ab qn (csf),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; cerebral spinal fluid; cerebrospinal fl; id; infectious disease; infectiousdisease; microbiology; neuro; neurology; neurosyphilis; point in time; qnt; quan; quant; quantitative; random; spinal fl; spinal fld; spinal flu; spinal fluid; syphilis; treponema,Qn
22470-9,rickettsia (proteus ox2) ab [presence] in serum,proteus ox2 ab ser ql,rickettsia (proteus ox2) ab ql (s),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; id; infectious disease; infectiousdisease; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; ricket; rickettsial; screen; serum; sr; weil felix agglutination test,Ord
22472-5,rickettsia (proteus oxk) ab [presence] in serum,proteus oxk ab ser ql,rickettsia (proteus oxk) ab ql (s),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; id; infectious disease; infectiousdisease; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; ricket; rickettsial; screen; serum; sr; weil felix agglutination test,Ord
22479-0,rickettsia spotted fever group igm ab [titer] in serum,rick sf igm titr ser,r. spotted fever group igm (s) [titer],abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; dilution factor; dilution factor (titer); id; immune globulin m; immunoglobulin m; infectious disease; infectiousdisease; microbiology; point in time; random; rick sf; ricket; rickettsial; serum; smqn; sr; titer; titered; titre; ttr,SemiQn
22486-5,rickettsia typhi ab [units/volume] in serum,r typhi ab ser-acnc,r. typhi ab qn (s),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; endemic typhus; id; infectious disease; infectiousdisease; microbiology; murine typhus; point in time; qnt; quan; quant; quantitative; r typhi; random; ricket; rickettsial; serum; sr; typh; typhus,Qn
22497-2,rubella virus ab [titer] in serum,rubv ab titr ser,rubella virus ab (s) [titer],abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; congenital rubella syndrome; dilution factor; dilution factor (titer); german measles; id; infectious disease; infectiousdisease; microbiology; point in time; random; rubv; serum; smqn; sr; titer; titered; titre; ttr,SemiQn
22500-3,measles virus igg ab [units/volume] in cerebral spinal fluid,mev igg csf-acnc,mev igg qn (csf),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; cerebral spinal fluid; cerebrospinal fl; id; immune globulin g; immunoglobulin g; infectious disease; infectiousdisease; mev; microbiology; msls; neuro; neurology; point in time; qnt; quan; quant; quantitative; random; rubeola; spinal fl; spinal fld; spinal flu; spinal fluid,Qn
22501-1,measles virus igg ab [titer] in cerebral spinal fluid,mev igg titr csf,mev igg (csf) [titer],abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; cerebral spinal fluid; cerebrospinal fl; dilution factor; dilution factor (titer); id; immune globulin g; immunoglobulin g; infectious disease; infectiousdisease; mev; microbiology; msls; neuro; neurology; point in time; random; rubeola; smqn; spinal fl; spinal fld; spinal flu; spinal fluid; titer; titered; titre; ttr,SemiQn
22507-8,saint louis encephalitis virus ab [presence] in cerebral spinal fluid,slev ab csf ql,slev ab ql (csf),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; cerebral spinal fluid; cerebrospinal fl; enc; enceph; encephalomyelitis; id; infectious disease; infectiousdisease; microbiology; neuro; neurology; ordinal; point in time; pr; ql; qual; qualitative; random; screen; sle virus; slev; spinal fl; spinal fld; spinal flu; spinal fluid; st louis,Ord
2250-9,estriol (e3).unconjugated [mass/volume] in serum or plasma,u estriol serpl-mcnc,e3.unconjugated [mass/vol],chemistry; e3; estriol free; gyn; gynecology; level; mass concentration; ob; obgyn; obstetrics; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; u estriol; ue3; uncnj; unconj; unconjug; unconjugat; universallaborders,Qn
22518-5,salmonella paratyphi a h ab [titer] in serum,s paraty a h ab titr ser,s. paratyphi a h ab (s) [titer],abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; bombay ab; dilution factor; dilution factor (titer); id; infectious disease; infectiousdisease; microbiology; paratyph; paratyphoid; point in time; random; s paraty; s paraty a; s paraty a h; s paratyph; s paratyphi; sal; sal paratyph; sal paratyphi; salmonel; serum; smqn; sr; titer; titered; titre; ttr,SemiQn
22525-0,salmonella paratyphi c o ab [presence] in serum,s paraty c o ab ser ql,s. paratyphi c o ab ql (s),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; id; infectious disease; infectiousdisease; microbiology; ordinal; paratyph; paratyphoid; point in time; pr; ql; qual; qualitative; random; s paraty; s paraty c; s paraty c o; s paratyph; s paratyphi; sal; sal paratyph; sal paratyphi; salmonel; screen; serum; sr,Ord
22552-4,streptococcus pneumoniae danish serotype 7f igg ab [units/volume] in serum,s pneum da 7f igg ser-acnc,s. pneumoniae danish type 7f igg qn (s),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; id; immune globulin g; immunoglobulin g; infectious disease; infectiousdisease; microbiology; pcv13; pneu; pneum; pneumo; pneumococ; pneumococcal; pneumococcal pneumonia; pneumococcus; pneumon; pneumonia; point in time; ppsv23; qnt; quan; quant; quantitative; random; s pneum da 7f; s pneum da 7f ab; s pneum da 7f igg; s pneum da type; s pneumo; s pneumoniae; serum; spn; sr; strep; strept; u.s. serotype 51,Qn
22555-7,streptococcus pneumoniae danish serotype 7f ab [ratio] in serum --2nd specimen/1st specimen,s pneum da 7f ab 2:1 ser-rto,s. pneumoniae danish type 7f ab 2nd specimen/1st specimen (s) [ratio],2:1; abs; aby; acute specimen; antby; anti; antibodies; antibody; autoantibodies; autoantibody; convalescent; first; id; infectious disease; infectiousdisease; microbiology; pcv13; pneu; pneum; pneumo; pneumococ; pneumococcal; pneumococcal pneumonia; pneumococcus; pneumon; pneumonia; point in time; post immunization; ppsv23; pre immunization; qnt; quan; quant; quantitative; random; ratios; rto; s pneum da 7f; s pneum da 7f ab; s pneum da type; s pneumo; s pneumoniae; second; serum; sp1; sp2; spec; spn; sr; strep; strept; u.s. serotype 51,Qn
22564-9,streptococcus pneumoniae igg ab [units/volume] in serum --2nd specimen,s pneum igg sp2 ser-acnc,s. pneumoniae igg spec 2 qn (s),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; convalescent; id; immune globulin g; immunoglobulin g; infectious disease; infectiousdisease; microbiology; pneu; pneum; pneumo; pneumococ; pneumococcal; pneumococcal pneumonia; pneumococcus; pneumon; pneumonia; point in time; post immunization; qnt; quan; quant; quantitative; random; s pneumo; s pneumoniae; second; serum; sp2; spec; spn; sr; strep; strept,Qn
22569-8,deprecated strongyloides sp ab [units/volume] in serum,deprecated strongyloides ab serpl-acnc,strongyloides sp ab qn,abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; id; infectious disease; infectiousdisease; microbiology; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; species; spp; sr; strongyloidiasis,Qn
22572-2,saccharomonospora viridis ab [presence] in serum,s viridis ab ser ql,s. viridis ab ql (s),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; farmers lung; id; infectious disease; infectiousdisease; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; s varidis; s viridis; sacch; saccharomona viridis; screen; serum; sr; t virides; t viridis; thermoactinomyces viridis,Ord
2257-4,estrone (e1) [mass/volume] in semen,estrone smn-mcnc,e1 (sem) [mass/vol],chemistry; e1; ejaculate; genitourinary; gu; level; mass concentration; point in time; qnt; quan; quant; quantitative; random; sem; seminal fluid; smn; smpls; uro; urology,Qn
22578-9,toxoplasma gondii iga ab [units/volume] in serum,t gondii iga ser-acnc,t. gondii iga qn (s),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; id; immune globulin a; immunoglobulin a; infectious disease; infectiousdisease; microbiology; point in time; qnt; quan; quant; quantitative; random; serum; sr; t gondii; toxo; toxoplasmosis,Qn
22587-0,treponema pallidum ab [presence] in serum,t pallidum ab ser ql,t. pallidum ab ql (s),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; id; infectious disease; infectiousdisease; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; sr; syphilis; t pallidum; treponemal; universallaborders,Ord
22588-8,deprecated treponema pallidum ab [presence] in serum,deprecated t pallidum ab serpl ql,t. pallidum ab ql,abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; id; infectious disease; infectiousdisease; microbiology; ordinal; pl; plasma; plsm; point in time; ql; qual; qualitative; random; screen; serp; serpl; serplas; serum; serum or plasma; sr; syphilis; t pallidum; treponemal,Ord
22596-1,trichinella spiralis ab [titer] in serum,t spiralis ab titr ser,t. spiralis ab (s) [titer],abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; dilution factor; dilution factor (titer); id; infectious disease; infectiousdisease; microbiology; point in time; random; serum; smqn; sr; t spiralis; titer; titered; titre; tric; trich; trichinellosis; trichinosis; ttr,SemiQn
22600-1,varicella zoster virus ab [presence] in serum,vzv ab ser ql,vzv ab ql (s),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; chicken pox; chicken pox virus; chickenpox; herpes zoster; hhv-3; human herpesvirus 3; id; infectious disease; infectiousdisease; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; shingles; sr; universallaborders; vz; vzv; zoster,Ord
22619-1,yersinia enterocolitica iga ab [units/volume] in serum,y enterocol iga ser-acnc,y. enterocolitica iga qn (s),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; id; immune globulin a; immunoglobulin a; infectious disease; infectiousdisease; microbiology; point in time; qnt; quan; quant; quantitative; random; serum; sr; y enterocol; y enterocolitica,Qn
22633-2,pathology report site of origin narrative,path report.site of origin spec,,anatomy; narrative; oncology; point in time; random; report; spec; tumor registry(naaccr),Nar
22634-0,pathology report gross observation narrative,path report.gross spec,,finding; findings; narrative; oncology; point in time; random; report; spec; tumor registry(naaccr),Nar
22638-1,pathology report comments [interpretation] narrative,path report.comments imp spec,,impression; impression/interpretation of study; impressions; interp; interpretation; narrative; oncology; point in time; random; report; spec; tumor registry(naaccr),Nar
22641-5,glutamine [moles/volume] in cerebral spinal fluid,glutamine csf-scnc,glutamine (csf) [moles/vol],cerebral spinal fluid; cerebrospinal fl; chemistry; gln; level; point in time; qnt; quan; quant; quantitative; random; spinal fl; spinal fld; spinal flu; spinal fluid; substance concentration,Qn
22642-3,tyrosine [moles/volume] in cerebral spinal fluid,tyrosine csf-scnc,tyrosine (csf) [moles/vol],cerebral spinal fluid; cerebrospinal fl; chemistry; level; point in time; qnt; quan; quant; quantitative; random; spinal fl; spinal fld; spinal flu; spinal fluid; substance concentration; tyr,Qn
22648-0,methionine [moles/volume] in cerebral spinal fluid,methionine csf-scnc,methionine (csf) [moles/vol],cerebral spinal fluid; cerebrospinal fl; chemistry; level; met; point in time; qnt; quan; quant; quantitative; random; spinal fl; spinal fld; spinal flu; spinal fluid; substance concentration,Qn
2266-5,etiocholanolone [presence] in urine,etiocholanolone ur ql,etiocholanolone ql (u),aetiocholanolone; chemistry; etiochol; ordinal; point in time; pr; ql; qual; qualitative; random; screen; ua; ur; urn,Ord
22691-0,aspartate/creatinine [molar ratio] in urine,aspartate/creat ur-srto,aspartate/creatinine (u) [molar ratio],asp; aspartic acid; chemistry; cr; crea; creat; point in time; qnt; quan; quant; quantitative; random; scrto; substance concentration ratio; substance ratio; ua; ucr; ur; urn,Qn
22694-4,citrulline/creatinine [molar ratio] in urine,citrulline/creat ur-srto,citrulline/creatinine (u) [molar ratio],chemistry; cit; citr; cr; crea; creat; point in time; qnt; quan; quant; quantitative; random; scrto; substance concentration ratio; substance ratio; ua; ucr; ur; urn,Qn
22697-7,arginine/creatinine [molar ratio] in urine,arginine/creat ur-srto,arginine/creatinine (u) [molar ratio],arg; chemistry; cr; crea; creat; point in time; qnt; quan; quant; quantitative; random; scrto; substance concentration ratio; substance ratio; ua; ucr; ur; urn,Qn
22707-4,homocystine/creatinine [molar ratio] in urine,(hcys)2/creat ur-srto,homocystine/creatinine (u) [molar ratio],(hcys)2; chemistry; cr; crea; creat; homocyst(e)ine; homocystin; point in time; qnt; quan; quant; quantitative; random; scrto; substance concentration ratio; substance ratio; ua; ucr; ur; urn,Qn
22720-7,glutamine [moles/volume] in specimen,glutamine spec-scnc,glutamine (specimen) [moles/vol],chemistry; gln; level; misc; miscellaneous; other; point in time; qnt; quan; quant; quantitative; random; spec; substance concentration; to be specified in another part of the message; unspecified,Qn
22723-1,aspartate [moles/volume] in specimen,aspartate spec-scnc,aspartate (specimen) [moles/vol],asp; aspartic acid; chemistry; level; misc; miscellaneous; other; point in time; qnt; quan; quant; quantitative; random; spec; substance concentration; to be specified in another part of the message; unspecified,Qn
22735-5,bicarbonate [moles/volume] in specimen,hco3 spec-scnc,hco3 (specimen) [moles/vol],bic; bicar; bicarb; chemistry; hco3; level; misc; miscellaneous; other; point in time; qnt; quan; quant; quantitative; random; spec; substance concentration; to be specified in another part of the message; unspecified,Qn
22749-6,amylase.pancreatic [enzymatic activity/volume] in urine,amylase p ur-ccnc,amylase.pancreatic (u) [catalytic activity/vol],alpha amylase; ams; amyl; amylase p; catalytic concentration; chemistry; diastase; gastro; gastroenterology; gi; k87; pancr; pancreatc; point in time; qnt; quan; quant; quantitative; random; ua; ur; urn,Qn
2276-4,ferritin [mass/volume] in serum or plasma,ferritin serpl-mcnc,ferritin [mass/vol],chemistry; ferr; level; mass concentration; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; universallaborders,Qn
22776-9,african horse sickness virus serotype [identifier] in specimen by neutralization test,ahsv sertyp spec nt,african horse sickness virus serotype neut test nom (specimen),african horse sickness; ahs; ahsv; conventional virus neutralization test; cvnt; equus spp; id; identity or presence; infectious disease; infectiousdisease; microbiology; misc; miscellaneous; neutralization; neutralization test; nominal; nt; orbivirus; other; peste equina africana; peste equine; point in time; random; sertyp; serum virus neutralization; spec; svn; to be specified in another part of the message; unspecified; vet; veterinary; virus neutralization test; vnt,Nom
22803-1,infectious bronchitis virus ab [titer] in serum by immunoassay,ibv ab titr ser ia,infectious bronchitis virus ab ia (s) [titer],abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; avian infectious bronchitis; dilution factor; dilution factor (titer); eia; elfa; elisa; enzyme immunoassay; iaa; ibv; id; infectious disease; infectiousdisease; meia; microbiology; point in time; random; serum; smqn; sr; suds; titer; titered; titre; ttr; vet; veterinary,SemiQn
22814-8,avian infectious laryngotracheitis virus neutralizing antibody [titer] in serum by neutralization test,ilt nab titr ser nt,avian infectious laryngotracheitis virus neut ab neut test (s) [titer],abs; aby; alpha-herpesvirus; antby; anti; antibodies; antibody; autoantibodies; autoantibody; avian infectious laryngotracheitis; bird; conventional virus neutralization test; cvnt; dilution factor; dilution factor (titer); fowl; id; ilt; infectious disease; infectiousdisease; microbiology; nab; neutralization; neutralization test; nt; point in time; random; serum; serum virus neutralization; smqn; sr; svn; titer; titered; titre; ttr; vet; veterinary; virus neutralization test; vnt,SemiQn
22839-5,avian pox virus neutralizing antibody [presence] in serum by neutralization test,fwpv nab ser ql nt,avian pox virus neut ab neut test ql (s),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; avian pox; bird; canker; conventional virus neutralization test; cvnt; fowl; fowlpox; fwpv; id; infectious disease; infectiousdisease; microbiology; nab; neutralization; neutralization test; nt; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; serum virus neutralization; sore head diphtheria; sr; svn; vet; veterinary; virus neutralization test; vnt,Ord
2284-8,folate [mass/volume] in serum or plasma,folate serpl-mcnc,folate [mass/vol],chemistry; folat; folic acid; level; mass concentration; pl; plasma; plsm; point in time; pteroylglutamate; pteroylglutamic acid; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; universallaborders; vit m; vitamin m,Qn
22850-2,babesia caballi ab [presence] in serum by immunoassay,b caballi ab ser ql ia,b. caballi ab ia ql (s),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; b caballi; babesia cabellii; babesiosis; eia; elfa; elisa; enzyme immunoassay; iaa; id; infectious disease; infectiousdisease; meia; microbiology; ordinal; piroplasmosis; point in time; pr; ql; qual; qualitative; random; screen; serum; sr; suds; vet; veterinary,Ord
22855-1,babesia divergens ab [presence] in serum,b divergens ab ser ql,b. divergens ab ql (s),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; b divergens; babesiosis; id; infectious disease; infectiousdisease; microbiology; ordinal; piroplasmosis; point in time; pr; ql; qual; qualitative; random; screen; serum; sr,Ord
22858-5,babesia sp identified in tissue by giemsa stain,babesia tiss gie stn,babesia sp identified giemsa stain nom (tiss),"babesiosis; gie stn; gms; id; identity or presence; infectious disease; infectiousdisease; microbiology; nominal; piroplasmosis; point in time; random; species; spp; st; stains; stn; tissue; tissue, unspecified",Nom
22860-1,bacillus anthracis ab [presence] in serum,b anthracis ab ser ql,b. anthracis ab ql (s),abs; aby; antby; anthrax; anti; antibodies; antibody; autoantibodies; autoantibody; b anthracis; charbon; id; infectious disease; infectiousdisease; malignant carbuncle; malignant pustule; microbiology; milzbrand; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; splenic fever; sr; woolsorters disease,Ord
22880-9,border disease virus ag [presence] in specimen by immune stain,border dv ag spec ql imstn,border disease virus ag immune stain ql (specimen),antigen; antigens; bdv; border disease; border dv; dis; diseases; dz; hairy shaker disease; id; ihc; imm; immunohistochemical stain; immunostain; imstn; imun; imune; infectious disease; infectiousdisease; microbiology; misc; miscellaneous; ordinal; other; pestivirus; point in time; pr; ql; qual; qualitative; random; screen; spec; st; stains; stn; to be specified in another part of the message; unspecified; vet; veterinary,Ord
22884-1,border disease virus rna [presence] in tissue by naa with probe detection,border dv rna tiss ql naa+probe,border disease virus rna naa+probe ql (tiss),"3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; bdv; border disease; border dv; dis; diseases; dna nucleic acid probe; dna probe; dz; hairy shaker disease; id; infectious disease; infectiousdisease; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; naa+probe; naat; nasba; nucleic acid sequence based analysis; ordinal; pcr; pestivirus; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; ribonucleic acid; screen; sda; strand displacement amplification; tissue; tissue, unspecified; tma; transcription mediated amplification; vet; veterinary",Ord
22885-8,border disease virus rna [presence] in blood by naa with probe detection,border dv rna bld ql naa+probe,border disease virus rna naa+probe ql (bld),3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; bdv; blood; border disease; border dv; dis; diseases; dna nucleic acid probe; dna probe; dz; hairy shaker disease; id; infectious disease; infectiousdisease; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; naa+probe; naat; nasba; nucleic acid sequence based analysis; ordinal; pcr; pestivirus; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; ribonucleic acid; screen; sda; strand displacement amplification; tma; transcription mediated amplification; wb; whole blood,Ord
22892-4,bovine diarrhea virus neutralizing antibody [titer] in serum by neutralization test,bvdv nab titr ser nt,bovine diarrhea virus neut ab neut test (s) [titer],abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; bdv; beef; bovine viral diarrhea; bvd; bvdv; conventional virus neutralization test; cvnt; dilution factor; dilution factor (titer); id; infectious disease; infectiousdisease; microbiology; mucosal disease; nab; neutralization; neutralization test; nt; pestivirus; point in time; random; serum; serum virus neutralization; smqn; sr; svn; titer; titered; titre; ttr; virus neutralization test; vnt,SemiQn
22915-3,bovine leukemia virus ab [presence] in milk,blv ab mlk ql,bovine leukemia virus ab ql (milk),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; beef; blv; enzootic bovine leukosis; id; infectious disease; infectiousdisease; microbiology; mlk; ordinal; point in time; pr; ql; qual; qualitative; random; retrovirus; screen; vet; veterinary,Ord
22931-0,brucella melitensis ab [presence] in serum,b melitensis ab ser ql,b. melitensis ab ql (s),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; b melitensis; bruc; brucellosis; id; infectious disease; infectiousdisease; malta fever; mediterranean fever; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; sr; undulant fever,Ord
22938-5,brucella ovis ab [presence] in serum by agglutination,b ovis ab ser ql aggl,b. ovis ab aggl ql (s),abs; aby; agg; agglut; agglutination; antby; anti; antibodies; antibody; autoantibodies; autoantibody; b ovis; bruc; brucellosis; id; infectious disease; infectiousdisease; microbiology; ordinal; ovine epididymitis; point in time; pr; ql; qual; qualitative; ram epididymitis; random; screen; serum; sr,Ord
22975-7,caprine arthritis encephalitis virus ag [presence] in specimen by immune stain,caev ag spec ql imstn,caprine arthritis encephalitis virus ag immune stain ql (specimen),antigen; antigens; arth; cae; caev; caprine arthritis; enc; enceph; encephalomyelitis; id; ihc; imm; immunohistochemical stain; immunostain; imstn; imun; imune; infectious disease; infectiousdisease; lentivirus; microbiology; misc; miscellaneous; ordinal; other; point in time; pr; ql; qual; qualitative; random; screen; spec; st; stains; stn; to be specified in another part of the message; unspecified; vet; veterinary,Ord
22977-3,caprine arthritis encephalitis virus dna [presence] in specimen by polyacrylamide gel electrophoresis (page),caev dna spec ql page,caprine arthritis encephalitis virus dna page ql (specimen),arth; cae; caev; caprine arthritis; deoxyribonucleic acid; enc; enceph; encephalomyelitis; id; infectious disease; infectiousdisease; lentivirus; microbiology; misc; miscellaneous; ordinal; other; point in time; polyacrylamide gel electrophoresis; pr; ql; qual; qualitative; random; screen; spec; to be specified in another part of the message; unspecified; vet; veterinary,Ord
2298-8,deprecated fructose aldolase [enzymatic activity/volume] in serum,deprecated aldolase ser-ccnc,aldolase (s) [catalytic activity/vol],catalytic concentration; chemistry; fructose aldolase; fructose biphosphate aldolase; point in time; qnt; quan; quant; quantitative; random; serum; sr,Qn
23006-0,classical swine fever virus ag [presence] in specimen by immunofluorescence,csfv ag spec ql if,classical swine fever virus ag if ql (specimen),acif; anticomplement immunofluorescence; antigen; antigens; classical swine fever; csfv; dfa; fa; fluorescent antibody; fluoresent; hog cholera; id; ifa; immune fluorescence; immunoflour; immunofluor; immunofluorescence; infectious disease; infectiousdisease; microbiology; misc; miscellaneous; ordinal; other; pestivirus; pig; point in time; pork; pr; ql; qual; qualitative; random; screen; spec; time resolved fluorescence; to be specified in another part of the message; trf; unspecified; vet; veterinary,Ord
23016-9,coxiella burnetii [presence] in placenta by light microscopy,c burnet placenta ql micro,c. burnetii lm ql (placenta),c burnet; c burnetii; coxiella burnettii; id; infectious disease; infectiousdisease; lm; micro; microbiology; micros; microscopic; ordinal; placent; placental; point in time; pr; q fev; q fever; qfever; ql; qual; qualitative; random; screen,Ord
23018-5,coxiella burnetii ab [presence] in serum by immunofluorescence,c burnet ab ser ql if,c. burnetii ab if ql (s),abs; aby; acif; antby; anti; antibodies; antibody; anticomplement immunofluorescence; autoantibodies; autoantibody; c burnet; c burnetii; coxiella burnettii; fa; fluorescent antibody; fluoresent; id; ifa; immune fluorescence; immunoflour; immunofluor; immunofluorescence; infectious disease; infectiousdisease; microbiology; ordinal; point in time; pr; q fev; q fever; qfever; ql; qual; qualitative; random; screen; serum; sr; time resolved fluorescence; trf,Ord
23021-9,coxiella burnetii ag [presence] in tissue by immunoassay,c burnet ag tiss ql ia,c. burnetii ag ia ql (tiss),"antigen; antigens; c burnet; c burnetii; coxiella burnettii; eia; elfa; elisa; enzyme immunoassay; iaa; id; infectious disease; infectiousdisease; meia; microbiology; ordinal; point in time; pr; q fev; q fever; qfever; ql; qual; qualitative; random; screen; suds; tissue; tissue, unspecified",Ord
23022-7,coxiella burnetii ag [presence] in placenta by immunofluorescence,c burnet ag placenta ql if,c. burnetii ag if ql (placenta),acif; anticomplement immunofluorescence; antigen; antigens; c burnet; c burnetii; coxiella burnettii; dfa; fa; fluorescent antibody; fluoresent; id; ifa; immune fluorescence; immunoflour; immunofluor; immunofluorescence; infectious disease; infectiousdisease; microbiology; ordinal; placent; placental; point in time; pr; q fev; q fever; qfever; ql; qual; qualitative; random; screen; time resolved fluorescence; trf,Ord
23023-5,coxiella burnetii ag [presence] in specimen by immunofluorescence,c burnet ag spec ql if,c. burnetii ag if ql (specimen),acif; anticomplement immunofluorescence; antigen; antigens; c burnet; c burnetii; coxiella burnettii; dfa; fa; fluorescent antibody; fluoresent; id; ifa; immune fluorescence; immunoflour; immunofluor; immunofluorescence; infectious disease; infectiousdisease; microbiology; misc; miscellaneous; ordinal; other; point in time; pr; q fev; q fever; qfever; ql; qual; qualitative; random; screen; spec; time resolved fluorescence; to be specified in another part of the message; trf; unspecified,Ord
23032-6,duck enteritis virus ag [presence] in specimen by agglutination,dve ag spec ql aggl,duck enteritis virus ag aggl ql (specimen),agg; agglut; agglutination; antigen; antigens; duck plague; duck virus enteritis; dve; herpesvirus; id; infectious disease; infectiousdisease; microbiology; misc; miscellaneous; ordinal; other; point in time; pr; ql; qual; qualitative; random; screen; spec; to be specified in another part of the message; unspecified; vet; veterinary,Ord
23039-1,duck hepatitis virus 3 ab [presence] in serum,dhv3 ab ser ql,duck hepatitis virus 3 ab ql (s),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; dhv; dhv3; dhv-3; duck virus hepatitis; hep; hepatis; hepatit; id; iii; infectious disease; infectiousdisease; microbiology; ordinal; picornavirus; point in time; pr; ql; qual; qualitative; random; screen; serum; sr; vet; veterinary,Ord
23042-5,eastern equine encephalitis virus ab [titer] in serum by hemagglutination inhibition,eeev ab titr ser hai,eeev ab hai (s) [titer],abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; dilution factor; dilution factor (titer); eee virus; eeev; enc; enceph; encephalomyelitis; equin; hemagglutination inhibition; hi; id; infectious disease; infectiousdisease; microbiology; point in time; random; serum; smqn; sr; titer; titered; titre; togavirus; ttr,SemiQn
2304-4,fumarylacetoacetate [mass/volume] in serum,fumarylacetoacetate ser-mcnc,fumarylacetoacetate (s) [mass/vol],chemistry; faa; level; mass concentration; point in time; qnt; quan; quant; quantitative; random; serum; sr,Qn
23045-8,eastern equine encephalitis virus igm ab [presence] in serum by immunoassay,eeev igm ser ql ia,eeev igm ia ql (s),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; eee virus; eeev; eia; elfa; elisa; enc; enceph; encephalomyelitis; enzyme immunoassay; equin; iaa; id; immune globulin m; immunoglobulin m; infectious disease; infectiousdisease; meia; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; sr; suds; togavirus,Ord
23049-0,eastern equine encephalitis virus ag [presence] in specimen by complement fixation,eeev ag spec ql cf,eeev ag cf ql (specimen),antigen; antigens; cf; comp fixation; compfix; complement fixation; eee virus; eeev; enc; enceph; encephalomyelitis; equin; id; infectious disease; infectiousdisease; microbiology; misc; miscellaneous; ordinal; other; point in time; pr; ql; qual; qualitative; random; screen; spec; to be specified in another part of the message; togavirus; unspecified,Ord
23053-2,echinococcus sp ag [presence] in stool by immunoassay,echinococcus ag stl ql ia,echinococcus sp ag ia ql (stl),antigen; antigens; bowel movement; echinococcosis; eia; elfa; elisa; enzyme immunoassay; faecal; faeces; fecal; feces; iaa; id; infectious disease; infectiousdisease; meia; microbiology; ordinal; p2; point in time; pr; ql; qual; qualitative; random; screen; species; spp; stl; stool = fecal; suds,Ord
23059-9,epizootic hemorrhagic disease virus ab [presence] in serum by immunoassay,ehdv ab ser ql ia,epizootic hemorrhagic disease virus ab ia ql (s),abs; aby; antby; anti; antibodies; antibody; arbovirus; autoantibodies; autoantibody; culicoides; dis; diseases; dz; ehdv; eia; elfa; elisa; enzyme immunoassay; epizootic hemorrhagic disease of deer; iaa; id; infectious disease; infectiousdisease; meia; microbiology; orbivirus; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; sr; suds; vet; veterinary,Ord
23071-4,equine arteritis virus neutralizing antibody [presence] in serum by neutralization test,eav nab ser ql nt,equine arteritis virus neut ab neut test ql (s),abs; aby; antby; anti; antibodies; antibody; arterivirus; autoantibodies; autoantibody; conventional virus neutralization test; cvnt; eav; equin; equine viral arteritis; id; infectious disease; infectiousdisease; microbiology; nab; neutralization; neutralization test; nt; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; serum virus neutralization; sr; svn; vet; veterinary; virus neutralization test; vnt,Ord
23072-2,equine arteritis virus ab [presence] in serum by immunofluorescence,eav ab ser ql if,equine arteritis virus ab if ql (s),abs; aby; acif; antby; anti; antibodies; antibody; anticomplement immunofluorescence; arterivirus; autoantibodies; autoantibody; eav; equin; equine viral arteritis; fa; fluorescent antibody; fluoresent; id; ifa; immune fluorescence; immunoflour; immunofluor; immunofluorescence; infectious disease; infectiousdisease; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; sr; time resolved fluorescence; trf; vet; veterinary,Ord
23083-9,equine herpesvirus 1 dna [presence] in specimen by naa with probe detection,ehv1 dna spec ql naa+probe,equine herpesvirus 1 dna naa+probe ql (specimen),3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; deoxyribonucleic acid; dna nucleic acid probe; dna probe; ehv; ehv1; ehv-1; equid; equid alphaherpesvirus 1; equin; equine abortion herpesvirus; equine rhinopneumonitis; herpes virus; i; id; infectious disease; infectiousdisease; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; misc; miscellaneous; naa+probe; naat; nasba; nucleic acid sequence based analysis; ordinal; other; pcr; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; screen; sda; spec; strand displacement amplification; tma; to be specified in another part of the message; transcription mediated amplification; unspecified; vet; veterinary,Ord
23101-9,equine influenza virus a1 ab [presence] in serum,eiv a1 ab ser ql,equine influenza virus a1 ab ql (s),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; eiv; eiv a1; equin; equine influenza; fluv; id; infectious disease; infectiousdisease; influ; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; sr; vet; veterinary,Ord
23112-6,foot and mouth disease virus ag [presence] in tissue by complement fixation,fmdv ag tiss ql cf,foot and mouth disease virus ag cf ql (tiss),"antigen; antigens; aphthovirus; cf; comp fixation; compfix; complement fixation; dis; diseases; dz; fmdv; foot and mouth disease; id; infectious disease; infectiousdisease; lower extremity; microbiology; ordinal; picornavirus; point in time; pr; ql; qual; qualitative; random; screen; tissue; tissue, unspecified; vet; veterinary",Ord
23117-5,foot and mouth disease virus serotype [identifier] in serum by immunoassay,fmdv sertyp ser ia,foot and mouth disease virus serotype ia nom (s),aphthovirus; dis; diseases; dz; eia; elfa; elisa; enzyme immunoassay; fmdv; foot and mouth disease; iaa; id; identity or presence; infectious disease; infectiousdisease; lower extremity; meia; microbiology; nominal; picornavirus; point in time; random; sertyp; serum; sr; suds; vet; veterinary,Nom
23129-0,francisella tularensis b rrna [presence] in tissue by probe,f tular b rrna tiss ql probe,f. tularensis b rrna probe ql (tiss),"dna nucleic acid probe; dna probe; f tular; f tular b; f tularensis; id; infectious disease; infectiousdisease; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; ribosomal rna; screen; tissue; tissue, unspecified; tularemia",Ord
23133-2,histoplasma farciminosum ab [presence] in serum by immunoassay,h capsul farci ab ser ql ia,h. farciminosum ab ia ql (s),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; eia; elfa; elisa; enzyme immunoassay; epizootic lymphangitis; equine histoplasmosis; h capsul; h capsul farci; h capsulatum; h farciminosum; histo; histopl; histoplasma farciminosum; histoplasmos; histoplasmosis; iaa; id; infectious disease; infectiousdisease; meia; microbiology; ordinal; point in time; pr; pseudofarcy; pseudoglanders; ql; qual; qualitative; random; screen; serum; sr; suds; vet; veterinary,Ord
23158-9,leishmania sp rrna [identifier] in specimen by probe,leishmania rrna spec probe,leishmania sp rrna probe nom (specimen),dna nucleic acid probe; dna probe; id; identity or presence; infectious disease; infectiousdisease; kala azar; leishmaniasis; leishmaniosis; microbiology; misc; miscellaneous; nominal; other; point in time; random; ribosomal rna; spec; species; spp; to be specified in another part of the message; unspecified; visceral leishmaniasis,Nom
23163-9,leptospira interrogans sv australis ab [presence] in serum by agglutination,l inter austral ab ser ql aggl,l. interrogans sv australis ab aggl ql (s),abs; aby; agg; agglut; agglutination; antby; anti; antibodies; antibody; autoantibodies; autoantibody; id; infectious disease; infectiousdisease; l inter; l inter austral; l interrogans; leptospirosis; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; sr,Ord
23164-7,leptospira interrogans sv australis ab [presence] in serum,l inter austral ab ser ql,l. interrogans sv australis ab ql (s),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; id; infectious disease; infectiousdisease; l inter; l inter austral; l interrogans; leptospirosis; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; sr,Ord
23169-6,leptospira interrogans sv bataviae ab [presence] in serum by agglutination,l inter batav ab ser ql aggl,l. interrogans sv bataviae ab aggl ql (s),abs; aby; agg; agglut; agglutination; antby; anti; antibodies; antibody; autoantibodies; autoantibody; id; infectious disease; infectiousdisease; l inter; l inter batav; l interrogans; leptospirosis; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; sr,Ord
23180-3,leptospira interrogans sv hardjo ab [presence] in serum by agglutination,l inter hard ab ser ql aggl,l. interrogans sv hardjo ab aggl ql (s),abs; aby; agg; agglut; agglutination; antby; anti; antibodies; antibody; autoantibodies; autoantibody; id; infectious disease; infectiousdisease; l inter; l inter hard; l interrogans; leptospirosis; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; sr,Ord
23186-0,leptospira interrogans ab [presence] in serum by immunoassay,l inter ab ser ql ia,l. interrogans ab ia ql (s),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; eia; elfa; elisa; enzyme immunoassay; iaa; id; infectious disease; infectiousdisease; l inter; l interrogans; leptospirosis; meia; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; sr; suds,Ord
23204-1,leptospira sp ag [presence] in tissue by immune stain,leptospira ag tiss ql imstn,leptospira sp ag immune stain ql (tiss),"antigen; antigens; id; ihc; imm; immunohistochemical stain; immunostain; imstn; imun; imune; infectious disease; infectiousdisease; leptospirosis; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; screen; species; spp; st; stains; stn; tissue; tissue, unspecified",Ord
23212-4,lumpy skin disease virus [presence] in tissue by electron microscopy,lsdv tiss ql em,lumpy skin disease virus em ql (tiss),"capripoxvirus; dis; diseases; dz; em; id; infectious disease; infectiousdisease; integument; knopvelsiekte; lsdv; lumpy skin disease; micro; microbiology; micros; microscopic; ordinal; point in time; pr; ql; qual; qualitative; random; screen; tissue; tissue, unspecified; vet; veterinary",Ord
23219-9,lumpy skin disease virus ag [presence] in specimen by immunoassay,lsdv ag spec ql ia,lumpy skin disease virus ag ia ql (specimen),antigen; antigens; capripoxvirus; dis; diseases; dz; eia; elfa; elisa; enzyme immunoassay; iaa; id; infectious disease; infectiousdisease; integument; knopvelsiekte; lsdv; lumpy skin disease; meia; microbiology; misc; miscellaneous; ordinal; other; point in time; pr; ql; qual; qualitative; random; screen; spec; suds; to be specified in another part of the message; unspecified; vet; veterinary,Ord
23226-4,mareks disease virus ab [presence] in serum by immunofluorescence,gahv ab ser ql if,mareks disease virus ab if ql (s),abs; aby; acif; antby; anti; antibodies; antibody; anticomplement immunofluorescence; autoantibodies; autoantibody; dis; diseases; dz; fa; fluorescent antibody; fluoresent; gahv; herpesvirus; herpesviruss; id; ifa; immune fluorescence; immunoflour; immunofluor; immunofluorescence; infectious disease; infectiousdisease; mareks disease; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; sr; time resolved fluorescence; trf; vet; veterinary,Ord
23232-2,mite identified in skin by flotation,mite skin flotation,mite identified flotation nom (skin),dermatologic; epidermis; id; identity or presence; infectious disease; infectiousdisease; integument; microbiology; mites; nominal; point in time; random; skn,Nom
23260-3,mycoplasma capricolum ss capripneumonia ab [presence] in serum by agglutination,m cap caprip ab ser ql aggl,m. capricolum ss capripneumonia ab aggl ql (s),abs; aby; agg; agglut; agglutination; antby; anti; antibodies; antibody; autoantibodies; autoantibody; contagious caprine pleuropneumonia; id; infectious disease; infectiousdisease; m cap; m cap caprip; m capricolum; microbiology; myco; mycoplas; mycoplasm; mycoplasmosis; mycoplsm; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; sr; ssp; vet; veterinary,Ord
23269-4,mycoplasma capricolum ss capripneumonia ag [presence] in specimen,m cap caprip ag spec ql,m. capricolum ss capripneumonia ag ql (specimen),antigen; antigens; contagious caprine pleuropneumonia; id; infectious disease; infectiousdisease; m cap; m cap caprip; m capricolum; microbiology; misc; miscellaneous; myco; mycoplas; mycoplasm; mycoplasmosis; mycoplsm; ordinal; other; point in time; pr; ql; qual; qualitative; random; screen; ssp; to be specified in another part of the message; unspecified; vet; veterinary,Ord
2328-3,gastrin releasing polypeptide [moles/volume] in cerebral spinal fluid,grp csf-scnc,gastrin releasing polypeptide (csf) [moles/vol],cerebral spinal fluid; cerebrospinal fl; chemistry; gastrin releasing peptide; grp; level; mammalian bombesin; point in time; polypeptides; qnt; quan; quant; quantitative; random; spinal fl; spinal fld; spinal flu; spinal fluid; substance concentration; total gastrins; zollinger-ellison syndrome,Qn
23285-0,mycoplasma mycoides ss mycoides small colony ab [presence] in serum,m myc my sc ab ser ql,m. mycoides ss mycoides small colony ab ql (s),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; colonies; contagious bovine pleuropneumonia; id; infectious disease; infectiousdisease; m myc; m myc my sc; m mycoides; microbiology; myco; mycoplas; mycoplasm; mycoplasmosis; mycoplsm; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; sr; ssp; vet; veterinary,Ord
23291-8,mycoplasma mycoides ss mycoides small colony ag [presence] in specimen by immunofluorescence,m myc my sc ag spec ql if,m. mycoides ss mycoides small colony ag if ql (specimen),acif; anticomplement immunofluorescence; antigen; antigens; colonies; contagious bovine pleuropneumonia; dfa; fa; fluorescent antibody; fluoresent; id; ifa; immune fluorescence; immunoflour; immunofluor; immunofluorescence; infectious disease; infectiousdisease; m myc; m myc my sc; m mycoides; microbiology; misc; miscellaneous; myco; mycoplas; mycoplasm; mycoplasmosis; mycoplsm; ordinal; other; point in time; pr; ql; qual; qualitative; random; screen; ssp; time resolved fluorescence; to be specified in another part of the message; trf; unspecified; vet; veterinary,Ord
23298-3,mycoplasma sp ag [presence] in specimen by immunofluorescence,mycoplasma ag spec ql if,mycoplasma sp ag if ql (specimen),acif; anticomplement immunofluorescence; antigen; antigens; dfa; fa; fluorescent antibody; fluoresent; id; ifa; immune fluorescence; immunoflour; immunofluor; immunofluorescence; infectious disease; infectiousdisease; microbiology; misc; miscellaneous; myco; mycoplas; mycoplasm; mycoplasmosis; mycoplsm; ordinal; other; point in time; pr; ql; qual; qualitative; random; screen; spec; species; spp; time resolved fluorescence; to be specified in another part of the message; trf; unspecified,Ord
23321-3,ovine herpesvirus 2 ab [presence] in serum,ovhv2 ab ser ql,ovine herpesvirus 2 ab ql (s),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; herpes virus; id; ii; infectious disease; infectiousdisease; malignant catarrhal fever; microbiology; ordinal; ovhv2; ovhv-2; point in time; pr; ql; qual; qualitative; random; screen; serum; sr; vet; veterinary,Ord
23326-2,ovine herpesvirus 2 ab [presence] in serum by immune stain,ovhv2 ab ser ql imstn,ovine herpesvirus 2 ab immune stain ql (s),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; herpes virus; id; ihc; ii; imm; immunohistochemical stain; immunostain; imstn; imun; imune; infectious disease; infectiousdisease; malignant catarrhal fever; microbiology; ordinal; ovhv2; ovhv-2; point in time; pr; ql; qual; qualitative; random; screen; serum; sr; st; stains; stn; vet; veterinary,Ord
23328-8,ovine progressive pneumonia virus ab [presence] in milk,oppv ab mlk ql,ovine progressive pneumonia virus ab ql (milk),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; id; infectious disease; infectiousdisease; lentivirus; maedi visna; microbiology; mlk; oppv; ordinal; ovine progressive pneumonia; point in time; pr; ql; qual; qualitative; random; screen; vet; veterinary,Ord
23334-6,ovine progressive pneumonia virus ag [presence] in specimen by immunofluorescence,oppv ag spec ql if,ovine progressive pneumonia virus ag if ql (specimen),acif; anticomplement immunofluorescence; antigen; antigens; dfa; fa; fluorescent antibody; fluoresent; id; ifa; immune fluorescence; immunoflour; immunofluor; immunofluorescence; infectious disease; infectiousdisease; lentivirus; maedi visna; microbiology; misc; miscellaneous; oppv; ordinal; other; ovine progressive pneumonia; point in time; pr; ql; qual; qualitative; random; screen; spec; time resolved fluorescence; to be specified in another part of the message; trf; unspecified; vet; veterinary,Ord
23339-5,paratuberculosis reaction wheal [diameter] --3 days post 0.1 ml avian tuberculin intradermal,map wheal 3d p .1ml av ppd diam,paratuberculosis reaction wheal 3 days post 0.1 ml avian tuberculin intradermal (skin) [diam],3d p .1ml av ppd; after; bird; dermatologic; diameter; epidermis; fowl; identifier; integument; intradermal; map; map wheal; point in time; ppd; pst; purified protein derivative; qnt; quan; quant; quantitative; random; react; rx wheal; rxn; skin test; skin tests; skn; tb; tuberculosis antigen,Qn
23347-8,pasteurella multocida serotype [identifier] in specimen by immunofluorescence,p multoc sertyp spec if,p. multocida serotype if nom (specimen),acif; anticomplement immunofluorescence; avian pasterurellosis; fa; fluorescent antibody; fluoresent; fowl cholera; id; identity or presence; ifa; immune fluorescence; immunoflour; immunofluor; immunofluorescence; infectious disease; infectiousdisease; microbiology; misc; miscellaneous; nominal; other; p multoc; p multocida; point in time; random; sertyp; spec; time resolved fluorescence; to be specified in another part of the message; trf; unspecified,Nom
23350-2,peste des petits ruminants virus ab [titer] in serum,pprv ab titr ser,peste des petits ruminants virus ab (s) [titer],abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; dilution factor; dilution factor (titer); id; infectious disease; infectiousdisease; microbiology; morbillivirus; peste des petits ruminants; point in time; pprv; pseudorinderpest; random; serum; smqn; sr; titer; titered; titre; ttr; vet; veterinary,SemiQn
23362-7,porcine enterovirus neutralizing antibody [presence] in serum by neutralization test,pev nab ser ql nt,porcine enterovirus neut ab neut test ql (s),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; conventional virus neutralization test; cvnt; entero virus; enterovirus encephalomyelitis; ev; id; infectious disease; infectiousdisease; microbiology; nab; neutralization; neutralization test; nt; ordinal; pev; point in time; pork; pr; ql; qual; qualitative; random; screen; serum; serum virus neutralization; sr; svn; swine; talfan disease; teschen disease; vet; veterinary; virus neutralization test; vnt,Ord
23368-4,prrsv neutralizing antibody [presence] in serum by neutralization test,prrsv nab ser ql nt,prrsv neut ab neut test ql (s),abortus blauw; abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; blue-eared pig disease; conventional virus neutralization test; cvnt; id; infectious disease; infectiousdisease; lelystad virus; microbiology; mystery swine disease; nab; neutralization; neutralization test; nt; ordinal; point in time; porcine epidemic abortion & respiratory syndrome; porcine reproductive and respiratory syndrome; pork; pr; prrs; prrsv; prrsv ab; prrsv nab; ql; qual; qualitative; random; screen; serum; serum virus neutralization; seuchenhafter spatabort der schweine; sirsv; sr; svn; swine; swine infertility and respiratory syndrome; syndrome dysgenesique et respiratoire porcin; vet; veterinary; virus neutralization test; vnt,Ord
23371-8,prrsv rna [presence] in semen by naa with probe detection,prrsv rna smn ql naa+probe,prrsv rna naa+probe ql (sem),3 self-sustaining sequence replication; 3sr sr; abortus blauw; amplif; amplification; amplified; blue-eared pig disease; dna nucleic acid probe; dna probe; ejaculate; genitourinary; gu; lat; lcr; lelystad virus; ligase chain reaction; ligation-activated transcription; microbiology; mystery swine disease; naa+probe; naat; nasba; nucleic acid sequence based analysis; ordinal; pcr; point in time; polymerase chain reaction; porcine epidemic abortion & respiratory syndrome; porcine reproductive and respiratory syndrome; pork; pr; probe amp; probe with ampification; probe with target amplification; prrs; prrsv; qbr; ql; qual; qualitative; random; ribonucleic acid; screen; sda; sem; seminal fluid; seuchenhafter spatabort der schweine; sirsv; smn; smpls; strand displacement amplification; swine; swine infertility and respiratory syndrome; syndrome dysgenesique et respiratoire porcin; tma; transcription mediated amplification; uro; urology; vet; veterinary,Ord
23380-9,abnormal prion protein [presence] in brain by immune stain,abn prion prot brain ql imstn,abnormal prion protein immune stain ql (brain),abn; abn prion prot; abnorm; bovine spongiform encephalopathy; bse; cerebral; cerebrum; head; ihc; imm; immunohistochemical stain; immunostain; imstn; imun; imune; intracranial; microbiology; neuro; neurology; ordinal; point in time; pr; prot; prp; ql; qual; qualitative; random; scrapie; screen; st; stains; stn,Ord
23381-7,abnormal prion protein [presence] in brain by electron microscopy,abn prion prot brain ql em,abnormal prion protein em ql (brain),abn; abn prion prot; abnorm; bovine spongiform encephalopathy; bse; cerebral; cerebrum; em; head; intracranial; micro; microbiology; micros; microscopic; neuro; neurology; ordinal; point in time; pr; prot; prp; ql; qual; qualitative; random; scrapie; screen,Ord
23395-7,deprecated reticuloendotheliosis virus ab [presence] in serum,deprecated rev ab ser ql,reticuloendotheliosis virus ab ql (s),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; avian reticuloendotheliosis; id; infectious disease; infectiousdisease; microbiology; ordinal; point in time; ql; qual; qualitative; random; rev; screen; serum; sr,Ord
23396-5,rift valley fever virus neutralizing antibody [titer] in serum by neutralization test,rvfv nab titr ser nt,rift valley fever virus neut ab neut test (s) [titer],abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; bunyavirus; conventional virus neutralization test; cvnt; dilution factor; dilution factor (titer); id; infectious disease; infectiousdisease; microbiology; nab; neutralization; neutralization test; nt; point in time; random; rift valley fever; rvfv; serum; serum virus neutralization; smqn; sr; svn; titer; titered; titre; ttr; virus neutralization test; vnt,SemiQn
23412-0,rinderpest virus ag [units/volume] in tissue by immunoassay,rpv ag tiss ia-acnc,rinderpest virus ag ia qn (tiss),"antigen; antigens; arbitrary concentration; eia; elfa; elisa; enzyme immunoassay; iaa; id; infectious disease; infectiousdisease; meia; microbiology; morbillivirus; point in time; qnt; quan; quant; quantitative; random; rinderpest; rpv; suds; tissue; tissue, unspecified; vet; veterinary",Qn
23418-7,salmonella abortus equi ab [presence] in serum by agglutination,s abortusequi ab ser ql aggl,s. abortus equi ab aggl ql (s),abort; abortusequi; abs; aby; agg; agglut; agglutination; antby; anti; antibodies; antibody; autoantibodies; autoantibody; equine salmonellosis; id; infectious disease; infectiousdisease; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; s abortus; s abortusequi; sal; salmonel; screen; serum; sr,Ord
23431-0,salmonella gallinarum dna [presence] in specimen by naa with probe detection,s gallinarum dna spec ql naa+probe,s. gallinarum dna naa+probe ql (specimen),3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; deoxyribonucleic acid; dna nucleic acid probe; dna probe; fowl typhoid; id; infectious disease; infectiousdisease; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; misc; miscellaneous; naa+probe; naat; nasba; nucleic acid sequence based analysis; ordinal; other; pcr; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; s gallinarum; sal; salmonel; screen; sda; spec; strand displacement amplification; tma; to be specified in another part of the message; transcription mediated amplification; unspecified; vet; veterinary,Ord
23441-9,swine vesicular disease virus ab [presence] in serum,svd ab ser ql,swine vesicular disease virus ab ql (s),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; dis; diseases; dz; id; infectious disease; infectiousdisease; microbiology; ordinal; picornavirus; pig; point in time; pork; pr; ql; qual; qualitative; random; screen; serum; sr; svd; swine vesicular disease; vet; veterinary,Ord
23451-8,taenia sp eggs [presence] in stool by probe,taenia eggs stl ql probe,taenia sp eggs probe ql (stl),bowel movement; dna nucleic acid probe; dna probe; faecal; faeces; fecal; feces; id; infectious disease; infectiousdisease; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; screen; species; spp; stl; stool = fecal; taenia eggs; tapeworm,Ord
23458-3,taylorella equigenitalis dna [presence] in genital specimen by naa with probe detection,t equigenit dna genital ql naa+probe,t. equigenitalis dna naa+probe ql (genital specimen),3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; cem; contagious equine metritis; deoxyribonucleic acid; dna nucleic acid probe; dna probe; gen; genital tract; id; infectious disease; infectiousdisease; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; naa+probe; naat; nasba; nucleic acid sequence based analysis; ordinal; pcr; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; screen; sda; strand displacement amplification; t equigenit; t equigenitalis; tma; transcription mediated amplification; urogenit; urogenital; vet; veterinary,Ord
2346-5,glucose [mass/volume] in pleural fluid,glucose plr-mcnc,glucose (pleur fld) [mass/vol],chemistry; glu; gluc; glucoseur; level; mass concentration; pleural; pleural fluid; point in time; qnt; quan; quant; quantitative; random; thoracentesis fluid,Qn
23467-4,theileria mutans ab [titer] in serum by immunofluorescence,t mutans ab titr ser if,t. mutans ab if (s) [titer],abs; aby; acif; antby; anti; antibodies; antibody; anticomplement immunofluorescence; autoantibodies; autoantibody; babesiosis; dilution factor; dilution factor (titer); fa; fluorescent antibody; fluoresent; id; ifa; immune fluorescence; immunoflour; immunofluor; immunofluorescence; infectious disease; infectiousdisease; microbiology; point in time; random; serum; smqn; sr; t mutans; theileriosis; time resolved fluorescence; titer; titered; titre; trf; ttr; vet; veterinary,SemiQn
23471-6,theileria mutans ab [titer] in serum,t mutans ab titr ser,t. mutans ab (s) [titer],abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; babesiosis; dilution factor; dilution factor (titer); id; infectious disease; infectiousdisease; microbiology; point in time; random; serum; smqn; sr; t mutans; theileriosis; titer; titered; titre; ttr; vet; veterinary,SemiQn
2348-1,glucose [mass/volume] in synovial fluid,glucose snv-mcnc,glucose (syn fld) [mass/vol],chemistry; glu; gluc; glucoseur; joint aspirate; joint fld; joint flu; joint fluid; level; mass concentration; point in time; qnt; quan; quant; quantitative; random; sf; snv; syn; syn fl; synov; synovial fluid,Qn
23482-3,theileria sp [presence] in blood by giemsa stain,theileria bld ql gie stn,t. sp giemsa stain ql (bld),babesiosis; blood; gie stn; gms; id; infectious disease; infectiousdisease; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; screen; species; spp; st; stains; stn; theileriosis; vet; veterinary; wb; whole blood,Ord
23490-6,deprecated transmissible gastroenteritis virus ab [presence] in serum,deprecated tgev ab ser ql,transmissible gastroenteritis virus ab ql (s),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; coronavirus; id; infectious disease; infectiousdisease; microbiology; ordinal; point in time; ql; qual; qualitative; random; screen; serum; sr; tgev; transmissible gastroenteritis,Ord
23496-3,transmissible gastroenteritis virus ag [presence] in small intestine tissue by immune stain,tgev ag tsmi ql imstn,transmissible gastroenteritis virus ag immune stain ql (small intestine tissue),antigen; antigens; coronavirus; id; ihc; imm; immunohistochemical stain; immunostain; imstn; imun; imune; infectious disease; infectiousdisease; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; screen; st; stains; stn; tgev; tissue small intestine; transmissible gastroenteritis; vet; veterinary,Ord
23508-5,trypanosoma congolense dna [presence] in blood by naa with probe detection,t congolense dna bld ql naa+probe,t. congolense dna naa+probe ql (bld),3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; blood; deoxyribonucleic acid; dna nucleic acid probe; dna probe; id; infectious disease; infectiousdisease; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; naa+probe; naat; nasba; nucleic acid sequence based analysis; ordinal; pcr; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; screen; sda; strand displacement amplification; t congolense; tma; transcription mediated amplification; trypanosomiasis; trypanosomosis; trypanosomosis (tse-tse borne); vet; veterinary; wb; whole blood,Ord
23515-0,trypanosoma equiperdum ab [presence] in serum,t equiperdum ab ser ql,t. equiperdum ab ql (s),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; beschalseuche; covering disease; dourine; el dourin; id; infectious disease; infectiousdisease; mal de coit; microbiology; morbo coitale maligno; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; slapsiekte; sluchnaya bolyezn; sr; t equiperdum; trypanosomiasis; trypanosomosis; vet; veterinary,Ord
23522-6,trypanosoma evansi ab [presence] in serum,t evansi ab ser ql,t. evansi ab ql (s),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; derrengadera; id; infectious disease; infectiousdisease; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; sr; surra; t evansi; trypanosomiasis; trypanosomosis; vet; veterinary,Ord
23524-2,trypanosoma evansi ab [units/volume] in serum by immunoassay,t evansi ab ser ia-acnc,t. evansi ab ia qn (s),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; derrengadera; eia; elfa; elisa; enzyme immunoassay; iaa; id; infectious disease; infectiousdisease; meia; microbiology; point in time; qnt; quan; quant; quantitative; random; serum; sr; suds; surra; t evansi; trypanosomiasis; trypanosomosis; vet; veterinary,Qn
23537-4,tuberculosis reaction wheal [diameter] --2 days post dose mammalian tuberculin intradermal,tb wheal 2d p mam tuberc diam,tuberculosis reaction wheal 2 days post dose mammalian tuberculin intradermal (skin) [diam],2d p mam tuberc; after; dermatologic; diameter; epidermis; identifier; integument; intradermal; p dose; point in time; ppd; pst; purified protein derivative; purified protein derivative skin test; purified protein derivative test; qnt; quan; quant; quantitative; random; react; rx wheal; rxn; skin test; skin tests; skn; tb; tb skin test; tb wheal; tst; tuberculosis antigen,Qn
23548-1,venezuelan equine encephalitis virus ag [presence] in specimen by neutralization test,veev ag spec ql nt,veev ag neut test ql (specimen),antigen; antigens; conventional virus neutralization test; cvnt; enc; enceph; encephalomyelitis; equin; id; infectious disease; infectiousdisease; microbiology; misc; miscellaneous; neutralization; neutralization test; nt; ordinal; other; point in time; pr; ql; qual; qualitative; random; screen; serum virus neutralization; spec; svn; to be specified in another part of the message; togavirus; unspecified; vee virus; veev; virus neutralization test; vnt,Ord
2354-9,glucose-6-phosphatase [enzymatic activity/volume] in serum,g6pas ser-ccnc,glucose-6-phosphatase (s) [catalytic activity/vol],catalytic concentration; chemistry; g6p; g6pas; glu; gluc; glucoseur; phos; phosphtase; point in time; qnt; quan; quant; quantitative; random; serum; sr,Qn
23558-0,vesicular stomatitis virus ag [presence] in throat by immunoassay,vsv ag throat ql ia,vesicular stomatitis virus ag ia ql (throat),antigen; antigens; eia; elfa; elisa; enzyme immunoassay; iaa; id; infectious disease; infectiousdisease; meia; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; rhabdovirus; screen; suds; throat; upper respiratory; vesicular stomatitis; vsv,Ord
23562-2,vesicular stomatitis indiana virus neutralizing antibody [presence] in serum by neutralization test,vsiv nab ser ql nt,vesicular stomatitis indiana virus neut ab neut test ql (s),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; conventional virus neutralization test; cvnt; id; infectious disease; infectiousdisease; microbiology; nab; neutralization; neutralization test; nt; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; serum virus neutralization; sr; svn; vesicular stomatitis virus indiana 1; virus neutralization test; vnt; vs; vsiv; vsv-in,Ord
23576-2,rabbit hemorrhagic disease virus ab [titer] in serum by immunoassay,rhdv ab titr ser ia,rabbit hemorrhagic disease virus ab ia (s) [titer],abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; calicivirus; dilution factor; dilution factor (titer); dis; diseases; dz; eia; elfa; elisa; enzyme immunoassay; f213; hemorrhagic septicemia; iaa; id; infectious disease; infectious necrotic hepatitis; infectiousdisease; meia; microbiology; oryctalagus spp; point in time; rabbit hemorrhagic disease; random; rhdv; serum; smqn; sr; suds; titer; titered; titre; ttr; vet; veterinary; viral hemorrhagic disease,SemiQn
2358-0,glucose-6-phosphate dehydrogenase [presence] in serum,g6pd ser ql,g6pd ql (s),chemistry; dehydrog; dehyrdogenase; g6pd; g-6-pd; g6pdh; glu; gluc; glucose-6-pd; glucose-6-pdh; glucoseur; gpd; hematology; heme; i phos; inorganic phosphate; ordinal; phos; phosphate total; phosphorous; phosphorus; phosphrous; pi; po4; point in time; pr; ql; qual; qualitative; random; screen; serum; sr,Ord
23595-2,dermatophilus congolensis [presence] in exudate by giemsa stain,d congo exudate ql gie stn,d. congolensis giemsa stain ql (exud),d congo; d congolensis; dermatophilosis; exud; gie stn; gms; id; infectious disease; infectiousdisease; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; screen; st; stains; stn; streptothrichosis,Ord
23601-8,mareks disease virus serotype [identifier] in tissue by organism specific culture,gahv sertyp tiss cult,mareks disease virus serotype org specific cx nom (tiss),"c&s; cult; cultures; dis; diseases; dz; gahv; herpesvirus; herpesviruss; id; identity or presence; infectious disease; infectiousdisease; mareks disease; microbiology; nominal; point in time; random; sertyp; spec; tissue; tissue, unspecified; vet; veterinary",Nom
23607-5,capreomycin [susceptibility] by method for slow-growing mycobacteria,capreomycin islt slowmyco,capreomycin method for slow-growing mycobacteria [susc],afb; antibiotic susceptibilities; ast; capastat; id; infectious disease; infectiousdisease; islt; isol; myco; mycobacteria susceptibility; mycobacterial susceptibility; ogostal; point in time; random; slowmyco; sus; suscept; susceptibilities; susceptibility; susceptibilty; tb; tuberculosis,OrdQn
23610-9,sparfloxacin [susceptibility] by method for slow-growing mycobacteria,sparfloxacin islt slowmyco,sparfloxacin method for slow-growing mycobacteria [susc],afb; antibiotic susceptibilities; ast; id; infectious disease; infectiousdisease; islt; isol; myco; mycobacteria susceptibility; mycobacterial susceptibility; point in time; random; slowmyco; sus; suscept; susceptibilities; susceptibility; susceptibilty; tb; tuberculosis; zagam,OrdQn
23615-8,vancomycin [susceptibility] by method for slow-growing mycobacteria,vancomycin islt slowmyco,vancomycin method for slow-growing mycobacteria [susc],afb; antibiotic susceptibilities; ast; c162; id; infectious disease; infectiousdisease; islt; isol; myco; mycobacteria susceptibility; mycobacterial susceptibility; point in time; random; slowmyco; sus; suscept; susceptibilities; susceptibility; susceptibilty; tb; tuberculosis; vanc; vancocin; vancor,OrdQn
23617-4,deprecated ethionamide [susceptibility] by method for slow-growing mycobacteria,deprecated ethionamide islt slowmyco,ethionamide slow-growing mycobacteria [susc],antibiotic susceptibilities; ast; id; infectious disease; infectiousdisease; islt; isol; point in time; random; sus; suscept; susceptibilities; susceptibility; susceptibilty; trecator,OrdQn
23622-4,deprecated ceftizoxime [susceptibility] by method for slow-growing mycobacteria,deprecated ceftizoxime islt slowmyco,ceftizoxime slow-growing mycobacteria [susc],antibiotic susceptibilities; ast; cefizox; ceftrix; eposelin; eposerin; id; infectious disease; infectiousdisease; islt; isol; point in time; random; sus; suscept; susceptibilities; susceptibility; susceptibilty,OrdQn
23629-9,para aminosalicylate [susceptibility],pas susc islt,para aminosalicylate [susc],aminosalicycic; aminosalycilate; antibiotic susceptibilities; ast; epusal; id; infectious disease; infectiousdisease; islt; isol; na-pas; nemasol sodium; p-aminosalicyclic acid; para aminosalicylic acid; pas; point in time; random; salf-pas; sodico; sodium pas; sus; suscept; susceptibilities; susceptibility; susceptibilty; therazid,OrdQn
23630-7,deprecated rifabutin [susceptibility] by method for slow-growing mycobacteria,deprecated rifabutin islt slowmyco,rifabutin slow-growing mycobacteria [susc],ansamycin; antibiotic susceptibilities; ast; id; infectious disease; infectiousdisease; islt; isol; mycobutin; point in time; random; sus; suscept; susceptibilities; susceptibility; susceptibilty,OrdQn
23637-2,cefdinir [susceptibility] by minimum inhibitory concentration (mic),cefdinir islt mic,cefdinir mic [susc],antibiotic susceptibilities; ast; id; infectious disease; infectiousdisease; islt; isol; minimum inhibitory concentration; omnicef; point in time; random; sus; suscept; susceptibilities; susceptibility; susceptibilty,OrdQn
23643-0,trovafloxacin [susceptibility] by minimum inhibitory concentration (mic),trovafloxacin islt mic,trovafloxacin mic [susc],antibiotic susceptibilities; ast; id; infectious disease; infectiousdisease; islt; isol; minimum inhibitory concentration; point in time; random; sus; suscept; susceptibilities; susceptibility; susceptibilty; trovan; turvel,OrdQn
23660-4,aspergillus sp ab [titer] in serum by immunoassay,aspergillus ab titr ser ia,aspergillus sp ab ia (s) [titer],abs; aby; antby; anti; antibodies; antibody; asperg; aspergil; aspergilis; aspergilla; aspergillin; aspergillosis; aspergils; aspergilus; autoantibodies; autoantibody; dilution factor; dilution factor (titer); eia; elfa; elisa; enzyme immunoassay; farmers lung; iaa; id; infectious disease; infectiousdisease; meia; microbiology; point in time; random; serum; smqn; species; spp; sr; suds; titer; titered; titre; ttr,SemiQn
23668-7,bartonella henselae ab [titer] in serum,b henselae ab titr ser,b. henselae ab (s) [titer],abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; b henselae; bacillary angiomaosis; bacillary pelliosis; cat scratch disease; cat scratch fever; csd; dilution factor; dilution factor (titer); id; infectious disease; infectiousdisease; microbiology; point in time; r henselae; random; rochalimaea henselae; serum; smqn; sr; titer; titered; titre; ttr,SemiQn
23673-7,bluetongue virus 13 neutralizing antibody [titer] in serum by neutralization test,btv13 nab titr ser nt,bluetongue virus 13 neut ab neut test (s) [titer],abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; bluetongue; btv; btv13; conventional virus neutralization test; cvnt; dilution factor; dilution factor (titer); id; infectious disease; infectiousdisease; microbiology; nab; neutralization; neutralization test; nt; orbivirus; point in time; random; reovirus; serum; serum virus neutralization; smqn; sr; svn; titer; titered; titre; ttr; vet; veterinary; virus neutralization test; vnt,SemiQn
23675-2,bluetongue virus 2 neutralizing antibody [titer] in serum by neutralization test,btv2 nab titr ser nt,bluetongue virus 2 neut ab neut test (s) [titer],abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; bluetongue; btv; btv2; conventional virus neutralization test; cvnt; dilution factor; dilution factor (titer); id; ii; infectious disease; infectiousdisease; microbiology; nab; neutralization; neutralization test; nt; orbivirus; point in time; random; reovirus; serum; serum virus neutralization; smqn; sr; svn; titer; titered; titre; ttr; vet; veterinary; virus neutralization test; vnt,SemiQn
23685-1,canine adenovirus 1 neutralizing antibody [presence] in serum by neutralization test,cadv1 nab ser ql nt,canine adenovirus 1 neut ab neut test ql (s),abs; aby; adeno virus; antby; anti; antibodies; antibody; autoantibodies; autoantibody; cadv; cadv1; conventional virus neutralization test; cvnt; dog; hadv; i; id; infectious canine hepatitis; infectious disease; infectiousdisease; microbiology; nab; neutralization; neutralization test; nt; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; serum virus neutralization; sr; svn; vet; veterinary; virus neutralization test; vnt,Ord
23697-6,canine herpesvirus neutralizing antibody [presence] in serum by neutralization test,cahv nab ser ql nt,canine herpesvirus neut ab neut test ql (s),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; cahv; conventional virus neutralization test; cvnt; dog; herpes virus; id; infectious disease; infectiousdisease; microbiology; nab; neutralization; neutralization test; nt; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; serum virus neutralization; sr; svn; vet; veterinary; virus neutralization test; vnt,Ord
23707-3,canine parvovirus dna [presence] in stool by probe,cpv dna stl ql probe,canine parvovirus dna probe ql (stl),bowel movement; cpv; deoxyribonucleic acid; dna nucleic acid probe; dna probe; dog; faecal; faeces; fecal; feces; id; infectious disease; infectiousdisease; microbiology; ordinal; parvo; parvo virus; parvov; point in time; pr; ql; qual; qualitative; random; screen; stl; stool = fecal; vet; veterinary,Ord
23717-2,feline coronavirus ab [presence] in serum,fcov ab ser ql,feline coronavirus ab ql (s),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; corona virus; fcov; id; infectious disease; infectiousdisease; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; sr; vet; veterinary,Ord
23726-3,feline infectious peritonitis virus ab [presence] in serum by immunoassay,fipv ab ser ql ia,feline infectious peritonitis virus ab ia ql (s),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; coronavirus; eia; elfa; elisa; enzyme immunoassay; feline infectious peritonitis; fip; fipv; iaa; id; infectious disease; infectiousdisease; meia; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; sr; suds; vet; veterinary,Ord
2373-9,glutamine [mass/volume] in urine,glutamine ur-mcnc,glutamine (u) [mass/vol],chemistry; gln; level; mass concentration; point in time; qnt; quan; quant; quantitative; random; ua; ur; urn,Qn
23744-6,giardia lamblia ag [presence] in specimen by immunofluorescence,g lamblia ag spec ql if,g. lamblia ag if ql (specimen),acif; anticomplement immunofluorescence; antigen; antigens; beaver fever; dfa; fa; fluorescent antibody; fluoresent; g duodenalis; g intestinalis; g lamblia; giardiasis; id; ifa; immune fluorescence; immunoflour; immunofluor; immunofluorescence; infectious disease; infectiousdisease; lamblia intestinalis; microbiology; misc; miscellaneous; ordinal; other; point in time; pr; ql; qual; qualitative; random; screen; spec; time resolved fluorescence; to be specified in another part of the message; trf; unspecified,Ord
2375-4,glutaryl coa dehydrogenase [enzymatic activity/mass] in tissue,gcdh tiss-ccnt,glutaryl coa dehydrogenase (tiss) [catalytic activity/mass],"catalytic content; chemistry; dehydrog; dehyrdogenase; gcdh; point in time; qnt; quan; quant; quantitative; random; tissue; tissue, unspecified",Qn
23754-5,mycoplasma sp ab [titer] in serum,mycoplasma ab titr ser,mycoplasma sp ab (s) [titer],abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; dilution factor; dilution factor (titer); id; infectious disease; infectiousdisease; microbiology; myco; mycoplas; mycoplasm; mycoplasmosis; mycoplsm; point in time; random; serum; smqn; species; spp; sr; titer; titered; titre; ttr,SemiQn
2376-2,glutathione peroxidase [enzymatic activity/volume] in serum or plasma,glutathione px serpl-ccnc,glutathione peroxidase [catalytic activity/vol],catalytic concentration; chemistry; glutathione px; gpx; gsh-px; peroxdse; pl; plasma; plsm; pod; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
23762-8,nitrate+nitrite [mass/volume] in specimen,nitrate+nitrite spec-mcnc,nitrate+nitrite (specimen) [mass/vol],drug/toxicology; drugs; level; mass concentration; misc; miscellaneous; no2; no3; nox; other; point in time; qnt; quan; quant; quantitative; random; spec; to be specified in another part of the message; unspecified,Qn
23770-1,porcine parvovirus ab [titer] in serum,ppv ab titr ser,porcine parvovirus ab (s) [titer],abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; dilution factor; dilution factor (titer); id; infectious disease; infectiousdisease; microbiology; parvo; parvo virus; parvov; point in time; porcine reproductive parvovirus; pork; ppv; random; serum; smqn; sr; swine; titer; titered; titre; ttr; vet; veterinary,SemiQn
23773-5,porcine rotavirus ag [presence] in tissue by immunofluorescence,porv ag tiss ql if,porcine rotavirus ag if ql (tiss),"acif; anticomplement immunofluorescence; antigen; antigens; dfa; fa; fluorescent antibody; fluoresent; id; ifa; immune fluorescence; immunoflour; immunofluor; immunofluorescence; infectious disease; infectiousdisease; microbiology; ordinal; point in time; pork; porv; pr; ql; qual; qualitative; random; rota virus; rotav; rotaviral; rotaviurs; rv; screen; swine; time resolved fluorescence; tissue; tissue, unspecified; trf; vet; veterinary",Ord
23777-6,salmonella pullorum ab [titer] in serum by agglutination,s pullorum ab titr ser aggl,s. pullorum ab aggl (s) [titer],abs; aby; agg; agglut; agglutination; antby; anti; antibodies; antibody; autoantibodies; autoantibody; dilution factor; dilution factor (titer); id; infectious disease; infectiousdisease; microbiology; point in time; pullorum disease; random; s pullorum; sal; salmonel; serum; smqn; sr; titer; titered; titre; ttr; vet; veterinary,SemiQn
23816-2,other antibiotic [mass/volume] in serum or plasma,other antibiotic serpl-mcnc,other antibiotic [mass/vol],drug/toxicology; drugs; level; mass concentration; other antibiotic; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
23820-4,aspergillus flavus ab [presence] in serum by immune diffusion (id),a flavus ab ser ql id,a. flavus ab immune diff ql (s),a flavus; abs; aby; antby; anti; antibodies; antibody; asperg; aspergil; aspergilis; aspergilla; aspergillin; aspergillosis; aspergils; aspergilus; autoantibodies; autoantibody; farmers lung; id; imm; immunodiff; immunodiffusion; imun; imune; infectious disease; infectiousdisease; m228; m311; m54; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; sr,Ord
23835-2,carbon disulfide [mass/volume] in urine,carbon dis ur-mcnc,carbon disulfide (u) [mass/vol],cs2; drug/toxicology; drugs; level; mass concentration; point in time; qnt; quan; quant; quantitative; random; ua; ur; urn,Qn
23843-6,cockatiel droppings ab [presence] in serum by immune diffusion (id),cockatiel drop ab ql id,cockatiel droppings ab immune diff ql (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; feces; id; imm; immunodiff; immunodiffusion; imun; imune; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; sr; stool,Ord
23879-0,immune complex [units/volume] in body fluid by c1q binding assay,ic fld c1q bind-acnc,immune complex c1q binding assay qn (body fld),"arbitrary concentration; b/f; bf; bind; bod; bodies; body fluid; body fluid, unsp; cic; circulating immune complex; compx; fl; fld; flu; fluid; ic; imm; imun; imune; point in time; qnt; quan; quant; quantitative; random; serology",Qn
23881-6,immune complex [mass/volume] in body fluid by polyethylene glycol (peg) assay,ic fld peg-mcnc,immune complex peg assay (body fld) [mass/vol],"b/f; bf; bod; bodies; body fluid; body fluid, unsp; cic; circulating immune complex; compx; fl; fld; flu; fluid; ic; imm; imun; imune; level; mass concentration; point in time; polyethylene glycol; qnt; quan; quant; quantitative; random; serology",Qn
23883-2,inhibin a [mass/volume] in serum or plasma,inhibin a serpl-mcnc,inhibin a [mass/vol],chemistry; dia; dimeric inhibin a; level; mass concentration; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; universallaborders,Qn
2388-7,deprecated glycerol [mass/volume] in serum or plasma,deprecated glycerol ser-mcnc,glycerol (s) [mass/vol],chemistry; level; mass concentration; point in time; qnt; quan; quant; quantitative; random; serum; sr,Qn
23887-3,isopentacarboxylporphyrin [mass/time] in unspecified time stool,isopenta-cp ?tm stl-mrate,isopentacarboxylporphyrin unsp time (stl) [mass/time],?tm; bowel movement; chemistry; faecal; faeces; fecal; feces; hematology; heme; isopenta-cp; mass rate; mrate; qnt; quan; quant; quantitative; stl; stool = fecal,Qn
23893-1,malaoxon [mass/volume] in blood,malaoxon bld-mcnc,malaoxon (bld) [mass/vol],blood; drug/toxicology; drugs; level; malathion metabolite; mass concentration; point in time; qnt; quan; quant; quantitative; random; wb; whole blood,Qn
23896-4,mercury [mass/mass] in specimen,mercury spec-mcnt,mercury (specimen) [mass/mass],drug/toxicology; drugs; hg; mass content; misc; miscellaneous; other; point in time; qnt; quan; quant; quantitative; random; spec; to be specified in another part of the message; unspecified,Qn
23903-8,monocytes+macrophages/leukocytes in specimen by manual count,monos+macros nfr spec manual,monocytes+macrophages/leukocytes manual cnt (specimen),hematology/cell counts; leuc; leuk; leukocyte; lkcs; macrop; macrophage; macros; macrphg; manl; misc; miscellaneous; mono; monocyte; monos; monos+macros; number fraction; other; percent; point in time; qnt; quan; quant; quantitative; random; spec; to be specified in another part of the message; unspecified; wbc; wbcs; white blood cell; white blood cells,Qn
23906-1,mycophenolate glucuronide [mass/volume] in serum or plasma,mycophenolate-g serpl-mcnc,mycophenolate glucuronide [mass/vol],cellcept; drug/toxicology; drugs; gluc; glucouronide; level; mass concentration; mmf; mpa; mpag; mpa-g; mycophenolate mofetil; mycophenolate-g; mycophenolic acid; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
23928-5,deprecated protoporphyrin [mass/volume] in serum or plasma,deprecated protopor serpl-mcnc,protoporphyrin [mass/vol],chemistry; dicarboxyl porphyrin; dicarboxylporphyrin; level; mass concentration; pl; plasma; plsm; point in time; protoporph; protoporphrn; protoporphyrins; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
2392-9,glycine [mass/volume] in urine,glycine ur-mcnc,glycine (u) [mass/vol],chemistry; gly; level; mass concentration; point in time; qnt; quan; quant; quantitative; random; ua; ur; urn,Qn
23930-1,salmonella typhi o d ab [titer] in serum by agglutination,s typhi o d ab titr ser aggl,s. typhi o d ab aggl (s) [titer],abs; aby; agg; agglut; agglutination; antby; anti; antibodies; antibody; autoantibodies; autoantibody; dextro; dilution factor; dilution factor (titer); id; infectious disease; infectiousdisease; microbiology; point in time; random; rh; rhesus; s typhi; s typhi o; s typhi o d; s typhosa; sal; salmonel; serum; smqn; sr; titer; titered; titre; ttr; typh; typhoid,SemiQn
23937-6,trans nonachlor [mass/volume] in serum or plasma,trans nonachlor serpl-mcnc,trans nonachlor [mass/vol],chlordane metabolite; drug/toxicology; drugs; enneachlor; level; mass concentration; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
23939-2,xylose [mass/volume] in blood --1 hour post 5 g xylose po,xylose 1h p 5 g xyl po bld-mcnc,xylose 1 hr post 5 g xylose po (bld) [mass/vol],1 hour; 1.0hr; 1h p 5 g xyl po; 60 min; 60 minutes; 60m; 60min; after; blood; chemistry.challenge testing; d-xylose; level; mass concentration; p 5 g xyl po; point in time; pst; qnt; quan; quant; quantitative; random; wb; whole blood; xylose absorption test,Qn
23947-5,deprecated isoniazid [susceptibility] by method for slow-growing mycobacteria,deprecated isoniazid islt slowmyco,isoniazid slow-growing mycobacteria [susc],antibiotic susceptibilities; ast; hyzyd; id; infectious disease; infectiousdisease; inh; islt; isol; isoniaz; isoniazide; nudrazod; point in time; random; sus; suscept; susceptibilities; susceptibility; susceptibilty,OrdQn
23975-6,bartonella quintana igm ab [titer] in cerebral spinal fluid by immunofluorescence,b quintana igm titr csf if,b. quintana igm if (csf) [titer],abs; aby; acif; antby; anti; antibodies; antibody; anticomplement immunofluorescence; autoantibodies; autoantibody; b quintana; cat scratch disease; cat scratch fever; cerebral spinal fluid; cerebrospinal fl; csd; dilution factor; dilution factor (titer); fa; fluorescent antibody; fluoresent; id; ifa; immune fluorescence; immune globulin m; immunoflour; immunofluor; immunofluorescence; immunoglobulin m; infectious disease; infectiousdisease; microbiology; neuro; neurology; point in time; r quintana; random; rochalimae quintana; rochalimaea quintana; smqn; spinal fl; spinal fld; spinal flu; spinal fluid; time resolved fluorescence; titer; titered; titre; trench fever; trf; ttr,SemiQn
23993-9,echovirus 7 ab [titer] in cerebral spinal fluid by complement fixation,ecv7 ab titr csf cf,echovirus 7 ab cf (csf) [titer],abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; cerebral spinal fluid; cerebrospinal fl; cf; comp fixation; compfix; complement fixation; dilution factor; dilution factor (titer); echo; echo virus; echovirus type 7; ecv; ecv7; ev; id; infectious disease; infectiousdisease; microbiology; neuro; neurology; point in time; random; smqn; spinal fl; spinal fld; spinal flu; spinal fluid; titer; titered; titre; ttr,SemiQn
23999-6,ganglioside gd1b igg ab [titer] in cerebral spinal fluid by immunoassay,gd1b gangl igg titr csf ia,ganglioside gd1b igg ia (csf) [titer],abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; cerebral spinal fluid; cerebrospinal fl; dilution factor; dilution factor (titer); disialolganglioside; disialylganglioside; eia; elfa; elisa; enzyme immunoassay; gd1b; gd1b gangl; iaa; immune globulin g; immunoglobulin g; meia; point in time; random; serology; smqn; spinal fl; spinal fld; spinal flu; spinal fluid; suds; titer; titered; titre; ttr,SemiQn
24023-4,deprecated streptococcus pneumoniae 3 ab [mass/volume] in serum,deprecated s pneum3 ab ser-mcnc,s. pneumoniae 3 ab (s) [mass/vol],abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; id; iii; infectious disease; infectiousdisease; level; mass concentration; microbiology; pneu; pneum; pneumo; pneumococ; pneumococcal; pneumococcal pneumonia; pneumococcus; pneumon; pneumonia; point in time; qnt; quan; quant; quantitative; random; s pneum3; s pneumo; s pneumoniae; serum; spn; sr; strep; strept,Qn
24028-3,toxocara canis iga ab [presence] in serum,t canis iga ser ql,t. canis iga ql (s),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; id; immune globulin a; immunoglobulin a; infectious disease; infectiousdisease; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; sr; t canis; visceral larva migrans,Ord
24032-5,rifabutin [mass/volume] in serum or plasma,rifabutin serpl-mcnc,rifabutin [mass/vol],ansamycin; drug/toxicology; drugs; level; mass concentration; mycobutin; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
24037-4,deprecated coccidioides immitis rrna [presence] in unspecified specimen by dna probe,deprecated c immitis rrna xxx ql prb,c. immitis rrna probe ql (specimen),arbitrary concentration; b immitis; blastomycoides immitis; c esteriformis; c immitis; coccidioides esteriformis; coccidiomycosis; coccio; dna nucleic acid probe; dna probe; g immite; g louisianoideum; g metaeuropea; geotrichum immite; glenospora metaeuropea; glenosporum louisianoideum; id; infectious disease; infectiousdisease; microbiology; misc; miscellaneous; ordinal; other; p esteriformis; p mazzai; point in time; posadasia esteriformis; pseudococcidioides mazzai; ql; qual; qualitative; random; ribosomal rna; san joaquin valley fever; screen; spec; t proteolyticum; to be specified in another part of the message; trichosporon proteolyticum; unspecified; valley fever,Ord
24040-8,taenia solium larva igg band pattern [interpretation] in cerebral spinal fluid by immunoblot,t sol lar igg patrn csf ib-imp,t. solium larva igg band pattern ib (csf) [interp],abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; bands; blt; bnd; cerebral spinal fluid; cerebrospinal fl; cysticercosis; cysticercus; id; igg patrn; immune blot; immune globulin g; immunobl; immunoblot; immunoglobulin g; impression; impression/interpretation of study; impressions; infectious disease; infectiousdisease; interp; interpretation; microbiology; neuro; neurology; nominal; patrn; point in time; random; riba; spinal fl; spinal fld; spinal flu; spinal fluid; t sol; t sol lar; t solium; tapeworm; wb; wblot; west blot; west blt; western blot,Nom
24058-0,aspartylglucosaminidase [enzymatic activity/mass] in fibroblast,aga fib-ccnt,aspartylglucosaminidase (fibroblast) [catalytic activity/mass],4-l-aspartylglycosylamine amido hydrolase; 4-l-aspartylglycosylamine amidohydrolase; aga; aspartylglucosaminuria; aspartylglucosylamine deaspartylase; aspartylglucosylaminidase; catalytic content; chemistry; fib; fibr; glycosylasparaginase; n4-(beta-n-acetylglucosaminyl)-l-asparaginase; point in time; qnt; quan; quant; quantitative; random,Qn
24060-6,beta galactosidase [enzymatic activity/mass] in fibroblast,b-galactosidase fib-ccnt,beta galactosidase (fibroblast) [catalytic activity/mass],b; b-galactosidase; catalytic content; chemistry; disaccharidase; fib; fibr; gm 1-gangliosidosis; lactase; morquio disease type b; mps iv b; point in time; qnt; quan; quant; quantitative; random,Qn
24101-8,acid sphingomyelinase [enzymatic activity/mass] in leukocytes,acid sphingomyelinase wbc-ccnt,acid sphingomyelinase (wbc) [catalytic activity/mass],acd; acids; catalytic content; chemistry; leukocytes; niemann-pick a and b variants; niemann-pick disease; nieman-pick a and b variants; point in time; qnt; quan; quant; quantitative; random; smase; sphingomyelin phosphodiesterase; sphingomyelinase; wbcs; white blood cells,Qn
24102-6,corynebacterium toxin [presence] in specimen by immune diffusion (id),corynebacterium tox spec ql id,corynebacterium toxin immune diff ql (specimen),corynebacterium diphtheriae toxin; corynebacterium tox; corynebacterium ulcerans toxin; elek test; id; imm; immunodiff; immunodiffusion; imun; imune; infectious disease; infectiousdisease; microbiology; misc; miscellaneous; ordinal; other; point in time; pr; ql; qual; qualitative; random; screen; spec; to be specified in another part of the message; unspecified,Ord
24113-3,hepatitis b virus core igm ab [presence] in serum or plasma by immunoassay,hbv core igm serpl ql ia,hbv core igm ia ql,abs; aby; antby; anti; antibodies; antibody; anti-hbc; autoantibodies; autoantibody; eia; elfa; elisa; enzyme immunoassay; hbc; hbv; hbv core; hep; hep b; hepatis; hepatit; hepatitis bc; hepatology; hepb; iaa; id; immune globulin m; immunoglobulin m; infectious disease; infectiousdisease; liver; meia; microbiology; ordinal; pl; plasma; plsm; point in time; pr; ql; qual; qualitative; random; screen; serp; serpl; serplas; serum; serum or plasma; sr; suds; universallaborders,Ord
24121-6,barmah forest virus igg ab [presence] in serum by immunoassay,bfv igg ser ql ia,barmah forest virus igg ia ql (s),abs; aby; antby; anti; antibodies; antibody; arbovirus; autoantibodies; autoantibody; bfv; eia; elfa; elisa; enzyme immunoassay; iaa; id; immune globulin g; immunoglobulin g; infectious disease; infectiousdisease; meia; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; sr; suds,Ord
24126-5,adenovirus type [identifier] in specimen by neutralization test,adenovirus typ spec nt,adenovirus type neut test nom (specimen),adeno virus; conventional virus neutralization test; cvnt; hadv; id; identity or presence; infectious disease; infectiousdisease; microbiology; misc; miscellaneous; neutralization; neutralization test; nominal; nt; other; point in time; random; serum virus neutralization; spec; svn; to be specified in another part of the message; unspecified; virus neutralization test; vnt,Nom
24127-3,bordetella pertussis.pertussis toxin igg ab [units/volume] in serum by immunoassay,b pert.pt igg ser ia-acnc,b. pertussis.pertussis toxin igg ia qn (s),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; b pert; b pert.pt; b pert.pt ab; b pert.pt igg; b pertussis; eia; elfa; elisa; enzyme immunoassay; iaa; id; immune globulin g; immunoglobulin g; infectious disease; infectiousdisease; meia; microbiology; pertussis; point in time; pt; qnt; quan; quant; quantitative; random; serum; sr; suds; whooping cough,Qn
24129-9,bordetella pertussis.pertussis toxin igm ab [units/volume] in serum by immunoassay,b pert.pt igm ser ia-acnc,b. pertussis.pertussis toxin igm ia qn (s),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; b pert; b pert.pt; b pert.pt ab; b pert.pt igm; b pertussis; eia; elfa; elisa; enzyme immunoassay; iaa; id; immune globulin m; immunoglobulin m; infectious disease; infectiousdisease; meia; microbiology; pertussis; point in time; pt; qnt; quan; quant; quantitative; random; serum; sr; suds; whooping cough,Qn
24131-5,deprecated food allergen mix 3 (oat+buckwheat+sesame seed+wheat+corn) ige ab [presence] in serum by multiple allergens,deprecated food allerg mix3 ige ql,oat+buckwheat+sesame seed+wheat+corn ige multidisk ql (s),abs; aby; allergen; allergens; allergy testing; allerscan; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; buchwheat; buckwheat; cereal mix; corn; f004; f007; f008; f010; f011; f10; f11; f141; f4; f7; f74; f8; food allerg mix3; food mix (cereals); fx3; immune globulin e; immunoglobulin e; maize; oat; oats; ordinal; point in time; ql; qual; qualitative; random; screen; serum; sesame seed; sesamum orientale; sr; triticum sativum; wheat,Ord
2414-1,hippurate [mass/time] in 24 hour urine,hippurate 24h ur-mrate,hippurate (24h u) [mass/time],1 day; 24 hours; 24hr; benzyl alcohol metabolite; drug/toxicology; drugs; hipp; hippramine; hippuran; hippuric acid; hiprex; hip-rex; mass rate; mrate; qnt; quan; quant; quantitative; toluene metabolite; ua; ur; urex; urn; urotractan,Qn
24146-3,western water hemp igg ab [units/volume] in serum,west water hemp igg qn,western water hemp igg qn (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; immune globulin g; immunoglobulin g; point in time; qnt; quan; quant; quantitative; random; serum; sr; w039; w39; west water hemp; western water hemp; western waterhemp,Qn
24176-0,adenovirus ab [titer] in serum by complement fixation --2nd specimen,hadv ab sp2 titr ser cf,adenovirus ab spec 2 cf (s) [titer],abs; aby; adeno virus; antby; anti; antibodies; antibody; autoantibodies; autoantibody; cf; comp fixation; compfix; complement fixation; convalescent; dilution factor; dilution factor (titer); hadv; id; infectious disease; infectiousdisease; microbiology; point in time; post immunization; random; second; serum; smqn; sp2; spec; sr; titer; titered; titre; ttr,SemiQn
2419-0,histidine [mass/volume] in blood,histidine bld-mcnc,histidine (bld) [mass/vol],blood; chemistry; formiminoglutamic acidemia; his; histidinemia; level; mass concentration; point in time; qnt; quan; quant; quantitative; random; wb; whole blood,Qn
24211-5,western equine encephalitis virus ab [titer] in serum by immunofluorescence --1st specimen,weev ab sp1 titr ser if,weev ab spec 1 if (s) [titer],abs; aby; acif; acute specimen; antby; anti; antibodies; antibody; anticomplement immunofluorescence; autoantibodies; autoantibody; dilution factor; dilution factor (titer); enc; enceph; encephalomyelitis; equin; fa; first; fluorescent antibody; fluoresent; id; ifa; immune fluorescence; immunoflour; immunofluor; immunofluorescence; infectious disease; infectiousdisease; microbiology; point in time; pre immunization; random; serum; smqn; sp1; spec; sr; time resolved fluorescence; titer; titered; titre; togavirus; trf; ttr; wee virus; weev; west,SemiQn
24212-3,western equine encephalitis virus ab [titer] in serum by immunofluorescence --2nd specimen,weev ab sp2 titr ser if,weev ab spec 2 if (s) [titer],abs; aby; acif; antby; anti; antibodies; antibody; anticomplement immunofluorescence; autoantibodies; autoantibody; convalescent; dilution factor; dilution factor (titer); enc; enceph; encephalomyelitis; equin; fa; fluorescent antibody; fluoresent; id; ifa; immune fluorescence; immunoflour; immunofluor; immunofluorescence; infectious disease; infectiousdisease; microbiology; point in time; post immunization; random; second; serum; smqn; sp2; spec; sr; time resolved fluorescence; titer; titered; titre; togavirus; trf; ttr; wee virus; weev; west,SemiQn
24213-1,eastern equine encephalitis virus ab [titer] in serum by immunofluorescence --1st specimen,eeev ab sp1 titr ser if,eeev ab spec 1 if (s) [titer],abs; aby; acif; acute specimen; antby; anti; antibodies; antibody; anticomplement immunofluorescence; autoantibodies; autoantibody; dilution factor; dilution factor (titer); eee virus; eeev; enc; enceph; encephalomyelitis; equin; fa; first; fluorescent antibody; fluoresent; id; ifa; immune fluorescence; immunoflour; immunofluor; immunofluorescence; infectious disease; infectiousdisease; microbiology; point in time; pre immunization; random; serum; smqn; sp1; spec; sr; time resolved fluorescence; titer; titered; titre; togavirus; trf; ttr,SemiQn
24236-2,mycoplasma pneumoniae ab [titer] in serum by complement fixation --1st specimen,m pneumo ab sp1 titr ser cf,m. pneumoniae ab spec 1 cf (s) [titer],abs; aby; acute specimen; antby; anti; antibodies; antibody; autoantibodies; autoantibody; cf; comp fixation; compfix; complement fixation; dilution factor; dilution factor (titer); enzootic pneumonia; first; id; infectious disease; infectiousdisease; m pneumo; m pneumonia; m pneumoniae; microbiology; myco; myco pneu; mycoplas; mycoplasm; mycoplasmoides pneumoniae; mycoplasmosis; mycoplsm; pneu; pneum; pneumo; pneumon; pneumonia; point in time; pre immunization; random; serum; smqn; sp1; spec; sr; titer; titered; titre; ttr,SemiQn
24239-6,chlamydia sp igg ab [units/volume] in serum --2nd specimen,chlamydia igg sp2 ser-acnc,chlamydia sp igg spec 2 qn (s),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; chlam; chlamid; convalescent; id; immune globulin g; immunoglobulin g; infectious disease; infectiousdisease; microbiology; point in time; post immunization; qnt; quan; quant; quantitative; random; second; serum; sp2; spec; species; spp; sr,Qn
24243-8,polio virus 1 ab [titer] in serum --1st specimen,pv1 ab sp1 titr ser,polio virus 1 ab spec 1 (s) [titer],abs; aby; acute specimen; antby; anti; antibodies; antibody; autoantibodies; autoantibody; dilution factor; dilution factor (titer); first; i; id; infectious disease; infectiousdisease; microbiology; point in time; polio virus type i; poliovirus; pre immunization; pv; pv1; random; serum; smqn; sp1; spec; sr; titer; titered; titre; ttr,SemiQn
24251-1,coxsackievirus b1 ab [titer] in serum --1st specimen,cv b1 ab sp1 titr ser,coxsackievirus b1 ab spec 1 (s) [titer],abs; aby; acute specimen; antby; anti; antibodies; antibody; autoantibodies; autoantibody; cav; coxsackie; coxsackie virus; cv; cv b1; dilution factor; dilution factor (titer); first; id; infectious disease; infectiousdisease; microbiology; point in time; pre immunization; random; serum; smqn; sp1; spec; sr; titer; titered; titre; ttr,SemiQn
24277-6,legionella pneumophila ab [titer] in serum --1st specimen,l pneumo ab sp1 titr ser,l. pneumophila ab spec 1 (s) [titer],abs; aby; acute specimen; antby; anti; antibodies; antibody; autoantibodies; autoantibody; dilution factor; dilution factor (titer); first; id; infectious disease; infectiousdisease; l pneumo; l pneumonphila; legion; legionela; microbiology; pneu; pneum; pneumophilia; point in time; pre immunization; random; serum; smqn; sp1; spec; sr; titer; titered; titre; ttr,SemiQn
24282-6,rickettsia spotted fever group igg ab [titer] in serum --2nd specimen,rick sf igg sp2 titr ser,r. spotted fever group igg spec 2 (s) [titer],abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; convalescent; dilution factor; dilution factor (titer); id; immune globulin g; immunoglobulin g; infectious disease; infectiousdisease; microbiology; point in time; post immunization; random; rick sf; ricket; rickettsial; second; serum; smqn; sp2; spec; sr; titer; titered; titre; ttr,SemiQn
24301-4,coxsackievirus a10 ab [titer] in serum --2nd specimen,cv a10 ab sp2 titr ser,coxsackievirus a10 ab spec 2 (s) [titer],abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; cav; convalescent; coxsackie; coxsackie virus; cv; cv a10; dilution factor; dilution factor (titer); id; infectious disease; infectiousdisease; microbiology; point in time; post immunization; random; second; serum; smqn; sp2; spec; sr; titer; titered; titre; ttr,SemiQn
24307-1,coxsackievirus a9 ab [titer] in serum --2nd specimen,cv a9 ab sp2 titr ser,coxsackievirus a9 ab spec 2 (s) [titer],abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; cav; convalescent; coxsackie; coxsackie virus; cv; cv a9; dilution factor; dilution factor (titer); id; infectious disease; infectiousdisease; microbiology; point in time; post immunization; random; second; serum; smqn; sp2; spec; sr; titer; titered; titre; ttr,SemiQn
24314-7,torch 1996 panel - serum,torch 1996 pnl ser,torch 1996 panel (s),"96; gyn; gynecology; id; infectious disease; infectiousdisease; microbiology; ob; obgyn; obstetrics; pan; panel.microbiology; panl; pnl; point in time; qnt; quan; quant; quantitative; random; serum; sr; torch 1996 pnl; toxoplasma, rubella. cytomegalovirus, herpes simplex virus",Qn
24318-8,manual differential panel - blood,manual diff bld,manual differential panel (bld),blood; diff; diff pnl; differl; differn; hematology/cell counts; pan; panel.hematology& cell counts; panl; pnl; point in time; qnt; quan; quant; quantitative; random; wb; whole blood,Qn
24341-0,gas and carbon monoxide panel - arterial blood,gas + co pnl blda,gas and carbon monoxide panel (blda),abg; art; art bld; art blood; arterial; arterial blood; blood arterial; chemistry; cooximetry; co-oximetry; co-oximetry panel; gas + co pnl; gases; pan; panel.chemistry; panl; pnl; point in time; qnt; quan; quant; quantitative; random,Qn
24355-0,deprecated urinalysis macroscopic panel in urine,deprecated ua macroscopic pnl ur,urinalysis macroscopic panel (u),pan; panel.urinalysis; panl; pnl; point in time; random; ua; ua macroscopic pnl; ur; urn,-
24392-3,cortisol [moles/volume] in serum or plasma --pre 1 mg dexamethasone po overnight,cortis pre 1 mg dex serpl-scnc,cortisol pre 1 mg dexamethasone po overnight [moles/vol],17-hydroxycorticosterone; before; c350; chemistry.challenge testing; compound f; coritsol; cort; decadron; dexameth; dexone; f; hexadrol; hydrocortisone; i; level; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; substance concentration,Qn
24410-3,brucella canis ab [presence] in serum by plate agglutination,b canis ab ser ql plate aggl,br. canis ab plate agglutination ql (s),abs; aby; agg; agglut; agglutination; antby; anti; antibodies; antibody; autoantibodies; autoantibody; b canis; bruc; brucellosis; id; infectious disease; infectiousdisease; microbiology; ordinal; plate aggl; point in time; pr; ql; qual; qualitative; random; screen; serum; sr,Ord
2442-2,hydroxylysine [mass/volume] in serum or plasma,oh-lysine serpl-mcnc,hydroxylysine [mass/vol],chemistry; hydroxy lysine; hydroxyl; level; mass concentration; oh-lysine; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
24436-8,3-methylcrotonylglycine/creatinine [molar ratio] in urine,3me-crotonylglycine/creat ur-srto,3-methylcrotonylglycine/creatinine (u) [molar ratio],3me-crotonylglycine; beta-methylcrotonylglycine; chemistry; cr; crea; creat; iii; point in time; qnt; quan; quant; quantitative; random; scrto; substance concentration ratio; substance ratio; ua; ucr; ur; urn,Qn
24451-7,carnitine [moles/mass] in tissue,carnitine tiss-scnt,carnitine (tiss) [moles/mass],"carnitine.total; chemistry; point in time; qnt; quan; quant; quantitative; random; substance content; tissue; tissue, unspecified",Qn
2446-3,hydroxyproline [mass/volume] in serum or plasma,oh-proline serpl-mcnc,hydroxyproline [mass/vol],chemistry; hydroxylproline; hydroxyprol; hydroxy-proline; hydrxprol; hydrxproln; hydrxyprln; hyp; level; mass concentration; ohpro; oh-proline; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
24463-2,keratan sulfate [presence] in urine,keratan sulfate ur ql,keratan sulfate ql (u),chemistry; chondroitin sulfate b; keratosulfate; ordinal; point in time; pr; ql; qual; qualitative; random; screen; so4; so4-2; sulf; ua; ur; urn,Ord
24469-9,hemoglobin xxx/hemoglobin.total in blood by electrophoresis,hgb xxx mfr bld elph,hemoglobin unsp elph (bld) [mass fraction],blood; elec; elect; electr; electro; electrophhrs; electrophrs; elp; elph; ep; haemaglobinopathy studies; haemoglobin; hb; hematology/cell counts; hgb; hgb xxx; mass fraction; percent; point in time; qnt; quan; quant; quantitative; random; tot; totl; wb; whole blood,Qn
24476-4,f2 gene mutations found [identifier] in blood or tissue by molecular genetics method nominal,f2 gene mut anl bld/t,f2 gene targeted mutation analysis molgen nom (bld/tiss),"blood; coagulation factor 2 gene; coagulation factor ii (thrombin); coagulation factor ii gene; genetics; heredity; heritable; identity or presence; inherited; molecular genetics; molecular pathology; molpath; molpath.mutations; mut; mut anl; mutations; nominal; pcr; point in time; prothrombin gene; prothrombin precursor; pt; random; rprgl2; thph1; tissue; tissue, unspecified; universallaborders; wb; whole blood; whole blood or tissue",Nom
24490-5,tree allergen mix 3 (mountain juniper+white oak+white elm+cottonwood+mesquite) ige ab rast class [presence] in serum by multidisk,tree allerg mix3 ige rast,mountain juniper+white oak+white elm+cottonwood+mesquite ige rast class multidisk (s) [presence],abs; aby; allergen; allergens; allergy testing; allerscan; american elm; antby; anti; antibodies; antibody; autoantibodies; autoantibody; cottonwood; elm; honey locust; ige rast; immune globulin e; immunoglobulin e; juniper sabinoides; juniperus ashei; mesquite; mountain cedar; mountain juniper; mt juniper; oak; point in time; pr; prosopis juliflora ab.ige.rast class; random; serum; smqn; sr; t006; t007; t008; t014; t020; t14; t20; t6; t7; t8; tree allerg mix3; tx3; white elm; white oak,SemiQn
24510-0,deprecated european hornet ige ab rast class [presence] in serum,deprecated european hornet ige rast ql,european hornet ige rast class (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; european hornet; i75; ige rast; immune globulin e; immunoglobulin e; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; sr,Ord
24528-2,left ventricular myocardial mass by us 2d modified biplane,lv myo mass us.2d.mod-bp,,2d us; card.us; cardiac; cardio; cardiology; echography; heart disease; hrt; hrt ventr; l; lt; lv; mod-bp; myo mass; point in time; qnt; quan; quant; quantitative; random; sonogram; sonograph; sonography; uls; ultrasound; ultrasound - 2-dimensional; us.2d.mod-bp; ventricular,Qn
24546-4,deprecated rfa aortic arch w contrast ia,deprecated ta arch rfa w contr ia,,ao; aortagram; aortic; aortogm; aortogram; aortography; arteriogram; c; contr; contra; contrst; document; films; finding; findings; fluor; fluoro; fluoroscopy; imaging; point in time; rad; radiology; random; rfa; ta arch; thorax; view; vws; w contr ia; wc,Doc
24594-4,mg guidance for aspiration of cyst of breast,mg guided brst cyst asp,,asp; brst; cyst asp; document; finding; findings; guid; guide; guided; imaging; perc; point in time; rad; radiology; random,Doc
24595-1,mg guidance for needle localization of mass of breast,mg guided brst needle loc mass,,brst; document; finding; findings; guid; guide; guided; imaging; local; ndl; needle loc mass; point in time; rad; radiology; random,Doc
24602-5,mg guidance for biopsy of breast,mg guided brst bx,,brst; bx; document; finding; findings; guid; guide; guided; imaging; perc; point in time; rad; radiology; random,Doc
24604-1,mg breast diagnostic limited views,mg brst views dx ltd,,brst; document; films; finding; findings; imaging; lmted; ltd; point in time; rad; radiology; random; view; views dx ltd; views ltd; vws,Doc
24609-0,mg guidance for percutaneous biopsy.core needle of breast,mg guided brst pc bx cn,,brst; bx; cn; cnb; document; finding; findings; guid; guide; guided; imaging; large needle; ndl; pc bx cn; perc; point in time; rad; radiology; random,Doc
24626-4,rfa guidance for reposition of cv catheter in vein-- w contrast iv,rfa guided vein cvc repos--w contr iv,,c; cardio; cardiology; cath; contr; contra; contrst; cvc repos; document; finding; findings; fluor; fluoro; fluoroscopy; guid; guide; guided; heart disease; imaging; misc; miscellaneous; other; point in time; rad; radiology; random; rfa; spec; to be specified in another part of the message; unspecified; ven; venogram; venography; venous; w contr iv; wc,Doc
24631-4,rf unspecified body region views for central venous catheter placement check,rf views for cvc place ck,,cath; document; films; finding; findings; fluor; fluoro; fluoroscopy; imaging; inspection; misc; miscellaneous; other; point in time; rad; radiology; random; spec; to be specified in another part of the message; unspecified; view; views for cvc place ck; vws,Doc
24640-5,xr chest apical lordotic,xr chest apical lord,,1v; cardio; cardiology; cxr; document; film; finding; findings; heart disease; imaging; lung; plain films; point in time; pulmonary; pulmonology; rad; radiology; random; respiratory; single view; thorax; vw; xray; x-ray,Doc
24648-8,xr chest pa upright,xr chest pa upr,,1v; cardio; cardiology; coreplaybook; cxr; document; erect; film; finding; findings; heart disease; imaging; lung; plain films; playbook; point in time; postero-anterior; pulmonary; pulmonology; rad; radiology; random; respiratory; single view; thorax; upr; uprt; vw; xray; x-ray,Doc
24653-8,xr chest ap and ap right lateral-decubitus,xr chest ap+ap r-lat debub,,anterio-posterior; anteroposterior; ap+ap r-lat debub; cardio; cardiology; cxr; document; films; finding; findings; heart disease; imaging; lat; lung; plain films; point in time; pulmonary; pulmonology; r prime; rad; radiology; random; respiratory; right; thorax; view; views & ap kub; views (ap; views+ap; vws; xray; x-ray,Doc
24662-9,us guidance for fluid aspiration of pleural space,us guided pl space pc fluid asp,,asp; document; echography; finding; findings; fld; guid; guide; guided; imaging; lung; pc fluid asp; perc; pl space; point in time; pulmonary; pulmonology; radiology; random; respiratory; sonogram; sonograph; sonography; thoracentesis; thorax; thorocentesis; uls; ultrasound,Doc
24665-2,xr sacrum and coccyx views,xr sacrum+coccyx views,,document; films; finding; findings; imaging; pelvic; plain films; point in time; rad; radiology; random; view; vws; xray; x-ray,Doc
24666-0,rf colon views w air and barium contrast pr,rf colon views w air+ba pr,,abd; abd+pelvis; abdo; abdominal; acbe; air contrast barium enema; ba; barium enema; be; c; contr; contra; contrst; coreplaybook; document; double contrast barium enema; films; finding; findings; fluor; fluoro; fluoroscopy; imaging; lgi; pelvic; playbook; point in time; rad; radiology; random; view; vws; w air contr pr; w air+ba pr; w ba pr,Doc
2467-9,igg subclass 2 [mass/volume] in serum,igg2 ser-mcnc,igg subclass 2 (s) [mass/vol],chemistry; igg 2; igg2; ii; immune globulin g; immunoglobulin g; immunoglobulin g subclass 2; level; mass concentration; point in time; qnt; quan; quant; quantitative; random; serum; sr; subclasses,Qn
24684-3,rfa guidance for embolectomy of extracranial vessels-- w contrast ia,rfa guided ec vess embolec--w contr ia,,arteriogram; c; contr; contra; contrst; document; ec vess; embolec; extracranial vessels.xxx; extraction; finding; findings; fluor; fluoro; fluoroscopy; guid; guide; guided; imaging; misc; miscellaneous; other; point in time; rad; radiology; random; remove; rfa; spec; to be specified in another part of the message; unspecified; vesl; vessels.xxx; w contr ia; wc,Doc
2469-5,igg subclass 4 [mass/volume] in serum,igg4 ser-mcnc,igg subclass 4 (s) [mass/vol],chemistry; igg 4; igg4; immune globulin g; immunoglobulin g; immunoglobulin g subclass 4; level; mass concentration; point in time; qnt; quan; quant; quantitative; random; serum; sr; subclasses,Qn
24695-9,xr facial bones views,xr face views,,brain; coreplaybook; cranial; cranium; document; face; films; finding; findings; imaging; intracranial; plain films; playbook; point in time; rad; radiology; random; skull; view; vws; xray; x-ray,Doc
24727-0,ct head w contrast iv,ct head w contr iv,,brain; c; cat scan; computed tomography; computerized tomography; contr; contra; contrst; coreplaybook; cranial; cranium; ct scan; document; finding; findings; imaging; intracranial; neuro; neurology; playbook; point in time; rad; radiology; random; skull; w contr iv; wc,Doc
24730-4,nm brain views,nm brain views w rnc iv,,brain; cerebral; cerebrum; cranial; cranium; document; films; finding; findings; head; imaging; intracranial; neuro; neurology; point in time; rad; radiology; random; rn; rnc; scan; skull; view; vws; w rnc iv,Doc
2474-5,indicans [presence] in urine,indicans ur ql,indicans ql (u),chemistry; indoxyl sulfate; ordinal; point in time; pr; ql; qual; qualitative; random; screen; ua; ur; urn,Ord
24747-8,deprecated head sagittal sinus mr angiogram w contrast iv,deprecated head.ss mr.angio w contr iv,,ang; angio; angiography; brain; c; contr; contra; contrst; cranial; cranium; document; finding; findings; head.ss; imaging; intracranial; magnetic resonance angiographies; magnetic resonance imaging; mitral regurgitation maximum velocity; mr angiography; mra; mri; mri.angio; point in time; rad; radiology; random; skull; w contr iv; wc,Doc
24778-3,xr kidney - bilateral 3 serial views wo and w contrast iv,xr kdny-bl 3v serial wo+w contr iv,,3v; 3v serial; 3vw; abd; abdo; abdomen+; abdominal; bil; bilat; both; c; contr; contra; contrst; document; films; finding; findings; iii; imaging; ivp; ivu; kdny-bl; kidney; kidneys; nephric; nephrogram; nephrography; nephrology; plain films; point in time; pyelogram; rad; radiology; random; renal; urogram; urography; view; vws; w contr iv; wc; wo & wc; wo+w contr; wo+w contr iv; wwo; xray; x-ray,Doc
24784-1,xr tomography kidney - bilateral wo and w contrast iv,xr tomo kdny-bl wo+w contr iv,,abd; abdo; abdomen+; abdominal; bil; bilat; both; c; contr; contra; contrst; document; finding; findings; imaging; ivp; ivu; kdny-bl; kidney; kidneys; nephric; nephrogram; nephrography; nephrology; nephrotomo; nephrotomogram; nephrotomograms; nephrotomography; plain films; point in time; pyelogram; rad; radiology; random; renal; urogram; urography; w contr iv; wc; wo & wc; wo+w contr; wo+w contr iv; wwo; xr tomo; xray; x-ray,Doc
24807-0,xr knee ap w standing,xr knee ap w stand,,1v; anterio-posterior; anteroposterior; document; ext; film; finding; findings; imaging; kn; le; leg; low; lower extremity joint; msk; musculoskeletal; ortho; orthopedics; plain films; point in time; rad; radiology; random; single view; stand); vw; wb; weight bearing; xray; x-ray,Doc
24819-5,deprecated liver and spleen nm w tc-99m calcium colloid iv,deprecated liver+spleen nm w tc99mca col,,99 mtc; 99mtc; abd; abdo; abdomen+; abdominal; ca; cal; document; films; finding; findings; hepar; hepatic; imaging; point in time; rad; radiology; random; scan; tc-99cm; tc99m; tc-99m; technetium 99m; view; vws; w tc99mca colloid iv,Doc
24824-5,nm lung portable views,nm lung views port w rnc iv,,document; films; finding; findings; imaging; lung; point in time; pulmonary; pulmonology; rad; radiology; random; respiratory; rn; rnc; scan; thorax; view; vws; w rnc iv,Doc
24831-0,nm small bowel views for meckel's diverticulum w tc-99m m04 iv,nm sm bowel meckel's div w tc99mm04 iv,,99 mtc; 99mtc; abd; abdo; abdomen+; abdominal; document; films; finding; findings; imaging; point in time; rad; radiology; random; s prime; sb; scan; small intestine; tc-99cm; tc99m; tc-99m; technetium 99m; view; vws; w tc99mm04 iv,Doc
24842-7,us neck,us neck,,document; echography; finding; findings; imaging; point in time; radiology; random; sonogram; sonograph; sonography; uls; ultrasound,Doc
24853-4,us eye+orbit - bilateral,us eye+orbit-bl,,bil; bilat; both; document; echography; eye; eye socket; eye.ultrasound; eye+orbit-bl; eyeball; finding; findings; occular; oculis; ophthalmologic; ophthalmology; ophtho; ophthy; optic globe; orbital; orbit-bl; orbits; point in time; random; sonogram; sonograph; sonography; uls; ultrasound; vision; visual,Doc
24859-1,us pancreas,us pancreas,,abd; abdo; abdomen+; abdominal; document; echography; finding; findings; imaging; pancr; pancreatc; pancreatic; point in time; radiology; random; sonogram; sonograph; sonography; uls; ultrasound,Doc
24862-5,rfa iliac artery internal views w contrast ia,rfa iliac a.int views w contr ia,,abd; abd+pelvis; abdo; abdominal; art; arteriogram; c; cardio; cardiology; contr; contra; contrst; document; films; finding; findings; fluor; fluoro; fluoroscopy; heart disease; iliac a.int; imaging; pelvic; pelvic artery; point in time; rad; radiology; random; rfa; view; vws; w contr ia; wc,Doc
24864-1,ct guidance for biopsy of pelvis,ct guided pelvis bx,,bx; cat scan; computed tomography; computerized tomography; ct scan; document; finding; findings; guid; guide; guided; imaging; pelvic; perc; point in time; rad; radiology; random,Doc
2486-9,somatomedins [mass/volume] in serum or plasma,somatomedins serpl-mcnc,somatomedins [mass/vol],chemistry; insulin-like growth factors; level; mass concentration; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
24880-7,mr pituitary and sella turcica,mr pit+sella turc,,brain; cranial; cranium; document; finding; findings; imaging; intracranial; mitral regurgitation maximum velocity; mri; pit+sella turc; pituitary+st; pitutary; point in time; rad; radiology; random; skull,Doc
24893-0,rf rectum single view post contrast pr during defecation,rf rectum 1v p contr pr during def,,1v; after; c; contr; contra; contrst; defecagram; defecogram; document; evacuating proctogram; film; finding; findings; fluor; fluoro; fluoroscopy; imaging; p contr pr during def; pelvic; point in time; pst; rad; radiology; random; rectal; single view; voiding proctogram; vw,Doc
24894-8,rf rectum and urinary bladder views w contrast pr and intra bladder during defecation and voiding,rf rect+blad vs w contr pr+ib def+void,,c; contr; contra; contrst; cystogram; defecagram; defecogram; document; dynamic cysto proctogram; dynamic cystoproctogram; films; finding; findings; fluor; fluoro; fluoroscopy; imaging; pelvic; point in time; rad; radiology; random; rect+blad; rect+bladder; rectal; view; vws; w contr iub; w contr pr; w contr pr+ib def+void; wc,Doc
24906-0,mr shoulder wo and w contrast iv,mr should wo+w contr iv,,arm; c; contr; contra; contrst; coreplaybook; document; ext; finding; findings; imaging; mitral regurgitation maximum velocity; mri; msk; musculoskeletal; ortho; orthopedics; playbook; point in time; rad; radiology; random; ue; up; upper extremity joint; w contr iv; wc; wo & wc; wo+w contr; wo+w contr iv; wwo,Doc
24911-0,rf shunt views,rf shunt views,,document; films; finding; findings; fluor; fluoro; fluoroscopy; imaging; misc; miscellaneous; other; point in time; rad; radiology; random; shuntogm; shuntogram; spec; to be specified in another part of the message; unspecified; view; vws,Doc
24936-7,mr cervical spine w anesthesia,mr c-spine w anesthesia,,c/sp; cerv; c-spine; document; finding; findings; imaging; mitral regurgitation maximum velocity; mri; point in time; rad; radiology; random; spinal; spinal cord,Doc
2494-3,iodine [mass/volume] in serum or plasma,iodine serpl-mcnc,iodine [mass/vol],c616; chemistry; i; i-; level; mass concentration; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; universallaborders,Qn
2497-6,iron [mass/mass] in hair,iron hair-mcnt,iron (hair) [mass/mass],chemistry; fe; har; mass content; point in time; qnt; quan; quant; quantitative; random,Qn
24986-2,ct guidance for biopsy of spine,ct guided spine bx,,bx; cat scan; computed tomography; computerized tomography; ct scan; document; finding; findings; guid; guide; guided; imaging; misc; miscellaneous; other; perc; point in time; rad; radiology; random; spec; spinal; spinal cord; to be specified in another part of the message; unspecified,Doc
250-1,fluconazole [susceptibility] by disk diffusion (kb),fluconazole islt kb,fluconazole disk diffusion (kb) [susc],antibiotic susceptibilities; ast; diflucan; disk diffusion; id; infectious disease; infectiousdisease; islt; isol; kb; kirby-bauer; point in time; random; sus; suscept; susceptibilities; susceptibility; susceptibilty,OrdQn
25023-3,rfa vein views w contrast iv,rfa vein views w contr iv,,c; cardio; cardiology; contr; contra; contrst; document; films; finding; findings; fluor; fluoro; fluoroscopy; heart disease; imaging; misc; miscellaneous; other; point in time; rad; radiology; random; rfa; spec; to be specified in another part of the message; unspecified; ven; venogram; venography; venous; view; vws; w contr iv; wc,Doc
25043-1,ct guidance for fluid aspiration of unspecified body region,ct guided pc fluid asp,,asp; cat scan; computed tomography; computerized tomography; ct scan; document; finding; findings; fld; guid; guide; guided; imaging; misc; miscellaneous; other; pc fluid asp; perc; point in time; rad; radiology; random; spec; to be specified in another part of the message; unspecified,Doc
25049-8,deprecated unspecified body region ct 3d multiple sagittal & coronal,deprecated xxx ct.3d sagittal & coronal,,cat scan; computed tomography; computerized tomography; ct scan; films; finding; findings; imaging; misc; miscellaneous; mult; multi; narrative; other; point in time; rad; radiology; random; report; sagittal+coronal; spec; to be specified in another part of the message; unspecified; view; vws,Nar
25069-6,rf guidance for biopsy of unspecified body region,rf guided bx,,bx; document; finding; findings; fluor; fluoro; fluoroscopy; guid; guide; guided; imaging; misc; miscellaneous; other; perc; point in time; rad; radiology; random; spec; to be specified in another part of the message; unspecified,Doc
25077-9,rfa guidance for placement of catheter in hepatic artery-- w contrast ia,rfa guided hep a cath place--w contr ia,,abd; abdo; abdomen+; abdominal; art; arteriogram; c; cardio; cardiology; cath; cath place; contr; contra; contrst; document; finding; findings; fluor; fluoro; fluoroscopy; guid; guide; guided; heart disease; hep a; hepar; imaging; liver; liver artery; plac of cath; point in time; rad; radiology; random; rfa; w contr ia; wc,Doc
25082-9,2-methyl-3-hydroxybutyrate (c5-oh)/creatinine [molar ratio] in urine,2me3oh-butyrate/creat ur-srto,2-methyl-3-hydroxybutyrate (c5-oh)/creatinine (u) [molar ratio],"2me3oh-butyrate; 2-methyl,3-hydroxy butyrate; 2-methyl,3-hydroxybutyric acid; 2-methyl-3-hydroxybutyrate; 3-hydroxy-2-methylbutanoate; 3-hydroxy-2-methylbutanoic acid; 3-hydroxy-2-methylbutyrate; 3-hydroxy-2-methyl-butyrate; 3-hydroxy-2-methylbutyric acid; 3-hydroxy-2-methyl-butyric acid; alpha-methyl-beta-hydroxybutyrate; alpha-methyl-beta-hydroxybutyric acid; c5oh; c5-oh; chemistry; cr; crea; creat; hmba; hydroxybutyric acid; ii; iii; point in time; qnt; quan; quant; quantitative; random; scrto; substance concentration ratio; substance ratio; ua; ucr; ur; urn",Qn
25116-5,methylmalonate/creatinine [molar ratio] in urine,methylmalonate/creat ur-srto,methylmalonate/creatinine (u) [molar ratio],chemistry; cr; crea; creat; methylmalonic acid; methylmalonic acidemia; mma; point in time; propionic acidemia; qnt; quan; quant; quantitative; random; scrto; substance concentration ratio; substance ratio; ua; ucr; ur; urn,Qn
25124-9,phenylacetate/creatinine [molar ratio] in urine,phenylacetate/creat ur-srto,phenylacetate/creatinine (u) [molar ratio],cr; crea; creat; drug/toxicology; drugs; phenylacetic acid; point in time; qnt; quan; quant; quantitative; random; scrto; substance concentration ratio; substance ratio; ua; ucr; ur; urn,Qn
25128-0,phosphoserine/creatinine [molar ratio] in urine,phosphoserine/creat ur-srto,phosphoserine/creatinine (u) [molar ratio],chemistry; cr; crea; creat; point in time; ps; qnt; quan; quant; quantitative; random; scrto; substance concentration ratio; substance ratio; ua; ucr; ur; urn,Qn
25155-3,cystine crystals [#/area] in urine sediment by microscopy high power field,cystine cry #/area urns hpf,cystine crystals lm.hpf (urine sed) [#/area],#/area; crys; cryst; crystal; cys-cys; dicysteine; kidney; lm; micro; micros; microscopic; nephrology; number areic; point in time; qnt; quan; quant; quantitative; random; renal; ua; ur; urinalysis; urine sediment; urn; urns,Qn
25159-5,fatty casts [presence] in urine sediment by light microscopy,fatty casts urns ql micro,fatty casts lm ql (urine sed),cast; kidney; lm; micro; micros; microscopic; nephrology; ordinal; point in time; pr; ql; qual; qualitative; random; renal; screen; ua; ur; urinalysis; urine sediment; urn; urns,Ord
25178-5,amikacin 30 ug/ml [susceptibility] by method for slow-growing mycobacteria,amikacin 30 ug/ml islt slowmyco,amikacin 30 ug/ml method for slow-growing mycobacteria [susc],30 ug/ml; afb; amikin; aminoglycosides; antibiotic susceptibilities; ast; id; infectious disease; infectiousdisease; islt; isol; mcg; myco; mycobacteria susceptibility; mycobacterial susceptibility; point in time; random; slowmyco; sus; suscept; susceptibilities; susceptibility; susceptibilty; tb; tuberculosis,OrdQn
25187-6,ethambutol 7.5 ug/ml [susceptibility] by method for slow-growing mycobacteria,ethambutol 7.5 ug/ml islt slowmyco,ethambutol 7.5 ug/ml method for slow-growing mycobacteria [susc],afb; antibiotic susceptibilities; ast; etambol; ethamb; id; inagen; infectious disease; infectiousdisease; islt; isol; mcg; myambutol; myco; mycobacteria susceptibility; mycobacterial susceptibility; mycobutol; olbutam; point in time; random; slowmyco; sus; suscept; susceptibilities; susceptibility; susceptibilty; tb; tuberculosis,OrdQn
2519-7,lactate [moles/volume] in venous blood,lactate bldv-scnc,lactate (bldv) [moles/vol],2-hydroxypropanoic acid; 2-hydroxy-propionate; 2-hydroxy-propionic acid; bld ven; bld venous; blood - venous; blood ven; blood venus; chemistry; lact; lactic acid; level; l-lactate; point in time; qnt; quan; quant; quantitative; random; substance concentration; venous,Qn
25200-7,rifabutin 2 ug/ml [susceptibility] by method for slow-growing mycobacteria,rifabutin 2 ug/ml islt slowmyco,rifabutin 2 ug/ml method for slow-growing mycobacteria [susc],2 ug/ml; afb; ansamycin; antibiotic susceptibilities; ast; id; infectious disease; infectiousdisease; islt; isol; mcg; myco; mycobacteria susceptibility; mycobacterial susceptibility; mycobutin; point in time; random; slowmyco; sus; suscept; susceptibilities; susceptibility; susceptibilty; tb; tuberculosis,OrdQn
25216-3,para aminosalicylate 8 ug/ml [susceptibility] by method for slow-growing mycobacteria,pas 8 ug/ml islt slowmyco,para aminosalicylate 8 ug/ml method for slow-growing mycobacteria [susc],8 ug/ml; afb; aminosalicycic; aminosalycilate; antibiotic susceptibilities; ast; epusal; id; infectious disease; infectiousdisease; islt; isol; mcg; myco; mycobacteria susceptibility; mycobacterial susceptibility; na-pas; nemasol sodium; p-aminosalicyclic acid; para aminosalicylic acid; pas; point in time; random; salf-pas; slowmyco; sodico; sodium pas; sus; suscept; susceptibilities; susceptibility; susceptibilty; tb; therazid; tuberculosis,OrdQn
25217-1,isoniazid 0.1 ug/ml [susceptibility] by method for slow-growing mycobacteria,isoniazid 0.1 ug/ml islt slowmyco,isoniazid 0.1 ug/ml method for slow-growing mycobacteria [susc],afb; antibiotic susceptibilities; ast; hyzyd; id; infectious disease; infectiousdisease; inh; islt; isol; isoniaz; isoniazide; mcg; myco; mycobacteria susceptibility; mycobacterial susceptibility; nudrazod; point in time; random; slowmyco; sus; suscept; susceptibilities; susceptibility; susceptibilty; tb; tuberculosis,OrdQn
25218-9,isoniazid 0.2 ug/ml [susceptibility] by method for slow-growing mycobacteria,isoniazid 0.2 ug/ml islt slowmyco,isoniazid 0.2 ug/ml method for slow-growing mycobacteria [susc],afb; antibiotic susceptibilities; ast; hyzyd; id; infectious disease; infectiousdisease; inh; islt; isol; isoniaz; isoniazide; mcg; myco; mycobacteria susceptibility; mycobacterial susceptibility; nudrazod; point in time; random; slowmyco; sus; suscept; susceptibilities; susceptibility; susceptibilty; tb; tuberculosis,OrdQn
25219-7,isoniazid 1 ug/ml [susceptibility] by method for slow-growing mycobacteria,isoniazid 1 ug/ml islt slowmyco,isoniazid 1 ug/ml method for slow-growing mycobacteria [susc],1 ug/ml; afb; antibiotic susceptibilities; ast; hyzyd; id; infectious disease; infectiousdisease; inh; islt; isol; isoniaz; isoniazide; mcg; myco; mycobacteria susceptibility; mycobacterial susceptibility; nudrazod; point in time; random; slowmyco; sus; suscept; susceptibilities; susceptibility; susceptibilty; tb; tuberculosis,OrdQn
25220-5,cefoxitin 30 ug/ml [susceptibility] by method for slow-growing mycobacteria,cefoxitin 30 ug/ml islt slowmyco,cefoxitin 30 ug/ml method for slow-growing mycobacteria [susc],30 ug/ml; afb; antibiotic susceptibilities; ast; id; infectious disease; infectiousdisease; islt; isol; mcg; mefj; mefoxin; myco; mycobacteria susceptibility; mycobacterial susceptibility; point in time; random; slowmyco; sus; suscept; susceptibilities; susceptibility; susceptibilty; tb; tuberculosis,OrdQn
25228-8,vancomycin 30 ug/ml [susceptibility] by method for slow-growing mycobacteria,vancomycin 30 ug/ml islt slowmyco,vancomycin 30 ug/ml method for slow-growing mycobacteria [susc],30 ug/ml; afb; antibiotic susceptibilities; ast; c162; id; infectious disease; infectiousdisease; islt; isol; mcg; myco; mycobacteria susceptibility; mycobacterial susceptibility; point in time; random; slowmyco; sus; suscept; susceptibilities; susceptibility; susceptibilty; tb; tuberculosis; vanc; vancocin; vancor,OrdQn
25231-2,ethionamide 10 ug/ml [susceptibility] by method for slow-growing mycobacteria,ethionamide 10 ug/ml islt slowmyco,ethionamide 10 ug/ml method for slow-growing mycobacteria [susc],10 ug/ml; afb; antibiotic susceptibilities; ast; id; infectious disease; infectiousdisease; islt; isol; mcg; myco; mycobacteria susceptibility; mycobacterial susceptibility; point in time; random; slowmyco; sus; suscept; susceptibilities; susceptibility; susceptibilty; tb; trecator; tuberculosis,OrdQn
25232-0,nafcillin [mass/volume] in specimen,nafcillin spec-mcnc,nafcillin (specimen) [mass/vol],drug/toxicology; drugs; level; mass concentration; misc; miscellaneous; nafj; other; point in time; qnt; quan; quant; quantitative; random; spec; to be specified in another part of the message; unipen; unspecified,Qn
25236-1,cefixime [mass/volume] in specimen,cefixime spec-mcnc,cefixime (specimen) [mass/vol],drug/toxicology; drugs; level; mass concentration; misc; miscellaneous; other; point in time; qnt; quan; quant; quantitative; random; spec; suprax; to be specified in another part of the message; unspecified,Qn
25246-0,cephalothin [mass/volume] in specimen,cephalothin spec-mcnc,cephalothin (specimen) [mass/vol],cefalotin; cephalotin; ceporacin; cepovenin; drug/toxicology; drugs; keflin; level; mass concentration; misc; miscellaneous; other; point in time; qnt; quan; quant; quantitative; random; spec; to be specified in another part of the message; unspecified,Qn
25256-9,ganciclovir [mass/volume] in specimen,ganciclovir spec-mcnc,ganciclovir (specimen) [mass/vol],cytovene; drug/toxicology; drugs; gcv; level; mass concentration; misc; miscellaneous; other; point in time; qnt; quan; quant; quantitative; random; spec; to be specified in another part of the message; unspecified; valcyte; valganciclovir,Qn
25261-9,nalidixate [mass/volume] in specimen,nalidixate spec-mcnc,nalidixate (specimen) [mass/vol],drug/toxicology; drugs; level; mass concentration; misc; miscellaneous; nalidix; nalidixic acid; neg; other; point in time; qnt; quan; quant; quantitative; random; spec; to be specified in another part of the message; unspecified,Qn
25262-7,neomycin [mass/volume] in specimen,neomycin spec-mcnc,neomycin (specimen) [mass/vol],aminoglycosides; drug/toxicology; drugs; level; mass concentration; misc; miscellaneous; neosporin; other; point in time; qnt; quan; quant; quantitative; random; spec; to be specified in another part of the message; unspecified,Qn
25265-0,oxacillin [mass/volume] in specimen,oxacillin spec-mcnc,oxacillin (specimen) [mass/vol],bactocill; c116; drug/toxicology; drugs; level; mass concentration; misc; miscellaneous; other; point in time; prostaphlin; qnt; quan; quant; quantitative; random; spec; to be specified in another part of the message; unspecified,Qn
252-7,5-fluorocytosine [susceptibility] by minimum lethal concentration (mlc),5-fluorocytosine islt mlc,5-fluorocytosine mlc [susc],alcobon; ancobon; ancotil; antibiotic susceptibilities; ast; flucytosine; fluorocytosin; id; infectious disease; infectiousdisease; islt; isol; mbc; minimum bactericidal concentration; minimum lethal concentration; point in time; qnt; quan; quant; quantitative; random; sus; suscept; susceptibilities; susceptibility; susceptibilty,Qn
25279-1,streptococcus pneumoniae danish serotype 6b igg ab [units/volume] in serum --1st specimen,s pneum da 6b igg sp1 ser-acnc,s. pneumoniae danish type 6b igg spec 1 qn (s),abs; aby; acute specimen; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; first; id; immune globulin g; immunoglobulin g; infectious disease; infectiousdisease; microbiology; pcv13; pcv7; pneu; pneum; pneumo; pneumococ; pneumococcal; pneumococcal pneumonia; pneumococcus; pneumon; pneumonia; point in time; ppsv23; pre immunization; qnt; quan; quant; quantitative; random; s pneum da 6b; s pneum da 6b ab; s pneum da 6b igg; s pneum da type; s pneumo; s pneumoniae; serum; sp1; spec; spn; sr; strep; strept; u.s. serotype 26,Qn
25291-6,deprecated streptococcus pneumoniae 14 igg ab [units/volume] in serum --2nd specimen,deprecated s pneum14 igg sp2 ser-acnc,s. pneumoniae 14 igg spec 2 qn (s),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; convalescent; id; immune globulin g; immunoglobulin g; infectious disease; infectiousdisease; microbiology; pneu; pneum; pneumo; pneumococ; pneumococcal; pneumococcal pneumonia; pneumococcus; pneumon; pneumonia; point in time; post immunization; qnt; quan; quant; quantitative; random; s pneum14; s pneumo; s pneumoniae; second; serum; sp2; spec; spn; sr; strep; strept,Qn
25307-0,deprecated alternaria alternata igg ab rast class in serum,deprecated a alternata igg rast ser ql,a. alternata igg rast class (s),a alternata; a tenuis; abs; aby; alternaria tenuis; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; gm6; id; igg rast; immune globulin g; immunoglobulin g; infectious disease; infectiousdisease; m006; m6; microbiology; ordinal; point in time; ql; qual; qualitative; random; screen; serum; sr,Ord
25308-8,ammonia [moles/time] in 24 hour urine,ammonia 24h ur-srate,ammonia (24h u) [moles/time],1 day; 24 hours; 24hr; amm; ammon; amon; chemistry; kidney; nephrology; nh3; qnt; quan; quant; quantitative; renal; srate; substance rate; ua; ur; urn,Qn
25337-7,taenia solium larva igg ab [units/volume] in serum,t sol lar igg ser-acnc,t. solium larva igg qn (s),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; cysticercosis; cysticercus; id; immune globulin g; immunoglobulin g; infectious disease; infectiousdisease; microbiology; point in time; qnt; quan; quant; quantitative; random; serum; sr; t sol; t sol lar; t solium; tapeworm,Qn
2533-8,lactate dehydrogenase [enzymatic activity/volume] in synovial fluid,ldh snv-ccnc,ldh (syn fld) [catalytic activity/vol],2-hydroxypropanoic acid; 2-hydroxy-propionate; 2-hydroxy-propionic acid; catalytic concentration; chemistry; dehydrog; dehyrdogenase; joint aspirate; joint fld; joint flu; joint fluid; l.d.h; lact; lactic acid; lactic acid dehydrogenase; ld; ldh; l-lactate; l-lactate dehydrogenase; point in time; qnt; quan; quant; quantitative; random; sf; snv; syn; syn fl; synov; synovial fluid; tumor marker,Qn
2534-6,lactate dehydrogenase [enzymatic activity/volume] in urine,ldh ur-ccnc,ldh (u) [catalytic activity/vol],2-hydroxypropanoic acid; 2-hydroxy-propionate; 2-hydroxy-propionic acid; catalytic concentration; chemistry; dehydrog; dehyrdogenase; l.d.h; lact; lactic acid; lactic acid dehydrogenase; ld; ldh; l-lactate; l-lactate dehydrogenase; point in time; qnt; quan; quant; quantitative; random; tumor marker; ua; ur; urn,Qn
25355-9,deprecated wheat bran igg ab rast class [presence] in serum,deprecated wheat bran igg rast ql,wheat bran igg rast class (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; igg rast; immune globulin g; immunoglobulin g; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; sr; wheat bran,Ord
25376-5,citrulline [moles/time] in 24 hour urine,citrulline 24h ur-srate,citrulline (24h u) [moles/time],1 day; 24 hours; 24hr; chemistry; cit; citr; qnt; quan; quant; quantitative; srate; substance rate; ua; ur; urn,Qn
25383-1,deprecated cow milk ige ab rast class [presence] in serum,deprecated cow milk ige rast ql,cow milk ige rast class (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; f002; f2; f43; ige rast; immune globulin e; immunoglobulin e; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; sr,Ord
25386-4,creatinine [moles/volume] in body fluid,creat fld-scnc,creatinine (body fld) [moles/vol],"b/f; bf; bod; bodies; body fluid; body fluid, unsp; chemistry; cr; crea; creat; fl; fld; flu; fluid; kidney; level; nephrology; point in time; qnt; quan; quant; quantitative; random; renal; substance concentration",Qn
25390-6,cytokeratin 19 [mass/volume] in serum or plasma,ck 19 serpl-mcnc,cytokeratin 19 [mass/vol],"autoimmune hepatitis; chemistry; ck; ck 19; cyfra 21-1; keratin 19; keratin, type i cytoskeletal 19; level; mass concentration; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr",Qn
25394-8,nortrimipramine [moles/volume] in serum or plasma,nortrimipramine serpl-scnc,nortrimipramine [moles/vol],addiction; desmeth; desmethyltrimipramine; drug/toxicology; drugs; drugs of abuse; illicit; level; pl; plasma; plsm; point in time; potentialforabuse; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; substance concentration; trimipramine metabolite,Qn
2539-5,lactate dehydrogenase 2/lactate dehydrogenase.total in serum or plasma by electrophoresis,ldh2 cfr serpl elph,ldh 2 elph [catalytic fraction],2-hydroxypropanoic acid; 2-hydroxy-propionate; 2-hydroxy-propionic acid; catalytic fraction; chemistry; dehydrog; dehyrdogenase; elec; elect; electr; electro; electrophhrs; electrophrs; elp; elph; ep; ii; l.d.h; lact; lactate dehydrogenase.fraction 2; lactic acid; lactic acid dehydrogenase; ld; ld2; ld-2; ldh; ldh isoenzyme 2; ldh2; l-lactate; l-lactate dehydrogenase; percent; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; tot; totl; tumor marker,Qn
25396-3,deprecated duck meat ige ab rast class [presence] in serum,deprecated duck meat ige rast ql,duck meat ige rast class (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; f157; ige rast; immune globulin e; immunoglobulin e; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; sr,Ord
25397-1,echinococcus sp ab [presence] in serum by immunoassay,echinococcus ab ser ql ia,echinococcus sp ab ia ql (s),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; echinococcosis; eia; elfa; elisa; enzyme immunoassay; iaa; id; infectious disease; infectiousdisease; meia; microbiology; ordinal; p2; point in time; pr; ql; qual; qualitative; random; screen; serum; species; spp; sr; suds,Ord
25402-9,estrogen [moles/time] in 24 hour urine,estrogen 24h ur-srate,estrogen (24h u) [moles/time],1 day; 24 hours; 24hr; chemistry; est; estr; estroge; estrogens; estrone+estradiol; estrone+estradiol+estriol; gyn; gynecology; ob; obgyn; obstetrics; qnt; quan; quant; quantitative; srate; substance rate; ua; ur; urn,Qn
2540-3,lactate dehydrogenase 2 [enzymatic activity/volume] in serum or plasma,ldh2 serpl-ccnc,ldh 2 [catalytic activity/vol],2-hydroxypropanoic acid; 2-hydroxy-propionate; 2-hydroxy-propionic acid; catalytic concentration; chemistry; dehydrog; dehyrdogenase; ii; l.d.h; lact; lactate dehydrogenase.fraction 2; lactic acid; lactic acid dehydrogenase; ld; ld2; ld-2; ldh; ldh isoenzyme 2; ldh2; l-lactate; l-lactate dehydrogenase; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; tumor marker,Qn
25410-2,filaria igg ab [units/volume] in serum by immunoassay,filaria igg ser ia-acnc,filaria igg ia qn (s),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; eia; elfa; elisa; enzyme immunoassay; filarial; filariasis; iaa; id; immune globulin g; immunoglobulin g; infectious disease; infectiousdisease; meia; microbiology; microfilaria; point in time; qnt; quan; quant; quantitative; random; serum; sr; suds,Qn
25413-6,fluoride [moles/time] in 24 hour urine,fluoride 24h ur-srate,fluoride (24h u) [moles/time],1 day; 24 hours; 24hr; drug/toxicology; drugs; fl; qnt; quan; quant; quantitative; srate; substance rate; ua; ur; urn,Qn
25424-3,trypanosoma sp ab [units/volume] in serum by immunofluorescence,trypanos ab ser if-acnc,trypanosoma sp ab if qn (s),abs; aby; acif; antby; anti; antibodies; antibody; anticomplement immunofluorescence; arbitrary concentration; autoantibodies; autoantibody; chagas disease; fa; fluorescent antibody; fluoresent; id; ifa; immune fluorescence; immunoflour; immunofluor; immunofluorescence; infectious disease; infectiousdisease; microbiology; point in time; qnt; quan; quant; quantitative; random; serum; sleeping sickness; species; spp; sr; time resolved fluorescence; trf; trypanosomiasis; trypanosomosis; trypanosomosis (tse-tse borne),Qn
2544-5,lactate dehydrogenase 4 [enzymatic activity/volume] in serum or plasma by chemical separation,ldh4 serpl chem sepn-ccnc,ldh 4 chemical separation [catalytic activity/vol],2-hydroxypropanoic acid; 2-hydroxy-propionate; 2-hydroxy-propionic acid; catalytic concentration; chem sepn; chemistry; dehydrog; dehyrdogenase; l.d.h; lact; lactate dehydrogenase.fraction 4; lactic acid; lactic acid dehydrogenase; ld; ld4; ldh; ldh isoenzyme 4; ldh4; l-lactate; l-lactate dehydrogenase; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; tumor marker,Qn
25449-0,iodine [moles/time] in 24 hour urine,iodine 24h ur-srate,iodine (24h u) [moles/time],1 day; 24 hours; 24hr; c616; chemistry; i; i-; qnt; quan; quant; quantitative; srate; substance rate; ua; ur; urn,Qn
25466-4,manganese [moles/volume] in blood,manganese bld-scnc,manganese (bld) [moles/vol],blood; drug/toxicology; drugs; level; mn; point in time; qnt; quan; quant; quantitative; random; substance concentration; wb; whole blood,Qn
25473-0,metanephrine [moles/volume] in serum or plasma,metaneph serpl-scnc,metanephrine [moles/vol],chemistry; level; metaneph; metanephrne; metenephrine; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; substance concentration,Qn
25496-1,deprecated abachi wood dust ige ab rast class [presence] in serum,deprecated abachi wood dust ige rast ql,abachi wood dust ige rast class (s),abachi wood dust; abs; aby; african maple tree; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; ige rast; immune globulin e; immunoglobulin e; k212; obeche; ordinal; point in time; pr; ql; qual; qualitative; random; rk212; samba; screen; serum; sr,Ord
2552-8,lactose [mass/volume] in serum or plasma,lactose serpl-mcnc,lactose [mass/vol],chemistry; level; mass concentration; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
25539-8,deprecated thermoactinomyces vulgaris igg ab rast class [presence] in serum,deprecated t vulgaris igg rast ql,t. vulgaris igg rast class (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; farmers lung; gm23; igg rast; immune globulin g; immunoglobulin g; m23; m51; ordinal; point in time; pr; ql; qual; qualitative; random; rgm23; rm213; screen; serum; sr; t vulgaris; thermoactnom,Ord
25541-4,topiramate [moles/volume] in serum or plasma,topiramate serpl-scnc,topiramate [moles/vol],atracurium besylate; c12h21no8s; drug/toxicology; drugs; lennox-gastaut syndrome; level; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; qudexy xr; random; serp; serpl; serplas; serum; serum or plasma; sr; substance concentration; topamax; toprimate; tracrium; trokendi xr,Qn
25546-3,tryptophan [moles/time] in 24 hour urine,tryptophan 24h ur-srate,tryptophan (24h u) [moles/time],1 day; 24 hours; 24hr; c244; chemistry; l-tryptophan; qnt; quan; quant; quantitative; srate; substance rate; trp; ua; ur; urn,Qn
25553-9,valine [moles/time] in 24 hour urine,valine 24h ur-srate,valine (24h u) [moles/time],1 day; 24 hours; 24hr; chemistry; qnt; quan; quant; quantitative; srate; substance rate; ua; ur; urn; val,Qn
25564-6,bilirubin.direct [moles/volume] in body fluid,bilirub direct fld-scnc,bilirubin.direct (body fld) [moles/vol],"alb; associated; b/f; bc; bf; bili; bili.delta; bili-alb; bilirub conj; bilirub delta; bilirub direct; bilirubin conjugated; bilirubin direct; bilirubin glucuronides; bilirubins; billirubin; bnd; bod; bodies; body fluid; body fluid, unsp; chemistry; delb; delta bilirubin; deltab; fl; fld; flu; fluid; level; point in time; protein.albumin; qnt; quan; quant; quantitative; random; substance concentration; tbil; tbil-(bu+bc); tbil-bu",Qn
25565-3,bougainvillea ige ab [units/volume] in serum,bougainvillea ige qn,bougainvillea ige qn (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; immune globulin e; immunoglobulin e; k214; point in time; qnt; quan; quant; quantitative; random; rk214; serum; sr,Qn
25572-9,c peptide [moles/volume] in serum or plasma --14th specimen post xxx challenge,c peptide sp14 p chal serpl-scnc,c peptide 14th specimen post unsp challenge [moles/vol],after; chemistry.challenge testing; connecting peptide of insulin; level; p chal; pept; pl; plasma; plsm; point in time; pro-insulin c peptide; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sp14; sp14 p chal; spec; sr; substance concentration,Qn
2558-5,deprecated leucine,deprecated leucine bld ql,leucine ql (bld),blood; chemistry; leu; level; mass concentration; ordinal; point in time; ql; qual; qualitative; random; screen; wb; whole blood,Ord
25585-1,deprecated cat serum albumin ige ab rast class [presence] in serum,deprecated cat serum alb ige rast ql,cat serum albumin ige rast class (s),abs; aby; alb; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; e220; feline; felis domesticus; ige rast; immune globulin e; immunoglobulin e; nfel d 2; ordinal; point in time; pr; protein.albumin; ql; qual; qualitative; random; re220; screen; ser; serum; sr,Ord
25587-7,chromogranin a [moles/volume] in serum or plasma,cga serpl-scnc,chromogranin a [moles/vol],cg; cga; chemistry; level; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; substance concentration; universallaborders,Qn
25638-8,eosinophil cationic protein (ecp) [mass/volume] in serum,ecp-mcnc,eosinophil cationic protein (ecp) (s) [mass/vol],allergen; allergens; allergy testing; ecp; eos; eosin; eosino; eosinophils; level; mass concentration; point in time; pr; prot; qnt; quan; quant; quantitative; random; serum; sr,Qn
25652-9,follitropin [units/volume] in serum or plasma by 2nd irp --9th specimen post xxx challenge,fsh sp9 p chal serpl irp2-acnc,follitropin 9th specimen post unsp challenge 2nd irp qn,2nd international reference preparation; after; arbitrary concentration; chemistry.challenge testing; follicle stimulating hormone; fsh; irp2; p chal; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; second; serp; serpl; serplas; serum; serum or plasma; sp9; sp9 p chal; spec; sr,Qn
25653-7,fosfomycin [susceptibility] by minimum inhibitory concentration (mic),fosfomycin islt mic,fosfomycin mic [susc],antibiotic susceptibilities; ast; c375; fosfomycine; fosomin; id; infectious disease; infectiousdisease; islt; isol; minimum inhibitory concentration; point in time; random; sus; suscept; susceptibilities; susceptibility; susceptibilty,OrdQn
25656-0,gastrin [moles/volume] in serum or plasma --3rd specimen post xxx challenge,gastrin sp3 p chal serpl-scnc,gastrin 3rd specimen post unsp challenge [moles/vol],after; chemistry.challenge testing; level; p chal; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sp3; sp3 p chal; spec; sr; substance concentration; total gastrins; zollinger-ellison syndrome,Qn
25660-2,gastrin [moles/volume] in serum or plasma --7th specimen post xxx challenge,gastrin sp7 p chal serpl-scnc,gastrin 7th specimen post unsp challenge [moles/vol],^7th spec pst xxx chal; after; chemistry.challenge testing; level; p chal; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sp7; sp7 p chal; spec; sr; substance concentration; total gastrins; zollinger-ellison syndrome,Qn
2566-8,deprecated fatty acids.nonesterified [mass/volume] in serum or plasma,deprecated nefa serpl-mcnc,fatty acids.nonesterified [mass/vol],acd; acid; aliphatic carboxylate c10-c26; chemistry; fatty acid; ffa; free fatty acids; level; lipid; mass concentration; nefa; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
2567-6,phospholipid phosphorus [mass/volume] in serum,phospholipid p ser-mcnc,phospholipid phosphorus (s) [mass/vol],chemistry; level; lipid; mass concentration; phoslpd; phospholipids; pl; point in time; qnt; quan; quant; quantitative; random; serum; sr,Qn
25681-8,kappa light chains [presence] in serum by immunoelectrophoresis,kappa lc ser ql iep,immunoglobulin light chains.kappa iep ql (s),bence jones protein; bj protein; bjp; chain; chemistry; hematology; heme; iep; imm elect; immune globulin; immuno; immunoelect; immunoglob; immunoglobin; imunoglbon; imunoglobn; kappa lc; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; sie; siep; sr,Ord
25691-7,insulin [moles/volume] in serum or plasma --1st specimen post xxx challenge,insulin sp1 p chal serpl-scnc,insulin 1st specimen post unsp challenge [moles/vol],acute specimen; after; chemistry.challenge testing; first; hum; humulin; ih7; insul; lente; level; nph; p chal; pl; plasma; plsm; point in time; pre immunization; pst; qnt; quan; quant; quantitative; random; semilente; serp; serpl; serplas; serum; serum or plasma; sliding; sp1; sp1 p chal; spec; sr; substance concentration; ultralente,Qn
25703-0,jujube ige ab [units/volume] in serum,jujube ige qn,jujube ige qn (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; chinese date; f336; immune globulin e; immunoglobulin e; jujube; point in time; qnt; quan; quant; quantitative; random; rf336; serum; sr,Qn
2571-8,triglyceride [mass/volume] in serum or plasma,trigl serpl-mcnc,triglyceride [mass/vol],cardio; cardiology; chemistry; heart disease; level; mass concentration; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; tg; trig; trigly; triglycerides; triglycrides; universallaborders,Qn
25719-6,lutropin [units/volume] in serum or plasma --2 hours post 100 ug luteinizing releasing hormone iv,lh 2h p 100 ug lrh iv serpl-acnc,lutropin 2 hr post 100 ug luteinizing releasing hormone iv qn,120 min; 120 minutes; 120min; 2 hours; 2h p 100 ug lrh iv; after; arbitrary concentration; chemistry.challenge testing; endocrine; endocrinology; horm; icsh; interstitial cell-stimulating hormone; interstitual cell stimulating hormone; leutinizing hormone; lh; luteinizing hormone; lutenin; lutenizing hormone; mcg; ovulation test; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
25726-1,oxcarbazepine [moles/volume] in serum or plasma,oxcarbazepine serpl-scnc,oxcarbazepine [moles/vol],drug/toxicology; drugs; level; oxc; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; substance concentration; trileptal,Qn
25731-1,plasmodium sp ab [titer] in serum by immunofluorescence,plasmodium ab titr ser if,plasmodium sp ab if (s) [titer],abs; aby; acif; antby; anti; antibodies; antibody; anticomplement immunofluorescence; autoantibodies; autoantibody; dilution factor; dilution factor (titer); fa; fluorescent antibody; fluoresent; id; ifa; immune fluorescence; immunoflour; immunofluor; immunofluorescence; infectious disease; infectiousdisease; malaria; malarial; microbiology; point in time; random; serum; smqn; species; spp; sr; time resolved fluorescence; titer; titered; titre; trf; ttr,SemiQn
25756-8,rotavirus igm ab [units/volume] in serum by immunoassay,rv igm ser ia-acnc,rotavirus igm ia qn (s),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; eia; elfa; elisa; enzyme immunoassay; iaa; id; immune globulin m; immunoglobulin m; infectious disease; infectiousdisease; meia; microbiology; point in time; qnt; quan; quant; quantitative; random; rota virus; rotav; rotaviral; rotaviurs; rv; serum; sr; suds,Qn
25763-4,insulin-like growth factor [moles/volume] in serum or plasma --1st specimen post xxx challenge,igf sp1 p chal serpl-scnc,insulin-like growth factor 1st specimen post unsp challenge [moles/vol],acute specimen; after; chemistry.challenge testing; fac; fact; first; hum; humulin; igf; ih7; insul; lente; level; nph; p chal; pl; plasma; plsm; point in time; pre immunization; pst; qnt; quan; quant; quantitative; random; semilente; serp; serpl; serplas; serum; serum or plasma; sliding; sp1; sp1 p chal; spec; sr; substance concentration; ultralente,Qn
25768-3,insulin-like growth factor [moles/volume] in serum or plasma --6th specimen post xxx challenge,igf sp6 p chal serpl-scnc,insulin-like growth factor 6th specimen post unsp challenge [moles/vol],after; chemistry.challenge testing; fac; fact; hum; humulin; igf; ih7; insul; lente; level; nph; p chal; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; semilente; serp; serpl; serplas; serum; serum or plasma; sliding; sp6; sp6 p chal; spec; sr; substance concentration; ultralente,Qn
25791-5,thyroxine (t4) free [moles/volume] in serum or plasma --2nd specimen post xxx challenge,t4 free sp2 p chal serpl-scnc,free t4 2nd specimen post unsp challenge [moles/vol],after; chemistry.challenge testing; convalescent; endocrine; endocrinology; fr; freet4; ft4; level; levothyroxine; levo-thyroxine; l-thyroxine; non-protein bound; p chal; pl; plasma; plsm; point in time; post immunization; pst; qnt; quan; quant; quantitative; random; second; serp; serpl; serplas; serum; serum or plasma; sp2; sp2 p chal; spec; sr; substance concentration; t4; t-4; t4 free; thyroid hormone; thyrox; thyroxin; thyrx; total t4; tt4,Qn
25797-2,thyroxine (t4) free [moles/volume] in serum or plasma --8th specimen post xxx challenge,t4 free sp8 p chal serpl-scnc,free t4 8th specimen post unsp challenge [moles/vol],after; chemistry.challenge testing; endocrine; endocrinology; fr; freet4; ft4; level; levothyroxine; levo-thyroxine; l-thyroxine; non-protein bound; p chal; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sp8; sp8 p chal; spec; sr; substance concentration; t4; t-4; t4 free; thyroid hormone; thyrox; thyroxin; thyrx; total t4; tt4,Qn
25823-6,deprecated staphylococcus aureus enterotoxin b ige ab rast class [presence] in serum,deprecated s aureus etx b ige rast ql,s. aureus enterotoxin b ige rast class (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; etx; ige rast; immune globulin e; immunoglobulin e; m81; o71; ordinal; point in time; pr; ql; qual; qualitative; random; s aureus; s aureus etx; s aureus etx b; screen; serum; sr; st a seb; staph; staphylococcal enterotoxin; toxic shock syndrome enterotoxin b,Ord
2583-3,lutropin.beta subunit [moles/volume] in serum or plasma,b-lh serpl-scnc,lutropin.beta subunit [moles/vol],b; beta lh; b-lh; chemistry; icsh; interstitial cell-stimulating hormone; interstitual cell stimulating hormone; leutinizing hormone; level; lh; luteinizing hormone; lutenin; lutenizing hormone; lutropin beta chain; ovulation test; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; substance concentration,Qn
25836-8,hiv 1 rna [#/volume] (viral load) in specimen by naa with probe detection,hiv1 rna # spec naa+probe,hiv 1 rna naa+probe (specimen) [#/vol],#; 3 self-sustaining sequence replication; 3sr sr; abs; absolute; absolutes; aids; amplif; amplification; amplified; cnt; count; count/volume; ct; dna nucleic acid probe; dna probe; hiv type 1; hiv type i; hiv1; human immunodeficiency virus; i; id; infectious disease; infectiousdisease; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; misc; miscellaneous; naa+probe; naat; nasba; nucleic acid sequence based analysis; number concentration; number concentration (count/vol); other; pcr; point in time; polymerase chain reaction; probe amp; probe with ampification; probe with target amplification; qbr; qnt; quan; quant; quantitative; random; ribonucleic acid; sda; spec; strand displacement amplification; tma; to be specified in another part of the message; transcription mediated amplification; universallaborders; unspecified; viral load,Qn
25843-4,alanine [moles/volume] in 24 hour urine,alanine 24h ur-scnc,alanine (24h u) [moles/vol],1 day; 24 hours; 24hr; ala; alpha alanine; chemistry; l-alanine; level; qnt; quan; quant; quantitative; substance concentration; ua; ur; urn,Qn
25869-9,beta alanine/creatinine [molar ratio] in 24 hour urine,b-alanine/creat 24h ur-srto,beta alanine/creatinine (24h u) [molar ratio],1 day; 24 hours; 24hr; ala; alpha alanine; b; bala; b-ala; b-alanine; chemistry; cr; crea; creat; l-alanine; qnt; quan; quant; quantitative; scrto; substance concentration ratio; substance ratio; ua; ucr; ur; urn,Qn
25881-4,coproporphyrin [moles/volume] in 24 hour urine,copro 24h ur-scnc,coproporphyrin (24h u) [moles/vol],1 day; 24 hours; 24hr; chemistry; copro; coproporph; coproporphyrins; hematology; heme; level; qnt; quan; quant; quantitative; substance concentration; tetracarboxyl porphyrin; tetracarboxylporphyrin; tetracarboxylporphyrins; tetracarboxyporphyrin; ua; ur; urn,Qn
25886-3,creatinine [moles/volume] in 24 hour urine,creat 24h ur-scnc,creatinine (24h u) [moles/vol],1 day; 24 hours; 24hr; chemistry; cr; crea; creat; kidney; level; nephrology; qnt; quan; quant; quantitative; renal; substance concentration; ua; ucr; ur; urn,Qn
25890-5,cysteate/creatinine [molar ratio] in 24 hour urine,cysteate/creat 24h ur-srto,cysteate/creatinine (24h u) [molar ratio],1 day; 24 hours; 24hr; beta sulfoalanine; chemistry; cr; crea; creat; cysteic acid; qnt; quan; quant; quantitative; scrto; substance concentration ratio; substance ratio; ua; ucr; ur; urn,Qn
25917-6,glutamate [moles/volume] in 24 hour urine,glutamate 24h ur-scnc,glutamate (24h u) [moles/vol],1 day; 24 hours; 24hr; c707; chemistry; glu; glutamic acid; level; qnt; quan; quant; quantitative; substance concentration; ua; ur; urn,Qn
25921-8,glycine [moles/volume] in 24 hour urine,glycine 24h ur-scnc,glycine (24h u) [moles/vol],1 day; 24 hours; 24hr; chemistry; gly; level; qnt; quan; quant; quantitative; substance concentration; ua; ur; urn,Qn
25929-1,homocystine/creatinine [molar ratio] in 24 hour urine,(hcys)2/creat 24h ur-srto,homocystine/creatinine (24h u) [molar ratio],(hcys)2; 1 day; 24 hours; 24hr; chemistry; cr; crea; creat; homocyst(e)ine; homocystin; qnt; quan; quant; quantitative; scrto; substance concentration ratio; substance ratio; ua; ucr; ur; urn,Qn
25937-4,iron [moles/volume] in 24 hour urine,iron 24h ur-scnc,iron (24h u) [moles/vol],1 day; 24 hours; 24hr; chemistry; fe; level; qnt; quan; quant; quantitative; substance concentration; ua; ur; urn,Qn
25942-4,leucine/creatinine [molar ratio] in 24 hour urine,leucine/creat 24h ur-srto,leucine/creatinine (24h u) [molar ratio],1 day; 24 hours; 24hr; chemistry; cr; crea; creat; leu; qnt; quan; quant; quantitative; scrto; substance concentration ratio; substance ratio; ua; ucr; ur; urn,Qn
25944-0,lutropin [units/volume] in serum or plasma by 1st irp --2nd specimen post xxx challenge,lh sp2 p chal serpl irp1-acnc,lutropin 2nd specimen post unsp challenge 1st irp qn,1st international reference preparation; after; arbitrary concentration; chemistry.challenge testing; convalescent; endocrine; endocrinology; first; icsh; interstitial cell-stimulating hormone; interstitual cell stimulating hormone; irp1; leutinizing hormone; lh; luteinizing hormone; lutenin; lutenizing hormone; ovulation test; p chal; pl; plasma; plsm; point in time; post immunization; pst; qnt; quan; quant; quantitative; random; second; serp; serpl; serplas; serum; serum or plasma; sp2; sp2 p chal; spec; sr,Qn
25981-2,serotonin [moles/volume] in 24 hour urine,serotonin 24h ur-scnc,serotonin (24h u) [moles/vol],1 day; 24 hours; 24hr; 5-ht; 5-hydroxytryptamine; 5-hydroxytryptophane; c10h12n2o; chemistry; enteramine; level; qnt; quan; quant; quantitative; substance concentration; ua; ur; urn,Qn
25986-1,testosterone [moles/volume] in 24 hour urine,testost 24h ur-scnc,testosterone (24h u) [moles/vol],1 day; 24 hours; 24hr; chemistry; level; qnt; quan; quant; quantitative; substance concentration; testo; testos; testost; ua; ur; urn,Qn
25993-7,trichinella spiralis ab [titer] in serum by immunofluorescence,t spiralis ab titr ser if,t. spiralis ab if (s) [titer],abs; aby; acif; antby; anti; antibodies; antibody; anticomplement immunofluorescence; autoantibodies; autoantibody; dilution factor; dilution factor (titer); fa; fluorescent antibody; fluoresent; id; ifa; immune fluorescence; immunoflour; immunofluor; immunofluorescence; infectious disease; infectiousdisease; microbiology; point in time; random; serum; smqn; sr; t spiralis; time resolved fluorescence; titer; titered; titre; trf; tric; trich; trichinellosis; trichinosis; ttr,SemiQn
26002-6,valine/creatinine [molar ratio] in 24 hour urine,valine/creat 24h ur-srto,valine/creatinine (24h u) [molar ratio],1 day; 24 hours; 24hr; chemistry; cr; crea; creat; qnt; quan; quant; quantitative; scrto; substance concentration ratio; substance ratio; ua; ucr; ur; urn; val,Qn
26003-4,vanillylmandelate [moles/volume] in 24 hour urine,vma 24h ur-scnc,vanillylmandelate (24h u) [moles/vol],"1 day; 24 hours; 24hr; 3-methoxy-4-hydroxymandelate; 3-methyl,4-hydroxy mandelate; 3-methyl,4-oh mandelic acid; catecholamine metabolite; chemistry; hmma; hydroxy-methoxy-mandelate; hydroxy-methoxy-mandelic acid; level; mhma; qnt; quan; quant; quantitative; substance concentration; tumor marker; ua; ur; urn; vanillylmandelic acid; vanilmandelate; vma",Qn
26009-1,treponema pallidum ab [titer] in serum by hemagglutination,t pallidum ab titr ser ha,t. pallidum ab ha (s) [titer],abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; dilution factor; dilution factor (titer); hatts; hemagglutination; id; iha; infectious disease; infectiousdisease; mha-tp; microbiology; point in time; random; serum; smqn; sr; syphilis; t pallidum; titer; titered; titre; tpha; treponemal; ttr,SemiQn
26011-7,macroamylase/amylase.total in serum or plasma,macroamylase cfr serpl,macroamylase [catalytic fraction],alpha amylase; ams; amyl; catalytic fraction; chemistry; diastase; k87; macro amylase; percent; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; tot; totl,Qn
26021-6,nordiazepam [moles/volume] in serum or plasma,nordiazepam serpl-scnc,nordiazepam [moles/vol],calmday; chlordiazepoxide metabolite; desmethyldiazepam; diazepam metabolite; dimethyldiazepam; drug/toxicology; drugs; level; madar; n-dimethyldiazepam; nordaz; nordazepam; nordiaze; pl; plasma; plsm; point in time; praxadium; prazepam metabolite; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; stilny; substance concentration; tranxilium n; vegesan,Qn
26023-2,extractable nuclear ab identified in serum,ena ser,extractable nuclear ab identified nom (s),abs; aby; ana; anf; antby; anti; antibodies; antibody; antinuclear antibody; autoantibodies; autoantibody; ena; identity or presence; isolated; na; nominal; nuc; point in time; random; serology; serum; sr,Nom
26025-7,deprecated meadow fescue ige ab rast class in serum,deprecated meadow fescue ige rast ql,meadow fescue ige rast class (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; festuca elator; festuca pratensis; g004; g4; ige rast; immune globulin e; immunoglobulin e; meadow fescue; ordinal; point in time; ql; qual; qualitative; random; screen; serum; sr,Ord
26026-5,deprecated hexahydrophthalic anhydride (hhpa) ige ab rast class [presence] in serum,deprecated hhpa ige rast ql,hexahydrophthalic anhydride (hhpa) ige rast class (s),abs; aby; allergen; allergens; allergy testing; anhydrid; antby; anti; antibodies; antibody; autoantibodies; autoantibody; hexahydrophtalic anhydrid; hhpa; ige rast; immune globulin e; immunoglobulin e; k209; ordinal; point in time; pr; ql; qual; qualitative; random; rk209; screen; serum; sr,Ord
26045-5,pheneturide [moles/volume] in serum or plasma,pheneturide serpl-scnc,pheneturide [moles/vol],benuride; drug/toxicology; drugs; ethylphenacemide; laburide; level; phenylethylacetylurea; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; substance concentration,Qn
26047-1,phytate [moles/volume] in serum or plasma,phytate serpl-scnc,phytate [moles/vol],drug/toxicology; drugs; inositol hexaphosphate; ip-6; level; phytic acid; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; substance concentration,Qn
26048-9,deprecated canary serum proteins ige ab rast class [presence] in serum,deprecated canary serum prot ige rast ql,canary serum proteins ige rast class (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; e199; ige rast; immune globulin e; immunoglobulin e; ordinal; point in time; pr; protein; ql; qual; qualitative; random; screen; ser; serum; sr,Ord
26049-7,cedar ige ab [units/volume] in serum,cedar ige qn,cedar ige qn (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; calocedrus decurrens; cedar; immune globulin e; immunoglobulin e; l decurrens; point in time; qnt; quan; quant; quantitative; random; rt212; serum; sr; t212,Qn
2606-2,melanin [presence] in urine,melanin ur ql,melanin ql (u),chemistry; ordinal; point in time; pr; ql; qual; qualitative; random; screen; ua; ur; urn,Ord
26068-7,rf salivary gland - left views w contrast intra salivary duct,rf saliv gland-l vs w contr intra duct,,brain; c; contr; contra; contrst; cranial; cranium; document; films; finding; findings; fluor; fluoro; fluoroscopy; imaging; intracranial; l; lt; point in time; ptyalography; rad; radiology; random; salivary gland-l; sialogram; sialography; skull; view; vws; w contr intra sd; wc,Doc
26073-7,rf knee - bilateral arthrogram,rf knee-bl views w contr is,,arthrogram; arthrography; bil; bilat; both; c; contr; contra; contrst; document; ext; extr-bl; films; finding; findings; fluor; fluoro; fluoroscopy; imaging; intraarticular; intrasynovial; kn; knee-bl; knees; le; le-bl; leg; low; lower extremity joint; msk; musculoskeletal; ortho; orthopedics; point in time; rad; radiology; random; view; vws; w contr is; wc,Doc
26087-7,xr knee - right views w standing,xr knee-r views w stand,,document; ext; extr-r; films; finding; findings; imaging; kn; knee-r; le; leg; le-r; low; lower extremity joint; msk; musculoskeletal; ortho; orthopedics; plain films; point in time; r; rad; radiology; random; rle; rt; stand); view; vws; wb; weight bearing; xray; x-ray,Doc
2608-8,metanephrines [mass/volume] in urine,metanephs ur-mcnc,metanephrines (u) [mass/vol],chemistry; level; mass concentration; metanephrine+normetanephrine; metanephs; point in time; qnt; quan; quant; quantitative; random; ua; ur; urn,Qn
26090-1,nm knee - right views,nm knee-r views w rnc iv,,document; ext; extr-r; films; finding; findings; imaging; kn; knee-r; le; leg; le-r; low; lower extremity joint; msk; musculoskeletal; ortho; orthopedics; point in time; r; rad; radiology; random; rle; rn; rnc; rt; scan; view; vws; w rnc iv,Doc
26093-5,nm scrotum and testicle - right views w tc-99m pertechnetate iv,nm scrotum+test-r views w tc99mp iv,,99 mtc; 99mtc; document; films; finding; findings; imaging; pelvic; point in time; r; rad; radiology; random; rt; scan; scrotal; scrotum+test-r; tc04; tc-04; tc-99cm; tc99m; tc-99m; technetium 99m; testicular; testies; testis; view; vws; w tc99mp iv,Doc
26095-0,xr foot - left views w standing,xr foot-l views w stand,,document; ext; extr-l; films; finding; findings; foot-l; imaging; l; le; leg; le-l; lle; low; lower extremity; lt; msk; musculoskeletal; ortho; orthopedics; plain films; point in time; rad; radiology; random; stand); view; vws; wb; weight bearing; xray; x-ray,Doc
26101-6,xr calcaneus - left views,xr heel-l views,,calcaneous; document; ext; extr-l; films; finding; findings; heel; heel-l; imaging; l; le; leg; le-l; lle; low; lt; os calcis; oscalcis; plain films; point in time; rad; radiology; random; view; vws; xray; x-ray,Doc
26113-1,xr lower extremity - left views,xr le-l views,,document; ext; extr-l; films; finding; findings; imaging; l; le; leg; le-l; lle; low; lt; plain films; point in time; rad; radiology; random; view; vws; xray; x-ray,Doc
26150-3,xr radius and ulna - right views,xr radius+ulna-r views,,arm; document; ext; extr-r; films; finding; findings; imaging; plain films; point in time; r; rad; radiology; radius+ulna-r; random; rt; rue; ue; ue-r; up; upper extremity; view; vws; xray; x-ray,Doc
26151-1,xr ribs - bilateral views,xr ribs-bl views,,bil; bilat; both; cxr; document; films; finding; findings; imaging; plain films; point in time; rad; radiology; random; ribs-bl; thorax; view; vws; xray; x-ray,Doc
26155-2,xr scapula - left views,xr scapula-l views,,cxr; document; films; finding; findings; imaging; l; lt; plain films; point in time; rad; radiology; random; scapula-l; thorax; upper extremity; view; vws; xray; x-ray,Doc
26157-8,xr shoulder - bilateral views,xr shoulder-bl views,,arm; bil; bilat; both; document; ext; extr-bl; films; finding; findings; imaging; msk; musculoskeletal; ortho; orthopedics; plain films; point in time; rad; radiology; random; shoulder-bl; ue; ue-bl; up; upper extremity joint; view; vws; xray; x-ray,Doc
26177-6,mg breast - right screening,mg brst-r screening,,asympt; asymptomatic; brst; brst-r; document; films; finding; findings; imaging; point in time; r; rad; radiology; random; rt; scn; view; vws,Doc
26202-2,mr shoulder - bilateral wo and w contrast iv,mr shoulder-bl wo+w contr iv,,arm; bil; bilat; both; c; contr; contra; contrst; document; ext; extr-bl; finding; findings; imaging; mitral regurgitation maximum velocity; mri; msk; musculoskeletal; ortho; orthopedics; point in time; rad; radiology; random; shoulder-bl; ue; ue-bl; up; upper extremity joint; w contr iv; wc; wo & wc; wo+w contr; wo+w contr iv; wwo,Doc
26204-8,mr shoulder - right wo and w contrast iv,mr should-r wo+w contr iv,,arm; c; contr; contra; contrst; document; ext; extr-r; finding; findings; imaging; mitral regurgitation maximum velocity; mri; msk; musculoskeletal; ortho; orthopedics; point in time; r; rad; radiology; random; rt; rue; should-r; ue; ue-r; up; upper extremity joint; w contr iv; wc; wo & wc; wo+w contr; wo+w contr iv; wwo,Doc
26226-1,ct extremity - left,ct extr-l,,cat scan; computed tomography; computerized tomography; ct scan; document; ext; extr-l; finding; findings; imaging; l; lt; point in time; rad; radiology; random,Doc
26229-5,mr lower extremity joint - right,mr le joint-r,,document; ext; extr-r; finding; findings; imaging; jnt; le; le joint-r; leg; le-r; low; mitral regurgitation maximum velocity; mri; point in time; r; rad; radiology; random; rle; rt,Doc
26235-2,mr thigh - bilateral,mr thigh-bl,,bil; bilat; both; document; ext; extr-bl; femoral; femur; finding; findings; imaging; le; le-bl; leg; low; lower extremity; mitral regurgitation maximum velocity; mri; point in time; rad; radiology; random; thigh-bl,Doc
26236-0,mr thigh - left,mr thigh-l,,document; ext; extr-l; femoral; femur; finding; findings; imaging; l; le; leg; le-l; lle; low; lower extremity; lt; mitral regurgitation maximum velocity; mri; point in time; rad; radiology; random; thigh-l,Doc
26242-8,mr foot - left,mr foot-l,,document; ext; extr-l; finding; findings; foot-l; imaging; l; le; leg; le-l; lle; low; lower extremity; lt; mitral regurgitation maximum velocity; mri; msk; musculoskeletal; ortho; orthopedics; point in time; rad; radiology; random,Doc
26247-7,mr hand - bilateral,mr hand-bl,,arm; bil; bilat; both; document; ext; extr-bl; finding; findings; hand-bl; hands; imaging; mitral regurgitation maximum velocity; mri; msk; musculoskeletal; ortho; orthopedics; point in time; rad; radiology; random; ue; ue-bl; up; upper extremity,Doc
26255-0,xr tomography internal auditory canal - right,xr tomo iac-r,,brain; cranial; cranium; document; ear canal; finding; findings; iac; iac-r; iam; imaging; internal auditory meatus; internal ear canal; intracranial; plain films; point in time; r; rad; radiology; random; rt; skull; xr tomo; xray; x-ray,Doc
26294-9,mg stereo guidance for biopsy of breast - right,mg.stereo guided brst-r bx,,brst; brst-r; bx; coreplaybook; document; finding; findings; guid; guide; guided; imaging; perc; playbook; point in time; r; rad; radiology; random; rt; stereo,Doc
26298-0,rfa guidance for atherectomy of vein - bilateral-- w contrast iv,rfa guided vein-bl atherect--w contr iv,,bil; bilat; both; c; cardio; cardiology; contr; contra; contrst; document; finding; findings; fluor; fluoro; fluoroscopy; guid; guide; guided; heart disease; imaging; misc; miscellaneous; other; point in time; rad; radiology; random; removal of clot; rfa; spec; to be specified in another part of the message; unspecified; vein-bl; ven; venogram; venography; venous; w contr iv; wc,Doc
26327-7,us guidance for drainage and placement of drainage catheter of extremity - right,us guided extr-r drain+cath place,,cath; document; drain; drain+cath place; echography; ext; extr-r; exudate; finding; findings; guid; guide; guided; imaging; point in time; r; radiology; random; removal of fluid; rt; sonogram; sonograph; sonography; uls; ultrasound,Doc
2633-6,methyltestosterone [mass/volume] in urine,met ur-mcnc,methyltestosterone (u) [mass/vol],android; drug/toxicology; drugs; level; mass concentration; metandren; oreton methyl; point in time; qnt; quan; quant; quantitative; random; testred; ua; ur; urn; virilon,Qn
26341-8,us guidance for biopsy of kidney - left,us guided kidney-l bx,,abd; abdo; abdomen+; abdominal; bx; document; echography; finding; findings; guid; guide; guided; imaging; kidney; kidney-l; l; lt; nephric; nephrology; perc; point in time; radiology; random; renal; sonogram; sonograph; sonography; uls; ultrasound,Doc
26343-4,mg guidance for aspiration of cyst of breast - bilateral,mg guided brst-bl cyst asp,,asp; bil; bilat; both; breast-bl; breasts; brst; brst-bl; cyst asp; document; finding; findings; guid; guide; guided; imaging; perc; point in time; rad; radiology; random,Doc
26346-7,mg breast - bilateral diagnostic,mg brst-bl dx,,bil; bilat; both; breast-bl; breasts; brst; brst-bl; coreplaybook; document; dx; films; finding; findings; imaging; playbook; point in time; rad; radiology; random; symptomatic; view; vws,Doc
26347-5,mg breast - left diagnostic,mg brst-l dx,,brst; brst-l; coreplaybook; document; dx; films; finding; findings; imaging; l; lt; playbook; point in time; rad; radiology; random; symptomatic; view; vws,Doc
26348-3,mg breast - right diagnostic,mg brst-r dx,,brst; brst-r; coreplaybook; document; dx; films; finding; findings; imaging; playbook; point in time; r; rad; radiology; random; rt; symptomatic; view; vws,Doc
26353-3,xr wrist - left and hand - left bone age views,xr wrist+hand-l views bone age,,arm; bone age survey; carpal bone; carpal bones; carpal bones and joint; document; ext; extr-l; films; finding; findings; imaging; l; lt; lue; msk; musculoskeletal; ortho; orthopedics; plain films; point in time; rad; radiology; random; ue; ue-l; up; upper extremity; upper extremity joint; view; vws; wrist+hand-l; wrist-l; xray; x-ray,Doc
26355-8,xr hand - bilateral arthritis,xr hand-bl arthritis,,1v; arm; arth; bil; bilat; both; document; ext; extr-bl; film; finding; findings; hand-bl; hands; imaging; msk; musculoskeletal; ortho; orthopedics; plain films; point in time; rad; radiology; random; single view; ue; ue-bl; up; upper extremity; vw; xray; x-ray,Doc
26372-3,rfa guidance for angioplasty of iliac artery - right-- w contrast ia,rfa guided iliac a-r angio--w contr ia,,abd; abd+pelvis; abdo; abdominal; angplsty; art; arteriogram; c; cardio; cardiology; contr; contra; contrst; document; finding; findings; fluor; fluoro; fluoroscopy; guid; guide; guided; heart disease; iliac a-r; imaging; pelvic; pelvic artery; point in time; r; rad; radiology; random; rfa; rt; w contr ia; wc,Doc
26373-1,deprecated rfa guidance for angioplasty of tibial artery - bilateral-- w contrast ia,deprecated rfa tibl a-bl angio guide w contr ia,,angplsty; art; arteriogram; bil; bilat; both; c; cardio; cardiology; contr; contra; contrst; document; ext; extr-bl; finding; findings; fluor; fluoro; fluoroscopy; guid; guide; guided; heart disease; imaging; le; le-bl; leg; low; point in time; rad; radiology; random; rfa; tibl a-bl; w contr ia; wc,Doc
26392-1,xr humerus - left 2 views,xr humerus-l 2v,,2v; 2vw; arm; document; ext; extr-l; films; finding; findings; humerus-l; ii; imaging; l; lt; lue; plain films; point in time; rad; radiology; random; ue; ue-l; up; upper extremity; view; vws; xray; x-ray,Doc
26393-9,xr humerus - right 2 views,xr humerus-r 2v,,2v; 2vw; arm; document; ext; extr-r; films; finding; findings; humerus-r; ii; imaging; plain films; point in time; r; rad; radiology; random; rt; rue; ue; ue-r; up; upper extremity; view; vws; xray; x-ray,Doc
26408-5,deprecated honey bee igg4 ab rast class [presence] in serum,deprecated honey bee igg4 rast ql,honey bee igg4 rast class (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; honey bee; honeybee; i001; i1; igg4 rast; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; sr,Ord
26417-6,cladosporium herbarum igg4 ab [units/volume] in serum,c herbarum igg4 qn,c. herbarum igg4 qn (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; c herbarum; hormodendrum; m002; m2; point in time; qnt; quan; quant; quantitative; random; serum; sr,Qn
26450-7,eosinophils/leukocytes in blood,eosinophil nfr bld,eosinophils/leukocytes (bld),blood; eos; eosin; eosino; eosinophil; eosins; hematology/cell counts; leuc; leuk; leukocyte; lkcs; number fraction; percent; point in time; qnt; quan; quant; quantitative; random; wb; wbc; wbcs; white blood cell; white blood cells; whole blood,Qn
26460-6,nucleated erythrocytes [#/volume] in body fluid,nrbc # fld,nucleated rbc (body fld) [#/vol],"#; abs; absolute; absolutes; b/f; bf; bod; bodies; body fluid; body fluid, unsp; cnt; count; count/volume; ct; discocytes; erthrocyte; erythroblasts; erythrocyte; fl; fld; flu; fluid; hematology/cell counts; normoblasts; nrbc; nrbcs; nuc; number concentration; number concentration (count/vol); point in time; qnt; quan; quant; quantitative; random; rbc; rbcs; red blood cell; red blood cells; red blood corpuscle; red blood corpusles; red cell; red cells",Qn
26467-1,leukocytes [#/volume] in pleural fluid,wbc # plr,wbc (pleur fld) [#/vol],#; abs; absolute; absolutes; cnt; count; count/volume; ct; hematology/cell counts; leuc; leuk; leukocyte; lkcs; number concentration; number concentration (count/vol); pleural; pleural fluid; point in time; qnt; quan; quant; quantitative; random; thoracentesis fluid; wbc; wbcs; white blood cell; white blood cells,Qn
26476-2,lymphocytes [#/volume] in body fluid,lymphocytes # fld,lymphocytes (body fld) [#/vol],"#; abs; absolute; absolutes; b/f; bf; bod; bodies; body fluid; body fluid, unsp; cnt; count; count/volume; ct; fl; fld; flu; fluid; hematology/cell counts; lymp; lymph; lympho; lymphocyte; lymphs; lymphs%; number concentration; number concentration (count/vol); point in time; qnt; quan; quant; quantitative; random",Qn
2649-2,n-acetylgalactosamine-6-sulfatase [enzymatic activity/mass] in tissue,galns tiss-ccnt,n-acetylgalactosamine-6-sulfatase (tiss) [catalytic activity/mass],"catalytic content; chemistry; chondroitin sulfatase; chondroitinase; galactose-6-sulfate sulfatase; galn6s; galns; morquio disease, type a; mps vi a; point in time; qnt; quan; quant; quantitative; random; tissue; tissue, unspecified",Qn
26-5,amphotericin b [susceptibility] by serum bactericidal titer,amphotericin b titr sbt,amphotericin b sbt (isol+s),antibiotic susceptibilities; dilution factor; dilution factor (titer); fungizone; id; infectious disease; infectiousdisease; islt; isol; point in time; random; sequence based typing; serum; serum bactericidal titer; serum killing test; smqn; sr; titer; titered; titre; ttr,SemiQn
26501-7,neutrophils [#/volume] in pleural fluid,neutrophils # plr,neutrophils (pleur fld) [#/vol],#; abs; absolute; absolutes; cnt; count; count/volume; ct; hematology/cell counts; lung; neut; neutr; neutrophil; number concentration; number concentration (count/vol); pleural; pleural fluid; pmn; pnm; point in time; pulmonary; pulmonology; qnt; quan; quant; quantitative; random; respiratory; thoracentesis fluid,Qn
26506-6,segmented neutrophils/leukocytes in cerebral spinal fluid,neuts seg nfr csf,segmented neutrophils/leukocytes (csf),cerebral spinal fluid; cerebrospinal fl; hematology/cell counts; leuc; leuk; leukocyte; lkcs; neuro; neurology; neut; neutr; neutrophil; neuts seg; n-seg; number fraction; percent; pmn; pnm; point in time; qnt; quan; quant; quantitative; random; seg; segs; spinal fl; spinal fld; spinal flu; spinal fluid; wbc; wbcs; white blood cell; white blood cells,Qn
26508-2,band form neutrophils/leukocytes in blood,neuts band nfr bld,band form neutrophils/leukocytes (bld),bands; blood; bnd; hematology/cell counts; leuc; leuk; leukocyte; lkcs; n-band; neut; neutr; neutrophil; neuts band; number fraction; percent; pmn; pnm; point in time; qnt; quan; quant; quantitative; random; wb; wbc; wbcs; white blood cell; white blood cells; whole blood,Qn
26525-6,cortisol free [mass/volume] in 24 hour urine --24 hours post dose corticotropin,cortis f 24h p acth 24h ur-mcnc,cortisol free 24 hr post dose corticotropin (24h u) [mass/vol],1 day; 17-hydroxycorticosterone; 24 hours; 24h p acth; 24hr; acth; adrenocorticotrophic hormone; adrenocorticotropin; after; c206; c74; chemistry.challenge testing; compound f; coritsol; cort; cortis f; cortrosyn; f; fr; hydrocortisone; level; mass concentration; non-protein bound; p acth; p dose; pst; qnt; quan; quant; quantitative; rc206; tumor marker; ua; ur; urn,Qn
26532-2,cortisol [mass/volume] in serum or plasma --48 hours post dose corticotropin,cortis 48h p acth serpl-mcnc,cortisol 48 hr post dose corticotropin [mass/vol],17-hydroxycorticosterone; 48h p acth; acth; adrenocorticotrophic hormone; adrenocorticotropin; after; c206; c74; chemistry.challenge testing; compound f; coritsol; cort; cortrosyn; f; hydrocortisone; level; mass concentration; p acth; p dose; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; rc206; serp; serpl; serplas; serum; serum or plasma; sr; tumor marker,Qn
26542-1,glucose [mass/volume] in urine --5 hours post dose glucose,glucose 5h p glc ur-mcnc,glucose 5 hr post dose glucose (u) [mass/vol],5h p glc; after; chemistry.challenge testing; endocrine; endocrinology; glu; glu tol; gluc; glucose tolerance; glucoseur; gtt; level; mass concentration; p dose; p glc; point in time; pst; qnt; quan; quant; quantitative; random; ua; ur; urn,Qn
26546-2,glucose [presence] in urine by test strip --1 hour post dose glucose,glucose 1h p glc ur ql strip,glucose 1 hr post dose glucose test strip ql (u),1 hour; 1.0hr; 1h p glc; 60 min; 60 minutes; 60m; 60min; after; chemistry.challenge testing; dip stick; dipstick; endocrine; endocrinology; glu; glu tol; gluc; glucose tolerance; glucoseur; gtt; ordinal; p dose; p glc; point in time; pr; pst; ql; qual; qualitative; random; screen; ua; ur; urn,Ord
26563-7,cd1a cells/cells in specimen,cd1a cells nfr spec,cd1a cells/cells (specimen),cd1a cells; cell; cell markers; cellularity; hta1; misc; miscellaneous; number fraction; other; percent; point in time; qnt; quan; quant; quantitative; r4; random; spec; to be specified in another part of the message; unspecified,Qn
26579-3,deprecated beta aminoisobutyrate/creatinine [molecular ratio] in urine,deprecated b-aib/creat ur-srto,beta aminoisobutyrate/creatinine (u) [molar conc ratio],3-aminoisobutyrate; 3-aminoisobutyric acid; b; b-aib; chemistry; cr; crea; creat; point in time; qnt; quan; quant; quantitative; random; substance concentration ratio; ua; ucr; ur; urn,Qn
26580-1,carnosine/creatinine [molar ratio] in urine,carnosine/creat ur-srto,carnosine/creatinine (u) [molar ratio],car; chemistry; cr; crea; creat; point in time; qnt; quan; quant; quantitative; random; scrto; substance concentration ratio; substance ratio; ua; ucr; ur; urn,Qn
26581-9,gamma aminobutyrate/creatinine [molar ratio] in urine,gaba/creat ur-srto,gamma aminobutyrate/creatinine (u) [molar ratio],4-aminobutanoic acid; 4-aminobutyrate; 4-aminobutyric acid; aminobutric; aminobutyric; amino-n-butyrate; chemistry; cr; crea; creat; gaba; gamma aminobutyric acid; gamma amino-butyric acid; gamma amino-n-butyrate; gamma amino-n-butyric acid; piperidic acid; point in time; qnt; quan; quant; quantitative; random; scrto; substance concentration ratio; substance ratio; ua; ucr; ur; urn,Qn
26586-8,alpha aminobutyrate [moles/volume] in cerebral spinal fluid,a-aminobutyr csf-scnc,alpha aminobutyrate (csf) [moles/vol],2-aminobutanoic acid; 2-aminobutyrate; 2-aminobutyric acid; a-aminobutyr; aanb; a-anb; alfa; alpha aminobutyric acid; alpha amino-n-butyrate; alpha amino-n-butyric acid; aminobutric; aminobutyric; amino-n-butyrate; cerebral spinal fluid; cerebrospinal fl; chemistry; level; point in time; qnt; quan; quant; quantitative; random; spinal fl; spinal fld; spinal flu; spinal fluid; substance concentration,Qn
26594-2,gamma aminobutyrate [moles/volume] in cerebral spinal fluid,gaba csf-scnc,gamma aminobutyrate (csf) [moles/vol],4-aminobutanoic acid; 4-aminobutyrate; 4-aminobutyric acid; aminobutric; aminobutyric; amino-n-butyrate; cerebral spinal fluid; cerebrospinal fl; chemistry; gaba; gamma aminobutyric acid; gamma amino-butyric acid; gamma amino-n-butyrate; gamma amino-n-butyric acid; level; piperidic acid; point in time; qnt; quan; quant; quantitative; random; spinal fl; spinal fld; spinal flu; spinal fluid; substance concentration,Qn
26602-3,tryptophan [moles/volume] in cerebral spinal fluid,tryptophan csf-scnc,tryptophan (csf) [moles/vol],c244; cerebral spinal fluid; cerebrospinal fl; chemistry; level; l-tryptophan; point in time; qnt; quan; quant; quantitative; random; spinal fl; spinal fld; spinal flu; spinal fluid; substance concentration; trp,Qn
26611-4,phosphoethanolamine [moles/time] in 24 hour urine,petn 24h ur-srate,phosphoethanolamine (24h u) [moles/time],1 day; 24 hours; 24hr; chemistry; pea; petn; qnt; quan; quant; quantitative; srate; substance rate; ua; ur; urn,Qn
26618-9,trypanosoma brucei rhodesiense ab [presence] in serum,t brucei rhodes ab ser ql,t. brucei rhodesiense ab ql (s),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; id; infectious disease; infectiousdisease; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; sleeping sickness; sr; t brucei; t brucei rhodes; trypanosomiasis; trypanosomosis; trypanosomosis (tse-tse borne),Ord
26619-7,campylobacter sp ab [presence] in serum,campylobacter ab ser ql,campylobacter sp ab ql (s),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; campy; id; infectious disease; infectiousdisease; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; species; spp; sr,Ord
26624-7,rickettsia conorii ab [presence] in serum,r conorii ab ser ql,r. conorii ab ql (s),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; boutonneuse fever; id; infectious disease; infectiousdisease; mediterranean spotted fever; microbiology; ordinal; point in time; pr; ql; qual; qualitative; r conorii; random; ricket; rickettsial; screen; serum; spotted fever; sr,Ord
26632-0,legionella dumoffii ab [presence] in serum,l dumoffii ab ser ql,l. dumoffii ab ql (s),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; id; infectious disease; infectiousdisease; l dumoffii; legion; legionela; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; sr,Ord
2664-1,deprecated nitrogen 24h stl qn,deprecated nitrogen 24h stl qn,nitrogen (24h stl) [mass],1 day; 24 hours; 24hr; bowel movement; chemistry; faecal; faeces; fecal; feces; n; n2; nit; qnt; quan; quant; quantitative; stl; stool = fecal,Qn
26651-0,rhizopus arrhizus ab [presence] in serum,r arrhizus ab ser ql,r. arrhizus ab ql (s),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; id; infectious disease; infectiousdisease; microbiology; ordinal; point in time; pr; ql; qual; qualitative; r arrhizus; random; screen; serum; sr,Ord
26656-9,htlv ii ab [presence] in serum,htlv ii ab ser ql,htlv ii ab ql (s),2; abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; human t-cell leukemia virus; human t-cell lymphotrophic virus; id; infectious disease; infectiousdisease; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; sr,Ord
26671-8,ascaris sp ab [presence] in serum,ascaris ab ser ql,ascaris sp ab ql (s),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; id; infectious disease; infectiousdisease; microbiology; ordinal; p1; point in time; pr; ql; qual; qualitative; random; screen; serum; species; spp; sr,Ord
26673-4,echinococcus granulosus ab [presence] in serum,e granulosus ab ser ql,e. granulosus ab ql (s),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; e granulosus; echinococcosis; id; infectious disease; infectiousdisease; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; sr,Ord
26677-5,bartonella quintana ab [presence] in serum,b quintana ab ser ql,b. quintana ab ql (s),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; b quintana; cat scratch disease; cat scratch fever; csd; id; infectious disease; infectiousdisease; microbiology; ordinal; point in time; pr; ql; qual; qualitative; r quintana; random; rochalimae quintana; rochalimaea quintana; screen; serum; sr; trench fever,Ord
26704-7,isospora belli [presence] in stool by immunofluorescence,i belli stl ql if,i. belli if ql (stl),acif; anticomplement immunofluorescence; bowel movement; fa; faecal; faeces; fecal; feces; fluorescent antibody; fluoresent; gastro; gastroenterology; gi; i belli; id; ifa; immune fluorescence; immunoflour; immunofluor; immunofluorescence; infectious disease; infectiousdisease; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; screen; stl; stool = fecal; time resolved fluorescence; trf,Ord
2670-8,normetanephrine [mass/volume] in urine,normetanephrine ur-mcnc,normetanephrine (u) [mass/vol],chemistry; level; mass concentration; normeta; normetaneph; normetanephrn; point in time; qnt; quan; quant; quantitative; random; ua; ur; urn,Qn
26714-6,phenylpropanolamine [mass/mass] in meconium,ppa mec-mcnt,phenylpropanolamine (mec) [mass/mass],addiction; dexatrim; drug/toxicology; drugs; drugs of abuse; illicit; mass content; mec; norephedrine; norephidrine; point in time; potentialforabuse; ppa; qnt; quan; quant; quantitative; random,Qn
2671-6,normetanephrine [mass/time] in 24 hour urine,normetanephrine 24h ur-mrate,normetanephrine (24h u) [mass/time],1 day; 24 hours; 24hr; chemistry; mass rate; mrate; normeta; normetaneph; normetanephrn; qnt; quan; quant; quantitative; ua; ur; urn,Qn
26723-7,varicella zoster virus ab [titer] in cerebral spinal fluid by immunofluorescence,vzv ab titr csf if,vzv ab if (csf) [titer],abs; aby; acif; antby; anti; antibodies; antibody; anticomplement immunofluorescence; autoantibodies; autoantibody; cerebral spinal fluid; cerebrospinal fl; chicken pox; chicken pox virus; chickenpox; dilution factor; dilution factor (titer); fa; fluorescent antibody; fluoresent; herpes zoster; hhv-3; human herpesvirus 3; id; ifa; immune fluorescence; immunoflour; immunofluor; immunofluorescence; infectious disease; infectiousdisease; microbiology; neuro; neurology; point in time; random; shingles; smqn; spinal fl; spinal fld; spinal flu; spinal fluid; time resolved fluorescence; titer; titered; titre; trf; ttr; vz; vzv; zoster,SemiQn
2672-4,octopamine [moles/volume] in urine,octopamine ur-scnc,octopamine (u) [moles/vol],chemistry; level; point in time; qnt; quan; quant; quantitative; random; substance concentration; ua; ur; urn,Qn
26735-1,rhodococcus equi ab [presence] in serum by immune diffusion (id),r equi ab ser ql id,r. equi ab immune diff ql (s),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; id; imm; immunodiff; immunodiffusion; imun; imune; infectious disease; infectiousdisease; microbiology; ordinal; point in time; pr; ql; qual; qualitative; r equi; random; screen; serum; sr,Ord
26747-6,cannabinoids/creatinine [mass ratio] in urine,cannabinoids/creat ur,cannabinoids/creatinine (u) [mass ratio],cannabinoid; cr; crea; creat; delta-9-tetrahydrocannabinol; drug/toxicology; drugs; marijuana; mass concentration ratio; mass ratio; mcrto; point in time; qnt; quan; quant; quantitative; random; thc; ua; ucr; ur; urn,Qn
26772-4,mephentermine [mass/mass] in stool,mephentermine stl-mcnt,mephentermine (stl) [mass/mass],addiction; bowel movement; drug/toxicology; drugs; drugs of abuse; faecal; faeces; fecal; feces; illicit; mass content; phentermine metabolite; point in time; potentialforabuse; qnt; quan; quant; quantitative; random; stl; stool = fecal,Qn
26795-5,alanine [presence] in 24 hour urine,alanine 24h ur ql,alanine ql (24h u),1 day; 24 hours; 24hr; ala; alpha alanine; chemistry; l-alanine; ordinal; pr; ql; qual; qualitative; screen; ua; ur; urn,Ord
26797-1,alpha hydroxybutyrate [presence] in urine,a-oh-butyr ur ql,alpha hydroxybutyrate ql (u),2-hydroxybutyrate; 2-hydroxybutyric acid; alfa; alpha hydroxy butyrate; a-oh-butyr; chemistry; hydroxybutyric acid; ordinal; point in time; pr; ql; qual; qualitative; random; screen; ua; ur; urn,Ord
26798-9,succinate [presence] in urine,succinate ur ql,succinate ql (u),butanedioate; butanedioic acid; chemistry; ordinal; point in time; pr; ql; qual; qualitative; random; screen; succinic acid; ua; ur; urn,Ord
26801-1,protein [mass/time] in 12 hour urine,prot 12h ur-mrate,protein (12h u) [mass/time],12 hours; 12hr; chemistry; kidney; mass rate; mrate; nephrology; pr; prot; qnt; quan; quant; quantitative; renal; ua; ur; urn,Qn
26808-6,histidine [presence] in 24 hour urine,histidine 24h ur ql,histidine ql (24h u),1 day; 24 hours; 24hr; chemistry; formiminoglutamic acidemia; his; histidinemia; ordinal; pr; ql; qual; qualitative; screen; ua; ur; urn,Ord
26810-2,hydroxyproline [presence] in 24 hour urine,oh-proline 24h ur ql,hydroxyproline ql (24h u),1 day; 24 hours; 24hr; chemistry; hydroxylproline; hydroxyprol; hydroxy-proline; hydrxprol; hydrxproln; hydrxyprln; hyp; ohpro; oh-proline; ordinal; pr; ql; qual; qualitative; screen; ua; ur; urn,Ord
26820-1,stachybotrys chartarum iga ab [mass/volume] in serum,s chartarum iga-mcnc,stachybotrys chartarum iga (s) [mass/vol],abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; immune globulin a; immunoglobulin a; level; m209; m24; mass concentration; point in time; qnt; quan; quant; quantitative; random; rm214; s atra; s chartarum; serum; sr; stachybotrys atra,Qn
26825-0,eastern equine encephalitis virus rna [presence] in cerebral spinal fluid by probe,eeev rna csf ql probe,eeev rna probe ql (csf),cerebral spinal fluid; cerebrospinal fl; dna nucleic acid probe; dna probe; eee virus; eeev; enc; enceph; encephalomyelitis; equin; id; infectious disease; infectiousdisease; microbiology; neuro; neurology; ordinal; point in time; pr; ql; qual; qualitative; random; ribonucleic acid; screen; spinal fl; spinal fld; spinal flu; spinal fluid; togavirus,Ord
26833-4,hippurate [presence] in urine,hippurate ur ql,hippurate ql (u),benzyl alcohol metabolite; drug/toxicology; drugs; hipp; hippramine; hippuran; hippuric acid; hiprex; hip-rex; ordinal; point in time; pr; ql; qual; qualitative; random; screen; toluene metabolite; ua; ur; urex; urn; urotractan,Ord
26836-7,hydroxyethylflurazepam [mass/mass] in hair,oh-ethylfluraz hair-mcnt,hydroxyethylflurazepam (hair) [mass/mass],drug/toxicology; drugs; flurazepam metabolite; har; hydroxy ethylflurazepam; mass content; oh-ethylfluraz; point in time; qnt; quan; quant; quantitative; random,Qn
2684-9,alpha-1-acid glycoprotein [mass/volume] in cerebral spinal fluid,a1acid glycoprotein csf-mcnc,alpha-1-acid glycoprotein (csf) [mass/vol],a1; a1acid glycoprotein; aag; acd; acids; agp; alfa; cerebral spinal fluid; cerebrospinal fl; chemistry; gg; glycoprot; glycoproteins; gp; i; level; mass concentration; neuro; neurology; orosomucoid; point in time; qnt; quan; quant; quantitative; random; spinal fl; spinal fld; spinal flu; spinal fluid,Qn
26865-6,codeine [mass/mass] in meconium,codeine mec-mcnt,codeine (mec) [mass/mass],addiction; c260; c300; drug/toxicology; drugs; drugs of abuse; illicit; mass content; mec; methylmorphine; morphine methyl ether; point in time; potentialforabuse; qnt; quan; quant; quantitative; random,Qn
26868-0,phenolphthalein [presence] in stool,phenolphthalein stl ql,phenolphthalein ql (stl),bowel movement; drug/toxicology; drugs; faecal; faeces; fecal; feces; ordinal; phenolthalein; point in time; pr; ql; qual; qualitative; random; screen; stl; stool = fecal,Ord
26872-2,orotate [units/volume] in urine,orotate ur-acnc,orotate qn (u),arbitrary concentration; chemistry; orotic acid; point in time; qnt; quan; quant; quantitative; random; ua; ur; urn,Qn
26904-3,2-methylcitrate [moles/volume] in serum or plasma,2me-citrate serpl-scnc,2-methylcitrate [moles/vol],2me-citrate; chemistry; ii; level; mca; methylcitric acid; methylmalonic acidemia; pl; plasma; plsm; point in time; propionic acidemia; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; substance concentration,Qn
26910-0,alpha hydroxyalprazolam [mass/mass] in meconium,a-oh alpraz mec-mcnt,alpha hydroxyalprazolam (mec) [mass/mass],alfa; alpha hydroxy alprazolam; alprozolam metabolite; a-oh alpraz; drug/toxicology; drugs; hydroxy alprazolam; hydroxyalpraz; mass content; mec; oh-alpraz; point in time; qnt; quan; quant; quantitative; random,Qn
26914-2,estazolam [mass/mass] in meconium,estazolam mec-mcnt,estazolam (mec) [mass/mass],drug/toxicology; drugs; esilgan; eurodin; mass content; mec; nuctalon; point in time; prosom; qnt; quan; quant; quantitative; random,Qn
26919-1,alpha aminobutyrate/creatinine [molar ratio] in urine,a-aminobutyr/creat ur-srto,alpha aminobutyrate/creatinine (u) [molar ratio],2-aminobutanoic acid; 2-aminobutyrate; 2-aminobutyric acid; a-aminobutyr; aanb; a-anb; alfa; alpha aminobutyric acid; alpha amino-n-butyrate; alpha amino-n-butyric acid; aminobutric; aminobutyric; amino-n-butyrate; chemistry; cr; crea; creat; point in time; qnt; quan; quant; quantitative; random; scrto; substance concentration ratio; substance ratio; ua; ucr; ur; urn,Qn
26928-2,vasopressin [presence] in 24 hour urine,vasopressin 24h ur ql,vasopressin ql (24h u),1 day; 24 hours; 24hr; adh; adiuretin; antidiuretic hormone; arginine vasopressin hormone; avh; chemistry; ordinal; pr; ql; qual; qualitative; screen; ua; ur; urn; vp,Ord
26936-5,hydroxyethylflurazepam [mass/mass] in meconium,oh-ethylfluraz mec-mcnt,hydroxyethylflurazepam (mec) [mass/mass],drug/toxicology; drugs; flurazepam metabolite; hydroxy ethylflurazepam; mass content; mec; oh-ethylfluraz; point in time; qnt; quan; quant; quantitative; random,Qn
26940-7,myelin basic protein [units/volume] in cerebral spinal fluid,mbp csf-acnc,myelin basic protein qn (csf),arbitrary concentration; cerebral spinal fluid; cerebrospinal fl; chemistry; mbp; neuro; neurology; point in time; pr; prot; qnt; quan; quant; quantitative; random; spinal fl; spinal fld; spinal flu; spinal fluid,Qn
26944-9,11-ketoandrosterone [mass/volume] in urine,11ketoandros ur-mcnc,11-ketoandrosterone (u) [mass/vol],11ketoandros; chemistry; ketoandrost; level; mass concentration; point in time; qnt; quan; quant; quantitative; random; ua; ur; urn,Qn
26973-8,beta aminoisobutyrate [moles/volume] in urine,b-aib ur-scnc,beta aminoisobutyrate (u) [moles/vol],3-aminoisobutyrate; 3-aminoisobutyric acid; b; b-aib; chemistry; level; point in time; qnt; quan; quant; quantitative; random; substance concentration; ua; ur; urn,Qn
27000-9,thyroxine (t4) [mass/volume] in saliva (oral fluid),t4 sal-mcnc,t4 (sal) [mass/vol],chemistry; level; levothyroxine; levo-thyroxine; l-thyroxine; mass concentration; oral fluid; point in time; qnt; quan; quant; quantitative; random; sal; t4; t-4; thyroid hormone; thyrox; thyroxin; thyrx; total t4; tt4,Qn
2700-3,oxalate [mass/volume] in urine,oxalate ur-mcnc,oxalate (u) [mass/vol],chemistry; ethanedioate; ethanedioic acid; level; mass concentration; oxal; oxalic acid; point in time; qnt; quan; quant; quantitative; random; ua; universallaborders; ur; urn,Qn
27004-1,benzfetamine [mass/mass] in meconium,benzfetamine mec-mcnt,benzfetamine (mec) [mass/mass],addiction; benzphetamine; didrex; drug/toxicology; drugs; drugs of abuse; illicit; mass content; mec; point in time; potentialforabuse; qnt; quan; quant; quantitative; random,Qn
27016-5,xylose [mass/volume] in serum or plasma --7th specimen post xxx challenge,xylose sp7 p chal serpl-mcnc,xylose 7th specimen post unsp challenge [mass/vol],^7th spec pst xxx chal; after; chemistry.challenge testing; d-xylose; level; mass concentration; p chal; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sp7; sp7 p chal; spec; sr; xylose absorption test,Qn
27033-0,proline [moles/volume] in amniotic fluid,proline amn-scnc,proline (amn fld) [moles/vol],af; amn; amn fl; amnio; amniotic flu; amniotic fluid; chemistry; level; point in time; pro; qnt; quan; quant; quantitative; random; substance concentration,Qn
27039-7,ammonia [mass/volume] in 24 hour urine,ammonia 24h ur-mcnc,ammonia (24h u) [mass/vol],1 day; 24 hours; 24hr; amm; ammon; amon; chemistry; kidney; level; mass concentration; nephrology; nh3; qnt; quan; quant; quantitative; renal; ua; ur; urn,Qn
27050-4,mephobarbital [mass/volume] in milk,mephobarbital mlk-mcnc,mephobarbital (milk) [mass/vol],barbiturate; drug/toxicology; drugs; level; mass concentration; mebaral; methylphenobarbital; mlk; phenitone; point in time; qnt; quan; quant; quantitative; random,Qn
27058-7,beta alanine [moles/volume] in amniotic fluid,b-alanine amn-scnc,beta alanine (amn fld) [moles/vol],af; ala; alpha alanine; amn; amn fl; amnio; amniotic flu; amniotic fluid; b; bala; b-ala; b-alanine; chemistry; l-alanine; level; point in time; qnt; quan; quant; quantitative; random; substance concentration,Qn
27081-9,itraconazole+hydroxyitraconazole [mass/volume] in serum or plasma,itraconaz+hit serpl-mcnc,itraconazole+hydroxyitraconazole [mass/vol],drug/toxicology; drugs; hydroxy itraconazole; itraconaz+hit; itraconazole metabolite; level; mass concentration; oh-itraconaz; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sporanax; sporanox; sr,Qn
27097-5,2-methylbutyrylglycine/creatinine [mass ratio] in urine,2me-butyrylglycine/creat ur,2-methylbutyrylglycine/creatinine (u) [mass ratio],2-mbg; 2me-butyrylglycine; chemistry; cr; crea; creat; ii; mass concentration ratio; mass ratio; mcrto; point in time; qnt; quan; quant; quantitative; random; ua; ucr; ur; urn,Qn
27119-7,deprecated streptococcus pneumoniae 23 ab [mass/volume] in serum --2nd specimen,deprecated s pneum23 ab sp2 ser-mcnc,s. pneumoniae 23 ab spec 2 (s) [mass/vol],abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; convalescent; id; infectious disease; infectiousdisease; level; mass concentration; microbiology; pneu; pneum; pneumo; pneumococ; pneumococcal; pneumococcal pneumonia; pneumococcus; pneumon; pneumonia; point in time; post immunization; qnt; quan; quant; quantitative; random; s pneum23; s pneumo; s pneumoniae; second; serum; sp2; spec; spn; sr; strep; strept; streptococcus pneumoniae 23f,Qn
27126-2,deprecated streptococcus pneumoniae 14 ab [mass/volume] in serum --2nd specimen,deprecated s pneum14 ab sp2 ser-mcnc,s. pneumoniae 14 ab spec 2 (s) [mass/vol],abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; convalescent; id; infectious disease; infectiousdisease; level; mass concentration; microbiology; pneu; pneum; pneumo; pneumococ; pneumococcal; pneumococcal pneumonia; pneumococcus; pneumon; pneumonia; point in time; post immunization; qnt; quan; quant; quantitative; random; s pneum14; s pneumo; s pneumoniae; second; serum; sp2; spec; spn; sr; strep; strept,Qn
27132-0,acetoacetate [presence] in urine,acetoacet ur ql,acetoacetate ql (u),3-ketobutyrate; 3-oxobutyric acid; acac; acetoacetates; acetoacetic acid; beta-ketobutyrate; chemistry; diacetate; diacetic acid; ordinal; oxobutyrate; point in time; pr; ql; qual; qualitative; random; screen; ua; ur; urn,Ord
27142-9,deprecated streptococcus pneumoniae 3 ab [mass/volume] in serum --1st specimen,deprecated s pneum3 ab sp1 ser-mcnc,s. pneumoniae 3 ab spec 1 (s) [mass/vol],abs; aby; acute specimen; antby; anti; antibodies; antibody; autoantibodies; autoantibody; first; id; iii; infectious disease; infectiousdisease; level; mass concentration; microbiology; pneu; pneum; pneumo; pneumococ; pneumococcal; pneumococcal pneumonia; pneumococcus; pneumon; pneumonia; point in time; pre immunization; qnt; quan; quant; quantitative; random; s pneum3; s pneumo; s pneumoniae; serum; sp1; spec; spn; sr; strep; strept,Qn
2714-4,fractional oxyhemoglobin in arterial blood,oxyhgb mfr blda,oxyhemoglobin (blda) [mass fraction],abg; art; art bld; art blood; arterial; arterial blood; blood arterial; chemistry; fo2hb; fractional hemoglobin; haemoglobin; haemoglobin oxygenated; hb; hbo2; hemoglobin oxygenated; hgb; mass fraction; o2 saturation; o2hb; oxygen saturation; oxygenated haemoglobin; oxygenated hemoglobin; oxyhaemoglobin; oxyhgb; oxyhgb %; percent; point in time; qnt; quan; quant; quantitative; random; sao2; so2; tot; totl,Qn
27145-2,deprecated streptococcus pneumoniae 9 ab [mass/volume] in serum --1st specimen,deprecated s pneum9 ab sp1 ser-mcnc,s. pneumoniae 9 ab spec 1 (s) [mass/vol],abs; aby; acute specimen; antby; anti; antibodies; antibody; autoantibodies; autoantibody; first; id; infectious disease; infectiousdisease; level; mass concentration; microbiology; pneu; pneum; pneumo; pneumococ; pneumococcal; pneumococcal pneumonia; pneumococcus; pneumon; pneumonia; point in time; pre immunization; qnt; quan; quant; quantitative; random; s pneum9; s pneumo; s pneumoniae; serum; sp1; spec; spn; sr; strep; strept; streptococcus pneumoniae 9n,Qn
27178-3,phendimetrazine [mass/volume] in vitreous fluid,phendimetrazine vitf-mcnc,phendimetrazine (vitr fld) [mass/vol],addiction; adipost; bontril; dital; drug/toxicology; drugs; drugs of abuse; illicit; level; mass concentration; melfiat; obesan-x; obex-la; phenazine; plegin; plegine; point in time; potentialforabuse; prelu-2; qnt; quan; quant; quantitative; random; rexigen forte; statobex; trimstat; vitf; vitreous fluid; vitreous humor; vitreous humour; x-trozine,Qn
27183-3,cardiolipin igg ab [presence] in serum,cardiolipin igg ser ql,cardiolipin igg ql (s),abs; aby; aca; acl; antby; anti; antibodies; antibody; anticardiolipin; autoantibodies; autoantibody; cardio; cardiolip; cardiolipn; cardiolpn; cl; coagulation; hematology; heme; immune globulin g; immunoglobulin g; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; sr,Ord
27184-1,alpha 1 globulin [presence] in urine,alpha1 glob ur ql,alpha 1 globulin ql (u),a1; alfa; alpha1 glob; chemistry; glb; glob; glob%; globul; globulins; i; kidney; nephrology; ordinal; point in time; pr; protein.alpha 1 globulin; ql; qual; qualitative; random; renal; screen; ua; ur; urn,Ord
27210-4,magnesium [presence] in blood,magnesium bld ql,magnesium ql (bld),blood; chemistry; mag; magnes; mg; ordinal; point in time; pr; ql; qual; qualitative; random; screen; wb; whole blood,Ord
27215-3,deprecated mitochondria m2 igg ab [units/volume] in serum,deprecated mitochondria m2 igg ser-acnc,mitochondria m2 igg qn (s),abs; aby; ama-m2; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; immune globulin g; immunoglobulin g; microtubule associated protein 2; mito; mitochon; mitochond; mitochondrial; mitochondrial m2; point in time; pyruvate dehydrogenase ab; qnt; quan; quant; quantitative; random; serology; serum; sr,Qn
27234-4,phentermine [mass/volume] in vitreous fluid,phentermine vitf-mcnc,phentermine (vitr fld) [mass/vol],addiction; drug/toxicology; drugs; drugs of abuse; illicit; ionamin; level; mass concentration; point in time; potentialforabuse; qnt; quan; quant; quantitative; random; vitf; vitreous fluid; vitreous humor; vitreous humour,Qn
27236-9,azatadine [mass/volume] in serum or plasma,azatadine serpl-mcnc,azatadine [mass/vol],c20h22n2; drug/toxicology; drugs; level; mass concentration; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
27240-1,phenobarbital [mass/mass] in stool,phenobarb stl-mcnt,phenobarbital (stl) [mass/mass],barbiturate; bowel movement; c417; drug/toxicology; drugs; faecal; faeces; fecal; feces; luminal; mass content; nirvonal; phbr; phenobarb; point in time; qnt; quan; quant; quantitative; random; stl; stool = fecal,Qn
27249-2,temazepam [mass/mass] in stool,temazepam stl-mcnt,temazepam (stl) [mass/mass],bowel movement; drug/toxicology; drugs; faecal; faeces; fecal; feces; mass content; normison; point in time; qnt; quan; quant; quantitative; random; restoril; stl; stool = fecal,Qn
27251-8,phenylpropanolamine [mass/volume] in vitreous fluid,ppa vitf-mcnc,phenylpropanolamine (vitr fld) [mass/vol],addiction; dexatrim; drug/toxicology; drugs; drugs of abuse; illicit; level; mass concentration; norephedrine; norephidrine; point in time; potentialforabuse; ppa; qnt; quan; quant; quantitative; random; vitf; vitreous fluid; vitreous humor; vitreous humour,Qn
27253-4,chlorphentermine [mass/volume] in vitreous fluid,chlorphentermin vitf-mcnc,chlorphentermine (vitr fld) [mass/vol],addiction; drug/toxicology; drugs; drugs of abuse; illicit; level; lucofen; mass concentration; point in time; potentialforabuse; qnt; quan; quant; quantitative; random; vitf; vitreous fluid; vitreous humor; vitreous humour,Qn
27273-2,chlamydia sp ab [titer] in cerebral spinal fluid by immunofluorescence,chlamydia ab titr csf if,chlamydia sp ab if (csf) [titer],abs; aby; acif; antby; anti; antibodies; antibody; anticomplement immunofluorescence; autoantibodies; autoantibody; cerebral spinal fluid; cerebrospinal fl; chlam; chlamid; dilution factor; dilution factor (titer); fa; fluorescent antibody; fluoresent; id; ifa; immune fluorescence; immunoflour; immunofluor; immunofluorescence; infectious disease; infectiousdisease; microbiology; neuro; neurology; point in time; random; smqn; species; spinal fl; spinal fld; spinal flu; spinal fluid; spp; time resolved fluorescence; titer; titered; titre; trf; ttr,SemiQn
27274-0,deprecated benzfetamine [mass/mass] in meconium,deprecated benzfetamine mec-mcnt,benzfetamine (mec) [mass/mass],addiction; benzphetamine; didrex; drug/toxicology; drugs; drugs of abuse; illicit; mass content; mec; point in time; potentialforabuse; qnt; quan; quant; quantitative; random,Qn
27298-9,protein [units/volume] in urine,prot ur-acnc,protein qn (u),arbitrary concentration; kidney; nephrology; point in time; pr; prot; qnt; quan; quant; quantitative; random; renal; ua; ur; urinalysis; urn,Qn
27306-0,testosterone [presence] in saliva (oral fluid),testost sal ql,testosterone ql (sal),chemistry; oral fluid; ordinal; point in time; pr; ql; qual; qualitative; random; sal; screen; testo; testos; testost,Ord
27311-0,codeine free [mass/mass] in stool,codeine free stl-mcnt,codeine free (stl) [mass/mass],bowel movement; c260; c300; codeine free; drug/toxicology; drugs; faecal; faeces; fecal; feces; fr; mass content; methylmorphine; morphine methyl ether; non-protein bound; point in time; qnt; quan; quant; quantitative; random; stl; stool = fecal,Qn
27317-7,asparagine [moles/volume] in urine,asparagine ur-scnc,asparagine (u) [moles/vol],asn; chemistry; level; point in time; qnt; quan; quant; quantitative; random; substance concentration; ua; ur; urn,Qn
2732-6,parathyrin.mid molecule [mass/volume] in serum or plasma,pth-m serpl-mcnc,parathyrin.mid molecule [mass/vol],chemistry; level; mass concentration; parathormone; parathyrin medium molecule; parathyroid hormone; pl; plasma; plsm; point in time; pth; pth-m; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
27331-8,imipenem [units/volume] in specimen,imipenem spec-acnc,imipenem qn (specimen),arbitrary concentration; drug/toxicology; drugs; imipeneum; imp; misc; miscellaneous; other; point in time; primaxin; qnt; quan; quant; quantitative; random; spec; to be specified in another part of the message; unspecified,Qn
27334-2,tryptophan [units/volume] in serum or plasma,tryptophan serpl-acnc,tryptophan qn,arbitrary concentration; c244; chemistry; l-tryptophan; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; trp,Qn
27354-0,toxoplasma gondii ige ab [presence] in serum,t gondii ige ser ql,t. gondii ige ql (s),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; id; immune globulin e; immunoglobulin e; infectious disease; infectiousdisease; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; sr; t gondii; toxo; toxoplasmosis,Ord
27355-7,lipoprotein.pre-beta [presence] in pleural fluid,vldl plr ql,lipoprotein.pre-beta ql (pleur fld),b; before; chemistry; lip; lipoprot; lipoproteins; lp; ordinal; pleural; pleural fluid; point in time; pr; ql; qual; qualitative; random; screen; thoracentesis fluid; very low density lipoproteins; vldl,Ord
27367-2,manganese/creatinine [mass ratio] in urine,manganese/creat ur,manganese/creatinine (u) [mass ratio],cr; crea; creat; drug/toxicology; drugs; mass concentration ratio; mass ratio; mcrto; mn; point in time; qnt; quan; quant; quantitative; random; ua; ucr; ur; urn,Qn
27369-8,somatotropin [mass/volume] in serum or plasma --2.5 hours post xxx challenge,gh 2.5h p chal serpl-mcnc,somatotropin 2.5 hr post unsp challenge [mass/vol],2.5h p chal; after; chemistry.challenge testing; endocrine; endocrinology; gh; growth hormone; hgh; human growth hormone; level; mass concentration; p chal; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; somatotropic hormone; sr; sth,Qn
27384-7,leptospira sp igm ab [units/volume] in cerebral spinal fluid by immunoassay,leptospira igm csf ia-acnc,leptospira sp igm ia qn (csf),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; cerebral spinal fluid; cerebrospinal fl; eia; elfa; elisa; enzyme immunoassay; iaa; id; immune globulin m; immunoglobulin m; infectious disease; infectiousdisease; leptospirosis; meia; microbiology; neuro; neurology; point in time; qnt; quan; quant; quantitative; random; species; spinal fl; spinal fld; spinal flu; spinal fluid; spp; suds,Qn
27391-2,candida sp igm ab [units/volume] in serum by immunoassay,candida igm ser ia-acnc,candida sp igm ia qn (s),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; cand; candidiasis; eia; elfa; elisa; enzyme immunoassay; iaa; id; immune globulin m; immunoglobulin m; infectious disease; infectiousdisease; meia; microbiology; monilia; point in time; qnt; quan; quant; quantitative; random; serum; species; spp; sr; suds; thrush,Qn
27414-2,fungus identified in stool by culture,fungus stl cult,fungus identified cx nom (stl),bowel movement; c&s; cult; cultures; faecal; faeces; fecal; feces; fung; fungal; fungi; gastro; gastroenterology; gi; id; identity or presence; infectious disease; infectiousdisease; microbiology; nominal; point in time; random; stl; stool = fecal,Nom
27439-9,alpha hydroxyalprazolam [mass/mass] in stool,a-oh alpraz stl-mcnt,alpha hydroxyalprazolam (stl) [mass/mass],alfa; alpha hydroxy alprazolam; alprozolam metabolite; a-oh alpraz; bowel movement; drug/toxicology; drugs; faecal; faeces; fecal; feces; hydroxy alprazolam; hydroxyalpraz; mass content; oh-alpraz; point in time; qnt; quan; quant; quantitative; random; stl; stool = fecal,Qn
2744-1,ph of arterial blood,ph blda,ph (blda),abg; art; art bld; art blood; arterial; arterial blood; blood arterial; chemistry; kidney; log molar concentration; lung; nephrology; point in time; pulmonary; pulmonology; random; renal; respiratory; smqn,SemiQn
27463-9,"deprecated cardiac rehabilitation treatment plan, medication timing + quantity tq2",deprecated,,attach; attach.rehab; attach.rehab.cardiac; cardiac rehabilitation tx; cardio; cardiology; heart disease; point in time; qnt; quan; quant; quantitative; random; rehabtx; timing - quantity; tx,Qn
27474-6,"deprecated alcohol-substance abuse rehabilitation treatment plan, new/revised",deprecated,,alc; alcoholic; alcohol-substance abuse rehabilitation tx; alcohol-substance abuse rehabilitation tx plan; attach; attach.rehab; attach.rehab.abuse; ordinal; point in time; ql; qual; qualitative; random; rehabilitation tx plan; rehabtx; screen; subs; tx; tx plan; typ,Ord
27481-1,"deprecated alcohol-substance abuse rehabilitation treatment plan, signature date date and time",deprecated,,alc; alcoholic; alcohol-substance abuse rehabilitation tx; alcohol-substance abuse rehabilitation tx plan; attach; attach.rehab; attach.rehab.abuse; date and time; point in time; qnt; quan; quant; quantitative; random; rehabilitation tx plan; rehabtx; subs; time stamp; timestamp; tx; tx plan,Qn
27494-4,"deprecated alcohol-substance abuse rehabilitation treatment plan, date rehabilitation professional signed",deprecated,,alc; alcoholic; alcohol-substance abuse rehabilitation tx; alcohol-substance abuse rehabilitation tx plan; attach; attach.rehab; attach.rehab.abuse; point in time; qnt; quan; quant; quantitative; random; rehabilitation tx plan; rehabtx; subs; tx; tx plan,Qn
27523-0,"deprecated alcohol-substance abuse rehabilitation treatment plan, primary diagnosis (narrative)",deprecated,,alc; alcoholic; alcohol-substance abuse rehabilitation tx; attach; attach.rehab; attach.rehab.abuse; dx; dx.primary; impression; impression/interpretation of study; impressions; interp; interpretation; narrative; point in time; random; rehabtx; report; subs; tx,Nar
27541-2,"deprecated cardiac rehabilitation treatment plan, date attending md signed date and time",deprecated,,attach; attach.rehab; attach.rehab.cardiac; cardiac rehabilitation tx; cardiac rehabilitation tx plan; cardio; cardiology; date and time; heart disease; point in time; qnt; quan; quant; quantitative; random; rehabilitation tx plan; rehabtx; time stamp; timestamp; tx; tx plan,Qn
27546-1,"deprecated cardiac rehabilitation treatment plan, prognosis for rehabilitation",deprecated,,attach; attach.rehab; attach.rehab.cardiac; cardiac rehabilitation tx; cardiac rehabilitation tx plan; cardio; cardiology; heart disease; impression; impression/interpretation of study; impressions; interp; interpretation; ordinal; point in time; ql; qual; qualitative; random; rehabilitation tx plan; rehabtx; screen; tx; tx plan,Ord
27547-9,"deprecated cardiac rehabilitation treatment plan, estimated date of completion date",deprecated,,attach; attach.rehab; attach.rehab.cardiac; cardiac rehabilitation tx; cardio; cardiology; heart disease; point in time; qnt; quan; quant; quantitative; random; rehabtx; tx,Qn
27549-5,"deprecated cardiac rehabilitation treatment plan, past medical history and level of function (narrative)",deprecated,,attach; attach.rehab; attach.rehab.cardiac; cardiac rehabilitation tx; cardiac rehabilitation tx plan; cardio; cardiology; fcn; finding; findings; func; funct; heart disease; hx; last; levels; levl; lv; lvl; narrative; past medical hx; past medical hx+level of function; point in time; random; rehabilitation tx plan; rehabtx; report; tx; tx plan,Nar
27575-0,"deprecated skilled nursing treatment plan, reason to continue (narrative)",deprecated,,attach; attach.rehab; attach.rehab.nurs; finding; findings; narrative; point in time; random; report; skilled nursing tx; skilled nursing tx plan; tx; tx plan,Nar
27591-7,"deprecated skilled nursing treatment plan, primary diagnosis identifier",deprecated,,attach; attach.rehab; attach.rehab.nurs; dx; dx.primary; ident; identifier; nominal; point in time; random; skilled nursing tx; tx,Nom
27610-5,"deprecated occupational therapy treatment plan, end date",deprecated,,attach; attach.rehab; attach.rehab.ot; date end; occupational therapy; occupational therapy tx; occupational therapy tx plan; ot; point in time; qnt; quan; quant; quantitative; random; tx; tx plan,Qn
27622-0,"deprecated occupational therapy treatment plan, past medical history and level of function (narrative)",deprecated,,attach; attach.rehab; attach.rehab.ot; fcn; finding; findings; func; funct; hx; last; levels; levl; lv; lvl; narrative; occupational therapy; occupational therapy tx; occupational therapy tx plan; ot; past medical hx; past medical hx+level of function; point in time; random; report; tx; tx plan,Nar
27625-3,deprecated occupational therapy treatment plan progress note and attainment of goals (narrative),deprecated,,attach; attach.rehab; attach.rehab.ot; encounter; evaluation and management; evaluation and management note; finding; findings; narrative; notes; occupational therapy; occupational therapy tx; ot; point in time; prog note; random; report; subsequent evaluation; subsequent visit evaluation; tx; visit note,Nar
27628-7,"deprecated occupational therapy treatment plan, psychiatric symptoms (narrative)",deprecated,,attach; attach.rehab; attach.rehab.ot; finding; findings; narrative; occupational therapy; occupational therapy tx; ot; point in time; random; report; sx; tx,Nar
27638-6,"deprecated occupational therapy treatment plan, primary diagnosis (narrative)",deprecated,,attach; attach.rehab; attach.rehab.ot; dx; dx.primary; impression; impression/interpretation of study; impressions; interp; interpretation; narrative; occupational therapy; occupational therapy tx; ot; point in time; random; report; tx,Nar
27643-6,"deprecated occupational therapy treatment plan, diagnosis addressed by plan identifier",deprecated,,attach; attach.rehab; attach.rehab.ot; dx; dx.addressed by plan; ident; identifier; nominal; occupational therapy; occupational therapy tx; ot; point in time; random; tx,Nom
27644-4,"deprecated occupational therapy treatment plan, diagnosis addressed by plan (narrative) text",deprecated,,attach; attach.rehab; attach.rehab.ot; dx; dx.addressed by plan; narrative; occupational therapy; occupational therapy tx; ot; point in time; random; report; text; tx,Nar
27664-2,"deprecated physical therapy treatment plan, diagnosis addressed by plan set",deprecated,,attach; attach.rehab; attach.rehab.pt; dx; dx.addressed by plan; impression; impression/interpretation of study; impressions; interp; interpretation; physical therapy; physical therapy tx; physical therapy tx plan; point in time; pt; random; tx; tx plan,Set
27676-6,"deprecated physical therapy treatment plan, date attending md referred patient for date",deprecated,,attach; attach.rehab; attach.rehab.pt; physical therapy; physical therapy tx; point in time; pt; qnt; quan; quant; quantitative; random; tx,Qn
2768-0,phenylalanine/tyrosine [mass ratio] in serum or plasma,phe/tyr serpl,phenylalanine/tyrosine [mass ratio],chemistry; mass concentration ratio; mass ratio; mcrto; phe; phe+tyr; phenylalanine +tyrosine; pl; plasma; plsm; point in time; ppa; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; tyr,Qn
2769-8,phenylketones [presence] in urine,phenylketones ur ql,phenylketones ql (u),chemistry; ordinal; phenyl ketones; point in time; pr; ql; qual; qualitative; random; screen; ua; ur; urn,Ord
27698-0,"physical therapy treatment plan, primary diagnosis set",,,attach; attach.rehab; attach.rehab.pt; complex; dx; dx.primary; physical therapy; physical therapy tx; point in time; pt; random; tx,Set
27707-9,"deprecated respiratory therapy treatment plan, signature date date and time",deprecated,,attach; attach.rehab; attach.rehab.rt; date and time; lung; point in time; pulmonary; pulmonology; qnt; quan; quant; quantitative; random; respiratory; respiratory therapy tx; respiratory therapy tx plan; time stamp; timestamp; tx; tx plan,Qn
27717-8,"deprecated respiratory therapy treatment plan, date rehabilitation professional signed date and time",deprecated,,attach; attach.rehab; attach.rehab.rt; date and time; lung; point in time; pulmonary; pulmonology; qnt; quan; quant; quantitative; random; respiratory; respiratory therapy tx; respiratory therapy tx plan; time stamp; timestamp; tx; tx plan,Qn
27730-1,"deprecated respiratory therapy treatment plan, psychiatric symptoms (narrative)",deprecated,,attach; attach.rehab; attach.rehab.rt; finding; findings; lung; narrative; point in time; pulmonary; pulmonology; random; report; respiratory; respiratory therapy tx; sx; tx,Nar
27736-8,"deprecated respiratory therapy treatment plan, author id identifier",deprecated,,attach; attach.rehab; attach.rehab.rt; ident; identifier; intradermal; lung; nominal; point in time; pulmonary; pulmonology; random; respiratory; respiratory therapy tx; respiratory therapy tx plan; tx; tx plan,Nom
27738-4,"deprecated respiratory therapy treatment plan, start date of hospitalization leading to treatment",deprecated,,attach; attach.rehab; attach.rehab.rt; hospitalization leading to respiratory therapy tx; lung; point in time; pulmonary; pulmonology; qnt; quan; quant; quantitative; random; respiratory; respiratory therapy tx; started; tx,Qn
27740-0,"deprecated respiratory therapy treatment plan, primary diagnosis (narrative)",deprecated,,attach; attach.rehab; attach.rehab.rt; dx; dx.primary; impression; impression/interpretation of study; impressions; interp; interpretation; lung; narrative; point in time; pulmonary; pulmonology; random; report; respiratory; respiratory therapy tx; tx,Nar
27744-2,"deprecated respiratory therapy treatment plan, primary diagnosis identifier",deprecated,,attach; attach.rehab; attach.rehab.rt; dx; dx.primary; ident; identifier; lung; nominal; point in time; pulmonary; pulmonology; random; respiratory; respiratory therapy tx; tx,Nom
27748-3,"deprecated respiratory therapy treatment plan, medication route identifier",deprecated,,attach; attach.rehab; attach.rehab.rt; identity or presence; lung; nominal; point in time; pulmonary; pulmonology; random; respiratory; respiratory therapy tx; tx,Nom
27756-6,"deprecated medical social services treatment plan, author name",deprecated,,attach; attach.rehab; attach.rehab.social; medical social services tx; medical social services tx plan; nominal; person name; point in time; random; tx; tx plan,Nom
2777-1,phosphate [mass/volume] in serum or plasma,phosphate serpl-mcnc,phosphate [mass/vol],chemistry; i phos; inorganic phosphate; level; mass concentration; phos; phosphate total; phosphorous; phosphorus; phosphrous; pi; pl; plasma; plsm; po4; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; universallaborders,Qn
27814-3,coagulation factor vii+coagulation factor x actual/normal in platelet poor plasma by coagulation assay,fact vii+fact x act/nor ppp,coagulation factor vii+coagulation factor x actual/normal coag (ppp) [relative time],act/nor; activ; actvty; autoprothrombin iii; clot; clottable; coag; coagulation assay; control; f7; fac; fact; fact vii; fact vii+fact x; fact x; factor 10; factor 7; fvii; fx; hematology; heme; movements; plas; platelet poor plasma; point in time; proconvertin; prothrombokinase; qnt; quan; quant; quantitative; random; rltm; serum prothrombin conversion accelerator; spca; stuart-prower factor; tilt tube,Qn
27822-6,protein s actual/normal in platelet poor plasma by coagulation assay,prot s act/nor ppp,protein s actual/normal coag (ppp) [relative time],act/nor; clot; clottable; coagulation; coagulation assay; control; functional assay; hematology; heme; plas; platelet poor plasma; point in time; pr; prot; prot s; ps; qnt; quan; quant; quantitative; random; rltm; s prime; tilt tube; universallaborders,Qn
27830-9,insulin [units/volume] in serum or plasma --1 hour post 75 g glucose po,insulin 1h p 75 g glc po serpl-acnc,insulin 1 hr post 75 g glucose po qn,1 hour; 1.0hr; 1h p 75 g glc po; 60 min; 60 minutes; 60m; 60min; 75gm; after; arbitrary concentration; chemistry.challenge testing; glu; glu tol; gluc; glucose tolerance; glucoseur; gtt; hum; humulin; ih7; insul; lente; nph; p 75 g glc po; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; semilente; serp; serpl; serplas; serum; serum or plasma; sliding; sr; ultralente,Qn
27835-8,somatotropin [mass/volume] in serum or plasma --11th specimen post xxx challenge,gh sp11 p chal serpl-mcnc,somatotropin 11th specimen post unsp challenge [mass/vol],after; chemistry.challenge testing; endocrine; endocrinology; gh; growth hormone; hgh; human growth hormone; level; mass concentration; p chal; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; somatotropic hormone; sp11; sp11 p chal; spec; sr; sth,Qn
27838-2,somatotropin [mass/volume] in serum or plasma --14th specimen post xxx challenge,gh sp14 p chal serpl-mcnc,somatotropin 14th specimen post unsp challenge [mass/vol],after; chemistry.challenge testing; endocrine; endocrinology; gh; growth hormone; hgh; human growth hormone; level; mass concentration; p chal; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; somatotropic hormone; sp14; sp14 p chal; spec; sr; sth,Qn
27839-0,c peptide [mass/volume] in serum or plasma --4 hours post xxx challenge,c peptide 4h p chal serpl-mcnc,c peptide 4 hr post unsp challenge [mass/vol],4h p chal; after; chemistry.challenge testing; connecting peptide of insulin; level; mass concentration; p chal; pept; pl; plasma; plsm; point in time; pro-insulin c peptide; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
27849-9,aldosterone [mass/volume] in serum or plasma --2nd specimen post xxx challenge,aldost sp2 p chal serpl-mcnc,aldosterone 2nd specimen post unsp challenge [mass/vol],after; chemistry.challenge testing; convalescent; endocrine; endocrinology; level; mass concentration; p chal; pl; plasma; plsm; point in time; post immunization; pst; qnt; quan; quant; quantitative; random; second; serp; serpl; serplas; serum; serum or plasma; sp2; sp2 p chal; spec; sr,Qn
27853-1,lutropin [units/volume] in serum or plasma --4th specimen post xxx challenge,lh sp4 p chal serpl-acnc,lutropin 4th specimen post unsp challenge qn,after; arbitrary concentration; chemistry.challenge testing; endocrine; endocrinology; icsh; interstitial cell-stimulating hormone; interstitual cell stimulating hormone; leutinizing hormone; lh; luteinizing hormone; lutenin; lutenizing hormone; ovulation test; p chal; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sp4; sp4 p chal; spec; sr,Qn
27855-6,lutropin [units/volume] in serum or plasma --6th specimen post xxx challenge,lh sp6 p chal serpl-acnc,lutropin 6th specimen post unsp challenge qn,after; arbitrary concentration; chemistry.challenge testing; endocrine; endocrinology; icsh; interstitial cell-stimulating hormone; interstitual cell stimulating hormone; leutinizing hormone; lh; luteinizing hormone; lutenin; lutenizing hormone; ovulation test; p chal; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sp6; sp6 p chal; spec; sr,Qn
27864-8,follitropin [units/volume] in serum or plasma --9th specimen post xxx challenge,fsh sp9 p chal serpl-acnc,follitropin 9th specimen post unsp challenge qn,after; arbitrary concentration; chemistry.challenge testing; follicle stimulating hormone; fsh; p chal; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sp9; sp9 p chal; spec; sr,Qn
27888-7,somatotropin [mass/volume] in serum or plasma --2nd specimen post xxx challenge,gh sp2 p chal serpl-mcnc,somatotropin 2nd specimen post unsp challenge [mass/vol],after; chemistry.challenge testing; convalescent; endocrine; endocrinology; gh; growth hormone; hgh; human growth hormone; level; mass concentration; p chal; pl; plasma; plsm; point in time; post immunization; pst; qnt; quan; quant; quantitative; random; second; serp; serpl; serplas; serum; serum or plasma; somatotropic hormone; sp2; sp2 p chal; spec; sr; sth,Qn
27889-5,somatotropin [mass/volume] in serum or plasma --3rd specimen post xxx challenge,gh sp3 p chal serpl-mcnc,somatotropin 3rd specimen post unsp challenge [mass/vol],after; chemistry.challenge testing; endocrine; endocrinology; gh; growth hormone; hgh; human growth hormone; level; mass concentration; p chal; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; somatotropic hormone; sp3; sp3 p chal; spec; sr; sth,Qn
27895-2,gastroenterology endoscopy studies (set),,,attach; attach.gi; complex; gi,Set
2789-6,phosphoethanolamine [mass/volume] in serum or plasma,petn serpl-mcnc,phosphoethanolamine [mass/vol],chemistry; level; mass concentration; pea; petn; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
27898-6,pathology studies (set),,,attach; attach.lab; complex; lab; path,Set
27903-4,coxsackievirus b2 ab [presence] in cerebral spinal fluid,cv b2 ab csf ql,coxsackievirus b2 ab ql (csf),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; cav; cerebral spinal fluid; cerebrospinal fl; coxsackie; coxsackie virus; cv; cv b2; id; infectious disease; infectiousdisease; microbiology; neuro; neurology; ordinal; point in time; pr; ql; qual; qualitative; random; screen; spinal fl; spinal fld; spinal flu; spinal fluid,Ord
27923-2,coenzyme q10 [mass/volume] in serum or plasma,ubiquinone10 serpl-mcnc,coenzyme q10 [mass/vol],chemistry; coenzyme q10; coq10; co-q10; level; mass concentration; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; ubiquinone10; universallaborders,Qn
27924-0,ascaris sp ab [titer] in serum by immunoassay,ascaris ab titr ser ia,ascaris sp ab ia (s) [titer],abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; dilution factor; dilution factor (titer); eia; elfa; elisa; enzyme immunoassay; iaa; id; infectious disease; infectiousdisease; meia; microbiology; p1; point in time; random; serum; smqn; species; spp; sr; suds; titer; titered; titre; ttr,SemiQn
27938-0,salmonella paratyphi b o ab [titer] in serum by agglutination,s paraty b o ab titr ser aggl,s. paratyphi b o ab aggl (s) [titer],abs; aby; agg; agglut; agglutination; antby; anti; antibodies; antibody; autoantibodies; autoantibody; dilution factor; dilution factor (titer); id; infectious disease; infectiousdisease; microbiology; paratyph; paratyphoid; point in time; random; s paraty; s paraty b; s paraty b o; s paratyph; s paratyphi; sal; sal paratyph; sal paratyphi; salmonel; serum; smqn; sr; titer; titered; titre; ttr,SemiQn
27942-2,follitropin [mass/volume] in serum or plasma,fsh serpl-mcnc,follitropin [mass/vol],chemistry; follicle stimulating hormone; fsh; level; mass concentration; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
2795-3,phosphofructokinase l subunit/phosphofructokinase.total in red blood cells,pfk-l cfr rbc,phosphofructokinase l subunit/total phosphofructokinase (rbc) [catalytic fraction],6-phosphofructokinase; catalytic fraction; chemistry; erythrocytes; left; levo; percent; pfk; pfk l; pfk-granulocytic leukocyte; pfk-l; phosphohexokinase; point in time; qnt; quan; quant; quantitative; random; red blood cells; red blood corpusles; tot; totl,Qn
27953-9,methionine [units/volume] in serum or plasma,methionine serpl-acnc,methionine qn,arbitrary concentration; chemistry; met; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
27957-0,pyruvate [mass/volume] in blood --4 hours post xxx challenge,pyruvate 4h p chal bld-mcnc,pyruvate 4 hr post unsp challenge (bld) [mass/vol],4h p chal; after; blood; chemistry.challenge testing; level; mass concentration; p chal; point in time; pst; pyruvic acid; qnt; quan; quant; quantitative; random; wb; whole blood,Qn
27962-0,butalbital [mass/mass] in meconium,butalbital mec-mcnt,butalbital (mec) [mass/mass],addiction; allylbarbital; allylbarbituric acid; barbiturate; drug/toxicology; drugs; drugs of abuse; fiorinal; illicit; mass content; mec; point in time; potentialforabuse; qnt; quan; quant; quantitative; random,Qn
27972-9,histidine [units/volume] in serum or plasma,histidine serpl-acnc,histidine qn,arbitrary concentration; chemistry; formiminoglutamic acidemia; his; histidinemia; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
27976-0,lactate [mass/volume] in blood --fasting,lactate p fast bld-mcnc,lactate post fast (bld) [mass/vol],2-hydroxypropanoic acid; 2-hydroxy-propionate; 2-hydroxy-propionic acid; after; blood; calorie fast; chemistry.challenge testing; fast; fasting; lact; lactic acid; level; l-lactate; mass concentration; p fast; pc; point in time; pst; qnt; quan; quant; quantitative; random; wb; whole blood,Qn
27989-3,thyroxine (t4) free [units/volume] in serum or plasma --1 hour post xxx challenge,t4 free 1h p chal serpl-acnc,free t4 1 hr post unsp challenge qn,1 hour; 1.0hr; 1h p chal; 60 min; 60 minutes; 60m; 60min; after; arbitrary concentration; chemistry.challenge testing; endocrine; endocrinology; fr; freet4; ft4; levothyroxine; levo-thyroxine; l-thyroxine; non-protein bound; p chal; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; t4; t-4; t4 free; thyroid hormone; thyrox; thyroxin; thyrx; total t4; tt4,Qn
27990-1,fibrinogen fragments [mass/volume] in platelet poor plasma by latex agglutination,fibrinogen frg ppp la-mcnc,fibrinogen fragments la (ppp) [mass/vol],coagulation; coagulation factor i; fgdp; fgn; fibrinogen frg; frag; fragment; hematology; heme; lat; latex agglutination; level; mass concentration; plas; platelet poor plasma; point in time; qnt; quan; quant; quantitative; random,Qn
27993-5,sympathomimetics [mass/volume] in urine,sympathomimetics ur-mcnc,sympathomimetics (u) [mass/vol],amphetamine; benzedrine; drug/toxicology; drugs; ephedrine; level; mass concentration; mescaline; point in time; qnt; quan; quant; quantitative; random; ua; ur; urn,Qn
28051-1,"1,3,5-trichlorobenzene [mass/volume] in serum or plasma","1,3,5tcb serpl-mcnc","1,3,5-trichlorobenzene [mass/vol]","1,3,5tcb; drug/toxicology; drugs; i; iii; level; mass concentration; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; tcb",Qn
28071-9,e selectin [mass/volume] in blood,e selectin bld-mcnc,e selectin (bld) [mass/vol],blood; cd62e; chemistry; elam-1; endothelial leukocyte adhesion molecule-1; level; mass concentration; point in time; qnt; quan; quant; quantitative; random; se-selectin; wb; whole blood,Qn
28072-7,dihydrocodeine+hydrocodeinone [mass/mass] in stool,dhc+hydrocod stl-mcnt,dihydrocodeine+hydrocodeinone (stl) [mass/mass],bowel movement; df-118; dhc; dhc+hydrocod; dhcplus; drocode; drug/toxicology; drugs; faecal; faeces; fecal; feces; mass content; point in time; qnt; quan; quant; quantitative; random; stl; stool = fecal,Qn
28083-4,acute pain [ccc],,,clinical care classification; finding; findings; nursing; ordinal; point in time; ql; qual; qualitative; random; screen; survey; survey.nursing.hhcc,Ord
28101-4,fear [ccc],,,clinical care classification; finding; findings; nursing; ordinal; point in time; ql; qual; qualitative; random; screen; survey; survey.nursing.hhcc,Ord
28102-2,fecal impaction [ccc],,,clinical care classification; finding; findings; gi; nursing; ordinal; point in time; ql; qual; qualitative; random; screen; survey; survey.nursing.hhcc,Ord
2813-4,porphobilinogen synthase [enzymatic activity/volume] in red blood cells,pbg synthase rbc-ccnc,porphobilinogen synthase (rbc) [catalytic activity/vol],ala dehydratase; catalytic concentration; chemistry; erythrocytes; hematology; heme; pbg; pbg synthase; point in time; porph; porphobili; porphoblngn; porpoblngn; qnt; quan; quant; quantitative; random; red blood cells; red blood corpusles,Qn
2814-2,porphyrins [mass/volume] in red blood cells,porphyrins rbc-mcnc,porphyrins (rbc) [mass/vol],chemistry; ep; erythrocyte porphyrin; erythrocytes; hematology; heme; level; mass concentration; point in time; porph; porphyrin; qnt; quan; quant; quantitative; random; red blood cells; red blood corpusles,Qn
28180-8,noncompliance with therapeutic regimen [ccc],,,clinical care classification; finding; findings; noncompliance w therapeutic regimen; nursing; ordinal; point in time; ql; qual; qualitative; random; screen; survey; survey.nursing.hhcc; ther,Ord
28212-9,social isolation [ccc],,,clinical care classification; finding; findings; isol; nursing; ordinal; point in time; ql; qual; qualitative; random; screen; survey; survey.nursing.hhcc,Ord
28215-2,stress urinary incontinence [ccc],,,clinical care classification; finding; findings; gu; nursing; ordinal; point in time; ql; qual; qualitative; random; screen; survey; survey.nursing.hhcc,Ord
28219-4,sanitation status family [omaha],,,finding; findings; nursing; ordinal; point in time; ql; qual; qualitative; random; sanitation status; screen; survey; survey.nursing.omaha,Ord
28226-9,swallowing impairment [ccc],,,clinical care classification; deglutition; finding; findings; gi; nursing; ordinal; point in time; ql; qual; qualitative; random; screen; survey; survey.nursing.hhcc,Ord
28259-0,cognition status [omaha],,,cognition status; finding; findings; nursing; ordinal; point in time; ql; qual; qualitative; random; screen; survey; survey.nursing.omaha,Ord
28268-1,dentition.status [omaha],,,finding; findings; mouth+throat; mouth+throat+teeth; nursing; oral; ordinal; point in time; ql; qual; qualitative; random; screen; survey; survey.nursing.omaha,Ord
28281-4,grief behavior [omaha],,,finding; findings; grief behavior; nursing; ordinal; point in time; ql; qual; qualitative; random; screen; survey; survey.nursing.omaha,Ord
2828-2,potassium [moles/volume] in urine,potassium ur-scnc,potassium (u) [moles/vol],chemistry; k; k+; level; point in time; potass; qnt; quan; quant; quantitative; random; substance concentration; ua; universallaborders; ur; urn,Qn
28307-7,neglect status [omaha],,,finding; findings; neglect status; neglected child/adult; nursing; ordinal; point in time; ql; qual; qualitative; random; screen; survey; survey.nursing.omaha,Ord
2830-8,potassium renal clearance in 24 hour urine and serum or plasma,potassium cl 24h ur+serpl-vrate,potassium renal clearance (24h u+s/p) [vol/time],1 day; 24 hours; 24hr; chemistry; cl; clear; clearanc; clearances; clr; flow; k; k+; kidney; pl; plasma; plsm; potass; qnt; quan; quant; quantitative; serp; serpl; serplas; serum; serum or plasma; sr; ua; ur; ur+serpl; urn; volume rate; vrate,Qn
28314-3,nutrition behavior [omaha],,,finding; findings; nursing; nutrition behavior; ordinal; point in time; ql; qual; qualitative; random; screen; survey; survey.nursing.omaha,Ord
28338-2,sanitation behavior [omaha],,,finding; findings; nursing; ordinal; point in time; ql; qual; qualitative; random; sanitation behavior; screen; survey; survey.nursing.omaha,Ord
28352-3,spirituality status [omaha],,,finding; findings; nursing; ordinal; point in time; ql; qual; qualitative; random; screen; spirituality status; survey; survey.nursing.omaha,Ord
28359-8,vision behavior [omaha],,,finding; findings; nursing; ordinal; point in time; ql; qual; qualitative; random; screen; survey; survey.nursing.omaha; vision behavior,Ord
28360-6,vision knowledge [omaha],,,finding; findings; nursing; ordinal; point in time; ql; qual; qualitative; random; screen; survey; survey.nursing.omaha; vision knowledge,Ord
28364-8,afraid of pain and suffering [living with hiv],,,finding; findings; nursing; ordinal; point in time; ql; qual; qualitative; random; screen; survey; survey.nursing.liv-hiv,Ord
2836-5,pregnanetriol [mass/time] in 24 hour urine,pregntrl 24h ur-mrate,pregnanetriol (24h u) [mass/time],1 day; 24 hours; 24hr; chemistry; mass rate; mrate; pregnanetr; pregntrl; qnt; quan; quant; quantitative; ua; ur; urn,Qn
28373-9,frightened over little control [living with hiv],,,finding; findings; nursing; ordinal; point in time; ql; qual; qualitative; random; screen; survey; survey.nursing.liv-hiv,Ord
28377-0,day sweats [hiv-ssc],,,1 day; 24 hours; 24hr; finding; findings; imm; imun; imune; nursing; ordinal; ql; qual; qualitative; screen; sign and symptom check-list for persons with hiv disease; survey; survey.nursing.hiv-ssc,Ord
28378-8,depression [hiv-ssc],,,1 day; 24 hours; 24hr; finding; findings; nursing; ordinal; ql; qual; qualitative; screen; sign and symptom check-list for persons with hiv disease; survey; survey.nursing.hiv-ssc,Ord
28388-7,loose stools [hiv-ssc],,,1 day; 24 hours; 24hr; finding; findings; gi; nursing; ordinal; ql; qual; qualitative; screen; sign and symptom check-list for persons with hiv disease; survey; survey.nursing.hiv-ssc,Ord
28416-6,communication with community resources knowledge family [omaha],,,communication with community resources knowledge; finding; findings; nursing; ordinal; point in time; ql; qual; qualitative; random; screen; survey; survey.nursing.omaha,Ord
28427-3,spirituality behavior family [omaha],,,finding; findings; nursing; ordinal; point in time; ql; qual; qualitative; random; screen; spirituality behavior; survey; survey.nursing.omaha,Ord
2845-6,proline [mass/volume] in serum or plasma,proline serpl-mcnc,proline [mass/vol],chemistry; level; mass concentration; pl; plasma; plsm; point in time; pro; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
28456-2,speech and language behavior family [omaha],,,finding; findings; nursing; ordinal; point in time; ql; qual; qualitative; random; screen; speech and language behavior; survey; survey.nursing.omaha,Ord
28461-2,dentition.status family [omaha],,,finding; findings; nursing; ordinal; point in time; ql; qual; qualitative; random; screen; survey; survey.nursing.omaha,Ord
28466-1,pain knowledge family [omaha],,,finding; findings; nursing; ordinal; pain knowledge; point in time; ql; qual; qualitative; random; screen; survey; survey.nursing.omaha,Ord
28469-5,consciousness knowledge family [omaha],,,consciousness knowledge; finding; findings; nursing; ordinal; point in time; ql; qual; qualitative; random; screen; survey; survey.nursing.omaha,Ord
28475-2,neuro-musculo-skeletal function knowledge family [omaha],,,fcn; finding; findings; func; funct; neuro-musculo-skeletal function knowledge; nursing; ordinal; point in time; ql; qual; qualitative; random; screen; survey; survey.nursing.omaha,Ord
28478-6,respiration knowledge family [omaha],,,finding; findings; nursing; ordinal; point in time; ql; qual; qualitative; random; respiration knowledge; screen; survey; survey.nursing.omaha,Ord
28492-7,antepartum/postpartum.behavior family [omaha],,,finding; findings; nursing; ordinal; point in time; postpart; postpartm; ql; qual; qualitative; random; screen; survey; survey.nursing.omaha,Ord
28493-5,antepartum/postpartum.status family [omaha],,,antepartum/postpartum.status; finding; findings; nursing; ordinal; point in time; postpart; postpartm; ql; qual; qualitative; random; screen; survey; survey.nursing.omaha,Ord
28543-7,basophils/leukocytes in body fluid,basophils nfr fld,basophils/leukocytes (body fld),"b/f; baso; basophil; basos; bf; bod; bodies; body fluid; body fluid, unsp; bph; fl; fld; flu; fluid; hematology/cell counts; leuc; leuk; leukocyte; lkcs; number fraction; percent; point in time; qnt; quan; quant; quantitative; random; wbc; wbcs; white blood cell; white blood cells",Qn
28544-5,mesothelial cells/leukocytes in body fluid,mesothl cell nfr fld,mesothelial cells/leukocytes (body fld),"b/f; bf; bod; bodies; body fluid; body fluid, unsp; cell; cellularity; fl; fld; flu; fluid; hematology/cell counts; leuc; leuk; leukocyte; lkcs; mesothl; mesothl cell; number fraction; percent; point in time; qnt; quan; quant; quantitative; random; wbc; wbcs; white blood cell; white blood cells",Qn
28545-2,mucus [#/area] in urine sediment by microscopy low power field,mucous threads #/area urns lpf,mucus lm.lpf (urine sed) [#/area],#/area; kidney; lm; micro; micros; microscopic; mucous; mucous threads; nephrology; number areic; point in time; qnt; quan; quant; quantitative; random; renal; ua; ur; urinalysis; urine sediment; urn; urns,Qn
28551-0,bladder tumor ag [units/volume] in urine by immunoassay,bladder tumor ag ur ia-acnc,bladder tumor ag ia qn (u),antigen; antigens; arbitrary concentration; bt; bta; eia; elfa; elisa; enzyme immunoassay; iaa; meia; point in time; qnt; quan; quant; quantitative; random; serology; suds; tumor marker; ua; ur; urn,Qn
28553-6,deprecated streptococcus pneumoniae 6+26 ab [mass/volume] in serum --1st specimen,deprecated s pneum6+26 ab sp1 ser-mcnc,s. pneumoniae 6+26 ab spec 1 (s) [mass/vol],abs; aby; acute specimen; antby; anti; antibodies; antibody; autoantibodies; autoantibody; first; id; infectious disease; infectiousdisease; level; mass concentration; microbiology; pneu; pneum; pneumo; pneumococ; pneumococcal; pneumococcal pneumonia; pneumococcus; pneumon; pneumonia; point in time; pre immunization; qnt; quan; quant; quantitative; random; s pneum6; s pneum6+26; s pneumo; s pneumoniae; serum; sp1; spec; spn; sr; strep; strept; streptococcus pneumoniae 6a; streptococcus pneumoniae 6a+6b,Qn
28559-3,hemoglobin a2 [presence] in blood,hgb a2 bld ql,hemoglobin a2 ql (bld),blood; haemoglobin; hb; hematology/cell counts; hgb; hgb a2; ordinal; point in time; pr; ql; qual; qualitative; random; screen; wb; whole blood,Ord
28560-1,neuronal thread protein [mass/volume] in cerebral spinal fluid,neuronal thread prot csf-mcnc,neuronal thread protein (csf) [mass/vol],ad7c; alzheimer disease; cerebral spinal fluid; cerebrospinal fl; level; mass concentration; neuro; neurology; ntp; point in time; pr; prot; qnt; quan; quant; quantitative; random; serology; spinal fl; spinal fld; spinal flu; spinal fluid,Qn
28564-3,xr skull views,xr skull views,,brain; cranial; cranium; document; films; finding; findings; head; imaging; intracranial; plain films; point in time; rad; radiology; random; skull; view; vws; xray; x-ray,Doc
28566-8,deprecated ct spine,deprecated ct spine,,cat scan; computed tomography; computerized tomography; ct scan; document; finding; findings; imaging; misc; miscellaneous; other; point in time; rad; radiology; random; spec; spinal; spinal cord; to be specified in another part of the message; unspecified,Doc
28575-9,nurse practitioner progress note,nurse pract prog note,,doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; notes; nursing; point in time; prog note; random; subsequent evaluation; subsequent visit evaluation; visit note,Doc
28592-4,beta aminoadipate/creatinine [ratio] in urine,baa/creat ur-rto,beta aminoadipate/creatinine (u) [ratio],aminoadipic acid; b; baa; chemistry; cr; crea; creat; point in time; qnt; quan; quant; quantitative; random; ratios; rto; ua; ucr; ur; urn,Qn
28600-5,phosphoserine/creatinine [ratio] in urine,phosphoserine/creat ur-rto,phosphoserine/creatinine (u) [ratio],chemistry; cr; crea; creat; point in time; ps; qnt; quan; quant; quantitative; random; ratios; rto; ua; ucr; ur; urn,Qn
28604-7,phosphoethanolamine/creatinine [ratio] in urine,petn/creat ur-rto,phosphoethanolamine/creatinine (u) [ratio],chemistry; cr; crea; creat; pea; petn; point in time; qnt; quan; quant; quantitative; random; ratios; rto; ua; ucr; ur; urn,Qn
28608-8,tryptophan/creatinine [ratio] in urine,tryptophan/creat ur-rto,tryptophan/creatinine (u) [ratio],c244; chemistry; cr; crea; creat; l-tryptophan; point in time; qnt; quan; quant; quantitative; random; ratios; rto; trp; ua; ucr; ur; urn,Qn
28609-6,alpha aminobutyrate/creatinine [ratio] in 24 hour urine,a-aminobutyr/creat 24h ur-rto,alpha aminobutyrate/creatinine (24h u) [ratio],1 day; 24 hours; 24hr; 2-aminobutanoic acid; 2-aminobutyrate; 2-aminobutyric acid; a-aminobutyr; aanb; a-anb; alfa; alpha aminobutyric acid; alpha amino-n-butyrate; alpha amino-n-butyric acid; aminobutric; aminobutyric; amino-n-butyrate; chemistry; cr; crea; creat; qnt; quan; quant; quantitative; ratios; rto; ua; ucr; ur; urn,Qn
28632-8,heterophoria study,heterophoria study,,doc.misc; document; finding; findings; misc; point in time; random; study report,Doc
28640-1,bicarbonate [moles/volume] in arterial cord blood,hco3 bldcoa-scnc,hco3 (bldcoa) [moles/vol],bic; bicar; bicarb; bld cord; chemistry; cord arterial blood; cord blda; gyn; gynecology; hco3; level; ob; obgyn; obstetrics; point in time; qnt; quan; quant; quantitative; random; substance concentration,Qn
28651-8,nurse transfer note,nurse transfer sum note,,doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; notes; nursing; point in time; random; transfer sum note; visit note,Doc
28657-5,coagulation factor x activated actual/normal in platelet poor plasma by chromogenic method,fact xa act/nor ppp chro,coagulation factor x activated actual/normal chromogenic method (ppp) [rel catalytic activity/vol],act/nor; activ; autoprothrombin iii; chromogenic assay; coag; control; enzy; enzymatic assay; fac; fact; fact x; fact xa; factor 10; fx; fxa; hematology; heme; plas; platelet poor plasma; point in time; prothrombokinase; qnt; quan; quant; quantitative; random; rlccnc; stuart-prower factor,Qn
28673-2,eye tonometry comment [interpretation],eye tonometry comment [imp] tono,,cmmt; cmnt; com; comm; comments; commt; eye; eye.tonometry; eyeball; glaucoma testing; impression; impression/interpretation of study; impressions; interp; interpretation; narrative; occular; oculis; ophthalmologic; ophthalmology; ophtho; ophthy; optic globe; point in time; random; remarks; report; vision; visual,Nar
28696-3,eye pupillary distance.binocular autorefractor.auto,eye pd binoc ar.auto,,ar.auto; eye; eye.refraction; eyeball; length; occular; oculis; ophthalmologic; ophthalmology; ophtho; ophthy; optic globe; pd binoc; point in time; qnt; quan; quant; quantitative; random; vision; visual,Qn
28699-7,right eye cylinder autorefractor.sciascopy,r eye cylinder sciascopy,,cyl; eye; eye.refraction; eyeball; inverse length; occular; oculis; ophthalmologic; ophthalmology; ophtho; ophthy; optic globe; point in time; qnt; quan; quant; quantitative; r; r eye; random; rt; vision; visual,Qn
28710-2,left eye visual acuity far by phoropter,l eye far va by phoropter,,by phoropter; distance; eye; eye.refraction; eyeball; far va; l; l eye; length ratio; lt; occular; oculis; ophthalmologic; ophthalmology; ophtho; ophthy; optic globe; point in time; qnt; quan; quant; quantitative; random; refraction; va; vision; visual,Qn
28717-7,right eye axis near 2 by phoropter,r eye axis near 2 by phoropter,,by phoropter; eye; eye.refraction; eyeball; ii; occular; oculis; ophthalmologic; ophthalmology; ophtho; ophthy; optic globe; point in time; qnt; quan; quant; quantitative; r; r eye; random; rt; vision; visual,Qn
2872-0,beta globulin [mass/volume] in synovial fluid by electrophoresis,b-globulin snv elph-mcnc,beta globulin elph (syn fld) [mass/vol],b; b-globulin; chemistry; elec; elect; electr; electro; electrophhrs; electrophrs; elp; elph; ep; glb; glob; glob%; globul; globulins; joint aspirate; joint fld; joint flu; joint fluid; level; mass concentration; point in time; protein beta globulin; qnt; quan; quant; quantitative; random; sf; snv; syn; syn fl; synov; synovial fluid,Qn
287-3,isoniazid [susceptibility] by minimum inhibitory concentration (mic),isoniazid islt mic,isoniazid mic [susc],antibiotic susceptibilities; ast; hyzyd; id; infectious disease; infectiousdisease; inh; islt; isol; isoniaz; isoniazide; minimum inhibitory concentration; nudrazod; point in time; random; sus; suscept; susceptibilities; susceptibility; susceptibilty,OrdQn
28748-2,right eye accommodation width absolute hand optometer,r eye acc width abs hand optometer,,acc width abs; eye; eye.refraction; eyeball; inverse length; occular; oculis; ophthalmologic; ophthalmology; ophtho; ophthy; optic globe; point in time; qnt; quan; quant; quantitative; r; r eye; random; rt; upper extremity; vision; visual,Qn
28755-7,left eye accommodation width absolute minus glass,l eye acc width abs minus glass,,acc width abs; eye; eye.refraction; eyeball; inverse length; l; l eye; lt; occular; oculis; ophthalmologic; ophthalmology; ophtho; ophthy; optic globe; point in time; qnt; quan; quant; quantitative; random; vision; visual,Qn
28764-9,deprecated worth test for heterophoria,deprecated worth test,,eye; eye.heterophoria; identity or presence; nominal; ophthalmologic; ophthalmology; ophtho; ophthy; point in time; random; vision; visual; wd4; worth dot test; worth's four dot test,Nom
28770-6,maddox double prism test for heterophoria,maddox double prism test,,double maddox rod test; eye; eye.heterophoria; identity or presence; nominal; ophthalmologic; ophthalmology; ophtho; ophthy; point in time; random; vision; visual,Nom
28777-1,right corrective lens type narrative by lensmeter,r corr lens type by lm,,by lm; corr lens; eye; eye.glasses; focimeter; lensometer; lm; narrative; ophthalmology; ophtho; ophthy; point in time; r; r corr lens; random; report; rt; typ,Nar
28784-7,right corrective lens sbm visual acuity far by lensmeter,r corr lens sbm va far by lm,,by lm; corr lens; distance; eye; eye.glasses; far va; focimeter; length ratio; lensometer; lm; ophthalmology; ophtho; ophthy; point in time; qnt; quan; quant; quantitative; r; r corr lens; random; refraction; rt; sbm va far; va,Qn
28785-4,left corrective lens sbm sphere far by lensmeter,l corr lens sbm sphere far by lm,,by lm; corr lens; distance; eye; eye.glasses; focimeter; inverse length; l; l corr lens; lensometer; lm; lt; ophthalmology; ophtho; ophthy; point in time; qnt; quan; quant; quantitative; random,Qn
28789-6,left glasses lens pupillary distance.monocular by lensmeter,l glasses pd monoc by lm,,by lm; eye; eye.glasses; focimeter; l; l glasses; length; lensometer; lm; lt; ophthalmology; ophtho; ophthy; pd; pd monoc; point in time; qnt; quan; quant; quantitative; random,Qn
28791-2,left corrective lens visual acuity far by lensmeter,l corr lens far va by lm,,by lm; corr lens; distance; eye; eye.glasses; far va; focimeter; l; l corr lens; length ratio; lensometer; lm; lt; ophthalmology; ophtho; ophthy; point in time; qnt; quan; quant; quantitative; random; refraction; va,Qn
2879-5,protein [presence] in cerebral spinal fluid,prot csf ql,protein ql (csf),cerebral spinal fluid; cerebrospinal fl; chemistry; neuro; neurology; ordinal; point in time; pr; prot; ql; qual; qualitative; random; screen; spinal fl; spinal fld; spinal flu; spinal fluid,Ord
28802-7,left corrective lens sphere near 1 by lensmeter,l corr lens sphere n 1 by lm,,by lm; corr lens; eye; eye.glasses; focimeter; i; inverse length; l; l corr lens; lensometer; lm; lt; ophthalmology; ophtho; ophthy; point in time; qnt; quan; quant; quantitative; random; sphere n 1,Qn
28814-2,corrective lens add 1 binocular by lensmeter,corr lens add 1 binoc by lm,,add 1 binoc; by lm; corr lens; eye; eye.glasses; focimeter; i; inverse length; lensometer; lm; ophthalmology; ophtho; ophthy; point in time; qnt; quan; quant; quantitative; random,Qn
28816-7,right corrective lens comment [interpretation] by lensmeter,r corr lens comment [imp] by lm,,by lm; cmmt; cmnt; com; comm; comments; commt; corr lens; eye; eye.glasses; focimeter; impression; impression/interpretation of study; impressions; interp; interpretation; lensometer; lm; nominal; ophthalmology; ophtho; ophthy; point in time; r; r corr lens; random; remarks; rt,Nom
28839-9,right glasses lens prescription visual acuity near,r glasses rx near va,,eye; eye.glasses; glasses rx; length ratio; near va; ophthalmology; ophtho; ophthy; point in time; qnt; quan; quant; quantitative; r; r glasses rx; random; refraction; rt; rx; va,Qn
28840-7,right glasses lens prescription pupillary distance.monocular,r glasses rx pd monoc,,eye; eye.glasses; glasses rx; length; ophthalmology; ophtho; ophthy; pd; pd monoc; point in time; qnt; quan; quant; quantitative; r; r glasses rx; random; rt; rx,Qn
28850-6,left glasses lens prescription cylinder near,l glasses rx cylinder near,,cyl; eye; eye.glasses; glasses rx; inverse length; l; l glasses rx; lt; ophthalmology; ophtho; ophthy; point in time; qnt; quan; quant; quantitative; random; rx,Qn
28852-2,left glasses lens prescription sphere near 2,l glasses rx sphere n 2,,eye; eye.glasses; glasses rx; ii; inverse length; l; l glasses rx; lt; ophthalmology; ophtho; ophthy; point in time; qnt; quan; quant; quantitative; random; rx; sphere n 2,Qn
28855-5,left glasses lens prescription hsa n,l glasses rx hsa n,,cornea/bridge distance; eye; eye.glasses; glasses rx; l; l glasses rx; length; lt; ophthalmology; ophtho; ophthy; point in time; qnt; quan; quant; quantitative; random; rx,Qn
28857-1,left glasses lens prescription pupillary distance.monocular,l glasses rx pd monoc,,eye; eye.glasses; glasses rx; l; l glasses rx; length; lt; ophthalmology; ophtho; ophthy; pd; pd monoc; point in time; qnt; quan; quant; quantitative; random; rx,Qn
2886-0,protein [mass/volume] in synovial fluid,prot snv-mcnc,protein (syn fld) [mass/vol],chemistry; joint aspirate; joint fld; joint flu; joint fluid; level; mass concentration; point in time; pr; prot; qnt; quan; quant; quantitative; random; sf; snv; syn; syn fl; synov; synovial fluid,Qn
28870-4,right contact lens material,r cont lens material,,cont lens; eye; eye.contact_lens; identity or presence; nominal; ophthalmology; ophtho; ophthy; point in time; r; r cont lens; random; rt,Nom
28880-3,right contact lens axis,r cont lens axis,,cont lens; eye; eye.contact_lens; ophthalmology; ophtho; ophthy; point in time; qnt; quan; quant; quantitative; r; r cont lens; random; rt,Qn
28900-9,left contact lens base curve 2,l cont lens base curve 2,,bc; cont lens; eye; eye.contact_lens; ii; l; l cont lens; length; lt; ophthalmology; ophtho; ophthy; point in time; qnt; quan; quant; quantitative; random,Qn
2890-2,protein/creatinine [mass ratio] in urine,prot/creat ur,protein/creatinine (u) [mass ratio],chemistry; cr; crea; creat; mass concentration ratio; mass ratio; mcrto; point in time; pr; prot; qnt; quan; quant; quantitative; random; ua; ucr; universallaborders; ur; urn,Qn
28922-3,right contact lens prescription producer code,r cont lens rx producer code,,cont lens; eye; eye.contact_lens; nominal; ophthalmology; ophtho; ophthy; point in time; r; r cont lens rx; random; rt; rx; typ,Nom
28980-1,right cornea sagittal radius.inferior by keratometry,r cornea sag rad.inf by km,,by km; corneal; eye; eye.refraction; inf; length; ophthalmology; ophthalmometer; ophtho; ophthy; point in time; qnt; quan; quant; quantitative; r; r cornea; random; rt; sag rad.inf; upper extremity,Qn
28984-3,left cornea base curve 1 by keratometry,l cornea base curve 1 by km,,bc; by km; corneal; eye; eye.refraction; i; l; l cornea; length; lt; ophthalmology; ophthalmometer; ophtho; ophthy; point in time; qnt; quan; quant; quantitative; random,Qn
29007-2,right eye tear secretion break up [time] schirmer test,r eye ts break up [time] schirmer,,eye; eye.px; eyeball; occular; oculis; ophthalmologic; ophthalmology; ophtho; ophthy; optic globe; point in time; qnt; quan; quant; quantitative; r; r eye; random; rt; ts break up; vision; visual,Qn
29013-0,right eye argon laser coagulation treatment spot size,r eye argon lc spot size,,argon lc; argon lc spot size; coag; eye; eye.retinal_rx; eyeball; lc; length; occular; oculis; ophthalmologic; ophthalmology; ophtho; ophthy; optic globe; point in time; qnt; quan; quant; quantitative; r; r eye; random; rt; treatment; vision; visual,Qn
29014-8,right eye argon laser coagulation treatment localization,r eye argon lc localization,,argon lc; argon lc localization; coag; eye; eye.retinal_rx; eyeball; identity or presence; lc; local; nominal; occular; oculis; ophthalmologic; ophthalmology; ophtho; ophthy; optic globe; point in time; r; r eye; random; rt; treatment; vision; visual,Nom
2902-5,pyrimidine-5'-nucleotidase [presence] in blood,p5nt bld ql,pyrimidine-5'-nucleotidase ql (bld),5nt; blood; chemistry; nt; ordinal; p5n; p5nt; p-5'-nt; point in time; pr; pyrimidine nucleotide n-ribosidase; pyrimidine-5'-nucleotide nucleosidase; ql; qual; qualitative; random; screen; wb; whole blood,Ord
29032-0,right eye yag intensity,r eye yag intensity,,energy; eye; eye.retinal_rx; eyeball; occular; oculis; ophthalmologic; ophthalmology; ophtho; ophthy; optic globe; point in time; qnt; quan; quant; quantitative; r; r eye; random; rt; treatment; vision; visual; yag intensity,Qn
29034-6,right eye yag comment [interpretation],r eye yag comment [imp],,cmmt; cmnt; com; comm; comments; commt; eye; eye.retinal_rx; eyeball; impression; impression/interpretation of study; impressions; interp; interpretation; narrative; occular; oculis; ophthalmologic; ophthalmology; ophtho; ophthy; optic globe; point in time; r; r eye; random; remarks; report; rt; treatment; vision; visual; yag comment,Nar
29050-2,perimeter format dicon,perimeter format dicon,,circum; circumference; eye; eye.visual_field; identity or presence; nominal; ophthalmology; ophtho; ophthy; point in time; random,Nom
29056-9,pressure device type perimetry,pressure device type perimetry,,eye; eye.visual_field; nominal; ophthalmology; ophtho; ophthy; point in time; random; typ,Nom
29071-8,left eye pressure skotome code perimetry,l eye pressure skotome code perimetry,,eye; eye.visual_field; eyeball; l; l eye; lt; nominal; occular; oculis; ophthalmologic; ophthalmology; ophtho; ophthy; optic globe; point in time; random; typ; vision; visual,Nom
29072-6,left eye pressure skotome text perimetry,l eye pressure skotome text perimetry,,eye; eye.visual_field; eyeball; identity or presence; l; l eye; lt; narrative; occular; oculis; ophthalmologic; ophthalmology; ophtho; ophthy; optic globe; point in time; random; report; vision; visual,Nar
29078-3,cover test for heterophoria,cover test,,eye; eye.heterophoria; identity or presence; nominal; ophthalmologic; ophthalmology; ophtho; ophthy; point in time; random; vision; visual,Nom
2909-0,pyruvate carboxylase [enzymatic activity/mass] in tissue,pyruvate carboxylase tiss-ccnt,pyruvate carboxylase (tiss) [catalytic activity/mass],"catalytic content; chemistry; pcd; point in time; pyruvic acid; qnt; quan; quant; quantitative; random; tissue; tissue, unspecified",Qn
29095-7,physical findings of right anterior chamber narrative,r ant chamber phys find,,ant chamber; exam; examination; eye; eye.px; finding; findings; narrative; ophthalmology; ophtho; ophthy; phys find; point in time; r; r ant chamber; random; report; rt,Nar
29096-5,physical findings of left anterior chamber narrative,l ant chamber phys find,,ant chamber; exam; examination; eye; eye.px; finding; findings; l; l ant chamber; lt; narrative; ophthalmology; ophtho; ophthy; phys find; point in time; random; report,Nar
29132-8,eye accommodation width measured 3,eye acc width meas 3,,acc width meas; acc width meas 3; eye; eye.refraction; eyeball; iii; length; occular; oculis; ophthalmologic; ophthalmology; ophtho; ophthy; optic globe; point in time; qnt; quan; quant; quantitative; random; vision; visual,Qn
29146-8,alpha 1 antitrypsin [mass/volume] in body fluid,a1at fld-mcnc,alpha 1 antitrypsin (body fld) [mass/vol],"a1; a1a; a1at; a-1-at; a1-at; aat; alfa; alpha-1-antitrypsin.total; alpha-1-protease inhibitor; alpha-1-proteinase inhibitor; alpha-1-trypsin inhibitor; b/f; bf; bod; bodies; body fluid; body fluid, unsp; chemistry; fl; fld; flu; fluid; hepatology; i; level; liver; lung; mass concentration; point in time; pulmonary; pulmonology; qnt; quan; quant; quantitative; random; respiratory",Qn
29160-9,benzodiazepines [mass/mass] in meconium,benzodiaz mec-mcnt,benzodiazepines (mec) [mass/mass],benz; benzodiaz; benzodiazepine; drug/toxicology; drugs; mass content; mec; point in time; qnt; quan; quant; quantitative; random,Qn
29163-3,"deprecated speech therapy treatment plan, date onset or exacerbation of primary diagnosis",deprecated,,attach; attach.rehab; attach.rehab.speech; diagnosis; point in time; primary dx for speech therapy tx plan; qnt; quan; quant; quantitative; random; speech therapy tx; speech therapy tx plan; tx; tx plan,Qn
2917-3,renin [mass/volume] in plasma --supine,renin sup plas-mcnc,renin supine (p) [mass/vol],angiotensin forming enzyme; angiotensinogenase; cardio; cardiology; chemistry.challenge testing; direct renin; drc; endocrine; endocrinology; heart disease; kidney; level; lying; mass concentration; nephrology; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; renal,Qn
29182-3,"deprecated speech therapy treatment plan, initial assessment (narrative)",deprecated,,attach; attach.rehab; attach.rehab.speech; finding; findings; narrative; point in time; random; report; speech therapy tx; speech therapy tx plan; tx; tx plan,Nar
29192-2,"deprecated speech therapy treatment plan, diagnosis addressed by plan identifier",deprecated,,attach; attach.rehab; attach.rehab.speech; dx; dx.addressed by plan; ident; identifier; nominal; point in time; random; speech therapy tx; tx,Nom
29200-3,"deprecated speech therapy treatment plan, signature date date and time",deprecated,,attach; attach.rehab; attach.rehab.speech; date and time; point in time; qnt; quan; quant; quantitative; random; speech therapy tx; speech therapy tx plan; time stamp; timestamp; tx; tx plan,Qn
29226-8,quinidine [mass/volume] in body fluid,quinidine fld-mcnc,quinidine (body fld) [mass/vol],"b/f; bf; bod; bodies; body fluid; body fluid, unsp; chinidine; drug/toxicology; drugs; fl; fld; flu; fluid; level; mass concentration; point in time; qnt; quan; quant; quantitative; random",Qn
2923-1,retinol [mass/volume] in serum or plasma,vit a serpl-mcnc,retinol [mass/vol],axerol; axerophthol; biosterol; chemistry; level; mass concentration; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; universallaborders; vit a; vit a alcohol; vit a1; vit a1 alcohol; vitamin a; vitamin a alcohol; vitamin a1,Qn
29236-7,herpes simplex virus 2 ab [units/volume] in body fluid,hsv2 ab fld-acnc,hsv 2 ab qn (body fld),"abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; b/f; bf; bod; bodies; body fluid; body fluid, unsp; fl; fld; flu; fluid; herp splx; herpes simplex virus type 2; herpes simplex virus type ii; hsv; hsv2; id; ii; infectious disease; infectiousdisease; microbiology; point in time; qnt; quan; quant; quantitative; random",Qn
29240-9,hyaluronate [mass/volume] in body fluid,hyaluronate fld-mcnc,hyaluronate (body fld) [mass/vol],"b/f; bf; bod; bodies; body fluid; body fluid, unsp; drug/toxicology; drugs; fl; fld; flu; fluid; ha; hyaluronan; hyaluronic acid; level; mass concentration; point in time; qnt; quan; quant; quantitative; random",Qn
29274-8,vital signs measurements,,,attach; attach.clinrpt; finding; findings; point in time; random,Multi
29280-5,fibrin d-dimer [presence] in platelet poor plasma by latex agglutination,d dimer ppp ql la,fibrin d-dimer la ql (ppp),coagulation; d dimer; dextro; fragment d-dimer; hematology; heme; lat; latex agglutination; ordinal; plas; platelet poor plasma; point in time; pr; ql; qual; qualitative; random; screen; universallaborders,Ord
29282-1,glutethimide [presence] in gastric fluid,glutethimide gast ql,glutethimide ql (gast fld),addiction; doriden; drug/toxicology; drugs; drugs of abuse; gast; gastric contents; gastric fluid; glutethimde; illicit; ordinal; point in time; potentialforabuse; pr; ql; qual; qualitative; random; screen,Ord
29297-9,deprecated color of unspecified specimen,deprecatedcolor,,appearance; colour; h+p; h+p.px; misc; miscellaneous; nominal; other; p prime; point in time; random; spec; to be specified in another part of the message; typ; unspecified,Nom
29314-2,adenovirus ab [titer] in body fluid by complement fixation,hadv ab titr fld cf,adenovirus ab cf (body fld) [titer],"abs; aby; adeno virus; antby; anti; antibodies; antibody; autoantibodies; autoantibody; b/f; bf; bod; bodies; body fluid; body fluid, unsp; cf; comp fixation; compfix; complement fixation; dilution factor; dilution factor (titer); fl; fld; flu; fluid; hadv; id; infectious disease; infectiousdisease; microbiology; point in time; random; smqn; titer; titered; titre; ttr",SemiQn
2932-2,sarcosine [mass/volume] in urine,sarcosine ur-mcnc,sarcosine (u) [mass/vol],chemistry; level; mass concentration; point in time; qnt; quan; quant; quantitative; random; sar; sarc; ua; ur; urn,Qn
29353-0,17-ketosteroids.total neutral [mass/time] in 12 hour urine,17ks neut 12h ur-mrate,17-ketosteroids.total neutral (12h u) [mass/time],12 hours; 12hr; 17ks; 17-ks; 17ks neut; chemistry; ketosteroid; ketostroids; mass rate; mrate; qnt; quan; quant; quantitative; tot; totl; ua; ur; urn,Qn
29362-1,deprecated streptococcus pneumoniae group b ag,deprecated s pneumb ag ser ql,s. pneumoniae group b ag ql (s),antigen; antigens; arbitrary concentration; id; infectious disease; infectiousdisease; microbiology; ordinal; pneu; pneum; pneumo; pneumococ; pneumococcal; pneumococcal pneumonia; pneumococcus; pneumon; pneumonia; point in time; ql; qual; qualitative; random; s pneumo; s pneumoniae; screen; serum; spn; sr; strep; strept,Ord
2937-1,serine [mass/volume] in urine,serine ur-mcnc,serine (u) [mass/vol],chemistry; level; mass concentration; point in time; qnt; quan; quant; quantitative; random; ser; ua; ur; urn,Qn
29374-6,ribonucleoprotein extractable nuclear ab [units/volume] in serum,ena rnp ab ser-acnc,ribonucleoprotein extractable nuclear ab qn (s),abs; aby; ana; anf; antby; anti; antibodies; antibody; antinuclear antibody; arbitrary concentration; autoantibodies; autoantibody; ena; ena rnp; na; nuc; point in time; qnt; quan; quant; quantitative; random; ribonuclear protein; rnp; ro; serology; serum; sr; universallaborders,Qn
29390-2,parathyrin.mid molecule [moles/volume] in serum or plasma,pth-m serpl-scnc,parathyrin.mid molecule [moles/vol],chemistry; level; parathormone; parathyrin medium molecule; parathyroid hormone; pl; plasma; plsm; point in time; pth; pth-m; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; substance concentration,Qn
29391-0,gastrin [mass/volume] in serum or plasma --2 hours post xxx challenge,gastrin 2h p chal serpl-mcnc,gastrin 2 hr post unsp challenge [mass/vol],120 min; 120 minutes; 120min; 2 hours; 2h p chal; after; chemistry.challenge testing; level; mass concentration; p chal; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; total gastrins; zollinger-ellison syndrome,Qn
29396-9,gastrin [mass/volume] in serum or plasma --1.5 hours post xxx challenge,gastrin 1.5h p chal serpl-mcnc,gastrin 1.5 hr post unsp challenge [mass/vol],1 1/2 hours; 1 1/2 hr; 1.5h p chal; 1.5hr; 90 min; 90 minutes; 90m; 90min; after; chemistry.challenge testing; level; mass concentration; p chal; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; total gastrins; zollinger-ellison syndrome,Qn
29397-7,gastrin [mass/volume] in serum or plasma --30 minutes pre xxx challenge,gastrin 30m pre chal serpl-mcnc,gastrin 30 min pre unsp challenge [mass/vol],30m pre chal; before; chemistry.challenge testing; level; mass concentration; pl; plasma; plsm; point in time; pre chal; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; total gastrins; zollinger-ellison syndrome,Qn
29399-3,clonazepam [mass/volume] in gastric fluid,clonazepam gast-mcnc,clonazepam (gast fld) [mass/vol],drug/toxicology; drugs; gast; gastric contents; gastric fluid; klonopin; level; mass concentration; point in time; qnt; quan; quant; quantitative; random,Qn
29403-3,thiothixene [mass/volume] in urine,thiothixene ur-mcnc,thiothixene (u) [mass/vol],drug/toxicology; drugs; level; mass concentration; navane; point in time; qnt; quan; quant; quantitative; random; ua; ur; urn,Qn
29417-3,parainfluenza virus 1 ab [titer] in body fluid,hpiv1 ab titr fld,parainfluenza virus 1 ab (body fld) [titer],"abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; b/f; bf; bod; bodies; body fluid; body fluid, unsp; dilution factor; dilution factor (titer); fl; fld; flu; fluid; hpiv; hpiv1; human respirovirus 1; i; id; infectious disease; infectiousdisease; microbiology; para; parainflu; parainfluenza type 1; parainfluenza type i; pi1; point in time; random; smqn; titer; titered; titre; ttr",SemiQn
29420-7,pulmonary vein - right lower maximum blood flow velocity during systole by us.doppler,pv-rl vmax sys dop,,bld flow; bld flow vel; bld flow.velocity; card.us; cardio; cardiology; dop; duplex; dynamic; echography; heart disease; largest; low; max v; maximal; maximum; peak; point in time; pulm v; pv-rl; qnt; quan; quant; quantitative; r; random; rlpv; rt; sonogram; sonograph; sonography; sys; sys.max; syst; uls; ultrasound; v max; v sys; vel; vel max; velocity; ven; venous; vmax; vmax sys,Qn
29432-2,interventricular septum thickness during systole by us 2d,ivs thickness sys 2d us,,2d us; card.us; cardiac; cardio; cardiology; echography; heart disease; hrt; is; ivs; ivss; length; point in time; qnt; quan; quant; quantitative; random; sonogram; sonograph; sonography; sys; syst; thick; thickness sys; uls; ultrasound; ultrasound - 2-dimensional,Qn
29447-0,left ventricular posterior wall thickening.fractional change by us.m-mode,lvpw thick.fract chng m-mode,,card.us; cardiac; cardio; cardiology; echography; exchange; heart disease; hrt; hrt ventr; l; length fraction; lt; lv; lv pw; lvpw; lvpwt%; mm; mmode; percent; point in time; qnt; quan; quant; quantitative; random; replace; sonogram; sonograph; sonography; thick.fract chng; uls; ultrasound; ventricular,Qn
29450-4,pulmonary vein maximum blood flow velocity during systole by us.doppler,pulm v vmax sys dop,,bld flow; bld flow vel; bld flow.velocity; card.us; cardio; cardiology; dop; duplex; dynamic; echography; heart disease; largest; max v; maximal; maximum; peak; point in time; pulm v; qnt; quan; quant; quantitative; random; sonogram; sonograph; sonography; sys; sys.max; syst; uls; ultrasound; v max; v sys; vel; vel max; velocity; ven; venous; vmax; vmax sys,Qn
29454-6,pulmonary vein - right upper maximum blood flow velocity during systole by us.doppler,pv-ru vmax sys dop,,bld flow; bld flow vel; bld flow.velocity; card.us; cardio; cardiology; dop; duplex; dynamic; echography; heart disease; largest; max v; maximal; maximum; peak; point in time; pulm v; pv-ru; qnt; quan; quant; quantitative; r; random; rt; rupv; sonogram; sonograph; sonography; sys; sys.max; syst; uls; ultrasound; up; v max; v sys; vel; vel max; velocity; ven; venous; vmax; vmax sys,Qn
29470-2,mitral valve annulus blood velocity-time integral by us.calculated,mv ann vti us calc,,bld vel; calc; calculation; card.us; cardio; cardiology; echography; heart disease; length; mv; mv ann; point in time; qnt; quan; quant; quantitative; random; sonogram; sonograph; sonography; tvi; uls; ultrasound; us calc; us+calc; vel; vti,Qn
29484-3,hepatic vein maximum blood flow velocity during systole/maximum blood flow velocity during diastole by us.doppler derived --inspiration,hep v vmax sys/dias insp dop.der,,bld flow; bld flow vel; bld flow.velocity; card.us; cardio; cardiology; dias; dias.max; diast; diastoli; dop; dop.der; duplex; dynamic; echography; heart disease; hep v; hep vein; hepar; in; insp; inspiratory; largest; liver; liver vein; maximal; maximum; peak; point in time; qnt; quan; quant; quantitative; random; s/d insp; sonogram; sonograph; sonography; sys; sys.max; syst; syst/diast insp; uls; ultrasound; v sys; vel; velocity ratio; ven; venous; vmax dias; vmax sys,Qn
29493-4,colistin [mass/volume] in specimen,colistin spec-mcnc,colistin (specimen) [mass/vol],colmycin; colymycin; drug/toxicology; drugs; level; mass concentration; misc; miscellaneous; other; point in time; qnt; quan; quant; quantitative; random; spec; to be specified in another part of the message; unspecified,Qn
29506-3,2-oxoadipate/creatinine [molar ratio] in urine,2-oxoadipate/creat ur-srto,2-oxoadipate/creatinine (u) [molar ratio],2-oxoadipic acid; alpha ketoadipate; alpha ketoadipic acid; chemistry; cr; crea; creat; ii; oxoadipate; point in time; qnt; quan; quant; quantitative; random; scrto; substance concentration ratio; substance ratio; ua; ucr; ur; urn,Qn
29509-7,beta hydroxybutyrate/creatinine [molar ratio] in urine,b-oh-butyr/creat ur-srto,beta hydroxybutyrate/creatinine (u) [molar ratio],3-hydroxybutyrate; 3-hydroxybutyric acid; b; beta hydroxy butyrate; beta hydroxybutyric acid; betahydroxybutyrate; betahydroxybutyric acid; bhb; bohb; b-oh-butyr; chemistry; cr; crea; creat; hydroxybutyric acid; point in time; qnt; quan; quant; quantitative; random; scrto; substance concentration ratio; substance ratio; ua; ucr; ur; urn,Qn
29515-4,3-hydroxypropionate (3-oh-c3)/creatinine [molar ratio] in urine,3oh-propionate/creat ur-srto,3-hydroxypropionate (3-oh-c3)/creatinine (u) [molar ratio],3-hydroxy-propionate; 3-hydroxypropionic acid; 3oh-propionate; chemistry; cr; crea; creat; iii; point in time; qnt; quan; quant; quantitative; random; scrto; substance concentration ratio; substance ratio; ua; ucr; ur; urn,Qn
2952-0,sodium [molar amount] in 24 hour stool,sodium 24h sub stl qn,sodium (24h stl) [molar amount],1 day; 24 hours; 24hr; bowel movement; chemistry; faecal; faeces; fecal; feces; gastro; gastroenterology; gi; na; na+; qnt; quan; quant; quantitative; stl; stool = fecal; substance amount,Qn
29526-1,azelate/creatinine [molar ratio] in urine,azelate/creat ur-srto,azelate/creatinine (u) [molar ratio],azelaic acid; azelex; cr; crea; creat; drug/toxicology; drugs; nonanedioate; nonanedioic acid; point in time; qnt; quan; quant; quantitative; random; scrto; substance concentration ratio; substance ratio; ua; ucr; ur; urn,Qn
29527-9,citrate/creatinine [molar ratio] in urine,citrate/creat ur-srto,citrate/creatinine (u) [molar ratio],chemistry; citric acid; cr; crea; creat; point in time; qnt; quan; quant; quantitative; random; scrto; substance concentration ratio; substance ratio; ua; ucr; ur; urn,Qn
29530-3,amphetamines [presence] in specimen,amphetamines spec ql,amphetamines ql (specimen),addiction; amph; amphetam; amphetamine; drug/toxicology; drugs; drugs of abuse; illicit; misc; miscellaneous; ordinal; other; point in time; potentialforabuse; pr; ql; qual; qualitative; random; screen; spec; speed; to be specified in another part of the message; unspecified,Ord
29538-6,west nile virus igm ab [units/volume] in cerebral spinal fluid,wnv igm csf-acnc,west nile virus igm qn (csf),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; cerebral spinal fluid; cerebrospinal fl; id; immune globulin m; immunoglobulin m; infectious disease; infectiousdisease; microbiology; neuro; neurology; point in time; qnt; quan; quant; quantitative; random; spinal fl; spinal fld; spinal flu; spinal fluid; wnv,Qn
29545-1,physical findings narrative,phys find,,exam; examination; finding; findings; h+p; h+p.px; narrative; p prime; phys find; point in time; random; report,Nar
29556-8,history of behavior disorders,hx of behavior disorders,,behaviour; h+p; h+p.hx; history; nominal; p prime; point in time; random; sx; symp + dis,Nom
29557-6,history of behavior disorders narrative,hx of behavior disorders,,behaviour; h+p; h+p.hx; history; narrative; p prime; point in time; random; report; sx; symp + dis,Nar
29569-1,west nile virus igm ab [presence] in cerebral spinal fluid by immunoassay,wnv igm csf ql ia,west nile virus igm ia ql (csf),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; cerebral spinal fluid; cerebrospinal fl; eia; elfa; elisa; enzyme immunoassay; iaa; id; immune globulin m; immunoglobulin m; infectious disease; infectiousdisease; meia; microbiology; neuro; neurology; ordinal; point in time; pr; ql; qual; qualitative; random; screen; spinal fl; spinal fld; spinal flu; spinal fluid; suds; wnv,Ord
29571-7,phenylalanine [presence] in dbs,phe dbs ql,phenylalanine ql (dbs),blood; chemistry; dbs; dried blood spot; filter paper; fp; ordinal; phe; pku; point in time; ppa; pr; ql; qual; qualitative; random; screen; universallaborders; wb; whole blood,Ord
29576-6,bacterial susceptibility panel,bacterial susc pnl islt,bacterial susceptibility panel (isol),antibiotic susceptibilities; bact; bacterial susc pnl; islt; isol; pan; panel.antibiotic susceptibilities; panl; pnl; point in time; random; sus; susc; suscept; susceptibilities; susceptibilty,OrdQn
29577-4,fungal susceptibility panel,fungal susc pnl islt,fungal susceptibility panel (isol),antibiotic susceptibilities; fungal susc pnl; islt; isol; mould susceptibility panel; pan; panel.antibiotic susceptibilities; panl; pnl; point in time; random; sus; susc; suscept; susceptibilities; susceptibilty,OrdQn
2957-9,sodium renal clearance in 24 hour urine and serum or plasma,sodium cl 24h ur+serpl-vrate,sodium renal clearance (24h u+s/p) [vol/time],1 day; 24 hours; 24hr; chemistry; cl; clear; clearanc; clearances; clr; flow; kidney; na; na+; pl; plasma; plsm; qnt; quan; quant; quantitative; serp; serpl; serplas; serum; serum or plasma; sr; ua; ur; ur+serpl; urn; volume rate; vrate,Qn
29592-3,amphetamine [mass/volume] in serum or plasma by confirmatory method,amphet serpl cfm-mcnc,amphetamine confirm [mass/vol],addiction; amph; amphet; amphetam; amphetamines; ampht; cfm; cnfr; cnfrm; conf; confirmation; confirmatory; drug/toxicology; drugs; drugs of abuse; gcms; illicit; lc/ms/ms; level; mass concentration; pl; plasma; plsm; point in time; potentialforabuse; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; speed; sr,Qn
2959-5,sodium/potassium [molar ratio] in urine,sodium/potassium ur-srto,sodium/potassium (u) [molar ratio],chemistry; k; k+; na; na+; point in time; potass; qnt; quan; quant; quantitative; random; scrto; substance concentration ratio; substance ratio; ua; ur; urn,Qn
29598-0,methylenedioxyamphetamine [mass/volume] in serum or plasma by confirmatory method,mda serpl cfm-mcnc,methylenedioxyamphetamine confirm [mass/vol],addiction; cfm; cnfr; cnfrm; conf; confirmation; confirmatory; drug/toxicology; drugs; drugs of abuse; gcms; illicit; lc/ms/ms; level; mass concentration; mda; methylenedioxymethamphetamine metabolite; pl; plasma; plsm; point in time; potentialforabuse; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
2960-3,somatostatin [presence] in plasma,somatostat plas ql,somatostatin ql (p),chemistry; ordinal; pl; plasma; plsm; point in time; pr; ql; qual; qualitative; random; screen; ss,Ord
29639-2,alkaline phosphatase [enzymatic activity/mass] in tissue,alp tiss-ccnt,alp (tiss) [catalytic activity/mass],"alk; alk phos; alkaline phos; alkaline phosphatase.total; alkp; alp; ap; catalytic content; chemistry; hepatology; liver; msk; musculoskeletal; ortho; orthopedics; phos; phosphtase; point in time; qnt; quan; quant; quantitative; random; tissue; tissue, unspecified",Qn
29646-7,parainfluenza virus 2 igm ab [presence] in serum by immunoassay,hpiv2 igm ser ql ia,parainfluenza virus 2 igm ia ql (s),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; eia; elfa; elisa; enzyme immunoassay; hpiv; hpiv2; human rubulavirus 2; iaa; id; ii; immune globulin m; immunoglobulin m; infectious disease; infectiousdisease; meia; microbiology; ordinal; para; parainflu; parainfluenza type 2; parainfluenza type ii; pi2; point in time; pr; ql; qual; qualitative; random; screen; serum; sr; suds,Ord
29651-7,rickettsia honei ab [presence] in serum by immunofluorescence,r honei ab ser ql if,r. honei ab if ql (s),abs; aby; acif; antby; anti; antibodies; antibody; anticomplement immunofluorescence; autoantibodies; autoantibody; fa; fisf; flinders island spotted fever; fluorescent antibody; fluoresent; id; ifa; immune fluorescence; immunoflour; immunofluor; immunofluorescence; infectious disease; infectiousdisease; microbiology; ordinal; point in time; pr; ql; qual; qualitative; r honei; random; ricket; rickettsial; screen; serum; spotted fever; sr; time resolved fluorescence; trf,Ord
29657-4,bordetella pertussis iga ab [presence] in serum by immunoassay,b pert iga ser ql ia,b. pertussis iga ia ql (s),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; b pert; b pertussis; eia; elfa; elisa; enzyme immunoassay; iaa; id; immune globulin a; immunoglobulin a; infectious disease; infectiousdisease; meia; microbiology; ordinal; pertussis; point in time; pr; ql; qual; qualitative; random; screen; serum; sr; suds; whooping cough,Ord
29663-2,dengue virus igm ab [presence] in serum or plasma by immunoassay,denv igm serpl ql ia,denv igm ia ql,abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; breakbone fever; denv; eia; elfa; elisa; enzyme immunoassay; flavivirus; iaa; id; immune globulin m; immunoglobulin m; infectious disease; infectiousdisease; meia; microbiology; ordinal; pl; plasma; plsm; point in time; pr; ql; qual; qualitative; random; screen; serp; serpl; serplas; serum; serum or plasma; sr; suds,Ord
29680-6,rickettsia akari ab [titer] in serum,r akari ab titr ser,r. akari ab (s) [titer],abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; dilution factor; dilution factor (titer); id; infectious disease; infectiousdisease; microbiology; point in time; r akari; random; ricket; rickettsial; rickettsial pox; serum; smqn; spotted fever; sr; titer; titered; titre; ttr,SemiQn
29682-2,rickettsia prowazekii ab [titer] in serum,r prowazek ab titr ser,r. prowazekii ab (s) [titer],abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; brill-zinsser disease; dilution factor; dilution factor (titer); epidemic typhus; id; infectious disease; infectiousdisease; microbiology; point in time; r prowazek; r prowazekii; random; recrudescent typhus; ricket; rickettsial; serum; smqn; sporadic typhus; sr; titer; titered; titre; ttr; typhus,SemiQn
29696-2,leptospira interrogans sv cynopteri ab [presence] in serum,l inter cynop ab ser ql,l. interrogans sv cynopteri ab ql (s),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; id; infectious disease; infectiousdisease; l inter; l inter cynop; l interrogans; leptospirosis; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; sr,Ord
29698-8,leptospira interrogans sv javanica ab [presence] in serum,l inter javani ab ser ql,l. interrogans sv javanica ab ql (s),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; id; infectious disease; infectiousdisease; l inter; l inter javani; l interrogans; leptospirosis; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; sr,Ord
2970-2,streptomyces proteinase [presence] in serum,streptomyces proteinase ser ql,streptomyces proteinase ql (s),chemistry; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; sr,Ord
29719-2,orientia tsutsugamushi litchfield ab [titer] in serum by immunofluorescence,o tsut litch ab titr ser if,o. tsutsugamushi litchfield ab if (s) [titer],abs; aby; acif; antby; anti; antibodies; antibody; anticomplement immunofluorescence; autoantibodies; autoantibody; dilution factor; dilution factor (titer); fa; fluorescent antibody; fluoresent; id; ifa; immune fluorescence; immunoflour; immunofluor; immunofluorescence; infectious disease; infectiousdisease; microbiology; o tsut; o tsut litch; o tsutsugamushi; oriental scrub typhus; point in time; r orienta; r tsutsugamuchi; r tsutsugamushi; random; rickettsia orienta; rickettsia tsutsugamuchi; rickettsia tsutsugamushi; rickettsia tsutsugamushi serotype litchfield; scrub typhus; serum; smqn; sr; time resolved fluorescence; titer; titered; titre; trf; ttr,SemiQn
29737-4,rickettsia rickettsii ab [titer] in serum,r rickettsi ab titr ser,r. rickettsii ab (s) [titer],abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; dilution factor; dilution factor (titer); id; infectious disease; infectiousdisease; microbiology; point in time; r rickettsi; r rickettsii; random; ricket; rickettsial; rmsf; rocky mountain spotted fever; serum; smqn; spotted fever; sr; titer; titered; titre; ttr,SemiQn
29743-2,cryofibrinogen [presence] in plasma by 3 day rt incubation,cryofib plas ql 3d rt inc,cryofibrinogen 3 day rt incubation ql (p),chemistry; ordinal; pl; plasma; plsm; point in time; pr; ql; qual; qualitative; random; screen,Ord
29746-5,cryoglobulin [presence] in serum by 3 day 37 degree c incubation,cryoglob ser ql 3d inc,cryoglobulin 3 day 37 degree c incubation ql (s),@37c; 3d inc; chemistry; cryo; cryoglobulins; cryoprecipitate; degree; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; sr,Ord
29751-5,critical care records,critical care records,,doc.misc; document; finding; findings; misc,Doc
29762-2,social history narrative,social hx,,finding; findings; h+p; h+p.hx; hx; narrative; p prime; point in time; random; report; social hx,Nar
29765-5,cholesterol [moles/volume] in body fluid,cholest fld-scnc,cholesterol (body fld) [moles/vol],"b/f; bf; bod; bodies; body fluid; body fluid, unsp; chemistry; chol; choles; cholest; cholesterol total; cholesterols; fl; fld; flu; fluid; level; lipid; point in time; qnt; quan; quant; quantitative; random; substance concentration",Qn
29770-5,karyotype [identifier] in blood or tissue nominal,karyotyp bld/t,karyotype nom (bld/tiss),"blood; chromosome analysis; genetics; genotype; heredity; heritable; identity or presence; inherited; karyogram; molecular pathology; molpath; nominal; point in time; random; tissue; tissue, unspecified; universallaborders; wb; whole blood; whole blood or tissue",Nom
29780-4,west nile virus igm ab [presence] in specimen,wnv igm spec ql,west nile virus igm ql (specimen),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; id; immune globulin m; immunoglobulin m; infectious disease; infectiousdisease; microbiology; misc; miscellaneous; ordinal; other; point in time; pr; ql; qual; qualitative; random; screen; spec; to be specified in another part of the message; unspecified; wnv,Ord
29785-3,eastern equine encephalitis virus igg ab [presence] in specimen by immunofluorescence,eeev igg spec ql if,eeev igg if ql (specimen),abs; aby; acif; antby; anti; antibodies; antibody; anticomplement immunofluorescence; autoantibodies; autoantibody; eee virus; eeev; enc; enceph; encephalomyelitis; equin; fa; fluorescent antibody; fluoresent; id; ifa; immune fluorescence; immune globulin g; immunoflour; immunofluor; immunofluorescence; immunoglobulin g; infectious disease; infectiousdisease; microbiology; misc; miscellaneous; ordinal; other; point in time; pr; ql; qual; qualitative; random; screen; spec; time resolved fluorescence; to be specified in another part of the message; togavirus; trf; unspecified,Ord
29800-0,jamestown canyon virus igm ab [presence] in cerebral spinal fluid by immunofluorescence,jcv igm csf ql if,jamestown canyon virus igm if ql (csf),abs; aby; acif; antby; anti; antibodies; antibody; anticomplement immunofluorescence; autoantibodies; autoantibody; cerebral spinal fluid; cerebrospinal fl; fa; fluorescent antibody; fluoresent; id; ifa; immune fluorescence; immune globulin m; immunoflour; immunofluor; immunofluorescence; immunoglobulin m; infectious disease; infectiousdisease; jcv; microbiology; neuro; neurology; ordinal; point in time; pr; ql; qual; qualitative; random; screen; spinal fl; spinal fld; spinal flu; spinal fluid; time resolved fluorescence; trf,Ord
2980-1,taurine [presence] in serum or plasma,taurine serpl ql,taurine ql,chemistry; ordinal; pl; plasma; plsm; point in time; pr; ql; qual; qualitative; random; screen; serp; serpl; serplas; serum; serum or plasma; sr; tau,Ord
29809-1,saint louis encephalitis virus neutralizing antibody [titer] in serum by neutralization test,slev nab titr ser nt,slev neut ab neut test (s) [titer],abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; conventional virus neutralization test; cvnt; dilution factor; dilution factor (titer); enc; enceph; encephalomyelitis; id; infectious disease; infectiousdisease; microbiology; nab; neutralization; neutralization test; nt; point in time; random; serum; serum virus neutralization; sle virus; slev; smqn; sr; st louis; svn; titer; titered; titre; ttr; virus neutralization test; vnt,SemiQn
29822-4,saint louis encephalitis virus ab [titer] in specimen,slev ab titr spec,slev ab (specimen) [titer],abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; dilution factor; dilution factor (titer); enc; enceph; encephalomyelitis; id; infectious disease; infectiousdisease; microbiology; misc; miscellaneous; other; point in time; random; sle virus; slev; smqn; spec; st louis; titer; titered; titre; to be specified in another part of the message; ttr; unspecified,SemiQn
29823-2,highlands j virus ab [titer] in specimen,hjv ab titr spec,highlands j virus ab (specimen) [titer],abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; dilution factor; dilution factor (titer); highland j virus; hjv; id; infectious disease; infectiousdisease; microbiology; misc; miscellaneous; other; point in time; random; smqn; spec; titer; titered; titre; to be specified in another part of the message; ttr; unspecified,SemiQn
29829-9,la crosse virus igm ab [presence] in specimen,lacv igm spec ql,la crosse virus igm ql (specimen),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; california encephalitis virus; id; immune globulin m; immunoglobulin m; infectious disease; infectiousdisease; lacrosse virus; lacv; microbiology; misc; miscellaneous; ordinal; other; point in time; pr; ql; qual; qualitative; random; screen; spec; to be specified in another part of the message; unspecified,Ord
29862-0,deprecated persimmon ige ab rast class [presence] in serum,deprecated persimmon ige rast ql,persimmon ige rast class (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; f301; ige rast; immune globulin e; immunoglobulin e; kaki fruit; ordinal; persimmon; persimon; point in time; pr; ql; qual; qualitative; random; rf301; screen; serum; sharon fruit; sr,Ord
29864-6,"2-oxo,3-methylvalerate [presence] in urine",2oxo3me-valerate ur ql,"2-oxo,3-methylvalerate ql (u)","2-keto-3-methylvalerate; 2-keto-3-methylvaleric acid; 2-oxo,3-methylvaleric acid; 2oxo3me-valerate; 3-methyl-2-oxovalerate; 3-methyl-2-oxovaleric acid; chemistry; ii; iii; ordinal; point in time; pr; ql; qual; qualitative; random; screen; ua; ur; urn",Ord
29871-1,4-hydroxyphenylpyruvate [presence] in urine,4oh-phenylpyruvate ur ql,4-hydroxyphenylpyruvate ql (u),4hpp; 4-hydroxy phenylpyruvate; 4-hydroxyphenylpyruvic acid; 4oh-phenylpyruvate; chemistry; ordinal; point in time; pr; ql; qual; qualitative; random; screen; ua; ur; urn,Ord
29891-9,helicobacter pylori [presence] in stomach by urea breath test,urea breath test ql,co2 post dose urea ql (exhl gas),after; breath; carbamide; carbonic anhydride; co2; exg; exhaled gas; exhaled gas (=breath); gases; gastro; gastroenterology; gi; helicobacter pylori breath test; microbiology; ordinal; p dose; p urea; point in time; pr; pst; ql; qual; qualitative; random; screen; ubt; universallaborders; urea breath test,Ord
29896-8,cryptococcus sp ag [presence] in cerebral spinal fluid by immunoassay,cryptoc ag csf ql ia,cryptococcus sp ag ia ql (csf),antigen; antigens; cerebral spinal fluid; cerebrospinal fl; crypt; crypto; cryptococcal; cryptococcosis; cryptococcosus; eia; elfa; elisa; enzyme immunoassay; iaa; id; infectious disease; infectiousdisease; meia; microbiology; neuro; neurology; ordinal; point in time; pr; ql; qual; qualitative; random; screen; species; spinal fl; spinal fld; spinal flu; spinal fluid; spp; suds,Ord
2990-0,testosterone.free+weakly bound [mass/volume] in serum or plasma,testosterone.free+wb serpl-mcnc,testosterone.free+weakly bound [mass/vol],associated; bnd; chemistry; fr; level; mass concentration; non-protein bound; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; testo; testos; testost; testost free; testosterone free+weakly bound; testosterone.bioavailable; testosterone.free+wb; testosterone.unconjugated; tumor marker,Qn
29907-3,haemophilus influenzae b dna [presence] in specimen by naa with probe detection,haem influ b dna spec ql naa+probe,h. influenzae b dna naa+probe ql (specimen),3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; deoxyribonucleic acid; dna nucleic acid probe; dna probe; h flu; h influenza; h influenzae; haem influ; haem influ b; haemoph; hib; id; infectious disease; infectiousdisease; influ; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; misc; miscellaneous; naa+probe; naat; nasba; nucleic acid sequence based analysis; ordinal; other; pcr; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; screen; sda; spec; strand displacement amplification; tma; to be specified in another part of the message; transcription mediated amplification; unspecified,Ord
29912-3,magnesium [mass/time] in stool,magnesium stl-mrate,magnesium (stl) [mass/time],bowel movement; chemistry; faecal; faeces; fecal; feces; mag; magnes; mass rate; mg; mrate; point in time; qnt; quan; quant; quantitative; random; stl; stool = fecal,Qn
29919-8,chromium/creatinine [mass ratio] in 24 hour urine,cr/creat 24h ur,chromium/creatinine (24h u) [mass ratio],1 day; 24 hours; 24hr; c609; chrome; cr; crea; creat; drug/toxicology; drugs; mass concentration ratio; mass ratio; mcrto; qnt; quan; quant; quantitative; ua; ucr; ur; urn,Qn
29929-7,titanium [mass/time] in 24 hour urine,titanium 24h ur-mrate,titanium (24h u) [mass/time],1 day; 24 hours; 24hr; drug/toxicology; drugs; mass rate; mrate; qnt; quan; quant; quantitative; ti; ua; ur; urn,Qn
29952-9,borrelia burgdorferi ag [mass/volume] in urine by immunoassay,b burgdor ag ur ia-mcnc,b. burgdorferi ag ia (u) [mass/vol],antigen; antigens; b burg; b burgdor; b burgdorferi; bb; burgdorf; eia; elfa; elisa; enzyme immunoassay; iaa; id; infectious disease; infectiousdisease; level; lyme; lyme disease; lymes; mass concentration; meia; microbiology; point in time; qnt; quan; quant; quantitative; random; suds; ua; ur; urn,Qn
29963-6,parietal cell igg ab [presence] in serum by immunofluorescence,pca igg ser ql if,parietal cell igg if ql (s),abs; aby; acif; antby; anti; antibodies; antibody; anticomplement immunofluorescence; autoantibodies; autoantibody; fa; fluorescent antibody; fluoresent; gastro; gastroenterology; gi; hematology; heme; ifa; immune fluorescence; immune globulin g; immunoflour; immunofluor; immunofluorescence; immunoglobulin g; ordinal; pca; point in time; pr; ql; qual; qualitative; random; screen; serology; serum; sr; time resolved fluorescence; trf,Ord
29970-1,rubidium/creatinine [mass ratio] in 24 hour urine,rubidium/creat 24h ur,rubidium/creatinine (24h u) [mass ratio],1 day; 24 hours; 24hr; cr; crea; creat; drug/toxicology; drugs; mass concentration ratio; mass ratio; mcrto; qnt; quan; quant; quantitative; rb; ua; ucr; ur; urn,Qn
29977-6,silver [mass/volume] in 24 hour urine,silver 24h ur-mcnc,silver (24h u) [mass/vol],1 day; 24 hours; 24hr; ag; drug/toxicology; drugs; level; mass concentration; qnt; quan; quant; quantitative; silv; ua; ur; urn,Qn
299-8,lincomycin [susceptibility] by minimum inhibitory concentration (mic),lincomycin islt mic,lincomycin mic [susc],albiotic; antibiotic susceptibilities; ast; c115; cillimicina; cillimycin; id; infectious disease; infectiousdisease; islt; isol; lincocin; lincocine; minimum inhibitory concentration; point in time; random; sus; suscept; susceptibilities; susceptibility; susceptibilty,OrdQn
2998-3,thiamine [mass/volume] in blood,vit b1 bld-mcnc,thiamine (bld) [mass/vol],blood; c106; c238; chemistry; level; mass concentration; point in time; qnt; quan; quant; quantitative; random; universallaborders; vit b1; vit b-1; vitamin b1; vitamin b-1; wb; whole blood,Qn
29997-4,basement membrane igg ab [units/volume] in serum by immunoassay,bm igg ser ia-acnc,basement membrane igg ia qn (s),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; basem; basemt; bm; eia; elfa; elisa; enzyme immunoassay; iaa; immune globulin g; immunoglobulin g; meia; point in time; qnt; quan; quant; quantitative; random; serology; serum; sr; suds,Qn
30011-1,borrelia burgdorferi 45kd igg ab [presence] in synovial fluid by immunoblot,b burgdor45kd igg snv ql ib,b. burgdorferi 45kd igg ib ql (syn fld),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; b burg; b burgdor; b burgdor45kd; b burgdorferi; bb; blt; burgdorf; id; immune blot; immune globulin g; immunobl; immunoblot; immunoglobulin g; infectious disease; infectiousdisease; joint aspirate; joint fld; joint flu; joint fluid; lyme; lyme disease; lymes; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; rheum; rheumatology; riba; screen; sf; snv; syn; syn fl; synov; synovial fluid; wb; wblot; west blot; west blt; western blot,Ord
30024-4,carbophenothion [mass/volume] in serum or plasma,carbophenothion serpl-mcnc,carbophenothion [mass/vol],acarithion; carbofenothion; carbofenthion; drug/toxicology; drugs; level; mass concentration; oleoakarithion; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; trithion,Qn
3003-1,thiocyanate [presence] in serum or plasma,thiocyanate serpl ql,thiocyanate ql,drug/toxicology; drugs; ordinal; pl; plasma; plsm; point in time; pr; ql; qual; qualitative; random; screen; serp; serpl; serplas; serum; serum or plasma; sr,Ord
30046-7,legionella pneumophila ab [units/volume] in serum by immunoassay,l pneumo ab ser ia-acnc,l. pneumophila ab ia qn (s),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; eia; elfa; elisa; enzyme immunoassay; iaa; id; infectious disease; infectiousdisease; l pneumo; l pneumonphila; legion; legionela; meia; microbiology; pneu; pneum; pneumophilia; point in time; qnt; quan; quant; quantitative; random; serum; sr; suds; universallaborders,Qn
30051-7,homocystine/creatinine [ratio] in urine,(hcys)2/creat ur-rto,homocystine/creatinine (u) [ratio],(hcys)2; chemistry; cr; crea; creat; homocyst(e)ine; homocystin; point in time; qnt; quan; quant; quantitative; random; ratios; rto; ua; ucr; ur; urn,Qn
3005-6,thiosulfate renal clearance in 24 hour urine and serum or plasma,thiosulfate cl 24h ur+serpl-vrate,thiosulfate renal clearance (24h u+s/p) [vol/time],1 day; 24 hours; 24hr; chemistry; cl; clear; clearanc; clearances; clr; flow; kidney; pl; plasma; plsm; qnt; quan; quant; quantitative; serp; serpl; serplas; serum; serum or plasma; sr; thiosulphate; ua; ur; ur+serpl; urn; volume rate; vrate,Qn
30068-1,alanine/creatinine [ratio] in urine,alanine/creat ur-rto,alanine/creatinine (u) [ratio],ala; alpha alanine; chemistry; cr; crea; creat; l-alanine; point in time; qnt; quan; quant; quantitative; random; ratios; rto; ua; ucr; ur; urn,Qn
30073-1,voltage-gated calcium channel ab [presence] in serum,vgcc ab ser ql,voltage-gated calcium channel ab ql (s),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; ca; cal; lamblia intestinalis; lems; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serology; serum; sr; vdcc; vg; v-g; vgcc; vgcca; voltage-dependent calcium channels,Ord
30096-2,neisseria meningitidis serogroup c ag [presence] in specimen by latex agglutination,n men sg c ag spec ql la,n. meningitidis c ag la ql (specimen),antigen; antigens; id; infectious disease; infectiousdisease; lat; latex agglutination; mening; meningid; meningitis; meningo; meningococcal meningitis; meningococcus; microbiology; misc; miscellaneous; n men; n men serogroup; n men sg c; n men sg c ag; n menigitidis; n meningitidis; neisseria meningitidis group c; neisseria meningitidis type c; ordinal; other; point in time; pr; ql; qual; qualitative; random; rh; rh blood group system; screen; spec; to be specified in another part of the message; unspecified,Ord
30097-0,neisseria meningitidis serogroup w135 ag [presence] in specimen by latex agglutination,n men sg w135 ag spec ql la,n. meningitidis w135 ag la ql (specimen),antigen; antigens; id; infectious disease; infectiousdisease; lat; latex agglutination; mening; meningid; meningitis; meningo; meningococcal meningitis; meningococcus; microbiology; misc; miscellaneous; n men; n men serogroup; n men sg w135; n men sg w135 ag; n menigitidis; n meningitidis; neisseria meningitidis group w135; neisseria meningitidis type w135; ordinal; other; point in time; pr; ql; qual; qualitative; random; screen; spec; to be specified in another part of the message; unspecified,Ord
30104-4,trypanosoma cruzi igg ab [titer] in specimen,t cruzi igg titr spec,t. cruzi igg (specimen) [titer],abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; chagas disease; dilution factor; dilution factor (titer); id; immune globulin g; immunoglobulin g; infectious disease; infectiousdisease; microbiology; misc; miscellaneous; other; point in time; random; smqn; spec; t cruzi; titer; titered; titre; to be specified in another part of the message; trypanosomiasis; trypanosomosis; ttr; unspecified,SemiQn
30111-9,thermoactinomyces vulgaris 2 ab [presence] in serum,t vulgaris2 ab ser ql,t. vulgaris 2 ab ql (s),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; farmers lung; id; ii; infectious disease; infectiousdisease; lung; m23; m51; microbiology; ordinal; point in time; pr; pulmonary; pulmonology; ql; qual; qualitative; random; respiratory; rm213; screen; serum; sr; t vulgaris; t vulgaris2; thermoactnom,Ord
30180-4,basophils/leukocytes in blood,basophils nfr bld,basophils/leukocytes (bld),baso; basophil; basos; blood; bph; hematology/cell counts; leuc; leuk; leukocyte; lkcs; number fraction; percent; point in time; qnt; quan; quant; quantitative; random; wb; wbc; wbcs; white blood cell; white blood cells; whole blood,Qn
30194-5,fatty acids.very long chain c22:0 (docosanoate) [moles/volume] in serum or plasma,vlcfa c22:0 serpl-scnc,fatty acids.very long chain c22:0 (docosanoate) [moles/vol],acd; acid; aliphatic carboxylate; behenate; behenic acid; c22:0; chains; chemistry; chn; docosanoate; docosanoic acid; fatty acid; level; lipid; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; substance concentration; vlc; vlcf; vlcfa; vlcfa c22:0,Qn
30212-5,coxiella burnetii igg ab [presence] in serum,c burnet igg ser ql,c. burnetii igg ql (s),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; c burnet; c burnetii; coxiella burnettii; id; immune globulin g; immunoglobulin g; infectious disease; infectiousdisease; microbiology; ordinal; point in time; pr; q fev; q fever; qfever; ql; qual; qualitative; random; screen; serum; sr,Ord
30218-2,coxsackievirus a7 ab [presence] in serum,cv a7 ab ser ql,coxsackievirus a7 ab ql (s),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; cav; coxsackie; coxsackie virus; cv; cv a7; id; infectious disease; infectiousdisease; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; sr,Ord
30222-4,coxsackievirus b3 ab [presence] in serum,cv b3 ab ser ql,coxsackievirus b3 ab ql (s),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; cav; coxsackie; coxsackie virus; cv; cv b3; id; infectious disease; infectiousdisease; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; sr,Ord
30244-8,acetylcholinesterase [enzymatic activity/volume] in blood,ache bld-ccnc,acetylcholinesterase (bld) [catalytic activity/vol],acetycholinesterase; acetylcholine acetylhydrolase; acetylhydrolase; ache; acle; blood; catalytic concentration; chemistry; choline esterase i; cholinesterase true; erythrocyte cholinesterase; point in time; qnt; quan; quant; quantitative; random; rbc cholinesterase; wb; whole blood,Qn
30247-1,cytomegalovirus dna [#/volume] (viral load) in serum or plasma by naa with probe detection,cmv dna # serpl naa+probe,cmv dna naa+probe [#/vol],#; 3 self-sustaining sequence replication; 3sr sr; abs; absolute; absolutes; amplif; amplification; amplified; cmv; cnt; count; count/volume; ct; cytomegalo virus; cytomgal; deoxyribonucleic acid; dna nucleic acid probe; dna probe; hhv-5; human herpesvirus-5; id; infectious disease; infectiousdisease; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; naa+probe; naat; nasba; nucleic acid sequence based analysis; number concentration; number concentration (count/vol); pcr; pl; plasma; plsm; point in time; polymerase chain reaction; probe amp; probe with ampification; probe with target amplification; qbr; qnt; quan; quant; quantitative; random; sda; serp; serpl; serplas; serum; serum or plasma; sr; strand displacement amplification; tma; transcription mediated amplification; universallaborders; viral load,Qn
30249-7,barbiturates [mass/volume] in serum or plasma by screen method,barbiturates serpl scn-mcnc,barbiturates screen [mass/vol],addiction; barb; barbiturate; barbs; drug/toxicology; drugs; drugs of abuse; illicit; level; mass concentration; pl; plasma; plsm; point in time; potentialforabuse; qnt; quan; quant; quantitative; random; scn; scr; scrn; serp; serpl; serplas; serum; serum or plasma; sr,Qn
30278-6,indinavir [susceptibility] by phenotype method,indinavir islt phenotyp,indinavir phenotype method [susc],antibiotic susceptibilities; ast; crixivan; id; idv; infectious disease; infectiousdisease; islt; isol; pheno; phenotype; phenotypic; point in time; random; sus; suscept; susceptibilities; susceptibility; susceptibilty; virtual phenotype,OrdQn
30283-6,lamivudine [susceptibility] by genotype method,lamivudine islt genotyp,lamivudine genotyping [susc],3tc; antibiotic susceptibilities; ast; epivir; genotype; genotypic; id; infectious disease; infectiousdisease; islt; isol; lmv; ordinal; point in time; ql; qual; qualitative; random; screen; sus; suscept; susceptibilities; susceptibility; susceptibilty,Ord
30311-5,nevirapine [susceptibility],nevirapine susc islt,nevirapine [susc],antibiotic susceptibilities; ast; id; infectious disease; infectiousdisease; islt; isol; nevirapin; nvp; point in time; random; sus; suscept; susceptibilities; susceptibility; susceptibilty; viramune,OrdQn
30358-6,hexanoylcarnitine (c6) [moles/volume] in serum or plasma,hexanoylcarn serpl-scnc,c6 [moles/vol],c6; chemistry; level; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; substance concentration,Qn
30373-5,basophils/leukocytes in bronchial specimen,basophils nfr bronch,basophils/leukocytes (bronch spec),baso; basophil; basos; bph; bro; hematology/cell counts; leuc; leuk; leukocyte; lkcs; number fraction; percent; point in time; qnt; quan; quant; quantitative; random; wbc; wbcs; white blood cell; white blood cells,Qn
30385-9,erythrocyte [distwidth] in red blood cells,rdw rbc,erythrocyte (rbc) [distwidth],erythrocytes; hematology/cell counts; point in time; qnt; quan; quant; quantitative; random; red blood cells; red blood corpusles,Qn
30388-3,erythrocytes [#/volume] in pericardial fluid,rbc # pcar,rbc (pericard fld) [#/vol],#; abs; absolute; absolutes; cardio; cardiology; cnt; count; count/volume; ct; discocytes; erthrocyte; erythrocyte; heart disease; hematology/cell counts; number concentration; number concentration (count/vol); pcar; pericardial fluid; point in time; qnt; quan; quant; quantitative; random; rbc; rbcs; red blood cell; red blood cells; red blood corpuscle; red blood corpusles; red cell; red cells,Qn
30399-0,deprecated hemoglobin distribution width [length] in blood,deprecated hdw bld,hemoglobin distribution width (bld) [length],blood; haemoglobin; hb; hdw; hematology/cell counts; hgb; length; point in time; qnt; quan; quant; quantitative; random; wb; whole blood,Qn
30400-6,hypochromia [presence] in blood,hypochromia bld ql,hypochromia ql (bld),blood; hematology/cell counts; hypochro; hypochromic; ordinal; point in time; pr; ql; qual; qualitative; random; screen; wb; whole blood,Ord
30404-8,leukocytes [#/volume] in stool,wbc # stl,wbc (stl) [#/vol],#; abs; absolute; absolutes; bowel movement; cnt; count; count/volume; ct; faecal; faeces; fecal; feces; gastro; gastroenterology; gi; hematology/cell counts; leuc; leuk; leukocyte; lkcs; number concentration; number concentration (count/vol); point in time; qnt; quan; quant; quantitative; random; stl; stool = fecal; wbc; wbcs; white blood cell; white blood cells,Qn
30406-3,leukocytes other [#/volume] in blood,wbc other # bld,wbc other (bld) [#/vol],#; abs; absolute; absolutes; blood; cnt; count; count/volume; ct; hematology/cell counts; leuc; leuk; leukocyte; lkcs; number concentration; number concentration (count/vol); othr; point in time; qnt; quan; quant; quantitative; random; wb; wbc; wbc other; wbcs; white blood cell; white blood cells; whole blood,Qn
30408-9,leukocytes other/leukocytes in pleural fluid,wbc other nfr plr,wbc other/leukocytes (pleur fld),hematology/cell counts; leuc; leuk; leukocyte; lkcs; number fraction; othr; percent; pleural; pleural fluid; point in time; qnt; quan; quant; quantitative; random; thoracentesis fluid; wbc; wbc other; wbcs; white blood cell; white blood cells,Qn
30409-7,leukocytes other/leukocytes in peritoneal fluid,wbc other nfr prt,wbc other/leukocytes (periton fld),ascites; ascitic fluid; ascitis; hematology/cell counts; leuc; leuk; leukocyte; lkcs; number fraction; othr; percent; peritoneal fluid; point in time; prt; qnt; quan; quant; quantitative; random; wbc; wbc other; wbcs; white blood cell; white blood cells,Qn
30460-0,granulocytes/leukocytes in gastric fluid,granulocytes nfr gast,granulocytes/leukocytes (gast fld),gast; gastric contents; gastric fluid; gran; grans; granulocyte; granulocytes; hematology/cell counts; leuc; leuk; leukocyte; lkcs; number fraction; percent; point in time; qnt; quan; quant; quantitative; random; wbc; wbcs; white blood cell; white blood cells,Qn
3047-8,triglyceride+ester in vldl [mass/volume] in serum or plasma,trigl+vldl ester serpl-mcnc,triglyceride+ester in vldl [mass/vol],chemistry; esters; level; mass concentration; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; tg; trig; trigl+vldl ester; trigly; triglycerides; triglycrides,Qn
30480-8,orotate [presence] in urine,orotate ur ql,orotate ql (u),chemistry; ordinal; orotic acid; point in time; pr; ql; qual; qualitative; random; screen; ua; ur; urn,Ord
30494-9,deprecated streptococcus pneumoniae 23 igg ab [mass/volume] in serum --1st specimen,deprecated s pneum23 igg sp1 ser-mcnc,s. pneumoniae 23 igg spec 1 (s) [mass/vol],abs; aby; acute specimen; antby; anti; antibodies; antibody; autoantibodies; autoantibody; first; id; immune globulin g; immunoglobulin g; infectious disease; infectiousdisease; level; mass concentration; microbiology; pneu; pneum; pneumo; pneumococ; pneumococcal; pneumococcal pneumonia; pneumococcus; pneumon; pneumonia; point in time; pre immunization; qnt; quan; quant; quantitative; random; s pneum23; s pneumo; s pneumoniae; serum; sp1; spec; spn; sr; strep; strept; streptococcus pneumoniae 23f,Qn
30522-7,c reactive protein [mass/volume] in serum or plasma by high sensitivity method,crp serpl hs-mcnc,crp high sensitivity method [mass/vol],cardiac crp; cardio; cardiology; chemistry; crp; heart disease; hs; hscrp; hs-crp; level; mass concentration; pl; plasma; plsm; point in time; pr; prot; qnt; quan; quant; quantitative; random; reac; react; serp; serpl; serplas; serum; serum or plasma; sr; universallaborders,Qn
30523-5,mycobacterium sp dna [presence] in urine by naa with probe detection,mycobacterium dna ur ql naa+probe,mycobacterium sp dna naa+probe ql (u),3 self-sustaining sequence replication; 3sr sr; acid fast; acid fast bacilli; acid fast bacillus; afb; amplif; amplification; amplified; deoxyribonucleic acid; dna nucleic acid probe; dna probe; id; infectious disease; infectiousdisease; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; myco; mycobact; naa+probe; naat; nasba; nucleic acid sequence based analysis; ordinal; pcr; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; screen; sda; species; spp; strand displacement amplification; tma; transcription mediated amplification; tuberculosis; ua; ur; urn,Ord
30528-4,heptacarboxylporphyrin [presence] in urine,hepta-cp ur ql,heptacarboxylporphyrin ql (u),chemistry; hematology; heme; hepacarboxyporph; heptacarbox; heptacarboxyl porphyrin; heptacarboxylate porphyrin; heptacarboxylporphyrins; heptacarboxyporph; heptacarboxyporphyrin; hepta-cp; heptaporphyrin; hexacarboxyl porphyrin; ordinal; point in time; pr; ql; qual; qualitative; random; screen; ua; ur; urn,Ord
305-3,lomefloxacin [susceptibility] by serum bactericidal titer,lomefloxacin titr sbt,lomefloxacin sbt (isol+s),antibiotic susceptibilities; dilution factor; dilution factor (titer); id; infectious disease; infectiousdisease; islt; isol; maxaquin; point in time; random; sequence based typing; serum; serum bactericidal titer; serum killing test; smqn; sr; titer; titered; titre; ttr,SemiQn
30541-7,octenoylcarnitine (c8:1) [moles/volume] in serum or plasma,octenoylcarn serpl-scnc,c8:1 [moles/vol],c8:1; chemistry; i; level; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; substance concentration,Qn
3054-4,triiodothyronine (t3).true [mass/volume] in serum or plasma,t3true serpl-mcnc,t3.true [mass/vol],chemistry; endocrine; endocrinology; level; mass concentration; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; t3; t-3; t3true; thyroid hormone; total t3; triodothyrne; universallaborders,Qn
3056-9,trimethylamine [mass/volume] in urine,trimet-amine ur-mcnc,trimethylamine (u) [mass/vol],chemistry; level; mass concentration; point in time; qnt; quan; quant; quantitative; random; tma; trimet-amine; ua; ur; urn,Qn
30570-6,triglyceride [percentile],trigl prctl serpl,triglyceride [%],cardio; cardiology; chemistry; heart disease; percentile; pl; plasma; plsm; point in time; random; serp; serpl; serplas; serum; serum or plasma; smqn; sr; tg; trig; trigly; triglycerides; triglycrides,SemiQn
3057-7,triokinase [enzymatic activity/volume] in plasma,triokinase plas-ccnc,triokinase (p) [catalytic activity/vol],catalytic concentration; chemistry; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random,Qn
30591-2,ct pituitary and sella turcica wo contrast,ct pit+sella turc wo contr,,brain; c; cat scan; computed tomography; computerized tomography; contr; contra; contrst; coreplaybook; cranial; cranium; ct scan; document; finding; findings; imaging; intracranial; pit+sella turc; pituitary+st; pitutary; playbook; point in time; rad; radiology; random; skull; without contrast,Doc
3059-3,trypsin [enzymatic activity/volume] in duodenal fluid,trypsin duod fl-ccnc,trypsin (duod fld) [catalytic activity/vol],catalytic concentration; chemistry; dudf; duodenal fluid; point in time; qnt; quan; quant; quantitative; random; tps,Qn
30608-4,ct guidance for fine needle aspiration of kidney - bilateral,ct guided kdny-bl fna,,abd; abdo; abdomen+; abdominal; asp; bil; bilat; both; cat scan; computed tomography; computerized tomography; ct scan; document; finding; findings; fna; guid; guide; guided; imaging; kdny-bl; kidney; kidneys; ndl; nephric; nephrology; perc; point in time; pyelogram; rad; radiology; random; renal,Doc
30617-5,deprecated kidney - bilateral and collecting system ct wo contrast,deprecated kd-bl+cs ct wo contr,,bil; bilat; both; c; cat scan; computed tomography; computerized tomography; contr; contra; contrst; cs; ct scan; finding; findings; imaging; kdny-bl; kidney; kidneys; narrative; nephric; nephrology; point in time; pyelogram; rad; radiology; random; renal; report; without contrast,Nar
30619-1,ct sacroiliac joint,ct sij,,cat scan; computed tomography; computerized tomography; ct scan; document; finding; findings; imaging; jnt; pelvic; point in time; rad; radiology; random; sac; si joint; si joints; sij,Doc
30623-3,cta pelvis vessels wo and w contrast iv,cta pelvis ves wo+w contr iv,,ang; angio; angiography; angm; c; cat scan; computed tomography; computerized tomography; contr; contra; contrst; coreplaybook; ct angiogram; ct angiography; ct scan; cta; document; finding; findings; imaging; pelvic; playbook; point in time; rad; radiology; random; vesl; vessels.xxx; w contr iv; wc; wo & wc; wo+w contr; wo+w contr iv; wwo,Doc
30633-2,rf esophagus views w barium contrast po,rf esophagus views w ba po,,ba; barium swallow; c; contr; contra; contrst; coreplaybook; document; esophageal; esophagram; films; finding; findings; fluor; fluoro; fluoroscopy; gastro; gastroenterology; gi; imaging; playbook; point in time; rad; radiology; random; thorax; view; vws; w ba po,Doc
30651-4,us guidance for percutaneous biopsy.core needle of breast,us guided brst pc bx cn,,brst; bx; cn; cnb; document; echography; finding; findings; guid; guide; guided; gyn; gynecology; imaging; large needle; ndl; ob; obgyn; obstetrics; pc bx cn; perc; point in time; radiology; random; sonogram; sonograph; sonography; uls; ultrasound,Doc
30664-7,mr guidance for radiation treatment of unspecified body region-- w contrast iv,mr guided rt--w contr iv,,c; contr; contra; contrst; document; finding; findings; guid; guide; guided; imaging; misc; miscellaneous; mitral regurgitation maximum velocity; mri; other; point in time; rad; radiology; random; rt; simulation; spec; to be specified in another part of the message; tx; unspecified; w contr iv; wc,Doc
30670-4,mr liver wo and w contrast iv,mr liver wo+w contr iv,,abd; abdo; abdomen+; abdominal; c; contr; contra; contrst; document; finding; findings; hepar; hepatic; imaging; mitral regurgitation maximum velocity; mri; point in time; rad; radiology; random; w contr iv; wc; wo & wc; wo+w contr; wo+w contr iv; wwo,Doc
30672-0,mr pelvis and hip wo and w contrast iv,mr pelvis and hip wo+w contr iv,,c; contr; contra; contrst; document; ext; finding; findings; imaging; le; leg; low; lower extremity joint; mitral regurgitation maximum velocity; mri; msk; musculoskeletal; ortho; orthopedics; pelvic; pelvis + hip; pelvis and hip; pelvis+le; point in time; rad; radiology; random; w contr iv; wc; wo & wc; wo+w contr; wo+w contr iv; wwo,Doc
30673-8,mr pelvis wo contrast,mr pelvis wo contr,,c; contr; contra; contrst; coreplaybook; document; finding; findings; imaging; mitral regurgitation maximum velocity; mri; pelvic; playbook; point in time; rad; radiology; random; without contrast,Doc
3067-6,trypsinogen i free [mass/volume] in serum or plasma,trypsinogen i free serpl-mcnc,trypsinogen i free [mass/vol],chemistry; fr; immunoreactive trypsin; irt; level; mass concentration; non-protein bound; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; trypsinogen i free,Qn
30676-1,deprecated kidney - bilateral and collecting system mri wo contrast,deprecated kd-bl+cs mri wo contr,,bil; bilat; both; c; contr; contra; contrst; cs; finding; findings; imaging; kdny-bl; kidneys; magnetic resonance imaging; mr; narrative; nephric; point in time; rad; radiology; random; renal; report; without contrast,Nar
30690-2,mr upper arm wo and w contrast iv,mr upper arm wo+w contr iv,,arm; c; contr; contra; contrst; coreplaybook; document; ext; finding; findings; humerus; imaging; mitral regurgitation maximum velocity; mri; playbook; point in time; rad; radiology; random; ue; up; upper extremity; w contr iv; wc; wo & wc; wo+w contr; wo+w contr iv; wwo,Doc
30695-1,nm thyroid gland views,nm thyroid views w rnc iv,,coreplaybook; document; films; finding; findings; imaging; playbook; point in time; rad; radiology; random; rn; rnc; scan; thy; view; vws; w rnc iv,Doc
30706-6,us liver during surgery,us liver in surg,,abd; abdo; abdomen+; abdominal; document; echography; finding; findings; hepar; hepatic; hepatology; imaging; in surg; intra operative; intraop; intraoperative; liver; point in time; radiology; random; sonogram; sonograph; sonography; surg; uls; ultrasound,Doc
30751-2,xr shoulder west point,xr should west point,,1v; arm; document; ext; film; finding; findings; imaging; msk; musculoskeletal; ortho; orthopedics; plain films; point in time; rad; radiology; random; single view; ue; up; upper extremity joint; vw; westpoint; xray; x-ray,Doc
30762-9,xr tomography abdomen,xr tomo abd,,abd; abdo; abdomen+; abdominal; document; finding; findings; imaging; plain films; point in time; rad; radiology; random; xr tomo; xray; x-ray,Doc
30767-8,xr pelvis and hip views,xr pelvis and hip views,,document; ext; films; finding; findings; imaging; le; leg; low; lower extremity joint; msk; musculoskeletal; ortho; orthopedics; pelvic; pelvis + hip; pelvis and hip; pelvis+le; plain films; point in time; rad; radiology; random; view; vws; xray; x-ray,Doc
30780-1,xr finger second views,xr finger.2nd views,,2nd; 2nd finger; arm; document; ext; films; finding; findings; finger.2nd; imaging; index finger; msk; musculoskeletal; ortho; orthopedics; plain films; point in time; rad; radiology; random; ue; up; view; vws; xray; x-ray,Doc
30782-7,xr finger fourth views,xr finger.4th views,,4th; 4th finger; arm; document; ext; films; finding; findings; finger.4th; imaging; msk; musculoskeletal; ortho; orthopedics; plain films; point in time; rad; radiology; random; ring finger; ue; up; view; vws; xray; x-ray,Doc
30786-8,xr hip lateral frog,xr hip lat frog,,1v; document; ext; film; finding; findings; imaging; lat; lat frog; lauenstein; lauenstein-hickey; le; leg; low; lower extremity joint; msk; musculoskeletal; ortho; orthopedics; plain films; point in time; rad; radiology; random; single view; vw; xray; x-ray,Doc
30791-8,xr patella views,xr patella views,,document; ext; films; finding; findings; imaging; knee cap; le; leg; low; plain films; point in time; rad; radiology; random; view; vws; xray; x-ray,Doc
30793-4,xr wrist ap and lateral,xr wrist ap+lat,,anterio-posterior; anteroposterior; ap+lat; arm; carpal bone; carpal bones; carpal bones and joint; document; ext; films; finding; findings; imaging; lat; plain films; point in time; rad; radiology; random; ue; up; upper extremity joint; view; views & ap kub; views (ap; views ap kub & lateral; views+ap; vws; xray; x-ray,Doc
30820-5,rfa carotid artery.external - bilateral views w contrast ia,rfa carot a.ext-bl views w contr ia,,art; arteriogram; bil; bilat; both; brain; c; cardio; cardiology; carot a; carot a.ext; carot a.ext-bl; contr; contra; contrst; cranial; cranium; document; ext; external carotid arteries; films; finding; findings; fluor; fluoro; fluoroscopy; heart disease; imaging; intracranial; point in time; rad; radiology; random; rfa; skull; view; vws; w contr ia; wc,Doc
30874-2,mra lower extremity vessels,mra le ves,,ang; angio; angiography; document; ext; extr ves; finding; findings; imaging; le; le ves; leg; low; magnetic resonance angiographies; magnetic resonance imaging; mitral regurgitation maximum velocity; mr angiography; mra; mri; mri.angio; point in time; rad; radiology; random; vesl; vessels.xxx,Doc
30875-9,mr upper extremity.joint,mr ue joint,,arm; document; ext; finding; findings; imaging; jnt; mitral regurgitation maximum velocity; mri; point in time; rad; radiology; random; ue; ue joint; up,Doc
30885-8,xr pelvis symphysis pubis views,xr pelvis symphysis pubis views,,document; films; finding; findings; imaging; pelvic; pelvis symphysis pubis; plain films; point in time; rad; radiology; random; view; vws; xray; x-ray,Doc
30889-0,xr temporomandibular joint - left views,xr tmj-l views,,brain; cranial; cranium; document; films; finding; findings; imaging; intracranial; jnt; l; lt; plain films; point in time; rad; radiology; random; skull; tmj; tmj-l; view; vws; xray; x-ray,Doc
30900-5,cold agglutinin [titer] in serum or plasma by adult rbc agglutination,ca titr serpl adult rbc aggl,cold agglutinin adult rbc agglutination [titer],adult rbc aggl; agg; agglut; agglutination; agglutinins; agglutins; agt; ca; cold agglutinin titration; dilution factor; dilution factor (titer); pl; plasma; plsm; point in time; random; serology; serp; serpl; serplas; serum; serum or plasma; smqn; sr; titer; titered; titre; ttr,SemiQn
3092-4,urea [mass/volume] in urine,urea ur-mcnc,urea (u) [mass/vol],chemistry; level; mass concentration; point in time; qnt; quan; quant; quantitative; random; ua; universallaborders; ur; urn,Qn
30944-3,date of vaccination temporary contraindication/precaution expiration,date vaccine temp contra/precaution exp,,date vaccine temp contra/precaution exp; exp; immunizations; point in time; qnt; quan; quant; quantitative; random; vaccine,Qn
30952-6,date and time of vaccination,date+time of vaccination,,date and time; date+time; date+time of vaccination; immunizations; point in time; qnt; quan; quant; quantitative; random; time stamp; timestamp; vaccine,Qn
30965-8,illness at time of vaccination,illness at time of vaccination,,finding; findings; immunizations; nominal; point in time; random; vaccine,Nom
30980-7,date vaccine due,date vaccine due,,point in time; qnt; quan; quant; quantitative; random,Qn
31003-7,grass allergen mix 6 (brome+bermuda grass+velvet grass+perennial rye grass+bahia grass+johnson grass) ige ab [presence] in serum by multidisk,grass allerg mix 6 ige ql,brome+bermuda grass+velvet grass+perennial rye grass+bahia grass+johnson grass ige multidisk ql (s),abs; aby; allergen; allergens; allergy testing; allerscan; antby; anti; antibodies; antibody; autoantibodies; autoantibody; bahia grass; bermuda grass; brome; brome grass; g002; g005; g010; g011; g013; g017; g10; g11; g13; g17; g2; g5; grass allerg mix 6; gx6; immune globulin e; immunoglobulin e; italian ryegrass; johnson grass; ordinal; per rye grass; perennial ryegrass; point in time; pr; ql; qual; qualitative; random; rescue grass; rgx6; rye grass; ryegrass; screen; serum; sr; velvet grass; yorkshire fog,Ord
31020-1,dehydroepiandrosterone (dhea) [mass/volume] in amniotic fluid,dhea amn-mcnc,dhea (amn fld) [mass/vol],af; amn; amn fl; amnio; amniotic flu; amniotic fluid; chemistry; dhea; endocrine; endocrinology; gyn; gynecology; level; mass concentration; ob; obgyn; obstetrics; point in time; prasterone; qnt; quan; quant; quantitative; random,Qn
31037-5,moxifloxacin [susceptibility] by minimum inhibitory concentration (mic),moxifloxacin islt mic,moxifloxacin mic [susc],antibiotic susceptibilities; ast; avelox; id; infectious disease; infectiousdisease; islt; isol; minimum inhibitory concentration; point in time; random; sus; suscept; susceptibilities; susceptibility; susceptibilty,OrdQn
31040-9,gatifloxacin [susceptibility] by disk diffusion (kb),gatifloxacin islt kb,gatifloxacin disk diffusion (kb) [susc],antibiotic susceptibilities; ast; disk diffusion; id; infectious disease; infectiousdisease; islt; isol; kb; kirby-bauer; point in time; random; sus; suscept; susceptibilities; susceptibility; susceptibilty; tequin,OrdQn
31044-1,immunization reaction,immunization reaction,,finding; findings; immunization status; nominal; point in time; random; react; rxn; vaccination; vaccinations; vaccine,Nom
31049-0,coxsackievirus a7 ab [titer] in body fluid by complement fixation,cv a7 ab titr fld cf,coxsackievirus a7 ab cf (body fld) [titer],"abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; b/f; bf; bod; bodies; body fluid; body fluid, unsp; cav; cf; comp fixation; compfix; complement fixation; coxsackie; coxsackie virus; cv; cv a7; dilution factor; dilution factor (titer); fl; fld; flu; fluid; id; infectious disease; infectiousdisease; microbiology; point in time; random; smqn; titer; titered; titre; ttr",SemiQn
3105-4,urobilinogen [presence] in stool,urobilinogen stl ql,urobilinogen ql (stl),bowel movement; chemistry; faecal; faeces; fecal; feces; ordinal; point in time; pr; ql; qual; qualitative; random; screen; stl; stool = fecal; ubg; urobili; urobilngn,Ord
31072-2,hiv 1 p41 ab [presence] in serum by immunoblot,hiv1 p41 ab ser ql ib,hiv 1 p41 ab ib ql (s),abs; aby; aids; antby; anti; antibodies; antibody; autoantibodies; autoantibody; blt; hiv type 1; hiv type i; hiv1; hiv1 p41; human immunodeficiency virus; i; id; immune blot; immunobl; immunoblot; infectious disease; infectiousdisease; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; riba; screen; serum; sr; wb; wblot; west blot; west blt; western blot,Ord
31076-3,rickettsia typhi igg ab [titer] in body fluid,r typhi igg titr fld,r. typhi igg (body fld) [titer],"abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; b/f; bf; bod; bodies; body fluid; body fluid, unsp; dilution factor; dilution factor (titer); endemic typhus; fl; fld; flu; fluid; id; immune globulin g; immunoglobulin g; infectious disease; infectiousdisease; microbiology; murine typhus; point in time; r typhi; random; ricket; rickettsial; smqn; titer; titered; titre; ttr; typh; typhus",SemiQn
31083-9,lead [mass/time] in 8 hour urine,lead 8h ur-mrate,lead (8h u) [mass/time],1/3 day; 8 hours; 8hr; drug/toxicology; drugs; mass rate; mrate; painter's colic; pb; plumbism; qnt; quan; quant; quantitative; ua; ur; urn,Qn
3108-8,urobilinogen [mass/time] in 24 hour urine,urobilinogen 24h ur-mrate,urobilinogen (24h u) [mass/time],1 day; 24 hours; 24hr; chemistry; mass rate; mrate; qnt; quan; quant; quantitative; ua; ubg; ur; urn; urobili; urobilngn,Qn
31099-5,amikacin [mass/volume] in serum or plasma --random post extended interval dosing,amikacin rand eid serpl-mcnc,amikacin rando min post extended interval dosing [mass/vol],after; amikin; aminoglycosides; drug/toxicology; drugs; eid; level; mass concentration; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; rand; rand eid; rando; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
31110-0,osmotic fragility of red blood cells--0.30% sodium chloride 24 hour 37 degree c incubation,of .30% nacl 24h inc nfr rbc,osmotic fragility 0.30% sodium chloride 24 hr 37 degree c incubation (rbc),.30% nacl; .30% nacl 24h inc; @37c; cl; cl-; degree; erythrocytes; frag; fragil; hematology/cell counts; na; na cl; na+; nacl; number fraction; of; osmo; osmo frag; percent; point in time; qnt; quan; quant; quantitative; random; red blood cells; red blood corpusles,Qn
31118-3,g2+m phase cells/cells in specimen,g2+m phs cells nfr spec,g2+m phase cells/cells (specimen),cell; cellularity; g2+m phs cells; misc; miscellaneous; molecular pathology; molpath; number fraction; other; percent; point in time; qnt; quan; quant; quantitative; random; spec; to be specified in another part of the message; unspecified,Qn
31119-1,cd227 cells/cells in blood,cd227 cells nfr bld,cd227 cells/cells (bld),blood; cd227 cells; cell; cell markers; cellularity; df3 antigen; ema; episialin; epithelial membrane antigen; h23 antigen; muc1; number fraction; pem; percent; point in time; pum; qnt; quan; quant; quantitative; random; wb; whole blood,Qn
31120-9,cd227 cells [#/volume] in blood,cd227 cells # bld,cd227 cells (bld) [#/vol],#; abs; absolute; absolutes; blood; cd227 cells; cell; cell markers; cellularity; cnt; count; count/volume; ct; df3 antigen; ema; episialin; epithelial membrane antigen; h23 antigen; muc1; number concentration; number concentration (count/vol); pem; point in time; pum; qnt; quan; quant; quantitative; random; wb; whole blood,Qn
31127-4,cd20+cd25- cells [#/volume] in blood,cd20+cd25- cells # bld,cd20+cd25- cells (bld) [#/vol],#; abs; absolute; absolutes; b1; b-1; blood; bp35; cd20 cells; cd20+cd25- cells; cd20+cd25+ cells; cell; cell markers; cellularity; cnt; count; count/volume; ct; il-2 receptor alpha chain; il-2r; il-2r tac antigen; ilr2; leu16; leu-16; number concentration; number concentration (count/vol); point in time; qnt; quan; quant; quantitative; random; tac antigen; wb; whole blood,Qn
31137-3,cocaine [mass/volume] in bile fluid,cocaine bifl-mcnc,cocaine (bile) [mass/vol],addiction; benzoylmethylecgonine; bifl; bile fluid; biliary fluid; coke; crack; drug/toxicology; drugs; drugs of abuse; ecgonine methyl ester benzoate; illicit; level; mass concentration; point in time; potentialforabuse; qnt; quan; quant; quantitative; random; snow,Qn
31143-1,cefepime [susceptibility] for meningitis by gradient strip,cefepime islt.mening grad strip,cefepime strip (isolate.meningitis) [susc],antibiotic susceptibilities; ast; cefipime; epsilometer; estrip; e-strip; grad strip; id; infectious disease; infectiousdisease; islt; islt.mening; isol; maxipime; mening; mic; minimum inhibitory concentration; point in time; random; sus; suscept; susceptibilities; susceptibility; susceptibilty,OrdQn
31145-6,thyroxine (t4) [moles/volume] in dbs,t4 dbs-scnc,t4 (dbs) [moles/vol],blood; chemistry; dbs; dried blood spot; filter paper; fp; level; levothyroxine; levo-thyroxine; l-thyroxine; point in time; qnt; quan; quant; quantitative; random; substance concentration; t4; t-4; thyroid hormone; thyrox; thyroxin; thyrx; total t4; tt4; wb; whole blood,Qn
31153-0,coccidioides sp ab [presence] in specimen by immune diffusion (id),coccidioides ab spec ql id,coccidioides sp ab immune diff ql (specimen),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; coccidiodes; id; imm; immunodiff; immunodiffusion; imun; imune; infectious disease; infectiousdisease; microbiology; misc; miscellaneous; ordinal; other; point in time; pr; ql; qual; qualitative; random; san joaquin valley fever; screen; spec; species; spp; to be specified in another part of the message; unspecified; valley fever,Ord
31189-4,microscopic observation [identifier] in neck mass fine needle aspirate by cyto stain,cyto neck mass fna,microscopic observation cyto stain nom (neck mass fine needle aspirate),cytology; cytology stain; cytostain; fine needle; identity or presence; neck mass fna; nominal; pap smear; pap stain; papanicolaou smear; point in time; random; st; stains; stn,Nom
31193-6,microscopic observation [identifier] in pancreas fine needle aspirate by cyto stain,cyto panc fna,microscopic observation cyto stain nom (pancreas fine needle aspirate),cytology; cytology stain; cytostain; fine needle; identity or presence; nominal; panc fna; pancr; pancreatc; pancreatic; pap smear; pap stain; papanicolaou smear; point in time; random; st; stains; stn,Nom
31195-1,microscopic observation [identifier] in soft tissue fine needle aspirate by cyto stain,cyto soft tiss fna,microscopic observation cyto stain nom (soft tissue fine needle aspirate),cytology; cytology stain; cytostain; fine needle; identity or presence; nominal; pap smear; pap stain; papanicolaou smear; point in time; random; soft tiss fna; st; stains; stn,Nom
31196-9,microscopic observation [identifier] in abdomen fine needle aspirate by cyto stain,cyto abdomen fna,microscopic observation cyto stain nom (abdomen fine needle aspirate),abd; abdo; abdomen fna; abdomen+; abdominal; cytology; cytology stain; cytostain; fine needle; identity or presence; nominal; pap smear; pap stain; papanicolaou smear; point in time; random; st; stains; stn,Nom
31226-4,asialoganglioside gm1 igg ab [units/volume] in serum,gm1 asialo igg ser-acnc,asialoganglioside gm1 igg qn (s),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; asialo gm1; asialogm1; autoantibodies; autoantibody; ganglioside asialo; gm1 asialo; immune globulin g; immunoglobulin g; monoasialoganglioside; point in time; qnt; quan; quant; quantitative; random; serology; serum; sr,Qn
31228-0,aspergillus clavatus ab [presence] in serum,a clavatus ab ser ql,a. clavatus ab ql (s),a clavatus; abs; aby; antby; anti; antibodies; antibody; asperg; aspergil; aspergilis; aspergilla; aspergillin; aspergillosis; aspergils; aspergilus; autoantibodies; autoantibody; id; infectious disease; infectiousdisease; m21; m312; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; sr,Ord
3124-5,vanillylmandelate/creatinine [mass ratio] in urine,vma/creat ur,vanillylmandelate/creatinine (u) [mass ratio],"3-methoxy-4-hydroxymandelate; 3-methyl,4-hydroxy mandelate; 3-methyl,4-oh mandelic acid; catecholamine metabolite; chemistry; cr; crea; creat; hmma; hydroxy-methoxy-mandelate; hydroxy-methoxy-mandelic acid; mass concentration ratio; mass ratio; mcrto; mhma; point in time; qnt; quan; quant; quantitative; random; tumor marker; ua; ucr; ur; urn; vanillylmandelic acid; vanilmandelate; vma; vma & creat",Qn
31245-4,babesia microti igm ab [units/volume] in serum,b microti igm ser-acnc,b. microti igm qn (s),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; b microti; babesiosis; id; immune globulin m; immunoglobulin m; infectious disease; infectiousdisease; microbiology; piroplasmosis; point in time; qnt; quan; quant; quantitative; random; serum; sr,Qn
31254-6,basement membrane igg ab [units/volume] in serum,bm igg ser-acnc,basement membrane igg qn (s),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; basem; basemt; bm; immune globulin g; immunoglobulin g; point in time; qnt; quan; quant; quantitative; random; serology; serum; sr,Qn
31276-9,burkholderia pseudomallei igg ab [units/volume] in specimen,b pseudomal igg spec-acnc,b. pseudomallei igg qn (specimen),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; b pseudomal; b pseudomallei; id; immune globulin g; immunoglobulin g; infectious disease; infectiousdisease; melioidosis; microbiology; misc; miscellaneous; other; point in time; pseudomonas pseudomallei; qnt; quan; quant; quantitative; random; spec; to be specified in another part of the message; unspecified,Qn
31291-8,chicken serum ab [presence] in serum,chicken serum ab ql,chicken serum ab ql (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; e25; f083; f83; gallus spp; ordinal; point in time; pr; ql; qual; qualitative; random; screen; ser; serum; sr,Ord
31300-7,chlamydophila pneumoniae iga ab [units/volume] in serum,c pneum iga ser-acnc,c. pneumoniae iga qn (s),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; c pneum; c pneumo; c pneumoniae; chlamydia; chlamydia pneumoniae; cpn; id; immune globulin a; immunoglobulin a; infectious disease; infectiousdisease; microbiology; pneu; pneum; pneumo; pneumon; pneumonia; point in time; qnt; quan; quant; quantitative; random; serum; sr; twar agent,Qn
31311-4,coxiella burnetii phase 1 ab [units/volume] in serum,c burnet ph1 ab ser-acnc,c. burnetii phase 1 ab qn (s),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; c burnet; c burnet ph1; c burnetii; coxiella burnetii phase i; coxiella burnettii; i; id; infectious disease; infectiousdisease; microbiology; point in time; q fev; q fever; qfever; qnt; quan; quant; quantitative; random; serum; sr,Qn
31316-3,coxiella burnetii phase 2 iga ab [units/volume] in serum,c burnet ph2 iga ser-acnc,c. burnetii phase 2 iga qn (s),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; c burnet; c burnet ph2; c burnetii; coxiella burnetii phase ii; coxiella burnettii; id; ii; immune globulin a; immunoglobulin a; infectious disease; infectiousdisease; microbiology; point in time; q fev; q fever; qfever; qnt; quan; quant; quantitative; random; serum; sr,Qn
31326-2,coxsackievirus b2 ab [units/volume] in body fluid,cv b2 ab fld-acnc,coxsackievirus b2 ab qn (body fld),"abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; b/f; bf; bod; bodies; body fluid; body fluid, unsp; cav; coxsackie; coxsackie virus; cv; cv b2; fl; fld; flu; fluid; id; infectious disease; infectiousdisease; microbiology; point in time; qnt; quan; quant; quantitative; random",Qn
31329-6,coxsackievirus b4 ab [units/volume] in cerebral spinal fluid,cv b4 ab csf-acnc,coxsackievirus b4 ab qn (csf),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; cav; cerebral spinal fluid; cerebrospinal fl; coxsackie; coxsackie virus; cv; cv b4; id; infectious disease; infectiousdisease; microbiology; neuro; neurology; point in time; qnt; quan; quant; quantitative; random; spinal fl; spinal fld; spinal flu; spinal fluid,Qn
31337-9,cytotoxic percent reactive ab [presence] in serum,ctox pct react ab ser ql,cytotoxic percent reactive ab ql (s),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; ctox pct react; hematology/cell counts; ordinal; point in time; pr; pra; ql; qual; qualitative; random; reac; react; screen; serum; sr,Ord
3134-4,xylose [mass/volume] in blood,xylose bld-mcnc,xylose (bld) [mass/vol],blood; chemistry; d-xylose; level; mass concentration; point in time; qnt; quan; quant; quantitative; random; wb; whole blood,Qn
31347-8,ganglioside gd1b igm ab [units/volume] in serum,gd1b gangl igm ser-acnc,ganglioside gd1b igm qn (s),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; disialolganglioside; disialylganglioside; gd1b; gd1b gangl; immune globulin m; immunoglobulin m; point in time; qnt; quan; quant; quantitative; random; serology; serum; sr,Qn
31365-0,endomysium ab [presence] in serum,endomysium ab ser ql,endomysium ab ql (s),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; ema; endomysial; gastro; gastroenterology; gi; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serology; serum; sr; transglutaminase,Ord
31375-9,epstein barr virus nuclear igm ab [units/volume] in serum,ebv na igm ser-acnc,ebv nuclear igm qn (s),abs; aby; ana; anf; antby; anti; antibodies; antibody; antinuclear antibody; arbitrary concentration; autoantibodies; autoantibody; ebna; ebv; ebv na; epstn; hhv-4; human herpesvirus 4; id; immune globulin m; immunoglobulin m; infectious disease; infectiousdisease; microbiology; mono; mononucleosis; na; nuc; point in time; qnt; quan; quant; quantitative; random; serum; sr,Qn
31382-5,escherichia coli verotoxin 2 ab [units/volume] in stool,e coli vtn2 ab stl-acnc,e. coli verotoxin 2 ab qn (stl),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; bowel movement; e coli; e coli vtn; e coli vtn2; faecal; faeces; fecal; feces; gastro; gastroenterology; gi; id; ii; infectious disease; infectiousdisease; microbiology; o002; point in time; qnt; quan; quant; quantitative; random; stl; stool = fecal,Qn
31383-3,european tick borne encephalitis virus ab [units/volume] in serum,tbev ab ser-acnc,european tick borne encephalitis virus ab qn (s),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; enc; enceph; encephalomyelitis; fsme; id; infectious disease; infectiousdisease; microbiology; point in time; qnt; quan; quant; quantitative; random; serum; sr; tbev; tbev ab,Qn
31390-8,feline panleukopenia virus ab [units/volume] in serum,fplv ab ser-acnc,feline panleukopenia virus ab qn (s),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; feline parvovirus; fpl; fplv; fpv; id; infectious disease; infectiousdisease; microbiology; point in time; qnt; quan; quant; quantitative; random; serum; sr; vet; veterinary,Qn
31395-7,filovirus ab [units/volume] in serum,filovirus ab ser-acnc,filovirus ab qn (s),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; ebola virus; filo virus; id; infectious disease; infectiousdisease; marburg virus; microbiology; point in time; qnt; quan; quant; quantitative; random; serum; sr,Qn
31408-8,hantavirus sin nombre igg ab [units/volume] in serum,snv igg ser-acnc,hantavirus sin nombre igg qn (s),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; hanta virus; hemorrhagic fever with renal syndrome; hfrs; hps; htnv; id; immune globulin g; immunoglobulin g; infectious disease; infectiousdisease; microbiology; orthohantavirus; point in time; qnt; quan; quant; quantitative; random; serum; snv; sr,Qn
31429-4,deprecated histoplasma capsulatum ab [units/volume] in serum,deprecated histoplasma ab ser-acnc,histoplasma sp ab qn (s),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; histo; histopl; histoplasmos; histoplasmosis; id; infectious disease; infectiousdisease; microbiology; point in time; qnt; quan; quant; quantitative; random; serum; species; spp; sr,Qn
31430-2,hiv 1 igg ab [presence] in cerebral spinal fluid,hiv1 igg csf ql,hiv 1 igg ql (csf),abs; aby; aids; antby; anti; antibodies; antibody; autoantibodies; autoantibody; cerebral spinal fluid; cerebrospinal fl; hiv type 1; hiv type i; hiv1; htlv 3; human immunodeficiency virus; i; id; immune globulin g; immunoglobulin g; infectious disease; infectiousdisease; microbiology; neuro; neurology; ordinal; point in time; pr; ql; qual; qualitative; random; screen; spinal fl; spinal fld; spinal flu; spinal fluid,Ord
3143-5,donor relation to patient,donor relation to patient,,clin; nominal; point in time; random; typ,Nom
31438-5,influenza virus a igm ab [units/volume] in serum,fluav igm ser-acnc,fluav igm qn (s),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; avian influenza; bird flu; flua; fluav; fluv; fowl plague; id; immune globulin m; immunoglobulin m; infectious disease; infectiousdisease; influ; influenza a; influenza a virus; microbiology; point in time; qnt; quan; quant; quantitative; random; serum; sr,Qn
31452-6,lassa virus igg ab [units/volume] in serum,lasv igg ser-acnc,lassa virus igg qn (s),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; id; immune globulin g; immunoglobulin g; infectious disease; infectiousdisease; lasv; microbiology; point in time; qnt; quan; quant; quantitative; random; serum; sr,Qn
31461-7,legionella pneumophila 4 ab [units/volume] in serum,l pneumo4 ab ser-acnc,l. pneumophila 4 ab qn (s),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; id; infectious disease; infectiousdisease; l pneumo; l pneumo4; l pneumonphila; legion; legionela; legionella pneumophila serogroup 4; los angeles 1; microbiology; pneu; pneum; pneumophilia; point in time; qnt; quan; quant; quantitative; random; serum; sr,Qn
31491-4,lymphocytic choriomeningitis virus ab [units/volume] in cerebral spinal fluid,lcmv ab csf-acnc,lymphocytic choriomeningitis virus ab qn (csf),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; cerebral spinal fluid; cerebrospinal fl; id; infectious disease; infectiousdisease; lcmv; microbiology; neuro; neurology; point in time; qnt; quan; quant; quantitative; random; spinal fl; spinal fld; spinal flu; spinal fluid,Qn
31492-2,lymphocytic choriomeningitis virus igg ab [units/volume] in cerebral spinal fluid,lcmv igg csf-acnc,lymphocytic choriomeningitis virus igg qn (csf),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; cerebral spinal fluid; cerebrospinal fl; id; immune globulin g; immunoglobulin g; infectious disease; infectiousdisease; lcmv; microbiology; neuro; neurology; point in time; qnt; quan; quant; quantitative; random; spinal fl; spinal fld; spinal flu; spinal fluid,Qn
31495-5,lymphocytic choriomeningitis virus igm ab [units/volume] in serum,lcmv igm ser-acnc,lymphocytic choriomeningitis virus igm qn (s),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; id; immune globulin m; immunoglobulin m; infectious disease; infectiousdisease; lcmv; microbiology; point in time; qnt; quan; quant; quantitative; random; serum; sr,Qn
31511-9,mycoplasma gallisepticum ab [units/volume] in serum,m gallisep ab ser-acnc,m. gallisepticum ab qn (s),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; avian mycoplasmosis; chronic respiratory disease; id; infectious disease; infectiousdisease; m gallisep; m gallisepticum; microbiology; myco; mycoplas; mycoplasm; mycoplasmosis; mycoplsm; point in time; qnt; quan; quant; quantitative; random; serum; sr; vet; veterinary,Qn
31521-8,myelin associated glycoprotein ab [presence] in serum,mag ab ser ql,myelin associated glycoprotein ab ql (s),abs; aby; antby; anti; antibodies; antibody; assoc; autoantibodies; autoantibody; gg; glycoprot; glycoproteins; gp; mag; neuro; neurology; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serology; serum; sr,Ord
3152-6,inhaled oxygen mechanism dose,inhaled o2 mechanism dose,,clin; dose med or substance; inhaled o2; inhaled o2 mechanism; nominal; o2; point in time; random; to2; typ,Nom
31557-2,parvovirus b19 igg ab [units/volume] in cerebral spinal fluid,b19v igg csf-acnc,parvovirus b19 igg qn (csf),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; b19 virus; b19v; cerebral spinal fluid; cerebrospinal fl; fifth disease; id; immune globulin g; immunoglobulin g; infectious disease; infectiousdisease; microbiology; neuro; neurology; parvo; parvo virus; parvov; point in time; qnt; quan; quant; quantitative; random; spinal fl; spinal fld; spinal flu; spinal fluid,Qn
31582-0,reovirus ab [units/volume] in body fluid,reovirus ab fld-acnc,reovirus ab qn (body fld),"abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; b/f; bf; bod; bodies; body fluid; body fluid, unsp; fl; fld; flu; fluid; id; infectious disease; infectiousdisease; microbiology; point in time; qnt; quan; quant; quantitative; random; reo virus; reov",Qn
31585-3,reticulin igg ab [presence] in serum,reticulin igg ser ql,reticulin igg ql (s),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; immune globulin g; immunoglobulin g; ordinal; point in time; pr; ql; qual; qualitative; random; reticuline; screen; serology; serum; sr,Ord
31615-8,ross river virus igm ab [presence] in serum,rrv igm ser ql,ross river virus igm ql (s),abs; aby; antby; anti; antibodies; antibody; arbovirus; autoantibodies; autoantibody; id; immune globulin m; immunoglobulin m; infectious disease; infectiousdisease; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; rrv; screen; serum; sr,Ord
31621-6,salmonella typhi h d ab [units/volume] in serum,s typhi h d ab ser-acnc,s. typhi h d ab qn (s),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; dextro; id; infectious disease; infectiousdisease; microbiology; point in time; qnt; quan; quant; quantitative; random; rh; rhesus; s typhi; s typhi h; s typhi h d; s typhosa; sal; salmonel; salmonella typhi d; serum; sr; typh; typhoid,Qn
31624-0,schistosoma sp igg ab [units/volume] in cerebral spinal fluid,schistosoma igg csf-acnc,schistosoma sp igg qn (csf),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; bilharziasis; blood fluke; cercarial dermatitis; cerebral spinal fluid; cerebrospinal fl; id; immune globulin g; immunoglobulin g; infectious disease; infectiousdisease; microbiology; neuro; neurology; point in time; qnt; quan; quant; quantitative; random; schistosomiasis; species; spinal fl; spinal fld; spinal flu; spinal fluid; spp,Qn
31633-1,sporothrix schenckii ab [units/volume] in cerebral spinal fluid,s schenckii ab csf-acnc,s. schenckii ab qn (csf),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; cerebral spinal fluid; cerebrospinal fl; id; infectious disease; infectiousdisease; microbiology; neuro; neurology; point in time; qnt; quan; quant; quantitative; random; s schenckii; spinal fl; spinal fld; spinal flu; spinal fluid; sporotrichosis,Qn
31639-8,streptococcus pneumoniae danish serotype 6b igg ab [units/volume] in serum --2nd specimen,s pneum da 6b igg sp2 ser-acnc,s. pneumoniae danish type 6b igg spec 2 qn (s),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; convalescent; id; immune globulin g; immunoglobulin g; infectious disease; infectiousdisease; microbiology; pcv13; pcv7; pneu; pneum; pneumo; pneumococ; pneumococcal; pneumococcal pneumonia; pneumococcus; pneumon; pneumonia; point in time; post immunization; ppsv23; qnt; quan; quant; quantitative; random; s pneum da 6b; s pneum da 6b ab; s pneum da 6b igg; s pneum da type; s pneumo; s pneumoniae; second; serum; sp2; spec; spn; sr; strep; strept; u.s. serotype 26,Qn
31640-6,deprecated streptococcus pneumoniae 3 ab [units/volume] in serum,deprecated s pneum3 ab ser-acnc,s. pneumoniae 3 ab qn (s),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; id; iii; infectious disease; infectiousdisease; microbiology; pneu; pneum; pneumo; pneumococ; pneumococcal; pneumococcal pneumonia; pneumococcus; pneumon; pneumonia; point in time; qnt; quan; quant; quantitative; random; s pneum3; s pneumo; s pneumoniae; serum; spn; sr; strep; strept,Qn
31646-3,streptococcus pneumoniae danish serotype 7f igg ab [units/volume] in serum --2nd specimen,s pneum da 7f igg sp2 ser-acnc,s. pneumoniae danish type 7f igg spec 2 qn (s),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; convalescent; id; immune globulin g; immunoglobulin g; infectious disease; infectiousdisease; microbiology; pcv13; pneu; pneum; pneumo; pneumococ; pneumococcal; pneumococcal pneumonia; pneumococcus; pneumon; pneumonia; point in time; post immunization; ppsv23; qnt; quan; quant; quantitative; random; s pneum da 7f; s pneum da 7f ab; s pneum da 7f igg; s pneum da type; s pneumo; s pneumoniae; second; serum; sp2; spec; spn; sr; strep; strept; u.s. serotype 51,Qn
31656-2,deprecated streptococcus pneumoniae 9 igg ab [units/volume] in serum --1st specimen,deprecated s pneum9 igg sp1 ser-acnc,s. pneumoniae 9 igg spec 1 qn (s),abs; aby; acute specimen; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; first; id; immune globulin g; immunoglobulin g; infectious disease; infectiousdisease; microbiology; pneu; pneum; pneumo; pneumococ; pneumococcal; pneumococcal pneumonia; pneumococcus; pneumon; pneumonia; point in time; pre immunization; qnt; quan; quant; quantitative; random; s pneum9; s pneumo; s pneumoniae; serum; sp1; spec; spn; sr; strep; strept; streptococcus pneumoniae 9n,Qn
31657-0,deprecated streptococcus pneumoniae 9 igg ab [units/volume] in serum --2nd specimen,deprecated s pneum9 igg sp2 ser-acnc,s. pneumoniae 9 igg spec 2 qn (s),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; convalescent; id; immune globulin g; immunoglobulin g; infectious disease; infectiousdisease; microbiology; pneu; pneum; pneumo; pneumococ; pneumococcal; pneumococcal pneumonia; pneumococcus; pneumon; pneumonia; point in time; post immunization; qnt; quan; quant; quantitative; random; s pneum9; s pneumo; s pneumoniae; second; serum; sp2; spec; spn; sr; strep; strept; streptococcus pneumoniae 9n,Qn
31667-9,sulfatide ab [presence] in serum,sulfatide ab ser ql,sulfatide ab ql (s),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; neuro; neurology; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serology; serum; sr,Ord
31678-6,ganglioside gq1b igg ab [units/volume] in serum,gq1b gangl igg ser-acnc,ganglioside gq1b igg qn (s),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; gq1b; gq1b gangl; immune globulin g; immunoglobulin g; point in time; qnt; quan; quant; quantitative; random; serology; serum; sr; tetrasialylganglioside,Qn
31687-7,trichinella sp igm ab [units/volume] in serum,trichinella igm ser-acnc,trichinella sp igm qn (s),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; id; immune globulin m; immunoglobulin m; infectious disease; infectiousdisease; microbiology; point in time; qnt; quan; quant; quantitative; random; serum; species; spp; sr; tric; trich,Qn
31689-3,trivittatus virus ab [units/volume] in serum,tvtv ab ser-acnc,trivittatus virus ab qn (s),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; id; infectious disease; infectiousdisease; microbiology; point in time; qnt; quan; quant; quantitative; random; serum; sr; tvtv,Qn
31704-0,west nile virus igm ab [presence] in serum,wnv igm ser ql,west nile virus igm ql (s),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; id; immune globulin m; immunoglobulin m; infectious disease; infectiousdisease; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; sr; wnv,Ord
31718-0,astrovirus ag [presence] in stool,hastv ag stl ql,astrovirus ag ql (stl),antigen; antigens; astro virus; bowel movement; faecal; faeces; fecal; feces; hastv; id; infectious disease; infectiousdisease; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; screen; stl; stool = fecal,Ord
31734-7,border disease virus ag [presence] in specimen,border dv ag spec ql,border disease virus ag ql (specimen),antigen; antigens; bdv; border disease; border dv; dis; diseases; dz; hairy shaker disease; id; infectious disease; infectiousdisease; microbiology; misc; miscellaneous; ordinal; other; pestivirus; point in time; pr; ql; qual; qualitative; random; screen; spec; to be specified in another part of the message; unspecified; vet; veterinary,Ord
31735-4,bordetella bronchiseptica ag [presence] in specimen,b bronch ag spec ql,b. bronchiseptica ag ql (specimen),antigen; antigens; b bronch; b bronchiseptica; id; infectious disease; infectiousdisease; microbiology; misc; miscellaneous; ordinal; other; point in time; pr; ql; qual; qualitative; random; screen; spec; to be specified in another part of the message; unspecified,Ord
31741-2,bovine diarrhea virus ag [presence] in nose,bvdv ag nose ql,bovine diarrhea virus ag ql (nose),antigen; antigens; bdv; beef; bovine viral diarrhea; bvd; bvdv; id; infectious disease; infectiousdisease; microbiology; mucosal disease; nasal; nos; nose (nasal passage); ordinal; pestivirus; point in time; pr; ql; qual; qualitative; random; screen; smell; vet; veterinary,Ord
31749-5,bovine herpesvirus 4 ag [presence] in body fluid,bohv4 ag fld ql,bovine herpesvirus 4 ag ql (body fld),"antigen; antigens; b/f; beef; bf; bod; bodies; body fluid; body fluid, unsp; bohv; bohv4; fl; fld; flu; fluid; herpes virus; id; infectious disease; infectiousdisease; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; screen; vet; veterinary",Ord
31751-1,bovine respiratory syncytial virus ag [presence] in lung,brsv ag lung ql,bovine respiratory syncytial virus ag ql (lung),antigen; antigens; beef; brsv; hrsv; id; infectious disease; infectiousdisease; lung; microbiology; ordinal; point in time; pr; pulmonary; pulmonology; ql; qual; qualitative; random; respiratory; rsv; screen; vet; veterinary,Ord
31754-5,brucella sp ag [presence] in placenta,brucella ag placenta ql,brucella sp ag ql (placenta),antigen; antigens; bruc; brucellosis; id; infectious disease; infectiousdisease; microbiology; ordinal; placent; placental; point in time; pr; ql; qual; qualitative; random; screen; species; spp,Ord
3175-7,antithrombin ag [units/volume] in platelet poor plasma by immunoassay,at iii ag ppp ia-acnc,antithrombin ag ia qn (ppp),anti thrombin; antigen; antigens; antithrm; antithrombin iii; antithrombn; arbitrary concentration; at; at iii; atiii; coagulation; eia; elfa; elisa; enzyme immunoassay; hematology; heme; heparin cofactor i; iaa; meia; plas; platelet poor plasma; point in time; qnt; quan; quant; quantitative; random; suds; thrombin inhibitor i; universallaborders,Qn
31758-6,candida albicans ag [presence] in serum,c albicans ag ser ql,c. albicans ag ql (s),antigen; antigens; c albicans; cand; candidiasis; id; infectious disease; infectiousdisease; m005; m5; microbiology; monilia; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; sr; thrush,Ord
31760-2,candida sp ag [units/volume] in serum,candida ag ser-acnc,candida sp ag qn (s),antigen; antigens; arbitrary concentration; cand; candidiasis; id; infectious disease; infectiousdisease; microbiology; monilia; point in time; qnt; quan; quant; quantitative; random; serum; species; spp; sr; thrush,Qn
31766-9,chlamydia sp ag [presence] in stool,chlamydia ag stl ql,chlamydia sp ag ql (stl),antigen; antigens; bowel movement; chlam; chlamid; faecal; faeces; fecal; feces; id; infectious disease; infectiousdisease; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; screen; species; spp; stl; stool = fecal,Ord
31768-5,chlamydia trachomatis ag [presence] in blood,c trach ag bld ql,c. trachomatis ag ql (bld),antigen; antigens; blood; c trac; c trach; c tracho; c trachomatis; chlam; chlam trac; chlamid; ct; id; infectious disease; infectiousdisease; lgv; lymphogranuloma venereum; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; screen; trachoma; wb; whole blood,Ord
31769-3,chlamydia trachomatis ag [presence] in conjunctival specimen,c trach ag conjunct ql,c. trachomatis ag ql (conj),antigen; antigens; c trac; c trach; c tracho; c trachomatis; chlam; chlam trac; chlamid; conjunct; conjunctiva; conjunctival; ct; id; infectious disease; infectiousdisease; lgv; lymphogranuloma venereum; microbiology; ordinal; palpebral sac; point in time; pr; ql; qual; qualitative; random; screen; trachoma,Ord
31781-8,classical swine fever virus ag [presence] in specimen,csfv ag spec ql,classical swine fever virus ag ql (specimen),antigen; antigens; classical swine fever; csfv; hog cholera; id; infectious disease; infectiousdisease; microbiology; misc; miscellaneous; ordinal; other; pestivirus; pig; point in time; pork; pr; ql; qual; qualitative; random; screen; spec; to be specified in another part of the message; unspecified; vet; veterinary,Ord
31785-9,deprecated cryptococcus neoformans ag [units/volume] in cerebral spinal fluid,deprecated c neoform ag csf-acnc,c. neoformans ag qn (csf),antigen; antigens; arbitrary concentration; c neoform; c neoformans; cerebral spinal fluid; cerebrospinal fl; crypt; crypto; cryptococcal; cryptococcosis; cryptococcosus; id; infectious disease; infectiousdisease; microbiology; neuro; neurology; point in time; qnt; quan; quant; quantitative; random; spinal fl; spinal fld; spinal flu; spinal fluid,Qn
31786-7,deprecated cryptococcus neoformans ag [units/volume] in serum,deprecated c neoform ag ser-acnc,c. neoformans ag qn (s),antigen; antigens; arbitrary concentration; c neoform; c neoformans; crypt; crypto; cryptococcal; cryptococcosis; cryptococcosus; id; infectious disease; infectiousdisease; microbiology; point in time; qnt; quan; quant; quantitative; random; serum; sr,Qn
31793-3,cryptosporidium sp ag [units/volume] in stool,cryptosp ag stl-acnc,cryptosporidium sp ag qn (stl),antigen; antigens; arbitrary concentration; bowel movement; crypt; crypto; cryptosporidiosis; faecal; faeces; fecal; feces; gastro; gastroenterology; gi; id; infectious disease; infectiousdisease; microbiology; point in time; qnt; quan; quant; quantitative; random; species; spp; stl; stool = fecal,Qn
31813-9,epizootic hemorrhagic disease virus ag [presence] in lung,ehdv ag lung ql,epizootic hemorrhagic disease virus ag ql (lung),antigen; antigens; arbovirus; culicoides; dis; diseases; dz; ehdv; epizootic hemorrhagic disease of deer; id; infectious disease; infectiousdisease; lung; microbiology; orbivirus; ordinal; point in time; pr; pulmonary; pulmonology; ql; qual; qualitative; random; respiratory; screen; vet; veterinary,Ord
31836-0,haemophilus influenzae c ag [presence] in specimen,haem influ c ag spec ql,h. influenzae c ag ql (specimen),antigen; antigens; h flu; h influenza; h influenzae; haem influ; haem influ c; haemoph; id; infectious disease; infectiousdisease; influ; microbiology; misc; miscellaneous; ordinal; other; point in time; pr; ql; qual; qualitative; random; rh; rh blood group system; screen; spec; to be specified in another part of the message; unspecified,Ord
3184-9,activated clotting time (act) of blood by coagulation assay,act bld,act coag (bld),act; activ; activated coagulation time; blood; clot; clottable; coagulation; coagulation activated; coagulation assay; coagulation time; hematology; heme; point in time; qnt; quan; quant; quantitative; random; rate; r-time; tilt tube; universallaborders; wb; whole blood,Qn
31849-3,herpes simplex virus 2 ag [presence] in genital specimen,hsv2 ag genital ql,hsv 2 ag ql (genital specimen),antigen; antigens; gen; genital tract; herp splx; herpes simplex virus type 2; herpes simplex virus type ii; hsv; hsv2; id; ii; infectious disease; infectiousdisease; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; screen; urogenit; urogenital,Ord
31850-1,herpes simplex virus 2 ag [presence] in skin,hsv2 ag skin ql,hsv 2 ag ql (skin),antigen; antigens; dermatologic; epidermis; herp splx; herpes simplex virus type 2; herpes simplex virus type ii; hsv; hsv2; id; ii; infectious disease; infectiousdisease; integument; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; screen; skn,Ord
31853-5,herpes simplex virus ag [presence] in serum,hsv ag ser ql,hsv ag ql (s),antigen; antigens; herp splx; hsv; id; infectious disease; infectiousdisease; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; sr,Ord
31888-1,mumps virus ag [presence] in cerebral spinal fluid,muv ag csf ql,muv ag ql (csf),antigen; antigens; cerebral spinal fluid; cerebrospinal fl; id; infectious disease; infectiousdisease; microbiology; muv; neuro; neurology; ordinal; point in time; pr; ql; qual; qualitative; random; screen; spinal fl; spinal fld; spinal flu; spinal fluid,Ord
31889-9,mumps virus ag [presence] in cervix,muv ag cvx ql,muv ag ql (cvx),antigen; antigens; cervix; genital tract; gyn; gynecology; id; infectious disease; infectiousdisease; microbiology; muv; ob; obgyn; obstetrics; ordinal; point in time; pr; ql; qual; qualitative; random; screen,Ord
31898-0,mumps virus ag [presence] in urine sediment,muv ag urns ql,muv ag ql (urine sed),antigen; antigens; id; infectious disease; infectiousdisease; microbiology; muv; ordinal; point in time; pr; ql; qual; qualitative; random; screen; ua; ur; urine sediment; urn; urns,Ord
31900-4,mumps virus ag [presence] in specimen,muv ag spec ql,muv ag ql (specimen),antigen; antigens; id; infectious disease; infectiousdisease; microbiology; misc; miscellaneous; muv; ordinal; other; point in time; pr; ql; qual; qualitative; random; screen; spec; to be specified in another part of the message; unspecified,Ord
31921-0,neisseria meningitidis serogroup y ag [presence] in specimen,n men sg y ag spec ql,n. meningitidis y ag ql (specimen),antigen; antigens; id; infectious disease; infectiousdisease; mening; meningid; meningitis; meningo; meningococcal meningitis; meningococcus; microbiology; misc; miscellaneous; n men; n men serogroup; n men sg y; n men sg y ag; n menigitidis; n meningitidis; neisseria meningitidis group y; neisseria meningitidis type y; ordinal; other; point in time; pr; ql; qual; qualitative; random; screen; spec; to be specified in another part of the message; unspecified,Ord
31931-9,plasmodium vivax ag [units/volume] in blood,p vivax ag bld-acnc,p. vivax ag qn (bld),antigen; antigens; arbitrary concentration; blood; id; infectious disease; infectiousdisease; malaria; malarial; microbiology; p vivax; point in time; qnt; quan; quant; quantitative; random; wb; whole blood,Qn
319-4,methacycline [susceptibility] by minimum inhibitory concentration (mic),methacycline islt mic,methacycline mic [susc],antibiotic susceptibilities; ast; benciclina; esarondil; franciclina; francomicinas; id; infectious disease; infectiousdisease; islt; isol; matamicina; medomycin; metacycline; metadomus; methylenecycline; minimum inhibitory concentration; paveciclina; physiomicine; point in time; quickmicina; random; rondomycin; rotilen; stafilon; sus; suscept; susceptibilities; susceptibility; susceptibilty; treis-ciclina; wassermicina,OrdQn
3194-8,coagulation factor v ag [units/volume] in platelet poor plasma by immunoassay,fact v ag ppp ia-acnc,coagulation factor v ag ia qn (ppp),antigen; antigens; arbitrary concentration; coag; eia; elfa; elisa; enzyme immunoassay; fac; fact; fact v; factor 5; fv; hematology; heme; iaa; meia; plas; platelet poor plasma; point in time; proaccelerin; proaccelerin accelerator globulin; qnt; quan; quant; quantitative; random; rh blood group system; suds; the labile factor,Qn
31959-0,rubella virus ag [presence] in nose,rubv ag nose ql,rubella virus ag ql (nose),antigen; antigens; congenital rubella syndrome; german measles; id; infectious disease; infectiousdisease; microbiology; nasal; nos; nose (nasal passage); ordinal; point in time; pr; ql; qual; qualitative; random; rubv; screen; smell,Ord
3196-3,coagulation factor vii inhibitor [units/volume] in platelet poor plasma by coagulation assay,fact vii inhib ppp-acnc,coagulation factor vii inhibitor coag qn (ppp),arbitrary concentration; clot; clottable; coag; coagulation assay; f7; fac; fact; fact vii; fact vii inhib; factor 7; fvii; hematology; heme; inhib; inhibit; plas; platelet poor plasma; point in time; proconvertin; qnt; quan; quant; quantitative; random; serum prothrombin conversion accelerator; spca; tilt tube,Qn
31967-3,streptococcus agalactiae ag [presence] in throat,gp b strep ag throat ql,s. agalactiae ag ql (throat),antigen; antigens; gbs; gp b strep; group b; group b strep; id; infectious disease; infectiousdisease; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; s agalactiae; screen; steptococcus group b; strep; strep b; strep group b; strept; streptococci group b; throat; upper respiratory,Ord
31969-9,streptococcus pneumoniae ag [presence] in specimen,s pneum ag spec ql,s. pneumoniae ag ql (specimen),antigen; antigens; id; infectious disease; infectiousdisease; microbiology; misc; miscellaneous; ordinal; other; pneu; pneum; pneumo; pneumococ; pneumococcal; pneumococcal pneumonia; pneumococcus; pneumon; pneumonia; point in time; pr; ql; qual; qualitative; random; s pneumo; s pneumoniae; screen; spec; spn; strep; strept; to be specified in another part of the message; unspecified,Ord
31974-9,taenia hydatigena ag [presence] in stool,t hydatigena ag stl ql,t. hydatigena ag ql (stl),antigen; antigens; bowel movement; faecal; faeces; fecal; feces; id; infectious disease; infectiousdisease; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; screen; stl; stool = fecal; t hydatigena; tapeworm,Ord
31981-4,varicella zoster virus ag [presence] in skin,vzv ag skin ql,vzv ag ql (skin),antigen; antigens; chicken pox; chicken pox virus; chickenpox; dermatologic; epidermis; herpes zoster; hhv-3; human herpesvirus 3; id; infectious disease; infectiousdisease; integument; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; screen; shingles; skn; vz; vzv; zoster,Ord
31987-1,western equine encephalitis virus ag [presence] in serum,weev ag ser ql,weev ag ql (s),antigen; antigens; enc; enceph; encephalomyelitis; equin; id; infectious disease; infectiousdisease; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; sr; togavirus; wee virus; weev; west,Ord
31991-3,acylcarnitine [presence] in serum or plasma,acylcarnitine serpl ql,acylcarnitine ql,acyl carnitine; acylcarni; chemistry; ordinal; pl; plasma; plsm; point in time; pr; ql; qual; qualitative; random; screen; serp; serpl; serplas; serum; serum or plasma; sr,Ord
32006-9,chlamydia trachomatis c ab [titer] in serum,c trach c ab titr ser,c. trachomatis c ab (s) [titer],abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; c trac; c trach; c trach c; c tracho; c trachomatis; chlam; chlam trac; chlamid; chlamydia trachomatis type c; ct; dilution factor; dilution factor (titer); id; infectious disease; infectiousdisease; lgv; lymphogranuloma venereum; microbiology; point in time; random; rh blood group system; serum; smqn; sr; titer; titered; titre; trachoma; ttr,SemiQn
32010-1,diuretics [identifier] in serum or plasma by screen method,diuretics serpl scn,diuretics screen nom,diuretic; drug/toxicology; drugs; identity or presence; nominal; pl; plasma; plsm; point in time; random; scn; scr; scrn; serp; serpl; serplas; serum; serum or plasma; sr,Nom
32017-6,hemoglobin.other/hemoglobin.total in blood by electrophoresis,hgb other mfr bld elph,hemoglobin.other elph (bld) [mass fraction],blood; elec; elect; electr; electro; electrophhrs; electrophrs; elp; elph; ep; haemoglobin; hb; hematology/cell counts; hgb; hgb other; mass fraction; othr; percent; point in time; qnt; quan; quant; quantitative; random; tot; totl; wb; whole blood,Qn
32022-6,hydroxyproline free [moles/volume] in 24 hour urine,oh-proline free 24h ur-scnc,hydroxyproline free (24h u) [moles/vol],1 day; 24 hours; 24hr; chemistry; fr; hydroxylproline; hydroxyprol; hydroxy-proline; hydrxprol; hydrxproln; hydrxyprln; hyp; level; non-protein bound; ohpro; oh-proline; oh-proline free; qnt; quan; quant; quantitative; substance concentration; ua; ur; urn,Qn
32030-9,nitrate [presence] in urine,nitrate ur ql,nitrate ql (u),drug/toxicology; drugs; no3; ordinal; point in time; pr; ql; qual; qualitative; random; screen; ua; ur; urn,Ord
32034-1,granulocytes [presence] in cerebral spinal fluid by wright stain,granulocytes csf ql wright stn,granulocytes wright stain ql (csf),cerebral spinal fluid; cerebrospinal fl; gran; grans; granulocyte; granulocytes; hematology/cell counts; ordinal; point in time; pr; ql; qual; qualitative; random; screen; spinal fl; spinal fld; spinal flu; spinal fluid; st; stains; stn; wright stn; wrights,Ord
32035-8,granulocytes [presence] in body fluid by wright stain,granulocytes fld ql wright stn,granulocytes wright stain ql (body fld),"b/f; bf; bod; bodies; body fluid; body fluid, unsp; fl; fld; flu; fluid; gran; grans; granulocyte; granulocytes; hematology/cell counts; ordinal; point in time; pr; ql; qual; qualitative; random; screen; st; stains; stn; wright stn; wrights",Ord
32038-2,granulocytes [presence] in peritoneal fluid by wright stain,granulocytes prt ql wright stn,granulocytes wright stain ql (periton fld),ascites; ascitic fluid; ascitis; gran; grans; granulocyte; granulocytes; hematology/cell counts; ordinal; peritoneal fluid; point in time; pr; ql; qual; qualitative; random; screen; st; stains; stn; wright stn; wrights,Ord
32043-2,uroporphyrin/creatinine [molar ratio] in 24 hour urine,uropor/creat 24h ur-srto,uroporphyrin/creatinine (24h u) [molar ratio],1 day; 24 hours; 24hr; chemistry; cr; crea; creat; octacarboxyl porphyrin; octacarboxylporphyrin; octacarboxyphyrin; qnt; quan; quant; quantitative; scrto; substance concentration ratio; substance ratio; ua; ucr; ur; urn; urophorph,Qn
32053-1,bupivacaine [moles/volume] in serum or plasma,bupivacaine serpl-scnc,bupivacaine [moles/vol],c285; drug/toxicology; drugs; level; marcain; marcaine; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; sensorcaine; serp; serpl; serplas; serum; serum or plasma; sr; substance concentration; vivacaine,Qn
32056-4,butalbital [moles/volume] in urine,butalbital ur-scnc,butalbital (u) [moles/vol],addiction; allylbarbital; allylbarbituric acid; barbiturate; drug/toxicology; drugs; drugs of abuse; fiorinal; illicit; level; point in time; potentialforabuse; qnt; quan; quant; quantitative; random; substance concentration; ua; ur; urn,Qn
32079-6,gold [moles/volume] in urine,gold ur-scnc,gold (u) [moles/vol],au; drug/toxicology; drugs; level; point in time; qnt; quan; quant; quantitative; random; substance concentration; ua; ur; urn,Qn
32090-3,mepivacaine [presence] in urine,mepivacaine ur ql,mepivacaine ql (u),carbocaine; drug/toxicology; drugs; isocaine; ordinal; point in time; polocaine; pr; ql; qual; qualitative; random; screen; ua; ur; urn,Ord
32111-7,secobarbital [presence] in specimen,secobarbital spec ql,secobarbital ql (specimen),addiction; barbiturate; drug/toxicology; drugs; drugs of abuse; illicit; misc; miscellaneous; ordinal; other; point in time; potentialforabuse; pr; ql; qual; qualitative; random; screen; secobarb; seconal; spec; to be specified in another part of the message; unspecified,Ord
32112-5,sertraline [presence] in urine,sertraline ur ql,sertraline ql (u),drug/toxicology; drugs; ordinal; point in time; pr; ql; qual; qualitative; random; screen; ua; ur; urn; zoloft,Ord
32127-3,ranitidine [presence] in specimen,ranitidine spec ql,ranitidine ql (specimen),drug/toxicology; drugs; misc; miscellaneous; ordinal; other; point in time; pr; ql; qual; qualitative; random; screen; spec; to be specified in another part of the message; unspecified; zantac,Ord
3213-6,coagulation factor viii ag [units/volume] in platelet poor plasma by immunoassay,fact viii ag ppp ia-acnc,coagulation factor viii ag ia qn (ppp),ahf; ahg; antigen; antigens; antihemophilic factor; antihemophilic globulin; arbitrary concentration; circulating anticoagulant; coag; eia; elfa; elisa; enzyme immunoassay; f8; fac; fact; fact viii; factor 8; factor viii clotting activity; fviii; hematology; heme; iaa; meia; plas; platelet poor plasma; point in time; qnt; quan; quant; quantitative; random; suds; thrombocyte cofactor a; viii:c,Qn
32150-5,urate crystals amorphous [#/area] in urine sediment by microscopy high power field,amorph urate cry #/area urns hpf,urate crystals amorphous lm.hpf (urine sed) [#/area],#/area; am; amorph; amorph cry; amorph urate cry; amorphic; crys; cryst; crystal; kidney; lm; micro; micros; microscopic; nephrology; number areic; point in time; qnt; quan; quant; quantitative; random; renal; ua; ur; urates; uric acid; urinalysis; urine sediment; urn; urns,Qn
32159-6,carbonated calcium phosphate/total in stone,carb ca phos mfr stone,carbonated calcium phosphate (stone) [mass fraction],ca; ca phos; ca10(po4-co3oh)6(oh)2; cal; calc; calcium carbapatite; calculi; cap; carb ca phos; carbonate apatite; chemistry; gastro; gastroenterology; gi; i phos; inorganic phosphate; kidney; mass fraction; nephrology; percent; phos; phosphate total; phosphorous; phosphorus; phosphrous; pi; po4; point in time; qnt; quan; quant; quantitative; random; renal; stn; stone; stones; tot; totl,Qn
3216-9,coagulation factor x inhibitor [units/volume] in platelet poor plasma by coagulation assay,fact x inhib ppp-acnc,coagulation factor x inhibitor coag qn (ppp),arbitrary concentration; autoprothrombin iii; clot; clottable; coag; coagulation assay; fac; fact; fact x; fact x inhib; factor 10; fx; hematology; heme; inhib; inhibit; plas; platelet poor plasma; point in time; prothrombokinase; qnt; quan; quant; quantitative; random; stuart-prower factor; tilt tube,Qn
32180-2,herpes simplex virus 1 ab [units/volume] in synovial fluid,hsv1 ab snv-acnc,hsv 1 ab qn (syn fld),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; herp splx; herpes simplex virus type 1; herpes simplex virus type i; hsv; hsv1; i; id; infectious disease; infectiousdisease; joint aspirate; joint fld; joint flu; joint fluid; microbiology; point in time; qnt; quan; quant; quantitative; random; rheum; rheumatology; sf; snv; syn; syn fl; synov; synovial fluid,Qn
32201-6,unidentified cells [#/volume] in cerebral spinal fluid by manual count,unident cells # csf manual,unidentified cells manual cnt (csf) [#/vol],#; abs; absolute; absolutes; cell; cellularity; cerebral spinal fluid; cerebrospinal fl; cnt; count; count/volume; ct; hematology/cell counts; manl; nos ab; number concentration; number concentration (count/vol); point in time; qnt; quan; quant; quantitative; random; spinal fl; spinal fld; spinal flu; spinal fluid; unident cells,Qn
32210-7,protein fractions [interpretation] in 24 hour urine by electrophoresis,prot pattern 24h ur elph-imp,protein fractions elph (24h u) [interp],1 day; 24 hours; 24hr; chemistry; elec; elect; electr; electro; electrophhrs; electrophrs; elp; elph; ep; impression; impression/interpretation of study; impressions; interp; interpretation; kidney; nephrology; nominal; peur; pr; prot; prot pattern; protein fractions; renal; ua; upep; ur; urn,Nom
32211-5,reducing substances [mass/volume] in stool,reducing subs stl-mcnc,reducing substances (stl) [mass/vol],bowel movement; chemistry; faecal; faeces; fecal; feces; level; mass concentration; point in time; qnt; quan; quant; quantitative; random; reduc; reduc subs; reducing substance; stl; stool = fecal,Qn
32213-1,salmonella paratyphi b ab [titer] in serum,s paraty b ab titr ser,s. paratyphi b ab (s) [titer],abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; dilution factor; dilution factor (titer); id; infectious disease; infectiousdisease; microbiology; paratyph; paratyphoid; point in time; random; s paraty; s paraty b; s paratyph; s paratyphi; sal; sal paratyph; sal paratyphi; salmonel; serum; smqn; sr; titer; titered; titre; ttr,SemiQn
32218-0,cyclic citrullinated peptide ab [units/volume] in serum by immunoassay,ccp ab ser ia-acnc,cyclic citrullinated peptide ab ia qn (s),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; ccp; ccp3; cyclic citrulinated peptide; eia; elfa; elisa; enzyme immunoassay; iaa; meia; pept; point in time; qnt; quan; quant; quantitative; random; rheum; rheumatoid arthritis; rheumatology; serology; serum; sr; suds; universallaborders,Qn
32222-2,alanine [moles/volume] in body fluid,alanine fld-scnc,alanine (body fld) [moles/vol],"ala; alpha alanine; b/f; bf; bod; bodies; body fluid; body fluid, unsp; chemistry; fl; fld; flu; fluid; l-alanine; level; point in time; qnt; quan; quant; quantitative; random; substance concentration",Qn
32228-9,argininosuccinate [moles/volume] in amniotic fluid,argininosuccinate amn-scnc,argininosuccinate (amn fld) [moles/vol],af; amn; amn fl; amnio; amniotic flu; amniotic fluid; argininosuccinic acid; arginosuccinate; arginosuccinic acid; asa; chemistry; level; point in time; qnt; quan; quant; quantitative; random; substance concentration,Qn
32239-6,ethanolamine [moles/volume] in amniotic fluid,ethanolamine amn-scnc,ethanolamine (amn fld) [moles/vol],af; amn; amn fl; amnio; amniotic flu; amniotic fluid; chemistry; ea; etn; level; point in time; qnt; quan; quant; quantitative; random; substance concentration,Qn
32241-2,glutamate [moles/volume] in vitreous fluid,glutamate vitf-scnc,glutamate (vitr fld) [moles/vol],c707; chemistry; glu; glutamic acid; level; point in time; qnt; quan; quant; quantitative; random; substance concentration; vitf; vitreous fluid; vitreous humor; vitreous humour,Qn
32265-1,phenylalanine/tyrosine [molar ratio] in serum or plasma,phe/tyr serpl-srto,phenylalanine/tyrosine [molar ratio],chemistry; phe; phe+tyr; phenylalanine +tyrosine; pl; plasma; plsm; point in time; ppa; qnt; quan; quant; quantitative; random; scrto; serp; serpl; serplas; serum; serum or plasma; sr; substance concentration ratio; substance ratio; tyr,Qn
32274-3,thiosulfate/creatinine [ratio] in urine,thiosulfate/creat ur-rto,thiosulfate/creatinine (u) [ratio],chemistry; cr; crea; creat; point in time; qnt; quan; quant; quantitative; random; ratios; rto; thiosulphate; ua; ucr; ur; urn,Qn
3227-6,coagulation factor xi activity [units/volume] in platelet poor plasma by chromogenic method,fact xi ppp chro-acnc,coagulation factor xi activity chromogenic method qn (ppp),activ; actvty; antihemophilic factor c; arbitrary concentration; chromogenic assay; coag; enzy; enzymatic assay; fac; fact; fact xi; factor 11; fxi; hematology; heme; movements; plas; plasma thromboplastin antecedent; platelet poor plasma; point in time; pta; qnt; quan; quant; quantitative; random,Qn
32329-5,magnesium [moles/volume] in specimen,magnesium spec-scnc,magnesium (specimen) [moles/vol],chemistry; level; mag; magnes; mg; misc; miscellaneous; other; point in time; qnt; quan; quant; quantitative; random; spec; substance concentration; to be specified in another part of the message; unspecified,Qn
32334-5,pipecolate [moles/volume] in serum or plasma,pipecolate serpl-scnc,pipecolate [moles/vol],chemistry; level; pipa; pipecolic acid; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; substance concentration,Qn
32357-6,deprecated microscopic observation [identifier] in stool by ova & parasite preparation,deprecated o+p stl,ova+parasites identified nom (stl),bowel movement; faecal; faeces; fecal; feces; gastro; gastroenterology; gi; id; identity or presence; infectious disease; infectiousdisease; isolated; microbiology; nominal; o&p; o+p; ova and parasite; ovum; parasite; point in time; random; stl; stool = fecal,Nom
32366-7,hepatitis b virus genotype [identifier] in serum or plasma by naa with probe detection,hbv gentyp serpl naa+probe,hbv genotype naa+probe,3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; dna nucleic acid probe; dna probe; gentyp; hbv; hep; hep b; hepatis; hepatit; hepatology; hepb; id; identity or presence; infectious disease; infectiousdisease; lat; lcr; ligase chain reaction; ligation-activated transcription; liver; microbiology; naa+probe; naat; nasba; nominal; nucleic acid sequence based analysis; pcr; pl; plasma; plsm; point in time; polymerase chain reaction; probe amp; probe with ampification; probe with target amplification; qbr; random; sda; serp; serpl; serplas; serum; serum or plasma; sr; strand displacement amplification; tma; transcription mediated amplification,Nom
32369-1,clostridium perfringens enterotoxin [identifier] in specimen,c perfringens etx spec,c. perfringens enterotoxin nom (specimen),c perfringens; c perfringens etx; etx; id; identity or presence; infectious disease; infectiousdisease; microbiology; misc; miscellaneous; nominal; other; point in time; random; spec; to be specified in another part of the message; unspecified,Nom
32374-1,cefotiam [susceptibility],cefotiam susc islt,cefotiam [susc],antibiotic susceptibilities; ast; id; infectious disease; infectiousdisease; islt; isol; point in time; random; spizef; sus; suscept; susceptibilities; susceptibility; susceptibilty,OrdQn
32376-6,clinafloxacin [susceptibility],clinafloxacin susc islt,clinafloxacin [susc],antibiotic susceptibilities; ast; id; infectious disease; infectiousdisease; islt; isol; point in time; random; sus; suscept; susceptibilities; susceptibility; susceptibilty,OrdQn
3242-5,recalcification time in platelet poor plasma by coagulation assay,recal time ppp,recalcification time coag (ppp) [time],ca; cal; clot; clottable; coag; coagulation assay; hematology; heme; plas; platelet poor plasma; point in time; qnt; quan; quant; quantitative; random; recal time; recalcification time; tilt tube,Qn
32425-1,physical findings of cornea,phys find cornea,,corneal; exam; examination; finding; findings; h+p; h+p.px; nominal; p prime; phys find; point in time; random,Nom
32435-0,history of hereditary disorders,hx of hereditary disorders,,h+p; h+p.hx; history; nominal; p prime; point in time; random; sx; symp + dis,Nom
3244-1,clot lysis [time] in platelet poor plasma by coagulation assay,clot lysis ppp,clot lysis coag (ppp) [time],clot; clot firmness reduction; clot lysis; clottable; coagulation; coagulation assay; eug; euglobulin clot lysis time; hematology; heme; plas; platelet poor plasma; point in time; qnt; quan; quant; quantitative; random; tilt tube,Qn
32459-0,physical findings of optic lens,phys find optic lens,,exam; examination; finding; findings; h+p; h+p.px; nominal; p prime; phys find; point in time; random,Nom
32483-0,physical findings of tongue,phys find tongue,,exam; examination; finding; findings; h+p; h+p.px; nominal; p prime; phys find; point in time; random,Nom
32518-3,cd3+cd8+ (t8 suppressor) cells/cells in specimen,cd3+cd8+ cells nfr spec,cd3+cd8+ (t8 suppressor) cells/cells (specimen),cd3 cells; cd3+cd8+ cells; cd8 t cells; cell; cell markers; cellularity; leu2; leu-2; leu4; leu-4; misc; miscellaneous; number fraction; other; percent; point in time; qnt; quan; quant; quantitative; random; spec; suppressor t cells; suppressor/cytotoxic t cells; t3; t8; t-8; t8 suppressor cells; to be specified in another part of the message; tsuppressor; unspecified,Qn
32521-7,cd10+cd19+ cells/cells in specimen,cd10+cd19+ cells nfr spec,cd10+cd19+ cells/cells (specimen),b4; b-4; calla; cd10 cells; cd10+cd19+ cells; cell; cell markers; cellularity; common acute lymphoblastic leukemia; common acute lymphoblastic leukemia antigen; enkephalinase; gp100; hd-37; j5; leu12; leu-12; misc; miscellaneous; nep; neprilysin; neutral endopeptidase metalloendopeptidase; number fraction; other; percent; point in time; qnt; quan; quant; quantitative; random; spec; to be specified in another part of the message; unspecified,Qn
32543-1,creatinine [molar amount] in urine collected for unspecified duration,creat ?tm sub ur qn,creatinine unsp time (u) [molar amount],?tm; chemistry; cr; crea; creat; kidney; nephrology; qnt; quan; quant; quantitative; renal; substance amount; ua; ucr; ur; urn,Qn
32551-4,protein [mass] in urine collected for unspecified duration,prot ?tm ur qn,protein unsp time (u) [mass],?tm; kidney; nephrology; pr; prot; qnt; quan; quant; quantitative; renal; ua; ur; urinalysis; urn,Qn
32552-2,pyruvate kinase [enzymatic activity/mass] in red blood cells,pk rbc-ccnt,pyruvate kinase (rbc) [catalytic activity/mass],catalytic content; chemistry; erythrocytes; pk; point in time; pyruvic acid; qnt; quan; quant; quantitative; random; red blood cells; red blood corpusles,Qn
32569-6,corynebacterium diphtheriae ab [units/volume] in serum --1st specimen,c diphtheriae ab sp1 ser-acnc,c. diphtheriae ab spec 1 qn (s),abs; aby; acute specimen; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; c diphtheriae; diphtheria; diptheria; first; id; infectious disease; infectiousdisease; microbiology; point in time; pre immunization; qnt; quan; quant; quantitative; random; serum; sp1; spec; sr,Qn
32587-8,androstenedione [moles/volume] in serum or plasma --2 hours post xxx challenge,androst 2h p chal serpl-scnc,androstenedione 2 hr post unsp challenge [moles/vol],120 min; 120 minutes; 120min; 2 hours; 2h p chal; after; chemistry.challenge testing; gamma-4-androstenedione; level; p chal; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; substance concentration,Qn
32588-6,androstenedione [moles/volume] in serum or plasma --1 hour post xxx challenge,androst 1h p chal serpl-scnc,androstenedione 1 hr post unsp challenge [moles/vol],1 hour; 1.0hr; 1h p chal; 60 min; 60 minutes; 60m; 60min; after; chemistry.challenge testing; gamma-4-androstenedione; level; p chal; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; substance concentration,Qn
32590-2,granulocytes units available [#],granulocytes avail bpu,granulocytes units available (bpu) [#],blood bank; blood product unit; blood product unit (pack); cnt; count; gran; grans; granulocyte; granulocytes; granulocytes avail; number; point in time; qnt; quan; quant; quantitative; random,Qn
3259-9,fibrinogen fragments ag [units/volume] in platelet poor plasma by immunoassay,fibrinogen frg ag ppp ia-acnc,fibrinogen fragments ag ia qn (ppp),antigen; antigens; arbitrary concentration; coagulation; coagulation factor i; eia; elfa; elisa; enzyme immunoassay; fgdp; fgn; fibrinogen frg; frag; fragment; hematology; heme; iaa; meia; plas; platelet poor plasma; point in time; qnt; quan; quant; quantitative; random; suds,Qn
32611-6,amino acids [moles/volume] in amniotic fluid,amino acids amn-scnc,amino acids (amn fld) [moles/vol],aa; acd; acid; af; amino acid; amino acids.total; amn; amn fl; amnio; amniotic flu; amniotic fluid; chemistry; level; point in time; qnt; quan; quant; quantitative; random; substance concentration,Qn
32612-4,amino acids [moles/volume] in vitreous fluid,amino acids vitf-scnc,amino acids (vitr fld) [moles/vol],aa; acd; acid; amino acid; amino acids.total; chemistry; level; point in time; qnt; quan; quant; quantitative; random; substance concentration; vitf; vitreous fluid; vitreous humor; vitreous humour,Qn
32617-3,ornithine carbamoyltransferase [enzymatic activity/mass] in tissue,oct tiss-ccnt,ornithine carbamoyltransferase (tiss) [catalytic activity/mass],"catalytic content; chemistry; oct; orn; ornithine transcarbamylase; point in time; qnt; quan; quant; quantitative; random; tissue; tissue, unspecified",Qn
32618-1,3-methoxytyramine [mass/time] in 24 hour urine,3me-tyramine 24h ur-mrate,3-methoxytyramine (24h u) [mass/time],1 day; 24 hours; 24hr; 3me-tyramine; chemistry; dopamine metabolite; iii; mass rate; mrate; qnt; quan; quant; quantitative; ua; ur; urn,Qn
32627-2,argininosuccinate lyase [enzymatic activity/mass] in red blood cells,asa lyase rbc-ccnt,argininosuccinate lyase (rbc) [catalytic activity/mass],argininosuccinic acid; arginosuccinate; arginosuccinic acid; asa; asa lyase; asal; catalytic content; chemistry; erythrocytes; point in time; qnt; quan; quant; quantitative; random; red blood cells; red blood corpusles,Qn
32630-6,msh2 gene+mlh1 gene mutations found [identifier] in blood or tissue by molecular genetics method nominal,msh2+mlh1 gene mut anl bld/t,msh2 gene+mlh1 gene targeted mutation analysis molgen nom (bld/tiss),"bat-26; blood; coca1; coca2; colon cancer nonpolyposis type 1; fcc1; fcc2; genetics; heredity; heritable; hmlh1; hnpcc; hnpcc1; hnpcc2; identity or presence; inherited; lcfs2; lynch syndrome; mgc5172; molecular genetics; molecular pathology; molpath; molpath.mutations; msh2+mlh1 gene; mut; mut anl; mutations; mutl homolog 1; mutl homolog 1, colon cancer, nonpolyposis type 2; muts homolog 2; nominal; pcr; point in time; random; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",Nom
32634-8,metanephrine free [mass/time] in 24 hour urine,metaneph free 24h ur-mrate,metanephrine free (24h u) [mass/time],1 day; 24 hours; 24hr; chemistry; fr; mass rate; metaneph; metaneph free; metanephrne; metenephrine; mrate; non-protein bound; qnt; quan; quant; quantitative; ua; unconjugated metanephrine; ur; urn,Qn
32644-7,coxiella burnetii phase 1 igg ab [presence] in serum,c burnet ph1 igg ser ql,c. burnetii phase 1 igg ql (s),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; c burnet; c burnet ph1; c burnetii; coxiella burnetii phase i; coxiella burnettii; i; id; immune globulin g; immunoglobulin g; infectious disease; infectiousdisease; microbiology; ordinal; point in time; pr; q fev; q fever; qfever; ql; qual; qualitative; random; screen; serum; sr,Ord
32645-4,coxiella burnetii phase 1 igm ab [presence] in serum,c burnet ph1 igm ser ql,c. burnetii phase 1 igm ql (s),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; c burnet; c burnet ph1; c burnetii; coxiella burnetii phase i; coxiella burnettii; i; id; immune globulin m; immunoglobulin m; infectious disease; infectiousdisease; microbiology; ordinal; point in time; pr; q fev; q fever; qfever; ql; qual; qualitative; random; screen; serum; sr,Ord
32665-2,anticonvulsants [identifier] in serum or plasma,anticonvulsants serpl,anticonvulsants nom,anticonvuls; anticonvulsant; antiepileptic; antiseizure; drug/toxicology; drugs; identity or presence; nominal; pl; plasma; plsm; point in time; random; serp; serpl; serplas; serum; serum or plasma; sr,Nom
32668-6,borrelia burgdorferi dna [presence] in cerebral spinal fluid by naa with probe detection,b burgdor dna csf ql naa+probe,b. burgdorferi dna naa+probe ql (csf),3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; b burg; b burgdor; b burgdorferi; bb; burgdorf; cerebral spinal fluid; cerebrospinal fl; deoxyribonucleic acid; dna nucleic acid probe; dna probe; id; infectious disease; infectiousdisease; lat; lcr; ligase chain reaction; ligation-activated transcription; lyme; lyme disease; lymes; microbiology; naa+probe; naat; nasba; neuro; neurology; nucleic acid sequence based analysis; ordinal; pcr; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; screen; sda; spinal fl; spinal fld; spinal flu; spinal fluid; strand displacement amplification; tma; transcription mediated amplification,Ord
32679-3,ehrlichia chaffeensis igm ab [presence] in cerebral spinal fluid,e chaffeensis igm csf ql,e. chaffeensis igm ql (csf),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; cerebral spinal fluid; cerebrospinal fl; e chaffeensis; hme; human monocytic ehrlichiosis; id; immune globulin m; immunoglobulin m; infectious disease; infectiousdisease; microbiology; neuro; neurology; ordinal; point in time; pr; ql; qual; qualitative; random; screen; spinal fl; spinal fld; spinal flu; spinal fluid,Ord
32689-2,herpes simplex virus identified in eye by organism specific culture,hsv eye cult,hsv identified org specific cx nom (eye),c&s; cult; cultures; eyeball; herp splx; hsv; id; identity or presence; infectious disease; infectiousdisease; microbiology; nominal; occular; oculis; ophthalmologic; optic globe; point in time; random; spec; vision; visual,Nom
32696-7,legionella pneumophila 1+2+3+4+5+6 ab [titer] in serum,l pneumo pool 1-6 ab titr ser,l. pneumophila 1+2+3+4+5+6 ab (s) [titer],abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; dilution factor; dilution factor (titer); i; id; ii; iii; infectious disease; infectiousdisease; l pneumo; l pneumo pool 1-6; l pneumo1; l pneumonphila; legion; legionela; legionella pneumophila serogroup 1; microbiology; philadelphia 1; pneu; pneum; pneumophilia; point in time; random; serum; smqn; sr; titer; titered; titre; ttr,SemiQn
32716-3,sjogrens syndrome-a extractable nuclear ab [titer] in serum,ena ss-a ab titr ser,sjogrens syndrome-a extractable nuclear ab (s) [titer],abs; aby; ana; anf; antby; anti; antibodies; antibody; antinuclear antibody; autoantibodies; autoantibody; dilution factor; dilution factor (titer); ena; ena ss-a; na; nuc; point in time; random; ro; ro ab; serology; serum; sjogren; smqn; sr; ss; ssa; ss-a; titer; titered; titre; ttr,SemiQn
32724-7,trichomonas sp [presence] in urine by light microscopy,trichomonas ur ql micro,trichomonas sp lm ql (u),id; infectious disease; infectiousdisease; lm; micro; microbiology; micros; microscopic; ordinal; point in time; pr; ql; qual; qualitative; random; screen; species; spp; tric; trich; trichimoniasis; trichomonad; trichomonads; trichomoniasis; ua; ur; urn,Ord
32728-8,beta 1 globulin/protein.total in cerebral spinal fluid by electrophoresis,beta1 glob mfr csf elph,beta 1 globulin elph (csf) [mass fraction],b; b1 globulin; beta1 glob; cerebral spinal fluid; cerebrospinal fl; chemistry; elec; elect; electr; electro; electrophhrs; electrophrs; elp; elph; ep; glb; glob; glob%; globul; globulins; i; mass fraction; neuro; neurology; percent; point in time; pr; prot; qnt; quan; quant; quantitative; random; spinal fl; spinal fld; spinal flu; spinal fluid; tot; totl; tp,Qn
32733-8,beta 2 globulin/protein.total in serum or plasma by electrophoresis,beta2 glob mfr serpl elph,beta 2 globulin elph [mass fraction],b; b2 globulin; beta2 glob; chemistry; elec; elect; electr; electro; electrophhrs; electrophrs; elp; elph; ep; glb; glob; glob%; globul; globulins; ii; mass fraction; percent; pl; plasma; plsm; point in time; pr; prot; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; spep; sr; tot; totl; tp,Qn
32745-2,cd62e cells/cells in specimen,cd62e cells nfr spec,cd62e cells/cells (specimen),cd62e cells; cell; cell markers; cellularity; elam-1; e-selectin; lecam-2; misc; miscellaneous; number fraction; other; percent; point in time; qnt; quan; quant; quantitative; random; spec; to be specified in another part of the message; unspecified,Qn
32756-9,cd3+cd4+ (t4 helper) cells/cd3+cd8+ (t8 suppressor cells) cells [# ratio] in bronchial specimen,cd3+cd4+ cells/cd3+cd8+ cll bronch,cd3+cd4+ (t4 helper) cells/cd3+cd8+ (t8 suppressor cells) cells (bronch spec) [# ratio],bro; cd3 cells; cd3+cd4+ cells; cd3+cd8+ cells; cd3+cd8+ cll; cd3-cd4+; cd4+ t cells; cd8 t cells; cell; cell markers; cellularity; helper t cells; inducer t cells; l3t4; leu2; leu-2; leu3; leu-3; leu4; leu-4; lung; number ratio; point in time; pulmonary; pulmonology; qnt; quan; quant; quantitative; random; respiratory; suppressor t cells; suppressor/cytotoxic t cells; t3; t4; t-4; t4 helper/inducer cells; t8; t-8; t8 suppressor cells; tsuppressor; w3/25,Qn
3278-9,kininogen hmw actual/normal in platelet poor plasma by immunoassay,hmwk act/nor ppp ia,kininogen hmw actual/normal ia (ppp) [relative mass conc],act/nor; alpha-1-cysteine proteinase inhibitor; alpha-1-thiol proteinase inhibitor; alpha-one-cystein proteinase inhibitor; coagulation; control; eia; elfa; elisa; enzyme immunoassay; fitzgerald factor; flaujeac factor; hematology; heme; hmrk; hmw; hmw kininogen; hmwk; iaa; meia; plas; platelet poor plasma; point in time; qnt; quan; quant; quantitative; random; relative mass concentration; rlmcnc; suds; williams factor; wt,Qn
32791-6,cytomegalovirus igg ab [ratio] in serum or plasma by immunoassay --1st specimen/2nd specimen,cmv igg 1:2 serpl ia-rto,cmv igg 1st specimen/2nd specimen ia [ratio],1:2; abs; aby; acute specimen; antby; anti; antibodies; antibody; autoantibodies; autoantibody; cmv; convalescent; cytomegalo virus; cytomgal; eia; elfa; elisa; enzyme immunoassay; first; hhv-5; human herpesvirus-5; iaa; id; immune globulin g; immunoglobulin g; infectious disease; infectiousdisease; meia; microbiology; pl; plasma; plsm; point in time; post immunization; pre immunization; qnt; quan; quant; quantitative; random; ratios; rto; second; serp; serpl; serplas; serum; serum or plasma; sp1; sp2; spec; sr; suds,Qn
32795-7,parvovirus b19 igm ab [units/volume] in serum by immunoassay --2nd specimen,b19v igm sp2 ser ia-acnc,parvovirus b19 igm spec 2 ia qn (s),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; b19 virus; b19v; convalescent; eia; elfa; elisa; enzyme immunoassay; fifth disease; iaa; id; immune globulin m; immunoglobulin m; infectious disease; infectiousdisease; meia; microbiology; parvo; parvo virus; parvov; point in time; post immunization; qnt; quan; quant; quantitative; random; second; serum; sp2; spec; sr; suds,Qn
32800-5,neisseria meningitidis serogroups c+w135 ag [presence] in specimen by latex agglutination,n men sg c+w135 ag spec ql la,n. meningitidis c+w135 ag la ql (specimen),antigen; antigens; id; infectious disease; infectiousdisease; lat; latex agglutination; mening; meningid; meningitis; meningo; meningococcal meningitis; meningococcus; microbiology; misc; miscellaneous; n men; n men sg c+w135; n men sg c+w135 ag; n menigitidis; n meningitidis; ordinal; other; point in time; pr; ql; qual; qualitative; random; screen; spec; to be specified in another part of the message; unspecified,Ord
32805-4,variant lymphocytes/leukocytes in bronchial specimen by manual count,variant lymphs nfr bronch manual,variant lymphocytes/leukocytes manual cnt (bronch spec),atypical lymphocytes; bro; hematology/cell counts; leuc; leuk; leukocyte; lkcs; lung; lymp; lymph; lympho; lymphocyte; lymphs; lymphs%; manl; number fraction; percent; point in time; pulmonary; pulmonology; qnt; quan; quant; quantitative; random; reactive lymphocytes; respiratory; variant lymphocytes; variant lymphs; wbc; wbcs; white blood cell; white blood cells,Qn
3282-1,aptt w excess hexagonal phase phospholipid in platelet poor plasma by coagulation assay,aptt hex pl ppp,aptt w excess hexagonal phase phospholipid coag (ppp) [time],activated partial thromboplastin time; aptt; aptt hex pl; clot; clottable; coag; coagulation assay; hematology; heme; hex; hpp; lipid; little(a)ptt; partial thromboplastin time; phoslpd; phospholipids; pl; plas; platelet poor plasma; point in time; ptt; qnt; quan; quant; quantitative; random; staclot la; surf; tilt tube; universallaborders,Qn
32832-8,variant lymphocytes/leukocytes in bronchial specimen,variant lymphs nfr bronch,variant lymphocytes/leukocytes (bronch spec),atypical lymphocytes; bro; hematology/cell counts; leuc; leuk; leukocyte; lkcs; lung; lymp; lymph; lympho; lymphocyte; lymphs; lymphs%; number fraction; percent; point in time; pulmonary; pulmonology; qnt; quan; quant; quantitative; random; reactive lymphocytes; respiratory; variant lymphocytes; variant lymphs; wbc; wbcs; white blood cell; white blood cells,Qn
32834-4,herpes simplex virus 2 igg ab [ratio] in serum --1st specimen/2nd specimen,hsv2 igg 1:2 ser-rto,hsv 2 igg 1st specimen/2nd specimen (s) [ratio],1:2; abs; aby; acute specimen; antby; anti; antibodies; antibody; autoantibodies; autoantibody; convalescent; first; herp splx; herpes simplex virus type 2; herpes simplex virus type ii; hsv; hsv2; id; ii; immune globulin g; immunoglobulin g; infectious disease; infectiousdisease; microbiology; point in time; post immunization; pre immunization; qnt; quan; quant; quantitative; random; ratios; rto; second; serum; sp1; sp2; spec; sr,Qn
32840-1,parvovirus b19 igm ab [ratio] in serum --1st specimen/2nd specimen,b19v igm 1:2 ser-rto,parvovirus b19 igm 1st specimen/2nd specimen (s) [ratio],1:2; abs; aby; acute specimen; antby; anti; antibodies; antibody; autoantibodies; autoantibody; b19 virus; b19v; convalescent; fifth disease; first; id; immune globulin m; immunoglobulin m; infectious disease; infectiousdisease; microbiology; parvo; parvo virus; parvov; point in time; post immunization; pre immunization; qnt; quan; quant; quantitative; random; ratios; rto; second; serum; sp1; sp2; spec; sr,Qn
32845-0,epstein barr virus capsid igg ab [ratio] in serum --1st specimen/2nd specimen,ebv vca igg 1:2 ser-rto,ebv capsid igg 1st specimen/2nd specimen (s) [ratio],1:2; abs; aby; acute specimen; antby; anti; antibodies; antibody; autoantibodies; autoantibody; cap; convalescent; ebv; ebv capsid ab; ebv vca; epstn; first; hhv-4; human herpesvirus 4; id; immune globulin g; immunoglobulin g; infectious disease; infectiousdisease; microbiology; mono; mononucleosis; point in time; post immunization; pre immunization; qnt; quan; quant; quantitative; random; ratios; rto; second; serum; sp1; sp2; spec; sr; vca; viral capsid,Qn
32869-0,tooth space {first tooth space boundary} {second tooth space boundary} measured,space 1st+2nd tooth bound measured,,1st+2nd tooth bound; 2nd; dental; dentistry; length; point in time; qnt; quan; quant; quantitative; random,Qn
32882-3,reason for dental evaluation,reason for dent eval,,assessment; dental; dentistry; eval; finding; findings; h&p; history and physical; nominal; point in time; random; reason for dent eval,Nom
32885-6,identification {tooth} observed,id {tooth} observ,,dental; dentistry; identity or presence; nominal; point in time; random,Nom
32894-8,second interdental papilla boundary [identifier] {tooth},2nd interdent papilla boundary {tooth},,2nd; 2nd interdent papilla boundary; dental; dentistry; identity or presence; nominal; point in time; random,Nom
32900-3,tooth space discrepancy {dental arch} measured,space discr {dent arch} measured,,{dent arch}; dental; dentistry; length; point in time; qnt; quan; quant; quantitative; random,Qn
3290-4,2-oxoisocaproate [mass/volume] in urine,2oxoisocaproate ur-mcnc,2-oxoisocaproate (u) [mass/vol],2-keto-4-methylvalerate; 2-ketoisocaproate; 2-ketoisocaproic acid; 2oxoisocaproate; 2-oxoisocaproic acid; alpha-ketoisocaproate; alpha-ketoisocaproic acid; chemistry; ii; level; mass concentration; point in time; qnt; quan; quant; quantitative; random; ua; ur; urn,Qn
32911-0,recession [length] {tooth}.{probe site} measured,recession tooth measured,,dental; dentistry; length; point in time; qnt; quan; quant; quantitative; random,Qn
32916-9,horizontal overlap [length] maxilla and mandible measured,horiz overlap maxi+mand measured,,dental; dentistry; horiz overlap; jaw; length; mand; maxi+mand; overjet; point in time; qnt; quan; quant; quantitative; random,Qn
32920-1,excursive distance maximum mandible measured,excursive distance max mandible measured,,dental; dentistry; excursive distance max; jaw; largest; length; mand; maximal; maximum; peak; point in time; qnt; quan; quant; quantitative; random,Qn
32925-0,sella-nasion plane to nasion-b point line [angle] skull x-ray measured,snb angle skull xr,,cranial; cranium; dental; dentistry; head; nb; plain films; point in time; qnt; quan; quant; quantitative; random; se-na; s-n; snb; supramentale; xray; x-ray,Qn
32927-6,sella-nasion plane to nasion-b point line [angle] skull digital model.measured,snb angle skull digital,,cranial; cranium; dental; dentistry; head; nb; point in time; qnt; quan; quant; quantitative; random; se-na; s-n; snb; supramentale,Qn
32942-5,maximum intercuspation right midline discrepancy [length] mandible+face measured,mi r-mdl discrepancy measured,,dental; dentistry; jaw; length; mand; mi; mi r-mdl discrepancy; point in time; qnt; quan; quant; quantitative; r; random; rt,Qn
32946-6,sella-nasion plane to nasion-a point line [angle] skull ct measured,sna angle skull ct,,cat scan; computed tomography; computerized tomography; cranial; cranium; ct scan; dental; dentistry; head; na; point in time; qnt; quan; quant; quantitative; random; se-na; s-n; sna; ss; subspinale,Qn
3295-3,acebutolol [mass/time] in 24 hour urine,acebutolol 24h ur-mrate,acebutolol (24h u) [mass/time],1 day; 24 hours; 24hr; acecor; alol; drug/toxicology; drugs; mass rate; monitan; mrate; neptal; prent; qnt; quan; quant; quantitative; rhotral; sectral; ua; ur; urn,Qn
32954-0,root development {tooth} estimated,root devel lenfr {tooth} est,,dental; dentistry; est; estimation; length fraction; percent; point in time; qnt; quan; quant; quantitative; random,Qn
32967-2,root apex development {tooth}.{surface} xr,root apex devel {tooth}.{surface} xr,,dental; dentistry; finding; findings; nominal; plain films; point in time; random; surf; xray; x-ray,Nom
32984-7,retention {dental arch}.denture.partial observed,retention {dent arch}.pd observ,,{dent arch}; {dent arch}.pd; dental; dentistry; impression; impression/interpretation of study; impressions; interp; interpretation; ordinal; point in time; ql; qual; qualitative; random; screen,Ord
3299-5,acetaminophen [presence] in urine,apap ur ql,acetaminophen ql (u),acet; acetamidophenol; acetaminoph; acetominophen; addiction; apap; c209; c55; drug/toxicology; drugs; drugs of abuse; hepatology; hydroxyacetanilide; illicit; liver; n-(4-hydroxyphenyl)acetanilide; n-acetyl-p-aminophenol; ordinal; p-acetamidophenol; paracetamol; p-hydroxyacetanilide; point in time; potentialforabuse; pr; ql; qual; qualitative; random; screen; tylenol; u209; ua; universallaborders; ur; urn,Ord
32996-1,her2 [mass/volume] in serum,her2 ser-mcnc,her2 (s) [mass/vol],c-erbb-2; erb; erb2; erb-2; erbb2; her-2; her-2/neu; level; mass concentration; oncology; pathology; point in time; qnt; quan; quant; quantitative; random; serum; sr,Qn
33000-1,rickettsia spotted fever group igm ab [presence] in serum,rick sf igm ser ql,r. spotted fever group igm ql (s),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; id; immune globulin m; immunoglobulin m; infectious disease; infectiousdisease; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; rick sf; ricket; rickettsial; screen; serum; sr,Ord
33004-3,kelp or seaweed ige ab [units/volume] in serum,kelp/seaweed ige qn,kelp or seaweed ige qn (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; immune globulin e; immunoglobulin e; kelp/seaweed; point in time; qnt; quan; quant; quantitative; random; seaweed; serum; sr,Qn
3301-9,acetazolamide [presence] in urine,acetazolamide ur ql,acetazolamide ql (u),acetadiazol; acetazolam; ak-zol; diamox; drug/toxicology; drugs; ordinal; point in time; pr; ql; qual; qualitative; random; screen; ua; ur; urn,Ord
33026-6,hemoglobin [mass/volume] in arterial cord blood by calculation,hgb bldcoa calc-mcnc,hemoglobin calc (bldcoa) [mass/vol],bld cord; calc; calculation; cord arterial blood; cord blda; haemoglobin; hb; hematology/cell counts; hgb; level; mass concentration; point in time; qnt; quan; quant; quantitative; random,Qn
33029-0,cd3+tcr cells/cells in blood,cd3+tcr cells nfr bld,cd3+tcr cells/cells (bld),blood; cd3 cells; cd3+tcr cells; cell; cell markers; cellularity; leu4; leu-4; number fraction; percent; point in time; qnt; quan; quant; quantitative; random; t3; wb; whole blood,Qn
33033-2,cd45 positive events [#] in specimen,cd45 pos events spec,cd45 positive events (specimen) [#],b220; cd45 pos events; cd45r; cd45ra; cd45rb; cd45rc; cd45ro; cell markers; cnt; count; lca; leukocyte common antigen; ly5; misc; miscellaneous; number; other; point in time; pos; qnt; quan; quant; quantitative; random; spec; t200; to be specified in another part of the message; unspecified,Qn
3303-5,acetazolamide [mass/time] in 24 hour urine,acetazolamide 24h ur-mrate,acetazolamide (24h u) [mass/time],1 day; 24 hours; 24hr; acetadiazol; acetazolam; ak-zol; diamox; drug/toxicology; drugs; mass rate; mrate; qnt; quan; quant; quantitative; ua; ur; urn,Qn
33040-7,hypnotics [presence] in serum or plasma by screen method,hypnotics serpl ql scn,hypnotics screen ql,drug/toxicology; drugs; ordinal; pl; plasma; plsm; point in time; pr; ql; qual; qualitative; random; scn; scr; screen; scrn; serp; serpl; serplas; serum; serum or plasma; sr,Ord
33049-8,hypertonic cryohemolysis of red blood cells,cht nfr rbc,hypertonic cryohemolysis (rbc),cht; erythrocytes; hematology/cell counts; hereditary spherocytosis; number fraction; percent; point in time; qnt; quan; quant; quantitative; random; red blood cells; red blood corpusles,Qn
33053-0,protoporphyrin [molar ratio] in red blood cells,protopor rbc-srto,protoporphyrin (rbc) [molar ratio],chemistry; dicarboxyl porphyrin; dicarboxylporphyrin; erythrocytes; hematology; heme; point in time; protoporph; protoporphrn; protoporphyrins; qnt; quan; quant; quantitative; random; red blood cells; red blood corpusles; scrto; substance concentration ratio; substance ratio,Qn
33058-9,ketones [mass/volume] in serum or plasma,ketones serpl-mcnc,ketones [mass/vol],acetest; acetoacetate; acetoacetates; acetone bodies; chemistry; ketone; ketone bodies; level; mass concentration; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; universallaborders,Qn
33080-3,gestational age estimated from biparietal diameter on us by lessoway 1998 method,ga from bpd.lessoway98,,98; biparietal diameter; echography; est; estimation; fetal; from bpd.lessoway98; ga; gest; gestation; gyn; gynecology; ob; obgyn; obsterical; obsterical.ultrasound; obstetrical; obstetrics; point in time; predicted; prenatal; qnt; quan; quant; quantitative; random; sonogram; sonograph; sonography; uls; ultrasound,Qn
33088-6,gestational age estimated from clavicle length by method of yarkoni 1985 (us),ga from cl.yarkoni85,,85; cl; echography; est; estimation; fetal; from cl.yarkoni85; ga; gest; gestation; gyn; gynecology; ob; obgyn; obsterical; obsterical.ultrasound; obstetrical; obstetrics; point in time; predicted; prenatal; qnt; quan; quant; quantitative; random; sonogram; sonograph; sonography; uls; ultrasound; us+est,Qn
33099-3,gestational age estimated from femur length on us by jeanty 1982 method,ga from fl.jeanty82,,82; echography; est; estimation; femur length; fetal; from fl.jeanty82; ga; gest; gestation; gyn; gynecology; ob; obgyn; obsterical; obsterical.ultrasound; obstetrical; obstetrics; point in time; predicted; prenatal; qnt; quan; quant; quantitative; random; sonogram; sonograph; sonography; uls; ultrasound,Qn
33-1,ampicillin+sulbactam [susceptibility] by disk diffusion (kb),ampicillin+sulbac islt kb,ampicillin+sulbactam disk diffusion (kb) [susc],amcil; amicil; amp; ampicilloyl; antibiotic susceptibilities; ast; c203; c5; disk diffusion; id; infectious disease; infectiousdisease; islt; isol; kb; kirby-bauer; omnipen; penbritin; point in time; polycillin; random; sulb; sulbact; sus; suscept; susceptibilities; susceptibility; susceptibilty; unasyn,OrdQn
33123-1,gestational age estimated from inter ocular distance on us by trout 1994 method,ga from iod.trout94,,94; echography; est; estimation; fetal; from iod.trout94; ga; gest; gestation; gyn; gynecology; inter ocular distance; inter orbital diameter; ob; obgyn; obsterical; obsterical.ultrasound; obstetrical; obstetrics; point in time; predicted; prenatal; qnt; quan; quant; quantitative; random; sonogram; sonograph; sonography; uls; ultrasound,Qn
33141-3,fetal weight estimated by method of shinozuka formula 1 1996 (us),fet weight from shinozuka96 1,,96; bdy weight; bod; bodies; echography; efw; est; estimated fetal weight; estimation; fetal; from shinozuka96 1; gyn; gynecology; ob; obgyn; obsterical; obsterical.ultrasound; obstetrical; obstetrics; point in time; predicted; qnt; quan; quant; quantitative; random; sonogram; sonograph; sonography; uls; ultrasound; us+est; wt,Qn
33147-0,fetal abdomen circumference measured by method of chitty 1994 (us),fet abd circum by chitty94,,94; abd; abd^fetus; abd+fetus; abdo; abdomen+; abdominal; abdominal circumference; abdominal circumference from gestational age; ac; ac by ga; by chitty94; circum; circumference; echography; fetal; gyn; gynecology; length; ob; obgyn; obsterical; obsterical.ultrasound; obstetrical; obstetrics; point in time; qnt; quan; quant; quantitative; random; sonogram; sonograph; sonography; uls; ultrasound; us+meas,Qn
33150-4,fetal abdomen diameter product estimated from gestational age by method of shinozuka 1996 (us),fet abd diam prod from ga.shinozuka96,,96; abd; abd^fetus; abd+fetus; abdo; abdomen+; abdominal; dia; diam; diam prod; echography; est; estimation; fetal; from ga.shinozuka96; gyn; gynecology; length; ob; obgyn; obsterical; obsterical.ultrasound; obstetrical; obstetrics; point in time; predicted; qnt; quan; quant; quantitative; random; sonogram; sonograph; sonography; uls; ultrasound; us+est,Qn
33153-8,fetal head diameter.biparietal estimated from gestational age by method of jeanty 1982 (us),fet bpd from ga.jeanty82,,82; bpd; bpd by ga; bpd predicted from gestational age; brain; cranial; cranium; dia; diam; echoencephalogram; echoencephalography; echography; est; estimation; fetal; from ga.jeanty82; gyn; gynecology; intracranial; length; ob; obgyn; obsterical; obsterical.ultrasound; obstetrical; obstetrics; point in time; predicted; qnt; quan; quant; quantitative; random; skull; sonogram; sonograph; sonography; uls; ultrasound; us+est,Qn
33155-3,fetal head diameter.biparietal estimated from gestational age by method of rempen 1991 (us),fet bpd from ga.rempen91,,91; bpd; bpd by ga; bpd predicted from gestational age; brain; cranial; cranium; dia; diam; echoencephalogram; echoencephalography; echography; est; estimation; fetal; from ga.rempen91; gyn; gynecology; intracranial; length; ob; obgyn; obsterical; obsterical.ultrasound; obstetrical; obstetrics; point in time; predicted; qnt; quan; quant; quantitative; random; skull; sonogram; sonograph; sonography; uls; ultrasound; us+est,Qn
33156-1,fetal head diameter.biparietal estimated from gestational age by method of shinozuka 1996 (us),fet bpd from ga.shinozuka96,,96; bpd; bpd by ga; bpd predicted from gestational age; brain; cranial; cranium; dia; diam; echoencephalogram; echoencephalography; echography; est; estimation; fetal; from ga.shinozuka96; gyn; gynecology; intracranial; length; ob; obgyn; obsterical; obsterical.ultrasound; obstetrical; obstetrics; point in time; predicted; qnt; quan; quant; quantitative; random; skull; sonogram; sonograph; sonography; uls; ultrasound; us+est,Qn
33174-4,fetal head circumference estimated from gestational age by method of chitty 1994 (us),fet head circum from ga.chitty94,,94; brain; circum; circumference; cranial; cranium; echoencephalogram; echoencephalography; echography; est; estimation; fetal; from ga.chitty94; gyn; gynecology; hc; hc by ga; hc(ga); head circumference; head circumference from gestational age; intracranial; length; ob; obgyn; obsterical; obsterical.ultrasound; obstetrical; obstetrics; point in time; predicted; qnt; quan; quant; quantitative; random; skull; sonogram; sonograph; sonography; uls; ultrasound; us+est,Qn
33188-4,fetal body weight growth percentile by method of arbuckle 1993 female twins (us),fwp by arbuckle93 female twins,,93; bdy weight; bdy weight growth prctl; bod; bodies; bwp; by arbuckle93 female twins; echography; efw; est; estimated fetal weight; estimation; fetal; fwp; gyn; gynecology; ob; obgyn; obsterical; obsterical.ultrasound; obstetrical; obstetrics; percentile; point in time; predicted; qnt; quan; quant; quantitative; random; sonogram; sonograph; sonography; uls; ultrasound; us+est; wt,Qn
331-9,mezlocillin [susceptibility] by minimum inhibitory concentration (mic),mezlocillin islt mic,mezlocillin mic [susc],antibiotic susceptibilities; ast; baypen; id; infectious disease; infectiousdisease; islt; isol; mezlin; minimum inhibitory concentration; optocillin; point in time; random; sus; suscept; susceptibilities; susceptibility; susceptibilty,OrdQn
33212-2,n-acetyl-l-aspartate [mass/volume] in body fluid,n-ac-l-asp fld-mcnc,n-acetyl-l-aspartate (body fld) [mass/vol],"asp; aspartic acid; b/f; bf; bod; bodies; body fluid; body fluid, unsp; chemistry; fl; fld; flu; fluid; left; level; levo; mass concentration; naa; n-ac-l-asp; point in time; qnt; quan; quant; quantitative; random",Qn
33216-3,platelets agranular [presence] in blood by light microscopy,agran platelets bld ql smear,platelets agranular lm ql (bld),agran platelets; agranulated platelets; blood; hematology/cell counts; lm; micro; micros; microscopic; ordinal; platelet; platelet adequacy; platelet estimate; platelt; plt; point in time; pr; ql; qual; qualitative; random; screen; thrb; thrombocyte; thrombocytes; wb; whole blood,Ord
3321-7,amikacin [mass/volume] in serum or plasma --trough,amikacin trough serpl-mcnc,amikacin trough [mass/vol],amikin; aminoglycosides; drug/toxicology; drugs; id; infectious disease; infectiousdisease; level; mass concentration; pl; plasma; plsm; point in time; pre; predose; pre-dose; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; universallaborders,Qn
33231-2,fatty casts [#/area] in urine by computer assisted method,fatty casts #/area ur comp assist,fatty casts computer assisted (u) [#/area],#/area; artificial intelligence; automated detection; cast; comp assist; kidney; nephrology; number areic; point in time; qnt; quan; quant; quantitative; random; renal; ua; ur; urinalysis; urn,Qn
33232-0,spermatozoa [presence] in urine by automated,sperm ur ql auto,spermatozoa auto ql (u),auto; automated detection; elec; elect; electr; ordinal; point in time; pr; ql; qual; qualitative; random; screen; sperm; ua; ur; urinalysis; urn,Ord
33234-6,calcium oxalate crystals [presence] in urine by computer assisted method,caox cry ur ql comp assist,calcium oxalate crystals computer assisted ql (u),artificial intelligence; automated detection; ca; cac2o4; cal; caox; caox cry; comp assist; crys; cryst; crystal; ethanedioate; ethanedioic acid; ordinal; oxal; oxalic acid; point in time; pr; ql; qual; qualitative; random; screen; ua; ur; urinalysis; urn,Ord
33256-9,leukocytes [#/volume] corrected for nucleated erythrocytes in blood by automated count,wbc nrbc cor # bld auto,wbc corrected for nucl rbc auto (bld) [#/vol],#; abs; absolute; absolutes; auto; automated detection; blood; cnt; count; count/volume; ct; discocytes; elec; elect; electr; erthrocyte; erythrocyte; hematology/cell counts; leuc; leuk; leukocyte; lkcs; nrbc cor; nuc; number concentration; number concentration (count/vol); point in time; qnt; quan; quant; quantitative; random; rbc; rbcs; red blood cell; red blood cells; red blood corpuscle; red blood corpusles; red cell; red cells; wb; wbc; wbcs; white blood cell; white blood cells; whole blood,Qn
33265-0,toxoplasma gondii iga ab [units/volume] in cerebral spinal fluid,t gondii iga csf-acnc,t. gondii iga qn (csf),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; cerebral spinal fluid; cerebrospinal fl; id; immune globulin a; immunoglobulin a; infectious disease; infectiousdisease; microbiology; neuro; neurology; point in time; qnt; quan; quant; quantitative; random; spinal fl; spinal fld; spinal flu; spinal fluid; t gondii; toxo; toxoplasmosis,Qn
33269-2,thyrotropin [units/volume] in serum or plasma --pre dose trh,tsh pre trh serpl-acnc,tsh pre dose trh qn,arbitrary concentration; before; chemistry.challenge testing; endocrine; endocrinology; pl; plasma; plsm; point in time; pre trh; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; thyroid stimulating hormone; thyrotropic hormone; tsh,Qn
33275-9,7-dehydrocholesterol [mass/volume] in serum or plasma,7-dhc serpl-mcnc,7-dehydrocholesterol [mass/vol],7-dhc; chemistry; level; mass concentration; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
33300-5,naproxen [presence] in urine by screen method,naproxen ur ql scn,naproxen screen ql (u),anaprox; c228; c283; drug/toxicology; drugs; ordinal; point in time; pr; ql; qual; qualitative; random; scn; scr; screen; scrn; ua; ur; urn,Ord
33308-8,phosphatidylethanolamine ab [presence] in serum,pe ab ser ql,phosphatidylethanolamine ab ql (s),abs; aby; antby; anti; antibodies; antibody; ape; autoantibodies; autoantibody; coagulation; hematology; heme; ordinal; pe; phosphatidyl ethanolamine; point in time; pr; ql; qual; qualitative; random; screen; serum; sr,Ord
33311-2,porphyrins [moles/volume] in serum or plasma,porphyrins serpl-scnc,porphyrins [moles/vol],chemistry; hematology; heme; level; pl; plasma; plsm; point in time; porph; porphyrin; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; substance concentration,Qn
33325-2,trypsin [mass/volume] in serum or plasma,trypsin serpl-mcnc,trypsin [mass/vol],chemistry; level; mass concentration; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; tps,Qn
33327-8,varicella zoster virus ab [titer] in cerebral spinal fluid by complement fixation,vzv ab titr csf cf,vzv ab cf (csf) [titer],abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; cerebral spinal fluid; cerebrospinal fl; cf; chicken pox; chicken pox virus; chickenpox; comp fixation; compfix; complement fixation; dilution factor; dilution factor (titer); herpes zoster; hhv-3; human herpesvirus 3; id; infectious disease; infectiousdisease; microbiology; neuro; neurology; point in time; random; shingles; smqn; spinal fl; spinal fld; spinal flu; spinal fluid; titer; titered; titre; ttr; vz; vzv; zoster,SemiQn
33335-1,diphenylmethoxyacetate [presence] in urine by screen method,diphenylmethoxyac ur ql scn,diphenylmethoxyacetate screen ql (u),diphenhydramine metabolite; diphenylmethoxyacetic acid; drug/toxicology; drugs; ordinal; point in time; pr; ql; qual; qualitative; random; scn; scr; screen; scrn; ua; ur; urn,Ord
33339-3,zolpidem [mass/volume] in urine,zolpidem ur-mcnc,zolpidem (u) [mass/vol],addiction; adormix; ambien; ambien cr; damixan; drug/toxicology; drugs; drugs of abuse; edluar; hypnogen; illicit; ivedal; level; lioran; mass concentration; myslee; nasen; nytamel; point in time; potentialforabuse; qnt; quan; quant; quantitative; random; sanval; somidem; stilnoct; stilnox; stilnox cr; sucedal; ua; ur; urn; zoldem; zolpihexal; zolpimist,Qn
33352-6,glucose/creatinine [mass ratio] in urine,glucose/creat ur,glucose/creatinine (u) [mass ratio],chemistry; cr; crea; creat; glu; gluc; glucoseur; mass concentration ratio; mass ratio; mcrto; point in time; qnt; quan; quant; quantitative; random; ua; ucr; ur; urn,Qn
33357-5,prothrombin time (pt) factor substitution in platelet poor plasma by coagulation assay --1 hour post incubation,pt 1h p inc ppp,pt factor substitution 1 hr post incubation coag (ppp) [time],1 hour; 1.0hr; 1h p inc; 60 min; 60 minutes; 60m; 60min; after; clot; clottable; coag; coagulation assay; fac; fact; hematology; heme; mixing studies; plas; platelet poor plasma; point in time; pro time; prothrombin time; protime; pst; pt; pt correction study; pt immediate mix; pt incubated mix; qnt; quan; quant; quantitative; random; tilt tube,Qn
33368-2,amylase [enzymatic activity/volume] in pericardial fluid,amylase pcar-ccnc,amylase (pericard fld) [catalytic activity/vol],alpha amylase; ams; amyl; cardio; cardiology; catalytic concentration; chemistry; diastase; heart disease; k87; pcar; pericardial fluid; point in time; qnt; quan; quant; quantitative; random,Qn
33370-8,variant lymphocytes/leukocytes in pleural fluid,variant lymphs nfr plr,variant lymphocytes/leukocytes (pleur fld),atypical lymphocytes; hematology/cell counts; leuc; leuk; leukocyte; lkcs; lung; lymp; lymph; lympho; lymphocyte; lymphs; lymphs%; number fraction; percent; pleural; pleural fluid; point in time; pulmonary; pulmonology; qnt; quan; quant; quantitative; random; reactive lymphocytes; respiratory; thoracentesis fluid; variant lymphocytes; variant lymphs; wbc; wbcs; white blood cell; white blood cells,Qn
33373-2,blasts/leukocytes in pleural fluid,blasts nfr plr,blasts/leukocytes (pleur fld),blast; hematology/cell counts; leuc; leuk; leukocyte; lkcs; number fraction; percent; pleural; pleural fluid; point in time; qnt; quan; quant; quantitative; random; thoracentesis fluid; wbc; wbcs; white blood cell; white blood cells,Qn
33381-5,coccidioides sp ab [units/volume] in serum,coccidioides ab ser-acnc,coccidioides sp ab qn (s),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; coccidiodes; id; infectious disease; infectiousdisease; microbiology; point in time; qnt; quan; quant; quantitative; random; san joaquin valley fever; serum; species; spp; sr; valley fever,Qn
33396-3,neisseria meningitidis serogroups a+c+w135+y ag [presence] in serum,n men sg a+c+w135+y ag ser ql,n. meningitidis a+c+w135+y ag ql (s),acyw135; antigen; antigens; id; infectious disease; infectiousdisease; mening; meningid; meningitis; meningo; meningococcal meningitis; meningococcus; microbiology; n men; n men sg a+c+w135+y; n menigitidis; n meningitidis; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; sr,Ord
3343-1,amoxapine [mass/volume] in urine,amoxapine ur-mcnc,amoxapine (u) [mass/vol],amox; asendin; defanyl; demolox; drug/toxicology; drugs; level; mass concentration; moxadil; point in time; qnt; quan; quant; quantitative; random; ua; ur; urn,Qn
33432-6,minumum expired volume setting ventilator alarm,vol exp min vent alarm,,end tidal volume; flow; lung; minimal; minimum; point in time; pulmonary; pulmonology; qnt; quan; quant; quantitative; random; respiratory; vent alarm; vet; vol; vol exp; vol exp min; volume rate; vrate,Qn
33435-9,inspiratory breath [time] --on ventilator,inspiratory breath on vent time,,lung; point in time; pulmonary; pulmonology; qnt; quan; quant; quantitative; random; respiratory,Qn
33436-7,drive pressure servo ventilator,drive pres servo vent,,drive pres; lung; point in time; pressure; pulmonary; pulmonology; qnt; quan; quant; quantitative; random; respiratory; servo vent,Qn
33465-6,francisella tularensis igg ab [titer] in serum,f tular igg titr ser,f. tularensis igg (s) [titer],abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; dilution factor; dilution factor (titer); f tular; f tularensis; id; immune globulin g; immunoglobulin g; infectious disease; infectiousdisease; microbiology; point in time; random; serum; smqn; sr; titer; titered; titre; ttr; tularemia,SemiQn
33479-7,epstein barr virus early restricted ab [titer] in serum,ebv ea-r ab titr ser,ebv early restricted ab (s) [titer],abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; dilution factor; dilution factor (titer); ea; ea-r; ebv; ebv ea; ebv ea-r; epstn; hhv-4; human herpesvirus 4; id; infectious disease; infectiousdisease; microbiology; mono; mononucleosis; point in time; random; serum; smqn; sr; titer; titered; titre; ttr,SemiQn
33480-5,methane/expired gas [volume fraction] in exhaled gas --2 hours post dose lactose po,breath methane 2h p lac po,methane/expired gas 2 hr post dose lactose po (exhl gas) [volume fraction],120 min; 120 minutes; 120min; 2 hours; 2h p lac po; after; breath; chemistry.challenge testing; exg; exhaled gas; exhaled gas (=breath); gases; ltt; p dose; percent; point in time; pst; qnt; quan; quant; quantitative; random; volfr; volume fraction,Qn
33487-0,patient symptoms [interpretation] --2 hours post dose lactose po,symptoms 2h p lac po patient-imp,patient symptoms 2 hr post dose lactose po [interp],120 min; 120 minutes; 120min; 2 hours; 2h p lac po; after; chemistry.challenge testing; impression; impression/interpretation of study; impressions; interp; interpretation; ltt; nominal; p dose; point in time; pst; random; sx,Nom
33490-4,hydrogen/expired gas [volume fraction] in exhaled gas --pre dose lactose po,breath h2 pre lac po,hydrogen/expired gas pre dose lactose po (exhl gas) [volume fraction],before; breath; chemistry.challenge testing; exg; exhaled gas; exhaled gas (=breath); gases; gastro; gastroenterology; gi; h2; hyd; ltt; percent; point in time; pre lac po; qnt; quan; quant; quantitative; random; volfr; volume fraction,Qn
33495-3,hydrogen/expired gas [volume fraction] in exhaled gas --2.5 hours post dose lactose po,breath h2 2.5h p lac po,hydrogen/expired gas 2.5 hr post dose lactose po (exhl gas) [volume fraction],2.5h p lac po; after; breath; chemistry.challenge testing; exg; exhaled gas; exhaled gas (=breath); gases; gastro; gastroenterology; gi; h2; hyd; ltt; p dose; percent; point in time; pst; qnt; quan; quant; quantitative; random; volfr; volume fraction,Qn
33496-1,hydrogen/expired gas [volume fraction] in exhaled gas --3 hours post dose lactose po,breath h2 3h p lac po,hydrogen/expired gas 3 hr post dose lactose po (exhl gas) [volume fraction],3h p lac po; after; breath; chemistry.challenge testing; exg; exhaled gas; exhaled gas (=breath); gases; gastro; gastroenterology; gi; h2; hyd; ltt; p dose; percent; point in time; pst; qnt; quan; quant; quantitative; random; volfr; volume fraction,Qn
33505-9,hydrogen+methane/expired gas [volume fraction] in exhaled gas --1 hour post dose lactose po,breath h2+methane 1h p lac po,hydrogen+methane/expired gas 1 hr post dose lactose po (exhl gas) [volume fraction],1 hour; 1.0hr; 1h p lac po; 60 min; 60 minutes; 60m; 60min; after; breath; chemistry.challenge testing; exg; exhaled gas; exhaled gas (=breath); gases; gastro; gastroenterology; gi; h2; hyd; ltt; p dose; percent; point in time; pst; qnt; quan; quant; quantitative; random; volfr; volume fraction,Qn
33516-6,immature reticulocytes/reticulocytes.total in blood,imm retics nfr,immature reticulocytes/total reticulocytes (bld),blood; hematology; hematology/cell counts; heme; imm; imm retics; immat; irf; number fraction; percent; point in time; polychromatophilic red cells; qnt; quan; quant; quantitative; random; retic; retics; reticulocyte; shift cells; stress cells; tot; totl; wb; whole blood,Qn
33521-6,platelet aggregation collagen induced in platelet rich plasma --low dose,pa coll lo dose prp,platelet aggregation collagen induced low dose (prp) [rel units/vol],agg; aggr; coagulation; hematology; heme; lo dose; pa; pa coll; pl; platelet rich plasma; platelets; platelt; plt; point in time; qnt; quan; quant; quantitative; random; rlacnc; thrombocyte; thrombocytes,Qn
33522-4,platelet aggregation ristocetin induced in platelet rich plasma --high dose,pa rist hi dose prp,platelet aggregation ristocetin induced high dose (prp) [rel units/vol],agg; aggr; coagulation; hematology; heme; hi dose; pa; pa rist; pl; platelet rich plasma; platelets; platelt; plt; point in time; qnt; quan; quant; quantitative; random; ripa; rlacnc; thrombocyte; thrombocytes,Qn
3353-0,amphotericin b [mass/volume] in cerebral spinal fluid,amphotericin b csf-mcnc,amphotericin b (csf) [mass/vol],cerebral spinal fluid; cerebrospinal fl; drug/toxicology; drugs; fungizone; level; mass concentration; point in time; qnt; quan; quant; quantitative; random; spinal fl; spinal fld; spinal flu; spinal fluid,Qn
33560-4,benzodiazepines [mass/volume] in gastric fluid,benzodiaz gast-mcnc,benzodiazepines (gast fld) [mass/vol],benz; benzodiaz; benzodiazepine; drug/toxicology; drugs; gast; gastric contents; gastric fluid; level; mass concentration; point in time; qnt; quan; quant; quantitative; random,Qn
33597-6,deprecated borrelia burgdorferi 34kd igm ab [units/volume] in serum,deprecated b burgdor34kd igm ser-acnc,b. burgdorferi 34kd igm qn (s),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; b burg; b burgdor; b burgdor34kd; b burgdorferi; bb; burgdorf; id; immune globulin m; immunoglobulin m; infectious disease; infectiousdisease; lyme; lyme disease; lymes; microbiology; osp b; ospb; outer surface protein b; point in time; qnt; quan; quant; quantitative; random; serum; sr,Qn
33606-5,dengue virus ab [titer] in serum,denv ab titr ser,denv ab (s) [titer],abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; breakbone fever; denv; dilution factor; dilution factor (titer); flavivirus; id; infectious disease; infectiousdisease; microbiology; point in time; random; serum; smqn; sr; titer; titered; titre; ttr,SemiQn
33611-5,phosphatidylethanolamine ab [units/volume] in serum,pe ab ser-acnc,phosphatidylethanolamine ab qn (s),abs; aby; antby; anti; antibodies; antibody; ape; arbitrary concentration; autoantibodies; autoantibody; coagulation; hematology; heme; pe; phosphatidyl ethanolamine; point in time; qnt; quan; quant; quantitative; random; serum; sr,Qn
33617-2,hla-dr+ cells [#/volume] in blood,hla-dr+ cells # bld,hla-dr+ cells (bld) [#/vol],#; abs; absolute; absolutes; blood; cell; cell markers; cellularity; cnt; count; count/volume; ct; hla-dr+ cells; human leukocyte antigen; i3; number concentration; number concentration (count/vol); point in time; qnt; quan; quant; quantitative; random; wb; whole blood,Qn
33620-6,tricarboxylporphyrin 1 [mass/time] in 24 hour stool,tri-cp 24h stl-mrate,tricarboxylporphyrin 1 (24h stl) [mass/time],1 day; 24 hours; 24hr; bowel movement; chemistry; faecal; faeces; fecal; feces; harderoporphyrin; hematology; heme; i; mass rate; mrate; qnt; quan; quant; quantitative; stl; stool = fecal; tricarboxyl porphyrin; tri-cp,Qn
33626-3,hematoporphyrin [mass/time] in 24 hour stool,hematopor 24h stl-mrate,hematoporphyrin (24h stl) [mass/time],1 day; 24 hours; 24hr; bowel movement; chemistry; faecal; faeces; fecal; feces; hematology; heme; mass rate; mrate; qnt; quan; quant; quantitative; stl; stool = fecal,Qn
33627-1,tenofovir [susceptibility],tenofovir susc islt,tenofovir [susc],antibiotic susceptibilities; ast; df; id; infectious disease; infectiousdisease; islt; isol; point in time; random; sus; suscept; susceptibilities; susceptibility; susceptibilty; tdf; tfv; viread,OrdQn
33636-2,iga.secretory [units/volume] in saliva (oral fluid),siga sal-acnc,iga.secretory qn (sal),arbitrary concentration; chemistry; immune globulin a; immunoglobulin a; oral fluid; point in time; qnt; quan; quant; quantitative; random; sal; salivary iga; siga,Qn
33641-2,lymphocyte proliferation stimulated by tuberculin [units/volume] in blood,lpt tuberc bld-acnc,lymphocyte proliferation stimulated by tuberculin qn (bld),arbitrary concentration; blood; lpa; lpt; lpt tuberc; lst; lymphocyte antigen proliferation; lymphocyte antigen stimulation; microbiology; pha; point in time; ppd; purified protein derivative; qnt; quan; quant; quantitative; random; stim; tuberculosis antigen; wb; whole blood,Qn
33647-9,protein.monoclonal/protein.total in serum or plasma by electrophoresis,m protein mfr serpl elph,protein.monoclonal elph [mass fraction],chemistry; elec; elect; electr; electro; electrophhrs; electrophrs; elp; elph; ep; m protein; mass fraction; m-band; monoclonal band; monoclonal spike; m-protein; m-spike; para protein; paraprotein; percent; pl; plasma; plsm; point in time; pr; prot; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; spep; sr; tot; totl; tp,Qn
33648-7,cryoglobulin rheumatoid factor [units/volume] in serum,cryoglob rf ser-acnc,cryoglobulin rheumatoid factor qn (s),arbitrary concentration; cryo; cryoglob rf; cryoglobulins; cryoprecipitate; fac; fact; point in time; qnt; quan; quant; quantitative; random; rf; rheum; rheumatology; serology; serum; sr,Qn
33650-3,cryoglobulin.iga [mass/volume] in serum,cryoglob iga ser-mcnc,cryoglobulin.iga (s) [mass/vol],cryo; cryoglob iga; cryoglobulins; cryoprecipitate; immune globulin a; immunoglobulin a; level; mass concentration; point in time; qnt; quan; quant; quantitative; random; serology; serum; sr,Qn
33652-9,cd56 cells/cd38 cells [# ratio] in blood,cd56 cells/cd38 cells bld,cd56 cells/cd38 cells (bld) [# ratio],adp-ribosyl cyclase; blood; cd38 cells; cd56 cells; cell; cell markers; cellularity; cyclic adp-ribose hydrolase; leu17; leu-17; leu19; leu-19; ncam; neural cell adhesion molecule; nkh1; number ratio; point in time; qnt; quan; quant; quantitative; random; t10; wb; whole blood,Qn
33662-8,erythrocytes.cd59 deficient/erythrocytes in blood,rbc cd59 deficient nfr,erythrocytes.cd59 deficient/cells.235a (bld),1f-5ag; blood; cd59 rbc; cd59.deficient; cell; cell markers; cellularity; discocytes; erthrocyte; erythrocyte; glycosylphosphatidylinositol-anchored protein; h19; hrf20; macif; membrane inhibitor of reactive lysis; mirl; number fraction; p-18; paroxysmal nocturnal hemoglobinuria; percent; plink; pnh; point in time; protectin; qnt; quan; quant; quantitative; random; rbc; rbcs; red blood cell; red blood cells; red blood corpuscle; red blood corpusles; red cell; red cells; wb; whole blood,Qn
33663-6,cd59 deficient cells/cells in blood,cd59 deficient cells nfr bld,cd59 deficient cells/cells (bld),1f-5ag; blood; cd59 cells; cd59 deficient cells; cd59.deficient; cell; cell markers; cellularity; glycosylphosphatidylinositol-linked proteins; h19; hrf20; macif; membrane inhibitor of reactive lysis; mirl; number fraction; p-18; paroxysmal nocturnal hemoglobinuria; percent; plink; pnh; point in time; protectin; qnt; quan; quant; quantitative; random; wb; whole blood,Qn
33679-2,francisella tularensis dna [presence] in specimen by naa with probe detection,f tular dna spec ql naa+probe,f. tularensis dna naa+probe ql (specimen),3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; deoxyribonucleic acid; dna nucleic acid probe; dna probe; f tular; f tularensis; id; infectious disease; infectiousdisease; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; misc; miscellaneous; naa+probe; naat; nasba; nucleic acid sequence based analysis; ordinal; other; pcr; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; screen; sda; spec; strand displacement amplification; tma; to be specified in another part of the message; transcription mediated amplification; tularemia; unspecified,Ord
33681-8,francisella tularensis [presence] in specimen by cell wall fatty acid analysis,f tular spec ql cfa,f. tularensis cell wall fatty acid analysis ql (specimen),acd; acids; cfa; f tular; f tularensis; gc; id; infectious disease; infectiousdisease; microbiology; misc; miscellaneous; ordinal; other; point in time; pr; ql; qual; qualitative; random; screen; spec; to be specified in another part of the message; tularemia; unspecified,Ord
33691-7,yersinia pestis dna [presence] in specimen by naa with probe detection,y pestis dna spec ql naa+probe,y. pestis dna naa+probe ql (specimen),3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; deoxyribonucleic acid; dna nucleic acid probe; dna probe; id; infectious disease; infectiousdisease; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; misc; miscellaneous; naa+probe; naat; nasba; nucleic acid sequence based analysis; ordinal; other; p pestis; pasturella pestis; pcr; plague; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; screen; sda; spec; strand displacement amplification; tma; to be specified in another part of the message; transcription mediated amplification; unspecified; y pestis,Ord
33693-3,yersinia pestis [presence] in isolate by phage lysis,y pestis islt ql phage lys,y. pestis phage lysis ql (isol),id; infectious disease; infectiousdisease; islt; isol; microbiology; ordinal; p pestis; pasturella pestis; plague; point in time; pr; ql; qual; qualitative; random; screen; y pestis,Ord
33716-2,non-gynecological cytology study,non-gynecological cytology study,non-gyn cytology study,document; finding; findings; non-gyn cyto stdy; pathology; point in time; random; study report; universallaborders,Doc
33733-7,sites of distant metastasis,sites of distant mets,sites of distant metastasis nar (spec),anatomy; metastases; mets; narrative; pathology; pathology protocols; pathology protocols general; point in time; random; report; sites of distant mets; spec,Nar
3373-8,deprecated barbiturate screen absent [identifier] in urine,deprecated barbiturate scn absent ur,barbiturate screen absent nom (u),barb; barbiturate scn absent; drug/toxicology; drugs; identity or presence; nominal; point in time; random; scn; scr; scrn; ua; ur; urn,Nom
33752-7,distance of carcinoma from closest lateral margin [length] in specimen,dist of ca from closest lat margin cap,distance of carcinoma from closest lateral margin (spec) [length],dist of ca from closest lat margin; lat; length; path.histo; pathology; point in time; qnt; quan; quant; quantitative; random; spec,Qn
33756-8,polyp size greatest dimension,polyp size greatest dim,polyp size greatest dimension (spec) [length],length; pathology; pathology protocols; pathology protocols general; point in time; qnt; quan; quant; quantitative; random; spec,Qn
33758-4,polyp stalk length by cap cancer protocols,polyp stalk length cap prot,polyp stalk length cap nom (spec),cap prot; identity or presence; len; nominal; pathology; pathology protocols; pathology protocols general; point in time; random; spec,Nom
33759-2,deepest extent of invasion [type] in specimen,deepest extent of inv spec ql,deepest extent of invasion ql (spec),deepest extent of inv; ordinal; path.histo; pathology; point in time; ql; qual; qualitative; random; screen; spec; typ,Ord
33779-0,igg+igm+iga heavy chain ag [presence] in tissue by immune stain,poly-sp ig ag tiss ql imstn,igg+igm+iga heavy chain ag immune stain ql (tiss),"antigen; antigens; chains; chn; iga hc; ihc; imm; immune globulin a; immune globulin g; immune globulin m; immunoglobulin a; immunoglobulin g; immunoglobulin m; immunohistochemical stain; immunostain; imstn; imun; imune; ordinal; pathology; point in time; poly-sp ig; polyspecific immunoglobulin; pr; ql; qual; qualitative; random; screen; st; stains; stn; tissue; tissue, unspecified",Ord
33786-5,immature basophils/leukocytes in blood by manual count,imm basophils nfr bld manual,immature basophils/leukocytes manual cnt (bld),baso; basophil; basos; blood; bph; hematology/cell counts; imm; imm basophils; immat; leuc; leuk; leukocyte; lkcs; manl; number fraction; percent; point in time; qnt; quan; quant; quantitative; random; wb; wbc; wbcs; white blood cell; white blood cells; whole blood,Qn
3378-7,bendroflumethiazide [presence] in urine,bendroflumethiaz ur ql,bendroflumethiazide ql (u),aprinox; bendrofluazide; benzide; berkozide; centyl; drug/toxicology; drugs; esbericid; naturetin; naturine; neo-naclex; ordinal; pluryl; point in time; pr; ql; qual; qualitative; random; salures; screen; sinesalin; ua; ur; urn,Ord
33793-1,calcium [moles/volume] in urine --7th specimen post xxx challenge,calcium sp7 p chal ur-scnc,calcium 7th specimen post unsp challenge (u) [moles/vol],^7th spec pst xxx chal; after; ca; cal; chemistry.challenge testing; level; p chal; point in time; pst; qnt; quan; quant; quantitative; random; sp7; sp7 p chal; spec; substance concentration; ua; ur; urn,Qn
33797-2,creatine [moles/time] in 12 hour urine,creatine 12h ur-srate,creatine (12h u) [moles/time],12 hours; 12hr; chemistry; qnt; quan; quant; quantitative; srate; substance rate; ua; ur; urn,Qn
33802-0,immature eosinophils [#/volume] in blood by manual count,imm eosinophil # bld manual,immature eosinophils manual cnt (bld) [#/vol],#; abs; absolute; absolutes; blood; cnt; count; count/volume; ct; eos; eosin; eosino; eosinophil; eosins; hematology/cell counts; imm; imm eosinophil; immat; manl; number concentration; number concentration (count/vol); point in time; qnt; quan; quant; quantitative; random; wb; whole blood,Qn
33819-4,insulin [units/volume] in serum or plasma --9th specimen post xxx challenge,insulin sp9 p chal serpl-acnc,insulin 9th specimen post unsp challenge qn,after; arbitrary concentration; chemistry.challenge testing; hum; humulin; ih7; insul; lente; nph; p chal; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; semilente; serp; serpl; serplas; serum; serum or plasma; sliding; sp9; sp9 p chal; spec; sr; ultralente,Qn
33821-0,interleukin 1 alpha [mass/volume] in serum or plasma,il1alpha serpl-mcnc,interleukin 1 alpha [mass/vol],alfa; cg antigen-specific helper factor; chemistry; epidermal cell derived thymocyte-activating factor; etaf; i; il; il1; il-1; il-1a; il1alpha; il-1; level; lymphocyte-activating factor; lymphocyte-stimulating hormone; macrophage cell factor; mass concentration; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; t helper factor,Qn
33831-9,lymphoblasts/leukocytes in blood by manual count,lymphoblasts nfr bld manual,lymphoblasts/leukocytes manual cnt (bld),blood; hematology/cell counts; leuc; leuk; leukocyte; lkcs; lymphoblast; manl; number fraction; percent; point in time; qnt; quan; quant; quantitative; random; wb; wbc; wbcs; white blood cell; white blood cells; whole blood,Qn
33832-7,lymphocytes immunoblastic [#/volume] in blood by manual count,ib lymphs # bld manual,lymphocytes immunoblastic manual cnt (bld) [#/vol],#; abs; absolute; absolutes; blood; cnt; count; count/volume; ct; hematology/cell counts; ib lymphs; lymp; lymph; lympho; lymphocyte; lymphs; lymphs%; manl; number concentration; number concentration (count/vol); point in time; qnt; quan; quant; quantitative; random; wb; whole blood,Qn
33836-8,malignant cells [#/volume] in blood by manual count,malignant cells # bld manual,malignant cells manual cnt (bld) [#/vol],#; abs; absolute; absolutes; blood; cell; cellularity; cnt; count; count/volume; ct; hematology/cell counts; malig; manl; number concentration; number concentration (count/vol); point in time; qnt; quan; quant; quantitative; random; wb; whole blood,Qn
33841-8,immature monocytes [#/volume] in blood by manual count,imm moncytes # bld manual,immature monocytes manual cnt (bld) [#/vol],#; abs; absolute; absolutes; blood; cnt; count; count/volume; ct; hematology/cell counts; imm; imm moncytes; immat; manl; mono; monocyte; monos; number concentration; number concentration (count/vol); point in time; qnt; quan; quant; quantitative; random; wb; whole blood,Qn
3385-2,benzodiazepines negative [identifier] in urine,benzodiaz neg ur,benzodiazepines negative nom (u),benz; benzodiaz; benzodiaz neg; benzodiazepine; drug/toxicology; drugs; identity or presence; neg; nominal; point in time; random; ua; ur; urn,Nom
33858-2,somatotropin [units/volume] in serum or plasma,gh serpl-acnc,somatotropin qn,arbitrary concentration; chemistry; endocrine; endocrinology; gh; growth hormone; hgh; human growth hormone; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; somatotropic hormone; sr; sth,Qn
33866-5,hiv 1 ab [presence] in capillary blood by immunoassay,hiv1 ab bldc ql ia,hiv 1 ab ia ql (bldc),abs; aby; aids; antby; anti; antibodies; antibody; autoantibodies; autoantibody; blood - capillary; cap bld; cap blood; capillary bld; capillary blood; eia; elfa; elisa; enzyme immunoassay; finger stick; hiv type 1; hiv type i; hiv1; human immunodeficiency virus; i; iaa; id; infectious disease; infectiousdisease; meia; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; screen; suds,Ord
33875-6,oligosaccharides pattern [interpretation] in urine,oligosaccharide pattern ur-imp,oligosaccharides pattern (u) [interp],chemistry; impression; impression/interpretation of study; impressions; interp; interpretation; nominal; oligosaccharide pattern; oligosaccharidoses; point in time; random; ua; ur; urn,Nom
3387-8,benzodiazepines positive [identifier] in urine,benzodiaz pos ur,benzodiazepines positive nom (u),benz; benzodiaz; benzodiaz pos; benzodiazepine; drug/toxicology; drugs; identity or presence; nominal; point in time; pos; random; ua; ur; urn,Nom
33881-4,prothrombin time (pt) factor substitution in control platelet poor plasma by coagulation assay --immediately after 1:4 addition of normal plasma,pt imm 1:4 np cont ppp,pt factor substitution immediately after 1:4 addition of normal plasma coag (ppp control) [time],clot; clottable; coag; coagulation assay; contrl; control; fac; fact; hematology; heme; i; imm 1:4 np; mixing studies; normal; plas; platelet poor plasma; point in time; pro time; prothrombin time; protime; pt; pt correction study; pt immediate mix; pt incubated mix; qnt; quan; quant; quantitative; random; tilt tube,Qn
33887-1,prothrombin time (pt) factor substitution in platelet poor plasma by coagulation assay --2h post incubation with normal plasma,pt 2h np ppp,pt factor substitution 2 hr post incubation with normal plasma coag (ppp) [time],120 min; 120 minutes; 120min; 2 hours; 2h np; 2h p inc; after; clot; clottable; coag; coagulation assay; control; fac; fact; hematology; heme; mixing studies; plas; platelet poor plasma; point in time; pro time; prothrombin time; protime; pst; pt; pt correction study; pt immediate mix; pt incubated mix; qnt; quan; quant; quantitative; random; tilt tube,Qn
33888-9,aptt.factor substitution in control platelet poor plasma by coagulation assay --1h post incubation with 1:4 normal plasma,aptt 1h p 1:4 np cont ppp,aptt.factor substitution 1 hr post incubation with 1:4 normal plasma coag (ppp control) [time],1 hour; 1.0hr; 1h p 1:4 np; 1h p inc; 60 min; 60 minutes; 60m; 60min; activated partial thromboplastin time; after; aptt; aptt correction study; clot; clottable; coag; coagulation assay; contrl; control; fac; fact; hematology; heme; i; little(a)ptt; mixing studies; normal; partial thromboplastin time; plas; platelet poor plasma; point in time; pst; ptt; qnt; quan; quant; quantitative; random; surf; tilt tube,Qn
33903-6,ketones [presence] in urine,ketones ur ql,ketones ql (u),acetest; acetoacetate; acetoacetates; acetone bodies; chemistry; ketone; ketone bodies; ordinal; point in time; pr; ql; qual; qualitative; random; screen; ua; universallaborders; ur; urn,Ord
33909-3,prolactin [moles/volume] in serum or plasma --2 hours post 200 ug trh iv,prolactin 2h p 200 ug trh iv serpl-scnc,prolactin 2 hr post 200 ug trh iv [moles/vol],120 min; 120 minutes; 120min; 2 hours; 2h p 200 ug trh iv; after; chemistry.challenge testing; lactotropic hormone; lactotropin; level; mammatropic hormone; mammotropin; mcg; pl; plasma; plsm; point in time; prl; prol; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; substance concentration,Qn
33915-0,anabasine [mass/volume] in urine,anabasine ur-mcnc,anabasine (u) [mass/vol],drug/toxicology; drugs; level; mass concentration; neonicotine; nicotine metabolite; point in time; qnt; quan; quant; quantitative; random; ua; universallaborders; ur; urn,Qn
33921-8,signal recognition particle (srp) ab [presence] in serum or plasma,srp ab serpl ql,signal recognition particle (srp) ab ql,abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; ordinal; pl; plasma; plsm; point in time; pr; ql; qual; qualitative; random; screen; serology; serp; serpl; serplas; serum; serum or plasma; sr; srp,Ord
3392-8,benzoylecgonine [mass/volume] in serum or plasma,bze serpl-mcnc,benzoylecgonine [mass/vol],bec; beg; benz; benzoylec; bze; cocaine degradation production; cocaine metabolite; crack metabolite; drug/toxicology; drugs; level; mass concentration; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
33928-3,efavirenz [mass/volume] in serum or plasma,efavirenz serpl-mcnc,efavirenz [mass/vol],drug/toxicology; drugs; efv; level; mass concentration; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; sustiva,Qn
33947-3,clostridioides difficile toxin neutralizing antibody [titer] in serum by neutralization test,c diff tox nab titr ser nt,c. difficile toxin neut ab neut test (s) [titer],abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; c diff; c diff tox; c difficile; clostridium difficile; conventional virus neutralization test; cvnt; dilution factor; dilution factor (titer); id; infectious disease; infectiousdisease; microbiology; nab; neutralization; neutralization test; nt; point in time; random; serum; serum virus neutralization; smqn; sr; svn; titer; titered; titre; ttr; virus neutralization test; vnt,SemiQn
33949-9,potassium/creatinine [molar ratio] in urine,potassium/creat ur-srto,potassium/creatinine (u) [molar ratio],chemistry; cr; crea; creat; k; k+; point in time; potass; qnt; quan; quant; quantitative; random; scrto; substance concentration ratio; substance ratio; ua; ucr; ur; urn,Qn
33952-3,immune complex.igm [mass/volume] in serum or plasma,ic igm serpl-mcnc,immune complex.igm [mass/vol],cic; circulating immune complex; compx; ic; ic igm; imm; immune globulin m; immunoglobulin m; imun; imune; level; mass concentration; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serology; serp; serpl; serplas; serum; serum or plasma; sr,Qn
33958-0,cholecalciferol (vit d3) [moles/volume] in serum or plasma,vitamin d3 serpl-scnc,vitamin d3 [moles/vol],c27h43oh; calciol; chemistry; colecalciferol; level; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; substance concentration; vit d3; vitamin d3,Qn
33959-8,procalcitonin [mass/volume] in serum or plasma,procalcitonin serpl-mcnc,procalcitonin [mass/vol],chemistry; level; mass concentration; pct; pl; plasma; plsm; point in time; proct; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
3396-9,cocaine [mass/volume] in serum or plasma,cocaine serpl-mcnc,cocaine [mass/vol],addiction; benzoylmethylecgonine; coke; crack; drug/toxicology; drugs; drugs of abuse; ecgonine methyl ester benzoate; illicit; level; mass concentration; pl; plasma; plsm; point in time; potentialforabuse; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; snow; sr,Qn
33988-7,thymidine phosphorylase [enzymatic activity/mass] in leukocytes,thdpase wbc-ccnt,thymidine phosphorylase (wbc) [catalytic activity/mass],catalytic content; chemistry; deoxythymidine; leukocytes; point in time; qnt; quan; quant; quantitative; random; thdpase; tp; wbcs; white blood cells,Qn
3-4,almecillin [susceptibility] by minimum inhibitory concentration (mic),almecillin islt mic,almecillin mic [susc],antibiotic susceptibilities; ast; id; infectious disease; infectiousdisease; islt; isol; minimum inhibitory concentration; point in time; random; sus; suscept; susceptibilities; susceptibility; susceptibilty,OrdQn
34003-4,tooth impaction,tooth impaction,,dental; dentistry; finding; findings; nominal; point in time; random,Nom
34017-4,tooth out of bone/tooth in bone measured,tooth out of bone/in bone measured,,dental; dentistry; length ratio; point in time; qnt; quan; quant; quantitative; random,Qn
34037-2,size alveolar ridge estimated,size alv ridge est,,alv ridge; arbitrary; dental; dentistry; est; estimation; ordinal; point in time; ql; qual; qualitative; random; screen,Ord
3404-1,bolasterone [mass/time] in 24 hour urine,bolasterone 24h ur-mrate,bolasterone (24h u) [mass/time],1 day; 24 hours; 24hr; drug/toxicology; drugs; mass rate; mrate; qnt; quan; quant; quantitative; ua; ur; urn,Qn
34045-5,oral evaluation exam,oral eval exam,,assessment; dental; dentistry; eval; h&p; history and physical; nominal; oral eval exam; point in time; random; typ,Nom
34049-7,number of impressions dentition,# impressions dentition,,# impressions; cnt; count; dental; dentistry; no; num; number; point in time; qnt; quan; quant; quantitative; random,Qn
34054-7,thyrotropin [units/volume] in serum or plasma --pre or post dose trh,tsh pre/p trh serpl-acnc,tsh pre or post dose trh qn,after; arbitrary concentration; before; chemistry.challenge testing; endocrine; endocrinology; p dose; p trh; pl; plasma; plsm; point in time; pre/p trh; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; thyroid stimulating hormone; thyrotropic hormone; tsh,Qn
34061-2,somatotropin [mass/volume] in serum or plasma --pre or post dose arginine,gh pre/p arg serpl-mcnc,somatotropin pre or post dose arginine [mass/vol],after; arg; before; chemistry.challenge testing; endocrine; endocrinology; gh; growth hormone; hgh; human growth hormone; level; mass concentration; p dose; pl; plasma; plsm; point in time; pre/p arg; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; somatotropic hormone; sr; sth,Qn
3407-4,brompheniramine [presence] in serum or plasma,brompheniramine serpl ql,brompheniramine ql,antial; bpn; bromarest; bromfed; bromfenex; dimegan; dimetane; dimetapp; dimotane; drug/toxicology; drugs; gammistin; ilvin; lodrane; ordinal; parabromdylamine maleate; pl; plasma; plsm; point in time; pr; probahist; ql; qual; qualitative; random; screen; serp; serpl; serplas; serum; serum or plasma; sr,Ord
34081-0,fda package insert pediatric use section,fda insert pediatric use,,document.ref; fda insert; narrative; peds; report; spl; structured product labelling,Nar
34082-8,fda package insert geriatric use section,fda insert geriatric use,,document.ref; fda insert; narrative; report; spl; structured product labelling,Nar
34109-9,note,note,,doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; notes; point in time; random; visit note,Doc
34118-0,patient's home initial evaluation note,pt's home initial eval note,,*^patient; assessment; doc.ont; document; encounter; eval; eval note; evaluation and management; evaluation and management note; finding; findings; h&p; history and physical; home health care; initial eval note; notes; point in time; pt's home; random; s prime; visit note,Doc
34135-4,cardiology attending outpatient supervisory note,cardio attend op supervisory note,,cardio attend; cardiology; cards; cvd; dis; diseases; doc.ont; document; dz; encounter; evaluation and management; evaluation and management note; finding; findings; notes; op; point in time; random; visit note,Doc
34158-6,histoplasma capsulatum ag [units/volume] in cerebral spinal fluid,h capsul ag csf-acnc,h. capsulatum ag qn (csf),antigen; antigens; arbitrary concentration; cerebral spinal fluid; cerebrospinal fl; h capsul; h capsulatum; h farciminosum; histo; histopl; histoplasma farciminosum; histoplasmos; histoplasmosis; id; infectious disease; infectiousdisease; microbiology; neuro; neurology; point in time; qnt; quan; quant; quantitative; random; spinal fl; spinal fld; spinal flu; spinal fluid,Qn
34162-8,hepatitis c virus igg band pattern [interpretation] in serum by immunoblot,hcv igg patrn ser ib-imp,hcv igg band pattern ib (s) [interp],abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; bands; blt; bnd; hcv; hcvab; hep; hep c; hepatis; hepatit; hepatology; id; igg patrn; immune blot; immune globulin g; immunobl; immunoblot; immunoglobulin g; impression; impression/interpretation of study; impressions; infectious disease; infectiousdisease; interp; interpretation; liver; microbiology; nominal; patrn; point in time; random; riba; serum; sr; wb; wblot; west blot; west blt; western blot,Nom
34179-2,herpes virus 6 igg ab [titer] in serum by immunoassay,hhv6 igg titr ser ia,hhv 6 igg ia (s) [titer],abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; dilution factor; dilution factor (titer); eia; elfa; elisa; enzyme immunoassay; herpesvirus; hhv; hhv6; hhv-6; human herpes virus; human herpes virus type 6; iaa; id; immune globulin g; immunoglobulin g; infectious disease; infectiousdisease; meia; microbiology; point in time; random; serum; smqn; sr; suds; titer; titered; titre; ttr,SemiQn
341-8,miocamycin [susceptibility] by serum bactericidal titer,miocamycin titr sbt,miocamycin sbt (isol+s),antibiotic susceptibilities; dilution factor; dilution factor (titer); id; infectious disease; infectiousdisease; islt; isol; macroral; midecamycin; miocamen; miokacin; miokamycin; momicine; myoxam; normicina; point in time; ponsinomycin; random; sequence based typing; serum; serum bactericidal titer; serum killing test; smqn; sr; titer; titered; titre; ttr,SemiQn
3418-1,butabarbital [mass/volume] in serum or plasma,butabarbital serpl-mcnc,butabarbital [mass/vol],addiction; barbiturate; butabarb; butabarbitl; butisol; drug/toxicology; drugs; drugs of abuse; illicit; level; mass concentration; pl; plasma; plsm; point in time; potentialforabuse; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
34186-7,para aminobenzoate [mass/time] in 24 hour urine,paba 24h ur-mrate,para aminobenzoate (24h u) [mass/time],1 day; 24 hours; 24hr; aminobenzoic acid; c701; drug/toxicology; drugs; mass rate; mrate; p aminobenzoate; pab; paba; pabanol; qnt; quan; quant; quantitative; ua; ur; urn,Qn
34193-3,smpd1 gene mutations tested for in blood or tissue by molecular genetics method nominal,smpd1 gene mut tested bld/t,smpd1 gene mutations tested for molgen nom (bld/tiss),"asm; asm gene deficiency; asmase; blood; gene mut tested; genetics; heredity; heritable; identity or presence; inherited; molecular genetics; molecular pathology; molpath; molpath.mutations; mut; mut tested; mutation; muts; niemann-pick a and b disease gene; niemann-pick disease type a; niemann-pick disease type b; nieman-pick disease type a; nominal; npd; npda; npdb; pcr; point in time; random; sphingomyelin phosphodiesterase 1, acid lysosomal; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",Nom
34199-0,neutrophils.hypersegmented [presence] in blood by automated count,neuts hyperseg bld ql auto,neutrophils.hypersegmented auto ql (bld),auto; automated detection; blood; elec; elect; electr; hematology/cell counts; hyperseg; hyper-seg; hypersegs; neut; neutr; neutrophil; neuts hyperseg; ordinal; pmn; pnm; point in time; pr; ql; qual; qualitative; random; screen; wb; whole blood,Ord
34200-6,nucleated erythrocytes [presence] in blood by automated count,nrbc bld ql auto,nucleated rbc auto ql (bld),auto; automated detection; blood; discocytes; elec; elect; electr; erthrocyte; erythroblasts; erythrocyte; hematology/cell counts; normoblasts; nrbc; nrbcs; nuc; ordinal; point in time; pr; ql; qual; qualitative; random; rbc; rbcs; red blood cell; red blood cells; red blood corpuscle; red blood corpusles; red cell; red cells; screen; wb; whole blood,Ord
34225-3,3-alpha-androstanediol glucuronide [moles/volume] in urine,3a-diol g ur-scnc,3-alpha-androstanediol glucuronide (u) [moles/vol],3a-diol g; 3-alpha-diol g; alfa; chemistry; gluc; glucouronide; iii; level; point in time; qnt; quan; quant; quantitative; random; substance concentration; ua; ur; urn,Qn
3423-1,caffeine [presence] in urine,caffeine ur ql,caffeine ql (u),caffn; drug/toxicology; drugs; ordinal; point in time; pr; ql; qual; qualitative; random; screen; ua; ur; urn,Ord
34242-8,androsterone [moles/volume] in urine,androsterone ur-scnc,androsterone (u) [moles/vol],androster; chemistry; level; point in time; qnt; quan; quant; quantitative; random; substance concentration; ua; ur; urn,Qn
34245-1,arsenic [moles/volume] in 24 hour urine,arsenic 24h ur-scnc,arsenic (24h u) [moles/vol],1 day; 24 hours; 24hr; as; drug/toxicology; drugs; level; qnt; quan; quant; quantitative; substance concentration; ua; ur; urn,Qn
34254-3,cadmium [moles/volume] in 24 hour urine,cadmium 24h ur-scnc,cadmium (24h u) [moles/vol],1 day; 24 hours; 24hr; cd; drug/toxicology; drugs; level; qnt; quan; quant; quantitative; substance concentration; ua; ur; urn,Qn
34266-7,citrate [moles/volume] in urine,citrate ur-scnc,citrate (u) [moles/vol],chemistry; citric acid; level; point in time; qnt; quan; quant; quantitative; random; substance concentration; ua; ur; urn,Qn
34272-5,collagen crosslinked n-telopeptide/creatinine [ratio] in urine,collagen ntx/creat ur-rto,collagen crosslinked n-telopeptide/creatinine (u) [ratio],aminoterminal cross-linking telopeptide of bone collagen; chemistry; collagen ntx; cr; crea; creat; n-telopeptide of type i collagen; ntx; point in time; qnt; quan; quant; quantitative; random; ratios; rto; ua; ucr; ur; urn,Qn
34279-0,dehydroepiandrosterone (dhea) [moles/volume] in urine,dhea ur-scnc,dhea (u) [moles/vol],chemistry; dhea; endocrine; endocrinology; level; point in time; prasterone; qnt; quan; quant; quantitative; random; substance concentration; ua; ur; urn,Qn
34292-3,estriol (e3) [moles/volume] in 24 hour urine,estriol 24h ur-scnc,e3 (24h u) [moles/vol],1 day; 24 hours; 24hr; chemistry; e3; gyn; gynecology; level; ob; obgyn; obstetrics; qnt; quan; quant; quantitative; substance concentration; ua; ur; urn,Qn
34298-0,estrone (e1) [moles/time] in 24 hour urine,estrone 24h ur-srate,e1 (24h u) [moles/time],1 day; 24 hours; 24hr; chemistry; e1; gyn; gynecology; ob; obgyn; obstetrics; qnt; quan; quant; quantitative; srate; substance rate; ua; ur; urn,Qn
34305-3,flupenthixol [mass/volume] in serum or plasma,flupenthixol serpl-mcnc,flupenthixol [mass/vol],depixol; drug/toxicology; drugs; fluanxol; level; mass concentration; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
34307-9,fructose [moles/volume] in 24 hour urine,fructose 24h ur-scnc,fructose (24h u) [moles/vol],1 day; 24 hours; 24hr; chemistry; level; levulose; qnt; quan; quant; quantitative; revulose; substance concentration; ua; ur; urn,Qn
34322-8,iron/creatinine [molar ratio] in urine,iron/creat ur-srto,iron/creatinine (u) [molar ratio],chemistry; cr; crea; creat; fe; point in time; qnt; quan; quant; quantitative; random; scrto; substance concentration ratio; substance ratio; ua; ucr; ur; urn,Qn
34347-5,normetanephrine [moles/volume] in urine,normetanephrine ur-scnc,normetanephrine (u) [moles/vol],chemistry; level; normeta; normetaneph; normetanephrn; point in time; qnt; quan; quant; quantitative; random; substance concentration; ua; ur; urn,Qn
34349-1,oxalate [moles/volume] in 24 hour urine,oxalate 24h ur-scnc,oxalate (24h u) [moles/vol],1 day; 24 hours; 24hr; chemistry; ethanedioate; ethanedioic acid; kidney; level; nephrology; oxal; oxalic acid; qnt; quan; quant; quantitative; renal; substance concentration; ua; ur; urn,Qn
34360-8,pregnanetriol [moles/volume] in 24 hour urine,pregntrl 24h ur-scnc,pregnanetriol (24h u) [moles/vol],1 day; 24 hours; 24hr; chemistry; level; pregnanetr; pregntrl; qnt; quan; quant; quantitative; substance concentration; ua; ur; urn,Qn
34363-2,pregnanetriolone [moles/volume] in urine,pregntrlone ur-scnc,pregnanetriolone (u) [moles/vol],chemistry; level; point in time; pregnanetr; pregntrlone; qnt; quan; quant; quantitative; random; substance concentration; ua; ur; urn,Qn
34368-1,pyridinoline [moles/time] in 24 hour urine,pyd 24h ur-srate,pyridinoline (24h u) [moles/time],1 day; 24 hours; 24hr; chemistry; pyd; pyr; pyridinium collagen crosslinks; qnt; quan; quant; quantitative; srate; substance rate; ua; ur; urn,Qn
34373-1,serotonin [moles/volume] in urine,serotonin ur-scnc,serotonin (u) [moles/vol],5-ht; 5-hydroxytryptamine; 5-hydroxytryptophane; c10h12n2o; chemistry; enteramine; level; point in time; qnt; quan; quant; quantitative; random; substance concentration; ua; ur; urn,Qn
34389-7,zinc/creatinine [molar ratio] in urine,zinc/creat ur-srto,zinc/creatinine (u) [molar ratio],cr; crea; creat; drug/toxicology; drugs; point in time; qnt; quan; quant; quantitative; random; scrto; substance concentration ratio; substance ratio; ua; ucr; ur; urn; zn,Qn
34392-1,food allergen mix 17 (apple+banana+pear+peach) ige ab [presence] in serum by multidisk,food allerg mix17 ige ql,apple+banana+pear+peach ige multidisk ql (s),abs; aby; allergen; allergens; allergy testing; allerscan; antby; anti; antibodies; antibody; apple; autoantibodies; autoantibody; banana; f049; f092; f094; f095; f49; f92; f94; f95; food allerg mix17; fx17; immune globulin e; immunoglobulin e; musa sp; ordinal; peach; pear; point in time; pr; pyrus malus; ql; qual; qualitative; random; rfx17; screen; serum; sr,Ord
3439-7,cathine [mass/volume] in urine,cathine ur-mcnc,cathine (u) [mass/vol],addiction; d-norpseudoephedrine; drug/toxicology; drugs; drugs of abuse; illicit; level; mass concentration; norpseudoephedrine; point in time; potentialforabuse; qnt; quan; quant; quantitative; random; ua; ur; urn,Qn
34397-0,amilsulpride [mass/volume] in serum or plasma,amilsulpride serpl-mcnc,amilsulpride [mass/vol],amilsulprid; drug/toxicology; drugs; level; mass concentration; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; solian; sr,Qn
34401-0,complement c3d [mass/volume] in serum or plasma,c3d serpl-mcnc,complement c3d [mass/vol],comp; complmt; hematology/cell counts; level; mass concentration; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
34406-9,exocrine pancreas ab [titer] in serum by immunofluorescence,exocrine pancreas ab titr ser if,exocrine pancreas ab if (s) [titer],abs; aby; acif; antby; anti; antibodies; antibody; anticomplement immunofluorescence; autoantibodies; autoantibody; dilution factor; dilution factor (titer); fa; fluorescent antibody; fluoresent; ifa; immune fluorescence; immunoflour; immunofluor; immunofluorescence; point in time; random; serology; serum; smqn; sr; time resolved fluorescence; titer; titered; titre; trf; ttr,SemiQn
34427-5,methadone.r [mass/volume] in serum or plasma,r-methadone serpl-mcnc,methadone.r [mass/vol],active enantiomer of methadone; dolophin; dolophine; drug/toxicology; drugs; level; mass concentration; metd; methadose; mtd; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; r prime; random; right; r-methadone; serp; serpl; serplas; serum; serum or plasma; sr,Qn
34441-6,spermatozoa [velocity] in semen,sperm smn qn,spermatozoa (sem) [velocity],ejaculate; fertility testing; genitourinary; gu; point in time; qnt; quan; quant; quantitative; random; sem; seminal fluid; smn; smpls; sperm; uro; urology; velocity,Qn
34456-4,powassan virus rna [presence] in blood by naa with probe detection,powv rna bld ql naa+probe,powassan virus rna naa+probe ql (bld),3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; blood; dna nucleic acid probe; dna probe; id; infectious disease; infectiousdisease; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; naa+probe; naat; nasba; nucleic acid sequence based analysis; ordinal; pcr; point in time; polymerase chain reaction; powv; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; ribonucleic acid; screen; sda; strand displacement amplification; tma; transcription mediated amplification; wb; whole blood,Ord
3450-4,ceftizoxime [mass/volume] in serum or plasma,ceftizoxime serpl-mcnc,ceftizoxime [mass/vol],cefizox; ceftrix; drug/toxicology; drugs; eposelin; eposerin; level; mass concentration; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
34524-9,band form neutrophils [presence] in blood by automated count,neuts band bld ql auto,band form neutrophils auto ql (bld),auto; automated detection; bands; blood; bnd; elec; elect; electr; hematology/cell counts; n-band; neut; neutr; neutrophil; neuts band; ordinal; pmn; pnm; point in time; pr; ql; qual; qualitative; random; screen; wb; whole blood,Ord
34528-0,pt panel - platelet poor plasma by coagulation assay,pt pnl ppp,pt panel coag (ppp),clot; clottable; coagulation; coagulation assay; pan; panel.coagulation; panl; plas; platelet poor plasma; pnl; point in time; protime; pt pnl; qnt; quan; quant; quantitative; random; tilt tube; universallaborders,Qn
34530-6,abo and rh group panel - blood,abo + rh pnl bld,abo and rh group panel (bld),abo + rh; abo + rh pnl; abo group and rh type; abo+rh gp; blood; blood bank; d phenotyping; d typing; hematology; heme; pan; panel.bloodbank; panl; pnl; point in time; random; rh phenotyping; rh typing; universallaborders; wb; whole blood,-
3453-8,cephalexin [mass/volume] in serum or plasma,cephalexin serpl-mcnc,cephalexin [mass/vol],cefadine; drug/toxicology; drugs; gracef; keflex; level; losporal; mass concentration; palitrex; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; salitex; serp; serpl; serplas; serum; serum or plasma; sr,Qn
34540-5,phenytoin free and total panel - serum or plasma,phenytoin free+total pnl serpl,phenytoin free and total panel,di-hydan; dilantin; dilj; diphenylhydantoin; dph; drug/toxicology; drugs; epanutin; fenantoin; fr; lehydan; neuro; neurology; non-protein bound; pan; panel.drug & toxicology; panl; phenhydan; phenytoin free+total pnl; phyt; pl; plasma; plsm; pnl; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sinergina; sr; tot; totl; zentropil,Qn
34550-4,immunoglobulin panel [mass/volume] - serum,immunoglobulin pnl ser-mcnc,immunoglobulin panel (s) [mass/vol],chemistry; immune globulin; immuno; immunoglob; immunoglobin; immunoglobulin pnl; imunoglbon; imunoglobn; level; mass concentration; pan; panel.chemistry; panl; pnl; point in time; qnt; quan; quant; quantitative; random; serum; sr; universallaborders,Qn
34566-0,vital signs with method details panel,vital signs pnl,,meth; method of; pan; panel.vital signs; panl; pnl; point in time; random; vital signs panel; vital signs pnl,-
34574-4,pathology report final diagnosis,path report.final dx spec,,dx; impression; impression/interpretation of study; impressions; interp; interpretation; nominal; oncology; path report.final dx; point in time; random; spec; tumor registry(naaccr),Nom
34578-5,barbiturates [presence] in meconium by screen method,barbiturates mec ql scn,barbiturates screen ql (mec),addiction; barb; barbiturate; barbs; drug/toxicology; drugs; drugs of abuse; illicit; mec; ordinal; point in time; potentialforabuse; pr; ql; qual; qualitative; random; scn; scr; screen; scrn,Ord
34595-9,collection time of gastric fluid,collect tme gast,collection time (gast fld) [date/time],coll; collect; collect tme; collected; date and time; gast; gastric contents; gastric fluid; point in time; qnt; quan; quant; quantitative; random; spec; time stamp; timestamp,Qn
34603-1,i ab [titer] in serum or plasma,i ab titr serpl,i ab [titer],abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; blood bank; dilution factor; dilution factor (titer); pl; plasma; plsm; point in time; random; serp; serpl; serplas; serum; serum or plasma; smqn; sr; titer; titered; titre; ttr,SemiQn
34606-4,minocycline [mass/volume] in cerebral spinal fluid,minocycline csf-mcnc,minocycline (csf) [mass/vol],aknemin; c128; cerebral spinal fluid; cerebrospinal fl; dentomycin; drug/toxicology; drugs; klinomysin; lederderm; level; mass concentration; mestacine; mino-50; minocin; minomycin; mynocine; point in time; qnt; quan; quant; quantitative; random; spinal fl; spinal fld; spinal flu; spinal fluid,Qn
34613-0,herpes simplex virus 1+2 igg ab [titer] in serum,hsv1+2 igg titr ser,hsv 1+2 igg (s) [titer],abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; dilution factor; dilution factor (titer); herp splx; herpes simplex virus type 1; herpes simplex virus type 1+2; herpes simplex virus type i+ii; hsv; hsv 1+2; hsv1; hsv1+2; i; id; ii; immune globulin g; immunoglobulin g; infectious disease; infectiousdisease; microbiology; point in time; random; serum; smqn; sr; titer; titered; titre; ttr,SemiQn
34616-3,amino acids [identifier] in cerebral spinal fluid,amino acids csf,amino acids nom (csf),aa; acd; acid; amino acid; amino acids.total; cerebral spinal fluid; cerebrospinal fl; chemistry; identity or presence; nominal; point in time; random; spinal fl; spinal fld; spinal flu; spinal fluid,Nom
34636-1,ciprofloxacin [mass/volume] in cerebral spinal fluid,ciprofloxacin csf-mcnc,ciprofloxacin (csf) [mass/vol],c250; c307; c81; cerebral spinal fluid; cerebrospinal fl; ciloxan; cipro; ciprofloxacn; ciprofloxin; drug/toxicology; drugs; level; mass concentration; point in time; qnt; quan; quant; quantitative; random; spinal fl; spinal fld; spinal flu; spinal fluid,Qn
34642-9,thyroid colloidal ab [titer] in serum,thyroid colloidal ab titr ser,thyroid colloidal ab (s) [titer],abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; dilution factor; dilution factor (titer); endocrine; endocrinology; point in time; random; serology; serum; smqn; sr; titer; titered; titre; ttr,SemiQn
34647-8,ppt1 gene targeted mutation analysis in blood or tissue by molecular genetics method,ppt1 gene mut anl bld/t,ppt1 gene targeted mutation analysis molgen doc (bld/tiss),"blood; ceroid lipofuscinosis, neuronal-1, infantile; cln1; document; finding; findings; genetics; heredity; heritable; incl; inherited; molecular genetics; molecular pathology; molpath; molpath.mutations; mut; mut anl; mutations; palmitoyl-protein thioesterase 1; palmitoyl-protein thioesterase gene; pcr; point in time; ppt; random; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",Doc
34665-0,torch panel - cerebral spinal fluid,torch pnl csf,torch panel (csf),"cerebral spinal fluid; cerebrospinal fl; gyn; gynecology; id; infectious disease; infectiousdisease; microbiology; neuro; neurology; ob; obgyn; obstetrics; pan; panel.microbiology; panl; pnl; point in time; qnt; quan; quant; quantitative; random; spinal fl; spinal fld; spinal flu; spinal fluid; torch pnl; toxoplasma, rubella. cytomegalovirus, herpes simplex virus",Qn
34669-2,pyrimethamine [mass/volume] in serum or plasma,pyrimethamine serpl-mcnc,pyrimethamine [mass/vol],daraprim; drug/toxicology; drugs; fansidar; level; mass concentration; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
34675-9,mitochondria genes targeted mutation analysis in blood or tissue by molecular genetics method,mtdna mut anl bld/t,mitochondria genes targeted mutation analysis molgen doc (bld/tiss),"blood; deoxyribonucleic acid; document; finding; findings; genetics; heredity; heritable; inherited; mito; mitochon; mitochond; mitochondrial; molecular genetics; molecular pathology; molpath; molpath.mutations; mtdna; mut; mut anl; mutations; pcr; point in time; random; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",Doc
34676-7,deprecated smn1 gene mutations found [identifier] in blood or tissue by molecular genetics method narrative,deprecated sma@ gene mut anal bld/t,sma@ gene mutation analysis molgen nar (bld/tiss),"bcd541; blood; gemin1; genetics; heredity; heritable; identity or presence; inherited; molecular genetics; molecular pathology; molpath; molpath.mutations; mut; mutations; narrative; pcr; point in time; random; report; sma; sma@; sma1; sma2; sma3; sma4; smn; smnt; t-bcd541; tdrd16a; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",Nar
34677-5,mitotic spindle apparatus ab [titer] in serum or plasma,mitotic spindle app ab titr serpl,mitotic spindle apparatus ab [titer],abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; dilution factor; dilution factor (titer); lung; msa; nuclear mitotic spindle; pl; plasma; plsm; point in time; pulmonary; pulmonology; random; respiratory; serology; serp; serpl; serplas; serum; serum or plasma; smqn; sr; titer; titered; titre; ttr,SemiQn
34684-1,aptt.factor substitution in platelet poor plasma by coagulation assay --immediately after addition of factor xiii depleted plasma,aptt imm fxiii dp ppp,aptt.factor substitution immediately after addition of factor xiii depleted plasma coag (ppp) [time],activated partial thromboplastin time; aptt; aptt correction study; clot; clottable; coag; coagulation assay; fac; fact; factor 13; fxiii; hematology; heme; imm fxiii dp; immediatedly after 1:1 addition of; little(a)ptt; mixing studies; partial thromboplastin time; plas; platelet poor plasma; point in time; ptt; qnt; quan; quant; quantitative; random; surf; tilt tube,Qn
34688-2,aptt.factor substitution in platelet poor plasma by coagulation assay --immediately after addition of factor xii depleted plasma,aptt imm fxii dp ppp,aptt.factor substitution immediately after addition of factor xii depleted plasma coag (ppp) [time],activated partial thromboplastin time; aptt; aptt correction study; clot; clottable; coag; coagulation assay; fac; fact; factor 12; fxii; hematology; heme; imm fxii dp; immediatedly after 1:1 addition of; little(a)ptt; mixing studies; partial thromboplastin time; plas; platelet poor plasma; point in time; ptt; qnt; quan; quant; quantitative; random; surf; tilt tube,Qn
34706-2,cftr gene c.3199del6 [presence] in blood or tissue by molecular genetics method,cftr c.3199del6 bld/t ql,cftr gene c.3199del6 molgen ql (bld/tiss),"3067_3072del6; abc35; abcc7; blood; c.3067_3072del6; cbavd; cf; cfa; cftr c.3199del6; cftr/mrp; cystic fibrosis transmembrane conductance regulator; cystic fibrosis transmembrane conductance regulator (atp-binding cassette sub-family c, member 7); dj760c5.1; genetics; heredity; heritable; inherited; molecular genetics; molecular pathology; molpath; molpath.mutations; mrp7; ordinal; pcr; point in time; pr; ql; qual; qualitative; random; screen; tissue; tissue, unspecified; tnr-cftr; wb; whole blood; whole blood or tissue",Ord
3471-0,chlorpromazine [mass/volume] in serum or plasma,chlorpromazine serpl-mcnc,chlorpromazine [mass/vol],chlopromazine; chlorpromaz; drug/toxicology; drugs; level; mass concentration; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; thorazine,Qn
34714-6,inr in blood by coagulation assay,inr bld,inr coag (bld) [relative time],blood; clot; clottable; coag; coagulation assay; fac; fact; hematology; heme; internat norm ratio; international normal ratio; international normalization ratio; international normalized ratio; point in time; pro time; prothrombin time; prothrombin time inr; protime; protime inr; pt; pt inr; qnt; quan; quant; quantitative; random; rltm; tilt tube; wb; whole blood,Qn
34715-3,cocaine [presence] in hair by screen method,cocaine hair ql scn,cocaine screen ql (hair),addiction; benzoylmethylecgonine; coke; crack; drug/toxicology; drugs; drugs of abuse; ecgonine methyl ester benzoate; har; illicit; ordinal; point in time; potentialforabuse; pr; ql; qual; qualitative; random; scn; scr; screen; scrn; snow,Ord
34754-2,critical care medicine note,ccm note,,ccm; continuity assessment record and evaluation; doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; notes; point in time; random; visit note,Doc
34762-5,gastroenterology note,gastroenterology note,,doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; gastro; gastroenterology; gi; notes; point in time; random; visit note,Doc
34765-8,general medicine note,general medicine note,,doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; notes; point in time; random; visit note,Doc
3476-9,chlorprothixene [mass/volume] in serum or plasma,chlorprothixene serpl-mcnc,chlorprothixene [mass/vol],drug/toxicology; drugs; level; mass concentration; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; tarasan; truxal; truxaletten; turactan,Qn
34775-7,deprecated general surgery pre-operative evaluation and management note,deprecated general surgery pre-op note,,assessment; clinical encounter note; doc.ont; document; e/m note; encounter; eval; evaluation and management; evaluation and management note; finding; findings; h&p; history and physical; notes; point in time; pre-op; pre-op note; pre-operative; random; surg; visit note,Doc
34779-9,hematology+medical oncology consult note,hemonc consult note,,cancer; consult note; doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; hematology; hematology and oncology; hematology+oncology; heme; hemonc; notes; oncology; point in time; random; visit note,Doc
34780-7,hematology+medical oncology note,hemonc note,,cancer; doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; hematology; hematology and oncology; hematology+oncology; heme; hemonc; notes; oncology; point in time; random; visit note,Doc
34784-9,kinesiotherapy note,kinesiotherapy note,,doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; notes; point in time; random; visit note,Doc
34794-8,interdisciplinary note,interdiscip note,,doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; multidisciplinary; notes; point in time; random; visit note,Doc
34795-5,nephrology consult note,nephrology consult note,,consult note; doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; kidney; nephrology; notes; point in time; random; renal; visit note,Doc
34834-2,recreational therapy note,rec therapy note,,doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; notes; point in time; random; rec therapy; visit note,Doc
34836-7,deprecated rehabilitation note,deprecated rehabilitation note,,doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; notes; point in time; random; visit note,Doc
34847-4,surgery consult note,surgery consult note,,consult note; doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; notes; point in time; random; surg; visit note,Doc
34866-4,psychology counseling note,psych counseling note,,doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; notes; point in time; random; visit note,Doc
34867-2,ophthalmology outpatient postoperative evaluation and management note,ophthalmol op post-op e/m note,,assessment; clinical encounter note; doc.ont; document; e/m note; encounter; eval; evaluation and management; evaluation and management note; eye; eye care; finding; findings; h&p; history and physical; notes; op; ophthalmology; ophtho; ophthy; point in time; post-op e/m note; post-operative; random; visit note,Doc
34875-5,surgery postoperative evaluation and management note,surgery post-op e/m note,,assessment; clinical encounter note; doc.ont; document; e/m note; encounter; eval; evaluation and management; evaluation and management note; finding; findings; h&p; history and physical; notes; point in time; post-op e/m note; post-operative; random; surg; visit note,Doc
34879-7,endocrinology consult note,endocrinology consult note,,consult note; doc.ont; document; encounter; endocrine; endocrinology; evaluation and management; evaluation and management note; finding; findings; notes; point in time; random; visit note,Doc
34882-1,ethanol [mass/volume] in saliva (oral fluid),ethanol sal-mcnc,ethanol (sal) [mass/vol],alc; alcohol; drug/toxicology; drugs; ethyl alcohol; etoh; level; mass concentration; oral fluid; point in time; qnt; quan; quant; quantitative; random; sal,Qn
34893-8,aino virus ab [titer] in serum,ainov ab titr ser,aino virus ab (s) [titer],abs; aby; ainov; antby; anti; antibodies; antibody; autoantibodies; autoantibody; dilution factor; dilution factor (titer); id; infectious disease; infectiousdisease; microbiology; point in time; random; serum; smqn; sr; titer; titered; titre; ttr,SemiQn
34894-6,akabane virus ab [titer] in serum,akav ab titr ser,akabane virus ab (s) [titer],abs; aby; akav; antby; anti; antibodies; antibody; autoantibodies; autoantibody; dilution factor; dilution factor (titer); id; infectious disease; infectiousdisease; microbiology; point in time; random; serum; smqn; sr; titer; titered; titre; ttr; vet; veterinary,SemiQn
34909-2,cortisol free [mass/volume] in 24 hour urine by hplc,cortis f 24h ur hplc-mcnc,cortisol free hplc (24h u) [mass/vol],1 day; 17-hydroxycorticosterone; 24 hours; 24hr; chemistry; compound f; coritsol; cort; cortis f; f; fr; high performance liquid chromatography; high pressure liquid chromatography; hydrocortisone; level; mass concentration; non-protein bound; qnt; quan; quant; quantitative; ua; ur; urn,Qn
34920-9,lymphocytes immunoblastic/leukocytes in blood,ib lymphs nfr bld,lymphocytes immunoblastic/leukocytes (bld),blood; hematology/cell counts; ib lymphs; leuc; leuk; leukocyte; lkcs; lymp; lymph; lympho; lymphocyte; lymphs; lymphs%; number fraction; percent; point in time; qnt; quan; quant; quantitative; random; wb; wbc; wbcs; white blood cell; white blood cells; whole blood,Qn
34923-3,monoblasts/leukocytes in blood,monoblasts nfr bld,monoblasts/leukocytes (bld),blood; hematology/cell counts; leuc; leuk; leukocyte; lkcs; monoblast; number fraction; percent; point in time; qnt; quan; quant; quantitative; random; wb; wbc; wbcs; white blood cell; white blood cells; whole blood,Qn
34936-5,cd3+cd8+cd45ro-cd45ra+ cells/cells in blood,cd3+8+45ro-45ra+ cells nfr bld,cd3+cd8+cd45ro-cd45ra+ cells/cells (bld),2h4; blood; cd3 cells; cd3+8+45ro+45ra- cells; cd3+8+45ro+45ra+ cells; cd3+8+45ro-45ra- cells; cd3+8+45ro-45ra+ cells; cd3+cd8+ cells; cd3+cd8+cd45ro+; cd8 t cells; cell; cell markers; cellularity; leu18; leu-18; leu2; leu-2; leu4; leu-4; number fraction; percent; point in time; qnt; quan; quant; quantitative; random; suppressor t cells; suppressor/cytotoxic t cells; t3; t8; t-8; t8 suppressor cells; tsuppressor; uchl-1; wb; whole blood,Qn
34953-0,rubella virus igg and igm panel - cerebral spinal fluid,rubv igg+igm pnl csf,rubella virus igg and igm panel (csf),cerebral spinal fluid; cerebrospinal fl; congenital rubella syndrome; german measles; id; immune globulin g; immune globulin m; immunoglobulin g; immunoglobulin m; infectious disease; infectiousdisease; microbiology; neuro; neurology; pan; panel.microbiology; panl; pnl; point in time; qnt; quan; quant; quantitative; random; rubv; rubv igg+igm pnl; spinal fl; spinal fld; spinal flu; spinal fluid,Qn
34961-3,rh [type] in blood by confirmatory method,rh bld cfm,rh confirm nom (bld),blood; blood bank; cfm; cnfr; cnfrm; conf; confirmation; confirmatory; d phenotyping; d typing; gcms; hematology; heme; lc/ms/ms; nominal; point in time; random; rh phenotyping; rh typing; typ; wb; whole blood,Nom
34968-8,osmotic fragility of red blood cells--0.20% sodium chloride,of .20% nacl nfr rbc,osmotic fragility 0.20% sodium chloride (rbc),.20% nacl; cl; cl-; erythrocytes; frag; fragil; hematology/cell counts; na; na cl; na+; nacl; number fraction; of; osmo; osmo frag; percent; point in time; qnt; quan; quant; quantitative; random; red blood cells; red blood corpusles,Qn
34970-4,ultrasound date,us date,ultrasound date,aoeobservation; misc; point in time; qnt; quan; quant; quantitative; random; us date,Qn
34979-5,volume of pleural fluid,specimen vol plr,specimen volume (pleur fld),pleural; pleural fluid; point in time; qnt; quan; quant; quantitative; random; spec; thoracentesis fluid; vol; volume,Qn
34996-9,promyelocytes [#/volume] in body fluid,promyelocytes # fld,promyelocytes (body fld) [#/vol],"#; abs; absolute; absolutes; b/f; bf; bod; bodies; body fluid; body fluid, unsp; cnt; count; count/volume; ct; fl; fld; flu; fluid; hematology/cell counts; number concentration; number concentration (count/vol); point in time; pro myelos; progranulocyte; progranulocytes; promyel; promyelocyte; qnt; quan; quant; quantitative; random",Qn
34997-7,promonocytes [#/volume] in body fluid,promonycytes # fld,promonocytes (body fld) [#/vol],"#; abs; absolute; absolutes; b/f; bf; bod; bodies; body fluid; body fluid, unsp; cnt; count; count/volume; ct; fl; fld; flu; fluid; hematology/cell counts; number concentration; number concentration (count/vol); point in time; promono; promonocyte; promonycytes; qnt; quan; quant; quantitative; random",Qn
35007-4,nonhematic cells [#/volume] in cerebral spinal fluid,nonhematic cells # csf,nonhematic cells (csf) [#/vol],#; abs; absolute; absolutes; cell; cellularity; cerebral spinal fluid; cerebrospinal fl; cnt; count; count/volume; ct; hematology/cell counts; non-hematic cells; number concentration; number concentration (count/vol); point in time; qnt; quan; quant; quantitative; random; spinal fl; spinal fld; spinal flu; spinal fluid,Qn
35017-3,myelocytes [#/volume] in cerebral spinal fluid,myelocytes # csf,myelocytes (csf) [#/vol],#; abs; absolute; absolutes; cerebral spinal fluid; cerebrospinal fl; cnt; count; count/volume; ct; hematology/cell counts; myel; myelo; myelocyte; number concentration; number concentration (count/vol); point in time; qnt; quan; quant; quantitative; random; spinal fl; spinal fld; spinal flu; spinal fluid,Qn
35040-5,lymphocytes immunoblastic [#/volume] in blood,ib lymphs # bld,lymphocytes immunoblastic (bld) [#/vol],#; abs; absolute; absolutes; blood; cnt; count; count/volume; ct; hematology/cell counts; ib lymphs; lymp; lymph; lympho; lymphocyte; lymphs; lymphs%; number concentration; number concentration (count/vol); point in time; qnt; quan; quant; quantitative; random; wb; whole blood,Qn
35045-4,variant lymphocytes [#/volume] in body fluid,variant lymphs # fld,variant lymphocytes (body fld) [#/vol],"#; abs; absolute; absolutes; atypical lymphocytes; b/f; bf; bod; bodies; body fluid; body fluid, unsp; cnt; count; count/volume; ct; fl; fld; flu; fluid; hematology/cell counts; lymp; lymph; lympho; lymphocyte; lymphs; lymphs%; number concentration; number concentration (count/vol); point in time; qnt; quan; quant; quantitative; random; reactive lymphocytes; variant lymphocytes; variant lymphs",Qn
35055-3,histiocytes/leukocytes in body fluid,histiocytes nfr fld,histiocytes/leukocytes (body fld),"b/f; bf; bod; bodies; body fluid; body fluid, unsp; fl; fld; flu; fluid; hematology/cell counts; histiocyte; histocytes; leuc; leuk; leukocyte; lkcs; number fraction; percent; point in time; qnt; quan; quant; quantitative; random; wbc; wbcs; white blood cell; white blood cells",Qn
35060-3,eosinophils [#/volume] in synovial fluid,eosinophil # snv,eosinophils (syn fld) [#/vol],#; abs; absolute; absolutes; cnt; count; count/volume; ct; eos; eosin; eosino; eosinophil; eosins; hematology/cell counts; joint aspirate; joint fld; joint flu; joint fluid; number concentration; number concentration (count/vol); point in time; qnt; quan; quant; quantitative; random; sf; snv; syn; syn fl; synov; synovial fluid,Qn
35074-4,basophils [#/volume] in synovial fluid,basophils # snv,basophils (syn fld) [#/vol],#; abs; absolute; absolutes; baso; basophil; basos; bph; cnt; count; count/volume; ct; hematology/cell counts; joint aspirate; joint fld; joint flu; joint fluid; number concentration; number concentration (count/vol); point in time; qnt; quan; quant; quantitative; random; sf; snv; syn; syn fl; synov; synovial fluid,Qn
35080-1,mononuclear cells [#/volume] in peritoneal fluid,mononuc cells # prt,mononuclear cells (periton fld) [#/vol],#; abs; absolute; absolutes; ascites; ascitic fluid; ascitis; cell; cellularity; cnt; count; count/volume; ct; hematology/cell counts; mononuc; mononuc cells; number concentration; number concentration (count/vol); peritoneal fluid; point in time; prt; qnt; quan; quant; quantitative; random,Qn
35094-2,blood pressure panel,bp pnl,,bp; bp pnl; pan; panel.bp; panl; pnl; point in time; random,-
35110-6,flecainide [mass/volume] in serum or plasma --trough,flecainide trough serpl-mcnc,flecainide trough [mass/vol],drug/toxicology; drugs; level; mass concentration; pl; plasma; plsm; point in time; pre; predose; pre-dose; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; tambocor,Qn
35119-7,chloral hydrate [presence] in serum or plasma,chloral hydrate serpl ql,chloral hydrate ql,chloraldurat; chloralix; dormel; drug/toxicology; drugs; elix-node; medianox; noctec; ordinal; pediatric chloral elixir; pl; plasma; plsm; point in time; pr; ql; qual; qualitative; random; screen; serp; serpl; serplas; serum; serum or plasma; sr; trichloroethanol; trichloroethyl alcohol; trichloroethylalcohol; welldorm,Ord
35124-7,dysferlin [presence] in leukocytes,dysferlin wbc ql,dysferlin ql (wbc),chemistry; dystrophy-associated fer-1-like protein; leukocytes; ordinal; point in time; pr; ql; qual; qualitative; random; screen; wbcs; white blood cells,Ord
35131-2,l-dopa decarboxylase [enzymatic activity/volume] in plasma,l-dopa decase plas-ccnc,l-dopa decarboxylase (p) [catalytic activity/vol],aromatic l-amino acid decarboxylase; catalytic concentration; chemistry; ddc; dopa decarboxylase; l-dopa decase; left; levo; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random,Qn
35136-1,patient symptoms [interpretation] --3 hours post dose lactose po,symptoms 3h p lac po patient-imp,patient symptoms 3 hr post dose lactose po [interp],3h p lac po; after; chemistry.challenge testing; impression; impression/interpretation of study; impressions; interp; interpretation; ltt; nominal; p dose; point in time; pst; random; sx,Nom
35155-1,hexadecenoate (c16:1w9) [moles/volume] in serum or plasma,hexadecenoate serpl-scnc,hexadecenoate (c16:1w9) [moles/vol],c16:1w9; chemistry; hexadecenoic acid; level; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; substance concentration,Qn
35157-7,myristate (c14:0) [moles/volume] in serum or plasma,myristate serpl-scnc,myristate (c14:0) [moles/vol],c14:0; chemistry; level; myristic acid; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; substance concentration; tetradecanoate; tetradecanoic acid,Qn
35181-7,docosapentaenate (c22:5w6) [moles/volume] in serum or plasma,docosapentaenate w6 serpl-scnc,docosapentaenate (c22:5w6) [moles/vol],c22:5w6; chemistry; docosapentaenic acid; dpa; level; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; substance concentration,Qn
35197-3,cholesterol in hdl [mass or moles/volume] in serum or plasma,hdlc serpl-mscnc,cholesterol in hdl [mass or moles/vol],cardio; cardiology; chemistry; chol; choles; cholest; cholesterol total; cholesterols; hdlc; hdl-c; heart disease; high density lipoprotein cholesterols; level; lipid; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; tchhdl,Qn
35202-1,cortisol [mass or moles/volume] in serum or plasma,cortis serpl-mscnc,cortisol [mass or moles/vol],17-hydroxycorticosterone; chemistry; compound f; coritsol; cort; f; hydrocortisone; level; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
3520-4,cyclosporine [mass/volume] in blood,cyclosporine bld-mcnc,cyclosporine (bld) [mass/vol],blood; ciclosporin; ciclosporine; csa; cyclosporin a; cyclosporins; drug/toxicology; drugs; gengraf; level; mass concentration; neoral; point in time; qnt; quan; quant; quantitative; random; restasis; sandimmune; sangcya; universallaborders; wb; whole blood,Qn
35221-1,phosphate [mass or moles/volume] in serum or plasma,phosphate serpl-mscnc,phosphate [mass or moles/vol],chemistry; i phos; inorganic phosphate; level; phos; phosphate total; phosphorous; phosphorus; phosphrous; pi; pl; plasma; plsm; po4; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
35241-9,urea nitrogen [mass or moles/volume] in dialysis fluid,urea nit dial fld-mscnc,urea nitrogen (dial fld) [mass or moles/vol],blood urea nitrogen; chemistry; diaf; dialysate; dialysis fluid; level; n; n2; nit; point in time; qnt; quan; quant; quantitative; random; un,Qn
35246-8,calcium [mass or moles/volume] in serum or plasma,calcium serpl-mscnc,calcium [mass or moles/vol],ca; cal; chemistry; level; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
35252-6,magnesium [mass or moles/volume] in 24 hour urine,magnesium 24h ur-mscnc,magnesium (24h u) [mass or moles/vol],1 day; 24 hours; 24hr; chemistry; kidney; level; mag; magnes; mg; nephrology; qnt; quan; quant; quantitative; renal; ua; ur; urn,Qn
35279-9,neutrophil cytoplasmic ab [presence] in serum by immunofluorescence,anca ab ser ql if,neutrophil cytoplasmic ab if ql (s),abs; aby; acif; acna; acpa; anca; antby; anti; antibodies; antibody; anticomplement immunofluorescence; autoantibodies; autoantibody; cytopl; cytoplas; fa; fluorescent antibody; fluoresent; granulocyte ab; granulocyte nucleus ab; ifa; immune fluorescence; immunoflour; immunofluor; immunofluorescence; neut; neutr; neutrophils; ordinal; pmn; pnm; point in time; pr; ql; qual; qualitative; random; screen; serology; serum; sr; time resolved fluorescence; trf; vasculitis,Ord
35281-5,toxoplasma gondii igg ab [presence] in serum by immunofluorescence,t gondii igg ser ql if,t. gondii igg if ql (s),abs; aby; acif; antby; anti; antibodies; antibody; anticomplement immunofluorescence; autoantibodies; autoantibody; fa; fluorescent antibody; fluoresent; id; ifa; immune fluorescence; immune globulin g; immunoflour; immunofluor; immunofluorescence; immunoglobulin g; infectious disease; infectiousdisease; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; sr; t gondii; time resolved fluorescence; toxo; toxoplasmosis; trf,Ord
35295-5,btk gene mutations found [identifier] in blood or tissue by molecular genetics method nominal,btk gene mut anl bld/t,btk gene targeted mutation analysis molgen nom (bld/tiss),"agammaglobulinaemia tyrosine kinase gene; agmx1; at; atk; b cell progenitor kinase gene; b-cell progenitor kinase; blood; bpk; bruton agammaglobulinemia tyrosine kinase; bruton agammaglobulinemia tyrosine kinase gene; bruton's tyrosine kinase; bruton's tyrosine kinase gene; genetics; heredity; heritable; identity or presence; imd1; inherited; molecular genetics; molecular pathology; molpath; molpath.mutations; mut; mut anl; mutations; nominal; pcr; point in time; psctk1; random; tissue; tissue, unspecified; tyrosine-protein kinase btk; tyrosine-protein kinase gene; wb; whole blood; whole blood or tissue; xla",Nom
35300-3,gjb2 gene targeted mutation analysis in blood or tissue by molecular genetics method,gjb2 gene mut anl bld/t,gjb2 gene targeted mutation analysis molgen doc (bld/tiss),"blood; connexin 26; cx26; deafness, autosomal dominant 3; deafness, autosomal recessive 1; dfna3; dfna3a; dfnb1; dfnb1a; document; finding; findings; gap junction beta-2 protein gene; gap junction protein, beta 2, 26kda; genetics; heredity; heritable; hid; inherited; kid; molecular genetics; molecular pathology; molpath; molpath.mutations; mut; mut anl; mutations; nsrd1; pcr; point in time; ppk; random; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",Doc
35303-7,glucosylceramidase [enzymatic activity/mass] in specimen,glucosylceramidase spec-ccnt,glucosylceramidase (specimen) [catalytic activity/mass],acid beta glucosidase; beta glucocerebrosidase; catalytic content; chemistry; misc; miscellaneous; other; point in time; qnt; quan; quant; quantitative; random; spec; to be specified in another part of the message; unspecified,Qn
35315-1,lipase [enzymatic activity/volume] in body fluid --3rd specimen post sincalide,lipase sp3 p sincalide fld-ccnc,lipase 3rd specimen post sincalide (body fld) [catalytic activity/vol],"after; b/f; bf; bod; bodies; body fluid; body fluid, unsp; catalytic concentration; chemistry.challenge testing; fl; fld; flu; fluid; kinevac; lipa; lipase; lps; p dose; pancreatic lipase; point in time; pst; qnt; quan; quant; quantitative; random; sp3; sp3 p sincalide; spec; steapsin; tributyrase; tributyrinase",Qn
35329-2,ph of body fluid--2nd specimen post sincalide,ph sp2 p sincalide fld,ph 2nd specimen post sincalide (body fld),"after; b/f; bf; bod; bodies; body fluid; body fluid, unsp; chemistry.challenge testing; convalescent; fl; fld; flu; fluid; kinevac; log molar concentration; p dose; point in time; post immunization; pst; random; second; smqn; sp2; sp2 p sincalide; spec",SemiQn
35334-2,collagen crosslinked n-telopeptide [moles/volume] in 24 hour urine,collagen ntx 24h ur-scnc,collagen crosslinked n-telopeptide (24h u) [moles/vol],1 day; 24 hours; 24hr; aminoterminal cross-linking telopeptide of bone collagen; chemistry; collagen ntx; level; n-telopeptide of type i collagen; ntx; qnt; quan; quant; quantitative; substance concentration; ua; ur; urn,Qn
35341-7,aspa gene p.ala305glu [presence] in blood or tissue by molecular genetics method,aspa p.a305e bld/t ql,aspa gene p.ala305glu molgen ql (bld/tiss),"acy2; acy-2; ala305glu; aminoacylase 2; asp; aspa p.a305e; aspartoacylase; aspartoacylase gene; blood; canavan disease; genetics; heredity; heritable; inherited; molecular genetics; molecular pathology; molpath; molpath.mutations; ordinal; p prime; pcr; point in time; pr; ql; qual; qualitative; random; screen; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",Ord
3534-5,desipramine [mass/volume] in urine,desipramine ur-mcnc,desipramine (u) [mass/vol],desi; desip; desipra; desmethylimipramine; drug/toxicology; drugs; imipramine metabolite; level; mass concentration; norpramin; point in time; qnt; quan; quant; quantitative; random; ua; ur; urn,Qn
35373-0,platelet aggregation xxx induced in platelet rich plasma from donor,pa xxx prp donr,platelet aggregation unsp induced (prp donor) [rel units/vol],agg; aggr; coagulation; donr; hematology; heme; pa; pa xxx; pl; platelet rich plasma; platelets; platelt; plt; point in time; qnt; quan; quant; quantitative; random; rlacnc; thrombocyte; thrombocytes,Qn
35379-7,hnpcc genes mutations found [identifier] in blood or tissue by molecular genetics method nominal,hnpcc genes mut anl bld/t,hnpcc genes targeted mutation analysis molgen nom (bld/tiss),"blood; coca2; fcc2; genetics; hereditary nonpolyposis colorectal cancer; heredity; heritable; hmlh1; hnpcc; hnpcc2; identity or presence; inherited; lynch syndrome; molecular genetics; molecular pathology; molpath; molpath.mutations; mut; mut anl; mutations; mutl homolog 1; nominal; pcr; point in time; random; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",Nom
35387-0,cholesterol. in lipoprotein (a) [presence] in serum or plasma,lpa cholest serpl ql,cholesterol. in lipoprotein (a) ql,cardio; cardiology; chemistry; chol; choles; cholest; cholesterol total; cholesterols; heart disease; lip; lipid; lipoprot; lipoproteins; lp; lp(a); lp(a) cholesterol; lpa; lpa cholest; lpa cholesterol; ordinal; pl; plasma; plsm; point in time; pr; ql; qual; qualitative; random; screen; serp; serpl; serplas; serum; serum or plasma; sr,Ord
35391-2,taenia solium larva igg ab [units/volume] in cerebral spinal fluid,t sol lar igg csf-acnc,t. solium larva igg qn (csf),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; cerebral spinal fluid; cerebrospinal fl; cysticercosis; cysticercus; id; immune globulin g; immunoglobulin g; infectious disease; infectiousdisease; microbiology; neuro; neurology; point in time; qnt; quan; quant; quantitative; random; spinal fl; spinal fld; spinal flu; spinal fluid; t sol; t sol lar; t solium; tapeworm,Qn
35430-8,herpes simplex virus identified in throat by organism specific culture,hsv throat cult,hsv identified org specific cx nom (throat),c&s; cult; cultures; herp splx; hsv; id; identity or presence; infectious disease; infectiousdisease; microbiology; nominal; point in time; random; spec; throat; upper respiratory,Nom
35449-8,hiv 1 p17 ab [presence] in saliva (oral fluid) by immunoblot,hiv1 p17 ab sal ql ib,hiv 1 p17 ab ib ql (sal),abs; aby; aids; antby; anti; antibodies; antibody; autoantibodies; autoantibody; blt; hiv type 1; hiv type i; hiv1; hiv1 p17; human immunodeficiency virus; i; id; immune blot; immunobl; immunoblot; infectious disease; infectiousdisease; microbiology; oral fluid; ordinal; point in time; pr; ql; qual; qualitative; random; riba; sal; screen; wb; wblot; west blot; west blt; western blot,Ord
35467-0,m-chlorophenylpiperazine [presence] in serum or plasma,m-cpp serpl ql,m-chlorophenylpiperazine ql,"1,3 - chlorophenyl piperazine; drug/toxicology; drugs; mcpp; m-cpp; meta-chlorophenylpiperazine; nefazodone metabolite; ordinal; pl; plasma; plsm; point in time; pr; ql; qual; qualitative; random; screen; serp; serpl; serplas; serum; serum or plasma; sr; trazodone metabolite",Ord
35479-5,diazinon [mass/volume] in urine,diazinon ur-mcnc,diazinon (u) [mass/vol],333-41-5; basudin; diazinone; dimpylate; drug/toxicology; drugs; level; mass concentration; neocidol; oleodiazinon; point in time; qnt; quan; quant; quantitative; random; spectracide; ua; ur; urn,Qn
35480-3,1-naphthol [mass/volume] in urine,1naphthol ur-mcnc,1-naphthol (u) [mass/vol],1naphthol; alpha-naphthol; carbaryl metabolite; drug/toxicology; drugs; i; level; mass concentration; naphthalene metabolite; point in time; qnt; quan; quant; quantitative; random; ua; ur; urn,Qn
35484-5,methyl parathion [mass/volume] in serum or plasma,methyl parathion serpl-mcnc,methyl parathion [mass/vol],diethyl parathion; drug/toxicology; drugs; ethyl parathion; folidol; level; mass concentration; metafos; parathion-methyl; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; thiophos,Qn
35489-4,chlorpyrifos [mass/volume] in serum or plasma,chlorpyrifos serpl-mcnc,chlorpyrifos [mass/vol],brodan; detmol ua; dowco 179; drug/toxicology; drugs; level; mass concentration; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
35496-9,nadh dehydrogenase [enzymatic activity/mass] in tissue,nadh dehydrog tiss-ccnt,nadh dehydrogenase (tiss) [catalytic activity/mass],"catalytic content; chemistry; dehydrog; dehyrdogenase; point in time; qnt; quan; quant; quantitative; random; tissue; tissue, unspecified",Qn
35502-4,mitochondrial myopathy enzyme panel [enzymatic activity/mass] - tissue,mito myopathy enzy pnl tiss-ccnt,mitochondrial myopathy enzyme panel (tiss) [catalytic activity/mass],"catalytic content; chemistry; enz; enzymes; mito myopathy enzy pnl; pan; panel.chemistry; panl; pnl; point in time; qnt; quan; quant; quantitative; random; tissue; tissue, unspecified",Qn
3551-9,diazepam [mass/volume] in urine,diazepam ur-mcnc,diazepam (u) [mass/vol],addiction; c311; drug/toxicology; drugs; drugs of abuse; illicit; level; mass concentration; point in time; potentialforabuse; qnt; quan; quant; quantitative; random; stesolid; ua; ur; urn; valium,Qn
35521-4,clinical trial protocol direct access to source data+documents section,ctp direct access to source data+docs,,ctp; dir; direct access to source data+docs; document.ref; document.ref.ctp; narrative; report; srce,Nar
35526-3,clinical trial protocol publication policy section,ctp publication policy,,ctp; document.ref; document.ref.ctp; narrative; report,Nar
35528-9,clinical trial protocol clinical trial protocol,ctp clin trial protocol.total,,clin trial protocol; clin trial protocol.total; ctp; document.ref; document.ref.ctp; narrative; report; tot; totl,Nar
35550-3,phthalic anhydride igg ab [mass/volume] in serum,pan igg-mcnc,phthalic anhydride igg (s) [mass/vol],"1,2-benzenedicarboxylic acid anhydride; 1,2-benzenedicarboxylic anhydride; 1,3-dioxophthalan; 1,3-isobenzofurandione; 1,3-phthalandione; abs; aby; allergen; allergens; allergy testing; anhydrid; antby; anti; antibodies; antibody; autoantibodies; autoantibody; immune globulin g; immunoglobulin g; k79; level; mass concentration; pan; phthalandione; point in time; qnt; quan; quant; quantitative; random; serum; sr",Qn
35566-9,parathyrin [mass/volume] in serum or plasma --baseline,pth bs serpl-mcnc,parathyrin baseline [mass/vol],bs; chemistry.challenge testing; level; mass concentration; parathormone; parathyroid hormone; pl; plasma; plsm; point in time; pth; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
35571-9,tyrosine [moles/volume] in dbs,tyrosine dbs-scnc,tyrosine (dbs) [moles/vol],blood; chemistry; dbs; dried blood spot; filter paper; fp; level; point in time; qnt; quan; quant; quantitative; random; substance concentration; tyr; universallaborders; wb; whole blood,Qn
3557-6,dichlorphenamide [mass/time] in 24 hour urine,dichlorphenamide 24h ur-mrate,dichlorphenamide (24h u) [mass/time],1 day; 24 hours; 24hr; adtidrasi; daranide; diclofenamide; drug/toxicology; drugs; fenamide; glauconide; glaumid; mass rate; mrate; oralcon; oratrol; qnt; quan; quant; quantitative; tensodilen; ua; ur; urn,Qn
3558-4,dicoumarol [mass/volume] in serum or plasma,dicoumarol serpl-mcnc,dicoumarol [mass/vol],dicoumarin; dicumarol; drug/toxicology; drugs; level; mass concentration; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
35593-3,creatinine renal clearance/1.73 sq m in urine and serum or plasma collected for unspecified duration,creat cl/1.73 sq m ?tm ur+serpl-arvrat,creatinine renal clearance/1.73 sq m unsp time (u+s/p) [vol rate/area],?tm; bsa; chemistry; cl; clear; clearanc; clearances; clr; cr; crea; creat; kidney; nephrology; pl; plasma; plsm; qnt; quan; quant; quantitative; renal; serp; serpl; serplas; serum; serum or plasma; square meter; sr; ua; ucr; ur; ur+serpl; urn; volume rate/area; volume rate/ratio,Qn
35599-0,carbamazepine [mass/volume] in serum or plasma by screen method,carbamazepine serpl scn-mcnc,carbamazepine screen [mass/vol],carbamazapine; carbamezapine; carbazepine; crbm; drug/toxicology; drugs; epitol; level; mass concentration; neuro; neurology; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; scn; scr; scrn; serp; serpl; serplas; serum; serum or plasma; sr; tegretol; teril,Qn
35601-4,chlorpromazine [mass/volume] in serum or plasma by screen method,chlorpromazine serpl scn-mcnc,chlorpromazine screen [mass/vol],chlopromazine; chlorpromaz; drug/toxicology; drugs; level; mass concentration; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; scn; scr; scrn; serp; serpl; serplas; serum; serum or plasma; sr; thorazine,Qn
35607-1,diazepam [mass/volume] in serum or plasma by screen method,diazepam serpl scn-mcnc,diazepam screen [mass/vol],addiction; c311; drug/toxicology; drugs; drugs of abuse; illicit; level; mass concentration; pl; plasma; plsm; point in time; potentialforabuse; qnt; quan; quant; quantitative; random; scn; scr; scrn; serp; serpl; serplas; serum; serum or plasma; sr; stesolid; valium,Qn
35650-1,lymphocytic choriomeningitis virus igg and igm panel - cerebral spinal fluid,lcmv igg+igm pnl csf,lymphocytic choriomeningitis virus igg and igm panel (csf),cerebral spinal fluid; cerebrospinal fl; id; immune globulin g; immune globulin m; immunoglobulin g; immunoglobulin m; infectious disease; infectiousdisease; lcmv; lcmv ab.igg+igm; lcmv igg+igm pnl; microbiology; neuro; neurology; pan; panel.microbiology; panl; pnl; point in time; qnt; quan; quant; quantitative; random; spinal fl; spinal fld; spinal flu; spinal fluid,Qn
35652-7,epithelial cells/cells in body fluid,epi cells nfr fld,epithelial cells/cells (body fld),"b/f; bf; bod; bodies; body fluid; body fluid, unsp; cell; cellularity; epi; epi cells; epith; epithelia; fl; fld; flu; fluid; hematology/cell counts; number fraction; percent; point in time; qnt; quan; quant; quantitative; random",Qn
3569-1,diphenhydramine [presence] in serum or plasma,diphenhy serpl ql,diphenhydramine ql,addiction; benadryl; diphenhydr; diphenylhydramine; drug/toxicology; drugs; drugs of abuse; illicit; ordinal; pl; plasma; plsm; point in time; potentialforabuse; pr; ql; qual; qualitative; random; screen; serp; serpl; serplas; serum; serum or plasma; sr,Ord
35698-0,metformin [mass/volume] in serum or plasma,metformin serpl-mcnc,metformin [mass/vol],drug/toxicology; drugs; glucophage; level; mass concentration; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
35720-2,deprecated chlamydia sp rrna [presence] in penis by dna probe,deprecated chlamydia rrna penis ql prb,chlamydia sp rrna probe ql (penis),arbitrary concentration; chlam; chlamid; dna nucleic acid probe; dna probe; id; infectious disease; infectiousdisease; microbiology; ordinal; pen; penile; point in time; ql; qual; qualitative; random; ribosomal rna; screen; species; spp,Ord
35736-8,chlamydia sp rrna [presence] in nasopharynx by probe,chlamydia rrna nph ql probe,chlamydia sp rrna probe ql (nph),chlam; chlamid; dna nucleic acid probe; dna probe; id; infectious disease; infectiousdisease; microbiology; nasopharynx; ordinal; point in time; pr; ql; qual; qualitative; random; ribosomal rna; screen; species; spp,Ord
35740-0,rickettsia sp igg and igm panel - serum,rickettsia igg+igm pnl ser,rickettsia sp igg and igm panel (s),id; immune globulin g; immune globulin m; immunoglobulin g; immunoglobulin m; infectious disease; infectiousdisease; microbiology; pan; panel.microbiology; panl; pnl; point in time; qnt; quan; quant; quantitative; random; ricket; rickettsia igg+igm pnl; rickettsial; serum; species; spp; sr,Qn
35746-7,hyperchromia [presence] in blood by automated count,hyperchromia bld ql auto,hyperchromia auto ql (bld),auto; automated detection; blood; elec; elect; electr; hematology/cell counts; hyperchromasia; hyperchromic; ordinal; point in time; pr; ql; qual; qualitative; random; screen; wb; whole blood,Ord
35747-5,hydrogen ion [moles/volume] in arterial blood,h ion blda-scnc,hydrogen ion (blda) [moles/vol],abg; art; art bld; art blood; arterial; arterial blood; blood arterial; chemistry; h ion; h2; hyd; level; point in time; qnt; quan; quant; quantitative; random; substance concentration,Qn
35769-9,cefotaxime+clavulanate [susceptibility] by disk diffusion (kb),cefotaxime+clav islt kb,cefotaxime+clavulanate disk diffusion (kb) [susc],antibiotic susceptibilities; ast; c305; claforan; clav; clavate; clavu; clavul; clavulanic; clavulanic acid; disk diffusion; esbl; id; infectious disease; infectiousdisease; islt; isol; kb; kirby-bauer; point in time; random; sus; suscept; susceptibilities; susceptibility; susceptibilty,OrdQn
35772-3,cefotiam [susceptibility] by disk diffusion (kb),cefotiam islt kb,cefotiam disk diffusion (kb) [susc],antibiotic susceptibilities; ast; disk diffusion; id; infectious disease; infectiousdisease; islt; isol; kb; kirby-bauer; point in time; random; spizef; sus; suscept; susceptibilities; susceptibility; susceptibilty,OrdQn
35787-1,daptomycin [susceptibility] by disk diffusion (kb),daptomycin islt kb,daptomycin disk diffusion (kb) [susc],antibiotic susceptibilities; ast; cubicin; disk diffusion; id; infectious disease; infectiousdisease; islt; isol; kb; kirby-bauer; point in time; random; sus; suscept; susceptibilities; susceptibility; susceptibilty,OrdQn
35796-2,enrofloxacin [susceptibility] by gradient strip,enrofloxacin islt grad strip,enrofloxacin strip [susc],antibiotic susceptibilities; ast; epsilometer; estrip; e-strip; grad strip; id; infectious disease; infectiousdisease; islt; isol; mic; minimum inhibitory concentration; point in time; random; sus; suscept; susceptibilities; susceptibility; susceptibilty,OrdQn
35822-6,mupirocin [susceptibility] by disk diffusion (kb),mupirocin islt kb,mupirocin disk diffusion (kb) [susc],antibiotic susceptibilities; ast; disk diffusion; id; infectious disease; infectiousdisease; islt; isol; kb; kirby-bauer; point in time; random; sus; suscept; susceptibilities; susceptibility; susceptibilty,OrdQn
35832-5,polymyxin b [susceptibility] by gradient strip,polymyxin b islt grad strip,polymyxin b strip [susc],antibiotic susceptibilities; ast; c218; epsilometer; estrip; e-strip; grad strip; id; infectious disease; infectiousdisease; islt; isol; mic; minimum inhibitory concentration; neosporin; point in time; random; sus; suscept; susceptibilities; susceptibility; susceptibilty,OrdQn
35833-3,pristinamycin [susceptibility] by disk diffusion (kb),pristinamycin islt kb,pristinamycin disk diffusion (kb) [susc],antibiotic susceptibilities; ast; disk diffusion; id; infectious disease; infectiousdisease; islt; isol; kb; kirby-bauer; point in time; random; sus; suscept; susceptibilities; susceptibility; susceptibilty,OrdQn
35843-2,telithromycin [susceptibility] by disk diffusion (kb),telithromycin islt kb,telithromycin disk diffusion (kb) [susc],antibiotic susceptibilities; ast; disk diffusion; id; infectious disease; infectiousdisease; islt; isol; kb; ketek; kirby-bauer; point in time; random; sus; suscept; susceptibilities; susceptibility; susceptibilty,OrdQn
35846-5,tiamulin [susceptibility] by disk diffusion (kb),tiamulin islt kb,tiamulin disk diffusion (kb) [susc],antibiotic susceptibilities; ast; denagard; disk diffusion; id; infectious disease; infectiousdisease; islt; isol; kb; kirby-bauer; point in time; random; sus; suscept; susceptibilities; susceptibility; susceptibilty; vet; veterinary,OrdQn
35847-3,tiamulin [susceptibility] by minimum inhibitory concentration (mic),tiamulin islt mic,tiamulin mic [susc],antibiotic susceptibilities; ast; denagard; id; infectious disease; infectiousdisease; islt; isol; minimum inhibitory concentration; point in time; random; sus; suscept; susceptibilities; susceptibility; susceptibilty; vet; veterinary,OrdQn
35852-3,trospectinomycin [susceptibility] by disk diffusion (kb),trospectinomycin islt kb,trospectinomycin disk diffusion (kb) [susc],antibiotic susceptibilities; ast; disk diffusion; id; infectious disease; infectiousdisease; islt; isol; kb; kirby-bauer; point in time; random; sus; suscept; susceptibilities; susceptibility; susceptibilty; trospectomycin,OrdQn
35855-6,trovafloxacin [susceptibility] by disk diffusion (kb),trovafloxacin islt kb,trovafloxacin disk diffusion (kb) [susc],antibiotic susceptibilities; ast; disk diffusion; id; infectious disease; infectiousdisease; islt; isol; kb; kirby-bauer; point in time; random; sus; suscept; susceptibilities; susceptibility; susceptibilty; trovan; turvel,OrdQn
35857-2,tylosin [susceptibility] by minimum inhibitory concentration (mic),tylosin islt mic,tylosin mic [susc],antibiotic susceptibilities; ast; id; infectious disease; infectiousdisease; islt; isol; minimum inhibitory concentration; point in time; random; sus; suscept; susceptibilities; susceptibility; susceptibilty; tylosin tartrate,OrdQn
35864-8,chronic lymphocytic leukemia gene mutations tested for in blood or tissue by molecular genetics method nominal,cll gene mut tested bld/t,chronic lymphocytic leukemia gene mutations tested for molgen nom (bld/tiss),"b-cell cll; blood; cll; cll gene; gene mut tested; genetics; heredity; heritable; identity or presence; inherited; lymphoma 1; molecular genetics; molecular pathology; molpath; molpath.mutations; mut; mut tested; mutation; muts; nominal; pcr; point in time; random; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",Nom
35873-9,penicillin+novobiocin [susceptibility] by minimum inhibitory concentration (mic),penicillin+novobiocin islt mic,penicillin+novobiocin mic [susc],albacillin; antibiotic susceptibilities; ast; crystallanic acid; id; infectious disease; infectiousdisease; islt; isol; minimum inhibitory concentration; pcn; pen; penicilloyl; point in time; random; streptonivicin; sus; suscept; susceptibilities; susceptibility; susceptibilty; tetra tripsin; wycillin,OrdQn
35877-0,rickettsia sp igg ab [units/volume] in serum,rickettsia igg ser-acnc,rickettsia sp igg qn (s),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; id; immune globulin g; immunoglobulin g; infectious disease; infectiousdisease; microbiology; point in time; qnt; quan; quant; quantitative; random; ricket; rickettsial; serum; species; spp; sr,Qn
35896-0,ct guidance for biopsy of lower extremity,ct guided le bx,,bx; cat scan; computed tomography; computerized tomography; ct scan; document; ext; finding; findings; guid; guide; guided; imaging; le; leg; low; perc; point in time; rad; radiology; random,Doc
3589-9,encainide [mass/volume] in serum or plasma,encainide serpl-mcnc,encainide [mass/vol],drug/toxicology; drugs; enkaid; level; mass concentration; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
35910-9,ct guidance for biopsy of chest-- wo and w contrast iv,ct guided chest bx--wo+w contr iv,,bx; c; cat scan; computed tomography; computerized tomography; contr; contra; contrst; ct scan; document; finding; findings; guid; guide; guided; imaging; perc; point in time; rad; radiology; random; thorax; w contr iv; wc; wo & wc; wo+w contr; wo+w contr iv; wwo,Doc
3591-5,ephedrine [mass/volume] in serum or plasma,ephedrin serpl-mcnc,ephedrine [mass/vol],addiction; drug/toxicology; drugs; drugs of abuse; ectasule; illicit; level; mass concentration; pl; plasma; plsm; point in time; potentialforabuse; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
3592-3,ephedrine [presence] in urine,ephedrin ur ql,ephedrine ql (u),addiction; drug/toxicology; drugs; drugs of abuse; ectasule; illicit; ordinal; point in time; potentialforabuse; pr; ql; qual; qualitative; random; screen; ua; ur; urn,Ord
35925-7,rf guidance for endoscopy of stomach,rf guided stom endo,,abd; abdo; abdomen+; abdominal; document; endoscopic guidance; finding; findings; fluor; fluoro; fluoroscopy; guid; guide; guided; imaging; point in time; rad; radiology; random,Doc
35927-3,rf guidance for injection of sacroiliac joint,rf guided sij inj,,document; finding; findings; fluor; fluoro; fluoroscopy; guid; guide; guided; imaging; inj; jnt; pelvic; point in time; rad; radiology; random; sac; si joint; si joints; sij,Doc
35931-5,ct guidance for nerve block of pelvis,ct guided pelvis nerve block,,cat scan; computed tomography; computerized tomography; ct scan; document; finding; findings; guid; guide; guided; imaging; pelvic; point in time; rad; radiology; random,Doc
35932-3,ct guidance for nerve block of lumbar spine,ct guided l-spine nerve block,,abd; abdo; abdomen+; abdominal; cat scan; computed tomography; computerized tomography; ct scan; document; finding; findings; guid; guide; guided; imaging; l/sp; l-spine; lumbar; lumbo; point in time; rad; radiology; random; spinal; spinal cord,Doc
35944-8,ct ankle - right,ct ankle-r,,ankle-r; cat scan; computed tomography; computerized tomography; ct scan; document; ext; extr-r; finding; findings; imaging; le; leg; le-r; low; lower extremity joint; msk; musculoskeletal; ortho; orthopedics; point in time; r; rad; radiology; random; rle; rt,Doc
35954-7,mr breast - left,mr brst-l,,brst; brst-l; document; finding; findings; imaging; l; lt; mitral regurgitation maximum velocity; mri; point in time; rad; radiology; random,Doc
35959-6,xr tomography clavicle,xr tomo clavicle,,cxr; document; finding; findings; imaging; plain films; point in time; rad; radiology; random; thorax; upper extremity; xr tomo; xray; x-ray,Doc
35961-2,mr clavicle,mr clavicle,,document; finding; findings; imaging; mitral regurgitation maximum velocity; mri; point in time; rad; radiology; random; thorax; upper extremity,Doc
35963-8,xr tomography elbow,xr tomo elbow,,arm; document; ext; finding; findings; imaging; msk; musculoskeletal; olecranon; ortho; orthopedics; plain films; point in time; rad; radiology; random; ue; up; upper extremity joint; xr tomo; xray; x-ray,Doc
35972-9,xr tomography lower extremity,xr tomo le,,document; ext; finding; findings; imaging; le; leg; low; plain films; point in time; rad; radiology; random; xr tomo; xray; x-ray,Doc
35974-5,mra lower extremity vessels - bilateral,mra le ves-bl,,ang; angio; angiography; bil; bilat; both; document; ext; extr ves; extr-bl; finding; findings; imaging; le; le ves; le ves-bl; le-bl; leg; low; magnetic resonance angiographies; magnetic resonance imaging; mitral regurgitation maximum velocity; mr angiography; mra; mri; mri.angio; point in time; rad; radiology; random; vesl; vessels.xxx,Doc
35978-6,mr lower extremity - left,mr le-l,,document; ext; extr-l; finding; findings; imaging; l; le; leg; le-l; lle; low; lt; mitral regurgitation maximum velocity; mri; point in time; rad; radiology; random,Doc
35984-4,ct thigh,ct thigh,,cat scan; computed tomography; computerized tomography; ct scan; document; ext; femoral; femur; finding; findings; imaging; le; leg; low; lower extremity; point in time; rad; radiology; random,Doc
35988-5,xr tomography femur - left,xr tomo femur-l,,document; ext; extr-l; femoral; femur-l; finding; findings; imaging; l; le; leg; le-l; lle; low; lower extremity; lt; plain films; point in time; rad; radiology; random; upper leg; xr tomo; xray; x-ray,Doc
3601-2,etafedrine [mass/time] in 24 hour urine,etafedrine 24h ur-mrate,etafedrine (24h u) [mass/time],1 day; 24 hours; 24hr; calmydone; ditenate; drug/toxicology; drugs; ethylephedrine; mass rate; mercodol; mrate; nethaprin; qnt; quan; quant; quantitative; ua; ur; urn,Qn
36018-0,ct hip - left,ct hip-l,,cat scan; computed tomography; computerized tomography; ct scan; document; ext; extr-l; finding; findings; hip-l; imaging; l; le; leg; le-l; lle; low; lower extremity joint; lt; msk; musculoskeletal; ortho; orthopedics; point in time; rad; radiology; random,Doc
3602-0,etamivan [presence] in urine,etamivan ur ql,etamivan ql (u),addiction; analepticon; clarivan; drug/toxicology; drugs; drugs of abuse; ethamivan; illicit; ordinal; point in time; potentialforabuse; pr; ql; qual; qualitative; random; screen; ua; ur; urn,Ord
3603-8,etamivan [mass/volume] in urine,etamivan ur-mcnc,etamivan (u) [mass/vol],addiction; analepticon; clarivan; drug/toxicology; drugs; drugs of abuse; ethamivan; illicit; level; mass concentration; point in time; potentialforabuse; qnt; quan; quant; quantitative; random; ua; ur; urn,Qn
36041-2,ct knee - left,ct knee-l,,cat scan; computed tomography; computerized tomography; ct scan; document; ext; extr-l; finding; findings; imaging; kn; knee-l; l; le; leg; le-l; lle; low; lower extremity joint; lt; msk; musculoskeletal; ortho; orthopedics; point in time; rad; radiology; random,Doc
36046-1,mr liver,mr liver,,abd; abdo; abdomen+; abdominal; document; finding; findings; hepar; hepatic; imaging; mitral regurgitation maximum velocity; mri; point in time; rad; radiology; random,Doc
36061-0,mr scapula,mr scapula,,document; finding; findings; imaging; mitral regurgitation maximum velocity; mri; point in time; rad; radiology; random; thorax; upper extremity,Doc
36075-0,mr lower leg - left,mr lower leg-l,,calf; document; ext; extr-l; fibula; finding; findings; imaging; l; le; leg; le-l; lle; low; lower extremity; lower leg-l; lt; mitral regurgitation maximum velocity; mri; point in time; rad; radiology; random; tibia,Doc
36076-8,mr lower leg - right,mr lower leg-r,,calf; document; ext; extr-r; fibula; finding; findings; imaging; le; leg; le-r; low; lower extremity; lower leg-r; mitral regurgitation maximum velocity; mri; point in time; r; rad; radiology; random; rle; rt; tibia,Doc
36094-1,mr upper extremity.joint limited,mr ue joint ltd,,arm; document; ext; finding; findings; imaging; jnt; lmted; ltd; mitral regurgitation maximum velocity; mri; point in time; rad; radiology; random; ue; ue joint; up,Doc
3609-5,ethchlorvynol [presence] in serum or plasma,ethchlorvynol serpl ql,ethchlorvynol ql,addiction; drug/toxicology; drugs; drugs of abuse; ethchlorvyn; illicit; ordinal; pl; placidyl; plasma; plsm; point in time; potentialforabuse; pr; ql; qual; qualitative; random; screen; serp; serpl; serplas; serum; serum or plasma; sr,Ord
36116-2,mr ankle - left arthrogram,mr ankle-l w contr is,,ankle-l; arthrogram; arthrography; c; contr; contra; contrst; document; ext; extr-l; finding; findings; imaging; intraarticular; intrasynovial; l; le; leg; le-l; lle; low; lower extremity joint; lt; mitral regurgitation maximum velocity; mri; msk; musculoskeletal; ortho; orthopedics; point in time; rad; radiology; random; w contr is; wc,Doc
3612-9,ethchlorvynol [mass/volume] in urine,ethchlorvynol ur-mcnc,ethchlorvynol (u) [mass/vol],addiction; drug/toxicology; drugs; drugs of abuse; ethchlorvyn; illicit; level; mass concentration; placidyl; point in time; potentialforabuse; qnt; quan; quant; quantitative; random; ua; ur; urn,Qn
3614-5,ethoheptazine [mass/volume] in urine,ethoheptazine ur-mcnc,ethoheptazine (u) [mass/vol],drug/toxicology; drugs; equgesic; level; mass concentration; point in time; qnt; quan; quant; quantitative; random; ua; ur; urn,Qn
36157-6,ct elbow w contrast iv,ct elbow w contr iv,,arm; c; cat scan; computed tomography; computerized tomography; contr; contra; contrst; ct scan; document; ext; finding; findings; imaging; msk; musculoskeletal; olecranon; ortho; orthopedics; point in time; rad; radiology; random; ue; up; upper extremity joint; w contr iv; wc,Doc
36160-0,mr elbow - left w contrast iv,mr elbow-l w contr iv,,arm; c; contr; contra; contrst; document; elbow-l; ext; extr-l; finding; findings; imaging; l; lt; lue; mitral regurgitation maximum velocity; mri; msk; musculoskeletal; olecranon; ortho; orthopedics; point in time; rad; radiology; random; ue; ue-l; up; upper extremity joint; w contr iv; wc,Doc
36179-0,mr foot w contrast iv,mr foot w contr iv,,c; contr; contra; contrst; document; ext; finding; findings; ft; imaging; le; leg; low; lower extremity; mitral regurgitation maximum velocity; mri; msk; musculoskeletal; ortho; orthopedics; point in time; rad; radiology; random; w contr iv; wc,Doc
3618-6,ethylmorphine [presence] in urine,emp ur ql,ethylmorphine ql (u),addiction; codethyline; collins elixir; dionina; drug/toxicology; drugs; drugs of abuse; emp; illicit; ordinal; point in time; potentialforabuse; pr; ql; qual; qualitative; random; screen; ua; ur; urn,Ord
36187-3,ct forearm - left w contrast iv,ct forearm-l w contr iv,,arm; c; cat scan; computed tomography; computerized tomography; contr; contra; contrst; ct scan; document; ext; extr-l; finding; findings; forearm-l; imaging; l; lt; lue; point in time; rad; radiology; random; ue; ue-l; ulna; up; upper extremity; w contr iv; wc,Doc
36191-5,ct hand w contrast iv,ct hand w contr iv,,arm; c; cat scan; computed tomography; computerized tomography; contr; contra; contrst; ct scan; document; ext; finding; findings; imaging; msk; musculoskeletal; ortho; orthopedics; point in time; rad; radiology; random; ue; up; upper extremity; w contr iv; wc,Doc
36192-3,mr hand w contrast iv,mr hand w contr iv,,arm; c; contr; contra; contrst; coreplaybook; document; ext; finding; findings; imaging; mitral regurgitation maximum velocity; mri; msk; musculoskeletal; ortho; orthopedics; playbook; point in time; rad; radiology; random; ue; up; upper extremity; w contr iv; wc,Doc
36210-3,mr upper arm - left w contrast iv,mr upper arm-l w contr iv,,arm; c; contr; contra; contrst; document; ext; extr-l; finding; findings; humerus; imaging; l; lt; lue; mitral regurgitation maximum velocity; mri; point in time; rad; radiology; random; ue; ue-l; up; upper arm-l; upper extremity; w contr iv; wc,Doc
36213-7,mr lower extremity joint w contrast iv,mr le joint w contr iv,,c; contr; contra; contrst; coreplaybook; document; ext; finding; findings; imaging; jnt; le; le joint; leg; low; mitral regurgitation maximum velocity; mri; playbook; point in time; rad; radiology; random; w contr iv; wc,Doc
36218-6,mr sacroiliac joint w contrast iv,mr sij w contr iv,,c; contr; contra; contrst; document; finding; findings; imaging; jnt; mitral regurgitation maximum velocity; mri; pelvic; point in time; rad; radiology; random; sac; si joint; si joints; sij; w contr iv; wc,Doc
36221-0,mr kidney - right w contrast iv,mr kidney-r w contr iv,,abd; abdo; abdomen+; abdominal; c; contr; contra; contrst; document; finding; findings; imaging; kidney; kidney-r; mitral regurgitation maximum velocity; mri; nephric; nephrogram; nephrography; nephrology; point in time; r; rad; radiology; random; renal; rt; w contr iv; wc,Doc
36229-3,ct larynx w contrast iv,ct larynx w contr iv,,brain; c; cat scan; computed tomography; computerized tomography; contr; contra; contrst; cranial; cranium; ct scan; document; finding; findings; imaging; intracranial; point in time; rad; radiology; random; skull; w contr iv; wc,Doc
36231-9,mr liver w contrast iv,mr liver w contr iv,,abd; abdo; abdomen+; abdominal; c; contr; contra; contrst; document; finding; findings; hepar; hepatic; imaging; mitral regurgitation maximum velocity; mri; point in time; rad; radiology; random; w contr iv; wc,Doc
36232-7,ct mandible w contrast iv,ct mandible w contr iv,,brain; c; cat scan; computed tomography; computerized tomography; contr; contra; contrst; cranial; cranium; ct scan; document; finding; findings; imaging; intracranial; jaw; mand; point in time; rad; radiology; random; skull; w contr iv; wc,Doc
36233-5,mr nasopharynx w contrast iv,mr nasopharynx w contr iv,,brain; c; contr; contra; contrst; cranial; cranium; document; finding; findings; imaging; intracranial; mitral regurgitation maximum velocity; mri; point in time; rad; radiology; random; skull; w contr iv; wc,Doc
36243-4,mr posterior fossa w contrast iv,mr post fossa w contr iv,,brain; c; contr; contra; contrst; cranial; cranium; document; finding; findings; imaging; intracranial; mitral regurgitation maximum velocity; mri; point in time; post fossa; rad; radiology; random; skull; w contr iv; wc,Doc
36262-4,ct lower leg - right w contrast iv,ct lower leg-r w contr iv,,c; calf; cat scan; computed tomography; computerized tomography; contr; contra; contrst; ct scan; document; ext; extr-r; fibula; finding; findings; imaging; le; leg; le-r; low; lower extremity; lower leg-r; point in time; r; rad; radiology; random; rle; rt; tibia; w contr iv; wc,Doc
36266-5,cta chest vessels w contrast iv,cta chest ves w contr iv,,ang; angio; angiography; angm; c; cat scan; computed tomography; computerized tomography; contr; contra; contrst; ct angiogram; ct angiography; ct scan; cta; document; finding; findings; imaging; point in time; rad; radiology; random; thorax; vesl; vessels.xxx; w contr iv; wc,Doc
36288-9,ct lower extremity wo and w contrast iv,ct le wo+w contr iv,,c; cat scan; computed tomography; computerized tomography; contr; contra; contrst; coreplaybook; ct scan; document; ext; finding; findings; imaging; le; leg; low; playbook; point in time; rad; radiology; random; w contr iv; wc; wo & wc; wo+w contr; wo+w contr iv; wwo,Doc
36290-5,ct lower extremity - left wo and w contrast iv,ct le-l wo+w contr iv,,c; cat scan; computed tomography; computerized tomography; contr; contra; contrst; ct scan; document; ext; extr-l; finding; findings; imaging; l; le; leg; le-l; lle; low; lt; point in time; rad; radiology; random; w contr iv; wc; wo & wc; wo+w contr; wo+w contr iv; wwo,Doc
36293-9,xr abdomen 3 views,xr abd 3v,,3v; 3vw; abd; abdo; abdomen+; abdominal; document; films; finding; findings; iii; imaging; plain films; point in time; rad; radiology; random; view; vws; xray; x-ray,Doc
3630-1,fenfluramine [mass/volume] in serum or plasma,fenfluramine serpl-mcnc,fenfluramine [mass/vol],dima-fen; drug/toxicology; drugs; fentrate; fenured; level; mass concentration; pesos; pl; plasma; plsm; point in time; ponderal; ponderax; pondimin; ponflurol; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
363-2,nitrofurantoin [susceptibility] by minimum inhibitory concentration (mic),nitrofurantoin islt mic,nitrofurantoin mic [susc],antibiotic susceptibilities; ast; furadantin; id; infectious disease; infectiousdisease; islt; isol; macrobid; macrodantin; minimum inhibitory concentration; nitrofurant; point in time; random; sus; suscept; susceptibilities; susceptibility; susceptibilty,OrdQn
3633-5,fenproporex [presence] in urine,fenproporex ur ql,fenproporex ql (u),addiction; antiobes; dicel; drug/toxicology; drugs; drugs of abuse; illicit; n-2-cyanoethylamphetamine; ordinal; perphoxene; point in time; potentialforabuse; pr; ql; qual; qualitative; random; screen; tegisec; ua; ur; urn,Ord
36337-4,mr upper extremity - right wo and w contrast iv,mr ue-r wo+w contr iv,,arm; c; contr; contra; contrst; document; ext; extr-r; finding; findings; imaging; mitral regurgitation maximum velocity; mri; point in time; r; rad; radiology; random; rt; rue; ue; ue-r; up; w contr iv; wc; wo & wc; wo+w contr; wo+w contr iv; wwo,Doc
36349-9,mr forearm - left wo and w contrast iv,mr forearm-l wo+w contr iv,,arm; c; contr; contra; contrst; document; ext; extr-l; finding; findings; forearm-l; imaging; l; lt; lue; mitral regurgitation maximum velocity; mri; point in time; rad; radiology; random; ue; ue-l; ulna; up; upper extremity; w contr iv; wc; wo & wc; wo+w contr; wo+w contr iv; wwo,Doc
36367-1,ct upper arm - left wo and w contrast iv,ct upper arm-l wo+w contr iv,,arm; c; cat scan; computed tomography; computerized tomography; contr; contra; contrst; ct scan; document; ext; extr-l; finding; findings; humerus; imaging; l; lt; lue; point in time; rad; radiology; random; ue; ue-l; up; upper arm-l; upper extremity; w contr iv; wc; wo & wc; wo+w contr; wo+w contr iv; wwo,Doc
36375-4,ct sacroiliac joint wo and w contrast iv,ct sij wo+w contr iv,,c; cat scan; computed tomography; computerized tomography; contr; contra; contrst; ct scan; document; finding; findings; imaging; jnt; pelvic; point in time; rad; radiology; random; sac; si joint; si joints; sij; w contr iv; wc; wo & wc; wo+w contr; wo+w contr iv; wwo,Doc
36385-3,mr pancreas wo and w contrast iv,mr pancreas wo+w contr iv,,abd; abdo; abdomen+; abdominal; c; contr; contra; contrst; document; finding; findings; imaging; mitral regurgitation maximum velocity; mri; pancr; pancreatc; pancreatic; point in time; rad; radiology; random; w contr iv; wc; wo & wc; wo+w contr; wo+w contr iv; wwo,Doc
3639-2,5-fluorocytosine [mass/volume] in serum or plasma,5-fluorocytosine serpl-mcnc,5-fluorocytosine [mass/vol],alcobon; ancobon; ancotil; drug/toxicology; drugs; flucytosine; fluorocytosin; level; mass concentration; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
36396-0,ct shoulder - left wo and w contrast iv,ct should-l wo+w contr iv,,arm; c; cat scan; computed tomography; computerized tomography; contr; contra; contrst; ct scan; document; ext; extr-l; finding; findings; imaging; l; lt; lue; msk; musculoskeletal; ortho; orthopedics; point in time; rad; radiology; random; should-l; ue; ue-l; up; upper extremity joint; w contr iv; wc; wo & wc; wo+w contr; wo+w contr iv; wwo,Doc
36398-6,ct sinuses wo and w contrast iv,ct sinuses wo+w contr iv,,brain; c; cat scan; computed tomography; computerized tomography; contr; contra; contrst; coreplaybook; cranial; cranium; ct scan; document; finding; findings; imaging; intracranial; paranasal sinuses; playbook; point in time; rad; radiology; random; sinus; skull; w contr iv; wc; wo & wc; wo+w contr; wo+w contr iv; wwo,Doc
36407-5,mr thyroid gland wo and w contrast iv,mr thyroid wo+w contr iv,,c; contr; contra; contrst; document; finding; findings; imaging; mitral regurgitation maximum velocity; mri; point in time; rad; radiology; random; thy; w contr iv; wc; wo & wc; wo+w contr; wo+w contr iv; wwo,Doc
36413-3,mr uterus wo and w contrast iv,mr uterus wo+w contr iv,,c; contr; contra; contrst; document; finding; findings; gyn; gynecology; imaging; mitral regurgitation maximum velocity; mri; ob; obgyn; obstetrics; pelvic; point in time; rad; radiology; random; uterine; w contr iv; wc; wo & wc; wo+w contr; wo+w contr iv; wwo,Doc
36426-5,ct ankle - left wo contrast,ct ankle-l wo contr,,ankle-l; c; cat scan; computed tomography; computerized tomography; contr; contra; contrst; ct scan; document; ext; extr-l; finding; findings; imaging; l; le; leg; le-l; lle; low; lower extremity joint; lt; msk; musculoskeletal; ortho; orthopedics; point in time; rad; radiology; random; without contrast,Doc
36431-5,ct abdominal aorta wo contrast,ct abd aorta wo contr,,ab ao; abd; abd aorta; abdo; abdomen; abdomen+; abdominal; ao; aortic; c; cat scan; computed tomography; computerized tomography; contr; contra; contrst; ct scan; document; finding; findings; imaging; point in time; rad; radiology; random; without contrast,Doc
36445-5,ct elbow - left wo contrast,ct elbow-l wo contr,,arm; c; cat scan; computed tomography; computerized tomography; contr; contra; contrst; ct scan; document; elbow-l; ext; extr-l; finding; findings; imaging; l; lt; lue; msk; musculoskeletal; olecranon; ortho; orthopedics; point in time; rad; radiology; random; ue; ue-l; up; upper extremity joint; without contrast,Doc
36451-3,mr lower extremity - bilateral wo contrast,mr le-bl wo contr,,bil; bilat; both; c; contr; contra; contrst; document; ext; extr-bl; finding; findings; imaging; le; le-bl; leg; low; mitral regurgitation maximum velocity; mri; point in time; rad; radiology; random; without contrast,Doc
36456-2,ct upper extremity - bilateral wo contrast,ct ue-bl wo contr,,arm; bil; bilat; both; c; cat scan; computed tomography; computerized tomography; contr; contra; contrst; ct scan; document; ext; extr-bl; finding; findings; imaging; point in time; rad; radiology; random; ue; ue-bl; up; without contrast,Doc
36460-4,ct thigh wo contrast,ct thigh wo contr,,c; cat scan; computed tomography; computerized tomography; contr; contra; contrst; ct scan; document; ext; femoral; femur; finding; findings; imaging; le; leg; low; lower extremity; point in time; rad; radiology; random; without contrast,Doc
36461-2,mr thigh wo contrast,mr thigh wo contr,,c; contr; contra; contrst; coreplaybook; document; ext; femoral; femur; finding; findings; imaging; le; leg; low; lower extremity; mitral regurgitation maximum velocity; mri; playbook; point in time; rad; radiology; random; without contrast,Doc
3646-7,fluoxymesterone [presence] in urine,fluoxymesterone ur ql,fluoxymesterone ql (u),drug/toxicology; drugs; halotestin; ordinal; point in time; pr; ql; qual; qualitative; random; screen; ua; ur; urn,Ord
36472-9,ct forearm wo contrast,ct forearm wo contr,,arm; c; cat scan; computed tomography; computerized tomography; contr; contra; contrst; ct scan; document; ext; finding; findings; imaging; point in time; rad; radiology; random; ue; ulna; up; upper extremity; without contrast,Doc
36474-5,mr forearm - left wo contrast,mr forearm-l wo contr,,arm; c; contr; contra; contrst; document; ext; extr-l; finding; findings; forearm-l; imaging; l; lt; lue; mitral regurgitation maximum velocity; mri; point in time; rad; radiology; random; ue; ue-l; ulna; up; upper extremity; without contrast,Doc
36477-8,ct hand wo contrast,ct hand wo contr,,arm; c; cat scan; computed tomography; computerized tomography; contr; contra; contrst; ct scan; document; ext; finding; findings; imaging; msk; musculoskeletal; ortho; orthopedics; point in time; rad; radiology; random; ue; up; upper extremity; without contrast,Doc
36481-0,mr hand - right wo contrast,mr hand-r wo contr,,arm; c; contr; contra; contrst; document; ext; extr-r; finding; findings; hand-r; imaging; mitral regurgitation maximum velocity; mri; msk; musculoskeletal; ortho; orthopedics; point in time; r; rad; radiology; random; rt; rue; ue; ue-r; up; upper extremity; without contrast,Doc
36525-4,mr shoulder - bilateral wo contrast,mr shoulder-bl wo contr,,arm; bil; bilat; both; c; contr; contra; contrst; document; ext; extr-bl; finding; findings; imaging; mitral regurgitation maximum velocity; mri; msk; musculoskeletal; ortho; orthopedics; point in time; rad; radiology; random; shoulder-bl; ue; ue-bl; up; upper extremity joint; without contrast,Doc
36530-4,ct spine wo contrast,ct spine wo contr,,c; cat scan; computed tomography; computerized tomography; contr; contra; contrst; ct scan; document; finding; findings; imaging; misc; miscellaneous; other; point in time; rad; radiology; random; spec; spinal; spinal cord; to be specified in another part of the message; unspecified; without contrast,Doc
36541-1,mr lower leg - right wo contrast,mr lower leg-r wo contr,,c; calf; contr; contra; contrst; document; ext; extr-r; fibula; finding; findings; imaging; le; leg; le-r; low; lower extremity; lower leg-r; mitral regurgitation maximum velocity; mri; point in time; r; rad; radiology; random; rle; rt; tibia; without contrast,Doc
36547-8,mra chest vessels wo contrast,mra chest ves wo contr,,ang; angio; angiography; c; contr; contra; contrst; coreplaybook; document; finding; findings; imaging; magnetic resonance angiographies; magnetic resonance imaging; mitral regurgitation maximum velocity; mr angiography; mra; mri; mri.angio; playbook; point in time; rad; radiology; random; thorax; vesl; vessels.xxx; without contrast,Doc
36549-4,mra neck vessels wo contrast,mra neck ves wo contr,,ang; angio; angiography; c; contr; contra; contrst; coreplaybook; document; finding; findings; imaging; magnetic resonance angiographies; magnetic resonance imaging; mitral regurgitation maximum velocity; mr angiography; mra; mri; mri.angio; playbook; point in time; rad; radiology; random; vesl; vessels.xxx; without contrast,Doc
36589-0,portable xr chest ap single view,xr port chest ap 1 view,,1v; anterio-posterior; anteroposterior; cardio; cardiology; cxr; document; film; finding; findings; heart disease; imaging; lung; plain films; point in time; pulmonary; pulmonology; rad; radiology; random; respiratory; single view; thorax; vw; xr port; xray; x-ray,Doc
36605-4,xr knee - bilateral lateral,xr knee-bl lat,,1v; bil; bilat; both; document; ext; extr-bl; film; finding; findings; imaging; kn; knee-bl; knees; lat; le; le-bl; leg; low; lower extremity joint; msk; musculoskeletal; ortho; orthopedics; plain films; point in time; rad; radiology; random; single view; vw; xray; x-ray,Doc
3660-8,furosemide [presence] in urine,furosemide ur ql,furosemide ql (u),c210; drug/toxicology; drugs; furj; lasix; lasj; ordinal; point in time; pr; ql; qual; qualitative; random; screen; ua; ur; urn,Ord
36619-5,xr knee oblique views,xr knee views obl,,document; ext; films; finding; findings; imaging; kn; le; leg; low; lower extremity joint; msk; musculoskeletal; obl; ortho; orthopedics; plain films; point in time; rad; radiology; random; view; views+obl; vws; xray; x-ray,Doc
3662-4,furosemide [mass/time] in 24 hour urine,furosemide 24h ur-mrate,furosemide (24h u) [mass/time],1 day; 24 hours; 24hr; c210; drug/toxicology; drugs; furj; lasix; lasj; mass rate; mrate; qnt; quan; quant; quantitative; ua; ur; urn,Qn
36632-8,xr humerus - left views,xr humerus-l views,,arm; document; ext; extr-l; films; finding; findings; humerus-l; imaging; l; lt; lue; plain films; point in time; rad; radiology; random; ue; ue-l; up; upper extremity; view; vws; xray; x-ray,Doc
36637-7,xr maxilla views,xr maxilla views,,brain; cranial; cranium; document; films; finding; findings; imaging; intracranial; plain films; point in time; rad; radiology; random; skull; view; vws; xray; x-ray,Doc
36641-9,xr abdomen 2 views,xr abd 2v,,2v; 2vw; abd; abdo; abdomen+; abdominal; document; films; finding; findings; ii; imaging; plain films; point in time; rad; radiology; random; view; vws; xray; x-ray,Doc
36648-4,xr elbow 2 views,xr elbow 2v,,2v; 2vw; arm; document; ext; films; finding; findings; ii; imaging; msk; musculoskeletal; olecranon; ortho; orthopedics; plain films; point in time; rad; radiology; random; ue; up; upper extremity joint; view; vws; xray; x-ray,Doc
366-5,norfloxacin [susceptibility] by minimum lethal concentration (mlc),norfloxacin islt mlc,norfloxacin mlc [susc],antibiotic susceptibilities; ast; id; infectious disease; infectiousdisease; islt; isol; mbc; minimum bactericidal concentration; minimum lethal concentration; noroxin; point in time; qnt; quan; quant; quantitative; random; sus; suscept; susceptibilities; susceptibility; susceptibilty,Qn
36652-6,xr femur 2 views,xr femur 2v,,2v; 2vw; coreplaybook; document; ext; femoral; films; finding; findings; ii; imaging; le; leg; low; lower extremity; plain films; playbook; point in time; rad; radiology; random; upper leg; view; vws; xray; x-ray,Doc
36655-9,xr finger 2 views,xr finger 2v,,2v; 2vw; arm; document; ext; films; finding; findings; ii; imaging; msk; musculoskeletal; ortho; orthopedics; plain films; point in time; rad; radiology; random; ue; up; view; vws; xray; x-ray,Doc
36657-5,xr foot - bilateral 2 views,xr foot-bl 2v,,2v; 2vw; bil; bilat; both; document; ext; extr-bl; films; finding; findings; foot-bl; ft; ii; imaging; le; le-bl; leg; low; lower extremity; msk; musculoskeletal; ortho; orthopedics; plain films; point in time; rad; radiology; random; view; vws; xray; x-ray,Doc
36658-3,xr radius and ulna 2 views,xr radius+ulna 2v,,2v; 2vw; arm; coreplaybook; document; ext; films; finding; findings; forearm; ii; imaging; plain films; playbook; point in time; rad; radiology; random; ue; up; upper extremity; view; vws; xray; x-ray,Doc
36666-6,xr scapula - left 2 views,xr scapula-l 2v,,2v; 2vw; cxr; document; films; finding; findings; ii; imaging; l; lt; plain films; point in time; rad; radiology; random; scapula-l; thorax; upper extremity; view; vws; xray; x-ray,Doc
36678-1,xr knee - bilateral 6 views,xr knee-bl 6v,,6v; bil; bilat; both; document; ext; extr-bl; films; finding; findings; imaging; kn; knee-bl; knees; le; le-bl; leg; low; lower extremity joint; msk; musculoskeletal; ortho; orthopedics; plain films; point in time; rad; radiology; random; view; vws; xray; x-ray,Doc
36691-4,xr elbow - left ap and lateral,xr elbow-l ap+lat,,anterio-posterior; anteroposterior; ap+lat; arm; document; elbow-l; ext; extr-l; films; finding; findings; imaging; l; lat; lt; lue; msk; musculoskeletal; olecranon; ortho; orthopedics; plain films; point in time; rad; radiology; random; ue; ue-l; up; upper extremity joint; view; views & ap kub; views (ap; views ap kub & lateral; views+ap; vws; xray; x-ray,Doc
36694-8,xr femur - bilateral ap and lateral,xr femur-bl ap+lat,,anterio-posterior; anteroposterior; ap+lat; bil; bilat; both; document; ext; extr-bl; femoral; femur-bl; films; finding; findings; imaging; lat; le; le-bl; leg; low; lower extremity; plain films; point in time; rad; radiology; random; upper leg; view; views & ap kub; views (ap; views ap kub & lateral; views+ap; vws; xray; x-ray,Doc
36696-3,xr foot - bilateral ap and lateral,xr foot-bl ap+lat,,anterio-posterior; anteroposterior; ap+lat; axial plantar; bil; bilat; both; document; dorsoplantar; ext; extr-bl; films; finding; findings; foot-bl; ft; imaging; lat; le; le-bl; leg; low; lower extremity; msk; musculoskeletal; ortho; orthopedics; plain films; point in time; rad; radiology; random; view; views & ap kub; views (ap; views ap kub & lateral; views+ap; vws; xray; x-ray,Doc
36699-7,xr radius and ulna - bilateral ap and lateral,xr radius+ulna-bl ap+lat,,anterio-posterior; anteroposterior; ap+lat; arm; bil; bilat; both; document; ext; extr-bl; films; finding; findings; forearm; imaging; lat; plain films; point in time; rad; radiology; radius+ulna-bl; random; ue; ue-bl; up; upper extremity; view; views & ap kub; views (ap; views ap kub & lateral; views+ap; vws; xray; x-ray,Doc
36700-3,xr radius and ulna - left ap and lateral,xr radius+ulna-l ap+lat,,anterio-posterior; anteroposterior; ap+lat; arm; document; ext; extr-l; films; finding; findings; forearm; imaging; l; lat; lt; lue; plain films; point in time; rad; radiology; radius+ulna-l; random; ue; ue-l; up; upper extremity; view; views & ap kub; views (ap; views ap kub & lateral; views+ap; vws; xray; x-ray,Doc
36711-0,xr mandible ap and lateral,xr mandible ap+lat,,anterio-posterior; anteroposterior; ap+lat; brain; cranial; cranium; document; films; finding; findings; imaging; intracranial; jaw; lat; mand; plain films; point in time; rad; radiology; random; skull; view; views & ap kub; views (ap; views ap kub & lateral; views+ap; vws; xray; x-ray,Doc
3671-5,haloperidol [mass/volume] in urine,haloperidol ur-mcnc,haloperidol (u) [mass/vol],drug/toxicology; drugs; haldol; level; mass concentration; point in time; qnt; quan; quant; quantitative; random; serenace; ua; ur; urn,Qn
36719-3,xr toes - left ap and lateral,xr toes-l ap+lat,,anterio-posterior; anteroposterior; ap+lat; distal metatarsals; document; ext; extr-l; films; finding; findings; imaging; interphalangeal joints; l; lat; le; leg; le-l; lle; low; lt; metatarsophalangeal joints; phalanges; plain films; point in time; rad; radiology; random; toe; toes-l; view; views & ap kub; views (ap; views ap kub & lateral; views+ap; vws; xray; x-ray,Doc
36730-0,xr foot - left ap and lateral and oblique,xr foot-l ap+lat+obl,,anterio-posterior; anteroposterior; ap+lat; ap+lat+obl; axial plantar; document; dorsoplantar; ext; extr-l; films; finding; findings; foot-l; imaging; l; lat; le; leg; le-l; lle; low; lower extremity; lt; msk; musculoskeletal; obl; ortho; orthopedics; plain films; point in time; rad; radiology; random; view; views & ap kub; views (ap; views ap kub & lateral; views+ap; vws; xray; x-ray,Doc
36747-4,xr mandible oblique views,xr mandible views obl,,brain; cranial; cranium; document; films; finding; findings; imaging; intracranial; jaw; mand; obl; plain films; point in time; rad; radiology; random; skull; view; views+obl; vws; xray; x-ray,Doc
36767-2,ct guidance for biopsy of adrenal gland,ct guided adrenal bx,,abd; abdo; abdomen+; abdominal; bx; cat scan; computed tomography; computerized tomography; ct scan; document; finding; findings; guid; guide; guided; imaging; perc; point in time; rad; radiology; random,Doc
36773-0,ct temporal bone,ct temporal bone,,bon; brain; cat scan; computed tomography; computerized tomography; cranial; cranium; ct scan; document; finding; findings; imaging; intracranial; point in time; rad; radiology; random; skull,Doc
36784-7,mra lower extremity veins - left,mra le vv-l,,ang; angio; angiography; cardio; cardiology; document; ext; extr-l; finding; findings; heart disease; imaging; l; le; le vv; le vv-l; leg; le-l; lle; low; lower extremity veins.left; lt; magnetic resonance angiographies; magnetic resonance imaging; mitral regurgitation maximum velocity; mr angiography; mra; mri; mri.angio; mrv; point in time; rad; radiology; random,Doc
36791-2,mra abdominal vessels,mra abd ves,,abd; abd ves; abdo; abdomen; abdomen+; abdominal; ang; angio; angiography; cardio; cardiology; document; finding; findings; heart disease; imaging; magnetic resonance angiographies; magnetic resonance imaging; mitral regurgitation maximum velocity; mr angiography; mra; mri; mri.angio; point in time; rad; radiology; random; vesl; vessels.xxx,Doc
36792-0,mra adrenal vessels,mra adrenal ves,,abd; abdo; abdomen+; abdominal; ang; angio; angiography; cardio; cardiology; document; finding; findings; heart disease; imaging; magnetic resonance angiographies; magnetic resonance imaging; mitral regurgitation maximum velocity; mr angiography; mra; mri; mri.angio; point in time; rad; radiology; random; vesl; vessels.xxx,Doc
36794-6,mra extremity vessels,mra extr ves,,ang; angio; angiography; document; ext; extr ves; finding; findings; imaging; magnetic resonance angiographies; magnetic resonance imaging; mitral regurgitation maximum velocity; mr angiography; mra; mri; mri.angio; point in time; rad; radiology; random; vesl; vessels.xxx,Doc
36796-1,mra lower extremity vessels - right,mra le ves-r,,ang; angio; angiography; document; ext; extr ves; extr-r; finding; findings; imaging; le; le ves; le ves-r; leg; le-r; low; lower extremity vessels.right; magnetic resonance angiographies; magnetic resonance imaging; mitral regurgitation maximum velocity; mr angiography; mra; mri; mri.angio; point in time; r; rad; radiology; random; rle; rt; vesl; vessels.xxx,Doc
36797-9,mra upper extremity vessels - left,mra ue ves-l,,ang; angio; angiography; arm; arm and hand vessels; document; ext; extr ves; extr-l; finding; findings; imaging; l; lt; lue; magnetic resonance angiographies; magnetic resonance imaging; mitral regurgitation maximum velocity; mr angiography; mra; mri; mri.angio; point in time; rad; radiology; random; ue; ue ves; ue ves-l; ue-l; up; vesl; vessels.xxx,Doc
3681-4,hydrocodone [mass/volume] in urine,hydrocodone ur-mcnc,hydrocodone (u) [mass/vol],addiction; anexsia; dihydrocodeinone; drug/toxicology; drugs; drugs of abuse; illicit; level; mass concentration; point in time; potentialforabuse; qnt; quan; quant; quantitative; random; ua; ur; urn; vicodin,Qn
36820-9,mr orbit w contrast iv,mr orbit w contr iv,,brain; c; contr; contra; contrst; cranial; cranium; document; eye socket; finding; findings; imaging; intracranial; mitral regurgitation maximum velocity; mri; orbital; point in time; rad; radiology; random; skull; w contr iv; wc,Doc
36821-7,mr orbit - left w contrast iv,mr orbit-l w contr iv,,brain; c; contr; contra; contrst; cranial; cranium; document; eye socket; finding; findings; imaging; intracranial; l; lt; mitral regurgitation maximum velocity; mri; orbital; orbit-l; point in time; rad; radiology; random; skull; w contr iv; wc,Doc
3683-0,hydromorphone [mass/volume] in serum or plasma,hydromorphone serpl-mcnc,hydromorphone [mass/vol],addiction; dihydromorphinone; dilaudid; drug/toxicology; drugs; drugs of abuse; hydromorphinone; illicit; level; mass concentration; pl; plasma; plsm; point in time; potentialforabuse; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
36843-1,mr orbit - left wo and w contrast iv,mr orbit-l wo+w contr iv,,brain; c; contr; contra; contrst; cranial; cranium; document; eye socket; finding; findings; imaging; intracranial; l; lt; mitral regurgitation maximum velocity; mri; orbital; orbit-l; point in time; rad; radiology; random; skull; w contr iv; wc; wo & wc; wo+w contr; wo+w contr iv; wwo,Doc
36852-2,mra upper extremity veins - right wo and w contrast iv,mra ue vv-r wo+w contr iv,,ang; angio; angiography; arm; c; cardio; cardiology; contr; contra; contrst; document; ext; extr-r; finding; findings; heart disease; imaging; magnetic resonance angiographies; magnetic resonance imaging; mitral regurgitation maximum velocity; mr angiography; mra; mri; mri.angio; mrv; point in time; r; rad; radiology; random; rt; rue; ue; ue vv; ue vv-r; ue-r; up; venogram; venography; w contr iv; wc; wo & wc; wo+w contr; wo+w contr iv; wwo,Doc
36854-8,mra pelvis veins wo and w contrast iv,mra pelvis vv wo+w contr iv,,ang; angio; angiography; c; cardio; cardiology; contr; contra; contrst; document; finding; findings; heart disease; imaging; magnetic resonance angiographies; magnetic resonance imaging; mitral regurgitation maximum velocity; mr angiography; mra; mri; mri.angio; mrv; pelvic; pelvic vv; pelvis vv; point in time; rad; radiology; random; venogram; venography; w contr iv; wc; wo & wc; wo+w contr; wo+w contr iv; wwo,Doc
3685-5,hydroxymethoxyphenamine [mass/volume] in urine,oh-methoxyphenamine ur-mcnc,hydroxymethoxyphenamine (u) [mass/vol],drug/toxicology; drugs; hydroxy methoxyphenamine; level; mass concentration; methoxyphenamine metabolite; oh-methoxyphenamine; point in time; qnt; quan; quant; quantitative; random; ua; ur; urn,Qn
36855-5,mra abdominal vessels wo and w contrast iv,mra abd ves wo+w contr iv,,abd; abd ves; abdo; abdomen; abdomen+; abdominal; ang; angio; angiography; c; cardio; cardiology; contr; contra; contrst; coreplaybook; document; finding; findings; heart disease; imaging; magnetic resonance angiographies; magnetic resonance imaging; mitral regurgitation maximum velocity; mr angiography; mra; mri; mri.angio; playbook; point in time; rad; radiology; random; vesl; vessels.xxx; w contr iv; wc; wo & wc; wo+w contr; wo+w contr iv; wwo,Doc
36860-5,mra upper extremity vessels - left wo and w contrast iv,mra ue ves-l wo+w contr iv,,ang; angio; angiography; arm; arm and hand vessels; c; contr; contra; contrst; document; ext; extr ves; extr-l; finding; findings; imaging; l; lt; lue; magnetic resonance angiographies; magnetic resonance imaging; mitral regurgitation maximum velocity; mr angiography; mra; mri; mri.angio; point in time; rad; radiology; random; ue; ue ves; ue ves-l; ue-l; up; vesl; vessels.xxx; w contr iv; wc; wo & wc; wo+w contr; wo+w contr iv; wwo,Doc
36866-2,ct temporal bone wo contrast,ct temporal bone wo contr,,bon; brain; c; cat scan; computed tomography; computerized tomography; contr; contra; contrst; coreplaybook; cranial; cranium; ct scan; document; finding; findings; imaging; intracranial; playbook; point in time; rad; radiology; random; skull; without contrast,Doc
36879-5,mra ankle vessels wo contrast,mra ankle ves wo contr,,ang; angio; angiography; c; contr; contra; contrst; document; ext; finding; findings; imaging; le; leg; low; lower extremity joint; magnetic resonance angiographies; magnetic resonance imaging; mitral regurgitation maximum velocity; mr angiography; mra; mri; mri.angio; point in time; rad; radiology; random; vesl; vessels.xxx; without contrast,Doc
36922-3,tpmt gene targeted mutation analysis in blood or tissue by molecular genetics method,tpmt gene mut anl bld/t,tpmt gene targeted mutation analysis molgen doc (bld/tiss),"blood; document; finding; findings; genetics; heredity; heritable; inherited; molecular genetics; molecular pathology; molpath; molpath.pharmg; mut; mut anl; mutations; pcr; point in time; random; thiopurine s-methyltransferase; thiopurine s-methyltransferase gene; tissue; tissue, unspecified; universallaborders; wb; whole blood; whole blood or tissue",Doc
36923-1,epstein barr virus dna [#/volume] (viral load) in blood by naa with probe detection,ebv dna # bld naa+probe,ebv dna naa+probe (bld) [#/vol],#; 3 self-sustaining sequence replication; 3sr sr; abs; absolute; absolutes; amplif; amplification; amplified; blood; cnt; count; count/volume; ct; deoxyribonucleic acid; dna nucleic acid probe; dna probe; ebv; epstn; hhv-4; human herpesvirus 4; id; infectious disease; infectiousdisease; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; mono; mononucleosis; naa+probe; naat; nasba; nucleic acid sequence based analysis; number concentration; number concentration (count/vol); pcr; point in time; polymerase chain reaction; probe amp; probe with ampification; probe with target amplification; qbr; qnt; quan; quant; quantitative; random; sda; strand displacement amplification; tma; transcription mediated amplification; viral load; wb; whole blood,Qn
36931-4,mr adrenal gland,mr adrenal,,abd; abdo; abdomen+; abdominal; document; finding; findings; imaging; mitral regurgitation maximum velocity; mri; point in time; rad; radiology; random,Doc
36936-3,mr guidance for stereotactic biopsy of brain,mr guided brain str bx,,brain; bx; cerebral; cerebrum; cranial; cranium; document; finding; findings; guid; guide; guided; head; imaging; intracranial; mitral regurgitation maximum velocity; mri; point in time; rad; radiology; random; skull; stereo; str bx,Doc
36938-9,ct maxillofacial region limited wo contrast,ct maxillofacial ltd wo contr,,brain; c; cat scan; computed tomography; computerized tomography; contr; contra; contrst; cranial; cranium; ct scan; document; facial bones + maxilla; facial bones+maxilla; finding; findings; imaging; intracranial; lmted; ltd; point in time; rad; radiology; random; skull; without contrast,Doc
36942-1,mr chest and abdomen w contrast iv,mr chest+abd w contr iv,,abd; abdo; abdomen+; abdominal; c; chest + abd; contr; contra; contrst; document; finding; findings; imaging; mitral regurgitation maximum velocity; mri; point in time; rad; radiology; random; thorax; w contr iv; wc,Doc
3694-7,indomethacin [mass/volume] in serum or plasma,indomethacin serpl-mcnc,indomethacin [mass/vol],c282; c54; drug/toxicology; drugs; indochron; indocin; indometacin; level; mass concentration; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
36947-0,xr foot - bilateral 3 views w standing,xr foot-bl 3v w stand,,3v; 3vw; bil; bilat; both; document; ext; extr-bl; films; finding; findings; foot-bl; ft; iii; imaging; le; le-bl; leg; low; lower extremity; msk; musculoskeletal; ortho; orthopedics; plain films; point in time; rad; radiology; random; stand); view; vws; wb; weight bearing; xray; x-ray,Doc
36951-2,mr adrenal gland wo and w contrast iv,mr adrenal wo+w contr iv,,abd; abdo; abdomen+; abdominal; c; contr; contra; contrst; document; finding; findings; imaging; mitral regurgitation maximum velocity; mri; point in time; rad; radiology; random; w contr iv; wc; wo & wc; wo+w contr; wo+w contr iv; wwo,Doc
36961-1,xr shoulder - left ap and west point and outlet,xr should-l ap+west point+outlet,,anterio-posterior; anteroposterior; ap+west point; ap+west point+outlet; arm; document; ext; extr-l; films; finding; findings; imaging; l; lt; lue; msk; musculoskeletal; ortho; orthopedics; plain films; point in time; rad; radiology; random; should-l; supraspinatus; ue; ue-l; up; upper extremity joint; view; views & ap kub; views (ap; views+ap; vws; xray; x-ray,Doc
36965-2,xr hand ball catcher,xr hand ball catcher,,1v; arm; document; ext; film; finding; findings; imaging; msk; musculoskeletal; norgaard; ortho; orthopedics; plain films; point in time; rad; radiology; random; single view; ue; up; upper extremity; vw; xray; x-ray,Doc
37027-0,xr knee - bilateral sunrise,xr knee-bl sunrise,,1v; bil; bilat; both; document; ext; extr-bl; film; finding; findings; imaging; kn; knee-bl; knees; le; le-bl; leg; low; lower extremity joint; msk; musculoskeletal; ortho; orthopedics; plain films; point in time; rad; radiology; random; settegast; single view; skyline; tangential; vw; xray; x-ray,Doc
37079-1,portable xr cervical spine ap and lateral and odontoid,xr port c-spine ap+lat+odont,,anterio-posterior; anteroposterior; ap+lat; ap+lat+odont; c/sp; cerv; c-spine; document; films; finding; findings; imaging; lat; plain films; point in time; rad; radiology; random; soft tissue; spinal; spinal cord; view; views & ap kub; views (ap; views ap kub & lateral; views+ap; vws; xr port; xray; x-ray,Doc
37093-2,xr hip - left ap and lateral frog,xr hip-l ap+lat frog,,anterio-posterior; anteroposterior; ap+lat; ap+lat frog; document; ext; extr-l; films; finding; findings; hip-l; imaging; l; lat; lauenstein; lauenstein-hickey; le; leg; le-l; lle; low; lower extremity joint; lt; msk; musculoskeletal; ortho; orthopedics; plain films; point in time; rad; radiology; random; view; views & ap kub; views (ap; views ap kub & lateral; views+ap; vws; xray; x-ray,Doc
37112-0,xr knee ap and lateral and tunnel,xr knee ap+lat+tunnel,,anterio-posterior; anteroposterior; ap+lat; ap+lat+tunnel; document; ext; films; finding; findings; imaging; kn; lat; le; leg; low; lower extremity joint; msk; musculoskeletal; ortho; orthopedics; plain films; point in time; rad; radiology; random; view; views & ap kub; views (ap; views ap kub & lateral; views+ap; vws; xray; x-ray,Doc
37136-9,xr shoulder - left lateral and y,xr should-l lat+y,,arm; document; ext; extr-l; films; finding; findings; imaging; l; lat; lat+y; lt; lue; msk; musculoskeletal; ortho; orthopedics; plain films; point in time; rad; radiology; random; should-l; ue; ue-l; up; upper extremity joint; view; vws; xray; x-ray,Doc
3714-3,lidocaine [mass/volume] in serum or plasma,lidocain serpl-mcnc,lidocaine [mass/vol],c232; c251; clid; drug/toxicology; drugs; level; mass concentration; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; universallaborders; xylocaine,Qn
37145-0,xr chest pa and lateral and ap right lateral-decubitus,xr chest pa+lat+ap r-lat-decub,,anterio-posterior; anteroposterior; cardio; cardiology; cxr; document; films; finding; findings; heart disease; imaging; lat; lung; pa+lat; pa+lat+ap r-lat-decub; plain films; point in time; postero-anterior; pulmonary; pulmonology; r prime; rad; radiology; random; respiratory; right; thorax; view; views pa & lateral & r-decubitus; views+pa; vws; xray; x-ray,Doc
37146-8,xr chest pa and lateral and left oblique,xr chest pa+lat+l-obl,,cardio; cardiology; cxr; document; films; finding; findings; heart disease; imaging; lat; left; levo; lung; obl; pa+lat; pa+lat+l-obl; plain films; point in time; postero-anterior; pulmonary; pulmonology; rad; radiology; random; respiratory; thorax; view; views+pa; vws; xray; x-ray,Doc
37150-0,xr chest pa and right oblique and left oblique,xr chest pa+r-obl+l-obl,,bilateral obliques; cardio; cardiology; cxr; document; films; finding; findings; heart disease; imaging; left; levo; lung; obl; obliques; pa+r-obl+l-obl; plain films; point in time; postero-anterior; pulmonary; pulmonology; r prime; rad; radiology; random; respiratory; right; thorax; view; views+pa; vws; xray; x-ray,Doc
37159-1,deprecated xr foot - left tarsal views,deprecated xr foot-l views tarsal,,document; ext; extr-l; films; finding; findings; foot-l; imaging; l; le; leg; le-l; lle; low; lower extremity; lt; msk; musculoskeletal; ortho; orthopedics; plain films; point in time; rad; radiology; random; view; vws; xray; x-ray,Doc
37163-3,xr knee - bilateral sunrise and tunnel,xr knee-bl sunrise+tunnel,,bil; bilat; both; document; ext; extr-bl; films; finding; findings; imaging; kn; knee-bl; knees; le; le-bl; leg; low; lower extremity joint; msk; musculoskeletal; ortho; orthopedics; plain films; point in time; rad; radiology; random; settegast; skyline; sunrise+tunnel; tangential; view; views+sunrise; vws; xray; x-ray,Doc
37167-4,xr shoulder - left grashey and west point,xr should-l grashey+west point,,arm; document; ext; extr-l; films; finding; findings; glenhumeral; glenohumeral; glenoid fossa; grashey+west point; imaging; l; lt; lue; msk; musculoskeletal; ortho; orthopedics; plain films; point in time; rad; radiology; random; should-l; true ap; ue; ue-l; up; upper extremity joint; view; vws; xray; x-ray,Doc
37183-1,rf ankle arthrogram,rf ankle views w contr is,,arthrogram; arthrography; c; contr; contra; contrst; coreplaybook; document; ext; films; finding; findings; fluor; fluoro; fluoroscopy; imaging; intraarticular; intrasynovial; le; leg; low; lower extremity joint; msk; musculoskeletal; ortho; orthopedics; playbook; point in time; rad; radiology; random; view; vws; w contr is; wc,Doc
37185-6,rf ankle - left arthrogram,rf ankle-l views w contr is,,ankle-l; arthrogram; arthrography; c; contr; contra; contrst; document; ext; extr-l; films; finding; findings; fluor; fluoro; fluoroscopy; imaging; intraarticular; intrasynovial; l; le; leg; le-l; lle; low; lower extremity joint; lt; msk; musculoskeletal; ortho; orthopedics; point in time; rad; radiology; random; view; vws; w contr is; wc,Doc
37186-4,rf elbow arthrogram,rf elbow views w contr is,,arm; arthrogram; arthrography; c; contr; contra; contrst; coreplaybook; document; ext; films; finding; findings; fluor; fluoro; fluoroscopy; imaging; intraarticular; intrasynovial; msk; musculoskeletal; olecranon; ortho; orthopedics; playbook; point in time; rad; radiology; random; ue; up; upper extremity joint; view; vws; w contr is; wc,Doc
37187-2,rf elbow - bilateral arthrogram,rf elbow-bl views w contr is,,arm; arthrogram; arthrography; bil; bilat; both; c; contr; contra; contrst; document; elbow-bl; ext; extr-bl; films; finding; findings; fluor; fluoro; fluoroscopy; imaging; intraarticular; intrasynovial; msk; musculoskeletal; olecranon; ortho; orthopedics; point in time; rad; radiology; random; ue; ue-bl; up; upper extremity joint; view; vws; w contr is; wc,Doc
37200-3,xr chest views w contrast po,xr chest views w contr po,,c; contr; contra; contrst; cxr; document; films; finding; findings; imaging; plain films; point in time; rad; radiology; random; thorax; view; vws; w contr po; wc; xray; x-ray,Doc
37201-1,xr ankle views w standing,xr ankle views w stand,,document; ext; films; finding; findings; imaging; le; leg; low; lower extremity joint; msk; musculoskeletal; ortho; orthopedics; plain films; point in time; rad; radiology; random; stand); view; vws; wb; weight bearing; xray; x-ray,Doc
37212-8,ct guidance for biopsy of epididymis,ct guided epid bx,,bx; cat scan; computed tomography; computerized tomography; ct scan; document; finding; findings; guid; guide; guided; imaging; pelvic; perc; point in time; rad; radiology; random,Doc
37229-2,xr tomography temporomandibular joint - left,xr tomo tmj-l,,brain; cranial; cranium; document; finding; findings; imaging; intracranial; jnt; l; lt; plain films; point in time; rad; radiology; random; skull; tmj; tmj-l; xr tomo; xray; x-ray,Doc
372-3,novobiocin [susceptibility] by disk diffusion (kb),novobiocin islt kb,novobiocin disk diffusion (kb) [susc],antibiotic susceptibilities; ast; crystallanic acid; disk diffusion; id; infectious disease; infectiousdisease; islt; isol; kb; kirby-bauer; point in time; random; streptonivicin; sus; suscept; susceptibilities; susceptibility; susceptibilty; tetra tripsin,OrdQn
37245-8,mr temporomandibular joint - bilateral w contrast iv,mr tmj-bl w contr iv,,bil; bilat; both; brain; c; contr; contra; contrst; cranial; cranium; document; finding; findings; imaging; intracranial; jnt; mitral regurgitation maximum velocity; mri; point in time; rad; radiology; random; skull; tmj; tmj-bl; tmjs; w contr iv; wc,Doc
37246-6,ct temporomandibular joint - left w contrast iv,ct tmj-l w contr iv,,brain; c; cat scan; computed tomography; computerized tomography; contr; contra; contrst; cranial; cranium; ct scan; document; finding; findings; imaging; intracranial; jnt; l; lt; point in time; rad; radiology; random; skull; tmj; tmj-l; w contr iv; wc,Doc
37259-9,xr spine lumbar and sacrum 3 views,xr l-spine+sacrum 3v,,3v; 3vw; abd; abdo; abdomen+; abdominal; document; films; finding; findings; iii; imaging; l/sp; l-spine; l-spine+sacrum; lumbar; lumbo; lumbosacral; pelvic; pelvis+l-spine; plain films; point in time; rad; radiology; random; spinal; spinal cord; view; vws; xray; x-ray,Doc
37269-8,mr temporomandibular joint - bilateral wo and w contrast iv,mr tmj-bl wo+w contr iv,,bil; bilat; both; brain; c; contr; contra; contrst; cranial; cranium; document; finding; findings; imaging; intracranial; jnt; mitral regurgitation maximum velocity; mri; point in time; rad; radiology; random; skull; tmj; tmj-bl; tmjs; w contr iv; wc; wo & wc; wo+w contr; wo+w contr iv; wwo,Doc
37271-4,mr temporomandibular joint - right wo and w contrast iv,mr tmj-r wo+w contr iv,,brain; c; contr; contra; contrst; cranial; cranium; document; finding; findings; imaging; intracranial; jnt; mitral regurgitation maximum velocity; mri; point in time; r; rad; radiology; random; rt; skull; tmj; tmj-r; w contr iv; wc; wo & wc; wo+w contr; wo+w contr iv; wwo,Doc
37281-3,mr parotid gland wo contrast,mr parotid gland wo contr,,c; contr; contra; contrst; document; finding; findings; imaging; mitral regurgitation maximum velocity; mri; parotic gland; point in time; rad; radiology; random; without contrast,Doc
37284-7,mr temporomandibular joint wo contrast,mr tmj wo contr,,brain; c; contr; contra; contrst; coreplaybook; cranial; cranium; document; finding; findings; imaging; intracranial; jnt; mitral regurgitation maximum velocity; mri; playbook; point in time; rad; radiology; random; skull; tmj; without contrast,Doc
37286-2,mr temporomandibular joint - left wo contrast,mr tmj-l wo contr,,brain; c; contr; contra; contrst; cranial; cranium; document; finding; findings; imaging; intracranial; jnt; l; lt; mitral regurgitation maximum velocity; mri; point in time; rad; radiology; random; skull; tmj; tmj-l; without contrast,Doc
37293-8,mr soft tissue wo contrast,mr soft tiss wo contr,,c; contr; contra; contrst; document; finding; findings; imaging; misc; miscellaneous; mitral regurgitation maximum velocity; mri; other; point in time; rad; radiology; random; spec; to be specified in another part of the message; unspecified; without contrast,Doc
37355-5,xr spine lumbar and sacrum 5 views,xr l-spine+sacrum 5v,,5v; 5vw; abd; abdo; abdomen+; abdominal; document; films; finding; findings; imaging; l/sp; l-spine; l-spine+sacrum; lumbar; lumbo; lumbosacral; pelvic; pelvis+l-spine; plain films; point in time; rad; radiology; random; spinal; spinal cord; view; vws; xray; x-ray,Doc
37361-3,xr cervical and thoracic spine ap and lateral,xr c+t-spine ap+lat,,anterio-posterior; anteroposterior; ap+lat; c/sp; c+t-spine; cerv; c-spine; cxr; document; dorsal spine; films; finding; findings; imaging; lat; plain films; point in time; rad; radiology; random; soft tissue; spinal; spinal cord; th/sp; thorax; t-spine; view; views & ap kub; views (ap; views ap kub & lateral; views+ap; vws; xray; x-ray,Doc
3738-2,maprotiline [mass/volume] in urine,maprotiline ur-mcnc,maprotiline (u) [mass/vol],drug/toxicology; drugs; level; ludiomil; mass concentration; novartis; point in time; qnt; quan; quant; quantitative; random; ua; ur; urn,Qn
37384-5,rfa vertebral artery views w contrast ia,rfa va views w contr ia,,art; arteriogram; brain; c; cardio; cardiology; contr; contra; contrst; cranial; cranium; document; films; finding; findings; fluor; fluoro; fluoroscopy; heart disease; imaging; intracranial; point in time; rad; radiology; random; rfa; skull; va; view; vws; w contr ia; wc,Doc
37395-1,rfa extremity arteries - left views w contrast ia,rfa extr aa-l views w contr ia,,arteriogram; c; contr; contra; contrst; document; ext; extr aa-l; extr-l; films; finding; findings; fluor; fluoro; fluoroscopy; imaging; l; lt; point in time; rad; radiology; random; rfa; view; vws; w contr ia; wc,Doc
37397-7,rfa gastric artery views w contrast ia,rfa gastric a views w contr ia,,abd; abdo; abdomen+; abdominal; art; arteriogram; c; cardio; cardiology; contr; contra; contrst; document; films; finding; findings; fluor; fluoro; fluoroscopy; heart disease; imaging; point in time; rad; radiology; random; rfa; view; vws; w contr ia; wc,Doc
37398-5,rfa gastric artery - left views w contrast ia,rfa gastric a-l views w contr ia,,abd; abdo; abdomen+; abdominal; art; arteriogram; c; cardio; cardiology; contr; contra; contrst; document; films; finding; findings; fluor; fluoro; fluoroscopy; gastric a-l; heart disease; imaging; l; lt; point in time; rad; radiology; random; rfa; view; vws; w contr ia; wc,Doc
37401-7,rfa internal maxillary artery views w contrast ia,rfa int max a views w contr ia,,art; arteriogram; brain; c; cardio; cardiology; contr; contra; contrst; cranial; cranium; document; films; finding; findings; fluor; fluoro; fluoroscopy; heart disease; imaging; int max a; intracranial; point in time; rad; radiology; random; rfa; skull; view; vws; w contr ia; wc,Doc
37410-8,rf temporomandibular joint - left arthrogram,rf tmj-l views w contr is,,arthrogram; arthrography; brain; c; contr; contra; contrst; cranial; cranium; document; films; finding; findings; fluor; fluoro; fluoroscopy; imaging; intraarticular; intracranial; intrasynovial; jnt; l; lt; msk; musculoskeletal; ortho; orthopedics; point in time; rad; radiology; random; skull; tmj; tmj-l; view; vws; w contr is; wc,Doc
37411-6,rfa azygos vein views w contrast iv,rfa azygos v views w contr iv,,abd; abdo; abdomen+; abdominal; c; cardio; cardiology; chest + abd; contr; contra; contrst; document; films; finding; findings; fluor; fluoro; fluoroscopy; heart disease; imaging; point in time; rad; radiology; random; rfa; thorax; ven; venogram; venography; venous; view; vws; w contr iv; wc,Doc
37425-6,abnormal prion protein [presence] in brain by immunoassay,abn prion prot brain ql ia,abnormal prion protein ia ql (brain),abn; abn prion prot; abnorm; bovine spongiform encephalopathy; bse; cerebral; cerebrum; eia; elfa; elisa; enzyme immunoassay; head; iaa; intracranial; meia; microbiology; neuro; neurology; ordinal; point in time; pr; prot; prp; ql; qual; qualitative; random; scrapie; screen; suds,Ord
37428-0,ct wrist,ct wrist,,arm; carpal bone; carpal bones; carpal bones and joint; cat scan; computed tomography; computerized tomography; ct scan; document; ext; finding; findings; imaging; point in time; rad; radiology; random; ue; up; upper extremity joint,Doc
37431-4,ct wrist - left,ct wrist-l,,arm; carpal bone; carpal bones; carpal bones and joint; cat scan; computed tomography; computerized tomography; ct scan; document; ext; extr-l; finding; findings; imaging; l; lt; lue; point in time; rad; radiology; random; ue; ue-l; up; upper extremity joint; wrist-l,Doc
3744-0,meperidine [presence] in serum or plasma,meperidine serpl ql,meperidine ql,addiction; algil; alodan; centralgine; demerol; dispadol; dolantin; dolosal; drug/toxicology; drugs; drugs of abuse; illicit; ordinal; pethidine; pl; plasma; plsm; point in time; potentialforabuse; pr; ql; qual; qualitative; random; screen; serp; serpl; serplas; serum; serum or plasma; sr,Ord
37444-7,mr wrist arthrogram,mr wrist w contr is,,arm; arthrogram; arthrography; c; carpal bone; carpal bones; carpal bones and joint; contr; contra; contrst; document; ext; finding; findings; imaging; intraarticular; intrasynovial; mitral regurgitation maximum velocity; mri; point in time; rad; radiology; random; ue; up; upper extremity joint; w contr is; wc,Doc
37451-2,mr wrist - left w contrast iv,mr wrist-l w contr iv,,arm; c; carpal bone; carpal bones; carpal bones and joint; contr; contra; contrst; document; ext; extr-l; finding; findings; imaging; l; lt; lue; mitral regurgitation maximum velocity; mri; point in time; rad; radiology; random; ue; ue-l; up; upper extremity joint; w contr iv; wc; wrist-l,Doc
37471-0,xr hand - bilateral bora,xr hand-bl bora,,1v; arm; bil; bilat; both; document; ext; extr-bl; film; finding; findings; hand-bl; hands; imaging; msk; musculoskeletal; ortho; orthopedics; plain films; point in time; rad; radiology; random; single view; ue; ue-bl; up; upper extremity; vw; xray; x-ray,Doc
37485-0,xr humerus ap and transthoracic,xr humerus ap+transthoracic,,anterio-posterior; anteroposterior; ap+transthoracic; arm; document; ext; films; finding; findings; imaging; plain films; point in time; rad; radiology; random; ue; up; upper arm; upper extremity; view; views & ap kub; views (ap; views+ap; vws; xray; x-ray,Doc
37486-8,xr ankle broden views w manual stress,xr ankle views broden w man stress,,document; ext; films; finding; findings; imaging; le; leg; low; lower extremity joint; msk; musculoskeletal; ortho; orthopedics; plain films; point in time; rad; radiology; random; view; vws; w man stress; w stress); xray; x-ray,Doc
37490-0,rfa vertebral artery - left views w contrast ia,rfa va-l views w contr ia,,art; arteriogram; brain; c; cardio; cardiology; contr; contra; contrst; cranial; cranium; document; films; finding; findings; fluor; fluoro; fluoroscopy; heart disease; imaging; intracranial; l; lt; point in time; rad; radiology; random; rfa; skull; va; va-l; view; vws; w contr ia; wc,Doc
37498-3,cta head vessels and neck vessels w contrast iv,cta head+neck ves w contr iv,,ang; angio; angiography; angm; brain; c; cardio; cardiology; cat scan; computed tomography; computerized tomography; contr; contra; contrst; cranial; cranium; ct angiogram; ct angiography; ct scan; cta; document; finding; findings; head+neck ves; heart disease; imaging; intracranial; neuro; neurology; point in time; rad; radiology; random; skull; vesl; vessels.xxx; w contr iv; wc,Doc
37517-0,xr finger fifth - bilateral views,xr finger.5th-bl views,,5th; arm; bil; bilat; both; document; ext; extr-bl; films; finding; findings; finger.5th-bl; finger-bl; imaging; msk; musculoskeletal; ortho; orthopedics; plain films; point in time; rad; radiology; random; ue; ue-bl; up; view; vws; xray; x-ray,Doc
37518-8,xr finger fifth - left views,xr finger.5th-l views,,5th; arm; document; ext; extr-l; films; finding; findings; finger.5th-l; finger-l; imaging; l; lt; lue; msk; musculoskeletal; ortho; orthopedics; plain films; point in time; rad; radiology; random; ue; ue-l; up; view; vws; xray; x-ray,Doc
37519-6,xr finger fourth - bilateral views,xr finger.4th-bl views,,4th; arm; bil; bilat; both; document; ext; extr-bl; films; finding; findings; finger.4th-bl; finger-bl; imaging; msk; musculoskeletal; ortho; orthopedics; plain films; point in time; rad; radiology; random; ue; ue-bl; up; view; vws; xray; x-ray,Doc
37521-2,xr finger second - bilateral views,xr finger.2nd-bl views,,2nd; arm; bil; bilat; both; document; ext; extr-bl; films; finding; findings; finger.2nd-bl; finger-bl; imaging; msk; musculoskeletal; ortho; orthopedics; plain films; point in time; rad; radiology; random; ue; ue-bl; up; view; vws; xray; x-ray,Doc
37523-8,xr finger third - bilateral views,xr finger.3rd-bl views,,3rd; arm; bil; bilat; both; document; ext; extr-bl; films; finding; findings; finger.3rd-bl; finger-bl; imaging; msk; musculoskeletal; ortho; orthopedics; plain films; point in time; rad; radiology; random; ue; ue-bl; up; view; vws; xray; x-ray,Doc
37540-2,xr knee - bilateral holmblad views w standing,xr knee-bl views holmblad w stand,,bil; bilat; both; document; ext; extr-bl; films; finding; findings; imaging; kn; knee-bl; knees; le; le-bl; leg; low; lower extremity joint; msk; musculoskeletal; ortho; orthopedics; plain films; point in time; rad; radiology; random; stand); view; vws; wb; weight bearing; xray; x-ray,Doc
3755-6,meprobamate [mass/volume] in urine,meprobamate ur-mcnc,meprobamate (u) [mass/vol],addiction; carisoprodol metabolite; drug/toxicology; drugs; drugs of abuse; equanil; illicit; level; mass concentration; point in time; potentialforabuse; qnt; quan; quant; quantitative; random; ua; ur; urn,Qn
37560-0,xr knee views w manual stress,xr knee views w man stress,,document; ext; films; finding; findings; imaging; kn; le; leg; low; lower extremity joint; msk; musculoskeletal; ortho; orthopedics; plain films; point in time; rad; radiology; random; view; vws; w man stress; w stress); xray; x-ray,Doc
37567-5,rf colon views w contrast via colostomy,rf colon views w contr via colostomy,,abd; abd+pelvis; abdo; abdominal; c; contr; contra; contrst; document; films; finding; findings; fluor; fluoro; fluoroscopy; imaging; lgi; pelvic; point in time; rad; radiology; random; view; vws; w contr via colostomy; wc,Doc
37568-3,rf unspecified body region views w contrast via fistula,rf views w contr via fistula,,c; contr; contra; contrst; coreplaybook; document; films; finding; findings; fistulogram; fluor; fluoro; fluoroscopy; imaging; misc; miscellaneous; other; playbook; point in time; rad; radiology; random; spec; to be specified in another part of the message; unspecified; view; vws; w contr via fistula; wc,Doc
3758-0,mersalyl [mass/time] in 24 hour urine,mersalyl 24h ur-mrate,mersalyl (24h u) [mass/time],1 day; 24 hours; 24hr; drug/toxicology; drugs; mass rate; mrate; qnt; quan; quant; quantitative; ua; ur; urn,Qn
37616-0,xr pelvis single view,xr pelvis 1v,,1v; coreplaybook; document; film; finding; findings; imaging; pelvic; plain films; playbook; point in time; rad; radiology; random; single view; vw; xray; x-ray,Doc
37621-0,xr pelvis ap and oblique,xr pelvis ap+obl,,anterio-posterior; anteroposterior; ap+obl; document; films; finding; findings; imaging; obl; pelvic; plain films; point in time; rad; radiology; random; view; views & ap kub; views (ap; views+ap; vws; xray; x-ray,Doc
37636-8,xr abdomen views,xr abd views,,abd; abdo; abdomen+; abdominal; document; films; finding; findings; imaging; plain films; point in time; rad; radiology; random; view; vws; xray; x-ray,Doc
37640-0,rfa renal vessels views w contrast,rfa renal ves views w contr,,abd; abdo; abdomen+; abdominal; c; cardio; cardiology; contr; contra; contrst; document; films; finding; findings; fluor; fluoro; fluoroscopy; heart disease; imaging; kidney; point in time; rad; radiology; random; rfa; vesl; vessels.xxx; view; vws; wc,Doc
3764-8,metandienone [presence] in urine,metandienone ur ql,metandienone ql (u),averbol; danabol; dbol; dianabol; drug/toxicology; drugs; metaboline; methandienone; methandrostenolone; ordinal; point in time; pr; ql; qual; qualitative; random; screen; ua; ur; urn,Ord
37650-9,xr sacroiliac joint ferguson,xr sij ferguson,,1v; document; film; finding; findings; imaging; jnt; pelvic; plain films; point in time; rad; radiology; random; sac; si joint; si joints; sij; single view; vw; xray; x-ray,Doc
3765-5,metandienone [mass/volume] in urine,metandienone ur-mcnc,metandienone (u) [mass/vol],averbol; danabol; dbol; dianabol; drug/toxicology; drugs; level; mass concentration; metaboline; methandienone; methandrostenolone; point in time; qnt; quan; quant; quantitative; random; ua; ur; urn,Qn
37658-2,xr thoracic and lumbar spine 2 views for scoliosis,xr t+l-spine 2v for scoli,,2v; 2v for scoli; 2vw; abd; abdo; abdomen+; abdominal; cxr; document; dorsal spine; films; finding; findings; ii; imaging; l/sp; l-spine; lumbar; lumbo; plain films; point in time; rad; radiology; random; spinal; spinal cord; t spine+ab; t+l-spine; th/sp; thorax; t-spine; view; vws; xray; x-ray,Doc
3766-3,metandienone [mass/time] in 24 hour urine,metandienone 24h ur-mrate,metandienone (24h u) [mass/time],1 day; 24 hours; 24hr; averbol; danabol; dbol; dianabol; drug/toxicology; drugs; mass rate; metaboline; methandienone; methandrostenolone; mrate; qnt; quan; quant; quantitative; ua; ur; urn,Qn
37685-5,xr elbow - right ap and lateral and oblique,xr elbow-r ap+lat+obl,,anterio-posterior; anteroposterior; ap+lat; ap+lat+obl; arm; document; elbow-r; ext; extr-r; films; finding; findings; imaging; lat; msk; musculoskeletal; obl; olecranon; ortho; orthopedics; plain films; point in time; r; rad; radiology; random; rt; rue; ue; ue-r; up; upper extremity joint; view; views & ap kub; views (ap; views ap kub & lateral; views+ap; vws; xray; x-ray,Doc
37704-4,xr foot - right oblique,xr foot-r obl,,1v; document; ext; extr-r; film; finding; findings; foot-r; ft; imaging; le; leg; le-r; low; lower extremity; msk; musculoskeletal; obl; ortho; orthopedics; plain films; point in time; r; rad; radiology; random; rle; rt; single view; vw; xray; x-ray,Doc
37717-6,xr tomography hand - right,xr tomo hand-r,,arm; document; ext; extr-r; finding; findings; hand-r; imaging; msk; musculoskeletal; ortho; orthopedics; plain films; point in time; r; rad; radiology; random; rt; rue; ue; ue-r; up; upper extremity; xr tomo; xray; x-ray,Doc
37733-3,xr lower extremity - right ap w standing,xr le-r ap w stand,,1v; anterio-posterior; anteroposterior; document; ext; extr-r; film; finding; findings; imaging; le; leg; le-r; low; plain films; point in time; r; rad; radiology; random; rle; rt; single view; stand); vw; wb; weight bearing; xray; x-ray,Doc
37734-1,xr lower extremity - right single view w standing,xr le-r 1v w stand,,1v; document; ext; extr-r; film; finding; findings; imaging; le; leg; le-r; low; plain films; point in time; r; rad; radiology; random; rle; rt; single view; stand); vw; wb; weight bearing; xray; x-ray,Doc
37735-8,xr tomography hip - right,xr tomo hip-r,,document; ext; extr-r; finding; findings; hip-r; imaging; le; leg; le-r; low; lower extremity joint; msk; musculoskeletal; ortho; orthopedics; plain films; point in time; r; rad; radiology; random; rle; rt; xr tomo; xray; x-ray,Doc
37736-6,xr humerus - right ap and lateral,xr humerus-r ap+lat,,anterio-posterior; anteroposterior; ap+lat; arm; document; ext; extr-r; films; finding; findings; humerus-r; imaging; lat; plain films; point in time; r; rad; radiology; random; rt; rue; ue; ue-r; up; upper extremity; view; views & ap kub; views (ap; views ap kub & lateral; views+ap; vws; xray; x-ray,Doc
37756-4,xr knee - right tunnel w standing,xr knee-r tunnel w stand,,1v; document; ext; extr-r; film; finding; findings; imaging; kn; knee-r; le; leg; le-r; low; lower extremity joint; msk; musculoskeletal; ortho; orthopedics; plain films; point in time; r; rad; radiology; random; rle; rt; single view; stand); vw; wb; weight bearing; xray; x-ray,Doc
37759-8,xr knee - right sunrise and tunnel,xr knee-r sunrise+tunnel,,document; ext; extr-r; films; finding; findings; imaging; kn; knee-r; le; leg; le-r; low; lower extremity joint; msk; musculoskeletal; ortho; orthopedics; plain films; point in time; r; rad; radiology; random; rle; rt; settegast; skyline; sunrise+tunnel; tangential; view; views+sunrise; vws; xray; x-ray,Doc
37762-2,xr knee - right 2 views w standing,xr knee-r 2v w stand,,2v; 2vw; document; ext; extr-r; films; finding; findings; ii; imaging; kn; knee-r; le; leg; le-r; low; lower extremity joint; msk; musculoskeletal; ortho; orthopedics; plain films; point in time; r; rad; radiology; random; rle; rt; stand); view; vws; wb; weight bearing; xray; x-ray,Doc
37776-2,xr patella - right ap and lateral,xr patella-r ap+lat,,anterio-posterior; anteroposterior; ap+lat; document; ext; extr-r; films; finding; findings; imaging; lat; le; leg; le-r; low; patella-r; plain films; point in time; r; rad; radiology; random; rle; rt; view; views & ap kub; views (ap; views ap kub & lateral; views+ap; vws; xray; x-ray,Doc
37785-3,rf sacroiliac joint - right arthrogram,rf sij-r views w contr is,,arthrogram; arthrography; c; contr; contra; contrst; document; films; finding; findings; fluor; fluoro; fluoroscopy; imaging; intraarticular; intrasynovial; jnt; msk; musculoskeletal; ortho; orthopedics; pelvic; point in time; r; rad; radiology; random; rt; sac; si joint; si joints; sij; sij-r; view; vws; w contr is; wc,Doc
37788-7,xr scapula - right ap and lateral,xr scapula-r ap+lat,,anterio-posterior; anteroposterior; ap+lat; cxr; document; films; finding; findings; imaging; lat; plain films; point in time; r; rad; radiology; random; rt; scapula-r; thorax; upper extremity; view; views & ap kub; views (ap; views ap kub & lateral; views+ap; vws; xray; x-ray,Doc
3779-6,methamphetamine [presence] in urine,methamphet ur ql,methamphetamine ql (u),addiction; desoxyn; drug/toxicology; drugs; drugs of abuse; illicit; methamphet; ordinal; point in time; potentialforabuse; pr; ql; qual; qualitative; random; screen; ua; ur; urn,Ord
3780-4,methamphetamine [mass/volume] in urine,methamphet ur-mcnc,methamphetamine (u) [mass/vol],addiction; desoxyn; drug/toxicology; drugs; drugs of abuse; illicit; level; mass concentration; methamphet; point in time; potentialforabuse; qnt; quan; quant; quantitative; random; ua; ur; urn,Qn
37819-0,xr tomography temporomandibular joint - right,xr tomo tmj-r,,brain; cranial; cranium; document; finding; findings; imaging; intracranial; jnt; plain films; point in time; r; rad; radiology; random; rt; skull; tmj; tmj-r; xr tomo; xray; x-ray,Doc
37839-8,xr shoulder ap and lateral and axillary,xr should ap+lat+ax,,anterio-posterior; anteroposterior; ap+lat; ap+lat+ax; arm; document; ext; films; finding; findings; imaging; lat; msk; musculoskeletal; ortho; orthopedics; plain films; point in time; rad; radiology; random; ue; up; upper extremity joint; view; views & ap kub; views (ap; views ap kub & lateral; views+ap; vws; xray; x-ray,Doc
37850-5,xr tomography shoulder,xr tomo should,,arm; document; ext; finding; findings; imaging; msk; musculoskeletal; ortho; orthopedics; plain films; point in time; rad; radiology; random; ue; up; upper extremity joint; xr tomo; xray; x-ray,Doc
37851-3,xr sinuses single view,xr sinuses 1v,,1v; brain; cranial; cranium; document; film; finding; findings; imaging; intracranial; paranasal sinuses; plain films; point in time; rad; radiology; random; single view; sinus; skull; vw; xray; x-ray,Doc
37860-4,xr sinuses pa and lateral and caldwell and waters,xr sinuses pa+lat+caldwell+waters,,brain; cranial; cranium; document; films; finding; findings; imaging; intracranial; lat; pa+lat; pa+lat+caldwell+waters; paranasal sinuses; plain films; point in time; postero-anterior; rad; radiology; random; sinus; skull; view; views+pa; vws; wat; xray; x-ray,Doc
37869-5,xr skull lateral and towne,xr skull lat+towne,,brain; cranial; cranium; document; films; finding; findings; head; imaging; intracranial; lat; lat+towne; plain films; point in time; rad; radiology; random; skull; townes; view; vws; xray; x-ray,Doc
37870-3,xr skull towne,xr skull towne,,1v; brain; cranial; cranium; document; film; finding; findings; head; imaging; intracranial; plain films; point in time; rad; radiology; random; single view; skull; townes; vw; xray; x-ray,Doc
37874-5,xr tomography skull,xr tomo skull,,brain; cranial; cranium; document; finding; findings; head; imaging; intracranial; plain films; point in time; rad; radiology; random; skull; xr tomo; xray; x-ray,Doc
37878-6,xr spine lateral crosstable,xr spine lat xtable,,1v; cross table; document; film; finding; findings; imaging; lat; lat xtable; misc; miscellaneous; other; plain films; point in time; rad; radiology; random; single view; spec; spinal; spinal cord; to be specified in another part of the message; unspecified; vw; xray; x-ray; xtable,Doc
3787-9,methaqualone [mass/volume] in urine,methaqualone ur-mcnc,methaqualone (u) [mass/vol],addiction; drug/toxicology; drugs; drugs of abuse; illicit; level; mass concentration; methaqualon; point in time; potentialforabuse; qnt; quaalude; quan; quant; quantitative; random; ua; ur; urn,Qn
37887-7,rf guidance for fluid aspiration of pleural space,rf guided pl space pc fluid asp,,asp; document; finding; findings; fld; fluor; fluoro; fluoroscopy; guid; guide; guided; imaging; lung; pc fluid asp; perc; pl space; point in time; pulmonary; pulmonology; rad; radiology; random; respiratory; thoracentesis; thorax; thorocentesis,Doc
37896-8,xr tibia and fibula ap and lateral,xr tib+fib ap+lat,,anterio-posterior; anteroposterior; ap+lat; document; ext; films; finding; findings; imaging; lat; le; leg; low; lower leg; plain films; point in time; rad; radiology; random; tib+fib; view; views & ap kub; views (ap; views ap kub & lateral; views+ap; vws; xray; x-ray,Doc
37911-5,xr tomography thoracic spine,xr tomo t-spine,,cxr; document; dorsal spine; finding; findings; imaging; plain films; point in time; rad; radiology; random; spinal; spinal cord; th/sp; thorax; t-spine; xr tomo; xray; x-ray,Doc
3792-9,methotrexate [mass/volume] in cerebral spinal fluid,mtx csf-mcnc,methotrexate (csf) [mass/vol],amethoperin; amethopterin; cerebral spinal fluid; cerebrospinal fl; drug/toxicology; drugs; level; mass concentration; methotrexat; mtx; point in time; qnt; quan; quant; quantitative; random; spinal fl; spinal fld; spinal flu; spinal fluid,Qn
37930-5,xr wrist lateral,xr wrist lat,,1v; arm; carpal bone; carpal bones; carpal bones and joint; document; ext; film; finding; findings; imaging; lat; plain films; point in time; rad; radiology; random; single view; ue; up; upper extremity joint; vw; xray; x-ray,Doc
37962-8,xr ribs anterior and posterior - right views,xr ribs ant+post-r views,,cxr; document; films; finding; findings; imaging; plain films; point in time; r; rad; radiology; random; ribs ant; ribs ant+post-r; ribs ant-r; rt; thorax; view; vws; xray; x-ray,Doc
37965-1,xr sternoclavicular joint - right views,xr sc joint-r views,,cxr; document; films; finding; findings; imaging; jnt; plain films; point in time; r; rad; radiology; random; rt; sc joint; sc joint-r; scj; thorax; upper extremity joint; view; vws; xray; x-ray,Doc
37972-7,rfa superior mesenteric vein views w contrast iv,rfa sm v views w contr iv,,abd; abdo; abdomen+; abdominal; c; cardio; cardiology; contr; contra; contrst; document; films; finding; findings; fluor; fluoro; fluoroscopy; heart disease; imaging; point in time; rad; radiology; random; rfa; sm v; sma; ven; venogram; venography; venous; view; vws; w contr iv; wc,Doc
37992-5,neutrophil cytoplasmic ab.classic [units/volume] in serum by immunoassay,c-anca ser ia-acnc,neutrophil cytoplasmic ab.classic ia qn (s),acna; acpa; anca; arbitrary concentration; canca; c-anca; cytopl; cytoplas; cytoplasmic anca; eia; elfa; elisa; enzyme immunoassay; granulocyte ab; granulocyte nucleus ab; iaa; meia; neut; neutr; neutrophils; pmn; pnm; point in time; qnt; quan; quant; quantitative; random; serology; serum; sr; suds; vasculitis,Qn
38004-8,xr shoulder - left grashey views wo and w weight,xr should-l views grashey wo+w wt,,arm; document; ext; extr-l; films; finding; findings; glenhumeral; glenohumeral; glenoid fossa; imaging; l; lt; lue; msk; musculoskeletal; ortho; orthopedics; plain films; point in time; rad; radiology; random; should-l; true ap; ue; ue-l; up; upper extremity joint; view; vws; w wt; wb; wo & wc; wo+w wt; wt; wwo; xray; x-ray,Doc
38013-9,us lower extremity - bilateral,us le-bl,,bil; bilat; both; document; echography; ext; extr-bl; finding; findings; imaging; le; le-bl; leg; low; point in time; radiology; random; sonogram; sonograph; sonography; uls; ultrasound,Doc
38027-9,deprecated us guidance for needle biopsy of kidney - bilateral,deprecated us kdny-bl bx needle guide,,abd; abdo; abdomen+; abdominal; bil; bilat; both; bx; document; echography; finding; findings; guid; guide; guided; imaging; kdny-bl; kidney; kidneys; ndl; needle bx; nephric; nephrology; point in time; radiology; random; renal; sonogram; sonograph; sonography; uls; ultrasound,Doc
38029-5,deprecated us guidance for needle biopsy of chest,deprecated us chest bx needle guide,,bx; document; echography; finding; findings; guid; guide; guided; imaging; ndl; needle bx; point in time; radiology; random; sonogram; sonograph; sonography; thorax; uls; ultrasound,Doc
38033-7,us guidance for fine needle aspiration of breast - right,us guided brst-r fna,,asp; brst; brst-r; document; echography; finding; findings; fna; guid; guide; guided; gyn; gynecology; imaging; ndl; ob; obgyn; obstetrics; perc; point in time; r; radiology; random; rt; sonogram; sonograph; sonography; uls; ultrasound,Doc
38038-6,us kidney - left,us kidney-l,,abd; abdo; abdomen+; abdominal; document; echography; finding; findings; imaging; kidney; kidney-l; l; lt; nephric; nephrology; point in time; radiology; random; renal; sonogram; sonograph; sonography; uls; ultrasound,Doc
38039-4,us lower extremity - left limited,us le-l ltd,,document; echography; ext; extr-l; finding; findings; imaging; l; le; leg; le-l; lle; lmted; low; lt; ltd; point in time; radiology; random; sonogram; sonograph; sonography; uls; ultrasound,Doc
3804-2,methylephedrine [mass/volume] in urine,me-ephedrine ur-mcnc,methylephedrine (u) [mass/vol],addiction; drug/toxicology; drugs; drugs of abuse; illicit; ivilco; level; mass concentration; me-ephedrine; pholcomed; point in time; potentialforabuse; qnt; quan; quant; quantitative; random; tossamine plus; ua; ur; urn,Qn
38044-4,us mediastinum,us mediastinum,,cardio; cardiology; document; echography; finding; findings; heart disease; imaging; lung; point in time; pulmonary; pulmonology; radiology; random; respiratory; sonogram; sonograph; sonography; thorax; uls; ultrasound,Doc
38054-3,us visceral artery,us visceral a,,abd; abdo; abdomen+; abdominal; art; cardio; cardiology; document; echography; finding; findings; heart disease; imaging; point in time; radiology; random; sonogram; sonograph; sonography; uls; ultrasound,Doc
38068-3,xr chest right anterior oblique,xr chest r-ant obl,,1v; cardio; cardiology; cxr; document; film; finding; findings; heart disease; imaging; lung; obl; plain films; point in time; pulmonary; pulmonology; r prime; rad; radiology; random; r-ant obl; rao; respiratory; right; single view; thorax; vw; xray; x-ray,Doc
38079-0,mg breast specimen - bilateral views,mg brst spec-bl views,,bil; bilat; both; brst spec; brst spec-bl; document; films; finding; findings; imaging; point in time; rad; radiology; random; spec; view; vws,Doc
3810-9,methylphenidate [mass/time] in 24 hour urine,me-phenidate 24h ur-mrate,methylphenidate (24h u) [mass/time],1 day; 24 hours; 24hr; addiction; drug/toxicology; drugs; drugs of abuse; illicit; mass rate; me-phenidate; mrate; potentialforabuse; qnt; quan; quant; quantitative; ritalin; ua; ur; urn,Qn
38125-1,rf cervical and thoracic and lumbar spine limited views w contrast it,rf c+t+l-spine views ltd w contr it,,abd; abdo; abdomen+; abdominal; c; c/sp; c+t+l-spine; c+t-spine; cerv; contr; contra; contrst; c-spine; document; dorsal spine; films; finding; findings; fluor; fluoro; fluoroscopy; imaging; intrathecal; l/sp; lmted; l-spine; ltd; lumbar; lumbo; myelogram; point in time; rad; radiology; random; spinal; spinal cord; t spine+ab; t+l-spine; th/sp; thorax; t-spine; view; views ltd; vws; w contr it; wc,Doc
38133-5,us guidance for aspiration of cyst of pancreas,us guided pancreas cyst asp,,abd; abdo; abdomen+; abdominal; asp; cyst asp; document; echography; finding; findings; guid; guide; guided; imaging; pancr; pancreatc; pancreatic; perc; point in time; radiology; random; sonogram; sonograph; sonography; uls; ultrasound,Doc
3817-4,metoprolol [mass/volume] in urine,metoprolol ur-mcnc,metoprolol (u) [mass/vol],drug/toxicology; drugs; level; lo; lopressor; mass concentration; point in time; qnt; quan; quant; quantitative; random; ua; ur; urn,Qn
38176-4,kappa light chains.free [mass/volume] in urine,kappa lc free ur-mcnc,immunoglobulin light chains.kappa.free (u) [mass/vol],bence jones protein; bj protein; bjp; chain; chemistry; fr; hematology; heme; immune globulin; immuno; immunoglob; immunoglobin; imunoglbon; imunoglobn; kappa lc; kappa lc free; level; mass concentration; non-protein bound; point in time; qnt; quan; quant; quantitative; random; ua; ur; urn,Qn
38185-5,beta galactosidase [presence] in blood,b-galactosidase bld ql,beta galactosidase ql (bld),b; b-galactosidase; blood; chemistry; disaccharidase; gm 1-gangliosidosis; lactase; morquio disease type b; mps iv b; ordinal; point in time; pr; ql; qual; qualitative; random; screen; wb; whole blood,Ord
38191-3,ammonium urate/total in stone,amm urate mfr stone,ammonium urate (stone) [mass fraction],amm; amm urate; ammon; ammonium acid urate; ammonium biurate; calc; calculi; chemistry; mass fraction; nh4; nh4u; percent; point in time; qnt; quan; quant; quantitative; random; stn; stone; stones; tot; totl; ua; urates; uric acid,Qn
38217-6,pain severity legs flacc,pain severity legs flacc,,face legs activity cry consolability scale; finding; findings; h+p; h+p.hx; ordinal; p prime; pain severity legs; point in time; ql; qual; qualitative; random; screen,Ord
38244-0,brucella abortus igm ab [presence] in serum,b abortus igm ser ql,b. abortus igm ql (s),abort; abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; b abortus; bangs disease; bovine brucellosis; bruc; brucellosis; contagious abortion; id; immune globulin m; immunoglobulin m; infectious disease; infectiousdisease; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; sr; undulant fever,Ord
38253-1,"carbon dioxide, total [moles/volume] in specimen",co2 spec-scnc,co2 (specimen) [moles/vol],carbonic anhydride; cco2; chemistry; co2; co2 total; co2ct; ctco2; level; misc; miscellaneous; other; point in time; qnt; quan; quant; quantitative; random; spec; substance concentration; tco2; to be specified in another part of the message; unspecified,Qn
3828-1,morphine free [presence] in urine,morphine free ur ql,morphine free ql (u),c260; drug/toxicology; drugs; fr; morphine free; morphine sulfate; ms; mso4; non-protein bound; omph; ordinal; point in time; pr; ql; qual; qualitative; random; screen; ua; unconjugated morphine; ur; urn,Ord
38283-8,lymphocyte proliferation stimulated by 9.67 ug/ml tetanus toxoid [units/volume] in blood,lpt 9.67 ug/ml tt bld-acnc,lymphocyte proliferation stimulated by 9.67 ug/ml tetanus toxoid qn (bld),arbitrary concentration; blood; lpa; lpt; lpt 9.67 ug/ml tt; lst; lymphocyte antigen proliferation; lymphocyte antigen stimulation; mcg; microbiology; pha; point in time; qnt; quan; quant; quantitative; random; stim; wb; whole blood,Qn
38285-3,erythrocytes [presence] in duodenal fluid,rbc duod fl ql,rbc ql (duod fld),discocytes; dudf; duodenal fluid; erthrocyte; erythrocyte; hematology/cell counts; ordinal; point in time; pr; ql; qual; qualitative; random; rbc; rbcs; red blood cell; red blood cells; red blood corpuscle; red blood corpusles; red cell; red cells; screen,Ord
38290-3,"1,4-dichlorobenzene [mass/volume] in water","1,4dcb wat-mcnc","1,4-dichlorobenzene (water) [mass/vol]","1,4dcb; 3,3'-dichlorobenzidine; c6h4cl2; dcb; dichloricide; dichlorocide; drug/toxicology; drugs; evola; globol; i; level; mass concentration; para; para dichlorobenzene; paracide; paradow; paramoth; paranuggets; para-zene; p-chlorophenyl chloride; pdb; pdcb; p-dcb; p-dichlorobenzene; p-dichlorobenzol; persia-perazol; point in time; qnt; quan; quant; quantitative; random; santochlor; wat",Qn
3830-7,morphine [presence] in urine,morphine ur ql,morphine ql (u),addiction; c260; drug/toxicology; drugs; drugs of abuse; illicit; morphine sulfate; ms; mso4; omph; ordinal; point in time; potentialforabuse; pr; ql; qual; qualitative; random; screen; ua; universallaborders; ur; urn,Ord
38326-5,pentachlorophenol [mass/volume] in water,pentachlorophen wat-mcnc,pentachlorophenol (water) [mass/vol],drug/toxicology; drugs; level; mass concentration; pcp; penta; point in time; qnt; quan; quant; quantitative; random; wat,Qn
38336-4,ethyl benzene [mass/volume] in water,ethyl benzene wat-mcnc,ethyl benzene (water) [mass/vol],cyclohexatriene; drug/toxicology; drugs; ethylbenzene; ethylbenzol; level; mass concentration; phenylethane; point in time; qnt; quan; quant; quantitative; random; wat,Qn
38356-2,thyroxine (t4) ab [presence] in serum,t4 ab ser ql,t4 ab ql (s),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; levothyroxine; levo-thyroxine; l-thyroxine; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serology; serum; sr; t4; t-4; thyroid hormone; thyrox; thyroxin; thyrx; total t4; tt4,Ord
38361-2,epidermal allergen mix 71 (chicken feather+duck feather+goose feather+turkey feather) igg ab [mass/volume] in serum by multidisk,epid allerg mix71 igg-mcnc,chicken feather+duck feather+goose feather+turkey feather igg multidisk (s) [mass/vol],abs; aby; allergen; allergens; allergy testing; allerscan; antby; anti; antibodies; antibody; autoantibodies; autoantibody; dander; e070; e085; e086; e70; e85; e86; e89; ep71; epid allerg mix a; epid allerg mix71; ex71; f083; f158; f83; feather mix; feathers; gallus spp; immune globulin g; immunoglobulin g; level; mass concentration; meleagis gallopavo; point in time; qnt; quan; quant; quantitative; random; serum; sr,Qn
38365-3,hexadecadienoate (c16:2)/creatinine [mass ratio] in urine,hexadecadienoate/creat ur,hexadecadienoate (c16:2)/creatinine (u) [mass ratio],c16:2; chemistry; cr; crea; creat; hexadecadienoic acid; mass concentration ratio; mass ratio; mcrto; point in time; qnt; quan; quant; quantitative; random; ua; ucr; ur; urn,Qn
38370-3,voriconazole [mass/volume] in serum or plasma,voriconazole serpl-mcnc,voriconazole [mass/vol],drug/toxicology; drugs; level; mass concentration; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; universallaborders; vfend,Qn
38376-0,cryptococcus sp identified in specimen by organism specific culture,cryptoc spec cult,cryptococcus sp identified org specific cx nom (specimen),c&s; crypt; crypto; cryptococcal; cryptococcosis; cryptococcosus; cult; cultures; id; identity or presence; infectious disease; infectiousdisease; microbiology; misc; miscellaneous; nominal; other; point in time; random; spec; species; spp; to be specified in another part of the message; unspecified,Nom
38393-5,legionella sp identified in pleural fluid by organism specific culture,legionella plr cult,legionella sp identified org specific cx nom (pleur fld),c&s; cult; cultures; id; identity or presence; infectious disease; infectiousdisease; legion; legionela; lung; microbiology; nominal; pleural; pleural fluid; point in time; pulmonary; pulmonology; random; respiratory; spec; species; spp; thoracentesis fluid,Nom
38427-1,thiocyanate [mass/time] in 24 hour urine,thiocyanate 24h ur-mrate,thiocyanate (24h u) [mass/time],1 day; 24 hours; 24hr; drug/toxicology; drugs; mass rate; mrate; qnt; quan; quant; quantitative; ua; ur; urn,Qn
38428-9,ibuprofen [mass/volume] in serum or plasma --pre dose,ibuprofen pre dose serpl-mcnc,ibuprofen pre dose [mass/vol],advil; before; c20; c235; c286; c53; drug/toxicology; drugs; level; mass concentration; motrin; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
38431-3,ibuprofen [mass/volume] in serum or plasma --1.5 hours post dose,ibuprofen 1.5h p serpl-mcnc,ibuprofen 1.5 hr post dose [mass/vol],1 1/2 hours; 1 1/2 hr; 1.5hr; 90 min; 90 minutes; 90m; 90min; advil; after; c20; c235; c286; c53; drug/toxicology; drugs; level; mass concentration; motrin; p dose; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
38436-2,colony count [#/mass] in specimen by visual count,cc spec #/mass vc,colony count visual count (specimen) [#/mass],cc; colonies; count/mass; id; infectious disease; infectiousdisease; microbiology; misc; miscellaneous; number content; other; point in time; qnt; quan; quant; quantitative; random; spec; to be specified in another part of the message; unspecified; visual count,Qn
38442-0,bilirubin crystals [#/area] in urine sediment by microscopy low power field,bilirub cry #/area urns lpf,bilirubin crystals lm.lpf (urine sed) [#/area],#/area; bili; bilirub cry; bilirubins; billirubin; crys; cryst; crystal; kidney; lm; micro; micros; microscopic; nephrology; number areic; point in time; qnt; quan; quant; quantitative; random; renal; tbil; ua; ur; urinalysis; urine sediment; urn; urns,Qn
38453-7,cftr gene c.3659delc [presence] in blood or tissue by molecular genetics method,cftr c.3659delc bld/t ql,cftr gene c.3659delc molgen ql (bld/tiss),"3659delc; abc35; abcc7; blood; cbavd; cf; cfa; cftr c.3659delc; cftr/mrp; cystic fibrosis transmembrane conductance regulator; cystic fibrosis transmembrane conductance regulator (atp-binding cassette sub-family c, member 7); dj760c5.1; genetics; heredity; heritable; inherited; molecular genetics; molecular pathology; molpath; molpath.mutations; mrp7; ordinal; pcr; point in time; pr; ql; qual; qualitative; random; screen; tissue; tissue, unspecified; tnr-cftr; wb; whole blood; whole blood or tissue",Ord
38461-0,legionella sp ag [presence] in pleural fluid by immunofluorescence,legionella ag plr ql if,legionella sp ag if ql (pleur fld),acif; anticomplement immunofluorescence; antigen; antigens; dfa; fa; fluorescent antibody; fluoresent; id; ifa; immune fluorescence; immunoflour; immunofluor; immunofluorescence; infectious disease; infectiousdisease; legion; legionela; lung; microbiology; ordinal; pleural; pleural fluid; point in time; pr; pulmonary; pulmonology; ql; qual; qualitative; random; respiratory; screen; species; spp; thoracentesis fluid; time resolved fluorescence; trf,Ord
38475-0,acid alpha glucosidase [enzymatic activity/volume] in serum or plasma,acid a-glucosidase serpl-ccnc,acid alpha glucosidase [catalytic activity/vol],"acd; acid a-glucosidase; acid maltase; acids; alfa; alpha galactosidase; alpha-1,4-glucosidase; catalytic concentration; chemistry; gaa; glucoinvertase; glucosidosucrase; maltase; maltase-glucoamylase; pl; plasma; plsm; point in time; pompe disease; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr",Qn
38482-6,creatine kinase.mb [presence] in serum or plasma,ck mb serpl ql,ck.mb ql,cardio; cardiology; chemistry; ck; ck 2; ck mb; ck-2; ckmb; ck-mb; cpk; creatine phosphokinase; heart disease; ordinal; pl; plasma; plsm; point in time; pr; ql; qual; qualitative; random; screen; serp; serpl; serplas; serum; serum or plasma; sr,Ord
38485-9,galactose 1 phosphate [moles/mass] in red blood cells,gal1po4 rbc-scnt,galactose 1 phosphate (rbc) [moles/mass],cerebrose; chemistry; erythrocytes; gal-1-p; gal1po4; gal-1-po4; i; i phos; inorganic phosphate; phos; phosphate total; phosphorous; phosphorus; phosphrous; pi; po4; point in time; qnt; quan; quant; quantitative; random; red blood cells; red blood corpusles; substance content,Qn
38498-2,spermatozoa nonviable/spermatozoa in semen,sperm nonvialbe nfr smn,spermatozoa nonviable/spermatozoa (sem),ejaculate; fertility testing; genitourinary; gu; number fraction; percent; point in time; qnt; quan; quant; quantitative; random; sem; seminal fluid; smn; smpls; sperm; sperm nonvialbe; uro; urology,Qn
38501-3,spermatozoa progressive grade 2/spermatozoa in semen,sperm prog 2 nfr smn,spermatozoa progressive grade 2/spermatozoa (sem),ejaculate; fertility testing; genitourinary; gu; ii; number fraction; percent; point in time; qnt; quan; quant; quantitative; random; sem; seminal fluid; smn; smpls; sperm; sperm prog; sperm prog 2; uro; urology,Qn
38541-9,spermatozoa motile [presence] in semen --pre washing,sperm motile pre wash smn ql,spermatozoa motile pre washing ql (sem),before; ejaculate; fertility testing; genitourinary; gu; mot; ordinal; point in time; pr; ql; qual; qualitative; random; screen; sem; seminal fluid; smn; smpls; sperm; sperm motile; sperm motility grade; uro; urology,Ord
38553-4,narcolepsy associated ag [presence] in serum or plasma,narcolepsy assoc ag serpl ql,narcolepsy associated ag ql,antigen; antigens; assoc; ordinal; pl; plasma; plsm; point in time; pr; ql; qual; qualitative; random; screen; serology; serp; serpl; serplas; serum; serum or plasma; sr,Ord
38560-9,spermatozoa.tail motile w iga/spermatozoa in semen by immunobead,sperm.tail w iga nfr smn ibt,spermatozoa.tail motile w iga/spermatozoa immunobead (sem),ejaculate; fertility testing; genitourinary; gu; iba; ibt; immune globulin a; immunoglobulin a; mot; number fraction; percent; point in time; qnt; quan; quant; quantitative; random; sem; seminal fluid; smn; smpls; sperm; sperm tail; sperm.tail w iga; uro; urology,Qn
38561-7,spermatozoa.tail motile w igg/spermatozoa in semen by immunobead,sperm.tail w igg nfr smn ibt,spermatozoa.tail motile w igg/spermatozoa immunobead (sem),ejaculate; fertility testing; genitourinary; gu; iba; ibt; immune globulin g; immunoglobulin g; mot; number fraction; percent; point in time; qnt; quan; quant; quantitative; random; sem; seminal fluid; smn; smpls; sperm; sperm tail; sperm.tail w igg; uro; urology,Qn
38574-0,beryllium [mass/volume] in air,beryllium air-mcnc,beryllium (air) [mass/vol],be; berylliosis; drug/toxicology; drugs; level; mass concentration; point in time; qnt; quan; quant; quantitative; random,Qn
38577-3,carbon disulfide [mass/volume] in air,carbon dis air-mcnc,carbon disulfide (air) [mass/vol],cs2; drug/toxicology; drugs; level; mass concentration; point in time; qnt; quan; quant; quantitative; random,Qn
38578-1,carbon tetrachloride [mass/volume] in air,carbon tet air-mcnc,carbon tetrachloride (air) [mass/vol],ccl4; drug/toxicology; drugs; level; mass concentration; point in time; qnt; quan; quant; quantitative; random; tetrachloromethane,Qn
38583-1,"1,2-dibromo-3-chloropropane [mass/volume] in air",dbcp air-mcnc,"1,2-dibromo-3-chloropropane (air) [mass/vol]","1,2-dibromo-3-cloropropano; dbcp; dibromochloropropane; drug/toxicology; drugs; i; ii; iii; level; mass concentration; point in time; qnt; quan; quant; quantitative; random",Qn
38594-8,epichlorohydrin [mass/volume] in air,epichlorohydrin air-mcnc,epichlorohydrin (air) [mass/vol],"1-chloro-2,3-epoxypropane; allyl chloride oxide; c3h5clo; chloro-1,2-epoxypropane; chloropropyl epoxide; chloropropylene; drug/toxicology; drugs; ech; epi; epichlorhydrin; epoxy-3-chloropropane; glycidyl chloride; level; mass concentration; oxirane, 2-(chloromethyl)-; point in time; propylene oxide; qnt; quan; quant; quantitative; random",Qn
38598-9,hexachlorobenzene [mass/volume] in air,hcb air-mcnc,hexachlorobenzene (air) [mass/vol],drug/toxicology; drugs; hcb; hexa cb; level; mass concentration; pentachlorophenyl; perchlorobenzene; phenyl perchloryl; point in time; qnt; quan; quant; quantitative; random,Qn
38608-6,methyl bromide [mass/volume] in air,me- bromide air-mcnc,methyl bromide (air) [mass/vol],br; ch3br; drug/toxicology; drugs; level; mass concentration; me- bromide; mebr; point in time; qnt; quan; quant; quantitative; random,Qn
38609-4,methyl tert-butyl ether [mass/volume] in air,mtbe air-mcnc,methyl tert-butyl ether (air) [mass/vol],2-methoxy-2-methylpropane; butyl methyl ether; drug/toxicology; drugs; level; mass concentration; methyl tertiary butyl ether; mtbe; point in time; qnt; quan; quant; quantitative; random; tbme; t-butyl methyl ether; tert-butyl methyl ether,Qn
38613-6,parathion [mass/volume] in air,parathion air-mcnc,parathion (air) [mass/vol],diethyl parathion; drug/toxicology; drugs; ethyl parathion; folidol; level; mass concentration; point in time; qnt; quan; quant; quantitative; random; thiophos,Qn
38620-1,tetrachloroethylene [mass/volume] in air,ttce air-mcnc,tetrachloroethylene (air) [mass/vol],drug/toxicology; drugs; level; mass concentration; perchloroethylene; point in time; qnt; quan; quant; quantitative; random; tetrachloroethene; ttce,Qn
38631-8,allyl chloride [mass/volume] in air,allyl chloride air-mcnc,allyl chloride (air) [mass/vol],3-chloroprene; 3-chloropropene; 3-chloropropylene; alpha-chloropropylene; chlorallylene; chloro-2-propene; cl; cl-; drug/toxicology; drugs; level; mass concentration; point in time; qnt; quan; quant; quantitative; random,Qn
38641-7,ethyl bromide [mass/volume] in air,ethyl bromide air-mcnc,ethyl bromide (air) [mass/vol],br; bromic ether; bromoethane; drug/toxicology; drugs; halon 2001; level; mass concentration; point in time; qnt; quan; quant; quantitative; random,Qn
38656-5,chlorobenzilate [mass/volume] in air,chlorobenzilate air-mcnc,chlorobenzilate (air) [mass/vol],drug/toxicology; drugs; level; mass concentration; point in time; qnt; quan; quant; quantitative; random,Qn
38666-4,diethylsulfate [mass/volume] in air,diethylsulfate air-mcnc,diethylsulfate (air) [mass/vol],diethyl ester sulfuric acid; diethyl sulphate; diethyl tetraoxosulfate; diethylsulfic acid; drug/toxicology; drugs; ds; level; mass concentration; point in time; qnt; quan; quant; quantitative; random,Qn
38684-7,sperm tail tip igm ab/spermatozoa in specimen by immunobead,sperm tail tip igm nfr spec ibt,sperm tail tip igm/spermatozoa immunobead (specimen),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; fertility testing; genitourinary; gu; iba; ibt; immune globulin m; immunoglobulin m; misc; miscellaneous; number fraction; other; percent; point in time; qnt; quan; quant; quantitative; random; spec; sperm; sperm tail; sperm tail tip; tail endpiece; to be specified in another part of the message; unspecified; uro; urology,Qn
38688-8,"1,1-dimethylhydrazine [mass/volume] in air",dmh air-mcnc,"1,1-dimethylhydrazine (air) [mass/vol]","asymmetric dimethylhydrazine; dimazin; dimazine; dmh; drug/toxicology; drugs; i; level; mass concentration; n,n-dimethylhydrazine; point in time; qnt; quan; quant; quantitative; random; udmh; unsymmetrical dimethylhydrazine",Qn
3870-3,norpropoxyphene [presence] in serum or plasma,norpropoxyph serpl ql,norpropoxyphene ql,drug/toxicology; drugs; n-desmethylproproxyphene; norpropoxyp; ordinal; pl; plasma; plsm; point in time; pr; propoxyphene metabolite; ql; qual; qualitative; random; screen; serp; serpl; serplas; serum; serum or plasma; sr,Ord
38706-8,chloromethane [mass/volume] in air,chloromethane air-mcnc,chloromethane (air) [mass/vol],drug/toxicology; drugs; level; mass concentration; methyl chloride; monochloromethane; point in time; qnt; quan; quant; quantitative; random,Qn
387-1,oxytetracycline [susceptibility] by minimum inhibitory concentration (mic),oxytetracycline islt mic,oxytetracycline mic [susc],antibiotic susceptibilities; ast; berkmycen; clinimycin; glomicin; hydroxytetracycline; id; imperacon; infectious disease; infectiousdisease; islt; isol; minimum inhibitory concentration; oxymicin; oxytetramix; point in time; random; riomitsin; sus; suscept; susceptibilities; susceptibility; susceptibilty; terramicina; terramycin; terramycine; terravenos,OrdQn
38719-1,"1,3-propane sultone [mass/volume] in air","1,3-ps air-mcnc","1,3-propane sultone (air) [mass/vol]","1,2-oxathiolane, 2,2-dioxide; 1,2-oxathrolane 2,2-dioxide; 1,3-ps; 1-propanesulfonic acid-3-hydroxy-gamma-sultone; 3-hydroxy-1-propanesulphonic acid sulfone; 3-hydroxy-1-propanesulphonic acid sultone; 3-hydroxythietane-1,1-dioxide; drug/toxicology; drugs; gamma-propane sultone; i; iii; level; mass concentration; point in time; ps; qnt; quan; quant; quantitative; random",Qn
38725-8,"styrene-7,8-oxide [mass/volume] in air","styrene-7,8-oxide air-mcnc","styrene-7,8-oxide (air) [mass/vol]","1,2-epoxyethylbenzene; 1-phenyl-1,2-epoxyethane; 2-phenyloxirane; alpha,beta-epoxystyrene; drug/toxicology; drugs; epoxyethylbenzene; epoxystyrene; level; mass concentration; phenethylene oxide; phenylethylene oxide; phenyloxirane; point in time; qnt; quan; quant; quantitative; random; styrene epoxide; styrene oxide; styryl oxide",Qn
38727-4,"2,4 toluenediamine [mass/volume] in air","2,4toluenediam air-mcnc","2,4 toluenediamine (air) [mass/vol]","1,3-diamino-4-methylbenzene; 2,4-diamino-1-methylbenzene; 2,4-diaminotoluene; 2,4-toluene diamine; 2,4toluenediam; 3-amino-p-toluidine; 5-amino-o-toluidine; diaminotoluene; drug/toxicology; drugs; ii; level; mass concentration; point in time; qnt; quan; quant; quantitative; random; tda; toluene-2,4-diamine",Qn
38730-8,"2,4,6-trichlorophenol [mass/volume] in air","2,4,6-tcp air-mcnc","2,4,6-trichlorophenol (air) [mass/vol]","2,4,6-t; 2,4,6-tcp; drug/toxicology; drugs; ii; level; mass concentration; point in time; qnt; quan; quant; quantitative; random; tcp",Qn
38731-6,triethylamine [mass/volume] in air,triethylamine air-mcnc,triethylamine (air) [mass/vol],"drug/toxicology; drugs; level; mass concentration; n,n-diethylethanamine; point in time; qnt; quan; quant; quantitative; random; tea; ten",Qn
38734-0,vinyl bromide [mass/volume] in air,vinyl bromide air-mcnc,vinyl bromide (air) [mass/vol],br; bromoethene; bromoethylene; drug/toxicology; drugs; level; mass concentration; monobromoethylene; point in time; qnt; quan; quant; quantitative; random,Qn
38744-9,hydrogen fluoride [mass/volume] in air,hydrogen fluoride air-mcnc,hydrogen fluoride (air) [mass/vol],drug/toxicology; drugs; fl; fluorhydric acid; h2; hf; hyd; hydrofluoric acid; level; mass concentration; point in time; qnt; quan; quant; quantitative; random,Qn
38747-2,methyl isocyanate [mass/volume] in air,methyl isocyanate air-mcnc,methyl isocyanate (air) [mass/vol],drug/toxicology; drugs; isocyanatomethane; level; mass concentration; methylcarbylamine; mic; point in time; qnt; quan; quant; quantitative; random,Qn
38755-5,dimethylbenzene [mass/volume] in air,dmb air-mcnc,dimethylbenzene (air) [mass/vol],dmb; drug/toxicology; drugs; level; mass concentration; point in time; qnt; quan; quant; quantitative; random; xylene; xylol,Qn
38759-7,aluminum [mass/volume] in air,aluminum air-mcnc,aluminum (air) [mass/vol],al; aluminium; drug/toxicology; drugs; level; mass concentration; point in time; qnt; quan; quant; quantitative; random,Qn
38769-6,mr lower extremity joint - right limited wo contrast,mr le joint-r ltd wo contr,,c; contr; contra; contrst; document; ext; extr-r; finding; findings; imaging; jnt; le; le joint-r; leg; le-r; lmted; low; ltd; mitral regurgitation maximum velocity; mri; point in time; r; rad; radiology; random; rle; rt; without contrast,Doc
38775-3,xr hand - right brewerton,xr hand-r brewerton,,1v; arm; document; ext; extr-r; film; finding; findings; hand-r; imaging; msk; musculoskeletal; ortho; orthopedics; plain films; point in time; r; rad; radiology; random; rt; rue; single view; ue; ue-r; up; upper extremity; vw; xray; x-ray,Doc
38780-3,xr shoulder - right velpeau axillary,xr should-r velpeau ax,,1v; arm; document; ext; extr-r; film; finding; findings; imaging; msk; musculoskeletal; ortho; orthopedics; plain films; point in time; r; rad; radiology; random; rt; rue; should-r; single view; ue; ue-r; up; upper extremity joint; vw; xray; x-ray,Doc
38782-9,xr shoulder - right ap and axillary and outlet and zanca,xr should-r ap+ax+outlet+zanca,,anterio-posterior; anteroposterior; ap+ax; ap+ax+outlet; ap+ax+outlet+zanca; arm; document; ext; extr-r; films; finding; findings; imaging; msk; musculoskeletal; ortho; orthopedics; plain films; point in time; r; rad; radiology; random; rt; rue; should-r; supraspinatus; ue; ue-r; up; upper extremity joint; view; views & ap kub; views (ap; views+ap; vws; xray; x-ray,Doc
38783-7,xr shoulder - right ap and axillary and y,xr should-r ap+ax+y,,anterio-posterior; anteroposterior; ap+ax; ap+ax+y; arm; document; ext; extr-r; films; finding; findings; imaging; msk; musculoskeletal; ortho; orthopedics; plain films; point in time; r; rad; radiology; random; rt; rue; should-r; ue; ue-r; up; upper extremity joint; view; views & ap kub; views (ap; views+ap; vws; xray; x-ray,Doc
38790-2,xr patella - right pa and lateral and sunrise,xr patella-r pa+lat+sunrise,,document; ext; extr-r; films; finding; findings; imaging; lat; le; leg; le-r; low; pa+lat; pa+lat+sunrise; patella-r; plain films; point in time; postero-anterior; r; rad; radiology; random; rle; rt; settegast; skyline; tangential; view; views+pa; vws; xray; x-ray,Doc
38797-7,xr humerus bicipital groove - right views,xr humerus bicipital groove-r views,,arm; bicepital groove; document; ext; extr-r; films; finding; findings; humerus bicipital groove-r; humerus-r; imaging; plain films; point in time; r; rad; radiology; random; rt; rue; ue; ue-r; up; upper extremity; view; vws; xray; x-ray,Doc
38798-5,xr olecranon - right views,xr olecranon-r views,,arm; document; ext; extr-r; films; finding; findings; imaging; olecranon-r; plain films; point in time; r; rad; radiology; random; rt; rue; ue; ue-r; up; view; vws; xray; x-ray,Doc
38802-5,ct wrist - right wo and w contrast iv,ct wrist-r wo+w contr iv,,arm; c; carpal bone; carpal bones; carpal bones and joint; cat scan; computed tomography; computerized tomography; contr; contra; contrst; ct scan; document; ext; extr-r; finding; findings; imaging; point in time; r; rad; radiology; random; rt; rue; ue; ue-r; up; upper extremity joint; w contr iv; wc; wo & wc; wo+w contr; wo+w contr iv; wrist-r; wwo,Doc
38832-2,mr upper extremity - left wo contrast,mr ue-l wo contr,,arm; c; contr; contra; contrst; document; ext; extr-l; finding; findings; imaging; l; lt; lue; mitral regurgitation maximum velocity; mri; point in time; rad; radiology; random; ue; ue-l; up; without contrast,Doc
38835-5,ct temporal bone - left w contrast iv,ct temporal bone-l w contr iv,,bon; brain; c; cat scan; computed tomography; computerized tomography; contr; contra; contrst; cranial; cranium; ct scan; document; finding; findings; imaging; intracranial; l; lt; point in time; rad; radiology; random; skull; temporal bone-l; w contr iv; wc,Doc
38836-3,mr orbit - left,mr orbit-l,,brain; cranial; cranium; document; eye socket; finding; findings; imaging; intracranial; l; lt; mitral regurgitation maximum velocity; mri; orbital; orbit-l; point in time; rad; radiology; random; skull,Doc
38893-4,aripiprazole [mass/volume] in serum or plasma,aripiprazole serpl-mcnc,aripiprazole [mass/vol],abilify; drug/toxicology; drugs; level; mass concentration; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
38899-1,fluphenazine [presence] in serum or plasma,fluphenazine serpl ql,fluphenazine ql,drug/toxicology; drugs; fluphenazine hydrochloride; ordinal; pl; plasma; plsm; point in time; pr; prolixin; ql; qual; qualitative; random; screen; serp; serpl; serplas; serum; serum or plasma; sr,Ord
38901-5,leflunomide [mass/volume] in serum or plasma,leflunomide serpl-mcnc,leflunomide [mass/vol],arava; drug/toxicology; drugs; level; mass concentration; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; universallaborders,Qn
38904-9,mfn2 gene targeted mutation analysis in blood or tissue by molecular genetics method,mfn2 gene mut anl bld/t,mfn2 gene targeted mutation analysis molgen doc (bld/tiss),"blood; charcot-marie tooth disease, type 2a; cmt2a; cmt2a2; cprp1; document; finding; findings; genetics; heredity; heritable; hsg; inherited; kiaa0214; marf; mitochondrial assembly regulatory factor; mitofusin 2; molecular genetics; molecular pathology; molpath; molpath.mutations; mut; mut anl; mutations; pcr; point in time; random; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",Doc
38906-4,msh6 gene targeted mutation analysis in blood or tissue by molecular genetics method,msh6 gene mut anl bld/t,msh6 gene targeted mutation analysis molgen doc (bld/tiss),"blood; document; finding; findings; g/t mismatch-binding protein gene; genetics; gtbp; gtmbp; heredity; heritable; hnpcc; hnpcc5; hsap; inherited; lynch syndrome; molecular genetics; molecular pathology; molpath; molpath.mutations; mut; mut anl; mutations; muts homolog 6; p160; pcr; point in time; random; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",Doc
38927-0,trps1 gene targeted mutation analysis in blood or tissue by molecular genetics method,trps1 gene mut anl bld/t,trps1 gene targeted mutation analysis molgen doc (bld/tiss),"blood; document; finding; findings; gc79; genetics; heredity; heritable; inherited; lgcr; molecular genetics; molecular pathology; molpath; molpath.mutations; mut; mut anl; mutations; pcr; point in time; random; tissue; tissue, unspecified; trichorhinophalangeal syndrome 1; trichorhinophalangeal syndrome i; trpsi; wb; whole blood; whole blood or tissue",Doc
38929-6,fah gene mutations found [identifier] in blood or tissue by molecular genetics method nominal,fah gene mut anl bld/t,fah gene targeted mutation analysis molgen nom (bld/tiss),"blood; fa; fa1; faa; faca; fah; fa-h; fanch; fanconi anemia, complementation group a; fumarylacetoacetase gene; genetics; heredity; heritable; identity or presence; inherited; molecular genetics; molecular pathology; molpath; molpath.mutations; mut; mut anl; mutations; nominal; pcr; point in time; random; tissue; tissue, unspecified; tyrosinemia type i; tys1; wb; whole blood; whole blood or tissue",Nom
38930-4,ext1 gene mutations found [identifier] in blood or tissue by molecular genetics method nominal,ext1 gene mut anl bld/t,ext1 gene targeted mutation analysis molgen nom (bld/tiss),"blood; exostoses (multiple) 1; exostosin glycosyltransferase 1; exostosin-1; ext; genetics; heredity; heritable; identity or presence; inherited; langer-giedion syndrome; lgcr; lgs; molecular genetics; molecular pathology; molpath; molpath.mutations; mut; mut anl; mutations; nominal; pcr; point in time; random; tissue; tissue, unspecified; trichorhinophalangeal syndrome 2; trps2; ttv; wb; whole blood; whole blood or tissue",Nom
38964-3,deprecated va compensation and pension (c and p) examination initial evaluation post-traumatic stress disorder,deprecated va c&p exam initial eval ptsd,,after; assessment; doc.ont; document; encounter; eval; evaluation and management; evaluation and management note; finding; findings; h&p; history and physical; notes; p prime; point in time; pst; ptsd; random; va c&p exam initial eval ptsd; veteran's affairs compensation & pension; visit note,Doc
3896-8,oxymesterone [mass/time] in 24 hour urine,oxymesterone 24h ur-mrate,oxymesterone (24h u) [mass/time],1 day; 24 hours; 24hr; anamidol; drug/toxicology; drugs; mass rate; methylandrostenediolone; mrate; oximesteronum; qnt; quan; quant; quantitative; ua; ur; urn,Qn
38968-4,deprecated va compensation and pension (c and p) examination lymphatic disorders,deprecated va c&p exam lymphatic disorders,,doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; notes; p prime; point in time; random; va c&p exam lymphatic disorders; veteran's affairs compensation & pension; visit note,Doc
38970-0,deprecated va compensation and pension (c and p) examination mouth/lips/tongue,deprecated va c&p exam mouth/lips/tongue,,doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; notes; p prime; point in time; random; va c&p exam mouth/lips/tongue; veteran's affairs compensation & pension; visit note,Doc
38971-8,deprecated va compensation and pension (c and p) examination muscles,deprecated va c&p exam muscles,,doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; notes; p prime; point in time; random; va c&p exam muscles; veteran's affairs compensation & pension; visit note,Doc
3899-2,oxymetholone [mass/time] in 24 hour urine,oxymetholone 24h ur-mrate,oxymetholone (24h u) [mass/time],1 day; 24 hours; 24hr; adroyd; anadrol; drug/toxicology; drugs; mass rate; mrate; qnt; quan; quant; quantitative; ua; ur; urn,Qn
38994-0,histiocytes [presence] in urine sediment by light microscopy,histiocytes urns ql micro,histiocytes lm ql (urine sed),histiocyte; histocytes; kidney; lm; micro; micros; microscopic; nephrology; ordinal; point in time; pr; ql; qual; qualitative; random; renal; screen; ua; ur; urinalysis; urine sediment; urn; urns,Ord
39010-4,methylmalonylcarnitine (c4-dc) [moles/volume] in serum or plasma,me-malonylcarn serpl-scnc,c4-dc [moles/vol],c4dc; c4-dc; c4-dcc; chemistry; dicarboxylic carnitine; level; me-malonylcarn; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; substance concentration,Qn
39022-9,sarcocystis neurona ab [presence] in serum by immunofluorescence,s neurona ab ser ql if,s. neurona ab if ql (s),abs; aby; acif; antby; anti; antibodies; antibody; anticomplement immunofluorescence; autoantibodies; autoantibody; fa; fluorescent antibody; fluoresent; id; ifa; immune fluorescence; immunoflour; immunofluor; immunofluorescence; infectious disease; infectiousdisease; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; sr; time resolved fluorescence; trf,Ord
39040-1,us av fistula,us avf,,arteriovenous fistula; avf; document; echography; finding; findings; hemodialysis access; imaging; misc; miscellaneous; other; point in time; radiology; random; sonogram; sonograph; sonography; spec; to be specified in another part of the message; uls; ultrasound; unspecified,Doc
39054-2,mg breast duct views w contrast intra duct,mg brst duct views w contr intra dct,,brst; brst duct; brst.duct; c; contr; contra; contrst; coreplaybook; document; ductogm; ductogram; ductography; films; finding; findings; galactogram; galactography; imaging; playbook; point in time; rad; radiology; random; view; vws; w contr intra dct; w contrast via duct; wc,Doc
39077-3,xr shoulder ap and transthoracic,xr should ap+transthoracic,,anterio-posterior; anteroposterior; ap+transthoracic; arm; document; ext; films; finding; findings; imaging; msk; musculoskeletal; ortho; orthopedics; plain films; point in time; rad; radiology; random; ue; up; upper extremity joint; view; views & ap kub; views (ap; views+ap; vws; xray; x-ray,Doc
39078-1,xr finger pa and lateral and oblique,xr finger pa+lat+obl,,arm; document; ext; films; finding; findings; imaging; lat; msk; musculoskeletal; obl; ortho; orthopedics; pa+lat; pa+lat+obl; plain films; point in time; postero-anterior; rad; radiology; random; ue; up; view; views+pa; vws; xray; x-ray,Doc
39082-3,gentamicin [mass/volume] in cerebral spinal fluid --peak,gentamicin peak csf-mcnc,gentamicin peak (csf) [mass/vol],aminoglycosides; c213; cerebral spinal fluid; cerebrospinal fl; drug/toxicology; drugs; garamycin; genirr; genj; gent; level; mass concentration; point in time; post; postdose; post-dose; qnt; quan; quant; quantitative; random; spinal fl; spinal fld; spinal flu; spinal fluid,Qn
39083-1,herpes virus 8 ab [presence] in serum,hhv8 ab ser ql,hhv 8 ab ql (s),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; herpesvirus; hhv; hhv8; hhv-8; human herpes virus; id; infectious disease; infectiousdisease; kaposi's sarcoma-associated herpesvirus; kshv; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; sr,Ord
39093-0,rfa hepatic veins views w contrast iv,rfa hep vv views w contr iv,,abd; abdo; abdomen+; abdominal; c; cardio; cardiology; contr; contra; contrst; coreplaybook; document; films; finding; findings; fluor; fluoro; fluoroscopy; heart disease; hep vs; hep vv; hepar; imaging; liver; playbook; point in time; rad; radiology; random; rfa; venogram; venography; view; vws; w contr iv; wc,Doc
39095-5,rfa carotid artery and cerebral artery views w contrast ia,rfa carot a+cerebral a vs w contr ia,,art; arteriogram; brain; c; cardio; cardiology; carot a; carot a and cerebral a; cereb; contr; contra; contrst; cranial; cranium; document; films; finding; findings; fluor; fluoro; fluoroscopy; heart disease; imaging; intracranial; neuro; neurology; point in time; rad; radiology; random; rfa; skull; view; vws; w contr ia; wc,Doc
39120-1,saturated abdominal dressings [#] of wound,sat abd dressing wnd,,abd; abdo; abdomen; cnt; count; h+p; h+p.hx; number; p prime; point in time; qnt; quan; quant; quantitative; random; sat abd dressing; wnd,Qn
39130-0,firmness of nail bed,firmness nail bed,,finding; findings; h+p; h+p.hx; nails; nominal; p prime; point in time; random; ungal nail,Nom
39147-4,mg breast duct - right views w contrast intra multiple ducts,mg brst duct-r views w contr intra dcts,,brst; brst duct; brst duct-r; brst.duct; brst.duct-r; c; contr; contra; contrst; document; ductogm; ductogram; ductography; films; finding; findings; galactogram; galactography; imaging; mult; multi; point in time; r; rad; radiology; random; rt; view; vws; w contr intra dcts; wc,Doc
39152-4,ffd mammogram breast diagnostic,ffdm brst dx,,brst; document; dx; ffdm; films; finding; findings; imaging; mam.ffd; point in time; rad; radiology; random; symptomatic; view; vws,Doc
39168-0,behavioral/mental health screen follow-up status cphs,,,attach; attach.cphs; behavioral/mental health screen follow-up status; behaviour; children's preventative health service; emotional stability; nominal; point in time; random; scn; scr; scrn; typ,Nom
39178-9,endocrine screen results indicator cphs,,,attach; attach.cphs; children's preventative health service; nominal; point in time; random; scn; scr; scrn; typ,Nom
39188-8,growth and development (includes speech) screen finding recency cphs,,,attach; attach.cphs; children's preventative health service; nominal; point in time; random; scn; scr; scrn; typ,Nom
39196-1,lead (exposure to) screen finding recency cphs,,,attach; attach.cphs; children's preventative health service; exp; nominal; painter's colic; pb; plumbism; point in time; random; scn; scr; scrn; typ,Nom
39203-5,nutrition screen finding recency cphs,,,attach; attach.cphs; children's preventative health service; nominal; point in time; random; scn; scr; scrn; typ,Nom
39204-3,orthopedic screen assessment set cphs,,,attach; attach.cphs; children's preventative health service; complex; ortho; orthopaedic; point in time; random; scn; scr; scrn,Set
3920-6,pentetrazol [presence] in urine,pentetrazol ur ql,pentetrazol ql (u),barbiturate; cardiorapide; carzol; drug/toxicology; drugs; leptazol; ordinal; pentamethazol; point in time; pr; ql; qual; qualitative; random; screen; ua; ur; urn,Ord
39211-8,tuberculosis exposure screen finding recency cphs,,,attach; attach.cphs; children's preventative health service; exp; nominal; point in time; random; scn; scr; scrn; tb; tb exposure screen finding recency; typ,Nom
39213-4,vision screen results indicator cphs,,,attach; attach.cphs; children's preventative health service; eyeball; nominal; occular; oculis; ophthalmologic; optic globe; point in time; random; scn; scr; scrn; typ; vision; visual,Nom
39249-8,program participation set cphs,,,attach; attach.cphs; children's preventative health service; complex; point in time; random,Set
39254-8,primary care practitioner (pcp) perform screen indicator cphs,,,arbitrary; attach; attach.cphs; children's preventative health service; ordinal; point in time; primary care physician; primary care pract (pcp) perform screen indicator; ql; qual; qualitative; random; scn; scr; screen; scrn,Ord
3925-5,pentobarbital [presence] in urine,pentobarb ur ql,pentobarbital ql (u),addiction; barbiturate; drug/toxicology; drugs; drugs of abuse; illicit; nembutal; ordinal; pentobarb; point in time; potentialforabuse; pr; ql; qual; qualitative; random; screen; ua; ur; urn,Ord
3926-3,pentobarbital [mass/volume] in urine,pentobarb ur-mcnc,pentobarbital (u) [mass/vol],addiction; barbiturate; drug/toxicology; drugs; drugs of abuse; illicit; level; mass concentration; nembutal; pentobarb; point in time; potentialforabuse; qnt; quan; quant; quantitative; random; ua; ur; urn,Qn
39268-8,"follow-up (referred to) provider /specialist, name cphs",,,"attach; attach.cphs; children's preventative health service; follow-up (referred to) provider/specialist; follow-up (referred to) provider/specialist, name; nominal; person name; point in time; random",Nom
39301-7,influenza virus a h14 ab [titer] in serum by hemagglutination inhibition,fluav h14 ab titr ser hai,fluav h14 ab hai (s) [titer],abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; avian influenza; bird flu; dilution factor; dilution factor (titer); flua; fluav; fluav h14; fluv; fowl plague; hemagglutination inhibition; hi; id; infectious disease; infectiousdisease; influ; influenza a; influenza a virus; microbiology; point in time; random; serum; smqn; sr; titer; titered; titre; ttr,SemiQn
3931-3,phenazocine [presence] in urine,phenazocine ur ql,phenazocine ql (u),addiction; drug/toxicology; drugs; drugs of abuse; illicit; narphen; ordinal; point in time; potentialforabuse; pr; ql; qual; qualitative; random; screen; ua; ur; urn,Ord
39315-7,influenza virus a n5 neutralizing antibody [presence] in serum by neutralization test,fluav n5 nab ser ql nt,fluav n5 neut ab neut test ql (s),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; avian influenza; bird flu; conventional virus neutralization test; cvnt; flua; fluav; fluav n5; fluv; fowl plague; id; infectious disease; infectiousdisease; influ; influenza a; influenza a virus; microbiology; nab; neutralization; neutralization test; nt; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; serum virus neutralization; sr; svn; virus neutralization test; vnt,Ord
39320-7,abnormal prion protein [presence] in tissue by immunoblot,abn prion prot tiss ql ib,abnormal prion protein ib ql (tiss),"abn; abn prion prot; abnorm; blt; bovine spongiform encephalopathy; bse; immune blot; immunobl; immunoblot; microbiology; neuro; neurology; ordinal; point in time; pr; prot; prp; ql; qual; qualitative; random; riba; scrapie; screen; tissue; tissue, unspecified; wb; wblot; west blot; west blt; western blot",Ord
39330-6,xr ankle - bilateral ap and lateral w standing,xr ankle-bl ap+lat w stand,,ankle-bl; ankles; anterio-posterior; anteroposterior; ap+lat; bil; bilat; both; document; ext; extr-bl; films; finding; findings; imaging; lat; le; le-bl; leg; low; lower extremity joint; msk; musculoskeletal; ortho; orthopedics; plain films; point in time; rad; radiology; random; stand); view; views & ap kub; views (ap; views ap kub & lateral; views+ap; vws; wb; weight bearing; xray; x-ray,Doc
39331-4,xr foot - bilateral ap and lateral w standing,xr foot-bl ap+lat w stand,,anterio-posterior; anteroposterior; ap+lat; axial plantar; bil; bilat; both; document; dorsoplantar; ext; extr-bl; films; finding; findings; foot-bl; ft; imaging; lat; le; le-bl; leg; low; lower extremity; msk; musculoskeletal; ortho; orthopedics; plain films; point in time; rad; radiology; random; stand); view; views & ap kub; views (ap; views ap kub & lateral; views+ap; vws; wb; weight bearing; xray; x-ray,Doc
39335-5,xr shoulder - left ap internal rotation and ap external rotation and axillary,xr should-l ap ir+ap er+ax,,anterio-posterior; anteroposterior; ap ir+ap er; ap ir+ap er+ax; arm; document; ext; extr-l; films; finding; findings; imaging; l; lt; lue; msk; musculoskeletal; ortho; orthopedics; plain films; point in time; rad; radiology; random; should-l; ue; ue-l; up; upper extremity joint; view; views & ap kub; views (ap; views+ap; vws; xray; x-ray,Doc
39343-9,xr shoulder - bilateral ap internal rotation and ap external rotation and y,xr shoulder-bl ap ir+ap er+y,,anterio-posterior; anteroposterior; ap ir+ap er; ap ir+ap er+y; arm; bil; bilat; both; document; ext; extr-bl; films; finding; findings; imaging; msk; musculoskeletal; ortho; orthopedics; plain films; point in time; rad; radiology; random; shoulder-bl; ue; ue-bl; up; upper extremity joint; view; views & ap kub; views (ap; views+ap; vws; xray; x-ray,Doc
39348-8,xr shoulder - left ap internal rotation and ap external rotation and y,xr should-l ap ir+ap er+y,,anterio-posterior; anteroposterior; ap ir+ap er; ap ir+ap er+y; arm; document; ext; extr-l; films; finding; findings; imaging; l; lt; lue; msk; musculoskeletal; ortho; orthopedics; plain films; point in time; rad; radiology; random; should-l; ue; ue-l; up; upper extremity joint; view; views & ap kub; views (ap; views+ap; vws; xray; x-ray,Doc
39358-7,cholinesterase.ro 020683 inhibited/cholinesterase in serum or plasma,ro 020683 inhib/che cfr serpl,cholinesterase.ro 020683 inhibited/cholinesterase [catalytic fraction],acylcholine acylhydrolase; bche; benzoyl cholinesterase; benzoylcholinesterase; butyrylcholine esterase; catalytic fraction; che; chemistry; choline esterase ii; chs; percent; pl; plasma; plsm; point in time; pseudocho; pseudocholinesterase; qnt; quan; quant; quantitative; random; ro 020683 number; serp; serpl; serplas; serum; serum or plasma; sr,Qn
39365-2,xr wrist - right 3 views and ulnar deviation,xr wrist-r 3v+ulnar deviation,,3v; 3v+ulnar deviation; 3vw; arm; carpal bone; carpal bones; carpal bones and joint; document; ext; extr-r; films; finding; findings; iii; imaging; plain films; point in time; r; rad; radiology; random; rt; rue; ue; ue-r; up; upper extremity joint; view; vws; wrist-r; xray; x-ray,Doc
39392-6,xr shoulder - right internal rotation and external rotation and axillary,xr should-r v ir+er+ax,,arm; document; ext; extr-r; films; finding; findings; imaging; msk; musculoskeletal; ortho; orthopedics; plain films; point in time; r; rad; radiology; random; rt; rue; should-r; ue; ue-r; up; upper extremity joint; v ir+er+ax; view; vws; xray; x-ray,Doc
39425-4,us.doppler iliac artery,dop iliac a,,abd; abd+pelvis; abdo; abdominal; art; cardio; cardiology; document; dop; duplex; echography; finding; findings; heart disease; imaging; pelvic; pelvic artery; point in time; radiology; random; sonogram; sonograph; sonography; uls; ultrasound,Doc
39430-4,us.doppler lower extremity vessels - left limited,dop le ves-l ltd,,cardio; cardiology; document; dop; duplex; echography; ext; extr ves; extr-l; finding; findings; heart disease; imaging; l; le; le ves; le ves-l; leg; le-l; lle; lmted; low; lower extremity vessels.left; lt; ltd; point in time; radiology; random; sonogram; sonograph; sonography; uls; ultrasound; vesl; vessels.xxx,Doc
39435-3,us.doppler renal artery,dop renal a,,abd; abdo; abdomen+; abdominal; art; cardio; cardiology; document; dop; duplex; echography; finding; findings; heart disease; imaging; kidney; nephrology; point in time; radiology; random; renal; sonogram; sonograph; sonography; uls; ultrasound,Doc
3943-8,phenmetrazine [mass/volume] in serum or plasma,phenmetrazine serpl-mcnc,phenmetrazine [mass/vol],addiction; drug/toxicology; drugs; drugs of abuse; illicit; level; mass concentration; oxazimedrine; pl; plasma; plsm; point in time; potentialforabuse; preludin endurets; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
39446-0,us.doppler testicular vessels,dop testicle ves,,document; dop; duplex; echography; finding; findings; genitourinary; gu; imaging; pelvic; point in time; radiology; random; sonogram; sonograph; sonography; testicle ves; uls; ultrasound; uro; urology; vesl; vessels.xxx,Doc
39455-1,9-hydroxyrisperidone [moles/volume] in serum or plasma,9oh-risperidone serpl-scnc,9-hydroxyrisperidone [moles/vol],9-hydroxy risperidone; 9-hydroxy-risperidone; 9-oh-risperidone; 9oh-risperidone; drug/toxicology; drugs; invega; level; paliperidone; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; risperidone metabolite; serp; serpl; serplas; serum; serum or plasma; sr; substance concentration,Qn
394-7,penicillin g [susceptibility] by serum bactericidal titer,penicillin g titr sbt,penicillin g sbt (isol+s),antibiotic susceptibilities; benzylpenicillin; c1; dilution factor; dilution factor (titer); id; infectious disease; infectiousdisease; islt; isol; pcn; pen; penicilloyl; point in time; random; sequence based typing; serum; serum bactericidal titer; serum killing test; smqn; sr; titer; titered; titre; ttr; wycillin,SemiQn
39473-4,creatinine [moles/volume] in 72 hour urine,creat 72h ur-scnc,creatinine (72 hour u) [moles/vol],3 days; 72 hours; 72hr; chemistry; cr; crea; creat; kidney; level; nephrology; qnt; quan; quant; quantitative; renal; substance concentration; ua; ucr; ur; urn,Qn
39493-2,xr ribs lower posterior - right views,xr ribs lower post-r views,,cxr; document; films; finding; findings; imaging; low; plain films; point in time; r; rad; radiology; random; ribs lower post; ribs lower post-r; rt; thorax; view; vws; xray; x-ray,Doc
3950-3,phenobarbital [mass/volume] in urine,phenobarb ur-mcnc,phenobarbital (u) [mass/vol],barbiturate; c417; drug/toxicology; drugs; level; luminal; mass concentration; nirvonal; phbr; phenobarb; point in time; qnt; quan; quant; quantitative; random; ua; ur; urn,Qn
39521-0,xr skull pa and right lateral and left lateral and caldwell and towne,xr skull pa+r-lat+l-lat+caldwell+towne,,brain; cranial; cranium; document; films; finding; findings; head; imaging; intracranial; lat; lateral.bilateral; left; levo; pa+r-lat; pa+r-lat+l-lat; pa+r-lat+l-lat+caldwell+towne; plain films; point in time; postero-anterior; r prime; rad; radiology; random; right; skull; townes; view; views+pa; vws; xray; x-ray,Doc
39523-6,us.doppler artery,dop artery,,art; cardio; cardiology; document; dop; duplex; echography; finding; findings; heart disease; imaging; misc; miscellaneous; other; point in time; radiology; random; sonogram; sonograph; sonography; spec; to be specified in another part of the message; uls; ultrasound; unspecified,Doc
39526-9,us extremity limited,us extr ltd,,document; echography; ext; finding; findings; imaging; lmted; ltd; point in time; radiology; random; sonogram; sonograph; sonography; uls; ultrasound,Doc
39547-5,tuna ige ab/ige total in serum,tuna ige/ige total %,tuna ige/total ige (s) [%],%; abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; f040; f40; ige total; immune globulin e; immunoglobulin e; point in time; qnt; quan; quant; quantitative; random; serum; sr; tot; total ige; totl; tuna; yellow fin,Qn
39554-1,endomysium igg ab [presence] in serum,endomysium igg ser ql,endomysium igg ql (s),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; ema; endomysial; gastro; gastroenterology; gi; immune globulin g; immunoglobulin g; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serology; serum; sr; transglutaminase,Ord
39556-6,coagulation factor x inhibitor [presence] in platelet poor plasma by coagulation assay,fact x inhib ppp ql,coagulation factor x inhibitor coag ql (ppp),autoprothrombin iii; clot; clottable; coag; coagulation assay; fac; fact; fact x; fact x inhib; factor 10; fx; hematology; heme; inhib; inhibit; ordinal; plas; platelet poor plasma; point in time; pr; prothrombokinase; ql; qual; qualitative; random; screen; stuart-prower factor; tilt tube,Ord
39561-6,glucose [mass/volume] in serum or plasma --1st specimen post dose lactose,glucose sp1 p lac serpl-mcnc,glucose 1st specimen post dose lactose [mass/vol],acute specimen; after; chemistry.challenge testing; endocrine; endocrinology; first; glu; glu tol; gluc; glucose tolerance; glucoseur; gtt; level; ltt; mass concentration; p dose; pl; plasma; plsm; point in time; pre immunization; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sp1; sp1 p lac; spec; sr,Qn
39566-5,pregnanetriol/creatinine [mass ratio] in 24 hour urine,pregntrl/creat 24h ur,pregnanetriol/creatinine (24h u) [mass ratio],1 day; 24 hours; 24hr; chemistry; cr; crea; creat; mass concentration ratio; mass ratio; mcrto; pregnanetr; pregntrl; qnt; quan; quant; quantitative; ua; ucr; ur; urn,Qn
39576-4,sulfate [mass/time] in 24 hour urine,sulfate 24h ur-mrate,sulfate (24h u) [mass/time],1 day; 24 hours; 24hr; chemistry; kidney; mass rate; mrate; nephrology; qnt; quan; quant; quantitative; renal; so4; so4-2; sulf; ua; ur; urn,Qn
39605-1,goose feather ige ab/ige total in serum,goose feather ige/ige total %,goose feather ige/total ige (s) [%],%; abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; e070; e70; f158; feathers; ige total; immune globulin e; immunoglobulin e; point in time; qnt; quan; quant; quantitative; random; serum; sr; tot; total ige; totl,Qn
39620-0,nm guidance for abscess localization limited of unspecified body region,nm guided abscess loc ltd--w rnc iv,,abscess loc ltd; document; finding; findings; guid; guide; guided; imaging; lmted; local; ltd; misc; miscellaneous; other; point in time; rad; radiology; random; rn; rnc; scan; spec; to be specified in another part of the message; unspecified; w rnc iv,Doc
39628-3,spect small bowel for meckel's diverticulum,spect small bowel meckel's div w rnc iv,,abd; abdo; abdomen+; abdominal; document; finding; findings; imaging; point in time; rad; radiology; random; rn; rnc; s prime; sb; scan; small intestine; w rnc iv,Doc
39629-1,nm small bowel views for meckel's diverticulum,nm sb views for meckel's div w rnc iv,,abd; abdo; abdomen+; abdominal; coreplaybook; document; films; finding; findings; imaging; playbook; point in time; rad; radiology; random; rn; rnc; s prime; sb; scan; small intestine; view; vws; w rnc iv,Doc
39636-6,nm brain views for blood flow,nm brain vs bld flow w rnc iv,,bld flow; brain; cardio; cardiology; cerebral; cerebrum; cranial; cranium; document; dynamic; films; finding; findings; head; heart disease; imaging; intracranial; neuro; neurology; point in time; rad; radiology; random; rn; rnc; scan; skull; view; vs bld flow; vws; w rnc iv,Doc
39640-8,spect brain w tc-99m dtpa iv,spect brain w tc99mdtpa iv,,99 mtc; 99mtc; brain; cerebral; cerebrum; cranial; cranium; diethylenetriamine pentaacetate; document; finding; findings; head; imaging; intracranial; neuro; neurology; point in time; rad; radiology; random; scan; skull; tc-99cm; tc99m; tc-99m; technetium 99m; w tc99mdtpa iv,Doc
39647-3,spect heart w tc-99m tetrofosmin iv,spect hrt w tc99mtf iv,,99 mtc; 99mtc; cardiac; document; finding; findings; hrt; imaging; myoview; point in time; rad; radiology; random; scan; tc-99cm; tc99m; tc-99m; technetium 99m; thorax; w tc99mtf iv,Doc
39651-5,nm heart views w adenosine and w tl-201 iv,nm hrt views w ade+tl-201 iv,,201ti; ado; aned; cardiac; document; films; finding; findings; hrt; imaging; medication stress; point in time; rad; radiology; random; scan; thallium 201; thallous; thorax; t-i201; tl-201; view; vws; w ade+tl-201 iv,Doc
39677-0,nm unspecified body region views for infection w ga-67 iv,nm views for infect w ga-67 iv,,document; films; finding; findings; gallium 67; imaging; misc; miscellaneous; neoscan; other; point in time; rad; radiology; random; scan; spec; to be specified in another part of the message; unspecified; view; vws,Doc
39680-4,spect whole body w ga-67 iv,spect whole body w ga-67 iv,,bod; bodies; document; finding; findings; gallium 67; imaging; neoscan; point in time; rad; radiology; random; scan; wb,Doc
39685-3,nm unspecified body region views for abscess w ga-67 iv,nm views for abscess w ga-67 iv,,document; films; finding; findings; gallium 67; imaging; misc; miscellaneous; neoscan; other; point in time; rad; radiology; random; scan; spec; to be specified in another part of the message; unspecified; view; vws,Doc
3969-3,phenytoin free [mass/volume] in serum or plasma,phenytoin free serpl-mcnc,phenytoin free [mass/vol],di-hydan; dilantin; dilj; diphenylhydantoin; dph; drug/toxicology; drugs; epanutin; fenantoin; fr; lehydan; level; mass concentration; non-protein bound; phenhydan; phenytoin free; phyt; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sinergina; sr; universallaborders; zentropil,Qn
39707-5,nm heart perfusion w dipyridamole and w tl-201 iv,nm hrt pf w dpy+tl-201 iv,,201ti; cardiac; document; films; finding; findings; hrt; imaging; medication stress; myocardial perfusion; persantine; pf; point in time; rad; radiology; random; scan; thallium 201; thallous; thorax; t-i201; tl-201; view; vws; w dpy+tl-201 iv,Doc
39712-5,spect heart perfusion,spect hrt pf w rnc iv,,cardiac; document; finding; findings; hrt; imaging; myocardial perfusion; pf; point in time; rad; radiology; random; rn; rnc; scan; thorax; w rnc iv,Doc
39715-8,nm heart perfusion w stress and w tl-201 iv,nm hrt pf w stress+w tl-201 iv,,201ti; cardiac; cardio; cardiology; document; exercise; films; finding; findings; heart disease; hrt; imaging; myocardial perfusion; pf; point in time; rad; radiology; random; scan; thallium 201; thallous; thorax; t-i201; tl-201; view; vws,Doc
39727-3,nm heart perfusion at rest and w stress and w tc-99m sestamibi iv,nm hrt pf rest+stress+w tc99mmibi iv,,99 mtc; 99mtc; cardiac; cardio; cardiolite; cardiology; document; exercise; films; finding; findings; heart disease; hrt; imaging; mibi; myocardial perfusion; pf; point in time; rad; radiology; random; rest+stress+w tc99mmibi iv; resting; scan; tc-99cm; tc99m; tc-99m; tc99mmibi; technetium 99m; thorax; view; vws; w stress+w tc99mmibi iv; w tc99mmibi iv,Doc
39732-3,nm heart perfusion w stress and w tc-99m sestamibi iv,nm hrt pf w stress+w tc99mmibi iv,,99 mtc; 99mtc; cardiac; cardio; cardiolite; cardiology; document; exercise; films; finding; findings; heart disease; hrt; imaging; mibi; myocardial perfusion; pf; point in time; rad; radiology; random; scan; tc-99cm; tc99m; tc-99m; tc99mmibi; technetium 99m; thorax; view; vws; w stress+w tc99mmibi iv; w tc99mmibi iv,Doc
3973-5,pipradrol [presence] in urine,pipradrol ur ql,pipradrol ql (u),addiction; alertonic; alpha-z-piperidylbenzhydrol; drug/toxicology; drugs; drugs of abuse; illicit; meretran; ordinal; point in time; potentialforabuse; pr; ql; qual; qualitative; random; screen; ua; ur; urn,Ord
39741-4,nm parathyroid gland delayed views,nm parathyroid gland delayed w rnc iv,,document; films; finding; findings; imaging; point in time; rad; radiology; random; rn; rnc; scan; view; vws; w rnc iv,Doc
39761-2,nm guidance limited for localization of tumor-- w tc-99m sestamibi iv,nm guide tum loc ltd--w tc99mmibi iv,,99 mtc; 99mtc; cardiolite; document; finding; findings; guid; guide; guided; imaging; lmted; local; ltd; mibi; misc; miscellaneous; other; point in time; rad; radiology; random; scan; spec; tc-99cm; tc99m; tc-99m; tc99mmibi; technetium 99m; to be specified in another part of the message; tum loc ltd; unspecified; w tc99mmibi iv,Doc
39765-3,nm vein views w tc-99m dtpa iv,nm vein views w tc99mdtpa iv,,99 mtc; 99mtc; cardio; cardiology; diethylenetriamine pentaacetate; document; films; finding; findings; heart disease; imaging; misc; miscellaneous; other; point in time; rad; radiology; random; scan; spec; tc-99cm; tc99m; tc-99m; technetium 99m; to be specified in another part of the message; unspecified; ven; venous; view; vws; w tc99mdtpa iv,Doc
39768-7,nm stomach views for gastric emptying w tc-99m sc po,nm stom views for ge w tc99msc po,,99 mtc; 99mtc; abd; abdo; abdomen+; abdominal; document; empty; films; finding; findings; ge; imaging; point in time; rad; radiology; random; scan; sulfur colloid; sulphur colloid; tc-99cm; tc99m; tc-99m; technetium 99m; view; views for ge; vws; w tc99msc po,Doc
39775-2,protoporphyrin free [moles/volume] in red blood cells,fep rbc-scnc,protoporphyrin free (rbc) [moles/vol],chemistry; dicarboxyl porphyrin; dicarboxylporphyrin; erythrocytes; fep; fr; free erythrocyte protoporphyrin; hematology; heme; level; non-protein bound; point in time; protoporph; protoporphrn; protoporphyrins; qnt; quan; quant; quantitative; random; red blood cells; red blood corpusles; substance concentration,Qn
3977-6,prazepam [mass/volume] in serum or plasma,prazepam serpl-mcnc,prazepam [mass/vol],centrax; demetrin; drug/toxicology; drugs; level; lysanxia; mass concentration; mono-detrimin; pl; plasma; plsm; point in time; prazene; qnt; quan; quant; quantitative; random; reapam; serp; serpl; serplas; serum; serum or plasma; sr; trepidan,Qn
39780-2,urea [moles/volume] in peritoneal dialysis fluid,urea diafp-scnc,urea (perit dial fld) [moles/vol],chemistry; diaf; diafp; dialysate; dialysis fluid; level; peritoneal dialysis fluid; point in time; qnt; quan; quant; quantitative; random; substance concentration,Qn
39781-0,urea [moles/volume] in peritoneal fluid,urea prt-scnc,urea (periton fld) [moles/vol],ascites; ascitic fluid; ascitis; chemistry; level; peritoneal fluid; point in time; prt; qnt; quan; quant; quantitative; random; substance concentration,Qn
39786-9,pyridoxine [moles/volume] in serum or plasma,vit b6 serpl-scnc,pyridoxine [moles/vol],c8h11no3; chemistry; level; pl; plasma; plsm; point in time; pyridoxol; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; substance concentration; vit b6; vitamin b6,Qn
39788-5,urate [moles/volume] in synovial fluid,urate snv-scnc,urate (syn fld) [moles/vol],chemistry; joint aspirate; joint fld; joint flu; joint fluid; level; point in time; qnt; quan; quant; quantitative; random; sf; snv; substance concentration; syn; syn fl; synov; synovial fluid; ua; urates; uric acid,Qn
3979-2,probenecid [presence] in urine,probenecid ur ql,probenecid ql (u),benemid; drug/toxicology; drugs; ordinal; point in time; pr; ql; qual; qualitative; random; screen; ua; ur; urn,Ord
39803-2,infliximab [mass/volume] in serum or plasma,infliximab serpl-mcnc,infliximab [mass/vol],drug/toxicology; drugs; level; mass concentration; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; remicade; serp; serpl; serplas; serum; serum or plasma; sr,Qn
39810-7,ruralurban continuum 1993,ruralurban continuum 1993,,arbitrary; beale code; oncology; ordinal; point in time; ql; qual; qualitative; random; ruralurbancontinuum; screen; tumor registry(naaccr),Ord
39819-8,nm bone delayed views,nm bone delayed w rnc iv,,bon; document; films; finding; findings; imaging; misc; miscellaneous; other; point in time; rad; radiology; random; rn; rnc; scan; spec; to be specified in another part of the message; unspecified; view; vws; w rnc iv,Doc
39825-5,spect whole body bone marrow,spect wb bone mar w rnc iv,,bm; bod; bodies; bon; document; finding; findings; imaging; point in time; rad; radiology; random; rn; rnc; scan; w rnc iv; wb; wb bone; wb bone mar,Doc
39829-7,nm whole body views for tumor w ga-67 iv,nm whole body views for tumor w ga-67 iv,,bod; bodies; document; films; finding; findings; gallium 67; imaging; neoscan; point in time; rad; radiology; random; scan; view; vws; wb,Doc
39831-3,nm unspecified body region limited views for tumor w ga-67 iv,nm vs for tumor ltd w ga-67 iv,,document; films; finding; findings; gallium 67; imaging; lmted; ltd; misc; miscellaneous; neoscan; other; point in time; rad; radiology; random; scan; spec; to be specified in another part of the message; unspecified; view; views ltd; vs for tumor ltd; vws,Doc
39848-7,nm head to pelvis views for shunt patency w in-111 it,nm head pelvis vs shunt pat w in-111 it,,111 in; 111in; abd; abd+pelvis; abdo; abdominal; brain; chest + abd; chest+abd+pelvis; cranial; cranium; document; films; finding; findings; head to abdomen; head to pelvis; imaging; indium 111; intracranial; neck to pelvis; pelvic; point in time; rad; radiology; random; scan; skull; thorax; view; vs for shunt pat; vws,Doc
39849-5,nm head to pelvis views for shunt patency w radionuclide it,nm head pelvis vs shunt pat w contr it,,abd; abd+pelvis; abdo; abdominal; brain; chest + abd; chest+abd+pelvis; cranial; cranium; document; films; finding; findings; head to abdomen; head to pelvis; imaging; intracranial; intrathecal; neck to pelvis; pelvic; point in time; rad; radiology; random; rn; rnc; scan; skull; thorax; view; vs for shunt pat; vws; w rnc it,Doc
39857-8,nm adrenal gland views w i-131 mibg iv,nm adrenal views w i-131 mibg iv,,131 iodine; 131i; abd; abdo; abdomen+; abdominal; document; films; finding; findings; imaging; metaiodobenzylguanidine; point in time; rad; radiology; rai; random; scan; view; vws,Doc
3985-9,prolintane [mass/volume] in urine,prolintane ur-mcnc,prolintane (u) [mass/vol],addiction; catorid; drug/toxicology; drugs; drugs of abuse; illicit; katovit n; level; mass concentration; point in time; potentialforabuse; promotil; qnt; quan; quant; quantitative; random; ua; ur; urn,Qn
3990-9,propranolol [mass/time] in 24 hour urine,propranolol 24h ur-mrate,propranolol (24h u) [mass/time],1 day; 24 hours; 24hr; drug/toxicology; drugs; inderal; mass rate; mrate; qnt; quan; quant; quantitative; ua; ur; urn,Qn
39915-4,nm heart gated,nm hrt gated w rnc iv,,cardiac; document; films; finding; findings; hrt; imaging; muga; point in time; rad; radiology; random; rn; rnc; scan; thorax; view; vws; w rnc iv,Doc
39922-0,nm heart gated at rest and w tc-99m pertechnetate iv,nm hrt gated rest+w tc-99mp iv,,99 mtc; 99mtc; cardiac; document; films; finding; findings; hrt; imaging; muga; point in time; rad; radiology; random; rest+w tc-99mp iv; resting; scan; tc04; tc-04; tc-99cm; tc99m; tc-99m; technetium 99m; thorax; view; vws; w tc99mp iv,Doc
39924-6,nm heart gated at rest and w stress and w radionuclide iv,nm hrt gated rest+stress+w rnc iv,,cardiac; cardio; cardiology; document; exercise; films; finding; findings; heart disease; hrt; imaging; muga; point in time; rad; radiology; random; rest+stress+w rnc iv; resting; rn; rnc; scan; thorax; view; vws; w rnc iv; w stress+w rnc iv,Doc
39925-3,nm heart gated and wall motion and ejection fraction at rest and w radionuclide iv,nm hrt gated+wm+ef rest+w rnc iv,,cardiac; document; ef; films; finding; findings; frac; fract; fractionation; fractions; gated+wm; gated+wm+ef; hrt; imaging; muga; point in time; rad; radiology; random; rest+w rnc iv; resting; rn; rnc; scan; thorax; view; vws; w rnc iv; wm,Doc
39927-9,nm heart gated w stress and w tc-99m pertechnetate iv,nm hrt gated w stress+w tc99mp iv,,99 mtc; 99mtc; cardiac; cardio; cardiology; document; exercise; films; finding; findings; heart disease; hrt; imaging; muga; point in time; rad; radiology; random; scan; tc04; tc-04; tc-99cm; tc99m; tc-99m; technetium 99m; thorax; view; vws; w stress+w tc99mp iv; w tc99mp iv,Doc
39947-7,nm lung ventilation and equilibrium,nm lung v+eq w rnc ih,,document; films; finding; findings; imaging; inhaled; lung; point in time; pulmonary; pulmonology; rad; radiology; random; respiratory; rn; rnc; scan; thorax; v+eq; view; vws; w rnc ih,Doc
39975-8,creatinine [mass/volume] in serum or plasma --4 days post xxx challenge,creat 4d p chal serpl-mcnc,creatinine 4 days post unsp challenge [mass/vol],4d p chal; after; chemistry.challenge testing; cr; crea; creat; level; mass concentration; p chal; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
39982-4,creatinine [mass/volume] in urine --baseline,creat bs ur-mcnc,creatinine baseline (u) [mass/vol],bs; chemistry.challenge testing; cr; crea; creat; kidney; level; mass concentration; nephrology; point in time; qnt; quan; quant; quantitative; random; renal; ua; ucr; ur; urn,Qn
39989-9,creatinine [mass/volume] in urine --3.5 hours post xxx challenge,creat 3.5h p chal ur-mcnc,creatinine 3.5 hr post unsp challenge (u) [mass/vol],3.5h p chal; after; chemistry.challenge testing; cr; crea; creat; level; mass concentration; p chal; point in time; pst; qnt; quan; quant; quantitative; random; ua; ucr; ur; urn,Qn
40017-6,glucose [mass/volume] in serum or plasma --18.5 hours post xxx challenge,glucose 18.5h p chal serpl-mcnc,glucose 18.5 hr post unsp challenge [mass/vol],18.5h p chal; after; chemistry.challenge testing; endocrine; endocrinology; glu; glu tol; gluc; glucose tolerance; glucoseur; gtt; level; mass concentration; p chal; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
40018-4,glucose [mass/volume] in serum or plasma --19.5 hours post xxx challenge,glucose 19.5h p chal serpl-mcnc,glucose 19.5 hr post unsp challenge [mass/vol],19.5h p chal; after; chemistry.challenge testing; endocrine; endocrinology; glu; glu tol; gluc; glucose tolerance; glucoseur; gtt; level; mass concentration; p chal; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
40030-9,glucose [mass/volume] in serum or plasma --16 minutes post xxx challenge,glucose 16m p chal serpl-mcnc,glucose 16 min post unsp challenge [mass/vol],16m p chal; after; chemistry.challenge testing; endocrine; endocrinology; glu; glu tol; gluc; glucose tolerance; glucoseur; gtt; level; mass concentration; p chal; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
40033-3,glucose [mass/volume] in serum or plasma --25 minutes post xxx challenge,glucose 25m p chal serpl-mcnc,glucose 25 min post unsp challenge [mass/vol],25m p chal; after; chemistry.challenge testing; endocrine; endocrinology; glu; glu tol; gluc; glucose tolerance; glucoseur; gtt; level; mass concentration; p chal; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
4004-8,pseudoephedrine [mass/volume] in urine,pseudoephedrine ur-mcnc,pseudoephedrine (u) [mass/vol],cenafed; drug/toxicology; drugs; level; mass concentration; point in time; pseudoephed; qnt; quan; quant; quantitative; random; sudafed; ua; ur; urn,Qn
40049-9,albumin [mass/volume] in serum or plasma --45 minutes post xxx challenge,albumin 45m p chal serpl-mcnc,albumin 45 min post unsp challenge [mass/vol],45m p chal; after; alb; chemistry.challenge testing; level; mass concentration; p chal; pl; plasma; plsm; point in time; protein.albumin; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
40061-4,albumin [mass/volume] in serum or plasma --2 days post xxx challenge,albumin 2d p chal serpl-mcnc,albumin 2 days post unsp challenge [mass/vol],2d p chal; after; alb; chemistry.challenge testing; level; mass concentration; p chal; pl; plasma; plsm; point in time; protein.albumin; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
40065-5,calcium [mass/volume] in serum or plasma --45 minutes pre xxx challenge,calcium 45m pre chal serpl-mcnc,calcium 45 min pre unsp challenge [mass/vol],45m pre chal; before; ca; cal; chemistry.challenge testing; level; mass concentration; pl; plasma; plsm; point in time; pre chal; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
4009-7,pyrilamine [presence] in urine,pyrilamine ur ql,pyrilamine ql (u),drug/toxicology; drugs; mepyramine; ordinal; point in time; pr; ql; qual; qualitative; random; screen; ua; ur; urn,Ord
4010-5,pyrilamine [mass/volume] in urine,pyrilamine ur-mcnc,pyrilamine (u) [mass/vol],drug/toxicology; drugs; level; mass concentration; mepyramine; point in time; qnt; quan; quant; quantitative; random; ua; ur; urn,Qn
40145-5,creatinine [moles/volume] in urine --6 hours post xxx challenge,creat 6h p chal ur-scnc,creatinine 6 hr post unsp challenge (u) [moles/vol],6h p chal; after; chemistry.challenge testing; cr; crea; creat; level; p chal; point in time; pst; qnt; quan; quant; quantitative; random; substance concentration; ua; ucr; ur; urn,Qn
40147-1,creatinine [moles/volume] in urine --1 day post xxx challenge,creat 1d p chal ur-scnc,creatinine 1 day post unsp challenge (u) [moles/vol],1d p chal; after; chemistry.challenge testing; cr; crea; creat; level; p chal; point in time; pst; qnt; quan; quant; quantitative; random; substance concentration; ua; ucr; ur; urn,Qn
40151-3,glucose [moles/volume] in serum or plasma --10 minutes pre xxx challenge,glucose 10m pre chal serpl-scnc,glucose 10 min pre unsp challenge [moles/vol],10m pre chal; before; chemistry.challenge testing; endocrine; endocrinology; glu; glu tol; gluc; glucose tolerance; glucoseur; gtt; level; pl; plasma; plsm; point in time; pre chal; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; substance concentration,Qn
40152-1,glucose [moles/volume] in serum or plasma --5 minutes pre xxx challenge,glucose 5m pre chal serpl-scnc,glucose 5 min pre unsp challenge [moles/vol],5m pre chal; before; chemistry.challenge testing; endocrine; endocrinology; glu; glu tol; gluc; glucose tolerance; glucoseur; gtt; level; pl; plasma; plsm; point in time; pre chal; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; substance concentration,Qn
40163-8,glucose [moles/volume] in serum or plasma --4 hours post xxx challenge,glucose 4h p chal serpl-scnc,glucose 4 hr post unsp challenge [moles/vol],4h p chal; after; chemistry.challenge testing; endocrine; endocrinology; glu; glu tol; gluc; glucose tolerance; glucoseur; gtt; level; p chal; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; substance concentration,Qn
40178-6,glucose [moles/volume] in serum or plasma --13 hours post xxx challenge,glucose 13h p chal serpl-scnc,glucose 13 hr post unsp challenge [moles/vol],13h p chal; after; chemistry.challenge testing; endocrine; endocrinology; glu; glu tol; gluc; glucose tolerance; glucoseur; gtt; level; p chal; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; substance concentration,Qn
40181-0,glucose [moles/volume] in serum or plasma --15.5 hours post xxx challenge,glucose 15.5h p chal serpl-scnc,glucose 15.5 hr post unsp challenge [moles/vol],15.5h p chal; after; chemistry.challenge testing; endocrine; endocrinology; glu; glu tol; gluc; glucose tolerance; glucoseur; gtt; level; p chal; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; substance concentration,Qn
40185-1,glucose [moles/volume] in serum or plasma --18.5 hours post xxx challenge,glucose 18.5h p chal serpl-scnc,glucose 18.5 hr post unsp challenge [moles/vol],18.5h p chal; after; chemistry.challenge testing; endocrine; endocrinology; glu; glu tol; gluc; glucose tolerance; glucoseur; gtt; level; p chal; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; substance concentration,Qn
40194-3,glucose [moles/volume] in serum or plasma --20 minutes pre xxx challenge,glucose 20m pre chal serpl-scnc,glucose 20 min pre unsp challenge [moles/vol],20m pre chal; before; chemistry.challenge testing; endocrine; endocrinology; glu; glu tol; gluc; glucose tolerance; glucoseur; gtt; level; pl; plasma; plsm; point in time; pre chal; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; substance concentration,Qn
40198-4,glucose [moles/volume] in serum or plasma --2 minutes post xxx challenge,glucose 2m p chal serpl-scnc,glucose 2 min post unsp challenge [moles/vol],2m p chal; after; chemistry.challenge testing; endocrine; endocrinology; glu; glu tol; gluc; glucose tolerance; glucoseur; gtt; level; p chal; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; substance concentration,Qn
40200-8,glucose [moles/volume] in serum or plasma --4 minutes post xxx challenge,glucose 4m p chal serpl-scnc,glucose 4 min post unsp challenge [moles/vol],4m p chal; after; chemistry.challenge testing; endocrine; endocrinology; glu; glu tol; gluc; glucose tolerance; glucoseur; gtt; level; p chal; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; substance concentration,Qn
40214-9,glucose [moles/volume] in serum or plasma --25 hours post xxx challenge,glucose 25h p chal serpl-scnc,glucose 25 hr post unsp challenge [moles/vol],25h p chal; after; chemistry.challenge testing; endocrine; endocrinology; glu; glu tol; gluc; glucose tolerance; glucoseur; gtt; level; p chal; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; substance concentration,Qn
40215-6,glucose [moles/volume] in serum or plasma --26 hours post xxx challenge,glucose 26h p chal serpl-scnc,glucose 26 hr post unsp challenge [moles/vol],26h p chal; after; chemistry.challenge testing; endocrine; endocrinology; glu; glu tol; gluc; glucose tolerance; glucoseur; gtt; level; p chal; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; substance concentration,Qn
40216-4,glucose [moles/volume] in serum or plasma --27 hours post xxx challenge,glucose 27h p chal serpl-scnc,glucose 27 hr post unsp challenge [moles/vol],27h p chal; after; chemistry.challenge testing; endocrine; endocrinology; glu; glu tol; gluc; glucose tolerance; glucoseur; gtt; level; p chal; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; substance concentration,Qn
40218-0,glucose [moles/volume] in serum or plasma --29 hours post xxx challenge,glucose 29h p chal serpl-scnc,glucose 29 hr post unsp challenge [moles/vol],29h p chal; after; chemistry.challenge testing; endocrine; endocrinology; glu; glu tol; gluc; glucose tolerance; glucoseur; gtt; level; p chal; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; substance concentration,Qn
40228-9,calcium [moles/volume] in serum or plasma --45 minutes post xxx challenge,calcium 45m p chal serpl-scnc,calcium 45 min post unsp challenge [moles/vol],45m p chal; after; ca; cal; chemistry.challenge testing; level; p chal; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; substance concentration,Qn
40243-8,calcium [moles/volume] in serum or plasma --20 hours post xxx challenge,calcium 20h p chal serpl-scnc,calcium 20 hr post unsp challenge [moles/vol],20h p chal; after; ca; cal; chemistry.challenge testing; level; p chal; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; substance concentration,Qn
40244-6,calcium [moles/volume] in serum or plasma --1 day post xxx challenge,calcium 1d p chal serpl-scnc,calcium 1 day post unsp challenge [moles/vol],1d p chal; after; ca; cal; chemistry.challenge testing; level; p chal; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; substance concentration,Qn
40252-9,creatinine [mass/volume] in serum or plasma --2 hours post xxx challenge,creat 2h p chal serpl-mcnc,creatinine 2 hr post unsp challenge [mass/vol],120 min; 120 minutes; 120min; 2 hours; 2h p chal; after; chemistry.challenge testing; cr; crea; creat; level; mass concentration; p chal; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
40255-2,creatinine [mass/volume] in serum or plasma --3 hours post xxx challenge,creat 3h p chal serpl-mcnc,creatinine 3 hr post unsp challenge [mass/vol],3h p chal; after; chemistry.challenge testing; cr; crea; creat; level; mass concentration; p chal; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
40269-3,creatinine [moles/volume] in serum or plasma --2.5 hours post xxx challenge,creat 2.5h p chal serpl-scnc,creatinine 2.5 hr post unsp challenge [moles/vol],2.5h p chal; after; chemistry.challenge testing; cr; crea; creat; level; p chal; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; substance concentration,Qn
40272-7,creatinine [moles/volume] in serum or plasma --6 hours post xxx challenge,creat 6h p chal serpl-scnc,creatinine 6 hr post unsp challenge [moles/vol],6h p chal; after; chemistry.challenge testing; cr; crea; creat; level; p chal; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; substance concentration,Qn
40289-1,insulin [moles/volume] in serum or plasma --1 hour post xxx challenge,insulin 1h p chal serpl-scnc,insulin 1 hr post unsp challenge [moles/vol],1 hour; 1.0hr; 1h p chal; 60 min; 60 minutes; 60m; 60min; after; chemistry.challenge testing; hum; humulin; ih7; insul; lente; level; nph; p chal; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; semilente; serp; serpl; serplas; serum; serum or plasma; sliding; sr; substance concentration; ultralente,Qn
40295-8,triiodothyronine (t3) free [moles/volume] in serum or plasma --2 hours post xxx challenge,t3free 2h p chal serpl-scnc,free t3 2 hr post unsp challenge [moles/vol],120 min; 120 minutes; 120min; 2 hours; 2h p chal; after; chemistry.challenge testing; endocrine; endocrinology; fr; free t3; ft3; level; non-protein bound; p chal; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; substance concentration; t3; t-3; t3free; thyroid hormone; total t3; triodothyrne,Qn
40308-9,somatotropin [mass/volume] in serum or plasma --4 hours post dose arginine,gh 4h p arg serpl-mcnc,somatotropin 4 hr post dose arginine [mass/vol],4h p arg; after; arg; chemistry.challenge testing; endocrine; endocrinology; gh; growth hormone; hgh; human growth hormone; level; mass concentration; p dose; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; somatotropic hormone; sr; sth,Qn
40309-7,somatotropin [mass/volume] in serum or plasma --pre or post dose glucose,gh pre/p glc serpl-mcnc,somatotropin pre or post dose glucose [mass/vol],after; before; chemistry.challenge testing; endocrine; endocrinology; gh; glu; glu tol; gluc; glucose tolerance; glucoseur; growth hormone; gtt; hgh; human growth hormone; level; mass concentration; p dose; p glc; pl; plasma; plsm; point in time; pre/p glc; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; somatotropic hormone; sr; sth,Qn
40316-2,cortisol [moles/volume] in serum or plasma --2 hours post dose triple bolus,cortis 2h p triple bolus serpl-scnc,cortisol 2 hr post dose triple bolus [moles/vol],120 min; 120 minutes; 120min; 17-hydroxycorticosterone; 2 hours; 2h p triple bolus; after; chemistry.challenge testing; compound f; coritsol; cort; f; hydrocortisone; level; p dose; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; substance concentration; tri; trip,Qn
40323-8,glucose [moles/volume] in serum or plasma --2 hours post dose triple bolus,glucose 2h p triple bolus serpl-scnc,glucose 2 hr post dose triple bolus [moles/vol],120 min; 120 minutes; 120min; 2 hours; 2h p triple bolus; after; chemistry.challenge testing; endocrine; endocrinology; glu; glu tol; gluc; glucose tolerance; glucoseur; gtt; level; p dose; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; substance concentration; tri; trip,Qn
40325-3,testosterone [moles/volume] in serum or plasma --pre dose triple bolus,testost pre triple bolus serpl-scnc,testosterone pre dose triple bolus [moles/vol],before; chemistry.challenge testing; level; pl; plasma; plsm; point in time; pre triple bolus; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; substance concentration; testo; testos; testost; tri; trip,Qn
40329-5,prolactin [mass/volume] in serum or plasma --pre dose triple bolus,prolactin pre triple bolus serpl-mcnc,prolactin pre dose triple bolus [mass/vol],before; chemistry.challenge testing; lactotropic hormone; lactotropin; level; mammatropic hormone; mammotropin; mass concentration; pl; plasma; plsm; point in time; pre triple bolus; prl; prol; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; tri; trip,Qn
40330-3,prolactin [mass/volume] in serum or plasma --15 minutes post dose triple bolus,prolactin 15m p triple bolus serpl-mcnc,prolactin 15 min post dose triple bolus [mass/vol],15m p triple bolus; after; chemistry.challenge testing; lactotropic hormone; lactotropin; level; mammatropic hormone; mammotropin; mass concentration; p dose; pl; plasma; plsm; point in time; prl; prol; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; tri; trip,Qn
40338-6,somatotropin [mass/volume] in serum or plasma --1 hour post dose triple bolus,gh 1h p triple bolus serpl-mcnc,somatotropin 1 hr post dose triple bolus [mass/vol],1 hour; 1.0hr; 1h p triple bolus; 60 min; 60 minutes; 60m; 60min; after; chemistry.challenge testing; endocrine; endocrinology; gh; growth hormone; hgh; human growth hormone; level; mass concentration; p dose; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; somatotropic hormone; sr; sth; tri; trip,Qn
4035-2,spironolactone [mass/time] in 24 hour urine,spironolactone 24h ur-mrate,spironolactone (24h u) [mass/time],1 day; 24 hours; 24hr; aldactone; drug/toxicology; drugs; mass rate; mrate; novospiroton; qnt; quan; quant; quantitative; ua; ur; urn,Qn
40376-6,lutropin [units/volume] in serum or plasma --2 hours post dose triple bolus,lh 2h p triple bolus serpl-acnc,lutropin 2 hr post dose triple bolus qn,120 min; 120 minutes; 120min; 2 hours; 2h p triple bolus; after; arbitrary concentration; chemistry.challenge testing; endocrine; endocrinology; icsh; interstitial cell-stimulating hormone; interstitual cell stimulating hormone; leutinizing hormone; lh; luteinizing hormone; lutenin; lutenizing hormone; ovulation test; p dose; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; tri; trip,Qn
40377-4,lutropin [units/volume] in serum or plasma --30 minutes post dose triple bolus,lh 30m p triple bolus serpl-acnc,lutropin 30 min post dose triple bolus qn,30m p triple bolus; after; arbitrary concentration; chemistry.challenge testing; endocrine; endocrinology; icsh; interstitial cell-stimulating hormone; interstitual cell stimulating hormone; leutinizing hormone; lh; luteinizing hormone; lutenin; lutenizing hormone; ovulation test; p dose; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; tri; trip,Qn
40379-0,maprotiline [presence] in gastric fluid,maprotiline gast ql,maprotiline ql (gast fld),drug/toxicology; drugs; gast; gastric contents; gastric fluid; ludiomil; novartis; ordinal; point in time; pr; ql; qual; qualitative; random; screen,Ord
40385-7,nicotine [presence] in meconium,nicotine mec ql,nicotine ql (mec),addiction; drug/toxicology; drugs; drugs of abuse; habitrol; illicit; mec; nicoderm; nictoine; ordinal; point in time; potentialforabuse; pr; ql; qual; qualitative; random; screen,Ord
4038-6,stanozolol [mass/time] in 24 hour urine,stanozolol 24h ur-mrate,stanozolol (24h u) [mass/time],1 day; 24 hours; 24hr; androstanazole; drug/toxicology; drugs; mass rate; methylstanazole; mrate; qnt; quan; quant; quantitative; stromba; strombaject; ua; ur; urn; winstrol,Qn
40389-9,nortriptyline [presence] in gastric fluid,nortrip gast ql,nortriptyline ql (gast fld),amitriptyline metabolite; aventyl; drug/toxicology; drugs; gast; gastric contents; gastric fluid; nortrip; nortriptylene; nortriptyln; ordinal; pamelor; point in time; pr; ql; qual; qualitative; random; screen,Ord
40393-1,pentazocine [presence] in gastric fluid,pentazocine gast ql,pentazocine ql (gast fld),addiction; drug/toxicology; drugs; drugs of abuse; gast; gastric contents; gastric fluid; illicit; ordinal; point in time; potentialforabuse; pr; ql; qual; qualitative; random; screen; talwin,Ord
40395-6,phentermine [presence] in gastric fluid,phentermine gast ql,phentermine ql (gast fld),addiction; drug/toxicology; drugs; drugs of abuse; gast; gastric contents; gastric fluid; illicit; ionamin; ordinal; point in time; potentialforabuse; pr; ql; qual; qualitative; random; screen,Ord
4042-8,sulfonamide [mass/volume] in urine,sulfonamide ur-mcnc,sulfonamide (u) [mass/vol],c75; drug/toxicology; drugs; level; mass concentration; point in time; qnt; quan; quant; quantitative; random; sulf; sulfa; sulfas; sulfonamides; ua; ur; urn,Qn
40432-7,osmotic fragility [interpretation] of red blood cells from control--incubated,of incubated rbc cont-imp,osmotic fragility incubated (rbc control) [interp],contrl; erythrocytes; frag; fragil; hematology/cell counts; impression; impression/interpretation of study; impressions; interp; interpretation; nominal; normal; of; osmo; osmo frag; point in time; random; red blood cells; red blood corpusles,Nom
40433-5,sucrose hemolysis of red blood cells from control,sucrose hemolysis nfr cont rbc,sucrose hemolysis (rbc control),contrl; erythrocytes; hem; hematology/cell counts; normal; number fraction; percent; pnh; point in time; qnt; quan; quant; quantitative; random; red blood cells; red blood corpusles; slt; sucro; sugar water test,Qn
40435-0,fungus identified in urine by culture,fungus ur cult,fungus identified cx nom (u),c&s; cult; cultures; fung; fungal; fungi; id; identity or presence; infectious disease; infectiousdisease; microbiology; nominal; point in time; random; ua; ur; urn,Nom
4044-4,tetracaine [mass/volume] in serum or plasma,tetracaine serpl-mcnc,tetracaine [mass/vol],c235; drug/toxicology; drugs; level; mass concentration; pl; plasma; plsm; point in time; pontocaine; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; tetrakain,Qn
40447-5,oxygen gas flow oxygen delivery system --resting,gas flow.o2 resting o2 delivery sys,,dynamic; flow; gas flow.o2; gases; lung; o2; o2 delivery sys; point in time; pulmonary; pulmonology; qnt; quan; quant; quantitative; random; respiratory; to2; volume rate; vrate,Qn
40454-1,clot lysis [presence] in platelet poor plasma by coagulation assay,clot lysis ppp ql,clot lysis coag ql (ppp),clot; clot firmness reduction; clot lysis; clottable; coagulation; coagulation assay; eug; euglobulin clot lysis time; hematology; heme; ordinal; plas; platelet poor plasma; point in time; pr; ql; qual; qualitative; random; screen; tilt tube,Ord
40470-7,lymphocytes [#/area] in semen by microscopy high power field,lymphocytes #/area smn hpf,lymphocytes lm.hpf (sem) [#/area],#/area; ejaculate; genitourinary; gu; hematology/cell counts; lm; lymp; lymph; lympho; lymphocyte; lymphs; lymphs%; micro; micros; microscopic; number areic; point in time; qnt; quan; quant; quantitative; random; sem; seminal fluid; smn; smpls; uro; urology,Qn
4047-7,theophylline [mass/volume] in blood,theophylline bld-mcnc,theophylline (bld) [mass/vol],aminophylline; biophyllin; blood; continus; drug/toxicology; drugs; lasma; level; mass concentration; nuelin; phyllocontin; point in time; pro-vent; qnt; quan; quant; quantitative; random; sabidal sr; slo-phyllin; somophyllin; somophylline; theo; theo-dur; theolair; uniphyllin; wb; whole blood,Qn
40483-0,phosphate crystals amorphous [#/area] in urine sediment by microscopy low power field,amorph phos cry #/area urns lpf,phosphate crystals amorphous lm.lpf (urine sed) [#/area],#/area; am; amorph; amorph cry; amorph phos cry; amorphic; crys; cryst; crystal; i phos; inorganic phosphate; kidney; lm; micro; micros; microscopic; nephrology; number areic; phos; phosphate total; phosphorous; phosphorus; phosphrous; pi; po4; point in time; qnt; quan; quant; quantitative; random; renal; ua; ur; urinalysis; urine sediment; urn; urns,Qn
40488-9,glucose/creatinine [ratio] in urine,glucose/creat ur-rto,glucose/creatinine (u) [ratio],chemistry; cr; crea; creat; glu; gluc; glucoseur; point in time; qnt; quan; quant; quantitative; random; ratios; rto; ua; ucr; ur; urn,Qn
4050-1,thiopental [mass/volume] in serum or plasma,thiopental serpl-mcnc,thiopental [mass/vol],barbiturate; drug/toxicology; drugs; level; mass concentration; pentothal; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
40505-0,chikungunya virus ab [titer] in serum by hemagglutination inhibition,chikv ab titr ser hai,chikv ab hai (s) [titer],abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; chikv; dilution factor; dilution factor (titer); hemagglutination inhibition; hi; id; infectious disease; infectiousdisease; microbiology; point in time; random; serum; smqn; sr; titer; titered; titre; ttr,SemiQn
40506-8,jamestown canyon virus ab [titer] in serum by immunofluorescence,jcv ab titr ser if,jamestown canyon virus ab if (s) [titer],abs; aby; acif; antby; anti; antibodies; antibody; anticomplement immunofluorescence; autoantibodies; autoantibody; dilution factor; dilution factor (titer); fa; fluorescent antibody; fluoresent; id; ifa; immune fluorescence; immunoflour; immunofluor; immunofluorescence; infectious disease; infectiousdisease; jcv; microbiology; point in time; random; serum; smqn; sr; time resolved fluorescence; titer; titered; titre; trf; ttr,SemiQn
40511-8,snowshoe hare virus ab [titer] in serum by hemagglutination inhibition,sshv ab titr ser hai,snowshoe hare virus ab hai (s) [titer],abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; dilution factor; dilution factor (titer); hemagglutination inhibition; hi; id; infectious disease; infectiousdisease; microbiology; point in time; random; serum; smqn; sr; sshv; titer; titered; titre; ttr,SemiQn
40539-9,eosinophils/leukocytes in peritoneal dialysis fluid by manual count,eosinophil nfr diafp manual,eosinophils/leukocytes manual cnt (perit dial fld),diaf; diafp; dialysate; dialysis fluid; eos; eosin; eosino; eosinophil; eosins; hematology/cell counts; leuc; leuk; leukocyte; lkcs; manl; number fraction; percent; peritoneal dialysis fluid; point in time; qnt; quan; quant; quantitative; random; wbc; wbcs; white blood cell; white blood cells,Qn
40543-1,leukocytes other/leukocytes in bronchial specimen by manual count,wbc other nfr bronch manual,wbc other/leukocytes manual cnt (bronch spec),bro; hematology/cell counts; leuc; leuk; leukocyte; lkcs; manl; number fraction; othr; percent; point in time; qnt; quan; quant; quantitative; random; wbc; wbc other; wbcs; white blood cell; white blood cells,Qn
40545-6,hemoglobin c [presence] in blood by electrophoresis,hgb c bld ql elph,hemoglobin c elph ql (bld),blood; elec; elect; electr; electro; electrophhrs; electrophrs; elp; elph; ep; haemoglobin; hb; hematology/cell counts; hgb; hgb c; ordinal; point in time; pr; ql; qual; qualitative; random; screen; wb; whole blood,Ord
40549-8,hemoglobin f [mass/volume] in blood by electrophoresis,hgb f bld elph-mcnc,hemoglobin f elph (bld) [mass/vol],blood; elec; elect; electr; electro; electrophhrs; electrophrs; elp; elph; ep; fetal hemoglobin; haemoglobin; hb; hbf; hematology/cell counts; hgb; hgb f; level; mass concentration; point in time; qnt; quan; quant; quantitative; random; wb; whole blood,Qn
40555-5,cd66e ag [presence] in tissue by immune stain,cd66e ag tiss ql imstn,cd66e ag immune stain ql (tiss),"antigen; antigens; carcinoembryonic antigen; cea; cell markers; ihc; imm; immunohistochemical stain; immunostain; imstn; imun; imune; ordinal; point in time; pr; ql; qual; qualitative; random; screen; st; stains; stn; tissue; tissue, unspecified",Ord
40567-0,myelocytes [#/volume] in body fluid by manual count,myelocytes # fld manual,myelocytes manual cnt (body fld) [#/vol],"#; abs; absolute; absolutes; b/f; bf; bod; bodies; body fluid; body fluid, unsp; cnt; count; count/volume; ct; fl; fld; flu; fluid; hematology/cell counts; manl; myel; myelo; myelocyte; number concentration; number concentration (count/vol); point in time; qnt; quan; quant; quantitative; random",Qn
40569-6,eosinophils [#/volume] in body fluid by manual count,eosinophil # fld manual,eosinophils manual cnt (body fld) [#/vol],"#; abs; absolute; absolutes; b/f; bf; bod; bodies; body fluid; body fluid, unsp; cnt; count; count/volume; ct; eos; eosin; eosino; eosinophil; eosins; fl; fld; flu; fluid; hematology/cell counts; manl; number concentration; number concentration (count/vol); point in time; qnt; quan; quant; quantitative; random",Qn
40577-9,yersinia enterocolitica o:3 ab [titer] in serum by agglutination,y entero o:3 ab titr ser aggl,y. enterocolitica o:3 ab aggl (s) [titer],abs; aby; agg; agglut; agglutination; antby; anti; antibodies; antibody; autoantibodies; autoantibody; dilution factor; dilution factor (titer); id; iii; infectious disease; infectiousdisease; microbiology; point in time; random; serum; smqn; sr; titer; titered; titre; ttr; y entero o:3; y entero o:3 ab; y enterocol; y enterocolitica,SemiQn
40586-0,deprecated heart beat^pre exercise: nrat: pt: xxx: qn: oximetry,deprecatedheart beat^pre exercise,,before; count/time; excz; heart rate; heart rate.molec; misc; miscellaneous; nrate; number rate; number rate = count/time; other; point in time; pre exc; pre exercise; pulse rate; qnt; quan; quant; quantitative; random; spec; to be specified in another part of the message; unspecified,Qn
40587-8,deprecated heart rate by oximetry --post exercise,deprecated heart rate p exc oximetry,,after; count/time; excz; heart beat; heart rate.molec; misc; miscellaneous; nrate; number rate; number rate = count/time; other; p exc; point in time; pst; pulse; qnt; quan; quant; quantitative; random; spec; to be specified in another part of the message; unspecified,Qn
40602-5,alpha 1 antitrypsin [presence] in urine by immunoelectrophoresis,a1at ur ql iep,alpha 1 antitrypsin iep ql (u),a1; a1a; a1at; a-1-at; a1-at; aat; alfa; alpha-1-antitrypsin.total; alpha-1-protease inhibitor; alpha-1-proteinase inhibitor; alpha-1-trypsin inhibitor; chemistry; hepatology; i; iep; imm elect; immunoelect; liver; lung; ordinal; point in time; pr; pulmonary; pulmonology; ql; qual; qualitative; random; respiratory; screen; ua; ur; urn,Ord
40608-2,ascaris lumbricoides igm ab [units/volume] in serum by immunoassay,a lumbric igm ser ia-acnc,a. lumbricoides igm ia qn (s),a lumbric; a lumbricoides; abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; eia; elfa; elisa; enzyme immunoassay; iaa; id; immune globulin m; immunoglobulin m; infectious disease; infectiousdisease; meia; microbiology; point in time; qnt; quan; quant; quantitative; random; serum; sr; suds,Qn
40620-7,carbon dioxide [partial pressure] adjusted to patient's actual temperature in capillary blood,pco2 temp adj bldc,co2 adjusted to patient's actual temperature (bldc) [partial pressure],adj; blood - capillary; cap bld; cap blood; capillary bld; capillary blood; carbonic anhydride; chemistry; co2; finger stick; lung; partial pressure; pco2; point in time; pulmonary; pulmonology; qnt; quan; quant; quantitative; random; respiratory; s prime; temp; temp adj,Qn
40623-1,cd3+cd4+ (t4 helper) cells/cells in bronchial specimen,cd3+cd4+ cells nfr bronch,cd3+cd4+ (t4 helper) cells/cells (bronch spec),bro; cd3 cells; cd3+cd4+ cells; cd3-cd4+; cd4+ t cells; cell; cell markers; cellularity; helper t cells; inducer t cells; l3t4; leu3; leu-3; leu4; leu-4; lung; number fraction; percent; point in time; pulmonary; pulmonology; qnt; quan; quant; quantitative; random; respiratory; t3; t4; t-4; t4 helper/inducer cells; w3/25,Qn
40624-9,cd3+cd8+ (t8 suppressor) cells/cells in bronchial specimen,cd3+cd8+ cells nfr bronch,cd3+cd8+ (t8 suppressor) cells/cells (bronch spec),bro; cd3 cells; cd3+cd8+ cells; cd8 t cells; cell; cell markers; cellularity; leu2; leu-2; leu4; leu-4; number fraction; percent; point in time; qnt; quan; quant; quantitative; random; suppressor t cells; suppressor/cytotoxic t cells; t3; t8; t-8; t8 suppressor cells; tsuppressor,Qn
40625-6,cocaine [presence] in specimen,cocaine spec ql,cocaine ql (specimen),addiction; benzoylmethylecgonine; coke; crack; drug/toxicology; drugs; drugs of abuse; ecgonine methyl ester benzoate; illicit; misc; miscellaneous; ordinal; other; point in time; potentialforabuse; pr; ql; qual; qualitative; random; screen; snow; spec; to be specified in another part of the message; unspecified,Ord
4063-4,trazodone [presence] in serum or plasma,trazodone serpl ql,trazodone ql,desyrel; drug/toxicology; drugs; ordinal; pl; plasma; plsm; point in time; pr; ql; qual; qualitative; random; screen; serp; serpl; serplas; serum; serum or plasma; sr; trazon; trialodine,Ord
40654-6,neutrophils.hypogranulated [presence] in blood by light microscopy,hypogran neuts bld ql smear,neutrophils.hypogranulated lm ql (bld),blood; hematology/cell counts; hypogran neuts; lm; micro; micros; microscopic; neut; neutr; neutrophil; ordinal; pmn; pnm; point in time; pr; ql; qual; qualitative; random; screen; wb; whole blood,Ord
40655-3,nuclear ab [titer] in serum by immunoassay,ana titr ser ia,nuclear ab ia (s) [titer],abs; aby; ana; anf; antby; anti; antibodies; antibody; antinuclear antibody; autoantibodies; autoantibody; dilution factor; dilution factor (titer); eia; elfa; elisa; enzyme immunoassay; iaa; meia; na; nuc; point in time; random; serology; serum; smqn; sr; suds; titer; titered; titre; ttr,SemiQn
4065-9,trazodone [presence] in urine,trazodone ur ql,trazodone ql (u),desyrel; drug/toxicology; drugs; ordinal; point in time; pr; ql; qual; qualitative; random; screen; trazon; trialodine; ua; ur; urn,Ord
40663-7,protein [mass/time] in 12 hour urine --upright,prot upr 12h ur-mrate,protein upright (12h u) [mass/time],12 hours; 12hr; chemistry; erect; kidney; mass rate; mrate; nephrology; pr; prot; qnt; quan; quant; quantitative; renal; standing; ua; upr; uprt; ur; urn,Qn
40672-8,sucrose [presence] in stool,sucrose stl ql,sucrose ql (stl),bowel movement; chemistry; faecal; faeces; fecal; feces; ordinal; point in time; pr; ql; qual; qualitative; random; screen; stl; stool = fecal; sucro,Ord
40684-3,acinetobacter sp multidrug resistant identified in specimen by organism specific culture,mdr-ab spec cult,acinetobacter sp multidrug resistant identified org specific cx nom (specimen),c&s; cult; cultures; id; identity or presence; infectious disease; infectiousdisease; mdr-ab; microbiology; misc; miscellaneous; nominal; other; point in time; random; spec; species; spp; to be specified in another part of the message; unspecified,Nom
40699-1,mycobacterium sp identified in specimen,mycobacterium spec,mycobacterium sp identified nom (specimen),acid fast; acid fast bacilli; acid fast bacillus; afb; id; identity or presence; infectious disease; infectiousdisease; microbiology; misc; miscellaneous; myco; mycobact; nominal; other; point in time; random; spec; species; spp; to be specified in another part of the message; tuberculosis; unspecified,Nom
4071-7,chloral hydrate [mass/volume] in blood,chloral hydrate bld-mcnc,chloral hydrate (bld) [mass/vol],blood; chloraldurat; chloralix; dormel; drug/toxicology; drugs; elix-node; level; mass concentration; medianox; noctec; pediatric chloral elixir; point in time; qnt; quan; quant; quantitative; random; trichloroethanol; trichloroethyl alcohol; trichloroethylalcohol; wb; welldorm; whole blood,Qn
40721-3,hemoglobin f [presence] in specimen by apt-downey method,hgb f spec ql apt-downey,hemoglobin f apt-downey method ql (specimen),fetal hemoglobin; haemoglobin; hb; hbf; hematology/cell counts; hgb; hgb f; misc; miscellaneous; ordinal; other; point in time; pr; ql; qual; qualitative; random; screen; spec; to be specified in another part of the message; unspecified,Ord
40725-4,hepatitis b virus core igg ab [presence] in serum by immunoassay,hbv core igg ser ql ia,hbv core igg ia ql (s),abs; aby; antby; anti; antibodies; antibody; anti-hbc; autoantibodies; autoantibody; eia; elfa; elisa; enzyme immunoassay; hbc; hbv; hbv core; hep; hep b; hepatis; hepatit; hepatitis bc; hepatology; hepb; iaa; id; immune globulin g; immunoglobulin g; infectious disease; infectiousdisease; liver; meia; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; sr; suds,Ord
40728-8,herpes simplex virus igg ab [presence] in serum by immunoassay,hsv igg ser ql ia,hsv igg ia ql (s),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; eia; elfa; elisa; enzyme immunoassay; herp splx; hsv; iaa; id; immune globulin g; immunoglobulin g; infectious disease; infectiousdisease; meia; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; sr; suds,Ord
40737-9,mumps virus igg ab [presence] in cerebral spinal fluid by immunoassay,muv igg csf ql ia,muv igg ia ql (csf),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; cerebral spinal fluid; cerebrospinal fl; eia; elfa; elisa; enzyme immunoassay; iaa; id; immune globulin g; immunoglobulin g; infectious disease; infectiousdisease; meia; microbiology; muv; neuro; neurology; ordinal; point in time; pr; ql; qual; qualitative; random; screen; spinal fl; spinal fld; spinal flu; spinal fluid; suds,Ord
40749-4,echinococcus sp ab [presence] in serum by complement fixation,echinococcus ab ser ql cf,echinococcus sp ab cf ql (s),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; cf; comp fixation; compfix; complement fixation; echinococcosis; id; infectious disease; infectiousdisease; microbiology; ordinal; p2; point in time; pr; ql; qual; qualitative; random; screen; serum; species; spp; sr,Ord
40762-7,coxsackievirus a ab [titer] in serum --1st specimen,cv a ab sp1 titr ser,coxsackievirus a ab spec 1 (s) [titer],abs; aby; acute specimen; antby; anti; antibodies; antibody; autoantibodies; autoantibody; cav; coxsackie; coxsackie virus; cv; cv a; dilution factor; dilution factor (titer); first; id; infectious disease; infectiousdisease; microbiology; point in time; pre immunization; random; serum; smqn; sp1; spec; sr; titer; titered; titre; ttr,SemiQn
40763-5,coxsackievirus b igm ab [titer] in serum --1st specimen,cv b igm sp1 titr ser,coxsackievirus b igm spec 1 (s) [titer],abs; aby; acute specimen; antby; anti; antibodies; antibody; autoantibodies; autoantibody; cav; cbv; coxsackie; coxsackie virus; cv; cv b; dilution factor; dilution factor (titer); first; id; immune globulin m; immunoglobulin m; infectious disease; infectiousdisease; microbiology; point in time; pre immunization; random; serum; smqn; sp1; spec; sr; titer; titered; titre; ttr,SemiQn
40766-8,coxsackievirus b igm ab [titer] in cerebral spinal fluid --1st specimen,cv b igm sp1 titr csf,coxsackievirus b igm spec 1 (csf) [titer],abs; aby; acute specimen; antby; anti; antibodies; antibody; autoantibodies; autoantibody; cav; cbv; cerebral spinal fluid; cerebrospinal fl; coxsackie; coxsackie virus; cv; cv b; dilution factor; dilution factor (titer); first; id; immune globulin m; immunoglobulin m; infectious disease; infectiousdisease; microbiology; neuro; neurology; point in time; pre immunization; random; smqn; sp1; spec; spinal fl; spinal fld; spinal flu; spinal fluid; titer; titered; titre; ttr,SemiQn
40773-4,histoplasma capsulatum igm ab [titer] in cerebral spinal fluid --1st specimen,h capsul igm sp1 titr csf,h. capsulatum igm spec 1 (csf) [titer],abs; aby; acute specimen; antby; anti; antibodies; antibody; autoantibodies; autoantibody; cerebral spinal fluid; cerebrospinal fl; dilution factor; dilution factor (titer); first; h capsul; h capsulatum; h farciminosum; histo; histopl; histoplasma farciminosum; histoplasmos; histoplasmosis; id; immune globulin m; immunoglobulin m; infectious disease; infectiousdisease; microbiology; neuro; neurology; point in time; pre immunization; random; smqn; sp1; spec; spinal fl; spinal fld; spinal flu; spinal fluid; titer; titered; titre; ttr,SemiQn
40774-2,histoplasma capsulatum igg ab [titer] in cerebral spinal fluid --2nd specimen,h capsul igg sp2 titr csf,h. capsulatum igg spec 2 (csf) [titer],abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; cerebral spinal fluid; cerebrospinal fl; convalescent; dilution factor; dilution factor (titer); h capsul; h capsulatum; h farciminosum; histo; histopl; histoplasma farciminosum; histoplasmos; histoplasmosis; id; immune globulin g; immunoglobulin g; infectious disease; infectiousdisease; microbiology; neuro; neurology; point in time; post immunization; random; second; smqn; sp2; spec; spinal fl; spinal fld; spinal flu; spinal fluid; titer; titered; titre; ttr,SemiQn
40784-1,streptococcus agalactiae ag [presence] in vaginal fluid,gp b strep ag vag ql,s. agalactiae ag ql (vag fld),antigen; antigens; gbs; genital vaginal; gp b strep; group b; group b strep; gyn; gynecology; id; infectious disease; infectiousdisease; microbiology; ob; obgyn; obstetrics; ordinal; point in time; pr; ql; qual; qualitative; random; s agalactiae; screen; steptococcus group b; strep; strep b; strep group b; strept; streptococci group b; vag fld; vag fluid; vagina; vaginal fluid,Ord
40787-4,calculus analysis [interpretation] in stone by infrared spectroscopy,stone analysis ir-imp,calculus analysis infrared spectroscopy [interp],calc; calculi; chemistry; gastro; gastroenterology; gi; impression; impression/interpretation of study; impressions; infared spectoscopy; interp; interpretation; ir; kidney; nephrology; nominal; point in time; random; renal; stn; stone; stone analysis; stones,Nom
4079-0,trimethoprim [presence] in serum or plasma,trimethoprim serpl ql,trimethoprim ql,c202; c242; c62; drug/toxicology; drugs; ordinal; pl; plasma; plsm; point in time; polytrim; pr; primsol; proloprim; ql; qual; qualitative; random; screen; serp; serpl; serplas; serum; serum or plasma; sr; tmp; trimeth; trimpex,Ord
40792-4,coproporphyrin 1 [moles/time] in 24 hour urine,copro1 24h ur-srate,coproporphyrin 1 (24h u) [moles/time],1 day; 24 hours; 24hr; chemistry; copro; copro1; coproporph; coproporphyrin i; coproporphyrins; hematology; heme; i; qnt; quan; quant; quantitative; srate; substance rate; tetracarboxyl porphyrin; tetracarboxylporphyrin; tetracarboxylporphyrins; tetracarboxyporphyrin; ua; ur; urn,Qn
40798-1,amphetamines [presence] in hair by screen method,amphetamines hair ql scn,amphetamines screen ql (hair),addiction; amph; amphetam; amphetamine; drug/toxicology; drugs; drugs of abuse; har; illicit; ordinal; point in time; potentialforabuse; pr; ql; qual; qualitative; random; scn; scr; screen; scrn; speed,Ord
40801-3,cannabinoids [presence] in saliva (oral fluid) by screen method,cannabinoids sal ql scn,cannabinoids screen ql (sal),addiction; cannabinoid; delta-9-tetrahydrocannabinol; drug/toxicology; drugs; drugs of abuse; illicit; marijuana; oral fluid; ordinal; point in time; potentialforabuse; pr; ql; qual; qualitative; random; sal; scn; scr; screen; scrn; thc,Ord
40802-1,cocaine [presence] in saliva (oral fluid) by screen method,cocaine sal ql scn,cocaine screen ql (sal),addiction; benzoylmethylecgonine; coke; crack; drug/toxicology; drugs; drugs of abuse; ecgonine methyl ester benzoate; illicit; oral fluid; ordinal; point in time; potentialforabuse; pr; ql; qual; qualitative; random; sal; scn; scr; screen; scrn; snow,Ord
40804-7,methamphetamine [presence] in saliva (oral fluid) by screen method,methamphet sal ql scn,methamphetamine screen ql (sal),addiction; desoxyn; drug/toxicology; drugs; drugs of abuse; illicit; methamphet; oral fluid; ordinal; point in time; potentialforabuse; pr; ql; qual; qualitative; random; sal; scn; scr; screen; scrn,Ord
40815-3,11-ketoetiocholanolone/creatinine [mass ratio] in 24 hour urine,11ketoetioch/creat 24h ur,11-ketoetiocholanolone/creatinine (24h u) [mass ratio],1 day; 11ketoetioch; 24 hours; 24hr; chemistry; cr; crea; creat; ketoetiochol; mass concentration ratio; mass ratio; mcrto; qnt; quan; quant; quantitative; ua; ucr; ur; urn,Qn
40833-6,sod1 gene allele 1 [identifier] in blood or tissue by molecular genetics method nominal,sod1 allele 1 bld/t,sod1 gene allele 1 molgen nom (bld/tiss),"als; als1; amyotrophic lateral sclerosis 1; blood; cu,zn superoxide dismutase gene; genetics; hel-s-44; heredity; heritable; homodimer; hsod1; i; identity or presence; indophenoloxidase a gene; inherited; ipoa; lou gehrig's disease; molecular genetics; molecular pathology; molpath; molpath.mutations; nominal; pcr; point in time; random; sod; sod1 allele 1; superoxide dismutase 1 gene; superoxide dismutase 1, soluble; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",Nom
40838-5,argininosuccinate [moles/volume] in cerebral spinal fluid,argininosuccinate csf-scnc,argininosuccinate (csf) [moles/vol],argininosuccinic acid; arginosuccinate; arginosuccinic acid; asa; cerebral spinal fluid; cerebrospinal fl; chemistry; level; point in time; qnt; quan; quant; quantitative; random; spinal fl; spinal fld; spinal flu; spinal fluid; substance concentration,Qn
40853-4,leishmania sp igg ab [units/volume] in cerebral spinal fluid,leishmania igg csf-acnc,leishmania sp igg qn (csf),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; cerebral spinal fluid; cerebrospinal fl; id; immune globulin g; immunoglobulin g; infectious disease; infectiousdisease; kala azar; leishmaniasis; leishmaniosis; microbiology; neuro; neurology; point in time; qnt; quan; quant; quantitative; random; species; spinal fl; spinal fld; spinal flu; spinal fluid; spp; visceral leishmaniasis,Qn
40855-9,chlamydia trachomatis l2 iga ab [titer] in serum,c trach l2 iga titr ser,c. trachomatis l2 iga (s) [titer],abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; c trac; c trach; c trach l2; c tracho; c trachomatis; chlam; chlam trac; chlamid; ct; dilution factor; dilution factor (titer); id; immune globulin a; immunoglobulin a; infectious disease; infectiousdisease; lgv; lymphogranuloma venereum; microbiology; point in time; random; serum; smqn; sr; titer; titered; titre; trachoma; ttr,SemiQn
40866-6,11-oxo-androsterone/creatinine [mass ratio] in 24 hour urine,11oxoandrost/creat 24h ur,11-oxo-androsterone/creatinine (24h u) [mass ratio],1 day; 11oxoandrost; 24 hours; 24hr; androster; chemistry; cr; crea; creat; mass concentration ratio; mass ratio; mcrto; qnt; quan; quant; quantitative; ua; ucr; ur; urn,Qn
40881-5,cd3-cd57+ cells/cells in bone marrow,cd3-cd57+ cells nfr mar,cd3-cd57+ cells/cells (bm),bm; bon; bone marrow; cd3 cells; cd3+cd57+ cells; cd3-cd57+ cells; cell; cell markers; cellularity; hnk1; leu4; leu-4; leu7; leu-7; lyme disease; mar; marrow (bone); minimal angle of resolution; minimum angle of resolution; number fraction; percent; point in time; qnt; quan; quant; quantitative; random; t3,Qn
40884-9,cd19+cd103+ cells/cells in tissue,cd19+cd103+ cells nfr tiss,cd19+cd103+ cells/cells (tiss),"b cells expressing cd19 as a percent of total lymphocytes; b4; b-4; cd19 cells; cd19+cd103+ cells; cell; cell markers; cellularity; hd-37; hml-1; human mucosal lymphocyte antigen 1; integrin alphae chain; itgae; leu12; leu-12; number fraction; percent; point in time; qnt; quan; quant; quantitative; random; tissue; tissue, unspecified",Qn
40885-6,cd19+cd103+ cells/cells in blood,cd19+cd103+ cells nfr bld,cd19+cd103+ cells/cells (bld),b cells expressing cd19 as a percent of total lymphocytes; b4; b-4; blood; cd19 cells; cd19+cd103+ cells; cell; cell markers; cellularity; hd-37; hml-1; human mucosal lymphocyte antigen 1; integrin alphae chain; itgae; leu12; leu-12; number fraction; percent; point in time; qnt; quan; quant; quantitative; random; wb; whole blood,Qn
40895-5,cd3+cd56+ cells [#/volume] in bone marrow,cd3+cd56+ cells # mar,cd3+cd56+ cells (bm) [#/vol],#; abs; absolute; absolutes; bm; bon; bone marrow; cd3 cells; cd3+cd56+ cells; cd3-cd56+ cells; cell; cell markers; cellularity; cnt; count; count/volume; ct; leu19; leu-19; leu4; leu-4; mar; marrow (bone); minimal angle of resolution; minimum angle of resolution; natural killer cells; ncam; neural cell adhesion molecule; nkh1; number concentration; number concentration (count/vol); point in time; qnt; quan; quant; quantitative; random; t3,Qn
4089-9,vancomycin free [mass/volume] in serum or plasma,vancomycin free serpl-mcnc,vancomycin free [mass/vol],c162; drug/toxicology; drugs; fr; level; mass concentration; non-protein bound; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; vanc; vancocin; vancomycin free; vancor,Qn
40903-7,deprecated streptococcus pneumoniae 12 igg ab [mass/volume] in serum by immunoassay,deprecated s pneum12 igg ser ia-mcnc,s. pneumoniae 12 igg ia (s) [mass/vol],abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; eia; elfa; elisa; enzyme immunoassay; iaa; id; immune globulin g; immunoglobulin g; infectious disease; infectiousdisease; level; mass concentration; meia; microbiology; pneu; pneum; pneumo; pneumococ; pneumococcal; pneumococcal pneumonia; pneumococcus; pneumon; pneumonia; point in time; qnt; quan; quant; quantitative; random; s pneum12; s pneumo; s pneumoniae; serum; spn; sr; strep; strept; streptococcus pneumoniae 12f; suds,Qn
40904-5,deprecated streptococcus pneumoniae 12 igg ab [mass/volume] in serum by immunoassay --1st specimen,deprecated s pneum12 igg sp1 ser ia-mcnc,s. pneumoniae 12 igg spec 1 ia (s) [mass/vol],abs; aby; acute specimen; antby; anti; antibodies; antibody; autoantibodies; autoantibody; eia; elfa; elisa; enzyme immunoassay; first; iaa; id; immune globulin g; immunoglobulin g; infectious disease; infectiousdisease; level; mass concentration; meia; microbiology; pneu; pneum; pneumo; pneumococ; pneumococcal; pneumococcal pneumonia; pneumococcus; pneumon; pneumonia; point in time; pre immunization; qnt; quan; quant; quantitative; random; s pneum12; s pneumo; s pneumoniae; serum; sp1; spec; spn; sr; strep; strept; streptococcus pneumoniae 12f; suds,Qn
40908-6,deprecated streptococcus pneumoniae 4 igg ab [mass/volume] in serum by immunoassay,deprecated s pneum4 igg ser ia-mcnc,s. pneumoniae 4 igg ia (s) [mass/vol],abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; eia; elfa; elisa; enzyme immunoassay; iaa; id; immune globulin g; immunoglobulin g; infectious disease; infectiousdisease; level; mass concentration; meia; microbiology; pneu; pneum; pneumo; pneumococ; pneumococcal; pneumococcal pneumonia; pneumococcus; pneumon; pneumonia; point in time; qnt; quan; quant; quantitative; random; s pneum4; s pneumo; s pneumoniae; serum; spn; sr; strep; strept; suds,Qn
40910-2,deprecated streptococcus pneumoniae 4 igg ab [mass/volume] in serum by immunoassay --2nd specimen,deprecated s pneum4 igg sp2 ser ia-mcnc,s. pneumoniae 4 igg spec 2 ia (s) [mass/vol],abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; convalescent; eia; elfa; elisa; enzyme immunoassay; iaa; id; immune globulin g; immunoglobulin g; infectious disease; infectiousdisease; level; mass concentration; meia; microbiology; pneu; pneum; pneumo; pneumococ; pneumococcal; pneumococcal pneumonia; pneumococcus; pneumon; pneumonia; point in time; post immunization; qnt; quan; quant; quantitative; random; s pneum4; s pneumo; s pneumoniae; second; serum; sp2; spec; spn; sr; strep; strept; suds,Qn
40914-4,streptococcus pneumoniae danish serotype 18c igg ab [mass/volume] in serum by immunoassay --1st specimen,s pneum da 18c igg sp1 ser ia-mcnc,s. pneumoniae danish type 18c igg spec 1 ia (s) [mass/vol],abs; aby; acute specimen; antby; anti; antibodies; antibody; autoantibodies; autoantibody; eia; elfa; elisa; enzyme immunoassay; first; iaa; id; immune globulin g; immunoglobulin g; infectious disease; infectiousdisease; level; mass concentration; meia; microbiology; pcv13; pcv7; pneu; pneum; pneumo; pneumococ; pneumococcal; pneumococcal pneumonia; pneumococcus; pneumon; pneumonia; point in time; ppsv23; pre immunization; qnt; quan; quant; quantitative; random; s pneum da 18c; s pneum da 18c ab; s pneum da 18c igg; s pneum da type; s pneumo; s pneumoniae; serum; sp1; spec; spn; sr; strep; strept; suds; u.s. serotype 56,Qn
40934-2,yersinia enterocolitica o:8 ab [presence] in serum,y entero o:8 ab ser ql,y. enterocolitica o:8 ab ql (s),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; id; infectious disease; infectiousdisease; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; sr; y entero o:8; y enterocol; y enterocolitica,Ord
40939-1,yersinia sp igm ab [units/volume] in serum by immunoassay,yersinia igm ser ia-acnc,yersinia sp igm ia qn (s),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; eia; elfa; elisa; enzyme immunoassay; iaa; id; immune globulin m; immunoglobulin m; infectious disease; infectiousdisease; meia; microbiology; point in time; qnt; quan; quant; quantitative; random; serum; species; spp; sr; suds,Qn
40944-1,yohimbine [mass/volume] in serum or plasma,yohimbine serpl-mcnc,yohimbine [mass/vol],actibine; aphrodyne; baron-x; dayto himbin; drug/toxicology; drugs; level; mass concentration; pl; plasma; plsm; point in time; prohim; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; thybine; yocon; yohimar; yohimex; yoman; yovital,Qn
4095-6,verapamil [presence] in urine,verapamil ur ql,verapamil ql (u),apo-trimip; calan; drug/toxicology; drugs; isoptin; ordinal; point in time; pr; ql; qual; qualitative; random; screen; ua; ur; urn,Ord
40957-3,zinc [presence] in urine,zinc ur ql,zinc ql (u),drug/toxicology; drugs; ordinal; point in time; pr; ql; qual; qualitative; random; screen; ua; ur; urn; zn,Ord
40968-0,deprecated streptococcus pneumoniae 43 igg ab [mass/volume] in serum,deprecated s pneum43 igg ser-mcnc,s. pneumoniae 43 igg (s) [mass/vol],abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; id; immune globulin g; immunoglobulin g; infectious disease; infectiousdisease; level; mass concentration; microbiology; pneu; pneum; pneumo; pneumococ; pneumococcal; pneumococcal pneumonia; pneumococcus; pneumon; pneumonia; point in time; qnt; quan; quant; quantitative; random; s pneum43; s pneumo; s pneumoniae; serum; spn; sr; strep; strept; streptococcus pneumoniae 11a,Qn
40972-2,xxx microorganism dna [presence] in serum or plasma by naa with probe detection,other microorg dna serpl ql naa+probe,unsp microorganism dna naa+probe ql,3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; deoxyribonucleic acid; dna nucleic acid probe; dna probe; id; infectious disease; infectiousdisease; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; microorganisms; naa+probe; naat; nasba; nucleic acid sequence based analysis; ordinal; org; organism; organisms; other microorg; pcr; pl; plasma; plsm; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; screen; sda; serp; serpl; serplas; serum; serum or plasma; sr; strand displacement amplification; tma; transcription mediated amplification,Ord
40982-1,influenza virus b rna [presence] in specimen by naa with probe detection,flubv rna spec ql naa+probe,flubv rna naa+probe ql (specimen),3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; dna nucleic acid probe; dna probe; flub; flubv; fluv; id; infectious disease; infectiousdisease; influ; influenza b; influenza b virus; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; misc; miscellaneous; naa+probe; naat; nasba; nucleic acid sequence based analysis; ordinal; other; pcr; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; ribonucleic acid; screen; sda; spec; strand displacement amplification; tma; to be specified in another part of the message; transcription mediated amplification; unspecified,Ord
40998-7,calcium hydrogen phosphate dihydrate/total in stone,ca h2 phos dihyd mfr stone,calcium hydrogen phosphate dihydrate (stone) [mass fraction],brushite; ca; ca h2 phos dihyd; cal; calc; calculi; chemistry; chpd; gastro; gastroenterology; gi; h2; hyd; i phos; inorganic phosphate; kidney; mass fraction; nephrology; percent; phos; phosphate total; phosphorous; phosphorus; phosphrous; pi; po4; point in time; qnt; quan; quant; quantitative; random; renal; stn; stone; stones; tot; totl,Qn
41000-1,human coronavirus rna [identifier] in specimen by naa with probe detection,hcov rna spec naa+probe,hcov rna naa+probe nom (specimen),3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; corona virus; dna nucleic acid probe; dna probe; hcov; id; identity or presence; infectious disease; infectiousdisease; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; misc; miscellaneous; naa+probe; naat; nasba; nominal; nucleic acid sequence based analysis; other; pcr; point in time; polymerase chain reaction; probe amp; probe with ampification; probe with target amplification; qbr; random; ribonucleic acid; sda; spec; strand displacement amplification; tma; to be specified in another part of the message; transcription mediated amplification; unspecified,Nom
41013-4,human coronavirus 229e igg ab [presence] in serum,hcov 229e igg ser ql,hcov 229e igg ql (s),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; corona virus; hcov; hcov 229e; id; immune globulin g; immunoglobulin g; infectious disease; infectiousdisease; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; sr,Ord
41022-5,citrate [molar amount] in urine collected for unspecified duration,citrate ?tm sub ur qn,citrate unsp time (u) [molar amount],?tm; chemistry; citric acid; qnt; quan; quant; quantitative; substance amount; ua; ur; urn,Qn
41026-6,fungus identified in genital specimen by culture,fungus genital cult,fungus identified cx nom (genital specimen),c&s; cult; cultures; fung; fungal; fungi; gen; genital tract; id; identity or presence; infectious disease; infectiousdisease; microbiology; nominal; point in time; random; urogenit; urogenital,Nom
41040-7,palmitoylcarnitine (c16) [moles/volume] in blood,palmitoylcarn bld-scnc,c16 (bld) [moles/vol],blood; c16; chemistry; hexadecanoylcarnitine; level; point in time; qnt; quan; quant; quantitative; random; substance concentration; wb; whole blood,Qn
41041-5,3-hydroxypalmitoylcarnitine (c16-oh) [moles/volume] in blood,3oh-palmitoylcarn bld-scnc,c16-oh (bld) [moles/vol],3-hydroxyhexadecanoylcarnitine; 3-hydroxy-hexadecanoylcarnitine; 3-hydroxy-palmitoylcarnitine; 3oh-palmitoylcarn; blood; c16oh; c16-oh; chemistry; iii; level; point in time; qnt; quan; quant; quantitative; random; substance concentration; wb; whole blood,Qn
41043-1,vhl gene mutations found [identifier] in blood or tissue by molecular genetics method nominal,vhl gene mut anl bld/t,vhl gene targeted mutation analysis molgen nom (bld/tiss),"blood; genetics; heredity; heritable; hrca1; identity or presence; inherited; molecular genetics; molecular pathology; molpath; molpath.mutations; mut; mut anl; mutations; nominal; pcr; point in time; pvhl; random; rca1; tissue; tissue, unspecified; vhl1; von hippel-lindau syndrome; von hippel-lindau tumor suppressor, e3 ubiquitin protein ligase; wb; whole blood; whole blood or tissue",Nom
41050-6,th gene mutations found [identifier] in blood or tissue by molecular genetics method nominal,th gene mut anl bld/t,th gene targeted mutation analysis molgen nom (bld/tiss),"blood; dyt14; dyt5b; genetics; heredity; heritable; identity or presence; inherited; molecular genetics; molecular pathology; molpath; molpath.mutations; mut; mut anl; mutations; nominal; pcr; point in time; random; thallium; tissue; tissue, unspecified; tyh; tyrosine 3-monooxygenase gene; tyrosine hydroxylase; tyrosine hydroxylase gene; wb; whole blood; whole blood or tissue",Nom
41056-3,slc22a18 gene mutations found [identifier] in blood or tissue by molecular genetics method nominal,slc22a18 gene mut anl bld/t,slc22a18 gene targeted mutation analysis molgen nom (bld/tiss),"beckwith-wiedemann syndrome chromosome region 1, candidate a; blood; bwr1a; bwscr1a; genetics; heredity; heritable; het; identity or presence; imprinted polyspecific membrane transporter 1; impt1; inherited; itm; molecular genetics; molecular pathology; molpath; molpath.mutations; mut; mut anl; mutations; nominal; orctl2; organic cation transporter-like 2; p45-bwr1a; pcr; point in time; random; slc22a1l; solute carrier family 22 (organic cation transporter), member 18; solute carrier family 22 (organic cation transporter), member 1-like; solute carrier family 22, member 18; tissue; tissue, unspecified; tssc5; wb; whole blood; whole blood or tissue",Nom
41060-5,sftpb gene mutations found [identifier] in blood or tissue by molecular genetics method nominal,sftpb gene mut anl bld/t,sftpb gene targeted mutation analysis molgen nom (bld/tiss),"blood; genetics; heredity; heritable; identity or presence; inherited; molecular genetics; molecular pathology; molpath; molpath.mutations; mut; mut anl; mutations; nominal; pcr; point in time; psp-b; random; sftb3; sftp3; smdp1; sp-b; surfactant protein b; surfactant, pulmonary-associated protein b gene; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",Nom
41073-8,nr0b1 gene mutations found [identifier] in blood or tissue by molecular genetics method nominal,nr0b1 gene mut anl bld/t,nr0b1 gene targeted mutation analysis molgen nom (bld/tiss),"adrenal hypoplasia congenita; ahc; ahch; ahcx; ahx; blood; dax1; dax-1; dss; genetics; gtd; heredity; heritable; hhg; identity or presence; inherited; molecular genetics; molecular pathology; molpath; molpath.mutations; mut; mut anl; mutations; nominal; nrob1; nuclear receptor subfamily 0, group b, member 1; pcr; point in time; random; srxy2; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",Nom
41076-1,npdc gene mutations found [identifier] in blood or tissue by molecular genetics method nominal,npdc gene mut anl bld/t,npdc gene targeted mutation analysis molgen nom (bld/tiss),"blood; genetics; heredity; heritable; identity or presence; inherited; molecular genetics; molecular pathology; molpath; molpath.mutations; mut; mut anl; mutations; niemann-pick disease type c; nieman-pick disease type c; nominal; pcr; point in time; random; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",Nom
4107-9,acyclovir [mass] of dose,acyclovir dose,acyclovir (dose) [mass],aciclovir; acifur; acv; acycloguanosine; avirax; dose med or substance; drug doses; point in time; qnt; quan; quant; quantitative; random; zovirax,Qn
41080-3,myotonic dystrophy gene mutations found [identifier] in blood or tissue by molecular genetics method nominal,mmd gene mut anl bld/t,myotonic dystrophy gene targeted mutation analysis molgen nom (bld/tiss),"blood; dm; genetics; heredity; heritable; identity or presence; inherited; mmd; mmd gene; molecular genetics; molecular pathology; molpath; molpath.mutations; mut; mut anl; mutations; myotonic muscular dystrophy; nominal; pcr; point in time; promm; proximal myotonic myopathy; random; steinert disease; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",Nom
41083-7,mtm1 gene mutations found [identifier] in blood or tissue by molecular genetics method nominal,mtm1 gene mut anl bld/t,mtm1 gene targeted mutation analysis molgen nom (bld/tiss),"blood; cg2; cnm; genetics; heredity; heritable; identity or presence; inherited; molecular genetics; molecular pathology; molpath; molpath.mutations; mtmx; mut; mut anl; mutations; myotubular myopathy 1; myotubularin 1; myotubularin gene; nominal; pcr; point in time; random; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue; xlmtm",Nom
41112-4,cmt axonal gene mutations found [identifier] in blood or tissue by molecular genetics method nominal,cmt2 gene mut anl bld/t,cmt axonal gene targeted mutation analysis molgen nom (bld/tiss),"axonal hmsn; blood; charcot-marie tooth disease, type 2; cmt; cmt2; cmt2 gene; genetics; gjb, mpz and nefl gene mutations; heredity; heritable; identity or presence; inherited; molecular genetics; molecular pathology; molpath; molpath.mutations; mut; mut anl; mutations; nominal; pcr; point in time; random; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",Nom
41126-4,deprecated salmonella typhi o d ab [presence] in serum,deprecated s typhi o d ab ser ql,s. typhi o d ab ql (s),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; dextro; id; infectious disease; infectiousdisease; microbiology; ordinal; point in time; ql; qual; qualitative; random; rh; rhesus; s typhi; s typhi o; s typhi o d; s typhosa; sal; salmonel; screen; serum; sr; typh; typhoid,Ord
41127-2,salmonella gallinarum ab [presence] in blood,s gallinarum ab bld ql,s. gallinarum ab ql (bld),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; blood; fowl typhoid; id; infectious disease; infectiousdisease; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; s gallinarum; sal; salmonel; screen; vet; veterinary; wb; whole blood,Ord
41130-6,mycobacterium avium ss paratuberculosis ab [units/volume] in serum,m avium paratb ab ser-acnc,m. avium ss paratuberculosis ab qn (s),abs; aby; acid fast; acid fast bacilli; acid fast bacillus; afb; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; id; infectious disease; infectiousdisease; johnes disease; m avium; m avium paratb; microbiology; myco; mycobact; mycobacterium paratuberculosis; paratuberculosis; point in time; qnt; quan; quant; quantitative; random; serum; sr; ssp; tuberculosis; vet; veterinary,Qn
41147-0,herpes virus 6 igm ab [presence] in serum,hhv6 igm ser ql,hhv 6 igm ql (s),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; herpesvirus; hhv; hhv6; hhv-6; human herpes virus; human herpes virus type 6; id; immune globulin m; immunoglobulin m; infectious disease; infectiousdisease; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; sr,Ord
41183-5,western equine encephalitis virus ab [titer] in serum by complement fixation,weev ab titr ser cf,weev ab cf (s) [titer],abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; cf; comp fixation; compfix; complement fixation; dilution factor; dilution factor (titer); enc; enceph; encephalomyelitis; equin; id; infectious disease; infectiousdisease; microbiology; point in time; random; serum; smqn; sr; titer; titered; titre; togavirus; ttr; wee virus; weev; west,SemiQn
41190-0,waxy casts [presence] in urine by computer assisted method,waxy casts ur ql comp assist,waxy casts computer assisted ql (u),artificial intelligence; automated detection; cast; comp assist; kidney; nephrology; ordinal; point in time; pr; ql; qual; qualitative; random; renal; screen; ua; ur; urinalysis; urn,Ord
41193-4,whitefaced hornet igg4 ab [presence] in serum,whitefaced hornet igg4 ql,whitefaced hornet igg4 ql (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; bald-faced hornet; i002; i2; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; sr; wasp; white faced hornet; whitefaced hornet,Ord
41207-2,wheat ige ab/ige total in serum,wheat ige/ige total %,wheat ige/total ige (s) [%],%; abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; f004; f4; ige total; immune globulin e; immunoglobulin e; point in time; qnt; quan; quant; quantitative; random; serum; sr; tot; total ige; totl; triticum sativum; wheat,Qn
41239-5,yellow fever virus ab [presence] in cerebral spinal fluid,yfv ab csf ql,yellow fever virus ab ql (csf),abs; aby; american plague; antby; anti; antibodies; antibody; autoantibodies; autoantibody; cerebral spinal fluid; cerebrospinal fl; id; infectious disease; infectiousdisease; microbiology; neuro; neurology; ordinal; point in time; pr; ql; qual; qualitative; random; screen; spinal fl; spinal fld; spinal flu; spinal fluid; yellow jack; yfv,Ord
4124-4,diethylpropion [mass] of dose,diethylpropion dose,diethylpropion (dose) [mass],addiction; amphepramone; diethylprop; dose med or substance; drug doses; drugs of abuse; illicit; point in time; potentialforabuse; qnt; quan; quant; quantitative; random; tenuate,Qn
41257-7,xylose [mass/volume] in urine --2 hours post 25 g xylose po,xylose 2h p 25 g xyl po ur-mcnc,xylose 2 hr post 25 g xylose po (u) [mass/vol],120 min; 120 minutes; 120min; 2 hours; 2h p 25 g xyl po; after; chemistry.challenge testing; d-xylose; level; mass concentration; p 25 g xyl po; point in time; pst; qnt; quan; quant; quantitative; random; ua; ur; urn; xylose absorption test,Qn
41283-3,hla-dq8 [presence],hla-dq8 ql,hla-dq8 ql (bld/tiss),"blood; genetics; heredity; heritable; hla antigen; human leukocyte antigen; inherited; ordinal; point in time; pr; ql; qual; qualitative; random; screen; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",Ord
41302-1,deprecated shoulder - left adduction passive range of motion quantitative,,,adduction prom; h+p; h+p.px; l; lt; msk; musculoskeletal; ortho; orthopedics; p prime; point in time; prom; qnt; quan; quant; quantitative; random; rnge; should-l; upper extremity joint,Qn
41303-9,shoulder - left internal rotation active range of motion quantitative,should-l int rot arom qn,,arom; h+p; h+p.px; int rot arom; l; lt; msk; musculoskeletal; ortho; orthopedics; p prime; point in time; qnt; quan; quant; quantitative; random; rnge; should-l; upper extremity joint,Qn
41310-4,shoulder - right extension passive range of motion quantitative,should-r ext prom qn,,ext; ext prom; h+p; h+p.px; msk; musculoskeletal; ortho; orthopedics; p prime; point in time; prom; qnt; quan; quant; quantitative; r; random; rnge; rt; should-r; upper extremity joint,Qn
41316-1,shoulder - right internal rotation passive range of motion quantitative,should-r int rot prom qn,,h+p; h+p.px; int rot prom; msk; musculoskeletal; ortho; orthopedics; p prime; point in time; prom; qnt; quan; quant; quantitative; r; random; rnge; rt; should-r; upper extremity joint,Qn
41318-7,shoulder - right external rotation passive range of motion quantitative,should-r ext rot prom qn,,ext; ext rot prom; h+p; h+p.px; msk; musculoskeletal; ortho; orthopedics; p prime; point in time; prom; qnt; quan; quant; quantitative; r; random; rnge; rt; should-r; upper extremity joint,Qn
4131-9,ascorbate.po [mass] of dose,vit c po dose,ascorbate.po (dose) [mass],ascorbic acid; c702; dose med or substance; drug doses; point in time; qnt; quan; quant; quantitative; random; vit c; vit c po; vitamin c,Qn
41338-5,hip - right adduction passive range of motion quantitative,hip-r adduction prom qn,,adduction prom; h+p; h+p.px; hip-r; lower extremity joint; msk; musculoskeletal; ortho; orthopedics; p prime; point in time; prom; qnt; quan; quant; quantitative; r; random; rnge; rt,Qn
41348-4,knee - right flexion passive range of motion quantitative,knee-r flx prom qn,,flx prom; h+p; h+p.px; kn; knee-r; lower extremity joint; msk; musculoskeletal; ortho; orthopedics; p prime; point in time; prom; qnt; quan; quant; quantitative; r; random; rnge; rt,Qn
41351-8,elbow - left flexion active range of motion quantitative,elbow-l flx arom qn,,arom; elbow-l; flx arom; h+p; h+p.px; l; lt; msk; musculoskeletal; olecranon; ortho; orthopedics; p prime; point in time; qnt; quan; quant; quantitative; random; rnge; upper extremity joint,Qn
41359-1,active range of motion panel quantitative,active range of motion pnl qn,,active range of motion pnl; arom; h+p; p prime; pan; panel.h&p; panl; pnl; point in time; qnt; quan; quant; quantitative; random; rnge,Qn
41393-0,collection date of body fluid,collect date fld,collection date (body fld) [date/time],"b/f; bf; bod; bodies; body fluid; body fluid, unsp; coll; collect; collect date; collected; date and time; fl; fld; flu; fluid; point in time; qnt; quan; quant; quantitative; random; spec; time stamp; timestamp",Qn
41408-6,ofloxacin 1 ug/ml [susceptibility] by method for slow-growing mycobacteria,ofloxacin 1 ug/ml islt slowmyco,ofloxacin 1 ug/ml method for slow-growing mycobacteria [susc],1 ug/ml; afb; antibiotic susceptibilities; ast; c409; floxin; id; infectious disease; infectiousdisease; islt; isol; mcg; myco; mycobacteria susceptibility; mycobacterial susceptibility; point in time; random; slowmyco; sus; suscept; susceptibilities; susceptibility; susceptibilty; tb; tuberculosis,OrdQn
41418-5,gnathostoma sp ab [presence] in serum by immunoblot,gnathostoma ab ser ql ib,gnathostoma sp ab ib ql (s),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; blt; id; immune blot; immunobl; immunoblot; infectious disease; infectiousdisease; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; riba; screen; serum; species; spp; sr; wb; wblot; west blot; west blt; western blot,Ord
41424-3,schistosoma mansoni ab [presence] in specimen by immunoblot,s mansoni ab spec ql ib,s. mansoni ab ib ql (specimen),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; bilharziasis; blt; id; immune blot; immunobl; immunoblot; infectious disease; infectiousdisease; microbiology; misc; miscellaneous; ordinal; other; p3; point in time; pr; ql; qual; qualitative; random; riba; s mansoni; schistosomiasis; screen; spec; to be specified in another part of the message; unspecified; wb; wblot; west blot; west blt; western blot,Ord
41425-0,toxocara canis ab [titer] in specimen by immunoassay,t canis ab titr spec ia,t. canis ab ia (specimen) [titer],abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; dilution factor; dilution factor (titer); eia; elfa; elisa; enzyme immunoassay; iaa; id; infectious disease; infectiousdisease; meia; microbiology; misc; miscellaneous; other; point in time; random; smqn; spec; suds; t canis; titer; titered; titre; to be specified in another part of the message; ttr; unspecified; visceral larva migrans,SemiQn
41444-1,naegleria fowleri dna [presence] in cerebral spinal fluid by naa with probe detection,n fowleri dna csf ql naa+probe,n. fowleri dna naa+probe ql (csf),3 self-sustaining sequence replication; 3sr sr; amebic meningoencephalitis; amplif; amplification; amplified; cerebral spinal fluid; cerebrospinal fl; deoxyribonucleic acid; dna nucleic acid probe; dna probe; id; infectious disease; infectiousdisease; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; n fowleri; naa+probe; naat; nasba; neuro; neurology; nucleic acid sequence based analysis; ordinal; pcr; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; screen; sda; spinal fl; spinal fld; spinal flu; spinal fluid; strand displacement amplification; tma; transcription mediated amplification,Ord
41446-6,parasite identified in specimen by culture,parasite spec cult,parasite identified cx nom (specimen),c&s; cult; cultures; id; identity or presence; infectious disease; infectiousdisease; microbiology; misc; miscellaneous; nominal; other; parasites; point in time; random; spec; to be specified in another part of the message; unspecified,Nom
4145-9,brompheniramine [mass] of dose,brompheniramine dose,brompheniramine (dose) [mass],antial; bpn; bromarest; bromfed; bromfenex; dimegan; dimetane; dimetapp; dimotane; dose med or substance; drug doses; gammistin; ilvin; lodrane; parabromdylamine maleate; point in time; probahist; qnt; quan; quant; quantitative; random,Qn
41470-6,atazanavir [mass/volume] in serum or plasma,atazanavir serpl-mcnc,atazanavir [mass/vol],atv; drug/toxicology; drugs; level; mass concentration; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; reyataz; serp; serpl; serplas; serum; serum or plasma; sr,Qn
41485-4,coxsackievirus b ab panel [titer] - serum by complement fixation,cv b virus ab pnl titr ser cf,coxsackievirus b ab panel cf (s) [titer],cav; cbv; cf; comp fixation; compfix; complement fixation; coxsackie; coxsackie virus; cv; cv b; cv b virus ab pnl; dilution factor; dilution factor (titer); id; infectious disease; infectiousdisease; microbiology; pan; panel.microbiology; panl; pnl; point in time; random; serum; smqn; sr; titer; titered; titre; ttr; universallaborders,SemiQn
41487-0,cryptosporidium parvum ag [presence] in stool by immunoassay,c parvum ag stl ql ia,c. parvum ag ia ql (stl),antigen; antigens; bowel movement; c parvum; crypt; crypto; cryptosporidiosis; eia; elfa; elisa; enzyme immunoassay; faecal; faeces; fecal; feces; gastro; gastroenterology; gi; iaa; id; infectious disease; infectiousdisease; meia; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; screen; stl; stool = fecal; suds; universallaborders,Ord
41488-8,cryptosporidium sp [presence] in specimen by acid fast stain,cryptosp spec ql acid fast stn,cryptosporidium sp acid fast stain ql (specimen),acd; acid fast stn; acids; afb stain; crypt; crypto; cryptosporidiosis; id; infectious disease; infectiousdisease; microbiology; misc; miscellaneous; ordinal; other; point in time; pr; ql; qual; qualitative; random; screen; spec; species; spp; st; stains; stn; to be specified in another part of the message; unspecified,Ord
41492-0,echovirus 7 neutralizing antibody [titer] in serum by neutralization test,ecv7 nab titr ser nt,echovirus 7 neut ab neut test (s) [titer],abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; conventional virus neutralization test; cvnt; dilution factor; dilution factor (titer); echo; echo virus; echovirus type 7; ecv; ecv7; ev; id; infectious disease; infectiousdisease; microbiology; nab; neutralization; neutralization test; nt; point in time; random; serum; serum virus neutralization; smqn; sr; svn; titer; titered; titre; ttr; virus neutralization test; vnt,SemiQn
41495-3,haemophilus influenzae b ag [presence] in body fluid,haem influ b ag fld ql,h. influenzae b ag ql (body fld),"antigen; antigens; b/f; bf; bod; bodies; body fluid; body fluid, unsp; fl; fld; flu; fluid; h flu; h influenza; h influenzae; haem influ; haem influ b; haemoph; hib; id; infectious disease; infectiousdisease; influ; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; screen",Ord
41505-9,parainfluenza virus ag panel - specimen by immunofluorescence,hpiv pnl spec if,parainfluenza virus ag panel if (specimen),acif; anticomplement immunofluorescence; dfa; fa; fluorescent antibody; fluoresent; hpiv; hpiv pnl; id; ifa; immune fluorescence; immunoflour; immunofluor; immunofluorescence; infectious disease; infectiousdisease; microbiology; misc; miscellaneous; other; pan; panel.microbiology; panl; para; parainflu; pnl; point in time; random; spec; time resolved fluorescence; to be specified in another part of the message; trf; unspecified,-
41515-8,hiv 1 rna [#/volume] (viral load) in serum or plasma by probe with amplification detection limit = 75 copies/ml,hiv1 rna # serpl probe amp dl=75,hiv 1 rna probe amp dl = 75 copies/ml [#/vol],#; abs; absolute; absolutes; aids; amplif; amplification; amplified; cnt; count; count/volume; ct; dna nucleic acid probe; dna probe; hiv type 1; hiv type i; hiv1; human immunodeficiency virus; i; id; infectious disease; infectiousdisease; microbiology; number concentration; number concentration (count/vol); pl; plasma; plsm; point in time; probe amp; probe amp dl=75; probe with ampification; qnt; quan; quant; quantitative; random; ribonucleic acid; serp; serpl; serplas; serum; serum or plasma; sr,Qn
4155-8,carisoprodol [mass] of dose,carisoprodol dose,carisoprodol (dose) [mass],carisoma; dose med or substance; drug doses; flexartal; isopropylmeprobamate; point in time; qnt; quan; quant; quantitative; random; rela; sanoma; soma; somadril; somalgit,Qn
41622-2,bacillus anthracis dna [identifier] in specimen by naa with probe detection,b anthracis dna spec naa+probe,b. anthracis dna naa+probe nom (specimen),3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; anthrax; b anthracis; charbon; deoxyribonucleic acid; dna nucleic acid probe; dna probe; id; identity or presence; infectious disease; infectiousdisease; lat; lcr; ligase chain reaction; ligation-activated transcription; malignant carbuncle; malignant pustule; microbiology; milzbrand; misc; miscellaneous; naa+probe; naat; nasba; nominal; nucleic acid sequence based analysis; other; pcr; point in time; polymerase chain reaction; probe amp; probe with ampification; probe with target amplification; qbr; random; sda; spec; splenic fever; strand displacement amplification; tma; to be specified in another part of the message; transcription mediated amplification; unspecified; woolsorters disease,Nom
41626-3,brucella sp dna [presence] in specimen by naa with probe detection,brucella dna spec ql naa+probe,brucella sp dna naa+probe ql (specimen),3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; bruc; brucellosis; deoxyribonucleic acid; dna nucleic acid probe; dna probe; id; infectious disease; infectiousdisease; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; misc; miscellaneous; naa+probe; naat; nasba; nucleic acid sequence based analysis; ordinal; other; pcr; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; screen; sda; spec; species; spp; strand displacement amplification; tma; to be specified in another part of the message; transcription mediated amplification; unspecified,Ord
41632-1,clostridium botulinum toxin b [presence] in specimen by immunofluorescence,c bot tox b spec ql if,c. botulinum toxin b if ql (specimen),acif; anticomplement immunofluorescence; bont; btx; c bot; c bot tox; c bot tox b; c botulinum; fa; fluorescent antibody; fluoresent; id; ifa; immune fluorescence; immunoflour; immunofluor; immunofluorescence; infectious disease; infectiousdisease; microbiology; misc; miscellaneous; ordinal; other; point in time; pr; ql; qual; qualitative; random; screen; spec; time resolved fluorescence; to be specified in another part of the message; trf; unspecified,Ord
41639-6,ricin toxin igm ab [presence] in serum by immunofluorescence,ricin tox igm ser ql if,ricin toxin igm if ql (s),abs; aby; acif; antby; anti; antibodies; antibody; anticomplement immunofluorescence; autoantibodies; autoantibody; drug/toxicology; drugs; fa; fluorescent antibody; fluoresent; ifa; immune fluorescence; immune globulin m; immunoflour; immunofluor; immunofluorescence; immunoglobulin m; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; sr; time resolved fluorescence; trf,Ord
41643-8,west nile virus ag [presence] in specimen by immunofluorescence,wnv ag spec ql if,west nile virus ag if ql (specimen),acif; anticomplement immunofluorescence; antigen; antigens; dfa; fa; fluorescent antibody; fluoresent; id; ifa; immune fluorescence; immunoflour; immunofluor; immunofluorescence; infectious disease; infectiousdisease; microbiology; misc; miscellaneous; ordinal; other; point in time; pr; ql; qual; qualitative; random; screen; spec; time resolved fluorescence; to be specified in another part of the message; trf; unspecified; wnv,Ord
41651-1,glucose [mass/volume] in arterial blood,glucose blda-mcnc,glucose (blda) [mass/vol],abg; art; art bld; art blood; arterial; arterial blood; blood arterial; chemistry; endocrine; endocrinology; glu; gluc; glucoseur; level; mass concentration; point in time; qnt; quan; quant; quantitative; random,Qn
41659-4,abt492 [susceptibility] by disk diffusion (kb),abt492 islt kb,abt492 disk diffusion (kb) [susc],antibiotic susceptibilities; ast; disk diffusion; id; infectious disease; infectiousdisease; islt; isol; kb; kirby-bauer; point in time; random; sus; suscept; susceptibilities; susceptibility; susceptibilty,OrdQn
41676-8,cefoxitin+clavulanate [susceptibility] by disk diffusion (kb),cefoxitin+clav islt kb,cefoxitin+clavulanate disk diffusion (kb) [susc],antibiotic susceptibilities; ast; c305; clav; clavate; clavu; clavul; clavulanic; clavulanic acid; disk diffusion; id; infectious disease; infectiousdisease; islt; isol; kb; kirby-bauer; mefj; mefoxin; point in time; random; sus; suscept; susceptibilities; susceptibility; susceptibilty,OrdQn
41679-2,cefpodoxime+clavulanate [susceptibility] by minimum inhibitory concentration (mic),cefpodoxime+clav islt mic,cefpodoxime+clavulanate mic [susc],antibiotic susceptibilities; ast; c305; cefodox; cefpodoxime proxetil; clav; clavate; clavu; clavul; clavulanic; clavulanic acid; id; infectious disease; infectiousdisease; islt; isol; minimum inhibitory concentration; orelox; podomexef; point in time; random; sus; suscept; susceptibilities; susceptibility; susceptibilty; vantin,OrdQn
41683-4,ceftriaxone+clavulanate [susceptibility] by gradient strip,ceftriaxone+clav islt grad strip,ceftriaxone+clavulanate strip [susc],antibiotic susceptibilities; ast; c305; c9; clav; clavate; clavu; clavul; clavulanic; clavulanic acid; epsilometer; estrip; e-strip; grad strip; id; infectious disease; infectiousdisease; islt; isol; mic; minimum inhibitory concentration; point in time; random; rocephin; rocj; sus; suscept; susceptibilities; susceptibility; susceptibilty,OrdQn
41707-1,oritavancin [susceptibility] by disk diffusion (kb),oritavancin islt kb,oritavancin disk diffusion (kb) [susc],antibiotic susceptibilities; ast; disk diffusion; id; infectious disease; infectiousdisease; islt; isol; kb; kirby-bauer; ly333328; point in time; random; sus; suscept; susceptibilities; susceptibility; susceptibilty,OrdQn
4171-5,cephalothin [mass] of dose,cephalothin dose,cephalothin (dose) [mass],cefalotin; cephalotin; ceporacin; cepovenin; dose med or substance; drug doses; keflin; point in time; qnt; quan; quant; quantitative; random,Qn
41728-7,biapenem [susceptibility],biapenem susc islt,biapenem [susc],antibiotic susceptibilities; ast; id; infectious disease; infectiousdisease; islt; isol; point in time; random; sus; suscept; susceptibilities; susceptibility; susceptibilty,OrdQn
41734-5,dalbavancin [susceptibility],dalbavancin susc islt,dalbavancin [susc],antibiotic susceptibilities; ast; id; infectious disease; infectiousdisease; islt; isol; point in time; random; sus; suscept; susceptibilities; susceptibility; susceptibilty,OrdQn
41739-4,sulbactam [susceptibility],sulbactam susc islt,sulbactam [susc],antibiotic susceptibilities; ast; id; infectious disease; infectiousdisease; islt; isol; point in time; random; sulb; sulbact; sus; suscept; susceptibilities; susceptibility; susceptibilty,OrdQn
41742-8,mold allergen mix 1 (alternaria alternata+aspergillus fumigatus+cladosporium herbarum+penicillium notatum) ige ab [units/volume] in serum by multidisk,mold allerg mix1 ige qn,alternaria alternata+aspergillus fumigatus+cladosporium herbarum+penicillium notatum ige multidisk qn (s),a alternata; a fumigatus; a tenuis; abs; aby; allergen; allergens; allergy testing; allerscan; alternaria tenuis; antby; anti; antibodies; antibody; arbitrary concentration; asperg; aspergil; aspergilis; aspergilla; aspergillin; aspergillosis; aspergils; aspergilus; autoantibodies; autoantibody; c herbarum; farmers lung; fum; hormodendrum; immune globulin e; immunoglobulin e; m001; m002; m003; m006; m1; m2; m3; m6; mold allerg mix1; mold mix; mould mix; mx1; p chrysogenum; p notatum; point in time; qnt; quan; quant; quantitative; random; serum; sr,Qn
41753-5,fkrp gene targeted mutation analysis in blood or tissue by molecular genetics method,fkrp gene mut anl bld/t,fkrp gene targeted mutation analysis molgen doc (bld/tiss),"blood; document; finding; findings; flj12576; fukutin related protein; fukutin related protein gene; genetics; heredity; heritable; inherited; lgmd2i; mdc1c; mddga5; mddgb5; mddgc5; mgc2991; molecular genetics; molecular pathology; molpath; molpath.mutations; mut; mut anl; mutations; pcr; point in time; random; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",Doc
41762-6,megestrol acetate [mass/volume] in serum or plasma,megestrol acetate serpl-mcnc,megestrol acetate [mass/vol],acetic acid; drug/toxicology; drugs; ethanoate; ethanoic acid; level; mass concentration; megace; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
41764-2,sbds gene targeted mutation analysis in blood or tissue by molecular genetics method,sbds gene mut anl bld/t,sbds gene targeted mutation analysis molgen doc (bld/tiss),"blood; cgi-97; document; finding; findings; flj10917; genetics; heredity; heritable; inherited; molecular genetics; molecular pathology; molpath; molpath.mutations; mut; mut anl; mutations; pcr; point in time; random; sds; shwachman-bodian-diamond syndrome; swds; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",Doc
41769-1,neuronal nuclear type 1 ab [presence] in serum by immunoblot,hu1 ab ser ql ib,neuronal nuclear type 1 ab ib ql (s),abs; aby; anna 1; anna-1; antby; anti; antibodies; antibody; autoantibodies; autoantibody; blt; hu; hu1; i; immune blot; immunobl; immunoblot; neuro; neurology; neuronal nuclear type i; nuc; oncology; ordinal; paraneoplastic syndrome; point in time; pr; ql; qual; qualitative; random; riba; screen; serology; serum; sr; wb; wblot; west blot; west blt; western blot,Ord
4177-2,chlorothiazide [mass] of dose,chlorothiazide dose,chlorothiazide (dose) [mass],diuril; dose med or substance; drug doses; point in time; qnt; quan; quant; quantitative; random,Qn
41778-2,portable xr femur - right views,xr port femur-r views,,document; ext; extr-r; femoral; femur-r; films; finding; findings; imaging; le; leg; le-r; low; lower extremity; plain films; point in time; r; rad; radiology; random; rle; rt; upper leg; view; vws; xr port; xray; x-ray,Doc
41780-8,deprecated tibia right x-ray,deprecated tib-r xr,,films; finding; findings; imaging; narrative; plain films; point in time; r; rad; radiology; random; report; rt; tib-r; view; vws; xray; x-ray,Nar
41786-5,portable xr elbow - right views,xr port elbow-r views,,arm; document; elbow-r; ext; extr-r; films; finding; findings; imaging; msk; musculoskeletal; olecranon; ortho; orthopedics; plain films; point in time; r; rad; radiology; random; rt; rue; ue; ue-r; up; upper extremity joint; view; vws; xr port; xray; x-ray,Doc
41787-3,portable xr wrist - right views,xr port wrist-r views,,arm; carpal bone; carpal bones; carpal bones and joint; document; ext; extr-r; films; finding; findings; imaging; plain films; point in time; r; rad; radiology; random; rt; rue; ue; ue-r; up; upper extremity joint; view; vws; wrist-r; xr port; xray; x-ray,Doc
41793-1,xr abdomen single view during surgery,xr abd 1v in surg,,1v; abd; abdo; abdomen+; abdominal; document; film; finding; findings; imaging; in surg; intra operative; intraop; intraoperative; plain films; point in time; rad; radiology; random; single view; surg; vw; xray; x-ray,Doc
41801-2,rfa guidance for placement of catheter in portal vein-- w contrast iv,rfa guided port v cath place--w contr iv,,abd; abdo; abdomen+; abdominal; c; cardio; cardiology; cath; cath place; contr; contra; contrst; document; finding; findings; fluor; fluoro; fluoroscopy; guid; guide; guided; heart disease; imaging; plac of cath; point in time; portogram; portography; pv; rad; radiology; random; rfa; ven; venogram; venography; venous; w contr iv; wc,Doc
41812-9,us lower extremity artery limited,us le a ltd,,art; coreplaybook; document; echography; ext; extr a; finding; findings; imaging; le; le a; leg; lmted; low; ltd; playbook; point in time; radiology; random; sonogram; sonograph; sonography; uls; ultrasound,Doc
41815-2,us lower extremity artery - right,us le a-r,,art; document; echography; ext; extr a; extr-r; finding; findings; imaging; le; le a; le a-r; leg; le-r; low; point in time; r; radiology; random; rle; rt; sonogram; sonograph; sonography; uls; ultrasound,Doc
41823-6,portable xr ankle - left views,xr port ankle-l views,,ankle-l; document; ext; extr-l; films; finding; findings; imaging; l; le; leg; le-l; lle; low; lower extremity joint; lt; msk; musculoskeletal; ortho; orthopedics; plain films; point in time; rad; radiology; random; view; vws; xr port; xray; x-ray,Doc
41862-4,viscosity of semen--20 minutes post collection,visc 20m p coll smn,viscosity 20 min post collection (sem) [visc],20m p coll; after; coll; collect; collected; ejaculate; genitourinary; gu; point in time; pst; qnt; quan; quant; quantitative; random; sem; seminal fluid; smn; smpls; spec; uro; urology; vicos; viscos; viscosity,Qn
41874-9,white birch ige ab [units/volume] in serum,white birch ige qn,white birch ige qn (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; gray birch; grey birch; immune globulin e; immunoglobulin e; old field birch; point in time; poplar birch; poverty birch; qnt; quan; quant; quantitative; random; serum; sr; t030; t30; universallaborders; white birch,Qn
4189-7,clindamycin [mass] of dose,clindamycin dose,clindamycin (dose) [mass],c306; cleocin; clij; dalacin; dose med or substance; drug doses; point in time; qnt; quan; quant; quantitative; random; sobelin; topical,Qn
41905-1,altitude,altitude,,blood pressure measurements.atom; length; point in time; qnt; quan; quant; quantitative; random,Qn
41914-3,type of blood coagulation device,blood coagulation device class,,nominal; point in time; random; typ,Nom
41915-0,blood coagulation device vendor name,blood coagulation device vendor name,,ident; identifier; nominal; point in time; random; vendor name,Nom
41930-9,type of peak flow meter,pfm class,,dynamic; nominal; pfm; point in time; random; typ,Nom
41934-1,peak flow meter vendor software version,pfm software vers,,dynamic; ident; identifier; nominal; pfm; point in time; random,Nom
41945-7,current medication 24 hour totals bolus,,,1 day; 24 hours; 24hr; attach; attach.meds; med; meds; qnt; quan; quant; quantitative,Qn
41947-3,pedometer device vendor name,pedometer device vendor name,,ident; identifier; nominal; point in time; random; vendor name,Nom
41951-5,number of steps in 24 hour mean measured,# steps 24h mean nrate measured,,# steps; 1 day; 24 hours; 24hr; average; avg; clin; count/time; no; nrate; num; number rate; number rate = count/time; qnt; quan; quant; quantitative,Qn
4196-2,clopenthixol [mass] of dose,clopenthixol dose,clopenthixol (dose) [mass],ciatyl; cisordinol; clopixol; dose med or substance; drug doses; point in time; qnt; quan; quant; quantitative; random; sedanxol; sordinol; zuclopenthixol,Qn
41963-0,hba1c measurement device vendor serial number,hba1c measurement device serial #,,ident; identifier; no; nominal; num; point in time; random; serial #,Nom
41976-2,insulin delivery device vendor name,insulin delivery device vendor name,,ident; identifier; nominal; point in time; random; vendor name,Nom
41988-7,"follow-up (referred to) provider /specialist, catchment location indicator cphs",,,"attach; attach.cphs; children's preventative health service; follow-up (referred to) provider/specialist; follow-up (referred to) provider/specialist, catchment location indicator; nominal; point in time; random; typ",Nom
41992-9,arsenic.inorganic [mass/volume] in 24 hour urine,inorg arsenic 24h ur-mcnc,arsenic.inorganic (24h u) [mass/vol],1 day; 24 hours; 24hr; as; drug/toxicology; drugs; inorg arsenic; level; mass concentration; qnt; quan; quant; quantitative; ua; ur; urn,Qn
42006-7,saint louis encephalitis virus igm ab [presence] in cerebral spinal fluid by immunoassay,slev igm csf ql ia,slev igm ia ql (csf),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; cerebral spinal fluid; cerebrospinal fl; eia; elfa; elisa; enc; enceph; encephalomyelitis; enzyme immunoassay; iaa; id; immune globulin m; immunoglobulin m; infectious disease; infectiousdisease; meia; microbiology; neuro; neurology; ordinal; point in time; pr; ql; qual; qualitative; random; screen; sle virus; slev; spinal fl; spinal fld; spinal flu; spinal fluid; st louis; suds,Ord
42008-3,xr humerus single view during surgery,xr humerus 1v in surg,,1v; arm; document; ext; film; finding; findings; imaging; in surg; intra operative; intraop; intraoperative; plain films; point in time; rad; radiology; random; single view; surg; ue; up; upper arm; upper extremity; vw; xray; x-ray,Doc
42023-2,naaccr facility identification system coding system,naaccr fin system coding system cancer,,ca; fin; identity or presence; misc; miscellaneous; naaccr fin system coding system; nominal; north american association of central cancer registries; oncology; other; point in time; random; spec; to be specified in another part of the message; tumor registry(naaccr); unspecified,Nom
42032-3,number of tumors at diagnosis cancer,# tumors at dx cancer,,# tumors at dx; ca; cnt; count; dx; misc; miscellaneous; no; num; number; oncology; other; point in time; qnt; quan; quant; quantitative; random; spec; to be specified in another part of the message; tumor registry(naaccr); unspecified,Qn
42046-3,2nd course hormonal therapy cancer rx,2nd course horm cancer rx,,2nd course horm; 2nd course tx; ca; identity or presence; nominal; oncology; point in time; random; second; treatment; tumor registry(naaccr); tx,Nom
42050-5,3rd course radiation cancer rx,3rd course rad cancer rx,,3rd course rad; 3rd course tx; ca; identity or presence; nominal; oncology; point in time; random; treatment; tumor registry(naaccr); tx,Nom
42052-1,3rd course hormonal therapy cancer rx,3rd course horm tx cancer rx,,3rd course horm tx; 3rd course tx; ca; identity or presence; nominal; oncology; point in time; random; treatment; tumor registry(naaccr); tx,Nom
42057-0,4th course chemotherapy cancer rx,4th course chemo cancer rx,,4th course chemo; ca; chemo; identity or presence; nominal; oncology; point in time; random; treatment; tumor registry(naaccr); tx,Nom
42062-0,county--current cancer,county--current cancer,,ca; identity or presence; misc; miscellaneous; nominal; oncology; other; point in time; random; spec; to be specified in another part of the message; tumor registry(naaccr); unspecified,Nom
42108-1,comorbidities and complications 3,comorbidi/complication 3,,comorbidi/complication 3; identity or presence; iii; nominal; oncology; point in time; random; tumor registry(naaccr),Nom
42115-6,comorbidities and complications 10,comorbidi/complication 10,,comorbidi/complication 10; identity or presence; nominal; oncology; point in time; random; tumor registry(naaccr),Nom
42118-0,readmission to the same hospital within 30 days of surgical discharge cancer,readmit within 30d of surg dis cancer,,arbitrary; ca; disch; hosp; misc; miscellaneous; oncology; ordinal; other; point in time; ql; qual; qualitative; random; readmit within 30d of surg dis; screen; spec; surg; to be specified in another part of the message; tumor registry(naaccr); unspecified,Ord
42129-7,site coding system.current cancer site,site coding system.current cancer site,,ca; cancer site; coding sys.current; misc; miscellaneous; nominal; oncology; other; point in time; random; spec; to be specified in another part of the message; tumor registry(naaccr); typ; unspecified,Nom
4215-0,dextromoramide [mass] of dose,d-moramide dose,dextromoramide (dose) [mass],dextrodiphenopyrine; dextro-moramide; d-moramid; d-moramide; dose med or substance; drug doses; jetrium; narcolo; palfium; point in time; qnt; quan; quant; quantitative; random,Qn
42155-2,deprecated chest x-ray ap lateral-decubitus,deprecated chest xr ap lat decub,,1v; anterio-posterior; anteroposterior; ap lat decub; cxr; film; finding; findings; imaging; lat; narrative; plain films; point in time; rad; radiology; random; report; single view; thorax; view decubitus; view r- or l- decubitus; vw; xray; x-ray,Nar
42158-6,nm adrenal gland views,nm adrenal views w rnc iv,,abd; abdo; abdomen+; abdominal; document; films; finding; findings; imaging; point in time; rad; radiology; random; rn; rnc; scan; view; vws; w rnc iv,Doc
421-8,polymyxin b [susceptibility] by disk diffusion (kb),polymyxin b islt kb,polymyxin b disk diffusion (kb) [susc],antibiotic susceptibilities; ast; c218; disk diffusion; id; infectious disease; infectiousdisease; islt; isol; kb; kirby-bauer; neosporin; point in time; random; sus; suscept; susceptibilities; susceptibility; susceptibilty,OrdQn
42188-3,cd3+cd16+cd56+ cells [#/volume] in blood,cd3+cd16+cd56+ cells # bld,cd3+cd16+cd56+ cells (bld) [#/vol],#; abs; absolute; absolutes; blood; cd3 cells; cd3+cd16+ cells; cd3+cd16+cd56+ cells; cd3-cd16+ cells; cd3-cd16+cd56+ cells; cell; cell markers; cellularity; cnt; count; count/volume; ct; fcgr3a; leu11; leu-11; leu11b; leu-11b; leu19; leu-19; leu4; leu-4; natural killer cells; ncam; neural cell adhesion molecule; nkh1; number concentration; number concentration (count/vol); point in time; qnt; quan; quant; quantitative; random; t3; wb; whole blood,Qn
42189-1,cd3+cd16+cd56+ cells/cells in blood,cd3+cd16+cd56+ cells nfr bld,cd3+cd16+cd56+ cells/cells (bld),blood; cd3 cells; cd3+cd16+ cells; cd3+cd16+cd56+ cells; cd3-cd16+ cells; cd3-cd16+cd56+ cells; cell; cell markers; cellularity; fcgr3a; leu11; leu-11; leu11b; leu-11b; leu19; leu-19; leu4; leu-4; natural killer cells; ncam; neural cell adhesion molecule; nkh1; number fraction; percent; point in time; qnt; quan; quant; quantitative; random; t3; wb; whole blood,Qn
42190-9,deprecated shigella sp dna [identifier] in unspecified specimen by probe and target amplification method,deprecated shigella dna xxx pcr,shigella sp dna naa+probe nom (specimen),3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; deoxyribonucleic acid; dna nucleic acid probe; dna probe; id; identity or presence; infectious disease; infectiousdisease; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; misc; miscellaneous; naa+probe; naat; nasba; nominal; nucleic acid sequence based analysis; other; pcr; point in time; polymerase chain reaction; probe amp; probe with ampification; probe with target amplification; qbr; random; sda; shigellosis; spec; species; spp; strand displacement amplification; tma; to be specified in another part of the message; transcription mediated amplification; unspecified,Nom
42205-5,human antimouse igg ab [mass/volume] in serum,human antimouse igg ser-mcnc,human antimouse igg (s) [mass/vol],abs; aby; antby; anti; antibodies; antibody; anti-mouse; autoantibodies; autoantibody; hama; human anti-monoclonal ab; human anti-mouse ab; immune globulin g; immunoglobulin g; level; mass concentration; point in time; qnt; quan; quant; quantitative; random; serology; serum; sr,Qn
42212-1,nucleolar nuclear ab pattern [titer] in body fluid,ana nucleolar titr fld,nucleolar nuclear ab pattern (body fld) [titer],"ana; ana nucleolar; ana pat; anf; antinuclear antibody; b/f; bf; bod; bodies; body fluid; body fluid, unsp; dilution factor; dilution factor (titer); fl; fld; flu; fluid; na; nuc; point in time; random; serology; smqn; titer; titered; titre; ttr",SemiQn
42222-0,manganese [moles/time] in 24 hour urine,manganese 24h ur-srate,manganese (24h u) [moles/time],1 day; 24 hours; 24hr; drug/toxicology; drugs; mn; qnt; quan; quant; quantitative; srate; substance rate; ua; ur; urn,Qn
42234-5,alpha subunit free [units/volume] in serum or plasma,alpha subunit free serpl-acnc,alpha subunit free qn,alfa; alpha subunit free; arbitrary concentration; chemistry; fr; non-protein bound; pituitary glycoproteins; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
42236-0,borrelia burgdorferi dna [presence] in tick by naa with probe detection,b burgdor dna tick ql naa+probe,b. burgdorferi dna naa+probe ql (tick),3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; b burg; b burgdor; b burgdorferi; bb; burgdorf; deoxyribonucleic acid; dna nucleic acid probe; dna probe; id; infectious disease; infectiousdisease; lat; lcr; ligase chain reaction; ligation-activated transcription; lyme; lyme disease; lymes; microbiology; naa+probe; naat; nasba; nucleic acid sequence based analysis; ordinal; pcr; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; screen; sda; strand displacement amplification; tma; transcription mediated amplification,Ord
42253-5,methylenedioxyamphetamine [presence] in urine,mda ur ql,methylenedioxyamphetamine ql (u),addiction; drug/toxicology; drugs; drugs of abuse; illicit; mda; methylenedioxymethamphetamine metabolite; ordinal; point in time; potentialforabuse; pr; ql; qual; qualitative; random; screen; ua; ur; urn,Ord
42261-8,nm kidney views for blood flow,nm kidney vs bld flow w rnc iv,,abd; abdo; abdomen+; abdominal; bld flow; document; dynamic; films; finding; findings; imaging; kidney; nephric; nephrology; point in time; rad; radiology; random; renal; renal function; renogram; rn; rnc; scan; view; vs bld flow; vws; w rnc iv,Doc
42265-9,ct guidance for superficial biopsy of bone,ct guided bone super bx,,bon; bx; cat scan; computed tomography; computerized tomography; ct scan; document; finding; findings; guid; guide; guided; imaging; misc; miscellaneous; other; point in time; rad; radiology; random; spec; super bx; to be specified in another part of the message; unspecified,Doc
42275-8,ct chest and abdomen w contrast iv,ct chest+abd w contr iv,,abd; abdo; abdomen+; abdominal; c; cat scan; chest + abd; computed tomography; computerized tomography; contr; contra; contrst; ct scan; document; finding; findings; imaging; point in time; rad; radiology; random; thorax; w contr iv; wc,Doc
42276-6,ct chest and abdomen wo contrast,ct chest+abd wo contr,,abd; abdo; abdomen+; abdominal; c; cat scan; chest + abd; computed tomography; computerized tomography; contr; contra; contrst; ct scan; document; finding; findings; imaging; point in time; rad; radiology; random; thorax; without contrast,Doc
4228-3,disopyramide [mass] of dose,disopyramide dose,disopyramide (dose) [mass],diso durules; dose med or substance; drug doses; norpace; point in time; pyramide; qnt; quan; quant; quantitative; random; rythmodan,Qn
42287-3,ct guidance for drainage and placement of drainage catheter of retroperitoneum,ct guide retroperitoneum drn+cath place,,abd; abd.reper; abdo; abdomen+; abdominal; cat scan; cath; computed tomography; computerized tomography; ct scan; document; drain; drain+cath place; exudate; finding; findings; guid; guide; guided; imaging; point in time; rad; radiology; random; removal of fluid; retroperitoneal,Doc
42291-5,ct retroperitoneum wo contrast,ct retroperitoneum wo contr,,abd; abd.reper; abdo; abdomen+; abdominal; c; cat scan; computed tomography; computerized tomography; contr; contra; contrst; ct scan; document; finding; findings; imaging; point in time; rad; radiology; random; retroperitoneal; without contrast,Doc
42292-3,spect whole body for tumor w tl-201 iv,spect whole body for tumor w tl-201 iv,,201ti; bod; bodies; document; finding; findings; imaging; point in time; rad; radiology; random; scan; thallium 201; thallous; t-i201; tl-201; wb,Doc
42301-2,mr uterus,mr uterus,,document; finding; findings; gyn; gynecology; imaging; mitral regurgitation maximum velocity; mri; ob; obgyn; obstetrics; pelvic; point in time; rad; radiology; random; uterine,Doc
42306-1,nm heart gated and wall motion,nm hrt gated+wm w rnc iv,,cardiac; document; films; finding; findings; gated+wm; hrt; imaging; muga; point in time; rad; radiology; random; rn; rnc; scan; thorax; view; vws; w rnc iv; wm,Doc
42342-6,rickettsia (proteus) ab panel - serum,ricket (proteus) ab pnl ser,rickettsia (proteus) ab panel (s),id; infectious disease; infectiousdisease; microbiology; pan; panel.microbiology; panl; pnl; point in time; qnt; quan; quant; quantitative; random; ricket; ricket (proteus) ab pnl; rickettsial; serum; sr,Qn
42349-1,reason for referral (narrative),,,attach; attach.clinrpt; finding; findings; narrative; point in time; random; report,Nar
42351-7,cefepime+clavulanate [susceptibility] by minimum inhibitory concentration (mic),cefepime+clav islt mic,cefepime+clavulanate mic [susc],antibiotic susceptibilities; ast; c305; cefipime; clav; clavate; clavu; clavul; clavulanic; clavulanic acid; esbl; id; infectious disease; infectiousdisease; islt; isol; maxipime; minimum inhibitory concentration; point in time; random; sus; suscept; susceptibilities; susceptibility; susceptibilty,OrdQn
4235-8,enoxacin [mass] of dose,enoxacin dose,enoxacin (dose) [mass],almitil; bactidan; comprecin; dose med or substance; drug doses; enoxen; flumark; gyramid; penetrex; point in time; qnt; quan; quant; quantitative; random,Qn
42358-2,hla-b*57:01 [presence] in specimen,hla-b*57:01 spec ql,hla-b*57:01 ql (specimen),abacavir hypersensititvity; hla antigen; hla-b57; hla-b57*01; hla-b5701; human leukocyte antigen; misc; miscellaneous; ordinal; other; point in time; pr; ql; qual; qualitative; random; screen; spec; to be specified in another part of the message; universallaborders; unspecified,Ord
42359-0,streptococcus pneumoniae 14 serotypes igg panel b [mass/volume] - serum,s pneum 14 serotypes igg pnl b ser-mcnc,s. pneumoniae 14 types igg panel b (s) [mass/vol],id; immune globulin g; immunoglobulin g; infectious disease; infectiousdisease; level; mass concentration; microbiology; pan; panel.microbiology; panl; pneu; pneum; pneumo; pneumococ; pneumococcal; pneumococcal pneumonia; pneumococcus; pneumon; pneumonia; pnl; point in time; qnt; quan; quant; quantitative; random; s pneum 14 serotypes igg pnl b; s pneum14; s pneumo; s pneumoniae; serum; spn; sr; strep; strept,Qn
42363-2,streptococcus pneumoniae 7 serotypes igg panel a [mass/volume] - serum,s pneum 7 serotypes igg pnl a ser-mcnc,s. pneumoniae 7 types igg panel a (s) [mass/vol],id; immune globulin g; immunoglobulin g; infectious disease; infectiousdisease; level; mass concentration; microbiology; pan; panel.microbiology; panl; pneu; pneum; pneumo; pneumococ; pneumococcal; pneumococcal pneumonia; pneumococcus; pneumon; pneumonia; pnl; point in time; qnt; quan; quant; quantitative; random; s pneum 7 serotypes igg pnl a; s pneum7; s pneumo; s pneumoniae; serum; spn; sr; strep; strept; streptococcus pneumoniae 7 serotypes; streptococcus pneumoniae 7a,Qn
42373-1,neisseria meningitidis serogroup x ag [presence] in isolate by agglutination,n men sg x ag islt ql aggl,n. meningitidis x ag aggl ql (isol),agg; agglut; agglutination; antigen; antigens; id; infectious disease; infectiousdisease; islt; isol; mening; meningid; meningitis; meningo; meningococcal meningitis; meningococcus; microbiology; n men; n men serogroup; n men sg x; n men sg x ag; n menigitidis; n meningitidis; neisseria meningitidis group x; neisseria meningitidis type x; ordinal; point in time; pr; ql; qual; qualitative; random; screen,Ord
42406-9,xr lumbar spine views ap w and wo left bending,xr l-spine views ap wo+w l-bending,,abd; abdo; abdomen+; abdominal; anterio-posterior; anteroposterior; document; films; finding; findings; imaging; l/sp; left; left sidebending; levo; l-spine; lumbar; lumbo; plain films; point in time; rad; radiology; random; spinal; spinal cord; view; views & ap kub; views (ap; views+ap; vws; wo & wc; wo+w l-bending; wwo; xray; x-ray,Doc
42408-5,xr lumbar spine views ap w right bending and w left bending and wo bending,xr l-spine views ap w+wo r+l-bending,,abd; abdo; abdomen+; abdominal; anterio-posterior; anteroposterior; document; films; finding; findings; imaging; l/sp; lateral bending; left; left sidebending; levo; l-spine; lumbar; lumbo; plain films; point in time; r prime; rad; radiology; random; right; right sidebending; spinal; spinal cord; view; views & ap kub; views (ap; views+ap; vws; w r+l-bending; w r+l-bending); w+wo l-bending; w+wo r+l-bending; xray; x-ray,Doc
42413-5,xr lumbar spine views w right bending and w left bending,xr l-spine views w r+l-bending,,abd; abdo; abdomen+; abdominal; document; films; finding; findings; imaging; l/sp; lateral bending; left; left sidebending; levo; l-spine; lumbar; lumbo; plain films; point in time; r prime; rad; radiology; random; right; right sidebending; spinal; spinal cord; view; vws; w r+l-bending; w r+l-bending); xray; x-ray,Doc
4241-6,ethacrynate [mass] of dose,ethacrynate dose,ethacrynate (dose) [mass],dose med or substance; drug doses; edecrin; etacrynate; etacrynic acid; ethacrynic acid; point in time; qnt; quan; quant; quantitative; random,Qn
42419-2,xr wrist - bilateral single view,xr wrist-bl 1v,,1v; arm; bil; bilat; both; carpal bone; carpal bones; carpal bones and joint; document; ext; extr-bl; film; finding; findings; imaging; plain films; point in time; rad; radiology; random; single view; ue; ue-bl; up; upper extremity joint; vw; wrist-bl; wrists; xray; x-ray,Doc
42427-5,xr thoracic and lumbar spine lateral for scoliosis w sitting,xr t+l-spine lat for scoli w sit,,1v; abd; abdo; abdomen+; abdominal; cxr; document; dorsal spine; film; finding; findings; imaging; l/sp; lat; lat for scoli; l-spine; lumbar; lumbo; plain films; point in time; rad; radiology; random; single view; spinal; spinal cord; t spine+ab; t+l-spine; th/sp; thorax; t-spine; vw; xray; x-ray,Doc
42428-3,xr thoracic and lumbar spine ap for scoliosis w standing in brace,xr t+l-spine ap for scoli stand brace,,1v; abd; abdo; abdomen+; abdominal; anterio-posterior; anteroposterior; ap abdomen; cxr; document; dorsal spine; film; finding; findings; imaging; kidney-ureter-bladder; l/sp; l-spine; lumbar; lumbo; plain films; point in time; rad; radiology; random; single view; spinal; spinal cord; stand brace; stand); t spine+ab; t+l-spine; th/sp; thorax; t-spine; view ap kub; vw; wb; weight bearing; xray; x-ray,Doc
42430-9,xr knee - right 2 views and (views w standing),xr knee-r 2v+(views stand),,2v; 2v + views; 2v+(views; 2v+(views stand; 2vw; document; ext; extr-r; films; finding; findings; ii; imaging; kn; knee-r; le; leg; le-r; low; lower extremity joint; msk; musculoskeletal; ortho; orthopedics; plain films; point in time; r; rad; radiology; random; rle; rt; stand); view; vws; wb; weight bearing; xray; x-ray,Doc
4243-2,ethchlorvynol [mass] of dose,ethchlorvynol dose,ethchlorvynol (dose) [mass],addiction; dose med or substance; drug doses; drugs of abuse; ethchlorvyn; illicit; placidyl; point in time; potentialforabuse; qnt; quan; quant; quantitative; random,Qn
42435-8,xr sella turcica 2 views,xr st 2v,,2v; 2vw; brain; cranial; cranium; document; films; finding; findings; ii; imaging; intracranial; plain films; point in time; rad; radiology; random; skull; st; view; vws; xray; x-ray,Doc
42449-9,us guidance for biopsy of breast - left,us guided brst-l bx,,brst; brst-l; bx; document; echography; finding; findings; guid; guide; guided; gyn; gynecology; imaging; l; lt; ob; obgyn; obstetrics; perc; point in time; radiology; random; sonogram; sonograph; sonography; uls; ultrasound,Doc
42469-7,rf gastrointestinal tract upper and small bowel and gallbladder single view w contrast po,rf ugi+sb+gb 1v w contr po,,1v; abd; abdo; abdomen+; abdominal; c; contr; contra; contrst; document; film; finding; findings; fluor; fluoro; fluoroscopy; gall bladder; gb; gi; imaging; point in time; rad; radiology; random; sb; single view; small intestine; ugi; ugi+sb; ugi+sb+gb; up; vw; w contr po; wc,Doc
42470-5,rf gastrointestinal tract upper and gallbladder single view w contrast po,rf ugi+gb 1v w contr po,,1v; abd; abdo; abdomen+; abdominal; c; contr; contra; contrst; document; film; finding; findings; fluor; fluoro; fluoroscopy; gall bladder; gb; gi; imaging; point in time; rad; radiology; random; single view; ugi; ugi+gb; up; vw; w contr po; wc,Doc
4247-3,ethylmorphine [mass] of dose,emp dose,ethylmorphine (dose) [mass],addiction; codethyline; collins elixir; dionina; dose med or substance; drug doses; drugs of abuse; emp; illicit; point in time; potentialforabuse; qnt; quan; quant; quantitative; random,Qn
42485-3,anion gap in vitreous fluid by calculation,anion gap vitf calc-scnc,anion gap calc (vitr fld) [moles/vol],ag; angap; calc; calculation; chemistry; eye; level; ophthalmology; ophtho; ophthy; point in time; qnt; quan; quant; quantitative; random; substance concentration; vitf; vitreous fluid; vitreous humor; vitreous humour,Qn
42497-8,epstein barr virus early ab [titer] in cerebral spinal fluid,ebv ea ab titr csf,ebv early ab (csf) [titer],abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; cerebral spinal fluid; cerebrospinal fl; dilution factor; dilution factor (titer); ea; ebv; ebv ea; epstn; hhv-4; human herpesvirus 4; id; infectious disease; infectiousdisease; microbiology; mono; mononucleosis; neuro; neurology; point in time; random; smqn; spinal fl; spinal fld; spinal flu; spinal fluid; titer; titered; titre; ttr,SemiQn
42504-1,hepatitis b virus surface ab [presence] in cerebral spinal fluid,hbv surface ab csf ql,hbv surface ab ql (csf),abs; aby; antby; anti; antibodies; antibody; anti-hbsag; autoantibodies; autoantibody; cerebral spinal fluid; cerebrospinal fl; hbs; hbsab; hbv; hbv surface; hep; hep b; hep bs; hepatis; hepatit; hepatology; hepb; id; infectious disease; infectiousdisease; liver; microbiology; neuro; neurology; ordinal; point in time; pr; ql; qual; qualitative; random; screen; spinal fl; spinal fld; spinal flu; spinal fluid; surf,Ord
42507-4,herpes simplex virus 1 igg ab [presence] in cerebral spinal fluid,hsv1 igg csf ql,hsv 1 igg ql (csf),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; cerebral spinal fluid; cerebrospinal fl; herp splx; herpes simplex virus type 1; herpes simplex virus type i; hsv; hsv1; i; id; immune globulin g; immunoglobulin g; infectious disease; infectiousdisease; microbiology; neuro; neurology; ordinal; point in time; pr; ql; qual; qualitative; random; screen; spinal fl; spinal fld; spinal flu; spinal fluid,Ord
42509-0,histoplasma capsulatum ab [presence] in pleural fluid by immune diffusion (id),h capsul ab plr ql id,h. capsulatum ab immune diff ql (pleur fld),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; h capsul; h capsulatum; h farciminosum; histo; histopl; histoplasma farciminosum; histoplasmos; histoplasmosis; id; imm; immunodiff; immunodiffusion; imun; imune; infectious disease; infectiousdisease; lung; microbiology; ordinal; pleural; pleural fluid; point in time; pr; pulmonary; pulmonology; ql; qual; qualitative; random; respiratory; screen; thoracentesis fluid,Ord
4251-5,fenetylline [mass] of dose,fenetylline dose,fenetylline (dose) [mass],7-ethyltheophylline ampetamin; amfetyline; captagon; dose med or substance; drug doses; fenethylline; phenethylline; point in time; qnt; quan; quant; quantitative; random,Qn
4252-3,fenfluramine [mass] of dose,fenfluramine dose,fenfluramine (dose) [mass],dima-fen; dose med or substance; drug doses; fentrate; fenured; pesos; point in time; ponderal; ponderax; pondimin; ponflurol; qnt; quan; quant; quantitative; random,Qn
42527-2,parietal cell ab [titer] in cerebral spinal fluid,pca ab titr csf,parietal cell ab (csf) [titer],abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; cerebral spinal fluid; cerebrospinal fl; dilution factor; dilution factor (titer); gastro; gastroenterology; gi; neuro; neurology; pca; point in time; random; serology; smqn; spinal fl; spinal fld; spinal flu; spinal fluid; titer; titered; titre; ttr,SemiQn
42528-0,phenothiazines [mass/volume] in serum or plasma,phenothiaz serpl-mcnc,phenothiazines [mass/vol],dibenzothiazine; drug/toxicology; drugs; level; mass concentration; phenothiaz; phenothiazine; phenothiazn; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
42529-8,pigeon serum ab [presence] in cerebral spinal fluid,pigeon serum ab csf ql,pigeon serum ab ql (csf),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; cerebral spinal fluid; cerebrospinal fl; e23; e93; neuro; neurology; ordinal; point in time; pr; ql; qual; qualitative; random; screen; ser; spinal fl; spinal fld; spinal flu; spinal fluid; sr,Ord
42561-1,event description environmental hazard/safety mersth,event desc envir hazard/safety mersth,,event desc envir hazard/safety; finding; findings; medical event reporting system-total health system; nominal; patient safety; point in time; random,Nom
42563-7,event description adverse event mersth,event desc ae mersth,,ae; event desc ae; finding; findings; medical event reporting system-total health system; nominal; patient safety; point in time; random,Nom
42566-0,contributing factor communication/documentation mersth,contrib fact communication/doc mersth,,contrib fact communication/doc; fac; fact; finding; findings; medical event reporting system-total health system; nominal; patient safety; point in time; random,Nom
42567-8,calcium.ionized [mass or moles/volume] in serum or plasma,ca-i serpl-mscnc,calcium.ionized [mass or moles/vol],ca; ca-i; cal; calcium active; calcium free; chemistry; coagulation factor i; ica; ion; level; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
42572-8,11-deoxycortisol [mass/volume] in urine,11dc ur-mcnc,11-deoxycortisol (u) [mass/vol],11dc; chemistry; compound s; cortexolone; cortodoxone; deoxycortisol; desoxycortisol; level; mass concentration; metopirone; point in time; qnt; quan; quant; quantitative; random; ua; ur; urn,Qn
42587-6,bk virus dna [units/volume] (viral load) in specimen by naa with probe detection,bkv dna spec naa+probe-acnc,bk virus dna naa+probe qn (specimen),3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; arbitrary concentration; bkv; deoxyribonucleic acid; dna nucleic acid probe; dna probe; id; infectious disease; infectiousdisease; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; misc; miscellaneous; naa+probe; naat; nasba; nucleic acid sequence based analysis; other; pcr; point in time; polymerase chain reaction; probe amp; probe with ampification; probe with target amplification; qbr; qnt; quan; quant; quantitative; random; sda; spec; strand displacement amplification; tma; to be specified in another part of the message; transcription mediated amplification; unspecified; viral load,Qn
42588-4,bordetella parapertussis dna [presence] in nasopharynx by naa with probe detection,b parapert dna nph ql naa+probe,b. parapertussis dna naa+probe ql (nph),3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; b parapert; b parapertussis; deoxyribonucleic acid; dna nucleic acid probe; dna probe; id; infectious disease; infectiousdisease; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; naa+probe; naat; nasba; nasopharynx; nucleic acid sequence based analysis; ordinal; pcr; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; screen; sda; strand displacement amplification; tma; transcription mediated amplification; whooping cough,Ord
42593-4,calcium [moles/volume] in capillary blood,calcium bldc-scnc,calcium (bldc) [moles/vol],blood - capillary; ca; cal; cap bld; cap blood; capillary bld; capillary blood; chemistry; finger stick; level; point in time; qnt; quan; quant; quantitative; random; substance concentration,Qn
42596-7,corticotropin [mass/volume] in plasma --30 minutes post xxx challenge,acth 30m p chal plas-mcnc,corticotropin 30 min post unsp challenge (p) [mass/vol],30m p chal; acth; adrenocorticotrophic hormone; adrenocorticotropin; after; c206; c74; chemistry.challenge testing; cortrosyn; level; mass concentration; p chal; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; rc206; tumor marker,Qn
42604-9,glucose [mass/volume] in urine --3 hours post dose lactose po,glucose 3h p lac po ur-mcnc,glucose 3 hr post dose lactose po (u) [mass/vol],3h p lac po; after; chemistry.challenge testing; glu; glu tol; gluc; glucose tolerance; glucoseur; gtt; level; ltt; mass concentration; p dose; point in time; pst; qnt; quan; quant; quantitative; random; ua; ur; urn,Qn
42610-6,salicylurate [mass/volume] in serum or plasma,salicylurate serpl-mcnc,salicylurate [mass/vol],2-hydroxybenzoylglycine; drug/toxicology; drugs; level; mass concentration; n-(2-hydroxybenzoyl)glycine; n-(o-hydroxybenzoyl)glycine; o-hydroxyhippurate; o-hydroxyhippuric acid; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; salicylglycine; salicyluric acid; serp; serpl; serplas; serum; serum or plasma; sr,Qn
42612-2,salicylurate [mass/volume] in urine,salicylurate ur-mcnc,salicylurate (u) [mass/vol],2-hydroxybenzoylglycine; drug/toxicology; drugs; level; mass concentration; n-(2-hydroxybenzoyl)glycine; n-(o-hydroxybenzoyl)glycine; o-hydroxyhippurate; o-hydroxyhippuric acid; point in time; qnt; quan; quant; quantitative; random; salicylglycine; salicyluric acid; ua; ur; urn,Qn
42619-7,cd28 cells/cells in bone marrow,cd28 cells nfr mar,cd28 cells/cells (bm),bm; bon; bone marrow; cd28 cells; cell; cell markers; cellularity; mar; marrow (bone); minimal angle of resolution; minimum angle of resolution; number fraction; percent; point in time; qnt; quan; quant; quantitative; random; t44; tp44,Qn
42620-5,terminal deoxyribonucleotidyl transferase cells/cells in bone marrow,tdt cells nfr mar,terminal deoxyribonucleotidyl transferase cells/cells (bm),bm; bon; bone marrow; cell; cell markers; cellularity; mar; marrow (bone); minimal angle of resolution; minimum angle of resolution; number fraction; percent; point in time; qnt; quan; quant; quantitative; random; tdt; tdt cells,Qn
42631-2,glucose [mass/volume] in urine --5 hours post dose lactose po,glucose 5h p lac po ur-mcnc,glucose 5 hr post dose lactose po (u) [mass/vol],5h p lac po; after; chemistry.challenge testing; glu; glu tol; gluc; glucose tolerance; glucoseur; gtt; level; ltt; mass concentration; p dose; point in time; pst; qnt; quan; quant; quantitative; random; ua; ur; urn,Qn
4264-8,flurazepam [mass] of dose,flurazepam dose,flurazepam (dose) [mass],dalmane; dose med or substance; drug doses; point in time; qnt; quan; quant; quantitative; random,Qn
42658-5,deprecated streptomycin 10.0 ug/ml [susceptibility] by method for slow-growing mycobacteria,deprecated streptomycin 10 ug/ml islt sl,streptomycin 10 ug/ml slow-growing mycobacteria [susc],10 ug/ml; aminoglycosides; antibiotic susceptibilities; ast; c232; c295; cidam est; id; infectious disease; infectiousdisease; islt; isol; mcg; novostrep; point in time; random; solustrep; streptocol; strepto-fatol; streptomyc; sus; suscept; susceptibilities; susceptibility; susceptibilty,OrdQn
42669-2,fatty acids [presence] in pleural fluid,fa plr ql,fatty acids ql (pleur fld),acd; acid; chemistry; fatty acid; lipid; ordinal; pleural; pleural fluid; point in time; pr; ql; qual; qualitative; random; screen; thoracentesis fluid,Ord
42679-1,heparin [units/volume] in platelet poor plasma by chromogenic method,heparin ppp chro-acnc,heparin chromogenic method qn (ppp),anti-xa; arbitrary concentration; chromogenic assay; coagulation; enzy; enzymatic assay; hematology; heme; hep; hepar; heparn; plas; platelet poor plasma; point in time; qnt; quan; quant; quantitative; random,Qn
4268-9,gentamicin [mass] of dose,gentamicin dose,gentamicin (dose) [mass],aminoglycosides; c213; dose med or substance; drug doses; garamycin; genirr; genj; gent; point in time; qnt; quan; quant; quantitative; random,Qn
4270-5,glutethimide [mass] of dose,glutethimide dose,glutethimide (dose) [mass],addiction; doriden; dose med or substance; drug doses; drugs of abuse; glutethimde; illicit; point in time; potentialforabuse; qnt; quan; quant; quantitative; random,Qn
42727-8,fibrin d-dimer [mass/volume] in cerebral spinal fluid by latex agglutination,d dimer csf la.ddu-mcnc,fibrin d-dimer la.ddu (csf) [mass/vol],cerebral spinal fluid; cerebrospinal fl; coagulation; d dimer; dextro; fragment d-dimer; lat; latex agglutination; level; mass concentration; neuro; neurology; point in time; qnt; quan; quant; quantitative; random; spinal fl; spinal fld; spinal flu; spinal fluid,Qn
42739-3,phosphatidylcholine iga ab b2gp1 dependent [multiple of the median] in serum,pc iga b2gp1 dep mom ser,phosphatidylcholine iga b2gp1 dependent (s) [mom],abs; aby; antby; anti; antibodies; antibody; apc; autoantibodies; autoantibody; beta 2 glycoprotein 1; coagulation; hematology; heme; iga b2gp1 dep; immune globulin a; immunoglobulin a; mom; multiple of the median; neonatal respiratory distress syndrome; pc; phosphatidyl choline; point in time; ptdcho; qnt; quan; quant; quantitative; random; serum; sr,Qn
42740-1,phosphatidylcholine iga ab b2gp1 independent [multiple of the median] in serum,pc iga b2gp1 indep mom ser,phosphatidylcholine iga b2gp1 independent (s) [mom],abs; aby; antby; anti; antibodies; antibody; apc; autoantibodies; autoantibody; beta 2 glycoprotein 1; coagulation; hematology; heme; iga b2gp1 indep; immune globulin a; immunoglobulin a; mom; multiple of the median; neonatal respiratory distress syndrome; pc; phosphatidyl choline; point in time; ptdcho; qnt; quan; quant; quantitative; random; serum; sr,Qn
42741-9,phosphatidylcholine igg ab b2gp1 dependent [multiple of the median] in serum,pc igg b2gp1 dep mom ser,phosphatidylcholine igg b2gp1 dependent (s) [mom],abs; aby; antby; anti; antibodies; antibody; apc; autoantibodies; autoantibody; beta 2 glycoprotein 1; coagulation; hematology; heme; igg b2gp1 dep; immune globulin g; immunoglobulin g; mom; multiple of the median; neonatal respiratory distress syndrome; pc; phosphatidyl choline; point in time; ptdcho; qnt; quan; quant; quantitative; random; serum; sr,Qn
42744-3,phosphatidylcholine igm ab b2gp1 independent [multiple of the median] in serum,pc igm b2gp1 indep mom ser,phosphatidylcholine igm b2gp1 independent (s) [mom],abs; aby; antby; anti; antibodies; antibody; apc; autoantibodies; autoantibody; beta 2 glycoprotein 1; coagulation; hematology; heme; igm b2gp1 indep; immune globulin m; immunoglobulin m; mom; multiple of the median; neonatal respiratory distress syndrome; pc; phosphatidyl choline; point in time; ptdcho; qnt; quan; quant; quantitative; random; serum; sr,Qn
42768-2,hiv 1 and 2 ab [interpretation] in serum narrative,hiv 1 & 2 ab ser-imp,hiv 1 and 2 ab nar (s) [interp],abs; aby; aids; antby; anti; antibodies; antibody; autoantibodies; autoantibody; hiv 1 and 2 ab; hiv type 1; hiv type i; hiv1; hiv1+2; human immunodeficiency virus; i; id; ii; impression; impression/interpretation of study; impressions; infectious disease; infectiousdisease; interp; interpretation; microbiology; narrative; point in time; random; report; serum; sr,Nar
42790-6,deprecated mitogen-activated protein kinase 14 ag [presence] in tissue by immune stain,deprecated map kinase 14 tiss ql imstn,map kinase 14 immune stain ql (tiss),"arbitrary concentration; ihc; imm; immunohistochemical stain; immunostain; imstn; imun; imune; ordinal; pathology; point in time; ql; qual; qualitative; random; screen; st; stains; stn; tissue; tissue, unspecified",Ord
42795-5,retinoblastoma protein [presence] in tissue by immune stain,rb protein tiss ql imstn,retinoblastoma protein immune stain ql (tiss),"ihc; imm; immunohistochemical stain; immunostain; imstn; imun; imune; ordinal; pathology; point in time; pr; prot; ql; qual; qualitative; random; rb; rb protein; screen; st; stains; stn; tissue; tissue, unspecified",Ord
42806-0,deprecated bacteria identified in isolate,deprecated bacteria islt,bacteria identified nom (isol),bact; id; identity or presence; infectious disease; infectiousdisease; islt; isol; microbiology; nominal; point in time; random,Nom
42810-2,hemoglobin [entitic mass] in reticulocytes,hgb retic qn,hemoglobin (reticulocytes) [entitic mass],chr; entitic mass; haemoglobin; hb; hematology/cell counts; hgb; point in time; qnt; quan; quant; quantitative; random; reticulocyte hemoglobin content,Qn
42813-6,xr wrist - bilateral scaphoid single view,xr wrist-bl scaphoid 1 view,,1v; arm; bil; bilat; both; carpal bone; carpal bones; carpal bones and joint; document; ext; extr-bl; film; finding; findings; imaging; navicular (wrist); plain films; point in time; rad; radiology; random; single view; ue; ue-bl; up; upper extremity joint; vw; wrist-bl; wrists; xray; x-ray,Doc
4282-0,imipenem [mass] of dose,imipenem dose,imipenem (dose) [mass],dose med or substance; drug doses; imipeneum; imp; point in time; primaxin; qnt; quan; quant; quantitative; random,Qn
42831-8,drug abuse [ccc],,,clinical care classification; drugs; finding; findings; nursing; ordinal; point in time; ql; qual; qualitative; random; screen; survey; survey.nursing.hhcc,Ord
42832-6,latex allergy response [ccc],,,clinical care classification; finding; findings; hevea braziliensis; k082; k82; ltx; nursing; ordinal; point in time; ql; qual; qualitative; random; screen; survey; survey.nursing.hhcc,Ord
4285-3,insulin lente [mass] of dose,insulin lente dose,insulin lente (dose) [mass],dose med or substance; drug doses; hum; humulin; ih7; insul; lente; nph; point in time; qnt; quan; quant; quantitative; random; semilente; sliding; ultralente,Qn
42860-7,cannabinoids [mass/volume] in urine,cannabinoids ur-mcnc,cannabinoids (u) [mass/vol],addiction; cannabinoid; delta-9-tetrahydrocannabinol; drug/toxicology; drugs; drugs of abuse; illicit; level; marijuana; mass concentration; point in time; potentialforabuse; qnt; quan; quant; quantitative; random; thc; ua; universallaborders; ur; urn,Qn
42862-3,carbofuran [presence] in urine,carbofuran ur ql,carbofuran ql (u),1563-66-2; curaterr; drug/toxicology; drugs; furadan; furadan 3g; ordinal; point in time; pr; ql; qual; qualitative; random; screen; ua; ur; urn; yaltox,Ord
42871-4,cd138 cells/cells in body fluid,cd138 cells nfr fld,cd138 cells/cells (body fld),"b/f; bf; bod; bodies; body fluid; body fluid, unsp; cd138 cells; cell; cell markers; cellularity; fl; fld; flu; fluid; heparan sulfate proteoglycan; number fraction; percent; point in time; qnt; quan; quant; quantitative; random; syndecan-1",Qn
42877-1,cd3-cd16+ cells [#/volume] in body fluid,cd3-cd16+ cells # fld,cd3-cd16+ cells (body fld) [#/vol],"#; abs; absolute; absolutes; b/f; bf; bod; bodies; body fluid; body fluid, unsp; cd3 cells; cd3+cd16+ cells; cd3-cd16+ cells; cell; cell markers; cellularity; cnt; count; count/volume; ct; fcgr3a; fl; fld; flu; fluid; leu11; leu-11; leu11b; leu-11b; leu4; leu-4; number concentration; number concentration (count/vol); point in time; qnt; quan; quant; quantitative; random; t3",Qn
4287-9,insulin regular [mass] of dose,insulin regular dose,insulin regular (dose) [mass],dose med or substance; drug doses; hum; humulin; ih7; insul; lente; nph; point in time; qnt; quan; quant; quantitative; random; semilente; sliding; ultralente,Qn
42889-6,cd79b cells/cells in bone marrow,cd79b cells nfr mar,cd79b cells/cells (bm),b29; bm; bon; bone marrow; cd79b cells; cell; cell markers; cellularity; ig beta; mar; marrow (bone); minimal angle of resolution; minimum angle of resolution; number fraction; percent; point in time; qnt; quan; quant; quantitative; random,Qn
42896-1,colorado tick fever virus igm ab [titer] in serum by immunofluorescence,ctfv igm titr ser if,colorado tick fever virus igm if (s) [titer],abs; aby; acif; antby; anti; antibodies; antibody; anticomplement immunofluorescence; autoantibodies; autoantibody; ctfv; dilution factor; dilution factor (titer); fa; fluorescent antibody; fluoresent; id; ifa; immune fluorescence; immune globulin m; immunoflour; immunofluor; immunofluorescence; immunoglobulin m; infectious disease; infectiousdisease; microbiology; point in time; random; serum; smqn; sr; time resolved fluorescence; titer; titered; titre; trf; ttr,SemiQn
42898-7,cyclic citrullinated peptide igg ab [presence] in serum,ccp igg ser ql,cyclic citrullinated peptide igg ql (s),abs; aby; antby; anti; antibodies; antibody; anti-ccp; autoantibodies; autoantibody; ccp; ccp3; cyclic citrulinated peptide; immune globulin g; immunoglobulin g; ordinal; pept; point in time; pr; ql; qual; qualitative; random; rheum; rheumatoid arthritis; rheumatology; screen; serology; serum; sr,Ord
42902-7,elastase.pancreatic [presence] in stool,elastase panc stl ql,elastase.pancreatic ql (stl),bowel movement; chemistry; ela; elastase panc; faecal; faeces; fecal; feces; ordinal; pancr; pancreatc; pancreatic elastase 1; pancreatic elastase i; pancreatopeptidase e; point in time; pr; ql; qual; qualitative; random; screen; stl; stool = fecal,Ord
42904-3,epicoccum purpurascens igg ab [mass/volume] in serum,e purpurascens igg-mcnc,epicoccum purpurascens igg (s) [mass/vol],abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; e nigrum; e purpurascens; epicoccum nigrans; epicoccum nigrum; epicoccus purpurascens; immune globulin g; immunoglobulin g; level; m14; m73; mass concentration; point in time; qnt; quan; quant; quantitative; random; serum; sr,Qn
42906-8,galactose 1 phosphate uridyl transferase [enzymatic activity/volume] in dbs,gal1put dbs-ccnc,galactose 1 phosphate uridyl transferase (dbs) [catalytic activity/vol],blood; catalytic concentration; cerebrose; chemistry; dbs; dried blood spot; filter paper; fp; gal-1-p; gal1po4; gal-1-po4; gal1pts; gal1put; gal-1-put; galactose 1 phosphate uridyltransferase; galactosemia; galt; gput; hexose-1-phosphate uridyltransferase; i; i phos; inorganic phosphate; phos; phosphate total; phosphorous; phosphorus; phosphrous; pi; po4; point in time; qnt; quan; quant; quantitative; random; wb; whole blood,Qn
42908-4,hematocrit [volume fraction] of capillary blood by calculation,hct vfr bldc calc,hematocrit calc (bldc) [volume fraction],blood - capillary; calc; calculation; cap bld; cap blood; capillary bld; capillary blood; discocyte; erc; erythrocytes; finger stick; hematology/cell counts; percent; point in time; qnt; quan; quant; quantitative; random; rbc; red blood cell; red blood cells; red blood corpuscle; red blood corpusles; red cell; red cells; spec; vol; volfr; volume fraction,Qn
42912-6,hemoglobin.gastrointestinal [presence] in specimen --2nd specimen,hemoccult sp2 spec ql,hemoglobin.gastrointestinal spec 2 ql (specimen),chemistry; convalescent; fecal occult blood; fob; gastrocult; gastrointest blood; gi; guiac; haemoglobin; hb; hemoccult; hemocult; hgb; misc; miscellaneous; occult blood; occult blood in stool; ordinal; other; point in time; post immunization; pr; ql; qual; qualitative; random; screen; second; sp2; spec; to be specified in another part of the message; unspecified,Ord
42925-8,myeloid cells/cells in body fluid,myeloid cells nfr fld,myeloid cells/cells (body fld),"b/f; bf; bod; bodies; body fluid; body fluid, unsp; cell; cellularity; fl; fld; flu; fluid; hematology/cell counts; myelo; number fraction; percent; point in time; qnt; quan; quant; quantitative; random",Qn
42926-6,myeloid cells/cells in blood,myeloid cells nfr bld,myeloid cells/cells (bld),blood; cell; cellularity; hematology/cell counts; myelo; number fraction; percent; point in time; qnt; quan; quant; quantitative; random; wb; whole blood,Qn
42928-2,filaria ag [presence] in serum,filaria ag ser ql,filaria ag ql (s),antigen; antigens; filarial; filariasis; id; infectious disease; infectiousdisease; microbiology; microfilaria; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; sr,Ord
4292-9,ketamine [mass] of dose,ketamine dose,ketamine (dose) [mass],dose med or substance; drug doses; ketalar; ketaset; ketavet; point in time; qnt; quan; quant; quantitative; random,Qn
42932-4,cd40 cells/cells in specimen,cd40 cells nfr spec,cd40 cells/cells (specimen),bp50; cd40 cells; cell; cell markers; cellularity; misc; miscellaneous; number fraction; other; percent; point in time; qnt; quan; quant; quantitative; random; spec; to be specified in another part of the message; unspecified,Qn
42934-0,cd83 cells/cells in specimen,cd83 cells nfr spec,cd83 cells/cells (specimen),cd83 cells; cell; cell markers; cellularity; hb15; misc; miscellaneous; number fraction; other; percent; point in time; qnt; quan; quant; quantitative; random; spec; to be specified in another part of the message; unspecified,Qn
42966-2,saint louis encephalitis virus igm ab [presence] in cerebral spinal fluid,slev igm csf ql,slev igm ql (csf),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; cerebral spinal fluid; cerebrospinal fl; enc; enceph; encephalomyelitis; id; immune globulin m; immunoglobulin m; infectious disease; infectiousdisease; microbiology; neuro; neurology; ordinal; point in time; pr; ql; qual; qualitative; random; screen; sle virus; slev; spinal fl; spinal fld; spinal flu; spinal fluid; st louis,Ord
42979-5,polio virus 3 ab [titer] in body fluid,pv3 ab titr fld,polio virus 3 ab (body fld) [titer],"abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; b/f; bf; bod; bodies; body fluid; body fluid, unsp; dilution factor; dilution factor (titer); fl; fld; flu; fluid; id; iii; infectious disease; infectiousdisease; microbiology; point in time; polio virus type iii; poliovirus; pv; pv3; random; smqn; titer; titered; titre; ttr",SemiQn
42983-7,parainfluenza virus 4 igg ab [presence] in serum,hpiv4 igg ser ql,parainfluenza virus 4 igg ql (s),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; hpiv; hpiv4; human rubulavirus 4; id; immune globulin g; immunoglobulin g; infectious disease; infectiousdisease; microbiology; ordinal; para; parainflu; point in time; pr; ql; qual; qualitative; random; screen; serum; sr,Ord
4298-6,levorphanol [mass] of dose,levorphanol dose,levorphanol (dose) [mass],addiction; dose med or substance; dromoran; drug doses; drugs of abuse; illicit; levo-dromoran; levorphan; methorphinan; point in time; potentialforabuse; qnt; quan; quant; quantitative; random,Qn
42990-2,mycoplasma pneumoniae igm ab [titer] in pleural fluid,m pneumo igm titr plr,m. pneumoniae igm (pleur fld) [titer],abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; dilution factor; dilution factor (titer); enzootic pneumonia; id; immune globulin m; immunoglobulin m; infectious disease; infectiousdisease; lung; m pneumo; m pneumonia; m pneumoniae; microbiology; myco; myco pneu; mycoplas; mycoplasm; mycoplasmoides pneumoniae; mycoplasmosis; mycoplsm; pleural; pleural fluid; pneu; pneum; pneumo; pneumon; pneumonia; point in time; pulmonary; pulmonology; random; respiratory; smqn; thoracentesis fluid; titer; titered; titre; ttr,SemiQn
43000-9,leishmania brasilensis ab [titer] in serum,l braziliensis ab titr ser,l. brasilensis ab (s) [titer],abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; dilution factor; dilution factor (titer); id; infectious disease; infectiousdisease; l brasilensis; l brasiliensis; l braziliensis; leishmaniasis; leishmaniosis; microbiology; point in time; random; serum; smqn; sr; titer; titered; titre; ttr,SemiQn
43006-6,jamestown canyon virus ab [titer] in serum,jcv ab titr ser,jamestown canyon virus ab (s) [titer],abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; dilution factor; dilution factor (titer); id; infectious disease; infectiousdisease; jcv; microbiology; point in time; random; serum; smqn; sr; titer; titered; titre; ttr,SemiQn
43018-1,histoplasma capsulatum mycelial phase ab [titer] in cerebral spinal fluid,h capsul myc ab titr csf,h. capsulatum mycelial phase ab (csf) [titer],abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; cerebral spinal fluid; cerebrospinal fl; dilution factor; dilution factor (titer); h capsul; h capsul myc; h capsulatum; h farciminosum; histo; histopl; histoplasma farciminosum; histoplasmin; histoplasmos; histoplasmosis; id; infectious disease; infectiousdisease; microbiology; mycel; neuro; neurology; point in time; random; smqn; spinal fl; spinal fld; spinal flu; spinal fluid; titer; titered; titre; ttr,SemiQn
43022-3,herpes virus 7 igm ab [titer] in serum,hhv7 igm titr ser,hhv 7 igm (s) [titer],abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; dilution factor; dilution factor (titer); herpesvirus; hhv; hhv7; human herpes virus; human herpes virus type 7; id; immune globulin m; immunoglobulin m; infectious disease; infectiousdisease; microbiology; point in time; random; serum; smqn; sr; titer; titered; titre; ttr,SemiQn
43026-4,herpes simplex virus 2 igm ab [presence] in cerebral spinal fluid,hsv2 igm csf ql,hsv 2 igm ql (csf),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; cerebral spinal fluid; cerebrospinal fl; herp splx; herpes simplex virus type 2; herpes simplex virus type ii; hsv; hsv2; id; ii; immune globulin m; immunoglobulin m; infectious disease; infectiousdisease; microbiology; neuro; neurology; ordinal; point in time; pr; ql; qual; qualitative; random; screen; spinal fl; spinal fld; spinal flu; spinal fluid,Ord
43049-6,coxsackievirus a10 ab [titer] in body fluid,cv a10 ab titr fld,coxsackievirus a10 ab (body fld) [titer],"abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; b/f; bf; bod; bodies; body fluid; body fluid, unsp; cav; coxsackie; coxsackie virus; cv; cv a10; dilution factor; dilution factor (titer); fl; fld; flu; fluid; id; infectious disease; infectiousdisease; microbiology; point in time; random; smqn; titer; titered; titre; ttr",SemiQn
43060-3,chlamydia trachomatis d+k iga ab [titer] in serum,c trach d+k iga titr ser,c. trachomatis d+k iga (s) [titer],abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; c trac; c trach; c trach d; c trach d+k; c tracho; c trachomatis; chlam; chlam trac; chlamid; ct; ct d and k; dextro; dilution factor; dilution factor (titer); id; immune globulin a; immunoglobulin a; infectious disease; infectiousdisease; kell blood group system; lgv; lymphogranuloma venereum; microbiology; point in time; random; serum; smqn; sr; titer; titered; titre; trachoma; ttr,SemiQn
43088-4,aspergillus sp ab [titer] in pleural fluid,aspergillus ab titr plr,aspergillus sp ab (pleur fld) [titer],abs; aby; antby; anti; antibodies; antibody; asperg; aspergil; aspergilis; aspergilla; aspergillin; aspergillosis; aspergils; aspergilus; autoantibodies; autoantibody; dilution factor; dilution factor (titer); farmers lung; id; infectious disease; infectiousdisease; lung; microbiology; pleural; pleural fluid; point in time; pulmonary; pulmonology; random; respiratory; smqn; species; spp; thoracentesis fluid; titer; titered; titre; ttr,SemiQn
43100-7,sjogrens syndrome-a and b extractable nuclear ab panel - serum,ena ss-a + ssb ab pnl ser,sjogrens syndrome-a and b extractable nuclear ab panel (s),"a,b; ana; anf; antinuclear antibody; ena; ena ab pnl; ena ss-a + ssb ab pnl; na; nuc; pan; panel.serology; panl; pnl; point in time; random; serology; serum; sr; ss",-
43108-0,metanephrine and normetanephrine panel [mass/volume] - serum or plasma,metaneph+normetaneph pnl serpl-mcnc,metanephrine and normetanephrine panel [mass/vol],chemistry; level; mass concentration; metaneph; metaneph+normetaneph; metaneph+normetaneph pnl; metanephrine fractionated; metanephrines panel; metanephrne; metenephrine; normeta; normetaneph; normetanephrn; pan; panel.chemistry; panl; pl; plasma; plsm; pnl; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
4310-9,meprobamate [mass] of dose,meprobamate dose,meprobamate (dose) [mass],addiction; carisoprodol metabolite; dose med or substance; drug doses; drugs of abuse; equanil; illicit; point in time; potentialforabuse; qnt; quan; quant; quantitative; random,Qn
43113-0,hemoglobin electrophoresis panel in blood,hgb pnl bld elph,hemoglobin panel elph (bld),blood; elec; elect; electr; electro; electrophhrs; electrophrs; elp; elph; ep; haemoglobin; hb; hematology/cell counts; hgb; hgb pnl; pan; panel.hematology& cell counts; panl; pnl; point in time; qnt; quan; quant; quantitative; random; wb; whole blood,Qn
43126-2,cortisol.free panel - 24 hour urine,cortisol free pnl 24h ur,cortisol.free panel (24h u),1 day; 17-hydroxycorticosterone; 24 hours; 24hr; chemistry; compound f; coritsol; cort; cortis f; cortisol free pnl; f; fr; hydrocortisone; non-protein bound; pan; panel.chemistry; panl; pnl; qnt; quan; quant; quantitative; ua; ufc; ur; urn,Qn
43138-7,population size investigation,population size invest,,clin; cnt; count; number; point in time; qnt; quan; quant; quantitative; random,Qn
43158-5,chlorine.free [mass/volume] in water,chlorine free wat-mcnc,chlorine.free (water) [mass/vol],chlorine free; cl2; drug/toxicology; drugs; fr; level; mass concentration; non-protein bound; point in time; qnt; quan; quant; quantitative; random; wat,Qn
43162-7,monochloramine [mass/volume] in water,monochloramine wat-mcnc,monochloramine (water) [mass/vol],drug/toxicology; drugs; level; mass concentration; nh2cl; point in time; qnt; quan; quant; quantitative; random; wat,Qn
431-7,ristocetin [susceptibility] by minimum lethal concentration (mlc),ristocetin islt mlc,ristocetin mlc [susc],antibiotic susceptibilities; ast; id; infectious disease; infectiousdisease; islt; isol; mbc; minimum bactericidal concentration; minimum lethal concentration; point in time; qnt; quan; quant; quantitative; random; sus; suscept; susceptibilities; susceptibility; susceptibilty,Qn
43180-9,herpes simplex virus 2 igg ab [presence] in serum or plasma by immunoassay,hsv2 igg serpl ql ia,hsv 2 igg ia ql,abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; eia; elfa; elisa; enzyme immunoassay; herp splx; herpes simplex virus type 2; herpes simplex virus type ii; hsv; hsv2; iaa; id; ii; immune globulin g; immunoglobulin g; infectious disease; infectiousdisease; meia; microbiology; ordinal; pl; plasma; plsm; point in time; pr; ql; qual; qualitative; random; screen; serp; serpl; serplas; serum; serum or plasma; sr; suds; universallaborders,Ord
43190-8,myelin associated glycoprotein/sulfated glucuronic paragloboside igm ab [titer] in serum by immunoassay,mag/sgpg igm titr ser ia,myelin associated glycoprotein/sulfated glucuronic paragloboside igm ia (s) [titer],abs; aby; antby; anti; antibodies; antibody; assoc; autoantibodies; autoantibody; dilution factor; dilution factor (titer); eia; elfa; elisa; enzyme immunoassay; gg; glycoprot; glycoproteins; gp; iaa; immune globulin m; immunoglobulin m; mag; mag/sgpg; magm; mag-sgpg; meia; point in time; random; serology; serum; sgpg.igm; smqn; sr; suds; titer; titered; titre; ttr,SemiQn
43206-2,tetrachloroethylene [mass/volume] in urine,ttce ur-mcnc,tetrachloroethylene (u) [mass/vol],drug/toxicology; drugs; level; mass concentration; perchloroethylene; point in time; qnt; quan; quant; quantitative; random; tetrachloroethene; ttce; ua; ur; urn,Qn
43215-3,cortisol [mass/volume] in serum or plasma --baseline,cortis bs serpl-mcnc,cortisol baseline [mass/vol],17-hydroxycorticosterone; bs; chemistry.challenge testing; compound f; coritsol; cort; f; hydrocortisone; level; mass concentration; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
4321-6,methaqualone [mass] of dose,methaqualone dose,methaqualone (dose) [mass],addiction; dose med or substance; drug doses; drugs of abuse; illicit; methaqualon; point in time; potentialforabuse; qnt; quaalude; quan; quant; quantitative; random,Qn
43223-7,sodium/creatinine [ratio] in urine,sodium/creat ur-rto,sodium/creatinine (u) [ratio],chemistry; cr; crea; creat; na; na+; point in time; qnt; quan; quant; quantitative; random; ratios; rto; ua; ucr; ur; urn,Qn
43226-0,2-hydroxyisocaproate [presence] in urine,2oh-isocaproate ur ql,2-hydroxyisocaproate ql (u),2-hydroxy-4-methylpentanoate; 2-hydroxy-4-methylpentanoic acid; 2-hydroxy-isocaproate; 2-hydroxyisocaproic acid; 2oh-isocaproate; alpha-hydroxyisocaproic acid; chemistry; ii; ordinal; point in time; pr; ql; qual; qualitative; random; screen; ua; ur; urn,Ord
43243-5,isobutyrylcarnitine (c4) [moles/volume] in serum or plasma,isobutyrylcarn serpl-scnc,isobutyrylcarnitine (c4) [moles/vol],c4; chemistry; level; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; substance concentration,Qn
43244-3,herpes virus 6 dna [presence] in serum by naa with probe detection,hhv6 dna ser ql naa+probe,hhv 6 dna naa+probe ql (s),3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; deoxyribonucleic acid; dna nucleic acid probe; dna probe; herpesvirus; hhv; hhv6; hhv-6; human herpes virus; human herpes virus type 6; id; infectious disease; infectiousdisease; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; naa+probe; naat; nasba; nucleic acid sequence based analysis; ordinal; pcr; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; screen; sda; serum; sr; strand displacement amplification; tma; transcription mediated amplification,Ord
43254-2,fev1 --pre excercise,fev1 pre exc,,before; breathing; end tidal volume; excz; exp; fev; fev1; forced expiratory volume in 1 second; lung; lungs; point in time; pre exc; pre exercise; pulmonary; pulmonology; qnt; quan; quant; quantitative; random; respiratory; rs; s prime; vet; vol; vol exp; volume,Qn
43271-6,ceftobiprole [susceptibility] by minimum inhibitory concentration (mic),ceftobiprole islt mic,ceftobiprole mic [susc],antibiotic susceptibilities; ast; ceftobiprole medocaril; id; infectious disease; infectiousdisease; islt; isol; minimum inhibitory concentration; point in time; random; sus; suscept; susceptibilities; susceptibility; susceptibilty,OrdQn
43275-7,cd3 cells/cd4 cells [# ratio] in specimen,cd3 cells/cd4 cells spec,cd3 cells/cd4 cells (specimen) [# ratio],cd3 cells; cd4 cells; cell; cell markers; cellularity; helper t cells; inducer t cells; l3t4; leu3; leu-3; leu4; leu-4; misc; miscellaneous; number ratio; other; point in time; qnt; quan; quant; quantitative; random; spec; t3; t4; t-4; to be specified in another part of the message; unspecified; w3/25,Qn
43277-3,gdap1 gene mutations found [identifier] in blood or tissue by molecular genetics method nominal,gdap1 gene mut anl bld/t,gdap1 gene targeted mutation analysis molgen nom (bld/tiss),"blood; cmt2g; cmt2h; cmt2k; cmt4; cmt4a; cmtria; ganglioside induced differentiation associated protein 1; ganglioside-induced differentiation-associated protein 1 gene; genetics; heredity; heritable; identity or presence; inherited; molecular genetics; molecular pathology; molpath; molpath.mutations; mut; mut anl; mutations; nominal; pcr; point in time; random; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",Nom
43279-9,hepatitis b virus ymdd [presence] in serum or plasma by naa with probe detection,hbv ymdd mut serpl ql naa+probe,hbv ymdd naa+probe ql,3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; antibiotic susceptibilities; dna nucleic acid probe; dna probe; hbv; hbv ymdd mut; hep; hep b; hepatis; hepatit; hepatology; hepb; id; infectious disease; infectiousdisease; lamivudine resistance; lat; lcr; ligase chain reaction; ligation-activated transcription; liver; mut; mutations; naa+probe; naat; nasba; nucleic acid sequence based analysis; ordinal; pcr; pl; plasma; plsm; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; screen; sda; serp; serpl; serplas; serum; serum or plasma; sr; strand displacement amplification; tma; transcription mediated amplification,Ord
43281-5,hepatitis d virus ag [mass/volume] in serum,hdv ag ser-mcnc,hdv ag (s) [mass/vol],antigen; antigens; delta hepatitis; dextro; hdv; hep; hep d; hep delta; hepatis; hepatit; hepatitis delta virus; hepatology; id; infectious disease; infectiousdisease; level; liver; mass concentration; microbiology; point in time; qnt; quan; quant; quantitative; random; serum; sr,Qn
43283-1,myeloid cells/cells in tissue,myeloid cells nfr tiss,myeloid cells/cells (tiss),"cell; cellularity; hematology/cell counts; myelo; number fraction; percent; point in time; qnt; quan; quant; quantitative; random; tissue; tissue, unspecified",Qn
43287-2,spermatozoa igg binding location [identifier] in semen,sperm igg bind location smn,spermatozoa igg binding location nom (sem),bind; ejaculate; fertility testing; genitourinary; gu; identity or presence; immune globulin g; immunoglobulin g; nominal; point in time; random; sem; seminal fluid; smn; smpls; sperm; sperm igg bind location; uro; urology,Nom
43290-6,hla-drb1 [presence],hla-drb1 ql,hla-drb1 ql (bld/tiss),"blood; genetics; heredity; heritable; hla antigen; human leukocyte antigen; inherited; ordinal; point in time; pr; ql; qual; qualitative; random; screen; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",Ord
43291-4,hla-dqb1 [presence],hla-dqb1 ql,hla-dqb1 ql (bld/tiss),"blood; genetics; heredity; heritable; hla antigen; human leukocyte antigen; inherited; ordinal; point in time; pr; ql; qual; qualitative; random; screen; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",Ord
43298-9,htlv i+ii rgp21 ab [presence] in serum,htlv i+ii rgp21 ab ser ql,htlv i+ii rgp21 ab ql (s),2; abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; htlv i+ii rpg21 ab; htlv type 1+2; htlv type i+ii; human t-cell leukemia virus; human t-cell lymphotrophic virus; id; infectious disease; infectiousdisease; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; sr,Ord
43333-4,equine herpesvirus 2 neutralizing antibody [titer] in serum by neutralization test,ehv2 nab titr ser nt,equine herpesvirus 2 neut ab neut test (s) [titer],abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; conventional virus neutralization test; cvnt; dilution factor; dilution factor (titer); ehv; ehv2; equin; herpes virus; id; ii; infectious disease; infectiousdisease; microbiology; nab; neutralization; neutralization test; nt; point in time; random; serum; serum virus neutralization; smqn; sr; svn; titer; titered; titre; ttr; vet; veterinary; virus neutralization test; vnt,SemiQn
43341-7,venezuelan equine encephalitis virus ab [titer] in serum by immunoassay,veev ab titr ser ia,veev ab ia (s) [titer],abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; dilution factor; dilution factor (titer); eia; elfa; elisa; enc; enceph; encephalomyelitis; enzyme immunoassay; equin; iaa; id; infectious disease; infectiousdisease; meia; microbiology; point in time; random; serum; smqn; sr; suds; titer; titered; titre; togavirus; ttr; vee virus; veev,SemiQn
43353-2,avian metapneumovirus c ab [presence] in serum,ampv c ab ser ql,avian metapneumovirus c ab ql (s),abs; aby; ampv; ampv c; antby; anti; antibodies; antibody; autoantibodies; autoantibody; avian pneumovirus; bird; fowl; id; infectious disease; infectiousdisease; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; rh blood group system; screen; serum; sr; swollen head syndrome; trtv; trtvc; turkey rhinotracheitis,Ord
43362-3,cardiolipin igg ab [mass/volume] in serum,cardiolipin igg ser-mcnc,cardiolipin igg (s) [mass/vol],abs; aby; aca; acl; antby; anti; antibodies; antibody; anticardiolipin; autoantibodies; autoantibody; cardio; cardiolip; cardiolipn; cardiolpn; cl; coagulation; hematology; heme; immune globulin g; immunoglobulin g; level; mass concentration; point in time; qnt; quan; quant; quantitative; random; serum; sr,Qn
43384-7,neisseria sp identified in urethra by organism specific culture,neisseria urth cult,neisseria sp identified org specific cx nom (urethra),c&s; cult; cultures; genital tract; id; identity or presence; infectious disease; infectiousdisease; microbiology; nominal; point in time; random; spec; species; spp; urth,Nom
43393-8,ldl 4 [mass/volume] in serum or plasma,ldl4 serpl-mcnc,ldl 4 [mass/vol],cardio; cardiology; chemistry; heart disease; ldl4; level; mass concentration; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
43413-4,blood product units requested [#],num bpu requested,blood product units requested (bpu) [#],blood bank; blood product unit; blood product unit (pack); bpu requested; cnt; count; number; point in time; qnt; quan; quant; quantitative; random,Qn
43438-1,bartonella henselae and bartonella quintana igg and igm panel - serum,b henselae+quintana igg+igm pnl ser,b. henselae and b. quintana igg and igm panel (s),b henselae; b henselae+quintana igg+igm pnl; b quintana; bacillary angiomaosis; bacillary pelliosis; cat scratch disease; cat scratch fever; csd; id; immune globulin g; immune globulin m; immunoglobulin g; immunoglobulin m; infectious disease; infectiousdisease; microbiology; pan; panel.microbiology; panl; pnl; point in time; r henselae; r quintana; random; rochalimae quintana; rochalimaea henselae; rochalimaea quintana; serum; sr; trench fever,-
43441-5,bacteria identified in bronchoalveolar lavage by aerobe culture,bacteria bal aerobe cult,bacteria identified aer cx nom (bal),aerobe; aerobe cult; aerobed; bact; bronchial alveolar lavage; bronchoalveolar lavage; c&s; cult; cultures; id; identity or presence; infectious disease; infectiousdisease; lung; microbiology; nominal; point in time; pulmonary; pulmonology; random; respiratory; universallaborders,Nom
43442-3,bacteria identified in bronchial brush by aerobe culture,bacteria bro brush aerobe cult,bacteria identified aer cx nom (bronchial brush),aerobe; aerobe cult; aerobed; bact; bro; bro brush; c&s; cult; cultures; id; identity or presence; infectious disease; infectiousdisease; lung; microbiology; nominal; point in time; pulmonary; pulmonology; random; respiratory,Nom
4345-5,naproxen [mass] of dose,naproxen dose,naproxen (dose) [mass],anaprox; c228; c283; dose med or substance; drug doses; point in time; qnt; quan; quant; quantitative; random,Qn
43455-5,mr oropharynx,mr oropharynx,,brain; cranial; cranium; document; finding; findings; imaging; intracranial; mitral regurgitation maximum velocity; mri; point in time; rad; radiology; random; skull,Doc
43483-7,xr foot - right 3 or 4 views,xr foot-r 3v or 4v,,3v; 3v or 4v; 3vw; document; ext; extr-r; films; finding; findings; foot-r; ft; iii; imaging; le; leg; le-r; low; lower extremity; msk; musculoskeletal; ortho; orthopedics; plain films; point in time; r; rad; radiology; random; rle; rt; view; vws; xray; x-ray,Doc
43487-8,us guidance for placement of radiation therapy fields in unspecified body region,us guided rt fields place,,document; echography; finding; findings; guid; guide; guided; imaging; misc; miscellaneous; oncology; other; point in time; radiology; random; rt fields place; sonogram; sonograph; sonography; spec; to be specified in another part of the message; uls; ultrasound; unspecified,Doc
43492-8,xr finger fifth - left ge 3 views,xr finger.5th-l ge 3v,,5th; arm; document; ext; extr-l; films; finding; findings; finger.5th-l; finger-l; ge 3v; iii; imaging; l; lt; lue; minimum 3 views; msk; musculoskeletal; ortho; orthopedics; plain films; point in time; rad; radiology; random; ue; ue-l; up; view; vws; xray; x-ray,Doc
43493-6,xr thumb - right ge 3 views,xr thumb-r ge 3v,,arm; document; ext; extr-r; films; finding; findings; ge 3v; iii; imaging; minimum 3 views; plain films; point in time; r; rad; radiology; random; rt; rue; thumb-r; ue; ue-r; up; view; vws; xray; x-ray,Doc
43495-1,xr finger third - right ge 3 views,xr finger.3rd-r ge 3v,,3rd; arm; document; ext; extr-r; films; finding; findings; finger.3rd-r; finger-r; ge 3v; iii; imaging; minimum 3 views; msk; musculoskeletal; ortho; orthopedics; plain films; point in time; r; rad; radiology; random; rt; rue; ue; ue-r; up; view; vws; xray; x-ray,Doc
43498-5,xr knee - left ge 3 views,xr knee-l ge 3v,,document; ext; extr-l; films; finding; findings; ge 3v; iii; imaging; kn; knee-l; l; le; leg; le-l; lle; low; lower extremity joint; lt; minimum 3 views; msk; musculoskeletal; ortho; orthopedics; plain films; point in time; rad; radiology; random; view; vws; xray; x-ray,Doc
43508-1,mr axilla - left,mr axilla-l,,ax; axilla-l; document; finding; findings; imaging; l; lt; mitral regurgitation maximum velocity; mri; point in time; rad; radiology; random; thorax; upper extremity,Doc
43521-4,xr mandible 1 or 2 views,xr mandible 1v or 2v,,1v or 2v; brain; cranial; cranium; document; films; finding; findings; i; ii; imaging; intracranial; jaw; mand; plain films; point in time; rad; radiology; random; skull; view; views le 2; vws; xray; x-ray,Doc
43522-2,xr pelvis 1 or 2 views,xr pelvis 1v or 2v,,1v or 2v; coreplaybook; document; films; finding; findings; i; ii; imaging; pelvic; plain films; playbook; point in time; rad; radiology; random; view; views le 2; vws; xray; x-ray,Doc
43526-3,spect unspecified body region,spect w rnc iv,,document; finding; findings; imaging; misc; miscellaneous; other; point in time; rad; radiology; random; rn; rnc; scan; to be specified in another part of the message; unspecified; w rnc iv,Doc
43536-2,rf videography lumbar spine views,rf video l-spine views,,abd; abdo; abdomen+; abdominal; document; films; finding; findings; fluor; fluoro; fluoroscopy; imaging; l/sp; l-spine; lumbar; lumbo; point in time; rad; radiology; random; rf video; spinal; spinal cord; view; vws,Doc
43548-7,deprecated finger fourth right x-ray ge 3 views,deprecated finger.4th-r xr ge 3v,,4th; films; finding; findings; finger.4th-r; ge 3v; iii; imaging; minimum 3 views; msk; musculoskeletal; narrative; ortho; orthopedics; plain films; point in time; r; rad; radiology; random; report; rt; view; vws; xray; x-ray,Nar
43557-8,nm liver and biliary ducts and gallbladder views,nm liver+bds+gb views w rnc iv,,abd; abdo; abdomen+; abdominal; bds; bds+gb; bile tract; biliary tract; coreplaybook; document; films; finding; findings; gall bladder; gb; hepar; hepatic; hepatobiliary; imaging; liver+bds+gb; playbook; point in time; rad; radiology; random; rn; rnc; scan; view; vws; w rnc iv,Doc
4358-8,norfenefrine [mass] of dose,norfenefrine dose,norfenefrine (dose) [mass],dose med or substance; drug doses; energona; esbuphon; m-norsynephrine; nevadral retard; norphenylephrine; novadral; point in time; qnt; quan; quant; quantitative; random; stagural; vingsal,Qn
43594-1,nidus [mass] in stone,nidus stone qn,nidus (stone) [mass],calc; calculi; gastro; gastroenterology; gi; kidney; nephrology; pathology; point in time; qnt; quan; quant; quantitative; random; renal; stn; stone; stones,Qn
43596-6,apple ige ab/ige total in serum,apple ige/ige total %,apple ige/total ige (s) [%],%; abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; apple; autoantibodies; autoantibody; f049; f49; ige total; immune globulin e; immunoglobulin e; point in time; pyrus malus; qnt; quan; quant; quantitative; random; serum; sr; tot; total ige; totl,Qn
43597-4,inner ear 68kd ab [presence] in serum or plasma by immunoblot,inner ear 68kd ab serpl ql ib,inner ear 68kd ab ib ql,abs; aby; antby; anti; antibodies; antibody; audiology; autoantibodies; autoantibody; blt; heat shock protein 70; hsp-70; immune blot; immunobl; immunoblot; ordinal; pl; plasma; plsm; point in time; pr; ql; qual; qualitative; random; riba; screen; serology; serp; serpl; serplas; serum; serum or plasma; sr; wb; wblot; west blot; west blt; western blot,Ord
43606-3,microalbumin [mass/time] in 4 hour urine,microalbumin 4h ur-mrate,albumin dl <= 20 mg/l (4 hour u) [mass/time],240 minutes; 4 hours; 4.0hr; 4hr; alb; chemistry; dl=20 mg/l; kidney; left; levo; ma; malb; mass rate; micro albumin; microalbumin; mrate; nephrology; protein.albumin; qnt; quan; quant; quantitative; renal; ua; ur; urn,Qn
43619-6,actinomyces sp ab [presence] in serum,actinomyces ab ser ql,actinomyces sp ab ql (s),abs; aby; actino; antby; anti; antibodies; antibody; autoantibodies; autoantibody; id; infectious disease; infectiousdisease; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; species; spp; sr,Ord
43633-7,5-oxoproline [presence] in 24 hour urine,5oxoproline 24h ur ql,5-oxoproline ql (24h u),1 day; 24 hours; 24hr; 5oxoproline; chemistry; ordinal; oxopro; pidolate; pidolic acid; pr; pyroglutamate; pyroglutamic acid; ql; qual; qualitative; screen; ua; ur; urn,Ord
43636-0,plasminogen activator tissue type [presence] in platelet poor plasma by chromogenic method,tpa ppp ql chro,plasminogen activator tissue type chromogenic method ql (ppp),blood plasminogen activator; chromogenic assay; coagulation; enzy; enzymatic assay; hematology; heme; ordinal; plas; platelet poor plasma; plg; plgn; point in time; pr; profibrinolysin; ql; qual; qualitative; random; screen; tissue plasminogen activator; tpa; t-pa; vascular plasminogen activator,Ord
43654-3,nm liver views for blood flow w tc-99m tagged rbc iv,nm liver vs bld flow w tc99m rbc iv,,99 mtc; 99mtc; abd; abdo; abdomen+; abdominal; bld flow; document; dynamic; films; finding; findings; hepar; hepatic; imaging; point in time; rad; radiology; random; scan; tc-99cm; tc99m; tc-99m; technetium 99m; view; vs bld flow; vws; w tc99m rbc iv,Doc
43659-2,spect heart perfusion qualitative at rest and w radionuclide iv,spect hrt pf ql rest+w rnc iv,,cardiac; document; finding; findings; hrt; imaging; myocardial perfusion; pf; pf ql; point in time; rad; radiology; random; rest+w rnc iv; resting; rn; rnc; scan; thorax; w rnc iv,Doc
436-6,rolitetracycline [susceptibility] by minimum inhibitory concentration (mic),rolitetracycline islt mic,rolitetracycline mic [susc],antibiotic susceptibilities; ast; id; infectious disease; infectiousdisease; islt; isol; minimum inhibitory concentration; pmt; point in time; pyrrolidinomethyltetracycline; random; reverin; sus; suscept; susceptibilities; susceptibility; susceptibilty; transcycline,OrdQn
4366-1,oxandrolone [mass] of dose,oxandrolone dose,oxandrolone (dose) [mass],anavar; dose med or substance; drug doses; lonavar; oxandrin; point in time; qnt; quan; quant; quantitative; random,Qn
43663-4,nm renal vessels views for blood flow w tc-99m glucoheptonate iv,nm renal ves vs bld flow w tc99mgha iv,,99 mtc; 99mtc; abd; abdo; abdomen+; abdominal; bld flow; document; dynamic; films; finding; findings; gh; gha; imaging; kidney; point in time; rad; radiology; random; scan; tc-99cm; tc99m; tc-99m; technetium 99m; vesl; vessels.xxx; view; vs bld flow; vws; w tc99mgha iv,Doc
43683-2,fda package insert recent major changes section,fda insert recent major changes,,document.ref; fda insert; narrative; report; spl; structured product labelling,Nar
43722-8,5-ethyl-5-phenylhydantoin [presence] in specimen,5-ethyl-5-phenylhydantoin spec ql,5-ethyl-5-phenylhydantoin ql (specimen),drug/toxicology; drugs; mephenytoin metabolite; misc; miscellaneous; nirvanol; ordinal; other; point in time; pr; ql; qual; qualitative; random; screen; spec; to be specified in another part of the message; unspecified,Ord
43727-7,lipoprotein.beta.subparticle.small [moles/volume] in serum or plasma,ldl small serpl-scnc,lipoprotein.beta.subparticle.small [moles/vol],b; chemistry; ldl; ldl particle concentration; ldl particle number; ldl small; level; lip; lipoprot; lipoproteins; low density lipoproteins; lp; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; substance concentration,Qn
43732-7,4-hydroxybenzoate [presence] in urine,4ohbenzoate ur ql,4-hydroxybenzoate ql (u),4-hydroxy benzoate; 4-hydroxybenzoic acid; 4ohbenzoate; drug/toxicology; drugs; hydroxybenzoic acid; ordinal; para-hydroxybenzoic acid; p-hydroxybenzoic acid; point in time; pr; ql; qual; qualitative; random; screen; ua; ur; urn,Ord
43741-8,temperature of semen,temp smn,temperature (sem) [temp],ejaculate; fertility testing; genitourinary; gu; point in time; qnt; quan; quant; quantitative; random; sem; seminal fluid; smn; smpls; temp; temperature; uro; urology,Qn
43747-5,oca2 gene mutations found [identifier] in blood or tissue by molecular genetics method nominal,oca2 gene mut anl bld/t,oca2 gene targeted mutation analysis molgen nom (bld/tiss),"bey; bey1; bey2; blood; boca; d15s12; eycl; eycl2; eycl3; genetics; hcl3; heredity; heritable; identity or presence; inherited; molecular genetics; molecular pathology; molpath; molpath.mutations; mut; mut anl; mutations; nominal; oculocutaneous albinism ii; p; p protein gene; pcr; ped; point in time; random; shep1; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",Nom
4375-2,para hydroxyamphetamine [mass] of dose,p-oh-amphet dose,para hydroxyamphetamine (dose) [mass],addiction; dose med or substance; drug doses; drugs of abuse; illicit; methylthyramine; para hydroxy amphetamine; p-oh-amphet; point in time; potentialforabuse; qnt; quan; quant; quantitative; random,Qn
43753-3,spermatozoa igm binding location [identifier] in semen,sperm igm bind location smn,spermatozoa igm binding location nom (sem),bind; ejaculate; fertility testing; genitourinary; gu; identity or presence; immune globulin m; immunoglobulin m; nominal; point in time; random; sem; seminal fluid; smn; smpls; sperm; sperm igm bind location; uro; urology,Nom
43760-8,us guidance for localization of breast - right,us guided brst-r loc,,brst; brst-r; document; echography; finding; findings; guid; guide; guided; gyn; gynecology; imaging; local; ob; obgyn; obstetrics; point in time; r; radiology; random; rt; sonogram; sonograph; sonography; uls; ultrasound,Doc
43769-9,mr brain and internal auditory canal wo and w contrast iv,mr brain+iac wo+w contr iv,,audiology; brain; brain+iac; c; cerebral; cerebrum; contr; contra; contrst; cranial; cranium; document; finding; findings; head; imaging; intracranial; mitral regurgitation maximum velocity; mri; neuro; neurology; point in time; rad; radiology; random; skull; w contr iv; wc; wo & wc; wo+w contr; wo+w contr iv; wwo,Doc
43772-3,mr brain and internal auditory canal,mr brain+iac,,audiology; brain; brain+iac; cerebral; cerebrum; cranial; cranium; document; finding; findings; head; imaging; intracranial; mitral regurgitation maximum velocity; mri; neuro; neurology; point in time; rad; radiology; random; skull,Doc
43775-6,mr kidney wo and w contrast iv,mr kidney wo+w contr iv,,abd; abdo; abdomen+; abdominal; c; contr; contra; contrst; document; finding; findings; imaging; kidney; mitral regurgitation maximum velocity; mri; nephric; nephrogram; nephrography; nephrology; point in time; rad; radiology; random; renal; w contr iv; wc; wo & wc; wo+w contr; wo+w contr iv; wwo,Doc
43777-2,nm heart perfusion at rest and w adenosine and w tl-201 iv,nm hrt pf rest+w ade+tl201 iv,,201ti; ado; aned; cardiac; cardio; cardiology; document; films; finding; findings; heart disease; hrt; imaging; medication stress; myocardial perfusion; pf; point in time; rad; radiology; random; rest+w ade+tl201 iv; resting; scan; thallium 201; thallous; thorax; t-i201; tl-201; view; vws; w ade+tl-201 iv,Doc
4377-8,pefloxacin [mass] of dose,pefloxacin dose,pefloxacin (dose) [mass],dose med or substance; drug doses; peflacin; peflacine; peflox; point in time; qnt; quan; quant; quantitative; random,Qn
43796-2,xr wrist - bilateral carpal tunnel views,xr wrist-bl views tunnel.carpal,,arm; bil; bilat; both; carpal bone; carpal bones; carpal bones and joint; document; ext; extr-bl; films; finding; findings; imaging; plain films; point in time; rad; radiology; random; ue; ue-bl; up; upper extremity joint; view; views tunnel.carpal; views+carpal tunnel; vws; wrist-bl; wrists; xray; x-ray,Doc
43800-2,choriogonadotropin.beta subunit [presence] in cerebral spinal fluid,b-hcg csf ql,hcg.beta subunit ql (csf),b; b hcg; beta hcg; beta human chorionic gonadotropin; b-hcg; cerebral spinal fluid; cerebrospinal fl; cg; chemistry; choriogonadotropin beta chain; choriogonadotropins total; chorionic gonadotropin; hcg; human chorionic gonadotropin; ordinal; point in time; pr; ql; qual; qualitative; random; screen; spinal fl; spinal fld; spinal flu; spinal fluid; tumor marker,Ord
43817-6,androstenedione [presence] in serum or plasma,androst serpl ql,androstenedione ql,chemistry; gamma-4-androstenedione; ordinal; pl; plasma; plsm; point in time; pr; ql; qual; qualitative; random; screen; serp; serpl; serplas; serum; serum or plasma; sr,Ord
43818-4,beta-2-microglobulin [presence] in serum,b2 microglob ser ql,beta-2-microglobulin ql (s),b; b2 microglob; b2-m; chemistry; hematology; heme; ii; microglob; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; sr,Ord
43826-7,androstanolone [presence] in serum or plasma,androstanolone serpl ql,androstanolone ql,chemistry; dht; dihydrotestosterone; ordinal; pl; plasma; plsm; point in time; pr; ql; qual; qualitative; random; screen; serp; serpl; serplas; serum; serum or plasma; sr,Ord
43830-9,nicotine [presence] in specimen,nicotine spec ql,nicotine ql (specimen),addiction; drug/toxicology; drugs; drugs of abuse; habitrol; illicit; misc; miscellaneous; nicoderm; nictoine; ordinal; other; point in time; potentialforabuse; pr; ql; qual; qualitative; random; screen; spec; to be specified in another part of the message; unspecified,Ord
43832-5,quinidine [presence] in specimen,quinidine spec ql,quinidine ql (specimen),chinidine; drug/toxicology; drugs; misc; miscellaneous; ordinal; other; point in time; pr; ql; qual; qualitative; random; screen; spec; to be specified in another part of the message; unspecified,Ord
43838-2,influenza virus a igm ab [presence] in serum,fluav igm ser ql,fluav igm ql (s),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; avian influenza; bird flu; flua; fluav; fluv; fowl plague; id; immune globulin m; immunoglobulin m; infectious disease; infectiousdisease; influ; influenza a; influenza a virus; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; sr,Ord
43842-4,borrelia burgdorferi ab [titer] in serum by immunoassay,b burgdor ab titr ser ia,b. burgdorferi ab ia (s) [titer],abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; b burg; b burgdor; b burgdorferi; bb; burgdorf; dilution factor; dilution factor (titer); eia; elfa; elisa; enzyme immunoassay; iaa; id; infectious disease; infectiousdisease; lyme; lyme disease; lymes; meia; microbiology; point in time; random; serum; smqn; sr; suds; titer; titered; titre; ttr,SemiQn
43849-9,coccidioides sp igg ab [presence] in serum by immunoassay,coccidioides igg ser ql ia,coccidioides sp igg ia ql (s),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; coccidiodes; eia; elfa; elisa; enzyme immunoassay; iaa; id; immune globulin g; immunoglobulin g; infectious disease; infectiousdisease; meia; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; san joaquin valley fever; screen; serum; species; spp; sr; suds; valley fever,Ord
43855-6,urease [presence] in tissue --2 hours post incubation,urease 2h p inc tiss ql,urease 2 hr post incubation ql (tiss),"120 min; 120 minutes; 120min; 2 hours; 2h p inc; after; clo test; clotest; gastro; gastroenterology; gi; helicobacter pylori biopsy test; microbiology; ordinal; point in time; pr; pst; ql; qual; qualitative; random; screen; tissue; tissue, unspecified",Ord
43863-0,benzthiazide [presence] in 24 hour urine,benzthiazide 24h ur ql,benzthiazide ql (24h u),1 day; 24 hours; 24hr; diurin; drug/toxicology; drugs; exna; ordinal; pr; ql; qual; qualitative; screen; ua; ur; urn,Ord
4386-9,perphenazine [mass] of dose,perphenazine dose,perphenazine (dose) [mass],dose med or substance; drug doses; point in time; qnt; quan; quant; quantitative; random; trilafon,Qn
43875-4,basement membrane igm ab [presence] in serum,bm igm ser ql,basement membrane igm ql (s),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; basem; basemt; bm; immune globulin m; immunoglobulin m; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serology; serum; sr,Ord
4387-7,phenacetin [mass] of dose,phenac dose,phenacetin (dose) [mass],aceto-p-phenetidide; addiction; cratodin rectal; dose med or substance; drug doses; drugs of abuse; gripponyl; hemagene tailleur; illicit; nevral; point in time; polypirine; potentialforabuse; qnt; quan; quant; quantitative; random,Qn
43882-0,bordetella pertussis filamentous hemagglutinin igm ab [presence] in serum,b pert fha igm ser ql,b. pertussis filamentous hemagglutinin igm ql (s),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; b pert; b pert fha; b pertussis; fha; filament; ha; id; immune globulin m; immunoglobulin m; infectious disease; infectiousdisease; microbiology; ordinal; pertussis; point in time; pr; ql; qual; qualitative; random; screen; serum; sr; whooping cough,Ord
43884-6,ampicillin [presence] in urine,ampicillin ur ql,ampicillin ql (u),amcil; amicil; amp; ampicilloyl; c203; c5; drug/toxicology; drugs; omnipen; ordinal; penbritin; point in time; polycillin; pr; ql; qual; qualitative; random; screen; ua; ur; urn,Ord
43892-9,borate [presence] in blood,borate bld ql,borate ql (bld),blood; boric acid; drug/toxicology; drugs; ordinal; point in time; pr; ql; qual; qualitative; random; screen; wb; whole blood,Ord
4389-3,phencyclidine [mass] of dose,pcp dose,phencyclidine (dose) [mass],addiction; angel dust; dose med or substance; drug doses; drugs of abuse; illicit; pcp; point in time; potentialforabuse; qnt; quan; quant; quantitative; random; sernylan,Qn
43896-0,bordetella pertussis [presence] in pleural fluid by organism specific culture,b pert plr ql cult,b. pertussis org specific cx ql (pleur fld),b pert; b pertussis; c&s; cult; cultures; id; infectious disease; infectiousdisease; lung; microbiology; ordinal; pertussis; pleural; pleural fluid; point in time; pr; pulmonary; pulmonology; ql; qual; qualitative; random; respiratory; screen; spec; thoracentesis fluid; whooping cough,Ord
43901-8,barium [presence] in 24 hour urine,barium 24h ur ql,barium ql (24h u),1 day; 24 hours; 24hr; ba; drug/toxicology; drugs; ordinal; pr; ql; qual; qualitative; screen; ua; ur; urn,Ord
43905-9,arbovirus igg ab [presence] in serum,arbovirus igg ser ql,arbovirus igg ql (s),abs; aby; antby; anti; antibodies; antibody; arbo virus; autoantibodies; autoantibody; id; immune globulin g; immunoglobulin g; infectious disease; infectiousdisease; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; sr,Ord
43908-3,avian encephalomyelitis virus ab [presence] in cerebral spinal fluid,aev ab csf ql,avian encephalomyelitis virus ab ql (csf),abs; aby; aev; antby; anti; antibodies; antibody; autoantibodies; autoantibody; bird; cerebral spinal fluid; cerebrospinal fl; fowl; id; infectious disease; infectiousdisease; microbiology; neuro; neurology; ordinal; point in time; pr; ql; qual; qualitative; random; screen; spinal fl; spinal fld; spinal flu; spinal fluid; vet; veterinary,Ord
43911-7,aspergillus versicolor ab [presence] in serum,a versicolor ab ql,a. versicolor ab ql (s),a versicolor; abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; asperg; aspergil; aspergilis; aspergilla; aspergillin; aspergillosis; aspergils; aspergilus; autoantibodies; autoantibody; farmers lung; m019; m19; m25; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; sr,Ord
43913-3,bordetella pertussis dna [presence] in nasopharynx by naa with probe detection,b pert dna nph ql naa+probe,b. pertussis dna naa+probe ql (nph),3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; b pert; b pertussis; deoxyribonucleic acid; dna nucleic acid probe; dna probe; id; infectious disease; infectiousdisease; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; naa+probe; naat; nasba; nasopharynx; nucleic acid sequence based analysis; ordinal; pcr; pertussis; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; screen; sda; strand displacement amplification; tma; transcription mediated amplification; whooping cough,Ord
43916-6,beta 2 glycoprotein 1 igm ab [presence] in serum,b2 glycoprot1 igm ser ql,beta 2 glycoprotein 1 igm ql (s),abs; aby; antby; anti; antibodies; antibody; apoh; apolipoprotein h; autoantibodies; autoantibody; b; b2 glycoprot1; b2 glycoprotein 1; b2gpi; b2-gpi; coagulation; gg; glycoprot; glycoproteins; gp; hematology; heme; i; ii; immune globulin m; immunoglobulin m; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; sr,Ord
4392-7,phenmetrazine [mass] of dose,phenmetrazine dose,phenmetrazine (dose) [mass],addiction; dose med or substance; drug doses; drugs of abuse; illicit; oxazimedrine; point in time; potentialforabuse; preludin endurets; qnt; quan; quant; quantitative; random,Qn
4393-5,phenobarbital [mass] of dose,phenobarb dose,phenobarbital (dose) [mass],barbiturate; c417; dose med or substance; drug doses; luminal; nirvonal; phbr; phenobarb; point in time; qnt; quan; quant; quantitative; random,Qn
43966-1,cd4+cd45ra+ cells/cells in specimen,cd4+cd45ra+ cells nfr spec,cd4+cd45ra+ cells/cells (specimen),2h4; cd4 cells; cd4+cd45ra+ cells; cell; cell markers; cellularity; helper t cells; inducer t cells; l3t4; leu18; leu-18; leu3; leu-3; misc; miscellaneous; number fraction; other; percent; point in time; qnt; quan; quant; quantitative; random; spec; t4; t-4; to be specified in another part of the message; unspecified; w3/25,Qn
4397-6,phenylbutazone [mass] of dose,phenylbutazone dose,phenylbutazone (dose) [mass],butacote; butadion; butadione; butazolidin; butazone; butrex; c231; c57; carudol; cotylbutazone; dose med or substance; drug doses; exiheudon n; inflazone; intrabutazone; kadol; novobutazone; point in time; qnt; quan; quant; quantitative; random; spondyril; ticinil,Qn
43976-0,measles virus ab [presence] in serum by immunoassay,mev ab ser ql ia,mev ab ia ql (s),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; eia; elfa; elisa; enzyme immunoassay; iaa; id; infectious disease; infectiousdisease; meia; mev; microbiology; msls; ordinal; point in time; pr; ql; qual; qualitative; random; rubeola; screen; serum; sr; suds,Ord
43984-4,benzoylecgonine [presence] in urine by screen method >150 ng/ml,bze ur ql scn>150 ng/ml,benzoylecgonine screen method >150 ng/ml ql (u),bec; beg; benz; benzoylec; bze; cocaine degradation production; cocaine metabolite; crack metabolite; drug/toxicology; drugs; nasogastric; ordinal; point in time; pr; ql; qual; qualitative; random; scn; scn&gt;150 ng/ml; scr; screen; scrn; ua; universallaborders; ur; urn,Ord
43986-9,clofazimine 2 ug/ml [susceptibility] by method for slow-growing mycobacteria,clofazamine 2 ug/ml islt slowmyco,clofazimine 2 ug/ml method for slow-growing mycobacteria [susc],2 ug/ml; afb; antibiotic susceptibilities; ast; clofazamine; id; infectious disease; infectiousdisease; islt; isol; mcg; myco; mycobacteria susceptibility; mycobacterial susceptibility; point in time; random; slowmyco; sus; suscept; susceptibilities; susceptibility; susceptibilty; tb; tuberculosis,OrdQn
43990-1,clarithromycin 3 ug/ml [susceptibility] by method for slow-growing mycobacteria,clarithro 3 ug/ml islt slowmyco,clarithromycin 3 ug/ml method for slow-growing mycobacteria [susc],3 ug/ml; afb; antibiotic susceptibilities; ast; biaxin; claripen; id; infectious disease; infectiousdisease; islt; isol; klacid; mcg; myco; mycobacteria susceptibility; mycobacterial susceptibility; point in time; random; slowmyco; sus; suscept; susceptibilities; susceptibility; susceptibilty; tb; tuberculosis,OrdQn
43994-3,trisomy 18 risk [likelihood] in fetus,ts 18 risk fetus,trisomy 18 risk qn (fetus),chemistry; edward syndrome; fetal; gyn; gynecology; ob; obgyn; obstetrics; point in time; qnt; quan; quant; quantitative; random; risk; t18 risk; ts; ts 18 risk,Qn
43996-8,alpha-1-fetoprotein [multiple of the median] adjusted for diabetes+weight in serum or plasma,afp diabetes+wt adj mom serpl,afp adjusted for diabetes+weight [mom],a1; adj; afp; alfa; alpha fetoprotein; alphafetoprotein; chemistry; diabetes adj; diabetes+wt adj; feto; i; mom; multiple of the median; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; tumor marker; wt,Qn
43999-2,choriogonadotropin [multiple of the median] in amniotic fluid,hcg mom amn,hcg (amn fld) [mom],af; amn; amn fl; amnio; amniotic flu; amniotic fluid; cg; chemistry; choriogonadotropins total; chorionic gonadotropin; hcg; human chorionic gonadotropin; mom; multiple of the median; point in time; qnt; quan; quant; quantitative; random,Qn
44000-8,choriogonadotropin [units/volume] in amniotic fluid,hcg amn-acnc,hcg qn (amn fld),af; amn; amn fl; amnio; amniotic flu; amniotic fluid; arbitrary concentration; cg; chemistry; choriogonadotropins total; chorionic gonadotropin; hcg; human chorionic gonadotropin; point in time; qnt; quan; quant; quantitative; random,Qn
44014-9,porphyrins [interpretation] in urine,porphyrins ur-imp,porphyrins (u) [interp],chemistry; hematology; heme; impression; impression/interpretation of study; impressions; interp; interpretation; nominal; point in time; porph; porphyrin; random; ua; ur; urn,Nom
4401-6,pholedrine [mass] of dose,pholedrine dose,pholedrine (dose) [mass],addiction; dose med or substance; drug doses; drugs of abuse; illicit; isodrine; paredrinol; point in time; potentialforabuse; pulsotyl; qnt; quan; quant; quantitative; random; veritol,Qn
44023-0,bacteria [presence] in vaginal fluid by wet preparation,bacteria vag ql wet prep,bacteria wet prep ql (vag fld),bact; genital vaginal; gyn; gynecology; id; infectious disease; infectiousdisease; microbiology; ob; obgyn; obstetrics; ordinal; point in time; pr; prep; ql; qual; qualitative; random; screen; universallaborders; vag fld; vag fluid; vagina; vaginal fluid; wet mount; wet prep,Ord
4404-0,pipradrol [mass] of dose,pipradrol dose,pipradrol (dose) [mass],addiction; alertonic; alpha-z-piperidylbenzhydrol; dose med or substance; drug doses; drugs of abuse; illicit; meretran; point in time; potentialforabuse; qnt; quan; quant; quantitative; random,Qn
44041-2,basophils [presence] in synovial fluid by light microscopy,basophils snv ql micro,basophils lm ql (syn fld),baso; basophil; basos; bph; hematology/cell counts; joint aspirate; joint fld; joint flu; joint fluid; lm; micro; micros; microscopic; ordinal; point in time; pr; ql; qual; qualitative; random; screen; sf; snv; syn; syn fl; synov; synovial fluid,Ord
44089-1,escherichia coli o157:h7 [identifier] in specimen by organism specific culture,e coli o157h7 spec cult,e. coli o157:h7 org specific cx nom (specimen),c&s; cult; cultures; e coli; e coli o157; e coli o157h7; enterohemorrhagic e. coli; id; identity or presence; infectious disease; infectiousdisease; microbiology; misc; miscellaneous; nominal; o002; other; point in time; random; spec; to be specified in another part of the message; unspecified,Nom
44093-3,neisseria meningitidis [identifier] in isolate by organism specific culture,n men islt cult,n. meningitidis org specific cx nom (isol),c&s; cult; cultures; id; identity or presence; infectious disease; infectiousdisease; islt; isol; mening; meningid; meningitis; meningo; meningococcal meningitis; meningococcus; microbiology; n men; n menigitidis; n meningitidis; nominal; point in time; random; spec,Nom
44104-8,ct guidance for fine needle aspiration of mediastinum,ct guided mediastinum fna,,asp; cat scan; computed tomography; computerized tomography; ct scan; document; finding; findings; fna; guid; guide; guided; imaging; ndl; perc; point in time; rad; radiology; random; thorax,Doc
44109-7,ct guidance for deep biopsy of muscle,ct guided muscle deep bx,,bx; cat scan; computed tomography; computerized tomography; ct scan; deep bx; document; finding; findings; guid; guide; guided; imaging; misc; miscellaneous; musc; muscl; other; point in time; rad; radiology; random; spec; to be specified in another part of the message; unspecified,Doc
4411-5,promazine [mass] of dose,promazine dose,promazine (dose) [mass],dose med or substance; drug doses; point in time; qnt; quan; quant; quantitative; random; sparine; tranquazine,Qn
44115-4,ct abdomen and pelvis,ct abd+pelvis,,abd; abd+pelvis; abdo; abdominal; cat scan; computed tomography; computerized tomography; ct scan; document; finding; findings; imaging; pelvic; point in time; rad; radiology; random,Doc
44121-2,deprecated mg guidance for percutaneous biopsy.needle of breast,deprecated mg brst pc bx needle guide,,brst; bx; document; finding; findings; guid; guide; guided; imaging; ndl; pc needle bx; perc; point in time; rad; radiology; random,Doc
44123-8,mr biliary ducts and pancreatic duct wo contrast,mr bd+pd wo contr,,abd; abdo; abdomen+; abdominal; bd+pd; bd+pds; bds; bile tract; biliary tract; c; cholangiopancreatogram; cholangiopancreatography; contr; contra; contrst; document; finding; findings; imaging; mitral regurgitation maximum velocity; mri; pancr; pancreatc; pd; point in time; rad; radiology; random; without contrast,Doc
44124-6,mr adrenal gland w contrast iv,mr adrenal w contr iv,,abd; abdo; abdomen+; abdominal; c; contr; contra; contrst; document; finding; findings; imaging; mitral regurgitation maximum velocity; mri; point in time; rad; radiology; random; w contr iv; wc,Doc
44128-7,mra lower extremity vessels wo and w contrast iv,mra le ves wo+w contr iv,,ang; angio; angiography; c; contr; contra; contrst; coreplaybook; document; ext; extr ves; finding; findings; imaging; le; le ves; leg; low; magnetic resonance angiographies; magnetic resonance imaging; mitral regurgitation maximum velocity; mr angiography; mra; mri; mri.angio; playbook; point in time; rad; radiology; random; vesl; vessels.xxx; w contr iv; wc; wo & wc; wo+w contr; wo+w contr iv; wwo,Doc
44133-7,mra renal vessels wo contrast,mra renal ves wo contr,,abd; abdo; abdomen+; abdominal; ang; angio; angiography; c; cardio; cardiology; contr; contra; contrst; document; finding; findings; heart disease; imaging; kidney; magnetic resonance angiographies; magnetic resonance imaging; mitral regurgitation maximum velocity; mr angiography; mra; mri; mri.angio; point in time; rad; radiology; random; vesl; vessels.xxx; without contrast,Doc
44134-5,mra renal vessels wo and w contrast iv,mra renal ves wo+w contr iv,,abd; abdo; abdomen+; abdominal; ang; angio; angiography; c; cardio; cardiology; contr; contra; contrst; document; finding; findings; heart disease; imaging; kidney; magnetic resonance angiographies; magnetic resonance imaging; mitral regurgitation maximum velocity; mr angiography; mra; mri; mri.angio; point in time; rad; radiology; random; vesl; vessels.xxx; w contr iv; wc; wo & wc; wo+w contr; wo+w contr iv; wwo,Doc
44152-7,spect brain w tc-99m bicisate iv,spect brain w tc99mbicisate iv,,99 mtc; 99mtc; brain; cerebral; cerebrum; cranial; cranium; document; finding; findings; head; imaging; intracranial; neuro; neurology; point in time; rad; radiology; random; scan; skull; tc-99cm; tc99m; tc-99m; technetium 99m; w tc99mbicisate iv,Doc
441-6,rosoxacin [susceptibility] by disk diffusion (kb),rosoxacin islt kb,rosoxacin disk diffusion (kb) [susc],acrosoxacin; antibiotic susceptibilities; ast; disk diffusion; eracine; eradacil; eradacin; id; infectious disease; infectiousdisease; islt; isol; kb; kirby-bauer; point in time; random; rosacin; sus; suscept; susceptibilities; susceptibility; susceptibilty; winuron,OrdQn
4418-0,pyrilamine [mass] of dose,pyrilamine dose,pyrilamine (dose) [mass],dose med or substance; drug doses; mepyramine; point in time; qnt; quan; quant; quantitative; random,Qn
44190-7,xr wrist ge 3 views,xr wrist ge 3v,,arm; carpal bone; carpal bones; carpal bones and joint; coreplaybook; document; ext; films; finding; findings; ge 3v; iii; imaging; minimum 3 views; plain films; playbook; point in time; rad; radiology; random; ue; up; upper extremity joint; view; vws; xray; x-ray,Doc
44200-4,deprecated sinuses x-ray 1 or 2 views limited,deprecated sinuses xr 1v or 2v ltd,,1v or 2v; 1v or 2v ltd; films; finding; findings; i; ii; imaging; lmted; ltd; narrative; paranasal sinuses; plain films; point in time; rad; radiology; random; report; sinus; view; views le 2; vws; xray; x-ray,Nar
44204-6,deprecated rf guidance for percutaneous biopsy.needle of lung,deprecated rf lung pc bx needle guide,,bx; document; finding; findings; fluor; fluoro; fluoroscopy; guid; guide; guided; imaging; lung; ndl; pc needle bx; perc; point in time; pulmonary; pulmonology; rad; radiology; random; respiratory; thorax,Doc
44213-7,rf guidance for endoscopy of pancreatic duct-- w contrast retrograde,rf guided pd endo--w contr retro,,abd; abdo; abdomen+; abdominal; c; contr; contra; contrst; coreplaybook; document; endoscopic guidance; finding; findings; fluor; fluoro; fluoroscopy; guid; guide; guided; imaging; pancr; pancreatc; pd; playbook; point in time; rad; radiology; random; retro; w contr retro; wc,Doc
44226-9,rf colon views for reduction w barium contrast pr,rf colon views for reduction w ba pr,,abd; abd+pelvis; abdo; abdominal; ba; barium enema; be; c; contr; contra; contrst; coreplaybook; document; films; finding; findings; fluor; fluoro; fluoroscopy; imaging; lgi; pelvic; playbook; point in time; rad; radiology; random; view; vws; w ba pr,Doc
44235-0,us.doppler superior mesenteric vessels,dop sm ves,,abd; abdo; abdomen+; abdominal; document; dop; duplex; echography; finding; findings; imaging; point in time; radiology; random; sm ves; sma; sonogram; sonograph; sonography; uls; ultrasound; vesl; vessels.xxx,Doc
44240-0,rfa peripheral arteries - bilateral views w contrast ia,rfa peripheral aa-bl views w contr ia,,arteriogram; bil; bilat; both; c; contr; contra; contrst; document; films; finding; findings; fluor; fluoro; fluoroscopy; imaging; misc; miscellaneous; other; periph; periph aa; periph aa-bl; peripheral aa-bl; point in time; rad; radiology; random; rfa; spec; to be specified in another part of the message; unspecified; view; vws; w contr ia; wc,Doc
44251-7,poor appetite or overeating in last 2 weeks [reported.phq],,,14 days; 2 weeks; finding; findings; mental health; mentalhealth; ordinal; past; patient health questionnaire; psych; psychiatry; ql; qual; qualitative; screen; survey; survey.phq,Ord
44259-0,"trouble falling or staying asleep, or sleeping too much in last 2 weeks [reported.phq]",,,14 days; 2 weeks; finding; findings; mental health; mentalhealth; ordinal; past; patient health questionnaire; psych; psychiatry; ql; qual; qualitative; screen; survey; survey.phq,Ord
44262-4,deprecated phq-9 interpretation,,,impression; impression/interpretation of study; impressions; interp; interpret; interpretation; interpt; intrp; ordinal; patient health questionnaire; phq9; point in time; ql; qual; qualitative; random; screen; survey; survey.phq,Ord
44270-7,bacillus anthracis spore ag [presence] in specimen by immunofluorescence,b anthracis spore ag spec ql if,b. anthracis spore ag if ql (specimen),acif; anthrax; anticomplement immunofluorescence; antigen; antigens; b anthracis; b anthracis spore; charbon; dfa; fa; fluorescent antibody; fluoresent; id; ifa; immune fluorescence; immunoflour; immunofluor; immunofluorescence; infectious disease; infectiousdisease; malignant carbuncle; malignant pustule; microbiology; milzbrand; misc; miscellaneous; ordinal; other; point in time; pr; ql; qual; qualitative; random; screen; spec; splenic fever; time resolved fluorescence; to be specified in another part of the message; trf; unspecified; woolsorters disease,Ord
44278-0,16-alpha hydroxydehydroepiandrosterone/creatinine [mass ratio] in urine,16a oh-dhea/creat ur,16-alpha hydroxydehydroepiandrosterone/creatinine (u) [mass ratio],16 alphaoh-dhea; 16a oh-dhea; 16-alpha hydroxy dehydroepiandrosterone; 16-alpha-hydroxy-dhea; alfa; chemistry; cr; crea; creat; mass concentration ratio; mass ratio; mcrto; point in time; qnt; quan; quant; quantitative; random; ua; ucr; ur; urn,Qn
44285-5,3-methylcrotonylglycine/creatinine [mass ratio] in 24 hour urine,3me-crotonylglycine/creat 24h ur,3-methylcrotonylglycine/creatinine (24h u) [mass ratio],1 day; 24 hours; 24hr; 3me-crotonylglycine; beta-methylcrotonylglycine; chemistry; cr; crea; creat; iii; mass concentration ratio; mass ratio; mcrto; qnt; quan; quant; quantitative; ua; ucr; ur; urn,Qn
4431-3,sulfamethoxazole [mass] of dose,sulfamethoxazole dose,sulfamethoxazole (dose) [mass],acetylsulfamethoxazole; c203; c223; c61; dose med or substance; drug doses; gantanol; point in time; qnt; quan; quant; quantitative; random; smx; sulfa; sulfamethox,Qn
44313-5,delta aminolevulinate/creatinine [mass ratio] in 24 hour urine,d-ala/creat 24h ur,delta aminolevulinate/creatinine (24h u) [mass ratio],1 day; 24 hours; 24hr; 5-ala; 5-aminolevulinate; 5-aminolevulinic acid; ala; aminolevulinic acid; amnolev; amnolevuunc; chemistry; cr; crea; creat; d-ala; delta-ala; delta-aminolevulinic acid; mass concentration ratio; mass ratio; mcrto; qnt; quan; quant; quantitative; ua; ucr; ur; urn,Qn
44324-2,iodine.inorganic [presence] in serum or plasma,inorg iodine serpl ql,iodine.inorganic ql,c616; chemistry; i; i-; inorg iodine; ordinal; pl; plasma; plsm; point in time; pr; ql; qual; qualitative; random; screen; serp; serpl; serplas; serum; serum or plasma; sr,Ord
44332-5,jo-1 extractable nuclear igg ab [presence] in serum,ena jo1 igg ser ql,jo-1 extractable nuclear igg ql (s),abs; aby; ana; ana igg; anf; antby; anti; antibodies; antibody; antinuclear antibody; autoantibodies; autoantibody; ena; ena jo1; histidyl-trna synthease; i; immune globulin g; immunoglobulin g; na; nuc; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serology; serum; sr,Ord
44337-4,metanephrine free/creatinine [mass ratio] in urine,metaneph free/creat ur,metanephrine free/creatinine (u) [mass ratio],chemistry; cr; crea; creat; fr; mass concentration ratio; mass ratio; mcrto; metaneph; metaneph free; metanephrne; metenephrine; non-protein bound; point in time; qnt; quan; quant; quantitative; random; ua; ucr; unconjugated metanephrine; ur; urn,Qn
44343-2,organic acids/creatinine [mass ratio] in urine,organic acids/creat ur,organic acids/creatinine (u) [mass ratio],acd; acid; chemistry; cr; crea; creat; mass concentration ratio; mass ratio; mcrto; point in time; qnt; quan; quant; quantitative; random; ua; ucr; ur; urn,Qn
44355-6,etiocholanolone/creatinine [mass ratio] in 24 hour urine,etiocholanolone/creat 24h ur,etiocholanolone/creatinine (24h u) [mass ratio],1 day; 24 hours; 24hr; aetiocholanolone; chemistry; cr; crea; creat; etiochol; mass concentration ratio; mass ratio; mcrto; qnt; quan; quant; quantitative; ua; ucr; ur; urn,Qn
4436-2,tetracaine [mass] of dose,tetracaine dose,tetracaine (dose) [mass],c235; dose med or substance; drug doses; point in time; pontocaine; qnt; quan; quant; quantitative; random; tetrakain,Qn
44373-9,homocysteine [presence] in urine,hcys ur ql,homocysteine ql (u),cardio; cardiology; chemistry; hcy; hcys; hcyst; heart disease; homocyst(e)ine; ordinal; point in time; pr; ql; qual; qualitative; random; screen; ua; ur; urn,Ord
44377-0,homocysteine/creatinine [molar ratio] in 24 hour urine,hcys/creat 24h ur-srto,homocysteine/creatinine (24h u) [molar ratio],1 day; 24 hours; 24hr; chemistry; cr; crea; creat; hcy; hcys; hcyst; homocyst(e)ine; qnt; quan; quant; quantitative; scrto; substance concentration ratio; substance ratio; ua; ucr; ur; urn,Qn
44381-2,deprecated japanese hop ige ab rast class [presence] in serum,deprecated japanese hop ige rast ql,japanese hop ige rast class (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; h japonicus; h scandens; ige rast; immune globulin e; immunoglobulin e; japanese hop; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; sr; w22,Ord
44385-3,hydroflumethiazide [presence] in 24 hour urine,hydroflumethiazide 24h ur ql,hydroflumethiazide ql (24h u),1 day; 24 hours; 24hr; diucardin; drug/toxicology; drugs; ordinal; pr; ql; qual; qualitative; screen; ua; ur; urn,Ord
4440-4,theophylline [mass] of dose,theophylline dose,theophylline (dose) [mass],aminophylline; biophyllin; continus; dose med or substance; drug doses; lasma; nuelin; phyllocontin; point in time; pro-vent; qnt; quan; quant; quantitative; random; sabidal sr; slo-phyllin; somophyllin; somophylline; theo; theo-dur; theolair; uniphyllin,Qn
44404-2,silicon/creatinine [mass ratio] in urine,silicon/creat ur,silicon/creatinine (u) [mass ratio],cr; crea; creat; drug/toxicology; drugs; mass concentration ratio; mass ratio; mcrto; point in time; qnt; quan; quant; quantitative; random; si; ua; ucr; ur; urn,Qn
44425-7,fda package insert storage and handling section,fda insert storage/handling,,document.ref; fda insert; narrative; report; spl; storage/handling; structured product labelling,Nar
44448-9,beta 2 glycoprotein 1 igg ab [units/volume] in serum or plasma by immunoassay,b2 glycoprot1 igg serpl ia-acnc,beta 2 glycoprotein 1 igg ia qn,abs; aby; antby; anti; antibodies; antibody; apoh; apolipoprotein h; arbitrary concentration; autoantibodies; autoantibody; b; b2 glycoprot1; b2 glycoprotein 1; b2gpi; b2-gpi; coagulation; eia; elfa; elisa; enzyme immunoassay; gg; glycoprot; glycoproteins; gp; hematology; heme; i; iaa; ii; immune globulin g; immunoglobulin g; meia; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; suds; universallaborders,Qn
44450-5,beta cortolone/creatinine [mass ratio] in urine,b-cortolone/creat ur,beta cortolone/creatinine (u) [mass ratio],b; b-cortolone; chemistry; cortisol metabolite; cr; crea; creat; mass concentration ratio; mass ratio; mcrto; point in time; qnt; quan; quant; quantitative; random; ua; ucr; ur; urn,Qn
44455-4,borrelia burgdorferi ab [units/volume] in serum by immunoassay --1st specimen,b burgdor ab sp1 ser ia-acnc,b. burgdorferi ab spec 1 ia qn (s),abs; aby; acute specimen; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; b burg; b burgdor; b burgdorferi; bb; burgdorf; eia; elfa; elisa; enzyme immunoassay; first; iaa; id; infectious disease; infectiousdisease; lyme; lyme disease; lymes; meia; microbiology; point in time; pre immunization; qnt; quan; quant; quantitative; random; serum; sp1; spec; sr; suds,Qn
44458-8,brucella abortus igg+igm ab [units/volume] in serum,b abortus igg+igm ser-acnc,b. abortus igg+igm qn (s),abort; abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; b abortus; bangs disease; bovine brucellosis; bruc; brucellosis; contagious abortion; id; immune globulin g; immune globulin m; immunoglobulin g; immunoglobulin m; infectious disease; infectiousdisease; microbiology; point in time; qnt; quan; quant; quantitative; random; serum; sr; undulant fever,Qn
44463-8,herpes simplex virus 1 [presence] in vaginal fluid by organism specific culture,hsv1 vag ql cult,hsv 1 org specific cx ql (vag fld),c&s; cult; cultures; genital vaginal; gyn; gynecology; herp splx; herpes simplex virus type 1; hsv; hsv1; i; id; infectious disease; infectiousdisease; microbiology; ob; obgyn; obstetrics; ordinal; point in time; pr; ql; qual; qualitative; random; screen; spec; vag fld; vag fluid; vagina; vaginal fluid,Ord
44471-1,herpes simplex virus 1 ag [presence] in cervix,hsv1 ag cvx ql,hsv 1 ag ql (cvx),antigen; antigens; cervix; genital tract; gyn; gynecology; herp splx; herpes simplex virus type 1; hsv; hsv1; i; id; infectious disease; infectiousdisease; microbiology; ob; obgyn; obstetrics; ordinal; point in time; pr; ql; qual; qualitative; random; screen,Ord
4447-9,tolbutamide [mass] of dose,tolbutamide dose,tolbutamide (dose) [mass],dose med or substance; drug doses; novo-butamide; orinase; point in time; qnt; quan; quant; quantitative; random,Qn
44481-0,herpes simplex virus 1+2 igg ab [presence] in cerebral spinal fluid,hsv1+2 igg csf ql,hsv 1+2 igg ql (csf),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; cerebral spinal fluid; cerebrospinal fl; herp splx; herpes simplex virus type 1; herpes simplex virus type 1+2; herpes simplex virus type i+ii; hsv; hsv 1+2; hsv1; hsv1+2; i; id; ii; immune globulin g; immunoglobulin g; infectious disease; infectiousdisease; microbiology; neuro; neurology; ordinal; point in time; pr; ql; qual; qualitative; random; screen; spinal fl; spinal fld; spinal flu; spinal fluid,Ord
44492-7,herpes simplex virus 2 ab [presence] in cerebral spinal fluid by immunofluorescence,hsv2 ab csf ql if,hsv 2 ab if ql (csf),abs; aby; acif; antby; anti; antibodies; antibody; anticomplement immunofluorescence; autoantibodies; autoantibody; cerebral spinal fluid; cerebrospinal fl; fa; fluorescent antibody; fluoresent; herp splx; herpes simplex virus type 2; herpes simplex virus type ii; hsv; hsv2; id; ifa; ii; immune fluorescence; immunoflour; immunofluor; immunofluorescence; infectious disease; infectiousdisease; microbiology; neuro; neurology; ordinal; point in time; pr; ql; qual; qualitative; random; screen; spinal fl; spinal fld; spinal flu; spinal fluid; time resolved fluorescence; trf,Ord
44494-3,herpes simplex virus 2 igm ab [presence] in serum by immunoassay,hsv2 igm ser ql ia,hsv 2 igm ia ql (s),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; eia; elfa; elisa; enzyme immunoassay; herp splx; herpes simplex virus type 2; herpes simplex virus type ii; hsv; hsv2; iaa; id; ii; immune globulin m; immunoglobulin m; infectious disease; infectiousdisease; meia; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; sr; suds,Ord
4449-5,tranylcypromine [mass] of dose,tranylcypromine dose,tranylcypromine (dose) [mass],addiction; dose med or substance; drug doses; drugs of abuse; illicit; parnate; point in time; potentialforabuse; qnt; quan; quant; quantitative; random,Qn
44505-6,herpes simplex virus igg ab [presence] in cerebral spinal fluid,hsv igg csf ql,hsv igg ql (csf),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; cerebral spinal fluid; cerebrospinal fl; herp splx; hsv; id; immune globulin g; immunoglobulin g; infectious disease; infectiousdisease; microbiology; neuro; neurology; ordinal; point in time; pr; ql; qual; qualitative; random; screen; spinal fl; spinal fld; spinal flu; spinal fluid,Ord
44515-5,herpes simplex virus ag [presence] in cervix by immunoassay,hsv ag cvx ql ia,hsv ag ia ql (cvx),antigen; antigens; cervix; eia; elfa; elisa; enzyme immunoassay; genital tract; gyn; gynecology; herp splx; hsv; iaa; id; infectious disease; infectiousdisease; meia; microbiology; ob; obgyn; obstetrics; ordinal; point in time; pr; ql; qual; qualitative; random; screen; suds,Ord
44531-2,hiv 1 ag [presence] in serum from donor,hiv1 ag ser donr ql,hiv 1 ag ql (s donor),aids; antigen; antigens; donr; hiv type 1; hiv type i; hiv1; human immunodeficiency virus; i; id; infectious disease; infectiousdisease; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; sr,Ord
44532-0,hiv 1 gp120 ab [presence] in serum,hiv1 gp120 ab ser ql,hiv 1 gp120 ab ql (s),abs; aby; aids; antby; anti; antibodies; antibody; autoantibodies; autoantibody; hiv type 1; hiv type i; hiv1; hiv1 gp120; human immunodeficiency virus; i; id; infectious disease; infectiousdisease; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; sr,Ord
44541-1,htlv ii dna [presence] in blood by probe,htlv ii dna bld ql probe,htlv ii dna probe ql (bld),2; blood; deoxyribonucleic acid; dna nucleic acid probe; dna probe; human t-cell leukemia virus; human t-cell lymphotrophic virus; id; infectious disease; infectiousdisease; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; screen; wb; whole blood,Ord
44545-2,human papilloma virus dna [presence] in urethra by probe,hpv dna urth ql probe,hpv dna probe ql (urethra),deoxyribonucleic acid; dna nucleic acid probe; dna probe; genital tract; genital warts; hpv; human papillomavirus; id; infectious disease; infectiousdisease; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; screen; urth,Ord
44568-4,influenza virus b ab [presence] in serum by complement fixation,flubv ab ser ql cf,flubv ab cf ql (s),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; cf; comp fixation; compfix; complement fixation; flub; flubv; fluv; id; infectious disease; infectiousdisease; influ; influenza b; influenza b virus; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; sr,Ord
44594-0,ige [presence] in serum,ige ser ql,ige ql (s),chemistry; immune globulin e; immunoglobulin e; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; sr,Ord
44603-9,igm.monoclonal [presence] in cerebral spinal fluid by immunofixation,m-igm csf ql ife,igm.monoclonal immunofixation ql (csf),cerebral spinal fluid; cerebrospinal fl; chemistry; ife; ifix; immune globulin m; immunofixation electrophoresis; immunoglobulin m; m-igm; ordinal; point in time; pr; ql; qual; qualitative; random; screen; spinal fl; spinal fld; spinal flu; spinal fluid,Ord
44605-4,kappa light chains [presence] in cerebral spinal fluid by immunofixation,kappa lc csf ql ife,immunoglobulin light chains.kappa immunofixation ql (csf),bence jones protein; bj protein; bjp; cerebral spinal fluid; cerebrospinal fl; chain; chemistry; ife; ifix; immune globulin; immuno; immunofixation electrophoresis; immunoglob; immunoglobin; imunoglbon; imunoglobn; kappa lc; ordinal; point in time; pr; ql; qual; qualitative; random; screen; spinal fl; spinal fld; spinal flu; spinal fluid,Ord
44611-2,deprecated heart rate episode mean by oximetry,deprecated heart rate episode mean oxime,,average; avg; count/time; heart beat; heart rate.molec; nrate; number rate; number rate = count/time; pulse; qnt; quan; quant; quantitative,Qn
44632-8,deprecated satellite nodule presence by cap cancer protocols,deprecated satellite nodule presence cap prot,satellite nodule presence cap nom (skin melanoma),cap prot; dermatologic; epidermis; identity or presence; integument; nominal; pathology; pathology protocols; pathology protocols skin; point in time; random; skn,Nom
44662-5,depth of invasion by tumor cannot be determined comment in skin melanoma narrative,depth of inv by tumor can't be det,depth of invasion by tumor cannot be determined comment nar (skin melanoma),cmmt; cmnt; com; comm; comments; commt; depth of inv by tumor can't be det; dermatologic; dpth; epidermis; finding; findings; integument; narrative; path.histo; pathology; point in time; random; remarks; report; skn,Nar
44666-6,deprecated m stage of distant metastasis in breast tumor qualitative by cap cancer protocols,deprecated m stage of distant mets bt ca,m stage of distant metastasis cap ql (breast tumor),brst; bt; cancer; cap prot; finding; findings; m stage of distant mets; metastases; mets; ordinal; pathology; pathology protocols; pathology protocols breast; point in time; ql; qual; qualitative; random; screen; tumors; tumour; tumours,Ord
44674-0,invasive carcinoma uninvolved margin closest in breast tumor,ic uninv marg closest bt,invasive carcinoma uninvolved margin closest nom (breast tumor),brst; bt; cancer; finding; findings; ic uninv marg closest; nominal; path.histo; pathology; point in time; random; tumors; tumour; tumours,Nom
44675-7,dcis.uninvolved margin.closest in breast tumor,dcis.uninv marg.closest bt,dcis.uninvolved margin.closest nom (breast tumor),brst; bt; cancer; dcis.uninv marg.closest; ductal carcinoma in situ; finding; findings; nominal; pathology; pathology protocols; pathology protocols breast; point in time; random; tumors; tumour; tumours,Nom
4468-5,deprecated carboxyhemoglobin/hemoglobin.total in blood,deprecated carbonyl hgb fr bld,carbonyl hemoglobin (bld) [mass fraction],blood; haemoglobin; hb; hematology/cell counts; hgb; mass fraction; percent; point in time; qnt; quan; quant; quantitative; random; tot; totl; wb; whole blood,Qn
44696-3,inflammation type in prostate tumor,inflammation type prt,inflammation type nom (prostate tumor),cancer; finding; findings; nominal; pathology; pathology protocols; pathology protocols prostate; point in time; prost; prostatic; prt; random; tumors; tumour; tumours,Nom
4470-1,choleglobin/hemoglobin.total in blood,choleglobin mfr bld,choleglobin (bld) [mass fraction],blood; haemoglobin; haemoglobin without fe; hb; hematology/cell counts; hemoglobin without fe; hgb; mass fraction; percent; point in time; qnt; quan; quant; quantitative; random; tot; totl; verdohemoglobin; wb; whole blood,Qn
44717-7,lipoprotein.beta/lipoprotein.alpha [mass ratio] in serum or plasma,ldl/hdl serpl,lipoprotein.beta/lipoprotein.alpha [mass ratio],alfa; b; chemistry; hdl; high density lipoproteins; ldl; lip; lipoprot; lipoproteins; low density lipoproteins; lp; mass concentration ratio; mass ratio; mcrto; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
4471-9,complement activity cell surface induced [units/volume] in serum or plasma,comp actv surf ind serpl-acnc,complement activity cell surface induced qn,activ; actvty; arbitrary concentration; comp; comp actv surf ind; complmt; hematology/cell counts; movements; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; surf,Qn
44722-7,histiocytes [presence] in body fluid by light microscopy,histiocytes fld ql micro,histiocytes lm ql (body fld),"b/f; bf; bod; bodies; body fluid; body fluid, unsp; fl; fld; flu; fluid; hematology/cell counts; histiocyte; histocytes; lm; micro; micros; microscopic; ordinal; point in time; pr; ql; qual; qualitative; random; screen",Ord
44736-7,asialoganglioside gm1 ab [presence] in serum by immunoassay,gm1 asialo ab ser ql ia,asialoganglioside gm1 ab ia ql (s),abs; aby; antby; anti; antibodies; antibody; asialo gm1; asialogm1; autoantibodies; autoantibody; eia; elfa; elisa; enzyme immunoassay; ganglioside asialo; gm1 asialo; iaa; meia; monoasialoganglioside; neuro; neurology; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serology; serum; sr; suds,Ord
44763-1,native inferior vena cava liver graft attachment,native ivc liver graft attachment,,inf; native ivc liver graft attachment; nominal; organ transplant; point in time; random; typ,Nom
44789-6,amylase and creatinine clearance panel - urine and serum or plasma,amylase + crcl pnl ur+serpl,amylase and creatinine clearance panel (u+s/p),accr; alpha amylase; ams; amyl; amylase + crcl pnl; amylase/crcl pnl; chemistry; cl; clear; clearanc; clearances; clr; cr; crea; creat; creat clear; diastase; k87; pan; panel.chemistry; panl; pl; plasma; plsm; pnl; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; ua; ucr; ur; ur+serpl; urn,Qn
44792-0,immunoglobulin light chains panel - urine,immunoglobulin lc pnl ur,immunoglobulin light chains panel (u),bence jones protein; bj protein; bjp; chain; chemistry; hematology; heme; immune globulin; immuno; immunoglob; immunoglobin; immunoglobulin lc pnl; imunoglbon; imunoglobn; pan; panel.chemistry; panl; pnl; point in time; qnt; quan; quant; quantitative; random; ua; ur; urn,Qn
44810-0,htlv i gp21e ab [presence] in serum,htlv i gp21e ab ser ql,htlv i gp21e ab ql (s),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; human t-cell leukemia virus; human t-cell lymphotrophic virus; id; infectious disease; infectiousdisease; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; sr,Ord
44813-4,hepatitis c virus c22p ab [presence] in serum by immunoblot,hcv c22p ab ser ql ib,hcv c22p ab ib ql (s),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; blt; hcv; hcv c22p; hep; hep c; hepatis; hepatit; hepatology; id; immune blot; immunobl; immunoblot; infectious disease; infectiousdisease; liver; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; riba; screen; serum; sr; wb; wblot; west blot; west blt; western blot,Ord
44814-2,coxiella burnetii phase 2 igm ab [titer] in serum by immunofluorescence,c burnet ph2 igm titr ser if,c. burnetii phase 2 igm if (s) [titer],abs; aby; acif; antby; anti; antibodies; antibody; anticomplement immunofluorescence; autoantibodies; autoantibody; c burnet; c burnet ph2; c burnetii; coxiella burnetii phase ii; coxiella burnettii; dilution factor; dilution factor (titer); fa; fluorescent antibody; fluoresent; id; ifa; ii; immune fluorescence; immune globulin m; immunoflour; immunofluor; immunofluorescence; immunoglobulin m; infectious disease; infectiousdisease; microbiology; point in time; q fev; q fever; qfever; random; serum; smqn; sr; time resolved fluorescence; titer; titered; titre; trf; ttr,SemiQn
44824-1,leishmania donovani igg ab [titer] in serum by immunofluorescence,l donovani igg titr ser if,l. donovani igg if (s) [titer],abs; aby; acif; antby; anti; antibodies; antibody; anticomplement immunofluorescence; autoantibodies; autoantibody; dilution factor; dilution factor (titer); fa; fluorescent antibody; fluoresent; id; ifa; immune fluorescence; immune globulin g; immunoflour; immunofluor; immunofluorescence; immunoglobulin g; infectious disease; infectiousdisease; l donovani; leishmaniasis; leishmaniosis; microbiology; point in time; random; serum; smqn; sr; time resolved fluorescence; titer; titered; titre; trf; ttr,SemiQn
44825-8,bartonella quintana igm ab [titer] in serum by immunofluorescence,b quintana igm titr ser if,b. quintana igm if (s) [titer],abs; aby; acif; antby; anti; antibodies; antibody; anticomplement immunofluorescence; autoantibodies; autoantibody; b quintana; cat scratch disease; cat scratch fever; csd; dilution factor; dilution factor (titer); fa; fluorescent antibody; fluoresent; id; ifa; immune fluorescence; immune globulin m; immunoflour; immunofluor; immunofluorescence; immunoglobulin m; infectious disease; infectiousdisease; microbiology; point in time; r quintana; random; rochalimae quintana; rochalimaea quintana; serum; smqn; sr; time resolved fluorescence; titer; titered; titre; trench fever; trf; ttr,SemiQn
44827-4,bartonella quintana igg ab [titer] in serum by immunofluorescence,b quintana igg titr ser if,b. quintana igg if (s) [titer],abs; aby; acif; antby; anti; antibodies; antibody; anticomplement immunofluorescence; autoantibodies; autoantibody; b quintana; cat scratch disease; cat scratch fever; csd; dilution factor; dilution factor (titer); fa; fluorescent antibody; fluoresent; id; ifa; immune fluorescence; immune globulin g; immunoflour; immunofluor; immunofluorescence; immunoglobulin g; infectious disease; infectiousdisease; microbiology; point in time; r quintana; random; rochalimae quintana; rochalimaea quintana; serum; smqn; sr; time resolved fluorescence; titer; titered; titre; trench fever; trf; ttr,SemiQn
44828-2,teriflunomide [mass/volume] in serum or plasma,teriflunomide serpl-mcnc,teriflunomide [mass/vol],drug/toxicology; drugs; leflunomide metabollite; level; mass concentration; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
44832-4,glycogen synthase i/glycogen synthase.total in blood,glycogen synthase i cfr bld,glycogen synthase i/total glycogen synthase (bld) [catalytic fraction],blood; catalytic fraction; chemistry; percent; point in time; qnt; quan; quant; quantitative; random; tot; totl; wb; whole blood,Qn
44842-3,bacteria # 3 identified in specimen by culture,bacteria spec cult org #3,bacteria identified # 3 cx nom (specimen),bact; c&s; cult; cultures; id; identity or presence; iii; infectious disease; infectiousdisease; microbiology; misc; miscellaneous; nominal; other; point in time; random; spec; to be specified in another part of the message; unspecified,Nom
44845-6,bacteria # 5 identified in specimen by culture,bacteria spec cult org #5,bacteria identified # 5 cx nom (specimen),bact; c&s; cult; cultures; id; identity or presence; infectious disease; infectiousdisease; microbiology; misc; miscellaneous; nominal; other; point in time; random; spec; to be specified in another part of the message; unspecified,Nom
44852-2,mycobacterium sp # 3 identified in specimen by organism specific culture,mycobacterium spec cult org #3,mycobacterium sp identified # 3 org specific cx nom (specimen),acid fast; acid fast bacilli; acid fast bacillus; afb; c&s; cult; cultures; id; identity or presence; iii; infectious disease; infectiousdisease; microbiology; misc; miscellaneous; myco; mycobact; nominal; other; point in time; random; spec; species; spp; to be specified in another part of the message; tuberculosis; unspecified,Nom
44853-0,bacteria # 3 identified in specimen by anaerobe culture,bacteria spec anaerobe cult org #3,bacteria identified # 3 anaer cx nom (specimen),anaero; anaerobe; anaerobe cult; bact; c&s; cult; cultures; id; identity or presence; iii; infectious disease; infectiousdisease; microbiology; misc; miscellaneous; nominal; other; point in time; random; spec; to be specified in another part of the message; unspecified,Nom
44856-3,bacteria # 4 identified in specimen by anaerobe culture,bacteria spec anaerobe cult org #4,bacteria identified # 4 anaer cx nom (specimen),anaero; anaerobe; anaerobe cult; bact; c&s; cult; cultures; id; identity or presence; infectious disease; infectiousdisease; microbiology; misc; miscellaneous; nominal; other; point in time; random; spec; to be specified in another part of the message; unspecified,Nom
44869-6,histoplasma capsulatum ab [presence] in serum by counterimmunoelectrophoresis (cie),h capsul ab ser ql cie,h. capsulatum ab cie ql (s),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; counterimmunoelectrophoresis; h capsul; h capsulatum; h farciminosum; histo; histopl; histoplasma farciminosum; histoplasmos; histoplasmosis; id; infectious disease; infectiousdisease; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; sr,Ord
44877-9,insulin dependent diabetes mellitus [presence],iddm patient ql,insulin dependent diabetes mellitus ql,dm; hum; humulin; iddm; ih7; insul; lente; misc; nph; ordinal; point in time; pr; ql; qual; qualitative; random; screen; semilente; sliding; ultralente,Ord
44891-0,malignant cells [#/volume] in pericardial fluid,malignant cells # pcar,malignant cells (pericard fld) [#/vol],#; abs; absolute; absolutes; cell; cellularity; cnt; count; count/volume; ct; hematology/cell counts; malig; number concentration; number concentration (count/vol); pcar; pericardial fluid; point in time; qnt; quan; quant; quantitative; random,Qn
44910-8,alpha-1-fetoprotein [units/volume] in body fluid,afp fld-acnc,afp qn (body fld),"a1; afp; alfa; alpha fetoprotein; alphafetoprotein; arbitrary concentration; b/f; bf; bod; bodies; body fluid; body fluid, unsp; chemistry; feto; fl; fld; flu; fluid; i; point in time; qnt; quan; quant; quantitative; random; tumor marker",Qn
44913-2,beta globulin+gamma globulin [mass/volume] in serum or plasma by electrophoresis,b+g-globulin serpl elph-mcnc,beta globulin+gamma globulin elph [mass/vol],b; b+g-globulin; b-globulin; chemistry; elec; elect; electr; electro; electrophhrs; electrophrs; elp; elph; ep; glb; glob; glob%; globul; globulins; level; mass concentration; pl; plasma; plsm; point in time; protein beta globulin; protein gamma globulin; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
44914-0,beta globulin+gamma globulin/protein.total in serum or plasma by electrophoresis,b+g-globulin mfr serpl elph,beta globulin+gamma globulin elph [mass fraction],b; b+g-globulin; b-globulin; chemistry; elec; elect; electr; electro; electrophhrs; electrophrs; elp; elph; ep; glb; glob; glob%; globul; globulins; mass fraction; percent; pl; plasma; plsm; point in time; pr; prot; protein beta globulin; protein gamma globulin; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; spep; sr; tot; totl; tp,Qn
44915-7,cholesterol in ldl/cholesterol in hdl [molar ratio] in serum or plasma,ldlc/hdlc serpl-srto,cholesterol in ldl/cholesterol in hdl [molar ratio],cardio; cardiology; chemistry; chol; choles; cholest; cholesterol total; cholesterols; hdlc; hdl-c; heart disease; high density lipoprotein cholesterols; ldlc; ldl-c; lipid; low density lipoprotein cholesterol; low density lipoprotein cholesterols; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; scrto; serp; serpl; serplas; serum; serum or plasma; sr; substance concentration ratio; substance ratio; tchhdl,Qn
44921-5,hemoglobin d/hemoglobin.total in blood by hplc,hgb d mfr bld hplc,hemoglobin d hplc (bld) [mass fraction],blood; dextro; haemoglobin; hb; hematology/cell counts; hgb; hgb d; high performance liquid chromatography; high pressure liquid chromatography; mass fraction; percent; point in time; qnt; quan; quant; quantitative; random; tot; totl; wb; whole blood,Qn
44923-1,hemoglobin s/hemoglobin.total in blood by hplc,hgb s mfr bld hplc,hemoglobin s hplc (bld) [mass fraction],blood; haemoglobin; hb; hbs; hematology/cell counts; hgb; hgb s; high performance liquid chromatography; high pressure liquid chromatography; mass fraction; percent; point in time; qnt; quan; quant; quantitative; random; s prime; sickle cell; sickle cells; tot; totl; wb; whole blood,Qn
44930-6,prolactin [units/volume] in serum or plasma --2 hours post dose trh iv,prolactin 2h p trh iv serpl-acnc,prolactin 2 hr post dose trh iv qn,120 min; 120 minutes; 120min; 2 hours; 2h p trh; 2h p trh iv; after; arbitrary concentration; chemistry.challenge testing; lactotropic hormone; lactotropin; mammatropic hormone; mammotropin; p dose; p trh; pl; plasma; plsm; point in time; prl; prol; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
44936-3,thyrotropin [units/volume] in serum or plasma --15 minutes pre dose trh iv,tsh 15m pre trh iv serpl-acnc,tsh 15 min pre dose trh iv qn,15m pre trh; 15m pre trh iv; arbitrary concentration; before; chemistry.challenge testing; endocrine; endocrinology; pl; plasma; plsm; point in time; pre trh; pre trh iv; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; thyroid stimulating hormone; thyrotropic hormone; tsh,Qn
44941-3,barriers to self management,barriers to self management,,finding; findings; h+p; h+p.hx; ordinal; p prime; point in time; ql; qual; qualitative; random; screen,Ord
44944-7,other alert,other alert,,finding; findings; h+p; h+p.hx; nominal; othr; p prime; point in time; random,Nom
44947-0,borrelia burgdorferi 31kd igm ab [presence] in serum by immunoblot,b burgdor31kd igm ser ql ib,b. burgdorferi 31kd igm ib ql (s),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; b burg; b burgdor; b burgdor31kd; b burgdorferi; bb; blt; burgdorf; id; immune blot; immune globulin m; immunobl; immunoblot; immunoglobulin m; infectious disease; infectiousdisease; lyme; lyme disease; lymes; microbiology; ordinal; osp a; ospa; outer surface protein a; point in time; pr; ql; qual; qualitative; random; riba; screen; serum; sr; wb; wblot; west blot; west blt; western blot,Ord
4499-0,deprecated complement c4a [mass/volume] in plasma,deprecated c4 activated ser qn,complement c4 activated (s),activ; beta 1 e-globulin; comp; complmt; hematology/cell counts; point in time; qnt; quan; quant; quantitative; random; serum; sr,Qn
45015-5,adenosine monophosphate.cyclic [moles/volume] in urine --baseline,camp bs ur-scnc,adenosine monophosphate.cyclic baseline (u) [moles/vol],adenosine 2'-phosphate; adenosine 3'-phosphate; adenosine 5'-phosphate; adenylic acid; ado; amp; aned; bs; camp; chemistry.challenge testing; cmp; level; medication stress; phosphaden; point in time; qnt; quan; quant; quantitative; random; substance concentration; ua; ur; urn,Qn
45025-4,hla-a sbt [type] by high resolution,hla-a sbt high res,hla-a sbt high resolution nom (bld/tiss),"blood; genetics; heredity; heritable; hla antigen; human leukocyte antigen; inherited; nominal; point in time; random; sequence based typing; tissue; tissue, unspecified; typ; wb; whole blood; whole blood or tissue",Nom
45033-8,cardiovascular physiologic and ekg assessment panel,cv assessment + ekg pnl,,cv assess; cv assessment pnl; pan; panl; pnl; point in time; random,-
45058-5,cyclosporine monoclonal and polyclonal panel [mass/volume] - blood,cyclosporine moncl+polycl pnl bld-mcnc,cyclosporine monoclonal and polyclonal panel (bld) [mass/vol],blood; ciclosporin; ciclosporine; csa; cyclosporin a; cyclosporine moncl+polycl pnl; cyclosporine monocl; cyclosporins; drug/toxicology; drugs; gengraf; level; mass concentration; neoral; pan; panel.drug & toxicology; panl; pnl; point in time; qnt; quan; quant; quantitative; random; restasis; sandimmune; sangcya; wb; whole blood,Qn
45061-9,spermatozoa iga and igg and igm panel - serum,sperm iga+igg+igm pnl ser,spermatozoa iga and igg and igm panel (s),fertility testing; immune globulin a; immune globulin g; immune globulin m; immunoglobulin a; immunoglobulin g; immunoglobulin m; pan; panel.fertility; panl; pnl; point in time; random; serum; sperm; sperm iga+igg+igm pnl; sr,-
4506-2,complement c5a [mass/volume] in plasma,c5a plas-mcnc,complement c5a (p) [mass/vol],comp; complmt; hematology/cell counts; level; mass concentration; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random,Qn
45065-0,deprecated comprehensive metabolic panel & glomerular filtration rate.predicted,deprecated comp metab pnl & egfr serpl,comprehensive metabolic panel and glomerular filtration rate.predicted,chemistry; comp metab pnl & egfr; gfr; glom; pan; panel.chemistry; panl; pl; plasma; plsm; pnl; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
4508-8,complement c7 [mass/volume] in serum or plasma,c7 serpl-mcnc,complement c7 [mass/vol],comp; complmt; hematology/cell counts; level; mass concentration; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
45088-2,deprecated chlamydia trachomatis rrna [presence] in penis by dna probe,deprecated c trach rrna penis ql prb,c. trachomatis rrna probe ql (penis),arbitrary concentration; c trac; c trach; c tracho; c trachomatis; chlam; chlam trac; chlamid; ct; dna nucleic acid probe; dna probe; id; infectious disease; infectiousdisease; lgv; lymphogranuloma venereum; microbiology; ordinal; pen; penile; point in time; ql; qual; qualitative; random; ribosomal rna; screen; trachoma,Ord
45094-0,chlamydia trachomatis [presence] in conjunctival specimen by organism specific culture,c trach conjunct ql cult,c. trachomatis org specific cx ql (conj),c trac; c trach; c tracho; c trachomatis; c&s; chlam; chlam trac; chlamid; conjunct; conjunctiva; conjunctival; ct; cult; cultures; id; infectious disease; infectiousdisease; lgv; lymphogranuloma venereum; microbiology; ordinal; palpebral sac; point in time; pr; ql; qual; qualitative; random; screen; spec; trachoma,Ord
45097-3,chlamydia sp identified in anal by organism specific culture,chlamydia anal cult,chlamydia sp identified org specific cx nom (anal),anus; c&s; chlam; chlamid; cult; cultures; id; identity or presence; infectious disease; infectiousdisease; microbiology; nominal; point in time; random; rectal specimen; spec; species; spp,Nom
45099-9,chlamydia sp identified in body fluid by organism specific culture,chlamydia fld cult,chlamydia sp identified org specific cx nom (body fld),"b/f; bf; bod; bodies; body fluid; body fluid, unsp; c&s; chlam; chlamid; cult; cultures; fl; fld; flu; fluid; id; identity or presence; infectious disease; infectiousdisease; microbiology; nominal; point in time; random; spec; species; spp",Nom
45106-2,chlamydia sp ag [presence] in cervix by immunoassay,chlamydia ag cvx ql ia,chlamydia sp ag ia ql (cvx),antigen; antigens; cervix; chlam; chlamid; eia; elfa; elisa; enzyme immunoassay; genital tract; gyn; gynecology; iaa; id; infectious disease; infectiousdisease; meia; microbiology; ob; obgyn; obstetrics; ordinal; point in time; pr; ql; qual; qualitative; random; screen; species; spp; suds,Ord
45112-0,chlamydia sp ag [presence] in urine by immunofluorescence,chlamydia ag ur ql if,chlamydia sp ag if ql (u),acif; anticomplement immunofluorescence; antigen; antigens; chlam; chlamid; dfa; fa; fluorescent antibody; fluoresent; id; ifa; immune fluorescence; immunoflour; immunofluor; immunofluorescence; infectious disease; infectiousdisease; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; screen; species; spp; time resolved fluorescence; trf; ua; ur; urn,Ord
45113-8,chlamydia sp ag [presence] in urethra by immunoassay,chlamydia ag urth ql ia,chlamydia sp ag ia ql (urethra),antigen; antigens; chlam; chlamid; eia; elfa; elisa; enzyme immunoassay; genital tract; iaa; id; infectious disease; infectiousdisease; meia; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; screen; species; spp; suds; urth,Ord
45124-5,vesicular stomatitis alagoas virus neutralizing antibody [titer] in serum by neutralization test,vsav nab titr ser nt,vesicular stomatitis alagoas virus neut ab neut test (s) [titer],abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; conventional virus neutralization test; cvnt; dilution factor; dilution factor (titer); id; infectious disease; infectiousdisease; microbiology; nab; neutralization; neutralization test; nt; point in time; random; serum; serum virus neutralization; smqn; sr; svn; titer; titered; titre; ttr; vesicular stomatitis virus indiana 3; virus neutralization test; vnt; vsav; vsiv 3; vsv-av,SemiQn
45128-6,vesicular stomatitis new jersey virus ag [presence] in specimen by complement fixation,vsnjv ag spec ql cf,vesicular stomatitis new jersey virus ag cf ql (specimen),antigen; antigens; cf; comp fixation; compfix; complement fixation; id; infectious disease; infectiousdisease; microbiology; misc; miscellaneous; ordinal; other; point in time; pr; ql; qual; qualitative; random; screen; spec; to be specified in another part of the message; unspecified; vs; vsnjv; vsv-nj,Ord
45132-8,chlamydia sp ag [presence] in nasopharynx by immunoassay,chlamydia ag nph ql ia,chlamydia sp ag ia ql (nph),antigen; antigens; chlam; chlamid; eia; elfa; elisa; enzyme immunoassay; iaa; id; infectious disease; infectiousdisease; meia; microbiology; nasopharynx; ordinal; point in time; pr; ql; qual; qualitative; random; screen; species; spp; suds,Ord
45133-6,chlamydia sp ag [presence] in nasopharynx,chlamydia ag nph ql,chlamydia sp ag ql (nph),antigen; antigens; chlam; chlamid; id; infectious disease; infectiousdisease; microbiology; nasopharynx; ordinal; point in time; pr; ql; qual; qualitative; random; screen; species; spp,Ord
45141-9,platelet associated ab [presence] in blood by flow cytometry (fc),pa ab bld ql fc,platelet associated ab fc ql (bld),abs; aby; antby; anti; antibodies; antibody; assoc; autoantibodies; autoantibody; blood; direct platelet antibody; dynamic; fc; hematology; heme; ordinal; pa; pl; platelet auto-antibodies; platelets; platelt; plt; point in time; pr; ql; qual; qualitative; random; screen; serology; thrombocyte; thrombocytes; wb; whole blood,Ord
4514-6,complement decay accelerating factor [entitic number] in red blood cells,comp daf entnum rbc,complement decay accelerating factor (rbc) [entitic number],cd 55; cluster of differentiation 55; comp; comp daf; complmt; daf; entitic; entitic number; erythrocytes; fac; fact; hematology/cell counts; point in time; qnt; quan; quant; quantitative; random; red blood cells; red blood corpusles,Qn
45163-3,alternaria alternata ab [presence] in serum,a alternata ab ql,a. alternata ab ql (s),a alternata; a tenuis; abs; aby; allergen; allergens; allergy testing; alternaria tenuis; antby; anti; antibodies; antibody; autoantibodies; autoantibody; m006; m6; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; sr,Ord
45167-4,ige [mass/volume] in specimen,ige spec-mcnc,ige (specimen) [mass/vol],chemistry; immune globulin e; immunoglobulin e; level; mass concentration; misc; miscellaneous; other; point in time; qnt; quan; quant; quantitative; random; spec; to be specified in another part of the message; unspecified,Qn
45172-4,purkinje cells ab [units/volume] in serum by immunofluorescence,purkinje cells ab ser if-acnc,purkinje cells ab if qn (s),abs; aby; acif; antby; anti; antibodies; antibody; anticomplement immunofluorescence; arbitrary concentration; autoantibodies; autoantibody; cell; cellularity; fa; fluorescent antibody; fluoresent; ifa; immune fluorescence; immunoflour; immunofluor; immunofluorescence; neuro; neurology; oncology; paraneoplastic syndrome; pca; point in time; qnt; quan; quant; quantitative; random; serology; serum; sr; time resolved fluorescence; trf; yo autoantibody,Qn
45180-7,1p chromosome deletion [presence] in blood or tissue by molecular genetics method,1p chrom del bld/t ql,1p chromosome del molgen ql (bld/tiss),"arbitrary; blood; chromosom; chromosomes; del; deletions; molecular genetics; molecular pathology; molpath; molpath.deletions; ordinal; pcr; point in time; ql; qual; qualitative; random; screen; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",Ord
45184-9,11-deoxycortisol/cortisol [mass ratio] in serum or plasma,11dc/cortis serpl,11-deoxycortisol/cortisol [mass ratio],11dc; 17-hydroxycorticosterone; chemistry; compound f; compound s; coritsol; cort; cortexolone; cortodoxone; deoxycortisol; desoxycortisol; f; hydrocortisone; mass concentration ratio; mass ratio; mcrto; metopirone; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
45185-6,2-oxo-3-hydroxy-lysergate diethylamide [mass/volume] in urine,2-oxo-3-oh-lds ur-mcnc,2-oxo-3-hydroxy-lysergate diethylamide (u) [mass/vol],2-oxo-3-oh-lds; drug/toxicology; drugs; hydrox; ii; iii; level; lsd; lsd metabolite; lysergic acid; lysergic acid diethylamide; mass concentration; oh; point in time; qnt; quan; quant; quantitative; random; ua; ur; urn,Qn
4518-7,complement factor d [mass/volume] in serum or plasma,comp fact d serpl-mcnc,complement factor d [mass/vol],c3 proactivator convertase; comp; comp fact d; complmt; dextro; fac; fact; gbg-ase; hematology/cell counts; level; mass concentration; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
45202-9,deprecated ganglioside gd1a ab [presence] in serum,deprecated gd1a gangl ab ser ql,ganglioside gd1a ab ql (s),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; disialolganglioside; gd1a; gd1a gangl; neuro; neurology; ordinal; point in time; ql; qual; qualitative; random; screen; serology; serum; sr,Ord
4520-3,complement factor i [mass/volume] in serum or plasma,comp fact i serpl-mcnc,complement factor i [mass/vol],c3b inactivator; c3b-ina; c4b inactivator; comp; comp fact i; complmt; conglutinogen activating factor; fac; fact; factor 1; fi; hematology/cell counts; kaf; level; mass concentration; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
45220-1,lymphocytic choriomeningitis virus igm ab [presence] in serum,lcmv igm ser ql,lymphocytic choriomeningitis virus igm ql (s),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; id; immune globulin m; immunoglobulin m; infectious disease; infectiousdisease; lcmv; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; sr,Ord
45222-7,methylmalonylcarnitine (c4-dc) [moles/volume] in dbs,me-malonylcarn dbs-scnc,c4-dc (dbs) [moles/vol],blood; c4dc; c4-dc; c4-dcc; chemistry; dbs; dicarboxylic carnitine; dried blood spot; filter paper; fp; level; me-malonylcarn; point in time; qnt; quan; quant; quantitative; random; substance concentration; wb; whole blood,Qn
45237-5,date lost to hiv treatment follow-up,date lost to hiv rx follow-up,,aids; anti-retroviral therapy; art; human immunodeficiency virus; id; infectious disease; infectiousdisease; point in time; qnt; quan; quant; quantitative; random; treatment,Qn
45239-1,current hiv treatment therapy duration,current hiv rx duration,,aids; anti-retroviral therapy; art; current hiv rx duration; derived; durat; human immunodeficiency virus; id; infectious disease; infectiousdisease; point in time; qnt; quan; quant; quantitative; random; treatment,Qn
45243-3,reason for discontinuation of anti-infective phrophylaxis medication,reason for d/c of anti-infect proph rx,,art; id; infectious disease; infectiousdisease; nominal; point in time; random; reason for d/c of anti-infect proph rx; typ,Nom
45246-6,degree of adherence to anti-retroviral drug regimen,degree of adherence to art,,art; degree of adherence to art; drugs; finding; findings; id; infectious disease; infectiousdisease; ordinal; point in time; ql; qual; qualitative; random; screen,Ord
45247-4,reason for missing hiv treatment administration schedule,reason for missing hiv rx schedule,,aids; anti-retroviral therapy; art; finding; findings; human immunodeficiency virus; id; infectious disease; infectiousdisease; nominal; point in time; random; reason for missing hiv rx schedule; treatment,Nom
45274-8,low molecular weight heparin induced platelet ab [presence] in serum,lmw heparin ind plt ab ser ql,low molecular weight heparin induced platelet ab ql (s),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; circulating platelet ab; coagulation; hematology; heme; hep; hepar; heparn; ind plt ab; lmw heparin; lmw heparin induced platelet ab; ordinal; pl; platelet ab.free; platelet auto-antibodies; platelets; platelt; plt; point in time; pr; ql; qual; qualitative; random; screen; serum; sr; thrombocyte; thrombocytes; wt,Ord
45291-2,coxsackievirus b2 ab [presence] in body fluid,cv b2 ab fld ql,coxsackievirus b2 ab ql (body fld),"abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; b/f; bf; bod; bodies; body fluid; body fluid, unsp; cav; coxsackie; coxsackie virus; cv; cv b2; fl; fld; flu; fluid; id; infectious disease; infectiousdisease; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; screen",Ord
45300-1,glycerol [moles/volume] in serum or plasma,glycerol serpl-scnc,glycerol [moles/vol],chemistry; level; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; substance concentration,Qn
45305-0,coproporphyrin 1 [moles/mass] in stool,copro1 stl-scnt,coproporphyrin 1 (stl) [moles/mass],bowel movement; chemistry; copro; copro1; coproporph; coproporphyrin i; coproporphyrins; faecal; faeces; fecal; feces; hematology; heme; i; point in time; qnt; quan; quant; quantitative; random; stl; stool = fecal; substance content; tetracarboxyl porphyrin; tetracarboxylporphyrin; tetracarboxylporphyrins; tetracarboxyporphyrin,Qn
4531-0,complement total hemolytic [units/volume] in blood,total hem comp bld-acnc,complement total hemolytic qn (bld),arbitrary concentration; blood; comp; complmt; hematology/cell counts; point in time; qnt; quan; quant; quantitative; random; tot; total hem comp; totl; wb; whole blood,Qn
45318-3,uroporphyrin 3 isomer/creatinine [molar ratio] in urine,uropor3/creat ur-srto,uroporphyrin 3 isomer/creatinine (u) [molar ratio],chemistry; cr; crea; creat; iii; isom; octacarboxyl porphyrin; octacarboxylporphyrin; octacarboxyphyrin; point in time; porphyria; porphyria cutanea tarda; qnt; quan; quant; quantitative; random; scrto; substance concentration ratio; substance ratio; ua; ucr; ur; urn; urophorph; uropor3; uroporphyrin iii,Qn
4535-1,cytotoxic percent reactive ab [presence] in serum by quick method,ctox pct react ab ser ql qck,cytotoxic percent reactive ab quick method ql (s),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; ctox pct react; hematology/cell counts; ordinal; point in time; pr; pra; qck; ql; qual; qualitative; random; reac; react; screen; serum; sr,Ord
45385-2,hippurate crystals [#/area] in urine sediment by microscopy low power field,hippurate cry #/area urns lpf,hippurate crystals lm.lpf (urine sed) [#/area],#/area; benzyl alcohol metabolite; crys; cryst; crystal; hipp; hippramine; hippuran; hippuric acid; hiprex; hip-rex; kidney; lm; micro; micros; microscopic; nephrology; number areic; point in time; qnt; quan; quant; quantitative; random; renal; toluene metabolite; ua; ur; urex; urinalysis; urine sediment; urn; urns; urotractan,Qn
45400-9,medicaid number,medicaid #,,admin; admin.patient; admin.patient.id; ident; identifier; intradermal; medicaid #; no; nominal; num; point in time; random,Nom
4540-1,deprecated ethanol gelation,deprecated ethanol gelation ser qn,ethanol gelation (s),alc; alcohol; ethyl alcohol; etoh; hematology/cell counts; point in time; qnt; quan; quant; quantitative; random; serum; sr,Qn
45413-2,history of stay in other nursing home [minimum data set],,,finding; findings; h/o; hx; ordinal; othr; point in time; ql; qual; qualitative; random; screen; stay in other nursing home hx; survey; survey.mds,Ord
4543-5,haptoglobin [mass/volume] in serum or plasma by electrophoresis,haptoglob serpl elph-mcnc,haptoglobin elph [mass/vol],elec; elect; electr; electro; electrophhrs; electrophrs; elp; elph; ep; haptoglob; hematology/cell counts; hp; hpt; level; mass concentration; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
45435-5,none of the listed cycle of daily events [minimum data set],,,finding; findings; ordinal; point in time; ql; qual; qualitative; random; screen; survey; survey.mds,Ord
45446-2,daily contact with relatives/close friends [minimum data set],,,finding; findings; ordinal; point in time; ql; qual; qualitative; random; screen; survey; survey.mds,Ord
45459-5,medicare ancillary part b [minimum data set],,,finding; findings; ordinal; point in time; ql; qual; qualitative; random; screen; survey; survey.mds,Ord
45460-3,champus per diem [minimum data set],,,civilian health and medical program of the uniformed services; finding; findings; ordinal; point in time; ql; qual; qualitative; random; screen; survey; survey.mds; tricare,Ord
45467-8,other legal oversight [minimum data set],,,finding; findings; ordinal; othr; point in time; ql; qual; qualitative; random; screen; survey; survey.mds,Ord
45468-6,health care durable power attorney [minimum data set],,,finding; findings; ordinal; point in time; ql; qual; qualitative; random; screen; survey; survey.mds,Ord
45469-4,financial durable power attorney [minimum data set],,,finding; findings; ordinal; point in time; ql; qual; qualitative; random; screen; survey; survey.mds,Ord
45471-0,patient responsible for self [minimum data set],,,finding; findings; ordinal; point in time; ql; qual; qualitative; random; screen; survey; survey.mds,Ord
45488-4,can recall that he or she is in nursing home [minimum data set],,,finding; findings; ordinal; point in time; ql; qual; qualitative; random; screen; survey; survey.mds,Ord
45501-4,other receptive communication techniques used [minimum data set],,,finding; findings; ordinal; othr; point in time; ql; qual; qualitative; random; screen; survey; survey.mds,Ord
45505-5,uses american sign language or braille [minimum data set],,,finding; findings; ordinal; point in time; ql; qual; qualitative; random; screen; survey; survey.mds,Ord
45506-3,uses signs/gestures/sounds [minimum data set],,,finding; findings; ordinal; point in time; ql; qual; qualitative; random; screen; survey; survey.mds,Ord
45526-1,range of motion upper extremity [minimum data set],,,arm; ext; finding; findings; ordinal; point in time; ql; qual; qualitative; random; rnge; screen; survey; survey.mds; ue; up,Ord
45527-9,voluntary movement upper extremity [minimum data set],,,arm; ext; finding; findings; ordinal; point in time; ql; qual; qualitative; random; screen; survey; survey.mds; ue; up,Ord
45528-7,range of motion hand [minimum data set],,,finding; findings; ordinal; point in time; ql; qual; qualitative; random; rnge; screen; survey; survey.mds; upper extremity,Ord
45529-5,voluntary movement hand [minimum data set],,,finding; findings; ordinal; point in time; ql; qual; qualitative; random; screen; survey; survey.mds; upper extremity,Ord
45556-8,mood persistence [minimum data set],,,finding; findings; ordinal; point in time; ql; qual; qualitative; random; screen; survey; survey.mds,Ord
45565-9,alterability of socially inappropriate or disruptive behavioral symptoms [minimum data set],,,finding; findings; ordinal; point in time; ql; qual; qualitative; random; screen; survey; survey.mds; sx,Ord
45579-0,openly expresses conflict/anger with family/friends [minimum data set],,,finding; findings; ordinal; point in time; ql; qual; qualitative; random; screen; survey; survey.mds,Ord
45581-6,recent loss of close family member/friend [minimum data set],,,finding; findings; ordinal; point in time; ql; qual; qualitative; random; screen; survey; survey.mds,Ord
4558-3,hemoglobin barts [presence] in blood by electrophoresis acid (ph 6.3),hgb barts bld ql elph acid,hemoglobin barts elph ph 6.3 ql (bld),bart; bart's; blood; elec; elect; electr; electro; electrophhrs; electrophrs; elp; elph; elph acid; ep; haemoglobin; hb; hematology/cell counts; hgb; hgb barts; ordinal; point in time; pr; ql; qual; qualitative; random; screen; wb; whole blood,Ord
45607-9,personal hygiene - support provided during assessment period [cms assessment],,,centers for medicare and medicaid assessment; finding; findings; ordinal; ql; qual; qualitative; report period; screen; survey,Ord
45611-1,task segmentation [minimum data set],,,finding; findings; ordinal; point in time; ql; qual; qualitative; random; screen; survey; survey.mds,Ord
45615-2,"difference in adl self-performance or adl support, comparing mornings to evenings [minimum data set]",,,activities of daily living; finding; findings; ordinal; point in time; ql; qual; qualitative; random; screen; survey; survey.mds,Ord
45624-4,bowel elimination pattern - none of above [minimum data set],,,bowel elim pattern; finding; findings; ordinal; point in time; ql; qual; qualitative; random; screen; survey; survey.mds,Ord
45639-2,arteriosclerotic heart disease [minimum data set],,,ashd; dis; diseases; dz; finding; findings; ordinal; point in time; ql; qual; qualitative; random; screen; survey; survey.mds,Ord
45657-4,hemiplegia or hemiparesis [minimum data set],,,finding; findings; ordinal; point in time; ql; qual; qualitative; random; screen; survey; survey.mds,Ord
45667-3,manic depression [minimum data set],,,bipolar disease; finding; findings; ordinal; point in time; ql; qual; qualitative; random; screen; survey; survey.mds,Ord
45672-3,diabetic retinopathy [minimum data set],,,finding; findings; ordinal; point in time; ql; qual; qualitative; random; screen; survey; survey.mds,Ord
45688-9,tuberculosis [minimum data set],,,finding; findings; ordinal; point in time; ql; qual; qualitative; random; screen; survey; survey.mds; tb,Ord
45689-7,urinary tract infection in last 30 days [minimum data set],,,finding; findings; ordinal; past; ql; qual; qualitative; screen; survey; survey.mds,Ord
45691-3,wound infection [minimum data set],,,finding; findings; ordinal; point in time; ql; qual; qualitative; random; screen; survey; survey.mds,Ord
45693-9,other current or more detailed diagnoses and icd9 codes [minimum data set],,,"identity or presence; international classification of diseases, ninth revision; nominal; othr; point in time; random; survey; survey.mds",Nom
45707-7,unsteady gait [minimum data set],,,finding; findings; ordinal; point in time; ql; qual; qualitative; random; screen; survey; survey.mds,Ord
457-2,spiramycin [susceptibility] by disk diffusion (kb),spiramycin islt kb,spiramycin disk diffusion (kb) [susc],antibiotic susceptibilities; ast; bykomycetin; c436; disk diffusion; id; infectious disease; infectiousdisease; islt; isol; kb; kirby-bauer; leucomycin; point in time; provamicina; random; rovamicina; rovamycin; rovamycine; selectomycin; sus; suscept; susceptibilities; susceptibility; susceptibilty,OrdQn
45729-1,"end-stage disease, 6 or fewer months to live [minimum data set]",,,"dis; diseases; dz; end-stage disease, 6 or fewer months to live; finding; findings; month; ordinal; point in time; ql; qual; qualitative; random; screen; survey; survey.mds",Ord
45737-4,complains about the taste of many foods [minimum data set],,,finding; findings; ordinal; point in time; ql; qual; qualitative; random; screen; survey; survey.mds,Ord
45750-7,proportion of total calories received through parenteral or tube feeding in last 7 days [minimum data set],,,finding; findings; ordinal; past; proportion of total calories received through parenteral or tube feeding in last 7 days; ql; qual; qualitative; screen; survey; survey.mds; tot; totl,Ord
4575-7,hemoglobin e/hemoglobin.total in blood,hgb e mfr bld,hemoglobin e (bld) [mass fraction],blood; haemoglobin; hb; hematology/cell counts; hgb; hgb e; mass fraction; percent; point in time; qnt; quan; quant; quantitative; random; tot; totl; wb; whole blood,Qn
45769-7,"debris - soft, easily movable substances - present in mouth prior to going to bed at night [minimum data set]",,,finding; findings; ordinal; point in time; ql; qual; qualitative; random; screen; survey; survey.mds,Ord
45771-3,some or all natural teeth lost but does not have or use dentures or partial plates [minimum data set],,,finding; findings; ordinal; point in time; ql; qual; qualitative; random; screen; survey; survey.mds,Ord
4577-3,hemoglobin f - texas [presence] in blood by electrophoresis acid (ph 6.3),hgb f-texas bld ql elph acid,hemoglobin f - texas elph ph 6.3 ql (bld),blood; elec; elect; electr; electro; electrophhrs; electrophrs; elp; elph; elph acid; ep; fetal hemoglobin; haemoglobin; hb; hbf; hematology/cell counts; hgb; hgb f; hgb f-texas; ordinal; point in time; pr; ql; qual; qualitative; random; screen; wb; whole blood,Ord
45777-0,ulcers.stage 2 # [minimum data set],,,cnt; count; ii; number; point in time; qnt; quan; quant; quantitative; random; survey; survey.mds,Qn
45781-2,stasis ulcer stage [minimum data set],,,finding; findings; nominal; point in time; pressure injury; pressure ulcer; pressure ulcers; random; stasis ulcer stage; survey; survey.mds; ulcer,Nom
45784-6,second or third degree burns [minimum data set],,,2nd; 2nd or third degree burns; 3rd; finding; findings; ordinal; point in time; ql; qual; qualitative; random; screen; survey; survey.mds,Ord
45788-7,skin tears or cuts (other than surgery) [minimum data set],,,finding; findings; integument; ordinal; othr; point in time; ql; qual; qualitative; random; screen; surg; survey; survey.mds,Ord
45795-2,ulcer care [minimum data set],,,finding; findings; ordinal; point in time; pressure injury; pressure ulcer; pressure ulcers; ql; qual; qualitative; random; screen; survey; survey.mds; ulcer,Ord
45803-4,open lesions on the foot [minimum data set],,,finding; findings; lower extremity; ordinal; point in time; ql; qual; qualitative; random; screen; survey; survey.mds,Ord
45805-9,received preventative or protective foot care [minimum data set],,,finding; findings; lower extremity; ordinal; point in time; ql; qual; qualitative; random; screen; survey; survey.mds,Ord
45821-6,activity preferences - music [minimum data set],,,activ; actvty; finding; findings; movements; ordinal; point in time; ql; qual; qualitative; random; screen; survey; survey.mds,Ord
45833-1,number of medications [minimum data set],,,# medications; cnt; count; no; num; number; point in time; qnt; quan; quant; quantitative; random; survey; survey.mds,Qn
45836-4,number of days antipsychotic medication received [minimum data set],,,# days antipsychotic medication received; cnt; count; dextro; no; num; number; point in time; qnt; quan; quant; quantitative; random; survey; survey.mds,Qn
45840-6,number of days diuretic medication received [minimum data set],,,# days diuretic medication received; cnt; count; dextro; no; num; number; point in time; qnt; quan; quant; quantitative; random; survey; survey.mds,Qn
45846-3,ostomy care [minimum data set],,,finding; findings; ordinal; point in time; ql; qual; qualitative; random; screen; survey; survey.mds,Ord
45853-9,special behavior symptom evaluation program [minimum data set],,,assessment; eval; finding; findings; h&p; history and physical; ordinal; point in time; ql; qual; qualitative; random; screen; special behavior symptom eval program; survey; survey.mds; sx,Ord
45865-3,number of days of training and skill practice in dressing or grooming [minimum data set],,,# days of training & skill practice in dressing or grooming; cnt; count; dextro; no; num; number; point in time; qnt; quan; quant; quantitative; random; survey; survey.mds,Qn
45868-7,number of days of training and skill practice in communication [minimum data set],,,# days of training & skill practice in communication; cnt; count; dextro; no; num; number; point in time; qnt; quan; quant; quantitative; random; survey; survey.mds,Qn
4587-2,hemoglobin h/hemoglobin.total in blood by electrophoresis,hgb h mfr bld elph,hemoglobin h elph (bld) [mass fraction],blood; elec; elect; electr; electro; electrophhrs; electrophrs; elp; elph; ep; haemoglobin; hb; hematology/cell counts; hgb; hgb h; mass fraction; percent; point in time; qnt; quan; quant; quantitative; random; tot; totl; wb; whole blood,Qn
45873-7,limb restraint [minimum data set],,,finding; findings; ordinal; point in time; ql; qual; qualitative; random; screen; survey; survey.mds,Ord
45888-5,therapy orders to begin in 1st 14 days of stay [minimum data set],,,finding; findings; first; ordinal; point in time; ql; qual; qualitative; random; screen; survey; survey.mds,Ord
45929-7,resident assessment protocol 7--psychosocial - proceed with care [minimum data set],,,finding; findings; ordinal; point in time; ql; qual; qualitative; random; rap; screen; survey; survey.mds,Ord
45932-1,resident assessment protocol 9--behavioral symptoms - triggered [minimum data set],,,finding; findings; nominal; point in time; random; rap; survey; survey.mds; sx,Nom
45936-2,resident assessment protocol 11--falls - triggered [minimum data set],,,finding; findings; nominal; point in time; random; rap; survey; survey.mds,Nom
45950-3,resident assessment protocol 18--physical restraints - triggered [minimum data set],,,finding; findings; nominal; point in time; random; rap; survey; survey.mds,Nom
45951-1,resident assessment protocol 18--physical restraints - proceed with care [minimum data set],,,finding; findings; ordinal; point in time; ql; qual; qualitative; random; rap; screen; survey; survey.mds,Ord
45952-9,national provider id,,,ident; identifier; intradermal; nominal; npi; point in time; random; survey; survey.mds,Nom
45955-2,pneumococcal vaccine status up to date [minimum data set],,,finding; findings; ordinal; point in time; ql; qual; qualitative; random; screen; survey; survey.mds,Ord
45956-0,reason pneumococcal vaccine not received during assessment period [cms assessment],,,centers for medicare and medicaid assessment; finding; findings; nominal; report period; survey,Nom
45975-0,customary routine section,,,pan; panel; panl; pnl; point in time; random; survey; survey.mds,-
45976-8,customary routine in year prior to date of entry set,,,pan; panel; panl; pnl; point in time; random; survey; survey.mds,Set
45979-2,adl patterns set,,,activities of daily living; pan; panel; panl; pnl; point in time; random; survey; survey.mds,Set
45981-8,deprecated mds full assessment form - version 2.0,,,form version; pan; panel; panl; pnl; point in time; random; survey; survey.mds,-
45987-5,cognitive patterns section,,,pan; panel; panl; pnl; point in time; random; survey; survey.mds,-
4598-9,hemoglobin j - oxford [presence] in blood by electrophoresis acid (ph 6.3),hgb j-oxf bld ql elph acid,hemoglobin j - oxford elph ph 6.3 ql (bld),blood; elec; elect; electr; electro; electrophhrs; electrophrs; elp; elph; elph acid; ep; haemoglobin; hb; hematology/cell counts; hgb; hgb j; hgb j-oxf; ordinal; point in time; pr; ql; qual; qualitative; random; screen; wb; whole blood,Ord
45995-8,visual limitations and dificulties set,,,pan; panel; panl; pnl; point in time; random; survey; survey.mds,Set
4600-3,hemoglobin kansas [presence] in blood,hgb kansas bld ql,hemoglobin kansas ql (bld),blood; haemoglobin; hb; hematology/cell counts; hgb; hgb kansas; ordinal; point in time; pr; ql; qual; qualitative; random; screen; wb; whole blood,Ord
46008-9,bathing during assessment period [cms assessment],,,centers for medicare and medicaid assessment; pan; panel; panel.survey.cms; panl; pnl; report period; survey,-
46023-8,neurological diseases or conditions set,,,pan; panel; panl; pnl; point in time; random; survey; survey.mds,Set
46029-5,other current or more detailed diagnoses and icd9 codes set,,,"international classification of diseases, ninth revision; othr; pan; panel; panl; pnl; point in time; random; survey; survey.mds",Set
46030-3,health conditions section,,,pan; panel; panl; pnl; point in time; random; survey; survey.mds,-
46065-9,"intervention programs for mood, behavior and cognitive loss set",,,pan; panel; panl; pnl; point in time; random; survey; survey.mds,Set
46066-7,nursing rehabilitation and restorative care set,,,pan; panel; panl; pnl; point in time; random; survey; survey.mds,Set
46074-1,recreational therapy set,,,pan; panel; panl; pnl; point in time; random; survey; survey.mds,Set
46090-7,leukocytes [#/volume] in cerebral spinal fluid --4th tube,wbc tube4 # csf,wbc 4th tube (csf) [#/vol],#; abs; absolute; absolutes; cerebral spinal fluid; cerebrospinal fl; cnt; count; count/volume; ct; hematology/cell counts; leuc; leuk; leukocyte; lkcs; neuro; neurology; number concentration; number concentration (count/vol); point in time; qnt; quan; quant; quantitative; random; spinal fl; spinal fld; spinal flu; spinal fluid; tube4; wbc; wbcs; white blood cell; white blood cells,Qn
46110-3,rubella virus igg ab [titer] in cerebral spinal fluid,rubv igg titr csf,rubella virus igg (csf) [titer],abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; cerebral spinal fluid; cerebrospinal fl; congenital rubella syndrome; dilution factor; dilution factor (titer); german measles; id; immune globulin g; immunoglobulin g; infectious disease; infectiousdisease; microbiology; neuro; neurology; point in time; random; rubv; smqn; spinal fl; spinal fld; spinal flu; spinal fluid; titer; titered; titre; ttr,SemiQn
46135-0,hyaline casts [#/area] in urine sediment by microscopy high power field,hyaline casts #/area urns hpf,hyaline casts lm.hpf (urine sed) [#/area],#/area; cast; kidney; lm; micro; micros; microscopic; nephrology; number areic; point in time; qnt; quan; quant; quantitative; random; renal; ua; ur; urinalysis; urine sediment; urn; urns,Qn
4613-6,hemoglobin n - baltimore [presence] in blood by electrophoresis acid (ph 6.3),hgb n-balt bld ql elph acid,hemoglobin n - baltimore elph ph 6.3 ql (bld),blood; elec; elect; electr; electro; electrophhrs; electrophrs; elp; elph; elph acid; ep; haemoglobin; hb; hematology/cell counts; hgb; hgb n-balt; ordinal; point in time; pr; ql; qual; qualitative; random; screen; wb; whole blood,Ord
461-4,streptomycin [susceptibility] by disk diffusion (kb),streptomycin islt kb,streptomycin disk diffusion (kb) [susc],aminoglycosides; antibiotic susceptibilities; ast; c232; c295; cidam est; disk diffusion; id; infectious disease; infectiousdisease; islt; isol; kb; kirby-bauer; novostrep; point in time; random; solustrep; streptocol; strepto-fatol; streptomyc; sus; suscept; susceptibilities; susceptibility; susceptibilty,OrdQn
46146-7,bathing (quarterly),,,pan; panel; panl; pnl; point in time; random; survey; survey.mds,-
46157-4,aspergillus glaucus ab [presence] in serum,a glaucus ab ser ql,a. glaucus ab ql (s),a glaucus; abs; aby; antby; anti; antibodies; antibody; asperg; aspergil; aspergilis; aspergilla; aspergillin; aspergillosis; aspergils; aspergilus; autoantibodies; autoantibody; farmers lung; id; infectious disease; infectiousdisease; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; sr,Ord
46178-0,chlamydia trachomatis d+e+f+g+h+i+j+k igm ab [titer] in serum,c trach d+e+f+g+h+i+j+k igm titr ser,c. trachomatis d+e+f+g+h+i+j+k igm (s) [titer],abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; c trac; c trach; c trach d; c trach d+e+f+g+h+i+j+k; c tracho; c trachomatis; chlam; chlam trac; chlamid; ct; dextro; dilution factor; dilution factor (titer); id; immune globulin m; immunoglobulin m; infectious disease; infectiousdisease; kell blood group system; lgv; lymphogranuloma venereum; microbiology; point in time; random; serum; smqn; sr; titer; titered; titre; trachoma; ttr,SemiQn
46184-8,echinococcus granulosus ab [units/volume] in serum,e granulosus ab ser-acnc,e. granulosus ab qn (s),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; e granulosus; echinococcosis; id; infectious disease; infectiousdisease; microbiology; point in time; qnt; quan; quant; quantitative; random; serum; sr,Qn
4619-3,hemoglobin ranier [presence] in blood,hgb ranier bld ql,hemoglobin ranier ql (bld),blood; haemoglobin; hb; hematology/cell counts; hgb; hgb ranier; ordinal; point in time; pr; ql; qual; qualitative; random; screen; wb; whole blood,Ord
46195-4,legionella pneumophila 2+3+4+5+6+8 ab [titer] in serum,l pneumo 2+3+4+5+6+8 ab titr ser,l. pneumophila 2+3+4+5+6+8 ab (s) [titer],abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; dilution factor; dilution factor (titer); id; ii; iii; infectious disease; infectiousdisease; l pneumo; l pneumo 2+3+4+5+6+8; l pneumo2; l pneumonphila; legion; legionela; legionella pneumophila serogroup 2; microbiology; pneu; pneum; pneumophilia; point in time; random; serum; smqn; sr; titer; titered; titre; togus 1; ttr,SemiQn
46197-0,measles virus ab [presence] in serum,mev ab ser ql,mev ab ql (s),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; id; infectious disease; infectiousdisease; mev; microbiology; msls; ordinal; point in time; pr; ql; qual; qualitative; random; rubeola; screen; serum; sr,Ord
46220-0,creatinine [moles/volume] in dialysis fluid --overnight,creat overnight dial fld-scnc,creatinine overnight (dial fld) [moles/vol],chemistry; cr; crea; creat; diaf; dialysate; dialysis fluid; kidney; level; nephrology; point in time; qnt; quan; quant; quantitative; random; renal; substance concentration,Qn
4622-7,hemoglobin s [presence] in blood by electrophoresis acid (ph 6.3),hgb s bld ql elph acid,hemoglobin s elph ph 6.3 ql (bld),blood; elec; elect; electr; electro; electrophhrs; electrophrs; elp; elph; elph acid; ep; haemoglobin; hb; hbs; hematology/cell counts; hgb; hgb s; ordinal; point in time; pr; ql; qual; qualitative; random; s prime; screen; sickle cell; sickle cell screen; sickle cells; sickledex; sicklequik; wb; whole blood,Ord
46240-8,history of hospitalizations+outpatient visits narrative,hx of hospitalizations+op visits,,h+p; h+p.hx; history; hospitalizations+op visits; narrative; op; outpt visits; p prime; point in time; random; report,Nar
46254-9,bordetella pertussis.pertussis toxin igg ab [units/volume] in serum by immunofluorescence,b pert.pt igg ser if-acnc,b. pertussis.pertussis toxin igg if qn (s),abs; aby; acif; antby; anti; antibodies; antibody; anticomplement immunofluorescence; arbitrary concentration; autoantibodies; autoantibody; b pert; b pert.pt; b pert.pt ab; b pert.pt igg; b pertussis; fa; fluorescent antibody; fluoresent; id; ifa; immune fluorescence; immune globulin g; immunoflour; immunofluor; immunofluorescence; immunoglobulin g; infectious disease; infectiousdisease; microbiology; pertussis; point in time; pt; qnt; quan; quant; quantitative; random; serum; sr; time resolved fluorescence; trf; whooping cough,Qn
46258-0,oxymorphone free [presence] in serum or plasma by screen method,oxymorphone free serpl ql scn,oxymorphone free screen ql,14-hydroxydihydromorphinone; drug/toxicology; drugs; fr; non-protein bound; numorphan; numorphone; opana; ordinal; oxymorphone free; pl; plasma; plsm; point in time; pr; ql; qual; qualitative; random; scn; scr; screen; scrn; serp; serpl; serplas; serum; serum or plasma; sr,Ord
46261-4,hydrocodone free [presence] in serum or plasma,hydrocodone free serpl ql,hydrocodone free ql,anexsia; dihydrocodeinone; drug/toxicology; drugs; fr; hydrocodone free; non-protein bound; ordinal; pl; plasma; plsm; point in time; pr; ql; qual; qualitative; random; screen; serp; serpl; serplas; serum; serum or plasma; sr; vicodin,Ord
46265-5,cryofibrinogen [presence] in plasma by 1 week cold incubation,cryofib plas ql 1w cold inc,cryofibrinogen 1 week cold incubation ql (p),7d cold incubation; chemistry; ordinal; pl; plasma; plsm; point in time; pr; ql; qual; qualitative; random; screen,Ord
46277-0,rhogam given by provider [identifier],rh imm gl gvn by provider,rh immune globulin given by nom (provider) [id],blood bank; d phenotyping; d typing; glb; glob; glob%; globul; globulins; ident; identifier; imm; imun; imune; nominal; point in time; random; rh ig; rh imm gl gvn by; rh phenotyping; rh typing; rhig; rhogam,Nom
46280-4,deprecated radius & ulna right dexa bone density,deprecated radius+ulna-r dexa bdm,,bmd; den; forearm; imaging; plain films; point in time; qnt; quan; quant; quantitative; r; rad; radiology; radius+ulna-r; random; rt; upper extremity; xray; x-ray,Qn
46289-5,ct guidance for biopsy of unspecified body region-- wo and w contrast iv,ct guided bx--wo+w contr iv,,bx; c; cat scan; computed tomography; computerized tomography; contr; contra; contrst; ct scan; document; finding; findings; guid; guide; guided; imaging; misc; miscellaneous; other; perc; point in time; rad; radiology; random; spec; to be specified in another part of the message; unspecified; w contr iv; wc; wo & wc; wo+w contr; wo+w contr iv; wwo,Doc
46294-5,rf guidance for percutaneous replacement of drainage catheter of stomach,rf guided stom pc drain cath replace,,abd; abdo; abdomen+; abdominal; cath; document; drain; exudate; finding; findings; fluor; fluoro; fluoroscopy; guid; guide; guided; imaging; pc drain cath replace; perc; point in time; rad; radiology; random; removal of fluid,Doc
46296-0,mg stereo guidance for percutaneous biopsy.core needle of breast,mg.stereo guided brst pc bx cn,,brst; bx; cn; cnb; document; finding; findings; guid; guide; guided; imaging; large needle; ndl; pc bx cn; perc; point in time; rad; radiology; random; stereo,Doc
46-3,aztreonam [susceptibility] by serum bactericidal titer,aztreonam titr sbt,aztreonam sbt (isol+s),antibiotic susceptibilities; azactam; azaj; azthreonam; dilution factor; dilution factor (titer); id; infectious disease; infectiousdisease; islt; isol; point in time; random; sequence based typing; serum; serum bactericidal titer; serum killing test; smqn; sr; titer; titered; titre; ttr,SemiQn
4630-0,hemoglobin zurich [presence] in blood by electrophoresis alkaline (ph 8.9),hgb zurich bld ql elph alk,hemoglobin zurich elph ph 8.9 ql (bld),blood; elec; elect; electr; electro; electrophhrs; electrophrs; elp; elph; elph alk; ep; haemoglobin; hb; hematology/cell counts; hgb; hgb zurich; ordinal; point in time; pr; ql; qual; qualitative; random; screen; wb; whole blood,Ord
46323-2,mr breast - unilateral w contrast iv,mr brst-ul w contr iv,,brst; brst-ul; c; contr; contra; contrst; document; finding; findings; imaging; mitral regurgitation maximum velocity; mri; point in time; rad; radiology; random; w contr iv; wc,Doc
46324-0,mra lower extremity vessels w contrast iv,mra le ves w contr iv,,ang; angio; angiography; c; contr; contra; contrst; document; ext; extr ves; finding; findings; imaging; le; le ves; leg; low; magnetic resonance angiographies; magnetic resonance imaging; mitral regurgitation maximum velocity; mr angiography; mra; mri; mri.angio; point in time; rad; radiology; random; vesl; vessels.xxx; w contr iv; wc,Doc
4632-6,hemoglobin f [presence] in blood by alkali denaturation,hgb f bld ql alk denat,hemoglobin f alkali denaturation ql (bld),alk denat; alkaline denaturation; blood; fetal hemoglobin; haemoglobin; hb; hbf; hematology/cell counts; hgb; hgb f; ordinal; point in time; pr; ql; qual; qualitative; random; screen; wb; whole blood,Ord
46332-3,mr orbit and face and neck wo contrast,mr orbit+face+neck wo contr,,brain; c; contr; contra; contrst; cranial; cranium; document; eye socket; finding; findings; imaging; intracranial; mitral regurgitation maximum velocity; mri; orbit+face+neck; orbital; point in time; rad; radiology; random; skull; without contrast,Doc
46341-4,rf abdomen views,rf abd views,,abd; abdo; abdomen+; abdominal; document; films; finding; findings; fluor; fluoro; fluoroscopy; imaging; point in time; rad; radiology; random; view; vws,Doc
46354-7,ffd mammogram breast - right screening,ffdm brst-r screening,,asympt; asymptomatic; brst; brst-r; document; ffdm; films; finding; findings; imaging; mam.ffd; point in time; r; rad; radiology; random; rt; scn; view; vws,Doc
46363-8,us lower extremity vein,us le v,,cardio; cardiology; document; echography; ext; extr v; finding; findings; heart disease; imaging; le; le v; leg; low; point in time; radiology; random; sonogram; sonograph; sonography; uls; ultrasound; ven; venous,Doc
46365-3,ct guidance for ablation of tissue of celiac plexus,ct guided celiac plexus ablation,,abd; abdo; abdomen+; abdominal; cat scan; computed tomography; computerized tomography; ct scan; document; finding; findings; guid; guide; guided; imaging; point in time; rad; radiology; random,Doc
46367-9,deprecated ct guidance for needle biopsy of adrenal gland,deprecated ct adrenal bx needle guide,,abd; abdo; abdomen+; abdominal; bx; cat scan; computed tomography; computerized tomography; ct scan; document; finding; findings; guid; guide; guided; imaging; ndl; needle bx; point in time; rad; radiology; random,Doc
46370-3,us guidance for biopsy of pelvis,us guided pelvis bx,,bx; document; echography; finding; findings; guid; guide; guided; imaging; pelvic; point in time; radiology; random; sonogram; sonograph; sonography; uls; ultrasound,Doc
46385-1,us.doppler upper extremity vessel for graft,dop ue ves for graft,,arm; cardio; cardiology; document; dop; duplex; echography; ext; extr ves; finding; findings; heart disease; imaging; point in time; radiology; random; sonogram; sonograph; sonography; ue; ue ves; uls; ultrasound; up; vesl,Doc
46397-6,cortisol [mass/volume] in serum or plasma --15 minutes post 1 ug/kg crh iv,cortis 15m p 1 ug/kg crh iv serpl-mcnc,cortisol 15 min post 1 ug/kg crh iv [mass/vol],15m p 1 ug/kg crh iv; 17-hydroxycorticosterone; after; chemistry.challenge testing; compound f; coritsol; cort; f; hydrocortisone; i; level; mass concentration; mcg; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
46407-3,somatotropin [mass/volume] in serum or plasma --1.5 hours post 1 g/kg glucose po,gh 1.5h p 1 g/kg glc po serpl-mcnc,somatotropin 1.5 hr post 1 g/kg glucose po [mass/vol],1 1/2 hours; 1 1/2 hr; 1.5h p 1 g/kg glc po; 1.5hr; 90 min; 90 minutes; 90m; 90min; after; chemistry.challenge testing; endocrine; endocrinology; gh; glu; glu tol; gluc; glucose tolerance; glucoseur; growth hormone; gtt; hgh; human growth hormone; i; level; mass concentration; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; somatotropic hormone; sr; sth,Qn
46413-1,calcitonin [mass/volume] in serum or plasma --7 minutes post 0.5 ug/kg pentagastrin iv,calcit 7m p 0.5 ug/kg pg iv serpl-mcnc,calcitonin 7 min post 0.5 ug/kg pentagastrin iv [mass/vol],7m p 0.5 ug/kg pg iv; after; chemistry.challenge testing; ct; level; mass concentration; mcg; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; thyrocalcitonin; tumor marker,Qn
4642-5,deprecated hemopexin [mass/volume] in serum,deprecated hemopexin ser-mcnc,hemopexin (s) [mass/vol],haemopexin; hematology/cell counts; hx; level; mass concentration; point in time; qnt; quan; quant; quantitative; random; serum; sr,Qn
46431-3,alpha 1 antitrypsin [mass/mass] in 72 hour stool,a1at 72h stl-mcnt,alpha 1 antitrypsin (72 hour stl) [mass/mass],3 days; 72 hours; 72hr; a1; a1a; a1at; a-1-at; a1-at; aat; alfa; alpha-1-antitrypsin.total; alpha-1-protease inhibitor; alpha-1-proteinase inhibitor; alpha-1-trypsin inhibitor; bowel movement; chemistry; faecal; faeces; fecal; feces; gastro; gastroenterology; gi; hepatology; i; liver; lung; mass content; pulmonary; pulmonology; qnt; quan; quant; quantitative; respiratory; stl; stool = fecal,Qn
46436-2,histamine [moles/volume] in blood,histamine bld-scnc,histamine (bld) [moles/vol],blood; drug/toxicology; drugs; level; point in time; qnt; quan; quant; quantitative; random; substance concentration; wb; whole blood,Qn
46441-2,follow-up/recurrence/death section set naaccr v.11,follow-up/recur/death sec naaccr v.11,,follow-up/recur/death sec; north american association of central cancer registries; pan; panel; panl; pnl; point in time; random; tumor registry(naaccr),Set
46455-2,shigella sp dna [presence] in specimen by naa with probe detection,shigella dna spec ql naa+probe,shigella sp dna naa+probe ql (specimen),3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; deoxyribonucleic acid; dna nucleic acid probe; dna probe; id; infectious disease; infectiousdisease; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; misc; miscellaneous; naa+probe; naat; nasba; nucleic acid sequence based analysis; ordinal; other; pcr; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; screen; sda; shigellosis; spec; species; spp; strand displacement amplification; tma; to be specified in another part of the message; transcription mediated amplification; unspecified,Ord
4645-8,hemosiderin [mass/volume] in urine,hemosiderin ur-mcnc,hemosiderin (u) [mass/vol],hematology/cell counts; level; mass concentration; point in time; qnt; quan; quant; quantitative; random; ua; ur; urn,Qn
46463-6,race or ethnicity,race or ethnicity,,admin; admin.demog; ethnicity; nominal; point in time; random; typ,Nom
46469-3,assisting person(s) other than home care agency staff [oasis],,,finding; findings; nominal; othr; outcome and assessment information set; persons; point in time; random; s prime; survey; survey.oasis,Nom
46470-1,type of primary caregiver assistance,,,outcome and assessment information set; point in time; random; survey; survey.oasis,-
46471-9,at home respiratory treatments [oasis],,,finding; findings; nominal; outcome and assessment information set; point in time; random; survey; survey.oasis; tx; txs,Nom
46472-7,depressive feelings [oasis],,,finding; findings; nominal; outcome and assessment information set; point in time; random; survey; survey.oasis,Nom
46478-4,grooming,,,outcome and assessment information set; point in time; random; survey; survey.oasis,-
46490-9,ability to use telephone,,,outcome and assessment information set; patient telephone; point in time; random; survey; survey.oasis,-
46492-5,management of inhalant /mist medications,,,outcome and assessment information set; point in time; random; survey; survey.oasis,-
46495-8,branch number during assessment period [cms assessment] agency,,,branch #; centers for medicare and medicaid assessment; ident; identifier; no; nominal; num; report period; survey,Nom
46500-5,discipline of person completing assessment during assessment period [cms assessment] provider,,,centers for medicare and medicaid assessment; nominal; persons; report period; survey; typ,Nom
46509-6,regimen change in past 14 days - icd code # 3 [oasis],,,exchange; identity or presence; iii; international classification of diseases; last; nominal; outcome and assessment information set; replace; survey; survey.oasis,Nom
46511-2,deprecated primary diagnosis icd code [cms assessment],,,centers for medicare and medicaid assessment; dx; dx icd code; identity or presence; international classification of diseases; nominal; point in time; primary dx icd code; random; survey,Nom
46524-5,rehabilitative prognosis [oasis],,,finding; findings; ordinal; outcome and assessment information set; point in time; ql; qual; qualitative; random; screen; survey; survey.oasis,Ord
46529-4,sensory status - vision [oasis],,,finding; findings; ordinal; outcome and assessment information set; point in time; ql; qual; qualitative; random; screen; survey; survey.oasis,Ord
4655-7,interleukin 6 [units/volume] in serum or plasma,il6 serpl-acnc,interleukin 6 qn,arbitrary concentration; b-cell differentiation factor-2; b-cell stimulatory factor-2; bsf-2; chemistry; hepatocyte-stimulating factor; hybridoma growth factor; ifn-beta 2; il; il6; il-6; mgi-2; myeloid differentiation-inducing protein; pl; plasma; plasmacytoma growth factor; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
46570-8,prior - management of oral medications [oasis],,,finding; findings; ordinal; outcome and assessment information set; point in time; ql; qual; qualitative; random; screen; survey; survey.oasis,Ord
46574-0,prior - management of injectable medications [oasis],,,finding; findings; ordinal; outcome and assessment information set; point in time; ql; qual; qualitative; random; screen; survey; survey.oasis,Ord
46580-7,acute care hospitalization reason [oasis],,,finding; findings; hospitalization hx; ordinal; outcome and assessment information set; point in time; ql; qual; qualitative; random; screen; survey; survey.oasis,Ord
46588-0,ostomy for bowel elimination [oasis],,,finding; findings; ordinal; outcome and assessment information set; point in time; ql; qual; qualitative; random; screen; survey,Ord
46590-6,when confused [oasis],,,finding; findings; ordinal; outcome and assessment information set; point in time; ql; qual; qualitative; random; screen; survey; survey.oasis,Ord
46593-0,receives psychiatric nursing during assessment period [cms assessment],,,centers for medicare and medicaid assessment; finding; findings; ordinal; ql; qual; qualitative; report period; screen; survey,Ord
46619-3,"performs activities within a schedule, maintains regular attendance, is punctual within customary tolerances [rfc]",,,finding; findings; ordinal; point in time; ql; qual; qualitative; random; residual functional capacity; rfca; screen; survey; survey.rfc,Ord
466-3,sulfadiazine [susceptibility] by serum bactericidal titer,sulfadiazine titr sbt,sulfadiazine sbt (isol+s),antibiotic susceptibilities; dilution factor; dilution factor (titer); id; infectious disease; infectiousdisease; islt; isol; microsulfon; point in time; random; sequence based typing; serum; serum bactericidal titer; serum killing test; smqn; sr; titer; titered; titre; ttr,SemiQn
46650-8,exertional limitations [rfc],,,finding; findings; narrative; point in time; random; report; residual functional capacity; rfca; survey; survey.rfc,Nar
46664-9,fingering [rfc],,,finding; findings; ordinal; point in time; ql; qual; qualitative; random; residual functional capacity; rfca; screen; survey; survey.rfc,Ord
46684-7,wetness [rfc],,,finding; findings; ordinal; point in time; ql; qual; qualitative; random; residual functional capacity; rfca; screen; survey; survey.rfc,Ord
46686-2,noise [rfc],,,finding; findings; ordinal; point in time; ql; qual; qualitative; random; residual functional capacity; rfca; screen; survey; survey.rfc,Ord
46687-0,vibrations [rfc],,,finding; findings; ordinal; point in time; ql; qual; qualitative; random; residual functional capacity; rfca; screen; survey; survey.rfc,Ord
46688-8,"fumes, odors, dusts, gases, poor ventilation, etc [rfc]",,,finding; findings; ordinal; point in time; ql; qual; qualitative; random; residual functional capacity; rfca; screen; survey; survey.rfc,Ord
46712-6,food allergen mix 2 (cod+blue mussel+shrimp+salmon+tuna) ige ab [units/volume] in serum by multidisk,food allerg mix2 ige qn,cod+blue mussel+shrimp+salmon+tuna ige multidisk qn (s),abs; aby; allergen; allergens; allergy testing; allerscan; antby; anti; antibodies; antibody; arbitrary concentration; atlantic salmon; autoantibodies; autoantibody; blue mussel; cod; codfish; f003; f024; f037; f040; f041; f24; f3; f37; f40; f41; fish; fish mix; food allerg mix2; food mix (sea food); fx2; immune globulin e; immunoglobulin e; point in time; prawns; qnt; quan; quant; quantitative; random; salmon; scrod; serum; shrimp; sr; tuna; yellow fin,Qn
46725-8,tropheryma whipplei dna [presence] in specimen by naa with probe detection,t whipplei dna spec ql naa+probe,t. whipplei dna naa+probe ql (specimen),3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; deoxyribonucleic acid; dna nucleic acid probe; dna probe; id; infectious disease; infectiousdisease; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; misc; miscellaneous; naa+probe; naat; nasba; nucleic acid sequence based analysis; ordinal; other; pcr; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; screen; sda; spec; strand displacement amplification; t whippelii; t whippelli; t whipplei; tma; to be specified in another part of the message; transcription mediated amplification; tropheryma whippelli; unspecified; whipple's disease,Ord
46735-7,endocrine disorders newborn screen interpretation,endocrine disorders dbs-imp,endocrine disorders ql (dbs) [interp],blood; chemistry; dbs; dried blood spot; filter paper; fp; impression; impression/interpretation of study; impressions; interp; interpretation; ordinal; point in time; ql; qual; qualitative; random; screen; wb; whole blood,Ord
46741-5,homocystinuria and/or other hypermethioninemias newborn screen interpretation,hcy/met dbs-imp,homocystinuria and/or other hypermethioninemias ql (dbs) [interp],blood; chemistry; dbs; dried blood spot; filter paper; fp; hcy; hcy/met; impression; impression/interpretation of study; impressions; interp; interpretation; met; ordinal; othr; point in time; ql; qual; qualitative; random; screen; wb; whole blood,Ord
46743-1,maple syrup urine disease newborn screen interpretation,msud dbs-imp,maple syrup urine disease (dbs) [interp],acer; blood; chemistry; dbs; dis; diseases; dried blood spot; dz; f377; filter paper; fp; impression; impression/interpretation of study; impressions; interp; interpretation; msud; nominal; point in time; random; wb; whole blood,Nom
46745-6,other amino acidopathies newborn screen interpretation,other amino acidopathies dbs-imp,other amino acidopathies ql (dbs) [interp],blood; chemistry; dbs; dried blood spot; filter paper; fp; impression; impression/interpretation of study; impressions; interp; interpretation; ordinal; othr; point in time; ql; qual; qualitative; random; screen; wb; whole blood,Ord
46758-9,congenital adrenal hyperplasia newborn screen interpretation,cah dbs-imp,congenital adrenal hyperplasia (dbs) [interp],21-hydroxylase deficiency; adrnl; blood; cah; chemistry; dbs; dried blood spot; filter paper; fp; impression; impression/interpretation of study; impressions; interp; interpretation; nominal; point in time; random; wb; whole blood,Nom
46773-8,galactose epimerase deficiency newborn screen interpretation,gale dbs-imp,galactose epimerase deficiency ql (dbs) [interp],blood; cerebrose; chemistry; dbs; dried blood spot; filter paper; fp; gale; impression; impression/interpretation of study; impressions; interp; interpretation; ordinal; point in time; ql; qual; qualitative; random; screen; wb; whole blood,Ord
46785-2,abuse status community [omaha],,,abuse status; abused child/adult; finding; findings; nursing; ordinal; point in time; ql; qual; qualitative; random; screen; survey; survey.nursing.omaha,Ord
4680-5,von willebrand factor (vwf) ristocetin cofactor [units/volume] in platelet poor plasma,vwf:rco ppp-acnc,vwf ristocetin cofactor qn (ppp),aggrecetin; arbitrary concentration; coagulation; cofact; fac; fact; hematology; heme; plas; platelet poor plasma; point in time; qnt; quan; quant; quantitative; random; risto; von will; vonwillebrand; vwf; vwf:rco,Qn
46825-6,income behavior community [omaha],,,finding; findings; income behavior; nursing; ordinal; point in time; ql; qual; qualitative; random; screen; survey; survey.nursing.omaha,Ord
46828-0,interpersonal relationship behavior community [omaha],,,finding; findings; interpersonal relationship behavior; nursing; ordinal; point in time; ql; qual; qualitative; random; screen; survey; survey.nursing.omaha,Ord
46830-6,interpersonal relationship status community [omaha],,,finding; findings; interpersonal relationship status; nursing; ordinal; point in time; ql; qual; qualitative; random; screen; survey; survey.nursing.omaha,Ord
46836-3,mental health status community [omaha],,,emotional stability; finding; findings; mental health status; nursing; ordinal; point in time; ql; qual; qualitative; random; screen; survey; survey.nursing.omaha,Ord
46850-4,oral health knowledge community [omaha],,,finding; findings; nursing; oral health knowledge; ordinal; point in time; ql; qual; qualitative; random; screen; survey; survey.nursing.omaha,Ord
46857-9,personal care status community [omaha],,,finding; findings; nursing; ordinal; personal care status; personal hygiene; point in time; ql; qual; qualitative; random; screen; survey; survey.nursing.omaha,Ord
46861-1,postpartum function behavior community [omaha],,,fcn; finding; findings; func; funct; nursing; ordinal; point in time; postpart; postpartm; postpartum function behavior; ql; qual; qualitative; random; screen; survey; survey.nursing.omaha,Ord
46867-8,reproductive function behavior community [omaha],,,fcn; finding; findings; func; funct; nursing; ordinal; point in time; ql; qual; qualitative; random; reproductive function behavior; screen; survey; survey.nursing.omaha,Ord
46882-7,sexuality behavior community [omaha],,,finding; findings; nursing; ordinal; point in time; ql; qual; qualitative; random; screen; sexuality behavior; survey; survey.nursing.omaha,Ord
46894-2,speech and language behavior community [omaha],,,finding; findings; nursing; ordinal; point in time; ql; qual; qualitative; random; screen; speech and language behavior; survey; survey.nursing.omaha,Ord
46896-7,speech and language status community [omaha],,,finding; findings; nursing; ordinal; point in time; ql; qual; qualitative; random; screen; speech and language status; survey; survey.nursing.omaha,Ord
46919-7,pregnancy function knowledge family [omaha],,,fcn; finding; findings; func; funct; gestation; gestations; gravida; nursing; ordinal; point in time; pregnancies; pregnancy function knowledge; ql; qual; qualitative; random; screen; survey; survey.nursing.omaha,Ord
46922-1,reproductive function knowledge family [omaha],,,fcn; finding; findings; func; funct; nursing; ordinal; point in time; ql; qual; qualitative; random; reproductive function knowledge; screen; survey; survey.nursing.omaha,Ord
46924-7,urinary function behavior family [omaha],,,fcn; finding; findings; func; funct; nursing; ordinal; point in time; ql; qual; qualitative; random; screen; survey; survey.nursing.omaha; urinary function behavior,Ord
46958-5,triamcinolone acetonide [mass/volume] in urine,triamcinolone aceto ur-mcnc,triamcinolone acetonide (u) [mass/vol],aristocort; atolone; azmacort; drug/toxicology; drugs; kenacort; kenalog; level; mass concentration; mycolog ii; nasacort; point in time; qnt; quan; quant; quantitative; random; ua; ur; urn,Qn
46964-3,cryptococcus sp ag [presence] in cerebral spinal fluid by latex agglutination,cryptoc ag csf ql la,cryptococcus sp ag la ql (csf),antigen; antigens; cerebral spinal fluid; cerebrospinal fl; crypt; crypto; cryptococcal; cryptococcosis; cryptococcosus; id; infectious disease; infectiousdisease; lat; latex agglutination; microbiology; neuro; neurology; ordinal; point in time; pr; ql; qual; qualitative; random; screen; species; spinal fl; spinal fld; spinal flu; spinal fluid; spp,Ord
46967-6,cd40 cells [#/volume] in blood,cd40 cells # bld,cd40 cells (bld) [#/vol],#; abs; absolute; absolutes; blood; bp50; cd40 cells; cell; cell markers; cellularity; cnt; count; count/volume; ct; number concentration; number concentration (count/vol); point in time; qnt; quan; quant; quantitative; random; wb; whole blood,Qn
46968-4,cd122 cells [#/volume] in blood,cd122 cells # bld,cd122 cells (bld) [#/vol],#; abs; absolute; absolutes; blood; cd122 cells; cell; cell markers; cellularity; cnt; count; count/volume; ct; il-2rbeta; interleukin 2 receptor beta chain; number concentration; number concentration (count/vol); point in time; qnt; quan; quant; quantitative; random; wb; whole blood,Qn
46982-5,liver kidney microsomal igg ab [titer] in serum by immunofluorescence,lkm igg titr ser if,liver kidney microsomal igg if (s) [titer],abs; aby; acif; antby; anti; antibodies; antibody; anticomplement immunofluorescence; autoantibodies; autoantibody; dilution factor; dilution factor (titer); fa; fluorescent antibody; fluoresent; hepatology; ifa; immune fluorescence; immune globulin g; immunoflour; immunofluor; immunofluorescence; immunoglobulin g; liver; liver kidney microsome; lkm; microsm; microsom; point in time; random; serology; serum; smqn; sr; time resolved fluorescence; titer; titered; titre; trf; ttr,SemiQn
46984-1,ldl 2 [mass/volume] in serum or plasma,ldl2 serpl-mcnc,ldl 2 [mass/vol],cardio; cardiology; chemistry; heart disease; ii; ldl2; level; mass concentration; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
46990-8,aspa gene targeted mutation analysis in blood or tissue by molecular genetics method,aspa gene mut anl bld/t,aspa gene targeted mutation analysis molgen doc (bld/tiss),"acy2; acy-2; aminoacylase 2; asp; aspartoacylase; aspartoacylase gene; blood; canavan disease; document; finding; findings; genetics; heredity; heritable; inherited; molecular genetics; molecular pathology; molpath; molpath.mutations; mut; mut anl; mutations; pcr; point in time; random; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",Doc
46991-6,blm gene targeted mutation analysis in blood or tissue by molecular genetics method,blm gene mut anl bld/t,blm gene targeted mutation analysis molgen doc (bld/tiss),"blood; bloom syndrome; bloom syndrome, recq helicase-like; bs; document; finding; findings; genetics; heredity; heritable; inherited; molecular genetics; molecular pathology; molpath; molpath.mutations; mut; mut anl; mutations; pcr; point in time; random; recq2; recql2; recql3; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",Doc
46993-2,hla ab panel - serum,hla ab pnl ser,hla ab panel (s),cytotoxic-lymphocytic antibody; cytotoxic-lymphocytic antibody screen; frozen lymphocyte antibody panel; hla ab pnl; hla antigen; human leukocyte antigen; lymphocyte antibody; lymphocytotoxic antibody; lymphocytotoxic antibody screen; pan; panel reactive ab; panel reactive antibody; panel.hla; panl; pnl; point in time; pra; random; serum; sr; white cell antibody screen,-
4701-9,hla-a36 [presence] in donor,hla-a36 donr ql,hla-a36 ql (bld/tiss donor),"blood; donr; genetics; heredity; heritable; hla antigen; human leukocyte antigen; inherited; ordinal; point in time; pr; ql; qual; qualitative; random; screen; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",Ord
47021-1,cdx2 ag [presence] in tissue by immune stain,cdx2 ag tiss ql imstn,cdx2 ag immune stain ql (tiss),"antigen; antigens; ihc; imm; immunohistochemical stain; immunostain; imstn; imun; imune; ordinal; pathology; point in time; pr; ql; qual; qualitative; random; screen; st; stains; stn; tissue; tissue, unspecified",Ord
47022-9,cd11c+cd19+ cells/cells in specimen,cd11c+cd19+ cells nfr spec,cd11c+cd19+ cells/cells (specimen),"alphax integrin chain; axb2; b4; b-4; cd11c cells; cd11c+cd19+ cells; cell; cell markers; cellularity; cr4; hd-37; leu12; leu-12; leukocyte surface antigen p150,95; leum5; leu-m5; misc; miscellaneous; number fraction; other; percent; point in time; qnt; quan; quant; quantitative; random; spec; to be specified in another part of the message; unspecified",Qn
47038-5,villin ag [presence] in tissue by immune stain,villin ag tiss ql imstn,villin ag immune stain ql (tiss),"antigen; antigens; ihc; imm; immunohistochemical stain; immunostain; imstn; imun; imune; ordinal; pathology; point in time; pr; ql; qual; qualitative; random; screen; st; stains; stn; tissue; tissue, unspecified",Ord
47042-7,counseling note,counseling note,,doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; notes; point in time; random; visit note,Doc
47054-2,legionella pneumophila 10 igm ab [titer] in serum by immunofluorescence,l pneumo 10 igm titr ser if,l. pneumophila 10 igm if (s) [titer],abs; aby; acif; antby; anti; antibodies; antibody; anticomplement immunofluorescence; autoantibodies; autoantibody; dilution factor; dilution factor (titer); fa; fluorescent antibody; fluoresent; id; ifa; immune fluorescence; immune globulin m; immunoflour; immunofluor; immunofluorescence; immunoglobulin m; infectious disease; infectiousdisease; l pneumo; l pneumo 10; l pneumo 10 ab; l pneumonphila; legion; legionela; microbiology; pneu; pneum; pneumophilia; point in time; random; serum; smqn; sr; time resolved fluorescence; titer; titered; titre; trf; ttr,SemiQn
47079-9,legionella pneumophila 8 igm ab [titer] in serum by immunofluorescence,l pneumo8 igm titr ser if,l. pneumophila 8 igm if (s) [titer],abs; aby; acif; antby; anti; antibodies; antibody; anticomplement immunofluorescence; autoantibodies; autoantibody; concord 3; dilution factor; dilution factor (titer); fa; fluorescent antibody; fluoresent; id; ifa; immune fluorescence; immune globulin m; immunoflour; immunofluor; immunofluorescence; immunoglobulin m; infectious disease; infectiousdisease; l pneumo; l pneumo8; l pneumonphila; legion; legionela; legionella pneumophila serogroup 8; microbiology; pneu; pneum; pneumophilia; point in time; random; serum; smqn; sr; time resolved fluorescence; titer; titered; titre; trf; ttr,SemiQn
47080-7,legionella pneumophila 9 igg ab [titer] in serum by immunofluorescence,l pneumo9 igg titr ser if,l. pneumophila 9 igg if (s) [titer],abs; aby; acif; antby; anti; antibodies; antibody; anticomplement immunofluorescence; autoantibodies; autoantibody; dilution factor; dilution factor (titer); fa; fluorescent antibody; fluoresent; id; ifa; immune fluorescence; immune globulin g; immunoflour; immunofluor; immunofluorescence; immunoglobulin g; in 23; infectious disease; infectiousdisease; l pneumo; l pneumo9; l pneumonphila; legion; legionela; legionella pneumophila serogroup 9; microbiology; pneu; pneum; pneumophilia; point in time; random; serum; smqn; sr; time resolved fluorescence; titer; titered; titre; trf; ttr,SemiQn
4708-4,hla-a68(28) [presence],hla-a68(28) ql,hla-a68(28) ql (bld/tiss),"blood; genetics; heredity; heritable; hla antigen; human leukocyte antigen; inherited; ordinal; point in time; pr; ql; qual; qualitative; random; screen; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",Ord
47099-7,chromium [moles/volume] in 24 hour urine,cr 24h ur-scnc,chromium (24h u) [moles/vol],1 day; 24 hours; 24hr; c609; chrome; cr; drug/toxicology; drugs; level; qnt; quan; quant; quantitative; substance concentration; ua; ur; urn,Qn
47100-3,copper [moles/volume] in blood,copper bld-scnc,copper (bld) [moles/vol],blood; cu; drug/toxicology; drugs; level; point in time; qnt; quan; quant; quantitative; random; substance concentration; wb; whole blood,Qn
47104-5,doxepin [moles/volume] in gastric fluid,doxepin gast-scnc,doxepin (gast fld) [moles/vol],adapin; aponal; dox; doxpin; drug/toxicology; drugs; gast; gastric contents; gastric fluid; level; point in time; qnt; quan; quant; quantitative; random; sinequan; substance concentration,Qn
47111-0,glutethimide [moles/volume] in urine,glutethimide ur-scnc,glutethimide (u) [moles/vol],addiction; doriden; drug/toxicology; drugs; drugs of abuse; glutethimde; illicit; level; point in time; potentialforabuse; qnt; quan; quant; quantitative; random; substance concentration; ua; ur; urn,Qn
47114-4,lorazepam [moles/volume] in gastric fluid,lorazepam gast-scnc,lorazepam (gast fld) [moles/vol],addiction; ativan; drug/toxicology; drugs; drugs of abuse; gast; gastric contents; gastric fluid; illicit; level; point in time; potentialforabuse; qnt; quan; quant; quantitative; random; substance concentration,Qn
471-3,sulfisoxazole [susceptibility] by minimum lethal concentration (mlc),sulfisoxaz islt mlc,sulfisoxazole mlc [susc],antibiotic susceptibilities; ast; gantrisin; id; infectious disease; infectiousdisease; islt; isol; mbc; minimum bactericidal concentration; minimum lethal concentration; point in time; qnt; quan; quant; quantitative; random; sulfizole; sus; suscept; susceptibilities; susceptibility; susceptibilty,Qn
47131-8,thioridazine [moles/volume] in gastric fluid,thioridazine gast-scnc,thioridazine (gast fld) [moles/vol],drug/toxicology; drugs; gast; gastric contents; gastric fluid; level; mellaril; novo-ridazine; point in time; qnt; quan; quant; quantitative; random; sonapax; substance concentration; thioridazine hydrochloride; thioril,Qn
47144-1,epinephrine [moles/volume] in plasma --4 hours post xxx challenge,epineph 4h p chal plas-scnc,epinephrine 4 hr post unsp challenge (p) [moles/vol],4h p chal; adrenalin; adrenaline; adreneline; after; chemistry.challenge testing; e; epi; epin; epinep; epineph; epinphrine; eppi; level; p chal; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; substance concentration,Qn
47167-2,norepinephrine [moles/volume] in plasma --4th specimen post xxx challenge,norepineph sp4 p chal plas-scnc,norepinephrine 4th specimen post unsp challenge (p) [moles/vol],after; chemistry.challenge testing; level; ne; noradrenalin; norepi; norepin; norepineph; norepinephr; noreppi; p chal; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; sp4; sp4 p chal; spec; substance concentration,Qn
47169-8,norepinephrine [moles/volume] in plasma --5th specimen post xxx challenge,norepineph sp5 p chal plas-scnc,norepinephrine 5th specimen post unsp challenge (p) [moles/vol],after; chemistry.challenge testing; level; ne; noradrenalin; norepi; norepin; norepineph; norepinephr; noreppi; p chal; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; sp5; sp5 p chal; spec; substance concentration,Qn
47173-0,catecholamines [moles/volume] in plasma --7th specimen post xxx challenge,catechols sp7 p chal plas-scnc,catecholamines 7th specimen post unsp challenge (p) [moles/vol],^7th spec pst xxx chal; after; cate; catec; catech; catechol; catecholamine; catecholamines.total; catechols; chemistry.challenge testing; epinephrine+norepinephrine+dopamine; level; p chal; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; sp7; sp7 p chal; spec; substance concentration,Qn
47178-9,parathyrin.intact [moles/volume] in serum or plasma --baseline,pth-intact bs serpl-scnc,parathyrin.intact baseline [moles/vol],bs; chemistry.challenge testing; intact parathormone; intact parathyroid hormone; ipth; level; parathormone; parathyroid hormone; pl; plasma; plsm; point in time; pth; pth-intact; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; substance concentration; tumor marker,Qn
47180-5,parathyrin [moles/volume] in serum or plasma --baseline,pth bs serpl-scnc,parathyrin baseline [moles/vol],bs; chemistry.challenge testing; level; parathormone; parathyroid hormone; pl; plasma; plsm; point in time; pth; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; substance concentration,Qn
47188-8,progesterone [moles/volume] in serum or plasma --5th specimen post xxx challenge,progest sp5 p chal serpl-scnc,progesterone 5th specimen post unsp challenge [moles/vol],after; chemistry.challenge testing; level; p chal; p4; pl; plasma; plsm; point in time; prog; proges; progest; progestin; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sp5; sp5 p chal; spec; sr; substance concentration,Qn
47197-9,triiodothyronine (t3) [moles/volume] in serum or plasma --8th specimen post xxx challenge,t3 sp8 p chal serpl-scnc,t3 8th specimen post unsp challenge [moles/vol],after; chemistry.challenge testing; endocrine; endocrinology; level; p chal; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sp8; sp8 p chal; spec; sr; substance concentration; t3; t-3; thyroid hormone; total t3; triodothyrne,Qn
47201-9,bentiromide [mass] of dose,bentiromide dose,bentiromide (dose) [mass],bentiramide; dose med or substance; drug doses; n-benzoyl-l-tyrosylp-aminobenzoic acid; point in time; qnt; quan; quant; quantitative; random,Qn
47203-5,pyridoxine [mass] of dose,vit b6 dose,pyridoxine (dose) [mass],c8h11no3; dose med or substance; drug doses; point in time; pyridoxol; qnt; quan; quant; quantitative; random; vit b6; vitamin b6,Qn
47207-6,secretin [mass] of dose,secretin dose,secretin (dose) [mass],dose med or substance; drug doses; point in time; qnt; quan; quant; quantitative; random,Qn
47211-8,chlamydia trachomatis l2 dna [presence] in specimen by naa with probe detection,c trach l2 dna spec ql naa+probe,c. trachomatis l2 dna naa+probe ql (specimen),3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; c trac; c trach; c trach l2; c tracho; c trachomatis; chlam; chlam trac; chlamid; ct; deoxyribonucleic acid; dna nucleic acid probe; dna probe; id; infectious disease; infectiousdisease; lat; lcr; lgv; ligase chain reaction; ligation-activated transcription; lymphogranuloma venereum; microbiology; misc; miscellaneous; naa+probe; naat; nasba; nucleic acid sequence based analysis; ordinal; other; pcr; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; screen; sda; spec; strand displacement amplification; tma; to be specified in another part of the message; trachoma; transcription mediated amplification; unspecified,Ord
4721-7,hla-a24(9) [presence] in donor,hla-a24(9) donr ql,hla-a24(9) ql (bld/tiss donor),"blood; donr; genetics; heredity; heritable; hla antigen; human leukocyte antigen; inherited; ordinal; point in time; pr; ql; qual; qualitative; random; screen; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",Ord
47217-5,immune complex c3d [mass/volume] in serum or plasma,ic c3d serpl-mcnc,immune complex c3d [mass/vol],cic; circulating immune complex; compx; ic; ic c3d; imm; imun; imune; level; mass concentration; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serology; serp; serpl; serplas; serum; serum or plasma; sr,Qn
47219-1,cholesterol in vldl 5+6 [mass/volume] in serum or plasma,vldl5+6c serpl-mcnc,cholesterol in vldl 5+6 [mass/vol],cardio; cardiology; chemistry; chol; choles; cholest; cholesterol total; cholesterols; heart disease; level; lipid; mass concentration; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; very low density lipoprotein cholesterols; vldl5+6c; vldlc,Qn
47250-6,adenosine monophosphate.cyclic [moles/volume] in urine --2nd specimen post xxx challenge,camp sp2 p chal ur-scnc,adenosine monophosphate.cyclic 2nd specimen post unsp challenge (u) [moles/vol],adenosine 2'-phosphate; adenosine 3'-phosphate; adenosine 5'-phosphate; adenylic acid; ado; after; amp; aned; camp; chemistry.challenge testing; cmp; convalescent; level; medication stress; p chal; phosphaden; point in time; post immunization; pst; qnt; quan; quant; quantitative; random; second; sp2; sp2 p chal; spec; substance concentration; ua; ur; urn,Qn
4725-8,hla-a26(10) [presence],hla-a26(10) ql,hla-a26(10) ql (bld/tiss),"blood; genetics; heredity; heritable; hla antigen; human leukocyte antigen; inherited; ordinal; point in time; pr; ql; qual; qualitative; random; screen; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",Ord
47264-7,adenosine monophosphate.cyclic [moles/volume] in urine --1st specimen post xxx challenge,camp sp1 p chal ur-scnc,adenosine monophosphate.cyclic 1st specimen post unsp challenge (u) [moles/vol],acute specimen; adenosine 2'-phosphate; adenosine 3'-phosphate; adenosine 5'-phosphate; adenylic acid; ado; after; amp; aned; camp; chemistry.challenge testing; cmp; first; level; medication stress; p chal; phosphaden; point in time; pre immunization; pst; qnt; quan; quant; quantitative; random; sp1; sp1 p chal; spec; substance concentration; ua; ur; urn,Qn
47272-0,adenosine monophosphate.cyclic/creatinine [ratio] in urine --5th specimen post xxx challenge,camp/creat sp5 p chal ur-rto,adenosine monophosphate.cyclic/creatinine 5th specimen post unsp challenge (u) [ratio],adenosine 2'-phosphate; adenosine 3'-phosphate; adenosine 5'-phosphate; adenylic acid; ado; after; amp; aned; camp; chemistry.challenge testing; cmp; cr; crea; creat; medication stress; p chal; phosphaden; point in time; pst; qnt; quan; quant; quantitative; random; ratios; rto; sp5; sp5 p chal; spec; ua; ucr; ur; urn,Qn
47287-8,deprecated hemogram without platelets panel in cord blood,deprecated cbc wo platelets bldco,hemogram without platelets panel (bldco),blood - (umbilical) cord; cbc wo platelets; complete blood count; cord (umbilical) blood; cord bld; cord blood; hematology/cell counts; pan; panel.hematology& cell counts; panl; platelet; platelets pnl; platelt; plt; pnl; point in time; qnt; quan; quant; quantitative; random; thrb; thrombocyte; thrombocytes,Qn
47289-4,igg and igg subclass panel [mass/volume] - serum,igg+igg subclass pnl ser-mcnc,igg and igg subclass panel (s) [mass/vol],chemistry; igg subclass pnl; igg+igg subclass pnl; immune globulin g; immunoglobulin g; level; mass concentration; pan; panel.chemistry; panl; pnl; point in time; qnt; quan; quant; quantitative; random; serum; sr; subclasses; universallaborders,Qn
47310-8,haemophilus influenzae b igg ab [mass/volume] in serum by immunoassay --1st specimen,haem influ b igg sp1 ser ia-mcnc,h. influenzae b igg spec 1 ia (s) [mass/vol],abs; aby; acute specimen; antby; anti; antibodies; antibody; autoantibodies; autoantibody; eia; elfa; elisa; enzyme immunoassay; first; h flu; h influenza; h influenzae; haem influ; haem influ b; haemoph; hib; iaa; id; immune globulin g; immunoglobulin g; infectious disease; infectiousdisease; influ; level; mass concentration; meia; microbiology; point in time; pre immunization; qnt; quan; quant; quantitative; random; serum; sp1; spec; sr; suds,Qn
47323-1,deprecated streptococcus pneumoniae 17 igg ab [mass/volume] in serum by immunoassay,deprecated s pneum17 igg ser ia-mcnc,s. pneumoniae 17 igg ia (s) [mass/vol],abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; eia; elfa; elisa; enzyme immunoassay; iaa; id; immune globulin g; immunoglobulin g; infectious disease; infectiousdisease; level; mass concentration; meia; microbiology; pneu; pneum; pneumo; pneumococ; pneumococcal; pneumococcal pneumonia; pneumococcus; pneumon; pneumonia; point in time; qnt; quan; quant; quantitative; random; s pneum17; s pneumo; s pneumoniae; serum; spn; sr; strep; strept; streptococcus pneumoniae 17f; suds,Qn
47328-0,deprecated streptococcus pneumoniae 2 igg ab [mass/volume] in serum by immunoassay --1st specimen,deprecated s pneum2 igg sp1 ser ia-mcnc,s. pneumoniae 2 igg spec 1 ia (s) [mass/vol],abs; aby; acute specimen; antby; anti; antibodies; antibody; autoantibodies; autoantibody; eia; elfa; elisa; enzyme immunoassay; first; iaa; id; ii; immune globulin g; immunoglobulin g; infectious disease; infectiousdisease; level; mass concentration; meia; microbiology; pneu; pneum; pneumo; pneumococ; pneumococcal; pneumococcal pneumonia; pneumococcus; pneumon; pneumonia; point in time; pre immunization; qnt; quan; quant; quantitative; random; s pneum2; s pneumo; s pneumoniae; serum; sp1; spec; spn; sr; strep; strept; suds,Qn
47344-7,deprecated streptococcus pneumoniae 43 igg ab [mass/volume] in serum by immunoassay --2nd specimen,deprecated s pneum43 igg sp2 ser ia-mcnc,s. pneumoniae 43 igg spec 2 ia (s) [mass/vol],abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; convalescent; eia; elfa; elisa; enzyme immunoassay; iaa; id; immune globulin g; immunoglobulin g; infectious disease; infectiousdisease; level; mass concentration; meia; microbiology; pneu; pneum; pneumo; pneumococ; pneumococcal; pneumococcal pneumonia; pneumococcus; pneumon; pneumonia; point in time; post immunization; qnt; quan; quant; quantitative; random; s pneum43; s pneumo; s pneumoniae; second; serum; sp2; spec; spn; sr; strep; strept; streptococcus pneumoniae 11a; suds,Qn
47346-2,streptococcus pneumoniae danish serotype 15b igg ab [mass/volume] in serum by immunoassay --2nd specimen,s pneum da 15b igg sp2 ser ia-mcnc,s. pneumoniae danish type 15b igg spec 2 ia (s) [mass/vol],abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; convalescent; eia; elfa; elisa; enzyme immunoassay; iaa; id; immune globulin g; immunoglobulin g; infectious disease; infectiousdisease; level; mass concentration; meia; microbiology; pneu; pneum; pneumo; pneumococ; pneumococcal; pneumococcal pneumonia; pneumococcus; pneumon; pneumonia; point in time; post immunization; ppsv23; qnt; quan; quant; quantitative; random; s pneum da 15 igg; s pneum da 15b; s pneum da 15b ab; s pneum da type; s pneumo; s pneumoniae; second; serum; sp2; spec; spn; sr; strep; strept; suds; u.s. serotype 54,Qn
47347-0,streptococcus pneumoniae danish serotype 15b igg ab [ratio] in serum --2nd specimen/1st specimen,s pneum da 15b igg 2:1 ser-rto,s. pneumoniae danish type 15b igg 2nd specimen/1st specimen (s) [ratio],2:1; abs; aby; acute specimen; antby; anti; antibodies; antibody; autoantibodies; autoantibody; convalescent; first; id; immune globulin g; immunoglobulin g; infectious disease; infectiousdisease; microbiology; pneu; pneum; pneumo; pneumococ; pneumococcal; pneumococcal pneumonia; pneumococcus; pneumon; pneumonia; point in time; post immunization; ppsv23; pre immunization; qnt; quan; quant; quantitative; random; ratios; rto; s pneum da 15 igg; s pneum da 15b; s pneum da 15b ab; s pneum da type; s pneumo; s pneumoniae; second; serum; sp1; sp2; spec; spn; sr; strep; strept; u.s. serotype 54,Qn
47370-2,xr hand - left ge 3 views,xr hand-l ge 3v,,arm; document; ext; extr-l; films; finding; findings; ge 3v; hand-l; iii; imaging; l; lt; lue; minimum 3 views; msk; musculoskeletal; ortho; orthopedics; plain films; point in time; rad; radiology; random; ue; ue-l; up; upper extremity; view; vws; xray; x-ray,Doc
47380-1,xr mandible le 3 views,xr mandible le 3v,,brain; coreplaybook; cranial; cranium; document; films; finding; findings; iii; imaging; intracranial; jaw; le 3v; less than or equal to 3; mand; maximum 3 views; plain films; playbook; point in time; rad; radiology; random; skull; view; vws; xray; x-ray,Doc
47406-4,entamoeba histolytica ab [presence] in cerebral spinal fluid,e histolyt ab csf ql,e. histolytica ab ql (csf),abs; aby; ameba; amebiasis; amebic; amoeba; antby; anti; antibodies; antibody; autoantibodies; autoantibody; cerebral spinal fluid; cerebrospinal fl; e histolyt; e histolytica; id; infectious disease; infectiousdisease; microbiology; neuro; neurology; ordinal; point in time; pr; ql; qual; qualitative; random; screen; spinal fl; spinal fld; spinal flu; spinal fluid,Ord
47425-4,aspergillus nidulans b ab [presence] in serum,a nidulans b ab ser ql,a. nidulans b ab ql (s),a nidulans; a nidulans b; abs; aby; antby; anti; antibodies; antibody; asperg; aspergil; aspergilis; aspergilla; aspergillin; aspergillosis; aspergils; aspergilus; autoantibodies; autoantibody; farmers lung; id; infectious disease; infectiousdisease; m310; m47; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; sr,Ord
47429-6,corynebacterium diphtheriae toxin ab [units/volume] in serum --1st specimen,c diphtheriae tox ab sp1 ser-acnc,c. diphtheriae toxin ab spec 1 qn (s),abs; aby; acute specimen; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; c diphtheriae; c diphtheriae tox; diphtheria; diptheria; first; id; infectious disease; infectiousdisease; microbiology; point in time; pre immunization; qnt; quan; quant; quantitative; random; serum; sp1; spec; sr,Qn
4743-1,hla-b22 [presence],hla-b22 ql,hla-b22 ql (bld/tiss),"blood; genetics; heredity; heritable; hla antigen; human leukocyte antigen; inherited; ordinal; point in time; pr; ql; qual; qualitative; random; screen; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",Ord
47431-2,echinococcus granulosus igg ab [units/volume] in serum,e granulosus igg ser-acnc,e. granulosus igg qn (s),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; e granulosus; echinococcosis; id; immune globulin g; immunoglobulin g; infectious disease; infectiousdisease; microbiology; point in time; qnt; quan; quant; quantitative; random; serum; sr,Qn
47433-8,epstein barr virus capsid igm ab [titer] in body fluid,ebv vca igm titr fld,ebv capsid igm (body fld) [titer],"abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; b/f; bf; bod; bodies; body fluid; body fluid, unsp; cap; dilution factor; dilution factor (titer); ebv; ebv capsid ab; ebv vca; epstn; fl; fld; flu; fluid; hhv-4; human herpesvirus 4; id; immune globulin m; immunoglobulin m; infectious disease; infectiousdisease; microbiology; mono; mononucleosis; point in time; random; smqn; titer; titered; titre; ttr; vca; viral capsid",SemiQn
47438-7,fowl adenovirus ab [presence] in serum,fadv1 ab ser ql,fowl adenovirus ab ql (s),abs; aby; adeno virus; antby; anti; antibodies; antibody; autoantibodies; autoantibody; fadv1; fadv-1; hadv; i; id; infectious disease; infectiousdisease; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; sr,Ord
47445-2,influenza virus a h10 ab [titer] in serum,fluav h10 ab titr ser,fluav h10 ab (s) [titer],abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; avian influenza; bird flu; dilution factor; dilution factor (titer); flua; fluav; fluav h10; fluv; fowl plague; id; infectious disease; infectiousdisease; influ; influenza a; influenza a virus; microbiology; point in time; random; serum; smqn; sr; titer; titered; titre; ttr,SemiQn
4744-9,hla-b41 [presence] in donor,hla-b41 donr ql,hla-b41 ql (bld/tiss donor),"blood; donr; genetics; heredity; heritable; hla antigen; human leukocyte antigen; inherited; ordinal; point in time; pr; ql; qual; qualitative; random; screen; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",Ord
4745-6,hla-b41 [presence],hla-b41 ql,hla-b41 ql (bld/tiss),"blood; genetics; heredity; heritable; hla antigen; human leukocyte antigen; inherited; ordinal; point in time; pr; ql; qual; qualitative; random; screen; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",Ord
47459-3,legionella pneumophila 10 igg ab [titer] in serum,l pneumo 10 igg titr ser,l. pneumophila 10 igg (s) [titer],abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; dilution factor; dilution factor (titer); id; immune globulin g; immunoglobulin g; infectious disease; infectiousdisease; l pneumo; l pneumo 10; l pneumo 10 ab; l pneumonphila; legion; legionela; microbiology; pneu; pneum; pneumophilia; point in time; random; serum; smqn; sr; titer; titered; titre; ttr,SemiQn
47469-2,legionella pneumophila 7 igg ab [titer] in serum,l pneumo7 igg titr ser,l. pneumophila 7 igg (s) [titer],abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; chicago 8; dilution factor; dilution factor (titer); id; immune globulin g; immunoglobulin g; infectious disease; infectiousdisease; l pneumo; l pneumo7; l pneumonphila; legion; legionela; legionella pneumophila serogroup 7; microbiology; pneu; pneum; pneumophilia; point in time; random; serum; smqn; sr; titer; titered; titre; ttr,SemiQn
474-7,sulfisoxazole [susceptibility] by serum bactericidal titer,sulfisoxaz titr sbt,sulfisoxazole sbt (isol+s),antibiotic susceptibilities; dilution factor; dilution factor (titer); gantrisin; id; infectious disease; infectiousdisease; islt; isol; point in time; random; sequence based typing; serum; serum bactericidal titer; serum killing test; smqn; sr; sulfizole; titer; titered; titre; ttr,SemiQn
47476-7,reagin ab [titer] in specimen,reagin ab titr spec,reagin ab (specimen) [titer],abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; dilution factor; dilution factor (titer); id; infectious disease; infectiousdisease; microbiology; misc; miscellaneous; neurosyphilis; other; point in time; random; smqn; spec; syphilis; titer; titered; titre; to be specified in another part of the message; treponema; ttr; unspecified,SemiQn
47488-2,deprecated streptococcus pneumoniae 2 igg ab [mass/volume] in serum --2nd specimen,deprecated s pneum2 igg sp2 ser-mcnc,s. pneumoniae 2 igg spec 2 (s) [mass/vol],abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; convalescent; id; ii; immune globulin g; immunoglobulin g; infectious disease; infectiousdisease; level; mass concentration; microbiology; pneu; pneum; pneumo; pneumococ; pneumococcal; pneumococcal pneumonia; pneumococcus; pneumon; pneumonia; point in time; post immunization; qnt; quan; quant; quantitative; random; s pneum2; s pneumo; s pneumoniae; second; serum; sp2; spec; spn; sr; strep; strept,Qn
47497-3,deprecated streptococcus pneumoniae 43 igg ab [mass/volume] in serum --1st specimen,deprecated s pneum43 igg sp1 ser-mcnc,s. pneumoniae 43 igg spec 1 (s) [mass/vol],abs; aby; acute specimen; antby; anti; antibodies; antibody; autoantibodies; autoantibody; first; id; immune globulin g; immunoglobulin g; infectious disease; infectiousdisease; level; mass concentration; microbiology; pneu; pneum; pneumo; pneumococ; pneumococcal; pneumococcal pneumonia; pneumococcus; pneumon; pneumonia; point in time; pre immunization; qnt; quan; quant; quantitative; random; s pneum43; s pneumo; s pneumoniae; serum; sp1; spec; spn; sr; strep; strept; streptococcus pneumoniae 11a,Qn
47500-4,deprecated streptococcus pneumoniae 5 igg ab [mass/volume] in serum --2nd specimen,deprecated s pneum5 igg sp2 ser-mcnc,s. pneumoniae 5 igg spec 2 (s) [mass/vol],abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; convalescent; id; immune globulin g; immunoglobulin g; infectious disease; infectiousdisease; level; mass concentration; microbiology; pneu; pneum; pneumo; pneumococ; pneumococcal; pneumococcal pneumonia; pneumococcus; pneumon; pneumonia; point in time; post immunization; qnt; quan; quant; quantitative; random; s pneum5; s pneumo; s pneumoniae; second; serum; sp2; spec; spn; sr; strep; strept,Qn
47518-6,yersinia pestis ab [presence] in specimen,y pestis ab spec ql,y. pestis ab ql (specimen),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; id; infectious disease; infectiousdisease; microbiology; misc; miscellaneous; ordinal; other; p pestis; pasturella pestis; plague; point in time; pr; ql; qual; qualitative; random; screen; spec; to be specified in another part of the message; unspecified; y pestis,Ord
47522-8,cytology report of nipple discharge cyto stain,cytology nipple dis doc cyto,cytology report cyto stain doc (nipple discharge),cytology stain; cytostain; disch; document; finding; findings; pap smear; pap stain; papanicolaou smear; point in time; random; st; stains; stn,Doc
47530-1,cytology report of breast ductal lavage cyto stain,cytology breast dl doc cyto,cytology report cyto stain doc (breast ductal lavage),breast dl; brst; cytology stain; cytostain; document; finding; findings; pap smear; pap stain; papanicolaou smear; point in time; random; st; stains; stn,Doc
47548-3,adenosine deaminase [enzymatic activity/mass] in fibroblast,adenosine deaminase fib-ccnt,adenosine deaminase (fibroblast) [catalytic activity/mass],ada; ado; aned; catalytic content; chemistry; fib; fibr; medication stress; point in time; qnt; quan; quant; quantitative; random,Qn
47554-1,alanine/amino acids.total in amniotic fluid,alanine sfr amn,alanine/total aa (amn fld) [molar fraction],aa; acd; acid; af; ala; alpha alanine; amino acid; amino acids.total; amn; amn fl; amnio; amniotic flu; amniotic fluid; chemistry; l-alanine; percent; point in time; qnt; quan; quant; quantitative; random; substance fraction; tot; totl,Qn
4755-5,hla-b w4 [presence],hla-b w4 ql,hla-b w4 ql (bld/tiss),"blood; genetics; heredity; heritable; hla antigen; human leukocyte antigen; inherited; ordinal; point in time; pr; ql; qual; qualitative; random; screen; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",Ord
47570-7,argininosuccinate lyase [enzymatic activity/mass] in fibroblast,asa lyase fib-ccnt,argininosuccinate lyase (fibroblast) [catalytic activity/mass],argininosuccinic acid; arginosuccinate; arginosuccinic acid; asa; asa lyase; asal; catalytic content; chemistry; fib; fibr; point in time; qnt; quan; quant; quantitative; random,Qn
47584-8,c peptide [moles/volume] in serum or plasma --10 minutes post dose glucose,c peptide 10m p glc serpl-scnc,c peptide 10 min post dose glucose [moles/vol],10m p glc; after; chemistry.challenge testing; connecting peptide of insulin; glu; glu tol; gluc; glucose tolerance; glucoseur; gtt; level; p dose; p glc; pept; pl; plasma; plsm; point in time; pro-insulin c peptide; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; substance concentration,Qn
4758-9,hla-b52(5) [presence] in donor,hla-b52(5) donr ql,hla-b52(5) ql (bld/tiss donor),"blood; donr; genetics; heredity; heritable; hla antigen; hla-b w52(5); human leukocyte antigen; inherited; ordinal; point in time; pr; ql; qual; qualitative; random; screen; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",Ord
47601-0,choriogonadotropin.beta subunit free [units/volume] in body fluid,b-hcg free fld-acnc,free beta hcg qn (body fld),"arbitrary concentration; b; b hcg; b/f; beta hcg; beta human chorionic gonadotropin; bf; b-hcg; b-hcg free; bod; bodies; body fluid; body fluid, unsp; cg; chemistry; choriogonadotropin beta chain; choriogonadotropins total; chorionic gonadotropin; fl; fld; flu; fluid; fr; hcg; human chorionic gonadotropin; non-protein bound; point in time; qnt; quan; quant; quantitative; random; tumor marker",Qn
47609-3,cortisol [moles/volume] in serum or plasma --pre 1 ug/kg crh iv,cortis pre 1 ug/kg crh iv serpl-scnc,cortisol pre 1 ug/kg crh iv [moles/vol],17-hydroxycorticosterone; before; chemistry.challenge testing; compound f; coritsol; cort; f; hydrocortisone; i; level; mcg; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; substance concentration,Qn
47616-8,estradiol (e2) [mass/volume] in serum or plasma --1 hour post dose corticotropin,estradiol 1h p acth serpl-mcnc,e2 1 hr post dose corticotropin [mass/vol],1 hour; 1.0hr; 17-beta estradiol; 1h p acth; 60 min; 60 minutes; 60m; 60min; acth; adrenocorticotrophic hormone; adrenocorticotropin; after; c206; c74; chemistry.challenge testing; cortrosyn; e2; level; mass concentration; oestradiol; p acth; p dose; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; rc206; serp; serpl; serplas; serum; serum or plasma; sr; tumor marker,Qn
47618-4,follitropin [units/volume] in serum or plasma --15 minutes post 100 ug luteinizing releasing hormone iv,fsh 15m p 100 ug lrh iv serpl-acnc,follitropin 15 min post 100 ug luteinizing releasing hormone iv qn,15m p 100 ug lrh iv; after; arbitrary concentration; chemistry.challenge testing; follicle stimulating hormone; fsh; horm; mcg; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
47650-7,homogentisate/creatinine [molar ratio] in urine,homogentisate/creat ur-srto,homogentisate/creatinine (u) [molar ratio],chemistry; cr; crea; creat; hga; homogen; homogentisic acid; homogentistic acid; melanate; melanic acid; point in time; qnt; quan; quant; quantitative; random; scrto; substance concentration ratio; substance ratio; ua; ucr; ur; urn,Qn
47656-4,insulin [units/volume] in serum or plasma --1 minute post dose glucose,insulin 1m p glc serpl-acnc,insulin 1 min post dose glucose qn,1m p glc; after; arbitrary concentration; chemistry.challenge testing; glu; glu tol; gluc; glucose tolerance; glucoseur; gtt; hum; humulin; ih7; insul; lente; nph; p dose; p glc; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; semilente; serp; serpl; serplas; serum; serum or plasma; sliding; sr; ultralente,Qn
4766-2,hla-b56(22) [presence] in donor,hla-b56(22) donr ql,hla-b56(22) ql (bld/tiss donor),"blood; donr; genetics; heredity; heritable; hla antigen; human leukocyte antigen; inherited; ordinal; point in time; pr; ql; qual; qualitative; random; screen; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",Ord
47666-3,insulin [units/volume] in serum or plasma --5 minutes pre dose glucose,insulin 5m pre glc serpl-acnc,insulin 5 min pre dose glucose qn,5m pre glc; arbitrary concentration; before; chemistry.challenge testing; glu; glu tol; gluc; glucose tolerance; glucoseur; gtt; hum; humulin; ih7; insul; lente; nph; pl; plasma; plsm; point in time; pre glc; qnt; quan; quant; quantitative; random; semilente; serp; serpl; serplas; serum; serum or plasma; sliding; sr; ultralente,Qn
47673-9,isoleucine/amino acids.total in cerebral spinal fluid,isoleucine sfr csf,isoleucine/total aa (csf) [molar fraction],aa; acd; acid; amino acid; amino acids.total; cerebral spinal fluid; cerebrospinal fl; chemistry; ile; percent; point in time; qnt; quan; quant; quantitative; random; spinal fl; spinal fld; spinal flu; spinal fluid; substance fraction; tot; totl,Qn
47687-9,lutropin [units/volume] in serum or plasma --15 minutes post 100 ug luteinizing releasing hormone iv,lh 15m p 100 ug lrh iv serpl-acnc,lutropin 15 min post 100 ug luteinizing releasing hormone iv qn,15m p 100 ug lrh iv; after; arbitrary concentration; chemistry.challenge testing; endocrine; endocrinology; horm; icsh; interstitial cell-stimulating hormone; interstitual cell stimulating hormone; leutinizing hormone; lh; luteinizing hormone; lutenin; lutenizing hormone; mcg; ovulation test; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
47691-1,lysine/amino acids.total in cerebral spinal fluid,lysine sfr csf,lysine/total aa (csf) [molar fraction],"2,6-diaminohexanoic acid; aa; acd; acid; amino acid; amino acids.total; cerebral spinal fluid; cerebrospinal fl; chemistry; lys; percent; point in time; qnt; quan; quant; quantitative; random; spinal fl; spinal fld; spinal flu; spinal fluid; substance fraction; tot; totl",Qn
477-0,sulfonamide [susceptibility] by disk diffusion (kb),sulfonamide islt kb,sulfonamide disk diffusion (kb) [susc],antibiotic susceptibilities; ast; c75; disk diffusion; id; infectious disease; infectiousdisease; islt; isol; kb; kirby-bauer; point in time; random; sulf; sulfa; sulfas; sulfonamides; sus; suscept; susceptibilities; susceptibility; susceptibilty,OrdQn
47702-6,methionine/amino acids.total in cerebral spinal fluid,methionine sfr csf,methionine/total aa (csf) [molar fraction],aa; acd; acid; amino acid; amino acids.total; cerebral spinal fluid; cerebrospinal fl; chemistry; met; percent; point in time; qnt; quan; quant; quantitative; random; spinal fl; spinal fld; spinal flu; spinal fluid; substance fraction; tot; totl,Qn
47756-2,somatotropin [units/volume] in serum or plasma --15 minutes pre dose arginine,gh 15m pre arg serpl-acnc,somatotropin 15 min pre dose arginine qn,15m pre arg; arbitrary concentration; arg; before; chemistry.challenge testing; endocrine; endocrinology; gh; growth hormone; hgh; human growth hormone; pl; plasma; plsm; point in time; pre arg; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; somatotropic hormone; sr; sth,Qn
47761-2,somatotropin [units/volume] in serum or plasma --1 hour post dose glucose po,gh 1h p glc po serpl-acnc,somatotropin 1 hr post dose glucose po qn,1 hour; 1.0hr; 1h p glc; 1h p glc po; 60 min; 60 minutes; 60m; 60min; after; arbitrary concentration; chemistry.challenge testing; endocrine; endocrinology; gh; glu; glu tol; gluc; glucose tolerance; glucoseur; growth hormone; gtt; hgh; human growth hormone; p dose; p glc; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; somatotropic hormone; sr; sth,Qn
47763-8,somatotropin [units/volume] in serum or plasma --1st specimen post xxx challenge,gh sp1 p chal serpl-acnc,somatotropin 1st specimen post unsp challenge qn,acute specimen; after; arbitrary concentration; chemistry.challenge testing; endocrine; endocrinology; first; gh; growth hormone; hgh; human growth hormone; p chal; pl; plasma; plsm; point in time; pre immunization; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; somatotropic hormone; sp1; sp1 p chal; spec; sr; sth,Qn
47771-1,somatotropin [units/volume] in serum or plasma --3 hours post dose glucose po,gh 3h p glc po serpl-acnc,somatotropin 3 hr post dose glucose po qn,3h p glc; 3h p glc po; after; arbitrary concentration; chemistry.challenge testing; endocrine; endocrinology; gh; glu; glu tol; gluc; glucose tolerance; glucoseur; growth hormone; gtt; hgh; human growth hormone; p dose; p glc; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; somatotropic hormone; sr; sth,Qn
47776-0,somatotropin [units/volume] in serum or plasma --pre dose glucose po,gh pre glc po serpl-acnc,somatotropin pre dose glucose po qn,arbitrary concentration; before; chemistry.challenge testing; endocrine; endocrinology; gh; glu; glu tol; gluc; glucose tolerance; glucoseur; growth hormone; gtt; hgh; human growth hormone; pl; plasma; plsm; point in time; pre glc; pre glc po; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; somatotropic hormone; sr; sth,Qn
47782-8,taurine [moles/volume] in dbs,taurine dbs-scnc,taurine (dbs) [moles/vol],blood; chemistry; dbs; dried blood spot; filter paper; fp; level; point in time; qnt; quan; quant; quantitative; random; substance concentration; tau; wb; whole blood,Qn
47785-1,threonine/amino acids.total in hair,threonine sfr hair,threonine/total aa (hair) [molar fraction],aa; acd; acid; amino acid; amino acids.total; chemistry; har; percent; point in time; qnt; quan; quant; quantitative; random; substance fraction; thr; tot; totl,Qn
47787-7,threonine/amino acids.total in amniotic fluid,threonine sfr amn,threonine/total aa (amn fld) [molar fraction],aa; acd; acid; af; amino acid; amino acids.total; amn; amn fl; amnio; amniotic flu; amniotic fluid; chemistry; percent; point in time; qnt; quan; quant; quantitative; random; substance fraction; thr; tot; totl,Qn
47794-3,tyrosine/amino acids.total in amniotic fluid,tyrosine sfr amn,tyrosine/total aa (amn fld) [molar fraction],aa; acd; acid; af; amino acid; amino acids.total; amn; amn fl; amnio; amniotic flu; amniotic fluid; chemistry; percent; point in time; qnt; quan; quant; quantitative; random; substance fraction; tot; totl; tyr,Qn
47800-8,valine/amino acids.total in hair,valine sfr hair,valine/total aa (hair) [molar fraction],aa; acd; acid; amino acid; amino acids.total; chemistry; har; percent; point in time; qnt; quan; quant; quantitative; random; substance fraction; tot; totl; val,Qn
47803-2,valine/amino acids.total in serum or plasma,valine sfr serpl,valine/total aa [molar fraction],aa; acd; acid; amino acid; amino acids.total; chemistry; percent; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; substance fraction; tot; totl; val,Qn
47806-5,xylose [presence] in urine,xylose ur ql,xylose ql (u),chemistry; d-xylose; ordinal; point in time; pr; ql; qual; qualitative; random; screen; ua; ur; urn,Ord
47810-7,2-methyl-3-hydroxyvalerate [moles/volume] in plasma,2-me3oh-valerate plas-scnc,2-methyl-3-hydroxyvalerate (p) [moles/vol],2-me3oh-valerate; 3-hydroxypentanoiate; 3-hydroxypentanoic acid; 3-hydroxy-valerate; 3-hydroxyvaleric acid; 3oh-valerate; chemistry; ii; iii; level; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; substance concentration,Qn
47828-9,adiponectin [mass/volume] in serum or plasma,adiponectin serpl-mcnc,adiponectin [mass/vol],chemistry; level; mass concentration; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
4783-7,hla-b64(14) [presence],hla-b64(14) ql,hla-b64(14) ql (bld/tiss),"blood; genetics; heredity; heritable; hla antigen; human leukocyte antigen; inherited; ordinal; point in time; pr; ql; qual; qualitative; random; screen; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",Ord
47839-6,deprecated carnitine acyltransferase ii [enzymatic activity/mass] in leukocytes,deprecated carnitine acyltransferase ii,carnitine acyltransferase ii (wbc) [catalytic activity/mass],2; carnitine act; carnitine acyl transferase; carnitine palmitoyl transerase; carnitine palmitoyltranserase; carnitine.total; catalytic content; chemistry; leukocytes; point in time; qnt; quan; quant; quantitative; random; wbcs; white blood cells,Qn
47846-1,cortisol [mass/volume] in serum or plasma --post 2 mg dexamethasone po 2.5 day high dose q6h,cortis p 2 mg dex high serpl-mcnc,cortisol post 2 mg dexamethasone po 2.5 day high dose q6h [mass/vol],17-hydroxycorticosterone; after; c350; chemistry.challenge testing; compound f; coritsol; cort; decadron; dexameth; dexone; f; hexadrol; hi dose; hydrocortisone; ii; level; mass concentration; p 2 mg dex high; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
47856-0,follitropin [units/volume] in serum or plasma --pre 100 ug luteinizing releasing hormone iv,fsh pre 100 ug lrh iv serpl-acnc,follitropin pre 100 ug luteinizing releasing hormone iv qn,arbitrary concentration; before; chemistry.challenge testing; follicle stimulating hormone; fsh; horm; mcg; pl; plasma; plsm; point in time; pre 100 ug lrh iv; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
47857-8,galactitol/creatinine [molar ratio] in urine,galactitol/creat ur-srto,galactitol/creatinine (u) [molar ratio],chemistry; cr; crea; creat; point in time; qnt; quan; quant; quantitative; random; scrto; substance concentration ratio; substance ratio; ua; ucr; ur; urn,Qn
47860-2,glutamate dehydrogenase [enzymatic activity/mass] in chorionic villus sample,gldh cvs-ccnt,glutamate dehydrogenase (cvs) [catalytic activity/mass],c707; catalytic content; chemistry; chorionic villi; chorionic villus sample; dehydrog; dehyrdogenase; gdh; gld; gldh; glu; glutamate oxidase; glutamic acid; gmd; point in time; qnt; quan; quant; quantitative; random,Qn
47877-6,propionyl coa carboxylase [enzymatic activity/mass] in chorionic villus sample,pcca cvs-ccnt,propionyl coa carboxylase (cvs) [catalytic activity/mass],catalytic content; chemistry; chorionic villi; chorionic villus sample; pcca; point in time; qnt; quan; quant; quantitative; random,Qn
47887-5,somatotropin [units/volume] in serum or plasma --1.5 hours post dose ornithine,gh 1.5h p orn serpl-acnc,somatotropin 1.5 hr post dose ornithine qn,1 1/2 hours; 1 1/2 hr; 1.5h p orn; 1.5hr; 90 min; 90 minutes; 90m; 90min; after; arbitrary concentration; chemistry.challenge testing; endocrine; endocrinology; gh; growth hormone; hgh; human growth hormone; orn; p dose; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; somatotropic hormone; sr; sth,Qn
47889-1,somatotropin [units/volume] in serum or plasma --1.75 hours post dose ornithine,gh 1.75h p orn serpl-acnc,somatotropin 1.75 hr post dose ornithine qn,1.75 hours; 1.75 hr; 1.75h p orn; 105 min; 105 minutes; 105min; after; arbitrary concentration; chemistry.challenge testing; endocrine; endocrinology; gh; growth hormone; hgh; human growth hormone; orn; p dose; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; somatotropic hormone; sr; sth,Qn
47896-6,somatotropin [units/volume] in serum or plasma --1 hour post dose propranolol+glucagon,gh 1h p propranolol+gc serpl-acnc,somatotropin 1 hr post dose propranolol+glucagon qn,1 hour; 1.0hr; 1h p propranolol+gc; 60 min; 60 minutes; 60m; 60min; after; arbitrary concentration; chemistry.challenge testing; endocrine; endocrinology; gh; growth hormone; hgf; hgh; human growth hormone; hyperglycemic factor; inderal; p dose; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; somatotropic hormone; sr; sth,Qn
47913-9,somatotropin [units/volume] in serum or plasma --30 minutes post dose ornithine,gh 30m p orn serpl-acnc,somatotropin 30 min post dose ornithine qn,30m p orn; after; arbitrary concentration; chemistry.challenge testing; endocrine; endocrinology; gh; growth hormone; hgh; human growth hormone; orn; p dose; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; somatotropic hormone; sr; sth,Qn
47921-2,somatotropin [units/volume] in serum or plasma --45 minutes post dose growth hormone releasing factor,gh 45m p grf serpl-acnc,somatotropin 45 min post dose growth hormone releasing factor qn,45m p grf; after; arbitrary concentration; chemistry.challenge testing; endocrine; endocrinology; fac; fact; gh; growth hormone; hgh; horm; human growth hormone; p dose; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; somatotropic hormone; sr; sth,Qn
47924-6,somatotropin [units/volume] in serum or plasma --5 minutes post dose arginine,gh 5m p arg serpl-acnc,somatotropin 5 min post dose arginine qn,5m p arg; 5m p dose; after; arbitrary concentration; arg; chemistry.challenge testing; endocrine; endocrinology; gh; growth hormone; hgh; human growth hormone; p dose; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; somatotropic hormone; sr; sth,Qn
47932-9,somatotropin [units/volume] in serum or plasma --9th specimen post xxx challenge,gh sp9 p chal serpl-acnc,somatotropin 9th specimen post unsp challenge qn,after; arbitrary concentration; chemistry.challenge testing; endocrine; endocrinology; gh; growth hormone; hgh; human growth hormone; p chal; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; somatotropic hormone; sp9; sp9 p chal; spec; sr; sth,Qn
47946-9,testosterone [mass/volume] in serum or plasma --pre dose corticotropin,testost pre acth serpl-mcnc,testosterone pre dose corticotropin [mass/vol],acth; adrenocorticotrophic hormone; adrenocorticotropin; before; c206; c74; chemistry.challenge testing; cortrosyn; level; mass concentration; pl; plasma; plsm; point in time; pre acth; qnt; quan; quant; quantitative; random; rc206; serp; serpl; serplas; serum; serum or plasma; sr; testo; testos; testost; tumor marker,Qn
47957-6,deoxyuridine [moles/volume] in serum or plasma,deoxyuridine serpl-scnc,deoxyuridine [moles/vol],chemistry; du; level; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; substance concentration,Qn
4796-9,hla-b73 [presence] in donor,hla-b73 donr ql,hla-b73 ql (bld/tiss donor),"blood; donr; genetics; heredity; heritable; hla antigen; human leukocyte antigen; inherited; ordinal; point in time; pr; ql; qual; qualitative; random; screen; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",Ord
47981-6,phenylalanine/creatinine [ratio] in 24 hour urine,phe/creat 24h ur-rto,phenylalanine/creatinine (24h u) [ratio],1 day; 24 hours; 24hr; chemistry; cr; crea; creat; phe; ppa; qnt; quan; quant; quantitative; ratios; rto; ua; ucr; ur; urn,Qn
47989-9,progesterone [moles/volume] in serum or plasma --7th specimen post xxx challenge,progest sp7 p chal serpl-scnc,progesterone 7th specimen post unsp challenge [moles/vol],^7th spec pst xxx chal; after; chemistry.challenge testing; level; p chal; p4; pl; plasma; plsm; point in time; prog; proges; progest; progestin; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sp7; sp7 p chal; spec; sr; substance concentration,Qn
47996-4,adenosine deaminase binding protein [units/volume] in urine,adenosine deaminase bp ur-acnc,adenosine deaminase binding protein qn (u),abp; ada; adabp; adenosine deaminase bp; ado; aned; arbitrary concentration; bind; chemistry; medication stress; point in time; pr; prot; qnt; quan; quant; quantitative; random; ua; ur; urn,Qn
48005-3,amino acid change (phgvs),amino acid change,amino acid change molgen nom (bld/tiss),"acd; acids; blood; exchange; finding; findings; genetic; genetics; genomic; hl7.genetics; molecular genetics; molpath.general; nominal; pcr; point in time; random; replace; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",Nom
48006-1,amino acid change [type],amino acid change type,amino acid change type molgen nom (bld/tiss),"acd; acids; blood; exchange; genetic; genetics; genomic; hl7.genetics; molecular genetics; molpath.general; nominal; pcr; point in time; random; replace; tissue; tissue, unspecified; typ; wb; whole blood; whole blood or tissue",Nom
48009-5,genechip manufacturer id [identifier] in blood or tissue by molecular genetics method,genechip manufacturer id bld/t,genechip manufacturer id molgen nom (bld/tiss) [id],"blood; ident; identifier; intradermal; misc; miscellaneous molecular pathology; molecular genetics; molecular pathology; molpath; nominal; pcr; point in time; random; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",Nom
48010-3,genechip id [identifier] in blood or tissue by molecular genetics method,genechip id bld/t,genechip id molgen nom (bld/tiss) [id],"blood; ident; identifier; intradermal; misc; miscellaneous molecular pathology; molecular genetics; molecular pathology; molpath; nominal; pcr; point in time; random; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",Nom
48020-2,forward primer [nucleotide sequence] in blood or tissue by molecular genetics method nominal,forward primer seq bld/t,forward primer molgen nom (bld/tiss),"blood; misc; miscellaneous molecular pathology; molecular genetics; molecular pathology; molpath; nominal; pcr; point in time; random; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",Nom
48021-0,reverse primer [nucleotide sequence] in blood or tissue by molecular genetics method nominal,reverse primer seq bld/t,reverse primer molgen nom (bld/tiss),"blood; misc; miscellaneous molecular pathology; molecular genetics; molecular pathology; molpath; nominal; pcr; point in time; random; rev; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",Nom
48031-9,sca10 gene cag repeats [presence] in blood or tissue by molecular genetics method,sca10 gene cag rpt bld/t ql,sca10 gene cag repeats molgen ql (bld/tiss),"blood; e46l; genetics; heredity; heritable; humeep; inherited; molecular genetics; molecular pathology; molpath; molpath.nucrepeat; ordinal; pcr; point in time; pr; ql; qual; qualitative; random; repeat; sca10; sca10 gene cag rpt; screen; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",Ord
48043-4,oxyphenisatin cutoff [mass/mass] in stool,oxyphenisatin cto stl-mcnt,oxyphenisatin cutoff (stl) [mass/mass],bowel movement; cto; drug/toxicology; drugs; faecal; faeces; fecal; feces; mass content; point in time; qnt; quan; quant; quantitative; random; stl; stool = fecal,Qn
48061-6,giardia lamblia+cryptosporidium sp ag [presence] in stool by immunofluorescence,g lamblia+cryptosp ag stl ql if,g. lamblia+cryptosporidium sp ag if ql (stl),acif; anticomplement immunofluorescence; antigen; antigens; beaver fever; bowel movement; crypt; crypto; cryptosporidiosis; dfa; fa; faecal; faeces; fecal; feces; fluorescent antibody; fluoresent; g duodenalis; g intestinalis; g lamblia; g lamblia+cryptosp; g lamblia+cryptosp ag; giardiasis; id; ifa; immune fluorescence; immunoflour; immunofluor; immunofluorescence; infectious disease; infectiousdisease; lamblia intestinalis; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; screen; species; spp; stl; stool = fecal; time resolved fluorescence; trf,Ord
48063-2,giardia lamblia+cryptosporidium parvum ag [presence] in stool by immunoassay,g lamblia+c parvum ag stl ql ia,g. lamblia+cryptosporidium parvum ag ia ql (stl),antigen; antigens; beaver fever; bowel movement; c parvum; crypt; crypto; cryptosporidiosis; eia; elfa; elisa; enzyme immunoassay; faecal; faeces; fecal; feces; g duodenalis; g intestinalis; g lamblia; g lamblia+c parvum; g lamblia+c parvum ag; giardiasis; iaa; id; infectious disease; infectiousdisease; lamblia intestinalis; meia; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; screen; stl; stool = fecal; suds,Ord
4806-6,hla-b13 [presence] in donor,hla-b13 donr ql,hla-b13 ql (bld/tiss donor),"blood; donr; genetics; heredity; heritable; hla antigen; human leukocyte antigen; inherited; ordinal; point in time; pr; ql; qual; qualitative; random; screen; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",Ord
4807-4,hla-b13 [presence],hla-b13 ql,hla-b13 ql (bld/tiss),"blood; genetics; heredity; heritable; hla antigen; human leukocyte antigen; inherited; ordinal; point in time; pr; ql; qual; qualitative; random; screen; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",Ord
48079-8,"3,6-epoxydodecanedioate/creatinine [molar ratio] in urine","3,6-epoxydodecanedioate/creat ur-srto","3,6-epoxydodecanedioate/creatinine (u) [molar ratio]","3,6-epoxydodecanedioic acid; chemistry; cr; crea; creat; iii; point in time; qnt; quan; quant; quantitative; random; scrto; substance concentration ratio; substance ratio; ua; ucr; ur; urn",Qn
48102-8,cortisol [mass/volume] in serum or plasma --4 am specimen,cortis 4 am specimen serpl-mcnc,cortisol 4 am specimen [mass/vol],17-hydroxycorticosterone; chemistry.challenge testing; compound f; coritsol; cort; f; hydrocortisone; level; mass concentration; morning; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; spec; sr,Qn
48107-7,erythritol/creatinine [molar ratio] in urine,erythritol/creat ur-srto,erythritol/creatinine (u) [molar ratio],cr; crea; creat; drug/toxicology; drugs; point in time; qnt; quan; quant; quantitative; random; scrto; substance concentration ratio; substance ratio; ua; ucr; ur; urn,Qn
48111-9,glutathione.reduced [moles/mass] in red blood cells,gsh rbc-scnt,glutathione.reduced (rbc) [moles/mass],chemistry; erythrocytes; gsh; point in time; qnt; quan; quant; quantitative; random; red blood cells; red blood corpusles; substance content,Qn
481-2,talampicillin [susceptibility] by disk diffusion (kb),talampicillin islt kb,talampicillin disk diffusion (kb) [susc],antibiotic susceptibilities; ast; disk diffusion; fisiopen; id; infectious disease; infectiousdisease; islt; isol; kb; kirby-bauer; point in time; random; sus; suscept; susceptibilities; susceptibility; susceptibilty; talpen; ticillina,OrdQn
48122-6,somatotropin [units/volume] in serum or plasma --15 minutes post dose trh,gh 15m p trh serpl-acnc,somatotropin 15 min post dose trh qn,15m p trh; after; arbitrary concentration; chemistry.challenge testing; endocrine; endocrinology; gh; growth hormone; hgh; human growth hormone; p dose; p trh; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; somatotropic hormone; sr; sth,Qn
4813-2,hla-b16 [presence],hla-b16 ql,hla-b16 ql (bld/tiss),"blood; genetics; heredity; heritable; hla antigen; human leukocyte antigen; inherited; ordinal; point in time; pr; ql; qual; qualitative; random; screen; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",Ord
48140-8,erythro-4-deoxytetronate/creatinine [molar ratio] in urine,erythro-4-deoxytetronate/creat ur-srto,erythro-4-deoxytetronate/creatinine (u) [molar ratio],chemistry; cr; crea; creat; erythro-4-deoxytetronic acid; point in time; qnt; quan; quant; quantitative; random; scrto; substance concentration ratio; substance ratio; ua; ucr; ur; urn,Qn
48148-1,osmolality of urine by calculated by sum of electrolytes,osmolality ur calc.sum of elec,osmolality calculated by sum of electrolytes (u) [osmolality],calc; calc.sum of elec; calculation; chemistry; kidney; nephrology; osmo; osmolality; point in time; qnt; quan; quant; quantitative; random; renal; ua; ur; urn,Qn
48164-8,enolase.neuron specific [mass/volume] in body fluid,nse fld-mcnc,enolase.neuron specific (body fld) [mass/vol],"b/f; bf; bod; bodies; body fluid; body fluid, unsp; chemistry; eno2; enolase 2; fl; fld; flu; fluid; gamma-enolase; level; mass concentration; nse; phosphopyruvate dehydratase; phosphopyruvate hydratase.gamma subunit; point in time; qnt; quan; quant; quantitative; random; spec; tumor marker",Qn
48178-8,reference change value 0.99 [#] in unspecified time population,rcv 0.99 ?tm pop,reference change value 0.99 unsp time (population) [#],?tm; cnt; count; exchange; nr stats; number; qnt; quan; quant; quantitative; rcv 0.99; replace,Qn
48188-7,latex triggered leukotriene release [mass/volume] by leukocytes,ltx lr-mcnc,latex triggered leukotriene release (wbc) [mass/vol],allergen; allergens; allergy testing; cast; hevea braziliensis; k082; k82; leukocytes; level; lr; ltx; mass concentration; point in time; qnt; quan; quant; quantitative; random; wbcs; white blood cells,Qn
4821-5,hla-b27 [presence],hla-b27 ql,hla-b27 ql (bld/tiss),"blood; genetics; heredity; heritable; hla antigen; human leukocyte antigen; inherited; ordinal; point in time; pr; ql; qual; qualitative; random; screen; tissue; tissue, unspecified; universallaborders; wb; whole blood; whole blood or tissue",Ord
48225-7,cow milk triggered leukotriene release [mass/volume] by leukocytes,cow milk lr-mcnc,cow milk triggered leukotriene release (wbc) [mass/vol],allergen; allergens; allergy testing; cast; f002; f2; f43; leukocytes; level; lr; mass concentration; point in time; qnt; quan; quant; quantitative; random; wbcs; white blood cells,Qn
48227-3,human serum albumin triggered leukotriene release [mass/volume] by leukocytes,has lr-mcnc,human serum albumin triggered leukotriene release (wbc) [mass/vol],alb; allergen; allergens; allergy testing; cast; has; leukocytes; level; lr; mass concentration; point in time; protein.albumin; qnt; quan; quant; quantitative; random; ser; sr; wbcs; white blood cells,Qn
48232-3,tyrophagus putrescentiae triggered leukotriene release [mass/volume] by leukocytes,t putrescentiae lr-mcnc,tyrophagus putrescentiae triggered leukotriene release (wbc) [mass/vol],allergen; allergens; allergy testing; cast; d72; leukocytes; level; lr; mass concentration; mite; point in time; qnt; quan; quant; quantitative; random; storage mite; t putrescentiae; wbcs; white blood cells,Qn
48242-2,cladosporium herbarum triggered leukotriene release [mass/volume] by leukocytes,c herbarum lr-mcnc,c. herbarum triggered leukotriene release (wbc) [mass/vol],allergen; allergens; allergy testing; c herbarum; cast; hormodendrum; leukocytes; level; lr; m002; m2; mass concentration; point in time; qnt; quan; quant; quantitative; random; wbcs; white blood cells,Qn
48247-1,white oak triggered leukotriene release [mass/volume] by leukocytes,white oak lr-mcnc,white oak triggered leukotriene release (wbc) [mass/vol],allergen; allergens; allergy testing; cast; leukocytes; level; lr; mass concentration; oak; point in time; qnt; quan; quant; quantitative; random; t007; t7; wbcs; white blood cells; white oak,Qn
4824-9,hla-b37 [presence] in donor,hla-b37 donr ql,hla-b37 ql (bld/tiss donor),"blood; donr; genetics; heredity; heritable; hla antigen; human leukocyte antigen; inherited; ordinal; point in time; pr; ql; qual; qualitative; random; screen; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",Ord
48249-7,silver birch triggered leukotriene release [mass/volume] by leukocytes,silver birch lr-mcnc,silver birch triggered leukotriene release (wbc) [mass/vol],allergen; allergens; allergy testing; cast; common silver birch; ifr; isoflavone reductase; leukocytes; level; lr; mass concentration; point in time; qnt; quan; quant; quantitative; random; silver birch; t3; wbcs; white blood cells,Qn
48274-5,diclofenac triggered leukotriene release [mass/volume] by leukocytes,diclofenac lr-mcnc,diclofenac triggered leukotriene release (wbc) [mass/vol],allergen; allergens; allergy testing; c215; c281; c52; cambia; cast; leukocytes; level; lr; mass concentration; point in time; qnt; quan; quant; quantitative; random; voltaren optha; voltaren opthalmic; wbcs; white blood cells,Qn
48283-6,mivacurium triggered leukotriene release [mass/volume] by leukocytes,mivacurium lr-mcnc,mivacurium triggered leukotriene release (wbc) [mass/vol],allergen; allergens; allergy testing; cast; cmiv; leukocytes; level; lr; mass concentration; mivacron; point in time; qnt; quan; quant; quantitative; random; wbcs; white blood cells,Qn
48303-2,brilliant black bn triggered leukotriene release [mass/volume] by leukocytes,brilliant black bn lr-mcnc,brilliant black bn triggered leukotriene release (wbc) [mass/vol],allergen; allergens; allergy testing; cast; leukocytes; level; lr; mass concentration; point in time; qnt; quan; quant; quantitative; random; wbcs; white blood cells,Qn
4830-6,hla-b40 [presence] in donor,hla-b40 donr ql,hla-b40 ql (bld/tiss donor),"blood; donr; genetics; heredity; heritable; hla antigen; human leukocyte antigen; inherited; ordinal; point in time; pr; ql; qual; qualitative; random; screen; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",Ord
48318-0,deprecated cat hair + cat dander ige ab rast class in serum,deprecated cat hair+epith ige rast ql,cat hair+cat epithelium ige rast class (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; epithelia; feline; felis domesticus; ige rast; immune globulin e; immunoglobulin e; ordinal; point in time; ql; qual; qualitative; random; screen; serum; sr,Ord
48321-4,tolbutamide [presence] in specimen,tolbutamide spec ql,tolbutamide ql (specimen),drug/toxicology; drugs; misc; miscellaneous; novo-butamide; ordinal; orinase; other; point in time; pr; ql; qual; qualitative; random; screen; spec; to be specified in another part of the message; unspecified,Ord
48326-3,glipizide [presence] in serum or plasma,glipizide serpl ql,glipizide ql,drug/toxicology; drugs; glucotrol; ordinal; pl; plasma; plsm; point in time; pr; ql; qual; qualitative; random; screen; serp; serpl; serplas; serum; serum or plasma; sr,Ord
48327-1,glyburide [presence] in serum or plasma,glyburide serpl ql,glyburide ql,diabeta; drug/toxicology; drugs; glynase; micronase; ordinal; pl; plasma; plsm; point in time; pr; ql; qual; qualitative; random; screen; serp; serpl; serplas; serum; serum or plasma; sr,Ord
48329-7,chlorpropamide [presence] in serum or plasma,chlorpropamide serpl ql,chlorpropamide ql,diabinese; drug/toxicology; drugs; ordinal; pl; plasma; plsm; point in time; pr; ql; qual; qualitative; random; screen; serp; serpl; serplas; serum; serum or plasma; sr,Ord
48334-7,1 minute apgar panel,1m apgar pnl,,after; apgar pnl; gyn; gynecology; neonat; ob; obgyn; obstetrics; p birth; pan; panel.neonat; panl; pnl; point in time; pst; random,-
48337-0,deprecated cryptococcus neoformans ag [presence] in tissue by immune stain,deprecated c neoform ag tiss ql imstn,c. neoformans ag immune stain ql (tiss),"antigen; antigens; arbitrary concentration; c neoform; c neoformans; crypt; crypto; cryptococcal; cryptococcosis; cryptococcosus; id; ihc; imm; immunohistochemical stain; immunostain; imstn; imun; imune; infectious disease; infectiousdisease; microbiology; ordinal; point in time; ql; qual; qualitative; random; screen; st; stains; stn; tissue; tissue, unspecified",Ord
4835-5,hla-b45(12) [presence],hla-b45(12) ql,hla-b45(12) ql (bld/tiss),"blood; genetics; heredity; heritable; hla antigen; human leukocyte antigen; inherited; ordinal; point in time; pr; ql; qual; qualitative; random; screen; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",Ord
48370-1,dihomogammalinolenate (c20:3n-6) [moles/volume] in serum or plasma,dihomogammalinolenate serpl-scnc,dihomogammalinolenate (c20:3n-6) [moles/vol],chemistry; level; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; substance concentration,Qn
48373-5,spermatozoa angled midpiece/spermatozoa in semen,sperm.angled midpiece nfr smn,spermatozoa angled midpiece/spermatozoa (sem),ejaculate; fertility testing; genitourinary; gu; number fraction; percent; point in time; qnt; quan; quant; quantitative; random; sem; seminal fluid; smn; smpls; sperm; sperm.angled midpiece; uro; urology,Qn
483-8,teicoplanin [susceptibility] by minimum lethal concentration (mlc),teicoplanin islt mlc,teicoplanin mlc [susc],antibiotic susceptibilities; ast; id; infectious disease; infectiousdisease; islt; isol; mbc; minimum bactericidal concentration; minimum lethal concentration; point in time; qnt; quan; quant; quantitative; random; sus; suscept; susceptibilities; susceptibility; susceptibilty; targocid; targosid; teichomycin; teicomid,Qn
48403-0,methadone+metabolite [mass/volume] in serum or plasma,methadone+metab serpl-mcnc,methadone+metabolite [mass/vol],addiction; dolophin; dolophine; drug/toxicology; drugs; drugs of abuse; illicit; level; mass concentration; metab; metabolites; metb; metd; methadose; mtd; pl; plasma; plsm; point in time; potentialforabuse; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
48406-3,parietal cell igg ab [titer] in serum,pca igg titr ser,parietal cell igg (s) [titer],abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; dilution factor; dilution factor (titer); gastro; gastroenterology; gi; hematology; heme; immune globulin g; immunoglobulin g; pca; point in time; random; serology; serum; smqn; sr; titer; titered; titre; ttr,SemiQn
48412-1,zygomycete sp ag [presence] in tissue by immune stain,zygomycete ag tiss ql imstn,zygomycete sp ag immune stain ql (tiss),"antigen; antigens; id; ihc; imm; immunohistochemical stain; immunostain; imstn; imun; imune; infectious disease; infectiousdisease; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; screen; species; spp; st; stains; stn; tissue; tissue, unspecified; zygomycota; zygote fungi",Ord
48420-4,complement c3c [mass/volume] in body fluid,c3c fld-mcnc,complement c3c (body fld) [mass/vol],"b/f; bf; bod; bodies; body fluid; body fluid, unsp; comp; complmt; fl; fld; flu; fluid; hematology/cell counts; level; mass concentration; point in time; qnt; quan; quant; quantitative; random",Qn
48428-7,rumenate (c18:2 cis-9 trans-11) [moles/volume] in serum or plasma,rumenate serpl-scnc,rumenate (c18:2 cis-9 trans-11) [moles/vol],"9,11-isolinoleate; 9,11-isolinoleic acid; 9,11-linoleate; 9,11-linoleic acid; 9,11-octadecadienoate; 9,11-octadecadienoic acid; c18:2 cis-9 trans-11 fatty acid; chemistry; cis-9, trans-11 18:2 acid; level; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; rumenic acid; serp; serpl; serplas; serum; serum or plasma; sr; substance concentration",Qn
48442-8,ct spine wo and w contrast it,ct spine wo+w contr it,,c; cat scan; computed tomography; computerized tomography; contr; contra; contrst; ct scan; document; finding; findings; imaging; intrathecal; misc; miscellaneous; myelogram; other; point in time; rad; radiology; random; spec; spinal; spinal cord; to be specified in another part of the message; unspecified; w contr it; wc; wo & wc; wo+w contr; wo+w contr it; wwo,Doc
48473-3,xr spine lumbar and sacrum 4 views,xr l-spine+sacrum 4v,,4v; 4vw; abd; abdo; abdomen+; abdominal; document; films; finding; findings; imaging; l/sp; l-spine; l-spine+sacrum; lumbar; lumbo; lumbosacral; pelvic; pelvis+l-spine; plain films; point in time; rad; radiology; random; spinal; spinal cord; view; vws; xray; x-ray,Doc
4848-8,hla-cw11 [presence] in donor,hla-cw11 donr ql,hla-cw11 ql (bld/tiss donor),"blood; donr; genetics; heredity; heritable; hla antigen; human leukocyte antigen; inherited; ordinal; point in time; pr; ql; qual; qualitative; random; screen; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",Ord
48503-7,platelet glycoprotein ib/ix igg ab [presence] in blood by immunoassay,plat gp ib/ix igg bld ql ia,platelet glycoprotein ib/ix igg ia ql (bld),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; blood; eia; elfa; elisa; enzyme immunoassay; gg; glycoprot; glycoproteins; gp; iaa; immune globulin g; immunoglobulin g; meia; ordinal; pl; plat gp; plat gp ib/ix; platelets; platelt; plt; point in time; pr; ql; qual; qualitative; random; screen; serology; suds; thrombocyte; thrombocytes; wb; whole blood,Ord
48519-3,are you afraid that something bad is going to happen to you [gds],,,finding; findings; gds survey; geriatric depression scale; ordinal; point in time; ql; qual; qualitative; random; screen; survey,Ord
48520-1,do you feel happy most of the time [gds],,,finding; findings; gds survey; geriatric depression scale; ordinal; point in time; ql; qual; qualitative; random; screen; survey,Ord
48540-9,is it easy for you to make decisions [gds],,,finding; findings; gds survey; geriatric depression scale; ordinal; point in time; ql; qual; qualitative; random; screen; survey,Ord
48549-0,hiv-signs and symptoms checklist (ssc) panel,,,aids; hiv-signs and symptoms checklist (ssc) pnl; human immunodeficiency virus; pan; panel.survey.hiv-ssc; panl; pnl; point in time; random; survey; sx,-
48552-4,hiv 1 rna [log #/volume] (viral load) in serum or plasma by probe and target amplification method detection limit = 2.6 log copies/ml,hiv1 rna serpl naa dl=2.6-log#,hiv 1 rna naa+probe dl = 2.6 log copies/ml [log #/vol],3 self-sustaining sequence replication; 3sr sr; aids; amplif; amplification; amplified; dna nucleic acid probe; dna probe; hiv type 1; hiv type i; hiv1; human immunodeficiency virus; i; id; infectious disease; infectiousdisease; lat; lcr; ligase chain reaction; ligation-activated transcription; log ncnc; log#; microbiology; naa dl=2.6; naa+probe; naat; nasba; nucleic acid sequence based analysis; pcr; pl; plasma; plsm; point in time; polymerase chain reaction; probe amp; probe with ampification; probe with target amplification; qbr; qnt; quan; quant; quantitative; random; ribonucleic acid; sda; serp; serpl; serplas; serum; serum or plasma; sr; strand displacement amplification; tma; transcription mediated amplification; viral load,Qn
48553-2,muscle sarcolemma ab [units/volume] in pleural fluid,mus sarcolemma ab plr-acnc,muscle sarcolemma ab qn (pleur fld),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; mus sarcolemma; musc; muscl; pleural; pleural fluid; point in time; qnt; quan; quant; quantitative; random; serology; thoracentesis fluid,Qn
48559-9,deprecated hiv gentotype [susceptibility],deprecated hiv genotype islt genotyp,hiv genotype genotyping [susc],aids; antibiotic susceptibilities; ast; genotype; genotypic; gentyp; human immunodeficiency virus; id; infectious disease; infectiousdisease; islt; isol; nominal; point in time; random; sus; suscept; susceptibilities; susceptibility; susceptibilty,Nom
48565-6,bacteria # 6 identified in specimen by respiratory culture,bacteria spec resp cult org #6,bacteria identified # 6 respiratory culture nom (specimen),bact; c&s; cult; cultures; id; identity or presence; infectious disease; infectiousdisease; microbiology; misc; miscellaneous; nominal; other; point in time; random; resp cult; spec; to be specified in another part of the message; unspecified,Nom
4857-9,hla-cw4 [presence],hla-cw4 ql,hla-cw4 ql (bld/tiss),"blood; genetics; heredity; heritable; hla antigen; human leukocyte antigen; inherited; ordinal; point in time; pr; ql; qual; qualitative; random; screen; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",Ord
48579-7,deprecated hfe gene c.187c>g [presence] in blood or tissue by molecular genetics method,deprecated hfe c.187c>g bld/t ql,hfe gene c.187c>g molgen ql (bld/tiss),"arbitrary; blood; c187g; genetics; haemochromatosis; hemochromatosis; hereditary hemochromatosis; heredity; heritable; hfe c.187c&gt;g; hfe1; hh; his63asp; hlah; hla-h; inherited; molecular genetics; molecular pathology; molpath; molpath.mutations; mvcd7; ordinal; pcr; point in time; ql; qual; qualitative; random; rs1799945; screen; tfqtl2; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",Ord
48599-5,clcn1 gene targeted mutation analysis in blood or tissue by molecular genetics method,clcn1 gene mut anl bld/t,clcn1 gene targeted mutation analysis molgen doc (bld/tiss),"blood; chloride channel protein 1; chloride channel protein, skeletal muscle; chloride channel, voltage-sensitive 1; clc1; clc-1; document; finding; findings; genetics; heredity; heritable; inherited; molecular genetics; molecular pathology; molpath; molpath.mutations; mut; mut anl; mutations; pcr; point in time; random; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",Doc
48604-3,deprecated yellow dye ige ab rast class [presence] in serum,deprecated yellow dye ige rast ql,yellow dye ige rast class (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; ige rast; immune globulin e; immunoglobulin e; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; sr,Ord
48608-4,2-hydroxyvalerate/creatinine [mass ratio] in urine,2oh-valerate/creat ur,2-hydroxyvalerate/creatinine (u) [mass ratio],2oh-valerate; chemistry; cr; crea; creat; ii; mass concentration ratio; mass ratio; mcrto; point in time; qnt; quan; quant; quantitative; random; ua; ucr; ur; urn,Qn
48619-1,apolipoprotein e1 [presence] in blood,apo e1 bld ql,apolipoprotein e1 ql (bld),apo; apo e1; apolipo; apolipoprot; apolipoprotein e-i; apolipoproteins; blood; chemistry; ordinal; point in time; pr; ql; qual; qualitative; random; screen; wb; whole blood,Ord
48628-2,insulin-like growth factor binding protein 3 [presence] in urine,igf bp3 ur ql,insulin-like growth factor binding protein 3 ql (u),bind; chemistry; fac; fact; hum; humulin; igf; igf bp; igf bp3; igfbp; ih7; iii; insul; lente; nph; ordinal; point in time; pr; prot; ql; qual; qualitative; random; screen; semilente; sliding; ua; ultralente; ur; urn,Ord
48635-7,cholesterol in ldl pattern a [presence] in serum or plasma,ldlc a serpl ql,cholesterol in ldl pattern a ql,cardio; cardiology; chemistry; chol; choles; cholest; cholesterol total; cholesterols; heart disease; ldlc; ldl-c; ldlc a; lipid; low density lipoprotein cholesterol; low density lipoprotein cholesterols; ordinal; pl; plasma; plsm; point in time; pr; ql; qual; qualitative; random; screen; serp; serpl; serplas; serum; serum or plasma; sr,Ord
4864-5,hla-cw8 [presence] in donor,hla-cw8 donr ql,hla-cw8 ql (bld/tiss donor),"blood; donr; genetics; heredity; heritable; hla antigen; human leukocyte antigen; inherited; ordinal; point in time; pr; ql; qual; qualitative; random; screen; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",Ord
48647-2,ej ab [presence] in serum by radioimmunoprecipitation assay (ripa),ej ab ser ql ripa,ej ab ripa ql (s),"abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; cadm; clinically amyopathic dm; dermatomyositis, adult type; glycyl trna synthetase; ordinal; point in time; polymyositis, idiopathic; pr; ql; qual; qualitative; radioimmunoprecipitation assay; random; screen; serology; serum; sr",Ord
48654-8,corynebacterium diphtheriae toxin igg ab [units/volume] in serum by immunoassay,c diphtheriae tox igg ser ia-acnc,c. diphtheriae toxin igg ia qn (s),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; c diphtheriae; c diphtheriae tox; diphtheria; diptheria; eia; elfa; elisa; enzyme immunoassay; iaa; id; immune globulin g; immunoglobulin g; infectious disease; infectiousdisease; meia; microbiology; point in time; qnt; quan; quant; quantitative; random; serum; sr; suds,Qn
48655-5,corynebacterium diphtheriae toxin ab [units/volume] in serum by immunoassay --2nd specimen,c diphtheriae tox ab sp2 ser ia-acnc,c. diphtheriae toxin ab spec 2 ia qn (s),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; c diphtheriae; c diphtheriae tox; convalescent; diphtheria; diptheria; eia; elfa; elisa; enzyme immunoassay; iaa; id; infectious disease; infectiousdisease; meia; microbiology; point in time; post immunization; qnt; quan; quant; quantitative; random; second; serum; sp2; spec; sr; suds,Qn
48682-9,smooth muscle myosin heavy chain ag [presence] in tissue by immune stain,sm-mhc ag tiss ql imstn,smooth muscle myosin heavy chain ag immune stain ql (tiss),"antigen; antigens; chains; chn; ihc; imm; immunohistochemical stain; immunostain; imstn; imun; imune; musc; muscl; ordinal; pathology; point in time; pr; ql; qual; qualitative; random; screen; sm; sm-mhc; st; stains; stn; tissue; tissue, unspecified",Ord
48695-1,xr skull base single view,xr skull.base 1v,,1v; brain; cranial; cranium; document; film; finding; findings; head; imaging; intracranial; plain films; point in time; rad; radiology; random; single view; skull; vw; xray; x-ray,Doc
48700-9,thyrotropin releasing hormone [mass] of dose,thyrotropin releasing horm dose,trh (dose) [mass],dose med or substance; drug doses; endocrine; endocrinology; horm; point in time; qnt; quan; quant; quantitative; random; thyroid stimulating hormone; thyroliberin; thyrotropic hormone; trf; tsh,Qn
48716-5,la crosse virus igg ab [units/volume] in serum by immunoassay,lacv igg ser ia-acnc,la crosse virus igg ia qn (s),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; california encephalitis virus; eia; elfa; elisa; enzyme immunoassay; iaa; id; immune globulin g; immunoglobulin g; infectious disease; infectiousdisease; lacrosse virus; lacv; meia; microbiology; point in time; qnt; quan; quant; quantitative; random; serum; sr; suds,Qn
48729-8,cyba gene targeted mutation analysis in blood or tissue by molecular genetics method,cyba gene mut anl bld/t,cyba gene targeted mutation analysis molgen doc (bld/tiss),"blood; cytochrome b-245, alpha polypeptide; cytochrome b-245, alpha polypeptide gene; document; finding; findings; genetics; heredity; heritable; inherited; molecular genetics; molecular pathology; molpath; molpath.mutations; mut; mut anl; mutations; p22-phox; pcr; point in time; random; secondary cgd gene; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",Doc
48730-6,x linked heterotaxy [identifier] in blood or tissue by fish narrative,x linked heterotaxy bld/t fish,x linked heterotaxy fish nar (bld/tiss),"blood; fluorescent in situ hybridization; genetics; heredity; heritable; identity or presence; inherited; molecular pathology; molpath; narrative; point in time; random; report; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",Nar
48732-2,ncf1 gene mutations found [identifier] in blood or tissue by molecular genetics method nominal,ncf1 gene mut anl bld/t,ncf1 gene targeted mutation analysis molgen nom (bld/tiss),"blood; genetics; heredity; heritable; identity or presence; inherited; molecular genetics; molecular pathology; molpath; molpath.mutations; mut; mut anl; mutations; ncf-1; ncf1a; ncf-47k; neutrophil cytosolic factor 1; neutrophil cytosolic factor 1, (chronic granulomatous disease, autosomal 1); nominal; noxo2; p47phox; pcr; point in time; random; sh3pxd1a; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",Nom
48736-3,mg guidance for sentinel lymph node injection of breast - left,mg guided brst-l sentinel ln inj,,brst; brst-l; document; finding; findings; guid; guide; guided; imaging; inj; l; ln; lt; point in time; rad; radiology; random; sentinel ln inj,Doc
48742-1,us.doppler scrotum and testicle,dop scrotum+test,,document; dop; duplex; echography; finding; findings; genitourinary; gu; imaging; pelvic; point in time; radiology; random; scrotal; scrotal contents; sonogram; sonograph; sonography; testicular; testies; testis; uls; ultrasound; uro; urology,Doc
48745-4,deprecated mandible - left x-ray,deprecated mandible-l xr,,document; films; finding; findings; imaging; jaw; l; lt; mand; mandible-l; plain films; point in time; rad; radiology; random; view; vws; xray; x-ray,Doc
48746-2,xr sacroiliac joint - bilateral ge 3 views,xr sij-bl ge 3v,,bil; bilat; both; coreplaybook; document; films; finding; findings; ge 3v; iii; imaging; jnt; minimum 3 views; pelvic; plain films; playbook; point in time; rad; radiology; random; sac; si joint; si joints; sij; sij-bl; view; vws; xray; x-ray,Doc
48747-0,xr orbit - bilateral ge 4 views,xr orbit-bl ge 4v,,bil; bilat; both; brain; coreplaybook; cranial; cranium; document; eye socket; films; finding; findings; ge 4v; imaging; intracranial; minimum 4 views; orbital; orbit-bl; orbits; plain films; playbook; point in time; rad; radiology; random; skull; view; vws; xray; x-ray,Doc
48764-5,summary purpose ccd document,summary purpose ccd doc,,continuity of care document; doc.misc; document; finding; findings; misc; point in time; random,Doc
48776-9,kappa light chains.free/lambda light chains.free [mass ratio] in cerebral spinal fluid,kappa lc free/lambda free csf,immunoglobulin light chains.kappa.free/immunoglobulin light chains.lambda.free (csf) [mass ratio],bence jones protein; bj protein; bjp; cerebral spinal fluid; cerebrospinal fl; chain; chemistry; fr; immune globulin; immuno; immunoglob; immunoglobin; imunoglbon; imunoglobn; kappa lc; kappa lc free; lambda free; lambda lc; lambda lc free; mass concentration ratio; mass ratio; mcrto; non-protein bound; point in time; qnt; quan; quant; quantitative; random; spinal fl; spinal fld; spinal flu; spinal fluid,Qn
48789-2,creatinine peritoneal dialysis clearance/1.73 sq m,creat cl/1.73 sq m diafp+serpl-arvrat,creatinine pd clearance/1.73 sq m (pd fluid+s/p) [vol rate/area],bsa; chemistry; cl; cl2; clear; clearanc; clearances; clr; cr; crcl; crea; creat; diaf; diafp; diafp+serpl; dialy; dialysate; dialysis fluid; peritoneal dialysis fluid; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; square meter; sr; volume rate/area; volume rate/ratio,Qn
487-9,temafloxacin [susceptibility] by minimum lethal concentration (mlc),temafloxacin islt mlc,temafloxacin mlc [susc],antibiotic susceptibilities; ast; id; infectious disease; infectiousdisease; islt; isol; mbc; minimum bactericidal concentration; minimum lethal concentration; omniflox; point in time; qnt; quan; quant; quantitative; random; sus; suscept; susceptibilities; susceptibility; susceptibilty; teflox; temac,Qn
48803-1,neural tube defect risk [likelihood] in fetus,neural tube defect risk fetus,neural tube defect risk qn (fetus),anencephaly; chemistry; fetal; gyn; gynecology; neural tube def; neural tube defct; ntd; ob; obgyn; obstetrics; ontd; open spina bifida; osb; point in time; qnt; quan; quant; quantitative; random; risk,Qn
48844-5,bartonella elizabethae igg ab [titer] in serum by immunofluorescence,b elizabethae igg titr ser if,b. elizabethae igg if (s) [titer],abs; aby; acif; antby; anti; antibodies; antibody; anticomplement immunofluorescence; autoantibodies; autoantibody; b elizabethae; dilution factor; dilution factor (titer); fa; fluorescent antibody; fluoresent; id; ifa; immune fluorescence; immune globulin g; immunoflour; immunofluor; immunofluorescence; immunoglobulin g; infectious disease; infectiousdisease; microbiology; point in time; r elizabethae; random; rochalimae elizabethae; rochalimaea elizabethae; serum; smqn; sr; time resolved fluorescence; titer; titered; titre; trf; ttr,SemiQn
48850-2,ehrlichia chaffeensis igm ab [titer] in serum by immunofluorescence,e chaffeensis igm titr ser if,e. chaffeensis igm if (s) [titer],abs; aby; acif; antby; anti; antibodies; antibody; anticomplement immunofluorescence; autoantibodies; autoantibody; dilution factor; dilution factor (titer); e chaffeensis; fa; fluorescent antibody; fluoresent; hme; human monocytic ehrlichiosis; id; ifa; immune fluorescence; immune globulin m; immunoflour; immunofluor; immunofluorescence; immunoglobulin m; infectious disease; infectiousdisease; microbiology; point in time; random; serum; smqn; sr; time resolved fluorescence; titer; titered; titre; trf; ttr,SemiQn
488-7,temafloxacin [susceptibility] by minimum inhibitory concentration (mic),temafloxacin islt mic,temafloxacin mic [susc],antibiotic susceptibilities; ast; id; infectious disease; infectiousdisease; islt; isol; minimum inhibitory concentration; omniflox; point in time; random; sus; suscept; susceptibilities; susceptibility; susceptibilty; teflox; temac,OrdQn
48879-1,bartonella bacilliformis igm ab [titer] in body fluid by immunofluorescence,b bacilliformis igm titr fld if,b. bacilliformis igm if (body fld) [titer],"abs; aby; acif; antby; anti; antibodies; antibody; anticomplement immunofluorescence; autoantibodies; autoantibody; b bacilliformis; b/f; bf; bod; bodies; body fluid; body fluid, unsp; dilution factor; dilution factor (titer); fa; fl; fld; flu; fluid; fluorescent antibody; fluoresent; id; ifa; immune fluorescence; immune globulin m; immunoflour; immunofluor; immunofluorescence; immunoglobulin m; infectious disease; infectiousdisease; microbiology; point in time; random; smqn; time resolved fluorescence; titer; titered; titre; trf; ttr",SemiQn
48886-6,bartonella vinsonii berkhoffii igm ab [titer] in body fluid by immunofluorescence,b vinsonii berkhoffii igm titr fld if,b. vinsonii berkhoffii igm if (body fld) [titer],"abs; aby; acif; antby; anti; antibodies; antibody; anticomplement immunofluorescence; autoantibodies; autoantibody; b vinsonii berkhoffii; b/f; bf; bod; bodies; body fluid; body fluid, unsp; dilution factor; dilution factor (titer); fa; fl; fld; flu; fluid; fluorescent antibody; fluoresent; id; ifa; immune fluorescence; immune globulin m; immunoflour; immunofluor; immunofluorescence; immunoglobulin m; infectious disease; infectiousdisease; microbiology; point in time; random; smqn; time resolved fluorescence; titer; titered; titre; trf; ttr",SemiQn
48892-4,coxiella burnetii phase 2 igm ab [titer] in body fluid by immunofluorescence,c burnet ph2 igm titr fld if,c. burnetii phase 2 igm if (body fld) [titer],"abs; aby; acif; antby; anti; antibodies; antibody; anticomplement immunofluorescence; autoantibodies; autoantibody; b/f; bf; bod; bodies; body fluid; body fluid, unsp; c burnet; c burnet ph2; c burnetii; coxiella burnetii phase ii; coxiella burnettii; dilution factor; dilution factor (titer); fa; fl; fld; flu; fluid; fluorescent antibody; fluoresent; id; ifa; ii; immune fluorescence; immune globulin m; immunoflour; immunofluor; immunofluorescence; immunoglobulin m; infectious disease; infectiousdisease; microbiology; point in time; q fev; q fever; qfever; random; smqn; time resolved fluorescence; titer; titered; titre; trf; ttr",SemiQn
48906-2,rickettsia conorii igm ab [titer] in body fluid by immunofluorescence,r conorii igm titr fld if,r. conorii igm if (body fld) [titer],"abs; aby; acif; antby; anti; antibodies; antibody; anticomplement immunofluorescence; autoantibodies; autoantibody; b/f; bf; bod; bodies; body fluid; body fluid, unsp; boutonneuse fever; dilution factor; dilution factor (titer); fa; fl; fld; flu; fluid; fluorescent antibody; fluoresent; id; ifa; immune fluorescence; immune globulin m; immunoflour; immunofluor; immunofluorescence; immunoglobulin m; infectious disease; infectiousdisease; mediterranean spotted fever; microbiology; point in time; r conorii; random; ricket; rickettsial; smqn; spotted fever; time resolved fluorescence; titer; titered; titre; trf; ttr",SemiQn
48925-2,"respiratory allergen panel, us - central midwest b - serum",resp allergen central midwest b pnl ser,"respiratory allergen panel, us - central midwest b (s)","allergen; allergens; allergy testing; alrgen; il, ia, mo, southern mn; pan; panel.allergy; panl; pnl; point in time; random; resp allergen central midwest b pnl; resp allergen pnl; serum; sr; universallaborders; zone 10",-
4892-6,hla-dw21 [presence] in donor,hla-dw21 donr ql,hla-dw21 ql (bld/tiss donor),"blood; donr; genetics; heredity; heritable; hla antigen; human leukocyte antigen; inherited; ordinal; point in time; pr; ql; qual; qualitative; random; screen; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",Ord
48931-0,"respiratory allergen panel, us - az, southeastern ca, western nm - serum","resp allergen az,ca,nm pnl ser","respiratory allergen panel, us - az, southeastern ca, western nm (s)","allergen; allergens; allergy testing; alrgen; az, southeastern ca, western nm, southwestern tx; pan; panel.allergy; panl; pnl; point in time; random; resp allergen az,ca,nm pnl; resp allergen pnl; serum; sr; universallaborders; west; zone 16",-
48932-8,"respiratory allergen panel, us - alaska b - serum",resp allergen ak b pnl ser,"respiratory allergen panel, us - alaska b (s)",ak; allergen; allergens; allergy testing; alrgen; pan; panel.allergy; panl; pnl; point in time; random; resp allergen ak b pnl; resp allergen pnl; serum; sr; universallaborders; zone 17,-
4894-2,hla-dw22 [presence] in donor,hla-dw22 donr ql,hla-dw22 ql (bld/tiss donor),"blood; donr; genetics; heredity; heritable; hla antigen; human leukocyte antigen; inherited; ordinal; point in time; pr; ql; qual; qualitative; random; screen; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",Ord
48943-5,cannabinoids [presence] in specimen by confirmatory method,cannabinoids spec ql cfm,cannabinoids confirm ql (specimen),addiction; cannabinoid; cfm; cnfr; cnfrm; conf; confirmation; confirmatory; delta-9-tetrahydrocannabinol; drug/toxicology; drugs; drugs of abuse; gcms; illicit; lc/ms/ms; marijuana; misc; miscellaneous; ordinal; other; point in time; potentialforabuse; pr; ql; qual; qualitative; random; screen; spec; thc; to be specified in another part of the message; unspecified,Ord
489-5,temafloxacin [susceptibility] by disk diffusion (kb),temafloxacin islt kb,temafloxacin disk diffusion (kb) [susc],antibiotic susceptibilities; ast; disk diffusion; id; infectious disease; infectiousdisease; islt; isol; kb; kirby-bauer; omniflox; point in time; random; sus; suscept; susceptibilities; susceptibility; susceptibilty; teflox; temac,OrdQn
48955-9,lorazepam [mass/volume] in specimen,lorazepam spec-mcnc,lorazepam (specimen) [mass/vol],addiction; ativan; drug/toxicology; drugs; drugs of abuse; illicit; level; mass concentration; misc; miscellaneous; other; point in time; potentialforabuse; qnt; quan; quant; quantitative; random; spec; to be specified in another part of the message; unspecified,Qn
48960-9,norpropoxyphene [mass/volume] in specimen,norpropoxyph spec-mcnc,norpropoxyphene (specimen) [mass/vol],drug/toxicology; drugs; level; mass concentration; misc; miscellaneous; n-desmethylproproxyphene; norpropoxyp; other; point in time; propoxyphene metabolite; qnt; quan; quant; quantitative; random; spec; to be specified in another part of the message; unspecified,Qn
48963-3,propoxyphene [mass/volume] in specimen by confirmatory method,propoxyph spec cfm-mcnc,propoxyphene confirm (specimen) [mass/vol],addiction; algaphan; cfm; cnfr; cnfrm; conf; confirmation; confirmatory; cosalgesic; cotonal-65; darvon; depronal; dextrogesic; dextropropoxyphene; distalgesic; dolasan; doloxene; d-propoxyphene; drug/toxicology; drugs; drugs of abuse; gcms; illicit; lc/ms/ms; level; mass concentration; misc; miscellaneous; napsalgesic; other; point in time; potentialforabuse; qnt; quan; quant; quantitative; random; spec; to be specified in another part of the message; unspecified,Qn
48964-1,propoxyphene [mass/volume] in specimen,propoxyph spec-mcnc,propoxyphene (specimen) [mass/vol],addiction; algaphan; cosalgesic; cotonal-65; darvon; depronal; dextrogesic; dextropropoxyphene; distalgesic; dolasan; doloxene; d-propoxyphene; drug/toxicology; drugs; drugs of abuse; illicit; level; mass concentration; misc; miscellaneous; napsalgesic; other; point in time; potentialforabuse; qnt; quan; quant; quantitative; random; spec; to be specified in another part of the message; unspecified,Qn
48969-0,dcx gene targeted mutation analysis in blood or tissue by molecular genetics method,dcx gene mut anl bld/t,dcx gene targeted mutation analysis molgen doc (bld/tiss),"blood; dbcn; dc; document; doublecortex; lissencephaly, x-linked (doublecortin); doublecortin; finding; findings; genetics; heredity; heritable; inherited; lisx; molecular genetics; molecular pathology; molpath; molpath.mutations; mut; mut anl; mutations; pcr; point in time; random; sclh; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue; xlis",Doc
48976-5,polg gene mutations found [identifier] in blood or tissue by molecular genetics method nominal,polg gene mut anl bld/t,polg gene targeted mutation analysis molgen nom (bld/tiss),"blood; genetics; heredity; heritable; identity or presence; inherited; mdp1; miras; molecular genetics; molecular pathology; molpath; molpath.mutations; mtdps4a; mtdps4b; mut; mut anl; mutations; nominal; pcr; peo; point in time; polg1; polga; polg-alpha; polymerase (dna directed), gamma; random; sando; scae; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",Nom
48988-0,glucose [mass/volume] in serum or plasma --12 pm specimen,glucose 12 pm serpl-mcnc,glucose 12 pm specimen [mass/vol],chemistry.challenge testing; endocrine; endocrinology; evening; glu; glu tol; gluc; glucose tolerance; glucoseur; gtt; level; mass concentration; noon; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; spec; sr,Qn
48990-6,glucose [mass/volume] in serum or plasma --8 pm specimen,glucose 8 pm serpl-mcnc,glucose 8 pm specimen [mass/vol],chemistry.challenge testing; endocrine; endocrinology; evening; glu; glu tol; gluc; glucose tolerance; glucoseur; gtt; level; mass concentration; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; spec; sr,Qn
48991-4,glucose [mass/volume] in serum or plasma --10 pm specimen,glucose 10 pm serpl-mcnc,glucose 10 pm specimen [mass/vol],chemistry.challenge testing; endocrine; endocrinology; evening; glu; glu tol; gluc; glucose tolerance; glucoseur; gtt; level; mass concentration; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; spec; sr,Qn
49001-1,osmolality of sweat,osmolality sweat,osmolality (sweat) [osmolality],chemistry; osmo; osmolality; point in time; qnt; quan; quant; quantitative; random; swt,Qn
49006-0,phosphate [moles/volume] in peritoneal dialysis fluid,phosphate diafp-scnc,phosphate (perit dial fld) [moles/vol],chemistry; diaf; diafp; dialysate; dialysis fluid; i phos; inorganic phosphate; level; peritoneal dialysis fluid; phos; phosphate total; phosphorous; phosphorus; phosphrous; pi; po4; point in time; qnt; quan; quant; quantitative; random; substance concentration,Qn
4901-5,hla-dw25 [presence],hla-dw25 ql,hla-dw25 ql (bld/tiss),"blood; genetics; heredity; heritable; hla antigen; human leukocyte antigen; inherited; ordinal; point in time; pr; ql; qual; qualitative; random; screen; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",Ord
49036-7,parathyrin.intact [mass/volume] in serum or plasma --post excision,pth-intact p excision serpl-mcnc,parathyrin.intact post excision [mass/vol],after; chemistry.challenge testing; intact parathormone; intact parathyroid hormone; ipth; level; mass concentration; p excision; parathormone; parathyroid hormone; pl; plasma; plsm; point in time; post surgery; pst; pth; pth-intact; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; tumor marker,Qn
49037-5,respiratory syncytial virus igg and igm panel [units/volume] - serum,rsv igg+igm pnl ser-acnc,rsv igg and igm panel qn (s),arbitrary concentration; hrsv; id; immune globulin g; immune globulin m; immunoglobulin g; immunoglobulin m; infectious disease; infectiousdisease; microbiology; pan; panel.microbiology; panl; pnl; point in time; qnt; quan; quant; quantitative; random; rsv; rsv igg+igm pnl; serum; sr,Qn
4904-9,hla-dw2 [presence] in donor,hla-dw2 donr ql,hla-dw2 ql (bld/tiss donor),"blood; donr; genetics; heredity; heritable; hla antigen; human leukocyte antigen; inherited; ordinal; point in time; pr; ql; qual; qualitative; random; screen; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",Ord
49077-1,influenza virus b igg ab [mass/volume] in cerebral spinal fluid,flubv igg csf-mcnc,flubv igg (csf) [mass/vol],abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; cerebral spinal fluid; cerebrospinal fl; flub; flubv; fluv; id; immune globulin g; immunoglobulin g; infectious disease; infectiousdisease; influ; influenza b; influenza b virus; level; mass concentration; microbiology; neuro; neurology; point in time; qnt; quan; quant; quantitative; random; spinal fl; spinal fld; spinal flu; spinal fluid,Qn
49079-7,deprecated american cockroach ige ab rast class [presence] in serum,deprecated amer roach ige rast ql,american cockroach ige rast class (s),abs; aby; allergen; allergens; allergy testing; amer roach; american cockroach; antby; anti; antibodies; antibody; autoantibodies; autoantibody; i100; i206; ige rast; immune globulin e; immunoglobulin e; ordinal; point in time; pr; ql; qual; qualitative; random; ri206; screen; serum; sr,Ord
49085-4,first and second trimester integrated maternal screen panel,integrated scn pnl patient,first and second trimester integrated maternal screen panel,2nd; alpha-1-fetoprotein & choriogonadotropin & estriol.unconjugated & inhibin a & pregnancy associated plasma protein a & nuchal translucency; chemistry; gestation; integrated scn; integrated scn pnl; pan; panel.chemistry; panl; pnl; point in time; prenatal; random; scn; scr; scrn,-
49128-2,rickettsia typhus group identified in specimen by sequencing,rick typhus spec seq,r. typhus group identified sequencing nom (specimen),high-throughput sequencing; hts; id; identity or presence; infectious disease; infectiousdisease; microbiology; misc; miscellaneous; next generation sequencing; ngs; nominal; other; point in time; random; rick typhus; ricket; rickettsial; spec; to be specified in another part of the message; typh; typhus; unspecified,Nom
49131-6,chylomicrons/total lipoprotein in serum or plasma,chylo mfr serpl,chylomicrons/total lipoprotein [mass fraction],chemistry; chylomicron; lip; lipoprot; lipoproteins; lp; mass fraction; percent; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; tot; totl; uldl; ultra low density lipoproteins,Qn
49140-7,california encephalitis virus igg ab [titer] in serum by immunofluorescence,cev igg titr ser if,cev igg if (s) [titer],abs; aby; acif; antby; anti; antibodies; antibody; anticomplement immunofluorescence; autoantibodies; autoantibody; ca; calif; cev; cev ab; cev igg; dilution factor; dilution factor (titer); enc; enceph; encephalomyelitis; fa; fluorescent antibody; fluoresent; id; ifa; immune fluorescence; immune globulin g; immunoflour; immunofluor; immunofluorescence; immunoglobulin g; infectious disease; infectiousdisease; microbiology; point in time; random; serum; smqn; sr; time resolved fluorescence; titer; titered; titre; trf; ttr,SemiQn
49175-3,human bocavirus igg ab [presence] in specimen,hbov igg spec ql,human bocavirus igg ql (specimen),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; hbov; hbov ab; id; immune globulin g; immunoglobulin g; infectious disease; infectiousdisease; microbiology; misc; miscellaneous; ordinal; other; point in time; pr; ql; qual; qualitative; random; screen; spec; to be specified in another part of the message; unspecified,Ord
49180-3,ehrlichia chaffeensis igg ab [titer] in body fluid,e chaffeensis igg titr fld,e. chaffeensis igg (body fld) [titer],"abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; b/f; bf; bod; bodies; body fluid; body fluid, unsp; dilution factor; dilution factor (titer); e chaffeensis; fl; fld; flu; fluid; hme; human monocytic ehrlichiosis; id; immune globulin g; immunoglobulin g; infectious disease; infectiousdisease; microbiology; point in time; random; smqn; titer; titered; titre; ttr",SemiQn
49183-7,coxiella burnetii phase 2 igg ab [titer] in body fluid,c burnet ph2 igg titr fld,c. burnetii phase 2 igg (body fld) [titer],"abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; b/f; bf; bod; bodies; body fluid; body fluid, unsp; c burnet; c burnet ph2; c burnetii; coxiella burnetii phase ii; coxiella burnettii; dilution factor; dilution factor (titer); fl; fld; flu; fluid; id; ii; immune globulin g; immunoglobulin g; infectious disease; infectiousdisease; microbiology; point in time; q fev; q fever; qfever; random; smqn; titer; titered; titre; ttr",SemiQn
49187-8,coxiella burnetii phase 1 iga ab [titer] in body fluid,c burnet ph1 iga titr fld,c. burnetii phase 1 iga (body fld) [titer],"abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; b/f; bf; bod; bodies; body fluid; body fluid, unsp; c burnet; c burnet ph1; c burnetii; coxiella burnetii phase i; coxiella burnettii; dilution factor; dilution factor (titer); fl; fld; flu; fluid; i; id; immune globulin a; immunoglobulin a; infectious disease; infectiousdisease; microbiology; point in time; q fev; q fever; qfever; random; smqn; titer; titered; titre; ttr",SemiQn
49188-6,corynebacterium diphtheriae toxin ab [units/volume] in serum --2nd specimen,c diphtheriae tox ab sp2 ser-acnc,c. diphtheriae toxin ab spec 2 qn (s),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; c diphtheriae; c diphtheriae tox; convalescent; diphtheria; diptheria; id; infectious disease; infectiousdisease; microbiology; point in time; post immunization; qnt; quan; quant; quantitative; random; second; serum; sp2; spec; sr,Qn
49204-1,bartonella henselae igm ab [titer] in body fluid,b henselae igm titr fld,b. henselae igm (body fld) [titer],"abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; b henselae; b/f; bacillary angiomaosis; bacillary pelliosis; bf; bod; bodies; body fluid; body fluid, unsp; cat scratch disease; cat scratch fever; csd; dilution factor; dilution factor (titer); fl; fld; flu; fluid; id; immune globulin m; immunoglobulin m; infectious disease; infectiousdisease; microbiology; point in time; r henselae; random; rochalimaea henselae; smqn; titer; titered; titre; ttr",SemiQn
4920-5,hla-dpw1 [presence] in donor,hla-dpw1 donr ql,hla-dpw1 ql (bld/tiss donor),"blood; donr; genetics; heredity; heritable; hla antigen; human leukocyte antigen; inherited; ordinal; point in time; pr; ql; qual; qualitative; random; screen; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",Ord
49210-8,bartonella bacilliformis igg ab [titer] in body fluid,b bacilliformis igg titr fld,b. bacilliformis igg (body fld) [titer],"abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; b bacilliformis; b/f; bf; bod; bodies; body fluid; body fluid, unsp; dilution factor; dilution factor (titer); fl; fld; flu; fluid; id; immune globulin g; immunoglobulin g; infectious disease; infectiousdisease; microbiology; point in time; random; smqn; titer; titered; titre; ttr",SemiQn
49213-2,anaplasma phagocytophilum igg ab [titer] in body fluid,a phagocytoph igg titr fld,a. phagocytophilum igg (body fld) [titer],"abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; b/f; bf; bod; bodies; body fluid; body fluid, unsp; dilution factor; dilution factor (titer); e equi; e phagocytophila; ehrlichia equi; ehrlichia phagocytophila; fl; fld; flu; fluid; hge; human granulocytic ehrlichiosis; id; immune globulin g; immunoglobulin g; infectious disease; infectiousdisease; microbiology; point in time; random; smqn; titer; titered; titre; ttr",SemiQn
49221-5,catalase [enzymatic activity/mass] in red blood cells,catalase rbc-ccnt,catalase (rbc) [catalytic activity/mass],catalytic content; chemistry; erythrocytes; point in time; qnt; quan; quant; quantitative; random; red blood cells; red blood corpusles,Qn
49227-2,stavudine [mass/volume] in serum or plasma,stavudine serpl-mcnc,stavudine [mass/vol],d4t; drug/toxicology; drugs; level; mass concentration; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; zerit,Qn
49233-0,"giardia lamblia+cryptosporidium parvum ag [presence] in stool by rapid, less than 30 minutes",g lamblia+c parvum ag stl ql rapid,"g. lamblia+cryptosporidium parvum ag rapid, less than 30 minutes ql (stl)",antigen; antigens; beaver fever; bowel movement; c parvum; crypt; crypto; cryptosporidiosis; faecal; faeces; fecal; feces; g duodenalis; g intestinalis; g lamblia; g lamblia+c parvum; g lamblia+c parvum ag; giardiasis; id; infectious disease; infectiousdisease; lamblia intestinalis; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; rapid test; screen; stl; stool = fecal,Ord
49252-0,calculus analysis [interpretation] in stone narrative,stone analysis-imp,calculus analysis nar [interp],calc; calculi; chemistry; gastro; gastroenterology; gi; impression; impression/interpretation of study; impressions; interp; interpretation; kidney; narrative; nephrology; point in time; random; renal; report; stn; stone; stone analysis; stones,Nar
49261-1,cryoproteins [interpretation] in serum by electrophoresis agarose gel narrative,cryoproteins ser ag elph-imp,cryoproteins elph agarose gel nar (s) [interp],ag elph; chemistry; cryoprotein; elec; elect; electr; electro; electrophhrs; electrophrs; elp; elph; ep; impression; impression/interpretation of study; impressions; interp; interpretation; narrative; point in time; random; report; serum; sr,Nar
49262-9,fatty acids pattern [interpretation] in serum or plasma narrative,fatty acids pattern serpl-imp,fatty acids pattern nar [interp],acd; acid; chemistry; fatty acid; impression; impression/interpretation of study; impressions; interp; interpretation; lipid; narrative; pl; plasma; plsm; point in time; random; report; serp; serpl; serplas; serum; serum or plasma; sr,Nar
49277-7,immunofixation for 24 hour urine narrative,interpretation 24h ur ife-imp,interpretation immunofixation nar (24h u) [interp],1 day; 24 hours; 24hr; chemistry; ife; ifix; immunofixation electrophoresis; impression; impression/interpretation of study; impressions; interp; interpret; interpretation; interpt; intrp; narrative; report; ua; ur; urn,Nar
49286-8,organic acids pattern [interpretation] in serum or plasma narrative,organic acids pattern serpl-imp,organic acids pattern nar [interp],acd; acid; chemistry; impression; impression/interpretation of study; impressions; interp; interpretation; narrative; pl; plasma; plsm; point in time; random; report; serp; serpl; serplas; serum; serum or plasma; sr,Nar
492-9,temocillin [susceptibility] by minimum inhibitory concentration (mic),temocillin islt mic,temocillin mic [susc],antibiotic susceptibilities; ast; id; infectious disease; infectiousdisease; islt; isol; minimum inhibitory concentration; nagaban; point in time; random; sus; suscept; susceptibilities; susceptibility; susceptibilty; temopen,OrdQn
49297-5,protein fractions [interpretation] in serum or plasma by immunofixation narrative,prot pattern serpl ife-imp,protein fractions immunofixation nar [interp],chemistry; ife; ifix; immunofixation electrophoresis; impression; impression/interpretation of study; impressions; interp; interpretation; narrative; pl; plasma; plsm; point in time; pr; prot; prot pattern; protein fractions; random; report; serp; serpl; serplas; serum; serum or plasma; sr,Nar
49306-4,hamster ova penetration test [interpretation] in semen narrative,spa smn-imp,hamster ova penetration test nar (sem) [interp],assessment; ejaculate; eval; fertility testing; genitourinary; gu; h&p; hamster zona-free ovum test; history and physical; humster test; hzfo test; impression; impression/interpretation of study; impressions; interp; interpretation; narrative; ovum; point in time; random; report; sem; seminal fluid; smn; smpls; spa; sperm; sperm penetration assay; uro; urology,Nar
49439-3,pneumocystis jirovecii dna [#/volume] in cerebral spinal fluid by naa with probe detection,p jirovecii dna # csf naa+probe,p. jirovecii dna naa+probe (csf) [#/vol],#; 3 self-sustaining sequence replication; 3sr sr; abs; absolute; absolutes; amplif; amplification; amplified; cerebral spinal fluid; cerebrospinal fl; cnt; count; count/volume; ct; deoxyribonucleic acid; dna nucleic acid probe; dna probe; id; infectious disease; infectiousdisease; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; naa+probe; naat; nasba; neuro; neurology; nucleic acid sequence based analysis; number concentration; number concentration (count/vol); p carinii; p jiroveci; p jirovecii; pcp; pcr; pneumocystis carinii; point in time; polymerase chain reaction; probe amp; probe with ampification; probe with target amplification; qbr; qnt; quan; quant; quantitative; random; sda; spinal fl; spinal fld; spinal flu; spinal fluid; strand displacement amplification; tma; transcription mediated amplification; viral load,Qn
49457-5,androgen receptor ag [presence] in tissue by immune stain,ar ag tiss ql imstn,androgen receptor ag immune stain ql (tiss),"antigen; antigens; ar; ihc; imm; immunohistochemical stain; immunostain; imstn; imun; imune; ordinal; pathology; point in time; pr; ql; qual; qualitative; random; rec; recept; receptors; recp; recptr; screen; st; stains; stn; tissue; tissue, unspecified",Ord
49480-7,herpes virus 8 latent nuclear ag [presence] in tissue by immune stain,hhv8 ln ag tiss ql imstn,hhv 8 latent nuclear ag immune stain ql (tiss),"antigen; antigens; herpesvirus; hhv; hhv8; hhv-8; hhv8 ln; hhv8 lna; hhv-8-lna; human herpes virus; id; ihc; imm; immunohistochemical stain; immunostain; imstn; imun; imune; infectious disease; infectiousdisease; kaposi's sarcoma-associated herpesvirus; kshv; microbiology; nuc; ordinal; point in time; pr; ql; qual; qualitative; random; screen; st; stains; stn; tissue; tissue, unspecified",Ord
49488-0,collection time of body fluid,collect tme fld,collection time (body fld) [date/time],"b/f; bf; bod; bodies; body fluid; body fluid, unsp; coll; collect; collect tme; collected; date and time; fl; fld; flu; fluid; point in time; qnt; quan; quant; quantitative; random; spec; time stamp; timestamp",Qn
49492-2,leukemia markers [interpretation] in cerebral spinal fluid narrative,leukemia markers csf-imp,leukemia markers nar (csf) [interp],cell markers; cerebral spinal fluid; cerebrospinal fl; impression; impression/interpretation of study; impressions; interp; interpretation; narrative; point in time; random; report; spinal fl; spinal fld; spinal flu; spinal fluid,Nar
4949-4,hla-dq9(3) [presence],hla-dq9(3) ql,hla-dq9(3) ql (bld/tiss),"blood; genetics; heredity; heritable; hla antigen; human leukocyte antigen; iii; inherited; ordinal; point in time; pr; ql; qual; qualitative; random; screen; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",Ord
49501-0,calcium oxalate monohydrate/total in stone by infrared spectroscopy,com mfr stone ir,calcium oxalate monohydrate infrared spectroscopy (stone) [mass fraction],ca; cac2o4; cal; calc; calculi; caox; chemistry; com; ethanedioate; ethanedioic acid; gastro; gastroenterology; gi; infared spectoscopy; ir; kidney; mass fraction; monohydrt; nephrology; oxal; oxalic acid; percent; point in time; qnt; quan; quant; quantitative; random; renal; stn; stone; stones; tot; totl; whewelite; whewellite,Qn
49522-6,influenza virus a h3 ag [presence] in isolate by immunofluorescence,fluav h3 ag islt ql if,fluav h3 ag if ql (isol),acif; anticomplement immunofluorescence; antigen; antigens; avian influenza; bird flu; dfa; fa; flua; fluav; fluav h3; fluorescent antibody; fluoresent; fluv; fowl plague; id; ifa; immune fluorescence; immunoflour; immunofluor; immunofluorescence; infectious disease; infectiousdisease; influ; influenza a; influenza a virus; islt; isol; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; screen; time resolved fluorescence; trf,Ord
49537-4,influenza virus a and b rna [identifier] in isolate by naa with probe detection,fluav + flubv rna islt naa+probe,fluav and flubv rna naa+probe nom (isol),"3 self-sustaining sequence replication; 3sr sr; a,b; amplif; amplification; amplified; avian influenza; bird flu; dna nucleic acid probe; dna probe; flua; fluav; fluav + flubv; fluav+flubv; fluv; fowl plague; id; identity or presence; infectious disease; infectiousdisease; influ; influenza a; influenza a virus; islt; isol; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; naa+probe; naat; nasba; nominal; nucleic acid sequence based analysis; pcr; point in time; polymerase chain reaction; probe amp; probe with ampification; probe with target amplification; qbr; random; ribonucleic acid; sda; strand displacement amplification; tma; transcription mediated amplification",Nom
49539-0,cytomegalovirus igm ab [presence] in serum or plasma by immunofluorescence,cmv igm serpl ql if,cmv igm if ql,abs; aby; acif; antby; anti; antibodies; antibody; anticomplement immunofluorescence; autoantibodies; autoantibody; cmv; cytomegalo virus; cytomgal; fa; fluorescent antibody; fluoresent; hhv-5; human herpesvirus-5; id; ifa; immune fluorescence; immune globulin m; immunoflour; immunofluor; immunofluorescence; immunoglobulin m; infectious disease; infectiousdisease; microbiology; ordinal; pl; plasma; plsm; point in time; pr; ql; qual; qualitative; random; screen; serp; serpl; serplas; serum; serum or plasma; sr; time resolved fluorescence; trf; universallaborders,Ord
49543-2,deprecated calcidiol+calciferol [mass/volume] in serum or plasma,deprecated calcidiol+calciferol serpl-mc,25-hydroxyvitamin d3+vitamin d2 [mass/vol],25(oh)d3; 25-hydroxycholecalciferol; 25-hydroxyvitamin d 3; 25-hydroxyvitamin d metabolites; 25-hydroxyvitamin d2 + d3; 25-hydroxyvitamin d3; activated ergosterol; c28h43oh; calciderol; calcidiol & calciferol; calcifediol; chemistry; ercalciol; ergocalciferol; level; mass concentration; pl; plasma; plsm; point in time; pro vitamin d; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; viosterol; vit d 1 25 hydroxy; vit d2; vitamin d 25 hydroxy; vitamin d2,Qn
49580-4,hiv 1+2 ab [presence] in specimen by rapid immunoassay,hiv1+2 ab spec ql ia.rapid,hiv 1+2 ab ia.rapid ql (specimen),abs; aby; aids; antby; anti; antibodies; antibody; autoantibodies; autoantibody; eia; elfa; elisa; enzyme immunoassay; hiv 1 & 2; hiv 1 and 2 ab; hiv type 1; hiv type i; hiv1; hiv1+2; human immunodeficiency virus; i; iaa; id; ii; infectious disease; infectiousdisease; meia; microbiology; misc; miscellaneous; ordinal; other; point in time; pr; ql; qual; qualitative; random; screen; spec; suds; to be specified in another part of the message; universallaborders; unspecified,Ord
49593-7,trichothecene iga ab [units/volume] in serum by immunoassay,trichothecene iga ser ia-acnc,trichothecene iga ia qn (s),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; eia; elfa; elisa; enzyme immunoassay; iaa; id; immune globulin a; immunoglobulin a; infectious disease; infectiousdisease; meia; microbiology; point in time; qnt; quan; quant; quantitative; random; serum; sr; suds,Qn
49597-8,trichothecene ige ab [units/volume] in serum by immunoassay,trichothecene ige ser ia-acnc,trichothecene ige ia qn (s),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; eia; elfa; elisa; enzyme immunoassay; iaa; id; immune globulin e; immunoglobulin e; infectious disease; infectiousdisease; meia; microbiology; point in time; qnt; quan; quant; quantitative; random; serum; sr; suds,Qn
49616-6,legionella sp dna [identifier] in specimen by naa with probe detection,legionella dna spec naa+probe,legionella sp dna naa+probe nom (specimen),3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; deoxyribonucleic acid; dna nucleic acid probe; dna probe; id; identity or presence; infectious disease; infectiousdisease; lat; lcr; legion; legionela; ligase chain reaction; ligation-activated transcription; microbiology; misc; miscellaneous; naa+probe; naat; nasba; nominal; nucleic acid sequence based analysis; other; pcr; point in time; polymerase chain reaction; probe amp; probe with ampification; probe with target amplification; qbr; random; sda; spec; species; spp; strand displacement amplification; tma; to be specified in another part of the message; transcription mediated amplification; unspecified,Nom
49622-4,tipranavir+ritonavir [susceptibility] by genotype method,tipranavir+ritonavir islt genotyp,tipranavir+ritonavir genotyping [susc],antibiotic susceptibilities; aptivus; ast; genotype; genotypic; id; infectious disease; infectiousdisease; islt; isol; norvir; ordinal; point in time; ql; qual; qualitative; random; rtv; screen; sus; suscept; susceptibilities; susceptibility; susceptibilty; tpv; tpv/r,Ord
49623-2,amprenavir or fosamprenavir [susceptibility] by genotype method,amprenavir/fosamprenavir islt genotyp,amprenavir or fosamprenavir genotyping [susc],908; agenerase; amp; amprenavir/fosamprenavir; antibiotic susceptibilities; apv; ast; fpv; genotype; genotypic; gw433908; id; infectious disease; infectiousdisease; islt; isol; lexiva; ordinal; point in time; ql; qual; qualitative; random; screen; sus; suscept; susceptibilities; susceptibility; susceptibilty; telzir; vx-478,Ord
4962-7,hla-dr16(2) [presence] in donor,hla-dr16(2) donr ql,hla-dr16(2) ql (bld/tiss donor),"blood; donr; genetics; heredity; heritable; hla antigen; human leukocyte antigen; ii; inherited; ordinal; point in time; pr; ql; qual; qualitative; random; screen; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",Ord
49636-4,ganglioside gm1 ab [units/volume] in cerebral spinal fluid by immunoassay,gm1 gangl ab csf ia-acnc,ganglioside gm1 ab ia qn (csf),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; cerebral spinal fluid; cerebrospinal fl; eia; elfa; elisa; enzyme immunoassay; ganglioside monosialo; gm1 gangl; iaa; meia; monosialoganglioside; point in time; qnt; quan; quant; quantitative; random; serology; spinal fl; spinal fld; spinal flu; spinal fluid; suds,Qn
4964-3,hla-dr17(3) [presence] in donor,hla-dr17(3) donr ql,hla-dr17(3) ql (bld/tiss donor),"blood; donr; genetics; heredity; heritable; hla antigen; human leukocyte antigen; iii; inherited; ordinal; point in time; pr; ql; qual; qualitative; random; screen; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",Ord
49648-9,mjd gene allele 2 cag repeats [entitic number] in blood or tissue by molecular genetics method,mjd allele2 cag rpt entnum bld/t,mjd gene allele 2 cag repeats molgen (bld/tiss) [entitic number],"at3; ataxia-3; ataxin 3; atx3; blood; entitic; entitic number; genetics; heredity; heritable; ii; inherited; jos; machado-joseph disease; mjd; mjd allele2 cag rpt; mjd1; molecular genetics; molecular pathology; molpath; molpath.nucrepeat; olivopontocerebellar ataxia 3; pcr; point in time; qnt; quan; quant; quantitative; random; repeat; sca3; sca3 gene; spinocerebellar ataxia; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",Qn
49669-5,emtricitabine [susceptibility] by phenotype method,emtricitabine islt phenotyp,emtricitabine phenotype method [susc],antibiotic susceptibilities; ast; emtriva; ftc; id; infectious disease; infectiousdisease; islt; isol; pheno; phenotype; phenotypic; point in time; random; sus; suscept; susceptibilities; susceptibility; susceptibilty; virtual phenotype,OrdQn
49673-7,lymphocyte proliferation stimulated by 100 umol beryllium [ratio] in blood --7 day post incubation,lpt 100 umol be 7d bld-rto,lymphocyte proliferation stimulated by 100 umol beryllium 7 day post incubation (bld) [ratio],after; be; belpt; berylliosis; blood; lpa; lpt; lpt 100 umol be; lst; lymphocyte antigen proliferation; lymphocyte antigen stimulation; pha; point in time; pst; qnt; quan; quant; quantitative; random; ratios; rto; serology; stim; wb; whole blood,Qn
49684-4,cpt2 gene p.arg503cys [presence] in blood by molecular genetics method,cpt2 p.r503c bld ql,cpt2 gene p.arg503cys molgen ql (bld),blood; carnitine palmitoyltransferase 2; carnitine palmitoyltransferase 2 gene; carnitine palmitoyltransferase ii gene; cpt1; cpt2 p.r503c; cptase; genetics; heredity; heritable; iiae4; inherited; molecular genetics; molecular pathology; molpath; molpath.mutations; ordinal; p prime; pcr; point in time; pr; ql; qual; qualitative; random; screen; wb; whole blood,Ord
49698-4,ph of arterial cord blood adjusted to patient's actual temperature,ph temp adj bldcoa,ph adjusted to patient's actual temperature (bldcoa),adj; bld cord; chemistry; cord arterial blood; cord blda; log molar concentration; point in time; random; s prime; smqn; temp; temp adj,SemiQn
4970-0,hla-dr53 [presence] in donor,hla-dr53 donr ql,hla-dr53 ql (bld/tiss donor),"blood; donr; genetics; heredity; heritable; hla antigen; human leukocyte antigen; inherited; ordinal; point in time; pr; ql; qual; qualitative; random; screen; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",Ord
49708-1,ttr gene targeted mutation analysis in blood or tissue by molecular genetics method,ttr gene mut anl bld/t,ttr gene targeted mutation analysis molgen doc (bld/tiss),"blood; cts; cts1; document; finding; findings; genetics; hel111; heredity; heritable; hst2651; inherited; molecular genetics; molecular pathology; molpath; molpath.mutations; mut; mut anl; mutations; palb; pcr; point in time; random; tbpa; tissue; tissue, unspecified; transthyretin; transthyretin (prealbumin, amyloidosis type i) gene; wb; whole blood; whole blood or tissue",Doc
49713-1,parainfluenza virus ab [titer] in serum by complement fixation,hpiv ab titr ser cf,parainfluenza virus ab cf (s) [titer],abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; cf; comp fixation; compfix; complement fixation; dilution factor; dilution factor (titer); hpiv; id; infectious disease; infectiousdisease; microbiology; para; parainflu; point in time; random; serum; smqn; sr; titer; titered; titre; ttr,SemiQn
49719-8,kentucky blue grass igg ab [mass/volume] in serum,kent blue grass igg-mcnc,kentucky blue grass igg (s) [mass/vol],abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; g008; g8; immune globulin g; immunoglobulin g; june blue grass; june grass; june kentucky blue grass; junegrass; kent blue grass; kentucky blue grass; kentucky bluegrass; level; mass concentration; meadow grass; point in time; qnt; quan; quant; quantitative; random; serum; sr,Qn
49723-0,tea igg ab [mass/volume] in serum,tea igg-mcnc,tea igg (s) [mass/vol],abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; f222; immune globulin g; immunoglobulin g; level; mass concentration; point in time; qnt; quan; quant; quantitative; random; rf222; serum; sr; tea,Qn
4978-3,hla-dr2 [presence] in donor,hla-dr2 donr ql,hla-dr2 ql (bld/tiss donor),"blood; donr; genetics; heredity; heritable; hla antigen; human leukocyte antigen; inherited; ordinal; point in time; pr; ql; qual; qualitative; random; screen; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",Ord
49794-1,"t(14;18)(q32;q21.3)(igh,bcl2) fusion transcript minor break points [presence] in bone marrow by molecular genetics method","t(14;18)(igh,bcl2) minor mar ql","t(14;18)(q32;q21.3)(igh,bcl2) fusion transcript minor break points molgen ql (bm)","arbitrary; b-cell leukemia/lymphoma 2; b-cell nhl; b-cell non-hodgkin lymphoma; bcl-2; bm; bon; bone marrow; breakpoint; dna; follicular b cell lymphoma; gene fusion; gene translocation; genetics; heredity; heritable; inherited; mar; marrow (bone); mcr; minimal angle of resolution; minimum angle of resolution; minor cluster region; molecular genetics; molecular pathology; molpath; molpath.translocation; ordinal; pcr; point in time; ql; qual; qualitative; random; rna; screen; t prime; t(14,18)(igh,bcl2) gene translocation; t(14,18)(igh,bcl2) gene translocation minor break points; t(14;18)(igh,bcl2); translocation",Ord
49795-8,"t(9;22)(q34.1;q11)(abl1,bcr) e1a2 fusion transcript [presence] in blood or tissue by molecular genetics method","t(abl1,bcr)e1a2 bld/t ql","t(9;22)(q34.1;q11)(abl1,bcr) e1a2 fusion transcript molgen ql (bld/tiss)","abl; all; arbitrary; bcr/abl; bcr1; bcr-abl1; blood; breakpoint cluster region; chronic myeloid leukemia; cml; d22s11; d22s662; dna; gene fusion; gene translocation; genetics; heredity; heritable; inherited; jtk7; major breakpoints; mbr; mcr; minor breakpoints; molecular genetics; molecular pathology; molpath; molpath.translocation; ordinal; p150; pcr; ph chromosome; philadelphia chromosome; phl; point in time; ql; qual; qualitative; random; rna; screen; t prime; t(9,22)(abl1,bcr) gene translocation; t(9,22)(abl1,bcr) p190 gene translocation; t(9,22)(abl1,bcr) translocation; t(9,22)(q34,q11); t(9,22)(q34.1,q11); t(9;22)(abl1,bcr); t(abl1,bcr)e1a2; tissue; tissue, unspecified; translocation; v-abl abelson murine leukemia viral oncogene homolog 1; wb; whole blood; whole blood or tissue",Ord
49812-1,2-hydroxyglutarate/creatinine [molar ratio] in 24 hour urine,2oh-gluterate/creat 24h ur-srto,2-hydroxyglutarate/creatinine (24h u) [molar ratio],1 day; 24 hours; 24hr; 2-hydroxy-glutarate; 2-hydroxyglutaric acid; 2oh-gluterate; alpha-hydroxyglutarate; alpha-hydroxyglutaric acid; chemistry; cr; crea; creat; ii; qnt; quan; quant; quantitative; scrto; substance concentration ratio; substance ratio; ua; ucr; ur; urn,Qn
49818-8,2-oxoisovalerate/creatinine [molar ratio] in 24 hour urine,2oxoisovalerate/creat 24h ur-srto,2-oxoisovalerate/creatinine (24h u) [molar ratio],1 day; 24 hours; 24hr; 2-ketoisovalerate; 2-ketoisovaleric acid; 2oxoisovalerate; 2-oxoisovaleric acid; chemistry; cr; crea; creat; ii; qnt; quan; quant; quantitative; scrto; substance concentration ratio; substance ratio; ua; ucr; ur; urn,Qn
49824-6,3-hydroxypropionate (3-oh-c3)/creatinine [molar ratio] in 24 hour urine,3oh-propionate/creat 24h ur-srto,3-hydroxypropionate (3-oh-c3)/creatinine (24h u) [molar ratio],1 day; 24 hours; 24hr; 3-hydroxy-propionate; 3-hydroxypropionic acid; 3oh-propionate; chemistry; cr; crea; creat; iii; qnt; quan; quant; quantitative; scrto; substance concentration ratio; substance ratio; ua; ucr; ur; urn,Qn
49834-5,leucine [presence] in urine,leucine ur ql,leucine ql (u),chemistry; leu; ordinal; point in time; pr; ql; qual; qualitative; random; screen; ua; ur; urn,Ord
49845-1,aptt.factor substitution in platelet poor plasma by coagulation assay --with normal plasma 1h post incubation separate tubes,aptt np 1h separate ppp,aptt.factor substitution with normal plasma 1 hr post incubation separate tubes coag (ppp) [time],1 hour; 1.0hr; 1h p inc; 60 min; 60 minutes; 60m; 60min; activated partial thromboplastin time; after; aptt; aptt correction study; clot; clottable; coag; coagulation assay; control; fac; fact; hematology; heme; little(a)ptt; mixing studies; np 1h separate; partial thromboplastin time; plas; platelet poor plasma; point in time; pst; ptt; qnt; quan; quant; quantitative; random; surf; tilt tube,Qn
49848-5,herpes simplex virus 1+2 igg ab [presence] in serum by immunoblot,hsv1+2 igg ser ql ib,hsv 1+2 igg ib ql (s),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; blt; herp splx; herpes simplex virus type 1; herpes simplex virus type 1+2; herpes simplex virus type i+ii; hsv; hsv 1+2; hsv1; hsv1+2; i; id; ii; immune blot; immune globulin g; immunobl; immunoblot; immunoglobulin g; infectious disease; infectiousdisease; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; riba; screen; serum; sr; universallaborders; wb; wblot; west blot; west blt; western blot,Ord
49850-1,insulin-like growth factor-i [mass/volume] in serum or plasma --baseline,igf-i bs serpl-mcnc,insulin-like growth factor-i baseline [mass/vol],bs; chemistry.challenge testing; fac; fact; factor 1; fi; hum; humulin; igf; igf1; igf-1; igf-i; ih7; insul; lente; level; mass concentration; nph; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; semilente; serp; serpl; serplas; serum; serum or plasma; sliding; somatomedin c; sr; ultralente,Qn
49853-5,transforming growth factor beta 1 [mass/volume] in serum or plasma,tgf-beta-1 serpl-mcnc,transforming growth factor beta 1 [mass/vol],b; chemistry; fac; fact; i; level; mass concentration; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; tgf-beta; tgf-beta-1,Qn
4985-8,hla-dr5 [presence],hla-dr5 ql,hla-dr5 ql (bld/tiss),"blood; genetics; heredity; heritable; hla antigen; human leukocyte antigen; inherited; ordinal; point in time; pr; ql; qual; qualitative; random; screen; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",Ord
49865-9,coagulation factor viii activity actual/normal in platelet poor plasma by chromogenic method,fact viii act/nor ppp chro,coagulation factor viii activity actual/normal chromogenic method (ppp) [rel units/vol],act/nor; activ; actvty; ahf; ahg; antihemophilic factor; antihemophilic globulin; chromogenic assay; circulating anticoagulant; coag; control; enzy; enzymatic assay; f8; fac; fact; fact viii; factor 8; factor viii clotting activity; fviii; hematology; heme; movements; plas; platelet poor plasma; point in time; qnt; quan; quant; quantitative; random; rlacnc; thrombocyte cofactor a; viii:c,Qn
4986-6,hla-dr7 [presence] in donor,hla-dr7 donr ql,hla-dr7 ql (bld/tiss donor),"blood; donr; genetics; heredity; heritable; hla antigen; human leukocyte antigen; inherited; ordinal; point in time; pr; ql; qual; qualitative; random; screen; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",Ord
49887-3,dehydroepiandrosterone (dhea) [mass/volume] in serum or plasma --1st specimen post xxx challenge,dhea sp1 p chal serpl-mcnc,dhea 1st specimen post unsp challenge [mass/vol],acute specimen; after; chemistry.challenge testing; dhea; first; level; mass concentration; p chal; pl; plasma; plsm; point in time; prasterone; pre immunization; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sp1; sp1 p chal; spec; sr,Qn
49967-3,charcoal [presence] in urine sediment by light microscopy,charcoal urns ql micro,charcoal lm ql (urine sed),kidney; lm; micro; micros; microscopic; nephrology; ordinal; point in time; pr; ql; qual; qualitative; random; renal; screen; ua; ur; urinalysis; urine sediment; urn; urns,Ord
49968-1,cortisol [molar concentration difference] in serum or plasma --1 hour post 250 ug corticotropin im,cortis 1h p 250 ug acth im serpl-scdiff,cortisol 1 hr post 250 ug corticotropin im [molar conc diff],1 hour; 1.0hr; 17-hydroxycorticosterone; 1h p 250 ug acth; 1h p 250 ug acth im; 60 min; 60 minutes; 60m; 60min; acth; adrenocorticotrophic hormone; adrenocorticotropin; after; c206; c74; chemistry.challenge testing; compound f; coritsol; cort; cortrosyn; f; hydrocortisone; mcg; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; rc206; scdiff; serp; serpl; serplas; serum; serum or plasma; sr; tumor marker,Qn
49976-4,borrelia burgdorferi 34kd igm ab [presence] in cerebral spinal fluid by immunoblot,b burgdor34kd igm csf ql ib,b. burgdorferi 34kd igm ib ql (csf),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; b burg; b burgdor; b burgdor34kd; b burgdorferi; bb; blt; burgdorf; cerebral spinal fluid; cerebrospinal fl; id; immune blot; immune globulin m; immunobl; immunoblot; immunoglobulin m; infectious disease; infectiousdisease; lyme; lyme disease; lymes; microbiology; neuro; neurology; ordinal; osp b; ospb; outer surface protein b; point in time; pr; ql; qual; qualitative; random; riba; screen; spinal fl; spinal fld; spinal flu; spinal fluid; wb; wblot; west blot; west blt; western blot,Ord
49977-2,borrelia burgdorferi 35kd igg ab [presence] in serum by immunoblot,b burgdor35kd igg ser ql ib,b. burgdorferi 35kd igg ib ql (s),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; b burg; b burgdor; b burgdor35kd; b burgdorferi; bb; blt; burgdorf; id; immune blot; immune globulin g; immunobl; immunoblot; immunoglobulin g; infectious disease; infectiousdisease; lyme; lyme disease; lymes; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; riba; screen; serum; sr; wb; wblot; west blot; west blt; western blot,Ord
4998-1,cytomegalovirus dna [presence] in tissue by naa with probe detection,cmv dna tiss ql naa+probe,cmv dna naa+probe ql (tiss),"3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; cmv; cytomegalo virus; cytomgal; deoxyribonucleic acid; dna nucleic acid probe; dna probe; hhv-5; human herpesvirus-5; id; infectious disease; infectiousdisease; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; naa+probe; naat; nasba; nucleic acid sequence based analysis; ordinal; pcr; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; screen; sda; strand displacement amplification; tissue; tissue, unspecified; tma; transcription mediated amplification",Ord
49981-4,borrelia burgdorferi 37kd igg ab [presence] in serum by immunoblot,b burgdor37kd igg ser ql ib,b. burgdorferi 37kd igg ib ql (s),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; b burg; b burgdor; b burgdor37kd; b burgdorferi; bb; blt; burgdorf; id; immune blot; immune globulin g; immunobl; immunoblot; immunoglobulin g; infectious disease; infectiousdisease; lyme; lyme disease; lymes; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; riba; screen; serum; sr; wb; wblot; west blot; west blt; western blot,Ord
50007-4,cytology report of bronchoalveolar lavage cyto stain,cytology bal doc cyto,cytology report cyto stain doc (bal),bronchial alveolar lavage; bronchoalveolar lavage; cytology stain; cytostain; document; finding; findings; pap smear; pap stain; papanicolaou smear; point in time; random; st; stains; stn,Doc
50011-6,transfusion start time,transf start time bpu,transfusion start time (bpu) [date/time],blood bank; blood product unit; blood product unit (pack); date and time; point in time; qnt; quan; quant; quantitative; random; started; time stamp; timestamp; transf start time; tx,Qn
50034-8,arbovirus neutralizing antibody [identifier] in specimen by neutralization test,arbovirus nab spec nt,arbovirus neut ab neut test nom (specimen),abs; aby; antby; anti; antibodies; antibody; arbo virus; autoantibodies; autoantibody; conventional virus neutralization test; cvnt; id; identity or presence; infectious disease; infectiousdisease; microbiology; misc; miscellaneous; nab; neutralization; neutralization test; nominal; nt; other; point in time; random; serum virus neutralization; spec; svn; to be specified in another part of the message; unspecified; virus neutralization test; vnt,Nom
50070-2,11-hydroxyandrostenedione [moles/volume] in serum or plasma --1 hour post 250 ug corticotropin,11oh-ad 1h p 250 ug acth serpl-scnc,11-hydroxyandrostenedione 1 hr post 250 ug corticotropin [moles/vol],1 hour; 1.0hr; 11-beta-hydroxyandrostenedione; 11-hydroxy androstenedione; 11oh-ad; 1h p 250 ug acth; 60 min; 60 minutes; 60m; 60min; acth; adrenocorticotrophic hormone; adrenocorticotropin; after; c206; c74; chemistry.challenge testing; cortrosyn; level; mcg; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; rc206; serp; serpl; serplas; serum; serum or plasma; sr; substance concentration; tumor marker,Qn
50071-0,11-deoxycortisol [moles/volume] in amniotic fluid,11dc amn-scnc,11-deoxycortisol (amn fld) [moles/vol],11dc; af; amn; amn fl; amnio; amniotic flu; amniotic fluid; chemistry; compound s; cortexolone; cortodoxone; deoxycortisol; desoxycortisol; level; metopirone; point in time; qnt; quan; quant; quantitative; random; substance concentration,Qn
50074-4,11-deoxycortisol [moles/volume] in serum or plasma --45 minutes post 250 ug corticotropin,11dc 45m p 250 ug acth serpl-scnc,11-deoxycortisol 45 min post 250 ug corticotropin [moles/vol],11dc; 45m p 250 ug acth; acth; adrenocorticotrophic hormone; adrenocorticotropin; after; c206; c74; chemistry.challenge testing; compound s; cortexolone; cortodoxone; cortrosyn; deoxycortisol; desoxycortisol; level; mcg; metopirone; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; rc206; serp; serpl; serplas; serum; serum or plasma; sr; substance concentration; tumor marker,Qn
50077-7,17-ketosteroids [mass/volume] in urine --2 days post dose dexamethasone,17ks 2d p dex ur-mcnc,17-ketosteroids 2 days post dose dexamethasone (u) [mass/vol],17ks; 17-ks; 2d p dex; after; c350; chemistry.challenge testing; decadron; dexameth; dexone; hexadrol; ketosteroid; ketostroids; level; mass concentration; p dex; p dose; point in time; pst; qnt; quan; quant; quantitative; random; ua; ur; urn,Qn
50089-2,2-methyl-3-hydroxybutyrylcarnitine (c5-oh) [moles/volume] in urine,2me3oh-butyrcarn ur-scnc,2-methyl-3-hydroxybutyrylcarnitine (c5-oh) (u) [moles/vol],2me3oh-butyrcarn; chemistry; ii; iii; level; point in time; qnt; quan; quant; quantitative; random; substance concentration; ua; ur; urn,Qn
500-9,ticarcillin [susceptibility] by minimum inhibitory concentration (mic),ticarcillin islt mic,ticarcillin mic [susc],antibiotic susceptibilities; ast; id; infectious disease; infectiousdisease; islt; isol; minimum inhibitory concentration; point in time; random; sus; suscept; susceptibilities; susceptibility; susceptibilty; ticar; timentin; timj,OrdQn
50097-5,21-deoxycortisol [moles/volume] in serum or plasma --1 hour post 250 ug corticotropin,21dc 1h p 250 ug acth serpl-scnc,21-deoxycortisol 1 hr post 250 ug corticotropin [moles/vol],1 hour; 1.0hr; 1h p 250 ug acth; 21dc; 21-df; 60 min; 60 minutes; 60m; 60min; acth; adrenocorticotrophic hormone; adrenocorticotropin; after; c206; c74; chemistry.challenge testing; cortrosyn; level; mcg; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; rc206; serp; serpl; serplas; serum; serum or plasma; sr; substance concentration; tumor marker,Qn
50116-3,3-hydroxyoleoylcarnitine (c18:1-oh) [moles/volume] in urine,3oh-oleoylcarn ur-scnc,c18:1-oh (u) [moles/vol],3-hydroxy-oleoylcarnitine; 3-hydroxyoleylcarnitine; 3oh-oleoylcarn; c18:1oh; c18:1-oh; chemistry; i; iii; level; point in time; qnt; quan; quant; quantitative; random; substance concentration; ua; ur; urn,Qn
50117-1,3-hydroxyoleoylcarnitine (c18:1-oh)/creatinine [molar ratio] in urine,3oh-oleoylcarn/creat ur-srto,c18:1-oh/creatinine (u) [molar ratio],3-hydroxy-oleoylcarnitine; 3-hydroxyoleylcarnitine; 3oh-oleoylcarn; c18:1oh; c18:1-oh; chemistry; cr; crea; creat; i; iii; point in time; qnt; quan; quant; quantitative; random; scrto; substance concentration ratio; substance ratio; ua; ucr; ur; urn,Qn
50126-2,3-hydroxypalmitoylcarnitine (c16-oh) [moles/volume] in amniotic fluid,3oh-palmitoylcarn amn-scnc,c16-oh (amn fld) [moles/vol],3-hydroxyhexadecanoylcarnitine; 3-hydroxy-hexadecanoylcarnitine; 3-hydroxy-palmitoylcarnitine; 3oh-palmitoylcarn; af; amn; amn fl; amnio; amniotic flu; amniotic fluid; c16oh; c16-oh; chemistry; iii; level; point in time; qnt; quan; quant; quantitative; random; substance concentration,Qn
50130-4,3-hydroxystearoylcarnitine (c18-oh) [moles/volume] in urine,3oh-stearoylcarn ur-scnc,c18-oh (u) [moles/vol],3-hydroxy stearoylcarnitine; 3oh-stearoylcarn; 3-oh-stearoylcarnitine; c18oh; c18-oh; chemistry; iii; level; point in time; qnt; quan; quant; quantitative; random; substance concentration; ua; ur; urn,Qn
50137-9,3-methoxy-4-hydroxyphenylglycol [moles/time] in urine,3me4oh-phenylglycol ur-srate,3-methoxy-4-hydroxyphenylglycol (u) [moles/time],3me4oh-phenylglycol; chemistry; iii; mhpg; norepinephrine metabolite; point in time; qnt; quan; quant; quantitative; random; srate; substance rate; ua; ur; urn; vanylglycol,Qn
50142-9,3-o-methyldopa [moles/volume] in urine,3-o-methyldopa ur-scnc,3-o-methyldopa (u) [moles/vol],3-methoxytyrosine; 3-omd; aldj; aldomet; dopamet; drug/toxicology; drugs; iii; level; novomedopa; point in time; qnt; quan; quant; quantitative; random; substance concentration; ua; ur; urn,Qn
50145-2,3-dechloroethylifosfamide [mass/volume] in blood --pre dose ifosfamide,3d-ifosfamide pre iff bld-mcnc,3-dechloroethylifosfamide pre dose ifosfamide (bld) [mass/vol],3-dechloroethyl-ifosfaminde; 3d-ifo; 3d-ifosfamide; before; blood; drug/toxicology; drugs; ifex; iff; ifosfamide metabolite; iii; level; mass concentration; mitoxana; point in time; pre iff; qnt; quan; quant; quantitative; random; wb; whole blood,Qn
50170-0,aldosterone [moles/volume] in serum or plasma --pre xxx challenge,aldost pre chal serpl-scnc,aldosterone pre unsp challenge [moles/vol],before; chemistry.challenge testing; endocrine; endocrinology; level; pl; plasma; plsm; point in time; pre chal; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; substance concentration,Qn
50176-7,alpha-2-macroglobulin/protein.total in serum or plasma,a2 macroglob mfr serpl,alpha-2-macroglobulin [mass fraction],a2; a2 macroglob; alfa; amg; chemistry; ii; macroglob; macroglobn; macroglobulins; mass fraction; percent; pl; plasma; plsm; point in time; pr; prot; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; tot; totl; tp,Qn
50183-3,calcitonin [mass/volume] in serum or plasma --1 minute post 2 mg/kg calcium and 0.5 ug/kg pentagastrin iv,calcit 1m p cpg iv serpl-mcnc,calcitonin 1 min post 2 mg/kg calcium and 0.5 ug/kg pentagastrin iv [mass/vol],1m p cpg iv; after; ca; cal; chemistry.challenge testing; ct; ii; level; mass concentration; mcg; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; thyrocalcitonin; tumor marker,Qn
50190-8,iron and iron binding capacity panel - serum or plasma,iron+tibc pnl serpl,iron and iron binding capacity panel,bind; chemistry; dtibc; fe; ibc; iron+tibc pnl; pan; panel.chemistry; panl; pl; plasma; plsm; pnl; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; tibc; total iron binding; universallaborders,Qn
50193-2,cholesterol in ldl.narrow density [mass/volume] in serum or plasma,ldlc nd serpl-mcnc,cholesterol in ldl.narrow density [mass/vol],cardio; cardiology; chemistry; chol; choles; cholest; cholesterol total; cholesterols; den; heart disease; ldlc; ldl-c; ldlc nd; level; lipid; low density lipoprotein cholesterol; low density lipoprotein cholesterols; mass concentration; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
50202-1,iron [mass/volume] in serum or plasma --5th specimen,iron sp5 serpl-mcnc,iron 5th specimen [mass/vol],chemistry; fe; level; mass concentration; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sp5; spec; sr,Qn
50204-7,iron [mass/volume] in serum or plasma --7th specimen,iron sp7 serpl-mcnc,iron 7th specimen [mass/vol],chemistry; fe; level; mass concentration; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sp7; spec; sr,Qn
50248-4,17-hydroxycorticosteroids [mass/time] in 24 hour urine --2 days post dose dexamethasone,17ohcs 2d p dex 24h ur-mrate,17-hydroxycorticosteroids 2 days post dose dexamethasone (24h u) [mass/time],1 day; 17-cs; 17-hydroxy corticosteroids; 17ohcs; 17-ohcs; 24 hours; 24hr; 2d p dex; after; c350; chemistry.challenge testing; decadron; dexameth; dexone; hexadrol; mass rate; mrate; p dex; p dose; pst; qnt; quan; quant; quantitative; ua; ur; urn,Qn
50270-8,2-dechloroethylifosfamide [mass/volume] in blood --5 days post dose ifosfamide,2-dce-if 5d p iff bld-mcnc,2-dechloroethylifosfamide 5 days post dose ifosfamide (bld) [mass/vol],2-dce-if; 2-dechloroethyl-ifosfaminde; 2d-ifo; 2d-ifosfamide; 5d p iff; after; blood; drug/toxicology; drugs; ifex; iff; ifosfamide metabolite; ii; level; mass concentration; mitoxana; p dose; p iff; point in time; pst; qnt; quan; quant; quantitative; random; wb; whole blood,Qn
50307-8,bcl10 ag [presence] in tissue by immune stain,bcl10 ag tiss ql imstn,bcl10 ag immune stain ql (tiss),"antigen; antigens; ihc; imm; immunohistochemical stain; immunostain; imstn; imun; imune; ordinal; pathology; point in time; pr; ql; qual; qualitative; random; screen; st; stains; stn; tissue; tissue, unspecified",Ord
50319-3,hbme-1 ag [presence] in tissue by immune stain,hbme-1 ag tiss ql imstn,hbme-1 ag immune stain ql (tiss),"antigen; antigens; i; ihc; imm; immunohistochemical stain; immunostain; imstn; imun; imune; ordinal; pathology; point in time; pr; ql; qual; qualitative; random; screen; st; stains; stn; tissue; tissue, unspecified",Ord
50358-1,phenylacetate/creatinine [molar ratio] in 24 hour urine,phenylacetate/creat 24h ur-srto,phenylacetate/creatinine (24h u) [molar ratio],1 day; 24 hours; 24hr; cr; crea; creat; drug/toxicology; drugs; phenylacetic acid; qnt; quan; quant; quantitative; scrto; substance concentration ratio; substance ratio; ua; ucr; ur; urn,Qn
50370-6,queen palm ige ab/ige total in serum,queen palm ige/ige total %,queen palm ige/total ige (s) [%],%; abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; arecastrum romanzoffianum; autoantibodies; autoantibody; ige total; immune globulin e; immunoglobulin e; point in time; qnt; quan; quant; quantitative; queen palm; random; serum; sr; t072; t72; tot; total ige; totl,Qn
50374-8,myelocytes.eosinophilic/cells in bone marrow by manual count,myelocytes.eos nfr mar manual,myelocytes.eosinophilic/cells manual cnt (bm),bm; bon; bone marrow; cell; cellularity; hematology/cell counts; manl; mar; marrow (bone); minimal angle of resolution; minimum angle of resolution; myel; myelo; myelocyte; number fraction; percent; point in time; qnt; quan; quant; quantitative; random,Qn
50379-7,creatinine dialysis fluid clearance/1.73 sq m,creat cl/1.73 sq m dial fld+serpl-arvrat,creatinine dialysis fluid clearance/1.73 sq m (dialysis fluid+s/p) [vol rate/area],bsa; chemistry; cl; clear; clearanc; clearances; clr; cr; cr df cl; crea; creat; diaf; dial fld+serpl; dialy; dialysate; dialysis fluid; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; square meter; sr; volume rate/area; volume rate/ratio,Qn
50381-3,"creatinine renal clearance/1.73 sq m.predicted among males by cockcroft-gault formula, bsa formula",creat cl/bsa pred.male serpl c-g-arvrat,"creatinine renal clearance/1.73 sq m.predicted among males cockcroft-gault formula, bsa formula [vol rate/area]",bsa pred.male; c-g; chemistry; cl; clear; clearanc; clearances; clr; cockroft-gault formula; cr; crcl/bsa pred; crcl/bsa pred.male; crea; creat; kidney; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; square meter; sr; volume rate/area; volume rate/ratio,Qn
50382-1,glutathione reductase [enzymatic activity/mass] in red blood cells,gr rbc-ccnt,glutathione reductase (rbc) [catalytic activity/mass],catalytic content; chemistry; erythrocytes; gr; gsr; point in time; qnt; quan; quant; quantitative; random; red blood cells; red blood corpusles,Qn
50390-4,coagulation factor ii circulating inhibitor [presence] in platelet poor plasma,fact ii circ inhib ppp ql,coagulation factor ii circulating inhibitor ql (ppp),2; circ; coag; fac; fact; fact ii circ inhib; factor 2; fii; hematology; heme; inhib; inhibit; ordinal; plas; platelet poor plasma; point in time; pr; prothrombin inhibitor; pt inhibitor; ql; qual; qualitative; random; screen,Ord
50403-5,blood pressure systolic and diastolic--before transfusion,bp sys/dias--pre transf,,art sys; before; blood pressure measurements.atom; bp; bp sys/dias; dias; diast; diastoli; point in time; pressure; qnt; quan; quant; quantitative; random; tx,Qn
504-1,ticarcillin+clavulanate [susceptibility] by minimum inhibitory concentration (mic),ticarcillin+clav islt mic,ticarcillin+clavulanate mic [susc],antibiotic susceptibilities; ast; betimol; blocadren; c305; clav; clavate; clavu; clavul; clavulanic; clavulanic acid; id; infectious disease; infectiousdisease; islt; isol; minimum inhibitory concentration; novo-timol; point in time; random; sus; suscept; susceptibilities; susceptibility; susceptibilty; ticar; ticar clav; timentin; timj,OrdQn
50426-6,corticotropin [mass/volume] in plasma --20 minutes post 100 ug crh iv,acth 20m p 100 ug crh iv plas-mcnc,corticotropin 20 min post 100 ug crh iv (p) [mass/vol],20m p 100 ug crh iv; acth; adrenocorticotrophic hormone; adrenocorticotropin; after; c206; c74; chemistry.challenge testing; cortrosyn; level; mass concentration; mcg; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; rc206; tumor marker,Qn
50429-0,cortisol [mass/volume] in serum or plasma --9 am specimen,cortis 9 am serpl-mcnc,cortisol 9 am specimen [mass/vol],17-hydroxycorticosterone; chemistry.challenge testing; compound f; coritsol; cort; f; hydrocortisone; level; mass concentration; morning; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; spec; sr,Qn
50440-7,corticotropin [mass/volume] in plasma --6 am specimen,acth 6 am plas-mcnc,corticotropin 6 am specimen (p) [mass/vol],acth; adrenocorticotrophic hormone; adrenocorticotropin; c206; c74; chemistry.challenge testing; cortrosyn; level; mass concentration; morning; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; rc206; spec; tumor marker,Qn
50450-6,corticotropin [mass/volume] in plasma --6th specimen,acth sp6 plas-mcnc,corticotropin 6th specimen (p) [mass/vol],acth; adrenocorticotrophic hormone; adrenocorticotropin; c206; c74; chemistry.challenge testing; cortrosyn; level; mass concentration; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; rc206; sp6; spec; tumor marker,Qn
50457-1,cortisol [mass/volume] in serum or plasma --5th specimen,cortis sp5 serpl-mcnc,cortisol 5th specimen [mass/vol],17-hydroxycorticosterone; chemistry.challenge testing; compound f; coritsol; cort; f; hydrocortisone; level; mass concentration; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sp5; spec; sr,Qn
50465-4,c peptide [moles/volume] in serum or plasma --5th specimen,c peptide sp5 serpl-scnc,c peptide 5th specimen [moles/vol],chemistry.challenge testing; connecting peptide of insulin; level; pept; pl; plasma; plsm; point in time; pro-insulin c peptide; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sp5; spec; sr; substance concentration,Qn
50471-2,calcitonin [mass/volume] in serum or plasma --3rd specimen,calcit sp3 serpl-mcnc,calcitonin spec 3 [mass/vol],chemistry.challenge testing; ct; level; mass concentration; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sp3; spec; sr; thyrocalcitonin; tumor marker,Qn
50479-5,follitropin [units/volume] in serum or plasma --3rd specimen,fsh sp3 serpl-acnc,follitropin spec 3 qn,arbitrary concentration; chemistry.challenge testing; follicle stimulating hormone; fsh; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sp3; spec; sr,Qn
50480-3,follitropin [units/volume] in serum or plasma --4th specimen,fsh sp4 serpl-acnc,follitropin spec 4 qn,arbitrary concentration; chemistry.challenge testing; follicle stimulating hormone; fsh; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sp4; spec; sr,Qn
50490-2,gastrin [mass/volume] in serum or plasma --6th specimen,gastrin sp6 serpl-mcnc,gastrin 6th specimen [mass/vol],chemistry.challenge testing; level; mass concentration; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sp6; spec; sr; total gastrins; zollinger-ellison syndrome,Qn
50499-3,somatotropin [mass/volume] in serum or plasma --7th specimen,gh sp7 serpl-mcnc,somatotropin 7th specimen [mass/vol],chemistry.challenge testing; endocrine; endocrinology; gh; growth hormone; hgh; human growth hormone; level; mass concentration; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; somatotropic hormone; sp7; spec; sr; sth,Qn
50522-2,prolactin [mass/volume] in serum or plasma --6th specimen,prolactin sp6 serpl-mcnc,prolactin 6th specimen [mass/vol],chemistry.challenge testing; lactotropic hormone; lactotropin; level; mammatropic hormone; mammotropin; mass concentration; pl; plasma; plsm; point in time; prl; prol; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sp6; spec; sr,Qn
50533-9,thyrotropin [units/volume] in serum or plasma --1st specimen,tsh sp1 serpl-acnc,tsh spec 1 qn,acute specimen; arbitrary concentration; chemistry.challenge testing; endocrine; endocrinology; first; pl; plasma; plsm; point in time; pre immunization; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sp1; spec; sr; thyroid stimulating hormone; thyrotropic hormone; tsh,Qn
50542-0,"2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine (eddp) [mass/volume] in urine",eddp ur-mcnc,"2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine (eddp) (u) [mass/vol]",addiction; drug/toxicology; drugs; drugs of abuse; eddp; i; ii; iii; illicit; level; mass concentration; methadone metabolite; point in time; potentialforabuse; qnt; quan; quant; quantitative; random; ua; ur; urn,Qn
50546-1,bacterial susceptibility panel by disk diffusion (kb),bacterial susc pnl islt kb,bacterial susceptibility panel disk diffusion (kb) (isol),antibiotic susceptibilities; bact; bacterial susc pnl; disk diffusion; islt; isol; kb; kirby-bauer; pan; panel.antibiotic susceptibilities; panl; pnl; point in time; random; sus; susc; suscept; susceptibilities; susceptibilty,OrdQn
50547-9,eastern equine encephalitis virus rna [presence] in specimen by naa with probe detection,eeev rna spec ql naa+probe,eeev rna naa+probe ql (specimen),3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; dna nucleic acid probe; dna probe; eee virus; eeev; enc; enceph; encephalomyelitis; equin; id; infectious disease; infectiousdisease; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; misc; miscellaneous; naa+probe; naat; nasba; nucleic acid sequence based analysis; ordinal; other; pcr; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; ribonucleic acid; screen; sda; spec; strand displacement amplification; tma; to be specified in another part of the message; togavirus; transcription mediated amplification; unspecified,Ord
50565-1,fda product label otc - keep out of reach of children section,fda label otc - kor of children,,document.regulatory; fda label; narrative; otc - kor of children; over-the-counter; report,Nar
50576-8,fda product label otc type a medicated article animal drug label,fda label otc_a ma animal drug label,,document.regulatory; drugs; fda label; narrative; otc_a ma animal drug label; over-the-counter; report,Nar
505-8,ticarcillin+clavulanate [susceptibility] by disk diffusion (kb),ticarcillin+clav islt kb,ticarcillin+clavulanate disk diffusion (kb) [susc],antibiotic susceptibilities; ast; betimol; blocadren; c305; clav; clavate; clavu; clavul; clavulanic; clavulanic acid; disk diffusion; id; infectious disease; infectiousdisease; islt; isol; kb; kirby-bauer; novo-timol; point in time; random; sus; suscept; susceptibilities; susceptibility; susceptibilty; ticar; ticar clav; timentin; timj,OrdQn
50587-5,glucose tolerance 4 hours panel - serum or plasma,gtt 4h pnl serpl,glucose tolerance 4 hours panel,chemistry.challenge testing; endocrine; endocrinology; glu; glu tol; gluc; glucose tolerance; glucoseur; gtt; gtt 4h pnl; pan; panel.challenge; panl; pl; plasma; plsm; pnl; qnt; quan; quant; quantitative; serp; serpl; serplas; serum; serum or plasma; sr,Qn
50595-8,pathologist interpretation of specimen tests,path interp spec-imp,pathologist interpretation (specimen) [interp],impression; impression/interpretation of study; impressions; interp; interpret; interpretation; interpt; intrp; misc; miscellaneous; nominal; other; path; path interp; pathology; point in time; random; spec; to be specified in another part of the message; unspecified,Nom
50609-7,nitroblue tetrazolium test (nbt) [units/volume] in blood,nbt bld-acnc,nitroblue tetrazolium test (nbt) qn (bld),arbitrary concentration; blood; hematology/cell counts; nbt; point in time; qnt; quan; quant; quantitative; random; wb; whole blood,Qn
50614-7,hydrogen/expired gas [volume fraction] in exhaled gas --4.5 hours post xxx challenge,breath h2 4.5h p chal,hydrogen/expired gas 4.5 hr post unsp challenge (exhl gas) [volume fraction],270 min; 4 1/2 hours; 4.5h p chal; after; breath; chemistry.challenge testing; exg; exhaled gas; exhaled gas (=breath); gases; h2; hyd; p chal; percent; point in time; pst; qnt; quan; quant; quantitative; random; volfr; volume fraction,Qn
5062-5,borrelia burgdorferi igg ab [units/volume] in serum by immunoassay,b burgdor igg ser ia-acnc,b. burgdorferi igg ia qn (s),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; b burg; b burgdor; b burgdorferi; bb; burgdorf; eia; elfa; elisa; enzyme immunoassay; iaa; id; immune globulin g; immunoglobulin g; infectious disease; infectiousdisease; lyme; lyme disease; lymes; meia; microbiology; point in time; qnt; quan; quant; quantitative; random; serum; sr; suds; universallaborders,Qn
50626-1,dmd gene targeted mutation analysis in blood or tissue by molecular genetics method,dmd gene mut anl bld/t,dmd gene targeted mutation analysis molgen doc (bld/tiss),"blood; bmd; cmd3b; document; dxs142; dxs164; dxs206; dxs230; dxs239; dxs268; dxs269; dxs270; dxs272; dystrophin; finding; findings; genetics; heredity; heritable; inherited; molecular genetics; molecular pathology; molpath; molpath.mutations; mrx85; muscular dystrophy, duchenne and becker types; mut; mut anl; mutations; pcr; point in time; pseudohypertrophic progressive; random; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",Doc
50636-0,giant japanese spider crab ige ab [units/volume] in serum,giant jap spider crab ige qn,giant japanese spider crab ige qn (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; giant jap spider crab; giant japanese spider crab; immune globulin e; immunoglobulin e; point in time; qnt; quan; quant; quantitative; random; serum; sr,Qn
50646-9,latex recombinant (rhev b) 1 ige ab [units/volume] in serum,latex (rhev b) 1 ige qn,latex recombinant (rhev b) 1 ige qn (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; hevea braziliensis; i; immune globulin e; immunoglobulin e; k082; k215; k82; latex (rhev b) 1; ltx; point in time; qnt; quan; quant; quantitative; random; serum; sr,Qn
50655-0,food allergen mix 24 (kiwi+hazelnut+banana+shrimp) ige ab [units/volume] in serum by multidisk,food allerg mix24 ige qn,kiwi+hazelnut+banana+shrimp ige multidisk qn (s),abs; aby; allergen; allergens; allergy testing; allerscan; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; banana; barcelona nut; chinese gooseberry; cob nut; f017; f024; f084; f092; f17; f24; f84; f92; filbert; food allerg mix24; fx24; hazel nut; hazelnut; immune globulin e; immunoglobulin e; kiwi fruit; kiwifruit; musa sp; point in time; prawns; qnt; quan; quant; quantitative; random; serum; shrimp; sr,Qn
50697-2,influenza virus a ag [identifier] in isolate,fluav ag islt,fluav ag nom (isol),antigen; antigens; avian influenza; bird flu; flua; fluav; fluv; fowl plague; id; identity or presence; infectious disease; infectiousdisease; influ; influenza a; influenza a virus; islt; isol; microbiology; nominal; point in time; random,Nom
50709-5,influenza virus b ab [titer] in serum by hemagglutination inhibition,flubv ab titr ser hai,flubv ab hai (s) [titer],abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; dilution factor; dilution factor (titer); flub; flubv; fluv; hemagglutination inhibition; hi; id; infectious disease; infectiousdisease; influ; influenza b; influenza b virus; microbiology; point in time; random; serum; smqn; sr; titer; titered; titre; ttr,SemiQn
50736-8,serotonin release.heparin.unfractionated panel - serum,sra ufh pnl ser,serotonin release.heparin.unfractionated panel (s),5-ht; 5-hydroxytryptamine; 5-hydroxytryptophane; c10h12n2o; enteramine; hep; hepar; heparin dependent platelet antibody; heparn; pan; panel.serology; panl; pnl; point in time; random; serology; serotonin release assay; serum; sr; sra; sra ufh pnl; ufh,-
50751-7,glucose [mass/volume] in serum or plasma --15 minutes post 0.1 u/kg insulin,glucose 15m p 0.1 u/kg ins serpl-mcnc,glucose 15 min post 0.1 u/kg insulin [mass/vol],15m p 0.1 u/kg ins; after; chemistry.challenge testing; endocrine; endocrinology; glu; glu tol; gluc; glucose tolerance; glucoseur; gtt; hum; humulin; ih7; insul; lente; level; mass concentration; nph; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; semilente; serp; serpl; serplas; serum; serum or plasma; sliding; sr; ultralente,Qn
50761-6,a igg ab [titer] in serum or plasma,a igg titr serpl,a igg [titer],abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; blood bank; dilution factor; dilution factor (titer); immune globulin g; immunoglobulin g; pl; plasma; plsm; point in time; random; serp; serpl; serplas; serum; serum or plasma; smqn; sr; titer; titered; titre; ttr,SemiQn
50770-7,ganglioside gm1 igg ab/igm ab [ratio] in serum by immunoassay,gm1 gangl igg/igm ser ia-rto,ganglioside gm1 igg/igm ia (s) [ratio],abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; eia; elfa; elisa; enzyme immunoassay; ganglioside monosialo; gm1 gangl; iaa; immune globulin g; immune globulin m; immunoglobulin g; immunoglobulin m; meia; monosialoganglioside; point in time; qnt; quan; quant; quantitative; random; ratios; rto; serology; serum; sr; suds,Qn
50771-5,ganglioside gm2 igg ab/igm ab [ratio] in serum by immunoassay,gm2 gangl igg/igm ser ia-rto,ganglioside gm2 igg/igm ia (s) [ratio],abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; eia; elfa; elisa; enzyme immunoassay; gm2 gangl; iaa; immune globulin g; immune globulin m; immunoglobulin g; immunoglobulin m; meia; monosialoganglioside; point in time; qnt; quan; quant; quantitative; random; ratios; rto; serology; serum; sr; suds,Qn
50775-6,cancer ag 125 [units/volume] in cerebral spinal fluid,cancer ag125 csf-acnc,cancer ag 125 qn (csf),arbitrary concentration; ca; ca 125; cancer ag125; cancer antigen 125; carbohydrate antigen; carbohydrate antigen 125; cerebral spinal fluid; cerebrospinal fl; chemistry; gyn; gynecology; ob; obgyn; obstetrics; oc125; point in time; qnt; quan; quant; quantitative; random; spinal fl; spinal fld; spinal flu; spinal fluid; tumor marker,Qn
50777-2,cancer ag 15-3 [units/volume] in pericardial fluid,cancer ag15-3 pcar-acnc,cancer ag 15-3 qn (pericard fld),arbitrary concentration; ca; ca 153; ca 15-3; cancer ag15-3; carbohydrate antigen; cardio; cardiology; chemistry; heart disease; iii; muc-1 gene associated ag ca 15-3; oncology; pcar; pericardial fluid; point in time; qnt; quan; quant; quantitative; random; tumor marker,Qn
50797-0,protein.monoclonal band 4 [mass/volume] in serum or plasma by electrophoresis,m protein 4 serpl elph-mcnc,protein.monoclonal band 4 elph [mass/vol],bands; bnd; chemistry; elec; elect; electr; electro; electrophhrs; electrophrs; elp; elph; ep; level; m protein; m protein 4; mass concentration; m-band; monoclonal band; monoclonal spike; m-protein; m-spike; para protein; paraprotein; pl; plasma; plsm; point in time; pr; prot; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; spep; sr,Qn
5081-5,chlamydophila psittaci igm ab [units/volume] in serum,c psittaci igm ser-acnc,c. psittaci igm qn (s),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; avian chlamydiosis; c psittaci; chlamydia; chlamydia psittaci; chlamydial abortion; cps; enzootic abortion of ewes; id; immune globulin m; immunoglobulin m; infectious disease; infectiousdisease; microbiology; ornithosis; ovine chlamydiosis; point in time; psittacosis; qnt; quan; quant; quantitative; random; serum; sr,Qn
508-2,tobramycin [susceptibility] by minimum inhibitory concentration (mic),tobramycin islt mic,tobramycin mic [susc],aminoglycosides; antibiotic susceptibilities; ast; id; infectious disease; infectiousdisease; islt; isol; minimum inhibitory concentration; nebcin; nebdin; point in time; random; sus; suscept; susceptibilities; susceptibility; susceptibilty; tobj; tobra,OrdQn
50837-4,calcium.ionized [moles/volume] in body fluid,ca-i fld-scnc,calcium.ionized (body fld) [moles/vol],"b/f; bf; bod; bodies; body fluid; body fluid, unsp; ca; ca-i; cal; calcium active; calcium free; chemistry; coagulation factor i; fl; fld; flu; fluid; ica; ion; level; point in time; qnt; quan; quant; quantitative; random; substance concentration",Qn
50856-4,deprecated hexaporphyrin [moles/time] in 24 hour urine,deprecated hexapor 24h ur-srate,hexaporphyrin (24h u) [moles/time],1 day; 24 hours; 24hr; chemistry; qnt; quan; quant; quantitative; srate; substance rate; ua; ur; urn,Qn
50882-0,molybdenum [moles/volume] in urine,molybdenum ur-scnc,molybdenum (u) [moles/vol],drug/toxicology; drugs; level; mo; point in time; qnt; quan; quant; quantitative; random; substance concentration; ua; ur; urn,Qn
50892-9,palladium [moles/mass] in hair,palladium hair-scnt,palladium (hair) [moles/mass],c629; drug/toxicology; drugs; har; pd; point in time; qnt; quan; quant; quantitative; random; substance content,Qn
50895-2,ph of pleural fluid by test strip,ph plr strip,ph test strip (pleur fld),chemistry; dip stick; dipstick; log molar concentration; pleural; pleural fluid; point in time; random; smqn; thoracentesis fluid,SemiQn
509-0,tobramycin [susceptibility] by disk diffusion (kb),tobramycin islt kb,tobramycin disk diffusion (kb) [susc],aminoglycosides; antibiotic susceptibilities; ast; disk diffusion; id; infectious disease; infectiousdisease; islt; isol; kb; kirby-bauer; nebcin; nebdin; point in time; random; sus; suscept; susceptibilities; susceptibility; susceptibilty; tobj; tobra,OrdQn
50905-9,silicon [moles/mass] in hair,silicon hair-scnt,silicon (hair) [moles/mass],drug/toxicology; drugs; har; point in time; qnt; quan; quant; quantitative; random; si; substance content,Qn
50908-3,silver [moles/mass] in hair,silver hair-scnt,silver (hair) [moles/mass],ag; drug/toxicology; drugs; har; point in time; qnt; quan; quant; quantitative; random; silv; substance content,Qn
50909-1,silver [moles/volume] in urine,silver ur-scnc,silver (u) [moles/vol],ag; drug/toxicology; drugs; level; point in time; qnt; quan; quant; quantitative; random; silv; substance concentration; ua; ur; urn,Qn
50930-7,uranium [moles/time] in 24 hour urine,uranium 24h ur-srate,uranium (24h u) [moles/time],1 day; 24 hours; 24hr; drug/toxicology; drugs; qnt; quan; quant; quantitative; srate; substance rate; u; ua; ur; urn,Qn
50931-5,uroporphyrin 1 isomer [moles/mass] in stool,uropor1 stl-scnt,uroporphyrin 1 isomer (stl) [moles/mass],bowel movement; chemistry; faecal; faeces; fecal; feces; hematology; heme; i; isom; octacarboxyl porphyrin; octacarboxylporphyrin; octacarboxyphyrin; point in time; porphyria; porphyria cutanea tarda; qnt; quan; quant; quantitative; random; stl; stool = fecal; substance content; urophorph; uropor1; uroporphyrin i,Qn
50935-6,vanadium [moles/volume] in red blood cells,vanadium rbc-scnc,vanadium (rbc) [moles/vol],drug/toxicology; drugs; erythrocytes; level; point in time; qnt; quan; quant; quantitative; random; red blood cells; red blood corpusles; substance concentration; v,Qn
50936-4,vanadium [moles/volume] in urine,vanadium ur-scnc,vanadium (u) [moles/vol],drug/toxicology; drugs; level; point in time; qnt; quan; quant; quantitative; random; substance concentration; ua; ur; urn; v,Qn
50941-4,mycobacterium sp [presence] in specimen by organism specific culture,mycobacterium spec ql cult,mycobacterium sp org specific cx ql (specimen),acid fast; acid fast bacilli; acid fast bacillus; afb; c&s; cult; cultures; id; infectious disease; infectiousdisease; microbiology; misc; miscellaneous; myco; mycobact; ordinal; other; point in time; pr; ql; qual; qualitative; random; screen; spec; species; spp; to be specified in another part of the message; tuberculosis; unspecified,Ord
50944-8,platelet aggregation adp induced [presence] in platelet rich plasma --20 umol/l,pa adp 20 umol/l prp ql,platelet aggregation adp induced 20 umol/l ql (prp),adenosine 5'-pyrophosphate; adenosine pyrophosphate; ado; adp; agg; aggr; aned; clopidogrel response assay; coagulation; hematology; heme; left; levo; medication stress; ordinal; p2y12 assay; p2y12 inhibition; pa; pa adp; pl; platelet rich plasma; platelets; platelt; plavix response assay; plt; point in time; pr; ql; qual; qualitative; random; screen; thrombocyte; thrombocytes,Ord
50953-9,phosphoethanolamine igm ab [presence] in serum or plasma,petn igm serpl ql,phosphoethanolamine igm ql,abs; aby; antby; anti; antibodies; antibody; apea; autoantibodies; autoantibody; coagulation; hematology; heme; immune globulin m; immunoglobulin m; ordinal; pea; petn; pl; plasma; plsm; point in time; pr; ql; qual; qualitative; random; screen; serp; serpl; serplas; serum; serum or plasma; sr,Ord
50958-8,indirect antiglobulin test.unspecified reagent [presence] in serum or plasma --after transfusion,iat p transf serpl ql,indirect antiglobulin test.unspecified reagent post transfusion ql,after; antiglob; blood bank; hematology; heme; iagt; iat; idc; ind; ind coombs; indir; indirect coomb; indirect coombs; ordinal; p transf; pl; plasma; plsm; point in time; pr; pst; ql; qual; qualitative; random; screen; serp; serpl; serplas; serum; serum or plasma; sr; tx,Ord
50964-6,liley zone [presence] in amniotic fluid by spectrophotometry,liley zone amn ql spect,liley zone spectrophotometry ql (amn fld),af; amn; amn fl; amnio; amniotic flu; amniotic fluid; chemistry; ordinal; point in time; pr; ql; qual; qualitative; random; screen,Ord
50971-1,cytology report of bronchial brush cyto stain,cyto bro brush,cytology report cyto stain doc (bronchial brush),bro; bro brush; cytology stain; cytostain; document; finding; findings; pap smear; pap stain; papanicolaou smear; point in time; random; st; stains; stn,Doc
50977-8,echovirus 5 ab [titer] in serum,ecv5 ab titr ser,echovirus 5 ab (s) [titer],abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; dilution factor; dilution factor (titer); echo; echo virus; ecv; ecv5; ev; id; infectious disease; infectiousdisease; microbiology; point in time; random; serum; smqn; sr; titer; titered; titre; ttr,SemiQn
51004-0,lipoprotein midband c [mass/volume] in serum or plasma,lipoprotein midband c serpl-mcnc,lipoprotein midband c [mass/vol],chemistry; level; lip; lipoprot; lipoproteins; lp; mass concentration; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
51011-5,cd3-cd16+cd56+cd244+ cells/cells in specimen,cd3-cd16+cd56+cd244+ cells nfr spec,cd3-cd16+cd56+cd244+ cells/cells (specimen),cb4; cd2b4; cd3 cells; cd3+cd16+ cells; cd3+cd16+cd56+ cells; cd3-cd16+ cells; cd3-cd16+cd56+ cells; cd3-cd16+cd56+cd244+ cells; cell; cell markers; cellularity; fcgr3a; leu11; leu-11; leu11b; leu-11b; leu19; leu-19; leu4; leu-4; misc; miscellaneous; natural killer cells; ncam; neural cell adhesion molecule; nkh1; number fraction; other; percent; point in time; qnt; quan; quant; quantitative; random; spec; t3; to be specified in another part of the message; unspecified,Qn
51012-3,bclxl cells/cells in specimen,bclxl cells nfr spec,bclxl cells/cells (specimen),bclxl cells; cell; cell markers; cellularity; misc; miscellaneous; number fraction; other; percent; point in time; qnt; quan; quant; quantitative; random; spec; to be specified in another part of the message; unspecified,Qn
51038-8,cd11b blasts/blasts in blood,cd11b blasts/blasts nfr bld,cd11b blasts/blasts (bld),alpham integrin chain; alpham-beta2; blast; blood; c3bir; cd11b blasts; cell markers; cr3; leu15; leu-15; mac-1; mo1; number fraction; percent; point in time; qnt; quan; quant; quantitative; r3; random; wb; whole blood,Qn
51055-2,cd127 blasts/blasts in bone marrow,cd127 blasts/blasts nfr mar,cd127 blasts/blasts (bm),blast; bm; bon; bone marrow; cd127 blasts; cell markers; il-7r; il-7r alpha; mar; marrow (bone); minimal angle of resolution; minimum angle of resolution; number fraction; p90 il7 r; percent; point in time; qnt; quan; quant; quantitative; random,Qn
51062-8,cytoplasmic cd13 blasts/blasts in blood,cycd13 blasts/blasts nfr bld,cytoplasmic cd13 blasts/blasts (bld),aminopeptidase n; apn; blast; blood; cell markers; cycd13; cycd13 blasts; cytopl; cytoplas; gp150; leum7; leu-m7; my7; my-7; number fraction; percent; point in time; qnt; quan; quant; quantitative; random; wb; whole blood,Qn
51073-5,cd135 blasts [units/volume] in blood,cd135 blasts bld-acnc,cd135 blasts qn (bld),arbitrary concentration; blast; blood; cd135 blasts; cell markers; flk-2; flt3; point in time; qnt; quan; quant; quantitative; random; wb; whole blood,Qn
5107-8,coxsackievirus b3 neutralizing antibody [titer] in serum by neutralization test,cv b3 nab titr ser nt,coxsackievirus b3 neut ab neut test (s) [titer],abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; cav; conventional virus neutralization test; coxsackie; coxsackie virus; cv; cv b3; cvnt; dilution factor; dilution factor (titer); id; infectious disease; infectiousdisease; microbiology; nab; neutralization; neutralization test; nt; point in time; random; serum; serum virus neutralization; smqn; sr; svn; titer; titered; titre; ttr; virus neutralization test; vnt,SemiQn
51107-1,cd1a blasts/blasts in blood,cd1a blasts/blasts nfr bld,cd1a blasts/blasts (bld),blast; blood; cd1a blasts; cell markers; hta1; number fraction; percent; point in time; qnt; quan; quant; quantitative; r4; random; wb; whole blood,Qn
51119-6,cytoplasmic cd22 blasts/blasts in blood,cycd22 blasts/blasts nfr bld,cytoplasmic cd22 blasts/blasts (bld),b3; b-3; blast; bl-cam; blood; cell markers; cycd22; cycd22 blasts; cytopl; cytoplas; leu14; leu-14; lyb8; number fraction; percent; point in time; qnt; quan; quant; quantitative; random; to-15; wb; whole blood,Qn
51123-8,cytoplasmic cd22 blasts [units/volume] in specimen,cycd22 blasts spec-acnc,cytoplasmic cd22 blasts qn (specimen),arbitrary concentration; b3; b-3; blast; bl-cam; cell markers; cycd22; cycd22 blasts; cytopl; cytoplas; leu14; leu-14; lyb8; misc; miscellaneous; other; point in time; qnt; quan; quant; quantitative; random; spec; to be specified in another part of the message; to-15; unspecified,Qn
51131-1,cd23 blasts/blasts in blood,cd23 blasts/blasts nfr bld,cd23 blasts/blasts (bld),b6; b-6; blast; blast-2; blood; cd23 blasts; cell markers; fcerii; leu20; leu-20; low affinity ige receptor; number fraction; percent; point in time; qnt; quan; quant; quantitative; random; wb; whole blood,Qn
51138-6,cytoplasmic cd3 blasts/blasts in blood,cycd3 blasts/blasts nfr bld,cytoplasmic cd3 blasts/blasts (bld),blast; blood; cell markers; cycd3; cycd3 blasts; cytopl; cytoplas; leu4; leu-4; number fraction; percent; point in time; qnt; quan; quant; quantitative; random; t3; wb; whole blood,Qn
511-6,trimethoprim [susceptibility] by minimum lethal concentration (mlc),trimethoprim islt mlc,trimethoprim mlc [susc],antibiotic susceptibilities; ast; c202; c242; c62; id; infectious disease; infectiousdisease; islt; isol; mbc; minimum bactericidal concentration; minimum lethal concentration; point in time; polytrim; primsol; proloprim; qnt; quan; quant; quantitative; random; sus; suscept; susceptibilities; susceptibility; susceptibilty; tmp; trimeth; trimpex,Qn
51162-6,cd34 blasts/blasts in bone marrow,cd34 blasts/blasts nfr mar,cd34 blasts/blasts (bm),blast; bm; bon; bone marrow; cd34 blasts; cell markers; gp105-120; hematopoietic stem cell; hsc; mar; marrow (bone); minimal angle of resolution; minimum angle of resolution; my10; my-10; number fraction; percent; point in time; qnt; quan; quant; quantitative; random; stem cells,Qn
51164-2,cd34 blasts [units/volume] in bone marrow,cd34 blasts mar-acnc,cd34 blasts qn (bm),arbitrary concentration; blast; bm; bon; bone marrow; cd34 blasts; cell markers; gp105-120; hematopoietic stem cell; hsc; mar; marrow (bone); minimal angle of resolution; minimum angle of resolution; my10; my-10; point in time; qnt; quan; quant; quantitative; random; stem cells,Qn
51187-3,cd15 ag [presence] in blood by immune stain,cd15 ag bld ql imstn,cd15 ag immune stain ql (bld),3-fal; 3-fl; antigen; antigens; blood; cell markers; ihc; imm; immunohistochemical stain; immunostain; imstn; imun; imune; lacto-n-neo-fucopentaose iii; leum1; leu-m1; lewis x; lex; lnfp iii; m-1; my1; my-1; ordinal; point in time; pr; ql; qual; qualitative; random; screen; ssea-1; st; stains; stn; wb; whole blood; x-hapten,Ord
51195-6,desbutylbupivacaine [mass/volume] in serum or plasma,desbutylbupivacaine serpl-mcnc,desbutylbupivacaine [mass/vol],drug/toxicology; drugs; level; mass concentration; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
51206-1,strontium [mass/volume] in body fluid,strontium fld-mcnc,strontium (body fld) [mass/vol],"b/f; bf; bod; bodies; body fluid; body fluid, unsp; drug/toxicology; drugs; fl; fld; flu; fluid; level; mass concentration; point in time; qnt; quan; quant; quantitative; random; sr",Qn
51216-0,cd10 cells/cells in bone marrow,cd10 cells nfr mar,cd10 cells/cells (bm),bm; bon; bone marrow; calla; cd10 cells; cell; cell markers; cellularity; common acute lymphoblastic leukemia; common acute lymphoblastic leukemia antigen; enkephalinase; gp100; j5; mar; marrow (bone); minimal angle of resolution; minimum angle of resolution; nep; neprilysin; neutral endopeptidase metalloendopeptidase; number fraction; percent; point in time; qnt; quan; quant; quantitative; random,Qn
51217-8,cd10 cells/cells in body fluid,cd10 cells nfr fld,cd10 cells/cells (body fld),"b/f; bf; bod; bodies; body fluid; body fluid, unsp; calla; cd10 cells; cell; cell markers; cellularity; common acute lymphoblastic leukemia; common acute lymphoblastic leukemia antigen; enkephalinase; fl; fld; flu; fluid; gp100; j5; nep; neprilysin; neutral endopeptidase metalloendopeptidase; number fraction; percent; point in time; qnt; quan; quant; quantitative; random",Qn
51220-2,cd103 cells/cells in cerebral spinal fluid,cd103 cells nfr csf,cd103 cells/cells (csf),cd103 cells; cell; cell markers; cellularity; cerebral spinal fluid; cerebrospinal fl; hml-1; human mucosal lymphocyte antigen 1; integrin alphae chain; itgae; number fraction; percent; point in time; qnt; quan; quant; quantitative; random; spinal fl; spinal fld; spinal flu; spinal fluid,Qn
51221-0,cd103 cells/cells in bone marrow,cd103 cells nfr mar,cd103 cells/cells (bm),bm; bon; bone marrow; cd103 cells; cell; cell markers; cellularity; hml-1; human mucosal lymphocyte antigen 1; integrin alphae chain; itgae; mar; marrow (bone); minimal angle of resolution; minimum angle of resolution; number fraction; percent; point in time; qnt; quan; quant; quantitative; random,Qn
51227-7,cd11b cells/cells in tissue,cd11b cells nfr tiss,cd11b cells/cells (tiss),"alpham integrin chain; alpham-beta2; c3bir; cd11b cells; cell; cell markers; cellularity; cr3; leu15; leu-15; mac-1; mo1; number fraction; percent; point in time; qnt; quan; quant; quantitative; r3; random; tissue; tissue, unspecified",Qn
51242-6,cd13+cd33+hla-dr+ cells/cells in cerebral spinal fluid,cd13+cd33+hla-dr+ cells nfr csf,cd13+cd33+hla-dr+ cells/cells (csf),aminopeptidase n; apn; cd13 cells; cd13+cd33+ cells; cd13+cd33+hla-dr+ cells; cell; cell markers; cellularity; cerebral spinal fluid; cerebrospinal fl; gp150; gp67; human leukocyte antigen; i3; leum7; leu-m7; leum9; leu-m9; my7; my-7; my9; my-9; number fraction; p67; percent; point in time; qnt; quan; quant; quantitative; random; spinal fl; spinal fld; spinal flu; spinal fluid,Qn
51246-7,cd138 cells/cells in cerebral spinal fluid,cd138 cells nfr csf,cd138 cells/cells (csf),cd138 cells; cell; cell markers; cellularity; cerebral spinal fluid; cerebrospinal fl; heparan sulfate proteoglycan; number fraction; percent; point in time; qnt; quan; quant; quantitative; random; spinal fl; spinal fld; spinal flu; spinal fluid; syndecan-1,Qn
51247-5,cd14 cells/cells in cerebral spinal fluid,cd14 cells nfr csf,cd14 cells/cells (csf),cd14 cells; cell; cell markers; cellularity; cerebral spinal fluid; cerebrospinal fl; leum3; leu-m3; lps receptor; lps-r; mo2; mo-2; my4; my-4; number fraction; percent; point in time; qnt; quan; quant; quantitative; random; spinal fl; spinal fld; spinal flu; spinal fluid,Qn
51249-1,cd15 cells/cells in tissue,cd15 cells nfr tiss,cd15 cells/cells (tiss),"3-fal; 3-fl; cd15 cells; cell; cell markers; cellularity; lacto-n-neo-fucopentaose iii; leum1; leu-m1; lewis x; lex; lnfp iii; m-1; my1; my-1; number fraction; percent; point in time; qnt; quan; quant; quantitative; random; ssea-1; tissue; tissue, unspecified; x-hapten",Qn
51253-3,cd16+cd56+ cells/cells in tissue,cd16+cd56+ cells nfr tiss,cd16+cd56+ cells/cells (tiss),"cd16 cells; cd16+cd56+ cells; cell; cell markers; cellularity; fcgr3a; leu11; leu-11; leu11b; leu-11b; leu19; leu-19; ncam; neural cell adhesion molecule; nkh1; number fraction; percent; point in time; qnt; quan; quant; quantitative; random; tissue; tissue, unspecified",Qn
51270-7,cd25 cells/cells in cerebral spinal fluid,cd25 cells nfr csf,cd25 cells/cells (csf),cd25 cells; cell; cell markers; cellularity; cerebral spinal fluid; cerebrospinal fl; il-2 receptor alpha chain; il-2r; il-2r tac antigen; ilr2; number fraction; percent; point in time; qnt; quan; quant; quantitative; random; spinal fl; spinal fld; spinal flu; spinal fluid; tac antigen,Qn
51290-5,cd30 cells/cells in body fluid,cd30 cells nfr fld,cd30 cells/cells (body fld),"b/f; ber-h2 ag; ber-h2 antigen; bf; bod; bodies; body fluid; body fluid, unsp; cd30 cells; cell; cell markers; cellularity; fl; fld; flu; fluid; ki-1 ag; ki-1 antigen; number fraction; percent; point in time; qnt; quan; quant; quantitative; random",Qn
51291-3,cd33 cells/cells in tissue,cd33 cells nfr tiss,cd33 cells/cells (tiss),"cd33 cells; cell; cell markers; cellularity; gp67; leum9; leu-m9; my9; my-9; number fraction; p67; percent; point in time; qnt; quan; quant; quantitative; random; tissue; tissue, unspecified",Qn
51296-2,cd38 cells/cells in tissue,cd38 cells nfr tiss,cd38 cells/cells (tiss),"adp-ribosyl cyclase; cd38 cells; cell; cell markers; cellularity; cyclic adp-ribose hydrolase; leu17; leu-17; number fraction; percent; point in time; qnt; quan; quant; quantitative; random; t10; tissue; tissue, unspecified",Qn
51303-6,cd4+cd7- cells/cells in cerebral spinal fluid,cd4+cd7- cells nfr csf,cd4+cd7- cells/cells (csf),cd4 cells; cd4+cd7- cells; cd4+cd7+ cells; cell; cell markers; cellularity; cerebral spinal fluid; cerebrospinal fl; gp40; helper t cells; inducer t cells; l3t4; leu3; leu-3; leu9; leu-9; neuro; neurology; number fraction; percent; point in time; qnt; quan; quant; quantitative; random; spinal fl; spinal fld; spinal flu; spinal fluid; t-2; t4; t-4; tp41; w3/25,Qn
51315-0,cd4+cd7-cd49d- cells/cells in body fluid,cd4+cd7-cd49d- cells nfr fld,cd4+cd7-cd49d- cells/cells (body fld),"alpha-4 integrin chain; b/f; bf; bod; bodies; body fluid; body fluid, unsp; cd4 cells; cd4+cd7- cells; cd4+cd7+ cells; cd4+cd7-cd49d- cells; cell; cell markers; cellularity; fl; fld; flu; fluid; gp40; helper t cells; inducer t cells; l3t4; leu3; leu-3; leu9; leu-9; number fraction; percent; point in time; qnt; quan; quant; quantitative; random; t-2; t4; t-4; tp41; vla-4 alpha chain; w3/25",Qn
5131-8,dna double strand ab [presence] in serum by immunofluorescence,dsdna ab ser ql if,dna double strand ab if ql (s),abs; aby; acif; antby; anti; antibodies; antibody; anticomplement immunofluorescence; autoantibodies; autoantibody; deoxyribonucleic acid; dna binding ab; ds; dsdna; dsnda; fa; fluorescent antibody; fluoresent; ifa; immune fluorescence; immunoflour; immunofluor; immunofluorescence; native dna; n-dna; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serology; serum; sr; stranded; strnd; time resolved fluorescence; trf,Ord
51319-2,cd41 cells/cells in bone marrow,cd41 cells nfr mar,cd41 cells/cells (bm),alpha iib integrin chain; bm; bon; bone marrow; cd41 cells; cell; cell markers; cellularity; glycoprotein iib; gpiib; mar; marrow (bone); minimal angle of resolution; minimum angle of resolution; number fraction; percent; point in time; qnt; quan; quant; quantitative; random,Qn
51321-8,cd42 cells/cells in tissue,cd42 cells nfr tiss,cd42 cells/cells (tiss),"cd42 cells; cell; cell markers; cellularity; number fraction; percent; point in time; qnt; quan; quant; quantitative; random; tissue; tissue, unspecified",Qn
51326-7,cd42b cells/cells in cerebral spinal fluid,cd42b cells nfr csf,cd42b cells/cells (csf),cd42b cells; cell; cell markers; cellularity; cerebral spinal fluid; cerebrospinal fl; glycocalicin; gpiba; gpibalpha; number fraction; percent; point in time; qnt; quan; quant; quantitative; random; spinal fl; spinal fld; spinal flu; spinal fluid,Qn
51348-1,cd56+cd57+ cells/cells in body fluid,cd56+cd57+ cells nfr fld,cd56+cd57+ cells/cells (body fld),"b/f; bf; bod; bodies; body fluid; body fluid, unsp; cd56 cells; cd56+cd57+ cells; cell; cell markers; cellularity; fl; fld; flu; fluid; hnk1; leu19; leu-19; leu7; leu-7; ncam; neural cell adhesion molecule; nkh1; number fraction; percent; point in time; qnt; quan; quant; quantitative; random",Qn
51361-4,cd61 cells/cells in bone marrow,cd61 cells nfr mar,cd61 cells/cells (bm),beta 3; beta 3 integrin chain; beta3; beta-3 integrin; bm; bon; bone marrow; cd61 cells; cd61a; cell; cell markers; cellularity; gpiib/iiia; mar; marrow (bone); minimal angle of resolution; minimum angle of resolution; number fraction; percent; point in time; qnt; quan; quant; quantitative; random,Qn
51390-3,deprecated abdomen x-ray ap & lateral,deprecated abd xr ap+lat,,abd; abdo; abdomen+; abdominal; anterio-posterior; anteroposterior; ap+lat; films; finding; findings; imaging; lat; narrative; plain films; point in time; rad; radiology; random; report; view; views & ap kub; views (ap; views ap kub & lateral; views ap+lateral; views+ap; vws; xray; x-ray,Nar
51394-5,xr ankle and foot - right views,xr ankle+foot-r views,,ankle+foot-r; ankle-r; document; ext; extr-r; films; finding; findings; ft; imaging; le; leg; le-r; low; lower extremity; lower extremity joint; msk; musculoskeletal; ortho; orthopedics; plain films; point in time; r; rad; radiology; random; rle; rt; view; vws; xray; x-ray,Doc
51397-8,cd65w cells/cells in cerebral spinal fluid,cd65w cells nfr csf,cd65w cells/cells (csf),cd65w cells; cell; cell markers; cellularity; cerebral spinal fluid; cerebrospinal fl; number fraction; percent; point in time; qnt; quan; quant; quantitative; random; spinal fl; spinal fld; spinal flu; spinal fluid,Qn
51398-6,cd65w cells/cells in bone marrow,cd65w cells nfr mar,cd65w cells/cells (bm),bm; bon; bone marrow; cd65w cells; cell; cell markers; cellularity; mar; marrow (bone); minimal angle of resolution; minimum angle of resolution; number fraction; percent; point in time; qnt; quan; quant; quantitative; random,Qn
51402-6,cd81 cells/cells in cerebral spinal fluid,cd81 cells nfr csf,cd81 cells/cells (csf),cd81 cells; cell; cell markers; cellularity; cerebral spinal fluid; cerebrospinal fl; number fraction; percent; point in time; qnt; quan; quant; quantitative; random; spinal fl; spinal fld; spinal flu; spinal fluid; tapa-1,Qn
5141-7,echovirus 3 ab [titer] in serum by complement fixation,ecv3 ab titr ser cf,echovirus 3 ab cf (s) [titer],abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; cf; comp fixation; compfix; complement fixation; dilution factor; dilution factor (titer); echo; echo virus; echovirus type 3; ecv; ecv3; ev; id; iii; infectious disease; infectiousdisease; microbiology; point in time; random; serum; smqn; sr; titer; titered; titre; ttr,SemiQn
51417-4,coproporphyrin/porphyrins.total in 24 hour urine,copro 24h sfr ur,coproporphyrin/total porphyrins (24h u) [molar fraction],1 day; 24 hours; 24hr; chemistry; copro; coproporph; coproporphyrins; hematology; heme; percent; porph; porphyrin; qnt; quan; quant; quantitative; substance fraction; tetracarboxyl porphyrin; tetracarboxylporphyrin; tetracarboxylporphyrins; tetracarboxyporphyrin; tot; totl; ua; ur; urn,Qn
51434-9,somatotropin [mass/volume] in serum or plasma --pre or post xxx challenge,gh pre/p chal serpl-mcnc,somatotropin pre or post unsp challenge [mass/vol],after; before; chemistry.challenge testing; endocrine; endocrinology; gh; growth hormone; hgh; human growth hormone; level; mass concentration; p chal; pl; plasma; plsm; point in time; pre/p chal; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; somatotropic hormone; sr; sth,Qn
51437-2,protein.monoclonal band 2 [mass/volume] in urine by electrophoresis,m protein 2 ur elph-mcnc,protein.monoclonal band 2 elph (u) [mass/vol],bands; bnd; chemistry; elec; elect; electr; electro; electrophhrs; electrophrs; elp; elph; ep; ii; kidney; level; m protein; m protein 2; mass concentration; m-band; monoclonal band; monoclonal spike; m-protein; m-spike; nephrology; para protein; paraprotein; peur; point in time; pr; prot; qnt; quan; quant; quantitative; random; renal; ua; upep; ur; urn,Qn
51441-4,macroprolactin/prolactin [mass] in serum or plasma,macroprolactin/prolactin mfr serpl,macroprolactin/prolactin [mass fraction],bbprl; big-big prolactin; chemistry; igg-bound prolactin; lactotropic hormone; lactotropin; mammatropic hormone; mammotropin; mass fraction; percent; pl; plasma; plsm; point in time; prl; prol; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
51443-0,cd117 cells [units/volume] in blood,cd117 cells bld-acnc,cd117 cells qn (bld),arbitrary concentration; blood; cd117 cells; cell; cell markers; cellularity; c-kit; point in time; qnt; quan; quant; quantitative; random; scfr; stem cell factor receptor; wb; whole blood,Qn
51455-4,filaria igg1 ab [units/volume] in serum,filaria igg1 ser-acnc,filaria igg1 ab qn (s),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; filarial; filariasis; id; igg 1; igg subgroup 1; infectious disease; infectiousdisease; microbiology; microfilaria; point in time; qnt; quan; quant; quantitative; random; serum; sr,Qn
51460-4,influenza virus a h16 ab [titer] in serum,fluav h16 ab titr ser,fluav h16 ab (s) [titer],abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; avian influenza; bird flu; dilution factor; dilution factor (titer); flua; fluav; fluav h16; fluv; fowl plague; id; infectious disease; infectiousdisease; influ; influenza a; influenza a virus; microbiology; point in time; random; serum; smqn; sr; titer; titered; titre; ttr,SemiQn
51468-7,plasmodium ovale igg ab [titer] in serum,p ovale igg titr ser,p. ovale igg (s) [titer],abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; dilution factor; dilution factor (titer); id; immune globulin g; immunoglobulin g; infectious disease; infectiousdisease; malaria; malarial; microbiology; p ovale; point in time; random; serum; smqn; sr; titer; titered; titre; ttr,SemiQn
51475-2,treponema pallidum ab [titer] in cerebral spinal fluid,t pallidum ab titr csf,t. pallidum ab (csf) [titer],abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; cerebral spinal fluid; cerebrospinal fl; dilution factor; dilution factor (titer); id; infectious disease; infectiousdisease; microbiology; neuro; neurology; point in time; random; smqn; spinal fl; spinal fld; spinal flu; spinal fluid; syphilis; t pallidum; titer; titered; titre; treponemal; ttr,SemiQn
51477-8,coccidioides sp igm ab [presence] in specimen by immune diffusion (id),coccidioides igm spec ql id,coccidioides sp igm immune diff ql (specimen),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; coccidiodes; id; imm; immune globulin m; immunodiff; immunodiffusion; immunoglobulin m; imun; imune; infectious disease; infectiousdisease; microbiology; misc; miscellaneous; ordinal; other; point in time; pr; ql; qual; qualitative; random; san joaquin valley fever; screen; spec; species; spp; to be specified in another part of the message; unspecified; valley fever,Ord
51486-9,epithelial cells.squamous [#/volume] in urine by automated count,squamous # ur auto,epithelial cells.squamous auto (u) [#/vol],#; abs; absolute; absolutes; auto; automated detection; cell; cellularity; cnt; count; count/volume; ct; elec; elect; electr; epi; epi cells; epith; epithelia; number concentration; number concentration (count/vol); point in time; qnt; quan; quant; quantitative; random; sec; sq; squamous cell; squamous epithelial cell; squamous epithelial cells; ua; ur; urinalysis; urn,Qn
5149-0,echovirus ab [titer] in serum by complement fixation,ecv ab titr ser cf,echovirus ab cf (s) [titer],abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; cf; comp fixation; compfix; complement fixation; dilution factor; dilution factor (titer); echo; echo virus; ecv; ev; id; infectious disease; infectiousdisease; microbiology; point in time; random; serum; smqn; sr; titer; titered; titre; ttr,SemiQn
51492-7,cortisol [mass/volume] in saliva (oral fluid) --3rd specimen post xxx challenge,cortis sp3 p chal sal-mcnc,cortisol 3rd specimen post unsp challenge (sal) [mass/vol],17-hydroxycorticosterone; after; chemistry.challenge testing; compound f; coritsol; cort; f; hydrocortisone; level; mass concentration; oral fluid; p chal; point in time; pst; qnt; quan; quant; quantitative; random; sal; sp3; sp3 p chal; spec,Qn
51501-5,estradiol (e2) [mass/volume] in serum or plasma --2nd specimen post xxx challenge,estradiol sp2 p chal serpl-mcnc,e2 2nd specimen post unsp challenge [mass/vol],17-beta estradiol; after; chemistry.challenge testing; convalescent; e2; level; mass concentration; oestradiol; p chal; pl; plasma; plsm; point in time; post immunization; pst; qnt; quan; quant; quantitative; random; second; serp; serpl; serplas; serum; serum or plasma; sp2; sp2 p chal; spec; sr,Qn
51516-3,lactate dehydrogenase 3/lactate dehydrogenase.total in cerebral spinal fluid by electrophoresis,ldh3 cfr csf elph,ldh 3 elph (csf) [catalytic fraction],2-hydroxypropanoic acid; 2-hydroxy-propionate; 2-hydroxy-propionic acid; catalytic fraction; cerebral spinal fluid; cerebrospinal fl; chemistry; dehydrog; dehyrdogenase; elec; elect; electr; electro; electrophhrs; electrophrs; elp; elph; ep; iii; l.d.h; lact; lactate dehydrogenase.fraction 3; lactic acid; lactic acid dehydrogenase; ld; ld3; ldh; ldh isoenzyme 3; ldh3; l-lactate; l-lactate dehydrogenase; percent; point in time; qnt; quan; quant; quantitative; random; spinal fl; spinal fld; spinal flu; spinal fluid; tot; totl; tumor marker,Qn
51533-8,european house dust mite igg ab [presence] in serum,d pteronyss igg ql,european house dust mite igg ql (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; d pteronyss; d pteronyssinus; d001; d1; european house dust mite; gd1; hdm; house dust mite; immune globulin g; immunoglobulin g; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; sr,Ord
51535-3,timothy igg ab [presence] in serum,timothy igg ql,timothy igg ql (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; g006; g6; gg6; immune globulin g; immunoglobulin g; ordinal; phleum pretense; point in time; pr; ql; qual; qualitative; random; screen; serum; sr; timothy; timothy grass,Ord
51545-2,budgerigar droppings igg ab [presence] in serum,budgie drop igg ql,budgerigar droppings igg ql (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; australian parrot; autoantibodies; autoantibody; budgeriar; budgie; budgie drop; e77; feces; immune globulin g; immunoglobulin g; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; sr; stool,Ord
51571-8,deprecated aspergillus fumigatus recombinant (rasp f) 4 ige ab rast class [presence] in serum,deprecated a fumigatus (rasp f) 4 ige rast ql,a. fumigatus recombinant (rasp f) 4 ige rast class (s),a fumigatus; a fumigatus (rasp f) 4; abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; asperg; aspergil; aspergilis; aspergilla; aspergillin; aspergillosis; aspergils; aspergilus; autoantibodies; autoantibody; farmers lung; fum; ige rast; immune globulin e; immunoglobulin e; m003; m221; m3; ordinal; point in time; pr; ql; qual; qualitative; random; rasp f 4; rm221; screen; serum; sr,Ord
51588-2,granulocytes [#/volume] in blood by manual count,granulocytes # bld manual,granulocytes manual cnt (bld) [#/vol],#; abs; absolute; absolutes; blood; cnt; count; count/volume; ct; gran; grans; granulocyte; granulocytes; hematology/cell counts; manl; number concentration; number concentration (count/vol); point in time; qnt; quan; quant; quantitative; random; wb; whole blood,Qn
51589-0,dyserythropoiesis [presence] in blood by light microscopy,dyserythropoiesis bld ql smear,dyserythropoiesis lm ql (bld),blood; hematology/cell counts; lm; micro; micros; microscopic; ordinal; point in time; pr; ql; qual; qualitative; random; screen; wb; whole blood,Ord
51592-4,creatinine [moles/time] in 12 hour urine,creat 12h ur-srate,creatinine (12h u) [moles/time],12 hours; 12hr; chemistry; cr; crea; creat; kidney; nephrology; qnt; quan; quant; quantitative; renal; srate; substance rate; ua; ucr; ur; urn,Qn
51596-5,glucose [moles/volume] in capillary blood,glucose bldc-scnc,glucose (bldc) [moles/vol],blood - capillary; cap bld; cap blood; capillary bld; capillary blood; chemistry; endocrine; endocrinology; finger stick; glu; gluc; glucoseur; level; point in time; qnt; quan; quant; quantitative; random; substance concentration,Qn
51605-4,triglyceride [moles/volume] in synovial fluid,trigl snv-scnc,triglyceride (syn fld) [moles/vol],chemistry; joint aspirate; joint fld; joint flu; joint fluid; level; point in time; qnt; quan; quant; quantitative; random; rheum; rheumatology; sf; snv; substance concentration; syn; syn fl; synov; synovial fluid; tg; trig; trigly; triglycerides; triglycrides,Qn
51626-0,prothrombin time (pt) factor substitution in platelet poor plasma by coagulation assay --with 1:4 normal plasma 1h post incubation separate tubes,pt 1:4 np 1h separate ppp,pt factor substitution with 1:4 normal plasma 1 hr post incubation separate tubes coag (ppp) [time],1 hour; 1.0hr; 1:4 np 1h separate; 1h p inc; 60 min; 60 minutes; 60m; 60min; after; clot; clottable; coag; coagulation assay; control; fac; fact; hematology; heme; i; mixing studies; plas; platelet poor plasma; point in time; pro time; prothrombin time; protime; pst; pt; pt correction study; pt immediate mix; pt incubated mix; qnt; quan; quant; quantitative; random; tilt tube,Qn
51634-4,reticulocytes.mid [#/volume] in blood,mid retics #,reticulocytes.mid (bld) [#/vol],#; abs; absolute; absolutes; blood; cnt; count; count/volume; ct; hematology; hematology/cell counts; heme; mid retics; number concentration; number concentration (count/vol); point in time; polychromatophilic red cells; qnt; quan; quant; quantitative; random; retic; retics; reticulocyte; wb; whole blood,Qn
51639-3,acanthocytes/1000 erythrocytes in blood by light microscopy,acanthocytes/1000 rbc nfr bld smear,acanthocytes/1000 rbc lm (bld),1000 rbc; acanthocyte; blood; discocytes; erthrocyte; erythrocyte; hematology/cell counts; lm; micro; micros; microscopic; number fraction; percent; point in time; qnt; quan; quant; quantitative; random; rbc; rbcs; red blood cell; red blood cells; red blood corpuscle; red blood corpusles; red cell; red cells; spur cells; wb; whole blood,Qn
51643-5,reticulocytes.high light scatter [#/volume] in blood,hl retics #,reticulocytes.high light scatter (bld) [#/vol],#; abs; absolute; absolutes; blood; cnt; count; count/volume; ct; hematology; hematology/cell counts; heme; hl retics; hlr; number concentration; number concentration (count/vol); point in time; polychromatophilic red cells; qnt; quan; quant; quantitative; random; retic; retics; reticulocyte; wb; whole blood,Qn
51651-8,ige ab [presence] in serum or plasma,ige ab serpl ql,ige ab ql,abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; chemistry; immune globulin e; immunoglobulin e; ordinal; pl; plasma; plsm; point in time; pr; ql; qual; qualitative; random; screen; serp; serpl; serplas; serum; serum or plasma; sr,Ord
51662-5,core respiratory allergens panel - serum,core resp allergen pnl ser,core respiratory allergens panel (s),allergen; allergens; allergy testing; core resp allergen pnl; pan; panel.allergy; panl; pnl; point in time; random; serum; sr; universallaborders,-
51664-1,chikungunya virus rna [presence] in specimen by naa with probe detection,chikv rna spec ql naa+probe,chikv rna naa+probe ql (specimen),3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; chikv; dna nucleic acid probe; dna probe; id; infectious disease; infectiousdisease; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; misc; miscellaneous; naa+probe; naat; nasba; nucleic acid sequence based analysis; ordinal; other; pcr; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; ribonucleic acid; screen; sda; spec; strand displacement amplification; tma; to be specified in another part of the message; transcription mediated amplification; unspecified,Ord
51674-0,17-hydroxypregnenolone [mass/volume] in serum or plasma --6th specimen post xxx challenge,17oh-preg sp6 p chal serpl-mcnc,17-hydroxypregnenolone 6th specimen post unsp challenge [mass/vol],17 alpha-hydroxypregnanolone; 17 hydroxy pregnenolone; 17-alpha-hydroxypregnenolone; 17alpha-hydroxypregnenolone; 17oh-preg; after; chemistry.challenge testing; level; mass concentration; p chal; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sp6; sp6 p chal; spec; sr,Qn
51678-1,17-hydroxypregnenolone [mass/volume] in serum or plasma --3rd specimen post xxx challenge,17oh-preg sp3 p chal serpl-mcnc,17-hydroxypregnenolone 3rd specimen post unsp challenge [mass/vol],17 alpha-hydroxypregnanolone; 17 hydroxy pregnenolone; 17-alpha-hydroxypregnenolone; 17alpha-hydroxypregnenolone; 17oh-preg; after; chemistry.challenge testing; level; mass concentration; p chal; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sp3; sp3 p chal; spec; sr,Qn
51680-7,17-hydroxyprogesterone [mass/volume] in serum or plasma --1st specimen post xxx challenge,17ohp sp1 p chal serpl-mcnc,17-hydroxyprogesterone 1st specimen post unsp challenge [mass/vol],"17-alpha-hydroxyprogesterone; 17-hydroxypregn-4-en-3,20-dione; 17-hydroxy-progest; 17-oh progesterone; 17ohp; 17-ohp; 17-p; acute specimen; after; chemistry.challenge testing; endocrine; endocrinology; first; genetics; heredity; heritable; hydroxyproges; hydroxyprogstron; inherited; level; mass concentration; p chal; pl; plasma; plsm; point in time; pre immunization; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sp1; sp1 p chal; spec; sr",Qn
51688-0,pregnenolone [mass/volume] in serum or plasma --4th specimen post xxx challenge,preg sp4 p chal serpl-mcnc,pregnenolone 4th specimen post unsp challenge [mass/vol],after; chemistry.challenge testing; level; mass concentration; p chal; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sp4; sp4 p chal; spec; sr,Qn
51697-1,cv2 ab [titer] in serum or plasma by immunofluorescence,cv2 ab titr serpl if,cv2 ab if [titer],abs; aby; acif; antby; anti; antibodies; antibody; anticomplement immunofluorescence; autoantibodies; autoantibody; collapsin response mediator protein 5; collapsin response mediator protein 5 ab; crmp5; crmp-5; dilution factor; dilution factor (titer); fa; fluorescent antibody; fluoresent; ifa; immune fluorescence; immunoflour; immunofluor; immunofluorescence; pl; plasma; plsm; point in time; pop66; random; serology; serp; serpl; serplas; serum; serum or plasma; smqn; sr; time resolved fluorescence; titer; titered; titre; trf; ttr; ulip,SemiQn
5169-8,giardia lamblia ab [units/volume] in serum,g lamblia ab ser-acnc,g. lamblia ab qn (s),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; beaver fever; g duodenalis; g intestinalis; g lamblia; giardiasis; id; infectious disease; infectiousdisease; lamblia intestinalis; microbiology; point in time; qnt; quan; quant; quantitative; random; serum; sr,Qn
51714-4,microscopic observation [identifier] in blood by giemsa stain,gie stn bld,microscopic observation giemsa stain nom (bld),blood; gie stn; gms; hematology/cell counts; id; identity or presence; infectious disease; infectiousdisease; nominal; point in time; random; st; stains; stn; universallaborders; wb; whole blood,Nom
51718-5,normoblasts polychromatophilic/cells in blood by microscopy,poly normoblasts nfr bld micro,normoblasts polychromatophilic/cells microscopy (bld),blood; cell; cellularity; erythroblast; erythroblasts; hematology/cell counts; immature erythrocytes; intermediate erythroblast; micro; micros; microscopic; mid erythroblast; normoblast; number fraction; percent; point in time; poly normoblasts; polychromatic erythroblast; qnt; quan; quant; quantitative; random; rubricyte; wb; whole blood,Qn
51751-6,pyruvate [moles/volume] in venous blood,pyruvate bldv-scnc,pyruvate (bldv) [moles/vol],bld ven; bld venous; blood - venous; blood ven; blood venus; chemistry; level; point in time; pyruvic acid; qnt; quan; quant; quantitative; random; substance concentration; venous,Qn
51757-3,pomt1 gene targeted mutation analysis in blood or tissue by molecular genetics method,pomt1 gene mut anl bld/t,pomt1 gene targeted mutation analysis molgen doc (bld/tiss),"blood; document; finding; findings; genetics; heredity; heritable; inherited; lgmd2k; mddga1; mddgb1; mddgc1; molecular genetics; molecular pathology; molpath; molpath.mutations; mut; mut anl; mutations; pcr; point in time; protein-o-mannosyltransferase 1; random; rt; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",Doc
51758-1,pomt2 gene targeted mutation analysis in blood or tissue by molecular genetics method,pomt2 gene mut anl bld/t,pomt2 gene targeted mutation analysis molgen doc (bld/tiss),"blood; document; finding; findings; genetics; heredity; heritable; inherited; lgmd2n; mddga2; mddgb2; mddgc2; molecular genetics; molecular pathology; molpath; molpath.mutations; mut; mut anl; mutations; pcr; point in time; protein-o-mannosyltransferase 2; random; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",Doc
51769-8,glucose [mass/volume] in serum or plasma --2 hours post dose fructose po,glucose 2h p fructose po serpl-mcnc,glucose 2 hr post dose fructose po [mass/vol],120 min; 120 minutes; 120min; 2 hours; 2h p fructose po; after; chemistry.challenge testing; endocrine; endocrinology; glu; glu tol; gluc; glucose tolerance; glucoseur; gtt; level; levulose; mass concentration; p dose; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; revulose; serp; serpl; serplas; serum; serum or plasma; sr,Qn
51779-7,cfh gene mutations found [identifier] in blood or tissue by molecular genetics method nominal,cfh gene mut anl bld/t,cfh gene targeted mutation analysis molgen nom (bld/tiss),"ahus1; ambp1; armd4; arms1; blood; cfhl3; complement factor h; fh; fhl1; genetics; heredity; heritable; hf; hf1; hf2; hus; identity or presence; inherited; molecular genetics; molecular pathology; molpath; molpath.mutations; mut; mut anl; mutations; nominal; pcr; point in time; random; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",Nom
51783-9,reagin ab [presence] in cord blood by vdrl,vdrl bldco ql,reagin ab vdrl ql (bldco),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; blood - (umbilical) cord; cord (umbilical) blood; cord bld; cord blood; gyn; gynecology; id; infectious disease; infectiousdisease; microbiology; microscopic flocculation; neurosyphilis; ob; obgyn; obstetrics; ordinal; point in time; pr; ql; qual; qualitative; random; screen; syphilis; treponema; venereal disease research laboratory,Ord
51788-8,coccidioides sp ab [titer] in serum by immune diffusion (id),coccidioides ab titr ser id,coccidioides sp ab immune diff (s) [titer],abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; coccidiodes; dilution factor; dilution factor (titer); id; imm; immunodiff; immunodiffusion; imun; imune; infectious disease; infectiousdisease; microbiology; point in time; random; san joaquin valley fever; serum; smqn; species; spp; sr; titer; titered; titre; ttr; valley fever,SemiQn
51792-0,citrate/creatinine [mass ratio] in urine collected for unspecified duration,citrate/creat ?tm ur,citrate/creatinine unsp time (u) [mass ratio],?tm; chemistry; citric acid; cr; crea; creat; mass concentration ratio; mass ratio; mcrto; qnt; quan; quant; quantitative; ua; ucr; ur; urn,Qn
51813-4,coxiella burnetii phase 2 igm ab [units/volume] in serum by immunoassay,c burnet ph2 igm ser ia-acnc,c. burnetii phase 2 igm ia qn (s),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; c burnet; c burnet ph2; c burnetii; coxiella burnetii phase ii; coxiella burnettii; eia; elfa; elisa; enzyme immunoassay; iaa; id; ii; immune globulin m; immunoglobulin m; infectious disease; infectiousdisease; meia; microbiology; point in time; q fev; q fever; qfever; qnt; quan; quant; quantitative; random; serum; sr; suds,Qn
51815-9,leptospira sp igg ab [units/volume] in serum by immunoassay,leptospira igg ser ia-acnc,leptospira sp igg ia qn (s),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; eia; elfa; elisa; enzyme immunoassay; iaa; id; immune globulin g; immunoglobulin g; infectious disease; infectiousdisease; leptospirosis; meia; microbiology; point in time; qnt; quan; quant; quantitative; random; serum; species; spp; sr; suds,Qn
51816-7,bartonella quintana igg ab [units/volume] in serum by immunoassay,b quintana igg ser ia-acnc,b. quintana igg ia qn (s),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; b quintana; cat scratch disease; cat scratch fever; csd; eia; elfa; elisa; enzyme immunoassay; iaa; id; immune globulin g; immunoglobulin g; infectious disease; infectiousdisease; meia; microbiology; point in time; qnt; quan; quant; quantitative; r quintana; random; rochalimae quintana; rochalimaea quintana; serum; sr; suds; trench fever,Qn
51819-1,leptospira sp igm ab [units/volume] in serum by immunoassay,leptospira igm ser ia-acnc,leptospira sp igm ia qn (s),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; eia; elfa; elisa; enzyme immunoassay; iaa; id; immune globulin m; immunoglobulin m; infectious disease; infectiousdisease; leptospirosis; meia; microbiology; point in time; qnt; quan; quant; quantitative; random; serum; species; spp; sr; suds,Qn
5182-1,hepatitis a virus igm ab [units/volume] in serum by radioimmunoassay (ria),hav igm ser ria-acnc,hav igm ria qn (s),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; hav; hep; hep a; hepatis; hepatit; hepatitis; hepatitis type a; id; immune globulin m; immunoglobulin m; infectious disease; infectiousdisease; microbiology; point in time; qnt; quan; quant; quantitative; radioimmunoassay; random; serum; sr,Qn
51832-4,brucella abortus ab [presence] in cerebral spinal fluid by acidified buffered plate agglutination,b abortus ab csf ql buff plate aggl,b. abortus ab acidified buffered plate agglutination ql (csf),abort; abs; aby; agg; agglut; agglutination; antby; anti; antibodies; antibody; autoantibodies; autoantibody; b abortus; bangs disease; bapa; bovine brucellosis; bruc; brucellosis; buff plate aggl; cerebral spinal fluid; cerebrospinal fl; contagious abortion; id; infectious disease; infectiousdisease; microbiology; neuro; neurology; ordinal; plate aggl; point in time; pr; ql; qual; qualitative; random; screen; spinal fl; spinal fld; spinal flu; spinal fluid; undulant fever; vet; veterinary,Ord
51835-7,angiotensin converting enzyme [enzymatic activity/volume] in pleural fluid,ace plr-ccnc,angiotensin converting enzyme (pleur fld) [catalytic activity/vol],ace; agt; angio convert enzy; angiotensin i converting enzyme; carboxycathepsin; catalytic concentration; chemistry; dipeptidylcarboxypeptidase; enz; enzymes; kininase ii; pdpa; peptidase p; peptidyl dipeptidase a; pleural; pleural fluid; point in time; proangiotensin; qnt; quan; quant; quantitative; random; thoracentesis fluid,Qn
5184-7,hepatitis a virus ab [units/volume] in serum by radioimmunoassay (ria),hav ab ser ria-acnc,hav ab ria qn (s),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; hav; hep; hep a; hepatis; hepatit; hepatitis; hepatitis type a; id; infectious disease; infectiousdisease; microbiology; point in time; qnt; quan; quant; quantitative; radioimmunoassay; random; serum; sr,Qn
51854-8,long term care facility consult note,ltc fac consult note,,consult note; doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; ltc fac; ltcf; notes; point in time; random; visit note,Doc
51860-5,parrot serum proteins+feathers+droppings igg ab [presence] in serum,parrot ser prot+feathers+dropp igg ql,parrot serum proteins+feathers+droppings igg ql (s),abs; aby; african gray parrot; african grey parrot; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; e26; e92; feces; ge92; immune globulin g; immunoglobulin g; macaw; ordinal; parrot ser prot+feathers+dropp; point in time; pr; protein; ql; qual; qualitative; random; rge92; screen; ser; serum; sr; stool,Ord
51869-6,washed packed erythrocytes given [volume],washed packed rbc gvn vol,washed packed rbc given [vol],blood bank; discocytes; erthrocyte; erythrocyte; gvn; packed rbc; point in time; prbc; qnt; quan; quant; quantitative; random; rbc; rbcs; red blood cell; red blood cells; red blood corpuscle; red blood corpusles; red cell; red cells; volume; washed packed rbc,Qn
51886-0,autologous whole blood units given [#],autol bld units gvn bpu,autologous whole blood units given (bpu) [#],autol; autol bld; autol bld units; autologus; blood bank; blood product unit; blood product unit (pack); cnt; count; gvn; number; point in time; qnt; quan; quant; quantitative; random; whole bld,Qn
51890-2,factor viii units given [#],fact viii gvn bpu,factor viii units given (bpu) [#],blood bank; blood product unit; blood product unit (pack); cnt; count; f8; fac; fact; fact viii; factor 8; fviii; gvn; number; point in time; qnt; quan; quant; quantitative; random,Qn
51903-3,chromium [mass/volume] in air,cr air-mcnc,chromium (air) [mass/vol],c609; chrome; cr; drug/toxicology; drugs; level; mass concentration; point in time; qnt; quan; quant; quantitative; random,Qn
51904-1,orange igg ab [mass/volume] in serum,orange igg-mcnc,orange igg (s) [mass/vol],abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; f033; f33; immune globulin g; immunoglobulin g; level; mass concentration; orange; point in time; qnt; quan; quant; quantitative; random; serum; sr,Qn
51911-6,giardia lamblia+cryptosporidium sp ag [presence] in stool --3rd specimen,g lamblia+cryptosp ag sp3 stl ql,g. lamblia+cryptosporidium sp ag spec 3 ql (stl),antigen; antigens; beaver fever; bowel movement; crypt; crypto; cryptosporidiosis; faecal; faeces; fecal; feces; g duodenalis; g intestinalis; g lamblia; g lamblia+cryptosp; g lamblia+cryptosp ag; giardiasis; id; infectious disease; infectiousdisease; lamblia intestinalis; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; screen; sp3; spec; species; spp; stl; stool = fecal,Ord
51913-2,hepatitis a virus igg+igm ab [presence] in serum,hav igg+igm ser ql,hav igg+igm ql (s),abs; aby; antby; anti; antibodies; antibody; anti-hav; autoantibodies; autoantibody; hav; hep; hep a; hepatis; hepatit; hepatitis; hepatitis type a; hepatology; id; immune globulin g; immune globulin m; immunoglobulin g; immunoglobulin m; infectious disease; infectiousdisease; liver; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; sr,Ord
51944-7,fda product label side panel of package,fda label side panel,,document.ref; fda label; narrative; pan; panl; pnl; report,Nar
51946-2,fda product label top panel of package,fda label top panel,,document.ref; fda label; narrative; pan; panl; pnl; report,Nar
51954-6,oxycodone free [mass/volume] in urine,oxycodone free ur-mcnc,oxycodone free (u) [mass/vol],drug/toxicology; drugs; fr; level; lortab; mass concentration; non-protein bound; oxycodone free; oxycontin; percocet; percodan; point in time; qnt; quan; quant; quantitative; random; ua; ur; urn; vicodin,Qn
5196-1,hepatitis b virus surface ag [presence] in serum or plasma by immunoassay,hbv surface ag serpl ql ia,hbv surface ag ia ql,antigen; antigens; australia antigen; eia; elfa; elisa; enzyme immunoassay; hbs; hbsag; hbv; hbv surface; hep; hep b; hep bs; hepatis; hepatit; hepatology; hepb; iaa; id; infectious disease; infectiousdisease; liver; meia; microbiology; ordinal; pl; plasma; plsm; point in time; pr; ql; qual; qualitative; random; screen; serp; serpl; serplas; serum; serum or plasma; sr; suds; surf; universallaborders,Ord
51986-8,nicardipine [presence] in serum or plasma,nicardipine serpl ql,nicardipine ql,cardene; drug/toxicology; drugs; ordinal; pl; plasma; plsm; point in time; pr; ql; qual; qualitative; random; screen; serp; serpl; serplas; serum; serum or plasma; sr,Ord
519-9,troleandomycin [susceptibility] by minimum lethal concentration (mlc),troleandomycin islt mlc,troleandomycin mlc [susc],antibiotic susceptibilities; ast; id; infectious disease; infectiousdisease; islt; isol; mbc; minimum bactericidal concentration; minimum lethal concentration; point in time; qnt; quan; quant; quantitative; random; sus; suscept; susceptibilities; susceptibility; susceptibilty; tao; treis-micina; triacetyloleandomycin; triocetin; viamicina,Qn
51994-2,homovanillate/creatinine [mass ratio] in urine collected for unspecified duration,hva/creat ?tm ur,homovanillate/creatinine unsp time (u) [mass ratio],?tm; 3-methoxy-4-hydroxy-phenylacetic acid; chemistry; cr; crea; creat; homovanilic; homovanillic acid; hva; hva & creat; mass concentration ratio; mass ratio; mcrto; qnt; quan; quant; quantitative; tumor marker; ua; ucr; ur; urn,Qn
52018-9,"ambulance transport, physician certification for transport indicator",,,arbitrary; attach; attach.amb; ordinal; point in time; ql; qual; qualitative; random; screen,Ord
52029-6,sterilization consent document,sterilization consent,,doc.ont; document; finding; findings; form; point in time; random,Doc
52033-8,general correspondence attachment,general correspnd attachment,,admin; doc.admin; document; finding; findings; point in time; random,Doc
52038-7,subscriber information including retroactive and presumptive eligibility,subscriber information eligibility,,admin; doc.admin; document; finding; findings; point in time; random,Doc
52049-4,manual wheelchair attachment,manual wheelchair attachment,,admin; doc.admin; document; finding; findings; point in time; random,Doc
52054-4,parenteral nutrition attachment,parenteral nutrition attachment,,admin; doc.admin; document; finding; findings; point in time; random,Doc
52089-0,"deprecated alcohol-substance abuse rehabilitation treatment plan, physician certification statement (narrative)",deprecated,,alc; alcoholic; alcohol-substance abuse rehabilitation tx; alcohol-substance abuse rehabilitation tx plan; attach; attach.rehab; attach.rehab.abuse; finding; findings; narrative; point in time; random; rehabilitation tx plan; rehabtx; report; subs; tx; tx plan,Nar
52099-9,alcohol-substance abuse rehabilitation treatment plan progress note and attainment of goals set,,,alc; alcoholic; alcohol-substance abuse rehabilitation tx; alcohol-substance abuse rehabilitation tx plan; attach; attach.rehab; attach.rehab.abuse; complex; encounter; evaluation and management; evaluation and management note; notes; point in time; prog note; random; rehabilitation tx plan; rehabtx; subs; subsequent evaluation; subsequent visit evaluation; tx; tx plan; visit note,Set
52104-7,"deprecated alcohol-substance abuse rehabilitation treatment plan, level of patient participation (narrative)",deprecated,,alc; alcoholic; alcohol-substance abuse rehabilitation tx; alcohol-substance abuse rehabilitation tx plan; attach; attach.rehab; attach.rehab.abuse; finding; findings; levels; levl; lv; lvl; narrative; point in time; random; rehabilitation tx plan; rehabtx; report; subs; tx; tx plan,Nar
52108-8,co sup(b) ab [presence] in serum or plasma,co sup(b) ab serpl ql,co sup(b) ab ql,abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; blood bank; co sup(b); co^b; colton blood group system; ordinal; pl; plasma; plsm; point in time; pr; ql; qual; qualitative; random; screen; serp; serpl; serplas; serum; serum or plasma; sr,Ord
52117-9,bx ab [presence] in serum or plasma,bx ab serpl ql,bx ab ql,abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; blood bank; bx; ordinal; pl; plasma; plsm; point in time; pr; ql; qual; qualitative; random; screen; serp; serpl; serplas; serum; serum or plasma; sr,Ord
5211-8,herpes virus 6 igg ab [units/volume] in serum,hhv6 igg ser-acnc,hhv 6 igg qn (s),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; herpesvirus; hhv; hhv6; hhv-6; human herpes virus; human herpes virus type 6; id; immune globulin g; immunoglobulin g; infectious disease; infectiousdisease; microbiology; point in time; qnt; quan; quant; quantitative; random; serum; sr; universallaborders,Qn
52141-9,"deprecated pulmonary therapy treatment plan, visit frequency tq2",deprecated,,attach; attach.rehab; attach.rehab.pulm; lung; ordinal; point in time; pulmonary; pulmonary therapy tx; pulmonary therapy tx plan; pulmonology; ql; qual; qualitative; random; respiratory; screen; timing - quantity; tx; tx plan,Ord
52146-8,"deprecated pulmonary therapy treatment plan, author profession identifier",deprecated,,attach; attach.rehab; attach.rehab.pulm; identity or presence; lung; nominal; point in time; pulmonary; pulmonary therapy tx; pulmonary therapy tx plan; pulmonology; random; respiratory; tx; tx plan,Nom
52148-4,"deprecated pulmonary therapy treatment plan, continuation status",deprecated,,attach; attach.rehab; attach.rehab.pulm; lung; ordinal; point in time; pulmonary; pulmonary therapy tx; pulmonary therapy tx plan; pulmonology; ql; qual; qualitative; random; respiratory; screen; tx; tx plan; typ,Ord
52162-5,"deprecated pulmonary therapy treatment plan, medication dosage",deprecated,,attach; attach.rehab; attach.rehab.pulm; lung; point in time; pulmonary; pulmonary therapy tx; pulmonology; qnt; quan; quant; quantitative; random; respiratory; tx,Qn
52165-8,"deprecated pulmonary therapy treatment plan, medication route identifier",deprecated,,attach; attach.rehab; attach.rehab.pulm; identity or presence; lung; nominal; point in time; pulmonary; pulmonary therapy tx; pulmonology; random; respiratory; tx,Nom
52168-2,"deprecated pulmonary therapy treatment plan, physician certification statement (narrative)",deprecated,,attach; attach.rehab; attach.rehab.pulm; finding; findings; lung; narrative; point in time; pulmonary; pulmonary therapy tx; pulmonary therapy tx plan; pulmonology; random; report; respiratory; tx; tx plan,Nar
52171-6,"pulmonary therapy treatment plan, level of function set",,,attach; attach.rehab; attach.rehab.pulm; complex; fcn; func; funct; levels; levl; lung; lv; lvl; point in time; pulmonary; pulmonary therapy tx; pulmonary therapy tx plan; pulmonology; random; respiratory; tx; tx plan,Set
52172-4,"deprecated pulmonary therapy treatment plan, prior level of function (narrative)",deprecated,,attach; attach.rehab; attach.rehab.pulm; fcn; finding; findings; func; funct; levels; levl; lung; lv; lvl; narrative; point in time; pulmonary; pulmonary therapy tx; pulmonary therapy tx plan; pulmonology; random; report; respiratory; tx; tx plan,Nar
52184-9,pulmonary therapy service attachment,rehab.pulm therapy service doc,,doc.misc; document; finding; findings; misc; point in time; pulm; random; rehab.pulm therapy service,Doc
52193-0,"deprecated cardiac rehabilitation treatment plan, referring person name",deprecated,,attach; attach.rehab; attach.rehab.cardiac; cardiac rehabilitation tx; cardiac rehabilitation tx plan; cardio; cardiology; heart disease; nominal; person name; persons; point in time; random; rehabilitation tx plan; rehabtx; tx; tx plan,Nom
52204-5,"cardiac rehabilitation treatment plan, level of function set",,,attach; attach.rehab; attach.rehab.cardiac; cardiac rehabilitation tx; cardiac rehabilitation tx plan; cardio; cardiology; complex; fcn; func; funct; heart disease; levels; levl; lv; lvl; point in time; random; rehabilitation tx plan; rehabtx; tx; tx plan,Set
52218-5,"medical social services treatment plan, referral information set",,,attach; attach.rehab; attach.rehab.social; complex; medical social services tx; medical social services tx plan; point in time; random; tx; tx plan,Set
52223-5,"medical social services treatment plan, responsible attending physician information set",,,attach; attach.rehab; attach.rehab.social; complex; medical social services tx; medical social services tx plan; point in time; random; tx; tx plan,Set
52226-8,"deprecated medical social services treatment plan, medication timing tq2",deprecated,,attach; attach.rehab; attach.rehab.social; medical social services tx; point in time; qnt; quan; quant; quantitative; random; timing - quantity; tx,Qn
52238-3,"deprecated medical social services treatment plan, mental status (narrative)",deprecated,,attach; attach.rehab; attach.rehab.social; finding; findings; medical social services tx; medical social services tx plan; narrative; point in time; random; report; tx; tx plan,Nar
52240-9,"deprecated medical social services treatment plan, treatment encounter (narrative)",deprecated,,attach; attach.rehab; attach.rehab.social; finding; findings; medical social services tx; medical social services tx plan; narrative; point in time; random; report; tx; tx encounter; tx plan,Nar
52241-7,medical social services treatment plan progress note and attainment of goals set,,,attach; attach.rehab; attach.rehab.social; complex; encounter; evaluation and management; evaluation and management note; medical social services tx; medical social services tx plan; notes; point in time; prog note; random; subsequent evaluation; subsequent visit evaluation; tx; tx plan; visit note,Set
52245-8,"deprecated occupational therapy treatment plan, referral information (narrative)",deprecated,,attach; attach.rehab; attach.rehab.ot; finding; findings; narrative; occupational therapy; occupational therapy tx; occupational therapy tx plan; ot; point in time; random; report; tx; tx plan,Nar
52251-6,"deprecated occupational therapy treatment plan, date range certifying the plan of care daterange",deprecated,,attach; attach.rehab; attach.rehab.ot; occupational therapy; occupational therapy tx; occupational therapy tx plan; ot; point in time; qnt; quan; quant; quantitative; random; rnge; tx; tx plan,Qn
52252-4,"deprecated occupational therapy treatment plan, physician certification statement (narrative)",deprecated,,attach; attach.rehab; attach.rehab.ot; finding; findings; narrative; occupational therapy; occupational therapy tx; occupational therapy tx plan; ot; point in time; random; report; tx; tx plan,Nar
52261-5,"deprecated occupational therapy treatment plan, activities permitted (narrative)",deprecated,,attach; attach.rehab; attach.rehab.ot; finding; findings; narrative; occupational therapy; occupational therapy tx; occupational therapy tx plan; ot; point in time; random; report; tx; tx plan,Nar
52273-0,"physical therapy treatment plan, referral information set",,,attach; attach.rehab; attach.rehab.pt; complex; physical therapy; physical therapy tx; physical therapy tx plan; point in time; pt; random; tx; tx plan,Set
52274-8,"deprecated physical therapy treatment plan, referral information (narrative)",deprecated,,attach; attach.rehab; attach.rehab.pt; finding; findings; narrative; physical therapy; physical therapy tx; physical therapy tx plan; point in time; pt; random; report; tx; tx plan,Nar
52277-1,"deprecated physical therapy treatment plan, date patient referred for treatment",deprecated,,attach; attach.rehab; attach.rehab.pt; date patient referred for tx; physical therapy; physical therapy tx; physical therapy tx plan; point in time; pt; qnt; quan; quant; quantitative; random; tx; tx plan,Qn
52284-7,"deprecated physical therapy treatment plan, actual start of care date",deprecated,,attach; attach.rehab; attach.rehab.pt; physical therapy; physical therapy tx; physical therapy tx plan; point in time; pt; qnt; quan; quant; quantitative; random; started; tx; tx plan,Qn
52287-0,"deprecated physical therapy treatment plan, prior level of function (narrative)",deprecated,,attach; attach.rehab; attach.rehab.pt; fcn; finding; findings; func; funct; levels; levl; lv; lvl; narrative; physical therapy; physical therapy tx; physical therapy tx plan; point in time; pt; random; report; tx; tx plan,Nar
52299-5,physical therapy treatment plan progress note and attainment of goals set,,,attach; attach.rehab; attach.rehab.pt; complex; encounter; evaluation and management; evaluation and management note; notes; physical therapy; physical therapy tx; physical therapy tx plan; point in time; prog note; pt; random; subsequent evaluation; subsequent visit evaluation; tx; tx plan; visit note,Set
52315-9,"deprecated psychiatric rehabilitation treatment plan, medication timing tq2",deprecated,,attach; attach.rehab; attach.rehab.psych; mental health; mentalhealth; point in time; psych; psychiatric rehabilitation tx; psychiatry; qnt; quan; quant; quantitative; random; rehabtx; timing - quantity; tx,Qn
52326-6,"deprecated psychiatric rehabilitation treatment plan, activities permitted (narrative)",deprecated,,attach; attach.rehab; attach.rehab.psych; finding; findings; mental health; mentalhealth; narrative; point in time; psych; psychiatric rehabilitation tx; psychiatric rehabilitation tx plan; psychiatry; random; rehabilitation tx plan; rehabtx; report; tx; tx plan,Nar
52338-1,"deprecated respiratory therapy treatment plan, referring person identifier",deprecated,,attach; attach.rehab; attach.rehab.rt; ident; identifier; lung; nominal; persons; point in time; pulmonary; pulmonology; random; respiratory; respiratory therapy tx; respiratory therapy tx plan; tx; tx plan,Nom
52353-0,"deprecated respiratory therapy treatment plan, treatment encounter (narrative)",deprecated,,attach; attach.rehab; attach.rehab.rt; finding; findings; lung; narrative; point in time; pulmonary; pulmonology; random; report; respiratory; respiratory therapy tx; respiratory therapy tx plan; tx; tx encounter; tx plan,Nar
52358-9,"skilled nursing treatment plan, referral information set",,,attach; attach.rehab; attach.rehab.nurs; complex; point in time; random; skilled nursing tx; skilled nursing tx plan; tx; tx plan,Set
52360-5,"deprecated skilled nursing treatment plan, referring person name",deprecated,,attach; attach.rehab; attach.rehab.nurs; nominal; person name; persons; point in time; random; skilled nursing tx; skilled nursing tx plan; tx; tx plan,Nom
52373-8,"deprecated skilled nursing treatment plan, current level of function (narrative)",deprecated,,attach; attach.rehab; attach.rehab.nurs; fcn; finding; findings; func; funct; levels; levl; lv; lvl; narrative; point in time; random; report; skilled nursing tx; skilled nursing tx plan; tx; tx plan,Nar
52377-9,"deprecated skilled nursing treatment plan, activities permitted (narrative)",deprecated,,attach; attach.rehab; attach.rehab.nurs; finding; findings; narrative; point in time; random; report; skilled nursing tx; skilled nursing tx plan; tx; tx plan,Nar
52386-0,"deprecated speech therapy treatment plan, referral information (narrative)",deprecated,,attach; attach.rehab; attach.rehab.speech; finding; findings; narrative; point in time; random; report; speech therapy tx; speech therapy tx plan; tx; tx plan,Nar
52391-0,"speech therapy treatment plan, responsible rehabilitation professional information set",,,attach; attach.rehab; attach.rehab.speech; complex; point in time; random; speech therapy tx; speech therapy tx plan; tx; tx plan,Set
52400-9,"deprecated speech therapy treatment plan, current level of function (narrative)",deprecated,,attach; attach.rehab; attach.rehab.speech; fcn; finding; findings; func; funct; levels; levl; lv; lvl; narrative; point in time; random; report; speech therapy tx; speech therapy tx plan; tx; tx plan,Nar
52417-3,"current medication, identifier",,,attach; attach.meds; ident; identifier; med; meds; nominal; point in time; random,Nom
5242-3,measles virus ab [units/volume] in serum by immunoassay,mev ab ser ia-acnc,mev ab ia qn (s),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; eia; elfa; elisa; enzyme immunoassay; iaa; id; infectious disease; infectiousdisease; meia; mev; microbiology; msls; point in time; qnt; quan; quant; quantitative; random; rubeola; serum; sr; suds,Qn
52438-9,"deprecated physical therapy treatment plan, medication identifier",deprecated,,attach; attach.rehab; attach.rehab.pt; ident; identifier; nominal; physical therapy; physical therapy tx; point in time; pt; random; tx,Nom
52448-8,"deprecated speech therapy treatment plan, medication name identifier",deprecated,,attach; attach.rehab; attach.rehab.speech; ident; identifier; nominal; point in time; random; speech therapy tx; tx,Nom
52462-9,nickname,nickname,,admin; admin.patient; nominal; person name; point in time; pseudonym; random,Nom
52478-5,number of major wounds,,,# major wounds; care survey; no; num; point in time; random; survey,-
52485-0,pulmonary function tests,,,care survey; fcn; func; funct; point in time; pulm; random; survey,-
52496-7,behavioral signs and symptoms,,,care survey; point in time; random; survey; sx,-
52500-6,pain,,,care survey; point in time; random; survey,-
52503-0,bladder and bowel management - use of device(s) and incontinence,,,care survey; point in time; random; s prime; survey,-
52508-9,grip strength,,,care survey; point in time; random; survey,-
52527-9,residential information,,,care survey; point in time; random; survey,-
52546-9,prior functioning.mobility - ambulation [care],,,care survey; continuity assessment record and evaluation; finding; findings; ordinal; point in time; ql; qual; qualitative; random; screen; survey,Ord
52552-7,falls in the past year,,,history; last; ordinal; ql; qual; qualitative; screen; survey,Ord
52553-5,language.primary is english,,,care survey; finding; findings; ordinal; point in time; primary language; ql; qual; qualitative; random; screen; sdoh; survey,Ord
5256-3,mycoplasma pneumoniae igm ab [units/volume] in serum by immunoassay,m pneumo igm ser ia-acnc,m. pneumoniae igm ia qn (s),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; eia; elfa; elisa; enzootic pneumonia; enzyme immunoassay; iaa; id; immune globulin m; immunoglobulin m; infectious disease; infectiousdisease; m pneumo; m pneumonia; m pneumoniae; meia; microbiology; myco; myco pneu; mycoplas; mycoplasm; mycoplasmoides pneumoniae; mycoplasmosis; mycoplsm; pneu; pneum; pneumo; pneumon; pneumonia; point in time; qnt; quan; quant; quantitative; random; serum; sr; suds; universallaborders,Qn
52575-8,number of pressure ulcers at assessment - stage 2 [care],,,# pressure ulcers at assessment - stage 2; care survey; cnt; continuity assessment record and evaluation; count; ii; no; num; number; ordinal; point in time; ql; qual; qualitative; random; screen; survey,Ord
52576-6,number of pressure ulcers at assessment - stage 3 [care],,,# pressure ulcers at assessment - stage 3; care survey; cnt; continuity assessment record and evaluation; count; iii; no; num; number; ordinal; point in time; ql; qual; qualitative; random; screen; survey,Ord
5260-5,myocardium ab [titer] in serum by immunofluorescence,myocardium ab titr ser if,myocardium ab if (s) [titer],abs; aby; acif; antby; anti; antibodies; antibody; anticomplement immunofluorescence; antimyocardial; antisarcolemma; autoantibodies; autoantibody; cardio; cardiology; dilution factor; dilution factor (titer); fa; fluorescent antibody; fluoresent; heart; heart disease; ifa; immune fluorescence; immunoflour; immunofluor; immunofluorescence; intermyofibrillar antibodies; myocardial; point in time; random; serology; serum; smqn; sr; time resolved fluorescence; titer; titered; titre; trf; ttr,SemiQn
52609-5,bladder - external or indwelling device or intermittent catheterization [care],,,care survey; continuity assessment record and evaluation; ext; finding; findings; ordinal; point in time; ql; qual; qualitative; random; screen; survey,Ord
52632-7,grip strength during 2 day assessment period hand - left [care],,,2 days; 48 hours; care survey; continuity assessment record and evaluation; finding; findings; hand-l; l; lt; ordinal; ql; qual; qualitative; screen; survey; upper extremity,Ord
52634-3,any impairments with respiratory status,,,care survey; finding; findings; ordinal; point in time; ql; qual; qualitative; random; resp status; screen; survey,Ord
52641-8,mobility device.other specified [care],,,care survey; continuity assessment record and evaluation; finding; findings; nominal; othr; point in time; random; survey,Nom
52645-9,toilet hygiene during 2 day assessment period [care],,,2 days; 48 hours; care survey; continuity assessment record and evaluation; finding; findings; ordinal; ql; qual; qualitative; screen; survey,Ord
52648-3,lying to sitting on side of bed during 2 day assessment period [care],,,2 days; 48 hours; care survey; continuity assessment record and evaluation; finding; findings; ordinal; ql; qual; qualitative; screen; survey,Ord
52651-7,toilet transfer during 2 day assessment period [care],,,2 days; 48 hours; care survey; continuity assessment record and evaluation; finding; findings; ordinal; ql; qual; qualitative; screen; survey,Ord
5267-0,paragonimus sp ab [titer] in serum by complement fixation,paragonimus ab titr ser cf,paragonimus sp ab cf (s) [titer],abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; cf; comp fixation; compfix; complement fixation; dilution factor; dilution factor (titer); id; infectious disease; infectiousdisease; microbiology; point in time; random; serum; smqn; species; spp; sr; titer; titered; titre; ttr,SemiQn
52680-6,make light meal during two day assessment period [care],,,2 days; 48 hours; care survey; continuity assessment record and evaluation; finding; findings; ordinal; ql; qual; qualitative; screen; survey,Ord
52683-0,laundry during two day assessment period [care],,,2 days; 48 hours; care survey; continuity assessment record and evaluation; finding; findings; ordinal; ql; qual; qualitative; screen; survey,Ord
52685-5,care goals documented,,,care survey; finding; findings; ordinal; point in time; ql; qual; qualitative; random; screen; survey,Ord
52717-6,reason for discharge delay,,,care survey; disch; finding; findings; nominal; point in time; random; survey,Nom
52723-4,admitted from.other specified facility [care],,,admin; care survey; continuity assessment record and evaluation; nominal; othr; point in time; random; survey; transferred; typ,Nom
52735-8,recall - sock [bims],,,brief interview for mental status; finding; findings; ordinal; point in time; ql; qual; qualitative; random; screen; survey,Ord
52760-6,prothrombin time (pt) pivka sensitive actual/normal in capillary blood by coagulation assay,pt pivka sensitive act/nor bldc,pt pivka sensitive actual/normal coag (bldc) [relative time],act/nor; blood - capillary; cap bld; cap blood; capillary bld; capillary blood; clot; clottable; coag; coagulation assay; control; fac; fact; finger stick; hematology; heme; point in time; pro time; prothrombin time; protime; pt; pt pivka sensitive; qnt; quan; quant; quantitative; random; rltm; tilt tube,Qn
52766-3,aptt in platelet poor plasma by coagulation assay -- after addition of protein c activator + factor v depleted plasma/aptt,aptt protein c activator+fv dp/aptt ppp,aptt after addition of protein c activator+factor v depleted plasma/coagulation surface induced coag (ppp) [time ratio],activated partial thromboplastin time; aptt; autoprothrombin ii-a; clot; clottable; coag; coagulation assay; fac; fact; factor 5; fv; hematology; heme; little(a)ptt; partial thromboplastin time; pc; plas; platelet poor plasma; point in time; pr; prot; prot c; prot c+fv activity-dependent aptt; protein c activator+fv dp; ptt; qnt; quan; quant; quantitative; random; surf; tilt tube; time ratio,Qn
52783-8,maximum clot firmness.extrinsic coagulation system activated [length] in blood by rotational teg,mcf.extrinsic bld rotem,maximum clot firmness.extrinsic coagulation system activated rotem (bld) [length],activ; blood; cf; coag; hematology; heme; length; ma; maximum amplitude; mcf; mcf.extrinsic; point in time; qnt; quan; quant; quantitative; random; rotem; teg; tem; thrombelastography; thrombelastometry; thromboelastometry; wb; whole blood,Qn
52786-1,maximum lysis.extrinsic coagulation system activated [length fraction] in blood by rotational teg,ml.extrinsic lenfr bld rotem,maximum lysis.extrinsic coagulation system activated rotem (bld) [length fraction],activ; blood; coag; hematology; heme; length fraction; ml; ml.extrinsic; percent; point in time; qnt; quan; quant; quantitative; random; rotem; teg; tem; thrombelastography; thrombelastometry; thromboelastometry; wb; whole blood,Qn
52787-9,maximum lysis.intrinsic coagulation system activated [length fraction] in blood by rotational teg,ml.intrinsic lenfr bld rotem,maximum lysis.intrinsic coagulation system activated rotem (bld) [length fraction],activ; blood; coag; hematology; heme; length fraction; ml; ml.intrinsic; percent; point in time; qnt; quan; quant; quantitative; random; rotem; teg; tem; thrombelastography; thrombelastometry; thromboelastometry; wb; whole blood,Qn
52789-5,clot initiation [time] in blood by thromboelastography,clot init bld teg,clot initiation teg (bld) [time],blood; coagulation; hematology; heme; point in time; qnt; quan; quant; quantitative; random; teg; thrombelastography; thrombelastometry; wb; whole blood,Qn
52791-1,ct guidance for percutaneous replacement of drainage catheter of pelvis,ct guided pelvis pc drain cath replace,,cat scan; cath; computed tomography; computerized tomography; ct scan; document; drain; exudate; finding; findings; guid; guide; guided; imaging; pc drain cath replace; pelvic; perc; point in time; rad; radiology; random; removal of fluid,Doc
52800-0,major treatments used on or 1 day prior to day of death [care],,,care survey; continuity assessment record and evaluation; finding; findings; major txs; major txs used on or 1d prior to day of death; nominal; point in time; random; survey; tx; txs,Nom
52803-4,major treatments discharged with panel,,,care survey; continuity assessment record and evaluation (care) pnl; major txs; major txs discharged with; major txs discharged with panel; pan; panl; pnl; point in time; random; survey; tx; txs,-
52810-9,"current medication, frequency",,,attach; attach.meds; count/time; med; meds; nrate; number rate; number rate = count/time; point in time; qnt; quan; quant; quantitative; random,Qn
52816-6,nucleated cells [#/volume] in cerebral spinal fluid by automated count,nuc cell # csf auto,nucleated cells auto (csf) [#/vol],#; abs; absolute; absolutes; auto; automated detection; cell; cellularity; cerebral spinal fluid; cerebrospinal fl; cnt; count; count/volume; ct; elec; elect; electr; hematology/cell counts; nuc; nuc cell; number concentration; number concentration (count/vol); point in time; qnt; quan; quant; quantitative; random; spinal fl; spinal fld; spinal flu; spinal fluid,Qn
52820-8,appearance of spun pericardial fluid,appearance spun pcar,appearance (spun pericard fld),appearance; cardio; cardiology; heart disease; nominal; pcar; pericardial fluid; point in time; random; spec; spun pcar; supernat; supernate,Nom
52822-4,eastern equine encephalitis virus igg ab [presence] in serum by immunoassay,eeev igg ser ql ia,eeev igg ia ql (s),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; eee virus; eeev; eia; elfa; elisa; enc; enceph; encephalomyelitis; enzyme immunoassay; equin; iaa; id; immune globulin g; immunoglobulin g; infectious disease; infectiousdisease; meia; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; sr; suds; togavirus,Ord
52823-2,la crosse virus igg ab [presence] in serum by immunoassay,lacv igg ser ql ia,la crosse virus igg ia ql (s),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; california encephalitis virus; eia; elfa; elisa; enzyme immunoassay; iaa; id; immune globulin g; immunoglobulin g; infectious disease; infectiousdisease; lacrosse virus; lacv; meia; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; sr; suds,Ord
52838-0,population distribution panel [nmmds],,,nursing management minimum data set; pan; panel.survey.nmmds; panl; pnl; point in time; population distribution pnl; random; survey; survey.nmmds,-
52851-3,total population of age 40-44 years population,,,number fraction; nursing management minimum data set; percent; point in time; qnt; quan; quant; quantitative; random; survey; survey.nmmds; tot; total population of age 40-44 years; totl,Qn
52856-2,total population of age 65-69 years population,,,number fraction; nursing management minimum data set; percent; point in time; qnt; quan; quant; quantitative; random; survey; survey.nmmds; tot; total population of age 65-69 years; totl,Qn
52867-9,state catchment area population [estimated],,,est; estimation; number fraction; nursing management minimum data set; percent; point in time; qnt; quan; quant; quantitative; random; survey; survey.nmmds,Qn
52874-5,cd1a cells/cells in bone marrow,cd1a cells nfr mar,cd1a cells/cells (bm),bm; bon; bone marrow; cd1a cells; cell; cell markers; cellularity; hta1; mar; marrow (bone); minimal angle of resolution; minimum angle of resolution; number fraction; percent; point in time; qnt; quan; quant; quantitative; r4; random,Qn
52876-0,cd1a cells/cells in tissue,cd1a cells nfr tiss,cd1a cells/cells (tiss),"cd1a cells; cell; cell markers; cellularity; hta1; number fraction; percent; point in time; qnt; quan; quant; quantitative; r4; random; tissue; tissue, unspecified",Qn
52882-8,cytoplasmic cd3 cells/cells in body fluid,cycd3 cells nfr fld,cytoplasmic cd3 cells/cells (body fld),"b/f; bf; bod; bodies; body fluid; body fluid, unsp; cell; cell markers; cellularity; cycd3; cycd3 cells; cytopl; cytoplas; fl; fld; flu; fluid; leu4; leu-4; number fraction; percent; point in time; qnt; quan; quant; quantitative; random; t3",Qn
52887-7,bismuth [moles/time] in 24 hour urine,bismuth 24h ur-srate,bismuth (24h u) [moles/time],1 day; 24 hours; 24hr; bi; drug/toxicology; drugs; qnt; quan; quant; quantitative; srate; substance rate; ua; ur; urn,Qn
52892-7,aluminum [moles/mass] in tissue,aluminum tiss-scnt,aluminum (tiss) [moles/mass],"al; aluminium; drug/toxicology; drugs; point in time; qnt; quan; quant; quantitative; random; substance content; tissue; tissue, unspecified",Qn
52895-0,tellurium [moles/volume] in urine,tellurium ur-scnc,tellurium (u) [moles/vol],drug/toxicology; drugs; level; point in time; qnt; quan; quant; quantitative; random; substance concentration; te; ua; ur; urn,Qn
52928-9,molybdenum/creatinine [molar ratio] in urine,molybdenum/creat ur-srto,molybdenum/creatinine (u) [molar ratio],cr; crea; creat; drug/toxicology; drugs; mo; point in time; qnt; quan; quant; quantitative; random; scrto; substance concentration ratio; substance ratio; ua; ucr; ur; urn,Qn
52968-5,streptococcus agalactiae [presence] in anal by organism specific culture,gp b strep anal ql cult,s. agalactiae org specific cx ql (anal),anus; c&s; cult; cultures; gbs; gp b strep; group b; group b strep; id; infectious disease; infectiousdisease; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; rectal specimen; s agalactiae; screen; spec; steptococcus group b; strep; strep b; strep group b; strept; streptococci group b,Ord
52970-1,cv2 ab [units/volume] in cerebral spinal fluid,cv2 ab csf-acnc,cv2 ab qn (csf),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; cerebral spinal fluid; cerebrospinal fl; collapsin response mediator protein 5; collapsin response mediator protein 5 ab; crmp5; crmp-5; neuro; neurology; point in time; pop66; qnt; quan; quant; quantitative; random; serology; spinal fl; spinal fld; spinal flu; spinal fluid; ulip,Qn
52976-8,cytomegalovirus ab [units/volume] in serum by complement fixation,cmv ab ser cf-acnc,cmv ab cf qn (s),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; cf; cmv; comp fixation; compfix; complement fixation; cytomegalo virus; cytomgal; hhv-5; human herpesvirus-5; id; infectious disease; infectiousdisease; microbiology; point in time; qnt; quan; quant; quantitative; random; serum; sr,Qn
52977-6,herpes simplex virus ab [units/volume] in serum by complement fixation,hsv ab ser cf-acnc,hsv ab cf qn (s),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; cf; comp fixation; compfix; complement fixation; herp splx; hsv; id; infectious disease; infectiousdisease; microbiology; point in time; qnt; quan; quant; quantitative; random; serum; sr,Qn
52979-2,trichinella spiralis igg ab [titer] in serum by immunofluorescence,t spiralis igg titr ser if,t. spiralis igg if (s) [titer],abs; aby; acif; antby; anti; antibodies; antibody; anticomplement immunofluorescence; autoantibodies; autoantibody; dilution factor; dilution factor (titer); fa; fluorescent antibody; fluoresent; id; ifa; immune fluorescence; immune globulin g; immunoflour; immunofluor; immunofluorescence; immunoglobulin g; infectious disease; infectiousdisease; microbiology; point in time; random; serum; smqn; sr; t spiralis; time resolved fluorescence; titer; titered; titre; trf; tric; trich; trichinellosis; trichinosis; ttr,SemiQn
52985-9,leishmania sp igg ab [titer] in serum by immunofluorescence,leishmania igg titr ser if,leishmania sp igg if (s) [titer],abs; aby; acif; antby; anti; antibodies; antibody; anticomplement immunofluorescence; autoantibodies; autoantibody; dilution factor; dilution factor (titer); fa; fluorescent antibody; fluoresent; id; ifa; immune fluorescence; immune globulin g; immunoflour; immunofluor; immunofluorescence; immunoglobulin g; infectious disease; infectiousdisease; kala azar; leishmaniasis; leishmaniosis; microbiology; point in time; random; serum; smqn; species; spp; sr; time resolved fluorescence; titer; titered; titre; trf; ttr; visceral leishmaniasis,SemiQn
52991-7,cytoplasmic cd79a cells/cells in blood,cycd79a cells nfr bld,cytoplasmic cd79a cells/cells (bld),blood; cell; cell markers; cellularity; cycd79a; cycd79a cells; cytopl; cytoplas; ig alpha; mb1; number fraction; percent; point in time; qnt; quan; quant; quantitative; random; wb; whole blood,Qn
52997-4,terminal deoxyribonucleotidyl transferase cells/cells in body fluid by flow cytometry (fc),tdt cells nfr fld fc,terminal deoxyribonucleotidyl transferase cells/cells fc (body fld),"b/f; bf; bod; bodies; body fluid; body fluid, unsp; cell; cell markers; cellularity; dynamic; fc; fl; fld; flu; fluid; number fraction; percent; point in time; qnt; quan; quant; quantitative; random; tdt; tdt cells",Qn
52999-0,leukocytes.disintegrated [#/volume] in blood,wbc.disintegrated # bld,wbc.disintegrated (bld) [#/vol],#; abs; absolute; absolutes; blood; cnt; count; count/volume; ct; hematology/cell counts; leuc; leuk; leukocyte; lkcs; number concentration; number concentration (count/vol); point in time; qnt; quan; quant; quantitative; random; wb; wbc; wbc.disintegrated; wbcs; white blood cell; white blood cells; whole blood,Qn
53003-0,mitotic spindle apparatus ab [titer] in serum or plasma by immunofluorescence,mitotic spindle app ab titr serpl if,mitotic spindle apparatus ab if [titer],abs; aby; acif; antby; anti; antibodies; antibody; anticomplement immunofluorescence; autoantibodies; autoantibody; dilution factor; dilution factor (titer); fa; fluorescent antibody; fluoresent; ifa; immune fluorescence; immunoflour; immunofluor; immunofluorescence; lung; msa; nuclear mitotic spindle; pl; plasma; plsm; point in time; pulmonary; pulmonology; random; respiratory; serology; serp; serpl; serplas; serum; serum or plasma; smqn; sr; time resolved fluorescence; titer; titered; titre; trf; ttr,SemiQn
53004-8,mitotic spindle apparatus ab [presence] in serum or plasma by immunofluorescence,mitotic spindle app ab serpl ql if,mitotic spindle apparatus ab if ql,abs; aby; acif; antby; anti; antibodies; antibody; anticomplement immunofluorescence; autoantibodies; autoantibody; fa; fluorescent antibody; fluoresent; ifa; immune fluorescence; immunoflour; immunofluor; immunofluorescence; msa; nuclear mitotic spindle; ordinal; pl; plasma; plsm; point in time; pr; ql; qual; qualitative; random; screen; serology; serp; serpl; serplas; serum; serum or plasma; sr; time resolved fluorescence; trf,Ord
53028-7,cyclic citrullinated peptide ab [presence] in serum,ccp ab ser ql,cyclic citrullinated peptide ab ql (s),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; ccp; ccp3; cyclic citrulinated peptide; ordinal; pept; point in time; pr; ql; qual; qualitative; random; rheum; rheumatoid arthritis; rheumatology; screen; serology; serum; sr,Ord
53033-7,include all data of the selected type that represents observations made two years or less before the starting date of service,,,2; attach; attach.modifier; point in time; random,-
53034-5,allelic state,allelic state,allelic state molgen nom (bld/tiss),"blood; finding; findings; genetic; genetics; genomic; heredity; heritable; hl7.genetics; inherited; molecular genetics; molpath.general; nominal; pcr; point in time; random; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",Nom
5304-1,rickettsia (proteus ox2) ab [presence] in serum by latex agglutination,proteus ox2 ab ser ql la,rickettsia (proteus ox2) ab la ql (s),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; id; infectious disease; infectiousdisease; lat; latex agglutination; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; ricket; rickettsial; screen; serum; sr; weil felix agglutination test,Ord
53043-6,dna marker analysis test coverage panel,dna mark analysis cover pnl,dna marker analysis test coverage panel molgen (bld/tiss),"blood; deoxyribonucleic acid; dna mark analysis cover pnl; genetic; genetics; genomic; heredity; heritable; hl7.genetics; inherited; mark; molecular genetics; molpath.general; pan; panel.hl7.genetics; panl; pcr; pnl; point in time; random; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",-
53054-3,carnitine free (c0) [moles/volume] in amniotic fluid,carnitine free amn-scnc,c0 (amn fld) [moles/vol],af; amn; amn fl; amnio; amniotic flu; amniotic fluid; c0; carnitine free; carnitine.total; chemistry; fc; fr; level; non-protein bound; point in time; qnt; quan; quant; quantitative; random; substance concentration,Qn
530-6,viomycin [susceptibility] by serum bactericidal titer,viomycin titr sbt,viomycin sbt (isol+s),antibiotic susceptibilities; dilution factor; dilution factor (titer); id; infectious disease; infectiousdisease; islt; isol; point in time; random; sequence based typing; serum; serum bactericidal titer; serum killing test; smqn; sr; titer; titered; titre; ttr; tuberactinomycin b,SemiQn
53064-2,beta aminoisobutyrate [moles/volume] in dbs,b-aib dbs-scnc,beta aminoisobutyrate (dbs) [moles/vol],3-aminoisobutyrate; 3-aminoisobutyric acid; b; b-aib; blood; chemistry; dbs; dried blood spot; filter paper; fp; level; point in time; qnt; quan; quant; quantitative; random; substance concentration; wb; whole blood,Qn
53089-9,"carbon dioxide, total [moles/volume] in nonbiological fluid by calculation",co2 fld.nb calc-scnc,co2 calc (nonbiological fluid) [moles/vol],calc; calculation; carbonic anhydride; cco2; chemistry; co2; co2 total; co2ct; ctco2; fld.nb; level; point in time; qnt; quan; quant; quantitative; random; substance concentration; tco2,Qn
53091-5,nitrogen.nonprotein [moles/volume] in serum or plasma,nitrogen nonprotein serpl-scnc,nitrogen.nonprotein [moles/vol],chemistry; level; n; n2; nit; nitrogen nonprotein; npn; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; substance concentration,Qn
53107-9,kynurenate/creatinine [molar ratio] in urine,kyn/creat ur-srto,kynurenate/creatinine (u) [molar ratio],chemistry; cr; crea; creat; kyn; kyna; kynurenic acid; point in time; qnt; quan; quant; quantitative; random; scrto; substance concentration ratio; substance ratio; ua; ucr; ur; urn,Qn
53110-3,5-hydroxytryptophan/creatinine [molar ratio] in 24 hour urine,5oh-tryptophan/creat 24h ur-srto,5-hydroxytryptophan/creatinine (24h u) [molar ratio],1 day; 24 hours; 24hr; 5-htp; 5-hydroxy tryptophan; 5oh-tryptophan; cr; crea; creat; drug/toxicology; drugs; qnt; quan; quant; quantitative; scrto; substance concentration ratio; substance ratio; ua; ucr; ur; urn,Qn
53140-0,calcium.ionized [moles/volume] adjusted to ph 7.4 in venous blood,ca-i adj ph7.4 bldv-scnc,calcium.ionized adjusted to ph 7.4 (bldv) [moles/vol],adj; adj ph7.4; bld ven; bld venous; blood - venous; blood ven; blood venus; ca; ca-i; cal; calcium active; calcium free; chemistry; coagulation factor i; ica; ion; level; point in time; qnt; quan; quant; quantitative; random; substance concentration; venous,Qn
53148-3,dna double strand ab [presence] in body fluid,dsdna ab fld ql,dna double strand ab ql (body fld),"abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; b/f; bf; bod; bodies; body fluid; body fluid, unsp; deoxyribonucleic acid; dna binding ab; ds; dsdna; dsnda; fl; fld; flu; fluid; native dna; n-dna; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serology; stranded; strnd",Ord
53154-1,alloisoleucine+isoleucine+leucine+hydroxyproline/alanine [molar ratio] in dbs,aile+ile+leu+hyp/alanine dbs-srto,alloisoleucine+isoleucine+leucine+hydroxyproline/alanine (dbs) [molar ratio],2-aminopropanoic acid; aile; aile+ile+leu+hyp; ala; alloile; allo-isoleucine; alpha alanine; blood; chemistry; dbs; dried blood spot; filter paper; fp; hydroxylproline; hydroxyprol; hydroxy-proline; hydrxprol; hydrxproln; hydrxyprln; hyp; ile; ile+leu; l-alanine; leu; msud; msud (maple syrup urine disease); ohpro; oh-proline; point in time; qnt; quan; quant; quantitative; random; scrto; substance concentration ratio; substance ratio; wb; whole blood,Qn
53159-0,tryptophan [moles/volume] in dbs,tryptophan dbs-scnc,tryptophan (dbs) [moles/vol],blood; c244; chemistry; dbs; dried blood spot; filter paper; fp; level; l-tryptophan; point in time; qnt; quan; quant; quantitative; random; substance concentration; trp; wb; whole blood,Qn
53163-2,propionylcarnitine (c3)/acetylcarnitine (c2) [molar ratio] in dbs,propionylcarn/c2 dbs-srto,c3/acetylcarnitine (c2) (dbs) [molar ratio],blood; c2; c3; c3-carntitine; chemistry; dbs; dried blood spot; filter paper; fp; point in time; propanoylcarnitine; qnt; quan; quant; quantitative; random; scrto; substance concentration ratio; substance ratio; wb; whole blood,Qn
53166-5,butyrylcarnitine+isobutyrylcarnitine (c4) [moles/volume] in dbs,butyryl+isobutyrylcarn dbs-scnc,butyrylcarnitine+isobutyrylcarnitine (c4) (dbs) [moles/vol],blood; butyryl+isobutyrylcarn; c4; chemistry; dbs; dried blood spot; filter paper; fp; level; point in time; qnt; quan; quant; quantitative; random; substance concentration; wb; whole blood,Qn
53170-7,tiglylcarnitine (c5:1) [moles/volume] in dbs,tiglylcarn dbs-scnc,tiglylcarnitine (c5:1) (dbs) [moles/vol],(c5:1); blood; c5:1; chemistry; dbs; dried blood spot; filter paper; fp; i; level; point in time; qnt; quan; quant; quantitative; random; substance concentration; wb; whole blood,Qn
53212-7,sebacylcarnitine (c10-dc) [moles/volume] in dbs,sebacylcarn dbs-scnc,c10-dc (dbs) [moles/vol],blood; c10dc; c10-dc; chemistry; dbs; dicarboxylic carnitine; dodecanedioylcarnitine; dried blood spot; filter paper; fp; level; point in time; qnt; quan; quant; quantitative; random; substance concentration; wb; whole blood,Qn
53217-6,dicarboxypalmitoleylcarnitine (c16:1-dc) [moles/volume] in dbs,dicarboxypalmitoleylcarn dbs-scnc,c16:1-dc (dbs) [moles/vol],blood; c16:1dc; c16:1-dc; chemistry; dbs; dried blood spot; filter paper; fp; i; level; point in time; qnt; quan; quant; quantitative; random; substance concentration; wb; whole blood,Qn
53248-1,plasmodium sp lactate dehydrogenase [presence] in blood,plasmodium ldh bld ql,plasmodium sp lactate dehydrogenase ql (bld),2-hydroxypropanoic acid; 2-hydroxy-propionate; 2-hydroxy-propionic acid; blood; dehydrog; dehyrdogenase; id; infectious disease; infectiousdisease; l.d.h; lact; lactic acid; lactic acid dehydrogenase; ld; ldh; l-lactate; l-lactate dehydrogenase; malaria; malarial; microbiology; ordinal; plasmodium ldh; pldh; point in time; pr; ql; qual; qualitative; random; screen; species; spp; tumor marker; wb; whole blood,Ord
53257-2,mycobacterium tuberculosis dna [#/volume] in specimen by naa with probe detection,m tb dna # spec naa+probe,m. tuberculosis dna naa+probe (specimen) [#/vol],#; 3 self-sustaining sequence replication; 3sr sr; abs; absolute; absolutes; acid fast; acid fast bacilli; acid fast bacillus; afb; amplif; amplification; amplified; cnt; count; count/volume; ct; deoxyribonucleic acid; dna nucleic acid probe; dna probe; id; infectious disease; infectiousdisease; lat; lcr; ligase chain reaction; ligation-activated transcription; m tb; m tuberculosis; microbiology; misc; miscellaneous; mtb; myco; mycobact; mycobacterium tuberculosum; naa+probe; naat; nasba; nucleic acid sequence based analysis; number concentration; number concentration (count/vol); other; pcr; point in time; polymerase chain reaction; probe amp; probe with ampification; probe with target amplification; qbr; qnt; quan; quant; quantitative; random; sda; spec; strand displacement amplification; tb; tma; to be specified in another part of the message; transcription mediated amplification; tuberculosis; unspecified; viral load,Qn
5326-4,bartonella henselae igg ab [units/volume] in serum,b henselae igg ser-acnc,b. henselae igg qn (s),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; b henselae; bacillary angiomaosis; bacillary pelliosis; cat scratch disease; cat scratch fever; csd; id; immune globulin g; immunoglobulin g; infectious disease; infectiousdisease; microbiology; point in time; qnt; quan; quant; quantitative; r henselae; random; rochalimaea henselae; serum; sr,Qn
53267-1,urinalysis yeast variants panel [#/area] - urine by computer assisted method,ua yeast pnl #/area ur comp assist,urinalysis yeast variants panel computer assisted (u) [#/area],#/area; artificial intelligence; automated detection; comp assist; number areic; pan; panel.urinalysis; panl; pnl; point in time; qnt; quan; quant; quantitative; random; ua; ua yeast pnl; ur; urn,Qn
53275-4,transitional cells [#/volume] in urine by computer assisted method,trans cells # ur comp assist,transitional cells computer assisted (u) [#/vol],#; abs; absolute; absolutes; artificial intelligence; automated detection; cell; cellularity; cnt; comp assist; count; count/volume; ct; number concentration; number concentration (count/vol); point in time; qnt; quan; quant; quantitative; random; trans cells; ua; ur; urinalysis; urn,Qn
53283-8,mixed cellular casts [#/volume] in urine by computer assisted method,mixed cell casts # ur comp assist,mixed cellular casts computer assisted (u) [#/vol],#; abs; absolute; absolutes; artificial intelligence; automated detection; cast; cnt; comp assist; count; count/volume; ct; kidney; mixed cell casts; nephrology; number concentration; number concentration (count/vol); point in time; qnt; quan; quant; quantitative; random; renal; ua; ur; urinalysis; urn,Qn
53285-3,rbc casts [#/volume] in urine by computer assisted method,rbc casts # ur comp assist,rbc casts computer assisted (u) [#/vol],#; abs; absolute; absolutes; artificial intelligence; automated detection; cast; cnt; comp assist; count; count/volume; ct; discocyte; erc; erythrocytes; kidney; nephrology; number concentration; number concentration (count/vol); point in time; qnt; quan; quant; quantitative; random; rbc; rbc casts; red blood cell; red blood cells; red blood corpuscle; red blood corpusles; red cell; red cells; renal; ua; ur; urinalysis; urn,Qn
53291-1,epithelial casts [#/area] in urine by computer assisted method,epith casts #/area ur comp assist,epithelial casts computer assisted (u) [#/area],#/area; artificial intelligence; automated detection; cast; comp assist; epi; epith; epith casts; epithelia; kidney; nephrology; number areic; point in time; qnt; quan; quant; quantitative; random; renal; ua; ur; urinalysis; urn,Qn
53292-9,erythrocytes [presence] in urine by automated,rbc ur ql auto,rbc auto ql (u),auto; automated detection; discocytes; elec; elect; electr; erthrocyte; erythrocyte; ordinal; point in time; pr; ql; qual; qualitative; random; rbc; rbcs; red blood cell; red blood cells; red blood corpuscle; red blood corpusles; red cell; red cells; screen; ua; ur; urinalysis; urn,Ord
53305-9,urinalysis type of crystal panel [#/area] - urine by computer assisted method,ua crystal pnl #/area ur comp assist,urinalysis type of crystal panel computer assisted (u) [#/area],#/area; artificial intelligence; automated detection; comp assist; number areic; pan; panel.urinalysis; panl; pnl; point in time; qnt; quan; quant; quantitative; random; ua; ua crystal pnl; ur; urn,Qn
53310-9,leucine crystals [#/area] in urine by computer assisted method,leucine cry #/area ur comp assist,leucine crystals computer assisted (u) [#/area],#/area; artificial intelligence; automated detection; comp assist; crys; cryst; crystal; leu; number areic; point in time; qnt; quan; quant; quantitative; random; ua; ur; urinalysis; urn,Qn
53316-6,leukocytes [presence] in urine by automated,wbc ur ql auto,wbc auto ql (u),auto; automated detection; elec; elect; electr; leuc; leuk; leukocyte; lkcs; ordinal; point in time; pr; ql; qual; qualitative; random; screen; ua; ur; urinalysis; urn; wbc; wbcs; white blood cell; white blood cells,Ord
53319-0,crystals [presence] in urine by automated,crystals ur ql auto,crystals auto ql (u),auto; automated detection; crys; cryst; crystal; elec; elect; electr; ordinal; point in time; pr; ql; qual; qualitative; random; screen; ua; ur; urinalysis; urn,Ord
53323-2,casts type not specified [#/volume] in urine by computer assisted method,casts not specif # ur comp assist,casts type not specified computer assisted (u) [#/vol],#; abs; absolute; absolutes; artificial intelligence; automated detection; cast; casts not specif; cnt; comp assist; count; count/volume; ct; kidney; nephrology; number concentration; number concentration (count/vol); point in time; qnt; quan; quant; quantitative; random; renal; ua; ur; urinalysis; urn,Qn
53331-5,crystals.amorphous [#/volume] in urine by computer assisted method,amorph cry # ur comp assist,crystals.amorphous computer assisted (u) [#/vol],#; abs; absolute; absolutes; am; amorph; amorph cry; amorphic; artificial intelligence; automated detection; cnt; comp assist; count; count/volume; crys; cryst; crystal; ct; number concentration; number concentration (count/vol); point in time; qnt; quan; quant; quantitative; random; ua; ur; urinalysis; urn,Qn
53350-5,thyroxine (t4) free [moles/volume] in dbs,t4 free dbs-scnc,free t4 (dbs) [moles/vol],blood; chemistry; dbs; dried blood spot; endocrine; endocrinology; filter paper; fp; fr; freet4; ft4; level; levothyroxine; levo-thyroxine; l-thyroxine; non-protein bound; point in time; qnt; quan; quant; quantitative; random; substance concentration; t4; t-4; t4 free; thyroid hormone; thyrox; thyroxin; thyrx; total t4; tt4; wb; whole blood,Qn
53400-8,stearoylcarnitine (c18)/propionylcarnitine (c3) [molar ratio] in dbs,stearoylcarn/c3 dbs-srto,c18/propionylcarnitine (c3) (dbs) [molar ratio],blood; c18; c3; c3-carntitine; chemistry; dbs; dried blood spot; filter paper; fp; point in time; propanoylcarnitine; qnt; quan; quant; quantitative; random; scrto; steroylcarnitine; substance concentration ratio; substance ratio; wb; whole blood,Qn
53419-8,fibroblast growth factor 23.intact [mass/volume] in plasma by immunoassay --1st specimen post xxx challenge,fgf-23.intact sp1 p chal plas ia-mcnc,fibroblast growth factor 23.intact 1st specimen post unsp challenge ia (p) [mass/vol],acute specimen; after; autosomal dominant hypophosphatemic rickets; chemistry.challenge testing; eia; elfa; elisa; enzyme immunoassay; fac; fact; familial tumoral calcinosis with hyperphosphatemia; fgf 23; fgf23; fgf-23; fgf-23.intact; first; iaa; ifgf23; level; mass concentration; meia; p chal; pl; plasma; plsm; point in time; pre immunization; pst; qnt; quan; quant; quantitative; random; sp1; sp1 p chal; spec; suds,Qn
53429-7,fibroblast growth factor 23 [units/volume] in plasma by immunoassay --4th specimen post xxx challenge,fgf-23 sp4 p chal plas ia-acnc,fibroblast growth factor 23 4th specimen post unsp challenge ia qn (p),after; arbitrary concentration; autosomal dominant hypophosphatemic rickets; chemistry.challenge testing; eia; elfa; elisa; enzyme immunoassay; fac; fact; familial tumoral calcinosis with hyperphosphatemia; fgf 23; fgf23; fgf-23; iaa; meia; p chal; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; sp4; sp4 p chal; spec; suds,Qn
53438-8,carnitine palmitoyltransferase 2 [enzymatic activity/mass] in fibroblast,cpt2 fib-ccnt,carnitine palmitoyltransferase 2 (fibroblast) [catalytic activity/mass],carnitine acyltransferase ii; carnitine.total; catalytic content; chemistry; cpt; cpt ii; cpt2; fib; fibr; ii; point in time; qnt; quan; quant; quantitative; random,Qn
53440-4,argininosuccinate synthase [enzymatic activity/mass] in liver from fetus,asa synthase liver fetus-ccnt,argininosuccinate synthase (liver fetus) [catalytic activity/mass],argininosuccinic acid; arginosuccinate; arginosuccinic acid; asa; asa synthase; catalytic content; chemistry; fetal; gyn; gynecology; hepar; hepatic; ob; obgyn; obstetrics; point in time; qnt; quan; quant; quantitative; random,Qn
53448-7,cycloguanil [mass/volume] in serum or plasma,cycloguanil serpl-mcnc,cycloguanil [mass/vol],drug/toxicology; drugs; level; mass concentration; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
53458-6,carbon dioxide [partial pressure] in nonbiological fluid,pco2 fld.nb,co2 (nonbiological fluid) [partial pressure],carbonic anhydride; chemistry; co2; fld.nb; lung; partial pressure; pco2; point in time; pulmonary; pulmonology; qnt; quan; quant; quantitative; random; respiratory,Qn
53459-4,decadienoylcarnitine (c10:2) [moles/volume] in amniotic fluid,decadienoylcarn amn-scnc,c10:2 (amn fld) [moles/vol],af; amn; amn fl; amnio; amniotic flu; amniotic fluid; c10:2; chemistry; ii; level; point in time; qnt; quan; quant; quantitative; random; substance concentration,Qn
5346-2,salmonella typhi o ab [presence] in serum by latex agglutination,s typhi o ab ser ql la,s. typhi o ab la ql (s),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; id; infectious disease; infectiousdisease; lat; latex agglutination; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; s typhi; s typhi o; s typhosa; sal; salmonel; screen; serum; sr; typh; typhoid,Ord
53463-6,beta aminoisobutyrate [moles/volume] in body fluid,b-aib fld-scnc,beta aminoisobutyrate (body fld) [moles/vol],"3-aminoisobutyrate; 3-aminoisobutyric acid; b; b/f; b-aib; bf; bod; bodies; body fluid; body fluid, unsp; chemistry; fl; fld; flu; fluid; level; point in time; qnt; quan; quant; quantitative; random; substance concentration",Qn
53488-3,3-o-methyldopa [moles/volume] in 24 hour urine,3-o-methyldopa 24h ur-scnc,3-o-methyldopa (24h u) [moles/vol],1 day; 24 hours; 24hr; 3-methoxytyrosine; 3-omd; aldj; aldomet; dopamet; drug/toxicology; drugs; iii; level; novomedopa; qnt; quan; quant; quantitative; substance concentration; ua; ur; urn,Qn
53497-4,5-hydroxytryptophan [moles/volume] in 24 hour urine,5oh-tryptophan 24h ur-scnc,5-hydroxytryptophan (24h u) [moles/vol],1 day; 24 hours; 24hr; 5-htp; 5-hydroxy tryptophan; 5oh-tryptophan; drug/toxicology; drugs; level; qnt; quan; quant; quantitative; substance concentration; ua; ur; urn,Qn
53518-7,leukocytes [#/volume] in dialysis fluid,wbc # dial fld,wbc (dial fld) [#/vol],#; abs; absolute; absolutes; cnt; count; count/volume; ct; diaf; dialysate; dialysis fluid; hematology/cell counts; kidney; leuc; leuk; leukocyte; lkcs; nephrology; number concentration; number concentration (count/vol); point in time; qnt; quan; quant; quantitative; random; renal; wbc; wbcs; white blood cell; white blood cells,Qn
53519-5,monocytes/leukocytes in dialysis fluid,monocytes nfr dial fld,monocytes/leukocytes (dial fld),diaf; dialysate; dialysis fluid; hematology/cell counts; leuc; leuk; leukocyte; lkcs; mono; monocyte; monos; number fraction; percent; point in time; qnt; quan; quant; quantitative; random; wbc; wbcs; white blood cell; white blood cells,Qn
53524-5,alkaline phosphatase.bile/alkaline phosphatase.total in serum or plasma,alp bile cfr serpl,alp bile [catalytic fraction],alk; alk phos; alkaline phos; alkaline phosphatase biliary; alkaline phosphatase.total; alkp; alp; alp bile; ap; catalytic fraction; chemistry; percent; phos; phosphtase; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; tot; totl,Qn
53534-4,varicella zoster virus igg ab [presence] in body fluid by immunoassay,vzv igg fld ql ia,vzv igg ia ql (body fld),"abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; b/f; bf; bod; bodies; body fluid; body fluid, unsp; chicken pox; chicken pox virus; chickenpox; eia; elfa; elisa; enzyme immunoassay; fl; fld; flu; fluid; herpes zoster; hhv-3; human herpesvirus 3; iaa; id; immune globulin g; immunoglobulin g; infectious disease; infectiousdisease; meia; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; screen; shingles; suds; vz; vzv; zoster",Ord
53537-7,measles virus igm ab [presence] in body fluid by immunoassay,mev igm fld ql ia,mev igm ia ql (body fld),"abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; b/f; bf; bod; bodies; body fluid; body fluid, unsp; eia; elfa; elisa; enzyme immunoassay; fl; fld; flu; fluid; iaa; id; immune globulin m; immunoglobulin m; infectious disease; infectiousdisease; meia; mev; microbiology; msls; ordinal; point in time; pr; ql; qual; qualitative; random; rubeola; screen; suds",Ord
535-5,mycobacterium sp identified in body fluid by organism specific culture,mycobacterium fld cult,mycobacterium sp identified org specific cx nom (body fld),"acid fast; acid fast bacilli; acid fast bacillus; afb; b/f; bf; bod; bodies; body fluid; body fluid, unsp; c&s; cult; cultures; fl; fld; flu; fluid; id; identity or presence; infectious disease; infectiousdisease; microbiology; myco; mycobact; nominal; point in time; random; spec; species; spp; tuberculosis",Nom
53555-9,specific gravity of red blood cells,sp gr rbc,specific gravity (rbc),chemistry; erythrocytes; point in time; qnt; quan; quant; quantitative; random; red blood cells; red blood corpusles; sp gr,Qn
53557-5,nucleated cells [#/volume] in synovial fluid by manual count,nuc cell # snv manual,nucleated cells manual cnt (syn fld) [#/vol],#; abs; absolute; absolutes; cell; cellularity; cnt; count; count/volume; ct; hematology/cell counts; joint aspirate; joint fld; joint flu; joint fluid; manl; nuc; nuc cell; number concentration; number concentration (count/vol); point in time; qnt; quan; quant; quantitative; random; sf; snv; syn; syn fl; synov; synovial fluid,Qn
53582-3,echovirus ab [units/volume] in serum by immunoassay,ecv ab ser ia-acnc,echovirus ab ia qn (s),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; echo; echo virus; ecv; eia; elfa; elisa; enzyme immunoassay; ev; iaa; id; infectious disease; infectiousdisease; meia; microbiology; point in time; qnt; quan; quant; quantitative; random; serum; sr; suds,Qn
53586-4,hla-b6 [presence],hla-b6 ql,hla-b6 ql (bld/tiss),"blood; genetics; heredity; heritable; hla antigen; human leukocyte antigen; inherited; ordinal; point in time; pr; ql; qual; qualitative; random; screen; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",Ord
53591-4,gamma globulin.abnormal band [mass/volume] in serum or plasma by electrophoresis,gamma glob abnormal serpl elph-mcnc,gamma globulin.abnormal band elph [mass/vol],abn; abnorm; bands; bnd; chemistry; elec; elect; electr; electro; electrophhrs; electrophrs; elp; elph; ep; gamma glob abnormal; glb; glob; glob%; globul; globulins; level; mass concentration; pl; plasma; plsm; point in time; protein gamma globulin; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
5361-1,spermatozoa ab [units/volume] in semen,sperm ab smn-acnc,spermatozoa ab qn (sem),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; ejaculate; fertility testing; genitourinary; gu; point in time; qnt; quan; quant; quantitative; random; sem; seminal fluid; smn; smpls; sperm; uro; urology,Qn
53644-1,carbaryl [presence] in gastric fluid,carbaryl gast ql,carbaryl ql (gast fld),"1-naphthalenol, methylcarbamate; 1-naphthol n-methylcarbamate; 1-naphthyl methylcarbamate; 1-naphthyl n-methylcarbamate; alpha-naphthalenyl methylcarbamate; alpha-naphthyl methylcarbamate; alpha-naphthyl n-methylcarbamate; drug/toxicology; drugs; gast; gastric contents; gastric fluid; ordinal; point in time; pr; ql; qual; qualitative; random; screen; sevin",Ord
5364-5,sporothrix schenckii ab [units/volume] in serum,s schenckii ab ser-acnc,s. schenckii ab qn (s),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; id; infectious disease; infectiousdisease; microbiology; point in time; qnt; quan; quant; quantitative; random; s schenckii; serum; sporotrichosis; sr,Qn
53653-2,ph of bile fluid,ph bifl,ph (bile),bifl; bile fluid; biliary fluid; chemistry; log molar concentration; point in time; random; smqn,SemiQn
53654-0,ph of dialysis fluid,ph dial fld,ph (dial fld),chemistry; diaf; dialysate; dialysis fluid; log molar concentration; point in time; random; smqn,SemiQn
5366-0,staphylolysin ab [units/volume] in serum,staphylolysin ab ser-acnc,staphylolysin ab qn (s),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; id; infectious disease; infectiousdisease; microbiology; point in time; qnt; quan; quant; quantitative; random; serum; sr,Qn
53664-9,method of prior gestational age estimate,method prior ga estimate,,finding; findings; ga; gest; gestation; gyn; gynecology; meth; method prior ga estimate; nominal; ob; obgyn; obsterical; obsterical.ultrasound; obstetrical; obstetrics; point in time; prenatal; random,Nom
53685-4,fetal left ventricle diameter during diastole us,fet lv diam diastole us.meas,,cardiac; cardio; cardiology; dia; diam; diam d; diam diastole; dias; diast; diastoli; echography; fetal; gyn; gynecology; heart disease; hrt; hrt ventr; l; length; lt; lv; ob; obgyn; obsterical; obsterical.ultrasound; obstetrical; obstetrics; point in time; qnt; quan; quant; quantitative; random; sonogram; sonograph; sonography; uls; ultrasound; us+meas; ventricular,Qn
53686-2,fetal neck narrative study observation us,us neck fetus study,,echography; fetal; finding; findings; gyn; gynecology; narrative; ob; obgyn; obsterical; obsterical.ultrasound; obstetrical; obstetrics; point in time; random; report; sonogram; sonograph; sonography; study report; uls; ultrasound,Nar
53688-8,fetal genitalia narrative study observation us,us genitalia fetus study,,echography; fetal; finding; findings; gyn; gynecology; narrative; ob; obgyn; obsterical; obsterical.ultrasound; obstetrical; obstetrics; point in time; random; report; sonogram; sonograph; sonography; study report; uls; ultrasound,Nar
53690-4,fetal skeletal system narrative study observation us,us skeletal fetus study,,echography; fetal; finding; findings; gyn; gynecology; narrative; ob; obgyn; obsterical; obsterical.ultrasound; obstetrical; obstetrics; point in time; random; report; sonogram; sonograph; sonography; study report; uls; ultrasound,Nar
53697-9,fetal nasal bone diaphysis [length] us,fet nasal bone length us.meas,,bon; echography; fetal; gyn; gynecology; length; ob; obgyn; obsterical; obsterical.ultrasound; obstetrical; obstetrics; point in time; qnt; quan; quant; quantitative; random; sonogram; sonograph; sonography; uls; ultrasound; us+meas,Qn
53713-4,pca-1 ab [titer] in cerebral spinal fluid,pca-1 ab titr csf,pca-1 ab (csf) [titer],abs; aby; antby; anti; antibodies; antibody; anti-yo-associated paraneoplastic cerebellar degeneration; autoantibodies; autoantibody; cerebral spinal fluid; cerebrospinal fl; cytopl; cytoplas; dilution factor; dilution factor (titer); i; paraneoplastic syndrome; pca1; pca-1; pcca-1; point in time; purkinje cell cytoplasmic antibody; purkinje cells; random; serology; smqn; spinal fl; spinal fld; spinal flu; spinal fluid; titer; titered; titre; ttr; yo ab,SemiQn
53715-9,paraneoplastic ab [presence] in cerebral spinal fluid by immunoblot,paraneoplastic ab csf ql ib,paraneoplastic ab ib ql (csf),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; blt; cerebral spinal fluid; cerebrospinal fl; immune blot; immunobl; immunoblot; ordinal; point in time; pr; ql; qual; qualitative; random; riba; screen; serology; spinal fl; spinal fld; spinal flu; spinal fluid; wb; wblot; west blot; west blt; western blot,Ord
53730-8,borrelia burgdorferi g39/40 igg ab [units/volume] in serum or plasma,b burgdor g39/40 igg serpl-acnc,b. burgdorferi g39/40 igg qn,abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; b burg; b burgdor; b burgdor g39/40; b burgdorferi; bb; burgdorf; id; immune globulin g; immunoglobulin g; infectious disease; infectiousdisease; lyme; lyme disease; lymes; microbiology; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
53732-4,gck gene targeted mutation analysis in blood or tissue by molecular genetics method,gck gene mut anl bld/t,gck gene targeted mutation analysis molgen doc (bld/tiss),"blood; document; fgqtl3; finding; findings; genetics; gk; glk; glucokinase (hexokinase 4); glucokinase (hexokinase 4, maturity onset diabetes of the young 2); heredity; heritable; hhf3; hk4; hkiv; hxkp; inherited; lglk; mody2; molecular genetics; molecular pathology; molpath; molpath.mutations; mut; mut anl; mutations; pcr; point in time; random; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",Doc
53733-2,color of spun body fluid,color spun fld,color (spun body fld),"b/f; bf; bod; bodies; body fluid; body fluid, unsp; fl; fld; flu; fluid; nominal; point in time; random; spec; spun fld; supernat; supernate",Nom
5374-4,taenia saginata ab [units/volume] in serum by immunoassay,t saginata ab ser ia-acnc,t. saginata ab ia qn (s),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; eia; elfa; elisa; enzyme immunoassay; iaa; id; infectious disease; infectiousdisease; meia; microbiology; point in time; qnt; quan; quant; quantitative; random; serum; sr; suds; t saginata; tapeworm,Qn
53755-5,hydrogen/expired gas [volume fraction] in exhaled gas --1.25 hours post xxx challenge,breath h2 1.25h p chal,hydrogen/expired gas 1.25 hr post unsp challenge (exhl gas) [volume fraction],1 1/4 h; 1.25 hours; 1.25 hr; 1.25h p chal; 75 min; 75 minutes; 75min; after; breath; chemistry.challenge testing; exg; exhaled gas; exhaled gas (=breath); gases; h2; hyd; p chal; percent; point in time; pst; qnt; quan; quant; quantitative; random; volfr; volume fraction,Qn
53756-3,respiratory status finding,resp status,,finding; findings; h+p; h+p.hx; nominal; p prime; point in time; random; resp status,Nom
53766-2,estrogen fraction panel - serum or plasma,estrogen fraction pnl serpl,estrogen fraction panel,chemistry; est; estr; estroge; estrogen fraction pnl; estrogens; estrone+estradiol; estrone+estradiol+estriol; frac; fract; fractionation; fractions; pan; panel.chemistry; panl; pl; plasma; plsm; pnl; point in time; random; serp; serpl; serplas; serum; serum or plasma; sr; universallaborders,-
53779-5,arsenic.methylated [mass/volume] in urine,arsenic.methylated ur-mcnc,arsenic.methylated (u) [mass/vol],as; drug/toxicology; drugs; level; mass concentration; point in time; qnt; quan; quant; quantitative; random; ua; ur; urn,Qn
53783-7,htt gene mutation panel - blood or tissue by molecular genetics method,htt gene mutation pnl bld/t,htt gene mutation panel molgen (bld/tiss),"5htt; 5-htt; 5-httlpr; blood; hd gene; hsert; htt; htt gene mutation pnl; huntingtin; huntington chorea; huntington disease; huntington's disease; it15; molecular genetics; molecular pathology; molpath; mut; mutations; ocd1; pan; panel.molpath; panl; pcr; pnl; point in time; random; sert; sert1; solute carrier family 6 (neurotransmitter transporter), member 4; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",-
53791-0,ptpn11 gene mutations tier 1 found [identifier] in blood or tissue by molecular genetics method nominal,ptpn11 gene mut anl tier1 bld/t,ptpn11 gene mutations tier 1 molgen nom (bld/tiss),"blood; bptp3; cfc; genetics; heredity; heritable; hgnc:8012; i; identity or presence; inherited; molecular genetics; molecular pathology; molpath; molpath.mutations; mut; mut anl; mut anl tier1; mutations; nominal; noonan syndrome 1; ns1; pcr; point in time; protein tyrosine phosphatase, non-receptor type 11; protein tyrosine phosphatase, non-receptor type 11 gene; ptp-1d; ptp2c; random; shp2; shp-2; shptp2; sh-ptp2; sh-ptp3; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",Nom
53799-3,major crossmatch [interpretation] by electronic,maj xm serpl electronic-imp,major crossmatch electronic [interp],blood bank; compatability testing; impression; impression/interpretation of study; impressions; interp; interpretation; maj xm; nominal; pl; plasma; plsm; point in time; random; serp; serpl; serplas; serum; serum or plasma; sr,Nom
53807-4,basement membrane zone bp230 igg ab [units/volume] in serum or plasma by immunoassay,bmz bp230 igg serpl ia-acnc,basement membrane zone bp230 igg ia qn,abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; basem; basemt; bm; bmz; bmz bp230; eia; elfa; elisa; enzyme immunoassay; iaa; immune globulin g; immunoglobulin g; meia; pemphigoid; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serology; serp; serpl; serplas; serum; serum or plasma; sr; suds,Qn
53816-5,alpha hydroxytriazolam [mass/volume] in serum,a-oh-triazolam ser-mcnc,alpha hydroxytriazolam (s) [mass/vol],1-hydroxytriazolam; alfa; alpha hydroxy triazolam; a-oh-triazolam; drug/toxicology; drugs; hydroxy triazolam; level; mass concentration; oh-triazolam; ohtrz; point in time; qnt; quan; quant; quantitative; random; serum; sr; triazolam metabolite,Qn
53827-2,history of neural tube defect qualitative,hx of ntd ql,,anencephaly; gyn; gynecology; h+p; h+p.hx; history; neural tube def; neural tube defct; ntd; ob; obgyn; obstetrics; ontd; open spina bifida; ordinal; osb; p prime; point in time; ql; qual; qualitative; random; screen,Ord
53841-3,atrx gene mutations found [identifier] in blood or tissue by molecular genetics method nominal,atrx gene mut anl bld/t,atrx gene targeted mutation analysis molgen nom (bld/tiss),"alpha thalassemia/mental retardation syndrome x-linked; atp-dependent helicase atrx; atr2; blood; genetics; heredity; heritable; identity or presence; inherited; jms; molecular genetics; molecular pathology; molpath; molpath.mutations; mrxhf1; mut; mut anl; mutations; nominal; pcr; point in time; rad54; rad54l; random; sfm1; shs; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue; xh2; x-linked helicase ii; x-linked nuclear protein; xnp; zinc finger helicase; znf-hx",Nom
53845-4,btd gene targeted mutation analysis in blood or tissue by molecular genetics method,btd gene mut anl bld/t,btd gene targeted mutation analysis molgen doc (bld/tiss),"biotinase; biotinidase; blood; document; finding; findings; genetics; heredity; heritable; inherited; molecular genetics; molecular pathology; molpath; molpath.mutations; mut; mut anl; mutations; pcr; point in time; random; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",Doc
53852-0,col2a1 gene+col11a1 gene mutations found [identifier] in blood or tissue by molecular genetics method nominal,col2a1+col11a1 gene mut anl bld/t,col2a1 gene+col11a1 gene targeted mutation analysis molgen nom (bld/tiss),"anfh; aom; blood; cartilage collagen gene; col11a3; col2a1+col11a1 gene; collagen, type ii, alpha 1; genetics; heredity; heritable; identity or presence; inherited; molecular genetics; molecular pathology; molpath; molpath.mutations; mut; mut anl; mutations; nominal; pcr; point in time; primary osteoarthritis; random; sedc; spondyloepiphyseal dysplasia; stickler syndrome; stl1; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",Nom
53878-5,deprecated neisseria gonorrhoeae rrna [presence] in penis by probe and target amplification method,deprecated n gonorrhoea rrna penis ql pc,n. gonorrhoeae rrna naa+probe ql (penis),3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; arbitrary concentration; dna nucleic acid probe; dna probe; gc; gen-probe; gono; gonorrhea; id; infectious disease; infectiousdisease; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; n gonorrhoea; n gonorrhoeae; naa+probe; naat; nasba; nucleic acid sequence based analysis; ordinal; pcr; pen; penile; point in time; polymerase chain reaction; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; ribosomal rna; screen; sda; strand displacement amplification; tma; transcription mediated amplification,Ord
53885-0,parvovirus b19 igg ab [units/volume] in body fluid,b19v igg fld-acnc,parvovirus b19 igg qn (body fld),"abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; b/f; b19 virus; b19v; bf; bod; bodies; body fluid; body fluid, unsp; fifth disease; fl; fld; flu; fluid; id; immune globulin g; immunoglobulin g; infectious disease; infectiousdisease; microbiology; parvo; parvo virus; parvov; point in time; qnt; quan; quant; quantitative; random",Qn
53894-2,trappc2 gene targeted mutation analysis in blood or tissue by molecular genetics method,trappc2 gene mut anl bld/t,trappc2 gene targeted mutation analysis molgen doc (bld/tiss),"blood; document; finding; findings; genetics; heredity; heritable; hyp38334; inherited; mbp-1 interacting protein-2a; mbp-1-interacting protein 2a; mip; mip2a; mip-2a; molecular genetics; molecular pathology; molpath; molpath.mutations; mut; mut anl; mutations; pcr; point in time; random; sedl; sedt; spondyloepiphyseal dysplasia, late; tissue; tissue, unspecified; trafficking protein particle complex 2; trappc2p1; trs20; wb; whole blood; whole blood or tissue; znf547l",Doc
53908-0,bacteria identified in esophageal brushing by culture,bacteria esoph brush cult,bacteria identified cx nom (esophageal brushing),bact; c&s; cult; cultures; esoph brush; esophagial brush; id; identity or presence; infectious disease; infectiousdisease; microbiology; nominal; point in time; random,Nom
53910-6,microscopic observation [identifier] in peritoneal fluid by rhodamine-auramine fluorochrome stain,rhodamine-auramine stn prt,microscopic observation rhodamine-auramine fluorochrome stain nom (periton fld),afb stain; ascites; ascitic fluid; ascitis; auramine stain; auramine-rhodamine stain; id; identity or presence; infectious disease; infectiousdisease; microbiology; nominal; peritoneal fluid; point in time; prt; random; rhodamine-auramine stn; st; stains; stn,Nom
53914-8,microscopic observation [identifier] in endometrium by rhodamine-auramine fluorochrome stain,rhodamine-auramine stn endometrium,microscopic observation rhodamine-auramine fluorochrome stain nom (endometrium),afb stain; auramine stain; auramine-rhodamine stain; endm; endometr; endometrium; gyn; gynecology; id; identity or presence; infectious disease; infectiousdisease; microbiology; nominal; ob; obgyn; obstetrics; point in time; random; rhodamine-auramine stn; st; stains; stn,Nom
53918-9,microscopic observation [identifier] in bone marrow by rhodamine-auramine fluorochrome stain,rhodamine-auramine stn mar,microscopic observation rhodamine-auramine fluorochrome stain nom (bm),afb stain; auramine stain; auramine-rhodamine stain; bm; bon; bone marrow; id; identity or presence; infectious disease; infectiousdisease; mar; marrow (bone); microbiology; minimal angle of resolution; minimum angle of resolution; nominal; point in time; random; rhodamine-auramine stn; st; stains; stn,Nom
53919-7,thyroglobulin ab [units/volume] in tissue fine needle aspirate,thyroglob ab tiss fna-acnc,thyroglobulin ab qn (tissue fine needle aspirate),"abs; aby; antby; anti; antibodies; antibody; antithyroglob; arbitrary concentration; autoantibodies; autoantibody; endocrine; endocrinology; fine needle; hashimoto's thyroiditis; point in time; qnt; quan; quant; quantitative; random; serology; tg; tgabs; thyglobulin; thyroglbn; thyroglob; tiss fna; tissue; tissue fine needle aspirate; tissue, unspecified; tumor marker",Qn
5392-6,treponema pallidum ab [units/volume] in serum by immobilization,t pallidum ab ser immob-acnc,t. pallidum ab immobilization qn (s),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; id; infectious disease; infectiousdisease; microbiology; point in time; qnt; quan; quant; quantitative; random; serum; sr; syphilis; t pallidum; treponemal,Qn
53934-6,lactate dehydrogenase in peritoneal fluid/lactate dehydrogenase in serum,ldh prt/serpl,ldh in peritoneal fluid/lactate dehydrogenase in serum (periton fld+s/p) [relative ratio],2-hydroxypropanoic acid; 2-hydroxy-propionate; 2-hydroxy-propionic acid; ascites; ascitic fluid; ascitis; chemistry; dehydrog; dehyrdogenase; l.d.h; lact; lactic acid; lactic acid dehydrogenase; ld; ldh; ldh prt; ldh.serum; l-lactate; l-lactate dehydrogenase; periton fld+serpl; peritoneal fluid; pl; plasma; plsm; point in time; prt; qnt; quan; quant; quantitative; random; relative ratio; ser; serp; serpl; serplas; serum; serum or plasma; sr; tumor marker,Qn
53942-9,vibrio cholerae toxin ctx gene [presence] in specimen by naa with probe detection,v cholerae ctx gene spec ql naa+probe,v. cholerae toxin ctx gene naa+probe ql (specimen),3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; ct; ctx; dna nucleic acid probe; dna probe; id; infectious disease; infectiousdisease; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; misc; miscellaneous; naa+probe; naat; nasba; nucleic acid sequence based analysis; ordinal; other; pcr; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; screen; sda; spec; strand displacement amplification; tma; to be specified in another part of the message; transcription mediated amplification; unspecified; v cholera; v cholerae; v cholerae ctx gene; v cholerae tox,Ord
53946-0,escherichia coli shiga-like toxin identified in specimen,e coli sxt spec,e. coli shiga-like toxin identified nom (specimen),e coli; e coli sltec; e coli sxt; ehec; enterohemorrhagic e coli; id; identity or presence; infectious disease; infectiousdisease; microbiology; misc; miscellaneous; nominal; o002; other; point in time; random; sltec; spec; to be specified in another part of the message; unspecified,Nom
53955-1,escherichia coli o157 identified in isolate by organism specific culture,e coli o157 islt cult,e. coli o157 identified org specific cx nom (isol),c&s; cult; cultures; e coli; e coli o157; id; identity or presence; infectious disease; infectiousdisease; islt; isol; microbiology; nominal; o002; point in time; random; spec,Nom
53957-7,choriogonadotropin.tumor marker [mass/volume] in serum or plasma,hcg-tm serpl-mcnc,hcg.tumor marker [mass/vol],cg; chemistry; choriogonadotropins total; chorionic gonadotropin; hcg; hcg-tm; human chorionic gonadotropin; level; mark; mass concentration; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; tumor marker,Qn
53964-3,leukocytes [presence] in urine by visual,wbc ur ql visual,wbc visual ql (u),leuc; leuk; leukocyte; lkcs; ordinal; point in time; pr; ql; qual; qualitative; random; screen; ua; ur; urinalysis; urn; wbc; wbcs; white blood cell; white blood cells,Ord
53974-2,erythrocyte morphology [interpretation] in urine sediment by light microscopy narrative,rbc morph urns micro-imp,erythrocyte morphology lm nar (urine sed) [interp],discocyte; erc; erythrocytes; impression; impression/interpretation of study; impressions; interp; interpretation; kidney; lm; micro; micros; microscopic; narrative; nephrology; point in time; random; rbc; rbc morph; red blood cell; red blood cells; red blood corpuscle; red blood corpusles; red cell; red cells; renal; report; ua; ur; urinalysis; urine sediment; urn; urns,Nar
53979-1,actin ab [presence] in serum or plasma by immunofluorescence,actin ab serpl ql if,actin ab if ql,abs; aby; acif; antby; anti; antibodies; antibody; anticomplement immunofluorescence; autoantibodies; autoantibody; fa; fluorescent antibody; fluoresent; ifa; immune fluorescence; immunoflour; immunofluor; immunofluorescence; ordinal; pl; plasma; plsm; point in time; pr; ql; qual; qualitative; random; screen; serology; serp; serpl; serplas; serum; serum or plasma; sr; time resolved fluorescence; trf,Ord
54006-2,nuclear membrane pores nuclear ab pattern [titer] in serum by immunofluorescence,ana nuclear membrane pores titr ser if,nuclear membrane pores nuclear ab pattern if (s) [titer],acif; ana; ana nuclear membrane pores; ana pat; anf; anticomplement immunofluorescence; antinuclear antibody; dilution factor; dilution factor (titer); fa; fana; fluorescent antibody; fluoresent; ifa; immune fluorescence; immunoflour; immunofluor; immunofluorescence; na; nuc; point in time; random; serology; serum; smqn; sr; time resolved fluorescence; titer; titered; titre; trf; ttr,SemiQn
54011-2,vimentin ab [presence] in serum by immunofluorescence,vimentin ab ser ql if,vimentin ab if ql (s),abs; aby; acif; antby; anti; antibodies; antibody; anticomplement immunofluorescence; autoantibodies; autoantibody; fa; fluorescent antibody; fluoresent; ifa; immune fluorescence; immunoflour; immunofluor; immunofluorescence; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serology; serum; sr; time resolved fluorescence; trf; tumor marker,Ord
54016-1,cathepsin g ab [presence] in serum,cathepsin g ab ser ql,cathepsin g ab ql (s),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serology; serum; sr,Ord
54030-2,smith extractable nuclear b ab [presence] in serum,ena sm-b ab ser ql,smith extractable nuclear b ab ql (s),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; ena; ena sm; ena sm-b; nuc; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serology; serum; sm; smb; sr,Ord
54034-4,anaplasma phagocytophilum ag [presence] in tissue by immune stain,a phagocytoph ag tiss ql imstn,a. phagocytophilum ag immune stain ql (tiss),"antigen; antigens; e equi; e phagocytophila; ehrlichia equi; ehrlichia phagocytophila; hge; human granulocytic ehrlichiosis; id; ihc; imm; immunohistochemical stain; immunostain; imstn; imun; imune; infectious disease; infectiousdisease; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; screen; st; stains; stn; tissue; tissue, unspecified",Ord
54043-5,hedis 2009 codes to identify sexually active women (chl-b),hedis 2009 chl-b,hedis 2009 codes to identify sexually active women (chl-b),hedis 2009 chl-b; pan; panel; panel.hedis; panl; pnl; point in time; random,-
54049-2,hedis 2009-2013 codes to identify lead (lsc-a),hedis 2009-13 lsc-a,hedis 2009-2013 codes to identify lead (lsc-a),hedis 2009-13 lsc-a; painter's colic; pan; panel; panel.hedis; panl; pb; plumbism; pnl; point in time; random,-
54092-2,citrulline/arginine [molar ratio] in dbs,citrulline/arginine dbs-srto,citrulline/arginine (dbs) [molar ratio],arg; blood; chemistry; cit; citr; dbs; dried blood spot; filter paper; fp; point in time; qnt; quan; quant; quantitative; random; scrto; substance concentration ratio; substance ratio; wb; whole blood,Qn
54095-5,chemotherapy effectiveness panel [identifier] - blood or tissue,chemotherapy effectiveness pnl bld/t,chemotherapy effectiveness panel doc (bld/tiss),"blood; chemo; chemotherapy effectiveness pnl; document; drug/toxicology; drugs; identity or presence; pan; panel.drug & toxicology; panl; pnl; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",Doc
54097-1,organophosphonate nerve agent metabolite panel [mass/volume] - urine,op nerve agent metab pnl ur-mcnc,organophosphonate nerve agent metabolite panel (u),drug/toxicology; drugs; level; mass concentration; metab; metabolites; metb; op nerve agent metab pnl; pan; panel.drug & toxicology; panl; pnl; point in time; random; ua; ur; urn,-
54102-9,monoethyl methylphosphonate [mass/volume] in urine,monoethyl me-phosphonate ur-mcnc,monoethyl methylphosphonate (u) [mass/vol],drug/toxicology; drugs; level; mass concentration; mep; methyl phosphonate; methyl phosphonic acid; methylphosphonic acid; monoethyl me-phosphonate; mp; mpa; mpn; point in time; qnt; quan; quant; quantitative; random; russian vx acid; ua; ur; urn; vx metabolite,Qn
54115-1,age range at onset of disease family member [ussg-fht],,,dis; diseases; dz; fam mem; fhh; nominal; point in time; random; rnge; survey; survey.ussgfht; typ; us surgeon general; us surgeon general family health portrait,Nom
54117-7,diseases history panel [ussg-fht] family member,,,diseases hx pnl; fam mem; fhh; hx; pan; panl; pnl; point in time; random; survey; survey.ussgfht; us surgeon general; us surgeon general family health portrait; ussgfht,-
54126-8,my health history [ussg-fht],,,fhh; hx; my health hx; pan; panel; panl; pnl; point in time; random; survey; survey.ussgfht; us surgeon general; us surgeon general family health portrait; ussgfht,-
54134-2,race [ussg-fht],,,ethnicity; fhh; nominal; point in time; random; survey; survey.ussgfht; typ; us surgeon general; us surgeon general family health portrait,Nom
54137-5,diseases history panel [ussg-fht],,,diseases hx pnl; fhh; hx; pan; panl; pnl; point in time; random; survey; survey.ussgfht; us surgeon general; us surgeon general family health portrait; ussgfht,-
54146-6,mycobacterium tuberculosis igg ab [units/volume] in serum by immunoassay,m tb igg ser ia-acnc,m. tuberculosis igg ia qn (s),abs; aby; acid fast; acid fast bacilli; acid fast bacillus; afb; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; eia; elfa; elisa; enzyme immunoassay; iaa; id; immune globulin g; immunoglobulin g; infectious disease; infectiousdisease; m tb; m tuberculosis; meia; microbiology; mtb; myco; mycobact; mycobacterium tuberculosum; point in time; qnt; quan; quant; quantitative; random; serum; sr; suds; tb; tuberculosis,Qn
5414-8,deprecated cd10 cells/100 cells in blood,deprecated cd10 wbc-acnc,cd10 qn (wbc),arbitrary concentration; calla; cell markers; common acute lymphoblastic leukemia; common acute lymphoblastic leukemia antigen; enkephalinase; gp100; j5; leukocytes; nep; neprilysin; neutral endopeptidase metalloendopeptidase; point in time; qnt; quan; quant; quantitative; random; wbcs; white blood cells,Qn
54154-0,intercellular bridge nuclear ab pattern [presence] in serum by immunofluorescence,ana intercell bridge ser ql if,intercellular bridge ana pattern if ql (s),acif; ana; ana intercell bridge; ana pat; anf; anticomplement immunofluorescence; antinuclear antibody; fa; fana; fluorescent antibody; fluoresent; ifa; immune fluorescence; immunoflour; immunofluor; immunofluorescence; midbody; na; nuc; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serology; serum; sr; stem body; time resolved fluorescence; trf,Ord
54156-5,rna polymerase i ab [presence] in serum by immunofluorescence,rnap i ab ser ql if,rna polymerase i ab if ql (s),abs; aby; acif; antby; anti; antibodies; antibody; anticomplement immunofluorescence; autoantibodies; autoantibody; fa; fluorescent antibody; fluoresent; ifa; immune fluorescence; immunoflour; immunofluor; immunofluorescence; ordinal; point in time; pol i; pr; ql; qual; qualitative; random; ribonucleic acid; rnap i; screen; serology; serum; sr; time resolved fluorescence; trf,Ord
54181-3,nitroxoline [susceptibility] by disk diffusion (kb),nitroxoline islt kb,nitroxoline disk diffusion (kb) [susc],antibiotic susceptibilities; ast; disk diffusion; id; infectious disease; infectiousdisease; islt; isol; kb; kirby-bauer; point in time; random; sus; suscept; susceptibilities; susceptibility; susceptibilty,OrdQn
54185-4,caspofungin [susceptibility] by gradient strip,caspofungin islt grad strip,caspofungin strip [susc],antibiotic susceptibilities; ast; epsilometer; estrip; e-strip; grad strip; id; infectious disease; infectiousdisease; islt; isol; mic; minimum inhibitory concentration; point in time; random; sus; suscept; susceptibilities; susceptibility; susceptibilty,OrdQn
54192-0,cefotaxime+sulbactam [susceptibility] by minimum inhibitory concentration (mic),cefotaxime+sulbac islt mic,cefotaxime+sulbactam mic [susc],antibiotic susceptibilities; ast; claforan; id; infectious disease; infectiousdisease; islt; isol; minimum inhibitory concentration; point in time; random; sulb; sulbact; sus; suscept; susceptibilities; susceptibility; susceptibilty,OrdQn
54222-5,lymphoma - acute screen markers [interpretation] in specimen narrative,lymphoma - acute screen markers spec-imp,lymphoma - acute screen markers nar (specimen) [interp],cell markers; hematology; heme; impression; impression/interpretation of study; impressions; interp; interpretation; misc; miscellaneous; narrative; other; point in time; random; report; scn; scr; scrn; spec; to be specified in another part of the message; unspecified,Nar
54246-4,protein and glucose panel [mass/volume] - body fluid,prot + glucose pnl fld-mcnc,protein and glucose panel (body fld) [mass/vol],"b/f; bf; bod; bodies; body fluid; body fluid, unsp; chemistry; fl; fld; flu; fluid; glu; gluc; glucoseur; level; mass concentration; pan; panel.chemistry; panl; pnl; point in time; pr; prot; prot + glucose pnl; qnt; quan; quant; quantitative; random",Qn
5424-7,deprecated cd115 cells/100 cells in blood,deprecated cd115 wbc-acnc,cd115 qn (wbc),arbitrary concentration; cell markers; c-fms; colony stimulating factor 1r; csf-1r; leukocytes; macrophage colony stimulating factor receptor; m-csfr; point in time; qnt; quan; quant; quantitative; random; wbcs; white blood cells,Qn
54247-2,drug screen comment [interpretation] in urine,drug screen comment ur-imp,drug screen comment (u) [interp],cmmt; cmnt; com; comm; comments; commt; drug/toxicology; drugs; impression; impression/interpretation of study; impressions; interp; interpretation; nominal; point in time; random; remarks; scn; scr; scrn; ua; ur; urn,Nom
5426-2,deprecated cd11a cells/100 cells in blood,deprecated cd11a wbc-acnc,cd11a qn (wbc),alphal integrin chain; arbitrary concentration; cell markers; leukocytes; lfa-1alpha; point in time; qnt; quan; quant; quantitative; random; wbcs; white blood cells,Qn
54275-3,glucose [moles/volume] in serum or plasma --45 minutes post dose ornithine alpha-ketoglutarate,glucose 45m p okg serpl-scnc,glucose 45 min post dose ornithine alpha-ketoglutarate [moles/vol],2-ketoglutarate; 2-ketoglutaric acid; 2-oxoglutarate; 2-oxoglutaric acid; 45m p okg; 45m p orn; after; akg; alfa; chemistry.challenge testing; endocrine; endocrinology; glu; glu tol; gluc; glucose tolerance; glucoseur; gtt; level; okg; orn; ornicetil; p dose; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; substance concentration,Qn
54286-0,glycolate [moles/volume] in cerebral spinal fluid,glycolate csf-scnc,glycolate (csf) [moles/vol],cerebral spinal fluid; cerebrospinal fl; chemistry; glycolic acid; level; point in time; qnt; quan; quant; quantitative; random; spinal fl; spinal fld; spinal flu; spinal fluid; substance concentration,Qn
54300-9,homocysteine [moles/volume] in amniotic fluid,hcys amn-scnc,homocysteine (amn fld) [moles/vol],af; amn; amn fl; amnio; amniotic flu; amniotic fluid; chemistry; genetics; gyn; gynecology; hcy; hcys; hcyst; heredity; heritable; homocyst(e)ine; inherited; level; neuro; neurology; ob; obgyn; obstetrics; point in time; qnt; quan; quant; quantitative; random; substance concentration,Qn
54310-8,linoleoylcarnitine (c18:2)/creatinine [molar ratio] in urine,linoleoylcarn/creat ur-srto,c18:2/creatinine (u) [molar ratio],c18:2; chemistry; cr; crea; creat; ii; linoleylcarnitine; point in time; qnt; quan; quant; quantitative; random; scrto; substance concentration ratio; substance ratio; ua; ucr; ur; urn,Qn
54317-3,methylmalonylcarnitine (c4-dc) [moles/volume] in cerebral spinal fluid,me-malonylcarn csf-scnc,c4-dc (csf) [moles/vol],c4dc; c4-dc; c4-dcc; cerebral spinal fluid; cerebrospinal fl; chemistry; dicarboxylic carnitine; level; me-malonylcarn; point in time; qnt; quan; quant; quantitative; random; spinal fl; spinal fld; spinal flu; spinal fluid; substance concentration,Qn
54318-1,methylmalonylcarnitine (c4-dc) [moles/volume] in amniotic fluid,me-malonylcarn amn-scnc,c4-dc (amn fld) [moles/vol],af; amn; amn fl; amnio; amniotic flu; amniotic fluid; c4dc; c4-dc; c4-dcc; chemistry; dicarboxylic carnitine; level; me-malonylcarn; point in time; qnt; quan; quant; quantitative; random; substance concentration,Qn
54320-7,octanoylcarnitine (c8)/creatinine [molar ratio] in urine,octanoylcarn/creat ur-srto,c8/creatinine (u) [molar ratio],c8; chemistry; cr; crea; creat; point in time; qnt; quan; quant; quantitative; random; scrto; substance concentration ratio; substance ratio; ua; ucr; ur; urn,Qn
54330-6,propionylcarnitine (c3) [moles/volume] in cerebral spinal fluid,propionylcarn csf-scnc,c3 (csf) [moles/vol],c3; c3-carntitine; cerebral spinal fluid; cerebrospinal fl; chemistry; level; point in time; propanoylcarnitine; qnt; quan; quant; quantitative; random; spinal fl; spinal fld; spinal flu; spinal fluid; substance concentration,Qn
54345-4,acetylcarnitine (c2) [moles/volume] in semen,acetylcarn smn-scnc,c2 (sem) [moles/vol],c2; chemistry; ejaculate; genitourinary; gu; level; point in time; qnt; quan; quant; quantitative; random; sem; seminal fluid; smn; smpls; substance concentration; uro; urology,Qn
5435-3,deprecated cd14 in blood,deprecated cd14 wbc-acnc,cd14 qn (wbc),arbitrary concentration; cell markers; leukocytes; leum3; leu-m3; lps receptor; lps-r; mo2; mo-2; my4; my-4; point in time; qnt; quan; quant; quantitative; random; wbcs; white blood cells,Qn
54369-4,chloride [moles/volume] in serum or plasma --post dialysis,chloride p dialysis serpl-scnc,chloride post dialysis [moles/vol],after; chemistry; cl; cl-; dialy; level; p dialysis; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; substance concentration,Qn
54385-0,dehydroascorbate/ascorbate in serum or plasma,dha/vit c sfr serpl,dehydroascorbate/ascorbate [molar fraction],ascorbic acid; c702; chemistry; dha; percent; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; substance fraction; vit c; vitamin c,Qn
54400-7,glucose [moles/volume] in serum or plasma --pre dose glucagon,glucose pre gc serpl-scnc,glucose pre dose glucagon [moles/vol],before; chemistry.challenge testing; endocrine; endocrinology; glu; glu tol; gluc; glucose tolerance; glucoseur; gtt; hgf; hyperglycemic factor; level; pl; plasma; plsm; point in time; pre gc; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; substance concentration,Qn
54402-3,4-hydroxymidazolam [mass/volume] in serum or plasma,4oh-midazolam serpl-mcnc,4-hydroxymidazolam [mass/vol],4-hydroxy midazolam; 4oh-midazolam; drug/toxicology; drugs; level; mass concentration; midazolam metabolite; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
54414-8,leukocyte-poor plateletpheresis units given [#],lp platpheresis gvn bpu,leukocyte-poor plateletpheresis units given (bpu) [#],blood bank; blood product unit; blood product unit (pack); cnt; count; gvn; leuc; leuk; leukocytes; leukodepleted; leukoreduced; lkcs; lp; lp platpheresis; number; pheresis; point in time; qnt; quan; quant; quantitative; random; wbc; wbcs; white blood cell; white blood cells,Qn
54427-0,transfuse frozen erythrocytes newborn units [volume],trans nb units frozen rbc vol patient,transfuse frozen rbc newborn units [vol],blood bank; discocytes; erthrocyte; erythrocyte; froz; frozen rbc; frozen rbc nb; frozn; new born; num nb units trans frozen rbc; point in time; qnt; quan; quant; quantitative; random; rbc; rbcs; red blood cell; red blood cells; red blood corpuscle; red blood corpusles; red cell; red cells; volume,Qn
54450-2,cyp2c9 and vkorc1 panel - blood or tissue by molecular genetics method,cyp2c9 + vkorc1 pnl bld/t,cyp2c9 and vkorc1 panel molgen (bld/tiss),"blood; cyp2c9 + vkorc1 pnl; molecular genetics; molecular pathology; molpath; molpath.pharmg; pan; panel.molpath; panel.molpath.pharmg; panl; pcr; pnl; point in time; random; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",-
54451-0,cyp2c9 and vkorc1 [interpretation] in blood or tissue by molecular genetics method narrative,cyp2c9 & vkorc1 bld/t-imp,cyp2c9 and vkorc1 molgen nar (bld/tiss) [interp],"blood; genetics; heredity; heritable; impression; impression/interpretation of study; impressions; inherited; interp; interpretation; molecular genetics; molecular pathology; molpath; molpath.pharmg; narrative; pcr; point in time; random; report; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",Nar
5445-2,deprecated cd19+kappa+ cells/100 cells in blood,deprecated cd19+smig kappa+ wbc-acnc,cd19+smig kappa+ qn (wbc),arbitrary concentration; b4; b-4; cell markers; hd-37; leu12; leu-12; leukocytes; point in time; qnt; quan; quant; quantitative; random; wbcs; white blood cells,Qn
54456-9,urea reduction ratio in serum or plasma,urea reduction ratio serpl,urea reduction ratio [molar fraction],chemistry; percent; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; substance fraction; urr,Qn
54457-7,biotinidase [enzymatic activity/volume] in serum or plasma from normal control,biotinidase serpl norm cont-ccnc,biotinidase (s/p normal control) [catalytic activity/vol],catalytic concentration; chemistry; contrl; control; norm cont; normal; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serpl^normal control; serplas; serum; serum or plasma; sr,Qn
54473-4,pimeloylcarnitine (c7-dc) [moles/volume] in cerebral spinal fluid,pimeloylcarn csf-scnc,c7-dc (csf) [moles/vol],cerebral spinal fluid; cerebrospinal fl; chemistry; dicarboxylic carnitine; level; point in time; qnt; quan; quant; quantitative; random; spinal fl; spinal fld; spinal flu; spinal fluid; substance concentration,Qn
5447-8,deprecated cd2 cells/100 cells in blood,deprecated cd2 wbc-acnc,cd2 qn (wbc),arbitrary concentration; cd2r; cell markers; e-rosette receptor; leu5; leu-5; leukocytes; lfa-2; lymphocyte-function antigen-2; point in time; qnt; quan; quant; quantitative; random; t11; wbcs; white blood cells,Qn
54482-5,dicarboxystearoylcarnitine (c18-dc) [moles/volume] in cerebral spinal fluid,dicarboxystearoylcarn csf-scnc,dicarboxystearoylcarnitine (c18-dc) (csf) [moles/vol],c18dc; c18-dc; cerebral spinal fluid; cerebrospinal fl; chemistry; dicarboxy stearoyl carnitine; dicarboxy stearoylcarnitine; dicarboxylic carnitine; level; octadecanedioyl carnitine; octadecanedioylcarnitine; point in time; qnt; quan; quant; quantitative; random; spinal fl; spinal fld; spinal flu; spinal fluid; substance concentration,Qn
54483-3,dicarboxystearoylcarnitine (c18-dc) [moles/volume] in amniotic fluid,dicarboxystearoylcarn amn-scnc,dicarboxystearoylcarnitine (c18-dc) (amn fld) [moles/vol],af; amn; amn fl; amnio; amniotic flu; amniotic fluid; c18dc; c18-dc; chemistry; dicarboxy stearoyl carnitine; dicarboxy stearoylcarnitine; dicarboxylic carnitine; level; octadecanedioyl carnitine; octadecanedioylcarnitine; point in time; qnt; quan; quant; quantitative; random; substance concentration,Qn
54488-2,pimeloylcarnitine (c7-dc)/creatinine [molar ratio] in urine,pimeloylcarn/creat ur-srto,c7-dc/creatinine (u) [molar ratio],chemistry; cr; crea; creat; dicarboxylic carnitine; point in time; qnt; quan; quant; quantitative; random; scrto; substance concentration ratio; substance ratio; ua; ucr; ur; urn,Qn
5449-4,deprecated cd21 cells/100 cells in blood,deprecated cd21 wbc-acnc,cd21 qn (wbc),arbitrary concentration; b2; b-2; c3d receptor; cell markers; cr2; ebv-r; epstein barr virus receptor; leukocytes; point in time; qnt; quan; quant; quantitative; random; wbcs; white blood cells,Qn
54498-1,glucose [moles/volume] in serum or plasma --7th specimen post xxx challenge,glucose sp7 p chal serpl-scnc,glucose 7th specimen post unsp challenge [moles/vol],^7th spec pst xxx chal; after; chemistry.challenge testing; endocrine; endocrinology; glu; glu tol; gluc; glucose tolerance; glucoseur; gtt; level; p chal; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sp7; sp7 p chal; spec; sr; substance concentration,Qn
5450-2,deprecated cd22 in blood,deprecated cd22 wbc-acnc,cd22 qn (wbc),arbitrary concentration; b3; b-3; bl-cam; cell markers; leu14; leu-14; leukocytes; lyb8; point in time; qnt; quan; quant; quantitative; random; to-15; wbcs; white blood cells,Qn
54511-1,behavior,,,pan; panel; panl; pnl; point in time; random; survey; survey.mds,-
54514-5,behavioral symptom - presence and frequency during assessment period [cms assessment],,,centers for medicare and medicaid assessment; pan; panel; panel.survey.cms; panl; pnl; report period; survey; sx,-
54515-2,impact on resident during assessment period [cms assessment],,,centers for medicare and medicaid assessment; pan; panel; panel.survey.cms; panl; pnl; report period; survey,-
54518-6,preferences for customary routine and activities,,,pan; panel; panl; pnl; point in time; random; survey; survey.mds,-
54534-3,gastrointestinal during assessment period [cms assessment],,,centers for medicare and medicaid assessment; gi; pan; panel; panel.survey.cms; panl; pnl; report period; survey,-
54556-6,health conditions,,,pan; panel; panl; pnl; point in time; random; survey; survey.mds,-
54570-7,oral/dental status,,,oral/dent status; pan; panel; panl; pnl; point in time; random; survey; survey.mds,-
54573-1,determination of pressure injury risk,,,pan; panel; panl; pnl; point in time; pressure injury; pressure ulcer; pressure ulcers; random; survey; survey.mds; ulcer,-
54584-8,pps assessment during assessment period [cms assessment],,,centers for medicare and medicaid assessment; nominal; report period; survey; typ,Nom
54600-2,speech clarity.description of speech pattern during assessment period [cms assessment],,,centers for medicare and medicaid assessment; finding; findings; ordinal; ql; qual; qualitative; report period; screen; survey,Ord
54637-4,little interest or pleasure in doing things in last 2 weeks.frequency [reported phq-9 cms],,,14 days; 2 weeks; finding; findings; mental health; mentalhealth; ordinal; past; patient health questionnaire; phq9; psych; psychiatry; ql; qual; qualitative; screen; survey,Ord
54653-1,"thoughts that you would be better off dead, or of hurting yourself in some way in last 2 weeks.frequency [reported phq-9 cms]",,,"14 days; 2 weeks; finding; findings; mental health; mentalhealth; ordinal; past; patient health questionnaire; phq9; psych; psychiatry; ql; qual; qualitative; screen; survey; you be better dead, or hurting yourself",Ord
54657-2,staff assessment of resident mood (phq-9-ov) [observed phq-9 cms],,,mental health; mentalhealth; pan; panel; panel.survey.cms; panl; patient health questionnaire; phq9; pnl; point in time; psych; psychiatry; random; survey,-
54659-8,little interest or pleasure in doing things in last 2 weeks.frequency [observed phq-9 cms],,,14 days; 2 weeks; finding; findings; mental health; mentalhealth; ordinal; past; patient health questionnaire; phq9; psych; psychiatry; ql; qual; qualitative; screen; survey,Ord
54662-2,"trouble falling or staying asleep, or sleeping too much in last 2 weeks.presence [observed phq-9 cms]",,,14 days; 2 weeks; finding; findings; mental health; mentalhealth; ordinal; past; patient health questionnaire; phq9; psych; psychiatry; ql; qual; qualitative; screen; survey,Ord
54663-0,"trouble falling or staying asleep, or sleeping too much in last 2 weeks.frequency [observed phq-9 cms]",,,"14 days; 2 weeks; finding; findings; mental health; mentalhealth; ordinal; past; patient health questionnaire; phq9; psych; psychiatry; ql; qual; qualitative; screen; survey; trouble falling or staying asleep, or sleeping too much.frequency",Ord
54683-8,verbal behavioral symptoms directed toward others during assessment period [cms assessment],,,centers for medicare and medicaid assessment; count/time; nrate; number rate; number rate = count/time; ordinal; ql; qual; qualitative; report period; screen; survey; sx,Ord
54687-9,significantly interfere with the resident's care during assessment period [cms assessment],,,centers for medicare and medicaid assessment; finding; findings; ordinal; ql; qual; qualitative; report period; s prime; screen; survey,Ord
54693-7,wandering - presence and frequency in last 7 days [cms assessment],,,centers for medicare and medicaid assessment; count/time; nrate; number rate; number rate = count/time; ordinal; past; ql; qual; qualitative; screen; survey,Ord
54703-4,how important it is to have your family or a close friend involved in discussions about your care while in this facility during assessment period [cms assessment],,,centers for medicare and medicaid assessment; finding; findings; ordinal; ql; qual; qualitative; report period; screen; survey,Ord
54720-8,resident prefers receiving bed bath [mdsv3],,,finding; findings; mds version 3; ordinal; point in time; ql; qual; qualitative; random; screen; survey; survey.mds,Ord
54721-6,resident prefers receiving sponge bath [mdsv3],,,finding; findings; mds version 3; ordinal; point in time; ql; qual; qualitative; random; screen; survey; survey.mds,Ord
54733-1,resident prefers spending time away from the nursing home [mdsv3],,,finding; findings; mds version 3; ordinal; point in time; ql; qual; qualitative; random; screen; survey; survey.mds,Ord
5473-4,deprecated cd4+cd8+ cells/100 cells in blood,deprecated cd4+cd8+ wbc-acnc,cd4+cd8+ qn (wbc),arbitrary concentration; cell markers; helper t cells; inducer t cells; l3t4; leu2; leu-2; leu3; leu-3; leukocytes; point in time; qnt; quan; quant; quantitative; random; suppressor t cells; t4; t-4; t8; t-8; tsuppressor; w3/25; wbcs; white blood cells,Qn
54738-0,transfer in last 7 days [mdsv3],,,finding; findings; mds version 3; ordinal; past; ql; qual; qualitative; screen; survey; survey.mds,Ord
54741-4,deprecated walk in room in last 7d mdsv3,,,finding; findings; mds version 3; ordinal; past; point in time; ql; qual; qualitative; random; screen; survey; survey.mds,Ord
54746-3,deprecated eating in last 7d mdsv3,,,finding; findings; mds version 3; ordinal; past; point in time; ql; qual; qualitative; random; screen; survey; survey.mds,Ord
54748-9,bathing in last 7 days [mdsv3],,,finding; findings; mds version 3; ordinal; past; ql; qual; qualitative; screen; survey; survey.mds,Ord
5479-1,deprecated cd42c cells/100 cells in blood,deprecated cd42c wbc-acnc,cd42c qn (wbc),arbitrary concentration; cell markers; gpibb; gpib-beta; leukocytes; point in time; qnt; quan; quant; quantitative; random; wbcs; white blood cells,Qn
54794-3,viral hepatitis in last 7 days [mdsv3],,,finding; findings; hep; hepatis; hepatit; mds version 3; ordinal; past; ql; qual; qualitative; screen; survey; survey.mds,Ord
54801-6,osteoporosis in last 7 days [mdsv3],,,finding; findings; mds version 3; ordinal; past; ql; qual; qualitative; screen; survey; survey.mds,Ord
54805-7,aphasia in last 7 days [mdsv3],,,finding; findings; mds version 3; ordinal; past; ql; qual; qualitative; screen; survey; survey.mds,Ord
54828-9,pain assessment interview should be conducted during assessment period [cms assessment],,,centers for medicare and medicaid assessment; finding; findings; ordinal; ql; qual; qualitative; report period; screen; survey,Ord
54840-4,deprecated adequacy of current therapeutic regimen to control pain in last 7d mdsv3,,,finding; findings; mds version 3; ordinal; past; point in time; ql; qual; qualitative; random; screen; survey; survey.mds; ther,Ord
54856-0,number of falls since admission or prior assessment - injury except major [cms assessment],,,# falls since admission or prior assessment; # falls since admission or prior assessment - injury except major; centers for medicare and medicaid assessment; cnt; count; no; num; num of falls; number; ordinal; ql; qual; qualitative; report period; screen; survey; ulcer,Ord
54861-0,complaints of difficulty or pain with swallowing in last 7 days [mdsv3],,,deglutition; finding; findings; mds version 3; ordinal; past; ql; qual; qualitative; screen; survey; survey.mds,Ord
54871-9,broken or loosely fitting full or partial denture in last 7 days [mdsv3],,,broken or loosely fitting full or partial dtr in last 7d; finding; findings; mds version 3; ordinal; past; ql; qual; qualitative; screen; survey; survey.mds,Ord
5488-2,deprecated cd46 cells/100 cells in blood,deprecated cd46 wbc-acnc,cd46 qn (wbc),arbitrary concentration; cell markers; cp; leukocytes; mcp; membrane cofactor protein; point in time; qnt; quan; quant; quantitative; random; wbcs; white blood cells,Qn
54893-3,number of pressure injuries - unstageable due to non-removable dressing or device during assessment period [cms assessment],,,centers for medicare and medicaid assessment; cnt; count; no; num; number; pressure ulcer; pressure ulcers; qnt; quan; quant; quantitative; report period; survey,Qn
54897-4,proportion of total calories the resident received through parenteral or tube feedings in the last 7 days [mdsv3],,,mds version 3; past; qnt; quan; quant; quantitative; survey; survey.mds; tot; totl,Qn
54898-2,other disease diagnoses in last 7 days [mdsv3],,,dis; diseases; dz; mds version 3; othr; pan; panel; panl; past; pnl; survey; survey.mds,-
54909-7,culex mosquito ige ab [units/volume] in serum,culex mosquito ige qn,culex mosquito ige qn (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; culex mosquito; immune globulin e; immunoglobulin e; mosquito; point in time; qnt; quan; quant; quantitative; random; serum; sr,Qn
54930-3,fava bean ige ab [units/volume] in serum,fava bean ige qn,fava bean ige qn (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; bell bean; broad bean; fava bean; field bean; horse bean; immune globulin e; immunoglobulin e; point in time; qnt; quan; quant; quantitative; random; serum; sr; tic bean,Qn
54949-3,deprecated date of onset of pressure ulcers onset in this facility - newest unstageable due to coverage of wound bed by slough/eschar mdsv3,,,date and time; date of onset of pressure ulcers onset in this facility - newest unstageable due to coverage of wound bed by slough/eschar; mds version 3; point in time; qnt; quan; quant; quantitative; random; survey; survey.mds; time stamp; timestamp,Qn
54950-1,number of pressure injuries - unstageable with suspected deep tissue injury in evolution during assessment period [cms assessment],,,centers for medicare and medicaid assessment; cnt; count; no; num; number; pressure ulcer; pressure ulcers; qnt; quan; quant; quantitative; report period; survey; ulcer,Qn
54955-0,number of current pressure injuries not present or were at a lesser stage on prior assessment - stage 4 during assessment period [cms assessment],,,centers for medicare and medicaid assessment; cnt; count; no; num; number; pressure ulcer; pressure ulcers; qnt; quan; quant; quantitative; report period; survey,Qn
54958-4,number of pressure injuries noted on prior assessment that have completely closed - stage 2 during assessment period [cms assessment],,,centers for medicare and medicaid assessment; cnt; count; ii; no; num; number; pressure ulcer; pressure ulcers; qnt; quan; quant; quantitative; report period; survey,Qn
54964-2,deprecated other foot or lower extremity open lesion(s) or infections in last 7d mdsv3,,,finding; findings; low; lower extremity; mds version 3; ordinal; othr; past; point in time; ql; qual; qualitative; random; s prime; screen; survey; survey.mds,Ord
54971-7,skin and ulcer treatments in last 7 days,,,integument; pan; panel; panl; past; pnl; pressure injury; pressure ulcer; pressure ulcers; skin and ulcer txs in last 7d; survey; survey.mds; tx; txs; ulcer,-
54975-8,nutrition or hydration intervention to manage skin problems provided in last 7 days [mdsv3],,,finding; findings; integument; mds version 3; ordinal; past; ql; qual; qualitative; screen; survey; survey.mds,Ord
54986-5,antidepressant received in last 7 days or since admission/reentry if less than 7 days [mdsv3],,,antidepressant received in last 7d or since admission/reentry if less than 7d; finding; findings; mds version 3; ordinal; past; ql; qual; qualitative; screen; survey; survey.mds,Ord
54999-8,suctioning in last 14 days - while a resident [mdsv3],,,finding; findings; mds version 3; ordinal; past; ql; qual; qualitative; screen; survey; survey.mds,Ord
55003-8,ventilator or respirator in last 14 days - while a resident [mdsv3],,,finding; findings; mds version 3; ordinal; past; ql; qual; qualitative; screen; survey; survey.mds,Ord
55011-1,dialysis in last 14 days - while a resident [mdsv3],,,dialy; finding; findings; mds version 3; ordinal; past; ql; qual; qualitative; screen; survey; survey.mds,Ord
55022-8,pneumococcal vaccination up to date during assessment period [cms assessment],,,centers for medicare and medicaid assessment; finding; findings; immunizations; ordinal; ql; qual; qualitative; report period; screen; survey; vaccine,Ord
55030-1,end date of physical therapy during assessment period [cms assessment],,,centers for medicare and medicaid assessment; pt; qnt; quan; quant; quantitative; report period; survey,Qn
55040-0,number of days physician examined the patient in last 14 days [cms assessment],,,# days physician examined the patient in last 14d; centers for medicare and medicaid assessment; count/time; dextro; no; nrate; num; number rate; number rate = count/time; past; qnt; quan; quant; quantitative; survey,Qn
55041-8,number of days physician orders changed in last 14 days [cms assessment],,,# days physician orders changed in last 14d; centers for medicare and medicaid assessment; count/time; dextro; no; nrate; num; number rate; number rate = count/time; past; qnt; quan; quant; quantitative; survey,Qn
5504-6,deprecated cd55 cells/100 cells in blood,deprecated cd55 wbc-acnc,cd55 qn (wbc),arbitrary concentration; cell markers; daf; decay accelerating factor; leukocytes; point in time; qnt; quan; quant; quantitative; random; wbcs; white blood cells,Qn
55047-5,physical restraints used in bed - other [mdsv3],,,finding; findings; mds version 3; ordinal; othr; point in time; ql; qual; qualitative; random; screen; survey; survey.mds,Ord
55058-2,information source for resident's overall goal during assessment period [cms assessment],,,centers for medicare and medicaid assessment; nominal; report period; s prime; source of info; srce; survey; typ,Nom
55069-9,state case mix - rug version code,,,nominal; point in time; random; resource utilization groups; survey; typ,Nom
55070-7,insurance billing,,,pan; panel; panel.survey.cms; panl; pnl; point in time; random; survey,-
55071-5,insurance case mix - rug group,,,nominal; point in time; random; resource utilization groups; survey; typ,Nom
55084-8,other special treatments and programs in last 14 days,,,other special txs and programs in last 14d; othr; pan; panel; panl; past; pnl; point in time; random; special txs and programs in last 14d; survey; survey.mds; tx; txs,-
55086-3,cancer treatments in last 14 days,,,cancer txs in last 14d; pan; panel; panl; past; pnl; point in time; random; survey; survey.mds; tx; txs,-
55090-5,cd3-cd56+ cells/cells in blood,cd3-cd56+ cells nfr bld,cd3-cd56+ cells/cells (bld),blood; cd3 cells; cd3+cd56+ cells; cd3-cd56+ cells; cell; cell markers; cellularity; leu19; leu-19; leu4; leu-4; natural killer cells; ncam; neural cell adhesion molecule; nkh1; number fraction; percent; point in time; qnt; quan; quant; quantitative; random; t3; wb; whole blood,Qn
55098-8,parainfluenza virus 2 [presence] in specimen by organism specific culture,hpiv2 spec ql cult,parainfluenza virus 2 org specific cx ql (specimen),c&s; cult; cultures; hpiv; hpiv2; human rubulavirus 2; id; ii; infectious disease; infectiousdisease; microbiology; misc; miscellaneous; ordinal; other; para; parainflu; parainfluenza type 2; parainfluenza type ii; pi2; point in time; pr; ql; qual; qualitative; random; screen; spec; to be specified in another part of the message; unspecified,Ord
55110-1,conclusions [interpretation] document,conclusions imp doc,,doc.misc; document; impression; impression/interpretation of study; impressions; interp; interpretation; misc; point in time; random,Doc
55121-8,multiple sclerosis panel - serum and csf,ms pnl ser+csf,multiple sclerosis panel (s+csf),both serum and cerebrospinal fluid; cerebral spinal fluid; cerebrospinal fl; chemistry; ms; ms pnl; mult; multi; neuro; neurology; pan; panel.chemistry; panl; pnl; point in time; random; serum; spinal fl; spinal fld; spinal flu; spinal fluid; sr,-
55129-1,physical restraints used in bed,,,pan; panel; panl; pnl; point in time; random; survey; survey.mds,-
55134-1,influenza virus a neuraminidase rna [identifier] in isolate by naa with probe detection,fluav na rna islt naa+probe,fluav na rna naa+probe nom (isol),3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; avian influenza; bird flu; dna nucleic acid probe; dna probe; flua; fluav; fluav na; fluv; fowl plague; id; identity or presence; infectious disease; infectiousdisease; influ; influenza a; influenza a virus; islt; isol; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; na; naa+probe; naat; nasba; nominal; nucleic acid sequence based analysis; pcr; point in time; polymerase chain reaction; probe amp; probe with ampification; probe with target amplification; qbr; random; ribonucleic acid; sda; strand displacement amplification; tma; transcription mediated amplification,Nom
55150-7,anaplasma phagocytophilum igg and igm panel - serum qualitative,a phagocytoph igg+igm pnl ser,a. phagocytophilum igg and igm panel ql (s),a phagocytoph igg+igm pnl; e equi; e phagocytophila; ehrlichia equi; ehrlichia phagocytophila; hge; human granulocytic ehrlichiosis; id; immune globulin g; immune globulin m; immunoglobulin g; immunoglobulin m; infectious disease; infectiousdisease; microbiology; ordinal; pan; panel.microbiology; panl; pnl; point in time; ql; qual; qualitative; random; screen; serum; sr,Ord
55151-5,aldosterone and renin activity panel - plasma,aldosterone + ra + arr pnl plas,aldosterone and renin activity panel (p),activ; actvty; aldosterone + ra + arr pnl; angiotensin forming enzyme; angiotensinogenase; chemistry; endocrine; endocrinology; movements; pan; panel.chemistry; panl; pl; plasma; plsm; pnl; point in time; qnt; quan; quant; quantitative; random; universallaborders,Qn
55154-9,ethambutol+rifampin [susceptibility] by method for slow-growing mycobacteria,ethambutol+rifampin islt slowmyco,ethambutol+rifampin method for slow-growing mycobacteria [susc],afb; antibiotic susceptibilities; ast; c301; etambol; ethamb; id; inagen; infectious disease; infectiousdisease; islt; isol; myambutol; myco; mycobacteria susceptibility; mycobacterial susceptibility; mycobutol; olbutam; point in time; random; rif; rifadin; rifampicin; rimactane; slowmyco; sus; suscept; susceptibilities; susceptibility; susceptibilty; tb; tuberculosis,OrdQn
55155-6,flunitrazepam and 7-aminoflunitrazepam panel [mass/volume] - urine,flunitrazepam+7amino pnl ur-mcnc,flunitrazepam and 7-aminoflunitrazepam panel (u) [mass/vol],7-amino flunitrazepam; 7aminoflunitrazepam; darkene; drug/toxicology; drugs; flunitrazepam metabolite; flunitrazepam+7amino pnl; hypnodorm; hypnor; level; mass concentration; narcozep; noriel; pan; panel.drug & toxicology; panl; pnl; point in time; qnt; quan; quant; quantitative; random; rohipnol; rohypnol; roipnol; ua; ur; urn; valsera,Qn
5516-0,deprecated cd66a cells/100 cells in blood,deprecated cd66a wbc-acnc,cd66a qn (wbc),arbitrary concentration; bgp; biliary glycoprotein; cell markers; leukocytes; nca-160; point in time; qnt; quan; quant; quantitative; random; wbcs; white blood cells,Qn
55161-4,bordetella pertussis iga and igg panel - serum by immunoassay,b pert iga+igg pnl ser ia,b. pertussis iga and igg panel ia (s),b pert; b pert iga+igg pnl; b pertussis; eia; elfa; elisa; enzyme immunoassay; iaa; id; immune globulin a; immune globulin g; immunoglobulin a; immunoglobulin g; infectious disease; infectiousdisease; meia; microbiology; pan; panel.microbiology; panl; pertussis; pnl; point in time; qnt; quan; quant; quantitative; random; serum; sr; suds; whooping cough,Qn
55163-0,streptococcus pyogenes enzyme ab panel - serum qualitative,s pyog enzyme ab pnl ser,s. pyogenes enzyme ab panel ql (s),enz; enzymes; gas; group a strep; id; infectious disease; infectiousdisease; microbiology; ordinal; pan; panel.microbiology; panl; pnl; point in time; ql; qual; qualitative; random; s pyog enzyme ab pnl; s pyog.enz; s pyogenes; screen; serum; sr; steptococcus group a; strep; strept; streptococci group a; streptococcus group a; streptozyme,Ord
55165-5,echinococcus sp igg4 ab [presence] in serum,echinococcus igg4 ser ql,echinococcus sp igg4 ql (s),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; echinococcosis; id; infectious disease; infectiousdisease; microbiology; ordinal; p2; point in time; pr; ql; qual; qualitative; random; screen; serum; species; spp; sr,Ord
55178-8,calcium phosphate crystals [presence] in specimen by light microscopy,ca phos cry spec ql micro,calcium phosphate crystals lm ql (specimen),ca; ca phos; ca phos cry; cal; cap; crys; cryst; crystal; i phos; inorganic phosphate; lm; micro; micros; microscopic; misc; miscellaneous; ordinal; other; phos; phosphate total; phosphorous; phosphorus; phosphrous; pi; po4; point in time; pr; ql; qual; qualitative; random; screen; spec; to be specified in another part of the message; unspecified; urinalysis,Ord
55179-6,sodium urate crystals [presence] in specimen by light microscopy,na urate cry spec ql micro,sodium urate crystals lm ql (specimen),crys; cryst; crystal; lm; micro; micros; microscopic; misc; miscellaneous; monosodium urate; na; na urate; na urate cry; na+; nau; ordinal; other; point in time; pr; ql; qual; qualitative; random; screen; spec; to be specified in another part of the message; ua; unspecified; urates; uric acid; urinalysis,Ord
55180-4,human epididymis protein 4 [moles/volume] in serum or plasma,he4 serpl-scnc,human epididymis protein 4 [moles/vol],chemistry; endometrial cancer; gyn; gynecology; he4; level; ob; obgyn; obstetrics; ovarian cancer; pl; plasma; plsm; point in time; pr; prot; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; substance concentration; tumor marker; universallaborders; wap four-disulfide core domain protein 2,Qn
55182-0,quality reporting document architecture incidence report document,,,document; finding; findings; point in time; qrda; qrda incidence report; random; survey; survey.qrda,Doc
55192-9,chromosome analysis.interphase [interpretation] in amniotic fluid by fish narrative,chrom analy interphase amn fish-imp,chr analysis.interphase fish nar (amn fld) [interp],af; amn; amn fl; amnio; amniotic flu; amniotic fluid; chrom analy; chrom analy interphase; chromosom; chromosomes; cytogenetics; fluorescent in situ hybridization; genetics; gyn; gynecology; heredity; heritable; impression; impression/interpretation of study; impressions; inherited; interp; interpretation; karyotype; molecular pathology; molpath; narrative; ob; obgyn; obstetrics; point in time; random; report,Nar
55216-6,physical assault on exposed person involving blood or semen,assault involving bld or semen,,assault involving bld or semen; finding; findings; nominal; persons; point in time; public health; publichealth; random,Nom
55220-8,asialoglycoprotein receptor ab [units/volume] in serum,asgpr ab ser-acnc,asialoglycoprotein receptor ab qn (s),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; asgpr; autoantibodies; autoantibody; hepatology; liver; point in time; qnt; quan; quant; quantitative; random; rec; recept; receptors; recp; recptr; serology; serum; sr,Qn
55236-4,hba2 gene alpha 4.2kb deletion [presence] in blood by molecular genetics method,hba2 alpha 4.2kb del bld ql,hba2 gene alpha 4.2kb del molgen ql (bld),"alfa; alpha thal; alpha thal 2; alpha thal 2 (- alpha^4.2 deletion); alpha thalassemia; alpha-2 globin; arbitrary; blood; del; deletions; hba2 alpha 4.2kb; hba2 gene alpha 4.2 deletion; hba-t2; hbh; hemoglobin, alpha 2; molecular genetics; molecular pathology; molpath; molpath.deletions; ordinal; pcr; point in time; ql; qual; qualitative; random; screen; wb; whole blood",Ord
55239-8,hbb gene c.441_442insac [presence] in blood by molecular genetics method,hbb c.441_442insac bld ql,hbb gene c.441_442insac molgen ql (bld),"beta globulin gene; beta thalessemia; beta-globin; blood; cd113t-c; genetics; hb tak; hbb c.441_442insac; hemoglobin beta chain; hemoglobin s gene; hemoglobin, beta; heredity; heritable; inherited; molecular genetics; molecular pathology; molpath; molpath.mutations; ordinal; pcr; point in time; pr; ql; qual; qualitative; random; screen; sickle cell anemia; wb; whole blood",Ord
55252-1,methoxsalen 0.02 mg/ml given [volume],methoxsalen 0.02 mg/ml gvn vol,methoxsalen 0.02 mg/ml given [vol],8-methoxypsoralen; 8-mop; drug doses; gvn; methoxsalen 0.02 mg/ml; oxsoralen; point in time; qnt; quan; quant; quantitative; random; uvadex; volume,Qn
5526-9,deprecated cd72 cells/100 cells in blood,deprecated cd72 wbc-acnc,cd72 qn (wbc),arbitrary concentration; cell markers; leukocytes; ly-19.2; ly-32.2; lyb-2; point in time; qnt; quan; quant; quantitative; random; wbcs; white blood cells,Qn
55274-5,varicella zoster virus status,vzv status,,chicken pox; chicken pox virus; chickenpox; h+p; h+p.hx; herpes zoster; hhv-3; history; human herpesvirus 3; id; infectious disease; infectiousdisease; nominal; p prime; point in time; random; shingles; vz; vzv; vzv status; zoster,Nom
55280-2,military service narrative,military service,,finding; findings; h+p; h+p.hx; narrative; p prime; point in time; random; report,Nar
55286-9,physical exam by body areas,physical exam by body areas,,bod; bodies; h+p; h+p.hx; p prime; pea; physical exam by body areas; point in time; random,Set
55287-7,time of death,time of death,,date and time; h+p; h+p.hx; p prime; point in time; qnt; quan; quant; quantitative; random; time stamp; timestamp,Qn
55290-1,sulopenem [susceptibility] by minimum inhibitory concentration (mic),sulopenem islt mic,sulopenem mic [susc],antibiotic susceptibilities; ast; id; infectious disease; infectiousdisease; islt; isol; minimum inhibitory concentration; point in time; random; sus; suscept; susceptibilities; susceptibility; susceptibilty,OrdQn
55292-7,linopristin+flopristin [susceptibility],linopristin+flopristin susc islt,linopristin+flopristin [susc],antibiotic susceptibilities; ast; id; infectious disease; infectiousdisease; islt; isol; nxl 103; point in time; random; sus; suscept; susceptibilities; susceptibility; susceptibilty; xrp 2868,OrdQn
55297-6,deprecated fip1l1+pdgfra gene rearrangements [presence] in blood or tissue by molecular genetics method,deprecated fip1l1+pdgfra gene rear bld/t,fip1l1+pdgfra rearrangements molgen ql (bld/tiss),"arbitrary; blood; cd140a; fip1l1+pdgfra rearrangements; fip1l1-pdgfra; genetics; heredity; heritable; inherited; molecular genetics; molecular pathology; molpath; molpath.rearrangements; ordinal; pcr; pdgfr2; pdgfr-2; platelet-derived growth factor receptor, alpha polypeptide; point in time; ql; qual; qualitative; random; rearr; rearrangement; rhepdgfra; screen; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",Ord
55302-4,deprecated paraneoplastic pemphigus ab [titer] in serum,deprecated paraneoplastic pemphigus ab titr ser,paraneoplastic pemphigus ab (s) [titer],abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; dilution factor; dilution factor (titer); point in time; qnt; quan; quant; quantitative; random; serology; serum; sr; titer; titered; titre; ttr,Qn
55325-5,js sup(a) ab [titer] in serum or plasma,js sup(a) ab titr serpl,js sup(a) ab [titer],abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; blood bank; dilution factor; dilution factor (titer); j (little s) (little a); js sup(a); js^a; kell blood group system; pl; plasma; plsm; point in time; random; s; s prime; serp; serpl; serplas; serum; serum or plasma; smqn; sr; titer; titered; titre; ttr,SemiQn
55337-0,p1 ab [titer] in serum or plasma,p1 ab titr serpl,p1 ab [titer],abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; blood bank; dilution factor; dilution factor (titer); pl; plasma; plsm; point in time; random; serp; serpl; serplas; serum; serum or plasma; smqn; sr; titer; titered; titre; ttr,SemiQn
55339-6,sd sup(a) ab [titer] in serum or plasma,sd sup(a) ab titr serpl,sd sup(a) ab [titer],abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; blood bank; dextro; dilution factor; dilution factor (titer); pl; plasma; plsm; point in time; random; s prime; sd sup(a); sd^e; serp; serpl; serplas; serum; serum or plasma; smqn; sr; titer; titered; titre; ttr,SemiQn
55341-2,xg sup(a) ab [titer] in serum or plasma,xg sup(a) ab titr serpl,xg sup(a) ab [titer],abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; blood bank; dilution factor; dilution factor (titer); pl; plasma; plsm; point in time; random; serp; serpl; serplas; serum; serum or plasma; smqn; sr; titer; titered; titre; ttr; x (little g) (little a); xg sup(a); xg^a,SemiQn
55346-1,clobazam+norclobazam [moles/volume] in serum or plasma,clobazam+norclobazam serpl-scnc,clobazam+norclobazam [moles/vol],clarmyl; clobazam metabolite; clopax; desmeth; desmethylclobazam; drug/toxicology; drugs; frisium; level; n-desmethylclobazam; noiafren; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; sederlona; serp; serpl; serplas; serum; serum or plasma; sr; substance concentration; urbadan; urbanol; urbanyl,Qn
55354-5,osmolality of urine--4 hours post fluid fast,osmolality p 4h ffst ur,osmolality post 4 hr fluid fast (u) [osmolality],after; chemistry.challenge testing; osmo; osmol; osmolality; osmolarity; p 4h ffst; point in time; pst; qnt; quan; quant; quantitative; random; ua; ur; urn,Qn
55362-8,thyrotropin [units/volume] in serum or plasma --pre xxx challenge,tsh pre chal serpl-acnc,tsh pre unsp challenge qn,arbitrary concentration; before; chemistry.challenge testing; endocrine; endocrinology; pl; plasma; plsm; point in time; pre chal; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; thyroid stimulating hormone; thyrotropic hormone; tsh,Qn
55363-6,argatroban [mass/volume] in platelet poor plasma,argatroban ppp-mcnc,argatroban (ppp) [mass/vol],drug/toxicology; drugs; level; mass concentration; plas; platelet poor plasma; point in time; qnt; quan; quant; quantitative; random,Qn
55427-9,seizure disorder tracking panel,seizure disorder tracking pnl,,neuro; neurology; pan; panl; phr panels; pnl; point in time; random; seizure disorder tracking pnl,-
55434-5,insulin [moles/volume] in serum or plasma --20 minutes post xxx challenge,insulin 20m p chal serpl-scnc,insulin 20 min post unsp challenge [moles/vol],20m p chal; after; chemistry.challenge testing; hum; humulin; ih7; insul; lente; level; nph; p chal; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; semilente; serp; serpl; serplas; serum; serum or plasma; sliding; sr; substance concentration; ultralente,Qn
55441-0,deprecated antithrombin ag in platelet poor plasma,deprecated at iii ag ppp,antithrombin ag (ppp),anti thrombin; antigen; antigens; antithrm; antithrombin iii; antithrombn; at; at iii; atiii; hematology; heme; heparin cofactor i; lab orders; limiteduselaborders; plas; platelet poor plasma; point in time; random; thrombin inhibitor i,-
55465-9,influenza virus a h1 2009 pandemic rna [presence] in specimen by naa with probe detection,fluav h1 2009 pand rna spec ql naa+probe,fluav h1 2009 pand rna naa+probe ql (specimen),3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; avian influenza; bird flu; dna nucleic acid probe; dna probe; flua; fluav; fluav h1; fluav h1 2009 pand; fluv; fowl plague; h1n1; h1n1v; id; infectious disease; infectiousdisease; influ; influenza a; influenza a virus; influenza virus a hemagglutinin h1 swine origin; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; misc; miscellaneous; naa+probe; naat; nasba; nucleic acid sequence based analysis; ordinal; other; pcr; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; ribonucleic acid; screen; sda; s-oiv; spec; strand displacement amplification; tma; to be specified in another part of the message; transcription mediated amplification; unspecified,Ord
55466-7,influenza virus a h1 2009 pandemic rna panel - specimen by naa with probe detection,fluav h1 2009 pan rna pnl spec naa+probe,fluav h1 2009 pand rna pnl naa+probe (specimen),3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; avian influenza; bird flu; dna nucleic acid probe; dna probe; flua; fluav; fluav h1; fluav h1 2009 pand; fluav h1 2009 pand rna pnl; fluv; fowl plague; h1n1; h1n1v; id; infectious disease; infectiousdisease; influ; influenza a; influenza a virus; influenza virus a hemagglutinin h1 swine origin; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; misc; miscellaneous; naa+probe; naat; nasba; nucleic acid sequence based analysis; other; pan; panel.microbiology; panl; pcr; pnl; point in time; polymerase chain reaction; probe amp; probe with ampification; probe with target amplification; qbr; random; ribonucleic acid; sda; s-oiv; spec; strand displacement amplification; tma; to be specified in another part of the message; transcription mediated amplification; unspecified,-
5546-7,deprecated cd95 cells/100 cells in blood,deprecated cd95 wbc-acnc,cd95 qn (wbc),apo-1; apt1; arbitrary concentration; cell markers; fas; fas antigen; igf; leukocytes; point in time; qnt; quan; quant; quantitative; random; tnfrsf6; wbcs; white blood cells,Qn
55472-5,cortisol [moles/volume] in serum or plasma --2.5 hours post xxx challenge,cortis 2.5h p chal serpl-scnc,cortisol 2.5 hr post unsp challenge [moles/vol],17-hydroxycorticosterone; 2.5h p chal; after; chemistry.challenge testing; compound f; coritsol; cort; f; hydrocortisone; level; p chal; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; substance concentration,Qn
55496-4,insulin [moles/volume] in serum or plasma --2 hours post dose glucose iv,insulin 2h p glc iv serpl-scnc,insulin 2 hr post dose glucose iv [moles/vol],120 min; 120 minutes; 120min; 2 hours; 2h p glc; 2h p glc iv; after; chemistry.challenge testing; glu; glu tol; gluc; glucose tolerance; glucoseur; gtt; hum; humulin; ih7; insul; lente; level; nph; p dose; p glc; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; semilente; serp; serpl; serplas; serum; serum or plasma; sliding; sr; substance concentration; ultralente,Qn
55499-8,insulin [moles/volume] in serum or plasma --15 minutes post dose glucose iv,insulin 15m p glc iv serpl-scnc,insulin 15 min post dose glucose iv [moles/vol],15m p glc; 15m p glc iv; after; chemistry.challenge testing; glu; glu tol; gluc; glucose tolerance; glucoseur; gtt; hum; humulin; ih7; insul; lente; level; nph; p dose; p glc; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; semilente; serp; serpl; serplas; serum; serum or plasma; sliding; sr; substance concentration; ultralente,Qn
55500-3,insulin [moles/volume] in serum or plasma --30 minutes post dose glucagon,insulin 30m p gc serpl-scnc,insulin 30 min post dose glucagon [moles/vol],30m p gc; after; chemistry.challenge testing; hgf; hum; humulin; hyperglycemic factor; ih7; insul; lente; level; nph; p dose; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; semilente; serp; serpl; serplas; serum; serum or plasma; sliding; sr; substance concentration; ultralente,Qn
55503-7,prolactin [mass/volume] in serum or plasma --40 minutes post dose trh iv,prolactin 40m p trh iv serpl-mcnc,prolactin 40 min post dose trh iv [mass/vol],40m p trh iv; after; chemistry.challenge testing; lactotropic hormone; lactotropin; level; mammatropic hormone; mammotropin; mass concentration; p dose; p trh; pl; plasma; plsm; point in time; prl; prol; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
5550-9,deprecated cd99 cells/100 cells in blood,deprecated cd99 wbc-acnc,cd99 qn (wbc),arbitrary concentration; cd99r; cell markers; e2; leukocytes; mic2 gene product; point in time; qnt; quan; quant; quantitative; random; wbcs; white blood cells,Qn
55520-1,6-monoacetylmorphine (6-mam) [moles/volume] in urine,6mam ur-scnc,6-monoacetylmorphine (6-mam) (u) [moles/vol],6 mam; 6 mono acetyl morphine; 6-acetylmorphine; 6mam; acetylmorphine; addiction; drug/toxicology; drugs; drugs of abuse; heroin metabolite; illicit; level; mam; point in time; potentialforabuse; qnt; quan; quant; quantitative; random; substance concentration; ua; ur; urn,Qn
55534-2,doxylamine [moles/volume] in serum or plasma,doxylamine serpl-scnc,doxylamine [moles/vol],decapryn; drug/toxicology; drugs; level; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; substance concentration,Qn
55540-9,furosemide [moles/volume] in serum or plasma,furosemide serpl-scnc,furosemide [moles/vol],c210; drug/toxicology; drugs; furj; lasix; lasj; level; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; substance concentration,Qn
55543-3,hydroxychloroquine [moles/volume] in serum or plasma,oh-chloroquine serpl-scnc,hydroxychloroquine [moles/vol],drug/toxicology; drugs; hcq; hydroxy chloroquine; level; oh-chloroquine; oxichlorochin; pl; plaquenil; plasma; plsm; point in time; qnt; quan; quant; quantitative; quensyl; random; serp; serpl; serplas; serum; serum or plasma; sr; substance concentration,Qn
55549-0,methocarbamol [moles/volume] in serum or plasma,methocarbamol serpl-scnc,methocarbamol [moles/vol],carbacot; drug/toxicology; drugs; level; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; robaxin; serp; serpl; serplas; serum; serum or plasma; skelex; sr; substance concentration,Qn
55552-4,methylphenidate [moles/volume] in serum or plasma,me-phenidate serpl-scnc,methylphenidate [moles/vol],addiction; drug/toxicology; drugs; drugs of abuse; illicit; level; me-phenidate; pl; plasma; plsm; point in time; potentialforabuse; qnt; quan; quant; quantitative; random; ritalin; serp; serpl; serplas; serum; serum or plasma; sr; substance concentration,Qn
55569-8,phentermine [moles/volume] in serum or plasma,phentermine serpl-scnc,phentermine [moles/vol],addiction; drug/toxicology; drugs; drugs of abuse; illicit; ionamin; level; pl; plasma; plsm; point in time; potentialforabuse; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; substance concentration,Qn
55599-5,leukocytes.disintegrated/leukocytes in cerebral spinal fluid by manual count,wbc.disintegrated nfr csf manual,wbc.disintegrated/leukocytes manual cnt (csf),cerebral spinal fluid; cerebrospinal fl; hematology/cell counts; leuc; leuk; leukocyte; lkcs; manl; number fraction; percent; point in time; qnt; quan; quant; quantitative; random; spinal fl; spinal fld; spinal flu; spinal fluid; wbc; wbc.disintegrated; wbcs; white blood cell; white blood cells,Qn
55618-3,atovaquone [susceptibility] by minimum inhibitory concentration (mic),atovaquone islt mic,atovaquone mic [susc],antibiotic susceptibilities; ast; atavaquone; id; infectious disease; infectiousdisease; islt; isol; lung; mepron; minimum inhibitory concentration; point in time; pulmonary; pulmonology; random; respiratory; sus; suscept; susceptibilities; susceptibility; susceptibilty,OrdQn
55624-1,cefacetrile [susceptibility] by minimum inhibitory concentration (mic),cefacetrile islt mic,cefacetrile mic [susc],antibiotic susceptibilities; ast; cephacetrile; id; infectious disease; infectiousdisease; islt; isol; minimum inhibitory concentration; point in time; random; sus; suscept; susceptibilities; susceptibility; susceptibilty,OrdQn
55627-4,cefacetrile [susceptibility] by gradient strip,cefacetrile islt grad strip,cefacetrile strip [susc],antibiotic susceptibilities; ast; cephacetrile; epsilometer; estrip; e-strip; grad strip; id; infectious disease; infectiousdisease; islt; isol; mic; minimum inhibitory concentration; point in time; random; sus; suscept; susceptibilities; susceptibility; susceptibilty,OrdQn
55635-7,cefamandole+sulbactam [susceptibility],cefamandole+sulbactam susc islt,cefamandole+sulbactam [susc],antibiotic susceptibilities; ast; c31; id; infectious disease; infectiousdisease; islt; isol; kefadol; mandol; manj; point in time; random; sulb; sulbact; sus; suscept; susceptibilities; susceptibility; susceptibilty,OrdQn
55636-5,cefamandole+sulbactam [susceptibility] by disk diffusion (kb),cefamandole+sulbactam islt kb,cefamandole+sulbactam disk diffusion (kb) [susc],antibiotic susceptibilities; ast; c31; disk diffusion; id; infectious disease; infectiousdisease; islt; isol; kb; kefadol; kirby-bauer; mandol; manj; point in time; random; sulb; sulbact; sus; suscept; susceptibilities; susceptibility; susceptibilty,OrdQn
55669-6,dibekacin [susceptibility] by minimum inhibitory concentration (mic),dibekacin islt mic,dibekacin mic [susc],antibiotic susceptibilities; ast; id; infectious disease; infectiousdisease; islt; isol; minimum inhibitory concentration; point in time; random; sus; suscept; susceptibilities; susceptibility; susceptibilty,OrdQn
55670-4,dibekacin [susceptibility],dibekacin susc islt,dibekacin [susc],antibiotic susceptibilities; ast; id; infectious disease; infectiousdisease; islt; isol; point in time; random; sus; suscept; susceptibilities; susceptibility; susceptibilty,OrdQn
55696-9,oxolinate [susceptibility],oxolinate susc islt,oxolinate [susc],antibiotic susceptibilities; ast; id; infectious disease; infectiousdisease; islt; isol; oxolinic acid; point in time; random; sus; suscept; susceptibilities; susceptibility; susceptibilty,OrdQn
55713-2,rosoxacin [susceptibility] by gradient strip,rosoxacin islt grad strip,rosoxacin strip [susc],acrosoxacin; antibiotic susceptibilities; ast; epsilometer; eracine; eradacil; eradacin; estrip; e-strip; grad strip; id; infectious disease; infectiousdisease; islt; isol; mic; minimum inhibitory concentration; point in time; random; rosacin; sus; suscept; susceptibilities; susceptibility; susceptibilty; winuron,OrdQn
55728-0,yersinia sp igg and igm panel - serum,yersinia sp igg+igm pnl ser,yersinia sp igg and igm panel (s),id; immune globulin g; immune globulin m; immunoglobulin g; immunoglobulin m; infectious disease; infectiousdisease; microbiology; pan; panel.microbiology; panl; pnl; point in time; random; serum; species; spp; sr; yersinia sp igg+igm pnl,-
55759-5,temporal orientation - care acute care,,,care survey; point in time; random; survey,-
55766-0,egfr gene c.2573t>g [presence] in blood or tissue by molecular genetics method,egfr c.2573t>g bld/t ql,egfr gene c.2573t>g molgen ql (bld/tiss),"blood; egfr c.2573t&gt;g; epidermal growth factor receptor; epidermal growth factor receptor gene; erbb; erbb1; genetics; her1; heredity; heritable; inherited; l858r; mena; molecular genetics; molecular pathology; molpath; molpath.mutations; nisbd2; oncogene erbb; oncology; ordinal; pcr; pig61; point in time; pr; ql; qual; qualitative; random; screen; t2573g; tissue; tissue, unspecified; v-erb-b avian erythroblastic leukemia viral oncogene homolog; wb; whole blood; whole blood or tissue",Ord
55778-5,eosinophils [#] in cerebral spinal fluid by manual count,eosinophil csf manual,eosinophils manual cnt (csf) [#],cerebral spinal fluid; cerebrospinal fl; cnt; count; eos; eosin; eosino; eosinophil; eosins; hematology/cell counts; manl; number; point in time; qnt; quan; quant; quantitative; random; spinal fl; spinal fld; spinal flu; spinal fluid,Qn
55787-6,lymphocytes [#] in cerebral spinal fluid by manual count,lymphocytes csf manual,lymphocytes manual cnt (csf) [#],cerebral spinal fluid; cerebrospinal fl; cnt; count; hematology/cell counts; lymp; lymph; lympho; lymphocyte; lymphs; lymphs%; manl; neuro; neurology; number; point in time; qnt; quan; quant; quantitative; random; spinal fl; spinal fld; spinal flu; spinal fluid,Qn
55794-2,other cells [#] in cerebral spinal fluid by manual count,other cells csf manual,other cells manual cnt (csf) [#],cell; cellularity; cerebral spinal fluid; cerebrospinal fl; cnt; count; hematology/cell counts; manl; number; othr; point in time; qnt; quan; quant; quantitative; random; spinal fl; spinal fld; spinal flu; spinal fluid,Qn
55805-6,cyclosporine [mass/volume] in blood by lc/ms/ms,cyclosporine bld lc/ms/ms-mcnc,cyclosporine lc/ms/ms (bld) [mass/vol],blood; ciclosporin; ciclosporine; csa; cyclosporin a; cyclosporins; drug/toxicology; drugs; gengraf; level; mass concentration; neoral; point in time; qnt; quan; quant; quantitative; random; restasis; sandimmune; sangcya; wb; whole blood,Qn
55811-4,18-hydroxycortisol [moles/time] in 24 hour urine,18oh-cortis 24h ur-srate,18-hydroxycortisol (24h u) [moles/time],1 day; 18oh-cortis; 24 hours; 24hr; chemistry; qnt; quan; quant; quantitative; srate; substance rate; ua; ur; urn,Qn
55817-1,amino acids [moles/mass] in hair,amino acids hair-scnt,amino acids (hair) [moles/mass],aa; acd; acid; amino acid; amino acids.total; chemistry; har; point in time; qnt; quan; quant; quantitative; random; substance content,Qn
55819-7,adiponectin.high molecular weight [mass/volume] in serum or plasma,adiponectin.hmw serpl-mcnc,adiponectin.high molecular weight [mass/vol],adiponectin.hmw; chemistry; hmw; level; mass concentration; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; wt,Qn
55822-1,allo-tetrahydrodeoxycortisol [mass/time] in 24 hour urine,allo-th-dc 24h ur-mrate,allo-tetrahydrodeoxycortisol (24h u) [mass/time],1 day; 24 hours; 24hr; allo th-dc; allo-th-dc; chemistry; mass rate; mrate; qnt; quan; quant; quantitative; tetrahydro-11-deoxycortisol; th-dc; ua; ur; urn,Qn
55829-6,catalase [enzymatic activity/mass] in tissue,catalase tiss-ccnt,catalase (tiss) [catalytic activity/mass],"catalytic content; chemistry; point in time; qnt; quan; quant; quantitative; random; tissue; tissue, unspecified",Qn
55835-3,vegetable fibers [presence] in stool by light microscopy,vegetable fibers stl ql micro,vegetable fibers lm ql (stl),bowel movement; chemistry; faecal; faeces; fecal; feces; fiber; lm; micro; micros; microscopic; ordinal; point in time; pr; ql; qual; qualitative; random; screen; stl; stool = fecal,Ord
55840-3,cholesterol esters [moles/volume] in serum or plasma,cholest ester serpl-scnc,cholesterol esters [moles/vol],chemistry; chol; choles; cholest; cholest ester; cholesterol total; cholesterols; ester; level; lipid; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; substance concentration,Qn
55843-7,corticosterone [moles/volume] in 24 hour urine,corticoster 24h ur-scnc,corticosterone (24h u) [moles/vol],1 day; 24 hours; 24hr; b; chemistry; compound b; cort; corticoster; level; qnt; quan; quant; quantitative; substance concentration; ua; ur; urn,Qn
55847-8,cryoglobulin.igg.monoclonal [presence] in serum,cryoglob igg moncl ser ql,cryoglobulin.igg.monoclonal ql (s),cryo; cryoglob igg; cryoglob igg moncl; cryoglobulins; cryoprecipitate; immune globulin g; immunoglobulin g; m-igg; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serology; serum; sr,Ord
5584-8,arsenic [mass/mass] in hair,arsenic hair-mcnt,arsenic (hair) [mass/mass],as; drug/toxicology; drugs; har; mass content; point in time; qnt; quan; quant; quantitative; random,Qn
55859-3,folate [mass/volume] in cerebral spinal fluid,folate csf-mcnc,folate (csf) [mass/vol],cerebral spinal fluid; cerebrospinal fl; chemistry; folat; folic acid; level; mass concentration; point in time; pteroylglutamate; pteroylglutamic acid; qnt; quan; quant; quantitative; random; spinal fl; spinal fld; spinal flu; spinal fluid; vit m; vitamin m,Qn
5587-1,arsenic [mass/time] in 24 hour urine,arsenic 24h ur-mrate,arsenic (24h u) [mass/time],1 day; 24 hours; 24hr; as; drug/toxicology; drugs; mass rate; mrate; qnt; quan; quant; quantitative; ua; ur; urn,Qn
55880-9,homovanillate [moles/volume] in serum,hva ser-scnc,homovanillate (s) [moles/vol],3-methoxy-4-hydroxy-phenylacetic acid; chemistry; homovanilic; homovanillic acid; hva; level; point in time; qnt; quan; quant; quantitative; random; serum; sr; substance concentration; tumor marker,Qn
55883-3,hydroxocobalamin [mass/volume] in body fluid,vit b12b fld-mcnc,hydroxocobalamin (body fld) [mass/vol],"b/f; bf; bod; bodies; body fluid; body fluid, unsp; chemistry; fl; fld; flu; fluid; hydroxycobalamin; level; mass concentration; point in time; qnt; quan; quant; quantitative; random; vit b12b; vitamin b12; vitamin b12b",Qn
55885-8,hydroxocobalamin [mass/volume] in urine,vit b12b ur-mcnc,hydroxocobalamin (u) [mass/vol],chemistry; hydroxycobalamin; level; mass concentration; point in time; qnt; quan; quant; quantitative; random; ua; ur; urn; vit b12b; vitamin b12; vitamin b12b,Qn
55891-6,hydroxylysine [moles/mass] in hair,oh-lysine hair-scnt,hydroxylysine (hair) [moles/mass],chemistry; har; hydroxy lysine; hydroxyl; oh-lysine; point in time; qnt; quan; quant; quantitative; random; substance content,Qn
55904-7,ige.monoclonal [presence] in serum by immunoelectrophoresis,m-ige ser ql iep,ige.monoclonal iep ql (s),chemistry; iep; imm elect; immune globulin e; immunoelect; immunoglobulin e; m-ige; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; sie; siep; sr,Ord
55912-0,arylsulfatase [enzymatic activity/volume] in dbs,arylsulfatase dbs-ccnc,arylsulfatase (dbs) [catalytic activity/vol],arylsulfatase.total; blood; catalytic concentration; chemistry; dbs; dried blood spot; filter paper; fp; point in time; qnt; quan; quant; quantitative; random; wb; whole blood,Qn
5591-3,benzene [presence] in serum or plasma,benzene serpl ql,benzene ql,cyclohexatriene; drug/toxicology; drugs; ordinal; pl; plasma; plsm; point in time; pr; ql; qual; qualitative; random; screen; serp; serpl; serplas; serum; serum or plasma; sr,Ord
55936-9,lysozyme [mass/volume] in cerebral spinal fluid,lysozyme csf-mcnc,lysozyme (csf) [mass/vol],"cerebral spinal fluid; cerebrospinal fl; chemistry; k208; level; lysozymes; mass concentration; muramidase; n-acetylmuramide glycanhydrolase; ngal d 4 lysozyme, egg; point in time; qnt; quan; quant; quantitative; random; rk208; spinal fl; spinal fld; spinal flu; spinal fluid",Qn
55957-5,oleoylcarnitine (c18:1) [moles/volume] in amniotic fluid,oleoylcarn amn-scnc,c18:1 (amn fld) [moles/vol],af; amn; amn fl; amnio; amniotic flu; amniotic fluid; c18:1; chemistry; i; level; octadecenoyl carnitine; octadecenoylcarnitine; oleoyl carnitine; oleyl carnitine; oleylcarnitine; point in time; qnt; quan; quant; quantitative; random; substance concentration,Qn
5596-2,beryllium [mass/time] in 24 hour urine,beryllium 24h ur-mrate,beryllium (24h u) [mass/time],1 day; 24 hours; 24hr; be; berylliosis; drug/toxicology; drugs; mass rate; mrate; qnt; quan; quant; quantitative; ua; ur; urn,Qn
55979-9,right corrective lens visual acuity far by lensmeter,r corr lens far va by lm,,by lm; corr lens; distance; eye; eye.glasses; far va; focimeter; length ratio; lensometer; lm; ophthalmology; ophtho; ophthy; point in time; qnt; quan; quant; quantitative; r; r corr lens; random; refraction; rt; va,Qn
55986-4,right glasses lens prescription n po,r glasses rx n po,,eye; eye.glasses; glasses rx; length; ophthalmology; ophtho; ophthy; oral; point in time; qnt; quan; quant; quantitative; r; r glasses rx; random; rt; rx,Qn
5598-8,bismuth [mass/volume] in urine,bismuth ur-mcnc,bismuth (u) [mass/vol],bi; drug/toxicology; drugs; level; mass concentration; point in time; qnt; quan; quant; quantitative; random; ua; ur; urn,Qn
55997-1,right contact lens over refraction sphere,r cont lens or sphere,,cont lens; eye; eye.contact_lens; inverse length; ophthalmology; ophtho; ophthy; or sphere; point in time; qnt; quan; quant; quantitative; r; r cont lens; random; rt,Qn
55998-9,right contact lens over refraction cylinder,r cont lens or cylinder,,cont lens; cyl; eye; eye.contact_lens; inverse length; ophthalmology; ophtho; ophthy; or cylinder; point in time; qnt; quan; quant; quantitative; r; r cont lens; random; rt,Qn
56019-3,platelet aggregation thrombin induced atp secretion in blood --1 u/ml,pa thromb atp secr 1 u/ml bld,platelet aggregation thrombin induced atp secretion 1 u/ml (bld) [rel units/vol],agg; aggr; blood; coagulation; hematology; heme; i; pa; pa thromb atp secr; pa thrombin; pl; platelets; platelt; plt; point in time; qnt; quan; quant; quantitative; random; rlacnc; throm; thrombocyte; thrombocytes; wb; whole blood,Qn
56041-7,beta defensin [mass/mass] in stool.wet,beta defensin stool.wet-mcnt,beta defensin (stool.wet) [mass/mass],b; bowel movement; chemistry; faecal; faeces; fecal; feces; mass content; point in time; qnt; quan; quant; quantitative; random; stl; stool = fecal,Qn
56047-4,shoulder horizontal adduction active range of motion quantitative,should horizontal adduction arom qn,,adduction arom; arom; h+p; h+p.px; horizontal adduction arom; msk; musculoskeletal; ortho; orthopedics; p prime; point in time; qnt; quan; quant; quantitative; random; rnge; upper extremity joint,Qn
56073-0,deprecated phenx measure - neck circumference,,,girth; pan; panel; panel.phenx; panl; pnl; point in time; random,-
56074-8,circumference neck,circumf neck,,girth; length; phenx; point in time; qnt; quan; quant; quantitative; random,Qn
56083-9,body weight --xxx time ago,weight xxx time ago,,bdy weight; bod; bodies; phenx; point in time; qnt; quan; quant; quantitative; random; wt,Qn
56086-2,adult waist circumference protocol,adult waist circumf,,girth; pan; panel; panel.phenx; panl; phenx; pnl; point in time; random,-
56092-0,birth weight gnwch,birth weight gnwch,,@ birth; bdy weight; bod; bodies; body weight.molec; new born; newborn; point in time; qnt; quan; quant; quantitative; random; wt,Qn
56096-1,phenx - hand dominance - 42 months and older protocol 020601 alspac,hand dom- 42mo proto alspac,,hand dom- 42mo proto; pan; panel; panel.phenx; panl; pnl; point in time; random; upper extremity,-
56098-7,hand dominance - throwing a ball [alspac],hand dom- throwing a ball alspac,,finding; findings; hand dom- throwing a ball; nominal; phenx; point in time; random; upper extremity,Nom
5610-1,cadmium [mass/mass] in hair,cadmium hair-mcnt,cadmium (hair) [mass/mass],cd; drug/toxicology; drugs; har; mass content; point in time; qnt; quan; quant; quantitative; random,Qn
56122-5,igg [mass/volume] in cord blood,igg bldco-mcnc,igg (bldco) [mass/vol],blood - (umbilical) cord; chemistry; cord (umbilical) blood; cord bld; cord blood; immune globulin g; immunoglobulin g; level; mass concentration; point in time; qnt; quan; quant; quantitative; random,Qn
5612-7,cadmium [mass/time] in 24 hour urine,cadmium 24h ur-mrate,cadmium (24h u) [mass/time],1 day; 24 hours; 24hr; cd; drug/toxicology; drugs; mass rate; mrate; qnt; quan; quant; quantitative; ua; ur; urn,Qn
56137-3,ldl 2 [moles/volume] in serum or plasma,ldl2 serpl-scnc,ldl 2 [moles/vol],cardio; cardiology; chemistry; heart disease; ii; ldl2; level; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; substance concentration,Qn
56145-6,cd55+cd59 deficient rbc+granulocytes [interpretation] in blood narrative,cd55+cd59 def rbc+gran bld-imp,cd55+cd59 deficient rbc+granulocytes nar (bld) [interp],1f-5ag; blood; cd55 granulocytes; cd55+cd59 def rbc+gran; cd59.deficient; cell markers; daf; decay accelerating factor; discocytes; erthrocyte; erythrocyte; gran; grans; granulocyte; granulocytes; h19; hrf20; impression; impression/interpretation of study; impressions; interp; interpretation; macif; membrane inhibitor of reactive lysis; mirl; narrative; p-18; point in time; protectin; random; rbc; rbcs; red blood cell; red blood cells; red blood corpuscle; red blood corpusles; red cell; red cells; report; wb; whole blood,Nar
56154-8,protein.abnormal band/protein.total in serum or plasma by electrophoresis,abn prot mfr serpl elph,protein.abnormal band elph [mass fraction],abn; abn prot; abnorm; bands; bnd; chemistry; elec; elect; electr; electro; electrophhrs; electrophrs; elp; elph; ep; mass fraction; percent; pl; plasma; plsm; point in time; pr; prot; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; spep; sr; tot; totl; tp,Qn
56157-1,hoxb13 gene/il17br gene [ratio] in tissue by molecular genetics method,hoxb13 gene/il17br gene tiss-rto,hoxb13 gene/il17br gene molgen (tiss) [ratio],"crl4; evi27; homeobox b13; il17br; il17rh1; interleukin 17 receptor b; molecular genetics; molecular pathology; molpath; pcr; point in time; psgd; qnt; quan; quant; quantitative; random; ratios; rto; tissue; tissue, unspecified",Qn
56166-2,gum arabic igg4 ab [mass/volume] in serum,gum arabic igg4-mcnc,gum arabic igg4 (s) [mass/vol],abs; aby; acacia gum; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; f297; f373; gum acacia; gum senegal; gum sudan; level; mass concentration; point in time; qnt; quan; quant; quantitative; random; rf297; senegal gum; serum; sr; sudan gum,Qn
56187-8,barley igg4 ab [mass/volume] in serum,barley igg4-mcnc,barley igg4 (s) [mass/vol],abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; barley; f006; f6; level; mass concentration; point in time; qnt; quan; quant; quantitative; random; serum; sr,Qn
56190-2,bermuda grass igg4 ab [mass/volume] in serum,bermuda grass igg4-mcnc,bermuda grass igg4 (s) [mass/vol],abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; bermuda grass; g002; g2; level; mass concentration; point in time; qnt; quan; quant; quantitative; random; serum; sr,Qn
56192-8,"bass, black igg4 ab [mass/volume] in serum",bass igg4-mcnc,"bass, black igg4 (s) [mass/vol]",abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; bass; black bass; chub; f368; largemouth bass; level; mass concentration; point in time; qnt; quan; quant; quantitative; random; serum; sr,Qn
56214-0,acremonium sp igg4 ab [mass/volume] in serum,acremonium igg4-mcnc,acremonium sp igg4 (s) [mass/vol],abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; cephalosporium; level; m202; mass concentration; point in time; qnt; quan; quant; quantitative; random; serum; species; spp; sr,Qn
5621-8,chromium [mass/volume] in red blood cells,cr rbc-mcnc,chromium (rbc) [mass/vol],c609; chrome; cr; drug/toxicology; drugs; erythrocytes; level; mass concentration; point in time; qnt; quan; quant; quantitative; random; red blood cells; red blood corpusles,Qn
56228-0,codfish igg4 ab [mass/volume] in serum,codfish igg4-mcnc,codfish igg4 (s) [mass/vol],abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; cod; codfish; f003; f3; fish; level; mass concentration; point in time; qnt; quan; quant; quantitative; random; scrod; serum; sr,Qn
56251-2,duck meat igg4 ab [mass/volume] in serum,duck meat igg4-mcnc,duck meat igg4 (s) [mass/vol],abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; f157; level; mass concentration; point in time; qnt; quan; quant; quantitative; random; serum; sr,Qn
56271-0,goldenrod igg4 ab [mass/volume] in serum,goldenrod igg4-mcnc,goldenrod igg4 (s) [mass/vol],abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; golden rod; goldenrod; level; mass concentration; point in time; qnt; quan; quant; quantitative; random; serum; sr; w012; w12,Qn
5627-5,cobalt [mass/volume] in serum or plasma,cobalt serpl-mcnc,cobalt [mass/vol],c617; co; drug/toxicology; drugs; level; mass concentration; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; universallaborders,Qn
56278-5,green pepper igg4 ab [mass/volume] in serum,green pepper igg4-mcnc,green pepper igg4 (s) [mass/vol],abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; f152; f263; f335; green pepper; level; mass concentration; point in time; qnt; quan; quant; quantitative; random; rf263; serum; sr,Qn
56283-5,hazelnut igg4 ab [mass/volume] in serum,hazelnut igg4-mcnc,hazelnut igg4 (s) [mass/vol],abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; barcelona nut; cob nut; f017; f17; filbert; hazel nut; hazelnut; level; mass concentration; point in time; qnt; quan; quant; quantitative; random; serum; sr,Qn
56287-6,deprecated melon igg4 ab [mass/volume] in serum,deprecated melon igg4-mcnc,melon igg4 (s) [mass/vol],abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; f87; honey dew; honeydew; level; mass concentration; melon; melons; point in time; qnt; quan; quant; quantitative; random; serum; sr,Qn
56294-2,johnson grass igg4 ab [mass/volume] in serum,johnson grass igg4-mcnc,johnson grass igg4 (s) [mass/vol],abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; g010; g10; johnson grass; level; mass concentration; point in time; qnt; quan; quant; quantitative; random; serum; sr,Qn
56296-7,kentucky blue grass igg4 ab [mass/volume] in serum,kent blue grass igg4-mcnc,kentucky blue grass igg4 (s) [mass/vol],abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; g008; g8; june blue grass; june grass; june kentucky blue grass; junegrass; kent blue grass; kentucky blue grass; kentucky bluegrass; level; mass concentration; meadow grass; point in time; qnt; quan; quant; quantitative; random; serum; sr,Qn
56299-1,firebush igg4 ab [mass/volume] in serum,firebush igg4-mcnc,firebush igg4 (s) [mass/vol],abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; burning bush; firebrush; firebush; kocha scoparia; level; mass concentration; point in time; qnt; quan; quant; quantitative; random; serum; sr; w017; w17,Qn
56310-6,lobster igg4 ab [mass/volume] in serum,lobster igg4-mcnc,lobster igg4 (s) [mass/vol],abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; f080; f80; level; lobster; mass concentration; point in time; qnt; quan; quant; quantitative; random; serum; sr,Qn
56320-5,mesquite igg4 ab [mass/volume] in serum,mesquite igg4-mcnc,mesquite igg4 (s) [mass/vol],abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; honey locust; level; mass concentration; mesquite; point in time; qnt; quan; quant; quantitative; random; serum; sr; t020; t20,Qn
56325-4,mugwort igg4 ab [mass/volume] in serum,mugwort igg4-mcnc,mugwort igg4 (s) [mass/vol],abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; level; mass concentration; mugwort; point in time; qnt; quan; quant; quantitative; random; serum; sr; w006; w6,Qn
56328-8,mustard igg4 ab [mass/volume] in serum,mustard igg4-mcnc,mustard igg4 (s) [mass/vol],abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; brassica/sinapis spp; f089; f89; level; mass concentration; point in time; qnt; quan; quant; quantitative; random; serum; sr,Qn
56329-6,nectarine igg4 ab [mass/volume] in serum,nectarine igg4-mcnc,nectarine igg4 (s) [mass/vol],abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; f095; f162; f95; level; mass concentration; nectarine; peach; point in time; qnt; quan; quant; quantitative; random; serum; sr,Qn
56333-8,oat igg4 ab [mass/volume] in serum,oat igg4-mcnc,oat igg4 (s) [mass/vol],abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; f007; f7; level; mass concentration; oat; oats; point in time; qnt; quan; quant; quantitative; random; serum; sr,Qn
56347-8,parrot feather igg4 ab [mass/volume] in serum,parrot feather igg4-mcnc,parrot feather igg4 (s) [mass/vol],abs; aby; african gray parrot; african grey parrot; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; e213; e91; feathers; level; macaw; mass concentration; point in time; qnt; quan; quant; quantitative; random; serum; sr,Qn
56357-7,perennial rye grass igg4 ab [mass/volume] in serum,per rye grass igg4-mcnc,perennial rye grass igg4 (s) [mass/vol],abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; g005; g5; italian ryegrass; level; mass concentration; per rye grass; perennial ryegrass; point in time; qnt; quan; quant; quantitative; random; rye grass; ryegrass; serum; sr,Qn
56388-2,shrimp igg4 ab [mass/volume] in serum,shrimp igg4-mcnc,shrimp igg4 (s) [mass/vol],abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; f024; f24; level; mass concentration; point in time; prawns; qnt; quan; quant; quantitative; random; serum; shrimp; sr,Qn
56398-1,sweet vernal grass igg4 ab [mass/volume] in serum,sw vernal grass igg4-mcnc,sweet vernal grass igg4 (s) [mass/vol],abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; g001; g1; level; mass concentration; point in time; qnt; quan; quant; quantitative; random; serum; sr; sw vernal grass; sweet vernal grass,Qn
56399-9,swiss cheese igg4 ab [mass/volume] in serum,swiss cheese igg4-mcnc,swiss cheese igg4 (s) [mass/vol],abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; f170; level; mass concentration; point in time; qnt; quan; quant; quantitative; random; serum; sr; swiss cheese,Qn
5640-8,ethanol [mass/volume] in blood,ethanol bld-mcnc,ethanol (bld) [mass/vol],alc; alcohol; blood; drug/toxicology; drugs; ethyl alcohol; etoh; level; mass concentration; point in time; qnt; quan; quant; quantitative; random; universallaborders; wb; whole blood,Qn
56413-8,virginia live oak igg4 ab [mass/volume] in serum,virg live oak igg4-mcnc,virginia live oak igg4 (s) [mass/vol],abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; level; live oak; mass concentration; point in time; qnt; quan; quant; quantitative; random; rt218; serum; sr; t103; t218; virg live oak; virginia live oak; virginia oak,Qn
56426-0,white oak igg4 ab [mass/volume] in serum,white oak igg4-mcnc,white oak igg4 (s) [mass/vol],abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; level; mass concentration; oak; point in time; qnt; quan; quant; quantitative; random; serum; sr; t007; t7; white oak,Qn
5643-2,ethanol [mass/volume] in serum or plasma,ethanol serpl-mcnc,ethanol [mass/vol],alc; alcohol; drug/toxicology; drugs; ethyl alcohol; etoh; level; mass concentration; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; universallaborders,Qn
56436-9,zucchini igg4 ab [mass/volume] in serum,zucchini igg4-mcnc,zucchini igg4 (s) [mass/vol],abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; f118; level; mass concentration; point in time; qnt; quan; quant; quantitative; random; serum; sr,Qn
5644-0,ethanol [presence] in urine,ethanol ur ql,ethanol ql (u),alc; alcohol; drug/toxicology; drugs; ethyl alcohol; etoh; ordinal; point in time; pr; ql; qual; qualitative; random; screen; ua; universallaborders; ur; urn,Ord
56447-6,deprecated plan of care note,deprecated plan of care note,,care plan; doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; notes; point in time; random; treatment plan; visit note,Doc
56453-4,cow dander igg4 ab [mass/volume] in serum,cow dander igg4-mcnc,cow dander igg4 (s) [mass/vol],abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; e004; e4; level; mass concentration; point in time; qnt; quan; quant; quantitative; random; serum; sr,Qn
56455-9,gelatin igg4 ab [mass/volume] in serum,gelatin igg4-mcnc,gelatin igg4 (s) [mass/vol],abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; c13; c74; f340; gelatine; level; mass concentration; point in time; qnt; quan; quant; quantitative; random; serum; sr,Qn
56460-9,pepper tree igg4 ab [mass/volume] in serum,pepper tree igg4-mcnc,pepper tree igg4 (s) [mass/vol],abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; level; mass concentration; pepper tree; peppertree; point in time; qnt; quan; quant; quantitative; random; rt217; serum; sr; t105; t217,Qn
56469-0,cardiac heart disease risk [ratio] in serum or plasma,chd risk serpl-rto,cardiac heart disease risk [ratio],chd risk; chemistry; dis; diseases; dz; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; ratios; rto; serp; serpl; serplas; serum; serum or plasma; sr,Qn
56470-8,blasts [#] in cerebral spinal fluid by manual count,blasts csf manual,blasts manual cnt (csf) [#],blast; cerebral spinal fluid; cerebrospinal fl; cnt; count; hematology/cell counts; manl; number; point in time; qnt; quan; quant; quantitative; random; spinal fl; spinal fld; spinal flu; spinal fluid,Qn
56515-0,plasmodium falciparum igg ab [presence] in serum by immunofluorescence,p falciparum igg ser ql if,p. falciparum igg if ql (s),abs; aby; acif; antby; anti; antibodies; antibody; anticomplement immunofluorescence; autoantibodies; autoantibody; fa; fluorescent antibody; fluoresent; id; ifa; immune fluorescence; immune globulin g; immunoflour; immunofluor; immunofluorescence; immunoglobulin g; infectious disease; infectiousdisease; malaria; malarial; microbiology; ordinal; p falciparum; point in time; pr; ql; qual; qualitative; random; screen; serum; sr; time resolved fluorescence; trf,Ord
56517-6,11-deoxycortisol [mass/volume] in serum or plasma --2 hours post xxx challenge,11dc 2h p chal serpl-mcnc,11-deoxycortisol 2 hr post unsp challenge [mass/vol],11dc; 120 min; 120 minutes; 120min; 2 hours; 2h p chal; after; chemistry.challenge testing; compound s; cortexolone; cortodoxone; deoxycortisol; desoxycortisol; level; mass concentration; metopirone; p chal; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
56519-2,11-deoxycortisol [mass/volume] in serum or plasma --30 minutes post xxx challenge,11dc 30m p chal serpl-mcnc,11-deoxycortisol 30 min post unsp challenge [mass/vol],11dc; 30m p chal; after; chemistry.challenge testing; compound s; cortexolone; cortodoxone; deoxycortisol; desoxycortisol; level; mass concentration; metopirone; p chal; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
5652-3,formaldehyde [mass/volume] in blood,formaldehyde bld-mcnc,formaldehyde (bld) [mass/vol],blood; drug/toxicology; drugs; formalin; k80; level; mass concentration; point in time; qnt; quan; quant; quantitative; random; wb; whole blood,Qn
56531-7,amphiphysin ab [titer] in cerebral spinal fluid by immunofluorescence,amphiphysin ab titr csf if,amphiphysin ab if (csf) [titer],abs; aby; acif; antby; anti; antibodies; antibody; anticomplement immunofluorescence; autoantibodies; autoantibody; breast cancer; cerebral spinal fluid; cerebrospinal fl; dilution factor; dilution factor (titer); fa; fluorescent antibody; fluoresent; ifa; immune fluorescence; immunoflour; immunofluor; immunofluorescence; neuro; neurology; paraneoplastic syndrome; point in time; random; serology; smqn; spinal fl; spinal fld; spinal flu; spinal fluid; stiff man syndrome; time resolved fluorescence; titer; titered; titre; trf; ttr,SemiQn
56535-8,8-dehydrocholesterol [moles/volume] in serum or plasma,8-dhc serpl-scnc,8-dehydrocholesterol [moles/vol],8-dhc; chemistry; level; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; substance concentration,Qn
56542-4,ganglioside gd1b igm ab [units/volume] in cerebral spinal fluid by immunoassay,gd1b gangl igm csf ia-acnc,ganglioside gd1b igm ia qn (csf),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; cerebral spinal fluid; cerebrospinal fl; disialolganglioside; disialylganglioside; eia; elfa; elisa; enzyme immunoassay; gd1b; gd1b gangl; iaa; immune globulin m; immunoglobulin m; meia; point in time; qnt; quan; quant; quantitative; random; serology; spinal fl; spinal fld; spinal flu; spinal fluid; suds,Qn
56563-0,somatotropin [mass/volume] in serum or plasma --7.5 hours post xxx challenge,gh 7.5h p chal serpl-mcnc,somatotropin 7.5 hr post unsp challenge [mass/vol],7.5h p chal; after; chemistry.challenge testing; endocrine; endocrinology; gh; growth hormone; hgh; human growth hormone; level; mass concentration; p chal; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; somatotropic hormone; sr; sth,Qn
56570-5,somatotropin [mass/volume] in serum or plasma --11.5 hours post xxx challenge,gh 11.5h p chal serpl-mcnc,somatotropin 11.5 hr post unsp challenge [mass/vol],11.5h p chal; after; chemistry.challenge testing; endocrine; endocrinology; gh; growth hormone; hgh; human growth hormone; level; mass concentration; p chal; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; somatotropic hormone; sr; sth,Qn
56572-1,somatotropin [mass/volume] in serum or plasma --20 hours post xxx challenge,gh 20h p chal serpl-mcnc,somatotropin 20 hr post unsp challenge [mass/vol],20h p chal; after; chemistry.challenge testing; endocrine; endocrinology; gh; growth hormone; hgh; human growth hormone; level; mass concentration; p chal; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; somatotropic hormone; sr; sth,Qn
56574-7,renin [enzymatic activity/volume] in plasma --1 hour post xxx challenge,renin 1h p chal plas-ccnc,renin 1 hr post unsp challenge (p) [catalytic activity/vol],1 hour; 1.0hr; 1h p chal; 60 min; 60 minutes; 60m; 60min; active renin; after; angiotensin forming enzyme; angiotensinogenase; cardio; cardiology; catalytic concentration; chemistry.challenge testing; endocrine; endocrinology; heart disease; kidney; nephrology; p chal; pl; plasma; plasma renin activity; plsm; point in time; pra; pst; qnt; quan; quant; quantitative; random; renal,Qn
56583-8,c peptide [mass/volume] in serum or plasma --45 minutes post xxx challenge,c peptide 45m p chal serpl-mcnc,c peptide 45 min post unsp challenge [mass/vol],45m p chal; after; chemistry.challenge testing; connecting peptide of insulin; level; mass concentration; p chal; pept; pl; plasma; plsm; point in time; pro-insulin c peptide; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
56594-5,thyrotropin [units/volume] in serum or plasma --3 hours post xxx challenge,tsh 3h p chal serpl-acnc,tsh 3 hr post unsp challenge qn,3h p chal; after; arbitrary concentration; chemistry.challenge testing; endocrine; endocrinology; p chal; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; thyroid stimulating hormone; thyrotropic hormone; tsh,Qn
56602-6,11-deoxycorticosterone [mass/volume] in serum or plasma --1st specimen post xxx challenge,11doc sp1 p chal serpl-mcnc,11-deoxycorticosterone 1st specimen post unsp challenge [mass/vol],11doc; 11-doc; 21-hydroxyprogesterone; acute specimen; after; chemistry.challenge testing; doc; first; level; mass concentration; p chal; pl; plasma; plsm; point in time; pre immunization; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sp1; sp1 p chal; spec; sr,Qn
56619-0,insulin-like growth factor-i [mass/volume] in serum or plasma --20 minutes post xxx challenge,igf-i 20m p chal serpl-mcnc,insulin-like growth factor-i 20 min post unsp challenge [mass/vol],20m p chal; after; chemistry.challenge testing; fac; fact; factor 1; fi; hum; humulin; igf; igf1; igf-1; igf-i; ih7; insul; lente; level; mass concentration; nph; p chal; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; semilente; serp; serpl; serplas; serum; serum or plasma; sliding; somatomedin c; sr; ultralente,Qn
56650-5,chromium/creatinine [ratio] in urine,cr/creat ur-rto,chromium/creatinine (u) [ratio],c609; chrome; cr; crea; creat; drug/toxicology; drugs; point in time; qnt; quan; quant; quantitative; random; ratios; rto; ua; ucr; ur; urn,Qn
56657-0,tetrahydrocortisone [moles/time] in 24 hour urine,thcortisone 24h ur-srate,tetrahydrocortisone (24h u) [moles/time],1 day; 24 hours; 24hr; drug/toxicology; drugs; qnt; quan; quant; quantitative; srate; substance rate; thcortisone; ua; ur; urn,Qn
56660-4,methyl formamide/creatinine [ratio] in urine,mehyl formamide/creat ur-rto,methyl formamide/creatinine (u) [ratio],c2h5no; cr; crea; creat; drug/toxicology; drugs; ek 7011; mehyl formamide; methylformamide; monomethylformamide; n-methyl-formamide; point in time; qnt; quan; quant; quantitative; random; ratios; rto; ua; ucr; ur; urn; x 188,Qn
5666-3,indium [mass/volume] in urine,indium ur-mcnc,indium (u) [mass/vol],drug/toxicology; drugs; in; level; mass concentration; point in time; qnt; quan; quant; quantitative; random; ua; ur; urn,Qn
56670-3,adrenal cortex igg ab [units/volume] in serum,adrenal cortex igg ser-acnc,adrenal cortex igg qn (s),abs; aby; aca; adrnl; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; immune globulin g; immunoglobulin g; point in time; qnt; quan; quant; quantitative; random; serology; serum; sr,Qn
56671-1,alanine/creatinine [ratio] in 24 hour urine,alanine/creat 24h ur-rto,alanine/creatinine (24h u) [ratio],1 day; 24 hours; 24hr; ala; alpha alanine; chemistry; cr; crea; creat; l-alanine; qnt; quan; quant; quantitative; ratios; rto; ua; ucr; ur; urn,Qn
56676-0,citrulline/creatinine [ratio] in 24 hour urine,citrulline/creat 24h ur-rto,citrulline/creatinine (24h u) [ratio],1 day; 24 hours; 24hr; chemistry; cit; citr; cr; crea; creat; qnt; quan; quant; quantitative; ratios; rto; ua; ucr; ur; urn,Qn
56678-6,ethanolamine/creatinine [ratio] in 24 hour urine,ethanolamine/creat 24h ur-rto,ethanolamine/creatinine (24h u) [ratio],1 day; 24 hours; 24hr; chemistry; cr; crea; creat; ea; etn; qnt; quan; quant; quantitative; ratios; rto; ua; ucr; ur; urn,Qn
56680-2,glutamine/creatinine [ratio] in 24 hour urine,glutamine/creat 24h ur-rto,glutamine/creatinine (24h u) [ratio],1 day; 24 hours; 24hr; chemistry; cr; crea; creat; gln; qnt; quan; quant; quantitative; ratios; rto; ua; ucr; ur; urn,Qn
56685-1,hydroxyproline free [moles/volume] in serum or plasma,oh-proline free serpl-scnc,hydroxyproline free [moles/vol],chemistry; fr; hydroxylproline; hydroxyprol; hydroxy-proline; hydrxprol; hydrxproln; hydrxyprln; hyp; level; non-protein bound; ohpro; oh-proline; oh-proline free; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; substance concentration,Qn
56687-7,pancreatic islet cell igg ab [titer] in serum by immunofluorescence,panc islet cell igg titr ser if,pancreatic islet cell igg if (s) [titer],abs; aby; acif; antby; anti; antibodies; antibody; anticomplement immunofluorescence; autoantibodies; autoantibody; dilution factor; dilution factor (titer); endocrine; endocrinology; fa; fluorescent antibody; fluoresent; ica; ifa; immune fluorescence; immune globulin g; immunoflour; immunofluor; immunofluorescence; immunoglobulin g; panc islet cell; pancr; pancreatc; point in time; random; serology; serum; smqn; sr; time resolved fluorescence; titer; titered; titre; trf; ttr; universallaborders,SemiQn
56691-9,insulin [mass/volume] in serum or plasma --20 hours post xxx challenge,insulin 20h p chal serpl-mcnc,insulin 20 hr post unsp challenge [mass/vol],20h p chal; after; chemistry.challenge testing; hum; humulin; ih7; insul; lente; level; mass concentration; nph; p chal; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; semilente; serp; serpl; serplas; serum; serum or plasma; sliding; sr; ultralente,Qn
56699-2,bupivacaine ige ab [units/volume] in serum,bupivacaine ige qn,bupivacaine ige qn (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; c285; immune globulin e; immunoglobulin e; marcain; marcaine; point in time; qnt; quan; quant; quantitative; random; sensorcaine; serum; sr; vivacaine,Qn
56703-2,piroxicam ige ab [units/volume] in serum,piroxicam ige qn,piroxicam ige qn (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; c304; feldene; immune globulin e; immunoglobulin e; point in time; qnt; quan; quant; quantitative; random; serum; sr,Qn
5671-3,lead [mass/volume] in blood,lead bld-mcnc,lead (bld) [mass/vol],blood; drug/toxicology; drugs; level; mass concentration; painter's colic; pb; plumbism; point in time; qnt; quan; quant; quantitative; random; universallaborders; wb; whole blood,Qn
56727-1,olive recombinant (role e) 2 ige ab [units/volume] in serum,olive (role e) 2 ige qn,olive recombinant (role e) 2 ige qn (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; black olive; f342; ii; immune globulin e; immunoglobulin e; olive; olive (role e) 2; point in time; qnt; quan; quant; quantitative; random; serum; sr,Qn
56759-4,deprecated lactate dehydrogenase [enzymatic activity/volume] in semen by lactate to pyruvate reaction,deprecated ldh smn l to p-ccnc,ldh lactate to pyruvate reaction (sem) [catalytic activity/vol],2-hydroxypropanoic acid; 2-hydroxy-propionate; 2-hydroxy-propionic acid; catalytic concentration; chemistry; dehydrog; dehyrdogenase; ejaculate; genitourinary; gu; l to p; l.d.h; lact; lactic acid; lactic acid dehydrogenase; ld; ldh; l-lactate; l-lactate dehydrogenase; point in time; qnt; quan; quant; quantitative; random; react; rxn; sem; seminal fluid; smn; smpls; tumor marker; uro; urology,Qn
56772-7,macrophages/leukocytes in bronchial specimen by flow cytometry (fc),macrophages nfr bronch fc,macrophages/leukocytes fc (bronch spec),bro; dynamic; fc; hematology/cell counts; leuc; leuk; leukocyte; lkcs; macrop; macrophage; macros; macrphg; number fraction; percent; point in time; qnt; quan; quant; quantitative; random; wbc; wbcs; white blood cell; white blood cells,Qn
56776-8,amylase s3+s4/amylase.total in serum or plasma,amylase s3+s4 cfr serpl,amylase s3+s4 [catalytic fraction],alpha amylase; ams; amyl; amylase s3; amylase s3+s4; catalytic fraction; chemistry; diastase; gastro; gastroenterology; gi; k87; percent; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; tot; totl,Qn
56782-6,amylase s4/amylase.total in serum or plasma,amylase s4 cfr serpl,amylase s4 [catalytic fraction],alpha amylase; ams; amyl; amylase s4; catalytic fraction; chemistry; diastase; gastro; gastroenterology; gi; k87; percent; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; tot; totl,Qn
56799-0,address,address,,address; admin; admin.patient; nominal; point in time; random,Nom
56811-3,primary care clinic or system [identifier] facility,primary care clinic or system facility,,admin; ident; identifier; nominal; point in time; random,Nom
56822-0,problem response to therapy,problem response to therapy,,deeds; emergency department; emergency department (deeds); finding; findings; nominal; point in time; random,Nom
56839-4,acuity assessment narrative,acuity assess,,finding; findings; h+p; h+p.px; narrative; p prime; point in time; random; report,Nar
56843-6,physical findings of nail bed narrative,phys find nail bed,,exam; examination; finding; findings; h+p; h+p.px; nails; narrative; p prime; phys find; point in time; random; report; ungal nail,Nar
5689-5,mercury [mass/volume] in urine,mercury ur-mcnc,mercury (u) [mass/vol],drug/toxicology; drugs; hg; level; mass concentration; point in time; qnt; quan; quant; quantitative; random; ua; ur; urn,Qn
56895-6,cd13+hla-dr+ cells/cells in bone marrow,cd13+hla-dr+ cells nfr mar,cd13+hla-dr+ cells/cells (bm),aminopeptidase n; apn; bm; bon; bone marrow; cd13 cells; cd13+hla-dr+ cells; cell; cell markers; cellularity; gp150; human leukocyte antigen; i3; leum7; leu-m7; mar; marrow (bone); minimal angle of resolution; minimum angle of resolution; my7; my-7; number fraction; percent; point in time; qnt; quan; quant; quantitative; random,Qn
56919-4,coxiella burnetii igg ab [titer] in serum by immunofluorescence --2nd specimen,c burnet igg sp2 titr ser if,c. burnetii igg spec 2 if (s) [titer],abs; aby; acif; antby; anti; antibodies; antibody; anticomplement immunofluorescence; autoantibodies; autoantibody; c burnet; c burnetii; convalescent; coxiella burnettii; dilution factor; dilution factor (titer); fa; fluorescent antibody; fluoresent; id; ifa; immune fluorescence; immune globulin g; immunoflour; immunofluor; immunofluorescence; immunoglobulin g; infectious disease; infectiousdisease; microbiology; point in time; post immunization; q fev; q fever; qfever; random; second; serum; smqn; sp2; spec; sr; time resolved fluorescence; titer; titered; titre; trf; ttr,SemiQn
56921-0,entamoeba histolytica ab [presence] in serum by immunofluorescence,e histolyt ab ser ql if,e. histolytica ab if ql (s),abs; aby; acif; ameba; amebiasis; amebic; amoeba; antby; anti; antibodies; antibody; anticomplement immunofluorescence; autoantibodies; autoantibody; e histolyt; e histolytica; fa; fluorescent antibody; fluoresent; id; ifa; immune fluorescence; immunoflour; immunofluor; immunofluorescence; infectious disease; infectiousdisease; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; sr; time resolved fluorescence; trf,Ord
56926-9,hepatitis c virus c1 ab [presence] in serum by immunoblot,hcv c1 ab ser ql ib,hcv c1 ab ib ql (s),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; blt; hcv; hcv c1; hep; hep c; hepatis; hepatit; hepatology; id; immune blot; immunobl; immunoblot; infectious disease; infectiousdisease; liver; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; riba; screen; serum; sr; wb; wblot; west blot; west blt; western blot,Ord
56935-0,hydrogen/expired gas [volume fraction] in exhaled gas --3.5 hour post dose lactose,breath h2 3.5h p lac,hydrogen/expired gas 3.5 hr post dose lactose (exhl gas) [volume fraction],3.5h p lac; after; breath; chemistry.challenge testing; exg; exhaled gas; exhaled gas (=breath); gases; gastro; gastroenterology; gi; h2; hyd; p dose; percent; point in time; pst; qnt; quan; quant; quantitative; random; volfr; volume fraction,Qn
56949-1,insulin [units/volume] in serum or plasma --40 hours post xxx challenge,insulin 40h p chal serpl-acnc,insulin 40 hr post unsp challenge qn,40h p chal; after; arbitrary concentration; chemistry.challenge testing; hum; humulin; ih7; insul; lente; nph; p chal; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; semilente; serp; serpl; serplas; serum; serum or plasma; sliding; sr; ultralente,Qn
56950-9,legionella pneumophila igg ab [titer] in serum by immunofluorescence --2nd specimen,l pneumo igg sp2 titr ser if,l. pneumophila igg spec 2 if (s) [titer],abs; aby; acif; antby; anti; antibodies; antibody; anticomplement immunofluorescence; autoantibodies; autoantibody; convalescent; dilution factor; dilution factor (titer); fa; fluorescent antibody; fluoresent; id; ifa; immune fluorescence; immune globulin g; immunoflour; immunofluor; immunofluorescence; immunoglobulin g; infectious disease; infectiousdisease; l pneumo; l pneumonphila; legion; legionela; microbiology; pneu; pneum; pneumophilia; point in time; post immunization; random; second; serum; smqn; sp2; spec; sr; time resolved fluorescence; titer; titered; titre; trf; ttr,SemiQn
56961-6,nicotinamide [mass/volume] in serum or plasma,nicotinamide serpl-mcnc,nicotinamide [mass/vol],drug/toxicology; drugs; level; mass concentration; niacinamide; nicobion; nicotylamide; papulex; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; ucemine pp; vit pp; vitamin pp,Qn
56962-4,ovary igg ab [presence] in serum by immunofluorescence,ovary igg ser ql if,ovary igg if ql (s),abs; aby; acif; antby; anti; antibodies; antibody; anticomplement immunofluorescence; aoa; autoantibodies; autoantibody; fa; fluorescent antibody; fluoresent; ifa; immune fluorescence; immune globulin g; immunoflour; immunofluor; immunofluorescence; immunoglobulin g; ordinal; ovarian; point in time; pr; ql; qual; qualitative; random; screen; serology; serum; sr; time resolved fluorescence; trf,Ord
56967-3,plasmodium falciparum ab [presence] in serum by immunoassay,p falciparum ab ser ql ia,p. falciparum ab ia ql (s),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; eia; elfa; elisa; enzyme immunoassay; iaa; id; infectious disease; infectiousdisease; malaria; malarial; meia; microbiology; ordinal; p falciparum; point in time; pr; ql; qual; qualitative; random; screen; serum; sr; suds,Ord
56970-7,porphyrins [mass/volume] in 24 hour urine,porphyrins 24h ur-mcnc,porphyrins (24h u) [mass/vol],1 day; 24 hours; 24hr; chemistry; hematology; heme; level; mass concentration; porph; porphyrin; qnt; quan; quant; quantitative; ua; ur; urn,Qn
56973-1,proline/creatinine [ratio] in 24 hour urine,proline/creat 24h ur-rto,proline/creatinine (24h u) [ratio],1 day; 24 hours; 24hr; chemistry; cr; crea; creat; pro; qnt; quan; quant; quantitative; ratios; rto; ua; ucr; ur; urn,Qn
56975-6,renin [mass/volume] in plasma --upright+30 minutes post xxx challenge,renin upr+30m p chal plas-mcnc,renin upright+30 min post unsp challenge (p) [mass/vol],30m p chal; after; angiotensin forming enzyme; angiotensinogenase; cardio; cardiology; chemistry.challenge testing; direct renin; drc; endocrine; endocrinology; erect; heart disease; kidney; level; mass concentration; nephrology; p chal; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; renal; standing; upr; upr+30m p chal; uprt,Qn
56985-5,taurine/creatinine [ratio] in 24 hour urine,taurine/creat 24h ur-rto,taurine/creatinine (24h u) [ratio],1 day; 24 hours; 24hr; chemistry; cr; crea; creat; qnt; quan; quant; quantitative; ratios; rto; tau; ua; ucr; ur; urn,Qn
56989-7,thyroxine (t4) free [mass/volume] in serum or plasma --20 minutes post xxx challenge,t4 free 20m p chal serpl-mcnc,free t4 20 min post unsp challenge [mass/vol],20m p chal; after; chemistry.challenge testing; endocrine; endocrinology; fr; freet4; ft4; level; levothyroxine; levo-thyroxine; l-thyroxine; mass concentration; non-protein bound; p chal; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; t4; t-4; t4 free; thyroid hormone; thyrox; thyroxin; thyrx; total t4; tt4,Qn
56996-2,urea/creatinine [mass ratio] in 24 hour urine,urea/creat 24h ur,urea/creatinine (24h u) [mass ratio],1 day; 24 hours; 24hr; chemistry; cr; crea; creat; mass concentration ratio; mass ratio; mcrto; qnt; quan; quant; quantitative; ua; ucr; ur; urn,Qn
57-0,capreomycin [susceptibility] by disk diffusion (kb),capreomycin islt kb,capreomycin disk diffusion (kb) [susc],antibiotic susceptibilities; ast; capastat; disk diffusion; id; infectious disease; infectiousdisease; islt; isol; kb; kirby-bauer; ogostal; point in time; random; sus; suscept; susceptibilities; susceptibility; susceptibilty,OrdQn
5700-0,nickel [mass/volume] in blood,nickel bld-mcnc,nickel (bld) [mass/vol],blood; drug/toxicology; drugs; level; mass concentration; ni; point in time; qnt; quan; quant; quantitative; random; wb; whole blood,Qn
57019-2,urinalysis dipstick w reflex culture panel - urine,ua dipstick w reflex culture pnl ur,urinalysis dipstick w reflex culture panel (u),pan; panel.urinalysis; panl; pnl; point in time; random; ua; ua dipstick w reflex culture pnl; ur; urn,-
57035-8,cow milk ab [presence] in serum by immune diffusion (id),cow milk ab ql id,cow milk ab immune diff ql (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; f002; f2; f43; id; imm; immunodiff; immunodiffusion; imun; imune; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; sr,Ord
57037-4,chromosome 13+18+21+x+y aneuploidy in amniotic fluid by molecular genetics method nominal,chr 13+18+21+x+y aneup amn,chr 13+18+21+x+y aneuploidy molgen nom (amn fld),af; amn; amn fl; amnio; amniotic flu; amniotic fluid; chr 13+18+21+x+y aneup; chromosom; chromosomes; finding; findings; molecular genetics; molecular pathology; molpath; nominal; pcr; point in time; random,Nom
57039-0,deprecated outcome and assessment information set (oasis) form - version c,,,form version; oasis-c; outcome and assessment information set; pan; panel; panel.survey.oasis; panl; pnl; point in time; random; survey; survey.oasis,-
57040-8,clinical record items during assessment period [cms assessment],,,centers for medicare and medicaid assessment; pan; panel; panel.survey.cms; panl; pnl; report period; survey,-
57042-4,sensory status during assessment period [cms assessment],,,centers for medicare and medicaid assessment; pan; panel; panel.survey.cms; panl; pnl; report period; survey,-
57053-1,nurse emergency department note,nurse ed note,,doc.ont; document; ed; encounter; evaluation and management; evaluation and management note; finding; findings; notes; nursing; point in time; random; visit note,Doc
57054-9,nurse emergency department triage+care note,nurse ed triage+care note,,doc.ont; document; ed; encounter; evaluation and management; evaluation and management note; finding; findings; notes; nursing; point in time; random; visit note,Doc
57076-2,postpartum hospitalization treatment narrative,postpartum hospitalization treatment,,finding; findings; h+p; h+p.px; hospitalization hx; narrative; p prime; point in time; postpart; postpartm; random; report; tx,Nar
57079-6,birth plan narrative,birth plan,,finding; findings; h+p; h+p.px; narrative; p prime; point in time; random; report,Nar
57087-9,biotinidase newborn screening panel,bio nb scn pnl dbs,biotinidase nbs panel (dbs),asympt; asymptomatic; bio nb scn pnl; blood; chemistry; dbs; dried blood spot; filter paper; fp; gyn; gynecology; nb screen pnl; nbs; new born; ob; obgyn; obstetrics; pan; panel.chemistry; panl; pnl; point in time; random; scn; wb; whole blood,-
57088-7,fetal movement - reported,fet movement reported,,fetal; finding; findings; gyn; gynecology; h+p; h+p.hx; ob; obgyn; obstetrics; ordinal; p prime; point in time; ql; qual; qualitative; random; screen,Ord
57099-4,follitropin [units/volume] in serum or plasma --1 hour post dose gonadotropin releasing hormone,fsh 1h p gnrh serpl-acnc,follitropin 1 hr post dose gonadotropin releasing hormone qn,1 hour; 1.0hr; 1h p gnrh; 60 min; 60 minutes; 60m; 60min; after; arbitrary concentration; chemistry.challenge testing; follicle stimulating hormone; fsh; ghr; gnrh; horm; lhrh; luliberin; luteinizing hormone releasing hormone; lutropin release factor; p dose; p gnrh; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
57101-8,follitropin [units/volume] in serum or plasma --20 minutes post dose gonadotropin releasing hormone,fsh 20m p gnrh serpl-acnc,follitropin 20 min post dose gonadotropin releasing hormone qn,20m p gnrh; after; arbitrary concentration; chemistry.challenge testing; follicle stimulating hormone; fsh; ghr; gnrh; horm; lhrh; luliberin; luteinizing hormone releasing hormone; lutropin release factor; p dose; p gnrh; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
57105-9,lutropin [units/volume] in serum or plasma --30 minutes post dose gonadotropin releasing hormone,lh 30m p gnrh serpl-acnc,lutropin 30 min post dose gonadotropin releasing hormone qn,30m p gnrh; after; arbitrary concentration; chemistry.challenge testing; endocrine; endocrinology; ghr; gnrh; horm; icsh; interstitial cell-stimulating hormone; interstitual cell stimulating hormone; leutinizing hormone; lh; lhrh; luliberin; luteinizing hormone; luteinizing hormone releasing hormone; lutenin; lutenizing hormone; lutropin release factor; ovulation test; p dose; p gnrh; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
57107-5,lutropin [units/volume] in serum or plasma --10 minutes pre dose gonadotropin releasing hormone,lh 10m pre gnrh serpl-acnc,lutropin 10 min pre dose gonadotropin releasing hormone qn,10m pre gnrh; arbitrary concentration; before; chemistry.challenge testing; endocrine; endocrinology; ghr; gnrh; horm; icsh; interstitial cell-stimulating hormone; interstitual cell stimulating hormone; leutinizing hormone; lh; lhrh; luliberin; luteinizing hormone; luteinizing hormone releasing hormone; lutenin; lutenizing hormone; lutropin release factor; ovulation test; pl; plasma; plsm; point in time; pre gnrh; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
57117-4,macular grid.outer temporal subfield thickness by oct,macular grid.ots thickness oct,,eye; eye.oct; eyeball; length; macular grid.ots thickness; occular; oculis; ophthalmologic; ophthalmology; ophtho; ophthy; optic globe; optical coherence tomography; point in time; qnt; quan; quant; quantitative; random; thick; vision; visual,Qn
57124-0,care capacity # [estimate],,,cnt; count; estimation; number; nursing management minimum data set; point in time; qnt; quan; quant; quantitative; random; survey; survey.nmmds,Qn
57125-7,care provided #,,,cnt; count; number; nursing management minimum data set; point in time; qnt; quan; quant; quantitative; random; survey; survey.nmmds,Qn
57127-3,method of care delivery [nmmds],,,meth; nominal; nursing management minimum data set; point in time; random; survey; survey.nmmds; typ,Nom
5713-3,platinum [mass/mass] in hair,platinum hair-mcnt,platinum (hair) [mass/mass],drug/toxicology; drugs; har; mass content; point in time; pt; qnt; quan; quant; quantitative; random,Qn
57134-9,dentistry referral note,dentistry referral note,,dentist; doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; notes; point in time; random; visit note,Doc
57137-2,endocrinology referral note,endocrinology referral note,,doc.ont; document; encounter; endocrine; endocrinology; evaluation and management; evaluation and management note; finding; findings; notes; point in time; random; visit note,Doc
57140-6,deprecated general surgery referral note,deprecated general surgery referral note,,doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; notes; point in time; random; surg; visit note,Doc
57156-2,podiatry referral note,podiatry referral note,,doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; notes; point in time; random; visit note,Doc
57175-2,orthopaedic surgery referral note,orthopaedic surgery referral note,,doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; notes; orthopedic; orthopedic surgery; point in time; random; surg; visit note,Doc
57179-4,obstetrics and gynecology referral note,obgyn referral note,,doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; gyn; gynecology; notes; ob; obgyn; obstetric; obstetrics; point in time; prenatal; random; visit note,Doc
57185-1,current number of unhealed pressure ulcers,,,no; num; outcome and assessment information set; pan; panel; panel.survey.oasis; panl; pnl; point in time; random; survey; survey.oasis,-
57201-6,date of physician-ordered start of care (resumption of care) during assessment period [cms assessment],,,centers for medicare and medicaid assessment; qnt; quan; quant; quantitative; report period; started; survey,Qn
57202-4,date of referral,,,point in time; qnt; quan; quant; quantitative; random; survey,Qn
5720-8,rubidium [mass/volume] in serum or plasma,rubidium serpl-mcnc,rubidium [mass/vol],drug/toxicology; drugs; level; mass concentration; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; rb; serp; serpl; serplas; serum; serum or plasma; sr,Qn
57214-9,patient lives in congregated situtation during assessment period [cms assessment],,,centers for medicare and medicaid assessment; finding; findings; nominal; report period; survey,Nom
57237-0,exertion level causing shortness of breath during assessment period [cms assessment],,,centers for medicare and medicaid assessment; finding; findings; levels; levl; lv; lvl; ordinal; ql; qual; qualitative; report period; screen; survey,Ord
57242-0,standardized depression screening was conducted during assessment period [cms assessment],,,asympt; asymptomatic; centers for medicare and medicaid assessment; finding; findings; nominal; pan; panel; panel.survey.cms; panl; pnl; report period; scn; survey,Nom
57245-3,toileting hygiene - functional ability during assessment period [cms assessment],,,centers for medicare and medicaid assessment; finding; findings; ordinal; ql; qual; qualitative; report period; screen; survey,Ord
57262-8,non-agency caregiver ability and willingness to assist with medication administration during assessment period [cms assessment],,,centers for medicare and medicaid assessment; finding; findings; ordinal; ql; qual; qualitative; report period; screen; survey,Ord
57268-5,therapy need during assessment period [cms assessment],,,centers for medicare and medicaid assessment; cnt; count; number; qnt; quan; quant; quantitative; report period; survey,Qn
572-8,fungus identified in bone marrow by culture,fungus mar cult,fungus identified cx nom (bm),bm; bon; bone marrow; c&s; cult; cultures; fung; fungal; fungi; id; identity or presence; infectious disease; infectiousdisease; mar; marrow (bone); microbiology; minimal angle of resolution; minimum angle of resolution; nominal; point in time; random,Nom
5728-1,silicon [mass/volume] in blood,silicon bld-mcnc,silicon (bld) [mass/vol],blood; drug/toxicology; drugs; level; mass concentration; point in time; qnt; quan; quant; quantitative; random; si; wb; whole blood,Qn
57281-8,medication follow-up during assessment period [cms assessment],,,centers for medicare and medicaid assessment; finding; findings; ordinal; ql; qual; qualitative; report period; screen; survey,Ord
57291-7,hla-b [type] by high resolution,hla-b high res,hla-b high resolution nom (bld/tiss),"blood; genetics; heredity; heritable; hla antigen; human leukocyte antigen; inherited; nominal; point in time; random; tissue; tissue, unspecified; typ; wb; whole blood; whole blood or tissue",Nom
57293-3,hla-drb1 [type] by high resolution,hla-drb1 high res,hla-drb1 high resolution nom (bld/tiss),"blood; genetics; heredity; heritable; hla antigen; human leukocyte antigen; inherited; nominal; point in time; random; tissue; tissue, unspecified; typ; wb; whole blood; whole blood or tissue",Nom
57297-4,hla-cw [type] by high resolution,hla-cw high res,hla-cw high resolution nom (bld/tiss),"blood; continuous wave; genetics; heredity; heritable; hla antigen; hla-cw; human leukocyte antigen; inherited; nominal; point in time; random; tissue; tissue, unspecified; typ; wb; whole blood; whole blood or tissue",Nom
57305-5,tropomyosin ige ab [mass/volume] in serum,tropomyosin ige-mcnc,tropomyosin ige (s) [mass/vol],abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; immune globulin e; immunoglobulin e; level; mass concentration; point in time; qnt; quan; quant; quantitative; random; serum; sr; tm,Qn
57313-9,pyrazole ige ab [units/volume] in serum,pyrazole ige qn,pyrazole ige qn (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; immune globulin e; immunoglobulin e; point in time; qnt; quan; quant; quantitative; random; serum; sr,Qn
57344-4,creatinine [mass/volume] in 2 hour urine,creat 2h ur-mcnc,creatinine (2h u) [mass/vol],120 min; 120 minutes; 120min; 2 hours; 2hr; chemistry; cr; crea; creat; kidney; level; mass concentration; nephrology; qnt; quan; quant; quantitative; renal; ua; ucr; ur; urn,Qn
57361-8,lactate [mass/volume] in serum or plasma --3 minutes post xxx challenge,lactate 3m p chal serpl-mcnc,lactate 3 min post unsp challenge [mass/vol],2-hydroxypropanoic acid; 2-hydroxy-propionate; 2-hydroxy-propionic acid; 3m p chal; after; chemistry.challenge testing; lact; lactic acid; level; l-lactate; mass concentration; p chal; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
57365-9,lactate [mass/volume] in serum or plasma --1.5 hours post xxx challenge,lactate 1.5h p chal serpl-mcnc,lactate 1.5 hr post unsp challenge [mass/vol],1 1/2 hours; 1 1/2 hr; 1.5h p chal; 1.5hr; 2-hydroxypropanoic acid; 2-hydroxy-propionate; 2-hydroxy-propionic acid; 90 min; 90 minutes; 90m; 90min; after; chemistry.challenge testing; lact; lactic acid; level; l-lactate; mass concentration; p chal; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
57390-7,volume [flow] of 12 hour urine,specimen vol 12h ur-vrate,specimen volume (12h u) [vol/time],12 hours; 12hr; flow; qnt; quan; quant; quantitative; spec; ua; ur; urn; vol; volume rate; vrate,Qn
57394-9,cd19+cd34+ cells/cells in body fluid,cd19+cd34+ cells nfr fld,cd19+cd34+ cells/cells (body fld),"b cells expressing cd19 as a percent of total lymphocytes; b/f; b4; b-4; bf; bod; bodies; body fluid; body fluid, unsp; cd19 cells; cd19+cd34+ cells; cell; cell markers; cellularity; fl; fld; flu; fluid; gp105-120; hd-37; hematopoietic stem cell; hsc; leu12; leu-12; my10; my-10; number fraction; percent; point in time; qnt; quan; quant; quantitative; random; stem cells",Qn
57402-0,cd42a cells/cells in body fluid,cd42a cells nfr fld,cd42a cells/cells (body fld),"b/f; bf; bod; bodies; body fluid; body fluid, unsp; cd42a cells; cell; cell markers; cellularity; fl; fld; flu; fluid; gpix; number fraction; percent; point in time; qnt; quan; quant; quantitative; random",Qn
57436-8,muscle specific receptor tyrosine kinase ab [units/volume] in serum by immunoassay,musk ab ser ia-acnc,muscle specific receptor tyrosine kinase ab ia qn (s),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; eia; elfa; elisa; enzyme immunoassay; iaa; meia; musc; muscl; musk; point in time; qnt; quan; quant; quantitative; random; rec; recept; receptors; recp; recptr; serology; serum; spec; sr; suds; tyr,Qn
57439-2,terminal deoxyribonucleotidyl transferase cells [presence] in body fluid,tdt cells fld ql,terminal deoxyribonucleotidyl transferase cells ql (body fld),"b/f; bf; bod; bodies; body fluid; body fluid, unsp; cell; cell markers; cellularity; fl; fld; flu; fluid; ordinal; point in time; pr; ql; qual; qualitative; random; screen; tdt; tdt cells",Ord
57443-4,spermatozoa progressive grade 3/spermatozoa in semen --post concentration,sperm prog 3 p conc nfr smn,spermatozoa progressive grade 3/spermatozoa post concentration (sem),after; ejaculate; fertility testing; genitourinary; gu; iii; number fraction; p conc; percent; point in time; post washing; pst; qnt; quan; quant; quantitative; random; sem; seminal fluid; smn; smpls; sperm; sperm prog; sperm prog 3; uro; urology,Qn
5744-8,thallium [mass/volume] in serum or plasma,thallium serpl-mcnc,thallium [mass/vol],drug/toxicology; drugs; level; mass concentration; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; tl,Qn
57448-3,nuclear ab pattern [interpretation] in synovial fluid by immunofluorescence,ana pat snv if-imp,nuclear ab pattern if (syn fld) [interp],abs; aby; acif; ana; ana pat; anf; antby; anti; antibodies; antibody; anticomplement immunofluorescence; antinuclear antibody; autoantibodies; autoantibody; fa; fana; fluorescent antibody; fluoresent; ifa; immune fluorescence; immunoflour; immunofluor; immunofluorescence; impression; impression/interpretation of study; impressions; interp; interpretation; joint aspirate; joint fld; joint flu; joint fluid; na; nominal; nuc; point in time; random; serology; sf; snv; syn; syn fl; synov; synovial fluid; time resolved fluorescence; trf,Nom
57467-3,calcitriol [mass/volume] in serum or plasma --pre dose calcium,"1,25(oh)2d3 pre ca serpl-mcnc","1,25-dihydroxyvitamin d3 pre dose calcium [mass/vol]","1,25(oh)2d3; 1,25-calcitriol; 1,25-dihydroxycholecalciferol; 1,25-dihydroxyvitamin d; 1,25-dihydroxyvitamin d3; before; ca; cal; chemistry.challenge testing; level; mass concentration; pl; plasma; plsm; point in time; pre ca; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr",Qn
57470-7,calcitriol [mass/volume] in serum or plasma --2 hours post dose calcium,"1,25(oh)2d3 2h p ca serpl-mcnc","1,25-dihydroxyvitamin d3 2 hr post dose calcium [mass/vol]","1,25(oh)2d3; 1,25-calcitriol; 1,25-dihydroxycholecalciferol; 1,25-dihydroxyvitamin d; 1,25-dihydroxyvitamin d3; 120 min; 120 minutes; 120min; 2 hours; 2h p ca; after; ca; cal; chemistry.challenge testing; level; mass concentration; p dose; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr",Qn
57478-0,11-ketoandrosterone [mass/time] in 24 hour urine --2 days post high dose dexamethasone,11ketoandros 2d p high dex 24h ur-mrate,11-ketoandrosterone 2 days post high dose dexamethasone (24h u) [mass/time],1 day; 11ketoandros; 24 hours; 24hr; 2d p high dex; after; c350; chemistry.challenge testing; decadron; dexameth; dexone; hexadrol; hi dose; ketoandrost; mass rate; mrate; p high dex; pst; qnt; quan; quant; quantitative; ua; ur; urn,Qn
57524-1,17-ketogenic steroids [mass/volume] in 24 hour urine --pre dose dexamethasone,17kgs pre dex 24h ur-mcnc,17-ketogenic steroids pre dose dexamethasone (24h u) [mass/vol],1 day; 17kgs; 17-kgs; 24 hours; 24hr; before; c350; chemistry.challenge testing; decadron; dexameth; dexone; hexadrol; ketogen; ketogenc; ketognc; level; mass concentration; pre dex; qnt; quan; quant; quantitative; ste; steriods; steroid; ua; ur; urn,Qn
57533-2,17-hydroxyprogesterone [mass/volume] in serum or plasma --10th specimen post xxx challenge,17ohp sp10 p chal serpl-mcnc,17-hydroxyprogesterone 10th specimen post unsp challenge [mass/vol],"17-alpha-hydroxyprogesterone; 17-hydroxypregn-4-en-3,20-dione; 17-hydroxy-progest; 17-oh progesterone; 17ohp; 17-ohp; 17-p; after; chemistry.challenge testing; endocrine; endocrinology; genetics; heredity; heritable; hydroxyproges; hydroxyprogstron; inherited; level; mass concentration; p chal; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sp10; sp10 p chal; spec; sr",Qn
57541-5,17-hydroxyprogesterone [mass/volume] in serum or plasma --4th specimen post dose gonadotropin releasing hormone,17ohp sp4 p gnrh serpl-mcnc,17-hydroxyprogesterone 4th specimen post dose gonadotropin releasing hormone [mass/vol],"17-alpha-hydroxyprogesterone; 17-hydroxypregn-4-en-3,20-dione; 17-hydroxy-progest; 17-oh progesterone; 17ohp; 17-ohp; 17-p; after; chemistry.challenge testing; endocrine; endocrinology; genetics; ghr; gnrh; heredity; heritable; horm; hydroxyproges; hydroxyprogstron; inherited; level; lhrh; luliberin; luteinizing hormone releasing hormone; lutropin release factor; mass concentration; p dose; p gnrh; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sp4; sp4 p gnrh; spec; sr",Qn
57546-4,17-hydroxyprogesterone [moles/volume] in serum or plasma --pre dose dexamethasone,17ohp pre dex serpl-scnc,17-hydroxyprogesterone pre dose dexamethasone [moles/vol],"17-alpha-hydroxyprogesterone; 17-hydroxypregn-4-en-3,20-dione; 17-hydroxy-progest; 17-oh progesterone; 17ohp; 17-ohp; 17-p; before; c350; chemistry.challenge testing; decadron; dexameth; dexone; endocrine; endocrinology; genetics; heredity; heritable; hexadrol; hydroxyproges; hydroxyprogstron; inherited; level; pl; plasma; plsm; point in time; pre dex; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; substance concentration",Qn
5756-2,vanadium [mass/volume] in serum or plasma,vanadium serpl-mcnc,vanadium [mass/vol],drug/toxicology; drugs; level; mass concentration; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; v,Qn
57579-5,aldosterone [mass/volume] in serum or plasma --post 25 mg captopril po,aldost p 25 mg cpl po serpl-mcnc,aldosterone post 25 mg captopril po [mass/vol],after; c246; chemistry.challenge testing; endocrine; endocrinology; level; mass concentration; p 25 mg cpl po; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
57582-9,aldosterone [mass/volume] in serum or plasma --pre 25 mg captopril po,aldost pre 25 mg cpl po serpl-mcnc,aldosterone pre 25 mg captopril po [mass/vol],before; c246; chemistry.challenge testing; endocrine; endocrinology; level; mass concentration; pl; plasma; plsm; point in time; pre 25 mg cpl po; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
57601-7,6-alpha hydroxytetrahydro-11-deoxycortisol [mass/volume] in 24 hour urine --pre dose dexamethasone,6a-oh-ths pre dex 24h ur-mcnc,6-alpha hydroxytetrahydro-11-deoxycortisol pre dose dexamethasone (24h u) [mass/vol],1 day; 11dc; 24 hours; 24hr; 6a-oh-ths; alfa; before; c350; chemistry.challenge testing; compound s; cortexolone; cortodoxone; decadron; deoxycortisol; desoxycortisol; dexameth; dexone; hexadrol; level; mass concentration; metopirone; pre dex; qnt; quan; quant; quantitative; ua; ur; urn,Qn
57615-7,5-alpha tetrahydrocortisol [mass/volume] in 24 hour urine --2 days post high dose dexamethasone,5-a thf 2d p high dex 24h ur-mcnc,5-alpha tetrahydrocortisol 2 days post high dose dexamethasone (24h u) [mass/vol],1 day; 24 hours; 24hr; 2d p high dex; 5-a thf; 5a-tetrahydrocortisol; after; alfa; c350; chemistry.challenge testing; cortisol metabolite; decadron; dexameth; dexone; hexadrol; hi dose; level; mass concentration; p high dex; pst; qnt; quan; quant; quantitative; thc; thf; ua; ur; urn,Qn
57624-9,alpha cortol [mass/time] in 24 hour urine --2 days post high dose dexamethasone,a-cortol 2d p high dex 24h ur-mrate,alpha cortol 2 days post high dose dexamethasone (24h u) [mass/time],1 day; 24 hours; 24hr; 2d p high dex; a-cortol; after; alfa; c350; chemistry.challenge testing; decadron; dexameth; dexone; hexadrol; hi dose; mass rate; mrate; p high dex; pst; qnt; quan; quant; quantitative; ua; ur; urn,Qn
57632-2,alpha cortolone [mass/time] in 24 hour urine --2 days post high dose dexamethasone,a-cortolone 2d p high dex 24h ur-mrate,alpha cortolone 2 days post high dose dexamethasone (24h u) [mass/time],1 day; 24 hours; 24hr; 2d p high dex; a-cortolone; after; alfa; c350; chemistry.challenge testing; cortisol metabolite; decadron; dexameth; dexone; hexadrol; hi dose; mass rate; mrate; p high dex; pst; qnt; quan; quant; quantitative; ua; ur; urn,Qn
5763-8,zinc [mass/volume] in serum or plasma,zinc serpl-mcnc,zinc [mass/vol],drug/toxicology; drugs; level; mass concentration; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; universallaborders; zn,Qn
57654-6,tidal volume.inspired maximum setting ventilator alarm,vt.inspired max setting vent alarm,,largest; lung; maximal; maximum; peak; point in time; pulmonary; pulmonology; qnt; quan; quant; quantitative; random; respiratory; tv; vent alarm; vol; volume; vt; vt.inspired; vt.inspired max setting,Qn
57660-3,ganglioside gq1b igg ab [units/volume] in serum by immunoassay,gq1b gangl igg ser ia-acnc,ganglioside gq1b igg ia qn (s),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; eia; elfa; elisa; enzyme immunoassay; gq1b; gq1b gangl; iaa; immune globulin g; immunoglobulin g; meia; point in time; qnt; quan; quant; quantitative; random; serology; serum; sr; suds; tetrasialylganglioside,Qn
57661-1,tubular basement membrane ab [titer] in serum by immunofluorescence,tbm ab titr ser if,tubular basement membrane ab if (s) [titer],abs; aby; acif; antby; anti; antibodies; antibody; anticomplement immunofluorescence; autoantibodies; autoantibody; basem; basemt; bm; dilution factor; dilution factor (titer); fa; fluorescent antibody; fluoresent; ifa; immune fluorescence; immunoflour; immunofluor; immunofluorescence; point in time; random; serology; serum; smqn; sr; tbm; time resolved fluorescence; titer; titered; titre; trf; ttr,SemiQn
57683-5,plasmodium falciparum igm ab [presence] in serum by immunoassay,p falciparum igm ser ql ia,p. falciparum igm ia ql (s),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; eia; elfa; elisa; enzyme immunoassay; iaa; id; immune globulin m; immunoglobulin m; infectious disease; infectiousdisease; malaria; malarial; meia; microbiology; ordinal; p falciparum; point in time; pr; ql; qual; qualitative; random; screen; serum; sr; suds,Ord
57687-6,cortisol [mass/volume] in saliva (oral fluid) --1st specimen,cortis sp1 sal-mcnc,cortisol spec 1 (sal) [mass/vol],17-hydroxycorticosterone; acute specimen; chemistry; compound f; coritsol; cort; f; first; hydrocortisone; level; mass concentration; oral fluid; point in time; pre immunization; qnt; quan; quant; quantitative; random; sal; sp1; spec,Qn
57693-4,cortisol [mass/volume] in saliva (oral fluid) --6th specimen,cortis sp6 sal-mcnc,cortisol 6th specimen (sal) [mass/vol],17-hydroxycorticosterone; chemistry; compound f; coritsol; cort; f; hydrocortisone; level; mass concentration; oral fluid; point in time; qnt; quan; quant; quantitative; random; sal; sp6; spec,Qn
57695-9,cortisol [mass/volume] in saliva (oral fluid) --8th specimen,cortis sp8 sal-mcnc,cortisol 8th specimen (sal) [mass/vol],17-hydroxycorticosterone; chemistry; compound f; coritsol; cort; f; hydrocortisone; level; mass concentration; oral fluid; point in time; qnt; quan; quant; quantitative; random; sal; sp8; spec,Qn
57710-6,amino acidemias newborn screening comment-discussion,amino acidemias nbs comment,amino acidemias newborn screening comment-discussion nar (dbs),aa; aa nbs comment; asympt; asymptomatic; blood; chemistry; cmmt; cmnt; com; comm; comments; commt; dbs; dried blood spot; filter paper; fp; narrative; nbs comment; new born; point in time; random; remarks; report; scn; text; urea cyle; wb; whole blood,Nar
5771-1,bilirubin crystals [presence] in urine sediment by light microscopy,bilirub cry urns ql micro,bilirubin crystals lm ql (urine sed),bili; bilirub cry; bilirubins; billirubin; crys; cryst; crystal; kidney; lm; micro; micros; microscopic; nephrology; ordinal; point in time; pr; ql; qual; qualitative; random; renal; screen; tbil; ua; ur; urinalysis; urine sediment; urn; urns,Ord
57717-1,newborn screen card data panel,nbs card data pnl,nbs card data panel (dbs),blood; chemistry; dbs; dried blood spot; filter paper; fp; gyn; gynecology; nbs card data pnl; new born; ob; obgyn; obstetrics; pan; panel.chemistry; panl; pnl; point in time; random; scn; scr; scrn; wb; whole blood,-
57725-4,corticotropin [mass/volume] in plasma --20 minutes post xxx challenge,acth 20m p chal plas-mcnc,corticotropin 20 min post unsp challenge (p) [mass/vol],20m p chal; acth; adrenocorticotrophic hormone; adrenocorticotropin; after; c206; c74; chemistry.challenge testing; cortrosyn; level; mass concentration; p chal; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; rc206; tumor marker,Qn
57734-6,ketones [presence] in urine by automated test strip,ketones ur ql strip.auto,ketones auto test strip ql (u),acetest; acetoacetate; acetoacetates; acetone bodies; auto; automated detection; dip stick; dipstick; elec; elect; electr; ketone; ketone bodies; ordinal; point in time; pr; ql; qual; qualitative; random; screen; ua; ur; urinalysis; urn,Ord
57736-1,cd154 cells/cells in body fluid,cd154 cells nfr fld,cd154 cells/cells (body fld),"b/f; bf; bod; bodies; body fluid; body fluid, unsp; cd154 cells; cd40 ligand; cd40l; cell; cell markers; cellularity; fl; fld; flu; fluid; gp39; number fraction; percent; point in time; qnt; quan; quant; quantitative; random; t-bam; trap; tumor necrosis factor related activation protein; x-linked hyper igm",Qn
57751-0,hemoglobin [presence] in urine by automated test strip,hgb ur ql strip.auto,hemoglobin auto test strip ql (u),auto; automated detection; blood; dip stick; dipstick; elec; elect; electr; haemoglobin; hb; hgb; ordinal; point in time; pr; ql; qual; qualitative; random; screen; ua; ur; urinalysis; urn,Ord
57758-5,tnfrsf13b gene mutations found [identifier] in blood or tissue by molecular genetics method nominal,tnfrsf13b gene mut anl bld/t,tnfrsf13b gene targeted mutation analysis molgen nom (bld/tiss),"baff; blood; blys; cd267; cvid; cvid2; genetics; heredity; heritable; identity or presence; igad2; inherited; molecular genetics; molecular pathology; molpath; molpath.mutations; mut; mut anl; mutations; nominal; pcr; point in time; random; ryzn; taci; tall1; thank; tissue; tissue, unspecified; tnfrsf14b; tnfsf20; tumor necrosis factor (ligand) superfamily, member 13b; tumor necrosis factor receptor superfamily, member 13b; wb; whole blood; whole blood or tissue; ztnf4",Nom
57764-3,microscopic exam [interpretation] of bone marrow by cytology,microscopic mar-imp,microscopic exam cytology (bm) [interp],bm; bon; bone marrow; impression; impression/interpretation of study; impressions; interp; interpretation; mar; marrow (bone); micro; minimal angle of resolution; minimum angle of resolution; nominal; point in time; random,Nom
57768-4,campylobacter jejuni+campylobacter coli ag [presence] in stool,c jejuni+c coli ag stl ql,c. jejuni+c. coli ag ql (stl),antigen; antigens; bowel movement; c coli; c jejuni; c jejuni+c coli; campy; faecal; faeces; fecal; feces; id; infectious disease; infectiousdisease; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; screen; stl; stool = fecal,Ord
57771-8,paraneoplastic ab [interpretation] in serum narrative,paraneoplastic ab ser-imp,paraneoplastic ab nar (s) [interp],abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; impression; impression/interpretation of study; impressions; interp; interpretation; narrative; point in time; random; report; serology; serum; sr,Nar
57772-6,metanephrine.free and normetanephrine.free panel [moles/volume] - serum or plasma,metaneph+normetaneph free pnl serpl-scnc,metanephrine.free and normetanephrine.free panel [moles/vol],chemistry; fr; level; metaneph; metaneph free; metaneph+normetaneph free pnl; metanephrne; metenephrine; non-protein bound; normeta; normetaneph; normetaneph free; normetanephrn; pan; panel.chemistry; panl; pl; plasma; plsm; pnl; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; substance concentration; unconjugated metanephrine; unconjugated normetanephrine,Qn
57779-1,disaccharidases [interpretation] in small intestine tissue narrative,disaccharidases tsmi-imp,disaccharidases nar (small intestine tissue) [interp],chemistry; impression; impression/interpretation of study; impressions; interp; interpretation; narrative; point in time; random; report; tissue small intestine,Nar
57788-2,dehydroepiandrosterone (dhea) [mass/time] in 24 hour urine --pre dose dexamethasone,dhea pre dex 24h ur-mrate,dhea pre dose dexamethasone (24h u) [mass/time],1 day; 24 hours; 24hr; before; c350; chemistry.challenge testing; decadron; dexameth; dexone; dhea; hexadrol; mass rate; mrate; prasterone; pre dex; qnt; quan; quant; quantitative; ua; ur; urn,Qn
57806-2,hedis 2010-2013 tests used in early prenatal care - rubella (ppc-c),hedis 2010-13 ppc-c rubv,hedis 2010-2013 tests used in early prenatal care - rubella (ppc-c),hedis 2010-13 ppc-c rubv; pan; panel; panel.hedis; panl; pnl; point in time; random,-
57812-0,hedis 2010 codes to identify physiologic monitoring tests (mpm-a),hedis 2010 mpm-a,hedis 2010 codes to identify physiologic monitoring tests (mpm-a),hedis 2010 mpm-a; pan; panel; panel.hedis; panl; pnl; point in time; random,-
57818-7,hedis 2010 codes to identify sexually active women (chl-b),hedis 2010 chl-b,hedis 2010 codes to identify sexually active women (chl-b),hedis 2010 chl-b; pan; panel; panel.hedis; panl; pnl; point in time; random,-
57840-1,eosinophils/leukocytes in dialysis fluid by manual count,eosinophil nfr dial fld manual,eosinophils/leukocytes manual cnt (dial fld),diaf; dialysate; dialysis fluid; eos; eosin; eosino; eosinophil; eosins; hematology/cell counts; leuc; leuk; leukocyte; lkcs; manl; number fraction; percent; point in time; qnt; quan; quant; quantitative; random; wbc; wbcs; white blood cell; white blood cells,Qn
57841-9,erythrocytes [#/volume] in dialysis fluid by automated count,rbc # dial fld auto,rbc auto (dial fld) [#/vol],#; abs; absolute; absolutes; auto; automated detection; cnt; count; count/volume; ct; diaf; dialysate; dialysis fluid; discocytes; elec; elect; electr; erthrocyte; erythrocyte; hematology/cell counts; number concentration; number concentration (count/vol); point in time; qnt; quan; quant; quantitative; random; rbc; rbcs; red blood cell; red blood cells; red blood corpuscle; red blood corpusles; red cell; red cells,Qn
578-5,fungus identified in tissue by culture,fungus tiss cult,fungus identified cx nom (tiss),"c&s; cult; cultures; fung; fungal; fungi; id; identity or presence; infectious disease; infectiousdisease; microbiology; nominal; point in time; random; tissue; tissue, unspecified",Nom
57877-3,deprecated cantaloupe igg ab rast class [presence] in serum,deprecated cantaloupe igg rast ql,cantaloupe igg rast class (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; cantalope; cantaloup; cantaloupe; f102; igg rast; immune globulin g; immunoglobulin g; musk melon; muskmelon; ordinal; point in time; pr; ql; qual; qualitative; random; rock melon; screen; serum; sr,Ord
57900-3,age of specimen,age of specimen,specimen age (specimen),misc; miscellaneous; other; point in time; qnt; quan; quant; quantitative; random; spec; to be specified in another part of the message; unspecified,Qn
5790-1,fungi.filamentous [#/area] in urine sediment by microscopy high power field,filament fungi #/area urns hpf,fungi.filamentous lm.hpf (urine sed) [#/area],#/area; filament; filament fungi; fungal hyphae; id; infectious disease; infectiousdisease; kidney; lm; micro; micros; microscopic; nephrology; number areic; point in time; qnt; quan; quant; quantitative; random; renal; ua; ur; urinalysis; urine sediment; urn; urns,Qn
57904-5,bg sup(a) ag [presence] on red blood cells,bg sup(a) ag rbc ql,bg sup(a) ag ql (rbc),antigen; antigens; bg sup(a); blood bank; erythrocytes; hematology; heme; ordinal; point in time; pr; ql; qual; qualitative; random; red blood cells; red blood corpusles; screen,Ord
57905-2,hemoglobin.gastrointestinal.lower [presence] in stool by immunoassay --1st specimen,hemoccult sp1 stl ql ia,lower gi hemoglobin spec 1 ia ql (stl),acute specimen; bowel movement; chemistry; eia; elfa; elisa; enzyme immunoassay; faecal; faeces; fecal; fecal occult blood; feces; first; fit; fob; fobt; gastrocult; gastrointest blood; gi; guiac; haemoglobin; hb; hemoccult; hemocult; hgb; iaa; ifobt; low; meia; occult blood; occult blood in stool; ordinal; point in time; pr; pre immunization; ql; qual; qualitative; random; screen; sp1; spec; stl; stool = fecal; suds,Ord
57916-9,borrelia burgdorferi c6 ab [presence] in serum,b burgdor c6 ab ser ql,b. burgdorferi c6 ab ql (s),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; b burg; b burgdor; b burgdor c6; b burgdorferi; bb; burgdorf; c6 lyme peptide; id; infectious disease; infectiousdisease; lyme; lyme disease; lymes; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; sr,Ord
57918-5,cacna1s+scn4a gene mutations found [identifier] in blood or tissue by molecular genetics method nominal,cacna1s+scn4a gene mut anl bld/t,cacna1s+scn4a gene targeted mutation analysis molgen nom (bld/tiss),"blood; genetics; heredity; heritable; hokpp2; hykpp; hypp; identity or presence; inherited; molecular genetics; molecular pathology; molpath; molpath.mutations; mut; mut anl; mutations; na(v)1.4; nac1a; nav1.4; nominal; pcr; point in time; random; skm1; sodium channel, voltage gated, type iv alpha subunit; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",Nom
57919-3,calcium [mass/volume] in nonbiological fluid,calcium fld.nb-mcnc,calcium (nonbiological fluid) [mass/vol],ca; cal; chemistry; fld.nb; level; mass concentration; point in time; qnt; quan; quant; quantitative; random,Qn
57922-7,"carbon dioxide, total [moles/volume] in serum or plasma by calculation",co2 serpl calc-scnc,co2 calc [moles/vol],calc; calculation; carbonic anhydride; cco2; chemistry; co2; co2 total; co2ct; ctco2; level; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; substance concentration; tco2,Qn
57930-0,cftr gene p.asp1152his [presence] in blood or tissue by molecular genetics method,cftr p.d1152h bld/t ql,cftr gene p.asp1152his molgen ql (bld/tiss),"abc35; abcc7; blood; cbavd; cf; cfa; cftr p.d1152h; cftr/mrp; cystic fibrosis transmembrane conductance regulator; cystic fibrosis transmembrane conductance regulator (atp-binding cassette sub-family c, member 7); dj760c5.1; genetics; heredity; heritable; inherited; molecular genetics; molecular pathology; molpath; molpath.mutations; mrp7; ordinal; p prime; pcr; point in time; pr; ql; qual; qualitative; random; screen; tissue; tissue, unspecified; tnr-cftr; wb; whole blood; whole blood or tissue",Ord
57933-4,cheese mold type ige ab/ige total in serum,cheese mold ige/ige total %,cheese mold type ige/total ige (s) [%],%; abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; f082; f82; ige total; immune globulin e; immunoglobulin e; mould; point in time; qnt; quan; quant; quantitative; random; serum; sr; tot; total ige; totl,Qn
57936-7,cholesterol in hdl 2a [mass/volume] in serum or plasma,hdlc 2a serpl-mcnc,cholesterol in hdl 2a [mass/vol],cardio; cardiology; chemistry; chol; choles; cholest; cholesterol total; cholesterols; hdlc; hdl-c; hdlc 2a; heart disease; high density lipoprotein cholesterols; level; lipid; mass concentration; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; tchhdl,Qn
57941-7,lime ige ab/ige total in serum,lime ige/ige total %,lime ige/total ige (s) [%],%; abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; f306; ige total; immune globulin e; immunoglobulin e; lime; point in time; qnt; quan; quant; quantitative; random; rf306; serum; sr; tot; total ige; totl,Qn
57951-6,cpvt1 gene mutations found [identifier] in blood or tissue by molecular genetics method nominal,cpvt1 gene mut anl bld/t,cpvt1 gene targeted mutation analysis molgen nom (bld/tiss),"blood; genetics; heredity; heritable; identity or presence; inherited; molecular genetics; molecular pathology; molpath; molpath.mutations; mut; mut anl; mutations; nominal; pcr; point in time; random; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",Nom
57952-4,honeydew melon ige ab/ige total in serum,melon ige/ige total %,melon ige/total ige (s) [%],%; abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; f87; honey dew; honeydew; ige total; immune globulin e; immunoglobulin e; melon; melons; point in time; qnt; quan; quant; quantitative; random; serum; sr; tot; total ige; totl,Qn
57991-2,lactalbumin ige ab/ige total in serum,lactalb ige/ige total %,lactalbumin ige/total ige (s) [%],%; abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; ige total; immune globulin e; immunoglobulin e; point in time; qnt; quan; quant; quantitative; random; serum; sr; tot; total ige; totl,Qn
5801-6,deprecated magnesium ammonium phosphate crystals [presence] in urine sediment by light microscopy,deprecated map cry urns ql micro,magnesium ammonium phosphate crystals lm ql (urine sed),amm; ammon; arbitrary concentration; crys; cryst; crystal; i phos; inorganic phosphate; lm; mag; magnes; mg; micro; micros; microscopic; nh4; ordinal; phos; phosphate total; phosphorous; phosphorus; phosphrous; pi; po4; point in time; ql; qual; qualitative; random; screen; ua; ur; urinalysis; urine sediment; urn; urns,Ord
58045-6,scn4a gene mutations found [identifier] in blood or tissue by molecular genetics method nominal,scn4a gene mut anl bld/t,scn4a gene targeted mutation analysis molgen nom (bld/tiss),"blood; genetics; heredity; heritable; hokpp2; hykpp; hypp; identity or presence; inherited; molecular genetics; molecular pathology; molpath; molpath.mutations; mut; mut anl; mutations; na(v)1.4; nac1a; nav1.4; nominal; pcr; point in time; random; skm1; sodium channel, voltage gated, type iv alpha subunit; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",Nom
58053-0,ch sup(a) ag [presence] on red blood cells,ch sup(a) ag rbc ql,ch sup(a) ag ql (rbc),antigen; antigens; blood bank; c (little h)(little a); ch sup(a); ch^a; ch1; chido; erythrocytes; hematology; heme; ordinal; point in time; pr; ql; qual; qualitative; random; red blood cells; red blood corpusles; screen,Ord
58063-9,in sup (b) ab [presence] in serum or plasma,in sup (b) ab serpl ql,in sup (b) ab ql,abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; blood bank; in sup (b); in^b; ordinal; pl; plasma; plsm; point in time; pr; ql; qual; qualitative; random; screen; serp; serpl; serplas; serum; serum or plasma; sr,Ord
58065-4,jr sup(a) ab [presence] in serum or plasma,jr sup(a) ab serpl ql,jr sup(a) ab ql,abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; blood bank; jr sup(a); jr^a; ordinal; pl; plasma; plsm; point in time; pr; ql; qual; qualitative; r prime; random; right; screen; serp; serpl; serplas; serum; serum or plasma; sr,Ord
58067-0,kn sup(a) ab [presence] in serum or plasma,kn sup(a) ab serpl ql,kn sup(a) ab ql,abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; blood bank; kell blood group system; kn sup(a); kn^a; ordinal; pl; plasma; plsm; point in time; pr; ql; qual; qualitative; random; screen; serp; serpl; serplas; serum; serum or plasma; sr,Ord
58106-6,inpatient discharge facility.other specified [oasis-c],,,disch; nominal; othr; outcome and assessment information set; point in time; random; survey; survey.oasis; typ,Nom
58108-2,entry/discharge reporting during assessment period [cms assessment],,,centers for medicare and medicaid assessment; disch; entry/discharge reporting; finding; findings; nominal; report period; survey,Nom
58116-5,respiratory failure in last 7 days [mdsv3],,,finding; findings; mds version 3; ordinal; past; ql; qual; qualitative; screen; survey; survey.mds,Ord
58124-9,diabetic foot ulcers [mdsv3],,,finding; findings; lower extremity; mds version 3; ordinal; point in time; ql; qual; qualitative; random; screen; survey; survey.mds,Ord
58151-2,prior assessment brief interview for mental status (bims) summary score [mdsv3],,,bims; bims summary score; mds version 3; point in time; prior assessment bims summary score; qnt; quan; quant; quantitative; random; scale; survey; survey.mds,Qn
58158-7,delirium - addressed in care plan [mdsv3],,,finding; findings; mds version 3; ordinal; point in time; ql; qual; qualitative; random; screen; survey; survey.mds,Ord
5817-2,urate crystals [presence] in urine sediment by light microscopy,urate cry urns ql micro,urate crystals lm ql (urine sed),crys; cryst; crystal; kidney; lm; micro; micros; microscopic; nephrology; ordinal; point in time; pr; ql; qual; qualitative; random; renal; screen; ua; ur; urates; uric acid; urinalysis; urine sediment; urn; urns,Ord
58178-5,nutritional status - addressed in care plan [mdsv3],,,finding; findings; mds version 3; ordinal; point in time; ql; qual; qualitative; random; screen; survey; survey.mds,Ord
58185-0,pressure injury - care area triggered [mdsv3],,,finding; findings; mds version 3; ordinal; point in time; pressure injury; pressure ulcer; pressure ulcers; ql; qual; qualitative; random; screen; survey; survey.mds; ulcer,Ord
58193-4,return to community referral - care area triggered [mdsv3],,,finding; findings; mds version 3; ordinal; point in time; ql; qual; qualitative; random; screen; survey; survey.mds,Ord
58205-6,other error requiring modification.other specified [mdsv3],,,mds version 3; nominal; othr; point in time; random; survey; survey.mds; typ,Nom
58207-2,reasons for inactivation - event did not occur [mdsv3],,,finding; findings; mds version 3; ordinal; point in time; ql; qual; qualitative; random; screen; survey; survey.mds,Ord
58217-1,insulin during assessment period [cms assessment],,,centers for medicare and medicaid assessment; hum; humulin; ih7; insul; lente; nph; pan; panel; panel.survey.cms; panl; pnl; report period; semilente; sliding; survey; ultralente,-
58218-9,speech-language pathology and audiology services - individual minutes in the last 7 days [cms assessment],,,centers for medicare and medicaid assessment; past; path; qnt; quan; quant; quantitative; survey,Qn
58220-5,physical therapy - individual minutes in the last 7 days [cms assessment],,,centers for medicare and medicaid assessment; past; pt; qnt; quan; quant; quantitative; survey,Qn
58226-2,visual function - care area triggered [mdsv3],,,fcn; finding; findings; func; funct; mds version 3; ordinal; point in time; ql; qual; qualitative; random; screen; survey; survey.mds,Ord
58263-5,ever had angiography for claudication or peripheral arterial disease,angiography for claudication or paf,,angiography for claudication or paf; dis; diseases; dz; finding; findings; ordinal; periph; phenx; point in time; ql; qual; qualitative; random; screen,Ord
58266-8,ever diagnosed by a doctor as having an abdominal aortic aneurysm,abdominal aortic aneurysm,,abd; abdo; abdomen; arterial stenosis; finding; findings; nominal; phenx; point in time; random,Nom
58270-0,emergency room visit or hospitalized or saw doctor for atrial fibrillation,er visit/hospital/saw doctor for af,,er visit/hospital/saw doctor for af; finding; findings; ordinal; phenx; point in time; ql; qual; qualitative; random; screen,Ord
58273-4,taking any anticoagulants for treatment of atrial fibrillation,anticoagulants for treatment of af,,anticoagulants for treatment of af; finding; findings; ordinal; phenx; point in time; ql; qual; qualitative; random; screen; tx,Ord
58276-7,ever had outpatient test(s) performed for deep vein thrombosis [date and time],op test(s) for dvt,,date and time; dvt; op; op test(s) for dvt; phenx; point in time; qnt; quan; quant; quantitative; random; s prime; time stamp; timestamp; ven; venous,Qn
58282-5,ever told by doctor that you had pulmonary embolus,pe,,finding; findings; ordinal; pe; phenx; point in time; pulm; ql; qual; qualitative; random; screen,Ord
58283-3,pulmonary embolism requiring hospitalization,pe requiring hospitalization,,finding; findings; hospitalization hx; nominal; pe requiring hospitalization; phenx; point in time; pulm; random,Nom
58313-8,frequency (number in past year) of chest discomfort,freq (past year) of chest discomf,,count/time; freq (past year) of chest discomf; last; no; nrate; num; number rate; number rate = count/time; phenx; point in time; qnt; quan; quant; quantitative; random,Qn
58339-3,outpatient or day surgery procedure to unblock blocked or narrowed blood vessels of the heart,op proced to unblock heart vessels,,finding; findings; op; op proced to unblock heart vessels; ordinal; phenx; point in time; ql; qual; qualitative; random; screen; surg,Ord
5834-7,adenovirus ag [presence] in specimen by immunofluorescence,hadv ag spec ql if,adenovirus ag if ql (specimen),acif; adeno virus; anticomplement immunofluorescence; antigen; antigens; dfa; fa; fluorescent antibody; fluoresent; hadv; id; ifa; immune fluorescence; immunoflour; immunofluor; immunofluorescence; infectious disease; infectiousdisease; microbiology; misc; miscellaneous; ordinal; other; point in time; pr; ql; qual; qualitative; random; screen; spec; time resolved fluorescence; to be specified in another part of the message; trf; universallaborders; unspecified,Ord
58355-9,plasma cells immature [#/volume] in blood,imm plasma cells # bld,plasma cells immature (bld) [#/vol],#; abs; absolute; absolutes; blood; cell; cellularity; cnt; count; count/volume; ct; hematology/cell counts; imm; imm plasma cells; immat; myeloma cells; number concentration; number concentration (count/vol); plasmacyte; plasmacytes; point in time; qnt; quan; quant; quantitative; random; wb; whole blood,Qn
58357-5,amphetamine/creatinine [mass ratio] in urine,amphet/creat ur,amphetamine/creatinine (u) [mass ratio],amph; amphet; amphetam; amphetamines; ampht; cr; crea; creat; drug/toxicology; drugs; mass concentration ratio; mass ratio; mcrto; point in time; qnt; quan; quant; quantitative; random; speed; ua; ucr; ur; urn,Qn
58362-5,norbuprenorphine [presence] in urine by confirmatory method,norbuprenorphine ur ql cfm,norbuprenorphine confirm ql (u),addiction; buprenorphine metabolite; cfm; cnfr; cnfrm; conf; confirmation; confirmatory; drug/toxicology; drugs; drugs of abuse; gcms; illicit; lc/ms/ms; nbu; norbup; ordinal; point in time; potentialforabuse; pr; ql; qual; qualitative; random; screen; ua; ur; urn,Ord
58369-0,temazepam/creatinine [mass ratio] in urine,temazepam/creat ur,temazepam/creatinine (u) [mass ratio],cr; crea; creat; drug/toxicology; drugs; mass concentration ratio; mass ratio; mcrto; normison; point in time; qnt; quan; quant; quantitative; random; restoril; ua; ucr; ur; urn,Qn
58378-1,ethyl glucuronide [mass/volume] in urine by confirmatory method,ethyl glucuronide ur cfm-mcnc,ethyl glucuronide confirm (u) [mass/vol],cfm; cnfr; cnfrm; conf; confirmation; confirmatory; drug/toxicology; drugs; etg; ethanol metabolite; gcms; gluc; glucouronide; lc/ms/ms; level; mass concentration; point in time; qnt; quan; quant; quantitative; random; ua; ur; urn,Qn
58379-9,fentanyl+norfentanyl [presence] in urine by screen method,fentanyl+norfentanyl ur ql scn,fentanyl+norfentanyl screen ql (u),actiq; drug/toxicology; drugs; duragesic; durogesic; fenpat; fentanil; fentanyl metabolite; ordinal; point in time; pr; ql; qual; qualitative; random; scn; scr; screen; scrn; sublimaze; ua; ur; urn,Ord
58390-6,"2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine (eddp)/creatinine [mass ratio] in urine",eddp/creat ur,"2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine (eddp)/creatinine (u) [mass ratio]",cr; crea; creat; drug/toxicology; drugs; eddp; i; ii; iii; mass concentration ratio; mass ratio; mcrto; methadone metabolite; point in time; qnt; quan; quant; quantitative; random; ua; ucr; ur; urn,Qn
58397-1,phencyclidine/creatinine [mass ratio] in urine,pcp/creat ur,phencyclidine/creatinine (u) [mass ratio],angel dust; cr; crea; creat; drug/toxicology; drugs; mass concentration ratio; mass ratio; mcrto; pcp; point in time; qnt; quan; quant; quantitative; random; sernylan; ua; ucr; ur; urn,Qn
58405-2,hepatitis b virus surface ab signal/cutoff in serum,hbv surface ab s/co ser,hbv surface ab signal/cutoff (s) [rel units/vol],abs; aby; antby; anti; antibodies; antibody; anti-hbsag; autoantibodies; autoantibody; co; cut off; hbs; hbsab; hbv; hbv surface; hbv surface ab s/co; hep; hep b; hep bs; hepatis; hepatit; hepb; id; infectious disease; infectiousdisease; microbiology; point in time; qnt; quan; quant; quantitative; random; rlacnc; serum; sr; surf,Qn
58414-4,herpes simplex virus 1+2 dna [presence] in amniotic fluid by naa with probe detection,hsv1+2 dna amn ql naa+probe,hsv 1+2 dna naa+probe ql (amn fld),3 self-sustaining sequence replication; 3sr sr; af; amn; amn fl; amnio; amniotic flu; amniotic fluid; amplif; amplification; amplified; deoxyribonucleic acid; dna nucleic acid probe; dna probe; gyn; gynecology; herp splx; herpes simplex virus type 1; herpes simplex virus type 1+2; herpes simplex virus type i+ii; hsv; hsv 1+2; hsv1; hsv1+2; i; id; ii; infectious disease; infectiousdisease; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; naa+probe; naat; nasba; nucleic acid sequence based analysis; ob; obgyn; obstetrics; ordinal; pcr; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; screen; sda; strand displacement amplification; tma; transcription mediated amplification,Ord
58430-0,oxycodone+oxymorphone [presence] in urine by screen method,oxycodone+oxymorphone ur ql scn,oxycodone+oxymorphone screen ql (u),14-hydroxydihydromorphinone; addiction; drug/toxicology; drugs; drugs of abuse; illicit; lortab; numorphan; numorphone; opana; ordinal; oxycontin; percocet; percodan; point in time; potentialforabuse; pr; ql; qual; qualitative; random; scn; scr; screen; scrn; ua; ur; urn; vicodin,Ord
58435-9,microorganisms panel - urine sediment,microrganisms pnl urns,microorganisms panel (urine sed),microrganisms pnl; pan; panel.urinalysis; panl; pnl; point in time; random; ua; ur; urinalysis; urine sediment; urn; urns,-
58437-5,microorganisms seen [type] in urine sediment by light microscopy,microorganisms urns micro,microorganisms seen lm nom (urine sed),kidney; lm; micro; micros; microscopic; nephrology; nominal; point in time; random; renal; typ; ua; ur; urinalysis; urine sediment; urn; urns,Nom
58438-3,cells [type] in urine sediment by light microscopy,cells urns micro,cells lm nom (urine sed),cell; cellularity; kidney; lm; micro; micros; microscopic; nephrology; nominal; point in time; random; renal; typ; ua; ur; urinalysis; urine sediment; urn; urns,Nom
58447-4,microalbumin/creatinine panel in 24h urine,microalbumin/creat pnl 24h ur,microalbumin/creatinine ratio panel (24h u),1 day; 24 hours; 24hr; chemistry; cr; crea; creat; creat ratio pnl; kidney; microalbumin/creat pnl; nephrology; pan; panel.chemistry; panl; pnl; qnt; quan; quant; quantitative; renal; ua; ucr; universallaborders; ur; urn,Qn
58459-9,ganglioside gt1b ab [presence] in serum by immunofluorescence,gt1b ganlg ab ser ql if,ganglioside gt1b ab if ql (s),abs; aby; acif; antby; anti; antibodies; antibody; anticomplement immunofluorescence; autoantibodies; autoantibody; fa; fluorescent antibody; fluoresent; gt1b ganlg; ifa; immune fluorescence; immunoflour; immunofluor; immunofluorescence; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serology; serum; sr; time resolved fluorescence; trf; trisialoganglioside,Ord
58467-2,horse bot fly igg4 ab [mass/volume] in serum,horse bot fly igg4-mcnc,horse bot fly igg4 (s) [mass/vol],abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; horse bot fly; i201; level; mass concentration; point in time; qnt; quan; quant; quantitative; random; serum; sr,Qn
58470-6,nucleated cells [#/volume] in cerebral spinal fluid,nuc cell # csf,nucleated cells (csf) [#/vol],#; abs; absolute; absolutes; cell; cellularity; cerebral spinal fluid; cerebrospinal fl; cnt; count; count/volume; ct; hematology/cell counts; nuc; nuc cell; number concentration; number concentration (count/vol); point in time; qnt; quan; quant; quantitative; random; spinal fl; spinal fld; spinal flu; spinal fluid,Qn
58471-4,erythrocytes.pitted/erythrocytes.total in red blood cells,rbc.pitted/rbc.total nfr rbc,rbc.pitted/total rbc (rbc),discocytes; erthrocyte; erythrocyte; erythrocytes; hematology/cell counts; number fraction; percent; point in time; qnt; quan; quant; quantitative; random; rbc; rbc.pitted; rbc.total; rbcs; red blood cell; red blood cells; red blood corpuscle; red blood corpusles; red cell; red cells; tot; totl,Qn
58474-8,fda product label cosmetic,fda label cosmetic,,document.regulatory; fda label; narrative; report,Nar
58481-3,protein c ag/coagulation factor ix ag [mass ratio] in platelet poor plasma by immunoassay,prot c ag/fact ix ag ppp ia,protein c ag/coagulation factor ix ag ia (ppp) [mass ratio],antigen; antigens; antihemophilic factor b; autoprothrombin ii-a; christmas factor; coag; eia; elfa; elisa; enzyme immunoassay; fac; fact; fact ix; factor 9; fix; hematology; heme; iaa; mass concentration ratio; mass ratio; mcrto; meia; pc; plas; plasma thromboplastin component; platelet poor plasma; point in time; pr; prot; prot c; ptc; qnt; quan; quant; quantitative; random; rh; rh blood group system; suds; thrombocyte cofactor ii,Qn
58485-4,estradiol (e2) [mass/volume] in serum or plasma by high sensitivity method --baseline,estradiol bs serpl hs-mcnc,e2 baseline high sensitivity method [mass/vol],17-beta estradiol; bs; chemistry.challenge testing; e2; gyn; gynecology; hs; level; mass concentration; ob; obgyn; obstetrics; oestradiol; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
5849-5,herpes simplex virus 2 ag [presence] in specimen by immunofluorescence,hsv2 ag spec ql if,hsv 2 ag if ql (specimen),acif; anticomplement immunofluorescence; antigen; antigens; dfa; fa; fluorescent antibody; fluoresent; herp splx; herpes simplex virus type 2; herpes simplex virus type ii; hsv; hsv2; id; ifa; ii; immune fluorescence; immunoflour; immunofluor; immunofluorescence; infectious disease; infectiousdisease; microbiology; misc; miscellaneous; ordinal; other; point in time; pr; ql; qual; qualitative; random; screen; spec; time resolved fluorescence; to be specified in another part of the message; trf; unspecified,Ord
58499-5,c peptide [moles/volume] in serum or plasma --15 minutes post 1 mg glucagon iv,c peptide 15m p 1 mg gc po serpl-scnc,c peptide 15 min post 1 mg glucagon iv [moles/vol],15m p 1 mg gc po; after; chemistry.challenge testing; connecting peptide of insulin; hgf; hyperglycemic factor; i; level; pept; pl; plasma; plsm; point in time; pro-insulin c peptide; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; substance concentration,Qn
58511-7,c peptide [mass/volume] in serum or plasma --3 hours post dose glucose,c peptide 3h p glc serpl-mcnc,c peptide 3 hr post dose glucose [mass/vol],3h p glc; after; chemistry.challenge testing; connecting peptide of insulin; glu; glu tol; gluc; glucose tolerance; glucoseur; gtt; level; mass concentration; p dose; p glc; pept; pl; plasma; plsm; point in time; pro-insulin c peptide; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
58516-6,c peptide [mass/volume] in serum or plasma --4 hours post dose glucose,c peptide 4h p glc serpl-mcnc,c peptide 4 hr post dose glucose [mass/vol],4h p glc; after; chemistry.challenge testing; connecting peptide of insulin; glu; glu tol; gluc; glucose tolerance; glucoseur; gtt; level; mass concentration; p dose; p glc; pept; pl; plasma; plsm; point in time; pro-insulin c peptide; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
58538-0,corticotropin [mass/volume] in plasma --10th specimen post xxx challenge,acth sp10 p chal plas-mcnc,corticotropin 10th specimen post unsp challenge (p) [mass/vol],acth; adrenocorticotrophic hormone; adrenocorticotropin; after; c206; c74; chemistry.challenge testing; cortrosyn; level; mass concentration; p chal; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; rc206; sp10; sp10 p chal; spec; tumor marker,Qn
58559-6,corticotropin [moles/volume] in plasma --1 hour post xxx challenge,acth 1h p chal plas-scnc,corticotropin 1 hr post unsp challenge (p) [moles/vol],1 hour; 1.0hr; 1h p chal; 60 min; 60 minutes; 60m; 60min; acth; adrenocorticotrophic hormone; adrenocorticotropin; after; c206; c74; chemistry.challenge testing; cortrosyn; level; p chal; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; rc206; substance concentration; tumor marker,Qn
58562-0,corticotropin [moles/volume] in plasma --2 pm specimen,acth 2 pm plas-scnc,corticotropin 2 pm specimen (p) [moles/vol],acth; adrenocorticotrophic hormone; adrenocorticotropin; c206; c74; chemistry.challenge testing; cortrosyn; evening; ii; level; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; rc206; spec; substance concentration; tumor marker,Qn
58568-7,corticotropin [moles/volume] in plasma --2.5 hours post dose glucose,acth 2.5h p glc plas-scnc,corticotropin 2.5 hr post dose glucose (p) [moles/vol],2.5h p glc; acth; adrenocorticotrophic hormone; adrenocorticotropin; after; c206; c74; chemistry.challenge testing; cortrosyn; glu; glu tol; gluc; glucose tolerance; glucoseur; gtt; level; p dose; p glc; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; rc206; substance concentration; tumor marker,Qn
58586-9,corticotropin [moles/volume] in plasma --30 minutes post xxx challenge,acth 30m p chal plas-scnc,corticotropin 30 min post unsp challenge (p) [moles/vol],30m p chal; acth; adrenocorticotrophic hormone; adrenocorticotropin; after; c206; c74; chemistry.challenge testing; cortrosyn; level; p chal; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; rc206; substance concentration; tumor marker,Qn
58588-5,corticotropin [moles/volume] in plasma --30 minutes pre 1 ug/kg crh iv,acth 30m pre 1 ug/kg crh iv plas-scnc,corticotropin 30 min pre 1 ug/kg crh iv (p) [moles/vol],acth; adrenocorticotrophic hormone; adrenocorticotropin; before; c206; c74; chemistry.challenge testing; cortrosyn; i; level; mcg; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; rc206; substance concentration; tumor marker,Qn
58597-6,corticotropin [moles/volume] in plasma --3 hours post dose glucose,acth 3h p glc plas-scnc,corticotropin 3 hr post dose glucose (p) [moles/vol],3h p glc; acth; adrenocorticotrophic hormone; adrenocorticotropin; after; c206; c74; chemistry.challenge testing; cortrosyn; glu; glu tol; gluc; glucose tolerance; glucoseur; gtt; level; p dose; p glc; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; rc206; substance concentration; tumor marker,Qn
58627-1,corticotropin [mass/volume] in plasma --pre dose metyrapone,acth pre mtp plas-mcnc,corticotropin pre dose metyrapone (p) [mass/vol],acth; adrenocorticotrophic hormone; adrenocorticotropin; before; c206; c74; chemistry.challenge testing; cortrosyn; level; mass concentration; pl; plasma; plsm; point in time; pre mtp; qnt; quan; quant; quantitative; random; rc206; tumor marker,Qn
58634-7,cortisol [moles/volume] in serum or plasma --10 am specimen,cortis 10 am serpl-scnc,cortisol 10 am specimen [moles/vol],17-hydroxycorticosterone; chemistry.challenge testing; compound f; coritsol; cort; f; hydrocortisone; level; morning; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; spec; sr; substance concentration,Qn
58635-4,cortisol [mass/volume] in serum or plasma --10 pm specimen,cortis 10 pm serpl-mcnc,cortisol 10 pm specimen [mass/vol],17-hydroxycorticosterone; chemistry.challenge testing; compound f; coritsol; cort; evening; f; hydrocortisone; level; mass concentration; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; spec; sr,Qn
5864-4,influenza virus b ag [presence] in throat by immunoassay,flubv ag throat ql ia,flubv ag ia ql (throat),antigen; antigens; eia; elfa; elisa; enzyme immunoassay; flub; flubv; fluv; iaa; id; infectious disease; infectiousdisease; influ; influenza b; influenza b virus; meia; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; screen; suds; throat; upper respiratory,Ord
58646-1,cortisol [mass/volume] in saliva (oral fluid) --12th specimen post xxx challenge,cortis sp12 p chal sal-mcnc,cortisol 12th specimen post unsp challenge (sal) [mass/vol],17-hydroxycorticosterone; after; chemistry.challenge testing; compound f; coritsol; cort; f; hydrocortisone; level; mass concentration; oral fluid; p chal; point in time; pst; qnt; quan; quant; quantitative; random; sal; sp12; sp12 p chal; spec,Qn
58688-3,cortisol [mass/volume] in serum or plasma --11th specimen post xxx challenge,cortis sp11 p chal serpl-mcnc,cortisol 11th specimen post unsp challenge [mass/vol],17-hydroxycorticosterone; after; chemistry.challenge testing; compound f; coritsol; cort; f; hydrocortisone; level; mass concentration; p chal; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sp11; sp11 p chal; spec; sr,Qn
58690-9,cortisol [mass/volume] in serum or plasma --12th specimen post xxx challenge,cortis sp12 p chal serpl-mcnc,cortisol 12th specimen post unsp challenge [mass/vol],17-hydroxycorticosterone; after; chemistry.challenge testing; compound f; coritsol; cort; f; hydrocortisone; level; mass concentration; p chal; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sp12; sp12 p chal; spec; sr,Qn
5870-1,parainfluenza virus 2 ag [presence] in throat by immunofluorescence,hpiv2 ag throat ql if,parainfluenza virus 2 ag if ql (throat),acif; anticomplement immunofluorescence; antigen; antigens; dfa; fa; fluorescent antibody; fluoresent; hpiv; hpiv2; human rubulavirus 2; id; ifa; ii; immune fluorescence; immunoflour; immunofluor; immunofluorescence; infectious disease; infectiousdisease; microbiology; ordinal; para; parainflu; parainfluenza type 2; parainfluenza type ii; pi2; point in time; pr; ql; qual; qualitative; random; screen; throat; time resolved fluorescence; trf; upper respiratory,Ord
58709-7,gliadin peptide iga ab [units/volume] in serum,gliadin peptide iga ser-acnc,gliadin peptide iga qn (s),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; celiac disease; deamidated gliadin peptide; deaminated gliadin; dgp; f98; gastro; gastroenterology; gi; gliadine; immune globulin a; immunoglobulin a; pept; point in time; qnt; quan; quant; quantitative; random; serology; serum; sr,Qn
5873-5,parainfluenza virus 3 ag [presence] in specimen by immunofluorescence,hpiv3 ag spec ql if,parainfluenza virus 3 ag if ql (specimen),acif; anticomplement immunofluorescence; antigen; antigens; dfa; fa; fluorescent antibody; fluoresent; hpiv; hpiv3; human respirovirus 3; id; ifa; iii; immune fluorescence; immunoflour; immunofluor; immunofluorescence; infectious disease; infectiousdisease; microbiology; misc; miscellaneous; ordinal; other; para; parainflu; parainfluenza type 3; parainfluenza type iii; pi3; point in time; pr; ql; qual; qualitative; random; screen; spec; time resolved fluorescence; to be specified in another part of the message; trf; unspecified,Ord
5874-3,respiratory syncytial virus ag [presence] in throat by immunoassay,rsv ag throat ql ia,rsv ag ia ql (throat),antigen; antigens; eia; elfa; elisa; enzyme immunoassay; hrsv; iaa; id; infectious disease; infectiousdisease; lung; meia; microbiology; ordinal; point in time; pr; pulmonary; pulmonology; ql; qual; qualitative; random; respiratory; rsv; screen; suds; throat; upper respiratory,Ord
58745-1,deprecated chest>coronary arteries ct angiogram and 3d reconstruction w contrast iv,deprecated chest>ca ct.angio +3dr w cont,,+3dr; ang; angio; angiography; angm; arteriogram; c; ca; cat scan; computed tomography; computerized tomography; contr; contra; contrst; coronary aa; ct angiogram; ct angiography; ct scan; cta; document; finding; findings; heart; imaging; point in time; rad; radiology; random; thorax; w contr iv; wc,Doc
58746-9,rfa av fistula views w contrast iv,rfa avf views w contr iv,,arteriovenous fistula; avf; c; contr; contra; contrst; coreplaybook; document; films; finding; findings; fistulogram; fluor; fluoro; fluoroscopy; hemodialysis access; imaging; misc; miscellaneous; other; playbook; point in time; rad; radiology; random; rfa; spec; to be specified in another part of the message; unspecified; view; vws; w contr iv; wc,Doc
58750-1,mr heart w stress,mr hrt w stress,,cardiac; cardio; cardiology; document; exercise; finding; findings; heart disease; hrt; imaging; mitral regurgitation maximum velocity; mri; point in time; rad; radiology; random; thorax,Doc
58756-8,parvovirus b19 igm ab [units/volume] in cerebral spinal fluid by immunoassay,b19v igm csf ia-acnc,parvovirus b19 igm ia qn (csf),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; b19 virus; b19v; cerebral spinal fluid; cerebrospinal fl; eia; elfa; elisa; enzyme immunoassay; fifth disease; iaa; id; immune globulin m; immunoglobulin m; infectious disease; infectiousdisease; meia; microbiology; neuro; neurology; parvo; parvo virus; parvov; point in time; qnt; quan; quant; quantitative; random; spinal fl; spinal fld; spinal flu; spinal fluid; suds,Qn
58761-8,coxiella burnetii phase 2 igg ab [titer] in cerebral spinal fluid by immunofluorescence,c burnet ph2 igg titr csf if,c. burnetii phase 2 igg if (csf) [titer],abs; aby; acif; antby; anti; antibodies; antibody; anticomplement immunofluorescence; autoantibodies; autoantibody; c burnet; c burnet ph2; c burnetii; cerebral spinal fluid; cerebrospinal fl; coxiella burnetii phase ii; coxiella burnettii; dilution factor; dilution factor (titer); fa; fluorescent antibody; fluoresent; id; ifa; ii; immune fluorescence; immune globulin g; immunoflour; immunofluor; immunofluorescence; immunoglobulin g; infectious disease; infectiousdisease; microbiology; neuro; neurology; point in time; q fev; q fever; qfever; random; smqn; spinal fl; spinal fld; spinal flu; spinal fluid; time resolved fluorescence; titer; titered; titre; trf; ttr,SemiQn
5879-2,rotavirus ag [presence] in stool by agglutination,rv ag stl ql aggl,rotavirus ag aggl ql (stl),agg; agglut; agglutination; antigen; antigens; bowel movement; faecal; faeces; fecal; feces; id; infectious disease; infectiousdisease; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; rota virus; rotav; rotaviral; rotaviurs; rv; screen; stl; stool = fecal,Ord
58805-3,leukocytes [#/volume] in urine by automated test strip,wbc # ur strip.auto,wbc auto test strip (u) [#/vol],#; abs; absolute; absolutes; auto; automated detection; cnt; count; count/volume; ct; dip stick; dipstick; elec; elect; electr; leuc; leuk; leukocyte; lkcs; number concentration; number concentration (count/vol); point in time; random; smqn; ua; ur; urinalysis; urn; wbc; wbcs; white blood cell; white blood cells,SemiQn
58815-2,17-hydroxyprogesterone [mass/volume] in serum or plasma --2nd specimen,17ohp sp2 serpl-mcnc,17-hydroxyprogesterone spec 2 [mass/vol],"17-alpha-hydroxyprogesterone; 17-hydroxypregn-4-en-3,20-dione; 17-hydroxy-progest; 17-oh progesterone; 17ohp; 17-ohp; 17-p; chemistry.challenge testing; convalescent; endocrine; endocrinology; genetics; heredity; heritable; hydroxyproges; hydroxyprogstron; inherited; level; mass concentration; pl; plasma; plsm; point in time; post immunization; qnt; quan; quant; quantitative; random; second; serp; serpl; serplas; serum; serum or plasma; sp2; spec; sr",Qn
58829-3,cortisol [mass/volume] in serum or plasma --15th specimen,cortis sp15 serpl-mcnc,cortisol 15th specimen [mass/vol],17-hydroxycorticosterone; chemistry.challenge testing; compound f; coritsol; cort; f; hydrocortisone; level; mass concentration; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sp15; spec; sr,Qn
58836-8,thyroxine (t4) free [mass/volume] in serum or plasma --3 hours post xxx challenge,t4 free 3h p chal serpl-mcnc,free t4 3 hr post unsp challenge [mass/vol],3h p chal; after; chemistry.challenge testing; endocrine; endocrinology; fr; freet4; ft4; level; levothyroxine; levo-thyroxine; l-thyroxine; mass concentration; non-protein bound; p chal; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; t4; t-4; t4 free; thyroid hormone; thyrox; thyroxin; thyrx; total t4; tt4,Qn
58842-6,somatotropin [mass/volume] in serum or plasma --25th specimen,gh sp25 serpl-mcnc,somatotropin 25th specimen [mass/vol],chemistry.challenge testing; endocrine; endocrinology; gh; growth hormone; hgh; human growth hormone; level; mass concentration; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; somatotropic hormone; sp25; spec; sr; sth,Qn
58846-7,somatotropin [mass/volume] in serum or plasma --18th specimen,gh sp18 serpl-mcnc,somatotropin 18th specimen [mass/vol],chemistry.challenge testing; endocrine; endocrinology; gh; growth hormone; hgh; human growth hormone; level; mass concentration; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; somatotropic hormone; sp18; spec; sr; sth,Qn
58851-7,testosterone [mass/volume] in serum or plasma --3 days post xxx challenge,testost 3d p chal serpl-mcnc,testosterone 3 days post unsp challenge [mass/vol],3d p chal; after; chemistry.challenge testing; level; mass concentration; p chal; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; testo; testos; testost,Qn
58895-4,pyruvate [mass/volume] in blood --post exercise,pyruvate p exc bld-mcnc,pyruvate post exercise (bld) [mass/vol],after; blood; chemistry.challenge testing; excz; level; mass concentration; p exc; point in time; pst; pyruvic acid; qnt; quan; quant; quantitative; random; wb; whole blood,Qn
58901-0,spermatozoa progressive [#/volume] in semen,sperm prog # smn,spermatozoa progressive (sem) [#/vol],#; abs; absolute; absolutes; cnt; count; count/volume; ct; ejaculate; fertility testing; genitourinary; gu; number concentration; number concentration (count/vol); point in time; qnt; quan; quant; quantitative; random; sem; seminal fluid; smn; smpls; sperm; sperm prog; uro; urology,Qn
58911-9,chicken droppings igg ab [mass/volume] in serum,chicken drop igg-mcnc,chicken droppings igg (s) [mass/vol],abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; e218; f083; f83; feces; gallus spp; immune globulin g; immunoglobulin g; level; mass concentration; point in time; qnt; quan; quant; quantitative; random; re218; serum; sr; stool,Qn
58914-3,aspergillus niger igg ab [mass/volume] in serum,a niger igg ser-mcnc,a. niger igg (s) [mass/vol],a niger; abs; aby; antby; anti; antibodies; antibody; asperg; aspergil; aspergilis; aspergilla; aspergillin; aspergillosis; aspergils; aspergilus; autoantibodies; autoantibody; farmers lung; id; immune globulin g; immunoglobulin g; infectious disease; infectiousdisease; level; m207; mass concentration; microbiology; point in time; qnt; quan; quant; quantitative; random; serum; sr,Qn
58918-4,androstanolone [mass/volume] in serum or plasma --30 minutes post xxx challenge,androstanolone 30m p chal serpl-mcnc,androstanolone 30 min post unsp challenge [mass/vol],30m p chal; after; chemistry.challenge testing; dht; dihydrotestosterone; level; mass concentration; p chal; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
58920-0,cd4+cd45ro+ cells/cd3+cd4+ (t4 helper) cells [# ratio] in blood,cd4+cd45ro+ cells/cd3+cd4+ bld,cd4+cd45ro+ cells/cd3+cd4+ (t4 helper) cells (bld) [# ratio],blood; cd3 cells; cd3+cd4+ cells; cd3-cd4+; cd4 cells; cd4+ t cells; cd4+cd45ro+ cells; cell; cell markers; cellularity; helper t cells; inducer t cells; l3t4; leu3; leu-3; leu4; leu-4; number ratio; point in time; qnt; quan; quant; quantitative; random; t3; t4; t-4; t4 helper/inducer cells; uchl-1; w3/25; wb; whole blood,Qn
58927-5,glutamine+histidine/creatinine [ratio] in urine,glutamine+histidine/creat ur-rto,glutamine+histidine/creatinine (u) [ratio],chemistry; cr; crea; creat; formiminoglutamic acidemia; gln; his; histidinemia; point in time; qnt; quan; quant; quantitative; random; ratios; rto; ua; ucr; ur; urn,Qn
58940-8,bacteria identified in total parental nutrition by culture,bacteria tpn cult,bacteria identified cx nom (total parental nutrition),bact; c&s; cult; cultures; id; identity or presence; infectious disease; infectiousdisease; microbiology; nominal; point in time; random; total parental nutrition,Nom
58954-9,deoxypyridinoline/pyridinoline [molar ratio] in urine,dpd/pyd ur-srto,deoxypyridinoline/pyridinoline (u) [molar ratio],chemistry; dpd; dpyr; free lysly-pyridinoline; lysylpyridinoline; point in time; pyd; pyr; pyradinium collagen crosslinks; pyridinium collagen crosslinks; qnt; quan; quant; quantitative; random; scrto; substance concentration ratio; substance ratio; ua; ur; urn,Qn
58959-8,bipap andor cpap setting ventilator,bipap andor cpap setting vent,,bi-level positive airway pressure; bipap andor cpap setting; biphasic positive airway pressure; continuous positive airway pressure; finding; findings; lung; ordinal; point in time; pulmonary; pulmonology; ql; qual; qualitative; random; respiratory; screen,Ord
58980-4,ganglioside gd2 igm ab [units/volume] in serum by immunoassay,gd2 gangl igm ser ia-acnc,ganglioside gd2 igm ia qn (s),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; disialolganglioside; eia; elfa; elisa; enzyme immunoassay; gd2 gangl; iaa; immune globulin m; immunoglobulin m; meia; point in time; qnt; quan; quant; quantitative; random; serology; serum; sr; suds,Qn
5898-2,deprecated activated partial thrombplastin time (aptt) in blood by coagulation assay,deprecated aptt plas qn,aptt coag (p) [time],activated partial thromboplastin time; aptt; clot; clottable; coag; coagulation assay; hematology; heme; little(a)ptt; partial thromboplastin time; pl; plasma; plsm; point in time; ptt; qnt; quan; quant; quantitative; random; surf; tilt tube,Qn
590-0,legionella sp identified in sputum by organism specific culture,legionella spt cult,legionella sp identified org specific cx nom (sput),c&s; cult; cultures; id; identity or presence; infectious disease; infectiousdisease; legion; legionela; lower respiratory; lung; microbiology; nominal; point in time; pulmonary; pulmonology; random; respiratory; spec; species; spp; spt; sputum,Nom
59025-7,neutrophil ab [units/volume] in serum by flow cytometry (fc),neutrophil ab ser fc-acnc,neutrophil ab fc qn (s),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; dynamic; fc; granulocytic ab; hematology; heme; neut; neutr; neutrophils; pmn; pnm; point in time; qnt; quan; quant; quantitative; random; serology; serum; sr,Qn
59037-2,phosphate [mass/volume] in peritoneal dialysis fluid,phosphate diafp-mcnc,phosphate (perit dial fld) [mass/vol],chemistry; diaf; diafp; dialysate; dialysis fluid; i phos; inorganic phosphate; level; mass concentration; peritoneal dialysis fluid; phos; phosphate total; phosphorous; phosphorus; phosphrous; pi; po4; point in time; qnt; quan; quant; quantitative; random,Qn
59055-4,glucagon [mass/volume] in serum or plasma --3rd specimen fasting,glucagon sp3 p fast serpl-mcnc,glucagon 3rd specimen fasting [mass/vol],after; calorie fast; chemistry.challenge testing; fast; fasting; hgf; hyperglycemic factor; level; mass concentration; p fast; pc; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sp3; sp3 p fast; spec; sr,Qn
59059-6,inflammatory bowel disease ab 7 panel - serum,ibd ab 7 pnl ser,inflammatory bowel disease ab 7 panel (s),dis; diseases; dz; ibd; ibd ab 7; ibd ab 7 pnl; pan; panel.serology; panl; pnl; point in time; random; serology; serum; sr,-
59087-7,ventricular pre ejection time heart rate-corrected by us,hrt ventr pre eject time hr cor us,,before; card.us; cardiac; cardio; cardiology; echography; heart beat; heart disease; hr cor; hrt; hrt ventr; misc; miscellaneous; other; pep; point in time; pre eject time; pulse; qnt; quan; quant; quantitative; random; sonogram; sonograph; sonography; spec; to be specified in another part of the message; uls; ultrasound; unspecified; ventricular,Qn
59091-9,heart valve d-e excursion [length] by us,valve d-e excursion us,,card.us; cardiac; cardio; cardiology; dextro; echography; heart disease; hrt; length; misc; miscellaneous; other; point in time; qnt; quan; quant; quantitative; random; sonogram; sonograph; sonography; spec; to be specified in another part of the message; uls; ultrasound; unspecified,Qn
59116-4,aortic sinotubular junction diameter/aortic root diameter by us,diam ao stj/oa root us,,ao; aortic; card.us; cardio; cardiology; dia; diam; diam ao root; diam ao stj; echography; heart disease; length ratio; oa root; point in time; qnt; quan; quant; quantitative; random; sonogram; sonograph; sonography; uls; ultrasound,Qn
59119-8,ventricular diastolic filling period by us,hrt ventr dias fill period us,,card.us; cardiac; cardio; cardiology; dfp; dias; dias fill period; diast; diastoli; echography; heart disease; hrt; hrt ventr; misc; miscellaneous; other; point in time; qnt; quan; quant; quantitative; random; sonogram; sonograph; sonography; spec; to be specified in another part of the message; uls; ultrasound; unspecified; ventricular,Qn
59120-6,dp/dt [pressure rate] by us,dp/dt us,,card.us; cardio; cardiology; circ; circ sys; echography; heart disease; misc; miscellaneous; other; point in time; pressure rate; qnt; quan; quant; quantitative; random; sonogram; sonograph; sonography; spec; to be specified in another part of the message; uls; ultrasound; unspecified,Qn
59123-0,heart valve jet cross-section [area] by us,valve jet xsection area us,,card.us; cardiac; cardio; cardiology; echography; heart disease; hrt; jet xsection; misc; miscellaneous; other; point in time; qnt; quan; quant; quantitative; random; sonogram; sonograph; sonography; spec; to be specified in another part of the message; uls; ultrasound; unspecified; xsection,Qn
59128-9,heart valve e-f slope [velocity] by us,valve e-f slope us,,card.us; cardiac; cardio; cardiology; echography; heart disease; hrt; misc; miscellaneous; other; point in time; qnt; quan; quant; quantitative; random; sonogram; sonograph; sonography; spec; to be specified in another part of the message; uls; ultrasound; unspecified; velocity,Qn
59131-3,atrium left atrium volume/right atrium volume by us,hrt.atria la vol/ra vol us,,atrial; card.us; cardiac; cardio; cardiology; echography; heart disease; hrt; hrt.atria; l; la vol; lt; point in time; qnt; quan; quant; quantitative; r; ra vol; random; rt; sonogram; sonograph; sonography; uls; ultrasound; vol; volume ratio,Qn
59134-7,ephedrine [mass/volume] in urine by confirmatory method,ephedrin ur cfm-mcnc,ephedrine confirm (u) [mass/vol],addiction; cfm; cnfr; cnfrm; conf; confirmation; confirmatory; drug/toxicology; drugs; drugs of abuse; ectasule; gcms; illicit; lc/ms/ms; level; mass concentration; point in time; potentialforabuse; qnt; quan; quant; quantitative; random; ua; ur; urn,Qn
59139-6,cd19+cd34+ cells/cells in bone marrow,cd19+cd34+ cells nfr mar,cd19+cd34+ cells/cells (bm),b cells expressing cd19 as a percent of total lymphocytes; b4; b-4; bm; bon; bone marrow; cd19 cells; cd19+cd34+ cells; cell; cell markers; cellularity; gp105-120; hd-37; hematopoietic stem cell; hsc; leu12; leu-12; mar; marrow (bone); minimal angle of resolution; minimum angle of resolution; my10; my-10; number fraction; percent; point in time; qnt; quan; quant; quantitative; random; stem cells,Qn
59141-2,cd11c-cd103+ cells/cells in blood,cd11c-cd103+ cells nfr bld,cd11c-cd103+ cells/cells (bld),"alphax integrin chain; axb2; blood; cd11c cells; cd11c+cd103+ cells; cd11c-cd103+ cells; cell; cell markers; cellularity; cr4; hml-1; human mucosal lymphocyte antigen 1; integrin alphae chain; itgae; leukocyte surface antigen p150,95; leum5; leu-m5; number fraction; percent; point in time; qnt; quan; quant; quantitative; random; wb; whole blood",Qn
59163-6,sodium [moles/volume] in 24 hour stool,sodium 24h stl-scnc,sodium (24h stl) [moles/vol],1 day; 24 hours; 24hr; bowel movement; chemistry; faecal; faeces; fecal; feces; gastro; gastroenterology; gi; level; na; na+; qnt; quan; quant; quantitative; stl; stool = fecal; substance concentration,Qn
59206-3,carnitine free (c0)/palmitoylcarnitine (c16)+stearoylcarnitine (c18) [molar ratio] in serum or plasma,carnitine free/c16+c18 serpl-srto,c0/palmitoylcarnitine (c16)+stearoylcarnitine (c18) [molar ratio],c0; c16; c16+c18; c18; carnitine free; carnitine.total; chemistry; fc; fr; hexadecanoylcarnitine; non-protein bound; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; scrto; serp; serpl; serplas; serum; serum or plasma; sr; steroylcarnitine; substance concentration ratio; substance ratio,Qn
59220-4,chromogranin a [units/volume] in pleural fluid,cga plr-acnc,chromogranin a qn (pleur fld),arbitrary concentration; cg; cga; chemistry; pleural; pleural fluid; point in time; qnt; quan; quant; quantitative; random; thoracentesis fluid,Qn
59240-2,testosterone [moles/volume] in body fluid,testost fld-scnc,testosterone (body fld) [moles/vol],"b/f; bf; bod; bodies; body fluid; body fluid, unsp; chemistry; fl; fld; flu; fluid; level; point in time; qnt; quan; quant; quantitative; random; substance concentration; testo; testos; testost",Qn
59246-9,palmitoyl protein thioesterase [enzymatic activity/volume] in dbs,ppt dbs-ccnc,palmitoyl protein thioesterase (dbs) [catalytic activity/vol],blood; catalytic concentration; chemistry; dbs; dried blood spot; filter paper; fp; point in time; ppt; pr; prot; qnt; quan; quant; quantitative; random; wb; whole blood,Qn
59251-9,n-carbamoyl beta alanine/creatinine [molar ratio] in urine,n-carbamoyl b-alanine/creat ur-srto,n-carbamoyl beta alanine/creatinine (u) [molar ratio],ala; alpha alanine; b; bala; b-ala; b-alanine; chemistry; cr; crea; creat; l-alanine; n-carbamoyl b-alanine; point in time; qnt; quan; quant; quantitative; random; scrto; substance concentration ratio; substance ratio; ua; ucr; ur; urn,Qn
59265-9,8-hydroxydeoxyguanosine/creatinine [mass ratio] in urine,8oh-deoxyguanosine/creat ur,8-hydroxydeoxyguanosine/creatinine (u) [mass ratio],8-hydroxy-deoxyguanosine; 8oh-deoxyguanosine; 8-ohdg; chemistry; cr; crea; creat; mass concentration ratio; mass ratio; mcrto; point in time; qnt; quan; quant; quantitative; random; ua; ucr; ur; urn,Qn
59270-9,surgical operative note panel,surgical operative note pnl,,encounter; evaluation and management; evaluation and management note; notes; pan; panel.doc; panl; pnl; point in time; random; surg; surgical operative note pnl; visit note,-
59318-6,ramelteon [mass/volume] in serum or plasma,ramelteon serpl-mcnc,ramelteon [mass/vol],drug/toxicology; drugs; level; mass concentration; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; rozerem; serp; serpl; serplas; serum; serum or plasma; sr,Qn
59334-3,dinorsibutramine [mass/volume] in serum or plasma,dinorsibutramine serpl-mcnc,dinorsibutramine [mass/vol],didesmethylsibutramine; drug/toxicology; drugs; level; mass concentration; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sibutramine metabolite; sr,Qn
59344-2,tadalafil [mass/volume] in urine,tadalafil ur-mcnc,tadalafil (u) [mass/vol],cialis; drug/toxicology; drugs; level; mass concentration; point in time; qnt; quan; quant; quantitative; random; ua; ur; urn,Qn
59357-4,vardenafil [mass/volume] in blood,vardenafil bld-mcnc,vardenafil (bld) [mass/vol],blood; drug/toxicology; drugs; level; levitra; mass concentration; phosphodiesterase #5 inhibitor; phosphodiesterase 5 inhibitor; point in time; qnt; quan; quant; quantitative; random; wb; whole blood,Qn
59382-2,aspergillus versicolor igg ab [mass/volume] in serum,a versicolor igg-mcnc,a. versicolor igg (s) [mass/vol],a versicolor; abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; asperg; aspergil; aspergilis; aspergilla; aspergillin; aspergillosis; aspergils; aspergilus; autoantibodies; autoantibody; farmers lung; gm25; immune globulin g; immunoglobulin g; level; m019; m19; m25; mass concentration; point in time; qnt; quan; quant; quantitative; random; rgm25; rm215; serum; sr,Qn
59407-7,oxygen saturation in blood preductal by pulse oximetry,sao2 % bld preductal pulseox,,bld preductal; bld.right hand; blda.right hand; blood; lung; mass fraction; o2; percent; point in time; preductal blood; pulmonary; pulmonology; pulseox; qnt; quan; quant; quantitative; random; respiratory; sao2; sat; satn; so2; spo2; to2; wb; whole blood,Qn
59423-4,influenza virus a hemagglutinin type rna [identifier] in specimen by naa with probe detection,fluav ha rna spec naa+probe,fluav ha type rna naa+probe nom (specimen) [id],3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; avian influenza; bird flu; dna nucleic acid probe; dna probe; flua; fluav; fluav ha; fluv; fowl plague; ha; id; ident; identifier; infectious disease; infectiousdisease; influ; influenza a; influenza a virus; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; misc; miscellaneous; naa+probe; naat; nasba; nominal; nucleic acid sequence based analysis; other; pcr; point in time; polymerase chain reaction; probe amp; probe with ampification; probe with target amplification; qbr; random; ribonucleic acid; sda; spec; strand displacement amplification; tma; to be specified in another part of the message; transcription mediated amplification; unspecified,Nom
59456-4,ambulatory aid [morse fall scale],,,finding; findings; mfs; morse fall score; ordinal; point in time; ql; qual; qualitative; random; screen; survey; survey.mfs,Ord
59463-0,lymphocytes/leukocytes in dialysis fluid,lymphocytes nfr dial fld,lymphocytes/leukocytes (dial fld),diaf; dialysate; dialysis fluid; hematology/cell counts; kidney; leuc; leuk; leukocyte; lkcs; lymp; lymph; lympho; lymphocyte; lymphs; lymphs%; nephrology; number fraction; percent; point in time; qnt; quan; quant; quantitative; random; renal; wbc; wbcs; white blood cell; white blood cells,Qn
59476-2,collaborative staging metastasis at diagnosis - brain involvement cancer,cs mets at dx - brain cancer,,ca; cs; cs mets at dx; cs mets at dx - brain; dx; identity or presence; metastases; mets; misc; miscellaneous; nominal; oncology; other; point in time; random; spec; to be specified in another part of the message; tumor registry(naaccr); unspecified,Nom
59487-9,collaborative staging pre treatment tumor size and extension evaluation cancer,cs pre rx tumor size/ext eval cancer,,assessment; before; ca; cs; cs pre rx tumor size; cs pre rx tumor size/ext eval; eval; ext; h&p; history and physical; identity or presence; misc; miscellaneous; nominal; oncology; other; point in time; random; spec; to be specified in another part of the message; tumor registry(naaccr); tx; unspecified,Nom
59489-5,collaborative staging site-specific factor 7 cancer,cs site-specific factor 7 cancer,,ca; cs; cs site-specific factor 7; fac; fact; identity or presence; misc; miscellaneous; nominal; oncology; other; point in time; random; spec; to be specified in another part of the message; tumor registry(naaccr); unspecified,Nom
59511-6,flag for date of conclusive diagnosis not populated cancer,flag for date of conclusive dx cancer,,ca; date of conclusive dx; dx; flag for date of conclusive dx; identity or presence; misc; miscellaneous; nominal; oncology; other; point in time; random; spec; to be specified in another part of the message; tumor registry(naaccr); unspecified,Nom
59525-6,derived american joint committee on cancer-7 n descriptor,derived ajcc-7 n descript cancer,,ajcc; ca; derived ajcc-7 n; derived ajcc-7 n descript; identity or presence; misc; miscellaneous; nominal; oncology; other; point in time; random; spec; to be specified in another part of the message; tumor registry(naaccr); unspecified,Nom
59528-0,derived american joint committee on cancer-7 t descriptor,derived ajcc-7 t descript cancer,,ajcc; ca; derived ajcc-7 t; derived ajcc-7 t descript; identity or presence; misc; miscellaneous; nominal; oncology; other; point in time; random; spec; t prime; to be specified in another part of the message; tumor registry(naaccr); unspecified,Nom
59535-5,derived pre treatment-7 m descriptor cancer,derived pre rx-7 m descript cancer,,before; ca; derived pre rx-7 m; derived pre rx-7 m descript; identity or presence; misc; miscellaneous; nominal; oncology; other; point in time; random; spec; to be specified in another part of the message; tumor registry(naaccr); tx; unspecified,Nom
5954-3,deprecated thrombin time in platelet poor plasma by coagulation assay,deprecated tt ppp qn,thrombin time tilt tube (ppp) [time],coag; hematology; heme; plas; platelet poor plasma; point in time; qnt; quan; quant; quantitative; random; tct; throm; thrombin clotting time; thrombin time; tt,Qn
59543-9,inpatient status cancer,inpatient status cancer,,ca; identity or presence; misc; miscellaneous; nominal; oncology; other; point in time; random; spec; to be specified in another part of the message; tumor registry(naaccr); unspecified,Nom
59546-2,flag for date 1st most definitive surgery rx for not populated cancer,flag for date 1st mst defn srg cancer,,ca; date 1st most defn srg; first; flag for date 1st mst defn srg; identity or presence; misc; miscellaneous; nominal; oncology; other; point in time; random; spec; surg; to be specified in another part of the message; treatment; tumor registry(naaccr); unspecified,Nom
59561-1,propofol glucuronide [mass/volume] in urine,propofol glucuronide ur-mcnc,propofol glucuronide (u) [mass/vol],cpro; diprivan; diprivan metabolite; disoprivan; drug/toxicology; drugs; gluc; glucouronide; level; mass concentration; point in time; qnt; quan; quant; quantitative; random; rapinovet; ua; ur; urn,Qn
59565-2,netilmicin [moles/volume] in serum or plasma --trough,netilmicin trough serpl-scnc,netilmicin trough [moles/vol],drug/toxicology; drugs; id; infectious disease; infectiousdisease; level; netilimicin; netromycin; pl; plasma; plsm; point in time; pre; predose; pre-dose; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; substance concentration,Qn
59590-0,1-hydroxymidazolam [mass/volume] in urine by confirmatory method,1oh-midazolam ur cfm-mcnc,1-hydroxymidazolam confirm (u) [mass/vol],1-hydroxy midazolam; 1oh-midazolam; alpha hydroxymidazolam; alpha-hydroxymidazolam; cfm; chlonazepam metabolite; cnfr; cnfrm; conf; confirmation; confirmatory; drug/toxicology; drugs; gcms; i; lc/ms/ms; level; mass concentration; point in time; qnt; quan; quant; quantitative; random; ua; ur; urn,Qn
59595-9,7-aminoclonazepam [mass/volume] in serum or plasma by confirmatory method,7aminoclonazepam serpl cfm-mcnc,7-aminoclonazepam confirm [mass/vol],7-amino clonazepam; 7aminoclonazepam; addiction; cfm; clonazepam metabolite; cnfr; cnfrm; conf; confirmation; confirmatory; drug/toxicology; drugs; drugs of abuse; gcms; illicit; lc/ms/ms; level; mass concentration; pl; plasma; plsm; point in time; potentialforabuse; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
59601-5,alpha hydroxyalprazolam [mass/volume] in body fluid,a-oh alpraz fld-mcnc,alpha hydroxyalprazolam (body fld) [mass/vol],"alfa; alpha hydroxy alprazolam; alprozolam metabolite; a-oh alpraz; b/f; bf; bod; bodies; body fluid; body fluid, unsp; drug/toxicology; drugs; fl; fld; flu; fluid; hydroxy alprazolam; hydroxyalpraz; level; mass concentration; oh-alpraz; point in time; qnt; quan; quant; quantitative; random",Qn
59608-0,alprazolam [mass/volume] in body fluid,alpraz fld-mcnc,alprazolam (body fld) [mass/vol],"b/f; bf; bod; bodies; body fluid; body fluid, unsp; drug/toxicology; drugs; fl; fld; flu; fluid; level; mass concentration; niravam; point in time; qnt; quan; quant; quantitative; random; xanax",Qn
59614-8,alprazolam [mass/mass] in tissue by confirmatory method,alpraz tiss cfm-mcnt,alprazolam confirm (tiss) [mass/mass],"cfm; cnfr; cnfrm; conf; confirmation; confirmatory; drug/toxicology; drugs; gcms; lc/ms/ms; mass content; niravam; point in time; qnt; quan; quant; quantitative; random; tissue; tissue, unspecified; xanax",Qn
59637-9,clonazepam [mass/volume] in blood by confirmatory method,clonazepam bld cfm-mcnc,clonazepam confirm (bld) [mass/vol],blood; cfm; cnfr; cnfrm; conf; confirmation; confirmatory; drug/toxicology; drugs; gcms; klonopin; lc/ms/ms; level; mass concentration; point in time; qnt; quan; quant; quantitative; random; wb; whole blood,Qn
59639-5,clonazepam [mass/volume] in body fluid by confirmatory method,clonazepam fld cfm-mcnc,clonazepam confirm (body fld) [mass/vol],"b/f; bf; bod; bodies; body fluid; body fluid, unsp; cfm; cnfr; cnfrm; conf; confirmation; confirmatory; drug/toxicology; drugs; fl; fld; flu; fluid; gcms; klonopin; lc/ms/ms; level; mass concentration; point in time; qnt; quan; quant; quantitative; random",Qn
59643-7,cocaethylene [mass/volume] in serum or plasma by confirmatory method,cocaethylene serpl cfm-mcnc,cocaethylene confirm [mass/vol],cfm; cnfr; cnfrm; cocaine/ethanol by-product; conf; confirmation; confirmatory; drug/toxicology; drugs; gcms; lc/ms/ms; level; mass concentration; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
59659-3,diazepam [mass/mass] in stool by confirmatory method,diazepam stl cfm-mcnt,diazepam confirm (stl) [mass/mass],addiction; bowel movement; c311; cfm; cnfr; cnfrm; conf; confirmation; confirmatory; drug/toxicology; drugs; drugs of abuse; faecal; faeces; fecal; feces; gcms; illicit; lc/ms/ms; mass content; point in time; potentialforabuse; qnt; quan; quant; quantitative; random; stesolid; stl; stool = fecal; valium,Qn
59664-3,estazolam [mass/volume] in blood,estazolam bld-mcnc,estazolam (bld) [mass/vol],blood; drug/toxicology; drugs; esilgan; eurodin; level; mass concentration; nuctalon; point in time; prosom; qnt; quan; quant; quantitative; random; wb; whole blood,Qn
59666-8,estazolam [mass/volume] in body fluid,estazolam fld-mcnc,estazolam (body fld) [mass/vol],"b/f; bf; bod; bodies; body fluid; body fluid, unsp; drug/toxicology; drugs; esilgan; eurodin; fl; fld; flu; fluid; level; mass concentration; nuctalon; point in time; prosom; qnt; quan; quant; quantitative; random",Qn
59668-4,estazolam [mass/volume] in serum or plasma by confirmatory method,estazolam serpl cfm-mcnc,estazolam confirm [mass/vol],cfm; cnfr; cnfrm; conf; confirmation; confirmatory; drug/toxicology; drugs; esilgan; eurodin; gcms; lc/ms/ms; level; mass concentration; nuctalon; pl; plasma; plsm; point in time; prosom; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
59682-5,hydroxyethylflurazepam [mass/volume] in blood,oh-ethylfluraz bld-mcnc,hydroxyethylflurazepam (bld) [mass/vol],blood; drug/toxicology; drugs; flurazepam metabolite; hydroxy ethylflurazepam; level; mass concentration; oh-ethylfluraz; point in time; qnt; quan; quant; quantitative; random; wb; whole blood,Qn
59683-3,hydroxyethylflurazepam [mass/volume] in blood by confirmatory method,oh-ethylfluraz bld cfm-mcnc,hydroxyethylflurazepam confirm (bld) [mass/vol],blood; cfm; cnfr; cnfrm; conf; confirmation; confirmatory; drug/toxicology; drugs; flurazepam metabolite; gcms; hydroxy ethylflurazepam; lc/ms/ms; level; mass concentration; oh-ethylfluraz; point in time; qnt; quan; quant; quantitative; random; wb; whole blood,Qn
59689-0,hydroxyethylflurazepam [mass/mass] in tissue by confirmatory method,oh-ethylfluraz tiss cfm-mcnt,hydroxyethylflurazepam confirm (tiss) [mass/mass],"cfm; cnfr; cnfrm; conf; confirmation; confirmatory; drug/toxicology; drugs; flurazepam metabolite; gcms; hydroxy ethylflurazepam; lc/ms/ms; mass content; oh-ethylfluraz; point in time; qnt; quan; quant; quantitative; random; tissue; tissue, unspecified",Qn
59691-6,hydroxytriazolam [mass/volume] in blood by confirmatory method,oh-triazolam bld cfm-mcnc,hydroxytriazolam confirm (bld) [mass/vol],addiction; blood; cfm; cnfr; cnfrm; conf; confirmation; confirmatory; drug/toxicology; drugs; drugs of abuse; gcms; hydroxy triazolam; illicit; lc/ms/ms; level; mass concentration; oh-triazolam; ohtrz; point in time; potentialforabuse; qnt; quan; quant; quantitative; random; triazolam metabolite; wb; whole blood,Qn
59699-9,lorazepam [mass/volume] in blood,lorazepam bld-mcnc,lorazepam (bld) [mass/vol],addiction; ativan; blood; drug/toxicology; drugs; drugs of abuse; illicit; level; mass concentration; point in time; potentialforabuse; qnt; quan; quant; quantitative; random; wb; whole blood,Qn
59701-3,lorazepam [mass/volume] in body fluid,lorazepam fld-mcnc,lorazepam (body fld) [mass/vol],"addiction; ativan; b/f; bf; bod; bodies; body fluid; body fluid, unsp; drug/toxicology; drugs; drugs of abuse; fl; fld; flu; fluid; illicit; level; mass concentration; point in time; potentialforabuse; qnt; quan; quant; quantitative; random",Qn
59704-7,lorazepam [mass/mass] in tissue,lorazepam tiss-mcnt,lorazepam (tiss) [mass/mass],"addiction; ativan; drug/toxicology; drugs; drugs of abuse; illicit; mass content; point in time; potentialforabuse; qnt; quan; quant; quantitative; random; tissue; tissue, unspecified",Qn
59711-2,midazolam [mass/volume] in serum or plasma by confirmatory method,midazolam serpl cfm-mcnc,midazolam confirm [mass/vol],cfm; cnfr; cnfrm; conf; confirmation; confirmatory; drug/toxicology; drugs; gcms; lc/ms/ms; level; mass concentration; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; versed,Qn
59733-6,potassium [mass/mass] in tissue,potassium tiss-mcnt,potassium (tiss) [mass/mass],"drug/toxicology; drugs; k; k+; mass content; point in time; potass; qnt; quan; quant; quantitative; random; tissue; tissue, unspecified",Qn
59735-1,salicylamide [mass/volume] in blood,salicylamide bld-mcnc,salicylamide (bld) [mass/vol],blood; drug/toxicology; drugs; level; lobac; mass concentration; point in time; qnt; quan; quant; quantitative; random; salicylamid; sinedol; triaprin-dc; utrosal; wb; whole blood,Qn
59741-9,silver [mass/mass] in tissue,silver tiss-mcnt,silver (tiss) [mass/mass],"ag; drug/toxicology; drugs; mass content; point in time; qnt; quan; quant; quantitative; random; silv; tissue; tissue, unspecified",Qn
59743-5,sumatriptan [mass/volume] in blood,sumatriptan bld-mcnc,sumatriptan (bld) [mass/vol],blood; drug/toxicology; drugs; imitrex; level; mass concentration; point in time; qnt; quan; quant; quantitative; random; wb; whole blood,Qn
59754-2,titanium [mass/mass] in hair,titanium hair-mcnt,titanium (hair) [mass/mass],drug/toxicology; drugs; har; mass content; point in time; qnt; quan; quant; quantitative; random; ti,Qn
59762-5,triazolam [mass/volume] in serum or plasma by confirmatory method,triazolam serpl cfm-mcnc,triazolam confirm [mass/vol],apo-triazo; cfm; cnfr; cnfrm; conf; confirmation; confirmatory; drug/toxicology; drugs; gcms; halcion; lc/ms/ms; level; mass concentration; novo-triolam; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
5977-4,plasminogen activator inhibitor 2 ag [mass/volume] in platelet poor plasma by immunoassay,pai2 ag ppp ia-mcnc,plasminogen activator inhibitor 2 ag ia (ppp) [mass/vol],antigen; antigens; coagulation; eia; elfa; elisa; endothelial cell type pa-i; enzyme immunoassay; fast acting pai; hematology; heme; iaa; ii; inhib; inhibit; level; mass concentration; meia; pai; pai 2; pai2; pa-inhibitor; pa-inhibitor 2; placental pa-i; plas; platelet pai; platelet poor plasma; plg; plgn; point in time; profibrinolysin; qnt; quan; quant; quantitative; random; suds; t-pa inhibitor; u-pa inhibitor,Qn
59774-0,procedure anesthesia narrative,anesthesia,,doc.misc; finding; findings; misc; narrative; point in time; random; report,Nar
59775-7,procedure disposition narrative,disposition,,doc.misc; finding; findings; misc; narrative; point in time; random; report,Nar
59776-5,procedure findings narrative,findings,,doc.misc; finding; findings; misc; narrative; point in time; random; report,Nar
59779-9,immunization schedule used,immunization schedule used,,finding; findings; immunization status; nominal; point in time; random; vaccination; vaccinations; vaccine,Nom
59785-6,indication for immunization,indication for immunization,,finding; findings; immunization status; nominal; point in time; random; vaccination; vaccinations; vaccine,Nom
59806-0,aptt.lupus sensitive.factor substitution in platelet poor plasma by coagulation assay --2h post incubation with normal plasma,aptt-la 2h np ppp,aptt.lupus sensitive.factor substitution 2 hr post incubation with normal plasma coag (ppp) [time],120 min; 120 minutes; 120min; 2 hours; 2h np; 2h p inc; activated partial thromboplastin time; after; aptt; aptt with platelin ls; aptt-la; clot; clottable; coag; coagulation assay; control; fac; fact; hematology; heme; little(a)ptt; partial thromboplastin time; plas; platelet poor plasma; point in time; pst; ptt; qnt; quan; quant; quantitative; random; surf; tilt tube,Qn
59823-5,tacrolimus [mass/volume] in serum or plasma --2 hours post dose,tacrolimus 2h p serpl-mcnc,tacrolimus 2 hr post dose [mass/vol],120 min; 120 minutes; 120min; 2 hours; after; drug/toxicology; drugs; fk506; fk-506; fujimycin; hecoria; l04ad02; level; mass concentration; p dose; pl; plasma; plsm; point in time; prograf; protopic; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
59824-3,cyanide [presence] in urine,cyanide ur ql,cyanide ql (u),cn; drug/toxicology; drugs; ordinal; point in time; pr; ql; qual; qualitative; random; screen; ua; ur; urn,Ord
59837-5,methylenedioxyamphetamine [mass/volume] in serum or plasma,mda serpl-mcnc,methylenedioxyamphetamine [mass/vol],addiction; drug/toxicology; drugs; drugs of abuse; illicit; level; mass concentration; mda; methylenedioxymethamphetamine metabolite; pl; plasma; plsm; point in time; potentialforabuse; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
59839-1,urate crystals [presence] in tissue by light microscopy,urate cry tiss ql micro,urate crystals lm ql (tiss),"crys; cryst; crystal; lm; micro; micros; microscopic; ordinal; pathology; point in time; pr; ql; qual; qualitative; random; screen; tissue; tissue, unspecified; ua; urates; uric acid",Ord
59846-6,salmonella sp identified [type] in isolate,salmonella islt,salmonella sp identified nom (isol),id; infectious disease; infectiousdisease; islt; isol; isolated; microbiology; nominal; point in time; random; sal; salmonel; species; spp; typ,Nom
59848-2,morphology.icd-o-3 cancer,morphology.icd-o-3 cancer,,ca; identity or presence; iii; international classification of diseases; international classification of diseases for oncology; misc; miscellaneous; nominal; oncology; other; point in time; random; spec; to be specified in another part of the message; tumor registry(naaccr); unspecified,Nom
59849-0,lactate [moles/volume] in serum or plasma --post exercise,lactate p exc serpl-scnc,lactate post exercise [moles/vol],2-hydroxypropanoic acid; 2-hydroxy-propionate; 2-hydroxy-propionic acid; after; chemistry.challenge testing; excz; lact; lactic acid; level; l-lactate; p exc; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; substance concentration,Qn
59857-3,pathology specimen collection date 5 cancer,path spec coll date 5 cancer,,ca; coll; collect; collect date; collected; date and time; misc; miscellaneous; oncology; other; path; path spec coll date 5; point in time; qnt; quan; quant; quantitative; random; spec; time stamp; timestamp; to be specified in another part of the message; tumor registry(naaccr); unspecified,Qn
59910-0,ibuprofen [moles/volume] in urine,ibuprofen ur-scnc,ibuprofen (u) [moles/vol],advil; c20; c235; c286; c53; drug/toxicology; drugs; level; motrin; point in time; qnt; quan; quant; quantitative; random; substance concentration; ua; ur; urn,Qn
5992-3,platelet aggregation adp induced in platelet rich plasma,pa adp prp,platelet aggregation adp induced (prp) [rel units/vol],adenosine 5'-pyrophosphate; adenosine pyrophosphate; ado; adp; agg; aggr; aned; clopidogrel response assay; coagulation; hematology; heme; medication stress; p2y12 assay; p2y12 inhibition; pa; pa adp; pl; platelet rich plasma; platelets; platelt; plavix response assay; plt; point in time; qnt; quan; quant; quantitative; random; rlacnc; thrombocyte; thrombocytes,Qn
59928-2,methaqualone [moles/volume] in urine,methaqualone ur-scnc,methaqualone (u) [moles/vol],addiction; drug/toxicology; drugs; drugs of abuse; illicit; level; methaqualon; point in time; potentialforabuse; qnt; quaalude; quan; quant; quantitative; random; substance concentration; ua; ur; urn,Qn
59946-4,olanzapine [moles/volume] in gastric fluid,olanzapine gast-scnc,olanzapine (gast fld) [moles/vol],drug/toxicology; drugs; gast; gastric contents; gastric fluid; lanzek; level; point in time; qnt; quan; quant; quantitative; random; substance concentration; zypadhera; zyprexa,Qn
59958-9,promazine [moles/volume] in urine,promazine ur-scnc,promazine (u) [moles/vol],drug/toxicology; drugs; level; point in time; qnt; quan; quant; quantitative; random; sparine; substance concentration; tranquazine; ua; ur; urn,Qn
59964-7,quetiapine [moles/volume] in gastric fluid,quetiapine gast-scnc,quetiapine (gast fld) [moles/vol],drug/toxicology; drugs; gast; gastric contents; gastric fluid; ketipinor; level; point in time; qnt; quan; quant; quantitative; random; seroquel; substance concentration; xeroquel,Qn
59985-2,11-deoxycorticosterone [mass/volume] in serum or plasma --7th specimen post xxx challenge,11doc sp7 p chal serpl-mcnc,11-deoxycorticosterone 7th specimen post unsp challenge [mass/vol],^7th spec pst xxx chal; 11doc; 11-doc; 21-hydroxyprogesterone; after; chemistry.challenge testing; doc; level; mass concentration; p chal; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sp7; sp7 p chal; spec; sr,Qn
59986-0,11-deoxycorticosterone [mass/volume] in serum or plasma --6th specimen post xxx challenge,11doc sp6 p chal serpl-mcnc,11-deoxycorticosterone 6th specimen post unsp challenge [mass/vol],11doc; 11-doc; 21-hydroxyprogesterone; after; chemistry.challenge testing; doc; level; mass concentration; p chal; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sp6; sp6 p chal; spec; sr,Qn
59990-2,testosterone [mass/volume] in serum or plasma --6th specimen post xxx challenge,testost sp6 p chal serpl-mcnc,testosterone 6th specimen post unsp challenge [mass/vol],after; chemistry.challenge testing; level; mass concentration; p chal; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sp6; sp6 p chal; spec; sr; testo; testos; testost,Qn
60040-3,acebutolol [mass/volume] in serum or plasma,acebutolol serpl-mcnc,acebutolol [mass/vol],acecor; alol; drug/toxicology; drugs; level; mass concentration; monitan; neptal; pl; plasma; plsm; point in time; prent; qnt; quan; quant; quantitative; random; rhotral; sectral; serp; serpl; serplas; serum; serum or plasma; sr,Qn
60043-7,acepromazine [mass/volume] in blood,acepromazine bld-mcnc,acepromazine (bld) [mass/vol],ace; acetylpromazine; acp; atravet; blood; drug/toxicology; drugs; level; mass concentration; notensil; plegicil; point in time; qnt; quan; quant; quantitative; random; vet; veterinary; wb; whole blood,Qn
60047-8,acetaldehyde [mass/mass] in tissue,acetaldehyde tiss-mcnt,acetaldehyde (tiss) [mass/mass],"addiction; drug/toxicology; drugs; drugs of abuse; ethanal; illicit; mass content; paraldehyde metabolite; point in time; potentialforabuse; qnt; quan; quant; quantitative; random; tissue; tissue, unspecified",Qn
60057-7,bismuth [mass/mass] in hair,bismuth hair-mcnt,bismuth (hair) [mass/mass],bi; drug/toxicology; drugs; har; mass content; point in time; qnt; quan; quant; quantitative; random,Qn
60058-5,bismuth [mass/volume] in red blood cells,bismuth rbc-mcnc,bismuth (rbc) [mass/vol],bi; drug/toxicology; drugs; erythrocytes; level; mass concentration; point in time; qnt; quan; quant; quantitative; random; red blood cells; red blood corpusles,Qn
60079-1,germanium [mass/volume] in blood,germanium bld-mcnc,germanium (bld) [mass/vol],blood; drug/toxicology; drugs; ge; level; mass concentration; point in time; qnt; quan; quant; quantitative; random; wb; whole blood,Qn
60096-5,loperamide [mass/volume] in urine,loperamide ur-mcnc,loperamide (u) [mass/vol],c29h33cln2o2; drug/toxicology; drugs; immodium; level; mass concentration; point in time; qnt; quan; quant; quantitative; random; ua; ur; urn,Qn
6010-3,protein c inhibitor [mass/volume] in platelet poor plasma by immunoassay,prot c inhib ppp ia-mcnc,protein c inhibitor ia (ppp) [mass/vol],activated protein c inhibitor; autoprothrombin ii-a; coagulation; eia; elfa; elisa; enzyme immunoassay; hematology; heme; iaa; inhib; inhibit; level; mass concentration; meia; pc; pci; plas; platelet poor plasma; point in time; pr; prot; prot c; prot c inhib; qnt; quan; quant; quantitative; random; suds,Qn
60106-2,olanzapine [mass/volume] in body fluid,olanzapine fld-mcnc,olanzapine (body fld) [mass/vol],"b/f; bf; bod; bodies; body fluid; body fluid, unsp; drug/toxicology; drugs; fl; fld; flu; fluid; lanzek; level; mass concentration; point in time; qnt; quan; quant; quantitative; random; zypadhera; zyprexa",Qn
60124-5,pancuronium [mass/volume] in urine,pancuronium ur-mcnc,pancuronium (u) [mass/vol],cpan; drug/toxicology; drugs; level; mass concentration; mioblock; pavulon; point in time; qnt; quan; quant; quantitative; random; ua; ur; urn,Qn
60130-2,paraoxon [mass/volume] in body fluid,paraoxon fld-mcnc,paraoxon (body fld) [mass/vol],"b/f; bf; bod; bodies; body fluid; body fluid, unsp; drug/toxicology; drugs; fl; fld; flu; fluid; level; mass concentration; parathion metabolite; point in time; qnt; quan; quant; quantitative; random",Qn
60132-8,parathion [mass/volume] in blood,parathion bld-mcnc,parathion (bld) [mass/vol],blood; diethyl parathion; drug/toxicology; drugs; ethyl parathion; folidol; level; mass concentration; point in time; qnt; quan; quant; quantitative; random; thiophos; wb; whole blood,Qn
60134-4,parathion [mass/mass] in tissue,parathion tiss-mcnt,parathion (tiss) [mass/mass],"diethyl parathion; drug/toxicology; drugs; ethyl parathion; folidol; mass content; point in time; qnt; quan; quant; quantitative; random; thiophos; tissue; tissue, unspecified",Qn
60138-5,paroxetine [mass/mass] in tissue,paroxetine tiss-mcnt,paroxetine (tiss) [mass/mass],"drug/toxicology; drugs; mass content; paxil; point in time; qnt; quan; quant; quantitative; random; tissue; tissue, unspecified",Qn
60141-9,penciclovir [mass/volume] in serum or plasma,penciclovir serpl-mcnc,penciclovir [mass/vol],denavir; drug/toxicology; drugs; famciclovir metabolite; famvir metabolite; level; mass concentration; pcv; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
60149-2,pentazocine [mass/volume] in blood,pentazocine bld-mcnc,pentazocine (bld) [mass/vol],addiction; blood; drug/toxicology; drugs; drugs of abuse; illicit; level; mass concentration; point in time; potentialforabuse; qnt; quan; quant; quantitative; random; talwin; wb; whole blood,Qn
60152-6,pentobarbital [mass/volume] in body fluid,pentobarb fld-mcnc,pentobarbital (body fld) [mass/vol],"addiction; b/f; barbiturate; bf; bod; bodies; body fluid; body fluid, unsp; drug/toxicology; drugs; drugs of abuse; fl; fld; flu; fluid; illicit; level; mass concentration; nembutal; pentobarb; point in time; potentialforabuse; qnt; quan; quant; quantitative; random",Qn
6016-0,corticotropin ige ab [units/volume] in serum,acth ige qn,corticotropin ige qn (s),abs; aby; acth; adrenocorticotrophic hormone; adrenocorticotropin; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; c206; c74; cortrosyn; immune globulin e; immunoglobulin e; point in time; qnt; quan; quant; quantitative; random; rc206; serum; sr; tumor marker,Qn
60164-1,phensuximide [mass/volume] in blood,phensuximide bld-mcnc,phensuximide (bld) [mass/vol],blood; drug/toxicology; drugs; level; mass concentration; milontin; point in time; qnt; quan; quant; quantitative; random; wb; whole blood,Qn
60166-6,platinum [mass/mass] in nail,platinum nail-mcnt,platinum (nail) [mass/mass],drug/toxicology; drugs; mass content; nails; point in time; pt; qnt; quan; quant; quantitative; random; ungal nail,Qn
60210-2,venlafaxine [mass/mass] in tissue,venlafaxine tiss-mcnt,venlafaxine (tiss) [mass/mass],"drug/toxicology; drugs; efexor; effexor; mass content; point in time; qnt; quan; quant; quantitative; random; tissue; tissue, unspecified; venlafaxin",Qn
60214-4,zolmitriptan [mass/volume] in blood,zolmitriptan bld-mcnc,zolmitriptan (bld) [mass/vol],ascotop; blood; drug/toxicology; drugs; level; mass concentration; point in time; qnt; quan; quant; quantitative; random; wb; whole blood; zolnod; zomig; zomigon; zomigoro,Qn
602-3,bacteria identified in bone by aerobe culture,bacteria bone aerobe cult,bacteria identified aer cx nom (bone),aerobe; aerobe cult; aerobed; bact; bon; c&s; cult; cultures; id; identity or presence; infectious disease; infectiousdisease; microbiology; nominal; point in time; random,Nom
60243-3,matrix metallopeptidase 9 [mass/volume] in serum,mmp9 ser-mcnc,matrix metallopeptidase 9 (s) [mass/vol],chemistry; level; mass concentration; mmp9; point in time; qnt; quan; quant; quantitative; random; serum; sr,Qn
6024-4,aspergillus flavus ige ab [units/volume] in serum,a flavus ige qn,a. flavus ige qn (s),a flavus; abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; asperg; aspergil; aspergilis; aspergilla; aspergillin; aspergillosis; aspergils; aspergilus; autoantibodies; autoantibody; farmers lung; immune globulin e; immunoglobulin e; m228; m311; m54; point in time; qnt; quan; quant; quantitative; random; serum; sr,Qn
60247-4,androstanolone [mass/volume] in serum or plasma --5th specimen post xxx challenge,androstanolone sp5 p chal serpl-mcnc,androstanolone 5th specimen post unsp challenge [mass/vol],after; chemistry.challenge testing; dht; dihydrotestosterone; level; mass concentration; p chal; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sp5; sp5 p chal; spec; sr,Qn
60249-0,androstanolone [mass/volume] in serum or plasma --3rd specimen post xxx challenge,androstanolone sp3 p chal serpl-mcnc,androstanolone 3rd specimen post unsp challenge [mass/vol],after; chemistry.challenge testing; dht; dihydrotestosterone; level; mass concentration; p chal; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sp3; sp3 p chal; spec; sr,Qn
60250-8,androstanolone [mass/volume] in serum or plasma --2nd specimen post xxx challenge,androstanolone sp2 p chal serpl-mcnc,androstanolone 2nd specimen post unsp challenge [mass/vol],after; chemistry.challenge testing; convalescent; dht; dihydrotestosterone; level; mass concentration; p chal; pl; plasma; plsm; point in time; post immunization; pst; qnt; quan; quant; quantitative; random; second; serp; serpl; serplas; serum; serum or plasma; sp2; sp2 p chal; spec; sr,Qn
60259-9,adenovirus dna [presence] in isolate by naa with probe detection,hadv dna islt ql naa+probe,adenovirus dna naa+probe ql (isol),3 self-sustaining sequence replication; 3sr sr; adeno virus; amplif; amplification; amplified; deoxyribonucleic acid; dna nucleic acid probe; dna probe; hadv; id; infectious disease; infectiousdisease; islt; isol; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; naa+probe; naat; nasba; nucleic acid sequence based analysis; ordinal; pcr; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; screen; sda; strand displacement amplification; tma; transcription mediated amplification,Ord
60263-1,enterovirus rna [presence] in isolate by naa with probe detection,ev rna islt ql naa+probe,enterovirus rna naa+probe ql (isol),3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; dna nucleic acid probe; dna probe; entero virus; ev; ev-pcr; id; infectious disease; infectiousdisease; islt; isol; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; naa+probe; naat; nasba; nucleic acid sequence based analysis; ordinal; pcr; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; ribonucleic acid; screen; sda; strand displacement amplification; tma; transcription mediated amplification,Ord
60264-9,hantavirus ab [titer] in serum,hantavirus ab titr ser,hantavirus ab (s) [titer],abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; dilution factor; dilution factor (titer); hanta virus; hemorrhagic fever with renal syndrome; hfrs; hps; htnv; id; infectious disease; infectiousdisease; microbiology; orthohantavirus; point in time; random; serum; smqn; snv; sr; titer; titered; titre; ttr,SemiQn
60273-0,rotavirus rna [presence] in isolate by naa with probe detection,rv rna islt ql naa+probe,rotavirus rna naa+probe ql (isol),3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; dna nucleic acid probe; dna probe; id; infectious disease; infectiousdisease; islt; isol; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; naa+probe; naat; nasba; nucleic acid sequence based analysis; ordinal; pcr; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; ribonucleic acid; rota virus; rotav; rotaviral; rotaviurs; rv; screen; sda; strand displacement amplification; tma; transcription mediated amplification,Ord
60301-9,disopyramide [moles/volume] in specimen,disopyramide spec-scnc,disopyramide (specimen) [moles/vol],diso durules; drug/toxicology; drugs; level; misc; miscellaneous; norpace; other; point in time; pyramide; qnt; quan; quant; quantitative; random; rythmodan; spec; substance concentration; to be specified in another part of the message; unspecified,Qn
60314-2,mefenamate [moles/volume] in specimen,mefenamate spec-scnc,mefenamate (specimen) [moles/vol],"c15h15no2; c56; drug/toxicology; drugs; du-diclo; forte mefenamic acid; level; mefenamic acid; mefic; misc; miscellaneous; n-(2,3-xylyl)anthranilic acid; other; point in time; ponstan; ponstel; qnt; quan; quant; quantitative; random; spec; substance concentration; to be specified in another part of the message; unspecified",Qn
60317-5,methotrimeprazine [moles/volume] in specimen,methotrimeprazine spec-scnc,methotrimeprazine (specimen) [moles/vol],drug/toxicology; drugs; hirnamin; lepurin; lerium; levamin; level; levohalte; levomazine; levomeprazine; levomeproma; levomepromazin; levomepromazina; levomepromazine; levomezine; levonormal; levopromazine; levoprome; levotomin; levozan; levozin; methotrimeprazine; milezin; minozinan; misc; miscellaneous; neozine; neuractil; neurocil; neurozil; novo-meprazine; nozinan; other; point in time; procrazine; qnt; quan; quant; quantitative; random; ronexine; sinogan; sofmin; spec; specia 246; substance concentration; tisercin; tisercine; tisercinetta; tisercinettes; to be specified in another part of the message; unspecified; veractil,Qn
60331-6,propranolol [moles/volume] in specimen,propranolol spec-scnc,propranolol (specimen) [moles/vol],drug/toxicology; drugs; inderal; level; misc; miscellaneous; other; point in time; qnt; quan; quant; quantitative; random; spec; substance concentration; to be specified in another part of the message; unspecified,Qn
60340-7,crystals.amorphous [presence] in urine sediment by light microscopy,amorph cry urns ql micro,crystals.amorphous lm ql (urine sed),am; amorph; amorph cry; amorphic; crys; cryst; crystal; kidney; lm; micro; micros; microscopic; nephrology; ordinal; point in time; pr; ql; qual; qualitative; random; renal; screen; ua; ur; urinalysis; urine sediment; urn; urns,Ord
60343-1,borrelia burgdorferi igm bands panel - serum by immunoblot,b burgdor igm bands pnl ser ib,b. burgdorferi igm bands panel ib (s),b burg; b burgdor; b burgdor igm bands pnl; b burgdorferi; bb; blt; burgdorf; id; immune blot; immune globulin m; immunobl; immunoblot; immunoglobulin m; infectious disease; infectiousdisease; lyme; lyme disease; lymes; microbiology; pan; panel.microbiology; panl; pnl; point in time; random; riba; serum; sr; wb; wblot; west blot; west blt; western blot,-
60348-0,almond igg ab [mass/volume] in serum,almond igg-mcnc,almond igg (s) [mass/vol],abs; aby; allergen; allergens; allergy testing; almond; amygdalus communis; antby; anti; antibodies; antibody; autoantibodies; autoantibody; f020; f20; immune globulin g; immunoglobulin g; level; mass concentration; point in time; prunus amygdalus; qnt; quan; quant; quantitative; random; serum; sr,Qn
60361-3,cauliflower igg ab [mass/volume] in serum,cauliflower igg-mcnc,cauliflower igg (s) [mass/vol],abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; cauliflower; f291; immune globulin g; immunoglobulin g; level; mass concentration; point in time; qnt; quan; quant; quantitative; random; rf291; serum; sr,Qn
60371-2,cucumber igg ab [mass/volume] in serum,cucumber igg-mcnc,cucumber igg (s) [mass/vol],abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; cucumber; f244; gherkin; immune globulin g; immunoglobulin g; level; mass concentration; point in time; qnt; quan; quant; quantitative; random; serum; sr,Qn
60385-2,nutmeg igg ab [mass/volume] in serum,nutmeg igg-mcnc,nutmeg igg (s) [mass/vol],abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; f282; immune globulin g; immunoglobulin g; level; mass concentration; myristica fragrans; point in time; qnt; quan; quant; quantitative; random; rf282; serum; sr,Qn
60389-4,pea igg ab [mass/volume] in serum,pea igg-mcnc,pea igg (s) [mass/vol],abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; f012; f12; green pea; immune globulin g; immunoglobulin g; level; mass concentration; pea; peas; point in time; qnt; quan; quant; quantitative; random; serum; sr,Qn
60401-7,scallop igg ab [mass/volume] in serum,scallop igg-mcnc,scallop igg (s) [mass/vol],abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; f053; f338; f53; immune globulin g; immunoglobulin g; level; mass concentration; point in time; qnt; quan; quant; quantitative; random; rf338; scallop; serum; sr,Qn
60406-6,spinach igg ab [mass/volume] in serum,spinach igg-mcnc,spinach igg (s) [mass/vol],abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; f214; immune globulin g; immunoglobulin g; level; mass concentration; point in time; qnt; quan; quant; quantitative; random; serum; spinach; sr,Qn
60426-4,sars coronavirus ab [titer] in serum,sars-cov ab titr ser,sars-cov ab (s) [titer],abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; corona virus; dilution factor; dilution factor (titer); id; infectious disease; infectiousdisease; microbiology; point in time; random; sars coronavirus 1; sars-cov; sars-cov-1; serum; severe acute respiratory syndrome; smqn; sr; titer; titered; titre; ttr,SemiQn
60442-1,hedis 2011 panel,hedis 2011 panel,hedis 2011 panel,pan; panel.hedis; panl; pnl; point in time; random,-
60456-1,cd3+cd8+cd57+ cells/cells in blood,cd3+cd8+cd57+ cells nfr bld,cd3+cd8+cd57+ cells/cells (bld),blood; cd3 cells; cd3+cd8+ cells; cd3+cd8+cd57+ cells; cd3-cd8-cd57+; cd8 t cells; cell; cell markers; cellularity; hnk1; leu2; leu-2; leu4; leu-4; leu7; leu-7; lyme disease; natural killer cells; number fraction; percent; point in time; qnt; quan; quant; quantitative; random; suppressor t cells; suppressor/cytotoxic t cells; t3; t8; t-8; t8 suppressor cells; tsuppressor; wb; whole blood,Qn
6046-7,black walnut pollen ige ab [units/volume] in serum,black walnut poln ige qn,black walnut pollen ige qn (s),abs; aby; allergen; allergens; allergy testing; american black walnut; american walnut; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; black walnut; black walnut poln; eastern black walnut; immune globulin e; immunoglobulin e; point in time; qnt; quan; quant; quantitative; random; serum; sr; t90; virginia walnut,Qn
60471-0,buspirone [mass/volume] in urine,buspirone ur-mcnc,buspirone (u) [mass/vol],buspar; drug/toxicology; drugs; level; mass concentration; point in time; qnt; quan; quant; quantitative; random; ua; ur; urn,Qn
60472-8,complement c5.functional [units/volume] in serum or plasma,c5.functional serpl-acnc,complement c5.functional qn,arbitrary concentration; beta 1 f-globulin; comp; complmt; hematology/cell counts; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
60475-1,serotonin release 0.2 iu/ml heparin.low molecular weight [units/volume] in serum,sra .2 iu/ml lmw heparin ser-acnc,serotonin release 0.2 iu/ml heparin.low molecular weight qn (s),5-ht; 5-hydroxytryptamine; 5-hydroxytryptophane; arbitrary concentration; c10h12n2o; clexane; enoxaparin; enteramine; hep; hepar; heparin dependent platelet antibody; heparn; lmwh; lovenox; point in time; qnt; quan; quant; quantitative; random; serology; serotonin release assay; serum; sr; sra; sra .2 iu; sra .2 iu/ml lmwh; wt,Qn
60505-5,patient-confidential section set naaccr v.12,patient-confidential section naaccr v.12,,north american association of central cancer registries; oncology; point in time; random; tumor registry(naaccr),Set
6052-5,broccoli ige ab [units/volume] in serum,broccoli ige qn,broccoli ige qn (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; brassica oleracea cymosa; brassica oleracea var italics; broccoli; f260; immune globulin e; immunoglobulin e; point in time; qnt; quan; quant; quantitative; random; serum; sr,Qn
60534-5,sars coronavirus rna [presence] in serum or plasma by naa with probe detection,sars-cov rna serpl ql naa+probe,sars-cov rna naa+probe ql,3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; corona virus; dna nucleic acid probe; dna probe; id; infectious disease; infectiousdisease; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; naa+probe; naat; nasba; nucleic acid sequence based analysis; ordinal; pcr; pl; plasma; plsm; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; ribonucleic acid; sars coronavirus 1; sars-cov; sars-cov-1; screen; sda; serp; serpl; serplas; serum; serum or plasma; severe acute respiratory syndrome; sr; strand displacement amplification; tma; transcription mediated amplification,Ord
60539-4,tryptase.beta [mass/volume] in serum or plasma,tryptase.beta serpl-mcnc,tryptase.beta [mass/vol],b; chemistry; level; mass concentration; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
60547-7,11-oxo-androsterone/creatinine [mass ratio] in urine,11oxoandrost/creat ur,11-oxo-androsterone/creatinine (u) [mass ratio],11oxoandrost; androster; chemistry; cr; crea; creat; mass concentration ratio; mass ratio; mcrto; point in time; qnt; quan; quant; quantitative; random; ua; ucr; ur; urn,Qn
60549-3,deprecated 8-estriol [mass/volume] in urine,deprecated 8-estriol ur-mcnc,8-estriol (u) [mass/vol],chemistry; e3; level; mass concentration; point in time; qnt; quan; quant; quantitative; random; ua; ur; urn,Qn
60551-9,interferon.beta 1a ab [titer] in serum or plasma,inf-b1a ab titr serpl,interferon.beta 1a ab [titer],abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; avonex; b; betaferon; b-ifn 1a+1b; dilution factor; dilution factor (titer); ifn; ifn-b; inf-b; inf-b1a; pl; plasma; plsm; point in time; random; rebif; serology; serp; serpl; serplas; serum; serum or plasma; smqn; sr; titer; titered; titre; ttr,SemiQn
6059-0,candida albicans ige ab [units/volume] in serum,c albicans ige qn,c. albicans ige qn (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; c albicans; cand; candidiasis; immune globulin e; immunoglobulin e; m005; m5; monilia; point in time; qnt; quan; quant; quantitative; random; serum; sr; thrush; universallaborders,Qn
60594-9,face low/face all skull x-ray measured,sn-me'/face all skull xr,,cranial; cranium; dental; dentistry; head; length ratio; plain films; point in time; qnt; quan; quant; quantitative; random; sn-me'; xray; x-ray,Qn
60599-8,face lower incisor to chin [length] skull x-ray measured,face l1 to chin skull xr,,cranial; cranium; dental; dentistry; face l1 to chin; head; length; low; plain films; point in time; qnt; quan; quant; quantitative; random; xray; x-ray,Qn
60624-4,holdaway angle skull x-ray measured,na'-pg'-ls skull xr,,cranial; cranium; dental; dentistry; head; na'-pg'-ls; plain films; point in time; qnt; quan; quant; quantitative; random; xray; x-ray,Qn
60626-9,facial axis skull x-ray measured,bana-cc skull xr,,bana-cc; cranial; cranium; dental; dentistry; head; plain films; point in time; qnt; quan; quant; quantitative; random; xray; x-ray,Qn
60630-1,y axis to sella-nasion plane skull x-ray measured,sena-segn skull xr,,cranial; cranium; dental; dentistry; head; plain films; point in time; qnt; quan; quant; quantitative; random; se-na; sena-segn; s-n; xray; x-ray,Qn
60646-7,subnasale to stomion [length] skull x-ray measured,st-sn skull xr,,cranial; cranium; dental; dentistry; head; length; plain films; point in time; qnt; quan; quant; quantitative; random; st-sn; xray; x-ray,Qn
60654-1,posterior cranial base [length] skull x-ray measured,se-ar skull xr,,cranial; cranium; dental; dentistry; head; length; plain films; point in time; qnt; quan; quant; quantitative; random; se-ar; xray; x-ray,Qn
60656-6,condylion to gonion [length] skull x-ray measured,cd-go skull xr,,cd-go; cranial; cranium; dental; dentistry; head; length; plain films; point in time; qnt; quan; quant; quantitative; random; xray; x-ray,Qn
6067-3,cheese cheddar type ige ab [units/volume] in serum,cheddar ige qn,cheese cheddar type ige qn (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; f081; f81; immune globulin e; immunoglobulin e; point in time; qnt; quan; quant; quantitative; random; serum; sr,Qn
60687-1,test of infant motor performance version 5.1,,,pan; panel; panel.timp; panl; pnl; point in time; random; test of infant motor performance; timp,-
60698-8,isolated left ankle movement [timp],,,finding; findings; l; lower extremity joint; lt; ordinal; point in time; ql; qual; qualitative; random; screen; test of infant motor performance,Ord
60700-2,ballistic movements of the arms or legs (swipes or swats) [timp],,,finding; findings; ordinal; point in time; ql; qual; qualitative; random; screen; test of infant motor performance,Ord
60716-8,defensive reaction - arm movements [timp],,,finding; findings; ordinal; point in time; ql; qual; qualitative; random; react; rxn; screen; test of infant motor performance; upper extremity,Ord
60723-4,lateral straightening of the head and body with arm support [timp],,,bod; bodies; finding; findings; lat; ordinal; point in time; ql; qual; qualitative; random; screen; test of infant motor performance; upper extremity,Ord
60727-5,crawling [timp],,,finding; findings; ordinal; point in time; ql; qual; qualitative; random; screen; test of infant motor performance,Ord
60728-3,head turn in prone to sound (right) [timp],,,finding; findings; ordinal; point in time; ql; qual; qualitative; r; random; rt; screen; test of infant motor performance,Ord
60738-2,intraluminal [pressure] esophagus,intraluminal esoph,,esophageal; gastro; gastroenterology; gi; point in time; pressure; qnt; quan; quant; quantitative; random,Qn
60739-0,expiration [time] respiratory system,exp time,,breathing; exp; lung; lungs; point in time; pulmonary; pulmonology; qnt; quan; quant; quantitative; random; respiratory; rs,Qn
60741-6,desflurane target [vfr/ppres] airway adaptor --at end expiration,desfl target end exp vfr/ppres away adap,,away adap; desfl target; exp; lung; point in time; pulmonary; pulmonology; qnt; quan; quant; quantitative; random; respiratory,Qn
60763-0,target isoflurane [vfr/ppres] airway adaptor --at end expiration,target isofl end exp vfr/ppres away adap,,away adap; exp; lung; point in time; pulmonary; pulmonology; qnt; quan; quant; quantitative; random; respiratory; target isofl,Qn
6078-0,cockroach ige ab [units/volume] in serum,roach ige qn,cockroach ige qn (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; b germanica; cockroach; german cockroach; i006; i6; immune globulin e; immunoglobulin e; point in time; qnt; quan; quant; quantitative; random; roach; serum; sr; universallaborders,Qn
60804-2,minimum alveolar concentration (mac) for anesthesia.xxx anesthetic agent.xxx,mac for anesthesia vfr anesthetic,,alv; lung; mac for anesthesia; misc; miscellaneous; other; percent; point in time; pulmonary; pulmonology; qnt; quan; quant; quantitative; random; respiratory; spec; to be specified in another part of the message; unspecified; volfr; volume fraction,Qn
60805-9,desflurane [vfr/ppres] airway adaptor --during inspiration,des during insp vfr/ppres away adap,,away adap; in; insp; inspiratory; lung; point in time; pulmonary; pulmonology; qnt; quan; quant; quantitative; random; respiratory,Qn
60826-5,lung compliance,compliance lung,,compliance; lung; point in time; pulmonary; pulmonology; qnt; quan; quant; quantitative; random; respiratory,Qn
60832-3,room temperature,room temp,,point in time; pulmonary; qnt; quan; quant; quantitative; random; temp; temperature,Qn
60866-1,oxygen [vfr/ppres] airway adaptor,o2 vfr/ppres away adap,,away adap; lung; o2; o2 partial pressure; po2; point in time; pulmonary; pulmonology; qnt; quan; quant; quantitative; random; respiratory; to2,Qn
60885-1,enflurane [vfr/ppres] airway adaptor --during inspiration,enf during insp vfr/ppres away adap,,away adap; compound 347; ethrane; in; insp; inspiratory; lung; methylflurether; point in time; pulmonary; pulmonology; qnt; quan; quant; quantitative; random; respiratory,Qn
60920-6,nitrogen [vfr/ppres] airway adaptor --at end expiration,n2 end exp vfr/ppres away adap,,away adap; exp; lung; n; n2; nit; point in time; pulmonary; pulmonology; qnt; quan; quant; quantitative; random; respiratory,Qn
60957-8,intracranial pressure (icp) diastolic,icp diastolic,,cranial; cranium; dias; diast; diastoli; head; neuro; neurology; point in time; pressure; qnt; quan; quant; quantitative; random,Qn
60960-2,st amplitude.lead ai,st amp l-ai,,cardiac; cardio; cardiology; ecg; ekg.measurements; electrical potential; electrocardiogram; electrocardiograph; heart disease; hrt; painter's colic; pb; plumbism; point in time; qnt; quan; quant; quantitative; random; st amp l-ai; voltage,Qn
60972-7,st amplitude.precordial lead,st amp.precordial lead,,cardiac; cardio; cardiology; ecg; ekg.measurements; electrical potential; electrocardiogram; electrocardiograph; heart disease; hrt; painter's colic; pb; plumbism; point in time; qnt; quan; quant; quantitative; random; st amp.precordial lead; voltage,Qn
60986-7,central venous pressure (cvp) diastolic,cvp dias,,blood pressure; blood pressure diastolic; blood pressure measurements.central.molec; bp; bp dias; bp diastolic; cardio; cardiology; cath; cvp; dbp; dias; dias bp; diast; diastoli; heart disease; intravenous; iv; point in time; pressure; qnt; quan; quant; quantitative; random,Qn
60987-5,central venous pressure (cvp) systolic,cvp sys,,blood pressure; blood pressure measurements.central.molec; blood pressure systolic; bp; bp sys; bp systolic; cardio; cardiology; cath; cvp; heart disease; intravenous; iv; point in time; pressure; qnt; quan; quant; quantitative; random; sbp; sys bp,Qn
6098-8,dog dander ige ab [units/volume] in serum,dog dander ige qn,dog dander ige qn (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; canine; dog hair; e005; e5; immune globulin e; immunoglobulin e; point in time; qnt; quan; quant; quantitative; random; serum; sr; universallaborders,Qn
60997-4,right atrial pressure diastolic,ra pressure dias,,atrial; blood pressure measurements.central.molec; bp diastolic; cardiac; cardio; cardiology; dbp; dias; dias bp; diast; diastoli; heart disease; hrt; intrachamber dias pres; intrachamber pres; point in time; pressure; qnt; quan; quant; quantitative; r; ra; random; rap; rt,Qn
61020-4,halothane [vfr/ppres] airway adaptor --during expiration,hal during expir vfr/ppres away adap,,anestan; away adap; bromochlorotrifluoroethane; c2hbrclf3; chalothane; exp; fc-123b1; fluktan; fluorothane; fluothane; freon 123b1; halan; halotan; halsan; lung; narcotan; narkotan; point in time; pulmonary; pulmonology; qnt; quan; quant; quantitative; random; respiratory; rhodialothan,Qn
61036-0,alpha hydroxyalprazolam [presence] in urine,a-oh alpraz ur ql,alpha hydroxyalprazolam ql (u),alfa; alpha hydroxy alprazolam; alprozolam metabolite; a-oh alpraz; drug/toxicology; drugs; hydroxy alprazolam; hydroxyalpraz; oh-alpraz; ordinal; point in time; pr; ql; qual; qualitative; random; screen; ua; ur; urn,Ord
61045-1,methylenedioxyamphetamine [presence] in serum or plasma,mda serpl ql,methylenedioxyamphetamine ql,addiction; drug/toxicology; drugs; drugs of abuse; illicit; mda; methylenedioxymethamphetamine metabolite; ordinal; pl; plasma; plsm; point in time; potentialforabuse; pr; ql; qual; qualitative; random; screen; serp; serpl; serplas; serum; serum or plasma; sr,Ord
61062-6,carboxy tetrahydrocannabinol [presence] in gastric fluid,carboxythc gast ql,carboxy tetrahydrocannabinol ql (gast fld),11-nor-9-carboxy-delta-9-thc; 11-nor-9-carboxy-thc; 11-nor-delta-9-thc-9-cooh; 9-carboxy-11-nor-delta-9-tetrahydrocannabinol; addiction; carboxytetrahydrocannabinol; carboxythc; carboxy-thc-delta-9; delta(9)-thc; delta-9-tetrahydrocannabinol; delta-9-tetrahydrocannabinol metabolite; dronabinol; drug/toxicology; drugs; drugs of abuse; gast; gastric contents; gastric fluid; illicit; marijuana; nabilone; ordinal; point in time; potentialforabuse; pr; ql; qual; qualitative; random; screen; thc; thca; thcc; thccooh; thc-cooh,Ord
61071-7,7-aminoflunitrazepam [presence] in gastric fluid,7aminoflunitrazepam gast ql,7-aminoflunitrazepam ql (gast fld),7-amino flunitrazepam; 7aminoflunitrazepam; drug/toxicology; drugs; flunitrazepam metabolite; gast; gastric contents; gastric fluid; ordinal; point in time; pr; ql; qual; qualitative; random; screen,Ord
61081-6,ketamine [presence] in gastric fluid,ketamine gast ql,ketamine ql (gast fld),drug/toxicology; drugs; gast; gastric contents; gastric fluid; ketalar; ketaset; ketavet; ordinal; point in time; pr; ql; qual; qualitative; random; screen,Ord
61083-2,methylenedioxymethamphetamine [presence] in gastric fluid,mdma gast ql,methylenedioxymethamphetamine ql (gast fld),addiction; drug/toxicology; drugs; drugs of abuse; ecstasy; gast; gastric contents; gastric fluid; illicit; mdma; ordinal; point in time; potentialforabuse; pr; ql; qual; qualitative; random; screen,Ord
61089-9,pseudoephedrine [presence] in gastric fluid,pseudoephedrine gast ql,pseudoephedrine ql (gast fld),cenafed; drug/toxicology; drugs; gast; gastric contents; gastric fluid; ordinal; point in time; pr; pseudoephed; ql; qual; qualitative; random; screen; sudafed,Ord
61107-9,slc25a13 gene targeted mutation analysis in blood or tissue by molecular genetics method,slc25a13 gene mut anl bld/t,slc25a13 gene targeted mutation analysis molgen doc (bld/tiss),"aralar2; blood; citrin; ctln2; document; finding; findings; genetics; heredity; heritable; inherited; molecular genetics; molecular pathology; molpath; molpath.mutations; mut; mut anl; mutations; pcr; point in time; random; solute carrier family 25 (aspartate/glutamate carrier), member 13; solute carrier family 25, member 13; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",Doc
61129-3,phenx domain - demographics,domain - demographics,,demographic; pan; panel; panel.phenx; panl; pnl; point in time; random,-
61133-5,clinical impression [timp],,,imp; impression; impression/interpretation of study; impressions; interp; interpretation; ordinal; point in time; ql; qual; qualitative; random; screen; test of infant motor performance,Ord
61142-6,trimellitic anhydride (tma) igg ab [mass/volume] in serum,tma igg-mcnc,trimellitic anhydride (tma) igg (s) [mass/vol],abs; aby; allergen; allergens; allergy testing; anhydrid; antby; anti; antibodies; antibody; autoantibodies; autoantibody; immune globulin g; immunoglobulin g; k86; level; mass concentration; point in time; qnt; quan; quant; quantitative; random; serum; sr; tma; trimelllitic anhydride,Qn
61149-1,objective narrative,objective,,doc.misc; finding; findings; misc; narrative; point in time; random; report,Nar
61152-5,albumin [mass/volume] in serum or plasma by bromocresol purple (bcp) dye binding method,albumin serpl bcp-mcnc,albumin bcp dye [mass/vol],alb; chemistry; hepatology; kidney; level; liver; mass concentration; nephrology; pl; plasma; plsm; point in time; protein.albumin; qnt; quan; quant; quantitative; random; renal; serp; serpl; serplas; serum; serum or plasma; sr,Qn
61153-3,glucose [mass/volume] in peritoneal dialysis fluid --baseline,glucose bs diafp-mcnc,glucose baseline (perit dial fld) [mass/vol],bs; chemistry.challenge testing; diaf; diafp; dialysate; dialysis fluid; glu; glu tol; gluc; glucose tolerance; glucoseur; gtt; level; mass concentration; peritoneal dialysis fluid; point in time; qnt; quan; quant; quantitative; random,Qn
61155-8,hepatitis b virus codon l80v [presence] by genotype method,hbv l80v islt ql genotyp,hbv codon l80v genotyping ql (isol),antibiotic susceptibilities; codon 80; genotype; genotypic; hbv; hbv l80v; hep; hep b; hepatis; hepatit; hepatology; hepb; id; infectious disease; infectiousdisease; islt; isol; liver; ordinal; point in time; pr; ql; qual; qualitative; random; screen,Ord
61157-4,hepatitis b virus codon m204v [presence] by genotype method,hbv m204v islt ql genotyp,hbv codon m204v genotyping ql (isol),antibiotic susceptibilities; codon 204; genotype; genotypic; hbv; hbv m204v; hep; hep b; hepatis; hepatit; hepatology; hepb; id; infectious disease; infectiousdisease; islt; isol; liver; ordinal; point in time; pr; ql; qual; qualitative; random; screen,Ord
6116-8,ficus sp ige ab [units/volume] in serum,ficus ige qn,ficus sp ige qn (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; immune globulin e; immunoglobulin e; k81; point in time; qnt; quan; quant; quantitative; random; serum; species; spp; sr,Qn
61171-5,hepatitis b virus codon m250i [presence] by genotype method,hbv m250i islt ql genotyp,hbv codon m250i genotyping ql (isol),antibiotic susceptibilities; codon 205; genotype; genotypic; hbv; hbv m250i; hep; hep b; hepatis; hepatit; hepatology; hepb; id; infectious disease; infectiousdisease; islt; isol; liver; ordinal; point in time; pr; ql; qual; qualitative; random; screen,Ord
61173-1,hepatitis b virus codon l80i [presence] by genotype method,hbv l80i islt ql genotyp,hbv codon l80i genotyping ql (isol),antibiotic susceptibilities; codon 80; genotype; genotypic; hbv; hbv l80i; hep; hep b; hepatis; hepatit; hepatology; hepb; id; infectious disease; infectiousdisease; islt; isol; liver; ordinal; point in time; pr; ql; qual; qualitative; random; screen,Ord
61177-2,paraneoplastic ab [presence] in serum by immunofluorescence,paraneoplastic ab ser ql if,paraneoplastic ab if ql (s),abs; aby; acif; antby; anti; antibodies; antibody; anticomplement immunofluorescence; autoantibodies; autoantibody; fa; fluorescent antibody; fluoresent; ifa; immune fluorescence; immunoflour; immunofluor; immunofluorescence; neuro; neurology; oncology; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serology; serum; sr; time resolved fluorescence; trf,Ord
61180-6,hemoglobin [mass/volume] in blood from fetus,hgb bld fetus-mcnc,hemoglobin (bld fetus) [mass/vol],blood; fetal; gyn; gynecology; haemoglobin; hb; hematology/cell counts; hgb; level; mass concentration; ob; obgyn; obstetrics; point in time; qnt; quan; quant; quantitative; random; wb; whole blood,Qn
61185-5,spermatozoa thick midpiece/spermatozoa in semen,sperm thick midpiece nfr smn,spermatozoa thick midpiece/spermatozoa (sem),ejaculate; fertility testing; genitourinary; gu; number fraction; percent; point in time; qnt; quan; quant; quantitative; random; sem; seminal fluid; smn; smpls; sperm; sperm thick midpiece; uro; urology,Qn
61196-2,albumin [mass/volume] in urine from fetus,albumin ur fetus-mcnc,albumin (u fetus) [mass/vol],alb; chemistry; fetal; gyn; gynecology; level; mass concentration; ob; obgyn; obstetrics; point in time; protein.albumin; qnt; quan; quant; quantitative; random; ua; ur; urn,Qn
61199-6,hiv 1 integrase gene mutations detected [identifier],hiv1 integrase gene mut det islt,hiv 1 integrase gene mutations detected nom (isol),aids; antibiotic susceptibilities; hiv type 1; hiv type i; hiv1; hiv1 integrase; hiv1 integrase gene; hiv1 intinh; human immunodeficiency virus; i; id; identity or presence; infectious disease; infectiousdisease; intinh; islt; isol; mut; mut det; mutation; muts; nominal; point in time; random,Nom
6120-0,fusarium culmorum ige ab [units/volume] in serum,f culmorum ige qn,fusarium culmorum ige qn (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; f culmorum; immune globulin e; immunoglobulin e; m18; point in time; qnt; quan; quant; quantitative; random; serum; sr,Qn
61200-2,colorado tick fever virus igg ab [titer] in serum by immunofluorescence,ctfv igg titr ser if,colorado tick fever virus igg if (s) [titer],abs; aby; acif; antby; anti; antibodies; antibody; anticomplement immunofluorescence; autoantibodies; autoantibody; ctfv; dilution factor; dilution factor (titer); fa; fluorescent antibody; fluoresent; id; ifa; immune fluorescence; immune globulin g; immunoflour; immunofluor; immunofluorescence; immunoglobulin g; infectious disease; infectiousdisease; microbiology; point in time; random; serum; smqn; sr; time resolved fluorescence; titer; titered; titre; trf; ttr,SemiQn
6121-8,fusarium moniliforme ige ab [units/volume] in serum,f moniliforme ige qn,fusarium moniliforme ige qn (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; f moniliforme; fusarium proliferatum; gibberella fujikuroi; immune globulin e; immunoglobulin e; m9; point in time; qnt; quan; quant; quantitative; random; serum; sr; universallaborders,Qn
61221-8,aspergillus niger ige ab/ige total in serum,a niger ige/ige total %,a. niger ige/total ige (s) [%],%; a niger; abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; asperg; aspergil; aspergilis; aspergilla; aspergillin; aspergillosis; aspergils; aspergilus; autoantibodies; autoantibody; farmers lung; ige total; immune globulin e; immunoglobulin e; m207; point in time; qnt; quan; quant; quantitative; random; serum; sr; tot; total ige; totl,Qn
61226-7,oat ige ab/ige total in serum,oat ige/ige total %,oat ige/total ige (s) [%],%; abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; f007; f7; ige total; immune globulin e; immunoglobulin e; oat; oats; point in time; qnt; quan; quant; quantitative; random; serum; sr; tot; total ige; totl,Qn
61230-9,cockroach ige ab/ige total in serum,roach ige/ige total %,cockroach ige/total ige (s) [%],%; abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; b germanica; cockroach; german cockroach; i006; i6; ige total; immune globulin e; immunoglobulin e; point in time; qnt; quan; quant; quantitative; random; roach; serum; sr; tot; total ige; totl,Qn
6124-2,giant ragweed ige ab [units/volume] in serum,giant ragweed ige qn,giant ragweed ige qn (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; giant ragweed; immune globulin e; immunoglobulin e; point in time; qnt; quan; quant; quantitative; random; serum; sr; w003; w3,Qn
61253-1,arizona cypress ige ab/ige total in serum,arizona cypress ige/ige total %,arizona cypress ige/total ige (s) [%],%; abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; arizona cypress; autoantibodies; autoantibody; cupressus glabra; ige total; immune globulin e; immunoglobulin e; point in time; qnt; quan; quant; quantitative; random; rt222; serum; sr; t222; tot; total ige; totl,Qn
6125-9,gluten ige ab [units/volume] in serum,gluten ige qn,gluten ige qn (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; f079; f79; immune globulin e; immunoglobulin e; point in time; qnt; quan; quant; quantitative; random; serum; sr; universallaborders,Qn
61260-6,erythromycin ige ab/ige total in serum,erythromycin ige/ige total %,erythromycin ige/total ige (s) [%],%; abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; c212; ees; erygel; erythromycn; ige total; ilosone; ilotycin; iltycin; immune globulin e; immunoglobulin e; point in time; qnt; quan; quant; quantitative; random; serum; sr; tot; total ige; totl,Qn
61269-7,gelatin ige ab/ige total in serum,gelatin ige/ige total %,gelatin ige/total ige (s) [%],%; abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; c13; c74; f340; gelatine; ige total; immune globulin e; immunoglobulin e; point in time; qnt; quan; quant; quantitative; random; serum; sr; tot; total ige; totl,Qn
61270-5,gluten ige ab/ige total in serum,gluten ige/ige total %,gluten ige/total ige (s) [%],%; abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; f079; f79; ige total; immune globulin e; immunoglobulin e; point in time; qnt; quan; quant; quantitative; random; serum; sr; tot; total ige; totl,Qn
6127-5,goat epithelium ige ab [units/volume] in serum,goat epith ige qn,goat epithelium ige qn (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; e80; epithelia; immune globulin e; immunoglobulin e; point in time; qnt; quan; quant; quantitative; random; serum; sr,Qn
61282-0,perennial rye grass ige ab/ige total in serum,per rye grass ige/ige total %,perennial rye grass ige/total ige (s) [%],%; abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; g005; g5; ige total; immune globulin e; immunoglobulin e; italian ryegrass; per rye grass; perennial ryegrass; point in time; qnt; quan; quant; quantitative; random; rye grass; ryegrass; serum; sr; tot; total ige; totl,Qn
61295-2,parsley ige ab/ige total in serum,parsley ige/ige total %,parsley ige/total ige (s) [%],%; abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; f086; f86; ige total; immune globulin e; immunoglobulin e; parsley; petrosilenum crispum; point in time; qnt; quan; quant; quantitative; random; serum; sr; tot; total ige; totl,Qn
61314-1,sheep wool ige ab/ige total in serum,sheep wool ige/ige total %,sheep wool ige/total ige (s) [%],%; abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; ige total; immune globulin e; immunoglobulin e; k21; ovine; point in time; qnt; quan; quant; quantitative; random; serum; sr; tot; total ige; totl,Qn
61315-8,red imported fire ant ige ab/ige total in serum,red imp fire ant ige/ige total %,red imported fire ant ige/total ige (s) [%],%; abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; fire ant; i070; i70; ige total; immune globulin e; immunoglobulin e; point in time; qnt; quan; quant; quantitative; random; red imp fire ant; red imported fire ant; serum; sr; tot; total ige; totl,Qn
61323-2,cranberry ige ab/ige total in serum,cranberry ige/ige total %,cranberry ige/total ige (s) [%],%; abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; cranberry; f177; f341; ige total; immune globulin e; immunoglobulin e; point in time; qnt; quan; quant; quantitative; random; rf341; serum; sr; tot; total ige; totl; vaccinium oxycoccus,Qn
6132-5,green coffee bean ige ab [units/volume] in serum,green coffee bean ige qn,green coffee bean ige qn (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; beans; f315; green bean; green coffee bean; immune globulin e; immunoglobulin e; k70; point in time; qnt; quan; quant; quantitative; random; rf315; serum; sr,Qn
61329-9,cucumber ige ab/ige total in serum,cucumber ige/ige total %,cucumber ige/total ige (s) [%],%; abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; cucumber; f244; gherkin; ige total; immune globulin e; immunoglobulin e; point in time; qnt; quan; quant; quantitative; random; serum; sr; tot; total ige; totl,Qn
61337-2,chicken feather ige ab/ige total in serum,chicken feather ige/ige total %,chicken feather ige/total ige (s) [%],%; abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; e085; e85; f083; f83; feathers; gallus spp; ige total; immune globulin e; immunoglobulin e; point in time; qnt; quan; quant; quantitative; random; serum; sr; tot; total ige; totl,Qn
61342-2,mouse urine proteins ige ab/ige total in serum,mouse urine prot ige/ige total %,mouse urine proteins ige/total ige (s) [%],%; abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; e72; ige total; immune globulin e; immunoglobulin e; mice; murine; mus musculus; point in time; protein; qnt; quan; quant; quantitative; random; serum; sr; tot; total ige; totl,Qn
61352-1,lymphocyte proliferation stimulated by 2.5 ug pokeweed mitogen in blood,lpt 2.5 ug pw bld,lymphocyte proliferation stimulated by 2.5 ug pokeweed mitogen (bld) [relative ratio],blood; lpa; lpt; lpt 2.5 ug pw; lst; lymphocyte antigen proliferation; lymphocyte antigen stimulation; mcg; pha; point in time; qnt; quan; quant; quantitative; random; relative ratio; serology; stim; wb; whole blood,Qn
61358-8,surgical operation consent document,operative consent,,doc.ont; document; finding; findings; form; operative consent; point in time; random; surg,Doc
61380-2,human papilloma virus 45 dna [presence] in specimen by naa with probe detection,hpv45 dna spec ql naa+probe,hpv 45 dna naa+probe ql (specimen),3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; deoxyribonucleic acid; dna nucleic acid probe; dna probe; genital warts; hpv; hpv45; human papillomavirus; id; infectious disease; infectiousdisease; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; misc; miscellaneous; naa+probe; naat; nasba; nucleic acid sequence based analysis; ordinal; other; papilloma virus intermediate risk; pcr; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; screen; sda; spec; strand displacement amplification; tma; to be specified in another part of the message; transcription mediated amplification; unspecified,Ord
61388-5,human papilloma virus 68 dna [presence] in specimen by naa with probe detection,hpv68 dna spec ql naa+probe,hpv 68 dna naa+probe ql (specimen),3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; deoxyribonucleic acid; dna nucleic acid probe; dna probe; genital warts; hpv; hpv68; human papillomavirus; id; infectious disease; infectiousdisease; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; misc; miscellaneous; naa+probe; naat; nasba; nucleic acid sequence based analysis; ordinal; other; pcr; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; screen; sda; spec; strand displacement amplification; tma; to be specified in another part of the message; transcription mediated amplification; unspecified,Ord
61409-9,cyclobenzaprine [presence] in urine by confirmatory method,cyclobenzaprine ur ql cfm,cyclobenzaprine confirm ql (u),amrix; cfm; cnfr; cnfrm; conf; confirmation; confirmatory; drug/toxicology; drugs; flexaril; flexeril; gcms; lc/ms/ms; ordinal; point in time; pr; ql; qual; qualitative; random; screen; ua; ur; urn,Ord
61418-0,imipramine [presence] in urine by confirmatory method,imipramine ur ql cfm,imipramine confirm ql (u),cfm; cnfr; cnfrm; conf; confirmation; confirmatory; drug/toxicology; drugs; gcms; imipra; lc/ms/ms; ordinal; point in time; pr; ql; qual; qualitative; random; screen; tofranil; ua; ur; urn,Ord
61433-9,how old was sample person when he or she completely stopped breastfeeding or being fed breast milk [phenx],age stopped breastfeed breast milk phenx,,age stopped breastfeed breast milk; f43; persons; point in time; qnt; quan; quant; quantitative; random,Qn
61434-7,was sample person ever breastfed or fed breast milk [phenx],ever fed breast milk phenx,,ever fed breast milk; f43; finding; findings; ordinal; persons; point in time; ql; qual; qualitative; random; screen,Ord
61445-3,how often did you eat macaroni and cheese in the past 30 days [phenx],macaroni cheese in 30d phenx,,finding; findings; last; macaroni cheese in 30d; ordinal; ql; qual; qualitative; screen,Ord
61446-1,"each time you ate macaroni and cheese, how much did you usually eat in the past 30 days [phenx]",how much macaroni cheese in 30d phenx,,finding; findings; how much macaroni cheese in 30d; last; ordinal; ql; qual; qualitative; screen,Ord
61455-2,how often did you eat pizza in the past 30 days [phenx],pizza in 30d phenx,,finding; findings; last; ordinal; pizza in 30d; ql; qual; qualitative; screen,Ord
61456-0,"each time you ate pizza, how much did you usually eat in past 30 days [phenx]",how much pizza in 30d phenx,,finding; findings; how much pizza in 30d; last; ordinal; ql; qual; qualitative; screen,Ord
61459-4,"how often did you eat cooked dried beans, such as refried beans, baked beans, bean soup, and pork and beans in past 30 days [phenx]",freq cooked dried beans in 30d phenx,,arterial stenosis; beans; f026; f26; finding; findings; freq cooked dried beans in 30d; last; ordinal; pig; porcine; ql; qual; qualitative; screen; sus spp; swine,Ord
61462-8,how often did you eat any kind of cheese in past 30 days [phenx],any cheese in 30d phenx,,any cheese in 30d; finding; findings; last; ordinal; ql; qual; qualitative; screen,Ord
61478-4,"how often did you drink black tea such as lipton, or earl grey [phenx]",black tea phenx,,arterial stenosis; finding; findings; ordinal; point in time; ql; qual; qualitative; random; screen,Ord
61484-2,"how often did you drink decaffeinated espresso and espresso drinks (latte, mocha, americano) [phenx]",decaf espresso phenx,,decaf espresso; finding; findings; ordinal; point in time; ql; qual; qualitative; random; screen,Ord
61488-3,how often did you drink diet colas and diet root beer (caffeine free) [phenx],diet cola no caffeine phenx,,caffn; diet cola no caffeine; finding; findings; fr; non-protein bound; ordinal; point in time; ql; qual; qualitative; random; screen,Ord
61493-3,"what is your serving size for espresso and espresso drinks, not decaffeinated (latte, mocha, americano) [phenx]",size espresso not decaf phenx,,finding; findings; ordinal; point in time; ql; qual; qualitative; random; screen; size espresso not decaf,Ord
61499-0,"what is your serving size for instant coffee, not decaffeinated (including flavored types) [phenx]",size instant coffee not decaf phenx,,finding; findings; ordinal; point in time; ql; qual; qualitative; random; screen; size instant coffee not decaf,Ord
61509-6,deprecated phenx measure - dietary supplements,,,measure - ds; pan; panel; panel.phenx; panl; pnl; point in time; random,-
61510-4,how often did you take b-complex or stress-tab type multiple vitamins [phenx],bcomplex stress vit phenx,,bcomplex stress vit; compx; finding; findings; mult; multi; ordinal; point in time; ql; qual; qualitative; random; screen,Ord
6151-5,italian cypress ige ab [units/volume] in serum,italian cypress ige qn,italian cypress ige qn (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; funeral cypress; immune globulin e; immunoglobulin e; italian cypress; mediterranean cypress; point in time; qnt; quan; quant; quantitative; random; serum; sr; t023; t23; universallaborders,Qn
61515-3,how often did you take flaxseed [phenx],flaxseed phenx,,finding; findings; ordinal; point in time; ql; qual; qualitative; random; screen,Ord
61529-4,how many years did you take coenzyme q-10 [phenx],years coenzyme q10 phenx,,point in time; qnt; quan; quant; quantitative; random; years coenzyme q10,Qn
61537-7,how many years did you take vitamin b-6 [phenx],years vit b6 phenx,,point in time; qnt; quan; quant; quantitative; random; years vit b6,Qn
61543-5,how often did you take vitamin e [phenx],vit e phenx,,finding; findings; ordinal; point in time; ql; qual; qualitative; random; screen; vit e,Ord
61545-0,how many years did you take vitamin e [phenx],years vit e phenx,,point in time; qnt; quan; quant; quantitative; random; years vit e,Qn
61563-3,about how often did you drink orange juice or grapefruit juice in past 12 months [phenx],how often orange juice in 12mo phenx,,1 year; 12mos; finding; findings; how often orange juice in 12mo; last; ordinal; ql; qual; qualitative; screen,Ord
61564-1,about how often did you eat fruit (not juices) in past 12 months [phenx],how often fruit not juice in 12mo phenx,,1 year; 12mos; finding; findings; how often fruit not juice in 12mo; last; ordinal; ql; qual; qualitative; screen,Ord
61566-6,"about how often did you eat cheese or cheese spread, regular fat, in past 12 months [phenx]",how often cheese reg fat in 12mo phenx,,1 year; 12mos; finding; findings; how often cheese reg fat in 12mo; last; ordinal; ql; qual; qualitative; screen,Ord
61571-6,about how often did you eat rice in past 12 months [phenx],about how often rice in 12mo phenx,,1 year; 12mos; about how often rice in 12mo; finding; findings; last; ordinal; ql; qual; qualitative; screen,Ord
61580-7,"in general, how would you rate your mental health, including your mood and your ability to think [promis]",,,"emotional stability; finding; findings; in general how would you rate your mental health, including your mood and your ability to think; ordinal; patient reported outcomes information system; point in time; promise; ql; qual; qualitative; random; screen; survey; survey.promis",Ord
61583-1,how would you rate your pain on average in past 7 days [promis],,,finding; findings; last; ordinal; patient reported outcomes information system; promise; ql; qual; qualitative; screen; survey; survey.promis,Ord
61593-0,how much do physical health problems now limit your usual physical activities (such as walking or climbing stairs) [promis],,,arterial stenosis; finding; findings; ordinal; patient reported outcomes information system; point in time; promise; ql; qual; qualitative; random; screen; survey; survey.promis,Ord
61596-3,are you able to stand for one hour [promis],,,finding; findings; ordinal; patient reported outcomes information system; point in time; promise; ql; qual; qualitative; random; screen; survey; survey.promis,Ord
61597-1,are you able to do chores such as vacuuming or yard work [promis],,,arterial stenosis; finding; findings; job; occupation; ordinal; patient reported outcomes information system; point in time; promise; ql; qual; qualitative; random; screen; survey; survey.promis,Ord
61598-9,are you able to push open a heavy door [promis],,,finding; findings; ordinal; patient reported outcomes information system; point in time; promise; ql; qual; qualitative; random; screen; survey; survey.promis,Ord
61601-1,are you able to stand up from an armless straight chair [promis],,,finding; findings; ordinal; patient reported outcomes information system; point in time; promise; ql; qual; qualitative; random; screen; survey; survey.promis,Ord
61603-7,are you able to reach into a high cupboard [promis],,,finding; findings; ordinal; patient reported outcomes information system; point in time; promise; ql; qual; qualitative; random; screen; survey; survey.promis,Ord
6160-6,lepidoglyphus destructor ige ab [units/volume] in serum,l destructor ige qn,lepidoglyphus destructor ige qn (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; d071; d71; immune globulin e; immunoglobulin e; l destructor; mite; point in time; qnt; quan; quant; quantitative; random; serum; sr; storage mite,Qn
61616-9,are you able to exercise hard for half an hour [promis],,,activity; excz; exercise; finding; findings; ordinal; patient reported outcomes information system; point in time; promise; ql; qual; qualitative; random; screen; survey; survey.promis,Ord
6162-2,lilac ige ab [units/volume] in serum,lilac ige qn,lilac ige qn (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; immune globulin e; immunoglobulin e; lilac; point in time; qnt; quan; quant; quantitative; random; serum; sr; t250,Qn
61628-4,are you able to get out of bed into a chair [promis],,,finding; findings; ordinal; patient reported outcomes information system; point in time; promise; ql; qual; qualitative; random; screen; survey; survey.promis,Ord
61632-6,are you able to brush your teeth [promis],,,finding; findings; ordinal; patient reported outcomes information system; point in time; promise; ql; qual; qualitative; random; screen; survey; survey.promis,Ord
61643-3,are you able to carry two bags filled with groceries 100 yards [promis],,,2; finding; findings; ordinal; patient reported outcomes information system; point in time; promise; ql; qual; qualitative; random; screen; survey; survey.promis,Ord
61665-6,are you able to open a new milk carton [promis],,,f43; finding; findings; ordinal; patient reported outcomes information system; point in time; promise; ql; qual; qualitative; random; screen; survey; survey.promis,Ord
61679-7,does your health now limit you in going for a short walk (less than 15 minutes) [promis],,,finding; findings; ordinal; patient reported outcomes information system; point in time; promise; ql; qual; qualitative; random; screen; survey; survey.promis,Ord
61698-7,does your health now limit you in climbing one flight of stairs [promis],,,finding; findings; limit climbing 1 flight stairs; ordinal; patient reported outcomes information system; point in time; promise; ql; qual; qualitative; random; screen; survey; survey.promis,Ord
61703-5,"are you able to use your hands, such as for turning faucets, using kitchen gadgets, or sewing [promis]",,,arterial stenosis; finding; findings; ordinal; patient reported outcomes information system; point in time; promise; ql; qual; qualitative; random; screen; survey; survey.promis,Ord
6172-1,deprecated melon ige ab [units/volume] in serum,deprecated melon ige qn,melon ige qn (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; f87; honey dew; honeydew; immune globulin e; immunoglobulin e; melon; melons; point in time; qnt; quan; quant; quantitative; random; serum; sr,Qn
6175-4,common millet ige ab [units/volume] in serum,common millet ige qn,common millet ige qn (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; common millet; f055; f55; immune globulin e; immunoglobulin e; point in time; qnt; quan; quant; quantitative; random; serum; sr,Qn
6176-2,mimosa ige ab [units/volume] in serum,mimosa ige qn,mimosa ige qn (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; immune globulin e; immunoglobulin e; point in time; qnt; quan; quant; quantitative; random; serum; sr,Qn
61777-9,how much did pain interfere with your enjoyment of social activities in past 7 days [promis],,,finding; findings; last; ordinal; patient reported outcomes information system; promise; ql; qual; qualitative; screen; survey; survey.promis,Ord
61792-8,how often did pain prevent you from sitting for more than one hour in past 7 days [promis],,,finding; findings; last; ordinal; pain prevent sitting one hour past 7d; patient reported outcomes information system; promise; ql; qual; qualitative; screen; survey; survey.promis,Ord
61796-9,to what degree did you have to push yourself to get things done because of your fatigue in past 7 days [promis],,,finding; findings; last; ordinal; patient reported outcomes information system; promise; ql; qual; qualitative; screen; survey; survey.promis,Ord
61798-5,how often did you have to push yourself to get things done because of your fatigue in past 7 days [promis],,,finding; findings; have push get things done due to fatigue past 7d; last; ordinal; patient reported outcomes information system; promise; ql; qual; qualitative; screen; survey; survey.promis,Ord
61808-2,how often did your fatigue interfere with your ability to engage in recreational activities in past 7 days [promis],,,fatigue interfere recreation activity past 7d; finding; findings; last; ordinal; patient reported outcomes information system; promise; ql; qual; qualitative; screen; survey; survey.promis,Ord
61839-7,to what degree did your fatigue make you feel less alert in past 7 days [promis],,,finding; findings; last; ordinal; patient reported outcomes information system; promise; ql; qual; qualitative; screen; survey; survey.promis,Ord
61843-9,how often did you feel run-down in past 7 days [promis],,,finding; findings; last; ordinal; patient reported outcomes information system; promise; ql; qual; qualitative; screen; survey; survey.promis,Ord
6185-3,mustard ige ab [units/volume] in serum,mustard ige qn,mustard ige qn (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; brassica/sinapis spp; f089; f89; immune globulin e; immunoglobulin e; point in time; qnt; quan; quant; quantitative; random; serum; sr,Qn
61862-9,how exhausted were you on average in past 7 days [promis],,,finding; findings; last; ordinal; patient reported outcomes information system; promise; ql; qual; qualitative; screen; survey; survey.promis,Ord
61866-0,how much mental energy did you have on average in past 7 days [promis],,,finding; findings; last; ordinal; patient reported outcomes information system; promise; ql; qual; qualitative; screen; survey; survey.promis,Ord
61869-4,how sluggish were you on average in past 7 days [promis],,,finding; findings; last; ordinal; patient reported outcomes information system; promise; ql; qual; qualitative; screen; survey; survey.promis,Ord
61876-9,how often did you have physical energy in past 7 days [promis],,,finding; findings; last; ordinal; patient reported outcomes information system; promise; ql; qual; qualitative; screen; survey; survey.promis,Ord
61878-5,i feel fatigued during the past 7 days [promis],,,finding; findings; last; ordinal; patient reported outcomes information system; promise; ql; qual; qualitative; screen; survey; survey.promis,Ord
6187-9,neurospora sitophila ige ab [units/volume] in serum,n sitophila ige qn,neurospora sitophila ige qn (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; immune globulin e; immunoglobulin e; n sitophila; point in time; qnt; quan; quant; quantitative; random; serum; sr,Qn
61883-5,i had trouble finishing things because i was tired in past 7 days [promis],,,finding; findings; last; ordinal; patient reported outcomes information system; promise; ql; qual; qualitative; screen; survey; survey.promis,Ord
61888-4,i had to limit my social activity because i was tired in past 7 days [promis],,,activ; actvty; finding; findings; last; movements; ordinal; patient reported outcomes information system; promise; ql; qual; qualitative; screen; survey; survey.promis,Ord
618-9,bacteria identified in pleural fluid by culture,bacteria plr cult,bacteria identified cx nom (pleur fld),bact; c&s; cult; cultures; id; identity or presence; infectious disease; infectiousdisease; lung; microbiology; nominal; pleural; pleural fluid; point in time; pulmonary; pulmonology; random; respiratory; thoracentesis fluid,Nom
6189-5,white oak ige ab [units/volume] in serum,white oak ige qn,white oak ige qn (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; immune globulin e; immunoglobulin e; oak; point in time; qnt; quan; quant; quantitative; random; serum; sr; t007; t7; universallaborders; white oak,Qn
61930-4,i had a racing or pounding heart in past 7 days [promis],,,finding; findings; last; ordinal; patient reported outcomes information system; promise; ql; qual; qualitative; screen; survey; survey.promis,Ord
61939-5,i felt terrified in past 7 days [promis],,,finding; findings; last; ordinal; patient reported outcomes information system; promise; ql; qual; qualitative; screen; survey; survey.promis,Ord
61946-0,many situations made me worry in past 7 days [promis],,,finding; findings; last; ordinal; patient reported outcomes information system; promise; ql; qual; qualitative; screen; survey; survey.promis,Ord
61952-8,promis item bank - emotional distress - depression - version 1.0,,,pan; panel; panel.survey.promis; panl; patient reported outcomes information system; pnl; point in time; promise; random; survey; survey.promis,-
61963-5,i had trouble feeling close to people in past 7 days [promis],,,finding; findings; last; ordinal; patient reported outcomes information system; promise; ql; qual; qualitative; screen; survey; survey.promis,Ord
61965-0,i felt that i was not needed in past 7 days [promis],,,finding; findings; last; ordinal; patient reported outcomes information system; promise; ql; qual; qualitative; screen; survey; survey.promis,Ord
61967-6,i felt depressed in past 7 days [promis],,,finding; findings; last; ordinal; patient reported outcomes information system; promise; ql; qual; qualitative; screen; survey; survey.promis,Ord
6197-8,paecilomyces sp ige ab [units/volume] in serum,paecilomyces ige qn,paecilomyces sp ige qn (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; immune globulin e; immunoglobulin e; m24; point in time; qnt; quan; quant; quantitative; random; serum; species; spp; sr,Qn
61990-8,i laid in bed for hours waiting to fall asleep in past 7 days [promis],,,finding; findings; last; ordinal; patient reported outcomes information system; promise; ql; qual; qualitative; screen; survey; survey.promis,Ord
61995-7,my sleep was light in past 7 days [promis],,,finding; findings; last; ordinal; patient reported outcomes information system; promise; ql; qual; qualitative; screen; survey; survey.promis,Ord
61997-3,i felt lousy when i woke up in past 7 days [promis],,,finding; findings; last; ordinal; patient reported outcomes information system; promise; ql; qual; qualitative; screen; survey; survey.promis,Ord
62013-8,i was sleepy during the daytime in past 7 days [promis],,,finding; findings; last; ordinal; patient reported outcomes information system; promise; ql; qual; qualitative; screen; survey; survey.promis,Ord
62014-6,i had trouble staying awake during the day in past 7 days [promis],,,finding; findings; last; ordinal; patient reported outcomes information system; promise; ql; qual; qualitative; screen; survey; survey.promis,Ord
62016-1,i had a hard time concentrating because i was sleepy in past 7 days [promis],,,finding; findings; last; ordinal; patient reported outcomes information system; promise; ql; qual; qualitative; screen; survey; survey.promis,Ord
62020-3,i had a hard time controlling my emotions because of poor sleep in past 7 days [promis],,,finding; findings; last; ordinal; patient reported outcomes information system; promise; ql; qual; qualitative; screen; survey; survey.promis,Ord
62025-2,when i woke up i felt ready to start the day in past 7 days [promis],,,finding; findings; last; ordinal; patient reported outcomes information system; promise; ql; qual; qualitative; screen; started; survey; survey.promis,Ord
62029-4,i was satisfied with my ability to do all of the community activities that are really important to me in past 7 days [promis],,,finding; findings; last; ordinal; patient reported outcomes information system; promise; ql; qual; qualitative; screen; survey; survey.promis,Ord
62035-1,i was happy with how much i do for my friends in past 7 days [promis],,,finding; findings; last; ordinal; patient reported outcomes information system; promise; ql; qual; qualitative; screen; survey; survey.promis,Ord
62044-3,i was satisfied with the amount of time i spend doing work (include work at home) in past 7 days [promis],,,finding; findings; job; last; occupation; ordinal; patient reported outcomes information system; promise; ql; qual; qualitative; screen; survey; survey.promis,Ord
62058-3,i worried about what could happen to me in past 7 days [promis],,,finding; findings; last; ordinal; patient reported outcomes information system; promise; ql; qual; qualitative; screen; survey; survey.promis,Ord
62062-5,i worried when i was away from home in past 7 days [promis],,,finding; findings; last; ordinal; patient reported outcomes information system; promise; ql; qual; qualitative; screen; survey; survey.promis,Ord
62063-3,i worried when i was at home in past 7 days [promis],,,finding; findings; last; ordinal; patient reported outcomes information system; promise; ql; qual; qualitative; screen; survey; survey.promis,Ord
62086-4,i felt too sad to eat in past 7 days [promis],,,finding; findings; last; ordinal; patient reported outcomes information system; promise; ql; qual; qualitative; screen; survey; survey.promis,Ord
62087-2,i didn't care about anything in past 7 days [promis],,,finding; findings; last; ordinal; patient reported outcomes information system; promise; ql; qual; qualitative; screen; survey; survey.promis; t prime,Ord
62088-0,i wanted to be by myself in past 7 days [promis],,,finding; findings; last; ordinal; patient reported outcomes information system; promise; ql; qual; qualitative; screen; survey; survey.promis,Ord
62090-6,it was hard for me to have fun in past 7 days [promis],,,finding; findings; last; ordinal; patient reported outcomes information system; promise; ql; qual; qualitative; screen; survey; survey.promis,Ord
62102-9,i felt too tired to spend time with my friends in past 7 days [promis],,,finding; findings; last; ordinal; patient reported outcomes information system; promise; ql; qual; qualitative; screen; survey; survey.promis,Ord
62115-1,i was too tired to take a bath or shower in past 7 days [promis],,,finding; findings; last; ordinal; patient reported outcomes information system; promise; ql; qual; qualitative; screen; survey; survey.promis,Ord
62124-3,i could get into bed by myself in past 7 days [promis],,,finding; findings; last; ordinal; patient reported outcomes information system; promise; ql; qual; qualitative; screen; survey; survey.promis,Ord
62140-9,i could walk across the room in past 7 days [promis],,,finding; findings; last; ordinal; patient reported outcomes information system; promise; ql; qual; qualitative; screen; survey; survey.promis,Ord
62151-6,it was hard to get along with other people when i had pain in past 7 days [promis],,,finding; findings; last; ordinal; othr; patient reported outcomes information system; promise; ql; qual; qualitative; screen; survey; survey.promis,Ord
62169-8,other kids wanted to be with me in past 7 days [promis],,,finding; findings; last; ordinal; othr; patient reported outcomes information system; promise; ql; qual; qualitative; screen; survey; survey.promis,Ord
62171-4,promis pediatric item bank - physical function - upper extremity - version 1.0,,,fcn; func; funct; pan; panel; panel.survey.promis; panl; patient reported outcomes information system; peds; pnl; point in time; promise; random; survey; survey.promis; up,-
62173-0,i could open a jar by myself in past 7 days [promis],,,finding; findings; last; ordinal; patient reported outcomes information system; promise; ql; qual; qualitative; screen; survey; survey.promis,Ord
62181-3,i felt fed up in past 7 days [promis],,,finding; findings; last; ordinal; patient reported outcomes information system; promise; ql; qual; qualitative; screen; survey; survey.promis,Ord
6218-2,pineapple ige ab [units/volume] in serum,pineapple ige qn,pineapple ige qn (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; f210; immune globulin e; immunoglobulin e; pineapple; point in time; qnt; quan; quant; quantitative; random; serum; sr,Qn
62194-6,promis short form - pain behavior 7a - version 1.0,,,pan; panel; panel.survey.promis; panl; patient reported outcomes information system; pnl; point in time; promise; random; survey; survey.promis,-
62226-6,i could move my hands or fingers in past 7 days [promis],,,finding; findings; last; ordinal; patient reported outcomes information system; promise; ql; qual; qualitative; screen; survey; survey.promis,Ord
62244-9,platelets [#/volume] in blood from fetus by automated count,platelet # bld fetus auto,platelets auto (bld fetus) [#/vol],#; abs; absolute; absolutes; auto; automated detection; blood; cnt; count; count/volume; ct; elec; elect; electr; fetal; gyn; gynecology; hematology/cell counts; number concentration; number concentration (count/vol); ob; obgyn; obstetrics; platelet; platelet count; platelt; plt; point in time; qnt; quan; quant; quantitative; random; thrb; thrombocyte; thrombocytes; wb; whole blood,Qn
62248-0,nucleated erythrocytes [#/volume] in blood from fetus by automated count,nrbc # bld fetus auto,nucleated rbc auto (bld fetus) [#/vol],#; abs; absolute; absolutes; auto; automated detection; blood; cnt; count; count/volume; ct; discocytes; elec; elect; electr; erthrocyte; erythroblasts; erythrocyte; fetal; gyn; gynecology; hematology/cell counts; normoblasts; nrbc; nrbcs; nuc; number concentration; number concentration (count/vol); ob; obgyn; obstetrics; point in time; qnt; quan; quant; quantitative; random; rbc; rbcs; red blood cell; red blood cells; red blood corpuscle; red blood corpusles; red cell; red cells; wb; whole blood,Qn
62249-8,reticulocytes [#/volume] in blood from fetus by automated count,retics # fetus auto,reticulocytes auto (bld fetus) [#/vol],#; abs; absolute; absolutes; auto; automated detection; blood; cnt; count; count/volume; ct; elec; elect; electr; fetal; gyn; gynecology; hematology; hematology/cell counts; heme; number concentration; number concentration (count/vol); ob; obgyn; obstetrics; point in time; polychromatophilic red cells; qnt; quan; quant; quantitative; random; retic; retics; reticulocyte; wb; whole blood,Qn
62250-6,immature reticulocytes/reticulocytes.total in blood from fetus by automated count,imm retics nfr fetus auto,immature reticulocytes/total reticulocytes auto (bld fetus),auto; automated detection; blood; elec; elect; electr; fetal; gyn; gynecology; hematology; hematology/cell counts; heme; imm; imm retics; immat; irf; number fraction; ob; obgyn; obstetrics; percent; point in time; polychromatophilic red cells; qnt; quan; quant; quantitative; random; retic; retics; reticulocyte; shift cells; stress cells; tot; totl; wb; whole blood,Qn
62252-2,cd79 cells/cells in blood,cd79 cells nfr bld,cd79 cells/cells (bld),blood; cd79 cells; cell; cell markers; cellularity; number fraction; percent; point in time; qnt; quan; quant; quantitative; random; wb; whole blood,Qn
62253-0,lipoprotein.alpha [entitic length] in serum or plasma,hdl serpl qn,lipoprotein.alpha [entitic length],alfa; chemistry; entitic length; hdl; high density lipoproteins; lip; lipoprot; lipoproteins; lp; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
62265-4,desflurane [vfr/ppres] airway adaptor --during expiration,des during expir vfr/ppres away adap,,away adap; exp; lung; point in time; pulmonary; pulmonology; qnt; quan; quant; quantitative; random; respiratory,Qn
62266-2,enflurane [vfr/ppres] airway adaptor,enf vfr/ppres away adap,,away adap; compound 347; ethrane; lung; methylflurether; point in time; pulmonary; pulmonology; qnt; quan; quant; quantitative; random; respiratory,Qn
62267-0,halothane [vfr/ppres] airway adaptor,hal vfr/ppres away adap,,anestan; away adap; bromochlorotrifluoroethane; c2hbrclf3; chalothane; fc-123b1; fluktan; fluorothane; fluothane; freon 123b1; halan; halotan; halsan; lung; narcotan; narkotan; point in time; pulmonary; pulmonology; qnt; quan; quant; quantitative; random; respiratory; rhodialothan,Qn
6227-3,red pepper ige ab [units/volume] in serum,red pepper ige qn,red pepper ige qn (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; f280; immune globulin e; immunoglobulin e; point in time; qnt; quan; quant; quantitative; random; red pepper; serum; sr,Qn
62279-5,phenx - breastfeeding protocol 050101,phenx - breastfeeding protocol,,pan; panel; panel.phenx; panl; pnl; point in time; random,-
6228-1,red top grass ige ab [units/volume] in serum,red top grass ige qn,red top grass ige qn (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; bent grass; bentgrass; g009; g9; immune globulin e; immunoglobulin e; point in time; qnt; quan; quant; quantitative; random; red top bent grass; red top grass; redtop; serum; sr,Qn
62281-1,phenx - dairy food protocol 050401,phenx - dairy food protocol,,pan; panel; panel.phenx; panl; pnl; point in time; random,-
62284-5,phenx - fruits and veg protocol 050701,phenx - fruits and veg protocol,,pan; panel; panel.phenx; panl; pnl; point in time; random,-
62307-4,krabbe disease newborn screening panel,krabbe disease nbs pnl dbs,krabbe disease nbs panel (dbs),asympt; asymptomatic; blood; chemistry; dbs; dis; diseases; dried blood spot; dz; filter paper; fp; galactocerebrosidase deficiency; galc; globoid cell leukodystrophy; gyn; gynecology; krabbe disease nbs pnl; nb screen pnl; nbs; new born; ob; obgyn; obstetrics; pan; panel.chemistry; panl; pnl; point in time; random; scn; wb; whole blood,-
62324-9,post-discharge provider name in provider,post-discharge provider name provider,post-discharge provider name nom (provider),after; chemistry; disch; nominal; person name; point in time; pst; random,Nom
62326-4,post-discharge provider practice name,post-discharge provider practice name,post-discharge provider practice name nom (provider) [id],after; chemistry; disch; ident; identifier; nominal; point in time; post-disch prov practice name; pst; random,Nom
62327-2,post-discharge provider practice address,post-disch prov practice address,post-discharge provider practice address nom (provider),address; after; chemistry; disch; nominal; point in time; post-disch prov practice address; pst; random,Nom
62343-9,chromosome analysis copy number change panel by microarray,cma # change pnl microarray,chr analysis copy number change panel microarray (bld/tiss),"arrcgh; blood; chrom analy; chromosom; chromosomes; cma # change pnl; cytogenetics; exchange; genetics; heredity; heritable; hl7.cytogen; inherited; karyotype; no; num; pan; panel.hl7.cytogen; panl; pnl; point in time; random; replace; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",-
62360-3,cells analyzed [#],cells analyzed,cells analyzed molgen (bld/tiss) [#],"blood; cell; cellularity; cnt; count; hl7.cytogen; molecular genetics; number; pcr; point in time; qnt; quan; quant; quantitative; random; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",Qn
62362-9,colonies counted [#],colonies counted,colonies counted molgen (bld/tiss) [#],"blood; cnt; count; hl7.cytogen; molecular genetics; number; pcr; point in time; qnt; quan; quant; quantitative; random; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",Qn
62363-7,mosaicism detected,mosaicism detected,mosaicism detected molgen nom (bld/tiss),"blood; finding; findings; hl7.cytogen; molecular genetics; nominal; pcr; point in time; random; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",Nom
62368-6,cell phase [type],cell phase,cell phase molgen nom (bld/tiss),"blood; hl7.cytogen; molecular genetics; nominal; pcr; point in time; random; tissue; tissue, unspecified; typ; wb; whole blood; whole blood or tissue",Nom
6238-0,salt grass ige ab [units/volume] in serum,salt grass ige qn,salt grass ige qn (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; g203; immune globulin e; immunoglobulin e; point in time; qnt; quan; quant; quantitative; random; rg203; salt grass; serum; sr,Qn
62401-5,phenx - deep venous thrombosis protocol 041201,deep venous thrombosis proto,,pan; panel; panel.phenx; panl; pnl; point in time; random,-
62402-3,phenx - pulmonary embolus protocol 041301,phenx - pulmonary embolus protocol,,pan; panel; panel.phenx; panl; pe; pnl; point in time; pulm; random,-
62413-0,phenx - neck circ protocol 021201,neck circumference proto,,neck circumference proto; pan; panel; panel.phenx; panl; pnl; point in time; random,-
6242-2,sesame seed ige ab [units/volume] in serum,sesame seed ige qn,sesame seed ige qn (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; f010; f10; immune globulin e; immunoglobulin e; point in time; qnt; quan; quant; quantitative; random; serum; sesame seed; sesamum orientale; sr; universallaborders,Qn
62431-2,eastern equine encephalitis virus igg ab [presence] in body fluid by immunoassay,eeev igg fld ql ia,eeev igg ia ql (body fld),"abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; b/f; bf; bod; bodies; body fluid; body fluid, unsp; eee virus; eeev; eia; elfa; elisa; enc; enceph; encephalomyelitis; enzyme immunoassay; equin; fl; fld; flu; fluid; iaa; id; immune globulin g; immunoglobulin g; infectious disease; infectiousdisease; meia; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; screen; suds; togavirus",Ord
62438-7,nucleated erythrocytes [#/volume] in synovial fluid by automated count,nrbc # snv auto,nucleated rbc auto (syn fld) [#/vol],#; abs; absolute; absolutes; auto; automated detection; cnt; count; count/volume; ct; discocytes; elec; elect; electr; erthrocyte; erythroblasts; erythrocyte; hematology/cell counts; joint aspirate; joint fld; joint flu; joint fluid; normoblasts; nrbc; nrbcs; nuc; number concentration; number concentration (count/vol); point in time; qnt; quan; quant; quantitative; random; rbc; rbcs; red blood cell; red blood cells; red blood corpuscle; red blood corpusles; red cell; red cells; sf; snv; syn; syn fl; synov; synovial fluid,Qn
62440-3,nucleated erythrocytes/leukocytes [ratio] in body fluid by automated count,nrbc fld auto-rto,nucleated rbc/leukocytes auto (body fld) [ratio],"auto; automated detection; b/f; bf; bod; bodies; body fluid; body fluid, unsp; discocytes; elec; elect; electr; erthrocyte; erythroblasts; erythrocyte; fl; fld; flu; fluid; hematology/cell counts; leuc; leuk; leukocyte; lkcs; normoblasts; nrbc; nrbcs; nuc; point in time; qnt; quan; quant; quantitative; random; ratios; rbc; rbcs; red blood cell; red blood cells; red blood corpuscle; red blood corpusles; red cell; red cells; rto; wbc; wbcs; white blood cell; white blood cells",Qn
62441-1,nucleated erythrocytes/leukocytes [ratio] in cerebral spinal fluid by automated count,nrbc csf auto-rto,nucleated rbc/leukocytes auto (csf) [ratio],auto; automated detection; cerebral spinal fluid; cerebrospinal fl; discocytes; elec; elect; electr; erthrocyte; erythroblasts; erythrocyte; hematology/cell counts; leuc; leuk; leukocyte; lkcs; normoblasts; nrbc; nrbcs; nuc; point in time; qnt; quan; quant; quantitative; random; ratios; rbc; rbcs; red blood cell; red blood cells; red blood corpuscle; red blood corpusles; red cell; red cells; rto; spinal fl; spinal fld; spinal flu; spinal fluid; wbc; wbcs; white blood cell; white blood cells,Qn
62460-1,candida sp dna [presence] in vaginal fluid by naa with probe detection,candida dna vag ql naa+probe,candida sp dna naa+probe ql (vag fld),3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; cand; candidiasis; deoxyribonucleic acid; dna nucleic acid probe; dna probe; genital vaginal; gyn; gynecology; id; infectious disease; infectiousdisease; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; monilia; naa+probe; naat; nasba; nucleic acid sequence based analysis; ob; obgyn; obstetrics; ordinal; pcr; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; screen; sda; species; spp; strand displacement amplification; thrush; tma; transcription mediated amplification; vag fld; vag fluid; vagina; vaginal fluid,Ord
62479-1,aspergillus terreus dna [presence] in specimen by naa with probe detection,a terreus dna spec ql naa+probe,a. terreus dna naa+probe ql (specimen),3 self-sustaining sequence replication; 3sr sr; a terreus; amplif; amplification; amplified; asperg; aspergil; aspergilis; aspergilla; aspergillin; aspergillosis; aspergils; aspergilus; deoxyribonucleic acid; dna nucleic acid probe; dna probe; farmers lung; id; infectious disease; infectiousdisease; lat; lcr; ligase chain reaction; ligation-activated transcription; m309; m36; microbiology; misc; miscellaneous; naa+probe; naat; nasba; nucleic acid sequence based analysis; ordinal; other; pcr; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; screen; sda; spec; strand displacement amplification; tma; to be specified in another part of the message; transcription mediated amplification; unspecified,Ord
62481-7,herpes virus 6a dna [presence] in cerebral spinal fluid by naa with probe detection,hhv 6a dna csf ql naa+probe,hhv 6a dna naa+probe ql (csf),3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; cerebral spinal fluid; cerebrospinal fl; deoxyribonucleic acid; dna nucleic acid probe; dna probe; herpesvirus; hhv; hhv 6a; human herpes virus; id; infectious disease; infectiousdisease; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; naa+probe; naat; nasba; neuro; neurology; nucleic acid sequence based analysis; ordinal; pcr; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; screen; sda; spinal fl; spinal fld; spinal flu; spinal fluid; strand displacement amplification; tma; transcription mediated amplification,Ord
62488-2,ova1 test [presence] in serum,ova1 ser ql,ova1 test ql (s),chemistry; ordinal; ovarian adnexal mass assessment score; point in time; pr; ql; qual; qualitative; random; screen; serum; sr; transthyretin+apolipoprotein a-1+beta-2 microglobulin+transferrin+ca 125,Ord
62539-2,deprecated phenx measure - environmental exposures - plastic exposures at work and home,,,job; measure - envir plast exp work home; occupation; pan; panel; panel.phenx; panl; pnl; point in time; random,-
62545-9,phenx - alcohol - age of first use protocol 030201,alcohol age first use proto,,alc; alcohol age first use proto; alcoholic; pan; panel; panel.phenx; panl; pnl; point in time; random,-
62552-5,deprecated phenx measure - tobacco - smoking status,,,measure - tobac smoking status; pan; panel; panel.phenx; panl; pnl; point in time; random; tobac smoke stat,-
62569-9,phenx - cancer - personal and family history protocol 070601,cancer pers family hx proto,,cancer pers family hx proto; hx; pan; panel; panel.phenx; panl; pnl; point in time; random,-
62576-4,phenx domain - oral health,domain - oral health,,pan; panel; panel.phenx; panl; pnl; point in time; random,-
62579-8,deprecated phenx measure - oral health - consumption of sweet beverages,,,measure - oral sweet beverages; pan; panel; panel.phenx; panl; pnl; point in time; random,-
62585-5,deprecated phenx measure - oral health - existence of cleft lip or palate,,,measure - oral cleft lip or palate; pan; panel; panel.phenx; panl; pnl; point in time; random,-
6258-8,sunflower seed ige ab [units/volume] in serum,sunflower seed ige qn,sunflower seed ige qn (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; f183; immune globulin e; immunoglobulin e; k84; point in time; qnt; quan; quant; quantitative; random; seeds; serum; sr; sunflower; sunflower pip; sunflower seed,Qn
62598-8,phenx - oral health - periodontal disease - prevalence protocol 081101,oral periodontal dis proto,,dis; diseases; dz; oral periodontal dis proto; pan; panel; panel.phenx; panl; pnl; point in time; random,-
62600-2,phenx - oral health - presence of dental fluorosis protocol 081201,oral dental fluorosis proto,,oral dental fluorosis proto; pan; panel; panel.phenx; panl; pnl; point in time; random,-
6260-4,sweet gum ige ab [units/volume] in serum,sweet gum ige qn,sweet gum ige qn (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; immune globulin e; immunoglobulin e; liquida styraciflua; point in time; qnt; quan; quant; quantitative; random; rt211; serum; sr; sweet gum; sweetgum; t211,Qn
62607-7,deprecated phenx measure - smoking quit attempts,,,pan; panel; panel.phenx; panl; pnl; point in time; random,-
62618-4,deprecated phenx measure - respiratory - exercise capacity - 6 minute walk test,,,excz; measure - resp exercise 6m walk; pan; panel; panel.phenx; panl; pnl; point in time; random,-
62625-9,phenx - respiratory - personal - family hx of respiratory symptoms - diseases - adult protocol 090901,resp fam hx resp sympt adult proto,,pan; panel; panel.phenx; panl; pnl; point in time; random; resp fam hx resp sympt adult proto; sx; symp + dis,-
62646-5,deprecated phenx measure - causes and treatments of known infertility,,,measure - causes known infertility; pan; panel; panel.phenx; panl; pnl; point in time; random; tx; txs,-
62664-8,phenx - male reproductive tract birth defects protocol 100901,male reproductive birth defects proto,,male reproductive birth defects proto; pan; panel; panel.phenx; panl; pnl; point in time; random,-
62676-2,phenx - testes development protocol 101501,testes development proto,,pan; panel; panel.phenx; panl; pnl; point in time; random,-
62685-3,phenx - eye diseases - treatment in young children protocol 110401,eye diseases young children proto,,eye diseases young children proto; pan; panel; panel.phenx; panl; pnl; point in time; random; tx,-
62686-1,deprecated phenx measure - eye drop use,,,pan; panel; panel.phenx; panl; pnl; point in time; random,-
6271-1,turkey meat ige ab [units/volume] in serum,turkey meat ige qn,turkey meat ige qn (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; f284; immune globulin e; immunoglobulin e; meleagis gallopavo; point in time; qnt; quan; quant; quantitative; random; serum; sr,Qn
62712-5,phenx - general psychiatric assessment - adult protocol 120101,gen psych assess adult proto,,gen psych assess adult proto; pan; panel; panel.phenx; panl; pnl; point in time; random,-
62718-2,phenx - obsessive compulsive disorder screener protocol 120301,obs - compuls screener proto,,obs - compuls screener proto; pan; panel; panel.phenx; panl; pnl; point in time; random,-
62723-2,phenx - depression - child protocol 120501,depression child proto,,depression child proto; pan; panel; panel.phenx; panl; pnl; point in time; random,-
62724-0,phenx - depression - adult protocol 120502,depression adult proto,,depression adult proto; pan; panel; panel.phenx; panl; pnl; point in time; random,-
62731-5,"deprecated phenx measure - medications - pain relievers, statins, steroids",,,measure - meds pain statins steroids; pan; panel; panel.phenx; panl; pnl; point in time; random; ste; steriods; steroid,-
6273-7,walnut ige ab [units/volume] in serum,walnut ige qn,walnut ige qn (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; f256; immune globulin e; immunoglobulin e; juglans sp; point in time; qnt; quan; quant; quantitative; random; serum; sr; universallaborders; walnut; walnuts,Qn
62758-8,deprecated phenx measure - clinical neuropathy,,,pan; panel; panel.phenx; panl; pnl; point in time; random,-
62766-1,deprecated phenx measure - history of head trauma,,,h/o; hx; measure - hx of head truama; pan; panel; panel.phenx; panl; pnl; point in time; random,-
62767-9,phenx - head trauma protocol 130601,head trauma proto,,pan; panel; panel.phenx; panl; pnl; point in time; random,-
62783-6,deprecated phenx measure - signs of essential tremor,,,pan; panel; panel.phenx; panl; pnl; point in time; random,-
62791-9,phenx - family history of diabetes protocol 140201,fam hx diabetes proto,,fam hx diabetes proto; family hx diabetes; h/o; hx; pan; panel; panel.phenx; panl; pnl; point in time; random,-
62806-5,deprecated phenx measure - serum creatinine assay for kidney function,,,cr; crea; creat; fcn; func; funct; pan; panel; panel.phenx; panl; pnl; point in time; random; ser; sr,-
62811-5,phenx - urinary creatinine assay for kidney function protocol 141601,urinary creatinine assay proto,,cr; crea; creat; fcn; func; funct; pan; panel; panel.phenx; panl; pnl; point in time; random; urinary creatinine assay proto,-
62815-6,phenx - cardiorespiratory fitness - treadmill protocol 150102,cardioresp fitness treadmill proto,,cardioresp fitness treadmill proto; pan; panel; panel.phenx; panl; pnl; point in time; random,-
62835-4,deprecated phenx measure - total physical activity - screener,,,activ; actvty; measure - total phys act screener; movements; pan; panel; panel.phenx; panl; pnl; point in time; random; tot; totl,-
62868-5,deprecated phenx measure - assay for hepatitis c,,,hep; hepatis; hepatit; pan; panel; panel.phenx; panl; pnl; point in time; random,-
62878-4,deprecated phenx measure - conditions relevant to immune response - screener,,,imm; imun; imune; measure - immune response screener; pan; panel; panel.phenx; panl; pnl; point in time; random,-
6288-5,yellow hornet ige ab [units/volume] in serum,yellow hornet ige qn,yellow hornet ige qn (s),abs; aby; aerial yellow jacket; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; i005; i5; immune globulin e; immunoglobulin e; point in time; qnt; quan; quant; quantitative; random; serum; sr; wasp; yellow hornet; yelow-faced hornet,Qn
62888-3,phenx - international travel history protocol 161201,international travel hx proto,,hx; international travel hx proto; pan; panel; panel.phenx; panl; pnl; point in time; random,-
62890-9,phenx - medical history protocol 161301,medical history proto,,hx; pan; panel; panel.phenx; panl; pnl; point in time; random,-
62892-5,phenx - personal - family history of autoimmune - inflammatory disorders protocol 161401,pers fam hx autoimm inflamm proto,,h/o; hx; pan; panel; panel.phenx; panl; pers fam hx autoimm inflamm proto; pnl; point in time; random,-
62894-1,"phenx - personal medical history of allergies, infectious diseases, and immunizations - child protocol 161601",hx allerg infect immun child proto,,allergies hx; h/o; hx; hx allerg infect immun child proto; pan; panel; panel.phenx; panl; pnl; point in time; random,-
62901-4,deprecated phenx measure - eczema,,,pan; panel; panel.phenx; panl; pnl; point in time; random,-
62904-8,phenx - pain protocol 170401,pain proto,,pan; panel; panel.phenx; panl; pnl; point in time; random,-
62924-6,phenx - emotional state - child protocol 180502,emotional state - child proto,,pan; panel; panel.phenx; panl; pnl; point in time; random,-
62934-5,deprecated phenx measure - temperament,,,pan; panel; panel.phenx; panl; pnl; point in time; random,-
62940-2,phenx - crime and delinquency - adult protocol 181202,crime delinquency adult proto,,crime delinquency adult proto; pan; panel; panel.phenx; panl; pnl; point in time; random,-
62942-8,phenx - chronic stress protocol 181301,chronic stress proto,,pan; panel; panel.phenx; panl; pnl; point in time; random,-
62949-3,phenx domain - gastrointestinal,domain - gastrointestinal,,gi; pan; panel; panel.phenx; panl; pnl; point in time; random,-
6295-0,complement c3d [presence] in red blood cells,c3d rbc ql,complement c3d ql (rbc),comp; complmt; erythrocytes; hematology/cell counts; ordinal; point in time; pr; ql; qual; qualitative; random; red blood cells; red blood corpusles; screen,Ord
62957-6,phenx - celiac sprue assay protocol 190301,celiac sprue assay proto,,pan; panel; panel.phenx; panl; pnl; point in time; random,-
62961-8,phenx - computed tomography (ct) of the abdominal organs protocol 190501,ctabdominal organs proto,,abd; abdo; abdomen; ctabdominal organs proto; pan; panel; panel.phenx; panl; pnl; point in time; random,-
62962-6,deprecated phenx measure - emotional distress,,,pan; panel; panel.phenx; panl; pnl; point in time; random,-
62971-7,phenx - personal history of gastrointestinal conditions protocol 191001,pers hx gi conditions proto,,gi; h/o; hx; pan; panel; panel.phenx; panl; pers hx gi conditions proto; pnl; point in time; random,-
63000-4,phenx - vertigo protocol 201101,vertigo proto,,pan; panel; panel.phenx; panl; pnl; point in time; random,-
63007-9,deprecated phenx measure - personal and family history of hearing loss,,,h/o; hx; measure fam hx hearing loss; pan; panel; panel.phenx; panl; pnl; point in time; random,-
6301-6,inr in platelet poor plasma by coagulation assay,inr ppp,inr coag (ppp) [relative time],clot; clottable; coag; coagulation assay; fac; fact; hematology; heme; internat norm ratio; international normal ratio; international normalization ratio; international normalized ratio; plas; platelet poor plasma; point in time; pro time; prothrombin time; prothrombin time inr; protime; protime inr; pt; pt inr; qnt; quan; quant; quantitative; random; rltm; tilt tube,Qn
63027-7,deprecated phenx measure - neighborhood safety,,,pan; panel; panel.phenx; panl; pnl; point in time; random; sdoh,-
6303-2,drvvt (la screen),screen drvvt,drvvt coag (ppp) [time],clot; clottable; coag; coagulation assay; ddrvtvt; dil; dil russell vip ven; dilut; drvv; drvvt; hematology; heme; plas; platelet poor plasma; point in time; qnt; quan; quant; quantitative; random; rus; rvv; screening test for lupus anticoagulant; tilt tube; universallaborders,Qn
63043-4,nuclei scored in tissue,nuclei scored tiss,nuclei scored (tiss) [#],"cnt; count; molecular pathology; molpath; number; point in time; qnt; quan; quant; quantitative; random; tissue; tissue, unspecified",Qn
63044-2,cotinine [presence] in saliva (oral fluid) by screen method,cotinine sal ql scn,cotinine screen ql (sal),drug/toxicology; drugs; nicotine metabolite; oral fluid; ordinal; point in time; pr; ql; qual; qualitative; random; sal; scn; scr; screen; scrn,Ord
63061-6,deprecated phenx measure - current employment status,,,job; occupation; pan; panel; panel.phenx; panl; pnl; point in time; random; work,-
63100-2,black-eye pea igg ab [mass/volume] in serum,black-eye pea igg-mcnc,black-eye pea igg (s) [mass/vol],abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; black-eye bean; blackeye pea; black-eye pea; black-eyed bean; cowpea; f127; immune globulin g; immunoglobulin g; level; mass concentration; point in time; qnt; quan; quant; quantitative; random; serum; sr; v senensis; vigna bean,Qn
63109-3,cashew nut igg ab [mass/volume] in serum,cashew nut igg-mcnc,cashew nut igg (s) [mass/vol],abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; cashew; cashew nut; f202; immune globulin g; immunoglobulin g; level; mass concentration; point in time; qnt; quan; quant; quantitative; random; serum; sr,Qn
63114-3,paprika igg ab [mass/volume] in serum,paprika igg-mcnc,paprika igg (s) [mass/vol],abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; f218; immune globulin g; immunoglobulin g; level; mass concentration; paprika; point in time; qnt; quan; quant; quantitative; random; serum; sr; sweet pepper,Qn
63119-2,honey igg ab [mass/volume] in serum,honey igg-mcnc,honey igg (s) [mass/vol],abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; f247; immune globulin g; immunoglobulin g; level; mass concentration; point in time; qnt; quan; quant; quantitative; random; rf247; serum; sr,Qn
63138-2,hop igg ab [mass/volume] in serum,hop igg-mcnc,hop igg (s) [mass/vol],abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; f324; fruit cone; hop; hops; hops oil; immune globulin g; immunoglobulin g; level; mass concentration; point in time; qnt; quan; quant; quantitative; random; rf324; serum; sr,Qn
63147-3,horseradish igg ab [mass/volume] in serum,horseradish igg-mcnc,horseradish igg (s) [mass/vol],abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; cochlearia armoracia; f375; horseradish; immune globulin g; immunoglobulin g; level; mass concentration; point in time; qnt; quan; quant; quantitative; random; serum; sr,Qn
63149-9,okra igg ab [mass/volume] in serum,okra igg-mcnc,okra igg (s) [mass/vol],abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; bamia; bhindi; bindi; f379; gumbo; hibiscus esculentus; immune globulin g; immunoglobulin g; lady's finger; level; mass concentration; okra; point in time; qnt; quan; quant; quantitative; random; serum; sr,Qn
63178-8,chaetomium globosum igg ab [mass/volume] in serum,c globosum igg-mcnc,chaetomium globosum igg (s) [mass/vol],abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; c globosum; immune globulin g; immunoglobulin g; level; m208; mass concentration; point in time; qnt; quan; quant; quantitative; random; rm208; serum; sr,Qn
63200-0,goldenrod igg ab [mass/volume] in serum,goldenrod igg-mcnc,goldenrod igg (s) [mass/vol],abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; golden rod; goldenrod; immune globulin g; immunoglobulin g; level; mass concentration; point in time; qnt; quan; quant; quantitative; random; serum; sr; w012; w12,Qn
63216-6,cv2 ab [presence] in cerebral spinal fluid by immunofluorescence,cv2 ab csf ql if,cv2 ab if ql (csf),abs; aby; acif; antby; anti; antibodies; antibody; anticomplement immunofluorescence; autoantibodies; autoantibody; cerebral spinal fluid; cerebrospinal fl; collapsin response mediator protein 5; collapsin response mediator protein 5 ab; crmp5; crmp-5; fa; fluorescent antibody; fluoresent; ifa; immune fluorescence; immunoflour; immunofluor; immunofluorescence; neuro; neurology; ordinal; point in time; pop66; pr; ql; qual; qualitative; random; screen; serology; spinal fl; spinal fld; spinal flu; spinal fluid; time resolved fluorescence; trf; ulip,Ord
63220-8,dna double strand ab [titer] in cerebral spinal fluid by immunofluorescence,dsdna ab titr csf if,dna double strand ab if (csf) [titer],abs; aby; acif; antby; anti; antibodies; antibody; anticomplement immunofluorescence; autoantibodies; autoantibody; cerebral spinal fluid; cerebrospinal fl; deoxyribonucleic acid; dilution factor; dilution factor (titer); dna binding ab; ds; dsdna; dsnda; fa; fluorescent antibody; fluoresent; ifa; immune fluorescence; immunoflour; immunofluor; immunofluorescence; native dna; n-dna; neuro; neurology; point in time; random; serology; smqn; spinal fl; spinal fld; spinal flu; spinal fluid; stranded; strnd; time resolved fluorescence; titer; titered; titre; trf; ttr,SemiQn
63222-4,dna double strand ab [units/volume] in pleural fluid by immunoassay,dsdna ab plr ia-acnc,dna double strand ab ia qn (pleur fld),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; deoxyribonucleic acid; dna binding ab; ds; dsdna; dsnda; eia; elfa; elisa; enzyme immunoassay; iaa; lung; meia; native dna; n-dna; pleural; pleural fluid; point in time; pulmonary; pulmonology; qnt; quan; quant; quantitative; random; respiratory; serology; stranded; strnd; suds; thoracentesis fluid,Qn
63229-9,dna double strand igg ab [units/volume] in cerebral spinal fluid by immunoassay,dsdna igg csf ia-acnc,dna double strand igg ia qn (csf),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; cerebral spinal fluid; cerebrospinal fl; deoxyribonucleic acid; dna binding ab; ds; dsdna; dsnda; eia; elfa; elisa; enzyme immunoassay; iaa; immune globulin g; immunoglobulin g; meia; native dna; n-dna; neuro; neurology; point in time; qnt; quan; quant; quantitative; random; serology; spinal fl; spinal fld; spinal flu; spinal fluid; stranded; strnd; suds,Qn
63232-3,dna double strand igm ab [presence] in body fluid by immunofluorescence,dsdna igm fld ql if,dna double strand igm if ql (body fld),"abs; aby; acif; antby; anti; antibodies; antibody; anticomplement immunofluorescence; autoantibodies; autoantibody; b/f; bf; bod; bodies; body fluid; body fluid, unsp; deoxyribonucleic acid; dna binding ab; ds; dsdna; dsnda; fa; fl; fld; flu; fluid; fluorescent antibody; fluoresent; ifa; immune fluorescence; immune globulin m; immunoflour; immunofluor; immunofluorescence; immunoglobulin m; native dna; n-dna; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serology; stranded; strnd; time resolved fluorescence; trf",Ord
63247-1,ganglioside gm1 igm ab [presence] in serum by immunoassay,gm1 gangl igm ser ql ia,ganglioside gm1 igm ia ql (s),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; eia; elfa; elisa; enzyme immunoassay; ganglioside monosialo; gm1 gangl; iaa; immune globulin m; immunoglobulin m; meia; monosialoganglioside; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serology; serum; sr; suds,Ord
6324-8,brucella abortus ab [titer] in serum by agglutination,b abortus ab titr ser aggl,b. abortus ab aggl (s) [titer],abort; abs; aby; agg; agglut; agglutination; antby; anti; antibodies; antibody; autoantibodies; autoantibody; b abortus; bangs disease; bovine brucellosis; bruc; brucellosis; contagious abortion; dilution factor; dilution factor (titer); id; infectious disease; infectiousdisease; microbiology; point in time; random; serum; smqn; sr; titer; titered; titre; ttr; undulant fever,SemiQn
63254-7,ganglioside gq1b igg ab [presence] in serum by immunoassay,gq1b gangl igg ser ql ia,ganglioside gq1b igg ia ql (s),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; eia; elfa; elisa; enzyme immunoassay; gq1b; gq1b gangl; iaa; immune globulin g; immunoglobulin g; meia; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serology; serum; sr; suds; tetrasialylganglioside,Ord
63255-4,ganglioside gq1b igm ab [presence] in serum by immunoassay,gq1b gangl igm ser ql ia,ganglioside gq1b igm ia ql (s),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; eia; elfa; elisa; enzyme immunoassay; gq1b; gq1b gangl; iaa; immune globulin m; immunoglobulin m; meia; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serology; serum; sr; suds; tetrasialylganglioside,Ord
63282-8,mitochondria m2 ab [presence] in cerebral spinal fluid by immunoassay,mitochondria m2 ab csf ql ia,mitochondria m2 ab ia ql (csf),abs; aby; ama-m2; antby; anti; antibodies; antibody; autoantibodies; autoantibody; cerebral spinal fluid; cerebrospinal fl; eia; elfa; elisa; enzyme immunoassay; iaa; meia; microtubule associated protein 2; mito; mitochon; mitochond; mitochondrial; mitochondrial m2; neuro; neurology; ordinal; point in time; pr; pyruvate dehydrogenase ab; ql; qual; qualitative; random; screen; serology; spinal fl; spinal fld; spinal flu; spinal fluid; suds,Ord
63287-7,myelin ab [presence] in cerebral spinal fluid by immunofluorescence,myelin ab csf ql if,myelin ab if ql (csf),abs; aby; acif; antby; anti; antibodies; antibody; anticomplement immunofluorescence; autoantibodies; autoantibody; cerebral spinal fluid; cerebrospinal fl; fa; fluorescent antibody; fluoresent; ifa; immune fluorescence; immunoflour; immunofluor; immunofluorescence; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serology; spinal fl; spinal fld; spinal flu; spinal fluid; time resolved fluorescence; trf,Ord
6328-9,brucella sp ab [titer] in serum by immunofluorescence,brucella ab titr ser if,brucella sp ab if (s) [titer],abs; aby; acif; antby; anti; antibodies; antibody; anticomplement immunofluorescence; autoantibodies; autoantibody; bruc; brucellosis; dilution factor; dilution factor (titer); fa; fluorescent antibody; fluoresent; id; ifa; immune fluorescence; immunoflour; immunofluor; immunofluorescence; infectious disease; infectiousdisease; microbiology; point in time; random; serum; smqn; species; spp; sr; time resolved fluorescence; titer; titered; titre; trf; ttr,SemiQn
63328-9,rna polymerase iii ab [presence] in serum by immunoassay,rnap iii ab ser ql ia,rna polymerase iii ab ia ql (s),3; abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; eia; elfa; elisa; enzyme immunoassay; iaa; meia; ordinal; point in time; pol iii; pr; ql; qual; qualitative; random; ribonucleic acid; rnap iii; screen; serology; serum; sr; suds,Ord
63341-2,sjogrens syndrome-a extractable nuclear 52kd ab [presence] in cerebral spinal fluid by immunoassay,ena ss-a 52kd ab csf ql ia,sjogrens syndrome-a extractable nuclear 52kd ab ia ql (csf),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; cerebral spinal fluid; cerebrospinal fl; eia; elfa; elisa; ena; ena ss-a; ena ss-a 52kd; enzyme immunoassay; iaa; meia; neuro; neurology; nuc; ordinal; point in time; pr; ql; qual; qualitative; random; ro; ro ab; screen; serology; sjogren; spinal fl; spinal fld; spinal flu; spinal fluid; ss; ssa; ss-a; suds,Ord
63346-1,sjogrens syndrome-a extractable nuclear ab [presence] in body fluid by immune diffusion (id),ena ss-a ab fld ql id,sjogrens syndrome-a extractable nuclear ab immune diff ql (body fld),"abs; aby; ana; anf; antby; anti; antibodies; antibody; antinuclear antibody; autoantibodies; autoantibody; b/f; bf; bod; bodies; body fluid; body fluid, unsp; ena; ena ss-a; fl; fld; flu; fluid; id; imm; immunodiff; immunodiffusion; imun; imune; na; nuc; ordinal; point in time; pr; ql; qual; qualitative; random; ro; ro ab; screen; serology; sjogren; ss; ssa; ss-a",Ord
63349-5,sjogrens syndrome-b extractable nuclear ab [presence] in body fluid by immune diffusion (id),ena ss-b ab fld ql id,sjogrens syndrome-b extractable nuclear ab immune diff ql (body fld),"abs; aby; ana; anf; antby; anti; antibodies; antibody; antinuclear antibody; autoantibodies; autoantibody; b/f; bf; bod; bodies; body fluid; body fluid, unsp; ena; ena ss-b; fl; fld; flu; fluid; ha; ha ab; id; imm; immunodiff; immunodiffusion; imun; imune; la ab; na; nuc; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serology; sjogren; ss; ssb; ss-b",Ord
63363-6,thyrotropin receptor ab [units/volume] in blood from fetus,tsh recep ab bld fetus-acnc,tsh receptor ab qn (bld fetus),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; blood; endocrine; endocrinology; fetal; gyn; gynecology; ob; obgyn; obstetrics; point in time; qnt; quan; quant; quantitative; random; rec; recept; receptors; recp; recptr; serology; thyroid stimulating hormone; thyroid stimulating hormone receptor antibody; thyrotropic hormone; trab; tsh; tsh recep; wb; whole blood,Qn
63366-9,thyrotropin receptor ab [units/volume] in cerebral spinal fluid,tsh recep ab csf-acnc,tsh receptor ab qn (csf),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; cerebral spinal fluid; cerebrospinal fl; endocrine; endocrinology; neuro; neurology; point in time; qnt; quan; quant; quantitative; random; rec; recept; receptors; recp; recptr; serology; spinal fl; spinal fld; spinal flu; spinal fluid; thyroid stimulating hormone; thyroid stimulating hormone receptor antibody; thyrotropic hormone; trab; tsh; tsh recep,Qn
63387-5,elastase ab [presence] in body fluid by immunoassay,elastase ab fld ql ia,elastase ab ia ql (body fld),"abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; b/f; bf; bod; bodies; body fluid; body fluid, unsp; eia; ela; elfa; elisa; enzyme immunoassay; fl; fld; flu; fluid; iaa; meia; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serology; suds",Ord
6340-4,chlamydophila psittaci ag [presence] in specimen by immunoassay,c psittaci ag spec ql ia,c. psittaci ag ia ql (specimen),antigen; antigens; avian chlamydiosis; c psittaci; chlamydia; chlamydia psittaci; chlamydial abortion; cps; eia; elfa; elisa; enzootic abortion of ewes; enzyme immunoassay; iaa; id; infectious disease; infectiousdisease; meia; microbiology; misc; miscellaneous; ordinal; ornithosis; other; ovine chlamydiosis; point in time; pr; psittacosis; ql; qual; qualitative; random; screen; spec; suds; to be specified in another part of the message; unspecified,Ord
63411-3,sjogrens syndrome-a extractable nuclear 60kd ab [presence] in serum by immunoassay,ena ss-a 60kd ab ser ql ia,sjogrens syndrome-a extractable nuclear 60kd ab ia ql (s),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; eia; elfa; elisa; ena; ena ss-a; ena ss-a 60kd; enzyme immunoassay; iaa; meia; nuc; ordinal; point in time; pr; ql; qual; qualitative; random; ro; ro ab; screen; serology; serum; sjogren; sr; ss; ssa; ss-a; suds,Ord
6341-2,chlamydophila psittaci ag [presence] in specimen by immunofluorescence,c psittaci ag spec ql if,c. psittaci ag if ql (specimen),acif; anticomplement immunofluorescence; antigen; antigens; avian chlamydiosis; c psittaci; chlamydia; chlamydia psittaci; chlamydial abortion; cps; dfa; enzootic abortion of ewes; fa; fluorescent antibody; fluoresent; id; ifa; immune fluorescence; immunoflour; immunofluor; immunofluorescence; infectious disease; infectiousdisease; microbiology; misc; miscellaneous; ordinal; ornithosis; other; ovine chlamydiosis; point in time; pr; psittacosis; ql; qual; qualitative; random; screen; spec; time resolved fluorescence; to be specified in another part of the message; trf; unspecified,Ord
63414-7,pompe disease newborn screening panel,pompe disease nbs pnl dbs,pompe disease nbs panel (dbs),acid alpha-glucosidase deficiency; acid maltase deficiency; asympt; asymptomatic; blood; chemistry; dbs; dis; diseases; dried blood spot; dz; filter paper; fp; gaa; glycogen storage disease type ii; gsd-ii; lysosomal alpha glucosidase; nb screen pnl; nbs; new born; pan; panel.chemistry; panl; pnl; point in time; pompe disease nbs pnl; random; scn; wb; whole blood,-
63417-0,fda product label indexing - indication,fda label indexing - indication,,document.regulatory; fda label; narrative; report,Nar
63425-3,bacterial heat-labile enterotoxin lt gene [presence] in specimen by naa with probe detection,lt spec ql naa+probe,bacterial heat-labile enterotoxin lt gene naa+probe ql (specimen),3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; bact; dna nucleic acid probe; dna probe; etx; heat-labile enterotoxin gene; id; infectious disease; infectiousdisease; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; misc; miscellaneous; naa+probe; naat; nasba; nucleic acid sequence based analysis; ordinal; other; pcr; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; screen; sda; spec; strand displacement amplification; tma; to be specified in another part of the message; transcription mediated amplification; unspecified,Ord
63441-0,tissue polypeptide ag [units/volume] in serum or plasma,tiss polypept ag serpl-acnc,tissue polypeptide ag qn,antigen; antigens; arbitrary concentration; chemistry; pl; plasma; plsm; point in time; polypeptides; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; tiss polypept; tpa; tumor marker,Qn
63458-4,mugwort native (nart v) 1 ige ab [units/volume] in serum,mugwort (nart v) 1 ige qn,mugwort native (nart v) 1 ige qn (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; i; immune globulin e; immunoglobulin e; mugwort; mugwort (nart v) 1; point in time; qnt; quan; quant; quantitative; random; serum; sr; w006; w231; w6,Qn
63466-7,ganglioside gm3 igg ab [units/volume] in cerebral spinal fluid by immunoassay,gm3 igg csf ia-acnc,ganglioside gm3 igg ia qn (csf),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; cerebral spinal fluid; cerebrospinal fl; eia; elfa; elisa; enzyme immunoassay; iaa; immune globulin g; immunoglobulin g; meia; monosialoganglioside; point in time; qnt; quan; quant; quantitative; random; serology; spinal fl; spinal fld; spinal flu; spinal fluid; suds,Qn
63483-2,penicillium notatum ab [presence] in serum by immune diffusion (id),p notatum ab ser ql id,p. notatum ab immune diff ql (s),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; id; imm; immunodiff; immunodiffusion; imun; imune; infectious disease; infectiousdisease; m001; m1; microbiology; ordinal; p chrysogenum; p notatum; point in time; pr; ql; qual; qualitative; random; screen; serum; sr,Ord
63488-1,epithelial cells.ciliated [presence] in bronchoalveolar lavage,ciliated bal ql,epithelial cells.ciliated ql (bal),bronchial alveolar lavage; bronchoalveolar lavage; cell; cellularity; epi; epi cells; epith; epithelia; hematology/cell counts; ordinal; point in time; pr; ql; qual; qualitative; random; screen,Ord
63509-4,"was your total family income from all sources less than 100,000 dollars or 100,000 dollars or more [phenx]",annual family income 100k phenx,,annual family income 100k; finding; findings; ordinal; point in time; ql; qual; qualitative; random; screen; sdoh; tot; totl,Ord
63522-7,phenx - body image protocol 020401,body image proto,,bod; bodies; pan; panel; panel.phenx; panl; pnl; point in time; random,-
63552-4,macrophages/cells in bone marrow by manual count,macrophages nfr mar manual,macrophages/cells manual cnt (bm),bm; bon; bone marrow; cell; cellularity; hematology/cell counts; macrop; macrophage; macros; macrphg; manl; mar; marrow (bone); minimal angle of resolution; minimum angle of resolution; number fraction; percent; point in time; qnt; quan; quant; quantitative; random,Qn
63557-3,hepatitis b virus surface ag [units/volume] in serum or plasma by immunoassay,hbv surface ag serpl ia-acnc,hbv surface ag ia qn,antigen; antigens; arbitrary concentration; australia antigen; eia; elfa; elisa; enzyme immunoassay; hbs; hbsag; hbv; hbv surface; hep; hep b; hep bs; hepatis; hepatit; hepatology; hepb; iaa; id; infectious disease; infectiousdisease; liver; meia; microbiology; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; suds; surf,Qn
63566-4,basement membrane ab pattern [interpretation] in serum by immunofluorescence,bm ab pattern ser if-imp,basement membrane ab pattern if (s) [interp],abs; aby; acif; antby; anti; antibodies; antibody; anticomplement immunofluorescence; autoantibodies; autoantibody; basem; basemt; bm; fa; fluorescent antibody; fluoresent; ifa; immune fluorescence; immunoflour; immunofluor; immunofluorescence; impression; impression/interpretation of study; impressions; interp; interpretation; nominal; point in time; random; serology; serum; sr; time resolved fluorescence; trf,Nom
63572-2,time received in laboratory of specimen,time received in lab spec,time received in laboratory (spec),date and time; genitourinary; gu; point in time; qnt; quan; quant; quantitative; random; spec; time stamp; timestamp; uro; urology,Qn
63586-2,"what was your best estimate of the total income of all family members from all sources, before taxes, in last year [phenx]",annual family income nrate phenx,,annual family income; count/time; gross income; nrate; number rate; number rate = count/time; past; qnt; quan; quant; quantitative; sdoh; tot; totl,Qn
63587-0,body scan image name [phenx],whole body scan image name phenx,,bod; bodies; finding; findings; nominal; point in time; random; wb,Nom
63606-8,which of these problems occurred together [ssaga ii],alc withdraw multiple problems ssaga ii,,2; alc withdraw multiple problems; finding; findings; nominal; phenx; point in time; random,Nom
63640-7,"how many cigarettes per day do, or did, you smoke",smoke quant 1d,,finding; findings; nominal; phenx; point in time; random; smoke quant 1d,Nom
63642-3,"do, or did, you smoke if you are so ill that you are in bed most of the day [ftnd]",smoke during illness ftnd,,finding; findings; ordinal; phenx; point in time; ql; qual; qualitative; random; screen; smoke during illness,Ord
63643-1,drug type used in your lifetime,lifetime drug med use,,drugs; h+p; h+p.hx; lifetime drug med use; nominal; p prime; typ,Nom
63668-8,were you unable to stop or cut down 3 or more times on this drug [ssaga ii],drug tried to stop 3x ssaga ii,,2; drug tried to stop 3x; drugs; finding; findings; iii; ordinal; phenx; point in time; ql; qual; qualitative; random; screen,Ord
63679-5,"did using this drug cause you to have any other problems, like an overdose that required medical treatment [ssaga ii]",drug use overdose ssaga ii,,2; drug use overdose; drugs; finding; findings; ordinal; othr; phenx; point in time; ql; qual; qualitative; random; screen; tx,Ord
63695-1,what is the approximate age of your building [mesa],building age mesa,,building age; phenx; point in time; qnt; quan; quant; quantitative; random,Qn
63703-3,how many years have or did you live there [nhexas],ys at address nhexas,,phenx; point in time; qnt; quan; quant; quantitative; random; ys at address,Qn
63705-8,"are automobiles, vans, trucks or other motor vehicles parked in this attached garage [nhexas]",garage vehicle parked nhexas,,finding; findings; garage vehicle parked; ordinal; othr; phenx; point in time; ql; qual; qualitative; random; screen,Ord
63711-6,during which month do you usually start using air conditioning to cool this house or apartment [nhexas],air conditioning start month nhexas,,air conditioning start month; finding; findings; month; nominal; phenx; point in time; random; started,Nom
63713-2,which fuels are used for heating this house or apartment [nhexas],house heating fuel nhexas,,finding; findings; house heating fuel; nominal; phenx; point in time; random,Nom
63716-5,during which month do you usually stop using heating devices [nhexas],house heating stop month nhexas,,finding; findings; house heating stop month; month; nominal; phenx; point in time; random,Nom
63718-1,what kind of pet lived or spent time inside your home [nhanes],house pet type nhanes,,finding; findings; house pet type; nominal; phenx; point in time; random,Nom
63731-4,what was your water supply if other [peg],residence water supply other peg,,finding; findings; nominal; othr; phenx; point in time; polyethylene glycol; random; residence water supply; residence water supply other,Nom
63742-1,what kind of business or industry is this [nhanes],job business industry nhanes,,finding; findings; job business industry; nominal; phenx; point in time; random,Nom
63751-2,about how long did you work at that job or business,longest job duration,,job; longest job duration; occupation; phenx; point in time; qnt; quan; quant; quantitative; random; work,Qn
63763-7,what kinds of tools and equipment did you use [nhanes],job hx tool equipment nhanes,,finding; findings; job hx tool equipment; nominal; phenx; point in time; random,Nom
63777-7,do you have a twin brother or sister [cbcs],twin brother sister cbcs,,cbcs; finding; findings; ordinal; phenx; point in time; ql; qual; qualitative; random; screen; twin brother sister,Ord
63806-4,were you near somebody who handled this air contaminant [riopa],exposure nearby riopa,,exposure nearby; finding; findings; ordinal; phenx; point in time; ql; qual; qualitative; random; screen; world heatlth organization,Ord
63819-7,"on 3 or more different occasions have you taken a drink to keep from having fits, seizures, or convulsions or to make them go away [ssaga ii]",drink allev withdraw sz 3x ssaga ii,,2; drink allev withdraw sz 3x; finding; findings; iii; ordinal; phenx; point in time; ql; qual; qualitative; random; screen,Ord
63824-7,did you ever get a skin rash from sun exposure [nhl],skin rash ever nhl,,exp; finding; findings; integument; ordinal; phenx; point in time; ql; qual; qualitative; random; screen; skin rash ever,Ord
6383-4,deprecated dengue virus ab in unspecified specimen,deprecated denv ab xxx,denv ab (specimen),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; breakbone fever; denv; flavivirus; id; infectious disease; infectiousdisease; microbiology; misc; miscellaneous; other; point in time; random; spec; to be specified in another part of the message; unspecified,OrdQn
63843-7,has child attended day care outside the home [phenx],child attended day care phenx,,finding; findings; ordinal; point in time; ql; qual; qualitative; random; screen,Ord
63860-1,"in this age range, did you drink alcoholic beverages at least once a week for 6 months or more [phenx]",drinking weekly phenx,,drinking weekly; finding; findings; ordinal; point in time; ql; qual; qualitative; random; rnge; screen,Ord
638-7,microscopic observation [identifier] in cerebral spinal fluid by india ink prep,india ink prep csf,microscopic observation india ink prep nom (csf),cerebral spinal fluid; cerebrospinal fl; id; identity or presence; infectious disease; infectiousdisease; microbiology; neuro; neurology; nominal; point in time; prep; random; spinal fl; spinal fld; spinal flu; spinal fluid,Nom
63874-2,have you ever taken premarin by mouth as pills [ca teachers],ever premarin cts,,arterial stenosis; ca; calif; cts; ever premarin; finding; findings; ordinal; phenx; point in time; ql; qual; qualitative; random; screen,Ord
63913-8,site of other cancer [phenx],site of other cancer phenx,,finding; findings; nominal; othr; point in time; random,Nom
63934-4,did you have this treatment or therapy for cancer [phenx],cancer treatment therapy phenx,,cancer treatment therapy; finding; findings; ordinal; point in time; ql; qual; qualitative; random; screen; tx,Ord
63941-9,did you receive any other types of therapy [phenx],cancer other therapy phenx,,cancer other therapy; finding; findings; ordinal; othr; point in time; ql; qual; qualitative; random; screen,Ord
63946-8,pain-relieving medication [ca teachers],pain-relieving medication cts,,ca; calif; cts; finding; findings; nominal; phenx; point in time; random,Nom
639-5,microscopic observation [identifier] in cerebral spinal fluid by koh preparation,koh prep csf,microscopic observation koh prep nom (csf),cerebral spinal fluid; cerebrospinal fl; id; identity or presence; infectious disease; infectiousdisease; microbiology; neuro; neurology; nominal; point in time; potassium hydroxide preparation; prep; random; spinal fl; spinal fld; spinal flu; spinal fluid,Nom
63961-7,cause of menopause if other [phenx],cause of menopause if other phenx,,finding; findings; nominal; othr; point in time; random,Nom
63989-8,does anyone in the family use toothpaste with fluoride [phenx],fam use toothpaste fluoride phenx,,fam use toothpaste fluoride; finding; findings; fl; ordinal; point in time; ql; qual; qualitative; random; screen,Ord
64000-3,"did you have painful sores or irritations around the lips or on the tongue, cheeks, or gums more than once in past 6 months [phenx]",sores lips tongue cheeks >1 in 6mo phenx,,finding; findings; last; ordinal; ql; qual; qualitative; screen; sores lips tongue cheeks &gt;1 in 6mo,Ord
64003-7,what was the main reason you last visited the dentist [phenx],reason last visited dentist phenx,,finding; findings; nominal; past; point in time; random; reason last visited dentist,Nom
64010-2,latitude for the residence [peg],latitude residence peg,,housing; latitude residence; living arrangement; living arrangements; phenx; point in time; polyethylene glycol; qnt; quan; quant; quantitative; random,Qn
64037-5,deprecated codfish recombinant (rgad c) 1 ige ab rast class [presence] in serum,deprecated codfish (rgad c) 1 ige rast ql,codfish recombinant (rgad c) 1 ige rast class (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; cod; codfish; codfish (rgad c) 1; f003; f3; f426; fish; i; ige rast; immune globulin e; immunoglobulin e; ordinal; point in time; pr; ql; qual; qualitative; random; screen; scrod; serum; sr,Ord
64042-5,"distance from the free gingival margin, fgm, to the sulcus base, sb tooth [phenx]",distance fgm to sb tooth phenx,,distance fgm to sb; fr; length; non-protein bound; point in time; qnt; quan; quant; quantitative; random,Qn
64051-6,nm breast lymphatic vessels - left views w radionuclide intra lymphatic,nm breast lymph ves-l vs w rnc il,,breast lymph ves-l; brst; brst-l; document; films; finding; findings; imaging; intralymphatic; l; lt; point in time; rad; radiology; random; rn; rnc; scan; vesl; vessels.xxx; view; vws; w rnc intra lymph,Doc
6405-5,ehrlichia sp ab [presence] in serum by immunoassay,ehrlichia ab ser ql ia,ehrlichia sp ab ia ql (s),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; eia; elfa; elisa; enzyme immunoassay; iaa; id; infectious disease; infectiousdisease; meia; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; species; spp; sr; suds,Ord
64066-4,surgery medical student hospital admission evaluation note,surg med stdnt hosp admit eval note,,admit eval note; assessment; doc.ont; document; encounter; eval; eval note; evaluation and management; evaluation and management note; finding; findings; h&p; history and physical; hosp; inpatient; ms; notes; point in time; random; surg; surg med stdnt; visit note,Doc
64067-2,surgery medical student hospital progress note,surg med stdnt hosp prog note,,doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; hosp; inpatient; ms; notes; point in time; prog note; random; subsequent evaluation; subsequent visit evaluation; surg; surg med stdnt; visit note,Doc
64075-5,cardiothoracic surgery medical student hospital progress note,cardiothor surg ms hosp prog note,,cardio; cardiology; cardiothor surg; cardiothor surg ms; doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; heart disease; hosp; inpatient; ms; notes; point in time; prog note; random; subsequent evaluation; subsequent visit evaluation; surg; surg med stdnt; visit note,Doc
64086-2,cells analyzed [#] in chorionic villus sample by molecular genetics method,cells analyzed cvs,cells analyzed molgen (cvs) [#],cell; cellularity; chorionic villi; chorionic villus sample; cnt; count; molecular genetics; molecular pathology; molpath; number; pcr; point in time; qnt; quan; quant; quantitative; random,Qn
6409-7,fungus identified in sputum tracheal aspirate by culture,fungus sputum trach asp cult,fungus identified cx nom (sputum tracheal aspirate),c&s; cult; cultures; fung; fungal; fungi; id; identity or presence; infectious disease; infectiousdisease; lung; microbiology; nominal; point in time; pulmonary; pulmonology; random; respiratory; sputum - tracheal aspirate; sputum trach asp,Nom
64101-9,fatigue --resting,fatigue resting,,finding; findings; ordinal; phenx; point in time; ql; qual; qualitative; random; screen,Ord
64120-9,fourth most predominant hemoglobin in dbs,4th most predominant hb dbs,fourth most predominant hemoglobin nom (dbs),4th; 4th most predominant hb; blood; dbs; dried blood spot; filter paper; finding; findings; fp; haemoglobin; hb; hematology/cell counts; hgb; most predominant hb; nominal; point in time; random; wb; whole blood,Nom
64130-8,diazepam/creatinine [mass ratio] in urine,diazepam/creat ur,diazepam/creatinine (u) [mass ratio],c311; cr; crea; creat; drug/toxicology; drugs; mass concentration ratio; mass ratio; mcrto; point in time; qnt; quan; quant; quantitative; random; stesolid; ua; ucr; ur; urn; valium,Qn
64141-5,rfa renal vessels - right views w contrast,rfa renal ves-r views w contr,,abd; abdo; abdomen+; abdominal; c; cardio; cardiology; contr; contra; contrst; document; films; finding; findings; fluor; fluoro; fluoroscopy; heart disease; imaging; kidney; point in time; r; rad; radiology; random; renal ves-r; rfa; rt; vesl; ves-r; vessels.xxx; view; vws; wc,Doc
64153-0,do you usually bring up phlegm at all on getting up or first thing in the morning [phenx],phlegm morning phenx,,finding; findings; ordinal; phlegm morning; point in time; ql; qual; qualitative; random; screen,Ord
64180-3,at what age was your first attack of bronchitis [phenx],bronchitis attack first age phenx,,bronchitis attack first age; point in time; qnt; quan; quant; quantitative; random,Qn
64186-0,at what age did hay fever start [phenx],hay fever start age phenx,,hay fever start age; point in time; qnt; quan; quant; quantitative; random; started,Qn
64196-9,do you still have asthma [phenx],asthma still have phenx,,asthma still have; finding; findings; ordinal; point in time; ql; qual; qualitative; random; screen,Ord
64214-0,was gas or chemical fumes exposure [phenx],chem fumes exp degree phenx,,chem fumes exp degree; exp; finding; findings; gases; ordinal; point in time; ql; qual; qualitative; random; screen,Ord
64233-0,benzylpiperazine [presence] in urine by confirmatory method,benzylpiperazine ur ql cfm,benzylpiperazine confirm ql (u),addiction; bzp; cfm; cnfr; cnfrm; conf; confirmation; confirmatory; drug/toxicology; drugs; drugs of abuse; gcms; illicit; lc/ms/ms; n-benzylpiperazine; ordinal; point in time; potentialforabuse; pr; ql; qual; qualitative; random; screen; ua; ur; urn,Ord
64236-3,have you ever had any chest operations [phenx],chest operations ever phenx,,chest operations ever; finding; findings; ordinal; point in time; ql; qual; qualitative; random; screen,Ord
64240-5,was your parent ever told by a doctor that he or she had emphysema [phenx],hx parent emphysema phenx,,finding; findings; hx parent emphysema; ordinal; point in time; ql; qual; qualitative; random; screen,Ord
64251-2,"in the last 12 months, have you been awakened from sleep by shortness of breath or a feeling of tightness in your chest [phenx]",hx awake breath chest tightness i phenx,,1 year; 12mos; finding; findings; hx awake breath chest tightness i; ordinal; past; ql; qual; qualitative; screen,Ord
64256-1,about how many such episodes of cough with phlegm that lasted 1 week or more have you had in the past 12 months [phenx],how many times cough phlegm > 1w phenx,,1 year; 12mos; count/time; hx cough phlegm &gt; 1w; i; last; nrate; number rate; number rate = count/time; qnt; quan; quant; quantitative,Qn
64284-3,readiness for duty assessment,readiness for duty assessment,,doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; notes; point in time; random; readiness for duty note; visit note,Doc
64288-4,prescription for eyewear,prescription for eyewear,,doc.ont; document; finding; findings; point in time; random; rx,Doc
64294-2,readiness for duty letter,readiness for duty letter,,doc.ont; document; finding; findings; point in time; random; readiness for duty letter,Doc
64295-9,nurse plan of care note,nurse plan of care note,,care plan; doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; notes; nursing; point in time; random; treatment plan; visit note,Doc
64297-5,death certificate,death certificate,,doc.ont; document; finding; findings; point in time; random,Doc
64299-1,legal document,legal document,,doc.ont; document; finding; findings; point in time; random,Doc
6430-3,hiv identified in semen by organism specific culture,hiv smn cult,hiv identified org specific cx nom (sem),aids; c&s; cult; cultures; ejaculate; genitourinary; gu; human immunodeficiency virus; id; identity or presence; infectious disease; infectiousdisease; microbiology; nominal; point in time; random; sem; seminal fluid; smn; smpls; spec; uro; urology,Nom
64307-2,part time dietitian staff positions filled at end of period population #,,,cnt; count; esrd; esrd survey; number; point in time; qnt; quan; quant; quantitative; random; survey,Qn
64316-3,part time licensed practical nurse and licensed vocational nurse staff positions vacant at end of period population #,,,cnt; count; esrd; esrd survey; number; nursing; point in time; qnt; quan; quant; quantitative; random; survey,Qn
64323-9,end stage renal disease (esrd) facility survey - omb cms form 2744,,,admin; dis; diseases; dz; end stage renal disease (esdr) pnl; end-stage renal disease; esrd; esrd cms form 2744; esrd survey; kidney; nephrology; pan; panel; panl; pnl; point in time; random; renal,-
64326-2,home dialysis patients at beginning of reporting period population #,,,cnt; count; dialy; esrd; esrd survey; number; point in time; qnt; quan; quant; quantitative; random; survey,Qn
6432-9,htlv i ab [presence] in serum by immunoblot,htlv i ab ser ql ib,htlv i ab ib ql (s),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; blt; human t-cell leukemia virus; human t-cell lymphotrophic virus; id; immune blot; immunobl; immunoblot; infectious disease; infectiousdisease; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; riba; screen; serum; sr; wb; wblot; west blot; west blt; western blot,Ord
64336-1,incenter dialysis patients who died population #,,,cnt; count; dialy; esrd; esrd survey; number; qnt; quan; quant; quantitative; report period; survey; world heatlth organization,Qn
64343-7,home patients who transferred to other dialysis unit population #,,,cnt; count; dialy; esrd; esrd survey; number; othr; qnt; quan; quant; quantitative; report period; survey; world heatlth organization,Qn
64378-3,kidney transplant center patients who received at least one kidney transplant with pending enrollment in medicare at end of period population #,,,cnt; count; esrd; esrd survey; number; point in time; qnt; quan; quant; quantitative; random; survey; world heatlth organization,Qn
64386-6,kidney transplant center non-dialysis patients who are awaiting a kidney transplant at end of period population #,,,cnt; count; dialy; esrd; esrd survey; number; point in time; qnt; quan; quant; quantitative; random; survey; world heatlth organization,Qn
64392-4,phenx - systemic lupus erythematosus protocol 171001,lupus sle proto,,le; lupus sle proto; pan; panel; panel.phenx; panl; pnl; point in time; random,-
64393-2,deprecated phenx measure - perceived stress,,,measure perceived stress; pan; panel; panel.phenx; panl; pnl; point in time; random,-
64409-6,at what age did this itchy rash first occur [phenx],itchy rash first age 6 phenx,,itchy rash first age 6; point in time; qnt; quan; quant; quantitative; random,Qn
64420-3,kir gene allele 2ds1 [presence] in blood or tissue by molecular genetics method,kir 2ds1 bld/t ql,kir gene allele 2ds1 molgen ql (bld/tiss),"blood; cd158e1; killer cell immunoglobulin-like recptor; kir; kir 2ds1; kir3dl1/s1; molecular genetics; molecular pathology; molpath; nkat3; nkat-3; nkb1; nkb1b; ordinal; pcr; point in time; pr; ql; qual; qualitative; random; screen; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",Ord
64444-3,how long did the worst attack of chest trouble last [phenx],worst chest attack last phenx,,past; point in time; qnt; quan; quant; quantitative; random; worst chest attack last,Qn
64469-0,"i walk slower than other people, or i stop for rests [phenx]",activities affect walk stop phenx,,activities affect walk stop; finding; findings; ordinal; othr; point in time; ql; qual; qualitative; random; screen,Ord
64473-2,"my breathing makes it difficult to do things such as walk up hills, carrying things up stairs, light gardening such as weeding, dance, play bowls or play golf [phenx]",breathing diff activ light phenx,,arterial stenosis; breathing diff activ light; finding; findings; ordinal; painad.breathing; point in time; ql; qual; qualitative; random; screen,Ord
64502-8,"while sleeping, does your child always snore [phenx]",child always snore phenx,,finding; findings; ordinal; point in time; ql; qual; qualitative; random; screen,Ord
6451-9,deprecated legionella sp rrna [presence] in unspecified specimen by dna probe,deprecated legionella rrna xxx ql prb,legionella sp rrna probe ql (specimen),arbitrary concentration; dna nucleic acid probe; dna probe; id; infectious disease; infectiousdisease; legion; legionela; microbiology; misc; miscellaneous; ordinal; other; point in time; ql; qual; qualitative; random; ribosomal rna; screen; spec; species; spp; to be specified in another part of the message; unspecified,Ord
64519-2,"if your child usually gets out of bed to urinate, how many times each night, on average [phenx]",child night urinate times phenx,,child night urinate times; count/time; nrate; number rate; number rate = count/time; point in time; qnt; quan; quant; quantitative; random,Qn
645-2,microscopic observation [identifier] in sputum by acid fast stain.kinyoun,acid fast kiny stn spt,microscopic observation acid fast stain.kinyoun nom (sput),acd; acid fast kiny stn; acid fast stn; acids; afb stain; id; identity or presence; infectious disease; infectiousdisease; lower respiratory; lung; microbiology; nominal; point in time; pulmonary; pulmonology; random; respiratory; spt; sputum; st; stains; stn,Nom
64528-3,does your child occasionally wet the bed [phenx],child wet bed phenx,,child wet bed; finding; findings; ordinal; point in time; ql; qual; qualitative; random; screen,Ord
64539-0,does your child have trouble falling back asleep if he or she wakes up at night [phenx],child trouble back asleep phenx,,child trouble back asleep; finding; findings; ordinal; point in time; ql; qual; qualitative; random; screen,Ord
6455-0,leptospira sp identified in urine by organism specific culture,leptospira ur cult,leptospira sp identified org specific cx nom (u),c&s; cult; cultures; id; identity or presence; infectious disease; infectiousdisease; leptospirosis; microbiology; nominal; point in time; random; spec; species; spp; ua; ur; urn,Nom
64563-0,"has your child ever felt unable to move for a short period, in bed, though awake and able to look around [phenx]",child unable move able ever phenx,,child unable move able ever; finding; findings; ordinal; point in time; ql; qual; qualitative; random; screen,Ord
64568-9,does your child use any recreational drugs [phenx],child recreational drug phenx,,child recreational drug; drug; finding; findings; ordinal; point in time; ql; qual; qualitative; random; screen,Ord
64570-5,"does your child use cigarettes, smokeless tobacco, snuff, or other tobacco products [phenx]",child use cigarette tobacco phenx,,child use cigarette tobacco; finding; findings; ordinal; othr; point in time; prods; product; ql; qual; qualitative; random; screen,Ord
64587-9,is the sleep disorder still present [phenx],child sleep disorder still present phenx,,child sleep disorder still present; finding; findings; ordinal; point in time; ql; qual; qualitative; random; screen,Ord
64588-7,"psychological, psychiatric, emotional, or behavioral problems diagnosed or suspected by a physician in your child [phenx]",child psych behav dx phenx,,child psych behav dx; finding; findings; nominal; point in time; random,Nom
64593-7,fev1 quality attribute respiratory system [phenx],fev1qa respiratory phenx,,breathing; fev1qa; finding; findings; lungs; nominal; point in time; random; rs,Nom
646-0,microscopic observation [identifier] in sputum by acid fast stain.kinyoun modified,acid fast mod kiny stn spt,microscopic observation acid fast stain.kinyoun modified nom (sput),acd; acid fast kiny stn; acid fast mod kiny stn; acid fast stn; acids; afb stain; id; identity or presence; infectious disease; infectiousdisease; lower respiratory; lung; microbiology; nominal; point in time; pulmonary; pulmonology; random; respiratory; spt; sputum; st; stains; stn,Nom
64619-0,have you ever had any other operation that makes it impossible for you to have a baby [phenx],other sterilization operation phenx,,finding; findings; ordinal; other sterilization operation; othr; point in time; ql; qual; qualitative; random; screen,Ord
64623-2,"as far as you know, is he completely sterile from this operation, that is, does it make it impossible for him to father a baby in the future [phenx]",completely sterile male phenx,,arterial stenosis; completely sterile male; finding; findings; ordinal; point in time; ql; qual; qualitative; random; screen,Ord
64643-0,would you say these physical changes [phenx],puberty reach phenx,,finding; findings; ordinal; point in time; puberty reach; ql; qual; qualitative; random; screen,Ord
64647-1,how many mos have you used nolvadex [phenx],nolvadex used mos phenx,,month; nolvadex used mos; point in time; qnt; quan; quant; quantitative; random,Qn
64659-6,other hormones currently used such as tri-est [phenx],current use hormones other phenx,,arterial stenosis; current use hormones other; finding; findings; nominal; othr; point in time; random,Nom
64664-6,age when received human papillomavirus vaccination,age when received hpv vaccine,,age when received hpv vaccine; immunizations; point in time; qnt; quan; quant; quantitative; random; vaccine,Qn
64689-3,"over the past 4 weeks when you had sexual stimulation or intercourse, how often did you ejaculate [phenx]",sex stimul intercourse ejaculate phenx,,4 weeks; finding; findings; last; ordinal; ql; qual; qualitative; screen; sex stimul intercourse ejaculate; stim,Ord
64696-8,"since the age of 18, have you ever experienced a time interval of 3 or months when you did not have a menstrual period [phenx]",no menstrual period 3 or more mos phenx,,finding; findings; iii; month; no menstrual period 3 or more mos; ordinal; point in time; ql; qual; qualitative; random; screen,Ord
64714-9,was the baby a boy or a girl [phenx],baby boy girl phenx,,baby boy girl; finding; findings; nominal; point in time; random,Nom
64729-7,how old were you the first time you had vaginal intercourse [phenx],vaginal intercourse first age phenx,,point in time; qnt; quan; quant; quantitative; random; vaginal intercourse first age,Qn
64731-3,with how many different partners have you had vaginal intercourse in the past 12 months [phenx],vag intercrse partners 12mo nrate phenx,,1 year; 12mos; count/time; last; nrate; number rate; number rate = count/time; qnt; quan; quant; quantitative; vag intercrse partners 12mo,Qn
6473-3,microscopic observation [identifier] in tissue by trichrome stain,tri stn tiss,microscopic observation trichrome stain nom (tiss),"id; identity or presence; infectious disease; infectiousdisease; microbiology; nominal; point in time; random; st; stains; stn; tissue; tissue, unspecified; tri stn; universallaborders",Nom
64735-4,"have you ever had any kind of sexual experience or sexual contact with a female, for women, or male, for men [phenx]",same gender sexual contact exper phenx,,finding; findings; ordinal; point in time; ql; qual; qualitative; random; same gender sexual contact exper; screen,Ord
64736-2,for females - have you ever had sex with a woman involving genital area or vaginal contact. for males - have you ever had sex with a man involving genital area or penis contact [phenx],same gender genital contact ever phenx,,finding; findings; gender; ordinal; point in time; ql; qual; qualitative; random; same gender genital contact ever; screen,Ord
64745-3,eye problem [phenx],eye problem phenx,,finding; findings; nominal; point in time; random,Nom
64755-2,does your child close or cover one eye when he or she is concentrating [phenx],close one eye concentrating phenx,,close one eye concentrating; finding; findings; ordinal; point in time; ql; qual; qualitative; random; screen,Ord
6475-8,mobiluncus sp rrna [presence] in specimen by probe,mobiluncus rrna spec ql probe,mobiluncus sp rrna probe ql (specimen),bacterial vaginosis; dna nucleic acid probe; dna probe; id; infectious disease; infectiousdisease; microbiology; misc; miscellaneous; ordinal; other; point in time; pr; ql; qual; qualitative; random; ribosomal rna; screen; spec; species; spp; to be specified in another part of the message; unspecified,Ord
64761-0,which relatives have vision problem [phenx],which relatives vison problem phenx,,finding; findings; nominal; point in time; random; which relatives vison problem,Nom
64766-9,"how many of his or her other relatives have, had, or were suspected of having this eye problem [#] [phenx]",eye problem other relatives phenx,,cnt; count; eye problem other relatives; number; othr; point in time; qnt; quan; quant; quantitative; random,Qn
64790-9,what month and year did your child first have this type of operation [date and time] [phenx],operation straighten eyes date phenx,,date and time; operation straighten eyes date; point in time; qnt; quan; quant; quantitative; random; time stamp; timestamp,Qn
64797-4,oxygen content in venous cord blood by calculation,o2 ct vfr bldcov calc,oxygen content calc (bldcov) [volume fraction],bld cord; calc; calculation; chemistry; cord bldv; cord venous blood; cto2; o2; o2 ct; o2ct; percent; point in time; qnt; quan; quant; quantitative; random; to2; volfr; volume fraction,Qn
64814-7,"at the present time, would you say your eyesight using both eyes, with glasses or contact lenses, if you wear them, is [phenx]",both eyes eyesight phenx,,both eyes eyesight; finding; findings; ordinal; point in time; ql; qual; qualitative; random; screen,Ord
64822-0,how many different times have you had laser treatment or surgery for diabetic eye disease [phenx],diabet retinop laser surg times phenx,,cnt; count; diabet retinop laser surg times; dis; diseases; dz; number; point in time; qnt; quan; quant; quantitative; random; surg; tx,Qn
64833-7,do you have any abnormal ocular features [phenx],abnormal ocular features phenx,,abn; abnorm; finding; findings; ordinal; point in time; ql; qual; qualitative; random; screen,Ord
64848-5,"how much pain or discomfort have you had in and around your eyes, for example, burning, itching, or aching [phenx]",pain discomfort around eyes phenx,,finding; findings; ordinal; pain discomfort around eyes; point in time; ql; qual; qualitative; random; screen,Ord
64858-4,how would you rate your overall health [phenx],rate overall health phenx,,cnt; count; number; ordinal; point in time; ql; qual; qualitative; random; rate overall health; screen,Ord
64874-1,were the glasses or contact lenses prescribed for short-sightedness or myopia [phenx],glasses contact lense myopia phenx,,finding; findings; glasses contact lense myopia; ordinal; point in time; ql; qual; qualitative; random; screen,Ord
64875-8,were the glasses or contact lenses prescribed for long-sightedness or hyperopia [phenx],glasses contact lense hyperopia phenx,,finding; findings; glasses contact lense hyperopia; ordinal; point in time; ql; qual; qualitative; random; screen,Ord
64880-8,age when first prescribed [phenx],glasses first age phenx,,glasses first age; point in time; qnt; quan; quant; quantitative; random,Qn
64883-2,how often did your child wear their glasses - contact lenses [phenx],glasses freq phenx,,finding; findings; glasses freq; ordinal; point in time; ql; qual; qualitative; random; screen,Ord
64898-0,i feel scared when i watch an operation [scared-r],anxiety operation scared-r,,anxiety operation; finding; findings; ordinal; phenx; point in time; ql; qual; qualitative; r prime; random; right; screen,Ord
64905-3,people tell me i worry too much [scared-r],anxiety told worry too much scared-r,,anxiety told worry too much; finding; findings; ordinal; phenx; point in time; ql; qual; qualitative; r prime; random; right; screen,Ord
64906-1,i don't like being away from my family [scared-r],anxiety away from family scared-r,,anxiety away from family; finding; findings; ordinal; phenx; point in time; ql; qual; qualitative; r prime; random; right; screen; t prime,Ord
64916-0,i don't like going to school [scared-r],anxiety school scared-r,,anxiety school; finding; findings; ordinal; phenx; point in time; ql; qual; qualitative; r prime; random; right; screen; t prime,Ord
64949-1,i have unbidden thoughts about a very aversive event i once experienced [scared-r],anxiety thoughts bad events scared-r,,anxiety thoughts bad events; finding; findings; ordinal; phenx; point in time; ql; qual; qualitative; r prime; random; right; screen,Ord
64970-7,london plane recombinant (rpla a) 3 ige ab [units/volume] in serum,london plane (rpla a) 3 ige qn,london plane recombinant (rpla a) 3 ige qn (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; iii; immune globulin e; immunoglobulin e; london plane; london plane (rpla a) 3; maple leaf sycamore; point in time; qnt; quan; quant; quantitative; random; serum; sr; t11,Qn
64994-7,vaccine funding program eligibility category,vaccine fund pgm elig cat,,finding; findings; nominal; point in time; random; vaccine fund pgm elig cat,Nom
65005-1,i often notice small sounds when others do not [aq],notice small sounds aq,,finding; findings; ordinal; phenx; point in time; ql; qual; qualitative; random; screen,Ord
65011-9,i find social situations easy [aq],social situations easy aq,,finding; findings; ordinal; phenx; point in time; ql; qual; qualitative; random; screen,Ord
65021-8,i don't particularly enjoy reading fiction [aq],don't enjoy fiction aq,,don't enjoy fiction; finding; findings; ordinal; phenx; point in time; ql; qual; qualitative; random; screen; t prime,Ord
65041-6,"i like to collect information about categories of things - types of car, types of bird, types of train, types of plant, etc [aq]",collect categories aq,,collect categories; finding; findings; ordinal; phenx; point in time; ql; qual; qualitative; random; screen,Ord
65049-9,i am not very good at remembering peoples date of birth [aq],difficulty remember birth dates aq,,difficulty remember birth dates; finding; findings; ordinal; phenx; point in time; ql; qual; qualitative; random; screen,Ord
65054-9,your child frequently gets so strongly absorbed in one thing that your child loses sight of other things [aq adolescent],child strongly absorbed aq adol,,child strongly absorbed; finding; findings; ordinal; othr; phenx; point in time; ql; qual; qualitative; random; screen,Ord
65060-6,"in a social group, your child can easily keep track of several different peoples conversations [aq adolescent]",child track diff conversations aq adol,,child track diff conversations; finding; findings; ordinal; phenx; point in time; ql; qual; qualitative; random; screen,Ord
65073-9,your child notices patterns in things all the time [aq adolescent],child notices patterns aq adol,,finding; findings; ordinal; phenx; point in time; ql; qual; qualitative; random; screen,Ord
65086-1,your child finds it easy to work out what someone is thinking or feeling just by looking at their face [aq adolescent],child easy to read face aq adol,,child easy to read face; finding; findings; job; occupation; ordinal; phenx; point in time; ql; qual; qualitative; random; screen,Ord
65100-0,does your child join in playing games with other children easily [cast],join games cast,,finding; findings; join games; ordinal; othr; phenx; point in time; ql; qual; qualitative; random; screen,Ord
65121-6,can your child dress him or herself [cast],get dressed cast,,finding; findings; get dressed; ordinal; phenx; point in time; ql; qual; qualitative; random; screen,Ord
65135-6,does your child often turn conversations to his or her favorite subject rather than following what the other person wants to talk about [cast],redirects conversation cast,,finding; findings; ordinal; othr; persons; phenx; point in time; ql; qual; qualitative; random; redirects conversation; screen,Ord
65147-1,i see myself as someone who does a thorough job [bfi],thorough job bfi,,arterial stenosis; finding; findings; occupation; ordinal; phenx; point in time; ql; qual; qualitative; random; screen; work; world heatlth organization,Ord
65170-3,i see myself as someone who has an assertive personality [bfi],assertive bfi,,arterial stenosis; finding; findings; ordinal; phenx; point in time; ql; qual; qualitative; random; screen; world heatlth organization,Ord
65176-0,"i see myself as someone who is considerate, kind to almost everyone [bfi]",considerate bfi,,arterial stenosis; finding; findings; ordinal; phenx; point in time; ql; qual; qualitative; random; screen; world heatlth organization,Ord
65189-3,"during the past 30 days, about how often did you feel nervous [kessler 6 distress]",nervous 30d k6,,finding; findings; k6; last; nervous 30d; ordinal; phenx; ql; qual; qualitative; screen,Ord
65199-2,"during the past 30 days, how often have physical health problems been the main cause of these feelings [kessler 6 distress]",physical health cause problems 30d k6,,finding; findings; k6; last; ordinal; phenx; physical health cause problems 30d; ql; qual; qualitative; screen,Ord
65212-3,"since the event, have you found yourself unable to see a future for yourself [phenx]",unable to see a future phenx,,finding; findings; ordinal; point in time; ql; qual; qualitative; random; screen,Ord
65223-0,age of onset of symptoms,age of onset,,h+p; h+p.hx; p prime; point in time; qnt; quan; quant; quantitative; random; sx,Qn
65224-8,"how often do you have trouble wrapping up the final details of a project, once the challenging parts have been done [asrs]",trouble wrapping up project asrs,,finding; findings; ordinal; phenx; point in time; ql; qual; qualitative; random; screen; trouble wrapping up project,Ord
65225-5,how often do you have difficulty getting things in order when you have to do a task that requires organization [asrs],difficulty getting organized asrs,,difficulty getting organized; finding; findings; ordinal; phenx; point in time; ql; qual; qualitative; random; screen,Ord
6522-7,rabies virus ab [units/volume] in cerebral spinal fluid,rabv ab csf-acnc,rabies virus ab qn (csf),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; cerebral spinal fluid; cerebrospinal fl; id; infectious disease; infectiousdisease; lyssavirus; microbiology; neuro; neurology; point in time; qnt; quan; quant; quantitative; rabies; rabv; random; spinal fl; spinal fld; spinal flu; spinal fluid,Qn
65230-5,how often do you make careless mistakes when you have to work on a boring or difficult project [asrs],careless mistakes tedious task asrs,,careless mistakes tedious task; finding; findings; job; occupation; ordinal; phenx; point in time; ql; qual; qualitative; random; screen,Ord
65234-7,how often are you distracted by activity or noise around you [asrs],freq distracted by noise asrs,,activ; actvty; finding; findings; freq distracted by noise; movements; ordinal; phenx; point in time; ql; qual; qualitative; random; screen,Ord
6523-5,rabies virus neutralizing antibody [units/volume] in cerebral spinal fluid by neutralization test,rabv nab csf nt-acnc,rabies virus neut ab neut test qn (csf),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; cerebral spinal fluid; cerebrospinal fl; conventional virus neutralization test; cvnt; id; infectious disease; infectiousdisease; lyssavirus; microbiology; nab; neuro; neurology; neutralization; neutralization test; nt; point in time; qnt; quan; quant; quantitative; rabies; rabv; random; serum virus neutralization; spinal fl; spinal fld; spinal flu; spinal fluid; svn; virus neutralization test; vnt,Qn
65237-0,how often do you have difficulty unwinding and relaxing when you have time to yourself [asrs],difficulty unwinding asrs,,finding; findings; ordinal; phenx; point in time; ql; qual; qualitative; random; screen,Ord
65244-6,"compared to other children, does this child listen when spoken to directly [swan]",listen when spoken to swan,,finding; findings; ordinal; othr; phenx; point in time; ql; qual; qualitative; random; screen,Ord
65256-0,"compared to other children, does this child modulate verbal activity, control excess talking [swan]",control excess talking swan,,activ; actvty; exs; finding; findings; movements; ordinal; othr; phenx; point in time; ql; qual; qualitative; random; screen,Ord
65257-8,"compared to other children, does this child reflect on questions, control blurting out answers [swan]",control blurting out swan,,finding; findings; ordinal; othr; phenx; point in time; ql; qual; qualitative; random; screen,Ord
65292-5,i am sensitive to the feelings of others [phenx],sensitive to others feelings phenx,,finding; findings; ordinal; point in time; ql; qual; qualitative; random; screen; sensitive to others feelings,Ord
65298-2,"for me, honesty really is the best policy [phenx]",honesty best policy phenx,,finding; findings; honesty best policy; ordinal; point in time; ql; qual; qualitative; random; screen,Ord
65303-0,it's easy to embarrass me [phenx],easily embarrassed phenx,,easily embarrassed; finding; findings; ordinal; point in time; ql; qual; qualitative; random; s prime; screen,Ord
65311-3,it's easy for me to relate to other people's emotions [phenx],relate to people's emotions phenx,,finding; findings; ordinal; othr; point in time; ql; qual; qualitative; random; relate to people's emotions; s prime; screen,Ord
65314-7,it doesn't bother me when people around me are hurting [phenx],not bothered people hurting phenx,,finding; findings; not bothered people hurting; ordinal; point in time; ql; qual; qualitative; random; screen; t prime,Ord
65320-4,fy3 ab [presence] in serum or plasma,fy3 ab serpl ql,fy3 ab ql,abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; blood bank; fy3; ordinal; pl; plasma; plsm; point in time; pr; ql; qual; qualitative; random; screen; serp; serpl; serplas; serum; serum or plasma; sr,Ord
65327-9,lu 14 ab [presence] in serum or plasma,lu 14 ab serpl ql,lu 14 ab ql,abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; blood bank; left; levo; lu 14; ordinal; pl; plasma; plsm; point in time; pr; ql; qual; qualitative; random; screen; serp; serpl; serplas; serum; serum or plasma; sr,Ord
65328-7,lw sup(a) ab [presence] in serum or plasma,lw sup(a) ab serpl ql,lw sup(a) ab ql,abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; blood bank; landsteiner-wiener; landsteiner-wiener blood group system; lw sup(a); ordinal; pl; plasma; plsm; point in time; pr; ql; qual; qualitative; random; screen; serp; serpl; serplas; serum; serum or plasma; sr,Ord
65334-5,sc2 ab [presence] in serum or plasma,sc2 ab serpl ql,sc2 ab ql,abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; blood bank; c; ii; ordinal; pl; plasma; plsm; point in time; pr; ql; qual; qualitative; random; s prime; sc2; scianna blood group system; screen; serp; serpl; serplas; serum; serum or plasma; sr,Ord
6534-2,deprecated rabies virus ag [units/volume] in unspecified specimen by immunofluorescence,deprecated rabv ag xxx if-acnc,rabies virus ag if qn (specimen),acif; anticomplement immunofluorescence; antigen; antigens; arbitrary concentration; dfa; fa; fluorescent antibody; fluoresent; id; ifa; immune fluorescence; immunoflour; immunofluor; immunofluorescence; infectious disease; infectiousdisease; lyssavirus; microbiology; misc; miscellaneous; other; point in time; qnt; quan; quant; quantitative; rabies; rabv; random; spec; time resolved fluorescence; to be specified in another part of the message; trf; unspecified,Qn
65346-9,glucagon [mass/volume] in serum or plasma --2nd specimen post xxx challenge,glucagon sp2 p chal serpl-mcnc,glucagon 2nd specimen post unsp challenge [mass/vol],after; chemistry.challenge testing; convalescent; hgf; hyperglycemic factor; level; mass concentration; p chal; pl; plasma; plsm; point in time; post immunization; pst; qnt; quan; quant; quantitative; random; second; serp; serpl; serplas; serum; serum or plasma; sp2; sp2 p chal; spec; sr,Qn
65358-4,proinsulin [moles/volume] in serum or plasma --7th specimen post xxx challenge,proinsulin sp7 p chal serpl-scnc,proinsulin 7th specimen post unsp challenge [moles/vol],^7th spec pst xxx chal; after; chemistry.challenge testing; level; p chal; pl; plasma; plsm; point in time; pro insulin; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sp7; sp7 p chal; spec; sr; substance concentration,Qn
65372-5,"shortly after waking up, either in the morning or after a nap, have you ever noticed uncontrollable jerking or clumsiness, such as dropping things or things suddenly flying from your hands [phenx]",uncontrollable jerking clumsiness phenx,,arterial stenosis; finding; findings; ordinal; point in time; ql; qual; qualitative; random; screen; uncontrollable jerking clumsiness,Ord
6537-5,deprecated rabies virus strain identified in tissue by organism specific culture,deprecated rabv tiss cult,rabies virus identified org specific cx nom (tiss),"c&s; cult; cultures; id; identity or presence; infectious disease; infectiousdisease; isolated; lyssavirus; microbiology; nominal; point in time; rabies; rabv; random; spec; tissue; tissue, unspecified",Nom
65381-6,because of your headaches on how many days in the last 3 months did you miss work or school [phenx],# ds miss school nrate phenx,,# ds miss school; 3 months; count/time; job; nrate; number rate; number rate = count/time; occupation; past; qnt; quan; quant; quantitative,Qn
65383-2,because of your headaches on how many days in the last 3 months did you not do household work [phenx],# ds no housework nrate phenx,,# ds no housework; 3 months; count/time; job; nrate; number rate; number rate = count/time; occupation; past; qnt; quan; quant; quantitative,Qn
65384-0,because of your headaches on how many days in the last 3 months was your productivity in house-hold work reduced by half or more [phenx],num ds housework reduced 1/2 nrate phenx,,3 months; count/time; job; nrate; num ds housework reduced 1/2; number rate; number rate = count/time; occupation; past; qnt; quan; quant; quantitative,Qn
65386-5,at what age did you begin having severe headaches [phenx],age headaches began phenx,,age headaches began; point in time; qnt; quan; quant; quantitative; random,Qn
65413-7,side [phenx],side phenx,,finding; findings; nominal; point in time; random,Nom
65426-9,"were you ever afraid that you might faint, lose control, or embarrass yourself in other ways [cidi-sf]",agoraphobia faint embarrass cidi-sf,,agoraphobia faint embarrass; finding; findings; ordinal; othr; phenx; point in time; ql; qual; qualitative; random; screen,Ord
65435-0,have you ever been bothered by having certain unpleasant thoughts of your own that kept entering your mind against your wishes [cidi-sf],ocd unpleasant thoughts germs cidi-sf,,finding; findings; ocd unpleasant thoughts germs; ordinal; phenx; point in time; ql; qual; qualitative; random; screen,Ord
65454-1,"have you found that your childs feelings or energy are generally up or down, but rarely in the middle [p-gbi]",mania feelings always extreme p-gbi,,finding; findings; mania feelings always extreme; ordinal; p prime; phenx; point in time; ql; qual; qualitative; random; screen,Ord
6545-8,rickettsia sp identified in sputum by organism specific culture,rickettsia spt cult,rickettsia sp identified org specific cx nom (sput),c&s; cult; cultures; id; identity or presence; infectious disease; infectiousdisease; lower respiratory; lung; microbiology; nominal; point in time; pulmonary; pulmonology; random; respiratory; ricket; rickettsial; spec; species; spp; spt; sputum,Nom
65464-0,"i did not feel like eating, i wasn't very hungry [ces-dc]",not hungry ces-dc,,finding; findings; not hungry; ordinal; phenx; point in time; ql; qual; qualitative; random; screen; sdoh; t prime,Ord
65492-1,did you have a lot more trouble concentrating than usual [cidi-sf],depression trouble concentrating cidi-sf,,depression trouble concentrating; finding; findings; ordinal; phenx; point in time; ql; qual; qualitative; random; screen,Ord
65498-8,about how old were you the last time you had a period of 2 weeks like this [cidi-sf],depression age last occurrence cidi-sf,,depression age last occurrence; past; phenx; point in time; qnt; quan; quant; quantitative; random,Qn
65502-7,falling asleep in past 7 days [qids],falling asleep qids,,finding; findings; last; ordinal; phenx; ql; qual; qualitative; screen,Ord
65510-0,increased weight within the last 2 weeks [qids],increased weight 2w [qids],,14 days; 2 weeks; finding; findings; ordinal; past; phenx; ql; qual; qualitative; screen; weight gain; wt,Ord
65518-3,have you felt fat [edds],felt fat edds,,finding; findings; ordinal; phenx; point in time; ql; qual; qualitative; random; screen,Ord
65523-3,"during the times when you ate an unusually large amount of food, did you experience a loss of control - feel you couldn't stop eating or control what or how much you were eating [edds]",couldn't stop eating edds,,finding; findings; ordinal; phenx; point in time; ql; qual; qualitative; random; screen; t prime,Ord
65540-7,how often do you get upset when you are in that situation [cidi-sf],specific upset with self cidi-sf,,finding; findings; ordinal; phenx; point in time; ql; qual; qualitative; random; screen; specific upset with self,Ord
65546-4,problem related to diabetes [phenx],diabetes problem phenx,,diabetes problem; finding; findings; nominal; point in time; random,Nom
6556-5,deprecated streptococcus pyogenes ag [presence] in throat by immunoassay,deprecated s pyo ag throat ql eia,s. pyogenes ag eia ql (throat),antigen; antigens; elfa; elisa; enzyme immunoassay; gas; group a strep; iaa; id; infectious disease; infectiousdisease; meia; microbiology; ordinal; point in time; ql; qual; qualitative; random; s pyogenes; screen; steptococcus group a; strep; strept; streptococci group a; streptococcus group a; suds; throat; upper respiratory,Ord
65577-9,"when you are traveling east by air and you cross over several time zones, how quickly do you return to your usual sleeping pattern [phenx]",jet lag west phenx,,jet lag west; point in time; qnt; quan; quant; quantitative; random,Qn
65623-1,"do you ever experience periods of muscle weakness, loss of muscle strength or limp muscles in any part of your body, such as the legs or face, when you are angry [phenx]",muscle weakness angry phenx,,arterial stenosis; bod; bodies; finding; findings; musc; muscl; muscle weakness angry; ordinal; point in time; ql; qual; qualitative; random; screen,Ord
65628-0,do you have any memory of these events [phenx],memory move in sleep phenx,,finding; findings; memory move in sleep; ordinal; point in time; ql; qual; qualitative; random; screen,Ord
6563-1,trichinella spiralis igg ab [presence] in serum by immunoassay,t spiralis igg ser ql ia,t. spiralis igg ia ql (s),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; eia; elfa; elisa; enzyme immunoassay; iaa; id; immune globulin g; immunoglobulin g; infectious disease; infectiousdisease; meia; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; sr; suds; t spiralis; tric; trich; trichinellosis; trichinosis,Ord
65640-5,tap left foot - 10 times [phenx],tap left foot phenx,,finding; findings; l; lower extremity; lt; ordinal; point in time; ql; qual; qualitative; random; screen,Ord
65643-9,relative humidity,relative humidity,,phenx; point in time; qnt; quan; quant; quantitative; random; rel; relative mass concentration; rlmcnc,Qn
65660-3,original sampling interval [phenx],original sampling interval phenx,,point in time; qnt; quan; quant; quantitative; random,Qn
65661-1,data points [#] [phenx],data points phenx,,cnt; count; number; point in time; qnt; quan; quant; quantitative; random,Qn
65662-9,flow time data point [phenx],flow time data point phenx,,cnt; count; dynamic; nominal; number; point in time; random,Nom
65671-0,other treatment or treatments you are receiving or you received for your eye problem [phenx],other treatment eye problem phenx,,finding; findings; nominal; other treatment eye problem; othr; point in time; random; tx; txs,Nom
65679-3,does this loss of sleep affect you the next day with respect to your desire for chocolate or sweets [phenx],sleep loss affect desire sweets phenx,,f052; f52; finding; findings; ordinal; point in time; ql; qual; qualitative; random; screen; sleep loss affect desire sweets,Ord
65680-1,how does this loss of sleep affect you the next day with respect to your desire for chocolate or sweets [phenx],sleep loss affect sweets how phenx,,f052; f52; finding; findings; ordinal; point in time; ql; qual; qualitative; random; screen; sleep loss affect desire sweets; sleep loss affect sweets how,Ord
656-9,microscopic observation [identifier] in specimen by acid fast stain.ziehl-neelsen,zn stn spec,microscopic observation acid fast stain.ziehl-neelsen nom (specimen),acd; acid fast stn; acids; afb stain; id; identity or presence; infectious disease; infectiousdisease; microbiology; misc; miscellaneous; nominal; other; point in time; random; spec; st; stains; stn; to be specified in another part of the message; unspecified; zn stn,Nom
65731-2,"have you ever had a sudden spell of double vision, which lasted 24 hours or longer [phenx]",double vision phenx,,finding; findings; ordinal; point in time; ql; qual; qualitative; random; screen,Ord
65733-8,things occurring with double vision [phenx],things with double vision phenx,,finding; findings; nominal; point in time; random; things with double vision,Nom
65752-8,liver pathology biopsy report,liver path bx report,pathology biopsy report nar (liver),bx; finding; findings; hepar; hepatic; narrative; path; path bx report; pathology; point in time; random; report,Nar
6576-3,escherichia coli verotoxin 2 [presence] in stool,e coli vtn2 stl ql,e. coli verotoxin 2 ql (stl),bowel movement; e coli; e coli vtn; e coli vtn2; faecal; faeces; fecal; feces; id; ii; infectious disease; infectiousdisease; microbiology; o002; ordinal; point in time; pr; ql; qual; qualitative; random; screen; stl; stool = fecal,Ord
65767-6,english walnut native (njug r) 2 ige ab [units/volume] in serum,english walnut (njug r) 2 ige qn,english walnut native (njug r) 2 ige qn (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; english walnut; english walnut (njug r) 2; ii; immune globulin e; immunoglobulin e; point in time; qnt; quan; quant; quantitative; r prime; random; right; serum; sr,Qn
65775-9,bermuda grass native (ncyn d) 1 ige ab [units/volume] in serum,bermuda grass (ncyn d) 1 ige qn,bermuda grass native (ncyn d) 1 ige qn (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; bermuda grass; bermuda grass (ncyn d) 1; dextro; g002; g2; g216; i; immune globulin e; immunoglobulin e; point in time; qnt; quan; quant; quantitative; random; serum; sr,Qn
6578-9,vibrio sp identified in blood by organism specific culture,vibrio bld cult,vibrio sp identified org specific cx nom (bld),blood; c&s; cult; cultures; id; identity or presence; infectious disease; infectiousdisease; microbiology; nominal; point in time; random; spec; species; spp; wb; whole blood,Nom
65798-1,rfa guidance for placement of stent in artery - right,rfa guided artery.-r stent place,,art; artery.-r; cardio; cardiology; document; finding; findings; fluor; fluoro; fluoroscopy; guid; guide; guided; heart disease; imaging; misc; miscellaneous; other; point in time; r; rad; radiology; random; rfa; rt; spec; stent place; to be specified in another part of the message; unspecified,Doc
65826-0,what number describes how much this eveningness tendency has affected your social life or relationships with your friends [phenx],social distress scale phenx,,cnt; count; no; num; number; ordinal; point in time; ql; qual; qualitative; random; screen; social distress scale,Ord
6583-9,virus identified in semen by culture,virus smn cult,virus identified cx nom (sem),c&s; cult; cultures; ejaculate; genitourinary; gu; id; identity or presence; infectious disease; infectiousdisease; microbiology; nominal; point in time; random; sem; seminal fluid; smn; smpls; uro; urology,Nom
6586-2,western equine encephalitis virus ag [presence] in serum by immunofluorescence,weev ag ser ql if,weev ag if ql (s),acif; anticomplement immunofluorescence; antigen; antigens; dfa; enc; enceph; encephalomyelitis; equin; fa; fluorescent antibody; fluoresent; id; ifa; immune fluorescence; immunoflour; immunofluor; immunofluorescence; infectious disease; infectiousdisease; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; sr; time resolved fluorescence; togavirus; trf; wee virus; weev; west,Ord
65863-3,heart failure 4y risk [#] framingham.kannel 1999,hf 4y risk,,card.risk; cardio; cardiology; cnt; count; heart disease; hf 4y risk; number; point in time; qnt; quan; quant; quantitative; random,Qn
65868-2,your testicles started increasing in size compared to your friends was this [phenx],testicle size peer compare phenx,,finding; findings; ordinal; point in time; ql; qual; qualitative; random; screen; testicle size peer compare,Ord
65906-0,estimated diameter of pupil left eye [retinal digital photography],diam pupil est l eye ret dig photog,,dia; diam; diam pupil est; eyeball; l; l eye; length; lt; occular; oculis; ophthalmologic; optic globe; phenx; point in time; qnt; quan; quant; quantitative; random; ret dig photog; vision; visual,Qn
65907-8,problems or unusual findings left eye,problems unusual findings l eye,,eyeball; finding; findings; l; l eye; lt; nominal; occular; oculis; ophthalmologic; optic globe; phenx; point in time; problems unusual findings; random; vision; visual,Nom
6591-2,yellow fever virus neutralizing antibody [units/volume] in serum by neutralization test,yfv nab ser nt-acnc,yellow fever virus neut ab neut test qn (s),abs; aby; american plague; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; conventional virus neutralization test; cvnt; id; infectious disease; infectiousdisease; microbiology; nab; neutralization; neutralization test; nt; point in time; qnt; quan; quant; quantitative; random; serum; serum virus neutralization; sr; svn; virus neutralization test; vnt; yellow jack; yfv,Qn
65916-9,aspects of your life [hcl-32],life aspects hcl-32,,finding; findings; life aspects; nominal; phenx; point in time; random,Nom
65960-7,suicidality notes [text] [di-pad],suicidality notes di-pad,,nominal; phenx; point in time; random; text,Nom
65968-0,how many hours do you normally sleep [di-pad],hs normal sleep di-pad,,hs normal sleep; phenx; point in time; qnt; quan; quant; quantitative; random,Qn
65977-1,racing thoughts [di-pad],racing thoughts di-pad,,finding; findings; ordinal; phenx; point in time; ql; qual; qualitative; random; screen,Ord
65978-9,distractibility [di-pad],distractibility di-pad,,finding; findings; ordinal; phenx; point in time; ql; qual; qualitative; random; screen,Ord
65990-4,third person auditory hallucinations [di-pad],3rd person auditory hallucination di-pad,,3rd; 3rd person auditory hallucination; finding; findings; ordinal; persons; phenx; point in time; ql; qual; qualitative; random; screen,Ord
65999-5,delusions of poverty [di-pad],delusions poverty di-pad,,delusions poverty; finding; findings; ordinal; phenx; point in time; ql; qual; qualitative; random; screen,Ord
66002-7,delusions of influence [di-pad],delusions influence di-pad,,delusions influence; finding; findings; ordinal; phenx; point in time; ql; qual; qualitative; random; screen,Ord
66003-5,persecutory delusions [di-pad],persecutory delusion di-pad,,finding; findings; ordinal; phenx; point in time; ql; qual; qualitative; random; screen,Ord
66010-0,relationship between psychotic and affective symptoms [di-pad],relat psych affective sympts di-pad,,finding; findings; ordinal; phenx; point in time; ql; qual; qualitative; random; relat psych affective sympts; screen; sx,Ord
66037-3,rigidity neck [updrs],rigidity neck updrs,,finding; findings; ordinal; point in time; ql; qual; qualitative; random; screen; unified parkinson's disease rating scale (updrs),Ord
66051-4,"i have much less control over what i do, because of my eyesight [phenx]",less control because eyesight phenx,,finding; findings; less control because eyesight; ordinal; point in time; ql; qual; qualitative; random; screen,Ord
66065-4,have you ever used this method to prevent pregnancy [phenx],prevent pregnancy methods ever phenx,,finding; findings; gestation; gestations; gravida; meth; method of; ordinal; point in time; pregnancies; prevent pregnancy methods ever; ql; qual; qualitative; random; screen,Ord
66070-4,"how many of your brothers have had, or were suspected of having this eye problem [#] [phenx]",brothers eye problem phenx,,brothers eye problem; cnt; count; number; point in time; qnt; quan; quant; quantitative; random,Qn
66074-6,"how many of your mother's brothers have had, or were suspected of having this eye problem [#] [phenx]",mothers brothers eye problem phenx,,cnt; count; mothers brothers eye problem; number; point in time; qnt; quan; quant; quantitative; random; s prime,Qn
66085-2,"because of your eyesight, how much difficulty do you have visiting with people in their homes, at parties, or in restaurants [phenx]",difficulty visit people phenx,,difficulty visit people; finding; findings; ordinal; point in time; ql; qual; qualitative; random; screen,Ord
66086-0,"because of your eyesight, how much difficulty do you have going out to see movies, plays, or sports events [phenx]",difficulty go out phenx,,difficulty go out; finding; findings; ordinal; point in time; ql; qual; qualitative; random; screen,Ord
66088-6,how often did having trouble falling asleep happen [qids],depression trouble sleeping freq qids,,depression trouble sleeping freq; finding; findings; ordinal; phenx; point in time; ql; qual; qualitative; random; screen,Ord
66094-4,do you ever have any prickling feelings in your legs or feet [phenx],prickling feelings phenx,,finding; findings; ordinal; point in time; ql; qual; qualitative; random; screen,Ord
66095-1,does it hurt when the bed covers touch your skin [phenx],bed covers hurt phenx,,bed covers hurt; finding; findings; integument; ordinal; point in time; ql; qual; qualitative; random; screen,Ord
66132-2,mononuclear+mesothelial cells/leukocytes in body fluid by manual count,mono+meso nfr fld manual,mononuclear+mesothelial cells/leukocytes manual cnt (body fld),"b/f; bf; bod; bodies; body fluid; body fluid, unsp; cell; cellularity; fl; fld; flu; fluid; hematology/cell counts; leuc; leuk; leukocyte; lkcs; manl; mesothl; mesothl cell; mono+meso; number fraction; percent; point in time; qnt; quan; quant; quantitative; random; wbc; wbcs; white blood cell; white blood cells",Qn
66145-4,leukocytes other [#/volume] in blood from fetus by manual count,wbc other # bld fetus manual,wbc other manual cnt (bld fetus) [#/vol],#; abs; absolute; absolutes; blood; cnt; count; count/volume; ct; fetal; gyn; gynecology; hematology/cell counts; leuc; leuk; leukocyte; lkcs; manl; number concentration; number concentration (count/vol); ob; obgyn; obstetrics; othr; point in time; qnt; quan; quant; quantitative; random; wb; wbc; wbc other; wbcs; white blood cell; white blood cells; whole blood,Qn
66158-7,has a medical person ever told you that you had kidney failure [phenx],kidney failure phenx,,finding; findings; ordinal; persons; point in time; ql; qual; qualitative; random; screen,Ord
6615-9,haemophilus influenzae f ag [presence] in cerebral spinal fluid by immunofluorescence,haem influ f ag csf ql if,h. influenzae f ag if ql (csf),acif; anticomplement immunofluorescence; antigen; antigens; cerebral spinal fluid; cerebrospinal fl; dfa; fa; fluorescent antibody; fluoresent; h flu; h influenza; h influenzae; haem influ; haem influ f; haemoph; id; ifa; immune fluorescence; immunoflour; immunofluor; immunofluorescence; infectious disease; infectiousdisease; influ; microbiology; neuro; neurology; ordinal; point in time; pr; ql; qual; qualitative; random; screen; spinal fl; spinal fld; spinal flu; spinal fluid; time resolved fluorescence; trf,Ord
66161-1,are you currently on renal dialysis [phenx],dialysis phenx,,dialy; finding; findings; kidney; ordinal; point in time; ql; qual; qualitative; random; screen,Ord
6617-5,visual acuity log mar eye - left,l eye visual acuity log mar,,complex; eye; eyeball; l; l eye; lt; minimal angle of resolution; minimum angle of resolution; occular; oculis; ophthalmologic; ophthalmology; ophtho; ophthy; optic globe; point in time; qnt; quan; quant; quantitative; random; refraction; va; vision; visual,Qn
66181-9,was full sample obtained [phenx],blood draw sample phenx,,blood draw sample; finding; findings; ordinal; point in time; ql; qual; qualitative; random; screen,Ord
66206-4,time between consuming dextrose solution and administering the second blood draw [phenx],ms between dextrose blood draw phenx,,2nd; ms between dextrose blood draw; point in time; qnt; quan; quant; quantitative; random,Qn
66228-8,will the pain keep you from squeezing as hard as you can [phenx],pain prevent squeeze phenx,,arterial stenosis; finding; findings; ordinal; pain prevent squeeze; point in time; ql; qual; qualitative; random; screen,Ord
66238-7,"is your doctor currently prescribing drugs, for example, water pills, for your blood pressure or heart condition [revised parq]",prescribed drugs rparq,,bp; drug; finding; findings; ordinal; par-q; phenx; point in time; prescribed drugs; ql; qual; qualitative; random; screen,Ord
66247-8,sit to stand frequency in 30 seconds,sit to stand # in 30s,,30s cst; 30-second chair stand; 30ssts; count/time; h+p; h+p.px; nrate; number rate; number rate = count/time; p prime; qnt; quan; quant; quantitative; stands,Qn
66256-9,aids for the walk [phenx],aids for walk phenx,,aids for walk; nominal; point in time; random; typ,Nom
66257-7,shorter of the two times [phenx],shorter of two times phenx,,2; point in time; qnt; quan; quant; quantitative; random; shorter of two times,Qn
66259-3,points for 3-meter walk [#] [phenx],3-meter walk points phenx,,3-meter walk points; cnt; count; iii; number; point in time; qnt; quan; quant; quantitative; random,Qn
66261-9,stood without using arms [phenx],stood w/o using arms phenx,,finding; findings; ordinal; point in time; ql; qual; qualitative; random; screen; stood w/o using arms,Ord
66296-5,last four digits of actigraph serial number [phenx],last 4 digits of ag serial number phenx,,ident; identifier; last 4 digits of ag serial number; no; nominal; num; past; point in time; random,Nom
66310-4,reviews form for completeness [phenx],qa actigraph review form phenx,,finding; findings; ordinal; point in time; qa actigraph review form; ql; qual; qualitative; random; screen,Ord
66318-7,diary completed [phenx],diary completed phenx,,finding; findings; ordinal; point in time; ql; qual; qualitative; random; screen,Ord
6633-2,wuchereria bancrofti ab [presence] in serum by immunoassay,w bancr ab ser ql ia,w. bancrofti ab ia ql (s),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; eia; elfa; elisa; enzyme immunoassay; filariasis; human lymphatic filariasis; iaa; id; infectious disease; infectiousdisease; meia; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; sr; suds; w bancr; w bancrofti; wucheria bancrofti,Ord
66340-1,how much difficulty do you have walking up 10 steps without resting [phenx],walking up 10 steps phenx,,finding; findings; ordinal; point in time; ql; qual; qualitative; random; screen,Ord
66346-8,how much difficulty do you have getting in or out of bed [phenx],getting out of bed phenx,,finding; findings; getting out of bed; ordinal; point in time; ql; qual; qualitative; random; screen,Ord
66350-0,how much difficulty do you have reaching up over your head [phenx],reaching over head phenx,,finding; findings; ordinal; point in time; ql; qual; qualitative; random; reaching over head; screen,Ord
66358-3,"it is within a 10-15 minute walk to a transit stop, such as bus, train, trolley, or tram, from my home [phenx]",transit stop phenx,,arterial stenosis; finding; findings; ordinal; point in time; ql; qual; qualitative; random; screen,Ord
66359-1,there are sidewalks on most of the streets in my neighborhood [phenx],sidewalks phenx,,finding; findings; ordinal; point in time; ql; qual; qualitative; random; screen,Ord
66363-3,i can be physically active during my free time on most days [phenx],physically active free time phenx,,finding; findings; fr; non-protein bound; ordinal; physically active free time; point in time; ql; qual; qualitative; random; screen,Ord
6638-1,influenza virus a texas ab [units/volume] in serum by hemagglutination inhibition,fluav tex ab ser hai-acnc,fluav tex ab hai qn (s),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; avian influenza; bird flu; flua; fluav; fluav tex; fluv; fowl plague; hemagglutination inhibition; hi; id; infectious disease; infectiousdisease; influ; influenza a; influenza a virus; microbiology; point in time; qnt; quan; quant; quantitative; random; serum; sr,Qn
66382-3,have you received any vaccinations in the past 4 weeks [phenx],vaccinations phenx,,4 weeks; finding; findings; last; ordinal; ql; qual; qualitative; screen,Ord
66383-1,is the child sick today [phenx],child sick today phenx,,finding; findings; ordinal; point in time; ql; qual; qualitative; random; screen,Ord
66400-3,travelled to country this year [phenx],travelled this y phenx,,finding; findings; ordinal; point in time; ql; qual; qualitative; random; screen; travelled this y,Ord
66412-8,country of exposure - other [phenx],other country exposure phenx,,exp; finding; findings; nominal; other country exposure; othr; point in time; random,Nom
6641-5,influenza virus a mississippi ab [units/volume] in serum by hemagglutination inhibition,fluav miss ab ser hai-acnc,fluav miss ab hai qn (s),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; avian influenza; bird flu; flua; fluav; fluav miss; fluv; fowl plague; hemagglutination inhibition; hi; id; infectious disease; infectiousdisease; influ; influenza a; influenza a virus; microbiology; point in time; qnt; quan; quant; quantitative; random; serum; sr,Qn
66420-1,abnormal lab test [phenx],abnormal lab test phenx,,abn; abnorm; finding; findings; ordinal; point in time; ql; qual; qualitative; random; screen,Ord
6642-3,influenza virus a leningrad ab [units/volume] in serum by hemagglutination inhibition,fluav lenin ab ser hai-acnc,fluav lenin ab hai qn (s),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; avian influenza; bird flu; flua; fluav; fluav lenin; fluv; fowl plague; hemagglutination inhibition; hi; id; infectious disease; infectiousdisease; influ; influenza a; influenza a virus; microbiology; point in time; qnt; quan; quant; quantitative; random; serum; sr,Qn
66426-8,prn medicine current medication [phenx],prn medicine medication.current phenx,,finding; findings; med; ordinal; point in time; ql; qual; qualitative; random; screen,Ord
66434-2,inflammatory disorder [phenx],inflammatory disorder phenx,,finding; findings; nominal; point in time; random,Nom
66441-7,beta hydroxybutyrate [moles/volume] in blood by test strip,b-oh-butyr bld strip-scnc,beta hydroxybutyrate test strip (bld) [moles/vol],3-hydroxybutyrate; 3-hydroxybutyric acid; b; beta hydroxy butyrate; beta hydroxybutyric acid; betahydroxybutyrate; betahydroxybutyric acid; bhb; blood; bohb; b-oh-butyr; chemistry; dip stick; dipstick; hydroxybutyric acid; level; point in time; random; smqn; substance concentration; wb; whole blood,SemiQn
66445-8,cyprinus carpio recombinant (rcyp c) 1 ige ab [units/volume] in serum,carp (rcyp c) 1 ige qn,carp recombinant (rcyp c) 1 ige qn (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; carp; carp (rcyp c) 1; f333; f355; i; immune globulin e; immunoglobulin e; point in time; qnt; quan; quant; quantitative; random; serum; sr,Qn
66452-4,wheat native (ntri a) 18 ige ab [units/volume] in serum,wheat (ntri a) 18 ige qn,wheat native (ntri a) 18 ige qn (s),abs; aby; agglutinin isolectin 1; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; f004; f4; immune globulin e; immunoglobulin e; point in time; qnt; quan; quant; quantitative; random; serum; sr; triticum sativum; wheat; wheat (ntri a) 18,Qn
66468-0,which of the following drugs have you injected using a needle [phenx],which drugs injected phenx,,drug; finding; findings; ndl; nominal; point in time; random; which drugs injected,Nom
66506-7,image name hand [phenx],image name hand phenx,,ident; identifier; nominal; point in time; random; upper extremity,Nom
66509-1,image name knee [phenx],image name knee phenx,,ident; identifier; kn; lower extremity joint; msk; musculoskeletal; nominal; ortho; orthopedics; point in time; random,Nom
66518-2,lichenification score head and neck [phenx],lichenification score head+neck phenx,,brain; cranial; cranium; intracranial; point in time; qnt; quan; quant; quantitative; random; scale; skull,Qn
66521-6,thickness score upper extremity - bilateral [phenx],thickness score ue-bl phenx,,arm; bil; bilat; both; ext; extr-bl; point in time; qnt; quan; quant; quantitative; random; scale; thick; ue; ue-bl; up,Qn
66525-7,redness score trunk [phenx],redness score trunk phenx,,point in time; qnt; quan; quant; quantitative; random; scale,Qn
66541-4,do you have any blood relatives with any type of autoimmune disease [phenx],autoimmune disease family hx phenx,,autoimmune disease family hx; dis; diseases; dz; finding; findings; ordinal; point in time; ql; qual; qualitative; random; screen,Ord
66545-5,do you have nail psoriasis [phenx],nail psoriasis phenx,,finding; findings; ordinal; point in time; ql; qual; qualitative; random; screen,Ord
66556-2,freckles,freckles,,finding; findings; h+p; h+p.px; ordinal; p prime; point in time; ql; qual; qualitative; random; screen,Ord
66585-1,my thinking is usually careful and purposeful [upps-p],thinking careful and purposeful upps-p,,"finding; findings; ordinal; p prime; phenx; point in time; ql; qual; qualitative; random; screen; thinking careful and purposeful; urgency,perseverance,premeditation,sensation seeking-impulsive behavior scale; urgency,perseverance,premeditation,sensation seeking-positive urgency-impulsive behavior scale",Ord
66599-2,i tend to lose control when i am in a great mood [upps-p],lose control upps-p,,"finding; findings; ordinal; p prime; phenx; point in time; ql; qual; qualitative; random; screen; urgency,perseverance,premeditation,sensation seeking-impulsive behavior scale; urgency,perseverance,premeditation,sensation seeking-positive urgency-impulsive behavior scale",Ord
66615-6,estimated or measured glomerular filtration rate less than 50 percent [reported],renal gfr <50% reported,,gfr; glom; history; ordinal; phenx; point in time; ql; qual; qualitative; random; renal gfr &lt;50%; screen,Ord
66625-5,cardiomyopathy [reported],cardiomyopathy reported,,history; ordinal; phenx; point in time; ql; qual; qualitative; random; screen,Ord
66629-7,i would enjoy parachute jumping [upps-p],would enjoy parachute jumping upps-p,,"finding; findings; ordinal; p prime; phenx; point in time; ql; qual; qualitative; random; screen; urgency,perseverance,premeditation,sensation seeking-impulsive behavior scale; urgency,perseverance,premeditation,sensation seeking-positive urgency-impulsive behavior scale",Ord
66636-2,i usually make up my mind through careful reasoning [upps-p],careful reasoning upps-p,,"finding; findings; ordinal; p prime; phenx; point in time; ql; qual; qualitative; random; screen; urgency,perseverance,premeditation,sensation seeking-impulsive behavior scale; urgency,perseverance,premeditation,sensation seeking-positive urgency-impulsive behavior scale",Ord
66653-7,"in the heat of an argument, i will often say things that i later regret [upps-p]",say things regret later upps-p,,"finding; findings; ordinal; p prime; phenx; point in time; ql; qual; qualitative; random; say things regret later; screen; urgency,perseverance,premeditation,sensation seeking-impulsive behavior scale; urgency,perseverance,premeditation,sensation seeking-positive urgency-impulsive behavior scale",Ord
66666-9,mesenteric insufficiency [phenx],mesenteric insufficiency phenx,,history; ordinal; point in time; ql; qual; qualitative; random; screen,Ord
66680-0,how well do you speak english [nlaas],how well speak english nlaas,,finding; findings; how well speak english; nlaas questionnaire; ordinal; phenx; point in time; ql; qual; qualitative; random; screen,Ord
66686-7,"i like new, thrilling things to happen [upps-r-child]",like thrilling things upps-r-c,,"finding; findings; like thrilling things; ordinal; phenx; point in time; ql; qual; qualitative; r prime; random; right; screen; upps-p impulsive behavior scale for children; urgency,perseverance,premeditation,sensation seeking-impulsive behavior scale",Ord
66698-2,i try to take a careful approach to things [upps-r-child],take a careful approach upps-r-c,,"finding; findings; ordinal; phenx; point in time; ql; qual; qualitative; r prime; random; right; screen; upps-p impulsive behavior scale for children; urgency,perseverance,premeditation,sensation seeking-impulsive behavior scale",Ord
66709-7,"when i am really thrilled, i tend not to think about the results of my actions [upps-r-child]",don't think action results upps-r-c,,"don't think action results; finding; findings; ordinal; phenx; point in time; ql; qual; qualitative; r prime; random; right; screen; upps-p impulsive behavior scale for children; urgency,perseverance,premeditation,sensation seeking-impulsive behavior scale",Ord
66734-5,glucagon [mass or moles/volume] in serum or plasma,glucagon serpl-mscnc,glucagon [mass or moles/vol],chemistry; hgf; hyperglycemic factor; level; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
66735-2,cortisol [mass or moles/volume] in serum or plasma --am peak specimen,cortis am peak serpl-mscnc,cortisol am peak specimen [mass or moles/vol],17-hydroxycorticosterone; 8 am; 8am; am diurnal peak; chemistry; circadian high; compound f; coritsol; cort; f; hydrocortisone; level; morning; pl; plasma; plsm; point in time; post; postdose; post-dose; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; spec; sr,Qn
66737-8,cyp2c19 gene c.1a>g(*4) [presence] in blood or tissue by molecular genetics method,cyp2c19 c.1a>g(*4) bld/t ql,cyp2c19 gene c.1a>g(*4) molgen ql (bld/tiss),"blood; cpcj; cyp2c; cyp2c19 c.1a&gt;g(*4); cypiic17; cypiic19; cytochrome p-450 ii c; cytochrome p450, family 2, subfamily c, polypeptide 19; genetics; heredity; heritable; inherited; molecular genetics; molecular pathology; molpath; molpath.pharmg; ordinal; p450c2c; p450iic19; pcr; point in time; pr; ql; qual; qualitative; random; screen; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",Ord
6675-3,microscopic observation [identifier] in tissue by periodic acid-schiff stain,pas stn tiss,microscopic observation periodic acid-schiff stain nom (tiss),"acd; acids; id; identity or presence; infectious disease; infectiousdisease; microbiology; nominal; pas stain; pas stn; point in time; random; st; stains; stn; tissue; tissue, unspecified",Nom
66768-3,leukocytes [#/volume] corrected for nucleated erythrocytes in cord blood,wbc nrbc cor # bldco,wbc corrected for nucl rbc (bldco) [#/vol],#; abs; absolute; absolutes; blood - (umbilical) cord; cnt; cord (umbilical) blood; cord bld; cord blood; count; count/volume; ct; discocytes; erthrocyte; erythrocyte; hematology/cell counts; leuc; leuk; leukocyte; lkcs; nrbc cor; nuc; number concentration; number concentration (count/vol); point in time; qnt; quan; quant; quantitative; random; rbc; rbcs; red blood cell; red blood cells; red blood corpuscle; red blood corpusles; red cell; red cells; wbc; wbcs; white blood cell; white blood cells,Qn
66774-1,how much have you felt this way during the past few ws [phenx],felt this way past few ws phenx,,felt this way past few ws; finding; findings; last; ordinal; point in time; ql; qual; qualitative; random; screen,Ord
66782-4,"when i am confronted with a problem, i can usually find several solutions [gse]",can find several solutions gse,,can find several solutions; finding; findings; ordinal; phenx; point in time; ql; qual; qualitative; random; screen,Ord
66792-3,how well can you have a chat with an unfamiliar person [seq-c],chat with unfamiliar person seq-c,,chat with unfamiliar person; finding; findings; nominal; persons; phenx; point in time; random,Nom
66805-3,how well do you succeed in suppressing unpleasant thoughts [seq-c],suppress unpleasant thoughts seq-c,,finding; findings; nominal; phenx; point in time; random; suppress unpleasant thoughts,Nom
66818-6,how often does he or she criticize you [midus ii],spouse criticize you midus ii,,2; finding; findings; ordinal; phenx; point in time; ql; qual; qualitative; random; screen; spouse criticize you,Ord
66831-9,"not including your spouse or partner, how much do members of your family really care about you [midus ii]",family really care about you midus ii,,2; finding; findings; ordinal; phenx; point in time; ql; qual; qualitative; random; screen,Ord
66841-8,how much do your friends really care about you [midus ii],friends care about you midus ii,,2; finding; findings; friends care about you; ordinal; phenx; point in time; ql; qual; qualitative; random; screen,Ord
66862-4,how often do you feel outgoing and friendly [ucla loneliness v3],outgoing and friendly ucla lone v3,,finding; findings; ordinal; phenx; point in time; ql; qual; qualitative; random; screen; ucla lone v3,Ord
66865-7,how often do you feel that your relationships with others are not meaningful [ucla loneliness v3],relationship not meaningful ucla lone v3,,finding; findings; ordinal; phenx; point in time; ql; qual; qualitative; random; relationship not meaningful; screen; ucla lone v3,Ord
66868-1,how often do you feel you can find companionship when you want it [ucla loneliness v3],companionship when want it ucla lone v3,,companionship when want it; finding; findings; ordinal; phenx; point in time; ql; qual; qualitative; random; screen; ucla lone v3,Ord
66891-3,"have you ever been involved in a man-made disaster, such as a fire, train crash, car accident, or building collapse [ltvh]",man-made disaster ltvh,,arterial stenosis; finding; findings; ordinal; phenx; point in time; ql; qual; qualitative; random; screen,Ord
6691-0,loxapine+8-hydroxyamoxapine [mass/volume] in serum or plasma,loxapine+8oh-amox serpl-mcnc,loxapine+8-hydroxyamoxapine [mass/vol],8-hydroxy amoxapine; 8oh-amoxapine; amoxapine metabolite; drug/toxicology; drugs; level; loxapine+8oh-amox; loxitane; mass concentration; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
66943-2,time fracture occurred [phenx],fracture occur time phenx,,finding; findings; fracture occur time; nominal; point in time; random,Nom
66957-2,"how many times in the last year have you avoided paying for things such as movies, bus or subway rides, and food or computer services [denver youth survey]",avoided paying nrate dys,,arterial stenosis; count/time; dys; nrate; number rate; number rate = count/time; past; phenx; qnt; quan; quant; quantitative,Qn
66958-0,how many times in the last year have you gone into or tried to go into a building to steal something [denver youth survey],steal from building nrate dys,,count/time; dys; nrate; number rate; number rate = count/time; past; phenx; qnt; quan; quant; quantitative; steal from building,Qn
66970-5,how many times in the last year have you used or tried to use a credit or bank cards without the owners permission [denver youth survey],bank cards nrate dys,,count/time; dys; nrate; number rate; number rate = count/time; past; phenx; qnt; quan; quant; quantitative,Qn
66971-3,how many times in the last year have you tried to cheat someone by selling them something that was worthless or not what you said it was [denver youth survey],cheat someone nrate dys,,count/time; dys; nrate; number rate; number rate = count/time; past; phenx; qnt; quan; quant; quantitative,Qn
66979-6,"how many times in the last year have you had or tried to have sexual relations with someone against their will, other than events you just mentioned [denver youth survey]",other forced sex nrate dys,,count/time; dys; nrate; number rate; number rate = count/time; other forced sex; othr; past; phenx; qnt; quan; quant; quantitative,Qn
66981-2,"how many times in the last year have you sold hard drugs such as heroin, cocaine, and lsd [denver youth survey]",sold hard drugs nrate dys,,arterial stenosis; benzoylmethylecgonine; coke; count/time; crack; drug; dys; ecgonine methyl ester benzoate; nrate; number rate; number rate = count/time; past; phenx; qnt; quan; quant; quantitative; snow,Qn
6698-5,deprecated aldolase [enzymatic activity/volume] in serum,deprecated aldolase ser-ccnc,aldolase (s) [catalytic activity/vol],catalytic concentration; chemistry; fructose aldolase; fructose biphosphate aldolase; point in time; qnt; quan; quant; quantitative; random; serum; sr,Qn
67005-9,"how many times in the last year did you steal, or try to steal, money or things worth over 500 dollars [denver youth survey]",stolen > $500 nrate dys,,count/time; dys; nrate; number rate; number rate = count/time; past; phenx; qnt; quan; quant; quantitative; stolen &gt; $500,Qn
67010-9,how many times in the last year have you used worthless checks or fake money to pay for something [denver youth survey],worthless checks nrate dys,,count/time; dys; nrate; number rate; number rate = count/time; past; phenx; qnt; quan; quant; quantitative,Qn
67044-8,your supervisor is always monitoring what you do at work [phenx],supervisor always monitoring phenx,,finding; findings; job; occupation; ordinal; point in time; ql; qual; qualitative; random; screen; supervisor always monitoring,Ord
67051-3,you have a lot of conflict with your partner [phenx],conflict with partner phenx,,conflict with partner; finding; findings; ordinal; point in time; ql; qual; qualitative; random; screen,Ord
67056-2,your partner doesn't show enough affection [phenx],partner not show enough affection phenx,,finding; findings; ordinal; partner not show enough affection; point in time; ql; qual; qualitative; random; screen; t prime,Ord
67060-4,you wonder whether you will ever get married [phenx],wonder if ever get married phenx,,finding; findings; ordinal; point in time; ql; qual; qualitative; random; screen; wonder if ever get married,Ord
67067-9,you feel your children don't listen to you [phenx],children don't listen phenx,,finding; findings; ordinal; point in time; ql; qual; qualitative; random; screen; t prime,Ord
67069-5,one or more children do not do well enough at school or work [phenx],children don't do well school phenx,,children don't do well school; finding; findings; job; occupation; ordinal; point in time; ql; qual; qualitative; random; screen,Ord
67086-9,you're trying to take on too many things at once [phenx],too many things at once phenx,,finding; findings; ordinal; point in time; ql; qual; qualitative; random; screen,Ord
67088-5,too much is expected of you by others [phenx],too much expected by others phenx,,finding; findings; ordinal; point in time; ql; qual; qualitative; random; screen; too much expected by others,Ord
67099-2,deprecated vendor device name,deprecated vendor device name,,ident; identifier; nominal; point in time; random; vendor name,Nom
67101-6,dermatologist name provider,dermatologist name provider,,nominal; person name; phenx; point in time; random,Nom
67103-2,body location affected by psoriasis now [anatomy] [phenx],body psoriasis now phenx,,anatomy; bod; bodies; body psoriasis now; nominal; point in time; random,Nom
6711-6,acetaminophen ige ab [units/volume] in serum,apap ige qn,acetaminophen ige qn (s),abs; aby; acet; acetamidophenol; acetaminoph; acetominophen; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; apap; arbitrary concentration; autoantibodies; autoantibody; c209; c55; hydroxyacetanilide; immune globulin e; immunoglobulin e; n-(4-hydroxyphenyl)acetanilide; n-acetyl-p-aminophenol; p-acetamidophenol; paracetamol; p-hydroxyacetanilide; point in time; qnt; quan; quant; quantitative; random; serum; sr; tylenol; u209,Qn
67118-0,"have you ever known someone who committed suicide or killed themselves; that is, a parent, a sister, a brother, a very close friend, a boyfriend or girlfriend, or someone who lived with you [ltvh]",child suicide ltvh,,child suicide; finding; findings; ordinal; phenx; point in time; ql; qual; qualitative; random; screen; world heatlth organization,Ord
67125-5,"situation in which you were afraid you might die or get really badly hurt, or when you were very scared or felt like there was nothing you could do to stop what was happening [ltvh]",other situation afraid ltvh,,finding; findings; nominal; other situation afraid; phenx; point in time; random,Nom
67188-3,infection [phenx],infection phenx,,nominal; point in time; random; typ,Nom
67195-8,icd-o-2 cancer classification - topography [#] [phenx],icdo2 cancer - topography phenx,,cnt; count; icdo2 cancer - topography; ii; international classification of diseases; international classification of diseases for oncology; number; point in time; qnt; quan; quant; quantitative; random,Qn
67197-4,icd-o-2 cancer classification - behavior [#] [phenx],icdo2 cancer - behavior phenx,,cnt; count; icdo2 cancer - behavior; ii; international classification of diseases; international classification of diseases for oncology; number; point in time; qnt; quan; quant; quantitative; random,Qn
67220-4,"in the past 2y, have you had a virtual ct colonoscopy [phenx]",virtual ct colonoscopy phenx,,finding; findings; last; ordinal; ql; qual; qualitative; screen,Ord
67223-8,initial reasons you had a colonoscopy or sigmoidoscopy [phenx],reasons had colon sigmoidoscopy phenx,,finding; findings; nominal; point in time; random; reasons had colon sigmoidoscopy,Nom
67269-1,my child's ability to follow directions spoken to him or her is [phenx],ability follow spoken directions phenx,,ability follow spoken directions; finding; findings; ordinal; point in time; ql; qual; qualitative; random; s prime; screen,Ord
67270-9,my child's ability to use the proper words when talking to others is [phenx],ability use proper words phenx,,ability use proper words; finding; findings; ordinal; point in time; ql; qual; qualitative; random; s prime; screen,Ord
67294-9,other resection [phenx],other resection phenx,,nominal; othr; point in time; random; typ,Nom
67298-0,"when your child was 2ys old, were you concerned that they were having difficulty learning to talk [phenx]",difficulty learning to talk phenx,,finding; findings; ordinal; point in time; ql; qual; qualitative; random; screen,Ord
67312-9,anyone in your child's family that doesn't read well [phenx],family hx doesn't read well phenx,,family hx doesn't read well; finding; findings; ordinal; point in time; ql; qual; qualitative; random; s prime; screen; t prime,Ord
67314-5,anyone in your child's family that has a poorer vocabulary than other family members [phenx],family hx poor vocabulary phenx,,family hx poor vocabulary; finding; findings; ordinal; othr; point in time; ql; qual; qualitative; random; s prime; screen,Ord
67318-6,"anyone in your child's family that is hard to follow when they tell you something, such as a personal experience [phenx]",family hx hard to follow phenx,,arterial stenosis; family hx hard to follow; finding; findings; ordinal; point in time; ql; qual; qualitative; random; s prime; screen,Ord
67325-1,do you complain a great deal about your tinnitus [phenx],tinnitus complain phenx,,finding; findings; ordinal; point in time; ql; qual; qualitative; random; screen; tinnitus complain,Ord
67344-2,does your tinnitus make you feel insecure [phenx],tinnitus insecure phenx,,finding; findings; ordinal; point in time; ql; qual; qualitative; random; screen; tinnitus insecure,Ord
67348-3,does walking down the aisle of a supermarket increase your problem [phenx],walking aisle increase problem phenx,,finding; findings; ordinal; point in time; ql; qual; qualitative; random; screen; walking aisle increase problem,Ord
67353-3,"because of your problem, are your afraid to leave your home without having someone accompany you [phenx]",afraid to leave unaccompanied phenx,,afraid to leave unaccompanied; finding; findings; ordinal; point in time; ql; qual; qualitative; random; screen,Ord
6735-5,soybean igg ab [units/volume] in serum,soybean igg qn,soybean igg qn (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; f014; f14; gly; immune globulin g; immunoglobulin g; largest; maximal; maximum; peak; point in time; qnt; quan; quant; quantitative; random; serum; soja hispida; soy bean; soya bean; soyabean; soybean; sr,Qn
67356-6,"because of your problem, do you avoid heights [phenx]",avoid heights phenx,,finding; findings; ordinal; point in time; ql; qual; qualitative; random; screen,Ord
67357-4,does turning over in bed increase your problem [phenx],turning in bed increase problem phenx,,finding; findings; ordinal; point in time; ql; qual; qualitative; random; screen; turning in bed increase problem,Ord
67368-1,does your problem interfere with your job or household responsibilities [phenx],problem interfere with job phenx,,finding; findings; occupation; ordinal; point in time; problem interfere with job; ql; qual; qualitative; random; screen; work,Ord
67370-7,my voice makes it difficult for people to hear me [phenx],difficult people to hear me phenx,,difficult people to hear me; finding; findings; ordinal; point in time; ql; qual; qualitative; random; screen,Ord
67385-5,my voice difficulties restrict my personal and social life [phenx],voice restricts social life phenx,,finding; findings; ordinal; point in time; ql; qual; qualitative; random; screen; voice restricts social life,Ord
67389-7,i use a great deal of effort to speak [phenx],great effort to speak phenx,,finding; findings; great effort to speak; ordinal; point in time; ql; qual; qualitative; random; screen,Ord
67392-1,my voice problem upsets me [phenx],voice upsets me phenx,,finding; findings; ordinal; point in time; ql; qual; qualitative; random; screen; voice upsets me,Ord
67401-0,how quickly did your hearing difficulty develop [phenx],how quickly difficulty develop phenx,,finding; findings; how quickly difficulty develop; ordinal; point in time; ql; qual; qualitative; random; screen,Ord
67410-1,have you ever had an ear operation [phenx],ear operation phenx,,finding; findings; ordinal; point in time; ql; qual; qualitative; random; screen,Ord
67411-9,have you ever suffered from attacks of dizziness in which things seem to spin around you [phenx],dizziness attack phenx,,dizziness attack; finding; findings; ordinal; point in time; ql; qual; qualitative; random; screen,Ord
67416-8,do you have any brothers or sisters with normal hearing [phenx],siblings normal hearing phenx,,control; finding; findings; ordinal; point in time; ql; qual; qualitative; random; screen; siblings normal hearing,Ord
67419-2,how many of your children have normal hearing [#] [phenx],number children w/ normal hearing phenx,,cnt; control; count; number; number children w/ normal hearing; point in time; qnt; quan; quant; quantitative; random,Qn
67422-6,name of your relative that have already participated in this investigation [phenx],other relative name phenx,,finding; findings; nominal; other relative name; point in time; random; rel,Nom
67423-4,do you suffer from migraine [phenx],migraine hx phenx,,history; migraine hx; ordinal; point in time; ql; qual; qualitative; random; screen,Ord
67428-3,have you ever had heart surgery [phenx],heart surgery phenx,,history; ordinal; point in time; ql; qual; qualitative; random; screen; surg,Ord
67432-5,do you suffer from intermittent claudication [phenx],intermittent claudication phenx,,history; ordinal; point in time; ql; qual; qualitative; random; screen,Ord
67447-3,have you ever received radiotherapy to your head or neck for a tumor [phenx],radiotherapy tumor phenx,,history; ordinal; point in time; ql; qual; qualitative; radiotherapy tumor; random; screen,Ord
67461-4,for how many years have you been exposed to this loud sound [phenx],leisure time loud sound ys phenx,,leisure time loud sound ys; point in time; qnt; quan; quant; quantitative; random,Qn
67465-5,do you have any children with hearing difficulties [phenx],children with hearing difficulties phenx,,finding; findings; ordinal; point in time; ql; qual; qualitative; random; screen,Ord
67489-5,total patients at the scene nemsis,total pts at scene nemsis,,finding; findings; national ems information services; nominal; point in time; random; tot; total pts at scene; totl,Nom
67523-1,contraindication for thrombolytic use nemsis,contra for thrombolytic nemsis,,contra for thrombolytic; finding; findings; national ems information services; nominal; point in time; random; thrombolysis,Nom
67538-9,protocol age category nemsis,protocol age category nemsis,,finding; findings; national ems information services; nominal; point in time; random,Nom
67540-5,response to medication nemsis,response to med nemsis,,finding; findings; national ems information services; nominal; point in time; random,Nom
6756-1,glucose [mass/volume] in serum or plasma --4.5 hours post 75 g glucose po,glucose 4.5h p 75 g glc po serpl-mcnc,glucose 4.5 hr post 75 g glucose po [mass/vol],270 min; 4 1/2 hours; 4.5h p 75 g glc po; 75gm; after; chemistry.challenge testing; endocrine; endocrinology; glu; glu tol; gluc; glucose tolerance; glucoseur; gtt; level; mass concentration; p 75 g glc po; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
67572-8,deprecated condition indicating eligibility for illness or injury registry,deprecated deprecated,,condition illness injury reg; finding; findings; national ems information services; nominal; point in time; random; ulcer,Nom
67574-4,reason cpr resuscitation discontinued,reason cpr discontinued,,finding; findings; nominal; point in time; random; reason cpr discontinued; trauma,Nom
67589-2,people have acted as if they think you are not smart [phenx],people think not smart phenx,,arterial stenosis; finding; findings; ordinal; people think not smart; point in time; ql; qual; qualitative; random; screen,Ord
67610-6,suppose that because of budget cuts the fire station closest to your home was going to be closed down by the city. how likely is it that neighborhood residents would organize to try to do something to keep the fire station open [phenx],neighbors keep station open phenx,,finding; findings; neighbors keep station open; ordinal; point in time; ql; qual; qualitative; random; screen,Ord
67611-4,"i feel safe walking in my neighborhood, day or night [phenx]",safe walking neighborhood phenx,,finding; findings; ordinal; point in time; ql; qual; qualitative; random; safe walking neighborhood; screen; sdoh,Ord
67625-4,"students are publicly recognized for their outstanding performances in speech, drama, art, music, etc [phenx]",students recognized for arts phenx,,finding; findings; ordinal; point in time; ql; qual; qualitative; random; screen; students recognized for arts,Ord
67626-2,"if this school had an extra period during the day, i would take an additional academic class [phenx]",take additional classes phenx,,add; finding; findings; ordinal; point in time; ql; qual; qualitative; random; screen; take additional classes,Ord
67631-2,i believe that teachers expect all students to learn [phenx],teachers expect students to learn phenx,,finding; findings; ordinal; point in time; ql; qual; qualitative; random; screen; teachers expect students to learn,Ord
67664-3,ems response narrative nemsis,ems response nemsis,,emergency medical service(s); ems; narrative; national ems information services; nemsis; pan; panel; panel.nemsis; panl; pnl; point in time; random; report,Nar
67681-7,negative change in parent's financial situation [phenx],parent's financial situation phenx,,exchange; finding; findings; neg; ordinal; point in time; ql; qual; qualitative; random; replace; s prime; screen,Ord
67696-5,parents got divorced [phenx],parents got divorced phenx,,finding; findings; ordinal; point in time; ql; qual; qualitative; random; screen,Ord
67699-9,parent got a new job [phenx],parent got new job phenx,,finding; findings; occupation; ordinal; parent got new job; point in time; ql; qual; qualitative; random; screen; work,Ord
67703-9,other infant factors that affect newborn screening interpretation narrative,other inf factors affecting nbs imp,,asympt; asymptomatic; clinical events; finding; findings; h+p; h+p.hx; inf factors affecting nbs imp; interp; interpret; interpt; intrp; narrative; new born; other inf factors affecting nbs imp; othr; p prime; point in time; random; report; scn,Nar
67704-7,feeding types,feeding types,,feed status; finding; findings; food sources; h+p; h+p.hx; nominal; p prime; point in time; random,Nom
67717-9,unspecified body region image id,image id,,ident; identifier; imaging; intradermal; misc; miscellaneous; nominal; other; point in time; radiology; random; spec; to be specified in another part of the message; unspecified,Nom
67727-8,heart surgery operation [phenx],heart surgery operation phenx,,nominal; point in time; random; surg; typ,Nom
67733-6,have you ever worked for more than 1 year in a place where you had to raise your voice to make yourself heard by someone standing 1 mile away from you [phenx],loud working environment phenx,,finding; findings; i; loud working environment; ordinal; point in time; ql; qual; qualitative; random; screen,Ord
67734-4,most important noise sources [phenx],most important noise sources phenx,,finding; findings; nominal; point in time; random,Nom
67736-9,noise dose [ratio] [phenx],noise dose phenx,,point in time; qnt; quan; quant; quantitative; random; ratios; rto,Qn
67756-7,two or more races alone [#] census tract,two races alone census tract,,2; cnt; count; number; phenx; point in time; qnt; quan; quant; quantitative; random; two races alone,Qn
67768-2,"hedis 2012, 2013 tests used in early prenatal care - abo and rh (ppc-c)",hedis 2012-13 ppc-c abo+rh,"hedis 2012, 2013 tests used in early prenatal care - abo and rh (ppc-c)",d phenotyping; d typing; hedis 2012-13 ppc-c abo+rh; pan; panel; panel.hedis; panl; pnl; point in time; random; rh phenotyping; rh typing,-
67770-8,"hedis 2012, 2013 tests used in early prenatal care (ppc-c)",hedis 2012-13 ppc-c,"hedis 2012, 2013 tests used in early prenatal care (ppc-c)",hedis 2012-13 ppc-c; pan; panel; panel.hedis; panl; pnl; point in time; random,-
67772-4,hospitalization sequence [phenx],hospitalization sequence phenx,,finding; findings; hospitalization hx; nominal; point in time; random,Nom
67797-1,did the encounter team administer any medications nemsis,team administer meds nemsis,,finding; findings; national ems information services; ordinal; point in time; ql; qual; qualitative; random; screen; team administer meds,Ord
6780-1,igg [mass/volume] in urine by electrophoresis,igg ur elph-mcnc,igg elph (u) [mass/vol],chemistry; elec; elect; electr; electro; electrophhrs; electrophrs; elp; elph; ep; immune globulin g; immunoglobulin g; level; mass concentration; point in time; qnt; quan; quant; quantitative; random; ua; ur; urn,Qn
67813-6,fatty casts [#/area] in urine sediment by microscopy high power field,fatty casts #/area urns hpf,fatty casts lm.hpf (urine sed) [#/area],#/area; cast; kidney; lm; micro; micros; microscopic; nephrology; number areic; point in time; qnt; quan; quant; quantitative; random; renal; ua; ur; urinalysis; urine sediment; urn; urns,Qn
67815-1,htlv i ab [units/volume] in serum by immunoassay,htlv i ab ser ia-acnc,htlv i ab ia qn (s),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; eia; elfa; elisa; enzyme immunoassay; human t-cell leukemia virus; human t-cell lymphotrophic virus; iaa; id; infectious disease; infectiousdisease; meia; microbiology; point in time; qnt; quan; quant; quantitative; random; serum; sr; suds,Qn
67838-3,mephedrone [presence] in urine by confirmatory method,mephedrone ur ql cfm,mephedrone confirm ql (u),4-methylephedrone; 4-methylmethcathinone; 4-mmc; addiction; bath salts; cfm; charge plus; cloud 9; cnfr; cnfrm; conf; confirmation; confirmatory; drug/toxicology; drugs; drugs of abuse; gcms; illicit; ivory wave ocean; lc/ms/ms; ordinal; point in time; potentialforabuse; pr; ql; qual; qualitative; random; screen; ua; ur; urn; white lightning,Ord
67846-6,deprecated glasgow coma score verbal nemsis,deprecated gcs verbal nemsis,,fcn; func; funct; function; gcs verbal; national ems information services; neuro; neurology; ordinal; point in time; ql; qual; qualitative; random; screen,Ord
67859-9,deprecated emergency department note,deprecated ed note,,doc.ont; document; ed; encounter; evaluation and management; evaluation and management note; finding; findings; notes; point in time; random; visit note,Doc
67871-4,patient demographics - end stage renal disease form 2728,,,demographic; dis; diseases; dz; end stage renal disease (esdr) pnl; end-stage renal disease; esrd; esrd survey; kidney; pan; panel; panl; patient demographics - esrd 2728; pnl; point in time; random; survey,-
67881-3,self-dialysis training facility npi dialysis facility,,,dialy; esrd; esrd survey; ident; identifier; national provider identifier; nominal; point in time; random; survey,Nom
6788-4,kappa light chains/lambda light chains [mass ratio] in serum by immunoassay,kappa lc/lambda ser ia,immunoglobulin light chains.kappa/immunoglobulin light chains.lambda ia (s) [mass ratio],bence jones protein; bj protein; bjp; chain; chemistry; eia; elfa; elisa; enzyme immunoassay; hematology; heme; iaa; immune globulin; immuno; immunoglob; immunoglobin; imunoglbon; imunoglobn; kappa lc; lambda lc; mass concentration ratio; mass ratio; mcrto; meia; point in time; qnt; quan; quant; quantitative; random; serum; sr; suds,Qn
67886-2,care by nephrologist prior to end stage renal disease therapy,,,dis; diseases; dz; end-stage renal disease; esrd; esrd survey; finding; findings; kidney; nephrologist care prior to esrd; ordinal; point in time; ql; qual; qualitative; random; screen; survey,Ord
6790-0,lambda light chains [presence] in urine by electrophoresis,lambda lc ur ql elph,immunoglobulin light chains.lambda elph ql (u),bence jones protein; bj protein; bjp; chain; chemistry; elec; elect; electr; electro; electrophhrs; electrophrs; elp; elph; ep; hematology; heme; immune globulin; immuno; immunoglob; immunoglobin; imunoglbon; imunoglobn; lambda lc; ordinal; point in time; pr; ql; qual; qualitative; random; screen; ua; ur; urn,Ord
67913-4,neuro-qol short form - satisfaction with social roles - version 1.0,,,neuroqol; neuroqol sf - satis social roles - v1.0; pan; panel; panel.survey.neuroq; panl; pnl; point in time; random; survey; survey.neuroq,-
67915-9,i felt nervous when my normal routine was disturbed in the past 7 days [neuroqol],,,control; finding; findings; last; nervous when normal routine disturbed; ordinal; ql; qual; qualitative; screen; survey; survey.neuroq,Ord
67918-3,i felt that i had no energy in the past 7 days [neuroqol],,,finding; findings; last; ordinal; past 7d i felt no energy; ql; qual; qualitative; screen; survey; survey.neuroq,Ord
6793-4,prealbumin [mass/volume] in serum or plasma by immunoassay,prealb serpl ia-mcnc,prealbumin ia [mass/vol],chemistry; eia; elfa; elisa; enzyme immunoassay; iaa; level; mass concentration; meia; palb; pl; plasma; plsm; point in time; pre albumin; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; suds; transthyretin,Qn
67946-4,"how much difficulty do you currently have going up and down a flight of stairs inside, using a handrail [neuroqol]",,,difficulty up and down stairs inside-handrail; finding; findings; ordinal; point in time; ql; qual; qualitative; random; screen; survey; survey.neuroq,Ord
67953-0,"how much difficulty do you currently have checking the accuracy of financial documents, like bills, checkbook, or bank statements [neuroqol]",,,difficulty checking financial documents; finding; findings; ordinal; point in time; ql; qual; qualitative; random; screen; survey; survey.neuroq,Ord
67954-8,how much difficulty do you currently have counting the correct amount of money when making purchases [neuroqol],,,difficulty counting money; finding; findings; ordinal; point in time; ql; qual; qualitative; random; screen; survey; survey.neuroq,Ord
67956-3,"how much difficulty do you currently have planning for and keeping appointments that are not part of your weekly routine, like a therapy or doctor appointment, or a social gathering with friends and family [neuroqol]",,,difficulty keeping appts not part routine; finding; findings; ordinal; point in time; ql; qual; qualitative; random; screen; survey; survey.neuroq,Ord
67970-4,i had trouble thinking clearly in the past 7 days [neuroqol],,,finding; findings; last; ordinal; past 7d trouble thinking clearly; ql; qual; qualitative; screen; survey; survey.neuroq,Ord
67971-2,my thinking was slow in the past 7 days [neuroqol],,,finding; findings; last; ordinal; past 7d thinking was slow; ql; qual; qualitative; screen; survey; survey.neuroq,Ord
67973-8,i had trouble concentrating in the past 7 days [neuroqol],,,finding; findings; last; ordinal; past 7d trouble concentrating; ql; qual; qualitative; screen; survey; survey.neuroq,Ord
67975-3,words i wanted to use seemed to be on the tip of my tongue in the past 7 days [neuroqol],,,finding; findings; last; ordinal; past 7d wanted words on tip of tongue; ql; qual; qualitative; screen; survey; survey.neuroq,Ord
67979-5,i reacted slowly to things that were said or done in the past 7 days [neuroqol],,,finding; findings; last; ordinal; past 7d reacted slowly to things; ql; qual; qualitative; screen; survey; survey.neuroq,Ord
67985-2,i said or did things without thinking in the past 7 days [neuroqol],,,finding; findings; last; ordinal; past 7d said did things w/o thinking; ql; qual; qualitative; screen; survey; survey.neuroq,Ord
67986-0,i got impatient with other people in the past 7 days [neuroqol],,,finding; findings; last; ordinal; othr; past 7d impatient with others; ql; qual; qualitative; screen; survey; survey.neuroq,Ord
67990-2,i was in conflict with others in the past 7 days [neuroqol],,,finding; findings; last; ordinal; past 7d conflict with others; ql; qual; qualitative; screen; survey; survey.neuroq,Ord
68005-8,lately my life was worth living [neuroqol],,,finding; findings; lately life worth living; ordinal; point in time; ql; qual; qualitative; random; screen; survey; survey.neuroq,Ord
68013-2,lately i felt emotionally stable [neuroqol],,,finding; findings; lately felt emotionally stable; ordinal; point in time; ql; qual; qualitative; random; screen; survey; survey.neuroq,Ord
68014-0,lately i felt lovable [neuroqol],,,finding; findings; lately felt lovable; ordinal; point in time; ql; qual; qualitative; random; screen; survey; survey.neuroq,Ord
68025-6,i had trouble sleeping because of bad dreams in the past 7 days [neuroqol],,,finding; findings; last; ordinal; past 7d trouble sleeping bad dreams; ql; qual; qualitative; screen; survey; survey.neuroq,Ord
68027-2,pain woke me up in the past 7 days [neuroqol],,,finding; findings; last; ordinal; past 7d pain woke me up; ql; qual; qualitative; screen; survey; survey.neuroq,Ord
68039-7,i have to limit my regular family activities in the past 7 days [neuroqol],,,finding; findings; last; ordinal; past 7d limit regular family activities; ql; qual; qualitative; screen; survey; survey.neuroq,Ord
68040-5,i am able to do all of the family activities that people expect me to do in the past 7 days [neuroqol],,,finding; findings; last; ordinal; past 7d able do family activities others expect; ql; qual; qualitative; screen; survey; survey.neuroq,Ord
68059-5,i am able to go out for entertainment as much as i want in the past 7 days [neuroqol],,,arterial stenosis; finding; findings; last; ordinal; past 7d entertainment as much as i want; ql; qual; qualitative; screen; survey; survey.neuroq,Ord
68061-1,i am doing fewer social activities with groups of people than usual for me in the past 7 days [neuroqol],,,finding; findings; last; ordinal; past 7d fewer social activities than usual; ql; qual; qualitative; screen; survey; survey.neuroq,Ord
68062-9,i am able to run errands without difficulty in the past 7 days [neuroqol],,,finding; findings; last; ordinal; past 7d able to run errands; ql; qual; qualitative; screen; survey; survey.neuroq,Ord
68071-0,i am bothered by my limitations in regular family activities in the past 7 days [neuroqol],,,finding; findings; last; ordinal; past 7d bothered by limits family activities; ql; qual; qualitative; screen; survey; survey.neuroq,Ord
6807-2,deprecated hla-dr8 [presence],deprecated hla-dr8 ql,hla-dr8 ql (bld/tiss),"arbitrary concentration; blood; genetics; heredity; heritable; hla antigen; human leukocyte antigen; inherited; ordinal; point in time; ql; qual; qualitative; random; screen; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",Ord
68081-9,i am disappointed in my ability to socialize with friends in the past 7 days [neuroqol],,,finding; findings; last; ordinal; past 7d disappointed in ability socialize with friends; ql; qual; qualitative; screen; survey; survey.neuroq,Ord
68082-7,i am disappointed in my ability to keep in touch with others in the past 7 days [neuroqol],,,finding; findings; last; ordinal; past 7d disappointed in ability to keep in touch; ql; qual; qualitative; screen; survey; survey.neuroq,Ord
68091-8,i am bothered by limitations in performing my work in the past 7 days [neuroqol],,,finding; findings; job; last; occupation; ordinal; past 7d bothered by limitations performing work; ql; qual; qualitative; screen; survey; survey.neuroq,Ord
68095-9,"lately, because of my illness, i felt left out of things [neuroqol]",,,because of illness felt left out; finding; findings; l; lt; ordinal; point in time; ql; qual; qualitative; random; screen; survey; survey.neuroq,Ord
68100-7,"lately, because of my illness, people were unkind to me [neuroqol]",,,because of illness people unkind; finding; findings; ordinal; point in time; ql; qual; qualitative; random; screen; survey; survey.neuroq,Ord
68129-6,neuro-qol pediatric item bank - peer interaction - version 1.0 [neuroqol.peds],,,neuroqol; neuroqol peds; neuro-qol peds peer interaction v1.0; pan; panel; panel.survey.neuroq; panl; peds; pnl; point in time; random; survey; survey.neuroq,-
68133-8,neuro-qol pediatric item bank - pain - version 1.0 [neuroqol.peds],,,neuroqol; neuroqol peds; neuro-qol peds pain v1.0; pan; panel; panel.survey.neuroq; panl; peds; pnl; point in time; random; survey; survey.neuroq,-
68144-5,"lately, because of my illness, others my age made fun of me [neuroqol.peds]",,,"because of illness, others made fun of me; finding; findings; ordinal; point in time; ql; qual; qualitative; random; screen; survey; survey.neuroq",Ord
68150-2,"lately, because of my illness, others my age bullied me [neuroqol.peds]",,,because of illness others bullied me; finding; findings; ordinal; point in time; ql; qual; qualitative; random; screen; survey; survey.neuroq,Ord
68156-9,"lately, because of my illness, i worried that i made life harder for my parents or guardians [neuroqol.peds]",,,because of my illness worried life harder for parents; finding; findings; ordinal; point in time; ql; qual; qualitative; random; screen; survey; survey.neuroq,Ord
68163-5,i was bored in the past 7 days [neuroqol.peds],,,finding; findings; last; ordinal; past 7d i was bored; ql; qual; qualitative; screen; survey; survey.neuroq,Ord
68201-3,i think i have fewer friends than other people my age in the past 7 days [neuroqol.peds],,,finding; findings; last; ordinal; othr; past 7d have fewer friends than others; ql; qual; qualitative; screen; survey; survey.neuroq,Ord
68227-8,i have to use written lists more often than other people my age so i will not forget things [neuroqol.peds],,,finding; findings; must use written lists so will not forget things; ordinal; othr; point in time; ql; qual; qualitative; random; screen; survey; survey.neuroq,Ord
68234-4,being tired makes me sad in the past 7 days [neuroqol.peds],,,finding; findings; last; ordinal; past 7d being tired makes me sad; ql; qual; qualitative; screen; survey; survey.neuroq,Ord
68239-3,i needed help doing my usual things at home in the past 7 days [neuroqol.peds],,,finding; findings; last; ordinal; past 7d needed help doing usual things at home; ql; qual; qualitative; screen; survey; survey.neuroq,Ord
68241-9,i had so much pain that i had to stop what i was doing in the past 7 days [neuroqol.peds],,,finding; findings; last; ordinal; past 7d had so much pain had to stop what i was doing; ql; qual; qualitative; screen; survey; survey.neuroq,Ord
68246-8,i could walk for 15 minutes in the past 7 days [neuroqol.peds],,,finding; findings; last; ordinal; past 7d i could walk 15m; ql; qual; qualitative; screen; survey; survey.neuroq,Ord
68247-6,i could walk between rooms in the past 7 days [neuroqol.peds],,,finding; findings; last; ordinal; past 7d could walk between rooms; ql; qual; qualitative; screen; survey; survey.neuroq,Ord
68294-8,i was able to use my fingers to point to something in the past 7 days [neuroqol.peds],,,finding; findings; last; ordinal; past 7d able to use my fingers to point; ql; qual; qualitative; screen; survey; survey.neuroq,Ord
68312-8,i was able to put on my clothes by myself in the past 7 days [neuroqol.peds],,,finding; findings; last; ordinal; past 7d able to put on my clothes; ql; qual; qualitative; screen; survey; survey.neuroq,Ord
6833-8,cat dander ige ab [units/volume] in serum,cat dander ige qn,cat dander ige qn (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; cat epithelium; cat hair; e1; feline; felis domesticus; immune globulin e; immunoglobulin e; point in time; qnt; quan; quant; quantitative; random; serum; sr; universallaborders,Qn
68341-7,dialysis at time of death,,,dialy; esrd; esrd survey; nominal; point in time; random; survey; typ,Nom
68367-2,bilirubin.total [moles/volume] in urine by automated test strip,bilirub ur strip.auto-scnc,bilirubin auto test strip (u) [moles/vol],auto; automated detection; bili; bilirubins; billirubin; dip stick; dipstick; elec; elect; electr; level; point in time; random; smqn; substance concentration; tbil; ua; ur; urinalysis; urn,SemiQn
68376-3,nuclear ab [titer] in body fluid by immunofluorescence,ana titr fld if,nuclear ab if (body fld) [titer],"abs; aby; acif; ana; anf; antby; anti; antibodies; antibody; anticomplement immunofluorescence; antinuclear antibody; autoantibodies; autoantibody; b/f; bf; bod; bodies; body fluid; body fluid, unsp; dilution factor; dilution factor (titer); fa; fana; fl; fld; flu; fluid; fluorescent antibody; fluoresent; ifa; immune fluorescence; immunoflour; immunofluor; immunofluorescence; na; nuc; point in time; random; serology; smqn; time resolved fluorescence; titer; titered; titre; trf; ttr",SemiQn
68379-7,phenylbutazone [moles/volume] in urine,phenylbutazone ur-scnc,phenylbutazone (u) [moles/vol],butacote; butadion; butadione; butazolidin; butazone; butrex; c231; c57; carudol; cotylbutazone; drug/toxicology; drugs; exiheudon n; inflazone; intrabutazone; kadol; level; novobutazone; point in time; qnt; quan; quant; quantitative; random; spondyril; substance concentration; ticinil; ua; ur; urn,Qn
68400-1,eosinophils [#/volume] in pleural fluid by manual count,eosinophil # plr manual,eosinophils manual cnt (pleur fld) [#/vol],#; abs; absolute; absolutes; cnt; count; count/volume; ct; eos; eosin; eosino; eosinophil; eosins; hematology/cell counts; manl; number concentration; number concentration (count/vol); pleural; pleural fluid; point in time; qnt; quan; quant; quantitative; random; thoracentesis fluid,Qn
68416-7,mesothelial cells [#/volume] in pleural fluid by manual count,mesothl cell # plr manual,mesothelial cells manual cnt (pleur fld) [#/vol],#; abs; absolute; absolutes; cell; cellularity; cnt; count; count/volume; ct; hematology/cell counts; manl; mesothl; mesothl cell; number concentration; number concentration (count/vol); pleural; pleural fluid; point in time; qnt; quan; quant; quantitative; random; thoracentesis fluid,Qn
68420-9,monocytes [#/volume] in pericardial fluid by manual count,monocytes # pcar manual,monocytes manual cnt (pericard fld) [#/vol],#; abs; absolute; absolutes; cardio; cardiology; cnt; count; count/volume; ct; heart disease; hematology/cell counts; manl; mono; monocyte; monos; number concentration; number concentration (count/vol); pcar; pericardial fluid; point in time; qnt; quan; quant; quantitative; random,Qn
68425-8,neutrophils [#/volume] in pericardial fluid by manual count,neutrophils # pcar manual,neutrophils manual cnt (pericard fld) [#/vol],#; abs; absolute; absolutes; cardio; cardiology; cnt; count; count/volume; ct; heart disease; hematology/cell counts; manl; neut; neutr; neutrophil; number concentration; number concentration (count/vol); pcar; pericardial fluid; pmn; pnm; point in time; qnt; quan; quant; quantitative; random,Qn
68435-7,erythrocytes [#/volume] in vitreous fluid by automated count,rbc # vitf auto,rbc auto (vitr fld) [#/vol],#; abs; absolute; absolutes; auto; automated detection; cnt; count; count/volume; ct; discocytes; elec; elect; electr; erthrocyte; erythrocyte; hematology/cell counts; number concentration; number concentration (count/vol); point in time; qnt; quan; quant; quantitative; random; rbc; rbcs; red blood cell; red blood cells; red blood corpuscle; red blood corpusles; red cell; red cells; vitf; vitreous fluid; vitreous humor; vitreous humour,Qn
68436-5,appearance of vitreous fluid,appearance vitf,appearance (vitr fld),appearance; nominal; point in time; random; spec; vitf; vitreous fluid; vitreous humor; vitreous humour,Nom
68449-8,arteriovenous fistula maturity,,,esrd; esrd survey; finding; findings; ordinal; point in time; ql; qual; qualitative; random; screen; survey,Ord
68463-9,rilpivirine [susceptibility] by genotype method,rilpivirine islt genotyp,rilpivirine genotyping [susc],antibiotic susceptibilities; ast; genotype; genotypic; id; infectious disease; infectiousdisease; islt; isol; ordinal; point in time; ql; qual; qualitative; random; screen; sus; suscept; susceptibilities; susceptibility; susceptibilty,Ord
68466-2,epstein-barr virus-encoded rna 1 [presence] in tissue by probe,ebv-encoded rna1 tiss ql probe,ebv-encoded rna 1 probe ql (tiss),"dna nucleic acid probe; dna probe; eber; eber1; ebv; ebv-encoded rna1; epstein-barr virus; epstn; hhv-4; human herpesvirus 4; i; id; infectious disease; infectiousdisease; microbiology; mono; mononucleosis; ordinal; point in time; pr; ql; qual; qualitative; random; ribonucleic acid; screen; tissue; tissue, unspecified",Ord
68476-1,nurse hospital restraint note,nurse hosp restraint note,,doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; hosp; inpatient; notes; nursing; point in time; random; visit note,Doc
68481-1,cardiothoracic surgery attending hospital progress note,cardiothor surg attend hosp progress nte,,cardio; cardiology; cardiothor surg; cardiothor surg attend; doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; heart disease; hosp; inpatient; notes; point in time; prog note; random; subsequent evaluation; subsequent visit evaluation; surg; surg attend; visit note,Doc
68482-9,nurse hospital transfer summary note,nurse hosp transfer sum note,,doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; hosp; inpatient; notes; nursing; point in time; random; transfer sum note; visit note,Doc
6851-0,penicillin g ige ab [units/volume] in serum,penicillin g ige qn,penicillin g ige qn (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; benzylpenicillin; c1; immune globulin e; immunoglobulin e; pcn; pen; penicilloyl; point in time; qnt; quan; quant; quantitative; random; serum; sr; universallaborders; wycillin,Qn
68513-1,how many day in the past week did you miss taking one or more of your medications [samhsa],,,1 week; count/time; dextro; last; miss taking medications d/w; nrate; number rate; number rate = count/time; qnt; quan; quant; quantitative; samsha; substance abuse and mental health services administration; survey; survey.samhsa,Qn
68518-0,how often do you have a drink containing alcohol,have alcohol nrate,,alc; alcoholic; count/time; h+p; h+p.hx; have alcohol; nrate; number rate; number rate = count/time; p prime; point in time; qnt; quan; quant; quantitative; random,Qn
68537-0,would you be interested in quitting tobacco use within the next few weeks [samhsa],,,finding; findings; interested quitting tobacco next few w; ordinal; point in time; ql; qual; qualitative; random; samsha; screen; substance abuse and mental health services administration; survey; survey.samhsa,Ord
68538-8,did you provide brief counseling-coaching to quit [samhsa],,,finding; findings; ordinal; point in time; ql; qual; qualitative; random; samsha; screen; substance abuse and mental health services administration; survey; survey.samhsa,Ord
68562-8,obstetrics and gynecology preoperative evaluation and management note,obgyn pre-op note,,assessment; clinical encounter note; doc.ont; document; e/m note; encounter; eval; evaluation and management; evaluation and management note; finding; findings; gyn; gynecology; h&p; history and physical; notes; ob; obgyn; obstetric; obstetrics; point in time; prenatal; pre-op; pre-op note; pre-operative; random; visit note,Doc
68564-4,obstetrics and gynecology progress note,obgyn prog note,,doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; gyn; gynecology; notes; ob; obgyn; obstetric; obstetrics; point in time; prenatal; prog note; random; subsequent evaluation; subsequent visit evaluation; visit note,Doc
68565-1,obstetrics and gynecology transfer summary note,obgyn transfer sum note,,doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; gyn; gynecology; notes; ob; obgyn; obstetric; obstetrics; point in time; prenatal; random; transfer sum note; visit note,Doc
68566-9,obstetrics and gynecology hospital consult note,obgyn hosp consult note,,consult note; doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; gyn; gynecology; hosp; inpatient; notes; ob; obgyn; obstetric; obstetrics; point in time; prenatal; random; visit note,Doc
6858-5,squid ige ab [units/volume] in serum,squid ige qn,squid ige qn (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; cuttlefish; f258; immune globulin e; immunoglobulin e; point in time; qnt; quan; quant; quantitative; random; rf258; serum; species; spp; squid; sr,Qn
68636-0,audiology note,audiology note,,audiology; doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; notes; point in time; random; visit note,Doc
68647-7,child and adolescent psychiatry transfer summary note,child+teen psych transfer sum note,,child+teen psych; doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; notes; point in time; psychiatric; random; transfer sum note; visit note,Doc
68660-0,clinical genetics transfer summary note,clinical genetics transfer sum note,,clinical genomics; doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; genetic; genomic; medical genetics; medical genomics; notes; point in time; random; transfer sum note; visit note,Doc
68666-7,developmental-behavioral pediatrics note,develop-behav peds note,,develop-behav peds; doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; mental health; mentalhealth; notes; peds; point in time; psych; psychiatry; random; visit note,Doc
68668-3,developmental-behavioral pediatrics progress note,develop-behav peds prog note,,develop-behav peds; doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; mental health; mentalhealth; notes; peds; point in time; prog note; psych; psychiatry; random; subsequent evaluation; subsequent visit evaluation; visit note,Doc
68669-1,developmental-behavioral pediatrics transfer summary note,develop-behav peds transfer sum note,,develop-behav peds; doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; mental health; mentalhealth; notes; peds; point in time; psych; psychiatry; random; transfer sum note; visit note,Doc
68670-9,developmental-behavioral pediatrics hospital consult note,develop-behav peds hosp consult note,,consult note; develop-behav peds; doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; hosp; inpatient; mental health; mentalhealth; notes; peds; point in time; psych; psychiatry; random; visit note,Doc
68672-5,geriatric medicine skilled nursing facility note,geri med skilled nurse facility note,,doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; geri med; gerontology; nh; notes; point in time; random; skilled nurse facility; snf; visit note,Doc
6868-4,adenosine monophosphate.cyclic [mass/volume] in urine,camp ur-mcnc,adenosine monophosphate.cyclic (u) [mass/vol],adenosine 2'-phosphate; adenosine 3'-phosphate; adenosine 5'-phosphate; adenylic acid; ado; amp; aned; camp; chemistry; cmp; level; mass concentration; medication stress; phosphaden; point in time; qnt; quan; quant; quantitative; random; ua; ur; urn,Qn
68700-4,neurology with special qualifications in child neurology note,child neuro note,,doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; neuro; neurology; neurology with special qualifications in child neurology; notes; point in time; random; visit note,Doc
68726-9,pediatric cardiology transfer summary note,peds cardiology transfer sum note,,cardio; cardiology; doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; heart disease; notes; peds; peds cardiology; point in time; random; transfer sum note; visit note,Doc
68738-4,pediatric gastroenterology discharge summary,peds gastroenterology d/c sum,,d/c sum; disch; discharge summary; doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; gastro; gastroenterology; gi; notes; peds; peds gastroenterology; point in time; random; visit note,Doc
68742-6,pediatric gastroenterology preoperative evaluation and management note,peds gastroenterology pre-op note,,assessment; clinical encounter note; doc.ont; document; e/m note; encounter; eval; evaluation and management; evaluation and management note; finding; findings; gastro; gastroenterology; gi; h&p; history and physical; notes; peds; peds gastroenterology; point in time; pre-op; pre-op note; pre-operative; random; visit note,Doc
68751-7,pediatric hematology-oncology history and physical note,peds hem-onc h&p note,,cancer; doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; h&p note; hematology; heme; hx; notes; oncology; peds; peds hem-onc; point in time; random; visit note,Doc
68754-1,pediatric hematology-oncology procedure note,peds hem-onc procedure note,,cancer; doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; hematology; heme; notes; oncology; peds; peds hem-onc; point in time; random; visit note,Doc
68763-2,pediatric infectious diseases progress note,peds infect disease prog note,,doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; id; infectious disease; infectiousdisease; notes; peds; peds infect disease; point in time; prog note; random; subsequent evaluation; subsequent visit evaluation; visit note,Doc
68784-8,pediatric pulmonology procedure note,peds pulmonology procedure note,,doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; lung; notes; peds; peds pulmonology; point in time; pulmonary; pulmonology; random; respiratory; visit note,Doc
68786-3,pediatric pulmonology transfer summary note,peds pulmonology transfer sum note,,doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; lung; notes; peds; peds pulmonology; point in time; pulmonary; pulmonology; random; respiratory; transfer sum note; visit note,Doc
68787-1,pediatric pulmonology hospital consult note,peds pulmonology hosp consult note,,consult note; doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; hosp; inpatient; lung; notes; peds; peds pulmonology; point in time; pulmonary; pulmonology; random; respiratory; visit note,Doc
68836-6,primary care procedure note,primary care procedure note,,continuity assessment record and evaluation; doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; notes; point in time; random; visit note,Doc
68843-2,speech-language pathology history and physical note,speech-lang path h&p note,,doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; h&p note; hx; notes; path; point in time; random; speech pathology; speech therapy; speech-lang path; visit note,Doc
68856-4,pediatric transplant hepatology discharge summary,peds transpl hepato d/c sum,,d/c sum; disch; discharge summary; doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; hepatology; liver; notes; peds; peds transpl hepato; point in time; random; visit note,Doc
68859-8,pediatric transplant hepatology note,peds transpl hepato note,,doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; hepatology; liver; notes; peds; peds transpl hepato; point in time; random; visit note,Doc
68868-9,pediatric nephrology procedure note,peds nephrology procedure note,,doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; kidney; nephrology; notes; peds; peds nephrology; point in time; random; renal; visit note,Doc
68875-4,pediatric otolaryngology hospital letter,peds otolaryngology hosp letter,,doc.ont; document; ear nose throat; ent; finding; findings; hosp; inpatient; oto; otolaryngology; otorhinolaryngology; peds; peds otolaryngology; point in time; random,Doc
68878-8,pediatric rheumatology progress note,peds rheumatology prog note,,doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; notes; peds; peds rheumatology; point in time; prog note; random; rheum; rheumatology; subsequent evaluation; subsequent visit evaluation; visit note,Doc
68882-0,pediatric urology note,peds urology note,,doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; genitourinary; gu; notes; peds; peds urology; point in time; random; uro; urology; visit note,Doc
68883-8,pediatrics transfer summary note,peds transfer sum note,,doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; notes; peds; point in time; random; transfer sum note; visit note,Doc
68894-5,pediatric endocrinology note,peds endocrinology note,,doc.ont; document; encounter; endocrine; endocrinology; evaluation and management; evaluation and management note; finding; findings; notes; peds; peds endocrinology; point in time; random; visit note,Doc
68917-4,parathyrin.intact [mass/volume] in serum or plasma --20 minutes post excision,pth-intact 20m p excision serpl-mcnc,parathyrin.intact 20 min post excision [mass/vol],20m p excision; after; chemistry.challenge testing; intact parathormone; intact parathyroid hormone; ipth; level; mass concentration; p excision; parathormone; parathyroid hormone; pl; plasma; plsm; point in time; post surgery; pst; pth; pth-intact; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; tumor marker,Qn
68927-3,cytokeratin 19 [mass/volume] in peritoneal fluid,ck 19 prt-mcnc,cytokeratin 19 (periton fld) [mass/vol],"ascites; ascitic fluid; ascitis; autoimmune hepatitis; chemistry; ck; ck 19; cyfra 21-1; keratin 19; keratin, type i cytoskeletal 19; level; mass concentration; peritoneal fluid; point in time; prt; qnt; quan; quant; quantitative; random",Qn
68950-5,herpes virus 8 igg ab [titer] in cerebral spinal fluid by immunofluorescence,hhv8 igg titr csf if,hhv 8 igg if (csf) [titer],abs; aby; acif; antby; anti; antibodies; antibody; anticomplement immunofluorescence; autoantibodies; autoantibody; cerebral spinal fluid; cerebrospinal fl; dilution factor; dilution factor (titer); fa; fluorescent antibody; fluoresent; herpesvirus; hhv; hhv8; hhv-8; human herpes virus; id; ifa; immune fluorescence; immune globulin g; immunoflour; immunofluor; immunofluorescence; immunoglobulin g; infectious disease; infectiousdisease; kaposi's sarcoma-associated herpesvirus; kshv; microbiology; neuro; neurology; point in time; random; smqn; spinal fl; spinal fld; spinal flu; spinal fluid; time resolved fluorescence; titer; titered; titre; trf; ttr,SemiQn
68986-9,influenza virus a h5a rna [presence] in specimen by naa with probe detection,fluav h5a rna spec ql naa+probe,fluav h5a rna naa+probe ql (specimen),3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; avian influenza; bird flu; dna nucleic acid probe; dna probe; flua; fluav; fluav h5a; fluv; fowl plague; id; infectious disease; infectiousdisease; influ; influenza a; influenza a virus; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; misc; miscellaneous; naa+probe; naat; nasba; nucleic acid sequence based analysis; ordinal; other; pcr; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; ribonucleic acid; screen; sda; spec; strand displacement amplification; tma; to be specified in another part of the message; transcription mediated amplification; unspecified,Ord
69001-6,heart rate --standing,heart rate stand,,art sys; count/time; heart beat; hrtrate.pstn.molec; nrate; number rate; number rate = count/time; point in time; pulse; qnt; quan; quant; quantitative; random; stand); wb; weight bearing,Qn
69017-2,immature granulocytes/leukocytes in synovial fluid,imm granulocytes nfr snv,immature granulocytes/leukocytes (syn fld),gran; grans; granulocyte; granulocytes; hematology/cell counts; imm; imm granulocytes; immat; joint aspirate; joint fld; joint flu; joint fluid; leuc; leuk; leukocyte; lkcs; number fraction; percent; point in time; qnt; quan; quant; quantitative; random; sf; snv; syn; syn fl; synov; synovial fluid; wbc; wbcs; white blood cell; white blood cells,Qn
69021-4,amphetamines panel - meconium by confirmatory method,amphetamines pnl mec cfm,amphetamines panel confirm (mec),amph; amphetam; amphetamine; amphetamines pnl; cfm; cnfr; cnfrm; conf; confirmation; confirmatory; drug/toxicology; drugs; gcms; lc/ms/ms; mec; pan; panel.drug & toxicology; panl; pnl; point in time; random; speed,-
69024-8,methylenedioxyethylamphetamine [mass/mass] in meconium by confirmatory method,mdea mec cfm-mcnt,methylenedioxyethylamphetamine confirm (mec) [mass/mass],addiction; cfm; cnfr; cnfrm; conf; confirmation; confirmatory; drug/toxicology; drugs; drugs of abuse; gcms; illicit; lc/ms/ms; mass content; mdea; mec; point in time; potentialforabuse; qnt; quan; quant; quantitative; random,Qn
69044-6,date first prenatal visit,,,point in time; qnt; quan; quant; quantitative; random; survey; survey.cdc,Qn
69049-5,coagulation specialist review of results,coagulation specialist review,coagulation specialist review [interp],coag; hematology; heme; impression; impression/interpretation of study; impressions; interp; interpretation; misc; miscellaneous; narrative; other; point in time; random; report; to be specified in another part of the message; unspecified,Nar
69057-8,xr hand - bilateral ap and lateral and oblique,xr hand-bl ap+lat+obl,,anterio-posterior; anteroposterior; ap+lat; ap+lat+obl; arm; bil; bilat; both; document; ext; extr-bl; films; finding; findings; hand-bl; hands; imaging; lat; msk; musculoskeletal; obl; ortho; orthopedics; plain films; point in time; rad; radiology; random; ue; ue-bl; up; upper extremity; view; views & ap kub; views (ap; views ap kub & lateral; views+ap; vws; xray; x-ray,Doc
69066-9,rfa abdominal vessels views w contrast iv,rfa abd ves views w contr iv,,abd; abd ves; abdo; abdomen; abdomen+; abdominal; c; cardio; cardiology; contr; contra; contrst; document; films; finding; findings; fluor; fluoro; fluoroscopy; heart disease; imaging; point in time; rad; radiology; random; rfa; vesl; vessels.xxx; view; vws; w contr iv; wc,Doc
69073-5,rf guidance for core needle biopsy of unspecified body region,rf guided cn bx,,bx; cn; cn bx; cnb; document; finding; findings; fluor; fluoro; fluoroscopy; guid; guide; guided; imaging; large needle; misc; miscellaneous; ndl; other; point in time; rad; radiology; random; spec; to be specified in another part of the message; unspecified,Doc
69076-8,rf guidance for percutaneous biopsy of bone,rf bone pc bx,,bon; bx; document; finding; findings; fluor; fluoro; fluoroscopy; guid; guide; guided; imaging; misc; miscellaneous; other; perc; point in time; rad; radiology; random; spec; to be specified in another part of the message; unspecified,Doc
69080-0,xr cervical spine 5 views w flexion and w extension,xr c-spine 5v w fe,,5v; 5vw; c/sp; cerv; c-spine; document; ext; films; finding; findings; imaging; plain films; point in time; rad; radiology; random; spinal; spinal cord; view; vws; w fe; w flx; xray; x-ray,Doc
69093-3,ct guidance for biopsy of pelvis-- w contrast iv,ct guided pelvis bx--w contr iv,,bx; c; cat scan; computed tomography; computerized tomography; contr; contra; contrst; ct scan; document; finding; findings; guid; guide; guided; imaging; pelvic; perc; point in time; rad; radiology; random; w contr iv; wc,Doc
6912-0,chlamydophila pneumoniae iga ab [titer] in serum by immunofluorescence,c pneum iga titr ser if,c. pneumoniae iga if (s) [titer],abs; aby; acif; antby; anti; antibodies; antibody; anticomplement immunofluorescence; autoantibodies; autoantibody; c pneum; c pneumo; c pneumoniae; chlamydia; chlamydia pneumoniae; cpn; dilution factor; dilution factor (titer); fa; fluorescent antibody; fluoresent; id; ifa; immune fluorescence; immune globulin a; immunoflour; immunofluor; immunofluorescence; immunoglobulin a; infectious disease; infectiousdisease; microbiology; pneu; pneum; pneumo; pneumon; pneumonia; point in time; random; serum; smqn; sr; time resolved fluorescence; titer; titered; titre; trf; ttr; twar agent,SemiQn
69121-2,rf guidance for aspiration of cyst of ovary,rf guided ovary cyst asp,,asp; cyst asp; document; finding; findings; fluor; fluoro; fluoroscopy; guid; guide; guided; gyn; gynecology; imaging; ob; obgyn; obstetrics; ovarian; pelvic; perc; point in time; rad; radiology; random,Doc
69125-3,deprecated rf guidance for needle biopsy of liver,deprecated rf liver bx needle guide,,abd; abdo; abdomen+; abdominal; bx; document; finding; findings; fluor; fluoro; fluoroscopy; guid; guide; guided; hepar; hepatic; imaging; ndl; needle bx; point in time; rad; radiology; random,Doc
69136-0,xr knee sunrise and tunnel,xr knee sunrise+tunnel,,document; ext; films; finding; findings; imaging; kn; le; leg; low; lower extremity joint; msk; musculoskeletal; ortho; orthopedics; plain films; point in time; rad; radiology; random; settegast; skyline; sunrise+tunnel; tangential; view; views+sunrise; vws; xray; x-ray,Doc
69142-8,xr knee - left 2 views and sunrise,xr knee-l 2v+sunrise,,2v; 2v+sunrise; 2vw; document; ext; extr-l; films; finding; findings; ii; imaging; kn; knee-l; l; le; leg; le-l; lle; low; lower extremity joint; lt; msk; musculoskeletal; ortho; orthopedics; plain films; point in time; rad; radiology; random; settegast; skyline; tangential; view; vws; xray; x-ray,Doc
69146-9,xr knee - left ap and lateral crosstable,xr knee-l ap+lat xtable,,anterio-posterior; anteroposterior; ap+lat; ap+lat xtable; cross table; document; ext; extr-l; films; finding; findings; imaging; kn; knee-l; l; lat; le; leg; le-l; lle; low; lower extremity joint; lt; msk; musculoskeletal; ortho; orthopedics; plain films; point in time; rad; radiology; random; view; views & ap kub; views (ap; views ap kub & lateral; views+ap; vws; xray; x-ray; xtable,Doc
69155-0,xr shoulder - left 3 views and y,xr should-l 3v+y,,3v; 3v+y; 3vw; arm; document; ext; extr-l; films; finding; findings; iii; imaging; l; lt; lue; msk; musculoskeletal; ortho; orthopedics; plain films; point in time; rad; radiology; random; should-l; ue; ue-l; up; upper extremity joint; view; vws; xray; x-ray,Doc
69161-8,mra circle of willis wo and w contrast iv,mra circle of willis wo+w contr iv,,ang; angio; angiography; brain; c; cardio; cardiology; contr; contra; contrst; cranial; cranium; document; finding; findings; heart disease; imaging; intracranial; magnetic resonance angiographies; magnetic resonance imaging; mitral regurgitation maximum velocity; mr angiography; mra; mri; mri.angio; neuro; neurology; point in time; rad; radiology; random; skull; w contr iv; wc; wo & wc; wo+w contr; wo+w contr iv; wwo,Doc
69171-7,mr elbow - bilateral wo contrast,mr elbow-bl wo contr,,arm; bil; bilat; both; c; contr; contra; contrst; document; elbow-bl; ext; extr-bl; finding; findings; imaging; mitral regurgitation maximum velocity; mri; msk; musculoskeletal; olecranon; ortho; orthopedics; point in time; rad; radiology; random; ue; ue-bl; up; upper extremity joint; without contrast,Doc
69173-3,mr femur - bilateral wo contrast,mr femur-bl wo contr,,bil; bilat; both; c; contr; contra; contrst; document; ext; extr-bl; femoral; femur-bl; finding; findings; imaging; le; le-bl; leg; low; lower extremity; mitral regurgitation maximum velocity; mri; point in time; rad; radiology; random; upper leg; without contrast,Doc
69177-4,mr hand - bilateral wo and w contrast iv,mr hand-bl wo+w contr iv,,arm; bil; bilat; both; c; contr; contra; contrst; document; ext; extr-bl; finding; findings; hand-bl; hands; imaging; mitral regurgitation maximum velocity; mri; msk; musculoskeletal; ortho; orthopedics; point in time; rad; radiology; random; ue; ue-bl; up; upper extremity; w contr iv; wc; wo & wc; wo+w contr; wo+w contr iv; wwo,Doc
69181-6,mr upper arm - bilateral wo and w contrast iv,mr upper arm-bl wo+w contr iv,,arm; bil; bilat; both; c; contr; contra; contrst; document; ext; extr-bl; finding; findings; humerus; imaging; mitral regurgitation maximum velocity; mri; point in time; rad; radiology; random; ue; ue-bl; up; upper arm-bl; upper extremity; w contr iv; wc; wo & wc; wo+w contr; wo+w contr iv; wwo,Doc
69186-5,mr upper extremity - bilateral wo and w contrast iv,mr ue-bl wo+w contr iv,,arm; bil; bilat; both; c; contr; contra; contrst; document; ext; extr-bl; finding; findings; imaging; mitral regurgitation maximum velocity; mri; point in time; rad; radiology; random; ue; ue-bl; up; w contr iv; wc; wo & wc; wo+w contr; wo+w contr iv; wwo,Doc
69204-6,mr finger - left wo and w contrast iv,mr finger-l wo+w contr iv,,arm; c; contr; contra; contrst; document; ext; extr-l; finding; findings; finger-l; imaging; l; lt; lue; mitral regurgitation maximum velocity; mri; msk; musculoskeletal; ortho; orthopedics; point in time; rad; radiology; random; ue; ue-l; up; w contr iv; wc; wo & wc; wo+w contr; wo+w contr iv; wwo,Doc
69207-9,mr hip - left arthrogram wo and w contrast,mr hip-l wo+w contr is,,arthrogram; arthrography; c; contr; contra; contrst; document; ext; extr-l; finding; findings; hip-l; imaging; intraarticular; intrasynovial; l; le; leg; le-l; lle; low; lower extremity joint; lt; mitral regurgitation maximum velocity; mri; msk; musculoskeletal; ortho; orthopedics; point in time; rad; radiology; random; w contr is; wc; wo & wc; wo+w contr; wo+w contr is; wwo,Doc
69221-0,mr scrotum and testicle w contrast iv,mr scrotum+test w contr iv,,c; contr; contra; contrst; document; finding; findings; imaging; mitral regurgitation maximum velocity; mri; pelvic; point in time; rad; radiology; random; scrotal; scrotal contents; testicular; testies; testis; w contr iv; wc,Doc
69225-1,deprecated rf guidance for needle biopsy of chest,deprecated rf chest bx needle guide,,bx; document; finding; findings; fluor; fluoro; fluoroscopy; guid; guide; guided; imaging; ndl; needle bx; point in time; rad; radiology; random; thorax,Doc
6923-7,adrenal cortex ab [units/volume] in serum by immunofluorescence,adrenal cortex ab ser if-acnc,adrenal cortex ab if qn (s),abs; aby; aca; acif; adrnl; antby; anti; antibodies; antibody; anticomplement immunofluorescence; arbitrary concentration; autoantibodies; autoantibody; endocrine; endocrinology; fa; fluorescent antibody; fluoresent; ifa; immune fluorescence; immunoflour; immunofluor; immunofluorescence; point in time; qnt; quan; quant; quantitative; random; serology; serum; sr; time resolved fluorescence; trf,Qn
69238-4,spect urinary bladder and urethra w contrast intra bladder during voiding,spect bladder+urethra w contr ib void,,c; contr; contra; contrst; cystogram; document; finding; findings; genital tract; imaging; pelvic; point in time; rad; radiology; random; urth; w contr ib void; w contr iub; wc,Doc
69246-7,deprecated rf guidance for percutaneous biopsy.needle of liver,deprecated rf liver pc bx needle guide,,abd; abdo; abdomen+; abdominal; bx; document; finding; findings; fluor; fluoro; fluoroscopy; guid; guide; guided; hepar; hepatic; imaging; ndl; pc needle bx; perc; point in time; rad; radiology; random,Doc
69247-5,deprecated rf guidance for percutaneous biopsy.needle of salivary gland,deprecated rf salivary gland pc bx needle guide,,brain; bx; cranial; cranium; document; finding; findings; fluor; fluoro; fluoroscopy; guid; guide; guided; imaging; intracranial; ndl; pc needle bx; perc; point in time; rad; radiology; random; skull,Doc
69248-3,rfa guidance for percutaneous transluminal angioplasty of renal artery-- w contrast ia,rfa guided renal a pta--w contr ia,,abd; abdo; abdomen+; abdominal; art; arteriogram; c; cardio; cardiology; contr; contra; contrst; document; finding; findings; fluor; fluoro; fluoroscopy; guid; guide; guided; heart disease; imaging; kidney; perc; point in time; pta; rad; radiology; random; rfa; w contr ia; wc,Doc
69250-9,rfa portal vein views w contrast iv,rfa portal v views w contr iv,,abd; abdo; abdomen+; abdominal; c; cardio; cardiology; contr; contra; contrst; document; films; finding; findings; fluor; fluoro; fluoroscopy; heart disease; imaging; point in time; portogram; portography; pv; rad; radiology; random; rfa; ven; venogram; venography; venous; view; vws; w contr iv; wc,Doc
69289-7,deprecated us guidance for needle biopsy of pancreas,deprecated us pancreas bx needle guide,,abd; abdo; abdomen+; abdominal; bx; document; echography; finding; findings; guid; guide; guided; imaging; ndl; needle bx; pancr; pancreatc; pancreatic; point in time; radiology; random; sonogram; sonograph; sonography; uls; ultrasound,Doc
6930-2,psilocybin [mass/volume] in urine,psilocybin ur-mcnc,psilocybin (u) [mass/vol],drug/toxicology; drugs; level; mass concentration; point in time; qnt; quan; quant; quantitative; random; ua; ur; urn,Qn
6932-8,penicillin [susceptibility] by minimum inhibitory concentration (mic),penicillin islt mic,penicillin mic [susc],antibiotic susceptibilities; ast; id; infectious disease; infectiousdisease; islt; isol; minimum inhibitory concentration; pcn; pen; penicilloyl; point in time; random; sus; suscept; susceptibilities; susceptibility; susceptibilty; wycillin,OrdQn
69333-3,neuro and emotional and behavioral status - resumption of care [oasis-c],,,neuro & emot & behav status - resumption care; neuro emotional behavioral status; outcome and assessment information set; pan; panel; panel.survey.oasis; panl; pnl; point in time; random; survey; survey.oasis,-
69351-5,"medical coding information - admission, home health [care]",,,"care survey; continuity assessment record and evaluation; continuity assessment record and evaluation (care) pnl; med coding info - care - admission, home health; pan; panel; panl; pnl; point in time; random; survey",-
69357-2,amylase [enzymatic activity/volume] in serum or plasma --fasting,amylase p fast serpl-ccnc,amylase post fast [catalytic activity/vol],after; alpha amylase; ams; amyl; calorie fast; catalytic concentration; chemistry.challenge testing; diastase; fast; fasting; gastro; gastroenterology; gi; k87; p fast; pc; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
69365-5,inpatient facility diagnoses - oasis b1 [oasis],,,inpt facility dx - oasis b1; outcome and assessment information set; pan; panel; panel.survey.oasis; panl; pnl; point in time; random; survey; survey.oasis,-
6936-9,deoxypyridinoline [mass/time] in 2 hour urine,dpd 2h ur-mrate,deoxypyridinoline (2h u) [mass/time],120 min; 120 minutes; 120min; 2 hours; 2hr; chemistry; dpd; dpyr; free lysly-pyridinoline; lysylpyridinoline; mass rate; mrate; pyradinium collagen crosslinks; qnt; quan; quant; quantitative; ua; ur; urn,Qn
69373-9,passive d ab [presence] in serum or plasma,passive d ab serpl ql,passive d ab ql,abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; blood bank; dextro; ordinal; pl; plasma; plsm; point in time; pr; ql; qual; qualitative; random; rh; rhesus; screen; serp; serpl; serplas; serum; serum or plasma; sr,Ord
69374-7,"cognitive status, mood, pain - discharge [care]",,,care survey; cognitive status d/c; continuity assessment record and evaluation; continuity assessment record and evaluation (care) pnl; disch; pan; panel; panl; pnl; point in time; random; survey,-
69394-5,us mesenteric arteries,us mesenteric aa,,abd; abdo; abdomen+; abdominal; document; echography; finding; findings; imaging; mesenteric aa; point in time; radiology; random; sonogram; sonograph; sonography; uls; ultrasound,Doc
69397-8,us.doppler breast vessels,dop breast ves,,brst; cardio; cardiology; document; dop; duplex; echography; finding; findings; gyn; gynecology; heart disease; imaging; ob; obgyn; obstetrics; point in time; radiology; random; sonogram; sonograph; sonography; uls; ultrasound; vesl; vessels.xxx,Doc
69399-4,us femoral vein and popliteal vein,us fem v+polliteal a,,cardio; cardiology; document; echography; ext; fem v; fem v+polliteal a; finding; findings; heart disease; imaging; le; leg; low; point in time; radiology; random; sonogram; sonograph; sonography; uls; ultrasound; ven; venous,Doc
69413-3,continuity assessment record and evaluation (care) tool - long term care hospital (ltch) - planned discharge - version 1.0,,,assessment; care; care survey; care tool - ltch - planned d/c v1.0; continuity assessment record and evaluation (care) pnl; disch; eval; h&p; history and physical; hosp; pan; panel; panl; pnl; point in time; random; survey,-
69415-8,continuity assessment record and evaluation (care) tool - long term care hospital (ltch) - expired - version 1.0,,,assessment; care; care survey; care tool - ltch - expired v1.0; continuity assessment record and evaluation (care) pnl; eval; h&p; history and physical; hosp; pan; panel; panl; pnl; point in time; random; survey,-
69420-8,heterophile ab [presence] in blood by immunoassay,heteroph ab bld ql ia,heterophile ab ia ql (bld),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; blood; eia; elfa; elisa; enzyme immunoassay; epstein-barr virus; hetero; heteroph; hetr; iaa; id; infectious disease; infectiousdisease; meia; microbiology; mono screen; mono slide; mono spot; mono test; mononucleosis screen; mononucleosis test; monospot; ordinal; point in time; pr; ql; qual; qualitative; random; screen; suds; wb; whole blood,Ord
69429-9,metabolic rate --resting,metabolic rate resting patient,metabolic rate resting [energy/time],basal metabolic rate; bmr; ee; energy expenditure; energy/time; misc; point in time; power; qnt; quan; quant; quantitative; random; rmr,Qn
6943-5,acetohexamide [mass/volume] in specimen,acetohexamide spec-mcnc,acetohexamide (specimen) [mass/vol],drug/toxicology; drugs; dymelor; level; mass concentration; misc; miscellaneous; other; point in time; qnt; quan; quant; quantitative; random; spec; to be specified in another part of the message; unspecified,Qn
6944-3,glipizide [mass/volume] in specimen,glipizide spec-mcnc,glipizide (specimen) [mass/vol],drug/toxicology; drugs; glucotrol; level; mass concentration; misc; miscellaneous; other; point in time; qnt; quan; quant; quantitative; random; spec; to be specified in another part of the message; unspecified,Qn
69443-0,did tobacco use contribute to death,,,finding; findings; ordinal; point in time; ql; qual; qualitative; random; screen; survey; survey.cdc,Ord
69448-9,injury leading to death associated with transportation event,,,assoc; death associated transportation injury; finding; findings; ordinal; point in time; ql; qual; qualitative; random; screen; survey; survey.cdc; ulcer,Ord
6945-0,glyburide [mass/volume] in specimen,glyburide spec-mcnc,glyburide (specimen) [mass/vol],diabeta; drug/toxicology; drugs; glynase; level; mass concentration; micronase; misc; miscellaneous; other; point in time; qnt; quan; quant; quantitative; random; spec; to be specified in another part of the message; unspecified,Qn
69458-8,cardiology monitoring,cardiology monitoring,,deeds; emergency department; emergency department (deeds); emergency department (deeds) panel; pan; panel; panl; pnl; point in time; random,-
69459-6,care record summary panel,crs pnl,,crs pnl; pan; panel.doc; panl; pnl; point in time; random,-
69-5,cefamandole [susceptibility] by disk diffusion (kb),cefamandole islt kb,cefamandole disk diffusion (kb) [susc],antibiotic susceptibilities; ast; c31; disk diffusion; id; infectious disease; infectiousdisease; islt; isol; kb; kefadol; kirby-bauer; mandol; manj; point in time; random; sus; suscept; susceptibilities; susceptibility; susceptibilty,OrdQn
69504-9,kneeling - difficulty [optimal],,,finding; findings; ordinal; outpatient physical therapy improvement in movement assessment log; point in time; ql; qual; qualitative; random; screen; survey; survey.optimal,Ord
69508-0,climbing stairs - difficulty [optimal],,,finding; findings; ordinal; outpatient physical therapy improvement in movement assessment log; point in time; ql; qual; qualitative; random; screen; survey; survey.optimal,Ord
69511-4,running - difficulty [optimal],,,finding; findings; ordinal; outpatient physical therapy improvement in movement assessment log; point in time; ql; qual; qualitative; random; screen; survey; survey.optimal,Ord
69516-3,lifting - difficulty [optimal],,,finding; findings; ordinal; outpatient physical therapy improvement in movement assessment log; point in time; ql; qual; qualitative; random; screen; survey; survey.optimal,Ord
69517-1,carrying - difficulty [optimal],,,finding; findings; ordinal; outpatient physical therapy improvement in movement assessment log; point in time; ql; qual; qualitative; random; screen; survey; survey.optimal,Ord
6951-8,tolazamide [mass/volume] in specimen,tolazamide spec-mcnc,tolazamide (specimen) [mass/vol],drug/toxicology; drugs; level; mass concentration; misc; miscellaneous; other; point in time; qnt; quan; quant; quantitative; random; spec; to be specified in another part of the message; tolinase; unspecified,Qn
69523-9,sitting - confidence [optimal],,,finding; findings; ordinal; outpatient physical therapy improvement in movement assessment log; point in time; ql; qual; qualitative; random; screen; survey; survey.optimal,Ord
69532-0,hopping - confidence [optimal],,,finding; findings; ordinal; outpatient physical therapy improvement in movement assessment log; point in time; ql; qual; qualitative; random; screen; survey; survey.optimal,Ord
69552-8,thromboelastography after addtion of heparinase panel - blood,teg after heparinase pnl bld,thromboelastography after addtion of heparinase panel (bld),blood; coagulation; pan; panel.coagulation; panl; pnl; point in time; random; teg after heparinase pnl; wb; whole blood,-
69567-6,megasphaera sp type 1 dna [presence] in vaginal fluid by naa with probe detection,mega1 dna vag ql naa+probe,megasphaera sp type 1 dna naa+probe ql (vag fld),3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; deoxyribonucleic acid; dna nucleic acid probe; dna probe; genital vaginal; gyn; gynecology; i; id; infectious disease; infectiousdisease; lat; lcr; ligase chain reaction; ligation-activated transcription; mega1; mega1 dna; microbiology; naa+probe; naat; nasba; nucleic acid sequence based analysis; ob; obgyn; obstetrics; ordinal; pcr; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; screen; sda; species; spp; strand displacement amplification; tma; transcription mediated amplification; vag fld; vag fluid; vagina; vaginal fluid,Ord
69569-2,risk of ovarian malignancy algorithm score in serum or plasma --premenopausal,roma score premen serpl,risk of ovarian malignancy algorithm score premenopausal [score],chemistry; gyn; gynecology; malig; ob; obgyn; obstetrics; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; roma; roma score; scale; serp; serpl; serplas; serum; serum or plasma; sr,Qn
69572-6,ercc1 ag [presence] in tissue by immune stain,ercc1 ag tiss ql imstn,ercc1 ag immune stain ql (tiss),"antigen; antigens; excision repair cross-complementation group 1; ihc; imm; immunohistochemical stain; immunostain; imstn; imun; imune; ordinal; pathology; point in time; pr; ql; qual; qualitative; random; screen; st; stains; stn; tissue; tissue, unspecified",Ord
69590-8,pulling - confidence - score change [optimal],,,exchange; outpatient physical therapy improvement in movement assessment log; point in time; pulling conf - score change; qnt; quan; quant; quantitative; random; replace; score difference; survey; survey.optimal,Qn
69605-4,rolling over - confidence - score change [optimal],,,exchange; outpatient physical therapy improvement in movement assessment log; point in time; qnt; quan; quant; quantitative; random; replace; rolling over conf - score; rolling over conf - score change; score difference; survey; survey.optimal,Qn
6960-9,yersinia enterocolitica o:5 ab [titer] in serum,y entero o:5 ab titr ser,y. enterocolitica o:5 ab (s) [titer],abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; dilution factor; dilution factor (titer); id; infectious disease; infectiousdisease; microbiology; point in time; random; serum; smqn; sr; titer; titered; titre; ttr; y entero o:5; y enterocol; y enterocolitica,SemiQn
69611-2,pulling - difficulty - score change [optimal],,,exchange; outpatient physical therapy improvement in movement assessment log; point in time; pulling diff - score change; qnt; quan; quant; quantitative; random; replace; score difference; survey; survey.optimal,Qn
69620-3,kneeling - difficulty - score change [optimal],,,exchange; kneeling diff - score; kneeling diff - score change; outpatient physical therapy improvement in movement assessment log; point in time; qnt; quan; quant; quantitative; random; replace; score difference; survey; survey.optimal,Qn
69671-6,bothered by stomach pain in last 4 weeks [reported.phq],,,4 weeks; finding; findings; ordinal; past; patient health questionnaire; ql; qual; qualitative; screen; survey; survey.phq,Ord
69673-2,"bothered by pain in your arms, legs, or joints - knees, hips, etc - in last 4 weeks [reported.phq]",,,"4 weeks; finding; findings; ordinal; pain in arms, legs, or joints last 4w; past; patient health questionnaire; ql; qual; qualitative; screen; survey; survey.phq",Ord
6967-4,yersinia pseudotuberculosis ab [titer] in serum,y pseudotb ab titr ser,y. pseudotuberculosis ab (s) [titer],abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; dilution factor; dilution factor (titer); id; infectious disease; infectiousdisease; microbiology; point in time; random; serum; smqn; sr; titer; titered; titre; ttr; y pseudotb; y pseudotuberculosis,SemiQn
69675-7,bothered by headaches in last 4 weeks [reported.phq],,,4 weeks; finding; findings; ordinal; past; patient health questionnaire; ql; qual; qualitative; screen; survey; survey.phq,Ord
69679-9,bothered by feeling your heart pound or race in last 4 weeks [reported.phq],,,4 weeks; ethnicity; feeling heart pound last 4w; finding; findings; ordinal; past; patient health questionnaire; ql; qual; qualitative; screen; survey; survey.phq,Ord
69683-1,"feeling nervous, anxious, on edge, or worrying a lot about different things in last 4 weeks [reported.phq]",,,"4 weeks; finding; findings; nervous, anxious, on edge, last 4w; ordinal; past; patient health questionnaire; ql; qual; qualitative; screen; survey; survey.phq",Ord
6969-0,myeloperoxidase ab [units/volume] in serum,myeloperoxidase ab ser-acnc,myeloperoxidase ab qn (s),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; mpo; mpo - anca; myeloperoxidase anca; p-anca; point in time; qnt; quan; quant; quantitative; random; serology; serum; sr; universallaborders; vasculitis,Qn
69715-1,were you afraid you were dying [reported.phq],,,finding; findings; ordinal; patient health questionnaire; point in time; ql; qual; qualitative; random; screen; survey; survey.phq,Ord
69719-3,fda product label health claim section,fda label health claim,,document.ref; fda label; narrative; report,Nar
69721-9,do you ever drink alcohol - including beer or wine [reported.phq],,,alc; alcoholic; drink alcohol beer or wine; finding; findings; ordinal; patient health questionnaire; point in time; ql; qual; qualitative; random; screen; survey; survey.phq,Ord
69725-0,"feeling nervous, anxious or on edge in last 2 weeks",,,14 days; 2 weeks; finding; findings; nervous anxious on edge last 2w; ordinal; past; patient health questionnaire; ql; qual; qualitative; screen; survey; survey.phq,Ord
69735-9,being so restless that it is hard to sit still in last 2 weeks [reported.phq],,,14 days; 2 weeks; finding; findings; ordinal; past; patient health questionnaire; ql; qual; qualitative; screen; so restless hard to sit still last 2w; survey; survey.phq,Ord
6974-0,zirconium [mass/volume] in specimen,zirconium spec-mcnc,zirconium (specimen) [mass/vol],drug/toxicology; drugs; level; mass concentration; misc; miscellaneous; other; point in time; qnt; quan; quant; quantitative; random; spec; to be specified in another part of the message; unspecified,Qn
69748-2,deprecated known allergies to food or environmental agents narrative nemsis,deprecated allergies to food environment,,allergies to food environment; finding; findings; narrative; national ems information services; point in time; random; report,Nar
69758-1,fda package insert diagram of device,fda insert diagram of device,,document.ref; fda insert; narrative; report; spl; structured product labelling,Nar
69773-0,dicarboxyoleylcarnitine (c18:1-dc) [moles/volume] in urine,dicarboxyoleylcarn ur-scnc,c18:1-dc (u) [moles/vol],c18:1dc; c18:1-dc; chemistry; dicarboxylic carnitine; dicarboxyoleoylcarnitine; i; level; octadecenediolcarnitine; point in time; qnt; quan; quant; quantitative; random; substance concentration; ua; ur; urn,Qn
69780-5,2-hydroxyisovalerate [moles/volume] in cerebral spinal fluid,2oh-isovalerate csf-scnc,2-hydroxyisovalerate (csf) [moles/vol],2-hia; 2-hydroxy-isovalerate; 2-hydroxyisovaleric acid; 2oh-isovalerate; cerebral spinal fluid; cerebrospinal fl; chemistry; ii; level; point in time; qnt; quan; quant; quantitative; random; spinal fl; spinal fld; spinal flu; spinal fluid; substance concentration,Qn
6978-1,amphotericin b [susceptibility] by gradient strip,amphotericin b islt grad strip,amphotericin b strip [susc],antibiotic susceptibilities; ast; epsilometer; estrip; e-strip; fungizone; grad strip; id; infectious disease; infectiousdisease; islt; isol; mic; minimum inhibitory concentration; point in time; random; sus; suscept; susceptibilities; susceptibility; susceptibilty,OrdQn
69781-3,2-hydroxyisovalerate [moles/volume] in serum or plasma,2oh-isovalerate serpl-scnc,2-hydroxyisovalerate [moles/vol],2-hia; 2-hydroxy-isovalerate; 2-hydroxyisovaleric acid; 2oh-isovalerate; chemistry; ii; level; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; substance concentration,Qn
69787-0,2-methylacetoacetate [moles/volume] in serum or plasma,2-methylacetoacetate serpl-scnc,2-methylacetoacetate [moles/vol],2-methylacetoacetic acid; chemistry; ii; level; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; substance concentration,Qn
69788-8,2-methyl-3-hydroxybutyrate (c5-oh) [moles/volume] in cerebral spinal fluid,2me3oh-butyrate csf-scnc,2-methyl-3-hydroxybutyrate (c5-oh) (csf) [moles/vol],"2me3oh-butyrate; 2-methyl,3-hydroxy butyrate; 2-methyl,3-hydroxybutyric acid; 2-methyl-3-hydroxybutyrate; 3-hydroxy-2-methylbutanoate; 3-hydroxy-2-methylbutanoic acid; 3-hydroxy-2-methylbutyrate; 3-hydroxy-2-methyl-butyrate; 3-hydroxy-2-methylbutyric acid; 3-hydroxy-2-methyl-butyric acid; alpha-methyl-beta-hydroxybutyrate; alpha-methyl-beta-hydroxybutyric acid; c5oh; c5-oh; cerebral spinal fluid; cerebrospinal fl; chemistry; hmba; hydroxybutyric acid; ii; iii; level; point in time; qnt; quan; quant; quantitative; random; spinal fl; spinal fld; spinal flu; spinal fluid; substance concentration",Qn
69801-9,2-oxoadipate [moles/volume] in cerebral spinal fluid,2-oxoadipate csf-scnc,2-oxoadipate (csf) [moles/vol],2-oxoadipic acid; alpha ketoadipate; alpha ketoadipic acid; cerebral spinal fluid; cerebrospinal fl; chemistry; ii; level; oxoadipate; point in time; qnt; quan; quant; quantitative; random; spinal fl; spinal fld; spinal flu; spinal fluid; substance concentration,Qn
69816-7,2-dechloroethylifosfamide [mass/volume] in 24 hour urine --4 days post dose ifosfamide,2-dce-if 4d p iff 24h ur-mcnc,2-dechloroethylifosfamide 4 days post dose ifosfamide (24h u) [mass/vol],1 day; 24 hours; 24hr; 2-dce-if; 2-dechloroethyl-ifosfaminde; 2d-ifo; 2d-ifosfamide; 4d p iff; after; drug/toxicology; drugs; ifex; iff; ifosfamide metabolite; ii; level; mass concentration; mitoxana; p dose; p iff; pst; qnt; quan; quant; quantitative; ua; ur; urn,Qn
6982-3,aztreonam [susceptibility] by gradient strip,aztreonam islt grad strip,aztreonam strip [susc],antibiotic susceptibilities; ast; azactam; azaj; azthreonam; epsilometer; estrip; e-strip; grad strip; id; infectious disease; infectiousdisease; islt; isol; mic; minimum inhibitory concentration; point in time; random; sus; suscept; susceptibilities; susceptibility; susceptibilty,OrdQn
69823-3,2-dechloroethylifosfamide [mass/time] in 24 hour urine --7 days post dose ifosfamide,2-dce-if 7d p iff 24h ur-mrate,2-dechloroethylifosfamide 7 days post dose ifosfamide (24h u) [mass/time],1 day; 24 hours; 24hr; 2-dce-if; 2-dechloroethyl-ifosfaminde; 2d-ifo; 2d-ifosfamide; 7d p iff; after; drug/toxicology; drugs; ifex; iff; ifosfamide metabolite; ii; mass rate; mitoxana; mrate; p dose; p iff; pst; qnt; quan; quant; quantitative; ua; ur; urn,Qn
69826-6,2-ethylhydracrylate [moles/volume] in serum or plasma,2-ethylhydracrylate serpl-scnc,2-ethylhydracrylate [moles/vol],2-eha; 2-ethyl-3-hydroxypropionate; 2-ethyl-3-hydroxypropionic acid; chemistry; ethyl lactate; ii; level; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; substance concentration,Qn
69839-9,2-hydroxy-3-methylvalerate [moles/volume] in serum or plasma,2oh3me-valerate serpl-scnc,2-hydroxy-3-methylvalerate [moles/vol],2-hydroxy-3-methyl valerate; 2-hydroxy-3-methylvaleric acid; 2oh3me-valerate; chemistry; hmva; hydrox; ii; iii; level; oh; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; substance concentration,Qn
69844-9,2-hydroxyglutarate [moles/volume] in cerebral spinal fluid,2oh-gluterate csf-scnc,2-hydroxyglutarate (csf) [moles/vol],2-hydroxy-glutarate; 2-hydroxyglutaric acid; 2oh-gluterate; alpha-hydroxyglutarate; alpha-hydroxyglutaric acid; cerebral spinal fluid; cerebrospinal fl; chemistry; ii; level; point in time; qnt; quan; quant; quantitative; random; spinal fl; spinal fld; spinal flu; spinal fluid; substance concentration,Qn
69849-8,2-hydroxyisocaproate [moles/volume] in serum or plasma,2oh-isocaproate serpl-scnc,2-hydroxyisocaproate [moles/vol],2-hydroxy-4-methylpentanoate; 2-hydroxy-4-methylpentanoic acid; 2-hydroxy-isocaproate; 2-hydroxyisocaproic acid; 2oh-isocaproate; alpha-hydroxyisocaproic acid; chemistry; ii; level; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; substance concentration,Qn
69858-9,"because of a physical, mental, or emotional condition, do you have serious difficulty concentrating, remembering, or making decisions",,,difficulty concentrating remembering making decisions; finding; findings; ordinal; point in time; ql; qual; qualitative; random; screen; survey; survey.hhs,Ord
69875-3,service comment 48,service cmnt 48-imp,service comment 48 [interp],cmmt; cmnt; com; comm; comment; comments; commt; impression; impression/interpretation of study; impressions; interp; interpretation; misc; miscellaneous; nominal; other; point in time; random; remarks; service cmnt; service cmnt 48; spec; to be specified in another part of the message; unspecified,Nom
69884-5,service comment 57,service cmnt 57-imp,service comment 57 [interp],cmmt; cmnt; com; comm; comment; comments; commt; impression; impression/interpretation of study; impressions; interp; interpretation; misc; miscellaneous; nominal; other; point in time; random; remarks; service cmnt; service cmnt 57; spec; to be specified in another part of the message; unspecified,Nom
69902-5,service comment 75,service cmnt 75-imp,service comment 75 [interp],cmmt; cmnt; com; comm; comment; comments; commt; impression; impression/interpretation of study; impressions; interp; interpretation; misc; miscellaneous; nominal; other; point in time; random; remarks; service cmnt; service cmnt 75; spec; to be specified in another part of the message; unspecified,Nom
69904-1,service comment 77,service cmnt 77-imp,service comment 77 [interp],cmmt; cmnt; com; comm; comment; comments; commt; impression; impression/interpretation of study; impressions; interp; interpretation; misc; miscellaneous; nominal; other; point in time; random; remarks; service cmnt; service cmnt 77; spec; to be specified in another part of the message; unspecified,Nom
69905-8,service comment 78,service cmnt 78-imp,service comment 78 [interp],cmmt; cmnt; com; comm; comment; comments; commt; impression; impression/interpretation of study; impressions; interp; interpretation; misc; miscellaneous; nominal; other; point in time; random; remarks; service cmnt; service cmnt 78; spec; to be specified in another part of the message; unspecified,Nom
69913-2,basophils+mast cells/leukocytes in cerebral spinal fluid,basophils/masts nfr csf,basophils+mast cells/leukocytes (csf),baso; basophil; basophils/masts; basos; bph; cell; cellularity; cerebral spinal fluid; cerebrospinal fl; hematology/cell counts; leuc; leuk; leukocyte; lkcs; masts; number fraction; percent; point in time; qnt; quan; quant; quantitative; random; spinal fl; spinal fld; spinal flu; spinal fluid; wbc; wbcs; white blood cell; white blood cells,Qn
69921-5,herpes simplex virus 1 igm ab [presence] in cerebral spinal fluid by immunoassay,hsv1 igm csf ql ia,hsv 1 igm ia ql (csf),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; cerebral spinal fluid; cerebrospinal fl; eia; elfa; elisa; enzyme immunoassay; herp splx; herpes simplex virus 1 ab; herpes simplex virus 1 antibody; herpes simplex virus 1 igm; herpes simplex virus type 1; herpes simplex virus type i; hsv; hsv1; i; iaa; id; immune globulin m; immunoglobulin m; infectious disease; infectiousdisease; meia; microbiology; neuro; neurology; ordinal; point in time; pr; ql; qual; qualitative; random; screen; spinal fl; spinal fld; spinal flu; spinal fluid; suds,Ord
69922-3,food allergen mix fx73 (beef+chicken+pork) ige ab [units/volume] in serum by multidisk,food allergen mix fx73 ige qn,beef+chicken+pork ige multidisk qn (s),abs; aby; allergen; allergens; allergy testing; allerscan; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; bos spp; f026; f027; f083; f26; f27; f83; food allergen mix fx73; fx73; gallus spp; immune globulin e; immunoglobulin e; pig; point in time; porcine; qnt; quan; quant; quantitative; random; serum; sr; sus spp; swine,Qn
69928-0,european tick borne encephalitis virus igg ab index [units/volume] in serum and csf by immunoassay,tbev igg index ser+csf ia-acnc,european tick borne encephalitis virus igg index ia qn (s+csf),abs; aby; ai; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; both serum and cerebrospinal fluid; cerebral spinal fluid; cerebrospinal fl; eia; elfa; elisa; enc; enceph; encephalomyelitis; enzyme immunoassay; fsme; iaa; id; immune globulin g; immunoglobulin g; infectious disease; infectiousdisease; meia; microbiology; point in time; qnt; quan; quant; quantitative; random; serum; spinal fl; spinal fld; spinal flu; spinal fluid; sr; suds; tbev; tbev ab,Qn
69929-8,respiratory syncytial virus iga ab [presence] in serum by immunoassay,rsv iga ser ql ia,rsv iga ia ql (s),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; eia; elfa; elisa; enzyme immunoassay; hrsv; iaa; id; immune globulin a; immunoglobulin a; infectious disease; infectiousdisease; meia; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; rsv; screen; serum; sr; suds,Ord
69938-9,astrovirus rna [presence] in specimen by naa with probe detection,hastv rna spec ql naa+probe,astrovirus rna naa+probe ql (specimen),3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; astro virus; dna nucleic acid probe; dna probe; hastv; id; infectious disease; infectiousdisease; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; misc; miscellaneous; naa+probe; naat; nasba; nucleic acid sequence based analysis; ordinal; other; pcr; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; ribonucleic acid; screen; sda; spec; strand displacement amplification; tma; to be specified in another part of the message; transcription mediated amplification; unspecified,Ord
69947-0,triglyceride [moles/volume] in pericardial fluid,trigl pcar-scnc,triglyceride (pericard fld) [moles/vol],cardio; cardiology; chemistry; heart disease; level; pcar; pericardial fluid; point in time; qnt; quan; quant; quantitative; random; substance concentration; tg; trig; trigly; triglycerides; triglycrides,Qn
69955-3,intestinal goblet cell ab [presence] in serum by immunoassay,intestinal goblet cell ab ser ql ia,intestinal goblet cell ab ia ql (s),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; eia; elfa; elisa; enzyme immunoassay; iaa; intest; intestine; meia; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serology; serum; sr; suds,Ord
69960-3,grass allergen mix 4 (sweet vernal grass+velvet grass+perennial rye grass+common reed+rye) ige ab [units/volume] in serum by multidisk,grass allerg mix4 ige qn,sweet vernal grass+velvet grass+perennial rye grass+common reed+rye ige multidisk qn (s),abs; aby; allergen; allergens; allergy testing; allerscan; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; common reed; common reed grass; f005; f5; g001; g005; g007; g013; g1; g13; g5; g7; gp4; grass allerg mix4; gx4; immune globulin e; immunoglobulin e; italian ryegrass; per rye grass; perennial ryegrass; point in time; qnt; quan; quant; quantitative; random; rye; rye grass; ryegrass; serum; sr; sw vernal grass; sweet vernal grass; velvet grass; yorkshire fog,Qn
69973-6,fef 25-75% --post bronchodilation,fef 25-75% p bd,,after; breathing; dynamic; exp; fef 25-75%; flow; forced expiratory flow rate; gases; lung; lungs; p bd; point in time; pst; pulmonary; pulmonology; qnt; quan; quant; quantitative; random; respiratory; rs; volume rate; vrate,Qn
7000-3,cephalothin [susceptibility] by gradient strip,cephalothin islt grad strip,cephalothin strip [susc],antibiotic susceptibilities; ast; cefalotin; cephalotin; ceporacin; cepovenin; epsilometer; estrip; e-strip; grad strip; id; infectious disease; infectiousdisease; islt; isol; keflin; mic; minimum inhibitory concentration; point in time; random; sus; suscept; susceptibilities; susceptibility; susceptibilty,OrdQn
70006-2,medication management note,med mgmt note,,doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; med mgmt note; notes; point in time; random; visit note,Doc
70007-0,restraint note,restraint note,,doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; notes; point in time; random; visit note,Doc
70015-3,streptococcus sp dna [presence] in blood by naa with probe detection,streptococcus dna bld ql naa+probe,streptococcus sp dna naa+probe ql (bld),3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; blood; deoxyribonucleic acid; dna nucleic acid probe; dna probe; id; infectious disease; infectiousdisease; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; naa+probe; naat; nasba; nucleic acid sequence based analysis; ordinal; pcr; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; screen; sda; species; spp; strand displacement amplification; strep; strept; tma; transcription mediated amplification; wb; whole blood,Ord
70024-5,candida parapsilosis dna [presence] in blood by naa with probe detection,c parap dna bld ql naa+probe,c. parapsilosis dna naa+probe ql (bld),3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; blood; c parap; cand; candidiasis; deoxyribonucleic acid; dna nucleic acid probe; dna probe; id; infectious disease; infectiousdisease; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; naa+probe; naat; nasba; nucleic acid sequence based analysis; ordinal; pcr; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; screen; sda; strand displacement amplification; tma; transcription mediated amplification; wb; whole blood,Ord
70035-1,siderophages/leukocytes in cerebral spinal fluid by manual count,siderophages nfr csf manual,siderophages/leukocytes manual cnt (csf),cerebral spinal fluid; cerebrospinal fl; hematology/cell counts; leuc; leuk; leukocyte; lkcs; manl; number fraction; percent; point in time; qnt; quan; quant; quantitative; random; spinal fl; spinal fld; spinal flu; spinal fluid; wbc; wbcs; white blood cell; white blood cells,Qn
70036-9,granulocytes/leukocytes in pericardial fluid by automated count,granulocytes nfr pcar auto,granulocytes/leukocytes auto (pericard fld),auto; automated detection; cardio; cardiology; elec; elect; electr; gran; grans; granulocyte; granulocytes; heart disease; hematology/cell counts; leuc; leuk; leukocyte; lkcs; number fraction; pcar; percent; pericardial fluid; point in time; qnt; quan; quant; quantitative; random; wbc; wbcs; white blood cell; white blood cells,Qn
70038-5,mononuclear cells/leukocytes in peritoneal fluid by automated count,mononuc cells nfr prt auto,mononuclear cells/leukocytes auto (periton fld),ascites; ascitic fluid; ascitis; auto; automated detection; cell; cellularity; elec; elect; electr; hematology/cell counts; leuc; leuk; leukocyte; lkcs; mononuc; mononuc cells; number fraction; percent; peritoneal fluid; point in time; prt; qnt; quan; quant; quantitative; random; wbc; wbcs; white blood cell; white blood cells,Qn
70068-2,streptococcus dysgalactiae subspecies equisimilis dna [presence] in specimen by naa with probe detection,s dysgal eqsmls dna spec ql naa+probe,s. dysgalactiae subspecies equisimilis dna naa+probe ql (specimen),3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; deoxyribonucleic acid; dna nucleic acid probe; dna probe; id; infectious disease; infectiousdisease; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; misc; miscellaneous; naa+probe; naat; nasba; nucleic acid sequence based analysis; ordinal; other; pcr; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; s dysgal eqsmls; s dysgal eqsmls dna; s dysgalactiae; s dysgalactiae ssp equisimilis; s dysgalactiae subsp equisimilis; screen; sda; sdse; ssp; strand displacement amplification; strep; strep dysgalactiae; strept; tma; to be specified in another part of the message; transcription mediated amplification; unspecified,Ord
70075-7,interleukin 1 alpha [mass/volume] in cerebral spinal fluid,il1alpha csf-mcnc,interleukin 1 alpha (csf) [mass/vol],alfa; cerebral spinal fluid; cerebrospinal fl; cg antigen-specific helper factor; chemistry; epidermal cell derived thymocyte-activating factor; etaf; i; il; il1; il-1; il-1a; il1alpha; il-1; level; lymphocyte-activating factor; lymphocyte-stimulating hormone; macrophage cell factor; mass concentration; point in time; qnt; quan; quant; quantitative; random; spinal fl; spinal fld; spinal flu; spinal fluid; t helper factor,Qn
7007-8,dirithromycin [susceptibility] by gradient strip,dirithromycin islt grad strip,dirithromycin strip [susc],antibiotic susceptibilities; ast; dynabac; epsilometer; estrip; e-strip; grad strip; id; infectious disease; infectiousdisease; islt; isol; mic; minimum inhibitory concentration; point in time; random; sus; suscept; susceptibilities; susceptibility; susceptibilty,OrdQn
70078-1,interleukin 2 [mass/volume] in body fluid,il2 fld-mcnc,interleukin 2 (body fld) [mass/vol],"b/f; bf; bod; bodies; body fluid; body fluid, unsp; chemistry; costimulator; fl; fld; flu; fluid; ii; il; il2; il-2; level; lymphocyte mitogenic factor; mass concentration; point in time; qnt; quan; quant; quantitative; random; t-cell growth factor; t-cell stimulating factor; tcgf; thymocyte stimulating factor",Qn
70092-2,prostaglandin e1 [mass/volume] in body fluid,prostaglandin e1 fld-mcnc,prostaglandin e1 (body fld) [mass/vol],"alprostadil; b/f; bf; bod; bodies; body fluid; body fluid, unsp; chemistry; fl; fld; flu; fluid; level; mass concentration; pg; pge1; point in time; qnt; quan; quant; quantitative; random",Qn
70100-3,methotrexate [moles/volume] in serum or plasma --3rd specimen,mtx sp3 serpl-scnc,methotrexate spec 3 [moles/vol],amethoperin; amethopterin; drug/toxicology; drugs; level; methotrexat; mtx; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sp3; spec; sr; substance concentration,Qn
70123-5,epithelial cells.ciliated [presence] in body fluid,ciliated fld ql,epithelial cells.ciliated ql (body fld),"b/f; bf; bod; bodies; body fluid; body fluid, unsp; cell; cellularity; epi; epi cells; epith; epithelia; fl; fld; flu; fluid; hematology/cell counts; ordinal; point in time; pr; ql; qual; qualitative; random; screen",Ord
70135-9,rickettsia spotted fever group igm ab [titer] in serum by immunofluorescence --1st specimen,rick sf igm sp1 titr ser if,r. spotted fever group igm spec 1 if (s) [titer],abs; aby; acif; acute specimen; antby; anti; antibodies; antibody; anticomplement immunofluorescence; autoantibodies; autoantibody; dilution factor; dilution factor (titer); fa; first; fluorescent antibody; fluoresent; id; ifa; immune fluorescence; immune globulin m; immunoflour; immunofluor; immunofluorescence; immunoglobulin m; infectious disease; infectiousdisease; microbiology; point in time; pre immunization; random; rick sf; ricket; rickettsial; serum; smqn; sp1; spec; sr; time resolved fluorescence; titer; titered; titre; trf; ttr,SemiQn
70138-3,amphetamines [mass/volume] in urine by screen method,amphetamines ur scn-mcnc,amphetamines screen (u) [mass/vol],addiction; amph; amphetam; amphetamine; drug/toxicology; drugs; drugs of abuse; illicit; level; mass concentration; point in time; potentialforabuse; qnt; quan; quant; quantitative; random; scn; scr; scrn; speed; ua; ur; urn,Qn
70145-8,cannabinoids [presence] in urine by screen method >50 ng/ml,cannabinoids ur ql scn>50 ng/ml,cannabinoids screen method >50 ng/ml ql (u),addiction; cannabinoid; delta-9-tetrahydrocannabinol; drug/toxicology; drugs; drugs of abuse; illicit; marijuana; nasogastric; ordinal; point in time; potentialforabuse; pr; ql; qual; qualitative; random; scn; scn&gt;50 ng/ml; scr; screen; scrn; thc; ua; universallaborders; ur; urn,Ord
70153-2,sample hemolyzed [presence] of cerebral spinal fluid qualitative,sample hemolyzed csf ql,sample hemolyzed ql (csf),cerebral spinal fluid; cerebrospinal fl; ordinal; point in time; pr; ql; qual; qualitative; random; screen; spec; spinal fl; spinal fld; spinal flu; spinal fluid,Ord
70156-5,"inv(16)(p13.1;q22.1)(myh11,cbfb) fusion transcript/control transcript [log number ratio] in blood or tissue",inv(16)(p13;q22)/control bld/t-lnrto,"inv(16)(p13.1;q22.1)(myh11,cbfb) fusion transcript/control transcript (bld/tiss) [log # ratio]","abl; abl1; abl1 transcript; acute myeloid leukemia; aml; blood; control gene; dna; gene fusion; gene translocation; genetics; heredity; heritable; inherited; inv(16)(cbfb,myh11) gene inversion; inv(16)(p13;q22); inversion 16; log nrto; log number ratio; molecular pathology; molpath; molpath.translocation; point in time; qnt; quan; quant; quantitative; random; rna; tissue; tissue, unspecified; translocation; wb; whole blood; whole blood or tissue",Qn
70165-6,trichomonas vaginalis rrna [presence] in vaginal fluid by naa with probe detection,t vaginalis rrna vag ql naa+probe,t. vaginalis rrna naa+probe ql (vag fld),3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; dna nucleic acid probe; dna probe; genital vaginal; gen-probe; gyn; gynecology; id; infectious disease; infectiousdisease; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; naa+probe; naat; nasba; nucleic acid sequence based analysis; ob; obgyn; obstetrics; ordinal; pcr; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; ribosomal rna; screen; sda; strand displacement amplification; t vaginalis; tma; transcription mediated amplification; tric; trich; trichimoniasis; trichomonad; trichomonads; trichomoniasis; vag fld; vag fluid; vagina; vaginal fluid,Ord
70170-6,nucleated erythrocytes/cells in pleural fluid,nrbc nfr plr,nucleated rbc/cells (pleur fld),cell; cellularity; discocytes; erthrocyte; erythroblasts; erythrocyte; hematology/cell counts; normoblasts; nrbc; nrbcs; nuc; nuc cell; number fraction; percent; pleural; pleural fluid; point in time; qnt; quan; quant; quantitative; random; rbc; rbcs; red blood cell; red blood cells; red blood corpuscle; red blood corpusles; red cell; red cells; thoracentesis fluid,Qn
70171-4,nucleated erythrocytes/cells in peritoneal fluid,nrbc nfr prt,nucleated rbc/cells (periton fld),ascites; ascitic fluid; ascitis; cell; cellularity; discocytes; erthrocyte; erythroblasts; erythrocyte; hematology/cell counts; normoblasts; nrbc; nrbcs; nuc; nuc cell; number fraction; percent; peritoneal fluid; point in time; prt; qnt; quan; quant; quantitative; random; rbc; rbcs; red blood cell; red blood cells; red blood corpuscle; red blood corpusles; red cell; red cells,Qn
70178-9,11-hydroxy delta-9 tetrahydrocannabinol [presence] in blood,11oh-thc bld ql,11-hydroxy delta-9 tetrahydrocannabinol ql (bld),11-hydroxy-delta(9)-thc; 11-hydroxytetrahydrocannabinol; 11-hydroxy-thc; 11-oh-thc; 11oh-thc; 7-hydroxy-delta(1)-tetrahydrocannabinol; blood; delta(9)-thc; delta-9-tetrahydrocannabinol; delta-9-tetrahydrocannabinol metabolite; dronabinol; drug/toxicology; drugs; hydrox; marijuana; nabilone; oh; ordinal; point in time; pr; ql; qual; qualitative; random; screen; thc; thc metabolite; wb; whole blood,Ord
70184-7,level of consciousness [nih stroke scale],,,finding; findings; levels; levl; lv; lvl; neuro; ordinal; point in time; ql; qual; qualitative; random; screen; survey; survey.neuro,Ord
70189-6,facial palsy [nih stroke scale],,,finding; findings; neuro; ordinal; point in time; ql; qual; qualitative; random; screen; survey; survey.neuro,Ord
70203-5,cholesterol in vldl 3 [moles/volume] in serum or plasma,vldl3c serpl-scnc,cholesterol in vldl 3 [moles/vol],cardio; cardiology; chemistry; chol; choles; cholest; cholesterol total; cholesterols; heart disease; iii; level; lipid; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; substance concentration; very low density lipoprotein cholesterols; vldl3c; vldlc,Qn
70220-9,"repeated disturbing memories, thoughts, or images of a stressful experience from the past in the last month [pcl-c]",,,1 month; 1 month (30 days); 30 days; finding; findings; last; month; ordinal; past; post traumatic stress disorder (ptsd) checklist - civilian version; ql; qual; qualitative; screen; survey; survey.mtlhlth,Ord
70227-4,[pcl-c],,,1 month; 1 month (30 days); 30 days; finding; findings; last; month; ordinal; past; post traumatic stress disorder (ptsd) checklist - civilian version; ql; qual; qualitative; screen; survey; survey.mtlhlth,Ord
70236-5,being super alert or watchful on guard in the last month [pcl-c],,,1 month; 1 month (30 days); 30 days; finding; findings; month; ordinal; past; post traumatic stress disorder (ptsd) checklist - civilian version; ql; qual; qualitative; screen; survey; survey.mtlhlth,Ord
70253-0,islet cell 512 igg ab [units/volume] in serum or plasma by immunoassay,islet cell512 igg serpl ia-acnc,islet cell 512 igg ia qn,abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; eia; elfa; elisa; endocrine; endocrinology; enzyme immunoassay; ia2; ia-2; ia2-ab; iaa; ica; ica512; ica-512; immune globulin g; immunoglobulin g; islet cell512; meia; pl; plasma; plsm; point in time; protein tyrosine phosphatase-like protein ia2; ptp-ia2; qnt; quan; quant; quantitative; random; serology; serp; serpl; serplas; serum; serum or plasma; sr; suds; tyrosine phosphatase,Qn
70257-1,sjogrens syndrome-a extractable nuclear 52kd igg ab [units/volume] in serum by immunoassay,ena ss-a 52kd igg ser ia-acnc,sjogrens syndrome-a extractable nuclear 52kd igg ia qn (s),abs; aby; ana igg; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; eia; elfa; elisa; ena; ena ss-a; ena ss-a 52kd; enzyme immunoassay; iaa; immune globulin g; immunoglobulin g; meia; nuc; point in time; qnt; quan; quant; quantitative; random; ro; ro ab; serology; serum; sjogren; sr; ss; ssa; ss-a; suds,Qn
70263-9,cholesterol in pericardial fluid/cholesterol in serum,chol pcar/ser,cholesterol in pericardial fluid/cholesterol in serum (pericard fld+s/p) [relative ratio],cardio; cardiology; chemistry; chol; chol pcar; choles; cholest; cholesterol total; cholesterols; heart disease; lipid; pcar; pericard fld+serpl; pericardial fluid; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; relative ratio; ser; serp; serpl; serplas; serum; serum or plasma; sr,Qn
70278-7,"t(3;21)(q26;q22.3)(mecom,runx1) fusion transcript [presence] in blood or tissue by molecular genetics method","t(3;21)(mecom,runx1) bld/t ql","t(3;21)(q26;q22.3)(mecom,runx1) fusion transcript molgen ql (bld/tiss)","21q22.3; acute myeloid leukemia 1; aml1; arbitrary; blood; cbfa2; dna; gene fusion; gene translocation; genetics; heredity; heritable; iii; inherited; molecular genetics; molecular pathology; molpath; molpath.translocation; ordinal; pcr; point in time; ql; qual; qualitative; random; rna; screen; t prime; t(3;21)(mecom,runx1); tissue; tissue, unspecified; translocation; wb; whole blood; whole blood or tissue",Ord
7028-4,amdinocillin [susceptibility] by gradient strip,amdinocillin islt grad strip,amdinocillin strip [susc],amdinocillin pivoxil; antibiotic susceptibilities; ast; epsilometer; estrip; e-strip; grad strip; id; infectious disease; infectiousdisease; islt; isol; mecillinam; mic; minimum inhibitory concentration; pivmecilliam; point in time; random; selexid; sus; suscept; susceptibilities; susceptibility; susceptibilty,OrdQn
70297-7,esrd patient information panel,,,end stage renal disease; end stage renal disease (esdr) pnl; esrd; esrd survey; pan; panl; pnl; point in time; pt info panel; random; survey,-
70298-5,esrd mineral metabolism panel,,,end stage renal disease; end stage renal disease (esdr) pnl; esrd survey; mineral metabolism pnl; pan; panl; pnl; point in time; random; survey,-
70303-3,i need help doing my usual activities in the past 7 days [facit],,,finding; findings; functional assessment of chronic illness therapy; help doing my activities past 7d; last; ordinal; ql; qual; qualitative; screen; survey; survey.gnhlth,Ord
70319-9,i have emotional ups and downs in the past 7 days [facit],,,emotional ups and downs past 7d; finding; findings; functional assessment of chronic illness therapy; last; ordinal; ql; qual; qualitative; screen; survey; survey.gnhlth,Ord
70325-6,i am able to make decisions and take responsibility in the past 7 days [facit],,,able to make decisions past 7d; finding; findings; functional assessment of chronic illness therapy; last; ordinal; ql; qual; qualitative; screen; survey; survey.gnhlth,Ord
70328-0,"i need help caring for myself - bathing, dressing, eating, etc in the past 7 days [facit]",,,finding; findings; functional assessment of chronic illness therapy; last; need help caring for self past 7d; ordinal; ql; qual; qualitative; screen; survey; survey.gnhlth,Ord
70329-8,i am able to put my thoughts into action in the past 7 days [facit],,,able to put thoughts into action past 7d; finding; findings; functional assessment of chronic illness therapy; last; ordinal; ql; qual; qualitative; screen; survey; survey.gnhlth,Ord
70354-6,i am able to maintain my balance in the past 7 days [facit],,,able to maintain balance past 7d; bal; finding; findings; functional assessment of chronic illness therapy; last; ordinal; ql; qual; qualitative; screen; survey; survey.gnhlth,Ord
70355-3,i am able to walk in the past 7 days [facit],,,finding; findings; functional assessment of chronic illness therapy; i am able to walk in past 7d; last; ordinal; ql; qual; qualitative; screen; survey; survey.gnhlth,Ord
7035-9,netilmicin [susceptibility] by gradient strip,netilmicin islt grad strip,netilmicin strip [susc],antibiotic susceptibilities; ast; epsilometer; estrip; e-strip; grad strip; id; infectious disease; infectiousdisease; islt; isol; mic; minimum inhibitory concentration; netilimicin; netromycin; point in time; random; sus; suscept; susceptibilities; susceptibility; susceptibilty,OrdQn
70359-5,i have pain in my back in the past 7 days [facit],,,finding; findings; functional assessment of chronic illness therapy; last; ordinal; pain in back past 7d; ql; qual; qualitative; screen; survey; survey.gnhlth,Ord
70379-3,i have night sweats in the past 7 days [facit],,,finding; findings; functional assessment of chronic illness therapy; last; night sweats past 7d; ordinal; ql; qual; qualitative; screen; survey; survey.gnhlth,Ord
70388-4,i am bothered by a change in my eating habits in the past 7 days [facit],,,bothered by chg eating habits past 7d; exchange; finding; findings; functional assessment of chronic illness therapy; last; ordinal; ql; qual; qualitative; replace; screen; survey; survey.gnhlth,Ord
70395-9,i feel nervous in the past 7 days [facit],,,finding; findings; functional assessment of chronic illness therapy; last; ordinal; ql; qual; qualitative; screen; survey; survey.gnhlth,Ord
70416-3,i am satisfied with family communication about my illness in the past 7 days [facit],,,finding; findings; functional assessment of chronic illness therapy; last; ordinal; ql; qual; qualitative; satisfied w family commun about illness past 7d; screen; survey; survey.gnhlth,Ord
70427-0,i am able to eat the foods that i like in the past 7 days [facit],,,able to eat foods i like past 7d; finding; findings; functional assessment of chronic illness therapy; last; ordinal; ql; qual; qualitative; screen; survey; survey.gnhlth,Ord
70434-6,i am able to eat as much food as i want in the past 7 days [facit],,,able to eat much food as i want past 7d; arterial stenosis; finding; findings; functional assessment of chronic illness therapy; last; ordinal; ql; qual; qualitative; screen; survey; survey.gnhlth,Ord
70450-2,i feel isolated from others because of my illness or treatment in the past 7 days [facit],,,finding; findings; functional assessment of chronic illness therapy; isolated from others b/c of illness past 7d; last; ordinal; ql; qual; qualitative; screen; survey; survey.gnhlth; tx,Ord
70484-1,i bleed easily in the past 7 days [facit],,,finding; findings; functional assessment of chronic illness therapy; i bleed easily past 7d; last; ordinal; ql; qual; qualitative; screen; survey; survey.gnhlth,Ord
70502-0,additional concerns [facit],,,add; functional assessment of chronic illness therapy; pan; panel; panel.survey.gnhlth; panl; pnl; point in time; random; survey; survey.gnhlth,-
70504-6,functional assessment of chronic illness therapy (facit) - general measures panel,,,facit; facit general measures panel; pan; panel.survey.gnhlth; panl; pnl; point in time; random; survey; survey.gnhlth,-
70519-4,functional assessment of cancer therapy for patient with multiple myeloma questionnaire - version 4 (fact-mm) [facit],,,fact; fact-mm; fact-mm - version 4; functional assessment of chronic illness therapy; mult; multi; pan; panel; panel.survey.gnhlth; panl; pnl; point in time; random; survey; survey.gnhlth,-
70522-8,functional assessment of cancer therapy for patients with vulva cancer questionnaire - version 4 (fact-v) [facit],,,facit; fact; fact-v; fact-v - version 4; functional assessment of chronic illness therapy; pan; panel; panel.survey.gnhlth; panl; pnl; point in time; random; survey; survey.gnhlth,-
70523-6,functional assessment of cancer therapy - general population questionnaire - version 4 (fact-gp) [facit],,,facit; fact; fact-gp; fact-gp - version 4; functional assessment of chronic illness therapy; pan; panel; panel.survey.gnhlth; panl; pnl; point in time; random; survey; survey.gnhlth,-
70526-9,i have had itching in the past 7 days [facit],,,finding; findings; functional assessment of chronic illness therapy; last; ordinal; ql; qual; qualitative; screen; survey; survey.gnhlth,Ord
70534-3,national comprehensive cancer network - bladder symptom index questionnaire - 18 items (nccn-fblsi-18) [facit],,,facit; fact; functional assessment of chronic illness therapy; nccn; nccn - fblsi-18; nccn-fact fblsi; pan; panel; panel.survey.gnhlth; panl; pnl; point in time; random; survey; survey.gnhlth; sx,-
70539-2,functional assessment of cancer therapy - colorectal symptom index questionnaire - 9 items (fcsi-9) [facit],,,facit; fact; fcsi; fcsi-9; functional assessment of chronic illness therapy; pan; panel; panel.survey.gnhlth; panl; pnl; point in time; random; survey; survey.gnhlth; sx,-
70544-2,national comprehensive cancer network - hepatibiliary symptom index questionnaire - 18 items (nccn-fact - fhsi-18) [facit],,,facit; fact; functional assessment of chronic illness therapy; nccn; nccn-fact - fhsi-18; pan; panel; panel.survey.gnhlth; panl; pnl; point in time; random; survey; survey.gnhlth; sx,-
70545-9,functional assessment of chronic illness therapy for patients with kidney cancer questionnaire -15 items (facit - fksi-15),,,facit; facit - fksi-15; fksi-15; pan; panel; panel.survey.gnhlth; panl; pnl; point in time; random; survey; survey.gnhlth,-
70549-1,functional assessment of cancer therapy - lung symptom index questionnaire - 6 items - version 4 (fact - flsi 6) [facit],,,facit; facit - flsi 6; fact; functional assessment of chronic illness therapy; pan; panel; panel.survey.gnhlth; panl; pnl; point in time; random; survey; survey.gnhlth; sx,-
70555-8,national comprehensive cancer network - ovarian symptom index questionnaire - 18 items (nccn_fact - fosi 18) [facit],,,fact; functional assessment of chronic illness therapy; nccn; nccn-fact - fosi-18; nccn-fact fosi-18; pan; panel; panel.survey.gnhlth; panl; pnl; point in time; random; survey; survey.gnhlth; sx,-
70562-4,i have numbness or tingling in my hands in the past 7 days [facit],,,finding; findings; functional assessment of chronic illness therapy; last; numbness tingling in hands past 7d; ordinal; ql; qual; qualitative; screen; survey; survey.gnhlth,Ord
70563-2,i have pain in my hands or feet when i am exposed to cold temperatures in the past 7 days [facit],,,finding; findings; functional assessment of chronic illness therapy; last; ordinal; pain hands feet exposed to cold past 7d; ql; qual; qualitative; screen; survey; survey.gnhlth,Ord
70566-5,i have difficulty urinating in the past 7 days [facit],,,difficulty urinating past 7d; finding; findings; functional assessment of chronic illness therapy; last; ordinal; ql; qual; qualitative; screen; survey; survey.gnhlth,Ord
70570-7,i have weakness in my legs in the past 7 days [facit],,,finding; findings; functional assessment of chronic illness therapy; last; ordinal; ql; qual; qualitative; screen; survey; survey.gnhlth; weakness in legs past 7d,Ord
70574-9,i worry about side effects from treatment for bone disease [facit],,,dis; diseases; dz; finding; findings; functional assessment of chronic illness therapy; ordinal; point in time; ql; qual; qualitative; random; screen; survey; survey.gnhlth; tx; worry about side effects from tx bone disease,Ord
70580-6,i believe that my treatment schedule for bone disease will be stressful to my family [facit],,,dis; diseases; dz; finding; findings; functional assessment of chronic illness therapy; ordinal; point in time; ql; qual; qualitative; random; screen; survey; survey.gnhlth; tx; tx bone disease stressful to family,Ord
70601-0,i feel that i have lost control of my food choices because i have a feeding tube in the past 7 days [facit],,,finding; findings; functional assessment of chronic illness therapy; last; lost control food choices b/c feeding tube past 7d; ordinal; ql; qual; qualitative; screen; survey; survey.gnhlth,Ord
70607-7,my skin or scalp feels irritated in the past 7 days [facit],,,finding; findings; functional assessment of chronic illness therapy; integument; last; ordinal; ql; qual; qualitative; screen; skin scalp feels irritated past 7d; survey; survey.gnhlth,Ord
70616-8,i avoid going out in public because of how my skin looks in the past 7 days [facit],,,avoid going out public b/c skin past 7d; finding; findings; functional assessment of chronic illness therapy; integument; last; ordinal; ql; qual; qualitative; screen; survey; survey.gnhlth,Ord
70625-9,i have numbness or tingling in my feet in the past 7 days [facit],,,finding; findings; functional assessment of chronic illness therapy; last; numbness tingling feet past 7d; ordinal; ql; qual; qualitative; screen; survey; survey.gnhlth,Ord
70632-5,i have trouble walking in the past 7 days [facit],,,finding; findings; functional assessment of chronic illness therapy; last; ordinal; ql; qual; qualitative; screen; survey; survey.gnhlth; trouble walking past 7d,Ord
7064-9,white alder ige ab [units/volume] in serum,white alder ige qn,white alder ige qn (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; immune globulin e; immunoglobulin e; point in time; qnt; quan; quant; quantitative; random; serum; sr; white alder,Qn
70668-9,i am bothered by a change in the way food tastes in the past 7 days [facit],,,bothered by way food tastes past 7d; exchange; finding; findings; functional assessment of chronic illness therapy; last; ordinal; ql; qual; qualitative; replace; screen; survey; survey.gnhlth,Ord
70684-6,"when i eat, i seem to get full quickly in the past 7 days [facit]",,,finding; findings; functional assessment of chronic illness therapy; last; ordinal; ql; qual; qualitative; screen; seem to get full quickly past 7d; survey; survey.gnhlth,Ord
7069-8,allspice ige ab [units/volume] in serum,allspice ige qn,allspice ige qn (s),abs; aby; allergen; allergens; allergy testing; allspice; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; clove pepper; f310; f339; immune globulin e; immunoglobulin e; jamaica pepper; p dioica; p officinalis; pimenta officinalis; pimento; point in time; qnt; quan; quant; quantitative; random; rf339; serum; sr,Qn
70698-6,i feel that i can manage things that come up around this infection in the past 7 days [facit],,,can manage things around infection past 7d; finding; findings; functional assessment of chronic illness therapy; last; ordinal; ql; qual; qualitative; screen; survey; survey.gnhlth,Ord
70699-4,i have accepted that i have this infection in the past 7 days [facit],,,accepted that i have infection past 7d; finding; findings; functional assessment of chronic illness therapy; last; ordinal; ql; qual; qualitative; screen; survey; survey.gnhlth,Ord
70708-3,i am frustrated by the infection in the past 7 days [facit],,,finding; findings; frustrated by infection past 7d; functional assessment of chronic illness therapy; last; ordinal; ql; qual; qualitative; screen; survey; survey.gnhlth,Ord
70729-9,i have trouble finishing things because i am tired in the past 7 days [facit],,,finding; findings; functional assessment of chronic illness therapy; last; ordinal; ql; qual; qualitative; screen; survey; survey.gnhlth; trouble finishing things b/c tired past 7d,Ord
7073-0,amylase ige ab [units/volume] in serum,amylase ige qn,amylase ige qn (s),abs; aby; allergen; allergens; allergy testing; alpha amylase; ams; amyl; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; diastase; immune globulin e; immunoglobulin e; k87; point in time; qnt; quan; quant; quantitative; random; serum; sr,Qn
70738-0,i am motivated to do my usual activities in the past 7 days [facit],,,finding; findings; functional assessment of chronic illness therapy; last; motivated to do usual activities past 7d; ordinal; ql; qual; qualitative; screen; survey; survey.gnhlth,Ord
70743-0,my arm on this side feels numb in the past 7 days [facit],,,arm this side numb past 7d; finding; findings; functional assessment of chronic illness therapy; last; ordinal; ql; qual; qualitative; screen; survey; survey.gnhlth; upper extremity,Ord
70762-0,i have had trouble concentrating in the past 7 days [facit],,,finding; findings; functional assessment of chronic illness therapy; have had trouble concentrating past 7d; last; ordinal; ql; qual; qualitative; screen; survey; survey.gnhlth,Ord
70765-3,"i have had trouble remembering new information, like phone numbers or simple instructions in the past 7 days [facit]",,,finding; findings; functional assessment of chronic illness therapy; had trouble remembering new information past 7d; last; ordinal; ql; qual; qualitative; screen; survey; survey.gnhlth,Ord
70772-9,i have forgotten names of people soon after being introduced in the past 7 days [facit],,,finding; findings; forgotten names after introduced past 7d; functional assessment of chronic illness therapy; last; ordinal; ql; qual; qualitative; screen; survey; survey.gnhlth,Ord
70777-8,my thinking has been slower than usual in the past 7 days [facit],,,finding; findings; functional assessment of chronic illness therapy; last; ordinal; ql; qual; qualitative; screen; survey; survey.gnhlth; thinking slower than usual past 7d,Ord
70778-6,i have had to work harder than usual to express myself clearly in the past 7 days [facit],,,finding; findings; functional assessment of chronic illness therapy; job; last; occupation; ordinal; ql; qual; qualitative; screen; survey; survey.gnhlth; work harder express myself clearly past 7d,Ord
70784-4,other people have told me i seemed confused in the past 7 days [facit],,,finding; findings; functional assessment of chronic illness therapy; last; ordinal; others told seemed confused past 7d; othr; ql; qual; qualitative; screen; survey; survey.gnhlth,Ord
70788-5,"i have been able to remember things, like where i left my keys or wallet, in the past 7 days [facit]",,,been able to remember things past 7d; finding; findings; functional assessment of chronic illness therapy; l; last; lt; ordinal; ql; qual; qualitative; screen; survey; survey.gnhlth,Ord
70795-0,impact on quality of life [facit],,,functional assessment of chronic illness therapy; pan; panel; panel.survey.gnhlth; panl; pnl; point in time; random; survey; survey.gnhlth,-
70801-6,i have vaginal itching - irritation - in the past 7 days [facit],,,finding; findings; functional assessment of chronic illness therapy; have vaginal itching past 7d; last; ordinal; ql; qual; qualitative; screen; survey; survey.gnhlth,Ord
70806-5,i am irritable in the past 7 days [facit],,,am irritable past 7d; finding; findings; functional assessment of chronic illness therapy; last; ordinal; ql; qual; qualitative; screen; survey; survey.gnhlth,Ord
70821-4,"i avoid or limit physical activity, because of concern with bleeding or bruising, in the past 7 days [facit]",,,activ; actvty; avoid phys activity b/c bleeding bruising past 7d; finding; findings; functional assessment of chronic illness therapy; last; movements; ordinal; ql; qual; qualitative; screen; survey; survey.gnhlth,Ord
70822-2,i am frustrated by not being able to do my usual activities in the past 7 days [facit],,,finding; findings; frustrated by not able do usual activities past 7d; functional assessment of chronic illness therapy; last; ordinal; ql; qual; qualitative; screen; survey; survey.gnhlth,Ord
70827-1,i am inconvenienced by platelet transfusions in the past 7 days [facit],,,finding; findings; functional assessment of chronic illness therapy; inconvenienced by platelet transfusions past 7d; last; ordinal; pl; platelets; platelt; plt; ql; qual; qualitative; screen; survey; survey.gnhlth; thrombocyte; thrombocytes,Ord
70862-8,rabies virus igm ab [presence] in cerebral spinal fluid by immunofluorescence,rabv igm csf ql if,rabies virus igm if ql (csf),abs; aby; acif; antby; anti; antibodies; antibody; anticomplement immunofluorescence; autoantibodies; autoantibody; cerebral spinal fluid; cerebrospinal fl; fa; fluorescent antibody; fluoresent; id; ifa; immune fluorescence; immune globulin m; immunoflour; immunofluor; immunofluorescence; immunoglobulin m; infectious disease; infectiousdisease; lyssavirus; microbiology; neuro; neurology; ordinal; point in time; pr; ql; qual; qualitative; rabies; rabv; random; screen; spinal fl; spinal fld; spinal flu; spinal fluid; time resolved fluorescence; trf,Ord
70880-0,additional concerns - fact-leu [facit],,,add; functional assessment of chronic illness therapy; pan; panel; panel.survey.gnhlth; panl; pnl; point in time; random; survey; survey.gnhlth,-
70883-4,additional concerns - fact-mm [facit],,,add; functional assessment of chronic illness therapy; pan; panel; panel.survey.gnhlth; panl; pnl; point in time; random; survey; survey.gnhlth,-
70887-5,additional concerns - fact-gog-ntx [facit],,,add; functional assessment of chronic illness therapy; pan; panel; panel.survey.gnhlth; panl; pnl; point in time; random; survey; survey.gnhlth,-
70893-3,additional concerns - faact [facit],,,add; functional assessment of chronic illness therapy; pan; panel; panel.survey.gnhlth; panl; pnl; point in time; random; survey; survey.gnhlth,-
70902-2,additional concerns - fait-f [facit],,,add; functional assessment of chronic illness therapy; pan; panel; panel.survey.gnhlth; panl; pnl; point in time; random; survey; survey.gnhlth,-
70905-5,physical well-being - facit-cd [facit],,,cluster of differentiation; functional assessment of chronic illness therapy; pan; panel; panel.survey.gnhlth; panl; physical well-being; physical well-being - facit-cd; pnl; point in time; random; survey; survey.gnhlth,-
70932-9,portable xr thoracic spine single view,xr port t-spine 1v,,1v; cxr; document; dorsal spine; film; finding; findings; imaging; plain films; point in time; rad; radiology; random; single view; spinal; spinal cord; th/sp; thorax; t-spine; vw; xr port; xray; x-ray,Doc
70938-6,refractive measurements narrative,refractive measurements,,doc.misc; finding; findings; misc; narrative; point in time; random; report,Nar
70942-8,ocular alignment and motility narrative,ocular alignment and motility,,doc.misc; finding; findings; misc; mot; narrative; point in time; random; report,Nar
7095-3,arizona ash ige ab [units/volume] in serum,arizona ash ige qn,arizona ash ige qn (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; arizona ash; autoantibodies; autoantibody; immune globulin e; immunoglobulin e; point in time; qnt; quan; quant; quantitative; random; serum; sr; t33,Qn
70965-9,kt/v.hemodialysis [daugirdas ii],,,2; esrd; esrd survey; point in time; qnt; quan; quant; quantitative; random; ratios; rto; survey,Qn
70975-8,how short of breath did you get washing dishes in the past 7 days [facit],,,finding; findings; functional assessment of chronic illness therapy; last; ordinal; ql; qual; qualitative; screen; sob washing dishes past 7d; survey; survey.gnhlth,Ord
70976-6,how short of breath did you get sweeping or mopping in the past 7 days [facit],,,finding; findings; functional assessment of chronic illness therapy; last; ordinal; ql; qual; qualitative; screen; sob sweeping or mopping past 7d; survey; survey.gnhlth,Ord
70977-4,how short of breath did you get making a bed in the past 7 days [facit],,,finding; findings; functional assessment of chronic illness therapy; last; ordinal; ql; qual; qualitative; screen; sob making a bed past 7d; survey; survey.gnhlth,Ord
7097-9,deprecated ash ab.igg,deprecated ash igg qn,ash igg qn (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; immune globulin g; immunoglobulin g; point in time; qnt; quan; quant; quantitative; random; serum; sr,Qn
70979-0,"how short of breath did you get carrying something weighing 10-20 lbs, about 4.5-9kg, like a large bag of groceries, from one room to another in the past 7 days [facit]",,,finding; findings; functional assessment of chronic illness therapy; last; ordinal; ql; qual; qualitative; screen; sob carrying 10-20 lbs one room to another past 7d; survey; survey.gnhlth,Ord
70987-3,how short of breath did you get standing for at least 5 minutes in the past 7 days [facit],,,finding; findings; functional assessment of chronic illness therapy; last; ordinal; ql; qual; qualitative; screen; sob standing 5m past 7d; survey; survey.gnhlth,Ord
70989-9,"how short of breath did you get walking half a mile, almost 1 km, on flat ground at a normal speed, without stopping in the past 7 days [facit]",,,control; finding; findings; functional assessment of chronic illness therapy; i; last; ordinal; ql; qual; qualitative; screen; sob walking .5 mile normal speed w/o stopping past 7d; survey; survey.gnhlth,Ord
71006-1,how short of breath did you get scrubbing the floor or counter in the past 7 days [facit],,,finding; findings; functional assessment of chronic illness therapy; last; ordinal; ql; qual; qualitative; screen; sob scrubbing the floor past 7d; survey; survey.gnhlth,Ord
71010-3,i have family members who will take on my responsibilities in the past 7 days [facit],,,finding; findings; functional assessment of chronic illness therapy; have family members take responsibilities past 7d; last; ordinal; ql; qual; qualitative; screen; survey; survey.gnhlth; world heatlth organization,Ord
71012-9,i feel like a burden to my family in the past 7 days [facit],,,feel like burden to family past 7d; finding; findings; functional assessment of chronic illness therapy; last; ordinal; ql; qual; qualitative; screen; survey; survey.gnhlth,Ord
71014-5,i have swelling in parts of my body in the past 7 days [facit],,,bod; bodies; finding; findings; functional assessment of chronic illness therapy; i have swelling parts of body past 7d; last; ordinal; ql; qual; qualitative; screen; survey; survey.gnhlth,Ord
71015-2,my mouth and throat are dry in the past 7 days [facit],,,finding; findings; functional assessment of chronic illness therapy; last; my mouth throat are dry past 7d; ordinal; ql; qual; qualitative; screen; survey; survey.gnhlth,Ord
71022-8,i am able to openly discuss my concerns with the people closest to me in the past 7 days [facit],,,able to discuss concerns w/ people closest to me past 7d; finding; findings; functional assessment of chronic illness therapy; last; ordinal; ql; qual; qualitative; screen; survey; survey.gnhlth,Ord
71037-6,i feel connected to other people in the past 7 days [facit],,,feel connected to other people past 7d; finding; findings; functional assessment of chronic illness therapy; last; ordinal; othr; ql; qual; qualitative; screen; survey; survey.gnhlth,Ord
71039-2,i feel love for others in the past 7 days [facit],,,finding; findings; functional assessment of chronic illness therapy; last; ordinal; ql; qual; qualitative; screen; survey; survey.gnhlth,Ord
71046-7,functional assessment of chronic illness therapy - spiritual well-being - non-illness questionnaire - version 4 (facit-sp - non-illness),,,facit; facit-sp - non-illness; facit-sp - non-illness - version 4; pan; panel; panel.survey.gnhlth; panl; pnl; point in time; random; survey; survey.gnhlth,-
71062-4,would you choose this treatment again,,,finding; findings; ordinal; point in time; ql; qual; qualitative; random; screen; survey; survey.gnhlth; tx,Ord
71075-6,did your doctor-s show genuine concern for you [facit],,,drs show genuine concern for you; finding; findings; functional assessment of chronic illness therapy; ordinal; point in time; ql; qual; qualitative; random; s prime; screen; survey; survey.gnhlth,Ord
71093-9,did your doctor-s seem to respect your opinions [facit],,,drs seem to respect your opinions; finding; findings; functional assessment of chronic illness therapy; ordinal; point in time; ql; qual; qualitative; random; s prime; screen; survey; survey.gnhlth,Ord
7110-0,groundsel tree ige ab [units/volume] in serum,groundsel tree ige qn,groundsel tree ige qn (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; groundsel tree; immune globulin e; immunoglobulin e; point in time; qnt; quan; quant; quantitative; random; serum; sr; universallaborders,Qn
7111-8,bahia grass triggered histamine release [units/volume] in blood,bahia grass basobnd ab qn,bahia grass triggered histamine release qn (bld),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; associated; autoantibodies; autoantibody; bahia grass; baso; basobnd ab; basophil release; basophils; basos; blood; bnd; bph; g017; g17; leukocyte histamine reaction; leukocyte histamine release; point in time; qnt; quan; quant; quantitative; random; wb; wbc release; whole blood,Qn
71118-4,thinking and fatigue [facit],,,functional assessment of chronic illness therapy; pan; panel; panel.survey.gnhlth; panl; pnl; point in time; random; survey; survey.gnhlth,-
71124-2,difficult times have strengthened my faith or spiritual beliefs in the past 7 days [facit],,,difficult times strengthened faith past 7d; finding; findings; functional assessment of chronic illness therapy; last; ordinal; ql; qual; qualitative; screen; survey; survey.gnhlth,Ord
71133-3,functional assessment of hiv infection questionnaire - version 4 (fahi) [facit],,,aids; facit; fahi; fahi - version 4; functional assessment of chronic illness therapy; human immunodeficiency virus; pan; panel; panel.survey.gnhlth; panl; pnl; point in time; random; survey; survey.gnhlth,-
71176-2,i worry when i go back to the hospital or clinic in the past 7 days [facit],,,finding; findings; functional assessment of chronic illness therapy; hosp; last; ordinal; ql; qual; qualitative; screen; survey; survey.gnhlth; worry when go back to the hospital past 7d,Ord
71177-0,i get nervous - frightened easily in the past 7 days [facit],,,finding; findings; functional assessment of chronic illness therapy; i get nervous - frightened easily past 7d; last; ordinal; ql; qual; qualitative; screen; survey; survey.gnhlth,Ord
71181-2,i worry about getting a job because of my illness in the past 7 days [facit],,,finding; findings; functional assessment of chronic illness therapy; last; occupation; ordinal; ql; qual; qualitative; screen; survey; survey.gnhlth; work; worry about getting job b/c of illness past 7d,Ord
71186-1,i would rather do something by myself than with other people in the past 7 days [facit],,,finding; findings; functional assessment of chronic illness therapy; last; ordinal; othr; ql; qual; qualitative; screen; survey; survey.gnhlth; would rather do something by myself past 7d,Ord
71192-9,i think i have fewer friends than other children in the past 7 days [facit],,,finding; findings; functional assessment of chronic illness therapy; have fewer friends than other children past 7d; last; ordinal; othr; ql; qual; qualitative; screen; survey; survey.gnhlth,Ord
71193-7,other children avoid playing with me because i am different in the past 7 days [facit],,,children avoid playing with me i am different past 7d; finding; findings; functional assessment of chronic illness therapy; last; ordinal; othr; ql; qual; qualitative; screen; survey; survey.gnhlth,Ord
71215-8,my child worries about getting a job because of his-her illness in the past 4 weeks [facit],,,4 weeks; finding; findings; functional assessment of chronic illness therapy; last; my child worries getting job b/c of illness past 4w; occupation; ordinal; ql; qual; qualitative; screen; survey; survey.gnhlth; work,Ord
71228-1,additional concerns - fact-br-peds [facit],,,add; functional assessment of chronic illness therapy; pan; panel; panel.survey.gnhlth; panl; pnl; point in time; random; survey; survey.gnhlth,-
7123-3,bayberry ige ab [units/volume] in serum,bayberry ige qn,bayberry ige qn (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; bayberry; immune globulin e; immunoglobulin e; point in time; qnt; quan; quant; quantitative; random; serum; sr; wax myrtle,Qn
71248-9,other people avoid hanging out with my child because s-he is different in the past 7 days [facit],,,finding; findings; functional assessment of chronic illness therapy; last; ordinal; othr; people avoid my child because is different past 7d; ql; qual; qualitative; s prime; screen; survey; survey.gnhlth,Ord
71272-9,other people pick on - tease my child in the past 7 days [facit],,,finding; findings; functional assessment of chronic illness therapy; last; ordinal; othr; people pick on child past 7d; ql; qual; qualitative; screen; survey; survey.gnhlth,Ord
71278-6,i lose my balance or fall down easily in the past 4 weeks [facit],,,4 weeks; bal; finding; findings; functional assessment of chronic illness therapy; last; lose balance easily past 4w; ordinal; ql; qual; qualitative; screen; survey; survey.gnhlth,Ord
71283-6,i get ill easily in the past 4 weeks [facit],,,4 weeks; finding; findings; functional assessment of chronic illness therapy; get ill easily past 4w; last; ordinal; ql; qual; qualitative; screen; survey; survey.gnhlth,Ord
71304-0,i am bothered by being unable to see well in the past 4 weeks [facit],,,4 weeks; bothered by unable to see well past 4w; finding; findings; functional assessment of chronic illness therapy; last; ordinal; ql; qual; qualitative; screen; survey; survey.gnhlth,Ord
71307-3,"when i speak, people have trouble understanding me in the past 4 weeks [facit]",,,4 weeks; finding; findings; functional assessment of chronic illness therapy; last; ordinal; people have trouble understanding me past 4w; ql; qual; qualitative; screen; survey; survey.gnhlth,Ord
71320-6,emotional well-being - fact-br -peds-parent_child [facit],,,emotional well-being fact-br peds-parent_child; functional assessment of chronic illness therapy; pan; panel; panel.survey.gnhlth; panl; pnl; point in time; random; survey; survey.gnhlth,-
71326-3,my child is bothered by headaches in the past 4 weeks [facit],,,4 weeks; child bothered by headaches past 4w; finding; findings; functional assessment of chronic illness therapy; last; ordinal; ql; qual; qualitative; screen; survey; survey.gnhlth,Ord
71339-6,urea renal clearance/1.73 sq m--hemodialysis urine and serum or plasma [esrd],,,bsa; cl; clear; clearanc; clearances; clr; end stage renal disease; esrd survey; hd; kidney; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; square meter; sr; survey; ua; ur; ur+serpl; urn; volume rate/area; volume rate/ratio,Qn
71340-4,deprecated time between hemodialysis sessons [esrd],,,end stage renal disease; esrd survey; interdialytic interval; point in time; qnt; quan; quant; quantitative; random; survey,Qn
71341-2,kt/v.peritoneal dialysis [percent of body weight],,,bod; bodies; dialy; esrd; esrd survey; point in time; qnt; quan; quant; quantitative; random; ratios; rto; survey; v.peritnl dialysis,Qn
71352-9,i have been so unhappy that i have been crying in the past 7 days [epds],,,edinburgh postnatal depression scale; finding; findings; last; ordinal; ql; qual; qualitative; screen; so unhappy been crying past 7d; survey; survey.epds,Ord
71363-6,alkaline phosphatase.placental 2/alkaline phosphatase.total in serum or plasma,alp plac 2 cfr serpl,alp plac 2 [catalytic fraction],alk; alk phos; alkaline phos; alkaline phosphatase.total; alkp; alp; alp plac; alp plac 2; ap; catalytic fraction; chemistry; ii; percent; phos; phosphtase; pl; placent; placenta; placntl; plap; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; tot; totl,Qn
71367-7,alkaline phosphatase.placental 2 [enzymatic activity/volume] in serum or plasma,alp plac 2 serpl-ccnc,alp plac 2 [catalytic activity/vol],alk; alk phos; alkaline phos; alkaline phosphatase.total; alkp; alp; alp plac; alp plac 2; ap; catalytic concentration; chemistry; ii; phos; phosphtase; pl; placent; placenta; placntl; plap; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
71368-5,desmosome igg ab [titer] in serum by immunofluorescence,desmosome igg titr ser if,desmosome igg if (s) [titer],abs; aby; acif; antby; anti; antibodies; antibody; anticomplement immunofluorescence; autoantibodies; autoantibody; dilution factor; dilution factor (titer); fa; fluorescent antibody; fluoresent; ifa; immune fluorescence; immune globulin g; immunoflour; immunofluor; immunofluorescence; immunoglobulin g; macula adherens; point in time; random; serology; serum; smqn; sr; time resolved fluorescence; titer; titered; titre; trf; ttr,SemiQn
7137-3,soybean triggered histamine release [units/volume] in blood,soybean basobnd ab qn,soybean triggered histamine release qn (bld),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; associated; autoantibodies; autoantibody; baso; basobnd ab; basophil release; basophils; basos; blood; bnd; bph; f014; f14; gly; largest; leukocyte histamine reaction; leukocyte histamine release; maximal; maximum; peak; point in time; qnt; quan; quant; quantitative; random; soja hispida; soy bean; soya bean; soyabean; soybean; wb; wbc release; whole blood,Qn
71374-3,food allergen mix 51 (carrot+tomato+mustard+potato+garlic) ige ab [units/volume] in serum by multidisk,food allerg mix 51 ige qn,carrot+tomato+mustard+potato+garlic ige multidisk qn (s),abs; aby; allergen; allergens; allergy testing; allerscan; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; brassica/sinapis spp; carrot; f031; f035; f047; f089; f25; f31; f35; f47; f89; food allerg mix 51; food allerg mix 51 ige; fp51; garlic; immune globulin e; immunoglobulin e; lycopersicon esculatum; lycopersicon lycopersicon; point in time; potato; qnt; quan; quant; quantitative; random; serum; sr; tomato; white potato,Qn
71395-8,cms - cardiovascular exam panel,,,narrative; pan; panel.survey.cms; panl; pnl; point in time; random; report; survey,Nar
71398-2,cms - genitourinary exam - male panel,,,gu; narrative; pan; panel.survey.cms; panl; pnl; point in time; random; report; survey,Nar
7141-5,white bean igg ab [units/volume] in serum,white bean igg qn,white bean igg qn (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; beans; cannellini bean; f015; f15; immune globulin g; immunoglobulin g; navy bean; phaseolus vulgaris; point in time; qnt; quan; quant; quantitative; random; serum; sr; white bean; white kidney bean,Qn
71424-6,cms - past medical - surgical history panel,,,hx; last; narrative; pan; panel.survey.cms; panl; pnl; point in time; random; report; surg; survey,Nar
7144-9,liver beef triggered histamine release [units/volume] in blood,liver beef basobnd ab qn,liver beef triggered histamine release qn (bld),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; associated; autoantibodies; autoantibody; baso; basobnd ab; basophil release; basophils; basos; blood; bnd; bos spp; bph; f027; f27; leukocyte histamine reaction; leukocyte histamine release; point in time; qnt; quan; quant; quantitative; random; wb; wbc release; whole blood,Qn
71451-9,moisture associated skin damage (masd) [mdsv3],,,assoc; finding; findings; integument; mds version 3; ordinal; point in time; ql; qual; qualitative; random; screen; survey; survey.mds,Ord
71463-4,date of infection onset [esrd],,,end stage renal disease; esrd survey; point in time; qnt; quan; quant; quantitative; random; survey,Qn
71469-1,medication frequency medication [esrd],,,end stage renal disease; esrd survey; finding; findings; med; ordinal; point in time; ql; qual; qualitative; random; screen; survey,Ord
7152-2,blueberry ige ab [units/volume] in serum,blueberry ige qn,blueberry ige qn (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; blue berry; blueberry; f288; immune globulin e; immunoglobulin e; point in time; qnt; quan; quant; quantitative; random; rf288; serum; sr,Qn
71527-6,record status [esrd],,,end stage renal disease; esrd survey; finding; findings; ordinal; point in time; ql; qual; qualitative; random; screen; survey,Ord
71529-2,back up npi dialysis facility [esrd],,,dialy; end stage renal disease; esrd survey; ident; identifier; national provider identifier; nominal; point in time; random; survey,Nom
715-3,normoblasts [#/volume] in blood,normoblasts # bld,normoblasts (bld) [#/vol],#; abs; absolute; absolutes; blood; cnt; count; count/volume; ct; erythroblast; erythroblasts; hematology/cell counts; immature erythrocytes; normoblast; number concentration; number concentration (count/vol); point in time; qnt; quan; quant; quantitative; random; wb; whole blood,Qn
71550-8,i feel worried or fearful in the last 2 weeks or more [m3],,,finding; findings; my mood monitor checklist; ordinal; past; point in time; ql; qual; qualitative; random; screen; survey; survey.mtlhlth; worried fearful last 2w,Ord
71559-9,i feel i must repeat certain acts or rituals in the last 2 weeks or more [m3],,,finding; findings; must repeat certain acts last 2w; my mood monitor checklist; ordinal; past; point in time; ql; qual; qualitative; random; screen; survey; survey.mtlhlth,Ord
71568-0,these symptoms have led to my using drugs [m3],,,drug; finding; findings; my mood monitor checklist; ordinal; point in time; ql; qual; qualitative; random; screen; survey; survey.mtlhlth; sx; these symptoms led to using drugs,Ord
71583-9,service requested of ems unit,service requested of ems,,emergency medical service(s); nominal; point in time; random; trauma; typ,Nom
71596-1,eosinophils/leukocytes [pure number fraction] in bronchial specimen by manual count,eosinophil nfr.df bronch manual,eosinophils/leukocytes manual cnt (bronch spec) [pure # fraction],bro; eos; eosin; eosino; eosinophil; eosins; hematology/cell counts; leuc; leuk; leukocyte; lkcs; manl; number fraction; point in time; qnt; quan; quant; quantitative; random; wbc; wbcs; white blood cell; white blood cells,Qn
71606-8,neutrophils/leukocytes [pure number fraction] in pericardial fluid by manual count,neutrophils nfr.df pcar manual,neutrophils/leukocytes manual cnt (pericard fld) [pure # fraction],cardio; cardiology; heart disease; hematology/cell counts; leuc; leuk; leukocyte; lkcs; manl; neut; neutr; neutrophil; number fraction; pcar; pericardial fluid; pmn; pnm; point in time; qnt; quan; quant; quantitative; random; wbc; wbcs; white blood cell; white blood cells,Qn
71624-1,lymphocytes/leukocytes [pure number fraction] in synovial fluid by manual count,lymphocytes nfr.df snv manual,lymphocytes/leukocytes manual cnt (syn fld) [pure # fraction],hematology/cell counts; joint aspirate; joint fld; joint flu; joint fluid; leuc; leuk; leukocyte; lkcs; lymp; lymph; lympho; lymphocyte; lymphs; lymphs%; manl; number fraction; point in time; qnt; quan; quant; quantitative; random; rheum; rheumatology; sf; snv; syn; syn fl; synov; synovial fluid; wbc; wbcs; white blood cell; white blood cells,Qn
71653-0,promyelocytes/leukocytes [pure number fraction] in cerebral spinal fluid by manual count,promyelocytes nfr.df csf manual,promyelocytes/leukocytes manual cnt (csf) [pure # fraction],cerebral spinal fluid; cerebrospinal fl; hematology/cell counts; leuc; leuk; leukocyte; lkcs; manl; number fraction; point in time; pro myelos; progranulocyte; progranulocytes; promyel; promyelocyte; qnt; quan; quant; quantitative; random; spinal fl; spinal fld; spinal flu; spinal fluid; wbc; wbcs; white blood cell; white blood cells,Qn
71667-0,myelocytes/leukocytes [pure number fraction] in blood by manual count,myelocytes nfr.df bld manual,myelocytes/leukocytes manual cnt (bld) [pure # fraction],blood; hematology; hematology/cell counts; heme; leuc; leuk; leukocyte; lkcs; manl; myel; myelo; myelocyte; number fraction; point in time; qnt; quan; quant; quantitative; random; wb; wbc; wbcs; white blood cell; white blood cells; whole blood,Qn
71673-8,lymphocytes/leukocytes [pure number fraction] in blood by manual count,lymphocytes nfr.df bld manual,lymphocytes/leukocytes manual cnt (bld) [pure # fraction],blood; hematology/cell counts; leuc; leuk; leukocyte; lkcs; lymp; lymph; lympho; lymphocyte; lymphs; lymphs%; manl; number fraction; point in time; qnt; quan; quant; quantitative; random; wb; wbc; wbcs; white blood cell; white blood cells; whole blood,Qn
71675-3,basophils/leukocytes [pure number fraction] in blood by manual count,basophils nfr.df bld manual,basophils/leukocytes manual cnt (bld) [pure # fraction],baso; basophil; basos; blood; bph; hematology/cell counts; leuc; leuk; leukocyte; lkcs; manl; number fraction; point in time; qnt; quan; quant; quantitative; random; wb; wbc; wbcs; white blood cell; white blood cells; whole blood,Qn
71691-0,hematopoietic progenitor cells [#/volume] in blood by automated count,hpc # bld auto,hematopoietic progenitor cells auto (bld) [#/vol],#; abs; absolute; absolutes; auto; automated detection; blood; cell; cellularity; cnt; count; count/volume; ct; elec; elect; electr; hematology/cell counts; hpc; number concentration; number concentration (count/vol); point in time; qnt; quan; quant; quantitative; random; wb; whole blood,Qn
71697-7,mononuclear cells/leukocytes in body fluid by automated count,mononuc cells nfr fld auto,mononuclear cells/leukocytes auto (body fld),"auto; automated detection; b/f; bf; bod; bodies; body fluid; body fluid, unsp; cell; cellularity; elec; elect; electr; fl; fld; flu; fluid; hematology/cell counts; leuc; leuk; leukocyte; lkcs; mononuc; mononuc cells; number fraction; percent; point in time; qnt; quan; quant; quantitative; random; wbc; wbcs; white blood cell; white blood cells",Qn
71719-9,mycobacterium avium complex dna [presence] in specimen by naa with probe detection,m avium cmplx dna spec ql naa+probe,m. avium complex dna naa+probe ql (specimen),3 self-sustaining sequence replication; 3sr sr; acid fast; acid fast bacilli; acid fast bacillus; afb; amplif; amplification; amplified; compx; deoxyribonucleic acid; dna nucleic acid probe; dna probe; id; infectious disease; infectiousdisease; lat; lcr; ligase chain reaction; ligation-activated transcription; m avium; m avium cmplx; microbiology; misc; miscellaneous; myco; mycobact; naa+probe; naat; nasba; nucleic acid sequence based analysis; ordinal; other; pcr; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; screen; sda; spec; strand displacement amplification; tma; to be specified in another part of the message; transcription mediated amplification; tuberculosis; unspecified,Ord
7173-8,candida albicans triggered histamine release [units/volume] in blood,c albicans basobnd ab qn,c. albicans triggered histamine release qn (bld),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; associated; autoantibodies; autoantibody; baso; basobnd ab; basophil release; basophils; basos; blood; bnd; bph; c albicans; cand; candidiasis; leukocyte histamine reaction; leukocyte histamine release; m005; m5; monilia; point in time; qnt; quan; quant; quantitative; random; thrush; wb; wbc release; whole blood,Qn
71746-2,personnel contact information panel [esrd] personnel,,,admin; end stage renal disease; end stage renal disease (esdr) pnl; esrd survey; pan; panl; personnel contact info pnl; pnl; point in time; random; survey,-
71751-2,primary contact phone number facility,,,admin; esrd; esrd survey; no; nominal; num; phone #; point in time; primary contact phone #; random; survey; telecommunication number; telephone number,Nom
71755-3,anxiety score [m3],,,my mood monitor checklist; point in time; qnt; quan; quant; quantitative; random; scale; survey; survey.mtlhlth,Qn
71756-1,score out of range [m3],,,finding; findings; my mood monitor checklist; ordinal; point in time; ql; qual; qualitative; random; rnge; screen; survey; survey.mtlhlth,Ord
71759-5,rotavirus rna [identifier] in isolate by naa with probe detection,rv rna islt naa+probe,rotavirus rna naa+probe nom (isol),3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; dna nucleic acid probe; dna probe; id; identity or presence; infectious disease; infectiousdisease; islt; isol; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; naa+probe; naat; nasba; nominal; nucleic acid sequence based analysis; pcr; point in time; polymerase chain reaction; probe amp; probe with ampification; probe with target amplification; qbr; random; ribonucleic acid; rota virus; rotav; rotaviral; rotaviurs; rv; sda; strand displacement amplification; tma; transcription mediated amplification,Nom
7176-1,deprecated melon igg ab [units/volume] in serum,deprecated melon igg qn,melon igg qn (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; f87; honey dew; honeydew; immune globulin g; immunoglobulin g; melon; melons; point in time; qnt; quan; quant; quantitative; random; serum; sr,Qn
7177-9,deprecated melon triggered histamine release [units/volume] in blood,deprecated melon basobnd ab qn,melon triggered histamine release qn (bld),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; associated; autoantibodies; autoantibody; baso; basobnd ab; basophil release; basophils; basos; blood; bnd; bph; f87; honey dew; honeydew; leukocyte histamine reaction; leukocyte histamine release; melon; melons; point in time; qnt; quan; quant; quantitative; random; wb; wbc release; whole blood,Qn
71793-4,treponema pallidum ab [titer] in serum or plasma by agglutination,t pallidum ab titr serpl aggl,t. pallidum ab aggl [titer],abs; aby; agg; agglut; agglutination; antby; anti; antibodies; antibody; autoantibodies; autoantibody; dilution factor; dilution factor (titer); id; infectious disease; infectiousdisease; microbiology; pl; plasma; plsm; point in time; random; serp; serpl; serplas; serum; serum or plasma; smqn; sr; syphilis; t pallidum; titer; titered; titre; tp-pa; treponemal; ttr,SemiQn
71795-9,maximum expiratory gas flow respiratory system airway by peak flow meter --pre therapy,pef pre therapy airway pfm,,before; breathing; dynamic; flow; gases; largest; lung; lungs; maximal; maximum; peak; peak expiratory flow; pef; pfm; point in time; pulmonary; pulmonology; qnt; quan; quant; quantitative; random; respiratory; rs; volume rate; vrate,Qn
71823-9,i can't get certain things out of my mind since i took my last screen [m3],,,can't get things out of mind since last screen; finding; findings; my mood monitor checklist; ordinal; past; point in time; ql; qual; qualitative; random; scn; scr; screen; scrn; survey; survey.mtlhlth; t prime,Ord
71828-8,hematocrit [pure volume fraction] of body fluid by calculation,hct vfr.df fld calc,hematocrit calc (body fld) [pure volume fraction],"b/f; bf; bod; bodies; body fluid; body fluid, unsp; calc; calculation; discocyte; erc; erythrocytes; fl; fld; flu; fluid; hematology/cell counts; point in time; qnt; quan; quant; quantitative; random; rbc; red blood cell; red blood cells; red blood corpuscle; red blood corpusles; red cell; red cells; spec; vol",Qn
71832-0,hematocrit [pure volume fraction] of arterial blood by calculation,hct vfr.df blda calc,hematocrit calc (blda) [pure volume fraction],abg; art; art bld; art blood; arterial; arterial blood; blood arterial; calc; calculation; discocyte; erc; erythrocytes; hematology/cell counts; point in time; qnt; quan; quant; quantitative; random; rbc; red blood cell; red blood cells; red blood corpuscle; red blood corpusles; red cell; red cells; spec; vol,Qn
71854-4,deoxyhemoglobin/hemoglobin.total [pure mass fraction] in arterial blood,do-hgb mfr.df blda,deoxyhemoglobin (blda) [pure mass fraction],abg; art; art bld; art blood; arterial; arterial blood; blood arterial; chemistry; deoxygenated hemoglobin; deoxyhaemoglobin; do-hgb; ferrohaemoglobin; ferrohemoglobin; haemoglobin; hb; hgb; hhb; point in time; qnt; quan; quant; quantitative; random; reduced hemoglobin; rhb; tot; totl,Qn
71872-6,hemoglobin a2/hemoglobin.total [pure mass fraction] in blood,hgb a2 mfr.df bld,hemoglobin a2 (bld) [pure mass fraction],blood; haemoglobin; hb; hematology/cell counts; hgb; hgb a2; point in time; qnt; quan; quant; quantitative; random; tot; totl; wb; whole blood,Qn
71880-9,methemoglobin/hemoglobin.total [pure mass fraction] in mixed venous blood,methgb mfr.df bldmv,methemoglobin (bldmv) [pure mass fraction],bld mixed venous; blood - mixed venous; chemistry; haemoglobin; hb; hemiglobin; hgb; hi; methaemoglobin; methb; methgb; point in time; qnt; quan; quant; quantitative; random; tot; totl,Qn
71882-5,methemoglobin/hemoglobin.total [pure mass fraction] in arterial blood,methgb mfr.df blda,methemoglobin (blda) [pure mass fraction],abg; art; art bld; art blood; arterial; arterial blood; blood arterial; chemistry; haemoglobin; hb; hemiglobin; hgb; hi; methaemoglobin; methb; methgb; point in time; qnt; quan; quant; quantitative; random; tot; totl,Qn
71890-8,carboxyhemoglobin/hemoglobin.total [pure mass fraction] in blood,cohgb mfr.df bld,carboxyhemoglobin (bld) [pure mass fraction],blood; carbon monoxide.hemoglobin; carbonmonoxyhemoglobin; carbonyl haemoglobin; carbonyl hemoglobin; carbonyl hgb; carboxyhaemoglobin; carboxyhemoglob; chemistry; co haemoglobin; co hemoglobin; cohb; cohgb; haemoglobin; hb; hbco; hemoglobin bound with carbon dioxide; hgb; lung; point in time; pulmonary; pulmonology; qnt; quan; quant; quantitative; random; respiratory; tot; totl; wb; whole blood,Qn
71894-0,cortisone free [moles/time] in 24 hour urine,cortisone free 24h ur-srate,cortisone free (24h u) [moles/time],1 day; 11-beta hsd; 11-beta-hsd1; 11-beta-hsd2; 11-beta-hydroxy steroid dehydrogenase; 11--hsd1; 11--hsd2; 24 hours; 24hr; c155; chemistry; compound e; cortisone free; fr; non-protein bound; qnt; quan; quant; quantitative; srate; substance rate; ua; ur; urn,Qn
71901-3,i am as healthy as anyone i know [veterans rand],,,arterial stenosis; finding; findings; ordinal; point in time; ql; qual; qualitative; random; screen; sf-12; sf-36; survey; survey.gnhlth; veterans rand,Ord
71906-2,did you feel worn out during the past 4 weeks [veterans rand],,,4 weeks; finding; findings; last; ordinal; ql; qual; qualitative; screen; sf-12; sf-36; survey; survey.gnhlth; veterans rand; worn out past 4w,Ord
71907-0,have you felt downhearted and blue during the past 4 weeks [veterans rand],,,4 weeks; downhearted blue past 4w; finding; findings; last; ordinal; ql; qual; qualitative; screen; sf-12; sf-36; survey; survey.gnhlth; veterans rand,Ord
71930-2,does your health now limit you in lifting or carrying groceries [veterans rand],,,finding; findings; ordinal; point in time; ql; qual; qualitative; random; screen; sf-12; sf-36; survey; survey.gnhlth; veterans rand,Ord
71931-0,"does your health now limit you in moderate activities, such as moving a table, pushing a vacuum cleaner, bowling or playing golf [veterans rand]",,,arterial stenosis; finding; findings; limit in moderate activities; ordinal; point in time; ql; qual; qualitative; random; screen; sf-12; sf-36; survey; survey.gnhlth; veterans rand,Ord
71932-8,"does your health now limit you in vigorous activities, such as running, lifting heavy objects, participating in strenuous sports [veterans rand]",,,arterial stenosis; finding; findings; limit in vigorous activities; ordinal; point in time; ql; qual; qualitative; random; screen; sf-12; sf-36; survey; survey.gnhlth; veterans rand,Ord
71937-7,"tolerance, worried, eye- opener, amnesia, cutdown screening test [tweak]",,,asympt; asymptomatic; pan; panel; panel.survey.gnhlth; panl; pnl; point in time; random; scn; survey; survey.gnhlth; tweak,-
71948-4,hip and knee outcomes questionnaire [hkoi],,,hip and knee outcomes instrument - american academy of orthopaedic surgeons; lower extremity joint; pan; panel; panel.survey.gnhlth; panl; pnl; point in time; random; survey; survey.gnhlth,-
71963-3,promis-29 fatigue score t-score,,,patient reported outcomes information system; point in time; promise; qnt; quan; quant; quantitative; random; survey; survey.gnhlth; t-score,Qn
71975-7,vr-36 social functioning (sf) score - oblique method,,,meth; method of; obl; point in time; qnt; quan; quant; quantitative; random; scale; sf-12; sf-36; survey; survey.gnhlth; veterans rand,Qn
71989-8,vr-36 physical component summary (pcs) score - oblique method t-score,,,meth; method of; obl; point in time; qnt; quan; quant; quantitative; random; sf-12; sf-36; survey; survey.gnhlth; t-score; veterans rand,Qn
71992-2,vr-36 role emotion (re) score - orthogonal method,,,meth; method of; point in time; qnt; quan; quant; quantitative; random; scale; sf-12; sf-36; survey; survey.gnhlth; veterans rand,Qn
72014-4,vr-12 bodily pain (bp) score - oblique method,,,meth; method of; obl; point in time; qnt; quan; quant; quantitative; random; scale; sf-12; sf-36; survey; survey.gnhlth; veterans rand,Qn
72018-5,vr-12 role emotion (re) score - oblique method t-score,,,meth; method of; obl; point in time; qnt; quan; quant; quantitative; random; sf-12; sf-36; survey; survey.gnhlth; t-score; veterans rand,Qn
72019-3,vr-12 social functioning (sf) score - oblique method t-score,,,meth; method of; obl; point in time; qnt; quan; quant; quantitative; random; sf-12; sf-36; survey; survey.gnhlth; t-score; veterans rand,Qn
72029-2,vaccination exclusion - medical reason,,,esrd; esrd survey; immunizations; nominal; point in time; random; survey; typ; vaccination exclusion med reason; vaccine,Nom
72032-6,type non-oral vitamin d analog prescribed [esrd],,,dextro; end stage renal disease; esrd survey; nominal; non-oral vit d analog prescribed; oral vit d analog prescribed; osteoporosis; point in time; random; rickets; survey; typ; vitamin d deficiency,Nom
72039-1,how often was static venous pressure measured,,,esrd; esrd survey; finding; findings; ordinal; point in time; ql; qual; qualitative; random; screen; survey,Ord
72051-6,date catheter removal,,,cath; esrd; esrd survey; extraction; point in time; qnt; quan; quant; quantitative; random; remove; survey,Qn
72052-4,date catheter placement,,,cath; esrd; esrd survey; point in time; qnt; quan; quant; quantitative; random; survey,Qn
72053-2,date arteriovenous fistula creation [esrd],,,date av fistula creation; end stage renal disease; esrd survey; point in time; qnt; quan; quant; quantitative; random; survey,Qn
72076-3,blood pressure home reading,,,bp; bp home reading; esrd; esrd survey; impression; impression/interpretation of study; impressions; interp; interpretation; ordinal; point in time; ql; qual; qualitative; random; screen; survey,Ord
72079-7,dry weight order present [esrd],,,dry wt order present; end stage renal disease; esrd survey; finding; findings; ordinal; point in time; ql; qual; qualitative; random; screen; survey; wt,Ord
72111-8,sapovirus rna [presence] in specimen by naa with probe detection,sapovirus rna spec ql naa+probe,sapovirus rna naa+probe ql (specimen),3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; dna nucleic acid probe; dna probe; id; infectious disease; infectiousdisease; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; misc; miscellaneous; naa+probe; naat; nasba; nucleic acid sequence based analysis; ordinal; other; pcr; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; ribonucleic acid; screen; sda; spec; strand displacement amplification; tma; to be specified in another part of the message; transcription mediated amplification; unspecified,Ord
72115-9,resuscitation attempted nemsis,resuscitation attempted nemsis,,national ems information services; nominal; point in time; random; typ,Nom
72182-9,tested for hiv significant other [rhea],,,aids; finding; findings; human immunodeficiency virus; ordinal; othr; point in time; ql; qual; qualitative; random; rwanda health enterprise architecture; screen; survey; survey.gnhlth,Ord
72186-0,obstetrical risk [rhea],,,finding; findings; nominal; point in time; random; rwanda health enterprise architecture; survey; survey.gnhlth,Nom
72191-0,total symptom score [kccq],,,kansas city cardiomyopathy questionnaire; point in time; qnt; quan; quant; quantitative; random; scale; survey; survey.gnhlth; sx; tot; totl,Qn
72192-8,symptom burden score [kccq],,,kansas city cardiomyopathy questionnaire; point in time; qnt; quan; quant; quantitative; random; scale; survey; survey.gnhlth; sx,Qn
72194-4,symptom stability score [kccq],,,kansas city cardiomyopathy questionnaire; point in time; qnt; quan; quant; quantitative; random; scale; survey; survey.gnhlth; sx,Qn
72196-9,social limitation score [kccq],,,kansas city cardiomyopathy questionnaire; point in time; qnt; quan; quant; quantitative; random; scale; survey; survey.gnhlth,Qn
72206-6,epstein barr virus nuclear 1 igg and igm [color ratio] in serum or plasma by rapid immunoassay,ebv na 1 igg+igm serpl ia.rapid-colrto,ebv nuclear 1 igg and igm ia.rapid nom,abs; aby; ana igg; antby; anti; antibodies; antibody; autoantibodies; autoantibody; colrto; ebna; ebv; ebv na; ebv na 1; eia; elfa; elisa; enzyme immunoassay; epstn; hhv-4; human herpesvirus 4; i; iaa; id; igg+igm; immune globulin g; immune globulin m; immunoglobulin g; immunoglobulin m; infectious disease; infectiousdisease; meia; microbiology; mono; mononucleosis; nominal; nuc; pl; plasma; plsm; point in time; random; serp; serpl; serplas; serum; serum or plasma; sr; suds,Nom
72209-0,"inv(16)(p13.1;q22.1)(myh11,cbfb) fusion transcript/control transcript [# ratio] in bone marrow by molecular genetics method",inv(16)(p13;q22)/control mar,"inv(16)(p13.1;q22.1)(myh11,cbfb) fusion transcript/control transcript molgen (bm) [# ratio]","abl; abl1; abl1 transcript; acute myeloid leukemia; aml; bm; bon; bone marrow; control gene; dna; gene fusion; gene translocation; inv(16)(cbfb,myh11) gene inversion; inv(16)(p13;q22); inversion 16; mar; marrow (bone); minimal angle of resolution; minimum angle of resolution; molecular genetics; molecular pathology; molpath; molpath.inv; number ratio; pcr; point in time; qnt; quan; quant; quantitative; random; rna; translocation",Qn
72221-5,fetal yolk sac study observation us,us yolk sac fetus study,,echography; fetal; finding; findings; gyn; gynecology; nominal; ob; obgyn; obsterical; obsterical.ultrasound; obstetrical; obstetrics; point in time; random; sonogram; sonograph; sonography; study report; uls; ultrasound; ys,Nom
72232-2,continuity of care document - recommended c-cda r1.1 sections,ccd c-cda r1.1 sections,,ccd c-cda r1.1 sections; congenital dyserythropoietic anaemia; pan; panel; panel.doc; panl; pnl; point in time; random,-
72244-7,mr pelvis endorectal wo and w contrast iv,mr pelvis endorectal wo+w contr iv,,c; contr; contra; contrst; coreplaybook; document; finding; findings; imaging; mitral regurgitation maximum velocity; mri; pelvic; playbook; point in time; rad; radiology; random; w contr iv; wc; wo & wc; wo+w contr; wo+w contr iv; wwo,Doc
72252-0,ct chest and abdomen and pelvis wo and w contrast iv,ct chest+abd+pelvis wo+w contr iv,,abd; abd+pelvis; abdo; abdominal; c; cat scan; chest + abd; chest+abd+pelvis; computed tomography; computerized tomography; contr; contra; contrst; ct scan; document; finding; findings; imaging; pelvic; point in time; rad; radiology; random; thorax; w contr iv; wc; wo & wc; wo+w contr; wo+w contr iv; wwo,Doc
72254-6,ct chest and abdomen and pelvis w contrast iv,ct chest+abd+pelvis w contr iv,,abd; abd+pelvis; abdo; abdominal; c; cat scan; chest + abd; chest+abd+pelvis; computed tomography; computerized tomography; contr; contra; contrst; ct scan; document; finding; findings; imaging; pelvic; point in time; rad; radiology; random; thorax; w contr iv; wc,Doc
72259-5,adefovir [mass/volume] in serum or plasma by lc/ms/ms,adefovir serpl lc/ms/ms-mcnc,adefovir lc/ms/ms [mass/vol],adv; bis-pom-pmea; drug/toxicology; drugs; hepsera; level; mass concentration; pl; plasma; plsm; point in time; preveon; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
72262-9,methemoglobin [moles/volume] in cerebral spinal fluid,methgb csf-scnc,methemoglobin (csf) [moles/vol],cerebral spinal fluid; cerebrospinal fl; chemistry; hemiglobin; hi; level; methaemoglobin; methb; methgb; point in time; qnt; quan; quant; quantitative; random; spinal fl; spinal fld; spinal flu; spinal fluid; substance concentration,Qn
72282-7,sagittal plane body position,sagittal plane body position,,bod; bodies; clin; ordinal; point in time; ql; qual; qualitative; random; screen,Ord
722-9,hemoglobin [mass/volume] in pleural fluid,hgb plr-mcnc,hemoglobin (pleur fld) [mass/vol],haemoglobin; hb; hematology/cell counts; hgb; level; mass concentration; pleural; pleural fluid; point in time; qnt; quan; quant; quantitative; random; thoracentesis fluid,Qn
72293-4,undermining [length] of wound,undermining wnd len,,h+p; h+p.px; length; p prime; point in time; qnt; quan; quant; quantitative; random; wnd,Qn
72305-6,wound closure type,wnd close type,,h+p; h+p.px; nominal; p prime; point in time; random; typ; wnd; wnd close type,Nom
72312-2,"t(1;19)(q23.3;p13.3)(pbx1,tcf3) fusion transcript/control transcript [# ratio] in blood or tissue by molecular genetics method","t(1;19)(pbx1,tcf3)/control bld/t","t(1;19)(q23.3;p13.3)(pbx1,tcf3) fusion transcript/control transcript molgen (bld/tiss) [# ratio]","abl; abl1; abl1 transcript; acute lymphoblastic leukaemia; acute lymphoblastic leukemia; acute myeloid leukemia; all; aml; blood; control gene; dna; e2a immunoglobulin enhancer binding factors e12/e47; gene fusion; gene translocation; genetics; heredity; heritable; i; immunoglobulin transcription factor 1; inherited; itf1; molecular genetics; molecular pathology; molpath; molpath.translocation; non-hodgkin lymphoma; number ratio; pbxp1; pcr; point in time; pre-b cell leukemia transcription factor-1; qnt; quan; quant; quantitative; random; rna; t prime; t(1;19)(pbx1,tcf3); tissue; tissue, unspecified; transcription factor 3; translocation; wb; whole blood; whole blood or tissue",Qn
72314-8,th-to igg ab [presence] in serum or plasma by immunoassay,th-to igg serpl ql ia,th-to igg ia ql,abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; eia; elfa; elisa; enzyme immunoassay; iaa; immune globulin g; immunoglobulin g; meia; ordinal; pl; plasma; plsm; point in time; pr; ql; qual; qualitative; random; screen; serology; serp; serpl; serplas; serum; serum or plasma; sr; suds; thallium,Ord
72327-0,amphiphysin igg ab [presence] in serum by immunoassay,amphiphysin igg ser ql ia,amphiphysin igg ia ql (s),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; breast cancer; eia; elfa; elisa; enzyme immunoassay; iaa; immune globulin g; immunoglobulin g; meia; ordinal; paraneoplastic syndrome; point in time; pr; ql; qual; qualitative; random; screen; serology; serum; sr; stiff man syndrome; suds,Ord
72333-8,jak2 gene p.val617phe [presence] in bone marrow by molecular genetics method,jak2 p.v617f mar ql,jak2 gene p.val617phe molgen ql (bm),bm; bon; bone marrow; erythrocytosis; genetics; heredity; heritable; inherited; jak2 p.v617f; janus kinase 2; janus kinase 2 gene; jtk10; mar; marrow (bone); minimal angle of resolution; minimum angle of resolution; molecular genetics; molecular pathology; molpath; molpath.mutations; ordinal; p prime; pcr; point in time; polycythemia vera; pr; pv; ql; qual; qualitative; random; screen; thcyt3,Ord
72345-2,neutrophils/round cells in prostatic fluid by manual count,neutrophils/rnd cells nfr prost fld man,neutrophils/round cells manual cnt (prost fld),cell; cellularity; eps; expressed prostatic secretion; hematology/cell counts; manl; neut; neutr; neutrophil; number fraction; percent; pmn; pnm; point in time; prost; prost fld; prostate; prostate secretion; prostati; prostatic secretion; qnt; quan; quant; quantitative; random; rnd cells,Qn
72362-7,starch granules [#/area] in urine sediment by microscopy low power field,starch granules #/area urns lpf,starch granules lm.lpf (urine sed) [#/area],#/area; granule; kidney; lm; micro; micros; microscopic; nephrology; number areic; point in time; qnt; quan; quant; quantitative; random; renal; ua; ur; urinalysis; urine sediment; urn; urns,Qn
72372-6,wound bed and edge panel,wnd bed+edge pnl,,h+p; p prime; pan; panel.h&p; panl; pnl; point in time; random; wnd; wnd bed+edge pnl,-
72381-7,alprazolam [mass/volume] in saliva (oral fluid),alpraz sal-mcnc,alprazolam (sal) [mass/vol],drug/toxicology; drugs; level; mass concentration; niravam; oral fluid; point in time; qnt; quan; quant; quantitative; random; sal; xanax,Qn
72382-5,her2 [units/volume] in tissue by immunoassay,her2 tiss ia-acnc,her2 ia qn (tiss),"arbitrary concentration; c-erbb-2; eia; elfa; elisa; enzyme immunoassay; erb; erb2; erb-2; erbb2; her-2; her-2/neu; iaa; meia; pathology; point in time; qnt; quan; quant; quantitative; random; suds; tissue; tissue, unspecified",Qn
72392-4,cortisol/cortisone [mass ratio] in serum or plasma,cortis/cortisone serpl,cortisol/cortisone [mass ratio],11-beta hsd; 11-beta-hsd1; 11-beta-hsd2; 11-beta-hydroxy steroid dehydrogenase; 11--hsd1; 11--hsd2; 17-hydroxycorticosterone; c155; compound e; compound f; coritsol; cort; drug/toxicology; drugs; f; hydrocortisone; mass concentration ratio; mass ratio; mcrto; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
72394-0,cell count panel - vitreous fluid by manual count,cell cnt pnl vitf manual,cell count panel manual cnt (vitr fld),cell cnt pnl; hematology/cell counts; manl; pan; panel.hematology& cell counts; panl; pnl; point in time; random; vitf; vitreous fluid; vitreous humor; vitreous humour,-
72395-7,differential panel - vitreous fluid,diff pnl vitf,differential panel (vitr fld),diff; diff pnl; differl; differn; hematology/cell counts; pan; panel.hematology& cell counts; panl; pnl; point in time; random; vitf; vitreous fluid; vitreous humor; vitreous humour,-
72424-5,3-methylhistidine/amino acids.total in serum or plasma,3me-histidine sfr serpl,3-methylhistidine/total aa [molar fraction],3me-histidine; 3-mh; aa; acd; acid; amino acid; amino acids.total; ch3hist; chemistry; iii; methyl-histidine; percent; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; substance fraction; tot; totl,Qn
72428-6,4-hydroxyphenylpyruvate [moles/volume] in serum or plasma,4oh-phenylpyruvate serpl-scnc,4-hydroxyphenylpyruvate [moles/vol],4hpp; 4-hydroxy phenylpyruvate; 4-hydroxyphenylpyruvic acid; 4oh-phenylpyruvate; chemistry; level; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; substance concentration,Qn
72449-2,3-hydroxyisovalerate [moles/volume] in cerebral spinal fluid,3oh-isovalerate csf-scnc,3-hydroxyisovalerate (csf) [moles/vol],3-hia; 3-hydroxy-isovalerate; 3-hydroxyisovaleric acid; 3oh-isovalerate; cerebral spinal fluid; cerebrospinal fl; chemistry; iii; level; point in time; qnt; quan; quant; quantitative; random; spinal fl; spinal fld; spinal flu; spinal fluid; substance concentration,Qn
72450-0,3-hydroxyisovalerate [moles/volume] in serum or plasma,3oh-isovalerate serpl-scnc,3-hydroxyisovalerate [moles/vol],3-hia; 3-hydroxy-isovalerate; 3-hydroxyisovaleric acid; 3oh-isovalerate; chemistry; iii; level; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; substance concentration,Qn
72460-9,jwh-073 3-hydroxybutyl (synthetic cannabinoid metabolite) [presence] in urine by confirmatory method,jwh-073 3oh-butyl ur ql cfm,jwh-073 3-hydroxybutyl confirm ql (u),addiction; cfm; cnfr; cnfrm; conf; confirmation; confirmatory; drug/toxicology; drugs; drugs of abuse; gcms; iii; illicit; jwh-073 3oh-butyl; jwh-073 n-(3-hydroxybutyl) metabolite; k2; lc/ms/ms; ordinal; point in time; potentialforabuse; pr; ql; qual; qualitative; random; screen; spice; spike; synthetic cannabinoid; synthetic cannabinoids; ua; ur; urn; yucatan fire,Ord
72463-3,am-2201 4-hydroxypentyl (synthetic cannabinoid metabolite) [presence] in urine by confirmatory method,am-2201 4oh-pentyl ur ql cfm,am-2201 4-hydroxypentyl confirm ql (u),addiction; am-2201 4oh-pentyl; am-2201 n-(4-hydroxypentyl) metabolite; cfm; cnfr; cnfrm; conf; confirmation; confirmatory; drug/toxicology; drugs; drugs of abuse; gcms; illicit; k2; lc/ms/ms; ordinal; point in time; potentialforabuse; pr; ql; qual; qualitative; random; screen; spice; spike; synthetic cannabinoid; synthetic cannabinoids; synthetic marijuana; ua; ur; urn; yucatan fire,Ord
72469-0,rcs-4 5-carboxypentyl (synthetic cannabinoid metabolite) [presence] in urine by confirmatory method,rcs-4 5-carboxypentyl ur ql cfm,rcs-4 5-carboxypentyl confirm ql (u),addiction; cfm; cnfr; cnfrm; conf; confirmation; confirmatory; drug/toxicology; drugs; drugs of abuse; gcms; illicit; k2; lc/ms/ms; ordinal; point in time; potentialforabuse; pr; ql; qual; qualitative; random; rcs-4 n-(5-carboxypentyl) metabolite; screen; spice; spike; synthetic cannabinoid; synthetic cannabinoids; ua; ur; urn; yucatan fire,Ord
72475-7,methadone+metabolite [presence] in saliva (oral fluid) by confirmatory method,methadone+metab sal ql cfm,methadone+metabolite confirm ql (sal),addiction; cfm; cnfr; cnfrm; conf; confirmation; confirmatory; dolophin; dolophine; drug/toxicology; drugs; drugs of abuse; gcms; illicit; lc/ms/ms; metab; metabolites; metb; metd; methadose; mtd; oral fluid; ordinal; point in time; potentialforabuse; pr; ql; qual; qualitative; random; sal; screen,Ord
72485-6,tapentadol [presence] in urine by screen method,tapentadol ur ql scn,tapentadol screen ql (u),addiction; drug/toxicology; drugs; drugs of abuse; illicit; nucynta; ordinal; palexia; point in time; potentialforabuse; pr; ql; qual; qualitative; random; scn; scr; screen; scrn; tapal; ua; ur; urn,Ord
72533-3,us guidance for ambulatory phlebectomy of extremity vein - left,us guided extr v-l amb phleb,,amb phleb; cardio; cardiology; document; echography; ext; extr v; extr v-l; extr-l; finding; findings; guid; guide; guided; heart disease; imaging; l; lt; phlebectomy; point in time; radiology; random; sonogram; sonograph; sonography; stab avulsion; uls; ultrasound; ven; venous,Doc
72534-1,us guidance for laser ablation of extremity vein - right,us guided extr v-r laser ablation,,document; echography; ext; extr v; extr v-r; extr-r; finding; findings; guid; guide; guided; imaging; point in time; r; radiology; random; rt; sonogram; sonograph; sonography; uls; ultrasound; ven; venous,Doc
7253-8,cottonseed igg ab [units/volume] in serum,cottonseed igg qn,cottonseed igg qn (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; cottonseed oil; f109; gossypium hirsutum; gossypium spp; immune globulin g; immunoglobulin g; k83; point in time; qnt; quan; quant; quantitative; random; serum; sr,Qn
72542-4,rf guidance for denervation of lumbar spine facet joint,rf guided l-spine facet joint denerv,,abd; abdo; abdomen+; abdominal; document; finding; findings; fluor; fluoro; fluoroscopy; guid; guide; guided; imaging; jnt; l/sp; l-spine; l-spine facet joint; lumbar; lumbo; point in time; rad; radiology; random; spinal; spinal cord; zygapophysial joint,Doc
72543-2,rf guidance for denervation of thoracic spine intercostal nerve,rf guided t-spine icn denerv,,document; dorsal spine; finding; findings; fluor; fluoro; fluoroscopy; guid; guide; guided; imaging; point in time; rad; radiology; random; spinal; spinal cord; th/sp; thorax; t-spine; t-spine icn,Doc
7254-6,black cottonwood ige ab [units/volume] in serum,black cottonwood ige qn,black cottonwood ige qn (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; black cottonwood; immune globulin e; immunoglobulin e; lombardy poplar; point in time; qnt; quan; quant; quantitative; random; serum; sr,Qn
72548-1,rfa guidance for removal of cv catheter from vein-- w contrast iv,rfa guided vein cvc rem--w contr iv,,c; cardio; cardiology; cath; contr; contra; contrst; cvc rem; document; extraction; finding; findings; fluor; fluoro; fluoroscopy; guid; guide; guided; heart disease; imaging; misc; miscellaneous; other; point in time; rad; radiology; random; remove; rfa; spec; to be specified in another part of the message; unspecified; ven; venogram; venography; venous; w contr iv; wc,Doc
72579-6,prealbumin/protein.total [pure mass fraction] in cerebral spinal fluid by electrophoresis,prealb mfr.df csf elph,prealbumin elph (csf) [pure mass fraction],cerebral spinal fluid; cerebrospinal fl; chemistry; elec; elect; electr; electro; electrophhrs; electrophrs; elp; elph; ep; neuro; neurology; palb; point in time; pr; pre albumin; prot; qnt; quan; quant; quantitative; random; spinal fl; spinal fld; spinal flu; spinal fluid; tot; totl; tp; transthyretin,Qn
72601-8,beta hydroxybutyrate + acetoacetate [moles/volume] in blood --pre-meal,b-oh-butyr+acetoacet pre-meal bld-scnc,beta hydroxybutyrate + acetoacetate pre-meal (bld) [moles/vol],3-hydroxybutyrate; 3-hydroxybutyric acid; 3-ketobutyrate; 3-oxobutyric acid; acac; acetoacetates; acetoacetic acid; b; before; beta hydroxy butyrate; beta hydroxybutyric acid; betahydroxybutyrate; betahydroxybutyric acid; beta-ketobutyrate; bhb; blood; bohb; b-oh-butyr; b-oh-butyr+acetoacet; chemistry.challenge testing; diacetate; diacetic acid; hydroxybutyric acid; ketone body ratio; level; oxobutyrate; point in time; qnt; quan; quant; quantitative; random; substance concentration; wb; whole blood,Qn
72603-4,beta hydroxybutyrate + acetoacetate [moles/volume] in blood,b-oh-butyr+acetoacet bld-scnc,beta hydroxybutyrate + acetoacetate (bld) [moles/vol],3-hydroxybutyrate; 3-hydroxybutyric acid; 3-ketobutyrate; 3-oxobutyric acid; acac; acetoacetates; acetoacetic acid; b; beta hydroxy butyrate; beta hydroxybutyric acid; betahydroxybutyrate; betahydroxybutyric acid; beta-ketobutyrate; bhb; blood; bohb; b-oh-butyr; b-oh-butyr+acetoacet; chemistry; diacetate; diacetic acid; hydroxybutyric acid; ketone body ratio; level; oxobutyrate; point in time; qnt; quan; quant; quantitative; random; substance concentration; wb; whole blood,Qn
72628-1,phenobarbital [presence] in saliva (oral fluid) by confirmatory method,phenobarb sal ql cfm,phenobarbital confirm ql (sal),barbiturate; c417; cfm; cnfr; cnfrm; conf; confirmation; confirmatory; drug/toxicology; drugs; gcms; lc/ms/ms; luminal; nirvonal; oral fluid; ordinal; phbr; phenobarb; point in time; pr; ql; qual; qualitative; random; sal; screen,Ord
72633-1,benzodiazepines [presence] in saliva (oral fluid) by screen method,benzodiaz sal ql scn,benzodiazepines screen ql (sal),benz; benzodiaz; benzodiazepine; drug/toxicology; drugs; oral fluid; ordinal; point in time; pr; ql; qual; qualitative; random; sal; scn; scr; screen; scrn,Ord
72646-3,albumin in serum - albumin in pericardial fluid [mass concentration difference],albumin ser-peric fld-mcdiff,albumin in serum - albumin in pericardial fluid (pericard fld+s/p) [mass conc diff],alb; alb pcar; alb ser; albumin gradient; albumin ser-peric fld; cardio; cardiology; chemistry; heart disease; mcdiff; pcar; pericard fld+serpl; pericardial fluid; pl; plasma; plsm; point in time; protein.albumin; qnt; quan; quant; quantitative; random; ser; serp; serpl; serplas; serum; serum or plasma; sr,Qn
72647-1,albumin in serum - albumin in pleural fluid [mass concentration difference],albumin ser-plr fld-mcdiff,albumin in serum - albumin in pleural fluid (s/p+pleur fld) [mass conc diff],alb; alb ser; albumin gradient; albumin ser-plr fld; chemistry; mcdiff; pl; plasma; pleural; pleural fluid; plsm; point in time; protein.albumin; qnt; quan; quant; quantitative; random; ser; serp; serpl; serpl+plr; serplas; serum; serum or plasma; sr; thoracentesis fluid,Qn
72649-7,glucose in serum - glucose in peritoneal fluid [molar concentration difference],glucose ser - prt fld-scdiff,glucose in serum - glucose in peritoneal fluid (periton fld+s/p) [molar conc diff],ascites; ascitic fluid; ascitis; chemistry; glu; gluc; glucose gradient; glucose ser - prt fld; glucoseur; periton fld+serpl; peritoneal fluid; pl; plasma; plsm; point in time; prt; qnt; quan; quant; quantitative; random; scdiff; ser; serp; serpl; serplas; serum; serum or plasma; sr,Qn
72654-7,snrpn gene 15q11 deletion and duplication mutation analysis [identifier] in blood or tissue by fish nominal,snrpn 15q11 del+dup bld/t fish,snrpn gene 15q11 del and dup mutation analysis fish nom (bld/tiss),"amplification; blood; del; del+dup; deletions; dp; fluorescent in situ hybridization; genetics; hcern3; heredity; heritable; identity or presence; inherited; molecular pathology; molpath; molpath.deletions; nominal; point in time; prader willi syndrome; pwcr; pws; random; rt-li; small nuclear ribonucleoprotein polypeptide n; sm-d; smn; sm-n; snrnp-n; snrpn 15q11; snrpn 15q11 del+dup; snurf-snrpn; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",Nom
72667-9,mycophenolate [mass/volume] in serum or plasma --trough,mycophenolate trough serpl-mcnc,mycophenolate trough [mass/vol],cellcept; drug/toxicology; drugs; level; mass concentration; mmf; mpa; mycophenolate mofetil; mycophenolic acid; pl; plasma; plsm; point in time; pre; predose; pre-dose; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
72676-0,sirolimus [mass/volume] in plasma --trough,sirolimus trough plas-mcnc,sirolimus trough (p) [mass/vol],drug/toxicology; drugs; level; mass concentration; pl; plasma; plsm; point in time; pre; predose; pre-dose; qnt; quan; quant; quantitative; random; rapamune; rapamycin; srl,Qn
72690-1,i felt worthless in the last week [bsl-23],,,1 week; borderline symptom list - 23 item; finding; findings; ordinal; past; ql; qual; qualitative; screen; survey; survey.mtlhlth,Ord
7270-2,curry ige ab [units/volume] in serum,curry ige qn,curry ige qn (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; f281; immune globulin e; immunoglobulin e; point in time; qnt; quan; quant; quantitative; random; rf281; santa maria; serum; sr,Qn
72715-6,i was absent-minded and unable to remember what i was actually doing in last week [bsl-23],,,1 week; absent minded; borderline symptom list - 23 item; finding; findings; ordinal; past; ql; qual; qualitative; screen; survey; survey.mtlhlth,Ord
72721-4,base excess.100% oxygenated [moles/volume] standard in arterial blood by calculation,base ex.oxy std blda calc-scnc,base excess.100% oxygenated standard calc (blda) [moles/vol],abe; abg; art; art bld; art blood; arterial; arterial blood; base ex; base ex.oxy; be; blood arterial; bse; calc; calculation; chemistry; exs; level; lung; point in time; pulmonary; pulmonology; qnt; quan; quant; quantitative; random; respiratory; sbe; std; substance concentration,Qn
72724-8,pm-scl-75 igg ab [presence] in serum or plasma by immunoassay,pm-scl75 igg serpl ql ia,pm-scl-75 igg ia ql,abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; eia; elfa; elisa; enzyme immunoassay; evening; iaa; immune globulin g; immunoglobulin g; meia; ordinal; pl; plasma; plsm; pm-scl75; pm-scl-75; point in time; polymyositis; pr; ql; qual; qualitative; random; scleroderma; screen; serology; serp; serpl; serplas; serum; serum or plasma; sr; suds; systemic sclerosis,Ord
72739-6,nordiazepam [mass/volume] in saliva (oral fluid) by confirmatory method,nordiazepam sal cfm-mcnc,nordiazepam confirm (sal) [mass/vol],calmday; cfm; chlordiazepoxide metabolite; cnfr; cnfrm; conf; confirmation; confirmatory; desmethyldiazepam; diazepam metabolite; dimethyldiazepam; drug/toxicology; drugs; gcms; lc/ms/ms; level; madar; mass concentration; n-dimethyldiazepam; nordaz; nordazepam; nordiaze; oral fluid; point in time; praxadium; prazepam metabolite; qnt; quan; quant; quantitative; random; sal; stilny; tranxilium n; vegesan,Qn
72752-9,morphine [mass/volume] in saliva (oral fluid) by confirmatory method,morphine sal cfm-mcnc,morphine confirm (sal) [mass/vol],addiction; c260; cfm; cnfr; cnfrm; conf; confirmation; confirmatory; drug/toxicology; drugs; drugs of abuse; gcms; illicit; lc/ms/ms; level; mass concentration; morphine sulfate; ms; mso4; omph; oral fluid; point in time; potentialforabuse; qnt; quan; quant; quantitative; random; sal,Qn
72772-7,o-desmethylvenlafaxine [mass/volume] in urine by confirmatory method,odv ur cfm-mcnc,o-desmethylvenlafaxine confirm (u) [mass/vol],cfm; cnfr; cnfrm; conf; confirmation; confirmatory; desmeth; desvenlafaxine; drug/toxicology; drugs; gcms; lc/ms/ms; level; mass concentration; norvenlafaxin; norvenlafaxine; o-desmethylvenlafaxine; odv; point in time; pristiq; qnt; quan; quant; quantitative; random; ua; ur; urn; venlafaxine metabolite,Qn
72777-6,deprecated jwh-018 butanol metabolite/creatinine [mass ratio] in urine,deprecated jwh-018 butanol/creat ur,jwh-018 butanol/creatinine (u) [mass ratio],1-butanol; am-678; cr; crea; creat; drug/toxicology; drugs; jwh-018 n-butanol metabolite; k2; mass concentration ratio; mass ratio; mcrto; n-butanol; n-butyl alcohol; point in time; propyl carbinol; qnt; quan; quant; quantitative; random; spice; spike; synthetic cannabinoid; synthetic cannabinoids; ua; ucr; ur; urn; yucatan fire,Qn
72781-8,jwh-018 pentanol (synthetic cannabinoid metabolite)/creatinine [mass ratio] in urine,jwh-018 pentanol/creat ur,jwh-018 pentanol/creatinine (u) [mass ratio],am-678; cr; crea; creat; drug/toxicology; drugs; jwh-018 n-pentanol metabolite; k2; mass concentration ratio; mass ratio; mcrto; point in time; qnt; quan; quant; quantitative; random; spice; spike; synthetic cannabinoid; synthetic cannabinoids; ua; ucr; ur; urn; yucatan fire,Qn
72787-5,deprecated 6-beta naltrexone [mass/volume] in urine by confirmatory method,deprecated 6b-naltrexone ur cfm-mcnc,6-beta naltrexone confirm (u) [mass/vol],6-beta naltrexol; 6b-naltrexone; addiction; b; cfm; cnfr; cnfrm; conf; confirmation; confirmatory; drug/toxicology; drugs; drugs of abuse; gcms; illicit; lc/ms/ms; level; mass concentration; naltrexone metabolite; point in time; potentialforabuse; qnt; quan; quant; quantitative; random; revia; ua; ur; urn; vivitrol,Qn
72800-6,norketamine/creatinine [mass ratio] in urine,norketamine/creat ur,norketamine/creatinine (u) [mass ratio],cr; crea; creat; drug/toxicology; drugs; ketamine metabolite; mass concentration ratio; mass ratio; mcrto; point in time; qnt; quan; quant; quantitative; random; ua; ucr; ur; urn,Qn
72810-5,gabapentin [mass/volume] in urine by confirmatory method,gabapentin ur cfm-mcnc,gabapentin confirm (u) [mass/vol],cfm; cnfr; cnfrm; conf; confirmation; confirmatory; drug/toxicology; drugs; gcms; horizant; lc/ms/ms; level; mass concentration; neurontin; point in time; qnt; quan; quant; quantitative; random; ua; ur; urn,Qn
72815-4,duloxetine/creatinine [mass ratio] in urine,duloxetine/creat ur,duloxetine/creatinine (u) [mass ratio],cr; crea; creat; cymbalta; drug/toxicology; drugs; mass concentration ratio; mass ratio; mcrto; point in time; qnt; quan; quant; quantitative; random; ua; ucr; ur; urn; yentreve,Qn
72820-4,5-hydroxyindoleacetate [mass/volume] in urine by confirmatory method,5oh-indoleacetate ur cfm-mcnc,5-hydroxyindoleacetate confirm (u) [mass/vol],5hia; 5hiaa; 5-hiaa; 5-hydroxy indoleacetate; 5-hydroxyindoleacetic acid; 5oh-indoleacetate; cfm; cnfr; cnfrm; conf; confirmation; confirmatory; drug/toxicology; drugs; gcms; hydroxyindoacet; lc/ms/ms; level; mass concentration; oncology; point in time; qnt; quan; quant; quantitative; random; serotonin metabolite; tumor marker; ua; ur; urn,Qn
72825-3,phencyclidine [mass/volume] in urine by screen method,pcp ur scn-mcnc,phencyclidine screen (u) [mass/vol],addiction; angel dust; drug/toxicology; drugs; drugs of abuse; illicit; level; mass concentration; pcp; point in time; potentialforabuse; qnt; quan; quant; quantitative; random; scn; scr; scrn; sernylan; ua; ur; urn,Qn
72846-9,hepatitis b virus codon 194 [identifier] by genotype method,hbv 194 islt genotyp,hbv codon 194 genotyping nom (isol),antibiotic susceptibilities; genotype; genotypic; hbv; hbv 194; hep; hep b; hepatis; hepatit; hepatology; hepb; id; identity or presence; infectious disease; infectiousdisease; islt; isol; liver; nominal; point in time; random,Nom
72891-5,staphylococcus protein a spa gene [presence] in isolate or specimen by naa with probe detection,spa gene islt/spm ql naa+probe,s. protein a spa gene naa+probe ql (islt/spec),3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; antibiotic susceptibilities; dna nucleic acid probe; dna probe; id; infectious disease; infectiousdisease; islt; islt/spm; isol; lat; lcr; ligase chain reaction; ligation-activated transcription; naa+probe; naat; nasba; nucleic acid sequence based analysis; ordinal; pcr; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; prot; qbr; ql; qual; qualitative; random; screen; sda; spec; staph; strand displacement amplification; tma; transcription mediated amplification,Ord
72896-4,glucose [moles/volume] in serum or plasma --15 minutes post dose lactose po,glucose 15m p lac po serpl-scnc,glucose 15 min post dose lactose po [moles/vol],15m p lac po; after; chemistry.challenge testing; endocrine; endocrinology; glu; glu tol; gluc; glucose tolerance; glucoseur; gtt; level; ltt; p dose; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; substance concentration,Qn
72901-2,insulin [moles/volume] in serum or plasma --2 hours post 75 g glucose po,insulin 2h p 75 g glc po serpl-scnc,insulin 2 hr post 75 g glucose po [moles/vol],120 min; 120 minutes; 120min; 2 hours; 2h p 75 g glc po; 75gm; after; chemistry.challenge testing; glu; glu tol; gluc; glucose tolerance; glucoseur; gtt; hum; humulin; ih7; insul; lente; level; nph; p 75 g glc po; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; semilente; serp; serpl; serplas; serum; serum or plasma; sliding; sr; substance concentration; ultralente,Qn
72910-3,hna 4a/4b ab [presence] in serum by immunoassay,hna 4a/4b ab ser ql ia,hna 4a/4b ab ia ql (s),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; eia; elfa; elisa; enzyme immunoassay; hna 4a/4b; human neutrophil antigen; human neutrophil antigens; iaa; meia; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; sr; suds,Ord
72912-9,hna 4a/4a ab [presence] in serum by immunoassay,hna 4a/4a ab ser ql ia,hna 4a/4a ab ia ql (s),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; eia; elfa; elisa; enzyme immunoassay; hna 4a/4a; human neutrophil antigen; human neutrophil antigens; iaa; meia; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; sr; suds,Ord
72922-8,hna 1a/1a ab [presence] in serum by immunoassay,hna 1a-1a ab ser ql ia,hna 1a/1a ab ia ql (s),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; eia; elfa; elisa; enzyme immunoassay; human neutrophil antigen; human neutrophil antigens; iaa; meia; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; sr; suds,Ord
72931-9,venlafaxine induced neutrophil igm ab [presence] in serum or plasma by flow cytometry (fc),venlafaxine (neut) igm serpl ql fc,venlafaxine induced neutrophil igm fc ql,(neut) ab; (neut) igm; abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; dynamic; efexor; effexor; fc; granulocytic ab; immune globulin m; immunoglobulin m; neut; neutr; neutrophils; ordinal; pl; plasma; plsm; pmn; pnm; point in time; pr; ql; qual; qualitative; random; screen; serology; serp; serpl; serplas; serum; serum or plasma; sr; venlafaxin,Ord
72939-2,topiramate induced neutrophil igm ab [presence] in serum or plasma by flow cytometry (fc),topiramate (neut) igm serpl ql fc,topiramate induced neutrophil igm fc ql,(neut) ab; (neut) igm; abs; aby; antby; anti; antibodies; antibody; atracurium besylate; autoantibodies; autoantibody; c12h21no8s; dynamic; fc; granulocytic ab; immune globulin m; immunoglobulin m; lennox-gastaut syndrome; neut; neutr; neutrophils; ordinal; pl; plasma; plsm; pmn; pnm; point in time; pr; ql; qual; qualitative; qudexy xr; random; screen; serology; serp; serpl; serplas; serum; serum or plasma; sr; topamax; toprimate; tracrium; trokendi xr,Ord
72944-2,tazobactam induced neutrophil igg ab [presence] in serum or plasma by flow cytometry (fc),tazobactam (neut) igg serpl ql fc,tazobactam induced neutrophil igg fc ql,(neut) ab; (neut) igg; abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; dynamic; fc; granulocytic ab; immune globulin g; immunoglobulin g; neut; neutr; neutrophils; ordinal; pl; plasma; plsm; pmn; pnm; point in time; pr; ql; qual; qualitative; random; screen; serology; serp; serpl; serplas; serum; serum or plasma; sr; tazobac,Ord
72947-5,sulfamethoxazole induced neutrophil igm ab [presence] in serum or plasma by flow cytometry (fc),sulfamethoxazole (neut) igm serpl ql fc,sulfamethoxazole induced neutrophil igm fc ql,(neut) ab; (neut) igm; abs; aby; acetylsulfamethoxazole; antby; anti; antibodies; antibody; autoantibodies; autoantibody; c203; c223; c61; dynamic; fc; gantanol; granulocytic ab; immune globulin m; immunoglobulin m; neut; neutr; neutrophils; ordinal; pl; plasma; plsm; pmn; pnm; point in time; pr; ql; qual; qualitative; random; screen; serology; serp; serpl; serplas; serum; serum or plasma; smx; sr; sulfa; sulfamethox,Ord
72952-5,simvastatin induced neutrophil igg ab [presence] in serum or plasma by flow cytometry (fc),simvastatin (neut) igg serpl ql fc,simvastatin induced neutrophil igg fc ql,(neut) ab; (neut) igg; abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; dynamic; fc; granulocytic ab; immune globulin g; immunoglobulin g; neut; neutr; neutrophils; ordinal; pl; plasma; plsm; pmn; pnm; point in time; pr; ql; qual; qualitative; random; screen; serology; serp; serpl; serplas; serum; serum or plasma; sr; zocor,Ord
7295-9,egg yolk triggered histamine release [units/volume] in blood,egg yolk basobnd ab qn,egg yolk triggered histamine release qn (bld),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; associated; autoantibodies; autoantibody; baso; basobnd ab; basophil release; basophils; basos; blood; bnd; bph; f075; f75; leukocyte histamine reaction; leukocyte histamine release; point in time; qnt; quan; quant; quantitative; random; wb; wbc release; whole blood,Qn
7296-7,eggplant ige ab [units/volume] in serum,eggplant ige qn,eggplant ige qn (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; aubergine; autoantibodies; autoantibody; eggplant; f262; immune globulin e; immunoglobulin e; point in time; qnt; quan; quant; quantitative; random; rf262; serum; sr,Qn
72971-5,phenytoin induced neutrophil igm ab [presence] in serum or plasma by flow cytometry (fc),phenytoin (neut) igm serpl ql fc,phenytoin induced neutrophil igm fc ql,(neut) ab; (neut) igm; abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; di-hydan; dilantin; dilj; diphenylhydantoin; dph; dynamic; epanutin; fc; fenantoin; granulocytic ab; immune globulin m; immunoglobulin m; lehydan; neut; neutr; neutrophils; ordinal; phenhydan; phyt; pl; plasma; plsm; pmn; pnm; point in time; pr; ql; qual; qualitative; random; screen; serology; serp; serpl; serplas; serum; serum or plasma; sinergina; sr; zentropil,Ord
72980-6,pantoprazole induced neutrophil igg ab [presence] in serum or plasma by flow cytometry (fc),pantoprazole (neut) igg serpl ql fc,pantoprazole induced neutrophil igg fc ql,(neut) ab; (neut) igg; abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; dynamic; fc; granulocytic ab; immune globulin g; immunoglobulin g; neut; neutr; neutrophils; ordinal; pl; plasma; plsm; pmn; pnm; point in time; pr; protonix; ql; qual; qualitative; random; screen; serology; serp; serpl; serplas; serum; serum or plasma; sr,Ord
72981-4,omeprazole induced neutrophil igm ab [presence] in serum or plasma by flow cytometry (fc),omeprazole (neut) igm serpl ql fc,omeprazole induced neutrophil igm fc ql,(neut) ab; (neut) igm; abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; dynamic; fc; granulocytic ab; immune globulin m; immunoglobulin m; neut; neutr; neutrophils; ordinal; pl; plasma; plsm; pmn; pnm; point in time; pr; prilosec; ql; qual; qualitative; random; screen; serology; serp; serpl; serplas; serum; serum or plasma; sr,Ord
72982-2,omeprazole induced neutrophil igg ab [presence] in serum or plasma by flow cytometry (fc),omeprazole (neut) igg serpl ql fc,omeprazole induced neutrophil igg fc ql,(neut) ab; (neut) igg; abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; dynamic; fc; granulocytic ab; immune globulin g; immunoglobulin g; neut; neutr; neutrophils; ordinal; pl; plasma; plsm; pmn; pnm; point in time; pr; prilosec; ql; qual; qualitative; random; screen; serology; serp; serpl; serplas; serum; serum or plasma; sr,Ord
73002-8,lisinopril induced neutrophil igg ab [presence] in serum or plasma by flow cytometry (fc),lisinopril (neut) igg serpl ql fc,lisinopril induced neutrophil igg fc ql,(neut) ab; (neut) igg; abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; dynamic; fc; granulocytic ab; immune globulin g; immunoglobulin g; neut; neutr; neutrophils; ordinal; pl; plasma; plsm; pmn; pnm; point in time; pr; prinivil; ql; qual; qualitative; random; screen; serology; serp; serpl; serplas; serum; serum or plasma; sr; tensopril,Ord
73009-3,ibuprofen induced neutrophil igm ab [presence] in serum or plasma by flow cytometry (fc),ibuprofen (neut) igm serpl ql fc,ibuprofen induced neutrophil igm fc ql,(neut) ab; (neut) igm; abs; aby; advil; antby; anti; antibodies; antibody; autoantibodies; autoantibody; c20; c235; c286; c53; dynamic; fc; granulocytic ab; immune globulin m; immunoglobulin m; motrin; neut; neutr; neutrophils; ordinal; pl; plasma; plsm; pmn; pnm; point in time; pr; ql; qual; qualitative; random; screen; serology; serp; serpl; serplas; serum; serum or plasma; sr,Ord
73020-0,fluconazole induced neutrophil igg ab [presence] in serum or plasma by flow cytometry (fc),fluconazole (neut) igg serpl ql fc,fluconazole induced neutrophil igg fc ql,(neut) ab; (neut) igg; abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; diflucan; dynamic; fc; granulocytic ab; immune globulin g; immunoglobulin g; neut; neutr; neutrophils; ordinal; pl; plasma; plsm; pmn; pnm; point in time; pr; ql; qual; qualitative; random; screen; serology; serp; serpl; serplas; serum; serum or plasma; sr,Ord
73046-5,cefepime induced neutrophil igg ab [presence] in serum or plasma by flow cytometry (fc),cefepime (neut) igg serpl ql fc,cefepime induced neutrophil igg fc ql,(neut) ab; (neut) igg; abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; cefipime; dynamic; fc; granulocytic ab; immune globulin g; immunoglobulin g; maxipime; neut; neutr; neutrophils; ordinal; pl; plasma; plsm; pmn; pnm; point in time; pr; ql; qual; qualitative; random; screen; serology; serp; serpl; serplas; serum; serum or plasma; sr,Ord
73049-9,carbamazepine induced neutrophil igm ab [presence] in serum or plasma by flow cytometry (fc),carbamazepine (neut) igm serpl ql fc,carbamazepine induced neutrophil igm fc ql,(neut) ab; (neut) igm; abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; carbamazapine; carbamezapine; carbazepine; crbm; dynamic; epitol; fc; granulocytic ab; immune globulin m; immunoglobulin m; neut; neutr; neutrophils; ordinal; pl; plasma; plsm; pmn; pnm; point in time; pr; ql; qual; qualitative; random; screen; serology; serp; serpl; serplas; serum; serum or plasma; sr; tegretol; teril,Ord
73050-7,carbamazepine induced neutrophil igg ab [presence] in serum or plasma by flow cytometry (fc),carbamazepine (neut) igg serpl ql fc,carbamazepine induced neutrophil igg fc ql,(neut) ab; (neut) igg; abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; carbamazapine; carbamezapine; carbazepine; crbm; dynamic; epitol; fc; granulocytic ab; immune globulin g; immunoglobulin g; neut; neutr; neutrophils; ordinal; pl; plasma; plsm; pmn; pnm; point in time; pr; ql; qual; qualitative; random; screen; serology; serp; serpl; serplas; serum; serum or plasma; sr; tegretol; teril,Ord
73054-9,atorvastatin induced neutrophil igg ab [presence] in serum or plasma by flow cytometry (fc),atorvastatin (neut) igg serpl ql fc,atorvastatin induced neutrophil igg fc ql,(neut) ab; (neut) igg; abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; dynamic; fc; granulocytic ab; immune globulin g; immunoglobulin g; lipitor; neut; neutr; neutrophils; ordinal; pl; plasma; plsm; pmn; pnm; point in time; pr; ql; qual; qualitative; random; screen; serology; serp; serpl; serplas; serum; serum or plasma; sr,Ord
73062-2,amoxicillin induced neutrophil igg ab [presence] in serum or plasma by flow cytometry (fc),amoxicillin (neut) igg serpl ql fc,amoxicillin induced neutrophil igg fc ql,(neut) ab; (neut) igg; abs; aby; amox; amoxicilloyl; amoxil; antby; anti; antibodies; antibody; autoantibodies; autoantibody; bristamox; c204; c6; dynamic; fc; granulocytic ab; immune globulin g; immunoglobulin g; larotid; moxalin; neut; neutr; neutrophils; ordinal; pl; plasma; plsm; pmn; pnm; point in time; polymox; pr; ql; qual; qualitative; random; screen; serology; serp; serpl; serplas; serum; serum or plasma; sr; sumox; trimox; wymox,Ord
73071-3,alendronate induced neutrophil igm ab [presence] in serum or plasma by flow cytometry (fc),alendronate (neut) igm serpl ql fc,alendronate induced neutrophil igm fc ql,(neut) ab; (neut) igm; abs; aby; alendronic acid; antby; anti; antibodies; antibody; autoantibodies; autoantibody; dynamic; fc; fosamax; granulocytic ab; immune globulin m; immunoglobulin m; neut; neutr; neutrophils; ordinal; pl; plasma; plsm; pmn; pnm; point in time; pr; ql; qual; qualitative; random; screen; serology; serp; serpl; serplas; serum; serum or plasma; sr,Ord
73095-2,valdecoxib induced platelet igm ab [presence] in serum or plasma by flow cytometry (fc),valdecoxib ind plt igm serpl ql fc,valdecoxib induced platelet igm fc ql,abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; bextra; circulating platelet ab; dynamic; fc; immune globulin m; immunoglobulin m; ind plt ab; ind plt igm; ordinal; pl; plasma; platelet ab.free; platelet auto-antibodies; platelets; platelt; plsm; plt; point in time; pr; ql; qual; qualitative; random; screen; serology; serp; serpl; serplas; serum; serum or plasma; sr; thrombocyte; thrombocytes,Ord
73097-8,valacyclovir induced platelet igm ab [presence] in serum or plasma by flow cytometry (fc),valacyclovir ind plt igm serpl ql fc,valacyclovir induced platelet igm fc ql,abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; circulating platelet ab; dynamic; fc; immune globulin m; immunoglobulin m; ind plt ab; ind plt igm; ordinal; pl; plasma; platelet ab.free; platelet auto-antibodies; platelets; platelt; plsm; plt; point in time; pr; ql; qual; qualitative; random; screen; serology; serp; serpl; serplas; serum; serum or plasma; sr; thrombocyte; thrombocytes; valaciclovir; valtrex; zelitrex,Ord
73102-6,triazolam induced platelet igg ab [presence] in serum or plasma by flow cytometry (fc),triazolam ind plt igg serpl ql fc,triazolam induced platelet igg fc ql,abs; aby; antby; anti; antibodies; antibody; apo-triazo; autoantibodies; autoantibody; circulating platelet ab; dynamic; fc; halcion; immune globulin g; immunoglobulin g; ind plt ab; ind plt igg; novo-triolam; ordinal; pl; plasma; platelet ab.free; platelet auto-antibodies; platelets; platelt; plsm; plt; point in time; pr; ql; qual; qualitative; random; screen; serology; serp; serpl; serplas; serum; serum or plasma; sr; thrombocyte; thrombocytes,Ord
73105-9,triamterene induced platelet igm ab [presence] in serum or plasma by flow cytometry (fc),triamterene ind plt igm serpl ql fc,triamterene induced platelet igm fc ql,abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; circulating platelet ab; dynamic; dyrenium; fc; immune globulin m; immunoglobulin m; ind plt ab; ind plt igm; ordinal; pl; plasma; platelet ab.free; platelet auto-antibodies; platelets; platelt; plsm; plt; point in time; pr; ql; qual; qualitative; random; screen; serology; serp; serpl; serplas; serum; serum or plasma; sr; thrombocyte; thrombocytes,Ord
73109-1,tramadol induced platelet igg ab [presence] in serum or plasma by flow cytometry (fc),tramadol ind plt igg serpl ql fc,tramadol induced platelet igg fc ql,abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; circulating platelet ab; dynamic; fc; immune globulin g; immunoglobulin g; ind plt ab; ind plt igg; ordinal; pl; plasma; platelet ab.free; platelet auto-antibodies; platelets; platelt; plsm; plt; point in time; pr; ql; qual; qualitative; random; screen; serology; serp; serpl; serplas; serum; serum or plasma; sr; thrombocyte; thrombocytes; tramal; ultram,Ord
73113-3,tolterodine induced platelet igm ab [presence] in serum or plasma by flow cytometry (fc),tolterodine ind plt igm serpl ql fc,tolterodine induced platelet igm fc ql,abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; circulating platelet ab; detrol; detrusitol; dynamic; fc; immune globulin m; immunoglobulin m; ind plt ab; ind plt igm; ordinal; pl; plasma; platelet ab.free; platelet auto-antibodies; platelets; platelt; plsm; plt; point in time; pr; ql; qual; qualitative; random; screen; serology; serp; serpl; serplas; serum; serum or plasma; sr; thrombocyte; thrombocytes,Ord
73120-8,tetracycline induced platelet igm ab [presence] in serum or plasma by flow cytometry (fc),tetracycline ind plt igm serpl ql fc,tetracycline induced platelet igm fc ql,abs; aby; achromycin v; antby; anti; antibodies; antibody; autoantibodies; autoantibody; c18; c211; c75; chemiciclina; circulating platelet ab; dynamic; fc; immune globulin m; immunoglobulin m; ind plt ab; ind plt igm; ordinal; panmycin; pl; plasma; platelet ab.free; platelet auto-antibodies; platelets; platelt; plsm; plt; point in time; pr; ql; qual; qualitative; random; screen; serology; serp; serpl; serplas; serum; serum or plasma; sr; tetrabioptal; thrombocyte; thrombocytes,Ord
73154-7,sertraline induced platelet igm ab [presence] in serum or plasma by flow cytometry (fc),sertraline ind plt igm serpl ql fc,sertraline induced platelet igm fc ql,abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; circulating platelet ab; dynamic; fc; immune globulin m; immunoglobulin m; ind plt ab; ind plt igm; ordinal; pl; plasma; platelet ab.free; platelet auto-antibodies; platelets; platelt; plsm; plt; point in time; pr; ql; qual; qualitative; random; screen; serology; serp; serpl; serplas; serum; serum or plasma; sr; thrombocyte; thrombocytes; zoloft,Ord
73181-0,quinapril induced platelet igg ab [presence] in serum or plasma by flow cytometry (fc),quinapril ind plt igg serpl ql fc,quinapril induced platelet igg fc ql,abs; aby; accupril; antby; anti; antibodies; antibody; autoantibodies; autoantibody; circulating platelet ab; dynamic; fc; immune globulin g; immunoglobulin g; ind plt ab; ind plt igg; ordinal; pl; plasma; platelet ab.free; platelet auto-antibodies; platelets; platelt; plsm; plt; point in time; pr; ql; qual; qualitative; random; screen; serology; serp; serpl; serplas; serum; serum or plasma; sr; thrombocyte; thrombocytes,Ord
73183-6,quetiapine induced platelet igg ab [presence] in serum or plasma by flow cytometry (fc),quetiapine ind plt igg serpl ql fc,quetiapine induced platelet igg fc ql,abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; circulating platelet ab; dynamic; fc; immune globulin g; immunoglobulin g; ind plt ab; ind plt igg; ketipinor; ordinal; pl; plasma; platelet ab.free; platelet auto-antibodies; platelets; platelt; plsm; plt; point in time; pr; ql; qual; qualitative; random; screen; serology; seroquel; serp; serpl; serplas; serum; serum or plasma; sr; thrombocyte; thrombocytes; xeroquel,Ord
73206-5,phenytoin induced platelet igg ab [presence] in serum or plasma by flow cytometry (fc),phenytoin ind plt igg serpl ql fc,phenytoin induced platelet igg fc ql,abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; circulating platelet ab; di-hydan; dilantin; dilj; diphenylhydantoin; dph; dynamic; epanutin; fc; fenantoin; immune globulin g; immunoglobulin g; ind plt ab; ind plt igg; lehydan; ordinal; phenhydan; phyt; pl; plasma; platelet ab.free; platelet auto-antibodies; platelets; platelt; plsm; plt; point in time; pr; ql; qual; qualitative; random; screen; serology; serp; serpl; serplas; serum; serum or plasma; sinergina; sr; thrombocyte; thrombocytes; zentropil,Ord
73211-5,perphenazine induced platelet igg ab [presence] in serum or plasma by flow cytometry (fc),perphenazine ind plt igg serpl ql fc,perphenazine induced platelet igg fc ql,abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; circulating platelet ab; dynamic; fc; immune globulin g; immunoglobulin g; ind plt ab; ind plt igg; ordinal; pl; plasma; platelet ab.free; platelet auto-antibodies; platelets; platelt; plsm; plt; point in time; pr; ql; qual; qualitative; random; screen; serology; serp; serpl; serplas; serum; serum or plasma; sr; thrombocyte; thrombocytes; trilafon,Ord
73245-3,nifedipine induced platelet igg ab [presence] in serum or plasma by flow cytometry (fc),nifedipine ind plt igg serpl ql fc,nifedipine induced platelet igg fc ql,abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; circulating platelet ab; dynamic; fc; immune globulin g; immunoglobulin g; ind plt ab; ind plt igg; ordinal; pl; plasma; platelet ab.free; platelet auto-antibodies; platelets; platelt; plsm; plt; point in time; pr; procardia; ql; qual; qualitative; random; screen; serology; serp; serpl; serplas; serum; serum or plasma; sr; thrombocyte; thrombocytes,Ord
7324-7,fusarium culmorum igg ab [units/volume] in serum,f culmorum igg qn,fusarium culmorum igg qn (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; f culmorum; immune globulin g; immunoglobulin g; m18; point in time; qnt; quan; quant; quantitative; random; serum; sr,Qn
73250-3,nafcillin induced platelet igm ab [presence] in serum or plasma by flow cytometry (fc),nafcillin ind plt igm serpl ql fc,nafcillin induced platelet igm fc ql,abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; circulating platelet ab; dynamic; fc; immune globulin m; immunoglobulin m; ind plt ab; ind plt igm; nafj; ordinal; pl; plasma; platelet ab.free; platelet auto-antibodies; platelets; platelt; plsm; plt; point in time; pr; ql; qual; qualitative; random; screen; serology; serp; serpl; serplas; serum; serum or plasma; sr; thrombocyte; thrombocytes; unipen,Ord
73253-7,mycophenolate induced platelet igg ab [presence] in serum or plasma by flow cytometry (fc),mycophenolate ind plt igg serpl ql fc,mycophenolate induced platelet igg fc ql,abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; cellcept; circulating platelet ab; dynamic; fc; immune globulin g; immunoglobulin g; ind plt ab; ind plt igg; mmf; mpa; mycophenolate mofetil; mycophenolic acid; ordinal; pl; plasma; platelet ab.free; platelet auto-antibodies; platelets; platelt; plsm; plt; point in time; pr; ql; qual; qualitative; random; screen; serology; serp; serpl; serplas; serum; serum or plasma; sr; thrombocyte; thrombocytes,Ord
73256-0,morphine induced platelet igm ab [presence] in serum or plasma by flow cytometry (fc),morphine ind plt igm serpl ql fc,morphine induced platelet igm fc ql,abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; c260; circulating platelet ab; dynamic; fc; immune globulin m; immunoglobulin m; ind plt ab; ind plt igm; morphine sulfate; ms; mso4; omph; ordinal; pl; plasma; platelet ab.free; platelet auto-antibodies; platelets; platelt; plsm; plt; point in time; pr; ql; qual; qualitative; random; screen; serology; serp; serpl; serplas; serum; serum or plasma; sr; thrombocyte; thrombocytes,Ord
73268-5,midazolam induced platelet igm ab [presence] in serum or plasma by flow cytometry (fc),midazolam ind plt igm serpl ql fc,midazolam induced platelet igm fc ql,abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; circulating platelet ab; dynamic; fc; immune globulin m; immunoglobulin m; ind plt ab; ind plt igm; ordinal; pl; plasma; platelet ab.free; platelet auto-antibodies; platelets; platelt; plsm; plt; point in time; pr; ql; qual; qualitative; random; screen; serology; serp; serpl; serplas; serum; serum or plasma; sr; thrombocyte; thrombocytes; versed,Ord
73269-3,midazolam induced platelet igg ab [presence] in serum or plasma by flow cytometry (fc),midazolam ind plt igg serpl ql fc,midazolam induced platelet igg fc ql,abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; circulating platelet ab; dynamic; fc; immune globulin g; immunoglobulin g; ind plt ab; ind plt igg; ordinal; pl; plasma; platelet ab.free; platelet auto-antibodies; platelets; platelt; plsm; plt; point in time; pr; ql; qual; qualitative; random; screen; serology; serp; serpl; serplas; serum; serum or plasma; sr; thrombocyte; thrombocytes; versed,Ord
73278-4,methylphenidate induced platelet igg ab [presence] in serum or plasma by flow cytometry (fc),me-phenidate ind plt igg serpl ql fc,methylphenidate induced platelet igg fc ql,abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; circulating platelet ab; dynamic; fc; immune globulin g; immunoglobulin g; ind plt ab; ind plt igg; me-phenidate; ordinal; pl; plasma; platelet ab.free; platelet auto-antibodies; platelets; platelt; plsm; plt; point in time; pr; ql; qual; qualitative; random; ritalin; screen; serology; serp; serpl; serplas; serum; serum or plasma; sr; thrombocyte; thrombocytes,Ord
73284-2,methocarbamol induced platelet igm ab [presence] in serum or plasma by flow cytometry (fc),methocarbamol ind plt igm serpl ql fc,methocarbamol induced platelet igm fc ql,abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; carbacot; circulating platelet ab; dynamic; fc; immune globulin m; immunoglobulin m; ind plt ab; ind plt igm; ordinal; pl; plasma; platelet ab.free; platelet auto-antibodies; platelets; platelt; plsm; plt; point in time; pr; ql; qual; qualitative; random; robaxin; screen; serology; serp; serpl; serplas; serum; serum or plasma; skelex; sr; thrombocyte; thrombocytes,Ord
73306-3,levofloxacin induced platelet igm ab [presence] in serum or plasma by flow cytometry (fc),levofloxacin ind plt igm serpl ql fc,levofloxacin induced platelet igm fc ql,abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; circulating platelet ab; dynamic; fc; immune globulin m; immunoglobulin m; ind plt ab; ind plt igm; ordinal; pl; plasma; platelet ab.free; platelet auto-antibodies; platelets; platelt; plsm; plt; point in time; pr; ql; qual; qualitative; random; screen; serology; serp; serpl; serplas; serum; serum or plasma; sr; thrombocyte; thrombocytes,Ord
73364-2,gentamicin induced platelet igm ab [presence] in serum or plasma by flow cytometry (fc),gentamicin ind plt igm serpl ql fc,gentamicin induced platelet igm fc ql,abs; aby; aminoglycosides; antby; anti; antibodies; antibody; autoantibodies; autoantibody; c213; circulating platelet ab; dynamic; fc; garamycin; genirr; genj; gent; immune globulin m; immunoglobulin m; ind plt ab; ind plt igm; ordinal; pl; plasma; platelet ab.free; platelet auto-antibodies; platelets; platelt; plsm; plt; point in time; pr; ql; qual; qualitative; random; screen; serology; serp; serpl; serplas; serum; serum or plasma; sr; thrombocyte; thrombocytes,Ord
73369-1,furosemide induced platelet igg ab [presence] in serum or plasma by flow cytometry (fc),furosemide ind plt igg serpl ql fc,furosemide induced platelet igg fc ql,abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; c210; circulating platelet ab; dynamic; fc; furj; immune globulin g; immunoglobulin g; ind plt ab; ind plt igg; lasix; lasj; ordinal; pl; plasma; platelet ab.free; platelet auto-antibodies; platelets; platelt; plsm; plt; point in time; pr; ql; qual; qualitative; random; screen; serology; serp; serpl; serplas; serum; serum or plasma; sr; thrombocyte; thrombocytes,Ord
73370-9,fosinopril induced platelet igm ab [presence] in serum or plasma by flow cytometry (fc),fosinopril ind plt igm serpl ql fc,fosinopril induced platelet igm fc ql,abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; circulating platelet ab; dynamic; fc; immune globulin m; immunoglobulin m; ind plt ab; ind plt igm; monopril; ordinal; pl; plasma; platelet ab.free; platelet auto-antibodies; platelets; platelt; plsm; plt; point in time; pr; ql; qual; qualitative; random; screen; serology; serp; serpl; serplas; serum; serum or plasma; sr; thrombocyte; thrombocytes,Ord
73382-4,fentanyl induced platelet igg ab [presence] in serum or plasma by flow cytometry (fc),fentanyl ind plt igg serpl ql fc,fentanyl induced platelet igg fc ql,abs; aby; actiq; antby; anti; antibodies; antibody; autoantibodies; autoantibody; circulating platelet ab; duragesic; durogesic; dynamic; fc; fenpat; fentanil; immune globulin g; immunoglobulin g; ind plt ab; ind plt igg; ordinal; pl; plasma; platelet ab.free; platelet auto-antibodies; platelets; platelt; plsm; plt; point in time; pr; ql; qual; qualitative; random; screen; serology; serp; serpl; serplas; serum; serum or plasma; sr; sublimaze; thrombocyte; thrombocytes,Ord
73383-2,fentanyl induced platelet igm ab [presence] in serum or plasma by flow cytometry (fc),fentanyl ind plt igm serpl ql fc,fentanyl induced platelet igm fc ql,abs; aby; actiq; antby; anti; antibodies; antibody; autoantibodies; autoantibody; circulating platelet ab; duragesic; durogesic; dynamic; fc; fenpat; fentanil; immune globulin m; immunoglobulin m; ind plt ab; ind plt igm; ordinal; pl; plasma; platelet ab.free; platelet auto-antibodies; platelets; platelt; plsm; plt; point in time; pr; ql; qual; qualitative; random; screen; serology; serp; serpl; serplas; serum; serum or plasma; sr; sublimaze; thrombocyte; thrombocytes,Ord
73385-7,fenofibrate induced platelet igg ab [presence] in serum or plasma by flow cytometry (fc),fenofibrate ind plt igg serpl ql fc,fenofibrate induced platelet igg fc ql,abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; circulating platelet ab; dynamic; fc; immune globulin g; immunoglobulin g; ind plt ab; ind plt igg; ordinal; pl; plasma; platelet ab.free; platelet auto-antibodies; platelets; platelt; plsm; plt; point in time; pr; ql; qual; qualitative; random; screen; serology; serp; serpl; serplas; serum; serum or plasma; sr; thrombocyte; thrombocytes; tricor,Ord
73387-3,famotidine induced platelet igg ab [presence] in serum or plasma by flow cytometry (fc),famotidine ind plt igg serpl ql fc,famotidine induced platelet igg fc ql,abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; circulating platelet ab; dynamic; fc; immune globulin g; immunoglobulin g; ind plt ab; ind plt igg; ordinal; pepcid; pl; plasma; platelet ab.free; platelet auto-antibodies; platelets; platelt; plsm; plt; point in time; pr; ql; qual; qualitative; random; screen; serology; serp; serpl; serplas; serum; serum or plasma; sr; thrombocyte; thrombocytes,Ord
73391-5,esomeprazole induced platelet igg ab [presence] in serum or plasma by flow cytometry (fc),esomeprazole ind plt igg serpl ql fc,esomeprazole induced platelet igg fc ql,abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; circulating platelet ab; dynamic; fc; immune globulin g; immunoglobulin g; ind plt ab; ind plt igg; nexium; ordinal; pl; plasma; platelet ab.free; platelet auto-antibodies; platelets; platelt; plsm; plt; point in time; pr; ql; qual; qualitative; random; screen; serology; serp; serpl; serplas; serum; serum or plasma; sr; thrombocyte; thrombocytes,Ord
73395-6,erythromycin induced platelet igg ab [presence] in serum or plasma by flow cytometry (fc),erythromycin ind plt igg serpl ql fc,erythromycin induced platelet igg fc ql,abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; c212; circulating platelet ab; dynamic; ees; erygel; erythromycn; fc; ilosone; ilotycin; iltycin; immune globulin g; immunoglobulin g; ind plt ab; ind plt igg; ordinal; pl; plasma; platelet ab.free; platelet auto-antibodies; platelets; platelt; plsm; plt; point in time; pr; ql; qual; qualitative; random; screen; serology; serp; serpl; serplas; serum; serum or plasma; sr; thrombocyte; thrombocytes,Ord
73412-9,diphenoxylate and atropine (lomatil) induced platelet igm ab [presence] in serum or plasma by flow cytometry (fc),diphenox+atropine ind plt igm sp ql fc,diphenoxylate and atropine (lomatil) induced platelet igm fc ql,abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; circulating platelet ab; co-phenotrope; diphenox+atropine; dynamic; enlon; fc; immune globulin m; immunoglobulin m; ind plt ab; ind plt igm; lomotil; ordinal; pl; plasma; platelet ab.free; platelet auto-antibodies; platelets; platelt; plsm; plt; point in time; pr; ql; qual; qualitative; random; screen; serology; serp; serpl; serplas; serum; serum or plasma; sr; thrombocyte; thrombocytes,Ord
73414-5,diphenhydramine induced platelet igm ab [presence] in serum or plasma by flow cytometry (fc),diphenhy ind plt igm serpl ql fc,diphenhydramine induced platelet igm fc ql,abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; benadryl; circulating platelet ab; diphenhydr; diphenylhydramine; dynamic; fc; immune globulin m; immunoglobulin m; ind plt ab; ind plt igm; ordinal; pl; plasma; platelet ab.free; platelet auto-antibodies; platelets; platelt; plsm; plt; point in time; pr; ql; qual; qualitative; random; screen; serology; serp; serpl; serplas; serum; serum or plasma; sr; thrombocyte; thrombocytes,Ord
73415-2,diphenhydramine induced platelet igg ab [presence] in serum or plasma by flow cytometry (fc),diphenhy ind plt igg serpl ql fc,diphenhydramine induced platelet igg fc ql,abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; benadryl; circulating platelet ab; diphenhydr; diphenylhydramine; dynamic; fc; immune globulin g; immunoglobulin g; ind plt ab; ind plt igg; ordinal; pl; plasma; platelet ab.free; platelet auto-antibodies; platelets; platelt; plsm; plt; point in time; pr; ql; qual; qualitative; random; screen; serology; serp; serpl; serplas; serum; serum or plasma; sr; thrombocyte; thrombocytes,Ord
73428-5,colchicine induced platelet igg ab [presence] in serum or plasma by flow cytometry (fc),colchicine ind plt igg serpl ql fc,colchicine induced platelet igg fc ql,abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; c22h25no6; circulating platelet ab; colchiceine methyl ether; colchineos; colchisol; colcin; colgout; colsaloid; condylon; dynamic; fc; immune globulin g; immunoglobulin g; ind plt ab; ind plt igg; n-acetyltrimethylcolchicinic acid methyl ether; ordinal; pl; plasma; platelet ab.free; platelet auto-antibodies; platelets; platelt; plsm; plt; point in time; pr; ql; qual; qualitative; random; screen; serology; serp; serpl; serplas; serum; serum or plasma; sr; thrombocyte; thrombocytes,Ord
7342-9,goldenrod igg ab [units/volume] in serum,goldenrod igg qn,goldenrod igg qn (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; golden rod; goldenrod; immune globulin g; immunoglobulin g; point in time; qnt; quan; quant; quantitative; random; serum; sr; w012; w12,Qn
73438-4,clavulanate induced platelet igm ab [presence] in serum or plasma by flow cytometry (fc),clavulanate ind plt igm serpl ql fc,clavulanate induced platelet igm fc ql,abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; c305; circulating platelet ab; clav; clavate; clavu; clavul; clavulanic; clavulanic acid; dynamic; fc; immune globulin m; immunoglobulin m; ind plt ab; ind plt igm; ordinal; pl; plasma; platelet ab.free; platelet auto-antibodies; platelets; platelt; plsm; plt; point in time; pr; ql; qual; qualitative; random; screen; serology; serp; serpl; serplas; serum; serum or plasma; sr; thrombocyte; thrombocytes,Ord
7345-2,grain ige ab [units/volume] in serum,grain ige qn,grain ige qn (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; immune globulin e; immunoglobulin e; point in time; qnt; quan; quant; quantitative; random; serum; sr,Qn
73454-1,chlorpromazine induced platelet igg ab [presence] in serum or plasma by flow cytometry (fc),chlorpromazine ind plt igg serpl ql fc,chlorpromazine induced platelet igg fc ql,abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; chlopromazine; chlorpromaz; circulating platelet ab; dynamic; fc; immune globulin g; immunoglobulin g; ind plt ab; ind plt igg; ordinal; pl; plasma; platelet ab.free; platelet auto-antibodies; platelets; platelt; plsm; plt; point in time; pr; ql; qual; qualitative; random; screen; serology; serp; serpl; serplas; serum; serum or plasma; sr; thorazine; thrombocyte; thrombocytes,Ord
73457-4,chlordiazepoxide induced platelet igg ab [presence] in serum or plasma by flow cytometry (fc),chlordiazep ind plt igg serpl ql fc,chlordiazepoxide induced platelet igg fc ql,abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; chlordiaz; chlordiaze; chlordiazep; circulating platelet ab; dynamic; fc; immune globulin g; immunoglobulin g; ind plt ab; ind plt igg; librium; ordinal; pl; plasma; platelet ab.free; platelet auto-antibodies; platelets; platelt; plsm; plt; point in time; pr; ql; qual; qualitative; random; screen; serology; serp; serpl; serplas; serum; serum or plasma; sr; thrombocyte; thrombocytes,Ord
73461-6,celecoxib induced platelet igg ab [presence] in serum or plasma by flow cytometry (fc),celecoxib ind plt igg serpl ql fc,celecoxib induced platelet igg fc ql,abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; celebrex; circulating platelet ab; dynamic; fc; immune globulin g; immunoglobulin g; ind plt ab; ind plt igg; ordinal; pl; plasma; platelet ab.free; platelet auto-antibodies; platelets; platelt; plsm; plt; point in time; pr; ql; qual; qualitative; random; screen; serology; serp; serpl; serplas; serum; serum or plasma; sr; thrombocyte; thrombocytes,Ord
73496-2,bupropion induced platelet igg ab [presence] in serum or plasma by flow cytometry (fc),bupropion ind plt igg serpl ql fc,bupropion induced platelet igg fc ql,abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; circulating platelet ab; dynamic; fc; immune globulin g; immunoglobulin g; ind plt ab; ind plt igg; ordinal; pl; plasma; platelet ab.free; platelet auto-antibodies; platelets; platelt; plsm; plt; point in time; pr; ql; qual; qualitative; random; screen; serology; serp; serpl; serplas; serum; serum or plasma; sr; thrombocyte; thrombocytes; wellbutrin; zyban,Ord
73502-7,bivalirudin induced platelet igm ab [presence] in serum or plasma by flow cytometry (fc),bivalirudin ind plt igm serpl ql fc,bivalirudin induced platelet igm fc ql,abs; aby; angiomax; angiox; antby; anti; antibodies; antibody; autoantibodies; autoantibody; circulating platelet ab; dynamic; fc; immune globulin m; immunoglobulin m; ind plt ab; ind plt igm; ordinal; pl; plasma; platelet ab.free; platelet auto-antibodies; platelets; platelt; plsm; plt; point in time; pr; ql; qual; qualitative; random; screen; serology; serp; serpl; serplas; serum; serum or plasma; sr; thrombocyte; thrombocytes,Ord
73533-2,amitriptyline induced platelet igm ab [presence] in serum or plasma by flow cytometry (fc),amitrip ind plt igm serpl ql fc,amitriptyline induced platelet igm fc ql,abs; aby; amit; amitrip; amitriptylene; amitriptyln; antby; anti; antibodies; antibody; autoantibodies; autoantibody; circulating platelet ab; dynamic; elatrol; elavil; endep; fc; immune globulin m; immunoglobulin m; ind plt ab; ind plt igm; ordinal; pl; plasma; platelet ab.free; platelet auto-antibodies; platelets; platelt; plsm; plt; point in time; pr; ql; qual; qualitative; random; screen; serology; serp; serpl; serplas; serum; serum or plasma; sr; thrombocyte; thrombocytes; trepiline; tryptanol; tryptizol,Ord
73564-7,alpha hydroxytriazolam [mass/mass] in meconium by confirmatory method,a-oh-triazolam mec cfm-mcnt,alpha hydroxytriazolam confirm (mec) [mass/mass],1-hydroxytriazolam; alfa; alpha hydroxy triazolam; a-oh-triazolam; cfm; cnfr; cnfrm; conf; confirmation; confirmatory; drug/toxicology; drugs; gcms; hydroxy triazolam; lc/ms/ms; mass content; mec; oh-triazolam; ohtrz; point in time; qnt; quan; quant; quantitative; random; triazolam metabolite,Qn
73565-4,trenbolone [presence] in urine,trenbolone ur ql,trenbolone ql (u),drug/toxicology; drugs; ordinal; point in time; pr; ql; qual; qualitative; random; screen; ua; ur; urn,Ord
73566-2,dextrorphan [mass/volume] in urine,dxo ur-mcnc,dextrorphan (u) [mass/vol],addiction; drug/toxicology; drugs; drugs of abuse; dxo; illicit; level; mass concentration; point in time; potentialforabuse; qnt; quan; quant; quantitative; random; ua; ur; urn,Qn
73571-2,osmol gap of stool,osmol gap stl,osmol gap (stl) [osmolality],bowel movement; chemistry; faecal; faeces; fecal; feces; osmo; osmolality; osmolarity; point in time; qnt; quan; quant; quantitative; random; stl; stool = fecal,Qn
73572-0,magnesium ionized [moles/volume] in blood by ion-selective membrane electrode (ise),mg ionized bld ise-scnc,magnesium ionized ise (bld) [moles/vol],blood; chemistry; img2+; ion; ion selective membrane electode; ion selective membrane electrode; ionized magnesium; ion-selective electrode; level; mag; magnes; mg; mg ionized; mg2+; point in time; qnt; quan; quant; quantitative; random; substance concentration; wb; whole blood,Qn
73574-6,acyclovir [susceptibility] by genotype method,acyclovir islt genotyp,acyclovir genotyping [susc],aciclovir; acifur; acv; acycloguanosine; antibiotic susceptibilities; ast; avirax; genotype; genotypic; id; infectious disease; infectiousdisease; islt; isol; ordinal; point in time; ql; qual; qualitative; random; screen; sus; suscept; susceptibilities; susceptibility; susceptibilty; zovirax,Ord
73584-5,norcitalopram [mass/volume] in urine,norcitalopram ur-mcnc,norcitalopram (u) [mass/vol],citalopram metabolite; desmeth; desmethylcitalopram; drug/toxicology; drugs; level; mass concentration; point in time; qnt; quan; quant; quantitative; random; ua; ur; urn,Qn
73586-0,tedizolid [susceptibility],tedizolid susc islt,tedizolid [susc],antibiotic susceptibilities; ast; id; infectious disease; infectiousdisease; islt; isol; point in time; random; sus; suscept; susceptibilities; susceptibility; susceptibilty; torezolid,OrdQn
7359-3,meadow fescue triggered histamine release [units/volume] in blood,meadow fescue basobnd ab qn,meadow fescue triggered histamine release qn (bld),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; associated; autoantibodies; autoantibody; baso; basobnd ab; basophil release; basophils; basos; blood; bnd; bph; festuca elator; festuca pratensis; g004; g4; leukocyte histamine reaction; leukocyte histamine release; meadow fescue; point in time; qnt; quan; quant; quantitative; random; wb; wbc release; whole blood,Qn
73615-7,ormetroprim+sulfamethoxazole [susceptibility] by minimum inhibitory concentration (mic),ormetroprim+sulfamethoxazole islt mic,ormetroprim+sulfamethoxazole mic [susc],acetylsulfamethoxazole; antibiotic susceptibilities; ast; c203; c223; c61; gantanol; id; infectious disease; infectiousdisease; islt; isol; minimum inhibitory concentration; point in time; primor; random; smx; sulfa; sulfamethox; sus; suscept; susceptibilities; susceptibility; susceptibilty; vet; veterinary,OrdQn
73626-4,ceftaroline+avibactam [susceptibility] by minimum inhibitory concentration (mic),ceftaroline+avibactam islt mic,ceftaroline+avibactam mic [susc],antibiotic susceptibilities; ast; id; infectious disease; infectiousdisease; islt; isol; minimum inhibitory concentration; point in time; random; sus; suscept; susceptibilities; susceptibility; susceptibilty; teflaro,OrdQn
73641-3,marbofloxacin [susceptibility] by disk diffusion (kb),marbofloxacin islt kb,marbofloxacin disk diffusion (kb) [susc],antibiotic susceptibilities; ast; disk diffusion; id; infectious disease; infectiousdisease; islt; isol; kb; kirby-bauer; marbocyl; point in time; random; sus; suscept; susceptibilities; susceptibility; susceptibilty; zeniquin,OrdQn
7365-0,cocksfoot igg ab [units/volume] in serum,cocksfoot igg qn,cocksfoot igg qn (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; cocksfoot; g003; g3; immune globulin g; immunoglobulin g; orchard grass; point in time; qnt; quan; quant; quantitative; random; serum; sr,Qn
73680-1,mycophenolate [mass/volume] in serum or plasma --peak,mycophenolate peak serpl-mcnc,mycophenolate peak [mass/vol],cellcept; drug/toxicology; drugs; level; mass concentration; mmf; mpa; mycophenolate mofetil; mycophenolic acid; pl; plasma; plsm; point in time; post; postdose; post-dose; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
73682-7,cyp2d6 gene allele 1 [identifier] in blood or tissue by molecular genetics method nominal,cyp2d6 allele 1 bld/t,cyp2d6 gene allele 1 molgen nom (bld/tiss),"blood; cpd6; cyp2d; cyp2d@; cyp2d6 allele; cyp2d6 allele 1; cyp2d7ap; cyp2d7bp; cyp2d7p2; cyp2d8p2; cyp2dl1; cypiid6; cytochrome p450; cytochrome p450, family 2, subfamily d, polypeptide 6; debrisoquine hydroxylation gene; hgnc:2629; i; identity or presence; molecular genetics; molecular pathology; molpath; molpath.pharmg; nominal; p450c2d; p450db1; p450-db1; pcr; point in time; random; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",Nom
73698-3,reason cchd oxygen saturation screening not performed,cchd sao2 scrn not prfrmd,,asympt; asymptomatic; cchd sao2 scrn not prfrmd; finding; findings; h+p; h+p.px; nominal; o2; p prime; point in time; random; sao2; sat; satn; scn; so2; to2,Nom
73711-4,food allergen mix 18 (peanut+soybean+peas) ige ab [units/volume] in serum by multidisk,food allerg mix18 ige qn,peanut+soybean+peas ige multidisk qn (s),abs; aby; allergen; allergens; allergy testing; allerscan; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; f012; f013; f014; f12; f13; f14; food allerg mix18; fx18; gly; green pea; immune globulin e; immunoglobulin e; largest; maximal; maximum; pea; peak; peanut; peas; point in time; qnt; quan; quant; quantitative; random; serum; soja hispida; soy bean; soya bean; soyabean; soybean; sr,Qn
73721-3,rocuronium ige ab [units/volume] in serum,rocuronium ige qn,rocuronium ige qn (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; c200; croc; esmeron; immune globulin e; immunoglobulin e; point in time; qnt; quan; quant; quantitative; random; serum; sr; zemuron,Qn
73735-3,acadvl gene mutations found [identifier] in blood or tissue by sequencing nominal,acadvl full mut anl bld/t seq,acadvl gene full mutation analysis sequencing nom (bld/tiss),"acad6; acadvl mut anl; acyl-coa dehydrogenase, very long chain; blood; full gene sequencing; full mut anl; genetics; heredity; heritable; high-throughput sequencing; hts; identity or presence; inherited; lcacd; molecular pathology; molpath; molpath.mutations; mut; mutations; next generation sequencing; ngs; nominal; point in time; random; sequencing of entire coding region; tissue; tissue, unspecified; vlcad; wb; whole blood; whole blood or tissue",Nom
73738-7,newborn screening test results panel - point of care,nbs test results pnl - poc,,asympt; asymptomatic; h+p; nbs test results pnl; new born; p prime; pan; panel.h&p; panl; pnl; point in time; random; scn,-
73740-3,screening duration of ear - left,screen dur ear-l,,asympt; asymptomatic; durat; ear-l; h+p; h+p.px; hearing; l; lt; otologic; p prime; point in time; qnt; quan; quant; quantitative; random; scn; screen dur,Qn
73741-1,newborn hearing screen panel of ear - left,nbs hear pnl ear-l,,audiology; ear-l; h+p; hearing; l; lt; nb hearing; nb hearing scn; nbs; nbs hear pnl; new born; otologic; p prime; pan; panel.h&p; panl; pnl; point in time; random; scn; scr; scrn,-
7374-2,perennial rye grass triggered histamine release [units/volume] in blood,per rye grass basobnd ab qn,perennial rye grass triggered histamine release qn (bld),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; associated; autoantibodies; autoantibody; baso; basobnd ab; basophil release; basophils; basos; blood; bnd; bph; g005; g5; italian ryegrass; leukocyte histamine reaction; leukocyte histamine release; per rye grass; perennial ryegrass; point in time; qnt; quan; quant; quantitative; random; rye grass; ryegrass; wb; wbc release; whole blood,Qn
73750-2,rai1 gene 17p11.2 deletion and duplication mutation analysis [identifier] in blood or tissue by fish nominal,rai1 17p11.2 del+dup bld/t fish,rai1 gene 17p11.2 del and dup mutation analysis fish nom (bld/tiss),"amplification; blood; del; del+dup; deletions; dp; fluorescent in situ hybridization; genetics; heredity; heritable; identity or presence; inherited; molecular pathology; molpath; molpath.deletions; nominal; point in time; random; retinoic acid induced 1; smcr; sms; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",Nom
73756-9,infant is being breastfed at discharge [us standard certificate of live birth],,,disch; echography; finding; findings; ordinal; point in time; ql; qual; qualitative; random; screen; sonogram; sonograph; sonography; survey; survey.cdc; uls; ultrasound; us live birth,Ord
73758-5,infant was transferred within 24 hours of delivery [us standard certificate of live birth],,,echography; finding; findings; infant transferred 24h deliv; ordinal; point in time; ql; qual; qualitative; random; screen; sonogram; sonograph; sonography; survey; survey.cdc; uls; ultrasound; us live birth,Ord
73776-7,no prenatal care [us standard certificate of live birth],,,echography; finding; findings; ordinal; point in time; ql; qual; qualitative; random; screen; sonogram; sonograph; sonography; survey; survey.cdc; uls; ultrasound; us live birth,Ord
7378-3,deprecated tall oat grass ige ab [units/volume] in serum,deprecated tall oat grass ige qn,tall oat grass ige qn (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; grasses; grs; immune globulin e; immunoglobulin e; point in time; qnt; quan; quant; quantitative; random; serum; sr; tall oat grass,Qn
73799-9,heart rate blood preductal pulse oximetry,heart rate bld preductal pulseox,,bld preductal; bld.right hand; blda.right hand; blood; cardio; cardiology; cardio-pulm; count/time; heart beat; heart disease; nrate; number rate; number rate = count/time; point in time; preductal blood; pulmonary; pulse; pulseox; qnt; quan; quant; quantitative; random; spo2; wb; whole blood,Qn
73803-9,oxygen saturation sensor type,sao2% device sao2% sensor type,,nominal; o2; point in time; random; sao2; sao2% device; sao2% sensor type; sat; satn; so2; to2; typ,Nom
73806-2,newborn age in hours,nwbrn age hours,,h+p; h+p.px; new born; nwbrn age hours; p prime; point in time; qnt; quan; quant; quantitative; random,Qn
73813-8,characteristics of labor and delivery [us standard certificate of live birth],,,characteristics of l+d; echography; finding; findings; nominal; point in time; random; sonogram; sonograph; sonography; survey; survey.cdc; uls; ultrasound; us live birth,Nom
7381-7,greasewood ige ab [units/volume] in serum,greasewood ige qn,greasewood ige qn (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; greasewood; immune globulin e; immunoglobulin e; point in time; qnt; quan; quant; quantitative; random; serum; sr,Qn
73828-6,"flunitrazepam [mass/volume] in serum, plasma or blood",flunitrazepam serplbld-mcnc,flunitrazepam (s/p/bld) [mass/vol],"blood; darkene; drug/toxicology; drugs; hypnodorm; hypnor; level; mass concentration; narcozep; noriel; pl; plasbld; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; rohipnol; rohypnol; roipnol; serp; serpl; serplas; serplbld; serum; serum or plasma; serum, plasma or whole blood; sr; valsera; wb; whole blood",Qn
73836-9,bacteria.fluoroquinolone resistant identified in anal by organism specific culture,bacteria.fluoroq resist anal cult,bacteria.fluoroquinolone resistant identified org specific cx nom (anal),anus; bact; bacteria.fluoroq resist; c&s; cult; cultures; flq; id; identity or presence; infectious disease; infectiousdisease; microbiology; nominal; point in time; random; rectal specimen; spec,Nom
738-5,macrocytes [presence] in blood by light microscopy,macrocytes bld ql smear,macrocytes lm ql (bld),blood; hematology/cell counts; lm; macrocyte; macrocytosis; macros; micro; micros; microscopic; ordinal; point in time; pr; ql; qual; qualitative; random; screen; wb; whole blood,Ord
73904-5,cd3-cd57+ cells/lymphocytes in blood by flow cytometry (fc),cd3-cd57+ cells/lymph nfr bld fc,cd3-cd57+ cells/lymphocytes fc (bld),blood; cd3 cells; cd3+cd57+ cells; cd3-cd57+ cells; cell; cell markers; cellularity; dynamic; fc; hnk1; leu4; leu-4; leu7; leu-7; lyme disease; lymp; lymph; lympho; lymphocyte; lymphs; lymphs%; number fraction; percent; point in time; qnt; quan; quant; quantitative; random; t3; wb; whole blood,Qn
73908-6,alloisoleucine/creatinine [ratio] in urine,alloisoleucine/creat ur-rto,alloisoleucine/creatinine (u) [ratio],aile; alloile; allo-isoleucine; chemistry; cr; crea; creat; msud; msud (maple syrup urine disease); point in time; qnt; quan; quant; quantitative; random; ratios; rto; ua; ucr; ur; urn,Qn
73930-0,rcs-4 5-carboxypentyl (synthetic cannabinoid metabolite) [presence] in blood,rcs-4 5-carboxypentyl bld ql,rcs-4 5-carboxypentyl ql (bld),addiction; blood; drug/toxicology; drugs; drugs of abuse; illicit; k2; ordinal; point in time; potentialforabuse; pr; ql; qual; qualitative; random; rcs-4 n-(5-carboxypentyl) metabolite; screen; spice; spike; synthetic cannabinoid; synthetic cannabinoids; wb; whole blood; yucatan fire,Ord
73934-2,"meperidine [mass/volume] in serum, plasma or blood",meperidine serplbld-mcnc,meperidine (s/p/bld) [mass/vol],"addiction; algil; alodan; blood; centralgine; demerol; dispadol; dolantin; dolosal; drug/toxicology; drugs; drugs of abuse; illicit; level; mass concentration; pethidine; pl; plasbld; plasma; plsm; point in time; potentialforabuse; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serplbld; serum; serum or plasma; serum, plasma or whole blood; sr; wb; whole blood",Qn
7401-3,herring igg ab [units/volume] in serum,herring igg qn,herring igg qn (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; f205; herring; immune globulin g; immunoglobulin g; point in time; qnt; quan; quant; quantitative; random; serum; sr,Qn
74041-5,bcr-abl1 p210 major molecular response (mmr) [presence] in blood or tissue by molecular genetics method --post treatment,"t(abl1,bcr)p210/cntrl.0.1% p tx bld/t ql","t(9;22)(q34.1;q11)(abl1,bcr) b2a2+b3a2 fusion transcript/control transcript.reduction to 0.1% post treatment molgen ql (bld/tiss)","abl; after; all; bcr/abl; bcr1; bcr-abl1; blood; breakpoint cluster region; chronic myeloid leukemia; cml; d22s11; d22s662; dna; e13a2; e14a2; gene fusion; gene translocation; genetics; hematology; heme; heredity; heritable; inherited; jtk7; major breakpoints; mbr; mcr; minor breakpoints; molecular genetics; molecular pathology; molpath; ordinal; p tx; p150; p210; pcr; ph chromosome; philadelphia chromosome; phl; point in time; pr; pst; ql; qual; qualitative; random; rna; screen; t prime; t(9,22)(abl1,bcr) gene translocation; t(9,22)(abl1,bcr) p210 gene translocation; t(9,22)(abl1,bcr) translocation; t(9,22)(q34,q11); t(9,22)(q34.1,q11); t(9;22)(abl1,bcr); t(abl1,bcr)b2a2; t(abl1,bcr)p210; tissue; tissue, unspecified; translocation; tx; v-abl abelson murine leukemia viral oncogene homolog 1; wb; whole blood; whole blood or tissue",Ord
74046-4,supplemental information about periodontal condition,suppl info periodontal cond,,admin; dental; dentistry; doc.admin; document; finding; findings; mouth; mouth+throat+teeth; point in time; random; supplement info perio cond,Doc
74047-2,periodontal procedure is related to orthodontic treatment plan,,,attach.periodontal; dental; dentistry; finding; findings; mouth; mouth+throat+teeth; ordinal; orthodontic tx; perio proc related ortho trt pln; point in time; ql; qual; qualitative; random; screen; tx,Ord
74054-8,dose form - rxnorm rxcui of medication,dose form rxnorm rxcui medication,,dose form rxnorm rxcui; ident; identifier; med; meds; nominal; point in time; random,Nom
7408-8,histamine extract triggered histamine release [units/volume] in blood,histamine ext basobnd ab qn,histamine extract triggered histamine release qn (bld),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; associated; autoantibodies; autoantibody; baso; basobnd ab; basophil release; basophils; basos; blood; bnd; bph; leukocyte histamine reaction; leukocyte histamine release; point in time; qnt; quan; quant; quantitative; random; wb; wbc release; whole blood,Qn
74097-7,tacrolimus [mass/volume] in blood by lc/ms/ms,tacrolimus bld lc/ms/ms-mcnc,tacrolimus lc/ms/ms (bld) [mass/vol],blood; drug/toxicology; drugs; fk506; fk-506; fujimycin; hecoria; l04ad02; level; mass concentration; point in time; prograf; protopic; qnt; quan; quant; quantitative; random; wb; whole blood,Qn
74109-0,4-hydroxycoumarins [presence] in specimen by screen method,4oh-coumarins spec ql scn,4-hydroxycoumarins screen ql (specimen),4oh-coumarins; coumarin; coumarins; drug/toxicology; drugs; misc; miscellaneous; ordinal; other; point in time; pr; ql; qual; qualitative; random; rodenticide; scn; scr; screen; scrn; spec; to be specified in another part of the message; unspecified,Ord
74119-9,p504s ag [presence] in tissue by immune stain,p504s ag tiss ql imstn,p504s ag immune stain ql (tiss),"antigen; antigens; ihc; imm; immunohistochemical stain; immunostain; imstn; imun; imune; ordinal; pathology; point in time; pr; ql; qual; qualitative; random; screen; st; stains; stn; tissue; tissue, unspecified",Ord
74132-2,aromatic solvents [presence] in blood,arom solvents bld ql,aromatic solvents ql (bld),arom solvents; blood; drug/toxicology; drugs; ordinal; point in time; pr; ql; qual; qualitative; random; screen; wb; whole blood,Ord
74136-3,"fentanyl [mass/volume] in serum, plasma or blood by confirmatory method",fentanyl serplbld cfm-mcnc,fentanyl confirm (s/p/bld) [mass/vol],"actiq; addiction; blood; cfm; cnfr; cnfrm; conf; confirmation; confirmatory; drug/toxicology; drugs; drugs of abuse; duragesic; durogesic; fenpat; fentanil; gcms; illicit; lc/ms/ms; level; mass concentration; pl; plasbld; plasma; plsm; point in time; potentialforabuse; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serplbld; serum; serum or plasma; serum, plasma or whole blood; sr; sublimaze; wb; whole blood",Qn
74138-9,immature monocytes [presence] in blood,imm moncytes bld ql,immature monocytes ql (bld),blood; hematology/cell counts; imm; imm moncytes; immat; mono; monocyte; monos; ordinal; point in time; pr; ql; qual; qualitative; random; screen; wb; whole blood,Ord
7414-6,hop igg ab [units/volume] in serum,hop igg qn,hop igg qn (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; f324; fruit cone; hop; hops; hops oil; immune globulin g; immunoglobulin g; point in time; qnt; quan; quant; quantitative; random; rf324; serum; sr,Qn
74157-9,"cannabinoids [presence] in serum, plasma or blood by screen method",cannabinoids serplbld ql scn,cannabinoids screen ql (s/p/bld),"addiction; blood; cannabinoid; delta-9-tetrahydrocannabinol; drug/toxicology; drugs; drugs of abuse; illicit; marijuana; ordinal; pl; plasbld; plasma; plsm; point in time; potentialforabuse; pr; ql; qual; qualitative; random; scn; scr; screen; scrn; serp; serpl; serplas; serplbld; serum; serum or plasma; serum, plasma or whole blood; sr; thc; wb; whole blood",Ord
74160-3,work days per week,work ds per w nrate,,count/time; h+p; h+p.hx; job; nrate; number rate; number rate = count/time; occupation; p prime; point in time; qnt; quan; quant; quantitative; random,Qn
74175-1,"generally speaking, i am very satisfied with nursing administration [nmmds]",,,finding; findings; nursing management minimum data set; ordinal; point in time; ql; qual; qualitative; random; screen; survey; survey.nmmds,Ord
741-9,microcytes [presence] in blood by light microscopy,microcytes bld ql smear,microcytes lm ql (bld),blood; hematology/cell counts; lm; micro; microcyte; microcytosis; micros; microscopic; ordinal; point in time; pr; ql; qual; qualitative; random; screen; wb; whole blood,Ord
74198-3,trauma summary registry report,trauma summary registry report,,doc.ont; document; finding; findings; point in time; random; registry rpt,Doc
7421-1,house dust ap ige ab [units/volume] in serum,house dust ap ige qn,house dust ap ige qn (s),abs; aby; acetone precipitated house dust; allergen; allergens; allergy testing; antby; anterio-posterior; anteroposterior; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; housedust; immune globulin e; immunoglobulin e; point in time; qnt; quan; quant; quantitative; random; serum; sr,Qn
74229-6,megakaryopoiesis assessment in bone marrow narrative,megakaryopoiesis mar,megakaryopoiesis assessment nar (bm),bm; bon; bone marrow; finding; findings; hematology/cell counts; mar; marrow (bone); minimal angle of resolution; minimum angle of resolution; narrative; point in time; random; report,Nar
7425-2,house dust hollister stier ige ab [units/volume] in serum,house dust hs ige qn,house dust hollister stier ige qn (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; h2; house dust hs; housedust; immune globulin e; immunoglobulin e; point in time; qnt; quan; quant; quantitative; random; serum; sr,Qn
74254-4,hedis 2014-2018 value set - rh,hedis 2014-18 rh,hedis 2014-2018 value set - rh,d phenotyping; d typing; hedis 2014-18 rh; pan; panel; panel.hedis; panl; pnl; point in time; random; rh phenotyping; rh typing,-
74263-5,dabigatran [mass/volume] in serum or plasma by lc/ms/ms,dabigatran serpl lc/ms/ms-mcnc,dabigatran lc/ms/ms [mass/vol],drug/toxicology; drugs; level; mass concentration; pl; plasma; plsm; point in time; pradax; pradaxa; prazaxa; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
74305-4,prrsv ag [presence] in specimen by immunofluorescence,prrsv ag spec ql if,prrsv ag if ql (specimen),abortus blauw; acif; anticomplement immunofluorescence; antigen; antigens; blue-eared pig disease; dfa; fa; fluorescent antibody; fluoresent; id; ifa; immune fluorescence; immunoflour; immunofluor; immunofluorescence; infectious disease; infectiousdisease; lelystad virus; microbiology; misc; miscellaneous; mystery swine disease; ordinal; other; point in time; porcine epidemic abortion & respiratory syndrome; porcine reproductive and respiratory syndrome; pork; pr; prrs; prrsv; prrsv ag; ql; qual; qualitative; random; screen; seuchenhafter spatabort der schweine; sirsv; spec; swine; swine infertility and respiratory syndrome; syndrome dysgenesique et respiratoire porcin; time resolved fluorescence; to be specified in another part of the message; trf; unspecified; vet; veterinary,Ord
74308-8,prrsv orf5 gene sequence homology to ingelvac atp in isolate by sequencing,prrsv ingatp hmlgy islt seq-nfr,prrsv orf5 gene sequence homology to ingelvac atp sequencing (isol),abortus blauw; blue-eared pig disease; high-throughput sequencing; hts; islt; isol; lelystad virus; microbiology; mystery swine disease; next generation sequencing; ngs; number fraction; percent; point in time; porcine epidemic abortion & respiratory syndrome; porcine reproductive and respiratory syndrome; pork; prrs; prrsv; prrsv ingatp hmlgy; prrsv orf5 gene; prrsv orf5 seq; qnt; quan; quant; quantitative; random; seuchenhafter spatabort der schweine; sirsv; swine; swine infertility and respiratory syndrome; syndrome dysgenesique et respiratoire porcin; vet; veterinary,Qn
74315-3,prrsv rna [#/volume] (viral load) in specimen by naa with probe detection,prrsv rna # spec naa+probe,prrsv rna naa+probe (specimen) [#/vol],#; 3 self-sustaining sequence replication; 3sr sr; abortus blauw; abs; absolute; absolutes; amplif; amplification; amplified; blue-eared pig disease; cnt; count; count/volume; ct; dna nucleic acid probe; dna probe; lat; lcr; lelystad virus; ligase chain reaction; ligation-activated transcription; microbiology; misc; miscellaneous; mystery swine disease; naa+probe; naat; nasba; nucleic acid sequence based analysis; number concentration; number concentration (count/vol); other; pcr; point in time; polymerase chain reaction; porcine epidemic abortion & respiratory syndrome; porcine reproductive and respiratory syndrome; pork; probe amp; probe with ampification; probe with target amplification; prrs; prrsv; qbr; qnt; quan; quant; quantitative; random; ribonucleic acid; sda; seuchenhafter spatabort der schweine; sirsv; spec; strand displacement amplification; swine; swine infertility and respiratory syndrome; syndrome dysgenesique et respiratoire porcin; tma; to be specified in another part of the message; transcription mediated amplification; unspecified; vet; veterinary; viral load,Qn
74318-7,prrsv north american strain rna [cycle threshold #] in specimen by naa with probe detection,prrsv na strain rna ct spec qn naa+probe,prrsv north american strain rna naa+probe (specimen) [threshnum],3 self-sustaining sequence replication; 3sr sr; abortus blauw; amplif; amplification; amplified; blue-eared pig disease; dna nucleic acid probe; dna probe; lat; lcr; lelystad virus; ligase chain reaction; ligation-activated transcription; microbiology; misc; miscellaneous; mystery swine disease; naa+probe; naat; nasba; nucleic acid sequence based analysis; other; pcr; point in time; polymerase chain reaction; porcine epidemic abortion & respiratory syndrome; porcine reproductive and respiratory syndrome; pork; probe amp; probe with ampification; probe with target amplification; prrs; prrsv; prrsv na strain; prrsv na strain rna; qbr; qnt; quan; quant; quantitative; random; ribonucleic acid; sda; seuchenhafter spatabort der schweine; sirsv; spec; strand displacement amplification; swine; swine infertility and respiratory syndrome; syndrome dysgenesique et respiratoire porcin; tma; to be specified in another part of the message; transcription mediated amplification; unspecified; vet; veterinary,Qn
74335-1,mica*016 igg ab [presence] in serum,mica*016 igg ser ql,mica*016 igg ql (s),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; immune globulin g; immunoglobulin g; major histocompatibility complex class i chain-related antigen a; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serology; serum; sr,Ord
74339-3,mica*009 igg ab [presence] in serum,mica*009 igg ser ql,mica*009 igg ql (s),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; immune globulin g; immunoglobulin g; major histocompatibility complex class i chain-related antigen a; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serology; serum; sr,Ord
74341-9,mica*007 igg ab [presence] in serum,mica*007 igg ser ql,mica*007 igg ql (s),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; immune globulin g; immunoglobulin g; major histocompatibility complex class i chain-related antigen a; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serology; serum; sr,Ord
74347-6,leukocyte aggregates [presence] in blood by light microscopy,leukocyte aggregates bld ql smear,leukocyte aggregates lm ql (bld),blood; hematology/cell counts; leuc; leuk; leukocytes; lkcs; lm; micro; micros; microscopic; ordinal; point in time; pr; ql; qual; qualitative; random; screen; wb; wbc; wbcs; white blood cell; white blood cells; whole blood,Ord
74356-7,bacteria identified in ventriculoperitoneal (vp) shunt by culture,bacteria vp shunt cult,bacteria identified cx nom (ventriculoperitoneal (vp) shunt),bact; c&s; cult; cultures; id; identity or presence; infectious disease; infectiousdisease; microbiology; nominal; point in time; random; ventriculo-peritoneal shunt,Nom
74375-7,"2,2',3,5'-tetrachlorobiphenyl (pcb) [mass/volume] in serum or plasma by confirmatory method","2,2',3,5'-pcb serpl cfm-mcnc","2,2',3,5'-tetrachlorobiphenyl (pcb) confirm [mass/vol]","2,2',3,5'-pcb; cfm; cnfr; cnfrm; conf; confirmation; confirmatory; drug/toxicology; drugs; gcms; ii; iii; lc/ms/ms; level; mass concentration; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr",Qn
74382-3,bupivacaine [mass/volume] in unknown substance,bupivacaine usub-mcnc,bupivacaine (unknown substance) [mass/vol],c285; drug/toxicology; drugs; level; marcain; marcaine; mass concentration; point in time; qnt; quan; quant; quantitative; random; sensorcaine; unknown substance; usub; vivacaine,Qn
74391-4,baclofen [mass/volume] in blood,baclofen bld-mcnc,baclofen (bld) [mass/vol],addiction; baclosan; beklo; blood; drug/toxicology; drugs; drugs of abuse; gablofen; illicit; kemstro; level; liofen; lioresal; mass concentration; point in time; potentialforabuse; qnt; quan; quant; quantitative; random; wb; whole blood,Qn
74398-9,neutrophils [#/volume] in cord blood,neutrophils # bldco,neutrophils (bldco) [#/vol],#; abs; absolute; absolutes; blood - (umbilical) cord; cnt; cord (umbilical) blood; cord bld; cord blood; count; count/volume; ct; gyn; gynecology; hematology/cell counts; neut; neutr; neutrophil; number concentration; number concentration (count/vol); ob; obgyn; obstetrics; pmn; pnm; point in time; qnt; quan; quant; quantitative; random,Qn
74412-8,cbc w differential panel - cord blood,cbc w diff pnl bldco,cbc w differential panel (bldco),blood - (umbilical) cord; cbc w diff pnl; cord (umbilical) blood; cord bld; cord blood; diff; diff pnl; differl; differn; hematology/cell counts; pan; panel.hematology& cell counts; panl; pnl; point in time; qnt; quan; quant; quantitative; random,Qn
7441-9,kiwifruit triggered histamine release [units/volume] in blood,kiwifruit basobnd ab qn,kiwifruit triggered histamine release qn (bld),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; associated; autoantibodies; autoantibody; baso; basobnd ab; basophil release; basophils; basos; blood; bnd; bph; chinese gooseberry; f084; f84; kiwi fruit; kiwifruit; leukocyte histamine reaction; leukocyte histamine release; point in time; qnt; quan; quant; quantitative; random; wb; wbc release; whole blood,Qn
74424-3,enterovirus rna [cycle threshold #] in stool by naa with probe detection,ev rna ct stl qn naa+probe,enterovirus rna naa+probe (stl) [threshnum],3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; bowel movement; dna nucleic acid probe; dna probe; entero virus; ev; ev-pcr; faecal; faeces; fecal; feces; gastro; gastroenterology; gi; id; infectious disease; infectiousdisease; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; naa+probe; naat; nasba; nucleic acid sequence based analysis; pcr; point in time; polymerase chain reaction; probe amp; probe with ampification; probe with target amplification; qbr; qnt; quan; quant; quantitative; random; ribonucleic acid; sda; stl; stool = fecal; strand displacement amplification; tma; transcription mediated amplification,Qn
7443-5,deprecated firebush ige ab [units/volume] in serum,deprecated firebush ige qn,firebush ige qn (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; burning bush; firebrush; firebush; immune globulin e; immunoglobulin e; kocha scoparia; point in time; qnt; quan; quant; quantitative; random; serum; sr; w017; w17,Qn
74436-7,d-lactate [moles/mass] in stool,d-lactate stl-scnt,d-lactate (stl) [moles/mass],2-hydroxypropanoic acid; 2-hydroxy-propionate; 2-hydroxy-propionic acid; bowel movement; chemistry; dextro; faecal; faeces; fecal; feces; lact; lactic acid; l-lactate; point in time; qnt; quan; quant; quantitative; random; stl; stool = fecal; substance content,Qn
74437-5,galactokinase [enzymatic activity/mass] in leukocytes,galactokinase wbc-ccnt,galactokinase (wbc) [catalytic activity/mass],catalytic content; chemistry; leukocytes; point in time; qnt; quan; quant; quantitative; random; wbcs; white blood cells,Qn
74438-3,lactose/creatinine [molar ratio] in urine,lactose/creat ur-srto,lactose/creatinine (u) [molar ratio],chemistry; cr; crea; creat; point in time; qnt; quan; quant; quantitative; random; scrto; substance concentration ratio; substance ratio; ua; ucr; ur; urn,Qn
74442-5,pyridoxal phosphate [moles/volume] in blood,pyridoxal phos bld-scnc,pyridoxal phosphate (bld) [moles/vol],blood; c8h10no6p; c8h9no3; chemistry; codecarboxylase; i phos; inorganic phosphate; level; phos; phosphate total; phosphorous; phosphorus; phosphrous; pi; plp; po4; point in time; pyridoxal 5-phosphate; pyridoxaldehyde; qnt; quan; quant; quantitative; random; substance concentration; vit b6; vit b6 coenzyme; vitamin b6; vitamin b6 coenzyme; vitamin b6 hydrochloride; wb; whole blood,Qn
74450-8,other cells [#/volume] in cord blood,other cells # bldco,other cells (bldco) [#/vol],#; abs; absolute; absolutes; blood - (umbilical) cord; cell; cellularity; cnt; cord (umbilical) blood; cord bld; cord blood; count; count/volume; ct; hematology/cell counts; number concentration; number concentration (count/vol); othr; point in time; qnt; quan; quant; quantitative; random,Qn
74454-0,normoblasts [#/volume] in blood from fetus,normoblasts # bld fetus,normoblasts (bld fetus) [#/vol],#; abs; absolute; absolutes; blood; cnt; count; count/volume; ct; erythroblast; erythroblasts; fetal; gyn; gynecology; hematology/cell counts; immature erythrocytes; normoblast; number concentration; number concentration (count/vol); ob; obgyn; obstetrics; point in time; qnt; quan; quant; quantitative; random; wb; whole blood,Qn
7446-8,lactalbumin triggered histamine release [units/volume] in blood,lactalb basobnd ab qn,lactalbumin triggered histamine release qn (bld),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; associated; autoantibodies; autoantibody; baso; basobnd ab; basophil release; basophils; basos; blood; bnd; bph; leukocyte histamine reaction; leukocyte histamine release; point in time; qnt; quan; quant; quantitative; random; wb; wbc release; whole blood,Qn
74483-9,homocitrulline [moles/volume] in urine,homocitrulline ur-scnc,homocitrulline (u) [moles/vol],chemistry; hci; homcit; homocit; level; point in time; qnt; quan; quant; quantitative; random; substance concentration; ua; ur; urn,Qn
745-0,deprecated myeloblasts [#/volume] in blood by automated count,deprecated myeloblasts # bld auto,myeloblasts auto (bld) [#/vol],#; abs; absolute; absolutes; auto; automated detection; blood; cnt; count; count/volume; ct; elec; elect; electr; hematology/cell counts; myelo; myeloblast; number concentration; number concentration (count/vol); point in time; qnt; quan; quant; quantitative; random; wb; whole blood,Qn
74500-0,age at time of event [ahrq],,,agency for healthcare research and quality; finding; findings; nominal; point in time; random; survey; survey.ahrq,Nom
74503-4,"16-beta,18-dihydroxydehydroepiandrosterone [moles/volume] in urine","16b,18-dioh-dhea ur-scnc","16-beta,18-dihydroxydehydroepiandrosterone (u) [moles/vol]","16b,18-dioh-dhea; 3 beta hydroxysteroid dehydrogenase; 3-beta hydroxysteroid dehydrogenase deficiency; b; chemistry; level; point in time; qnt; quan; quant; quantitative; random; substance concentration; ua; ur; urn",Qn
74508-3,16-alpha hydroxypregnenolone [moles/volume] in 24 hour urine,16a oh-preg 24h ur-scnc,16-alpha hydroxypregnenolone (24h u) [moles/vol],"1 day; 16 alphaoh-preg; 16a oh-preg; 16-alpha hydroxy pregnenolone; 24 hours; 24hr; 3 beta,16 alpha-dihydroxypregn-5-en-20-one; alfa; chemistry; level; qnt; quan; quant; quantitative; substance concentration; ua; ur; urn",Qn
74521-6,complement total hemolytic ch50 actual/normal in serum by immunoassay,ch50 act/nor ser ia,complement total hemolytic ch50 actual/normal ia (s) [rel units/vol],act/nor; comp; complement ch50; complmt; control; eia; elfa; elisa; enzyme immunoassay; hematology/cell counts; iaa; meia; point in time; qnt; quan; quant; quantitative; random; rlacnc; serum; sr; suds; tot; total hem comp; totl,Qn
74532-3,energy content [energy/mass] of 24 hour stool.wet,energy content 24h stool.wet,energy content (24h stool.wet) [energy/mass],1 day; 24 hours; 24hr; bowel movement; energy content; faecal; faeces; fecal; feces; qnt; quan; quant; quantitative; spec; stl; stool = fecal,Qn
74534-9,neisseria meningitidis serogroup y dna [presence] in specimen by naa with probe detection,n men sg y dna spec ql naa+probe,n. meningitidis y dna naa+probe ql (specimen),3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; deoxyribonucleic acid; dna nucleic acid probe; dna probe; id; infectious disease; infectiousdisease; lat; lcr; ligase chain reaction; ligation-activated transcription; mening; meningid; meningitis; meningo; meningococcal meningitis; meningococcus; microbiology; misc; miscellaneous; n men; n men serogroup; n men sg dna; n men sg y; n menigitidis; n meningitidis; naa+probe; naat; nasba; neisseria meningitidis group y; neisseria meningitidis type y; nucleic acid sequence based analysis; ordinal; other; pcr; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; screen; sda; spec; strand displacement amplification; tma; to be specified in another part of the message; transcription mediated amplification; unspecified,Ord
74545-5,tryptophan-related indole profiling panel - platelet rich plasma,tryp-related indole profile pnl prp,tryptophan-related indole profiling panel (prp),c244; chemistry; l-tryptophan; pan; panel.chemistry; panl; platelet rich plasma; pnl; point in time; random; trp; tryp-related indole profile pnl,-
74546-3,reporter job or position,,,nominal; occupation; point in time; random; survey; survey.ahrq; typ; work,Nom
74553-9,location of patient safety event or unsafe condition - narrative [ahrq],,,agency for healthcare research and quality; finding; findings; narrative; point in time; pt safety event; random; report; survey; survey.ahrq,Nar
74563-8,incident preventability [ahrq],,,agency for healthcare research and quality; finding; findings; nominal; point in time; random; survey; survey.ahrq,Nom
74565-3,event was a national quality forum (nqf) serious reportable event [ahrq],,,agency for healthcare research and quality; finding; findings; ordinal; point in time; ql; qual; qualitative; random; screen; survey; survey.ahrq,Ord
74569-5,action that prevented the near miss incident from reaching the patient [ahrq],,,agency for healthcare research and quality; finding; findings; near miss prevention action; nominal; point in time; random; survey; survey.ahrq,Nom
7457-5,deprecated lenscale ige ab [units/volume] in serum,deprecated lenscale ige qn,lenscale ige qn (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; immune globulin e; immunoglobulin e; lenscale; point in time; qnt; quan; quant; quantitative; random; scale; serum; sr; w015; w15,Qn
74588-5,succinate cytochrome c reductase [enzymatic activity/mass] in fibroblast,succinate cyc reduct fib-ccnt,succinate cytochrome c reductase (fibroblast) [catalytic activity/mass],butanedioate; butanedioic acid; catalytic content; chemistry; cyt; fib; fibr; point in time; qnt; quan; quant; quantitative; random; succinate cyc reduct; succinic acid,Qn
74597-6,3-hydroxypalmitoylcarnitine (c16-oh) [enzymatic activity/mass] in fibroblast,3oh-palmitoylcarn fib-ccnt,c16-oh (fibroblast) [catalytic activity/mass],3-hydroxyhexadecanoylcarnitine; 3-hydroxy-hexadecanoylcarnitine; 3-hydroxy-palmitoylcarnitine; 3oh-palmitoylcarn; c16oh; c16-oh; catalytic content; chemistry; fib; fibr; iii; point in time; qnt; quan; quant; quantitative; random,Qn
74600-8,palmitoleylcarnitine (c16:1) [enzymatic activity/mass] in fibroblast,palmitoleylcarn fib-ccnt,c16:1 (fibroblast) [catalytic activity/mass],c16:1; catalytic content; chemistry; fib; fibr; hexadecenoylcarnitine; i; point in time; qnt; quan; quant; quantitative; random,Qn
74610-7,decadienoylcarnitine (c10:2) [enzymatic activity/mass] in fibroblast,decadienoylcarn fib-ccnt,c10:2 (fibroblast) [catalytic activity/mass],c10:2; catalytic content; chemistry; fib; fibr; ii; point in time; qnt; quan; quant; quantitative; random,Qn
74613-1,fatty acids.very long chain c24:0 (tetracosanoate) [mass/mass] in fibroblast,vlcfa c24:0 fib-mcnt,fatty acids.very long chain c24:0 (tetracosanoate) (fibroblast) [mass/mass],acd; acid; aliphatic carboxylate; c24:0; chains; chemistry; chn; fatty acid; fib; fibr; lignocerate; lignoceric acid; lipid; mass content; point in time; qnt; quan; quant; quantitative; random; tetracosanoate; tetracosanoic acid; vlc; vlcf; vlcfa; vlcfa c24:0,Qn
7464-1,lime ige ab [units/volume] in serum,lime ige qn,lime ige qn (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; f306; immune globulin e; immunoglobulin e; lime; point in time; qnt; quan; quant; quantitative; random; rf306; serum; sr,Qn
74660-2,phencyclidine [presence] in saliva (oral fluid) by confirmatory method,pcp sal ql cfm,phencyclidine confirm ql (sal),addiction; angel dust; cfm; cnfr; cnfrm; conf; confirmation; confirmatory; drug/toxicology; drugs; drugs of abuse; gcms; illicit; lc/ms/ms; oral fluid; ordinal; pcp; point in time; potentialforabuse; pr; ql; qual; qualitative; random; sal; screen; sernylan,Ord
74662-8,sertraline [mass/volume] in urine,sertraline ur-mcnc,sertraline (u) [mass/vol],drug/toxicology; drugs; level; mass concentration; point in time; qnt; quan; quant; quantitative; random; ua; ur; urn; zoloft,Qn
74678-4,carboxy tetrahydrocannabinol [presence] in saliva (oral fluid) by confirmatory method,carboxythc sal ql cfm,carboxy tetrahydrocannabinol confirm ql (sal),11-nor-9-carboxy-delta-9-thc; 11-nor-9-carboxy-thc; 11-nor-delta-9-thc-9-cooh; 9-carboxy-11-nor-delta-9-tetrahydrocannabinol; addiction; carboxytetrahydrocannabinol; carboxythc; carboxy-thc-delta-9; cfm; cnfr; cnfrm; conf; confirmation; confirmatory; delta(9)-thc; delta-9-tetrahydrocannabinol; delta-9-tetrahydrocannabinol metabolite; dronabinol; drug/toxicology; drugs; drugs of abuse; gcms; illicit; lc/ms/ms; marijuana; nabilone; oral fluid; ordinal; point in time; potentialforabuse; pr; ql; qual; qualitative; random; sal; screen; thc; thca; thcc; thccooh; thc-cooh,Ord
746-8,myeloblasts [#/volume] in blood by manual count,myeloblasts # bld manual,myeloblasts manual cnt (bld) [#/vol],#; abs; absolute; absolutes; blood; cnt; count; count/volume; ct; hematology/cell counts; manl; myelo; myeloblast; number concentration; number concentration (count/vol); point in time; qnt; quan; quant; quantitative; random; wb; whole blood,Qn
74699-0,cefuroxime [susceptibility] by disk diffusion (kb),cefuroxime islt kb,cefuroxime disk diffusion (kb) [susc],antibiotic susceptibilities; ast; c308; c33; ceftin; cefuroxime axetil; disk diffusion; id; infectious disease; infectiousdisease; islt; isol; kb; kirby-bauer; point in time; random; sus; suscept; susceptibilities; susceptibility; susceptibilty; zinacef,OrdQn
74724-6,best description of the event or unsafe condition [ahrq],,,agency for healthcare research and quality; finding; findings; nominal; point in time; random; survey; survey.ahrq,Nom
74725-3,"patient safety event report - hospital - device or medical andor surgical supply, including health information technology (hit) - version 1.2 [ahrq]",,,agency for healthcare research and quality; ahrq survey pnl; hosp; pan; panel; panl; pnl; point in time; pt safety event; random; surg; survey; survey.ahrq,-
74726-1,other unique product identifier,other udi,,ident; identifier; nominal; other udi; othr; point in time; random,Nom
7473-2,black locust ige ab [units/volume] in serum,black locust ige qn,black locust ige qn (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; black locust; immune globulin e; immunoglobulin e; point in time; qnt; quan; quant; quantitative; random; serum; sr,Qn
74757-6,soluble fms-like tyrosine kinase-1/placental growth factor [ratio] in serum,sflt-1/pigf d ser-rto,soluble fms-like tyrosine kinase-1/placental growth factor (s) [ratio],chemistry; fac; fact; i; pigf; pigf d; placent; placenta; placntl; point in time; preeclampsia; qnt; quan; quant; quantitative; random; ratios; rto; serum; sflt-1; sr; tyr,Qn
74773-3,immunoglobulin light chains and heavy chains panel - serum or plasma,imm hevylite pnl serpl,immunoglobulin light chains and heavy chains panel,bence jones protein; bj protein; bjp; chain; chemistry; imm hevylite pnl; immune globulin; immuno; immunoglob; immunoglobin; imunoglbon; imunoglobn; pan; panel.chemistry; panl; pl; plasma; plsm; pnl; point in time; random; serp; serpl; serplas; serum; serum or plasma; sr,-
74786-5,influenza virus b yamagata lineage rna [presence] in specimen by naa with probe detection,flubv yam rna spec ql naa+probe,flubv yam rna naa+probe ql (specimen),3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; dna nucleic acid probe; dna probe; flub; flubv; flubv yam; fluv; id; infectious disease; infectiousdisease; influ; influenza b; influenza b virus; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; misc; miscellaneous; naa+probe; naat; nasba; nucleic acid sequence based analysis; ordinal; other; pcr; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; ribonucleic acid; screen; sda; spec; strand displacement amplification; tma; to be specified in another part of the message; transcription mediated amplification; unspecified,Ord
74824-4,powassan virus ab [presence] in serum by hemagglutination inhibition,powv ab ser ql hai,powassan virus ab hai ql (s),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; hemagglutination inhibition; hi; id; infectious disease; infectiousdisease; microbiology; ordinal; point in time; powv; pr; ql; qual; qualitative; random; screen; serum; sr,Ord
748-4,myelocytes [#/volume] in blood by manual count,myelocytes # bld manual,myelocytes manual cnt (bld) [#/vol],#; abs; absolute; absolutes; blood; cnt; count; count/volume; ct; hematology; hematology/cell counts; heme; manl; myel; myelo; myelocyte; number concentration; number concentration (count/vol); point in time; qnt; quan; quant; quantitative; random; wb; whole blood,Qn
74861-6,chromosome 17 copy number/nucleus in tissue by fish,chr 17 copy num/nucleus entnum tiss fish,chromosome 17 copy number/nucleus fish (tiss) [entitic number],"cep17; chr 17 copy num; chromosom; chromosome 17 centromere; chromosome enumeration probe 17; chromosomes; entitic; entitic number; fluorescent in situ hybridization; genetics; heredity; heritable; inherited; molecular pathology; molpath; no; num; point in time; qnt; quan; quant; quantitative; random; tissue; tissue, unspecified",Qn
7490-6,deprecated melon igg ab [units/volume] in serum,deprecated melon igg qn,melon igg qn (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; f87; honey dew; honeydew; immune globulin g; immunoglobulin g; melon; melons; point in time; qnt; quan; quant; quantitative; random; serum; sr,Qn
74906-9,bilirubin.total [moles/volume] in cerebral spinal fluid,bilirub csf-scnc,bilirubin (csf) [moles/vol],bili; bilirubins; billirubin; cerebral spinal fluid; cerebrospinal fl; chemistry; level; point in time; qnt; quan; quant; quantitative; random; spinal fl; spinal fld; spinal flu; spinal fluid; substance concentration; tbil,Qn
74909-3,calcium oxalate dihydrate/total in stone,calcium oxalate dihydrate mfr stone,calcium oxalate dihydrate (stone) [mass fraction],ca; cac2o4; cal; calc; calculi; caox; chemistry; ethanedioate; ethanedioic acid; gastro; gastroenterology; gi; kidney; mass fraction; nephrology; oxal; oxalic acid; percent; point in time; qnt; quan; quant; quantitative; random; renal; stn; stone; stones; tot; totl,Qn
74911-9,sertraline [mass/volume] in serum or plasma --trough,sertraline trough serpl-mcnc,sertraline trough [mass/vol],drug/toxicology; drugs; level; mass concentration; pl; plasma; plsm; point in time; pre; predose; pre-dose; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; zoloft,Qn
74913-5,deprecated escitalopram [mass/volume] in serum or plasma --trough,deprecated escitalopram trough serpl-mcn,escitalopram trough [mass/vol],cipralex; drug/toxicology; drugs; level; lexamil; lexapro; mass concentration; pl; plasma; plsm; point in time; pre; predose; pre-dose; qnt; quan; quant; quantitative; random; seroplex; serp; serpl; serplas; serum; serum or plasma; sr,Qn
74917-6,cxcl13 ag [mass/volume] in cerebral spinal fluid,cxcl13 ag csf-mcnc,cxcl13 ag (csf) [mass/vol],antigen; antigens; bca1; bca-1; b-lymphocyte chemoattractant; cerebral spinal fluid; cerebrospinal fl; chemistry; chemokine (c-x-c motif) ligand 13 (b-cell chemoattractant); level; mass concentration; point in time; qnt; quan; quant; quantitative; random; spinal fl; spinal fld; spinal flu; spinal fluid,Qn
74919-2,caffeine [mass/volume] in serum or plasma --trough,caffeine trough serpl-mcnc,caffeine trough [mass/vol],caffn; drug/toxicology; drugs; level; mass concentration; pl; plasma; plsm; point in time; pre; predose; pre-dose; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
74923-4,deprecated temazepam [mass/volume] in serum or plasma --trough,deprecated temazepam trough serpl-mcnc,temazepam trough [mass/vol],drug/toxicology; drugs; level; mass concentration; normison; pl; plasma; plsm; point in time; pre; predose; pre-dose; qnt; quan; quant; quantitative; random; restoril; serp; serpl; serplas; serum; serum or plasma; sr,Qn
74933-3,deprecated n-desalkylflurazepam [mass/volume] in serum or plasma --trough,deprecated desalkylfluraz trough serpl-m,n-desalkylflurazepam trough [mass/vol],desalkyfluraz; desalkylfluraz; desalkylflurazepam; drug/toxicology; drugs; flurazepam metabolite; level; mass concentration; norfludiazepam; pl; plasma; plsm; point in time; pre; predose; pre-dose; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
74935-8,palmitoyl protein thioesterase [enzymatic activity/mass] in leukocytes,ppt wbc-ccnt,palmitoyl protein thioesterase (wbc) [catalytic activity/mass],catalytic content; chemistry; leukocytes; point in time; ppt; pr; prot; qnt; quan; quant; quantitative; random; wbcs; white blood cells,Qn
74962-2,maprotiline [mass/volume] in serum or plasma --trough,maprotiline trough serpl-mcnc,maprotiline trough [mass/vol],drug/toxicology; drugs; level; ludiomil; mass concentration; novartis; pl; plasma; plsm; point in time; pre; predose; pre-dose; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
74963-0,deprecated promethazine [mass/volume] in serum or plasma --trough,deprecated promethazine trough serpl-mcn,promethazine trough [mass/vol],atosil; avomine; drug/toxicology; drugs; fargan; farganesse; lergigan; level; mass concentration; phenergan; pl; plasma; plsm; point in time; pre; predose; pre-dose; promethegan; prothiazine; qnt; quan; quant; quantitative; random; receptozine; romergan; serp; serpl; serplas; serum; serum or plasma; sominex; sr,Qn
74972-1,deprecated 9-hydroxyrisperidone [mass/volume] in serum or plasma --trough,deprecated 9oh-risperidone trough serpl-,9-hydroxyrisperidone trough [mass/vol],9-hydroxy risperidone; 9-hydroxy-risperidone; 9-oh-risperidone; 9oh-risperidone; drug/toxicology; drugs; invega; level; mass concentration; paliperidone; pl; plasma; plsm; point in time; pre; predose; pre-dose; qnt; quan; quant; quantitative; random; risperidone metabolite; serp; serpl; serplas; serum; serum or plasma; sr,Qn
74985-3,alprazolam [mass/volume] in serum or plasma --trough,alpraz trough serpl-mcnc,alprazolam trough [mass/vol],drug/toxicology; drugs; level; mass concentration; niravam; pl; plasma; plsm; point in time; pre; predose; pre-dose; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; xanax,Qn
75004-2,food allergen mix fp73 (beef+chicken+pork+lamb) ige ab [units/volume] in serum by multidisk,food allergen mix fp73 ige qn,beef+chicken+pork+lamb ige multidisk qn (s),abs; aby; allergen; allergens; allergy testing; allerscan; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; bos spp; f026; f027; f083; f088; f26; f27; f83; f88; food allergen mix fp73; food allergen mix fx73; fp73; fx73; gallus spp; immune globulin e; immunoglobulin e; mutton; ovis spp; pig; point in time; porcine; qnt; quan; quant; quantitative; random; serum; sr; sus spp; swine,Qn
75025-7,coproporphyrin 3/porphyrins.total in stool,copro3 sfr stl,coproporphyrin 3/total porphyrins (stl) [molar fraction],bowel movement; chemistry; copro; copro3; coproporph; coproporphyrin iii; coproporphyrins; faecal; faeces; fecal; feces; hematology; heme; iii; percent; point in time; porph; porphyrin; qnt; quan; quant; quantitative; random; stl; stool = fecal; substance fraction; tetracarboxyl porphyrin; tetracarboxylporphyrin; tetracarboxylporphyrins; tetracarboxyporphyrin; tot; totl,Qn
75029-9,zanamivir [susceptibility] by genotype method,zanamivir islt genotyp,zanamivir genotyping [susc],antibiotic susceptibilities; ast; genotype; genotypic; id; infectious disease; infectiousdisease; islt; isol; ordinal; point in time; ql; qual; qualitative; random; relenza; screen; sus; suscept; susceptibilities; susceptibility; susceptibilty,Ord
75039-8,biopterin [moles/volume] in serum or plasma,biopterin serpl-scnc,biopterin [moles/vol],biopt; chemistry; level; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; substance concentration,Qn
75040-6,d-lactate [moles/volume] in cerebral spinal fluid,d-lactate csf-scnc,d-lactate (csf) [moles/vol],2-hydroxypropanoic acid; 2-hydroxy-propionate; 2-hydroxy-propionic acid; cerebral spinal fluid; cerebrospinal fl; chemistry; dextro; lact; lactic acid; level; l-lactate; point in time; qnt; quan; quant; quantitative; random; spinal fl; spinal fld; spinal flu; spinal fluid; substance concentration,Qn
75048-9,tetrahydrofolate [moles/volume] in cerebral spinal fluid,thfolate csf-scnc,tetrahydrofolate (csf) [moles/vol],cerebral spinal fluid; cerebrospinal fl; chemistry; fh4; level; point in time; qnt; quan; quant; quantitative; random; spinal fl; spinal fld; spinal flu; spinal fluid; substance concentration; tetrahydrofolic acid; thf; thfa; thfolate,Qn
75075-2,4-hydroxybenzoate [moles/volume] in serum or plasma,4ohbenzoate serpl-scnc,4-hydroxybenzoate [moles/vol],4-hydroxy benzoate; 4-hydroxybenzoic acid; 4ohbenzoate; chemistry; hydroxybenzoic acid; level; para-hydroxybenzoic acid; p-hydroxybenzoic acid; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; substance concentration,Qn
75094-3,galactose 1 phosphate uridyl transferase [enzymatic activity/volume] in dbs --post therapeutic diet,gal1put p diet dbs-ccnc,galactose 1 phosphate uridyl transferase post therapeutic diet (dbs) [catalytic activity/vol],after; blood; catalytic concentration; cerebrose; chemistry.challenge testing; dbs; dried blood spot; filter paper; fp; gal-1-p; gal1po4; gal-1-po4; gal1pts; gal1put; gal-1-put; galactose 1 phosphate uridyltransferase; galactose tolerance test; galactosemia; galt; gput; hexose-1-phosphate uridyltransferase; i; i phos; inorganic phosphate; p diet; phos; phosphate total; phosphorous; phosphorus; phosphrous; pi; po4; point in time; pst; qnt; quan; quant; quantitative; random; ther; wb; whole blood,Qn
75115-6,palmitate (c16:0) [entitic substance] in red blood cells,palmitate entsub rbc,palmitate (c16:0) (rbc) [entitic substance],c16:0; chemistry; entitic substance; erythrocytes; hexadecanoate; hexadecanoic acid; palmitic acid; point in time; qnt; quan; quant; quantitative; random; red blood cells; red blood corpusles,Qn
75118-0,octadecanoate (c18:0) [entitic substance] in red blood cells,octadecanoate entsub rbc,octadecanoate (c18:0) (rbc) [entitic substance],1-heptadecanecarboxylic acid; c18:0; c18h36o2; cetylacetic acid; chemistry; elaidate; entitic substance; erythrocytes; octadecanoic acid; point in time; qnt; quan; quant; quantitative; random; red blood cells; red blood corpusles; stearate; stearic acid,Qn
7512-7,deprecated white mulberry ige ab [units/volume] in serum,deprecated white mulberry ige qn,white mulberry ige qn (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; immune globulin e; immunoglobulin e; mulberry; point in time; qnt; quan; quant; quantitative; random; serum; sr; t070; t70; white mulberry,Qn
75131-3,adenine [moles/volume] in serum or plasma,adenine serpl-scnc,adenine [moles/vol],b4 hemosan; chemistry; leuco-4; level; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; substance concentration; vit b4; vitamin b4,Qn
7513-5,white mulberry igg ab [units/volume] in serum,white mulberry igg qn,white mulberry igg qn (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; immune globulin g; immunoglobulin g; mulberry; point in time; qnt; quan; quant; quantitative; random; serum; sr; t070; t70; white mulberry,Qn
75135-4,hypoxanthine [moles/volume] in serum or plasma,hypoxanthine serpl-scnc,hypoxanthine [moles/vol],chemistry; level; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; substance concentration,Qn
75168-5,mother's most recent non-treponemal test result [cdc.cs],,,centers for disease control and prevention; centers for disease control congenital syphilis (cs) case investigation and report; finding; findings; mat; maternal; matnl; ordinal; point in time; ql; qual; qualitative; random; screen; survey; survey.cdc,Ord
7517-6,oyster mushroom ige ab [units/volume] in serum,oyster mushroom ige qn,oyster mushroom ige qn (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; f32; immune globulin e; immunoglobulin e; oyster mushroom; point in time; qnt; quan; quant; quantitative; random; serum; sr,Qn
75179-2,mother's hiv status during pregnancy [cdc.cs],,,aids; centers for disease control and prevention; centers for disease control congenital syphilis (cs) case investigation and report; finding; findings; gestation; gestations; gravida; human immunodeficiency virus; mat; maternal; matnl; nominal; point in time; pregnancies; random; survey; survey.cdc,Nom
75187-5,non-treponemal test was reactive [cdc.cs],,,centers for disease control and prevention; centers for disease control congenital syphilis (cs) case investigation and report; finding; findings; ordinal; point in time; ql; qual; qualitative; random; reac; react; screen; survey; survey.cdc,Ord
75197-4,syphilis treatment was given and treatment description [cdc.cs],,,centers for disease control and prevention; centers for disease control congenital syphilis (cs) case investigation and report; finding; findings; nominal; point in time; random; survey; survey.cdc; tx,Nom
75206-3,deprecated gestational age indicator [cdc.cs],,,arbitrary; centers for disease control and prevention; centers for disease control congenital syphilis (cs) case investigation and report; ga; gest; gestation; ordinal; point in time; prenatal; ql; qual; qualitative; random; screen; survey; survey.cdc,Ord
75208-9,maternal information section [cdc.cs],,,centers for disease control and prevention; centers for disease control congenital syphilis (cs) case investigation and report; mat; maternal; maternal info sec; matnl; pan; panel; panel.survey.cdc; panl; pnl; point in time; random; survey; survey.cdc,-
75211-3,propionylcarnitine (c3)+palmitoylcarnitine (c16) [moles/volume] in dbs,c3+c16 dbs-scnc,c3+c16 (dbs) [moles/vol],blood; c16; c3; c3+c16; c3-carntitine; chemistry; dbs; dried blood spot; filter paper; fp; hexadecanoylcarnitine; level; point in time; propanoylcarnitine; qnt; quan; quant; quantitative; random; substance concentration; wb; whole blood,Qn
75214-7,arginine/ornithine [molar ratio] in dbs,arginine/ornithine dbs-srto,arginine/ornithine (dbs) [molar ratio],arg; blood; chemistry; dbs; dried blood spot; filter paper; fp; orn; point in time; qnt; quan; quant; quantitative; random; scrto; substance concentration ratio; substance ratio; wb; whole blood,Qn
75226-1,8-hydroxyamoxapine [presence] in urine,8oh-amoxapine ur ql,8-hydroxyamoxapine ql (u),8-hydroxy amoxapine; 8oh-amoxapine; amoxapine metabolite; drug/toxicology; drugs; ordinal; point in time; pr; ql; qual; qualitative; random; screen; ua; ur; urn,Ord
75230-3,m-chlorophenylpiperazine [presence] in urine,m-cpp ur ql,m-chlorophenylpiperazine ql (u),"1,3 - chlorophenyl piperazine; drug/toxicology; drugs; mcpp; m-cpp; meta-chlorophenylpiperazine; nefazodone metabolite; ordinal; point in time; pr; ql; qual; qualitative; random; screen; trazodone metabolite; ua; ur; urn",Ord
75237-8,erythrocytes [#/area] in synovial fluid by microscopy high power field,rbc #/area snv hpf,rbc lm.hpf (syn fld) [#/area],#/area; discocytes; erthrocyte; erythrocyte; hematology/cell counts; joint aspirate; joint fld; joint flu; joint fluid; lm; micro; micros; microscopic; number areic; point in time; qnt; quan; quant; quantitative; random; rbc; rbcs; red blood cell; red blood cells; red blood corpuscle; red blood corpusles; red cell; red cells; sf; snv; syn; syn fl; synov; synovial fluid,Qn
75239-4,albumin.ischemia modified [units/volume] in serum,ima ser-acnc,albumin.ischemia modified qn (s),alb; arbitrary concentration; chemistry; ima; point in time; protein.albumin; qnt; quan; quant; quantitative; random; serum; sr,Qn
75256-8,disability information and assistance needed panel [hhs.aca section 4302.onc],,,"department of health and human services, affordable care act section 4302; department of health and human services, affordable care act section 4302 and office of the national coordinator for health information technology (onc); hhs.acasec4302; hhs.acasec4302.onc; pan; panel.survey.hhs; panl; pnl; point in time; random; survey; survey.hhs",-
75260-0,what is your level of pain right now [promis],,,finding; findings; levels; levl; lv; lvl; ordinal; patient reported outcomes information system; point in time; promise; ql; qual; qualitative; r; random; rt; screen; survey; survey.promis,Ord
75265-9,blood group antibody screen [presence] in serum or plasma by polyethylene glycol (peg) method,bld gp ab scn serpl ql peg,blood group antibody screen peg method ql,ab; bld gp ab scn; blood bank; ordinal; pl; plasma; plsm; point in time; polyethylene glycol; pr; ql; qual; qualitative; random; scn; scr; screen; scrn; serp; serpl; serplas; serum; serum or plasma; sr,Ord
75295-6,deprecated fluid intake oral 24 hour,deprecated fluid intake oral 24h,,1 day; 24 hours; 24hr; fld; flow; fluid intake oral; io_intake; io_intake.timed.molec; qnt; quan; quant; quantitative; volume rate; vrate,Qn
75320-2,advance directive,advance directive,,advanced; directives; hl7ccda; nominal; point in time; random; typ,Nom
7533-3,interior live oak ige ab [units/volume] in serum,interior live oak ige qn,interior live oak ige qn (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; immune globulin e; immunoglobulin e; interior live oak; point in time; qnt; quan; quant; quantitative; random; serum; sr,Qn
75348-3,deprecated cognitive function (ordinal) hl7.ccdar2,deprecated cogn func hl7ccdar2,,ccda; cogn func; cognition; cognitive status; consolidated cda; fcn; finding; findings; func; funct; hl7ccda; hl7ccdar2; ordinal; point in time; ql; qual; qualitative; random; screen,Ord
75386-3,men1 gene mutation analysis limited to known familial mutations in blood or tissue by molecular genetics method,men1 gene fam mut anl bld/t,men1 gene familial mut analysis molgen doc (bld/tiss),"blood; document; fam mut anl; finding; findings; genetics; heredity; heritable; inherited; lmted; ltd; meai; menin; molecular genetics; molecular pathology; molpath; molpath.mutations; multiple endocrine neoplasia i; multiple endocrine neoplasia type i; mut; mutation; mutations; muts; pcr; point in time; random; scg2; tissue; tissue, unspecified; wb; wermer syndrome; whole blood; whole blood or tissue; zollinger-ellison syndrome",Doc
75409-3,"hepatitis b virus surface ab [presence] in serum, plasma or blood by rapid immunoassay",hbv surface ab serplbld ql ia.rapid,hbv surface ab ia.rapid ql (s/p/bld),"abs; aby; antby; anti; antibodies; antibody; anti-hbsag; autoantibodies; autoantibody; blood; eia; elfa; elisa; enzyme immunoassay; hbs; hbsab; hbv; hbv surface; hep; hep b; hep bs; hepatis; hepatit; hepatology; hepb; iaa; id; infectious disease; infectiousdisease; liver; meia; microbiology; ordinal; pl; plasbld; plasma; plsm; point in time; pr; ql; qual; qualitative; random; screen; serp; serpl; serplas; serplbld; serum; serum or plasma; serum, plasma or whole blood; sr; suds; surf; wb; whole blood",Ord
75419-2,pcori patient-reported outcomes recommended measures [promis],,,pan; panel; panl; patient reported outcomes information system; pcori recommended measures; pnl; point in time; promise; random; survey,-
75435-8,internal medicine note,internal med note,,doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; notes; point in time; random; visit note,Doc
75438-2,long term care facility note,ltc fac note,,doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; ltc fac; ltcf; notes; point in time; random; visit note,Doc
7545-7,deprecated olive ige ab [units/volume] in serum,deprecated olive ige qn,olive ige qn (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; immune globulin e; immunoglobulin e; point in time; qnt; quan; quant; quantitative; random; serum; sr,Qn
7546-5,olive igg ab [units/volume] in serum,olive igg qn,olea europaea igg qn (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; black olive; f342; immune globulin g; immunoglobulin g; olive; point in time; qnt; quan; quant; quantitative; random; serum; sr,Qn
75471-3,attending note,attend note,,doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; notes; point in time; random; visit note,Doc
75500-9,triage note,triage note,,doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; notes; point in time; random; visit note,Doc
75507-4,aptt.lupus sensitive w excess phospholipid percent correction,aptt % correction,aptt.lupus sensitive percent correction coag (ppp) [% diff],activated partial thromboplastin time; aptt; aptt with platelin ls; aptt-la; aptt-la % correction; clot; clottable; coag; coagulation assay; correctn; hematology; heme; little(a)ptt; partial thromboplastin time; plas; platelet poor plasma; point in time; ptt; qnt; quan; quant; quantitative; random; surf; tilt tube,Qn
75510-8,aptt.lupus sensitive with 1:1 pnp (la mix),mixing aptt,aptt-la w 1:1 pnp coag (ppp) [time],activated partial thromboplastin time; aptt; aptt with platelin ls; aptt-la; aptt-la w 1:1 pnp; clot; clottable; coag; coagulation assay; control; hematology; heme; i; little(a)ptt; partial thromboplastin time; plas; platelet poor plasma; point in time; ptt; qnt; quan; quant; quantitative; random; surf; tilt tube,Qn
75524-9,facility identifier,,,admin; ident; identifier; nominal; point in time; random; survey; survey.pcornet,Nom
75525-6,type of encounter [mscdm],,,mini-sentinel common data model; nominal; point in time; random; survey; survey.pcornet; typ,Nom
7553-1,oregano igg ab [units/volume] in serum,oregano igg qn,oregano igg qn (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; f283; immune globulin g; immunoglobulin g; oregano; oreganum; point in time; qnt; quan; quant; quantitative; random; rf283; serum; sr,Qn
75533-0,"nmmds accreditation, certification, and licensure panel [nmmds]",,,nursing management minimum data set; pan; panel.survey.nmmds; panl; pnl; point in time; random; survey; survey.nmmds,-
75540-5,hepatitis a virus rna+parvovirus b19 dna [interpretation] in plasma from donor qualitative by naa with probe detection,hav rna+b19v dna plas donr naa+probe-imp,hav rna+parvovirus b19 dna naa+probe ql (p donor) [interp],3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; b19; b19 virus; b19v; deoxyribonucleic acid; dna nucleic acid probe; dna probe; donr; fifth disease; hav; hav rna+b19v; hep; hep a; hepatis; hepatit; hepatitis; hepatitis a; hepatitis type a; hepatology; id; impression; impression/interpretation of study; impressions; infectious disease; infectiousdisease; interp; interpretation; lat; lcr; ligase chain reaction; ligation-activated transcription; liver; microbiology; naa+probe; naat; nasba; nucleic acid sequence based analysis; ordinal; parvo; parvo virus; parvov; parvovirus type b19; pcr; pl; plasma; plsm; point in time; polymerase chain reaction; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; ribonucleic acid; screen; sda; strand displacement amplification; tma; transcription mediated amplification,Ord
75543-9,parvovirus b19 dna [presence] in plasma from donor by naa with probe detection,b19v dna plas donr ql naa+probe,parvovirus b19 dna naa+probe ql (p donor),3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; b19 virus; b19v; deoxyribonucleic acid; dna nucleic acid probe; dna probe; donr; fifth disease; id; infectious disease; infectiousdisease; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; naa+probe; naat; nasba; nucleic acid sequence based analysis; ordinal; parvo; parvo virus; parvov; pcr; pl; plasma; plsm; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; screen; sda; strand displacement amplification; tma; transcription mediated amplification,Ord
75549-6,performing laboratory phone number,performing lab phone #,performing laboratory phone nom (facility),admin; no; nominal; num; performing lab phone #; phone #; point in time; random; telecommunication number; telephone number,Nom
75569-4,fetal monosomy x risk [likelihood] based on plasma cell-free+wbc dna by dosage of chromosome-specific cfdna narrative,fet ms x risk wbc.dna+cfdna,monosomy x risk dosage of chromosome-specific cfdna nar (plasma cell-free+wbc dna),chromosom; chromosomes; leukocytes; molecular pathology; molpath; ms x risk; narrative; pl; plasma; plsm; point in time; random; report; risk; spec; turner syndrome; wbc.dna+cfdna; wbcs; white blood cells,Nar
75570-2,fetal monosomy x risk [interpretation] based on plasma cell-free+wbc dna by dosage of chromosome-specific cfdna qualitative,fet ms x risk wbc.dna+cfdna ql,monosomy x risk dosage of chromosome-specific cfdna ql (plasma cell-free+wbc dna) [interp],chromosom; chromosomes; impression; impression/interpretation of study; impressions; interp; interpretation; leukocytes; molecular pathology; molpath; ms x risk; ordinal; pl; plasma; plsm; point in time; ql; qual; qualitative; random; screen; spec; turner syndrome; wbc.dna+cfdna; wbcs; white blood cells,Ord
75579-3,comment on fetal 22q11.2 deletion risk [text] in plasma cell-free+wbc dna by dosage of chromosome-specific cfdna narrative,fet 22q11.2 del risk comment,comment on fetal 22q11.2 del risk dosage of chromosome-specific cfdna nar (plasma cell-free+wbc dna),22q11.2 del risk; chromosom; chromosomes; cmmt; cmnt; com; comm; comments; commt; fet 22q11.2del risk comment; genetics; heredity; heritable; inherited; leukocytes; molecular pathology; molpath; molpath.deletions; narrative; pl; plasma; plsm; point in time; random; remarks; report; spec; text; wbc.dna+cfdna; wbcs; white blood cells,Nar
755-9,neutrophils [#/volume] in cerebral spinal fluid by manual count,neutrophils # csf manual,neutrophils manual cnt (csf) [#/vol],#; abs; absolute; absolutes; cerebral spinal fluid; cerebrospinal fl; cnt; count; count/volume; ct; hematology/cell counts; manl; neuro; neurology; neut; neutr; neutrophil; number concentration; number concentration (count/vol); pmn; pnm; point in time; qnt; quan; quant; quantitative; random; spinal fl; spinal fld; spinal flu; spinal fluid,Qn
75590-0,fetal angelman syndrome risk [interpretation] based on plasma cell-free+wbc dna by dosage of chromosome-specific cfdna qualitative,fet as risk wbc.dna+cfdna ql,angelman syndrome risk dosage of chromosome-specific cfdna ql (plasma cell-free+wbc dna) [interp],as risk; chromosom; chromosomes; genetics; heredity; heritable; impression; impression/interpretation of study; impressions; inherited; interp; interpretation; leukocytes; molecular pathology; molpath; ordinal; pl; plasma; plsm; point in time; ql; qual; qualitative; random; screen; spec; wbc.dna+cfdna; wbcs; white blood cells,Ord
75593-4,fetal 5p deletion prior risk [likelihood] based on general population risk narrative,fet 5p del prior risk from pop risk,5p del prior risk based on general population risk nar (fetus),5p del prior risk; fetal; from pop risk; genetics; gyn; gynecology; heredity; heritable; inherited; molecular pathology; molpath; molpath.deletions; narrative; ob; obgyn; obstetrics; point in time; random; report; risk,Nar
75597-5,comment on fetal 5p deletion risk [text] in plasma cell-free+wbc dna by dosage of chromosome-specific cfdna narrative,fet 5p del risk comment,comment on fetal 5p del risk dosage of chromosome-specific cfdna nar (plasma cell-free+wbc dna),5p-; 5p del risk; 5p minus; chromosom; chromosomes; cmmt; cmnt; com; comm; comments; commt; cri-du-chat syndrome; fet 5p del risk comment; genetics; heredity; heritable; inherited; leukocytes; molecular pathology; molpath; molpath.deletions; narrative; pl; plasma; plsm; point in time; random; remarks; report; spec; text; wbc.dna+cfdna; wbcs; white blood cells,Nar
75609-8,birth defects outpatient registry report,birth defects op registry rpt,,doc.ont; document; finding; findings; op; point in time; random; registry rpt,Doc
7561-4,deprecated careless weed ige ab [units/volume] in serum,deprecated careless weed ige qn,careless weed ige qn (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; careless weed; immune globulin e; immunoglobulin e; point in time; qnt; quan; quant; quantitative; random; serum; sr; w082; w82,Qn
75617-1,residence [namcs],,,housing; living arrangement; living arrangements; nominal; point in time; random; survey; survey.nhcs; typ,Nom
75630-4,interstitial collagenase [mass/volume] in serum or plasma,mmp-1 serpl-mcnc,interstitial collagenase [mass/vol],chemistry; fibroblast collagenase; level; mass concentration; matrix metalloproteinase 1; mmp1; mmp-1; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
75651-0,tetrahydrocannabivarin [mass/volume] in urine,carboxythcv ur-mcnc,tetrahydrocannabivarin (u) [mass/vol],carboxythcv; drug/toxicology; drugs; level; mass concentration; point in time; qnt; quan; quant; quantitative; random; thcv; thv; ua; ur; urn,Qn
75653-6,manual differential comment [interpretation] in body fluid narrative,manual dif comment fld-imp,manual differential comment nar (body fld) [interp],"b/f; bf; bod; bodies; body fluid; body fluid, unsp; cmmt; cmnt; com; comm; comments; commt; diff; differl; differn; fl; fld; flu; fluid; hematology/cell counts; impression; impression/interpretation of study; impressions; interp; interpretation; manual dif comment; narrative; point in time; random; remarks; report",Nar
75654-4,manual differential comment [interpretation] in cerebral spinal fluid narrative,manual dif comment csf-imp,manual differential comment nar (csf) [interp],cerebral spinal fluid; cerebrospinal fl; cmmt; cmnt; com; comm; comments; commt; diff; differl; differn; hematology/cell counts; impression; impression/interpretation of study; impressions; interp; interpretation; manual dif comment; narrative; point in time; random; remarks; report; spinal fl; spinal fld; spinal flu; spinal fluid,Nar
75655-1,mononuclear cells [#] in cerebral spinal fluid by manual count,mononuc cells csf manual,mononuclear cells manual cnt (csf) [#],cell; cellularity; cerebral spinal fluid; cerebrospinal fl; cnt; count; hematology/cell counts; manl; mononuc; mononuc cells; number; point in time; qnt; quan; quant; quantitative; random; spinal fl; spinal fld; spinal flu; spinal fluid,Qn
75661-9,granulocytes [#] in pleural fluid by manual count,granulocytes plr manual,granulocytes manual cnt (pleur fld) [#],cnt; count; gran; grans; granulocyte; granulocytes; hematology/cell counts; manl; number; pleural; pleural fluid; point in time; qnt; quan; quant; quantitative; random; thoracentesis fluid,Qn
75667-6,electrolytes 3 panel - 24 hour urine,lytes 3 pnl 24h ur,electrolytes 3 panel (24h u),1 day; 24 hours; 24hr; chemistry; elect; electr; electrolyte; iii; lytes; lytes 3 pnl; pan; panel.chemistry; panl; pnl; qnt; quan; quant; quantitative; ua; ur; urn,Qn
7567-1,parrot serum ige ab [units/volume] in serum,parrot serum ige qn,parrot serum ige qn (s),abs; aby; african gray parrot; african grey parrot; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; e26; immune globulin e; immunoglobulin e; macaw; point in time; qnt; quan; quant; quantitative; random; ser; serum; sr,Qn
75686-6,deprecated carbapenem resistance blaimp gene [presence] by nucleic acid capture and probe detection in positive blood culture,deprecated blaimp bld pos ql prb mag,carbapenem resistance blaimp gene nucleic acid capture and probe detection ql (pos bld culture),antibiotic susceptibilities; bact; bld pos; blood; cpr; dna nucleic acid probe; dna probe; id; infectious disease; infectiousdisease; ordinal; point in time; pr; prb mag; ql; qual; qualitative; random; resist; resistanc; resistant; resistent; screen; wb; whole blood,Ord
75688-2,deprecated gram negative bacteria identified [interpretation] by nucleic acid capture and probe detection in positive blood culture,deprecated gn bact bld pos prb mag-imp,gram negative bacteria identified nucleic acid capture and probe detection (pos bld culture) [interp],bact; bld pos; blood; dna nucleic acid probe; dna probe; gn bact; id; impression; impression/interpretation of study; impressions; infectious disease; infectiousdisease; interp; interpretation; isolated; microbiology; neg; nominal; point in time; prb mag; random; wb; whole blood,Nom
75709-6,calcitonin [mass/volume] in lymph node fine needle aspirate,calcit ln fna-mcnc,calcitonin (lymph node fine needle aspirate) [mass/vol],chemistry; ct; endocrine; endocrinology; fine needle; level; ln; ln fna; mass concentration; point in time; qnt; quan; quant; quantitative; random; thyrocalcitonin; tumor marker,Qn
75714-6,cyp1a2 gene c.-2467delt [presence] in blood or tissue by molecular genetics method,cyp1a2 c.-2467delt bld/t ql,cyp1a2 gene c.-2467delt molgen ql (bld/tiss),"blood; cp12; cyp1a2 c.-2467delt; cytochrome p450, family 1, subfamily a, polypeptide 2; genetics; heredity; heritable; inherited; molecular genetics; molecular pathology; molpath; molpath.pharmg; ordinal; p3-450; p450(pa); pcr; point in time; pr; ql; qual; qualitative; random; screen; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",Ord
75722-9,cyp1a2 gene c.-163c>a [presence] in blood or tissue by molecular genetics method,cyp1a2 c.-163c>a bld/t ql,cyp1a2 gene c.-163c>a molgen ql (bld/tiss),"blood; cp12; cyp1a2 c.-163c&gt;a; cytochrome p450, family 1, subfamily a, polypeptide 2; genetics; heredity; heritable; inherited; molecular genetics; molecular pathology; molpath; molpath.pharmg; ordinal; p3-450; p450(pa); pcr; point in time; pr; ql; qual; qualitative; random; screen; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",Ord
75725-2,cyp1a2 gene c.-729c>t [presence] in blood or tissue by molecular genetics method,cyp1a2 c.-729c>t bld/t ql,cyp1a2 gene c.-729c>t molgen ql (bld/tiss),"blood; cp12; cyp1a2 c.-729c&gt;t; cytochrome p450, family 1, subfamily a, polypeptide 2; genetics; heredity; heritable; inherited; molecular genetics; molecular pathology; molpath; molpath.pharmg; ordinal; p3-450; p450(pa); pcr; point in time; pr; ql; qual; qualitative; random; screen; t prime; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",Ord
75728-6,htr2a gene c.74c>a [presence] in blood or tissue by molecular genetics method,htr2a c.74c>a bld/t ql,htr2a gene c.74c>a molgen ql (bld/tiss),"5-ht-2a; 5-hydroxytryptamine receptor 2a gene; blood; genetics; heredity; heritable; htr2a c.74c&gt;a; inherited; molecular genetics; molecular pathology; molpath; molpath.mutations; ordinal; pcr; point in time; pr; ql; qual; qualitative; random; screen; serotonin receptor 2a gene; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",Ord
75730-2,htr2c gene c.796g>c [presence] in blood or tissue by molecular genetics method,htr2c c.796g>c bld/t ql,htr2c gene c.796g>c molgen ql (bld/tiss),"5-ht1c; 5ht-1c; 5-ht2c; 5-ht-2c; 5htr2c; 5-htr2c; 5-hydroxytryptamine (serotonin) receptor 2c, g protein-coupled; 5-hydroxytryptamine receptor 2c gene; blood; genetics; heredity; heritable; htr1c; htr2c c.796g&gt;c; inherited; molecular genetics; molecular pathology; molpath; molpath.pharmg; ordinal; pcr; point in time; pr; ql; qual; qualitative; random; screen; serotonin receptor 2c gene; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",Ord
75748-4,ct guidance for fluid aspiration of cervical spine intervertebral disc,ct guided c-spine disc pc fluid asp,,asp; c/sp; cat scan; cerv; computed tomography; computerized tomography; c-spine; c-spine interv disc; ct scan; document; finding; findings; fld; guid; guide; guided; i-disc; imaging; pc fluid asp; perc; point in time; rad; radiology; random; spinal; spinal cord; spine.disc.cervical,Doc
75751-8,rf guidance for drainage of abscess and placement of chest tube of pleural space - left,rf guided pl space-l absc drn+ct place,,absc drainage; absc drn+ct place; document; drain; exudate; finding; findings; fluor; fluoro; fluoroscopy; guid; guide; guided; imaging; l; lt; lung; pl space; pl space-l; point in time; pulmonary; pulmonology; rad; radiology; random; removal of fluid; respiratory; thorax,Doc
75757-5,chlamydia sp ab [presence] in serum by complement fixation,chlamydia ab ser ql cf,chlamydia sp ab cf ql (s),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; cf; chlam; chlamid; comp fixation; compfix; complement fixation; id; infectious disease; infectiousdisease; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; species; spp; sr,Ord
75782-3,thoughts regarding autopsy narrative - reported,thoughts regarding autopsy reported,,clin; finding; findings; narrative; point in time; random; report,Nar
7578-8,pear igg ab [units/volume] in serum,pear igg qn,pear igg qn (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; f094; f94; immune globulin g; immunoglobulin g; pear; point in time; qnt; quan; quant; quantitative; random; serum; sr,Qn
75793-0,other directives that have not otherwise been documented narrative - reported,other directives not documented reported,,clin; finding; findings; narrative; other directives not documented; othr; point in time; random; report,Nar
75796-3,physical well being - fact-gp [facit],,,functional assessment of chronic illness therapy; pan; panel; panel.survey.gnhlth; panl; physical well-being; pnl; point in time; random; survey; survey.gnhlth,-
75801-1,how have things been going for you during the past 4 weeks [coop],,,4 weeks; last; ordinal; ql; qual; qualitative; scale; screen; survey,Ord
75816-9,rf spine.thoracic epidural space views w contrast epidural,rf t-spine space views w contr ep,,c; contr; contra; contrst; document; dorsal spine; films; finding; findings; fluor; fluoro; fluoroscopy; imaging; point in time; rad; radiology; random; spinal; spinal cord; th/sp; thorax; t-spine; t-spine space; view; vws; w contr ep; wc,Doc
75819-3,erythrocyte chromasia [identifier] in blood by light microscopy,rbc chrm bld smear,rbc chromasia lm nom (bld),blood; chromasia; discocyte; erc; erythrocytes; hematology/cell counts; identity or presence; lm; micro; micros; microscopic; nominal; point in time; random; rbc; rbc chrm; red blood cell; red blood cells; red blood corpuscle; red blood corpusles; red cell; red cells; wb; whole blood,Nom
75826-8,"over the past week, are you able to open a new milk carton [haq]",,,1 week; f43; finding; findings; health assessment questionnaire; last; ordinal; ql; qual; qualitative; screen; survey,Ord
75829-2,"over the past week, are you able to wash and dry your body [haq]",,,1 week; bod; bodies; finding; findings; health assessment questionnaire; last; ordinal; ql; qual; qualitative; screen; survey,Ord
75837-5,"over the past week, are you able to run errands and shop [haq]",,,1 week; finding; findings; health assessment questionnaire; last; ordinal; ql; qual; qualitative; screen; survey,Ord
75841-7,total score [pasii],,,patient activity scale; point in time; qnt; quan; quant; quantitative; random; scale; survey; tot; totl,Qn
75842-5,clinical disease activity index [cdai],,,activ; actvty; dis; diseases; dz; movements; pan; panel; panel.survey.gnhlth; panl; pnl; point in time; random; survey; survey.gnhlth,-
75851-6,"over the past week, are you able to move heavy objects [haqii]",,,1 week; finding; findings; last; ordinal; ql; qual; qualitative; screen; survey,Ord
75861-5,hedis 2015-2020 value set - ldl-c tests,hedis 2015-20 ldl-c,hedis 2015-2020 value set - ldl-c tests,hedis 2015-20 ldl-c; pan; panel; panel.hedis; panl; pnl; point in time; random,-
75865-6,hedis 2015-2018 value set - psa test exclusion,hedis 2015-18 psa test excl,hedis 2015-2018 value set - psa test exclusion,hedis 2015-18 psa test excl; pan; panel; panel.hedis; panl; pnl; point in time; random,-
75869-8,"hedis 2015, 2016 value set - pregnancy test exclusion",hedis 2015-16 preg test excl,"hedis 2015, 2016 value set - pregnancy test exclusion",gestation; gestations; gravida; gyn; gynecology; hedis 2015-16 preg test excl; ob; obgyn; obstetrics; pan; panel; panel.hedis; panl; pg test; pnl; point in time; preg test; pregnancies; random,-
75871-4,deprecated promis short form 8a - pain interference tscore,,,patient reported outcomes information system; point in time; promise; qnt; quan; quant; quantitative; random; survey; survey.promis; t-score,Qn
75902-7,how many days in the past week did your child miss taking one or more medications # [samhsa],,,1 week; cnt; count; dextro; last; number; qnt; quan; quant; quantitative; samsha; substance abuse and mental health services administration; survey; survey.samhsa,Qn
7591-1,chili pepper ige ab [units/volume] in serum,chili pepper ige qn,chili pepper ige qn (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; chili pepper; f279; immune globulin e; immunoglobulin e; point in time; qnt; quan; quant; quantitative; random; rf279; serum; sr,Qn
75914-2,aptt w hexagonal phospholipid/normal (staclot la confirm),normalized confirm aptt staclot,aptt w excess hexagonal phase phospholipid actual/normal coag (ppp) [relative time],act/nor; activated partial thromboplastin time; aptt; aptt hex pl; clot; clottable; coag; coagulation assay; control; hematology; heme; hex; hpp; lipid; little(a)ptt; partial thromboplastin time; phoslpd; phospholipids; pl; plas; platelet poor plasma; point in time; ptt; qnt; quan; quant; quantitative; random; rltm; staclot la; surf; tilt tube,Qn
75919-1,left ventricular cardiac index,lv cardiac index,,bdy surface; bod; bodies; bsa; cardiac; cardio; cardiology; co; heart disease; hemodynamics; hemodynamics.molec; hrt; hrt ventr; l; lt; lv; point in time; qnt; quan; quant; quantitative; random; surf; ventricular; volume rate/area; volume rate/ratio,Qn
75930-8,relative humidity setting infant microenvironment.incubator,rel humidity set inf microenvt.incub,,inf microenvt; inf microenvt.incub; neonat; point in time; qnt; quan; quant; quantitative; random; rel; rel humidity set; relative mass concentration; rlmcnc,Qn
75945-6,right eye pupil reaction [time],r eye pupil reaction [time],,eye; eye.px; eyeball; occular; oculis; ophthalmologic; ophthalmology; ophtho; ophthy; optic globe; point in time; qnt; quan; quant; quantitative; r; r eye; random; react; rt; rxn; vision; visual,Qn
7595-2,red pepper triggered histamine release [units/volume] in blood,red pepper basobnd ab qn,red pepper triggered histamine release qn (bld),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; associated; autoantibodies; autoantibody; baso; basobnd ab; basophil release; basophils; basos; blood; bnd; bph; f280; leukocyte histamine reaction; leukocyte histamine release; point in time; qnt; quan; quant; quantitative; random; red pepper; wb; wbc release; whole blood,Qn
75988-6,left ventricular end diastolic volume,lv ed vol,,cardiac; cardio; cardiology; cardio-pulm; dias; diast; diastoli; ed vol; heart disease; hrt; hrt ventr; l; lt; lung; lv; point in time; pulmonary; pulmonology; qnt; quan; quant; quantitative; random; respiratory; ventricular; vol; volume,Qn
7600-0,phospholipase ige ab [units/volume] in serum,phospholipase ige qn,phospholipase ige qn (s),"abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; immune globulin e; immunoglobulin e; k203; napi m 1 phospholipase a2, bee; point in time; qnt; quan; quant; quantitative; random; rk203; serum; sr",Qn
76025-6,arylsulfatase c [enzymatic activity/mass] in fibroblast,arylsulfatase c fib-ccnt,arylsulfatase c (fibroblast) [catalytic activity/mass],arylsulfatase.total; catalytic content; chemistry; fib; fibr; point in time; qnt; quan; quant; quantitative; random,Qn
76034-8,gaa gene full mutation analysis in blood or tissue by sequencing,gaa full mut anl bld/t seq,gaa gene full mutation analysis sequencing doc (bld/tiss),"blood; document; finding; findings; full gene sequencing; full mut anl; genetics; glucosidase, alpha; acid; heredity; heritable; high-throughput sequencing; hts; inherited; lyag; molecular pathology; molpath; molpath.mutations; mut; mutations; next generation sequencing; ngs; point in time; random; sequencing of entire coding region; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",Doc
76048-8,st amplitude.lead v2,st amp l-v2,,cardiac; cardio; cardiology; ecg; ekg.measurements; electrical potential; electrocardiogram; electrocardiograph; heart disease; hrt; painter's colic; pb; plumbism; point in time; qnt; quan; quant; quantitative; random; st amp l-v2; voltage,Qn
76056-1,st amplitude.lead avf,st amp l-avf,,cardiac; cardio; cardiology; ecg; ekg.measurements; electrical potential; electrocardiogram; electrocardiograph; heart disease; hrt; painter's colic; pb; plumbism; point in time; qnt; quan; quant; quantitative; random; st amp l-avf; voltage,Qn
76063-7,msh2 gene+mlh1 gene+msh6 gene mutation analysis limited to known familial mutations in blood or tissue by molecular genetics method,msh2+mlh1+msh6 gene fam mut anl bld/t,msh2 gene+mlh1 gene+msh6 gene familial mut analysis molgen doc (bld/tiss),"bat-26; blood; coca1; coca2; colon cancer nonpolyposis type 1; document; fam mut anl; fcc1; fcc2; finding; findings; g/t mismatch-binding protein gene; genetics; gtbp; gtmbp; hereditary nonpolyposis colorectal cancer; heredity; heritable; hmlh1; hnpcc; hnpcc1; hnpcc2; hnpcc5; hsap; inherited; lcfs2; lmted; ltd; lynch syndrome; mgc5172; molecular genetics; molecular pathology; molpath; molpath.mutations; msh2+mlh1 gene; msh2+mlh1+msh6 gene; mut; mutation; mutations; mutl homolog 1; mutl homolog 1, colon cancer, nonpolyposis type 2; muts; muts homolog 2; muts homolog 6; p160; pcr; point in time; random; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",Doc
76069-4,erythrocytes.hypochromic/erythrocytes in blood by automated count,%hypo/rbc nfr bld auto,rbc.hypochromic/erythrocytes auto (bld),%hypo; auto; automated detection; blood; discocytes; elec; elect; electr; erthrocyte; erythrocyte; hematology/cell counts; hypochromasia; number fraction; percent; point in time; qnt; quan; quant; quantitative; random; rbc; rbcs; red blood cell; red blood cells; red blood corpuscle; red blood corpusles; red cell; red cells; wb; whole blood,Qn
76072-8,enterovirus d68 rna [presence] in specimen by naa with probe detection,ev d68 rna spec ql naa+probe,enterovirus d68 rna naa+probe ql (specimen),3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; dna nucleic acid probe; dna probe; entero virus; ev; ev d68; ev d68 rna; ev-d68; ev-pcr; hev d68; hev-d68; id; infectious disease; infectiousdisease; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; misc; miscellaneous; naa+probe; naat; nasba; nucleic acid sequence based analysis; ordinal; other; pcr; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; ribonucleic acid; screen; sda; spec; strand displacement amplification; tma; to be specified in another part of the message; transcription mediated amplification; unspecified,Ord
76074-4,enterovirus rna [presence] in nasopharynx by naa with probe detection,ev rna nph ql naa+probe,enterovirus rna naa+probe ql (nph),3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; dna nucleic acid probe; dna probe; entero virus; ev; ev-pcr; id; infectious disease; infectiousdisease; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; naa+probe; naat; nasba; nasopharynx; nucleic acid sequence based analysis; ordinal; pcr; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; ribonucleic acid; screen; sda; strand displacement amplification; tma; transcription mediated amplification,Ord
76086-8,parainfluenza virus 3 rna [presence] in nasopharynx by naa with probe detection,hpiv3 rna nph ql naa+probe,parainfluenza virus 3 rna naa+probe ql (nph),3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; dna nucleic acid probe; dna probe; hpiv; hpiv3; human respirovirus 3; id; iii; infectious disease; infectiousdisease; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; naa+probe; naat; nasba; nasopharynx; nucleic acid sequence based analysis; ordinal; para; parainflu; parainfluenza type 3; parainfluenza type iii; pcr; pi3; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; ribonucleic acid; screen; sda; strand displacement amplification; tma; transcription mediated amplification,Ord
76109-8,xenon [vfr/ppres] gas delivery system.inspiratory limb --during inspiration,xe during insp vfr/ppres gas ds.il,,gas ds; gas ds.il; gases; in; insp; inspiratory; lung; point in time; pulmonary; pulmonology; qnt; quan; quant; quantitative; random; respiratory; xe,Qn
76112-2,nitrogen [vfr/ppres] gas delivery system,n2 vfr/ppres gas ds,,gas ds; gases; lung; n; n2; nit; point in time; pulmonary; pulmonology; qnt; quan; quant; quantitative; random; respiratory,Qn
76119-7,helium gas delivered during case [volume] from gas delivery system,he gas del dur case vol gas ds,,gas ds; gases; he; he gas del dur case; lung; pulmonary; pulmonology; qnt; quan; quant; quantitative; respiratory; volume,Qn
76120-5,nitric oxide [vfr/ppres] airway adaptor --during inspiration,no during insp vfr/ppres away adap,,away adap; in; insp; inspiratory; lung; no; point in time; pulmonary; pulmonology; qnt; quan; quant; quantitative; random; respiratory,Qn
76122-1,helium gas delivered.total [volume] in reporting period from gas delivery system,he gas del.total rptperiod vol gas ds,,gas ds; gases; he; he gas del.total; lung; pulmonary; pulmonology; qnt; quan; quant; quantitative; report period; respiratory; tot; totl; volume,Qn
76127-0,argon [vfr/ppres] gas delivery system,argon vfr/ppres gas ds,,gas ds; gases; lung; point in time; pulmonary; pulmonology; qnt; quan; quant; quantitative; random; respiratory,Qn
76130-4,isoflurane liquid delivered during case [volume] from gas delivery system,isofl liq del dur case vol gas ds,,gas ds; gases; isofl liq del dur case; liquids; lung; pulmonary; pulmonology; qnt; quan; quant; quantitative; respiratory; volume,Qn
76133-8,sugar absorption test panel [molar ratio] - 5 hour urine,sugar absorption test pnl 5h ur-srto,sugar absorption test panel (5 hour u) [molar ratio],5 hours; 5.0hr; 5hr; absorp; chemistry; pan; panel.chemistry; panl; pnl; scrto; substance concentration ratio; substance ratio; sugar absorption test pnl; ua; ur; urn,-
76137-9,platelet component distribution width [mass/volume] in blood by calculation,pcdw bld calc-mcnc,platelet component distribution width calc (bld) [mass/vol],blood; calc; calculation; hematology/cell counts; level; mass concentration; pcdw; pl; platelets; platelt; plt; point in time; qnt; quan; quant; quantitative; random; thrombocyte; thrombocytes; wb; whole blood,Qn
76145-2,prulifloxacin [susceptibility] by minimum inhibitory concentration (mic),prulifloxacin islt mic,prulifloxacin mic [susc],antibiotic susceptibilities; ast; id; infectious disease; infectiousdisease; islt; isol; minimum inhibitory concentration; point in time; pruquin; random; sus; suscept; susceptibilities; susceptibility; susceptibilty,OrdQn
76154-4,airway pressure delta --on ventilator,away press delta on vent pressdiff,,away press delta; breathing; lung; lungs; point in time; pulmonary; pulmonology; qnt; quan; quant; quantitative; random; respiratory; rs,Qn
7619-0,poison ivy ige ab [units/volume] in serum,poison ivy ige qn,poison ivy ige qn (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; immune globulin e; immunoglobulin e; oak poison; point in time; poison oak; qnt; quan; quant; quantitative; random; serum; sr; toxicodendron radicans,Qn
76244-3,positive pressure phase duration [time] ventilator,pos press dur on vent in pos press mode,,durat; lung; point in time; pos; pos press phase dur; pulmonary; pulmonology; qnt; quan; quant; quantitative; random; respiratory,Qn
76250-0,minimum expiratory pressure respiratory system airway,min exp press airway,,breathing; exp pressure; lung; lungs; min exp press; minimal; minimum; point in time; press.min; pressure; pulmonary; pulmonology; qnt; quan; quant; quantitative; random; respiratory; rs,Qn
76268-2,pressure.ambient room,press.ambient room,,lung; point in time; press.ambient; pressure; pulmonary; pulmonology; qnt; quan; quant; quantitative; random; respiratory,Qn
76282-3,heart rate.beat-to-beat by ekg,heart rate.btb by ekg,,cardiac; cardio; cardiology; count/time; ecg; ekg.measurements; electrocardiogram; electrocardiograph; heart beat; heart disease; heart rate.btb; hrt; nrate; number rate; number rate = count/time; point in time; pulse; qnt; quan; quant; quantitative; random,Qn
76300-3,doses.delivered [#] in reporting period infusion pump,doses.del rptperiod inf pump,,cnt; count; inf pump; io_in.infus; io_intake; number; qnt; quan; quant; quantitative; report period,Qn
76304-5,infused volume.total reporting period infusion pump,inf vol.tot rptperiod inf pump,,inf pump; inf vol.tot; io_in.infus; io_intake; qnt; quan; quant; quantitative; report period; tot; totl; vol; volume,Qn
76308-6,infusion time.remaining infusion pump,inf time.remain inf pump,,inf pump; inf time.remain; io_in.infus; io_intake; point in time; qnt; quan; quant; quantitative; random,Qn
76312-8,pca dose number.max 1 hour infusion pump,pca dose num.max 1h nrate inf pump,,1 hour; 1.0hr; 1hr; 60 min; 60 minutes; 60m; 60min; count/time; dose #; inf pump; io_in.infus; io_intake; largest; maximal; maximum; no; nrate; num; number rate; number rate = count/time; pca dose num.max; peak; qnt; quan; quant; quantitative,Qn
76332-6,infusion pump reason pump stopped infusing,inf pump reason pump stop infus,,inf pump; nominal; point in time; random; reason pump stop infus; typ,Nom
76355-7,employment position panel [nmmds],,,nursing management minimum data set; pan; panel.survey.nmmds; panl; pnl; point in time; random; survey; survey.nmmds,-
7635-6,psyllium seed ige ab [units/volume] in serum,psyllium seed ige qn,psyllium seed ige qn (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; immune globulin e; immunoglobulin e; point in time; qnt; quan; quant; quantitative; random; seeds; serum; sr,Qn
76365-6,age category panel [nmmds],,,nursing management minimum data set; pan; panel.survey.nmmds; panl; pnl; point in time; random; survey; survey.nmmds,-
7638-0,pullularia sp igg ab [units/volume] in serum,pullaria igg qn,pullularia sp igg qn (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; immune globulin g; immunoglobulin g; point in time; pullaria; qnt; quan; quant; quantitative; random; serum; species; spp; sr,Qn
76380-5,licensed nursing staff.highest level of education in a non-nursing degree/licensed nursing staff [nmmds],,,levels; levl; lv; lvl; number fraction; nursing management minimum data set; percent; point in time; qnt; quan; quant; quantitative; random; survey; survey.nmmds,Qn
76386-2,nursing certification provider [nmmds],,,nominal; nursing management minimum data set; point in time; random; survey; survey.nmmds; typ,Nom
76429-0,physical therapy discharge date,pt discharge date,,disch; h+p; h+p.hx; p prime; point in time; pt; pt discharge date; qnt; quan; quant; quantitative; random,Qn
76442-3,primary health condition,primary health cond,,apta; finding; findings; nominal; physical therapy; point in time; pt; random,Nom
76455-5,physical therapy reexamination panel,pt reexam pnl,,apta; pan; panel.apta; panl; physical therapy; pnl; point in time; pt; pt reexam pnl; random,-
76462-1,reason for discharge apta,reason for discharge apta,,american physical therapy association; disch; finding; findings; nominal; physical therapy; point in time; pt; random,Nom
76467-0,surgical history relevant to physical therapy treatment,surg hx relevant to pt tx,,apta; hx; nominal; physical therapy; point in time; pt; random; surg; surg hx relevant to pt tx; tx; typ,Nom
7647-1,desert ragweed ige ab [units/volume] in serum,desert ragweed ige qn,desert ragweed ige qn (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; burrobush; desert ragweed; franseria dumosa; immune globulin e; immunoglobulin e; point in time; qnt; quan; quant; quantitative; random; serum; sr; white burrobush,Qn
76480-3,albumin [moles/volume] in cerebral spinal fluid,albumin csf-scnc,albumin (csf) [moles/vol],alb; cerebral spinal fluid; cerebrospinal fl; chemistry; level; neuro; neurology; point in time; protein.albumin; qnt; quan; quant; quantitative; random; spinal fl; spinal fld; spinal flu; spinal fluid; substance concentration,Qn
76505-7,highest pressure ulcer stage npuap,highest press ulcer stage npuap,,finding; findings; h+p; h+p.hx; highest press ulcer stage; nominal; p prime; point in time; pressure injury; pressure ulcer; pressure ulcers; random; ulcer,Nom
76530-5,mean pressure respiratory system airway --on ventilator,mean pres on vent airway,,average; avg; breathing; lung; lungs; map; mean pres; point in time; pressure; pressure mean; pulmonary; pulmonology; qnt; quan; quant; quantitative; random; respiratory; rs,Qn
76536-2,mean blood pressure by noninvasive,bp mean by noninvasive,,art sys; average; avg; blood pressure mean; blood pressure measurements.molec; bp; bp mean; cardio; cardiology; heart disease; intravenous; iv; mbp; point in time; pressure; qnt; quan; quant; quantitative; random,Qn
76543-8,weight management summary report,weight management sum rpt,,doc.ont; document; finding; findings; healthy weight; hw; hws; point in time; random; weight management sum rpt; wt,Doc
76565-1,left ventricular cardiac output by us.2d+calculated,lv output us.2d+calc,,2d us; calc; calculation; card.us; cardiac; cardio; cardiology; co; echography; flow; heart disease; hrt; hrt ventr; l; lt; lv; point in time; qnt; quan; quant; quantitative; random; sonogram; sonograph; sonography; uls; ultrasound; ultrasound - 2-dimensional; ventricular; volume rate; vrate,Qn
76581-8,streptococcus pyogenes csrs gene [presence] in swab specimen by naa with probe detection,s pyogenes csrs swab ql naa+probe,s. pyogenes csrs gene naa+probe ql (swab specimen),3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; dna nucleic acid probe; dna probe; gas; group a strep; id; infectious disease; infectiousdisease; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; misc; miscellaneous; naa+probe; naat; nasba; nucleic acid sequence based analysis; ordinal; other; pcr; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; s pyogenes; screen; sda; spec; steptococcus group a; strand displacement amplification; strep; strept; streptococci group a; streptococcus group a; tma; to be specified in another part of the message; transcription mediated amplification; unspecified,Ord
76583-4,klebsiella pneumoniae phoe gene [presence] in swab specimen by naa with probe detection,kl pneum phoe swab ql naa+probe,k. pneumoniae phoe gene naa+probe ql (swab specimen),3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; dna nucleic acid probe; dna probe; id; infectious disease; infectiousdisease; k pneumon; kl pneum phoe; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; misc; miscellaneous; naa+probe; naat; nasba; nucleic acid sequence based analysis; ordinal; other; pcr; pneu; pneum; pneumo; pneumon; pneumonia; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; screen; sda; spec; strand displacement amplification; tma; to be specified in another part of the message; transcription mediated amplification; unspecified,Ord
76593-3,pseudomonas aeruginosa rega gene [#/mass] in xxx.tissue by naa with probe detection,p aerug rega xxx.tiss naa+probe,p. aeruginosa rega gene naa+probe (unsp tissue) [#/mass],3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; count/mass; dna nucleic acid probe; dna probe; id; infectious disease; infectiousdisease; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; misc; miscellaneous; naa+probe; naat; nasba; nucleic acid sequence based analysis; number content; other; p aerug rega; p aeruginosa; pcr; point in time; polymerase chain reaction; probe amp; probe with ampification; probe with target amplification; qbr; qnt; quan; quant; quantitative; random; sda; spec; strand displacement amplification; tma; to be specified in another part of the message; transcription mediated amplification; unspecified,Qn
76597-4,streptococcus agalactiae cfb gene [#/mass] in xxx.tissue by naa with probe detection,s agalact cfb xxx.tiss naa+probe,s. agalactiae cfb gene naa+probe (unsp tissue) [#/mass],3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; count/mass; dna nucleic acid probe; dna probe; gbs; gp b strep; group b; group b strep; id; infectious disease; infectiousdisease; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; misc; miscellaneous; naa+probe; naat; nasba; nucleic acid sequence based analysis; number content; other; pcr; point in time; polymerase chain reaction; probe amp; probe with ampification; probe with target amplification; qbr; qnt; quan; quant; quantitative; random; s agalact cfb; s agalactiae; sda; spec; steptococcus group b; strand displacement amplification; strep; strep b; strep group b; strept; streptococci group b; tma; to be specified in another part of the message; transcription mediated amplification; unspecified,Qn
76604-8,serratia marcescens gyrb gene [#/volume] in xxx.body fluid by naa with probe detection,s marcesc gyrb # xxx.body fld naa+probe,s. marcescens gyrb gene naa+probe (unsp body fluid) [#/vol],#; 3 self-sustaining sequence replication; 3sr sr; abs; absolute; absolutes; amplif; amplification; amplified; bod; bodies; cnt; count; count/volume; ct; dna nucleic acid probe; dna probe; id; infectious disease; infectiousdisease; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; misc; miscellaneous; naa+probe; naat; nasba; nucleic acid sequence based analysis; number concentration; number concentration (count/vol); other; pcr; point in time; polymerase chain reaction; probe amp; probe with ampification; probe with target amplification; qbr; qnt; quan; quant; quantitative; random; s marcesc gyrb; s marcescens; sda; spec; strand displacement amplification; tma; to be specified in another part of the message; transcription mediated amplification; unspecified; viral load; xxx.body fld,Qn
76613-9,transferrin.carbohydrate deficient.pentasialo+hexasialo/transferrin.total in serum or plasma,cdt pentasialo+hexasialo/tf mfr serpl,transferrin.carbohydrate deficient.pentasialo+hexasialo/total transferrin [mass fraction],cdt; cdt pentasialo; cdt pentasialo+hexasialo; chemistry; glycosylated transferrin; mass fraction; percent; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; siderophilin; sr; tf; tot; totl; trf; trfrn,Qn
76614-7,lysosomal acid lipase [enzymatic activity/mass] in fibroblast by 4-mu-oleate substrate,lal fib 4-muo substrate-ccnt,lysosomal acid lipase 4-mu-oleate substrate (fibroblast) [catalytic activity/mass],4-muo substrate; acd; acids; catalytic content; chemistry; fib; fibr; lal; point in time; qnt; quan; quant; quantitative; random,Qn
76621-2,lysosomal acid lipase panel - fibroblast,lal panel fib,lysosomal acid lipase panel (fibroblast),acd; acids; chemistry; fib; fibr; lal; lal panel; pan; panel.chemistry; panl; pnl; point in time; random,-
7663-8,redwood dust ige ab [units/volume] in serum,redwood dust ige qn,redwood dust ige qn (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; immune globulin e; immunoglobulin e; point in time; qnt; quan; quant; quantitative; random; redwood; redwood dust; serum; sr,Qn
76643-6,r-r interval.standard deviation (heart rate variability) by ekg,rr.sd (hr var),,cardiac; cardio; cardiology; ecg; ekg.measurements; electrocardiogram; electrocardiograph; heart disease; heart rate variability; hr variability; hrt; point in time; qnt; quan; quant; quantitative; random; r-r interval; rr.sd (hr var),Qn
76644-4,r-r interval.coefficient of variation by ekg,rr.coeff of var,,cardiac; cardio; cardiology; ecg; ekg.measurements; electrocardiogram; electrocardiograph; heart disease; heart rate variability; hr variability; hrt; qnt; quan; quant; quantitative; r-r interval; rr.coeff of var; time ratio,Qn
76666-7,protein [mass/volume] in cerebral spinal fluid --2nd tube,prot tube2 csf-mcnc,protein 2nd tube (csf) [mass/vol],cerebral spinal fluid; cerebrospinal fl; chemistry; level; mass concentration; neuro; neurology; point in time; pr; prot; qnt; quan; quant; quantitative; random; second; spinal fl; spinal fld; spinal flu; spinal fluid; tube2,Qn
7667-9,rhubarb ige ab [units/volume] in serum,rhubarb ige qn,rhubarb ige qn (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; f178; immune globulin e; immunoglobulin e; point in time; qnt; quan; quant; quantitative; random; rhubarb; serum; sr,Qn
76690-7,sexual orientation,sexual orientation,,clin; nominal; point in time; random; sex orient; typ,Nom
76715-2,do you have someone with whom you can do something enjoyable [promis],,,finding; findings; ordinal; patient reported outcomes information system; point in time; promise; ql; qual; qualitative; random; screen; survey; survey.promis,Ord
7672-9,wheat stem rust ige ab [units/volume] in serum,wheat stem rust ige qn,wheat stem rust ige qn (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; immune globulin e; immunoglobulin e; point in time; qnt; quan; quant; quantitative; random; serum; sr; wheat stem rust,Qn
76729-3,i have someone to give me information if i need it [promis],,,finding; findings; ordinal; patient reported outcomes information system; point in time; promise; ql; qual; qualitative; random; screen; survey; survey.promis,Ord
76733-5,promis short form - companionship 6a - version 2.0,,,pan; panel; panel.survey.promis; panl; patient reported outcomes information system; pnl; point in time; promise; random; survey; survey.promis,-
76734-3,promis short form - emotional support 6a - version 2.0,,,pan; panel; panel.survey.promis; panl; patient reported outcomes information system; pnl; point in time; promise; random; survey; survey.promis,-
76736-8,promis short form - emotional support 8a - version 2.0,,,pan; panel; panel.survey.promis; panl; patient reported outcomes information system; pnl; point in time; promise; random; survey; survey.promis,-
76737-6,i am satisfied with my ability to do things for my family [promis],,,finding; findings; ordinal; patient reported outcomes information system; point in time; promise; ql; qual; qualitative; random; screen; survey; survey.promis,Ord
76738-4,i am satisfied with my ability to do the work that is really important to me (include work at home) [promis],,,finding; findings; job; occupation; ordinal; patient reported outcomes information system; point in time; promise; ql; qual; qualitative; random; screen; survey; survey.promis,Ord
76739-2,i am satisfied with my ability to do things for fun outside my home [promis],,,finding; findings; ordinal; patient reported outcomes information system; point in time; promise; ql; qual; qualitative; random; screen; survey; survey.promis,Ord
76752-5,do you have someone to prepare your meals if you are unable to do it yourself [promis],,,finding; findings; ordinal; patient reported outcomes information system; point in time; promise; ql; qual; qualitative; random; screen; survey; survey.promis,Ord
76756-6,do you have someone to take over all of your responsibilities at home if you need it [promis],,,finding; findings; ordinal; patient reported outcomes information system; point in time; promise; ql; qual; qualitative; random; screen; survey; survey.promis,Ord
76760-8,i feel like a stranger to those around me [promis],,,finding; findings; ordinal; patient reported outcomes information system; point in time; promise; ql; qual; qualitative; random; screen; survey; survey.promis,Ord
76767-3,schistosoma sp identified in semen by light microscopy,schistosoma smn micro,schistosoma sp identified lm nom (sem),bilharziasis; blood fluke; cercarial dermatitis; ejaculate; genitourinary; gu; identity or presence; lm; micro; microbiology; micros; microscopic; nominal; point in time; random; schistosomiasis; sem; seminal fluid; smn; smpls; species; spp; uro; urology,Nom
76777-2,i am satisfied with my ability to maintain friendships [promis],,,finding; findings; ordinal; patient reported outcomes information system; point in time; promise; ql; qual; qualitative; random; screen; survey; survey.promis,Ord
76782-2,i am satisfied with how much work i can do (include work at home) [promis],,,finding; findings; job; occupation; ordinal; patient reported outcomes information system; point in time; promise; ql; qual; qualitative; random; screen; survey; survey.promis,Ord
76787-1,promis item bank - ability to participate in social roles and activities - version 2.0,,,pan; panel; panel.survey.promis; panl; patient reported outcomes information system; pnl; point in time; promise; random; survey; survey.promis,-
76788-9,promis item bank - companionship - version 2.0,,,pan; panel; panel.survey.promis; panl; patient reported outcomes information system; pnl; point in time; promise; random; survey; survey.promis,-
76792-1,promis short form - informational support 4a - version 2.0,,,pan; panel; panel.survey.promis; panl; patient reported outcomes information system; pnl; point in time; promise; random; survey; survey.promis,-
76793-9,promis short form - informational support 6a - version 2.0,,,pan; panel; panel.survey.promis; panl; patient reported outcomes information system; pnl; point in time; promise; random; survey; survey.promis,-
76803-6,promis short form - social isolation 8a - version 2.0,,,isol; pan; panel; panel.survey.promis; panl; patient reported outcomes information system; pnl; point in time; promise; random; survey; survey.promis,-
76816-8,i am happy with how much i do for my friends [promis],,,finding; findings; ordinal; patient reported outcomes information system; point in time; promise; ql; qual; qualitative; random; screen; survey; survey.promis,Ord
76828-3,i am satisfied with my ability to run errands for others [promis],,,finding; findings; ordinal; patient reported outcomes information system; point in time; promise; ql; qual; qualitative; random; screen; survey; survey.promis,Ord
7684-4,deprecated sagebrush ige ab [units/volume] in serum,deprecated sagbrsh ige qn,common sagebrush ige qn (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; common sagebrush; great basin sagebrush; immune globulin e; immunoglobulin e; point in time; qnt; quan; quant; quantitative; random; sagbrsh; sagebrush; serum; sr; w43,Qn
76846-5,i have trouble doing all of the activities with friends that are really important to me [promis],,,finding; findings; ordinal; patient reported outcomes information system; point in time; promise; ql; qual; qualitative; random; screen; survey; survey.promis,Ord
76872-1,i get support from my friends [promis],,,finding; findings; ordinal; patient reported outcomes information system; point in time; promise; ql; qual; qualitative; random; screen; survey; survey.promis,Ord
76873-9,i feel close to my partner (or the person who is my main support) [promis],,,finding; findings; ordinal; patient reported outcomes information system; persons; point in time; promise; ql; qual; qualitative; random; screen; survey; survey.promis; world heatlth organization,Ord
76884-6,i feel that some of my friends avoid me [promis],,,finding; findings; ordinal; patient reported outcomes information system; point in time; promise; ql; qual; qualitative; random; screen; survey; survey.promis,Ord
76899-4,promis item bank - alcohol - alcohol use - version 1.0,,,alc; alcoholic; pan; panel; panel.survey.promis; panl; patient reported outcomes information system; pnl; point in time; promise; random; survey; survey.promis,-
76911-7,"in a typical week in past 30d, i drank... [promis]",,,consumed; drink; finding; findings; last; ordinal; patient reported outcomes information system; promise; ql; qual; qualitative; screen; survey; survey.promis,Ord
76918-2,i had cravings for alcohol in past 30d [promis],,,alc; alcoholic; finding; findings; last; ordinal; patient reported outcomes information system; promise; ql; qual; qualitative; screen; survey; survey.promis,Ord
76930-7,i drank because i felt tense in past 30d [promis],,,consumed; drink; finding; findings; last; ordinal; patient reported outcomes information system; promise; ql; qual; qualitative; screen; survey; survey.promis,Ord
76933-1,i drank because i was sad in past 30d [promis],,,consumed; drink; finding; findings; last; ordinal; patient reported outcomes information system; promise; ql; qual; qualitative; screen; survey; survey.promis,Ord
76950-5,drinking can be harmful to physical health [promis],,,finding; findings; ordinal; patient reported outcomes information system; point in time; promise; ql; qual; qualitative; random; screen; survey; survey.promis,Ord
76952-1,i worried when i drank in past 30d [promis],,,consumed; drink; finding; findings; last; ordinal; patient reported outcomes information system; promise; ql; qual; qualitative; screen; survey; survey.promis,Ord
76954-7,i felt nervous when i drank in past 30d [promis],,,consumed; drink; finding; findings; last; ordinal; patient reported outcomes information system; promise; ql; qual; qualitative; screen; survey; survey.promis,Ord
76976-0,i looked sloppy when i drank in past 30d [promis],,,consumed; drink; finding; findings; last; ordinal; patient reported outcomes information system; promise; ql; qual; qualitative; screen; survey; survey.promis,Ord
7700-8,shrimp igg ab [units/volume] in serum,shrimp igg qn,shrimp igg qn (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; f024; f24; immune globulin g; immunoglobulin g; point in time; prawns; qnt; quan; quant; quantitative; random; serum; shrimp; sr,Qn
77017-2,cftr gene mutation analysis [interpretation] in blood or tissue qualitative by ms.maldi,cftr mut anl bld/t ms.maldi-imp,cftr gene targeted mutation analysis ms.maldi-tof ql (bld/tiss) [interp],"abc35; abcc7; blood; cbavd; cf; cfa; cftr/mrp; cystic fibrosis transmembrane conductance regulator; cystic fibrosis transmembrane conductance regulator (atp-binding cassette sub-family c, member 7); dj760c5.1; genetics; heredity; heritable; impression; impression/interpretation of study; impressions; inherited; interp; interpretation; molecular pathology; molpath; molpath.mutations; mrp7; mut; mut anl; mutations; ordinal; point in time; ql; qual; qualitative; random; screen; tissue; tissue, unspecified; tnr-cftr; wb; whole blood; whole blood or tissue",Ord
7702-4,smelt ige ab [units/volume] in serum,smelt ige qn,smelt ige qn (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; immune globulin e; immunoglobulin e; point in time; qnt; quan; quant; quantitative; random; serum; sr,Qn
77033-9,"t(14;16)(q32;q23)(igh,maf) fusion transcript in blood or tissue by fish","t(14;16)(igh,maf) bld/t fish","t(14;16)(q32;q23)(igh,maf) fusion transcript fish doc (bld/tiss)","blood; dna; document; finding; findings; fluorescent in situ hybridization; gene fusion; gene translocation; genetics; heredity; heritable; inherited; mm; molecular pathology; molpath; molpath.translocation; multiple myeloma; point in time; random; rna; t prime; t(14;16)(igh,maf); tissue; tissue, unspecified; translocation; wb; whole blood; whole blood or tissue",Doc
77034-7,"inv(16)(p13.1;q22.1)(myh11,cbfb) fusion transcript in blood or tissue by fish",inv(16)(p13;q22) bld/t fish,"inv(16)(p13.1;q22.1)(myh11,cbfb) fusion transcript fish doc (bld/tiss)","acute myeloid leukemia; aml; blood; dna; document; finding; findings; fluorescent in situ hybridization; gene fusion; gene translocation; genetics; heredity; heritable; inherited; inv(16)(cbfb,myh11) gene inversion; inv(16)(p13;q22); inversion 16; molecular pathology; molpath; molpath.translocation; point in time; random; rna; tissue; tissue, unspecified; translocation; wb; whole blood; whole blood or tissue",Doc
77048-7,acsf3 gene mutation analysis limited to known familial mutations in blood or tissue by molecular genetics method,acsf3 fam mut anl bld/t,acsf3 gene familial mut analysis molgen doc (bld/tiss),"acyl-coa synthetase family member 3; blood; document; fam mut anl; finding; findings; genetics; heredity; heritable; inherited; lmted; ltd; malonic aciduria; malonyl-coa synthetase; methylmalonic aciduria; molecular genetics; molecular pathology; molpath; molpath.mutations; mut; mutation; mutations; muts; pcr; point in time; random; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",Doc
77057-8,cyp17a1 gene full mutation analysis in blood or tissue by sequencing,cyp17a1 full mut anl bld/t seq,cyp17a1 gene full mutation analysis sequencing doc (bld/tiss),"17-alpha-hydroxylase/17,20-lyase deficiency; adrenal hyperplasia; blood; cpt7; cyp17; cytochrome p450, family 17, subfamily a, polypeptide 1; document; finding; findings; full gene sequencing; full mut anl; genetics; heredity; heritable; high-throughput sequencing; hts; inherited; molecular pathology; molpath; molpath.mutations; mut; mutations; next generation sequencing; ngs; p450c17; point in time; pseudohermaphroditism; random; s17ah; sequencing of entire coding region; steroid-17 alpha-hydroxylase deficiency; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",Doc
77060-2,gnmt gene mutation analysis limited to known familial mutations in blood or tissue by molecular genetics method,gnmt fam mut anl bld/t,gnmt gene familial mut analysis molgen doc (bld/tiss),"blood; document; fam mut anl; finding; findings; genetics; glycine n-methyltransferase; glycine sarcosine methyltransferase; heredity; heritable; hypermethioninemia; inherited; lmted; ltd; molecular genetics; molecular pathology; molpath; molpath.mutations; mut; mutation; mutations; muts; pcr; point in time; random; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",Doc
77063-6,tat gene full mutation analysis in blood or tissue by sequencing,tat full mut anl bld/t seq,tat gene full mutation analysis sequencing doc (bld/tiss),"blood; document; finding; findings; full gene sequencing; full mut anl; genetics; heredity; heritable; high-throughput sequencing; hts; inherited; molecular pathology; molpath; molpath.mutations; mut; mutations; next generation sequencing; ngs; point in time; random; richner-hanhart syndrome; sequencing of entire coding region; tissue; tissue, unspecified; tyrosine aminotransferase; tyrosinemia; tyrosinemia type ii; wb; whole blood; whole blood or tissue",Doc
77064-4,tat gene mutation analysis limited to known familial mutations in blood or tissue by molecular genetics method,tat fam mut anl bld/t,tat gene familial mut analysis molgen doc (bld/tiss),"blood; document; fam mut anl; finding; findings; genetics; heredity; heritable; inherited; lmted; ltd; molecular genetics; molecular pathology; molpath; molpath.mutations; mut; mutation; mutations; muts; pcr; point in time; random; richner-hanhart syndrome; tissue; tissue, unspecified; tyrosine aminotransferase; tyrosinemia; tyrosinemia type ii; wb; whole blood; whole blood or tissue",Doc
77082-6,fars2 gene full mutation analysis in blood or tissue by sequencing,fars2 full mut anl bld/t seq,fars2 gene full mutation analysis sequencing doc (bld/tiss),"blood; combined oxidative phosphorylation deficiency 14; coxpd14; dj520b18.2; document; fars1; finding; findings; full gene sequencing; full mut anl; genetics; heredity; heritable; high-throughput sequencing; hspc320; hts; inherited; molecular pathology; molpath; molpath.mutations; mut; mutations; next generation sequencing; ngs; phenylalanyl-trna synthetase 2, mitochondrial; phers; point in time; random; sequencing of entire coding region; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",Doc
77086-7,tyrobp gene full mutation analysis in blood or tissue by sequencing,tyrobp full mut anl bld/t seq,tyrobp gene full mutation analysis sequencing doc (bld/tiss),"blood; dap12; document; finding; findings; full gene sequencing; full mut anl; genetics; heredity; heritable; high-throughput sequencing; hts; inherited; karap; molecular pathology; molpath; molpath.mutations; mut; mutations; nasu-hakola disease; next generation sequencing; ngs; plosl; point in time; polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy; random; sequencing of entire coding region; tissue; tissue, unspecified; tyro protein tyrosine kinase binding protein; wb; whole blood; whole blood or tissue",Doc
77092-5,mrrf gene full mutation analysis in blood or tissue by sequencing,mrrf full mut anl bld/t seq,mrrf gene full mutation analysis sequencing doc (bld/tiss),"blood; document; end stage renal failure; finding; findings; full gene sequencing; full mut anl; genetics; heredity; heritable; high-throughput sequencing; hts; inherited; lyme disease; mitochondrial ribosome recycling factor; molecular pathology; molpath; molpath.mutations; mrff; mtrrf; mut; mutations; next generation sequencing; ngs; point in time; random; rrf; sequencing of entire coding region; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",Doc
77131-1,cdhr1 gene full mutation analysis in blood or tissue by sequencing,cdhr1 full mut anl bld/t seq,cdhr1 gene full mutation analysis sequencing doc (bld/tiss),"blood; cadherin-related family member 1; cord15; document; finding; findings; full gene sequencing; full mut anl; genetics; heredity; heritable; high-throughput sequencing; hts; inherited; molecular pathology; molpath; molpath.mutations; mut; mutations; next generation sequencing; ngs; pcdh21; point in time; prcad; random; retinal dystrophy; rp65; sequencing of entire coding region; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",Doc
77156-8,ems unit level of care capability,ems level of care,,emergency medical service(s); levels; levl; lv; lvl; nemsis; nominal; point in time; random; typ,Nom
771-6,nucleated erythrocytes [#/volume] in blood by automated count,nrbc # bld auto,nucleated rbc auto (bld) [#/vol],#; abs; absolute; absolutes; auto; automated detection; blood; cnt; count; count/volume; ct; discocytes; elec; elect; electr; erthrocyte; erythroblasts; erythrocyte; hematology/cell counts; normoblasts; nrbc; nrbcs; nuc; number concentration; number concentration (count/vol); point in time; qnt; quan; quant; quantitative; random; rbc; rbcs; red blood cell; red blood cells; red blood corpuscle; red blood corpusles; red cell; red cells; wb; whole blood,Qn
77168-3,cyclosporine [mass/volume] in blood --4 hours post dose,cyclosporine 4h p bld-mcnc,cyclosporine 4 hr post dose (bld) [mass/vol],after; blood; ciclosporin; ciclosporine; csa; cyclosporin a; cyclosporins; drug/toxicology; drugs; gengraf; level; mass concentration; neoral; p dose; point in time; pst; qnt; quan; quant; quantitative; random; restasis; sandimmune; sangcya; wb; whole blood,Qn
7717-2,yellow squash igg ab [units/volume] in serum,yellow squash igg qn,yellow squash igg qn (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; immune globulin g; immunoglobulin g; point in time; qnt; quan; quant; quantitative; random; serum; sr; yellow squash,Qn
77174-1,calr gene exon 9 mutations found [identifier] in blood or tissue by molecular genetics method nominal,calr exon 9 mut anl bld/t,calr gene exon 9 targeted mutation analysis molgen nom (bld/tiss),"blood; calr exon 9; calreticulin; cc1qr; crt; hel-s-99n; identity or presence; molecular genetics; molecular pathology; molpath; mut; mut anl; mutations; nominal; pcr; point in time; random; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",Nom
7718-0,zucchini ige ab [units/volume] in serum,zucchini ige qn,zucchini ige qn (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; f118; immune globulin e; immunoglobulin e; point in time; qnt; quan; quant; quantitative; random; serum; sr,Qn
77200-4,si gene mutations found [identifier] in blood or tissue by molecular genetics method nominal,si gene mut anl bld/t,si gene targeted mutation analysis molgen nom (bld/tiss),"blood; identity or presence; molecular genetics; molecular pathology; molpath; mut; mut anl; mutations; nominal; oligosaccharide alpha-1,6-glucosidase; pcr; point in time; random; sucrase-isomaltase (alpha-glucosidase); tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",Nom
77210-3,salivary gland protein 1 igg ab [units/volume] in serum by immunoassay,sp-1 igg ser ia-acnc,salivary gland protein 1 igg ia qn (s),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; eia; elfa; elisa; enzyme immunoassay; i; iaa; immune globulin g; immunoglobulin g; meia; point in time; pr; prot; qnt; quan; quant; quantitative; random; serology; serum; sp-1; sr; suds,Qn
77221-0,"clinical knowledge, decision making, and mental workload panel [nmmds]",,,decision-making; nursing management minimum data set; pan; panel.survey.nmmds; panl; pnl; point in time; random; survey; survey.nmmds,-
77226-9,workload dimensions panel [nmmds],,,nursing management minimum data set; pan; panel.survey.nmmds; panl; pnl; point in time; random; survey; survey.nmmds,-
77247-5,readiness for change for improved exercise [reported],,,activity; exchange; excz; exercise; ordinal; point in time; ql; qual; qualitative; random; replace; scale; screen; survey; survey.hws,Ord
77255-8,"nursing staff job positions, quantity, turnover, and retention panel [nmmds]",,,nursing management minimum data set; occupation; pan; panel.survey.nmmds; panl; pnl; report period; survey; survey.nmmds; work,-
77257-4,number of actual nursing staff by job position in a reporting period [nmmds],,,cnt; count; number; nursing management minimum data set; qnt; quan; quant; quantitative; report period; survey; survey.nmmds,Qn
77265-7,number of new nursing staff by job position who remained in a reporting period [nmmds],,,cnt; count; number; nursing management minimum data set; qnt; quan; quant; quantitative; report period; survey; survey.nmmds; world heatlth organization,Qn
77279-8,nursing staff retention panel [nmmds],,,nursing management minimum data set; pan; panel.survey.nmmds; panl; pnl; report period; survey; survey.nmmds,-
77287-1,"management, administrative, andor support staff [nmmds]",,,nominal; nursing management minimum data set; report period; survey; survey.nmmds; typ,Nom
77294-7,"yesterday, how many times did the patient eat any vegetables #",,,1 day; 24 hours; 24h; 24hr; cnt; count; number; qnt; quan; quant; quantitative; survey; survey.hws,Qn
77303-6,provider preference for care action,provider pref for care action,,finding; findings; h+p; h+p.hx; nominal; p prime; point in time; provider pref for care action; random,Nom
77329-1,temazepam [moles/volume] in specimen,temazepam spec-scnc,temazepam (specimen) [moles/vol],drug/toxicology; drugs; level; misc; miscellaneous; normison; other; point in time; qnt; quan; quant; quantitative; random; restoril; spec; substance concentration; to be specified in another part of the message; unspecified,Qn
77330-9,protriptyline [moles/volume] in specimen,protrip spec-scnc,protriptyline (specimen) [moles/vol],drug/toxicology; drugs; level; misc; miscellaneous; other; point in time; qnt; quan; quant; quantitative; random; spec; substance concentration; to be specified in another part of the message; unspecified; vivactil,Qn
77337-4,trimipramine+nortrimipramine [moles/volume] in specimen,trimipram+nor spec-scnc,trimipramine+nortrimipramine (specimen) [moles/vol],addiction; cotrimazine; desmeth; desmethyltrimipramine; drug/toxicology; drugs; drugs of abuse; illicit; level; misc; miscellaneous; other; point in time; potentialforabuse; qnt; quan; quant; quantitative; random; spec; substance concentration; surmontil; tmp; to be specified in another part of the message; trimipram+nor; trimipramine metabolite; unspecified,Qn
77339-0,indocyanine green [mass/volume] in plasma --15 minutes post dose indocyanine green,icg 15m p dose icg plas-mcnc,indocyanine green 15 min post dose indocyanine green (p) [mass/vol],15m p dose icg; after; chemistry.challenge testing; icg; level; mass concentration; p dose; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random,Qn
77349-9,everolimus [mass/volume] in blood by lc/ms/ms --trough,everolimus trough bld lc/ms/ms-mcnc,everolimus trough lc/ms/ms (bld) [mass/vol],afinitor; blood; certican; drug/toxicology; drugs; level; mass concentration; point in time; pre; predose; pre-dose; qnt; quan; quant; quantitative; rad-001; random; wb; whole blood; zortress,Qn
77359-8,protein [mass/volume] in saliva (oral fluid),prot sal-mcnc,protein (sal) [mass/vol],chemistry; level; mass concentration; oral fluid; point in time; pr; prot; qnt; quan; quant; quantitative; random; sal,Qn
77365-5,nitrogen panel - 24 hour stool,nitrogen pnl 24h stl,nitrogen panel (24h stl),1 day; 24 hours; 24hr; bowel movement; chemistry; faecal; faeces; fecal; feces; n; n2; nit; nitrogen pnl; pan; panel.chemistry; panl; pnl; stl; stool = fecal,-
77366-3,metanephrine.free and normetanephrine.free and 3-methoxytyramine.free panel - serum or plasma,"free mn, nmn and 3-mt serpl",metanephrine.free and normetanephrine.free and 3-methoxytyramine.free panel,"3me-tyramine; chemistry; dopamine metabolite; fr; free 3-mt; free mn, nmn and 3-mt; iii; metaneph; metaneph free; metanephrne; metenephrine; non-protein bound; normeta; normetaneph; normetaneph free; normetanephrn; pan; panel.chemistry; panl; pl; plasma; plsm; pnl; point in time; random; serp; serpl; serplas; serum; serum or plasma; sr; unconjugated metanephrine; unconjugated normetanephrine",-
77377-0,human papilloma virus 16 and 18 and 31+33+35+39+45+51+52+56+58+59+66+68 dna [interpretation] in specimen,hpv16+18+h risk 12 dna spec-imp,hpv 16 and 18 and 31+33+35+39+45+51+52+56+58+59+66+68 dna (specimen) [interp],deoxyribonucleic acid; genital warts; hpv; hpv i/h risk 4; hpv16; hpv16 and 18; hpv16+18; hpv16+18+h risk 12; hpv16+18+hrisk12dna; human papillomavirus; id; impression; impression/interpretation of study; impressions; infectious disease; infectiousdisease; interp; interpretation; microbiology; misc; miscellaneous; nominal; other; papilloma virus high risk; point in time; random; spec; to be specified in another part of the message; unspecified,Nom
77402-6,anesthesiology evaluation note,anesthesiology eval note,,anesthesia; assessment; doc.ont; document; encounter; eval; eval note; evaluation and management; evaluation and management note; finding; findings; h&p; history and physical; notes; point in time; random; visit note,Doc
77409-1,cardiology discharge summary,cardiology d/c sum,,cardiology; cards; cvd; d/c sum; dis; disch; discharge summary; diseases; doc.ont; document; dz; encounter; evaluation and management; evaluation and management note; finding; findings; notes; point in time; random; visit note,Doc
77414-1,cardiology transfer summary note,cardiology transfer sum note,,cardiology; cards; cvd; dis; diseases; doc.ont; document; dz; encounter; evaluation and management; evaluation and management note; finding; findings; notes; point in time; random; transfer sum note; visit note,Doc
77417-4,critical care medicine discharge summary,ccm d/c sum,,ccm; continuity assessment record and evaluation; d/c sum; disch; discharge summary; doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; notes; point in time; random; visit note,Doc
77418-2,critical care medicine discharge teaching note,ccm discharge teach note,,ccm; continuity assessment record and evaluation; disch; discharge teach note; doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; notes; point in time; random; visit note,Doc
77423-2,audiology education note,audiology educ note,,doc.ont; document; educ note; encounter; evaluation and management; evaluation and management note; finding; findings; notes; point in time; random; visit note,Doc
77426-5,audiology progress note,audiology prog note,,audiology; doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; notes; point in time; prog note; random; subsequent evaluation; subsequent visit evaluation; visit note,Doc
77429-9,allergy and immunology consult note,allergy+immunology consult note,,consult note; doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; notes; point in time; random; visit note,Doc
77443-0,allergy and immunology plan of care note,allergy+immunology plan of care note,,care plan; doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; notes; point in time; random; treatment plan; visit note,Doc
77456-2,ct hindfoot and midfoot w contrast iv,ct hind+mid ft w contr iv,,c; calcaneous; calcaneus; cat scan; computed tomography; computerized tomography; contr; contra; contrst; ct scan; document; ext; finding; findings; heel; hind+mid ft; imaging; le; leg; low; msk; musculoskeletal; ortho; orthopedics; point in time; rad; radiology; random; talus; w contr iv; wc,Doc
77469-5,ct hindfoot - right and midfoot - right wo and w contrast iv,ct hind+mid ft-r wo+w contr iv,,c; calcaneous; calcaneus; cat scan; computed tomography; computerized tomography; contr; contra; contrst; ct scan; document; ext; extr-r; finding; findings; heel; hind+mid ft; hind+mid ft-r; imaging; le; leg; le-r; low; msk; musculoskeletal; ortho; orthopedics; point in time; r; rad; radiology; random; rle; rt; talus; w contr iv; wc; wo & wc; wo+w contr; wo+w contr iv; wwo,Doc
77473-7,deprecated hindfoot - right and midfoot - right x-ray single view,deprecated hind+mid ft-r xr 1v,,1v; calcaneous; calcaneus; document; ext; extr-r; film; finding; findings; heel; hind+mid ft; hind+mid ft-r; i; imaging; le; leg; le-r; low; plain films; point in time; r; radiology; random; rle; rt; single view; talus; vw; xray; x-ray,Doc
77475-2,deprecated hindfoot - left and midfoot - left x-ray harris,deprecated hind+mid ft-l xr harris,,1v; calcaneous; calcaneus; document; ext; extr-l; film; finding; findings; heel; hind+mid ft; hind+mid ft-l; imaging; l; le; leg; le-l; lle; low; lt; plain films; point in time; radiology; random; single view; talus; vw; xray; x-ray,Doc
7747-9,trout igg ab [units/volume] in serum,trout igg qn,trout igg qn (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; f204; immune globulin g; immunoglobulin g; point in time; qnt; quan; quant; quantitative; random; salmo gairdnieri; serum; sr; trout,Qn
77479-4,deprecated hindfoot - left and midfoot - left x-ray,deprecated hind+mid ft-l xr,,calcaneous; calcaneus; document; ext; extr-l; films; finding; findings; heel; hind+mid ft; hind+mid ft-l; imaging; l; le; leg; le-l; lle; low; lt; plain films; point in time; radiology; random; talus; view; vws; xray; x-ray,Doc
7748-7,tryptase ige ab [units/volume] in serum,tryptase ige qn,tryptase ige qn (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; immune globulin e; immunoglobulin e; point in time; qnt; quan; quant; quantitative; random; serum; sr,Qn
77500-7,can pronounce capon [amnart],,,american national adult reading test (amnart); finding; findings; ordinal; point in time; ql; qual; qualitative; random; screen; survey,Ord
77502-3,can pronounce chord [amnart],,,american national adult reading test (amnart); finding; findings; ordinal; point in time; ql; qual; qualitative; random; screen; survey,Ord
77504-9,can pronounce deny [amnart],,,american national adult reading test (amnart); finding; findings; ordinal; point in time; ql; qual; qualitative; random; screen; survey,Ord
77522-1,can pronounce cellist [amnart],,,american national adult reading test (amnart); finding; findings; ordinal; point in time; ql; qual; qualitative; random; screen; survey,Ord
77528-8,can pronounce virulent [amnart],,,american national adult reading test (amnart); finding; findings; ordinal; point in time; ql; qual; qualitative; random; screen; survey,Ord
7752-9,turkey triggered histamine release [units/volume] in blood,turkey basobnd ab qn,turkey triggered histamine release qn (bld),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; associated; autoantibodies; autoantibody; baso; basobnd ab; basophil release; basophils; basos; blood; bnd; bph; leukocyte histamine reaction; leukocyte histamine release; meleagis gallopavo; point in time; qnt; quan; quant; quantitative; random; wb; wbc release; whole blood,Qn
7753-7,turkey feather ige ab [units/volume] in serum,turkey feather ige qn,turkey feather ige qn (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; e89; feathers; immune globulin e; immunoglobulin e; meleagis gallopavo; point in time; qnt; quan; quant; quantitative; random; serum; sr,Qn
77547-8,american national adult reading test (amnart) panel,,,amnart; pan; panl; pnl; point in time; random; survey,-
77565-0,pain interference score [bpi short form],,,1 day; 24 hours; 24hr; ordinal; ql; qual; qualitative; scale; screen; survey; survey.bpi,Ord
77581-7,alpha 2 globulin [mass/volume] by electrophoresis in urine collected for unspecified duration,alpha2 glob ?tm ur elph-mcnc,alpha 2 globulin unsp time elph (u) [mass/vol],?tm; a2; alfa; alpha2 glob; chemistry; elec; elect; electr; electro; electrophhrs; electrophrs; elp; elph; ep; glb; glob; glob%; globul; globulins; ii; level; mass concentration; protein.alpha 2 globulin; qnt; quan; quant; quantitative; ua; ur; urn,Qn
7758-6,veal triggered histamine release [units/volume] in blood,veal basobnd ab qn,veal triggered histamine release qn (bld),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; associated; autoantibodies; autoantibody; baso; basobnd ab; basophil release; basophils; basos; blood; bnd; bph; leukocyte histamine reaction; leukocyte histamine release; point in time; qnt; quan; quant; quantitative; random; wb; wbc release; whole blood,Qn
77587-4,"during the last 7 days, on how many days did you walk for at least 10 minutes at a time [ipaq]",,,activity; count/time; dextro; exercise; nrate; number rate; number rate = count/time; past; qnt; quan; quant; quantitative; survey,Qn
77595-7,total physical activity score [ipaq],,,activ; activity; actvty; exercise; movements; ordinal; ql; qual; qualitative; scale; screen; survey; tot; total phys activity score; totl,Ord
77627-8,hbb gene mutations found [identifier] in blood or tissue by sequencing nominal,hbb gene full mut anl bld/t seq,hbb gene full mutation analysis sequencing nom (bld/tiss),"beta globulin gene; beta thalessemia; beta-globin; blood; cd113t-c; full gene sequencing; full mut anl; genetics; hemoglobin beta chain; hemoglobin s gene; hemoglobin, beta; heredity; heritable; high-throughput sequencing; hts; identity or presence; inherited; molecular pathology; molpath; molpath.mutations; mut; mutations; next generation sequencing; ngs; nominal; point in time; random; sequencing of entire coding region; sickle cell anemia; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",Nom
77629-4,park7 gene mutations found [identifier] in blood or tissue by molecular genetics method nominal,park7 gene mut anl bld/t,park7 gene targeted mutation analysis molgen nom (bld/tiss),"blood; dj-1; genetics; hel-s-67p; heredity; heritable; identity or presence; inherited; molecular genetics; molecular pathology; molpath; molpath.mutations; mut; mut anl; mutations; nominal; parkinson disease; pcr; point in time; random; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",Nom
77647-6,fda product label animal compounded drug label,fda label animal compded drug label,,animal compded drug label; document.regulatory; drugs; fda label; narrative; report,Nar
77666-6,methicillin resistance meca mrna [presence] by fish in positive blood culture,meca mrna bld pos ql fish,methicillin resistance meca mrna fish ql (pos bld culture),antibiotic susceptibilities; bact; bld pos; blood; celbenin; dimethoxypenicillin; fluorescent in situ hybridization; id; infectious disease; infectiousdisease; metacillin; metin; ordinal; point in time; pr; ql; qual; qualitative; random; resist; resistanc; resistant; resistent; screen; staficyn; staphicillin; wb; whole blood,Ord
77673-2,gastrin [moles/volume] in serum or plasma --5 minutes post xxx challenge,gastrin 5m p chal serpl-scnc,gastrin 5 min post unsp challenge [moles/vol],5m p chal; after; chemistry.challenge testing; level; p chal; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; substance concentration; total gastrins; zollinger-ellison syndrome,Qn
77698-9,fall scale [updrs],fall scale updrs,,fall scale; finding; findings; ordinal; point in time; ql; qual; qualitative; random; screen; unified parkinson's disease rating scale (updrs),Ord
77708-6,unpredictable off period indicator in the past week [updrs],unpredictable off period 1w updrs,,1 week; finding; findings; ordinal; ql; qual; qualitative; screen; unified parkinson's disease rating scale (updrs),Ord
77718-5,"mentation, behavior and mood panel [updrs]","mentation, behav, mood pnl updrs",,"mentation, behav, mood pnl; pan; panl; pnl; point in time; random; unified parkinson's disease rating scale (updrs)",-
77730-0,"oxycodone [mass/volume] in serum, plasma or blood by confirmatory method",oxycodone serplbld cfm-mcnc,oxycodone confirm (s/p/bld) [mass/vol],"addiction; blood; cfm; cnfr; cnfrm; conf; confirmation; confirmatory; drug/toxicology; drugs; drugs of abuse; gcms; illicit; lc/ms/ms; level; lortab; mass concentration; oxycontin; percocet; percodan; pl; plasbld; plasma; plsm; point in time; potentialforabuse; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serplbld; serum; serum or plasma; serum, plasma or whole blood; sr; vicodin; wb; whole blood",Qn
77731-8,"oxycodone+oxymorphone [interpretation] in serum, plasma or blood qualitative by confirmatory method",oxycodone+oxymorphone serplbld cfm-imp,oxycodone+oxymorphone confirm ql (s/p/bld) [interp],"14-hydroxydihydromorphinone; addiction; blood; cfm; cnfr; cnfrm; conf; confirmation; confirmatory; drug/toxicology; drugs; drugs of abuse; gcms; illicit; impression; impression/interpretation of study; impressions; interp; interpretation; lc/ms/ms; lortab; numorphan; numorphone; opana; ordinal; oxycontin; percocet; percodan; pl; plasbld; plasma; plsm; point in time; potentialforabuse; ql; qual; qualitative; random; screen; serp; serpl; serplas; serplbld; serum; serum or plasma; serum, plasma or whole blood; sr; vicodin; wb; whole blood",Ord
77735-9,mycobacterium abscessus complex clarithromycin resistance erm(41) truncated gene [presence] by molecular method,m absces erm(41) trunc islt/spm ql,m. abscessus complex clarithromycin resistance erm(41) truncated gene molgen ql (islt/spec),acid fast; acid fast bacilli; acid fast bacillus; afb; antibiotic susceptibilities; biaxin; claripen; compx; id; infectious disease; infectiousdisease; islt; islt/spm; isol; klacid; m absces erm(41) trunc; m. abscessus; m. bolletii; m. massiliense; mabsc; molecular genetics; myco; mycobact; ordinal; pcr; point in time; pr; ql; qual; qualitative; random; resist; resistanc; resistant; resistent; respiratory infections; screen; spec; tuberculosis,Ord
77737-5,mycobacterium abscessus complex clarithromycin resistance erm(41) gene panel by molecular genetics method,m abscessus erm(41) pnl islt/spm,m. abscessus complex clarithromycin resistance erm(41) gene panel molgen (islt/spec),acid fast; acid fast bacilli; acid fast bacillus; afb; antibiotic susceptibilities; biaxin; claripen; compx; islt; islt/spm; isol; klacid; m abscessus erm(41); m abscessus erm(41) pnl; m. abscessus; m. bolletii; m. massiliense; mabsc; molecular genetics; myco; mycobact; pan; panel.antibiotic susceptibilities; panl; pcr; pnl; point in time; random; resist; resistanc; resistant; resistent; respiratory infections; spec; tuberculosis,-
77741-7,streptavidin [presence] in serum or plasma by immunoblot,streptavidin serpl ql ib,streptavidin ib ql,blt; id; immune blot; immunobl; immunoblot; infectious disease; infectiousdisease; microbiology; ordinal; pl; plasma; plsm; point in time; pr; ql; qual; qualitative; random; riba; screen; serp; serpl; serplas; serum; serum or plasma; sr; wb; wblot; west blot; west blt; western blot,Ord
77765-6,citalopram+escitalopram [mass/volume] in urine by confirmatory method,citalopram+escitalopram ur cfm-mcnc,citalopram+escitalopram confirm (u) [mass/vol],celexa; cfm; cipralex; cipramil; cnfr; cnfrm; conf; confirmation; confirmatory; drug/toxicology; drugs; gcms; lc/ms/ms; level; lexamil; lexapro; mass concentration; point in time; qnt; quan; quant; quantitative; random; seroplex; ua; ur; urn,Qn
77778-9,noroxycodone cutoff [mass/volume] in saliva (oral fluid) for confirmatory method,noroxycodone cto sal cfm-mcnc,noroxycodone cutoff confirm (sal) [mass/vol],cfm; cnfr; cnfrm; conf; confirmation; confirmatory; cto; drug/toxicology; drugs; gcms; lc/ms/ms; level; mass concentration; oral fluid; point in time; qnt; quan; quant; quantitative; random; sal,Qn
77782-1,promis short form - alcohol - positive consequences 7a - version 1.0 raw score,,,alc; alcoholic; patient reported outcomes information system; point in time; pos; promise; qnt; quan; quant; quantitative; random; scale; survey; survey.promis,Qn
77792-0,promis short form - emotional support 4a - version 2.0 raw score,,,patient reported outcomes information system; point in time; promise; qnt; quan; quant; quantitative; random; scale; survey; survey.promis,Qn
77794-6,promis short form - alcohol - negative consequences 7a - version 1.0 raw score,,,alc; alcoholic; neg; patient reported outcomes information system; point in time; promise; qnt; quan; quant; quantitative; random; scale; survey; survey.promis,Qn
77797-9,promis short form - physical function 6b - version 1.2 raw score,,,fcn; func; funct; patient reported outcomes information system; point in time; promise; qnt; quan; quant; quantitative; random; scale; survey; survey.promis,Qn
77805-0,promis short form - instrumental support 6a - version 2.0 raw score,,,patient reported outcomes information system; point in time; promise; qnt; quan; quant; quantitative; random; scale; survey; survey.promis,Qn
77806-8,promis short form - instrumental support 4a - version 2.0 raw score,,,patient reported outcomes information system; point in time; promise; qnt; quan; quant; quantitative; random; scale; survey; survey.promis,Qn
77810-0,promis short form - emotional support 8a - version 2.0 raw score,,,patient reported outcomes information system; point in time; promise; qnt; quan; quant; quantitative; random; scale; survey; survey.promis,Qn
77813-4,promis short form - companionship 4a - version 2.0 raw score,,,patient reported outcomes information system; point in time; promise; qnt; quan; quant; quantitative; random; scale; survey; survey.promis,Qn
77819-1,promis short form - physical function 4a - version 1.0 raw score,,,fcn; func; funct; patient reported outcomes information system; point in time; promise; qnt; quan; quant; quantitative; random; scale; survey; survey.promis,Qn
77837-3,promis short form - emotional distress - anger 8a - version 1.0 raw score,,,patient reported outcomes information system; point in time; promise; qnt; quan; quant; quantitative; random; scale; survey; survey.promis,Qn
7784-2,baker's yeast triggered histamine release [units/volume] in blood,baker's yeast basobnd ab qn,baker's yeast triggered histamine release qn (bld),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; associated; autoantibodies; autoantibody; bakers yeast; baker's yeast; baso; basobnd ab; basophil release; basophils; basos; blood; bnd; bph; f045; f403; f45; leukocyte histamine reaction; leukocyte histamine release; point in time; qnt; quan; quant; quantitative; random; sca; wb; wbc release; whole blood; yeast,Qn
77864-7,promis fatigue - version 1.0 tscore,,,patient reported outcomes information system; point in time; promise; qnt; quan; quant; quantitative; random; survey; survey.promis; t prime; t-score,Qn
77868-8,promis pediatric peer relationships - version 1.0 tscore,,,patient reported outcomes information system; peds; point in time; promise; qnt; quan; quant; quantitative; random; survey; survey.promis; t prime; t-score,Qn
77899-3,left ventricular myocardial mass/body surface area [mass/area] by us.2d+calculated by truncated ellipsoid method,lv myo mass/bsa us.2d+trunc ellips,,2d us; bdy surface; bod; bodies; bsa; calc; calculation; card.us; cardiac; cardio; cardiology; echography; heart disease; hrt; hrt ventr; l; lt; lv; maric; myo mass; point in time; qnt; quan; quant; quantitative; random; sonogram; sonograph; sonography; surf; uls; ultrasound; ultrasound - 2-dimensional; us.2d+trunc ellips; ventricular,Qn
77902-5,right ventricular minor axis at end diastole [length] by us.2d.a4c,rv ed minor axis a4c,,2d us; card.us; cardiac; cardio; cardiology; dias; diast; diastoli; echography; ed; ed minor axis; heart disease; hrt; hrt ventr; length; point in time; qnt; quan; quant; quantitative; r; random; rt; rv; sax; short axis; sonogram; sonograph; sonography; uls; ultrasound; ultrasound - 2-dimensional; ventricular,Qn
77920-7,left ventricular myocardial mass/height exp 2.7 [mass/area] by us 2d,lv myo mass/ht exp 2.7 2d us,,2d us; card.us; cardiac; cardio; cardiology; echography; heart disease; hrt; hrt ventr; l; lt; lv; maric; myo mass; point in time; qnt; quan; quant; quantitative; random; sonogram; sonograph; sonography; uls; ultrasound; ultrasound - 2-dimensional; ventricular,Qn
7792-5,dohle body [presence] in blood by light microscopy,dohle bod bld ql smear,dohle body lm ql (bld),blood; bod; bodies; hematology/cell counts; lm; micro; micros; microscopic; ordinal; point in time; pr; ql; qual; qualitative; random; screen; wb; whole blood,Ord
77933-0,cortisol [moles/volume] in serum or plasma --9 hours post xxx challenge,cortis 9h p chal serpl-scnc,cortisol 9 hr post unsp challenge [moles/vol],17-hydroxycorticosterone; 9h p chal; after; chemistry.challenge testing; compound f; coritsol; cort; f; hydrocortisone; level; p chal; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; substance concentration,Qn
77937-1,cortisol [moles/volume] in serum or plasma --12 hours post xxx challenge,cortis 12h p chal serpl-scnc,cortisol 12 hr post unsp challenge [moles/vol],12h p chal; 17-hydroxycorticosterone; after; chemistry.challenge testing; compound f; coritsol; cort; f; hydrocortisone; level; p chal; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; substance concentration,Qn
77938-9,deprecated cortisol [moles/volume] in serum or plasma --124 hours post xxx challenge,deprecated cortis 124h p xxx chal serpl-,cortisol 124 hr post unsp challenge [moles/vol],124h p xxx chal; 17-hydroxycorticosterone; after; chemistry.challenge testing; compound f; coritsol; cort; f; hydrocortisone; level; p chal; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; substance concentration,Qn
77941-3,final patient acuity nemsis,final patient acuity nemsis,,finding; findings; national ems information services; nominal; point in time; random,Nom
77952-0,"trypanosoma cruzi ab [presence] in serum, plasma or blood by rapid immunoassay",t cruzi ab serplbld ql ia.rapid,t. cruzi ab ia.rapid ql (s/p/bld),"abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; blood; chagas disease; eia; elfa; elisa; enzyme immunoassay; iaa; id; infectious disease; infectiousdisease; meia; microbiology; ordinal; pl; plasbld; plasma; plsm; point in time; pr; ql; qual; qualitative; random; screen; serp; serpl; serplas; serplbld; serum; serum or plasma; serum, plasma or whole blood; sr; suds; t cruzi; trypanosomiasis; trypanosomosis; wb; whole blood",Ord
77953-8,west nile virus igg ab [presence] in cerebral spinal fluid by immunoassay,wnv igg csf ql ia,west nile virus igg ia ql (csf),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; cerebral spinal fluid; cerebrospinal fl; eia; elfa; elisa; enzyme immunoassay; iaa; id; immune globulin g; immunoglobulin g; infectious disease; infectiousdisease; meia; microbiology; neuro; neurology; ordinal; point in time; pr; ql; qual; qualitative; random; screen; spinal fl; spinal fld; spinal flu; spinal fluid; suds; wnv,Ord
77957-9,yersinia enterocolitica o:9 igg ab [presence] in serum by agglutination,y entero o:9 igg ser ql aggl,y. enterocolitica o:9 igg aggl ql (s),abs; aby; agg; agglut; agglutination; antby; anti; antibodies; antibody; autoantibodies; autoantibody; id; immune globulin g; immunoglobulin g; infectious disease; infectiousdisease; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; sr; y entero o:9; y enterocol; y enterocolitica,Ord
7797-4,rouleaux [presence] in blood by light microscopy,rouleaux bld ql smear,rouleaux lm ql (bld),blood; hematology/cell counts; lm; micro; micros; microscopic; ordinal; point in time; pr; ql; qual; qualitative; random; screen; wb; whole blood,Ord
78018-9,toscana virus igg ab [presence] in cerebral spinal fluid by immunoassay,tosv igg csf ql ia,toscana virus igg ia ql (csf),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; cerebral spinal fluid; cerebrospinal fl; eia; elfa; elisa; enzyme immunoassay; iaa; id; immune globulin g; immunoglobulin g; infectious disease; infectiousdisease; meia; microbiology; neuro; neurology; ordinal; phleboviruses; point in time; pr; ql; qual; qualitative; random; sand fly fever; screen; spinal fl; spinal fld; spinal flu; spinal fluid; suds; tosv; tosv ab,Ord
78026-2,diagnosis present on admission,,,dx; dx pres on admission; finding; findings; ordinal; point in time; ql; qual; qualitative; random; screen; survey; survey.nhcs,Ord
78032-0,cta thoracic and abdominal aorta and bilateral runoff vessels wo and w contrast iv,cta t+a.ao+ro v-bl wo+w contr iv,,ab ao; abd; abd aort+roves-bl; abd aorta; abdo; abdomen; abdomen+; abdominal; ang; angio; angiography; angm; ao; aortic; bil; bilat; both; c; cardio; cardiology; cat scan; computed tomography; computerized tomography; contr; contra; contrst; ct angiogram; ct angiography; ct scan; cta; document; ext; extr-bl; finding; findings; heart disease; imaging; le; le-bl; leg; low; pelvic; pelvis+le; pelvis+le-bl; point in time; rad; radiology; random; t+a.ao+ro v-bl; ta + aa; thorax; vesl; vessels.xxx; w contr iv; wc; wo & wc; wo+w contr; wo+w contr iv; wwo,Doc
78044-5,disease assessed [identifier] blood or tissue,disease assessed bld/t,,"blood; clin; dis; diseases; dz; ident; identifier; nominal; point in time; random; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",Nom
78048-6,"are you able to dress yourself, including tying shoelaces and buttoning your clothes [promis]",,,finding; findings; ordinal; patient reported outcomes information system; point in time; promise; ql; qual; qualitative; random; screen; survey; survey.promis,Ord
78052-8,"does your health now limit you in hiking a couple of miles (3 km) on uneven surfaces, including hills [promis]",,,finding; findings; iii; ordinal; patient reported outcomes information system; point in time; promise; ql; qual; qualitative; random; screen; survey; survey.promis,Ord
78062-7,are you able to run ten miles (16 km) [promis],,,finding; findings; ordinal; patient reported outcomes information system; point in time; promise; ql; qual; qualitative; random; screen; survey; survey.promis,Ord
7807-1,aspergillus sp ab [units/volume] in serum,aspergillus ab ser-acnc,aspergillus sp ab qn (s),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; asperg; aspergil; aspergilis; aspergilla; aspergillin; aspergillosis; aspergils; aspergilus; autoantibodies; autoantibody; farmers lung; id; infectious disease; infectiousdisease; microbiology; point in time; qnt; quan; quant; quantitative; random; serum; species; spp; sr,Qn
78079-1,i felt sad for no reason in past 7 days [promis.peds],,,finding; findings; last; ordinal; patient reported outcomes information system; promise; ql; qual; qualitative; screen; survey; survey.promis,Ord
78092-4,i knew what i could expect from others in my family in past 4 weeks [promis.peds],,,4 weeks; finding; findings; last; ordinal; patient reported outcomes information system; promise; ql; qual; qualitative; screen; survey; survey.promis,Ord
7809-7,astrovirus [presence] in stool by electron microscopy,hastv stl ql em,astrovirus em ql (stl),astro virus; bowel movement; em; faecal; faeces; fecal; feces; hastv; id; infectious disease; infectiousdisease; micro; microbiology; micros; microscopic; ordinal; point in time; pr; ql; qual; qualitative; random; screen; stl; stool = fecal,Ord
78097-3,i felt that i could trust the people in my family in past 4 weeks [promis.peds],,,4 weeks; finding; findings; last; ordinal; patient reported outcomes information system; promise; ql; qual; qualitative; screen; survey; survey.promis,Ord
78098-1,i could trust others in my family in past 4 weeks [promis.peds],,,4 weeks; finding; findings; last; ordinal; patient reported outcomes information system; promise; ql; qual; qualitative; screen; survey; survey.promis,Ord
78104-7,my family showed that they cared about me in past 4 weeks [promis.peds],,,4 weeks; finding; findings; last; ordinal; patient reported outcomes information system; promise; ql; qual; qualitative; screen; survey; survey.promis,Ord
78113-8,i could rely on my family in past 4 weeks [promis.peds],,,4 weeks; finding; findings; last; ordinal; patient reported outcomes information system; promise; ql; qual; qualitative; screen; survey; survey.promis,Ord
78146-8,my child felt he or she had a strong relationship with our family in past 4 weeks [promis.parentproxy],,,4 weeks; finding; findings; last; ordinal; patient reported outcomes information system; promise; ql; qual; qualitative; screen; survey; survey.promis,Ord
7815-4,bartonella henselae igg ab [units/volume] in serum by immunoassay,b henselae igg ser ia-acnc,b. henselae igg ia qn (s),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; b henselae; bacillary angiomaosis; bacillary pelliosis; cat scratch disease; cat scratch fever; csd; eia; elfa; elisa; enzyme immunoassay; iaa; id; immune globulin g; immunoglobulin g; infectious disease; infectiousdisease; meia; microbiology; point in time; qnt; quan; quant; quantitative; r henselae; random; rochalimaea henselae; serum; sr; suds,Qn
78154-2,my child felt he or she was really important to our family in past 4 weeks [promis.parentproxy],,,4 weeks; finding; findings; last; ordinal; patient reported outcomes information system; promise; ql; qual; qualitative; screen; survey; survey.promis,Ord
78180-7,right ventricular intrachamber.systole.max by us.doppler,rv intrachamber.sys.max dop,,card.us; cardiac; cardio; cardiology; dop; duplex; echography; heart disease; hrt; hrt ventr; intrachamber pres; intrachamber.sys pres; intrachamber.sys.max; largest; maximal; maximum; peak; point in time; pressure; qnt; quan; quant; quantitative; r; random; rt; rv; sonogram; sonograph; sonography; sys; sys.max; syst; uls; ultrasound; ventricular,Qn
78186-4,mitral valve lateral annulus tissue velocity.e-wave.max by us.tissue doppler,mv lat ann e-prime vmax tdi,,blood flow.diastolic.early wave.max; card.us; cardio; cardiology; early wave; echography; e-prime vmax; e-wave; heart disease; largest; lat; max v; maximal; maximum; mv; mv ann; mv lat ann; peak; peak e-wave; point in time; qnt; quan; quant; quantitative; random; sonogram; sonograph; sonography; tdi; uls; ultrasound; v max; vel; velocity; vmax,Qn
78190-6,mitral valve lateral annulus e-wave/tissue velocity.e-wave.max by us.doppler+tissue doppler,mv lat ann e-wave/e-prime vmax dop+tdi,,blood flow.diastolic.early wave.max; card.us; cardio; cardiology; dop; dop+tdi; duplex; early wave; echography; e-prime vmax; e-wave; heart disease; largest; lat; maximal; maximum; mv; mv ann; mv lat ann; peak; peak e-wave; point in time; qnt; quan; quant; quantitative; random; sonogram; sonograph; sonography; uls; ultrasound; vel; velocity ratio,Qn
78200-3,resource identifier [uri] for study,resource id uri study,resource identifier nom (study),misc; nominal; point in time; random,Nom
78207-8,9q34 chromosome region deletion [interpretation] in blood or tissue by fish narrative,9q34 del bld/t fish-imp,9q34 chromosome region del fish nar (bld/tiss) [interp],"abl; bcr/abl; blood; chromosom; chromosomes; chronic myeloid leukemia; cml; cyto loc; del; deletions; fluorescent in situ hybridization; genetics; heredity; heritable; impression; impression/interpretation of study; impressions; inherited; interp; interpretation; molecular pathology; molpath; molpath.deletions; narrative; point in time; random; report; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",Nar
78212-8,cells.9q34 chromosome region deletion/cells counted in blood or tissue by fish,cells.9q34 del/cells cnt nfr bld/t fish,cells.9q34 chromosome region del/cells counted fish (bld/tiss),"abl; bcr/abl; blood; cell; cellularity; chromosom; chromosomes; chronic myeloid leukemia; cml; cyto loc; del; deletions; fluorescent in situ hybridization; genetics; heredity; heritable; inherited; molecular pathology; molpath; molpath.deldup; number fraction; percent; point in time; qnt; quan; quant; quantitative; random; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",Qn
78224-3,rara gene rearrangements [interpretation] in blood or tissue by fish narrative,rara rearrange bld/t fish-imp,rara rearrangements fish nar (bld/tiss) [interp],"blood; fluorescent in situ hybridization; genetics; heredity; heritable; impression; impression/interpretation of study; impressions; inherited; interp; interpretation; molecular pathology; molpath; molpath.rearrangements; narrative; nr1b1; point in time; random; rar alpha form; rara rearrange; raralpha; rearr; rearrangement; report; retinoic acid receptor alpha; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",Nar
78234-2,cells.mll gene rearrangements/cells counted in blood or tissue by fish,cells.mll rear/cells cnt nfr bld/t fish,cells.mll rearrangements/cells counted fish (bld/tiss),"all1; all-1; blood; cell; cells.mll rearr; cellularity; cxxc7; fluorescent in situ hybridization; genetics; heredity; heritable; hrx; htrx; htrx1; inherited; lysine (k)-specific methyltransferase 2a; mll; mll/gas7; mll1; mll1a; molecular pathology; molpath; molpath.rearrangements; myeloid/lymphoid or mixed-lineage leukemia (trithorax (drosophila) homolog); number fraction; percent; point in time; qnt; quan; quant; quantitative; random; rearr; rearrangement; tet1-mll; tissue; tissue, unspecified; trx1; wb; wdsts; whole blood; whole blood or tissue",Qn
78243-3,vascular surgery surgical operation note,vascular surgery operative note,,doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; notes; operative note; point in time; random; surg; visit note,Doc
78256-5,gastroenterology diagnostic study note,gastroenterology diag study note,,diag study note; doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; gastro; gastroenterology; gi; notes; point in time; random; study report; visit note,Doc
78281-3,infectious disease education note,infectious disease educ note,,dis; diseases; doc.ont; document; dz; educ note; encounter; evaluation and management; evaluation and management note; finding; findings; id; infectious disease; infectiousdisease; notes; point in time; random; visit note,Doc
78297-9,gastroenterology flowsheet,gastroenterology flowsheet,,doc.ont; document; finding; findings; gastro; gastroenterology; gi; point in time; random,Doc
78305-0,mental health form,mental health form,,doc.ont; document; emotional stability; finding; findings; point in time; random,Doc
78306-8,mental health history and physical note,mental health h&p note,,doc.ont; document; emotional stability; encounter; evaluation and management; evaluation and management note; finding; findings; h&p note; hx; notes; point in time; random; visit note,Doc
7833-7,coxsackievirus a16 ab [units/volume] in serum,cv a16 ab ser-acnc,coxsackievirus a16 ab qn (s),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; cav; coxsackie; coxsackie virus; cv; cv a16; id; infectious disease; infectiousdisease; microbiology; point in time; qnt; quan; quant; quantitative; random; serum; sr,Qn
78343-1,cells.myb gene deletion/cells counted in blood or tissue by fish,cells.myb del/cells cnt nfr bld/t fish,cells.myb gene del/cells counted fish (bld/tiss),"6q deletion; blood; cell; cellularity; chronic lymphocytic leukemia; cll; del; del 6q; del 6q23; deletions; fluorescent in situ hybridization; genetics; heredity; heritable; inherited; leukemia; molecular pathology; molpath; molpath.deletions; myb deletion; non-hodgkin lymphoma; number fraction; percent; point in time; qnt; quan; quant; quantitative; random; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",Qn
7834-5,coxsackievirus a7 ab [units/volume] in serum,cv a7 ab ser-acnc,coxsackievirus a7 ab qn (s),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; cav; coxsackie; coxsackie virus; cv; cv a7; id; infectious disease; infectiousdisease; microbiology; point in time; qnt; quan; quant; quantitative; random; serum; sr,Qn
78353-0,hexadecadienoate (c16:2) [entitic substance] in red blood cells,hexadecadienoate entsub rbc,hexadecadienoate (c16:2) (rbc) [entitic substance],c16:2; chemistry; entitic substance; erythrocytes; hexadecadienoic acid; point in time; qnt; quan; quant; quantitative; random; red blood cells; red blood corpusles,Qn
78385-2,budgerigar serum proteins+feathers+droppings igg ab [mass/volume] in serum,budgie ser prot+feathers+dropp igg-mcnc,budgerigar serum proteins+feathers+droppings igg (s) [mass/vol],abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; australian parrot; autoantibodies; autoantibody; budgeriar; budgie; budgie ser prot+feathers+dropp; budgie serum prot; e79; e90; feces; ge90; immune globulin g; immunoglobulin g; level; mass concentration; point in time; protein; qnt; quan; quant; quantitative; random; rge90; ser; serum; sr; stool,Qn
78386-0,neonatal perinatal medicine admission history and physical note,neo peri med admit h&p note,,admit h&p note; doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; h&p note; hx; neo peri med; notes; point in time; random; visit note,Doc
78406-6,nurse practitioner consult note,nurse pract consult note,,consult note; doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; notes; nursing; point in time; random; visit note,Doc
78411-6,nephrology discharge instructions,nephrology discharge instruct,,disch; doc.ont; document; finding; findings; kidney; nephrology; point in time; random; renal,Doc
78412-4,neurology discharge instructions,neurology discharge instruct,,disch; doc.ont; document; finding; findings; neuro; neurology; point in time; random,Doc
78414-0,nurse practitioner discharge instructions,nurse pract discharge instruct,,disch; doc.ont; document; finding; findings; nursing; point in time; random,Doc
78422-3,neonatal perinatal medicine discharge teaching note,neo peri med discharge teach note,,disch; discharge teach note; doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; neo peri med; notes; point in time; random; visit note,Doc
78447-0,emergency department checklist,ed checklist,,doc.ont; document; ed; finding; findings; point in time; random,Doc
78481-9,nutrition and dietetics progress note,nutr+diet prog note,,doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; notes; nutr+diet; nutrition+dietetics; point in time; prog note; random; subsequent evaluation; subsequent visit evaluation; visit note,Doc
7848-5,taenia solium larva igm ab [presence] in cerebral spinal fluid,t sol lar igm csf ql,t. solium larva igm ql (csf),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; cerebral spinal fluid; cerebrospinal fl; cysticercosis; cysticercus; id; immune globulin m; immunoglobulin m; infectious disease; infectiousdisease; microbiology; neuro; neurology; ordinal; point in time; pr; ql; qual; qualitative; random; screen; spinal fl; spinal fld; spinal flu; spinal fluid; t sol; t sol lar; t solium; tapeworm,Ord
78495-9,anesthesiology checklist,anesthesiology checklist,,anesthesia; doc.ont; document; finding; findings; point in time; random,Doc
78501-4,cardiopulmonary referral note,cardio+pulm dis referral note,,cardio+pulm dis; cardiology; cards; cvd; dis; diseases; doc.ont; document; dz; encounter; evaluation and management; evaluation and management note; finding; findings; notes; point in time; pulmonary; random; respirology; visit note,Doc
78532-9,creatinine [moles/volume] in peritoneal dialysis fluid --2 hour dwell specimen,creat 2h dwell spec diafp-scnc,creatinine 2 hr dwell specimen (perit dial fld) [moles/vol],120 min; 120 minutes; 120min; 2 hours; chemistry; cr; crea; creat; diaf; diafp; dialysate; dialysis fluid; kidney; level; nephrology; peritoneal dialysis fluid; point in time; qnt; quan; quant; quantitative; random; renal; spec; substance concentration,Qn
7854-3,dengue virus 1 ab [presence] in serum by immunoassay,denv1 ab ser ql ia,denv 1 ab ia ql (s),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; breakbone fever; dengue type i; denv; denv1; eia; elfa; elisa; enzyme immunoassay; flavivirus; i; iaa; id; infectious disease; infectiousdisease; meia; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; sr; suds,Ord
78571-7,rheumatology diagnostic study note,rheumatology diag study note,,diag study note; doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; notes; point in time; random; study report; visit note,Doc
78576-6,urology diagnostic study note,urology diag study note,,diag study note; doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; genitourinary; gu; notes; point in time; random; study report; uro; urology; visit note,Doc
78580-8,respiratory therapy discharge instructions,resp therapy discharge instruct,,disch; doc.ont; document; finding; findings; lung; point in time; pulmonary; pulmonology; random; resp therapy; respiratory,Doc
78581-6,recreational therapy discharge instructions,rec therapy discharge instruct,,disch; doc.ont; document; finding; findings; point in time; random; rec therapy,Doc
7858-4,dengue virus 4 ab [presence] in serum by immunoassay,denv4 ab ser ql ia,denv 4 ab ia ql (s),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; breakbone fever; dengue type iv; denv; denv4; eia; elfa; elisa; enzyme immunoassay; flavivirus; iaa; id; infectious disease; infectiousdisease; meia; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; sr; suds,Ord
78588-1,recreational therapy discharge teaching note,rec therapy discharge teach note,,disch; discharge teach note; doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; notes; point in time; random; rec therapy; visit note,Doc
7859-2,dengue virus ab [units/volume] in serum,denv ab ser-acnc,denv ab qn (s),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; breakbone fever; denv; flavivirus; id; infectious disease; infectiousdisease; microbiology; point in time; qnt; quan; quant; quantitative; random; serum; sr,Qn
78598-0,transplant surgery education note,transpl surg educ note,,doc.ont; document; educ note; encounter; evaluation and management; evaluation and management note; finding; findings; notes; point in time; random; surg; transpl surg; visit note,Doc
7860-0,eastern equine encephalitis virus igg ab [units/volume] in serum,eeev igg ser-acnc,eeev igg qn (s),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; eee virus; eeev; enc; enceph; encephalomyelitis; equin; id; immune globulin g; immunoglobulin g; infectious disease; infectiousdisease; microbiology; point in time; qnt; quan; quant; quantitative; random; serum; sr; togavirus,Qn
78600-4,rheumatology education note,rheumatology educ note,,doc.ont; document; educ note; encounter; evaluation and management; evaluation and management note; finding; findings; notes; point in time; random; visit note,Doc
78637-6,physical therapy flowsheet,pt flowsheet,,doc.ont; document; finding; findings; point in time; pt; random,Doc
78638-4,ophthalmology flowsheet,ophthalmol flowsheet,,doc.ont; document; eye; eye care; finding; findings; ophthalmology; ophtho; ophthy; point in time; random,Doc
78639-2,rheumatology flowsheet,rheumatology flowsheet,,doc.ont; document; finding; findings; point in time; random,Doc
78651-7,pain medicine initial evaluation note,pain medicine initial eval note,,assessment; doc.ont; document; encounter; eval; eval note; evaluation and management; evaluation and management note; finding; findings; h&p; history and physical; initial eval note; notes; point in time; random; visit note,Doc
78656-6,radiation oncology procedure note,radiation onc procedure note,,cancer; doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; notes; oncology; point in time; random; visit note,Doc
7866-7,echovirus 19 ab [units/volume] in serum,ecv19 ab ser-acnc,echovirus 19 ab qn (s),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; echo; echo virus; echovirus type 19; ecv; ecv19; ev; id; infectious disease; infectiousdisease; microbiology; point in time; qnt; quan; quant; quantitative; random; serum; sr,Qn
78693-9,dihydrothymine/creatinine [molar ratio] in urine,dihydrothymine/creat ur-srto,dihydrothymine/creatinine (u) [molar ratio],"5,6-dihydrothymine; 5-methyl-1,3-diazinane-2,4-dione; chemistry; cr; crea; creat; dihydropyrimidinase deficiency; point in time; qnt; quan; quant; quantitative; random; scrto; substance concentration ratio; substance ratio; ua; ucr; ur; urn",Qn
78706-9,oncology form,oncology form,,cancer; doc.ont; document; finding; findings; oncology; point in time; random,Doc
78712-7,ophthalmology checklist,ophthalmol checklist,,doc.ont; document; eye; eye care; finding; findings; ophthalmology; ophtho; ophthy; point in time; random,Doc
78723-4,obstetrics and gynecology initial evaluation note,obgyn initial eval note,,assessment; doc.ont; document; encounter; eval; eval note; evaluation and management; evaluation and management note; finding; findings; gyn; gynecology; h&p; history and physical; initial eval note; notes; ob; obgyn; obstetric; obstetrics; point in time; prenatal; random; visit note,Doc
78728-3,respiratory therapy initial evaluation note,resp therapy initial eval note,,assessment; doc.ont; document; encounter; eval; eval note; evaluation and management; evaluation and management note; finding; findings; h&p; history and physical; initial eval note; lung; notes; point in time; pulmonary; pulmonology; random; resp therapy; respiratory; visit note,Doc
7875-8,ehrlichia chaffeensis igg ab [units/volume] in serum by immunoassay,e chaffeensis igg ser ia-acnc,e. chaffeensis igg ia qn (s),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; e chaffeensis; eia; elfa; elisa; enzyme immunoassay; hme; human monocytic ehrlichiosis; iaa; id; immune globulin g; immunoglobulin g; infectious disease; infectiousdisease; meia; microbiology; point in time; qnt; quan; quant; quantitative; random; serum; sr; suds,Qn
78761-4,7-aminoclonazepam [mass/mass] in hair,7aminoclonazepam hair-mcnt,7-aminoclonazepam (hair) [mass/mass],7-amino clonazepam; 7aminoclonazepam; addiction; clonazepam metabolite; drug/toxicology; drugs; drugs of abuse; har; illicit; mass content; point in time; potentialforabuse; qnt; quan; quant; quantitative; random,Qn
78766-3,fentanyl [mass/volume] in urine -- adjusted for lean body mass+urine creatinine,fentanyl adj bodymass+crea ur-mcnc,fentanyl adjusted for lean body mass+urine creatinine (u) [mass/vol],actiq; adj; adj bodymass+crea; bod; bodies; cr; crea; creat; drug/toxicology; drugs; duragesic; durogesic; fenpat; fentanil; level; mass concentration; point in time; qnt; quan; quant; quantitative; random; sublimaze; ua; ucr; ur; urn,Qn
78769-7,hydrocodone [mass/volume] in urine -- adjusted for lean body mass+urine creatinine,hydrocodone adj bodymass+crea ur-mcnc,hydrocodone adjusted for lean body mass+urine creatinine (u) [mass/vol],adj; adj bodymass+crea; anexsia; bod; bodies; cr; crea; creat; dihydrocodeinone; drug/toxicology; drugs; level; mass concentration; point in time; qnt; quan; quant; quantitative; random; ua; ucr; ur; urn; vicodin,Qn
78772-1,abacavir [mass/volume] in amniotic fluid,abacavir amn-mcnc,abacavir (amn fld) [mass/vol],1592u89; abc; af; amn; amn fl; amnio; amniotic flu; amniotic fluid; drug/toxicology; drugs; level; mass concentration; point in time; qnt; quan; quant; quantitative; random; ziagen,Qn
7877-4,anaplasma phagocytophilum ab [presence] in serum,a phagocytoph ab ser ql,a. phagocytophilum ab ql (s),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; e equi; e phagocytophila; ehrlichia equi; ehrlichia phagocytophila; hge; human granulocytic ehrlichiosis; id; infectious disease; infectiousdisease; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; sr,Ord
78776-2,acepromazine [mass/mass] in hair,acepromazine hair-mcnt,acepromazine (hair) [mass/mass],ace; acetylpromazine; acp; atravet; drug/toxicology; drugs; har; mass content; notensil; plegicil; point in time; qnt; quan; quant; quantitative; random; vet; veterinary,Qn
78781-2,alprazolam cutoff [mass/volume] in urine for confirmatory method,alpraz cto ur cfm-mcnc,alprazolam cutoff confirm (u) [mass/vol],cfm; cnfr; cnfrm; conf; confirmation; confirmatory; cto; drug/toxicology; drugs; gcms; lc/ms/ms; level; mass concentration; niravam; point in time; qnt; quan; quant; quantitative; random; ua; ur; urn; xanax,Qn
7878-2,deprecated anaplasma phagocytophilum ab [presence] in serum,deprecated a phagocytoph ab ser ql,a. phagocytophilum ab ql (s),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; e equi; e phagocytophila; ehrlichia equi; ehrlichia phagocytophila; hge; human granulocytic ehrlichiosis; id; infectious disease; infectiousdisease; microbiology; ordinal; point in time; ql; qual; qualitative; random; screen; serum; sr,Ord
78793-7,aripiprazole [mass/mass] in hair,aripiprazole hair-mcnt,aripiprazole (hair) [mass/mass],abilify; drug/toxicology; drugs; har; mass content; point in time; qnt; quan; quant; quantitative; random,Qn
78798-6,atenolol [mass/mass] in hair,atenolol hair-mcnt,atenolol (hair) [mass/mass],drug/toxicology; drugs; har; mass content; point in time; qnt; quan; quant; quantitative; random; tenormin,Qn
78802-6,baclofen [mass/mass] in hair,baclofen hair-mcnt,baclofen (hair) [mass/mass],addiction; baclosan; beklo; drug/toxicology; drugs; drugs of abuse; gablofen; har; illicit; kemstro; liofen; lioresal; mass content; point in time; potentialforabuse; qnt; quan; quant; quantitative; random,Qn
78807-5,barium [moles/volume] in serum or plasma,barium serpl-scnc,barium [moles/vol],ba; drug/toxicology; drugs; level; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; substance concentration,Qn
78814-1,cannabicyclohexanol cutoff [mass/volume] in urine for confirmatory method,cannabicyclohexanol cto ur cfm-mcnc,cannabicyclohexanol cutoff confirm (u) [mass/vol],cch; cfm; cnfr; cnfrm; conf; confirmation; confirmatory; cp 47; cto; drug/toxicology; drugs; gcms; lc/ms/ms; level; mass concentration; point in time; qnt; quan; quant; quantitative; random; spice; ua; ur; urn,Qn
78816-6,carisoprodol+meprobamate [presence] in blood by confirmatory method,carisoprodol+meprob bld ql cfm,carisoprodol+meprobamate confirm ql (bld),addiction; blood; carisoma; carisoprodol metabolite; cfm; cnfr; cnfrm; conf; confirmation; confirmatory; drug/toxicology; drugs; drugs of abuse; equanil; flexartal; gcms; illicit; isopropylmeprobamate; lc/ms/ms; ordinal; point in time; potentialforabuse; pr; ql; qual; qualitative; random; rela; sanoma; screen; soma; somadril; somalgit; wb; whole blood,Ord
78818-2,citalopram cutoff [mass/volume] in urine for confirmatory method,citalopram cto ur cfm-mcnc,citalopram cutoff confirm (u) [mass/vol],celexa; cfm; cipramil; cnfr; cnfrm; conf; confirmation; confirmatory; cto; drug/toxicology; drugs; gcms; lc/ms/ms; level; mass concentration; point in time; qnt; quan; quant; quantitative; random; ua; ur; urn,Qn
78826-5,ethyl acetate [mass/volume] in urine,ethyl acetate ur-mcnc,ethyl acetate (u) [mass/vol],acetic acid; acetic acid ethyl ester; acetic ether; acetoxyethane; drug/toxicology; drugs; ethanoate; ethanoic acid; etoac; level; mass concentration; point in time; qnt; quan; quant; quantitative; random; ua; ur; urn,Qn
78834-9,hydroxylurasidone cutoff [mass/volume] in urine for confirmatory method,oh-lurasidone cto ur cfm-mcnc,hydroxylurasidone cutoff confirm (u) [mass/vol],cfm; cnfr; cnfrm; conf; confirmation; confirmatory; cto; drug/toxicology; drugs; gcms; lc/ms/ms; level; lurasidone metabolite; mass concentration; oh-lurasidone; point in time; qnt; quan; quant; quantitative; random; ua; ur; urn,Qn
78850-5,jwh-250 5-hydroxypentyl (synthetic cannabinoid metabolite) cutoff [mass/volume] in urine for confirmatory method,jwh-250 5oh-pentyl cto ur cfm-mcnc,jwh-250 5-hydroxypentyl cutoff confirm (u) [mass/vol],cfm; cnfr; cnfrm; conf; confirmation; confirmatory; cto; drug/toxicology; drugs; gcms; jwh-250 5oh-pentyl; jwh-250 n-(5-hydroxypentyl) metabolite; k2; lc/ms/ms; level; mass concentration; point in time; qnt; quan; quant; quantitative; random; spice; spike; synthetic cannabinoid; synthetic cannabinoids; ua; ur; urn; yucatan fire,Qn
78854-7,m-chlorophenylpiperazine [mass/volume] in serum or plasma,m-cpp serpl-mcnc,m-chlorophenylpiperazine [mass/vol],"1,3 - chlorophenyl piperazine; drug/toxicology; drugs; level; mass concentration; mcpp; m-cpp; meta-chlorophenylpiperazine; nefazodone metabolite; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; trazodone metabolite",Qn
78870-3,opc3373 (metabolite of ariprazole) [mass/volume] in urine by confirmatory method,opc3373 ur cfm-mcnc,opc3373 (metabolite of ariprazole) confirm (u) [mass/vol],aripiprazole metabolite; cfm; cnfr; cnfrm; conf; confirmation; confirmatory; drug/toxicology; drugs; gcms; lc/ms/ms; level; mass concentration; point in time; qnt; quan; quant; quantitative; random; ua; ur; urn,Qn
78872-9,opc3373 (metabolite of ariprazole) [z-score] in urine,opc3373 z-score ur,opc3373 (metabolite of ariprazole) (u) [z-score],aripiprazole metabolite; drug/toxicology; drugs; point in time; qnt; quan; quant; quantitative; random; standard score; ua; ur; urn; z score; z value; z-score,Qn
78881-0,rcs-4 5-hydroxypentyl (synthetic cannabinoid metabolite) cutoff [mass/volume] in urine for confirmatory method,rcs-4 5oh-pentyl cto ur cfm-mcnc,rcs-4 5-hydroxypentyl cutoff confirm (u) [mass/vol],cfm; cnfr; cnfrm; conf; confirmation; confirmatory; cto; drug/toxicology; drugs; gcms; k2; lc/ms/ms; level; mass concentration; point in time; qnt; quan; quant; quantitative; random; rcs-4 5oh-pentyl; rcs-4 n-(5-hydroxypentyl) metabolite; spice; spike; synthetic cannabinoid; synthetic cannabinoids; ua; ur; urn; yucatan fire,Qn
78900-8,percent stenosis of av nodal artery by cardiac angiogram,percent sten of av nodal by angiogram,,ang; angio; angm; art; av nodal; card.proc; cardio; cardiology; heart disease; length fraction; percent; point in time; qnt; quan; quant; quantitative; random; sten deg,Qn
78905-7,percent stenosis of distal left anterior descending artery by cardiac angiogram,percent sten of dlad by angiogram,,ang; angio; angm; art; card.proc; cardio; cardiology; coronary segment 8; dlad; heart disease; l; length fraction; lt; percent; point in time; qnt; quan; quant; quantitative; random; sten deg,Qn
78908-1,percent stenosis of proximal left circumflex artery by cardiac angiogram,percent sten of pcx by angiogram,,ang; angio; angm; art; card.proc; cardio; cardiology; coronary segment 11; heart disease; l; length fraction; lt; pcx; percent; point in time; qnt; quan; quant; quantitative; random; sten deg,Qn
78912-3,percent stenosis of posterior descending branch from left circumflex artery by cardiac angiogram,percent sten of l-pda by angiogram,,ang; angio; angm; art; card.proc; cardio; cardiology; coronary segment 15; heart disease; l; length fraction; l-pda; lt; percent; point in time; qnt; quan; quant; quantitative; random; sten deg,Qn
7891-5,giardia lamblia igg ab [units/volume] in serum,g lamblia igg ser-acnc,g. lamblia igg qn (s),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; beaver fever; g duodenalis; g intestinalis; g lamblia; giardiasis; id; immune globulin g; immunoglobulin g; infectious disease; infectiousdisease; lamblia intestinalis; microbiology; point in time; qnt; quan; quant; quantitative; random; serum; sr,Qn
78923-0,comorbid condition panel,comorbid cond pnl,,comorbid cond pnl; h+p; p prime; pan; panel.h&p; panl; pnl; point in time; random,-
78924-8,history of hyperuricemia,hx of hyperuricemia,,h+p; h+p.hx; history; ordinal; p prime; point in time; ql; qual; qualitative; random; screen,Ord
78925-5,history of cerebrovascular accident,cva hx,,cva; h+p; h+p.hx; history; ordinal; p prime; point in time; ql; qual; qualitative; random; screen; stroke,Ord
78930-5,right heart catheterization performed,right heart cath performed,,card.proc; cardio; cardiology; finding; findings; heart disease; ordinal; point in time; ql; qual; qualitative; r; random; right heart cath performed; rt; screen,Ord
78945-3,catheterization device guiding catheter size,cath device guid cath size,,cath; cath device; circumference; guid cath size; point in time; qnt; quan; quant; quantitative; random,Qn
78962-8,igg clearance/transferrin clearance [ratio] in urine and serum or plasma,igg/transf clear ur+serpl-rto,igg clearance/transferrin clearance (u+s/p) [ratio],chemistry; cl; clear; clearanc; clearances; clr; immune globulin g; immunoglobulin g; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; ratios; rto; serp; serpl; serplas; serum; serum or plasma; siderophilin; sr; tf; transf clear; trf; trfrn; ua; ur; ur+serpl; urn,Qn
78965-1,neurofilament medium chain ab [mass/volume] in cerebral spinal fluid,nfm ab csf-mcnc,neurofilament medium chain ab (csf) [mass/vol],abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; cerebral spinal fluid; cerebrospinal fl; chains; chemistry; chn; level; mass concentration; nfm; point in time; qnt; quan; quant; quantitative; random; spinal fl; spinal fld; spinal flu; spinal fluid,Qn
78967-7,sedoheptulose/creatinine [molar ratio] in urine,sedoheptulose/creat ur-srto,sedoheptulose/creatinine (u) [molar ratio],chemistry; cr; crea; creat; point in time; qnt; quan; quant; quantitative; random; scrto; substance concentration ratio; substance ratio; ua; ucr; ur; urn,Qn
78968-5,benperidol [mass/volume] in serum or plasma,benperidol serpl-mcnc,benperidol [mass/vol],anquil; benperidol neuraxpharm; drug/toxicology; drugs; frenactil; level; mass concentration; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
78973-5,ct scanogram lower extremity - bilateral for leg measurement wo contrast,ct.scanogram le-bl leg meas wo contr,,bil; bilat; both; c; cat scan; computed tomography; computerized tomography; contr; contra; contrst; coreplaybook; ct scan; ct scanogram; document; ext; extr-bl; finding; findings; imaging; le; le-bl; leg; low; lower extremity; playbook; point in time; rad; radiology; random; scanogram; without contrast,Doc
78981-8,coronary stent product name,cor stent prod name,,angio device; cor stent prod name; ident; identifier; nominal; point in time; random,Nom
78986-7,prolactin.dimeric/prolactin in serum or plasma,prolactin.dim/prolactin % serpl,prolactin.dimeric/prolactin [%],%; big prolactin; chemistry; lactotropic hormone; lactotropin; mammatropic hormone; mammotropin; pl; plasma; plsm; point in time; prl; prol; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
78990-9,flavin adenine dinucleotide [moles/volume] in serum or plasma,fad serpl-scnc,flavin adenine dinucleotide [moles/vol],b4 hemosan; chemistry; fad; leuco-4; level; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; substance concentration; vit b4; vitamin b4,Qn
78991-7,flavin adenine dinucleotide [moles/volume] in blood,fad bld-scnc,flavin adenine dinucleotide (bld) [moles/vol],b4 hemosan; blood; chemistry; fad; leuco-4; level; point in time; qnt; quan; quant; quantitative; random; substance concentration; vit b4; vitamin b4; wb; whole blood,Qn
79001-4,how much difficulty do you currently have opening previously opened jars [promis],,,finding; findings; ordinal; patient reported outcomes information system; point in time; promise; ql; qual; qualitative; random; screen; survey; survey.promis,Ord
79003-0,are you able to roll onto your stomach while lying in bed [promis],,,finding; findings; ordinal; patient reported outcomes information system; point in time; promise; ql; qual; qualitative; random; screen; survey; survey.promis,Ord
7900-4,helicobacter pylori ab [units/volume] in serum,h pylori ab ser-acnc,h. pylori ab qn (s),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; c pylori; campylobacter pylori; gastro; gastroenterology; gi; h pyl; h pylori; microbiology; point in time; qnt; quan; quant; quantitative; random; serum; sr; universallaborders,Qn
79007-1,are you able to open and squeeze a new tube of toothpaste [promis],,,finding; findings; ordinal; patient reported outcomes information system; point in time; promise; ql; qual; qualitative; random; screen; survey; survey.promis,Ord
79015-4,are you able to pull a sweater or t-shirt over your head [promis],,,finding; findings; ordinal; patient reported outcomes information system; point in time; promise; ql; qual; qualitative; random; screen; survey; survey.promis; t prime,Ord
79024-6,are you able to do housework like vacuuming or sweeping floors [promis],,,finding; findings; ordinal; patient reported outcomes information system; point in time; promise; ql; qual; qualitative; random; screen; survey; survey.promis,Ord
79026-1,are you able to take a letter out of an envelope [promis],,,finding; findings; ordinal; patient reported outcomes information system; point in time; promise; ql; qual; qualitative; random; screen; survey; survey.promis,Ord
79030-3,are you able to take a shower [promis],,,finding; findings; ordinal; patient reported outcomes information system; point in time; promise; ql; qual; qualitative; random; screen; survey; survey.promis,Ord
79043-6,"how much difficulty do you currently have sitting down on a low, soft couch [promis]",,,finding; findings; ordinal; patient reported outcomes information system; point in time; promise; ql; qual; qualitative; random; screen; survey; survey.promis,Ord
79046-9,are you able to transfer from a bed to a chair or a wheelchair [promis],,,finding; findings; ordinal; patient reported outcomes information system; point in time; promise; ql; qual; qualitative; random; screen; survey; survey.promis,Ord
79055-0,"how much difficulty do you currently have getting into and out of a truck, bus, shuttle van or sport utility vehicle [promis]",,,finding; findings; ordinal; patient reported outcomes information system; point in time; promise; ql; qual; qualitative; random; screen; survey; survey.promis,Ord
79059-2,are you able to exercise regularly [promis],,,activity; excz; exercise; finding; findings; ordinal; patient reported outcomes information system; point in time; promise; ql; qual; qualitative; random; screen; survey; survey.promis,Ord
79062-6,promis item bank - physical function w mobility aids - version 1.0,,,fcn; func; funct; ordinal; pan; panel; panel.survey.promis; panl; patient reported outcomes information system; pnl; point in time; promise; ql; qual; qualitative; random; screen; survey; survey.promis,Ord
79063-4,promis short form - physical function w mobility aids - version 1.0,,,fcn; func; funct; ordinal; pan; panel; panel.survey.promis; panl; patient reported outcomes information system; pnl; point in time; promise; ql; qual; qualitative; random; screen; survey; survey.promis,Ord
79066-7,ct abdomen 3d post processing wo contrast,ct abd p 3d proc wo contr,,abd; abdo; abdomen+; abdominal; after; c; cat scan; computed tomography; computerized tomography; contr; contra; contrst; coreplaybook; ct scan; document; finding; findings; imaging; p 3d proc; playbook; point in time; pst; rad; radiology; random; without contrast,Doc
79071-7,ct colon and rectum wo contrast iv and w air contrast pr,ct colon+rect wo contr iv+w air contr pr,,abd; abd+pelvis; abdo; abdominal; c; cat scan; colonography; computed tomography; computerized tomography; contr; contra; contrst; coreplaybook; ct scan; document; finding; findings; imaging; lgi; pelvic; playbook; point in time; rad; radiology; random; rectal; rectum+colon; virtual colonoscopy; w air contr pr; without contrast; wo contr iv+w air contr pr,Doc
79086-5,ct chest for screening wo contrast,ct chest screening wo contr,,asympt; asymptomatic; c; cat scan; computed tomography; computerized tomography; contr; contra; contrst; coreplaybook; ct scan; document; finding; findings; imaging; playbook; point in time; rad; radiology; random; scn; thorax; without contrast,Doc
79124-4,total score - informant interview [gpcog],,,general practitioner assessment of cognition; point in time; qnt; quan; quant; quantitative; random; scale; survey; survey.gpcog; tot; totl,Qn
79133-5,9-hydroxyrisperidone [mass/volume] in body fluid,9oh-risperidone fld-mcnc,9-hydroxyrisperidone (body fld) [mass/vol],"9-hydroxy risperidone; 9-hydroxy-risperidone; 9-oh-risperidone; 9oh-risperidone; b/f; bf; bod; bodies; body fluid; body fluid, unsp; drug/toxicology; drugs; fl; fld; flu; fluid; invega; level; mass concentration; paliperidone; point in time; qnt; quan; quant; quantitative; random; risperidone metabolite",Qn
79136-8,acepromazine [mass/volume] in body fluid,acepromazine fld-mcnc,acepromazine (body fld) [mass/vol],"ace; acetylpromazine; acp; atravet; b/f; bf; bod; bodies; body fluid; body fluid, unsp; drug/toxicology; drugs; fl; fld; flu; fluid; level; mass concentration; notensil; plegicil; point in time; qnt; quan; quant; quantitative; random; vet; veterinary",Qn
79145-9,tapentadol [presence] in blood by confirmatory method,tapentadol bld ql cfm,tapentadol confirm ql (bld),addiction; blood; cfm; cnfr; cnfrm; conf; confirmation; confirmatory; drug/toxicology; drugs; drugs of abuse; gcms; illicit; lc/ms/ms; nucynta; ordinal; palexia; point in time; potentialforabuse; pr; ql; qual; qualitative; random; screen; tapal; wb; whole blood,Ord
79148-3,tramadol [presence] in blood by screen method,tramadol bld ql scn,tramadol screen ql (bld),addiction; blood; drug/toxicology; drugs; drugs of abuse; illicit; ordinal; point in time; potentialforabuse; pr; ql; qual; qualitative; random; scn; scr; screen; scrn; tramal; ultram; wb; whole blood,Ord
79150-9,clock drawing panel [gpcog],,,clock drawing pnl; general practitioner assessment of cognition; pan; panel.survey.gpcog; panl; pnl; point in time; random; survey; survey.gpcog,-
79154-1,alizapride [mass/volume] in body fluid,alizapride fld-mcnc,alizapride (body fld) [mass/vol],"b/f; bf; bod; bodies; body fluid; body fluid, unsp; drug/toxicology; drugs; fl; fld; flu; fluid; level; litican; mass concentration; plitican; point in time; qnt; quan; quant; quantitative; random; superan; vergentan",Qn
79156-6,cold agglutinin [titer] in serum by 37 degree c incubation --1 hour post incubation,ca 1h p inc titr ser inc,cold agglutinin 1 hr post incubation 37 degree c incubation (s) [titer],@37c; 1 hour; 1.0hr; 1h p inc; 60 min; 60 minutes; 60m; 60min; after; agglut; agglutination; agglutinins; agglutins; agt; ca; cold agglutinin titration; degree; dilution factor; dilution factor (titer); point in time; pst; random; serology; serum; smqn; sr; titer; titered; titre; ttr,SemiQn
79171-5,apple recombinant (rmal d) 4 ige ab [units/volume] in serum,apple (rmal d) 4 ige qn,apple recombinant (rmal d) 4 ige qn (s),a796; abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; apple; apple (rmal d) 4; arbitrary concentration; autoantibodies; autoantibody; dextro; immune globulin e; immunoglobulin e; point in time; qnt; quan; quant; quantitative; random; serum; sr,Qn
79173-1,somatotropin [units/volume] in serum or plasma --2 hours post xxx challenge,gh 2h p chal serpl-acnc,somatotropin 2 hr post unsp challenge qn,120 min; 120 minutes; 120min; 2 hours; 2h p chal; after; arbitrary concentration; chemistry.challenge testing; endocrine; endocrinology; gh; growth hormone; hgh; human growth hormone; p chal; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; somatotropic hormone; sr; sth,Qn
79174-9,somatotropin [units/volume] in serum or plasma --1.5 hours post xxx challenge,gh 1.5h p chal serpl-acnc,somatotropin 1.5 hr post unsp challenge qn,1 1/2 hours; 1 1/2 hr; 1.5h p chal; 1.5hr; 90 min; 90 minutes; 90m; 90min; after; arbitrary concentration; chemistry.challenge testing; endocrine; endocrinology; gh; growth hormone; hgh; human growth hormone; p chal; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; somatotropic hormone; sr; sth,Qn
79175-6,somatotropin [units/volume] in serum or plasma --1 hour post xxx challenge,gh 1h p chal serpl-acnc,somatotropin 1 hr post unsp challenge qn,1 hour; 1.0hr; 1h p chal; 60 min; 60 minutes; 60m; 60min; after; arbitrary concentration; chemistry.challenge testing; endocrine; endocrinology; gh; growth hormone; hgh; human growth hormone; p chal; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; somatotropic hormone; sr; sth,Qn
79186-3,cells.cd3+cd4+cd8+ (double positive)/cells in blood,cd3+cd4+cd8+ nfr bld,cells.cd3+cd4+cd8+ (double positive)/cells (bld),blood; cd3 cells; cd3+cd4+ cells; cd3-cd4+; cd4+ t cells; cell; cell markers; cellularity; helper t cells; inducer t cells; l3t4; leu2; leu-2; leu3; leu-3; leu4; leu-4; number fraction; percent; point in time; qnt; quan; quant; quantitative; random; suppressor t cells; t3; t4; t-4; t4 helper/inducer cells; t8; t-8; tsuppressor; w3/25; wb; whole blood,Qn
79198-8,somatotropin [mass/volume] in serum or plasma --2.25 hours post dose arginine+insulin,gh 2.25h p arg+ins serpl-mcnc,somatotropin 2.25 hr post dose arginine+insulin [mass/vol],135 minutes; 135m; 2.25h p arg+ins; after; arg; chemistry.challenge testing; endocrine; endocrinology; gh; growth hormone; hgh; hum; human growth hormone; humulin; ih7; insul; lente; level; mass concentration; nph; p dose; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; semilente; serp; serpl; serplas; serum; serum or plasma; sliding; somatotropic hormone; sr; sth; ultralente,Qn
79199-6,somatotropin [mass/volume] in serum or plasma --15 minutes post dose arginine+insulin,gh 15m p arg+ins serpl-mcnc,somatotropin 15 min post dose arginine+insulin [mass/vol],15m p arg; 15m p arg+ins; after; arg; chemistry.challenge testing; endocrine; endocrinology; gh; growth hormone; hgh; hum; human growth hormone; humulin; ih7; insul; lente; level; mass concentration; nph; p dose; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; semilente; serp; serpl; serplas; serum; serum or plasma; sliding; somatotropic hormone; sr; sth; ultralente,Qn
79200-2,somatotropin [mass/volume] in serum or plasma --2.5 hours post dose arginine+insulin,gh 2.5h p arg+ins serpl-mcnc,somatotropin 2.5 hr post dose arginine+insulin [mass/vol],2.5h p arg+ins; after; arg; chemistry.challenge testing; endocrine; endocrinology; gh; growth hormone; hgh; hum; human growth hormone; humulin; ih7; insul; lente; level; mass concentration; nph; p dose; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; semilente; serp; serpl; serplas; serum; serum or plasma; sliding; somatotropic hormone; sr; sth; ultralente,Qn
79208-5,brca2 gene mutation analysis limited to known familial mutations in blood or tissue by molecular genetics method,brca2 gene fam mut anl bld/t,brca2 gene familial mut analysis molgen doc (bld/tiss),"ashkenazi jewish workup; blood; brca; brcc2; breast cancer 2, early onset; brovca2; document; facd; fad; fad1; fam mut anl; fancb; fancd; fancd1; finding; findings; genetics; glm3; heredity; heritable; inherited; lmted; ltd; molecular genetics; molecular pathology; molpath; molpath.mutations; mut; mutation; mutations; muts; oncology; pcr; pnca2; point in time; random; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue; xrcc11",Doc
79212-7,fetal microdeletions risk [interpretation] in plasma cell-free dna qualitative by sequencing,fet microdel risk plas.cfdna seq-imp,microdels risk sequencing ql (cfdna) [interp],genetics; heredity; heritable; high-throughput sequencing; hts; impression; impression/interpretation of study; impressions; inherited; interp; interpretation; microdel risk; molecular pathology; molpath; next generation sequencing; ngs; ordinal; pl; plasma; plsm; point in time; ql; qual; qualitative; random; screen,Ord
79213-5,type of education program assigned to patient,educ program assigned to pt,,clin; educ program assigned to pt; nominal; point in time; random; typ,Nom
7923-6,influenza virus a hong kong ab [units/volume] in serum,fluav hk ab ser-acnc,fluav hk ab qn (s),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; avian influenza; bird flu; flua; fluav; fluav hk; fluv; fowl plague; id; infectious disease; infectiousdisease; influ; influenza a; influenza a virus; microbiology; point in time; qnt; quan; quant; quantitative; random; serum; sr,Qn
79251-5,diazepam cutoff [mass/volume] in saliva (oral fluid) for confirmatory method,diazepam cto sal cfm-mcnc,diazepam cutoff confirm (sal) [mass/vol],c311; cfm; cnfr; cnfrm; conf; confirmation; confirmatory; cto; drug/toxicology; drugs; gcms; lc/ms/ms; level; mass concentration; oral fluid; point in time; qnt; quan; quant; quantitative; random; sal; stesolid; valium,Qn
79255-6,oxycodone cutoff [mass/volume] in saliva (oral fluid) for confirmatory method,oxycodone cto sal cfm-mcnc,oxycodone cutoff confirm (sal) [mass/vol],cfm; cnfr; cnfrm; conf; confirmation; confirmatory; cto; drug/toxicology; drugs; gcms; lc/ms/ms; level; lortab; mass concentration; oral fluid; oxycontin; percocet; percodan; point in time; qnt; quan; quant; quantitative; random; sal; vicodin,Qn
79257-2,methylenedioxyamphetamine cutoff [mass/volume] in saliva (oral fluid) for confirmatory method,mda cto sal cfm-mcnc,methylenedioxyamphetamine cutoff confirm (sal) [mass/vol],cfm; cnfr; cnfrm; conf; confirmation; confirmatory; cto; drug/toxicology; drugs; gcms; lc/ms/ms; level; mass concentration; mda; methylenedioxymethamphetamine metabolite; oral fluid; point in time; qnt; quan; quant; quantitative; random; sal,Qn
79259-8,fentanyl cutoff [mass/volume] in urine for confirmatory method,fentanyl cto ur cfm-mcnc,fentanyl cutoff confirm (u) [mass/vol],actiq; cfm; cnfr; cnfrm; conf; confirmation; confirmatory; cto; drug/toxicology; drugs; duragesic; durogesic; fenpat; fentanil; gcms; lc/ms/ms; level; mass concentration; point in time; qnt; quan; quant; quantitative; random; sublimaze; ua; ur; urn,Qn
79262-2,methamphetamine cutoff [mass/volume] in saliva (oral fluid) for confirmatory method,methamphet cto sal cfm-mcnc,methamphetamine cutoff confirm (sal) [mass/vol],cfm; cnfr; cnfrm; conf; confirmation; confirmatory; cto; desoxyn; drug/toxicology; drugs; gcms; lc/ms/ms; level; mass concentration; methamphet; oral fluid; point in time; qnt; quan; quant; quantitative; random; sal,Qn
79276-2,"7,8-dihydrobiopterin [moles/volume] in cerebral spinal fluid","7,8-bh2 csf-scnc","7,8-dihydrobiopterin (csf) [moles/vol]","7,8-bh2; 7,8-dihydro-l-biopterin; bh4 deficiency; biopterin deficiency; cerebral spinal fluid; cerebrospinal fl; chemistry; dihydrobiopterin; hyperphenylalaninaemia; hyperphenylalaninemia; level; point in time; pterins; qnt; quan; quant; quantitative; random; spinal fl; spinal fld; spinal flu; spinal fluid; substance concentration",Qn
79277-0,7-lathosterol [moles/volume] in serum or plasma,7-lathosterol serpl-scnc,7-lathosterol [moles/vol],5 alpha-cholest-7-en-3 beta-ol; cerebrotendinous xantomatosis; chemistry; ctx; lathosterolosis; level; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; substance concentration,Qn
79282-0,biopterin/biopterin+neopterin [molar ratio] in urine,biopterin/biop+neop ur-srto,biopterin/biopterin+neopterin (u) [molar ratio],biop+neop; biopt; chemistry; neopterine; point in time; qnt; quan; quant; quantitative; random; scrto; substance concentration ratio; substance ratio; ua; ur; urn,Qn
793-0,erythrocytes [#/volume] in pleural fluid by manual count,rbc # plr manual,rbc manual cnt (pleur fld) [#/vol],#; abs; absolute; absolutes; cnt; count; count/volume; ct; discocytes; erthrocyte; erythrocyte; hematology/cell counts; manl; number concentration; number concentration (count/vol); pleural; pleural fluid; point in time; qnt; quan; quant; quantitative; random; rbc; rbcs; red blood cell; red blood cells; red blood corpuscle; red blood corpusles; red cell; red cells; thoracentesis fluid,Qn
79300-0,d- and l-2-hydroxyglutarate pattern [interpretation] in serum or plasma narrative,d2hg + l2hg pattern serpl-imp,d- and l-2-hydroxyglutarate pattern nar [interp],2-hydroxy-glutarate; 2-hydroxyglutaric acid; 2oh-gluterate; alpha-hydroxyglutarate; alpha-hydroxyglutaric acid; chemistry; d2hg + l2hg pattern; dextro; hydroxyglutaric aciduria; ii; impression; impression/interpretation of study; impressions; interp; interpretation; l2hg; l-2-hg; l2hga; l-2-hga; left; levo; narrative; pl; plasma; plsm; point in time; random; report; serp; serpl; serplas; serum; serum or plasma; sr,Nar
79306-7,d-2-hydroxyglutarate [moles/volume] in dbs,d2hg dbs-scnc,d-2-hydroxyglutarate (dbs) [moles/vol],2-hydroxy-glutarate; 2-hydroxyglutaric acid; 2oh-gluterate; alpha-hydroxyglutarate; alpha-hydroxyglutaric acid; blood; chemistry; d2hg; d-2-hg; d2hga; d-2-hga; dbs; dextro; dried blood spot; filter paper; fp; hydroxyglutaric aciduria; ii; level; point in time; qnt; quan; quant; quantitative; random; substance concentration; wb; whole blood,Qn
79307-5,d-2-hydroxyglutarate [moles/volume] in amniotic fluid,d2hg amn-scnc,d-2-hydroxyglutarate (amn fld) [moles/vol],2-hydroxy-glutarate; 2-hydroxyglutaric acid; 2oh-gluterate; af; alpha-hydroxyglutarate; alpha-hydroxyglutaric acid; amn; amn fl; amnio; amniotic flu; amniotic fluid; chemistry; d2hg; d-2-hg; d2hga; d-2-hga; dextro; hydroxyglutaric aciduria; ii; level; point in time; qnt; quan; quant; quantitative; random; substance concentration,Qn
79311-7,gamma butyrobetaine/creatinine [molar ratio] in urine,g-butyrobetaine/creat ur-srto,gamma butyrobetaine/creatinine (u) [molar ratio],chemistry; cr; crea; creat; g-butyrobetaine; point in time; qnt; quan; quant; quantitative; random; scrto; substance concentration ratio; substance ratio; tmlhe; trimethyllysine hydroxylase epsilon deficiency; ua; ucr; ur; urn,Qn
79329-9,trimethyllysine [moles/volume] in cerebral spinal fluid,tml csf-scnc,trimethyllysine (csf) [moles/vol],"6-n-l-trimethyl-l-lysine; carnitine deficiency disorder; cerebral spinal fluid; cerebrospinal fl; chemistry; epsilon-trimethyllysine; level; n(6),n(6),n(6)-trimethyl-l-lysine; point in time; qnt; quan; quant; quantitative; random; spinal fl; spinal fld; spinal flu; spinal fluid; substance concentration; tml",Qn
79342-2,carnitine biosynthesis intermediates pattern [interpretation] in urine narrative,carnitine biosynthesis pattern ur-imp,carnitine biosynthesis intermediates pattern nar (u) [interp],carnitine biosynthesis pattern; carnitine.total; chemistry; impression; impression/interpretation of study; impressions; interp; interpretation; narrative; point in time; random; report; ua; ur; urn,Nar
7934-3,japanese encephalitis virus ab [presence] in serum by immunoassay,jev ab ser ql ia,jev ab ia ql (s),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; eia; elfa; elisa; enc; enceph; encephalomyelitis; enzyme immunoassay; flavivirus; iaa; id; infectious disease; infectiousdisease; japanese b encephalitis; japanese encephalitis; jbe; je virus; jev; meia; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; sr; suds,Ord
79348-9,body weight --used for drug calculation,weight used for drug calc,,bdy weight; bod; bodies; clin; drugs; point in time; qnt; quan; quant; quantitative; random; wt,Qn
79351-3,xr cervical spine ge 2 views,xr c-spine ge 2v,,c/sp; cerv; c-spine; document; films; finding; findings; ge 2v; ii; imaging; minimum 2 views; plain films; point in time; rad; radiology; random; spinal; spinal cord; view; vws; xray; x-ray,Doc
79363-8,xr knee - bilateral ap and lateral and merchants and (views w standing),xr knee-bl ap+lat+merch+views stand,,anterio-posterior; anteroposterior; ap+lat; ap+lat+merchants; ap+lat+merchants+(views; ap+lat+merchants+stand; bil; bilat; both; document; ext; extr-bl; films; finding; findings; imaging; kn; knee-bl; knees; lat; le; le-bl; leg; low; lower extremity joint; msk; musculoskeletal; ortho; orthopedics; plain films; point in time; rad; radiology; random; stand); view; views & ap kub; views (ap; views ap kub & lateral; views+ap; vws; wb; weight bearing; xray; x-ray,Doc
79394-3,hepatocyte growth factor [mass/volume] in serum or plasma,hgf serpl-mcnc,hepatocyte growth factor [mass/vol],chemistry; fac; fact; hepatopoietin a; hgf; level; mass concentration; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; scatter factor; serp; serpl; serplas; serum; serum or plasma; sr,Qn
79398-4,prolactin isoforms pattern [interpretation] in serum or plasma narrative,prolactin isoforms pattern serpl-imp,prolactin isoforms pattern nar [interp],chemistry; impression; impression/interpretation of study; impressions; interp; interpretation; lactotropic hormone; lactotropin; mammatropic hormone; mammotropin; narrative; pl; plasma; plsm; point in time; prl; prol; random; report; serp; serpl; serplas; serum; serum or plasma; sr,Nar
79412-3,mianserin trough and normianserin panel - serum or plasma,mianserin trgh + nor pnl serpl,mianserin trough and normianserin panel,antidepressant; bolvidon; depnon; drug/toxicology; drugs; lantanon; lerivon; lumin; mianserin metabolite; mianserin trgh + nor pnl; norval; pan; panel.drug & toxicology; panl; pl; plasma; plsm; pnl; point in time; random; serp; serpl; serplas; serum; serum or plasma; sr; tolvon,-
7941-8,la crosse virus igm ab [units/volume] in serum,lacv igm ser-acnc,la crosse virus igm qn (s),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; california encephalitis virus; id; immune globulin m; immunoglobulin m; infectious disease; infectiousdisease; lacrosse virus; lacv; microbiology; point in time; qnt; quan; quant; quantitative; random; serum; sr,Qn
7942-6,lassa virus igg ab [presence] in serum by immunoassay,lasv igg ser ql ia,lassa virus igg ia ql (s),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; eia; elfa; elisa; enzyme immunoassay; iaa; id; immune globulin g; immunoglobulin g; infectious disease; infectiousdisease; lasv; meia; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; sr; suds,Ord
79431-3,quality of life score change [hoos],,,exchange; hip dysfunction and osteoarthritis outcome score; hoos jr; point in time; qnt; qol score; qol score change; quan; quant; quantitative; random; replace; score difference; survey; survey.gnhlth,Qn
79436-2,quality of life score change [koos],,,"exchange; knee injury and osteoarthritis outcome score; koos jr; koos, jr; point in time; qnt; qol score; qol score change; quan; quant; quantitative; random; replace; score difference; survey; survey.gnhlth",Qn
79438-8,activities of daily living score change [koos],,,"adl score; adl score change; exchange; knee injury and osteoarthritis outcome score; koos jr; koos, jr; point in time; qnt; quan; quant; quantitative; random; replace; score difference; survey; survey.gnhlth",Qn
7944-2,lassa virus igm ab [presence] in serum by immunoassay,lasv igm ser ql ia,lassa virus igm ia ql (s),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; eia; elfa; elisa; enzyme immunoassay; iaa; id; immune globulin m; immunoglobulin m; infectious disease; infectiousdisease; lasv; meia; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; sr; suds,Ord
79458-6,beta-n-acetylhexosaminidase [enzymatic activity/volume] in dbs,b-nah dbs-ccnc,beta-n-acetylhexosaminidase (dbs) [catalytic activity/vol],b; blood; b-nah; catalytic concentration; chemistry; dbs; dried blood spot; filter paper; fp; gm2-gangliosidosis; hex a; hex b; hexa; hexosaminidase; point in time; qnt; quan; quant; quantitative; random; sandhoff disease; tay sachs disease; wb; whole blood,Qn
79459-4,dihydropteridine reductase [enzymatic activity/mass] in red blood cells,dhp reduct rbc-ccnt,dihydropteridine reductase (rbc) [catalytic activity/mass],catalytic content; chemistry; dhp reduct; dhpr; erythrocytes; point in time; qnt; quan; quant; quantitative; random; red blood cells; red blood corpusles,Qn
79462-8,iduronate-2-sulfatase [enzymatic activity/volume] in dbs,iduronate2sulfatas dbs-ccnc,iduronate-2-sulfatase (dbs) [catalytic activity/vol],blood; catalytic concentration; chemistry; dbs; dried blood spot; filter paper; fp; hunter disease; iduronate2sulfatas; ii; mps ii; point in time; qnt; quan; quant; quantitative; random; wb; whole blood,Qn
79492-5,furoylglycine [moles/volume] in serum or plasma,furoylglycine serpl-scnc,furoylglycine [moles/vol],2-furoylglycine; chemistry; furfuroylglycine; level; pl; plasma; plsm; point in time; pyromucurate; pyromucuric acid; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; substance concentration,Qn
79502-1,4-hydroxyvalerate [moles/volume] in serum or plasma,4oh-valerate serpl-scnc,4-hydroxyvalerate [moles/vol],4oh-valerate; chemistry; level; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; substance concentration,Qn
79503-9,4-hydroxyhippurate [moles/volume] in serum or plasma,4oh-hippurate serpl-scnc,4-hydroxyhippurate [moles/vol],4-hydroxyhippuric acid; 4oh-hippurate; chemistry; level; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; substance concentration,Qn
79513-8,"1,4-cyclohexanediol [moles/volume] in serum or plasma","1,4-cyclohexanediol serpl-scnc","1,4-cyclohexanediol [moles/vol]","chemistry; cis-1,4-cyclohexanediol; cyclohexane-1,4-diol; i; level; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; quinitol; random; serp; serpl; serplas; serum; serum or plasma; sr; substance concentration; trans-1,4-cyclohexanediol",Qn
7951-7,legionella pneumophila 4 ab [titer] in serum by immunofluorescence,l pneumo4 ab titr ser if,l. pneumophila 4 ab if (s) [titer],abs; aby; acif; antby; anti; antibodies; antibody; anticomplement immunofluorescence; autoantibodies; autoantibody; dilution factor; dilution factor (titer); fa; fluorescent antibody; fluoresent; id; ifa; immune fluorescence; immunoflour; immunofluor; immunofluorescence; infectious disease; infectiousdisease; l pneumo; l pneumo4; l pneumonphila; legion; legionela; legionella pneumophila serogroup 4; los angeles 1; microbiology; pneu; pneum; pneumophilia; point in time; random; serum; smqn; sr; time resolved fluorescence; titer; titered; titre; trf; ttr,SemiQn
79524-5,p-cresol [moles/volume] in serum or plasma,p-cresol serpl-scnc,p-cresol [moles/vol],1-hydroxy-4-methylbenzene; 1-methyl-4-hydroxybenzene; 4-cresol; 4-hydroxytoluene; 4-methylphenol; chemistry; level; p prime; paracresol; para-cresol; para-cresylic acid; paramethyl phenol; p-hydroxytoluene; pl; plasma; plsm; p-methylhydroxybenzene; p-methylphenol; point in time; p-toluol; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; substance concentration,Qn
79528-6,5-hydroxymethyl-2-furoate [moles/volume] in serum or plasma,5oh-methyl-2-furoate serpl-scnc,5-hydroxymethyl-2-furoate [moles/vol],2-furaldehyde metabolite; 5-hydroxymethyl-2-furoic acid; 5oh-methyl-2-furoate; chemistry; furancarboxylic acid; furfural metabolite; furoic acid; ii; level; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; substance concentration,Qn
79556-7,fluid output neurological drain [volume] measured,fluid output neuro drain vol meas,,fld; fluid output neuro drain; io_output; io_output.molec; point in time; qnt; quan; quant; quantitative; random; volume,Qn
79563-3,mucopolysaccharidosis type i newborn screening panel,mps i nbs pnl dbs,mucopolysaccharidosis type i nbs panel (dbs),alpha-l-iduronidase; asympt; asymptomatic; blood; chemistry; dbs; dried blood spot; filter paper; fp; gyn; gynecology; idua; mps i; mps i nbs pnl; mps-i; nb screen pnl; nbs; new born; ob; obgyn; obstetrics; pan; panel.chemistry; panl; pnl; point in time; random; scn; wb; whole blood,-
79564-1,mucopolysaccharidosis type i newborn screen interpretation,mps i dbs-imp,mucopolysaccharidosis type i (dbs) [interp],alpha-l-iduronidase; blood; chemistry; dbs; dried blood spot; filter paper; fp; idua; impression; impression/interpretation of study; impressions; interp; interpretation; mps i; mps-i; nominal; point in time; random; wb; whole blood,Nom
79583-1,r- and s-beta aminoisobutyrate and d- and l-serine panel - serum or plasma,r- + s-baib + d- + l-serine panel serpl,r- and s-beta aminoisobutyrate and d- and l-serine panel,3-aminoisobutyrate; 3-aminoisobutyric acid; b; b-aib; chemistry; dextro; left; levo; levo-serine; pan; panel.chemistry; panl; pl; plasma; plsm; pnl; point in time; r- + s-baib + d- + l-serine panel; r prime; random; right; s prime; s-b-aib; ser; serp; serpl; serplas; serum; serum or plasma; sr,-
7959-0,leptospira sp ab [titer] in serum,leptospira ab titr ser,leptospira sp ab (s) [titer],abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; dilution factor; dilution factor (titer); id; infectious disease; infectiousdisease; leptospirosis; microbiology; point in time; random; serum; smqn; species; spp; sr; titer; titered; titre; ttr; universallaborders,SemiQn
79593-0,allocystathionine/creatinine [molar ratio] in urine,allocystathionine/creat ur-srto,allocystathionine/creatinine (u) [molar ratio],chemistry; cr; crea; creat; esoteric; point in time; qnt; quan; quant; quantitative; random; scrto; substance concentration ratio; substance ratio; ua; ucr; ur; urn,Qn
79595-5,"n,n'-dimethylarginine [moles/volume] in serum or plasma","n,n'-dimethylarginine serpl-scnc","n,n'-dimethylarginine [moles/vol]","adma; asymmetric dimethylarginine; chemistry; dimethyl-l-arginine; esoteric; guanidino-n(1),n(2)-dimethylarginine; level; n(g)-dimethylarginine; n(g1),n(g1)-dimethylarginine; n(g1),n(g2)-dimethylarginine; n,n-dimethylarginine; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; sdma; sdma arginine; serp; serpl; serplas; serum; serum or plasma; sr; substance concentration; symmetric dimethylarginine",Qn
79596-3,d-serine/creatinine [molar ratio] in urine,d-serine/creat ur-srto,d-serine/creatinine (u) [molar ratio],chemistry; cr; crea; creat; dextro; dextro-serine; esoteric; point in time; qnt; quan; quant; quantitative; random; scrto; ser; substance concentration ratio; substance ratio; ua; ucr; ur; urn,Qn
79597-1,n-monomethylarginine/creatinine [molar ratio] in urine,n-monomethylarginine/creat ur-srto,n-monomethylarginine/creatinine (u) [molar ratio],(2s)-2-amino-5-(3-methylcarbamimidamido)pentanoic acid; chemistry; cr; crea; creat; esoteric; l-monomethylarginine; l-nmma; l-targinine; n(g)-monomethyl-l-arginine; n-monomethyl-l-arginine; point in time; qnt; quan; quant; quantitative; random; scrto; substance concentration ratio; substance ratio; targinine; ua; ucr; ur; urn,Qn
79605-2,r- and s-beta aminoisobutyrate and d- and l-serine panel - urine,r- + s-baib + d- + l-serine panel ur,r- and s-beta aminoisobutyrate and d- and l-serine panel (u),3-aminoisobutyrate; 3-aminoisobutyric acid; b; b-aib; chemistry; dextro; left; levo; levo-serine; pan; panel.chemistry; panl; pnl; point in time; r- + s-baib + d- + l-serine panel; r prime; random; right; s prime; s-b-aib; ser; ua; ur; urn,-
79606-0,cysteate [moles/volume] in serum or plasma,cysteate serpl-scnc,cysteate [moles/vol],beta sulfoalanine; chemistry; cysteic acid; esoteric; level; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; substance concentration,Qn
7962-4,measles virus igg ab [units/volume] in serum,mev igg ser-acnc,mev igg qn (s),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; id; immune globulin g; immunoglobulin g; infectious disease; infectiousdisease; mev; microbiology; msls; point in time; qnt; quan; quant; quantitative; random; rubeola; serum; sr,Qn
79624-3,5-s-cysteinyldopa [moles/volume] in serum or plasma,5-s-cysteinyldopa serpl-scnc,5-s-cysteinyldopa [moles/vol],5-s-cysteinyldopa; 5-s-cysteinyl-dopa; chemistry; cysteinyl-dihydroxyphenylalanine; cysteinyldopa; esoteric; level; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; s prime; serp; serpl; serplas; serum; serum or plasma; sr; substance concentration,Qn
79641-7,glutathione.reduced/creatinine [molar ratio] in urine,gsh/creat ur-srto,glutathione.reduced/creatinine (u) [molar ratio],chemistry; cr; crea; creat; esoteric; gsh; point in time; qnt; quan; quant; quantitative; random; scrto; substance concentration ratio; substance ratio; ua; ucr; ur; urn,Qn
79648-2,d-serine [moles/volume] in cerebral spinal fluid,d-serine csf-scnc,d-serine (csf) [moles/vol],cerebral spinal fluid; cerebrospinal fl; chemistry; dextro; dextro-serine; esoteric; level; point in time; qnt; quan; quant; quantitative; random; ser; spinal fl; spinal fld; spinal flu; spinal fluid; substance concentration,Qn
79649-0,homocysteine cysteine disulfide/creatinine [molar ratio] in urine,hycs-cys dis/creat ur-srto,homocysteine cysteine disulfide/creatinine (u) [molar ratio],2-amino-4-[(2-amino-2-carboxyethyl)disulfanyl]butanoic acid; chemistry; cr; crea; creat; cys; cys-homo-cys-mixed disulfide; cysteine-homocysteine mixed disulfide; cysteinylhomocysteine mixed disulfide; esoteric; hcy; hcys; hcyst; homocyst(e)ine; homocysteine-cysteine mixed disulfide; hycs-cys dis; hycs-cys disulfide; point in time; qnt; quan; quant; quantitative; random; scrto; substance concentration ratio; substance ratio; ua; ucr; ur; urn,Qn
79659-9,purine and pyrimidine pattern [interpretation] in serum or plasma narrative,purine + pyrimidine pattern serpl-imp,purine and pyrimidine pattern nar [interp],chemistry; esoteric; impression; impression/interpretation of study; impressions; interp; interpretation; narrative; pl; plasma; plsm; point in time; purine + pyrimidine pattern; random; report; serp; serpl; serplas; serum; serum or plasma; sr,Nar
79663-1,guanine [moles/volume] in cerebral spinal fluid,guanine csf-scnc,guanine (csf) [moles/vol],"2-amino-3,7-dihydropurin-6-one; c5h5n5o; cerebral spinal fluid; cerebrospinal fl; chemistry; esoteric; level; point in time; qnt; quan; quant; quantitative; random; spinal fl; spinal fld; spinal flu; spinal fluid; substance concentration",Qn
7966-5,mumps virus igg ab [units/volume] in serum,muv igg ser-acnc,muv igg qn (s),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; id; immune globulin g; immunoglobulin g; infectious disease; infectiousdisease; microbiology; muv; point in time; qnt; quan; quant; quantitative; random; serum; sr; universallaborders,Qn
7967-3,mumps virus igm ab [units/volume] in serum,muv igm ser-acnc,muv igm qn (s),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; id; immune globulin m; immunoglobulin m; infectious disease; infectiousdisease; microbiology; muv; point in time; qnt; quan; quant; quantitative; random; serum; sr,Qn
79679-7,5-aminoimidazole-4-carboxamide [moles/volume] in serum or plasma,5-aminoimidazole-4-carboxamide srpl-scnc,5-aminoimidazole-4-carboxamide [moles/vol],4-amino-1h-imidazole-5-carboxamide; 4-amino-5-imidazolecarboxamide; 4-carbamoyl-5-aminoimidazole; aica; aicar; chemistry; colahepat; diazol-c; esoteric; level; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; substance concentration,Qn
79693-8,"5,6-dihydrouracil [moles/volume] in cerebral spinal fluid","5,6-dihydrouracil csf-scnc","5,6-dihydrouracil (csf) [moles/vol]","1,3-diazinane-2,4-dione; 5,6-dihydro-2,4-dihydroxypyrimidine; cerebral spinal fluid; cerebrospinal fl; chemistry; dihydrouracil; esoteric; hydrouracil; level; point in time; qnt; quan; quant; quantitative; random; spinal fl; spinal fld; spinal flu; spinal fluid; substance concentration",Qn
79699-5,cis-11-eicosenoate (cis 11 c20:1w9) [moles/volume] in serum or plasma,cis-11-eicosenoate serpl-scnc,cis-11-eicosenoate (cis 11 c20:1w9) [moles/vol],chemistry; esoteric; gondoic acid; level; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; substance concentration,Qn
79715-9,cyp2d6 gene product metabolic activity interpretation in blood or tissue qualitative by molecular genetics method,cyp2d6 gene prod met act imp bld/t-imp,cyp2d6 gene product metabolic activity interpretation molgen ql (bld/tiss) [interp],"activ; actvty; blood; cpd6; cyp2d; cyp2d@; cyp2d6 gene prod met act imp; cyp2d7ap; cyp2d7bp; cyp2d7p2; cyp2d8p2; cyp2dl1; cypiid6; cytochrome p450; cytochrome p450, family 2, subfamily d, polypeptide 6; debrisoquine hydroxylation gene; drug metabolism; gene prod met act imp; hgnc:2629; impression; impression/interpretation of study; impressions; interp; interpret; interpretation; interpt; intrp; molecular genetics; molecular pathology; molpath; molpath.pharmg; movements; ordinal; p450c2d; p450db1; p450-db1; pcr; phenotype; point in time; ql; qual; qualitative; random; screen; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",Ord
79718-3,ugt1a1 gene product metabolic activity interpretation in blood or tissue qualitative by molecular genetics method,ugt1a1 gene prod met act imp bld/t-imp,ugt1a1 gene product metabolic activity interpretation molgen ql (bld/tiss) [interp],"activ; actvty; biliqtl1; blood; crigler-najjar syndrome, type i; drug metabolism; gene prod met act imp; gilbert syndrome; gnt1; hug-br1; impression; impression/interpretation of study; impressions; interp; interpret; interpretation; interpt; intrp; molecular genetics; molecular pathology; molpath; molpath.pharmg; movements; ordinal; pcr; phenotype; point in time; ql; qual; qualitative; random; screen; tissue; tissue, unspecified; udp glucuronosyltransferase 1 family, polypeptide a1; udp glycosyltransferase 1 family, polypeptide a1 gene; udpgt; udpgt 1-1; ugt1; ugt1a; ugt1a1 gene prod met act imp; ugt1a5; wb; whole blood; whole blood or tissue",Ord
79722-5,slco1b1 gene product functional interpretation in blood or tissue qualitative by molecular genetics method,slco1b1 gene prod funct imp bld/t,slco1b1 gene product functional interpretation molgen ql (bld/tiss) [interp],"blood; impression; impression/interpretation of study; impressions; interp; interpret; interpretation; interpt; intrp; molecular genetics; molecular pathology; molpath; molpath.pharmg; ordinal; pcr; point in time; ql; qual; qualitative; random; screen; slco1b1 gene prod fnc imp; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",Ord
79741-5,eye-related brain mri findings,eye-rel brain mri find,,eye; eye.hx; eye.hx.nei; eye-rel brain mri find; finding; findings; nominal; ophthalmology; ophtho; ophthy; point in time; rad; radiology; random,Nom
79769-6,right retina arden ratio by eog,r ret arden rto eog,,arden rto; eog; eye; eye.eog; eye.eog.nei; ophthalmology; ophtho; ophthy; point in time; qnt; quan; quant; quantitative; r; r ret; random; rt,Qn
79777-9,a-wave implicit time right retina dark-adapted by erg,a-wave impl time r ret dark-adapt erg,,atrial wave; a-wave impl time; erg; eye; eye.erg; eye.erg.nei; ophthalmology; ophtho; ophthy; point in time; qnt; quan; quant; quantitative; r; r ret; random; rt,Qn
79779-5,a-wave implicit time right retina light-adapted by erg,a-wave impl time r ret light-adapt erg,,atrial wave; a-wave impl time; erg; eye; eye.erg; eye.erg.nei; ophthalmology; ophtho; ophthy; point in time; qnt; quan; quant; quantitative; r; r ret; random; rt,Qn
79783-7,b-wave amplitude right retina light-adapted by erg,b-wave amp r ret light-adapt erg,,electrical potential; erg; eye; eye.erg; eye.erg.nei; ophthalmology; ophtho; ophthy; point in time; qnt; quan; quant; quantitative; r; r ret; random; rt; voltage,Qn
79784-5,b-wave amplitude left retina light-adapted by erg,b-wave amp l ret light-adapt erg,,electrical potential; erg; eye; eye.erg; eye.erg.nei; l; l ret; lt; ophthalmology; ophtho; ophthy; point in time; qnt; quan; quant; quantitative; random; voltage,Qn
79785-2,b-wave implicit time left retina dark-adapted by erg,b-wave impl time l ret dark-adapt erg,,b-wave impl time; erg; eye; eye.erg; eye.erg.nei; l; l ret; lt; ophthalmology; ophtho; ophthy; point in time; qnt; quan; quant; quantitative; random,Qn
79791-0,erg reference electrode [location],erg ref electrode loc,,brain; cranial; cranium; erg; eye; eye.erg; eye.erg.nei; intracranial; location; nominal; ophthalmology; ophtho; ophthy; point in time; random; ref electrode; skull,Nom
79795-1,flicker response wave amplitude right retina light-adapted by erg,flicker resp amp r ret light-adapt erg,,electrical potential; erg; eye; eye.erg; eye.erg.nei; flicker resp amp; ophthalmology; ophtho; ophthy; point in time; qnt; quan; quant; quantitative; r; r ret; random; rt; voltage,Qn
79816-5,right retina foveal thickness by oct,r ret foveal thickness oct,,eye; eye.oct; eye.oct.nei; length; ophthalmology; ophtho; ophthy; optical coherence tomography; point in time; qnt; quan; quant; quantitative; r; r ret; random; rt; thick,Qn
79819-9,study observation left retina by oct,study obs l ret oct,,eye; eye.oct; eye.oct.nei; finding; findings; l; l ret; lt; nominal; ophthalmology; ophtho; ophthy; optical coherence tomography; point in time; random; study report,Nom
79828-0,contrast sensitivity [log inverse percent] of left eye by pelli-robson eye chart,l eye contr sens pelli-robson,,c; contr; contr sens; contra; contrst; eye; eye.px; eye.px.nei; eyeball; l; l eye; lt; occular; oculis; ophthalmologic; ophthalmology; ophtho; ophthy; optic globe; point in time; qnt; quan; quant; quantitative; random; vision; visual,Qn
79835-5,right eye cylinder--wo cycloplegia by objective refraction,r eye cylinder--wo cyclo obj refraction,,cyl; eye; eye.refraction; eye.refraction.nei; eyeball; inverse length; obj refraction; occular; oculis; ophthalmologic; ophthalmology; ophtho; ophthy; optic globe; point in time; qnt; quan; quant; quantitative; r; r eye; random; rt; vision; visual,Qn
79839-7,right eye sphere--wo cycloplegia by objective refraction,r eye sphere--wo cyclo obj refraction,,eye; eye.refraction; eye.refraction.nei; eyeball; inverse length; obj refraction; occular; oculis; ophthalmologic; ophthalmology; ophtho; ophthy; optic globe; point in time; qnt; quan; quant; quantitative; r; r eye; random; rt; vision; visual,Qn
79845-4,left eye axis--wo cycloplegia by subjective refraction,l eye axis--wo cyclo subj refraction,,eye; eye.refraction; eye.refraction.nei; eyeball; l; l eye; lt; occular; oculis; ophthalmologic; ophthalmology; ophtho; ophthy; optic globe; point in time; qnt; quan; quant; quantitative; random; subj refraction; vision; visual,Qn
79846-2,right eye cylinder--w cycloplegia by subjective refraction,r eye cylinder--w cyclo subj refraction,,cyl; eye; eye.refraction; eye.refraction.nei; eyeball; inverse length; occular; oculis; ophthalmologic; ophthalmology; ophtho; ophthy; optic globe; point in time; qnt; quan; quant; quantitative; r; r eye; random; rt; subj refraction; vision; visual,Qn
79884-3,study observation right visual pathway vep,study obs visual pathway-r vep,,eye; eye.px; eye.px.nei; finding; findings; ophthalmology; ophtho; ophthy; ordinal; point in time; ql; qual; qualitative; r; random; rt; screen; study report; visual pathway-r,Ord
79887-6,left anterior chamber cells slit lamp biomicroscopy,l ant chamber cells slit lamp,,ant chamber; cell; cellularity; cnt; count; eye; eye.slitlamp; eye.slitlamp.nei; l; l ant chamber; lt; number; ophthalmology; ophtho; ophthy; point in time; qnt; quan; quant; quantitative; random,Qn
79898-3,objective refraction panel,obj refraction pnl,,eye; eyeball; obj refraction pnl; occular; oculis; ophthalmologic; ophthalmology; ophtho; ophthy; optic globe; pan; panel.eye; panl; pnl; point in time; random; vision; visual,-
7990-5,respiratory syncytial virus ab [units/volume] in serum,rsv ab ser-acnc,rsv ab qn (s),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; hrsv; id; infectious disease; infectiousdisease; microbiology; point in time; qnt; quan; quant; quantitative; random; rsv; serum; sr,Qn
79916-3,pulmonary vein maximum d-wave velocity by ultrasound.doppler.pw,pulm vein d wave vmax,,bld flow; bld flow vel; bld flow.velocity; card.us; card.us.dicom; cardio; cardiology; dextro; dop; dop.pw; duplex; d-wave vmax; dynamic; echography; heart disease; largest; max v; maximal; maximum; peak; point in time; pulm v; qnt; quan; quant; quantitative; random; sonogram; sonograph; sonography; uls; ultrasound; v max; vel; vel max; velocity; ven; venous; vmax,Qn
79928-8,pulmonic valve blood flow acceleration time during systole by us.doppler,pv flow accel time sys,,acc; accel; acct1; at; bld flow; card.us; card.us.dicom; cardio; cardiology; dop; duplex; dynamic; echography; flow accel time sys; heart disease; point in time; pv; pvat; qnt; quan; quant; quantitative; random; sonogram; sonograph; sonography; sys; syst; uls; ultrasound,Qn
79938-7,tricuspid valve mean pressure gradient dur diastole by us.doppler+calculated by simplified bernoulli,tv mean press grad dias simp bern,,average; avg; calc; calculation; card.us; card.us.dicom; cardio; cardiology; dias; diast; diastoli; dop; duplex; echography; grad; gradient dia; heart disease; mean grad dia; mean press grad dias; point in time; press grad; qnt; quan; quant; quantitative; random; simp bern; sonogram; sonograph; sonography; tv; tvg mean; uls; ultrasound,Qn
79940-3,aortic valve annulus diameter at end systole by us 2d,av ann es diameter 2d us,,2d us; ao; aov; av; av ann; card.us; card.us.dicom; cardio; cardiology; dia; diam; echography; es; es diameter; heart disease; length; point in time; qnt; quan; quant; quantitative; random; sonogram; sonograph; sonography; sys; syst; uls; ultrasound; ultrasound - 2-dimensional,Qn
7994-7,rickettsia sp ab [units/volume] in serum,rickettsia ab ser-acnc,rickettsia sp ab qn (s),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; id; infectious disease; infectiousdisease; microbiology; point in time; qnt; quan; quant; quantitative; random; ricket; rickettsial; serum; species; spp; sr,Qn
79975-9,left atrial minor axis at end systole [length] by us 2d,la es minor axis 2d us,,2d us; atrial; card.us; card.us.dicom; cardiac; cardio; cardiology; echography; es; es minor axis; heart disease; hrt; l; la; length; lt; point in time; qnt; quan; quant; quantitative; random; sax; short axis; sonogram; sonograph; sonography; sys; syst; uls; ultrasound; ultrasound - 2-dimensional,Qn
79981-7,left atrial end-systolic volume by us.2d+calculated by biplane area-length method,la es vol biplane area-length,,2d us; atrial; calc; calculation; card.us; card.us.dicom; cardiac; cardio; cardiology; echography; es vol; heart disease; hrt; l; la; laa; lt; point in time; qnt; quan; quant; quantitative; random; sonogram; sonograph; sonography; uls; ultrasound; ultrasound - 2-dimensional; vol; volume,Qn
79992-4,left ventricular ejection fraction by us.2d.a2c+calculated by single plane method of disks,lv ef a2c mod,,2d us; a2c mod; calculated; card.us; card.us.dicom; cardiac; cardio; cardiology; echography; ef; frac; fract; fractionation; fractions; heart disease; hrt; hrt ventr; l; lt; lv; lvef; percent; point in time; qnt; quan; quant; quantitative; random; sonogram; sonograph; sonography; uls; ultrasound; ultrasound - 2-dimensional; ventricular; volfr; volume fraction,Qn
80010-2,left ventricular minor axis at end diastole (by us 2d)/body surface area,lv ed minor axis (2d us)/bsa,,2d us; bdy surface; bod; bodies; bsa; card.us; card.us.dicom; cardiac; cardio; cardiology; dias; diast; diastoli; echography; ed; ed minor axis; heart disease; hrt; hrt ventr; l; lt; lv; lvad; point in time; qnt; quan; quant; quantitative; random; sax; short axis; sonogram; sonograph; sonography; surf; uls; ultrasound; ultrasound - 2-dimensional; ventricular,Qn
80041-7,left ventricular basal septum time to max tissue velocity during systole by us.tissue doppler,lv.basal sept time to s vmax tdi,,card.us; card.us.dicom; cardiac; cardio; cardiology; echography; heart disease; hrt; hrt ventr; l; largest; lt; lv; lv.basal sept; maximal; maximum; peak; point in time; qnt; quan; quant; quantitative; random; sonogram; sonograph; sonography; sys; syst; tdi; time to s vmax; uls; ultrasound; v sys; vel; ventricular,Qn
80068-0,mitral valve maximum orifice area during diastole by us.2d.psax+measured by planimetry,mv max orifice area diastole planimetry,,2d us; card.us; card.us.dicom; cardio; cardiology; dias; dias.max; diast; diastoli; echography; heart disease; largest; max orifice area dias; maximal; maximum; mv; mva; peak; point in time; qnt; quan; quant; quantitative; random; sonogram; sonograph; sonography; uls; ultrasound; ultrasound - 2-dimensional; us.2d.psax+planimetry,Qn
80073-0,mitral valve mean pressure gradient dur diastole by us.doppler+calculated by simplified bernoulli,mv mean press grad dias simp bern,,average; avg; calc; calculation; card.us; card.us.dicom; cardio; cardiology; dias; diast; diastoli; dop; duplex; echography; grad; gradient dia; heart disease; mean grad dia; mean press grad dias; mv; mvg; point in time; press grad; qnt; quan; quant; quantitative; random; simp bern; sonogram; sonograph; sonography; uls; ultrasound,Qn
80097-9,glycyl-4-hydroxyproline [moles/volume] in serum or plasma,glycyl-4-oh-proline serpl-scnc,glycyl-4-hydroxyproline [moles/vol],chemistry; esoteric; glycine hydroxyproline dipeptide; glycyl-4-oh-proline; glycylhydroxyproline; gly-hyp; hydroxylproline; hydroxyprol; hydroxy-proline; hydrxprol; hydrxproln; hydrxyprln; hyp; level; ohpro; oh-proline; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; substance concentration,Qn
80107-6,stereopsis by randot,stereopsis randot,,eye; eye.px; eye.px.nei; eyeball; occular; oculis; ophthalmologic; ophthalmology; ophtho; ophthy; optic globe; ordinal; point in time; ql; qual; qualitative; random; screen; vision; visual,Ord
80134-0,amphetamine [mass/mass] in hair by confirmatory method,amphet hair cfm-mcnt,amphetamine confirm (hair) [mass/mass],addiction; amph; amphet; amphetam; amphetamines; ampht; cfm; cnfr; cnfrm; conf; confirmation; confirmatory; drug/toxicology; drugs; drugs of abuse; gcms; har; illicit; lc/ms/ms; mass content; point in time; potentialforabuse; qnt; quan; quant; quantitative; random; speed,Qn
80136-5,antihistamines [presence] in blood by screen method,antihistamines bld ql scn,antihistamines screen ql (bld),antihistamine; anti-histamine; anti-histamines; blood; drug/toxicology; drugs; ordinal; point in time; pr; ql; qual; qualitative; random; scn; scr; screen; scrn; wb; whole blood,Ord
80143-1,atazanavir [mass/volume] in cord blood,atazanavir bldco-mcnc,atazanavir (bldco) [mass/vol],atv; blood - (umbilical) cord; cord (umbilical) blood; cord bld; cord blood; drug/toxicology; drugs; level; mass concentration; point in time; qnt; quan; quant; quantitative; random; reyataz,Qn
80177-9,s-adenosylmethionine [moles/volume] in cerebral spinal fluid,same csf-scnc,s-adenosylmethionine (csf) [moles/vol],"adenosylmethionine; cerebral spinal fluid; cerebrospinal fl; chemistry; dementias; depression, emotional; level; point in time; qnt; quan; quant; quantitative; random; s prime; s-adenosyl methionine; same; sam-e; sammy; spinal fl; spinal fld; spinal flu; spinal fluid; substance concentration",Qn
80202-5,clotting time of depleted plasma with 1:1 phospholipid by coagulation assay --after addition of factor x activated,ppl p fxa ppp,clotting time of depleted plasma with 1:1 phospholipid after addition of factor x activated coag (ppp),activ; clot; clottable; coagulation; coagulation assay; coagulation time; fac; fact; factor 10; fx; hematology; heme; i; lipid; p fxa; phoslpd; phospholipids; pl; plas; platelet poor plasma; point in time; ppl; procoagulant phospholipids; qnt; quan; quant; quantitative; random; rate; r-time; tilt tube,Qn
80216-5,"social, psychological and behavioral observations - 2015 edition health it certification criteria set",soc psych behav 2015 set,,clin; meaningful use; mu3; pan; panel; panel.clinical; panl; pnl; point in time; random; soc psych behav 2015 set,-
80220-7,nmdar igg ab [titer] in cerebral spinal fluid by immunofluorescence,nmdar igg titr csf if,nmdar igg if (csf) [titer],abs; aby; acif; antby; anti; antibodies; antibody; anticomplement immunofluorescence; asp; aspartic acid; autoantibodies; autoantibody; cerebral spinal fluid; cerebrospinal fl; dextro; dilution factor; dilution factor (titer); encephalitis; fa; fluorescent antibody; fluoresent; ifa; immune fluorescence; immune globulin g; immunoflour; immunofluor; immunofluorescence; immunoglobulin g; nmda receptor; nmdar; n-methylaspartate receptors; n-methyl-d-aspartic acid; point in time; random; rec; recept; receptors; recp; recptr; serology; smqn; spinal fl; spinal fld; spinal flu; spinal fluid; time resolved fluorescence; titer; titered; titre; trf; ttr,SemiQn
80241-3,coronary stent expansion time,cor stent expan time,,angio device; card.proc; cardio; cardiology; cor stent expan time; heart disease; point in time; qnt; quan; quant; quantitative; random,Qn
80248-8,posterolateral branch from right coronary artery [presence] on angiogram,r-plb pr on angio,,ang; angio; angm; card.proc; cardio; cardiology; coronary aa; heart; heart disease; ordinal; point in time; pr; ql; qual; qualitative; r; random; r-plb; rt; screen,Ord
80250-4,additional first diagonal artery [presence] on angiogram,d1a pr on angio,,ang; angio; angm; card.proc; cardio; cardiology; coronary aa; d1a; heart; heart disease; ordinal; point in time; pr; ql; qual; qualitative; random; screen,Ord
80259-5,gastrointestinal assessment panel,gi assessment pnl,,gi; gi assess; gi assessment pnl; h+p; p prime; pan; panel.h&p; panl; pnl; point in time; random,-
80267-8,bowel sounds quality by auscultation,bowel sounds qual by auscultation,,ausc; gastro; gastroenterology; gi; h+p; h+p.px; nominal; p prime; point in time; random; typ,Nom
80277-7,heart murmur assessment panel,murmur assessment pnl,,cvs; h+p; murmur assessment pnl; p prime; pan; panel.h&p; panl; pnl; point in time; random,-
80306-4,glossopharyngeal nerve (cn ix) exam,cn ix exam,,cn ix exam; finding; findings; h+p; h+p.px; ordinal; p prime; point in time; ql; qual; qualitative; random; screen,Ord
80307-2,vagus nerve (cn x) exam,cn x exam,,cn x exam; finding; findings; h+p; h+p.px; ordinal; p prime; point in time; ql; qual; qualitative; random; screen,Ord
80311-4,pupil shape [shape] of left pupil,pupil shape shape l pupil,,h+p; h+p.px; l; l pupil; lt; nominal; p prime; point in time; random,Nom
80317-1,pain assessment [interpretation],pain assessment imp,,h+p; h+p.px; impression; impression/interpretation of study; impressions; interp; interpretation; ordinal; p prime; point in time; ql; qual; qualitative; random; screen,Ord
80323-9,involuntary movements,invol movements,,finding; findings; h+p; h+p.px; invol movements; nominal; p prime; point in time; random,Nom
80333-8,other elements in urine,other elements ur,,h+p; h+p.px; nominal; othr; p prime; point in time; random; typ; ua; ur; urn,Nom
80357-7,cause of death record axis code [automated],,,auto; automated detection; elec; elect; electr; finding; findings; nominal; point in time; random; survey; survey.cdc,Nom
80359-3,cause of death.underlying [manual],,,finding; findings; manl; nominal; point in time; random; survey; survey.cdc,Nom
80360-1,chlamydia trachomatis+neisseria gonorrhoeae rrna [presence] in urine by naa with probe detection,c trach+gc rrna ur ql naa+probe,c. trachomatis+n. gonorrhoeae rrna naa+probe ql (u),3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; c trac; c trach; c trach+gc; c tracho; c trachomatis; chlam; chlam trac; chlamid; ct; ct/gc; dna nucleic acid probe; dna probe; gc; gen-probe; gono; gonorrhea; id; infectious disease; infectiousdisease; lat; lcr; lgv; ligase chain reaction; ligation-activated transcription; lymphogranuloma venereum; microbiology; n gonorrhoea; n gonorrhoeae; naa+probe; naat; nasba; nucleic acid sequence based analysis; ordinal; pcr; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; ribosomal rna; screen; sda; strand displacement amplification; tma; trachoma; transcription mediated amplification; ua; ur; urn,Ord
80386-6,bladder tumor ag [presence] in urine by rapid immunoassay,bladder tumor ag ur ql ia.rapid,bladder tumor ag ia.rapid ql (u),antigen; antigens; bt; bta; eia; elfa; elisa; enzyme immunoassay; iaa; meia; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serology; suds; tumor marker; ua; ur; urn,Ord
80391-6,level of care [type],level of care type,,deeds; emergency department; emergency department (deeds); levels; levl; lv; lvl; nominal; point in time; random; typ,Nom
80394-0,emergency management incident type,em incident type,,deeds; em incident type; emergency department; emergency department (deeds); nominal; point in time; random; typ,Nom
80395-7,date of gestational age estimate,date of ga estimate,,clin; date of ga estimate; ga; gest; gestation; point in time; prenatal; qnt; quan; quant; quantitative; random,Qn
80400-5,testing facility panel,testing facility pnl,,clin; esrd; facility pnl; pan; panel.clinical; panl; pnl; point in time; random; testing facility pnl,-
8041-6,treponema pallidum ab [presence] in serum by hemagglutination,t pallidum ab ser ql ha,t. pallidum ab ha ql (s),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; hatts; hemagglutination; id; iha; infectious disease; infectiousdisease; mha-tp; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; sr; syphilis; t pallidum; tpha; treponemal,Ord
80430-2,past employer address,past employer addr,,address; admin; admin.patient; last; nominal; point in time; random,Nom
80444-3,fluid intake panel,fluid in pnl,,diet; dietetics; fld; fluid in pnl; nutrition; pan; panl; pnl,-
80464-1,protein servings 24 hour measured,protein servings 24h nrate measured,,1 day; 24 hours; 24hr; count/time; diet; dietetics; nrate; number rate; number rate = count/time; nutrition; pr; prot; qnt; quan; quant; quantitative,Qn
80489-8,caffeine intake 24 hour estimated,caffeine intake 24h est,,1 day; 24 hours; 24hr; caffn; diet; dietetics; est; estimation; mass rate; mrate; nutrition; qnt; quan; quant; quantitative,Qn
80513-5,mr bone marrow w contrast iv,mr bone mar w contr iv,,blood flow; blood supply; bm; bon; c; contr; contra; contrst; document; finding; findings; imaging; misc; miscellaneous; mitral regurgitation maximum velocity; mri; other; point in time; rad; radiology; random; spec; to be specified in another part of the message; unspecified; w contr iv; wc,Doc
80536-6,methylenedioxyethylamphetamine [mass/volume] in blood,mdea bld-mcnc,methylenedioxyethylamphetamine (bld) [mass/vol],addiction; blood; drug/toxicology; drugs; drugs of abuse; illicit; level; mass concentration; mdea; point in time; potentialforabuse; qnt; quan; quant; quantitative; random; wb; whole blood,Qn
80539-0,morphine [mass/mass] in hair,morphine hair-mcnt,morphine (hair) [mass/mass],addiction; c260; drug/toxicology; drugs; drugs of abuse; har; illicit; mass content; morphine sulfate; ms; mso4; omph; point in time; potentialforabuse; qnt; quan; quant; quantitative; random,Qn
80541-6,nicotine [mass/mass] in hair,nicotine hair-mcnt,nicotine (hair) [mass/mass],addiction; drug/toxicology; drugs; drugs of abuse; habitrol; har; illicit; mass content; nicoderm; nictoine; point in time; potentialforabuse; qnt; quan; quant; quantitative; random,Qn
80544-0,nortriptyline [mass/volume] in dbs,nortrip dbs-mcnc,nortriptyline (dbs) [mass/vol],amitriptyline metabolite; aventyl; blood; dbs; dried blood spot; drug/toxicology; drugs; filter paper; fp; level; mass concentration; nortrip; nortriptylene; nortriptyln; pamelor; point in time; qnt; quan; quant; quantitative; random; wb; whole blood,Qn
80548-1,sirolimus [mass/volume] in dbs,sirolimus dbs-mcnc,sirolimus (dbs) [mass/vol],blood; dbs; dried blood spot; drug/toxicology; drugs; filter paper; fp; level; mass concentration; point in time; qnt; quan; quant; quantitative; random; rapamune; rapamycin; srl; wb; whole blood,Qn
80554-9,zopiclone [mass/volume] in serum or plasma,zopiclone serpl-mcnc,zopiclone [mass/vol],addiction; drug/toxicology; drugs; drugs of abuse; illicit; imovane; level; mass concentration; pl; plasma; plsm; point in time; potentialforabuse; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; zopliclone,Qn
80576-2,cardiac surgery education note,cardiac surgery educ note,,cardio; cardiology; doc.ont; document; educ note; encounter; evaluation and management; evaluation and management note; finding; findings; heart disease; notes; point in time; random; surg; visit note,Doc
80596-0,rhinovirus 5' utr rna [presence] in nasopharynx by naa with probe detection,rhinovirus 5' utr rna nph ql naa+probe,rhinovirus 5' utr rna naa+probe ql (nph),3 self-sustaining sequence replication; 3sr sr; 5 prime untranslated region; 5 utr; 5-utr; amplif; amplification; amplified; dna nucleic acid probe; dna probe; hrv; id; infectious disease; infectiousdisease; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; naa+probe; naat; nasba; nasopharynx; nucleic acid sequence based analysis; ordinal; pcr; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; rhino virus; rhv; ribonucleic acid; screen; sda; strand displacement amplification; tma; transcription mediated amplification,Ord
806-0,leukocytes [#/volume] in cerebral spinal fluid by manual count,wbc # csf manual,wbc manual cnt (csf) [#/vol],#; abs; absolute; absolutes; cerebral spinal fluid; cerebrospinal fl; cnt; count; count/volume; ct; hematology/cell counts; leuc; leuk; leukocyte; lkcs; manl; neuro; neurology; number concentration; number concentration (count/vol); point in time; qnt; quan; quant; quantitative; random; spinal fl; spinal fld; spinal flu; spinal fluid; wbc; wbcs; white blood cell; white blood cells,Qn
80605-9,desacetylrifampicin [mass/volume] in dbs,desacetylrifampicin dbs-mcnc,desacetylrifampicin (dbs) [mass/vol],25-dac-rif; 25-deacetylrifampicin; 25-desacetyl-rifampicin; blood; dac-rif; dbs; dried blood spot; drug/toxicology; drugs; filter paper; fp; level; mass concentration; point in time; qnt; quan; quant; quantitative; random; rifampicin; wb; whole blood,Qn
80620-8,zika virus neutralizing antibody [titer] in serum by neutralization test,zikv nab titr ser nt,zikv neut ab neut test (s) [titer],abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; conventional virus neutralization test; cvnt; dilution factor; dilution factor (titer); id; infectious disease; infectiousdisease; microbiology; nab; neutralization; neutralization test; nt; point in time; random; serum; serum virus neutralization; smqn; sr; svn; titer; titered; titre; ttr; virus neutralization test; vnt; zika virus nab; zikv,SemiQn
8062-2,cardiolipin ab [units/volume] in serum,cardiolipin ab ser-acnc,cardiolipin ab qn (s),abs; aby; aca; acl; antby; anti; antibodies; antibody; anticardiolipin; arbitrary concentration; autoantibodies; autoantibody; cardio; cardiolip; cardiolipn; cardiolpn; cl; coagulation; hematology; heme; point in time; qnt; quan; quant; quantitative; random; serum; sr,Qn
80642-2,floxacillin free [mass/volume] in serum or plasma,floxacillin free serpl-mcnc,floxacillin free [mass/vol],drug/toxicology; drugs; flopen; floxacillin free; floxapen; flucloxacillin; fr; id; infectious disease; infectiousdisease; ladropen; level; mass concentration; non-protein bound; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
80643-0,gadolinium [mass/mass] in tissue,gadolinium tiss-mcnt,gadolinium (tiss) [mass/mass],"drug/toxicology; drugs; gado; gadolium; gd; mass content; point in time; qnt; quan; quant; quantitative; random; tissue; tissue, unspecified",Qn
80681-0,cryptosporidium parvum+hominis oocyst wall protein cowp gene [presence] in stool by naa with probe detection,c parvum+hominis cowp stl ql naa+probe,c. parvum+hominis oocyst wall protein cowp gene naa+probe ql (stl),3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; bowel movement; c parvum; c parvum+hominis; c parvum+hominis cowp; crypt; crypto; cryptosporidiosis; dna nucleic acid probe; dna probe; faecal; faeces; fecal; feces; gastro; gastroenterology; gi; id; infectious disease; infectiousdisease; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; naa+probe; naat; nasba; nucleic acid sequence based analysis; ordinal; pcr; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; prot; qbr; ql; qual; qualitative; random; screen; sda; stl; stool = fecal; strand displacement amplification; tma; transcription mediated amplification,Ord
80682-8,entamoeba histolytica 18s rrna [presence] in stool by naa with probe detection,e histolytica 18s rrna stl ql naa+probe,e. histolytica 18s rrna naa+probe ql (stl),3 self-sustaining sequence replication; 3sr sr; ameba; amebiasis; amebic; amoeba; amplif; amplification; amplified; bowel movement; dna nucleic acid probe; dna probe; e histolyt; e histolytica; e histolytica 18s; faecal; faeces; fecal; feces; gen-probe; id; infectious disease; infectiousdisease; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; naa+probe; naat; nasba; nucleic acid sequence based analysis; ordinal; pcr; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; ribosomal rna; screen; sda; stl; stool = fecal; strand displacement amplification; tma; transcription mediated amplification,Ord
80695-0,hiv 1 proviral dna genotype in mononuclear cells from whole blood,hiv 1 proviral dna gentyp bld mc doc,hiv 1 proviral dna genotype genotyping doc (bld mc),aids; antibiotic susceptibilities; blood; deoxyribonucleic acid; document; finding; findings; genotype; genotypic; gentyp; hiv type 1; hiv type i; hiv1; hiv1 proviral dna; hiv1 proviral dna genotype; human immunodeficiency virus; i; id; infectious disease; infectiousdisease; pbmc; peripheral blood mononuclear cells; point in time; random; wb; whole blood,Doc
8069-7,epidermis ab [titer] in serum,epidis ab titr ser,epidermis ab (s) [titer],abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; dilution factor; dilution factor (titer); epidermal; epidis; point in time; random; serology; serum; smqn; sr; titer; titered; titre; ttr,SemiQn
80708-1,cd27-cd45ra- cells/cd3+cd4+ (t4 helper) cells in blood,cd27-cd45ra- cells/cd3+cd4+ nfr bld,cd27-cd45ra- cells/cd3+cd4+ (t4 helper) cells (bld),2h4; blood; cd27 cells; cd27- cells; cd27+cd45ra- cells; cd27+cd45ra+ cells; cd27-cd45ra- cells; cd27-cd45ra+ cells; cd3 cells; cd3+cd4+ cells; cd3-cd4+; cd4+ t cells; cell; cell markers; cells.cd27+; cellularity; helper t cells; inducer t cells; l3t4; leu18; leu-18; leu3; leu-3; leu4; leu-4; number fraction; percent; point in time; qnt; quan; quant; quantitative; random; s152; t14; t3; t4; t-4; t4 helper/inducer cells; w3/25; wb; whole blood,Qn
80709-9,cd27-cd45ra+ cells/cd3+cd4+ (t4 helper) cells in blood,cd27-cd45ra+ cells/cd3+cd4+ nfr bld,cd27-cd45ra+ cells/cd3+cd4+ (t4 helper) cells (bld),2h4; blood; cd27 cells; cd27- cells; cd27+cd45ra- cells; cd27+cd45ra+ cells; cd27-cd45ra- cells; cd27-cd45ra+ cells; cd3 cells; cd3+cd4+ cells; cd3-cd4+; cd4+ t cells; cell; cell markers; cells.cd27+; cellularity; helper t cells; inducer t cells; l3t4; leu18; leu-18; leu3; leu-3; leu4; leu-4; number fraction; percent; point in time; qnt; quan; quant; quantitative; random; s152; t14; t3; t4; t-4; t4 helper/inducer cells; w3/25; wb; whole blood,Qn
80723-0,b-cell cd27 and igd subsets [interpretation] in blood narrative,b-cell cd27 + igd subsets bld-imp nar,b-cell cd27 and igd subsets nar (bld) [interp],b cell; b-all; b-cell acute lymphoblastic leukemia; b-cell cd27 + igd subsets; bcells; blood; cell markers; immune globulin d; immunoglobulin d; impression; impression/interpretation of study; impressions; interp; interpretation; narrative; point in time; random; report; s152; t14; wb; whole blood,Nar
80736-2,blood banking and transfusion medicine consult note,bld bnk+trans med consult note,,bld bnk+trans med; blood conservation; consult note; doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; notes; point in time; random; tx; visit note,Doc
80744-6,colon and rectal surgery plan of care note,col+rec surg plan of care note,,care plan; col+rec surg; doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; notes; point in time; random; surg; treatment plan; visit note,Doc
80761-0,neurology plan of care note,neurology plan of care note,,care plan; doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; neuro; neurology; notes; point in time; random; treatment plan; visit note,Doc
8076-2,jo-1 extractable nuclear ab [presence] in serum,ena jo1 ab ser ql,jo-1 extractable nuclear ab ql (s),abs; aby; ana; anf; antby; anti; antibodies; antibody; antinuclear antibody; autoantibodies; autoantibody; ena; ena jo1; histidyl-trna synthease; i; na; nuc; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serology; serum; sr,Ord
80764-4,pain medicine plan of care note,pain medicine plan of care note,,care plan; doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; notes; point in time; random; treatment plan; visit note,Doc
80769-3,oral and maxillofacial surgery plan of care note,oms plan of care note,,care plan; doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; notes; oms; point in time; random; surg; treatment plan; visit note,Doc
80777-6,primary care plan of care note,primary care plan of care note,,care plan; continuity assessment record and evaluation; doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; notes; point in time; random; treatment plan; visit note,Doc
80788-3,social worker plan of care note,sw plan of care note,,care plan; doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; notes; point in time; random; social work; sw; treatment plan; visit note,Doc
80795-8,pulmonary initial evaluation note,pulmonary disease initial eval note,,assessment; dis; diseases; doc.ont; document; dz; encounter; eval; eval note; evaluation and management; evaluation and management note; finding; findings; h&p; history and physical; initial eval note; lung; notes; point in time; pulmonary; pulmonology; random; respiratory; respirology; visit note,Doc
80797-4,pharmacology plan of care note,pharmacology plan of care note,,care plan; doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; notes; pharmacy; point in time; random; treatment plan; visit note,Doc
80800-6,surgical oncology checklist,surg onc checklist,,cancer; doc.ont; document; finding; findings; general surgical oncology; oncology; point in time; random; surg; surg onc,Doc
80829-5,pepsin a+pepsinogen a [interpretation] in lower respiratory specimen narrative,pepsina+pepsinogena lower resp-imp,pepsin a+pepsinogen a nar (lower resp) [interp],"breathing; chemistry; impression; impression/interpretation of study; impressions; interp; interpretation; k213; low; lower resp; lungs; narrative; nsus s pepsin, swine; pepsina+pepsinogena; pg; point in time; random; report; rk213; rs; spec; total pepsinogens",Nar
80837-8,us for multiple gestation pregnancy with fetal abnormality,us mult gest w fet abnl,,coreplaybook; document; echography; fetal; finding; findings; gestation; gestations; gravida; gyn; gynecology; imaging; mult; mult gest w fet abnl; multi; ob; obgyn; obstetrics; pelvic; pelvis+fetus; playbook; point in time; pregnancies; radiology; random; sonogram; sonograph; sonography; uls; ultrasound,Doc
80845-1,deprecated us guidance for core needle biopsy of breast - left,deprecated us brst-l cn bx guide,,brst; brst-l; bx; cn; cn bx; cnb; coreplaybook; document; echography; finding; findings; guid; guide; guided; gyn; gynecology; imaging; l; large needle; lt; ndl; ob; obgyn; obstetrics; playbook; point in time; radiology; random; sonogram; sonograph; sonography; uls; ultrasound,Doc
80848-5,us guidance for fine needle biopsy of breast - right,us guided brst-r fn bx,,brst; brst-r; bx; coreplaybook; document; echography; finding; findings; fn bx; guid; guide; guided; gyn; gynecology; imaging; ndl; ob; obgyn; obstetrics; perc; playbook; point in time; r; radiology; random; rt; sonogram; sonograph; sonography; uls; ultrasound,Doc
8085-3,neutrophil cytoplasmic ab.perinuclear [units/volume] in serum,p-anca ser-acnc,neutrophil cytoplasmic ab.perinuclear qn (s),acna; acpa; anca; arbitrary concentration; cytopl; cytoplas; granulocyte ab; granulocyte nucleus ab; neut; neutr; neutrophils; nsna; panca; p-anca; perinuclear anca; pmn; pnm; point in time; qnt; quan; quant; quantitative; random; serology; serum; sr; vasculitis,Qn
80882-4,us guidance of unspecified body region-- during surgery,us guided guide--in surg,,coreplaybook; document; echography; finding; findings; guid; guide; guided; imaging; in surg; intra operative; intraop; intraoperative; misc; miscellaneous; other; playbook; point in time; radiology; random; sonogram; sonograph; sonography; spec; surg; to be specified in another part of the message; uls; ultrasound; unspecified,Doc
80892-3,heparin unfractionated [units/volume] in blood by heparin protamine titration,ufh bld hpt-acnc,heparin unfractionated heparin protamine titration qn (bld),arbitrary concentration; blood; coagulation; hematology; heme; hep; hepar; heparn; hpt; point in time; qnt; quan; quant; quantitative; random; ufh; wb; whole blood,Qn
80901-2,paternal information narrative,paternal info,,father; finding; findings; h+p; h+p.hx; narrative; p prime; point in time; random; report,Nar
80903-8,birth certificate id,,,birth cert id; ident; identifier; no; nominal; num; point in time; random; survey; survey.cdc,Nom
80957-4,ceftriaxone free [mass/volume] in serum or plasma,ceftriaxone free serpl-mcnc,ceftriaxone free [mass/vol],c9; ceftriaxone free; drug/toxicology; drugs; fr; level; mass concentration; non-protein bound; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; rocephin; rocj; serp; serpl; serplas; serum; serum or plasma; sr,Qn
80983-0,chloride intake 24 hour measured,chloride intake 24h measured,,1 day; 24 hours; 24hr; cl; cl-; io_intake_salts+calories; mass rate; mrate; qnt; quan; quant; quantitative,Qn
80986-3,cardiac arrest within 24 hours prior to procedure,cardiac arrest 24 hours prior to proc,,1 day; 24 hours; 24hr; cardiac arrest 24h prior to proc; h+p; h+p.hx; history; ordinal; p prime; ql; qual; qualitative; screen,Ord
80987-1,cardiogenic shock within 24 hours prior to procedure,cardiogenic shock 24 hours pre proc,,1 day; 24 hours; 24hr; cardiogenic shock 24h prior to proc; h+p; h+p.hx; history; ordinal; p prime; ql; qual; qualitative; screen,Ord
81001-0,timi grade coronary artery segment --post procedure,timi grade p procedure,,after; ang; angio; angm; card.proc; cardio; cardiology; cor aa seg; coronary aa; heart; heart disease; ordinal; p procedure; point in time; pst; ql; qual; qualitative; random; scale; screen,Ord
81006-9,magnesium intake 24 hour measured,magnesium intake 24h measured,,1 day; 24 hours; 24hr; io_intake_salts+calories; mag; magnes; mass rate; mg; mrate; qnt; quan; quant; quantitative,Qn
81010-1,potassium intake 24 hour estimated,potassium intake 24h est,,1 day; 24 hours; 24hr; est; estimation; io_intake_salts+calories; k; k+; mass rate; mrate; potass; qnt; quan; quant; quantitative,Qn
81021-8,cholesterol intake 24 hour estimated,cholesterol intake 24h est,,1 day; 24 hours; 24hr; chol; choles; cholest; cholesterol total; cholesterols; diet; dietetics; est; estimation; lipid; mass rate; mrate; nutrition; qnt; quan; quant; quantitative,Qn
81027-5,copper intake 24 hour estimated,copper intake 24h est,,1 day; 24 hours; 24hr; cu; diet; dietetics; est; estimation; mass rate; mrate; nutrition; qnt; quan; quant; quantitative,Qn
81031-7,alpha-linoate+linoleate intake 24 hour estimated,alpha-linoate+linoleate intake 24h est,,"1 day; 24 hours; 24hr; alfa; c18:2w6; cis-9, cis-12-octadecadienoate; cis-9, cis-12-octadecadienoic acid; diet; dietetics; efa; essential fatty acid; essential fatty acids; est; estimation; linoleic acid; mass rate; mrate; nutrition; qnt; quan; quant; quantitative",Qn
81043-2,leucine intake 24 hour estimated,leucine intake 24h est,,1 day; 24 hours; 24hr; diet; dietetics; est; estimation; leu; mass rate; mrate; nutrition; qnt; quan; quant; quantitative,Qn
81044-0,leucine intake 24 hour measured,leucine intake 24h measured,,1 day; 24 hours; 24hr; diet; dietetics; leu; mass rate; mrate; nutrition; qnt; quan; quant; quantitative,Qn
81047-3,valine intake 24 hour estimated,valine intake 24h est,,1 day; 24 hours; 24hr; diet; dietetics; est; estimation; mass rate; mrate; nutrition; qnt; quan; quant; quantitative; val,Qn
81050-7,sucrose intake 24 hour measured,sucrose intake 24h measured,,1 day; 24 hours; 24hr; diet; dietetics; mass rate; mrate; nutrition; qnt; quan; quant; quantitative; sucro,Qn
81060-6,insoluble fiber intake 24 hour estimated,fiber insol intake 24h est,,1 day; 24 hours; 24hr; diet; dietetics; est; estimation; fiber insol intake; fibers; mass rate; mrate; nutrition; qnt; quan; quant; quantitative; roughage,Qn
81066-3,vitamin b9 (folate) intake 24 hour estimated,vit b9 intake 24h est,,1 day; 24 hours; 24hr; diet; dietetics; est; estimation; folacin; folate; folic acid; mass rate; mrate; nutrition; pteroylglutamic acid; qnt; quan; quant; quantitative; vit b9; vit b9 intake; vitamin b9,Qn
81088-7,zinc intake 24 hour measured,zinc intake 24h measured,,1 day; 24 hours; 24hr; diet; dietetics; mass rate; mrate; nutrition; qnt; quan; quant; quantitative; zn,Qn
81095-2,left ventricular myocardial mass/body surface area [mass/area] by us.2d+calculated by devereux method,lv myo mass/bsa 2d devereux,,2d devereux; 2d us; bdy surface; bod; bodies; bsa; calc; calculation; card.us; cardiac; cardio; cardiology; echography; heart disease; hrt; hrt ventr; l; lt; lv; maric; myo mass; point in time; qnt; quan; quant; quantitative; random; sonogram; sonograph; sonography; surf; uls; ultrasound; ultrasound - 2-dimensional; ventricular,Qn
81103-4,leptospira interrogans sv kremastos ab [titer] in serum by agglutination,l inter krema ab titr ser aggl,l. interrogans sv kremastos ab aggl (s) [titer],abs; aby; agg; agglut; agglutination; antby; anti; antibodies; antibody; autoantibodies; autoantibody; dilution factor; dilution factor (titer); id; infectious disease; infectiousdisease; l inter; l inter krema; l interrogans; leptospirosis; microbiology; point in time; random; serum; smqn; sr; titer; titered; titre; ttr,SemiQn
81111-7,murray valley encephalitis virus igg ab [presence] in serum,mvev igg ser ql,mvev igg ql (s),abs; aby; antby; anti; antibodies; antibody; australian encephalitis; autoantibodies; autoantibody; enc; enceph; encephalomyelitis; esoteric; id; immune globulin g; immunoglobulin g; infectious disease; infectiousdisease; microbiology; mvev; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; sr,Ord
81113-3,murray valley encephalitis virus igm ab [presence] in serum,mvev igm ser ql,mvev igm ql (s),abs; aby; antby; anti; antibodies; antibody; australian encephalitis; autoantibodies; autoantibody; enc; enceph; encephalomyelitis; esoteric; id; immune globulin m; immunoglobulin m; infectious disease; infectiousdisease; microbiology; mvev; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; sr,Ord
81115-8,murray valley encephalitis virus ab [titer] in serum,mvev ab titr ser,mvev ab (s) [titer],abs; aby; antby; anti; antibodies; antibody; australian encephalitis; autoantibodies; autoantibody; dilution factor; dilution factor (titer); enc; enceph; encephalomyelitis; esoteric; id; infectious disease; infectiousdisease; microbiology; mvev; point in time; random; serum; smqn; sr; titer; titered; titre; ttr,SemiQn
81121-6,murray valley encephalitis virus ab [presence] in serum,mvev ab ser ql,mvev ab ql (s),abs; aby; antby; anti; antibodies; antibody; australian encephalitis; autoantibodies; autoantibody; enc; enceph; encephalomyelitis; esoteric; id; infectious disease; infectiousdisease; microbiology; mvev; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; sr,Ord
81123-2,coagulation factor vii inhibitor [presence] in platelet poor plasma by coagulation assay,fact vii inhib ppp ql,coagulation factor vii inhibitor coag ql (ppp),clot; clottable; coag; coagulation assay; f7; fac; fact; fact vii; fact vii inhib; factor 7; fvii; hematology; heme; inhib; inhibit; ordinal; plas; platelet poor plasma; point in time; pr; proconvertin; ql; qual; qualitative; random; screen; serum prothrombin conversion accelerator; spca; tilt tube,Ord
81137-2,calcium intake 24 hour estimated,calcium intake 24h est,,1 day; 24 hours; 24hr; ca; cal; est; estimation; io_intake_salts+calories; mass rate; mrate; qnt; quan; quant; quantitative,Qn
81143-0,galactokinase [enzymatic activity/mass] in red blood cells,galactokinase rbc-ccnt,galactokinase (rbc) [catalytic activity/mass],catalytic content; chemistry; erythrocytes; point in time; qnt; quan; quant; quantitative; random; red blood cells; red blood corpusles,Qn
81147-1,specimen source patient identification [interpretation] narrative,spec source id patient-imp,specimen source identification nar [interp],impression; impression/interpretation of study; impressions; interp; interpretation; molecular pathology; molpath; narrative; point in time; random; report; spec; spec source id; srce,Nar
81149-7,zika virus envelope e gene [presence] in amniotic fluid by naa with probe detection,zika e gene amn ql naa+probe,zikv e gene naa+probe ql (amn fld),3 self-sustaining sequence replication; 3sr sr; af; amn; amn fl; amnio; amniotic flu; amniotic fluid; amplif; amplification; amplified; dna nucleic acid probe; dna probe; gyn; gynecology; id; infectious disease; infectiousdisease; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; naa+probe; naat; nasba; nucleic acid sequence based analysis; ob; obgyn; obstetrics; ordinal; pcr; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; screen; sda; strand displacement amplification; tma; transcription mediated amplification; zika e gene; zikv,Ord
81155-4,islet cell 512 ab [moles/volume] in serum,islet cell512 ab ser-scnc,islet cell 512 ab (s) [moles/vol],abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; endocrine; endocrinology; ia2; ia-2; ia2-ab; ica; ica512; ica-512; islet cell512; level; point in time; protein tyrosine phosphatase-like protein ia2; ptp-ia2; qnt; quan; quant; quantitative; random; serology; serum; sr; substance concentration; tyrosine phosphatase,Qn
81171-1,lesser curvature of stomach [length] in specimen,stom.lesser curve spec,lesser curvature of stomach (spec) [length],length; pathology; point in time; qnt; quan; quant; quantitative; random; spec; stom.lesser curve,Qn
81173-7,duodenum [length] in specimen,duodenum length spec,duodenum length (spec) [length],len; length; pathology; point in time; qnt; quan; quant; quantitative; random; spec,Qn
8117-4,cd19 cells/cells in blood,cd19 cells nfr bld,cd19 cells/cells (bld),b cells expressing cd19 as a percent of total lymphocytes; b4; b-4; blood; cd19 cells; cell; cell markers; cellularity; hd-37; leu12; leu-12; number fraction; percent; point in time; qnt; quan; quant; quantitative; random; wb; whole blood,Qn
81174-5,tumor type in stomach cancer by macroscopy,tumor type stomach cancer ql macro,tumor type macroscopy ql (stomach cancer),ca; gastric cancer; gastric cancers; ordinal; pathology; point in time; ql; qual; qualitative; random; screen; tumor-infiltrating immune cells; typ; urothelial carcinoma,Ord
81186-9,gastric cancer pathology panel,gastric cancer path pnl,cancer pathology panel (stomach cancer),ca; cancer path pnl; gastric cancer; gastric cancers; pan; panel.path; panl; path; pathology; pnl; point in time; random,-
81197-6,amino acid intake 24 hour estimated,amino acid intake 24h est,,1 day; 24 hours; 24hr; acd; acids; diet; dietetics; est; estimation; mass rate; mrate; nutrition; qnt; quan; quant; quantitative,Qn
81203-2,fda product label bulk ingredient - animal drug,fda label bulk ingredient - anml drg,,bulk ingredient - anml drg; document.regulatory; drugs; fda label; narrative; report,Nar
81209-9,clomipramine and norclomipramine panel - urine,clomipramine+nor pnl ur,clomipramine and norclomipramine panel (u),anafranil; anofranil; clom; clomip; clomipramine metabolite; clomipramine+nor; clomipramine+nor pnl; desmeth; desmethylclomip; desmethylclomipramine; drug/toxicology; drugs; pan; panel.drug & toxicology; panl; pnl; point in time; random; ua; ur; urn,-
81212-3,clomipramine and norclomipramine panel - specimen,clomipramine+nor pnl spec,clomipramine and norclomipramine panel (specimen),anafranil; anofranil; clom; clomip; clomipramine metabolite; clomipramine+nor; clomipramine+nor pnl; desmeth; desmethylclomip; desmethylclomipramine; drug/toxicology; drugs; misc; miscellaneous; other; pan; panel.drug & toxicology; panl; pnl; point in time; random; spec; to be specified in another part of the message; unspecified,-
81222-2,consultation note - recommended c-cda r2.0 and r2.1 sections,consult note c-cda r2.0+2.1 sections,,congenital dyserythropoietic anaemia; consult note; consult note c-cda r2.0+2.1 sections; encounter; evaluation and management; evaluation and management note; notes; pan; panel; panel.doc; panl; pnl; point in time; random; visit note,-
8122-4,cd3 cells [#/volume] in blood,cd3 cells # bld,cd3 cells (bld) [#/vol],#; abs; absolute; absolutes; blood; cd3 cells; cell; cell markers; cellularity; cnt; count; count/volume; ct; leu4; leu-4; number concentration; number concentration (count/vol); point in time; qnt; quan; quant; quantitative; random; t3; wb; whole blood,Qn
81242-0,enhanced discharge summary - recommended cdp set 1 r1.0 sections,encd discharge sum cdp1 r1.0,,disch; encd discharge sum cdp1 r1.0; i; pan; panel; panel.doc; panl; pnl; point in time; random,-
81243-8,enhanced encounter note - recommended cdp set 1 r1.0 and r1.1 sections,encd encounter nte cdp1 r1.0+1.1,,encd encounter nte cdp1 r1.0+1.1; encounter; evaluation and management; evaluation and management note; i; notes; pan; panel; panel.doc; panl; pnl; point in time; random; visit note,-
81244-6,enhanced procedure note - recommended cdp set 1 r1.0 and r1.1 sections,encd proced nte cdp1 r1.0+r1.1,,encd proced nte cdp1 r1.0+r1.1; encounter; evaluation and management; evaluation and management note; i; notes; pan; panel; panel.doc; panl; pnl; point in time; random; visit note,-
81254-5,genomic allele start-end,gen allele loc id,genomic allele start-end,ident; identifier; molecular pathology; molpath; nominal; point in time; random; started,Nom
81256-0,cosmic [id],cosmic simple var id,cosmic simple variant nom [id],ident; identifier; molecular pathology; molpath; nominal; point in time; random,Nom
81265-1,maximum body temperature reporting period maximum,body temp.max rptperiod max,,bdy temp; bod; bodies; body temp.max; h+p; h+p.hx; largest; maximal; maximum; p prime; peak; qnt; quan; quant; quantitative; report period; temp; temperature,Qn
81273-5,fentanyl and norfentanyl panel - specimen,fentanyl+norfentanyl pnl spec,fentanyl and norfentanyl panel (specimen),actiq; drug/toxicology; drugs; duragesic; durogesic; fenpat; fentanil; fentanyl metabolite; fentanyl+norfentanyl; fentanyl+norfentanyl pnl; misc; miscellaneous; other; pan; panel.drug & toxicology; panl; pnl; point in time; random; spec; sublimaze; to be specified in another part of the message; unspecified,-
81286-7,structural variant [identifier],struct var id,structural variant nom [id],ident; identifier; molecular pathology; molpath; nominal; point in time; random; struct var,Nom
81292-5,simple variant [type],simple var type,simple variant nom,molecular pathology; molpath; nominal; point in time; random; typ,Nom
81294-1,genetic form configuration controls nominal,ref seq coding system pnl,genetic form configuration controls nom,arbitrary; genetics; genomic; molecular pathology; molpath; nominal; point in time; random,Nom
81300-6,structural variant [length],struct var len,structural variant [length],length; molecular pathology; molpath; point in time; qnt; quan; quant; quantitative; random; struct var,Qn
81310-5,carbonic anhydrase 2 ab [presence] in serum by immunoassay,ca 2 ab ser ql ia,carbonic anhydrase 2 ab ia ql (s),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; ca 2; ca 2 ab; eia; elfa; elisa; enzyme immunoassay; iaa; ii; meia; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serology; serum; sr; suds,Ord
81318-8,spermatozoa.normal morphology [#] in semen by automated count,sperm.norm morph smn auto,spermatozoa.normal morphology auto (sem) [#],auto; automated detection; cnt; control; count; ejaculate; elec; elect; electr; fertility testing; genitourinary; gu; number; point in time; qnt; quan; quant; quantitative; random; sem; seminal fluid; smn; smpls; sperm; sperm norm; sperm.norm morph; uro; urology,Qn
81323-8,urine collection associated observations panel - 24 hour urine,urine collection assoc obs pnl 24h ur,urine collection associated observations panel (24h u),1 day; 24 hours; 24hr; assoc; coll; collect; collected; pan; panel.spec; panl; pnl; spec; ua; ur; urine collection assoc obs pnl; urn,-
81331-1,thoughts on tube feeding narrative - reported,thoughts on tube feeding reported,,clin; finding; findings; narrative; point in time; random; report,Nar
81335-2,patient healthcare agent,healthcare agent,,doc.misc; document; finding; findings; misc; point in time; random,Doc
81341-0,circumstances that activate healthcare agent's powers narrative - reported,circum activate agent's powers reported,,circum activate agent's powers; clin; finding; findings; narrative; point in time; random; report; s prime,Nar
81343-6,healthcare agent advisor - reported,healthcare agent advisor reported,,clin; nominal; person name; point in time; random,Nom
81345-1,healthcare agent authority to inspect and disclose specially protected health information narrative - reported,agent auth re protected phi reported,,agent auth re protected phi; clin; finding; findings; narrative; point in time; random; report,Nar
81354-3,prescribed anticipatory medication - reported,prescribed anticipatory medication repor,,clin; finding; findings; nominal; point in time; random,Nom
8136-4,cd71 cells/cells in blood,cd71 cells nfr bld,cd71 cells/cells (bld),blood; cd71 cells; cd71transferrin; cell; cell markers; cellularity; number fraction; percent; point in time; qnt; quan; quant; quantitative; random; t9; transferrin receptor; wb; whole blood,Qn
81366-7,unfinished business narrative - reported,unfinished business reported,,clin; finding; findings; narrative; point in time; random; report,Nar
81368-3,statement of witness [reported],statement of witness witness reported,,clin; finding; findings; narrative; point in time; random; report,Nar
81374-1,notary seal id,notary seal id,,admin; ident; identifier; intradermal; nominal; point in time; random,Nom
81379-0,"goals, preferences, and priorities upon death narrative - reported",gpp upon death reported,,clin; finding; findings; gpp upon death; narrative; point in time; random; report,Nar
8138-0,deprecated cd8 cells/100 cells in blood,deprecated cd8 cells nfr bld,cd8 cells/100 cells (bld),blood; cd8 cells; cell; cell markers; cellularity; gated cells; leu2; leu-2; number fraction; percent; point in time; qnt; quan; quant; quantitative; random; suppressor t cells; t8; t-8; tsuppressor; wb; whole blood,Qn
81382-4,statement of document creator narrative - reported,statement of doc creator reported,,clin; finding; findings; narrative; point in time; random; report; statement of doc creator,Nar
81386-5,mitral valve maximum e-wave velocity/tissue velocity.e-wave.max by us.doppler+tissue doppler,mv e-wave vmax/e-prime vmax dop+tdi,,bld flow; bld flow vel; bld flow.velocity; blood flow.diastolic.early wave.max; card.us; cardio; cardiology; dop; dop+tdi; duplex; dynamic; early wave; echography; e-prime vmax; e-wave; e-wave vmax; heart disease; largest; maximal; maximum; mv; peak; peak e-wave; point in time; qnt; quan; quant; quantitative; random; sonogram; sonograph; sonography; uls; ultrasound; vel; velocity ratio,Qn
81397-2,mitral valve lateral annulus tissue velocity.a-wave.max by us.tissue doppler,mv lat ann a-prime vmax tdi,,a-prime vmax; atrial wave; a-wave; blood flow.diastolic.atrial wave.max; card.us; cardio; cardiology; echography; heart disease; largest; lat; max v; maximal; maximum; mv; mv ann; mv lat ann; peak; peak a-wave; point in time; qnt; quan; quant; quantitative; random; sonogram; sonograph; sonography; tdi; uls; ultrasound; v max; vel; velocity; vmax,Qn
81402-0,left ventricular maximum strain by us 3d,lv max strain 3d us,,3d us; card.us; cardiac; cardio; cardiology; echography; heart disease; hrt; hrt ventr; l; largest; length ratio; lt; lv; max strain; maximal; maximum; peak; point in time; qnt; quan; quant; quantitative; random; sonogram; sonograph; sonography; uls; ultrasound; ventricular,Qn
81404-6,left ventricular maximum radial strain rate during systole by us 2d,lv max radial strain rate sys 2d us,,2d us; arbitrary rate; card.us; cardiac; cardio; cardiology; echography; heart disease; hrt; hrt ventr; l; largest; lt; lv; max radial strain rate sys; max strain rate sys; maximal; maximum; peak; point in time; qnt; quan; quant; quantitative; random; sonogram; sonograph; sonography; sys; sys.max; syst; uls; ultrasound; ultrasound - 2-dimensional; ventricular,Qn
8140-6,amphetamines [presence] in gastric fluid,amphetamines gast ql,amphetamines ql (gast fld),addiction; amph; amphetam; amphetamine; drug/toxicology; drugs; drugs of abuse; gast; gastric contents; gastric fluid; illicit; ordinal; point in time; potentialforabuse; pr; ql; qual; qualitative; random; screen; speed,Ord
81411-1,left ventricular maximum longitudinal strain rate during diastole by us 2d,lv max long strain rate dias 2d us,,2d us; arbitrary rate; card.us; cardiac; cardio; cardiology; dias; dias.max; diast; diastoli; echography; heart disease; hrt; hrt ventr; l; largest; lt; lv; max long strain rate dias; max strain rate dias; maximal; maximum; peak; point in time; qnt; quan; quant; quantitative; random; sonogram; sonograph; sonography; uls; ultrasound; ultrasound - 2-dimensional; ventricular,Qn
81416-0,left ventricular maximum basal rotation [angle] by us 2d,lv max basal rot angle 2d us,,2d us; card.us; cardiac; cardio; cardiology; echography; heart disease; hrt; hrt ventr; l; largest; lt; lv; max basal rot; maximal; maximum; peak; point in time; qnt; quan; quant; quantitative; random; sonogram; sonograph; sonography; uls; ultrasound; ultrasound - 2-dimensional; ventricular,Qn
81422-8,gata1 gene exon 2 targeted mutation analysis in blood or tissue by sequencing,gata1 exon 2 mut anl bld/t seq,gata1 gene exon 2 targeted mutation analysis sequencing doc (bld/tiss),"blood; document; finding; findings; gata1 exon 2; genetics; heredity; heritable; high-throughput sequencing; hts; ii; inherited; megakaryoblastic leukemia; molecular pathology; molpath; molpath.mutations; mut; mut anl; mutations; next generation sequencing; ngs; point in time; random; tissue; tissue, unspecified; transient myeloproliferative disorder; wb; whole blood; whole blood or tissue; x-linked anemia",Doc
81434-3,spasm symptom induced,spasm symp induced,,card.proc; cardio; cardiology; finding; findings; heart disease; ordinal; point in time; ql; qual; qualitative; random; screen; spasm symp induced; sx,Ord
81444-2,maximum inspiratory pressure respiratory system --pre bronchodilation,max insp press pre bd respiratory,,before; breathing; largest; lung; lungs; max insp press; maximal; maximum; peak; point in time; pre bd; press.max; pressure; pressure max; pulmonary; pulmonology; qnt; quan; quant; quantitative; random; respiratory; rs,Qn
81448-3,inspiratory gas flow.max respiratory system airway --pre bronchodilation,insp gas flow.max pre bd airway,,before; breathing; dynamic; flow; gases; insp gas flow; insp gas flow.max; largest; lung; lungs; maximal; maximum; peak; point in time; pre bd; pulmonary; pulmonology; qnt; quan; quant; quantitative; random; respiratory; rs; volume rate; vrate,Qn
81450-9,total lung capacity --pre bronchodilation,tlc pre bd,,before; breathing; lung; lungs; point in time; pre bd; pulmonary; pulmonology; qnt; quan; quant; quantitative; random; respiratory; rs; tc; tlc; tot; totl; volume,Qn
81460-8,i have had trouble forming thoughts in past 7 days [promis],,,finding; findings; last; ordinal; patient reported outcomes information system; promise; ql; qual; qualitative; screen; survey; survey.promis,Ord
81470-7,i have had trouble recalling the name of an object while talking to someone in past 7 days [promis],,,finding; findings; last; ordinal; patient reported outcomes information system; promise; ql; qual; qualitative; screen; survey; survey.promis,Ord
81476-4,my reactions in everyday situations have been slow in past 7 days [promis],,,finding; findings; last; ordinal; patient reported outcomes information system; promise; ql; qual; qualitative; screen; survey; survey.promis,Ord
81479-8,i have had to work harder than usual to keep track of what i was doing in past 7 days [promis],,,finding; findings; job; last; occupation; ordinal; patient reported outcomes information system; promise; ql; qual; qualitative; screen; survey; survey.promis,Ord
81493-9,i have been able to bring to mind words that i wanted to use while talking to someone in past 7 days [promis],,,finding; findings; last; ordinal; patient reported outcomes information system; promise; ql; qual; qualitative; screen; survey; survey.promis,Ord
81498-8,my memory has been as good as usual in past 7 days [promis],,,arterial stenosis; finding; findings; last; ordinal; patient reported outcomes information system; promise; ql; qual; qualitative; screen; survey; survey.promis,Ord
81500-1,i have been able to shift back and forth between two activities that require thinking in past 7 days [promis],,,2; finding; findings; last; ordinal; patient reported outcomes information system; promise; ql; qual; qualitative; screen; survey; survey.promis,Ord
8150-5,amphetamines [mass/volume] in urine,amphetamines ur-mcnc,amphetamines (u) [mass/vol],addiction; amph; amphetam; amphetamine; drug/toxicology; drugs; drugs of abuse; illicit; level; mass concentration; point in time; potentialforabuse; qnt; quan; quant; quantitative; random; speed; ua; universallaborders; ur; urn,Qn
81509-2,my ability to remember important dates has been as good as usual in past 7 days [promis],,,arterial stenosis; finding; findings; last; ordinal; patient reported outcomes information system; promise; ql; qual; qualitative; screen; survey; survey.promis,Ord
81521-7,i have been able to mentally focus in past 7 days [promis],,,finding; findings; last; ordinal; patient reported outcomes information system; promise; ql; qual; qualitative; screen; survey; survey.promis,Ord
81529-0,promis short form - cognitive function 6a - version 2.0,,,cogn func; cognition; cognitive status; fcn; func; funct; pan; panel; panel.survey.promis; panl; patient reported outcomes information system; pnl; promise; survey; survey.promis,-
81541-5,resource identifier [uri] for patient education material,resource id uri pt education,,*^patient; clin; nominal; point in time; pt educ material; random,Nom
81543-1,nm head views for csf leak with rhinorrhea or otorrhea w radionuclide it,nm head vs csf leak rhino+oto w rnc it,,brain; cerebral spinal fluid; cerebrospinal fl; coreplaybook; cranial; cranium; document; films; finding; findings; imaging; intracranial; intrathecal; playbook; point in time; rad; radiology; random; rn; rnc; scan; skull; spinal fl; spinal fld; spinal flu; spinal fluid; view; vs csf leak rhino+oto; vws; w rnc it,Doc
81544-9,nm gastrointestinal tract views for gastrointestinal bleeding,nm gi tract vs gi bleed w rnc iv,,abd; abd+pelvis; abdo; abdominal; coreplaybook; document; films; finding; findings; gi; gi tract; imaging; pelvic; playbook; point in time; rad; radiology; random; rn; rnc; scan; view; vs gi bleed; vws; w rnc iv,Doc
81562-1,spect heart w single state of exercise,spect hrt w sing exer+w rnc iv,,cardiac; cardio; cardiology; coreplaybook; document; excz; finding; findings; heart disease; hrt; imaging; playbook; point in time; rad; radiology; random; rn; rnc; scan; thorax; w rnc iv; w sing exer; w sing exer+w rnc iv,Doc
81563-9,nm heart first pass and blood pool,nm hrt fp+bp w rnc iv,,cardiac; coreplaybook; document; films; finding; findings; fp; fp+bp; hrt; imaging; playbook; point in time; rad; radiology; random; rn; rnc; scan; thorax; view; vws; w rnc iv,Doc
81565-4,pt heart for tissue viability,pt hrt for tiss viability w rnc iv,,cardiac; coreplaybook; document; finding; findings; for tiss viability; hrt; imaging; pet scan; playbook; point in time; position emmision tomography; positron emission tomography; rad; radiology; radnuc.pet; random; rn; rnc; scan; thorax; w rnc iv,Doc
81578-7,pt brain metabolic,pt brain metabolic w rnc iv,,brain; cerebral; cerebrum; coreplaybook; cranial; cranium; document; finding; findings; head; imaging; intracranial; pet scan; playbook; point in time; position emmision tomography; positron emission tomography; rad; radiology; radnuc.pet; random; rn; rnc; scan; skull; w rnc iv,Doc
81593-6,nm lymph node views,nm ln views w rnc iv,,coreplaybook; document; films; finding; findings; imaging; ln; misc; miscellaneous; other; playbook; point in time; rad; radiology; random; rn; rnc; scan; spec; to be specified in another part of the message; unspecified; view; vws; w rnc iv,Doc
81599-3,nm guidance for multiple days for localization of tumor of whole body,nm guided wb ds tum loc--w rnc iv,,bod; bodies; coreplaybook; document; ds tum loc; finding; findings; guid; guide; guided; imaging; local; mult; multi; playbook; point in time; rad; radiology; random; rn; rnc; scan; w rnc iv; wb,Doc
81600-9,nm unspecified body region limited views for infection or inflammation w tc-99m tagged wbc iv,nm vs ltd infect+inflam w tc99m wbc iv,,99 mtc; 99mtc; coreplaybook; document; films; finding; findings; imaging; lmted; ltd; misc; miscellaneous; other; playbook; point in time; rad; radiology; random; scan; spec; tc-99cm; tc99m; tc-99m; technetium 99m; to be specified in another part of the message; unspecified; view; views ltd; vs infect+inflam ltd; vws; w tc99m wbc iv,Doc
8161-2,bismuth [mass/volume] in blood,bismuth bld-mcnc,bismuth (bld) [mass/vol],bi; blood; drug/toxicology; drugs; level; mass concentration; point in time; qnt; quan; quant; quantitative; random; wb; whole blood,Qn
8162-0,tetrahydrocannabinol [mass/volume] in gastric fluid,thc gast-mcnc,tetrahydrocannabinol (gast fld) [mass/vol],delta(9)-thc; delta-9-tetrahydrocannabinol; dronabinol; drug/toxicology; drugs; gast; gastric contents; gastric fluid; level; marijuana; mass concentration; nabilone; point in time; qnt; quan; quant; quantitative; random; thc,Qn
81624-9,methotrexate pentaglutamate [moles/volume] in red blood cells,mtx-pg5 rbc-scnc,methotrexate pentaglutamate (rbc) [moles/vol],amethoperin; amethopterin; drug/toxicology; drugs; erythrocytes; level; methotrexat; mtx; mtx-pg5; point in time; qnt; quan; quant; quantitative; random; red blood cells; red blood corpusles; substance concentration,Qn
81628-0,methotrexate monoglutamate [moles/volume] in red blood cells,mtx-pg1 rbc-scnc,methotrexate monoglutamate (rbc) [moles/vol],amethoperin; amethopterin; drug/toxicology; drugs; erythrocytes; level; methotrexat; mtx; mtx-pg1; point in time; qnt; quan; quant; quantitative; random; red blood cells; red blood corpusles; substance concentration,Qn
81636-3,pressure injury risk level braden scale,pressure ulcer risk braden scale,,finding; findings; h+p; h+p.hx; levels; levl; lv; lvl; ordinal; p prime; point in time; pressure injury; pressure ulcer; pressure ulcer risk; pressure ulcers; ql; qual; qualitative; random; screen; ulcer,Ord
81643-9,von willebrand factor (vwf) ristocetin cofactor/von willebrand factor (vwf) ag [ratio] in platelet poor plasma,vwf:rco/vwf ag ppp-rto,vwf ristocetin cofactor act/vwf ag (ppp) [ratio],activ; actvty; aggrecetin; coagulation; cofact; fac; fact; hematology; heme; movements; plas; platelet poor plasma; point in time; qnt; quan; quant; quantitative; random; ratios; risto; rto; von will; von willebrand factor activity; vonwillebrand; vwf; vwf activity; vwf:ag; vwf:rco,Qn
81648-8,clostridium botulinum toxin g botg gene [presence] in specimen by naa with probe detection,c botg gene spec ql naa+probe,c. botulinum toxin g botg gene naa+probe ql (specimen),3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; bont; btx; c bot; c bot tox; c botg gene; c botulinum; dna nucleic acid probe; dna probe; id; infectious disease; infectiousdisease; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; misc; miscellaneous; naa+probe; naat; nasba; nucleic acid sequence based analysis; ordinal; other; pcr; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; screen; sda; spec; strand displacement amplification; tma; to be specified in another part of the message; transcription mediated amplification; unspecified,Ord
81659-5,escherichia coli stx1 and stx2 toxin stx1 and stx2 genes panel - stool by naa with probe detection,ec stx1 + stx2 genes pnl stl naa+probe,e. coli stx1 and stx2 genes panel naa+probe (stl),3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; bowel movement; dna nucleic acid probe; dna probe; e coli; ec stx1 + stx2 genes; ec stx1 + stx2 genes pnl; ec stx1+stx2 genes; faecal; faeces; fecal; feces; gastro; gastroenterology; gi; id; infectious disease; infectiousdisease; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; naa+probe; naat; nasba; nucleic acid sequence based analysis; o002; pan; panel.microbiology; panl; pcr; pnl; point in time; polymerase chain reaction; probe amp; probe with ampification; probe with target amplification; qbr; random; sda; shiga-like toxins; stl; stool = fecal; strand displacement amplification; tma; transcription mediated amplification,-
81660-3,nausea [presence],nausea,,clin; ordinal; point in time; pr; ql; qual; qualitative; random; screen,Ord
81668-6,incontinent voids [#] urinary tract,incont voids urinary,,cnt; count; incont voids; io_output; io_output.molec; number; point in time; qnt; quan; quant; quantitative; random,Qn
81669-4,diaper count,diaper cnt,,cnt; count; diaper cnt; io_output; io_output.molec; number; point in time; qnt; quan; quant; quantitative; random,Qn
81675-1,nutrition and fluid intake assessment [interpretation],nutr+fluid intake assess imp,,fld; h+p; h+p.hx; impression; impression/interpretation of study; impressions; interp; interpretation; nominal; nutr+fluid intake assess; p prime; point in time; random,Nom
8167-9,tetrahydrocannabinol [presence] in meconium,thc mec ql,tetrahydrocannabinol ql (mec),delta(9)-thc; delta-9-tetrahydrocannabinol; dronabinol; drug/toxicology; drugs; marijuana; mec; nabilone; ordinal; point in time; pr; ql; qual; qualitative; random; screen; thc,Ord
81691-8,dna mismatch repair protein mlh1 [presence] in cancer specimen by immune stain,mmr prot mlh1 ca spec ql imstn,dna mismatch repair protein mlh1 immune stain ql (cancer specimen),ca; ca spec; deoxyribonucleic acid; dna mmr; ihc; imm; immunohistochemical stain; immunostain; imstn; imun; imune; mmr prot mlh1; ordinal; pathology; point in time; pr; prot; ql; qual; qualitative; random; screen; spec; st; stains; stn,Ord
81692-6,dna mismatch repair protein msh2 [presence] in cancer specimen by immune stain,mmr prot msh2 ca spec ql imstn,dna mismatch repair protein msh2 immune stain ql (cancer specimen),ca; ca spec; deoxyribonucleic acid; dna mmr; ihc; imm; immunohistochemical stain; immunostain; imstn; imun; imune; mmr prot msh2; ordinal; pathology; point in time; pr; prot; ql; qual; qualitative; random; screen; spec; st; stains; stn,Ord
81709-8,microsatellite markers exhibiting instability [#] in cancer specimen,msi mark found ca spec,microsatellite markers exhibiting instability (cancer specimen) [#],ca; ca spec; cnt; count; msi mark found; number; pathology; point in time; qnt; quan; quant; quantitative; random; spec,Qn
81732-0,pm-scl-100 ab [presence] in serum by line blot,pm/scl-100 ab ser ql line blot,pm-scl-100 ab line blot ql (s),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; evening; ordinal; pm/scl-100; pm1-alpha; point in time; polymyositis; pr; ql; qual; qualitative; random; scleroderma; screen; serology; serum; sr; systemic sclerosis,Ord
81742-9,th-to ab [units/volume] in serum by line blot,th-to ab ser line blot-acnc,th-to ab line blot qn (s),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; point in time; qnt; quan; quant; quantitative; random; serology; serum; sr; thallium,Qn
81760-1,lymphocyte proliferation.anti-cd3.maximum/cd45 in blood by flow cytometry (fc),lpt acd3 max/cd45 nfr bld fc,lymphocyte proliferation.anti-cd3.maximum/cd45 fc (bld),b220; blood; cd45r; cd45ra; cd45rb; cd45rc; cd45ro; dynamic; fc; hematology/cell counts; lca; leu4; leu-4; leukocyte common antigen; lpa; lpt; lpt acd3 max; lst; ly5; lymphocyte antigen proliferation; lymphocyte antigen stimulation; number fraction; percent; pha; point in time; qnt; quan; quant; quantitative; random; t200; t3; wb; whole blood,Qn
81762-7,f8 gene intron 1 inversion targeted mutation analysis in blood or tissue by molecular genetics method,f8 intron 1 inv mut anl bld/t,f8 gene intron 1 inversion targeted mutation analysis molgen doc (bld/tiss),"ahf; blood; classic hemophilia; coagulation factor viii gene; coagulation factor viii, procoagulant component; document; dxs1253e; f8 intron 1 inv; f8b; f8c; factor 8; finding; findings; fviii; fviii gene; genetics; haemophilia; hema; hemophilia a; heredity; heritable; i; inherited; molecular genetics; molecular pathology; molpath; molpath.inv; mut; mut anl; mutations; pcr; point in time; procoagulant component; random; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",Doc
81765-0,docosatrienoate (c22:3w9) [entitic substance] in red blood cells,docosatrienoate entsub rbc,docosatrienoate (c22:3w9) (rbc) [entitic substance],chemistry; entitic substance; erythrocytes; esoteric; point in time; qnt; quan; quant; quantitative; random; red blood cells; red blood corpusles,Qn
81772-6,european house dust mite igg ab [mass/volume] in serum,d pteronyss igg-mcnc,european house dust mite igg (s) [mass/vol],abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; d pteronyss; d pteronyssinus; d001; d1; european house dust mite; gd1; hdm; house dust mite; immune globulin g; immunoglobulin g; level; mass concentration; point in time; qnt; quan; quant; quantitative; random; serum; sr,Qn
81793-2,tetrahydrodeoxycortisol/creatinine [molar ratio] in 24 hour urine,th-dc/creat 24h ur-srto,tetrahydrodeoxycortisol/creatinine (24h u) [molar ratio],1 day; 24 hours; 24hr; chemistry; cr; crea; creat; esoteric; qnt; quan; quant; quantitative; scrto; substance concentration ratio; substance ratio; tetrahydro-11-deoxycortisol; th-dc; ua; ucr; ur; urn,Qn
81803-9,beta cortolone/creatinine [molar ratio] in urine,b-cortolone/creat ur-srto,beta cortolone/creatinine (u) [molar ratio],b; b-cortolone; chemistry; cortisol metabolite; cr; crea; creat; esoteric; point in time; qnt; quan; quant; quantitative; random; scrto; substance concentration ratio; substance ratio; ua; ucr; ur; urn,Qn
81821-1,rmrp gene targeted mutation analysis in blood or tissue by molecular genetics method,rmrp mut anl bld/t,rmrp gene targeted mutation analysis molgen doc (bld/tiss),"blood; chh; document; finding; findings; genetics; heredity; heritable; inherited; molecular genetics; molecular pathology; molpath; molpath.mutations; mut; mut anl; mutations; nme1; pcr; point in time; random; rmrpr; rna component of mitochondrial rna processing endoribonuclease; rrp2; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",Doc
81828-6,slc37a4 gene targeted mutation analysis in blood or tissue by molecular genetics method,slc37a4 mut anl bld/t,slc37a4 gene targeted mutation analysis molgen doc (bld/tiss),"blood; document; finding; findings; g6pt1; g6pt2; g6pt3; genetics; gsd1b; gsd1c; gsd1d; heredity; heritable; inherited; molecular genetics; molecular pathology; molpath; molpath.mutations; mut; mut anl; mutations; pcr; point in time; pro0685; random; solute carrier family 37 member 4; tissue; tissue, unspecified; trg19; trg-19; wb; whole blood; whole blood or tissue",Doc
81839-3,cln8 gene targeted mutation analysis in blood or tissue by molecular genetics method,cln8 mut anl bld/t,cln8 gene targeted mutation analysis molgen doc (bld/tiss),"blood; c8orf61; ceroid-lipofuscinosis, neuronal 8; document; epmr; finding; findings; genetics; heredity; heritable; inherited; molecular genetics; molecular pathology; molpath; molpath.mutations; mut; mut anl; mutations; pcr; point in time; random; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",Doc
81846-8,c9orf72 gene ggggcc repeat analysis in blood or tissue by molecular genetics method,c9orf72 ggggcc repeat analysis bld/t,c9orf72 gene ggggcc repeat analysis molgen doc (bld/tiss),"als; alsftd; amyotrophic lateral sclerosis; blood; c9orf72 ggggcc; chromosome 9 open reading frame 72; document; finding; findings; frontotemporal dementia; ftd; ftdals; ftdals1; genetics; heredity; heritable; inherited; molecular genetics; molecular pathology; molpath; molpath.nucrepeat; pcr; point in time; random; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",Doc
81857-5,gdap1 gene targeted mutation analysis in blood or tissue by molecular genetics method,gdap1 gene mut anl bld/t,gdap1 gene targeted mutation analysis molgen doc (bld/tiss),"blood; cmt2g; cmt2h; cmt2k; cmt4; cmt4a; cmtria; document; finding; findings; ganglioside induced differentiation associated protein 1; ganglioside-induced differentiation-associated protein 1 gene; genetics; heredity; heritable; inherited; molecular genetics; molecular pathology; molpath; molpath.mutations; mut; mut anl; mutations; pcr; point in time; random; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",Doc
81907-8,send document that conforms to c-cda r2.0 template,,,attach; attach.modifier; congenital dyserythropoietic anaemia; point in time; random; scope.mod.doc temp; send doc conforms c-cda r2.0,-
81919-3,methionine intake 24 hour measured,methionine intake 24h measured,,1 day; 24 hours; 24hr; diet; dietetics; mass rate; met; mrate; nutrition; qnt; quan; quant; quantitative,Qn
81935-9,homocysteine intake 24 hour measured,hcys intake 24h measured,,1 day; 24 hours; 24hr; diet; dietetics; hcy; hcys; hcys intake; hcyst; homocyst(e)ine; mass rate; mrate; nutrition; qnt; quan; quant; quantitative,Qn
81945-8,boron intake 24 hour measured,boron intake 24h measured,,1 day; 24 hours; 24hr; b; diet; dietetics; mass rate; mrate; nutrition; qnt; quan; quant; quantitative,Qn
81949-0,multi-trace element supplement intake 24 hour,multi-trace element intake 24h,,1 day; 24 hours; 24hr; diet; dietetics; finding; findings; micromineral; micronutrient; multi-trace element intake; nutrition; ordinal; ql; qual; qualitative; screen,Ord
81965-6,deprecated common ragweed native (namb a) 1 ige ab rast class [presence] in serum,deprecated common ragweed (namb a) 1 ige rast ql,common ragweed native (namb a) 1 ige rast class (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; common ragweed; common ragweed (namb a) 1; i; ige rast; immune globulin e; immunoglobulin e; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; sr; w230,Ord
81978-9,deprecated horse recombinant (requ c) 1 ige ab rast class [presence] in serum,deprecated horse (requ c) 1 ige rast ql,horse recombinant (requ c) 1 ige rast class (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; equus spp; horse (requ c) 1; i; ige rast; immune globulin e; immunoglobulin e; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; sr,Ord
81979-7,deprecated cat recombinant (rfel d) 4 ige ab rast class [presence] in serum,deprecated cat (rfel d) 4 ige rast ql,cat recombinant (rfel d) 4 ige rast class (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; cat (rfel d) 4; dextro; e228; feline; felis domesticus; ige rast; immune globulin e; immunoglobulin e; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; sr,Ord
81998-7,deprecated soybean native (ngly m) 6 ige ab rast class [presence] in serum,deprecated soybean (ngly m) 6 ige rast ql,soybean native (ngly m) 6 ige rast class (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; f014; f14; f432; gly; ige rast; immune globulin e; immunoglobulin e; largest; maximal; maximum; ordinal; peak; point in time; pr; ql; qual; qualitative; random; screen; serum; soja hispida; soy bean; soya bean; soyabean; soybean; soybean (ngly m) 6; sr,Ord
82000-1,deprecated apple recombinant (rmal d) 1 ige ab rast class [presence] in serum,deprecated apple (rmal d) 1 ige rast ql,apple recombinant (rmal d) 1 ige rast class (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; apple; apple (rmal d) 1; autoantibodies; autoantibody; dextro; f434; i; ige rast; immune globulin e; immunoglobulin e; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; sr,Ord
82014-2,deprecated latex recombinant (rhev b) 6.02 ige ab rast class [presence] in serum,deprecated latex (rhev b) 6.02 ige rast ql,latex recombinant (rhev b) 6.02 ige rast class (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; hevea braziliensis; ige rast; immune globulin e; immunoglobulin e; k082; k220; k82; latex (rhev b) 6.02; ltx; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; sr,Ord
82022-5,"deprecated galactose-alpha-1,3-galactose (alpha-gal) ige ab rast class [presence] in serum",deprecated alpha-gal ige rast ql,"galactose-alpha-1,3-galactose (alpha-gal) ige rast class (s)",a1; abs; aby; alfa; allergen; allergens; allergy testing; alpha-gal; alpha-gal ab; antby; anti; antibodies; antibody; autoantibodies; autoantibody; cerebrose; i; ige rast; iii; immune globulin e; immunoglobulin e; lone star tick; meat allergy; o215; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; sr,Ord
82029-0,deprecated olive pollen native (nole e) 1 ige ab rast class [presence] in serum,deprecated olive (nole e) 1 ige rast ql,olive pollen native (nole e) 1 ige rast class (s),a482; abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; black olive; f342; i; ige rast; immune globulin e; immunoglobulin e; olive; olive (nole e) 1; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; sr; t224,Ord
82035-7,tree allergen mix 6 (boxelder+silver birch+american beech+white oak+california walnut) ige ab [units/volume] in serum by multidisk,tree allerg mix6 ige qn,boxelder+silver birch+american beech+white oak+california walnut ige multidisk qn (s),a negundo; abs; aby; allergen; allergens; allergy testing; allerscan; amer beech; american beech; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; box elder; boxelder; common silver birch; ifr; immune globulin e; immunoglobulin e; isoflavone reductase; oak; point in time; qnt; quan; quant; quantitative; random; serum; silver birch; sr; t001; t005; t007; t1; t3; t5; t7; tree allerg mix6; tree mix (late flowering); tx6; white oak,Qn
82039-9,weed allergen mix 209 (common ragweed+western ragweed+giant ragweed) ige ab rast class [presence] in serum by multidisk,weed allerg mix209 ige rast,common ragweed+western ragweed+giant ragweed ige rast class multidisk (s) [presence],a artemisiifolia; a elatior; abs; aby; allergen; allergens; allergy testing; allerscan; ambrosia artemisiifolia; ambrosia trifida ab.ige.rast class; antby; anti; antibodies; antibody; autoantibodies; autoantibody; common ragweed; giant ragweed; ige rast; immune globulin e; immunoglobulin e; point in time; pr; random; rw209; serum; short ragweed; smqn; sr; w001; w002; w003; w1; w2; w209; w3; weed allerg mix209; west ragweed; western ragweed; wx209,SemiQn
82060-5,food allergen mix 18 (peanut+soybean+peas) ige ab rast class [presence] in serum by multidisk,food allerg mix18 ige rast,peanut+soybean+peas ige rast class multidisk (s) [presence],abs; aby; allergen; allergens; allergy testing; allerscan; antby; anti; antibodies; antibody; autoantibodies; autoantibody; f012; f013; f014; f12; f13; f14; food allerg mix18; fx18; gly; green pea; ige rast; immune globulin e; immunoglobulin e; largest; maximal; maximum; pea; peak; peanut; peas; pisum sativum ab.ige.rast class; point in time; pr; random; serum; smqn; soja hispida; soy bean; soya bean; soyabean; soybean; sr,SemiQn
82069-6,food allergen mix 3 (oat+buckwheat+sesame seed+wheat+corn) ige ab rast class [presence] in serum by multidisk,food allerg mix3 ige rast,oat+buckwheat+sesame seed+wheat+corn ige rast class multidisk (s) [presence],abs; aby; allergen; allergens; allergy testing; allerscan; antby; anti; antibodies; antibody; autoantibodies; autoantibody; buchwheat; buckwheat; cereal mix; corn; f004; f007; f008; f010; f011; f10; f11; f141; f4; f7; f74; f8; food allerg mix3; food mix (cereals); fx3; ige rast; immune globulin e; immunoglobulin e; maize; oat; oats; point in time; pr; random; serum; sesame seed; sesamum orientale; smqn; sr; triticum sativum; wheat; zea mays ab.ige.rast class,SemiQn
82074-6,food allergen mix 72 (fennel seed+basil+anise+ginger) ige ab [units/volume] in serum by multidisk,food allerg mix72 ige qn,fennel seed+basil+anise+ginger ige multidisk qn (s),abs; aby; allergen; allergens; allergy testing; allerscan; anise; aniseed; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; basil; f219; f269; f270; f271; fennel; fennel seed; finocchio; food allerg mix72; fx72; ginger; ginger ige; immune globulin e; immunoglobulin e; point in time; qnt; quan; quant; quantitative; random; rf219; rf269; rf270; rf271; seeds; serum; sr,Qn
82079-5,food allergen mix 9 (kiwi+melon+banana+almond+grape) ige ab rast class [presence] in serum by multidisk,food allerg mix9 ige rast,kiwi+melon+banana+almond+grape ige rast class multidisk (s) [presence],abs; aby; allergen; allergens; allergy testing; allerscan; almond; amygdalus communis; antby; anti; antibodies; antibody; autoantibodies; autoantibody; banana; chinese gooseberry; f020; f084; f092; f20; f259; f84; f92; food allerg mix9; fruit mix; fx9; grape; grapes; ige rast; immune globulin e; immunoglobulin e; kiwi fruit; kiwifruit; musa sp; point in time; pr; prunus amygdalus; random; serum; smqn; sr; vitis vinifera ab.ige.rast class,SemiQn
82090-2,occupational allergen mix 3 (alternaria alternata+aspergillus fumigatus+rye pollen+wheat pollen) ige ab [units/volume] in serum by multidisk,occup allerg mix3 ige qn,alternaria alternata+aspergillus fumigatus+rye pollen+wheat pollen ige multidisk qn (s),a alternata; a fumigatus; a tenuis; abs; aby; allergen; allergens; allergy testing; allerscan; alternaria tenuis; antby; anti; antibodies; antibody; arbitrary concentration; asperg; aspergil; aspergilis; aspergilla; aspergillin; aspergillosis; aspergils; aspergilus; autoantibodies; autoantibody; farmers lung; fum; immune globulin e; immunoglobulin e; m003; m006; m3; m6; occup allerg mix3; pax3; point in time; qnt; quan; quant; quantitative; random; serum; sr,Qn
82104-1,regional allergen mix 2 (alternaria alternata+cat dander+american house dust mite+dog dander+horse dander) ige ab rast class [presence] in serum by multidisk,region allerg mix2 ige rast,alternaria alternata+cat dander+american house dust mite+dog dander+horse dander ige rast class multidisk (s) [presence],a alternata; a tenuis; abs; aby; allergen; allergens; allergy testing; allerscan; alternaria tenuis; american house dust mite; antby; anti; antibodies; antibody; autoantibodies; autoantibody; canine; cat epithelium; cat hair; d farinae; d002; d2; dermatophagoides farianae; dog hair; e003; e005; e1; e3; e5; equus spp; feline; felis domesticus; hdm; horse dander ab.ige.rast class; house dust mite; ige rast; immune globulin e; immunoglobulin e; m006; m6; perennial mix; point in time; pr; random; region allerg mix2; rrx2; rx2; serum; smqn; sr,SemiQn
82134-8,respiratory pathogens dna and rna tested for in respiratory system specimen by naa with probe detection,resp path dna+rna tested resp naa+probe,respiratory pathogens dna and rna tested naa+probe nom (respiratory system specimen),3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; breathing; deoxyribonucleic acid; dna nucleic acid probe; dna probe; id; identity or presence; infectious disease; infectiousdisease; lat; lcr; ligase chain reaction; ligation-activated transcription; lung; lungs; microbiology; naa+probe; naat; nasba; nominal; nucleic acid sequence based analysis; pcr; point in time; polymerase chain reaction; probe amp; probe with ampification; probe with target amplification; pulmonary; pulmonology; qbr; random; resp path dna+; resp path dna+rna; resp path dna+rna tst; resp pathogens; respiratory; respiratory bacteria & viruses; respiratory bacteria & viruses dna & rna; ribonucleic acid; rs; sda; spec; strand displacement amplification; tma; transcription mediated amplification,Nom
8214-9,opiates [presence] in meconium,opiates mec ql,opiates ql (mec),addiction; drug/toxicology; drugs; drugs of abuse; heroin; illicit; mec; op; opi; opiate; ordinal; point in time; potentialforabuse; pr; ql; qual; qualitative; random; screen; universallaborders,Ord
82170-2,influenza virus b rna [presence] in nasopharynx by naa with non-probe detection,flubv rna nph ql naa+non-probe,flubv rna naa+non-probe ql (nph),3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; dna nucleic acid probe; dna probe; flub; flubv; fluv; id; infectious disease; infectiousdisease; influ; influenza b; influenza b virus; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; naa+non-probe; naa+probe; naat; nasba; nasopharynx; nucleic acid sequence based analysis; ordinal; pcr; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; ribonucleic acid; screen; sda; strand displacement amplification; tma; transcription mediated amplification,Ord
82175-1,rhinovirus+enterovirus rna [presence] in nasopharynx by naa with non-probe detection,rv+ev rna nph ql naa+non-probe,rhinovirus+enterovirus rna naa+non-probe ql (nph),3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; dna nucleic acid probe; dna probe; entero virus; ev; ev-pcr; hrv; id; infectious disease; infectiousdisease; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; naa+non-probe; naa+probe; naat; nasba; nasopharynx; nucleic acid sequence based analysis; ordinal; pcr; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; rhino virus; rhv; ribonucleic acid; rv+ev; rv+ev rna; screen; sda; strand displacement amplification; tma; transcription mediated amplification,Ord
82204-9,escherichia coli o157 dna [presence] in stool by naa with non-probe detection,e coli o157 dna stl ql naa+non-probe,e. coli o157 dna naa+non-probe ql (stl),3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; bowel movement; deoxyribonucleic acid; dna nucleic acid probe; dna probe; e coli; e coli o157; e coli o157 dna; faecal; faeces; fecal; feces; id; infectious disease; infectiousdisease; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; naa+non-probe; naa+probe; naat; nasba; nucleic acid sequence based analysis; o002; ordinal; pcr; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; screen; sda; stl; stool = fecal; strand displacement amplification; tma; transcription mediated amplification,Ord
82205-6,cryptosporidium sp dna [presence] in stool by naa with non-probe detection,cryptosp dna stl ql naa+non-probe,cryptosporidium sp dna naa+non-probe ql (stl),3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; bowel movement; crypt; crypto; cryptosporidiosis; deoxyribonucleic acid; dna nucleic acid probe; dna probe; faecal; faeces; fecal; feces; gastro; gastroenterology; gi; id; infectious disease; infectiousdisease; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; naa+non-probe; naa+probe; naat; nasba; nucleic acid sequence based analysis; ordinal; pcr; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; screen; sda; species; spp; stl; stool = fecal; strand displacement amplification; tma; transcription mediated amplification,Ord
82226-2,neck disability index [ndi],,,pan; panel; panel.survey.gnhlth; panl; pnl; point in time; random; survey; survey.gnhlth,-
82236-1,recreation [ndi],,,finding; findings; ordinal; point in time; ql; qual; qualitative; random; screen; survey; survey.gnhlth,Ord
82251-0,chromosome 3 and 7 and 17 aneuploidy and chromosome region 9p21 deletion in urine by fish,chr 3+7+17 aneu + 9p21 del ur fish,chr 3 and 7 and 17 aneuploidy and chr region 9p21 del fish doc (u),bladder cancers; bladder cell cancer; bladder tumor; chr 3 + 7 + 17 aneup + chr 9p21 del; chr 3+7+17 aneu + 9p21; chromosom; chromosomes; cyto loc; del; deletions; document; finding; findings; fluorescent in situ hybridization; genetics; heredity; heritable; iii; inherited; misc; miscellaneous molecular pathology; molecular pathology; molpath; point in time; random; ua; ur; urn,Doc
82255-1,marker and derivative chromosome analysis in blood or tissue document by cytogenetics,mar + der chrom analy bld/t doc,marker and derivative chromosome analysis cytogenetics doc (bld/tiss),"blood; chrom analy; chromosom; chromosomes; cytog; cytogenetics; cytology; document; finding; findings; genetics; heredity; heritable; inherited; karyotype; mar + der chrom analy; mark; point in time; random; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",Doc
82256-9,chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in blood or tissue by fish,12ts+11p22.3+13q14+17p13.1 del bl/t fish,chr 12 trisomy and chr region 11q22.3 and 13q14 and 17p13.1 del fish doc (bld/tiss),"blood; chr 12 ts; chr 12 ts + chr 11q22.3 + 13q14 + 17p13.1 del; chr 12ts + 11q22.3+13q14+17p13.1; chromosom; chromosomes; chronic lymphocytic leukemia; cyto loc; del; deletions; document; finding; findings; fluorescent in situ hybridization; genetics; heredity; heritable; inherited; misc; miscellaneous molecular pathology; molecular pathology; molpath; point in time; random; tissue; tissue, unspecified; ts; wb; whole blood; whole blood or tissue",Doc
82262-7,estimated activity metabolic rate/standard rmr [relative energy/time],est act metab rate/standard rmr,,1 minute; act metab rate; activ; activity; actvty; average; avg; basal metabolic rate; bmr; clin; ee; energy expenditure; est; estimation; exercise; movements; qnt; quan; quant; quantitative; rmr; stand rmr; stndrd rmr,Qn
8226-3,opiates [presence] in unknown substance by screen method,opiates usub ql scn,opiates screen ql (unknown substance),addiction; drug/toxicology; drugs; drugs of abuse; heroin; illicit; op; opi; opiate; ordinal; point in time; potentialforabuse; pr; ql; qual; qualitative; random; scn; scr; screen; scrn; unknown substance; usub,Ord
82263-5,reported activity metabolic rate/standard rmr [relative energy/time],reported act metab rate/standard rmr,,1 minute; act metab rate; activ; activity; actvty; average; avg; basal metabolic rate; bmr; clin; ee; energy expenditure; exercise; movements; qnt; quan; quant; quantitative; rmr; stand rmr; stndrd rmr,Qn
82267-6,reported activity metabolic rate/measured rmr [relative energy/time],reported act metab rate/meas rmr,,1 minute; act metab rate; activ; activity; actvty; average; avg; basal metabolic rate; bmr; clin; ee; energy expenditure; exercise; meas rmr; movements; qnt; quan; quant; quantitative; rmr,Qn
82275-9,reported activity metabolic rate/predicted rmr [relative energy/time],reported act metab rate/pred rmr,,1 minute; act metab rate; activ; activity; actvty; average; avg; basal metabolic rate; bmr; clin; ee; energy expenditure; exercise; movements; pred rmr; predicted rmr; qnt; quan; quant; quantitative; rmr,Qn
82285-8,population rmr,population rmr,,1 minute; average; avg; basal metabolic rate; bmr; clin; ee; energy expenditure; energy/time; pop rmr; power; qnt; quan; quant; quantitative; rmr,Qn
82287-4,physical activity panel,physical activity pnl,,activ; actvty; clin; movements; pan; panel.clinical; panl; physical activity pnl; pnl; report period,-
82301-3,salmonella sp [presence] in stool by culture,salmonella stl ql cult,salmonella sp cx ql (stl),bowel movement; c&s; cult; cultures; faecal; faeces; fecal; feces; gastro; gastroenterology; gi; id; infectious disease; infectiousdisease; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; sal; salmonel; screen; species; spp; stl; stool = fecal,Ord
82306-2,chlamydia trachomatis rrna [presence] in throat by naa with probe detection,c trach rrna throat ql naa+probe,c. trachomatis rrna naa+probe ql (throat),3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; c trac; c trach; c tracho; c trachomatis; chlam; chlam trac; chlamid; ct; dna nucleic acid probe; dna probe; gen-probe; id; infectious disease; infectiousdisease; lat; lcr; lgv; ligase chain reaction; ligation-activated transcription; lymphogranuloma venereum; microbiology; naa+probe; naat; nasba; nucleic acid sequence based analysis; ordinal; pcr; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; ribosomal rna; screen; sda; strand displacement amplification; throat; tma; trachoma; transcription mediated amplification; upper respiratory,Ord
82312-0,blood transfusion andor organ transplant 12 months,bld transf &or organ transp 12mo,,1 year; 12mos; bld transf &or organ transp; h+p; h+p.hx; history; ordinal; p prime; ql; qual; qualitative; screen; tx,Ord
82321-1,"degree of difficulty experienced due to your hip while lying in bed (turning over, maintaining hip position) in the last week [hoos]",,,1 week; finding; findings; hip dysfunction and osteoarthritis outcome score; hoos jr; lower extremity joint; ordinal; past; ql; qual; qualitative; screen; survey; survey.gnhlth,Ord
82322-9,degree of difficulty experienced due to your hip while sitting in the last week [hoos],,,1 week; finding; findings; hip dysfunction and osteoarthritis outcome score; hoos jr; lower extremity joint; ordinal; past; ql; qual; qualitative; screen; survey; survey.gnhlth,Ord
82331-0,degree of difficulty experienced due to your knee while bending to floor andor pick up an object in the last week [koos],,,"1 week; finding; findings; knee injury and osteoarthritis outcome score; koos jr; koos, jr; lower extremity joint; ordinal; past; ql; qual; qualitative; screen; survey; survey.gnhlth",Ord
82360-9,reproductive endocrinology and infertility diagnostic study note,rei diag study note,,diag study note; doc.ont; document; encounter; endocrine; endocrinology; evaluation and management; evaluation and management note; finding; findings; notes; point in time; random; rei; study report; visit note,Doc
8236-2,phencyclidine [presence] in serum or plasma by screen method,pcp serpl ql scn,phencyclidine screen ql,addiction; angel dust; drug/toxicology; drugs; drugs of abuse; illicit; ordinal; pcp; pl; plasma; plsm; point in time; potentialforabuse; pr; ql; qual; qualitative; random; scn; scr; screen; scrn; sernylan; serp; serpl; serplas; serum; serum or plasma; sr,Ord
82362-5,reproductive endocrinology and infertility flowsheet,rei flowsheet,,doc.ont; document; endocrine; endocrinology; finding; findings; point in time; random; rei,Doc
82402-9,ganglioside gd3 igg ab [presence] in serum by line blot,gd3 gangl igg ser ql line blot,ganglioside gd3 igg line blot ql (s),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; disialolganglioside; gd3 gangl; immune globulin g; immunoglobulin g; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serology; serum; sr,Ord
82403-7,deprecated ganglioside gd3 igg+igm ab [presence] in serum by immunoassay,deprecated gd3 gangl igg+igm ser ql ia,ganglioside gd3 igg+igm ib ql (s),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; blt; disialolganglioside; gd3 gangl; immune blot; immune globulin g; immune globulin m; immunobl; immunoblot; immunoglobulin g; immunoglobulin m; ordinal; point in time; pr; ql; qual; qualitative; random; riba; screen; serology; serum; sr; wb; wblot; west blot; west blt; western blot,Ord
8240-4,phencyclidine [presence] in unknown substance,pcp usub ql,phencyclidine ql (unknown substance),addiction; angel dust; drug/toxicology; drugs; drugs of abuse; illicit; ordinal; pcp; point in time; potentialforabuse; pr; ql; qual; qualitative; random; screen; sernylan; unknown substance; usub,Ord
82405-2,deprecated ganglioside gm3 igg+igm ab [presence] in serum by immunoblot,deprecated gm3 igg+igm ser ql ib,ganglioside gm3 igg+igm ib ql (s),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; blt; immune blot; immune globulin g; immune globulin m; immunobl; immunoblot; immunoglobulin g; immunoglobulin m; monosialoganglioside; ordinal; point in time; pr; ql; qual; qualitative; random; riba; screen; serology; serum; sr; wb; wblot; west blot; west blt; western blot,Ord
82411-0,ganglioside gt1a igg ab [presence] in serum by line blot,gt1a gangl igg ser ql line blot,ganglioside gt1a igg line blot ql (s),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; gt1a gangl; immune globulin g; immunoglobulin g; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serology; serum; sr; trisialoganglioside,Ord
82421-9,ks ab [units/volume] in serum by line blot,ks ab ser line blot-acnc,ks ab line blot qn (s),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; asparaginyl trna synthetase; autoantibodies; autoantibody; ild; interstitial lung disease; point in time; qnt; quan; quant; quantitative; random; serology; serum; sr,Qn
82430-0,oj ab [units/volume] in serum by line blot,oj ab ser line blot-acnc,oj ab line blot qn (s),"abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; cadm; clinically amyopathic dm; dermatomyositis, adult type; ild; interstitial lung disease; isoleucyl trna synthetase; point in time; polymyositis, idiopathic; qnt; quan; quant; quantitative; random; serology; serum; sr",Qn
82432-6,platelet-derived growth factor receptor ab [presence] in serum by line blot,pdgfr ab ser ql line blot,platelet-derived growth factor receptor ab line blot ql (s),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; fac; fact; ordinal; pdgfr; pdgf-r; pdgfr ab; pl; platelets; platelt; plt; point in time; pr; ql; qual; qualitative; random; rec; recept; receptors; recp; recptr; screen; serology; serum; sr; thrombocyte; thrombocytes,Ord
82434-2,deprecated ribosomal ab [presence] in serum by immunoblot,deprecated ribosomal ab ser ql ib,ribosomal ab ib ql (s),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; blt; immune blot; immunobl; immunoblot; ordinal; point in time; pr; ql; qual; qualitative; random; riba; screen; serology; serum; sr; wb; wblot; west blot; west blt; western blot,Ord
82437-5,deprecated sjogrens syndrome-a extractable nuclear ab [presence] in cerebral spinal fluid by immunoblot,deprecated ena ss-a ab csf ql ib,sjogrens syndrome-a extractable nuclear ab ib ql (csf),abs; aby; ana; anf; antby; anti; antibodies; antibody; antinuclear antibody; autoantibodies; autoantibody; blt; cerebral spinal fluid; cerebrospinal fl; ena; ena ss-a; immune blot; immunobl; immunoblot; na; neuro; neurology; nuc; ordinal; point in time; pr; ql; qual; qualitative; random; riba; ro; ro ab; screen; serology; sjogren; spinal fl; spinal fld; spinal flu; spinal fluid; ss; ssa; ss-a; wb; wblot; west blot; west blt; western blot,Ord
82455-7,ganglioside ab panel - serum,gangl ab pnl ser,ganglioside ab panel (s),gangl ab pnl; pan; panel.serology; panl; pnl; point in time; random; serology; serum; sr,-
82458-1,alaska pollock roe ige ab [units/volume] in serum,alaska pollock roe ige qn,alaska pollock roe ige qn (s),abs; aby; alaska pollock roe; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; f350; immune globulin e; immunoglobulin e; point in time; qnt; quan; quant; quantitative; random; serum; sr; the ch 1; theragra chalcogramma; walleye pike,Qn
82461-5,influenza virus a and b and h1 2009 pandemic rna [identifier] in upper respiratory specimen by naa with probe detection,fluav+flubv+h1 09 pan rna upres naa+pr,fluav and flubv and h1 2009 pan rna naa+probe nom (upper resp),"3 self-sustaining sequence replication; 3sr sr; a,b; amplif; amplification; amplified; avian influenza; bird flu; breathing; dna nucleic acid probe; dna probe; flua; fluav; fluav + flubv; fluav+flubv; fluav+flubv+h1 2009 pan; fluv; fowl plague; id; identity or presence; infectious disease; infectiousdisease; influ; influenza a; influenza a virus; lat; lcr; ligase chain reaction; ligation-activated transcription; lung; lungs; microbiology; naa+probe; naat; nasba; nominal; nucleic acid sequence based analysis; pcr; point in time; polymerase chain reaction; probe amp; probe with ampification; probe with target amplification; pulmonary; pulmonology; qbr; random; respiratory; ribonucleic acid; rs; sda; spec; strand displacement amplification; tma; transcription mediated amplification; up; upper resp",Nom
82475-5,borrelia miyamotoi glpq gene [presence] in blood by naa with non-probe detection,b miyamotoi glpq bld ql naa+non-probe,b. miyamotoi glpq gene naa+non-probe ql (bld),3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; b miyamotoi; b miyamotoi glpq; blood; dna nucleic acid probe; dna probe; id; infectious disease; infectiousdisease; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; naa+non-probe; naa+probe; naat; nasba; nucleic acid sequence based analysis; ordinal; pcr; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; screen; sda; strand displacement amplification; tbrf; tick borne diseases; tick-borne relapsing fever; tma; transcription mediated amplification; wb; whole blood,Ord
82486-2,trbv19 gene segments/trbv gene segments.total in blood,trbv19 seg/trbv seg total nfr bld,trbv19 gene segments/trbv gene segments.total (bld),blood; genetics; heredity; heritable; inherited; molecular pathology; molpath; number fraction; percent; point in time; qnt; quan; quant; quantitative; random; tot; totl; trbv seg total; trbv19 seg; wb; whole blood,Qn
82492-0,trbv12 gene segments/trbv gene segments.total in blood,trbv12 seg/trbv seg total nfr bld,trbv12 gene segments/trbv gene segments.total (bld),blood; genetics; heredity; heritable; inherited; molecular pathology; molpath; number fraction; percent; point in time; qnt; quan; quant; quantitative; random; tot; totl; trbv seg total; trbv12 seg; wb; whole blood,Qn
82512-5,hepatitis c virus genotype 1 [type] in serum or plasma by naa with probe detection,hcv gentyp 1 serpl naa+probe,hcv genotype 1 naa+probe nom,3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; antibiotic susceptibilities; dna nucleic acid probe; dna probe; hcv; hcv gentyp 1; hep; hep c; hepatis; hepatit; hepatology; i; id; infectious disease; infectiousdisease; lat; lcr; ligase chain reaction; ligation-activated transcription; liver; naa+probe; naat; nasba; nominal; nucleic acid sequence based analysis; pcr; pl; plasma; plsm; point in time; polymerase chain reaction; probe amp; probe with ampification; probe with target amplification; qbr; random; sda; serp; serpl; serplas; serum; serum or plasma; sr; strand displacement amplification; tma; transcription mediated amplification; typ,Nom
82529-9,sdhd gene deletion+duplication and full mutation analysis in blood or tissue by molecular genetics method,sdhd gene del+dup + full mut anl bld/t,sdhd gene del+dup and full mutation analysis molgen doc (bld/tiss),"amplification; blood; cbt1; cii-4; cws3; cybs; del; del+dup; del+dup + full mut anl; deletions; document; dp; finding; findings; full gene sequencing; full mut anl; genetics; heredity; heritable; inherited; molecular genetics; molecular pathology; molpath; molpath.mutations; mut; mutations; paraganglioma or familial glomus tumors 1; pcr; pgl; pgl1; point in time; qps3; random; sdh4; sequencing of entire coding region; succinate dehydrogenase complex, subunit d, integral membrane protein; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",Doc
82536-4,sos1 gene full mutation analysis in blood or tissue by sequencing,sos1 gene full mut anl bld/t seq,sos1 gene full mutation analysis sequencing doc (bld/tiss),"blood; document; finding; findings; full gene sequencing; full mut anl; genetics; gf1; ggf1; gingf; heredity; heritable; hgf; high-throughput sequencing; hts; inherited; molecular pathology; molpath; molpath.mutations; mut; mutations; next generation sequencing; ngs; ns4; point in time; random; sequencing of entire coding region; son of sevenless homolog 1 (drosophila); sos-1; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",Doc
82539-8,cashew nut recombinant (rana o) 3 ige ab [units/volume] in serum,cashew nut (rana o) 3 ige qn,cashew nut recombinant (rana o) 3 ige qn (s),2s albumin; abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; cashew; cashew nut; cashew nut (rana o) 3; f202; f443; iii; immune globulin e; immunoglobulin e; point in time; qnt; quan; quant; quantitative; random; serum; sr,Qn
82546-3,deprecated english walnut recombinant (rjug r) 1 ige ab rast class [presence] in serum,deprecated english walnut (rjug r) 1 ige rast ql,english walnut recombinant (rjug r) 1 ige rast class (s),2s albumin; abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; english walnut; english walnut (rjug r) 1; f441; i; ige rast; immune globulin e; immunoglobulin e; ordinal; point in time; pr; ql; qual; qualitative; r prime; random; right; screen; serum; sr,Ord
82548-9,food allergen mix 30a (kiwi+papaya+mango+banana+avocado) ige ab rast class [presence] in serum by multidisk,food allerg mix 30a ige rast,kiwi+papaya+mango+banana+avocado ige rast class multidisk (s) [presence],abs; aby; allergen; allergens; allergy testing; allerscan; alligator pear; antby; anti; antibodies; antibody; autoantibodies; autoantibody; avocado; banana; chinese gooseberry; f091; f092; f096; f293; f91; f92; f96; food allerg mix 30a; fx30; ige rast; immune globulin e; immunoglobulin e; kiwi; kiwi fruit; kiwifruit; mango; musa sp; papaw; papaya; paw paw; persea americana ab.ige.rast class; point in time; pr; prickly pear; random; rf293; serum; smqn; sr; tree melon,SemiQn
82563-8,food allergen mix 77 (kiwi+cashew nut+hazel nut+tomato+sesame seed) ige ab [presence] in serum by multidisk,food allerg mix77 ige ql,kiwi+cashew nut+hazel nut+tomato+sesame seed ige multidisk ql (s),abs; aby; allergen; allergens; allergy testing; allerscan; antby; anti; antibodies; antibody; autoantibodies; autoantibody; barcelona nut; cashew; cashew nut; chinese gooseberry; cob nut; f010; f017; f084; f10; f17; f202; f25; f84; filbert; food allerg mix77; fx77; hazel nut; hazelnut; immune globulin e; immunoglobulin e; kiwi fruit; kiwifruit; lycopersicon esculatum; lycopersicon lycopersicon; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; sesame seed; sesamum orientale; sr; tomato,Ord
82584-4,dicarboxyhexenoylcarnitine (c6:1-dc)/creatinine [molar ratio] in urine,dicarboxyhexenoylcarn/creat ur-srto,c6:1-dc/creatinine (u) [molar ratio],3-hydroxy-3-methylglutaryl-coenzyme a lyase deficiency; 3-methylglutarylcarnitine; chemistry; cr; crea; creat; esoteric; i; point in time; qnt; quan; quant; quantitative; random; scrto; substance concentration ratio; substance ratio; ua; ucr; ur; urn,Qn
82587-7,leukocytes [#/volume] in bone marrow by automated count,wbc # mar auto,wbc auto (bm) [#/vol],#; abs; absolute; absolutes; auto; automated detection; bm; bon; bone marrow; cnt; count; count/volume; ct; elec; elect; electr; hematology/cell counts; leuc; leuk; leukocyte; lkcs; mar; marrow (bone); minimal angle of resolution; minimum angle of resolution; number concentration; number concentration (count/vol); point in time; qnt; quan; quant; quantitative; random; wbc; wbcs; white blood cell; white blood cells,Qn
82604-0,deprecated latex recombinant (rhev b) 2 ige ab rast class [presence] in serum,deprecated latex (rhev b) 2 ige rast ql,latex recombinant (rhev b) 2 ige rast class (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; hevea braziliensis; ige rast; ii; immune globulin e; immunoglobulin e; k082; k82; latex (rhev b) 2; ltx; ordinal; point in time; pr; ql; qual; qualitative; random; rk216; screen; serum; sr,Ord
82627-1,mean phase [angle] left ventricle spect --w stress,mean phase w stress angle lv spect,,average; avg; card.proc; cardiac; cardio; cardiology; exercise; heart disease; hrt; hrt ventr; l; lt; lv; mean phase; point in time; qnt; quan; quant; quantitative; rad; radiology; random; ventricular,Qn
82628-9,phase.standard deviation [angle] left ventricle spect --w stress,ph.sd w stress angle lv spect,,card.proc; cardiac; cardio; cardiology; exercise; heart disease; hrt; hrt ventr; l; lt; lv; ph.sd; point in time; qnt; quan; quant; quantitative; rad; radiology; random; ventricular,Qn
82657-8,cardiac phase measurement panel left ventricle spect,card phase meas pnl lv spect,,card phase meas pnl; cardiac; cardio; cardiology; heart disease; hrt; hrt ventr; l; lt; lv; pan; panel.cardiac; panl; pnl; point in time; rad; radiology; random; ventricular,-
82667-7,total score [dast-10],,,1 year; 12mos; drug abuse screening test; drug abuse screening test-10; qnt; quan; quant; quantitative; scale; survey; tot; totl,Qn
82678-4,cta abdominal aorta wo and w contrast iv,cta abd aorta wo+w contr iv,,ab ao; abd; abd aorta; abdo; abdomen; abdomen+; abdominal; ang; angio; angiography; angm; ao; aortic; c; cat scan; computed tomography; computerized tomography; contr; contra; contrst; ct angiogram; ct angiography; ct scan; cta; document; finding; findings; imaging; point in time; rad; radiology; random; w contr iv; wc; wo & wc; wo+w contr; wo+w contr iv; wwo,Doc
82679-2,cta abdominal vessels and pelvis vessels wo and w contrast iv,cta abd ves+pelvis ves wo+w contr iv,,abd; abd ves; abd ves+pelvis ves; abdo; abdomen; abdomen+; abdominal; ang; angio; angiography; angm; c; cat scan; computed tomography; computerized tomography; contr; contra; contrst; ct angiogram; ct angiography; ct scan; cta; document; finding; findings; imaging; pelvic; point in time; rad; radiology; random; vesl; vessels.xxx; w contr iv; wc; wo & wc; wo+w contr; wo+w contr iv; wwo,Doc
82683-4,ct clavicle - right wo contrast,ct clavicle-r wo contr,,c; cat scan; clavicle-r; computed tomography; computerized tomography; contr; contra; contrst; ct scan; document; finding; findings; imaging; point in time; r; rad; radiology; random; rt; thorax; upper extremity; without contrast,Doc
82687-5,ct clavicle wo contrast,ct clavicle wo contr,,c; cat scan; computed tomography; computerized tomography; contr; contra; contrst; ct scan; document; finding; findings; imaging; point in time; rad; radiology; random; thorax; upper extremity; without contrast,Doc
82688-3,ct colon and rectum wo and w contrast iv and w air contrast pr,ct colon+rect wo+w contr iv+air contr pr,,abd; abd+pelvis; abdo; abdominal; c; cat scan; colonography; computed tomography; computerized tomography; contr; contra; contrst; ct scan; document; finding; findings; imaging; lgi; pelvic; point in time; rad; radiology; random; rectal; rectum+colon; virtual colonoscopy; w air contr pr; w contr iv; w contr iv+air contr pr; wc; wo & wc; wo+w contr; wo+w contr iv; wo+w contr iv+air contr pr; wwo,Doc
82693-3,ct pelvis and lower extremity w contrast iv,ct pelvis+le w contr iv,,c; cat scan; computed tomography; computerized tomography; contr; contra; contrst; ct scan; document; ext; finding; findings; imaging; le; leg; low; pelvic; pelvis+le; point in time; rad; radiology; random; w contr iv; wc,Doc
82695-8,ct pelvis and lower extremity - bilateral w contrast iv,ct pelvis+le-bl w contr iv,,bil; bilat; both; c; cat scan; computed tomography; computerized tomography; contr; contra; contrst; ct scan; document; ext; extr-bl; finding; findings; imaging; le; le-bl; leg; low; pelvic; pelvis+le; pelvis+le-bl; point in time; rad; radiology; random; w contr iv; wc,Doc
82701-4,ct ribs - right wo contrast,ct ribs-r wo contr,,c; cat scan; computed tomography; computerized tomography; contr; contra; contrst; ct scan; document; finding; findings; imaging; point in time; r; rad; radiology; random; ribs-r; rt; thorax; without contrast,Doc
82702-2,ct ribs - right wo and w contrast iv,ct ribs-r wo+w contr iv,,c; cat scan; computed tomography; computerized tomography; contr; contra; contrst; ct scan; document; finding; findings; imaging; point in time; r; rad; radiology; random; ribs-r; rt; thorax; w contr iv; wc; wo & wc; wo+w contr; wo+w contr iv; wwo,Doc
82710-5,cta lower extremity vessels - right,cta le ves-r,,ang; angio; angiography; angm; cat scan; computed tomography; computerized tomography; ct angiogram; ct angiography; ct scan; cta; document; ext; extr ves; extr-r; finding; findings; imaging; le; le ves; le ves-r; leg; le-r; low; lower extremity vessels.right; point in time; r; rad; radiology; random; rle; rt; vesl; vessels.xxx,Doc
82714-7,cta upper extremity vessels - right,cta ue ves-r,,ang; angio; angiography; angm; arm; arm and hand vessels; cat scan; computed tomography; computerized tomography; ct angiogram; ct angiography; ct scan; cta; document; ext; extr ves; extr-r; finding; findings; imaging; point in time; r; rad; radiology; random; rt; rue; ue; ue ves; ue ves-r; ue-r; up; vesl; vessels.xxx,Doc
82717-0,ct ribs - left wo and w contrast iv,ct ribs-l wo+w contr iv,,c; cat scan; computed tomography; computerized tomography; contr; contra; contrst; ct scan; document; finding; findings; imaging; l; lt; point in time; rad; radiology; random; ribs-l; thorax; w contr iv; wc; wo & wc; wo+w contr; wo+w contr iv; wwo,Doc
82723-8,cocaine+benzoylecgonine+cocaethylene [presence] in urine by confirmatory method,coc+benzoylecgon+cocaethyl ur ql cfm,cocaine+benzoylecgonine+cocaethylene confirm ql (u),addiction; bec; beg; benz; benzoylec; benzoylmethylecgonine; bze; cfm; cnfr; cnfrm; coc+benzoylecgon+cocaethyl; cocaine degradation production; cocaine metabolite; cocaine/ethanol by-product; cocaine+bze; coke; conf; confirmation; confirmatory; crack; crack metabolite; drug/toxicology; drugs; drugs of abuse; ecgonine methyl ester benzoate; gcms; illicit; lc/ms/ms; ordinal; point in time; potentialforabuse; pr; ql; qual; qualitative; random; screen; snow; ua; ur; urn,Ord
82729-5,natural killer cell cytotoxicity.100:1 effector to target cell ratio/positive control in blood mononuclear cells,nk cytotox.100:1 e:t/pos cntrl bld mc,nk cytotoxicity 100:1 e:t ratio/positive control (bld mc) [rel units/vol],blood; hematology/cell counts; i; nk; nk cytotox.100:1 e:t; nk cytotoxicity; pbmc; peripheral blood mononuclear cells; point in time; pos; pos cntrl; qnt; quan; quant; quantitative; random; rlacnc; wb; whole blood,Qn
8279-2,chest circumference at nipple line,chest circumf.at nipple line,,body circumference.molec; circumf.at nipple line; girth; length; point in time; qnt; quan; quant; quantitative; random; thorax,Qn
82794-9,spontaneous clot formation [time] in platelet poor plasma,cft.spont ppp,spontaneous clot formation coag (ppp) [time],activated clotting time; cft; cft.spont; clot; clot time; clottable; coagulation; coagulation assay; hematology; heme; kinetics; k-time; plas; platelet poor plasma; point in time; qnt; quan; quant; quantitative; random; tilt tube,Qn
82795-6,clot growth mean [velocity] platelet poor plasma,clot growth mean ppp qn,clot growth coag (stdy mean ppp) [velocity],average; avg; clot; clottable; coagulation; coagulation assay; hematology; heme; plas; platelet poor plasma; qnt; quan; quant; quantitative; studies; study; sutdies; tilt tube; v mean; velocity; vmean,Qn
82797-2,initial clot growth [velocity] in platelet poor plasma,clot growth.init ppp qn,initial clot growth coag (ppp) [velocity],clot; clottable; coagulation; coagulation assay; hematology; heme; plas; platelet poor plasma; point in time; qnt; quan; quant; quantitative; random; tilt tube; velocity,Qn
82809-5,pet+ct guidance for localization of tumor of skull base to mid-thigh-- w 18f-fdg iv and w contrast iv,pt+ct skull-thigh tum loc w fdg+contr,,bod; bodies; c; cat scan; computed tomography; computerized tomography; contr; contra; contrst; cranial; cranium; ct scan; document; femoral; femur; finding; findings; guid; guide; guided; head; imaging; local; lower extremity; pet scan; pet+ct; point in time; position emmision tomography; positron emission tomography; rad; radiology; radnuc.pet; random; skull to thigh; skull.base; tum loc; w 18f-fdg+contr iv; w contr iv; wb; wc,Doc
82815-2,physical abuse--before 18 years old [ace],,,adverse childhood experiences; before; finding; findings; ordinal; point in time; ql; qual; qualitative; random; screen; survey; survey.mtlhlth,Ord
82817-8,emotional neglect--before 18 years old [ace],,,adverse childhood experiences; before; finding; findings; ordinal; point in time; ql; qual; qualitative; random; screen; survey; survey.mtlhlth,Ord
82822-8,mental illness in household--before 18 years old [ace],,,adverse childhood experiences; before; finding; findings; ordinal; point in time; ql; qual; qualitative; random; screen; survey; survey.mtlhlth,Ord
82846-7,11-dehydrocorticosterone+tetrahydrocorticosterone+allo-tetrahydrocorticosterone/androsterone+etiocholanolone [molar ratio] in 24 hour urine,11-dhc+thb+5a-thb/an+et 24h ur-srto,11-dehydrocorticosterone+tetrahydrocorticosterone+allo-tetrahydrocorticosterone/androsterone+etiocholanolone (24h u) [molar ratio],1 day; 11-dhc+thb+5a-thb; 24 hours; 24hr; 5-alpha tetrahydrocorticosterone; 5a-tetrahydrocorticosterone; aetiocholanolone; allo-thb; an+et; androster; chemistry; esoteric; etiochol; qnt; quan; quant; quantitative; scrto; substance concentration ratio; substance ratio; thb; ua; ur; urn,Qn
82847-5,11-dehydrocorticosterone+tetrahydrocorticosterone+allo-tetrahydrocorticosterone/androsterone+etiocholanolone [molar ratio] in urine,11-dhc+thb+5a-thb/an+et ur-srto,11-dehydrocorticosterone+tetrahydrocorticosterone+allo-tetrahydrocorticosterone/androsterone+etiocholanolone (u) [molar ratio],11-dhc+thb+5a-thb; 5-alpha tetrahydrocorticosterone; 5a-tetrahydrocorticosterone; aetiocholanolone; allo-thb; an+et; androster; chemistry; esoteric; etiochol; point in time; qnt; quan; quant; quantitative; random; scrto; substance concentration ratio; substance ratio; thb; ua; ur; urn,Qn
82908-5,tetrahydrocortisol/5-alpha tetrahydrocortisol [molar ratio] in 24 hour urine,thf/5a-thf 24h ur-srto,tetrahydrocortisol/5-alpha tetrahydrocortisol (24h u) [molar ratio],1 day; 24 hours; 24hr; 5-a thf; 5a-tetrahydrocortisol; 5a-thf; alfa; chemistry; cortisol metabolite; esoteric; qnt; quan; quant; quantitative; scrto; substance concentration ratio; substance ratio; thc; thf; ua; ur; urn,Qn
8290-9,head occipital-frontal circumference --at birth- by tape measure,head circumf ofc @ birth by tape measure,,@ birth; body circumference.molec; brain; circumf ofc; cranial; cranium; girth; intracranial; length; new born; newborn; point in time; qnt; quan; quant; quantitative; random; skull,Qn
82920-0,legionella pneumophila iga ab [units/volume] in serum by immunoassay,l pneumo iga ser ia-acnc,l. pneumophila iga ia qn (s),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; eia; elfa; elisa; enzyme immunoassay; esoteric; iaa; id; immune globulin a; immunoglobulin a; infectious disease; infectiousdisease; l pneumo; l pneumonphila; legion; legionela; meia; microbiology; pneu; pneum; pneumophilia; point in time; qnt; quan; quant; quantitative; random; serum; sr; suds,Qn
82921-8,liver cytosol igg ab [presence] in serum by line blot,liver cytosol igg ser ql line blot,liver cytosol igg line blot ql (s),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; hepatology; immune globulin g; immunoglobulin g; liver; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serology; serum; sr,Ord
82925-9,pm-scl-100 igg ab [presence] in serum by line blot,pm/scl-100 igg ser ql line blot,pm-scl-100 igg line blot ql (s),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; evening; immune globulin g; immunoglobulin g; ordinal; pm/scl-100; pm1-alpha; point in time; polymyositis; pr; ql; qual; qualitative; random; scleroderma; screen; serology; serum; sr; systemic sclerosis,Ord
82931-7,nuclear pore protein gp210 igg ab [presence] in serum by line blot,nucl pore prot gp210 igg ser ql ln blot,nuclear pore protein gp210 igg line blot ql (s),abs; aby; ana igg; antby; anti; antibodies; antibody; autoantibodies; autoantibody; immune globulin g; immunoglobulin g; nuc; nuclear pore glycoprotein-210; nuclear pore prot gp210; nucleoporin 210kda; nup210; ordinal; point in time; pr; prot; ql; qual; qualitative; random; screen; serology; serum; sr,Ord
82939-0,genetic variant details in blood or tissue by molecular genetics method narrative,genetic variant details bld/t,genetic variant details molgen nar (bld/tiss),"blood; finding; findings; genetics; genomic; heredity; heritable; inherited; molecular genetics; molecular pathology; molpath; narrative; pcr; point in time; random; report; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",Nar
82960-6,"hedis 2017, 2018 value set - group a strep tests",hedis 2017-18 grp a strep,"hedis 2017, 2018 value set - group a strep tests",hedis 2017-18 grp a strep; pan; panel; panel.hedis; panl; pnl; point in time; random,-
82967-1,"amphetamine [mass/volume] in serum, plasma or blood by confirmatory method",amphet serplbld cfm-mcnc,amphetamine confirm (s/p/bld) [mass/vol],"addiction; amph; amphet; amphetam; amphetamines; ampht; blood; cfm; cnfr; cnfrm; conf; confirmation; confirmatory; drug/toxicology; drugs; drugs of abuse; gcms; illicit; lc/ms/ms; level; mass concentration; pl; plasbld; plasma; plsm; point in time; potentialforabuse; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serplbld; serum; serum or plasma; serum, plasma or whole blood; speed; sr; wb; whole blood",Qn
82975-4,desmosome igg ab [presence] in serum or plasma by immunofluorescence,desmosome igg serpl ql if,desmosome igg if ql,abs; aby; acif; antby; anti; antibodies; antibody; anticomplement immunofluorescence; autoantibodies; autoantibody; fa; fluorescent antibody; fluoresent; ifa; immune fluorescence; immune globulin g; immunoflour; immunofluor; immunofluorescence; immunoglobulin g; macula adherens; ordinal; pl; plasma; plsm; point in time; pr; ql; qual; qualitative; random; screen; serology; serp; serpl; serplas; serum; serum or plasma; sr; time resolved fluorescence; trf,Ord
82981-2,nmdar igg ab [presence] in serum or plasma by immunofluorescence,nmdar igg serpl ql if,nmdar igg if ql,abs; aby; acif; antby; anti; antibodies; antibody; anticomplement immunofluorescence; asp; aspartic acid; autoantibodies; autoantibody; dextro; encephalitis; fa; fluorescent antibody; fluoresent; ifa; immune fluorescence; immune globulin g; immunoflour; immunofluor; immunofluorescence; immunoglobulin g; nmda receptor; nmdar; n-methylaspartate receptors; n-methyl-d-aspartic acid; ordinal; pl; plasma; plsm; point in time; pr; ql; qual; qualitative; random; rec; recept; receptors; recp; recptr; screen; serology; serp; serpl; serplas; serum; serum or plasma; sr; time resolved fluorescence; trf,Ord
82997-8,mi-2 alpha igg ab [presence] in serum by line blot,mi-2 alpha igg ser ql line blot,mi-2 alpha igg line blot ql (s),abs; aby; alfa; antby; anti; antibodies; antibody; autoantibodies; autoantibody; chd2; chromodomain-helicase-dna-binding protein 2; dermatomyositis; idiopathic inflammatory myopathies; ii; immune globulin g; immunoglobulin g; inclusion body myositis; mi2; mi-2 alpha antibody; msas; myositis-specific autoantibodies; ordinal; point in time; polymyositis; pr; ql; qual; qualitative; random; screen; serology; serum; sr,Ord
82998-6,dense fine speckled 70 protein igg ab [presence] in serum or plasma by line blot,dfs70 igg serpl ql line blot,dense fine speckled 70 protein igg line blot ql,abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; dfs70; immune globulin g; immunoglobulin g; ordinal; pl; plasma; plsm; point in time; pr; prot; ql; qual; qualitative; random; screen; serology; serp; serpl; serplas; serum; serum or plasma; sr,Ord
83009-1,genetic variation's effect on high-risk allele,genetic var eff high-risk allele,genetic variation effect on high-risk allele ql [interp],genetic var eff high-risk allele; genetics; genomic; impression; impression/interpretation of study; impressions; interp; interpretation; molecular pathology; molpath; molpath.pharmg; ordinal; point in time; ql; qual; qualitative; random; screen,Ord
83020-8,xr bones complete survey views,xr bones survey comp,,bone survey; coreplaybook; document; films; finding; findings; imaging; misc; miscellaneous; other; plain films; playbook; point in time; rad; radiology; random; spec; to be specified in another part of the message; unspecified; view; vws; xray; x-ray,Doc
8302-2,body height,body height,,aoeobservation; axial length; bod; bodies; body height(length).atom; body length; length; point in time; qnt; quan; quant; quantitative; random,Qn
83022-4,xr cervical spine 2 or 3 views and (views w flexion and w extension) and views oblique,xr c-spn v2-3+views w fe+views obl,,2-3v + views w flx+w ext + views oblique; 2v; 2v or 3v; 2v or 3v + views; 2v or 3v + views w flx+w ext; 2vw; c/sp; cerv; coreplaybook; c-spine; document; ext; films; finding; findings; ii; iii; imaging; obl; plain films; playbook; point in time; rad; radiology; random; spinal; spinal cord; view; views+obl; vws; w fe; w flx; xray; x-ray,Doc
83031-5,xr pelvis ap and hip - bilateral ge 2 views,xr pelvis ap + hip-bl ge 2v,,1v; anterio-posterior; anteroposterior; ap + ge 2v; ap + views; bil; bilat; both; coreplaybook; document; ext; extr-bl; film; films; finding; findings; ge 2v; hip-bl; hips; ii; imaging; le; le-bl; leg; low; lower extremity joint; minimum 2 views; msk; musculoskeletal; ortho; orthopedics; pelvic; pelvis + hip-bl; pelvis and hip-bl; pelvis+le; pelvis+le-bl; plain films; playbook; point in time; rad; radiology; random; single view; view; vw; vws; xray; x-ray,Doc
83035-6,xr knee 1 or 2 views during surgery,xr knee 1v or 2v in surg,,1v or 2v; coreplaybook; document; ext; films; finding; findings; i; ii; imaging; in surg; intra operative; intraop; intraoperative; kn; le; leg; low; lower extremity joint; msk; musculoskeletal; ortho; orthopedics; plain films; playbook; point in time; rad; radiology; random; surg; view; views le 2; vws; xray; x-ray,Doc
83053-9,cells.programmed cell death ligand 1/viable tumor cells in tissue by immune stain,cells.pd-l1/viab tum nfr tiss imstn,cells.programmed cell death ligand 1/viable tumor cells immune stain (tiss),"b7 homolog 1; b7-h1; cd274; cell; cells.pd-l1; cellularity; cluster of differentiation 274; i; ihc; imm; immunohistochemical stain; immunostain; imstn; imun; imune; number fraction; pathology; pdl1; pd-l1; percent; point in time; qnt; quan; quant; quantitative; random; st; stains; stn; tc; tissue; tissue, unspecified; viab tum",Qn
83060-4,nras gene [vcf] in cancer specimen by sequencing,nras gene vcf ca spec seq,nras gene sequencing doc (cancer specimen),alps4; ca; ca spec; cmns; document; genetics; heredity; heritable; high-throughput sequencing; hts; inherited; molecular pathology; molpath; ncms; neuroblastoma ras viral (v-ras) oncogene homolog; next generation sequencing; ngs; n-ras; nras1; ns6; oncogene nras; point in time; random; spec; v-ras neuroblastoma ras viral oncogene homolog,Doc
83095-0,epstein barr virus capsid+early igg ab [presence] in serum by immunoassay,ebv vca+ea igg ser ql ia,ebv capsid+early igg ia ql (s),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; cap; ea; ebv; ebv vca; ebv vca+ea; eia; elfa; elisa; enzyme immunoassay; epstn; hhv-4; human herpesvirus 4; iaa; id; immune globulin g; immunoglobulin g; infectious disease; infectiousdisease; meia; microbiology; mono; mononucleosis; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; sr; suds; vca; viral capsid,Ord
83100-8,hepatitis b virus core igg+igm ab [presence] in serum or plasma by immunoassay,hbv core igg+igm serpl ql ia,hbv core igg+igm ia ql,abs; aby; antby; anti; antibodies; antibody; anti-hbc; autoantibodies; autoantibody; eia; elfa; elisa; enzyme immunoassay; hbc; hbv; hbv core; hep; hep b; hepatis; hepatit; hepatitis bc; hepatology; hepb; iaa; id; immune globulin g; immune globulin m; immunoglobulin g; immunoglobulin m; infectious disease; infectiousdisease; liver; meia; microbiology; ordinal; pl; plasma; plsm; point in time; pr; ql; qual; qualitative; random; screen; serp; serpl; serplas; serum; serum or plasma; sr; suds,Ord
83101-6,hiv 1+2 ab and hiv1 p24 ag panel - serum or plasma by immunoassay,hiv 1+2 ab + hiv 1 p24 pnl serpl ia,hiv 1+2 ab and hiv1 p24 ag panel ia,aids; eia; elfa; elisa; enzyme immunoassay; hiv 1 & 2; hiv 1 and 2 ab; hiv 1+2 ab + hiv 1 p24 pnl; hiv 1+2 ab+hiv1 p24; hiv 1+2 ab+hiv1p24; hiv type 1; hiv type i; hiv1; hiv1+2; hiv1+2 ab+hiv1p24ag; human immunodeficiency virus; i; iaa; id; ii; infectious disease; infectiousdisease; meia; microbiology; pan; panel.microbiology; panl; pl; plasma; plsm; pnl; point in time; random; serp; serpl; serplas; serum; serum or plasma; sr; suds,-
83104-0,mullerian inhibiting substance [mass/volume] in serum or plasma by immunoassay,mis serpl ia-mcnc,mullerian inhibiting substance ia [mass/vol],amh; anti mullerian hormone; chemistry; eia; elfa; elisa; enzyme immunoassay; iaa; level; mass concentration; meia; mif; mih; mis; mullerian inhibiting factor; mullerian inhibiting hormone; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; subs; suds,Qn
83106-5,myoglobin [mass/volume] in serum or plasma by immunoassay,myoglobin serpl ia-mcnc,myoglobin ia [mass/vol],cardio; cardiology; chemistry; eia; elfa; elisa; enzyme immunoassay; heart disease; iaa; level; mass concentration; mb; meia; myog; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; suds,Qn
83114-9,s100 calcium binding protein b [mass/volume] in serum by immunoassay,s100 ca binding protein b ser ia-mcnc,s100 calcium binding protein b ia (s) [mass/vol],bind; ca; cal; chemistry; eia; elfa; elisa; enzyme immunoassay; iaa; level; mass concentration; meia; point in time; pr; prot; qnt; quan; quant; quantitative; random; s100 ca binding protein b; s-100b; s-100-beta; serum; sr; suds,Qn
83120-6,thyroxine (t4) [moles/volume] in serum or plasma by immunoassay,t4 serpl ia-scnc,t4 ia [moles/vol],chemistry; eia; elfa; elisa; endocrine; endocrinology; enzyme immunoassay; iaa; level; levothyroxine; levo-thyroxine; l-thyroxine; meia; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; substance concentration; suds; t4; t-4; thyroid hormone; thyrox; thyroxin; thyrx; total t4; tt4,Qn
8312-1,body temperature 8 hour maximum,bdy temp 8h max,,1/3 day; 8 hours; 8hr; bdy temp; bod; bodies; body temperature.timed.molec; maximum; misc; miscellaneous; other; qnt; quan; quant; quantitative; spec; temp; temperature; to be specified in another part of the message; unspecified,Qn
83122-2,thyroxine (t4) free [mass/volume] in serum or plasma by immunoassay,t4 free serpl ia-mcnc,free t4 ia [mass/vol],chemistry; eia; elfa; elisa; endocrine; endocrinology; enzyme immunoassay; fr; freet4; ft4; iaa; level; levothyroxine; levo-thyroxine; l-thyroxine; mass concentration; meia; non-protein bound; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; suds; t4; t-4; t4 free; thyroid hormone; thyrox; thyroxin; thyrx; total t4; tt4,Qn
83127-1,triiodothyronine (t3) free [mass/volume] in serum or plasma by immunoassay,t3free serpl ia-mcnc,free t3 ia [mass/vol],chemistry; eia; elfa; elisa; endocrine; endocrinology; enzyme immunoassay; fr; free t3; ft3; iaa; level; mass concentration; meia; non-protein bound; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; suds; t3; t-3; t3free; thyroid hormone; total t3; triodothyrne,Qn
83131-3,pregnanolone [moles/time] in 24 hour urine,pregnanolone 24h ur-srate,pregnanolone (24h u) [moles/time],1 day; 24 hours; 24hr; chemistry; esoteric; qnt; quan; quant; quantitative; srate; substance rate; ua; ur; urn,Qn
83135-4,allo-pregnanediolone/creatinine [molar ratio] in urine,allo-pregnanediolone/creat ur-srto,allo-pregnanediolone/creatinine (u) [molar ratio],"5-alpha-pregnan-3-alpha,17-alpha-diol-20-one; allo-pdl; chemistry; cr; crea; creat; esoteric; pdl; point in time; qnt; quan; quant; quantitative; random; scrto; substance concentration ratio; substance ratio; ua; ucr; ur; urn",Qn
83136-2,allo-pregnanediol/creatinine [molar ratio] in urine,allo-pregnanediol/creat ur-srto,allo-pregnanediol/creatinine (u) [molar ratio],5alpha-pregnane-3alpha-20alpha-diol; chemistry; cr; crea; creat; esoteric; point in time; pregnanedi; ptl; qnt; quan; quant; quantitative; random; scrto; substance concentration ratio; substance ratio; ua; ucr; ur; urn,Qn
83158-6,9-hole pegboard dexterity - scale score fully adjusted hand.dominant [nih toolbox],pegboard full adj hand.dom nih,,adj; age-adj; ethnicity; full adj; gender; point in time; qnt; quan; quant; quantitative; random; scale; upper extremity,Qn
83161-0,ap postural sway score [nih toolbox] --eyes closed and on foam surface,ap sway score eyes closed+foam nih,,anterio-posterior; anteroposterior; ap sway score; ap sway score^eyes closed+foam; eyes closed+foam; point in time; qnt; quan; quant; quantitative; random; scale; surf,Qn
83176-8,grip strength test - scale score age adjusted hand.non-dominant [nih toolbox],grip scale scr age-adj hand.non-dom nih,,adj; age-adj; grip scale score; point in time; qnt; quan; quant; quantitative; random; scale; upper extremity,Qn
831-8,deprecated a variant subtype ab [presence] in serum or plasma from donor,deprecated a var subtyp serpl donr ql,a variant subtype rbc aggl ql (s/p donor),a var subtyp; agg; agglut; agglutination; arbitrary concentration; blood bank; donr; ordinal; pl; plasma; plsm; point in time; ql; qual; qualitative; random; screen; serp; serpl; serplas; serum; serum or plasma; sr,Ord
83197-4,walking 10 feet on uneven surfaces - functional goal during 3 day assessment period [cms assessment],,,3 days; centers for medicare and medicaid assessment; finding; findings; ordinal; ql; qual; qualitative; screen; survey; walk 10 ft uneven goal,Ord
83229-5,oral hygiene - functional goal during 3 day assessment period [cms assessment],,,3 days; centers for medicare and medicaid assessment; finding; findings; oral hygiene goal; ordinal; ql; qual; qualitative; screen; survey,Ord
83231-1,eating - functional goal during 3 day assessment period [cms assessment],,,3 days; centers for medicare and medicaid assessment; eating goal; finding; findings; ordinal; ql; qual; qualitative; screen; survey,Ord
8323-8,body temperature 10 hour,bdy temp 10h,,10 hours; 10hr; bdy temp; bod; bodies; body temperature.timed.molec; misc; miscellaneous; other; qnt; quan; quant; quantitative; spec; temp; temperature; to be specified in another part of the message; unspecified,Qn
83242-8,bowel continence during 3 day assessment period [cms assessment],,,3 days; centers for medicare and medicaid assessment; finding; findings; ordinal; ql; qual; qualitative; screen; survey,Ord
83245-1,usual ability to swallow during 3 day assessment period [cms assessment],,,3 days; centers for medicare and medicaid assessment; finding; findings; nominal; survey; swallow nutrional ability,Nom
83291-5,ct thumb wo contrast,ct thumb wo contr,,1st metacarpal; arm; c; cat scan; computed tomography; computerized tomography; contr; contra; contrst; ct scan; document; ext; finding; findings; first finger; imaging; point in time; rad; radiology; random; ue; up; without contrast,Doc
83312-9,exchanged drugs andor money for sex in the past year,exch drugs &or money for sex in past y,,drug; exch drugs &or money for sex in past y; finding; findings; gender; h+p; h+p.hx; last; ordinal; p prime; ql; qual; qualitative; screen,Ord
83327-7,hiv 1 rna phenotype in isolate,hiv 1 rna phenotype islt,hiv 1 rna phenotype phenotype method doc (isol),aids; antibiotic susceptibilities; document; finding; findings; hiv type 1; hiv type i; hiv1; human immunodeficiency virus; i; id; infectious disease; infectiousdisease; islt; isol; pheno; phenotype; phenotypic; point in time; random; ribonucleic acid,Doc
83329-3,health and well-being panel [pcam],,,pan; panel.survey.gnhlth; panl; patient centered assessment method; pnl; point in time; random; survey; survey.gnhlth,-
83330-1,physical health impacting mental well-being [pcam],,,finding; findings; ordinal; patient centered assessment method; point in time; ql; qual; qualitative; random; screen; survey; survey.gnhlth,Ord
83333-5,other mental well-being concerns [pcam],,,finding; findings; ordinal; othr; patient centered assessment method; point in time; ql; qual; qualitative; random; screen; survey; survey.gnhlth,Ord
83336-8,health literacy and communication panel [pcam],,,pan; panel.survey.gnhlth; panl; patient centered assessment method; pnl; point in time; random; sdoh; survey; survey.gnhlth,-
83338-4,can engage in healthcare discussions [pcam],,,finding; findings; ordinal; patient centered assessment method; point in time; ql; qual; qualitative; random; screen; sdoh; survey; survey.gnhlth,Ord
83373-1,mode setting nebulizer,mode setting neb,,lung; nominal; point in time; pulmonary; pulmonology; random; respiratory; typ,Nom
83375-6,current nebulization cycle time.elapsed nebulizer,neb cycle time.elapsed neb,,lung; neb cycle time.elapsed; point in time; pulmonary; pulmonology; qnt; quan; quant; quantitative; random; respiratory,Qn
8337-8,body weight special circumstances,bdy weight special circumstances,,bdy weight; bdy weight special circumstances; bod; bodies; body weight.atom; nominal; point in time; random; typ; wt,Nom
83384-8,current nebulization cycle volume.remaining nebulizer,neb cycle vol.remain neb,,lung; neb cycle vol.remain; point in time; pulmonary; pulmonology; qnt; quan; quant; quantitative; random; respiratory; vol; vol.remain; volume,Qn
8347-7,body weight measured --pre dialysis,weight pre dial measured,,bdy weight; before; bod; bodies; body weight.molec; dialy; point in time; qnt; quan; quant; quantitative; random; wt,Qn
83517-3,cardiology attending intensive care unit note,cardio attend icu note,,cardio attend; cardiology; cards; critical care unit; cvd; dis; diseases; doc.ont; document; dz; encounter; evaluation and management; evaluation and management note; finding; findings; icu; notes; point in time; random; visit note,Doc
83518-1,cardiology attending note,cardio attend note,,cardio attend; cardiology; cards; cvd; dis; diseases; doc.ont; document; dz; encounter; evaluation and management; evaluation and management note; finding; findings; notes; point in time; random; visit note,Doc
83529-8,cardiology patient's home note,cardiology pt's home note,,*^patient; cardiology; cards; cvd; dis; diseases; doc.ont; document; dz; encounter; evaluation and management; evaluation and management note; finding; findings; home health care; notes; point in time; pt's home; random; s prime; visit note,Doc
83531-4,cardiology nurse note,cardio nurse note,,cardio nurse; cardiology; cards; cvd; dis; diseases; doc.ont; document; dz; encounter; evaluation and management; evaluation and management note; finding; findings; notes; nursing; point in time; random; visit note,Doc
83547-0,mental health nurse practitioner note,mh np note,,doc.ont; document; emotional stability; encounter; evaluation and management; evaluation and management note; finding; findings; mh np; mh nurse; notes; nursing; point in time; random; visit note,Doc
83554-6,nurse practitioner hospital note,nurse pract hosp note,,doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; hosp; inpatient; notes; nursing; point in time; random; visit note,Doc
8356-8,type of weighing device,weighing device class,,nominal; point in time; random; typ,Nom
83569-4,dermatology nurse outpatient note,dermatology nurse op note,,derm; dermatology nurse; doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; notes; nursing; op; point in time; random; visit note,Doc
83573-6,endocrinology nurse outpatient note,endocrin nurse op note,,doc.ont; document; encounter; endocrin nurse; evaluation and management; evaluation and management note; finding; findings; notes; nursing; op; point in time; random; visit note,Doc
8357-6,blood pressure method,bp method,,blood pressure measurements.atom; bp; bp method; meth; method of; nominal; point in time; random; typ,Nom
83580-1,hematology+medical oncology nurse outpatient note,hemonc nurse op note,,cancer; doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; hematology; hematology and oncology; hematology+oncology; heme; hemonc; hemonc nurse; notes; nursing; oncology; op; point in time; random; visit note,Doc
8358-4,blood pressure device cuff size,bp device cuff size,,bp; bp cuff; bp device; length; point in time; random,OrdQn
83591-8,otolaryngology nurse outpatient note,otolaryngology nurse op note,,doc.ont; document; ear nose throat; encounter; ent; evaluation and management; evaluation and management note; finding; findings; notes; nursing; op; oto; otolaryngology; otolaryngology nurse; otorhinolaryngology; point in time; random; visit note,Doc
83593-4,radiation oncology nurse education note,radiation nurse educ note,,cancer; doc.ont; document; educ note; encounter; evaluation and management; evaluation and management note; finding; findings; notes; nursing; oncology; point in time; radiation nurse; random; visit note,Doc
83609-8,psychiatry nurse consult note,psychiatry nurse consult note,,consult note; doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; mental health; mentalhealth; notes; nursing; point in time; psych; psychiatric; psychiatry; psychiatry nurse; random; visit note,Doc
83611-4,psychiatry nurse note,psychiatry nurse note,,doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; mental health; mentalhealth; notes; nursing; point in time; psych; psychiatric; psychiatry; psychiatry nurse; random; visit note,Doc
83622-1,geriatric medicine nurse note,geri med nurse note,,doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; geri med; geri med nurse; gerontology; notes; nursing; point in time; random; visit note,Doc
83626-2,infectious disease nurse note,infect disease nurse note,,dis; diseases; doc.ont; document; dz; encounter; evaluation and management; evaluation and management note; finding; findings; id; infect disease nurse; infectious disease; infectiousdisease; notes; nursing; point in time; random; visit note,Doc
83627-0,infectious disease nurse outpatient note,infect disease nurse op note,,dis; diseases; doc.ont; document; dz; encounter; evaluation and management; evaluation and management note; finding; findings; id; infect disease nurse; infectious disease; infectiousdisease; notes; nursing; op; point in time; random; visit note,Doc
83641-1,palliative care nurse note,palltv care nurse note,,continuity assessment record and evaluation; doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; notes; nursing; palltv care nurse; point in time; random; visit note,Doc
83651-0,pain medicine outpatient procedure note,pain medicine op procedure note,,doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; notes; op; point in time; random; visit note,Doc
83663-5,orthopaedic surgery attending note,ortho surg attend note,,doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; notes; ortho surg attend; orthopedic; orthopedic surgery; point in time; random; surg; surg attend; visit note,Doc
83672-6,surgery attending intensive care unit note,surg attend icu note,,critical care unit; doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; icu; notes; point in time; random; surg; surg attend; visit note,Doc
83684-1,gastroenterology attending note,gastroenterology attend note,,doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; gastro; gastroenterology; gastroenterology attend; gi; notes; point in time; random; visit note,Doc
83688-2,neurology attending admission evaluation note,neurology attend admit eval note,,admit eval note; assessment; doc.ont; document; encounter; eval; eval note; evaluation and management; evaluation and management note; finding; findings; h&p; history and physical; neuro; neurology; neurology attend; notes; point in time; random; visit note,Doc
83703-9,primary care attending patient's home note,primary care attend pt's home note,,*^patient; continuity assessment record and evaluation; doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; home health care; notes; point in time; primary care attend; pt's home; random; s prime; visit note,Doc
83707-0,physical medicine and rehab administrative note,pm+r administrative note,,doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; notes; pm+r; point in time; random; visit note,Doc
83711-2,physical medicine and rehab conference note,pm+r conf note,,conf note; doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; notes; pm+r; point in time; random; visit note,Doc
83717-9,physical medicine and rehab initial evaluation note,pm+r initial eval note,,assessment; doc.ont; document; encounter; eval; eval note; evaluation and management; evaluation and management note; finding; findings; h&p; history and physical; initial eval note; notes; pm+r; point in time; random; visit note,Doc
83725-2,physical medicine and rehab outpatient note,pm+r op note,,doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; notes; op; pm+r; point in time; random; visit note,Doc
837-5,ax ag [presence] on red blood cells from donor,ax ag rbc donr ql,ax ag ql (rbc donor),antigen; antigens; ao; blood bank; donr; erythrocytes; hematology; heme; ordinal; point in time; pr; ql; qual; qualitative; random; red blood cells; red blood corpusles; screen,Ord
83760-9,interventional radiology resident note,ir resident note,,doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; ir; ir resident; notes; point in time; random; visit note,Doc
83766-6,ophthalmology resident note,ophthal res note,,doc.ont; document; encounter; evaluation and management; evaluation and management note; eye care; finding; findings; notes; ophthal res; point in time; random; visit note,Doc
8378-2,celiac trunk artery diastolic blood pressure,celiac trunk a bp dias,,art; blood pressure; blood pressure diastolic; blood pressure measurements.central.molec; bp; bp dias; bp diastolic; cardio; cardiology; dbp; dias; dias bp; diast; diastoli; heart disease; intravenous; iv; point in time; pressure; qnt; quan; quant; quantitative; random,Qn
83785-6,palliative care physician note,palltv care md note,,continuity assessment record and evaluation; doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; m.d.; md; notes; palltv care md; point in time; random; visit note,Doc
83790-6,spinal cord injury medicine attending note,scim attend note,,doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; notes; point in time; random; scim; scim attend; ulcer; visit note,Doc
8380-8,ductus arteriosus diastolic blood pressure,da bp dias,,blood pressure; blood pressure diastolic; blood pressure measurements.central.molec; bp; bp dias; bp diastolic; cardio; cardiology; da; dbp; dias; dias bp; diast; diastoli; heart disease; intravenous; iv; point in time; pressure; qnt; quan; quant; quantitative; random,Qn
83813-6,physician assistant patient's home note,pa pt's home note,,*^patient; doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; home health care; m.d.; md; notes; point in time; pt's home; random; s prime; visit note,Doc
83833-4,dentistry postoperative evaluation and management note,dentistry post-op e/m note,,assessment; clinical encounter note; dentist; doc.ont; document; e/m note; encounter; eval; evaluation and management; evaluation and management note; finding; findings; h&p; history and physical; notes; point in time; post-op e/m note; post-operative; random; visit note,Doc
83860-7,podiatry outpatient risk assessment and screening note,podiatry op risk assess+scrn note,,asympt; asymptomatic; doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; notes; op; point in time; random; risk assess and screen; risk assess+scrn note; scn; visit note,Doc
83869-8,preventive medicine counseling note,preventive med counseling note,,doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; notes; point in time; random; visit note,Doc
83881-3,psychiatry case manager note,psychiatry case mgr note,,doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; notes; point in time; psychiatric; psychiatry case mgr; random; visit note,Doc
83899-5,psychology custodial care facility note,psych cust care fac note,,cust care fac; doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; notes; point in time; random; visit note,Doc
83918-3,radiation oncology outpatient note,radiation onc op note,,cancer; doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; notes; oncology; op; point in time; random; visit note,Doc
83921-7,recreational therapy discharge summary,rec therapy d/c sum,,d/c sum; disch; discharge summary; doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; notes; point in time; random; rec therapy; visit note,Doc
83925-8,recreational therapy interdisciplinary note,rec therapy interdiscip note,,doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; multidisciplinary; notes; point in time; random; rec therapy; rec therapy interdiscip; visit note,Doc
83952-2,registered nurse hospital note,rn hosp note,,doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; hosp; inpatient; notes; nursing; point in time; random; rn; visit note,Doc
83961-3,social worker patient's home discharge summary,sw pt's home d/c sum,,*^patient; d/c sum; disch; discharge summary; doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; home health care; notes; point in time; pt's home; random; s prime; social work; sw; visit note,Doc
83967-0,social worker long term care facility consult note,sw ltc fac consult note,,consult note; doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; ltc fac; ltcf; notes; point in time; random; social work; sw; visit note,Doc
83977-9,social worker outreach note,sw outreach note,,doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; notes; point in time; random; social work; sw; visit note,Doc
8398-0,descending thoracic aorta mean blood pressure,dta bp mean,,ao; aortic; average; avg; blood pressure mean; blood pressure measurements.central.molec; bp; bp mean; cardio; cardiology; dta; heart disease; intravenous; iv; mbp; point in time; pressure; qnt; quan; quant; quantitative; random; thorax,Qn
83981-1,social worker transfer summary note,sw transfer sum note,,doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; notes; point in time; random; social work; sw; transfer sum note; visit note,Doc
83984-5,speech-language pathology consult note,speech-lang path consult note,,consult note; doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; notes; path; point in time; random; speech pathology; speech therapy; speech-lang path; visit note,Doc
8400-4,right atrial intrachamber mean pressure,ra intrachamber mean pres,,atrial; average; avg; blood pressure mean; blood pressure measurements.central.molec; bp mean; cardiac; cardio; cardiology; heart disease; hrt; intrachamber mean pres; intrachamber pres; mbp; point in time; pressure; qnt; quan; quant; quantitative; r; ra; random; rap; rt,Qn
84004-1,spinal cord injury medicine outpatient annual evaluation note,scim op annual eval note,,annual eval note; assessment; doc.ont; document; encounter; eval; eval note; evaluation and management; evaluation and management note; finding; findings; h&p; history and physical; notes; op; point in time; random; scim; ulcer; visit note,Doc
84008-2,spinal cord injury medicine team note,scim team note,,doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; notes; point in time; random; scim; scim team; ulcer; visit note,Doc
84011-6,spinal cord injury medicine interdisciplinary plan of care note,scim interdiscip plan of care note,,care plan; doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; multidisciplinary; notes; point in time; random; scim; scim interdiscip; treatment plan; ulcer; visit note,Doc
84029-8,team long term care facility conference note,team ltc fac conf note,,conf note; doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; ltc fac; ltcf; notes; point in time; random; visit note,Doc
84046-2,urology telephone encounter note,urology phone note,,doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; genitourinary; gu; notes; point in time; random; uro; urology; visit note,Doc
84049-6,vascular surgery hospital note,vascular surgery hosp note,,doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; hosp; inpatient; notes; point in time; random; surg; visit note,Doc
84074-4,colon and rectal surgery procedure note,col+rec surg procedure note,,col+rec surg; doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; notes; point in time; random; surg; visit note,Doc
84076-9,dermatology administrative note,dermatology administrative note,,derm; doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; notes; point in time; random; visit note,Doc
84103-1,gastroenterology clinical nurse specialist note,gastroenterology cns note,,clin nurse specialist; doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; gastroenterology cns; notes; nursing; point in time; random; visit note,Doc
84108-0,gastroenterology telephone encounter note,gastroenterology phone note,,doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; gastro; gastroenterology; gi; notes; point in time; random; visit note,Doc
84111-4,geriatric medicine case manager note,geri med case mgr note,,doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; geri med; geri med case mgr; gerontology; notes; point in time; random; visit note,Doc
84120-5,geriatric medicine pharmacist note,geri med pharmacist note,,doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; geri med; geri med pharmacist; gerontology; notes; pharmd; point in time; random; visit note,Doc
8414-5,pulmonary artery mean blood pressure,pa bp mean,,art; average; avg; blood pressure mean; blood pressure measurements.central.molec; bp; bp mean; cardio; cardiology; heart disease; intravenous; iv; mbp; pa; pap; point in time; pressure; qnt; quan; quant; quantitative; random,Qn
84166-8,infectious disease counseling note,infectious disease counseling note,,dis; diseases; doc.ont; document; dz; encounter; evaluation and management; evaluation and management note; finding; findings; id; infectious disease; infectiousdisease; notes; point in time; random; visit note,Doc
84172-6,interdisciplinary hospital plan of care note,interdiscip hosp plan of care note,,care plan; doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; hosp; inpatient; multidisciplinary; notes; point in time; random; treatment plan; visit note,Doc
84174-2,interventional cardiology note,ic note,,cardio; cardiology; doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; heart disease; ic; notes; point in time; random; visit note,Doc
84190-8,medical toxicology consult note,med tox consult note,,consult note; doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; med tox; notes; point in time; random; visit note,Doc
84196-5,mental health custodial care facility note,mental health cust care fac note,,cust care fac; doc.ont; document; emotional stability; encounter; evaluation and management; evaluation and management note; finding; findings; notes; point in time; random; visit note,Doc
84204-7,mental health interdisciplinary note,mh interdisp note,,doc.ont; document; emotional stability; encounter; evaluation and management; evaluation and management note; finding; findings; mh interdisp; multidisciplinary; notes; point in time; random; visit note,Doc
84207-0,mental health outpatient group counseling note,mental health op group counseling note,,doc.ont; document; emotional stability; encounter; evaluation and management; evaluation and management note; finding; findings; notes; op; point in time; random; visit note,Doc
84210-4,mental health outpatient plan of care note,mental health op plan of care note,,care plan; doc.ont; document; emotional stability; encounter; evaluation and management; evaluation and management note; finding; findings; notes; op; point in time; random; treatment plan; visit note,Doc
84219-5,nephrology patient's home note,nephrology pt's home note,,*^patient; doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; home health care; kidney; nephrology; notes; point in time; pt's home; random; renal; s prime; visit note,Doc
84231-0,neurology telehealth consult note,neurology telehealth consult note,,consult note; doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; neuro; neurology; notes; point in time; random; telemedicine; visit note,Doc
84244-3,nurse intensive care unit plan of care note,nurse icu plan of care note,,care plan; critical care unit; doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; icu; notes; nursing; point in time; random; treatment plan; visit note,Doc
84250-0,nurse group counseling note,nurse group counseling note,,doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; notes; nursing; point in time; random; visit note,Doc
84252-6,nurse patient's home initial evaluation note,nurse pt's home initial eval note,,*^patient; assessment; doc.ont; document; encounter; eval; eval note; evaluation and management; evaluation and management note; finding; findings; h&p; history and physical; home health care; initial eval note; notes; nursing; point in time; pt's home; random; s prime; visit note,Doc
84263-3,nurse observation unit note,nurse obs unit note,,doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; notes; nursing; obs unit; point in time; random; visit note,Doc
84279-9,nutrition and dietetics group counseling note,nutr+diet group counseling note,,doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; notes; nutr+diet; nutrition+dietetics; point in time; random; visit note,Doc
84280-7,nutrition and dietetics patient's home consult note,nutr+diet pt's home consult note,,*^patient; consult note; doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; home health care; notes; nutr+diet; nutrition+dietetics; point in time; pt's home; random; s prime; visit note,Doc
84288-0,nutrition and dietetics outpatient initial evaluation note,nutr+diet op initial eval note,,assessment; doc.ont; document; encounter; eval; eval note; evaluation and management; evaluation and management note; finding; findings; h&p; history and physical; initial eval note; notes; nutr+diet; nutrition+dietetics; op; point in time; random; visit note,Doc
84316-9,physical therapy team note,pt team note,,doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; notes; point in time; pt; pt team; random; visit note,Doc
84322-7,physical therapy medication management note,pt med mgmt note,,doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; med mgmt note; notes; point in time; pt; random; visit note,Doc
84330-0,physical therapy patient's home initial evaluation note,pt pt's home initial eval note,,*^patient; assessment; doc.ont; document; encounter; eval; eval note; evaluation and management; evaluation and management note; finding; findings; h&p; history and physical; home health care; initial eval note; notes; point in time; pt; pt's home; random; s prime; visit note,Doc
84334-2,pathology telephone encounter note,pathology phone note,,doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; notes; path; point in time; random; visit note,Doc
84346-6,pastoral care group counseling note,pastoral care group counseling note,,continuity assessment record and evaluation; doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; notes; point in time; random; visit note,Doc
84360-7,palliative care counseling note,palliative care counseling note,,continuity assessment record and evaluation; doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; notes; point in time; random; visit note,Doc
8437-6,mesenteric artery systolic blood pressure,mesenteric a bp sys,,art; blood pressure; blood pressure measurements.central.molec; blood pressure systolic; bp; bp sys; bp systolic; cardio; cardiology; heart disease; intravenous; iv; point in time; pressure; qnt; quan; quant; quantitative; random; sbp; sys bp,Qn
8438-4,inferior mesenteric artery systolic blood pressure,im a bp sys,,art; blood pressure; blood pressure measurements.central.molec; blood pressure systolic; bp; bp sys; bp systolic; cardio; cardiology; heart disease; im a; inf; intravenous; iv; point in time; pressure; qnt; quan; quant; quantitative; random; sbp; sys bp,Qn
84395-3,occupational therapy patient's home initial evaluation note,ot pt's home initial eval note,,*^patient; assessment; doc.ont; document; encounter; eval; eval note; evaluation and management; evaluation and management note; finding; findings; h&p; history and physical; home health care; initial eval note; notes; point in time; pt's home; random; s prime; visit note,Doc
84398-7,occupational therapy long term care facility consult note,ot ltc fac consult note,,consult note; doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; ltc fac; ltcf; notes; point in time; random; visit note,Doc
84416-7,grip strength test - scale score fully adjusted hand.dominant [nih toolbox],grip scale score full adj hand.dom nih,,adj; age-adj; ethnicity; full adj; gender; grip scale score; point in time; qnt; quan; quant; quantitative; random; scale; upper extremity,Qn
84421-7,standing balance test - unadjusted scale score [nih toolbox],balance unadj score nih,,bal; balance unadj score; point in time; qnt; quan; quant; quantitative; random; scale,Qn
84424-1,standing balance test - national percentile [nih toolbox],standing balance national prctl nih,,bal; percentile; point in time; qnt; quan; quant; quantitative; random; standing balance national prctl,Qn
84429-0,level 3 emergency medical services patient care report - recommended cda r1 and r2 set,l3 ems pt care rpt cda r1+r2 set,,congenital dyserythropoietic anaemia; iii; l3 ems pt care rpt cda r1+r2 set; levels; levl; lv; lvl; pan; panel; panel.doc; panl; pnl; point in time; random,-
84430-8,occupational therapy interdisciplinary note,ot interdiscip note,,doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; multidisciplinary; notes; ot interdiscip; point in time; random; visit note,Doc
84431-6,optometry technician note,optometry tech note,,doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; notes; optometry tech; point in time; random; visit note,Doc
8444-2,renal artery - right systolic blood pressure,renal a-r bp sys,,art; blood pressure; blood pressure measurements.central.molec; blood pressure systolic; bp; bp sys; bp systolic; cardio; cardiology; heart disease; intravenous; iv; kidney; point in time; pressure; qnt; quan; quant; quantitative; r; random; renal a-r; rt; sbp; sys bp,Qn
84450-6,picture vocabulary test - english - theta score [nih toolbox],pvt - theta score nih,,mental health; mentalhealth; point in time; psych; psychiatry; pvt; pvt - theta score; qnt; quan; quant; quantitative; random; scale,Qn
84453-0,dimensional change card sort test - scale score age adjusted [nih toolbox],dccs score age-adj nih,,adj; age-adj; dccs; dccs score; exchange; mental health; mentalhealth; point in time; psych; psychiatry; qnt; quan; quant; quantitative; random; replace; scale,Qn
84455-5,dimensional change card sort test - scale score fully adjusted [nih toolbox],dccs score full adj nih,,adj; age-adj; dccs; dccs score; ethnicity; exchange; full adj; gender; mental health; mentalhealth; point in time; psych; psychiatry; qnt; quan; quant; quantitative; random; replace; scale,Qn
84457-1,dimensional change card sort test - unadjusted scale score [nih toolbox],dccs - unadj score nih,,dccs; dccs - unadj score; exchange; mental health; mentalhealth; point in time; psych; psychiatry; qnt; quan; quant; quantitative; random; replace; scale,Qn
84460-5,able to point to the letter d [nih toolbox],point to d nih,,dextro; finding; findings; mental health; mentalhealth; ordinal; point in time; point to d; psych; psychiatry; ql; qual; qualitative; random; screen,Ord
84464-7,flanker inhibitory control and attention test - scale score age adjusted [nih toolbox],flanker score age-adj nih,,adj; age-adj; flanker attention test; flanker score; mental health; mentalhealth; point in time; psych; psychiatry; qnt; quan; quant; quantitative; random; scale,Qn
84468-8,flanker inhibitory control and attention test - unadjusted scale score [nih toolbox],flanker - unadj score nih,,flanker - unadj score; flanker attention test; mental health; mentalhealth; point in time; psych; psychiatry; qnt; quan; quant; quantitative; random; scale,Qn
8447-5,diastolic blood pressure--inspiration,bp dias--insp,,art sys; blood pressure; blood pressure diastolic; blood pressure measurements.molec; bp; bp dias; bp diastolic; cardio; cardiology; dbp; dias; dias bp; diast; diastoli; heart disease; in; insp; inspiratory; intravenous; iv; point in time; pressure; qnt; quan; quant; quantitative; random,Qn
84476-1,oral reading recognition test - english - national percentile [nih toolbox],oral reading national prctl nih,,mental health; mentalhealth; oral reading national prctl; ordinal; percentile; point in time; psych; psychiatry; ql; qual; qualitative; random; screen,Ord
84484-5,pattern comparison processing speed test - scale score age adjusted [nih toolbox],pattern comparison score age-adj nih,,adj; age-adj; compare; mental health; mentalhealth; pattern comparison score; point in time; psych; psychiatry; qnt; quan; quant; quantitative; random; scale,Qn
84521-4,can pronounce ostensibly [nih toolbox],pronounce ostensibly nih,,finding; findings; mental health; mentalhealth; ordinal; point in time; psych; psychiatry; ql; qual; qualitative; random; screen,Ord
84536-2,can pronounce doctrine [nih toolbox],pronounce doctrine nih,,finding; findings; mental health; mentalhealth; ordinal; point in time; psych; psychiatry; ql; qual; qualitative; random; screen,Ord
84554-5,can pronounce sedate [nih toolbox],pronounce sedate nih,,finding; findings; mental health; mentalhealth; ordinal; point in time; psych; psychiatry; ql; qual; qualitative; random; screen,Ord
84557-8,can pronounce stevedore [nih toolbox],pronounce stevedore nih,,finding; findings; mental health; mentalhealth; ordinal; point in time; psych; psychiatry; ql; qual; qualitative; random; screen,Ord
84564-4,can pronounce amplify [nih toolbox],pronounce amplify nih,,finding; findings; mental health; mentalhealth; ordinal; point in time; psych; psychiatry; ql; qual; qualitative; random; screen,Ord
84567-7,can pronounce effigial [nih toolbox],pronounce effigial nih,,finding; findings; mental health; mentalhealth; ordinal; point in time; psych; psychiatry; ql; qual; qualitative; random; screen,Ord
84575-0,can pronounce forisfamiliate [nih toolbox],pronounce forisfamiliate nih,,finding; findings; mental health; mentalhealth; ordinal; point in time; psych; psychiatry; ql; qual; qualitative; random; screen,Ord
8458-2,mean blood pressure--supine,bp mean--sup,,art sys; average; avg; blood pressure mean; blood pressure measurements.position.molec; bp; bp mean; cardio; cardiology; heart disease; intravenous; iv; lying; mbp; point in time; position; pressure; qnt; quan; quant; quantitative; random,Qn
84587-5,can pronounce apocryphal [nih toolbox],pronounce apocryphal nih,,finding; findings; mental health; mentalhealth; ordinal; point in time; psych; psychiatry; ql; qual; qualitative; random; screen,Ord
84600-6,can pronounce lymph [nih toolbox],pronounce lymph nih,,finding; findings; mental health; mentalhealth; ordinal; point in time; psych; psychiatry; ql; qual; qualitative; random; screen,Ord
84602-2,can pronounce much [nih toolbox],pronounce much nih,,finding; findings; mental health; mentalhealth; ordinal; point in time; psych; psychiatry; ql; qual; qualitative; random; screen,Ord
8462-4,diastolic blood pressure,bp dias,,art sys; blood pressure; blood pressure diastolic; blood pressure measurements.atom; bp; bp dias; bp diastolic; cardio; cardiology; dbp; dias; dias bp; diast; diastoli; heart disease; intravenous; iv; point in time; pressure; qnt; quan; quant; quantitative; random,Qn
84625-3,can pronounce cello [nih toolbox],pronounce cello nih,,finding; findings; mental health; mentalhealth; ordinal; point in time; psych; psychiatry; ql; qual; qualitative; random; screen,Ord
84638-6,can pronounce lieutenant [nih toolbox],pronounce lieutenant nih,,finding; findings; mental health; mentalhealth; ordinal; point in time; psych; psychiatry; ql; qual; qualitative; random; screen,Ord
84646-9,can pronounce oscillating [nih toolbox],pronounce oscillating nih,,finding; findings; mental health; mentalhealth; ordinal; point in time; psych; psychiatry; ql; qual; qualitative; random; screen,Ord
84666-7,can pronounce excruciating [nih toolbox],pronounce excruciating nih,,finding; findings; mental health; mentalhealth; ordinal; point in time; psych; psychiatry; ql; qual; qualitative; random; screen,Ord
84673-3,can pronounce j [nih toolbox],pronounce j nih,,finding; findings; mental health; mentalhealth; ordinal; point in time; psych; psychiatry; ql; qual; qualitative; random; screen,Ord
84677-4,can pronounce poky [nih toolbox],pronounce poky nih,,finding; findings; mental health; mentalhealth; ordinal; point in time; psych; psychiatry; ql; qual; qualitative; random; screen,Ord
84697-2,can pronounce acquiescence [nih toolbox],pronounce acquiescence nih,,finding; findings; mental health; mentalhealth; ordinal; point in time; psych; psychiatry; ql; qual; qualitative; random; screen,Ord
8469-9,diastolic blood pressure 8 hour mean,bp dias 8h mean,,1/3 day; 8 hours; 8hr; art sys; average; avg; blood pressure; blood pressure diastolic; blood pressure mean; blood pressure measurements.timed.molec; bp; bp dias; bp diastolic; bp mean; cardio; cardiology; dbp; dias; dias bp; diast; diastoli; heart disease; intravenous; iv; mbp; pressure; qnt; quan; quant; quantitative,Qn
84702-0,can pronounce ersatz [nih toolbox],pronounce ersatz nih,,finding; findings; mental health; mentalhealth; ordinal; point in time; psych; psychiatry; ql; qual; qualitative; random; screen,Ord
84720-2,can pronounce stay [nih toolbox],pronounce stay nih,,finding; findings; mental health; mentalhealth; ordinal; point in time; psych; psychiatry; ql; qual; qualitative; random; screen,Ord
84726-9,can pronounce viscera [nih toolbox],pronounce viscera nih,,finding; findings; mental health; mentalhealth; ordinal; point in time; psych; psychiatry; ql; qual; qualitative; random; screen,Ord
84735-0,can pronounce crux [nih toolbox],pronounce crux nih,,finding; findings; mental health; mentalhealth; ordinal; point in time; psych; psychiatry; ql; qual; qualitative; random; screen,Ord
84746-7,can pronounce one [nih toolbox],pronounce one nih,,finding; findings; mental health; mentalhealth; ordinal; point in time; psych; psychiatry; ql; qual; qualitative; random; screen,Ord
84749-1,can pronounce p [nih toolbox],pronounce p nih,,finding; findings; mental health; mentalhealth; ordinal; p prime; point in time; psych; psychiatry; ql; qual; qualitative; random; screen,Ord
84755-8,can pronounce quixotic [nih toolbox],pronounce quixotic nih,,finding; findings; mental health; mentalhealth; ordinal; point in time; psych; psychiatry; ql; qual; qualitative; random; screen,Ord
84762-4,can pronounce try [nih toolbox],pronounce try nih,,finding; findings; mental health; mentalhealth; ordinal; point in time; psych; psychiatry; ql; qual; qualitative; random; screen,Ord
84767-3,can pronounce were [nih toolbox],pronounce were nih,,finding; findings; mental health; mentalhealth; ordinal; point in time; psych; psychiatry; ql; qual; qualitative; random; screen,Ord
84793-9,positive affect survey version 2.0 - parent report - ages 3-7 - t-score [nih toolbox],,,iii; point in time; pos; qnt; quan; quant; quantitative; random; t prime; t-score,Qn
84796-2,positive affect survey - self-report - national percentile [nih toolbox],,,percentile; point in time; pos; qnt; quan; quant; quantitative; random,Qn
84799-6,positive affect survey - self report - cat item bank - ages 18+ [nih toolbox],,,feline; felis domesticus; pan; panel; panl; pnl; pos,-
848-2,a1 b ag [presence] on red blood cells from blood product unit,a1 b ag rbc bpu ql,a1 b ag ql (rbc bpu),antigen; antigens; blood bank; blood product unit; blood product unit (pack); erythrocytes; hematology; heme; ordinal; point in time; pr; ql; qual; qualitative; random; red blood cells; red blood corpusles; screen,Ord
8483-0,systolic blood pressure 10 hour maximum,bp sys 10h max,,10 hours; 10hr; art sys; blood pressure; blood pressure measurements.timed.molec; blood pressure systolic; bp; bp sys; bp systolic; cardio; cardiology; heart disease; intravenous; iv; maximum; pressure; qnt; quan; quant; quantitative; sbp; sys bp,Qn
8485-5,systolic blood pressure 24 hour maximum,bp sys 24h max,,1 day; 24 hours; 24hr; art sys; blood pressure; blood pressure measurements.timed.molec; blood pressure systolic; bp; bp sys; bp systolic; cardio; cardiology; heart disease; intravenous; iv; maximum; pressure; qnt; quan; quant; quantitative; sbp; sys bp,Qn
84895-2,seminal vesicles [presence] in specimen,seminal vesicles spec ql,seminal vesicles ql (spec),ordinal; pathology; point in time; pr; ql; qual; qualitative; random; screen; spec,Ord
84899-4,other nodules greater than 10mm in diameter [presence] in prostate tumor,other nodules >10mm diameter prt ql,other nodules greater than 10mm in diameter ql (prostate tumor),cancer; dia; diam; ordinal; other nodules &gt;10mm diameter; othr; pathology; point in time; pr; prost; prostatic; ql; qual; qualitative; random; screen; tumors; tumour; tumours,Ord
84901-8,other nodule plane [anatomy] in prostate tumor,other nodule plane prt,other nodule plane nom (prostate tumor),anatomy; cancer; nominal; othr; pathology; point in time; prost; prostatic; prt; random; tumors; tumour; tumours,Nom
84908-3,cancer pathology panel - prostate cancer,cancer path pnl prostate cancer,cancer pathology panel (prostate cancer),ca; cancer path pnl; misc; miscellaneous; other; pan; panel.path; panl; path; pathology; pnl; point in time; prost; prostatic; random; spec; to be specified in another part of the message; unspecified,-
84916-6,cells.chromosome region 17p13.1 deletion/cells counted in blood or tissue by fish,cells.17p13.1 del/cells nfr bld/t fish,cells.chromosome region 17p13.1 del/cells counted fish (bld/tiss),"blood; cell; cells.17p13.1; cellularity; chr 17p13.1; chr 17p13.1 del; chromosom; chromosomes; cyto loc; del; deletions; fluorescent in situ hybridization; genetics; heredity; heritable; inherited; molecular pathology; molpath; molpath.deldup; number fraction; percent; point in time; qnt; quan; quant; quantitative; random; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",Qn
84922-4,cells.chromosome 7 monosomy/cells counted in blood or tissue by fish,cells.chr mono 7/cells nfr bld/t fish,cells.chromosome 7 monosomy/cells counted fish (bld/tiss),"blood; cell; cells.chr mono 7; cellularity; chromosom; chromosomes; fluorescent in situ hybridization; genetics; heredity; heritable; inherited; molecular pathology; molpath; molpath.deldup; number fraction; percent; point in time; qnt; quan; quant; quantitative; random; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",Qn
84932-3,friendship survey - fixed length form - ages 18+ [nih toolbox],,,1 month; 1 month (30 days); 30 days; len; pan; panel; panl; pnl,-
8499-6,posterior tibial artery diastolic blood pressure,post tibl a bp dias,,art; blood pressure; blood pressure diastolic; blood pressure measurements.molec; bp; bp dias; bp diastolic; calf; cardio; cardiology; dbp; dias; dias bp; diast; diastoli; heart disease; intravenous; iv; point in time; post tibl a; pressure; qnt; quan; quant; quantitative; random,Qn
85016-4,general life satisfaction survey - fixed length form a - ages 18+ [nih toolbox],,,len; pan; panel; panl; pnl; point in time; random,-
8503-5,dorsal pedal artery mean blood pressure,dors pedal a bp mean,,art; average; avg; blood pressure mean; blood pressure measurements.molec; bp; bp mean; cardio; cardiology; dors pedal a; feet; foot; heart disease; intravenous; iv; mbp; point in time; pressure; qnt; quan; quant; quantitative; random,Qn
85049-5,esbl by cefotaxime to cefotaxime-clavulanate ic ratio [presence] by ard gradient strip,esbl cefot + cefot-clav ic islt ql grad,esbl by cefotaxime to cefotaxime-clavulanate ic ratio ard gradient strip ql (isol),antibiotic susceptibilities; b; betalactamase; b-lactamase; c305; claforan; clav; clavate; clavu; clavul; clavulanic; clavulanic acid; epsilometer; esbl; esbl by cefot to cefot-clav ic rto; estrip; e-strip; grad strip; grad strip ard; id; infectious disease; infectiousdisease; islt; isol; mic; minimum inhibitory concentration; ordinal; point in time; pr; ql; qual; qualitative; random; screen,Ord
85087-5,hexanoate (c6:0) [moles/volume] in serum or plasma,hexanoate serpl-scnc,hexanoate (c6:0) [moles/vol],chemistry; level; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; substance concentration,Qn
85089-1,dothiepin and nordothiepin and dothiepin sulfoxide panel - serum or plasma,dothiepin+metabolites pnl serpl,dothiepin and nordothiepin and dothiepin sulfoxide panel,desmethyldothiepin; dosulepin; dosulepin sulfoxide; dothiepin metabolite; dothiepin+metabolites pnl; dothiepin+metabs pnl; dothiepin+nordothiepin; drug/toxicology; drugs; northiaden; pan; panel.drug & toxicology; panl; pl; plasma; plsm; pnl; point in time; prothiaden; random; serp; serpl; serplas; serum; serum or plasma; sr,-
85090-9,citalopram and norcitalopram and didesmethylcitalopram panel - serum or plasma,citalopram+metabolites pnl serpl,citalopram and norcitalopram and didesmethylcitalopram panel,celexa; cipramil; citalopram metabolite; citalopram+metabolites pnl; desmeth; desmethylcitalopram; didesmet-citalopram; drug/toxicology; drugs; pan; panel.drug & toxicology; panl; pl; plasma; plsm; pnl; point in time; random; serp; serpl; serplas; serum; serum or plasma; sr,-
85096-6,myoglobin casts [presence] in urine sediment by light microscopy,myoglobin casts urns ql micro,myoglobin casts lm ql (urine sed),cast; kidney; lm; mb; micro; micros; microscopic; myog; nephrology; ordinal; point in time; pr; ql; qual; qualitative; random; renal; screen; ua; ur; urinalysis; urine sediment; urn; urns,Ord
85-1,cefaclor [susceptibility] by disk diffusion (kb),cefaclor islt kb,cefaclor disk diffusion (kb) [susc],alfatil; antibiotic susceptibilities; ast; c7; ceclor; disk diffusion; distaclor; id; infectious disease; infectiousdisease; islt; isol; kb; kefalor; kirby-bauer; panacef; panoral; point in time; random; rc7; sus; suscept; susceptibilities; susceptibility; susceptibilty,OrdQn
85115-4,positive affect survey version 2.0 - parent report - cat item bank - ages 3-7 [nih toolbox],,,feline; felis domesticus; iii; pan; panel; panl; pnl; point in time; pos; random,-
85129-5,self-efficacy survey version 2.0 - ages 13-17 - t-score [nih toolbox],,,point in time; qnt; quan; quant; quantitative; random; t prime; t-score,Qn
8513-4,umbilical artery systolic blood pressure,umb a bp sys,,art; blood pressure; blood pressure measurements.molec; blood pressure systolic; bp; bp sys; bp systolic; cardio; cardiology; heart disease; intravenous; iv; point in time; pressure; qnt; quan; quant; quantitative; random; sbp; sys bp; umb a,Qn
85140-2,sadness survey - cat item bank - age 18+ [nih toolbox],,,feline; felis domesticus; pan; panel; panl; pnl; point in time; random,-
85143-6,fear survey version 2.0 - fixed length form - ages 8-17 [nih toolbox],,,len; pan; panel; panl; pnl; point in time; random,-
85146-9,meaning and purpose survey - cat item bank - age 18+ [nih toolbox],,,feline; felis domesticus; pan; panel; panl; pnl; point in time; random,-
85162-6,pharmacology nurse outpatient evaluation and management of anticoagulation note,pharmacology nurse op e/m coag note,,assessment; doc.ont; document; e/m coag note; encounter; eval; evaluation and management; evaluation and management note; finding; findings; h&p; history and physical; notes; nursing; op; pharmacology nurse; pharmacy; point in time; random; visit note,Doc
8516-7,dorsal pedal artery - right diastolic blood pressure,dors pedal a-r bp dias,,art; blood pressure; blood pressure diastolic; blood pressure measurements.molec; bp; bp dias; bp diastolic; cardio; cardiology; dbp; dias; dias bp; diast; diastoli; dors pedal a; dors pedal a-r; feet; foot; heart disease; intravenous; iv; point in time; pressure; qnt; quan; quant; quantitative; r; random; rt,Qn
85169-1,pharmacology team note,pharmacology team note,,doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; notes; pharmacology team; pharmacy; point in time; random; visit note,Doc
85191-5,long term care facility conference note,ltc fac conf note,,conf note; doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; ltc fac; ltcf; notes; point in time; random; visit note,Doc
85194-9,long term care facility fall risk assessment note,ltc fac fall risk assess note,,doc.ont; document; encounter; evaluation and management; evaluation and management note; fall risk assess note; finding; findings; ltc fac; ltcf; notes; point in time; random; risk assess note; visit note,Doc
85195-6,long term care facility group counseling note,ltc fac group counseling note,,doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; ltc fac; ltcf; notes; point in time; random; visit note,Doc
85197-2,long term care facility risk assessment and screening note,ltc fac risk assess+scrn note,,asympt; asymptomatic; doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; ltc fac; ltcf; notes; point in time; random; risk assess and screen; risk assess+scrn note; scn; visit note,Doc
85204-6,patient's home risk assessment and screening note,pt's home risk assess+scrn note,,*^patient; asympt; asymptomatic; doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; home health care; notes; point in time; pt's home; random; risk assess and screen; risk assess+scrn note; s prime; scn; visit note,Doc
85207-9,telehealth education note,telehealth educ note,,doc.ont; document; educ note; encounter; evaluation and management; evaluation and management note; finding; findings; notes; point in time; random; telemedicine; visit note,Doc
85212-9,respite note,respite note,,doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; notes; point in time; random; visit note,Doc
85240-0,internal medicine intensive care unit discharge summary,internal med icu d/c sum,,critical care unit; d/c sum; disch; discharge summary; doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; icu; notes; point in time; random; visit note,Doc
85256-6,radiology attending note,radiology attend note,,doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; notes; point in time; radiology attend; random; visit note,Doc
85257-4,radiology education note,radiology educ note,,doc.ont; document; educ note; encounter; evaluation and management; evaluation and management note; finding; findings; notes; point in time; rad; radiology; random; visit note,Doc
85285-5,polyp in which invasive carcinoma arose [type] in colorectal cancer specimen by light microscopy,polyp type in which inv carc arose micro,polyp in which invasive carcinoma arose lm nom (colorectal cancer specimen),ca; ca spec; crc spec; lm; micro; micros; microscopic; nominal; pathology; point in time; polyp in which inv carc arose; random; spec; typ,Nom
85306-9,distance of carcinoma from lateral margin [length] in breast cancer specimen by light microscopy,dist ca lat marg br ca spec micro,distance of carcinoma from lateral margin lm (breast cancer specimen) [length],br ca spec; brst; ca; ca spec; dist ca lat marg; lat; length; lm; micro; micros; microscopic; pathology; point in time; qnt; quan; quant; quantitative; random; spec,Qn
85316-8,extent of superior margin carcinoma involvement in breast cancer specimen qualitative by light microscopy,sup marg ca extent br ca spec ql micro,extent of superior margin carcinoma involvement lm ql (breast cancer specimen),br ca spec; brst; ca; ca spec; finding; findings; lm; micro; micros; microscopic; ordinal; pathology; point in time; ql; qual; qualitative; random; screen; spec; sup marg ca extent,Ord
85318-4,erbb2 gene duplication [presence] in breast cancer specimen by fish,erbb2 gene dp br ca spec ql fish,erbb2 gene dup fish ql (breast cancer specimen),amplification; br ca spec; brst; ca; ca spec; cd340; c-erb b2; dp; erbb2 duplication; erb-b2 receptor tyrosine kinase 2; fluorescent in situ hybridization; genetics; her2; her-2; her-2/neu; heredity; heritable; inherited; mln 19; molecular pathology; molpath; neu; ngl; oncology; ordinal; point in time; pr; ql; qual; qualitative; random; screen; spec; tkr1; v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 2 (neuro/glioblastoma derived oncogene homolog),Ord
85325-9,cells.progesterone receptor/cells in breast cancer specimen by immune stain,pr+ cells nfr br ca spec imstn,cells.progesterone receptor/cells immune stain (breast cancer specimen),br ca spec; brst; ca; ca spec; cell; cellularity; ihc; imm; immunohistochemical stain; immunostain; imstn; imun; imune; number fraction; oncology; p4; pathology; percent; point in time; pr; pr+ cells; prog; proges; progest; progestin; qnt; quan; quant; quantitative; random; rec; recept; receptors; recp; recptr; spec; st; stains; stn,Qn
8533-2,dorsal pedal artery - right mean blood pressure,dors pedal a-r bp mean,,art; average; avg; blood pressure mean; blood pressure measurements.molec; bp; bp mean; cardio; cardiology; dors pedal a; dors pedal a-r; feet; foot; heart disease; intravenous; iv; mbp; point in time; pressure; qnt; quan; quant; quantitative; r; random; rt,Qn
85344-0,lymph nodes with micrometastases [#] in cancer specimen by light microscopy,ln micromets ca spec micro,lymph nodes with micrometastases lm (cancer specimen) [#],ca; ca spec; cnt; count; lm; ln micromets; micro; micros; microscopic; number; pathology; point in time; qnt; quan; quant; quantitative; random; spec,Qn
85362-2,mycobacterium tuberculosis complex dna [presence] in sputum or bronchial by naa with probe detection,m tb cmplx dna spt/bro ql naa+probe,m. tuberculosis complex dna naa+probe ql (sput/bronchial),3 self-sustaining sequence replication; 3sr sr; acid fast; acid fast bacilli; acid fast bacillus; afb; amplif; amplification; amplified; bro; compx; deoxyribonucleic acid; dna nucleic acid probe; dna probe; id; infectious disease; infectiousdisease; lat; lcr; ligase chain reaction; ligation-activated transcription; lower respiratory; lung; m tb; m tb cmplx; m tuberculosis; microbiology; mtb; mtbc; myco; mycobact; mycobacterium tuberculosum; naa+probe; naat; nasba; nucleic acid sequence based analysis; ordinal; pcr; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; pulmonary; pulmonology; qbr; ql; qual; qualitative; random; respiratory; screen; sda; spt; spt/bro; sputum; sputum or bronchial; strand displacement amplification; tb; tma; transcription mediated amplification; tuberculosis,Ord
85382-0,osmolarity in tear,osmolarity tear,osmolarity (tear) [osmolarity],chemistry; point in time; qnt; quan; quant; quantitative; random; tears,Qn
85385-3,dxa humerus [mass/area] bone density,dxa humerus armass bmd,,arm; bmd; bone densiometry; bone density scan; den; densiometry; dex; dexa; dual energy x ray absorptiometry; ext; films; imaging; maric; point in time; qnt; quan; quant; quantitative; rad; radiology; random; ue; up; upper arm; upper extremity; view; views for bmd; vws,Qn
85405-9,irf-pai - impairment group - admission during assessment period [cms assessment],,,centers for medicare and medicaid assessment; pan; panel; panel.survey.cms; panl; pnl; report period; survey,-
85415-8,patient discharged alive during assessment period [cms assessment],,,centers for medicare and medicaid assessment; finding; findings; ordinal; ql; qual; qualitative; report period; screen; survey,Ord
85416-6,deprecated discharge location,,,disch; nominal; point in time; random; survey; typ,Nom
85417-4,discharge living arrangement during assessment period [cms assessment],,,centers for medicare and medicaid assessment; disch; finding; findings; housing; living arrangements; nominal; report period; residence; survey,Nom
85421-6,bacterial identification and susceptibility panel - isolate,bact id + susc pnl islt,bacterial identification and susceptibility panel (isol),bact; bact id + susc pnl; id; infectious disease; infectiousdisease; islt; isol; microbiology; pan; panel.microbiology; panl; pnl; point in time; random; sus; susc; suscept; susceptibilities; susceptibilty,-
85422-4,cefazolin [susceptibility] for uti by minimum inhibitory concentration (mic),cefazolin islt.uti mic,cefazolin mic (isolate.uti) [susc],ancef; antibiotic susceptibilities; ast; c32; cefamezin; id; infectious disease; infectiousdisease; islt; islt.uti; isol; kefj; kefzol; minimum inhibitory concentration; point in time; random; sus; suscept; susceptibilities; susceptibility; susceptibilty; totacef; zolicef,OrdQn
85424-0,imipenem+relebactam [susceptibility] by minimum inhibitory concentration (mic),imi+rel islt mic,imipenem+relebactam mic [susc],antibiotic susceptibilities; ast; id; imi+rel; imipeneum; imp; infectious disease; infectiousdisease; islt; isol; minimum inhibitory concentration; point in time; primaxin; random; sus; suscept; susceptibilities; susceptibility; susceptibilty,OrdQn
85440-6,vascular surgery discharge summary,vascular surgery d/c sum,,d/c sum; disch; discharge summary; doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; notes; point in time; random; surg; visit note,Doc
85445-5,geriatric medicine note,geri med note,,doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; geri med; gerontology; notes; point in time; random; visit note,Doc
8545-6,ulnar artery - right mean blood pressure,ulnar a-r bp mean,,art; average; avg; blood pressure mean; blood pressure measurements.molec; bp; bp mean; cardio; cardiology; heart disease; intravenous; iv; mbp; point in time; pressure; qnt; quan; quant; quantitative; r; random; rt; ulnar a-r,Qn
85465-3,health literacy and communication panel [epcam],,,electronic patient centered assessment method; pan; panel.survey.gnhlth; panl; pnl; point in time; random; sdoh; survey; survey.gnhlth,-
85469-5,are current services involved with this client well-coordinated - visual analog rating [epcam],,,electronic patient centered assessment method; point in time; qnt; quan; quant; quantitative; random; scale; survey; survey.gnhlth,Qn
85470-3,patient's home medication management note,pt's home med mgmt note,,*^patient; doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; home health care; med mgmt note; notes; point in time; pt's home; random; s prime; visit note,Doc
85482-8,fda product label human cell and tissue establishment registration and product listing,fda label cell tiss est reg,,cell tiss est reg; document.regulatory; fda label; narrative; report,Nar
85487-7,sc1 ag [presence] on red blood cells,sc1 ag rbc ql,sc1 ag ql (rbc),antigen; antigens; blood bank; c; erythrocytes; i; ordinal; point in time; pr; ql; qual; qualitative; random; red blood cells; red blood corpusles; s prime; sc1; screen,Ord
85501-5,carbapenem resistance blavim gene [presence] by molecular method,blavim islt/spm ql,carbapenem resistance blavim gene molgen ql (islt/spec),antibiotic susceptibilities; bact; cpr; id; infectious disease; infectiousdisease; islt; islt/spm; isol; molecular genetics; ordinal; pcr; point in time; pr; ql; qual; qualitative; random; resist; resistanc; resistant; resistent; screen; spec,Ord
85503-1,carbapenem resistance blaoxa-48 gene [presence] by molecular method,blaoxa-48 islt/spm ql,carbapenem resistance blaoxa-48 gene molgen ql (islt/spec),antibiotic susceptibilities; bact; cpr; id; infectious disease; infectiousdisease; islt; islt/spm; isol; molecular genetics; ordinal; pcr; point in time; pr; ql; qual; qualitative; random; resist; resistanc; resistant; resistent; screen; spec,Ord
85506-4,pten gene mutations found [identifier] in colorectal cancer specimen by molecular genetics method nominal,pten gene mut anl crc spec,pten gene targeted mutation analysis molgen nom (colorectal cancer specimen),"10q23del; bannayan-zonana syndrome; bzs; ca; ca spec; crc spec; cws1; dec; genetics; glm2; heredity; heritable; human mutated in multiple advanced cancers protein (mmac1) mrna, complete cds; identity or presence; inherited; mgc11227; mham; mmac1; molecular genetics; molecular pathology; molpath; molpath.mutations; mut; mut anl; mutated in multiple advanced cancers 1; mutations; nominal; pcr; phosphatase and tensin homolog; point in time; pten1; random; spec; tep1",Nom
85511-4,braf gene mutations found [identifier] in colorectal cancer specimen by molecular genetics method nominal,braf gene mut anl crc spec,braf gene targeted mutation analysis molgen nom (colorectal cancer specimen),"b-raf proto-oncogene, serine/threonine kinase; braf1; b-raf1; ca; ca spec; crc spec; genetics; heredity; heritable; identity or presence; inherited; molecular genetics; molecular pathology; molpath; molpath.mutations; mut; mut anl; mutations; nominal; ns7; pcr; point in time; rafb1; random; spec; v-raf",Nom
8551-4,dorsal pedal artery - right systolic blood pressure,dors pedal a-r bp sys,,art; blood pressure; blood pressure measurements.molec; blood pressure systolic; bp; bp sys; bp systolic; cardio; cardiology; dors pedal a; dors pedal a-r; feet; foot; heart disease; intravenous; iv; point in time; pressure; qnt; quan; quant; quantitative; r; random; rt; sbp; sys bp,Qn
85515-5,bariatric surgery progress note,bariatric surg prog note,,doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; metabolic and bariatric surgery; notes; point in time; prog note; random; subsequent evaluation; subsequent visit evaluation; surg; visit note,Doc
85523-9,promis short form - global - version 1.2 raw score,,,patient reported outcomes information system; point in time; promise; qnt; quan; quant; quantitative; random; scale; survey; survey.promis,Qn
85527-0,mycoplasma hyopneumoniae p146 gene sequence and phylogenetic analysis in specimen document,m hyopneumo seq + phylo spec doc,m. hyopneumoniae p146 gene sequence and phylogenetic analysis doc (specimen),document; finding; findings; id; infectious disease; infectiousdisease; m hyopneumo; m hyopneumo p146; m hyopneumo seq + phylo; m hyopneumoniae; microbiology; misc; miscellaneous; myco; mycoplas; mycoplasm; mycoplasmosis; mycoplsm; other; point in time; porcine respiratory mycoplasmosis; random; spec; to be specified in another part of the message; unspecified; vet; veterinary,Doc
85528-8,prrsv european strain igg ab [titer] in serum by immunofluorescence,prrsv european igg titr ser if,prrsv european strain igg if (s) [titer],abortus blauw; abs; aby; acif; antby; anti; antibodies; antibody; anticomplement immunofluorescence; autoantibodies; autoantibody; blue-eared pig disease; dilution factor; dilution factor (titer); fa; fluorescent antibody; fluoresent; ifa; immune fluorescence; immune globulin g; immunoflour; immunofluor; immunofluorescence; immunoglobulin g; lelystad virus; microbiology; mystery swine disease; point in time; porcine epidemic abortion & respiratory syndrome; porcine reproductive and respiratory syndrome; pork; prrs; prrsv; prrsv european; prrsv european strain igg; random; serum; seuchenhafter spatabort der schweine; sirsv; smqn; sr; swine; swine infertility and respiratory syndrome; syndrome dysgenesique et respiratoire porcin; time resolved fluorescence; titer; titered; titre; trf; ttr; vet; veterinary,SemiQn
85555-1,service coordination panel [epcam],,,electronic patient centered assessment method; pan; panel.survey.gnhlth; panl; pnl; point in time; random; survey; survey.gnhlth,-
85558-5,physical therapy - concurrent minutes--week 1 [cms assessment],,,centers for medicare and medicaid assessment; i; pt; qnt; quan; quant; quantitative; report period; survey,Qn
85560-1,physical therapy - co-treatment minutes--week 1 [cms assessment],,,centers for medicare and medicaid assessment; i; pt; qnt; quan; quant; quantitative; report period; survey; tx,Qn
85574-2,occupational therapy - co-treatment minutes--week 2 [cms assessment],,,centers for medicare and medicaid assessment; ii; ot; qnt; quan; quant; quantitative; report period; survey; tx,Qn
85584-1,dengue virus rna [presence] in plasma from donor by naa with probe detection,denv rna plas donr ql naa+probe,denv rna naa+probe ql (p donor),3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; breakbone fever; denv; denv rna; dna nucleic acid probe; dna probe; donr; flavivirus; id; infectious disease; infectiousdisease; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; naa+probe; naat; nasba; nucleic acid sequence based analysis; ordinal; pcr; pl; plasma; plsm; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; ribonucleic acid; screen; sda; strand displacement amplification; tma; transcription mediated amplification,Ord
85591-6,irf-pai - speech-language pathology services - week 2 [cms assessment],,,centers for medicare and medicaid assessment; ii; pan; panel; panel.survey.cms; panl; path; pnl; report period; survey,-
85592-4,planned location for hemodialysis,planned hd loc,,clin; nominal; planned hd loc; point in time; random; typ,Nom
85596-5,preferred kidney failure treatment if kidney disease progresses to kidney failure,pref kidney failure tx if needed,,clin; dis; diseases; dz; nominal; point in time; pref kidney failure tx if needed; random; tx; typ,Nom
85606-2,did your heart failure prevent you from living as you wanted during the past month (4 weeks) by making your sexual activities difficult [mlhfq],,,1 month; 1 month (30 days); 30 days; arterial stenosis; finding; findings; last; minnesota living with heart failure questionnaire; month; ordinal; ql; qual; qualitative; screen; survey,Ord
85609-6,emotional score [mlhfq],,,emot score; minnesota living with heart failure questionnaire; point in time; qnt; quan; quant; quantitative; random; scale; survey,Qn
85610-4,did your heart failure prevent you from living as you wanted during the past month (4 weeks) by making you stay in a hospital [mlhfq],,,1 month; 1 month (30 days); 30 days; arterial stenosis; finding; findings; hosp; last; minnesota living with heart failure questionnaire; month; ordinal; ql; qual; qualitative; screen; survey,Ord
85613-8,did your heart failure prevent you from living as you wanted during the past month (4 weeks) by making you feel you are a burden to your family or friends [mlhfq],,,1 month; 1 month (30 days); 30 days; arterial stenosis; finding; findings; last; minnesota living with heart failure questionnaire; month; ordinal; ql; qual; qualitative; screen; survey,Ord
85614-6,did your heart failure prevent you from living as you wanted during the past month (4 weeks) by making you feel a loss of self-control in your life [mlhfq],,,1 month; 1 month (30 days); 30 days; arterial stenosis; finding; findings; last; minnesota living with heart failure questionnaire; month; ordinal; ql; qual; qualitative; screen; survey,Ord
85624-5,kidney failure 2-year risk [likelihood] by kfre,kidney fail 2y risk kfre.dynamic,kidney failure 2-year risk kfre qn,chemistry; kidney fail 2y risk; kidney failure risk equation - dynamic; point in time; qnt; quan; quant; quantitative; random; risk,Qn
8563-9,middle finger arteries - left systolic blood pressure,middle finger aa-l bp sys,,blood pressure; blood pressure measurements.molec; blood pressure systolic; bp; bp sys; bp systolic; cardio; cardiology; heart disease; intravenous; iv; l; lt; middle finger aa-l; point in time; pressure; qnt; quan; quant; quantitative; random; sbp; sys bp,Qn
85639-3,lcds v3.00 - functional abilities and goals [cms assessment],,,centers for medicare and medicaid assessment; pan; panel; panel.survey.cms; panl; pnl; survey,-
8564-7,middle finger arteries - right systolic blood pressure,middle finger aa-r bp sys,,blood pressure; blood pressure measurements.molec; blood pressure systolic; bp; bp sys; bp systolic; cardio; cardiology; heart disease; intravenous; iv; middle finger aa-r; point in time; pressure; qnt; quan; quant; quantitative; r; random; rt; sbp; sys bp,Qn
85654-2,deprecated long-term care hospital (ltch) continuity assessment record and evaluation (care) data set (lcds) - version 3.00 [cms assessment],,,assessment; centers for medicare and medicaid assessment; eval; h&p; history and physical; hosp; pan; panel; panel.survey.cms; panl; pnl; point in time; random; survey,-
85657-5,occupation industry cdc census code,industry cdc census code,,admin; admin.patient; admin.pt.demog; job; nominal; point in time; random; typ; work,Nom
85660-9,lcds v3.00 - mobility - discharge goal during 3d assessment period [cms assessment],,,3 days; centers for medicare and medicaid assessment; disch; pan; panel; panel.survey.cms; panl; pnl; survey,-
85673-2,lcds v4.00 - administrative information - expired during assessment period [cms assessment],,,admin info; centers for medicare and medicaid assessment; pan; panel; panel.survey.cms; panl; pnl; report period; survey,-
85678-1,haemophilus influenzae acs gene [cycle threshold #] in specimen by naa with probe detection,h influen acs ct spec qn naa+probe,h. influenzae acs gene naa+probe (specimen) [threshnum],3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; dna nucleic acid probe; dna probe; h flu; h influen acs; h influenza; h influenzae; haem influ; haemoph; id; infectious disease; infectiousdisease; influ; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; misc; miscellaneous; naa+probe; naat; nasba; nucleic acid sequence based analysis; other; pcr; point in time; polymerase chain reaction; probe amp; probe with ampification; probe with target amplification; qbr; qnt; quan; quant; quantitative; random; sda; spec; strand displacement amplification; tma; to be specified in another part of the message; transcription mediated amplification; unspecified,Qn
85679-9,haemophilus influenzae bex gene [cycle threshold #] in specimen by naa with probe detection,h influen bex ct spec qn naa+probe,h. influenzae bex gene naa+probe (specimen) [threshnum],3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; dna nucleic acid probe; dna probe; h flu; h influen bex; h influenza; h influenzae; haem influ; haemoph; id; infectious disease; infectiousdisease; influ; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; misc; miscellaneous; naa+probe; naat; nasba; nucleic acid sequence based analysis; other; pcr; point in time; polymerase chain reaction; probe amp; probe with ampification; probe with target amplification; qbr; qnt; quan; quant; quantitative; random; sda; spec; strand displacement amplification; tma; to be specified in another part of the message; transcription mediated amplification; unspecified,Qn
85690-6,rubella virus genotype in specimen,rubv gentyp spec,rubella virus genotype (specimen),congenital rubella syndrome; gentyp; german measles; id; infectious disease; infectiousdisease; microbiology; misc; miscellaneous; nominal; other; point in time; random; rubv; rubv genotype; spec; to be specified in another part of the message; typ; unspecified,Nom
85693-0,previous rubella virus test result,prev rubella virus tx result,,congenital rubella syndrome; finding; findings; german measles; nominal; point in time; prev; prev rubella virus tx result; random; rubv; vaccine,Nom
85700-3,age and setting of exposure to illness verified,,,age and setting verified; exp; exposure; exposure setting; finding; findings; ordinal; point in time; ql; qual; qualitative; random; screen; survey; survey.cdc,Ord
85704-5,year of previous delivery in the u.s. [date] from mother,year of prev delivery in u.s. mother,,h+p; h+p.hx; mat; maternal; matnl; p prime; point in time; prev; qnt; quan; quant; quantitative; random; s prime; year of prev delivery in u.s.,Qn
85709-4,traveled outside the u.s. during first trimester of pregnancy of mother,travel outside us dur 1st tri mother,,finding; findings; gestation; gestations; gravida; h+p; h+p.hx; mat; maternal; matnl; ordinal; p prime; point in time; pregnancies; ql; qual; qualitative; random; s prime; screen; travel outside us dur 1st tri,Ord
85719-3,gestational age in weeks--at cessation of pregnancy,ga (weeks)--at cess of preg,,at cess of preg; end; fetal; ga; ga (weeks); gest; gestation; gestations; gravida; gyn; gynecology; h+p; h+p.hx; ob; obgyn; obstetrics; p prime; pause; point in time; pregnancies; prenatal; qnt; quan; quant; quantitative; random; suspend; termination,Qn
85723-5,mother attended a family planning clinic prior to conception,attend fam plan prior conception mother,,attend fam plan prior conception; finding; findings; h+p; h+p.hx; mat; maternal; matnl; ordinal; p prime; point in time; ql; qual; qualitative; random; screen,Ord
85726-8,other maternal symptoms of illness,other maternal symp of illness,other symptoms of illness nom (mother),finding; findings; h+p; h+p.hx; mat; maternal; matnl; nominal; other symp of illness; othr; p prime; point in time; random; sx,Nom
85737-5,bombay phenotype [presence] on red blood cells,bombay phenotype rbc ql,bombay phenotype ql (rbc),blood bank; erythrocytes; hematology; heme; o sub h phenotype; o(null) phenotype; ordinal; point in time; pr; ql; qual; qualitative; random; red blood cells; red blood corpusles; screen,Ord
85747-4,streptococcus pneumoniae danish serotype 1 dna [cycle threshold #] in specimen by naa with probe detection,s pneum da 1 dna ct spec qn naa+probe,s. pneumoniae danish type 1 dna naa+probe (specimen) [threshnum],3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; deoxyribonucleic acid; dna nucleic acid probe; dna probe; i; id; infectious disease; infectiousdisease; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; misc; miscellaneous; naa+probe; naat; nasba; nucleic acid sequence based analysis; other; pcr; pcv13; pneu; pneum; pneumo; pneumococ; pneumococcal; pneumococcal pneumonia; pneumococcus; pneumon; pneumonia; point in time; polymerase chain reaction; ppsv23; probe amp; probe with ampification; probe with target amplification; qbr; qnt; quan; quant; quantitative; random; s pneum da 1; s pneum da 1 dna; s pneum da type; s pneumo; s pneumoniae; sda; spec; spn; strand displacement amplification; strep; strept; tma; to be specified in another part of the message; transcription mediated amplification; u.s. serotype 1; unspecified,Qn
85748-2,streptococcus pneumoniae danish serotypes 7a+7f dna [cycle threshold #] in specimen by naa with probe detection,s pneum da 7a+7f dna ct spec qn naa+prb,s. pneumoniae danish types 7a+7f dna naa+probe (specimen) [threshnum],3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; deoxyribonucleic acid; dna nucleic acid probe; dna probe; id; infectious disease; infectiousdisease; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; misc; miscellaneous; naa+probe; naat; nasba; nucleic acid sequence based analysis; other; pcr; pneu; pneum; pneumo; pneumococ; pneumococcal; pneumococcal pneumonia; pneumococcus; pneumon; pneumonia; point in time; polymerase chain reaction; probe amp; probe with ampification; probe with target amplification; qbr; qnt; quan; quant; quantitative; random; s pneum da 7a+7f; s pneum da 7a+7f dna; s pneumo; s pneumoniae; sda; spec; spn; strand displacement amplification; strep; strept; tma; to be specified in another part of the message; transcription mediated amplification; unspecified,Qn
85774-8,klebsiella oxytoca dna [presence] by naa with non-probe detection in positive blood culture,k oxytoca dna bld pos ql naa+non-probe,k. oxytoca dna naa+non-probe ql (pos bld culture),3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; bld pos; blood; deoxyribonucleic acid; dna nucleic acid probe; dna probe; id; infectious disease; infectiousdisease; k oxytoca; k oxytoca dna; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; naa+non-probe; naa+probe; naat; nasba; nucleic acid sequence based analysis; ordinal; pcr; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; screen; sda; strand displacement amplification; tma; transcription mediated amplification; wb; whole blood,Ord
85780-5,pseudomonas aeruginosa dna [presence] by naa with non-probe detection in positive blood culture,p aeruginosa dna bld pos naa+non-probe,p. aeruginosa dna naa+non-probe ql (pos bld culture),3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; bld pos; blood; deoxyribonucleic acid; dna nucleic acid probe; dna probe; id; infectious disease; infectiousdisease; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; naa+non-probe; naa+probe; naat; nasba; nucleic acid sequence based analysis; ordinal; p aeruginosa; pcr; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; screen; sda; strand displacement amplification; tma; transcription mediated amplification; wb; whole blood,Ord
85788-8,carbapenem resistance blakpc gene [presence] by naa with non-probe detection in positive blood culture,blakpc bld pos ql naa+non-probe,carbapenem resistance blakpc gene naa+non-probe ql (pos bld culture),3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; antibiotic susceptibilities; bact; bld pos; blood; carbapenem resistance gene; cpr; dna nucleic acid probe; dna probe; id; infectious disease; infectiousdisease; lat; lcr; ligase chain reaction; ligation-activated transcription; naa+non-probe; naa+probe; naat; nasba; nucleic acid sequence based analysis; ordinal; pcr; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; resist; resistanc; resistant; resistent; screen; sda; strand displacement amplification; tma; transcription mediated amplification; wb; whole blood,Ord
85792-0,cd3+cd4+cd45ro+ cells [#/volume] in blood,cd3+cd4+cd45ro+ # bld,cd3+cd4+cd45ro+ cells (bld) [#/vol],#; abs; absolute; absolutes; blood; cd3 cells; cd3+cd4+ cells; cd3-cd4+; cd4+ t cells; cell; cell markers; cellularity; cnt; count; count/volume; ct; helper t cells; inducer t cells; l3t4; leu3; leu-3; leu4; leu-4; number concentration; number concentration (count/vol); point in time; qnt; quan; quant; quantitative; random; t3; t4; t-4; t4 helper/inducer cells; uchl-1; w3/25; wb; whole blood,Qn
85793-8,specimen source subject [type],spec source subj,specimen source subject nom,nominal; point in time; random; spec; spec source subj; srce; typ,Nom
85813-4,irf-pai - payment source during assessment period [cms assessment],,,centers for medicare and medicaid assessment; pan; panel; panel.survey.cms; panl; pnl; report period; srce; survey,-
85815-9,lcds - pre-admission service use during assessment period [cms assessment],,,before; centers for medicare and medicaid assessment; pan; panel; panel.survey.cms; panl; pnl; report period; survey,-
8582-9,left atrial a-wave amplitude,la a-wave amp,,atrial; atrial wave; a-wave; a-wave amp; blood pressure measurements.venous.molec; cardiac; cardio; cardiology; heart disease; hrt; l; la; lt; point in time; pressure; qnt; quan; quant; quantitative; random; venous,Qn
85847-2,patient care team information,pt care team info,,doc.misc; document; finding; findings; misc; point in time; random,Doc
85850-6,cardiothoracic surgery history and physical note,cardiothor surg h&p note,,cardio; cardiology; cardiothor surg; doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; h&p note; heart disease; hx; notes; point in time; random; surg; visit note,Doc
85861-3,womens health nurse outpatient note,wmns hlth nurse op note,,doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; notes; nursing; op; point in time; random; visit note; wmns hlth; wmns hlth nurse,Doc
85876-1,neuropsychology note,neuropsych note,,doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; notes; point in time; random; visit note,Doc
8587-8,pulmonary artery wedge mean blood pressure,paw bp mean,,art; average; avg; blood pressure mean; blood pressure measurements.venous.molec; bp; bp mean; cardio; cardiology; heart disease; intravenous; iv; mbp; pa; pap; paw; pawp; pcwp; point in time; pressure; pulmonary capillary wedge pressure; qnt; quan; quant; quantitative; random; venous,Qn
85890-2,neuropsychology consult note,neuropsych consult note,,consult note; doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; notes; point in time; random; visit note,Doc
85895-1,nuclear medicine diagnostic study note,nuc medicine diag study note,,diag study note; doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; notes; nuc med; nuc medicine; point in time; random; study report; visit note,Doc
85921-5,oasis c2 - respiratory status - soc or roc during assessment period [cms assessment],,,centers for medicare and medicaid assessment; outcome and assessment information set; pan; panel; panel.survey.cms; panl; pnl; report period; resp status; started; survey,-
85924-9,oasis c2 - functional abilities and goals - soc or roc during assessment period [cms assessment],,,centers for medicare and medicaid assessment; outcome and assessment information set; pan; panel; panel.survey.cms; panl; pnl; report period; started; survey,-
85928-0,oasis c2 - medications - soc or roc during assessment period [cms assessment],,,centers for medicare and medicaid assessment; outcome and assessment information set; pan; panel; panel.survey.cms; panl; pnl; report period; started; survey,-
85933-0,cough duration,cough duration,cough duration [time],durat; h+p; h+p.hx; p prime; point in time; qnt; quan; quant; quantitative; random,Qn
85940-5,clinical cardiac electrophysiology postoperative evaluation and management note,electrophysiology post-op e/m note,,assessment; clinical encounter note; doc.ont; document; e/m note; encounter; eval; evaluation and management; evaluation and management note; finding; findings; h&p; history and physical; notes; point in time; post-op e/m note; post-operative; random; visit note,Doc
85966-0,streptococcus pneumoniae danish serotype 1 ab [units/volume] in serum by immunoassay --1st specimen,s pneum da 1 ab sp1 ser ia-acnc,s. pneumoniae danish type 1 ab spec 1 ia qn (s),abs; aby; acute specimen; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; eia; elfa; elisa; enzyme immunoassay; first; i; iaa; id; infectious disease; infectiousdisease; meia; microbiology; pcv13; pneu; pneum; pneumo; pneumococ; pneumococcal; pneumococcal pneumonia; pneumococcus; pneumon; pneumonia; point in time; ppsv23; pre immunization; qnt; quan; quant; quantitative; random; s pneum da 1; s pneum da 1 ab; s pneum da type; s pneumo; s pneumoniae; serum; sp1; spec; spn; sr; strep; strept; suds; u.s. serotype 1,Qn
85996-7,streptococcus pneumoniae danish serotype 14 igg ab [mass/volume] in serum --1st specimen,s pneum da 14 igg sp1 ser-mcnc,s. pneumoniae danish type 14 igg spec 1 (s) [mass/vol],abs; aby; acute specimen; antby; anti; antibodies; antibody; autoantibodies; autoantibody; first; id; immune globulin g; immunoglobulin g; infectious disease; infectiousdisease; level; mass concentration; microbiology; pcv13; pcv7; pneu; pneum; pneumo; pneumococ; pneumococcal; pneumococcal pneumonia; pneumococcus; pneumon; pneumonia; point in time; ppsv23; pre immunization; qnt; quan; quant; quantitative; random; s pneum da 14; s pneum da 14 ab; s pneum da 14 igg; s pneum da type; s pneumo; s pneumoniae; serum; sp1; spec; spn; sr; strep; strept; u.s. serotype 14,Qn
8604-1,type of pacemaker by ekg,pacemaker class ekg,,"cardiac pacemaker; cardio; cardiology; device, heart-assist; ecg; electrocardiogram; electrocardiograph; heart disease; nominal; point in time; prosthetic; random; typ",Nom
86041-1,streptococcus pneumoniae danish serotype 2 igg ab [mass/volume] in serum --1st specimen,s pneum da 2 igg sp1 ser-mcnc,s. pneumoniae danish type 2 igg spec 1 (s) [mass/vol],abs; aby; acute specimen; antby; anti; antibodies; antibody; autoantibodies; autoantibody; first; id; ii; immune globulin g; immunoglobulin g; infectious disease; infectiousdisease; level; mass concentration; microbiology; pneu; pneum; pneumo; pneumococ; pneumococcal; pneumococcal pneumonia; pneumococcus; pneumon; pneumonia; point in time; ppsv23; pre immunization; qnt; quan; quant; quantitative; random; s pneum da 19f ab; s pneum da 19f igg; s pneum da 2; s pneum da type; s pneumo; s pneumoniae; serum; sp1; spec; spn; sr; strep; strept; u.s. serotype 2,Qn
86065-0,streptococcus pneumoniae danish serotype 23f igg ab [mass/volume] in serum --1st specimen,s pneum da 23f igg sp1 ser-mcnc,s. pneumoniae danish type 23f igg spec 1 (s) [mass/vol],abs; aby; acute specimen; antby; anti; antibodies; antibody; autoantibodies; autoantibody; first; id; immune globulin g; immunoglobulin g; infectious disease; infectiousdisease; level; mass concentration; microbiology; pcv13; pcv7; pneu; pneum; pneumo; pneumococ; pneumococcal; pneumococcal pneumonia; pneumococcus; pneumon; pneumonia; point in time; ppsv23; pre immunization; qnt; quan; quant; quantitative; random; s pneum da 23f; s pneum da 23f ab; s pneum da 23f igg; s pneum da type; s pneumo; s pneumoniae; serum; sp1; spec; spn; sr; strep; strept; u.s. serotype 23,Qn
86082-5,streptococcus pneumoniae danish serotype 3 igg ab [units/volume] in serum,s pneum da 3 igg ser-acnc,s. pneumoniae danish type 3 igg qn (s),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; id; iii; immune globulin g; immunoglobulin g; infectious disease; infectiousdisease; microbiology; pcv13; pneu; pneum; pneumo; pneumococ; pneumococcal; pneumococcal pneumonia; pneumococcus; pneumon; pneumonia; point in time; ppsv23; qnt; quan; quant; quantitative; random; s pneum da 3; s pneum da 3 ab; s pneum da 3 igg; s pneum da type; s pneumo; s pneumoniae; serum; spn; sr; strep; strept; u.s. serotype 3,Qn
86095-7,streptococcus pneumoniae danish serotype 3 ab [units/volume] in serum by immunoassay --2nd specimen,s pneum da 3 ab sp2 ser ia-acnc,s. pneumoniae danish type 3 ab spec 2 ia qn (s),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; convalescent; eia; elfa; elisa; enzyme immunoassay; iaa; id; iii; infectious disease; infectiousdisease; meia; microbiology; pcv13; pneu; pneum; pneumo; pneumococ; pneumococcal; pneumococcal pneumonia; pneumococcus; pneumon; pneumonia; point in time; post immunization; ppsv23; qnt; quan; quant; quantitative; random; s pneum da 3; s pneum da 3 ab; s pneum da type; s pneumo; s pneumoniae; second; serum; sp2; spec; spn; sr; strep; strept; suds; u.s. serotype 3,Qn
86124-5,streptococcus pneumoniae danish serotype 11a igg ab [mass/volume] in serum --1st specimen,s pneum da 11a igg sp1 ser-mcnc,s. pneumoniae danish type 11a igg spec 1 (s) [mass/vol],abs; aby; acute specimen; antby; anti; antibodies; antibody; autoantibodies; autoantibody; first; id; immune globulin g; immunoglobulin g; infectious disease; infectiousdisease; level; mass concentration; microbiology; pneu; pneum; pneumo; pneumococ; pneumococcal; pneumococcal pneumonia; pneumococcus; pneumon; pneumonia; point in time; ppsv23; pre immunization; qnt; quan; quant; quantitative; random; s pneum da 11a; s pneum da 11a ab; s pneum da 11a igg; s pneum da type; s pneumo; s pneumoniae; serum; sp1; spec; spn; sr; strep; strept; u.s. serotype 43,Qn
86125-2,streptococcus pneumoniae danish serotype 11a igg ab [mass/volume] in serum by immunoassay --1st specimen,s pneum da 11a igg sp1 ser ia-mcnc,s. pneumoniae danish type 11a igg spec 1 ia (s) [mass/vol],abs; aby; acute specimen; antby; anti; antibodies; antibody; autoantibodies; autoantibody; eia; elfa; elisa; enzyme immunoassay; first; iaa; id; immune globulin g; immunoglobulin g; infectious disease; infectiousdisease; level; mass concentration; meia; microbiology; pneu; pneum; pneumo; pneumococ; pneumococcal; pneumococcal pneumonia; pneumococcus; pneumon; pneumonia; point in time; ppsv23; pre immunization; qnt; quan; quant; quantitative; random; s pneum da 11a; s pneum da 11a ab; s pneum da 11a igg; s pneum da type; s pneumo; s pneumoniae; serum; sp1; spec; spn; sr; strep; strept; suds; u.s. serotype 43,Qn
86131-0,streptococcus pneumoniae danish serotype 5 igg ab [mass/volume] in serum by immunoassay --1st specimen,s pneum da 5 igg sp1 ser ia-mcnc,s. pneumoniae danish type 5 igg spec 1 ia (s) [mass/vol],abs; aby; acute specimen; antby; anti; antibodies; antibody; autoantibodies; autoantibody; eia; elfa; elisa; enzyme immunoassay; first; iaa; id; immune globulin g; immunoglobulin g; infectious disease; infectiousdisease; level; mass concentration; meia; microbiology; pcv13; pneu; pneum; pneumo; pneumococ; pneumococcal; pneumococcal pneumonia; pneumococcus; pneumon; pneumonia; point in time; ppsv23; pre immunization; qnt; quan; quant; quantitative; random; s pneum da 5; s pneum da 5 ab; s pneum da 5 igg; s pneum da type; s pneumo; s pneumoniae; serum; sp1; spec; spn; sr; strep; strept; suds; u.s. serotype 5,Qn
86134-4,streptococcus pneumoniae danish serotype 5 igg ab [mass/volume] in serum --2nd specimen,s pneum da 5 igg sp2 ser-mcnc,s. pneumoniae danish type 5 igg spec 2 (s) [mass/vol],abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; convalescent; id; immune globulin g; immunoglobulin g; infectious disease; infectiousdisease; level; mass concentration; microbiology; pcv13; pneu; pneum; pneumo; pneumococ; pneumococcal; pneumococcal pneumonia; pneumococcus; pneumon; pneumonia; point in time; post immunization; ppsv23; qnt; quan; quant; quantitative; random; s pneum da 5; s pneum da 5 ab; s pneum da 5 igg; s pneum da type; s pneumo; s pneumoniae; second; serum; sp2; spec; spn; sr; strep; strept; u.s. serotype 5,Qn
86144-3,streptococcus pneumoniae danish serotype 8 ab [presence] in serum by immunoassay,s pneum da 8 ab ser ql ia,s. pneumoniae danish type 8 ab ia ql (s),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; eia; elfa; elisa; enzyme immunoassay; iaa; id; infectious disease; infectiousdisease; meia; microbiology; ordinal; pneu; pneum; pneumo; pneumococ; pneumococcal; pneumococcal pneumonia; pneumococcus; pneumon; pneumonia; point in time; ppsv23; pr; ql; qual; qualitative; random; s pneum da 8; s pneum da 8 ab; s pneum da type; s pneumo; s pneumoniae; screen; serum; spn; sr; strep; strept; suds; u.s. serotype 8,Ord
86149-2,streptococcus pneumoniae danish serotype 8 igg ab [units/volume] in serum,s pneum da 8 igg ser-acnc,s. pneumoniae danish type 8 igg qn (s),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; id; immune globulin g; immunoglobulin g; infectious disease; infectiousdisease; microbiology; pneu; pneum; pneumo; pneumococ; pneumococcal; pneumococcal pneumonia; pneumococcus; pneumon; pneumonia; point in time; ppsv23; qnt; quan; quant; quantitative; random; s pneum da 8; s pneum da 8 ab; s pneum da 8 igg; s pneum da type; s pneumo; s pneumoniae; serum; spn; sr; strep; strept; u.s. serotype 8,Qn
86155-9,streptococcus pneumoniae danish serotype 8 igg ab [mass/volume] in serum --2nd specimen,s pneum da 8 igg sp2 ser-mcnc,s. pneumoniae danish type 8 igg spec 2 (s) [mass/vol],abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; convalescent; id; immune globulin g; immunoglobulin g; infectious disease; infectiousdisease; level; mass concentration; microbiology; pneu; pneum; pneumo; pneumococ; pneumococcal; pneumococcal pneumonia; pneumococcus; pneumon; pneumonia; point in time; post immunization; ppsv23; qnt; quan; quant; quantitative; random; s pneum da 8; s pneum da 8 ab; s pneum da 8 igg; s pneum da type; s pneumo; s pneumoniae; second; serum; sp2; spec; spn; sr; strep; strept; u.s. serotype 8,Qn
86166-6,streptococcus pneumoniae danish serotype 9n igg ab [mass/volume] in serum by immunoassay,s pneum da 9n igg ser ia-mcnc,s. pneumoniae danish type 9n igg ia (s) [mass/vol],abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; eia; elfa; elisa; enzyme immunoassay; iaa; id; immune globulin g; immunoglobulin g; infectious disease; infectiousdisease; level; mass concentration; meia; microbiology; pneu; pneum; pneumo; pneumococ; pneumococcal; pneumococcal pneumonia; pneumococcus; pneumon; pneumonia; point in time; ppsv23; qnt; quan; quant; quantitative; random; s pneum da 9n; s pneum da 9n ab; s pneum da 9n igg; s pneum da type; s pneumo; s pneumoniae; serum; spn; sr; strep; strept; suds; u.s. serotype 9,Qn
86174-0,streptococcus pneumoniae danish serotype 9n igg ab [units/volume] in serum --2nd specimen,s pneum da 9n igg sp2 ser-acnc,s. pneumoniae danish type 9n igg spec 2 qn (s),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; convalescent; id; immune globulin g; immunoglobulin g; infectious disease; infectiousdisease; microbiology; pneu; pneum; pneumo; pneumococ; pneumococcal; pneumococcal pneumonia; pneumococcus; pneumon; pneumonia; point in time; post immunization; ppsv23; qnt; quan; quant; quantitative; random; s pneum da 9n; s pneum da 9n ab; s pneum da 9n igg; s pneum da type; s pneumo; s pneumoniae; second; serum; sp2; spec; spn; sr; strep; strept; u.s. serotype 9,Qn
86191-4,eutylone [mass/volume] in urine by confirmatory method,eutylone ur cfm-mcnc,eutylone confirm (u) [mass/vol],addiction; cfm; cnfr; cnfrm; conf; confirmation; confirmatory; drug/toxicology; drugs; drugs of abuse; gcms; illicit; lc/ms/ms; level; mass concentration; point in time; potentialforabuse; qnt; quan; quant; quantitative; random; ua; ur; urn,Qn
86201-1,porcine epidemic diarrhea virus gene sequence and phylogenetic analysis in specimen document,pedv seq + phylo xxx doc spec doc,pedv gene sequence and phylogenetic analysis doc (specimen),document; finding; findings; id; infectious disease; infectiousdisease; microbiology; misc; miscellaneous; other; pedv; pedv gene; pedv seq + phylo xxx doc; point in time; pork; random; spec; swine; to be specified in another part of the message; unspecified; vet; veterinary,Doc
86216-9,porcine epidemic diarrhea virus neutralizing antibody [titer] in serum by neutralization test,pedv nab titr ser nt,porcine epidemic diarrhea virus neut ab neut test (s) [titer],abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; conventional virus neutralization test; cvnt; dilution factor; dilution factor (titer); id; infectious disease; infectiousdisease; microbiology; nab; neutralization; neutralization test; nt; pedv; pedv ab; pedv nab; point in time; pork; random; serum; serum virus neutralization; smqn; sr; svn; swine; titer; titered; titre; ttr; vet; veterinary; virus neutralization test; vnt,SemiQn
86252-4,"oasis c2, d - medications - follow-up during assessment period [cms assessment]",,,centers for medicare and medicaid assessment; dextro; outcome and assessment information set; pan; panel; panel.survey.cms; panl; pnl; report period; survey,-
86264-9,deprecated outcome and assessment information set (oasis) form - version c2 - discharged from agency [cms assessment],,,centers for medicare and medicaid assessment; form version; ltpac; outcome and assessment information set; pan; panel; panel.survey.cms; panl; pnl; point in time; random; survey,-
86267-2,oasis c2 - integumentary status - discharge from agency during assessment period [cms assessment],,,centers for medicare and medicaid assessment; disch; outcome and assessment information set; pan; panel; panel.survey.cms; panl; pnl; report period; survey,-
86271-4,transferrin.gastrointestinal [mass/volume] in stool by immunoassay,transferrin.gastrointestinal stl ia-mcnc,transferrin.gastrointestinal ia (stl) [mass/vol],bowel movement; chemistry; eia; elfa; elisa; enzyme immunoassay; faecal; faeces; fecal; feces; gi; iaa; level; mass concentration; meia; occult blood; point in time; qnt; quan; quant; quantitative; random; siderophilin; stl; stool = fecal; suds; tf; trf; trfrn,Qn
86274-8,right retina retinal nerve fiber layer.temporal superior thickness by oct,r ret rnfl temp sup thickness oct,,eye; eye.oct; fibers; length; ophthalmology; ophtho; ophthy; optical coherence tomography; point in time; qnt; quan; quant; quantitative; r; r ret; random; retinaldehyde; retinene; retinene 1; rnfl; rnfl temp sup thickness; rt; thick; vit a aldehyde; vit a1 aldehyde; vitamin a aldehyde; vitamin a1 aldehyde,Qn
86290-4,left retina retinal nerve fiber layer.mean thickness by oct,l ret rnfl mean thickness oct,,average; avg; eye; eye.oct; fibers; l; l ret; length; lt; ophthalmology; ophtho; ophthy; optical coherence tomography; point in time; qnt; quan; quant; quantitative; random; retinaldehyde; retinene; retinene 1; rnfl; rnfl mean thickness; thick; vit a aldehyde; vit a1 aldehyde; vitamin a aldehyde; vitamin a1 aldehyde,Qn
86291-2,retina retinal nerve fiber layer panel by oct,retina rnfl pnl oct,,eye; fibers; ophthalmology; ophtho; ophthy; optical coherence tomography; pan; panel.eye; panl; pnl; point in time; random; retinaldehyde; retinene; retinene 1; rnfl; rnfl pnl; vit a aldehyde; vit a1 aldehyde; vitamin a aldehyde; vitamin a1 aldehyde,-
86298-7,left retina retinal nerve fiber layer.clock hour 6 thickness by oct,l ret rnfl 6 o'clock thickness oct,,eye; eye.oct; fibers; l; l ret; length; lt; ophthalmology; ophtho; ophthy; optical coherence tomography; point in time; qnt; quan; quant; quantitative; random; retinaldehyde; retinene; retinene 1; rnfl; rnfl 6 o'clock thickness; thick; vit a aldehyde; vit a1 aldehyde; vitamin a aldehyde; vitamin a1 aldehyde,Qn
86302-7,left retina retinal nerve fiber layer.clock hour 10 thickness by oct,l ret rnfl 10 o'clock thickness oct,,eye; eye.oct; fibers; l; l ret; length; lt; ophthalmology; ophtho; ophthy; optical coherence tomography; point in time; qnt; quan; quant; quantitative; random; retinaldehyde; retinene; retinene 1; rnfl; rnfl 10 o'clock thickness; thick; vit a aldehyde; vit a1 aldehyde; vitamin a aldehyde; vitamin a1 aldehyde,Qn
86306-8,right retina retinal nerve fiber layer.clock hour 2 thickness by oct,r ret rnfl 2 o'clock thickness oct,,eye; eye.oct; fibers; ii; length; ophthalmology; ophtho; ophthy; optical coherence tomography; point in time; qnt; quan; quant; quantitative; r; r ret; random; retinaldehyde; retinene; retinene 1; rnfl; rnfl 2 o'clock thickness; rt; thick; vit a aldehyde; vit a1 aldehyde; vitamin a aldehyde; vitamin a1 aldehyde,Qn
863-1,deprecated a3 ab [presence] in serum or plasma from blood product unit,deprecated a3 ab serpl bpu ql,a3 ab rbc aggl ql (s/p bpu),abs; aby; agg; agglut; agglutination; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; blood bank; blood product unit; blood product unit (pack); ordinal; pl; plasma; plsm; point in time; ql; qual; qualitative; random; screen; serp; serpl; serpl^bpu; serplas; serum; serum or plasma; sr,Ord
86338-1,streptococcus pneumoniae danish serotype 6a+6b ab [units/volume] in serum,s pneum da 6a+6b ab ser-acnc,s. pneumoniae danish type 6a+6b ab qn (s),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; id; infectious disease; infectiousdisease; microbiology; pcv13; pneu; pneum; pneumo; pneumococ; pneumococcal; pneumococcal pneumonia; pneumococcus; pneumon; pneumonia; point in time; qnt; quan; quant; quantitative; random; s pneum da 6a; s pneum da 6a+6b; s pneum da 6a+6b ab; s pneum da type; s pneumo; s pneumoniae; serum; spn; sr; strep; strept; u.s. serotype 6,Qn
86351-4,mg guidance for additional aspiration of cyst of breast - left,mg guided brst-l cyst asp addl,,add; asp; brst; brst-l; coreplaybook; cyst asp addl; document; finding; findings; guid; guide; guided; imaging; l; lt; playbook; point in time; rad; radiology; random,Doc
86353-0,mg guidance for placement of clip in breast - left,mg guided brst-l clip place,,brst; brst-l; clip place; coreplaybook; document; finding; findings; guid; guide; guided; imaging; l; lt; marker placement; playbook; point in time; rad; radiology; random,Doc
86361-3,mg stereo guidance for additional biopsy of breast - left,mg.stereo guided brst-l bx addl,,add; brst; brst-l; bx; bx addl; coreplaybook; document; finding; findings; guid; guide; guided; imaging; l; lt; playbook; point in time; rad; radiology; random; stereo,Doc
86368-8,mg breast - left diagnostic for clinical call back,mg brst-l dx for clin call back,,brst; brst-l; coreplaybook; document; dx; dx for clin call back; films; finding; findings; imaging; l; lt; playbook; point in time; rad; radiology; random; symptomatic; view; vws,Doc
86369-6,mg breast - right diagnostic for clinical call back,mg brst-r dx for clin call back,,brst; brst-r; coreplaybook; document; dx; dx for clin call back; films; finding; findings; imaging; playbook; point in time; r; rad; radiology; random; rt; symptomatic; view; vws,Doc
86377-9,rf guidance for advancement of feeding tube of gastrointestinal tract,rf guided gi tract adv feed tube,,abd; abd+pelvis; abdo; abdominal; adv feed tube; coreplaybook; document; finding; findings; fluor; fluoro; fluoroscopy; gi; gi tract; guid; guide; guided; imaging; pelvic; playbook; point in time; rad; radiology; random,Doc
86392-8,rf kidney and ureter and urinary bladder limited views w contrast iv,rf kid+uret+blad views ltd w contr iv,,abd; abd+pelvis; abdo; abdominal; c; contr; contra; contrst; coreplaybook; cystogram; document; films; finding; findings; fluor; fluoro; fluoroscopy; imaging; kid+uret+blad; kidney; lmted; ltd; nephric; nephrogram; nephrography; nephrology; pelvic; playbook; point in time; pyelogram; pyelography; rad; radiology; random; renal; ureter+blad; view; views ltd; vws; w contr iv; wc,Doc
86412-4,rfa pedal lymphatic vessels views w contrast intra lymphatic,rfa ped lymph ves views w contr il,,c; contr; contra; contrst; document; ext; films; finding; findings; fluor; fluoro; fluoroscopy; imaging; intralymphatic; le; leg; low; ped lymph ves; point in time; rad; radiology; random; rfa; vesl; vessels.xxx; view; vws; w contr il; wc,Doc
86413-2,rf guidance for placement of long feeding tube in gastrointestinal tract,rf guided gi tract long feed tube place,,abd; abd+pelvis; abdo; abdominal; coreplaybook; document; finding; findings; fluor; fluoro; fluoroscopy; gi; gi tract; guid; guide; guided; imaging; long feed tube place; pelvic; playbook; point in time; rad; radiology; random,Doc
86416-5,mg breast - bilateral guidance for needle localization and breast specimen views,mg brst-bl needle loc + brst spec view,,bil; bilat; both; breast-bl; breast-bl and breast specimen-bl; breasts; brst; brst spec; brst spec-bl; brst-bl; coreplaybook; document; films; finding; findings; guid; guide; guided; imaging; local; ndl; needle loc + views; playbook; point in time; rad; radiology; random; spec; view; vws,Doc
86419-9,rfa visceral arteries views w contrast ia,rfa visc aa views w contr ia,,abd; abdo; abdomen+; abdominal; arteriogram; c; contr; contra; contrst; coreplaybook; document; films; finding; findings; fluor; fluoro; fluoroscopy; imaging; playbook; point in time; rad; radiology; random; rfa; view; visc aa; vws; w contr ia; wc,Doc
86436-3,rf guidance for treatment of fistula-- w contrast intra fistula,rf guided fistula tx w contr int fist,,c; contr; contra; contrst; coreplaybook; document; finding; findings; fistulogram; fluor; fluoro; fluoroscopy; guid; guide; guided; imaging; misc; miscellaneous; other; playbook; point in time; rad; radiology; random; spec; to be specified in another part of the message; tx; unspecified; w contr intra fist; wc,Doc
86445-4,fda package insert blanket no changes certification of product listing,fda insert blnkt no chngs cert prod list,,blnkt no chngs cert prod list; document.regulatory; fda insert; narrative; report; spl; structured product labelling,Nar
86447-0,fda product label human cell and tissue establishment registration and product listing change in information,fda label cell tiss est reg info change,,cell tiss est reg; cell tiss est reg info change; document.regulatory; exchange; fda label; narrative; replace; report,Nar
8645-4,deprecated visual acuity log mar.right: cmplx: pt: eye.right: qn:,deprecatedvisual acuity log mar,,complex; eye; eyeball; minimal angle of resolution; minimum angle of resolution; occular; oculis; ophthalmologic; ophthalmology; ophtho; ophthy; optic globe; point in time; qnt; quan; quant; quantitative; r; r eye; random; refraction; rt; va; vision; visual,Qn
86456-1,brucella sp ab [presence] in serum by card agglutination,brucella ab ser ql card aggl,brucella sp ab aggl.card ql (s),abs; aby; agg; agglut; agglutination; antby; anti; antibodies; antibody; autoantibodies; autoantibody; bruc; brucellosis; card aggl; id; infectious disease; infectiousdisease; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; species; spp; sr; vet; veterinary,Ord
86465-2,ast to platelet ratio index in serum and blood by calculation,apri ser+bld calc-rto,ast to platelet ratio index calc (s+bld) [ratio],apri; blood; both serum and blood; calc; calculation; chemistry; pl; platelets; platelt; plt; point in time; qnt; quan; quant; quantitative; random; ratios; rto; serbld; serum; serum or whole blood; sr; thrombocyte; thrombocytes; wb; whole blood,Qn
86479-3,"swelling in your feet, ankles or legs when you woke up over the past 2 weeks [kccq]",,,14 days; 2 weeks; finding; findings; kansas city cardiomyopathy questionnaire; last; ordinal; ql; qual; qualitative; screen; survey; survey.gnhlth; times swelling in the am over past 2w,Ord
86480-1,"bothered by swelling in your feet, ankles or legs over the past 2 weeks [kccq]",,,14 days; 2 weeks; finding; findings; kansas city cardiomyopathy questionnaire; last; ordinal; ql; qual; qualitative; screen; survey; survey.gnhlth; swelling feet ankles legs past 2w,Ord
86493-4,participation in visiting family or friends out of your home limited by heart failure over the past 2 weeks [kccq],,,14 days; 2 weeks; finding; findings; hf limited visiting past 2w; kansas city cardiomyopathy questionnaire; last; lmted; ltd; ordinal; ql; qual; qualitative; screen; survey; survey.gnhlth,Ord
8651-2,hospital discharge dx,hospital discharge dx,,diagnosis; disch; h+p; h+p.hx; hosp; impression; impression/interpretation of study; impressions; interp; interpretation; nominal; p prime; point in time; random,Nom
86514-7,chikungunya virus rna [presence] in amniotic fluid by naa with probe detection,chikv rna amn ql naa+probe,chikv rna naa+probe ql (amn fld),3 self-sustaining sequence replication; 3sr sr; af; amn; amn fl; amnio; amniotic flu; amniotic fluid; amplif; amplification; amplified; chikv; dna nucleic acid probe; dna probe; gyn; gynecology; id; infectious disease; infectiousdisease; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; naa+probe; naat; nasba; nucleic acid sequence based analysis; ob; obgyn; obstetrics; ordinal; pcr; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; ribonucleic acid; screen; sda; strand displacement amplification; tma; transcription mediated amplification,Ord
86541-0,herpes simplex virus 2 dna [presence] in tissue by naa with probe detection,hsv2 dna tiss ql naa+probe,hsv 2 dna naa+probe ql (tiss),"3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; deoxyribonucleic acid; dna nucleic acid probe; dna probe; herp splx; herpes simplex virus type 2; herpes simplex virus type ii; hsv; hsv2; id; ii; infectious disease; infectiousdisease; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; naa+probe; naat; nasba; nucleic acid sequence based analysis; ordinal; pcr; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; screen; sda; strand displacement amplification; tissue; tissue, unspecified; tma; transcription mediated amplification",Ord
86545-1,herpes virus 8 dna [presence] in blood by naa with probe detection,hhv8 dna bld ql naa+probe,hhv 8 dna naa+probe ql (bld),3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; blood; deoxyribonucleic acid; dna nucleic acid probe; dna probe; herpesvirus; hhv; hhv8; hhv-8; human herpes virus; id; infectious disease; infectiousdisease; kaposi's sarcoma-associated herpesvirus; kshv; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; naa+probe; naat; nasba; nucleic acid sequence based analysis; ordinal; pcr; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; screen; sda; strand displacement amplification; tma; transcription mediated amplification; wb; whole blood,Ord
86548-5,hiv 2 rna [#/volume] (viral load) in plasma by naa with probe detection,hiv 2 rna # plas naa+probe,hiv 2 rna naa+probe (p) [#/vol],#; 3 self-sustaining sequence replication; 3sr sr; abs; absolute; absolutes; aids; amplif; amplification; amplified; cnt; count; count/volume; ct; dna nucleic acid probe; dna probe; hiv type 2; hiv type ii; human immunodeficiency virus; id; ii; infectious disease; infectiousdisease; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; naa+probe; naat; nasba; nucleic acid sequence based analysis; number concentration; number concentration (count/vol); pcr; pl; plasma; plsm; point in time; polymerase chain reaction; probe amp; probe with ampification; probe with target amplification; qbr; qnt; quan; quant; quantitative; random; ribonucleic acid; sda; strand displacement amplification; tma; transcription mediated amplification; viral load,Qn
86554-3,staff [#] who provided documentation of influenza vaccine receipt,,,cnt; count; number; qnt; quan; quant; quantitative; report period; staff provide doc flu vac; survey; survey.cdc; world heatlth organization,Qn
86561-8,human papilloma virus 16+18+31+33+35+39+45+51+52+56+58+59+68 dna [presence] in tissue by naa with probe detection,hpv i/h risk 1 dna tiss ql naa+probe,hpv 16+18+31+33+35+39+45+51+52+56+58+59+68 dna naa+probe ql (tiss),"3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; deoxyribonucleic acid; dna nucleic acid probe; dna probe; genital warts; hpv; hpv i/h risk 1; hpv ihr; hpv16; hpv16 and 18; hpv16+18; human papillomavirus; id; infectious disease; infectiousdisease; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; naa+probe; naat; nasba; nucleic acid sequence based analysis; ordinal; papilloma virus high risk; papilloma virus intermediate/high risk; pcr; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; screen; sda; strand displacement amplification; tissue; tissue, unspecified; tma; transcription mediated amplification",Ord
86569-1,influenza virus a rna [presence] in tissue by naa with probe detection,fluav rna tiss ql naa+probe,fluav rna naa+probe ql (tiss),"3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; avian influenza; bird flu; dna nucleic acid probe; dna probe; flua; fluav; fluv; fowl plague; id; infectious disease; infectiousdisease; influ; influenza a; influenza a virus; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; naa+probe; naat; nasba; nucleic acid sequence based analysis; ordinal; pcr; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; ribonucleic acid; screen; sda; strand displacement amplification; tissue; tissue, unspecified; tma; transcription mediated amplification",Ord
86597-2,potential indicators of psychosis during assessment period [cms assessment],,,centers for medicare and medicaid assessment; finding; findings; indicator; nominal; report period; survey,Nom
86601-2,functional status during assessment period [cms assessment],,,centers for medicare and medicaid assessment; pan; panel; panel.survey.cms; panl; pnl; report period; survey,-
86603-8,periodontal attachment - recommended cda r1 set,perio attach cda r1 set,,congenital dyserythropoietic anaemia; pan; panel; panel.doc; panl; perio attach cda r1 set; pnl; point in time; random,-
86608-7,norcodeine/creatinine [mass ratio] in urine by confirmatory method,norcodeine/creat ur cfm,norcodeine/creatinine confirm (u) [mass ratio],addiction; cfm; cnfr; cnfrm; conf; confirmation; confirmatory; cr; crea; creat; drug/toxicology; drugs; drugs of abuse; gcms; illicit; lc/ms/ms; mass concentration ratio; mass ratio; mcrto; point in time; potentialforabuse; qnt; quan; quant; quantitative; random; ua; ucr; ur; urn,Qn
86622-8,mrsa sccmec and meca+mecc genes panel - nose,sccmec + meca+mecc pnl nose,mrsa sccmec and meca+mecc genes panel (nose),antibiotic susceptibilities; celbenin; dimethoxypenicillin; metacillin; metin; nasal; nos; nose (nasal passage); o71; pan; panel.antibiotic susceptibilities; panl; pnl; point in time; random; resist; resistanc; resistant; resistent; s aureus; sccmec + meca+mecc; sccmec + meca+mecc pnl; smell; staficyn; staph; staphicillin; staphylococcus cassette chromosome (sccmec),-
86624-4,bladder and bowel appliances used during assessment period [cms assessment],,,appls; centers for medicare and medicaid assessment; finding; findings; nominal; report period; survey,Nom
86625-1,"mds v3.0 - rai v1.14.1, v1.15.1, v1.16.1 - swallowing/nutritional status during assessment period [cms assessment]",,,centers for medicare and medicaid assessment; deglutition; pan; panel; panel.survey.cms; panl; pnl; report period; survey; swallowing/nutritional status,-
86628-5,send document that conforms to oncology treatment plan summary r1.2.1 template,,,attach; attach.modifier; cancer; point in time; random; scope.mod.doc temp; send doc conforms onc plan r1.2.1; tx,-
86630-1,send document that conforms to level 3 ems r1 template,,,attach; attach.modifier; emergency medical service(s); iii; levels; levl; lv; lvl; point in time; random; scope.mod.doc temp; send doc conforms l3 ems r1,-
86633-5,pain panel [hoosjr],,,1 week; hoos jr; pan; panel.survey.gnhlth; panl; pnl; survey; survey.gnhlth,-
8663-7,cigarettes smoked current (pack per day) - reported,cigs smoked (pack/day) nrate reported,,cigs smoked (pack/day); count/time; h+p; h+p.hx; nrate; number rate; number rate = count/time; p prime; point in time; qnt; quan; quant; quantitative; random,Qn
86663-2,hiv referral information panel [fpar],,,aids; family planning annual report; hiv referral pnl; human immunodeficiency virus; pan; panel.survey.hhs; panl; pnl; point in time; random; survey; survey.hhs,-
86667-3,level of tumor invasion in skin melanoma qualitative by clark,tumor invasion level mel ql clark,level of tumor invasion clark ql (skin melanoma),dermatologic; epidermis; finding; findings; integument; levels; levl; lv; lvl; ordinal; path.histo; pathology; point in time; ql; qual; qualitative; random; screen; skn; tumor invasion level,Ord
86669-9,mitotic figures [#/area] in cancer specimen by light microscopy,mitotic figures #/area ca spec micro,mitotic figures lm (cancer specimen) [#/area],#/area; ca; ca spec; lm; micro; micros; microscopic; mitoses; number areic; path.histo; pathology; point in time; qnt; quan; quant; quantitative; random; spec,Qn
86674-9,other health conditions during assessment period [cms assessment],,,centers for medicare and medicaid assessment; othr; pan; panel; panel.survey.cms; panl; pnl; report period; survey,-
8670-2,history of family member diseases,family member diseases hx,,fam mem; family member diseases hx; h/o; h+p; h+p.hx; history; hx; nominal; p prime; point in time; random,Nom
86703-6,porcine respiratory coronavirus rna [cycle threshold #] in specimen by naa with probe detection,prcov rna ct spec qn naa+probe,porcine respiratory coronavirus rna naa+probe (specimen) [threshnum],3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; corona virus; dna nucleic acid probe; dna probe; id; infectious disease; infectiousdisease; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; misc; miscellaneous; naa+probe; naat; nasba; nucleic acid sequence based analysis; other; pcr; point in time; polymerase chain reaction; pork; prcov; probe amp; probe with ampification; probe with target amplification; qbr; qnt; quan; quant; quantitative; random; ribonucleic acid; sda; spec; strand displacement amplification; swine; tma; to be specified in another part of the message; transcription mediated amplification; unspecified; vet; veterinary,Qn
86730-9,leptospira borgpetersenii sv hardjo-bovis dna [cycle threshold #] in specimen by naa with probe detection,l borg har-bovis dna ct spec qn naa+prb,l. borgpetersenii sv hardjo-bovis dna naa+probe (specimen) [threshnum],3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; deoxyribonucleic acid; dna nucleic acid probe; dna probe; id; infectious disease; infectiousdisease; l borg har-bovis; l borgp; l borgp hardjo-bovis dna; l borgpetersenii; lat; lcr; leptospirosis; ligase chain reaction; ligation-activated transcription; microbiology; misc; miscellaneous; naa+probe; naat; nasba; nucleic acid sequence based analysis; other; pcr; point in time; polymerase chain reaction; probe amp; probe with ampification; probe with target amplification; qbr; qnt; quan; quant; quantitative; random; sda; spec; strand displacement amplification; tma; to be specified in another part of the message; transcription mediated amplification; unspecified; vet; veterinary,Qn
86738-2,toxoplasma gondii igg ab [presence] in specimen by immunoassay,t gondii igg spec ql ia,t. gondii igg ia ql (specimen),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; eia; elfa; elisa; enzyme immunoassay; iaa; id; immune globulin g; immunoglobulin g; infectious disease; infectiousdisease; meia; microbiology; misc; miscellaneous; ordinal; other; point in time; pr; ql; qual; qualitative; random; screen; spec; suds; t gondii; to be specified in another part of the message; toxo; toxoplasmosis; unspecified,Ord
86746-5,dimensions of unhealed stage 3 or 4 pressure injuries or eschar during assessment period [cms assessment],,,centers for medicare and medicaid assessment; iii; pan; panel; panel.survey.cms; panl; pnl; pressure ulcer; pressure ulcers; report period; survey,-
86748-1,skin and ulcer/injury treatments during assessment period [cms assessment],,,centers for medicare and medicaid assessment; finding; findings; integument; nominal; pressure injury; pressure ulcer; pressure ulcers; report period; survey; tx; txs; ulcer,Nom
86754-9,number of days hypnotic received in last 7 days or since admission/reentry if less than 7 days [cms assessment],,,centers for medicare and medicaid assessment; count/time; dextro; hypnotic received in last 7d or since admission/reentry if less than 7d; no; nrate; num; number rate; number rate = count/time; past; qnt; quan; quant; quantitative; survey,Qn
86755-6,number of days anticoagulant received in last 7 days or since admission/reentry if less than 7 days [cms assessment],,,anticoag; anticoagulant received in last 7d or since admission/reentry if less than 7d; centers for medicare and medicaid assessment; count/time; dextro; no; nrate; num; number rate; number rate = count/time; past; qnt; quan; quant; quantitative; survey,Qn
86760-6,procedures performed during last 14 days - while not a resident [cms assessment],,,centers for medicare and medicaid assessment; finding; findings; nominal; past; survey,Nom
86761-4,procedures performed during last 14 days - while a resident [cms assessment],,,centers for medicare and medicaid assessment; finding; findings; nominal; past; survey,Nom
86765-5,speech-language pathology and audiology services - co-treatment minutes during 7 day assessment period [cms assessment],,,centers for medicare and medicaid assessment; path; qnt; quan; quant; quantitative; survey; tx,Qn
86771-3,date therapy regimen resumed during assessment period [cms assessment],,,centers for medicare and medicaid assessment; qnt; quan; quant; quantitative; report period; survey,Qn
86780-4,number of days of training and skill practice in dressing or grooming in last 7 calendar days [cms assessment],,,# days of training & skill practice in dressing or grooming; centers for medicare and medicaid assessment; count/time; dextro; no; nrate; num; number rate; number rate = count/time; past; qnt; quan; quant; quantitative; survey,Qn
86785-3,physical restraints during assessment period [cms assessment],,,centers for medicare and medicaid assessment; pan; panel; panel.survey.cms; panl; pnl; report period; survey,-
86789-5,other physical restraints used in bed during assessment period [cms assessment],,,centers for medicare and medicaid assessment; count/time; nrate; number rate; number rate = count/time; ordinal; othr; ql; qual; qualitative; report period; screen; survey,Ord
868-0,a3 ag [presence] on red blood cells,a3 ag rbc ql,a3 ag ql (rbc),antigen; antigens; blood bank; erythrocytes; hematology; heme; ordinal; point in time; pr; ql; qual; qualitative; random; red blood cells; red blood corpusles; screen,Ord
86813-3,"mds v3.0 - rai v1.14.1, v1.15.1, v1.16.1 - hearing, speech, and vision - no, nod, so, sod during assessment period [cms assessment]",,,centers for medicare and medicaid assessment; pan; panel; panel.survey.cms; panl; pnl; report period; survey,-
86814-1,"mds v3.0 - rai v1.17.2 - staff assessment for mental status - nd, sd, ipa, osa during assessment period [cms assessment]",,,centers for medicare and medicaid assessment; pan; panel; panel.survey.cms; panl; pnl; report period; survey,-
86817-4,mds v3.0 - rai v1.17.2 - functional status - osa during assessment period [cms assessment],,,centers for medicare and medicaid assessment; pan; panel; panel.survey.cms; panl; pnl; report period; survey,-
86824-0,"mds v3.0 - rai v1.14.1, v1.15.1, v1.16.1 - swallowing/nutritional status - no, so during assessment period [cms assessment]",,,centers for medicare and medicaid assessment; deglutition; pan; panel; panel.survey.cms; panl; pnl; report period; survey; swallowing/nutritional status,-
86831-5,mds v3.0 - rai v1.17.2 - medications - osa during assessment period [cms assessment],,,centers for medicare and medicaid assessment; pan; panel; panel.survey.cms; panl; pnl; report period; survey,-
86841-4,"mds v3.0 - rai v1.17.2 - therapies - np, nq during assessment period [cms assessment]",,,centers for medicare and medicaid assessment; pan; panel; panel.survey.cms; panl; pnl; report period; survey,-
86842-2,"mds v3.0 - rai v1.14.1, v1.15.1, v1.16.1 - therapies - ns, nsd, ss, ssd during assessment period [cms assessment]",,,centers for medicare and medicaid assessment; pan; panel; panel.survey.cms; panl; pnl; report period; survey,-
8685-0,deprecated history of psychiatric symptoms and diseases,deprecated psych symptoms & diseases hx,,finding; findings; h/o; h+p; h+p.hx; hx; nominal; p prime; point in time; psych symptoms & diseases hx; random; sx; symp + dis,Nom
86857-0,flavivirus neutralizing antibody [presence] in specimen by neutralization test,flavivirus nab spec ql nt,flavivirus neut ab neut test ql (specimen),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; conventional virus neutralization test; cvnt; flav ab; flavi virus; id; infectious disease; infectiousdisease; microbiology; misc; miscellaneous; nab; neutralization; neutralization test; nt; ordinal; other; point in time; pr; ql; qual; qualitative; random; screen; serum virus neutralization; spec; svn; to be specified in another part of the message; unspecified; virus neutralization test; vnt,Ord
86859-6,dengue virus 3 neutralizing antibody [titer] in specimen by neutralization test,denv3 nab titr spec nt,denv 3 neut ab neut test (specimen) [titer],abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; breakbone fever; conventional virus neutralization test; cvnt; dengue type iii; denv; denv3; dilution factor; dilution factor (titer); flavivirus; id; iii; infectious disease; infectiousdisease; microbiology; misc; miscellaneous; nab; neutralization; neutralization test; nt; other; point in time; random; serum virus neutralization; smqn; spec; svn; titer; titered; titre; to be specified in another part of the message; ttr; unspecified; virus neutralization test; vnt,SemiQn
86861-2,dengue virus 4 neutralizing antibody [titer] in specimen by neutralization test,denv4 nab titr spec nt,denv 4 neut ab neut test (specimen) [titer],abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; breakbone fever; conventional virus neutralization test; cvnt; dengue type iv; denv; denv4; dilution factor; dilution factor (titer); flavivirus; id; infectious disease; infectiousdisease; microbiology; misc; miscellaneous; nab; neutralization; neutralization test; nt; other; point in time; random; serum virus neutralization; smqn; spec; svn; titer; titered; titre; to be specified in another part of the message; ttr; unspecified; virus neutralization test; vnt,SemiQn
86865-3,dengue virus 1 neutralizing antibody [presence] in specimen by neutralization test,denv1 nab spec ql nt,denv 1 neut ab neut test ql (specimen),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; breakbone fever; conventional virus neutralization test; cvnt; dengue type i; denv; denv1; flavivirus; i; id; infectious disease; infectiousdisease; microbiology; misc; miscellaneous; nab; neutralization; neutralization test; nt; ordinal; other; point in time; pr; ql; qual; qualitative; random; screen; serum virus neutralization; spec; svn; to be specified in another part of the message; unspecified; virus neutralization test; vnt,Ord
8686-8,history of respiratory system disorders,hx of respiratory disorders,,breathing; h+p; h+p.hx; history; lungs; nominal; p prime; point in time; random; rs; sx; symp + dis,Nom
86879-4,"mds v3.0 - rai v1.16.1 - bladder and bowel - nd, sd during assessment period [cms assessment]",,,centers for medicare and medicaid assessment; pan; panel; panel.survey.cms; panl; pnl; report period; survey,-
86882-8,"mds v3.0 - rai v1.16.1 - cognitive patterns - nd, sd during assessment period [cms assessment]",,,centers for medicare and medicaid assessment; pan; panel; panel.survey.cms; panl; pnl; report period; survey,-
86893-5,"mds v3.0 - rai v1.17.2 - physical therapy - nd, sd during assessment period [cms assessment]",,,centers for medicare and medicaid assessment; pan; panel; panel.survey.cms; panl; pnl; pt; report period; survey,-
86899-2,vedolizumab ab [mass/volume] in serum or plasma by immunoassay,vedolizumab ab serpl ia-mcnc,vedolizumab ab ia [mass/vol],abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; drug/toxicology; drugs; eia; elfa; elisa; entyvio; enzyme immunoassay; iaa; level; mass concentration; meia; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; suds; vedol; vemab,Qn
86904-0,carboxyhemoglobin/hemoglobin.total in arterial blood by pulse oximetry,cohgb % blda pulseox,,abg; art; art bld; art blood; arterial; arterial blood; blood arterial; carbon monoxide.hemoglobin; carbonmonoxyhemoglobin; carbonyl haemoglobin; carbonyl hemoglobin; carbonyl hgb; carboxyhaemoglobin; carboxyhemoglob; co haemoglobin; co hemoglobin; cohb; cohgb; haemoglobin; hb; hbco; hemoglobin bound with carbon dioxide; hgb; lung; mass fraction; percent; point in time; pulmonary; pulmonology; pulseox; qnt; quan; quant; quantitative; random; respiratory; spo2; tot; totl,Qn
86915-6,calcium goal [mass/volume] serum or plasma,calcium goal mcnc serpl,,ca; cal; clin; level; mass concentration; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
86920-6,bicarbonate goal [moles/volume] blood,hco3 goal scnc bld,,bic; bicar; bicarb; blood; clin; hco3; hco3 goal; level; point in time; qnt; quan; quant; quantitative; random; substance concentration; wb; whole blood,Qn
86926-3,transmissible gastroenteritis virus ab/negative control in serum by immunoassay,tgev ab ser ia,transmissible gastroenteritis virus ab/negative control ia (s) [relative ratio],abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; coronavirus; eia; elfa; elisa; enzyme immunoassay; iaa; id; infectious disease; infectiousdisease; meia; microbiology; neg; point in time; qnt; quan; quant; quantitative; random; relative ratio; serum; sr; suds; tgev; transmissible gastroenteritis; vet; veterinary,Qn
86936-2,"i have been able to maintain (keep up with) lifestyle changes, like eating right or exercising [pam]",,,finding; findings; ordinal; point in time; ql; qual; qualitative; r; random; rt; screen; survey; survey.gnhlth,Ord
86952-9,preliminary testing done specimen,preliminary testing done spec,,aoeobservation; ordinal; point in time; pr; public health; public health documents; publichealth; ql; qual; qualitative; random; screen; spec,Ord
86970-1,ct sacrum and coccyx wo contrast,ct sacrum+coccyx wo contr,,c; cat scan; computed tomography; computerized tomography; contr; contra; contrst; ct scan; document; finding; findings; imaging; pelvic; point in time; rad; radiology; random; without contrast,Doc
86974-3,ct thoracic and lumbar spine wo and w contrast iv,ct t+l-spine wo+w contr iv,,abd; abdo; abdomen+; abdominal; c; cat scan; computed tomography; computerized tomography; contr; contra; contrst; ct scan; document; dorsal spine; finding; findings; imaging; l/sp; l-spine; lumbar; lumbo; point in time; rad; radiology; random; spinal; spinal cord; t spine+ab; t+l-spine; th/sp; thorax; t-spine; w contr iv; wc; wo & wc; wo+w contr; wo+w contr iv; wwo,Doc
86979-2,ct pelvis and hip - bilateral wo contrast,ct pelvis and hip-bl wo contr,,bil; bilat; both; c; cat scan; computed tomography; computerized tomography; contr; contra; contrst; ct scan; document; ext; extr-bl; finding; findings; hip-bl; hips; imaging; le; le-bl; leg; low; lower extremity joint; msk; musculoskeletal; ortho; orthopedics; pelvic; pelvis + hip-bl; pelvis and hip-bl; pelvis+le; pelvis+le-bl; point in time; rad; radiology; random; without contrast,Doc
86995-8,guidance for abscess,guided unsp region abscess,,document; finding; findings; guid; guide; guided; imaging; misc; miscellaneous; other; point in time; rad; radiology; random; spec; to be specified in another part of the message; unspecified,Doc
86999-0,guidance for additional percutaneous mechanical thrombectomy of artery,guided artery mech thromb addl,,add; art; cardio; cardiology; coreplaybook; document; finding; findings; guid; guide; guided; heart disease; imaging; mech thromb addl; misc; miscellaneous; other; perc; playbook; point in time; rad; radiology; random; spec; to be specified in another part of the message; unspecified,Doc
8702-3,physical findings of heart,phys find hrt,,cardiac; cardio; cardiology; exam; examination; finding; findings; h+p; h+p.px; heart disease; hrt; nominal; p prime; phys find; point in time; random,Nom
87027-9,guidance for biopsy of chest pleura,guided chest pleura bx,,bx; chest pleura; chest.pleura; coreplaybook; document; finding; findings; guid; guide; guided; imaging; perc; playbook; point in time; rad; radiology; random; thorax,Doc
87033-7,guidance for drainage and placement of chest tube of pleural space,guided pl space drain+ct place,,coreplaybook; document; drain; drain+ct place; exudate; finding; findings; guid; guide; guided; imaging; pl space; playbook; point in time; rad; radiology; random; removal of fluid; thorax,Doc
87038-6,guidance for additional transluminal angioplasty of iliac artery,guided iliac a pta addl,,abd; abd+pelvis; abdo; abdominal; add; art; cardio; cardiology; coreplaybook; document; finding; findings; guid; guide; guided; heart disease; imaging; pelvic; pelvic artery; perc; playbook; point in time; pta; pta addl; rad; radiology; random,Doc
87039-4,guidance for additional vertebroplasty of lumbar spine,guided l-spine vertebroplasty addl,,abd; abdo; abdomen+; abdominal; add; coreplaybook; document; finding; findings; guid; guide; guided; imaging; l/sp; l-spine; lumbar; lumbo; playbook; point in time; rad; radiology; random; spinal; spinal cord; vertebroplasty addl,Doc
87046-9,guidance for cholangioscopy of gallbladder,guided gb cholangioscopy,,abd; abdo; abdomen+; abdominal; coreplaybook; document; finding; findings; gall bladder; gb; guid; guide; guided; imaging; playbook; point in time; rad; radiology; random,Doc
87050-1,guidance for cryoablation of liver,guided liver cryoablation,,abd; abdo; abdomen+; abdominal; coreplaybook; document; finding; findings; guid; guide; guided; hepar; hepatic; imaging; playbook; point in time; rad; radiology; random,Doc
87062-6,guidance for nerve block of celiac plexus,guided celiac plexus nerve block,,abd; abdo; abdomen+; abdominal; coreplaybook; document; finding; findings; guid; guide; guided; imaging; playbook; point in time; rad; radiology; random,Doc
87067-5,guidance for transjugular biopsy of kidney,guided kidney transjugular bx,,abd; abdo; abdomen+; abdominal; bx; coreplaybook; document; finding; findings; guid; guide; guided; imaging; kidney; nephric; nephrology; playbook; point in time; rad; radiology; random; renal; transjugular bx,Doc
8707-2,physical findings of pelvis,phys find pelvis,,exam; examination; finding; findings; h+p; h+p.px; nominal; p prime; pelvic; phys find; point in time; random,Nom
87076-6,guidance for transjugular biopsy and hemodynamic evaluation of liver,guided liver transjugular bx+hemo eval,,abd; abdo; abdomen+; abdominal; assessment; bx; coreplaybook; document; eval; finding; findings; guid; guide; guided; h&p; hepar; hepatic; history and physical; imaging; playbook; point in time; rad; radiology; random; transjugular bx; transjugular bx+hemo eval,Doc
87079-0,guidance for paracentesis and insertion of tube of peritoneum,guided peritoneum paracent+tube insert,,abd; abdo; abdomen+; abdominal; coreplaybook; document; finding; findings; guid; guide; guided; imaging; insertions; paracent+tube insert; playbook; point in time; rad; radiology; random,Doc
87082-4,guidance for removal of catheter from peritoneum,guided peritoneum cath rem,,abd; abdo; abdomen+; abdominal; cath; cath rem; coreplaybook; document; extraction; finding; findings; guid; guide; guided; imaging; playbook; point in time; rad; radiology; random; remove,Doc
87101-2,guidance for percutaneous transluminal angioplasty of brachiocephalic artery,guided brachceph a pta,,art; brachceph a; brachiocephalic; cardio; cardiology; coreplaybook; document; finding; findings; guid; guide; guided; heart disease; imaging; innominate artery; perc; playbook; point in time; pta; rad; radiology; random; thorax,Doc
87122-8,guidance for kyphoplasty of thoracic spine,guided t-spine kyphoplasty,,coreplaybook; document; dorsal spine; finding; findings; guid; guide; guided; imaging; playbook; point in time; rad; radiology; random; spinal; spinal cord; th/sp; thorax; t-spine,Doc
87128-5,guidance for placement of venous filter in superior vena cava,guided svc filter place,,coreplaybook; document; filter place; finding; findings; guid; guide; guided; heart; imaging; playbook; point in time; rad; radiology; random; svc; thorax; vc,Doc
87134-3,guidance for placement of stent in femoral artery and popliteal artery,guided fem a+pop a stent place,,art; cardio; cardiology; coreplaybook; document; ext; extr-ul; fem a; fem a+pop a; fem a+popliteal a; finding; findings; guid; guide; guided; heart disease; imaging; knee artery; le; leg; low; playbook; point in time; rad; radiology; random; stent place; thigh,Doc
87136-8,guidance for arthrocentesis of knee,guided knee arthrocentesis,,asp; coreplaybook; document; ext; finding; findings; fld; guid; guide; guided; imaging; kn; le; leg; low; lower extremity joint; msk; musculoskeletal; ortho; orthopedics; pc fluid asp; perc; playbook; point in time; rad; radiology; random,Doc
87139-2,guidance for additional transluminal angioplasty of lower leg,guided lower leg pta addl,,add; calf; coreplaybook; document; ext; fibula; finding; findings; guid; guide; guided; imaging; le; leg; low; lower extremity; perc; playbook; point in time; pta; pta addl; rad; radiology; random; tibia,Doc
87146-7,guidance for injection of shoulder,guided should inj,,arm; coreplaybook; document; ext; finding; findings; guid; guide; guided; imaging; inj; msk; musculoskeletal; ortho; orthopedics; playbook; point in time; rad; radiology; random; ue; up; upper extremity joint,Doc
87154-1,guidance for diagnostic puncture of cervical spine,guided c-spine diag puncture,,c/sp; cerv; coreplaybook; c-spine; diag puncture; document; finding; findings; guid; guide; guided; imaging; playbook; point in time; rad; radiology; random; spinal; spinal cord,Doc
87164-0,guidance for secondary mechanical thrombectomy of artery,guided artery secondary mech thromb,,art; cardio; cardiology; coreplaybook; document; finding; findings; guid; guide; guided; heart disease; imaging; misc; miscellaneous; other; perc; playbook; point in time; rad; radiology; random; secondary mech thromb; spec; to be specified in another part of the message; unspecified,Doc
87166-5,guidance for percutaneous transluminal angioplasty of vein,guided vein pta,,cardio; cardiology; coreplaybook; document; finding; findings; guid; guide; guided; heart disease; imaging; misc; miscellaneous; other; perc; playbook; point in time; pta; rad; radiology; random; spec; to be specified in another part of the message; unspecified; ven; venous,Doc
87183-0,guidance for greater than 2 injections of trigger point of muscle,guided muscle trigger point inject ge3,,coreplaybook; document; finding; findings; guid; guide; guided; iii; imaging; inj; misc; miscellaneous; musc; muscl; other; playbook; point in time; rad; radiology; random; spec; to be specified in another part of the message; trigger point injection ge3; unspecified,Doc
8720-5,surgical operation note preoperative diagnosis,operative note pre-op dx,,diagnosis; encounter; evaluation and management; evaluation and management note; h+p; h+p.surgical procedures; impression; impression/interpretation of study; impressions; interp; interpretation; nominal; notes; operative note; operative note pre-op dx; p prime; point in time; pre-op; random; surg; visit note,Nom
87219-2,attesting individual first name during assessment period [cms assessment] provider,,,centers for medicare and medicaid assessment; given name; nominal; person name; report period; survey,Nom
87229-1,"mds v3.0 - rai v1.14.1, v1.15.1, v1.16.1 - assessment administration - nd, sd during assessment period [cms assessment]",,,centers for medicare and medicaid assessment; pan; panel; panel.survey.cms; panl; pnl; report period; survey,-
87234-1,dialysis education note,dialy educ note,,dialy; doc.ont; document; educ note; encounter; evaluation and management; evaluation and management note; finding; findings; notes; point in time; random; visit note,Doc
87237-4,dialysis plan of care note,dialy plan of care note,,care plan; dialy; doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; notes; point in time; random; treatment plan; visit note,Doc
87241-6,bacillus atrophaeus [presence] in laboratory device by culture,b atrophaeus lab device ql cult,b. atrophaeus cx ql (laboratory device),b atrophaeus; bacillus subtilis var. niger; c&s; cult; cultures; id; infectious disease; infectiousdisease; lab device; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; screen,Ord
8724-7,surgical operation note description narrative,operative note description,,encounter; evaluation and management; evaluation and management note; finding; findings; h+p; h+p.surgical procedures; narrative; notes; operative note; operative note description; p prime; point in time; random; report; surg; visit note,Nar
87248-1,addiction medicine education note,addiction med educ note,,doc.ont; document; educ note; encounter; evaluation and management; evaluation and management note; finding; findings; notes; point in time; random; substance abuse; visit note,Doc
87261-4,addiction medicine case manager note,addiction med case mgr note,,addiction med case mgr; doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; notes; point in time; random; substance abuse; visit note,Doc
87286-1,birth attendant [extended identifier],birth attendant ext id provider,,admin; ext id; nominal; point in time; random,Nom
87287-9,birth certifier [extended identifier],birth certifier ext id provider,,admin; ext id; nominal; point in time; random,Nom
87310-9,guidance for transhepatic exchange of catheter of biliary ducts,guided bds transhep cath exchange,,abd; abdo; abdomen+; abdominal; bds; bile tract; biliary tract; cath; change; coreplaybook; document; finding; findings; guid; guide; guided; imaging; playbook; point in time; ptbd; rad; radiology; random; replace; transhep cath exchange,Doc
8731-2,ventricular cardiac output by 2d echo,hrt ventr output 2d echo,,cardiac; cardio; cardiology; co; flow; heart disease; hemodynamics; hemodynamics.molec; hrt; hrt ventr; point in time; qnt; quan; quant; quantitative; random; ultrasound; ventricular; volume rate; vrate,Qn
8732-0,left ventricular cardiac output by angiography biplane,lv output angio bp,,angio; angio bp; cardiac; cardio; cardiology; co; flow; heart disease; hemodynamics; hemodynamics.molec; hrt; hrt ventr; l; lt; lv; point in time; qnt; quan; quant; quantitative; random; ventricular; volume rate; vrate,Qn
87324-0,porcine circovirus type 2 [presence] in specimen by organism specific culture,pcv2 spec ql cult,pcv type 2 org specific cx ql (specimen),c&s; circo virus; cult; cultures; id; ii; infectious disease; infectiousdisease; microbiology; misc; miscellaneous; ordinal; other; pcv; pcv2; point in time; pork; pr; ql; qual; qualitative; random; screen; spec; swine; to be specified in another part of the message; unspecified; vet; veterinary,Ord
87332-3,porcine circovirus type 2 ag [presence] in tissue by immune stain,pcv2 ag tiss ql imstn,pcv type 2 ag immune stain ql (tiss),"antigen; antigens; circo virus; id; ihc; ii; imm; immunohistochemical stain; immunostain; imstn; imun; imune; infectious disease; infectiousdisease; microbiology; ordinal; pcv; pcv2; pcv2 ag; point in time; pork; pr; ql; qual; qualitative; random; screen; st; stains; stn; swine; tissue; tissue, unspecified; vet; veterinary",Ord
87338-0,porcine circovirus type 2 strain identified [type] in isolate by sequencing,pcv2 islt seq,pcv type 2 strain identified sequencing nom (isol),circo virus; high-throughput sequencing; hts; id; ii; infectious disease; infectiousdisease; islt; isol; isolated; microbiology; next generation sequencing; ngs; nominal; pcv; pcv2; pcv2 cult; point in time; pork; random; swine; typ; vet; veterinary,Nom
87340-6,porcine circovirus type 2b dna [cycle threshold #] in specimen by naa with probe detection,pcv2b dna ct spec qn naa+probe,pcv type 2b dna naa+probe (specimen) [threshnum],3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; circo virus; deoxyribonucleic acid; dna nucleic acid probe; dna probe; id; infectious disease; infectiousdisease; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; misc; miscellaneous; naa+probe; naat; nasba; nucleic acid sequence based analysis; other; pcr; pcv; pcv2b; point in time; polymerase chain reaction; pork; probe amp; probe with ampification; probe with target amplification; qbr; qnt; quan; quant; quantitative; random; sda; spec; strand displacement amplification; swine; tma; to be specified in another part of the message; transcription mediated amplification; unspecified; vet; veterinary,Qn
87343-0,pseudorabies virus glycoprotein 1 ab/negative control in serum by immunoassay,prv glycoprot 1 ab ser ia,pseudorabies virus glycoprotein 1 ab/negative control ia (s) [relative ratio],abs; aby; alpha-herpesvirus; antby; anti; antibodies; antibody; aujeszky's disease; aujeszkys disease virus; aujezskys disease; autoantibodies; autoantibody; eia; elfa; elisa; enzyme immunoassay; gg; glycoprot; glycoproteins; gp; i; iaa; id; infectious disease; infectiousdisease; meia; microbiology; neg; pdv glyco 1 ab; phv1; point in time; porcine herpes virus 1; prv; prv glycoprot 1; pseudorabies; qnt; quan; quant; quantitative; random; relative ratio; serum; shv-1; sr; suds; suid herpesvirus-1; vet; veterinary,Qn
87347-1,senecavirus a igg ab/positive control in serum by immunoassay,sva igg/pos cntrl ser ia,senecavirus a igg/positive control ia (s) [relative ratio],abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; eia; elfa; elisa; enzyme immunoassay; iaa; id; immune globulin g; immunoglobulin g; infectious disease; infectiousdisease; meia; microbiology; point in time; pos; pos cntrl; qnt; quan; quant; quantitative; random; relative ratio; seneca valley virus; serum; sr; suds; sva; sva ab; sva igg; vet; veterinary,Qn
87370-3,escherichia coli fasa gene [presence] in isolate by naa with probe detection,ec fasa gene islt ql naa+probe,e. coli fasa gene naa+probe ql (isol),3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; dna nucleic acid probe; dna probe; e coli; e. coli 987p pilus gene; ec fasa gene; id; infectious disease; infectiousdisease; islt; isol; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; naa+probe; naat; nasba; nucleic acid sequence based analysis; o002; ordinal; pcr; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; screen; sda; strand displacement amplification; tma; transcription mediated amplification,Ord
87388-5,porcine sapelovirus [presence] in specimen by organism specific culture,psv spec ql cult,porcine sapelovirus org specific cx ql (specimen),c&s; cult; cultures; id; infectious disease; infectiousdisease; microbiology; misc; miscellaneous; ordinal; other; point in time; pork; pr; psv; ql; qual; qualitative; random; screen; spec; swine; to be specified in another part of the message; unspecified; vet; veterinary,Ord
87402-4,escherichia coli aida-i gene [presence] in isolate by naa with probe detection,ec aida-i gene islt ql naa+probe,e. coli aida-i gene naa+probe ql (isol),3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; dna nucleic acid probe; dna probe; e coli; ec aida-i gene; escherichia coli adhesion-involved-indiffuse-adherence; id; infectious disease; infectiousdisease; islt; isol; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; naa+probe; naat; nasba; nucleic acid sequence based analysis; o002; ordinal; pcr; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; screen; sda; strand displacement amplification; tma; transcription mediated amplification; vet; veterinary,Ord
87416-4,diagnostic imaging report - recommended dicom ps3.20 sections,dir dicom ps3.20 sections,,dir dicom ps3.20 sections; pan; panel; panel.doc; panl; pnl; point in time; random,-
87434-7,protein and creatinine panel - urine,protein + creat pnl ur,protein and creatinine panel (u),chemistry; cr; crea; creat; creat pnl; pan; panel.chemistry; panl; pnl; point in time; pr; prot; protein + creat pnl; qnt; quan; quant; quantitative; random; ua; ucr; ur; urn,Qn
87445-3,fungus [presence] in food by culture,fungus food ql cult,fungus cx ql (food),c&s; cult; cultures; food sample; foods; fung; fungal; fungi; id; infectious disease; infectiousdisease; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; screen,Ord
87455-2,potassium [mass/mass] in specimen,potassium spec-mcnt,potassium (specimen) [mass/mass],chemistry; k; k+; mass content; misc; miscellaneous; other; point in time; potass; qnt; quan; quant; quantitative; random; spec; to be specified in another part of the message; unspecified; vet; veterinary,Qn
87495-8,ab-chminaca butanoate (synthetic cannabinoid metabolite) [presence] in urine by confirmatory method,ab-chminaca butanoate ur ql cfm,ab-chminaca butanoate confirm ql (u),addiction; cfm; cloud 10; cnfr; cnfrm; conf; confirmation; confirmatory; drug/toxicology; drugs; drugs of abuse; gcms; illicit; k2; lc/ms/ms; ordinal; point in time; potentialforabuse; potpourri; pr; ql; qual; qualitative; random; screen; spice; synthetic cannabinoid; ua; ur; urn; zombie,Ord
87498-2,3-methoxytyramine.free/creatinine [molar ratio] in 24 hour urine,free 3-mt/creat 24h ur-srto,3-methoxytyramine.free/creatinine (24h u) [molar ratio],1 day; 24 hours; 24hr; 3me-tyramine; chemistry; cr; crea; creat; dopamine metabolite; fr; free 3-mt; iii; non-protein bound; qnt; quan; quant; quantitative; scrto; substance concentration ratio; substance ratio; ua; ucr; ur; urn,Qn
87514-6,cerebral monitor,cerebral monitor,,cereb; neuro; neurology; nominal; point in time; random; typ,Nom
87520-3,coverage type,coverage type,,admin; admin.patient; nominal; point in time; random; typ,Nom
87521-1,"irf-pai v3.0, lcds v4.00 - medications - admission during assessment period [cms assessment]",,,centers for medicare and medicaid assessment; pan; panel; panel.survey.cms; panl; pnl; report period; survey,-
87531-0,most important symptom to manage,important symptom to manage,,clin; finding; findings; nominal; point in time; random; sx,Nom
87537-7,lcds v4.00 - spontaneous breathing trial during assessment period [cms assessment],,,centers for medicare and medicaid assessment; painad.breathing; pan; panel; panel.survey.cms; panl; pnl; report period; survey,-
87547-6,"borrelia burgdorferi ab and anaplasma phagocytophilum, babesia microti and ehrlichia chaffeensis igg panel - serum",tick igg + b burgdor ab pnl ser,"b. burgdorferi ab and anaplasma phagocytophilum, babesia microti and ehrlichia chaffeensis igg panel (s)",b burg; b burgdor; b burgdorferi; b microti; babesiosis; bb; burgdorf; e chaffeensis; e equi; e phagocytophila; ehrlichia equi; ehrlichia phagocytophila; hge; hme; human granulocytic ehrlichiosis; human monocytic ehrlichiosis; id; immune globulin g; immunoglobulin g; infectious disease; infectiousdisease; lyme; lyme disease; lymes; microbiology; pan; panel.microbiology; panl; piroplasmosis; pnl; point in time; random; serum; sr; tick igg + b burgdor ab pnl; tick igg ab pnl,-
87549-2,"1,25-dihydroxyvitamin d and 1,25-dihydroxyvitamin d2 and 1,25-dihydroxyvitamin d3 panel - serum or plasma",dhvd+dhvd2+dhvd3 pnl serpl,"1,25-dihydroxyvitamin d and 1,25-dihydroxyvitamin d2 and 1,25-dihydroxyvitamin d3 panel","1,25(oh)2d; 1,25(oh)2d2; chemistry; dextro; dhvd+dhvd2+dhvd3 pnl; i; pan; panel.chemistry; panl; pl; plasma; plsm; pnl; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr",Qn
87565-8,zearalenol [mass/mass] in specimen,zearalenol spec-mcnt,zearalenol (specimen) [mass/mass],drug/toxicology; drugs; mass content; misc; miscellaneous; other; point in time; qnt; quan; quant; quantitative; random; spec; to be specified in another part of the message; unspecified; vet; veterinary,Qn
87567-4,t-2 toxin [mass/mass] in specimen,t-2 toxin spec-mcnt,t-2 toxin (specimen) [mass/mass],drug/toxicology; drugs; ii; mass content; misc; miscellaneous; other; point in time; qnt; quan; quant; quantitative; random; spec; t prime; t-2 mycotoxin; to be specified in another part of the message; unspecified; vet; veterinary,Qn
87568-2,ochratoxin a [mass/mass] in specimen,ota spec-mcnt,ochratoxin a (specimen) [mass/mass],drug/toxicology; drugs; mass content; misc; miscellaneous; ota; other; point in time; qnt; quan; quant; quantitative; random; spec; to be specified in another part of the message; unspecified; vet; veterinary,Qn
87572-4,fumonisin b2 [mass/mass] in specimen,fumonisin b2 spec-mcnt,fumonisin b2 (specimen) [mass/mass],drug/toxicology; drugs; mass content; misc; miscellaneous; mycotoxin; other; point in time; qnt; quan; quant; quantitative; random; spec; to be specified in another part of the message; unspecified; vet; veterinary,Qn
8757-7,right ventricular cardiac index by angiography single plane,rv cardiac index angio sp,,angio; angio sp; bdy surface; bod; bodies; bsa; cardiac; cardio; cardiology; co; heart disease; hemodynamics; hemodynamics.molec; hrt; hrt ventr; point in time; qnt; quan; quant; quantitative; r; random; rt; rv; surf; ventricular; volume rate/area; volume rate/ratio,Qn
87580-7,aflatoxin m1 [mass/mass] in specimen,aflatoxin m1 spec-mcnt,aflatoxin m1 (specimen) [mass/mass],aflatoxicosis; drug/toxicology; drugs; mass content; misc; miscellaneous; mycotoxin; other; point in time; qnt; quan; quant; quantitative; random; spec; to be specified in another part of the message; unspecified; vet; veterinary,Qn
87584-9,aflatoxin b1 [mass/mass] in specimen,aflatoxin b1 spec-mcnt,aflatoxin b1 (specimen) [mass/mass],aflatoxicosis; drug/toxicology; drugs; mass content; misc; miscellaneous; mycotoxin; other; point in time; qnt; quan; quant; quantitative; random; spec; to be specified in another part of the message; unspecified; vet; veterinary,Qn
87601-1,carbadox [mass/mass] in specimen,carbadox spec-mcnt,carbadox (specimen) [mass/mass],carbomethoxyhydrazone; drug/toxicology; drugs; mass content; mecadox; misc; miscellaneous; other; point in time; qdno; qnt; quan; quant; quantitative; random; spec; to be specified in another part of the message; unspecified; vet; veterinary,Qn
87607-8,difethialone [mass/mass] in specimen,difethialone spec-mcnt,difethialone (specimen) [mass/mass],drug/toxicology; drugs; mass content; misc; miscellaneous; other; point in time; qnt; quan; quant; quantitative; random; spec; to be specified in another part of the message; unspecified; vet; veterinary,Qn
87610-2,chlorophacinone [mass/mass] in specimen,chlorophacinone spec-mcnt,chlorophacinone (specimen) [mass/mass],drug/toxicology; drugs; mass content; misc; miscellaneous; other; point in time; qnt; quan; quant; quantitative; random; spec; to be specified in another part of the message; unspecified; vet; veterinary,Qn
87615-1,sulfate [mass/mass] in specimen,sulfate spec-mcnt,sulfate (specimen) [mass/mass],drug/toxicology; drugs; mass content; misc; miscellaneous; other; point in time; qnt; quan; quant; quantitative; random; so4; so4-2; spec; sulf; to be specified in another part of the message; unspecified; vet; veterinary,Qn
87625-0,hedis 2018 value sets,hedis 2018 value sets,hedis 2018 value sets,pan; panel; panel.hedis; panl; pnl; point in time; random,-
87637-5,fenchlorphos [mass/mass] in specimen,fenchlorphos spec-mcnt,fenchlorphos (specimen) [mass/mass],dermafos; drug/toxicology; drugs; fenclofos; mass content; misc; miscellaneous; other; phenchlorfos; point in time; qnt; quan; quant; quantitative; random; ronnel; spec; to be specified in another part of the message; unspecified; vet; veterinary,Qn
87640-9,dichlorodiphenyldichloroethylene [mass/mass] in specimen,dde spec-mcnt,dichlorodiphenyldichloroethylene (specimen) [mass/mass],"dde; drug/toxicology; drugs; mass content; misc; miscellaneous; other; p,p'-dde; point in time; qnt; quan; quant; quantitative; random; spec; to be specified in another part of the message; unspecified; vet; veterinary",Qn
87668-0,aldrin [mass/mass] in specimen,aldrin spec-mcnt,aldrin (specimen) [mass/mass],aldocit; aldrex; aldrite; aldrosol; compound 118; dimethanonaphthalene; drinox; drug/toxicology; drugs; hhdm; hhdn; hhpn; kortofin; mass content; misc; miscellaneous; octalene; oms-194; other; point in time; qnt; quan; quant; quantitative; random; seedrin; spec; tatuzinho; tipula; to be specified in another part of the message; unspecified; vet; veterinary,Qn
87671-4,cholecalciferol (vit d3) [mass/mass] in specimen,vitamin d3 spec-mcnt,vitamin d3 (specimen) [mass/mass],c27h43oh; calciol; chemistry; colecalciferol; mass content; misc; miscellaneous; other; point in time; qnt; quan; quant; quantitative; random; spec; to be specified in another part of the message; unspecified; vet; veterinary; vit d3; vitamin d3,Qn
87707-6,job supervisory level or pay grade,supervisory level or pay grade,,finding; findings; h+p; h+p.hx; levels; levl; lv; lvl; nominal; occupation; p prime; point in time; random; supervisory level; work,Nom
87711-8,rotavirus b vp7 gene [nucleotide sequence] in isolate by sequencing,rvb vp7 islt-seq,rotavirus b vp7 gene sequence nom (isol),high-throughput sequencing; hts; id; infectious disease; infectiousdisease; islt; isol; microbiology; next generation sequencing; ngs; nominal; point in time; random; rota virus; rotav; rotaviral; rotaviurs; rv; rvb; rvb vp7; vet; veterinary,Nom
87713-4,rotavirus a vp4 gene [nucleotide sequence] in isolate by sequencing,rva vp4 islt-seq,rotavirus a vp4 gene sequence nom (isol),high-throughput sequencing; hts; id; infectious disease; infectiousdisease; islt; isol; microbiology; next generation sequencing; ngs; nominal; point in time; random; rota virus; rotav; rotaviral; rotaviurs; rv; rva; rva vp4; vet; veterinary,Nom
8772-6,left ventricular stroke volume by mr,lv sv mr,,cardiac; cardiac output/heart beat; cardio; cardiology; heart disease; hemodynamics; hemodynamics.molec; hrt; hrt ventr; l; lt; lv; mitral regurgitation maximum velocity; mri; point in time; qnt; quan; quant; quantitative; rad; radiology; random; sv; ventricular; vol; volume,Qn
87741-5,systolic blood pressure--post exercise,bp sys--p exc,,after; art sys; blood pressure; blood pressure measurements.molec; blood pressure systolic; bp; bp sys; bp systolic; excz; intravenous; iv; p exc; point in time; pressure; pst; qnt; quan; quant; quantitative; random; sbp; sys bp,Qn
87763-9,ezogabine/creatinine [mass ratio] in urine by confirmatory method,ezogabine/creat ur cfm,ezogabine/creatinine confirm (u) [mass ratio],cfm; cnfr; cnfrm; conf; confirmation; confirmatory; cr; crea; creat; drug/toxicology; drugs; gcms; lc/ms/ms; mass concentration ratio; mass ratio; mcrto; point in time; qnt; quan; quant; quantitative; random; retigabine; ua; ucr; ur; urn,Qn
87766-2,10-hydroxycarbazepine/creatinine [mass ratio] in urine by confirmatory method,10oh-carbazepine/creat ur cfm,10-hydroxycarbazepine/creatinine confirm (u) [mass ratio],"10,11-dihydro-10-hydroxycarbamazepine; 10-hydroxy carbazepine; 10-hydroxycarbamazepine; 10-monohydroxyoxcarbazepine; 10-oh-carbazepine; 10oh-carbazepine; cfm; cnfr; cnfrm; conf; confirmation; confirmatory; cr; crea; creat; drug/toxicology; drugs; gcms; lc/ms/ms; licarbazepine; mass concentration ratio; mass ratio; mcrto; oxcarbazepine metabolite; point in time; qnt; quan; quant; quantitative; random; ua; ucr; ur; urn",Qn
87772-0,lamotrigine/creatinine [mass ratio] in urine by confirmatory method,lamotrigine/creat ur cfm,lamotrigine/creatinine confirm (u) [mass ratio],cfm; cnfr; cnfrm; conf; confirmation; confirmatory; cr; crea; creat; drug/toxicology; drugs; gcms; lamictal; lc/ms/ms; mass concentration ratio; mass ratio; mcrto; point in time; qnt; quan; quant; quantitative; random; ua; ucr; ur; urn,Qn
87786-0,bupivacaine/creatinine [mass ratio] in urine by confirmatory method,bupivacaine/creat ur cfm,bupivacaine/creatinine confirm (u) [mass ratio],c285; cfm; cnfr; cnfrm; conf; confirmation; confirmatory; cr; crea; creat; drug/toxicology; drugs; gcms; lc/ms/ms; marcain; marcaine; mass concentration ratio; mass ratio; mcrto; point in time; qnt; quan; quant; quantitative; random; sensorcaine; ua; ucr; ur; urn; vivacaine,Qn
87790-2,carbadox [susceptibility] by minimum inhibitory concentration (mic),carbadox islt mic,carbadox mic [susc],antibiotic susceptibilities; ast; carbomethoxyhydrazone; id; infectious disease; infectiousdisease; islt; isol; mecadox; minimum inhibitory concentration; point in time; qdno; random; sus; suscept; susceptibilities; susceptibility; susceptibilty; vet; veterinary,OrdQn
87793-6,nitrofurazone [susceptibility] by minimum inhibitory concentration (mic),nitrofurazone islt mic,nitrofurazone mic [susc],antibiotic susceptibilities; ast; furacilin; furacin; furacin.topical; id; infectious disease; infectiousdisease; islt; isol; minimum inhibitory concentration; nitrofural; point in time; random; sus; suscept; susceptibilities; susceptibility; susceptibilty; vet; veterinary,OrdQn
87794-4,furazolidone [susceptibility] by minimum inhibitory concentration (mic),furazolidone islt mic,furazolidone mic [susc],antibiotic susceptibilities; ast; dependal-m; furoxone; id; infectious disease; infectiousdisease; islt; isol; minimum inhibitory concentration; point in time; random; sus; suscept; susceptibilities; susceptibility; susceptibilty; vet; veterinary,OrdQn
87802-5,sulfachloropyridazine [susceptibility],sulfachloropyridazine susc islt,sulfachloropyridazine [susc],antibiotic susceptibilities; ast; bs poeder; coccidiox; coliprim; cordixina; cosumix; id; infectious disease; infectiousdisease; islt; isol; point in time; prinzone; pyradan; random; sulfachlorpyridazine; sulfaclozine sodium; sulphachlorpyridazine; sus; suscept; susceptibilities; susceptibility; susceptibilty; vet; veterinary; vetisulid,OrdQn
87818-1,tapentadol [presence] in saliva (oral fluid) by screen method,tapentadol sal ql scn,tapentadol screen ql (sal),addiction; drug/toxicology; drugs; drugs of abuse; illicit; nucynta; oral fluid; ordinal; palexia; point in time; potentialforabuse; pr; ql; qual; qualitative; random; sal; scn; scr; screen; scrn; tapal,Ord
87820-7,zolpidem [presence] in saliva (oral fluid) by screen method,zolpidem sal ql scn,zolpidem screen ql (sal),addiction; adormix; ambien; ambien cr; damixan; drug/toxicology; drugs; drugs of abuse; edluar; hypnogen; illicit; ivedal; lioran; myslee; nasen; nytamel; oral fluid; ordinal; point in time; potentialforabuse; pr; ql; qual; qualitative; random; sal; sanval; scn; scr; screen; scrn; somidem; stilnoct; stilnox; stilnox cr; sucedal; zoldem; zolpihexal; zolpimist,Ord
87824-9,6-beta naltrexol [mass/volume] in saliva (oral fluid) by confirmatory method,6-beta naltrexol sal cfm-mcnc,6-beta naltrexol confirm (sal) [mass/vol],6 alpha-hydroxynaltrexone; 6 beta-hydroxynaltrexone; 6 beta-naltrexol; 6b-naltrexol; addiction; b; beta-naltrexol; cfm; cnfr; cnfrm; conf; confirmation; confirmatory; drug/toxicology; drugs; drugs of abuse; gcms; illicit; lc/ms/ms; level; mass concentration; naltrexone metabolite; oral fluid; point in time; potentialforabuse; qnt; quan; quant; quantitative; random; sal,Qn
87832-2,fibroblast growth factor 21.intact [mass/volume] in serum or plasma,fgf-21.intact serpl-mcnc,fibroblast growth factor 21.intact [mass/vol],chemistry; fac; fact; fgf21; fgf-21.intact; ifgf21; level; mass concentration; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
87850-4,cta deep inferior epigastric artery wo and w contrast iv,cta deep inf epigastric a wo+w contr iv,,abd; abd+pelvis; abdo; abdominal; ang; angio; angiography; angm; art; arteriogram; c; cardio; cardiology; cat scan; computed tomography; computerized tomography; contr; contra; contrst; coreplaybook; ct angiogram; ct angiography; ct scan; cta; deep inf epigastric a; diea; diep; document; finding; findings; heart disease; imaging; inf; pelvic; playbook; point in time; rad; radiology; random; w contr iv; wc; wo & wc; wo+w contr; wo+w contr iv; wwo,Doc
87862-9,ct abdomen wo and ct abdomen and pelvis w contrast iv,ct abd wo + ct abd+pel w contr iv,,abd; abd + abd+pel; abd+pelvis; abdo; abdominal; c; cat scan; computed tomography; computerized tomography; contr; contra; contrst; ct scan; document; finding; findings; imaging; pelvic; point in time; rad; radiology; random; without contrast,Doc
87877-7,ct neck and chest wo contrast,ct neck+chest wo contr,,c; cat scan; computed tomography; computerized tomography; contr; contra; contrst; ct scan; document; finding; findings; imaging; point in time; rad; radiology; random; thorax; without contrast,Doc
87881-9,ct thigh - bilateral wo contrast,ct thigh-bl wo contr,,bil; bilat; both; c; cat scan; computed tomography; computerized tomography; contr; contra; contrst; ct scan; document; ext; extr-bl; femoral; femur; finding; findings; imaging; le; le-bl; leg; low; lower extremity; point in time; rad; radiology; random; thigh-bl; without contrast,Doc
87884-3,ct shoulder - bilateral arthrogram,ct shoulder-bl w contr is,,arm; arthrogram; arthrography; bil; bilat; both; c; cat scan; computed tomography; computerized tomography; contr; contra; contrst; ct scan; document; ext; extr-bl; finding; findings; imaging; intraarticular; intrasynovial; msk; musculoskeletal; ortho; orthopedics; point in time; rad; radiology; random; shoulder-bl; ue; ue-bl; up; upper extremity joint; w contr is; wc,Doc
87893-4,ct finger third - right wo contrast,ct finger.3rd-r wo contr,,3rd; arm; c; cat scan; computed tomography; computerized tomography; contr; contra; contrst; ct scan; document; ext; extr-r; finding; findings; finger.3rd-r; finger-r; imaging; msk; musculoskeletal; ortho; orthopedics; point in time; r; rad; radiology; random; rt; rue; ue; ue-r; up; without contrast,Doc
87906-4,ct maxillofacial region - right w contrast iv,ct maxillofacial-r w contr iv,,brain; c; cat scan; computed tomography; computerized tomography; contr; contra; contrst; cranial; cranium; ct scan; document; facial bones + maxilla; facial bones+maxilla; finding; findings; imaging; intracranial; maxillofacial-r; point in time; r; rad; radiology; random; rt; skull; w contr iv; wc,Doc
87907-2,pet+ct brain for amyloidosis,pet+ct brain for amyloidosis w rnc iv,,brain; cat scan; cerebral; cerebrum; computed tomography; computerized tomography; cranial; cranium; ct scan; document; finding; findings; head; imaging; intracranial; pet scan; pet+ct; point in time; position emmision tomography; positron emission tomography; rad; radiology; radnuc.pet; random; rn; rnc; scan; skull; w rnc iv,Doc
87908-0,ct head and maxillofacial region w contrast iv,ct head+maxillofacial w contr iv,,brain; c; cat scan; computed tomography; computerized tomography; contr; contra; contrst; cranial; cranium; ct scan; document; facial bones + maxilla; facial bones+maxilla; finding; findings; head+maxillofacial; imaging; intracranial; point in time; rad; radiology; random; skull; w contr iv; wc,Doc
87913-0,ct pelvis by reconstruction,ct pelvis by reconstr,,cat scan; computed tomography; computerized tomography; ct scan; document; finding; findings; imaging; pelvic; point in time; rad; radiology; random,Doc
87914-8,ct pelvis bones wo and w contrast iv,ct pelvis bones wo+w contr iv,,c; cat scan; computed tomography; computerized tomography; contr; contra; contrst; ct scan; document; finding; findings; imaging; pelvic; point in time; rad; radiology; random; w contr iv; wc; wo & wc; wo+w contr; wo+w contr iv; wwo,Doc
87917-1,ct pelvis bones wo contrast,ct pelvis bones wo contr,,c; cat scan; computed tomography; computerized tomography; contr; contra; contrst; ct scan; document; finding; findings; imaging; pelvic; point in time; rad; radiology; random; without contrast,Doc
8793-2,left ventricular stroke volume index by nuclear blood pool,lv svi nuc bp,,bdy surface; bod; bodies; bsa; cardiac; cardiac output/heart beat; cardio; cardiology; heart disease; hemodynamics; hemodynamics.molec; hrt; hrt ventr; l; lt; lv; nuc bp; point in time; qnt; quan; quant; quantitative; random; surf; sv; ventricular; vol; volume/area,Qn
87945-2,borrelia sp identified in cerebral spinal fluid by organism specific culture,borrelia csf cult,borrelia sp identified org specific cx nom (csf),c&s; cerebral spinal fluid; cerebrospinal fl; cult; cultures; id; identity or presence; infectious disease; infectiousdisease; lyme; lyme disease; microbiology; neuro; neurology; nominal; point in time; random; relapsing fever; spec; species; spinal fl; spinal fld; spinal flu; spinal fluid; spp,Nom
87950-2,chlamydia trachomatis [presence] in tissue by organism specific culture,c trach tiss ql cult,c. trachomatis org specific cx ql (tiss),"c trac; c trach; c tracho; c trachomatis; c&s; chlam; chlam trac; chlamid; ct; cult; cultures; id; infectious disease; infectiousdisease; lgv; lymphogranuloma venereum; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; screen; spec; tissue; tissue, unspecified; trachoma",Ord
87976-7,fungus identified in implanted device by culture,fungus implnt dev cult,fungus identified cx nom (implanted device),c&s; cult; cultures; fung; fungal; fungi; id; identity or presence; implnt dev; infectious disease; infectiousdisease; microbiology; nominal; point in time; prostheses; prosthesis; prosthetic; random,Nom
87977-5,fungus identified in pericardial fluid by culture,fungus pcar cult,fungus identified cx nom (pericard fld),c&s; cardio; cardiology; cult; cultures; fung; fungal; fungi; heart disease; id; identity or presence; infectious disease; infectiousdisease; microbiology; nominal; pcar; pericardial fluid; point in time; random,Nom
87982-5,toxoplasma gondii [presence] in bone marrow by organism specific culture,t gondii mar ql cult,t. gondii org specific cx ql (bm),bm; bon; bone marrow; c&s; cult; cultures; id; infectious disease; infectiousdisease; mar; marrow (bone); microbiology; minimal angle of resolution; minimum angle of resolution; ordinal; point in time; pr; ql; qual; qualitative; random; screen; spec; t gondii; toxo; toxoplasmosis,Ord
88005-4,glutarylcarnitine (c5-dc)/acetylcarnitine (c2) [molar ratio] in serum or plasma,glutarylcarn/c2 serpl-srto,c5-dc/acetylcarnitine (c2) [molar ratio],c2; c5dc; c5-dc; chemistry; dicarboxylic carnitine; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; scrto; serp; serpl; serplas; serum; serum or plasma; sr; substance concentration ratio; substance ratio,Qn
88024-5,palmitoylcarnitine (c16)/carnitine.free (c0) [molar ratio] in dbs,palmitoylcarn/c0 dbs-srto,c16/carnitine.free (c0) (dbs) [molar ratio],blood; c0; c16; carnitine free; carnitine.total; chemistry; dbs; dried blood spot; fc; filter paper; fp; fr; hexadecanoylcarnitine; non-protein bound; point in time; qnt; quan; quant; quantitative; random; scrto; substance concentration ratio; substance ratio; wb; whole blood,Qn
88034-4,ventilator settings document,vent settings doc,,doc.misc; document; finding; findings; misc; point in time; random,Doc
88038-5,hy ab [presence] in serum or plasma,hy ab serpl ql,hy ab ql,abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; blood bank; dombrock blood group system; hy; ordinal; pl; plasma; plsm; point in time; pr; ql; qual; qualitative; random; screen; serp; serpl; serplas; serum; serum or plasma; sr,Ord
88059-1,acetaminophen [presence] in blood by screen method,apap bld ql scn,acetaminophen screen ql (bld),acet; acetamidophenol; acetaminoph; acetominophen; addiction; apap; blood; c209; c55; drug/toxicology; drugs; drugs of abuse; hepatology; hydroxyacetanilide; illicit; liver; n-(4-hydroxyphenyl)acetanilide; n-acetyl-p-aminophenol; ordinal; p-acetamidophenol; paracetamol; p-hydroxyacetanilide; point in time; potentialforabuse; pr; ql; qual; qualitative; random; scn; scr; screen; scrn; tylenol; u209; wb; whole blood,Ord
88070-8,time of extubation,extubation time,,date and time; extubation time; lung; point in time; pulmonary; pulmonology; qnt; quan; quant; quantitative; random; respiratory; time stamp; timestamp,Qn
88090-6,physician specialty,md specialty,,admin; md specialty; nominal; point in time; random; typ,Nom
88105-2,injured body site,injured body site,,anatomy; bdy site; bod; bodies; h+p; h+p.px; nominal; p prime; point in time; random,Nom
88127-6,herpes simplex virus identified in cornea or conjunctiva by organism specific culture,hsv corn/cnjt cult,hsv identified org specific cx nom (corn/cnjt),c&s; corn/cnjt; corneal; cult; cultures; herp splx; hsv; id; identity or presence; infectious disease; infectiousdisease; microbiology; nominal; point in time; random; spec,Nom
88154-0,microscopic observation [identifier] in sinus by acid fast stain,acid fast stn sinus,microscopic observation acid fast stain nom (sinus),acd; acid fast stn; acids; afb stain; id; identity or presence; infectious disease; infectiousdisease; microbiology; nominal; point in time; random; st; stains; stn,Nom
88162-3,acanthamoeba sp identified in cornea or conjunctiva by organism specific culture,acanthamoeba corn/cnjt cult,acanthamoeba sp identified org specific cx nom (corn/cnjt),amebic keratitis; amebic meningoencephalitis; c&s; corn/cnjt; corneal; cult; cultures; id; identity or presence; infectious disease; infectiousdisease; microbiology; nominal; point in time; random; soil amoeba; spec; species; spp,Nom
88169-8,deprecated microscopic observation [presence] in vomitus by acid fast stain,deprecated acid fast stn vom ql,microscopic observation acid fast stain ql (vomitus),acd; acid fast stn; acids; afb stain; gastro; gastroenterology; gi; id; infectious disease; infectiousdisease; microbiology; ordinal; pr; ql; qual; qualitative; regurgitation; screen; st; stains; stn; vom; vomitus,Ord
88170-6,microscopic observation [identifier] in cornea or conjunctiva by gram stain,gram stn corn/cnjt,microscopic observation gram stain nom (corn/cnjt),corn/cnjt; corneal; eye; gram stn; id; identity or presence; infectious disease; infectiousdisease; microbiology; nominal; ophthalmology; ophtho; ophthy; point in time; random; st; stains; stn,Nom
88178-9,coxiella burnetii dna [presence] in tissue by naa with probe detection,c burnet dna tiss ql naa+probe,c. burnetii dna naa+probe ql (tiss),"3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; c burnet; c burnetii; coxiella burnettii; deoxyribonucleic acid; dna nucleic acid probe; dna probe; id; infectious disease; infectiousdisease; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; naa+probe; naat; nasba; nucleic acid sequence based analysis; ordinal; pcr; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; q fev; q fever; qbr; qfever; ql; qual; qualitative; random; screen; sda; strand displacement amplification; tissue; tissue, unspecified; tma; transcription mediated amplification",Ord
88198-7,middle east respiratory syndrome coronavirus (mers-cov) rna [presence] in cornea or conjunctiva by naa with probe detection,mers-cov rna corn/cnjt ql naa+probe,mers-cov rna naa+probe ql (corn/cnjt),3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; camel flu; corn/cnjt; corneal; corona virus; dna nucleic acid probe; dna probe; hcov-emc/2012; id; infectious disease; infectiousdisease; lat; lcr; ligase chain reaction; ligation-activated transcription; mers-cov; mers-cov rna; microbiology; naa+probe; naat; nasba; nucleic acid sequence based analysis; ordinal; pcr; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; ribonucleic acid; screen; sda; strand displacement amplification; tma; transcription mediated amplification,Ord
88205-0,lymphocytic choriomeningitis virus igm ab [presence] in serum by immunoassay,lcmv igm ser ql ia,lymphocytic choriomeningitis virus igm ia ql (s),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; eia; elfa; elisa; enzyme immunoassay; iaa; id; immune globulin m; immunoglobulin m; infectious disease; infectiousdisease; lcmv; meia; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; sr; suds,Ord
88213-4,rhinovirus rna [presence] in cornea or conjunctiva by naa with probe detection,rhinovirus rna corn/cnjt ql naa+probe,rhinovirus rna naa+probe ql (corn/cnjt),3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; corn/cnjt; corneal; dna nucleic acid probe; dna probe; hrv; id; infectious disease; infectiousdisease; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; naa+probe; naat; nasba; nucleic acid sequence based analysis; ordinal; pcr; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; rhino virus; rhv; ribonucleic acid; screen; sda; strand displacement amplification; tma; transcription mediated amplification,Ord
88214-2,rabies virus rna [presence] in tissue by naa with probe detection,rabv rna tiss ql naa+probe,rabies virus rna naa+probe ql (tiss),"3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; dna nucleic acid probe; dna probe; id; infectious disease; infectiousdisease; lat; lcr; ligase chain reaction; ligation-activated transcription; lyssavirus; microbiology; naa+probe; naat; nasba; nucleic acid sequence based analysis; ordinal; pcr; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; rabies; rabv; random; ribonucleic acid; screen; sda; strand displacement amplification; tissue; tissue, unspecified; tma; transcription mediated amplification",Ord
88215-9,rabies virus rna [presence] in saliva (oral fluid) by naa with probe detection,rabv rna sal ql naa+probe,rabies virus rna naa+probe ql (sal),3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; dna nucleic acid probe; dna probe; id; infectious disease; infectiousdisease; lat; lcr; ligase chain reaction; ligation-activated transcription; lyssavirus; microbiology; naa+probe; naat; nasba; nucleic acid sequence based analysis; oral fluid; ordinal; pcr; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; rabies; rabv; random; ribonucleic acid; sal; screen; sda; strand displacement amplification; tma; transcription mediated amplification,Ord
88226-6,mycoplasma genitalium dna [presence] in urine by naa with probe detection,m genitalium dna ur ql naa+probe,m. genitalium dna naa+probe ql (u),3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; deoxyribonucleic acid; dna nucleic acid probe; dna probe; id; infectious disease; infectiousdisease; lat; lcr; ligase chain reaction; ligation-activated transcription; m genitalium; m genitalium dna; microbiology; myco; mycoplas; mycoplasm; mycoplasmoides genitalium; mycoplasmosis; mycoplsm; naa+probe; naat; nasba; nucleic acid sequence based analysis; ordinal; pcr; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; screen; sda; strand displacement amplification; tma; transcription mediated amplification; ua; ur; urn,Ord
8822-9,right ventricular end-diastolic volume by imaging,rv ed vol imaging,,cardiac; cardio; cardiology; dias; diast; diastoli; ed vol; heart disease; hemodynamics; hemodynamics.molec; hrt; hrt ventr; point in time; qnt; quan; quant; quantitative; r; random; rt; rv; ventricular; vol; volume,Qn
88229-0,mycoplasma genitalium dna [presence] in anorectal by naa with probe detection,m genitalium dna anorectl ql naa+probe,m. genitalium dna naa+probe ql (anorectal),3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; anorectl; deoxyribonucleic acid; dna nucleic acid probe; dna probe; id; infectious disease; infectiousdisease; lat; lcr; ligase chain reaction; ligation-activated transcription; m genitalium; m genitalium dna; microbiology; myco; mycoplas; mycoplasm; mycoplasmoides genitalium; mycoplasmosis; mycoplsm; naa+probe; naat; nasba; nucleic acid sequence based analysis; ordinal; pcr; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; rectum; screen; sda; strand displacement amplification; tma; transcription mediated amplification,Ord
88246-4,carbapenem resistance blakpc gene [presence] by probe in positive blood culture,blakpc bld pos ql probe,carbapenem resistance blakpc gene probe ql (pos bld culture),antibiotic susceptibilities; bact; bld pos; blood; carbapenem resistance gene; cpr; dna nucleic acid probe; dna probe; id; infectious disease; infectiousdisease; ordinal; point in time; pr; ql; qual; qualitative; random; resist; resistanc; resistant; resistent; screen; wb; whole blood,Ord
88253-0,vancomycin resistance vanb gene [presence] by probe in positive blood culture,vanb bld pos ql probe,vancomycin resistance vanb gene probe ql (pos bld culture),antibiotic susceptibilities; bact; bld pos; blood; c162; dna nucleic acid probe; dna probe; id; infectious disease; infectiousdisease; ordinal; point in time; pr; ql; qual; qualitative; random; resist; resistanc; resistant; resistent; screen; vanc; vancocin; vancomycin resistance gene; vancor; wb; whole blood,Ord
88256-3,enterococcus faecalis hsp60 gene [presence] by probe in positive blood culture,e faecalis hsp60 bld pos ql probe,e. faecalis hsp60 gene probe ql (pos bld culture),bld pos; blood; dna nucleic acid probe; dna probe; e faecalis; e faecalis hsp60; id; infectious disease; infectiousdisease; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; screen; wb; whole blood,Ord
88258-9,escherichia coli oppa gene [presence] by probe in positive blood culture,ec oppa gene bld pos ql probe,e. coli oppa gene probe ql (pos bld culture),bld pos; blood; dna nucleic acid probe; dna probe; e coli; ec oppa gene; id; infectious disease; infectiousdisease; microbiology; o002; ordinal; point in time; pr; ql; qual; qualitative; random; screen; wb; whole blood,Ord
88259-7,gram negative bacteria identified [interpretation] by probe in positive blood culture,gn bact bld pos probe-imp,gram negative bacteria identified probe (pos bld culture) [interp],bact; bld pos; blood; dna nucleic acid probe; dna probe; gn bact; id; impression; impression/interpretation of study; impressions; infectious disease; infectiousdisease; interp; interpretation; isolated; microbiology; neg; nominal; point in time; random; wb; whole blood,Nom
88261-3,gram positive bacteria identified [interpretation] by probe in positive blood culture,gp bact bld pos probe-imp,gram positive bacteria identified probe (pos bld culture) [interp],bact; bld pos; blood; dna nucleic acid probe; dna probe; gp bact; gp bact identified; id; impression; impression/interpretation of study; impressions; infectious disease; infectiousdisease; interp; interpretation; isolated; microbiology; nominal; point in time; pos; random; wb; whole blood,Nom
88264-7,klebsiella pneumoniae ygge gene [presence] by probe in positive blood culture,k pneumoniae ygge bld pos ql probe,k. pneumoniae ygge gene probe ql (pos bld culture),bld pos; blood; dna nucleic acid probe; dna probe; id; infectious disease; infectiousdisease; k pneumon; k pneumoniae ygge; microbiology; ordinal; pneu; pneum; pneumo; pneumon; pneumonia; point in time; pr; ql; qual; qualitative; random; screen; wb; whole blood,Ord
88267-0,proteus sp atpd gene [presence] by probe in positive blood culture,proteus sp atpd bld pos ql probe,proteus sp atpd gene probe ql (pos bld culture),bld pos; blood; dna nucleic acid probe; dna probe; id; infectious disease; infectiousdisease; microbiology; ordinal; point in time; pr; proteus sp atpd; ql; qual; qualitative; random; screen; species; spp; wb; whole blood,Ord
88269-6,staphylococcus aureus gyrb gene [presence] by probe in positive blood culture,s aureus gyrb bld pos ql probe,s. aureus gyrb gene probe ql (pos bld culture),bld pos; blood; dna nucleic acid probe; dna probe; id; infectious disease; infectiousdisease; microbiology; o71; ordinal; point in time; pr; ql; qual; qualitative; random; s aureus; screen; staph; wb; whole blood,Ord
88288-6,deprecated mds v3.0 - rai v1.15.1 - swing bed pps (sp) item set [cms assessment],,,centers for medicare and medicaid assessment; pan; panel; panel.survey.cms; panl; pnl; point in time; random; species; spp; survey,-
88297-7,gradual dose reduction (gdr) attempted during assessment period [cms assessment],,,centers for medicare and medicaid assessment; finding; findings; ordinal; ql; qual; qualitative; report period; screen; survey,Ord
88307-4,restraints and alarms during assessment period [cms assessment],,,centers for medicare and medicaid assessment; pan; panel; panel.survey.cms; panl; pnl; report period; survey,-
88310-8,bed alarm used during assessment period [cms assessment],,,centers for medicare and medicaid assessment; finding; findings; ordinal; ql; qual; qualitative; report period; screen; survey,Ord
88335-5,predominant leukocyte identified [type] in ear by light microscopy,predominant leukocyte ear micro,predominant leukocyte identified lm nom (ear),hearing; hematology/cell counts; isolated; leuc; leuk; leukocytes; lkcs; lm; micro; micros; microscopic; nominal; otologic; point in time; random; typ; wbc; wbcs; white blood cell; white blood cells,Nom
8834-4,pulmonary vascular resistance index,pv ri,,bdy surface; bod; bodies; bsa; hemodynamics; hemodynamics.molec; point in time; pulmonary vascular; pulmonary vascular resistance index; pv; pvri; qnt; quan; quant; quantitative; random; resist; resistanc; resistance/area; resistant; resistent; surf,Qn
88348-8,nurse long term care facility transfer summary note,nurse ltc fac transfer sum note,,doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; ltc fac; ltcf; notes; nursing; point in time; random; transfer sum note; visit note,Doc
8835-1,systemic vascular resistance index by fick method,sv ri fick,,bdy surface; bod; bodies; bsa; hemodynamics; hemodynamics.molec; point in time; qnt; quan; quant; quantitative; random; resist; resistanc; resistance/area; resistant; resistent; surf; sv; svr; svri; systemic vascular resistance index,Qn
88360-3,pharmacology alert,pharmacology alert,,doc.ont; document; finding; findings; pharmacy; point in time; random,Doc
88364-5,actinobacillus pleuropneumoniae igg ab/positive control in saliva (oral fluid) by immunoassay,a pleuropn igg/pos cntrl sal ia,a. pleuropneumoniae igg/positive control ia (sal) [relative ratio],a pleuropn; a pleuropneumoniae; abs; aby; actino; antby; anti; antibodies; antibody; autoantibodies; autoantibody; contagious swine pleuropneumonia; eia; elfa; elisa; enzyme immunoassay; iaa; id; immune globulin g; immunoglobulin g; infectious disease; infectiousdisease; meia; microbiology; oral fluid; point in time; pos; pos cntrl; qnt; quan; quant; quantitative; random; relative ratio; sal; suds,Qn
88365-2,glucose [mass/volume] in blood --pre-meal,glucose pre-meal bld-mcnc,glucose pre-meal (bld) [mass/vol],before; blood; chemistry.challenge testing; endocrine; endocrinology; glu; glu tol; gluc; glucose tolerance; glucoseur; gtt; level; mass concentration; point in time; qnt; quan; quant; quantitative; random; wb; whole blood,Qn
88374-4,chemotherapy infusion start and stop date and time panel,chemo infus date and time pnl,,chemo; chemo infus date and time pnl; date+time; pan; panel.io; panl; pnl; point in time; random; started,-
88386-8,"during the last 7 days, on how many days did you walk for at least 10 minutes at a time as a part of your work, not counting any walking you did to travel to or from work [ipaq]",,,activity; arterial stenosis; count/time; dextro; exercise; job; nrate; number rate; number rate = count/time; occupation; past; qnt; quan; quant; quantitative; survey,Qn
88391-8,"during the last 7 days, on how many days did you bicycle for at least 10 minutes at a time to go from place to place [ipaq]",,,count/time; dextro; nrate; number rate; number rate = count/time; past; qnt; quan; quant; quantitative; survey,Qn
88392-6,how much time did you usually spend on one of those days to bicycle from place to place during the last 7 days [ipaq],,,count/time; dextro; nrate; number rate; number rate = count/time; past; qnt; quan; quant; quantitative; survey,Qn
88395-9,"housework, house maintenance, and caring for family panel [ipaq]",,,pan; panl; pnl; point in time; random; survey,-
88405-6,"during the last 7 days, on how many days did you do vigorous physical activities like aerobics, running, fast bicycling, or fast swimming in your leisure time for at least 10 minutes at a time [ipaq]",,,count/time; dextro; nrate; number rate; number rate = count/time; past; qnt; quan; quant; quantitative; survey,Qn
88406-4,how much time did you usually spend on one of those days doing vigorous physical activities in your leisure time during the last 7 days [ipaq],,,count/time; dextro; nrate; number rate; number rate = count/time; past; qnt; quan; quant; quantitative; survey,Qn
88430-4,walking physical activity.leisure-time domain [ipaq],,,activ; activity; actvty; arbitrary rate; exercise; movements; qnt; quan; quant; quantitative; survey; walking pa.leisure-time; walking phys activity,Qn
88435-3,cardiac compression start time,cardiac comp start time clock time,,card.proc; cardiac comp start time; cardio; cardiology; clock time; heart disease; point in time; qnt; quan; quant; quantitative; random; started,Qn
88439-5,hydrogen/expired gas [volume fraction] in exhaled gas --10m post dose fructose po,breath h2 10m p fruct po,hydrogen/expired gas 10 min post dose fructose po (exhl gas) [volume fraction],10m p fruct po; after; breath; chemistry.challenge testing; exg; exhaled gas; exhaled gas (=breath); gases; h2; hyd; levulose; p dose; percent; point in time; pst; qnt; quan; quant; quantitative; random; revulose; volfr; volume fraction,Qn
88442-9,hydrogen/expired gas [volume fraction] in exhaled gas --40 minutes post dose lactose po,breath h2 40m p lac po,hydrogen/expired gas 40 min post dose lactose po (exhl gas) [volume fraction],40m p lac po; after; breath; chemistry.challenge testing; exg; exhaled gas; exhaled gas (=breath); gases; gastro; gastroenterology; gi; h2; hyd; ltt; p dose; percent; point in time; pst; qnt; quan; quant; quantitative; random; volfr; volume fraction,Qn
88445-2,hydrogen/expired gas [volume fraction] in exhaled gas --50m post dose lactose po,breath h2 50m p lact po,hydrogen/expired gas 50 min post dose lactose po (exhl gas) [volume fraction],50m p lact po; after; breath; chemistry.challenge testing; exg; exhaled gas; exhaled gas (=breath); gases; gastro; gastroenterology; gi; h2; hyd; ltt; p dose; percent; point in time; pst; qnt; quan; quant; quantitative; random; volfr; volume fraction,Qn
88453-6,"hiv 1 rna+hepatitis c virus rna+hepatitis b virus dna [presence] in serum, plasma or blood from donor by naa with probe detection",hiv1+hcv+hbv serplbld donr naa+prb,hiv 1+hcv rna + hbv dna naa+probe ql (s/p/bld donor),"3 self-sustaining sequence replication; 3sr sr; aids; amplif; amplification; amplified; blood; deoxyribonucleic acid; dna nucleic acid probe; dna probe; donr; hbv; hcv; hep; hep b; hep b virus; hep c; hepatis; hepatit; hepatitis c virus; hepb; hiv; hiv 1 rna+hcv rna+hbv; hiv 1+hcv rna+hbv dna; hiv type 1; hiv type i; hiv1; human immunodeficiency virus; i; id; infectious disease; infectiousdisease; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; naa+probe; naat; nasba; nucleic acid sequence based analysis; ordinal; pcr; pl; plasbld; plasma; plsm; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; ribonucleic acid; screen; sda; serp; serpl; serplas; serplbld; serum; serum or plasma; serum, plasma or whole blood; sr; strand displacement amplification; tma; transcription mediated amplification; wb; whole blood",Ord
88460-1,serotonin release 50 iu/ml heparin.low molecular weight [units/volume] in serum,sra 50 iu/ml lmw heparin ser-acnc,serotonin release 50 iu/ml heparin.low molecular weight qn (s),5-ht; 5-hydroxytryptamine; 5-hydroxytryptophane; arbitrary concentration; c10h12n2o; clexane; enoxaparin; enteramine; hep; hepar; heparin dependent platelet antibody; heparn; hit/hitt; lmwh; lmwh-induced thrombocytopenia; lovenox; point in time; qnt; quan; quant; quantitative; random; serology; serotonin release assay; serum; sr; sra; sra 50 iu; sra 50 iu/ml heparin; sra 50 iu/ml lmw heparin; thrombocytopenia with thrombosis syndrome; wt,Qn
88476-7,"how many times have you had chest pain, chest tightness or angina over the past 4 weeks [saq]",,,4 weeks; finding; findings; last; ordinal; ql; qual; qualitative; screen; seattle angina questionnaire; survey; survey.gnhlth,Ord
88481-7,activity limitations panel [saq],,,activ; actvty; movements; pan; panel.survey.gnhlth; panl; pnl; seattle angina questionnaire; survey; survey.gnhlth,-
8849-2,ductus arteriosus oxygen saturation,sao2 % da,,da; hemodynamics; hemodynamics.molec; lung; mass fraction; o2; percent; point in time; pulmonary; pulmonology; qnt; quan; quant; quantitative; random; respiratory; sao2; sat; satn; so2; to2,Qn
88525-1,irf-pai v2.0 - quality indicators - discharge during assessment period [cms assessment],,,centers for medicare and medicaid assessment; disch; pan; panel; panel.survey.cms; panl; pnl; report period; survey,-
88528-5,respiratory syncytial virus rna [presence] in cornea or conjunctiva by naa with probe detection,rsv rna corn/cnjt ql naa+probe,rsv rna naa+probe ql (corn/cnjt),3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; corn/cnjt; corneal; dna nucleic acid probe; dna probe; hrsv; id; infectious disease; infectiousdisease; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; naa+probe; naat; nasba; nucleic acid sequence based analysis; ordinal; pcr; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; ribonucleic acid; rsv; screen; sda; strand displacement amplification; tma; transcription mediated amplification,Ord
8853-4,right pulmonary artery oxygen saturation,sao2 % pa-r,,art; cardio; cardiology; heart disease; hemodynamics; hemodynamics.molec; lung; mass fraction; o2; pa; pa-r; percent; point in time; pulmonary; pulmonology; qnt; quan; quant; quantitative; r; random; respiratory; rt; sao2; sat; satn; so2; to2,Qn
88535-0,cytomegalovirus dna [presence] in dbs by naa with probe detection,cmv dna dbs ql naa+probe,cmv dna naa+probe ql (dbs),3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; blood; cmv; cytomegalo virus; cytomgal; dbs; deoxyribonucleic acid; dna nucleic acid probe; dna probe; dried blood spot; filter paper; fp; hhv-5; human herpesvirus-5; id; infectious disease; infectiousdisease; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; naa+probe; naat; nasba; nucleic acid sequence based analysis; ordinal; pcr; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; screen; sda; strand displacement amplification; tma; transcription mediated amplification; wb; whole blood,Ord
88546-7,chlamydophila pneumoniae dna [presence] in aspirate by naa with probe detection,c pneum dna aspirate ql naa+probe,c. pneumoniae dna naa+probe ql (asp),3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; aspirate; c pneum; c pneumo; c pneumoniae; chlamydia; chlamydia pneumoniae; cpn; deoxyribonucleic acid; dna nucleic acid probe; dna probe; id; infectious disease; infectiousdisease; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; naa+probe; naat; nasba; nucleic acid sequence based analysis; ordinal; pcr; pneu; pneum; pneumo; pneumon; pneumonia; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; screen; sda; strand displacement amplification; tma; transcription mediated amplification; twar agent,Ord
88549-1,scedosporium apiospermum dna [presence] in isolate by naa with probe detection,s apiospermum dna islt ql naa+probe,s. apiospermum dna naa+probe ql (isol),3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; deoxyribonucleic acid; dna nucleic acid probe; dna probe; id; infectious disease; infectiousdisease; islt; isol; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; naa+probe; naat; nasba; nucleic acid sequence based analysis; ordinal; pcr; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; s apiospermum; s apiospermum dna; screen; sda; strand displacement amplification; tma; transcription mediated amplification,Ord
88550-9,scedosporium apiospermum dna [presence] in lower respiratory specimen by naa with probe detection,s apiospermum dna low resp ql naa+probe,s. apiospermum dna naa+probe ql (lower resp),3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; breathing; deoxyribonucleic acid; dna nucleic acid probe; dna probe; id; infectious disease; infectiousdisease; lat; lcr; ligase chain reaction; ligation-activated transcription; low; lower resp; lung; lungs; microbiology; naa+probe; naat; nasba; nucleic acid sequence based analysis; ordinal; pcr; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; pulmonary; pulmonology; qbr; ql; qual; qualitative; random; respiratory; rs; s apiospermum; s apiospermum dna; screen; sda; spec; strand displacement amplification; tma; transcription mediated amplification,Ord
88555-8,galactomannan ag [presence] in bronchoalveolar lavage,galactomannan ag bal ql,galactomannan ag ql (bal),antigen; antigens; aspergillus galactomannan; bronchial alveolar lavage; bronchoalveolar lavage; gm; id; infectious disease; infectiousdisease; lung; microbiology; ordinal; point in time; pr; pulmonary; pulmonology; ql; qual; qualitative; random; respiratory; screen,Ord
8856-7,oxygen saturation device measurement site,sao2% device measurement site,,anatomy; nominal; o2; point in time; random; sao2% device; sat; satn,Nom
88573-1,onchocerca sp igg2 ab [presence] in serum by immunoassay,onchocerca igg2 ser ql ia,onchocerca sp igg2 ia ql (s),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; eia; elfa; elisa; enzyme immunoassay; filariasis; iaa; id; infectious disease; infectiousdisease; meia; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; river blindness; screen; serum; species; spp; sr; suds,Ord
8857-5,hemodynamic shunt method,hemodynamic shunt method,,cardiac shunt method; hemodynamics; hemodynamics.atom; meth; method of; nominal; point in time; random; typ,Nom
8858-3,pulmonary vascular intrapulmonary shunt,pv intrapulmonary shunt,,flow; hemodynamics; hemodynamics.molec; intrapulmonary shunt; point in time; pulmonary vascular; pv; qnt; quan; quant; quantitative; random; volume rate; vrate,Qn
8859-1,intracardiac shunt left-right,intracardiac shunt l-r,,cardiac; cardio; cardiology; flow; heart disease; hemodynamics; hemodynamics.molec; hrt; intracardiac shunt l-r; l; lt; point in time; qnt; quan; quant; quantitative; r; random; rt; volume rate; vrate,Qn
88620-0,human coronavirus rna [presence] in lower respiratory specimen by naa with probe detection,hcov rna lower resp ql naa+probe,hcov rna naa+probe ql (lower resp),3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; breathing; corona virus; dna nucleic acid probe; dna probe; hcov; id; infectious disease; infectiousdisease; lat; lcr; ligase chain reaction; ligation-activated transcription; low; lower resp; lung; lungs; microbiology; naa+probe; naat; nasba; nucleic acid sequence based analysis; ordinal; pcr; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; pulmonary; pulmonology; qbr; ql; qual; qualitative; random; respiratory; ribonucleic acid; rs; screen; sda; spec; strand displacement amplification; tma; transcription mediated amplification,Ord
8862-5,right ventricular stroke work,rv stroke work,,cardiac; cardio; cardiology; energy; heart beat; heart disease; hemodynamics; hemodynamics.molec; hrt; hrt ventr; job; occupation; point in time; pulse; qnt; quan; quant; quantitative; r; random; rt; rv; ventricular,Qn
88633-3,microscopic observation [identifier] in lower respiratory specimen by giemsa stain,gie stn lower resp,microscopic observation giemsa stain nom (lower resp),breathing; gie stn; gms; id; identity or presence; infectious disease; infectiousdisease; low; lower resp; lung; lungs; microbiology; nominal; point in time; pulmonary; pulmonology; random; respiratory; rs; spec; st; stains; stn,Nom
88641-6,community health care adult day care center discharge summary,comm hlth care adcc d/c sum,,adcc; comm hlth care; continuity assessment record and evaluation; d/c sum; disch; discharge summary; doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; notes; point in time; random; visit note,Doc
88648-1,hematology+medical oncology parenteral therapy note,hemonc parentrl thrpy note,,cancer; doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; hematology; hematology and oncology; hematology+oncology; heme; hemonc; notes; oncology; parentrl thrpy note; point in time; random; visit note,Doc
88651-5,parenteral therapy note,parentrl thrpy note,,doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; notes; parentrl thrpy note; point in time; random; visit note,Doc
88662-2,defibrillator type,defibrillator type,,nominal; point in time; random; typ,Nom
88682-0,leishmania sp igm ab [titer] in serum by immunofluorescence,leishmania igm titr ser if,leishmania sp igm if (s) [titer],abs; aby; acif; antby; anti; antibodies; antibody; anticomplement immunofluorescence; autoantibodies; autoantibody; dilution factor; dilution factor (titer); fa; fluorescent antibody; fluoresent; id; ifa; immune fluorescence; immune globulin m; immunoflour; immunofluor; immunofluorescence; immunoglobulin m; infectious disease; infectiousdisease; kala azar; leishmaniasis; leishmaniosis; microbiology; point in time; random; serum; smqn; species; spp; sr; time resolved fluorescence; titer; titered; titre; trf; ttr; visceral leishmaniasis,SemiQn
88685-3,microscopic observation [identifier] in lower respiratory specimen by koh preparation,koh prep lower resp,microscopic observation koh prep nom (lower resp),breathing; id; identity or presence; infectious disease; infectiousdisease; low; lower resp; lung; lungs; microbiology; nominal; point in time; potassium hydroxide preparation; prep; pulmonary; pulmonology; random; respiratory; rs; spec,Nom
88691-1,pneumocystis jirovecii ag [presence] in bronchoalveolar lavage by immunofluorescence,p jirovecii ag bal ql if,p. jirovecii ag if ql (bal),acif; anticomplement immunofluorescence; antigen; antigens; bronchial alveolar lavage; bronchoalveolar lavage; dfa; fa; fluorescent antibody; fluoresent; id; ifa; immune fluorescence; immunoflour; immunofluor; immunofluorescence; infectious disease; infectiousdisease; lung; microbiology; ordinal; p carinii; p jiroveci; p jirovecii; pcp; pneumocystis carinii; point in time; pr; pulmonary; pulmonology; ql; qual; qualitative; random; respiratory; screen; time resolved fluorescence; trf,Ord
88696-0,"ulcers, wounds and skin problems in the last 7 days [cms assessment]",,,centers for medicare and medicaid assessment; finding; findings; integument; nominal; past; survey,Nom
88698-6,protein electrophoresis panel - body fluid,prot elph pnl fld elph,protein electrophoresis panel elph (body fld),"b/f; bf; bod; bodies; body fluid; body fluid, unsp; chemistry; elec; elect; electr; electro; electrophhrs; electrophrs; elp; elph; ep; fl; fld; flu; fluid; frac; fract; fraction; fractionated; fractionation; pan; panel.chemistry; panl; pnl; point in time; pr; prot; prot elph pnl; random; serum electrophoresis",-
88703-4,bedaquiline [susceptibility] by minimum inhibitory concentration (mic),bedaquiline islt mic,bedaquiline mic [susc],antibiotic susceptibilities; ast; extensively drug resistant tuberculosis; id; infectious disease; infectiousdisease; islt; isol; mdr tb; mdr tuberculosis; minimum inhibitory concentration; multi drug resistant tuberculosis; point in time; random; sirturo; sus; suscept; susceptibilities; susceptibility; susceptibilty; tb; tuberculosis; xdr tb,OrdQn
88704-2,bedaquiline [susceptibility] by method for slow-growing mycobacteria,bedaquiline islt slowmyco,bedaquiline method for slow-growing mycobacteria [susc],afb; antibiotic susceptibilities; ast; extensively drug resistant tuberculosis; id; infectious disease; infectiousdisease; islt; isol; mdr tb; mdr tuberculosis; multi drug resistant tuberculosis; myco; mycobacteria susceptibility; mycobacterial susceptibility; point in time; random; sirturo; slowmyco; sus; suscept; susceptibilities; susceptibility; susceptibilty; tb; tuberculosis; xdr tb,OrdQn
88709-1,albumin/globulin [mass ratio] in body fluid by electrophoresis,albumin/glob fld elph,albumin/globulin elph (body fld) [mass ratio],"alb; b/f; bf; bod; bodies; body fluid; body fluid, unsp; chemistry; elec; elect; electr; electro; electrophhrs; electrophrs; elp; elph; ep; fl; fld; flu; fluid; glb; glob; glob%; globul; globulins; hepatology; kidney; liver; mass concentration ratio; mass ratio; mcrto; nephrology; point in time; protein.albumin; qnt; quan; quant; quantitative; random; renal",Qn
88712-5,lipase [enzymatic activity/volume] in peritoneal dialysis fluid,lipase diafp-ccnc,lipase (perit dial fld) [catalytic activity/vol],catalytic concentration; chemistry; diaf; diafp; dialysate; dialysis fluid; lipa; lipase; lps; pancreatic lipase; peritoneal dialysis fluid; point in time; qnt; quan; quant; quantitative; random; steapsin; tributyrase; tributyrinase,Qn
88722-4,streptococcus pneumoniae serotype [type] in isolate,s pneum sertyp islt,s. pneumoniae serotype nom (isol),id; infectious disease; infectiousdisease; islt; isol; microbiology; nominal; pneu; pneum; pneumo; pneumococ; pneumococcal; pneumococcal pneumonia; pneumococcus; pneumon; pneumonia; point in time; random; s pneum serotype; s pneumo; s pneumoniae; sertyp; spn; strep; strept; typ,Nom
88734-9,pca-tr ab [units/volume] in serum by line blot,pca-tr ab ser line blot-acnc,pca-tr ab line blot qn (s),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; cytopl; cytoplas; hodgkin's lymphoma; limbic encephalopathy; paraneoplastic cerebellar degeneration; paraneoplastic neurological syndrome; paraneoplastic syndrome; pcd; pns; point in time; qnt; quan; quant; quantitative; random; serology; serum; sr,Qn
88735-6,pm-scl-100 ab [units/volume] in serum by line blot,pm/scl-100 ab ser line blot-acnc,pm-scl-100 ab line blot qn (s),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; evening; pm/scl-100; pm1-alpha; point in time; polymyositis; qnt; quan; quant; quantitative; random; scleroderma; serology; serum; sr; systemic sclerosis,Qn
88737-2,rna polymerase iii rp11 ab [units/volume] in serum by line blot,rnap iii rp11 ab ser line blot-acnc,rna polymerase iii rp11 ab line blot qn (s),3; abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; point in time; pol iii; pol3rk; pol3rk gene; qnt; quan; quant; quantitative; random; ribonucleic acid; rnap iii; rnap iii rp11; rnap iii rp11 ab; serology; serum; sr,Qn
88744-8,"inv(2)(p21;p23)(eml4,alk) fusion transcript [presence] in tissue by molecular genetics method","inv(2)(eml4,alk) tiss ql","inv(2)(p21;p23)(eml4,alk) fusion transcript molgen ql (tiss)","anaplastic lymphoma kinase (ki-1); dna; gene fusion; gene translocation; ii; inv(2)(eml4,alk); molecular genetics; molecular pathology; molpath; ordinal; pcr; point in time; pr; ql; qual; qualitative; random; rna; screen; tissue; tissue, unspecified; translocation",Ord
88772-9,degree of difficulty experienced due to your hip while standing in the last week [hoos],,,1 week; finding; findings; hip dysfunction and osteoarthritis outcome score; hoos jr; lower extremity joint; ordinal; past; ql; qual; qualitative; screen; survey; survey.gnhlth,Ord
8878-1,heart rate 24 hour,heart rate 24h,,1 day; 24 hours; 24hr; count/time; heart beat; heart rate.timed.mol; misc; miscellaneous; nrate; number rate; number rate = count/time; other; pulse; qnt; quan; quant; quantitative; spec; to be specified in another part of the message; unspecified,Qn
88795-0,does your knee catch or hang up when moving during the last week [koos],,,"1 week; finding; findings; knee injury and osteoarthritis outcome score; koos jr; koos, jr; lower extremity joint; ordinal; past; ql; qual; qualitative; screen; survey; survey.gnhlth",Ord
88800-8,have you modified your life style to avoid activities potentially damaging to your knee [koos],,,"finding; findings; knee injury and osteoarthritis outcome score; koos jr; koos, jr; lower extremity joint; ordinal; point in time; ql; qual; qualitative; random; screen; survey; survey.gnhlth",Ord
88801-6,how often are you aware of your knee problem [koos],,,"finding; findings; knee injury and osteoarthritis outcome score; koos jr; koos, jr; lower extremity joint; ordinal; point in time; ql; qual; qualitative; random; screen; survey; survey.gnhlth",Ord
88805-7,amount of knee pain experienced while bending the knee fully in the last week [koos],,,"1 week; finding; findings; knee injury and osteoarthritis outcome score; koos jr; koos, jr; lower extremity joint; ordinal; past; ql; qual; qualitative; screen; survey; survey.gnhlth",Ord
88806-5,how often do you experience knee pain [koos],,,"finding; findings; knee injury and osteoarthritis outcome score; koos jr; koos, jr; lower extremity joint; ordinal; point in time; ql; qual; qualitative; random; screen; survey; survey.gnhlth",Ord
8880-7,heart rate 8 hour minimum,heart rate 8h min,,1/3 day; 8 hours; 8hr; count/time; heart beat; heart rate.timed.mol; minimal; minimum; misc; miscellaneous; nrate; number rate; number rate = count/time; other; pulse; qnt; quan; quant; quantitative; spec; to be specified in another part of the message; unspecified,Qn
88814-9,"degree of difficulty experienced due to your knee while doing heavy domestic duties (moving heavy boxes, scrubbing floors, etc) in the last week [koos]",,,"1 week; finding; findings; knee injury and osteoarthritis outcome score; koos jr; koos, jr; lower extremity joint; ordinal; past; ql; qual; qualitative; screen; survey; survey.gnhlth",Ord
88830-5,fda package insert immunogenicity,fda insert immunogenicity,,document.ref; fda insert; narrative; report; spl; structured product labelling,Nar
88832-1,rf kidney - left and ureter views w contrast retrograde intra ureter,rf kid-l+uret views w contr retro iu,,abd; abd+pelvis; abdo; abdominal; c; contr; contra; contrst; document; films; finding; findings; fluor; fluoro; fluoroscopy; imaging; kid-l+uret; kidney; kidney-l; l; lt; nephric; nephrology; pelvic; point in time; pyelogram; pyelography; rad; radiology; random; renal; retro; view; vws; w contr retro; w contr retro iu; wc,Doc
88836-2,microbiology cnamts panel - throat,micro cnamts panel throat,microbiology cnamts panel (throat),micro cnamts panel; pan; panel.microbiology; panl; pnl; point in time; random; throat; upper respiratory,-
88844-6,microbiology cnamts panel - bronchial specimen,micro cnamts panel bronch,microbiology cnamts panel (bronch spec),bro; micro cnamts panel; pan; panel.microbiology; panl; pnl; point in time; random,-
88848-7,microbiology cnamts panel - urine,micro cnamts panel ur,microbiology cnamts panel (u),micro cnamts panel; pan; panel.microbiology; panl; pnl; point in time; random; ua; ur; urn,-
8885-6,heart rate measurement site,heart rate measurement site,,anatomy; heart beat; heart rate.atom; nominal; point in time; pulse; random,Nom
88858-6,donor type score for risk calculation,donor type risk score,,clin; clin.risk; donor type risk score; ordinal; point in time; ql; qual; qualitative; random; scale; screen,Ord
88872-7,irf-pai v2.0 - medications - admission [cms assessment],,,3 days; centers for medicare and medicaid assessment; pan; panel; panel.survey.cms; panl; pnl; survey,-
88874-3,mycobacterium tuberculosis complex dna [presence] in isolate or specimen by molecular genetics method,m tb cmplx dna islt/spm ql,m. tuberculosis complex dna molgen ql (islt/spec),acid fast; acid fast bacilli; acid fast bacillus; afb; compx; deoxyribonucleic acid; id; infectious disease; infectiousdisease; islt; islt/spm; isol; m tb; m tb cmplx; m tuberculosis; microbiology; molecular genetics; mtb; mtbc; myco; mycobact; mycobacterium tuberculosum; ordinal; pcr; point in time; pr; ql; qual; qualitative; random; screen; spec; tb; tuberculosis,Ord
88878-4,date of condition abatement,date of condition abatement,,h+p; h+p.hx; p prime; point in time; qnt; quan; quant; quantitative; random,Qn
88916-2,leishmania sp dna [identifier] in tissue by naa with probe detection,leishmania dna tiss naa+probe,leishmania sp dna naa+probe nom (tiss),"3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; deoxyribonucleic acid; dna nucleic acid probe; dna probe; id; identity or presence; infectious disease; infectiousdisease; kala azar; lat; lcr; leishmaniasis; leishmaniosis; ligase chain reaction; ligation-activated transcription; microbiology; naa+probe; naat; nasba; nominal; nucleic acid sequence based analysis; pcr; point in time; polymerase chain reaction; probe amp; probe with ampification; probe with target amplification; qbr; random; sda; species; spp; strand displacement amplification; tissue; tissue, unspecified; tma; transcription mediated amplification; visceral leishmaniasis",Nom
8893-0,heart rate peripheral artery by palpation,heart rate periph a palpation,,art; cardio; cardiology; count/time; heart beat; heart disease; heart rate.molec; nrate; number rate; number rate = count/time; periph; periph a; point in time; pulse; qnt; quan; quant; quantitative; random,Qn
88931-1,guidance for embolization for tumor of hepatic artery-- w embolic agent ia,guided hep a tum embol--w emb ag ia,,abd; abdo; abdomen+; abdominal; art; cardio; cardiology; document; finding; findings; guid; guide; guided; heart disease; hep a; hepar; imaging; liver; liver artery; point in time; rad; radiology; random; tum embol; w emb ag ia,Doc
8894-8,p wave atrium by ekg,p wave atrium by ekg,,atrial; cardiac; cardio; cardiology; count/time; ecg; electrocardiogram; electrocardiograph; heart disease; heart rate; heart rate.molec; hrt; hrt.atria; nrate; number rate; number rate = count/time; p prime; point in time; qnt; quan; quant; quantitative; random,Qn
88950-1,deprecated mds v3.0 - rai v1.16.1 - swing bed pps (sp) item set [cms assessment],,,centers for medicare and medicaid assessment; pan; panel; panel.survey.cms; panl; pnl; point in time; random; species; spp; survey,-
88955-0,deprecated mds v3.0 - rai v1.16.1 - nursing home quarterly (nq) item set [cms assessment],,,centers for medicare and medicaid assessment; pan; panel; panel.survey.cms; panl; pnl; point in time; random; survey,-
889-6,blood group antibodies identified in blood product unit,blood group antibodies bpu,blood group antibodies identified nom (bpu),blood bank; blood product unit; blood product unit (pack); identity or presence; nominal; point in time; random,Nom
88993-1,acute kidney injury risk [likelihood] by calculated by nephrocheck,acute kidney injury risk nephrocheck,acute kidney injury risk calculated by nephrocheck qn,acute renal failure; aki risk; arf; calc; calc.nephrocheck; calculation; chemistry; nephrocheck test system; point in time; qnt; quan; quant; quantitative; random; risk; ulcer,Qn
8899-7,pulse intensity brachial artery - right by palpation,pulse intensity brach a-r palpation,,art; brach a; brach a-r; cardio; cardiology; heart disease; heart rate; heart rate.molec; mechanical force; ordinal; point in time; ql; qual; qualitative; r; random; rt; screen; upper arm,Ord
89000-4,ethyl glucuronide [mass/mass] in hair by confirmatory method,ethyl glucuronide hair cfm-mcnt,ethyl glucuronide confirm (hair) [mass/mass],cfm; cnfr; cnfrm; conf; confirmation; confirmatory; drug/toxicology; drugs; etg; ethanol metabolite; gcms; gluc; glucouronide; har; lc/ms/ms; mass content; point in time; qnt; quan; quant; quantitative; random,Qn
89011-1,ems assistant name,ems assistant name,,emergency medical service(s); nominal; person name; point in time; random; trauma,Nom
89024-4,hearing threshold ear - left --500 hz,hearing threshold 500 hz ear-l,,audio; audiology; ear-l; hearing; l; lt; otologic; point in time; qnt; quan; quant; quantitative; random,Qn
89035-0,sleep medicine physician note,sleep medicine md note,,doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; m.d.; md; notes; point in time; random; sleep medicine md; visit note,Doc
89036-8,trauma note,trauma note,,doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; notes; point in time; random; visit note,Doc
8904-5,pulse intensity femoral artery - left by palpation,pulse intensity fem a-l palpation,,art; cardio; cardiology; fem a; fem a-l; heart disease; heart rate; heart rate.molec; l; lt; mechanical force; ordinal; point in time; ql; qual; qualitative; random; screen; thigh,Ord
89047-5,"mds v3.0 - rai v1.16.1 - skin conditions - nod, sod during assessment period [cms assessment]",,,centers for medicare and medicaid assessment; integument; pan; panel; panel.survey.cms; panl; pnl; report period; survey,-
89074-9,aspirin usage--post enrollment in adaptable study [adaptable],,,after; finding; findings; ordinal; point in time; post adaptable; pst; ql; qual; qualitative; random; screen; study report; survey; survey.gnhlth,Ord
89075-6,willing to change aspirin dose,,,exchange; finding; findings; ordinal; point in time; ql; qual; qualitative; random; replace; screen; survey; survey.gnhlth,Ord
89082-2,early visit item set [adaptable],,,pan; panel; panel.survey.gnhlth; panl; pnl; point in time; random; survey; survey.gnhlth,-
89084-8,i have trouble doing all of my regular leisure activities with others in the past 7 days [adaptable],,,finding; findings; last; ordinal; ql; qual; qualitative; screen; survey; survey.gnhlth; trouble leisure activities with others,Ord
8908-6,pulse intensity posterior tibial artery - right by palpation,pulse intensity post tibl a-r palpation,,art; calf; cardio; cardiology; heart disease; heart rate; heart rate.molec; mechanical force; ordinal; point in time; post tibl a; post tibl a-r; ql; qual; qualitative; r; random; rt; screen,Ord
89096-2,"compared to 10 years ago, has there been any change in the ability to do two things at once [ecog.partner]",,,2; eastern cooperative oncology group; everyday cognition; everyday cognition partner version; exchange; finding; findings; ordinal; point in time; ql; qual; qualitative; random; replace; screen; survey; survey.gnhlth,Ord
89099-6,"compared to 10 years ago, has there been any change in prioritizing tasks by importance [ecog.partner]",,,eastern cooperative oncology group; everyday cognition; everyday cognition partner version; exchange; finding; findings; ordinal; point in time; ql; qual; qualitative; random; replace; screen; survey; survey.gnhlth,Ord
89101-0,"compared to 10 years ago, has there been any change in balancing the checkbook without error [ecog.partner]",,,eastern cooperative oncology group; everyday cognition; everyday cognition partner version; exchange; finding; findings; ordinal; point in time; ql; qual; qualitative; random; replace; screen; survey; survey.gnhlth,Ord
89110-1,"compared to 10 years ago, has there been any change in finding the way back to a meeting spot in the mall or other location [ecog.partner]",,,eastern cooperative oncology group; everyday cognition; everyday cognition partner version; exchange; finding; findings; ordinal; othr; point in time; ql; qual; qualitative; random; replace; screen; survey; survey.gnhlth,Ord
89115-0,"compared to 10 years ago, has there been any change in describing a program he or she has watched on tv [ecog.partner]",,,eastern cooperative oncology group; everyday cognition; everyday cognition partner version; exchange; finding; findings; ordinal; point in time; ql; qual; qualitative; random; replace; screen; survey; survey.gnhlth,Ord
89126-7,"compared to 10 years ago, has there been any change in repeating stories andor questions [ecog.partner]",,,eastern cooperative oncology group; everyday cognition; everyday cognition partner version; exchange; finding; findings; ordinal; point in time; ql; qual; qualitative; random; replace; screen; survey; survey.gnhlth,Ord
89141-6,"compared to 10 years ago, has there been any change in the ability to do two things at once [ecog]",,,2; eastern cooperative oncology group; everyday cognition; exchange; finding; findings; ordinal; point in time; ql; qual; qualitative; random; replace; screen; survey; survey.gnhlth,Ord
8914-4,pulse wave form brachial artery - left by us.doppler,pulse wave form brach a-l dop,,art; brach a; brach a-l; cardio; cardiology; dop; duplex; echography; heart disease; heart rate; heart rate.molec; impression; impression/interpretation of study; impressions; interp; interpretation; l; lt; nominal; point in time; random; sonogram; sonograph; sonography; uls; ultrasound; upper arm,Nom
89151-5,"compared to 10 years ago, has there been any change in remembering appointments, meetings, or engagements [ecog]",,,eastern cooperative oncology group; everyday cognition; exchange; finding; findings; ordinal; point in time; ql; qual; qualitative; random; replace; screen; survey; survey.gnhlth,Ord
89158-0,"compared to 10 years ago, has there been any change in keeping living and work space organized [ecog]",,,eastern cooperative oncology group; everyday cognition; exchange; finding; findings; job; occupation; ordinal; point in time; ql; qual; qualitative; random; replace; screen; survey; survey.gnhlth,Ord
89173-9,"compared to 10 years ago, has there been any change in balancing the checkbook without error [ecog]",,,eastern cooperative oncology group; everyday cognition; exchange; finding; findings; ordinal; point in time; ql; qual; qualitative; random; replace; screen; survey; survey.gnhlth,Ord
89175-4,billing information panel,billing info pnl,,admin; billing info pnl; pan; panel.admin; panl; pnl; point in time; random,-
8917-7,pulse wave form carotid artery - right by us.doppler,pulse wave form carot a-r dop,,art; cardio; cardiology; carot a; carot a-r; dop; duplex; echography; heart disease; heart rate; heart rate.molec; impression; impression/interpretation of study; impressions; interp; interpretation; nominal; point in time; r; random; rt; sonogram; sonograph; sonography; uls; ultrasound,Nom
89184-6,biophysical agent used,biophysical agent used,,apta; identity or presence; nominal; physical therapy; point in time; pt; random,Nom
89190-3,performance-based measure name,,,ident; identifier; nominal; perf based measure name; point in time; random; survey; survey.gnhlth,Nom
8919-3,pulse wave form dorsal pedal artery by us.doppler,pulse wave form dors pedal a dop,,art; cardio; cardiology; dop; dors pedal a; duplex; echography; feet; foot; heart disease; heart rate; heart rate.molec; impression; impression/interpretation of study; impressions; interp; interpretation; nominal; point in time; random; sonogram; sonograph; sonography; uls; ultrasound,Nom
89195-2,patient reported outcome measure name,,,ident; identifier; nominal; point in time; pro measure name; random; survey; survey.gnhlth,Nom
89221-6,gynecology history and physical note,gynecology h&p note,,doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; gyn; gynecology; h&p note; hx; notes; ob; obgyn; obstetrics; point in time; random; visit note,Doc
89223-2,gynecology procedure note,gynecology procedure note,,doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; gyn; gynecology; notes; ob; obgyn; obstetrics; point in time; random; visit note,Doc
89227-3,obstetrics consult note,ob consult note,,consult note; doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; gyn; gynecology; notes; ob; obgyn; obstetric; obstetrics; point in time; prenatal; random; visit note,Doc
89233-1,obstetrics progress note,ob prog note,,doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; gyn; gynecology; notes; ob; obgyn; obstetric; obstetrics; point in time; prenatal; prog note; random; subsequent evaluation; subsequent visit evaluation; visit note,Doc
89252-1,episode of wound,episode wnd,,h+p; h+p.hx; nominal; p prime; point in time; random; typ; wnd,Nom
89256-2,wound edge panel,wound edge panel,,h+p; p prime; pan; panel.h&p; panl; pnl; point in time; random; wnd,-
89266-1,"procedures, services, or supplies code",proc+serv+supp code,,admin; nominal; point in time; proc+serv+supp code; random; typ,Nom
89269-5,body height measured --at birth,body height @ birth measured,,@ birth; axial length; bod; bodies; body length; clin; length; new born; newborn; point in time; qnt; quan; quant; quantitative; random,Qn
89272-9,oxygen saturation in arterial blood by pulse oximetry --during apnea,sao2 during apnea % blda pulseox,sao2% during apnea pulse oximetry (blda) [mass fraction],abg; art; art bld; art blood; arterial; arterial blood; blood arterial; chemistry; lung; mass fraction; o2; percent; point in time; pulmonary; pulmonology; pulseox; qnt; quan; quant; quantitative; random; respiratory; sao2; sat; satn; so2; spo2; to2,Qn
8927-6,pulse wave form radial artery - right by us.doppler,pulse wave form radial a-r dop,,art; cardio; cardiology; dop; duplex; echography; forearm; heart disease; heart rate; heart rate.molec; impression; impression/interpretation of study; impressions; interp; interpretation; nominal; point in time; r; radial a-r; random; rt; sonogram; sonograph; sonography; uls; ultrasound,Nom
89284-4,mr cervical and thoracic spine w contrast iv,mr c+t-spine w contr iv,,c; c/sp; c+t-spine; cerv; contr; contra; contrst; c-spine; document; dorsal spine; finding; findings; imaging; mitral regurgitation maximum velocity; mri; point in time; rad; radiology; random; spinal; spinal cord; th/sp; thorax; t-spine; w contr iv; wc,Doc
89291-9,heart rate --w pain,heart rate w pain,,count/time; heart beat; hrtrate.pstn.molec; misc; miscellaneous; nrate; number rate; number rate = count/time; other; point in time; pulse; qnt; quan; quant; quantitative; random; spec; to be specified in another part of the message; unspecified,Qn
89311-5,cd3-cd45+ cells/cells in blood,cd3-cd45+ cells nfr bld,cd3-cd45+ cells/cells (bld),b220; blood; cd3 cells; cd3+cd45+ cells; cd3-cd45+ cells; cd45r; cd45ra; cd45rb; cd45rc; cd45ro; cell; cell markers; cellularity; lca; leu4; leu-4; leukocyte common antigen; ly5; number fraction; percent; point in time; qnt; quan; quant; quantitative; random; t200; t3; wb; whole blood,Qn
89316-4,cd4+cd25+cd45ro+cd127low+ cells [#/volume] in blood,cd4+cd25+cd45ro+cd127low+ cells # bld,cd4+cd25+cd45ro+cd127low+ cells (bld) [#/vol],#; abs; absolute; absolutes; blood; cd4 cells; cd4+cd25+ cells; cd4+cd25+cd45ro+cd127low+ cells; cell; cell markers; cellularity; cnt; count; count/volume; ct; helper t cells; il-2 receptor alpha chain; il-2r; il-2r tac antigen; ilr2; inducer t cells; l3t4; leu3; leu-3; number concentration; number concentration (count/vol); point in time; qnt; quan; quant; quantitative; random; t4; t-4; tac antigen; uchl-1; w3/25; wb; whole blood,Qn
89319-8,cd25+cd45ra+cd127low+ cells/cd4 cells in blood,cd25+cd45ra+cd127l+/cd4 nfr bld,cd25+cd45ra+cd127low+ cells/cd4 cells (bld),2h4; blood; cd25 cells; cd25+cd45ra+cd127l+ cells; cd4 cells; cell; cell markers; cellularity; helper t cells; il-2 receptor alpha chain; il-2r; il-2r tac antigen; ilr2; inducer t cells; l3t4; leu18; leu-18; leu3; leu-3; number fraction; percent; point in time; qnt; quan; quant; quantitative; random; t4; t-4; tac antigen; w3/25; wb; whole blood,Qn
89322-2,norbuprenorphine-3-glucuronide [mass/volume] in serum or plasma by confirmatory method,n3g serpl cfm-mcnc,norbuprenorphine-3-glucuronide confirm [mass/vol],addiction; buprenorphine metabolite; cfm; cnfr; cnfrm; conf; confirmation; confirmatory; drug/toxicology; drugs; drugs of abuse; gcms; gluc; glucouronide; iii; illicit; lc/ms/ms; level; mass concentration; n3g; nbu; norbup; norbuprenorphine glucuronide; pl; plasma; plsm; point in time; potentialforabuse; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
89325-5,cd3+cd8+cd28+hla dr+ cells [#/volume] in blood,cd3+cd8+cd28+hla dr+ cellls # bld,cd3+cd8+cd28+hla dr+ cells (bld) [#/vol],#; abs; absolute; absolutes; blood; cd3 cells; cd3+cd8+ cells; cd3+cd8+cd28+hla dr+ cellls; cd8 t cells; cell; cell markers; cellularity; cnt; count; count/volume; ct; hla-dr; human leukocyte antigen; i3; leu2; leu-2; leu4; leu-4; number concentration; number concentration (count/vol); point in time; qnt; quan; quant; quantitative; random; suppressor t cells; suppressor/cytotoxic t cells; t3; t44; t8; t-8; t8 suppressor cells; tp44; tsuppressor; wb; whole blood,Qn
89336-2,cd45ro cells/cd3+cd8+ (t8 suppressor cells) cells in blood,cd45ro cells/cd3+cd8+ cll nfr bld,cd45ro cells/cd3+cd8+ (t8 suppressor cells) cells (bld),blood; cd3 cells; cd3+cd8+ cells; cd3+cd8+ cll; cd45ro cells; cd8 t cells; cell; cell markers; cellularity; leu2; leu-2; leu4; leu-4; number fraction; percent; point in time; qnt; quan; quant; quantitative; random; suppressor t cells; suppressor/cytotoxic t cells; t3; t8; t-8; t8 suppressor cells; tsuppressor; uchl-1; wb; whole blood,Qn
89345-3,cd19+igm+ cells [#/volume] in blood,cd19+igm+ cells # bld,cd19+igm+ cells (bld) [#/vol],#; abs; absolute; absolutes; b cells expressing cd19 as a percent of total lymphocytes; b4; b-4; blood; cd19 cells; cd19+igm+ cells; cell; cell markers; cellularity; cnt; count; count/volume; ct; hd-37; igm b cells; immune globulin m; immunoglobulin m; leu12; leu-12; number concentration; number concentration (count/vol); point in time; qnt; quan; quant; quantitative; random; wb; whole blood,Qn
89352-9,cd27+igd+igm+ cells/cells.cd19 in blood,cd27+igd+igm+/cd19 cells nfr bld,cd27+igd+igm+ cells/cells.cd19 (bld),b cells expressing cd19 as a percent of total lymphocytes; b4; b-4; blood; cd19 cells; cd27 cells; cd27- cells; cd27+igd- cells; cd27+igd+ cells; cd27+igd+igm+ cells; cd27+igd-igm- cells; cd27+igd-igm+ cells; cd27-igd+ cells; cell; cell markers; cellularity; hd-37; immune globulin d; immune globulin m; immunoglobulin d; immunoglobulin m; leu12; leu-12; number fraction; percent; point in time; qnt; quan; quant; quantitative; random; s152; t14; wb; whole blood,Qn
89353-7,cd19+cd27+ cells [#/volume] in blood,cd19+cd27+ cells # bld,cd19+cd27+ cells (bld) [#/vol],#; abs; absolute; absolutes; b cells expressing cd19 as a percent of total lymphocytes; b4; b-4; blood; cd19 cells; cd19+cd27+ cells; cell; cell markers; cellularity; cnt; count; count/volume; ct; hd-37; leu12; leu-12; number concentration; number concentration (count/vol); point in time; qnt; quan; quant; quantitative; random; s152; t14; total memory b cells; wb; whole blood,Qn
89360-2,cd45ra cells/cd4 cells in blood,cd45ra cells/cd4 cells nfr bld,cd45ra cells/cd4 cells (bld),2h4; blood; cd4 cells; cd45ra cells; cell; cell markers; cellularity; helper t cells; inducer t cells; l3t4; leu18; leu-18; leu3; leu-3; number fraction; percent; point in time; qnt; quan; quant; quantitative; random; t4; t-4; w3/25; wb; whole blood,Qn
89362-8,cd45ro cells/cd4 cells in blood,cd45ro cells/cd4 cells nfr bld,cd45ro cells/cd4 cells (bld),blood; cd4 cells; cd45ro cells; cell; cell markers; cellularity; helper t cells; inducer t cells; l3t4; leu3; leu-3; number fraction; percent; point in time; qnt; quan; quant; quantitative; random; t4; t-4; uchl-1; w3/25; wb; whole blood,Qn
89371-9,mtb complex dna and rpob rif resistance mutation panel [presence],mtb and rif resistance pnl islt/spm,m. tuberculosis complex dna and rpob rif resistance mutation panel (islt/spec),acid fast; acid fast bacilli; acid fast bacillus; afb; antibiotic susceptibilities; c301; compx; deoxyribonucleic acid; islt; islt/spm; isol; m tb; m tb cmplx; m tuberculosis; mtb; mtb and rif resistance pnl; mtbc; mut; mutations; myco; mycobact; mycobacterium tuberculosum; pan; panel.antibiotic susceptibilities; panl; pnl; point in time; random; resist; resistanc; resistant; resistent; rif; rifadin; rifampicin; rimactane; spec; tb; tuberculosis,-
893-8,blood group antibody screen.autologous [interpretation] in serum or plasma,bld gp ab autol scn serpl-imp,blood group antibody screen.autologous [interp],ab; autol; autologus; bld gp ab autol scn; bld gp ab scn; blood bank; impression; impression/interpretation of study; impressions; interp; interpretation; nominal; pl; plasma; plsm; point in time; random; scn; scr; scrn; serp; serpl; serplas; serum; serum or plasma; sr,Nom
89385-9,walk 10 feet - functional goal during assessment period [cms assessment],,,adl; centers for medicare and medicaid assessment; finding; findings; functionalstatus; iadl; ordinal; ql; qual; qualitative; report period; screen; survey,Ord
89409-7,eating - functional goal during assessment period [cms assessment],,,centers for medicare and medicaid assessment; finding; findings; ordinal; ql; qual; qualitative; report period; screen; survey,Ord
89413-9,car transfer - functional ability during assessment period [cms assessment],,,centers for medicare and medicaid assessment; finding; findings; ordinal; ql; qual; qualitative; report period; screen; survey,Ord
89415-4,bed-to-chair transfer - functional ability during assessment period [cms assessment],,,centers for medicare and medicaid assessment; finding; findings; ordinal; ql; qual; qualitative; report period; screen; survey,Ord
89416-2,go up and down 4 steps - functional goal during assessment period [cms assessment],,,adl; centers for medicare and medicaid assessment; finding; findings; functionalstatus; iadl; ordinal; ql; qual; qualitative; report period; screen; survey,Ord
89425-3,cpr flowsheet,cpr flowsheet,,cpr; cpr flowsheet; doc.ont; document; finding; findings; point in time; random,Doc
89429-5,surgical operation order,operative order,,doc.ont; document; finding; findings; operative order; point in time; random; surg,Doc
89430-3,outpatient medical history screening form,op medical hx screening form,,asympt; asymptomatic; doc.ont; document; finding; findings; hx; medical hx screening form; op; point in time; random; scn,Doc
89470-9,obstetrics summary note,ob summary note,,doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; gyn; gynecology; notes; ob; obgyn; obstetric; obstetrics; point in time; prenatal; random; visit note,Doc
89492-3,umbilical cord examination findings document,umbilical cord exam findings,,doc.misc; document; exam findings; finding; findings; misc; point in time; random,Doc
89506-0,nucleosome ab [presence] in serum by line blot,nucleosome ab ser ql line blot,nucleosome ab line blot ql (s),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serology; serum; sr,Ord
89513-6,rna polymerase iii ab [presence] in serum by line blot,rnap iii ab ser ql line blot,rna polymerase iii ab line blot ql (s),3; abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; ordinal; point in time; pol iii; pr; ql; qual; qualitative; random; ribonucleic acid; rnap iii; screen; serology; serum; sr,Ord
8953-2,fluid intake enteral tube measured,fluid intake enteral tube measured,,fld; fluid intake enteral tube; io_intake; io_intake.molec; point in time; qnt; quan; quant; quantitative; random; ugi; up; upr gi tract; volume,Qn
89540-9,ganglioside gm1 igm ab [presence] in cerebral spinal fluid by line blot,gm1 gangl igm csf ql line blot,ganglioside gm1 igm line blot ql (csf),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; cerebral spinal fluid; cerebrospinal fl; ganglioside monosialo; gm1 gangl; immune globulin m; immunoglobulin m; monosialoganglioside; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serology; spinal fl; spinal fld; spinal flu; spinal fluid,Ord
89546-6,wells pulmonary embolism risk calculator panel,wells pe risk pnl,,clin; clin.risk; pan; panel.clinical; panl; pnl; point in time; pulm; random,-
89548-2,total score revised geneva score,total score geneva.revised,,clin; clin.risk; point in time; qnt; quan; quant; quantitative; random; scale; tot; totl,Qn
89558-1,anxiety symptoms score [cubs],,,point in time; qnt; quan; quant; quantitative; random; scale; survey; survey.mtlhlth; sx,Qn
89559-9,lifetime suicide risk score [cubs],,,qnt; quan; quant; quantitative; scale; survey; survey.mtlhlth,Qn
89563-1,eating disorder symptoms score [cubs],,,point in time; qnt; quan; quant; quantitative; random; scale; survey; survey.mtlhlth; sx,Qn
89568-0,child care availability status [cubs],,,finding; findings; ordinal; point in time; ql; qual; qualitative; random; screen; survey; survey.mtlhlth,Ord
89585-4,herpes simplex virus 1 dna [presence] in lower respiratory specimen by naa with probe detection,hsv1 dna lower resp ql naa+probe,hsv 1 dna naa+probe ql (lower resp),3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; breathing; deoxyribonucleic acid; dna nucleic acid probe; dna probe; herp splx; herpes simplex virus type 1; hsv; hsv1; i; id; infectious disease; infectiousdisease; lat; lcr; ligase chain reaction; ligation-activated transcription; low; lower resp; lung; lungs; microbiology; naa+probe; naat; nasba; nucleic acid sequence based analysis; ordinal; pcr; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; pulmonary; pulmonology; qbr; ql; qual; qualitative; random; respiratory; rs; screen; sda; spec; strand displacement amplification; tma; transcription mediated amplification,Ord
89601-9,proof of encounter certificate,encounter certificate,,admission certificate; doc.ont; document; finding; findings; point in time; proof of visit; random,Doc
89603-5,ct guidance for aspiration of cyst of kidney - right,ct guided kidney-r cyst asp,,abd; abdo; abdomen+; abdominal; asp; cat scan; computed tomography; computerized tomography; ct scan; cyst asp; document; finding; findings; guid; guide; guided; imaging; kidney; kidney-r; nephric; nephrology; perc; point in time; pyelogram; r; rad; radiology; random; renal; rt,Doc
89608-4,ct guidance for fluid aspiration of lung - left,ct guided lung-l pc fluid asp,,asp; cat scan; computed tomography; computerized tomography; ct scan; document; finding; findings; fld; guid; guide; guided; imaging; l; lt; lung; lung-l; pc fluid asp; perc; point in time; pulmonary; pulmonology; rad; radiology; random; respiratory; thorax,Doc
89612-6,ct guidance for fluid aspiration of pleural space - left,ct guided pl space-l pc fluid asp,,asp; cat scan; computed tomography; computerized tomography; ct scan; document; finding; findings; fld; guid; guide; guided; imaging; l; lt; lung; pc fluid asp; perc; pl space; pl space-l; point in time; pulmonary; pulmonology; rad; radiology; random; respiratory; thoracentesis; thorax; thorocentesis,Doc
89614-2,ct guidance for biopsy of kidney-- wo contrast,ct guided kidney bx--wo contr,,abd; abdo; abdomen+; abdominal; bx; c; cat scan; computed tomography; computerized tomography; contr; contra; contrst; ct scan; document; finding; findings; guid; guide; guided; imaging; kidney; nephric; nephrology; perc; point in time; pyelogram; rad; radiology; random; renal; without contrast,Doc
89622-5,ct guidance for fluid aspiration of peritoneal space,ct guided peritoneal space pc fluid asp,,abd; abdo; abdomen+; abdominal; asp; cat scan; computed tomography; computerized tomography; ct scan; document; finding; findings; fld; guid; guide; guided; imaging; pc fluid asp; perc; peritoneal cavity; point in time; rad; radiology; random,Doc
89623-3,ct guidance for drainage and placement of drainage catheter of peritoneal space,ct guided peritoneal drain+cath place,,abd; abdo; abdomen+; abdominal; cat scan; cath; computed tomography; computerized tomography; ct scan; document; drain; drain+cath place; exudate; finding; findings; guid; guide; guided; imaging; peritoneal cavity; point in time; rad; radiology; random; removal of fluid,Doc
89663-9,i felt irritable in past 7 days [promis],,,finding; findings; last; ordinal; patient reported outcomes information system; promise; ql; qual; qualitative; screen; survey; survey.promis,Ord
89667-0,i felt unloved in past 7 days [promis],,,finding; findings; last; ordinal; patient reported outcomes information system; promise; ql; qual; qualitative; screen; survey; survey.promis,Ord
89673-8,how much did you worry about pain in past 7 days [promis],,,finding; findings; last; ordinal; patient reported outcomes information system; promise; ql; qual; qualitative; screen; survey; survey.promis,Ord
89704-1,ct guidance for injection of shoulder - right,ct guided should-r inj,,arm; cat scan; computed tomography; computerized tomography; ct scan; document; ext; extr-r; finding; findings; guid; guide; guided; imaging; inj; msk; musculoskeletal; ortho; orthopedics; point in time; r; rad; radiology; random; rt; rue; should-r; ue; ue-r; up; upper extremity joint,Doc
89713-2,ct upper extremity joint - right arthrogram,ct ue joint-r w contr is,,arm; arthrogram; arthrography; c; cat scan; computed tomography; computerized tomography; contr; contra; contrst; ct scan; document; ext; extr-r; finding; findings; imaging; intraarticular; intrasynovial; jnt; point in time; r; rad; radiology; random; rt; rue; ue; ue joint-r; ue-r; up; w contr is; wc,Doc
89714-0,ct upper extremity joint - left arthrogram,ct ue joint-l w contr is,,arm; arthrogram; arthrography; c; cat scan; computed tomography; computerized tomography; contr; contra; contrst; ct scan; document; ext; extr-l; finding; findings; imaging; intraarticular; intrasynovial; jnt; l; lt; lue; point in time; rad; radiology; random; ue; ue joint-l; ue-l; up; w contr is; wc,Doc
89718-1,ct guidance for stereotactic localization of unspecified body region-- w contrast iv,ct guided str loc--w contr iv,,c; cat scan; computed tomography; computerized tomography; contr; contra; contrst; ct scan; document; finding; findings; guid; guidance.stereotactic for localization; guide; guided; imaging; local; misc; miscellaneous; other; point in time; rad; radiology; random; spec; stereo; str loc; to be specified in another part of the message; unspecified; w contr iv; wc,Doc
89719-9,ct guidance for drainage of abscess and placement of drainage catheter of lung - right,ct guided lung-r absc drain+cath place,,absc drain+cath place; absc drainage; cat scan; cath; computed tomography; computerized tomography; ct scan; document; drain; exudate; finding; findings; guid; guide; guided; imaging; lung; lung-r; point in time; pulmonary; pulmonology; r; rad; radiology; random; removal of fluid; respiratory; rt; thorax,Doc
89729-8,finance and administration [cdc emergency operations centers],,,cdc emergency operations centers; cdc eoc; centers for disease control and prevention; pan; panel; panel.survey.cdc; panl; pnl; point in time; random; survey; survey.cdc,-
89735-5,activate and deactivate decision [cdc emergency operations centers],,,cdc emergency operations centers; cdc eoc; centers for disease control and prevention; pan; panel; panel.survey.cdc; panl; pnl; point in time; random; survey; survey.cdc,-
89758-7,situation analysis [cdc emergency operations centers],,,cdc emergency operations centers; cdc eoc; centers for disease control and prevention; pan; panel; panel.survey.cdc; panl; pnl; point in time; random; survey; survey.cdc,-
89759-5,planning [cdc emergency operations centers],,,cdc emergency operations centers; cdc eoc; centers for disease control and prevention; pan; panel; panel.survey.cdc; panl; pnl; point in time; random; survey; survey.cdc,-
89767-8,risk assessment and consultation [cdc emergency operations centers],,,cdc emergency operations centers; cdc eoc; centers for disease control and prevention; pan; panel; panel.survey.cdc; panl; pnl; point in time; random; survey; survey.cdc,-
89786-8,human resources management [cdc emergency operations centers],,,cdc emergency operations centers; cdc eoc; centers for disease control and prevention; pan; panel; panel.survey.cdc; panl; pnl; point in time; random; survey; survey.cdc,-
89801-5,ethics team conference note,ethics team conf note,,conf note; doc.ont; document; encounter; ethics team; evaluation and management; evaluation and management note; finding; findings; notes; point in time; random; visit note,Doc
89804-9,hematology telephone encounter note,hematology phone note,,doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; hematology; heme; notes; point in time; random; visit note,Doc
89810-6,neurological surgery team conference note,neuro surg team conf note,,conf note; doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; neuro surg team; neuro surgery; notes; point in time; random; surg; visit note,Doc
89813-0,rapid response team progress note,rapid response team prog note,,doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; notes; point in time; prog note; random; subsequent evaluation; subsequent visit evaluation; visit note,Doc
89828-8,ct guidance for superficial biopsy of muscle,ct guided muscle super bx,,bx; cat scan; computed tomography; computerized tomography; ct scan; document; finding; findings; guid; guide; guided; imaging; misc; miscellaneous; musc; muscl; other; point in time; rad; radiology; random; spec; super bx; to be specified in another part of the message; unspecified,Doc
89839-5,ct guidance for biopsy of sternum,ct guided sternum bx,,bx; cat scan; computed tomography; computerized tomography; ct scan; document; finding; findings; guid; guide; guided; imaging; point in time; rad; radiology; random; thorax; xiphoid; xyphoid,Doc
89847-8,ct midfoot - right and forefoot - right,ct mid+fore ft-r,,cat scan; computed tomography; computerized tomography; ct scan; document; ext; extr-r; finding; findings; imaging; le; leg; le-r; low; mid ft-r; mid+fore ft-r; msk; musculoskeletal; ortho; orthopedics; point in time; r; rad; radiology; random; rle; rt,Doc
89850-2,ct finger - left wo contrast,ct finger-l wo contr,,arm; c; cat scan; computed tomography; computerized tomography; contr; contra; contrst; ct scan; document; ext; extr-l; finding; findings; finger-l; imaging; l; lt; lue; msk; musculoskeletal; ortho; orthopedics; point in time; rad; radiology; random; ue; ue-l; up; without contrast,Doc
89856-9,ct guidance for stereotactic localization of unspecified body region-- wo contrast,ct guided str loc--wo contr,,c; cat scan; computed tomography; computerized tomography; contr; contra; contrst; ct scan; document; finding; findings; guid; guidance.stereotactic for localization; guide; guided; imaging; local; misc; miscellaneous; other; point in time; rad; radiology; random; spec; stereo; str loc; to be specified in another part of the message; unspecified; without contrast,Doc
89861-9,braf gene p.val600lys [presence] in tissue by molecular genetics method,braf p.v600k tiss ql,braf gene p.val600lys molgen ql (tiss),"b-raf kinases; braf p.v600k; b-raf proto-oncogene, serine/threonine kinase; b-raf, proto-oncogene protein; braf1; b-raf1; c.1798_1799delgtinsaa; genetics; heredity; heritable; inherited; melanoma; molecular genetics; molecular pathology; molpath; molpath.mutations; ns7; ordinal; p prime; pcr; point in time; pr; ql; qual; qualitative; rafb1; random; screen; tissue; tissue, unspecified; v-raf",Ord
89896-5,developmental-behavioral pediatrics telehealth note,develop-behav peds telehealth note,,develop-behav peds; doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; mental health; mentalhealth; notes; peds; point in time; psych; psychiatry; random; telemedicine; visit note,Doc
89908-8,insulin was taken in last 8h 8 hour,insulin taken in last 8h 8h,,1/3 day; 8 hours; 8hr; finding; findings; h+p; h+p.hx; hum; humulin; ih7; insul; insulin taken in last 8h; lente; nph; ordinal; p prime; past; ql; qual; qualitative; screen; semilente; sliding; ultralente,Ord
89915-3,condition triggering eoc response termination,,,finding; findings; nominal; point in time; random; survey; survey.cdc; trigger eoc response termination,Nom
89918-7,emergency management plan approver name,,,em plan approver name; ident; identifier; nominal; point in time; random; survey; survey.cdc,Nom
89929-4,ct guidance for fluid aspiration of intervertebral disc,ct guided i-disc pc fluid asp,,asp; cat scan; computed tomography; computerized tomography; ct scan; document; finding; findings; fld; guid; guide; guided; i-disc; imaging; misc; miscellaneous; other; pc fluid asp; perc; point in time; rad; radiology; random; spec; to be specified in another part of the message; unspecified,Doc
89971-6,8-hydroxyloxapine [presence] in urine by screen method,8oh-loxapine ur ql scn,8-hydroxyloxapine screen ql (u),8-hydroxy loxapine; 8oh-loxapine; drug/toxicology; drugs; hydroxyl; loxitane metabolite; ordinal; point in time; pr; ql; qual; qualitative; random; scn; scr; screen; scrn; ua; ur; urn,Ord
89977-3,7-hydroxychlorpromazine [presence] in urine by screen method,7oh-chlorpromazine ur ql scn,7-hydroxychlorpromazine screen ql (u),7oh-chlorpromazine; drug/toxicology; drugs; ordinal; point in time; pr; ql; qual; qualitative; random; scn; scr; screen; scrn; ua; ur; urn,Ord
90008-4,pharmacogenomics telehealth note,pharmacogenomics telehealth note,,doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; notes; point in time; random; telemedicine; visit note,Doc
90018-3,psoriasis care satisfaction questionnaire [psosat],,,pan; panel; panel.survey.gnhlth; panl; pnl; point in time; psosat questionnaire; random; survey; survey.gnhlth,-
90031-6,"over the past week, are you able to walk two miles or three kilometers, if you wish [haq]",,,1 week; 2; 3; activity; exercise; finding; findings; health assessment questionnaire; last; ordinal; ql; qual; qualitative; screen; survey,Ord
90038-1,weighted score [rapid3],,,point in time; qnt; quan; quant; quantitative; random; rapid-3; scale; survey; survey.gnhlth,Qn
90057-1,name of contact at organization,organization contact name,,admin; nominal; person name; point in time; random,Nom
90061-3,public communication document type,public commun doc type,,nominal; point in time; public commun doc type; public health; public health documents; publichealth; random; typ,Nom
90081-1,public communication document name,public communication doc name,,ident; identifier; nominal; point in time; public communication doc name; public health; public health documents; publichealth; random,Nom
90083-7,public communication target group,public comm target group,,nominal; point in time; public comm target group; public health; publichealth; random; typ,Nom
90095-1,event managing group at lead department or agency organization,,,ident; identifier; lead event managing group; nominal; painter's colic; pb; plumbism; point in time; random; survey; survey.cdc,Nom
90100-9,listeria sp identified in isolate by organism specific culture,listeria islt cult,listeria sp identified org specific cx nom (isol),c&s; cult; cultures; identity or presence; internallabuse; islt; isol; listeriosis; microbiology; nominal; point in time; random; spec; species; spp,Nom
90113-2,chief of staff name,chief of staff name,,admin; nominal; person name; point in time; random,Nom
90117-3,estimated date of next emergency response plan release,est date next emerg resp plan,,doc.misc; est date next emerg resp plan; misc; point in time; qnt; quan; quant; quantitative; random,Qn
90125-6,response team member name,response team member name,,admin; nominal; person name; point in time; random,Nom
90151-2,your child forgets things easily in past 4 weeks - severity [promis.parentproxy],,,4 weeks; finding; findings; last; ordinal; patient reported outcomes information system; promise; ql; qual; qualitative; screen; survey; survey.promis,Ord
90152-0,it is hard for your child to concentrate in school in past 4 weeks - frequency [promis.parentproxy],,,4 weeks; cnc; conc; finding; findings; last; ordinal; patient reported outcomes information system; promise; ql; qual; qualitative; screen; survey; survey.promis,Ord
90162-9,your child has to use written lists more often than other people his or her age so he or she will not forget things in past 4 weeks - frequency [promis.parentproxy],,,4 weeks; finding; findings; last; ordinal; othr; patient reported outcomes information system; promise; ql; qual; qualitative; screen; survey; survey.promis,Ord
9018-3,fluid intake synovial measured,fluid intake synovial measured,,fld; fluid intake synovial; io_intake; io_intake.molec; point in time; qnt; quan; quant; quantitative; random; volume,Qn
90211-4,i have trouble remembering to do things like school projects or chores in past 4 weeks - frequency [promis.peds],,,4 weeks; finding; findings; last; ordinal; patient reported outcomes information system; promise; ql; qual; qualitative; screen; survey; survey.promis,Ord
90214-8,i have trouble paying attention to the teacher in past 4 weeks - severity [promis.peds],,,4 weeks; finding; findings; last; ordinal; patient reported outcomes information system; promise; ql; qual; qualitative; screen; survey; survey.promis; trouble paying attention to teacher,Ord
90232-0,histoplasma capsulatum ab [identifier] in serum or plasma by immune diffusion (id),h capsul ab serpl id,h. capsulatum ab immune diff nom,abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; h capsul; h capsulatum; h farciminosum; histo; histopl; histoplasma farciminosum; histoplasmos; histoplasmosis; id; identity or presence; imm; immunodiff; immunodiffusion; imun; imune; infectious disease; infectiousdisease; microbiology; nominal; pl; plasma; plsm; point in time; random; serp; serpl; serplas; serum; serum or plasma; sr,Nom
9024-1,type of upper gi tube,upper gi tube class,,"gastrointestinal content; g-tube; io; io.tube; nominal; point in time; random; tub; tube, unspecified; typ; up",Nom
90255-1,satisfaction with knee andor hip replacement result,knee/hip replacement satisfaction,,clin; finding; findings; knee/hip replacement satisfaction; lower extremity joint; ordinal; point in time; ql; qual; qualitative; random; screen,Ord
90268-4,microscopic observation [identifier] in peritoneal fluid by giemsa stain,gie stn prt,microscopic observation giemsa stain nom (periton fld),ascites; ascitic fluid; ascitis; gie stn; gms; id; identity or presence; infectious disease; infectiousdisease; microbiology; nominal; peritoneal fluid; point in time; prt; random; st; stains; stn,Nom
90273-4,bacteria identified in catheter tip by anaerobe culture,bacteria cath tip anaerobe cult,bacteria identified anaer cx nom (catheter tip),anaero; anaerobe; anaerobe cult; bact; c&s; cath tip; catheter tip; cult; cultures; id; identity or presence; infectious disease; infectiousdisease; microbiology; nominal; point in time; random,Nom
90281-7,bacteria identified in peritoneal fluid by aerobe culture,bacteria prt aerobe cult,bacteria identified aer cx nom (periton fld),aerobe; aerobe cult; aerobed; ascites; ascitic fluid; ascitis; bact; c&s; cult; cultures; id; identity or presence; infectious disease; infectiousdisease; microbiology; nominal; peritoneal fluid; point in time; prt; random,Nom
90284-1,mycobacterium sp identified in bile fluid by organism specific culture,mycobacterium bifl cult,mycobacterium sp identified org specific cx nom (bile),acid fast; acid fast bacilli; acid fast bacillus; afb; bifl; bile fluid; biliary fluid; c&s; cult; cultures; id; identity or presence; infectious disease; infectiousdisease; microbiology; myco; mycobact; nominal; point in time; random; spec; species; spp; tuberculosis,Nom
90286-6,trichomonas vaginalis [presence] in vaginal fluid by light microscopy,t vaginalis vag ql micro,t. vaginalis lm ql (vag fld),genital vaginal; gyn; gynecology; id; infectious disease; infectiousdisease; lm; micro; microbiology; micros; microscopic; ob; obgyn; obstetrics; ordinal; point in time; pr; ql; qual; qualitative; random; screen; t vaginalis; tric; trich; trichimoniasis; trichomonad; trichomonads; trichomoniasis; vag fld; vag fluid; vagina; vaginal fluid,Ord
90291-6,epcam ab [units/volume] in serum or plasma by immunoassay,epcam ab serpl ia-acnc,epcam ab ia qn,abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; eia; elfa; elisa; enzyme immunoassay; epcam; epcam ab; epi; epith; epithelia; iaa; meia; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serology; serp; serpl; serplas; serum; serum or plasma; sr; suds,Qn
90296-5,microscopic observation [identifier] in skin by gram stain,gram stn skin,microscopic observation gram stain nom (skin),dermatologic; epidermis; gram stn; id; identity or presence; infectious disease; infectiousdisease; integument; microbiology; nominal; point in time; random; skn; st; stains; stn,Nom
90305-4,"t(2;5)(p23;q35.1)(alk,npm1) fusion transcript in blood or tissue by molecular genetics method","t(2;5)(alk,npm1) bld/t","t(2;5)(p23;q35.1)(alk,npm1) fusion transcript molgen doc (bld/tiss)","anaplastic lymphoma kinase (ki-1); blood; dna; document; finding; findings; gene fusion; gene translocation; genetics; heredity; heritable; ii; inherited; molecular genetics; molecular pathology; molpath; molpath.translocation; npm; nucleolar phosphoprotein b23; numatrin; pcr; point in time; random; rna; t prime; t(2,5)(alk,npm1) gene translocation; t(2;5)(alk,npm1); tissue; tissue, unspecified; translocation; wb; whole blood; whole blood or tissue",Doc
90317-9,ct guidance for drainage and placement of drainage catheter of lower extremity - left,ct guided le-l drain+cath place,,cat scan; cath; computed tomography; computerized tomography; ct scan; document; drain; drain+cath place; ext; extr-l; exudate; finding; findings; guid; guide; guided; imaging; l; le; leg; le-l; lle; low; lt; point in time; rad; radiology; random; removal of fluid,Doc
90322-9,haemophilus parasuis serotype [identifier] in specimen by naa with probe detection,h parasuis sertyp spec naa+probe,h. parasuis serotype naa+probe nom (specimen) [id],3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; dna nucleic acid probe; dna probe; h parasuis; h parasuis serotype; haemoph; id; ident; identifier; infectious disease; infectiousdisease; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; misc; miscellaneous; naa+probe; naat; nasba; nominal; nucleic acid sequence based analysis; other; pcr; point in time; polymerase chain reaction; probe amp; probe with ampification; probe with target amplification; qbr; random; sda; sertyp; spec; strand displacement amplification; tma; to be specified in another part of the message; transcription mediated amplification; unspecified; vet; veterinary,Nom
90330-2,porcine parainfluenza virus 1 rna [#/volume] (viral load) in specimen by naa with probe detection,ppiv1 rna # spec naa+probe,porcine parainfluenza virus 1 rna naa+probe (specimen) [#/vol],#; 3 self-sustaining sequence replication; 3sr sr; abs; absolute; absolutes; amplif; amplification; amplified; cnt; count; count/volume; ct; dna nucleic acid probe; dna probe; hpiv; hpiv1; human respirovirus 1; i; id; infectious disease; infectiousdisease; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; misc; miscellaneous; naa+probe; naat; nasba; nucleic acid sequence based analysis; number concentration; number concentration (count/vol); other; para; parainflu; parainfluenza type 1; parainfluenza type i; pcr; pi1; point in time; polymerase chain reaction; pork; ppiv1; probe amp; probe with ampification; probe with target amplification; qbr; qnt; quan; quant; quantitative; random; ribonucleic acid; sda; spec; strand displacement amplification; swine; tma; to be specified in another part of the message; transcription mediated amplification; unspecified; vet; veterinary; viral load,Qn
90364-1,cholesterol.in ldl.small dense [mass/volume] in serum or plasma,chol.in ldl.small dense serpl-mcnc,cholesterol.in ldl.small dense [mass/vol],cardio; cardiology; chemistry; chol; chol.in ldl.small dense; choles; cholest; cholesterol total; cholesterols; heart disease; ldlc; ldl-c; level; lipid; low density lipoprotein cholesterol; low density lipoprotein cholesterols; mass concentration; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; sdldl; serp; serpl; serplas; serum; serum or plasma; sr,Qn
90385-6,"considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when walking (faster than your usual speed) for 1/2 mile (almost 1 km) without stopping [promis]",,,finding; findings; i; last; ordinal; patient reported outcomes information system; promise; ql; qual; qualitative; screen; survey; survey.promis,Ord
90387-2,"considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when taking a shower [promis]",,,finding; findings; last; ordinal; patient reported outcomes information system; promise; ql; qual; qualitative; screen; survey; survey.promis,Ord
90392-2,"considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when walking up 5 stairs without stopping [promis]",,,finding; findings; last; ordinal; patient reported outcomes information system; promise; ql; qual; qualitative; screen; survey; survey.promis,Ord
90395-5,"considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when scrubbing the floor or counter [promis]",,,finding; findings; last; ordinal; patient reported outcomes information system; promise; ql; qual; qualitative; screen; survey; survey.promis,Ord
9039-9,oral tube site,oral tube site,,anatomy; io; io.tube; nominal; point in time; random,Nom
90421-9,apolipoprotein ciii-1/apolipoprotein ciii-2 [mass ratio] in serum or plasma,apo ciii-1/apo ciii-2 serpl,apolipoprotein ciii-1/apolipoprotein ciii-2 [mass ratio],apo; apo ciii-1; apo ciii-2; apolipo; apolipoprot; apolipoproteins; chemistry; i; ii; mass concentration ratio; mass ratio; mcrto; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
90429-2,microorganism preliminary growth [presence] in body fluid by aerobe culture,microorg prel grow fld ql aerobe cult,microorganism preliminary growth aer cx ql (body fld),"aerobe; aerobe cult; aerobed; b/f; bf; bod; bodies; body fluid; body fluid, unsp; c&s; cult; cultures; fl; fld; flu; fluid; id; infectious disease; infectiousdisease; internallabuse; microbiology; microorg prel grow; microorganisms; ordinal; org; organism; organisms; point in time; pr; ql; qual; qualitative; random; screen",Ord
9044-9,urinary bladder irrigation tube site,urinary bladder irrigation tube site,,anatomy; io.tube; nominal; point in time; random,Nom
90457-3,influenza virus types a and b panel - tissue by naa with probe detection,fluav + flubv pnl tiss naa+probe,fluav and flubv pnl naa+probe (tiss),"3 self-sustaining sequence replication; 3sr sr; a,b; amplif; amplification; amplified; avian influenza; bird flu; dna nucleic acid probe; dna probe; flua; fluav; fluav + flubv; fluav + flubv pnl; fluav+flubv; fluv; fowl plague; id; infectious disease; infectiousdisease; influ; influenza a; influenza a virus; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; naa+probe; naat; nasba; nucleic acid sequence based analysis; pan; panel.microbiology; panl; pcr; pnl; point in time; polymerase chain reaction; probe amp; probe with ampification; probe with target amplification; qbr; random; ribonucleic acid; sda; strand displacement amplification; tissue; tissue, unspecified; tma; transcription mediated amplification",-
90458-1,actinomyces sp identified in aspirate by organism specific culture,actinomyces aspirate cult,actinomyces sp identified org specific cx nom (asp),actino; aspirate; c&s; cult; cultures; id; identity or presence; infectious disease; infectiousdisease; microbiology; nominal; point in time; random; spec; species; spp,Nom
90463-1,adenovirus dna [presence] in lower respiratory specimen by naa with probe detection,hadv dna lower resp ql naa+probe,adenovirus dna naa+probe ql (lower resp),3 self-sustaining sequence replication; 3sr sr; adeno virus; amplif; amplification; amplified; breathing; deoxyribonucleic acid; dna nucleic acid probe; dna probe; hadv; id; infectious disease; infectiousdisease; lat; lcr; ligase chain reaction; ligation-activated transcription; low; lower resp; lung; lungs; microbiology; naa+probe; naat; nasba; nucleic acid sequence based analysis; ordinal; pcr; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; pulmonary; pulmonology; qbr; ql; qual; qualitative; random; respiratory; rs; screen; sda; spec; strand displacement amplification; tma; transcription mediated amplification,Ord
90467-2,hydroxyaripiprazole [mass/volume] in urine by confirmatory method,oh-aripiprazole ur cfm-mcnc,hydroxyaripiprazole confirm (u) [mass/vol],aripiprazole metabolite; cfm; cnfr; cnfrm; conf; confirmation; confirmatory; drug/toxicology; drugs; gcms; lc/ms/ms; level; mass concentration; oh-aripiprazole; point in time; qnt; quan; quant; quantitative; random; ua; ur; urn,Qn
90474-8,"mds v3.0 - rai v1.17.1, 1.17.2 - nursing home pps (np) item set during assessment period [cms assessment]",,,centers for medicare and medicaid assessment; pan; panel; panel.survey.cms; panl; pnl; report period; survey,-
90487-0,"mds v3.0 - rai v1.17.2 - health conditions - np, nq, sp during assessment period [cms assessment]",,,centers for medicare and medicaid assessment; pan; panel; panel.survey.cms; panl; pnl; report period; species; spp; survey,-
90503-4,mds v3.0 - rai v1.17.2 - identification information - ipa during assessment period [cms assessment],,,centers for medicare and medicaid assessment; pan; panel; panel.survey.cms; panl; pnl; report period; survey,-
90505-9,"mds v3.0 - rai v1.17.2 - hearing, speech, and vision - ipa, osa during assessment period [cms assessment]",,,centers for medicare and medicaid assessment; pan; panel; panel.survey.cms; panl; pnl; report period; survey,-
90523-2,mds v3.0 - rai v1.17.2 - optional state assessment during assessment period [cms assessment],,,centers for medicare and medicaid assessment; pan; panel; panel.survey.cms; panl; pnl; report period; survey,-
90524-0,type of assessment for state payment during assessment period [cms assessment],,,centers for medicare and medicaid assessment; nominal; report period; survey; typ,Nom
90531-5,occupational therapy - individual minutes during assessment period [cms assessment],,,centers for medicare and medicaid assessment; ot; qnt; quan; quant; quantitative; report period; survey,Qn
90535-6,physical therapy - individual minutes during assessment period [cms assessment],,,centers for medicare and medicaid assessment; pt; qnt; quan; quant; quantitative; report period; survey,Qn
90546-3,occupational therapy since the start date of the resident's most recent medicare part a stay [cms assessment],,,centers for medicare and medicaid assessment; ot; pan; panel; panel.survey.cms; panl; pnl; report period; started; survey,-
90547-1,physical therapy since the start date of the resident's most recent medicare part a stay [cms assessment],,,centers for medicare and medicaid assessment; pan; panel; panel.survey.cms; panl; pnl; pt; report period; started; survey,-
90569-5,mds v3.0 - rai v1.17.2 - identification information - npe during assessment period [cms assessment],,,centers for medicare and medicaid assessment; pan; panel; panel.survey.cms; panl; pnl; report period; survey,-
90572-9,promis parent proxy life satisfaction - version 1.0 t-score,,,patient reported outcomes information system; point in time; promise; qnt; quan; quant; quantitative; random; survey; survey.promis; t prime; t-score,Qn
90589-3,"thinking about the past 4 weeks, my child was satisfied with his/her skills and talents [promis.parentproxy]",,,4 weeks; finding; findings; last; ordinal; patient reported outcomes information system; promise; ql; qual; qualitative; screen; survey; survey.promis,Ord
90592-7,"thinking about the past 4 weeks, my child was happy with life in his/her neighborhood [promis.parentproxy]",,,4 weeks; finding; findings; last; ordinal; patient reported outcomes information system; promise; ql; qual; qualitative; screen; survey; survey.promis,Ord
90596-8,"thinking about the past 4 weeks, my child was happy with his/her social life [promis.parentproxy]",,,4 weeks; finding; findings; last; ordinal; patient reported outcomes information system; promise; ql; qual; qualitative; screen; survey; survey.promis,Ord
90603-2,"thinking about the past 4 weeks, my child had what he/she needed in life [promis.parentproxy]",,,4 weeks; finding; findings; last; ordinal; patient reported outcomes information system; promise; ql; qual; qualitative; screen; survey; survey.promis,Ord
90605-7,"thinking about the past 4 weeks, my child was happy with the way things were [promis.parentproxy]",,,4 weeks; finding; findings; last; ordinal; patient reported outcomes information system; promise; ql; qual; qualitative; screen; survey; survey.promis,Ord
90610-7,"thinking about the past 4 weeks, my child's life was good [promis.parentproxy]",,,4 weeks; finding; findings; last; ordinal; patient reported outcomes information system; promise; ql; qual; qualitative; s prime; screen; survey; survey.promis,Ord
9062-1,carbohydrate intake 8 hour,carbohydrate intake 8h,,1/3 day; 8 hours; 8hr; io_intake_salts+calories; mass rate; mrate; qnt; quan; quant; quantitative,Qn
90634-7,"thinking about the past 4 weeks, i was satisfied with my skills and talents [promis]",,,4 weeks; finding; findings; last; ordinal; patient reported outcomes information system; promise; ql; qual; qualitative; screen; survey; survey.promis,Ord
90645-3,"thinking about the past 4 weeks, i enjoyed my life more than most kids enjoyed their lives [promis]",,,4 weeks; finding; findings; last; ordinal; patient reported outcomes information system; promise; ql; qual; qualitative; screen; survey; survey.promis,Ord
90654-5,"thinking about the past 4 weeks, my life was going very well [promis]",,,4 weeks; finding; findings; last; ordinal; patient reported outcomes information system; promise; ql; qual; qualitative; screen; survey; survey.promis,Ord
90655-2,"thinking about the past 4 weeks, my life was good [promis]",,,4 weeks; finding; findings; last; ordinal; patient reported outcomes information system; promise; ql; qual; qualitative; screen; survey; survey.promis,Ord
90662-8,wells pulmonary embolism risk score interpretation,wells pe risk score interp,,clin; clin.risk; impression; impression/interpretation of study; impressions; interp; interpret; interpretation; interpt; intrp; ordinal; point in time; pulm; ql; qual; qualitative; random; screen; wells pe risk score interp,Ord
90669-3,other kids wanted to talk to my child in past 7 days [promis.parentproxy],,,finding; findings; last; ordinal; othr; patient reported outcomes information system; promise; ql; qual; qualitative; screen; survey; survey.promis,Ord
90679-2,promis parent proxy item bank - peer relationships - version 2.0,,,pan; panel; panel.survey.promis; panl; patient reported outcomes information system; pnl; point in time; promise; random; survey; survey.promis,-
90681-8,my child has been physically able to do the activities he/she enjoys most in past 7 days [promis.parentproxy],,,finding; findings; last; ordinal; patient reported outcomes information system; promise; ql; qual; qualitative; screen; survey; survey.promis,Ord
90682-6,my child could ride a bike in past 7 days [promis.parentproxy],,,finding; findings; last; ordinal; patient reported outcomes information system; promise; ql; qual; qualitative; screen; survey; survey.promis,Ord
9069-6,fat intake 8 hour,fat intake 8h,,1/3 day; 8 hours; 8hr; io_intake_salts+calories; mass rate; mrate; qnt; quan; quant; quantitative,Qn
90726-1,"during the past month, how often did you eat pizza",,,1 month; 1 month (30 days); 30 days; count/time; last; month; nrate; number rate; number rate = count/time; qnt; quan; quant; quantitative; survey; survey.nhanes,Qn
90730-3,self-perception of body weight,self-perception of body wgt,,bdy weight; bod; bodies; finding; findings; h+p; h+p.hx; ordinal; p prime; point in time; ql; qual; qualitative; random; screen; self-perception of body wgt; wt,Ord
90738-6,erythrocytes.cd59 complete loss/erythrocytes in blood,rbc cd59 complete loss nfr,erythrocytes.cd59 complete loss/cells.235a (bld),blood; cd59 rbc; cell; cell markers; cellularity; discocytes; erthrocyte; erythrocyte; glycosylphosphatidylinositol-anchored protein; number fraction; paroxysmal nocturnal hemoglobinuria; percent; plink; pnh; point in time; qnt; quan; quant; quantitative; random; rbc; rbcs; rbcs cd59- comp loss; red blood cell; red blood cells; red blood corpuscle; red blood corpusles; red cell; red cells; wb; whole blood,Qn
90745-1,surgical procedures requiring active snf care during assessment period [cms assessment],,,centers for medicare and medicaid assessment; finding; findings; nominal; report period; surg; surg proc; survey,Nom
90751-9,social worker adult day care center note,sw adcc note,,adcc; doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; notes; point in time; random; social work; sw; visit note,Doc
90759-2,primary care social worker note,primary care sw note,,continuity assessment record and evaluation; doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; notes; point in time; primary care sw; random; social work; sw; visit note,Doc
90769-1,heart failure plan of care note,heart failure plan of care note,,cardio; cardiology; care plan; doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; heart disease; heart function; notes; point in time; random; treatment plan; visit note,Doc
90775-8,disease severity level [reported],,,dis; diseases; dz; finding; findings; levels; levl; lv; lvl; ordinal; point in time; ql; qual; qualitative; random; screen; survey; survey.gnhlth,Ord
90782-4,f2-isoprostanes [mass/volume] in urine,f2-isops ur-mcnc,f2-isops (u) [mass/vol],8-iso-prostaglandin f2alpha; chemistry; f2-isops; level; mass concentration; point in time; qnt; quan; quant; quantitative; random; ua; ur; urn,Qn
90784-0,cystinuria panel - urine,cystinuria pnl ur,cystinuria panel (u),chemistry; cystinuria pnl; pan; panel.chemistry; panl; pnl; point in time; random; ua; ur; urn,-
90808-7,candida krusei dna [presence] in serum by naa with probe detection,c krusei dna ser ql naa+probe,c. krusei dna naa+probe ql (s),3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; c krusei; cand; candidiasis; deoxyribonucleic acid; dna nucleic acid probe; dna probe; id; infectious disease; infectiousdisease; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; naa+probe; naat; nasba; nucleic acid sequence based analysis; ordinal; pcr; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; screen; sda; serum; sr; strand displacement amplification; tma; transcription mediated amplification,Ord
90810-3,candida tropicalis dna [presence] in serum by naa with probe detection,c tropicls dna ser ql naa+probe,c. tropicalis dna naa+probe ql (s),3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; c tropicls; cand; candidiasis; deoxyribonucleic acid; dna nucleic acid probe; dna probe; id; infectious disease; infectiousdisease; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; naa+probe; naat; nasba; nucleic acid sequence based analysis; ordinal; pcr; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; screen; sda; serum; sr; strand displacement amplification; tma; transcription mediated amplification,Ord
9081-1,protein intake 1 hour,protein intake 1h,,1 hour; 1.0hr; 1hr; 60 min; 60 minutes; 60m; 60min; io_intake_salts+calories; mass rate; mrate; pr; prot; qnt; quan; quant; quantitative,Qn
90822-8,cv2 ab [units/volume] in cerebral spinal fluid by line blot,cv2 ab csf line blot-acnc,cv2 ab line blot qn (csf),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; cerebral spinal fluid; cerebrospinal fl; collapsin response mediator protein 5; collapsin response mediator protein 5 ab; crmp5; crmp-5; neuro; neurology; point in time; pop66; qnt; quan; quant; quantitative; random; serology; spinal fl; spinal fld; spinal flu; spinal fluid; ulip,Qn
90839-2,nmdar subunit 1 ab [presence] in cerebral spinal fluid by cell binding immunofluorescent assay,nmdar1 ab csf ql cba ifa,nmdar subunit 1 ab cell binding immunofluorescent assay ql (csf),"abs; aby; antby; anti; antibodies; antibody; asp; aspartic acid; autoantibodies; autoantibody; cerebral spinal fluid; cerebrospinal fl; dextro; encephalitis; glutamate receptor ionotropic, nmda 1; i; indirect fluorescence antibody; nmda receptor; nmdar; nmdar1; n-methylaspartate receptors; n-methyl-d-aspartic acid; ordinal; paraneoplastic syndrome; point in time; pr; ql; qual; qualitative; random; rec; recept; receptors; recp; recptr; screen; serology; spinal fl; spinal fld; spinal flu; spinal fluid",Ord
90845-9,pca-tr ab [presence] in cerebral spinal fluid by immunofluorescence,pca-tr ab csf ql if,pca-tr ab if ql (csf),abs; aby; acif; antby; anti; antibodies; antibody; anticomplement immunofluorescence; autoantibodies; autoantibody; cerebral spinal fluid; cerebrospinal fl; cytopl; cytoplas; fa; fluorescent antibody; fluoresent; hodgkin's lymphoma; ifa; immune fluorescence; immunoflour; immunofluor; immunofluorescence; limbic encephalopathy; neuro; neurology; ordinal; paraneoplastic cerebellar degeneration; paraneoplastic neurological syndrome; paraneoplastic syndrome; pcd; pns; point in time; pr; ql; qual; qualitative; random; screen; serology; spinal fl; spinal fld; spinal flu; spinal fluid; time resolved fluorescence; trf,Ord
90852-5,patient fax number,patient fax #,,admin; admin.patient; no; nominal; num; point in time; random; telecommunication number; telephone number,Nom
90883-0,promis pediatric item bank - mobility - version 2.0,,,pan; panel; panel.survey.promis; panl; patient reported outcomes information system; peds; pnl; point in time; promise; random; survey; survey.promis,-
90888-9,porcine circovirus type 3 dna [#/volume] (viral load) in specimen by naa with probe detection,pcv3 dna # spec naa+probe,pcv type 3 dna naa+probe (specimen) [#/vol],#; 3 self-sustaining sequence replication; 3sr sr; abs; absolute; absolutes; amplif; amplification; amplified; circo virus; cnt; count; count/volume; ct; deoxyribonucleic acid; dna nucleic acid probe; dna probe; id; iii; infectious disease; infectiousdisease; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; misc; miscellaneous; naa+probe; naat; nasba; nucleic acid sequence based analysis; number concentration; number concentration (count/vol); other; pcr; pcv; pcv3; pcv3 dna; point in time; polymerase chain reaction; pork; probe amp; probe with ampification; probe with target amplification; qbr; qnt; quan; quant; quantitative; random; sda; spec; strand displacement amplification; swine; tma; to be specified in another part of the message; transcription mediated amplification; unspecified; vet; veterinary; viral load,Qn
90912-7,eicosapentaenoate (c20:5w3)/fatty acids.c14-c22 in blood,epa/fatty acids.c14-c22 mfr bld,epa/fatty acids.c14-c22 (bld) [mass fraction],acd; acid; blood; c20:5w3; chemistry; eicosapentaenoic acid; epa; fatty acid; icosapentaenoate; lipid; mass fraction; percent; point in time; qnt; quan; quant; quantitative; random; timnodonate; timnodonic acid; wb; whole blood,Qn
90914-3,docosahexaenoate (c22:6w3)/fatty acids.c14-c22 in blood,dha/fatty acids.c14-c22 mfr bld,dha/fatty acids.c14-c22 (bld) [mass fraction],acd; acid; blood; c22:6w3; cervonate; cervonic acid; chemistry; dha; docosahexaenoic acid; fatty acid; lipid; mass fraction; percent; point in time; qnt; quan; quant; quantitative; random; wb; whole blood,Qn
90944-0,promis parent proxy short form - peer relationship 7a - version 2.0,,,pan; panel; panel.survey.promis; panl; patient reported outcomes information system; pnl; promise; survey; survey.promis,-
90950-7,promis pediatric short form - depressive symptoms 8a - version 2.0 raw score,,,patient reported outcomes information system; peds; point in time; promise; qnt; quan; quant; quantitative; random; scale; survey; survey.promis; sx,Qn
9095-1,fluid balance 10 hour,fluid balance 10h,,10 hours; 10hr; bal; fld; flow; io_intake; io_intake.summary; qnt; quan; quant; quantitative; volume rate; vrate,Qn
90954-9,promis pediatric short form - life satisfaction 8a - version 1.0 raw score,,,patient reported outcomes information system; peds; point in time; promise; qnt; quan; quant; quantitative; random; scale; survey; survey.promis,Qn
90956-4,promis pediatric short form - mobility 8a - version 2.0 raw score,,,patient reported outcomes information system; peds; point in time; promise; qnt; quan; quant; quantitative; random; scale; survey; survey.promis,Qn
90958-0,promis pediatric short form - pain interference 8a - version 2.0 raw score,,,patient reported outcomes information system; peds; point in time; promise; qnt; quan; quant; quantitative; random; scale; survey; survey.promis,Qn
90962-2,promis short form - applied cognition - general concerns 4a - version 1.0 raw score,,,patient reported outcomes information system; point in time; promise; qnt; quan; quant; quantitative; random; scale; survey; survey.promis,Qn
90970-5,promis short form - emotional distress - anger 5a - version 1.1 raw score,,,patient reported outcomes information system; point in time; promise; qnt; quan; quant; quantitative; random; scale; survey; survey.promis,Qn
90979-6,vortioxetine [mass/volume] in serum or plasma,vortioxetine serpl-mcnc,vortioxetine [mass/vol],drug/toxicology; drugs; level; mass concentration; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
90984-6,hedis 2019-2020 value set - psa test exclusion,hedis 2019-20 psa test excl,hedis 2019-2020 value set - psa test exclusion,hedis 2019-20 psa test excl; pan; panel; panel.hedis; panl; pnl; point in time; random,-
90988-7,hedis 2019-2020 value set - hpv tests,hedis 2019-20 hpv tests,hedis 2019-2020 value set - hpv tests,hedis 2019-20 hpv tests; pan; panel; panel.hedis; panl; pnl; point in time; random,-
90990-3,protein.monoclonal isotype [identifier] in serum or plasma by ms.maldi-tof,m protein isotype serpl ms.maldi-tof,protein.monoclonal isotype ms.maldi-tof nom,chemistry; identity or presence; m protein; m protein isotype; m-band; monoclonal band; monoclonal spike; m-protein; m-spike; nominal; para protein; paraprotein; pl; plasma; plsm; point in time; pr; prot; random; serp; serpl; serplas; serum; serum or plasma; sr,Nom
91000-0,event-associated cases [#] during reporting period,event-associated cases # in rptperiod,,cnt; count; number; public health; publichealth; qnt; quan; quant; quantitative; report period,Qn
91014-1,status of water supply systems narrative,status of water supply systems,,finding; findings; narrative; point in time; public health; publichealth; random; report,Nar
91037-2,methamphetamine+methylenedioxymethamphetamine [presence] in urine by screen method,methamphet+mdma ur ql scn,methamphetamine+mdma screen ql (u),addiction; desoxyn; drug/toxicology; drugs; drugs of abuse; ecstasy; illicit; mdma; methamphet; methamphet+mdma; ordinal; point in time; potentialforabuse; pr; ql; qual; qualitative; random; scn; scr; screen; scrn; ua; ur; urn,Ord
91038-0,cocaine+benzoylecgonine [presence] in body fluid by screen method,cocaine+bze fld ql scn,cocaine+benzoylecgonine screen ql (body fld),"addiction; b/f; bec; beg; benz; benzoylec; benzoylmethylecgonine; bf; bod; bodies; body fluid; body fluid, unsp; bze; cocaine degradation production; cocaine metabolite; cocaine+bze; coke; crack; crack metabolite; drug/toxicology; drugs; drugs of abuse; ecgonine methyl ester benzoate; fl; fld; flu; fluid; illicit; ordinal; point in time; potentialforabuse; pr; ql; qual; qualitative; random; scn; scr; screen; scrn; snow",Ord
91043-0,opiates [presence] in body fluid by screen method,opiates fld ql scn,opiates screen ql (body fld),"addiction; b/f; bf; bod; bodies; body fluid; body fluid, unsp; drug/toxicology; drugs; drugs of abuse; fl; fld; flu; fluid; heroin; illicit; op; opi; opiate; ordinal; point in time; potentialforabuse; pr; ql; qual; qualitative; random; scn; scr; screen; scrn",Ord
91045-5,methamphetamine+methylenedioxymethamphetamine [presence] in hair by screen method,methamphet+mdma hair ql scn,methamphetamine+mdma screen ql (hair),addiction; desoxyn; drug/toxicology; drugs; drugs of abuse; ecstasy; har; illicit; mdma; methamphet; methamphet+mdma; ordinal; point in time; potentialforabuse; pr; ql; qual; qualitative; random; scn; scr; screen; scrn,Ord
91046-3,methadone+metabolite [presence] in hair by screen method,methadone+metab hair ql scn,methadone+metabolite screen ql (hair),addiction; dolophin; dolophine; drug/toxicology; drugs; drugs of abuse; har; illicit; metab; metabolites; metb; metd; methadose; mtd; ordinal; point in time; potentialforabuse; pr; ql; qual; qualitative; random; scn; scr; screen; scrn,Ord
91057-0,tropheryma whipplei dna [presence] in stool by naa with probe detection,t whipplei dna stl ql naa+probe,t. whipplei dna naa+probe ql (stl),3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; bowel movement; deoxyribonucleic acid; dna nucleic acid probe; dna probe; faecal; faeces; fecal; feces; id; infectious disease; infectiousdisease; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; naa+probe; naat; nasba; nucleic acid sequence based analysis; ordinal; pcr; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; screen; sda; stl; stool = fecal; strand displacement amplification; t whippelii; t whippelli; t whipplei; tma; transcription mediated amplification; tropheryma whippelli; whipple's disease,Ord
91080-2,zika virus igg ab [presence] in serum or plasma by immunoassay,zikv igg serpl ql ia,zikv igg ia ql,abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; eia; elfa; elisa; enzyme immunoassay; iaa; id; immune globulin g; immunoglobulin g; infectious disease; infectiousdisease; meia; microbiology; ordinal; pl; plasma; plsm; point in time; pr; ql; qual; qualitative; random; screen; serp; serpl; serplas; serum; serum or plasma; sr; suds; zikv,Ord
91083-6,fungal 18s rrna gene [presence] in isolate by naa with probe detection,fungal 18s rrna gene islt ql naa+probe,fungal 18s rrna gene naa+probe ql (isol),3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; dna nucleic acid probe; dna probe; gen-probe; id; infectious disease; infectiousdisease; islt; isol; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; naa+probe; naat; nasba; nucleic acid sequence based analysis; ordinal; pcr; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; rdna; ribosomal rna; screen; sda; strand displacement amplification; tma; transcription mediated amplification,Ord
91089-3,fungal bt2 gene [presence] in lower respiratory specimen by naa with probe detection,fungal bt2 gene lower resp ql naa+probe,fungal bt2 gene naa+probe ql (lower resp),3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; breathing; dna nucleic acid probe; dna probe; id; infectious disease; infectiousdisease; lat; lcr; ligase chain reaction; ligation-activated transcription; low; lower resp; lungs; microbiology; naa+probe; naat; nasba; nucleic acid sequence based analysis; ordinal; pcr; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; rs; screen; sda; spec; strand displacement amplification; tma; transcription mediated amplification,Ord
91092-7,fungal its region [presence] in dermatologic specimen by naa with probe detection,fungal its region derm spec ql naa+probe,fungal its region naa+probe ql (derm),3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; derm spec; dermatologic; dna nucleic acid probe; dna probe; epidermis; har; id; infectious disease; infectiousdisease; integument; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; naa+probe; naat; nails; nasba; nucleic acid sequence based analysis; ordinal; pcr; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; screen; sda; skn; strand displacement amplification; tma; transcription mediated amplification; ungal nail,Ord
91099-2,people tested [#] population,people tested pop,,cnt; count; number; point in time; public health; publichealth; qnt; quan; quant; quantitative; random,Qn
91100-8,people with confirmed positive lab results [#] population,confirmed positive lab results pop,,cnt; count; number; point in time; pos; public health; publichealth; qnt; quan; quant; quantitative; random,Qn
9112-4,chest tube site type,chest tube site type,,io; io.tube; nominal; point in time; random; typ,Nom
91160-2,when my child was in pain he or she limped in past 7 days [promis.parentproxy],,,finding; findings; last; ordinal; patient reported outcomes information system; promise; ql; qual; qualitative; screen; survey; survey.promis,Ord
91168-5,when my child was in pain he or she tightened his or her jaw in past 7 days [promis.parentproxy],,,finding; findings; last; ordinal; patient reported outcomes information system; promise; ql; qual; qualitative; screen; survey; survey.promis,Ord
91176-8,"when my child was in pain he or she asked people to bring him or her things (food, games) in past 7 days [promis.parentproxy]",,,finding; findings; last; ordinal; patient reported outcomes information system; promise; ql; qual; qualitative; screen; survey; survey.promis,Ord
91177-6,when my child was in pain he or she couldn't stay still in past 7 days [promis.parentproxy],,,finding; findings; last; ordinal; patient reported outcomes information system; promise; ql; qual; qualitative; screen; survey; survey.promis; t prime,Ord
91185-9,when my child was in pain he or she complained in past 7 days [promis.parentproxy],,,finding; findings; last; ordinal; patient reported outcomes information system; promise; ql; qual; qualitative; screen; survey; survey.promis,Ord
91188-3,when my child was in pain he or she argued with people in past 7 days [promis.parentproxy],,,finding; findings; last; ordinal; patient reported outcomes information system; promise; ql; qual; qualitative; screen; survey; survey.promis,Ord
91196-6,when my child was in pain he or she took breaks from what he or she was doing in past 7 days [promis.parentproxy],,,finding; findings; last; ordinal; patient reported outcomes information system; promise; ql; qual; qualitative; screen; survey; survey.promis,Ord
91198-2,when my child was in pain it showed on his or her face in past 7 days [promis.parentproxy],,,finding; findings; last; ordinal; patient reported outcomes information system; promise; ql; qual; qualitative; screen; survey; survey.promis,Ord
91212-1,how many days was your child so physically active that he or she sweated in past 7 days [promis.parentproxy],,,dextro; finding; findings; last; ordinal; patient reported outcomes information system; promise; ql; qual; qualitative; screen; survey; survey.promis,Ord
91217-0,how many days did you run for 10 minutes or more in past 7 days [promis.peds],,,dextro; finding; findings; last; ordinal; patient reported outcomes information system; promise; ql; qual; qualitative; screen; survey; survey.promis,Ord
91220-4,"on a usual day, how physically active were you in past 7 days [promis.peds]",,,finding; findings; last; ordinal; patient reported outcomes information system; promise; ql; qual; qualitative; screen; survey; survey.promis,Ord
91222-0,how many days did you exercise or play so hard that your muscles burned in past 7 days [promis.peds],,,dextro; excz; finding; findings; last; ordinal; patient reported outcomes information system; promise; ql; qual; qualitative; screen; survey; survey.promis,Ord
91238-6,i felt blissful in past 7 days [promis.peds],,,finding; findings; last; ordinal; patient reported outcomes information system; promise; ql; qual; qualitative; screen; survey; survey.promis,Ord
91244-4,i smiled a lot in past 7 days [promis.peds],,,finding; findings; last; ordinal; patient reported outcomes information system; promise; ql; qual; qualitative; screen; survey; survey.promis,Ord
91260-0,i felt carefree in past 7 days [promis.peds],,,finding; findings; last; ordinal; patient reported outcomes information system; promise; ql; qual; qualitative; screen; survey; survey.promis,Ord
91261-8,i felt positive in past 7 days [promis.peds],,,finding; findings; last; ordinal; patient reported outcomes information system; pos; promise; ql; qual; qualitative; screen; survey; survey.promis,Ord
91265-9,i felt satisfied in past 7 days [promis.peds],,,finding; findings; last; ordinal; patient reported outcomes information system; promise; ql; qual; qualitative; screen; survey; survey.promis,Ord
91267-5,my child felt healthy in past 7 days [promis.parentproxy],,,finding; findings; last; ordinal; patient reported outcomes information system; promise; ql; qual; qualitative; screen; survey; survey.promis,Ord
91269-1,my child felt full of pep in past 7 days [promis.parentproxy],,,finding; findings; last; ordinal; patient reported outcomes information system; promise; ql; qual; qualitative; screen; survey; survey.promis,Ord
9127-2,fluid output cerebral ventricle drain 24 hour,drain output 24h cerebral vents,,1 day; 24 hours; 24hr; cereb; cerebral spinal fluid output; cerebral vents; cerebrospinal fluid output; csf output; fld; flow; fluid output cereb vent drain; io_output; io_output.timed.mole; qnt; quan; quant; quantitative; volume rate; vrate,Qn
91276-6,my child felt blissful in past 7 days [promis.parentproxy],,,finding; findings; last; ordinal; patient reported outcomes information system; promise; ql; qual; qualitative; screen; survey; survey.promis,Ord
91292-3,my child felt proud in past 7 days [promis.parentproxy],,,finding; findings; last; ordinal; patient reported outcomes information system; promise; ql; qual; qualitative; screen; survey; survey.promis,Ord
91313-7,i had trouble concentrating in past 7 days [promis.peds],,,finding; findings; last; ordinal; patient reported outcomes information system; promise; ql; qual; qualitative; screen; survey; survey.promis,Ord
91334-3,how many days was your child strong enough to open a heavy door in past 7 days [promis.parentproxy],,,dextro; finding; findings; last; ordinal; patient reported outcomes information system; promise; ql; qual; qualitative; screen; survey; survey.promis,Ord
91343-4,i have dressed more slowly than usual because of back pain in the last 2 weeks [start back],,,14 days; 2 weeks; finding; findings; ordinal; past; ql; qual; qualitative; screen; started; survey; survey.gnhlth,Ord
91344-2,"thinking about the last 2 weeks, it's not really safe for a person with a condition like mine to be physically active [start back]",,,14 days; 2 weeks; finding; findings; ordinal; past; persons; ql; qual; qualitative; s prime; screen; started; survey; survey.gnhlth,Ord
91351-7,total score [start back],,,point in time; qnt; quan; quant; quantitative; random; scale; started; survey; survey.gnhlth; tot; totl,Qn
91352-5,start back screening risk level,,,asympt; asymptomatic; finding; findings; levels; levl; lv; lvl; ordinal; point in time; ql; qual; qualitative; random; sbst risk level; scn; screen; started; survey; survey.gnhlth,Ord
91355-8,promis pediatric item bank - positive affect - version 1.0,,,pan; panel; panel.survey.promis; panl; patient reported outcomes information system; peds; pnl; point in time; pos; promise; random; survey; survey.promis,-
91365-7,my child felt unable to manage things in his or her life in past 7 days [promis.parentproxy],,,finding; findings; last; ordinal; patient reported outcomes information system; promise; ql; qual; qualitative; screen; survey; survey.promis,Ord
91385-5,age when first used cocaine or crack,age first used cocaine or crack,,age first used cocaine or crack; benzoylmethylecgonine; coke; crack; ecgonine methyl ester benzoate; h+p; h+p.hx; p prime; point in time; qnt; quan; quant; quantitative; random; snow,Qn
91399-6,my child felt everything in his or her life went wrong in past 7 days [promis.parentproxy],,,finding; findings; last; ordinal; patient reported outcomes information system; promise; ql; qual; qualitative; screen; survey; survey.promis,Ord
91406-9,promis parent proxy depressive symptoms - version 2.0 t-score,,,patient reported outcomes information system; point in time; promise; qnt; quan; quant; quantitative; random; survey; survey.promis; sx; t prime; t-score,Qn
91409-3,it was hard for my child to play with pets because of asthma in past 7 days [promis.parentproxy],,,finding; findings; last; ordinal; patient reported outcomes information system; promise; ql; qual; qualitative; screen; survey; survey.promis,Ord
914-2,b ag [presence] on red blood cells from blood product unit,b ag rbc bpu ql,b ag ql (rbc bpu),antigen; antigens; blood bank; blood product unit; blood product unit (pack); erythrocytes; hematology; heme; ordinal; point in time; pr; ql; qual; qualitative; random; red blood cells; red blood corpusles; screen,Ord
91435-8,"i had trouble breathing, even when i was not exercising or playing hard in past 7 days [promis.peds]",,,finding; findings; last; ordinal; painad.breathing; patient reported outcomes information system; promise; ql; qual; qualitative; screen; survey; survey.promis,Ord
91441-6,my breathing was fast in past 7 days [promis.peds],,,finding; findings; last; ordinal; painad.breathing; patient reported outcomes information system; promise; ql; qual; qualitative; screen; survey; survey.promis,Ord
91449-9,my neck felt tight in past 7 days [promis.peds],,,finding; findings; last; ordinal; patient reported outcomes information system; promise; ql; qual; qualitative; screen; survey; survey.promis,Ord
91463-0,"thinking about my life, i expect things to work out for the best [promis.peds]",,,finding; findings; job; occupation; ordinal; patient reported outcomes information system; point in time; promise; ql; qual; qualitative; random; screen; survey; survey.promis,Ord
91465-5,"thinking about my life, i expect to achieve what i want in life [promis.peds]",,,finding; findings; ordinal; patient reported outcomes information system; point in time; promise; ql; qual; qualitative; random; screen; survey; survey.promis,Ord
91479-6,"thinking about my life, i have things i need to do in life [promis.peds]",,,finding; findings; ordinal; patient reported outcomes information system; point in time; promise; ql; qual; qualitative; random; screen; survey; survey.promis,Ord
91481-2,"thinking about my life, i have things i want to do in life [promis.peds]",,,finding; findings; ordinal; patient reported outcomes information system; point in time; promise; ql; qual; qualitative; random; screen; survey; survey.promis,Ord
9148-8,fluid output emesis [mass/time] 24 hour,fluid output emesis 24h mrate,,1 day; 24 hours; 24hr; fld; fluid output emesis; io_output; io_output.timed.mole; mass rate; mrate; qnt; quan; quant; quantitative; ugi; up; upr gi tract; vomitus,Qn
91490-3,"thinking about my life, my life has meaning [promis.peds]",,,finding; findings; ordinal; patient reported outcomes information system; point in time; promise; ql; qual; qualitative; random; screen; survey; survey.promis,Ord
91492-9,"thinking about my life, my life is filled with important things [promis.peds]",,,finding; findings; ordinal; patient reported outcomes information system; point in time; promise; ql; qual; qualitative; random; screen; survey; survey.promis,Ord
91499-4,"thinking about my life, when bad things happen, i expect them to get better [promis.peds]",,,finding; findings; ordinal; patient reported outcomes information system; point in time; promise; ql; qual; qualitative; random; screen; survey; survey.promis,Ord
91502-5,how many days were you strong enough to get down on the floor in past 7 days [promis.peds],,,dextro; finding; findings; last; ordinal; patient reported outcomes information system; promise; ql; qual; qualitative; screen; survey; survey.promis,Ord
91511-6,how many days were you strong enough to reach above your head to get heavy things in past 7 days [promis.peds],,,dextro; finding; findings; last; ordinal; patient reported outcomes information system; promise; ql; qual; qualitative; screen; survey; survey.promis,Ord
9151-2,fluid output gastric tube 8 hour,fluid output g-tube 8h,,1/3 day; 8 hours; 8hr; fld; flow; fluid output g-tube; gastrostomy tube; g-tube; io_output; io_output.timed.mole; peg; percutaneous endoscopic gastrostomy; qnt; quan; quant; quantitative; ugi; up; upr gi tract; volume rate; vrate,Qn
91519-9,dbt breast - bilateral diagnostic for implant,dbt brst-bl dx for implant,,bil; bilat; both; breast-bl; breasts; brst; brst-bl; dbt; document; dx; dx for implant; finding; findings; imaging; mammography tomo; mammography tomosynthesis; point in time; radiology; random,Doc
91524-9,mr chest and abdomen and pelvis wo and w contrast iv,mr chest+abd+pelvis wo+w contr iv,,abd; abd+pelvis; abdo; abdominal; c; chest + abd; chest+abd+pelvis; contr; contra; contrst; document; finding; findings; imaging; mitral regurgitation maximum velocity; mri; pelvic; point in time; radiology; random; thorax; w contr iv; wc; wo & wc; wo+w contr; wo+w contr iv; wwo,Doc
91536-3,promis pediatric item bank - depressive symptoms - version 2.0,,,pan; panel; panel.survey.promis; panl; patient reported outcomes information system; peds; pnl; promise; survey; survey.promis; sx,-
91552-0,"mds v3.0 - rai v1.17.1, 1.17.2 - swing bed discharge (sd) item set during assessment period [cms assessment]",,,centers for medicare and medicaid assessment; disch; pan; panel; panel.survey.cms; panl; pnl; report period; survey,-
91562-9,performing laboratory identifier facility,performing laboratory id facility,,admin; ident; identifier; nominal; point in time; random,Nom
91565-2,key words related to public health emergency,key words for ph emerg,,finding; findings; key words for ph emerg; nominal; point in time; public health; publichealth; random,Nom
91568-6,shot up or injected any non-prescription drugs lifetime,shot up injected non-rx drugs lifetime,,drug; finding; findings; h+p; h+p.hx; ordinal; p prime; ql; qual; qualitative; rx; screen; shot up injected non-rx drugs,Ord
9157-9,fluid output insensible 10 hour estimated,fluid output insensible 10h est,,10 hours; 10hr; est; estimation; fld; flow; fluid output insensible; io_output; io_output.timed.mole; qnt; quan; quant; quantitative; volume rate; vrate,Qn
91589-2,longitude event,longitude event,,admin; point in time; qnt; quan; quant; quantitative; random,Qn
9159-5,fluid output insensible 24 hour estimated,fluid output insensible 24h est,,1 day; 24 hours; 24hr; est; estimation; fld; flow; fluid output insensible; io_output; io_output.timed.mole; qnt; quan; quant; quantitative; volume rate; vrate,Qn
91611-4,promis item bank - upper extremity - version 2.0,,,pan; panel; panel.survey.promis; panl; patient reported outcomes information system; pnl; point in time; promise; random; survey; survey.promis; up,-
91631-2,"have you been bothered by any illness, bodily disorder, pains, or fears about your health during the past month [nhanes]",,,1 month; 1 month (30 days); 30 days; finding; findings; last; month; ordinal; ql; qual; qualitative; screen; survey; survey.mtlhlth,Ord
91632-0,"have you been anxious, worried, or upset during the past month [nhanes]",,,1 month; 1 month (30 days); 30 days; finding; findings; last; month; ordinal; ql; qual; qualitative; screen; survey; survey.mtlhlth,Ord
91634-6,how often is the following kind of support available to you if you need it - someone you can count on to listen to you when you need to talk [mos social support survey],,,finding; findings; mos sss; ordinal; point in time; ql; qual; qualitative; random; screen; survey.mtlhlth,Ord
91648-6,tangible support score [mos social support survey],,,mos sss; point in time; qnt; quan; quant; quantitative; random; scale; sdoh; survey.mtlhlth,Qn
91651-0,general well-being schedule - 18 item - total score [nhanes],,,general well-being scale; gwb schedule 18 item; gwb schedule 18 item score; point in time; qnt; quan; quant; quantitative; random; scale; survey; survey.gnhlth; tot; totl,Qn
91656-9,how often is the following kind of support available to you if you need it - someone who hugs you [mos social support survey],,,finding; findings; mos sss; ordinal; point in time; ql; qual; qualitative; random; screen; survey.mtlhlth; world heatlth organization,Ord
91657-7,how often is the following kind of support available to you if you need it - someone to get together with for relaxation [mos social support survey],,,finding; findings; mos sss; ordinal; point in time; ql; qual; qualitative; random; screen; survey.mtlhlth,Ord
91662-7,how often is the following kind of support available to you if you need it - someone who understands your problems [mos social support survey],,,finding; findings; mos sss; ordinal; point in time; ql; qual; qualitative; random; screen; sdoh; survey.mtlhlth; world heatlth organization,Ord
91671-8,transferrin.carbohydrate deficient.disialo/transferrin.total standardized per ifcc-rmp for cdt in serum or plasma,cdt disialo/tf per ifcc-rmp cdt mfr s/p,transferrin.carbohydrate deficient.disialo/total transferrin standardized per ifcc-rmp for cdt [mass fraction],cdt; cdt disialo; chemistry; di-oligo; glycosylated transferrin; mass fraction; percent; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; siderophilin; sr; tf; tot; totl; trf; trfrn,Qn
91674-2,cd3+cd16+cd56+ cells [#/volume] in bone marrow,cd3+cd16+cd56+ cells # mar,cd3+cd16+cd56+ cells (bm) [#/vol],#; abs; absolute; absolutes; bm; bon; bone marrow; cd3 cells; cd3+cd16+ cells; cd3+cd16+cd56+ cells; cd3-cd16+ cells; cd3-cd16+cd56+ cells; cell; cell markers; cellularity; cnt; count; count/volume; ct; fcgr3a; leu11; leu-11; leu11b; leu-11b; leu19; leu-19; leu4; leu-4; mar; marrow (bone); minimal angle of resolution; minimum angle of resolution; natural killer cells; ncam; neural cell adhesion molecule; nkh1; number concentration; number concentration (count/vol); point in time; qnt; quan; quant; quantitative; random; t3,Qn
9167-8,fluid output miscellaneous route,fluid output misc.route,,fld; fluid output misc; fluid output misc.route; io_output; io_output.molec; misc; miscellaneous; nominal; other; point in time; random; spec; to be specified in another part of the message; typ; unspecified,Nom
91695-7,personnel qualification,personnel qualification,,admin; nominal; point in time; random; typ,Nom
91708-8,corticotropin [mass/volume] in plasma --10 minutes post 1 ug/kg crh iv,acth 10m p 1 ug/kg crh iv plas-mcnc,corticotropin 10 min post 1 ug/kg crh iv (p) [mass/vol],10m p 1 ug/kg crh iv; acth; adrenocorticotrophic hormone; adrenocorticotropin; after; c206; c74; chemistry.challenge testing; cortrosyn; i; level; mass concentration; mcg; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; rc206; tumor marker,Qn
91715-3,mr spine lumbar and sacrum w contrast iv,mr l-spine+sacrum w contr iv,,abd; abdo; abdomen+; abdominal; c; contr; contra; contrst; document; finding; findings; imaging; l/sp; l-spine; l-spine+sacrum; lumbar; lumbo; lumbosacral; mitral regurgitation maximum velocity; mri; pelvic; pelvis+l-spine; point in time; radiology; random; spinal; spinal cord; w contr iv; wc,Doc
91718-7,mr unspecified body region post mortem,mr pm,,after; document; finding; findings; imaging; misc; miscellaneous; mitral regurgitation maximum velocity; mri; other; pm; point in time; pst; radiology; random; spec; to be specified in another part of the message; unspecified,Doc
91735-1,are you able to carry a large baby (15 lbs or 7 kg) out of the house to a car or taxi [promis],,,finding; findings; ordinal; patient reported outcomes information system; point in time; promise; ql; qual; qualitative; random; screen; survey; survey.promis,Ord
91743-5,are you able to jump over an object that is 1 foot (30 cm) tall [promis],,,finding; findings; i; lower extremity; ordinal; patient reported outcomes information system; point in time; promise; ql; qual; qualitative; random; screen; survey; survey.promis,Ord
91746-8,are you able to come to a complete stop while running [promis],,,finding; findings; ordinal; patient reported outcomes information system; point in time; promise; ql; qual; qualitative; random; screen; survey; survey.promis,Ord
917-5,b variant subtype ab [presence] in serum or plasma from blood product unit,b var subtyp ab serpl bpu ql,b variant subtype ab ql (s/p bpu),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; b var subtyp; blood bank; blood product unit; blood product unit (pack); ordinal; pl; plasma; plsm; point in time; pr; ql; qual; qualitative; random; screen; serp; serpl; serpl^bpu; serplas; serum; serum or plasma; sr,Ord
91751-8,are you able to hit the backboard with a basketball from the free throw line 13 ft or 4 m [promis],,,are you able to hit the backboard with a basketball from the free throw line 13 ft or 4 m; finding; findings; fr; non-protein bound; ordinal; patient reported outcomes information system; point in time; promise; ql; qual; qualitative; random; screen; survey; survey.promis,Ord
91753-4,are you able to do a pull-up [promis],,,finding; findings; ordinal; patient reported outcomes information system; point in time; promise; ql; qual; qualitative; random; screen; survey; survey.promis,Ord
91761-7,giardia sp ag [presence] in stool by rapid immunoassay,giardia ag stl ql ia.rapid,giardia sp ag ia.rapid ql (stl),antigen; antigens; bowel movement; eia; elfa; elisa; enzyme immunoassay; faecal; faeces; fecal; feces; giardiasis; iaa; meia; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; screen; species; spp; stl; stool = fecal; suds,Ord
91787-2,mumps virus [presence] in upper respiratory specimen by organism specific culture,muv upper resp ql cult,muv org specific cx ql (upper resp),breathing; c&s; cult; cultures; lungs; microbiology; muv; ordinal; point in time; pr; ql; qual; qualitative; random; rs; screen; spec; up; upper resp,Ord
9179-3,fluid output peritoneal drain,fluid output peritoneal drain,,fld; fluid output peritoneal drain; io_output; io_output.molec; peritoneal cavity; point in time; qnt; quan; quant; quantitative; random; volume,Qn
91802-9,parainfluenza virus 1 rna [presence] in upper respiratory specimen by naa with probe detection,hpiv1 rna upper resp ql naa+probe,parainfluenza virus 1 rna naa+probe ql (upper resp),3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; breathing; dna nucleic acid probe; dna probe; hpiv; hpiv1; human respirovirus 1; i; lat; lcr; ligase chain reaction; ligation-activated transcription; lungs; microbiology; naa+probe; naat; nasba; nucleic acid sequence based analysis; ordinal; para; parainflu; parainfluenza type 1; parainfluenza type i; pcr; pi1; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; ribonucleic acid; rs; screen; sda; spec; strand displacement amplification; tma; transcription mediated amplification; up; upper resp,Ord
91803-7,neisseria meningitidis dna [presence] in upper respiratory specimen by naa with probe detection,n men dna upper resp ql naa+probe,n. meningitidis dna naa+probe ql (upper resp),3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; breathing; deoxyribonucleic acid; dna nucleic acid probe; dna probe; lat; lcr; ligase chain reaction; ligation-activated transcription; lungs; mening; meningid; meningitis; meningo; meningococcal meningitis; meningococcus; microbiology; n men; n menigitidis; n meningitidis; naa+probe; naat; nasba; nucleic acid sequence based analysis; ordinal; pcr; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; rs; screen; sda; spec; strand displacement amplification; tma; transcription mediated amplification; up; upper resp,Ord
91805-2,mycobacterium leprae dna [presence] in upper respiratory specimen by naa with probe detection,m leprae dna upper resp ql naa+probe,mycobacterium leprae dna naa+probe ql (upper resp),3 self-sustaining sequence replication; 3sr sr; acid fast; acid fast bacilli; acid fast bacillus; afb; amplif; amplification; amplified; breathing; deoxyribonucleic acid; dna nucleic acid probe; dna probe; hansen disease; lat; lcr; ligase chain reaction; ligation-activated transcription; lungs; microbiology; myco; mycobact; naa+probe; naat; nasba; nucleic acid sequence based analysis; ordinal; pcr; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; rs; screen; sda; spec; strand displacement amplification; tma; transcription mediated amplification; tuberculosis; up; upper resp,Ord
91809-4,human metapneumovirus rna [presence] in upper respiratory specimen by naa with probe detection,hmpv rna upper resp ql naa+probe,hmpv rna naa+probe ql (upper resp),3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; breathing; dna nucleic acid probe; dna probe; hmpv; lat; lcr; ligase chain reaction; ligation-activated transcription; lungs; microbiology; naa+probe; naat; nasba; nucleic acid sequence based analysis; ordinal; pcr; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; ribonucleic acid; rs; screen; sda; spec; strand displacement amplification; tma; transcription mediated amplification; up; upper resp,Ord
91814-4,bordetella sp ag [presence] in upper respiratory specimen by immunofluorescence,bordetella ag upper resp ql if,bordetella sp ag if ql (upper resp),acif; anticomplement immunofluorescence; antigen; antigens; breathing; dfa; fa; fluorescent antibody; fluoresent; ifa; immune fluorescence; immunoflour; immunofluor; immunofluorescence; lungs; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; rs; screen; spec; species; spp; time resolved fluorescence; trf; up; upper resp,Ord
91818-5,bacteria identified in upper respiratory specimen by anaerobe culture,bacteria upper resp anaerobe cult,bacteria identified anaer cx nom (upper resp),anaero; anaerobe; anaerobe cult; bact; breathing; c&s; cult; cultures; identity or presence; lungs; microbiology; nominal; point in time; random; rs; spec; up; upper resp,Nom
91819-3,bacteria identified in upper respiratory specimen by aerobe culture,bacteria upper resp aerobe cult,bacteria identified aer cx nom (upper resp),aerobe; aerobe cult; aerobed; bact; breathing; c&s; cult; cultures; identity or presence; lungs; microbiology; nominal; point in time; random; rs; spec; up; upper resp,Nom
91827-6,mycoplasma hominis dna [presence] in lower respiratory specimen by naa with probe detection,m hominis dna lower resp ql naa+probe,m. hominis dna naa+probe ql (lower resp),3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; breathing; deoxyribonucleic acid; dna nucleic acid probe; dna probe; lat; lcr; ligase chain reaction; ligation-activated transcription; low; lower resp; lungs; m hominis; metamycoplasma hominis; microbiology; myco; mycoplas; mycoplasm; mycoplasmosis; mycoplsm; naa+probe; naat; nasba; nucleic acid sequence based analysis; ordinal; pcr; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; rs; screen; sda; spec; strand displacement amplification; tma; transcription mediated amplification,Ord
91835-9,herpes simplex virus 1 ag [presence] in lower respiratory specimen by immunofluorescence,hsv1 ag lower resp ql if,hsv 1 ag if ql (lower resp),acif; anticomplement immunofluorescence; antigen; antigens; breathing; dfa; fa; fluorescent antibody; fluoresent; herp splx; herpes simplex virus type 1; hsv; hsv1; i; ifa; immune fluorescence; immunoflour; immunofluor; immunofluorescence; low; lower resp; lungs; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; rs; screen; spec; time resolved fluorescence; trf,Ord
91855-7,human papilloma virus 16+18+31+33+35+39+45+51+52+56+58+59+68 dna [presence] in genital specimen by naa with probe detection,hpv i/h risk 1 dna genital ql naa+probe,hpv 16+18+31+33+35+39+45+51+52+56+58+59+68 dna naa+probe ql (genital specimen),3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; deoxyribonucleic acid; dna nucleic acid probe; dna probe; gen; genital tract; genital warts; hpv; hpv i/h risk 1; hpv ihr; hpv16; hpv16 and 18; hpv16+18; human papillomavirus; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; naa+probe; naat; nasba; nucleic acid sequence based analysis; ordinal; papilloma virus high risk; papilloma virus intermediate/high risk; pcr; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; screen; sda; strand displacement amplification; tma; transcription mediated amplification; urogenit; urogenital,Ord
91857-3,herpes simplex virus dna [presence] in genital specimen by naa with probe detection,hsv dna genital ql naa+probe,hsv dna naa+probe ql (genital specimen),3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; deoxyribonucleic acid; dna nucleic acid probe; dna probe; gen; genital tract; herp splx; hsv; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; naa+probe; naat; nasba; nucleic acid sequence based analysis; ordinal; pcr; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; screen; sda; strand displacement amplification; tma; transcription mediated amplification; urogenit; urogenital,Ord
91881-3,location of meeting,meeting location,,admin; location; meeting location; nominal; point in time; random,Nom
91896-1,mycoplasma pneumoniae ab [titer] in serum by agglutination,m pneumo ab titr ser aggl,m. pneumoniae ab aggl (s) [titer],abs; aby; agg; agglut; agglutination; antby; anti; antibodies; antibody; autoantibodies; autoantibody; dilution factor; dilution factor (titer); enzootic pneumonia; m pneumo; m pneumonia; m pneumoniae; microbiology; myco; myco pneu; mycoplas; mycoplasm; mycoplasmoides pneumoniae; mycoplasmosis; mycoplsm; pneu; pneum; pneumo; pneumon; pneumonia; point in time; random; serum; smqn; sr; titer; titered; titre; ttr,SemiQn
91900-1,parasite [presence] in blood by light microscopy,parasite bld ql smear,parasite lm ql (bld),blood; lm; micro; microbiology; micros; microscopic; ordinal; parasites; point in time; pr; ql; qual; qualitative; random; screen; wb; whole blood,Ord
91934-0,promis parent proxy fatigue - version 2.0 t-score,,,patient reported outcomes information system; point in time; promise; qnt; quan; quant; quantitative; random; survey; survey.promis; t prime; t-score,Qn
91936-5,promis pediatric item bank - pain behavior - version 1.0,,,pan; panel; panel.survey.promis; panl; patient reported outcomes information system; peds; pnl; promise; survey; survey.promis,-
91940-7,wheni was in pain i told people i couldn't do things with them in past 7 days [promis],,,finding; findings; last; ordinal; patient reported outcomes information system; promise; ql; qual; qualitative; screen; survey; survey.promis; t prime,Ord
91949-8,when i was in pain i pulled away if someone touched me where it hurt in past 7 days [promis],,,finding; findings; last; ordinal; patient reported outcomes information system; promise; ql; qual; qualitative; screen; survey; survey.promis,Ord
91950-6,when i was in pain i asked to see a doctor in past 7 days [promis],,,finding; findings; last; ordinal; patient reported outcomes information system; promise; ql; qual; qualitative; screen; survey; survey.promis,Ord
91954-8,when i was in pain i avoided lifting or carrying heavy things in past 7 days [promis],,,finding; findings; last; ordinal; patient reported outcomes information system; promise; ql; qual; qualitative; screen; survey; survey.promis,Ord
91966-2,when i was in pain i didn't let anyone touch me in past 7 days [promis],,,finding; findings; last; ordinal; patient reported outcomes information system; promise; ql; qual; qualitative; screen; survey; survey.promis; t prime,Ord
91976-1,when i was in pain i yelled for someone to help me in past 7 days [promis],,,finding; findings; last; ordinal; patient reported outcomes information system; promise; ql; qual; qualitative; screen; survey; survey.promis,Ord
91982-9,specific airway resistance measured/predicted by plethysmograph body box,specific airway resist meas/pred pleth,,airway resist; average; avg; bod; bodies; breathing; lungs; pulmonary; qnt; quan; quant; quantitative; raw; resist; resistanc; resistant; resistent; rs; spec; specific airway resist; sraw/predicted; studies; study; sutdies,Qn
91992-8,my child worried when he or she went to bed at night in past 7 days [promis.parentproxy],,,finding; findings; last; ordinal; patient reported outcomes information system; promise; ql; qual; qualitative; screen; survey; survey.promis,Ord
91998-5,my child worried when he or she was away from home in past 7 days [promis.parentproxy],,,finding; findings; last; ordinal; patient reported outcomes information system; promise; ql; qual; qualitative; screen; survey; survey.promis,Ord
92000-9,my child worried about what could happen to him or her in past 7 days [promis.parentproxy],,,finding; findings; last; ordinal; patient reported outcomes information system; promise; ql; qual; qualitative; screen; survey; survey.promis,Ord
9200-7,fluid output wound drain 1 hour,fluid output wound drain 1h,,1 hour; 1.0hr; 1hr; 60 min; 60 minutes; 60m; 60min; fld; flow; fluid output wound drain; io_output; io_output.timed.mole; qnt; quan; quant; quantitative; surg; volume rate; vrate,Qn
9201-5,fluid output wound drain 12 hour,fluid output wound drain 12h,,12 hours; 12hr; fld; flow; fluid output wound drain; io_output; io_output.timed.mole; qnt; quan; quant; quantitative; surg; volume rate; vrate,Qn
92024-9,plazomicin [mass/volume] in serum or plasma --trough,plazomicin trough serpl-mcnc,plazomicin trough [mass/vol],drug/toxicology; drugs; level; mass concentration; pl; plasma; plsm; point in time; pre; predose; pre-dose; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
92030-6,personnel supervisor address,personnel supervisor address,,address; admin; nominal; point in time; random,Nom
92035-5,personnel job experience,personnel job experience,,admin; finding; findings; nominal; occupation; point in time; random; work,Nom
92039-7,information communication technology name,ict name,,ict name; ident; identifier; nominal; point in time; random,Nom
92059-5,my child's palms were sweaty in past 7 days [promis.parentproxy],,,finding; findings; last; ordinal; patient reported outcomes information system; promise; ql; qual; qualitative; s prime; screen; survey; survey.promis,Ord
92068-6,my child's body shook in past 7 days [promis.parentproxy],,,bod; bodies; finding; findings; last; ordinal; patient reported outcomes information system; promise; ql; qual; qualitative; s prime; screen; survey; survey.promis,Ord
92071-0,my child's back hurt in past 7 days [promis.parentproxy],,,finding; findings; last; ordinal; patient reported outcomes information system; promise; ql; qual; qualitative; s prime; screen; survey; survey.promis,Ord
92082-7,"thinking about your child's life, my child is satisfied with his or her purpose in life [promis.parentproxy]",,,finding; findings; ordinal; patient reported outcomes information system; point in time; promise; ql; qual; qualitative; random; s prime; screen; survey; survey.promis,Ord
92087-6,"thinking about your child's life, my child thinks his or her life is filled with purpose [promis.parentproxy]",,,finding; findings; ordinal; patient reported outcomes information system; point in time; promise; ql; qual; qualitative; random; s prime; screen; survey; survey.promis,Ord
92095-9,"thinking about your child's life, my child's life is filled with important things [promis.parentproxy]",,,finding; findings; ordinal; patient reported outcomes information system; point in time; promise; ql; qual; qualitative; random; s prime; screen; survey; survey.promis,Ord
92101-5,"thinking about your child's life, my child has things he or she wants to accomplish in life [promis.parentproxy]",,,finding; findings; ordinal; patient reported outcomes information system; point in time; promise; ql; qual; qualitative; random; s prime; screen; survey; survey.promis,Ord
9210-6,deprecated fluid output.wound drain: vrat: 24h: surgical site: qn:,deprecatedfluid output.wound drain,,1 day; 24 hours; 24hr; fld; flow; fluid output wound drain; io_output; io_output.timed.mole; qnt; quan; quant; quantitative; surg; volume rate; vrate,Qn
92113-0,"thinking about your child's life, when bad things happen, my child expects them to get better [promis.parentproxy]",,,finding; findings; ordinal; patient reported outcomes information system; point in time; promise; ql; qual; qualitative; random; s prime; screen; survey; survey.promis,Ord
92119-7,"thinking about your child's life, my child expects to enjoy his or her future life [promis.parentproxy]",,,finding; findings; ordinal; patient reported outcomes information system; point in time; promise; ql; qual; qualitative; random; s prime; screen; survey; survey.promis,Ord
92122-1,"thinking about your child's life, my child expects to have a job in the future [promis.parentproxy]",,,finding; findings; occupation; ordinal; patient reported outcomes information system; point in time; promise; ql; qual; qualitative; random; s prime; screen; survey; survey.promis; work,Ord
92131-2,respiratory syncytial virus rna [presence] in respiratory system specimen by naa with probe detection,rsv rna resp ql naa+probe,rsv rna naa+probe ql (respiratory system specimen),3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; breathing; dna nucleic acid probe; dna probe; hrsv; lat; lcr; ligase chain reaction; ligation-activated transcription; lungs; microbiology; naa+probe; naat; nasba; nucleic acid sequence based analysis; ordinal; pcr; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; ribonucleic acid; rs; rsv; screen; sda; spec; strand displacement amplification; tma; transcription mediated amplification,Ord
92137-9,parainfluenza virus 4 rna [presence] in respiratory system specimen by naa with probe detection,hpiv4 rna resp ql naa+probe,parainfluenza virus 4 rna naa+probe ql (respiratory system specimen),3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; breathing; dna nucleic acid probe; dna probe; hpiv; hpiv4; human rubulavirus 4; lat; lcr; ligase chain reaction; ligation-activated transcription; lungs; microbiology; naa+probe; naat; nasba; nucleic acid sequence based analysis; ordinal; para; parainflu; pcr; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; ribonucleic acid; rs; screen; sda; spec; strand displacement amplification; tma; transcription mediated amplification,Ord
92146-0,human coronavirus 229e+nl63 rna [presence] in respiratory system specimen by naa with probe detection,hcov 229e+nl63 rna resp ql naa+probe,hcov 229e+nl63 rna naa+probe ql (respiratory system specimen),3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; breathing; corona virus; dna nucleic acid probe; dna probe; hcov; hcov 229e; hcov 229e+nl63; hcov 229e+nl63 rna; lat; lcr; ligase chain reaction; ligation-activated transcription; lungs; microbiology; naa+probe; naat; nasba; nucleic acid sequence based analysis; ordinal; pcr; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; ribonucleic acid; rs; screen; sda; spec; strand displacement amplification; tma; transcription mediated amplification,Ord
92158-5,how short of breath did you get walking (faster than your usual speed) for at least 1 mile (a little more than 1.5 km) without stopping over past 7 days [promis],,,finding; findings; i; last; ordinal; patient reported outcomes information system; promise; ql; qual; qualitative; screen; survey; survey.promis,Ord
92159-3,how short of breath did you get walking (faster than your usual speed) for 50 steps without stopping over past 7 days [promis],,,finding; findings; last; ordinal; patient reported outcomes information system; promise; ql; qual; qualitative; screen; survey; survey.promis,Ord
9216-3,output.stool [mass/time] 24 hour,output.stool 24h mrate,,1 day; 24 hours; 24hr; io_output; io_output.timed.mole; lgi; low; mass rate; mrate; qnt; quan; quant; quantitative,Qn
921-7,deprecated b variant nos ag [presence] on red blood cells from donor,deprecated b var nos ag rbc donr ql,b variant nos ag ql (rbc donor),antigen; antigens; b var nos; blood bank; donr; erythrocytes; ordinal; other; point in time; pr; ql; qual; qualitative; random; red blood cells; red blood corpusles; screen,Ord
92170-0,"how short of breath did you get moderate-intensity leisure activity (bicycling on level terrain, etc.) over past 7 days [promis]",,,activ; actvty; finding; findings; last; levels; levl; lv; lvl; movements; ordinal; patient reported outcomes information system; promise; ql; qual; qualitative; screen; survey; survey.promis,Ord
92189-0,date range for emergency response plan,date range for emerg response plan,,date range for emerg response plan; point in time; public health; publichealth; qnt; quan; quant; quantitative; random; rnge,Qn
92197-3,public health emergency budget [#] reporting period,ph emergency budget rptperiod,,admin; cnt; count; number; ph emergency budget; qnt; quan; quant; quantitative; report period,Qn
92209-6,smoking helps me reduce tension [promis],,,finding; findings; ordinal; patient reported outcomes information system; point in time; promise; ql; qual; qualitative; random; screen; survey; survey.promis,Ord
92211-2,smoking calms me down [promis],,,finding; findings; ordinal; patient reported outcomes information system; point in time; promise; ql; qual; qualitative; random; screen; survey; survey.promis,Ord
92236-9,lab observation result status,lab obs result status,lab observation result status nom,lab obs result status; lab orders; nominal; point in time; random; typ,Nom
92244-3,microorganism resistance mutation nucleic acid change type by molecular method,micro resist mut na change type islt/spm,microorganism resistance mutation nucleic acid change type molgen nom (islt/spec),acd; acids; antibiotic susceptibilities; exchange; islt; islt/spm; isol; micro resist mut na change; microorganism resist mut; microorganisms; molecular genetics; mut; mutations; nominal; org; organism; organisms; pcr; point in time; random; replace; resist; resistanc; resistant; resistent; spec; typ,Nom
9224-7,output.colostomy [mass/time] 1 hour,output.colostomy 1h mrate,,1 hour; 1.0hr; 1hr; 60 min; 60 minutes; 60m; 60min; io_output; io_output.timed.mole; lgi; low; mass rate; mrate; qnt; quan; quant; quantitative,Qn
92256-7,has infectious disease or illness,has infectious disease or illness,,dis; diseases; dz; finding; findings; h+p; h+p.hx; ordinal; p prime; point in time; ql; qual; qualitative; random; screen,Ord
92258-3,smoking makes my lungs hurt [promis],,,finding; findings; ordinal; patient reported outcomes information system; point in time; promise; ql; qual; qualitative; random; screen; survey; survey.promis,Ord
9226-2,output.colostomy [mass/time] 10 hour,output.colostomy 10h mrate,,10 hours; 10hr; io_output; io_output.timed.mole; lgi; low; mass rate; mrate; qnt; quan; quant; quantitative,Qn
92281-5,brand name of cigarettes smoked most often 30 days,brand name cigs smoked often 30d,,brand name cigs smoked often; h+p; h+p.hx; nominal; p prime; typ,Nom
92290-6,my cigarette smoking bothers others [promis],,,finding; findings; ordinal; patient reported outcomes information system; point in time; promise; ql; qual; qualitative; random; screen; smoke; smokes; smoking; survey; survey.promis; tobacco,Ord
92291-4,if i quit smoking my friends will respect me more [promis],,,finding; findings; ordinal; patient reported outcomes information system; point in time; promise; ql; qual; qualitative; random; screen; survey; survey.promis,Ord
92296-3,i feel embarrassed when i smoke [promis],,,finding; findings; ordinal; patient reported outcomes information system; point in time; promise; ql; qual; qualitative; random; screen; survey; survey.promis,Ord
92298-9,"when i'm really craving a cigarette, it feels like i'm in the grip of some unknown force that i cannot control [promis]",,,finding; findings; ordinal; patient reported outcomes information system; point in time; promise; ql; qual; qualitative; random; screen; smoke; smokes; smoking; survey; survey.promis; tobacco; tx,Ord
92300-3,"when i haven't been able to smoke for a few hours, the craving gets intolerable [promis]",,,finding; findings; ordinal; patient reported outcomes information system; point in time; promise; ql; qual; qualitative; random; screen; survey; survey.promis; t prime,Ord
92304-5,the idea of not having any cigarettes causes me stress [promis],,,finding; findings; ordinal; patient reported outcomes information system; point in time; promise; ql; qual; qualitative; random; screen; survey; survey.promis,Ord
92318-5,cravings for a cigarette make it difficult for me to quit [promis],,,finding; findings; ordinal; patient reported outcomes information system; point in time; promise; ql; qual; qualitative; random; screen; smoke; smokes; smoking; survey; survey.promis; tobacco,Ord
92327-6,i feel a bond with other smokers [promis],,,finding; findings; ordinal; othr; patient reported outcomes information system; point in time; promise; ql; qual; qualitative; random; screen; survey; survey.promis,Ord
92335-9,current level of confidence i can relax my body to reduce my anxiety [promis],,,bod; bodies; finding; findings; levels; levl; lv; lvl; ordinal; patient reported outcomes information system; point in time; promise; ql; qual; qualitative; random; screen; survey; survey.promis,Ord
92344-1,current level of confidence i can keep anxiety from becoming overwhelming [promis],,,finding; findings; levels; levl; lv; lvl; ordinal; patient reported outcomes information system; point in time; promise; ql; qual; qualitative; random; screen; survey; survey.promis,Ord
92345-8,current level of confidence i can hear about symptoms and side effects without getting discouraged [promis],,,finding; findings; levels; levl; lv; lvl; ordinal; patient reported outcomes information system; point in time; promise; ql; qual; qualitative; random; screen; survey; survey.promis; sx,Ord
9234-6,output.colostomy 24 hour,output.colostomy 24h,,1 day; 24 hours; 24hr; flow; io_output; io_output.timed.mole; lgi; low; qnt; quan; quant; quantitative; volume rate; vrate,Qn
92351-6,current level of confidence i can bounce back from disappointment [promis],,,finding; findings; levels; levl; lv; lvl; ordinal; patient reported outcomes information system; point in time; promise; ql; qual; qualitative; random; screen; survey; survey.promis,Ord
92352-4,current level of confidence i can avoid upsetting thoughts [promis],,,finding; findings; levels; levl; lv; lvl; ordinal; patient reported outcomes information system; point in time; promise; ql; qual; qualitative; random; screen; survey; survey.promis,Ord
92353-2,current level of confidence i can avoid feeling helpless [promis],,,finding; findings; levels; levl; lv; lvl; ordinal; patient reported outcomes information system; point in time; promise; ql; qual; qualitative; random; screen; survey; survey.promis,Ord
92368-0,current level of confidence i can prepare my own meals (for example: plan and cook full meals by myself) [promis],,,finding; findings; levels; levl; lv; lvl; ordinal; patient reported outcomes information system; point in time; promise; ql; qual; qualitative; random; screen; survey; survey.promis,Ord
92371-4,current level of confidence i can manage my clothes when i need to use the toilet [promis],,,finding; findings; levels; levl; lv; lvl; ordinal; patient reported outcomes information system; point in time; promise; ql; qual; qualitative; random; screen; survey; survey.promis,Ord
9240-3,output.ileostomy [mass/time] 24 hour,output.ileostomy 24h mrate,,1 day; 24 hours; 24hr; io_output; io_output.timed.mole; lgi; low; mass rate; mrate; qnt; quan; quant; quantitative,Qn
92407-6,current level of confidence i can talk to others about my condition without being embarrassed [promis],,,finding; findings; levels; levl; lv; lvl; ordinal; patient reported outcomes information system; point in time; promise; ql; qual; qualitative; random; screen; survey; survey.promis,Ord
92425-8,"current level of confidence i can use technology to help me manage my medication and treatments (for example: to get information, avoid side-effects, schedule reminders) [promis]",,,finding; findings; levels; levl; lv; lvl; ordinal; patient reported outcomes information system; point in time; promise; ql; qual; qualitative; random; screen; survey; survey.promis; tx; txs,Ord
92426-6,current level of confidence i can use my own judgment regarding treatment alternatives (including not having treatment) [promis],,,finding; findings; levels; levl; lv; lvl; ordinal; patient reported outcomes information system; point in time; promise; ql; qual; qualitative; random; screen; survey; survey.promis; tx,Ord
92427-4,current level of confidence i can travel to my local pharmacy to fill my prescriptions [promis],,,finding; findings; levels; levl; lv; lvl; ordinal; patient reported outcomes information system; point in time; promise; ql; qual; qualitative; random; screen; survey; survey.promis,Ord
92434-0,current level of confidence i can remember to refill my prescriptions before they run out [promis],,,finding; findings; levels; levl; lv; lvl; ordinal; patient reported outcomes information system; point in time; promise; ql; qual; qualitative; random; screen; survey; survey.promis,Ord
92435-7,current level of confidence i can manage my medication without help [promis],,,finding; findings; levels; levl; lv; lvl; ordinal; patient reported outcomes information system; point in time; promise; ql; qual; qualitative; random; screen; survey; survey.promis,Ord
92436-5,"current level of confidence i can list my medications, including the doses and schedule [promis]",,,finding; findings; levels; levl; lv; lvl; ordinal; patient reported outcomes information system; point in time; promise; ql; qual; qualitative; random; screen; survey; survey.promis,Ord
92441-5,current level of confidence i can find information to learn more about my treatment [promis],,,finding; findings; levels; levl; lv; lvl; ordinal; patient reported outcomes information system; point in time; promise; ql; qual; qualitative; random; screen; survey; survey.promis; tx,Ord
92470-4,current level of confidence i can keep my symptoms from interfering with my personal care [promis],,,finding; findings; levels; levl; lv; lvl; ordinal; patient reported outcomes information system; personal hygiene; point in time; promise; ql; qual; qualitative; random; screen; survey; survey.promis; sx,Ord
92476-1,current level of confidence i can control my symptoms by taking my medications [promis],,,finding; findings; levels; levl; lv; lvl; ordinal; patient reported outcomes information system; point in time; promise; ql; qual; qualitative; random; screen; survey; survey.promis; sx,Ord
92502-4,hemoglobin s inferred phenotype [presence] in blood or tissue by molecular genetics method,hemoglobin s inferred bld/t ql,hemoglobin s inferred molgen ql (bld/tiss),"bldbk.geno; blood; blood bank; haemoglobin; hb; hbs; hgb; hgb s; molecular genetics; ordinal; pcr; point in time; pr; ql; qual; qualitative; random; s prime; screen; sickle cell; sickle cell screen; sickle cells; sickledex; sicklequik; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",Ord
92512-3,co sup(a) ag inferred phenotype [presence] in blood or tissue by molecular genetics method,co sup(a) ag inferred bld/t ql,co sup(a) ag inferred phenotype molgen ql (bld/tiss),"bldbk.geno; blood; blood bank; co sup(a); co sup(a) ag inferred; co^a; colton blood group system; molecular genetics; ordinal; pcr; point in time; pr; ql; qual; qualitative; random; screen; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",Ord
92513-1,c ag inferred phenotype [presence] in blood or tissue by molecular genetics method,c ag inferred bld/t ql,c ag inferred phenotype molgen ql (bld/tiss),"bldbk.geno; blood; blood bank; molecular genetics; ordinal; pcr; point in time; pr; ql; qual; qualitative; random; rh; rh blood group system; screen; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",Ord
92515-6,number of cigarettes smoked in lifetime,# cigarettes smoked lifetime,,# cigarettes smoked; cnt; count; h+p; h+p.hx; no; num; number; p prime; qnt; quan; quant; quantitative,Qn
92523-0,m ag inferred phenotype [presence] in blood or tissue from donor by molecular genetics method,m ag inferred bld/t donr ql,m ag inferred phenotype molgen ql (bld/tiss donor),"bldbk.geno; blood; blood bank; donr; mnss blood group system; molecular genetics; ordinal; pcr; point in time; pr; ql; qual; qualitative; random; screen; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",Ord
92532-1,kp sup(b) ag inferred phenotype [presence] in blood or tissue from donor by molecular genetics method,kp sup(b) ag inferred bld/t donr ql,kp sup(b) ag inferred phenotype molgen ql (bld/tiss donor),"bldbk.geno; blood; blood bank; donr; k (little p) (little b); kell blood group system; kp sup(b); kp sup(b) ag inferred; kp^b; molecular genetics; ordinal; p; p prime; pcr; point in time; pr; ql; qual; qualitative; random; screen; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",Ord
9254-4,type of wound drain device,wound drain device class,,drn; nominal; point in time; random; typ; wnd,Nom
92550-3,co sup(a) ag inferred phenotype [presence] in blood or tissue from donor by molecular genetics method,co sup(a) ag inferred bld/t donr ql,co sup(a) ag inferred phenotype molgen ql (bld/tiss donor),"bldbk.geno; blood; blood bank; co sup(a); co sup(a) ag inferred; co^a; colton blood group system; donr; molecular genetics; ordinal; pcr; point in time; pr; ql; qual; qualitative; random; screen; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",Ord
92567-7,ct guidance for percutaneous drainage and placement of drainage catheter of unspecified body region,ct guided pc drn+cath place,,cat scan; cath; computed tomography; computerized tomography; ct scan; document; drain; exudate; finding; findings; guid; guide; guided; imaging; misc; miscellaneous; other; pc drainage; pc drn+cath place; perc; point in time; radiology; random; removal of fluid; spec; to be specified in another part of the message; unspecified,Doc
925-8,blood product disposition [type],bld prod disposition bpu,blood product disposition nom (bpu),blood bank; blood product unit; blood product unit (pack); nominal; point in time; random,Nom
92592-5,promis short form - self-efficacy for managing medications and treatments 8a - version 1.0,,,pan; panel; panel.survey.promis; panl; patient reported outcomes information system; pnl; point in time; promise; random; survey; survey.promis; tx; txs,-
92608-9,promis short form - physical function 10a - version 2.0 raw score,,,fcn; func; funct; patient reported outcomes information system; point in time; promise; qnt; quan; quant; quantitative; random; scale; survey; survey.promis,Qn
92625-3,promis short form - self-efficacy for managing daily activities 4a - version 1.0 raw score,,,patient reported outcomes information system; point in time; promise; qnt; quan; quant; quantitative; random; scale; survey; survey.promis,Qn
92649-3,naloxone [presence] in urine by confirmatory method,naloxone ur ql cfm,naloxone confirm ql (u),addiction; cfm; cnfr; cnfrm; conf; confirmation; confirmatory; drug/toxicology; drugs; drugs of abuse; gcms; illicit; lc/ms/ms; narcan; ordinal; point in time; potentialforabuse; pr; ql; qual; qualitative; random; screen; ua; ur; urn,Ord
92656-8,number of menstrual periods per year,# menstrual periods per y,,# menstrual periods per y; count/time; h+p; h+p.hx; no; nrate; num; number rate; number rate = count/time; p prime; point in time; qnt; quan; quant; quantitative; random,Qn
92662-6,current age or age at death of family member,current age or death age fam mem,,age @ death; current age or death age; fam mem; h+p; h+p.hx; p prime; point in time; qnt; quan; quant; quantitative; random,Qn
92674-1,csf3r gene exons 14 and 17 targeted mutation analysis in blood or tissue by molecular genetics method,csf3r gene exon 14+17 mut anl bld/t,csf3r gene exons 14 and 17 targeted mutation analysis molgen doc (bld/tiss),"blood; cd114; colony stimulating factor 3 receptor; csf3r gene exon 14+17; document; finding; findings; gcsfr; molecular genetics; molecular pathology; molpath; molpath.mutations; mut; mut anl; mutations; pcr; point in time; random; scn7; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",Doc
92675-8,msh2 gene deletion+duplication and full mutation analysis in blood or tissue by molecular genetics method,msh2 gene del+dup + full mut anl bld/t,msh2 gene del+dup and full mutation analysis molgen doc (bld/tiss),"amplification; bat-26; blood; coca1; colon cancer nonpolyposis type 1; del; del+dup; del+dup + full mut anl; deletions; document; dp; fcc1; finding; findings; full gene sequencing; full mut anl; hnpcc; hnpcc1; lcfs2; lynch syndrome; molecular genetics; molecular pathology; molpath; mut; mutations; muts homolog 2; pcr; point in time; random; sequencing of entire coding region; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",Doc
92689-9,entamoeba histolytica dna [presence] in stool by naa with probe detection,e histolyt dna stl ql naa+probe,e. histolytica dna naa+probe ql (stl),3 self-sustaining sequence replication; 3sr sr; ameba; amebiasis; amebic; amoeba; amplif; amplification; amplified; bowel movement; deoxyribonucleic acid; dna nucleic acid probe; dna probe; e histolyt; e histolytica; faecal; faeces; fecal; feces; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; naa+probe; naat; nasba; nucleic acid sequence based analysis; ordinal; pcr; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; screen; sda; stl; stool = fecal; strand displacement amplification; tma; transcription mediated amplification,Ord
92718-6,lipoprotein.broad beta.subparticle.small [moles/volume] in serum,idl small ser-scnc,idl small (s) [moles/vol],b; chemistry; idl small; ldl particle concentration; ldl particle number; level; lip; lipoprot; lipoproteins; lp; point in time; qnt; quan; quant; quantitative; random; serum; sr; substance concentration,Qn
92722-8,lipoprotein subparticle profile panel - serum,lipoprotein subparticle profile pnl ser,lipoprotein subparticle profile panel (s),chemistry; lip; lipoprot; lipoprotein subparticle profile pnl; lipoproteins; lp; pan; panel.chemistry; panl; pnl; point in time; prof; random; serum; sr,-
92726-9,17-hydroxyprogesterone [mass/volume] in dbs by lc/ms/ms,17ohp dbs lc/ms/ms-mcnc,17-hydroxyprogesterone lc/ms/ms (dbs) [mass/vol],"17-alpha-hydroxyprogesterone; 17-hydroxypregn-4-en-3,20-dione; 17-hydroxy-progest; 17-oh progesterone; 17ohp; 17-ohp; 17-p; blood; chemistry; dbs; dried blood spot; filter paper; fp; hydroxyproges; hydroxyprogstron; level; mass concentration; point in time; qnt; quan; quant; quantitative; random; wb; whole blood",Qn
92727-7,tacrolimus [auc] in blood,tacrolimus bld-auc,tacrolimus (bld) [auc],auc; blood; drug/toxicology; drugs; fk506; fk-506; fujimycin; hecoria; l04ad02; point in time; prograf; protopic; qnt; quan; quant; quantitative; random; wb; whole blood,Qn
92737-6,"7-alpha,12-alpha dihydroxycholest-4-en-3-one and 7-alpha hydroxy-4-cholesten-3-one panel - blood",ctx pnl bld,"7-alpha,12-alpha dihydroxycholest-4-en-3-one & 7-alpha hydroxy-4-cholesten-3-one panel (bld)","7a,12a-dihydroxy-4-cholesten-3-one; 7a12adiohchol4en3one; 7a-hydroxy-4-cholesten-3-one; 7-alpha,12-alpha-dihydroxycholest-4-en-3-one; 7alpha,12alpha-dihydroxycholest-4-en-3-one; 7a-oh-4-chol-3-one; 7-hydroxy-4-cholesten-3-one; alfa; blood; cerebrotendinous xanthomatosis panel; chemistry; ctx pnl; hydrox; iii; oh; pan; panel.chemistry; panl; pnl; point in time; random; wb; whole blood",-
92754-1,globotriaosylsphingosine [moles/volume] in dbs,globotriaosylsphingosine dbs-scnc,globotriaosylsphingosine (dbs) [moles/vol],blood; chemistry; dbs; dried blood spot; fabry disease; filter paper; fp; globotriaosyl lysosphingolipid; level; lgb3; lysogb3; lyso-gb3; point in time; qnt; quan; quant; quantitative; random; substance concentration; wb; whole blood,Qn
92756-6,"cholestane-3-beta, 5-alpha, 6-beta triol [moles/volume] in blood","chol-3b,5a,6b-triol bld-scnc","cholestane-3-beta, 5-alpha, 6-beta triol (bld) [moles/vol]","5-alpha,6-beta-dihydroxycholestanol; 5alpha,6beta-dihydroxycholestanol; alfa; b; blood; chemistry; chol-3b,5a,6b-triol; cholestane-3,5,6-triol; cholestane-3beta,5alpha,6beta-triol; cot; iii; level; point in time; qnt; quan; quant; quantitative; random; substance concentration; wb; whole blood",Qn
92759-0,"7-alpha,12-alpha dihydroxycholest-4-en-3-one [moles/volume] in blood",7a12adiohchol4en3one bld-scnc,"7-alpha,12-alpha dihydroxycholest-4-en-3-one (bld) [moles/vol]","7a,12a-dihydroxy-4-cholesten-3-one; 7a12adiohchol4en3one; 7-alpha,12-alpha-dihydroxycholest-4-en-3-one; 7alpha,12alpha-dihydroxycholest-4-en-3-one; alfa; blood; chemistry; iii; level; point in time; qnt; quan; quant; quantitative; random; substance concentration; wb; whole blood",Qn
92763-2,7-alpha hydroxy-4-cholesten-3-one [moles/volume] in dbs,7a-oh-4-chol-3-one dbs-scnc,7-alpha hydroxy-4-cholesten-3-one (dbs) [moles/vol],7a-hydroxy-4-cholesten-3-one; 7a-oh-4-chol-3-one; 7-hydroxy-4-cholesten-3-one; alfa; blood; chemistry; dbs; dried blood spot; filter paper; fp; hydrox; iii; level; oh; point in time; qnt; quan; quant; quantitative; random; substance concentration; wb; whole blood,Qn
92764-0,7-ketocholesterol [moles/volume] in serum or plasma,7-ketochol serpl-scnc,7-ketocholesterol [moles/vol],3-beta-hydroxycholest-5-en-7-one; 7-keto-cholesterol; 7-oxocholesterol; 7-oxo-cholesterol; chemistry; level; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; substance concentration,Qn
92780-6,listeria monocytogenes dna [presence] by naa with probe detection in positive blood culture,l monocytog dna bld pos ql naa+probe,l. monocytogenes dna naa+probe ql (pos bld culture),3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; bld pos; blood; deoxyribonucleic acid; dna nucleic acid probe; dna probe; l monocytog; l monocytogenes; lat; lcr; ligase chain reaction; ligation-activated transcription; listeriosis; microbiology; naa+probe; naat; nasba; nucleic acid sequence based analysis; ordinal; pcr; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; screen; sda; strand displacement amplification; tma; transcription mediated amplification; wb; whole blood,Ord
9278-3,breath rate special circumstances,breath rate special circumstances,,nominal; point in time; random; resp.atom; respiratory; typ,Nom
92784-8,enterococcus sp dna [presence] by naa with probe detection in positive blood culture,enterococ dna bld pos ql naa+probe,enterococcus sp dna naa+probe ql (pos bld culture),3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; bld pos; blood; deoxyribonucleic acid; dna nucleic acid probe; dna probe; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; naa+probe; naat; nasba; nucleic acid sequence based analysis; ordinal; pcr; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; screen; sda; species; spp; strand displacement amplification; tma; transcription mediated amplification; wb; whole blood,Ord
92799-6,candida parapsilosis dna [presence] by naa with probe detection in positive blood culture,c parap dna bld pos ql naa+probe,c. parapsilosis dna naa+probe ql (pos bld culture),3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; bld pos; blood; c parap; cand; candidiasis; deoxyribonucleic acid; dna nucleic acid probe; dna probe; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; naa+probe; naat; nasba; nucleic acid sequence based analysis; ordinal; pcr; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; screen; sda; strand displacement amplification; tma; transcription mediated amplification; wb; whole blood,Ord
92808-5,influenza virus a h3 rna [presence] in upper respiratory specimen by naa with probe detection,fluav h3 rna upper resp ql naa+probe,fluav h3 rna naa+probe ql (upper resp),3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; avian influenza; bird flu; breathing; dna nucleic acid probe; dna probe; flua; fluav; fluav h3; fluv; fowl plague; influ; influenza a; influenza a virus; lat; lcr; ligase chain reaction; ligation-activated transcription; lungs; microbiology; naa+probe; naat; nasba; nucleic acid sequence based analysis; ordinal; pcr; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; ribonucleic acid; rs; screen; sda; spec; strand displacement amplification; tma; transcription mediated amplification; up; upper resp,Ord
92824-2,source of population allelic frequency data,pop allelic freq data source,source of population allelic frequency data nom (population),molecular pathology; molpath; nominal; point in time; pop allelic freq data source; random; srce; typ,Nom
92827-5,mycobacterium tuberculosis complex species identified in specimen by sequencing,mtb complex sp spec seq,m. tuberculosis complex sp identified sequencing nom (specimen),acid fast; acid fast bacilli; acid fast bacillus; afb; compx; high-throughput sequencing; hts; identity or presence; m tb; m tb cmplx; m tuberculosis; microbiology; misc; miscellaneous; mtb; mtb complex sp; myco; mycobact; mycobacterium tuberculosum; next generation sequencing; ngs; nominal; other; point in time; random; tb; to be specified in another part of the message; tuberculosis; unspecified,Nom
9283-3,respiratory rate 12 hour maximum,resp rate 12h max,,12 hours; 12hr; breathing; count/time; lungs; maximum; nrate; number rate; number rate = count/time; qnt; quan; quant; quantitative; resp.timed.molec; respiratory rate; rs,Qn
92836-6,desmoplastic melanoma [identifier] in skin melanoma,desmoplastic melanoma mel,desmoplastic melanoma nom (skin melanoma),dermatologic; epidermis; identity or presence; integument; nominal; pathology; point in time; random; skn,Nom
92850-7,range of motion during assessment period [cms assessment] upper extremity,,,arm; centers for medicare and medicaid assessment; ext; finding; findings; ordinal; ql; qual; qualitative; report period; rnge; screen; survey; ue; up,Ord
92853-1,adenovirus and bocavirus dna panel - upper respiratory specimen by naa with probe detection,hadv + hbov dna pnl upper resp naa+probe,adenovirus and bocavirus dna panel naa+probe (upper resp),3 self-sustaining sequence replication; 3sr sr; adeno virus; amplif; amplification; amplified; breathing; deoxyribonucleic acid; dna nucleic acid probe; dna probe; hadv; hadv + hbov dna pnl; lat; lcr; ligase chain reaction; ligation-activated transcription; lungs; microbiology; naa+probe; naat; nasba; nucleic acid sequence based analysis; pan; panel.microbiology; panl; pcr; pnl; point in time; polymerase chain reaction; probe amp; probe with ampification; probe with target amplification; qbr; random; rs; sda; spec; strand displacement amplification; tma; transcription mediated amplification; up; upper resp,-
92885-3,rhinovirus+enterovirus rna [presence] in lower respiratory specimen by naa with probe detection,rv+ev rna lower resp ql naa+probe,rhinovirus+enterovirus rna naa+probe ql (lower resp),3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; breathing; dna nucleic acid probe; dna probe; entero virus; ev; ev-pcr; hrv; lat; lcr; ligase chain reaction; ligation-activated transcription; low; lower resp; lungs; microbiology; naa+probe; naat; nasba; nucleic acid sequence based analysis; ordinal; pcr; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; rhino virus; rhv; ribonucleic acid; rs; rv+ev; rv+ev rna; screen; sda; spec; strand displacement amplification; tma; transcription mediated amplification,Ord
92892-9,microbiology - parasitic studies,parasite studies,,doc.misc; document; finding; findings; misc; parasite studies; point in time; random,Doc
92897-8,aldosterone [mass/volume] in serum or plasma by immunoassay,aldost serpl ia-mcnc,aldosterone ia [mass/vol],chemistry; eia; elfa; elisa; enzyme immunoassay; iaa; level; mass concentration; meia; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; suds,Qn
92898-6,hepatitis b virus core ab and surface and little e ab and ag panel - serum or plasma,hbv core + surf + little e pnl serpl,hbv core ab and surface and little e ab and ag panel,anti-hbc; e; hbc; hbe; hbv; hbv core; hbv core + surf + little e pnl; hep; hep b; hep be; hepatis; hepatit; hepatitis bc; hepb; microbiology; pan; panel.microbiology; panl; pl; plasma; plsm; pnl; point in time; random; rh blood group system; serp; serpl; serplas; serum; serum or plasma; sr; surf,-
92913-3,immunology telehealth note,immunology telehealth note,,doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; notes; point in time; random; telemedicine; visit note,Doc
92916-6,ct guidance for aspiration of retroperitoneum,ct guided retroperitoneum asp,,abd; abd.reper; abdo; abdomen+; abdominal; asp; cat scan; computed tomography; computerized tomography; ct scan; document; finding; findings; guid; guide; guided; imaging; point in time; radiology; random; retroperitoneal,Doc
92923-2,ct guidance for aspiration of kidney,ct guided kidney asp,,abd; abdo; abdomen+; abdominal; asp; cat scan; computed tomography; computerized tomography; ct scan; document; finding; findings; guid; guide; guided; imaging; nephric; point in time; pyelogram; radiology; random; renal,Doc
92929-9,"measles, mumps and rubella virus igg panel [units/volume] - serum or plasma",mev + muv + rubv igg pnl serpl-acnc,"measles, mumps and rubella virus igg panel qn",arbitrary concentration; congenital rubella syndrome; german measles; immune globulin g; immunoglobulin g; mev + muv + rubv igg pnl; microbiology; mmr panel; pan; panel.microbiology; panl; pl; plasma; plsm; pnl; point in time; qnt; quan; quant; quantitative; random; rubv; serp; serpl; serplas; serum; serum or plasma; sr,Qn
92932-3,kif6 gene.c.2155t>c [genotype] in blood or tissue by molecular genetics method nominal,kif6 c.2155t>c geno bld/t,kif6 gene.c.2155t>c genotype molgen (bld/tiss),"blood; kif6 719arg; kif6 c.2155t&gt;c; kif6 trp719arg; molecular genetics; molecular pathology; molpath; molpath.mutations; nominal; pcr; point in time; random; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",Nom
92951-3,streptococcus agalactiae dna [ncncrange] in bronchoalveolar lavage by naa with non-probe detection,gp b strep dna bal naa+non-prb-ncncrng,s. agalactiae dna naa+non-probe (bal) [ncncrange],3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; bronchial alveolar lavage; bronchoalveolar lavage; deoxyribonucleic acid; dna nucleic acid probe; dna probe; gbs; gp b strep; group b; group b strep; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; naa+non-probe; naa+probe; naat; nasba; ncncrng; nucleic acid sequence based analysis; pcr; point in time; polymerase chain reaction; probe amp; probe with ampification; probe with target amplification; qbr; random; s agalactiae; sda; smqn; steptococcus group b; strand displacement amplification; strep; strep b; strep group b; strept; streptococci group b; tma; transcription mediated amplification,SemiQn
92956-2,rhinovirus+enterovirus rna [presence] in lower respiratory specimen by naa with non-probe detection,rv+ev rna lower resp ql naa+non-probe,rhinovirus+enterovirus rna naa+non-probe ql (lower resp),3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; breathing; dna nucleic acid probe; dna probe; entero virus; ev; ev-pcr; hrv; lat; lcr; ligase chain reaction; ligation-activated transcription; low; lower resp; lungs; microbiology; naa+non-probe; naa+probe; naat; nasba; nucleic acid sequence based analysis; ordinal; pcr; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; rhino virus; rhv; ribonucleic acid; rs; rv+ev; rv+ev rna; screen; sda; spec; strand displacement amplification; tma; transcription mediated amplification,Ord
92958-8,respiratory pathogens dna and rna panel - lower respiratory specimen by naa with non-probe detection,resp path dna+rna pnl l resp naa+non-prb,respiratory pathogens dna and rna panel naa+non-probe (lower resp),3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; breathing; deoxyribonucleic acid; dna nucleic acid probe; dna probe; lat; lcr; ligase chain reaction; ligation-activated transcription; low; lower resp; lungs; microbiology; naa+non-probe; naa+probe; naat; nasba; nucleic acid sequence based analysis; pan; panel.microbiology; panl; pcr; pnl; point in time; polymerase chain reaction; probe amp; probe with ampification; probe with target amplification; qbr; random; resp path dna+; resp path dna+rna; resp path dna+rna pnl; resp pathogens; respiratory bacteria & viruses; respiratory bacteria & viruses dna & rna; ribonucleic acid; rs; sda; spec; strand displacement amplification; tma; transcription mediated amplification,-
92977-8,influenza virus a rna [presence] in lower respiratory specimen by naa with non-probe detection,fluav rna lower resp ql naa+non-probe,fluav rna naa+non-probe ql (lower resp),3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; avian influenza; bird flu; breathing; dna nucleic acid probe; dna probe; flua; fluav; fluv; fowl plague; influ; influenza a; influenza a virus; lat; lcr; ligase chain reaction; ligation-activated transcription; low; lower resp; lungs; microbiology; naa+non-probe; naa+probe; naat; nasba; nucleic acid sequence based analysis; ordinal; pcr; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; ribonucleic acid; rs; screen; sda; spec; strand displacement amplification; tma; transcription mediated amplification,Ord
93015-6,gait and turn and tandem gait assessment,gait+turn+tandem gait,,gait+turn+tandem gait; neuro; ordinal; point in time; ql; qual; qualitative; random; scale; screen,Ord
9304-7,respiration rhythm,respiration rhythm,,breathing; breathing pattern; function; lungs; nominal; point in time; random; resp rhythm; resp.atom; respiratory pattern; rs,Nom
93054-5,"mds v3.0 - rai v1.17.2 - assessment administration - nd, sd during assessment period [cms assessment]",,,centers for medicare and medicaid assessment; pan; panel; panel.survey.cms; panl; pnl; report period; survey,-
9306-2,granulocytes/leukocytes in body fluid by manual count,granulocytes nfr fld manual,granulocytes/leukocytes manual cnt (body fld),"b/f; bf; bod; bodies; body fluid; body fluid, unsp; fl; fld; flu; fluid; gran; grans; granulocyte; granulocytes; hematology/cell counts; leuc; leuk; leukocyte; lkcs; manl; number fraction; percent; point in time; qnt; quan; quant; quantitative; random; wbc; wbcs; white blood cell; white blood cells",Qn
93068-5,"are you feeling bothered, upset, or worried at this point in your pregnancy about working or caring for your family during your pregnancy [nupdq]",,,finding; findings; gestation; gestations; gravida; ordinal; point in time; pregnancies; ql; qual; qualitative; random; screen; survey; survey.mtlhlth,Ord
93078-4,"are you feeling bothered, upset, or worried at this point in your pregnancy about changes in your relationships with other people due to having a baby [nupdq]",,,finding; findings; gestation; gestations; gravida; ordinal; othr; point in time; pregnancies; ql; qual; qualitative; random; screen; survey; survey.mtlhlth,Ord
9308-8,"2,4-dinitrophenylhydrazine reacting substances [presence] in urine",dnph ur ql,"2,4-dinitrophenylhydrazine reacting substances ql (u)",brady's reagent; chemistry; dnph; ii; ordinal; point in time; pr; ql; qual; qualitative; random; screen; ua; ur; urn,Ord
93088-3,quality of working life questionnaire for cancer survivors [quality of working life questionnaire for cancer survivors],,,4 weeks; pan; panel; panel.survey.gnhlth; panl; pnl; survey; survey.gnhlth,-
93095-8,"during the past 4 weeks, i am suited to my work [quality of working life questionnaire for cancer survivors]",,,4 weeks; finding; findings; job; last; occupation; ordinal; ql; qual; qualitative; screen; survey; survey.gnhlth,Ord
93100-6,"during the past 4 weeks, i am content with my work [quality of working life questionnaire for cancer survivors]",,,4 weeks; finding; findings; job; last; occupation; ordinal; ql; qual; qualitative; screen; survey; survey.gnhlth,Ord
9310-4,androstenedione [mass/time] in 24 hour urine,androst 24h ur-mrate,androstenedione (24h u) [mass/time],1 day; 24 hours; 24hr; chemistry; gamma-4-androstenedione; mass rate; mrate; qnt; quan; quant; quantitative; ua; ur; urn,Qn
93104-8,"during the past 4 weeks, i have good relations with my immediate superior [quality of working life questionnaire for cancer survivors]",,,4 weeks; finding; findings; last; ordinal; ql; qual; qualitative; screen; survey; survey.gnhlth,Ord
93109-7,"during the past 4 weeks, i am limited in my work [quality of working life questionnaire for cancer survivors]",,,4 weeks; finding; findings; job; last; lmted; ltd; occupation; ordinal; ql; qual; qualitative; screen; survey; survey.gnhlth,Ord
93116-2,understanding and recognition in your organization [quality of working life questionnaire for cancer survivors],,,4 weeks; pan; panel; panel.survey.gnhlth; panl; pnl; survey; survey.gnhlth,-
9312-0,aminocaproate [mass/volume] in serum or plasma,amicaproate serpl-mcnc,aminocaproate [mass/vol],amicaproate; amicar; aminocaproic acid; drug/toxicology; drugs; level; mass concentration; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
93120-4,left eye dark-mediated rod adaptation time,l eye dark rod adaptation tm,,dark rod adaptation tm; eye.px; eyeball; l; l eye; lt; occular; oculis; ophthalmologic; optic globe; point in time; qnt; quan; quant; quantitative; random; rod intercept (tm); vision; visual,Qn
93128-7,inpatient rehabilitation facility - patient assessment instrument (irf-pai) - version 4.0 during assessment period [cms assessment],,,centers for medicare and medicaid assessment; pan; panel; panel.survey.cms; panl; pnl; report period; survey,-
9314-6,western equine encephalitis virus ab [titer] in cerebral spinal fluid by immunofluorescence,weev ab titr csf if,weev ab if (csf) [titer],abs; aby; acif; antby; anti; antibodies; antibody; anticomplement immunofluorescence; autoantibodies; autoantibody; cerebral spinal fluid; cerebrospinal fl; dilution factor; dilution factor (titer); enc; enceph; encephalomyelitis; equin; fa; fluorescent antibody; fluoresent; id; ifa; immune fluorescence; immunoflour; immunofluor; immunofluorescence; infectious disease; infectiousdisease; microbiology; neuro; neurology; point in time; random; smqn; spinal fl; spinal fld; spinal flu; spinal fluid; time resolved fluorescence; titer; titered; titre; togavirus; trf; ttr; wee virus; weev; west,SemiQn
93148-5,xr ulna bone development stage,xr ulna bone dev stage,,arm; bone dev stage; ext; imaging; plain films; point in time; qnt; quan; quant; quantitative; radiology; random; scale; ue; up; upper extremity; xray; x-ray,Qn
93183-2,route of current reconciled medication list transmission to patient during assessment period [cms assessment],,,centers for medicare and medicaid assessment; finding; findings; nominal; reconciled med list; report period; survey,Nom
93189-9,xr wrist and hand total skeletal maturity score,xr wrist+hand total maturity score,,arm; carpal bone; carpal bones; carpal bones and joint; ext; imaging; plain films; point in time; qnt; quan; quant; quantitative; radiology; random; scale; tot; total maturity score; totl; ue; up; upper extremity; upper extremity joint; xray; x-ray,Qn
93193-1,tpmt gene and nudt15 gene targeted mutation analysis in blood or tissue by molecular genetics method,tpmt + nudt15 mut anl bld/t,tpmt gene and nudt15 gene targeted mutation analysis molgen doc (bld/tiss),"blood; document; finding; findings; molecular genetics; molecular pathology; molpath; molpath.pharmg; mut; mut anl; mutations; pcr; point in time; random; thiopurine s-methyltransferase; thiopurine s-methyltransferase gene; tissue; tissue, unspecified; tpmt + nudt15; wb; whole blood; whole blood or tissue",Doc
93195-6,nudt15 gene product metabolic activity interpretation in blood or tissue qualitative by molecular genetics method,nudt15 gene prod met act imp bld/t-imp,nudt15 gene product metabolic activity interpretation molgen ql (bld/tiss) [interp],"activ; actvty; blood; drug metabolism; gene prod met act imp; impression; impression/interpretation of study; impressions; interp; interpret; interpretation; interpt; intrp; molecular genetics; molecular pathology; molpath; molpath.pharmg; movements; nudt15 gene prod met act imp; ordinal; pcr; phenotype; point in time; ql; qual; qualitative; random; screen; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",Ord
93196-4,warfarin response genotype panel - blood or tissue by molecular genetics method,warfarin genotype pnl bld/t,warfarin response genotype panel molgen (bld/tiss),"4-hydroxycoumarin; blood; coumadin; coumarin; coumarins; molecular genetics; molecular pathology; molpath; molpath.pharmg; pan; panel.molpath; panel.molpath.pharmg; panl; panwarfin; pcr; pnl; point in time; random; sofarin; tissue; tissue, unspecified; warfarin genotype pnl; wb; whole blood; whole blood or tissue",-
93215-2,"lcds v5.00 - hearing, speech, and vision - admission during assessment period [cms assessment]",,,centers for medicare and medicaid assessment; pan; panel; panel.survey.cms; panl; pnl; report period; survey,-
93232-7,imipenem+relebactam [susceptibility] by gradient strip,imi+rel islt grad strip,imipenem+relebactam strip [susc],antibiotic susceptibilities; ast; epsilometer; estrip; e-strip; grad strip; imi+rel; imipeneum; imp; islt; isol; mic; minimum inhibitory concentration; point in time; primaxin; random; sus; suscept; susceptibilities; susceptibility; susceptibilty,OrdQn
93237-6,aptt.lupus sensitive.excess phospholipid actual/normal in platelet poor plasma by coagulation assay --post heparin neutralization,aptt-la confirm act/nor p hep neut ppp,aptt.lupus sensitive.excess phospholipid actual/normal post heparin neutralization coag (ppp) [relative time],act/nor; activated partial thromboplastin time; after; aptt; aptt with platelin ls; aptt-la; aptt-la confirm; aptt-la confirm actual; clot; clottable; coag; coagulation assay; control; exs; hep; hepar; heparin nt; heparn; lipid; little(a)ptt; neut; neutr; p hep neut; partial thromboplastin time; phoslpd; phospholipids; pl; plas; platelet poor plasma; point in time; pst; ptt; qnt; quan; quant; quantitative; random; rltm; surf; tilt tube,Qn
93249-1,"active suicidal ideation with some intent to act, without specific plan 1 month",,,1 month; 1 month (30 days); 30 days; finding; findings; ordinal; ql; qual; qualitative; screen; spec; survey; survey.cssrs,Ord
93275-6,date of most lethal suicide attempt,,,point in time; qnt; quan; quant; quantitative; random; survey; survey.cssrs,Qn
93282-2,potential lethality most recent suicide attempt [c-ssrs],,,finding; findings; ordinal; point in time; ql; qual; qualitative; random; screen; survey; survey.cssrs,Ord
93297-0,active suicidal ideation with any methods (not plan) without intent to act lifetime,,,finding; findings; ordinal; ql; qual; qualitative; screen; survey; survey.cssrs,Ord
93344-0,treatment to which genetic variant confers resistance [identifier] in blood or tissue nominal,variant assoc therapy resist,treatment to which genetic variant confers resistance nom (bld/tiss),"blood; genetics; genomic; identity or presence; molecular pathology; molpath; nominal; point in time; random; resist; resistanc; resistant; resistent; tissue; tissue, unspecified; tx; variant assoc tx resist; wb; whole blood; whole blood or tissue",Nom
93347-3,available treatment related to genetic variant and not to patient diagnosis [identifier] in blood or tissue nominal,avail tx for variant but not dx bld/t,available treatment related to genetic variant and not to patient diagnosis nom (bld/tiss),"avail tx for variant but not dx; blood; dx; genetics; genomic; identity or presence; molecular pathology; molpath; nominal; point in time; random; tissue; tissue, unspecified; tx; unrelated therapy; wb; whole blood; whole blood or tissue",Nom
93365-5,genetic variant prognostic significance [interpretation] in blood or tissue narrative,genetic variant prog sig bld/t-imp,genetic variant prognostic significance nar (bld/tiss) [interp],"blood; genetic variant prog sig; genetics; genomic; impression; impression/interpretation of study; impressions; interp; interpretation; molecular pathology; molpath; narrative; point in time; random; report; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",Nar
93371-3,von willebrand factor (vwf) cleaving protease activity [enzymatic activity/volume] in platelet poor plasma by chromogenic method,vwf cp act ppp chro-ccnc,vwf cleaving protease activity chromogenic method (ppp) [catalytic activity/vol],activ; actvty; adamts13; adamts-13; catalytic concentration; chromogenic assay; coagulation; enzy; enzymatic assay; fac; fact; fret; movements; plas; platelet poor plasma; point in time; pr; qnt; quan; quant; quantitative; random; ttp; von will; vonwillebrand; vwcp; vwf; vwf cp; vwf cp act; vwfcp; vwf-cp,Qn
93393-7,proteus sp dna [presence] by naa with probe detection in positive blood culture,proteus sp dna bld pos ql naa+probe,proteus sp dna naa+probe ql (pos bld culture),3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; bld pos; blood; deoxyribonucleic acid; dna nucleic acid probe; dna probe; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; naa+probe; naat; nasba; nucleic acid sequence based analysis; ordinal; pcr; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; screen; sda; species; spp; strand displacement amplification; tma; transcription mediated amplification; wb; whole blood,Ord
9340-1,apolipoprotein b/apolipoprotein a-i [percentile],apo b/apo a-i prctl serpl,apolipoprotein b/apolipoprotein a-i [%],apo; apo a; apo a-i; apo b; apoa1; apob; apolipo; apolipoprot; apolipoprotein a1; apolipoproteins; chemistry; percentile; pl; plasma; plsm; point in time; random; serp; serpl; serplas; serum; serum or plasma; smqn; sr,SemiQn
93413-3,mechanical circulatory support consultation note,mcs+consult note,,consult note; doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; mcs+consult note; notes; point in time; random; visit note,Doc
93416-6,deprecated inattention in last 3 days [cms assessment],,,3 days; centers for medicare and medicaid assessment; finding; findings; nominal; past; survey,Nom
9341-9,cerebroside sulfatase [mass/time] in 24 hour urine,arylsulfatase a 24h ur-mrate,cerebroside sulfatase (24h u) [mass/time],1 day; 24 hours; 24hr; aryl sulfatase a; arylsulfatase a; chemistry; mass rate; metachromatic leucodystrophy; mrate; qnt; quan; quant; quantitative; ua; ur; urn,Qn
93438-0,herpes simplex virus 2 dna [presence] in blood by naa with non-probe detection,hsv2 dna bld ql naa+non-probe,hsv 2 dna naa+non-probe ql (bld),3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; blood; deoxyribonucleic acid; dna nucleic acid probe; dna probe; herp splx; herpes simplex virus type 2; herpes simplex virus type ii; hsv; hsv2; ii; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; naa+non-probe; naa+probe; naat; nasba; nucleic acid sequence based analysis; ordinal; pcr; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; screen; sda; strand displacement amplification; tma; transcription mediated amplification; wb; whole blood,Ord
93441-4,home accessibility modification date,home access mod date,,clin; home access mod date; point in time; qnt; quan; quant; quantitative; random,Qn
93446-3,accessibility of home interior,access home int,,access home int; clin; finding; findings; nominal; point in time; random,Nom
93450-5,coagulation factor viii inhibitor [units/volume] in platelet poor plasma by chromogenic method,fact viii inhib ppp chro-acnc,coagulation factor viii inhibitor chromogenic method qn (ppp),ahf; ahg; antihemophilic factor; antihemophilic globulin; arbitrary concentration; chromogenic assay; circulating anticoagulant; coag; enzy; enzymatic assay; f8; fac; fact; fact viii; fact viii inhib; factor 8; factor viii clotting activity; fviii; inhib; inhibit; plas; platelet poor plasma; point in time; qnt; quan; quant; quantitative; random; thrombocyte cofactor a; viii:c,Qn
93451-3,nor-w-18+nor-w-15 [mass/volume] in urine by confirmatory method,nor-w-18+nor-w-15 ur cfm-mcnc,nor-w-18+nor-w-15 confirm (u) [mass/vol],4-chloro-n-(1-(4-nitrophenethyl)piperidin-2-ylidene)benzenesulfonamide; 4-chloro-n-[1-(2-phenylethyl)-2-piperidinylidene]-benzenesulfonamide; addiction; c19h20cln3o4s; c19h21cln2o2s; cfm; cnfr; cnfrm; conf; confirmation; confirmatory; drug/toxicology; drugs; drugs of abuse; gcms; illicit; lc/ms/ms; level; mass concentration; point in time; potentialforabuse; qnt; quan; quant; quantitative; random; synthetic opioid; ua; ur; urn,Qn
93476-0,busulfan [area under the curve] in plasma,busulfan plas-auc,busulfan (stdy p) [area under the curve],auc; drug/toxicology; drugs; myleran; pl; plasma; plsm; qnt; quan; quant; quantitative; studies; study; sutdies,Qn
93477-8,busulfan given [mass] of dose,busulfan gvn ?tm dose,busulfan given unsp time (dose) [mass],?tm; dose med or substance; drug doses; gvn; myleran; qnt; quan; quant; quantitative,Qn
93480-2,cortisol post crh stimulation panel - serum or plasma,cortisol p crh stimulation pnl serpl,cortisol post crh stimulation panel,17-hydroxycorticosterone; acth; acth rh; adrenocorticotrophic hormone; adrenocorticotropin; after; c206; c74; chemistry.challenge testing; compound f; coritsol; cort; corticotropin releasing factor; cortisol p crh stimulation pnl; cortrosyn; crf; crh; f; horm; hydrocortisone; pan; panel.challenge; panl; pl; plasma; plsm; pnl; point in time; pst; qnt; quan; quant; quantitative; random; rc206; serp; serpl; serplas; serum; serum or plasma; sr; stim; tumor marker,Qn
93488-5,guanidinoacetate [moles/volume] in dbs,guanidinoacetate dbs-scnc,guanidinoacetate (dbs) [moles/vol],blood; chemistry; dbs; dried blood spot; filter paper; fp; gaa; glycocyamine; guanidinoacetic acid; guanidoacetic acid; level; point in time; qnt; quan; quant; quantitative; random; substance concentration; wb; whole blood,Qn
9359-1,tacrine [mass/volume] in serum or plasma,tacrine serpl-mcnc,tacrine [mass/vol],cognex; drug/toxicology; drugs; level; mass concentration; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
93624-5,pulmonic valve pressure gradient.early diastole.max by us.doppler,pv pres grad.early dias.max dop,,card.us; cardiology; dias; dias.max; diast; diastoli; dop; duplex; echography; grad; largest; maximal; maximum; peak; point in time; pres grad.early dias.max; press grad; pv; pvg; qnt; quan; quant; quantitative; random; sonogram; sonograph; sonography; uls; ultrasound,Qn
93632-8,heart left ventricular outflow tract/aortic valve vti by us.doppler,hrt lvot/av vti dop,,av vti; card.us; cardiac; cardiology; dop; duplex; echography; hrt; l; length ratio; lt; lvot; lvot/av vti; point in time; qnt; quan; quant; quantitative; random; sonogram; sonograph; sonography; uls; ultrasound; vel,Qn
9363-3,bordetella pertussis igg ab [units/volume] in serum,b pert igg ser-acnc,b. pertussis igg qn (s),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; b pert; b pertussis; id; immune globulin g; immunoglobulin g; infectious disease; infectiousdisease; microbiology; pertussis; point in time; qnt; quan; quant; quantitative; random; serum; sr; whooping cough,Qn
93633-6,heart left ventricular outflow tract/maximum blood flow aortic valve by us.doppler,hrt lvot/aortic valve dop,,bld flow; bld flow vel; bld flow.velocity; card.us; cardiac; cardiology; dop; duplex; dynamic; echography; hrt; l; largest; lt; lvot; lvot/av vmax; maximal; maximum; peak; peak velocity; point in time; qnt; quan; quant; quantitative; random; sonogram; sonograph; sonography; uls; ultrasound; vel; velocity ratio; vmax,Qn
93644-3,left ventricular ejection fraction by us.2d.a2c+calc by single plane area-length method,lv ef a2c sp a-l,,2d us; a2c sp a-l; calculated; card.us; cardiac; cardiology; echography; ef; frac; fract; fractionation; fractions; hrt; hrt ventr; l; lt; lv; lvef; percent; point in time; qnt; quan; quant; quantitative; random; sonogram; sonograph; sonography; uls; ultrasound; ultrasound - 2-dimensional; ventricular; volfr; volume fraction,Qn
93645-0,left ventricular ejection fraction by us.2d.a4c+calc by single plane area-length method,lv ef a4c sp a-l,,2d us; a4c sp a-l; calculated; card.us; cardiac; cardiology; echography; ef; frac; fract; fractionation; fractions; hrt; hrt ventr; l; lt; lv; lvef; percent; point in time; qnt; quan; quant; quantitative; random; sonogram; sonograph; sonography; uls; ultrasound; ultrasound - 2-dimensional; ventricular; volfr; volume fraction,Qn
93655-9,left ventricular stroke volume by us.2d.a2c+calculated by single plane method of disks,lv sv a2c mod,,2d us; a2c mod; calculated; card.us; cardiac; cardiac output/heart beat; cardiology; echography; hrt; hrt ventr; l; lt; lv; point in time; qnt; quan; quant; quantitative; random; sonogram; sonograph; sonography; sv; uls; ultrasound; ultrasound - 2-dimensional; ventricular; vol; volume,Qn
9366-6,arsenic [mass/mass] in specimen,arsenic spec-mcnt,arsenic (specimen) [mass/mass],as; drug/toxicology; drugs; mass content; misc; miscellaneous; other; point in time; qnt; quan; quant; quantitative; random; spec; to be specified in another part of the message; unspecified,Qn
93670-8,do you have trouble paying for your gas or electricity bills [wellrx],,,finding; findings; gases; ordinal; point in time; ql; qual; qualitative; random; screen; sdoh; survey,Ord
93684-9,ammonia [moles/volume] in arterial blood,ammonia blda-scnc,ammonia (blda) [moles/vol],abg; amm; ammon; amon; art; art bld; art blood; arterial; arterial blood; blood arterial; chemistry; level; nh3; point in time; qnt; quan; quant; quantitative; random; substance concentration,Qn
93688-0,psychosine [moles/volume] in dbs,psychosine dbs-scnc,psychosine (dbs) [moles/vol],"1-beta-d-galactosphingosine; blood; chemistry; dbs; dried blood spot; filter paper; fp; galactosylsphingosine; globoid cell leukodystrophies; globoid cell leukodystrophy; krabbe disease; leukodystrophy, krabbe; level; point in time; psy; qnt; quan; quant; quantitative; random; sphingosine galactoside; substance concentration; wb; whole blood",Qn
93695-5,liver steatosis score in serum or plasma,liver steatosis score serpl,liver steatosis score [score],chemistry; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; scale; serp; serpl; serplas; serum; serum or plasma; sr,Qn
93713-6,epstein barr virus capsid igg ab [presence] in serum from donor by immunoassay,ebv vca igg ser donr ql ia,ebv capsid igg ia ql (s donor),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; cap; donr; ebv; ebv capsid ab; ebv vca; eia; elfa; elisa; enzyme immunoassay; epstn; hhv-4; human herpesvirus 4; iaa; immune globulin g; immunoglobulin g; meia; microbiology; mono; mononucleosis; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; sr; suds; vca; viral capsid,Ord
9372-4,cotinine [mass/volume] in specimen,cotinine spec-mcnc,cotinine (specimen) [mass/vol],drug/toxicology; drugs; level; mass concentration; misc; miscellaneous; nicotine metabolite; other; point in time; qnt; quan; quant; quantitative; random; spec; to be specified in another part of the message; unspecified,Qn
93746-6,protein catabolic rate based on 24 hour urine [calculated],protein catabolic rate 24h ur-mrate,protein catabolic rate (24h u) [mass/time],1 day; 24 hours; 24hr; chemistry; mass rate; mrate; pr; prot; qnt; quan; quant; quantitative; ua; ur; urn,Qn
93759-9,influenza virus a pb2 gene [nucleotide sequence] in isolate by sequencing,fluav pb2 gene islt-seq,fluav pb2 gene sequence nom (isol),avian influenza; bird flu; flua; fluav; fluav pb2 gene; fluv; fowl plague; high-throughput sequencing; hts; influ; influenza a; influenza a virus; islt; isol; microbiology; next generation sequencing; ngs; nominal; point in time; random,Nom
93760-7,influenza virus a pb1 gene [nucleotide sequence] in isolate by sequencing,fluav pb1 gene islt-seq,fluav pb1 gene sequence nom (isol),avian influenza; bird flu; flua; fluav; fluav pb1 gene; fluv; fowl plague; high-throughput sequencing; hts; influ; influenza a; influenza a virus; islt; isol; microbiology; next generation sequencing; ngs; nominal; point in time; random,Nom
93762-3,influenza virus a np gene [nucleotide sequence] in isolate by sequencing,fluav np gene islt-seq,fluav np gene sequence nom (isol),avian influenza; bird flu; flua; fluav; fluav np gene; fluv; fowl plague; high-throughput sequencing; hts; influ; influenza a; influenza a virus; islt; isol; microbiology; next generation sequencing; ngs; nominal; point in time; random,Nom
93769-8,choriogonadotropin.intact+beta subunit [mass/volume] in serum or plasma,hcg intact+b serpl-mcnc,hcg.intact+beta subunit [mass/vol],b; cg; chemistry; choriogonadotropins total; chorionic gonadotropin; chorionic gonadotropin.intact; hcg; hcg intact; hcg intact+b; human chorionic gonadotropin; level; mass concentration; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
93779-7,large b-cell lymphoma and cell of origin [type] in tissue,lg b-cell lymph+coo tiss,large b-cell lymphoma and cell of origin nom (tiss),"b cell; b-all; b-cell acute lymphoblastic leukemia; bcells; blym; lg b-cell lymph; lg b-cell lymph+coo; nominal; pathology; point in time; random; tissue; tissue, unspecified; typ",Nom
93804-3,chromosome 12 copy number/nucleus in tissue by fish,chr 12 copy num/nucleus entnum tiss fish,chr 12 copy num/nucleus fish (tiss) [entitic number],"chr 12 copy num; chromosom; chromosomes; entitic; entitic number; fluorescent in situ hybridization; molecular pathology; molpath; no; num; point in time; qnt; quan; quant; quantitative; random; tissue; tissue, unspecified",Qn
93811-8,f9 gene full mutation analysis in blood or tissue by sequencing,f9 gene full mut anl bld/t seq,f9 gene full mutation analysis sequencing doc (bld/tiss),"blood; christmas factor; coagulation factor 9 gene; coagulation factor ix; coagulation factor ix gene; document; finding; findings; fix; full gene sequencing; full mut anl; hemb; high-throughput sequencing; hts; molecular pathology; molpath; mut; mutations; next generation sequencing; ngs; p19; point in time; ptc; random; sequencing of entire coding region; thph8; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",Doc
9382-3,coproporphyrin [mass/time] in unspecified time stool,copro ?tm stl-mrate,coproporphyrin unsp time (stl) [mass/time],?tm; bowel movement; chemistry; copro; coproporph; coproporphyrins; faecal; faeces; fecal; feces; hematology; heme; mass rate; mrate; qnt; quan; quant; quantitative; stl; stool = fecal; tetracarboxyl porphyrin; tetracarboxylporphyrin; tetracarboxylporphyrins; tetracarboxyporphyrin,Qn
93824-1,calories burned in unspecified time --during cycling,calories burned dur cycle ?tm,,?tm; dur cycle; energy/time; power; qnt; quan; quant; quantitative,Qn
93834-0,coccidioides sp igm ab [units/volume] in cerebral spinal fluid by immunoassay,coccidioides igm csf ia-acnc,coccidioides sp igm ia qn (csf),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; cerebral spinal fluid; cerebrospinal fl; coccidiodes; eia; elfa; elisa; enzyme immunoassay; iaa; immune globulin m; immunoglobulin m; meia; microbiology; point in time; qnt; quan; quant; quantitative; random; san joaquin valley fever; species; spinal fl; spinal fld; spinal flu; spinal fluid; spp; suds; valley fever,Qn
93842-3,hoga1 gene full mutation analysis in blood or tissue by sequencing,hoga1 full mut anl bld/t seq,hoga1 gene full mutation analysis sequencing doc (bld/tiss),"4-hydroxy-2-oxoglutarate aldolase 1; blood; c10orf65; dhdps2; dhdpsl; dihydrodipicolinate synthase-like, mitochondrial; dihydrodipicolinate synthetase homolog 2; document; finding; findings; full gene sequencing; full mut anl; high-throughput sequencing; hts; molecular pathology; molpath; molpath.mutations; mut; mutations; next generation sequencing; ngs; point in time; random; sequencing of entire coding region; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",Doc
93847-2,aspergillus oryzae ige ab [units/volume] in serum,a. oryzae ige qn,a. oryzae ige qn (s),a oryzae ige; a. oryzae; abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; asperg; aspergil; aspergilis; aspergilla; aspergillin; aspergillosis; aspergils; aspergilus; autoantibodies; autoantibody; immune globulin e; immunoglobulin e; k87; point in time; qnt; quan; quant; quantitative; random; serum; sr,Qn
93889-4,methane/expired gas [volume fraction] in exhaled gas --15 minutes post dose carbohydrate,breath methane 15m p carb,methane/expired gas 15 min post dose carbohydrate (exhl gas) [volume fraction],15m p carb; after; breath; chemistry.challenge testing; exg; exhaled gas; exhaled gas (=breath); gases; p carb; p dose; percent; point in time; pst; qnt; quan; quant; quantitative; random; volfr; volume fraction,Qn
93899-3,psychiatry letter,psychiatric letter,,doc.ont; document; finding; findings; point in time; psychiatric; random,Doc
93910-8,fy3 ag [presence] on red blood cells,fy3 ag rbc ql,fy3 ag ql (rbc),antigen; antigens; blood bank; erythrocytes; fy3; fy3 ag; ordinal; point in time; pr; ql; qual; qualitative; random; red blood cells; red blood corpusles; screen,Ord
93914-0,blood group antigens panel - red blood cells,bld grp ag pnl rbc,blood group antigens panel (rbc),ag; bld grp ag pnl; blood bank; erythrocytes; pan; panel.bloodbank; panl; pnl; point in time; random; red blood cells; red blood corpusles,-
93919-9,little c ag [presence] on red blood cells --after transfusion reaction,little c ag p transf rx rbc ql,little c ag post transfusion reaction ql (rbc),after; antigen; antigens; blood bank; c; c ag^p transf rx; erythrocytes; little c ag^p transf rx; ordinal; p transf; p transf rx; point in time; pr; pst; ql; qual; qualitative; random; react; red blood cells; red blood corpusles; rh; rh blood group system; rxn; screen; transf react; tx,Ord
93930-6,d ag [presence] on red blood cells --post hematopoietic stem cell transplant,d ag p hsct rbc ql,d ag post hsct ql (rbc),after; antigen; antigens; blood bank; d ag^p stem trnsplt; dextro; erythrocytes; ordinal; p hsct; point in time; pr; pst; ql; qual; qualitative; random; red blood cells; red blood corpusles; rh; rhesus; screen,Ord
93942-1,k ag [presence] in cord red blood cells,k ag rbcco ql,k ag ql (cord rbc),antigen; antigens; blood bank; kel1; kell blood group system; ordinal; point in time; pr; ql; qual; qualitative; random; red blood cells cord; screen,Ord
93951-2,rh antigens and k ag panel - blood,rh ags+k ag pnl bld,rh antigens & k ag panel (bld),blood; blood bank; d phenotyping; d typing; kel1; kell blood group system; pan; panel.bloodbank; panl; pnl; point in time; random; rh ags+k ag pnl; rh phenotyping; rh typing; wb; whole blood,-
93952-0,metamyelocytes.neutrophilic/leukocytes in bone marrow by manual count,metamyelocytes.neut nfr mar manual,metamyelocytes.neutrophilic/leukocytes manual cnt (bm),bm; bon; bone marrow; hematology/cell counts; leuc; leuk; leukocyte; lkcs; manl; mar; marrow (bone); meta; metamyelo; metamyelocyte; metamyelocyte%; metas; minimal angle of resolution; minimum angle of resolution; number fraction; percent; point in time; qnt; quan; quant; quantitative; random; wbc; wbcs; white blood cell; white blood cells,Qn
93964-5,pharmacogenomics diagnostic study note,pharmacogenomics diag study note,,diag study note; doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; notes; point in time; random; study report; visit note,Doc
93971-0,elevation climbed [length/time] 24 hour,elevation climbed 24h lrate,,1 day; 24 hours; 24hr; elevation gain; elevation gained; h+p; h+p.hx; lrate; p prime; qnt; quan; quant; quantitative,Qn
93980-1,iothalamate [mass/volume] in serum or plasma,iothalamate serpl-mcnc,iothalamate [mass/vol],chemistry; level; mass concentration; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
93988-4,hydrogen/expired gas [volume fraction] in exhaled gas --post dose carbohydrate,breath h2 p carb,hydrogen/expired gas post dose carbohydrate (exhl gas) [volume fraction],after; breath; chemistry.challenge testing; exg; exhaled gas; exhaled gas (=breath); gases; h2; hyd; p carb; p dose; percent; point in time; pst; qnt; quan; quant; quantitative; random; volfr; volume fraction,Qn
93996-7,osmolality of serum or plasma--7 hours post fluid fast,osmolality p 7h ffst serpl,osmolality post 7 hr fluid fast [osmolality],after; chemistry.challenge testing; osmo; osmol; osmolality; osmolarity; p 7h ffst; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
93997-5,sodium [moles/volume] in serum or plasma --1 hour post dose vasopressin,sodium 1h p vaso serpl-scnc,sodium 1 hr post dose vasopressin [moles/vol],1 hour; 1.0hr; 1h p vaso; 60 min; 60 minutes; 60m; 60min; adh; adiuretin; after; antidiuretic hormone; arginine vasopressin hormone; avh; chemistry.challenge testing; level; na; na+; p dose; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; substance concentration; vp,Qn
93999-1,creatinine [mass/volume] in serum or plasma --1 hour post dose vasopressin,creat 1h p vaso serpl-mcnc,creatinine 1 hr post dose vasopressin [mass/vol],1 hour; 1.0hr; 1h p vaso; 60 min; 60 minutes; 60m; 60min; adh; adiuretin; after; antidiuretic hormone; arginine vasopressin hormone; avh; chemistry.challenge testing; cr; crea; creat; level; mass concentration; p dose; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; vp,Qn
9400-3,platinum [mass/volume] in specimen,platinum spec-mcnc,platinum (specimen) [mass/vol],drug/toxicology; drugs; level; mass concentration; misc; miscellaneous; other; point in time; pt; qnt; quan; quant; quantitative; random; spec; to be specified in another part of the message; unspecified,Qn
9401-1,silicon [mass/volume] in specimen,silicon spec-mcnc,silicon (specimen) [mass/vol],drug/toxicology; drugs; level; mass concentration; misc; miscellaneous; other; point in time; qnt; quan; quant; quantitative; random; si; spec; to be specified in another part of the message; unspecified,Qn
94011-4,anion gap 3 in serum or plasma --2 hours post dose vasopressin,anion gap3 2h p vaso serpl-scnc,anion gap 3 2 hr post dose vasopressin [moles/vol],120 min; 120 minutes; 120min; 2 hours; 2h p vaso; adh; adiuretin; after; ag; angap; anion gap3; antidiuretic hormone; arginine vasopressin hormone; avh; chemistry.challenge testing; iii; level; p dose; pl; plasma; plsm; point in time; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; substance concentration; vp,Qn
94030-4,substance use disorder severity,sud severity,,h+p; h+p.hx; impression; impression/interpretation of study; impressions; interp; interpretation; ordinal; p prime; point in time; ql; qual; qualitative; random; screen; subs; sud severity,Ord
94036-1,suicide risk factor,suicide risk factor,,fac; fact; finding; findings; h+p; h+p.hx; nominal; p prime; point in time; random,Nom
94040-3,adenovirus a+b+c+d+e dna [presence] in respiratory system specimen by naa with probe detection,hadv a+b+c+d+e dna resp ql naa+probe,adenovirus a+b+c+d+e dna naa+probe ql (respiratory system specimen),"3 self-sustaining sequence replication; 3sr sr; a,b; adeno virus; amplif; amplification; amplified; breathing; deoxyribonucleic acid; dextro; dna nucleic acid probe; dna probe; hadv; hadv a+b+c+d+e; lat; lcr; ligase chain reaction; ligation-activated transcription; lungs; microbiology; naa+probe; naat; nasba; nucleic acid sequence based analysis; ordinal; pcr; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; rs; screen; sda; spec; strand displacement amplification; tma; transcription mediated amplification",Ord
94061-9,bacterial gidb gene drug resistance mutation [identifier] by molecular method,bacterial gidb drug res mut islt/spm,bacterial gidb gene drug resistance mutation molgen nom (islt/spec),antibiotic susceptibilities; bact; bacterial gidb drug res mut; drugs; identity or presence; islt; islt/spm; isol; molecular genetics; mut; mutations; nominal; pcr; point in time; random; resist; resistanc; resistant; resistent; spec,Nom
94066-8,person-centered primary care measure [pcpcm],,,pan; panel; panel.survey.gnhlth; panl; persons; pnl; point in time; random; sdoh; survey; survey.gnhlth,-
94080-9,rrm2b gene mutations found [identifier] in blood or tissue by sequencing nominal,rrm2b full mut anl bld/t seq,rrm2b gene full mutation analysis sequencing nom (bld/tiss),"blood; full gene sequencing; full mut anl; high-throughput sequencing; hts; identity or presence; mitochondrial encephalomyopathy; mitochondrial neurogastrointestinal encephalopathy; mngie syndrome; molecular pathology; molpath; molpath.mutations; mut; mutations; next generation sequencing; ngs; nominal; p53r2; point in time; random; ribonucleotide reductase m2 b (tp53 inducible); ribonucleotide reductase regulatory tp53 inducible subunit m2b; sequencing of entire coding region; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",Nom
94086-6,wound shape,wnd shape,,h+p; h+p.px; nominal; p prime; point in time; random; wnd; wnd shape,Nom
94094-0,rfa unspecified body region limited views for therapy or embolization or infusion w contrast via existing catheter,rfa vs ltd w contr via exist cath,,c; cath; contr; contra; contrst; document; films; finding; findings; fluor; fluoro; fluoroscopy; imaging; lmted; ltd; lvs thpy or emb or inf^w c v ex cath; misc; miscellaneous; other; point in time; radiology; random; rfa; spec; to be specified in another part of the message; unspecified; view; views ltd; vs ltd; vws; w contr via exist cath; wc,Doc
94101-3,hantavirus seoul igg ab [presence] in serum or plasma by line blot,h seoul igg serpl ql line blot,hantavirus seoul igg line blot ql,abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; h seoul; hanta virus; hemorrhagic fever with renal syndrome; hfrs; hps; htnv; immune globulin g; immunoglobulin g; microbiology; ordinal; orthohantavirus; pl; plasma; plsm; point in time; pr; ql; qual; qualitative; random; screen; seoul orthohantavirus; serp; serpl; serplas; serum; serum or plasma; snv; sr,Ord
94108-8,1-hydroxymidazolam [presence] in urine by screen method,1oh-midazolam ur ql scn,1-hydroxymidazolam screen ql (u),1-hydroxy midazolam; 1oh-midazolam; alpha hydroxymidazolam; alpha-hydroxymidazolam; chlonazepam metabolite; drug/toxicology; drugs; i; ordinal; point in time; pr; ql; qual; qualitative; random; scn; scr; screen; scrn; ua; ur; urn,Ord
94109-6,lorazepam glucuronide [presence] in urine by screen method,lorazepam glucuronide ur ql scn,lorazepam glucuronide screen ql (u),ativan; drug/toxicology; drugs; gluc; glucouronide; lorazepam metabolite; ordinal; point in time; pr; ql; qual; qualitative; random; scn; scr; screen; scrn; ua; ur; urn,Ord
94134-4,personnel funeral service licensee or other agent assuming custody of the body of the deceased,personnel funeral service licensee,,admin; bod; bodies; nominal; othr; person name; point in time; random,Nom
9413-6,deprecated lipids [mass/time] in 24 hour stool,deprecated lipids 24h stl-mrate,lipids (24h stl) [mass/time],1 day; 24 hours; 24hr; bowel movement; chemistry; faecal; faeces; fecal; feces; lip; lipid; mass rate; mrate; qnt; quan; quant; quantitative; stl; stool = fecal,Qn
94136-9,controlled substance agreement,cntrl substance agreement,,cntrl substance agreement; contract; doc.ont; document; finding; findings; point in time; random; subs,Doc
94138-5,hedis 2020 value set - bmi,hedis 2020 bmi,hedis 2020 value set - bmi,hedis 2020 bmi; pan; panel; panel.hedis; panl; pnl; point in time; random,-
94142-7,hedis 2020 value set - urine protein tests,hedis 2020 urine prot tests,hedis 2020 value set - urine protein tests,hedis 2020 urine prot tests; pan; panel; panel.hedis; panl; pnl; point in time; pr; prot; random,-
94166-6,promis parent proxy short form - mobility 8 - version 1.0,,,pan; panel; panel.survey.promis; panl; patient reported outcomes information system; pnl; promise; survey; survey.promis,-
94185-6,borrelia miyamotoi glpq gene [presence] in specimen by naa with probe detection,b miyamotoi glpq spec ql naa+probe,b. miyamotoi glpq gene naa+probe ql (specimen),3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; b miyamotoi; b miyamotoi glpq; dna nucleic acid probe; dna probe; id; infectious disease; infectiousdisease; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; misc; miscellaneous; naa+probe; naat; nasba; nucleic acid sequence based analysis; ordinal; other; pcr; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; screen; sda; spec; strand displacement amplification; tbrf; tick borne diseases; tick-borne relapsing fever; tma; to be specified in another part of the message; transcription mediated amplification; unspecified,Ord
94201-1,gnptab gene full mutation analysis in blood or tissue by sequencing,gnptab full mut anl bld/t seq,gnptab gene full mutation analysis sequencing doc (bld/tiss),"blood; document; finding; findings; full gene sequencing; full mut anl; genetics; gnpta; heredity; heritable; high-throughput sequencing; hts; icd; inherited; molecular pathology; molpath; mut; mutations; n-acetylglucosamine-1-phosphate transferase subunits alpha and beta; next generation sequencing; ngs; point in time; random; sequencing of entire coding region; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",Doc
94206-0,mmachc gene full mutation analysis in blood or tissue by sequencing,mmachc full mut anl bld/t seq,mmachc gene full mutation analysis sequencing doc (bld/tiss),"blood; document; finding; findings; full gene sequencing; full mut anl; genetics; heredity; heritable; high-throughput sequencing; hts; inherited; metabolism of cobalamin associated c; molecular pathology; molpath; mut; mutations; next generation sequencing; ngs; point in time; random; sequencing of entire coding region; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",Doc
94278-9,cat recombinant (rfel d) 7 ige ab [units/volume] in serum,cat (rfel d) 7 ige qn,cat recombinant (rfel d) 7 ige qn (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; cat (rfel d) 7; dextro; e231; feline; felis domesticus; immune globulin e; immunoglobulin e; point in time; qnt; quan; quant; quantitative; random; serum; sr,Qn
94279-7,deprecated honey bee acid phosphatase recombinant (rapi m) 3 ige ab rast class [presence] in serum,deprecated honey bee (rapi m) 3 ige rast ql,honey bee acid phosphatase recombinant (rapi m) 3 ige rast class (s),abs; aby; ac phos; acd; acid phosphatase.total; acids; acp; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; honey bee; honey bee (rapi m) 3; honeybee; i001; i1; i215; ige rast; iii; immune globulin e; immunoglobulin e; ordinal; phos; phosphtase; point in time; pr; ql; qual; qualitative; random; screen; serum; sr,Ord
94281-3,deprecated dog recombinant 6 ige ab rast class [presence] in serum,deprecated dog (rcan f) 6 ige rast ql,dog recombinant 6 ige rast class (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; canine; dog (rcan f) 6; e230; ige rast; immune globulin e; immunoglobulin e; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; sr,Ord
94282-1,deprecated cat recombinant (rfel d) 7 ige ab rast class [presence] in serum,deprecated cat (rfel d) 7 ige rast ql,cat recombinant (rfel d) 7 ige rast class (s),abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; cat (rfel d) 7; dextro; e231; feline; felis domesticus; ige rast; immune globulin e; immunoglobulin e; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serum; sr,Ord
9428-4,benzodiazepines [mass/volume] in urine,benzodiaz ur-mcnc,benzodiazepines (u) [mass/vol],benz; benzodiaz; benzodiazepine; drug/toxicology; drugs; level; mass concentration; point in time; qnt; quan; quant; quantitative; random; ua; universallaborders; ur; urn,Qn
9430-0,isobutylcarbinol [mass/volume] in blood,isobutylcarbinol bld-mcnc,isobutylcarbinol (bld) [mass/vol],blood; drug/toxicology; drugs; isoamyl alcohol; isopentanol; isopentyl alcohol; level; mass concentration; point in time; qnt; quan; quant; quantitative; random; wb; whole blood,Qn
94328-2,patient health questionnaire 8 item (phq-8) total score [reported],,,patient health questionnaire; phq; phq-8; phq-8 total score; point in time; qnt; quan; quant; quantitative; random; scale; survey; survey.phq; tot; totl,Qn
9433-4,isoflurane [mass/volume] in blood,isofl bld-mcnc,isoflurane (bld) [mass/vol],blood; drug/toxicology; drugs; level; mass concentration; point in time; qnt; quan; quant; quantitative; random; wb; whole blood,Qn
94360-5,glial fibrillary acidic protein alpha subunit igg ab [presence] in cerebral spinal fluid by immunofluorescence,gfap alpha igg csf ql if,glial fibrillary acidic protein alpha subunit igg if ql (csf),abs; aby; acif; alfa; antby; anti; antibodies; antibody; anticomplement immunofluorescence; autoantibodies; autoantibody; cerebral spinal fluid; cerebrospinal fl; fa; fluorescent antibody; fluoresent; gfap; gfap alpha; ifa; immune fluorescence; immune globulin g; immunoflour; immunofluor; immunofluorescence; immunoglobulin g; neuro; neurology; ordinal; pituitary glycoproteins; point in time; pr; prot; ql; qual; qualitative; random; screen; serology; spinal fl; spinal fld; spinal flu; spinal fluid; stroke; tbi (traumatic brain injury); time resolved fluorescence; traumatic brain injuries; trf,Ord
9438-3,morphine [presence] in gastric fluid,morphine gast ql,morphine ql (gast fld),addiction; c260; drug/toxicology; drugs; drugs of abuse; gast; gastric contents; gastric fluid; illicit; morphine sulfate; ms; mso4; omph; ordinal; point in time; potentialforabuse; pr; ql; qual; qualitative; random; screen,Ord
94390-2,neuronal nuclear type 1 igg ab [presence] in cerebral spinal fluid by line blot,hu1 igg csf ql line blot,neuronal nuclear type 1 igg line blot ql (csf),abs; aby; ana igg; anna 1; anna-1; antby; anti; antibodies; antibody; autoantibodies; autoantibody; cerebral spinal fluid; cerebrospinal fl; hu; hu1; i; immune globulin g; immunoglobulin g; neuronal nuclear type i; nuc; oncology; ordinal; paraneoplastic syndrome; point in time; pr; ql; qual; qualitative; random; screen; serology; spinal fl; spinal fld; spinal flu; spinal fluid,Ord
94419-9,candida auris [presence] in isolate by ms.maldi-tof,c auris islt ql ms.maldi-tof,c. auris ms.maldi-tof ql (isol),c auris; cand; candidiasis; id; infectious disease; infectiousdisease; islt; isol; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; screen,Ord
94448-8,hla-dp and dq and dr (class ii) igg intermediate risk [identifier] in serum or plasma by flow cytometry (fc),hla class ii ab.igg med risk serpl fc,hla-dp & dq & dr (class ii) ab.igg intermediate risk fc nom,2; dynamic; fc; genetics; heredity; heritable; hla antigen; hla class ii; hla class ii ab.igg med risk; hla-dp+dq+dr; hla-dp+dq+dr (class ii); human leukocyte antigen; identity or presence; immune globulin g; immunoglobulin g; inherited; nominal; pl; plasma; plsm; point in time; random; serp; serpl; serplas; serum; serum or plasma; sr,Nom
94466-0,solid organ transplant progress note,solid org transplant prog note,,doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; notes; point in time; prog note; random; solid org transplant; subsequent evaluation; subsequent visit evaluation; visit note,Doc
94481-9,human coronavirus nl63 rna [presence] in lower respiratory specimen by naa with non-probe detection,hcov nl63 rna low resp ql naa+non-probe,hcov nl63 rna naa+non-probe ql (lower resp),3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; breathing; corona virus; dna nucleic acid probe; dna probe; hcov; hcov nl63; id; infectious disease; infectiousdisease; lat; lcr; ligase chain reaction; ligation-activated transcription; low; lower resp; lung; lungs; microbiology; naa+non-probe; naa+probe; naat; nasba; nucleic acid sequence based analysis; ordinal; pcr; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; pulmonary; pulmonology; qbr; ql; qual; qualitative; random; respiratory; ribonucleic acid; rs; screen; sda; spec; strand displacement amplification; tma; transcription mediated amplification,Ord
94490-0,protoporphyrin fractions panel - red blood cells,protoporphyrin fract pnl rbc,protoporphyrin fractions panel (rbc),chemistry; dicarboxyl porphyrin; dicarboxylporphyrin; erythrocytes; frac; fract; fraction; fractionated; fractionation; hematology; heme; pan; panel.chemistry; panl; pnl; point in time; protoporph; protoporphrn; protoporphyrin fract pnl; protoporphyrins; qnt; quan; quant; quantitative; random; red blood cells; red blood corpusles,Qn
94497-5,packed erythrocytes [volume] of specimen,packed rbc vol spec,packed rbc (spec) [vol],discocytes; erthrocyte; erythrocyte; packed rbc; point in time; prbc; qnt; quan; quant; quantitative; random; rbc; rbcs; red blood cell; red blood cells; red blood corpuscle; red blood corpusles; red cell; red cells; spec; volume,Qn
94499-1,respiratory viral pathogens dna and rna panel - respiratory system specimen qualitative by naa with probe detection,resp viral path dna+rna pnl resp naa+prb,respiratory viral pathogens dna and rna panel naa+probe ql (respiratory system specimen),3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; breathing; deoxyribonucleic acid; dna nucleic acid probe; dna probe; id; infectious disease; infectiousdisease; lat; lcr; ligase chain reaction; ligation-activated transcription; lung; lungs; microbiology; naa+probe; naat; nasba; nucleic acid sequence based analysis; ordinal; pan; panel.microbiology; panl; pcr; pnl; point in time; polymerase chain reaction; probe amp; probe with ampification; probe with target amplification; pulmonary; pulmonology; qbr; ql; qual; qualitative; random; resp viral path dna+rna pnl; respiratory; ribonucleic acid; rs; screen; sda; spec; strand displacement amplification; tma; transcription mediated amplification,Ord
94525-3,infectious disease discharge summary,infectious disease d/c sum,,d/c sum; dis; disch; discharge summary; diseases; doc.ont; document; dz; encounter; evaluation and management; evaluation and management note; finding; findings; id; infectious disease; infectiousdisease; notes; point in time; random; visit note,Doc
94527-9,trauma discharge summary,trauma d/c sum,,d/c sum; disch; discharge summary; doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; notes; point in time; random; visit note,Doc
94531-1,sars-cov-2 (covid-19) rna panel - respiratory system specimen by naa with probe detection,sars-cov-2 rna pnl resp naa+probe,sars-cov-2 (covid-19) rna panel naa+probe (respiratory system specimen),2019 novel coronavirus; 2019-ncov; 3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; breathing; corona virus; covid19; covid-19; dna nucleic acid probe; dna probe; id; ii; infectious disease; infectiousdisease; lat; lcr; ligase chain reaction; ligation-activated transcription; lungs; microbiology; naa+probe; naat; nasba; nucleic acid sequence based analysis; pan; panel.microbiology; panl; pcr; pnl; point in time; polymerase chain reaction; probe amp; probe with ampification; probe with target amplification; qbr; random; ribonucleic acid; rs; sars coronavirus 1; sars-cov; sars-cov-1; sars-cov-2; sars-cov-2 rna pnl; sda; severe acute respiratory syndrome; spec; strand displacement amplification; tma; transcription mediated amplification; viral pneumonias; wuhan coronavirus,-
94551-9,hexacarboxylporphyrin iii [mass/time] in 24 hour stool,hexa-cpr3 24h stl-mrate,hexacarboxylporphyrin iii (24h stl) [mass/time],1 day; 24 hours; 24hr; 3; bowel movement; chemistry; faecal; faeces; fecal; feces; hematology; heme; hexacarbox; hexacarboxyl porphyrin; hexacarboxylporphyrins; hexacarboxyporphy; hexacarboxyporphyrin; hexa-cp; hexa-cpr3; hexaporphyrin; mass rate; mrate; qnt; quan; quant; quantitative; stl; stool = fecal,Qn
94557-6,drvvt in platelet poor plasma by coagulation assay --post doac neutralization,drvvt p doac neut ppp,drvvt post doac neutralization coag (ppp) [time],activated charcoal; after; clot; clottable; coag; coagulation assay; ddrvtvt; dil; dil russell vip ven; dilut; direct oral anticoagulants; doac remove; doac-stop; drvv; drvvt; hematology; heme; neut; neutr; p doac neut; plas; platelet poor plasma; point in time; pst; qnt; quan; quant; quantitative; random; rus; rvv; screening test for lupus anticoagulant; tilt tube,Qn
94560-0,diabetes risk [score] calculated,diabetes risk score calc,,calc; calculation; clin; clin.risk; endocrine; endocrinology; point in time; qnt; quan; quant; quantitative; random; scale,Qn
94577-4,maximum amplitude arachidonate induced [length] in blood by resonance teg,ma aa bld res teg,maximum amplitude aa induced resonance teg (bld) [length],"5,8,11,14 eicosatetraenoic acid; aa; arachidonic acid; arch acid; blood; c20:4w6; coagulation; eicosatetraenoate; hematology; heme; length; ma aa; point in time; qnt; quan; quant; quantitative; random; res teg; teg; thrombelastography; thrombelastometry; wb; whole blood",Qn
94602-0,west nile virus igm ab/positive control in serum by immunoassay,wnv igm/pos cntrl ser ia,west nile virus igm/positive control ia (s) [relative ratio],abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; eia; elfa; elisa; enzyme immunoassay; iaa; id; immune globulin m; immunoglobulin m; infectious disease; infectiousdisease; meia; microbiology; point in time; pos; pos cntrl; qnt; quan; quant; quantitative; random; relative ratio; serum; sr; suds; vet; veterinary; wnv,Qn
9460-7,deprecated streptococcus pneumoniae 6+26 igg ab [units/volume] in serum by immunoassay,deprecated s pneum6+26 igg ser ia-acnc,s. pneumoniae 6+26 igg ia qn (s),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; eia; elfa; elisa; enzyme immunoassay; iaa; id; immune globulin g; immunoglobulin g; infectious disease; infectiousdisease; meia; microbiology; pneu; pneum; pneumo; pneumococ; pneumococcal; pneumococcal pneumonia; pneumococcus; pneumon; pneumonia; point in time; qnt; quan; quant; quantitative; random; s pneum6; s pneum6+26; s pneumo; s pneumoniae; serum; spn; sr; strep; strept; streptococcus pneumoniae 6a; streptococcus pneumoniae 6a+6b; suds,Qn
9461-5,deprecated streptococcus pneumoniae 8 igg ab [units/volume] in serum by immunoassay,deprecated s pneum8 igg ser ia-acnc,s. pneumoniae 8 igg ia qn (s),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; eia; elfa; elisa; enzyme immunoassay; iaa; id; immune globulin g; immunoglobulin g; infectious disease; infectiousdisease; meia; microbiology; pneu; pneum; pneumo; pneumococ; pneumococcal; pneumococcal pneumonia; pneumococcus; pneumon; pneumonia; point in time; qnt; quan; quant; quantitative; random; s pneum8; s pneumo; s pneumoniae; serum; spn; sr; strep; strept; suds,Qn
94615-2,bovine herpesvirus 1 dna [cycle threshold #] in specimen by naa with probe detection,bohv1 dna ct spec qn naa+probe,bovine herpesvirus 1 dna naa+probe (specimen) [threshnum],3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; beef; bhv1; bohv; bohv1; bohv-1; bovine herpes virus; deoxyribonucleic acid; dna nucleic acid probe; dna probe; herpes virus; i; ibr; id; infectious bovine rhinotracheitis; infectious disease; infectious pustular vulvovaginitis; infectiousdisease; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; misc; miscellaneous; naa+probe; naat; nasba; nucleic acid sequence based analysis; other; pcr; point in time; polymerase chain reaction; probe amp; probe with ampification; probe with target amplification; qbr; qnt; quan; quant; quantitative; random; sda; spec; strand displacement amplification; tma; to be specified in another part of the message; transcription mediated amplification; unspecified; vet; veterinary,Qn
94663-2,coccidioides immitis igm ab [presence] in cerebral spinal fluid by immune diffusion (id),c immitis igm csf ql id,c. immitis igm immune diff ql (csf),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; b immitis; blastomycoides immitis; c esteriformis; c immitis; cerebral spinal fluid; cerebrospinal fl; coccidioides esteriformis; coccidiomycosis; coccio; g immite; g louisianoideum; g metaeuropea; geotrichum immite; glenospora metaeuropea; glenosporum louisianoideum; id; imm; immune globulin m; immunodiff; immunodiffusion; immunoglobulin m; imun; imune; infectious disease; infectiousdisease; microbiology; ordinal; p esteriformis; p mazzai; point in time; posadasia esteriformis; pr; pseudococcidioides mazzai; ql; qual; qualitative; random; san joaquin valley fever; screen; spinal fl; spinal fld; spinal flu; spinal fluid; t proteolyticum; trichosporon proteolyticum; valley fever,Ord
94677-2,"glomerular filtration rate [volume rate/area] in serum, plasma or blood by creatinine and cystatin c-based formula (ckd-epi)/1.73 sq m",gfr/bsa.pred serplbld creat+cyst ckd-epi,gfr creatinine and cystatin c-based formula (ckd-epi)/1.73 sq m (s/p/bld) [vol rate/area],"blood; chemistry; creat+cyst ckd-epi; gfr; glom; kidney; nephrology; pl; plasbld; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; renal; serp; serpl; serplas; serplbld; serum; serum or plasma; serum, plasma or whole blood; square meter; sr; volume rate/area; volume rate/ratio; wb; whole blood",Qn
94679-8,xr chest single view and abdomen supine and upright and lateral-decubitus,xr chest 1v + abd sup+upr+lat-decub,,1v; abd; abdo; abdomen+; abdominal; chest + abd; chest+abd; cxr; document; erect; film; films; finding; findings; imaging; lat; plain films; point in time; rad; radiology; random; single view; sup+upr; thorax; upr; uprt; view; view + sup+up; view + sup+up+lat-decub; view + views; views ap (kub & upright); vw; vws; xray; x-ray,Doc
94688-9,cta neck vessels and chest vessels wo and w contrast iv,cta neck+chest ves wo+w contr iv,,ang; angio; angiography; angm; c; cat scan; computed tomography; computerized tomography; contr; contra; contrst; ct angiogram; ct angiography; ct scan; cta; document; finding; findings; imaging; neck+chest ves; point in time; rad; radiology; random; thorax; vesl; vessels.xxx; w contr iv; wc; wo & wc; wo+w contr; wo+w contr iv; wwo,Doc
94689-7,cd20 cells/cells.cd19 in blood,cd20 cells/cells.cd19 nfr bld,cd20 cells/cells.cd19 (bld),b cells expressing cd19 as a percent of total lymphocytes; b1; b-1; b4; b-4; blood; bp35; cd19 cells; cd20 cells; cell; cell markers; cells.cd20+; cells.cd20+/cells.cd19+; cellularity; hd-37; hematology; heme; leu12; leu-12; leu16; leu-16; number fraction; percent; point in time; qnt; quan; quant; quantitative; random; wb; whole blood,Qn
94716-8,agtr1 gene c.1166a>c [genotype] in blood by molecular genetics method nominal,agtr1 c.1166a>c geno bld,agtr1 gene c.1166a>c genotype molgen (bld),agtr1 c.1166a&gt;c; blood; genetics; heredity; heritable; inherited; molecular genetics; molecular pathology; molpath; molpath.mutations; nominal; pcr; point in time; random; wb; whole blood,Nom
9472-2,heptachlor [mass/volume] in serum or plasma,heptachlor serpl-mcnc,heptachlor [mass/vol],chlordane metabolite; drug/toxicology; drugs; heptachlorane; level; mass concentration; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
94723-4,emergency department covid-19 initial evaluation form,ed covid-19 initial eval form,,2019 novel coronavirus; 2019-ncov; assessment; coronavirus disease 2019; covid19; covid-19 initial eval form; doc.ont; document; ed; eval; finding; findings; h&p; history and physical; point in time; random; sars coronavirus; sars-cov-2; sars-related coronavirus,Doc
94728-3,duloxetine [mass/volume] in saliva (oral fluid) by confirmatory method,duloxetine sal cfm-mcnc,duloxetine confirm (sal) [mass/vol],cfm; cnfr; cnfrm; conf; confirmation; confirmatory; cymbalta; drug/toxicology; drugs; gcms; lc/ms/ms; level; mass concentration; oral fluid; point in time; qnt; quan; quant; quantitative; random; sal; yentreve,Qn
94735-8,prostate tumor area with gleason pattern 4+5/total tumor area [area fraction] in prostate tumor by microscopy,gleason 4+5/total areafr prt micro,prostate tumor area with gleason pattern 4+5/total tumor area microscopy (prostate tumor) [area fraction],cancer; genitourinary; gleason 4+5; gleason 4+5/total; gu; micro; micros; microscopic; oncology; pathology; point in time; prost; prostatic; prt; qnt; quan; quant; quantitative; random; tot; totl; tumors; tumour; tumours; uro; urology,Qn
94748-1,medical aid in dying patient consent document,maid patient consent,,assisted suicide; death with dignity; doc.ont; document; end of life option; finding; findings; form; maid; maid patient; medical assistance in dying; medical assisted death; physician-assisted death; point in time; random,Doc
94756-4,sars-cov-2 (covid-19) n gene [presence] in respiratory system specimen by nucleic acid amplification using cdc primer-probe set n1,sars-cov-2 n gene resp ql naa n1,sars-cov-2 (covid-19) n gene naa+probe cdc primer-probe set n1 ql (respiratory system specimen),2019 novel coronavirus; 2019-ncov; 3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; breathing; centers for disease control and prevention; corona virus; covid19; covid-19; dna nucleic acid probe; dna probe; id; ii; infectious disease; infectiousdisease; lat; lcr; ligase chain reaction; ligation-activated transcription; lungs; microbiology; naa n1; naa+probe; naat; nasba; nucleic acid sequence based analysis; ordinal; pcr; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; rs; sars coronavirus 1; sars-cov; sars-cov-1; sars-cov-2; sars-cov-2 n gene; screen; sda; severe acute respiratory syndrome; spec; strand displacement amplification; tma; transcription mediated amplification; viral pneumonias; wuhan coronavirus,Ord
94764-8,sars-cov-2 (covid-19) whole genome [nucleotide sequence] in isolate or specimen by sequencing,sars-cov-2 genome islt/spm-seq,sars-cov-2 (covid-19) genome sequence nom (islt/spec),2019 novel coronavirus; 2019-ncov; corona virus; covid19; covid-19; high-throughput sequencing; hts; id; ii; infectious disease; infectiousdisease; islt; islt/spm; isol; microbiology; next generation sequencing; ngs; nominal; point in time; random; sars coronavirus 1; sars-cov; sars-cov-1; sars-cov-2; sars-cov-2 genome; severe acute respiratory syndrome; spec; viral pneumonias; wuhan coronavirus,Nom
94775-4,critical care medicine telehealth note,ccm telehealth note,,ccm; continuity assessment record and evaluation; doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; notes; point in time; random; telemedicine; visit note,Doc
94781-2,general medicine telehealth note,general medicine telehealth note,,doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; notes; point in time; random; telemedicine; visit note,Doc
94790-3,nutrition and dietetics telehealth note,nutr+diet telehealth note,,diet; dietetics; doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; notes; nutr+diet; nutrition; nutrition+dietetics; point in time; random; telemedicine; visit note,Doc
94799-4,radiation oncology telehealth note,radiation onc telehealth note,,cancer; doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; notes; oncology; point in time; random; telemedicine; visit note,Doc
94807-5,attending covid-19 intubation consultation note,attend covid-19 intub+consult,,2019 novel coronavirus; 2019-ncov; consult note; coronavirus disease 2019; covid19; covid-19 intub+consult; doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; notes; point in time; random; sars coronavirus; sars-cov-2; sars-related coronavirus; visit note,Doc
9481-3,ph of water,ph wat,ph (water),chemistry; log molar concentration; point in time; random; smqn; wat,SemiQn
94831-5,varicella zoster virus dna [units/volume] (viral load) in amniotic fluid by naa with probe detection,vzv dna amn naa+probe-acnc,vzv dna naa+probe qn (amn fld),3 self-sustaining sequence replication; 3sr sr; af; amn; amn fl; amnio; amniotic flu; amniotic fluid; amplif; amplification; amplified; arbitrary concentration; chicken pox; chicken pox virus; chickenpox; deoxyribonucleic acid; dna nucleic acid probe; dna probe; herpes zoster; hhv-3; human herpesvirus 3; id; infectious disease; infectiousdisease; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; naa+probe; naat; nasba; nucleic acid sequence based analysis; pcr; point in time; polymerase chain reaction; probe amp; probe with ampification; probe with target amplification; qbr; qnt; quan; quant; quantitative; random; sda; shingles; strand displacement amplification; tma; transcription mediated amplification; viral load; vz; vzv; zoster,Qn
94834-9,herpes simplex virus 1+2 dna [log #/volume] (viral load) in amniotic fluid by naa with probe detection,hsv1+2 dna amn naa+probe-log#,hsv 1+2 dna naa+probe (amn fld) [log #/vol],3 self-sustaining sequence replication; 3sr sr; af; amn; amn fl; amnio; amniotic flu; amniotic fluid; amplif; amplification; amplified; deoxyribonucleic acid; dna nucleic acid probe; dna probe; gyn; gynecology; herp splx; herpes simplex virus type 1; herpes simplex virus type 1+2; herpes simplex virus type i+ii; hsv; hsv 1+2; hsv1; hsv1+2; i; id; ii; infectious disease; infectiousdisease; lat; lcr; ligase chain reaction; ligation-activated transcription; log ncnc; log#; microbiology; naa+probe; naat; nasba; nucleic acid sequence based analysis; ob; obgyn; obstetrics; pcr; point in time; polymerase chain reaction; probe amp; probe with ampification; probe with target amplification; qbr; qnt; quan; quant; quantitative; random; sda; strand displacement amplification; tma; transcription mediated amplification; viral load,Qn
94841-4,potassium [moles/volume] in urine from fetus,potassium ur fetus-scnc,potassium (u fetus) [moles/vol],chemistry; fetal; k; k+; kidney; level; nephrology; point in time; potass; qnt; quan; quant; quantitative; random; renal; substance concentration; ua; ur; urn,Qn
94853-9,west nile virus igg and igm panel - cerebral spinal fluid qualitative,wnv igg+igm pnl csf,west nile virus igg and igm panel ql (csf),cerebral spinal fluid; cerebrospinal fl; id; immune globulin g; immune globulin m; immunoglobulin g; immunoglobulin m; infectious disease; infectiousdisease; microbiology; ordinal; pan; panel.microbiology; panl; pnl; point in time; ql; qual; qualitative; random; screen; spinal fl; spinal fld; spinal flu; spinal fluid; wnv; wnv igg+igm pnl,Ord
94862-0,transthyretin peak 2 [mass] in blood,ttr 2 bld qn,transthyretin peak 2 (bld) [mass],blood; chemistry; ii; neuro; neurology; point in time; prealbumin; qnt; quan; quant; quantitative; random; ttr; ttr 2; wb; whole blood,Qn
94869-5,ganglioside gd1b igm ab [titer] in serum by immunoassay,gd1b gangl igm titr ser ia,ganglioside gd1b igm ia (s) [titer],abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; dilution factor; dilution factor (titer); disialolganglioside; disialylganglioside; eia; elfa; elisa; enzyme immunoassay; gd1b; gd1b gangl; iaa; immune globulin m; immunoglobulin m; meia; neuro; neurology; point in time; random; serology; serum; smqn; sr; suds; titer; titered; titre; ttr,SemiQn
94870-3,ganglioside gd1b igm ab [presence] in serum by immunoassay,gd1b gangl igm ser ql ia,ganglioside gd1b igm ia ql (s),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; disialolganglioside; disialylganglioside; eia; elfa; elisa; enzyme immunoassay; gd1b; gd1b gangl; iaa; immune globulin m; immunoglobulin m; meia; neuro; neurology; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serology; serum; sr; suds,Ord
94878-6,instrumental activities of daily living priorities for the next 6 months during assessment period [cms assessment],,,centers for medicare and medicaid assessment; finding; findings; narrative; report; report period; survey,Nar
94880-2,need for and availability of a walker during assessment period [cms assessment],,,centers for medicare and medicaid assessment; finding; findings; ordinal; ql; qual; qualitative; report period; screen; survey,Ord
94884-4,need for and availability of a wheelchair during assessment period [cms assessment],,,centers for medicare and medicaid assessment; finding; findings; ordinal; ql; qual; qualitative; report period; screen; survey,Ord
94885-1,need for and availability of a manual wheelchair during assessment period [cms assessment],,,centers for medicare and medicaid assessment; finding; findings; ordinal; ql; qual; qualitative; report period; screen; survey,Ord
94904-0,need for and availability of ramps during assessment period [cms assessment],,,centers for medicare and medicaid assessment; finding; findings; ordinal; ql; qual; qualitative; report period; screen; survey,Ord
94917-2,paid caregiver's ability and willingness to provide mobility assistance during assessment period [cms assessment],,,centers for medicare and medicaid assessment; finding; findings; ordinal; ql; qual; qualitative; report period; s prime; screen; survey,Ord
94921-4,paid caregiver's ability and willingness to provide medication administration assistance during assessment period [cms assessment],,,centers for medicare and medicaid assessment; finding; findings; ordinal; ql; qual; qualitative; report period; s prime; screen; survey,Ord
94928-9,unpaid caregiver's ability and willingness to provide supervision during assessment period [cms assessment],,,centers for medicare and medicaid assessment; finding; findings; ordinal; ql; qual; qualitative; report period; s prime; screen; survey,Ord
94936-2,shower/bathe self - most dependent performance during the past month [cms assessment],,,1 month; 1 month (30 days); 30 days; adl; centers for medicare and medicaid assessment; finding; findings; functionalstatus; iadl; last; month; ordinal; ql; qual; qualitative; screen; survey,Ord
94972-7,medication management.injectable medications - most dependent performance during the past month [cms assessment],,,1 month; 1 month (30 days); 30 days; centers for medicare and medicaid assessment; finding; findings; last; month; ordinal; ql; qual; qualitative; screen; survey,Ord
94996-6,walks indoors - usual functional ability during assessment period [cms assessment],,,adl; centers for medicare and medicaid assessment; finding; findings; functionalstatus; iadl; ordinal; ql; qual; qualitative; report period; screen; survey,Ord
95008-9,sit to stand - usual functional ability during assessment period [cms assessment],,,30s cst; 30-second chair stand; 30ssts; adl; centers for medicare and medicaid assessment; finding; findings; functionalstatus; iadl; ordinal; ql; qual; qualitative; report period; screen; stands; survey,Ord
95013-9,lower body dressing - usual functional ability during assessment period [cms assessment],,,adl; bod; bodies; centers for medicare and medicaid assessment; finding; findings; functionalstatus; iadl; low; ordinal; ql; qual; qualitative; report period; screen; survey,Ord
95033-7,fasi v1.0 - preferences for customary routine and activities [cms assessment],,,centers for medicare and medicaid assessment; pan; panel; panel.survey.cms; panl; pnl; survey,-
95036-0,fasi v1.0 - availability of paid assistance during assessment period [cms assessment],,,centers for medicare and medicaid assessment; pan; panel; panel.survey.cms; panl; pnl; report period; survey,-
95055-0,dopamine [mass/volume] in plasma --standing,dopamine stand plas-mcnc,dopamine standing (p) [mass/vol],chemistry.challenge testing; endocrine; endocrinology; level; mass concentration; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; stand); wb; weight bearing,Qn
95085-7,c peptide [mass/volume] in serum or plasma --3.5 hours post meal,c peptide 3.5h p meal serpl-mcnc,c peptide 3.5 hr post meal [mass/vol],3.5h p meal; after; chemistry.challenge testing; connecting peptide of insulin; endocrine; endocrinology; level; mass concentration; p meal; pc; pept; pl; plasma; plsm; point in time; post pran; post prandial; pp; pro-insulin c peptide; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
95091-5,glucagon post fasting and meal stimulation panel - serum or plasma,glucagon p cfst + meal pnl serpl,glucagon post fasting and meal stimulation panel,after; chemistry.challenge testing; endocrine; endocrinology; glucagon p cfst + meal pnl; hgf; hyperglycemic factor; pan; panel.challenge; panl; pl; plasma; plsm; pnl; point in time; pst; random; serp; serpl; serplas; serum; serum or plasma; sr; stim,-
95096-4,glucagon [mass/volume] in serum or plasma --3.5 hours post meal,glucagon 3.5h p meal serpl-mcnc,glucagon 3.5 hr post meal [mass/vol],3.5h p meal; after; chemistry.challenge testing; endocrine; endocrinology; hgf; hyperglycemic factor; level; mass concentration; p meal; pc; pl; plasma; plsm; point in time; post pran; post prandial; pp; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
95111-1,insulin [units/volume] in serum or plasma --1.5 hours post meal,insulin 1.5h p meal serpl-acnc,insulin 1.5 hr post meal qn,1 1/2 hours; 1 1/2 hr; 1.5h p meal; 1.5hr; 90 min; 90 minutes; 90m; 90min; after; arbitrary concentration; chemistry.challenge testing; endocrine; endocrinology; hum; humulin; ih7; insul; lente; nph; p meal; pc; pl; plasma; plsm; point in time; post pran; post prandial; pp; pst; qnt; quan; quant; quantitative; random; semilente; serp; serpl; serplas; serum; serum or plasma; sliding; sr; ultralente,Qn
95121-0,coagulation factor viii activity and inhibitor panel - platelet poor plasma by chromogenic method,fact viii act + inhib pnl ppp chro,coagulation factor viii activity and inhibitor panel chromogenic method (ppp),activ; actvty; ahf; ahg; antihemophilic factor; antihemophilic globulin; chromogenic assay; circulating anticoagulant; coag; enzy; enzymatic assay; f8; fac; fact; fact viii; fact viii act + inhib pnl; factor 8; factor viii clotting activity; fviii; hematology; heme; inhib; inhibit; movements; pan; panel.coagulation; panl; plas; platelet poor plasma; pnl; point in time; random; thrombocyte cofactor a; viii:c,-
95129-3,dense fine speckled 70 protein igg ab [units/volume] in serum or plasma by immunoassay,dfs70 igg serpl ia-acnc,dense fine speckled 70 protein igg ia qn,abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; dfs70; eia; elfa; elisa; enzyme immunoassay; iaa; immune globulin g; immunoglobulin g; meia; pl; plasma; plsm; point in time; pr; prot; qnt; quan; quant; quantitative; random; rheum; rheumatology; serology; serp; serpl; serplas; serum; serum or plasma; sr; suds,Qn
95135-0,noroxycodone [mass/volume] in urine,noroxycodone ur-mcnc,noroxycodone (u) [mass/vol],addiction; drug/toxicology; drugs; drugs of abuse; illicit; level; mass concentration; point in time; potentialforabuse; qnt; quan; quant; quantitative; random; ua; ur; urn,Qn
95142-6,hepatitis a virus igm panel - serum,hav igm pnl ser,hav igm panel (s),hav; hav igm pnl; hep; hep a; hepatis; hepatit; hepatitis; hepatitis type a; id; immune globulin m; immunoglobulin m; infectious disease; infectiousdisease; microbiology; pan; panel.microbiology; panl; pnl; point in time; random; serum; sr,-
95150-9,avian infectious laryngotracheitis virus rna [#/volume] (viral load) in specimen by naa with probe detection,ilt rna # spec naa+probe,avian infectious laryngotracheitis virus rna naa+probe (specimen) [#/vol],#; 3 self-sustaining sequence replication; 3sr sr; abs; absolute; absolutes; alpha-herpesvirus; amplif; amplification; amplified; avian infectious laryngotracheitis; bird; cnt; count; count/volume; ct; dna nucleic acid probe; dna probe; fowl; id; ilt; infectious disease; infectiousdisease; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; misc; miscellaneous; naa+probe; naat; nasba; nucleic acid sequence based analysis; number concentration; number concentration (count/vol); other; pcr; point in time; polymerase chain reaction; probe amp; probe with ampification; probe with target amplification; qbr; qnt; quan; quant; quantitative; random; ribonucleic acid; sda; spec; strand displacement amplification; tma; to be specified in another part of the message; transcription mediated amplification; unspecified; vet; veterinary; viral load,Qn
95168-1,avian infectious laryngotracheitis virus rna [cycle threshold #] in specimen by naa with probe detection,ilt rna ct spec qn naa+probe,avian infectious laryngotracheitis virus rna naa+probe (specimen) [threshnum],3 self-sustaining sequence replication; 3sr sr; alpha-herpesvirus; amplif; amplification; amplified; avian infectious laryngotracheitis; bird; dna nucleic acid probe; dna probe; fowl; id; ilt; infectious disease; infectiousdisease; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; misc; miscellaneous; naa+probe; naat; nasba; nucleic acid sequence based analysis; other; pcr; point in time; polymerase chain reaction; probe amp; probe with ampification; probe with target amplification; qbr; qnt; quan; quant; quantitative; random; ribonucleic acid; sda; spec; strand displacement amplification; tma; to be specified in another part of the message; transcription mediated amplification; unspecified; vet; veterinary,Qn
95189-7,cd107a+b expressing hla-b7 cmv specific cd8 cells [#/volume] in blood by flow cytometry (fc),cd107ab hla-b7 cmv cd8 cells # bld fc,cd107a+b expressing hla-b7 cmv specific cd8 cells fc (bld) [#/vol],#; abs; absolute; absolutes; ag; blood; cd107ab hla-b7 cmv cd8 cells; cd8 cells; cell; cell markers; cellularity; cnt; count; count/volume; ct; dynamic; esoteric; fc; hla-b7 cmv cd8 cells; human leukocyte antigen; lamp-1; leu2; leu-2; lysosome-associated membrane-protein 1; number concentration; number concentration (count/vol); point in time; qnt; quan; quant; quantitative; random; spec; suppressor t cells; t8; t-8; tsuppressor; wb; whole blood,Qn
95218-4,leukocytes [#/volume] in stem cell product,wbc # stem prod,wbc (stem cell product) [#/vol],#; abs; absolute; absolutes; cnt; count; count/volume; ct; hematology; hematology/cell counts; heme; leuc; leuk; leukocyte; lkcs; number concentration; number concentration (count/vol); point in time; qnt; quan; quant; quantitative; random; stem prod; wbc; wbcs; white blood cell; white blood cells,Qn
95225-9,band form neutrophils/leukocytes in stem cell product by manual count,neuts band nfr stem prod manual,band form neutrophils/leukocytes manual cnt (stem cell product),bands; bnd; hematology; hematology/cell counts; heme; leuc; leuk; leukocyte; lkcs; manl; n-band; neut; neutr; neutrophil; neuts band; number fraction; percent; pmn; pnm; point in time; qnt; quan; quant; quantitative; random; stem prod; wbc; wbcs; white blood cell; white blood cells,Qn
95244-0,platelet aggregation epinephrine induced in platelet rich plasma --1 umol/l,pa epineph 1 umol/l prp,platelet aggregation epinephrine induced 1 umol/l (prp) [rel units/vol],adrenalin; adrenaline; adreneline; agg; aggr; coagulation; e; epi; epin; epinep; epineph; epinphrine; eppi; hematology; heme; i; left; levo; pa; pa epineph; pl; platelet rich plasma; platelets; platelt; plt; point in time; qnt; quan; quant; quantitative; random; rlacnc; thrombocyte; thrombocytes,Qn
95260-6,"in the last 12 months, how often did any of the children skip meals because there wasn't enough money for food [u.s. fss]",,,1 year; 12mos; finding; findings; ordinal; past; ql; qual; qualitative; s prime; screen; sdoh; t prime,Ord
95261-4,"in the last 12 months, were the children ever hungry but you just couldn't afford more food [u.s. fss]",,,1 year; 12mos; finding; findings; ordinal; past; ql; qual; qualitative; s prime; screen; sdoh; t prime,Ord
9528-1,histoplasma capsulatum iga ab [units/volume] in serum by immunoassay,h capsul iga ser ia-acnc,h. capsulatum iga ia qn (s),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; eia; elfa; elisa; enzyme immunoassay; h capsul; h capsulatum; h farciminosum; histo; histopl; histoplasma farciminosum; histoplasmos; histoplasmosis; iaa; id; immune globulin a; immunoglobulin a; infectious disease; infectiousdisease; meia; microbiology; point in time; qnt; quan; quant; quantitative; random; serum; sr; suds,Qn
9529-9,histoplasma capsulatum igg ab [units/volume] in serum or plasma by immunoassay,h capsul igg serpl ia-acnc,h. capsulatum igg ia qn,abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; eia; elfa; elisa; enzyme immunoassay; h capsul; h capsulatum; h farciminosum; histo; histopl; histoplasma farciminosum; histoplasmos; histoplasmosis; iaa; id; immune globulin g; immunoglobulin g; infectious disease; infectiousdisease; meia; microbiology; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; suds,Qn
95310-9,left cornea mean refractive power by keratometry,l cornea refractive power.mean by km,,average; avg; by km; corneal; eye; eye.refraction; inverse length; l; l cornea; lt; ophthalmology; ophthalmometer; ophtho; ophthy; point in time; qnt; quan; quant; quantitative; random; refract pwr,Qn
95322-4,cylinder mode,cylinder mode,,cyl; eye; eye.lensometry; focimeter; lensometer; lm; ophthalmology; ophtho; ophthy; ordinal; point in time; ql; qual; qualitative; random; screen; typ,Ord
95324-0,prism mode,prism mode,,eye; eye.lensometry; focimeter; lensometer; lm; ophthalmology; ophtho; ophthy; ordinal; point in time; ql; qual; qualitative; random; screen; typ,Ord
95326-5,corrective lens spherical equivalent calculated,corr lens sph equiv calc,,calc; calculation; corr lens; eye; eye.lensometry; inverse length; ophthalmology; ophtho; ophthy; point in time; qnt; quan; quant; quantitative; random; sph equiv,Qn
95332-3,right corrective lens prism by lensmeter,r corr lens prism by lm,,by lm; corr lens; eye; eye.lensometry; focimeter; inverse length; lensometer; lm; ophthalmology; ophtho; ophthy; point in time; qnt; quan; quant; quantitative; r; r corr lens; random; rt,Qn
95343-0,right corrective lens vertical prism - down by lensmeter,r corr lens v prism-down by lm,,by lm; corr lens; eye; eye.lensometry; focimeter; inverse length; lensometer; lm; ophthalmology; ophtho; ophthy; point in time; qnt; quan; quant; quantitative; r; r corr lens; random; rt; v prism-down,Qn
95349-7,glasses pupillary distance.binocular near by lensmeter,glasses pd binoc near by lm,,by lm; eye; eye.lensometry; focimeter; length; lensometer; lm; ophthalmology; ophtho; ophthy; pd binoc; pd binoc near; point in time; qnt; quan; quant; quantitative; random,Qn
95359-6,rabbit hemorrhagic disease virus type 1 rna [cycle threshold #] in specimen by naa with probe detection,rhdv1 rna ct spec qn naa+probe,rabbit hemorrhagic disease virus type 1 rna naa+probe (specimen) [threshnum],3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; calicivirus; dis; diseases; dna nucleic acid probe; dna probe; dz; f213; hemorrhagic septicemia; i; infectious necrotic hepatitis; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; misc; miscellaneous; naa+probe; naat; nasba; nucleic acid sequence based analysis; oryctalagus spp; other; pcr; point in time; polymerase chain reaction; probe amp; probe with ampification; probe with target amplification; qbr; qnt; quan; quant; quantitative; rabbit hemorrhagic disease; random; rhdv; rhdv1; rhdva; ribonucleic acid; sda; spec; strand displacement amplification; tma; to be specified in another part of the message; transcription mediated amplification; unspecified; vet; veterinary; viral hemorrhagic disease,Qn
9536-4,influenza virus b igm ab [titer] in serum,flubv igm titr ser,flubv igm (s) [titer],abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; dilution factor; dilution factor (titer); flub; flubv; fluv; id; immune globulin m; immunoglobulin m; infectious disease; infectiousdisease; influ; influenza b; influenza b virus; microbiology; point in time; random; serum; smqn; sr; titer; titered; titre; ttr,SemiQn
95366-1,date of first positive specimen collection,dt of 1st pos specimen collection,date of first positive specimen collection,coll; collect; collected; dt of 1st pos specimen collection; point in time; pos; qnt; quan; quant; quantitative; random; spec,Qn
95372-9,workplace setting,workplace,,admin; admin.demog; nominal; point in time; random; typ,Nom
95383-6,symptom resolution status,symptom res status,,clin; finding; findings; ordinal; point in time; ql; qual; qualitative; random; screen; sx; symptom res status,Ord
95389-3,have you used an illegal drug or a prescription medication for nonmedical reasons in the past 3 months caregiver [seek],,,3 months; drugs; finding; findings; last; ordinal; ql; qual; qualitative; rx; screen; survey,Ord
9540-6,la crosse virus igm ab [titer] in cerebral spinal fluid by immunofluorescence,lacv igm titr csf if,la crosse virus igm if (csf) [titer],abs; aby; acif; antby; anti; antibodies; antibody; anticomplement immunofluorescence; autoantibodies; autoantibody; california encephalitis virus; cerebral spinal fluid; cerebrospinal fl; dilution factor; dilution factor (titer); fa; fluorescent antibody; fluoresent; id; ifa; immune fluorescence; immune globulin m; immunoflour; immunofluor; immunofluorescence; immunoglobulin m; infectious disease; infectiousdisease; lacrosse virus; lacv; microbiology; neuro; neurology; point in time; random; smqn; spinal fl; spinal fld; spinal flu; spinal fluid; time resolved fluorescence; titer; titered; titre; trf; ttr,SemiQn
95412-3,covid-19 case report,covid-19 case rprt,,2019 novel coronavirus; 2019-ncov; case rprt; coronavirus disease 2019; covid19; covid-19 case rprt; doc.ont; document; finding; findings; ph; point in time; public health; publichealth; random; sars coronavirus; sars-cov-2; sars-related coronavirus,Doc
95414-9,level of paid and unpaid caregiver assistance [cms assessment],,,1 month; 1 month (30 days); 30 days; centers for medicare and medicaid assessment; levels; levl; lv; lvl; pan; panel; panel.survey.cms; panl; pnl; survey,-
95421-4,whether patient resides in a congregate care setting,resides in a congregate care setting,,aoeobservation; finding; findings; h+p; h+p.hx; ordinal; p prime; point in time; ql; qual; qualitative; random; screen,Ord
95422-2,influenza virus a and b and sars-cov-2 (covid-19) rna panel - respiratory system specimen by naa with probe detection,fluabv + sars-cov-2 pnl resp naa+prb,influenza virus a and b and sars-cov-2 (covid-19) rna panel naa+probe (respiratory system specimen),2019 novel coronavirus; 2019-ncov; 3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; avian influenza; bird flu; breathing; corona virus; covid19; covid-19; dna nucleic acid probe; dna probe; flua; fluabv + sars-cov-2; fluabv+sars-cov-2 rna pnl; fluav; flub; flubv; fluv; fowl plague; id; ii; infectious disease; infectiousdisease; influ; influenza a; influenza a virus; influenza b; influenza b virus; lat; lcr; ligase chain reaction; ligation-activated transcription; lungs; microbiology; naa+probe; naat; nasba; nucleic acid sequence based analysis; pan; panel.microbiology; panl; pcr; ph; pnl; point in time; polymerase chain reaction; probe amp; probe with ampification; probe with target amplification; public health; publichealth; qbr; random; ribonucleic acid; rs; sars coronavirus 1; sars-cov; sars-cov-1; sars-cov-2; sars-cov-2 rna pnl; sda; severe acute respiratory syndrome; spec; strand displacement amplification; tma; transcription mediated amplification; viral pneumonias; wuhan coronavirus,-
95424-8,sars-cov-2 (covid-19) rna [presence] in respiratory system specimen by sequencing,sars-cov-2 rna resp ql seq,sars-cov-2 (covid-19) rna sequencing ql (respiratory system specimen),2019 novel coronavirus; 2019-ncov; breathing; corona virus; covid19; covid-19; high-throughput sequencing; hts; id; ii; infectious disease; infectiousdisease; lungs; microbiology; next generation sequencing; ngs; ordinal; ph; point in time; pr; public health; publichealth; ql; qual; qualitative; random; ribonucleic acid; rs; sars coronavirus 1; sars-cov; sars-cov-1; sars-cov-2; screen; severe acute respiratory syndrome; spec; viral pneumonias; wuhan coronavirus,Ord
95429-7,sars-cov-2 (covid-19) igg ab [titer] in serum or plasma by immunofluorescence,sars-cov-2 igg titr serpl if,sars-cov-2 (covid-19) igg if [titer],2019 novel coronavirus; 2019-ncov; abs; aby; acif; antby; anti; antibodies; antibody; anticomplement immunofluorescence; autoantibodies; autoantibody; corona virus; covid19; covid-19; dilution factor; dilution factor (titer); fa; fluorescent antibody; fluoresent; id; ifa; ii; immune fluorescence; immune globulin g; immunoflour; immunofluor; immunofluorescence; immunoglobulin g; infectious disease; infectiousdisease; microbiology; ph; pl; plasma; plsm; point in time; public health; publichealth; random; sars coronavirus 1; sars-cov; sars-cov-1; sars-cov-2; serp; serpl; serplas; serum; serum or plasma; severe acute respiratory syndrome; smqn; sr; time resolved fluorescence; titer; titered; titre; trf; ttr; viral pneumonias; wuhan coronavirus,SemiQn
95437-0,"during the past 3 months, how often have you used street opioids",,,3 months; finding; findings; last; mental health; mentalhealth; ordinal; psych; psychiatry; ql; qual; qualitative; screen; survey; survey.nida,Ord
95445-3,"during the past 3 months, how often have you had a strong desire or urge to use sedatives or sleeping pills [nida]",,,3 months; finding; findings; last; mental health; mentalhealth; ordinal; psych; psychiatry; ql; qual; qualitative; screen; survey; survey.nida,Ord
95454-5,"during the past 3 months, how often has your use of inhalants led to health, social, legal or financial problems [nida]",,,3 months; finding; findings; last; mental health; mentalhealth; ordinal; psych; psychiatry; ql; qual; qualitative; screen; survey; survey.nida,Ord
95468-5,"during the past 3 months, how often have you failed to do what was normally expected of you because of your use of prescription opioids [nida]",,,3 months; finding; findings; last; mental health; mentalhealth; ordinal; psych; psychiatry; ql; qual; qualitative; rx; screen; survey; survey.nida,Ord
95482-6,"have you ever tried and failed to control, cut down or stop using cannabis [nida]",,,finding; findings; mental health; mentalhealth; ordinal; point in time; psych; psychiatry; ql; qual; qualitative; random; screen; survey; survey.nida,Ord
95487-5,"have you ever tried and failed to control, cut down or stop using sedatives or sleeping pills [nida]",,,finding; findings; mental health; mentalhealth; ordinal; point in time; psych; psychiatry; ql; qual; qualitative; random; screen; survey; survey.nida,Ord
95488-3,"have you ever tried and failed to control, cut down or stop using hallucinogens [nida]",,,finding; findings; mental health; mentalhealth; ordinal; point in time; psych; psychiatry; ql; qual; qualitative; random; screen; survey; survey.nida,Ord
95490-9,"have you ever tried and failed to control, cut down or stop using prescription opioids [nida]",,,finding; findings; mental health; mentalhealth; ordinal; point in time; psych; psychiatry; ql; qual; qualitative; random; rx; screen; survey; survey.nida,Ord
95494-1,substances used during the past 3 months,substances used past 3mo,,h+p; h+p.hx; last; nominal; p prime; point in time; random; substances used past 3mo; typ,Nom
95502-1,substances that have caused you to fail to do what was normally expected of you during the past 3 months [nida],,,3 months; last; mental health; mentalhealth; nominal; psych; psychiatry; survey; survey.nida; typ,Nom
95507-0,inhalants substance involvement score [nida],,,mental health; mentalhealth; point in time; psych; psychiatry; qnt; quan; quant; quantitative; random; scale; subs; survey; survey.nida,Qn
95509-6,hallucinogens substance involvement score [nida],,,mental health; mentalhealth; point in time; psych; psychiatry; qnt; quan; quant; quantitative; random; scale; subs; survey; survey.nida,Qn
95512-0,other substance involvement score [nida],,,mental health; mentalhealth; othr; point in time; psych; psychiatry; qnt; quan; quant; quantitative; random; scale; subs; survey; survey.nida,Qn
9551-3,legionella pneumophila 5 igm ab [titer] in serum by immunofluorescence,l pneumo5 igm titr ser if,l. pneumophila 5 igm if (s) [titer],abs; aby; acif; antby; anti; antibodies; antibody; anticomplement immunofluorescence; autoantibodies; autoantibody; dallas 1e; dilution factor; dilution factor (titer); fa; fluorescent antibody; fluoresent; id; ifa; immune fluorescence; immune globulin m; immunoflour; immunofluor; immunofluorescence; immunoglobulin m; infectious disease; infectiousdisease; l pneumo; l pneumo5; l pneumonphila; legion; legionela; legionella pneumophila serogroup 5; microbiology; pneu; pneum; pneumophilia; point in time; random; serum; smqn; sr; time resolved fluorescence; titer; titered; titre; trf; ttr,SemiQn
95516-1,angiotensin (1-7) [mass/volume] in plasma,ang-(1-7) plas-mcnc,angiotensin (1-7) (p) [mass/vol],agt; ang-(1-7); chemistry; i; level; mass concentration; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random,Qn
95536-9,human papilloma virus 45 dna [presence] in cervix by naa with probe detection,hpv45 dna cvx ql naa+probe,hpv 45 dna naa+probe ql (cvx),3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; cervix; deoxyribonucleic acid; dna nucleic acid probe; dna probe; genital tract; genital warts; hpv; hpv45; human papillomavirus; id; infectious disease; infectiousdisease; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; naa+probe; naat; nasba; nucleic acid sequence based analysis; ordinal; papilloma virus intermediate risk; pcr; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; screen; sda; strand displacement amplification; tma; transcription mediated amplification,Ord
95537-7,human papilloma virus 35+39+68 dna [presence] in cervix by naa with probe detection,hpv35+39+68 dna cvx ql naa+probe,hpv 35+39+68 dna naa+probe ql (cvx),3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; cervix; deoxyribonucleic acid; dna nucleic acid probe; dna probe; genital tract; genital warts; hpv; hpv35; hpv35+39+68; human papillomavirus; id; infectious disease; infectiousdisease; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; naa+probe; naat; nasba; nucleic acid sequence based analysis; ordinal; pcr; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; screen; sda; strand displacement amplification; tma; transcription mediated amplification,Ord
95549-2,cardiovascular disease lifetime risk [likelihood] acc-aha pooled cohort by goff 2013,cvd lifetime risk acc-aha.goff 2013,,acc-aha.goff 2013; ascvd; atherosclerosis; atherosclerotic cardiovascular disease; card.risk; cardio; cardiology; cardiovascular disease; cvd; cvd lifetime risk; dis; diseases; dz; heart disease; point in time; qnt; quan; quant; quantitative; random; risk,Qn
95551-8,chromosome region 17p11.2 deletion in blood or tissue by fish,chr 17p11.2 del bld/t fish,17p11.2 del fish doc (bld/tiss),"blood; chr 17p11.2; chr 17p11.2 deletion; chromosom; chromosomes; cyto loc; del; deletions; document; finding; findings; fluorescent in situ hybridization; molecular pathology; molpath; molpath.deldup; point in time; potocki-lupski syndrome; ptls; rai1; random; smith-magenis syndrome; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",Doc
95555-9,f7 gene p.arg353gln [genotype] in blood or tissue by molecular genetics method nominal,f7 r353q geno bld/t,f7 gene p.arg353gln genotype molgen (bld/tiss),"blood; cf gene; coagulation factor vii (serum prothrombin conversion accelerator); coagulation factor vii gene; f7 r353q; factor 7; factor vii; factor vii deficiencies; genetics; heredity; heritable; inherited; molecular genetics; molecular pathology; molpath; molpath.mutations; nominal; p prime; pcr; point in time; random; rs6046; serum prothrombin conversion accelerator; spca; thrombophilia; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",Nom
95557-5,detection basis of tumor,detection basis tumor,,cancer; h+p; h+p.hx; mode of discovery; nominal; p prime; point in time; random; tumors; tumour; tumours; typ,Nom
95563-3,16-alpha hydroxydehydroepiandrosterone [mass/time] in 24 hour urine,16a oh-dhea 24h ur-mrate,16-alpha hydroxydehydroepiandrosterone (24h u) [mass/time],1 day; 16 alphaoh-dhea; 16a oh-dhea; 16-alpha hydroxy dehydroepiandrosterone; 16-alpha-hydroxy-dhea; 24 hours; 24hr; alfa; chemistry; endocrine; endocrinology; mass rate; mrate; qnt; quan; quant; quantitative; ua; ur; urn,Qn
95574-0,deprecated 17 alpha-hydroxypregnanolone [mass/time] in 24 hour urine,deprecated 17a-oh-pregnanolone 24h ur-mrate,17 alpha-hydroxypregnanolone (24h u) [mass/time],1 day; 17a-oh-pregnanolone; 24 hours; 24hr; alfa; chemistry; endocrine; endocrinology; mass rate; mrate; qnt; quan; quant; quantitative; ua; ur; urn,Qn
95586-4,cortisone [z-score] in 24 hour urine,cortisone 24h z-score ur,cortisone (24h u) [z-score],1 day; 11-beta hsd; 11-beta-hsd1; 11-beta-hsd2; 11-beta-hydroxy steroid dehydrogenase; 11--hsd1; 11--hsd2; 24 hours; 24hr; c155; chemistry; compound e; endocrine; endocrinology; qnt; quan; quant; quantitative; standard score; ua; ur; urn; z score; z value; z-score,Qn
95591-4,11-ketoetiocholanolone [z-score] in 24 hour urine,11ketoetioch 24h z-score ur,11-ketoetiocholanolone (24h u) [z-score],1 day; 11ketoetioch; 24 hours; 24hr; chemistry; endocrine; endocrinology; ketoetiochol; qnt; quan; quant; quantitative; standard score; ua; ur; urn; z score; z value; z-score,Qn
9559-6,cd5 cells [#/volume] in blood,cd5 cells # bld,cd5 cells (bld) [#/vol],#; abs; absolute; absolutes; blood; cd5 cells; cell; cell markers; cellularity; cnt; count; count/volume; ct; leu1; leu-1; ly-1; number concentration; number concentration (count/vol); point in time; qnt; quan; quant; quantitative; random; t1; tp67; wb; whole blood,Qn
95614-4,total score [hits],,,point in time; qnt; quan; quant; quantitative; random; scale; sdoh; survey; tot; totl,Qn
95616-9,threaten you with physical harm,,,1 year; 12mos; finding; findings; ordinal; ql; qual; qualitative; screen; sdoh; survey; survey.mtlhlth; threaten w/ physical harm,Ord
95626-8,pain/agitation severity.vital signs variability,pain/agi severity vital sign var,,finding; findings; neonat; ordinal; pain/agi severity vital sign var; pain/agitat; point in time; ql; qual; qualitative; random; screen,Ord
95644-1,japanese encephalitis virus neutralizing antibody [titer] in specimen by neutralization test,jev nab titr spec nt,jev neut ab neut test (specimen) [titer],abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; conventional virus neutralization test; cvnt; dilution factor; dilution factor (titer); enc; enceph; encephalomyelitis; flavivirus; id; infectious disease; infectiousdisease; japanese b encephalitis; japanese encephalitis; jbe; je virus; jev; microbiology; misc; miscellaneous; nab; neutralization; neutralization test; nt; other; point in time; random; serum virus neutralization; smqn; spec; svn; titer; titered; titre; to be specified in another part of the message; ttr; unspecified; virus neutralization test; vnt,SemiQn
95647-4,powassan virus neutralizing antibody [titer] in specimen by neutralization test,powv nab titr spec nt,powassan virus neut ab neut test (specimen) [titer],abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; conventional virus neutralization test; cvnt; dilution factor; dilution factor (titer); id; infectious disease; infectiousdisease; microbiology; misc; miscellaneous; nab; neutralization; neutralization test; nt; other; point in time; powv; random; serum virus neutralization; smqn; spec; svn; titer; titered; titre; to be specified in another part of the message; ttr; unspecified; virus neutralization test; vnt,SemiQn
95654-0,eastern equine encephalitis virus neutralizing antibody [titer] in specimen by neutralization test,eeev nab titr spec nt,eeev neut ab neut test (specimen) [titer],abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; conventional virus neutralization test; cvnt; dilution factor; dilution factor (titer); eee virus; eeev; enc; enceph; encephalomyelitis; equin; id; infectious disease; infectiousdisease; microbiology; misc; miscellaneous; nab; neutralization; neutralization test; nt; other; ph; point in time; public health; publichealth; random; serum virus neutralization; smqn; spec; svn; titer; titered; titre; to be specified in another part of the message; togavirus; ttr; unspecified; virus neutralization test; vnt,SemiQn
95657-3,flavivirus identified in specimen by neutralization test,flavivirus spec nt,flavivirus identified neut test nom (specimen),conventional virus neutralization test; cvnt; flavi virus; id; identity or presence; infectious disease; infectiousdisease; microbiology; misc; miscellaneous; neutralization; neutralization test; nominal; nt; other; ph; point in time; public health; publichealth; random; serum virus neutralization; spec; svn; to be specified in another part of the message; unspecified; virus neutralization test; vnt,Nom
95660-7,eastern equine encephalitis virus igm ab [presence] in specimen by immunoassay,eeev igm spec ql ia,eeev igm ia ql (specimen),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; eee virus; eeev; eia; elfa; elisa; enc; enceph; encephalomyelitis; enzyme immunoassay; equin; iaa; id; immune globulin m; immunoglobulin m; infectious disease; infectiousdisease; meia; microbiology; misc; miscellaneous; ordinal; other; point in time; pr; ql; qual; qualitative; random; screen; spec; suds; to be specified in another part of the message; togavirus; unspecified,Ord
95665-6,snowshoe hare virus igg ab [presence] in specimen by immunoassay,sshv igg spec ql ia,snowshoe hare virus igg ia ql (specimen),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; eia; elfa; elisa; enzyme immunoassay; iaa; id; immune globulin g; immunoglobulin g; infectious disease; infectiousdisease; meia; microbiology; misc; miscellaneous; ordinal; other; point in time; pr; ql; qual; qualitative; random; screen; spec; sshv; suds; to be specified in another part of the message; unspecified,Ord
95678-9,western equine encephalitis virus igg ab [presence] in specimen by immunoassay,weev igg spec ql ia,weev igg ia ql (specimen),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; eia; elfa; elisa; enc; enceph; encephalomyelitis; enzyme immunoassay; equin; iaa; id; immune globulin g; immunoglobulin g; infectious disease; infectiousdisease; meia; microbiology; misc; miscellaneous; ordinal; other; point in time; pr; ql; qual; qualitative; random; screen; spec; suds; to be specified in another part of the message; togavirus; unspecified; wee virus; weev; west,Ord
95680-5,snowshoe hare virus igm ab [presence] in specimen by immunoassay,sshv igm spec ql ia,snowshoe hare virus igm ia ql (specimen),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; eia; elfa; elisa; enzyme immunoassay; iaa; id; immune globulin m; immunoglobulin m; infectious disease; infectiousdisease; meia; microbiology; misc; miscellaneous; ordinal; other; point in time; pr; ql; qual; qualitative; random; screen; spec; sshv; suds; to be specified in another part of the message; unspecified,Ord
95683-9,highlands j virus igm ab [presence] in specimen by immunoassay,hjv igm spec ql ia,highlands j virus igm ia ql (specimen),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; eia; elfa; elisa; enzyme immunoassay; highland j virus; hjv; iaa; id; immune globulin m; immunoglobulin m; infectious disease; infectiousdisease; meia; microbiology; misc; miscellaneous; ordinal; other; point in time; pr; ql; qual; qualitative; random; screen; spec; suds; to be specified in another part of the message; unspecified,Ord
95690-4,yellow fever virus igm ab [presence] in specimen by immunoassay,yfv igm spec ql ia,yellow fever virus igm ia ql (specimen),abs; aby; american plague; antby; anti; antibodies; antibody; autoantibodies; autoantibody; eia; elfa; elisa; enzyme immunoassay; iaa; id; immune globulin m; immunoglobulin m; infectious disease; infectiousdisease; meia; microbiology; misc; miscellaneous; ordinal; other; point in time; pr; ql; qual; qualitative; random; screen; spec; suds; to be specified in another part of the message; unspecified; yellow jack; yfv,Ord
95723-3,glycine receptor ab [presence] in cerebral spinal fluid by immunoassay,glyr ab csf ql ia,glycine receptor ab ia ql (csf),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; cerebral spinal fluid; cerebrospinal fl; eia; elfa; elisa; enzyme immunoassay; gly; glyr; glyr ab; iaa; meia; neuro; neurology; ordinal; point in time; pr; ql; qual; qualitative; random; rec; recept; receptors; recp; recptr; screen; serology; spinal fl; spinal fld; spinal flu; spinal fluid; suds,Ord
95739-9,indicate the type of wheelchair/scooter used during assessment period [cms assessment],,,centers for medicare and medicaid assessment; nominal; report period; survey; typ,Nom
95740-7,understanding verbal and non-verbal content during assessment period [cms assessment],,,centers for medicare and medicaid assessment; finding; findings; ordinal; ql; qual; qualitative; report period; screen; survey,Ord
95744-9,hearing.ability to hear during assessment period [cms assessment],,,centers for medicare and medicaid assessment; finding; findings; ordinal; ql; qual; qualitative; report period; screen; survey,Ord
95755-5,allergy initial evaluation note,allergy initial eval note,,allergy; assessment; doc.ont; document; encounter; eval; eval note; evaluation and management; evaluation and management note; finding; findings; h&p; history and physical; initial eval note; notes; point in time; random; visit note,Doc
95757-1,allergy progress note,allergy prog note,,allergy; doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; notes; point in time; prog note; random; subsequent evaluation; subsequent visit evaluation; visit note,Doc
95758-9,allergy flowsheet,allergy flowsheet,,allergy; doc.ont; document; finding; findings; point in time; random,Doc
95800-9,immunoglobulin light chains.free panel - urine,immunoglobulin lc free pnl ur,immunoglobulin light chains.free panel (u),bence jones protein; bj protein; bj protein free; bjp; chain; chemistry; flc; fr; immune globulin; immuno; immunoglob; immunoglobin; immunoglobulin lc free pnl; imunoglbon; imunoglobn; non-protein bound; pan; panel.chemistry; panl; pnl; ua; ur; urn,-
95827-2,viable cd3 cells/cells.cd3 in blood product unit,viable cd3 cells/cd3 nfr bpu,viable cd3 cells/cells.cd3 (bpu),blood bank; blood product unit; blood product unit (pack); cell; cellularity; leu4; leu-4; number fraction; percent; point in time; qnt; quan; quant; quantitative; random; t3,Qn
95835-5,cd34 cells [#] in blood product unit,cd34 cells bpu,cd34 cells (bpu) [#],blood bank; blood product unit; blood product unit (pack); cd34 cells; cell; cellularity; cnt; count; gp105-120; hematopoietic stem cell; hsc; my10; my-10; number; point in time; qnt; quan; quant; quantitative; random; stem cells,Qn
95860-3,lcds v4.00 - self-care - discharge goal during assessment period [cms assessment],,,centers for medicare and medicaid assessment; disch; pan; panel; panel.survey.cms; panl; pnl; report period; survey,-
95865-2,lcds v4.00 - swallowing/nutritional status during assessment period [cms assessment],,,centers for medicare and medicaid assessment; deglutition; pan; panel; panel.survey.cms; panl; pnl; report period; survey; swallowing/nutritional status,-
95875-1,brief anxiety and depression scale [bads],,,brief anxiety and depression scale; pan; panel; panel.survey.mtlhlth; panl; pnl; point in time; random; survey; survey.mtlhlth,-
958-9,c sup(w) ag [presence] on red blood cells from blood product unit,c sup(w) ag rbc bpu ql,c sup(w) ag ql (rbc bpu),antigen; antigens; blood bank; blood product unit; blood product unit (pack); c sup(w); erythrocytes; hematology; heme; ordinal; point in time; pr; ql; qual; qualitative; random; red blood cells; red blood corpusles; screen,Ord
95891-8,intensive care unit beds occupied/icu beds,icu beds occupied/icu beds nfr,,icu beds; icu beds occupied; number fraction; percent; ph; point in time; public health; publichealth; qnt; quan; quant; quantitative; random,Qn
95897-5,percent increase or decrease in event-associated cases compared to previous reporting period,% diff in cases since prev rptperiod,,% diff in case # from prev rpt period; case # compared to prev rpt period; ph; prev; public health; publichealth; qnt; quan; quant; quantitative; report period,Qn
9590-1,borrelia burgdorferi 28kd igg ab [presence] in serum by immunoblot,b burgdor28kd igg ser ql ib,b. burgdorferi 28kd igg ib ql (s),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; b burg; b burgdor; b burgdor28kd; b burgdorferi; bb; blt; burgdorf; id; immune blot; immune globulin g; immunobl; immunoblot; immunoglobulin g; infectious disease; infectiousdisease; lyme; lyme disease; lymes; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; riba; screen; serum; sr; wb; wblot; west blot; west blt; western blot,Ord
9591-9,borrelia burgdorferi 30kd igg ab [presence] in serum by immunoblot,b burgdor30kd igg ser ql ib,b. burgdorferi 30kd igg ib ql (s),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; b burg; b burgdor; b burgdor30kd; b burgdorferi; bb; blt; burgdorf; id; immune blot; immune globulin g; immunobl; immunoblot; immunoglobulin g; infectious disease; infectiousdisease; lyme; lyme disease; lymes; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; riba; screen; serum; sr; wb; wblot; west blot; west blt; western blot,Ord
95932-0,pulmonary hypertension [class],pulmonary hypertension class,,htn; lung; nominal; point in time; pulm; pulmonary; pulmonology; random; respiratory,Nom
95938-7,fetal cerebellum diameter transverse percentile per estimated gestational age,fetal tcd us prctl per est ga,,cerebellar; comp of est fetal wgt w std pop dist at same; dia; diam; diam transverse; est; estimation; fetal; gest; gestation; gyn; gynecology; ob; obgyn; obsterical; obsterical.ultrasound; obstetrical; obstetrics; per est ga; percentile; point in time; prenatal; qnt; quan; quant; quantitative; random; tcd; transcerebellar diameter,Qn
95957-7,rooibos ige ab [units/volume] in serum,rooibos ige qn,rooibos ige qn (s),abs; aby; allergen; allergens; allergy; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; f235; f328; immune globulin e; immunoglobulin e; point in time; qnt; quan; quant; quantitative; random; rooibos; rooibos ige; serum; sr,Qn
95959-3,black salsify ige ab [units/volume] in serum,black salsify ige qn,black salsify ige qn (s),abs; aby; allergen; allergens; allergy; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; black salsify; black salsify ige; f142; immune globulin e; immunoglobulin e; point in time; qnt; quan; quant; quantitative; random; serum; spanish salsify; sr,Qn
95972-6,sars-cov-2 stimulated gamma interferon release by t-cells [units/volume] corrected for background in blood,sars cov-2 ifn-g tcel bkgrd cor bld-acnc,sars-cov-2 stimulated gamma interferon release by t-cells corrected for background qn (bld),2019 novel coronavirus; 2019-ncov; arbitrary concentration; bckgrd cor; blood; cell; cellularity; corona virus; covid19; covid-19; ifn; igra; ii; microbiology; point in time; qnt; quan; quant; quantitative; random; sars coronavirus 1; sars-cov; sars-cov-1; sars-cov-2; sars-cov-2 ifn-g; sars-cov-2 ifn-g t cells; severe acute respiratory syndrome; t prime; viral pneumonias; wb; whole blood; wuhan coronavirus,Qn
95974-2,sars-cov-2 stimulated gamma interferon panel - blood,sars-cov-2 ifn-g pnl bld,sars-cov-2 stimulated gamma interferon panel (bld),2019 novel coronavirus; 2019-ncov; blood; corona virus; covid19; covid-19; ifn; igra; ii; microbiology; pan; panel.microbiology; panl; pnl; point in time; random; sars coronavirus 1; sars-cov; sars-cov-1; sars-cov-2; sars-cov-2 ifn-g; sars-cov-2 ifn-g pnl; severe acute respiratory syndrome; viral pneumonias; wb; whole blood; wuhan coronavirus,-
95977-5,emotion score [skindex-16],,,1 week; derm; dermatology; qnt; quan; quant; quantitative; scale; skin; survey; survey.gnhlth,Qn
95980-9,"during the past 1 week, how often have you been bothered by your skin condition itching [skindex-16]",,,1 week; derm; dermatology; finding; findings; integument; last; ordinal; ql; qual; qualitative; screen; skin; survey; survey.gnhlth,Ord
95989-0,"during the past 1 week, how often have you been bothered by feeling depressed about your skin condition [skindex-16]",,,1 week; derm; dermatology; finding; findings; integument; last; ordinal; ql; qual; qualitative; screen; skin; survey; survey.gnhlth,Ord
95995-7,"during the past 1 week, how often have you been bothered by your skin condition hurting [skindex-16]",,,1 week; derm; dermatology; finding; findings; integument; last; ordinal; ql; qual; qualitative; screen; skin; survey; survey.gnhlth,Ord
95999-9,function score [skindex-29],,,4 weeks; derm; dermatology; fcn; func; funct; qnt; quan; quant; quantitative; scale; skin; survey; survey.gnhlth,Qn
96000-5,total score [skindex-29],,,4 weeks; derm; dermatology; qnt; quan; quant; quantitative; scale; skin; survey; survey.gnhlth; tot; totl,Qn
96001-3,"during the past 4 weeks, my skin hurts [skindex-29]",,,4 weeks; derm; dermatology; finding; findings; integument; last; ordinal; ql; qual; qualitative; screen; skin; survey; survey.gnhlth,Ord
96018-7,"during the past 4 weeks,, my skin condition bleeds [skindex-29]",,,4 weeks; derm; dermatology; finding; findings; integument; last; ordinal; ql; qual; qualitative; screen; skin; survey; survey.gnhlth,Ord
96025-2,"during the past 4 weeks, my skin condition affects my interactions with others [skindex-29]",,,4 weeks; derm; dermatology; finding; findings; integument; last; ordinal; ql; qual; qualitative; screen; skin; survey; survey.gnhlth,Ord
96033-6,"during the past 1 week, how often have you been bothered by effects of your skin problem on your activities [skindex mini]",,,1 week; derm; dermatology; finding; findings; integument; last; ordinal; ql; qual; qualitative; screen; skin; survey; survey.gnhlth,Ord
96034-4,skindex mini [skindex mini],,,1 week; pan; panel; panel.survey.gnhlth; panl; pnl; survey; survey.gnhlth,-
96043-5,uracil [mass/volume] in serum or plasma,uracil serpl-mcnc,uracil [mass/vol],chemistry; level; mass concentration; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
96057-5,interferon beta igg ab [presence] in serum,ifn-b igg ser ql,interferon beta igg ql (s),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; b; betaferon; b-ifn 1a+1b; ifn; ifn-b; immune globulin g; immunoglobulin g; inf-b; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serology; serum; sr,Ord
96064-1,hedis my 2020 value set - diastolic blood pressure,hedis my 2020 diastolic bp,hedis my 2020 value set - diastolic bp,bp; dias; diast; diastoli; hedis my 2020 diastolic bp; pan; panel; panel.hedis; panl; pnl; point in time; random,-
96086-4,hedis my 2020 value set - urine creatinine lab test,hedis my 2020 ur creat lab test,hedis my 2020 value set - urine creatinine lab test,cr; crea; creat; hedis my 2020 ur creat lab test; pan; panel; panel.hedis; panl; pnl; point in time; random; ucr,-
96091-4,sars-cov-2 (covid-19) rdrp gene [presence] in saliva (oral fluid) by naa with probe detection,sars-cov-2 rdrp sal ql naa+probe,sars-cov-2 (covid-19) rdrp gene naa+probe ql (sal),2019 novel coronavirus; 2019-ncov; 3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; corona virus; covid19; covid-19; dna nucleic acid probe; dna probe; id; ii; infectious disease; infectiousdisease; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; naa+probe; naat; nasba; nucleic acid sequence based analysis; oral fluid; ordinal; pcr; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; sal; sars coronavirus 1; sars-cov; sars-cov-1; sars-cov-2; sars-cov-2 rdrp; screen; sda; severe acute respiratory syndrome; strand displacement amplification; tma; transcription mediated amplification; viral pneumonias; wuhan coronavirus,Ord
96098-9,wash upper body - functional goal during assessment period [cms assessment],,,bod; bodies; centers for medicare and medicaid assessment; finding; findings; ordinal; ql; qual; qualitative; report period; screen; survey; up,Ord
9610-7,hepatitis c virus c33c ab [presence] in serum by immunoblot,hcv c33c ab ser ql ib,hcv c33c ab ib ql (s),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; blt; hcv; hcv c33c; hep; hep c; hepatis; hepatit; hepatology; id; immune blot; immunobl; immunoblot; infectious disease; infectiousdisease; liver; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; riba; screen; serum; sr; wb; wblot; west blot; west blt; western blot,Ord
96123-5,sars-cov-2 (covid-19) rdrp gene [presence] in upper respiratory specimen by naa with probe detection,sars-cov-2 rdrp upper resp ql naa+probe,sars-cov-2 (covid-19) rdrp gene naa+probe ql (upper resp),2019 novel coronavirus; 2019-ncov; 3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; breathing; corona virus; covid19; covid-19; dna nucleic acid probe; dna probe; id; ii; infectious disease; infectiousdisease; lat; lcr; ligase chain reaction; ligation-activated transcription; lungs; microbiology; naa+probe; naat; nasba; nucleic acid sequence based analysis; ordinal; pcr; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; rs; sars coronavirus 1; sars-cov; sars-cov-1; sars-cov-2; sars-cov-2 rdrp; screen; sda; severe acute respiratory syndrome; spec; strand displacement amplification; tma; transcription mediated amplification; up; upper resp; viral pneumonias; wuhan coronavirus,Ord
96125-0,fetal abdomen circumference per estimated gestational age,fet abd prctl circum per est ga,,abd; abd^fetus; abd+fetus; abdo; abdomen+; abdominal; abdominal circumference; ac; circum; circumference; comp of est fetal wgt w std pop dist at same; est; estimation; fetal; gest; gestation; gyn; gynecology; ob; obgyn; obsterical; obsterical.ultrasound; obstetrical; obstetrics; per est ga; percentile; point in time; prenatal; qnt; quan; quant; quantitative; random,Qn
96128-4,colon and rectal surgery evaluation note,col+rec surg eval note,,assessment; col+rec surg; doc.ont; document; encounter; eval; eval note; evaluation and management; evaluation and management note; finding; findings; h&p; history and physical; notes; point in time; random; surg; visit note,Doc
96130-0,surgical oncology evaluation note,surg onc eval note,,assessment; cancer; doc.ont; document; encounter; eval; eval note; evaluation and management; evaluation and management note; finding; findings; general surgical oncology; h&p; history and physical; notes; point in time; random; surg; surg onc; visit note,Doc
96140-9,nephrology evaluation note,nephrology eval note,,assessment; doc.ont; document; encounter; eval; eval note; evaluation and management; evaluation and management note; finding; findings; h&p; history and physical; notes; point in time; random; visit note,Doc
96145-8,emergency medicine evaluation note,emergency med eval note,,assessment; doc.ont; document; encounter; eval; eval note; evaluation and management; evaluation and management note; finding; findings; h&p; history and physical; notes; point in time; random; visit note,Doc
96146-6,critical care medicine evaluation note,ccm eval note,,assessment; ccm; continuity assessment record and evaluation; doc.ont; document; encounter; eval; eval note; evaluation and management; evaluation and management note; finding; findings; h&p; history and physical; notes; point in time; random; visit note,Doc
96160-7,endocrinology evaluation note,endocrinology eval note,,assessment; doc.ont; document; encounter; eval; eval note; evaluation and management; evaluation and management note; finding; findings; h&p; history and physical; notes; point in time; random; visit note,Doc
96174-8,interventional radiology evaluation note,ir eval note,,assessment; doc.ont; document; encounter; eval; eval note; evaluation and management; evaluation and management note; finding; findings; h&p; history and physical; ir; notes; point in time; rad; radiology; random; visit note,Doc
96196-1,left rods function by erg,l rods function erg,,erg; eye; eye.erg; fcn; finding; findings; func; funct; l; l rods; lt; ophthalmology; ophtho; ophthy; ordinal; point in time; ql; qual; qualitative; random; screen,Ord
96198-7,left cones and rods function by erg,l cones+rods function erg,,erg; eye; eye.erg; fcn; finding; findings; func; funct; l; l cones+rods; l rods; lt; ophthalmology; ophtho; ophthy; ordinal; point in time; ql; qual; qualitative; random; screen,Ord
96202-7,left optic disc and retinal nerve fiber layer function by erg,l optic disc+rnfl function erg,,erg; eye; eye.erg; fcn; fibers; finding; findings; func; funct; l; l optic disc+rnfl; lt; ophthalmology; ophtho; ophthy; ordinal; point in time; ql; qual; qualitative; random; rnfl; screen,Ord
96208-4,left macula function compared to previous assessment by erg,l macula comp func erg,,comp func; erg; eye; eye.erg; fcn; finding; findings; func; funct; l; l macula; lt; ophthalmology; ophtho; ophthy; ordinal; point in time; prev; ql; qual; qualitative; random; screen,Ord
96227-4,multifocal electroretinography (mferg) panel,mferg pnl,,erg; erg pnl; eye; mferg; mferg pnl; pan; panel.eye; panl; pnl; point in time; random,-
96240-7,right macula p1 implicit time--light-adapted by mferg,r macula p1 impl time--light-adapt mferg,,erg; eye; eye.erg; mferg; ophthalmology; ophtho; ophthy; p1 impl time; point in time; qnt; quan; quant; quantitative; r; r macula; random; rt,Qn
96257-1,copper free [mass/volume] in serum or plasma,copper free serpl-mcnc,copper free [mass/vol],chemistry; copper free; cu; fr; level; mass concentration; non-protein bound; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
96260-5,prothrombin time (pt) factor substitution in platelet poor plasma by coagulation assay --2h post incubation with 1:1 normal plasma,pt 2h p 1:1 np ppp,pt factor substitution 2 hr post incubation with 1:1 normal plasma coag (ppp) [time],120 min; 120 minutes; 120min; 2 hours; 2h p 1:1 np; 2h p inc; after; clot; clottable; coag; coagulation assay; control; fac; fact; hematology; heme; i; mixing studies; plas; platelet poor plasma; point in time; pro time; prothrombin time; protime; pst; pt; pt correction study; pt immediate mix; pt incubated mix; qnt; quan; quant; quantitative; random; tilt tube,Qn
96265-4,aptt.factor substitution in platelet poor plasma by coagulation assay --2h post incubation with 1:1 normal plasma,aptt 2h p 1:1 np ppp,aptt.factor substitution 2 hr post incubation with 1:1 normal plasma coag (ppp) [time],120 min; 120 minutes; 120min; 2 hours; 2h p 1:1 np; 2h p inc; activated partial thromboplastin time; after; aptt; aptt correction study; clot; clottable; coag; coagulation assay; control; fac; fact; hematology; heme; i; little(a)ptt; mixing studies; partial thromboplastin time; plas; platelet poor plasma; point in time; pst; ptt; qnt; quan; quant; quantitative; random; surf; tilt tube,Qn
96267-0,delta aptt w excess hexagonal phospholipid [time] in platelet poor plasma by coagulation assay,delta aptt hex ppp,delta aptt w excess hexagonal phospholipid coag (ppp) [time diff],activated partial thromboplastin time; aptt; aptt hex pl; clot; clottable; coag; coagulation assay; delta aptt hex; hematology; heme; hex; hpp; lipid; little(a)ptt; partial thromboplastin time; phoslpd; phospholipids; pl; plas; platelet poor plasma; point in time; ptt; qnt; quan; quant; quantitative; random; staclot la; surf; tilt tube; time difference,Qn
96280-3,european ash wood dust ige ab [units/volume] in serum,european ash wood dust ige qn,european ash wood dust ige qn (s),abs; aby; allergen; allergens; allergy; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; european ash; european ash wood dust; immune globulin e; immunoglobulin e; k34; point in time; qnt; quan; quant; quantitative; random; serum; sr; t25,Qn
96289-4,morphine ige ab [units/volume] in serum,morphine ige qn,morphine ige qn (s),abs; aby; allergen; allergens; allergy; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; c260; immune globulin e; immunoglobulin e; morphine sulfate; ms; mso4; omph; point in time; qnt; quan; quant; quantitative; random; serum; sr,Qn
96292-8,quinoline ige ab [units/volume] in serum,quinoline ige qn,quinoline ige qn (s),1-azanaphthalene; 1-benzazine; 1-benzine; abs; aby; allergen; allergens; allergy; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; benzopyridine; c704; immune globulin e; immunoglobulin e; point in time; qnt; quan; quant; quantitative; quinoline ige; random; serum; sr,Qn
96317-3,acinetobacter calcoaceticus-baumannii complex dna [ncncrange] in lower respiratory specimen by naa with non-probe detection,acb cmplx dna l resp naa+non-prb-ncncrng,a. calcoaceticus-baumannii complex dna naa+non-probe (lower resp) [ncncrange],3 self-sustaining sequence replication; 3sr sr; acb complex; amplif; amplification; amplified; breathing; compx; deoxyribonucleic acid; dna nucleic acid probe; dna probe; id; infectious disease; infectiousdisease; lat; lcr; ligase chain reaction; ligation-activated transcription; low; lower resp; lungs; microbiology; naa+non-probe; naa+probe; naat; nasba; ncncrng; nucleic acid sequence based analysis; pcr; point in time; polymerase chain reaction; probe amp; probe with ampification; probe with target amplification; qbr; random; rs; sda; smqn; spec; strand displacement amplification; tma; transcription mediated amplification,SemiQn
96322-3,klebsiella oxytoca dna [ncncrange] in lower respiratory specimen by naa with non-probe detection,k oxytoca dna l resp naa+non-prb-ncncrng,k. oxytoca dna naa+non-probe (lower resp) [ncncrange],3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; breathing; deoxyribonucleic acid; dna nucleic acid probe; dna probe; id; infectious disease; infectiousdisease; k oxytoca; k oxytoca dna; lat; lcr; ligase chain reaction; ligation-activated transcription; low; lower resp; lungs; microbiology; naa+non-probe; naa+probe; naat; nasba; ncncrng; nucleic acid sequence based analysis; pcr; point in time; polymerase chain reaction; probe amp; probe with ampification; probe with target amplification; qbr; random; rs; sda; smqn; spec; strand displacement amplification; tma; transcription mediated amplification,SemiQn
96329-8,serratia marcescens dna [ncncrange] in lower respiratory specimen by naa with non-probe detection,s marc dna l resp naa+non-prb-ncncrng,s. marcescens dna naa+non-probe (lower resp) [ncncrange],3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; breathing; deoxyribonucleic acid; dna nucleic acid probe; dna probe; id; infectious disease; infectiousdisease; lat; lcr; ligase chain reaction; ligation-activated transcription; low; lower resp; lungs; microbiology; naa+non-probe; naa+probe; naat; nasba; ncncrng; nucleic acid sequence based analysis; pcr; point in time; polymerase chain reaction; probe amp; probe with ampification; probe with target amplification; qbr; random; rs; s marcescens; sda; smqn; spec; strand displacement amplification; tma; transcription mediated amplification,SemiQn
96334-8,diabetology diagnostic study note,diabetology diag study note,,diag study note; doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; notes; point in time; random; study report; visit note,Doc
96354-6,platelets large [#/volume] in blood by automated count,lg platelets # bld auto,platelets large auto (bld) [#/vol],#; abs; absolute; absolutes; auto; automated detection; blood; cnt; count; count/volume; ct; elec; elect; electr; hematology; hematology/cell counts; heme; lg platelets; number concentration; number concentration (count/vol); platelet; platelet count; platelt; plt; point in time; qnt; quan; quant; quantitative; random; thrb; thrombocyte; thrombocytes; wb; whole blood,Qn
96364-5,gabapentin [presence] in saliva (oral fluid) by confirmatory method,gabapentin sal ql cfm,gabapentin confirm ql (sal),cfm; cnfr; cnfrm; conf; confirmation; confirmatory; drug/toxicology; drugs; gcms; horizant; lc/ms/ms; neurontin; oral fluid; ordinal; point in time; pr; ql; qual; qualitative; random; sal; screen,Ord
96408-0,pancreatic polypeptide [mass/volume] in serum or plasma --25m post sham feeding,panc polypept 25m p sham feed serpl-mcnc,pancreatic polypeptide 25m post sham feeding [mass/vol],25m p sham feed; after; chemistry; endocrine; endocrinology; level; mass concentration; panc polypept; pancr; pancreatc; pl; plasma; plsm; point in time; polypeptides; pp; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
96453-6,coagulation factor xi activity and inhibitor panel - platelet poor plasma by coagulation assay,fact xi act + inhib pnl ppp,coagulation factor xi activity and inhibitor panel coag (ppp),activ; actvty; antihemophilic factor c; clot; clottable; coag; coagulation assay; fac; fact; fact xi; fact xi act + inhib pnl; factor 11; fxi; inhib; inhibit; movements; pan; panel.coagulation; panl; plas; plasma thromboplastin antecedent; platelet poor plasma; pnl; point in time; pta; random; tilt tube,-
96455-1,coagulation factor ii activity and inhibitor panel - platelet poor plasma by coagulation assay,fact ii act + inhib pnl ppp,coagulation factor ii activity and inhibitor panel coag (ppp),2; activ; actvty; clot; clottable; coag; coagulation assay; fac; fact; fact ii act + inhib pnl; factor 2; fii; inhib; inhibit; movements; pan; panel.coagulation; panl; plas; platelet poor plasma; pnl; point in time; random; tilt tube,-
96465-0,"inositol 1,4,5-trisphosphate receptor type 1 igg ab [titer] in serum by immunofluorescence",ip3r 1 igg titr ser if,"inositol 1,4,5-trisphosphate receptor type 1 igg if (s) [titer]","abs; aby; acif; antby; anti; antibodies; antibody; anticomplement immunofluorescence; autoantibodies; autoantibody; cyclohexane-1,2,3,4,5,6-hexol; dilution factor; dilution factor (titer); fa; fluorescent antibody; fluoresent; i; ifa; immune fluorescence; immune globulin g; immunoflour; immunofluor; immunofluorescence; immunoglobulin g; insp3r1; ip3 receptor isoform 1; ip3r 1; ip3r 1 ab; ip3r 1 igg; itpr; itpr1; point in time; random; rec; recept; receptors; recp; recptr; serology; serum; smqn; sr; time resolved fluorescence; titer; titered; titre; trf; ttr; type 1 inositol 1,4,5-trisphosphate receptor; type 1 insp3 receptor",SemiQn
96475-9,rho gtpase-activating protein 26 igg ab [presence] in cerebral spinal fluid by cell binding immunofluorescent assay,graf igg csf ql cba ifa,rho gtpase-activating protein 26 igg cell binding immunofluorescent assay ql (csf),abs; aby; antby; anti; antibodies; antibody; arhgap26; autoantibodies; autoantibody; autoimmune cerebellar ataxia; cerebral spinal fluid; cerebrospinal fl; graf; graf ab; graf igg; gtpase regulator associated with focal adhesion kinase pp125; immune globulin g; immunoglobulin g; indirect fluorescence antibody; neuro; neurology; oligophrenin-1-like protein; ophn1l; ordinal; point in time; pr; prot; ql; qual; qualitative; random; screen; serology; spinal fl; spinal fld; spinal flu; spinal fluid,Ord
96476-7,iglon5 igg ab [presence] in serum by immunofluorescence,iglon5 igg ser ql if,iglon5 igg if ql (s),abs; aby; acif; antby; anti; antibodies; antibody; anticomplement immunofluorescence; autoantibodies; autoantibody; fa; fluorescent antibody; fluoresent; ifa; iglon5; iglon5 ab; iglon5 igg; immune fluorescence; immune globulin g; immunoflour; immunofluor; immunofluorescence; immunoglobulin g; ordinal; point in time; pr; ql; qual; qualitative; random; screen; serology; serum; sr; time resolved fluorescence; trf,Ord
96526-9,onyong-nyong virus igm ab [presence] in specimen by immunoassay,onn virus igm spec ql ia,onyong-nyong virus igm ia ql (specimen),abs; aby; alphaviruses; antby; anti; antibodies; antibody; autoantibodies; autoantibody; eia; elfa; elisa; enzyme immunoassay; iaa; id; immune globulin m; immunoglobulin m; infectious disease; infectiousdisease; meia; microbiology; misc; miscellaneous; onn virus; o'nyong-nyong virus; ordinal; other; point in time; pr; ql; qual; qualitative; random; screen; spec; suds; to be specified in another part of the message; unspecified,Ord
965-4,c sup(x) ag [presence] on red blood cells from donor,c sup(x) ag rbc donr ql,c sup(x) ag ql (rbc donor),antigen; antigens; blood bank; c sup(x); donr; erythrocytes; hematology; heme; ordinal; point in time; pr; ql; qual; qualitative; random; red blood cells; red blood corpusles; screen,Ord
9656-0,echinococcus sp igg ab [units/volume] in serum by immunoassay,echinococcus igg ser ia-acnc,echinococcus sp igg ia qn (s),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; echinococcosis; eia; elfa; elisa; enzyme immunoassay; iaa; id; immune globulin g; immunoglobulin g; infectious disease; infectiousdisease; meia; microbiology; p2; point in time; qnt; quan; quant; quantitative; random; serum; species; spp; sr; suds,Qn
96560-8,nuclear pore protein gp210 ab [units/volume] in serum by immunoassay,nuclear pore prot gp210 ab ser ia-acnc,nuclear pore protein gp210 ab ia qn (s),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; eia; elfa; elisa; enzyme immunoassay; iaa; meia; nuc; nuclear pore glycoprotein-210; nuclear pore prot gp210; nucleoporin 210kda; nup210; point in time; pr; prot; qnt; quan; quant; quantitative; random; serology; serum; sr; suds,Qn
96566-5,cabotegravir [susceptibility] by genotype method,cabotegravir islt genotyp,cabotegravir genotyping [susc],antibiotic susceptibilities; ast; genotype; genotypic; islt; isol; ordinal; point in time; ql; qual; qualitative; random; screen; sus; suscept; susceptibilities; susceptibility; susceptibilty,Ord
96569-9,lace index panel,lace index panel,,clin; clin.risk; lace pnl; pan; panel.clinical; panl; pnl; point in time; random,-
96583-0,during the last month did your meals only include a few kinds of cheap foods because your family was running out of money to buy food [u.s. fss - child],,,1 month; 1 month (30 days); 30 days; finding; findings; month; ordinal; past; ql; qual; qualitative; s prime; screen; sdoh,Ord
96585-5,during the last month did you worry that food at home would run out before your family got money to buy more [u.s. fss - child],,,1 month; 1 month (30 days); 30 days; finding; findings; month; ordinal; past; ql; qual; qualitative; s prime; screen; sdoh,Ord
96587-1,aspartate aminotransferase [enzymatic activity/volume] in dbs,ast dbs-ccnc,ast (dbs) [catalytic activity/vol],asp; aspartate amino transferase; aspartate transaminase; aspartic acid; ast; blood; catalytic concentration; chemistry; dbs; dried blood spot; filter paper; fp; glutamic oxaloacetic transaminase; point in time; qnt; quan; quant; quantitative; random; sgot; wb; whole blood,Qn
96590-5,creatinine [mass/volume] in dbs,creat dbs-mcnc,creatinine (dbs) [mass/vol],blood; chemistry; cr; crea; creat; dbs; dried blood spot; filter paper; fp; kidney; level; mass concentration; nephrology; point in time; qnt; quan; quant; quantitative; random; renal; wb; whole blood,Qn
96603-6,sars-cov-2 (covid-19) s protein rbd neutralizing antibody [presence] in serum or plasma by svnt,sars-cov-2 s rbd nab serpl ql svnt,sars-cov-2 (covid-19) s protein rbd neut ab svnt ql,2019 novel coronavirus; 2019-ncov; abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; corona virus; covid19; covid-19; id; ii; infectious disease; infectiousdisease; microbiology; nab; ordinal; pl; plasma; plsm; point in time; pr; prot; ql; qual; qualitative; random; sars coronavirus 1; sars-cov; sars-cov-1; sars-cov-2; sars-cov-2 s; sars-cov-2 s rbd; sars-cov-2 s rbd nab; screen; serp; serpl; serplas; serum; serum or plasma; severe acute respiratory syndrome; sr; surrogate virus neutralization testing; svnt; viral pneumonias; wuhan coronavirus,Ord
96612-7,chlamydia trachomatis and neisseria gonorrhoeae and trichomonas vaginalis dna panel - specimen by naa with probe detection,ct + ng + tv dna pnl spec naa+probe,chlamydia trachomatis and neisseria gonorrhoeae and trichomonas vaginalis dna panel naa+probe (specimen),3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; c trac; c trach; c trach+gc; c tracho; c trachomatis; chlam; chlam trac; chlamid; ct; ct + ng + tv; ct + ng + tv dna; ct + ng + tv dna pnl; ct/gc; deoxyribonucleic acid; dna nucleic acid probe; dna probe; gc; gono; gonorrhea; id; infectious disease; infectiousdisease; lat; lcr; lgv; ligase chain reaction; ligation-activated transcription; lymphogranuloma venereum; microbiology; misc; miscellaneous; n gonorrhoea; n gonorrhoeae; naa+probe; naat; nasba; nucleic acid sequence based analysis; other; pan; panel.microbiology; panl; pcr; pnl; point in time; polymerase chain reaction; probe amp; probe with ampification; probe with target amplification; qbr; random; sda; spec; strand displacement amplification; t vaginalis; tma; to be specified in another part of the message; trachoma; transcription mediated amplification; tric; trich; trichimoniasis; trichomonad; trichomonads; trichomoniasis; unspecified,-
96614-3,hla-a and b and c (class i) typing panel - blood or tissue from donor by high resolution,hla cls i typ pnl bld/t donr high res,hla-a and b and c (class i) typing panel high resolution (bld/tiss donor),"a,b; blood; donr; genetics; heredity; heritable; hla antigen; hla class i; hla cls i typ pnl; hla-a+b; hla-a+b+c; hla-a+b+c (class i); human leukocyte antigen; inherited; pan; panel.hla; panl; pnl; point in time; random; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",-
96620-0,hla-b unresolved alleles [type] by high resolution,hla-b unreslvd alleles high res,hla-b unresolved alleles high resolution nom (bld/tiss),"blood; genetics; heredity; heritable; hla antigen; hla-b unreslvd alleles; human leukocyte antigen; inherited; nominal; point in time; random; tissue; tissue, unspecified; typ; wb; whole blood; whole blood or tissue",Nom
96621-8,hla-c [type] in donor by high resolution,hla-c donr high res,hla-c high resolution nom (bld/tiss donor),"blood; donr; genetics; heredity; heritable; hla antigen; human leukocyte antigen; inherited; nominal; point in time; random; tissue; tissue, unspecified; typ; wb; whole blood; whole blood or tissue",Nom
96627-5,hla-a [type] in donor,hla-a donr,hla-a nom (bld/tiss donor),"blood; donr; hla antigen; human leukocyte antigen; nominal; point in time; random; tissue; tissue, unspecified; typ; wb; whole blood; whole blood or tissue",Nom
96630-9,hla-b [type] in donor by low resolution,hla-b donr low res,hla-b low res nom (bld/tiss donor),"blood; donr; genetics; heredity; heritable; hla antigen; human leukocyte antigen; inherited; nominal; point in time; random; tissue; tissue, unspecified; typ; wb; whole blood; whole blood or tissue",Nom
96642-4,hla-dpa1 [type] in donor by low resolution,hla-dpa1 donr low res,hla-dpa1 low res nom (bld/tiss donor),"blood; donr; genetics; heredity; heritable; hla antigen; human leukocyte antigen; inherited; nominal; point in time; random; tissue; tissue, unspecified; typ; wb; whole blood; whole blood or tissue",Nom
96651-5,hla-dpb1 unresolved alleles [type] by high resolution,hla-dpb1 unreslvd alleles high res,hla-dpb1 unresolved alleles high resolution nom (bld/tiss),"blood; genetics; heredity; heritable; hla antigen; hla-dpb1 unreslvd alleles; human leukocyte antigen; inherited; nominal; point in time; random; tissue; tissue, unspecified; typ; wb; whole blood; whole blood or tissue",Nom
96665-5,hla-drb1 [type] in donor,hla-drb1 donr,hla-drb1 nom (bld/tiss donor),"blood; donr; hla antigen; human leukocyte antigen; nominal; point in time; random; tissue; tissue, unspecified; typ; wb; whole blood; whole blood or tissue",Nom
96669-7,hla-drb3 and hla-drb4 and hla drb5 [type] in donor by low resolution,hla-drb3 + 4 + 5 donr low res,hla-drb3 & hla-drb4 & hla drb5 low res nom (bld/tiss donor),"blood; donr; genetics; heredity; heritable; hla antigen; hla-drb3 + 4 + 5; hla-drb5; human leukocyte antigen; inherited; nominal; point in time; random; tissue; tissue, unspecified; typ; wb; whole blood; whole blood or tissue",Nom
96681-2,activated clotting time.diatomaceous earth+clay induced of blood by microviscometry,act diatom earth+clay ind bld micrvisc,activated clotting time.diatomaceous earth+clay induced microviscometry (bld),act; act diatom earth+clay ind; activ; activated coagulation time; blood; celite; clot; clottable; coagulation; coagulation activated; coagulation time; hematology; heme; micrvisc; point in time; qnt; quan; quant; quantitative; random; rate; r-time; wb; whole blood,Qn
96687-9,clot formation.diatomaceous earth induced panel - blood by microviscometry,clt frm diat erth ind pnl bld micrvisc,clot formation.diatomaceous earth induced panel microviscometry (bld),activated clotting time; blood; celite; cft; clot time; clt frm diat erth ind pnl; coagulation; kinetics; k-time; micrvisc; pan; panel.coagulation; panl; pnl; point in time; random; wb; whole blood,-
96694-5,rate of fibrin formation.diatomaceous earth induced [units] in blood by microviscometry,clot rate diatom earth ind bld micrvisc,rate of fibrin formation.diatomaceous earth induced microviscometry (bld) [units/time],arbitrary rate; blood; celite; clot rate diatom earth ind; coagulation; hematology; heme; micrvisc; point in time; qnt; quan; quant; quantitative; random; wb; whole blood,Qn
96701-8,carbon monoxide/gas total corrected for ambient co exhaled gas --at end expiration,etcoc,,ambient co cor; breath; etcoc; exg; exhaled gas; exhaled gas (=breath); exp; gases; lung; percent; point in time; pulmonary; pulmonology; qnt; quan; quant; quantitative; random; respiratory; tot; totl; volfr; volume fraction,Qn
96722-4,amyloid bodies [#/area] in prostatic fluid by light microscopy,amyloid #/area prost fld micro,amyloid bodies lm (prost fld) [#/area],#/area; bod; body; eps; expressed prostatic secretion; lm; micro; micros; microscopic; number areic; pathology; point in time; prost; prost fld; prostate; prostate secretion; prostati; prostatic secretion; qnt; quan; quant; quantitative; random,Qn
96725-7,xanthoma cells [#/volume] in lower respiratory specimen by manual count,xanthoma cells # lower resp manual,xanthoma cells manual cnt (lower resp) [#/vol],#; abs; absolute; absolutes; breathing; cell; cellularity; cnt; count; count/volume; ct; foamy histiocyte; hematology/cell counts; histiocyte; low; lower resp; lungs; manl; number concentration; number concentration (count/vol); point in time; qnt; quan; quant; quantitative; random; rs; spec,Qn
96730-7,calcified elastic fibers [#/volume] in lower respiratory specimen by manual count,elastic fibers.calc # lower resp manual,calcified elastic fibers manual cnt (lower resp) [#/vol],#; abs; absolute; absolutes; breathing; cnt; count; count/volume; ct; fiber; low; lower resp; lungs; manl; number concentration; number concentration (count/vol); pathology; point in time; qnt; quan; quant; quantitative; random; rs; spec,Qn
96731-5,curschmann's spirals and crystals [type] in lower respiratory specimen by light microscopy,cursch spir + crys lower resp micro,curschmann's spirals and crystals lm nom (lower resp),breathing; crys; cryst; crystal; cursch spir + crys; hematology/cell counts; identity or presence; lm; low; lower resp; lungs; micro; micros; microscopic; nominal; point in time; random; rs; s prime; spec,Nom
9674-3,salmonella sp igm ab [units/volume] in serum,salmonella igm ser-acnc,salmonella sp igm qn (s),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; id; immune globulin m; immunoglobulin m; infectious disease; infectiousdisease; microbiology; point in time; qnt; quan; quant; quantitative; random; sal; salmonel; serum; species; spp; sr,Qn
9677-6,silicone igg ab [units/volume] in serum,silicone igg ser-acnc,silicone igg qn (s),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; dimethylpolysiloxane; immune globulin g; immunoglobulin g; point in time; qnt; quan; quant; quantitative; random; serology; serum; sr,Qn
96780-2,wants help finding or keeping work or a job,,,finding; findings; job; occupation; ordinal; point in time; ql; qual; qualitative; random; screen; sdoh; survey; survey.gnhlth; work,Ord
96783-6,howrwe panel [r-outcomes],,,pan; panel.survey.r-outcomes; panl; pnl; point in time; r prime; random; right; survey; survey.r-outcomes,-
96790-1,sofa total score,sofa total score sofa,,clin; clin.risk; point in time; qnt; quan; quant; quantitative; random; scale; tot; totl,Qn
96798-4,"cortisol, glucose, and somatotropin post arginine stimulation panel - serum or plasma",cortisol+glucose+gh p arginine pnl serpl,"cortisol, glucose, and somatotropin post arginine stimulation panel",17-hydroxycorticosterone; after; arg; chemistry.challenge testing; compound f; coritsol; cort; cortisol+glucose+gh p arginine pnl; endocrine; endocrinology; f; gh; glu; glu tol; gluc; glucose tolerance; glucoseur; growth hormone; gtt; hgh; human growth hormone; hydrocortisone; pan; panel.challenge; panl; pl; plasma; plsm; pnl; point in time; pst; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; somatotropic hormone; sr; sth; stim,Qn
9680-0,cd16+cd57+ cells/cells in blood,cd16+cd57+ cells nfr bld,cd16+cd57+ cells/cells (bld),blood; cd16 cells; cd16+cd57- cells; cd16+cd57+ cells; cd16-cd57+ cells; cell; cell markers; cellularity; fcgr3a; hnk1; leu11; leu-11; leu11b; leu-11b; leu7; leu-7; number fraction; percent; point in time; qnt; quan; quant; quantitative; random; wb; whole blood,Qn
96835-4,"dizzy, lightheaded, or faint, when exposed to news about the coronavirus in past 2 weeks",,,14 days; 2 weeks; c-19 anxiety - dizzy faint; corona virus; finding; findings; last; mental health; mentalhealth; ordinal; psych; psychiatry; ql; qual; qualitative; screen; survey,Ord
96838-8,lost interest in eating when i thought about or was exposed to information about the coronavirus in past 2 weeks,,,14 days; 2 weeks; c-19 anxiety - eating; corona virus; finding; findings; last; mental health; mentalhealth; ordinal; psych; psychiatry; ql; qual; qualitative; screen; survey,Ord
96842-0,how often have you used any tobacco product in past 12 months,tobacco freq 12mo,,1 year; 12mos; count/time; h+p; h+p.hx; last; nrate; number rate; number rate = count/time; ordinal; p prime; ql; qual; qualitative; screen; tobacco freq 12mo,Ord
96882-6,"in the past month, have recommendations for socially distancing caused stress for you",,,1 month; 1 month (30 days); 30 days; c-19 soc dist stress past m; finding; findings; last; month; ordinal; ql; qual; qualitative; screen; survey,Ord
96885-9,"thinking about your current social habits, in the last 5 days: i have attended social gatherings outside my home of more than 10 people",,,5 days; finding; findings; ordinal; ql; qual; qualitative; screen; survey,Ord
96891-7,how often in the past month are you doing the recommended pandemic hygiene,,,1 month; 1 month (30 days); 30 days; c-19 recommended hygiene past mo; finding; findings; last; month; ordinal; ql; qual; qualitative; screen; survey,Ord
96892-5,covid-19 participant experience survey,,,2019 novel coronavirus; 2019-ncov; c-19 participant exp surv; coronavirus disease 2019; covid19; pan; panel; panl; pnl; point in time; random; sars coronavirus; sars-cov-2; sars-related coronavirus,-
96905-5,"mds v3.0 - rai v1.17.2 - bladder and bowel - nd, sd during assessment period [cms assessment]",,,centers for medicare and medicaid assessment; pan; panel; panel.survey.cms; panl; pnl; report period; survey,-
96909-7,cenobamate [mass/volume] in serum or plasma by confirmatory method,cenobamate serpl cfm-mcnc,cenobamate confirm [mass/vol],cfm; cnfr; cnfrm; conf; confirmation; confirmatory; drug/toxicology; drugs; gcms; lc/ms/ms; level; mass concentration; neuro; neurology; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; xcopri,Qn
96917-0,ct average diameter on frontal scout image,ct avg diam frontal scout,,avg diam frontal scout; cat scan; computed tomography; computerized tomography; ct scan; dia; diam; imaging; length; point in time; qnt; quan; quant; quantitative; rad; radiology; random,Qn
96921-2,speckled nuclear ab pattern [titer] in cerebral spinal fluid by immunofluorescence,ana speckled titr csf if,speckled nuclear ab pattern if (csf) [titer],acif; ana; ana pat; ana speckled; anf; anticomplement immunofluorescence; antinuclear antibody; cerebral spinal fluid; cerebrospinal fl; dilution factor; dilution factor (titer); fa; fana; fluorescent antibody; fluoresent; ifa; immune fluorescence; immunoflour; immunofluor; immunofluorescence; na; nuc; point in time; random; rheum; rheumatology; serology; smqn; spinal fl; spinal fld; spinal flu; spinal fluid; time resolved fluorescence; titer; titered; titre; trf; ttr,SemiQn
96941-0,thinking about your friends and family: i have people to talk to,,,finding; findings; ordinal; point in time; ql; qual; qualitative; r prime; random; right; screen; survey; survey.r-outcomes,Ord
96950-1,how do you feel about caring for your health: i know enough about my health,,,finding; findings; ordinal; point in time; ql; qual; qualitative; r prime; random; right; screen; survey; survey.r-outcomes,Ord
9696-6,8-hydroxyloxapine [mass/volume] in serum or plasma,8oh-loxapine serpl-mcnc,8-hydroxyloxapine [mass/vol],8-hydroxy loxapine; 8oh-loxapine; drug/toxicology; drugs; hydroxyl; level; loxitane metabolite; mass concentration; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
96966-7,cd79a gene mutations found [identifier] in blood or tissue by molecular genetics method nominal,cd79a mut anl bld/t,cd79a gene targeted mutation analysis molgen nom (bld/tiss),"agammaglobulinemia 3; b-cell antigen receptor complex-associated protein; blood; identity or presence; ig alpha; iga; mb1; molecular genetics; molecular pathology; molpath; molpath.mutations; mut; mut anl; mutations; nominal; pcr; point in time; random; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",Nom
96979-0,"trisomy 13, trisomy 18 or triploidy risk [interpretation] in plasma cell-free+wbc dna qualitative by calculation",t13+t18+trip risk wbc.dna+cfdna calc-imp,"trisomy 13, trisomy 18 or triploidy risk calc ql (plasma cell-free+wbc dna) [interp]",calc; calculation; edward syndrome; gyn; gynecology; impression; impression/interpretation of study; impressions; interp; interpretation; leukocytes; molecular pathology; molpath; ob; obgyn; obstetrics; ordinal; pl; plasma; plsm; point in time; ql; qual; qualitative; random; screen; t13+t18+trip risk; ts; wbc.dna+cfdna; wbcs; white blood cells,Ord
96980-8,comment on overall fetal aneuploidy risk [text] in plasma cell-free+wbc dna by dosage of chromosome-specific cfdna narrative,comment aneu risk wbc.dna+cfdna,comment on overall fetal aneuploidy risk dosage of chromosome-specific cfdna nar (plasma cell-free+wbc dna),chromosom; chromosomes; cmmt; cmnt; com; comm; comment aneu risk; comments; commt; gyn; gynecology; leukocytes; molecular pathology; molpath; narrative; ob; obgyn; obstetrics; pl; plasma; plsm; point in time; random; remarks; report; spec; text; wbc.dna+cfdna; wbcs; white blood cells,Nar
96984-0,chromosome analysis in products of conception by microarray,chrom analy poc microarray,chr analysis microarray doc (products of conception),arrcgh; chrom analy; chromosom; chromosomes; cytogenetics; document; finding; findings; gyn; gynecology; karyotype; molecular pathology; molpath; ob; obgyn; obstetrics; point in time; products of conception; random,Doc
96985-7,sex [type] in products of conception by molecular genetics method,sex poc,sex molgen nom (products of conception),gender; gyn; gynecology; molecular genetics; molecular pathology; molpath; nominal; ob; obgyn; obstetrics; pcr; point in time; products of conception; random; typ,Nom
96987-3,mass vaccination status [cdc emergency operations centers],,,cdc emergency operations centers; cdc eoc; centers for disease control and prevention; immunizations; pan; panel; panel.survey.cdc; panl; ph; pnl; point in time; public health; publichealth; random; survey; survey.cdc; vaccine,-
96992-3,state where vaccine was administered,vaccine administration state,,location; nominal; ph; point in time; public health; publichealth; random,Nom
96996-4,people who have received first dose of vaccine [#] population,people rcvd first dose of vaccine pop,,cnt; count; number; people rcvd first dose of vaccine; ph; point in time; public health; publichealth; qnt; quan; quant; quantitative; random; world heatlth organization,Qn
96998-0,count of people who are fully vaccinated in population,people who fully vaccinated pop,,cnt; count; number; people who fully vaccinated; ph; point in time; public health; publichealth; qnt; quan; quant; quantitative; random; vaccine; world heatlth organization,Qn
9701-4,sulfisoxazole [mass/volume] in serum or plasma,sulfisoxaz serpl-mcnc,sulfisoxazole [mass/vol],drug/toxicology; drugs; gantrisin; level; mass concentration; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; sulfizole,Qn
97030-1,level of spine intervention,level of spine intervention,,finding; findings; levels; levl; lv; lvl; nominal; point in time; random; surg,Nom
97037-6,medication for spinal surgery or pathology,meds spinal surgery/pathology,,finding; findings; meds spinal surgery/pathology; nominal; path; point in time; random; surg,Nom
97039-2,overall outcome of spine surgery,overall outcome of spine surgery,,finding; findings; nominal; point in time; random; surg,Nom
97043-4,postoperative complication occurred,postop comp occurred,,finding; findings; ordinal; point in time; postop comp occurred; ql; qual; qualitative; random; screen; surg,Ord
97044-2,postoperative complication timing,postop complication timing,,finding; findings; nominal; point in time; postop complication timing; random; surg,Nom
97047-5,postoperative complication effect on recovery,postop comp effect on recvry,,finding; findings; nominal; point in time; postop comp effect on recvry; random; surg,Nom
97058-2,waist circumference score for risk calculation,waist circ score for risk calc,,girth; h+p; h+p.px; ordinal; p prime; point in time; ql; qual; qualitative; random; scale; screen; waist circ score for risk calc,Ord
97103-6,zygosity [type] in fetuses by molecular genetics method,zygosity in fetuses,zygosity molgen nom (fetuses),fetal; gyn; gynecology; molecular genetics; molecular pathology; molpath; multiple births; nominal; ob; obgyn; obstetrics; pcr; point in time; random; twin zygosity; typ,Nom
97104-4,sars-cov-2 (covid-19) orf1ab region [units/volume] (viral load) in upper respiratory specimen by naa with probe detection,sars-cov-2 orf1ab u resp naa+probe-acnc,sars-cov-2 (covid-19) orf1ab region naa+probe qn (upper resp),2019 novel coronavirus; 2019-ncov; 3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; arbitrary concentration; breathing; corona virus; covid19; covid-19; dna nucleic acid probe; dna probe; id; ii; infectious disease; infectiousdisease; lat; lcr; ligase chain reaction; ligation-activated transcription; lungs; microbiology; naa+probe; naat; nasba; nucleic acid sequence based analysis; pcr; ph; point in time; polymerase chain reaction; probe amp; probe with ampification; probe with target amplification; public health; publichealth; qbr; qnt; quan; quant; quantitative; random; rs; sars coronavirus 1; sars-cov; sars-cov-1; sars-cov-2; sars-cov-2 orf1ab; sda; severe acute respiratory syndrome; spec; strand displacement amplification; tma; transcription mediated amplification; up; upper resp; viral load; viral pneumonias; wuhan coronavirus,Qn
97106-9,hepatitis a virus cellular receptor 1 [mass/volume] in urine by immunoassay,havcr-1 ur ia-mcnc,havcr-1 ia (u) [mass/vol],chemistry; eia; elfa; elisa; enzyme immunoassay; hav; havcr-1; hep; hep a; hepatis; hepatit; hepatitis; hepatitis type a; i; iaa; id; infectious disease; infectiousdisease; kidney injury molecule 1; kim-1; level; mass concentration; meia; point in time; qnt; quan; quant; quantitative; random; rec; recept; receptors; recp; recptr; suds; t-cell immunoglobulin and mucin domain-containing protein 1; t-cell immunoglobulin mucin receptor 1; t-cell membrane protein 1; tim-1; timd-1; ua; ur; urn,Qn
97127-5,how helpful has cooking or baking been as a coping strategy during the covid-19 outbreak,,,2019 novel coronavirus; 2019-ncov; arterial stenosis; coronavirus disease 2019; covid19; finding; findings; ordinal; point in time; ql; qual; qualitative; random; sars coronavirus; sars-cov-2; sars-related coronavirus; screen; survey,Ord
97129-1,how helpful has cleaning or doing household chores been as a coping strategy during the covid-19 outbreak,,,2019 novel coronavirus; 2019-ncov; arterial stenosis; coronavirus disease 2019; covid19; finding; findings; ordinal; point in time; ql; qual; qualitative; random; sars coronavirus; sars-cov-2; sars-related coronavirus; screen; survey,Ord
97146-5,how helpful was your child's coping strategy during the covid-19 outbreak,,,2019 novel coronavirus; 2019-ncov; coronavirus disease 2019; covid19; finding; findings; ordinal; point in time; ql; qual; qualitative; random; s prime; sars coronavirus; sars-cov-2; sars-related coronavirus; screen; survey,Ord
97148-1,guanidinoacetate [moles/volume] in urine,guanidinoacetate ur-scnc,guanidinoacetate (u) [moles/vol],chemistry; gaa; glycocyamine; guanidinoacetic acid; guanidoacetic acid; level; neuro; neurology; point in time; qnt; quan; quant; quantitative; random; substance concentration; ua; ur; urn,Qn
97150-7,prostate health index in serum or plasma by calculation,phi score serpl calc,prostate health index calc [score],calc; calculation; chemistry; phi; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; scale; serp; serpl; serplas; serum; serum or plasma; sr,Qn
97157-2,human papilloma virus 6+11+42+43+44 dna [presence] in genital specimen by probe with signal amplification,hpv low risk dna genital ql prb+sig amp,hpv 6+11+42+43+44 dna probe+sig amp ql (genital specimen),amplif; amplification; amplified; bdna; bdn-a; branched chain dna; deoxyribonucleic acid; dna nucleic acid probe; dna probe; gen; genital tract; genital warts; hc; hpa; hpv; hpv low risk; hpv6; hpv6+11; human papillomavirus; hybidization protection assay; hybrid capture; hybrid capture nucleic acid hybridization; id; infectious disease; infectiousdisease; microbiology; ordinal; papilloma virus low risk; point in time; pr; probe amp; probe with ampification; probe with signal amplification; probe+sig amp; ql; qual; qualitative; random; screen; urogenit; urogenital,Ord
9716-2,streptococcal hyaluronidase ab [titer] in serum,str hyaluronidase ab titr ser,s. hyaluronidase ab (s) [titer],abs; aby; ah; antby; anti; antibodies; antibody; autoantibodies; autoantibody; dilution factor; dilution factor (titer); id; infectious disease; infectiousdisease; microbiology; point in time; random; serum; smqn; sr; str hyaluronidase; titer; titered; titre; ttr,SemiQn
97202-6,icteric interference index of urine,icteric interf index ur-acnc,icteric interference index qn (u),arbitrary concentration; icteric interf index; point in time; qnt; quan; quant; quantitative; random; spec; ua; ur; urn,Qn
97203-4,lipemic interference index of urine,lipemic interf index ur-acnc,lipemic interference index qn (u),arbitrary concentration; lipemic interf index; point in time; qnt; quan; quant; quantitative; random; spec; ua; ur; urn,Qn
97218-2,alprazolam [presence] in cord tissue by screen method,alpraz tissco ql scn,alprazolam screen ql (umb cord tissue),drug/toxicology; drugs; niravam; ordinal; point in time; pr; ql; qual; qualitative; random; scn; scr; screen; scrn; xanax,Ord
97233-1,cocaethylene [presence] in cord tissue by confirmatory method,cocaethylene tissco ql cfm,cocaethylene confirm ql (umb cord tissue),cfm; cnfr; cnfrm; cocaine/ethanol by-product; conf; confirmation; confirmatory; drug/toxicology; drugs; gcms; lc/ms/ms; ordinal; point in time; pr; ql; qual; qualitative; random; screen,Ord
97237-2,codeine free [presence] in cord tissue by confirmatory method,codeine free tissco ql cfm,codeine free confirm ql (umb cord tissue),addiction; c260; c300; cfm; cnfr; cnfrm; codeine free; conf; confirmation; confirmatory; drug/toxicology; drugs; drugs of abuse; fr; gcms; illicit; lc/ms/ms; methylmorphine; morphine methyl ether; non-protein bound; ordinal; point in time; potentialforabuse; pr; ql; qual; qualitative; random; screen,Ord
9725-3,spermatozoa igm ab [units/volume] in serum,sperm igm ser-acnc,spermatozoa igm qn (s),abs; aby; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; fertility testing; genitourinary; gu; immune globulin m; immunoglobulin m; point in time; qnt; quan; quant; quantitative; random; serum; sperm; sr; uro; urology,Qn
97253-9,flurazepam [presence] in cord tissue by confirmatory method,flurazepam tissco ql cfm,flurazepam confirm ql (umb cord tissue),cfm; cnfr; cnfrm; conf; confirmation; confirmatory; dalmane; drug/toxicology; drugs; gcms; lc/ms/ms; ordinal; point in time; pr; ql; qual; qualitative; random; screen,Ord
97254-7,hydrocodone free [presence] in cord tissue by screen method,hydrocodone free tissco ql scn,hydrocodone free screen ql (umb cord tissue),addiction; anexsia; dihydrocodeinone; drug/toxicology; drugs; drugs of abuse; fr; hydrocodone free; illicit; non-protein bound; ordinal; point in time; potentialforabuse; pr; ql; qual; qualitative; random; scn; scr; screen; scrn; vicodin,Ord
97261-2,lorazepam [presence] in cord tissue by confirmatory method,lorazepam tissco ql cfm,lorazepam confirm ql (umb cord tissue),addiction; ativan; cfm; cnfr; cnfrm; conf; confirmation; confirmatory; drug/toxicology; drugs; drugs of abuse; gcms; illicit; lc/ms/ms; ordinal; point in time; potentialforabuse; pr; ql; qual; qualitative; random; screen,Ord
97268-7,meperidine [presence] in cord tissue by screen method,meperidine tissco ql scn,meperidine screen ql (umb cord tissue),addiction; algil; alodan; centralgine; demerol; dispadol; dolantin; dolosal; drug/toxicology; drugs; drugs of abuse; illicit; ordinal; pethidine; point in time; potentialforabuse; pr; ql; qual; qualitative; random; scn; scr; screen; scrn,Ord
97274-5,methamphetamine [presence] in cord tissue by screen method,methamphet tissco ql scn,methamphetamine screen ql (umb cord tissue),addiction; desoxyn; drug/toxicology; drugs; drugs of abuse; illicit; methamphet; ordinal; point in time; potentialforabuse; pr; ql; qual; qualitative; random; scn; scr; screen; scrn,Ord
97284-4,norfentanyl [presence] in cord tissue by screen method,norfentanyl tissco ql scn,norfentanyl screen ql (umb cord tissue),addiction; drug/toxicology; drugs; drugs of abuse; fentanyl metabolite; illicit; ordinal; point in time; potentialforabuse; pr; ql; qual; qualitative; random; scn; scr; screen; scrn,Ord
97310-7,zolpidem [presence] in cord tissue by screen method,zolpidem tissco ql scn,zolpidem screen ql (umb cord tissue),addiction; adormix; ambien; ambien cr; damixan; drug/toxicology; drugs; drugs of abuse; edluar; hypnogen; illicit; ivedal; lioran; myslee; nasen; nytamel; ordinal; point in time; potentialforabuse; pr; ql; qual; qualitative; random; sanval; scn; scr; screen; scrn; somidem; stilnoct; stilnox; stilnox cr; sucedal; zoldem; zolpihexal; zolpimist,Ord
9731-1,phosphoethanolamine [mass/time] in 24 hour urine,petn 24h ur-mrate,phosphoethanolamine (24h u) [mass/time],1 day; 24 hours; 24hr; chemistry; mass rate; mrate; pea; petn; qnt; quan; quant; quantitative; ua; ur; urn,Qn
97341-2,xr finger second - right ap,xr finger.2nd-r ap,,1v; 2nd; anterio-posterior; anteroposterior; arm; document; ext; extr-r; film; finding; findings; finger.2nd-r; finger-r; imaging; msk; musculoskeletal; ortho; orthopedics; plain films; point in time; r; radiology; random; rt; rue; single view; ue; ue-r; up; vw; xray; x-ray,Doc
97342-0,xr finger second - right pa,xr finger.2nd-r pa,,1v; 2nd; arm; document; ext; extr-r; film; finding; findings; finger.2nd-r; finger-r; imaging; msk; musculoskeletal; ortho; orthopedics; plain films; point in time; postero-anterior; r; radiology; random; rt; rue; single view; ue; ue-r; up; vw; xray; x-ray,Doc
97346-1,xr radius and ulna - left ap,xr radius+ulna-l ap,,1v; anterio-posterior; anteroposterior; arm; document; ext; extr-l; film; finding; findings; forearm; imaging; l; lt; lue; msk; musculoskeletal; ortho; orthopedics; plain films; point in time; radiology; radius+ulna-l; random; single view; ue; ue-l; up; upper extremity; vw; xray; x-ray,Doc
97368-5,xr shoulder ap internal rotation,xr should ap ir,,1v; anterio-posterior; anteroposterior; ap ir; arm; document; ext; film; finding; findings; imaging; msk; musculoskeletal; ortho; orthopedics; plain films; point in time; radiology; random; single view; ue; up; upper extremity joint; vw; xray; x-ray,Doc
97369-3,xr sternoclavicular joint - bilateral oblique,xr sc joint-bl obl,,1v; bil; bilat; both; cxr; document; film; finding; findings; imaging; jnt; msk; musculoskeletal; obl; ortho; orthopedics; plain films; point in time; radiology; random; sc joint; sc joint-bl; scj; single view; thorax; upper extremity joint; vw; xray; x-ray,Doc
97371-9,xr sternoclavicular joint - bilateral ap,xr sc joint-bl ap,,1v; anterio-posterior; anteroposterior; bil; bilat; both; cxr; document; film; finding; findings; imaging; jnt; msk; musculoskeletal; ortho; orthopedics; plain films; point in time; radiology; random; sc joint; sc joint-bl; scj; single view; thorax; upper extremity joint; vw; xray; x-ray,Doc
97397-4,xr finger third - left ap and lateral,xr finger.3rd-l ap+lat,,3rd; anterio-posterior; anteroposterior; ap+lat; arm; document; ext; extr-l; films; finding; findings; finger.3rd-l; finger-l; imaging; l; lat; lt; lue; msk; musculoskeletal; ortho; orthopedics; plain films; point in time; radiology; random; ue; ue-l; up; view; views & ap kub; views (ap; views ap kub & lateral; views+ap; vws; xray; x-ray,Doc
97399-0,xr finger fourth - left ap and lateral,xr finger.4th-l ap+lat,,4th; anterio-posterior; anteroposterior; ap+lat; arm; document; ext; extr-l; films; finding; findings; finger.4th-l; finger-l; imaging; l; lat; lt; lue; msk; musculoskeletal; ortho; orthopedics; plain films; point in time; radiology; random; ue; ue-l; up; view; views & ap kub; views (ap; views ap kub & lateral; views+ap; vws; xray; x-ray,Doc
97404-8,xr finger second - right ap and lateral,xr finger.2nd-r ap+lat,,2nd; anterio-posterior; anteroposterior; ap+lat; arm; document; ext; extr-r; films; finding; findings; finger.2nd-r; finger-r; imaging; lat; msk; musculoskeletal; ortho; orthopedics; plain films; point in time; r; radiology; random; rt; rue; ue; ue-r; up; view; views & ap kub; views (ap; views ap kub & lateral; views+ap; vws; xray; x-ray,Doc
97413-9,xr great toe - left ap and lateral and oblique,xr great toe-l ap+lat+obl,,anterio-posterior; anteroposterior; ap+lat; ap+lat+obl; document; ext; extr-l; films; finding; findings; great toe-l; imaging; l; lat; le; leg; le-l; lle; low; lt; msk; musculoskeletal; obl; ortho; orthopedics; phalange; plain films; point in time; radiology; random; view; views & ap kub; views (ap; views ap kub & lateral; views+ap; vws; xray; x-ray,Doc
97415-4,xr toe fourth - left ap and lateral,xr toe 4th-l ap+lat,,4th; 4th toe; anterio-posterior; anteroposterior; ap+lat; document; ext; extr-l; films; finding; findings; imaging; l; lat; le; leg; le-l; lle; low; lt; msk; musculoskeletal; ortho; orthopedics; phalange; plain films; point in time; radiology; random; ring toe; toe 4th-l; view; views & ap kub; views (ap; views ap kub & lateral; views+ap; vws; xray; x-ray,Doc
97417-0,xr toe fifth - left ap and lateral,xr toe 5th-l ap+lat,,5th; 5th toe; anterio-posterior; anteroposterior; ap+lat; document; ext; extr-l; films; finding; findings; imaging; l; lat; le; leg; le-l; little toe; lle; low; lt; msk; musculoskeletal; ortho; orthopedics; phalange; plain films; point in time; radiology; random; toe 5th-l; view; views & ap kub; views (ap; views ap kub & lateral; views+ap; vws; xray; x-ray,Doc
97418-8,xr great toe - left ap and lateral,xr great toe-l ap+lat,,anterio-posterior; anteroposterior; ap+lat; document; ext; extr-l; films; finding; findings; great toe-l; imaging; l; lat; le; leg; le-l; lle; low; lt; msk; musculoskeletal; ortho; orthopedics; phalange; plain films; point in time; radiology; random; view; views & ap kub; views (ap; views ap kub & lateral; views+ap; vws; xray; x-ray,Doc
97433-7,xr finger fourth - right lateral,xr finger.4th-r lat,,1v; 4th; arm; document; ext; extr-r; film; finding; findings; finger.4th-r; finger-r; imaging; lat; msk; musculoskeletal; ortho; orthopedics; plain films; point in time; r; radiology; random; rt; rue; single view; ue; ue-r; up; vw; xray; x-ray,Doc
9743-6,isoleucine [mass/volume] in cerebral spinal fluid,isoleucine csf-mcnc,isoleucine (csf) [mass/vol],cerebral spinal fluid; cerebrospinal fl; chemistry; ile; level; mass concentration; point in time; qnt; quan; quant; quantitative; random; spinal fl; spinal fld; spinal flu; spinal fluid,Qn
97445-1,xr finger third - right oblique,xr finger.3rd-r obl,,1v; 3rd; arm; document; ext; extr-r; film; finding; findings; finger.3rd-r; finger-r; imaging; msk; musculoskeletal; obl; ortho; orthopedics; plain films; point in time; r; radiology; random; rt; rue; single view; ue; ue-r; up; vw; xray; x-ray,Doc
97454-3,xr toe third - bilateral oblique,xr toe 3rd-bl obl,,1v; 3rd; 3rd toe; bil; bilat; both; document; ext; extr-bl; film; finding; findings; imaging; le; le-bl; leg; low; middle toe; msk; musculoskeletal; obl; ortho; orthopedics; phalange; plain films; point in time; radiology; random; single view; toe 3rd-bl; vw; xray; x-ray,Doc
97458-4,xr toe fourth - bilateral ap,xr toe 4th-bl ap,,1v; 4th; 4th toe; anterio-posterior; anteroposterior; bil; bilat; both; document; ext; extr-bl; film; finding; findings; imaging; le; le-bl; leg; low; msk; musculoskeletal; ortho; orthopedics; phalange; plain films; point in time; radiology; random; ring toe; single view; toe 4th-bl; vw; xray; x-ray,Doc
97467-5,xr great toe - left lateral,xr great toe-l lat,,1v; document; ext; extr-l; film; finding; findings; great toe-l; imaging; l; lat; le; leg; le-l; lle; low; lt; msk; musculoskeletal; ortho; orthopedics; phalange; plain films; point in time; radiology; random; single view; vw; xray; x-ray,Doc
97483-2,xr toe fourth - right oblique,xr toe 4th-r obl,,1v; 4th; 4th toe; document; ext; extr-r; film; finding; findings; imaging; le; leg; le-r; low; msk; musculoskeletal; obl; ortho; orthopedics; phalange; plain films; point in time; r; radiology; random; ring toe; rle; rt; single view; toe 4th-r; vw; xray; x-ray,Doc
97504-5,percent sensor usage,sensor usage %,,calc; calculation; h+p; h+p.hx; p prime; qnt; quan; quant; quantitative; report period; sensor usage %,Qn
97508-6,number of providers seen for condition of interest,num providers seen,,cnt; count; disease; disorder; h+p; h+p.hx; no; num; num providers seen; number; p prime; point in time; qnt; quan; quant; quantitative; random; virus,Qn
97523-5,hepatitis a virus rna [presence] in specimen by naa with probe detection,hav rna spec ql naa+probe,hav rna naa+probe ql (specimen),3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; dna nucleic acid probe; dna probe; hav; hep; hep a; hepatis; hepatit; hepatitis; hepatitis type a; id; infectious disease; infectiousdisease; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; misc; miscellaneous; naa+probe; naat; nasba; nucleic acid sequence based analysis; ordinal; other; pcr; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; ribonucleic acid; screen; sda; spec; strand displacement amplification; tma; to be specified in another part of the message; transcription mediated amplification; unspecified,Ord
97529-2,naegleria fowleri [presence] in specimen by organism specific culture,n fowleri spec ql cult,n. fowleri org specific cx ql (specimen),amebic meningoencephalitis; c&s; cult; cultures; id; infectious disease; infectiousdisease; microbiology; misc; miscellaneous; n fowleri; ordinal; other; point in time; pr; ql; qual; qualitative; random; screen; spec; to be specified in another part of the message; unspecified,Ord
9753-5,coxsackievirus a2 ab [titer] in serum by complement fixation,cv a2 ab titr ser cf,coxsackievirus a2 ab cf (s) [titer],abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; cav; cf; comp fixation; compfix; complement fixation; coxsackie; coxsackie virus; cv; cv a2; dilution factor; dilution factor (titer); id; infectious disease; infectiousdisease; microbiology; point in time; random; serum; smqn; sr; titer; titered; titre; ttr,SemiQn
97538-3,carbon dioxide [partial pressure] in central venous blood,pco2 bldcv,co2 (bldcv) [partial pressure],carbonic anhydride; chemistry; co2; partial pressure; pco2; point in time; qnt; quan; quant; quantitative; random,Qn
97546-6,base excess in central venous blood by calculation,base excess bldcv calc-scnc,base excess calc (bldcv) [moles/vol],base ex; be; bse; calc; calculation; chemistry; exs; level; point in time; qnt; quan; quant; quantitative; random; substance concentration,Qn
97588-8,dextromethorphan+levomethorphan [presence] in cord tissue by screen method,d+l-methorphan tissco ql scn,dextromethorphan+levomethorphan screen ql (umb cord tissue),addiction; d+l-methorphan; dextro-methorphan; d-methorphan; drug/toxicology; drugs; drugs of abuse; illicit; ordinal; point in time; potentialforabuse; pr; ql; qual; qualitative; random; scn; scr; screen; scrn,Ord
97589-6,dextromethorphan+levomethorphan [presence] in cord tissue by confirmatory method,d+l-methorphan tissco ql cfm,dextromethorphan+levomethorphan confirm ql (umb cord tissue),addiction; cfm; cnfr; cnfrm; conf; confirmation; confirmatory; d+l-methorphan; dextro-methorphan; d-methorphan; drug/toxicology; drugs; drugs of abuse; gcms; illicit; lc/ms/ms; ordinal; point in time; potentialforabuse; pr; ql; qual; qualitative; random; screen,Ord
97595-3,cd3+cd4+ (t4 helper) cells/lymphocytes in lower respiratory specimen by flow cytometry (fc),cd3+cd4+ cells/lymph nfr lower resp fc,cd3+cd4+ (t4 helper) cells/lymphocytes fc (lower resp),breathing; cd3 cells; cd3+cd4+ cells; cd3-cd4+; cd4+ t cells; cell; cell markers; cellularity; dynamic; fc; helper t cells; inducer t cells; l3t4; leu3; leu-3; leu4; leu-4; low; lower resp; lung; lungs; lymp; lymph; lympho; lymphocyte; lymphs; lymphs%; number fraction; percent; point in time; pulmonary; pulmonology; qnt; quan; quant; quantitative; random; respiratory; rs; spec; t3; t4; t-4; t4 helper/inducer cells; w3/25,Qn
97606-8,plpeth [mass/volume] in blood,plpeth bld-mcnc,plpeth (bld) [mass/vol],1-palmitoyl-2-linoleoyl-sn-glycero-3-phosphoethanol; binge drinking; blood; drug/toxicology; drugs; ii; level; mass concentration; peth; phosphatidylethanol 16:0/18:2; plpeth; point in time; qnt; quan; quant; quantitative; random; wb; whole blood,Qn
97618-3,enterococcus faecium dna [presence] in synovial fluid by naa with non-probe detection,e faecium dna snv ql naa+non-probe,e. faecium dna naa+non-probe ql (syn fld),3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; deoxyribonucleic acid; dna nucleic acid probe; dna probe; e faecium; id; infectious disease; infectiousdisease; joint aspirate; joint fld; joint flu; joint fluid; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; msk; musculoskeletal; naa+non-probe; naa+probe; naat; nasba; nucleic acid sequence based analysis; ordinal; ortho; orthopedics; pcr; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; screen; sda; sf; snv; strand displacement amplification; syn; syn fl; synov; synovial fluid; tma; transcription mediated amplification,Ord
97621-7,haemophilus influenzae dna [presence] in synovial fluid by naa with non-probe detection,haem influ dna snv ql naa+non-probe,h. influenzae dna naa+non-probe ql (syn fld),3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; deoxyribonucleic acid; dna nucleic acid probe; dna probe; h flu; h influenza; h influenzae; haem influ; haemoph; id; infectious disease; infectiousdisease; influ; joint aspirate; joint fld; joint flu; joint fluid; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; msk; musculoskeletal; naa+non-probe; naa+probe; naat; nasba; nucleic acid sequence based analysis; ordinal; ortho; orthopedics; pcr; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; screen; sda; sf; snv; strand displacement amplification; syn; syn fl; synov; synovial fluid; tma; transcription mediated amplification,Ord
97624-1,klebsiella pneumoniae+klebsiella variicola+klebsiella quasipneumoniae dna [presence] in synovial fluid by naa with non-probe detection,k. pneumon group dna snv ql naa+non-prb,k. pneumoniae+variicola+quasipneumoniae dna naa+non-probe ql (syn fld),3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; deoxyribonucleic acid; dna nucleic acid probe; dna probe; id; infectious disease; infectiousdisease; joint aspirate; joint fld; joint flu; joint fluid; k pneumon; k. pneumon group; klebsiella pneumoniae group; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; msk; musculoskeletal; naa+non-probe; naa+probe; naat; nasba; nucleic acid sequence based analysis; ordinal; ortho; orthopedics; pcr; pneu; pneum; pneumo; pneumon; pneumonia; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; screen; sda; sf; snv; strand displacement amplification; syn; syn fl; synov; synovial fluid; tma; transcription mediated amplification,Ord
97627-4,parvimonas micra dna [presence] in synovial fluid by naa with non-probe detection,p micra dna snv ql naa+non-probe,p. micra dna naa+non-probe ql (syn fld),3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; deoxyribonucleic acid; dna nucleic acid probe; dna probe; id; infectious disease; infectiousdisease; joint aspirate; joint fld; joint flu; joint fluid; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; msk; musculoskeletal; naa+non-probe; naa+probe; naat; nasba; nucleic acid sequence based analysis; ordinal; ortho; orthopedics; p micra; p micra dna; pcr; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; screen; sda; sf; snv; strand displacement amplification; syn; syn fl; synov; synovial fluid; tma; transcription mediated amplification,Ord
97638-1,streptococcus pyogenes dna [presence] in synovial fluid by naa with non-probe detection,s pyo dna snv ql naa+non-probe,s. pyogenes dna naa+non-probe ql (syn fld),3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; deoxyribonucleic acid; dna nucleic acid probe; dna probe; gas; group a strep; id; infectious disease; infectiousdisease; joint aspirate; joint fld; joint flu; joint fluid; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; msk; musculoskeletal; naa+non-probe; naa+probe; naat; nasba; nucleic acid sequence based analysis; ordinal; ortho; orthopedics; pcr; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; s pyogenes; screen; sda; sf; snv; steptococcus group a; strand displacement amplification; strep; strept; streptococci group a; streptococcus group a; syn; syn fl; synov; synovial fluid; tma; transcription mediated amplification,Ord
97642-3,drvvt/drvvt.excess phospholipid [ratio] normalized in platelet poor plasma by coagulation assay,drvvt/drvvt cfm nrmlzd ppp-rto,drvvt/drvvt.excess phospholipid normalized coag (ppp) [ratio],clot; clottable; coag; coagulation assay; coagulation dilute russell viper venom induced confirmatory test; dil; dil russell vip ven; dilut; drvv; drvvt; drvvt cfm; drvvt confirm; drvvt confirmation test; drvvt/drvvt cfm; exs; hematology; heme; lipid; nrmlzd; phoslpd; phospholipids; pl; plas; platelet poor plasma; point in time; qnt; quan; quant; quantitative; random; ratios; rto; rus; rvv; screening test for lupus anticoagulant; tilt tube,Qn
97645-6,parainfluenza virus 1+2+3+4 rna [presence] in specimen by naa with probe detection,hpiv 1+2+3+4 rna spec ql naa+probe,parainfluenza virus 1+2+3+4 rna naa+probe ql (specimen),3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; dna nucleic acid probe; dna probe; hpiv; hpiv 1+2+3+4; hpiv 1+2+3+4 rna; hpiv1; hpiv1+2+3; human respirovirus 1; i; id; ii; iii; infectious disease; infectiousdisease; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; misc; miscellaneous; naa+probe; naat; nasba; nucleic acid sequence based analysis; ordinal; other; para; parainflu; parainfluenza type 1; parainfluenza type i; pcr; pi1; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; ribonucleic acid; screen; sda; spec; strand displacement amplification; tma; to be specified in another part of the message; transcription mediated amplification; unspecified,Ord
97685-2,rheumatology history and physical note,rheumatology h&p note,,doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; h&p note; hx; notes; point in time; random; visit note,Doc
97696-9,psychiatry evaluation note,psychiatric eval note,,assessment; doc.ont; document; encounter; eval; eval note; evaluation and management; evaluation and management note; finding; findings; h&p; history and physical; notes; point in time; psychiatric; random; visit note,Doc
97700-9,burn management discharge summary,burn d/c sum,,d/c sum; disch; discharge summary; doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; notes; point in time; random; visit note,Doc
97704-1,radiation oncology discharge summary,radiation onc d/c sum,,cancer; d/c sum; disch; discharge summary; doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; notes; point in time; random; visit note,Doc
97715-7,surgery of the hand history and physical note,hand surgery h&p note,,doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; h&p note; hand surgery; hx; notes; point in time; random; surg; upper extremity; visit note,Doc
97742-1,estradiol (e2) [mass/volume] in aspirate,estradiol aspirate-mcnc,e2 (asp) [mass/vol],17-beta estradiol; aspirate; chemistry; e2; endocrine; endocrinology; level; mass concentration; oestradiol; point in time; qnt; quan; quant; quantitative; random,Qn
97755-3,oxalate [mass/volume] in body fluid,oxalate fld-mcnc,oxalate (body fld) [mass/vol],"b/f; bf; bod; bodies; body fluid; body fluid, unsp; chemistry; ethanedioate; ethanedioic acid; fl; fld; flu; fluid; level; mass concentration; oxal; oxalic acid; point in time; qnt; quan; quant; quantitative; random",Qn
97763-7,beta 2 globulin/protein.total in 24 hour urine by electrophoresis,beta2 glob 24h mfr ur elph,beta 2 globulin elph (24h u) [mass fraction],1 day; 24 hours; 24hr; b; b2 globulin; beta2 glob; chemistry; elec; elect; electr; electro; electrophhrs; electrophrs; elp; elph; ep; glb; glob; glob%; globul; globulins; ii; mass fraction; percent; peur; pr; prot; qnt; quan; quant; quantitative; tot; totl; tp; ua; upep; ur; urn,Qn
97771-0,protein.monoclonal band 1 [mass/volume] in 24 hour urine by electrophoresis,m protein 1 24h ur elph-mcnc,protein.monoclonal band 1 elph (24h u) [mass/vol],1 day; 24 hours; 24hr; bands; bnd; chemistry; elec; elect; electr; electro; electrophhrs; electrophrs; elp; elph; ep; hematology; heme; i; level; m protein; m protein 1; mass concentration; m-band; monoclonal band; monoclonal spike; m-protein; m-spike; para protein; paraprotein; peur; pr; prot; qnt; quan; quant; quantitative; ua; upep; ur; urn,Qn
97779-3,sodium [moles/volume] in dialysis fluid --1 hour specimen,sodium 1h spec dial fld-scnc,sodium 1 hour specimen (dial fld) [moles/vol],1 hour; 1.0hr; 60 min; 60 minutes; 60m; 60min; chemistry; diaf; dialysate; dialysis fluid; kidney; level; na; na+; nephrology; point in time; qnt; quan; quant; quantitative; random; renal; spec; substance concentration,Qn
97781-9,sodium [moles/volume] in dialysis fluid --4 hour specimen,sodium 4h spec dial fld-scnc,sodium 4 hr specimen (dial fld) [moles/vol],chemistry; diaf; dialysate; dialysis fluid; kidney; level; na; na+; nephrology; point in time; qnt; quan; quant; quantitative; random; renal; spec; substance concentration,Qn
97796-7,osteoporotic vertebral fractures classification,osteo vertebral frac class,,msk; musculoskeletal; nominal; ortho; orthopedics; osteo vertebral frac class; point in time; random; surg; typ,Nom
97797-5,type of spondylolisthesis,spondylolisthesis type,,msk; musculoskeletal; nominal; ortho; orthopedics; point in time; random; surg; typ,Nom
9781-6,acanthamoeba sp identified in specimen by organism specific culture,acanthamoeba spec cult,acanthamoeba sp identified org specific cx nom (specimen),amebic keratitis; amebic meningoencephalitis; c&s; cult; cultures; id; identity or presence; infectious disease; infectiousdisease; microbiology; misc; miscellaneous; nominal; other; point in time; random; soil amoeba; spec; species; spp; to be specified in another part of the message; unspecified,Nom
97828-8,level of deformity correction,defomity correction lvl,,correctn; defomity correction lvl; finding; findings; levels; levl; lv; lvl; msk; musculoskeletal; nominal; ortho; orthopedics; point in time; random; surg,Nom
97834-6,measures used during spine surgery,surgical measures,,finding; findings; msk; musculoskeletal; nominal; ortho; orthopedics; point in time; random; surg; surgical measures,Nom
97846-0,name use person,name use person,,^person; admin; finding; findings; humanname.use; nominal; persons; point in time; random,Nom
97853-6,anticomplementary activity [titer] in specimen by complement fixation,anticompl act titr spec cf,anticomplementary activity cf (specimen) [titer],activ; actvty; anticompl act; anticomplement; anti-complementary; cf; comp fixation; compfix; complement fixation; dilution factor; dilution factor (titer); id; infectious disease; infectiousdisease; microbiology; misc; miscellaneous; movements; other; point in time; random; smqn; spec; titer; titered; titre; to be specified in another part of the message; ttr; unspecified,SemiQn
97859-3,fungal ab panel - specimen by complement fixation,fungal ab pnl spec cf,fungal ab panel cf (specimen),cf; comp fixation; compfix; complement fixation; fungal ab pnl; id; infectious disease; infectiousdisease; microbiology; misc; miscellaneous; other; pan; panel.microbiology; panl; pnl; point in time; random; spec; to be specified in another part of the message; unspecified,-
9787-3,sarcoptes scabiei identified in skin by light microscopy,s scabiei skin micro,s. scabiei identified lm nom (skin),dermatologic; epidermis; id; identity or presence; infectious disease; infectiousdisease; integument; lm; micro; microbiology; micros; microscopic; nominal; point in time; random; s scabiei; scabies; skn,Nom
97879-1,push with hands to stand up from chair,push with hands to stand up from chair,,finding; findings; h+p; h+p.hx; ordinal; p prime; point in time; ql; qual; qualitative; random; screen,Ord
97882-5,loss of feeling in feet,loss of feeling in feet,,finding; findings; h+p; h+p.hx; neuro; neurology; ordinal; p prime; point in time; ql; qual; qualitative; random; screen,Ord
97885-8,stay independent total score [stay independent],,,point in time; qnt; quan; quant; quantitative; random; scale; survey; survey.gnhlth; tot; totl,Qn
97892-4,go to sleep at the same time,,,finding; findings; ordinal; point in time; ql; qual; qualitative; r prime; random; right; screen; survey; survey.r-outcomes,Ord
97901-3,manage medication well,,,finding; findings; ordinal; point in time; ql; qual; qualitative; r prime; random; right; screen; survey; survey.r-outcomes,Ord
97921-1,bunyamwera virus rna [presence] in specimen by naa with probe detection,bunyamwera virus rna spec ql naa+probe,bunyamwera virus rna naa+probe ql (specimen),3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; bunyamwera vir rna; dna nucleic acid probe; dna probe; id; infectious disease; infectiousdisease; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; misc; miscellaneous; naa+probe; naat; nasba; nucleic acid sequence based analysis; ordinal; orthobunyaviruses; other; pcr; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; ribonucleic acid; screen; sda; spec; strand displacement amplification; tma; to be specified in another part of the message; transcription mediated amplification; unspecified,Ord
97940-1,cryptococcus sp [presence] in isolate by organism specific culture,cryptoc islt ql cult,cryptococcus sp org specific cx ql (isol),c&s; crypt; crypto; cryptococcal; cryptococcosis; cryptococcosus; cult; cultures; id; infectious disease; infectiousdisease; islt; isol; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; screen; spec; species; spp,Ord
9794-9,cathepsin d [moles/mass] in tissue,cathepsin d tiss-scnt,cathepsin d (tiss) [moles/mass],"chemistry; ctg; dextro; point in time; qnt; quan; quant; quantitative; random; substance content; tissue; tissue, unspecified",Qn
97951-8,venezuelan equine encephalitis virus rna [presence] in specimen by naa with probe detection,veev rna spec ql naa+probe,veev rna naa+probe ql (specimen),3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; dna nucleic acid probe; dna probe; enc; enceph; encephalomyelitis; equin; id; infectious disease; infectiousdisease; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; misc; miscellaneous; naa+probe; naat; nasba; nucleic acid sequence based analysis; ordinal; other; pcr; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; ribonucleic acid; screen; sda; spec; strand displacement amplification; tma; to be specified in another part of the message; togavirus; transcription mediated amplification; unspecified; vee virus; veev; veev rna,Ord
97976-5,codfish recombinant (rgad c) 1 igg4 ab [mass/volume] in serum,codfish (rgad c) 1 igg4-mcnc,codfish recombinant (rgad c) 1 igg4 (s) [mass/vol],abs; aby; allergen; allergens; allergy; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; cod; codfish; codfish (rgad c) 1; f003; f3; f426; fish; i; level; mass concentration; point in time; qnt; quan; quant; quantitative; random; scrod; serum; sr,Qn
97980-7,hazelnut recombinant (rcor a) 14 igg4 ab [mass/volume] in serum,hazelnut (rcor a) 14 igg4-mcnc,hazelnut recombinant (rcor a) 14 igg4 (s) [mass/vol],2s albumin; abs; aby; allergen; allergens; allergy; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; barcelona nut; cob nut; f017; f17; f439; filbert; hazel nut; hazelnut; hazelnut (rcor a) 14; level; mass concentration; point in time; qnt; quan; quant; quantitative; random; serum; sr,Qn
97994-8,platelets large/platelets in blood by automated count.optical,lg platelets nfr bld auto optical,platelets large/platelets auto.optical (bld),auto; auto optical; automated detection; blood; elec; elect; electr; hematology/cell counts; lg platelets; number fraction; percent; platelet; platelt; plt; point in time; qnt; quan; quant; quantitative; random; thrb; thrombocyte; thrombocytes; wb; whole blood,Qn
97998-9,hpa ab [identifier] in serum or plasma,hpa ab serpl,hpa ab nom,abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; hla antigen; human leukocyte antigen; human platelet antigen; identity or presence; nominal; pl; plasma; plsm; point in time; random; serp; serpl; serplas; serum; serum or plasma; sr,Nom
98001-1,hla-dp and dq and dr (class ii) [type] by low resolution,hla-dp+dq+dr (class ii) low res,hla-dp and dq and dr (class ii) low res nom (bld/tiss),"2; blood; hla antigen; hla class ii; hla-dp+dq+dr; hla-dp+dq+dr (class ii); human leukocyte antigen; nominal; point in time; random; tissue; tissue, unspecified; typ; wb; whole blood; whole blood or tissue",Nom
9801-2,shape of stone,shape stone,shape nom (stone),calc; calculi; gastro; gastroenterology; gi; kidney; nephrology; nominal; pathology; point in time; random; renal; stn; stone; stones; typ,Nom
98020-1,leukocytes [#/volume] in lower respiratory specimen by manual count,wbc # lower resp manual,wbc manual cnt (lower resp) [#/vol],#; abs; absolute; absolutes; breathing; cnt; count; count/volume; ct; hematology/cell counts; leuc; leuk; leukocyte; lkcs; low; lower resp; lungs; manl; number concentration; number concentration (count/vol); point in time; qnt; quan; quant; quantitative; random; rs; spec; wbc; wbcs; white blood cell; white blood cells,Qn
98025-0,fungus identified in prostatic fluid by fungus stain,fungus prost fld fungus stn,fungus identified fungus stain nom (prost fld),eps; expressed prostatic secretion; fung; fungal; fungi; fungus stn; id; identity or presence; infectious disease; infectiousdisease; microbiology; nominal; point in time; prost; prost fld; prostate; prostate secretion; prostati; prostatic secretion; random; st; stains; stn,Nom
98032-6,fetal body weight/heaviest fetus body weight us+calculated,fetal bdy wt/heaviest fetus wt us+calc,,bdy weight; bod; bodies; calc; calculation; echography; efwr; estimated fetal weight ratio; fetal; heaviest fetus wt; mass concentration ratio; mass ratio; mcrto; obsterical; obsterical.ultrasound; obstetrical; obstetrics; point in time; qnt; quan; quant; quantitative; random; sonogram; sonograph; sonography; uls; ultrasound; us calc; wt; wt current fetus,Qn
98037-5,jewish descent preconception andor prenatal carrier screening multigene analysis in blood or tissue by molecular genetics method,jewish carrier multigene anl bld/t,jewish descent preconception/prenatal carrier screening multigene analysis molgen doc (bld/tiss),"asympt; asymptomatic; blood; document; finding; findings; gene; gene panel; gyn; gynecology; jewish carrier multigene anl; molecular genetics; molecular pathology; molpath; multi-gene study; multiple-gene panel test; ob; obgyn; obstetrics; pcr; point in time; random; reproductive carrier multigene anl; scn; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",Doc
98070-6,medical research council breathlessness scale grade,mrc breathlessness scale grade,,finding; findings; lung; mrc breathlessness scale grade; ordinal; point in time; pulmonary; pulmonology; ql; qual; qualitative; random; respiratory; screen,Ord
98080-5,sars-cov-2 (covid-19) and sars-related cov rna panel - saliva (oral fluid) by naa with probe detection,sars-cov-2+sarsr-cov rna pnl sal naa+prb,sars-cov-2 (covid-19) and sars-related cov rna panel naa+probe (sal),2019 novel coronavirus; 2019-ncov; 3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; corona virus; covid19; covid-19; dna nucleic acid probe; dna probe; id; ii; infectious disease; infectiousdisease; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; naa+probe; naat; nasba; nucleic acid sequence based analysis; oral fluid; pan; panel.microbiology; panl; pcr; ph; pnl; point in time; polymerase chain reaction; probe amp; probe with ampification; probe with target amplification; public health; publichealth; qbr; random; ribonucleic acid; sal; sars coronavirus 1; sars-cov; sars-cov-1; sars-cov-2; sars-cov-2+sarsr-cov; sars-cov-2+sarsr-cov rna; sars-cov-2+sarsr-cov rna pnl; sarsr-cov; sda; severe acute respiratory syndrome; strand displacement amplification; tma; transcription mediated amplification; viral pneumonias; wuhan coronavirus,-
9810-3,quinine [presence] in gastric fluid,quinine gast ql,quinine ql (gast fld),drug/toxicology; drugs; gast; gastric contents; gastric fluid; ordinal; point in time; pr; ql; qual; qualitative; random; screen,Ord
98122-5,neutrophil.fmlp and pma stimulated dhr panel by flow cytometry (fc),neut fmlp + pma stim dhr pnl patient fc,neutrophil.fmlp and pma stimulated dhr panel fc,dynamic; fc; hematology/cell counts; neut; neut fmlp + pma stim dhr pnl; neutr; neutrophils; pan; panel.hematology& cell counts; panl; pmn; pnl; pnm; point in time; random,-
98137-3,pain assessment report,pain assessment rpt,,doc.ont; document; finding; findings; pain assessment rpt; point in time; random,Doc
98153-0,child-pugh panel,,,hepatology; liver; pan; panl; pnl; point in time; random; survey,-
98175-3,routine doctor's visits andor check-ups postponed in the last 12 months,,,1 year; 12mos; finding; findings; inspection; ordinal; past; postponed dr. visits last 12mo; ql; qual; qualitative; s prime; screen; survey,Ord
98182-9,thyroxine (t4) free [moles/volume] in cord blood,t4 free bldco-scnc,free t4 (bldco) [moles/vol],blood - (umbilical) cord; chemistry; cord (umbilical) blood; cord bld; cord blood; fr; freet4; ft4; level; levothyroxine; levo-thyroxine; l-thyroxine; non-protein bound; point in time; qnt; quan; quant; quantitative; random; substance concentration; t4; t-4; t4 free; thyroid hormone; thyrox; thyroxin; thyrx; total t4; tt4,Qn
98189-4,benzocaine ige ab [units/volume] in serum,benzocaine ige qn,benzocaine ige qn (s),abs; aby; allergen; allergens; allergy; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; benzocaine ige; c86; immune globulin e; immunoglobulin e; point in time; qnt; quan; quant; quantitative; random; serum; sr,Qn
98196-9,echinacea ige ab [units/volume] in serum,echinacea ige qn,echinacea ige qn (s),abs; aby; allergen; allergens; allergy; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; c145; echinacea ige; immune globulin e; immunoglobulin e; point in time; qnt; quan; quant; quantitative; random; serum; sr,Qn
98203-3,(diffusion capacity/alveolar volume)/predicted,(diff cap/alv vol)/predicted,,(diff cap; (diff cap/alv vol)/predicted; alv; breathing; diff cap; dl; lung; lungs; point in time; pulmonary; pulmonology; qnt; quan; quant; quantitative; random; respiratory; rs; vol,Qn
98204-1,borrelia burgdorferi igg and igm bands panel - serum by immunoblot,b burgdor igg+igm bands pnl ser ib,b. burgdorferi igg and igm bands panel ib (s),b burg; b burgdor; b burgdor igg+igm bands pnl; b burgdorferi; bb; blt; burgdorf; id; immune blot; immune globulin g; immune globulin m; immunobl; immunoblot; immunoglobulin g; immunoglobulin m; infectious disease; infectiousdisease; lyme; lyme disease; lymes; microbiology; pan; panel.microbiology; panl; pnl; point in time; random; riba; serum; sr; wb; wblot; west blot; west blt; western blot,-
98220-7,treponema pallidum igg ab [presence] in cerebral spinal fluid by immunoblot,t pallidum igg csf ql ib,t. pallidum igg ib ql (csf),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; blt; cerebral spinal fluid; cerebrospinal fl; id; immune blot; immune globulin g; immunobl; immunoblot; immunoglobulin g; infectious disease; infectiousdisease; microbiology; neuro; neurology; ordinal; point in time; pr; ql; qual; qualitative; random; riba; screen; spinal fl; spinal fld; spinal flu; spinal fluid; syphilis; t pallidum; treponemal; wb; wblot; west blot; west blt; western blot,Ord
98229-8,ofloxacin ige ab [units/volume] in serum,ofloxacin ige qn,ofloxacin ige qn (s),abs; aby; allergen; allergens; allergy; allergy testing; antby; anti; antibodies; antibody; arbitrary concentration; autoantibodies; autoantibody; c118; c409; floxin; immune globulin e; immunoglobulin e; ofloxacin ige; point in time; qnt; quan; quant; quantitative; random; serum; sr,Qn
9825-1,mycobacterium sp identified in isolate,mycobacterium islt,mycobacterium sp identified nom (isol),acid fast; acid fast bacilli; acid fast bacillus; afb; id; identity or presence; infectious disease; infectiousdisease; islt; isol; microbiology; myco; mycobact; nominal; point in time; random; species; spp; tuberculosis,Nom
98251-2,stage [type] in endometrial cancer specimen by figo,stage ec spec figo,stage figo nom (endometrial cancer specimen),ca; ca spec; cancer of the corpus uteri; ec spec; female reproductive organs; nominal; oncology; pathology; point in time; random; spec; typ; uterine cancer; uterine cancers,Nom
98266-0,uterine serosa involvement [presence] in endometrial cancer specimen,uterine serosa involvmnt ec spec ql,uterine serosa involvement ql (endometrial cancer specimen),ca; ca spec; cancer of the corpus uteri; ec spec; female reproductive organs; oncology; ordinal; pathology; point in time; pr; ql; qual; qualitative; random; screen; spec; uterine cancer; uterine cancers; uterine serosa involvmnt,Ord
98273-6,left pelvic lymph nodes positive [#] in specimen,l pelvic ln positive spec,left pelvic lymph nodes positive (spec) [#],cnt; count; l; l pelvic ln positive; lt; number; oncology; pathology; point in time; pos; qnt; quan; quant; quantitative; random; spec,Qn
98295-9,xr lower extremity joint - left lateral views w manual stress,xr le joint-l views lat w man stress,,document; ext; extr-l; films; finding; findings; imaging; jnt; l; lat; le; le joint-l; leg; le-l; lle; low; lt; msk; musculoskeletal; ortho; orthopedics; plain films; point in time; radiology; random; view; vws; w man stress; w stress); xray; x-ray,Doc
98299-1,xr ankle - right mortise w gravity stress,xr ankle-r mortise w gravity stress,,1v; ankle-r; document; ext; extr-r; film; finding; findings; grav; imaging; le; leg; le-r; low; lower extremity joint; msk; musculoskeletal; ortho; orthopedics; plain films; point in time; r; radiology; random; rle; rt; single view; true ap ankle; vw; xray; x-ray,Doc
98300-7,xr calcaneus - right le 3 broden views,xr heel-r le 3v broden,,broden limited; calcaneous; document; ext; extr-r; films; finding; findings; heel; heel-r; iii; imaging; le; le 3v; le 3v broden; leg; le-r; less than or equal to 3; limited broden; low; maximum 3 views; msk; musculoskeletal; ortho; orthopedics; os calcis; oscalcis; plain films; point in time; r; radiology; random; rle; rt; view; vws; xray; x-ray,Doc
98311-4,xr calcaneus - left lateral,xr heel-l lat,,1v; calcaneous; document; ext; extr-l; film; finding; findings; heel; heel-l; imaging; l; lat; le; leg; le-l; lle; low; lt; msk; musculoskeletal; ortho; orthopedics; os calcis; oscalcis; plain films; point in time; radiology; random; single view; vw; xray; x-ray,Doc
98316-3,xr knee - bilateral single view w valgus stress,xr knee-bl 1v w valgus stress,,1v; bil; bilat; both; document; ext; extr-bl; film; finding; findings; imaging; kn; knee-bl; knees; le; le-bl; leg; low; lower extremity joint; msk; musculoskeletal; ortho; orthopedics; plain films; point in time; radiology; random; single view; vw; xray; x-ray,Doc
98319-7,xr calcaneus - bilateral le 3 broden views,xr heel-bl le 3v broden,,bil; bilat; both; broden limited; calcanei; calcaneous; document; ext; extr-bl; films; finding; findings; heel; heel-bl; heels; iii; imaging; le; le 3v; le 3v broden; le-bl; leg; less than or equal to 3; limited broden; low; maximum 3 views; msk; musculoskeletal; ortho; orthopedics; os calcis; oscalcis; plain films; point in time; radiology; random; view; vws; xray; x-ray,Doc
98321-3,xr toe second - bilateral lateral,xr toe 2nd-bl lat,,1v; 2nd; 2nd toe; bil; bilat; both; document; ext; extr-bl; film; finding; findings; imaging; index toe; lat; le; le-bl; leg; low; msk; musculoskeletal; ortho; orthopedics; phalange; plain films; point in time; radiology; random; single view; toe 2nd-bl; vw; xray; x-ray,Doc
98334-6,xr hamate - right single view,xr hamate-r 1v,,1v; arm; carpal bone; carpal bones; carpal bones and joint; document; ext; extr-r; film; finding; findings; hamate-r; imaging; msk; musculoskeletal; ortho; orthopedics; plain films; point in time; r; radiology; random; rt; rue; single view; ue; ue-r; up; upper extremity joint; vw; wrist-r; xray; x-ray,Doc
98335-3,xr pisiform and triquetrum - right single view,xr pisiform+triquetrum-r 1v,,1v; arm; carpal bone; carpal bones; carpal bones and joint; document; ext; extr-r; film; finding; findings; imaging; msk; musculoskeletal; ortho; orthopedics; pisiform+triquetrum-r; plain films; point in time; r; radiology; random; rt; rue; single view; ue; ue-r; up; upper extremity joint; vw; wrist-r; xray; x-ray,Doc
98336-1,xr wrist - right ap,xr wrist-r ap,,1v; anterio-posterior; anteroposterior; arm; carpal bone; carpal bones; carpal bones and joint; document; ext; extr-r; film; finding; findings; imaging; msk; musculoskeletal; ortho; orthopedics; plain films; point in time; r; radiology; random; rt; rue; single view; ue; ue-r; up; upper extremity joint; vw; wrist-r; xray; x-ray,Doc
9837-6,hiv 1 proviral dna [presence] in blood by probe with amplification,hiv 1 pro dna bld ql probe amp,hiv 1 proviral dna probe amp ql (bld),aids; amplif; amplification; amplified; blood; deoxyribonucleic acid; dna nucleic acid probe; dna probe; hiv type 1; hiv type i; hiv1; hiv1 proviral dna; human immunodeficiency virus; i; id; infectious disease; infectiousdisease; microbiology; ordinal; point in time; pr; probe amp; probe with ampification; ql; qual; qualitative; random; screen; wb; whole blood,Ord
98396-5,aspergillus sp cyp51 gene [identifier] in isolate by sequencing,asperg sp cyp51 islt seq,aspergillus sp cyp51 gene sequencing nom (isol),asperg; asperg sp cyp51; aspergil; aspergilis; aspergilla; aspergillin; aspergillosis; aspergils; aspergilus; farmers lung; high-throughput sequencing; hts; id; identity or presence; infectious disease; infectiousdisease; islt; isol; microbiology; next generation sequencing; ngs; nominal; point in time; random; species; spp,Nom
98397-3,aspergillus colony [color] in isolate by culture,aspergillus colony islt cult-color,aspergillus colony cx (isol) [color],asperg; aspergil; aspergilis; aspergilla; aspergillin; aspergillosis; aspergils; aspergilus; c&s; colonies; cult; cultures; id; infectious disease; infectiousdisease; islt; isol; microbiology; nominal; point in time; random,Nom
98-4,cefonicid [susceptibility] by serum bactericidal titer,cefonocid titr sbt,cefonicid sbt (isol+s),antibiotic susceptibilities; cefonocid; dilution factor; dilution factor (titer); id; infectious disease; infectiousdisease; islt; isol; monocid; point in time; random; sequence based typing; serum; serum bactericidal titer; serum killing test; smqn; sr; titer; titered; titre; ttr,SemiQn
98401-3,yeast [morphology] in isolate by light microscopy,yeast morph islt micro,yeast lm nom (isol),id; infectious disease; infectiousdisease; islt; isol; lm; micro; microbiology; micros; microscopic; morphology; nominal; point in time; random,Nom
98418-7,diagnostic audiology results panel,dx audio result pnl,,audiology; clin; dx audio result pnl; pan; panel.clinical; panl; pnl; point in time; random,-
98428-6,hearing loss degree.min ear - right,hl degree.min ear-r,,audio; audiology; ear nose throat; ear-r; ent; finding; findings; hearing; hl degree; hl degree.min; minimal; minimum; ordinal; oto; otolaryngology; otologic; point in time; ql; qual; qualitative; r; random; rt; screen,Ord
98432-8,reason diagnostic audiology assessment not performed,reason dx audio not performed,,audiology; ear nose throat; ent; finding; findings; nominal; oto; otolaryngology; point in time; random; reason dx audio not performed,Nom
98433-6,phoropter cylinder mode intermediate,phoropter cylinder mode inter,,by phoropter; cyl; eye.refraction; eyeball; occular; oculis; ophthalmologic; optic globe; ordinal; point in time; ql; qual; qualitative; random; screen; typ; vision; visual,Ord
98437-7,left eye cylinder intermediate by phoropter,l eye cylinder inter by phoropter,,by phoropter; cyl; eye.refraction; eyeball; inverse length; l; l eye; lt; occular; oculis; ophthalmologic; optic globe; point in time; qnt; quan; quant; quantitative; random; vision; visual,Qn
98448-4,right eye horizontal prism - in intermediate by phoropter,r eye h prism-in inter by phoropter,,by phoropter; eye.refraction; eyeball; h prism-in; h prism-in inter; inverse length; occular; oculis; ophthalmologic; optic globe; point in time; qnt; quan; quant; quantitative; r; r eye; random; rt; vision; visual,Qn
98452-6,right eye vertical prism - down intermediate by phoropter,r eye v prism-down inter by phoropter,,by phoropter; eye.refraction; eyeball; inverse length; occular; oculis; ophthalmologic; optic globe; point in time; qnt; quan; quant; quantitative; r; r eye; random; rt; v prism-down; v prism-down inter; vision; visual,Qn
98455-9,contrast ratio for intermediate visual acuity measurement by phoropter,contrast for inter va by phoropter,,by phoropter; c; contr; contra; contrast for inter va; contrst; eye.refraction; eyeball; number fraction; occular; oculis; ophthalmologic; optic globe; percent; point in time; qnt; quan; quant; quantitative; random; refraction; va; vision; visual,Qn
9845-9,body region circumference percentile,body reg circumf prctl,,body circumference.atom; girth; misc; miscellaneous; other; percentile; point in time; qnt; quan; quant; quantitative; random; spec; to be specified in another part of the message; unspecified,Qn
98473-2,right eye vertical prism - down near by phoropter,r eye v prism-down near by phoropter,,by phoropter; eye; eye.refraction; eyeball; inverse length; occular; oculis; ophthalmologic; ophthalmology; ophtho; ophthy; optic globe; point in time; qnt; quan; quant; quantitative; r; r eye; random; rt; v prism-down; v prism-down near; vision; visual,Qn
98477-3,right eye pupillary distance.monocular near by phoropter,r eye pd monoc near by phoropter,,by phoropter; eye; eye.refraction; eyeball; length; occular; oculis; ophthalmologic; ophthalmology; ophtho; ophthy; optic globe; pd; pd monoc; pd monoc near; point in time; qnt; quan; quant; quantitative; r; r eye; random; rt; vision; visual,Qn
98492-2,apolipoprotein e and beta amyloid alzheimer's risk panel - cerebral spinal fluid,apoe+abeta alz risk pnl csf,apolipoprotein e and beta amyloid alzheimer's risk panel (csf),apo; apo e; apoe; apoe+abeta alz risk pnl; apolipo; apolipoprot; apolipoprotein epsilon; apolipoproteins; b; beta-amyloid; cerebral spinal fluid; cerebrospinal fl; chemistry; neuro; neurology; pan; panel.chemistry; panl; pnl; point in time; random; s prime; spinal fl; spinal fld; spinal flu; spinal fluid,-
98503-6,visual acuity.binocular near uncorrected eye,eye near va.binoc--uncorr,,eye; eye.refraction; eyeball; length ratio; near va.binoc; occular; oculis; ophthalmologic; ophthalmology; ophtho; ophthy; optic globe; point in time; qnt; quan; quant; quantitative; random; refraction; va; va.binoc; vision; visual,Qn
98505-1,visual acuity far uncorrected right eye,r eye far va--uncorr,,distance; eye; eye.refraction; eyeball; far va; length ratio; occular; oculis; ophthalmologic; ophthalmology; ophtho; ophthy; optic globe; point in time; qnt; quan; quant; quantitative; r; r eye; random; refraction; rt; va; vision; visual,Qn
98520-0,promis item bank - dyspnea characteristics - version 1.0,,,pan; panel; panel.survey.promis; panl; patient reported outcomes information system; pnl; point in time; promise; random; survey; survey.promis,-
98527-5,things are in the house that trigger breathing problems,,,finding; findings; ordinal; painad.breathing; patient reported outcomes information system; point in time; ql; qual; qualitative; random; screen; survey; survey.promis,Ord
98541-6,felt useless before illness,,,finding; findings; ordinal; patient reported outcomes information system; point in time; ql; qual; qualitative; random; screen; survey; survey.promis,Ord
98558-0,feel isolated from others since illness,,,finding; findings; ordinal; patient reported outcomes information system; point in time; ql; qual; qualitative; random; screen; survey; survey.promis,Ord
98561-4,felt disconnected from others before illness,,,finding; findings; ordinal; patient reported outcomes information system; point in time; ql; qual; qualitative; random; screen; survey; survey.promis,Ord
98563-0,felt like a burden to others before illness,,,finding; findings; ordinal; patient reported outcomes information system; point in time; ql; qual; qualitative; random; screen; survey; survey.promis,Ord
98566-3,feel avoided since illness,,,finding; findings; ordinal; patient reported outcomes information system; point in time; ql; qual; qualitative; random; screen; survey; survey.promis,Ord
98576-2,worry about the future since illness,,,finding; findings; ordinal; patient reported outcomes information system; point in time; ql; qual; qualitative; random; screen; survey; survey.promis,Ord
98585-3,worried about health interfering with life before illness,,,finding; findings; ordinal; patient reported outcomes information system; point in time; ql; qual; qualitative; random; screen; survey; survey.promis,Ord
98588-7,worry about health interfering with sleep since illness,,,finding; findings; ordinal; patient reported outcomes information system; point in time; ql; qual; qualitative; random; screen; survey; survey.promis,Ord
98589-5,worried about health interfering with sleep before illness,,,finding; findings; ordinal; patient reported outcomes information system; point in time; ql; qual; qualitative; random; screen; survey; survey.promis,Ord
98599-4,life lacked purpose before illness,,,finding; findings; ordinal; patient reported outcomes information system; point in time; ql; qual; qualitative; random; screen; survey; survey.promis,Ord
98617-4,sensory nerve conduction panel left median nerve,sensory nc pnl l median n,,l; l median n; lt; neuro; pan; panel.neuro; panl; pnl; point in time; random; sensory nc pnl,-
98620-8,sensory nerve conduction velocity left median nerve,sensory nc velocity l median n,,l; l median n; lt; neuro; point in time; qnt; quan; quant; quantitative; random; sensory nc velocity; vel; velocity,Qn
98622-4,sensory nerve conduction panel right median nerve,sensory nc pnl r median n,,neuro; pan; panel.neuro; panl; pnl; point in time; r; r median n; random; rt; sensory nc pnl,-
9862-4,pacemaker lead vendor model number by ekg,pacemaker lead model # ekg,,"cardiac pacemaker; cardio; cardiology; device, heart-assist; ecg; electrocardiogram; electrocardiograph; heart disease; identity or presence; model #; no; nominal; num; point in time; prosthetic; random",Nom
98629-9,peak sensory nerve conduction latency [time] left ulnar nerve,peak sensory nc latency time l ulnar n,,l; l ulnar n; lt; neuro; peak sensory nc latency; point in time; qnt; quan; quant; quantitative; random,Qn
98633-1,sensory nerve action potential amplitude right ulnar nerve,snap amplitude r ulnar n,,electrical potential; neuro; point in time; qnt; quan; quant; quantitative; r; r ulnar n; random; rt; snap amplitude; voltage,Qn
98654-7,peak sensory nerve conduction latency [time] right lateral antebrachial cutaneous nerve,peak sensory nc latency time r lacn,,lat; neuro; peak sensory nc latency; point in time; qnt; quan; quant; quantitative; r; r lacn; random; rt,Qn
98659-6,sensory nerve action potential amplitude left sural nerve,snap amplitude l sural n,,electrical potential; l; l sural n; lt; neuro; point in time; qnt; quan; quant; quantitative; random; snap amplitude; voltage,Qn
98662-0,sensory nerve action potential area [area under the curve] left sural nerve,snap area auc l sural n,,auc; l; l sural n; lt; neuro; point in time; qnt; quan; quant; quantitative; random; snap area,Qn
98678-6,motor nerve conduction panel left ulnar nerve,motor nc pnl l ulnar n,,l; l ulnar n; lt; motor nc pnl; neuro; pan; panel.neuro; panl; pnl; point in time; random,-
98685-1,peak motor nerve conduction latency [time] left fibular nerve,peak motor nc latency time l fibular n,,l; l fibular n; lt; neuro; peak motor nc latency; point in time; qnt; quan; quant; quantitative; random,Qn
98704-0,f-wave motor nerve conduction panel nerve,f-wave motor nc pnl nerve,,f-wave motor nc pnl; motor nc pnl; neuro; pan; panel.neuro; panl; pnl; point in time; random,-
98705-7,minimum f-wave latency [time] nerve,min f-wave latency time nerve,,min f-wave latency; neuro; point in time; qnt; quan; quant; quantitative; random,Qn
98711-5,number of stimuli muscle,num of stimuli muscle,,cnt; count; musc; muscl; neuro; no; num; num of stimuli; number; point in time; qnt; quan; quant; quantitative; random,Qn
98718-0,insertional activity of muscle on emg,insertional activity muscle emg,,activ; actvty; finding; findings; movements; musc; muscl; neuro; ordinal; point in time; ql; qual; qualitative; random; screen,Ord
98720-6,spontaneous activity.positive sharp waves of muscle on emg,spont activity.psws muscle emg,,activ; actvty; finding; findings; movements; musc; muscl; neuro; ordinal; point in time; pos; ql; qual; qualitative; random; screen; spont activity; spont activity.psws,Ord
98721-4,spontaneous activity.fibrillation of muscle on emg,spont activity.fibrillation muscle emg,,activ; actvty; finding; findings; movements; musc; muscl; neuro; ordinal; point in time; ql; qual; qualitative; random; screen; spont activity; spont activity.fibrillation,Ord
98737-0,eye worth 4 dot test near [interpretation],eye worth 4 dot near [imp],,eye.px; eyeball; impression; impression/interpretation of study; impressions; interp; interpretation; nominal; occular; oculis; ophthalmologic; optic globe; point in time; random; vision; visual; worth 4 dot near,Nom
98740-4,type of phoria exam method,type of phoria exam method,,eye.px; eyeball; meth; method of; nominal; occular; oculis; ophthalmologic; optic globe; point in time; random; typ; vision; visual,Nom
98746-1,right eye horizontal prism - out for far phoria by phoropter,r eye h prism-out far phor by phoropter,,by phoropter; eye.refraction; eyeball; h prism-out; h prism-out far phor; inverse length; occular; oculis; ophthalmologic; optic globe; point in time; qnt; quan; quant; quantitative; r; r eye; random; rt; vision; visual,Qn
98747-9,left eye horizontal prism - out for far phoria by phoropter,l eye h prism-out far phor by phoropter,,by phoropter; eye.refraction; eyeball; h prism-out; h prism-out far phor; inverse length; l; l eye; lt; occular; oculis; ophthalmologic; optic globe; point in time; qnt; quan; quant; quantitative; random; vision; visual,Qn
98749-5,left eye horizontal prism - in for far phoria by phoropter,l eye h prism-in far phor by phoropter,,by phoropter; eye.refraction; eyeball; h prism-in; h prism-in far phor; inverse length; l; l eye; lt; occular; oculis; ophthalmologic; optic globe; point in time; qnt; quan; quant; quantitative; random; vision; visual,Qn
98760-2,right eye horizontal prism - in for near phoria by phoropter,r eye h prism-in near phor by phoropter,,by phoropter; eye.refraction; eyeball; h prism-in; h prism-in near phor; inverse length; occular; oculis; ophthalmologic; optic globe; point in time; qnt; quan; quant; quantitative; r; r eye; random; rt; vision; visual,Qn
98769-3,far convergence blur by phoropter,far con blur by phoropter,,by phoropter; eye.refraction; eyeball; far con blur; inverse length; occular; oculis; ophthalmologic; optic globe; point in time; qnt; quan; quant; quantitative; random; vision; visual,Qn
98771-9,far convergence recovery by phoropter,far con recovery by phoropter,,by phoropter; eye.refraction; eyeball; far con recovery; inverse length; occular; oculis; ophthalmologic; optic globe; point in time; qnt; quan; quant; quantitative; random; vision; visual,Qn
98779-2,near divergence break by phoropter,near divergence break by phoropter,,by phoropter; eye.refraction; eyeball; inverse length; occular; oculis; ophthalmologic; optic globe; point in time; qnt; quan; quant; quantitative; random; vision; visual,Qn
987-8,di sup(b) ab [presence] in serum or plasma,di sup(b) ab serpl ql,di sup(b) ab ql,abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; blood bank; d (little i) (little b); dextro; di sup(b); di^b; diego; diego blood group system; i; ordinal; pl; plasma; plsm; point in time; pr; ql; qual; qualitative; random; screen; serp; serpl; serplas; serum; serum or plasma; sr,Ord
98786-7,eye for near supravergence measurement,near supra measurement eye,,eye.refraction; eyeball; finding; findings; near supra measurement eye; nominal; occular; oculis; ophthalmologic; optic globe; point in time; random; vision; visual,Nom
98789-1,eye horizontal prism - in far for sheard by phoropter,eye h prism-in far sheard by phoropter,,by phoropter; eye.refraction; eyeball; h prism-in; h prism-in far; h prism-in far sheard; inverse length; occular; oculis; ophthalmologic; optic globe; point in time; qnt; quan; quant; quantitative; random; vision; visual,Qn
9880-6,j point depression in lead i,j pnt depr l-i,,cardiac; cardio; cardiology; ecg; ekg.measurements; electrical potential; electrocardiogram; electrocardiograph; heart disease; hrt; j pnt depr l-i; painter's colic; pb; plumbism; point in time; qnt; quan; quant; quantitative; random; voltage,Qn
98809-7,right eye horizontal prism - out for monocular accommodative lag by phoropter,r eye h prism-out mon acc lag phoropter,,by phoropter; eye.refraction; eyeball; h prism-out; h prism-out mon acc lag; inverse length; occular; oculis; ophthalmologic; optic globe; point in time; qnt; quan; quant; quantitative; r; r eye; random; rt; vision; visual,Qn
9881-4,j point depression in lead ii,j pnt depr l-ii,,2; cardiac; cardio; cardiology; ecg; ekg.measurements; electrical potential; electrocardiogram; electrocardiograph; heart disease; hrt; j pnt depr l-ii; painter's colic; pb; plumbism; point in time; qnt; quan; quant; quantitative; random; voltage,Qn
98827-9,left eye horizontal prism - out for far fixation disparity by phoropter,l eye h prism-out for far fix disp phor,,by phoropter; eye.refraction; eyeball; h prism-out; h prism-out for far fix disparity; inverse length; l; l eye; lt; occular; oculis; ophthalmologic; optic globe; point in time; qnt; quan; quant; quantitative; random; vision; visual,Qn
98830-3,right eye vertical prism - up for far fixation disparity by phoropter,r eye v prism-up for far fix disp phor,,by phoropter; eye.refraction; eyeball; inverse length; occular; oculis; ophthalmologic; optic globe; point in time; qnt; quan; quant; quantitative; r; r eye; random; rt; v prism-up; v prism-up for far fix disparity; vision; visual,Qn
98831-1,left eye vertical prism - up for far fixation disparity by phoropter,l eye v prism-up for far fix disp phor,,by phoropter; eye.refraction; eyeball; inverse length; l; l eye; lt; occular; oculis; ophthalmologic; optic globe; point in time; qnt; quan; quant; quantitative; random; v prism-up; v prism-up for far fix disparity; vision; visual,Qn
98833-7,left eye vertical prism - down for far fixation disparity by phoropter,l eye v prism-down for far fix disp phor,,by phoropter; eye.refraction; eyeball; inverse length; l; l eye; lt; occular; oculis; ophthalmologic; optic globe; point in time; qnt; quan; quant; quantitative; random; v prism-down; v prism-down for far fix disparity; vision; visual,Qn
98838-6,right eye horizontal prism - out for near fixation disparity by phoropter,r eye h prism-out for near fix disp phor,,by phoropter; eye.refraction; eyeball; h prism-out; h prism-out for near fix disparity; inverse length; occular; oculis; ophthalmologic; optic globe; point in time; qnt; quan; quant; quantitative; r; r eye; random; rt; vision; visual,Qn
98875-8,able to participate in remote learning,,,finding; findings; ordinal; point in time; ql; qual; qualitative; random; screen; survey,Ord
98896-4,household income changed significantly since the beginning of the pandemic,,,finding; findings; nominal; point in time; random; survey,Nom
98907-9,hemoglobinopathy panel,hemoglobinopathy panel patient,hemoglobinopathy panel,hematology/cell counts; pan; panel.hematology& cell counts; panl; pnl; point in time; random,-
98909-5,shock index calculated,si calc,,calc; calculation; clin; clin.risk; point in time; qnt; quan; quant; quantitative; random; ratios; rto; si,Qn
98927-7,have enough energy for everyday life in last 2 weeks,,,14 days; 2 weeks; enough energy for everyday life last 2w; finding; findings; ordinal; past; ql; qual; qualitative; screen; survey; survey.gnhlth,Ord
98935-0,satisfaction with capacity for work in last 2 weeks,,,14 days; 2 weeks; finding; findings; job; occupation; ordinal; past; ql; qual; qualitative; satisfact w/capacity for work last 2w; screen; survey; survey.gnhlth,Ord
98940-0,satisfaction with condition of living place in last 2 weeks,,,14 days; 2 weeks; finding; findings; ordinal; past; ql; qual; qualitative; satisf w/cond of living place last 2w; screen; survey; survey.gnhlth,Ord
98944-2,total score [whoqol_bref],,,14 days; 2 weeks; qnt; quan; quant; quantitative; scale; survey; survey.gnhlth; tot; totl,Qn
98952-5,reason for not participating in remote learning in last 12 months,,,1 year; 12mos; finding; findings; nominal; past; reason not partic remote learn last 12mo; reason not participate remote learning; survey,Nom
98977-2,number of residential moves in past 12 months,,,1 year; 12mos; cnt; count; last; no; num; number; qnt; quan; quant; quantitative; survey,Qn
98996-2,transferrin [mass/volume] in serum or plasma by electrophoresis,transferrin serpl elph-mcnc,transferrin elph [mass/vol],chemistry; elec; elect; electr; electro; electrophhrs; electrophrs; elp; elph; ep; level; mass concentration; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; siderophilin; sr; tf; trf; trfrn,Qn
99024-2,proteus sp dna [presence] in urine by naa with probe detection,proteus sp dna ur ql naa+probe,proteus sp dna naa+probe ql (u),3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; deoxyribonucleic acid; dna nucleic acid probe; dna probe; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; naa+probe; naat; nasba; nucleic acid sequence based analysis; ordinal; pcr; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; screen; sda; species; spp; strand displacement amplification; tma; transcription mediated amplification; ua; ur; urn,Ord
99026-7,providencia stuartii dna [presence] in urine by naa with probe detection,p stuartii dna ur ql naa+probe,providencia stuartii dna naa+probe ql (u),3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; deoxyribonucleic acid; dna nucleic acid probe; dna probe; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; naa+probe; naat; nasba; nucleic acid sequence based analysis; ordinal; p stuartii; pcr; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; proteus stuartii; qbr; ql; qual; qualitative; random; screen; sda; strand displacement amplification; tma; transcription mediated amplification; ua; ur; urn,Ord
99041-6,trajectory of foreign object at wound entry panel,trajectory wound entry panel,,h+p; p prime; pan; panel.h&p; panl; pnl; point in time; random; trajectory wound entry panel; wnd,-
9904-4,p wave duration in lead i,p wave dur l-i,,cardiac; cardio; cardiology; durat; ecg; ekg.measurements; electrocardiogram; electrocardiograph; heart disease; hrt; p prime; p wave dur l-i; painter's colic; pb; plumbism; point in time; p-wave interval; qnt; quan; quant; quantitative; random,Qn
99057-2,slc12a1 gene full mutation analysis in blood by molecular genetics method,slc12a1 full mut anl bld,slc12a1 gene full mutation analysis molgen doc (bld),blood; bsc1 gene; document; finding; findings; full gene sequencing; full mut anl; molecular genetics; molecular pathology; molpath; molpath.mutations; mut; mutations; nkcc2 gene; pcr; point in time; random; sequencing of entire coding region; wb; whole blood,Doc
99071-3,kelch-like protein 11 igg ab [titer] in cerebral spinal fluid by immunofluorescence,klhl11 igg titr csf if,kelch-like protein 11 igg if (csf) [titer],abs; aby; acif; antby; anti; antibodies; antibody; anticomplement immunofluorescence; autoantibodies; autoantibody; cerebral spinal fluid; cerebrospinal fl; dilution factor; dilution factor (titer); fa; fluorescent antibody; fluoresent; ifa; immune fluorescence; immune globulin g; immunoflour; immunofluor; immunofluorescence; immunoglobulin g; klhl11; neuro; neurology; oncology; point in time; pr; prot; random; serology; smqn; spinal fl; spinal fld; spinal flu; spinal fluid; time resolved fluorescence; titer; titered; titre; trf; ttr,SemiQn
99082-0,coccidioides sp ag [mass/volume] in body fluid by immunoassay,coccidioides ag fld ia-mcnc,coccidioides sp ag ia (body fld) [mass/vol],"antigen; antigens; b/f; bf; bod; bodies; body fluid; body fluid, unsp; coccidiodes; eia; elfa; elisa; enzyme immunoassay; fl; fld; flu; fluid; iaa; level; mass concentration; meia; microbiology; point in time; qnt; quan; quant; quantitative; random; san joaquin valley fever; species; spp; suds; valley fever",Qn
99093-7,streptococcus agalactiae dna [presence] in cerebral spinal fluid by naa with probe detection,gp b strep dna csf ql naa+probe,s. agalactiae dna naa+probe ql (csf),3 self-sustaining sequence replication; 3sr sr; amplif; amplification; amplified; cerebral spinal fluid; cerebrospinal fl; deoxyribonucleic acid; dna nucleic acid probe; dna probe; gbs; gp b strep; group b; group b strep; lat; lcr; ligase chain reaction; ligation-activated transcription; microbiology; naa+probe; naat; nasba; nucleic acid sequence based analysis; ordinal; pcr; point in time; polymerase chain reaction; pr; probe amp; probe with ampification; probe with target amplification; qbr; ql; qual; qualitative; random; s agalactiae; screen; sda; spinal fl; spinal fld; spinal flu; spinal fluid; steptococcus group b; strand displacement amplification; strep; strep b; strep group b; strept; streptococci group b; tma; transcription mediated amplification,Ord
99099-4,procalcitonin [moles/volume] in serum or plasma,procalcitonin serpl-scnc,procalcitonin [moles/vol],chemistry; level; pct; pl; plasma; plsm; point in time; proct; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr; substance concentration,Qn
99100-0,norepinephrine [mass/volume] in serum or plasma,norepineph serpl-mcnc,norepinephrine [mass/vol],chemistry; level; mass concentration; ne; noradrenalin; norepi; norepin; norepineph; norepinephr; noreppi; pl; plasma; plsm; point in time; qnt; quan; quant; quantitative; random; serp; serpl; serplas; serum; serum or plasma; sr,Qn
99107-5,stimulants drug panel - urine by screen method,stimulants drug panel ur scn,stimulants drug panel screen (u),drug/toxicology; drugs; pan; panel.drug & toxicology; panl; pnl; point in time; random; scn; scr; scrn; stimul; stimulant; ua; ur; urn,-
99126-5,notch1 gene mutations found [identifier] in blood or tissue by molecular genetics method nominal,notch1 mut anl bld/t,notch1 gene targeted mutation analysis molgen nom (bld/tiss),"aos5; aovd1; blood; hn1; identity or presence; molecular genetics; molecular pathology; molpath; molpath.mutations; mut; mut anl; mutations; nominal; notch 1; pcr; point in time; random; tan1; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",Nom
99127-3,birc3 gene mutations found [identifier] in blood or tissue by molecular genetics method nominal,birc3 gene mut anl bld/t,birc3 gene targeted mutation analysis molgen nom (bld/tiss),"blood; identity or presence; molecular genetics; molecular pathology; molpath; molpath.mutations; mut; mut anl; mutations; nominal; pcr; point in time; random; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",Nom
99130-7,outcome and assessment information set (oasis) form - version e during assessment period [cms assessment],,,centers for medicare and medicaid assessment; form version; outcome and assessment information set; pan; panel; panel.survey.cms; panl; pnl; report period; survey,-
99147-1,"oasis e - preferences for customary routine activities - soc, roc during assessment period [cms assessment]",,,centers for medicare and medicaid assessment; outcome and assessment information set; pan; panel; panel.survey.cms; panl; pnl; report period; survey,-
99150-5,oasis e - mobility - follow-up performance during assessment period [cms assessment],,,centers for medicare and medicaid assessment; outcome and assessment information set; pan; panel; panel.survey.cms; panl; pnl; report period; survey,-
99171-1,oasis e - swallowing and or nutritional status - roc during assessment period [cms assessment],,,centers for medicare and medicaid assessment; deglutition; outcome and assessment information set; pan; panel; panel.survey.cms; panl; pnl; report period; survey,-
99212-3,frequency of seeing starbursts or halos that are bothersome or make it difficult to see when around bright lights at night,,,finding; findings; ordinal; point in time; ql; qual; qualitative; random; screen; survey,Ord
99213-1,experienced glare in past 7 days,experienced glare past 7d,,experienced glare past 7d; eye; eye.hx; finding; findings; last; ordinal; ql; qual; qualitative; screen,Ord
99221-4,satisfaction level with present vision,satisfaction level w/ vision,,eye; eye.hx; finding; findings; levels; levl; lv; lvl; ordinal; point in time; ql; qual; qualitative; random; satisfaction level w/ vision; screen,Ord
99251-1,impact of best corrective lenses on halos,,,best corr lens impact on halos; finding; findings; ordinal; point in time; ql; qual; qualitative; random; screen; survey,Ord
99259-4,impact of best corrective lenses on starbursts,,,best corr lens impact on starbursts; finding; findings; ordinal; point in time; ql; qual; qualitative; random; screen; survey,Ord
99266-9,deschloroetizolam [mass/volume] in urine by confirmatory method,deschloroetizolam ur cfm-mcnc,deschloroetizolam confirm (u) [mass/vol],cfm; cnfr; cnfrm; conf; confirmation; confirmatory; drug/toxicology; drugs; gcms; lc/ms/ms; level; mass concentration; point in time; qnt; quan; quant; quantitative; random; ua; ur; urn,Qn
9926-7,q wave depth in lead avl,q wave dpth l-avl,,cardiac; cardio; cardiology; dpth; ecg; ekg.measurements; electrical potential; electrocardiogram; electrocardiograph; heart disease; hrt; painter's colic; pb; plumbism; point in time; q wave dpth; q wave dpth l-avl; q wave dpth lead; qnt; quan; quant; quantitative; random; voltage,Qn
992-8,do sup(a) ab [presence] in serum or plasma from donor,do sup(a) ab serpl donr ql,do sup(a) ab ql (s/p donor),abs; aby; antby; anti; antibodies; antibody; autoantibodies; autoantibody; blood bank; d (little o) (little a); dextro; do sup(a); do^a; dombrock; dombrock blood group system; donr; ordinal; pl; plasma; plsm; point in time; pr; ql; qual; qualitative; random; screen; serp; serpl; serplas; serum; serum or plasma; sr,Ord
99287-5,checklist of nonverbal pain indicators panel [cnpi],,,cnpi panel; nonverb pain ind; pan; panl; pnl; point in time; random; survey; survey.cnpi,-
99305-5,checklist of nonverbal pain indicators assessment [cnpi],,,cnpi assessment; impression; impression/interpretation of study; impressions; interp; interpretation; nominal; nonverb pain ind; point in time; random; survey; survey.cnpi,Nom
99346-9,temperature taken reporting period,temperature taken rptperiod,,finding; findings; h+p; h+p.hx; ordinal; p prime; ql; qual; qualitative; report period; screen; temp,Ord
99356-8,influenza virus vaccination received in last 12 months,flu vacc last 12mo,,1 year; 12mos; finding; findings; flu vacc last 12mo; fluv; h+p; h+p.hx; immunizations; influ; influenza vacc received; ordinal; p prime; past; ql; qual; qualitative; screen; vaccine,Ord
99387-3,carbon monoxide [moles/volume] in blood,co bld-scnc,carbon monoxide (bld) [moles/vol],blood; chemistry; co; level; point in time; qnt; quan; quant; quantitative; random; substance concentration; wb; whole blood,Qn
99394-9,siderocytes [presence] in blood or marrow by prussian blue stain,siderocytes bld/mar ql prus bl st,siderocytes prussian blue stain ql (bld/bm),bld/mar; blood; bm; bon; bone marrow; hematology/cell counts; mar; marrow (bone); minimal angle of resolution; minimum angle of resolution; ordinal; point in time; pr; prus bl st; ql; qual; qualitative; random; screen; st; stains; stn; wb; whole blood; whole blood or bone marrow,Ord
99397-2,siderocytes.type 2/erythroblasts in blood or marrow by prussian blue stain,siderocytes.tp 2 nfr bld/mar prus bl st,siderocytes.type 2/erythroblasts prussian blue stain (bld/bm),bld/mar; blood; bm; bon; bone marrow; hematology/cell counts; ii; mar; marrow (bone); minimal angle of resolution; minimum angle of resolution; number fraction; percent; point in time; prus bl st; qnt; quan; quant; quantitative; random; siderocytes.tp 2; st; stains; stn; wb; whole blood; whole blood or bone marrow,Qn
99405-3,cells.cd19+fmc7+/cells in blood,cells.cd19+fmc7+ nfr bld,cells.cd19+fmc7+/cells (bld),b cells expressing cd19 as a percent of total lymphocytes; b4; b-4; blood; cd19 cells; cell; cell markers; cellularity; fmc-7; hd-37; leu12; leu-12; number fraction; percent; point in time; qnt; quan; quant; quantitative; random; wb; whole blood,Qn
99410-3,italian cypress igg ab [mass/volume] in serum,italian cypress igg-mcnc,italian cypress igg (s) [mass/vol],abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; funeral cypress; immune globulin g; immunoglobulin g; italian cypress; level; mass concentration; mediterranean cypress; point in time; qnt; quan; quant; quantitative; random; serum; sr; t023; t23,Qn
99421-0,know available choices for treatment plan,,,finding; findings; ordinal; point in time; ql; qual; qualitative; r prime; random; right; screen; survey; survey.r-outcomes; tx,Ord
99427-7,blomia tropicalis igg4 ab [mass/volume] in serum,b tropicalis igg4-mcnc,blomia tropicalis igg4 (s) [mass/vol],abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; b tropicalis; d201; hdm; house dust mite; level; mass concentration; mite; point in time; qnt; quan; quant; quantitative; random; serum; sr,Qn
99433-5,sugar beet seed (beta vulgaris seed) igg4 ab [mass/volume] in serum,sugar beet seed igg4-mcnc,sugar beet seed igg4 (s) [mass/vol],abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; b; f227; level; mass concentration; point in time; qnt; quan; quant; quantitative; random; rf227; rw210; seeds; serum; sr; sugar beet; sugar beet seed; w210,Qn
99465-7,velvet grass igg ab [mass/volume] in serum,velvet grass igg-mcnc,velvet grass igg (s) [mass/vol],abs; aby; allergen; allergens; allergy testing; antby; anti; antibodies; antibody; autoantibodies; autoantibody; g013; g13; immune globulin g; immunoglobulin g; level; mass concentration; point in time; qnt; quan; quant; quantitative; random; serum; sr; velvet grass; yorkshire fog,Qn
99484-8,obstetrics midwife procedure note,ob midwife procedure note,,doc.ont; document; encounter; evaluation and management; evaluation and management note; finding; findings; notes; ob; ob midwife; obstetric; point in time; prenatal; random; visit note,Doc
99494-7,diagnosis type,diagnosis type,,dx; h+p; h+p.hx; nominal; p prime; point in time; random; typ,Nom
99495-4,speed of condition onset,speed of condition onset,,finding; findings; h+p; h+p.hx; nominal; p prime; point in time; random,Nom
99501-9,sex parameter for clinical use,spcu,,admin; admin.patient; admin.pt.demog; gender; nominal; point in time; random; sfcu; spcu; typ,Nom
99509-2,xr hip - left judet internal oblique,xr hip-l judet int obl,,1v; document; ext; extr-l; film; finding; findings; hip-l; imaging; judet int obl; l; le; leg; le-l; lle; low; lower extremity joint; lt; obl; plain films; point in time; radiology; random; single view; vw; xray; x-ray,Doc
9951-5,qrs duration in lead avr,qrs dur l-avr,,cardiac; cardio; cardiology; durat; ecg; ekg.measurements; electrocardiogram; electrocardiograph; heart disease; hrt; painter's colic; pb; plumbism; point in time; qnt; qrs dur l-avr; quan; quant; quantitative; random,Qn
99519-1,volume of gallbladder,volume gb,volume (gallbladder),gall bladder; gb; pathology; point in time; qnt; quan; quant; quantitative; random; vol; volume,Qn
99540-7,stenosis degree [length fraction] in distal left anterior descending artery by autopsy,sten deg lenfr dlad autopsy,stenosis degree autopsy (distal left anterior descending artery) [length fraction],art; coronary segment 8; dlad; l; length fraction; lt; pathology; percent; point in time; qnt; quan; quant; quantitative; random; sten deg,Qn
99547-2,stenosis degree [length fraction] in distal right coronary artery by autopsy,sten deg lenfr drca autopsy,stenosis degree autopsy (distal right coronary artery) [length fraction],art; coronary segment 3; drca; length fraction; pathology; percent; point in time; qnt; quan; quant; quantitative; r; random; rt; sten deg,Qn
99559-7,nothing prevents behavior change,,,exchange; finding; findings; ordinal; point in time; ql; qual; qualitative; r prime; random; replace; right; screen; survey; survey.r-outcomes,Ord
99561-3,change behavior without thinking,,,exchange; finding; findings; ordinal; point in time; ql; qual; qualitative; r prime; random; replace; right; screen; survey; survey.r-outcomes,Ord
99571-2,activities done differently following loss,,,finding; findings; ordinal; point in time; ql; qual; qualitative; r prime; random; right; screen; survey; survey.r-outcomes,Ord
99601-7,beta 2 globulin [mass/volume] in 24 hour urine by electrophoresis,beta2 glob 24h ur elph-mcnc,beta 2 globulin elph (24h u) [mass/vol],1 day; 24 hours; 24hr; b; b2 globulin; beta2 glob; chemistry; elec; elect; electr; electro; electrophhrs; electrophrs; elp; elph; ep; glb; glob; glob%; globul; globulins; ii; level; mass concentration; qnt; quan; quant; quantitative; ua; ur; urn,Qn
99603-3,band form neutrophils/leukocytes in peritoneal fluid by manual count,neuts band nfr prt manual,band form neutrophils/leukocytes manual cnt (periton fld),ascites; ascitic fluid; ascitis; bands; bnd; hematology/cell counts; leuc; leuk; leukocyte; lkcs; manl; n-band; neut; neutr; neutrophil; neuts band; number fraction; percent; peritoneal fluid; pmn; pnm; point in time; prt; qnt; quan; quant; quantitative; random; wbc; wbcs; white blood cell; white blood cells,Qn
99648-8,effectiveness of avoiding airplanes to keep safe from condition of interest,,,disease; disorder; finding; findings; ordinal; point in time; ql; qual; qualitative; random; screen; survey; survey.gnhlth; virus,Ord
9965-5,qrs initial amplitude in lead ii,qrs i-amp l-ii,,2; cardiac; cardio; cardiology; ecg; ekg.measurements; electrical potential; electrocardiogram; electrocardiograph; heart disease; hrt; painter's colic; pb; plumbism; point in time; qnt; qrs i-amp l-ii; quan; quant; quantitative; random; voltage,Qn
99688-4,pacemaker post-ventricular atrial refractory period setting,pacemaker pvarp setting,,"after; cardiac pacemaker; device, heart-assist; point in time; prosthetic; pst; pvarp setting; qnt; quan; quant; quantitative; random",Qn
99693-4,temporary pacemaker ventricular stimulation setting,temp pacemaker ventric stim setting,,"cardiac pacemaker; device, heart-assist; point in time; prosthetic; qnt; quan; quant; quantitative; random; stim; temp pacemaker; ventric stim setting",Qn
99703-1,mr perfusion brain,mr perfusion brain,,brain; cerebral; cerebrum; cranial; cranium; document; finding; findings; head; imaging; intracranial; mitral regurgitation maximum velocity; mr perfusion; mri; pf; point in time; radiology; random; skull,Doc
9970-5,qrs initial amplitude in lead v4,qrs i-amp l-v4,,cardiac; cardio; cardiology; ecg; ekg.measurements; electrical potential; electrocardiogram; electrocardiograph; heart disease; hrt; painter's colic; pb; plumbism; point in time; qnt; qrs i-amp l-v4; quan; quant; quantitative; random; voltage,Qn
99726-2,peritoneal dialysis fluid,peritoneal dialysis fluid,,clin; dialy; fld; nominal; point in time; random; typ,Nom
99736-1,reason for filter change renal replacement therapy circuit,reason for filter change rrt circuit,,clin; exchange; finding; findings; kidney; nominal; point in time; random; replace; rrt circuit,Nom
99757-7,happiness level of having lasik,,,finding; findings; levels; levl; lv; lvl; ordinal; point in time; ql; qual; qualitative; random; screen; survey,Ord
99760-1,reason not to have or recommend lasik,,,finding; findings; ordinal; point in time; ql; qual; qualitative; random; screen; survey,Ord
99770-0,tumor necrosis factor.alpha [mass/volume] in cerebral spinal fluid,a-tumor necrosis fact csf-mcnc,tumor necrosis factor.alpha (csf) [mass/vol],alfa; a-tumor necrosis fact; cachectin; cachectine; cerebral spinal fluid; cerebrospinal fl; chemistry; fac; fact; level; mass concentration; point in time; qnt; quan; quant; quantitative; random; spinal fl; spinal fld; spinal flu; spinal fluid; tnf,Qn
99773-4,sars coronavirus 2 stimulated gamma interferon release by t-cells.spike ag spot count [#] corrected for background in blood,sarscov2 igra spike ct bckgrd cor bld,sars coronavirus 2 stimulated gamma interferon release by t-cells.spike ag spot count corrected for background (bld) [#],2019 novel coronavirus; 2019-ncov; bckgrd cor; blood; cell; cellularity; cnt; corona virus; count; covid19; covid-19; id; ifn; igra; ii; infectious disease; infectiousdisease; microbiology; number; point in time; qnt; quan; quant; quantitative; random; sars coronavirus 1; sars-cov; sars-cov-1; sars-cov-2; sars-cov-2 ifn-g; sars-cov-2 ifn-g t cells; sarscov2 igra spike ct; severe acute respiratory syndrome; t prime; viral pneumonias; wb; whole blood; wuhan coronavirus,Qn
99775-9,leukocytes [#/volume] in peritoneal dialysis fluid by automated count,wbc # diafp auto,wbc auto (perit dial fld) [#/vol],#; abs; absolute; absolutes; auto; automated detection; cnt; count; count/volume; ct; diaf; diafp; dialysate; dialysis fluid; elec; elect; electr; hematology/cell counts; leuc; leuk; leukocyte; lkcs; number concentration; number concentration (count/vol); peritoneal dialysis fluid; point in time; qnt; quan; quant; quantitative; random; wbc; wbcs; white blood cell; white blood cells,Qn
99781-7,adalimumab and adalimumab ab panel - serum or plasma by immunoassay,adalimumab + adalimumab ab pnl serpl ia,adalimumab and adalimumab ab panel ia,adalimumab + adalimumab ab pnl; eia; elfa; elisa; enzyme immunoassay; humira; iaa; meia; pan; panel.serology; panl; pl; plasma; plsm; pnl; point in time; random; serology; serp; serpl; serplas; serum; serum or plasma; sr; suds,-
99793-2,functional communication measure - cognition ages 6 or older score [asha noms],,,point in time; qnt; quan; quant; quantitative; random; scale; slp; survey; survey.slp,Qn
99798-1,"number of household members enrolled in college or trade school, including four-year colleges, community colleges, technical institutes, and vocational schools",,,cnt; count; no; num; number; ordinal; point in time; ql; qual; qualitative; random; screen; survey; survey.gnhlth,Ord
99805-4,number of smartphones used in household use for learning,,,cnt; count; no; num; number; point in time; qnt; quan; quant; quantitative; random; survey; survey.gnhlth,Qn
99809-6,provider of educational activities,,,finding; findings; nominal; point in time; random; survey; survey.gnhlth,Nom
99810-4,number of household members enrolled in middle school or junior high that had school suspended or canceled because of the condition of interest,,,cnt; count; disease; disorder; no; num; number; ordinal; point in time; ql; qual; qualitative; random; screen; survey; virus,Ord
99812-0,number of household members enrolled in high school that have had school suspended or canceled because of the condition of interest,,,cnt; count; disease; disorder; no; num; number; ordinal; point in time; ql; qual; qualitative; random; screen; survey; virus,Ord
9982-0,qrs terminal amplitude in lead v4,qrs t-amp l-v4,,cardiac; cardio; cardiology; ecg; ekg.measurements; electrical potential; electrocardiogram; electrocardiograph; heart disease; hrt; painter's colic; pb; plumbism; point in time; qnt; qrs t-amp l-v4; quan; quant; quantitative; random; voltage,Qn
99830-2,frequency of participating in meaningful short structured conversations in low demand situations,,,finding; findings; ordinal; point in time; ql; qual; qualitative; random; screen; slp; survey; survey.slp,Ord
9983-8,qrs terminal amplitude in lead v5,qrs t-amp l-v5,,cardiac; cardio; cardiology; ecg; ekg.measurements; electrical potential; electrocardiogram; electrocardiograph; heart disease; hrt; painter's colic; pb; plumbism; point in time; qnt; qrs t-amp l-v5; quan; quant; quantitative; random; voltage,Qn
99842-7,frequency of participating in spoken language comprehension communication without assistance,,,finding; findings; ordinal; point in time; ql; qual; qualitative; random; screen; slp; survey; survey.slp,Ord
99861-7,erythrocytes.non-dysmorphic [#/volume] in urine sediment by computer assisted method,non-dys rbc # urns comp assist,rbc.non-dysmorphic computer assisted (urine sed) [#/vol],#; abs; absolute; absolutes; artificial intelligence; automated detection; cnt; comp assist; count; count/volume; ct; discocytes; erthrocyte; erythrocyte; isomorphic rbc; non-dys rbc; nondysmorphic rbc; number concentration; number concentration (count/vol); point in time; qnt; quan; quant; quantitative; random; rbc; rbcs; red blood cell; red blood cells; red blood corpuscle; red blood corpusles; red cell; red cells; ua; ur; urinalysis; urine sediment; urn; urns,Qn
99875-7,deep transitional cells [presence] in urine sediment by computer assisted method,deep trans cells urns ql comp assist,deep transitional cells computer assisted ql (urine sed),artificial intelligence; automated detection; cell; cellularity; comp assist; deep trans cells; ordinal; point in time; pr; ql; qual; qualitative; random; screen; trans cells; ua; ur; urinalysis; urine sediment; urn; urns,Ord
99892-2,microorganism casts [#/area] in urine sediment by computer assisted method,microorganism casts #/area urns ai asst,microorganism casts computer assisted (urine sed) [#/area],#/area; artificial intelligence; automated detection; cast; comp assist; microorg casts; microorganisms; number areic; org; organism; organisms; point in time; qnt; quan; quant; quantitative; random; ua; ur; urinalysis; urine sediment; urn; urns,Qn
99894-8,calcium oxalate monohydrate crystals [presence] in urine sediment by computer assisted method,com cry urns ql comp assist,calcium oxalate monohydrate crystals computer assisted ql (urine sed),artificial intelligence; automated detection; ca; cac2o4; cac2o4.h2o; cal; caox; com cry; comp assist; crys; cryst; crystal; ethanedioate; ethanedioic acid; monohydrt; ordinal; oxal; oxalic acid; point in time; pr; ql; qual; qualitative; random; screen; ua; ur; urinalysis; urine sediment; urn; urns; whewelite; whewellite,Ord
99906-0,urate crystals amorphous [#/area] in urine sediment by computer assisted method,amorph urate cry #/area urns comp assist,urate crystals amorphous computer assisted (urine sed) [#/area],#/area; am; amorph; amorph cry; amorph urate cry; amorphic; artificial intelligence; automated detection; comp assist; crys; cryst; crystal; number areic; point in time; qnt; quan; quant; quantitative; random; ua; ur; urates; uric acid; urinalysis; urine sediment; urn; urns,Qn
99910-2,atypical crystals [#/area] in urine sediment by computer assisted method,atypical crystals #/area urns comp asst,atypical crystals computer assisted (urine sed) [#/area],#/area; artificial intelligence; atyp; atyp crystals; automated detection; comp assist; crys; cryst; crystal; number areic; point in time; qnt; quan; quant; quantitative; random; reactive; ua; ur; urinalysis; urine sediment; urn; urns,Qn
99916-9,cocci bacteria [#/area] in urine sediment by automated count,cocci #/area urns auto,cocci bacteria auto (urine sed) [#/area],#/area; auto; automated detection; bact; elec; elect; electr; number areic; point in time; qnt; quan; quant; quantitative; random; ua; ur; urinalysis; urine sediment; urn; urns,Qn
99928-4,leukocytes [presence] in body fluid by automated,wbc fld ql auto,wbc auto ql (body fld),"auto; automated detection; b/f; bf; bod; bodies; body fluid; body fluid, unsp; elec; elect; electr; fl; fld; flu; fluid; hematology/cell counts; leuc; leuk; leukocyte; lkcs; ordinal; point in time; pr; ql; qual; qualitative; random; screen; wbc; wbcs; white blood cell; white blood cells",Ord
99932-6,bacteria [presence] in body fluid by automated,bacteria fld ql auto,bacteria auto ql (body fld),"auto; automated detection; b/f; bact; bf; bod; bodies; body fluid; body fluid, unsp; elec; elect; electr; fl; fld; flu; fluid; microbiology; ordinal; point in time; pr; ql; qual; qualitative; random; screen",Ord
99943-3,frequency of pain related hospitalizations,freq of pain related hospitalizations,,finding; findings; freq of pain related hospitalizations; h+p; h+p.hx; ordinal; p prime; point in time; ql; qual; qualitative; random; screen,Ord
99954-0,entity city,entity city,,admin; location; nominal; point in time; random,Nom
99955-7,entity country,entity country,,admin; location; nominal; point in time; random,Nom
99964-9,mpl gene exon 10 full mutation analysis in blood or tissue by sequencing,mpl exon 10 full mut anl bld/t seq,mpl gene exon 10 full mutation analysis sequencing doc (bld/tiss),"blood; cd110; c-mpl; document; finding; findings; full gene sequencing; full mut anl; high-throughput sequencing; hts; molecular pathology; molpath; mpl exon 10; mpl proto-oncogene, thrombopoietin receptor; mplv; mut; mutations; myeloproliferative leukemia virus oncogene; next generation sequencing; ngs; point in time; random; sequencing of entire coding region; thcyt2; thrombopoietin receptor mutations; tissue; tissue, unspecified; tpor; wb; whole blood; whole blood or tissue",Doc
99966-4,kit gene exon 17 full mutation analysis in blood or tissue by sequencing,kit exon 17 full mut anl bld/t seq,kit gene exon 17 full mutation analysis sequencing doc (bld/tiss),"blood; cd117; c-kit; document; finding; findings; full gene sequencing; full mut anl; high-throughput sequencing; hts; kit exon 17; mast/stem cell growth factor receptor; molecular pathology; molpath; mut; mutations; next generation sequencing; ngs; pbt; piebald trait; point in time; proto-oncogene tyrosine-protein kinase kit; random; scfr; sequencing of entire coding region; soluble kit variant; tissue; tissue, unspecified; v-kit hardy-zuckerman 4 feline sarcoma viral oncogene; v-kit hardy-zuckerman 4 feline sarcoma viral oncogene homolog; wb; whole blood; whole blood or tissue",Doc
99970-6,hereditary thrombocytopenia multigene analysis in blood or tissue by molecular genetics method,it multigene analysis bld/t,hereditary thrombocytopenia multigene analysis molgen doc (bld/tiss),"blood; document; finding; findings; gene; gene panel; it multigene analysis; molecular genetics; molecular pathology; molpath; multi-gene study; multiple-gene panel test; pcr; point in time; random; tissue; tissue, unspecified; wb; whole blood; whole blood or tissue",Doc
99977-1,no injury related to transfer andor transport during care,,,finding; findings; ordinal; point in time; ql; qual; qualitative; random; screen; survey; survey.pnds; ulcer,Ord
9997-8,r wave axis,r wave axis,,cardiac; cardio; cardiology; ecg; ekg.measurements; electrocardiogram; electrocardiograph; heart disease; hrt; point in time; qnt; quan; quant; quantitative; r prime; random; right,Qn
99986-2,tissue perfusion is maintained at or improved from baseline levels,,,finding; findings; ordinal; pf; point in time; ql; qual; qualitative; random; screen; survey; survey.pnds,Ord
99990-4,endocrine status is maintained at or improved from baseline levels,,,finding; findings; ordinal; point in time; ql; qual; qualitative; random; screen; survey; survey.pnds,Ord
